PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kitamura, A; Nishimoto, M; Sengoku, T; Shibata, R; Jager, G; Bjork, GR; Grosjean, H; Yokoyama, S; Bessho, Y				Kitamura, Aya; Nishimoto, Madoka; Sengoku, Toru; Shibata, Rie; Jager, Gunilla; Bjork, Glenn R.; Grosjean, Henri; Yokoyama, Shigeyuki; Bessho, Yoshitaka			Characterization and Structure of the Aquifex aeolicus Protein DUF752 A BACTERIAL tRNA-METHYLTRANSFERASE (MnmC2) FUNCTIONING WITHOUT THE USUALLY FUSED OXIDASE DOMAIN (MnmC1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL TRANSFER-RNAS; BIFUNCTIONAL ENZYME MNMC; BIOSYNTHESIS; SEQUENCE; GIDA; IDENTIFICATION; TRANSLATION; BIOGENESIS; MODOMICS; INSIGHTS	Post-transcriptional modifications of the wobble uridine (U34) of tRNAs play a critical role in reading NNA/G codons belonging to split codon boxes. In a subset of Escherichia coli tRNA, this wobble uridine is modified to 5-methylaminomethyluridine (mnm(5)U34) through sequential enzymatic reactions. Uridine 34 is first converted to 5-carboxymethylaminomethyluridine (cmnm(5)U34) by the MnmE-Mnm Genzyme complex. The cmnm(5)U34 is further modified to mnm(5)U by the bifunctional MnmC protein. In the first reaction, the FAD-dependent oxidase domain (MnmC1) converts cmnm(5)U into 5-aminomethyluridine (nm(5)U34), and this reaction is immediately followed by the methylation of the free amino group into mnm(5)U34 by the S-adenosylmethionine-dependent domain (MnmC2). Aquifex aeolicus lacks a bifunctional MnmC protein fusion and instead encodes the Rossmann-fold protein DUF752, which is homologous to the methyltransferase MnmC2 domain of Escherichia coli MnmC (26% identity). Here, we determined the crystal structure of the A. aeolicus DUF752 protein at 2.5 angstrom resolution, which revealed that it catalyzes the S-adenosylmethionine-dependent methylation of nm(5)U in vitro, to form mnm(5)U34 in tRNA. We also showed that naturally occurring tRNA from A. aeolicus contains the 5-mnm group attached to the C5 atom of U34. Taken together, these results support the recent proposal of an alternative MnmC1-independent shortcut pathway for producing mnm(5)U34 in tRNAs.	[Nishimoto, Madoka; Sengoku, Toru; Shibata, Rie; Yokoyama, Shigeyuki; Bessho, Yoshitaka] RIKEN Syst & Struct Biol Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Kitamura, Aya; Bessho, Yoshitaka] RIKEN SPring 8 Ctr, Harima Inst, Sayo, Hyogo 6795148, Japan; [Jager, Gunilla; Bjork, Glenn R.] Umea Univ, Dept Mol Biol, S-90187 Umea, Sweden; [Grosjean, Henri] Univ Paris 11, Ctr Genet Mol, UPR 3404, CNRS,FRC 3115, F-91190 Gif Sur Yvette, France; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Struct Biol Lab, Bunkyo Ku, Tokyo 1130033, Japan; [Yokoyama, Shigeyuki] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130033, Japan	RIKEN; RIKEN; Umea University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Tokyo; University of Tokyo	Yokoyama, S (corresponding author), RIKEN Syst & Struct Biol Ctr, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	yokoyama@riken.jp; bessho@spring8.or.jp	Yokoyama, Shigeyuki/N-6911-2015; Bessho, Yoshitaka/K-7702-2012; Sengoku, Toru/E-4304-2013; Björk, Glenn/AAE-8219-2022	Yokoyama, Shigeyuki/0000-0003-3133-7338; Bessho, Yoshitaka/0000-0001-9297-7473; Sengoku, Toru/0000-0001-9461-8714; 	RIKEN Structural Genomics/Proteomics Initiative; National Project on Protein Structural and Functional Analyses; Targeted Proteins Research Program; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Naito Foundation [2011-164]; Swedish Science Research Council [BU-2930]; Carl Tryggers Foundation	RIKEN Structural Genomics/Proteomics Initiative; National Project on Protein Structural and Functional Analyses(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); Swedish Science Research Council; Carl Tryggers Foundation	This work was supported in part by the RIKEN Structural Genomics/Proteomics Initiative, the National Project on Protein Structural and Functional Analyses, the Targeted Proteins Research Program, the X-ray Free Electron Laser Priority Strategy Program from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Naito Foundation Grant 2011-164 (to Y.B.), Swedish Science Research Council Project Grant BU-2930, and the Carl Tryggers Foundation (to G.R.B.).	Agris PF, 2008, EMBO REP, V9, P629, DOI 10.1038/embor.2008.104; ANDACHI Y, 1989, J MOL BIOL, V209, P37, DOI 10.1016/0022-2836(89)90168-X; Armengod ME, 2012, BIOCHIMIE, V94, P1510, DOI 10.1016/j.biochi.2012.02.019; Awai T, 2011, J BIOL CHEM, V286, P35236, DOI 10.1074/jbc.M111.253641; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barbe V, 2009, MICROBIOL-SGM, V155, P1758, DOI 10.1099/mic.0.027839-0; Bessho Y., 2009, DNA RNA MODIFICATION, P409; Bjork GR, 2005, ECOSAL ESCHERICHIA C; Bujnicki JM, 2004, RNA, V10, P1236, DOI 10.1261/rna.7470904; Chen P, 2005, EMBO J, V24, P1842, DOI 10.1038/sj.emboj.7600666; Constantinesco F, 1999, J MOL BIOL, V291, P375, DOI 10.1006/jmbi.1999.2976; Czerwoniec A, 2009, NUCLEIC ACIDS RES, V37, pD118, DOI 10.1093/nar/gkn710; de Crecy-Lagard V, 2007, IUBMB LIFE, V59, P634, DOI 10.1080/15216540701604632; EDQVIST J, 1992, NUCLEIC ACIDS RES, V20, P6575, DOI 10.1093/nar/20.24.6575; ELLIS SR, 1986, J BIOL CHEM, V261, P9703; ELSEVIERS D, 1984, NUCLEIC ACIDS RES, V12, P3521, DOI 10.1093/nar/12.8.3521; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GEHRKE CW, 1989, J CHROMATOGR, V471, P3, DOI 10.1016/S0021-9673(00)94152-9; GEHRKE CW, 1982, J CHROMATOGR, V230, P297, DOI 10.1016/S0378-4347(00)80479-X; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grosjean H., 2009, DNA RNA MODIFICATION, P1; Grosjean H, 2010, FEBS LETT, V584, P252, DOI 10.1016/j.febslet.2009.11.052; HAGERVALL TG, 1987, J BIOL CHEM, V262, P8488; Ihsanawati, 2008, J MOL BIOL, V383, P871, DOI 10.1016/j.jmb.2008.08.068; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kitamura A, 2011, PROTEIN SCI, V20, P1105, DOI 10.1002/pro.659; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; KOWALAK JA, 1994, BIOCHEMISTRY-US, V33, P7869, DOI 10.1021/bi00191a014; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Meyer S, 2009, J MOL BIOL, V392, P910, DOI 10.1016/j.jmb.2009.07.004; Moukadiri I, 2009, NUCLEIC ACIDS RES, V37, P7177, DOI 10.1093/nar/gkp762; Newby ZER, 2002, P NATL ACAD SCI USA, V99, P7922, DOI 10.1073/pnas.122231499; Osawa T, 2009, STRUCTURE, V17, P713, DOI 10.1016/j.str.2009.03.013; Pearson D, 2011, NUCLEIC ACIDS RES, V39, P4818, DOI 10.1093/nar/gkr071; REINHART MP, 1986, NUCLEIC ACIDS RES, V14, P1131, DOI 10.1093/nar/14.3.1131; Roovers M, 2008, PROTEINS, V71, P2076, DOI 10.1002/prot.21918; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Schubert HL, 2003, BIOCHEMISTRY-US, V42, P5592, DOI 10.1021/bi034026p; Shi R, 2009, J BACTERIOL, V191, P7614, DOI 10.1128/JB.00650-09; Shigi N, 2006, J BIOL CHEM, V281, P14296, DOI 10.1074/jbc.M511675200; Suzuki T, 2002, EMBO J, V21, P6581, DOI 10.1093/emboj/cdf656; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Takeda Hiroshi, 2002, Nucleic Acids Res Suppl, P229; TAYA Y, 1973, BIOCHEM BIOPH RES CO, V51, P1062, DOI 10.1016/0006-291X(73)90035-1; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Tucker J, 1996, BIOCHEM J, V317, P891, DOI 10.1042/bj3170891; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Urbonavicius J, 2007, METHOD ENZYMOL, V425, P103; WATANABE K, 1974, FEBS LETT, V43, P59, DOI 10.1016/0014-5793(74)81105-1; Watanabe K, 2010, P JPN ACAD B-PHYS, V86, P11, DOI 10.2183/pjab.86.11; YAMADA Y, 1981, NUCLEIC ACIDS RES, V9, P1933, DOI 10.1093/nar/9.8.1933; Yim L, 2006, NUCLEIC ACIDS RES, V34, P5892, DOI 10.1093/nar/gkl752	52	9	9	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43950	43960		10.1074/jbc.M112.409300	http://dx.doi.org/10.1074/jbc.M112.409300			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23091054	Green Published, hybrid			2022-12-25	WOS:000312940800070
J	Gao, JL; Lu, YL; Browne, G; Yap, BCM; Trewhella, J; Hunter, N; Nguyen, KA				Gao, Jin-Long; Lu, Yanling; Browne, Gina; Yap, Benjamin C. -M.; Trewhella, Jill; Hunter, Neil; Ky-Anh Nguyen			The Role of Heme Binding by DNA-protective Protein from Starved Cells (Dps) in the Tolerance of Porphyromonas gingivalis to Heme Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTATHIONINE BETA-SYNTHASE; GRAM-NEGATIVE BACTERIA; HYDROGEN-PEROXIDE; THIOLATE LIGATION; BIOLOGICAL MACROMOLECULES; STAPHYLOCOCCUS-AUREUS; STRESS RESISTANCE; ESCHERICHIA-COLI; IRON; GENE	The widely expressed DNA-protective protein from starved-cells (Dps) family proteins are considered major contributors to prokaryotic resistance to stress. We show here that Porphyromonas gingivalis Dps (PgDps), previously described as an iron-storage and DNA-binding protein, also mediates heme sequestration. We determined that heme binds strongly to PgDps with an apparent K-d of 3.7 x 10(-8) M and is coordinated by a single surface-located cysteine at the fifth axial ligand position. Heme and iron sequestered in separate sites by PgDps provide protection of DNA from H2O2-mediated free radical damage and were found to be important for growth of P. gingivalis under excess heme as the only iron source. Conservation of the heme-coordinating cysteine among Dps isoforms from the Bacteroidales order suggests that this function may be a common feature within these anaerobic bacteria.	[Gao, Jin-Long; Hunter, Neil; Ky-Anh Nguyen] Univ Sydney, Fac Dent, Sydney, NSW 2006, Australia; [Lu, Yanling; Trewhella, Jill] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Gao, Jin-Long; Browne, Gina; Yap, Benjamin C. -M.; Hunter, Neil; Ky-Anh Nguyen] Westmead Hosp, Westmead Millennium Inst, Inst Dent Res, Westmead, NSW 2145, Australia; [Gao, Jin-Long; Browne, Gina; Yap, Benjamin C. -M.; Hunter, Neil; Ky-Anh Nguyen] Westmead Hosp, Westmead Ctr Oral Hlth, Westmead, NSW 2145, Australia	University of Sydney; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Sydney	Nguyen, KA (corresponding author), Inst Dent Res, POB 533, Wentworthville, NSW 2145, Australia.	kyanhn@gmail.com	; Nguyen, Ky-Anh/A-4971-2010	Trewhella, Jill/0000-0002-8555-6766; Nguyen, Ky-Anh/0000-0002-1643-6576; Gao, Jinlong/0000-0002-5153-5393	National Institutes of Health [DE 09761]; Australian Research Council [LP0562660]; Ramaciotti Foundation, Australia [RN38/08]; Bela Schwartz Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE009761] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian Research Council(Australian Research Council); Ramaciotti Foundation, Australia; Bela Schwartz Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE 09761 (to Jan Potempa and subcontracted to K.-A.N.). This work was also supported in part by Grant LP0562660 from the Australian Research Council (to N. H.) and Establishment Grant RN38/08 from the Ramaciotti Foundation, Australia (to K.-A.N.).; Recipient of fellowship support from The Bela Schwartz Foundation.	AFT RL, 1983, J BIOL CHEM, V258, P2069; ANDREWS SC, 1995, J BIOL CHEM, V270, P23268, DOI 10.1074/jbc.270.40.23268; Anzaldi LL, 2010, INFECT IMMUN, V78, P4977, DOI 10.1128/IAI.00613-10; Asher C, 2009, INORG CHEM, V48, P7994, DOI 10.1021/ic900647y; Bagshaw C. R., 1987, SPECTROPHOTOMETRY SP, P91; Barnard JP, 1999, INFECT IMMUN, V67, P6558; BULLEN JJ, 1981, REV INFECT DIS, V3, P1127; Calhoun LN, 2011, J APPL MICROBIOL, V110, P375, DOI 10.1111/j.1365-2672.2010.04890.x; Carrondo MA, 2003, EMBO J, V22, P1959, DOI 10.1093/emboj/cdg215; Ceci P, 2003, J BIOL CHEM, V278, P20319, DOI 10.1074/jbc.M302114200; Chapple ILC, 1996, J CLIN PATHOL-CL MOL, V49, pM247; Chiancone E, 2010, BBA-GEN SUBJECTS, V1800, P798, DOI 10.1016/j.bbagen.2010.01.013; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Chowdhury RP, 2008, BIOCHEMISTRY-US, V47, P11110, DOI 10.1021/bi801158e; Dashper SG, 2000, J BACTERIOL, V182, P6456, DOI 10.1128/JB.182.22.6456-6462.2000; Dashper SG, 2009, J BACTERIOL, V191, P1044, DOI 10.1128/JB.01270-08; de Villiers KA, 2007, J BIOL INORG CHEM, V12, P101, DOI 10.1007/s00775-006-0170-1; Ezzo PJ, 2003, PERIODONTOL 2000, V32, P24, DOI 10.1046/j.0906-6713.2003.03203.x; FLETCHER HM, 1995, INFECT IMMUN, V63, P1521, DOI 10.1128/IAI.63.4.1521-1528.1995; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gao JL, 2010, J BIOL CHEM, V285, P40028, DOI 10.1074/jbc.M110.163535; Gibson FC, 2004, CIRCULATION, V109, P2801, DOI 10.1161/01.CIR.0000129769.17895.F0; Haikarainen T, 2010, CELL MOL LIFE SCI, V67, P341, DOI 10.1007/s00018-009-0168-2; Huang TJ, 2001, ANTIOXID REDOX SIGN, V3, P685, DOI 10.1089/15230860152543023; Ishikawa T, 2003, J BACTERIOL, V185, P1010, DOI 10.1128/JB.185.3.1010-1017.2003; Jeffries CM, 2008, J MOL BIOL, V377, P1186, DOI 10.1016/j.jmb.2008.01.080; Jeffries CM, 2011, J MOL BIOL, V414, P735, DOI 10.1016/j.jmb.2011.10.029; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KERY V, 1994, J BIOL CHEM, V269, P25283; Knight DA, 2008, POLYHEDRON, V27, P1795, DOI 10.1016/j.poly.2008.02.013; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; LADAN H, 1993, FEMS MICROBIOL LETT, V112, P173; Lewis JP, 2006, MICROBIOL-SGM, V152, P3367, DOI 10.1099/mic.0.29011-0; Lewis JP, 2010, PERIODONTOL 2000, V52, P94, DOI 10.1111/j.1600-0757.2009.00329.x; Liu XF, 2006, J BIOL CHEM, V281, P27827, DOI 10.1074/jbc.M601398200; LU Y, 1993, P NATL ACAD SCI USA, V90, P11456, DOI 10.1073/pnas.90.24.11456; Lynch MC, 1999, INFECT IMMUN, V67, P3367, DOI 10.1128/IAI.67.7.3367-3375.1999; Meier M, 2001, EMBO J, V20, P3910, DOI 10.1093/emboj/20.15.3910; Nguyen KA, 2009, MICROBIOL-SGM, V155, P328, DOI 10.1099/mic.0.024323-0; NIKOLICH MP, 1992, ANTIMICROB AGENTS CH, V36, P1005, DOI 10.1128/AAC.36.5.1005; NITZAN Y, 1994, CURR MICROBIOL, V29, P125, DOI 10.1007/BF01570752; Omura T, 2005, BIOCHEM BIOPH RES CO, V338, P404, DOI 10.1016/j.bbrc.2005.08.267; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; PENA MMO, 1995, J BIOL CHEM, V270, P22478, DOI 10.1074/jbc.270.38.22478; Perera R, 2003, P NATL ACAD SCI USA, V100, P3641, DOI 10.1073/pnas.0737142100; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Ratliff M, 2001, J BACTERIOL, V183, P6394, DOI 10.1128/JB.183.21.6394-6403.2001; RIVERA M, 1995, ANAL BIOCHEM, V230, P295, DOI 10.1006/abio.1995.1477; Roper JM, 2000, J BIOL CHEM, V275, P40316, DOI 10.1074/jbc.M007146200; RUF HH, 1979, J INORG BIOCHEM, V11, P189, DOI 10.1016/S0162-0134(00)80017-3; Seymour GJ, 2007, CLIN MICROBIOL INFEC, V13, P3, DOI 10.1111/j.1469-0691.2007.01798.x; Shepherd M, 2007, BIOCHEMISTRY-US, V46, P5030, DOI 10.1021/bi700183u; Sigman JA, 1999, BIOCHEMISTRY-US, V38, P11122, DOI 10.1021/bi990815o; Simpson W, 2000, J BACTERIOL, V182, P5737, DOI 10.1128/JB.182.20.5737-5748.2000; Skaar EP, 2004, J BIOL CHEM, V279, P436, DOI 10.1074/jbc.M307952200; Slakeski N, 2000, ORAL MICROBIOL IMMUN, V15, P388, DOI 10.1034/j.1399-302x.2000.150609.x; Smalley JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017182; Smith JL, 2004, CRIT REV MICROBIOL, V30, P173, DOI 10.1080/10408410490435151; SONO M, 1985, INORG CHEM, V24, P4339, DOI 10.1021/ic00219a028; Su MH, 2005, BIOCHEMISTRY-US, V44, P5572, DOI 10.1021/bi0472705; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svistunenko DA, 2005, BBA-BIOENERGETICS, V1707, P127, DOI 10.1016/j.bbabio.2005.01.004; Ueshima J, 2003, INFECT IMMUN, V71, P1170, DOI 10.1128/IAI.71.3.1170-1178.2003; Wegner N, 2010, ARTHRITIS RHEUM-US, V62, P2662, DOI 10.1002/art.27552; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x; Zhu WM, 2000, J BACTERIOL, V182, P6783, DOI 10.1128/JB.182.23.6783-6790.2000	67	15	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42243	42258		10.1074/jbc.M112.392787	http://dx.doi.org/10.1074/jbc.M112.392787			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086936	Green Published, hybrid			2022-12-25	WOS:000312103000060
J	Oeemig, JS; Lynggaard, C; Knudsen, DH; Hansen, FT; Norgaard, KD; Schneider, T; Vad, BS; Sandvang, DH; Nielsen, LA; Neve, S; Kristensen, HH; Sahl, HG; Otzen, DE; Wimmer, R				Oeemig, Jesper S.; Lynggaard, Carina; Knudsen, Daniel H.; Hansen, Frederik T.; Norgaard, Kent D.; Schneider, Tanja; Vad, Brian S.; Sandvang, Dorthe H.; Nielsen, Line A.; Neve, Soren; Kristensen, Hans-Henrik; Sahl, Hans-Georg; Otzen, Daniel E.; Wimmer, Reinhard			Eurocin, a New Fungal Defensin STRUCTURE, LIPID BINDING, AND ITS MODE OF ACTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDES; ARTHROPOD DEFENSIN; PROTEIN STRUCTURES; ANTIBACTERIAL; CATHELICIDINS; CONFORMATION; LEUKOCYTES; INHIBITION; PLECTASIN; MECHANISM	Antimicrobial peptides are a new class of antibiotics that are promising for pharmaceutical applications because they have retained efficacy throughout evolution. One class of antimicrobial peptides are the defensins, which have been found in different species. Here we describe a new fungal defensin, eurocin. Eurocin acts against a range of Gram-positive human pathogens but not against Gram-negative bacteria. Eurocin consists of 42 amino acids, forming a cysteine-stabilized alpha/beta-fold. The thermal denaturation data point shows the disulfide bridges being responsible for the stability of the fold. Eurocin does not form pores in cell membranes at physiologically relevant concentrations; it does, however, lead to limited leakage of a fluorophore from small unilamellar vesicles. Eurocin interacts with detergent micelles, and it inhibits the synthesis of cell walls by binding equimolarly to the cell wall precursor lipid II.	[Oeemig, Jesper S.; Lynggaard, Carina; Knudsen, Daniel H.; Hansen, Frederik T.; Norgaard, Kent D.; Wimmer, Reinhard] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, DK-9000 Aalborg, Denmark; [Schneider, Tanja; Sahl, Hans-Georg] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, Pharmaceut Microbiol Sect, D-53115 Bonn, Germany; [Vad, Brian S.; Otzen, Daniel E.] Univ Aarhus, Dept Mol Biol, Interdisciplinary Nanosci Ctr iNANO, DK-8000 Aarhus C, Denmark; [Sandvang, Dorthe H.; Nielsen, Line A.; Neve, Soren; Kristensen, Hans-Henrik] Novozymes AS, DK-2880 Bagsvaerd, Denmark	Aalborg University; University of Bonn; Aarhus University; Novozymes	Wimmer, R (corresponding author), Aalborg Univ, Dept Biotechnol Chem & Environm Engn, Sohngaardsholmsvej 49, DK-9000 Aalborg, Denmark.	rw@bio.aau.dk	Schneider, Tanja/L-8049-2013; Wimmer, Reinhard/M-2346-2019; Wimmer, Reinhard/A-7901-2012	Wimmer, Reinhard/0000-0001-6942-5056; Otzen, Daniel/0000-0002-2918-8989; Teilfeldt Hansen, Frederik/0000-0003-2500-2072; Schneider, Tanja/0000-0001-7269-4716	Obel Foundation; SparNord Foundation; Lundbeck Foundation; Danish Research Foundation	Obel Foundation; SparNord Foundation; Lundbeck Foundation(Lundbeckfonden); Danish Research Foundation	This work was supported by the Obel and SparNord Foundations.; Supported by the Lundbeck Foundation and the Danish Research Foundation.	Brotz H, 1998, ANTIMICROB AGENTS CH, V42, P154, DOI 10.1128/AAC.42.1.154; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; CORNET B, 1995, STRUCTURE, V3, P435, DOI 10.1016/S0969-2126(01)00177-0; Da Silva P, 2003, PROTEIN SCI, V12, P438, DOI 10.1110/ps.0228303; de Leeuw E, 2010, FEBS LETT, V584, P1543, DOI 10.1016/j.febslet.2010.03.004; De Smet K, 2005, BIOTECHNOL LETT, V27, P1337, DOI 10.1007/s10529-005-0936-5; Delepierre M, 1999, BIOCHEMISTRY-US, V38, P16756, DOI 10.1021/bi991685m; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ganz T, 2003, NAT REV IMMUNOL, V3, P710, DOI 10.1038/nri1180; Garcia-Olmedo F, 1998, BIOPOLYMERS, V47, P479, DOI 10.1002/(SICI)1097-0282(1998)47:6<479::AID-BIP6>3.0.CO;2-K; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; Gueguen Y, 2006, J BIOL CHEM, V281, P313, DOI 10.1074/jbc.M510850200; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T; Guntert P, 1998, J BIOMOL NMR, V12, P543, DOI 10.1023/A:1008391403193; Hancock RD, 2001, COORDIN CHEM REV, V212, P1, DOI 10.1016/S0010-8545(00)00418-5; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; HANZAWA H, 1990, FEBS LETT, V269, P413, DOI 10.1016/0014-5793(90)81206-4; Hubert F, 1996, EUR J BIOCHEM, V240, P302, DOI 10.1111/j.1432-1033.1996.0302h.x; Izadpanah A, 2005, J AM ACAD DERMATOL, V52, P381, DOI 10.1016/j.jaad.2004.08.026; Jing W, 2003, J PEPT RES, V61, P219, DOI 10.1034/j.1399-3011.2003.00050.x; Katsu T, 2007, ANAL SCI, V23, P517, DOI 10.2116/analsci.23.517; Keller R., 2004, COMPUTER AIDED RESON, V1; KOHLRAUSCH U, 1991, J BACTERIOL, V173, P3425, DOI 10.1128/jb.173.11.3425-3431.1991; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Krzeminski M, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-51; Lamberty M, 2001, BIOCHEMISTRY-US, V40, P11995, DOI 10.1021/bi0103563; Landon C, 1997, PROTEIN SCI, V6, P1878, DOI 10.1002/pro.5560060908; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lehrer RI, 2004, NAT REV MICROBIOL, V2, P727, DOI 10.1038/nrmicro976; Lowenberger C, 2001, INSECT BIOCHEM MOLEC, V31, P219, DOI 10.1016/S0965-1748(00)00141-7; Melo FR, 2002, PROTEINS, V48, P311, DOI 10.1002/prot.10142; MENDEZ E, 1990, EUR J BIOCHEM, V194, P533, DOI 10.1111/j.1432-1033.1990.tb15649.x; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; Nygaard MKE, 2012, J BIOMOL NMR, V52, P277, DOI 10.1007/s10858-012-9608-7; Pal D, 1999, J MOL BIOL, V294, P271, DOI 10.1006/jmbi.1999.3217; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; Pelegrini PB, 2005, INT J BIOCHEM CELL B, V37, P2239, DOI 10.1016/j.biocel.2005.06.011; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Popplewell JF, 2007, BBA-BIOMEMBRANES, V1768, P13, DOI 10.1016/j.bbamem.2006.05.016; REYNOLDS PE, 1989, EUR J CLIN MICROBIOL, V8, P943, DOI 10.1007/BF01967563; Sass V, 2010, INFECT IMMUN, V78, P2793, DOI 10.1128/IAI.00688-09; Savarin P, 1999, PROTEIN SCI, V8, P2672; Sawai MV, 2002, PROTEIN ENG, V15, P225, DOI 10.1093/protein/15.3.225; Schneider T, 2004, MOL MICROBIOL, V53, P675, DOI 10.1111/j.1365-2958.2004.04149.x; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Seo JK, 2005, BIOCHEM BIOPH RES CO, V338, P1998, DOI 10.1016/j.bbrc.2005.11.013; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shenkarev ZO, 2006, FEBS J, V273, P2658, DOI 10.1111/j.1742-4658.2006.05282.x; STAFFORD RE, 1989, BIOCHEMISTRY-US, V28, P5113, DOI 10.1021/bi00438a031; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang YQ, 1999, SCIENCE, V286, P498, DOI 10.1126/science.286.5439.498; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Todd SM, 2007, MED VET ENTOMOL, V21, P141, DOI 10.1111/j.1365-2915.2007.00682.x; Tran D, 2002, J BIOL CHEM, V277, P3079, DOI 10.1074/jbc.M109117200; Vad B, 2010, BBA-PROTEINS PROTEOM, V1804, P806, DOI 10.1016/j.bbapap.2009.12.006; van Heijenoort J, 2007, MICROBIOL MOL BIOL R, V71, P620, DOI 10.1128/MMBR.00016-07; Willey JM, 2007, ANNU REV MICROBIOL, V61, P477, DOI 10.1146/annurev.micro.61.080706.093501; WIMLEY WC, 1994, PROTEIN SCI, V3, P1362, DOI 10.1002/pro.5560030902; Wimmer R, 2006, BIOCHEMISTRY-US, V45, P481, DOI 10.1021/bi051876r; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yang YS, 2000, BIOCHEMISTRY-US, V39, P14436, DOI 10.1021/bi0011835; ZANETTI M, 1995, FEBS LETT, V374, P1, DOI 10.1016/0014-5793(95)01050-O; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhu S., 2012, P NATL ACAD SCI USA, V109, P1; Zhu SY, 2008, MOL IMMUNOL, V45, P828, DOI 10.1016/j.molimm.2007.06.354	68	64	66	0	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42361	42372		10.1074/jbc.M112.382028	http://dx.doi.org/10.1074/jbc.M112.382028			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23093408	hybrid, Green Published			2022-12-25	WOS:000312103000071
J	Fuller, C; Michie, S; Savage, J; McAteer, J; Besser, S; Charlett, A; Hayward, A; Cookson, BD; Cooper, BS; Duckworth, G; Jeanes, A; Roberts, J; Teare, L; Stone, S				Fuller, Christopher; Michie, Susan; Savage, Joanne; McAteer, John; Besser, Sarah; Charlett, Andre; Hayward, Andrew; Cookson, Barry D.; Cooper, Ben S.; Duckworth, Georgia; Jeanes, Annette; Roberts, Jenny; Teare, Louise; Stone, Sheldon			The Feedback Intervention Trial (FIT)-Improving Hand-Hygiene Compliance in UK Healthcare Workers: A Stepped Wedge Cluster Randomised Controlled Trial	PLOS ONE			English	Article							BEHAVIOR; STAFF; RISK	Introduction: Achieving a sustained improvement in hand-hygiene compliance is the WHO's first global patient safety challenge. There is no RCT evidence showing how to do this. Systematic reviews suggest feedback is most effective and call for long term well designed RCTs, applying behavioural theory to intervention design to optimise effectiveness. Methods: Three year stepped wedge cluster RCT of a feedback intervention testing hypothesis that the intervention was more effective than routine practice in 16 English/Welsh Hospitals (16 Intensive Therapy Units [ITU]; 44 Acute Care of the Elderly [ACE] wards) routinely implementing a national cleanyourhands campaign). Intervention-based on Goal & Control theories. Repeating 4 week cycle (20 mins/week) of observation, feedback and personalised action planning, recorded on forms. Computer-generated stepwise entry of all hospitals to intervention. Hospitals aware only of own allocation. Primary outcome: direct blinded hand hygiene compliance (%). Results: All 16 trusts (60 wards) randomised, 33 wards implemented intervention (11 ITU, 22 ACE). Mixed effects regression analysis (all wards) accounting for confounders, temporal trends, ward type and fidelity to intervention (forms/month used). Intention to Treat Analysis: Estimated odds ratio (OR) for hand hygiene compliance rose post randomisation (1.44; 95% CI 1.18, 1.76; p<0.001) in ITUs but not ACE wards, equivalent to 7-9% absolute increase in compliance. Per-Protocol Analysis for Implementing Wards: OR for compliance rose for both ACE (1.67 [1.28-2.22]; p<0.001) & ITUs (2.09 [1.55-2.81]; p<0.001) equating to absolute increases of 10-13% and 13-18% respectively. Fidelity to intervention closely related to compliance on ITUs (OR 1.12 [1.04, 1.20];p = 0.003 per completed form) but not ACE wards. Conclusion: Despite difficulties in implementation, intention-to-treat, per-protocol and fidelity to intervention, analyses showed an intervention coupling feedback to personalised action planning produced moderate but significant sustained improvements in hand-hygiene compliance, in wards implementing a national hand-hygiene campaign. Further implementation studies are needed to maximise the intervention's effect in different settings.	[Fuller, Christopher; Savage, Joanne; Besser, Sarah; Hayward, Andrew; Stone, Sheldon] UCL, Sch Med, London, England; [Charlett, Andre; Cookson, Barry D.; Cooper, Ben S.; Duckworth, Georgia] Hlth Protect Agcy, London, England; [Jeanes, Annette] Univ Coll London Hosp, London, England; [Roberts, Jenny] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Teare, Louise] Mid Essex NHS Trust, Chelmsford, Essex, England	University of London; University College London; UCL Medical School; Health Protection Agency; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Stone, S (corresponding author), UCL, Sch Med, Royal Free Campus, London, England.	s.stone@medsch.ucl.ac.uk	Cooper, Ben/HGC-7082-2022; Jeanes, Annette/L-6927-2019; Hayward, Andrew C/C-3268-2013; Michie, Susan/A-1745-2010	Hayward, Andrew C/0000-0002-3549-6232; Besser, Sarah Jane/0000-0003-3252-9665; Cooper, Ben/0000-0002-9445-7217; Michie, Susan/0000-0003-0063-6378	Patient Safety Research Programme [PS/029]; Trustees of the Royal Free; GOJO industries	Patient Safety Research Programme; Trustees of the Royal Free; GOJO industries	This work was supported by the Patient Safety Research Programme (PS/029), http://www.publichealth.bham.ac.uk/psrp; Trustees of the Royal Free, http://royalfreecharity.org; and GOJO industries, www.gojo.com (who provided an educational grant). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown C.A., 2006, BMC MED RES METHODOL, V6, P54, DOI DOI 10.1186/1471-2288-6-54; Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694; Carver CS, 2000, HDB SELF REGULATION; Curtis V, 2003, LANCET INFECT DIS, V3, P275, DOI 10.1016/S1473-3099(03)00606-6; DUBBERT PM, 1990, INFECT CONT HOSP EP, V11, P191; Erasmus V, 2010, INFECT CONT HOSP EP, V31, P283, DOI 10.1086/650451; Feiveson AH, 2002, STATA J, V2, P107, DOI 10.1177/1536867X0200200201; Fuller C, 2010, AM J INFECT CONTROL, V38, P332, DOI 10.1016/j.ajic.2009.10.005; Gardner B, 2010, SOC SCI MED, V70, P1618, DOI 10.1016/j.socscimed.2010.01.039; Glanz K, 2010, ANNU REV PUBL HEALTH, V31, P399, DOI 10.1146/annurev.publhealth.012809.103604; Gould DJ, 2008, J HOSP INFECT, V68, P193, DOI 10.1016/j.jhin.2007.11.013; Grimshaw JM, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8060; Hugonnet S, 2002, ARCH INTERN MED, V162, P1037, DOI 10.1001/archinte.162.9.1037; Hussain M, 1996, J HOSP INFECT, V32, P117, DOI 10.1016/S0195-6701(96)90053-5; Jamtvedt G, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000259.pub2; Magiorakos AP, 2010, EUROSURVEILLANCE, V15; MAYER JA, 1986, INFECT CONT HOSP EP, V7, P259, DOI 10.1017/S0195941700064171; McAteer J, 2008, J HOSP INFECT, V68, P222, DOI 10.1016/j.jhin.2007.12.009; MCATEER J, 2006, J HOSP INFECT S1, V64, pS53; McAteer J, 2010, THESIS U COLL LONDON; Michie S, 2005, QUAL SAF HEALTH CARE, V14, P26, DOI 10.1136/qshc.2004.011155; Michie S, 2008, APPL PSYCHOL-INT REV, V57, P660, DOI 10.1111/j.1464-0597.2008.00341.x; Naikoba S, 2001, J HOSP INFECT, V47, P173, DOI 10.1053/jhin.2000.0882; National Patient Safety Agency, 2004, ACH OUR AIMS EV RES; National Patient Safety Agency, 2004, READ STEAD GO FULL G; Nosocomial Infection National Surveillance Service, 2002, SURV HOSP ACQ BACT E; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pratt R. J., 2001, Journal of Hospital Infection, V47, pS1; RAJU TNK, 1991, AM J MED SCI, V302, P355, DOI 10.1097/00000441-199112000-00006; Salemi C, 2002, INFECT CONT HOSP EP, V23, P32, DOI 10.1086/501965; Skinner B. F., 1953, SCI HUMAN BEHAV; Stone S, 2001, LANCET, V357, P479, DOI 10.1016/S0140-6736(05)71288-5; Stone S, 2012, REPORT PATIENT SAFET; Stone SP, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3005; The Joint commission, 2009, MEAS HAND HYG ADH OV; Tibballs J, 1996, MED J AUSTRALIA, V164, P395, DOI 10.5694/j.1326-5377.1996.tb122084.x; van de Mortel T, 2000, Aust Crit Care, V13, P91, DOI 10.1016/S1036-7314(00)70630-8; WHO, 2009, PAT SAF WORLD ALL SA; World Health Organisation, 2010, INCR ACH	41	106	110	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e41617	10.1371/journal.pone.0041617	http://dx.doi.org/10.1371/journal.pone.0041617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110040	Green Published, gold			2022-12-25	WOS:000310193600001
J	Stritih, N; Cokl, A				Stritih, Natasa; Cokl, Andrej			Mating Behaviour and Vibratory Signalling in Non-Hearing Cave Crickets Reflect Primitive Communication of Ensifera	PLOS ONE			English	Article							COMPLEX TIBIAL ORGAN; TROGLOPHILUS-NEGLECTUS; EVOLUTIONARY ORIGIN; FEMALE PREFERENCE; NEZARA-VIRIDULA; COURTSHIP SONG; ORTHOPTERA; NEUROANATOMY; PHYSIOLOGY; GRYLLACRIDIDAE	In Ensifera, the lack of well-supported phylogeny and the focus on acoustic communication of the terminal taxa hinders understanding of the evolutionary history of their signalling behaviour and the related sensory structures. For Rhaphidophoridae, the most relic of ensiferans following morphology-based phylogenies, the signalling modes are still unknown. Together with a detailed description of their mating process, we provide evidence on vibratory signalling for the sympatric European species Troglophilus neglectus and T. cavicola. Despite their temporal shift in reproduction, the species' behaviours differ significantly. Signalling by abdominal vibration constitutes an obligatory part of courtship in T. neglectus, while it is absent in T. cavicola. Whole-body vibration is expressed after copulation in both species. While courtship signalling appears to stimulate females for mating, the function of post-copulation signals remains unclear. Mating and signalling of both species were found to take place in most cases on bark, and less frequently on other available substrates, like moss and rock. The signals' frequency spectra were substrate dependent, but with the dominant peak always expressed below 120 Hz. On rock, the intensity of T. neglectus courtship signals was below the species' physiological detection range, presumably constraining the evolution of such signalling in caves. The species' behavioural divergence appears to reflect their divergent mating habitats, in and outside caves. We propose that short-range tremulation signalling in courtship, such as is expressed by T. neglectus, represents the primitive mode and context of mechanical signalling in Ensifera. The absence of high-frequency components in the signals may be related to the absence of the crista acoustica homologue (CAH) in the vibratory tibial organ of Rhaphidophoridae. This indirectly supports the hypothesis proposing that the CAH, as an evolutionary precursor of the ear, evolved in Ensifera along the (more) complex vibratory communication, also associated with signals of higher carrier frequency.	[Stritih, Natasa; Cokl, Andrej] Natl Inst Biol, Dept Entomol, Ljubljana, Slovenia	National Institute of Biology - Slovenia	Stritih, N (corresponding author), Natl Inst Biol, Dept Entomol, Ljubljana, Slovenia.	natasa.stritih@nib.si	Peljhan, Natasa Stritih/M-5369-2019		Slovenian Research Agency [J1-0823-0105, P1-0255-0105]	Slovenian Research Agency(Slovenian Research Agency - Slovenia)	The work was funded by the Slovenian Research Agency (project J1-0823-0105 and program P1-0255-0105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RD, 1967, U MICHIGAN MISCELLAN; Bailey W.J., 1991, ACOUSTIC BEHAV INSEC; Ball E.E., 1989, P391; BARTH RH, 1968, ADV REPROD PHYSIOL, V3, P167; BELL PD, 1980, CAN J ZOOL, V58, P1861, DOI 10.1139/z80-254; Boldyrev B., 1912, REV RUSSE ENTOMOLOGI, V12, P552; Boldyrev B. T., 1913, Revue Russe d'Entomologie, V13; Chopard L., 1932, Archives de Zoologie Experimentale et Generale Paris, V74, P263; CHOPARD L, 1938, BIOL ORTHOPTERES; Cocroft RB, 2010, BIOL J LINN SOC, V99, P60, DOI 10.1111/j.1095-8312.2009.01345.x; Cokl A, 2005, J EXP BIOL, V208, P1481, DOI 10.1242/jeb.01557; Cokl A, 2007, BEHAV PROCESS, V75, P40, DOI 10.1016/j.beproc.2007.01.003; Cooley JR, 2001, MOL ECOL, V10, P661, DOI 10.1046/j.1365-294x.2001.01210.x; Coyne JA, 1997, EVOLUTION, V51, P295, DOI 10.1111/j.1558-5646.1997.tb02412.x; Dambach M, 1989, CRICKET BEHAV NEUROB, P179, DOI 10.1016/S0003-3472(05)80655-4; De Luca PA, 1998, BEHAVIOUR, V135, P777, DOI 10.1163/156853998792640422; Desutter-Grandcolas L, 2003, ZOOL SCR, V32, P525, DOI 10.1046/j.1463-6409.2003.00142.x; EADES D. C., 1964, TRANS AMER ENTOMOL SOC, V90, P73; Elias DO, 2004, J EXP BIOL, V207, P4105, DOI 10.1242/jeb.01261; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Ewing AW, 1989, ARTHROPOD BIOACUSTIC; Field Laurence H., 2001, P271, DOI 10.1079/9780851994086.0271; Field Laurence H., 2001, P429, DOI 10.1079/9780851994086.0429; Field LH, 1997, J NAT HIST, V31, P1127, DOI 10.1080/00222939700770591; Gerhardt HC, 1999, DESIGN OF ANIMAL COMMUNICATION, P515; Gogala M, 1964, THESIS U LJUBLJANA; Greenfield MD, 2002, SIGNALLERS RECEIVERS; Gwynne Darryl T., 1997, P110, DOI 10.1017/CBO9780511721946.007; Gwynne Darryl T., 1995, Journal of Orthoptera Research, V4, P203; Gwynne TD, 2001, KATYDIDS BUSH CRICKE; Heidelbach J, 1997, ETHOLOGY, V103, P827; Hill PSM, 2001, AM ZOOL, V41, P1200, DOI 10.1668/0003-1569(2001)041[1200:TBSSVS]2.0.CO;2; Hubbel TH, 1978, U MICHIGAN MISCELLAN; JERAM S, 1995, J MORPHOL, V223, P109, DOI 10.1002/jmor.1052230110; Jost MC, 2006, MOL PHYLOGENET EVOL, V38, P510, DOI 10.1016/j.ympev.2005.10.004; Karaman I, 2011, ZOOL J LINN SOC-LOND, V163, P1035, DOI 10.1111/j.1096-3642.2011.00738.x; KASTBERGER G, 1984, PHYSIOL ENTOMOL, V9, P297, DOI 10.1111/j.1365-3032.1984.tb00712.x; Kastberger G., 1989, Mitteilungen des Naturwissenschaftlichen Vereines fuer Steiermark, V119, P129; KASTBERGER G, 1985, PHYSIOL ENTOMOL, V10, P407, DOI 10.1111/j.1365-3032.1985.tb00062.x; Kastberger Gerald, 1993, Mitteilungen des Naturwissenschaftlichen Vereines fuer Steiermark, V123, P207; Kastberger Gerald, 1991, Mitteilungen des Naturwissenschaftlichen Vereines fuer Steiermark, V121, P219; Keuper A., 1985, P135; Kevan D.K.McE., 1982, P352; Kevan DK, 1955, COLLOQUE ACOUSTIQUE, P103; Lakes R, 1990, TETTIGONIIDAE BIOL S, P167; Legendre F, 2010, SYST ENTOMOL, V35, P475, DOI 10.1111/j.1365-3113.2009.00519.x; LEROY YVELINE, 1967, ANN SPELEOL, V22, P659; Loher W., 1989, P43; Magal C, 2000, J ACOUST SOC AM, V108, P2412, DOI 10.1121/1.1286098; Markl H., 1983, P332; Mason J.B., 1961, EOS, V37, P505; McVean A, 1996, J ZOOL, V239, P101, DOI 10.1111/j.1469-7998.1996.tb05440.x; MEIER T, 1990, J NEUROBIOL, V21, P592, DOI 10.1002/neu.480210407; MORRIS GK, 1980, ANIM BEHAV, V28, P42, DOI 10.1016/S0003-3472(80)80006-6; MORRIS GK, 1994, J ZOOL, V233, P129, DOI 10.1111/j.1469-7998.1994.tb05266.x; Novak T, 1983, MEM BIOSPEOL, V10, P183; Novak T, 1982, MEM BIOSPEOL, V8, P27; Otte D., 1977, ANIMALS COMMUNICATE, P334; Pehani Spela, 1997, Entomologist, V116, P224; Remy P., 1931, Annales des Sciences Naturelles (Zoologie) Paris, V(10), P263; Richards A. M., 1961, Transactions of the Royal Society of New Zealand Zoology, V1, P121; Robinson DJ, 2002, ADV INSECT PHYSIOL, V29, P151, DOI 10.1016/S0065-2806(02)29003-7; Rossler W, 2006, CONT T ENT, P35; Seliskar A., 1923, Zoologischer Anzeiger Leipzig, V57, P253; SIMON D, 1977, Z TIERPSYCHOL, V44, P80; SISMONDO E, 1980, J INSECT PHYSIOL, V26, P209, DOI 10.1016/0022-1910(80)90082-7; Strauss J, 2008, J COMP NEUROL, V511, P81, DOI 10.1002/cne.21836; Strauss J, 2008, BRAIN BEHAV EVOLUT, V71, P167, DOI 10.1159/000114405; Strauss J, 2010, J COMP NEUROL, V518, P4567, DOI 10.1002/cne.22478; Stritih N, 2009, J COMP NEUROL, V516, P519, DOI 10.1002/cne.22138; Stritih N, 2009, ZOOLOGY, V112, P48, DOI 10.1016/j.zool.2008.04.005; TINKHAM ER, 1969, PAN-PAC ENTOMOL, V45, P4; Tregenza T, 2006, ANIM BEHAV, V72, P809, DOI 10.1016/j.anbehav.2006.01.019; Turner C. L., 1916, Annals of the Entomological Society of America, V9; Vahed Karim, 1996, Journal of Orthoptera Research, V5, P199; Weissman David B., 2001, P351, DOI 10.1079/9780851994086.0351; Weissmann Michael Jay, 1997, Journal of Orthoptera Research, V6, P33; Zuk M, 2008, ANIM BEHAV, V76, P1065, DOI 10.1016/j.anbehav.2008.02.018	78	21	21	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47646	10.1371/journal.pone.0047646	http://dx.doi.org/10.1371/journal.pone.0047646			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094071	Green Published, Green Submitted, gold			2022-12-25	WOS:000310050200037
J	Kashima, S; Matsumoto, M; Ogawa, T; Eboshida, A; Takeuchi, K				Kashima, Saori; Matsumoto, Masatoshi; Ogawa, Takahiko; Eboshida, Akira; Takeuchi, Keisuke			The Impact of Travel Time on Geographic Distribution of Dialysis Patients	PLOS ONE			English	Article							STAGE RENAL-DISEASE; QUALITY-OF-LIFE; PRACTICE PATTERNS; MORTALITY; OUTCOMES; CARE	Backgrounds: The geographic disparity of prevalence rates among dialysis patients is unclear. We evaluate the association between travel time to dialysis facilities and prevalence rates of dialysis patients living in 1,867 census areas of Hiroshima, Japan. Furthermore, we study the effects of geographic features (mainland or island) on the prevalence rates and assess if these effects modify the association between travel time and prevalence. Methods: The study subjects were all 7,374 people that were certified as the "renal disabled'' by local governments in 2011. The travel time from each patient to the nearest available dialysis facility was calculated by incorporating both travel time and the capacity of all 98 facilities. The effect of travel time on the age-and sex-adjusted standard prevalence rate (SPR) and 95% confidence intervals (CIs) at each census area was evaluated in two-level Poisson regression models with 1,867 census areas (level 1) nested within 35 towns or cities (level 2). The results were adjusted for area-based parameters of socioeconomic status, urbanity, and land type. Furthermore, the SPR of dialysis patients was calculated in each specific subgroup of population for travel time, land type, and combination of land type and travel time. Results: In the regression analysis, SPR decreased by 5.2% (95% CI: -27.9-22.3) per 10-min increase in travel time even after adjusting for potential confounders. The effect of travel time on prevalence was different in the mainland and island groups. There was no travel time-dependent SPR disparity on the islands. The SPR among remote residents (>30 min from facilities) in the mainland was lower (0.77, 95% CI: 0.71-0.85) than that of closer residents (<= 30 min; 0.95, 95% CI: 0.92-0.97). Conclusions: The prevalence of dialysis patients was lower among remote residents. Geographic difficulties for commuting seem to decrease the prevalence rate.	[Kashima, Saori; Eboshida, Akira] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Publ Hlth & Hlth Policy, Hiroshima, Japan; [Matsumoto, Masatoshi; Takeuchi, Keisuke] Hiroshima Univ, Fac Med, Dept Community Based Med Syst, Hiroshima, Japan; [Ogawa, Takahiko] Hiroshima Prefectural Hosp, Ctr Kidney Dis, Hiroshima, Japan	Hiroshima University; Hiroshima University	Kashima, S (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Publ Hlth & Hlth Policy, Hiroshima, Japan.	saori_ksm@ybb.ne.jp	Kashima, Saori/B-4524-2010	Kashima, Saori/0000-0002-3401-8191; Matsumoto, Masatoshi/0000-0002-8341-9303	Hiroshima Dialysis Association; Hiroshima Association of Kidney Patients; Higher Education Grant Program of ESRI Japan Corp.	Hiroshima Dialysis Association; Hiroshima Association of Kidney Patients; Higher Education Grant Program of ESRI Japan Corp.	The authors thank the Hiroshima Dialysis Association and the Hiroshima Association of Kidney Patients, for their support of this study. The software used in this study was supported by the Higher Education Grant Program of ESRI Japan Corp.	[Anonymous], 2011, OV REG DIAL TREATM J; [Anonymous], 2007, MIN INT AFF COMM JAP; Disability and Welfare Section Hiroshima City, 2004, PHYS GUID DIS CERT; Fukuhara Shunichi, 2007, Int J Health Care Finance Econ, V7, P217, DOI 10.1007/s10754-007-9017-8; Greenland S, 2008, MODERN EPIDEMIOLOGY, P258; Ikegami N, 2011, LANCET, V378, P1106, DOI 10.1016/S0140-6736(11)60828-3; Imasawa T, 2010, JAPANESE J NEPHROLOG, V52, P1015; Japanese Society for Dialysis Therapy, 2012, OV REG DIAL TREATM J; Judge A, 2011, NEPHROL DIAL TRANSPL; Klag MJ, 1997, JAMA-J AM MED ASSOC, V277, P1293, DOI 10.1001/jama.277.16.1293; Lawson A, 2003, DIS MAPPING WINBUGS, Vxiii; Lawson A.B., 2006, STAT METHODS SPATIAL, P41; Maheswaran R, 2003, J EPIDEMIOL COMMUN H, V57, P523, DOI 10.1136/jech.57.7.523; Matsumoto M, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-28; Matsumoto M, 2010, HEALTH PLACE, V16, P164, DOI 10.1016/j.healthplace.2009.07.005; Moist LM, 2008, AM J KIDNEY DIS, V51, P641, DOI 10.1053/j.ajkd.2007.12.021; Nakai S, 2012, NIHON TOSEKI IGAKKAI, V45, P1; OECD, 2011, HLTH GLANC 2011 OECD; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Rasbash J, 2010, MLWIN VERSION  2 22; Roderick P, 1999, J Health Serv Res Policy, V4, P139; Rucker D, 2011, KIDNEY INT, V79, P210, DOI 10.1038/ki.2010.376; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Sugisawa H, 2010, J JAPANESE ASS DIAL, V25, P135; Tonelli M, 2007, CAN MED ASSOC J, V177, P1039, DOI 10.1503/cmaj.070343; Udayaraj UP, 2010, J EPIDEMIOL COMMUN H, V64, P535, DOI 10.1136/jech.2009.093518; Untas A, 2011, CLIN J AM SOC NEPHRO, V6, P142, DOI 10.2215/CJN.02340310; White P, 2006, QJM-INT J MED, V99, P445, DOI 10.1093/qjmed/hcl054; WHITTLE JC, 1991, ARCH INTERN MED, V151, P1359, DOI 10.1001/archinte.151.7.1359	29	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47753	10.1371/journal.pone.0047753	http://dx.doi.org/10.1371/journal.pone.0047753			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082209	Green Submitted, Green Published, gold			2022-12-25	WOS:000311146900106
J	Naoi, N; Watanabe, S; Maekawa, K; Hibiya, J				Naoi, Nozomi; Watanabe, Shigeru; Maekawa, Kikuo; Hibiya, Junko			Prosody Discrimination by Songbirds (Padda oryzivora)	PLOS ONE			English	Article							BUDGERIGARS MELOPSITTACUS-UNDULATUS; FREQUENCY-RANGE DISCRIMINATIONS; FINCHES TAENIOPYGIA-GUTTATA; LANGUAGE DISCRIMINATION; SPEECH-PERCEPTION; JAVA SPARROWS; JAPANESE-QUAIL; ABSOLUTE PITCH; YOUNG INFANTS; HOMO-SAPIENS	In human verbal communication, not only lexical information, but also paralinguistic information plays an important role in transmitting the speakers' mental state. Paralinguistic information is conveyed mainly through acoustic features like pitch, rhythm, tempo and so on. These acoustic features are generally known as prosody. It is known that some species of birds can discriminate certain aspects of human speech. However, there have not been any studies on the discrimination of prosody in human language which convey different paralinguistic meanings by birds. In the present study, we have shown that the Java sparrow (Padda oryzivora) can discriminate different prosodic patterns of Japanese sentences. These birds could generalize prosodic discrimination to novel sentences, but could not generalize sentence discrimination to those with novel prosody. Moreover, unlike Japanese speakers, Java sparrows used the first part of the utterance as the discrimination cue.	[Naoi, Nozomi; Watanabe, Shigeru] Keio Univ, Dept Psychol, Tokyo, Japan; [Maekawa, Kikuo] Natl Inst Japanese Language & Linguist NINJAL, Tokyo, Japan; [Hibiya, Junko] Int Christian Univ, Coll Liberal Arts, Tokyo, Japan	Keio University; International Christian University	Naoi, N (corresponding author), Japan Agcy Sci & Technol, ERATO, Okanoya Emot Informat Project, Saitama, Japan.	nnaoi@educ.kyoto-u.ac.jp			Global COE Program "Centre for Advanced Research on Logic and Sensibility"	Global COE Program "Centre for Advanced Research on Logic and Sensibility"	This research was supported by Global COE Program "Centre for Advanced Research on Logic and Sensibility". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN BP, 1983, J EXP CHILD PSYCHOL, V35, P487, DOI 10.1016/0022-0965(83)90023-1; BALL GF, 1994, BRAIN BEHAV EVOLUT, V44, P234, DOI 10.1159/000113579; Banse R, 1996, J PERS SOC PSYCHOL, V70, P614, DOI 10.1037/0022-3514.70.3.614; Boersma P., 2020, PRAAT DOING PHONETIC; Carew T.J., 2000, BEHAV NEUROBIOLOGY C; CUTLER A, 1993, J PHONETICS, V21, P103, DOI 10.1016/S0095-4470(19)31323-3; Dent ML, 2000, J ACOUST SOC AM, V107, P2657, DOI 10.1121/1.428651; Dent ML, 1997, J ACOUST SOC AM, V102, P1891, DOI 10.1121/1.420111; DOOLING RJ, 1989, PERCEPT PSYCHOPHYS, V46, P65, DOI 10.3758/BF03208075; DOOLING RJ, 1995, J ACOUST SOC AM, V97, P1839, DOI 10.1121/1.412058; Doupe AJ, 1999, ANNU REV NEUROSCI, V22, P567, DOI 10.1146/annurev.neuro.22.1.567; FERNALD A, 1993, CHILD DEV, V64, P657, DOI 10.2307/1131209; FERNALD A, 1991, DEV PSYCHOL, V27, P209, DOI 10.1037/0012-1649.27.2.209; GOSY M, 1994, J PHONETICS, V22, P269; Grossmann T, 2005, NEUROREPORT, V16, P1825, DOI 10.1097/01.wnr.0000185964.34336.b1; HIRSHPASEK K, 1987, COGNITION, V26, P269, DOI 10.1016/S0010-0277(87)80002-1; Jusczyk PW, 1999, TRENDS COGN SCI, V3, P323, DOI 10.1016/S1364-6613(99)01363-7; JUSCZYK PW, 1992, COGNITIVE PSYCHOL, V24, P252, DOI 10.1016/0010-0285(92)90009-Q; JUSCZYK PW, 1993, J PHONETICS, V21, P3, DOI 10.1016/S0095-4470(19)31319-1; Kawakami Shin, 1963, KOKUGOKENKYUU, V16, P25; Kluender KR, 1998, J ACOUST SOC AM, V104, P3568, DOI 10.1121/1.423939; KLUENDER KR, 1987, SCIENCE, V237, P1195, DOI 10.1126/science.3629235; KOJIMA S, 1989, INT J PRIMATOL, V10, P199, DOI 10.1007/BF02735200; KUHL PK, 1978, J ACOUST SOC AM, V63, P905, DOI 10.1121/1.381770; LADD DR, 1985, J ACOUST SOC AM, V78, P435, DOI 10.1121/1.392466; Ladd RobertD., 1996, INTONATIONAL PHONOLO; Lee TTY, 2006, J COMP PSYCHOL, V120, P217, DOI 10.1037/0735-7036.120.3.217; LIEBERMAN P, 1962, J ACOUST SOC AM, V34, P922, DOI 10.1121/1.1918222; Lotto AJ, 1997, J ACOUST SOC AM, V102, P1134, DOI 10.1121/1.419865; MacDougallShackleton SA, 1996, J COMP PSYCHOL, V110, P139, DOI 10.1037/0735-7036.110.2.139; Maekawa K., 1998, P 5 INT C SPOK LANG, V2, P635; Maekawa K, 2004, P SPEECH PROS 2004, P367; Makarova V, 2001, J PHONETICS, V29, P137, DOI 10.1006/jpho.2001.0137; MARGOLIASH D, 1994, BRAIN BEHAV EVOLUT, V44, P247, DOI 10.1159/000113580; MEHRABIAN A, 1967, J PERS SOC PSYCHOL, V6, P109, DOI 10.1037/h0024532; Metzner W, 1996, J COMP NEUROL, V368, P252; MORGAN JL, 1994, INFANT BEHAV DEV, V17, P389, DOI 10.1016/0163-6383(94)90031-0; MORGAN JL, 1981, J VERB LEARN VERB BE, V20, P67, DOI 10.1016/S0022-5371(81)90312-1; MORSE PA, 1975, PERCEPT PSYCHOPHYS, V17, P9, DOI 10.3758/BF03203991; Nachtigall PE, 2003, J ACOUST SOC AM, V113, P3425, DOI 10.1121/1.1570438; Nazzi T, 2003, SPEECH COMMUN, V41, P233, DOI 10.1016/S0167-6393(02)00106-1; NJEGOVAN M, 1995, J EXP PSYCHOL ANIM B, V21, P33, DOI 10.1037/0097-7403.21.1.33; Oshinsky J.S., 1977, MOTIV EMOTION, V1, P331, DOI [10.1007/BF00992539, DOI 10.1007/BF00992539, 10.1007/BF009 92539]; Peters A. M., 1985, CROSSLINGUISTIC STUD, V2, P1029; PISACRETA R, 1986, J EXP ANAL BEHAV, V45, P269, DOI 10.1901/jeab.1986.45-269; Poole JH, 2005, NATURE, V434, P455, DOI 10.1038/434455a; Ramus F, 2000, SCIENCE, V288, P349, DOI 10.1126/science.288.5464.349; SCHERER KR, 1991, MOTIV EMOTION, V15, P123, DOI 10.1007/BF00995674; SINNOTT JM, 1987, J COMP PSYCHOL, V101, P355, DOI 10.1037/0735-7036.101.4.355; Soderstrom M, 2003, J MEM LANG, V49, P249, DOI 10.1016/S0749-596X(03)00024-X; Thompson WF, 2006, SEMIOTICA, V158, P407, DOI 10.1515/SEM.2006.017; Thorsen N, 1980, J ACOUST SOC AM, V67, P1015; Tincoff R, 2005, DEVELOPMENTAL SCI, V8, P26, DOI 10.1111/j.1467-7687.2005.00390.x; Toro JM, 2005, COGNITION, V97, pB25, DOI 10.1016/j.cognition.2005.01.006; Toro JM, 2005, J EXP PSYCHOL-ANIM B, V31, P95, DOI 10.1037/0097-7403.31.1.95; Toro JM, 2003, ANIM COGN, V6, P131, DOI 10.1007/s10071-003-0172-0; VICARIO DS, 1994, BRAIN BEHAV EVOLUT, V44, P265, DOI 10.1159/000113581; Watanabe S, 2005, BEHAV PROCESS, V70, P203, DOI 10.1016/j.beproc.2005.06.001; Watanabe S, 1999, BEHAV PROCESS, V47, P53, DOI 10.1016/S0376-6357(99)00049-2; Watanabe S, 2006, BEHAV PROCESS, V73, P114, DOI 10.1016/j.beproc.2006.01.013; Weisman R, 1998, J COMP PSYCHOL, V112, P244, DOI 10.1037/0735-7036.112.3.244; Weisman RG, 2010, BEHAV PROCESS, V84, P421, DOI 10.1016/j.beproc.2010.01.010	62	11	11	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47446	10.1371/journal.pone.0047446	http://dx.doi.org/10.1371/journal.pone.0047446			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082167	Green Submitted, gold, Green Published			2022-12-25	WOS:000311146900063
J	Haraoka, T; Ojima, T; Murata, C; Hayasaka, S				Haraoka, Tomoko; Ojima, Toshiyuki; Murata, Chiyoe; Hayasaka, Shinya			Factors Influencing Collaborative Activities between Non-Professional Disaster Volunteers and Victims of Earthquake Disasters	PLOS ONE			English	Article								Background: Assistance from non-professional disaster volunteers (hereinafter, volunteers) is essential for disaster victims to recover physically and rebuild their lives; however, disaster victims in some areas are reluctant to accept assistance from volunteers. This study explored factors that may influence collaborative activities between volunteers and victims of earthquake disasters. Methods: From July to September 2008, a self-reporting questionnaire survey was conducted with all 302 leaders of neighborhood associations in a city within Niigata Prefecture at the time of the Niigataken Chuetsu-oki Earthquake in 2007. Each factor was determined based on the Health Belief Model. Multiple regression analysis was conducted, using collaborative activities as the objective variable. Results: From 261 valid responses received (response rate 86.4%), 41.3% of leaders collaborated with volunteers, and 60.2% of associations had residents who collaborated with volunteers. Collaboration with volunteers was significantly and positively related to perceived severity of an earthquake disaster (standardized partial regression coefficient beta = 0.224, p<0.001) and neighborhood association activities during the earthquake disaster (beta = 0.539, p<0.001). A positive and marginally significant relation was found between such collaboration and sense of coherence within a community (beta = 0.137, p = 0.06), social capital (beta = 0.119, p = 0.08), and perceived benefits (beta = 0.116, p = 0.09). Conclusion: Collaboration between disaster victims and volunteers during the response to an earthquake may require the preemptive estimation of damage by residents during normal times and the enhancement of neighborhood association activities during a disaster. For residents to have such estimation abilities, public institutions should provide information related to anticipated disaster damage and appropriate disaster prevention training and education. In addition, residents should create a disaster prevention map with other residents. Lastly, promoting neighborhood association activities may require the participation of many residents in disaster drills and education as well as a preemptive discussion of neighborhood activities during a disaster.	[Haraoka, Tomoko] Hamamatsu Univ Sch Med, Dept Reg Med Management, Higashi Ku, Hamamatsu, Shizuoka 4312102, Japan; [Haraoka, Tomoko; Ojima, Toshiyuki; Hayasaka, Shinya] Hamamatsu Univ Sch Med, Dept Community Hlth & Prevent Med, Higashi Ku, Hamamatsu, Shizuoka 4312102, Japan; [Murata, Chiyoe] NCGG, CGSS, Dept Social Sci, Sect Social Participat & Support, Aichi, Japan; [Hayasaka, Shinya] Daito Bunka Univ, Dept Sports & Hlth Sci, Saitama, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine	Haraoka, T (corresponding author), Hamamatsu Univ Sch Med, Dept Reg Med Management, Higashi Ku, Hamamatsu, Shizuoka 4312102, Japan.	tomohara@hama-med.ac.jp			Ministry of Health, Labor and Welfare, Japan (Research on Health Security Control) [H19-kenki-ippan-007]	Ministry of Health, Labor and Welfare, Japan (Research on Health Security Control)	The present study was conducted as part of research related to volunteer aid preparedness in a community based critical health management project (Critical Community Health Management Research Project) funded by a Grant-in-Aid from Ministry of Health, Labor and Welfare, Japan (Research on Health Security Control: H19-kenki-ippan-007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Antonovsky A., 1987, UNRAVELING MYSTERY H; ARONSON E, 1992, SOCIAL ANIMAL; BECKER MH, 1974, AM J PUBLIC HEALTH, V64, P205, DOI 10.2105/AJPH.64.3.205; Britton R.N., 1991, NONPROFIT VOLUNTARY, V20, P395, DOI DOI 10.1177/089976409102000404; Cabinet Office Government of Japan, 2006, GREAT HANSH AW EARTH; Cabinet Office Government of Japan, 2002, PUBL OP RES DIS PREV; City Kashiwazaki, 2006, KASH CIT NEIGHB ASS; Glanz K., 2015, HLTH BEHAV HLTH ED T; Green G., 2008, ASSET BUILDING COMMU, V(2nd); Hayashi H, 2005, REGIONAL POLICY RES, V33, P16; Hirao T, 2005, COMMUNITY ENV WELFAR, V18, P75; Japan National Council of Social Welfare, 2011, DIS AR AID DIS VOL I; Kanagawa K, 2010, EUR GROUP PUBL ADM E, P8; Kondo K, 2008, VERIFICATION SOCIAL; Munakata T, 1992, HLTH ILLNESS BASED B; Murosaki Y, 2005, REGIONAL POLICY RES, V33, P7; Nakamura Y, 2009, INTRO STAT MED SCI; National Cancer Institute, 2005, THEOR GLANC GUID HLT; Ojima T., 2008, Journal of the National Institute of Public Health, V57, P245; Ojima T, 2010, SUPPORT SYSTEM VOLUN; Osborne Stephen, 2003, VOLUNTARY NONPROFIT; Pekkanen R., 2006, JAPANS DUAL CIVIL SO; Public Relations Office Government of Japan, 2011, CAB OFF ONL NEWSL; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; Simo G, 2007, PUBLIC ADMIN REV, V67, P125, DOI 10.1111/j.1540-6210.2007.00821.x; Sugama S, 2008, INTRO DISASTER VOLUN; Suzuki I., 2006, BETTER INTEGRATED MA, V1st ed., P153; Takahashi K, 2007, J TOKYO KASEI GAKUIM, V47, P95; Togari T, 2007, J EPIDEMIOL COMMUN H, V61, DOI 10.1136/jech.2006.056697; Tsukuba T, 2005, J ARCHITECTURAL I JA, V48, P55; Yanai H, 2007, STAT DATA ANAL SPSS	31	15	15	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47203	10.1371/journal.pone.0047203	http://dx.doi.org/10.1371/journal.pone.0047203			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23094037	Green Published, Green Submitted, gold			2022-12-25	WOS:000310135800032
J	Kim, KA; Gu, W; Lee, IA; Joh, EH; Kim, DH				Kim, Kyung-Ah; Gu, Wan; Lee, In-Ah; Joh, Eun-Ha; Kim, Dong-Hyun			High Fat Diet-Induced Gut Microbiota Exacerbates Inflammation and Obesity in Mice via the TLR4 Signaling Pathway	PLOS ONE			English	Article							NF-KAPPA-B; ADIPOSE-TISSUE; INFILTRATION; ACTIVATION; RESISTANCE; ECOLOGY; SYSTEM; MODEL	Background & Aims: While it is widely accepted that obesity is associated with low-grade systemic inflammation, the molecular origin of the inflammation remains unknown. Here, we investigated the effect of endotoxin-induced inflammation via TLR4 signaling pathway at both systemic and intestinal levels in response to a high-fat diet. Methods: C57BL/6J and TLR4-deficient C57BL/10ScNJ mice were maintained on a low-fat (10 kcal % fat) diet (LFD) or a high-fat (60 kcal % fat) diet (HFD) for 8 weeks. Results: HFD induced macrophage infiltration and inflammation in the adipose tissue, as well as an increase in the circulating proinflammatory cytokines. HFD increased both plasma and fecal endotoxin levels and resulted in dysregulation of the gut microbiota by increasing the Firmicutes to Bacteriodetes ratio. HFD induced the growth of Enterobecteriaceae and the production of endotoxin in vitro. Furthermore, HFD induced colonic inflammation, including the increased expression of proinflammatory cytokines, the induction of Toll-like receptor 4 (TLR4), iNOS, COX-2, and the activation of NF-kappa B in the colon. HFD reduced the expression of tight junction-associated proteins claudin-1 and occludin in the colon. HFD mice demonstrated higher levels of Akt and FOXO3 phosphorylation in the colon compared to the LFD mice. While the body weight of HFD-fed mice was significantly increased in both TLR4-deficient and wild type mice, the epididymal fat weight and plasma endotoxin level of HFD-fed TLR4-deficient mice were 69% and 18% of HFD-fed wild type mice, respectively. Furthermore, HFD did not increase the proinflammatory cytokine levels in TLR4-deficient mice. Conclusions: HFD induces inflammation by increasing endotoxin levels in the intestinal lumen as well as in the plasma by altering the gut microbiota composition and increasing its intestinal permeability through the induction of TLR4, thereby accelerating obesity.	[Kim, Kyung-Ah; Gu, Wan; Lee, In-Ah; Joh, Eun-Ha; Kim, Dong-Hyun] Kyung Hee Univ, Coll Pharm, Dept Life & Nanopharmaceut Sci, Seoul, South Korea	Kyung Hee University	Kim, DH (corresponding author), Kyung Hee Univ, Coll Pharm, Dept Life & Nanopharmaceut Sci, Seoul, South Korea.	dhkim@khu.ac.kr			World Class University through the National Research Foundation of Korea; Ministry of Education, Science and Technology [R33-2008-000-10018-0]	World Class University through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by a grant from World Class University Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (R33-2008-000-10018-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Brun P, 2007, AM J PHYSIOL-GASTR L, V292, pG518, DOI 10.1152/ajpgi.00024.2006; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Chakraborty S, 2010, ANN NY ACAD SCI, V1207, pE94, DOI 10.1111/j.1749-6632.2010.05752.x; Chun J, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-101; Clark DA, 2008, AM J REPROD IMMUNOL, V60, P529, DOI 10.1111/j.1600-0897.2008.00652.x; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; Ding SL, 2011, CURR OPIN CLIN NUTR, V14, P328, DOI 10.1097/MCO.0b013e3283478727; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Faulds MH, 2012, CURR OPIN ONCOL, V24, P58, DOI 10.1097/CCO.0b013e32834e0582; Geurts L, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00149; Ghanim H, 2009, DIABETES CARE, V32, P2281, DOI 10.2337/dc09-0979; Hollenbach E, 2005, J BIOL CHEM, V280, P14981, DOI 10.1074/jbc.M500966200; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Joh EH, 2011, BRIT J PHARMACOL, V162, P1731, DOI 10.1111/j.1476-5381.2010.01195.x; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kim DH, 2008, BIOGERONTOLOGY, V9, P33, DOI 10.1007/s10522-007-9114-6; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Li H, 2008, METABOLISM, V57, P1704, DOI 10.1016/j.metabol.2008.07.029; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Monteiro R, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/289645; Neuman MG, 2007, TRANSL RES, V149, P173, DOI 10.1016/j.trsl.2006.11.009; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451	34	774	800	9	192	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47713	10.1371/journal.pone.0047713	http://dx.doi.org/10.1371/journal.pone.0047713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091640	Green Published, gold, Green Submitted			2022-12-25	WOS:000310135800066
J	Seal, S; Chatterjee, P; Bhattacharya, S; Pal, D; Dasgupta, S; Kundu, R; Mukherjee, S; Bhattacharya, S; Bhuyan, M; Bhattacharyya, PR; Baishya, G; Barua, NC; Baruah, PK; Rao, PG; Bhattacharya, S				Seal, Soma; Chatterjee, Priyajit; Bhattacharya, Sushmita; Pal, Durba; Dasgupta, Suman; Kundu, Rakesh; Mukherjee, Sandip; Bhattacharya, Shelley; Bhuyan, Mantu; Bhattacharyya, Pranab R.; Baishya, Gakul; Barua, Nabin C.; Baruah, Pranab K.; Rao, Paruchuri G.; Bhattacharya, Samir			Vapor of Volatile Oils from Litsea cubeba Seed Induces Apoptosis and Causes Cell Cycle Arrest in Lung Cancer Cells	PLOS ONE			English	Article							PHOSPHATIDYLINOSITOL 3-KINASE/AKT PATHWAY; AKT PHOSPHORYLATION; KINASE-B; ACTIVATION; BAD; PACLITAXEL; SURVIVAL; P53; OVEREXPRESSION; INVOLVEMENT	Non-small cell lung carcinoma (NSCLC) is a major killer in cancer related human death. Its therapeutic intervention requires superior efficient molecule(s) as it often becomes resistant to present chemotherapy options. Here we report that vapor of volatile oil compounds obtained from Litsea cubeba seeds killed human NSCLC cells, A549, through the induction of apoptosis and cell cycle arrest. Vapor generated from the combined oils (VCO) deactivated Akt, a key player in cancer cell survival and proliferation. Interestingly VCO dephosphorylated Akt at both Ser(473) and Thr(308); through the suppression of mTOR and pPDK1 respectively. As a consequence of this, diminished phosphorylation of Bad occurred along with the decreased Bcl-xL expression. This subsequently enhanced Bax levels permitting the release of mitochondrial cytochrome c into the cytosol which concomitantly activated caspase 9 and caspase 3 resulting apoptotic cell death. Impairment of Akt activation by VCO also deactivated Mdm2 that effected overexpression of p53 which in turn upregulated p21 expression. This causes enhanced p21 binding to cyclin D1 that halted G1 to S phase progression. Taken together, VCO produces two prong effects on lung cancer cells, it induces apoptosis and blocked cancer cell proliferation, both occurred due to the deactivation of Akt. In addition, it has another crucial advantage: VCO could be directly delivered to lung cancer tissue through inhalation.	[Seal, Soma; Chatterjee, Priyajit; Bhattacharya, Sushmita; Pal, Durba; Dasgupta, Suman; Kundu, Rakesh; Mukherjee, Sandip; Bhattacharya, Shelley; Bhattacharya, Samir] Visva Bharati Univ, Sch Life Sci, Ctr Adv Studies Zool, Santini Ketan, W Bengal, India; [Dasgupta, Suman; Bhuyan, Mantu; Bhattacharyya, Pranab R.; Baishya, Gakul; Barua, Nabin C.; Baruah, Pranab K.; Rao, Paruchuri G.; Bhattacharya, Samir] CSIR, N E Inst Sci & Technol, Jorhat, Assam, India	Visva Bharati University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - North East Institute of Science & Technology (NEIST)	Bhattacharya, S (corresponding author), Visva Bharati Univ, Sch Life Sci, Ctr Adv Studies Zool, Santini Ketan, W Bengal, India.	bhattacharyasa@gmail.com	Kundu, Rakesh/AAG-2582-2021; Kundu, Rakesh/ABE-3083-2021; Rao, Paruchuri/C-3050-2009; Kundu, Rakesh Kundu/AAC-3543-2019; Dasgupta, Suman/B-8808-2013	Rao, Paruchuri/0000-0002-1058-9248; Kundu, Rakesh Kundu/0000-0001-8871-0565; Dasgupta, Suman/0000-0003-2599-2299; CHATTERJEE, PRIYAJIT/0000-0001-6728-0981	CSIR-NEEP [HCP-005]; Council of Scientific and Industrial Research (CSIR), New Delhi	CSIR-NEEP; Council of Scientific and Industrial Research (CSIR), New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This research work was financially supported by the grant from CSIR-NEEP Project (HCP-005). The authors SS and PC are thankful to the Department of Science & Technology, Govt. of India, New Delhi; Sushmita Bhattacharya, DP and RK are indebted to Council of Scientific and Industrial Research (CSIR), New Delhi, for the award of Research Fellowships. SD is thankful to UGC for Dr. D. S. Kothari PDF & CSIR-NEIST for QHF; and Samir Bhattacharya to the Indian National Science Academy for his INSA Senior Scientist position. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, CLIN LUNG CANCER, V7, P17, DOI 10.1016/S1525-7304(11)70385-0; Balsara BR, 2004, CARCINOGENESIS, V25, P2053, DOI 10.1093/carcin/bgh226; Brognard J, 2001, CANCER RES, V61, P3986; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; David O, 2004, CLIN CANCER RES, V10, P6865, DOI 10.1158/1078-0432.CCR-04-0174; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elrod HA, 2007, MOL CANCER THER, V6, P2029, DOI 10.1158/1535-7163.MCT-07-0004; Franke TF, 1997, NATURE, V390, P116, DOI 10.1038/36442; Han JW, 2001, J BIOL CHEM, V276, P42084, DOI 10.1074/jbc.M106688200; Hu LM, 2002, CANCER RES, V62, P1087; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; KROPP PJ, 1995, J ORG CHEM, V60, P4146, DOI 10.1021/jo00118a035; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liu G, 2003, J BIOL CHEM, V278, P17557, DOI 10.1074/jbc.M210696200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maira SM, 2009, FUTURE MED CHEM, V1, P137, DOI 10.4155/FMC.09.5; Massion PP, 2004, AM J RESP CRIT CARE, V170, P1088, DOI 10.1164/rccm.200404-487OC; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; Mishina T, 1999, BRIT J CANCER, V80, P1289, DOI 10.1038/sj.bjc.6690500; Nacht M, 2001, P NATL ACAD SCI USA, V98, P15203, DOI 10.1073/pnas.261414598; Nadkar A, 2006, EXPERT OPIN DRUG MET, V2, P753, DOI 10.1517/17425255.2.5.753; Namsa ND, 2011, J ETHNOBIOL ETHNOMED, V31, P1; Nimako K, 2012, MEDICINE, V40, P202; Ottilie S, 1997, J BIOL CHEM, V272, P30866, DOI 10.1074/jbc.272.49.30866; PHAN SH, 1985, J CLIN INVEST, V76, P241, DOI 10.1172/JCI111953; Rowinsky EK, 1999, CLIN CANCER RES, V5, P767; Salvesen GS, 2007, ADV EXP MED BIOL, V615; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schuurbiers OCJ, 2009, J THORAC ONCOL, V4, P761, DOI 10.1097/JTO.0b013e3181a1084f; Scripture CD, 2006, CURR NEUROPHARMACOL, V4, P165, DOI 10.2174/157015906776359568; Sinha S, 2006, PROSTATE, V66, P1257, DOI 10.1002/pros.20415; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Spira A, 2004, NEW ENGL J MED, V350, P379, DOI 10.1056/NEJMra035536; Srivastava RC, 2009, INDIAN J TRADIT KNOW, V8, P146; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Tang JM, 2006, LUNG CANCER, V51, P181, DOI 10.1016/j.lungcan.2005.10.003; Tsurutani J, 2006, J CLIN ONCOL, V24, P306, DOI 10.1200/JCO.2005.02.4133; Vincent EE, 2011, BRIT J CANCER, V104, P1755, DOI 10.1038/bjc.2011.132; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	43	41	44	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47014	10.1371/journal.pone.0047014	http://dx.doi.org/10.1371/journal.pone.0047014			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091605	Green Submitted, gold, Green Published			2022-12-25	WOS:000310135800020
J	Monteiro, LJ; Khongkow, P; Kongsema, M; Morris, JR; Man, C; Weekes, D; Koo, CY; Gomes, AR; Pinto, PH; Varghese, V; Kenny, LM; Coombes, RC; Freire, R; Medema, RH; Lam, EWF				Monteiro, L. J.; Khongkow, P.; Kongsema, M.; Morris, J. R.; Man, C.; Weekes, D.; Koo, C-Y; Gomes, A. R.; Pinto, P. H.; Varghese, V.; Kenny, L. M.; Coombes, R. Charles; Freire, R.; Medema, R. H.; Lam, E. W-F			The Forkhead Box M1 protein regulates BRIP1 expression and DNA damage repair in epirubicin treatment	ONCOGENE			English	Article						FOXM1; BRIP1; DNA damage; epirubicin; resistance; breast cancer	BREAST-CANCER CELLS; TRANSCRIPTION FACTOR FOXM1; DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; MAMMALIAN-CELLS; BINDING DOMAIN; RESISTANCE; BACH1; PROGRESSION; GENE	FOXM1 is implicated in genotoxic drug resistance but its role and mechanism of action remain unclear. Here, we establish that gamma H2AX foci, indicative of DNA double-strand breaks (DSBs), accumulate in a time-dependent manner in the drug-sensitive MCF-7 cells but not in the resistant counterparts in response to epirubicin. We find that FOXM1 expression is associated with epirubicin sensitivity and DSB repair. Ectopic expression of FOXM1 can increase cell viability and abrogate DSBs sustained by MCF-7 cells following epirubicin, owing to an enhancement in repair efficiency. Conversely, alkaline comet and gamma H2AX foci formation assays show that Foxm1-null cells are hypersensitive to DNA damage, epirubicin and gamma-irradiation. Furthermore, we find that FOXM1 is required for DNA repair by homologous recombination (HR) but not non-homologous end joining (NHEJ), using HeLa cell lines harbouring an integrated direct repeat green fluorescent protein reporter for DSB repair. We also identify BRIP1 as a direct transcription target of FOXM1 by promoter analysis and chromatin-immunoprecipitation assay. In agreement, depletion of FOXM1 expression by small interfering RNA downregulates BRIP1 expression at the protein and mRNA levels in MCF-7 and the epirubicin-resistant MCF-7 Epi(R) cells. Remarkably, the requirement for FOXM1 for DSB repair can be circumvented by reintroduction of BRIP1, suggesting that BRIP1 is an important target of FOXM1 in DSB repair. Indeed, like FOXM1, BRIP1 is needed for HR. These data suggest that FOXM1 regulates BRIP1 expression to modulate epirubicin-induced DNA damage repair and drug resistance.	[Monteiro, L. J.; Khongkow, P.; Kongsema, M.; Koo, C-Y; Gomes, A. R.; Pinto, P. H.; Varghese, V.; Kenny, L. M.; Coombes, R. Charles; Lam, E. W-F] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London W12 0NN, England; [Morris, J. R.] Univ Birmingham, Coll Med & Dent Sci, Sch Canc Sci, Birmingham, W Midlands, England; [Man, C.] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China; [Weekes, D.] Kings Coll London, Guys Hosp, Dept Med & Mol Genet, London SE1 9RT, England; [Freire, R.] Hosp Univ Canarias, Unidad Invest, Inst Tecnol Biomed, Tenerife, Spain; [Medema, R. H.] Netherlands Canc Inst, Div Cell Biol, Amsterdam, CX, Netherlands	Imperial College London; University of Birmingham; Hong Kong Polytechnic University; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Universidad de la Laguna; Netherlands Cancer Institute	Lam, EWF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Room 134,1st Floor,Hammersmith Hosp Campus,Du Can, London W12 0NN, England.	eric.lam@imperial.ac.uk	Kongsema, Mesayamas/H-3063-2017; Medema, Rene H/E-2981-2013; Lam, Eric W-F/AAW-8566-2020; Morris, Joanna/AAK-3388-2021; Monteiro, Lara J/AAU-8518-2020; Freire, Raimundo/Q-7660-2019	Lam, Eric W-F/0000-0003-1274-3576; Freire, Raimundo/0000-0003-4473-8894; Kongsema, Mesayamas/0000-0001-7146-9349; Medema, Rene/0000-0002-6754-0381; Coombes, Raoul Charles/0000-0002-4811-1100; Morris, Joanna/0000-0001-9762-8133; Weekes, Daniel/0000-0001-8083-7617; Koo, Chuay Yeng/0000-0002-9495-0554; Khongkow, Pasarat/0000-0003-3068-2412	Cancer Research UK; Breast Cancer Campaign; Fundacao para a Ciencia e a Tecnologia; Royal Thai Government Scholarships; Imperial College NHS Trust; Cancer Research UK [12011] Funding Source: researchfish; National Institute for Health Research [NIHR/CS/009/009] Funding Source: researchfish; Breast Cancer Campaign [2012NovPhD016, 2012MayPR070] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Breast Cancer Campaign; Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Royal Thai Government Scholarships; Imperial College NHS Trust; Cancer Research UK(Cancer Research UK); National Institute for Health Research(National Institute for Health Research (NIHR)); Breast Cancer Campaign	EW-FL, ARG and RCC were supported by grants from Cancer Research UK, EW-FL and C-YK by grants from Breast Cancer Campaign and Imperial College NHS Trust, LJM grants from Fundacao para a Ciencia e a Tecnologia, and PK and MK from the Royal Thai Government Scholarships. We also thank Dr Keng Heng for help with the microscopy and flow cytometry work.	Ahmad A, 2010, BREAST CANCER RES TR, V122, P337, DOI 10.1007/s10549-009-0572-1; Alvarez RH, 2010, J CLIN ONCOL, V28, P3366, DOI 10.1200/JCO.2009.25.4011; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Carr JR, 2010, CANCER RES, V70, P5054, DOI 10.1158/0008-5472.CAN-10-0545; Dai B, 2007, ONCOGENE, V26, P6212, DOI 10.1038/sj.onc.1210443; de Olano N, 2012, MOL CANCER RES, V10, P1189, DOI 10.1158/1541-7786.MCR-11-0559; Delacote F, 2002, NUCLEIC ACIDS RES, V30, P3454, DOI 10.1093/nar/gkf452; Dohrn L, 2012, BIOCHEM J, V441, P919, DOI 10.1042/BJ20110314; Fu Z, 2008, NAT CELL BIOL, V10, P1076, DOI 10.1038/ncb1767; Garinis GA, 2005, EMBO J, V24, P3952, DOI 10.1038/sj.emboj.7600849; Gong ZH, 2010, MOL CELL, V37, P438, DOI 10.1016/j.molcel.2010.01.002; Hegde NS, 2011, NAT CHEM, V3, P725, DOI [10.1038/NCHEM.1114, 10.1038/nchem.1114]; Karadedou CT, 2012, ONCOGENE, V31, P1845, DOI 10.1038/onc.2011.368; Koo CY, 2012, BBA-GENE REGUL MECH, V1819, P28, DOI 10.1016/j.bbagrm.2011.09.004; Korver W, 1997, GENOMICS, V46, P435, DOI 10.1006/geno.1997.5065; Kruse V, 2011, ACTA CLIN BELG, V66, P2, DOI 10.1179/ACB.66.1.2062507; Kwok JMM, 2010, MOL CANCER RES, V8, P24, DOI 10.1158/1541-7786.MCR-09-0432; Kwok JMM, 2008, MOL CANCER THER, V7, P2022, DOI 10.1158/1535-7163.MCT-08-0188; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Li Q, 2009, CANCER RES, V69, P3501, DOI 10.1158/0008-5472.CAN-08-3045; Lin SX, 2010, NAT REV ENDOCRINOL, V6, P485, DOI 10.1038/nrendo.2010.92; Litman R, 2005, CANCER CELL, V8, P255, DOI 10.1016/j.ccr.2005.08.004; Madureira PA, 2006, J BIOL CHEM, V281, P25167, DOI 10.1074/jbc.M603906200; McGovern UB, 2009, MOL CANCER THER, V8, P582, DOI 10.1158/1535-7163.MCT-08-0805; Millour J, 2010, ONCOGENE, V29, P2983, DOI 10.1038/onc.2010.47; Millour J, 2011, MOL CANCER THER, V10, P1046, DOI 10.1158/1535-7163.MCT-11-0024; Minotti G, 2004, PHARMACOL REV, V56, P185, DOI 10.1124/pr.56.2.6; Myatt SS, 2008, NAT REV CANCER, V8, P244, DOI 10.1038/nrc2223-c2; Myatt SS, 2007, NAT REV CANCER, V7, P847, DOI 10.1038/nrc2223; Nowak DE, 2005, BIOTECHNIQUES, V39, P715, DOI 10.2144/000112014; Palmieri C, 2010, NAT REV CLIN ONCOL, V7, P561, DOI 10.1038/nrclinonc.2010.122; Park HJ, 2008, MOL CELL BIOL, V28, P5162, DOI 10.1128/MCB.00387-08; Park YY, 2012, CARCINOGENESIS, V33, P1843, DOI 10.1093/carcin/bgs167; Peck B, 2010, MOL CANCER THER, V9, P844, DOI 10.1158/1535-7163.MCT-09-0971; Raguz S, 2008, BRIT J CANCER, V99, P387, DOI 10.1038/sj.bjc.6604510; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; SINGH NP, 1988, EXP CELL RES, V175, P184, DOI 10.1016/0014-4827(88)90265-0; Stearns V, 2004, PHARMACOGENOMICS J, V4, P143, DOI 10.1038/sj.tpj.6500242; Tan YJ, 2007, MOL CELL BIOL, V27, P1007, DOI 10.1128/MCB.01068-06; TEWEY KM, 1984, SCIENCE, V226, P466, DOI 10.1126/science.6093249; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Weinstock David M, 2007, Nat Cell Biol, V9, P978; Weinstock DM, 2006, METHOD ENZYMOL, V409, P524, DOI 10.1016/S0076-6879(05)09031-2; Xie J, 2010, ONCOGENE, V29, P2499, DOI 10.1038/onc.2010.18; Yao KM, 1997, J BIOL CHEM, V272, P19827, DOI 10.1074/jbc.272.32.19827; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753; Zelnak A, 2010, BREAST J, V16, P309, DOI 10.1111/j.1524-4741.2010.00911.x; Zhang HJ, 2006, MOL ENDOCRINOL, V20, P1853, DOI 10.1210/me.2006-0056	50	64	67	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 26	2013	32	39					4634	4645		10.1038/onc.2012.491	http://dx.doi.org/10.1038/onc.2012.491			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	226YD	23108394	Green Accepted			2022-12-25	WOS:000325072200005
J	Peng, H; Liu, J; Sun, Q; Chen, R; Wang, Y; Duan, J; Li, C; Li, B; Jing, Y; Chen, X; Mao, Q; Xu, KF; Walker, CL; Li, J; Wang, J; Zhang, H				Peng, H.; Liu, J.; Sun, Q.; Chen, R.; Wang, Y.; Duan, J.; Li, C.; Li, B.; Jing, Y.; Chen, X.; Mao, Q.; Xu, K-F; Walker, C. L.; Li, J.; Wang, J.; Zhang, H.			mTORC1 enhancement of STIM1-mediated store-operated Ca2+ entry constrains tuberous sclerosis complex-related tumor development	ONCOGENE			English	Article						TSC; mTORC1; STIM1; calcium; tumorigenesis	MAMMALIAN TARGET; TRANSCRIPTIONAL CONTROL; CELL PROLIFERATION; MOUSE MODELS; IFN-GAMMA; CANCER; RAPAMYCIN; CALCIUM; GROWTH; ACTIVATION	The protein complex of tuberous sclerosis complex (TSC) 1 and TSC2 tumor suppressors is a key negative regulator of mammalian target of rapamycin (mTOR). Hyperactive mTOR signaling due to the loss-of-function of mutations in either TSC1 or TSC2 gene causes TSC, an autosomal dominant disorder featured with benign tumors in multiple organs. As the ubiquitous second messenger calcium (Ca2+) regulates various cellular processes involved in tumorigenesis, we explored the potential role of mTOR in modulation of cellular Ca2+ homeostasis, and in turn the effect of Ca2+ signaling in TSC-related tumor development. We found that loss of Tsc2 potentiated store-operated Ca2+ entry (SOCE) in an mTOR complex 1 (mTORC1)-dependent way. The endoplasmic reticulum Ca2+ sensor, stromal interaction molecule 1 (STIM1), was upregulated in Tsc2-deficient cells, and was suppressed by mTORC1 inhibitor rapamycin. In addition, SOCE repressed AKT1 phosphorylation. Blocking SOCE either by depleting STIM1 or ectopically expressing dominant-negative Orai1 accelerated TSC-related tumor development, likely because of restored AKT1 activity and enhanced tumor angiogenesis. Our data, therefore, suggest that mTORC1 enhancement of store-operated Ca2+ signaling hinders TSC-related tumor growth through suppression of AKT1 signaling. The augmented SOCE by hyperactive mTORC1-STIM1 cascade may contribute to the benign nature of TSC-related tumors. Application of SOCE agonists could thus be a contraindication for TSC patients. In contrast, SOCE agonists should attenuate mTOR inhibitors-mediated AKT reactivation and consequently potentiate their efficacy in the treatment of the patients with TSC.	[Peng, H.; Chen, R.; Wang, Y.; Duan, J.; Li, C.; Li, B.; Jing, Y.; Chen, X.; Zhang, H.] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Dept Physiol & Pathophysiol, Beijing 100005, Peoples R China; [Peng, H.; Chen, R.; Wang, Y.; Duan, J.; Li, C.; Li, B.; Jing, Y.; Chen, X.; Zhang, H.] Chinese Acad Med Sci, Sch Basic Med, Beijing 100005, Peoples R China; [Peng, H.; Chen, R.; Wang, Y.; Duan, J.; Li, C.; Li, B.; Jing, Y.; Chen, X.; Zhang, H.] Peking Union Med Coll, Beijing 100005, Peoples R China; [Liu, J.; Wang, J.] Capital Med Univ, Dept Physiol, Beijing 100069, Peoples R China; [Sun, Q.] Tianjin Med Univ, Tianjin Canc Inst & Hosp, Dept Immunol, Tianjin, Peoples R China; [Mao, Q.] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Urol, Beijing 100005, Peoples R China; [Xu, K-F] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Resp Med, Beijing 100005, Peoples R China; [Walker, C. L.] Texas A&M Hlth Sci Ctr, Ctr Translat Canc Res, Inst Biosci & Technol, Houston, TX USA; [Li, J.] Huazhong Univ Sci & Technol, Inst Cardiovasc Dis, Union Hosp, Tongji Med Coll,Dept Cardiol, Wuhan 430074, Peoples R China; [Zhang, H.] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing 100005, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Capital Medical University; Tianjin Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Huazhong University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Wang, J (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Physiol, 10 Xitoutiao, Beijing 100069, Peoples R China.	wang_jun@ccmu.edu.cn; hbzhang@ibms.pumc.edu.cn	Peng, Haiyong/S-8045-2016; Xu, Kai-Feng/AAO-2445-2020		National Basic Research Program of China 973 Program [2009CB522107, 2009CB522203]; National Natural Science Foundation of China [30971503, 81130085]; Ministry of Education of China 111 Project [B08007]; NATIONAL CANCER INSTITUTE [R01CA143811] Funding Source: NIH RePORTER	National Basic Research Program of China 973 Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China 111 Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The mouse kidney tumor tissues were kindly provided by David J Kwiatkowski, Brigham and Women's Hospital. This work was supported by the National Basic Research Program of China 973 Program Grant (2009CB522107 and 2009CB522203), the National Natural Science Foundation of China Grants (30971503 and 81130085), and the Ministry of Education of China 111 Project (B08007).	Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Chen YF, 2011, P NATL ACAD SCI USA, V108, P15225, DOI 10.1073/pnas.1103315108; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323; Davies DM, 2011, CLIN CANCER RES, V17, P4071, DOI 10.1158/1078-0432.CCR-11-0445; Derler I, 2012, ADV EXP MED BIOL, V740, P383, DOI 10.1007/978-94-007-2888-2_16; El Boustany C, 2008, HEPATOLOGY, V47, P2068, DOI 10.1002/hep.22263; El-Hashemite N, 2004, CANCER RES, V64, P3436, DOI 10.1158/0008-5472.CAN-03-3609; El-Hashemite N, 2003, CANCER RES, V63, P5173; Engh A, 2012, FRONT BIOSCI-LANDMRK, V17, P1613, DOI 10.2741/4007; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Feske S, 2010, CLIN IMMUNOL, V135, P169, DOI 10.1016/j.clim.2010.01.011; Feske S, 2010, PFLUG ARCH EUR J PHY, V460, P417, DOI 10.1007/s00424-009-0777-5; Flourakis M, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.52; Gilio K, 2010, J BIOL CHEM, V285, P23629, DOI 10.1074/jbc.M110.108696; Gough NR, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003044; Grosse J, 2007, J CLIN INVEST, V117, P3540, DOI 10.1172/JCI32312; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Harrington LS, 2005, TRENDS BIOCHEM SCI, V30, P35, DOI 10.1016/j.tibs.2004.11.003; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; HOWE SR, 1995, AM J PATHOL, V146, P1568; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huang GN, 2006, NAT CELL BIOL, V8, P1003, DOI 10.1038/ncb1454; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; KOBAYASHI T, 1995, NAT GENET, V9, P70, DOI 10.1038/ng0195-70; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee L, 2005, GENE CHROMOSOME CANC, V42, P213, DOI 10.1002/gcc.20118; Lewis RS, 2007, NATURE, V446, P284, DOI 10.1038/nature05637; Ma JH, 2010, J CLIN INVEST, V120, P103, DOI 10.1172/JCI37964; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Ogawa A, 2012, AM J PHYSIOL-CELL PH, V302, pC405, DOI 10.1152/ajpcell.00337.2011; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Pollizzi K, 2009, HUM MOL GENET, V18, P2378, DOI 10.1093/hmg/ddp176; Roczniak-Ferguson A, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002790; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Roskoski R, 2007, CRIT REV ONCOL HEMAT, V62, P179, DOI 10.1016/j.critrevonc.2007.01.006; Sabbioni S, 1997, CANCER RES, V57, P4493; Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Suyama E, 2004, J BIOL CHEM, V279, P38083, DOI 10.1074/jbc.C400313200; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64; Yang SY, 2009, CANCER CELL, V15, P124, DOI 10.1016/j.ccr.2008.12.019; Yecies JL, 2011, CANCER RES, V71, P2815, DOI 10.1158/0008-5472.CAN-10-4158; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984	50	30	30	1	16	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 26	2013	32	39					4702	4711		10.1038/onc.2012.481	http://dx.doi.org/10.1038/onc.2012.481			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	226YD	23108404	Green Accepted			2022-12-25	WOS:000325072200012
J	Amato, R; Scumaci, D; D'Antona, L; Iuliano, R; Menniti, M; Di Sanzo, M; Faniello, MC; Colao, E; Malatesta, P; Zingone, A; Agosti, V; Costanzo, FS; Mileo, AM; Paggi, MG; Lang, F; Cuda, G; Lavia, P; Perrotti, N				Amato, R.; Scumaci, D.; D'Antona, L.; Iuliano, R.; Menniti, M.; Di Sanzo, M.; Faniello, M. C.; Colao, E.; Malatesta, P.; Zingone, A.; Agosti, V.; Costanzo, F. S.; Mileo, A. M.; Paggi, M. G.; Lang, F.; Cuda, G.; Lavia, P.; Perrotti, N.			Sgk1 enhances RANBP1 transcript levels and decreases taxol sensitivity in RKO colon carcinoma cells	ONCOGENE			English	Article						Sgk1; RANBP1; taxol sensitivity; mitotic microtubule stabilization	INDUCIBLE PROTEIN-KINASE; BINDING PROTEIN-1; DOWN-REGULATION; CANCER-CELLS; SERUM; ACTIVATION; PHOSPHORYLATION; IDENTIFICATION; COORDINATION; EXPRESSION	The serum- and glucocorticoid-regulated kinase (Sgk1) is essential for hormonal regulation of epithelial sodium channel-mediated sodium transport and is involved in the transduction of growth factor-dependent cell survival and proliferation signals. Growing evidence now points to Sgk1 as a key element in the development and/or progression of human cancer. To gain insight into the mechanisms through which Sgk1 regulates cell proliferation, we adopted a proteomic approach to identify up- or downregulated proteins after Sgk1-specific RNA silencing. Among several proteins, the abundance of which was found to be up- or downregulated upon Sgk1 silencing, we focused our attention of RAN-binding protein 1 (RANBP1), a major effector of the GTPase RAN. We report that Sgk1-dependent regulation of RANBP1 has functional consequences on both mitotic microtubule activity and taxol sensitivity of cancer cells.	[Amato, R.; D'Antona, L.; Menniti, M.; Perrotti, N.] Magna Graecia Univ Catanzaro, Dept Human Hlth, Catanzaro, Italy; [Scumaci, D.; Iuliano, R.; Di Sanzo, M.; Faniello, M. C.; Agosti, V.; Costanzo, F. S.; Cuda, G.] Magna Graecia Univ Catanzaro, Dept Expt & Clin Med, Catanzaro, Italy; [Iuliano, R.; Colao, E.; Malatesta, P.; Perrotti, N.] Univ Hosp, Unit Med Genet & Pathol, Policlin Mater Domini, Catanzaro, Italy; [Zingone, A.] NCI, Multiple Myeloma Sect, Metab Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Mileo, A. M.; Paggi, M. G.] Natl Canc Inst Regina Elena, Dept Dev Therapeut Programs, Rome, Italy; [Lang, F.] Univ Tubingen, Dept Physiol, Tubingen, Germany; [Lavia, P.] Univ Roma La Sapienza, CNR, IBPM Inst Mol Biol & Pathol, I-00185 Rome, Italy	Magna Graecia University of Catanzaro; Magna Graecia University of Catanzaro; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Eberhard Karls University of Tubingen; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome	Lavia, P (corresponding author), Univ Roma La Sapienza, CNR, IBPM Inst Mol Biol & Pathol, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	patrizia.lavia@uniroma1.it; perrotti@unicz.it	Scumaci, Domenica/AAH-1493-2019; Cuda, Giovanni/AAC-2821-2019; Paggi, Marco G./K-3494-2018; Mileo, Anna Maria/J-3667-2016; Lavia, Patrizia/AAL-3982-2021; Costanzo, Francesco Saverio/K-3168-2018; Cuda, Giovanni/F-5359-2012; Lavia, Patrizia/J-5793-2019	Cuda, Giovanni/0000-0001-6313-1866; Mileo, Anna Maria/0000-0002-1970-3297; Costanzo, Francesco Saverio/0000-0002-3096-9416; Cuda, Giovanni/0000-0001-6313-1866; Lavia, Patrizia/0000-0003-3310-6701; Scumaci, Domenica/0000-0002-8117-834X; AGOSTI, Valter/0000-0001-6785-093X; Amato, Rosario/0000-0001-7162-1099; FANIELLO, Concetta Maria/0000-0001-6938-2754	Italian Association for Cancer Research (AIRC) [IG10164]; INAIL, CZ	Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); INAIL, CZ	This work was supported in part by the Italian Association for Cancer Research (AIRC grant IG10164 to PL). RA was supported in part by INAIL, CZ.	Amato R, 2007, J MOL MED, V85, P707, DOI 10.1007/s00109-007-0205-2; Amato R, 2009, J MOL MED, V87, P1221, DOI 10.1007/s00109-009-0525-5; Archer MC, 2011, CELL METABOL GENES C, V2, P712; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; Chen SY, 1999, P NATL ACAD SCI USA, V96, P2514, DOI 10.1073/pnas.96.5.2514; Ciciarello M, 2007, CELL MOL LIFE SCI, V64, P1891, DOI 10.1007/s00018-007-6568-2; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; de la Rosa DA, 1999, J BIOL CHEM, V274, P37834, DOI 10.1074/jbc.274.53.37834; Di Fiore B, 1999, J BIOL CHEM, V274, P10339, DOI 10.1074/jbc.274.15.10339; Di Fiore B, 2003, J CELL SCI, V116, P3399, DOI 10.1242/jcs.00624; Faletti CJ, 2001, AM J PHYSIOL, V283, pC494; Faniello MC, 2008, INT J BIOCHEM CELL B, V40, P2110, DOI 10.1016/j.biocel.2008.02.010; Feng Z, P NATL ACAD SCI US, V109, P7013; Firestone GL, 2003, CELL PHYSIOL BIOCHEM, V13, P1, DOI 10.1159/000070244; Gaspari M, 2007, J SEP SCI, V30, P2210, DOI 10.1002/jssc.200700192; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; Guarguaglini G, 2000, CELL GROWTH DIFFER, V11, P455; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027; Hu R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019490; Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959; Kim HS, 2009, J BIOL CHEM, V284, P15475, DOI 10.1074/jbc.M808734200; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lang F, 2010, INT J BIOCHEM CELL B, V42, P1571, DOI 10.1016/j.biocel.2010.05.016; Leong MLL, 2003, J BIOL CHEM, V278, P5871, DOI 10.1074/jbc.M211649200; Li HY, 2007, CELL CYCLE, V6, P1886, DOI 10.4161/cc.6.15.4487; Liu D, 2000, CURR BIOL, V10, P1233, DOI 10.1016/S0960-9822(00)00733-8; McCaig C, 2011, BIOCHEM BIOPH RES CO, V411, P227, DOI 10.1016/j.bbrc.2011.06.092; Menniti M, 2005, AM J PHYSIOL-CELL PH, V288, pC148, DOI 10.1152/ajpcell.00284.2004; Menniti M, 2010, CELL PHYSIOL BIOCHEM, V26, P587, DOI 10.1159/000322326; Nasir O, 2009, IUBMB LIFE, V61, P768, DOI 10.1002/iub.209; Peloponese JM, 2005, P NATL ACAD SCI USA, V102, P18974, DOI 10.1073/pnas.0506659103; Perrotti N, 2001, J BIOL CHEM, V276, P9406, DOI 10.1074/jbc.M007052200; Plafker K, 2002, J BIOL CHEM, V277, P30121, DOI 10.1074/jbc.M203006200; Rensen WM, 2009, ONCOGENE, V28, P1748, DOI 10.1038/onc.2009.24; Tan NY, 2009, MOL CELL BIOL, V29, P2483, DOI 10.1128/MCB.01828-08; Tedeschi A, 2007, J CELL SCI, V120, P3748, DOI 10.1242/jcs.009308; Wang K, 2010, CELL PHYSIOL BIOCHEM, V25, P271, DOI 10.1159/000276561; Yamada HY, 2010, CURR CANCER DRUG TAR, V10, P623, DOI 10.2174/156800910791859434; Yuen HF, 2012, CLIN CANCER RES, V18, P380, DOI 10.1158/1078-0432.CCR-11-2035; Zhang Y, 2010, INT J BIOCHEM CELL B, V42, P1964, DOI 10.1016/j.biocel.2010.08.007	42	46	47	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 19	2013	32	38					4572	4578		10.1038/onc.2012.470	http://dx.doi.org/10.1038/onc.2012.470			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	223SW	23108393				2022-12-25	WOS:000324831300013
J	Zhang, JP; Valianou, M; Simmons, H; Robinson, MK; Lee, HO; Mullins, SR; Marasco, WA; Adams, GP; Weiner, LM; Cheng, JD				Zhang, Jiping; Valianou, Matthildi; Simmons, Heidi; Robinson, Matthew K.; Lee, Hyung-Ok; Mullins, Stefanie R.; Marasco, Wayne A.; Adams, Gregory P.; Weiner, Louis M.; Cheng, Jonathan D.			Identification of inhibitory scFv antibodies targeting fibroblast activation protein utilizing phage display functional screens	FASEB JOURNAL			English	Article						serine protease; single-chain variable fragment	TUMOR STROMAL FIBROBLASTS; SERINE-PROTEASE; EXTRACELLULAR-MATRIX; EPITHELIAL CANCERS; MOLECULAR-CLONING; DIFFERENTIAL EXPRESSION; OVARIAN-CANCER; COLON-CANCER; PHASE-I; CELLS	Fibroblast activation protein (FAP) is a serine protease selectively expressed on tumor stromal fibroblasts in epithelial carcinomas and is important in cancer growth, adhesion, and metastases. As FAP enzymatic activity is a potent therapeutic target, we aimed to identify inhibitory antibodies. Using a competitive inhibition strategy, we used phage display techniques to identify 53 single-chain variable fragments (scFvs) after three rounds of panning against FAP. These scFvs were expressed and characterized for binding to FAP by surface plasmon resonance and flow cytometry. Functional assessment of these antibodies yielded an inhibitory scFv antibody, named E3, which could attenuate 35% of FAP cleavage of the fluorescent substrate Ala-Pro-7-amido-4-trifluoromethylcoumarin compared with nonfunctional scFv control. Furthermore, a mutant E3 scFv was identified by yeast affinity maturation. It had higher affinity (4-fold) and enhanced inhibitory effect on FAP enzyme activity (3-fold) than E3. The application of both inhibitory anti-FAP scFvs significantly affected the formation of 3-dimensional FAP-positive cell matrix, as demonstrated by reducing the fibronectin fiber orientation from 41.18% (negative antibody control) to 34.06% (E3) and 36.15% (mutant E3), respectively. Thus, we have identified and affinity-maturated the first scFv antibody capable of inhibiting FAP function. This scFv antibody has the potential to disrupt the role of FAP in tumor invasion and metastasis.-Zhang, J., Valianou, M., Simmons, H., Robinson, M. K., Lee, H.-O., Mullins, S. R., Marasco, W. A., Adams, G. P., Weiner, L. M., Cheng, J. D. Identification of inhibitory ScFv antibodies targeting fibroblast activation protein utilizing phage display functional screens. FASEB J. 27, 581-589 (2013). www.fasebj.org	[Valianou, Matthildi; Lee, Hyung-Ok; Mullins, Stefanie R.; Cheng, Jonathan D.] Fox Chase Canc Ctr, Dept Med Oncol, Philadelphia, PA 19111 USA; [Zhang, Jiping; Simmons, Heidi; Robinson, Matthew K.; Adams, Gregory P.] Fox Chase Canc Ctr, Dev Therapeut Program, Philadelphia, PA 19111 USA; [Marasco, Wayne A.] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA; [Weiner, Louis M.] Georgetown Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC USA	Fox Chase Cancer Center; Fox Chase Cancer Center; Harvard University; Dana-Farber Cancer Institute	Cheng, JD (corresponding author), Fox Chase Canc Ctr, Dept Med Oncol, 333 Cottman Ave, Philadelphia, PA 19111 USA.	j_cheng@fccc.edu	Adams, Gregory/ABE-8245-2020		U.S. National Institutes of Health [CA090468, CA103991-01, CA09035-28]; Frank Strick Foundation; Bernard A. and Rebecca S. Bernard Foundation; NATIONAL CANCER INSTITUTE [K08CA090468, P30CA051008, T32CA009035, R21CA103991] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Frank Strick Foundation; Bernard A. and Rebecca S. Bernard Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by U.S. National Institutes of Health grants CA090468, CA103991-01, and CA09035-28; the Frank Strick Foundation; the Bernard A. and Rebecca S. Bernard Foundation; and an appropriation from the Commonwealth of Pennsylvania and the American Cancer Society.	Adams GP, 2001, CANCER RES, V61, P4750; Aertgeerts K, 2005, J BIOL CHEM, V280, P19441, DOI 10.1074/jbc.C500092200; Amatangelo MD, 2005, AM J PATHOL, V167, P475, DOI 10.1016/S0002-9440(10)62991-4; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Cheng JD, 2005, MOL CANCER THER, V4, P351; Cheng JD, 2002, CANCER RES, V62, P4767; Colby DW, 2004, METHOD ENZYMOL, V388, P348; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Crnogorac-Jurcevic T, 2002, ONCOGENE, V21, P4587, DOI 10.1038/sj.onc.1205570; GARINCHESA P, 1990, P NATL ACAD SCI USA, V87, P7235, DOI 10.1073/pnas.87.18.7235; Goldstein LA, 1997, BBA-MOL BASIS DIS, V1361, P11, DOI 10.1016/S0925-4439(97)00032-X; Harrison JL, 1996, METHOD ENZYMOL, V267, P83; Henry LR, 2007, CLIN CANCER RES, V13, P1736, DOI 10.1158/1078-0432.CCR-06-1746; Huang Y, 2004, CANCER RES, V64, P2712, DOI 10.1158/0008-5472.CAN-03-3184; IOZZO RV, 1995, LAB INVEST, V73, P157; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Kurose K, 2001, HUM MOL GENET, V10, P1907, DOI 10.1093/hmg/10.18.1907; Lee HO, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-245; Levy MT, 1999, HEPATOLOGY, V29, P1768, DOI 10.1002/hep.510290631; LIOTTA LA, 1986, CANCER RES, V46, P1; Niedermeyer J, 1998, EUR J BIOCHEM, V254, P650, DOI 10.1046/j.1432-1327.1998.2540650.x; Niedermeyer J, 1997, INT J CANCER, V71, P383, DOI 10.1002/(SICI)1097-0215(19970502)71:3<383::AID-IJC14>3.0.CO;2-H; Park JE, 1999, J BIOL CHEM, V274, P36505, DOI 10.1074/jbc.274.51.36505; Poul MA, 2000, J MOL BIOL, V301, P1149, DOI 10.1006/jmbi.2000.4026; Radisky D, 2002, CANCER INVEST, V20, P139, DOI 10.1081/CNV-120000374; RETTIG WJ, 1993, CANCER RES, V53, P3327; RETTIG WJ, 1988, P NATL ACAD SCI USA, V85, P3110, DOI 10.1073/pnas.85.9.3110; RETTIG WJ, 1986, CANCER RES, V46, P6406; Roskelley CD, 2002, SEMIN CANCER BIOL, V12, P97, DOI 10.1006/scbi.2001.0417; Ruiter D, 2002, LANCET ONCOL, V3, P35, DOI 10.1016/S1470-2045(01)00620-9; SCANLAN MJ, 1994, P NATL ACAD SCI USA, V91, P5657, DOI 10.1073/pnas.91.12.5657; SCHIER R, 1995, IMMUNOTECHNOLOGY, V1, P73, DOI 10.1016/1380-2933(95)00007-0; Scott AM, 2003, CLIN CANCER RES, V9, P1639; Sui JH, 2004, P NATL ACAD SCI USA, V101, P2536, DOI 10.1073/pnas.0307140101; Sun SX, 2002, PROTEIN EXPRES PURIF, V24, P274, DOI 10.1006/prep.2001.1572; WELT S, 1994, J CLIN ONCOL, V12, P1193, DOI 10.1200/JCO.1994.12.6.1193; Wolf BB, 2008, MINI-REV MED CHEM, V8, P719, DOI 10.2174/138955708784567449; Yuan QA, 2006, MOL CANCER THER, V5, P2096, DOI 10.1158/1535-7163.MCT-06-0115	38	14	19	3	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	FEB	2013	27	2					581	589		10.1096/fj.12-210377	http://dx.doi.org/10.1096/fj.12-210377			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23104982	Green Published			2022-12-25	WOS:000314358000017
J	Behnke, BJ; Stabley, JN; McCullough, DJ; Davis, RT; Dominguez, JM; Muller-Delp, JM; Delp, MD				Behnke, Bradley J.; Stabley, John N.; McCullough, Danielle J.; Davis, Robert T., III; Dominguez, James M., II; Muller-Delp, Judy M.; Delp, Michael D.			Effects of spaceflight and ground recovery on mesenteric artery and vein constrictor properties in mice	FASEB JOURNAL			English	Article						orthostatic hypotension; microgravity; microcirculation	SIMULATED MICROGRAVITY; ORTHOSTATIC INTOLERANCE; HINDLIMB SUSPENSION; BLOOD-PRESSURE; SMOOTH-MUSCLE; VASOCONSTRICTOR RESPONSIVENESS; RESISTANCE ARTERIES; CA2+ RELEASE; FLOW; RYANODINE	Following exposure to microgravity, there is a reduced ability of astronauts to augment peripheral vascular resistance, often resulting in orthostatic hypotension. The purpose of this study was to test the hypothesis that mesenteric arteries and veins will exhibit diminished vasoconstrictor responses after spaceflight. Mesenteric arteries and veins from female mice flown on the Space Transportation System (STS)-131 (n = 11), STS-133 (n = 6), and STS-135 (n = 3) shuttle missions and respective ground-based control mice (n = 30) were isolated for in vitro experimentation. Vasoconstrictor responses were evoked in arteries via norepinephrine (NE), potassium chloride (KCl), and caffeine, and in veins through NE across a range of intraluminal pressures (2-12 cmH(2)O). Vasoconstriction to NE was also determined in mesenteric arteries at 1, 5, and 7 d postlanding. In arteries, maximal constriction to NE, KCl, and caffeine were reduced immediately following spaceflight and 1 d postflight. Spaceflight also reduced arterial ryanodine receptor-3 mRNA levels. In mesenteric veins, there was diminished constriction to NE after flight. The results indicate that the impaired vasoconstriction following spaceflight occurs through the ryanodine receptor-mediated intracellular Ca2+ release mechanism. Such vascular changes in astronauts could compromise the maintenance of arterial pressure during orthostatic stress.-Behnke, B. J., Stabley, J. N., McCullough, D. J., Davis, R. T., III, Dominguez, J. M., II, Muller-Delp, J. M., Delp, M. D. Effects of spaceflight and ground recovery on mesenteric artery and vein constrictor properties in mice. FASEB J. 27, 399-409 (2013). www.fasebj.org	[Behnke, Bradley J.; Stabley, John N.; McCullough, Danielle J.; Davis, Robert T., III; Dominguez, James M., II; Delp, Michael D.] Univ Florida, Dept Appl Physiol & Kinesiol, Gainesville, FL 32611 USA; [Behnke, Bradley J.; Stabley, John N.; McCullough, Danielle J.; Davis, Robert T., III; Dominguez, James M., II; Delp, Michael D.] Univ Florida, Ctr Exercise Sci, Gainesville, FL 32611 USA; [Muller-Delp, Judy M.] Univ Florida, Dept Physiol & Funct Genom, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Delp, MD (corresponding author), Univ Florida, Dept Appl Physiol & Kinesiol, POB 118205, Gainesville, FL 32611 USA.	mdelp@ufl.edu		Delp, Michael/0000-0002-2916-0783; Muller-Delp, Judy/0000-0001-5322-0611; /0000-0002-1825-7846	NASA [NNX08AQ62G, NNX09AP06G]; U.S. National Institutes of Health [AG-31317]; Florida Biomedical Research Program [1BN-02]; Department of Applied Physiology and Kinesiology, University of Florida; NATIONAL INSTITUTE ON AGING [R36AG036816] Funding Source: NIH RePORTER	NASA(National Aeronautics & Space Administration (NASA)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Florida Biomedical Research Program; Department of Applied Physiology and Kinesiology, University of Florida; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	These studies were originally flown on space shuttle mission STS-107, on which the orbiter Columbia tragically disintegrated during its return flight to Earth. This manuscript is dedicated to the STS-107 crew, who were willing to risk their lives to advance our understanding of the effects of microgravity on human health. The authors thank Blaze Emerson for technical assistance and Richard Boyle, Paula Dumars, Marianne Steele, Marilyn Vasquez, and Vera Vizir [U.S. National Aeronautics and Space Administration (NASA) Ames Research Center, Mountain View, CA, USA] for their logistical support. This study was supported by grants from NASA (NNX08AQ62G and NNX09AP06G), the U.S. National Institutes of Health (AG-31317), the Florida Biomedical Research Program (1BN-02), and the Jane Adams Edmonds endowed doctoral fellowship (Department of Applied Physiology and Kinesiology, University of Florida).	Arbeille P, 2008, AM J PHYSIOL-HEART C, V295, pH1846, DOI 10.1152/ajpheart.509.2008; Arbeille P.F., 1996, ACTA ASTRONAUT, V36, P6; Arbeille PP, 2005, J APPL PHYSIOL, V99, P1853, DOI 10.1152/japplphysiol.00331.2005; ARMSTRONG RB, 1987, J APPL PHYSIOL, V62, P1285, DOI 10.1152/jappl.1987.62.3.1285; Baevsky RM, 2007, J APPL PHYSIOL, V103, P156, DOI 10.1152/japplphysiol.00137.2007; Ballard R. W., 1994, FINAL REPORTS US EXP, V1, P374; Behnke BJ, 2001, RESP PHYSIOL, V126, P53, DOI 10.1016/S0034-5687(01)00195-5; Behnke BJ, 2008, J APPL PHYSIOL, V104, P1273, DOI 10.1152/japplphysiol.00954.2006; Behnke BJ, 2010, J APPL PHYSIOL, V108, P14, DOI 10.1152/japplphysiol.00970.2009; Blomqvist C. G., 1983, HDB PHYSL PERIPHERAL, P1027; BRENNER BM, 1990, PHYSIOL REV, V70, P665, DOI 10.1152/physrev.1990.70.3.665; Buckey JC, 1996, J APPL PHYSIOL, V81, P7, DOI 10.1152/jappl.1996.81.1.7; BULLARD RW, 1972, ANNU REV PHYSIOL, V34, P205, DOI 10.1146/annurev.ph.34.030172.001225; Callera GE, 1999, GEN PHARMACOL, V33, P457, DOI 10.1016/S0306-3623(99)00042-7; Catterson A.D., 1963, AEROMEDICAL OBSERVAT, P299; Colleran PN, 2008, AM J PHYSIOL-REG I, V294, pR1577, DOI 10.1152/ajpregu.00084.2008; Convertino V. A, 1997, CLIN AUTONOMIC DISOR, V33, P429; Coussin F, 2000, J BIOL CHEM, V275, P9596, DOI 10.1074/jbc.275.13.9596; Dabertrand F, 2012, J APPL PHYSIOL, V112, P471, DOI 10.1152/japplphysiol.00733.2011; Davis MJ, 1999, PHYSIOL REV, V79, P387, DOI 10.1152/physrev.1999.79.2.387; DAVIS MJ, 1992, AM J PHYSIOL, V262, pC1083, DOI 10.1152/ajpcell.1992.262.4.C1083; DELP MD, 1995, J APPL PHYSIOL, V78, P2079, DOI 10.1152/jappl.1995.78.6.2079; DELP MD, 1993, J APPL PHYSIOL, V75, P2620, DOI 10.1152/jappl.1993.75.6.2620; Delp MD, 2000, AM J PHYSIOL-HEART C, V278, pH1866, DOI 10.1152/ajpheart.2000.278.6.H1866; Delp MD, 1999, J APPL PHYSIOL, V86, P1178, DOI 10.1152/jappl.1999.86.4.1178; Donato AJ, 2005, CARDIOVASC RES, V66, P393, DOI 10.1016/j.cardiores.2004.10.023; Dunbar SL, 2000, J APPL PHYSIOL, V89, P2073, DOI 10.1152/jappl.2000.89.5.2073; Ertl AC, 2002, J PHYSIOL-LONDON, V538, P321, DOI 10.1113/jphysiol.2001.012576; Essin K, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/135249; FAREH J, 1994, J APPL PHYSIOL, V76, P641, DOI 10.1152/jappl.1994.76.2.641; FENGERGRON J, 1995, J PHYSIOL-LONDON, V488, P753, DOI 10.1113/jphysiol.1995.sp021006; Gashev AA, 2006, AM J PHYSIOL-HEART C, V290, pH2295, DOI 10.1152/ajpheart.00260.2005; Halet G., 1999, AM J PHYSIOL, V277, pC139; Hatton DC, 2002, J APPL PHYSIOL, V92, P13, DOI 10.1152/jappl.2002.92.1.13; KONG JQ, 1994, J PHARMACOL EXP THER, V268, P1153; Leech CJ, 1996, AM J PHYSIOL-HEART C, V270, pH710, DOI 10.1152/ajpheart.1996.270.2.H710; Levine BD, 1997, CIRCULATION, V96, P517; Lin LJ, 2009, J APPL PHYSIOL, V107, P1710, DOI 10.1152/japplphysiol.00493.2009; Ma J, 1996, J Gravit Physiol, V3, P9; McCurdy MR, 2000, J APPL PHYSIOL, V89, P398, DOI 10.1152/jappl.2000.89.1.398; MCDONALD KS, 1992, J APPL PHYSIOL, V72, P2210, DOI 10.1152/jappl.1992.72.6.2210; Meck JV, 2001, PSYCHOSOM MED, V63, P865, DOI 10.1097/00006842-200111000-00003; Miriel VA, 1999, J PHYSIOL-LONDON, V518, P815, DOI 10.1111/j.1469-7793.1999.0815p.x; Morel J. L., 1997, AM J PHYSIOL, V273, pH2867; MULVAGH SL, 1991, J CLIN PHARMACOL, V31, P1024, DOI 10.1002/j.1552-4604.1991.tb03666.x; Neri G, 2002, AM J PHYSIOL-REG I, V283, pR832, DOI 10.1152/ajpregu.00099.2002; Norsk P, 2006, HYPERTENSION, V47, P69, DOI 10.1161/01.HYP.0000194332.98674.57; Nyhan D, 2002, J APPL PHYSIOL, V92, P33, DOI 10.1152/jappl.2002.92.1.33; OVERTON JM, 1990, J APPL PHYSIOL, V68, P355, DOI 10.1152/jappl.1990.68.1.355; Papadopoulos A, 2003, J APPL PHYSIOL, V94, P439, DOI 10.1152/japplphysiol.00734.2002; Purdy RE, 1998, J APPL PHYSIOL, V85, P1307, DOI 10.1152/jappl.1998.85.4.1307; Rowell L, 1993, HUMAN CARDIOVASCULAR; ROWELL LB, 1972, J APPL PHYSIOL, V32, P213, DOI 10.1152/jappl.1972.32.2.213; Sangha DS, 2000, J APPL PHYSIOL, V88, P507, DOI 10.1152/jappl.2000.88.2.507; SAYET I, 1995, J APPL PHYSIOL, V78, P1882, DOI 10.1152/jappl.1995.78.5.1882; Serova L.V., 1984, PHYSIOLOGIST, V27, pS107; SHOUKAS AA, 1990, AM J PHYSIOL, V259, pH674, DOI 10.1152/ajpheart.1990.259.3.H674; Smimov K. V., 1987, KOS BIOL AVIAK MED, V21, P8; Spier SA, 2004, J PHYSIOL-LONDON, V556, P947, DOI 10.1113/jphysiol.2003.060301; Stabley JN, 2012, J APPL PHYSIOL, V113, P1439, DOI 10.1152/japplphysiol.00772.2012; Steenbergen JF, 1996, J BIOL CHEM, V271, P1821, DOI 10.1074/jbc.271.4.1821; Sun GS, 2010, NUTRITION, V26, P1163, DOI 10.1016/j.nut.2009.09.018; WATANABE J, 1994, CARDIOVASC RES, V28, P480, DOI 10.1093/cvr/28.4.480; WATANABE J, 1993, CIRC RES, V73, P465, DOI 10.1161/01.RES.73.3.465; Watenpaugh D.E., 2011, COMPR PHYSIOL, DOI [10.1002/cphy.cp040129, DOI 10.1002/CPHY.CP040129]; Waters WW, 2002, J APPL PHYSIOL, V92, P586, DOI 10.1152/japplphysiol.00544.2001; White AR, 2010, EUR J APPL PHYSIOL, V110, P395, DOI 10.1007/s00421-010-1514-7; Wilkerson MK, 1999, J APPL PHYSIOL, V87, P2115, DOI 10.1152/jappl.1999.87.6.2115; WOODMAN CR, 1995, J APPL PHYSIOL, V79, P1762, DOI 10.1152/jappl.1995.79.5.1762; Xue JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019775; Zhang LF, 2001, J APPL PHYSIOL, V91, P2415, DOI 10.1152/jappl.2001.91.6.2415; Zheng YM, 2008, J VASC RES, V45, P469, DOI 10.1159/000127438	72	32	36	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2013	27	1					399	409		10.1096/fj.12-218503	http://dx.doi.org/10.1096/fj.12-218503			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	064VJ	23099650	Green Published			2022-12-25	WOS:000313103200038
J	Davalos, V; Suarez-Lopez, L; Castano, J; Messent, A; Abasolo, I; Fernandez, Y; Guerra-Moreno, A; Espin, E; Armengol, M; Musulen, E; Ariza, A; Sayos, J; Arango, D; Schwartz, S				Davalos, Veronica; Suarez-Lopez, Lucia; Castano, Julio; Messent, Anthea; Abasolo, Ibane; Fernandez, Yolanda; Guerra-Moreno, Angel; Espin, Eloy; Armengol, Manel; Musulen, Eva; Ariza, Aurelio; Sayos, Joan; Arango, Diego; Schwartz, Simo, Jr.			Human SMC2 Protein, a Core Subunit of Human Condensin Complex, Is a Novel Transcriptional Target of the WNT Signaling Pathway and a New Therapeutic Target	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CHROMOSOME CONDENSATION; BETA-CATENIN; CELL-DIVISION; CANCER CELLS; C-MYC; ACTIVATION; PHOSPHORYLATION; OVEREXPRESSION; IDENTIFICATION; INHIBITION	Human SMC2 is part of the condensin complex, which is responsible for tightly packaging replicated genomic DNA prior to segregation into daughter cells. Engagement of the WNT signaling pathway is known to have a mitogenic effect on cells, but relatively little is known about WNT interaction with mitotic structural organizer proteins. In this work, we described the novel transcriptional regulation of SMC2 protein by direct binding of the beta-catenin.TCF4 transcription factor to the SMC2 promoter. Furthermore, we identified the precise region in the SMC2 promoter that is required for beta-catenin-mediated promoter activation. Finally, we explored the functional significance of down-regulating SMC2 protein in vivo. Treatment of WNT-activated intestinal tumor cells with SMC2 siRNA significantly reduced cell proliferation in nude mice, compared with untreated controls (p = 0.02). Therefore, we propose that WNT signaling can directly activate SMC2 transcription as a key player in the mitotic cell division machinery. Furthermore, SMC2 represents a new target for oncological therapeutic intervention.	[Davalos, Veronica; Suarez-Lopez, Lucia; Castano, Julio; Messent, Anthea; Abasolo, Ibane; Fernandez, Yolanda; Guerra-Moreno, Angel; Espin, Eloy; Armengol, Manel; Schwartz, Simo, Jr.] Univ Autonoma Barcelona, Vall Hebron Inst Recerca, Drug Delivery & Targeting Grp, Mol Biol & Biochem Res Ctr Nano Med CIBBIM Nanome, Barcelona 08035, Spain; [Messent, Anthea; Abasolo, Ibane; Fernandez, Yolanda; Guerra-Moreno, Angel; Espin, Eloy; Armengol, Manel; Sayos, Joan; Schwartz, Simo, Jr.] Inst Salud Carlos III, Networking Res Ctr Bioengn Biomat & Nanomed CIBER, Zaragoza 50018, Spain; [Espin, Eloy; Armengol, Manel] Univ Hosp Vall Hebron, Dept Gen Surg, Barcelona 08035, Spain; [Musulen, Eva; Ariza, Aurelio] Hosp Trias & Pujol, Dept Pathol, Badalona 08916, Spain; [Sayos, Joan] Univ Autonoma Barcelona, Univ Hosp Vall Hebron, Vall Hebron Inst Recerca, CIBBIM Nanomed,Immunobiol Grp, Barcelona 08035, Spain; [Arango, Diego] Univ Autonoma Barcelona, Univ Hosp Vall Hebron, Vall Hebron Inst Recerca, CIBBIM Nanomed,Mol Oncol Grp, Barcelona 08035, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Instituto de Salud Carlos III; Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR)	Schwartz, S (corresponding author), Univ Autonoma Barcelona, Univ Hosp Vall Hebron, Vall Hebron Inst Recerca,Drug Delivery & Targeti, Mol Biol & Biochem Res Ctr Nanomed CIBBIM Nanomed, Barcelona 08035, Spain.	simo.schwartz@vhir.org	Abasolo, Ibane/H-7741-2012; Sayos, Joan/B-6119-2009; Guerra-Moreno, Angel/K-6258-2015; Musulen, Eva/AAI-9169-2020; Arango, Diego/AFW-0125-2022; Davalos, Veronica/AAR-8547-2020; Arango, Diego/M-5667-2016; Angel, Guerra-Moreno/AAF-7135-2021; Cardoso, Julio Castaño/AAB-5820-2019; Davalos, Veronica/S-1668-2016	Abasolo, Ibane/0000-0001-5970-6276; Sayos, Joan/0000-0002-4664-3461; Guerra-Moreno, Angel/0000-0003-2321-1129; Musulen, Eva/0000-0002-9667-6464; Arango, Diego/0000-0003-2953-3284; Arango, Diego/0000-0003-2953-3284; Angel, Guerra-Moreno/0000-0003-2321-1129; Davalos, Veronica/0000-0003-4077-5137; Armengol, Manuel/0000-0002-3211-3195; Schwartz, Simo/0000-0001-8297-7971; Suarez Lopez, Lucia/0000-0002-3719-0536; Castano Cardoso, Julio/0000-0002-0712-5856; Espin-Basany, Eloy/0000-0002-9139-4548	Spanish Ministry of Science and Innovation [EU2008-0170]; "Fondo de Investigaciones Sanitarias" [PI080771]; Spanish Ministry of Science and Innovation; Networking Centre on Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN); Instituto de Salud Carlos III	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); "Fondo de Investigaciones Sanitarias"(Instituto de Salud Carlos III); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Networking Centre on Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission)	This work was supported in part by Grants EU2008-0170 from the Spanish Ministry of Science and Innovation, PI080771 from the "Fondo de Investigaciones Sanitarias," and grants from the Spanish Ministry of Science and Innovation, the Networking Centre on Bioengineering, Biomaterials, and Nanomedicine (CIBER-BBN), Instituto de Salud Carlos III, and Spanish Ministry of Science and Innovation.	Arango D, 2003, BRIT J CANCER, V89, P1757, DOI 10.1038/sj.bjc.6601338; Bahmanyar S, 2008, GENE DEV, V22, P91, DOI 10.1101/gad.1596308; Banks JD, 2004, CURR BIOL, V14, P2033, DOI 10.1016/j.cub.2004.10.049; Bazile F, 2010, CELL CYCLE, V9, P3243, DOI 10.4161/cc.9.16.12620; Bex A, 2001, CANCER GENET CYTOGEN, V124, P98, DOI 10.1016/S0165-4608(00)00332-0; Chien AJ, 2009, J INVEST DERMATOL, V129, P1614, DOI 10.1038/jid.2008.445; Davidson G, 2010, TRENDS CELL BIOL, V20, P453, DOI 10.1016/j.tcb.2010.05.002; Dikovskaya D, 2004, MOL BIOL CELL, V15, P2978, DOI 10.1091/mbc.E03-08-0613; Ghiselli G, 2003, J BIOL CHEM, V278, P20259, DOI 10.1074/jbc.M209511200; Ghiselli G, 2000, J BIOL CHEM, V275, P20235, DOI 10.1074/jbc.C000213200; Ham MF, 2007, CANCER SCI, V98, P1041, DOI 10.1111/j.1349-7006.2007.00500.x; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; Hubbard TJP, 2007, NUCLEIC ACIDS RES, V35, pD610, DOI 10.1093/nar/gkl996; Hudson DF, 2009, CHROMOSOME RES, V17, P131, DOI 10.1007/s10577-008-9009-7; Ilyas M, 1997, P NATL ACAD SCI USA, V94, P10330, DOI 10.1073/pnas.94.19.10330; Kaplan DD, 2004, J BIOL CHEM, V279, P10829, DOI 10.1074/jbc.C400035200; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Lee G, 2009, P NATL ACAD SCI USA, V106, P4701, DOI 10.1073/pnas.0900751106; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; Oliveira RA, 2010, BIOCHEM SOC T, V38, P1639, DOI 10.1042/BST0381639; Orford K, 1999, J CELL BIOL, V146, P855, DOI 10.1083/jcb.146.4.855; Paliulis LV, 2004, CURR BIOL, V14, P2124, DOI 10.1016/j.cub.2004.11.052; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; St-Pierre J, 2009, MOL CELL, V34, P416, DOI 10.1016/j.molcel.2009.04.013; Strunnikov AV, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-15; Takemoto A, 2004, J BIOL CHEM, V279, P4551, DOI 10.1074/jbc.M310925200; Takemoto A, 2007, NUCLEIC ACIDS RES, V35, P2403, DOI 10.1093/nar/gkm157; Takemoto A, 2006, EMBO J, V25, P5339, DOI 10.1038/sj.emboj.7601394; Takemoto A, 2009, NAT STRUCT MOL BIOL, V16, P1302, DOI 10.1038/nsmb.1708; Thomson Scientific, SCI; Tone SO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014345; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van de Wetering M, 2003, EMBO REP, V4, P609, DOI 10.1038/sj.embor.embor865	35	33	34	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43472	43481		10.1074/jbc.M112.428466	http://dx.doi.org/10.1074/jbc.M112.428466			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23095742	Green Published, hybrid			2022-12-25	WOS:000312940800028
J	Huang, SF; Dai, W; Sun, S; Zhang, XJ; Zhang, LP				Huang, Shifeng; Dai, Wei; Sun, Shan; Zhang, Xiaojiao; Zhang, Liping			Prevalence of Plasmid-Mediated Quinolone Resistance and Aminoglycoside Resistance Determinants among Carbapeneme Non-Susceptible Enterobacter cloacae	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; KLEBSIELLA-PNEUMONIAE; QNR PREVALENCE; EMERGENCE; ARMA	Background: Simultaneous resistance to aminoglycosides and fluoroquinolones in carbapeneme non-susceptible (CNS) isolates will inevitably create problems. The present study was performed to characterize the prevalence of the plasmid-mediated quinolone resistance determinants (QRDs) and aminoglycoside resistance determinants (ARDs) among the CNS Enterobacter cloacae (E. cloacae) isolates in a Chinese teaching hospital, and to acquire their molecular epidemiological characteristics. Methods: The beta-lactamases genes (including class A carbapenemase genes bla(KPC) and bla(SME), metallo-beta-lactamase genes (MBLs) bla(IMP), bla(VIM) and bla(NDM), and extended spectrum beta-lactamases (ESBLs), bla(CTX-M), bla(TEM) and bla(SHV)), QRDs (including qnrA, qnrB, qnrS and aac(6')-Ib-cr) and ARDs (including aac(6')-Ib, armA and rmtB) of these 35 isolates were determined by PCR and sequenced bidirectionally. The clonal relatedness was investigated by pulsed-field gel electrophoresis (PFGE). Results: Of the 35 isolates, 9 (25.7%) harbored a carbapenemase gene; 23 (65.7%) carried ESBLs; 24 (68.6%) were QRD positive; and 27 (77.1%) were ARD positive. Among the 5 bla(IMP-8) positive strains, 4 (80%) contained both ESBL and QRD genes, and all the 5 (100%) harbored ARD genes. Of the 23 ESBLs positive isolates, 6 (26.1%) were carbapenemase positive, 14 (60.9%) were QRD positive, and 18 (78.3%) were ARD positive. PFGE revealed genetic diversity among the 35 isolates, indicating that the high prevalence of CNS E. cloacae isolates was not caused by clonal dissemination. Conclusion: QRD and ARD genes were highly prevalent among the CNS E. cloacae isolates. Multiple resistant genes were co-expressed in the same isolates. The CNS E. cloacae isolate co-expressing bla(NDM-1), bla(IMP-26), qnrA1 and qnrS1 was first reported.	[Huang, Shifeng; Dai, Wei; Sun, Shan; Zhang, Xiaojiao; Zhang, Liping] Chongqing Med Univ, Affiliated Hosp 1, Dept Lab Med, Chongqing, Peoples R China	Chongqing Medical University	Zhang, LP (corresponding author), Chongqing Med Univ, Affiliated Hosp 1, Dept Lab Med, Chongqing, Peoples R China.	liuzhangcq@yahoo.com		Huang, Shifeng/0000-0001-7641-8823	National Science Foundation of China [81071621, 30973378]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the National Science Foundation of China (Grant No. 81071621 and No. 30973378; http://www.nsfc.gov.cn/Portal0/default152.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bush K, 2010, CURR OPIN MICROBIOL, V13, P558, DOI 10.1016/j.mib.2010.09.006; Chmelnitsky I, 2008, ANTIMICROB AGENTS CH, V52, P2962, DOI 10.1128/AAC.01341-07; Cornaglia G, 2011, LANCET INFECT DIS, V11, P381, DOI 10.1016/S1473-3099(11)70056-1; Folster JP, 2009, ANTIMICROB AGENTS CH, V53, P4563, DOI 10.1128/AAC.00656-09; Kim HK, 2009, J AM COLL CARDIOL, V53, P2009, DOI 10.1016/j.jacc.2009.01.066; Liu Y, 2009, ANTIMICROB AGENTS CH, V53, P1642, DOI 10.1128/AAC.01325-08; Livermore DM, 2011, J ANTIMICROB CHEMOTH, V66, P48, DOI 10.1093/jac/dkq408; Ma L, 2009, ANTIMICROB AGENTS CH, V53, P104, DOI 10.1128/AAC.00852-08; Mammeri H, 2005, ANTIMICROB AGENTS CH, V49, P71, DOI 10.1128/AAC.49.1.71-76.2005; Mc Gann P, 2012, ANTIMICROB AGENTS CH, V56, P1673, DOI 10.1128/AAC.05604-11; Miriagou V, 2010, CLIN MICROBIOL INFEC, V16, P112, DOI 10.1111/j.1469-0691.2009.03116.x; Naas T, 2011, J CLIN MICROBIOL, V49, P1608, DOI 10.1128/JCM.02607-10; O'Neill A, 2008, EXPERT OPIN INV DRUG, V17, P297, DOI 10.1517/13543784.17.3.297 ; Paterson DL, 2000, CLIN MICROBIOL INFEC, V6, P460, DOI 10.1046/j.1469-0691.2000.00107.x; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Pitout JDD, 2005, J ANTIMICROB CHEMOTH, V56, P52, DOI 10.1093/jac/dki166; Poirel L, 2011, ANTIMICROB AGENTS CH, V55, P5403, DOI 10.1128/AAC.00585-11; Robicsek A, 2006, NAT MED, V12, P83, DOI 10.1038/nm1347; Robicsek A, 2006, ANTIMICROB AGENTS CH, V50, P2872, DOI 10.1128/AAC.01647-05; Robicsek A, 2006, LANCET INFECT DIS, V6, P629, DOI 10.1016/S1473-3099(06)70599-0; Rodriguez-Martinez JM, 2007, ANTIMICROB AGENTS CH, V51, P2236, DOI 10.1128/AAC.01444-06; Strahilevitz J, 2007, ANTIMICROB AGENTS CH, V51, P3001, DOI 10.1128/aac.00256-07; Strahilevitz J, 2009, CLIN MICROBIOL REV, V22, P664, DOI 10.1128/CMR.00016-09; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; Vakulenko SB, 2003, CLIN MICROBIOL REV, V16, P430, DOI 10.1128/CMR.16.3.430-450.2003; Wu JJ, 2007, ANTIMICROB AGENTS CH, V51, P1223, DOI 10.1128/AAC.01195-06; Wu Q, 2010, DIAGN MICR INFEC DIS, V66, P326, DOI 10.1016/j.diagmicrobio.2009.10.003; Yang FC, 2012, J CLIN MICROBIOL, V50, P223, DOI 10.1128/JCM.01263-11; Yang H, 2008, ANTIMICROB AGENTS CH, V52, P4268, DOI 10.1128/AAC.00830-08; Zacharczuk K, 2011, ANTIMICROB AGENTS CH, V55, P443, DOI 10.1128/AAC.00386-10	30	37	50	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47636	10.1371/journal.pone.0047636	http://dx.doi.org/10.1371/journal.pone.0047636			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110085	Green Published, gold, Green Submitted			2022-12-25	WOS:000310193600019
J	August, SL; De Rosa, MJ				August, Suzanne L.; De Rosa, Michael J.			Evaluation of the Prevalence of Urinary Tract Infection in Rural Panamanian Women	PLOS ONE			English	Article							ASYMPTOMATIC BACTERIURIA	Objective: Urinary tract infection (UTI) is the most common non-intestinal infection worldwide. In the developed world, incidence and prevalence of UTI would be similar owing to the relatively short duration of illness experienced by women with ready access to healthcare services. We hypothesize that, in the developing world, factors limiting access to care and those which may increase the likelihood of developing UTI, result in increased morbidity. This difference is reflected in an increased prevalence of UTI in regions where women suffer the effects of UTI for extended periods of time. Methods: This study represents a cross sectional analysis of UTI prevalence in rural western Panama conducted over the course of a 3-day medical mission. All women 18-45 years of age reporting to the medical brigade clinic were tested for UTI by dipstick urinalysis and a brief history regardless of whether they themselves were presenting with a complaint. Results: UTI was diagnosed clinically by providers in 29.8% of the women tested although only 21.15% of these same women met the evidence-based study criteria. This prevalence of 21.15% is seven times greater than reported by the Panamanian Ministry of Health. When comparing the effectiveness of clinical diagnosis relative to urinalysis by dipstick, a Kappa coefficient revealed only low moderate agreement (0.42; SE 0.0955). Conclusions: The prevalence of UTI in rural western Panama is greater than would be expected based on prevalence data from either the US or Panamanian Ministry of Health and may represent an opportunity for targeted interventions, including educational programming about UTI prevention.	[August, Suzanne L.] Samuel Merritt Univ, Sch Nursing, Oakland, CA USA; [De Rosa, Michael J.] Samuel Merritt Univ, Phys Assistant Dept, Oakland, CA USA	Samuel Merritt University; Samuel Merritt University	August, SL (corresponding author), Samuel Merritt Univ, Sch Nursing, Oakland, CA USA.	saugust@samuelmerritt.edu						Akinloye O, 2006, BRIT J BIOMED SCI, V63, P109, DOI 10.1080/09674845.2006.11732734; [Anonymous], 2006, IND BAS SAL REP PAN; Awonuga DO, 2010, NIGER J MED, V19, P339; Delzell JE, 2000, AM FAM PHYSICIAN, V61, P713; Dielubanza EJ, 2011, MED CLIN N AM, V95, P27, DOI 10.1016/j.mcna.2010.08.023; Gau JT, 2009, J AM OSTEOPATH ASSOC, V109, P220; Hooton TM, 2000, NEW ENGL J MED, V343, P1037; Kovavisarach Ekachai, 2009, Journal of the Medical Association of Thailand, V92, P606; Liao YM, 2009, INT J NURS STUD, V46, P633, DOI 10.1016/j.ijnurstu.2008.12.001; Masinde A, 2009, Tanzan J Health Res, V11, P154; Medina-Bombardo D, 2003, FAM PRACT, V20, P103, DOI 10.1093/fampra/20.2.103; Mehnert-Kay SA, 2005, AM FAM PHYSICIAN, V72, P451; National Institutes of Health, 2021, UROLOGIC DIS AM; OLUSANYA O, 1992, CENT AFR J MED, V38, P297; Trestioreanu AZ, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007182.pub2; Vital and Health Statistics, 2004, VITAL HLTH STAT, V13; World Health Organization (WHO), 2019, DEM KEY FACTS	17	15	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47752	10.1371/journal.pone.0047752	http://dx.doi.org/10.1371/journal.pone.0047752			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094080	Green Submitted, gold, Green Published			2022-12-25	WOS:000310050200041
J	Cuypers, KF; Loos, RJF; Kvaloy, K; Kulle, B; Romundstad, P; Holmen, TL				Cuypers, Koenraad Frans; Loos, Ruth J. F.; Kvaloy, Kirsti; Kulle, Bettina; Romundstad, Pal; Holmen, Turid Lingaas			Obesity-Susceptibility Loci and Their Influence on Adiposity-Related Traits in Transition from Adolescence to Adulthood - The HUNT Study	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; NORD-TRONDELAG HEALTH; BODY-MASS INDEX; PHYSICAL-ACTIVITY; FTO GENE; OVERWEIGHT; CHILDHOOD; VARIANTS; VALIDITY; RELIABILITY	Introduction: Obesity-susceptibility loci have been related to adiposity traits in adults and may affect body fat estimates in adolescence. There are indications that different sets of obesity-susceptibility loci influence level of and change in obesity-related traits from adolescence to adulthood. Objectives: To investigate whether previously reported obesity-susceptible loci in adults influence adiposity traits in adolescence and change in BMI and waist circumference (WC) from adolescence into young adulthood. We also examined whether physical activity modifies the effects of these genetic loci on adiposity-related traits. Methods: Nine obesity-susceptibility variants were genotyped in 1 643 adolescents (13-19 years old) from the HUNT study, Norway, who were followed-up into young adulthood. Lifestyle was assessed using questionnaires and anthropometric measurements were taken. The effects of genetic variants individually and combined in a genetic predisposition score (GPS) on obesity-related traits were studied cross-sectionally and longitudinally. A modifying effect of physical activity was tested. Results: The GPS was significantly associated to BMI (B: 0.046 SD/allele [0.020, 0.073], p = 0.001) in adolescence and in young adulthood (B: 0.041 SD/allele [0.015, 0.067], p = 0.002) as it was to waist circumference (WC). The GPS was not associated to change in BMI (p = 0.762) or WC (p = 0.726). We found no significant interaction effect between the GPS and physical activity. Conclusions: Our observations suggest that obesity-susceptibility loci established in adults affect BMI and WC already in adolescence. However, an association with change in adiposity-related traits from adolescence to adulthood could not be verified for these loci. Neither could an attenuating effect of physical activity on the association between the obesity-susceptibility genes and body fat estimates be revealed.	[Cuypers, Koenraad Frans; Kvaloy, Kirsti; Holmen, Turid Lingaas] Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth & Gen Practice, HUNT Res Ctr, N-7034 Trondheim, Norway; [Loos, Ruth J. F.] Addenbrookes Hosp, Inst Metab Sci, MRC, Epidemiol Unit, Cambridge, England; [Loos, Ruth J. F.] Mt Sinai Sch Med, Charles Bronfman Inst Personalized Med, Inst Child Hlth, Genet Obes & Related Metab Traits Program, New York, NY USA; [Kulle, Bettina] Univ Oslo, Akershus Univ Hosp, Inst Clin Med, Epi Gen, Oslo, Norway; [Kulle, Bettina] Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo, Norway; [Romundstad, Pal] Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth & Gen Practice, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Icahn School of Medicine at Mount Sinai; University of Oslo; University of Oslo; Norwegian University of Science & Technology (NTNU)	Cuypers, KF (corresponding author), Norwegian Univ Sci & Technol, Fac Med, Dept Publ Hlth & Gen Practice, HUNT Res Ctr, N-7034 Trondheim, Norway.	Koenraad.cuypers@ntnu.no	Loos, Ruth/GON-5877-2022; Loos, Ruth J F/Q-2862-2016	Loos, Ruth J F/0000-0002-8532-5087; Romundstad, Pal Richard/0000-0003-2061-4336	Norwegian Research Council; European Science Foundation [ESF- 4064]; MRC [MC_U106188470] Funding Source: UKRI; Medical Research Council [MC_U106188470] Funding Source: researchfish	Norwegian Research Council(Research Council of NorwayEuropean Commission); European Science Foundation(European Science Foundation (ESF)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The present study was supported by a grant of The Norwegian Research Council. The Nord-Trondelag Health Study (HUNT) is a cooperation between the HUNT Research Center, Faculty of Medicine, Norwegian University of Science and Technology (NTNU), the Norwegian Institute for Public Health and the Nord-Trondelag County Council. We also acknowledge the support received from the European Science Foundation (ESF- 4064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell CG, 2005, NAT REV GENET, V6, P221, DOI 10.1038/nrg1556; Bratberg GH, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-54; Coady SA, 2002, OBES RES, V10, P675, DOI 10.1038/oby.2002.91; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; den Hoed M, 2010, DIABETES, V59, P2980, DOI 10.2337/db10-0370; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Goris A, 2006, EUR J HUM GENET, V14, P1064, DOI 10.1038/sj.ejhg.5201665; Hardy R, 2010, HUM MOL GENET, V19, P545, DOI 10.1093/hmg/ddp504; Haworth CMA, 2008, OBESITY, V16, P1585, DOI 10.1038/oby.2008.240; Haworth CMA, 2008, OBESITY, V16, P2663, DOI 10.1038/oby.2008.434; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Heid IM, 2010, NAT GENET, V42, P949, DOI 10.1038/ng.685; Hill JO, 2006, ENDOCR REV, V27, P750, DOI 10.1210/er.2006-0032; Hjelmborg JVB, 2008, OBESITY, V16, P847, DOI 10.1038/oby.2007.135; Holmen J, 2003, NORSK EPIDEMIOLOGI, V13, P19, DOI DOI 10.1093/eurheartj/eht019; Janssens ACJW, 2007, GENET MED, V9, P528, DOI 10.1097/GIM.0b013e31812eece0; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Krokstad S, 2002, SCAND J PUBLIC HEALT, V30, P113, DOI 10.1080/14034940210133753; Kurtze N, 2007, EUR J EPIDEMIOL, V22, P379, DOI 10.1007/s10654-007-9110-9; Li S, AM J CLIN NUTR, V91, P184; Li SX, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000332; Lindgren CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000508; Livingstone M B, 2001, Public Health Nutr, V4, P109; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Mei H, 2010, HUM GENET, V128, P589, DOI 10.1007/s00439-010-0883-7; Ortega-Alonso A, 2009, BEHAV GENET, V39, P154, DOI 10.1007/s10519-008-9245-9; Page GP, 2003, AM J HUM GENET, V73, P711, DOI 10.1086/378900; Papas MA, 2007, EPIDEMIOL REV, V29, P129, DOI 10.1093/epirev/mxm009; Patton GC, 2011, J ADOLESCENT HEALTH, V48, P275, DOI 10.1016/j.jadohealth.2010.06.019; Rangul V, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-47; Ruiz JR, ARCH PEDIAT ADOLESC, V164, P328; Singh AS, 2008, OBES REV, V9, P474, DOI 10.1111/j.1467-789X.2008.00475.x; Sovio U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001307; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Zhao JH, 2009, OBESITY, V17, P2254, DOI 10.1038/oby.2009.159	37	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e46912	10.1371/journal.pone.0046912	http://dx.doi.org/10.1371/journal.pone.0046912			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094032	Green Submitted, gold, Green Published			2022-12-25	WOS:000310050200014
J	Karlsgodt, KH; Rosser, T; Lutkenhoff, ES; Cannon, TD; Silva, A; Bearden, CE				Karlsgodt, Katherine H.; Rosser, Tena; Lutkenhoff, Evan S.; Cannon, Tyrone D.; Silva, Alcino; Bearden, Carrie E.			Alterations in White Matter Microstructure in Neurofibromatosis-1	PLOS ONE			English	Article							OLIGODENDROCYTE-MYELIN GLYCOPROTEIN; APPARENT DIFFUSION-COEFFICIENT; CORPUS-CALLOSUM MORPHOLOGY; PEDIATRIC-PATIENTS; COGNITIVE FUNCTION; BRAIN; CHILDREN; TYPE-1; REGISTRATION; ROBUST	Neurofibromatosis (NF1) represents the most common single gene cause of learning disabilities. NF1 patients have impairments in frontal lobe based cognitive functions such as attention, working memory, and inhibition. Due to its well-characterized genetic etiology, investigations of NF1 may shed light on neural mechanisms underlying such difficulties in the general population or other patient groups. Prior neuroimaging findings indicate global brain volume increases, consistent with neural over-proliferation. However, little is known about alterations in white matter microstructure in NF1. We performed diffusion tensor imaging (DTI) analyses using tract-based spatial statistics (TBSS) in 14 young adult NF1 patients and 12 healthy controls. We also examined brain volumetric measures in the same subjects. Consistent with prior studies, we found significantly increased overall gray and white matter volume in NF1 patients. Relative to healthy controls, NF1 patients showed widespread reductions in white matter integrity across the entire brain as reflected by decreased fractional anisotropy (FA) and significantly increased absolute diffusion (ADC). When radial and axial diffusion were examined we found pronounced differences in radial diffusion in NF1 patients, indicative of either decreased myelination or increased space between axons. Secondary analyses revealed that FA and radial diffusion effects were of greatest magnitude in the frontal lobe. Such alterations of white matter tracts connecting frontal regions could contribute to the observed cognitive deficits. Furthermore, although the cellular basis of these white matter microstructural alterations remains to be determined, our findings of disproportionately increased radial diffusion against a background of increased white matter volume suggest the novel hypothesis that one potential alteration contributing to increased cortical white matter in NF1 may be looser packing of axons, with or without myelination changes. Further, this indicates that axial and radial diffusivity can uniquely contribute as markers of NF1-associated brain pathology in conjunction with the typically investigated measures.	[Karlsgodt, Katherine H.; Cannon, Tyrone D.; Silva, Alcino; Bearden, Carrie E.] Univ Calif Los Angeles, Semel Inst Neurosci & Behav, Los Angeles, CA 90095 USA; [Karlsgodt, Katherine H.; Cannon, Tyrone D.; Bearden, Carrie E.] Univ Calif Los Angeles, Ctr Cognit Neurosci, Los Angeles, CA USA; [Lutkenhoff, Evan S.; Cannon, Tyrone D.; Silva, Alcino; Bearden, Carrie E.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Rosser, Tena] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Silva, Alcino] Univ Calif Los Angeles, Dept Neurobiol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Children's Hospital Los Angeles; University of California System; University of California Los Angeles	Karlsgodt, KH (corresponding author), Univ Calif Los Angeles, Semel Inst Neurosci & Behav, Los Angeles, CA 90095 USA.	kkarlsgodt@nshs.edu	Silva, Alcino/ABD-7684-2021; Karlsgodt, Katherine H/H-2964-2013	Silva, Alcino/0000-0002-1587-4558; Karlsgodt, Katherine H/0000-0003-3332-4231; Bearden, Carrie/0000-0002-8516-923X	Carol Moss Spivak Foundation; National Institutes of Health [MH084315]; National Institute of Mental Health [R34 MH089299-01]; NATIONAL INSTITUTE OF MENTAL HEALTH [R34MH089299, R01MH084315] Funding Source: NIH RePORTER	Carol Moss Spivak Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Carol Moss Spivak Foundation and National Institutes of Health grant MH084315 to AS, and the National Institute of Mental Health (R34 MH089299-01 to CEB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta-Cabronero J, 2010, BRAIN, V133, P529, DOI 10.1093/brain/awp257; Alkan A, 2005, EUR J RADIOL, V56, P229, DOI 10.1016/j.ejrad.2005.05.008; Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson J.L.R, 2007, TR07JA2 FMRIB; [Anonymous], 1988, ARCH NEUROL-CHICAGO, V45, P575, DOI 10.1097/00005537-199606000-00007; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; Bennett MR, 2008, AUST NZ J PSYCHIAT, V42, P662, DOI 10.1080/00048670802203467; Boyanapalli M, 2006, BIOCHEM BIOPH RES CO, V340, P1200, DOI 10.1016/j.bbrc.2005.12.129; Cutting LE, 2002, NEUROLOGY, V59, P1388, DOI 10.1212/01.WNL.0000032370.68306.8A; de Zeeuw P, 2012, HUM BRAIN MAPP, V33, P1941, DOI 10.1002/hbm.21335; DIPAOLO DP, 1995, RADIOLOGY, V195, P721, DOI 10.1148/radiology.195.3.7754001; Dubovsky EC, 2001, AM J NEURORADIOL, V22, P190; Eastwood JD, 2001, RADIOLOGY, V219, P354, DOI 10.1148/radiology.219.2.r01ap25354; First M. B., 1997, STRUCTURED CLIN INTE; Ford JC, 1998, JMRI-J MAGN RESON IM, V8, P775, DOI 10.1002/jmri.1880080405; Gil V, 2010, CEREB CORTEX, V20, P1769, DOI 10.1093/cercor/bhp246; GILLBERG C, 1984, J AUTISM DEV DISORD, V14, P1, DOI 10.1007/BF02408551; Golabchi FN, 2010, MAGN RESON MED, V63, P1510, DOI 10.1002/mrm.22337; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Greenwood RS, 2005, ARCH NEUROL-CHICAGO, V62, P1904, DOI 10.1001/archneur.62.12.1904; Hikida T, 2007, P NATL ACAD SCI USA, V104, P14501, DOI 10.1073/pnas.0704774104; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Huijbregts SCJ, 2011, BEHAV GENET, V41, P430, DOI 10.1007/s10519-010-9430-5; HUSON SM, 1989, ARCH DIS CHILD, V64, P745, DOI 10.1136/adc.64.5.745; Hyman SL, 2005, NEUROLOGY, V65, P1037, DOI 10.1212/01.wnl.0000179303.72345.ce; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Johnson MR, 2000, J NEUROL NEUROSUR PS, V68, P643, DOI 10.1136/jnnp.68.5.643; Karlsgodt KH, 2012, CURR PHARM DESIGN, V18, P422; Karlsgodt KH, 2009, BIOL PSYCHIAT, V66, P562, DOI 10.1016/j.biopsych.2009.03.013; Kayl AE, 2000, J CHILD NEUROL, V15, P90, DOI 10.1177/088307380001500206; Kweh F, 2009, MOL CARCINOGEN, V48, P1005, DOI 10.1002/mc.20552; Lee JS, 2010, HUM MOL GENET, V19, P4643, DOI 10.1093/hmg/ddq395; Margariti PN, 2007, EUR RADIOL, V17, P433, DOI 10.1007/s00330-006-0323-1; Mautner VF, 2002, DEV MED CHILD NEUROL, V44, P164, DOI 10.1017/S0012162201001876; MIKOL DD, 1993, GENOMICS, V17, P604, DOI 10.1006/geno.1993.1379; Moore BD, 2000, NEUROLOGY, V54, P914, DOI 10.1212/WNL.54.4.914; Mori S.W., 2005, MRI ATLAS HUMAN WHIT; Nagel BJ, 2011, J AM ACAD CHILD PSY, V50, P283, DOI 10.1016/j.jaac.2010.12.003; NORTH K, 1994, NEUROLOGY, V44, P878, DOI 10.1212/WNL.44.5.878; North K, 2000, AM J MED GENET, V97, P119, DOI 10.1002/1096-8628(200022)97:2<119::AID-AJMG3>3.0.CO;2-3; North KN, 1997, NEUROLOGY, V48, P1121, DOI 10.1212/WNL.48.4.1121; Ozonoff S, 1999, AM J MED GENET, V89, P45, DOI 10.1002/(SICI)1096-8628(19990326)89:1<45::AID-AJMG9>3.0.CO;2-J; Payne JM, 2010, J NEUROL NEUROSUR PS, V81, P304, DOI 10.1136/jnnp.2009.179630; Pride N, 2010, J CHILD NEUROL, V25, P834, DOI 10.1177/0883073809350723; Rowbotham I, 2009, NEUROPSYCHOLOGY, V23, P50, DOI 10.1037/a0013927; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Sheikh SF, 2003, J COMPUT ASSIST TOMO, V27, P681, DOI 10.1097/00004728-200309000-00004; Shilyansky C, 2010, P NATL ACAD SCI USA, V107, P13141, DOI 10.1073/pnas.1004829107; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song AW, 2003, NEUROIMAGE; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Tamm L, 2012, PSYCHIAT RES-NEUROIM, V202, P150, DOI 10.1016/j.pscychresns.2012.04.001; Tognini G, 2005, J COMPUT ASSIST TOMO, V29, P298, DOI 10.1097/01.rct.0000162406.71300.b7; van Engelen SJPM, 2008, AM J NEURORADIOL, V29, P816, DOI 10.3174/ajnr.A0921; VISKOCHIL D, 1991, MOL CELL BIOL, V11, P906, DOI 10.1128/MCB.11.2.906; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wignall EL, 2010, AM J NEURORADIOL, V31, P856, DOI 10.3174/ajnr.A2005; Wozniak JR, 2006, NEUROSCI BIOBEHAV R, V30, P762, DOI 10.1016/j.neubiorev.2006.06.003; Zamboni SL, 2007, AM J NEURORADIOL, V28, P773; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424	65	46	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47854	10.1371/journal.pone.0047854	http://dx.doi.org/10.1371/journal.pone.0047854			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094098	gold, Green Submitted, Green Published			2022-12-25	WOS:000310050200051
J	Karn, RC; Laukaitis, CM				Karn, Robert C.; Laukaitis, Christina M.			The Roles of Gene Duplication, Gene Conversion and Positive Selection in Rodent Esp and Mup Pheromone Gene Families with Comparison to the Abp Family	PLOS ONE			English	Article							ANDROGEN-BINDING-PROTEIN; MAJOR URINARY PROTEINS; GC-CONTENT EVOLUTION; MULTIPLE SEQUENCE ALIGNMENT; SEXUAL ISOLATION; HOUSE MOUSE; COMPREHENSIVE ANALYSIS; PHYLOGENETIC ANALYSIS; ADAPTIVE EVOLUTION; SULFATED STEROIDS	Three proteinaceous pheromone families, the androgen-binding proteins (ABPs), the exocrine-gland secreting peptides (ESPs) and the major urinary proteins (MUPs) are encoded by large gene families in the genomes of Mus musculus and Rattus norvegicus. We studied the evolutionary histories of the Mup and Esp genes and compared them with what is known about the Abp genes. Apparently gene conversion has played little if any role in the expansion of the mouse Class A and Class B Mup genes and pseudogenes, and the rat Mups. By contrast, we found evidence of extensive gene conversion in many Esp genes although not in all of them. Our studies of selection identified at least two amino acid sites in beta-sheets as having evolved under positive selection in the mouse Class A and Class B MUPs and in rat MUPs. We show that selection may have acted on the ESPs by determining K-a/K-s for Exon 3 sequences with and without the converted sequence segment. While it appears that purifying selection acted on the ESP signal peptides, the secreted portions of the ESPs probably have undergone much more rapid evolution. When the inner gene converted fragment sequences were removed, eleven Esp paralogs were present in two or more pairs with K-a/K-s > 1.0 and thus we propose that positive selection is detectable by this means in at least some mouse Esp paralogs. We compare and contrast the evolutionary histories of all three mouse pheromone gene families in light of their proposed functions in mouse communication.	[Karn, Robert C.; Laukaitis, Christina M.] Univ Arizona, Coll Med, Dept Med, Tucson, AZ 85719 USA	University of Arizona	Karn, RC (corresponding author), Univ Arizona, Coll Med, Dept Med, Tucson, AZ 85719 USA.	rkarn@butler.edu	Laukaitis, Christina M/AAL-5865-2021; Laukaitis, Christina/AAW-2510-2020; Laukaitis, Christina/ABF-1739-2021	Laukaitis, Christina M/0000-0003-1466-7941; 	National Cancer Institute at the National Institutes of Health;  [P50 CA095060];  [P30 CA023074]; NATIONAL CANCER INSTITUTE [P50CA095060, P30CA023074] Funding Source: NIH RePORTER	National Cancer Institute at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Cancer Institute at the National Institutes of Health CML received salary support from P50 CA095060 and laboratory support from P30 CA023074. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armstrong SD, 2005, BIOCHEM J, V391, P343, DOI 10.1042/BJ20050404; Arnheim N., 1983, P38; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Beynon RJ, 2003, BIOCHEM SOC T, V31, P142, DOI 10.1042/bst0310142; Bielawski Joseph P., 2003, Journal of Structural and Functional Genomics, V3, P201, DOI 10.1023/A:1022642807731; Bimova B, 2005, BIOL J LINN SOC, V84, P349, DOI 10.1111/j.1095-8312.2005.00439.x; Bimova BV, 2011, MOL ECOL, V20, P2403, DOI 10.1111/j.1365-294X.2011.05106.x; Bradford JR, 2001, PROTEIN DESIGN BIOPH; Callebaut I, 2000, ANN NY ACAD SCI, V923, P90; Castillo-Davis CI, 2004, GENOME RES, V14, P802, DOI 10.1101/gr.2195604; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Cheetham SA, 2007, CURR BIOL, V17, P1771, DOI 10.1016/j.cub.2007.10.007; Chevret P, 2005, BIOL J LINN SOC, V84, P417, DOI 10.1111/j.1095-8312.2005.00444.x; CLARK AJ, 1985, EMBO J, V4, P3159, DOI 10.1002/j.1460-2075.1985.tb04059.x; CLARK AJ, 1985, EMBO J, V4, P3167, DOI 10.1002/j.1460-2075.1985.tb04060.x; Clark NL, 2005, PLOS GENET, V1, P335, DOI 10.1371/journal.pgen.0010035; CLISSOLD PM, 1984, BIOCHEM GENET, V22, P379, DOI 10.1007/BF00484236; Coyne JA, 1997, GENETICS, V145, P1015; Dean MD, 2009, MOL BIOL EVOL, V26, P1733, DOI 10.1093/molbev/msp094; DLOUHY SR, 1983, BIOCHEM GENET, V21, P1057, DOI 10.1007/BF00488459; DLOUHY SR, 1987, GENETICS, V115, P535; Dulac C, 2006, ANNU REV GENET, V40, P449, DOI 10.1146/annurev.genet.39.073003.093937; Ellegren H, 2007, NAT REV GENET, V8, P689, DOI 10.1038/nrg2167; Emes RD, 2004, GENOME RES, V14, P1516, DOI 10.1101/gr.2540304; Emes RD, 2003, HUM MOL GENET, V12, P701, DOI 10.1093/hmg/ddg078; Galtier N, 2003, TRENDS GENET, V19, P65, DOI 10.1016/S0168-9525(02)00002-1; Galtier N, 2001, GENETICS, V159, P907; Galtier N, 2009, TRENDS GENET, V25, P1, DOI 10.1016/j.tig.2008.10.011; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; GRAUR D, 2000, FUNDAMENTALS MOL EVO; Haga S, 2010, NATURE, V466, P118, DOI 10.1038/nature09142; HAYASHIDA H, 1983, P NATL ACAD SCI-BIOL, V80, P2671, DOI 10.1073/pnas.80.9.2671; Hsu FF, 2008, BIOCHEMISTRY-US, V47, P14009, DOI 10.1021/bi801392j; Hughes A.L., 1999, ADAPTIVE EVOLUTION G; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Hurst JL, 2009, BEHAV BRAIN RES, V200, P295, DOI 10.1016/j.bbr.2008.12.020; Hurst LD, 1999, CURR BIOL, V9, P747, DOI 10.1016/S0960-9822(99)80334-0; Hwang JM, 1997, J HERED, V88, P93, DOI 10.1093/oxfordjournals.jhered.a023083; Janousek V, 2012, GENOME BIOL EV UNPUB; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jensen JD, 2007, TRENDS GENET, V23, P568, DOI 10.1016/j.tig.2007.08.009; Karn RC, 1999, MOL BIOL EVOL, V16, P1192, DOI 10.1093/oxfordjournals.molbev.a026209; Karn RC, 2003, BIOCHEMISTRY-US, V42, P7162, DOI 10.1021/bi027424l; Karn RC, 2002, MOL BIOL EVOL, V19, P462, DOI 10.1093/oxfordjournals.molbev.a004102; KARN RC, 1991, J HERED, V82, P453, DOI 10.1093/oxfordjournals.jhered.a111127; Karn RC, 2008, MOL BIOL EVOL, V25, P2301, DOI 10.1093/molbev/msn182; Karn RC, 2009, GENOME BIOL EVOL, V1, P494, DOI 10.1093/gbe/evp049; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kimoto H, 2005, NATURE, V437, P898, DOI 10.1038/nature04033; Kimoto H, 2007, CURR BIOL, V17, P1879, DOI 10.1016/j.cub.2007.09.042; Kudla G, 2004, MOL BIOL EVOL, V21, P1438, DOI 10.1093/molbev/msh146; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Laukaitis C.M., 2012, EVOLUTION HOUSE MOUS, P150, DOI [10.1017/CBO9781139044547.009, DOI 10.1017/CBO9781139044547.009]; Laukaitis CM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-46; Laukaitis CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035898; Laukaitis CM, 2003, MAMM GENOME, V14, P679, DOI 10.1007/s00335-003-2291-y; Laukaitis CM, 1997, EVOLUTION, V51, P2000, DOI [10.2307/2411020, 10.1111/j.1558-5646.1997.tb05121.x]; Lawson MJ, 2009, NUCLEIC ACIDS RES, V37, P4570, DOI 10.1093/nar/gkp421; Li W. H, 1997, MOL EVOLUTION; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Logan DW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003280; Lyon JD, 1999, DEV BIOL, V214, P151, DOI 10.1006/dbio.1999.9411; McGrath CL, 2009, GENETICS, V182, P615, DOI 10.1534/genetics.109.101428; MUCIGNATCARETTA C, 1995, J PHYSIOL-LONDON, V486, P517, DOI 10.1113/jphysiol.1995.sp020830; Mudge JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r91; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nodari F, 2008, J NEUROSCI, V28, P6407, DOI 10.1523/JNEUROSCI.1425-08.2008; Ohno S., 1970, P1; OHTA T, 1983, THEOR POPUL BIOL, V23, P216, DOI 10.1016/0040-5809(83)90015-1; Ohta T., 1980, EVOLUTION VARIATION, V37, DOI [10.1007/978-3-642-93138-3, DOI 10.1007/978-3-642-93138-3]; Orr HA, 2005, EVOLUTION, V59, P216; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rhead B, 2010, NUCLEIC ACIDS RES, V38, pD613, DOI 10.1093/nar/gkp939; Robertson DHL, 1996, BIOCHEM J, V316, P265, DOI 10.1042/bj3160265; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; Shen HB, 2007, BIOCHEM BIOPH RES CO, V363, P297, DOI 10.1016/j.bbrc.2007.08.140; Sherborne AL, 2007, CURR BIOL, V17, P2061, DOI 10.1016/j.cub.2007.10.041; Smadja C, 2009, HEREDITY, V102, P77, DOI 10.1038/hdy.2008.55; Stowers L, 2002, SCIENCE, V295, P1493, DOI 10.1126/science.1069259; Swanson WJ, 2004, GENETICS, V168, P1457, DOI 10.1534/genetics.104.030478; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Talley HM, 2001, EVOLUTION, V55, P631, DOI 10.1554/0014-3820(2001)055[0631:FPFMSI]2.0.CO;2; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thom MD, 2008, CURR BIOL, V18, P619, DOI 10.1016/j.cub.2008.03.056; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wong KK, 2007, AM J HUM GENET, V80, P91, DOI 10.1086/510560; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, MOL BIOL EVOL, V17, P1446, DOI 10.1093/oxfordjournals.molbev.a026245; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	94	11	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47697	10.1371/journal.pone.0047697	http://dx.doi.org/10.1371/journal.pone.0047697			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094077	Green Submitted, gold, Green Published			2022-12-25	WOS:000310050200039
J	Villafuerte-Galvez, J; Sotelo-Olivera, MI; Cok, J; Piscoya-Rivera, A; Huerta-Mercado, J				Villafuerte-Galvez, Javier; Isabel Sotelo-Olivera, Maria; Cok, Jaime; Piscoya-Rivera, Alejandro; Huerta-Mercado, Jorge			Colonoscopic Findings in Peruvian Patients with Chronic Diarrhea	PLOS ONE			English	Article							GASTROINTESTINAL SYMPTOMS; MICROSCOPIC COLITIS; SINGLE-CENTER; PREVALENCE	Objective: To report the colonoscopic and pathological findings in patients with chronic diarrhea from a gastroenterology unit during approximately 3 years in a general teaching hospital located in Lima-Peru. Materials and Methods: Patients with chronic diarrhea as the motive for colonoscopy from March 2008 to December 2010 were selected from the colonoscopy report computerized database. Colonoscopic findings were registered. Biopsies taken during the procedure were prospectively reviewed. Results: 226 patients were included, of which 162 (71.7%) had a colon biopsy available. The average age of the patients was 53.6 +/- 16.36. 85.8% of patients were reported to have a normal colon. 14.8% of patients were found to have a normal colonic mucosa or mucosal edema, 35.8% of patients had lymphocytic colitis and 28.4% had paucicelular colitis. Conclusions: The majority of colonoscopies were reported with unremarkable macroscopic findings. Lymphocytic colitis was unusually frequent compared to previous reports.	[Villafuerte-Galvez, Javier; Isabel Sotelo-Olivera, Maria] Univ Peruana Cayetano Heredia, Sch Med, Lima, Peru; [Villafuerte-Galvez, Javier] Soc Cient Estudiantes Med Cayetano Heredia SOCEMC, Lima, Peru; [Cok, Jaime] Hosp Nacl Cayetano Heredia, Dept Pathol, Lima, Peru; [Cok, Jaime] Univ Peruana Cayetano Heredia, Dept Preclin Sci & Diagnost Aid, Lima, Peru; [Piscoya-Rivera, Alejandro; Huerta-Mercado, Jorge] Hosp Nacl Cayetano Heredia, Dept Med, Gastroenteol Unit, Lima, Peru; [Huerta-Mercado, Jorge] Univ Peruana Cayetano Heredia, Dept Clin Med, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia	Villafuerte-Galvez, J (corresponding author), Univ Peruana Cayetano Heredia, Sch Med, Lima, Peru.	javier.villafuerte@upch.pe	Piscoya, Alejandro/C-6380-2012	Piscoya, Alejandro/0000-0002-4420-2419; Villafuerte Galvez, Javier/0000-0002-3379-5271				Arévalo F, 2008, Rev. gastroenterol. Perú, V28, P140; Carmona-Sanchez R, 2000, REV GASTROENTEROL ME, V72, P349; Coronel F, 2005, GASTROENTEROL LATINO, V16, P186; Fernandez-Banarcs F, 2009, AM J GASTROENTEROL, V104, P1189, DOI 10.1038/ajg.2009.65; Fine KD, 1999, GASTROENTEROLOGY, V116, P1464, DOI 10.1016/S0016-5085(99)70513-5; Gado AS, 2011, SAUDI J GASTROENTERO, V17, P383, DOI 10.4103/1319-3767.87178; Gopalan SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029936; Ichiyanagui C, 1997, BOL SOC PER MED INT, V10; Nyhlin N, 2006, ALIMENT PHARM THER, V23, P1525, DOI 10.1111/j.1365-2036.2006.02913.x; Pardi DS, 2011, GASTROENTEROLOGY, V140, P1155, DOI 10.1053/j.gastro.2011.02.003; Rubio-Tapia A, 2007, INT J COLORECTAL DIS, V22, P1031, DOI 10.1007/s00384-006-0258-7; TALLEY NJ, 1992, GASTROENTEROLOGY, V102, P895, DOI 10.1016/0016-5085(92)90175-X; TALLEY NJ, 1992, AM J EPIDEMIOL, V136, P165, DOI 10.1093/oxfordjournals.aje.a116483; Valle Mansilla JL, 2002, REV GASTROENTEROL PE, V22, P275	14	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e46690	10.1371/journal.pone.0046690	http://dx.doi.org/10.1371/journal.pone.0046690			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094029	Green Published, gold, Green Submitted			2022-12-25	WOS:000312384500003
J	Inoue, K; Kashima, S; Ohara, C; Matsumoto, M; Akimoto, K				Inoue, Kazuo; Kashima, Saori; Ohara, Chisako; Matsumoto, Masatoshi; Akimoto, Kimihiko			Concordance of Two Diabetes Diagnostic Criteria Using Fasting Plasma Glucose and Hemoglobin A1c: The Yuport Medical Checkup Centre Study	PLOS ONE			English	Article							EXPERT COMMITTEE; MELLITUS; CLASSIFICATION	Background: We tested the concordance of the two diagnostic criteria for diabetes using fasting plasma glucose (FPG) and hemoglobin A1c (HbA1c) by the Japan Diabetes Society (JDS) and American Diabetes Association (ADA). Methods: We used data from 7,328 subjects without known diabetes who participated in a voluntary health checkup program at least twice between 1998 and 2006, at intervals <= 2 years. For repeat participants who attended the screening over two times, data from the first and second checkups were used for this study. At the first visit, diabetes was diagnosed both at FPG >= 7.0 mmol/L and HbA1c >= 6.5% using the JDS criteria. In addition, diabetes was diagnosed using two ADA criteria; ADA-FPG diabetes for persistent fasting hyperglycemia (FPG >= 7.0 mmol/L) or ADA-HbA1c diabetes for hyperglycated hemoglominemia (HbA1c >= 6.5%), both at the first and second checkups. Subsequently, the concordance of diagnosis between the JDS and the ADA criteria was evaluated. Results: At the first checkup, 153 (2.1%) persons were diagnosed with diabetes by the JDS criteria. They had higher levels of risk factors for diabetes than non-diabetic subjects. Using the first and second checkups, 174 (2.4%) and 175 (2.4%) were diagnosed with diabetes by the ADA-FPG criteria, respectively. Among 153 subjects diagnosed with diabetes by the JDS criteria, 125 (81.7%) and 129 (84.3%) had ADA-FPG and ADA-HbA1c diabetes, respectively. The kappa coefficients of the JDS criteria with ADA-FPG and ADA-HbA1c criteria were 0.759 and 0.782 (P<0.001), respectively. In the subgroup analysis stratified by sex, the concordance was well preserved at the kappa coefficients around 0.8 (between 0.725 and 0.836). Conclusion: The JDS diagnostic criteria for diabetes have a substantial and acceptable concordance with the ADA criteria. The JDS criteria may be a practical method for diagnosing diabetes that maintains compatibility with the ADA criteria.	[Inoue, Kazuo] Teikyo Univ, Sch Med, Chiba Med Ctr, Dept Community Med, Chiba, Japan; [Kashima, Saori] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Publ Hlth & Hlth Policy, Hiroshima, Japan; [Ohara, Chisako] Teikyo Univ, Grad Sch Publ Hlth, Dept Publ Hlth, Tokyo 173, Japan; [Matsumoto, Masatoshi] Hiroshima Univ, Fac Med, Dept Community Based Med Syst, Hiroshima, Japan; [Akimoto, Kimihiko] Akimoto Occupat Hlth Consultant Off, Tokyo, Japan	Teikyo University; Hiroshima University; Teikyo University; Hiroshima University	Inoue, K (corresponding author), Teikyo Univ, Sch Med, Chiba Med Ctr, Dept Community Med, Chiba, Japan.	inouek@med.teikyo-u.ac.jp	Kashima, Saori/B-4524-2010	Kashima, Saori/0000-0002-3401-8191; Matsumoto, Masatoshi/0000-0002-8341-9303				[Anonymous], 2012, DIABETES CARE S1, V35, pS11; Avignon A, 1997, DIABETES CARE, V20, P1822, DOI 10.2337/diacare.20.12.1822; Barr RG, 2002, ANN INTERN MED, V137, P263, DOI 10.7326/0003-4819-137-4-200208200-00011; BOGARDUS C, 1984, J CLIN INVEST, V74, P1238, DOI 10.1172/JCI111533; Centers for Disease Control and Prevention, 2011, NAT DIAB FACT SHEET; DINNEEN S, 1992, NEW ENGL J MED, V327, P707, DOI 10.1056/NEJM199209033271007; Gavin JR, 1997, DIABETES CARE, V20, P1183; Inoue K, 2009, DIABETIC MED, V26, P1175, DOI 10.1111/j.1464-5491.2009.02850.x; Inoue K, 2012, DIABETIC MED, V29, P1327; Inoue K, 2008, DIABETIC MED, V25, P1157, DOI 10.1111/j.1464-5491.2008.02572.x; Kuzuya T, 2002, DIABETES RES CLIN PR, V55, P65, DOI 10.1016/S0168-8227(01)00365-5; Nathan DM, 2009, DIABETES CARE, V32, P1327, DOI 10.2337/dc09-9033; Ollerton RL, 1999, DIABETES CARE, V22, P394, DOI 10.2337/diacare.22.3.394; Rohlfing CL, 2002, DIABETES CARE, V25, P275, DOI 10.2337/diacare.25.2.275; ROTHMAN DL, 1991, SCIENCE, V254, P573, DOI 10.1126/science.1948033; Seino Y, 2010, DIABETOL INT, V1, P2, DOI 10.1007/s13340-010-0006-7; Viera AJ, 2005, FAM MED, V37, P360; Young TK, 2001, CAN MED ASSOC J, V164, P24	18	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47747	10.1371/journal.pone.0047747	http://dx.doi.org/10.1371/journal.pone.0047747			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082207	Green Submitted, gold, Green Published			2022-12-25	WOS:000311146900104
J	Penney, D; McNeil, A; Green, DI; Bradley, RS; Jepson, JE; Withers, PJ; Preziosi, RF				Penney, David; McNeil, Andrew; Green, David I.; Bradley, Robert S.; Jepson, James E.; Withers, Philip J.; Preziosi, Richard F.			Ancient Ephemeroptera-Collembola Symbiosis Fossilized in Amber Predicts Contemporary Phoretic Associations	PLOS ONE			English	Article							MAYFLIES EPHEMEROPTERA; GLOBAL DIVERSITY; INSECTA	X-ray computed tomography is used to identify a unique example of fossilized phoresy in 16 million-year-old Miocene Dominican amber involving a springtail being transported by a mayfly. It represents the first evidence (fossil or extant) of phoresy in adult Ephemeroptera and only the second record in Collembola (the first is also preserved in amber). This is the first record of Collembola using winged insects for dispersal. This fossil predicts the occurrence of similar behaviour in living springtails and helps explain the global distribution of Collembola today.	[Penney, David; Preziosi, Richard F.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [McNeil, Andrew; Bradley, Robert S.; Withers, Philip J.] Univ Manchester, Manchester Xray Imaging Facil, Sch Mat, Manchester, Lancs, England; [Green, David I.; Jepson, James E.] Amgueddfa Cymru Natl Museum Wales, Dept Geol, Cardiff, S Glam, Wales; [Jepson, James E.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England	University of Manchester; University of Manchester; University of Manchester	Penney, D (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	david.penney@manchester.ac.uk	Preziosi, Richard F/A-8626-2010; Withers, Phil/A-6760-2009; Bradley, Robert/X-1861-2019	Preziosi, Richard F/0000-0003-0468-6655; Withers, Phil/0000-0002-1946-5647; Jepson, James/0000-0003-3184-8277	Engineering and Physical Sciences Research Council; Engineering and Physical Sciences Research Council [EP/I02249X/1] Funding Source: researchfish; EPSRC [EP/I02249X/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The Engineering and Physical Sciences Research Council are acknowledged for funding the Manchester X-Ray Imaging Facility at the University of Manchester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arillo A, 2007, GEOL ACTA, V5, P159; Avila-Jimenez Maria Luisa, 2011, Insects, V2, P273, DOI 10.3390/insects2030273; Barber-James HM, 2008, HYDROBIOLOGIA, V595, P339, DOI 10.1007/s10750-007-9028-y; Betz V, 2007, LAPIS, V32, P22; Boucot A.J., 2010, FOSSIL BEHAV COMPEND; BRITTAIN JE, 1982, ANNU REV ENTOMOL, V27, P119, DOI 10.1146/annurev.en.27.010182.001003; CHRISTIANSEN K, 1994, ORIENT INSECTS, V28, P309; Christiansen K., 1971, University of California Publications in Entomology, V63, P45; Davis Steven R., 2006, Transactions of the Kansas Academy of Science, V109, P191, DOI 10.1660/0022-8443(2006)109[191:DWIDAC]2.0.CO;2; Deharveng L, 2008, HYDROBIOLOGIA, V595, P329, DOI 10.1007/s10750-007-9116-z; Dunger W, 2002, PEDOBIOLOGIA, V46, P316, DOI 10.1078/0031-4056-00139; Dunlop JA, 2012, BIOL LETTERS, V8, P457, DOI 10.1098/rsbl.2011.0923; EPLER JH, 1986, FLA ENTOMOL, V69, P319, DOI 10.2307/3494936; Fiera C, 2012, BIOL J LINN SOC, V105, P498, DOI 10.1111/j.1095-8312.2011.01816.x; Gordh G, 2011, DICT ENTOMOLOGY; Iturralde-Vinent MA, 2001, CARIBB J SCI, V37, P141; Knecht RJ, 2011, P NATL ACAD SCI USA, V108, P6515, DOI 10.1073/pnas.1015948108; Monaghan MT, 2005, P ROY SOC B-BIOL SCI, V272, P1829, DOI 10.1098/rspb.2005.3139; MUTT JAM, 1983, P ENTOMOL SOC WASH, V85, P575; Ohl M, 2011, NATURWISSENSCHAFTEN, V98, P453, DOI 10.1007/s00114-011-0783-2; Penney D., 2010, BIODIVERSITY FOSSILS; Penney D., 2011, FOSSILS AMBER REMARK; Penney D, 2011, ZOOTAXA, P60; Perez-Gelabert DE, 2008, ZOOTAXA, P1; Poinar G.O., 2010, FOSSIL BEHAV COMPEND, P183; Poinar G, 2010, ANN SOC ENTOMOL FR, V46, P23, DOI 10.1080/00379271.2010.10697637; Poinar George O. Jr., 1998, Acta Arachnologica, V47, P79, DOI 10.2476/asjaa.47.79; Soldan T, 2012, MAYFL EUR EPH; Staniczek Arnold H., 2003, Stuttgarter Beitraege zur Naturkunde Serie B (Geologie und Palaeontologie), V341, P1; von Tschirnhaus Michael, 2009, Denisia, P171; Wichard W., 2009, AQUATIC INSECTS BALT; Willkommen J, 2007, ARTHROPOD STRUCT DEV, V36, P253, DOI 10.1016/j.asd.2007.01.003	32	17	19	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47651	10.1371/journal.pone.0047651	http://dx.doi.org/10.1371/journal.pone.0047651			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082186	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000311146900083
J	Firat, E; Weyerbrock, A; Gaedicke, S; Grosu, AL; Niedermann, G				Firat, Elke; Weyerbrock, Astrid; Gaedicke, Simone; Grosu, Anca-Ligia; Niedermann, Gabriele			Chloroquine or Chloroquine-PI3K/Akt Pathway Inhibitor Combinations Strongly Promote gamma-Irradiation-Induced Cell Death in Primary Stem-Like Glioma Cells	PLOS ONE			English	Article							GLIOBLASTOMA-MULTIFORME; MALIGNANT GLIOMA; AKT INHIBITION; RADIATION; AUTOPHAGY; APOPTOSIS; RADIOSENSITIVITY; RADIORESISTANCE; RADIOTHERAPY; TEMOZOLOMIDE	We asked whether inhibitors of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway, which is highly active in cancer stem cells (CSCs) and upregulated in response to genotoxic treatments, promote gamma-irradiation gamma IR)-induced cell death in highly radioresistant, patient-derived stem-like glioma cells (SLGCs). Surprisingly, in most cases the inhibitors did not promote gamma IR-induced cell death. In contrast, the strongly cytostatic Ly294002 and PI-103 even tended to reduce it. Since autophagy was induced we examined whether addition of the clinically applicable autophagy inhibitor chloroquine (CQ) would trigger cell death in SLGCs. Triple therapy with CQ at doses as low as 5 to 10 mu M indeed caused strong apoptosis. At slightly higher doses, CQ alone strongly promoted gamma IR-induced apoptosis in all SLGC lines examined. The strong apoptosis in combinations with CQ was invariably associated with strong accumulation of the autophagosomal marker LC3-II,indicating inhibition of late autophagy. Thus, autophagy-promoting effects of PI3K/Akt pathway inhibitors apparently hinder cell death induction in gamma-irradiated SLGCs. However, as we show here for the first time, the late autophagy inhibitor CQ strongly promotes gamma IR-induced cell death in highly radioresistant CSCs, and triple combinations of CQ, gamma IR and a PI3K/Akt pathway inhibitor permit reduction of the CQ dose required to trigger cell death.	[Firat, Elke; Gaedicke, Simone; Grosu, Anca-Ligia; Niedermann, Gabriele] Univ Hosp Freiburg, Dept Radiat Oncol, Freiburg, Germany; [Weyerbrock, Astrid] Univ Hosp Freiburg, Dept Neurosurg, Freiburg, Germany	University of Freiburg; University of Freiburg	Niedermann, G (corresponding author), Univ Hosp Freiburg, Dept Radiat Oncol, Freiburg, Germany.	gabriele.niedermann@uniklinik-freiburg.de	Weyerbrock, Astrid/AAI-1731-2020; Weyerbrock, Astrid/E-8493-2014	Weyerbrock, Astrid/0000-0001-9060-4462; 	Clotten Foundation	Clotten Foundation	This research was supported by a grant from the Clotten Foundation to GN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADELUSI SA, 1982, J PHARM PHARMACOL, V34, P733, DOI 10.1111/j.2042-7158.1982.tb06211.x; Amaravadi RK, 2011, CLIN CANCER RES, V17, P654, DOI 10.1158/1078-0432.CCR-10-2634; Becher OJ, 2010, CANCER RES, V70, P2548, DOI 10.1158/0008-5472.CAN-09-2503; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Boya P, 2003, ONCOGENE, V22, P3927, DOI 10.1038/sj.onc.1206622; Briceno Eduardo, 2003, Neurosurg Focus, V14, pe3; Chautard E, 2010, NEURO-ONCOLOGY, V12, P434, DOI 10.1093/neuonc/nop059; Chen JS, 2008, MOL CANCER THER, V7, P841, DOI 10.1158/1535-7163.MCT-07-0393; Cheng CK, 2009, BRAIN PATHOL, V19, P112, DOI 10.1111/j.1750-3639.2008.00233.x; Cooper RG, 2008, INDIAN J MED RES, V127, P305; de la Pena L, 2006, MOL CANCER THER, V5, P1504, DOI 10.1158/1535-7163.MCT-06-0091; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; DJORDJEVIC B, 1992, RADIAT RES, V130, P267, DOI 10.2307/3578284; Elgendy M, 2011, MOL CELL, V42, P23, DOI 10.1016/j.molcel.2011.02.009; Eyler CE, 2008, STEM CELLS, V26, P3027, DOI 10.1634/stemcells.2007-1073; Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029; Fan QW, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001017; Fan QW, 2011, CURR TOP MICROBIOL, V347, P279, DOI 10.1007/82_2010_67; Firat E, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-71; Geng Y, 2010, NEURO-ONCOLOGY, V12, P473, DOI 10.1093/neuonc/nop048; Gonzalez-Polo RA, 2005, J CELL SCI, V118, P3091, DOI 10.1242/jcs.02447; Guillard S, 2009, CELL CYCLE, V8, P443, DOI 10.4161/cc.8.3.7643; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Janku F., 2011, NAT REV CLIN ONCOL; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kim EL, 2010, NEURO-ONCOLOGY, V12, P389, DOI 10.1093/neuonc/nop046; Kim MJ, 2008, MOL CANCER RES, V6, P1872, DOI 10.1158/1541-7786.MCR-08-0084; Kogel D, 2010, ANTI-CANCER AGENT ME, V10, P438, DOI 10.2174/1871520611009060438; Lathia JD, 2011, STEM CELL REV REP, V7, P227, DOI 10.1007/s12015-010-9194-6; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Lipani JD, 2008, TECHNOL CANCER RES T, V7, P249, DOI 10.1177/153303460800700311; Lomonaco SL, 2009, INT J CANCER, V125, P717, DOI 10.1002/ijc.24402; Maugeri-Sacca M, 2011, CLIN CANCER RES, V17, P4942, DOI 10.1158/1078-0432.CCR-10-2538; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mzayek F, 2007, PLOS CLIN TRIALS E, pe6; Paglin S, 2001, CANCER RES, V61, P439; Perry J, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/428565; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Prevo R, 2008, CANCER RES, V68, P5915, DOI 10.1158/0008-5472.CAN-08-0757; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sotelo J, 2006, ANN INTERN MED, V144, P337, DOI 10.7326/0003-4819-144-5-200603070-00008; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Yang S, GENES DEV, V25, P717; Zaidi AU, 2001, J NEUROPATH EXP NEUR, V60, P937, DOI 10.1093/jnen/60.10.937; Zhang M, 2010, P NATL ACAD SCI USA, V107, P3522, DOI 10.1073/pnas.0910179107; Zhao H, 2005, RADIAT RES, V164, P250, DOI 10.1667/RR3436.1	48	66	72	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47357	10.1371/journal.pone.0047357	http://dx.doi.org/10.1371/journal.pone.0047357			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091617	Green Submitted, gold, Green Published			2022-12-25	WOS:000310135800040
J	Kang, EL; Biscaro, B; Piazza, F; Tesco, G				Kang, Eugene L.; Biscaro, Barbara; Piazza, Fabrizio; Tesco, Giuseppina			BACE1 Protein Endocytosis and Trafficking Are Differentially Regulated by Ubiquitination at Lysine 501 and the Di-leucine Motif in the Carboxyl Terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE ACTIVITY; TRANS-GOLGI NETWORK; MULTIVESICULAR BODY PATHWAY; ALZHEIMERS-DISEASE; GGA PROTEINS; A-BETA; MEMORY DEFICITS; SORTING SIGNAL; EGF RECEPTOR	beta-Site amyloid precursor protein-cleaving enzyme (BACE1) is a membrane-tethered member of the aspartyl proteases that has been identified as beta-secretase. BACE1 is targeted through the secretory pathway to the plasma membrane and then is internalized to endosomes. Sorting of membrane proteins to the endosomes and lysosomes is regulated by the interaction of signals present in their carboxyl-terminal fragment with specific trafficking molecules. The BACE1 carboxyl-terminal fragment contains a di-leucine sorting signal ((DDISLL500)-D-495) and a ubiquitination site at Lys-501. Here, we report that lack of ubiquitination at Lys-501 (BACE1K501R) does not affect the rate of endocytosis but produces BACE1 stabilization and accumulation of BACE1 in early and late endosomes/lysosomes as well as at the cell membrane. In contrast, the disruption of the di-leucine motif (BACE1LLAA) greatly impairs BACE1 endocytosis and produces a delayed retrograde transport of BACE1 to the trans-Golgi network (TGN) and a delayed delivery of BACE1 to the lysosomes, thus decreasing its degradation. Moreover, the combination of the lack of ubiquitination at Lys-501 and the disruption of the di-leucine motif (BACE1LLAA/KR) produces additive effects on BACE1 stabilization and defective internalization. Finally, BACE1LLAA/KR accumulates in the TGN, while its levels are decreased in EEA1-positive compartments indicating that both ubiquitination at Lys-501 and the di-leucine motif are necessary for the trafficking of BACE1 from the TGN to early endosomes. Our studies have elucidated a differential role for the di-leucine motif and ubiquitination at Lys-501 in BACE1 endocytosis, trafficking, and degradation and suggest the involvement of multiple adaptor molecules.	[Kang, Eugene L.; Biscaro, Barbara; Piazza, Fabrizio; Tesco, Giuseppina] Tufts Univ, Sch Med, Dept Neurosci, Alzheimer Dis Res Lab, Boston, MA 02111 USA	Tufts University	Tesco, G (corresponding author), Tufts Univ, Sch Med, Dept Neurosci, Alzheimer Dis Res Lab, 136 Harrison Ave,Ste 328A, Boston, MA 02111 USA.	Giuseppina.Tesco@Tufts.edu	Piazza, Fabrizio/L-2094-2016	Piazza, Fabrizio/0000-0002-3385-3224	National Institutes of Health [5R01AG025952-07, P30 NS047243]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG025952] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant 5R01AG025952-07 (to G. T.).; We thank Dr. Kendall Walker for the useful comments in the preparation and editing of this manuscript. We thank Dr. Alenka Lovy-Wheeler of the Tufts Imaging Facility for help with confocal microscopy (Tufts Center for Neuroscience Research, supported by National Institutes of Health Grant P30 NS047243).	Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Bilodeau PS, 2004, J BIOL CHEM, V279, P54808, DOI 10.1074/jbc.M406654200; Bishop N, 2002, J CELL BIOL, V157, P91, DOI 10.1083/jcb.200112080; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Cai HB, 2001, NAT NEUROSCI, V4, P233, DOI 10.1038/85064; Creemers JWM, 2001, J BIOL CHEM, V276, P4211, DOI 10.1074/jbc.M006947200; Cuartero Y, 2012, TRAFFIC, V13, P1393, DOI 10.1111/j.1600-0854.2012.01392.x; Davies BA, 2009, CHEM REV, V109, P1575, DOI 10.1021/cr800473s; De Strooper B, 2010, PHYSIOL REV, V90, P465, DOI 10.1152/physrev.00023.2009; Deng Y, 2009, J BIOL CHEM, V284, P23830, DOI 10.1074/jbc.M109.030015; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; He XY, 2003, BIOCHEMISTRY-US, V42, P12174, DOI 10.1021/bi035199h; Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150; Hu XY, 2006, NAT NEUROSCI, V9, P1520, DOI 10.1038/nn1797; Huang FT, 2006, MOL CELL, V21, P737, DOI 10.1016/j.molcel.2006.02.018; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Jaskolski F, 2005, J NEUROSCI METH, V146, P42, DOI 10.1016/j.jneumeth.2005.01.012; Kang EL, 2010, J BIOL CHEM, V285, P24108, DOI 10.1074/jbc.M109.092742; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Kawasaki M, 2005, GENES CELLS, V10, P639, DOI 10.1111/j.1365-2443.2005.00865.x; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Lauwers E, 2010, TRENDS CELL BIOL, V20, P196, DOI 10.1016/j.tcb.2010.01.004; Lauwers E, 2009, J CELL BIOL, V185, P493, DOI 10.1083/jcb.200810114; Liu KN, 2002, BIOCHEMISTRY-US, V41, P3128, DOI 10.1021/bi015800g; Longva KE, 2002, J CELL BIOL, V156, P843, DOI 10.1083/jcb.200106056; Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Ohno M, 2006, EUR J NEUROSCI, V23, P251, DOI 10.1111/j.1460-9568.2005.04551.x; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Ohno M, 2007, NEUROBIOL DIS, V26, P134, DOI 10.1016/j.nbd.2006.12.008; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Pastorino L, 2002, MOL CELL NEUROSCI, V19, P175, DOI 10.1006/mcne.2001.1065; Piper RC, 2007, CURR OPIN CELL BIOL, V19, P459, DOI 10.1016/j.ceb.2007.07.002; Prabhu Y, 2012, MOL BIOL CELL, V23, P2339, DOI 10.1091/mbc.E11-11-0944; Prag G, 2005, P NATL ACAD SCI USA, V102, P2334, DOI 10.1073/pnas.0500118102; Puertollano R, 2004, NAT CELL BIOL, V6, P244, DOI 10.1038/ncb1106; Ren XF, 2010, EMBO J, V29, P1045, DOI 10.1038/emboj.2010.6; Roberds SL, 2001, HUM MOL GENET, V10, P1317, DOI 10.1093/hmg/10.12.1317; Sankaranarayanan S, 2008, J PHARMACOL EXP THER, V324, P957, DOI 10.1124/jpet.107.130039; Sannerud R, 2011, P NATL ACAD SCI USA, V108, pE559, DOI 10.1073/pnas.1100745108; Savonenko AV, 2008, P NATL ACAD SCI USA, V105, P5585, DOI 10.1073/pnas.0710373105; Scott PM, 2004, NAT CELL BIOL, V6, P252, DOI 10.1038/ncb1107; Shiba T, 2004, TRAFFIC, V5, P437, DOI 10.1111/j.1600-0854.2004.00188.x; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; von Arnim CAF, 2004, J CELL SCI, V117, P5437, DOI 10.1242/jcs.01422; Wahle T, 2005, MOL CELL NEUROSCI, V29, P453, DOI 10.1016/j.mcn.2005.03.014; Walter J, 2001, J BIOL CHEM, V276, P14634, DOI 10.1074/jbc.M011116200; Willem M, 2006, SCIENCE, V314, P664, DOI 10.1126/science.1132341; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107	57	38	38	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42867	42880		10.1074/jbc.M112.407072	http://dx.doi.org/10.1074/jbc.M112.407072			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23109336	Green Published, hybrid			2022-12-25	WOS:000312501600045
J	Oku, T; Nakano, M; Kaneko, Y; Ando, Y; Kenmotsu, H; Itoh, S; Tsuiji, M; Seyama, Y; Toyoshima, S; Tsuji, T				Oku, Teruaki; Nakano, Mai; Kaneko, Yutaka; Ando, Yusuke; Kenmotsu, Hiroki; Itoh, Saotomo; Tsuiji, Makoto; Seyama, Yoshiyuki; Toyoshima, Satoshi; Tsuji, Tsutomu			Constitutive Turnover of Phosphorylation at Thr-412 of Human p57/Coronin-1 Regulates the Interaction with Actin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; LEUCINE-ZIPPER MOTIF; T-CELL-ACTIVATION; PROTEIN-KINASE-C; BINDING-PROTEIN; CORONIN FAMILY; TRANSIENT ASSOCIATION; DICTYOSTELIUM CELLS; CYTOSKELETON; NEUTROPHILS	The actin-binding protein p57/coronin-1, a member of the coronin protein family, is selectively expressed in hematopoietic cells and plays crucial roles in the immune response through reorganization of the actin cytoskeleton. We previously reported that p57/coronin-1 is phosphorylated by protein kinase C, and the phosphorylation down-regulates the association of this protein with actin. In this study we analyzed the phosphorylation sites of p57/coronin-1 derived from HL60 human leukemic cells by MALDI-TOF-MS, two-dimensional gel electrophoresis, and Phos-tag (R) acrylamide gel electrophoresis in combination with site-directed mutagenesis and identified Ser-2 and Thr-412 as major phosphorylation sites. A major part of p57/coronin-1 was found as an unphosphorylated form in HL60 cells, but phosphorylation at Thr-412 of p57/coronin-1 was detected after the cells were treated with calyculin A, a Ser/Thr phosphatase inhibitor, suggesting that p57/coronin-1 undergoes constitutive turnover of phosphorylation/dephosphorylation at Thr-412. A diphosphorylated form of p57/coronin-1 was detected after the cells were treated with phorbol 12-myristate 13-acetate plus calyculin A. We then assessed the effects of phosphorylation at Thr-412 on the association of p57/coronin-1 with actin. A co-immunoprecipitation experiment with anti-p57/coronin-1 antibodies and HL60 cell lysates revealed that beta-actin was co-precipitated with the unphosphorylated form but not with the phosphorylated form at Thr-412 of p57/coronin-1. Furthermore, the phosphorylation mimic (T412D) of p57/coronin-1 expressed in HEK293T cells exhibited lower affinity for actin than the wild-type or the unphosphorylation mimic (T412A) did. These results indicate that the constitutive turnover of phosphorylation at Thr-412 of p57/coronin-1 regulates its interaction with actin.	[Tsuji, Tsutomu] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Microbiol, Shinagawa Ku, Tokyo 1428501, Japan; [Seyama, Yoshiyuki] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Clin Chem, Tokyo 1428501, Japan; [Toyoshima, Satoshi] Japan Pharmacists Educ Ctr, Tokyo 1070052, Japan	Hoshi University; Hoshi University	Tsuji, T (corresponding author), Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Microbiol, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan.	tsuji@hoshi.ac.jp		Tsuiji, Makoto/0000-0002-5607-4880; Ando, Yukio/0000-0001-7115-9105	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Open Research Center Project; Hoshi University Otani Research Grants; Araki Medical and Biochemical Research Memorial Fund	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Open Research Center Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hoshi University Otani Research Grants; Araki Medical and Biochemical Research Memorial Fund	This work was supported in part by the Ministry of Education, Culture, Sports, Science, and Technology of Japan, by the Open Research Center Project, by Hoshi University Otani Research Grants, and by the Araki Medical and Biochemical Research Memorial Fund.	Allen LAH, 1999, BLOOD, V93, P3521, DOI 10.1182/blood.V93.10.3521.410k21_3521_3530; Cai L, 2005, J BIOL CHEM, V280, P31913, DOI 10.1074/jbc.M504146200; Combaluzier B, 2009, J IMMUNOL, V182, P1954, DOI 10.4049/jimmunol.0801811; Das V, 2002, IMMUNOL REV, V189, P123, DOI 10.1034/j.1600-065X.2002.18911.x; de Hostos EL, 1999, TRENDS CELL BIOL, V9, P345, DOI 10.1016/S0962-8924(99)01620-7; DEHOSTOS EL, 1991, EMBO J, V10, P4097, DOI 10.1002/j.1460-2075.1991.tb04986.x; DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163; Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0; Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563; Foger N, 2011, J EXP MED, V208, P1777, DOI 10.1084/jem.20101757; GAMBLE JR, 1988, J IMMUNOL METHODS, V109, P175, DOI 10.1016/0022-1759(88)90240-2; Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042; GERISCH G, 1995, CURR BIOL, V5, P1280, DOI 10.1016/S0960-9822(95)00254-5; GERISCH G, 1993, SYM SOC EXP BIOL, V47, P297; Hacker U, 1997, J CELL SCI, V110, P105; Haraldsson MK, 2008, IMMUNITY, V28, P40, DOI 10.1016/j.immuni.2007.11.023; Hogquist KA, 2008, NAT IMMUNOL, V9, P1207, DOI 10.1038/ni1108-1207; Itoh S, 2006, J BIOMED MATER RES A, V77A, P294, DOI 10.1002/jbm.a.30608; Itoh S, 2002, BIOL PHARM BULL, V25, P837, DOI 10.1248/bpb.25.837; Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640; Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043; Kaminski S, 2011, J AUTOIMMUN, V37, P198, DOI 10.1016/j.jaut.2011.05.018; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Liu CZ, 2006, CELL RES, V16, P106, DOI 10.1038/sj.cr.7310014; MANIAK M, 1995, CELL, V83, P915, DOI 10.1016/0092-8674(95)90207-4; Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570; Mueller P, 2011, J IMMUNOL, V186, P4039, DOI 10.4049/jimmunol.1003352; Mugnier B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003467; Nal B, 2004, INT IMMUNOL, V16, P231, DOI 10.1093/intimm/dxh022; Oku T, 2005, BIOCHEM J, V387, P325, DOI 10.1042/BJ20041020; Oku T, 2003, BIOL PHARM BULL, V26, P409; Oku T, 2008, J BIOL CHEM, V283, P28918, DOI 10.1074/jbc.M709990200; Pareek TK, 2010, J EXP MED, V207, P2507, DOI 10.1084/jem.20100876; Shiow LR, 2008, NAT IMMUNOL, V9, P1307, DOI 10.1038/ni.1662; Shiow LR, 2009, CLIN IMMUNOL, V131, P24, DOI 10.1016/j.clim.2008.11.002; Siegmund K, 2011, J IMMUNOL, V186, P3452, DOI 10.4049/jimmunol.1003491; SUZUKI K, 1995, FEBS LETT, V364, P283, DOI 10.1016/0014-5793(95)00393-N; Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002; Yan M, 2005, MOL BIOL CELL, V16, P3077, DOI 10.1091/mbc.E04-11-0989; Yan M, 2007, J IMMUNOL, V178, P5769, DOI 10.4049/jimmunol.178.9.5769	40	7	13	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42910	42920		10.1074/jbc.M112.349829	http://dx.doi.org/10.1074/jbc.M112.349829			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23100250	hybrid, Green Published			2022-12-25	WOS:000312501600049
J	Adams, RA; Perrinet, LU; Friston, KJ				Adams, Rick A.; Perrinet, Laurent U.; Friston, Karl J.			Smooth Pursuit and Visual Occlusion: Active Inference and Oculomotor Control in Schizophrenia	PLOS ONE			English	Article							CORTICAL NETWORK MODEL; WORKING-MEMORY; EYE-MOVEMENTS; PREFRONTAL CORTEX; TRANSIENT DISAPPEARANCE; SENSORY CONSEQUENCES; DOPAMINE MODULATION; MOTION SIGNALS; MOTOR CONTROL; TRACKING	This paper introduces a model of oculomotor control during the smooth pursuit of occluded visual targets. This model is based upon active inference, in which subjects try to minimise their (proprioceptive) prediction error based upon posterior beliefs about the hidden causes of their (exteroceptive) sensory input. Our model appeals to a single principle - the minimisation of variational free energy - to provide Bayes optimal solutions to the smooth pursuit problem. However, it tries to accommodate the cardinal features of smooth pursuit of partially occluded targets that have been observed empirically in normal subjects and schizophrenia. Specifically, we account for the ability of normal subjects to anticipate periodic target trajectories and emit pre-emptive smooth pursuit eye movements - prior to the emergence of a target from behind an occluder. Furthermore, we show that a single deficit in the postsynaptic gain of prediction error units (encoding the precision of posterior beliefs) can account for several features of smooth pursuit in schizophrenia: namely, a reduction in motor gain and anticipatory eye movements during visual occlusion, a paradoxical improvement in tracking unpredicted deviations from target trajectories and a failure to recognise and exploit regularities in the periodic motion of visual targets. This model will form the basis of subsequent (dynamic causal) models of empirical eye tracking measurements, which we hope to validate, using psychopharmacology and studies of schizophrenia.	[Adams, Rick A.; Perrinet, Laurent U.; Friston, Karl J.] UCL, Wellcome Trust Ctr Neuroimaging, London, England; [Perrinet, Laurent U.] Aix Marseille Univ, Inst Neurosci Timone, CNRS, Marseille, France	University of London; University College London; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Adams, RA (corresponding author), UCL, Wellcome Trust Ctr Neuroimaging, Queen Sq, London, England.	rick.adams@ucl.ac.uk	Friston, Karl/D-9230-2011; Adams, Rick/M-7640-2015; Perrinet, Laurent U./C-4900-2009	Friston, Karl/0000-0001-7984-8909; Adams, Rick/0000-0002-7661-8881; Perrinet, Laurent U./0000-0002-9536-010X	Wellcome Trust [088130/Z/09/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by a Wellcome Trust (http://www.wellcome.ac.uk/) Program grant to KJF (088130/Z/09/Z). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Dargham A, 2002, J NEUROSCI, V22, P3708, DOI 10.1523/jneurosci.22-09-03708.2002; Allen AJ, 2009, SCHIZOPHR RES, V109, P24, DOI 10.1016/j.schres.2009.01.016; Avila MT, 2006, J NEUROPHYSIOL, V95, P593, DOI 10.1152/jn.00369.2005; BALLARD DH, 1983, NATURE, V306, P21, DOI 10.1038/306021a0; Barnes GR, 2008, BRAIN COGNITION, V68, P309, DOI 10.1016/j.bandc.2008.08.020; Beal Matthew James, 2003, VARIATIONAL ALGORITH; BECKER W, 1985, EXP BRAIN RES, V57, P562; Bennett SJ, 2003, J NEUROPHYSIOL, V90, P2504, DOI 10.1152/jn.01145.2002; Bialek W, 2001, NEURAL COMPUT, V13, P2409, DOI 10.1162/089976601753195969; Braver TS, 1999, BIOL PSYCHIAT, V46, P312, DOI 10.1016/S0006-3223(99)00116-X; Brunel N, 2001, J COMPUT NEUROSCI, V11, P63, DOI 10.1023/A:1011204814320; Calkins ME, 2008, BRAIN COGNITION, V68, P436, DOI 10.1016/j.bandc.2008.09.001; Chen Y, 1999, ARCH GEN PSYCHIAT, V56, P155, DOI 10.1001/archpsyc.56.2.155; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Corlett PR, 2007, BRAIN, V130, P2387, DOI 10.1093/brain/awm173; Corlett PR, 2010, NEUROPSYCHOPHARMACOL; DAYAN P, 1995, NEURAL COMPUT, V7, P889, DOI 10.1162/neco.1995.7.5.889; de Xivry JJO, 2006, J NEUROPHYSIOL, V95, P418, DOI 10.1152/jn.00596.2005; Durstewitz D, 1999, J NEUROSCI, V19, P2807; Durstewitz D, 2008, BIOL PSYCHIAT, V64, P739, DOI 10.1016/j.biopsych.2008.05.015; FELDMAN AG, 1995, BEHAV BRAIN SCI, V18, P723, DOI 10.1017/S0140525X0004070X; Feldman H, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00215; Fletcher PC, 2009, NAT REV NEUROSCI, V10, P48, DOI 10.1038/nrn2536; Friston K, 2011, NEURON, V72, P488, DOI 10.1016/j.neuron.2011.10.018; Friston KJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002327; Friston KJ, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/937860; Friston KJ, 2011, BIOL CYBERN, V104, P137, DOI 10.1007/s00422-011-0424-z; Friston KJ, 2010, MATH PROBL ENG, V2010, DOI 10.1155/2010/621670; Friston KJ, 2010, BIOL CYBERN, V102, P227, DOI 10.1007/s00422-010-0364-z; Friston KJ, 2009, NEURAL NETWORKS, V22, P1093, DOI 10.1016/j.neunet.2009.07.023; Friston KJ, 2009, TRENDS COGN SCI, V13, P293, DOI 10.1016/j.tics.2009.04.005; Friston KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006421; Friston KJ, 2009, PHILOS T R SOC B, V364, P1211, DOI 10.1098/rstb.2008.0300; Friston KJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000211; Friston KJ, 2005, BEHAV BRAIN SCI, V28, P764, DOI 10.1017/S0140525X05290131; Friston KJ, 2003, NEURAL NETWORKS, V16, P1325, DOI 10.1016/j.neunet.2003.06.005; Frith CD, 1992, COGNITIVE NEUROPSYCH, Vxiv; GINZBURG VL, 1955, NUOVO CIMENTO, V2, P1235; Goldman-Rakic PS, 1999, BIOL PSYCHIAT, V46, P650, DOI 10.1016/S0006-3223(99)00130-4; Gray JA, 1998, SCHIZOPHRENIA BULL, V24, P249, DOI 10.1093/oxfordjournals.schbul.a033324; GRAY JA, 1991, BEHAV BRAIN SCI, V14, P1, DOI 10.1017/S0140525X00065055; GREGORY RL, 1980, PHILOS T ROY SOC B, V290, P181, DOI 10.1098/rstb.1980.0090; Grossberg S, 1997, J NEUROSCI, V17, P9706; Haken H, 1983, SYNERGETICS INTRO AD; Hong LE, 2008, BIOL PSYCHIAT, V63, P458, DOI 10.1016/j.biopsych.2007.06.004; Hong LE, 2009, BIOL PSYCHIAT, V65, P1079, DOI 10.1016/j.biopsych.2008.10.021; Hong LE, 2006, ARCH GEN PSYCHIAT, V63, P259, DOI 10.1001/archpsyc.63.3.259; Hong LE, 2005, EXP BRAIN RES, V165, P125, DOI 10.1007/s00221-005-2276-z; Hong LE, 2005, BIOL PSYCHIAT, V57, P726, DOI 10.1016/j.biopsych.2004.12.015; Howes OD, 2009, SCHIZOPHRENIA BULL, V35, P549, DOI 10.1093/schbul/sbp006; Hutton S, 1998, NEUROLOGY, V50, P604, DOI 10.1212/WNL.50.3.604; Hutton SB, 1998, PSYCHOL MED, V28, P685, DOI 10.1017/S0033291798006722; Jones SH, 1997, BEHAV BRAIN RES, V88, P103, DOI 10.1016/S0166-4328(97)02312-7; Kapur S, 2003, AM J PSYCHIAT, V160, P13, DOI 10.1176/appi.ajp.160.1.13; Kattoulas E, 2011, EXP BRAIN RES, V215, P207, DOI 10.1007/s00221-011-2887-5; Kattoulas E, 2011, EXP BRAIN RES, V215, P219, DOI 10.1007/s00221-011-2888-4; Kiebel Stefan J, 2009, Front Neuroinform, V3, P20, DOI 10.3389/neuro.11.020.2009; Kiebel SJ, 2009, HUM BRAIN MAPP, V30, P1866, DOI 10.1002/hbm.20775; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Krauzlis RJ, 1989, NEURAL COMPUT, V1, P116, DOI 10.1162/neco.1989.1.1.116; Laruelle M, 2003, ANN NY ACAD SCI, V1003, P138, DOI 10.1196/annals.1300.063; Lencer R, 2008, BRAIN COGNITION, V68, P219, DOI 10.1016/j.bandc.2008.08.013; LEVY DL, 1993, SCHIZOPHRENIA BULL, V19, P461, DOI 10.1093/schbul/19.3.461; Lindner A, 2005, CURR BIOL, V15, P1119, DOI 10.1016/j.cub.2005.05.049; Lisberger SG, 2010, NEURON, V66, P477, DOI 10.1016/j.neuron.2010.03.027; Maloney LT, 2010, VISION RES, V50, P2362, DOI 10.1016/j.visres.2010.09.031; Moutoussis M, 2011, COGN NEUROPSYCHIATRY, V16, P422, DOI 10.1080/13546805.2010.548678; MUMFORD D, 1992, BIOL CYBERN, V66, P241, DOI 10.1007/BF00198477; Murray GK, 2008, MOL PSYCHIATR, V13, P267, DOI 10.1038/sj.mp.4002058; Nkam I, 2010, BIOL PSYCHIAT, V67, P992, DOI 10.1016/j.biopsych.2009.11.029; O'Driscoll GA, 2008, BRAIN COGNITION, V68, P359, DOI 10.1016/j.bandc.2008.08.023; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; ROBINSON DA, 1986, BIOL CYBERN, V55, P43, DOI 10.1007/BF00363977; Rolls ET, 2008, NAT REV NEUROSCI, V9, P696, DOI 10.1038/nrn2462; Schneider U, 2002, SCHIZOPHR RES, V53, P101, DOI 10.1016/S0920-9964(00)00172-9; Schnell K, 2008, BRAIN, V131, P2783, DOI 10.1093/brain/awn184; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Shergill SS, 2005, AM J PSYCHIAT, V162, P2384, DOI 10.1176/appi.ajp.162.12.2384; Shibata T, 2005, NEURAL NETWORKS, V18, P213, DOI 10.1016/j.neunet.2005.01.001; Smyrnis N, 2007, EXP BRAIN RES, V179, P397, DOI 10.1007/s00221-006-0797-8; Stephan KE, 2006, BIOL PSYCHIAT, V59, P929, DOI 10.1016/j.biopsych.2005.10.005; Synofzik M, 2010, BRAIN, V133, P262, DOI 10.1093/brain/awp291; Thaker GK, 1998, ARCH GEN PSYCHIAT, V55, P830, DOI 10.1001/archpsyc.55.9.830; Thaker GK, 2003, PSYCHOPHYSIOLOGY, V40, P277, DOI 10.1111/1469-8986.00029; Thaker GK, 1999, PSYCHIAT RES, V88, P209, DOI 10.1016/S0165-1781(99)00084-0; Thakkar KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027089; Turetsky BI, 2007, SCHIZOPHRENIA BULL, V33, P69, DOI 10.1093/schbul/sbl060; Voss M, 2010, BRAIN, V133, P3104, DOI 10.1093/brain/awq152; WEINBERGER DR, 1987, ARCH GEN PSYCHIAT, V44, P660, DOI 10.1001/archpsyc.1987.01800190080012; Williams LE, 2010, SCHIZOPHR RES, V121, P101, DOI 10.1016/j.schres.2009.10.021; Yuille A, 2006, TRENDS COGN SCI, V10, P301, DOI 10.1016/j.tics.2006.05.002	92	54	55	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47502	10.1371/journal.pone.0047502	http://dx.doi.org/10.1371/journal.pone.0047502			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	026GL	23110076	gold, Green Published, Green Submitted			2022-12-25	WOS:000310262500013
J	Cho, LY; Yang, JJ; Ko, KP; Ma, SH; Shin, A; Choi, BY; Han, DS; Song, KS; Kim, YS; Chang, SH; Shin, HR; Kang, D; Yoo, KY; Park, SK				Cho, Lisa Y.; Yang, Jae Jeong; Ko, Kwang-Pil; Ma, Seung Hyun; Shin, Aesun; Choi, Bo Youl; Han, Dong Soo; Song, Kyu Sang; Kim, Yong Sung; Chang, Soung-Hoon; Shin, Hai-Rim; Kang, Daehee; Yoo, Keun-Young; Park, Sue K.			Genetic Susceptibility Factors on Genes Involved in the Steroid Hormone Biosynthesis Pathway and Progesterone Receptor for Gastric Cancer Risk	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; HUMAN BREAST-CANCER; SINGLE-NUCLEOTIDE POLYMORPHISMS; TISSUE-SPECIFIC EXPRESSION; REPRODUCTIVE FACTORS; POSTMENOPAUSAL WOMEN; PROSTATE-CANCER; AROMATASE GENE; SEX-HORMONES; QUANTITATIVE-ANALYSIS	Background: The objective of the study was to investigate the role of genes (HSD3B1, CYP17A1, CYP19A1, HSD17B2, HSD17B1) involved in the steroid hormone biosynthesis pathway and progesterone receptor (PGR) in the etiology of gastric cancer in a population-based two-phase genetic association study. Methods: In the discovery phase, 108 candidate SNPs in the steroid hormone biosynthesis pathway related genes and PGR were analyzed in 76 gastric cancer cases and 322 controls in the Korean Multi-Center Cancer Cohort. Statistically significant SNPs identified in the discovery phase were re-evaluated in an extended set of 386 cases and 348 controls. Pooled-and meta-analyses were conducted to summarize the results. Results: Of the 108 SNPs in steroid hormone biosynthesis pathway related genes and PGR analyzed in the discovery phase, 23 SNPs in PGR in the recessive model and 10 SNPs in CYP19A1 in the recessive or additive models were significantly associated with increased gastric cancer risk (p<0.05). The minor allele frequencies of the SNPs in both the discovery and extension phases were not statistically different. Pooled-and meta-analyses showed CYP19A1 rs1004982, rs16964228, and rs1902580 had an increased risk for gastric cancer (pooled OR [95% CI] = 1.22 [1.01-1.48], 1.31 [1.03-1.66], 3.03 [1.12-8.18], respectively). In contrast, all PGR SNPs were not statistically significantly associated with gastric cancer risk. Conclusions: Our findings suggest CYP19A1 that codes aromatase may play an important role in the association of gastric cancer risk and be a genetic marker for gastric cancer susceptibility.	[Cho, Lisa Y.; Yang, Jae Jeong; Ma, Seung Hyun; Kang, Daehee; Yoo, Keun-Young; Park, Sue K.] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Cho, Lisa Y.; Yang, Jae Jeong; Ma, Seung Hyun; Kang, Daehee; Park, Sue K.] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Ko, Kwang-Pil] Gachon Univ, Grad Sch Med, Dept Prevent Med, Inchon, South Korea; [Shin, Aesun] Natl Canc Ctr, Res Inst, Mol Epidemiol Branch, Goyang Si, South Korea; [Choi, Bo Youl] Hanyang Univ, Coll Med, Dept Prevent Med, Seoul 133791, South Korea; [Han, Dong Soo] Hanyang Univ, Coll Med, Dept Internal Med, Seoul 133791, South Korea; [Song, Kyu Sang] Chungnam Natl Univ, Coll Med, Dept Pathol, Taejon, South Korea; [Kim, Yong Sung] Korea Res Inst Biosci & Biotechnol, Med Genom Res Ctr, Taejon, South Korea; [Chang, Soung-Hoon] Konkuk Univ, Dept Prevent Med, Chungju, South Korea; [Shin, Hai-Rim] Natl Canc Ctr, Canc Epidemiol Branch, Goyang Si, South Korea; [Shin, Hai-Rim] WHO, Western Pacific Reg Off, Non Communicable Dis & Hlth Promot, Manila, Philippines; [Kang, Daehee; Park, Sue K.] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Gachon University; National Cancer Center - Korea (NCC); Hanyang University; Hanyang University; Chungnam National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Konkuk University; Konkuk University Medical Center; National Cancer Center - Korea (NCC); WHO Western Pacific Regional Office; World Health Organization; Seoul National University (SNU)	Park, SK (corresponding author), Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.	suepark@snu.ac.kr	Han, Dong Soo/P-1753-2015; Shin, Aesun/E-9145-2014; Han, Dong Soo/AHD-6285-2022; Park, Sue Kyung/J-2757-2012; Yoo, Keun-Young/J-5548-2012	Shin, Aesun/0000-0002-6426-1969; Han, Dong Soo/0000-0001-7103-3318; Kang, Daehee/0000-0003-4031-5878	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea [0520140]; National Research Foundation of Korea; Ministry of Education, Science and Technology [NRF-2009-353-0066258, 2011-0001564]; Basic Research Laboratory (BRL) program through the National Research Foundation of Korea	National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Basic Research Laboratory (BRL) program through the National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by a grant from (1) the National R&D Program for Cancer Control, Ministry of Health & Welfare, Republic of Korea (0520140); (2) the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology [NRF-2009-353-0066258]; and (3) the Basic Research Laboratory (BRL) program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology [2011-0001564]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal VR, 1996, J CLIN ENDOCR METAB, V81, P3843, DOI 10.1210/jc.81.11.3843; Al Sarakbi W, 2006, ANTICANCER RES, V26, P4985; Ashton KA, 2010, CANCER EPIDEMIOL, V34, P328, DOI 10.1016/j.canep.2010.03.005; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brodie A, 1997, J STEROID BIOCHEM, V61, P281; Bulun SE, 2003, J STEROID BIOCHEM, V86, P219, DOI 10.1016/S0960-0760(03)00359-5; Cai H, 2008, PHARMACOGENET GENOM, V18, P657, DOI 10.1097/FPC.0b013e3282fe3326; Camargo MC, 2012, CANCER EPIDEM BIOMAR, V21, P20, DOI 10.1158/1055-9965.EPI-11-0834; Canzian F, 2010, HUM MOL GENET, V19, P3873, DOI 10.1093/hmg/ddq291; Cho LY, 2009, ANN EPIDEMIOL, V19, P644, DOI 10.1016/j.annepidem.2009.04.011; Cunningham JM, 2007, CANCER EPIDEM BIOMAR, V16, P969, DOI 10.1158/1055-9965.EPI-06-0767; Duell EJ, 2010, AM J EPIDEMIOL, V172, P1384, DOI 10.1093/aje/kwq321; Dunning AM, 2004, JNCI-J NATL CANCER I, V96, P936, DOI 10.1093/jnci/djh167; Ferlay J, 2010, IARC CANCERBASE, V10; Fernandez E, 2003, INT J CANCER, V105, P408, DOI 10.1002/ijc.11083; Freedman ND, 2007, GUT, V56, P1671, DOI 10.1136/gut.2007.129411; Freedman ND, 2009, CARCINOGENESIS, V30, P71, DOI 10.1093/carcin/bgn258; Frise S, 2006, ANN EPIDEMIOL, V16, P908, DOI 10.1016/j.annepidem.2006.03.001; FURUKAWA H, 1982, CANCER RES, V42, P5181; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Goodman MT, 2008, ENDOCR-RELAT CANCER, V15, P1055, DOI 10.1677/ERC-08-0104; Haiman CA, 2007, CANCER RES, V67, P1893, DOI 10.1158/0008-5472.CAN-06-4123; HARADA N, 1993, P NATL ACAD SCI USA, V90, P11312, DOI 10.1073/pnas.90.23.11312; Hardy RJ, 1998, STAT MED, V17, P841, DOI 10.1002/(SICI)1097-0258(19980430)17:8<841::AID-SIM781>3.0.CO;2-D; Heuch I, 2000, CANCER CAUSE CONTROL, V11, P869, DOI 10.1023/A:1008975817061; Heuch I, 2003, INT J CANCER, V106, P982, DOI 10.1002/ijc.11291; Ikeda S, 2008, AM J GASTROENTEROL, V103, P1476, DOI 10.1111/j.1572-0241.2008.01810.x; Inoue M, 2002, INT J CANCER, V97, P833, DOI 10.1002/ijc.10149; Irahara N, 2006, INT J CANCER, V118, P1915, DOI 10.1002/ijc.21562; Irahara N, 2006, CANCER LETT, V243, P23, DOI 10.1016/j.canlet.2005.11.010; Izawa M, 2008, GASTRIC CANCER, V11, P103, DOI 10.1007/s10120-008-0463-x; Jacobs E, 1997, EUR J CANCER, V33, P1130, DOI 10.1016/S0959-8049(97)00070-1; Justenhoven C, 2008, BREAST CANCER RES TR, V108, P137, DOI 10.1007/s10549-007-9586-8; Kaneko S, 2003, CANCER CAUSE CONTROL, V14, P53, DOI 10.1023/A:1022596104796; Karat D, 1999, BRIT J CANCER, V80, P1271, DOI 10.1038/sj.bjc.6690497; Katoh M, 2003, INT J MOL MED, V12, P3; Kim JY, 2009, ONCOL REP, V22, P487, DOI 10.3892/or_0000461; Kominea A, 2004, J CANCER RES CLIN, V130, P253, DOI 10.1007/s00432-003-0531-x; LAVECCHIA C, 1993, INT J CANCER, V53, P215, DOI 10.1002/ijc.2910530207; LAVECCHIA C, 1994, INT J CANCER, V59, P761, DOI 10.1002/ijc.2910590609; Lindblad M, 2006, BRIT J CANCER, V94, P136, DOI 10.1038/sj.bjc.6602906; Low YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001012; Ma XY, 2010, BREAST CANCER RES TR, V122, P495, DOI 10.1007/s10549-009-0693-6; MACAULAY VM, 1994, BRIT J CANCER, V69, P77, DOI 10.1038/bjc.1994.12; MAHENDROO MS, 1991, J BIOL CHEM, V266, P11276; Ohtani M, 2007, CARCINOGENESIS, V28, P2597, DOI 10.1093/carcin/bgm150; PALLI D, 1994, INT J CANCER, V56, P812, DOI 10.1002/ijc.2910560609; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Persson C, 2008, EUR J CANCER PREV, V17, P345, DOI 10.1097/CEJ.0b013e3282f521e4; Pricci M, 2001, ANTICANCER RES, V21, P3215; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Simpson E R, 1994, Int J Fertil Menopausal Stud, V39 Suppl 2, P75; Sipponen Pentti, 2002, Gastric Cancer, V5, P213, DOI 10.1007/s101200200037; Sissung TM, 2011, J CLIN ENDOCR METAB, V96, pE368, DOI 10.1210/jc.2010-2070; Sonoda T, 2010, EUR J CANCER PREV, V19, P131, DOI 10.1097/CEJ.0b013e328333fbe2; Takano N, 2002, CANCER LETT, V176, P129, DOI 10.1016/S0304-3835(01)00739-X; Tsuchiya Y, 2005, CANCER LETT, V227, P115, DOI 10.1016/j.canlet.2004.10.007; Ueyama T, 2002, ENDOCRINOLOGY, V143, P3162, DOI 10.1210/en.143.8.3162; Utsumi T, 1996, J CLIN ENDOCR METAB, V81, P2344, DOI 10.1210/jc.81.6.2344; Wang H, 2011, MOL HUM REPROD, V17, P386, DOI 10.1093/molehr/gar007; WU CW, 1992, GASTROENTEROLOGY, V102, P1639, DOI 10.1016/0016-5085(92)91724-I; WU CW, 1990, CANCER, V65, P1396, DOI 10.1002/1097-0142(19900315)65:6<1396::AID-CNCR2820650625>3.0.CO;2-2; Yang HP, 2010, CARCINOGENESIS, V31, P827, DOI 10.1093/carcin/bgp328; Yoo Keun Young, 2002, Asian Pac J Cancer Prev, V3, P85	64	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47603	10.1371/journal.pone.0047603	http://dx.doi.org/10.1371/journal.pone.0047603			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110082	Green Published, gold, Green Submitted			2022-12-25	WOS:000310193600018
J	Bond, CE; Umapathy, A; Buttenshaw, RL; Wockner, L; Leggett, BA; Whitehall, VLJ				Bond, Catherine E.; Umapathy, Aarti; Buttenshaw, Ron L.; Wockner, Leesa; Leggett, Barbara A.; Whitehall, Vicki L. J.			Chromosomal Instability in BRAF Mutant, Microsatellite Stable Colorectal Cancers	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; III COLON-CANCER; TGF-BETA; AURORA-B; GENOMIC INSTABILITY; GENETIC ALTERATIONS; SERRATED ADENOMAS; PROGNOSTIC IMPACT; MUTATIONS; EXPRESSION	The BRAF oncogene is mutated in 15% of sporadic colorectal cancers. Approximately half of these BRAF mutant cancers demonstrate frequent frameshift mutations termed microsatellite instability (MSI), but are diploid and chromosomally stable. BRAF wild type cancers are typically microsatellite stable (MSS) and instead acquire chromosomal instability (CIN). In these cancers, CIN is associated with a poor outcome. BRAF mutant cancers that are MSS, typically present at an advanced stage and have a particularly poor prognosis. We have previously demonstrated clinical and molecular similarities between MSS cancers with or without a BRAF mutation, and therefore hypothesised that CIN may also be frequent in BRAF mutant/MSS cancers. BRAF mutant/MSS (n = 60), and BRAF wild type/MSS CRCs (n = 90) were investigated for CIN using loss of heterozygosity analysis over twelve loci encompassing chromosomal regions 5q, 8p, 17p and 18q. CIN was frequent in BRAF mutant/MSS cancers (41/57, 72%), which was comparable to the rate found in BRAF wild type/MSS cancers (74/90, 82%). The greatest loss in BRAF mutant/MSS cancers occurred at 8p (26/44, 59%), and the least at 5q (19/49, 39%). CIN in BRAF mutant/MSS cancers correlated with advanced stage (AJCC III/IV: 15/17, 88%; p = 0.02); showed high rates of co-occurrence with the CpG Island Methylator Phenotype (17/23, 74%); and CIN at 18q and 8p associated with worse survival (p = 0.02, p < 0.05). This study demonstrates that CIN commonly occurs in advanced BRAF mutant/MSS colorectal cancers where it may contribute to poorer survival, and further highlights molecular similarities occurring between these and BRAF wild type cancers.	[Bond, Catherine E.; Umapathy, Aarti; Buttenshaw, Ron L.; Leggett, Barbara A.; Whitehall, Vicki L. J.] Queensland Inst Med Res, Conjoint Gastroenterol Lab, Brisbane, Qld 4006, Australia; [Bond, Catherine E.; Leggett, Barbara A.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Buttenshaw, Ron L.; Whitehall, Vicki L. J.] Queensland Hlth, Clin & Statewide Serv, Pathol Queensland, Brisbane, Qld, Australia; [Wockner, Leesa] Queensland Inst Med Res, Stat Unit, Brisbane, Qld 4006, Australia; [Leggett, Barbara A.] Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia	QIMR Berghofer Medical Research Institute; University of Queensland; Queensland Health; QIMR Berghofer Medical Research Institute; Royal Brisbane & Women's Hospital	Bond, CE (corresponding author), Queensland Inst Med Res, Conjoint Gastroenterol Lab, Brisbane, Qld 4006, Australia.	Catherine.Bond@qimr.edu.au	; Whitehall, Vicki/B-6262-2013	Wockner, Leesa/0000-0002-8921-9265; Bond, Catherine/0000-0002-9615-5300; Leggett, Barbara/0000-0003-2062-7380; Whitehall, Vicki/0000-0002-8285-2391	National Health and Medical Research Council grant [NHMRC 442965]; Pathology Queensland, Clinical and Statewide Services, Queensland, Australia; Australian Postgraduate Award (APA)	National Health and Medical Research Council grant(National Health and Medical Research Council (NHMRC) of Australia); Pathology Queensland, Clinical and Statewide Services, Queensland, Australia; Australian Postgraduate Award (APA)(Australian Government)	This research was supported by a National Health and Medical Research Council grant (NHMRC 442965); Pathology Queensland, Clinical and Statewide Services, Queensland, Australia; and an Australian Postgraduate Award (APA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Joint Committee on Cancer, 2010, AJCC CANC STAGING HD, V7th; Andersen CL, 2007, CARCINOGENESIS, V28, P38, DOI 10.1093/carcin/bgl086; Andersen CL, 2011, INT J CANCER, V129, P1848, DOI 10.1002/ijc.25841; Baba Y, 2009, NEOPLASIA, V11, P418, DOI 10.1593/neo.09154; Bertagnolli MM, 2011, J CLIN ONCOL, V29, P3153, DOI 10.1200/JCO.2010.33.0092; Boland CR, 1998, CANCER RES, V58, P5248; Bond CE, 2012, INT J CANCER, V130, P1567, DOI 10.1002/ijc.26175; Bonet C, 2012, J BIOL CHEM, V287, P29887, DOI 10.1074/jbc.M112.371682; Chang SC, 2006, INT J CANCER, V118, P1721, DOI 10.1002/ijc.21563; Cheng YW, 2008, CLIN CANCER RES, V14, P6005, DOI 10.1158/1078-0432.CCR-08-0216; Dar AA, 2010, MOL CANCER THER, V9, P268, DOI 10.1158/1535-7163.MCT-09-0765; Derks S, 2009, CARCINOGENESIS, V30, P1041, DOI 10.1093/carcin/bgp073; Derynck R, 2001, NAT GENET, V29, P117, DOI 10.1038/ng1001-117; Diep CB, 2003, J CLIN ONCOL, V21, P820, DOI 10.1200/JCO.2003.05.190; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Goel A, 2003, CANCER RES, V63, P1608; Goel A, 2007, GASTROENTEROLOGY, V132, P127, DOI 10.1053/j.gastro.2006.09.018; Halling KC, 1999, JNCI-J NATL CANCER I, V91, P1295, DOI 10.1093/jnci/91.15.1295; Hollingsworth SJ, 2005, J SURG ONCOL, V92, P317, DOI 10.1002/jso.20321; Iino H, 1999, J CLIN PATHOL, V52, P5, DOI 10.1136/jcp.52.1.5; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jass JR, 1999, J CLIN PATHOL, V52, P455, DOI 10.1136/jcp.52.6.455; Jass JR, 1998, GUT, V42, P673, DOI 10.1136/gut.42.5.673; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Kakar S, 2008, ARCH PATHOL LAB MED, V132, P958, DOI 10.1043/1543-2165(2008)132[958:CCCIMP]2.0.CO;2; Kambara T, 2004, GUT, V53, P1137, DOI 10.1136/gut.2003.037671; Kane MF, 1997, CANCER RES, V57, P808; Katayama H, 1999, J NATL CANCER I, V91, P1160, DOI 10.1093/jnci/91.13.1160; Koinuma K, 2004, INT J CANCER, V108, P237, DOI 10.1002/ijc.11523; Kretzschmar M, 1999, GENE DEV, V13, P804, DOI 10.1101/gad.13.7.804; Kurai M, 2005, HUM PATHOL, V36, P1281, DOI 10.1016/j.humpath.2005.09.014; Lanza G, 1998, INT J CANCER, V79, P390, DOI 10.1002/(SICI)1097-0215(19980821)79:4<390::AID-IJC14>3.3.CO;2-M; Lassmann S, 2007, J MOL MED-JMM, V85, P289, DOI 10.1007/s00109-006-0126-5; Leggett B, 2010, GASTROENTEROLOGY, V138, P2088, DOI 10.1053/j.gastro.2009.12.066; Lehmann K, 2000, GENE DEV, V14, P2610, DOI 10.1101/gad.181700; Lin ZZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-461; LOTHE RA, 1993, CANCER RES, V53, P5849; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Melcher R, 2011, CARCINOGENESIS, V32, P636, DOI 10.1093/carcin/bgr011; Nagasaka T, 2008, GASTROENTEROLOGY, V134, P1950, DOI 10.1053/j.gastro.2008.02.094; O'Brien MJ, 2006, AM J SURG PATHOL, V30, P1491, DOI 10.1097/01.pas.0000213313.36306.85; Ogino S, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-72; Ogino S, 2012, CLIN CANCER RES, V18, P890, DOI 10.1158/1078-0432.CCR-11-2246; Ogino S, 2009, J CLIN ONCOL, V27, P4591, DOI 10.1200/JCO.2009.22.8858; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Peyssonnaux C, 2001, BIOL CELL, V93, P53, DOI 10.1016/S0248-4900(01)01125-X; Pino MS, 2010, GASTROENTEROLOGY, V138, P1406, DOI 10.1053/j.gastro.2009.12.010; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Rosenberg DW, 2007, CANCER RES, V67, P3551, DOI 10.1158/0008-5472.CAN-07-0343; Samowitz WS, 2005, CANCER RES, V65, P6063, DOI 10.1158/0008-5472.CAN-05-0404; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Sinicrope FA, 2006, GASTROENTEROLOGY, V131, P729, DOI 10.1053/j.gastro.2006.06.005; Spring KJ, 2006, GASTROENTEROLOGY, V131, P1400, DOI 10.1053/j.gastro.2006.08.038; Tanaka T, 2009, DIAGN MOL PATHOL, V18, P219, DOI 10.1097/PDM.0b013e3181910f17; Toyota M, 1999, CANCER RES, V59, P2307; Trautmann K, 2006, CLIN CANCER RES, V12, P6379, DOI 10.1158/1078-0432.CCR-06-1248; Vlajnic T, 2011, MODERN PATHOL, V24, P1404, DOI 10.1038/modpathol.2011.96; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Walther A, 2008, GUT, V57, P941, DOI 10.1136/gut.2007.135004; Watanabe T, 2001, NEW ENGL J MED, V344, P1196, DOI 10.1056/NEJM200104193441603; Watanabe T, 2012, J CLIN ONCOL, V30, P2256, DOI 10.1200/JCO.2011.38.6490; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834	65	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e47483	10.1371/journal.pone.0047483	http://dx.doi.org/10.1371/journal.pone.0047483			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110075	Green Published, gold, Green Submitted			2022-12-25	WOS:000310193400010
J	Fujita, Y; Kuchimaru, T; Kadonosono, T; Tanaka, S; Hase, Y; Tomimoto, H; Hiraoka, M; Kizaka-Kondoh, S; Ihara, M; Takahashi, R				Fujita, Youshi; Kuchimaru, Takahiro; Kadonosono, Tetsuya; Tanaka, Shotaro; Hase, Yoshiki; Tomimoto, Hidekazu; Hiraoka, Masahiro; Kizaka-Kondoh, Shinae; Ihara, Masafumi; Takahashi, Ryosuke			In Vivo Imaging of Brain Ischemia Using an Oxygen-Dependent Degradative Fusion Protein Probe	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; INDUCIBLE FACTOR-I; GENE-EXPRESSION; ACUTE STROKE; BCL-XL; HYPOXIA; RAT; PENUMBRA; INJURY; MOUSE	Within the ischemic penumbra, blood flow is sufficiently reduced that it results in hypoxia severe enough to arrest physiological function. Nevertheless, it has been shown that cells present within this region can be rescued and resuscitated by restoring perfusion and through other protective therapies. Thus, the early detection of the ischemic penumbra can be exploited to improve outcomes after focal ischemia. Hypoxia-inducible factor (HIF)-1 is a transcription factor induced by a reduction in molecular oxygen levels. Although the role of HIF-1 in the ischemic penumbra remains unknown, there is a strong correlation between areas with HIF-1 activity and the ischemic penumbra. We recently developed a near-infrared fluorescently labeled-fusion protein, POH-N, with an oxygen-dependent degradation property identical to the alpha subunit of HIF-1. Here, we conduct in vivo imaging of HIF-active regions using POH-N in ischemic brains after transient focal cerebral ischemia induced using the intraluminal middle cerebral artery occlusion technique in mice. The results demonstrate that POH-N enables the in vivo monitoring and ex vivo detection of HIF-1-active regions after ischemic brain injury and suggest its potential in imaging and drug delivery to HIF-1-active areas in ischemic brains.	[Fujita, Youshi; Hase, Yoshiki; Ihara, Masafumi; Takahashi, Ryosuke] Kyoto Univ, Dept Neurol, Grad Sch Med, Sakyo Ku, Kyoto, Japan; [Kuchimaru, Takahiro; Kadonosono, Tetsuya; Kizaka-Kondoh, Shinae] Tokyo Inst Technol, Dept Biomol Engn, Grad Sch Biosci & Biotechnol, Midori Ku, Yokohama, Kanagawa 227, Japan; [Tomimoto, Hidekazu] Mie Univ, Sch Med, Dept Neurol, Tsu, Mie, Japan; [Tanaka, Shotaro] Tokyo Womens Med Univ, Sch Med, Dept Biochem, Tokyo, Japan; [Hiraoka, Masahiro] Kyoto Univ, Dept Radiat Oncol & Image Appl Therapy, Grad Sch Med, Sakyo Ku, Kyoto, Japan; [Ihara, Masafumi] Inst Biomed Res & Innovat, Dept Regenerat Med & Res, Chuo Ku, Kobe, Hyogo, Japan	Kyoto University; Tokyo Institute of Technology; Mie University; Tokyo Women's Medical University; Kyoto University; Institute for Biomedical Research & Innovation (IBRI)	Ihara, M (corresponding author), Kyoto Univ, Dept Neurol, Grad Sch Med, Sakyo Ku, Kyoto, Japan.	iharama@gmail.com	Kadonosono, Tetsuya/D-4651-2019; Kondoh, Shinae/AAF-8745-2020; Kondoh, Shinae/C-6937-2015; Ihara, Masafumi/O-5020-2019; Kuchimaru, Takahiro/B-9269-2015	Kondoh, Shinae/0000-0003-3085-5782; Kondoh, Shinae/0000-0003-3085-5782; Ihara, Masafumi/0000-0002-7102-4048; Kuchimaru, Takahiro/0000-0002-5355-3165; Fujita, Youshi/0000-0002-9056-5878	Japanese Ministry of Education, Science, and Culture; Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan; Grants-in-Aid for Scientific Research [23390233, 22112009] Funding Source: KAKEN	Japanese Ministry of Education, Science, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Young Scientists (B) (to YF) and for Scientific Research (B) (to MI) from the Japanese Ministry of Education, Science, and Culture and by the Global COE Program "Center for Frontier Medicine'' funded by the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan. This study is part of a joint research program focusing on the development of technology to establish a Center of Excellence for nanomedicine and carried out by the Kyoto City Collaboration of Regional Entities for Advancing Technology Excellence assigned by the Japan Science and Technology Agency. The funders had no role in study design, data collection and analysis, the decision to publish, or manuscript preparation.	ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Bergeron M, 1999, EUR J NEUROSCI, V11, P4159, DOI 10.1046/j.1460-9568.1999.00845.x; Cao GD, 2002, J NEUROSCI, V22, P5423; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Fisher M, 2008, CURR OPIN DRUG DISC, V11, P626; Gonzalez RG, 2006, AM J NEURORADIOL, V27, P728; Harada H, 2007, ONCOGENE, V26, P7508, DOI 10.1038/sj.onc.1210556; Harada H, 2002, CANCER RES, V62, P2013; Harada H, 2005, MOL IMAGING, V4, P182; Harada H, 2006, FEBS LETT, V580, P5718, DOI 10.1016/j.febslet.2006.09.025; Hase Y, 2012, EXP NEUROL, V233, P523, DOI 10.1016/j.expneurol.2011.11.038; Hiraga T, 2007, CANCER RES, V67, P4157, DOI 10.1158/0008-5472.CAN-06-2355; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kilic E, 2002, ANN NEUROL, V52, P617, DOI 10.1002/ana.10356; Kilic U, 2003, STROKE, V34, P1304, DOI 10.1161/01.STR.0000066869.45310.50; Kim DW, 2005, MOL CELLS, V19, P88; KINOUCHI H, 1993, BRAIN RES, V619, P334, DOI 10.1016/0006-8993(93)91630-B; Kizaka-Kondoh S, 2009, CLIN CANCER RES, V15, P3433, DOI 10.1158/1078-0432.CCR-08-2267; Koistinaho J, 1999, STROKE, V30, P114, DOI 10.1161/01.STR.30.1.114; Kuchimaru T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015736; Kucinski T, 2005, AM J NEURORADIOL, V26, P815; Labiche Lise A, 2004, NeuroRx, V1, P46, DOI 10.1007/BF03206567; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; NEDERGAARD M, 1987, ACTA NEUROPATHOL, V73, P267, DOI 10.1007/BF00686621; Savitz SI, 2007, ANN NEUROL, V61, P396, DOI 10.1002/ana.21127; Schlaug G, 1999, NEUROLOGY, V53, P1528, DOI 10.1212/WNL.53.7.1528; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Schwarze SR, 1999, SCIENCE, V285, P1569, DOI 10.1126/science.285.5433.1569; Semenza GL, 2000, J APPL PHYSIOL, V88, P1474, DOI 10.1152/jappl.2000.88.4.1474; Shah Zahoor Ahmad, 2006, J Stroke Cerebrovasc Dis, V15, P133, DOI 10.1016/j.jstrokecerebrovasdis.2006.04.002; Sharp FR, 2000, J CEREBR BLOOD F MET, V20, P1011, DOI 10.1097/00004647-200007000-00001; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; YUAN F, 1994, CANCER RES, V54, P4564	34	5	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e48051	10.1371/journal.pone.0048051	http://dx.doi.org/10.1371/journal.pone.0048051			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094105	Green Submitted, Green Published, gold			2022-12-25	WOS:000310050200057
J	Fukuda, K; Ishida, W; Uchiyama, J; Rashel, M; Kato, S; Morita, T; Muraoka, A; Sumi, T; Matsuzaki, S; Daibata, M; Fukushima, A				Fukuda, Ken; Ishida, Waka; Uchiyama, Jumpei; Rashel, Mohammad; Kato, Shin-ichiro; Morita, Tamae; Muraoka, Asako; Sumi, Tamaki; Matsuzaki, Shigenobu; Daibata, Masanori; Fukushima, Atsuki			Pseudomonas aeruginosa Keratitis in Mice: Effects of Topical Bacteriophage KPP12 Administration	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; BACTERIAL-INFECTIONS; THERAPY; INFLAMMATION; ELIMINATION; RESISTANCE; LYSIN	The therapeutic effects of bacteriophage (phage) KPP12 in Pseudomonas aeruginosa keratitis were investigated in mice. Morphological analysis showed that phage KPP12 is a member of the family Myoviridae, morphotype A1, and DNA sequence analysis revealed that phage KPP12 is similar to PB1-like viruses. Analysis of the phage KPP12 genome did not identify any genes related to drug resistance, pathogenicity or lysogenicity, and so phage KPP12 may be a good candidate for therapeutic. KPP12 showed a broad host range for P. aeruginosa strains isolated from clinical ophthalmic infections. Inoculation of the scarified cornea with P. aeruginosa caused severe keratitis and eventual corneal perforation. Subsequent single-dose administration of KPP12 eye-drops significantly improved disease outcome, and preserved the structural integrity and transparency of the infected cornea. KPP12 treatment resulted in the suppression of neutrophil infiltration and greatly enhanced bacterial clearance in the infected cornea. These results indicate that bacteriophage eye-drops may be a novel adjunctive or alternative therapeutic agent for the treatment of infectious keratitis secondary to antibiotic-resistant bacteria.	[Fukuda, Ken; Ishida, Waka; Sumi, Tamaki; Fukushima, Atsuki] Kochi Med Sch, Dept Ophthalmol & Visual Sci, Kochi, Japan; [Uchiyama, Jumpei; Rashel, Mohammad; Matsuzaki, Shigenobu; Daibata, Masanori] Kochi Med Sch, Dept Microbiol & Infect, Kochi, Japan; [Kato, Shin-ichiro] Kochi Univ, Res Inst Mol Genet, Kochi 780, Japan; [Morita, Tamae] Kochi Med Sch Hosp, Kochi, Japan; [Muraoka, Asako] Kochi Gakuen Jr Coll, Kochi, Japan	Kochi University; Kochi University; Kochi University; Kochi University	Fukuda, K (corresponding author), Kochi Med Sch, Dept Ophthalmol & Visual Sci, Kochi, Japan.	k.fukuda@kochi-u.ac.jp	Uchiyama, Jumpei/GNP-6661-2022; Uchiyama, Jumpei/GWC-4189-2022; Fukuda, Ken/A-3076-2011	Uchiyama, Jumpei/0000-0003-0846-0100; Fukuda, Ken/0000-0003-4990-6308	Grants-in-Aid for Scientific Research [23591391, 24791025] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Biswas B, 2002, INFECT IMMUN, V70, P204, DOI 10.1128/IAI.70.1.204-210.2002; Carmody LA, 2010, J INFECT DIS, V201, P264, DOI 10.1086/649227; Comeau AM, 2008, MOL BIOL EVOL, V25, P1321, DOI 10.1093/molbev/msn080; d'Herelle F, 1917, CR HEBD ACAD SCI, V165, P373; Dabrowska K, 2005, J APPL MICROBIOL, V98, P7, DOI 10.1111/j.1365-2672.2004.02422.x; DUCKWORTH DH, 1976, BACTERIOL REV, V40, P793, DOI 10.1128/MMBR.40.4.793-802.1976; Fischetti VA, 2010, INT J MED MICROBIOL, V300, P357, DOI 10.1016/j.ijmm.2010.04.002; Gorski A, 2009, OPHTHALMOLOGICA, V223, P162, DOI 10.1159/000193293; Hazlett LD, 2000, INVEST OPHTH VIS SCI, V41, P805; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Khosravi A. D., 2007, SMJ Singapore Medical Journal, V48, P741; Loeffler JM, 2001, SCIENCE, V294, P2170, DOI 10.1126/science.1066869; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Matsuzaki S, 2003, J INFECT DIS, V187, P613, DOI 10.1086/374001; Merabishvili M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004944; Merril C, 2003, NAT REV DRUG DISCOV, V2, P489, DOI 10.1038/nrd1111; Nelson D, 2001, P NATL ACAD SCI USA, V98, P4107, DOI 10.1073/pnas.061038398; Proskurov V A, 1970, Vestn Oftalmol, V6, P82; Rashel M, 2007, J INFECT DIS, V196, P1237, DOI 10.1086/521305; Schuch R, 2002, NATURE, V418, P884, DOI 10.1038/nature01026; Sheehan MM, 1997, MOL MICROBIOL, V25, P717, DOI 10.1046/j.1365-2958.1997.5101880.x; SLOPEK S, 1987, ARCH IMMUNOL THER EX, V35, P569; Sulakvelidze A, 2005, BACTERIOPHAGE: BIOLOGY AND APPLICATIONS, P381; Wang J, 2006, INT J MOL MED, V17, P347; Wang J, 2006, INT J MOL MED, V17, P309, DOI 10.1177/1045389X06054331; Weber-Dabrowska Beata, 2000, Archivum Immunologiae et Therapiae Experimentalis, V48, P547; Willcox MDP, 2007, OPTOMETRY VISION SCI, V84, P273, DOI 10.1097/OPX.0b013e3180439c3e; Willcox MDP, 2011, CLIN EXP OPTOM, V94, P161, DOI 10.1111/j.1444-0938.2010.00536.x; WILLIAMS RN, 1982, CURR EYE RES, V2, P465, DOI 10.3109/02713688208996350; Wu MH, 2009, J IMMUNOL, V182, P1609, DOI 10.4049/jimmunol.182.3.1609	30	54	61	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47742	10.1371/journal.pone.0047742	http://dx.doi.org/10.1371/journal.pone.0047742			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082205	gold, Green Published, Green Submitted			2022-12-25	WOS:000311146900102
J	Krstic, D; Rodriguez, M; Knuesel, I				Krstic, Dimitrije; Rodriguez, Myriam; Knuesel, Irene			Regulated Proteolytic Processing of Reelin through Interplay of Tissue Plasminogen Activator (tPA), ADAMTS-4, ADAMTS-5, and Their Modulators	PLOS ONE			English	Article							C-TERMINAL REGION; ALZHEIMERS-DISEASE; VLDL RECEPTOR; A-BETA; PROTEIN; AGGRECANASE-1; BINDING; EXPRESSION; MODEL; MICE	The extracellular signaling protein Reelin, indispensable for proper neuronal migration and cortical layering during development, is also expressed in the adult brain where it modulates synaptic functions. It has been shown that proteolytic processing of Reelin decreases its signaling activity and promotes Reelin aggregation in vitro, and that proteolytic processing is affected in various neurological disorders, including Alzheimer's disease (AD). However, neither the pathophysiological significance of dysregulated Reelin cleavage, nor the involved proteases and their modulators are known. Here we identified the serine protease tissue plasminogen activator (tPA) and two matrix metalloproteinases, ADAMTS-4 and ADAMTS-5, as Reelin cleaving enzymes. Moreover, we assessed the influence of several endogenous protease inhibitors, including tissue inhibitors of metalloproteinases (TIMPs), alpha-2-Macroglobulin, and multiple serpins, as well as matrix metalloproteinase 9 (MMP-9) on Reelin cleavage, and described their complex interplay in the regulation of this process. Finally, we could demonstrate that in the murine hippocampus, the expression levels and localization of Reelin proteases largely overlap with that of Reelin. While this pattern remained stable during normal aging, changes in their protein levels coincided with accelerated Reelin aggregation in a mouse model of AD.	[Krstic, Dimitrije; Rodriguez, Myriam; Knuesel, Irene] Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland	University of Zurich	Knuesel, I (corresponding author), Univ Zurich, Inst Pharmacol & Toxicol, Zurich, Switzerland.	knuesel@pharma.uzh.ch		Knuesel, Irene/0000-0003-0396-9952	Swiss National Science Foundation [310030-132629]; Gottfried und Julia Bangerter-Rhyner-Stiftung; Novartis Foundation; Alzheimer and Depression - Fonds, Swiss Academy of Medical Sciences	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Gottfried und Julia Bangerter-Rhyner-Stiftung; Novartis Foundation(Novartis); Alzheimer and Depression - Fonds, Swiss Academy of Medical Sciences	This work was supported by the Swiss National Science Foundation, Grant No 310030-132629 to IK, Gottfried und Julia Bangerter-Rhyner-Stiftung to IK and DK, The Novartis Foundation, formerly Ciba-Geigy Jubilee Foundation to IK and DK, Alzheimer and Depression - Fonds, Swiss Academy of Medical Sciences to IK and DK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beffert U, 2002, J BIOL CHEM, V277, P49958, DOI 10.1074/jbc.M209205200; Bock HH, 2003, J BIOL CHEM, V278, P38772, DOI 10.1074/jbc.M306416200; Botella-Lopez A, 2006, P NATL ACAD SCI USA, V103, P5573, DOI 10.1073/pnas.0601279103; Botella-Lopez A, 2010, NEUROBIOL DIS, V37, P682, DOI 10.1016/j.nbd.2009.12.006; DArcangelo G, 1997, J NEUROSCI, V17, P23, DOI 10.1523/JNEUROSCI.17-01-00023.1997; de Rouvroit CL, 1999, EXP NEUROL, V156, P214, DOI 10.1006/exnr.1998.7007; deBergeyck V, 1997, MOL BRAIN RES, V50, P85, DOI 10.1016/S0169-328X(97)00166-6; Doehner J, 2012, EUR J NEUROSCI, V35, P1938, DOI 10.1111/j.1460-9568.2012.08154.x; Doehner J, 2010, J ALZHEIMERS DIS, V19, P1339, DOI 10.3233/JAD-2010-1333; Ducharme P, 2010, NEUROSCIENCE, V167, P633, DOI 10.1016/j.neuroscience.2010.02.039; Dupuis LE, 2011, DEV BIOL, V357, P152, DOI 10.1016/j.ydbio.2011.06.041; Duveau V, 2011, HIPPOCAMPUS, V21, P935, DOI 10.1002/hipo.20793; Fatemi SH, 2005, BIOL PSYCHIAT, V57, P777, DOI 10.1016/j.biopsych.2004.12.018; Fatemi SH, 2005, MOL PSYCHIATR, V10, P251, DOI 10.1038/sj.mp.4001613; Fatemi SH, 2001, NEUROREPORT, V12, P3209, DOI 10.1097/00001756-200110290-00014; Forster E, 2010, EUR J NEUROSCI, V31, P1511, DOI 10.1111/j.1460-9568.2010.07222.x; Fosang AJ, 2008, EUR CELLS MATER, V15, P11, DOI 10.22203/eCM.v015a02; Hashimoto G, 2001, FEBS LETT, V494, P192, DOI 10.1016/S0014-5793(01)02323-7; Hatada I, 2008, J HUM GENET, V53, P185, DOI 10.1007/s10038-007-0228-0; Herring A, 2012, J ALZHEIMERS DIS, V30, P963, DOI 10.3233/JAD-2012-112069; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Hibi T, 2009, FEBS LETT, V583, P1299, DOI 10.1016/j.febslet.2009.03.024; Hiesberger T, 1999, NEURON, V24, P481, DOI 10.1016/S0896-6273(00)80861-2; Hoe HS, 2006, J BIOL CHEM, V281, P35176, DOI 10.1074/jbc.M602162200; Hoe HS, 2009, J NEUROSCI, V29, P7459, DOI 10.1523/JNEUROSCI.4872-08.2009; Jossin Y, 2004, J NEUROSCI, V24, P514, DOI 10.1523/JNEUROSCI.3408-03.2004; Jossin Y, 2007, J NEUROSCI, V27, P4243, DOI 10.1523/JNEUROSCI.0023-07.2007; Knuesel I, 2010, PROG NEUROBIOL, V91, P257, DOI 10.1016/j.pneurobio.2010.04.002; Knuesel I, 2009, NEUROBIOL AGING, V30, P697, DOI 10.1016/j.neurobiolaging.2007.08.011; Kocherhans S, 2010, J NEUROSCI, V30, P9228, DOI 10.1523/JNEUROSCI.0418-10.2010; Kohno S, 2009, BIOCHEM BIOPH RES CO, V380, P93, DOI 10.1016/j.bbrc.2009.01.039; Kohno T, 2009, J NEUROSCI RES, V87, P3043, DOI 10.1002/jnr.22143; Kubo K, 2002, NEUROSCI RES, V43, P381, DOI 10.1016/S0168-0102(02)00068-8; Lauer-Fields JL, 2008, ANAL BIOCHEM, V373, P43, DOI 10.1016/j.ab.2007.09.014; Lee JY, 2007, NEUROSCI LETT, V423, P82, DOI 10.1016/j.neulet.2007.06.037; Lugli Giovanni, 2003, BMC Biochem, V4, P9, DOI 10.1186/1471-2091-4-9; Martinez-Vicente M, 2005, EXP GERONTOL, V40, P622, DOI 10.1016/j.exger.2005.07.005; McCulloch DR, 2009, GENE EXPR PATTERNS, V9, P314, DOI 10.1016/j.gep.2009.02.006; Medina MG, 2005, EMBO J, V24, P1706, DOI 10.1038/sj.emboj.7600650; Nakano Y, 2007, J BIOL CHEM, V282, P20544, DOI 10.1074/jbc.M702300200; Nomura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001454; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Ohkubo N, 2002, FASEB J, V16, P295, DOI 10.1096/fj.02-0434fje; PITTMAN RN, 1989, J NEUROSCI, V9, P4269; Pratta MA, 2003, ARTHRITIS RHEUM, V48, P119, DOI 10.1002/art.10726; Rogers JT, 2008, NEURON GLIA BIOL, V4, P259, DOI 10.1017/S1740925X09990184; Salles FJ, 2002, J NEUROSCI, V22, P2125, DOI 10.1523/JNEUROSCI.22-06-02125.2002; Strasser V, 2004, MOL CELL BIOL, V24, P1378, DOI 10.1128/MCB.24.3.1378-1386.2004; Tissir F, 2003, NAT REV NEUROSCI, V4, P496, DOI 10.1038/nrn1113; Tissir F, 2002, BRAZ J MED BIOL RES, V35, P1473, DOI 10.1590/S0100-879X2002001200007; Tortorella MD, 2008, CURR PHARM BIOTECHNO, V9, P16, DOI 10.2174/138920108783497622; Tortorella MD, 2005, ARCH BIOCHEM BIOPHYS, V444, P34, DOI 10.1016/j.abb.2005.09.018; Tortorella MD, 2004, J BIOL CHEM, V279, P17554, DOI 10.1074/jbc.M313041200; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Tsirka SE, 1997, J NEUROSCI, V17, P543; Utsunomiya-Tate N, 2000, P NATL ACAD SCI USA, V97, P9729, DOI 10.1073/pnas.160272497; Vankemmelbeke MN, 2003, EUR J BIOCHEM, V270, P2394, DOI 10.1046/j.1432-1033.2003.03607.x; Wagsater D, 2008, ATHEROSCLEROSIS, V196, P514, DOI 10.1016/j.atherosclerosis.2007.05.018; Wang P, 2004, J BIOL CHEM, V279, P15434, DOI 10.1074/jbc.M312797200; Weaver MS, 2010, J BIOL CHEM, V285, P5868, DOI 10.1074/jbc.M109.070318; Yasui N, 2011, J BIOL CHEM, V286, P35247, DOI 10.1074/jbc.M111.242719; Yuan W, 2002, NEUROSCIENCE, V114, P1091, DOI 10.1016/S0306-4522(02)00347-0; Zeng WL, 2006, BBA-GEN SUBJECTS, V1760, P517, DOI 10.1016/j.bbagen.2006.01.013	63	64	64	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47793	10.1371/journal.pone.0047793	http://dx.doi.org/10.1371/journal.pone.0047793			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082219	Green Accepted, gold, Green Submitted, Green Published			2022-12-25	WOS:000311146900116
J	Maia, R; Brasileiro, L; Lacava, RV; Macedo, RH				Maia, Rafael; Brasileiro, Luiza; Lacava, Roberto V.; Macedo, Regina H.			Social Environment Affects Acquisition and Color of Structural Nuptial Plumage in a Sexually Dimorphic Tropical Passerine	PLOS ONE			English	Article							BLUE-BLACK GRASSQUITS; IRIDESCENT PLUMAGE; SATIN BOWERBIRDS; BEHAVIOR; TITS; MOLT; REFLECTANCE; PARASITES; DISPLAY; STRESS	Structural colors result from the physical interaction of light with organic materials of differing refractive indexes organized at nanoscale dimensions to produce significant interference effects. Because color properties emerge from these finely organized nanostructures, the production of structural coloration could respond to environmental factors and be developmentally more plastic than expected, functioning as an indicator of individual quality. However, there are many unknown factors concerning the function and mechanisms regulating structural coloration, especially relative to social environment. We hypothesized that social environment, in the form of competitive settings, can influence the developmental pathways involving production of feather structural coloration. We experimentally assessed the impact of social environment upon body condition, molt and spectral properties of two types of structural color that compose the nuptial plumage in blue-black grassquits: black iridescent plumage and white underwing patches. We manipulated male social environment during nine months by keeping individuals in three treatments: (1) pairs; (2) all-male groups; and (3) male-female mixed groups. All morphological characters and spectral plumage measures varied significantly through time, but only acquisition of nuptial plumage coverage and nuptial plumage color were influenced by social environment. Compared with males in the paired treatment, those in treatments with multiple males molted into nuptial plumage faster and earlier, and their plumage was more UV-purple-shifted. Our results provide experimental evidence that social context strongly influences development and expression of structural plumage. These results emphasize the importance of longterm experimental studies to identify the phenotypic consequences of social dynamics relative to ornament expression.	[Brasileiro, Luiza; Lacava, Roberto V.; Macedo, Regina H.] Univ Brasilia, Dept Zool, Lab Comportamento Anim, Brasilia, DF, Brazil; [Maia, Rafael; Brasileiro, Luiza; Lacava, Roberto V.] Univ Brasilia, Programa Posgrad Ecol, Brasilia, DF, Brazil; [Maia, Rafael] Univ Akron, Integrated Biosci Program, Dept Biol, Akron, OH 44325 USA	Universidade de Brasilia; Universidade de Brasilia; University System of Ohio; University of Akron	Macedo, RH (corresponding author), Univ Brasilia, Dept Zool, Lab Comportamento Anim, Brasilia, DF, Brazil.	rhfmacedo@unb.br	Macedo, Regina/GSE-3916-2022; Macedo, Regina H. F./C-1411-2013	Macedo, Regina H. F./0000-0003-3510-9172; Maia, Rafael/0000-0002-7563-9795; Lacava, Roberto Victor/0000-0003-3734-2488	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq [302063/2007-2]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico CNPq (www.cnpq.br) [302063/2007-2 to RHM]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilar TM, 2008, BEHAV ECOL, V19, P292, DOI 10.1093/beheco/arm130; ALDERTON CORA C., 1963, CONDOR, V65, P154, DOI 10.2307/1365492; Almeida JB, 2001, AUK, V118, P404, DOI 10.1642/0004-8038(2001)118[0404:LLMSOT]2.0.CO;2; Andersson Malte, 1994; Badyaev AV, 2002, AUK, V119, P301, DOI 10.1642/0004-8038(2002)119[0301:PSTITC]2.0.CO;2; Bortolotti G. R., 2006, BIRD COLORATION, V2, P3, DOI DOI 10.2307/J.CTV22JNR8K.4; Brawner WR, 2000, AUK, V117, P952, DOI 10.1642/0004-8038(2000)117[0952:EOCAMI]2.0.CO;2; Carvalho CBV., 2007, Braz. J. Biol., V67, P275, DOI 10.1590/S1519-69842007000200012; Carvalho CBV, 2006, CONDOR, V108, P579, DOI 10.1650/0010-5422(2006)108[579:BSOASM]2.0.CO;2; COLLIS K, 1993, ETHOLOGY, V94, P59; Costa FJV, 2005, ANIM BEHAV, V70, P1401, DOI 10.1016/j.anbehav.2005.03.024; Cuthill IC, 1999, AM NAT, V153, P183, DOI 10.1086/303160; Dias Raphael I., 2009, Oecologia Brasiliensis, V13, P183; Dias RI, 2009, CONDOR, V111, P706, DOI 10.1525/cond.2009.090142; DIETZ MW, 1992, PHYSIOL ZOOL, V65, P1217, DOI 10.1086/physzool.65.6.30158276; Dijkstra PD, 2007, BEHAV ECOL SOCIOBIOL, V61, P599, DOI 10.1007/s00265-006-0289-7; Doucet SM, 2002, CONDOR, V104, P30, DOI 10.1650/0010-5422(2002)104[0030:SPCMBS]2.0.CO;2; Doucet SM, 2005, BEHAV ECOL, V16, P218, DOI 10.1093/beheco/arh154; Doucet SM, 2006, J EXP BIOL, V209, P380, DOI 10.1242/jeb.01988; Doucet SM, 2003, BEHAV ECOL, V14, P503, DOI 10.1093/beheco/arg035; Doucet SM, 2009, J R SOC INTERFACE, V6, pS115, DOI 10.1098/rsif.2008.0395.focus; Dufresne ER, 2009, SOFT MATTER, V5, P1792, DOI 10.1039/b902775k; Endler JA, 1996, AM NAT, V148, P421, DOI 10.1086/285934; FINGER E, 1994, VISION RES, V34, P1509, DOI 10.1016/0042-6989(94)90152-X; Fitze PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005111; Fitzpatrick S, 1998, ANN ZOOL FENN, V35, P67; FOLSTAD I, 1992, AM NAT, V139, P603, DOI 10.1086/285346; Galvan I, 2008, BIOL LETTERS, V4, P12, DOI 10.1098/rsbl.2007.0504; Galvan I, 2008, BEHAV ECOL SOCIOBIOL, V63, P303, DOI 10.1007/s00265-008-0662-9; Ghiradella HT, 2009, J R SOC INTERFACE, V6, pS243, DOI 10.1098/rsif.2008.0372.focus; GOSLER AG, 1994, BIRD STUDY, V41, P146, DOI 10.1080/00063659409477211; GREENEWALT CH, 1960, J OPT SOC AM, V50, P1005, DOI 10.1364/JOSA.50.001005; Hart NS, 2000, J COMP PHYSIOL A, V186, P375, DOI 10.1007/s003590050437; HASTIE T, 1993, J ROY STAT SOC B MET, V55, P757; Hill GE, 2005, ANIM BEHAV, V69, P387, DOI 10.1016/j.anbehav.2004.03.013; Hunt S, 1998, P ROY SOC B-BIOL SCI, V265, P451, DOI 10.1098/rspb.1998.0316; Jouventin P, 2007, WATERBIRDS, V30, P573, DOI 10.1675/1524-4695(2007)030[0573:DCSAOB]2.0.CO;2; Karubian J, 2011, ANIM BEHAV, V81, P795, DOI 10.1016/j.anbehav.2011.01.012; Keyser AJ, 1999, P ROY SOC B-BIOL SCI, V266, P771, DOI 10.1098/rspb.1999.0704; Kimball Rebecca T., 2006, P431; Kinoshita S, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/7/076401; KLAASSEN M, 1995, OECOLOGIA, V104, P424, DOI 10.1007/BF00341339; Lacava RV, 2011, HORM BEHAV, V59, P51, DOI 10.1016/j.yhbeh.2010.10.003; Land M F, 1972, Prog Biophys Mol Biol, V24, P75, DOI 10.1016/0079-6107(72)90004-1; Loiseau C, 2008, GEN COMP ENDOCR, V155, P101, DOI 10.1016/j.ygcen.2007.03.004; LOZANO GA, 1994, OIKOS, V70, P309, DOI 10.2307/3545643; Maia R, 2011, J ROYAL SOC INTERFAC; Maia R, 2011, J ORNITHOL, V152, P243, DOI 10.1007/s10336-010-0576-y; Maia R, 2009, J R SOC INTERFACE, V6, pS203, DOI 10.1098/rsif.2008.0460.focus; Martinez-Padilla J, 2010, J EVOLUTION BIOL, V23, P902, DOI 10.1111/j.1420-9101.2010.01956.x; McGraw KJ, 2002, J EXP BIOL, V205, P3747; Meylan S, 2007, OIKOS, V116, P650, DOI 10.1111/j.2007.0030-1299.15432.x; Montgomerie Robert, 2006, P90; Munoz A, 2008, BEHAV ECOL, V19, P404, DOI 10.1093/beheco/arm148; Osorio D, 2002, J EXP BIOL, V205, P2017; Osorio D, 1999, EVOL ECOL, V13, P673, DOI 10.1023/A:1011059715610; Peters A, 2011, J EVOLUTION BIOL, V24, P976, DOI 10.1111/j.1420-9101.2011.02229.x; Peters A, 2000, BEHAV ECOL SOCIOBIOL, V47, P438, DOI 10.1007/s002650050688; Peters A, 2007, AM NAT, V169, pS122, DOI 10.1086/510139; Prum RO, 2009, J R SOC INTERFACE, V6, pS253, DOI 10.1098/rsif.2008.0466.focus; Prum RO, 2006, BIRD COLORATION, V1, P295; R Development Core Team, 2012, R LANG ENV STAT COMP; Rasband W., 2006, IMAGEJ; Rubenstein DR, 2008, TRENDS ECOL EVOL, V23, P655, DOI 10.1016/j.tree.2008.07.010; Santos ESA, 2009, BEHAV ECOL, V20, P553, DOI 10.1093/beheco/arp031; Senar JC, 2002, BEHAV ECOL, V13, P725, DOI 10.1093/beheco/13.6.725; Shawkey MD, 2007, AM NAT, V169, pS112, DOI 10.1086/510100; Shawkey MD, 2006, J EXP BIOL, V209, P1245, DOI 10.1242/jeb.02115; Sick H, 2001, ORNITOLOGIA BRASILEI; Siefferman L, 2007, BEHAV ECOL SOCIOBIOL, V61, P1839, DOI 10.1007/s00265-007-0416-0; Stoddard MC, 2011, BEHAV ECOL, V22, P1042, DOI 10.1093/beheco/arr088; von Schantz T, 1999, P ROY SOC B-BIOL SCI, V266, P1, DOI 10.1098/rspb.1999.0597; WEBBER T, 1985, CONDOR, V87, P543, DOI 10.2307/1367957; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	74	16	17	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47501	10.1371/journal.pone.0047501	http://dx.doi.org/10.1371/journal.pone.0047501			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082172	Green Submitted, Green Published, gold			2022-12-25	WOS:000311146900068
J	Zhu, JJ; Gonda, Y; Yu, LZ; Li, FQ; Yan, QL; Sun, YR				Zhu, Jiaojun; Gonda, Yutaka; Yu, Lizhong; Li, Fengqin; Yan, Qiaoling; Sun, Yirong			Regeneration of a Coastal Pine (Pinus thunbergii Parl.) Forest 11 Years after Thinning, Niigata, Japan	PLOS ONE			English	Article							GAP SIZE; SEEDLING ESTABLISHMENT; GROWTH; VEGETATION; AUSTRALIA; SURVIVAL	To examine the effects of thinning intensity on wind vulnerability and regeneration in a coastal pine (Pinus thunbergii) forest, thinning with intensities of 20%, 30% and 50% was conducted in December 1997; there was an unthinned treatment as the control (total 8 stands). We re-measured the permanent sites to assess the regeneration characteristics 11 years after thinning. In the 50% thinned stand, seedlings aged from 2 to 10 years exhibited the highest pine seedling density and growth. The age composition ranged from 1-3 years with densities of 9.9 and 5.1 seedlings m(-2) in 30% and 20% thinned stands; only 1-year-old seedlings with a density of 6.1 seedlings m(-2) in the unthinned stand. Similar trends were found for the regeneration of broadleaved species such as Robinia pseudoacacia and Prunus serrulata. We speculate that the canopy openness and moss coverage contributed to the regeneration success in the 50% thinned stand, while the higher litter depth and lack of soil moisture induced the regeneration failure in the unthinned stand. The stands thinned at 20% or 30% were less favourable for pine regeneration than the stands thinned at 50%. Therefore, thinning with less than 30% canopy openness (20% and 30% thinned stands) should be avoided, and thinning at higher than 30% canopy openness (50% thinned stand, approximately 1500 stems ha(-1) at ages 40-50 years) is suggested for increasing regeneration in the coastal pine forest. The implications of thinning-based silviculture in the coastal pine forest management are also discussed. The ongoing development of the broadleaved seedlings calls for further observations.	[Zhu, Jiaojun; Yu, Lizhong; Li, Fengqin; Yan, Qiaoling; Sun, Yirong] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China; [Zhu, Jiaojun; Yu, Lizhong; Li, Fengqin; Yan, Qiaoling; Sun, Yirong] Chinese Acad Sci, Qingyuan Expt Stn Forest Ecol, Shenyang, Peoples R China; [Gonda, Yutaka] Niigata Univ, Fac Agr, Niigata 95021, Japan	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; Chinese Academy of Sciences; Niigata University	Zhu, JJ (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Peoples R China.	jiaojunzhu@iae.ac.cn		ZHU, Jiaojun/0000-0002-2512-7900; GONDA, Yutaka/0000-0002-9266-9275	National Natural Science Foundation of China [30830085]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was partly supported by the National Natural Science Foundation of China (30830085). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brett RB, 1998, CAN J FOREST RES, V28, P1825, DOI 10.1139/cjfr-28-12-1825; CANHAM CD, 1989, ECOLOGY, V70, P548, DOI 10.2307/1940200; Cheng Jinhua, 2003, Yingyong Shengtai Xuebao, V14, P1825; Deal RL, 2007, BIOL CONSERV, V137, P520, DOI 10.1016/j.biocon.2007.03.014; Frazer GW, 1999, GAP LIGHT ANAL GLA V; Fule PZ, 2005, FOREST ECOL MANAG, V218, P129, DOI 10.1016/j.foreco.2005.07.005; Gardiner B, 2008, FORESTRY, V81, P447, DOI 10.1093/forestry/cpn022; Gray AN, 1996, J ECOL, V84, P635, DOI 10.2307/2261327; Han Guang-xuan, 2009, Shengtaixue Zazhi, V28, P2171; Han GuangXuan, 2010, Scientia Silvae Sinicae, V46, P158; Ilisson T, 2007, FOREST ECOL MANAG, V250, P17, DOI 10.1016/j.foreco.2007.03.022; Iverson LR, 2008, FOREST ECOL MANAG, V255, P3035, DOI 10.1016/j.foreco.2007.09.088; Jung SC, 2009, J FOREST RES-JPN, V14, P101, DOI 10.1007/s10310-008-0109-1; Kathke S, 2010, FOREST ECOL MANAG, V259, P1597, DOI 10.1016/j.foreco.2010.01.036; Mason B, 2001, 40 FOR COMM; Mizunaga H, 2010, J FOREST RES-JPN, V15, P1, DOI 10.1007/s10310-009-0177-x; Murai H, 1992, COASTAL FOREST JAPAN; Myers GP, 2000, FOREST ECOL MANAG, V127, P119, DOI 10.1016/S0378-1127(99)00124-3; Ogasawara R., 1988, Research Bulletin of the Tottori University Forests, P37; Osem Y, 2009, FOREST ECOL MANAG, V259, P14, DOI 10.1016/j.foreco.2009.09.034; Parhizkar P, 2011, FORESTRY, V84, P177, DOI 10.1093/forestry/cpr004; Prevosto B, 2008, FOREST ECOL MANAG, V256, P2058, DOI 10.1016/j.foreco.2008.07.027; Steege H, 1994, HEMIPHOT PROGRAMME A; Taniguchi T, 2008, SOIL BIOL BIOCHEM, V40, P1235, DOI 10.1016/j.soilbio.2007.12.017; Taniguchi T, 2007, J FOREST RES-JPN, V12, P350, DOI 10.1007/s10310-007-0023-y; Van Der Meer PJ, 2007, FOREST ECOL MANAG, V244, P102, DOI 10.1016/j.foreco.2007.03.055; Van Der Meer PJ, 1999, FOREST ECOL MANAG, V117, P33, DOI 10.1016/S0378-1127(98)00471-X; Wang HeXin, 2005, Forest Research, Beijing, V18, P524; Xiong SJ, 1999, J ECOL, V87, P984, DOI 10.1046/j.1365-2745.1999.00414.x; Xu JingWei, 2003, Journal of Northeast Forestry University, V31, P4; Zhang Dan, 2011, Chinese Journal of Plant Ecology, V35, P926, DOI 10.3724/SP.J.1258.2011.00926; [张志东 ZHANG Zhidong], 2010, [生态学报, Acta Ecologica Sinica], V30, P2205; Zhu Jiao-jun, 2003, Journal of Forestry Research (Harbin), V14, P1, DOI 10.1007/BF02856755; Zhu JJ, 2003, FOREST ECOL MANAG, V182, P339, DOI 10.1016/S0378-1127(03)00094-X; Zhu JJ, 2001, J FOR RES, V6, P287	35	10	14	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47593	10.1371/journal.pone.0047593	http://dx.doi.org/10.1371/journal.pone.0047593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091632	Green Published, Green Submitted, gold			2022-12-25	WOS:000310135800056
J	Modis, K; Coletta, C; Erdelyi, K; Papapetropoulos, A; Szabo, C				Modis, Katalin; Coletta, Ciro; Erdelyi, Katalin; Papapetropoulos, Andreas; Szabo, Csaba			Intramitochondrial hydrogen sulfide production by 3-mercaptopyruvate sulfurtransferase maintains mitochondrial electron flow and supports cellular bioenergetics	FASEB JOURNAL			English	Article						gasotransmitter; ATP; hepatocyte	CYSTATHIONINE-BETA-SYNTHASE; H2S; OXIDATION; LIVER; CELLS; ENDOTHELIUM; ADAPTATIONS; INHIBITION; METABOLISM; CYSTEINE	It is well established that exposure of mammalian cells to hydrogen sulfide (H2S) suppresses mitochondrial function by inhibiting cytochrome-c oxidase (CcOX; complex IV). However, recent experimental data show that administration of H2S to mammalian cells can serve as an electron donor and inorganic source of energy. The aim of our study was to investigate the role of endogenously produced H2S in the regulation of mitochondrial electron transport and oxidative phosphorylation in isolated liver mitochondria and in the cultured murine hepatoma cell line Hepa1c1c7. Low concentrations of H2S (0.1-1 mu M) elicited a significant increase in mitochondrial function, while higher concentrations of H2S (3-30 mu M) were inhibitory. The positive bioenergetic effect of H2S required a basal activity of the Krebs cycle and was most pronounced at intermediate concentrations of succinate. 3-mercaptopyruvate (3-MP), the substrate of the mitochondrial enzyme 3-mercaptopyruvate sulfurtransferase (3-MST) stimulated mitochondrial H2S production and enhanced mitochondrial electron transport and cellular bioenergetics at low concentrations (10-100 nM), while at higher concentrations, it inhibited cellular bioenergetics. SiRNA silencing of 3-MST reduced basal bioenergetic parameters and prevented the stimulating effect of 3-MP on mitochondrial bioenergetics. Silencing of sulfide quinone oxidoreductase (SQR) also reduced basal and 3-MP-stimulated bioenergetic parameters. We conclude that an endogenous intramitochondrial H2S-producing pathway, governed by 3-MST, complements and balances the bioenergetic role of Krebs cycle-derived electron donors. This pathway may serve a physiological role in the maintenance of mitochondrial electron transport and cellular bioenergetics.-Modis, K., Coletta, C., Erdelyi, K., Papapetropoulos, A., Szabo, C. Intramitochondrial hydrogen sulfide production by 3-mercaptopyruvate sulfurtransferase maintains mitochondrial electron flow and supports cellular bioenergetics. FASEB J. 27, 601-611 (2013). www.fasebj.org	[Modis, Katalin; Coletta, Ciro; Erdelyi, Katalin; Papapetropoulos, Andreas; Szabo, Csaba] Univ Texas Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; [Szabo, Csaba] Shriners Burns Hosp Children, Galveston, TX USA	University of Texas System; University of Texas Medical Branch Galveston	Szabo, C (corresponding author), Univ Texas Med Branch, Dept Anesthesiol, 601 Harborside Dr, Galveston, TX 77555 USA.	szabocsaba@aol.com	Szabo, Csaba/D-1882-2013; Andreas, Papapetropoulos/AAJ-3089-2020; Szabo, Csaba/ABG-2644-2021	Papapetropoulos, Andreas/0000-0002-4253-5930	Shriners of North America [8661]; American Diabetes Association [7-12-BS-184]; University of Texas; American Heart Association	Shriners of North America; American Diabetes Association(American Diabetes Association); University of Texas; American Heart Association(American Heart Association)	This study was supported by a grant from the Shriners of North America (grant 8661) and by a grant from the American Diabetes Association (7-12-BS-184) to C. S. M. K. is supported by a McLaughlin Fellowship of the University of Texas. C. C. is supported by a postdoctoral fellowship of the American Heart Association.	Aslami H, 2009, CURR MED CHEM, V16, P1295, DOI 10.2174/092986709787846631; Banerjee R, 2005, ARCH BIOCHEM BIOPHYS, V433, P144, DOI 10.1016/j.abb.2004.08.037; Blackstone E, 2005, SCIENCE, V308, P518, DOI 10.1126/science.1108581; Bouillaud F, 2011, ANTIOXID REDOX SIGN, V15, P379, DOI 10.1089/ars.2010.3678; Chen XL, 2004, J BIOL CHEM, V279, P52082, DOI 10.1074/jbc.C400481200; Coletta C, 2012, P NATL ACAD SCI USA, V109, P9161, DOI 10.1073/pnas.1202916109; Collman J, 2009, P NATL ACAD SCI USA, V106, P22090, DOI 10.1073/pnas.0904082106; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Erdelyi K, 2009, FASEB J, V23, P3553, DOI 10.1096/fj.09-133264; Ferrick DA, 2008, DRUG DISCOV TODAY, V13, P268, DOI 10.1016/j.drudis.2007.12.008; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Fu M, 2012, P NATL ACAD SCI USA, V109, P2943, DOI 10.1073/pnas.1115634109; Goubern M, 2007, FASEB J, V21, P1699, DOI 10.1096/fj.06-7407com; Grieshaber MK, 1998, ANNU REV PHYSIOL, V60, P33, DOI 10.1146/annurev.physiol.60.1.33; Groeger M, 2012, SHOCK, V38, P367, DOI 10.1097/SHK.0b013e3182651fe6; Kannampuzha JVA, 2009, J RHEUMATOL, V36, P2758, DOI 10.3899/jrheum.090098; KHAN AA, 1990, TOXICOL APPL PHARM, V103, P482, DOI 10.1016/0041-008X(90)90321-K; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Lagoutte E, 2010, BBA-BIOENERGETICS, V1797, P1500, DOI 10.1016/j.bbabio.2010.04.004; Madden JA, 2012, J APPL PHYSIOL, V112, P411, DOI 10.1152/japplphysiol.01049.2011; MARTENSSON J, 1984, FEBS LETT, V176, P334, DOI 10.1016/0014-5793(84)81191-6; Mimoun S, 2012, ANTIOXID REDOX SIGN, V17, P1, DOI 10.1089/ars.2011.4186; Modis K, 2012, BIOCHEM PHARMACOL, V83, P633, DOI 10.1016/j.bcp.2011.12.014; Modis K, 2009, BRIT J PHARMACOL, V158, P1565, DOI 10.1111/j.1476-5381.2009.00432.x; Nagahara N, 1998, HISTOCHEM CELL BIOL, V110, P243, DOI 10.1007/s004180050286; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; NICHOLLS P, 1975, BIOCHEM SOC T, V3, P316, DOI 10.1042/bst0030316; OHTA J, 1989, ACTA MED OKAYAMA, V43, P89; Olson KR, 2012, J COMP PHYSIOL B, V182, P881, DOI 10.1007/s00360-012-0654-y; POWELL MA, 1986, SCIENCE, V233, P563, DOI 10.1126/science.233.4763.563; Rogers GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021746; Shibuya N, 2009, J BIOCHEM, V146, P623, DOI 10.1093/jb/mvp111; Shibuya N, 2009, ANTIOXID REDOX SIGN, V11, P703, DOI [10.1089/ars.2008.2253, 10.1089/ARS.2008.2253]; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Stachowska E, 2000, FLUORIDE, V33, P115; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; Suzuki K, 2011, P NATL ACAD SCI USA, V108, P13829, DOI 10.1073/pnas.1105121108; Szabo C, 2007, NAT REV DRUG DISCOV, V6, P917, DOI 10.1038/nrd2425; Tanizawa K, 2011, J BIOCHEM, V149, P357, DOI 10.1093/jb/mvr018; Thangaraju M, 2009, BIOCHEM J, V417, P379, DOI 10.1042/BJ20081132; Voet D., 2008, INT STUDENT VERSION; Volkel S, 1996, EUR J BIOCHEM, V235, P231, DOI 10.1111/j.1432-1033.1996.00231.x; Wagner F, 2009, CRIT CARE, V13, DOI 10.1186/cc7700; Wang R, 2012, PHYSIOL REV, V92, P791, DOI 10.1152/physrev.00017.2011; Wlodek P, 2010, NEPHROLOGY, V15, P755, DOI 10.1111/j.1440-1797.2010.01353.x; Yong R, 2001, COMP BIOCHEM PHYS B, V129, P129, DOI 10.1016/S1096-4959(01)00309-8; Zhao D, 2007, FRONT BIOSCI-LANDMRK, V12, P3774, DOI 10.2741/2351; Zhu AP, 2010, ANAL BIOCHEM, V396, P146, DOI 10.1016/j.ab.2009.09.017	48	207	212	1	48	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					601	611		10.1096/fj.12-216507	http://dx.doi.org/10.1096/fj.12-216507			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23104984				2022-12-25	WOS:000314358000019
J	Sparks, JL; Kumar, R; Singh, M; Wold, MS; Pandita, TK; Burgers, PM				Sparks, Justin L.; Kumar, Rakesh; Singh, Mayank; Wold, Marc S.; Pandita, Tej K.; Burgers, Peter M.			Human Exonuclease 5 Is a Novel Sliding Exonuclease Required for Genome Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUMERMYCIN-INDUCED DIMERIZATION; IRON-SULFUR CLUSTER; CROSS-LINK REPAIR; BREAK REPAIR; DNA-DAMAGE; PROTEIN; NUCLEASES; CELLS; END; MECHANISM	Previously, we characterized Saccharomyces cerevisiae exonuclease 5 (EXO5), which is required for mitochondrial genome maintenance. Here, we identify the human homolog (C1orf176; EXO5) that functions in the repair of nuclear DNA damage. Human EXO5 (hEXO5) contains an iron-sulfur cluster. It is a single-stranded DNA (ssDNA)-specific bidirectional exonuclease with a strong preference for 5'-ends. After loading at an ssDNA end, hEXO5 slides extensively along the ssDNA prior to cutting, hence the designation sliding exonuclease. However, the single-stranded binding protein human replication protein A (hRPA) restricts sliding and enforces a unique, species-specific 5'-directionality onto hEXO5. This specificity is lost with a mutant form of hRPA (hRPA-t11) that fails to interact with hEXO5. hEXO5 localizes to nuclear repair foci in response to DNA damage, and its depletion in human cells leads to an increased sensitivity to DNA-damaging agents, in particular interstrand cross-linking-inducing agents. Depletion of hEXO5 also results in an increase in spontaneous and damage-induced chromosome abnormalities including the frequency of triradial chromosomes, suggesting an additional defect in the resolution of stalled DNA replication forks in hEXO5-depleted cells.	[Kumar, Rakesh; Singh, Mayank; Pandita, Tej K.] Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Sparks, Justin L.; Burgers, Peter M.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Wold, Marc S.] Univ Iowa, Carver Coll Med, Dept Biochem, Iowa City, IA 52242 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Washington University (WUSTL); University of Iowa	Pandita, TK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA.	tej.pandita@utsouthwestern.edu; burgers@biochem.wustl.edu	Burgers, Peter M/AAW-6621-2021; Singh, Mayank/ABE-5733-2021; singh, mayank/N-6931-2014; Pandita, Tej K/AAM-9188-2020	Singh, Mayank/0000-0003-0728-1936; Wold, Marc/0000-0002-4580-1624; kumar, rakesh/0000-0002-0741-3663	National Institutes of Health [GM032431, GM083970, CA123232, CA129537, CA154320, U19A1091175, GM44721]; NATIONAL CANCER INSTITUTE [R01CA129537, R01CA123232, R01CA154320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044721, R01GM032431, R01GM083970] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM032431 and GM083970 (to P. M. B.); CA123232, CA129537, CA154320, and U19A1091175 (to T. K. P.); and GM44721 (to M. S. W.).	Binz SK, 2004, DNA REPAIR, V3, P1015, DOI 10.1016/j.dnarep.2004.03.028; Burgers PM, 2010, MOL CELL BIOL, V30, P1457, DOI 10.1128/MCB.01321-09; Bylund GO, 2006, METHOD ENZYMOL, V409, P1, DOI 10.1016/S0076-6879(05)09001-4; D'Andrea AD, 2010, NEW ENGL J MED, V362, P1909, DOI 10.1056/NEJMra0809889; de Laat WL, 1998, GENE DEV, V12, P2598, DOI 10.1101/gad.12.16.2598; Farrar MA, 2000, METHOD ENZYMOL, V327, P421, DOI 10.1016/S0076-6879(00)27293-5; Farrar MA, 1996, NATURE, V383, P178, DOI 10.1038/383178a0; Gupta A, 2005, MOL CELL BIOL, V25, P5292, DOI 10.1128/MCB.25.12.5292-5305.2005; Gupta A, 2009, CELL CYCLE, V8, P2198, DOI 10.4161/cc.8.14.8947; Hunt CR, 2007, CANCER RES, V67, P3010, DOI 10.1158/0008-5472.CAN-06-4328; Kantake N, 2003, J BIOL CHEM, V278, P23410, DOI 10.1074/jbc.M302995200; Knipscheer P, 2009, SCIENCE, V326, P1698, DOI 10.1126/science.1182372; Majka J, 2006, J BIOL CHEM, V281, P27855, DOI 10.1074/jbc.M605176200; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Minko IG, 2008, J BIOL CHEM, V283, P17075, DOI 10.1074/jbc.M801238200; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Nimonkar AV, 2011, GENE DEV, V25, P350, DOI 10.1101/gad.2003811; Pandita RK, 2006, MOL CELL BIOL, V26, P1850, DOI 10.1128/MCB.26.5.1850-1864.2006; Pandita TK, 1996, RADIAT RES, V145, P730, DOI 10.2307/3579364; Pandita TK, 1996, ONCOGENE, V13, P1423; Pandita TK, 1999, MOL CELL BIOL, V19, P5096; PLOOY ACM, 1985, CARCINOGENESIS, V6, P561, DOI 10.1093/carcin/6.4.561; Pokharel S, 2012, NUCLEIC ACIDS RES, V40, P7821, DOI 10.1093/nar/gks534; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030; Saikrishnan K, 2012, EMBO J, V31, P1568, DOI 10.1038/emboj.2012.9; Schlacher K, 2011, CELL, V145, P529, DOI 10.1016/j.cell.2011.03.041; Singleton MR, 2004, NATURE, V432, P187, DOI 10.1038/nature02988; Tsutakawa SE, 2011, CELL, V145, P198, DOI 10.1016/j.cell.2011.03.004; Umezu K, 1998, GENETICS, V148, P989; WALKER J, 1993, MOL BIOCHEM PARASIT, V61, P255, DOI 10.1016/0166-6851(93)90071-5; Yang W, 2011, Q REV BIOPHYS, V44, P1, DOI 10.1017/S0033583510000181; Yeeles JTP, 2009, J BIOL CHEM, V284, P7746, DOI 10.1074/jbc.M808526200	32	18	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42773	42783		10.1074/jbc.M112.422444	http://dx.doi.org/10.1074/jbc.M112.422444			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23095756	Green Published, hybrid			2022-12-25	WOS:000312501600036
J	Westphal, K; Langklotz, S; Thomanek, N; Narberhaus, F				Westphal, Kai; Langklotz, Sina; Thomanek, Nikolas; Narberhaus, Franz			A Trapping Approach Reveals Novel Substrates and Physiological Functions of the Essential Protease FtsH in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATP-DEPENDENT PROTEASE; TRANSCRIPTION FACTOR SIGMA(32); AMINO-ACID DEHYDROGENASE; IN-VITRO DEGRADATION; AAA PROTEASE; FORMATE DEHYDROGENASE; TURNOVER ELEMENT; REGULATED DEGRADATION; PHOSPHORELAY SYSTEM; NITRATE REDUCTASE	Proteolysis is a universal strategy to rapidly adjust the amount of regulatory and metabolic proteins to cellular demand. FtsH is the only membrane-anchored and essential ATP-dependent protease in Escherichia coli. Among the known functions of FtsH are the control of the heat shock response by proteolysis of the transcription factor RpoH (sigma(32)) and its essential role in lipopolysaccharide biosynthesis by degradation of the two key enzymes LpxC and KdtA. Here, we identified new FtsH substrates by using a proteomic-based substrate trapping approach. AnFtsH variant (FtsH(trap)) carrying a single amino acid exchange in the proteolytic center was expressed and purified in E. coli. FtsH(trap) is devoid of its proteolytic activity but fully retains ATPase activity allowing for unfolding and translocation of substrates into the inactivated proteolytic chamber. Proteins associated with FtsH(trap) and wild-type FtsH (FtsH(WT)) were purified, separated by two-dimensional PAGE, and subjected to mass spectrometry. Over-representation of LpxC in the FtsHtrap preparation validated the trapping strategy. Four novel FtsH substrates were identified. The sulfur delivery protein IscS and the D-amino acid dehydrogenase DadA were degraded under all tested conditions. The formate dehydrogenase subunit FdoH and the yet uncharacterized YfgM protein were subject to growth condition-dependent regulated proteolysis. Several lines of evidence suggest that YfgM serves as negative regulator of the RcsB-dependent stress response pathway, which must be degraded under stress conditions. The proteins captured by FtsH(trap) revealed previously unknown biological functions of the physiologically most important AAA(+) protease in E. coli.	[Narberhaus, Franz] Ruhr Univ Bochum, Fak Biol & Biotechnol, Inst Biol Mikroorganismen, D-44801 Bochum, Germany	Ruhr University Bochum	Narberhaus, F (corresponding author), Ruhr Univ Bochum, Fak Biol & Biotechnol, Inst Biol Mikroorganismen, Univ Str 150, D-44801 Bochum, Germany.	franz.narberhaus@rub.de	Schäkermann, Sina/HCI-7539-2022	Schäkermann, Sina/0000-0001-7969-0005; Narberhaus, Franz/0000-0002-8552-5310	German Research Foundation [SFB 642]	German Research Foundation(German Research Foundation (DFG))	This work was supported by German Research Foundation Grant SFB 642 for GTP- and ATP-dependent membrane processes (to F. N.).	ABAIBOU H, 1995, J BACTERIOL, V177, P7141, DOI 10.1128/jb.177.24.7141-7149.1995; Akiyama Y, 1996, FEBS LETT, V399, P26, DOI 10.1016/S0014-5793(96)01283-5; Akiyama Y, 1996, J BIOL CHEM, V271, P31196, DOI 10.1074/jbc.271.49.31196; Akiyama Y, 2009, J BIOCHEM, V146, P449, DOI 10.1093/jb/mvp071; Bandow JE, 2008, PROTEOMICS, V8, P3030, DOI 10.1002/pmic.200701184; Benoit S, 1998, J BACTERIOL, V180, P6625, DOI 10.1128/JB.180.24.6625-6634.1998; Bieniossek C, 2006, P NATL ACAD SCI USA, V103, P3066, DOI 10.1073/pnas.0600031103; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chiba S, 2002, J BACTERIOL, V184, P4775, DOI 10.1128/JB.184.17.4775-4782.2002; ENOCH HG, 1975, J BIOL CHEM, V250, P6693; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Fuhrer F, 2007, J MOL BIOL, V372, P485, DOI 10.1016/j.jmb.2007.06.083; Fuhrer F, 2006, MOL MICROBIOL, V59, P1025, DOI 10.1111/j.1365-2958.2005.04994.x; Gamer J, 1996, EMBO J, V15, P607, DOI 10.1002/j.1460-2075.1996.tb00393.x; Gonzalez M, 1998, GENE DEV, V12, P3889, DOI 10.1101/gad.12.24.3889; Griffith KL, 2004, MOL MICROBIOL, V51, P1801, DOI 10.1046/j.1365-2958.2003.03952.x; Guisbert E, 2004, GENE DEV, V18, P2812, DOI 10.1101/gad.1219204; Gur E, 2011, NAT REV MICROBIOL, V9, P839, DOI 10.1038/nrmicro2669; Hagiwara D, 2003, J BACTERIOL, V185, P5735, DOI 10.1128/JB.185.19.5735-5746.2003; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; Herman C, 1997, J BACTERIOL, V179, P358, DOI 10.1128/jb.179.2.358-363.1997; HERMAN C, 1995, P NATL ACAD SCI USA, V92, P3516, DOI 10.1073/pnas.92.8.3516; Horikoshi M, 2004, J BACTERIOL, V186, P7474, DOI 10.1128/JB.186.22.7474-7480.2004; IOBBINIVOL C, 1990, EUR J BIOCHEM, V188, P679, DOI 10.1111/j.1432-1033.1990.tb15450.x; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Jishage M, 1998, P NATL ACAD SCI USA, V95, P4953, DOI 10.1073/pnas.95.9.4953; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Johnson MD, 2011, J BACTERIOL, V193, P3653, DOI 10.1128/JB.05040-11; Joly N, 2010, FEMS MICROBIOL REV, V34, P797, DOI 10.1111/j.1574-6976.2010.00240.x; Katz C, 2008, J BACTERIOL, V190, P7117, DOI 10.1128/JB.00871-08; Kihara A, 1997, P NATL ACAD SCI USA, V94, P5544, DOI 10.1073/pnas.94.11.5544; Klusener S, 2010, MOL GENET GENOMICS, V283, P575, DOI 10.1007/s00438-010-0542-7; Krzywda S, 2002, STRUCTURE, V10, P1073, DOI 10.1016/S0969-2126(02)00806-7; Kuroda A, 1999, P NATL ACAD SCI USA, V96, P14264, DOI 10.1073/pnas.96.25.14264; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; Langklotz S, 2012, BBA-MOL CELL RES, V1823, P40, DOI 10.1016/j.bbamcr.2011.08.015; Langklotz S, 2011, MOL MICROBIOL, V80, P1313, DOI 10.1111/j.1365-2958.2011.07646.x; Lasserre JP, 2006, ELECTROPHORESIS, V27, P3306, DOI 10.1002/elps.200500912; Leffers GG, 1998, J BACTERIOL, V180, P1573, DOI 10.1128/JB.180.6.1573-1577.1998; LOBOCKA M, 1994, J BACTERIOL, V176, P1500, DOI 10.1128/jb.176.5.1500-1510.1994; Maddalo G, 2011, J PROTEOME RES, V10, P1848, DOI 10.1021/pr101105c; Majdalani N, 2002, MOL MICROBIOL, V46, P813, DOI 10.1046/j.1365-2958.2002.03203.x; Matern Y, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-251; Narberhaus F, 2009, RES MICROBIOL, V160, P652, DOI 10.1016/j.resmic.2009.08.011; Obrist M, 2005, J BACTERIOL, V187, P3807, DOI 10.1128/JB.187.11.3807-3813.2005; Obrist M, 2009, FEMS MICROBIOL LETT, V290, P199, DOI 10.1111/j.1574-6968.2008.01423.x; Ogura T, 2001, GENES CELLS, V6, P575, DOI 10.1046/j.1365-2443.2001.00447.x; Ogura T, 1999, MOL MICROBIOL, V31, P833, DOI 10.1046/j.1365-2958.1999.01221.x; Okuno T, 2006, J STRUCT BIOL, V156, P109, DOI 10.1016/j.jsb.2006.02.003; OLSIEWSKI PJ, 1980, J BIOL CHEM, V255, P4487; Peterson CN, 2006, J BACTERIOL, V188, P3175, DOI 10.1128/JB.188.9.3175-3181.2006; PLUNKETT G, 1993, NUCLEIC ACIDS RES, V21, P3391, DOI 10.1093/nar/21.15.3391; POMMIER J, 1992, BIOCHIM BIOPHYS ACTA, V1107, P305, DOI 10.1016/0005-2736(92)90417-K; Rodriguez F, 2008, MOL CELL, V32, P347, DOI 10.1016/j.molcel.2008.09.016; Saikawa N, 2002, BIOCHEMISTRY-US, V41, P1861, DOI 10.1021/bi015748o; Sambrook J, 2001, MOL CLONING LAB MANU; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Shah IM, 2006, J MOL BIOL, V357, P718, DOI 10.1016/j.jmb.2005.12.088; Singh S, 2011, J BACTERIOL, V193, P6436, DOI 10.1128/JB.05942-11; Sledjeski DD, 1996, J BACTERIOL, V178, P1204, DOI 10.1128/jb.178.4.1204-1206.1996; Srinivasan R, 2007, J BASIC MICROB, V47, P251, DOI 10.1002/jobm.200610236; TOMOYASU T, 1993, J BACTERIOL, V175, P1352, DOI 10.1128/JB.175.5.1352-1357.1993; TOMOYASU T, 1995, EMBO J, V14, P2551, DOI 10.1002/j.1460-2075.1995.tb07253.x; Van Melderen L, 2009, RES MICROBIOL, V160, P645, DOI 10.1016/j.resmic.2009.08.021; WEINER L, 1991, GENE DEV, V5, P1912, DOI 10.1101/gad.5.10.1912; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wu GF, 2008, BIOCHEM BIOPH RES CO, V374, P399, DOI 10.1016/j.bbrc.2008.07.050; Yamada-Inagawa T, 2003, J BIOL CHEM, V278, P50182, DOI 10.1074/jbc.M308327200	70	46	46	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42962	42971		10.1074/jbc.M112.388470	http://dx.doi.org/10.1074/jbc.M112.388470			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23091052	Green Published, hybrid			2022-12-25	WOS:000312501600053
J	Molano, A; Huang, ZF; Marko, MG; Azzi, A; Wu, DY; Wang, E; Kelly, SL; Merrill, AH; Bunnell, SC; Meydani, SN				Molano, Alberto; Huang, Zhaofeng; Marko, Melissa G.; Azzi, Angelo; Wu, Dayong; Wang, Elaine; Kelly, Samuel L.; Merrill, Alfred H., Jr.; Bunnell, Stephen C.; Meydani, Simin Nikbin			Age-Dependent Changes in the Sphingolipid Composition of Mouse CD4(+) T Cell Membranes and Immune Synapses Implicate Glucosylceramides in Age-Related T Cell Dysfunction	PLOS ONE			English	Article							QUANTITATIVE-ANALYSIS; CYTOKINE PRODUCTION; HUMAN-LYMPHOCYTES; CERAMIDE; SPHINGOSINE; ACCUMULATION; ASSOCIATION; INHIBITION; LONGEVITY; SYNTHASE	To determine whether changes in sphingolipid composition are associated with age-related immune dysfunction, we analyzed the core sphingolipidome (i.e., all of the metabolites through the first headgroup additions) of young and aged CD4(+) T cells. Since sphingolipids influence the biophysical properties of membranes, we evaluated the compositions of immune synapse (IS) and non-IS fractions prepared by magnetic immuno-isolation. Broadly, increased amounts of sphingomyelins, dihydrosphingomyelins and ceramides were found in aged CD4(+) T cells. After normalizing for total sphingolipid content, a statistically significant decrease in the molar fraction of glucosylceramides was evident in both the non-IS and IS fractions of aged T cells. This change was balanced by less dramatic increases in the molar fractions of sphingomyelins and dihydrosphingomyelins in aged CD4(+) T cells. In vitro, the direct or enzymatic enhancement of ceramide levels decreased CD4(+) T cell proliferation without regard for the age of the responding T cells. In contrast, the in vitro inhibition of glucosylceramidase preferentially increased the proliferation of aged CD4(+) T cells. These results suggest that reductions in glucosylceramide abundance contribute to age-related impairments in CD4(+) T cell function.	[Bunnell, Stephen C.; Meydani, Simin Nikbin] Tufts Univ, Dept Pathol, Sackler Grad Sch Biomed Sci, Boston, MA 02111 USA; [Molano, Alberto; Huang, Zhaofeng; Marko, Melissa G.; Azzi, Angelo; Meydani, Simin Nikbin] Tufts Univ, Jean Mayer USDA Human Nutr Res Ctr Aging, Boston, MA 02111 USA; [Wang, Elaine; Kelly, Samuel L.; Merrill, Alfred H., Jr.] Georgia Inst Technol, Parker H Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA	Tufts University; Tufts University; United States Department of Agriculture (USDA); University System of Georgia; Georgia Institute of Technology	Bunnell, SC (corresponding author), Tufts Univ, Dept Pathol, Sackler Grad Sch Biomed Sci, Boston, MA 02111 USA.	stephen.bunnell@tufts.edu; simin.meydani@tufts.edu		Merrill, Alfred/0000-0002-6673-968X; Bunnell, Stephen/0000-0001-6887-0828	United States Department of Agriculture-Agricultural Research Service (USDA-ARS) [58-1950-7-707]; National Institute on Aging (NIA) [R21-AG030931, R01-AG009140-14]; LIPID MAPS Consortium [GM069338]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM069338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG030931, R01AG009140] Funding Source: NIH RePORTER	United States Department of Agriculture-Agricultural Research Service (USDA-ARS)(United States Department of Agriculture (USDA)USDA Agricultural Research Service); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); LIPID MAPS Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by United States Department of Agriculture-Agricultural Research Service (USDA-ARS) contract number 58-1950-7-707, National Institute on Aging (NIA) R21-AG030931, R01-AG009140-14, and LIPID MAPS Consortium grant GM069338. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson O, 2001, J IMMUNOL, V167, P3809, DOI 10.4049/jimmunol.167.7.3809; Agarwal S, 2010, ANN ALLERG ASTHMA IM, V104, P183, DOI 10.1016/j.anai.2009.11.009; Barbat C, 2007, BIOCHEM J, V402, P471, DOI 10.1042/BJ20061061; Bitterman KJ, 2003, MICROBIOL MOL BIOL R, V67, P376, DOI 10.1128/MMBR.67.3.376-399.2003; Blank N, 2005, BIOCHEM PHARMACOL, V71, P126, DOI 10.1016/j.bcp.2005.10.004; Camoletto PG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005310; Castillo SS, 2007, EXP CELL RES, V313, P2680, DOI 10.1016/j.yexcr.2007.04.002; Chen YF, 2010, NEUROMOL MED, V12, P306, DOI 10.1007/s12017-010-8132-8; Cowart LA, 2007, J BIOL CHEM, V282, P12330, DOI 10.1074/jbc.M700685200; Dbaibo GS, 1998, J CLIN INVEST, V102, P329, DOI 10.1172/JCI1180; DBAIBO GS, 1995, P NATL ACAD SCI USA, V92, P1347, DOI 10.1073/pnas.92.5.1347; Elson EL, 2010, ANNU REV BIOPHYS, V39, P207, DOI 10.1146/annurev.biophys.093008.131238; Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008; Garofalo T, 2002, J BIOL CHEM, V277, P11233, DOI 10.1074/jbc.M109601200; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Harder T, 2000, J CELL BIOL, V151, P199, DOI 10.1083/jcb.151.2.199; Huang SX, 2011, P NATL ACAD SCI USA, V108, P19335, DOI 10.1073/pnas.1112969108; Ikeda K, 2008, J LIPID RES, V49, P2678, DOI 10.1194/jlr.D800038-JLR200; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Jazwinski SM, 2000, ACTA BIOCHIM POL, V47, P269, DOI 10.18388/abp.2000_4007; Jiang JC, 2004, EXP GERONTOL, V39, P999, DOI 10.1016/j.exger.2004.03.026; KANFER JN, 1975, BIOCHEM BIOPH RES CO, V67, P85, DOI 10.1016/0006-291X(75)90286-7; Kaucic K, 2006, METHOD ENZYMOL, V417, P168, DOI 10.1016/S0076-6879(06)17013-5; Lee JY, 2000, EXP CELL RES, V261, P303, DOI 10.1006/excr.2000.5028; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Liu YY, 2001, FASEB J, V15, P719, DOI 10.1096/fj.00-0223com; Marko MG, 2007, J IMMUNOL, V178, P1443, DOI 10.4049/jimmunol.178.3.1443; MARSH NL, 1995, J CLIN INVEST, V95, P2903, DOI 10.1172/JCI117997; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; MIYAKE Y, 1995, BIOCHEM BIOPH RES CO, V211, P396, DOI 10.1006/bbrc.1995.1827; Nakamura S, 1996, J BIOL CHEM, V271, P1255, DOI 10.1074/jbc.271.3.1255; Natoli TA, 2010, NAT MED, V16, P788, DOI 10.1038/nm.2171; Nguyen K, 2008, IMMUNITY, V28, P810, DOI 10.1016/j.immuni.2008.04.019; RANI CSS, 1995, J BIOL CHEM, V270, P2859, DOI 10.1074/jbc.270.6.2859; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Seminario MC, 2008, IMMUNOL REV, V221, P90, DOI 10.1111/j.1600-065X.2008.00593.x; Shaner RL, 2009, J LIPID RES, V50, P1692, DOI 10.1194/jlr.D800051-JLR200; Shaw AS, 2006, NAT IMMUNOL, V7, P1139, DOI 10.1038/ni1405; SHAYMAN JA, 1991, J BIOL CHEM, V266, P22968; Stefanic S, 2010, J LIPID RES, V51, P2527, DOI 10.1194/jlr.M003392; Taha TA, 2006, BBA-BIOMEMBRANES, V1758, P2027, DOI 10.1016/j.bbamem.2006.10.018; Tamir A, 2000, J IMMUNOL, V165, P1243, DOI 10.4049/jimmunol.165.3.1243; Wheeler D, 2009, J NEUROCHEM, V109, P1237, DOI 10.1111/j.1471-4159.2009.06038.x; Zech T, 2009, EMBO J, V28, P466, DOI 10.1038/emboj.2009.6; Zhu YX, 2011, J BIOL CHEM, V286, P14787, DOI 10.1074/jbc.M111.218610; Zitomer NC, 2009, J BIOL CHEM, V284, P4786, DOI 10.1074/jbc.M808798200	48	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47650	10.1371/journal.pone.0047650	http://dx.doi.org/10.1371/journal.pone.0047650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110086	Green Published, Green Submitted, gold			2022-12-25	WOS:000310262500016
J	Ritzinger, B; Huberle, E; Karnath, HO				Ritzinger, Bernd; Huberle, Elisabeth; Karnath, Hans-Otto			Bilateral Theta-Burst TMS to Influence Global Gestalt Perception	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; HUMAN MOTOR CORTEX; MONKEY INFEROTEMPORAL CORTEX; VISUAL FORM AGNOSIA; OBJECT RECOGNITION; LOCAL FEATURES; SIMULTANAGNOSIA; ATTENTION; LESIONS; BRAIN	While early and higher visual areas along the ventral visual pathway in the inferotemporal cortex are critical for the recognition of individual objects, the neural representation of human perception of complex global visual scenes remains under debate. Stroke patients with a selective deficit in the perception of a complex global Gestalt with intact recognition of individual objects - a deficit termed simultanagnosia - greatly helped to study this question. Interestingly, simultanagnosia typically results from bilateral lesions of the temporo-parietal junction (TPJ). The present study aimed to verify the relevance of this area for human global Gestalt perception. We applied continuous theta-burst TMS either unilaterally (left or right) or bilateral simultaneously over TPJ. Healthy subjects were presented with hierarchically organized visual stimuli that allowed parametrical degrading of the object at the global level. Identification of the global Gestalt was significantly modulated only for the bilateral TPJ stimulation condition. Our results strengthen the view that global Gestalt perception in the human brain involves TPJ and is co-dependent on both hemispheres.	[Ritzinger, Bernd; Huberle, Elisabeth; Karnath, Hans-Otto] Univ Tubingen, Div Neuropsychol, Ctr Neurol, Hertie Inst Clin Brain Res, Tubingen, Germany; [Huberle, Elisabeth] Luzerner Kantonsspital, Neurol & Neurorehabil Ctr, Luzern, Switzerland; [Karnath, Hans-Otto] Univ S Carolina, Dept Psychol, Columbia, SC 29208 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Lucerne Cantonal Hospital; University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Karnath, HO (corresponding author), Univ Tubingen, Div Neuropsychol, Ctr Neurol, Hertie Inst Clin Brain Res, Tubingen, Germany.	Karnath@uni-tuebingen.de			Bundesministerium fur Bildung und Forschung [BMBF-Verbund 01GW0654]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the Bundesministerium fur Bildung und Forschung (BMBF-Verbund 01GW0654 "Visuo-spatial cognition"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann CF, 2003, CURR BIOL, V13, P342, DOI 10.1016/S0960-9822(03)00052-6; Balint R, 1909, MON PSYCHIATR NEUROL, V25, P51; Borchers S, 2012, NAT REV NEUROSCI, V13, P63, DOI 10.1038/nrn3140; Chechlacz M, 2012, J COGNITIVE NEUROSCI, V24, P718, DOI 10.1162/jocn_a_00159; Clavagnier S, 2006, NEUROPSYCHOLOGIA, V44, P2330, DOI 10.1016/j.neuropsychologia.2006.05.012; Di Lazzaro V, 2005, J PHYSIOL-LONDON, V565, P945, DOI 10.1113/jphysiol.2005.087288; Downing PE, 2006, CEREB CORTEX, V16, P1453, DOI 10.1093/cercor/bhj086; Fink GR, 1996, NATURE, V382, P626, DOI 10.1038/382626a0; Fink GR, 1999, NEUROPSYCHOLOGIA, V37, P31; Fink GR, 1997, BRAIN, V120, P1779, DOI 10.1093/brain/120.10.1779; FRIEDMANHILL SR, 1995, SCIENCE, V269, P853, DOI 10.1126/science.7638604; Gamboa OL, 2010, EXP BRAIN RES, V204, P181, DOI 10.1007/s00221-010-2293-4; Gentner R, 2008, CEREB CORTEX, V18, P2046, DOI 10.1093/cercor/bhm239; H-O Karnath, 2012, KOGNITIVE NEUROWISSE, P293; Hellige J. B., 1993, HEMISPHERIC ASYMMETR; Himmelbach M, 2009, NEUROPSYCHOLOGIA, V47, P1173, DOI 10.1016/j.neuropsychologia.2008.10.025; Huang YZ, 2007, CLIN NEUROPHYSIOL, V118, P1028, DOI 10.1016/j.clinph.2007.01.021; Huang YZ, 2011, CLIN NEUROPHYSIOL, V122, P1011, DOI 10.1016/j.clinph.2010.08.016; Huang YZ, 2009, CLIN NEUROPHYSIOL, V120, P796, DOI 10.1016/j.clinph.2009.01.003; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Huberle E, 2006, NEUROPSYCHOLOGIA, V44, P905, DOI 10.1016/j.neuropsychologia.2005.08.013; Huberle E, 2012, BRAIN STRUCT FUNCT, V217, P735, DOI 10.1007/s00429-011-0369-y; Huberle E, 2010, EXP BRAIN RES, V204, P595, DOI 10.1007/s00221-010-2328-x; Huberle E, 2010, NEUROPSYCHOLOGIA, V48, P1677, DOI 10.1016/j.neuropsychologia.2010.02.013; James TW, 2003, BRAIN, V126, P2463, DOI 10.1093/brain/awg248; Jones LS, 2007, SCIENCE, V315, P1663; Karnath H.-O., 2003, NEUROLOGICAL DISORDE, P277, DOI DOI 10.1016/B978-012125831-3/50221-5; Karnath HO, 2009, J NEUROSCI, V29, P5854, DOI 10.1523/JNEUROSCI.5192-08.2009; Karnath HO, 2000, NEUROCASE, V6, P295, DOI 10.1080/13554790008402778; KARPOV BA, 1979, NEUROPSYCHOLOGIA, V17, P281, DOI 10.1016/0028-3932(79)90074-5; Koffka K, 1935, PRINCIPLES GESTALT P; Kourtzi Z, 2003, NEURON, V37, P333, DOI 10.1016/S0896-6273(02)01174-1; Kveraga K, 2007, BRAIN COGNITION, V65, P145, DOI 10.1016/j.bandc.2007.06.007; Kveraga K, 2007, J NEUROSCI, V27, P13232, DOI 10.1523/JNEUROSCI.3481-07.2007; Lerner Y, 2001, CEREB CORTEX, V11, P287, DOI 10.1093/cercor/11.4.287; Logothetis NK, 1996, ANNU REV NEUROSCI, V19, P577, DOI 10.1146/annurev.ne.19.030196.003045; LURIA AR, 1959, BRAIN, V82, P437, DOI 10.1093/brain/82.3.437; McAllister SM, 2009, CLIN NEUROPHYSIOL, V120, P820, DOI 10.1016/j.clinph.2009.02.003; Milner A. D., 1995, VISUAL BRAIN ACTION; MILNER AD, 1991, BRAIN, V114, P405, DOI 10.1093/brain/114.1.405; Peelen MV, 2005, HUM BRAIN MAPP, V25, P402, DOI 10.1002/hbm.20116; Rafal R. D., 1997, BEHAV NEUROLOGY NEUR, P337; RIZZO M, 1987, NEUROLOGY, V37, P1642, DOI 10.1212/WNL.37.10.1642; Rizzo V, 2004, J PHYSIOL-LONDON, V554, P483, DOI 10.1113/jphysiol.2003.048777; ROBERTSON LC, 1988, J NEUROSCI, V8, P3757; Romei V, 2011, CURR BIOL, V21, P334, DOI 10.1016/j.cub.2011.01.035; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Rusconi E, 2009, CORTEX, V45, P1021, DOI 10.1016/j.cortex.2009.05.001; Sripati AP, 2010, J NEUROSCI, V30, P7948, DOI 10.1523/JNEUROSCI.0016-10.2010; Sripati AP, 2010, J NEUROSCI, V30, P1258, DOI 10.1523/JNEUROSCI.1908-09.2010; Sripati AP, 2009, J NEUROSCI, V29, P7788, DOI 10.1523/JNEUROSCI.5766-08.2009; Tanaka K, 1996, ANNU REV NEUROSCI, V19, P109, DOI 10.1146/annurev.ne.19.030196.000545; Tang-Wai DF, 2004, NEUROLOGY, V63, P1168, DOI 10.1212/01.WNL.0000140289.18472.15; Thielscher A, 2004, CLIN NEUROPHYSIOL, V115, P1697, DOI 10.1016/j.clinph.2004.02.019; Thielscher A, 2002, NEUROIMAGE, V17, P1117, DOI 10.1006/nimg.2002.1282; TREISMAN A, 1988, PSYCHOL REV, V95, P15, DOI 10.1037/0033-295X.95.1.15; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Ungerleider L.G., 1982, ANAL VISUAL BEHAV, P549; Valenza N, 2004, NEUROPSYCHOLOGIA, V42, P1737, DOI 10.1016/j.neuropsychologia.2004.05.001; Wassermann EM, 1998, EVOKED POTENTIAL, V108, P1, DOI 10.1016/S0168-5597(97)00096-8; Wolpert I, 1924, Z GESAMTE NEUROL PSY, V93, P397, DOI 10.1007/BF02900065; Yamaguchi S, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-09-j0002.2000; Yi DJ, 2006, BRAIN RES, V1080, P53, DOI 10.1016/j.brainres.2006.01.090	63	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47820	10.1371/journal.pone.0047820	http://dx.doi.org/10.1371/journal.pone.0047820			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110106	Green Submitted, Green Published, gold			2022-12-25	WOS:000310262500020
J	Hashimoto, T; Soeno, Y; Maeda, G; Taya, Y; Aoba, T; Nasu, M; Kawashiri, S; Imai, K				Hashimoto, Takashi; Soeno, Yuichi; Maeda, Genta; Taya, Yuji; Aoba, Takaaki; Nasu, Masanori; Kawashiri, Shuichi; Imai, Kazushi			Progression of Oral Squamous Cell Carcinoma Accompanied with Reduced E-Cadherin Expression but Not Cadherin Switch	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; N-CADHERIN; BETA-CATENIN; DIFFERENTIAL EXPRESSION; PROGNOSTIC-SIGNIFICANCE; P-CADHERIN; CANCER; METASTASIS; INVASION; BINDING	The cadherin switch from E-cadherin to N-cadherin is considered as a hallmark of the epithelial-mesenchymal transition and progression of carcinomas. Although it enhances aggressive behaviors of adenocarcinoma cells, the significance and role of cadherin switch in squamous cell carcinomas (SCCs) are largely controversial. In the present study, we immunohistochemically examined expression of E-cadherin and N-cadherin in oral SCCs (n = 63) and its implications for the disease progression. The E-cadherin-positive carcinoma cells were rapidly decreased at the invasive front. The percentage of carcinoma cells stained E-cadherin at the cell membrane was reduced in parallel with tumor dedifferentiation (P<0.01) and enhanced invasion (P<0.01). In contrast, N-cadherin-positive cells were very limited and did not correlate with the clinicopathological parameters. Mouse tongue tumors xenotransplantated oral SCC cell lines expressing both cadherins in vitro reproduced the reduction of E-cadherin-positive carcinoma cells at the invasive front and the negligible expression of N-cadherin. These results demonstrate that the reduction of E-cadherin-mediated carcinoma cell-cell adhesion at the invasive front, but not the cadherin switch, is an important determinant for oral SCC progression, and suggest that the environments surrounding carcinoma cells largely affect the cadherin expression.	[Hashimoto, Takashi; Maeda, Genta; Imai, Kazushi] Nippon Dent Univ Tokyo, Dept Biochem, Tokyo, Japan; [Soeno, Yuichi; Taya, Yuji; Aoba, Takaaki] Nippon Dent Univ Tokyo, Dept Pathol, Tokyo, Japan; [Nasu, Masanori] Nippon Dent Univ Tokyo, Res Ctr Odontol, Tokyo, Japan; [Kawashiri, Shuichi] Kanazawa Univ, Dept Oral Surg, Kanazawa, Ishikawa, Japan	Nippon Dental University; Nippon Dental University; Nippon Dental University; Kanazawa University	Imai, K (corresponding author), Nippon Dent Univ Tokyo, Dept Biochem, Tokyo, Japan.	kimai@tky.ndu.ac.jp	Nasu, Masanori/ABA-4141-2020; Soeno, Yuuichi/W-1367-2019; Imai, Kazushi/E-7206-2012; Taya, Yuji/ABA-2220-2020	Soeno, Yuuichi/0000-0001-8466-6376; Taya, Yuji/0000-0001-5663-0835	Japan Society for the Promotion of Science [22592103]; Grants-in-Aid for Scientific Research [24592780, 23592782] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant from the Japan Society for the Promotion of Science #22592103. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anbalagan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033017; Bauer K, 2009, CARCINOGENESIS, V30, P1781, DOI 10.1093/carcin/bgp175; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Chiba T, 2009, CANCER RES, V69, P7216, DOI 10.1158/0008-5472.CAN-09-1140; Choi S, 2008, J DENT RES, V87, P14, DOI 10.1177/154405910808700104; Cohen D, 2007, CLIN GENITOURIN CANC, V5, P264, DOI 10.3816/CGC.2007.n.002; Di Domenico M, 2011, ANTICANCER RES, V31, P4211; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Gasparotto D, 2011, ONCOTARGET, V2, P1165; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Imai K, 2012, SQUAMOUS CELL CARCIN, P121; Kan NG, 2007, DEVELOPMENT, V134, P31, DOI 10.1242/dev.02722; Kawashiri S, 2001, HEAD NECK-J SCI SPEC, V23, P764, DOI 10.1002/hed.1109.abs; Kudo Y, 2004, CLIN CANCER RES, V10, P5455, DOI 10.1158/1078-0432.CCR-04-0372; Langner C, 2004, J CLIN PATHOL, V57, P773, DOI 10.1136/jcp.2003.015743; Li S, 2009, ONCOL REP, V21, P1223, DOI 10.3892/or_00000345; Liu H, 2007, CELL STRUCT FUNCT, V32, P127, DOI 10.1247/csf.07023; Maeda G, 2005, INT J ONCOL, V27, P1535; Maeda G, 2007, CLIN CANCER RES, V13, P5041, DOI 10.1158/1078-0432.CCR-07-0463; Matsuyoshi N, 1997, BIOCHEM BIOPH RES CO, V235, P355, DOI 10.1006/bbrc.1997.6707; Mink SR, 2010, MOL CANCER RES, V8, P809, DOI 10.1158/1541-7786.MCR-09-0460; Miyazawa J, 2004, CANCER RES, V64, P2024, DOI 10.1158/0008-5472.CAN-03-1855; Mizunuma H, 2003, BRIT J CANCER, V88, P1543, DOI 10.1038/sj.bjc.6600952; Nguyen PT, 2011, HISTOL HISTOPATHOL, V26, P147, DOI 10.14670/HH-26.147; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Pyo SW, 2007, J CRANIO MAXILL SURG, V35, P1, DOI 10.1016/j.jcms.2006.11.004; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SHORE EM, 1991, J BIOL CHEM, V266, P19672; Srinivasan R, 2000, CANCER RES, V60, P1483; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tinkle CL, 2004, P NATL ACAD SCI USA, V101, P552, DOI 10.1073/pnas.0307437100; Tsuchiya B, 2006, ARCH HISTOL CYTOL, V69, P135, DOI 10.1679/aohc.69.135; Ukpo OC, 2012, HEAD NECK PATHOL, V6, P38, DOI 10.1007/s12105-011-0306-7; Uraguchi M, 2004, J DENT RES, V83, P327, DOI 10.1177/154405910408300411; Vallorosi CJ, 2000, J BIOL CHEM, V275, P3328, DOI 10.1074/jbc.275.5.3328; Wendt MK, 2010, ONCOGENE, V29, P6485, DOI 10.1038/onc.2010.377; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; YAMAMOTO E, 1983, CANCER, V51, P2175, DOI 10.1002/1097-0142(19830615)51:12<2175::AID-CNCR2820511205>3.0.CO;2-M; Yu CC, 2011, J ONCOL, V2011, DOI 10.1155/2011/609259; Zhang JY, 2010, J PATHOL, V222, P76, DOI 10.1002/path.2742; Zynger DL, 2008, HISTOPATHOLOGY, V52, P348, DOI 10.1111/j.1365-2559.2007.02952.x	42	31	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47899	10.1371/journal.pone.0047899	http://dx.doi.org/10.1371/journal.pone.0047899			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110125	Green Published, Green Submitted, gold			2022-12-25	WOS:000310193600036
J	Varela-Alvarez, E; Garreta, AG; Lluch, JR; Soler, NS; Serrao, EA; Siguan, MAR				Varela-Alvarez, Elena; Gomez Garreta, Amelia; Rull Lluch, Jordi; Salvador Soler, Noemi; Serrao, Ester A.; Ribera Siguan, Maria Antonia			Mediterranean Species of Caulerpa Are Polyploid with Smaller Genomes in the Invasive Ones	PLOS ONE			English	Article							NUCLEAR-DNA QUANTIFICATION; RACEMOSA VAR. CYLINDRACEA; GREAT-BARRIER-REEF; TAXIFOLIA CAULERPALES; GREEN-ALGAE; CELL-CYCLE; SEXUAL REPRODUCTION; SPARTINA-ANGLICA; PLOIDY LEVELS; BROWN-ALGAE	Caulerpa species are marine green algae, which often act as invasive species with rapid clonal proliferation when growing outside their native biogeographical borders. Despite many publications on the genetics and ecology of Caulerpa species, their life history and ploidy levels are still to be resolved and are the subject of large controversy. While some authors claimed that the thallus found in nature has a haplodiplobiontic life cycle with heteromorphic alternation of generations, other authors claimed a diploid or haploid life cycle with only one generation involved. DAPI-staining with image analysis and microspectrophotometry were used to estimate relative nuclear DNA contents in three species of Caulerpa from the Mediterranean, at individual, population and species levels. Results show that ploidy levels and genome size vary in these three Caulerpa species, with a reduction in genome size for the invasive ones. Caulerpa species in the Mediterranean are polyploids in different life history phases; all sampled C. taxifolia and C. racemosa var. cylindracea were in haplophasic phase, but in C. prolifera, the native species, individuals were found in both diplophasic and haplophasic phases. Different levels of endopolyploidy were found in both C. prolifera and C. racemosa var. cylindracea. Life history is elucidated for the Mediterranean C. prolifera and it is hypothesized that haplophasic dominance in C. racemosa var. cylindracea and C. taxifolia is a beneficial trait for their invasive strategies.	[Varela-Alvarez, Elena; Serrao, Ester A.] Univ Algarve, CIMAR Lab Assoc, CCMAR, Faro, Portugal; [Gomez Garreta, Amelia; Rull Lluch, Jordi; Ribera Siguan, Maria Antonia] Univ Barcelona, Fac Farm, Lab Bot, E-08028 Barcelona, Spain; [Salvador Soler, Noemi] Univ Autonoma Chile, Fac Educ, Temuco, Chile	Universidade do Algarve; University of Barcelona; Universidad Autonoma de Chile	Varela-Alvarez, E (corresponding author), Univ Algarve, CIMAR Lab Assoc, CCMAR, Faro, Portugal.	evarela@ualg.pt	Serrao, Ester A/C-6686-2012; Varela-Álvarez, Elena/M-4495-2013	Serrao, Ester A/0000-0003-1316-658X; Varela-Álvarez, Elena/0000-0001-7262-3475; Rull Lluch, Jordi/0000-0002-0163-8909	FCT-FSE (Fundacao para a Ciencia e a Tecnologia-Fundo Social Europeo) [SFRH/BPD/17206/2004]; two FCT-FEDER (Fundacao para a Ciencia e a Tecnologia-Fundo Europeu de Desenvolvimento Regional) [PTDC/MAR/70921/2006, PEst-C/MAR/LA0015/2011]; MCI (Ministerio de Ciencia e Innovacion) [CGL2009-09589 MECD]; Fundação para a Ciência e a Tecnologia [PD/BD/142793/2018, PTDC/MAR/70921/2006] Funding Source: FCT	FCT-FSE (Fundacao para a Ciencia e a Tecnologia-Fundo Social Europeo); two FCT-FEDER (Fundacao para a Ciencia e a Tecnologia-Fundo Europeu de Desenvolvimento Regional); MCI (Ministerio de Ciencia e Innovacion)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundação para a Ciência e a Tecnologia	Funded by a FCT-FSE (Fundacao para a Ciencia e a Tecnologia-Fundo Social Europeo) Postdoctoral fellowship (SFRH/BPD/17206/2004), two FCT-FEDER (Fundacao para a Ciencia e a Tecnologia-Fundo Europeu de Desenvolvimento Regional) projects: (PTDC/MAR/70921/2006) to EV-A and PEst-C/MAR/LA0015/2011 to CCMAR/CIMAR; and a MCI (Ministerio de Ciencia e Innovacion) project to AGG (CGL2009-09589 MECD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2004, BIOL J LINN SOC, V82, P467, DOI 10.1111/j.1095-8312.2004.00333.x; Adams KL, 2005, CURR OPIN PLANT BIOL, V8, P135, DOI 10.1016/j.pbi.2005.01.001; Ainouche ML, 2009, BIOL INVASIONS, V11, P1159, DOI 10.1007/s10530-008-9383-2; Ainouche ML, 2004, BIOL J LINN SOC, V82, P475, DOI 10.1111/j.1095-8312.2004.00334.x; Amat J. N., 2008, Aquatic Invasions, V3, P417, DOI 10.3391/ai.2008.3.4.8; Amsellem L, 2001, PLANT SYST EVOL, V228, P171, DOI 10.1007/s006060170027; BARLOW PW, 1978, ACTA BIOTHEOR, V27, P1, DOI 10.1007/BF00048400; Barow M., 2007, FLOW CYTOMETRY PLANT, P349, DOI DOI 10.1002/9783527610921.CH15; Barrett S.C.H., 1986, P21; Bennett MD, 1998, ANN BOT-LONDON, V82, P121, DOI 10.1006/anbo.1998.0785; Benzie JAH, 2000, BOT MAR, V43, P169, DOI 10.1515/BOT.2000.018; Benzie JAH, 1997, J PHYCOL, V33, P491, DOI 10.1111/j.0022-3646.1997.00491.x; Bisova K, 2005, PLANT PHYSIOL, V137, P475, DOI 10.1104/pp.104.054155; Bleeker W, 2005, HEREDITY, V94, P664, DOI 10.1038/sj.hdy.6800687; Boudouresque CF, 1995, SCI MAR, V59, P21; Brian EL, 2010, HARMFUL ALGAE, V9, P112; Brochmann C, 2004, BIOL J LINN SOC, V82, P521, DOI 10.1111/j.1095-8312.2004.00337.x; Campbell L, 2010, J PHYCOL, V46, P66, DOI 10.1111/j.1529-8817.2009.00791.x; Carvalho N, 1997, 3 INT WORKSH CAUL TA, P127; Clifton KE, 1999, J PHYCOL, V35, P24, DOI 10.1046/j.1529-8817.1999.3510024.x; Clifton KE, 1997, SCIENCE, V275, P1116, DOI 10.1126/science.275.5303.1116; CLOWES AW, 1983, LAB INVEST, V49, P327; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; DEVILLELE X, 1995, BOT MAR, V38, P79, DOI 10.1515/botm.1995.38.1-6.79; Dolezel J, 1998, ANN BOT-LONDON, V82, P17, DOI 10.1006/anbo.1998.0730; Dorken ME, 2002, EVOLUTION, V56, P31, DOI 10.1111/j.0014-3820.2002.tb00847.x; Dostal R, 1929, PLANTA, V8, P84; Dostal R, 1928, PLANTA, V5, P622; DRUEHL LD, 1989, MAR BIOL, V101, P451, DOI 10.1007/BF00541646; Durand C, 2002, J EVOLUTION BIOL, V15, P122, DOI 10.1046/j.1420-9101.2002.00370.x; Eckert CG, 2001, EVOL ECOL, V15, P501, DOI 10.1023/A:1016005519651; ENOMOTO S, 1987, Japanese Journal of Phycology, V35, P167; Ernst A, 1931, PLANTA, V15, P459; Fama P, 2002, J PHYCOL, V38, P1040, DOI 10.1046/j.1529-8817.2002.t01-1-01237.x; Fama P, 2000, EUR J PHYCOL, V35, P349, DOI 10.1080/09670260010001735951; GALL JG, 1981, J CELL BIOL, V91, pS3, DOI 10.1083/jcb.91.3.3s; Garbary DJ, 2002, BOT MAR, V45, P211, DOI 10.1515/BOT.2002.020; GOFF LJ, 1984, P NATL ACAD SCI-BIOL, V81, P5420, DOI 10.1073/pnas.81.17.5420; Goff LJ, 1990, BIOL RED ALGAE, P43; GOLDSTEIN M, 1970, ANN NY ACAD SCI, V175, P660, DOI 10.1111/j.1749-6632.1970.tb45183.x; Garreta AG, 2010, PHYCOLOGIA, V49, P64, DOI 10.2216/09-14.1; Gregory TR, 2005, ANN BOT-LONDON, V95, P133, DOI 10.1093/aob/mci009; Greilhuber J, 2005, ANN BOT-LONDON, V95, P255, DOI 10.1093/aob/mci019; Greilhuber J, 2009, CHROMOSOMA, V118, P391, DOI 10.1007/s00412-009-0205-9; Guiry MD, 2012, ALGAEBASE; Hegarty MJ, 2008, CURR BIOL, V18, pR435, DOI 10.1016/j.cub.2008.03.043; Hildenbrand C, 2011, J BACTERIOL, V193, P734, DOI 10.1128/JB.01016-10; HINSON TK, 1991, HELGOLANDER MEERESUN, V45, P273, DOI 10.1007/BF02365520; Hori T, 1981, JAP J PHYCOL, V29, P162; Ishiwara J, 1981, P 8 INT SEAW S, P112; Iyengar MOP, 1940, INDIAN BOT SOC, V19, P191; Jochem FJ, 1999, MAR ECOL PROG SER, V185, P301, DOI 10.3354/meps185301; Jousson O, 2000, NATURE, V408, P157, DOI 10.1038/35041623; KAJIMURA M, 1977, Bulletin of the Japanese Society of Phycology, V25, P27; Kapraun DF, 2005, ANN BOT-LONDON, V95, P7, DOI 10.1093/aob/mci002; KAPRAUN DF, 1994, PHYCOLOGIA, V33, P42, DOI 10.2216/i0031-8884-33-1-42.1; Kapraun Donald F., 1994, Cryptogamic Botany, V4, P410; Knight CA, 2005, ANN BOT-LONDON, V95, P177, DOI 10.1093/aob/mci011; Lapointe BE, 2006, ESTUAR COAST, V29, P966, DOI 10.1007/BF02798657; Larsen A, 1998, PHYCOLOGIA, V37, P412, DOI 10.2216/i0031-8884-37-6-412.1; LEGALL Y, 1993, PROTOPLASMA, V173, P123; Leitch IJ., 2007, FLOW CYTOMETRY PLANT, P153, DOI [DOI 10.1002/9783527610921.CH7, 10.1002/9783527610921.ch7]; Liddle LB, 1998, PHYCOLOGIA, V37, P310, DOI 10.2216/i0031-8884-37-4-310.1; MCAULEY PJ, 1986, J CELL SCI, V85, P73; MEINESZ A, 1979, BOT MAR, V22, P123, DOI 10.1515/botm.1979.22.2.123; Meinesz A., 1999, KILLER ALGAE; Meinesz Alexandre, 2001, Biological Invasions, V3, P201, DOI 10.1023/A:1014549500678; Meusnier I, 2004, EUR J PHYCOL, V39, P83, DOI 10.1080/09670260310001646531; Meusnier I, 2002, MOL ECOL, V11, P2317, DOI 10.1046/j.1365-294X.2002.01627.x; Meusnier I, 2001, MOL ECOL, V10, P931, DOI 10.1046/j.1365-294X.2001.01245.x; Miyake K, 1937, CYTOLOGIA, V8, P205, DOI DOI 10.1508/CYTOLOGIA.8.205; NOVAK SJ, 1991, AM J BOT, V78, P1586, DOI 10.2307/2444984; OHBA H, 1992, BOT MAG TOKYO, V105, P589, DOI 10.1007/BF02489433; Pandit MK, 2006, BOT J LINN SOC, V151, P395, DOI 10.1111/j.1095-8339.2006.00515.x; Phillips JA, 2009, EUR J PHYCOL, V44, P81, DOI 10.1080/09670260802343640; Phillips N, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr001; Piazzi L, 2001, 4 INT WORKSH CAUL TA, P71; Prentis PJ, 2008, TRENDS PLANT SCI, V13, P288, DOI 10.1016/j.tplants.2008.03.004; PRICE HJ, 1976, BOT REV, V42, P27, DOI 10.1007/BF02860861; PRICE I R, 1972, Phycologia, V11, P217, DOI 10.2216/i0031-8884-11-2-217b.1; Puiseaux-Dao S, 1966, CHROMOSOMES ALGAE, P52; Ribera-Sigu&aacute;n MA, 2011, CRYP ALGOL, V32, P205219; Soler NS, 2009, EUR J PHYCOL, V44, P381, DOI 10.1080/09670260902780782; Sarma Y.S.R.K., 1983, P177; Schaffelke B, 2002, MAR POLLUT BULL, V44, P204, DOI 10.1016/S0025-326X(01)00202-8; Schierenbeck KA, 2006, INVAD NAT SPRING SER, P193; Schussnig B, 1939, BOT NOTISER, P75; Semon M, 2007, MOL BIOL EVOL, V24, P860, DOI 10.1093/molbev/msm003; Soltis DE, 2004, BIOL J LINN SOC, V82, P485, DOI 10.1111/j.1095-8312.2004.00335.x; Soltis PS, 2000, P NATL ACAD SCI USA, V97, P7051, DOI 10.1073/pnas.97.13.7051; Suda J, 2007, FLOW CYTOMETRY PLANT, P103, DOI DOI 10.1002/9783527610921.CH5; THOMPSON JD, 1991, BIOSCIENCE, V41, P393, DOI 10.2307/1311746; Varela-Alvarez E, 2006, J PHYCOL, V42, P741, DOI 10.1111/j.1529-8817.2006.00218.x; Varela-Alvarez E, 2011, J APPL PHYCOL, V23, P715, DOI 10.1007/s10811-010-9568-9; Verlaque M, 2004, BIOL INVASIONS, V6, P269, DOI 10.1023/B:BINV.0000034589.18347.d3; Verlaque M, 2003, EUR J PHYCOL, V38, P325, DOI 10.1080/09670260310001612592; Vinogradov AE, 2003, TRENDS GENET, V19, P609, DOI 10.1016/j.tig.2003.09.010; Weiss TL, 2011, J APPL PHYCOL, V23, P833, DOI 10.1007/s10811-010-9586-7; Weiss TL, 2010, J PHYCOL, V46, P534, DOI 10.1111/j.1529-8817.2010.00820.x; Whittick A, 1986, J BR PHYCOL, V21, P314; Williams SL, 2007, J EXP MAR BIOL ECOL, V350, P89, DOI 10.1016/j.jembe.2007.05.032; Winkler E, 2001, EVOL ECOL, V15, P281, DOI 10.1023/A:1016080714200; Zuljevic A, 2000, PHYCOLOGIA, V39, P157, DOI 10.2216/i0031-8884-39-2-157.1; Zuljevic A, 2012, PHYCOLOGIA, V51, P283, DOI 10.2216/11-22.1	104	25	25	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e47728	10.1371/journal.pone.0047728	http://dx.doi.org/10.1371/journal.pone.0047728			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110095	gold, Green Published			2022-12-25	WOS:000310193400015
J	Lucas, R; Fraga, S; Ramos, E; Barros, H				Lucas, Raquel; Fraga, Silvia; Ramos, Elisabete; Barros, Henrique			Early Initiation of Smoking and Alcohol Drinking as a Predictor of Lower Forearm Bone Mineral Density in Late Adolescence: A Cohort Study in Girls	PLOS ONE			English	Article							BIOPSYCHOSOCIAL VARIABLES; RISK; MASS; DETERMINANTS; OSTEOPOROSIS; CONSUMPTION; FRACTURE; TOBACCO; HEALTH; WOMEN	Background: Adolescence is a critical stage for bone accrual. It is also decisive for the establishment of behaviors such as smoking and alcohol drinking. Objective: To quantify the short-and long-term associations between smoking and drinking initiation and bone mineral density in adolescent girls. Methods: We used prospective data from 731 girls identified in public and private schools in Porto, Portugal. Evaluations were conducted when participants were 13 and 17 years old. Bone mineral density (BMD) was measured at the forearm by dual-energy X-ray absorptiometry and weight, height and fat-free mass were measured. Pubertal development status was estimated using menarche age. Self-administered questionnaires were used to collect data on smoking and alcohol drinking, physical exercise and calcium and vitamin D intakes. BMD in early and late adolescence was analyzed as a continuous or dichotomous (Z-score cutoff: -1.0) variable. Associations were calculated using linear or logistic regression. Results: Over one quarter of these girls had tried smoking by 13, while 59% had drunk alcoholic beverages and 20% had experienced both behaviors by that age. Lower mean BMD at 17 years of age was observed in girls who had ever smoked by 13, as well as in those who reported drinking at that age. There were no significant cross-sectional associations between experience and frequency of smoking or drinking and BMD at 13 years of age. However, we observed significant associations between BMD z-score<-1 in late adolescence and having ever smoked by 13, after adjustment for menarche age and sports practice, (OR = 1.92; 95% CI: 1.21, 3.05) and with ever smoking and drinking in the same period (OR = 2.33; 95% CI: 1.36, 4.00). Conclusion: Our study adds prospective evidence to the role of early initiation of smoking and alcohol drinking as relevant markers of lower bone mineral density in late adolescence.	[Lucas, Raquel; Fraga, Silvia; Ramos, Elisabete; Barros, Henrique] Univ Porto, Sch Med, Dept Clin Epidemiol Predict Med & Publ Hlth, P-4100 Oporto, Portugal; [Lucas, Raquel; Fraga, Silvia; Ramos, Elisabete; Barros, Henrique] Univ Porto, Inst Publ Hlth, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Lucas, R (corresponding author), Univ Porto, Sch Med, Dept Clin Epidemiol Predict Med & Publ Hlth, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	rlucas@med.up.pt	Ramos, Elisabete/F-3473-2013; Barros, Henrique/A-5488-2008; Barros, Henrique/Q-8609-2019	Ramos, Elisabete/0000-0001-6573-218X; Barros, Henrique/0000-0003-4699-6571; Fraga, Silvia/0000-0002-5268-7751; Lucas, Raquel/0000-0002-4408-8134	Portuguese Foundation for Science and Technology [PTDC/SAU-ESA/108407/2008, PTDC/SAU-EPI/115254/2009, SFRH/BD/40656/2007]	Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology)	This work was supported by the Portuguese Foundation for Science and Technology: Grant numbers PTDC/SAU-ESA/108407/2008, PTDC/SAU-EPI/115254/2009, and SFRH/BD/40656/2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachrach LK, 2001, TRENDS ENDOCRIN MET, V12, P22, DOI 10.1016/S1043-2760(00)00336-2; Baim S, 2008, J CLIN DENSITOM, V11, P6, DOI 10.1016/j.jocd.2007.12.002; Berg KM, 2008, AM J MED, V121, P406, DOI 10.1016/j.amjmed.2007.12.012; Botvin GJ, 2007, INT REV PSYCHIATR, V19, P607, DOI 10.1080/09540260701797753; Bouxsein ML, 2003, OSTEOPOROSIS INT, V14, pS118, DOI 10.1007/s00198-003-1489-x; Brener ND, 2003, J ADOLESCENT HEALTH, V33, P436, DOI 10.1016/S1054-139X(03)00052-1; Clark EM, 2006, PEDIATRICS, V117, pE291, DOI 10.1542/peds.2005-1404; Coleman L, 2002, J ADOLESCENCE, V25, P535, DOI 10.1006/jado.2002.0494; Crabtree NJ, 2007, CURR CLIN PRACT, P41, DOI 10.1007/978-1-59745-211-3_3; Elgan C, 2003, CONTRACEPTION, V67, P439, DOI 10.1016/S0010-7824(03)00048-9; Fraga S, 2011, J PUBLIC HEALTH-HEID, V19, pS21, DOI 10.1007/s10389-010-0376-0; Harel Z, 2007, J ADOLESCENT HEALTH, V40, P44, DOI 10.1016/j.jadohealth.2006.08.013; Harel Z, 2010, CONTRACEPTION, V82, P503, DOI 10.1016/j.contraception.2010.04.022; Hawker GA, 2002, AM J EPIDEMIOL, V156, P418, DOI 10.1093/aje/kwf061; Heaney RP, 2003, AM J CLIN NUTR, V78, P350, DOI 10.1093/ajcn/78.2.350; Heaney RP, 2000, OSTEOPOROSIS INT, V11, P985, DOI 10.1007/s001980070020; Hernandez CJ, 2003, OSTEOPOROSIS INT, V14, P843, DOI 10.1007/s00198-003-1454-8; HOPPER JL, 1994, NEW ENGL J MED, V330, P387, DOI 10.1056/NEJM199402103300603; Javaid MK, 2002, BEST PRACT RES CL EN, V16, P349, DOI 10.1053/beem.2002.0199; Jugdaohsingh R, 2006, P NUTR SOC, V65, P291, DOI 10.1079/PNS2006508; Kanis JA, 2005, OSTEOPOROSIS INT, V16, P737, DOI [10.1007/s00198-004-1734-y, 10.1007/s00198-004-1640-3]; Koo MM, 1997, ANN HUM BIOL, V24, P61, DOI 10.1080/03014469700004782; Korkor Adel B, 2009, WMJ, V108, P181; Lopes C, 2007, J AM DIET ASSOC, V107, P276, DOI 10.1016/j.jada.2006.11.008; Lorentzon M, 2007, J CLIN ENDOCR METAB, V92, P497, DOI 10.1210/jc.2006-1294; Maurel DB, 2012, OSTEOPOROSIS INT, V23, P1, DOI 10.1007/s00198-011-1787-7; Mikkola TM, 2008, J BONE MINER RES, V23, P492, DOI 10.1359/JBMR.071205; OrtegoCenteno N, 1997, CALCIFIED TISSUE INT, V60, P496, DOI 10.1007/s002239900270; Powell S, 2008, J CLIN ENDOCR METAB, V93, P521, DOI 10.1210/jc.2007-1139; Ralston SH, 2007, P NUTR SOC, V66, P158, DOI 10.1017/S002966510700540X; Ramos E, 2007, ACTA PAEDIATR, V96, P281, DOI 10.1111/j.1651-2227.2007.00107.x; Ronis Martin J J, 2011, Curr Osteoporos Rep, V9, P53, DOI 10.1007/s11914-011-0049-0; Taes Y, 2010, J BONE MINER RES, V25, P379, DOI 10.1359/jbmr.090809; Turner RT, 2000, ALCOHOL CLIN EXP RES, V24, P1693, DOI 10.1111/j.1530-0277.2000.tb01971.x; Turner RT, 2001, ALCOHOL RES HEALTH, V25, P276; VALIMAKI MJ, 1994, BMJ-BRIT MED J, V309, P230, DOI 10.1136/bmj.309.6949.230; Waugh EJ, 2009, OSTEOPOROSIS INT, V20, P1, DOI 10.1007/s00198-008-0643-x; Wong PKK, 2007, CLIN SCI, V113, P233, DOI 10.1042/CS20060173; Yan C, CURR OSTEOPOROS REP, V9, P202; Yoon V, 2012, OSTEOPOROSIS INT, V23, P2081, DOI 10.1007/s00198-012-1940-y	40	23	23	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e46940	10.1371/journal.pone.0046940	http://dx.doi.org/10.1371/journal.pone.0046940			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	054ZN	23094033	Green Published, gold, Green Submitted			2022-12-25	WOS:000312384500005
J	Comenge, J; Sotelo, C; Romero, F; Gallego, O; Barnadas, A; Parada, TGC; Dominguez, F; Puntes, VF				Comenge, Joan; Sotelo, Carmen; Romero, Francisco; Gallego, Oscar; Barnadas, Agusti; Garcia-Caballero Parada, Tomas; Dominguez, Fernando; Puntes, Victor F.			Detoxifying Antitumoral Drugs via Nanoconjugation: The Case of Gold Nanoparticles and Cisplatin	PLOS ONE			English	Article							TUMOR VASCULAR-PERMEABILITY; IN-VIVO; CANCER-THERAPY; OXIDE NANOPARTICLES; TARGETED DELIVERY; BIODISTRIBUTION; SIZE; THERAPEUTICS; TOXICITY; SYSTEMS	Nanoparticles (NPs) have emerged as a potential tool to improve cancer treatment. Among the proposed uses in imaging and therapy, their use as a drug delivery scaffold has been extensively highlighted. However, there are still some controversial points which need a deeper understanding before clinical application can occur. Here the use of gold nanoparticles (AuNPs) to detoxify the antitumoral agent cisplatin, linked to a nanoparticle via a pH-sensitive coordination bond for endosomal release, is presented. The NP conjugate design has important effects on pharmacokinetics, conjugate evolution and biodistribution and results in an absence of observed toxicity. Besides, AuNPs present unique opportunities as drug delivery scaffolds due to their size and surface tunability. Here we show that cisplatin-induced toxicity is clearly reduced without affecting the therapeutic benefits in mice models. The NPs not only act as carriers, but also protect the drug from deactivation by plasma proteins until conjugates are internalized in cells and cisplatin is released. Additionally, the possibility to track the drug (Pt) and vehicle (Au) separately as a function of organ and time enables a better understanding of how nanocarriers are processed by the organism.	[Sotelo, Carmen; Dominguez, Fernando] Univ Santiago de Compostela, Dept Physiol, Fac Med, Santiago De Compostela, Spain; [Comenge, Joan; Puntes, Victor F.] Univ Autonoma Barcelona, ICN, E-08193 Barcelona, Spain; [Comenge, Joan] Int Iberian Nanotechnol Lab INL, Braga, Portugal; [Romero, Francisco] Univ Valencia, Inst Mol Sci, Paterna, Spain; [Gallego, Oscar; Barnadas, Agusti] St Pau Hosp, Dept Oncol, Barcelona, Spain; [Garcia-Caballero Parada, Tomas] Univ Santiago de Compostela, Clin Hosp, Sch Med Univ, Dept Morphol Sci, Santiago De Compostela, Spain; [Puntes, Victor F.] ICREA, Barcelona, Spain	Universidade de Santiago de Compostela; Autonomous University of Barcelona; International Iberian Nanotechnology Laboratory; University of Valencia; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; ICREA	Puntes, VF (corresponding author), Univ Santiago de Compostela, Dept Physiol, Fac Med, Santiago De Compostela, Spain.	fernando.dominguez@usc.es; victor.puntes@icn.cat	Puntes, Victor/AAL-6081-2021; Puntes, Víctor F./F-8407-2013; Romero, Francisco M./M-1683-2013	Puntes, Victor/0000-0001-8996-9499; Puntes, Víctor F./0000-0001-8996-9499; Romero, Francisco M./0000-0002-1936-0781; dominguez, fernando/0000-0002-5003-4335	Spanish Government [MAT2009-14734-C02-01, MAT2009-14734-C02-02, CSD2006-00012]; Catalan Government [VALTEC09-2-0085, VALTEC09-2-0089, 2009-SGR-776]; ICREA Funding Source: Custom	Spanish Government(Spanish GovernmentEuropean Commission); Catalan Government; ICREA(ICREA)	The authors acknowledge financial support from the grants "Plan Nacional" (MAT2009-14734-C02-01 and MAT2009-14734-C02-02) and NANOBIOMED-CONSOLIDER (CSD2006-00012) from the Spanish Government. Also grants VALTEC09-2-0085, VALTEC09-2-0089, and 2009-SGR-776 from the Catalan Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelhalim MAK, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-133; Ajima K, 2008, ACS NANO, V2, P2057, DOI 10.1021/nn800395t; Arvizo RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024374; Bajaj G, PHARM RES, V27, P735; Bastus NG, 2008, NANOTOXICOLOGY, V2, P99, DOI 10.1080/17435390802217830; Bastus NG, 2011, LANGMUIR, V27, P11098, DOI 10.1021/la201938u; Bastus NG, 2009, ACS NANO, V3, P1335, DOI 10.1021/nn8008273; Bishop KJM, 2007, CHEMPHYSCHEM, V8, P2171, DOI 10.1002/cphc.200700349; Borm P, 2006, TOXICOL SCI, V90, P23, DOI 10.1093/toxsci/kfj084; Burger KNJ, 2002, NAT MED, V8, P81, DOI 10.1038/nm0102-81; Casals E, 2010, ACS NANO, V4, P3623, DOI 10.1021/nn901372t; Chen JP, 2006, NAT NANOTECHNOL, V1, P142, DOI 10.1038/nnano.2006.91; Chen YS, 2009, NANOSCALE RES LETT, V4, P858, DOI 10.1007/s11671-009-9334-6; Cheng K, 2009, J AM CHEM SOC, V131, P10637, DOI 10.1021/ja903300f; Cheng LH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025433; Chithrani DB, RAD RES, V173, P719; Cho WS, 2009, TOXICOL APPL PHARM, V236, P16, DOI 10.1016/j.taap.2008.12.023; Choi HS, 2007, NAT BIOTECHNOL, V25, P1165, DOI 10.1038/nbt1340; Comenge J, 2010, J CONTROL RELEASE, V148, pE31, DOI 10.1016/j.jconrel.2010.07.041; Craig GE, 2012, INORG CHEM, V51, P3490, DOI 10.1021/ic202197g; Davis ME, 2008, NAT REV DRUG DISCOV, V7, P771, DOI 10.1038/nrd2614; DECONTI RC, 1973, CANCER RES, V33, P1310; Dhar S, 2011, P NATL ACAD SCI USA, V108, P1850, DOI 10.1073/pnas.1011379108; Dhar S, 2009, J AM CHEM SOC, V131, P14652, DOI 10.1021/ja9071282; Dou H, 2006, BLOOD, V108, P2827, DOI 10.1182/blood-2006-03-012534; Dreher MR, 2007, JNCI-J NATL CANCER I, V99, P983, DOI 10.1093/jnci/djm042; Dreher MR, 2006, JNCI-J NATL CANCER I, V98, P335, DOI 10.1093/jnci/djj070; El-Sayed IH, 2005, NANO LETT, V5, P829, DOI 10.1021/nl050074e; El-Sayed IH, 2006, CANCER LETT, V239, P129, DOI 10.1016/j.canlet.2005.07.035; Farokhzad OC, 2006, P NATL ACAD SCI USA, V103, P6315, DOI 10.1073/pnas.0601755103; Farokhzad OC, 2009, ACS NANO, V3, P16, DOI 10.1021/nn900002m; Feazell RP, 2007, J AM CHEM SOC, V129, P8438, DOI 10.1021/ja073231f; Ghosh P, 2008, ADV DRUG DELIVER REV, V60, P1307, DOI 10.1016/j.addr.2008.03.016; Graham MA, 2000, CLIN CANCER RES, V6, P1205; Griset AP, 2009, J AM CHEM SOC, V131, P2469, DOI 10.1021/ja807416t; Gupta AK, 2007, NANOMEDICINE-UK, V2, P23, DOI 10.2217/17435889.2.1.23; Han G, 2007, NANOMEDICINE-UK, V2, P113, DOI 10.2217/17435889.2.1.113; Heckel K, 2004, AM J PHYSIOL-LUNG C, V287, pL867, DOI 10.1152/ajplung.00078.2004; Huang XL, 2008, J MATER SCI-MATER M, V19, P2581, DOI 10.1007/s10856-007-3210-7; Jabr-Milane LS, 2008, CANCER TREAT REV, V34, P592, DOI 10.1016/j.ctrv.2008.04.003; Jain PK, 2007, NANO TODAY, V2, P18, DOI 10.1016/S1748-0132(07)70016-6; Jung YW, 2007, CHEM REV, V107, P1387, DOI 10.1021/cr068207j; Kato T, 2003, CELL TISSUE RES, V311, P47, DOI 10.1007/s00441-002-0647-3; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kelland LR, 2000, PLATINUM BASED DRUGS; Khlebtsov N, 2011, CHEM SOC REV, V40, P1647, DOI 10.1039/c0cs00018c; Kim B, 2010, NAT NANOTECHNOL, V5, P465, DOI [10.1038/nnano.2010.58, 10.1038/NNANO.2010.58]; Lasagna-Reeves C, 2010, BIOCHEM BIOPH RES CO, V393, P649, DOI 10.1016/j.bbrc.2010.02.046; Lipka J, 2010, BIOMATERIALS, V31, P6574, DOI 10.1016/j.biomaterials.2010.05.009; Lu HX, 2007, CANCER CHEMOTH PHARM, V59, P175, DOI 10.1007/s00280-006-0256-z; Lundqvist M, 2008, P NATL ACAD SCI USA, V105, P14265, DOI 10.1073/pnas.0805135105; Lynch I, 2009, NAT NANOTECHNOL, V4, P546, DOI 10.1038/nnano.2009.248; Madaan A, 2012, ONCOLOGY, P1; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Amigo JM, 2011, ANAL CHIM ACTA, V683, P170, DOI 10.1016/j.aca.2010.10.014; McMahon SJ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00018; Mehta D, 2004, AM J PHYSIOL-LUNG C, V287, pL1081, DOI 10.1152/ajplung.00268.2004; Meng H, 2011, ACS NANO, V5, P4131, DOI 10.1021/nn200809t; Michel CC, 1999, PHYSIOL REV, V79, P703, DOI 10.1152/physrev.1999.79.3.703; Mikhail AS, 2009, J CONTROL RELEASE, V138, P214, DOI 10.1016/j.jconrel.2009.04.010; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Minelli C, 2010, SMALL, V6, P2336, DOI 10.1002/smll.201000523; Moghimi SM, 2001, PHARMACOL REV, V53, P283; Moreno D, 2010, EUR J PHARM BIOPHARM, V74, P265, DOI 10.1016/j.ejpb.2009.10.005; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Murphy CJ, 2008, ACCOUNTS CHEM RES, V41, P1721, DOI 10.1021/ar800035u; Nam J, 2009, J AM CHEM SOC, V131, P13639, DOI 10.1021/ja902062j; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Niu JL, 2007, CARDIOVASC RES, V73, P549, DOI 10.1016/j.cardiores.2006.11.031; Ojea-Jimenez I, 2009, J AM CHEM SOC, V131, P13320, DOI 10.1021/ja902894s; Oliver TG, GENES DEV, V24, P837; Owens DE, 2006, INT J PHARMACEUT, V307, P93, DOI 10.1016/j.ijpharm.2005.10.010; Paciotti GF, 2006, DRUG DEVELOP RES, V67, P47, DOI 10.1002/ddr.20066; Peleg-Shulman T, 2002, J INORG BIOCHEM, V91, P306, DOI 10.1016/S0162-0134(02)00362-8; Perrault SD, 2009, NANO LETT, V9, P1909, DOI 10.1021/nl900031y; Pujals S, 2009, CHEMBIOCHEM, V10, P1025, DOI 10.1002/cbic.200800843; Reedijk J, 2003, P NATL ACAD SCI USA, V100, P3611, DOI 10.1073/pnas.0737293100; Rehemtulla A, 2000, NEOPLASIA, V2, P491, DOI 10.1038/sj.neo.7900121; Ren L, 2003, MAT SCI ENG C-BIO S, V23, P113, DOI 10.1016/S0928-4931(02)00247-3; Ren L, 2008, J BIOMED MATER RES A, V85A, P787, DOI 10.1002/jbm.a.31608; ROSENBERG B, 1969, NATURE, V222, P385, DOI 10.1038/222385a0; Ruenraroengsak P, J CONTROLLED RELEASE, V141, P265; Ruenraroengsak P, 2010, J CONTROL RELEASE, V141, P265, DOI 10.1016/j.jconrel.2009.10.032; Simpson CA, 2010, CHEM RES TOXICOL, V23, P1608, DOI 10.1021/tx100209t; Sinha R, 2006, MOL CANCER THER, V5, P1909, DOI 10.1158/1535-7163.MCT-06-0141; Sonavane G, 2008, COLLOID SURFACE B, V66, P274, DOI 10.1016/j.colsurfb.2008.07.004; Sperling RA, 2009, CURR DRUG METAB, V10, P895, DOI 10.2174/138920009790274577; Takakura Y, 1996, PHARMACEUT RES, V13, P820, DOI 10.1023/A:1016084508097; Thakor AS, 2011, NANO LETT, V11, P4029, DOI 10.1021/nl202559p; Tseng CL, 2009, BIOMATERIALS, V30, P3476, DOI 10.1016/j.biomaterials.2009.03.010; Varmus H, 2006, SCIENCE, V312, P1162, DOI 10.1126/science.1126758; Vasir JK, 2005, CURR NANOSCI, V1, P47, DOI 10.2174/1573413052953110; Vickers AEM, 2004, TOXICOL PATHOL, V32, P577, DOI 10.1080/01926230490508821; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Zhang GD, 2009, BIOMATERIALS, V30, P1928, DOI 10.1016/j.biomaterials.2008.12.038; Zhang XD, 2011, INT J NANOMED, V6, P2071, DOI 10.2147/IJN.S21657; Zhang XD, 2010, INT J NANOMED, V5, P771, DOI 10.2147/IJN.S8428	98	68	70	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47562	10.1371/journal.pone.0047562	http://dx.doi.org/10.1371/journal.pone.0047562			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082177	Green Published, gold, Green Submitted			2022-12-25	WOS:000311146900073
J	Dozieres, A; Chapuis, JL; Thibault, S; Baudry, E				Dozieres, Anne; Chapuis, Jean-Louis; Thibault, Sophie; Baudry, Emmanuelle			Genetic Structure of the French Red Squirrel Populations: Implication for Conservation	PLOS ONE			English	Article							SCIURUS-VULGARIS L.; HABITAT FRAGMENTATION; PHYLOGEOGRAPHY; DISTANCE; GROWTH; RATES; UNITS	The decline of the red squirrel (Sciurus vulgaris) in several European countries due to the introduction of the American grey squirrel (S. carolinensis) and the predicted arrival of the grey squirrel in France in the near future has lead to the development of a preventative conservation project in this country. In this study, we conducted an extensive survey of mitochondrial DNA variation in French red squirrels using a fragment of the mitochondrial D-loop and we compared the results with previously published data from other European populations. Our main aims were: (1) to determine whether genetically differentiated populations, which could represent prioritized units for conservation purposes, were present in France and (2) to determine whether the French population, which is currently largely undisturbed, could provide information on the postglacial recolonization history of the species. We found that French D-loop haplotypes show almost no tendency to cluster by geographic origin, be it region or country, suggesting that French red squirrels have not been isolated from other populations during an evolutionarily significant period and that they do not constitute an Evolutionary Significant Unit. The French red squirrels showed strong signals of population expansion, the opposite to what is observed in most other European populations, making them of particular interest to study the postglacial expansion history of the species.	[Dozieres, Anne; Chapuis, Jean-Louis] Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite, UMR Conservat Especes Restaurat & Suivi Populat 7, MNHN CNRS P6, F-75231 Paris, France; [Thibault, Sophie; Baudry, Emmanuelle] Univ Paris 11, Lab Ecol Syst & Evolut, CNRS UMR 8079, Orsay, France	Museum National d'Histoire Naturelle (MNHN); AgroParisTech; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Paris Saclay	Dozieres, A (corresponding author), Museum Natl Hist Nat, Dept Ecol & Gest Biodiversite, UMR Conservat Especes Restaurat & Suivi Populat 7, MNHN CNRS P6, F-75231 Paris, France.	dozieres@mnhn.fr	Baudry, Emmanuelle/G-4005-2010		Office National des Forets (ONF); French Ministere de l'Environment	Office National des Forets (ONF); French Ministere de l'Environment	This work was funded by the Office National des Forets (ONF) and the French Ministere de l'Environment. Several members of the ONF, in particular Franck Basset and Sebastien Laguet, helped to collect samples (see Acknowledgments). The French Ministere had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barratt EM, 1999, MOL ECOL, V8, pS55, DOI 10.1046/j.1365-294X.1999.00771.x; Bertolino S, 2008, CURR SCI INDIA, V95, P903; Bray SCE, 2013, DIVERS DISTRIB, V19, P245, DOI 10.1111/j.1472-4642.2012.00923.x; Charlesworth B, 2003, ANNU REV ECOL EVOL S, V34, P99, DOI 10.1146/annurev.ecolsys.34.011802.132359; Corbet G.B, 1978, MAMMALS PALAEARCTIC; Delin AE, 1999, LANDSCAPE ECOL, V14, P67, DOI 10.1023/A:1008040001801; Emerson BC, 2001, TRENDS ECOL EVOL, V16, P707, DOI 10.1016/S0169-5347(01)02305-9; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Finnegan LA, 2008, CONSERV GENET, V9, P1099, DOI 10.1007/s10592-007-9419-7; Fu YX, 1997, GENETICS, V147, P915; Grill A, 2009, MOL ECOL, V18, P2687, DOI 10.1111/j.1365-294X.2009.04215.x; GURNELL J, 1993, MAMMAL REV, V23, P127, DOI 10.1111/j.1365-2907.1993.tb00424.x; Gurnell J, 1987, NATURAL HIST SQUIRRE; Hale ML, 2001, SCIENCE, V293, P2246, DOI 10.1126/science.1062574; Hale ML, 2004, CONSERV GENET, V5, P167, DOI 10.1023/B:COGE.0000030001.86288.12; Hancock J.M., 1997, MICROSATELLITES EVOL, P1; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; IFN, 2010, INV FOR NAT FOR FRAN; Kuhner MK, 1998, GENETICS, V149, P429; Li WH, 1996, MOL PHYLOGENET EVOL, V5, P182, DOI 10.1006/mpev.1996.0012; Lurz Peter W. W., 2005, Mammalian Species, P1; Lurz PWW, 2001, LANDSCAPE ECOL, V16, P407, DOI 10.1023/A:1017508711713; Martinoli A, 2010, HYSTRIX, V21, P127, DOI 10.4404/Hystrix-21.2-4463; Mather AS, 1999, J RURAL STUD, V15, P65, DOI 10.1016/S0743-0167(98)00023-0; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Ogden R, 2005, CONSERV GENET, V6, P511, DOI 10.1007/s10592-005-9006-8; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Shar S, 2008, IUCN 2011 IUCN RED L; Shuttleworth Craig M., 2003, Urban Ecosystems, V5, P109, DOI 10.1023/A:1022387620713; SIDOROWICZ J, 1971, Zoologischer Anzeiger, V187, P123; SLATKIN M, 1991, GENETICS, V129, P555; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TEMPLETON AR, 2006, POPULATION GENETICS; Trizio I, 2005, MOL ECOL, V14, P469, DOI 10.1111/j.1365-294X.2005.02428.x; Wauters L.A., 1997, CONSERVATION RED SQU, P79; WAUTERS LA, 1994, P ROY SOC B-BIOL SCI, V255, P107, DOI 10.1098/rspb.1994.0015; Wauters LA, 1999, ETHOLOGY, V105, P1053, DOI 10.1046/j.1439-0310.1999.10512488.x; Wauters LA, 2004, MAMMALIA, V68, P37, DOI 10.1515/mamm.2004.005; Wauters LA, 2011, MAMM BIOL, V76, P369, DOI 10.1016/j.mambio.2010.04.003; Wauters LA, 2010, POPUL ECOL, V52, P527, DOI 10.1007/s10144-010-0203-z	45	14	16	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47607	10.1371/journal.pone.0047607	http://dx.doi.org/10.1371/journal.pone.0047607			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082180	Green Published, Green Submitted, gold			2022-12-25	WOS:000311146900076
J	Song, JT; Hu, B; Qu, HY; Bi, CL; Huang, XZ; Zhang, M				Song, Jian Tao; Hu, Bo; Qu, Hai Yan; Bi, Cheng Long; Huang, Xiao Zhen; Zhang, Mei			Mechanical Stretch Modulates MicroRNA 21 Expression, Participating in Proliferation and Apoptosis in Cultured Human Aortic Smooth Muscle Cells	PLOS ONE			English	Article							TGF-BETA; FLOW; BIOMARKERS; TARGETS; MIR-21	Objectives: Stretch affects vascular smooth muscle cell proliferation and apoptosis, and several responsible genes have been proposed. We tested whether the expression of microRNA 21 (miR-21) is modulated by stretch and is involved in stretch-induced proliferation and apoptosis of human aortic smooth muscle cells (HASMCs). Methods and Results: RT-PCR revealed that elevated stretch (16% elongation, 1 Hz) increased miR-21 expression in cultured HASMCs, and moderate stretch (10% elongation, 1 Hz) decreased the expression. BrdU incorporation assay and cell counting showed miR-21 involved in the proliferation of HASMCs mediated by stretch, likely by regulating the expression of p27 and phosphorylated retinoblastoma protein (p-Rb). FACS analysis revealed that the complex of miR-21 and programmed cell death protein 4 (PDCD4) participated in regulating apoptosis with stretch. Stretch increased the expression of primary miR-21 and pre-miR-21 in HASMCs. Electrophoretic mobility shift assay (EMSA) demonstrated that stretch increased NF-kB and AP-1 activities in HASMCs, and blockade of AP-1 activity by c-jun siRNA significantly suppressed stretch-induced miR-21 expression. Conclusions: Cyclic stretch modulates miR-21 expression in cultured HASMCs, and miR-21 plays important roles in regulating proliferation and apoptosis mediated by stretch. Stretch upregulates miR-21 expression at least in part at the transcription level and AP-1 is essential for stretch-induced miR-21 expression.	[Song, Jian Tao; Hu, Bo; Qu, Hai Yan; Bi, Cheng Long; Huang, Xiao Zhen; Zhang, Mei] Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Song, Jian Tao; Hu, Bo; Qu, Hai Yan; Bi, Cheng Long; Huang, Xiao Zhen; Zhang, Mei] Shandong Univ, Chinese Minist Hlth, Dept Cardiol, Qilu Hosp, Jinan 250100, Shandong, Peoples R China; [Hu, Bo] Shandong Univ, Dept Emergency, Shandong Prov Hosp, Jinan 250100, Shandong, Peoples R China; [Qu, Hai Yan] Shandong Prov Chest Hosp, Dept Cardiol, Jinan, Peoples R China	Shandong University; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University	Zhang, M (corresponding author), Shandong Univ, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.	daixh@vip.sina.com			National Basic Research Program of China (973 Program) [2010CB732605, 2011CB503906]; National Nature Science Foundation of China [30728025, 30970709]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program, 2010CB732605, 2011CB503906) and the National Nature Science Foundation of China (30728025, 30970709). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boettger T, 2012, CIRC RES, V110, P1000, DOI 10.1161/CIRCRESAHA.111.247742; Chapman GB, 2000, AM J PHYSIOL-HEART C, V278, pH748, DOI 10.1152/ajpheart.2000.278.3.H748; Cheng JZ, 2007, J BIOL CHEM, V282, P34268, DOI 10.1074/jbc.M703115200; Cheng WP, 2008, CARDIOVASC RES, V77, P551, DOI 10.1093/cvr/cvm057; Cheng WP, 2012, CARDIOVASC RES, V93, P181, DOI 10.1093/cvr/cvr280; Cheng YH, 2010, J CARDIOVASC TRANSL, V3, P251, DOI 10.1007/s12265-010-9169-7; Cheng YH, 2009, J MOL CELL CARDIOL, V47, P5, DOI 10.1016/j.yjmcc.2009.01.008; Corsini LR, 2012, EXPERT OPIN THER TAR, V16, pS103, DOI 10.1517/14728222.2011.650632; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; D'Alessandra Y, 2012, CURR OPIN CARDIOL, V27, P228, DOI 10.1097/HCO.0b013e3283522052; Dong SM, 2009, J BIOL CHEM, V284, P29514, DOI 10.1074/jbc.M109.027896; Frankel LB, 2008, J BIOL CHEM, V283, P1026, DOI 10.1074/jbc.M707224200; Haga JH, 2007, J BIOMECH, V40, P947, DOI 10.1016/j.jbiomech.2006.04.011; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Joki N, 2000, HYPERTENS RES, V23, P91, DOI 10.1291/hypres.23.91; Kim YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028308; Kohanbash G, 2012, SEMIN CANCER BIOL, V22, P70, DOI 10.1016/j.semcancer.2011.12.010; Li CH, 2003, FASEB J, V17, P2106, DOI 10.1096/fj.03-0150fje; Liu G, 2010, HYPERTENS RES, V33, P1250, DOI 10.1038/hr.2010.187; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Mohamed JS, 2010, J BIOL CHEM, V285, P29336, DOI 10.1074/jbc.M110.101147; Pan XA, 2010, CANCER BIOL THER, V10, P1224, DOI 10.4161/cbt.10.12.14252; Papageorgiou N, 2012, CURR MED CHEM, V19, P2605, DOI 10.2174/092986712800493048; Qin XM, 2010, P NATL ACAD SCI USA, V107, P3240, DOI 10.1073/pnas.0914882107; Sacco J, 2012, CURR OPIN LIPIDOL, V23, P220, DOI 10.1097/MOL.0b013e3283534c9f; Sedding DG, 2003, CIRCULATION, V108, P616, DOI 10.1161/01.CIR.0000079102.08464.E2; Su BY, 2006, J VASC RES, V43, P229, DOI 10.1159/000091102; Wang KC, 2010, P NATL ACAD SCI USA, V107, P3234, DOI 10.1073/pnas.0914825107; Wang T, 2012, INT J BIOCHEM CELL B, V44, P366, DOI 10.1016/j.biocel.2011.11.012; Weber M, 2010, BIOCHEM BIOPH RES CO, V393, P643, DOI 10.1016/j.bbrc.2010.02.045; Wu XQ, 2010, ARTERIOSCL THROM VAS, V30, P471, DOI 10.1161/ATVBAHA.109.184259; Yehya N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-154; Zhou J, 2011, P NATL ACAD SCI USA, V108, P10355, DOI 10.1073/pnas.1107052108; Zhou R, 2010, NUCLEIC ACIDS RES, V38, P3222, DOI 10.1093/nar/gkq056	35	48	52	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47657	10.1371/journal.pone.0047657	http://dx.doi.org/10.1371/journal.pone.0047657			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082189	Green Published, gold, Green Submitted			2022-12-25	WOS:000311146900086
J	Brull, F; Mensink, RP; Steinbusch, MF; Husche, C; Lutjohann, D; Wesseling, GJ; Plat, J				Brull, Florence; Mensink, Ronald P.; Steinbusch, Mandy F.; Husche, Constanze; Luetjohann, Dieter; Wesseling, Geert-Jan; Plat, Jogchum			Beneficial Effects of Sitostanol on the Attenuated Immune Function in Asthma Patients: Results of an In Vitro Approach	PLOS ONE			English	Article							REGULATORY T-CELLS; ALLERGIC AIRWAY INFLAMMATION; NATURAL-KILLER-CELLS; NKT CELLS; PLANT STEROLS; PERIPHERAL-BLOOD; TLR2 AGONIST; MURINE MODEL; SIMVASTATIN; STANOLS	Background: In vitro and animal studies have suggested that plant sterols and stanols increase cytokine production by T-helper-1 cells. This may be beneficial for patient groups characterized by a T-helper-2 dominant immune response, e. g. asthma patients. (1) to evaluate whether sitostanol induces a T-helper-1 shift in peripheral blood mononuclear cells (PBMCs) from asthma patients, and (2) to unravel the role of regulatory T-cells in this respect. Methodology/Principal Findings: PBMCs from 10 asthma patients and 10 healthy subjects were isolated and incubated with 1.2 mu M sitostanol, while stimulated with 5 mu g/ml PHA. Similar amounts of cholesterol were used to determine whether effects were specific for plant stanols or for sterols in general. Changes in cytokine production were measured using antibody arrays and ELISAs. Changes in regulatory T-cell population size were measured by flow cytometry, using intracellular Foxp3 staining. Sitostanol increased production of IFN gamma by 6.5% and IL-2 by 6.0% compared to cholesterol (p < 0.01). No changes in IL-4 and IL-13 were found. Interestingly, this effect was only present in PBMCs from asthma patients. The number of Foxp3+ cells tended to increase and their activity, measured by IL-10 production, increased after sitostanol treatment in PBMCs from asthma patients compared to controls by 32.3% (p = 0.077) and 13.3% (p < 0.05), respectively. Conclusions/Significance: Altogether, the sitostanol-induced Thelper-1 shift in PBMCs from asthma patients and the stimulating effects of sitostanol on Treg cell numbers and activity indicate a possible novel approach for plant stanol ester enriched functional foods in the amelioration of asthmatic symptoms. Functional effects, however, require further evaluation.	[Brull, Florence; Mensink, Ronald P.; Steinbusch, Mandy F.; Plat, Jogchum] Maastricht Univ, Med Ctr, Sch Nutr Toxicol & Metab, Dept Human Biol, Maastricht, Netherlands; [Husche, Constanze; Luetjohann, Dieter] Univ Bonn, Inst Clin Chem & Clin Pharmacol, Bonn, Germany; [Wesseling, Geert-Jan] Maastricht Univ, Med Ctr, Dept Resp Med, Maastricht, Netherlands	Maastricht University; University of Bonn; Maastricht University	Plat, J (corresponding author), Maastricht Univ, Med Ctr, Sch Nutr Toxicol & Metab, Dept Human Biol, Maastricht, Netherlands.	J.Plat@HB.unimaas.nl			Raisio Nutrition Ltd, Finland; Raisio Nutrition Ltd	Raisio Nutrition Ltd, Finland; Raisio Nutrition Ltd	Performing the study was financially supported by Raisio Nutrition Ltd, Finland. The firm had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors did receive financial support from Raisio Nutrition Ltd, but this does not alter their adherence to all the PLOS ONE policies on sharing data and materials.	Akbari O, 2003, CURR OPIN IMMUNOL, V15, P627, DOI 10.1016/j.coi.2003.09.012; Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Alter G, 2004, J IMMUNOL METHODS, V294, P15, DOI 10.1016/j.jim.2004.08.008; Annunziato F, 2007, J EXP MED, V204, P1849, DOI 10.1084/jem.20070663; Aumeunier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011484; Blease K, 2001, J IMMUNOL, V166, P5219, DOI 10.4049/jimmunol.166.8.5219; Bouic P J, 1999, Altern Med Rev, V4, P170; Breytenbach U, 2001, CELL BIOL INT, V25, P43, DOI 10.1006/cbir.2000.0676; Brull F, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.M109.036343; Brull F, 2009, CLIN LIPIDOL, V4, P355, DOI 10.2217/CLP.09.26; Calpe-Berdiel L, 2007, LIFE SCI, V80, P1951, DOI 10.1016/j.lfs.2007.02.032; Cosmi L, 2011, ALLERGY, V66, P989, DOI 10.1111/j.1398-9995.2011.02576.x; Cowan DC, 2010, THORAX, V65, P891, DOI 10.1136/thx.2010.138990; Desai F, 2009, INT IMMUNOPHARMACOL, V9, P153, DOI 10.1016/j.intimp.2008.10.019; Eigenmann PA, 2008, CLIN EXP IMMUNOL, V151, P546, DOI 10.1111/j.1365-2249.2007.03582.x; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Frossard CP, 2007, J ALLERGY CLIN IMMUN, V119, P952, DOI 10.1016/j.jaci.2006.12.615; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; Hamzaoui A, 2006, MEDIAT INFLAMM, V2006, DOI 10.1155/MI/2006/71214; Hsu CY, 2010, GENE THER, V17, P1011, DOI 10.1038/gt.2010.39; Iwamura C, 2010, CURR OPIN IMMUNOL, V22, P807, DOI 10.1016/j.coi.2010.10.008; Katan MB, 2003, MAYO CLIN PROC, V78, P965, DOI 10.4065/78.8.965; Kim KW, 2011, LUNG, V189, P417, DOI 10.1007/s00408-011-9312-5; Kolls JK, 2004, IMMUNITY, V21, P467, DOI 10.1016/j.immuni.2004.08.018; Lee JH, 2007, CLIN EXP IMMUNOL, V148, P53, DOI 10.1111/j.1365-2249.2007.03329.x; Leech MD, 2007, J IMMUNOL, V179, P7050, DOI 10.4049/jimmunol.179.10.7050; Mahajan SG, 2011, EUR J PHARMACOL, V650, P458, DOI 10.1016/j.ejphar.2010.09.075; Mamessier E, 2008, ALLERGY, V63, P1202, DOI 10.1111/j.1398-9995.2008.01687.x; McKay A, 2004, J IMMUNOL, V172, P2903, DOI 10.4049/jimmunol.172.5.2903; Menzies D, 2007, J ALLERGY CLIN IMMUN, V119, P328, DOI 10.1016/j.jaci.2006.10.014; Meyer EH, 2008, ANNU REV MED, V59, P281, DOI 10.1146/annurev.med.59.061506.154139; O'Garra A, 2003, NAT IMMUNOL, V4, P304, DOI 10.1038/ni0403-304; Ostroukhova M, 2009, ANN ALLERG ASTHMA IM, V103, P463, DOI 10.1016/S1081-1206(10)60261-X; Page K, 2009, J IMMUNOL, V183, P3400, DOI 10.4049/jimmunol.0900838; Paiva H, 2005, CLIN PHARMACOL THER, V78, P60, DOI 10.1016/j.clpt.2005.03.006; Patel M, 2005, J IMMUNOL, V174, P7558, DOI 10.4049/jimmunol.174.12.7558; Pham-Thi N, 2006, J ALLERGY CLIN IMMUN, V117, P217, DOI 10.1016/j.jaci.2005.09.052; Plat J, 2001, NUTR METAB CARDIOVAS, V11, P31; Ple C, 2010, SCAND J IMMUNOL, V72, P118, DOI 10.1111/j.1365-3083.2010.02419.x; Ray A, 2010, MUCOSAL IMMUNOL, V3, P216, DOI 10.1038/mi.2010.4; Rosenkranz SK, 2010, EUR J APPL PHYSIOL, V109, P499, DOI 10.1007/s00421-010-1390-1; Scordamaglia F, 2008, J ALLERGY CLIN IMMUN, V121, P479, DOI 10.1016/j.jaci.2007.09.047; Smart JM, 2002, J ALLERGY CLIN IMMUN, V110, P450, DOI 10.1067/mai.2002.127283; Sutmuller RPM, 2006, TRENDS IMMUNOL, V27, P387, DOI 10.1016/j.it.2006.06.005; Sutmuller RPM, 2006, J CLIN INVEST, V116, P485, DOI 10.1172/JCI25439; Umetsu DT, 2010, J ALLERGY CLIN IMMUN, V125, P975, DOI 10.1016/j.jaci.2010.02.006; Valerio M, 2011, INFLAMM RES, V60, P457, DOI 10.1007/s00011-010-0288-z; Wang YH, 2011, CURR ALLERGY ASTHMA; Wei HM, 2005, J ALLERGY CLIN IMMUN, V115, P841, DOI 10.1016/j.jaci.2004.11.026; Wei W, 2010, INT ARCH ALLERGY IMM, V153, P19, DOI 10.1159/000301575; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Xu YQ, 2010, J ASTHMA, V47, P367, DOI 10.3109/02770903.2010.481340; Xue KY, 2007, J HUAZHONG U SCI-MED, V27, P31, DOI 10.1007/s11596-007-0109-y; Xystrakis E, 2006, EXPERT OPIN BIOL TH, V6, P121, DOI 10.1517/14712598.6.2.121; Xystrakis E, 2006, J CLIN INVEST, V116, P146, DOI 10.1172/JCI21759; Zhou G, 2010, VACCINE, V28, P1838, DOI 10.1016/j.vaccine.2009.11.081	56	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e46895	10.1371/journal.pone.0046895	http://dx.doi.org/10.1371/journal.pone.0046895			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091602	gold, Green Published, Green Submitted			2022-12-25	WOS:000310135800015
J	Gkantidis, N; Blumer, S; Katsaros, C; Graf, D; Chiquet, M				Gkantidis, Nikolaos; Blumer, Susan; Katsaros, Christos; Graf, Daniel; Chiquet, Matthias			Site-Specific Expression of Gelatinolytic Activity during Morphogenesis of the Secondary Palate in the Mouse Embryo	PLOS ONE			English	Article							MATRIX METALLOPROTEINASES; CLEFT-PALATE; SUBSTRATE-SPECIFICITY; MOLECULAR-MECHANISMS; SKELETAL-MUSCLE; PALATOGENESIS; SHELF; INHIBITORS; BINDING; GROWTH	Morphogenesis of the secondary palate in mammalian embryos involves two major events: first, reorientation of the two vertically oriented palatal shelves into a horizontal position above the tongue, and second, fusion of the two shelves at the midline. Genetic evidence in humans and mice indicates the involvement of matrix metalloproteinases (MMPs). As MMP expression patterns might differ from sites of activity, we used a recently developed highly sensitive in situ zymography technique to map gelatinolytic MMP activity in the developing mouse palate. At embryonic day 14.5 (E14.5), we detected strong gelatinolytic activity around the lateral epithelial folds of the nasopharyngeal cavity, which is generated as a consequence of palatal shelf elevation. Activity was concentrated in the basement membrane of the epithelial fold but extended into the adjacent mesenchyme, and increased in intensity with lateral outgrowth of the cavity at E15.5. Gelatinolytic activity at this site was not the consequence of epithelial fold formation, as it was also observed in Bmp7-deficient embryos where shelf elevation is delayed. In this case, gelatinolytic activity appeared in vertical shelves at the exact position where the epithelial fold will form during elevation. Mmp2 and Mmp14 (MT1-MMP), but not Mmp9 and Mmp13, mRNAs were expressed in the mesenchyme around the epithelial folds of the elevated palatal shelves; this was confirmed by immunostaining for MMP-2 and MT1-MMP. Weak gelatinolytic activity was also found at the midline of E14.5 palatal shelves, which increased during fusion at E15.5. Whereas MMPs have been implicated in palatal fusion before, this is the first report showing that gelatinases might contribute to tissue remodeling during early stages of palatal shelf elevation and formation of the nasopharynx.	[Gkantidis, Nikolaos; Blumer, Susan; Katsaros, Christos; Chiquet, Matthias] Univ Bern, Sch Dent Med, Dept Orthodont & Dentofacial Orthoped, Bern, Switzerland; [Graf, Daniel] Univ Zurich, Inst Oral Biol, Ctr Dent Med, Zurich, Switzerland	University of Bern; University of Zurich	Chiquet, M (corresponding author), Univ Bern, Sch Dent Med, Dept Orthodont & Dentofacial Orthoped, Bern, Switzerland.	matthias.chiquet@zmk.unibe.ch	Gkantidis, Nikolaos/ABC-4727-2020	Gkantidis, Nikolaos/0000-0002-3180-6272; Chiquet, Matthias/0000-0001-7812-4853; Graf, Daniel/0000-0003-1163-8117; Katsaros, Christos/0000-0001-5545-6740	Swiss National Science Foundation [31003A-135530]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was funded in part by grant 31003A-135530 from the Swiss National Science Foundation (http://www.snf.ch/E/Pages/default.aspx). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Baker AH, 2002, J CELL SCI, V115, P3719, DOI 10.1242/jcs.00063; Blavier L, 2001, MOL BIOL CELL, V12, P1457, DOI 10.1091/mbc.12.5.1457; Briknarova K, 2001, J BIOL CHEM, V276, P27613, DOI 10.1074/jbc.M101105200; BRINKLEY LL, 1987, DEVELOPMENT, V100, P629; Brown GD, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-93; Bush JO, 2012, DEVELOPMENT, V139, P231, DOI 10.1242/dev.067082; Chin JR, 1997, DEVELOPMENT, V124, P1519; Chou MJ, 2004, ANAT EMBRYOL, V208, P19, DOI 10.1007/s00429-004-0379-0; Cowell S, 1998, BIOCHEM J, V331, P453, DOI 10.1042/bj3310453; Evans Richard D., 2007, V135, P239; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; Fluck M, 2000, J CELL SCI, V113, P3583; Frederiks WM, 2004, J HISTOCHEM CYTOCHEM, V52, P711, DOI 10.1369/jhc.4R6251.2004; Gkantidis N, 2012, HISTOCHEM CELL BIOL, V138, P557, DOI 10.1007/s00418-012-0982-8; Gritli-Linde A, 2007, DEV BIOL, V301, P309, DOI 10.1016/j.ydbio.2006.07.042; Gritli-Linde A, 2008, CURR TOP DEV BIOL, V84, P37, DOI 10.1016/S0070-2153(08)00602-9; Hornebeck W, 2002, SEMIN CANCER BIOL, V12, P231, DOI 10.1016/S1044-579X(02)00026-3; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Iseki S, 2007, BIRTH DEFECTS RES A, V79, P688, DOI 10.1002/bdra.20400; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Jin JZ, 2010, DEV DYNAM, V239, P2110, DOI 10.1002/dvdy.22339; Jugessur A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039240; Jugessur A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005385; KAARTINEN V, 1995, NAT GENET, V11, P415, DOI 10.1038/ng1295-415; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; KOCH M, 1995, J CELL BIOL, V130, P1005, DOI 10.1083/jcb.130.4.1005; Kouskoura Thaleia, 2011, Schweiz Monatsschr Zahnmed, V121, P636; Meng L, 2009, J DENT RES, V88, P22, DOI 10.1177/0022034508327868; Miettinen PJ, 1999, NAT GENET, V22, P69, DOI 10.1038/8773; Mitchell J C, 2000, J Pediatr Health Care, V14, P13, DOI 10.1016/S0891-5245(00)70039-3; Mitchell LE, 2009, COMPREHENSIVE CLEFT; Moretti RM, 2011, INT J ONCOL, V39, P225, DOI 10.3892/ijo.2011.1030; Morris-Wiman J, 1999, J CRAN GENET DEV BIO, V19, P201; MORRISWIMAN J, 1992, ANAT RECORD, V234, P575, DOI 10.1002/ar.1092340413; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; PAULSSON M, 1987, EUR J BIOCHEM, V166, P11, DOI 10.1111/j.1432-1033.1987.tb13476.x; PROETZEL G, 1995, NAT GENET, V11, P409, DOI 10.1038/ng1295-409; Robbins JR, 1999, DEV BIOL, V212, P255, DOI 10.1006/dbio.1999.9373; Ruta A, 2009, EXP LUNG RES, V35, P59, DOI 10.1080/01902140802406059; Shi J, 2008, DEV BIOL, V313, P196, DOI 10.1016/j.ydbio.2007.10.017; Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01; Snyder-Warwick AK, 2010, P NATL ACAD SCI USA, V107, P2515, DOI 10.1073/pnas.0913985107; Stanier P, 2004, HUM MOL GENET, V13, pR73, DOI 10.1093/hmg/ddh052; Wozniak MA, 2009, NAT REV MOL CELL BIO, V10, P34, DOI 10.1038/nrm2592; Yu K, 2011, DEV DYNAM, V240, P1737, DOI 10.1002/dvdy.22670; Zheng GP, 2009, AM J PATHOL, V175, P580, DOI 10.2353/ajpath.2009.080983; Zouvelou V, 2009, INT J DEV BIOL, V53, P597, DOI 10.1387/ijdb.082648vz; Zouvelou V, 2009, J EXP ZOOL PART B, V312B, P361, DOI 10.1002/jez.b.21262	52	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47762	10.1371/journal.pone.0047762	http://dx.doi.org/10.1371/journal.pone.0047762			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091646	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000310135800072
J	Sels, JWEM; Elsenberg, EHAM; Hoefer, IE; van Zonneveld, AJ; Kuiper, J; Jukema, JW; Pijls, NHJ; Pasterkamp, G				Sels, Jan-Willem E. M.; Elsenberg, Ellen H. A. M.; Hoefer, Imo E.; van Zonneveld, Anton Jan; Kuiper, Johan; Jukema, J. Wouter; Pijls, Nico H. J.; Pasterkamp, Gerard			Fractional Flow Reserve Is Not Associated with Inflammatory Markers in Patients with Stable Coronary Artery Disease	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; C-REACTIVE PROTEIN; INCREMENTAL PROGNOSTIC VALUE; MYOCARDIAL-INFARCTION; ANTIPLATELET THERAPY; FUNCTIONAL SEVERITY; MONONUCLEAR-CELLS; UNSTABLE ANGINA; UP-REGULATION; INTERVENTION	Background: Atherosclerosis is an inflammatory condition and increased blood levels of inflammatory biomarkers have been observed in acute coronary syndromes. In addition, high expression of inflammatory markers is associated with worse prognosis of coronary artery disease. The presence and extent of inducible ischemia in patients with stable angina has previously been shown to have strong prognostic value. We hypothesized that evidence of inducible myocardial ischemia by local lesions, as measured by fractional flow reserve (FFR), is associated with increased levels of blood based inflammatory biomarkers. Methods: Whole blood samples of 89 patients with stable angina pectoris and 16 healthy controls were analyzed. The patients with stable angina pectoris underwent coronary angiography and FFR of all coronary lesions. We analyzed plasma levels of cytokines IL-6, IL-8 and TNF-alpha and membrane expression of Toll-like receptor 2 and 4, CD11b, CD62L and CD14 on monocytes and granulocytes as markers of inflammation. Furthermore, we quantified the severity of hemodynamically significant coronary artery disease by calculating Functional Syntax Score (FSS), an extension of the Syntax Score. Results: For the majority of biomarkers, we observed lower levels in the healthy control group compared with patients with stable angina who underwent coronary catheterization. We found no difference for any of the selected biomarkers between patients with a positive FFR (<= 0.75) and negative FFR (>0.80). We observed no relationship between the investigated biomarkers and FSS. Conclusion: The presence of local atherosclerotic lesions that result in inducible myocardial ischemia as measured by FFR in patients with stable coronary artery disease is not associated with increased plasma levels of IL-6, IL-8 and TNF-a or increased expression of TLR2 and TLR4, CD11b, CD62L and CD14 on circulating leukocytes.	[Sels, Jan-Willem E. M.; Pijls, Nico H. J.] Catharina Hosp, Dept Cardiol, Eindhoven, Netherlands; [Elsenberg, Ellen H. A. M.; Hoefer, Imo E.; Pasterkamp, Gerard] Univ Med Ctr Utrecht, Lab Expt Cardiol, Utrecht, Netherlands; [Sels, Jan-Willem E. M.; Pijls, Nico H. J.] Eindhoven Univ Technol, Dept Biomed Engn, NL-5600 MB Eindhoven, Netherlands; [van Zonneveld, Anton Jan] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Kuiper, Johan] Leiden Univ, Div Biopharmaceut, Leiden, Netherlands; [Jukema, J. Wouter] Leiden Univ, Med Ctr, Dept Cardiol, Leiden, Netherlands	Catharina Hospital; Utrecht University; Utrecht University Medical Center; Eindhoven University of Technology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Sels, JWEM (corresponding author), Catharina Hosp, Dept Cardiol, Eindhoven, Netherlands.	jan-willem.sels@cze.nl	Jukema, J. Wouter/ABD-6503-2021; van Zonneveld, Anton Jan/D-8060-2018	Jukema, J. Wouter/0000-0002-3246-8359; van Zonneveld, Anton Jan/0000-0002-1676-7738	project CIRCULATING CELLS [01C-102]; Dutch Heart Foundation; St Jude Medical Inc.; Stichting Vrienden van het Hart Zuid-Oost Brabant, The Netherlands; Astellas; Astra-Zeneca; Bayer; Biotronik; Boston Scientific; Daiichi Sankyo; Lilly; Genzyme; Medtronic; Merck-Schering-Plough; Pfizer; Orbus Neich; Novartis; Roche; Servier; Sanofi Aventis; Netherlands Heart Foundation; Interuniversity Cardiology Institute of the Netherlands; European Community; St Jude Medical; Abbott; Maquet	project CIRCULATING CELLS; Dutch Heart Foundation(Netherlands Heart Foundation); St Jude Medical Inc.(St. Jude Medical); Stichting Vrienden van het Hart Zuid-Oost Brabant, The Netherlands(Netherlands Government); Astellas(Astellas Pharmaceuticals); Astra-Zeneca(AstraZeneca); Bayer(Bayer AG); Biotronik; Boston Scientific(Boston Scientific); Daiichi Sankyo(Daiichi Sankyo Company Limited); Lilly(Eli Lilly); Genzyme(Sanofi-AventisGenzyme Corporation); Medtronic(Medtronic); Merck-Schering-Plough(Merck & CompanySchering Plough Corporation); Pfizer(Pfizer); Orbus Neich; Novartis(Novartis); Roche(Roche Holding); Servier(Servier); Sanofi Aventis(Sanofi-Aventis); Netherlands Heart Foundation(Netherlands Heart Foundation); Interuniversity Cardiology Institute of the Netherlands; European Community(European Commission); St Jude Medical(St. Jude Medical); Abbott(Abbott Laboratories); Maquet	This research was performed within the framework of CTMM, the Center for Translational Molecular Medicine (www.ctmm.nl), project CIRCULATING CELLS (grant 01C-102), and supported by the Dutch Heart Foundation, St Jude Medical Inc. and Stichting Vrienden van het Hart Zuid-Oost Brabant, The Netherlands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.; The authors have read the journal's policy and have the following potential conflicts: GP is founder of Cavadis, a biomarker company. There is no association with the content of this paper. JJ has received research grants from and was speaker on (CME accredited) meetings sponsored by Astellas, Astra-Zeneca, Bayer, Biotronik, Boston Scientific, Daiichi Sankyo, Lilly, Genzyme, Medtronic, Merck-Schering-Plough, Pfizer, Orbus Neich, Novartis, Roche, Servier, Sanofi Aventis, the Netherlands Heart Foundation, the Interuniversity Cardiology Institute of the Netherlands and the European Community Framework KP7 Programme. NHJP has received research grants from St Jude Medical, Abbott and Maquet and is a consultant for St Jude Medical. Other authors have no potential conflicts to disclose.	Anguera I, 2002, AM HEART J, V144, P811, DOI 10.1067/mhj.2002.124831; Bruun JM, 2003, EUR J ENDOCRINOL, V148, P535, DOI 10.1530/eje.0.1480535; De Bruyne B, 2001, CIRCULATION, V104, P157, DOI 10.1161/01.CIR.104.2.157; Deliargyris EN, 2000, AM J CARDIOL, V86, P913, DOI 10.1016/S0002-9149(00)01121-8; ElMokhtari N, 2010, J THROMB THROMBOLYS, V30, P391, DOI 10.1007/s11239-010-0466-4; Elsenberg EH, 2011, CLIN SCI, V122, P527; Graff J, 2005, CLIN PHARMACOL THER, V78, P468, DOI 10.1016/j.clpt.2005.08.002; Hachamovitch R, 1997, AM J CARDIOL, V80, P426, DOI 10.1016/S0002-9149(97)00390-1; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Ikonomidis I, 2005, CIRCULATION, V112, P3272, DOI 10.1161/CIRCULATIONAHA.104.532259; Inoue T, 2008, INT J CARDIOL, V124, P319, DOI 10.1016/j.ijcard.2007.02.012; ISKANDRIAN AS, 1993, J AM COLL CARDIOL, V22, P665, DOI 10.1016/0735-1097(93)90174-Y; Ley K, 2003, TRENDS MOL MED, V9, P263, DOI 10.1016/S1471-4914(03)00071-6; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Li HL, 2007, J CELL MOL MED, V11, P88, DOI 10.1111/j.1582-4934.2007.00011.x; Liuzzo G, 2001, CIRCULATION, V103, P2236; Luc G, 2003, ARTERIOSCL THROM VAS, V23, P1255, DOI 10.1161/01.ATV.0000079512.66448.1D; Methe H, 2005, CIRCULATION, V111, P2654, DOI 10.1161/CIRCULATIONAHA.104.498865; Mizia-Stec K, 2003, CORONARY ARTERY DIS, V14, P431, DOI 10.1097/00019501-200309000-00003; Mizia-Stec Katarzyna, 2002, Eur J Intern Med, V13, P115, DOI 10.1016/S0953-6205(02)00004-3; Muhlestein JB, 2010, THROMB HAEMOSTASIS, V103, P71, DOI 10.1160/TH09-03-0177; Musaad S, 2007, EPIDEMIOL REV, V29, P98, DOI 10.1093/epirev/mxm005; Nam CW, 2011, J AM COLL CARDIOL, V58, P1211, DOI 10.1016/j.jacc.2011.06.020; Ortego M, 1999, ATHEROSCLEROSIS, V147, P253, DOI 10.1016/S0021-9150(99)00193-8; PIJLS NHJ, 1995, CIRCULATION, V92, P3183, DOI 10.1161/01.CIR.92.11.3183; Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Pijls NHJ, 2012, J AM COLL CARDIOL, V59, P1045, DOI 10.1016/j.jacc.2011.09.077; Quinn MJ, 2004, AM J CARDIOL, V93, P679, DOI 10.1016/j.amjcard.2003.11.048; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2000, CIRCULATION, V101, P2149, DOI 10.1161/01.CIR.101.18.2149; Scholtes VPW, 2011, CLIN SCI, V121, P205, DOI 10.1042/CS20100601; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; Shaw LJ, 2008, CIRCULATION, V117, P1283, DOI 10.1161/CIRCULATIONAHA.107.743963; Steinhubl SR, 2007, VASC MED, V12, P113, DOI 10.1177/1358863X07077462; Takemoto M, 2001, ARTERIOSCL THROM VAS, V21, P1712, DOI 10.1161/hq1101.098486; Tonino PAL, 2010, J AM COLL CARDIOL, V55, P2816, DOI 10.1016/j.jacc.2009.11.096; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Tziakas DN, 2008, EUR HEART J, V29, P2713, DOI 10.1093/eurheartj/ehn382; Ueda K, 1999, AM HEART J, V138, P908, DOI 10.1016/S0002-8703(99)70016-5; Vilahur G, 2009, J THROMB HAEMOST, V7, P485, DOI 10.1111/j.1538-7836.2008.03244.x; Vink A, 2002, CIRCULATION, V106, P1985, DOI 10.1161/01.CIR.0000032146.75113.EE; Virmani Renu, 2003, J Interv Cardiol, V16, P267, DOI 10.1034/j.1600-0854.2003.8042.x; Willerson JT, 2009, TEX HEART I J, V36, P530; Yong ASC, 2011, BLOOD, V117, P11, DOI 10.1182/blood-2010-04-278812	45	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e46356	10.1371/journal.pone.0046356	http://dx.doi.org/10.1371/journal.pone.0046356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091596	Green Submitted, Green Published, gold			2022-12-25	WOS:000310135800007
J	Su, SF; Chang, YW; Andreu-Vieyra, C; Fang, JY; Yang, Z; Han, B; Lee, AS; Liang, G				Su, S-F; Chang, Y-W; Andreu-Vieyra, C.; Fang, J. Y.; Yang, Z.; Han, B.; Lee, A. S.; Liang, G.			miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer	ONCOGENE			English	Article						microRNA; GRP78; apoptosis; drug resistance; anti-cancer therapy	UNFOLDED PROTEIN RESPONSE; NEGATIVE REGULATION; PROSTATE-CANCER; DOWN-REGULATION; TUMOR-GROWTH; MICRORNAS; STRESS; TARGET; GENES; EXPRESSION	GRP78, a major endoplasmic reticulum chaperone and signaling regulator, is commonly overexpressed in cancer. Moreover, induction of GRP78 by a variety of anti-cancer drugs, including histone deacetylase inhibitors, confers chemoresistance to cancer, thereby contributing to tumorigenesis. Thus, therapies aimed at decreasing GRP78 levels, which results in the inhibition of tumor cell proliferation and resensitization of tumor cells to chemotherapeutic drugs may hold promise for cancer treatment. Despite advances in our understanding of GRP78 actions, little is known about endogenous inhibitors controlling its expression. As endogenous regulators, microRNAs (miRNAs) play important roles in modulating gene expression; therefore, we sought to identify miRNA(s) that target GRP78, under the hypothesis that these miRNAs may serve as therapeutic agents. Here, we report that three miRNAs (miR-30d, miR-181a, miR-199a-5p) predicted to target GRP78 are down-regulated in prostate, colon and bladder tumors, and human cancer cell lines. We show that in C42B prostate cancer cells, these miRNAs down-regulate GRP78 and induce apoptosis by directly targeting its 3' untranslated region. Importantly, we demonstrate that the three miRNAs act cooperatively to decrease GRP78 levels, suggesting that multiple miRNAs may be required to efficiently control the expression of some genes. In addition, delivery of multiple miRNAs by either transient transfection or lentivirus transduction increased the sensitivity of cancer cells to the histone deacetylase inhibitor, trichostatin A, in C42B, HCT116 and HL-60 cells. Together, our results indicate that the delivery of co-transcribed miRNAs can efficiently suppress GRP78 levels and GRP78-mediated chemoresistance, and suggest that this strategy holds therapeutic potential.	[Su, S-F; Chang, Y-W; Andreu-Vieyra, C.; Liang, G.] Univ So Calif, Sch Med, Dept Urol, Los Angeles, CA 90033 USA; [Su, S-F] Program Genet Mol & Cellular Biol, Los Angeles, CA USA; [Chang, Y-W; Lee, A. S.] Dept Biochem & Mol Biol, Los Angeles, CA USA; [Fang, J. Y.; Yang, Z.; Han, B.] Univ So Calif, Keck Sch Med, USC Norris Comprehens Canc Ctr, Dept Surg, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Liang, G (corresponding author), Univ So Calif, Keck Sch Med, USC Norris Comprehens Canc Ctr, Dept Urol, NOR7338,1441 Eastlake Ave, Los Angeles, CA 90089 USA.	gliang@usc.edu	Su, Sheng-Fang/AAT-3642-2021; Fang, Josephine/AAS-5996-2020	Su, Sheng-Fang/0000-0002-1624-5745; Liang, Gangning/0000-0001-8664-922X; Lee, Amy/0000-0002-0378-5443	NCI [RO1 CA138794, RO1 CA027607]; NATIONAL CANCER INSTITUTE [R01CA138794, R01CA027607] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr PA Jones for supporting this work; Dr KT Pfaffenbach for the experimental suggestions; Drs J Zhou and Q Li for data analysis; Drs TK Kelly for careful reading of the manuscript; Ms K Pandiyan and Mr C Duymich for the overview. This work was supported by NCI Grants (RO1 CA138794, GL, RO1 CA027607, ASL).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Backer MV, 2011, METHOD ENZYMOL, V491, P37, DOI 10.1016/B978-0-12-385928-0.00003-1; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baumeister P, 2009, MOL CANCER THER, V8, P1086, DOI 10.1158/1535-7163.MCT-08-1166; Booth L, 2012, CANCER BIOL THER, V13, P224, DOI 10.4161/cbt.13.4.18877; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cook KL, 2012, CANCER RES, V72, P3337, DOI 10.1158/0008-5472.CAN-12-0269; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Daneshmand S, 2007, HUM PATHOL, V38, P1547, DOI 10.1016/j.humpath.2007.03.014; Dong DZ, 2011, CANCER RES, V71, P2848, DOI 10.1158/0008-5472.CAN-10-3151; Duan QL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031518; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Fu Y, 2008, P NATL ACAD SCI USA, V105, P19444, DOI 10.1073/pnas.0807691105; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grkovic S, 2013, ONCOGENE, V32, P2412, DOI 10.1038/onc.2012.264; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hetz C, 2006, SCIENCE, V312, P572, DOI 10.1126/science.1123480; Hu WW, 2010, MOL CELL, V38, P689, DOI 10.1016/j.molcel.2010.05.027; Kahali S, 2012, FASEB J, V26, P2437, DOI 10.1096/fj.11-193706; Kappelmann M, 2013, ONCOGENE, V32, P2984, DOI 10.1038/onc.2012.307; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Kumar M, 2011, ONCOGENE, V30, P843, DOI 10.1038/onc.2010.457; Kuwahara K, 2010, TISSUE ENG PART C-ME, V16, P609, DOI 10.1089/ten.TEC.2009.0406; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li N, 2013, ONCOGENE, V32, P1933, DOI 10.1038/onc.2012.212; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lopez-Serra P, 2012, ONCOGENE, V31, P1609, DOI 10.1038/onc.2011.354; Luo B, 2013, ONCOGENE, V32, P805, DOI 10.1038/onc.2012.130; Marasa BS, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000442; Mavrakis KJ, 2011, CELL CYCLE, V10, P2845, DOI 10.4161/cc.10.17.16959; Mavrakis KJ, 2011, NAT GENET, V43, P673, DOI 10.1038/ng.858; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Pfaffenbach KT, 2011, CURR OPIN CELL BIOL, V23, P150, DOI 10.1016/j.ceb.2010.09.007; Pootrakul L, 2006, CLIN CANCER RES, V12, P5987, DOI 10.1158/1078-0432.CCR-06-0133; Pyrko P, 2007, CANCER RES, V67, P9809, DOI 10.1158/0008-5472.CAN-07-0625; Qiu XN, 2011, BIOCHEM BIOPH RES CO, V411, P276, DOI 10.1016/j.bbrc.2011.06.123; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roue G, 2011, BLOOD, V117, P1270, DOI 10.1182/blood-2010-04-278853; Saito Y, 2006, CANCER CELL, V9, P435, DOI 10.1016/j.ccr.2006.04.020; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Shen QL, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-227; Virrey JJ, 2008, MOL CANCER RES, V6, P1268, DOI 10.1158/1541-7786.MCR-08-0060; Wey S, 2012, BLOOD, V119, P817, DOI 10.1182/blood-2011-06-357384; Wolff EM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000917; Yeung BHY, 2008, ONCOGENE, V27, P6782, DOI 10.1038/onc.2008.290; Zhang J, 2001, J CLIN INVEST, V107, P1235, DOI 10.1172/JCI11685; Zhang Y, 2012, BLOOD, V120, P1678, DOI 10.1182/blood-2012-02-410647	53	93	103	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 26	2013	32	39					4694	4701		10.1038/onc.2012.483	http://dx.doi.org/10.1038/onc.2012.483			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	226YD	23085757	Green Published, hybrid			2022-12-25	WOS:000325072200011
J	Schroeder, MC; Chen, CL; Gajewski, K; Halder, G				Schroeder, M. C.; Chen, C-L; Gajewski, K.; Halder, G.			A non-cell-autonomous tumor suppressor role for Stat in eliminating oncogenic scribble cells	ONCOGENE			English	Article						cell competition; JAK/STAT; scribble	TISSUE OVERGROWTH; GENETIC MOSAICS; DROSOPHILA; GROWTH; POLARITY; PATHWAY; COMPETITION; ACTIVATION; EXPRESSION; MUTANTS	Elucidating signaling events between tumor cells and their microenvironment is a major challenge in understanding cancer development. Drosophila melanogaster has emerged as an important tool for dissecting the genetic circuits tumors depend on because their imaginal discs, simple epithelia present in the larva, can be genetically manipulated to serve as models to study cancer mechanisms. Imaginal disc cells mutant for the tumor-suppressor gene scribble (scrib) lose apical-basal polarity and have the potential to form large neoplastic tumors. Interestingly, when scrib mutant (scrib(-)) cells are surrounded by normal cells the scrib(-) population is eliminated. However, the signals and mechanisms that cause the elimination of clones of scrib(-) cells are poorly understood. Here, we analyzed the role of Stat, a component of the JAK/STAT signaling pathway, in tissues with clones of scrib(-) cells. We found that Stat activity is required in normal cells for the elimination of neighboring scrib(-) cells. Importantly, these competitive defects of stat mutant cells are not simply due to defects in cell proliferation because even stat(-) cells manipulated to hyperproliferate are unable to eliminate scrib(-) cells. These data identify Stat activity as a critical determinant of whether or not a tissue can eliminate abnormal cells and provide an important step forward in understanding the complex network of signals operating in and around tumorigenic cells.	[Schroeder, M. C.; Halder, G.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA; [Schroeder, M. C.; Chen, C-L; Halder, G.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Chen, C-L; Halder, G.] Univ Texas MD Anderson Canc Ctr, Program Genes & Dev, Houston, TX 77030 USA; [Gajewski, K.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA; [Halder, G.] Univ Louvain, KU Leuven Ctr Human Genet, VIB Ctr Biol Dis, B-3000 Louvain, Belgium; [Chen, C-L] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Flanders Institute for Biotechnology (VIB); KU Leuven; Harvard University; Harvard Medical School	Halder, G (corresponding author), Univ Louvain, KU Leuven Ctr Human Genet, VIB Ctr Biol Dis, B-3000 Louvain, Belgium.	georg.halder@med.kuleuven.be	Halder, Georg/F-2966-2015	Halder, Georg/0000-0001-7580-3236	NIH; Baylor Research Advocates for Student Scientists scholarship	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baylor Research Advocates for Student Scientists scholarship	We thank Erika Bach, Hugo Bellen, Andreas Bergmann, David Bilder, Michael Galko, Robert Holmgren, Kenneth Irvine, Jin Jiang, Ed Laufer, Graeme Mardon, Sang-Chul Nam, Duojia Pan, Hong Wen and the Developmental Studies Hybridoma Bank (University of Iowa) for fly stocks and antibodies. We thank Leisa McCord for artwork and the Halder lab for discussions. This work was supported by an NIH grant to GH and a Baylor Research Advocates for Student Scientists scholarship to MCS.	Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Blair SS, 2003, DEVELOPMENT, V130, P5065, DOI 10.1242/dev.00774; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Chen CL, 2012, P NATL ACAD SCI USA, V109, P484, DOI 10.1073/pnas.1113882109; Cordero JB, 2010, DEV CELL, V18, P999, DOI 10.1016/j.devcel.2010.05.014; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; Doggett K, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-57; Ekas LA, 2006, DEVELOPMENT, V133, P4721, DOI 10.1242/dev.02675; Flaherty MS, 2009, DEV DYNAM, V238, P2235, DOI 10.1002/dvdy.21989; Grusche FA, 2011, DEV BIOL, V350, P255, DOI 10.1016/j.ydbio.2010.11.020; Halder G, 2011, DEVELOPMENT, V138, P9, DOI 10.1242/dev.045500; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Igaki T, 2009, APOPTOSIS, V14, P1021, DOI 10.1007/s10495-009-0361-7; Igaki T, 2009, DEV CELL, V16, P458, DOI 10.1016/j.devcel.2009.01.002; Johnston LA, 2009, SCIENCE, V324, P1679, DOI 10.1126/science.1163862; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Leong GR, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-62; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Moreno E, 2008, NAT REV CANCER, V8, P141, DOI 10.1038/nrc2252; Narisawa A, 2012, HUM MOL GENET, V21, P1496, DOI 10.1093/hmg/ddr585; Neto-Silva RM, 2010, DEV CELL, V19, P507, DOI 10.1016/j.devcel.2010.09.009; Newsome TP, 2000, DEVELOPMENT, V127, P851; Ohsawa S, 2011, DEV CELL, V20, P315, DOI 10.1016/j.devcel.2011.02.007; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Rogulja D, 2008, DEV CELL, V15, P309, DOI 10.1016/j.devcel.2008.06.003; Silver DL, 2001, CELL, V107, P831, DOI 10.1016/S0092-8674(01)00607-9; Tyler DM, 2007, GENETICS, V175, P643, DOI 10.1534/genetics.106.061929; Uhlirova M, 2005, P NATL ACAD SCI USA, V102, P13123, DOI 10.1073/pnas.0504170102; Willecke M, 2008, P NATL ACAD SCI USA, V105, P14897, DOI 10.1073/pnas.0805201105; Wu M, 2010, NATURE, V463, P545, DOI 10.1038/nature08702; XU T, 1993, DEVELOPMENT, V117, P1223; XU TA, 1995, DEVELOPMENT, V121, P1053; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yuan M, 2008, CELL DEATH DIFFER, V15, P1752, DOI 10.1038/cdd.2008.108; Zeidler MP, 2000, ONCOGENE, V19, P2598, DOI 10.1038/sj.onc.1203482; Ziosi M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001140	42	23	22	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 19	2013	32	38					4471	4479		10.1038/onc.2012.476	http://dx.doi.org/10.1038/onc.2012.476			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	223SW	23108407				2022-12-25	WOS:000324831300002
J	Arai, R; Fukui, S; Kobayashi, N; Sekiguchi, J				Arai, Ryoichi; Fukui, Sadaharu; Kobayashi, Naoya; Sekiguchi, Junichi			Solution Structure of IseA, an Inhibitor Protein of DL-Endopeptidases from Bacillus subtilis, Reveals a Novel Fold with a Characteristic Inhibitory Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SEPARATION; ESCHERICHIA-COLI; HYDROLASE GENE; NMR; RECOGNITION; ENZYMES; COMPLEX; BINDING; DOMAIN; METABOLISM	In Bacillus subtilis, LytE, LytF, CwlS, and CwlO are vegetative autolysins, DL-endopeptidases in the NlpC/P60 family, and play essential roles in cell growth and separation. IseA (YoeB) is a proteinaceous inhibitor against the DL-endopeptidases, peptidoglycan hydrolases. Overexpression of IseA caused significantly long chained cell morphology, because IseA inhibits the cell separation DL-endopeptidases post-translationally. Here, we report the first three-dimensional structure of IseA, determined by NMR spectroscopy. The structure includes a single domain consisting of three alpha-helices, one 3(10)-helix, and eight beta-strands, which is a novel fold like a "hacksaw." Noteworthy is a dynamic loop between beta 4 and the 3(10)-helix, which resembles a "blade." The electrostatic potential distribution shows that most of the surface is positively charged, but the region around the loop is negatively charged. In contrast, the LytF active-site cleft is expected to be positively charged. NMR chemical shift perturbation of IseA interacting with LytF indicated that potential interaction sites are located around the loop. Furthermore, the IseA mutants D100K/D102K and G99P/G101P at the loop showed dramatic loss of inhibition activity against LytF, compared with wild-type IseA, indicating that the beta 4-3(10) loop plays an important role in inhibition. Moreover, we built a complex structure model of IseA-LytF by docking simulation, suggesting that the beta 4-3(10) loop of IseA gets stuck deep in the cleft of LytF, and the active site is occluded. These results suggest a novel inhibition mechanism of the hacksaw-like structure, which is different from known inhibitor proteins, through interactions around the characteristic loop regions with the active-site cleft of enzymes.	[Arai, Ryoichi; Fukui, Sadaharu; Kobayashi, Naoya; Sekiguchi, Junichi] Shinshu Univ, Fac Text Sci & Technol, Div Appl Biol, Ueda, Nagano 3868567, Japan; [Arai, Ryoichi] Shinshu Univ, Int Young Researchers Empowerment Ctr, Ueda, Nagano 3868567, Japan	Shinshu University; Shinshu University	Arai, R (corresponding author), Shinshu Univ, Fac Text Sci & Technol, Div Appl Biol, Ueda, Nagano 3868567, Japan.	rarai@shinshu-u.ac.jp; jsekigu@shinshu-u.ac.jp	Arai, Ryoichi/M-7804-2019	Kobayashi, Naoya/0000-0002-6599-1680; Arai, Ryoichi/0000-0001-5606-8483	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan;  [19380047];  [22248008];  [22113508];  [24113707];  [24780097]; Grants-in-Aid for Scientific Research [24780097] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; ; ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-aid for Scientific Research (KAKENHI) (B) 19380047 and (A) 22248008 (to J. S.), Grants-in-aid for Scientific Research on Innovative Areas 22113508 and 24113707 and for Young Scientists (B) 24780097, and Program for Dissemination of Tenure-Track System (to R. A.), funded by Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Abergel C, 2007, P NATL ACAD SCI USA, V104, P6394, DOI 10.1073/pnas.0611019104; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r11; Aramini JM, 2008, BIOCHEMISTRY-US, V47, P9715, DOI 10.1021/bi8010779; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Bisicchia P, 2007, MOL MICROBIOL, V65, P180, DOI 10.1111/j.1365-2958.2007.05782.x; Bisicchia P, 2010, MOL MICROBIOL, V75, P972, DOI 10.1111/j.1365-2958.2009.07036.x; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Clarke CA, 2010, J BIOL CHEM, V285, P14843, DOI 10.1074/jbc.C110.120931; CLORE GM, 1994, METHOD ENZYMOL, V239, P349; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; Cushman I, 2004, J MOL BIOL, V344, P303, DOI 10.1016/j.jmb.2004.09.043; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Drenth J, 1971, Adv Protein Chem, V25, P79, DOI 10.1016/S0065-3233(08)60279-X; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fukushima T, 2006, J BACTERIOL, V188, P5541, DOI 10.1128/JB.00188-06; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hashimoto M, 2012, J BACTERIOL, V194, P796, DOI 10.1128/JB.05569-11; Hoelz A, 2003, MOL CELL, V11, P1241, DOI 10.1016/S1097-2765(03)00171-0; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Ishikawa S, 1998, J BACTERIOL, V180, P2549, DOI 10.1128/JB.180.9.2549-2555.1998; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kigawa T, 1999, FEBS LETT, V442, P15, DOI 10.1016/S0014-5793(98)01620-2; Kigawa Takanori, 2004, Journal of Structural and Functional Genomics, V5, P63, DOI 10.1023/B:JSFG.0000029204.57846.7d; Kobayashi N, 2007, J BIOMOL NMR, V39, P31, DOI 10.1007/s10858-007-9175-5; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larson ET, 2009, J BIOL CHEM, V284, P26839, DOI 10.1074/jbc.M109.003780; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Matsuda Takayoshi, 2006, Journal of Structural and Functional Genomics, V7, P93, DOI 10.1007/s10969-006-9012-1; Matsuda T, 2007, J BIOMOL NMR, V37, P225, DOI 10.1007/s10858-006-9127-5; Monchois V, 2001, J BIOL CHEM, V276, P18437, DOI 10.1074/jbc.M010297200; Motoyama T, 2002, ACTA CRYSTALLOGR D, V58, P148, DOI 10.1107/S0907444901017371; Ohnishi R, 1999, J BACTERIOL, V181, P3178, DOI 10.1128/JB.181.10.3178-3184.1999; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pfeffer JM, 2012, BACTERIAL GLYCOMICS: CURRENT RESEARCH, TECHNOLOGY AND APPLICATIONS, P55; Pilgrim S, 2003, INFECT IMMUN, V71, P3473, DOI 10.1128/IAI.71.6.3473-3484.2003; Salzberg LI, 2007, J BACTERIOL, V189, P4671, DOI 10.1128/JB.00403-07; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Smith TJ, 2000, MICROBIOL-UK, V146, P249, DOI 10.1099/00221287-146-2-249; Suzuki T, 2003, J BACTERIOL, V185, P2379, DOI 10.1128/JB.185.7.2379-2382.2003; Tovchigrechko A, 2005, PROTEINS, V60, P296, DOI 10.1002/prot.20573; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; VAKSER IA, 1994, PROTEINS, V20, P320, DOI 10.1002/prot.340200405; VAKSER IA, 1995, PROTEIN ENG, V8, P371, DOI 10.1093/protein/8.4.371; Wang SX, 2007, STRUCTURE, V15, P535, DOI 10.1016/j.str.2007.03.012; Wang SX, 2006, P NATL ACAD SCI USA, V103, P11503, DOI 10.1073/pnas.0600489103; Xu QP, 2010, ACTA CRYSTALLOGR F, V66, P1354, DOI 10.1107/S1744309110021214; Xu QP, 2009, STRUCTURE, V17, P303, DOI 10.1016/j.str.2008.12.008; Yamaguchi H, 2004, J BIOSCI BIOENG, V98, P174, DOI 10.1263/jbb.98.174; Yamamoto H, 2008, MOL MICROBIOL, V70, P168, DOI 10.1111/j.1365-2958.2008.06398.x	61	10	10	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44736	44748		10.1074/jbc.M112.414763	http://dx.doi.org/10.1074/jbc.M112.414763			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23091053	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000312938600068
J	Fujii, Y; Dohmae, N; Takio, K; Kawsar, SMA; Matsumoto, R; Hasan, I; Koide, Y; Kanaly, RA; Yasumitsu, H; Ogawa, Y; Sugawara, S; Hosono, M; Nitta, K; Hamako, J; Matsui, T; Ozeki, Y				Fujii, Yuki; Dohmae, Naoshi; Takio, Koji; Kawsar, Sarkar M. A.; Matsumoto, Ryo; Hasan, Imtiaj; Koide, Yasuhiro; Kanaly, Robert A.; Yasumitsu, Hidetaro; Ogawa, Yukiko; Sugawara, Shigeki; Hosono, Masahiro; Nitta, Kazuo; Hamako, Jiharu; Matsui, Taei; Ozeki, Yasuhiro			A Lectin from the Mussel Mytilus galloprovincialis Has a Highly Novel Primary Structure and Induces Glycan-mediated Cytotoxicity of Globotriaosylceramide-expressing Lymphoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GALACTOSIDE-SPECIFIC LECTIN; SILURUS-ASOTUS LECTIN; C-TYPE LECTIN; BINDING PROFILE; MOLECULAR CHARACTERIZATION; AFFINITY-CHROMATOGRAPHY; MARINE SPONGE; OLIGOSACCHARIDE; IDENTIFICATION; PURIFICATION	A novel lectin structure was found for a 17-kDa alpha-D-galactose-binding lectin (termed "MytiLec") isolated from the Mediterranean mussel, Mytilus galloprovincialis. The complete primary structure of the lectin was determined by Edman degradation and mass spectrometric analysis. MytiLec was found to consist of 149 amino acids with a total molecular mass of 16,812.59 Da by Fourier transform-ion cyclotron resonance mass spectrometry, in good agreement with the calculated value of 16,823.22 Da. MytiLec had an N terminus of acetylthreonine and a primary structure that was highly novel in comparison with those of all known lectins in the structure database. The polypeptide structure consisted of three tandem-repeat domains of similar to 50 amino acids each having 45-52% homology with each other. Frontal affinity chromatography technology indicated that MytiLec bound specifically to globotriose (Gb3; Gal alpha 1-4Gal beta 1-4Glc), the epitope of globotriaosylceramide. MytiLec showed a dose-dependent cytotoxic effect on human Burkitt lymphoma Raji cells (which have high surface expression of Gb3) but had no such effect on erythroleukemia K562 cells (which do not express Gb3). The cytotoxic effect of MytiLec was specifically blocked by the co-presence of an alpha-galactoside. MytiLec treatment of Raji cells caused increased binding of anti-annexin V antibody and incorporation of propidium iodide, which are indicators of cell membrane inversion and perforation. MytiLec is the first reported lectin having a primary structure with the highly novel triple tandem-repeat domain and showing transduction of apoptotic signaling against Burkitt lymphoma cells by interaction with a glycosphingolipid-enriched microdomain containing Gb3.	[Fujii, Yuki; Kawsar, Sarkar M. A.; Matsumoto, Ryo; Hasan, Imtiaj; Koide, Yasuhiro; Kanaly, Robert A.; Yasumitsu, Hidetaro; Ozeki, Yasuhiro] Yokohama City Univ, Grad Sch NanoBio Sci, Dept Life & Environm Syst Sci, Lab Glycobiol & Marine Biochem,Kanazawa Ku, Yokohama, Kanagawa 2360027, Japan; [Dohmae, Naoshi; Takio, Koji] RIKEN Adv Sci Inst, Biomol Characterizat Team, Wako, Saitama 3510198, Japan; [Fujii, Yuki; Ogawa, Yukiko] Nagasaki Int Univ, Fac Pharmaceut Sci, Dept Pharm, Div Funct Morphol, Sasebo, Nagasaki 8593298, Japan; [Fujii, Yuki; Ogawa, Yukiko] Nagasaki Int Univ, Fac Pharmaceut Sci, Dept Pharm, Div Microbiol, Sasebo, Nagasaki 8593298, Japan; [Kawsar, Sarkar M. A.] Univ Chittagong, Fac Sci, Dept Chem, Lab Carbohydrate & Prot Chem, Chittagong 4331, Bangladesh; [Hasan, Imtiaj] Rajshahi Univ, Fac Sci, Dept Biochem & Mol Biol, Rajshahi 6205, Bangladesh; [Sugawara, Shigeki; Hosono, Masahiro; Nitta, Kazuo] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Cell Recognit Study, Aoba Ku, Sendai, Miyagi 9818558, Japan; [Hamako, Jiharu; Matsui, Taei] Fujita Hlth Univ, Dept Biol, Toyoake, Aichi 4701192, Japan	Yokohama City University; RIKEN; Nagasaki International University; Nagasaki International University; University of Chittagong; University of Rajshahi; Tohoku Medical & Pharmaceutical University; Fujita Health University	Ozeki, Y (corresponding author), Yokohama City Univ, Grad Sch NanoBio Sci, Dept Life & Environm Syst Sci, Lab Glycobiol & Marine Biochem,Kanazawa Ku, 22-2 Seto, Yokohama, Kanagawa 2360027, Japan.	ozeki@yokohama-cu.ac.jp	Kawsar, Prof. Dr. S. M. Abe/AAF-5893-2022; Dohmae, Naoshi/C-2040-2011; Ozeki, Yasuhiro/O-8493-2015; Sugawara, Shigeki/AAB-2757-2021; Hasan, Imtiaj/O-8298-2017; Kawsar, Prof. Dr. S. M. Abe/ABC-9066-2022	Kawsar, Prof. Dr. S. M. Abe/0000-0001-7964-9117; Dohmae, Naoshi/0000-0002-5242-9410; Ozeki, Yasuhiro/0000-0002-2782-6158; Hasan, Imtiaj/0000-0002-4715-9022; Kawsar, Prof. Dr. S. M. Abe/0000-0001-7964-9117	Japan Society for the Promotion of Science; Japanese Association for Marine Biology from the Ministry of Education, Culture, Sports, Science, and Technology Japan; City of Yokohama "Blue Carbon Project"; Yachiyo Engineering Co., Ltd.,	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japanese Association for Marine Biology from the Ministry of Education, Culture, Sports, Science, and Technology Japan; City of Yokohama "Blue Carbon Project"; Yachiyo Engineering Co., Ltd.,	This work was supported in part by grants-in-aid for scientific research from the Japan Society for the Promotion of Science and Japanese Association for Marine Biology from the Ministry of Education, Culture, Sports, Science, and Technology Japan.; We thank the City of Yokohama "Blue Carbon Project" and Yachiyo Engineering Co., Ltd., for their support. Naoko Masuda and Chihiro Iwahara are specially thanked for assistance with experiments. We thank Dr. Stephen Anderson for the English editing of the manuscript.	ALTSCHUL SF, 1990, P NATL ACAD SCI USA, V87, P5509, DOI 10.1073/pnas.87.14.5509; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angeloni S, 2005, GLYCOBIOLOGY, V15, P31, DOI 10.1093/glycob/cwh143; Belogortseva NI, 1998, COMP BIOCHEM PHYS C, V119, P45, DOI 10.1016/S0742-8413(97)00180-1; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Chen JH, 2011, FISH SHELLFISH IMMUN, V30, P750, DOI 10.1016/j.fsi.2010.12.025; Espinosa EP, 2010, COMP BIOCHEM PHYS A, V156, P495, DOI 10.1016/j.cbpa.2010.04.004; Fujii Y, 2012, PROTEIN J, V31, P15, DOI 10.1007/s10930-011-9369-2; Gorbushin AM, 2011, FISH SHELLFISH IMMUN, V30, P434, DOI 10.1016/j.fsi.2010.10.002; Gourdine JP, 2008, J BIOL CHEM, V283, P30112, DOI 10.1074/jbc.M804353200; Gros E., 1967, METHOD ENZYMOL, V11, P238; Gutternigg M, 2007, GLYCOCONJUGATE J, V24, P475, DOI 10.1007/s10719-007-9040-5; HEWICK RM, 1981, J BIOL CHEM, V256, P7990; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hirabayashi J, 2003, METHOD ENZYMOL, V362, P353; Hirabayashi J, 2008, J BIOCHEM, V144, P139, DOI 10.1093/jb/mvn043; Ishiyama M, 1997, TALANTA, V44, P1299, DOI 10.1016/S0039-9140(97)00017-9; Kasai K, 1996, J BIOCHEM-TOKYO, V119, P1; KASAI KI, 1978, J BIOCHEM, V84, P1061, DOI 10.1093/oxfordjournals.jbchem.a132220; KASAI KI, 1978, J BIOCHEM-TOKYO, V84, P1051, DOI 10.1093/oxfordjournals.jbchem.a132219; Kawano T, 2008, BIOL PHARM BULL, V31, P998, DOI 10.1248/bpb.31.998; Kawano T, 2009, BIOL PHARM BULL, V32, P345, DOI 10.1248/bpb.32.345; Kawsar SMA, 2008, COMP BIOCHEM PHYS B, V150, P349, DOI 10.1016/j.cbpb.2008.04.004; Kawsar SMA, 2011, PROTEIN J, V30, P509, DOI 10.1007/s10930-011-9356-7; Kawsar SMA, 2009, COMP BIOCHEM PHYS B, V152, P382, DOI 10.1016/j.cbpb.2009.01.009; Kim YM, 2006, J BIOL CHEM, V281, P26854, DOI 10.1074/jbc.M601251200; Kinoshita S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021238; Kotake T, 2005, PLANT PHYSIOL, V138, P1563, DOI 10.1104/pp.105.062562; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li CH, 2011, FISH SHELLFISH IMMUN, V30, P1202, DOI 10.1016/j.fsi.2011.02.022; MASAKI T, 1981, BIOCHIM BIOPHYS ACTA, V660, P44, DOI 10.1016/0005-2744(81)90106-6; Matsumoto R, 2012, TOXINS, V4, P323, DOI 10.3390/toxins4050323; Matsumoto R, 2011, COMP BIOCHEM PHYS B, V158, P266, DOI 10.1016/j.cbpb.2010.12.004; Naganuma T, 2006, MOL DIVERS, V10, P607, DOI 10.1007/s11030-006-9051-3; Naismith JH, 1996, J BIOL CHEM, V271, P972, DOI 10.1074/jbc.271.2.972; Ogawa Tomohisa, 2011, J Amino Acids, V2011, P838914, DOI 10.4061/2011/838914; OZEKI Y, 1991, BIOCHEMISTRY-US, V30, P2391, DOI 10.1021/bi00223a014; Pepper C, 1998, LEUKEMIA RES, V22, P439, DOI 10.1016/S0145-2126(98)00013-7; SHINOHARA Y, 1994, EUR J BIOCHEM, V223, P189, DOI 10.1111/j.1432-1033.1994.tb18982.x; SIMPSON RJ, 1976, J BIOL CHEM, V251, P1936; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stepan H, 2012, GLYCOCONJUGATE J, V29, P189, DOI 10.1007/s10719-012-9391-4; Sugawara S, 2005, YAKUGAKU ZASSHI, V125, P327, DOI 10.1248/yakushi.125.327; Sugawara S, 2005, BIOL PHARM BULL, V28, P434, DOI 10.1248/bpb.28.434; Tahirov TH, 1998, J MOL BIOL, V284, P101, DOI 10.1006/jmbi.1998.2146; Tasumi S, 2007, J IMMUNOL, V179, P3086, DOI 10.4049/jimmunol.179.5.3086; Tateno H, 2007, GLYCOBIOLOGY, V17, P1138, DOI 10.1093/glycob/cwm084; TENNANT JR, 1964, TRANSPLANTATION, V2, P685, DOI 10.1097/00007890-196411000-00001; TITANI K, 1964, J BIOCHEM-TOKYO, V56, P241, DOI 10.1093/oxfordjournals.jbchem.a127986; Transue TR, 1997, NAT STRUCT BIOL, V4, P779, DOI 10.1038/nsb1097-779; Vakonakis I, 2008, STRUCTURE, V16, P944, DOI 10.1016/j.str.2008.02.020; Velkova L, 2011, GLYCOCONJUGATE J, V28, P385, DOI 10.1007/s10719-011-9337-2; Venier P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-69; Venier P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-72; Vukelic Z, 2005, J AM SOC MASS SPECTR, V16, P571, DOI 10.1016/j.jasms.2005.01.013; Weis WI, 1998, IMMUNOL REV, V163, P19, DOI 10.1111/j.1600-065X.1998.tb01185.x; WIECHELMAN KJ, 1988, ANAL BIOCHEM, V175, P231, DOI 10.1016/0003-2697(88)90383-1; Xu NX, 1997, J AM SOC MASS SPECTR, V8, P116, DOI 10.1016/S1044-0305(96)00233-4	58	64	66	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44772	44783		10.1074/jbc.M112.418012	http://dx.doi.org/10.1074/jbc.M112.418012			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23093409	Green Published, hybrid			2022-12-25	WOS:000312938600071
J	Sykes, AM; Palstra, N; Abankwa, D; Hill, JM; Skeldal, S; Matusica, D; Venkatraman, P; Hancock, JF; Coulson, EJ				Sykes, Alex M.; Palstra, Nickless; Abankwa, Daniel; Hill, Justine M.; Skeldal, Sune; Matusica, Dusan; Venkatraman, Prahatha; Hancock, John F.; Coulson, Elizabeth J.			The Effects of Transmembrane Sequence and Dimerization on Cleavage of the p75 Neurotrophin Receptor by gamma-Secretase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; NERVE GROWTH-FACTOR; NUCLEAR TRANSLOCATION; DEPENDENT CLEAVAGE; DOMAIN; GXXXG; DIMER; DEATH; NOTCH; FRET	Cleavage of transmembrane receptors by gamma-secretase is the final step in the process of regulated intramembrane proteolysis (RIP) and has a significant impact on receptor function. Although relatively little is known about the molecular mechanism of gamma-secretase enzymatic activity, it is becoming clear that substrate dimerization and/or the alpha-helical structure of the substrate can regulate the site and rate of gamma-secretase activity. Here we show that the transmembrane domain of the pan-neurotrophin receptor p75(NTR), best known for regulating neuronal death, is sufficient for its homodimerization. Although the p75(NTR) ligands NGF and pro-NGF do not induce homerdimerization or RIP, homodimers of p75(NTR) are gamma-secretase substrates. However, dimerization is not a requirement for p75(NTR) cleavage, suggesting that gamma-secretase has the ability to recognize and cleave each receptor molecule independently. The transmembrane cysteine 257, which mediates covalent p75(NTR) interactions, is not crucial for homodimerization, but this residue is required for normal rates of gamma-secretase cleavage. Similarly, mutation of the residues alanine 262 and glycine 266 of an AXXXG dimerization motif flanking the gamma-secretase cleavage site within the p75(NTR) transmembrane domain alters the orientation of the domain and inhibits gamma-secretase cleavage of p75(NTR). Nonetheless, heteromer interactions of p75(NTR) with TrkA increase full-length p75(NTR) homodimerization, which in turn potentiates the rate of gamma-cleavage following TrkA activation independently of rates of alpha-cleavage. These results provide support for the idea that the helical structure of the p75(NTR) transmembrane domain, which may be affected by co-receptor interactions, is a key element in gamma-secretase-catalyzed cleavage.	[Sykes, Alex M.; Palstra, Nickless; Skeldal, Sune; Matusica, Dusan; Coulson, Elizabeth J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Abankwa, Daniel; Venkatraman, Prahatha; Hancock, John F.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Hill, Justine M.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Hill, Justine M.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland; University of Queensland; University of Queensland	Coulson, EJ (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	e.coulson@uq.edu.au	Hill, Justine M/C-5781-2009; Coulson, Elizabeth J./C-8766-2009; Matusica, Dusan/G-8138-2011	Coulson, Elizabeth J./0000-0003-3783-6197; Matusica, Dusan/0000-0001-6472-7653; Abankwa, Daniel/0000-0003-2769-0745; Hancock, John/0000-0003-0542-4710; Sykes, Alex/0000-0001-8981-6652	National Health and Medical Research Council of Australia (NHMRC) [569507, 10012610]; NHMRC [401748, 569601]	National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by National Health and Medical Research Council of Australia (NHMRC) project Grants 569507 and 10012610.; Supported by NHMRC Career Development (RD Wright) Fellowship 401748.; Supported by NHMRC Career Development (RD Wright) Fellowship 569601.	Abad C, 2009, BBA-BIOMEMBRANES, V1788, P2132, DOI 10.1016/j.bbamem.2009.07.008; Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Abankwa D, 2007, J CELL SCI, V120, P2953, DOI 10.1242/jcs.001404; Aurikko JP, 2005, J BIOL CHEM, V280, P33453, DOI 10.1074/jbc.M503189200; Beel AJ, 2008, CELL MOL LIFE SCI, V65, P1311, DOI 10.1007/s00018-008-7462-2; Ceni C, 2010, J CELL SCI, V123, P2299, DOI 10.1242/jcs.062612; Chakravarthy B, 2010, J ALZHEIMERS DIS, V19, P915, DOI 10.3233/JAD-2010-1288; Choi S, 2005, J BIOL CHEM, V280, P42573, DOI 10.1074/jbc.M509238200; Coulson EJ, 2000, J BIOL CHEM, V275, P30537, DOI 10.1074/jbc.M005214200; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; del Valle J, 2010, J ALZHEIMERS DIS, V19, P1303, DOI 10.3233/JAD-2010-1321; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Dews IC, 2007, P NATL ACAD SCI USA, V104, P20782, DOI 10.1073/pnas.0708909105; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Feng D, 2010, J MOL BIOL, V396, P967, DOI 10.1016/j.jmb.2009.12.030; Fombonne J, 2009, ANN NEUROL, V65, P294, DOI 10.1002/ana.21578; Geetha T, 2005, EMBO J, V24, P3859, DOI 10.1038/sj.emboj.7600845; Gong Y, 2008, NATURE, V454, P789, DOI 10.1038/nature07089; Gorman PM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-17; Hansen G, 2008, CELL, V134, P496, DOI 10.1016/j.cell.2008.05.053; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Kleiger G, 2002, BIOCHEMISTRY-US, V41, P5990, DOI 10.1021/bi0200763; Kommaddi RP, 2011, FASEB J, V25, P2061, DOI 10.1096/fj.10-173740; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; Lee SF, 2004, J BIOL CHEM, V279, P4144, DOI 10.1074/jbc.M309745200; LI SC, 1992, FEBS LETT, V311, P217, DOI 10.1016/0014-5793(92)81106-V; Liu W, 2005, BIOCHEMISTRY-US, V44, P3591, DOI 10.1021/bi047827g; MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131; Meyer BH, 2006, P NATL ACAD SCI USA, V103, P2138, DOI 10.1073/pnas.0507686103; Miyashita N, 2009, J AM CHEM SOC, V131, P3438, DOI 10.1021/ja809227c; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Munter LM, 2010, J BIOL CHEM, V285, P21636, DOI 10.1074/jbc.M109.088005; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Sakamoto K, 2005, EXP CELL RES, V302, P281, DOI 10.1016/j.yexcr.2004.09.016; Sato T, 2009, P NATL ACAD SCI USA, V106, P1421, DOI 10.1073/pnas.0812261106; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Schroeter EH, 2003, P NATL ACAD SCI USA, V100, P13075, DOI 10.1073/pnas.1735338100; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; Skeldal S, 2012, J BIOL CHEM, V287, P43798, DOI 10.1074/jbc.M112.374710; Skeldal S, 2011, BIOESSAYS, V33, P614, DOI 10.1002/bies.201100036; Sotthibundhu A, 2008, J NEUROSCI, V28, P3941, DOI 10.1523/JNEUROSCI.0350-08.2008; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Underwood CK, 2008, MOL CELL NEUROSCI, V37, P346, DOI 10.1016/j.mcn.2007.10.005; Vilar M, 2009, J CELL SCI, V122, P3351, DOI 10.1242/jcs.055061; Vilar M, 2009, NEURON, V62, P72, DOI 10.1016/j.neuron.2009.02.020; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; Weskamp G, 2004, J BIOL CHEM, V279, P4241, DOI 10.1074/jbc.M307974200; Ye J, 2000, P NATL ACAD SCI USA, V97, P5123, DOI 10.1073/pnas.97.10.5123; Zhang JM, 2002, J BIOL CHEM, V277, P15069, DOI 10.1074/jbc.M105375200	54	32	33	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43810	43824		10.1074/jbc.M112.382903	http://dx.doi.org/10.1074/jbc.M112.382903			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23105112	Green Published, hybrid			2022-12-25	WOS:000312940800059
J	Haga, CL; Phinney, DG				Haga, Christopher L.; Phinney, Donald G.			MicroRNAs in the Imprinted DLK1-DIO3 Region Repress the Epithelial-to-Mesenchymal Transition by Targeting the TWIST1 Protein Signaling Network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIR-200 FAMILY; CANCER; ZEB1; HYPOXIA; GENES; ATM; PHOSPHORYLATION; ACTIVATION; EXPRESSION; REGULATORS	Development of metastatic disease accounts for the vast majority of cancer-related deaths. Nevertheless, few treatments exist that are designed to specifically inhibit processes that drive tumor metastasis. The imprinted DLK1-DIO3 region contains tumor-suppressing miRNAs, but their identity and function remain indeterminate. In this study we identify seven miRNAs in the imprinted DLK1-DIO3 region that function cooperatively to repress the epithelial-to-mesenchymal transition, a critical step that drives tumor metastasis, as well as proliferation of carcinoma cells. These seven miRNAs (miRs 300, 382, 494, 495, 539, 543, and 544) repress a signaling network comprising TWIST1, BMI1, ZEB1/2, and miR-200 family miRNAs and silencing of the cluster, which occurs via hypermethylation of upstream CpG islands in human ductal carcinomas, confers morphological, molecular, and function changes consistent with an epithelial-to-mesenchymal transition. Moreover, ectopic expression of miR-544 independently inhibited proliferation of numerous tumor cell lines by inducing the ATM cell cycle checkpoint pathway. These results establish the DLKI-DIO3 miRNA cluster as a critical checkpoint regulating tumor growth and metastasis and implicate epigenetic modification of the cluster in driving tumor progression. These results also suggest that promoter methylation status and miRNA expression levels represent new diagnostic tools and therapeutic targets to predict and inhibit, respectively, tumor metastasis in carcinoma patients.	[Haga, Christopher L.; Phinney, Donald G.] Scripps Res Inst Florida, Dept Mol Therapeut, Jupiter, FL 33458 USA	Scripps Research Institute	Phinney, DG (corresponding author), Scripps Res Inst Florida, Dept Mol Therapeut, A213,130 Scripps Way, Jupiter, FL 33458 USA.	dphinney@scripps.edu	Phinney, Donald G/D-2155-2014	Phinney, Donald/0000-0002-8688-2619	National Institutes of Health [R01 NS052301-01A2]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported, in whole or in part, by National Institutes of Health Grant R01 NS052301-01A2 (to D. G. P.).	Aigner K, 2007, ONCOGENE, V26, P6979, DOI 10.1038/sj.onc.1210508; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bencokova Z, 2009, MOL CELL BIOL, V29, P526, DOI 10.1128/MCB.01301-08; Cannito S, 2008, CARCINOGENESIS, V29, P2267, DOI 10.1093/carcin/bgn216; Cui J, 2012, J MOL CELL BIOL, V4, P174, DOI 10.1093/jmcb/mjs017; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Garzon R, 2010, NAT REV DRUG DISCOV, V9, P775, DOI 10.1038/nrd3179; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gregory PA, 2011, MOL BIOL CELL, V22, P1686, DOI 10.1091/mbc.E11-02-0103; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hagan JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004352; Hu HL, 2010, P NATL ACAD SCI USA, V107, P1506, DOI 10.1073/pnas.0907763107; Khosravi R, 1999, P NATL ACAD SCI USA, V96, P14973, DOI 10.1073/pnas.96.26.14973; Le QT, 2004, CANCER METAST REV, V23, P293, DOI 10.1023/B:CANC.0000031768.89246.d7; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Li W, 2011, CELL RES, V21, P550, DOI 10.1038/cr.2011.25; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Tomaskovic-Crook E, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2416; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Zhang H, 2010, ONCOGENE, V29, P937, DOI 10.1038/onc.2009.406	36	105	110	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42695	42707		10.1074/jbc.M112.387761	http://dx.doi.org/10.1074/jbc.M112.387761			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105110	Green Published, hybrid			2022-12-25	WOS:000312501600030
J	Truong, K; Lee, TD; Li, BZ; Chen, Y				Khue Truong; Lee, Terry D.; Li, Baozong; Chen, Yuan			Sumoylation of SAE2 C Terminus Regulates SAE Nuclear Localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODIFIER SUMO RECOGNITION; LEPTOMYCIN B; ACTIVATING ENZYME; UBIQUITIN LIGASE; BINDING MOTIF; SR PROTEINS; IMPORT; E1; IDENTIFICATION; ACCUMULATION	SUMOylation occurs predominantly in the nucleus, but nonnuclear proteins can also be SUMOylated. It is unclear how intracellular trafficking of the SUMOylation enzymes is regulated to catalyze SUMOylation in different cellular compartments. Here we report that the SAE2 subunit of human SUMO activation enzyme (SAE) underwent rapid nucleocytoplasmic shuttling and its nuclear accumulation depended on SUMO modification at the C terminus. The SUMOylation sites included three Lys residues on the bipartite nuclear localization sequence (NLS) and two Lys residues outside of but adjacent to the NLS, and their SUMOylation was catalyzed by Ubc9. Because SAE2 forms a tight heterodimer with SAE1 and it controls the trafficking of the heterodimer, this study has identified the mechanism used to localize SAE to the nucleus. Similar mechanisms are likely to exist for other proteins that depend on SUMOylation for nuclear localization.	[Khue Truong; Li, Baozong; Chen, Yuan] City Hope Natl Med Ctr, Dept Mol Med, Duarte, CA 91010 USA; [Lee, Terry D.] City Hope Natl Med Ctr, Beckman Res Inst, Duarte, CA 91010 USA	City of Hope; City of Hope; Beckman Research Institute of City of Hope	Chen, Y (corresponding author), City Hope Natl Med Ctr, Dept Mol Med, Duarte, CA 91010 USA.	ychen@coh.org	Li, Baozong/ABD-4742-2020		NIGMS, National Institutes of Health [R01 GM086171, R01 GM102538]; NCI, National Institutes of Health [P30 CA033572]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102538, R01GM086171] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by Grant R01 GM086171 and R01 GM102538 (to Y. C.) from the NIGMS, National Institutes of Health and Grant P30 CA033572 from the NCI, National Institutes of Health.	ADAM SA, 1991, CELL, V66, P837, DOI 10.1016/0092-8674(91)90431-W; Bailey D, 2004, J BIOL CHEM, V279, P692, DOI 10.1074/jbc.M306195200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; DOHMEN RJ, 1995, J BIOL CHEM, V270, P18099, DOI 10.1074/jbc.270.30.18099; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gong LM, 1999, FEBS LETT, V448, P185, DOI 10.1016/S0014-5793(99)00367-1; Hay RT, 2004, NAT CELL BIOL, V6, P89, DOI 10.1038/ncb0204-89; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hofmann WA, 2009, J CELL BIOL, V186, P193, DOI 10.1083/jcb.200905016; Itahana Y, 2006, MOL CELL BIOL, V26, P4675, DOI 10.1128/MCB.01830-05; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Johnson ES, 1997, EMBO J, V16, P5509, DOI 10.1093/emboj/16.18.5509; Kaikkonen S, 2009, MOL ENDOCRINOL, V23, P292, DOI 10.1210/me.2008-0219; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Truong K, 2012, J BIOL CHEM, V287, P15154, DOI 10.1074/jbc.M112.353789; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Li X, 2008, CELL DEATH DIFFER, V15, P739, DOI 10.1038/sj.cdd.4402303; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; MOROIANU J, 1995, P NATL ACAD SCI USA, V92, P6532, DOI 10.1073/pnas.92.14.6532; Moutty MC, 2011, MOL BIOL CELL, V22, P652, DOI 10.1091/mbc.E10-05-0461; Namanja AT, 2012, J BIOL CHEM, V287, P3231, DOI 10.1074/jbc.M111.293118; Okuma T, 1999, BIOCHEM BIOPH RES CO, V254, P693, DOI 10.1006/bbrc.1998.9995; Rangasamy D, 2000, J BIOL CHEM, V275, P37999, DOI 10.1074/jbc.M007777200; RESZKA AA, 1995, P NATL ACAD SCI USA, V92, P8881, DOI 10.1073/pnas.92.19.8881; Rodriguez MS, 2001, J BIOL CHEM, V276, P12654, DOI 10.1074/jbc.M009476200; Saito K, 2010, J BIOCHEM, V147, P833, DOI 10.1093/jb/mvq020; SIOMI H, 1995, J CELL BIOL, V129, P551, DOI 10.1083/jcb.129.3.551; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Stade K, 2002, J BIOL CHEM, V277, P49554, DOI 10.1074/jbc.M207991200; Subramaniam S, 2010, J BIOL CHEM, V285, P20428, DOI 10.1074/jbc.C110.127191; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Sundvall M, 2012, J BIOL CHEM, V287, P23216, DOI 10.1074/jbc.M111.335927; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Vethantham V, 2008, GENE DEV, V22, P499, DOI 10.1101/gad.1628208; Wang JH, 2009, J BIOL CHEM, V284, P20340, DOI 10.1074/jbc.M109.000257; WEIS K, 1995, SCIENCE, V268, P1049, DOI 10.1126/science.7754385; Weisshaar SR, 2008, FEBS LETT, V582, P3174, DOI 10.1016/j.febslet.2008.08.008; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Yao Z, 2001, ONCOGENE, V20, P7588, DOI 10.1038/sj.onc.1204963; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200	47	34	35	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42611	42619		10.1074/jbc.M112.420877	http://dx.doi.org/10.1074/jbc.M112.420877			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23095757	hybrid, Green Published			2022-12-25	WOS:000312501600022
J	Saikia, M; Krokowski, D; Guan, BJ; Ivanov, P; Parisien, M; Hu, GF; Anderson, P; Pan, T; Hatzoglou, M				Saikia, Mridusmita; Krokowski, Dawid; Guan, Bo-Jhih; Ivanov, Pavel; Parisien, Marc; Hu, Guo-fu; Anderson, Paul; Pan, Tao; Hatzoglou, Maria			Genome-wide Identification and Quantitative Analysis of Cleaved tRNA Fragments Induced by Cellular Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE STRESS; TRANSLATION INITIATION; OSMOTIC-STRESS; ANGIOGENIN; KINASE; STARVATION; INHIBITOR; SURVIVAL; PHOSPHORYLATION; RIBONUCLEASE	Certain stress conditions can induce cleavage of tRNAs around the anticodon loop via the use of the ribonuclease angiogenin. The cellular factors that regulate tRNA cleavage are not well known. In this study we used normal and eIF2 alpha phosphorylation-deficient mouse embryonic fibroblasts and applied a microarray-based methodology to identify and compare tRNA cleavage patterns in response to hypertonic stress, oxidative stress (arsenite), and treatment with recombinant angiogenin. In all three scenarios mouse embryonic fibroblasts deficient in eIF2 alpha phosphorylation showed a higher accumulation of tRNA fragments including those derived from initiator-tRNA(Met). We have shown that tRNA cleavage is regulated by the availability of angiogenin, its substrate (tRNA), the levels of the angiogenin inhibitor RNH1, and the rates of protein synthesis. These conclusions are supported by the following findings: (i) exogenous treatment with angiogenin or knockdown of RNH1 increased tRNA cleavage; (ii) tRNA fragment accumulation was higher during oxidative stress than hypertonic stress, in agreement with a dramatic decrease of RNH1 levels during oxidative stress; and (iii) a positive correlation was observed between angiogenin-mediated tRNA cleavage and global protein synthesis rates. Identification of the stress-specific tRNA cleavage mechanisms and patterns will provide insights into the role of tRNA fragments in signaling pathways and stress-related disorders.	[Saikia, Mridusmita; Krokowski, Dawid; Guan, Bo-Jhih; Hatzoglou, Maria] Case Western Reserve Univ, Dept Nutr, Cleveland, OH 44106 USA; [Ivanov, Pavel; Anderson, Paul] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA 02115 USA; [Parisien, Marc; Pan, Tao] Univ Chicago, Dept Biochem & Mol Biol, Chicago, IL 60637 USA; [Hu, Guo-fu] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA	Case Western Reserve University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Chicago; Tufts Medical Center	Saikia, M (corresponding author), Case Western Reserve Univ, Dept Nutr, 10900 Euclid Ave,RT 600H, Cleveland, OH 44106 USA.	mxs945@case.edu; mxh8@case.edu	Ivanov, Pavel/F-3339-2016	Ivanov, Pavel/0000-0002-7986-7760; Parisien, Marc/0000-0003-2924-5960; Saikia, Mridusmita/0000-0002-5848-3303	National Institutes of Health [DK060596, DK053307, DP1OD008169]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053307, R01DK060596, R37DK060596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065237] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD008169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants DK060596 and DK053307 (to M. H.) and DP1OD008169 (to T. P.).	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Bevilacqua E, 2010, J BIOL CHEM, V285, P17098, DOI 10.1074/jbc.M110.109439; Bjork GR, 1995, TRNA STRUCTURE BIOSY, P165; Bordeleau ME, 2006, NAT CHEM BIOL, V2, P213, DOI 10.1038/nchembio776; Brostrom CO, 1998, PROG NUCLEIC ACID RE, V58, P79; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Chen JJ, 2000, COLD SPRING HARBOR M, V39, P529; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; Dittmar KA, 2004, J MOL BIOL, V337, P31, DOI 10.1016/j.jmb.2004.01.024; Dittmar KA, 2005, EMBO REP, V6, P151, DOI 10.1038/sj.embor.7400341; Emara MM, 2010, J BIOL CHEM, V285, P10959, DOI 10.1074/jbc.M109.077560; Fu HJ, 2009, FEBS LETT, V583, P437, DOI 10.1016/j.febslet.2008.12.043; Gaccioli F, 2006, J BIOL CHEM, V281, P17929, DOI 10.1074/jbc.M600341200; Giege R, 2008, NAT STRUCT MOL BIOL, V15, P1007, DOI 10.1038/nsmb.1498; Go WY, 2004, P NATL ACAD SCI USA, V101, P10673, DOI 10.1073/pnas.0403139101; Gustilo EM, 2008, CURR OPIN MICROBIOL, V11, P134, DOI 10.1016/j.mib.2008.02.003; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; HIGA T, 1981, TETRAHEDRON LETT, V22, P2777, DOI 10.1016/S0040-4039(01)90550-7; HIGA T, 1981, CHEM LETT, P1647, DOI 10.1246/cl.1981.1647; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Jochl C, 2008, NUCLEIC ACIDS RES, V36, P2677, DOI 10.1093/nar/gkn123; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kaufman RJ, 2000, COLD SPRING HARBOR M, V39, P503; Kawaji H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-157; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Kishikawa H, 2008, EXPERT OPIN THER TAR, V12, P1229, DOI 10.1517/14728222.12.10.1229 ; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Komar AA, 2011, CELL CYCLE, V10, P229, DOI 10.4161/cc.10.2.14472; Krokowski D, 2011, CELL CYCLE, V10, P2691, DOI 10.4161/cc.10.16.16844; Kwon MS, 2009, PHYSIOLOGY, V24, P186, DOI 10.1152/physiol.00005.2009; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Lee SH, 2010, J BIOL CHEM, V285, P41280, DOI 10.1074/jbc.M110.182188; Lee SR, 2005, J BIOL CHEM, V280, P42744, DOI 10.1074/jbc.M510356200; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; LEVITZ R, 1990, EMBO J, V9, P1383, DOI 10.1002/j.1460-2075.1990.tb08253.x; Li SP, 2012, J CELL PHYSIOL, V227, P2822, DOI 10.1002/jcp.23051; Lu LR, 2001, MOL CELL BIOL, V21, P7971, DOI 10.1128/MCB.21.23.7971-7980.2001; Luo Lihui, 2005, Eye Contact Lens, V31, P186, DOI 10.1097/01.ICL.0000162759.79740.46; Majumder M, 2012, MOL CELL BIOL, V32, P992, DOI 10.1128/MCB.06665-11; Marshall L, 2008, CELL, V133, P78, DOI 10.1016/j.cell.2008.02.035; McEwen E, 2005, J BIOL CHEM, V280, P16925, DOI 10.1074/jbc.M412882200; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Naddeo N, 2005, FEBS LETT, V579, P2663, DOI 10.1016/j.febslet.2005.03.087; NEGRUTSKII BS, 1991, P NATL ACAD SCI USA, V88, P4991, DOI 10.1073/pnas.88.11.4991; NEGRUTSKII BS, 1994, P NATL ACAD SCI USA, V91, P964, DOI 10.1073/pnas.91.3.964; Netzer N, 2009, NATURE, V462, P522, DOI 10.1038/nature08576; Ron D, 2000, COLD SPRING HARBOR M, V39, P547; Saikia M, 2010, RNA, V16, P1317, DOI 10.1261/rna.2057810; SAXENA SK, 1992, J BIOL CHEM, V267, P21982; Schaefer M, 2010, GENE DEV, V24, P1590, DOI 10.1101/gad.586710; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Schwartz L, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-21; SHAPIRO R, 1987, P NATL ACAD SCI USA, V84, P2238, DOI 10.1073/pnas.84.8.2238; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; STAPULIONIS R, 1995, P NATL ACAD SCI USA, V92, P7158, DOI 10.1073/pnas.92.16.7158; Stohrer M, 2000, CANCER RES, V60, P4251; Thompson DM, 2008, RNA, V14, P2095, DOI 10.1261/rna.1232808; Thompson DM, 2009, CELL, V138, P215, DOI 10.1016/j.cell.2009.07.001; Thompson DM, 2009, J CELL BIOL, V185, P43, DOI 10.1083/jcb.200811119; Tsuji T, 2005, CANCER RES, V65, P1352, DOI 10.1158/0008-5472.CAN-04-2058; van Es MA, 2011, ANN NEUROL, V70, P964, DOI 10.1002/ana.22611; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Yamasaki S, 2008, CURR OPIN CELL BIOL, V20, P222, DOI 10.1016/j.ceb.2008.01.013; Yamasaki S, 2009, J CELL BIOL, V185, P35, DOI 10.1083/jcb.200811106; Zaborske JM, 2009, J BIOL CHEM, V284, P25254, DOI 10.1074/jbc.M109.000877; Zhang SD, 2009, PLANT PHYSIOL, V150, P378, DOI 10.1104/pp.108.134767	70	143	149	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42708	42725		10.1074/jbc.M112.371799	http://dx.doi.org/10.1074/jbc.M112.371799			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23086926	hybrid, Green Published			2022-12-25	WOS:000312501600031
J	Ding, WX; Guo, FL; Ni, HM; Bockus, A; Manley, S; Stolz, DB; Eskelinen, EL; Jaeschke, H; Yin, XM				Ding, Wen-Xing; Guo, Fengli; Ni, Hong-Min; Bockus, Abigail; Manley, Sharon; Stolz, Donna B.; Eskelinen, Eeva-Liisa; Jaeschke, Hartmut; Yin, Xiao-Ming			Parkin and Mitofusins Reciprocally Regulate Mitophagy and Mitochondrial Spheroid Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME SYSTEM; CELL-DEATH; CASPASE ACTIVATION; OXIDATIVE STRESS; AUTOPHAGY; DISEASE; FUSION; LIVER; FRAGMENTATION; DEGRADATION	Mitochondrial homeostasis via mitochondrial dynamics and quality control is crucial to normal cellular functions. Mitophagy (mitochondria removed by autophagy) stimulated by a mitochondrial uncoupler, carbonyl cyanide m-chlorophenylhydrazone (CCCP), requires Parkin, but it is not clear why Parkin is crucial to this process. We found that in the absence of Parkin, carbonyl cyanide m-chlorophenylhydrazone induced the formation of mitochondrial spheroids. Mitochondrial spheroid formation is also induced in vivo in the liver by acetaminophen overdose, a condition causing severe oxidative mitochondrial damages and liver injury. Mitochondrial spheroids could undergo a maturation process by interactions with acidic compartments. The formation of this new structure required reactive oxygen species and mitofusins. Parkin suppressed these mitochondrial dynamics by promoting mitofusin degradation. Consistently, genetic deletion of mitofusins without concomitant expression of Parkin was sufficient to prevent mitochondrial spheroid formation and resumed mitophagy. Mitochondrial spheroid formation and mitophagy could represent different strategies of mitochondrial homeostatic response to oxidative stress and are reciprocally regulated by mitofusins and Parkin.	[Ding, Wen-Xing; Ni, Hong-Min; Bockus, Abigail; Manley, Sharon; Jaeschke, Hartmut] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Guo, Fengli] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Stolz, Donna B.] Univ Pittsburgh, Dept Cell Biol & Physiol, Sch Med, Pittsburgh, PA 15261 USA; [Eskelinen, Eeva-Liisa] Univ Helsinki, Div Biochem & Biotechnol, Dept Biosci, FIN-00014 Helsinki, Finland; [Yin, Xiao-Ming] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA	University of Kansas; University of Kansas Medical Center; Stowers Institute for Medical Research; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Helsinki; Indiana University System; Indiana University Bloomington	Ding, WX (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, MS 1018,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	wxding@kumc.edu; xmyin@iupui.edu	Jaeschke, Hartmut/J-6285-2013; Eskelinen, Eeva-Liisa/AAF-3496-2019	Eskelinen, Eeva-Liisa/0000-0003-0006-7785; Manley, Sharon/0000-0002-2411-9706	National Institutes of Health [R01 AA020518-01, R21AA017421, P20 RR021940, P20 RR016475, R01CA111456, R01CA83817]; NATIONAL CANCER INSTITUTE [R01CA083817, R01CA111456] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR021940, P20RR016475] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM103529, P20GM103418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA020518, R01AA020518, R21AA017421] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AA020518-01, R21AA017421, P20 RR021940, and P20 RR016475 (to W.X.D.) and R01CA111456 and R01CA83817 (to X.M.Y.).	Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; CHRISTENSEN AK, 1959, EXP CELL RES, V18, P576, DOI 10.1016/0014-4827(59)90323-4; Detmer SA, 2007, J CELL BIOL, V176, P405, DOI 10.1083/jcb.200611080; Ding WX, 2007, AM J PATHOL, V171, P513, DOI 10.2353/ajpath.2007.070188; Ding WX, 2012, J BIOL CHEM, V287, P42373, DOI 10.1074/jbc.M112.413674; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Eskelinen EL, 2004, MOL BIOL CELL, V15, P3132, DOI 10.1091/mbc.E04-02-0103; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Izeradjene K, 2005, CANCER RES, V65, P7436, DOI 10.1158/0008-5472.CAN-04-2628; Jaeschke H, 2011, LIFE SCI, V88, P737, DOI 10.1016/j.lfs.2011.01.025; Kanki T, 2010, MOL MICROBIOL, V75, P795, DOI 10.1111/j.1365-2958.2009.07035.x; KIESSLING KH, 1964, EXP CELL RES, V33, P350, DOI 10.1016/S0014-4827(64)81040-5; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; LAUBER JK, 1983, CURR EYE RES, V2, P855, DOI 10.3109/02713688209020022; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Liot G, 2009, CELL DEATH DIFFER, V16, P899, DOI 10.1038/cdd.2009.22; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Matsuyama S, 2000, NAT CELL BIOL, V2, P318, DOI 10.1038/35014006; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Pletjushkina OY, 2006, BBA-BIOENERGETICS, V1757, P518, DOI 10.1016/j.bbabio.2006.03.018; Ricci JE, 2003, CELL DEATH DIFFER, V10, P488, DOI 10.1038/sj.cdd.4401225; Sandoval H, 2008, NATURE, V454, P232, DOI 10.1038/nature07006; Scheffler I.E., 1999, MITOCHONDRIA, p[15, 145]; Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057; STEPHENS RJ, 1965, J CELL BIOL, V24, P500, DOI 10.1083/jcb.24.3.500; Tanaka A, 2010, J CELL BIOL, V191, P1367, DOI 10.1083/jcb.201007013; Tian CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005546; Tolkovsky AM, 2009, BBA-MOL CELL RES, V1793, P1508, DOI 10.1016/j.bbamcr.2009.03.002; Tujios S, 2011, NAT REV GASTRO HEPAT, V8, P202, DOI 10.1038/nrgastro.2011.22; Vives-Bauza C, 2010, P NATL ACAD SCI USA, V107, P378, DOI 10.1073/pnas.0911187107; Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	41	94	97	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42379	42388		10.1074/jbc.M112.413682	http://dx.doi.org/10.1074/jbc.M112.413682			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23095748	Green Published, hybrid			2022-12-25	WOS:000312103000073
J	Kotiguda, GG; Weinberg, D; Dessau, M; Salvi, C; Serino, G; Chamovitz, DA; Hirsch, JA				Kotiguda, Giri Gowda; Weinberg, Dahlia; Dessau, Moshe; Salvi, Chiara; Serino, Giovanna; Chamovitz, Daniel A.; Hirsch, Joel A.			The Organization of a CSN5-containing Subcomplex of the COP9 Signalosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS COP9; CELL-CYCLE; SUBUNIT INTERACTION; 26S PROTEASOME; LIGHT CONTROL; PCI DOMAIN; COMPLEX; ARCHITECTURE; PROTEIN; GENE	The COP9 signalosome (CSN) is an evolutionarily conserved multi-protein complex that interfaces with the ubiquitin-proteasome pathway and plays critical developmental roles in both animals and plants. Although some subunits are present only in an similar to 320-kDa complex-dependent form, other subunits are also detected in configurations distinct from the 8-subunit holocomplex. To date, the only known biochemical activity intrinsic to the complex, deneddylation of the Cullin subunits from Cullin-RING ubiquitin ligases, is assigned to CSN5. As an essential step to understanding the structure and assembly of a CSN5-containing subcomplex of the CSN, we reconstituted a CSN4-5-6-7 subcomplex. The core of the subcomplex is based on a stable heterotrimeric association of CSN7, CSN4, and CSN6, requiring coexpression in a bacterial reconstitution system. To this heterotrimer, we could then add CSN5 in vitro to reconstitute a quaternary complex. Using biochemical and biophysical methods, we identified pairwise and combinatorial interactions necessary for the formation of the CSN4-5-6-7 subcomplex. The subcomplex is stabilized by three types of interactions: MPN-MPN between CSN5 and CSN6, PCI-PCI between CSN4 and CSN7, and interactions mediated through the CSN6 C terminus with CSN4 and CSN7. CSN8 was also found to interact with the CSN4-6-7 core. These data provide a strong framework for further investigation of the organization and assembly of this pivotal regulatory complex.	[Kotiguda, Giri Gowda; Weinberg, Dahlia; Chamovitz, Daniel A.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Biol & Ecol Plants, IL-69978 Ramat Aviv, Israel; [Dessau, Moshe; Hirsch, Joel A.] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, IL-69978 Ramat Aviv, Israel; [Kotiguda, Giri Gowda; Dessau, Moshe; Hirsch, Joel A.] Tel Aviv Univ, George S Wise Fac Life Sci, Inst Biol Struct, IL-69978 Ramat Aviv, Israel; [Salvi, Chiara; Serino, Giovanna] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol, Rome, Italy; [Serino, Giovanna] New York Bot Garden, Bronx, NY 10458 USA	Tel Aviv University; Tel Aviv University; Tel Aviv University; Sapienza University Rome; New York Botanical Garden	Chamovitz, DA (corresponding author), Tel Aviv Univ, George S Wise Fac Life Sci, Dept Mol Biol & Ecol Plants, IL-69978 Ramat Aviv, Israel.	dannyc@tauex.tau.ac.il; jhirsch@post.tau.ac.il	Chamovitz, Daniel/S-5021-2019; Serino, Giovanna/W-4683-2019; Hirsch, Joel/AAC-8000-2021	Chamovitz, Daniel/0000-0002-2815-2909; Serino, Giovanna/0000-0001-8689-6132; Hirsch, Joel/0000-0001-7544-8668	Israel Science Foundation [145/09]; Sapienza University [C26F09JTKN]; Manna Center for Plant Biosciences (Tel Aviv University)	Israel Science Foundation(Israel Science Foundation); Sapienza University; Manna Center for Plant Biosciences (Tel Aviv University)	This work was funded by a grant (145/09) from the Israel Science Foundation (to D. A. C.) and a 2009 Research Grant (Project C26F09JTKN) from Sapienza University (to G. S.).; Recipient of a George S. Wise post-doctoral fellowship and support from the Manna Center for Plant Biosciences (Tel Aviv University).	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Chamovitz DA, 1996, CELL, V86, P115, DOI 10.1016/S0092-8674(00)80082-3; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; Deng XW, 2000, TRENDS GENET, V16, P202, DOI 10.1016/S0168-9525(00)01982-X; Denti S, 2006, J BIOL CHEM, V281, P32188, DOI 10.1074/jbc.M604746200; Dessau M, 2008, PLANT CELL, V20, P2815, DOI 10.1105/tpc.107.053801; Dohmann EMN, 2005, PLANT CELL, V17, P1967, DOI 10.1105/tpc.105.032870; Emberley ED, 2012, J BIOL CHEM, V287, P29679, DOI 10.1074/jbc.M112.352484; Enchev RI, 2010, STRUCTURE, V18, P518, DOI 10.1016/j.str.2010.02.008; Fischer ES, 2011, CELL, V147, P1024, DOI 10.1016/j.cell.2011.10.035; Fu HY, 2001, EMBO J, V20, P7096, DOI 10.1093/emboj/20.24.7096; Fukumoto A, 2005, FEBS LETT, V579, P1047, DOI 10.1016/j.febslet.2004.12.076; Golemis E A, 1997, Methods Mol Biol, V63, P197; Gusmaroli G, 2007, PLANT CELL, V19, P564, DOI 10.1105/tpc.106.047571; Halimi Y, 2011, PLANT MOL BIOL, V77, P77, DOI 10.1007/s11103-011-9795-8; Harari-Steinberg O, 2004, CURR PROTEIN PEPT SC, V5, P185, DOI 10.2174/1389203043379792; Hofmann K, 1998, TRENDS BIOCHEM SCI, V23, P204, DOI 10.1016/S0968-0004(98)01217-1; Kapelari B, 2000, J MOL BIOL, V300, P1169, DOI 10.1006/jmbi.2000.3912; Karniol B, 1999, PLANT CELL, V11, P839, DOI 10.1105/tpc.11.5.839; Kwok SF, 1998, PLANT CELL, V10, P1779, DOI 10.1105/tpc.10.11.1779; Lander GC, 2012, NATURE, V482, P186, DOI 10.1038/nature10774; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Menon S, 2007, NAT IMMUNOL, V8, P1236, DOI 10.1038/ni1514; Mundt KE, 2002, MOL BIOL CELL, V13, P493, DOI 10.1091/mbc.01-10-0521; Opatowsky Y, 2003, J BIOL CHEM, V278, P52323, DOI 10.1074/jbc.M303564200; Oron E, 2002, DEVELOPMENT, V129, P4399; Oron E, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100150; Peng ZH, 2001, DEVELOPMENT, V128, P4277; Pick E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043980; Pick E, 2009, MOL CELL, V35, P260, DOI 10.1016/j.molcel.2009.07.009; Scheel H, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-71; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Serino G, 1999, PLANT CELL, V11, P1967, DOI 10.1105/tpc.11.10.1967; Serino G, 2003, PLANT CELL, V15, P719, DOI 10.1105/tpc.009092; Sharon M, 2009, STRUCTURE, V17, P31, DOI 10.1016/j.str.2008.10.012; Tomoda K, 2002, J BIOL CHEM, V277, P2302, DOI 10.1074/jbc.M104431200; Tomoda K, 2005, BLOOD, V105, P775, DOI 10.1182/blood-2004-04-1242; Tomoda K, 2004, J BIOL CHEM, V279, P43013, DOI 10.1074/jbc.M406559200; Tsuge T, 2001, J MOL BIOL, V305, P1, DOI 10.1006/jmbi.2000.4288; Turoverov KK, 2010, PROG BIOPHYS MOL BIO, V102, P73, DOI 10.1016/j.pbiomolbio.2010.01.003; Wei N, 2003, ANNU REV CELL DEV BI, V19, P261, DOI 10.1146/annurev.cellbio.19.111301.112449; WEI N, 1994, CELL, V78, P117, DOI 10.1016/0092-8674(94)90578-9; Wei N, 2008, TRENDS BIOCHEM SCI, V33, P592, DOI 10.1016/j.tibs.2008.09.004	45	24	28	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42031	42041		10.1074/jbc.M112.387977	http://dx.doi.org/10.1074/jbc.M112.387977			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086934	Green Published, hybrid			2022-12-25	WOS:000312103000042
J	Thompson, CH; Porter, JC; Kahlig, KM; Daniels, MA; George, AL				Thompson, Christopher H.; Porter, J. Christopher; Kahlig, Kristopher M.; Daniels, Melissa A.; George, Alfred L., Jr.			Nontruncating SCN1A Mutations Associated with Severe Myoclonic Epilepsy of Infancy Impair Cell Surface Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED SODIUM-CHANNELS; LONG QT SYNDROME; CYSTIC-FIBROSIS; MOLECULAR-BASIS; SEIZURES; TRAFFICKING; RESCUE; INTERNEURONS; DYSFUNCTION; DISORDERS	Mutations in SCN1A, encoding the voltage-gated sodium channel Na(V)1.1, are the most common cause of severe myoclonic epilepsy of infancy (SMEI) or Dravet syndrome. SMEI is most often associated with premature truncations of Na(V)1.1 that cause loss of function, but nontruncating mutations also occur. We hypothesized that some nontruncating mutations might impair trafficking of NaV1.1 to the plasma membrane. Here we demonstrated that seven nontruncating missense or in-frame deletion mutations (L986F, delF1289, R1648C, F1661S, G1674R, and G1979E) exhibited reduced cell surface expression relative to wild type (WT) Na(V)1.1 consistent with impaired trafficking. We tested whether two commonly prescribed antiepileptic drugs (phenytoin, lamotrigine), as well as the cystic fibrosis transmembrane conductance regulator (CFTR) trafficking corrector VRT-325, could rescue cell surface and functional expression of two representative Na(V)1.1 mutants (R1648C, G1674R). Treatment of cells with phenytoin increased cell surface expression of WT-Na(V)1.1 and both mutant channels, whereas lamotrigine only increased surface expression of R1648C. VRT-325 did not alter surface expression of WT-Na(V)1.1 or mutant channels. Although phenytoin increased surface expression of G1674R, channel function was not restored, suggesting that this mutation also causes an intrinsic loss of function. Both phenytoin and lamotrigine increased functional expression of R1648C, but lamotrigine also increased persistent sodium current evoked by this mutation. Our findings indicate that certain nontruncating SCN1A mutations associated with SMEI have impaired cell surface expression and that some alleles may be amenable to pharmacological rescue of this defect. However, rescue of dysfunctional Na(V)1.1 channels to the plasma membrane could contribute to exacerbating rather than ameliorating the disease.	[Thompson, Christopher H.; Porter, J. Christopher; Daniels, Melissa A.; George, Alfred L., Jr.] Vanderbilt Univ, Div Genet Med, Dept Med, Nashville, TN 37232 USA; [Kahlig, Kristopher M.; George, Alfred L., Jr.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	George, AL (corresponding author), Vanderbilt Univ, Div Genet Med, Dept Med, 2215 Garland Ave,529 Light Hall, Nashville, TN 37232 USA.	al.george@vanderbilt.edu	Porter, Joanna/C-7162-2009	Porter, Joanna/0000-0002-7307-169X	National Institutes of Health [NS032387]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH065215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS032387, R37NS032387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS032387 (to A. L. G.).	Becq F, 2011, J CYST FIBROS, V10, pS129, DOI 10.1016/S1569-1993(11)60018-0; Catterall WA, 2010, J PHYSIOL-LONDON, V588, P1849, DOI 10.1113/jphysiol.2010.187484; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Ficker E, 2002, J BIOL CHEM, V277, P4989, DOI 10.1074/jbc.M107345200; George AL, 2005, J CLIN INVEST, V115, P1990, DOI 10.1172/JCI25505; Guerrini R, 1998, EPILEPSIA, V39, P508, DOI 10.1111/j.1528-1157.1998.tb01413.x; Guerrini R, 1998, EPILEPSIA, V39, pS2, DOI 10.1111/j.1528-1157.1998.tb05118.x; Isom LL, 2001, NEUROSCIENTIST, V7, P42, DOI 10.1177/107385840100700108; Kahlig KM, 2008, P NATL ACAD SCI USA, V105, P9799, DOI 10.1073/pnas.0711717105; Kahlig KM, 2010, P NATL ACAD SCI USA, V107, P1343, DOI 10.1073/pnas.0910383107; Lossin C, 2002, NEURON, V34, P877, DOI 10.1016/S0896-6273(02)00714-6; Lossin C, 2009, BRAIN DEV-JPN, V31, P114, DOI 10.1016/j.braindev.2008.07.011; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Meisler MH, 2010, J PHYSIOL-LONDON, V588, P1841, DOI 10.1113/jphysiol.2010.188482; Mulley JC, 2005, HUM MUTAT, V25, P535, DOI 10.1002/humu.20178; Ogiwara I, 2007, J NEUROSCI, V27, P5903, DOI 10.1523/JNEUROSCI.5270-06.2007; Ohmori I, 2006, EPILEPSIA, V47, P1636, DOI 10.1111/j.1528-1167.2006.00643.x; Rhodes TH, 2005, J PHYSIOL-LONDON, V569, P433, DOI 10.1113/jphysiol.2005.094326; Rhodes TH, 2004, P NATL ACAD SCI USA, V101, P11147, DOI 10.1073/pnas.0402482101; Rusconi R, 2007, J NEUROSCI, V27, P11037, DOI 10.1523/JNEUROSCI.3515-07.2007; Sanders CR, 2004, ANNU REV BIOPH BIOM, V33, P25, DOI 10.1146/annurev.biophys.33.110502.140348; Thompson CH, 2011, EPILEPSIA, V52, P1000, DOI 10.1111/j.1528-1167.2011.03040.x; Van Goor F, 2006, AM J PHYSIOL-LUNG C, V290, pL1117, DOI 10.1152/ajplung.00169.2005; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Volkers L, 2011, EUR J NEUROSCI, V34, P1268, DOI 10.1111/j.1460-9568.2011.07826.x; Yu FH, 2006, NAT NEUROSCI, V9, P1142, DOI 10.1038/nn1754; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123	27	32	34	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42001	42008		10.1074/jbc.M112.421883	http://dx.doi.org/10.1074/jbc.M112.421883			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086956	Green Published, hybrid			2022-12-25	WOS:000312103000039
J	Hwang, I; Kim, J; Jeong, S				Hwang, Injoo; Kim, Jeeho; Jeong, Sunjoo			beta-Catenin and Peroxisome Proliferator-activated Receptor-delta Coordinate Dynamic Chromatin Loops for the Transcription of Vascular Endothelial Growth Factor A Gene in Colon Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Vascular endothelial growth factor A (VEGFA) mRNA is regulated by beta-catenin and peroxisome proliferator activated receptor delta (PPAR-delta) activation in colon cancer cells, but the detailed mechanism remains to be elucidated. As chromatin loops are generally hubs for transcription factors, we tested here whether beta-catenin could modulate chromatin looping near the VEGFA gene and play any important role for PPAR-delta activated VEGFA transcription. First, we identified the far upstream site as an important site for VEGFA transcription by luciferase assay and chromatin immunoprecipitation in colorectal carcinoma HCT116 cells. Chromatin conformation capture analysis also revealed the chromatin loops formed by the beta-catenin bindings on these sites near the VEGFA gene. Dynamic association and dissociation of beta-catenin/TCF-4/PPAR-delta on the far upstream site and beta-catenin/NF-kappa B p65 on the downstream site were also detected depending on PPAR-delta activation. Interestingly, beta-catenin-mediated chromatin loops were relieved by PPAR-delta activation, suggesting a regulatory role of beta-catenin for VEGFA transcription. Based on these data, we propose a model for PPAR-delta-activated VEGFA transcription that relies on beta-catenin-mediated chromatin looping as a prerequisite for the activation. Our findings could extend to other beta-catenin regulated target genes and could provide a general mechanism and novel paradigm for beta-catenin-mediated oncogenesis.	Dankook Univ, Natl Res Lab RNA Cell Biol, Grad Program RNA Biol BK21, Inst Nanosensor & Biotechnol, Gyeonggi Do 448701, South Korea; [Jeong, Sunjoo] Dankook Univ, Dept Mol Biol, Gyeonggi Do 448701, South Korea	Dankook University; Dankook University	Jeong, S (corresponding author), Dankook Univ, Dept Mol Biol, Gyeonggi Do 448701, South Korea.	sjsj@dankook.ac.kr		Kim, Jeeho/0000-0001-6869-3606				Aarenstrup L, 2008, J INVEST DERMATOL, V128, P1095, DOI 10.1038/sj.jid.5701146; Allred CD, 2008, J NUTR, V138, P250, DOI 10.1093/jn/138.2.250; Babbar N, 2003, J BIOL CHEM, V278, P47762, DOI 10.1074/jbc.M307265200; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Billin AN, 2000, MOL CELL BIOL, V20, P6882, DOI 10.1128/MCB.20.18.6882-6890.2000; Castrillo A, 2004, ANNU REV CELL DEV BI, V20, P455, DOI 10.1146/annurev.cellbio.20.012103.134432; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Choi YS, 2007, NUCLEIC ACIDS RES, V35, P5511, DOI 10.1093/nar/gkm547; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; de Laat W, 2003, CHROMOSOME RES, V11, P447, DOI 10.1023/A:1024922626726; Dekker J, 2006, NAT METHODS, V3, P17, DOI 10.1038/NMETH823; Easwaran V, 2003, CANCER RES, V63, P3145; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fauconnet S, 2002, J BIOL CHEM, V277, P23534, DOI 10.1074/jbc.M200172200; Foreman JE, 2011, MOL CARCINOGEN, V50, P884, DOI 10.1002/mc.20757; Goodwin A. M., 2002, Angiogenesis, V5, P1, DOI 10.1023/A:1021563510866; Grothey A, 2009, NAT REV CLIN ONCOL, V6, P507, DOI 10.1038/nrclinonc.2009.110; Gupta RA, 2000, P NATL ACAD SCI USA, V97, P13275, DOI 10.1073/pnas.97.24.13275; Hampsey M, 2011, ADV ENZYME REGUL, V51, P118, DOI 10.1016/j.advenzreg.2010.10.001; Han C, 2008, J CELL BIOCHEM, V105, P534, DOI 10.1002/jcb.21852; Handeli S, 2008, MOL CANCER THER, V7, P521, DOI 10.1158/1535-7163.MCT-07-2063; Hao CY, 2005, CLIN CANCER RES, V11, P1400, DOI 10.1158/1078-0432.CCR-04-1942; Harman FS, 2004, NAT MED, V10, P481, DOI 10.1038/nm1026; Hatzis P, 2008, MOL CELL BIOL, V28, P2732, DOI 10.1128/MCB.02175-07; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hollingshead HE, 2007, CARCINOGENESIS, V28, P2641, DOI 10.1093/carcin/bgm183; Hsu PY, 2010, GENOME RES, V20, P733, DOI 10.1101/gr.101923.109; Hwang I, 2010, BIOCHEM BIOPH RES CO, V403, P79, DOI 10.1016/j.bbrc.2010.10.118; Ignatenko NA, 2004, MOL CARCINOGEN, V39, P91, DOI 10.1002/mc.10166; Kim DJ, 2006, CELL DEATH DIFFER, V13, P53, DOI 10.1038/sj.cdd.4401713; Kim YJ, 2011, P NATL ACAD SCI USA, V108, P7391, DOI 10.1073/pnas.1018279108; Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Kwak H, 2009, MOL CANCER THER, V8, P2664, DOI 10.1158/1535-7163.MCT-09-0214; Li QL, 2006, TRENDS GENET, V22, P197, DOI 10.1016/j.tig.2006.02.004; Margariti A, 2010, CIRC RES, V106, P1202, DOI 10.1161/CIRCRESAHA.109.213165; Moraes LA, 2006, PHARMACOL THERAPEUT, V110, P371, DOI 10.1016/j.pharmthera.2005.08.007; Mosimann C, 2009, NAT REV MOL CELL BIO, V10, P276, DOI 10.1038/nrm2654; Muller R, 2004, J CANCER RES CLIN, V130, P429, DOI 10.1007/s00432-004-0570-y; Notterman DA, 2001, CANCER RES, V61, P3124; Oishi Y, 2008, NAT MED, V14, P656, DOI 10.1038/nm1756; Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046; Park BH, 2001, P NATL ACAD SCI USA, V98, P2598, DOI 10.1073/pnas.051630998; Peeters Louis L. H., 2005, Angiogenesis, V8, P373; Rao TP, 2010, CIRC RES, V106, P1798, DOI 10.1161/CIRCRESAHA.110.219840; Reed KR, 2004, ONCOGENE, V23, P8992, DOI 10.1038/sj.onc.1208143; Rohrl C, 2011, J CANCER RES CLIN, V137, P29, DOI 10.1007/s00432-010-0856-1; Saif MW, 2010, CANCER J, V16, P196, DOI 10.1097/PPO.0b013e3181e076af; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Stephen RL, 2004, CANCER RES, V64, P3162, DOI 10.1158/0008-5472.CAN-03-2760; Takayama O, 2006, BRIT J CANCER, V95, P889, DOI 10.1038/sj.bjc.6603343; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Wagner N, 2009, CARDIOVASC RES, V83, P61, DOI 10.1093/cvr/cvp106; Wang DZ, 2007, CELL CYCLE, V6, P682, DOI 10.4161/cc.6.6.4030; Wang DZ, 2006, P NATL ACAD SCI USA, V103, P19069, DOI 10.1073/pnas.0607948103; Wang DZ, 2008, PPAR RES, V2008, DOI 10.1155/2008/931074; Wang DZ, 2004, CANCER CELL, V6, P285, DOI 10.1016/j.ccr.2004.08.011; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Wu CW, 2009, ONCOL REP, V22, P451, DOI 10.3892/or_00000456; Yochum GS, 2007, P NATL ACAD SCI USA, V104, P3324, DOI 10.1073/pnas.0611576104; Yochum GS, 2010, P NATL ACAD SCI USA, V107, P145, DOI 10.1073/pnas.0912294107; Yochum GS, 2008, MOL CELL BIOL, V28, P7368, DOI 10.1128/MCB.00744-08; Zhang XB, 2001, CANCER RES, V61, P6050; Zuo XS, 2009, JNCI-J NATL CANCER I, V101, P762, DOI 10.1093/jnci/djp078	65	21	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41364	41373		10.1074/jbc.M112.377739	http://dx.doi.org/10.1074/jbc.M112.377739			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	V34EZ	23086933	hybrid, Green Published			2022-12-25	WOS:000209071000001
J	Bagamian, KH; Towner, JS; Kuenzi, AJ; Douglass, RJ; Rollin, PE; Waller, LA; Mills, JN				Bagamian, Karoun H.; Towner, Jonathan S.; Kuenzi, Amy J.; Douglass, Richard J.; Rollin, Pierre E.; Waller, Lance A.; Mills, James N.			Transmission Ecology of Sin Nombre Hantavirus in Naturally Infected North American Deermouse Populations in Outdoor Enclosures	PLOS ONE			English	Article							MOUSE PEROMYSCUS-MANICULATUS; MALE NORWAY RATS; SOUTHWESTERN UNITED-STATES; CREEK CANAL VIRUS; DEER MICE; SEOUL-VIRUS; GENETIC IDENTIFICATION; PUUMALA HANTAVIRUS; PULMONARY SYNDROME; HEMORRHAGIC-FEVER	Sin Nombre hantavirus (SNV), hosted by the North American deermouse (Peromyscus maniculatus), causes hantavirus pulmonary syndrome (HPS) in North America. Most transmission studies in the host were conducted under artificial conditions, or extrapolated information from mark-recapture data. Previous studies using experimentally infected deermice were unable to demonstrate SNV transmission. We explored SNV transmission in outdoor enclosures using naturally infected deermice. Deermice acquiring SNV in enclosures had detectable viral RNA in blood throughout the acute phase of infection and acquired significantly more new wounds (indicating aggressive encounters) than uninfected deermice. Naturally-infected wild deermice had a highly variable antibody response to infection, and levels of viral RNA sustained in blood varied as much as 100-fold, even in individuals infected with identical strains of virus. Deermice that infected other susceptible individuals tended to have a higher viral RNA load than those that did not infect other deermice. Our study is a first step in exploring the transmission ecology of SNV infection in deermice and provides new knowledge about the factors contributing to the increase of the prevalence of a zoonotic pathogen in its reservoir host and to changes in the risk of HPS to human populations. The techniques pioneered in this study have implications for a wide range of zoonotic disease studies.	[Bagamian, Karoun H.; Mills, James N.] Emory Univ, Populat Biol Ecol & Evolut Program, Atlanta, GA 30322 USA; [Bagamian, Karoun H.; Towner, Jonathan S.; Rollin, Pierre E.; Mills, James N.] Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA; [Bagamian, Karoun H.; Kuenzi, Amy J.; Douglass, Richard J.] Univ Montana, Dept Biol, Butte, MT USA; [Waller, Lance A.] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat, Atlanta, GA 30322 USA	Emory University; Centers for Disease Control & Prevention - USA; University of Montana System; University of Montana; Emory University; Rollins School Public Health	Bagamian, KH (corresponding author), Emory Univ, Populat Biol Ecol & Evolut Program, Atlanta, GA 30322 USA.	karoun11@gmail.com	Towner, Jonathan/ABC-3780-2020; Waller, Lance A./AAA-1012-2021	Rollin, Pierre/0000-0002-4608-2641	Oak Ridge Institute for Science and Education (ORISE); National Institutes of Health-Centers for Disease Control and Prevention (NIH-CDC) Public Health Dissertation Research [R-36]; NIH from the IDeA Network of Biomedical Research Excellence-Biomedical Research Infrastructure Network (INBRE-BRIN) program of the National Center for Research Resources [P20 RR16455-06, P20 RR16455-07]; CDC Viral Special Pathogens Branch; Montana Tech, University of Montana; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015525] Funding Source: NIH RePORTER	Oak Ridge Institute for Science and Education (ORISE); National Institutes of Health-Centers for Disease Control and Prevention (NIH-CDC) Public Health Dissertation Research; NIH from the IDeA Network of Biomedical Research Excellence-Biomedical Research Infrastructure Network (INBRE-BRIN) program of the National Center for Research Resources; CDC Viral Special Pathogens Branch; Montana Tech, University of Montana; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This project was funded by the Oak Ridge Institute for Science and Education (ORISE) Research Fellowship, National Institutes of Health-Centers for Disease Control and Prevention (NIH-CDC) Public Health Dissertation Research Grant R-36, NIH Grant P20 RR16455-06,07 from the IDeA Network of Biomedical Research Excellence-Biomedical Research Infrastructure Network (INBRE-BRIN) program of the National Center for Research Resources, CDC Viral Special Pathogens Branch, and Montana Tech, University of Montana. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler FR, 2008, B MATH BIOL, V70, P236, DOI 10.1007/s11538-007-9251-8; Bagamian KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037254; Bagamian KH, PLOS ONE IN PRESS, Vi; Botten J, 2000, P NATL ACAD SCI USA, V97, P10578, DOI 10.1073/pnas.180197197; Botten J, 2003, J VIROL, V77, P1540, DOI 10.1128/JVI.77.2.1540-1550.2002; Botten J, 2002, J VIROL, V76, P7587, DOI 10.1128/JVI.76.15.7587-7594.2002; Calisher CH, 2007, J WILDLIFE DIS, V43, P1, DOI 10.7589/0090-3558-43.1.1; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P449; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P521; CHILDS JE, 1994, J INFECT DIS, V169, P1271, DOI 10.1093/infdis/169.6.1271; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Clay CA, 2009, P R SOC B, V276, P1305, DOI 10.1098/rspb.2008.1693; DOHMAE K, 1994, J INFECT DIS, V170, P1589, DOI 10.1093/infdis/170.6.1589; Douglass RJ, 2007, J WILDLIFE DIS, V43, P12, DOI 10.7589/0090-3558-43.1.12; Douglass RJ, 2001, AM J TROP MED HYG, V65, P33, DOI 10.4269/ajtmh.2001.65.33; Easterbrook JD, 2007, HORM BEHAV, V52, P474, DOI 10.1016/j.yhbeh.2007.07.001; Easterbrook JD, 2007, P NATL ACAD SCI USA, V104, P15502, DOI 10.1073/pnas.0707453104; Fuller CA, 1996, ECOLOGY, V77, P2196, DOI 10.2307/2265712; GAVRILOVSKAYA IN, 1990, ARCH VIROL         S, V1, P57; GLASS GE, 1988, EPIDEMIOL INFECT, V101, P459, DOI 10.1017/S0950268800054418; Glass GE, 2000, EMERG INFECT DIS, V6, P238, DOI 10.3201/eid0603.000303; Hardestam J, 2008, EMERG INFECT DIS, V14, P1209, DOI 10.3201/eid1408.080221; Hinson ER, 2004, AM J TROP MED HYG, V70, P310, DOI 10.4269/ajtmh.2004.70.310; Hutchinson KL, 2000, J MED VIROL, V60, P70, DOI 10.1002/(SICI)1096-9071(200001)60:1<70::AID-JMV12>3.0.CO;2-1; Hutchinson KL, 1998, AM J TROP MED HYG, V59, P58, DOI 10.4269/ajtmh.1998.59.58; Kariwa H, 1998, ARCH VIROL, V143, P365, DOI 10.1007/s007050050292; KAUFMAN GA, 1989, J MAMMAL, V70, P656, DOI 10.2307/1381445; Klein SL, 2004, ANIM BEHAV, V67, P421, DOI 10.1016/j.anbehav.2003.03.022; Kuenzi AJ, 2005, J WILDLIFE DIS, V41, P473, DOI 10.7589/0090-3558-41.3.473; Kuenzi AJ, 2001, AM J TROP MED HYG, V64, P137, DOI 10.4269/ajtmh.2001.64.137; LEDUC JW, 1992, ANNU REV PUBL HEALTH, V13, P79, DOI 10.1146/annurev.pu.13.050192.000455; LEE HW, 1981, AM J TROP MED HYG, V30, P1106, DOI 10.4269/ajtmh.1981.30.1106; Luis AD, P NATL ACAD IN PRESS; Luis AD, 2012, OECOLOGIA, V169, P431, DOI 10.1007/s00442-011-2219-2; Mills J.N., 1995, METHODS TRAPPING SAM, P61; Mills JN, 2010, VECTOR-BORNE ZOONOT, V10, P563, DOI 10.1089/vbz.2009.0018; Mills JN, 1999, EMERG INFECT DIS, V5, P135, DOI 10.3201/eid0501.990116; Nemirov K, 2003, J VIROL, V77, P8793, DOI 10.1128/JVI.77.16.8793-8800.2003; NICHOL ST, 1993, SCIENCE, V262, P914, DOI 10.1126/science.8235615; Padula P, 2004, J VIROL, V78, P11972, DOI 10.1128/JVI.78.21.11972-11979.2004; PETERS C. J., 2006, TROPICAL INFECT DIS, P762; Plyusnin A, 1996, J GEN VIROL, V77, P2677, DOI 10.1099/0022-1317-77-11-2677; Schauber EM, 1997, ECOL APPL, V7, P143, DOI 10.1890/1051-0761(1997)007[0143:IEOSMI]2.0.CO;2; Schountz T, 2007, EMERG INFECT DIS, V13, P1604, DOI 10.3201/eid1310.070383; Schountz T, 2007, P NATL ACAD SCI USA, V104, P15496, DOI 10.1073/pnas.0707454104; Schountz T, 2012, J VIROL, V86, P10015, DOI 10.1128/JVI.06875-11; Sundstrom KB, 2011, J VIROL, V85, P1747, DOI 10.1128/JVI.01428-10; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; YANAGIHARA R, 1985, J VIROL, V55, P34, DOI 10.1128/JVI.55.1.34-38.1985; Yates TL, 2002, BIOSCIENCE, V52, P989, DOI 10.1641/0006-3568(2002)052[0989:TEAEHO]2.0.CO;2	50	16	17	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47731	10.1371/journal.pone.0047731	http://dx.doi.org/10.1371/journal.pone.0047731			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110096	gold, Green Published, Green Submitted			2022-12-25	WOS:000310262500019
J	Fernandez, P; Soria, M; Blesa, D; DiRienzo, J; Moschen, S; Rivarola, M; Clavijo, BJ; Gonzalez, S; Peluffo, L; Principi, D; Dosio, G; Aguirrezabal, L; Garcia-Garcia, F; Conesa, A; Hopp, E; Dopazo, J; Heinz, RA; Paniego, N				Fernandez, Paula; Soria, Marcelo; Blesa, David; DiRienzo, Julio; Moschen, Sebastian; Rivarola, Maximo; Jose Clavijo, Bernardo; Gonzalez, Sergio; Peluffo, Lucila; Principi, Dario; Dosio, Guillermo; Aguirrezabal, Luis; Garcia-Garcia, Francisco; Conesa, Ana; Hopp, Esteban; Dopazo, Joaquin; Amelia Heinz, Ruth; Paniego, Norma			Development, Characterization and Experimental Validation of a Cultivated Sunflower (Helianthus annuus L.) Gene Expression Oligonucleotide Microarray	PLOS ONE			English	Article							CDNA MICROARRAY; FUNCTIONAL ANNOTATION; SIGNAL-TRANSDUCTION; CANDIDATE GENES; SNP DISCOVERY; GENOMICS; DATABASE; TOOL; TRANSCRIPTOME; INFORMATION	Oligonucleotide-based microarrays with accurate gene coverage represent a key strategy for transcriptional studies in orphan species such as sunflower, H. annuus L., which lacks full genome sequences. The goal of this study was the development and functional annotation of a comprehensive sunflower unigene collection and the design and validation of a custom sunflower oligonucleotide-based microarray. A large scale EST (>130,000 ESTs) curation, assembly and sequence annotation was performed using Blast2GO (www.blast2go.de). The EST assembly comprises 41,013 putative transcripts (12,924 contigs and 28,089 singletons). The resulting Sunflower Unigen Resource (SUR version 1.0) was used to design an oligonucleotide-based Agilent microarray for cultivated sunflower. This microarray includes a total of 42,326 features: 1,417 Agilent controls, 74 control probes for sunflower replicated 10 times (740 controls) and 40,169 different non-control probes. Microarray performance was validated using a model experiment examining the induction of senescence by water deficit. Pre-processing and differential expression analysis of Agilent microarrays was performed using the Bioconductor limma package. The analyses based on p-values calculated by eBayes (p<0.01) allowed the detection of 558 differentially expressed genes between water stress and control conditions; from these, ten genes were further validated by qPCR. Over-represented ontologies were identified using FatiScan in the Babelomics suite. This work generated a curated and trustable sunflower unigene collection, and a custom, validated sunflower oligonucleotide-based microarray using Agilent technology. Both the curated unigene collection and the validated oligonucleotide microarray provide key resources for sunflower genome analysis, transcriptional studies, and molecular breeding for crop improvement.	[Fernandez, Paula; Moschen, Sebastian; Jose Clavijo, Bernardo; Hopp, Esteban; Amelia Heinz, Ruth; Paniego, Norma] Inst Nacl Tecnol Agropecuaria, Ctr Invest Ciencias Agron & Vet, Inst Biotecnol, Buenos Aires, DF, Argentina; [Soria, Marcelo] Univ Buenos Aires, Fac Agron, Buenos Aires, DF, Argentina; [Blesa, David; Garcia-Garcia, Francisco; Conesa, Ana; Dopazo, Joaquin] Ctr Invest Principe Felipe, Dept Bioinformat & Genom, Valencia, Spain; [DiRienzo, Julio] Univ Nacl Cordoba, Fac Ciencias Agr, Catedra Estadist & Biometria, RA-5000 Cordoba, Argentina; [Moschen, Sebastian; Dosio, Guillermo; Aguirrezabal, Luis] Univ Nacl Mar del Plata, Unidad Integrada, Lab Fisiol Vegetal, Estn Expt Agr INTA Balcarce, Buenos Aires, DF, Argentina; [Fernandez, Paula; Rivarola, Maximo; Peluffo, Lucila; Principi, Dario; Dosio, Guillermo; Aguirrezabal, Luis; Amelia Heinz, Ruth; Paniego, Norma] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Gonzalez, Sergio] Univ Buenos Aires, Fac Ingn, Buenos Aires, DF, Argentina; [Hopp, Esteban; Amelia Heinz, Ruth] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina; [Fernandez, Paula] Univ Nacl San Martin, Escuela Ciencia & Tecnol, Buenos Aires, DF, Argentina; [Garcia-Garcia, Francisco; Dopazo, Joaquin] Ctr Invest Principe Felipe, Natl Inst Bioinformat, Valencia, Spain	Instituto Nacional de Tecnologia Agropecuaria (INTA); University of Buenos Aires; Prince Felipe Research Center; National University of Cordoba; Instituto Nacional de Tecnologia Agropecuaria (INTA); National University of Mar del Plata; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires; Prince Felipe Research Center	Paniego, N (corresponding author), Inst Nacl Tecnol Agropecuaria, Ctr Invest Ciencias Agron & Vet, Inst Biotecnol, Buenos Aires, DF, Argentina.	npaniego@cnia.inta.gov.ar	García-García, Francisco/B-1929-2014; Paniego, Norma/AAK-6140-2021; Rivarola, Maximo L/C-1261-2014; Cegarra, Ana V Conesa/A-9559-2014; Blesa, David/D-8067-2018; García-García, Francisco/N-2263-2019; Dopazo, Joaquin/A-9270-2014	García-García, Francisco/0000-0001-8354-5636; Cegarra, Ana V Conesa/0000-0001-9597-311X; Blesa, David/0000-0002-1762-7833; García-García, Francisco/0000-0001-8354-5636; Dopazo, Joaquin/0000-0003-3318-120X; Dosio, Guillermo/0000-0003-1274-5862; Paniego, Norma/0000-0003-3906-5330; Clavijo, Bernardo J./0000-0002-7597-2774; Rivarola, Maximo/0000-0003-2818-1037; Moschen, Sebastian/0000-0002-9127-7958; Hopp, H. Esteban/0000-0002-2230-641X	Instituto Nacional de Tecnologia Agropecuaria (INTA, Argentina) [PPR241001/245001, PE245711/245732]; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, Argentina), Proyecto de Areas Estrategicas [PAE 2007 37100, PME 023, PID 073, PICT 15-32905]; Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET, Argentina), Proyectos de Investigacion Plurianuales [PIP 5788]; Universidad Nacional de Mar del Plata (UNMdP, Argentina) [AGR212/AGR260]; Agencia Espanola de Cooperacion Internacional y Desarrollo (AECID, Spain) [D/016099/08, D/024562/09, D/031348/10]; CONICET, Ing; AECID; Lic; ANPCyT fellowship	Instituto Nacional de Tecnologia Agropecuaria (INTA, Argentina); Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, Argentina), Proyecto de Areas Estrategicas; Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET, Argentina), Proyectos de Investigacion Plurianuales; Universidad Nacional de Mar del Plata (UNMdP, Argentina)(National University of La Plata); Agencia Espanola de Cooperacion Internacional y Desarrollo (AECID, Spain); CONICET, Ing; AECID; Lic; ANPCyT fellowship(ANPCyT)	This work was supported by grants from Instituto Nacional de Tecnologia Agropecuaria (INTA, Argentina) PPR241001/245001, PE245711/245732; Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT, Argentina), Proyecto de Areas Estrategicas PAE 2007 37100, PME 023, PID 073, PICT 15-32905; Consejo Nacional de Investigaciones Cientificas y Tecnologicas (CONICET, Argentina), Proyectos de Investigacion Plurianuales, PIP 5788; Universidad Nacional de Mar del Plata (UNMdP, Argentina) AGR212/AGR260; Agencia Espanola de Cooperacion Internacional y Desarrollo (AECID, Spain) D/016099/08, D/024562/09, D/031348/10. Dr. LP holds a fellowship from CONICET, Ing. SG holds a fellowship from AECID and Lic. SM holds an ANPCyT fellowship. Dr. PF, Dr. RAH, Dr. NP, Dr. MR, Dr. GD and Dr. LA are career members of the CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shahrour F, 2005, NUCLEIC ACIDS RES, V33, pW460, DOI 10.1093/nar/gki456; Al-Shahrour F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-114; Alignan M, 2006, NEW PHYTOL, V170, P523, DOI 10.1111/j.1469-8137.2006.01696.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bachlava E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029814; Bazin J, 2011, PLANT CELL, V23, P2196, DOI 10.1105/tpc.111.086694; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Booman M, 2011, MAR BIOTECHNOL, V13, P733, DOI 10.1007/s10126-010-9335-6; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brouillette LC, 2011, ANN BOT-LONDON, V107, P101, DOI 10.1093/aob/mcq203; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; Chen YA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-191; Cheng F, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-136; Clarke JD, 2006, PLANT J, V45, P630, DOI 10.1111/j.1365-313X.2006.02668.x; Close TJ, 2004, PLANT PHYSIOL, V134, P960, DOI 10.1104/pp.103.034462; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Di Rienzo J.A, 2009, FGSTATISTICS; Edwards KD, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-142; Ewing R M, 2000, Pac Symp Biocomput, P430; Fenart S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-592; Fernandez P, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-11; Fernandez P, 2011, PLANT CELL REP, V30, P63, DOI 10.1007/s00299-010-0944-3; Forment J, 2005, PLANT MOL BIOL, V57, P375, DOI 10.1007/s11103-004-7926-1; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hardiman G, 2004, PHARMACOGENOMICS, V5, P487, DOI 10.1517/14622416.5.5.487; Heesacker A, 2008, THEOR APPL GENET, V117, P1021, DOI 10.1007/s00122-008-0841-0; Hewezi T, 2006, PLANTA, V223, P948, DOI 10.1007/s00425-005-0151-6; Hewezi T, 2006, J EXP BOT, V57, P3109, DOI 10.1093/jxb/erl080; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; JAN CC, 2007, GENETIC RESOURCES CH, V4, P103; Kane NC, 2011, BOTANY, V89, P429, DOI [10.1139/B11-032, 10.1139/b11-032]; Lai Z, 2006, MOL ECOL, V15, P1213, DOI 10.1111/j.1365-294X.2006.02775.x; Lai Z, 2008, GENETICS, V179, P1881, DOI 10.1534/genetics.108.091041; Lai Z, 2012, AM J BOT, V99, P209, DOI 10.3732/ajb.1100313; Larkin JE, 2005, NAT METHODS, V2, P337, DOI 10.1038/nmeth757; Li XY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-60; Martinez-Godoy MA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-318; Mascarell-Creus A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-467; Nazar RN, 2010, MOL BIOTECHNOL, V44, P8, DOI 10.1007/s12033-009-9212-6; Novaes E, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-312; Ophir R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-269; Paniego N., 2007, Oilseeds, P153; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Privat I, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-5; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Rensink WA, 2005, TRENDS PLANT SCI, V10, P603, DOI 10.1016/j.tplants.2005.10.003; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Roche J, 2007, PLANTA, V226, P601, DOI 10.1007/s00425-007-0508-0; Rozen S, 2000, Methods Mol Biol, V132, P365; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Seiler G, 2010, GENET GENOM BREED CR, P1, DOI 10.1201/b10192-2; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Trick M, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-50; Trick M, 2009, PLANT BIOTECHNOL J, V7, P334, DOI 10.1111/j.1467-7652.2008.00396.x; Udall JA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-81; Vick BA, 2010, GENET GENOM BREED CR, P313, DOI 10.1201/b10192-11; Wan YF, 2009, PLANT BIOTECHNOL J, V7, P401, DOI 10.1111/j.1467-7652.2009.00405.x; Wurmbach E, 2003, METHODS, V31, P306, DOI 10.1016/S1046-2023(03)00161-0	64	24	24	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e45899	10.1371/journal.pone.0045899	http://dx.doi.org/10.1371/journal.pone.0045899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110046	Green Submitted, gold, Green Published			2022-12-25	WOS:000310262500003
J	Tam, AB; Mercado, EL; Hoffmann, A; Niwa, M				Tam, Arvin B.; Mercado, Ellen L.; Hoffmann, Alexander; Niwa, Maho			ER Stress Activates NF-kappa B by Integrating Functions of Basal IKK Activity, IRE1 and PERK	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; GENE-EXPRESSION; MESSENGER-RNA; TRANSLATION INITIATION; TRANSMEMBRANE PROTEIN; TRANSCRIPTION FACTORS; CARCINOMA-CELLS; KINASE-ACTIVITY; TUMOR-GROWTH	NF-kappa B, a transcription factor, becomes activated during the Unfolded Protein Response (UPR), an endoplasmic reticulum (ER) stress response pathway. NF-kappa B is normally held inactive by its inhibitor, I kappa B alpha. Multiple cellular pathways activate IKK (I kappa B alpha Kinase) which phosphorylate I kappa B alpha leading to its degradation and NF-kappa B activation. Here, we find that IKK is required for maximum activation of NF-kappa B in response to ER stress. However, unlike canonical NF kappa B activation, IKK activity does not increase during ER stress, but rather the level of basal IKK activity is critical for determining the extent of NF-kappa B activation. Furthermore, a key UPR initiator, IRE1, acts to maintain IKK basal activity through IRE1's kinase, but not RNase, activity. Inputs from IRE1 and IKK, in combination with translation repression by PERK, another UPR initiator, lead to maximal NF-kappa B activation during the UPR. These interdependencies have a significant impact in cancer cells with elevated IKK/NF-kappa B activity such as renal cell carcinoma cells (786-0). Inhibition of IKK by an IKK inhibitor, which significantly decreases NF-kappa B activity, is overridden by UPR induction, arguing for the importance of considering UPR activation in cancer treatment.	[Tam, Arvin B.; Niwa, Maho] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA; [Mercado, Ellen L.; Hoffmann, Alexander] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Niwa, M (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA.	niwa@ucsd.edu			National Institutes of Health (NIH) [GM087415]; American Cancer Society [RSG-10-027-01-CSM, RSG-05-01-GMC]; NIH [GM071573]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087415, R01GM071573] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) (GM087415), and American Cancer Society (RSG-10-027-01-CSM & RSG-05-01-GMC) to MN and by NIH (GM071573) to AF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Basseres DS, 2006, ONCOGENE, V25, P6817, DOI 10.1038/sj.onc.1209942; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bi MX, 2005, EMBO J, V24, P3470, DOI 10.1038/sj.emboj.7600777; Bicknell AA, 2007, J CELL BIOL, V177, P1017, DOI 10.1083/jcb.200702101; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Deng J, 2004, MOL CELL BIOL, V24, P10161, DOI 10.1128/MCB.24.23.10161-10168.2004; DiDonato J, 1996, MOL CELL BIOL, V16, P1295; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Feldman DE, 2005, MOL CANCER RES, V3, P597, DOI 10.1158/1541-7786.MCR-05-0221; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hoffmann A, 2003, EMBO J, V22, P5530, DOI 10.1093/emboj/cdg534; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Jackson-Bernitsas DG, 2007, ONCOGENE, V26, P1385, DOI 10.1038/sj.onc.1209945; Jiang HY, 2003, MOL CELL BIOL, V23, P5651, DOI 10.1128/MCB.23.16.5651-5663.2003; Karin M, 2004, NAT REV DRUG DISCOV, V3, P17, DOI 10.1038/nrd1279; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kishore N, 2003, J BIOL CHEM, V278, P32861, DOI 10.1074/jbc.M211439200; Laszlo CF, 2009, MOL CELL BIOCHEM, V328, P9, DOI 10.1007/s11010-009-0067-8; Lee E, 2006, CANCER RES, V66, P7849, DOI 10.1158/0008-5472.CAN-06-1660; Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702; Lee TH, 2004, J BIOL CHEM, V279, P33185, DOI 10.1074/jbc.M404206200; Li QT, 1999, GENE DEV, V13, P1322, DOI 10.1101/gad.13.10.1322; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Nguyen LT, 1999, IMMUNITY, V11, P379, DOI 10.1016/S1074-7613(00)80113-2; O'Dea EL, 2008, MOL CELL, V30, P632, DOI 10.1016/j.molcel.2008.03.017; O'Dea EL, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100148; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; PAHL HL, 1995, EMBO J, V14, P2580, DOI 10.1002/j.1460-2075.1995.tb07256.x; Papandreou I, BLOOD; Parker SH, 2006, MOL CELL BIOCHEM, V293, P173, DOI 10.1007/s11010-006-9239-y; Ranganathan AC, 2006, CANCER RES, V66, P1702, DOI 10.1158/0008-5472.CAN-05-3092; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; Romero-Ramirez L, 2004, CANCER RES, V64, P5943, DOI 10.1158/0008-5472.CAN-04-1606; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; STREWLER GJ, 1983, J CLIN INVEST, V71, P769, DOI 10.1172/JCI110825; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; Tergaonkar V, 2003, MOL CELL BIOL, V23, P8070, DOI 10.1128/MCB.23.22.8070-8083.2003; Tirasophon W, 2000, GENE DEV, V14, P2725, DOI 10.1101/gad.839400; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; van den Beucken T, 2006, CANCER BIOL THER, V5, P749, DOI 10.4161/cbt.5.7.2972; WEK RC, 1994, TRENDS BIOCHEM SCI, V19, P491, DOI 10.1016/0968-0004(94)90136-8; Werner SL, 2005, SCIENCE, V309, P1857, DOI 10.1126/science.1113319; Yang JM, 2001, CANCER RES, V61, P4901; Yoshida H, 1998, J BIOL CHEM, V273, P33741, DOI 10.1074/jbc.273.50.33741; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002	56	221	230	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e45078	10.1371/journal.pone.0045078	http://dx.doi.org/10.1371/journal.pone.0045078			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110043	Green Published, gold			2022-12-25	WOS:000310262500002
J	Sarup, P; Pedersen, SMM; Nielsen, NC; Malmendal, A; Loeschcke, V				Sarup, Pernille; Pedersen, Simon Metz Mariendal; Nielsen, Niels Chr.; Malmendal, Anders; Loeschcke, Volker			The Metabolic Profile of Long-Lived Drosophila melanogaster	PLOS ONE			English	Article							NEURONAL CELL-DEATH; SELECTION; STRESS; SENESCENCE; RESISTANCE; LONGEVITY; MICE; LIFE; REPRODUCTION; RESPONSES	We investigated the age-related changes in the metabolic profile of male Drosophila melanogaster and compared the metabolic profile of flies selected for increased longevity to that of control flies of equal age. We found clear differences in metabolite composition between selection regimes and among age groups. Contrary to results found in a previous study of the transcriptome of these lines the metabolic profile did not show a younger pattern in longevity-selected (LS) flies than in same aged control (C) flies. Rather, many of the metabolites affected by age had levels common to older control individuals in the young LS flies. Furthermore, ageing affected the metabolome in a different LS specific direction. The selection induced difference increased with age. Some metabolites involved in oxidative phosphorylation changed with age highlighting the importance of mitochondrial function in the ageing process. However, these metabolites were not affected by selection for increased longevity, indicating that improvements of mitochondrial function were not involved in the increased lifespan of LS lines. Of the eight metabolites identified as having a significant difference in relative abundance between selection regimes in our study choline, lysine and glucose also show difference among lifespan phenotypes in C. elegans indicating that the correlation between the concentration of these metabolites and longevity was evolutionary conserved. Links between longevity and choline concentration is also found in mice making this metabolite an obvious target for further study.	[Sarup, Pernille; Loeschcke, Volker] Aarhus Univ, Dept Biosci, Aarhus, Denmark; [Pedersen, Simon Metz Mariendal; Nielsen, Niels Chr.; Malmendal, Anders] Aarhus Univ, Ctr Insoluble Prot Struct, Aarhus, Denmark; [Pedersen, Simon Metz Mariendal] Aarhus Univ, Dept Food Sci, Tjele, Denmark; [Malmendal, Anders] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark	Aarhus University; Aarhus University; Aarhus University; University of Copenhagen	Sarup, P (corresponding author), Aarhus Univ, Dept Biosci, Aarhus, Denmark.	pernille.sarup@biology.au.dk; malmendal@sund.ku.dk	Sarup, Pernille/B-8632-2014; Loeschcke, Volker/J-2527-2013; Malmendal, Anders/F-1198-2017; Malmendal, Anders/S-2014-2019; Sarup, Pernille/AAY-2230-2020	Sarup, Pernille/0000-0002-5838-1251; Loeschcke, Volker/0000-0003-1450-0754; Malmendal, Anders/0000-0002-8413-9717; Malmendal, Anders/0000-0002-8413-9717; Nielsen, Niels Chr./0000-0003-2978-4366	Danish Council for Independent Research, Natural Sciences [10-093806/FNU]; Danish Natural Sciences Research Council; Velux foundation; Lundbeck Foundation; Carlsbergfondet; FNU; Danish Dairy Research Fund; iNANO	Danish Council for Independent Research, Natural Sciences(Det Frie Forskningsrad (DFF)); Danish Natural Sciences Research Council(Danish Natural Science Research Council); Velux foundation(Velux Fonden); Lundbeck Foundation(Lundbeckfonden); Carlsbergfondet(Carlsberg Foundation); FNU(Danish Natural Science Research Council); Danish Dairy Research Fund; iNANO	This work is funded by The Danish Council for Independent Research, Natural Sciences: 10-093806/FNU, the Danish Natural Sciences Research Council (frame and centre grant to V. L.), Velux foundation, Lundbeck Foundation and Carlsbergfondet, and FNU (stipends to PS) for financial support, The Danish Dairy Research Fund and iNANO (stipend to SMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexeyev MF, 2004, CLIN SCI, V107, P355, DOI 10.1042/CS20040148; Bayley M, 2010, PHYSIOL BIOCHEM ZOOL, V83, P541, DOI 10.1086/651459; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Bubliy OA, 2005, J EVOLUTION BIOL, V18, P789, DOI 10.1111/j.1420-9101.2005.00928.x; Butler JA, 2010, FASEB J, V24, P4977, DOI 10.1096/fj.10-162941; Buttini M, 2002, J NEUROSCI, V22, P10539; Bylesjo M, 2006, J CHEMOMETR, V20, P341, DOI 10.1002/cem.1006; CHEN PS, 1977, BIOCHEMISTRY-US, V16, P4080, DOI 10.1021/bi00637a022; Collatz Klaus-Guenter, 2006, P241, DOI 10.1016/B978-012369391-4/50022-9; Coquin L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.71; FAIRBANKS LD, 1970, J INSECT PHYSIOL, V16, P1429, DOI 10.1016/0022-1910(70)90141-1; FOWLER K, 1989, NATURE, V338, P760, DOI 10.1038/338760a0; Fuchs S, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-14; HAMILTON WD, 1966, J THEOR BIOL, V12, P12, DOI 10.1016/0022-5193(66)90184-6; Hercus MJ, 2000, P ROY SOC B-BIOL SCI, V267, P2105, DOI 10.1098/rspb.2000.1256; Hirai MY, 2004, P NATL ACAD SCI USA, V101, P10205, DOI 10.1073/pnas.0403218101; Hoffmann AA, 2003, J THERM BIOL, V28, P175, DOI 10.1016/S0306-4565(02)00057-8; Kaplan F, 2004, PLANT PHYSIOL, V135, P1674, DOI 10.1104/pp.104.040808; Keun HC, 2003, ANAL CHIM ACTA, V490, P265, DOI 10.1016/S0003-2670(03)00094-1; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; LUCKINBILL LS, 1984, EVOLUTION, V38, P996, DOI 10.1111/j.1558-5646.1984.tb00369.x; Makinen VP, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100205; Malmendal A, 2006, AM J PHYSIOL-REG I, V291, pR205, DOI 10.1152/ajpregu.00867.2005; MIQUEL J, 1980, EXP GERONTOL, V15, P575, DOI 10.1016/0531-5565(80)90010-8; Mishur RJ, 2012, MASS SPECTROM REV, V31, P70, DOI 10.1002/mas.20338; Mukhopadhyay A, 2007, TRENDS CELL BIOL, V17, P65, DOI 10.1016/j.tcb.2006.12.004; Okuda S, 1998, J NEUROCHEM, V70, P299; Okuda S, 1996, P NATL ACAD SCI USA, V93, P12553, DOI 10.1073/pnas.93.22.12553; Overgaard J, 2007, J INSECT PHYSIOL, V53, P1218, DOI 10.1016/j.jinsphys.2007.06.012; Partridge L, 2009, AGING CELL, V8, P509, DOI 10.1111/j.1474-9726.2009.00498.x; Pearl R, 1923, AM NAT, V57, P153, DOI 10.1086/279913; Pedersen KS, 2008, GENETICS, V180, P1233, DOI 10.1534/genetics.108.089144; Pereira CS, 2006, J PHYS CHEM B, V110, P15572, DOI 10.1021/jp060789l; Rose MR, 2008, REJUV RES, V11, P527, DOI 10.1089/rej.2008.0688; ROSEN DR, 1989, P NATL ACAD SCI USA, V86, P2478, DOI 10.1073/pnas.86.7.2478; Sarup P, 2011, AGE, V33, P69, DOI 10.1007/s11357-010-9162-8; Savorani F, 2010, J MAGN RESON, V202, P190, DOI 10.1016/j.jmr.2009.11.012; Schwarcz R, 2010, PROG NEUROBIOL, V90, P230, DOI 10.1016/j.pneurobio.2009.04.005; SERVICE PM, 1989, J INSECT PHYSIOL, V35, P447, DOI 10.1016/0022-1910(89)90120-0; Sgro CM, 2000, EVOLUTION, V54, P2152, DOI 10.1111/j.0014-3820.2000.tb01257.x; Soltow QA, 2010, INTEGR COMP BIOL, V50, P844, DOI 10.1093/icb/icq094; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Van Dam D, 2011, BRIT J PHARMACOL, V164, P1285, DOI 10.1111/j.1476-5381.2011.01299.x; Vermeulen CJ, 2007, EXP GERONTOL, V42, P153, DOI 10.1016/j.exger.2006.09.014; Vermeulen CJ, 2006, J EVOLUTION BIOL, V19, P216, DOI 10.1111/j.1420-9101.2005.00972.x; Waagner D, 2010, COMP BIOCHEM PHYS A, V157, P177, DOI 10.1016/j.cbpa.2010.06.171; Watson MJO, 1996, EVOLUTION, V50, P1182, DOI 10.1111/j.1558-5646.1996.tb02359.x; Wijeyesekera A, 2012, J PROTEOME RES, V11, P2224, DOI 10.1021/pr2010154; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; WOLD S, 1978, TECHNOMETRICS, V20, P397, DOI 10.2307/1267639; Zadori D, 2009, J NEURAL TRANSM, V116, P1403, DOI 10.1007/s00702-009-0263-4; ZWAAN B, 1995, EVOLUTION, V49, P649, DOI 10.2307/2410318	54	32	32	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47461	10.1371/journal.pone.0047461	http://dx.doi.org/10.1371/journal.pone.0047461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110072	gold, Green Published, Green Submitted			2022-12-25	WOS:000310193600015
J	Kim, JY; Sohn, JH; Choi, JM; Lee, JH; Hong, CS; Lee, JS; Park, JW				Kim, Joo Young; Sohn, Jung Ho; Choi, Je-Min; Lee, Jae-Hyun; Hong, Chein-Soo; Lee, Joo-Shil; Park, Jung-Won			Alveolar Macrophages Play a Key Role in Cockroach-Induced Allergic Inflammation via TNF-alpha Pathway	PLOS ONE			English	Article							PROTEASE-ACTIVATED RECEPTOR-2; AIRWAY EPITHELIAL-CELLS; INNATE IMMUNE-RESPONSE; GERMAN-COCKROACH; DUST-MITE; IL-8 EXPRESSION; LUNG-DISEASE; ASTHMA; EXPOSURE; SENSITIZATION	The activity of the serine protease in the German cockroach allergen is important to the development of allergic disease. The protease-activated receptor (PAR)-2, which is expressed in numerous cell types in lung tissue, is known to mediate the cellular events caused by inhaled serine protease. Alveolar macrophages express PAR-2 and produce considerable amounts of tumor necrosis factor (TNF)-alpha. We determined whether the serine protease in German cockroach extract (GCE) enhances TNF-alpha production by alveolar macrophages through the PAR-2 pathway and whether the TNF-alpha production affects GCE-induced pulmonary inflammation. Effects of GCE on alveolar macrophages and TNF-alpha production were evaluated using in vitro MH-S and RAW264.6 cells and in vivo GCE-induced asthma models of BALB/c mice. GCE contained a large amount of serine protease. In the MH-S and RAW264.7 cells, GCE activated PAR-2 and thereby produced TNF-alpha. In the GCE-induced asthma model, intranasal administration of GCE increased airway hyperresponsiveness (AHR), inflammatory cell infiltration, productions of serum immunoglobulin E, interleukin (IL)-5, IL-13 and TNF-alpha production in alveolar macrophages. Blockade of serine proteases prevented the development of GCE induced allergic pathologies. TNF-alpha blockade also prevented the development of such asthma-like lesions. Depletion of alveolar macrophages reduced AHR and intracellular TNF-alpha level in pulmonary cell populations in the GCE-induced asthma model. These results suggest that serine protease from GCE affects asthma through an alveolar macrophage and TNF-alpha dependent manner, reflecting the close relation of innate and adaptive immune response in allergic asthma model.	[Sohn, Jung Ho; Lee, Jae-Hyun; Hong, Chein-Soo; Park, Jung-Won] Yonsei Univ, Coll Med, Dept Internal Med, Seoul 120749, South Korea; [Kim, Joo Young] Ewha Womans Univ, Pharmaceut Sci Res Inst, Coll Pharm, Seoul, South Korea; [Sohn, Jung Ho; Choi, Je-Min] Hanyang Univ, Dept Life Sci, Seoul 133791, South Korea; [Kim, Joo Young; Park, Jung-Won] Yonsei Univ, Coll Med, Brain Korea Project Med Sci 21, Seoul 120749, South Korea; [Lee, Jae-Hyun; Hong, Chein-Soo; Park, Jung-Won] Yonsei Univ, Coll Med, Inst Allergy, Seoul 120749, South Korea; [Lee, Joo-Shil] Korea Natl Inst Hlth, Ctr Immunol & Pathol, Osong, South Korea	Yonsei University; Yonsei University Health System; Ewha Womans University; Hanyang University; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Korea CDC Center for Immunology & Pathology	Park, JW (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Seoul 120749, South Korea.	parkjw@yuhs.ac	Lee, Jae-Hyun/ABE-3803-2020; Kim, Jooyoung/R-5839-2018	Lee, Jae-Hyun/0000-0002-0760-0071; Kim, Jooyoung/0000-0003-4846-6259; Park, Jung-Won/0000-0003-0249-8749; Choi, Je-Min/0000-0002-9482-710X	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A092076]	Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This study was supported by the grant of the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (A092076). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arizmendi NG, 2011, ALLERGY ASTHMA CL IM, V7, DOI 10.1186/1710-1492-7-22; Arizmendi NG, 2011, J IMMUNOL, V186, P3164, DOI 10.4049/jimmunol.0903812; Bedoret D, 2009, J CLIN INVEST, V119, P3723, DOI 10.1172/JCI39717; Berger P, 2001, J APPL PHYSIOL, V91, P1372, DOI 10.1152/jappl.2001.91.3.1372; Berry MA, 2006, NEW ENGL J MED, V354, P697, DOI 10.1056/NEJMoa050580; Bhat RK, 2003, CLIN EXP ALLERGY, V33, P35, DOI 10.1046/j.1365-2222.2002.01481.x; Brightling C, 2008, J ALLERGY CLIN IMMUN, V121, P5, DOI 10.1016/j.jaci.2007.10.028; Chapman MD, 2007, CURR ALLERGY ASTHM R, V7, P363, DOI 10.1007/s11882-007-0055-6; Chapman MD, 2007, J ALLERGY CLIN IMMUN, V119, P414, DOI 10.1016/j.jaci.2006.11.001; Cocks TM, 1999, NATURE, V398, P156, DOI 10.1038/18223; Colognato R, 2003, BLOOD, V102, P2645, DOI 10.1182/blood-2002-08-2497; Compton SJ, 2001, BRIT J PHARMACOL, V134, P705, DOI 10.1038/sj.bjp.0704303; Day SB, 2010, J INNATE IMMUN, V2, P495, DOI 10.1159/000317195; Dery O, 1998, AM J PHYSIOL-CELL PH, V274, pC1429, DOI 10.1152/ajpcell.1998.274.6.C1429; Di Valentin E, 2009, AM J PHYSIOL-LUNG C, V296, pL185, DOI 10.1152/ajplung.90367.2008; Douwes J, 2002, THORAX, V57, P643, DOI 10.1136/thorax.57.7.643; Ebeling C, 2005, J ALLERGY CLIN IMMUN, V115, P623, DOI 10.1016/j.jaci.2004.11.042; Ebeling C, 2007, J IMMUNOL, V179, P2910, DOI 10.4049/jimmunol.179.5.2910; Feola DJ, 2010, ANTIMICROB AGENTS CH, V54, P2437, DOI 10.1128/AAC.01424-09; Fields RC, 2003, AM J PATHOL, V162, P1817, DOI 10.1016/S0002-9440(10)64316-7; Goplen N, 2009, J ALLERGY CLIN IMMUN, V123, P925, DOI 10.1016/j.jaci.2009.02.009; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gough L, 2003, CLIN EXP ALLERGY, V33, P1159, DOI 10.1046/j.1365-2222.2003.01716.x; Hong JH, 2004, J ALLERGY CLIN IMMUN, V113, P315, DOI 10.1016/j.jaci.2003.11.026; Howarth PH, 2005, THORAX, V60, P1012, DOI 10.1136/thx.2005.045260; Huang H, 2010, J IMMUNOL, V185, P5003, DOI 10.4049/jimmunol.0903446; Jeon SK, 2008, J INVEST DERMATOL, V128, P1930, DOI 10.1038/jid.2008.13; Johnson JR, 2004, AM J RESP CRIT CARE, V169, P378, DOI 10.1164/rccm.200308-1094OC; Kauffman Henk F, 2006, Clin Mol Allergy, V4, P5, DOI 10.1186/1476-7961-4-5; Kelso EB, 2006, J PHARMACOL EXP THER, V316, P1017, DOI 10.1124/jpet.105.093807; Kelso EB, 2007, ARTHRITIS RHEUM, V56, P765, DOI 10.1002/art.22423; Kheradmand F, 2002, J IMMUNOL, V169, P5904, DOI 10.4049/jimmunol.169.10.5904; Kim EY, 2008, NAT MED, V14, P633, DOI 10.1038/nm1770; Kiselyov K, 2003, CELL SIGNAL, V15, P243, DOI 10.1016/S0898-6568(02)00074-8; Lee KE, 2007, CLIN EXP ALLERGY, V37, P1364, DOI 10.1111/j.1365-2222.2007.02797.x; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Page K, 2003, J ALLERGY CLIN IMMUN, V112, P1112, DOI 10.1016/j.jaci.2003.08.050; Page K, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-62; Park JW, 2004, AM J RESP CRIT CARE, V169, P726, DOI 10.1164/rccm.200307-1042OC; Peters T, 2010, J PHARMACOL EXP THER, V335, P424, DOI 10.1124/jpet.109.163253; Pomes A, 2002, AM J RESP CRIT CARE, V165, P391, DOI 10.1164/ajrccm.165.3.2104027; Roscic-Mrkic B, 2001, J VIROL, V75, P3343, DOI 10.1128/JVI.75.7.3343-3351.2001; Rosenstreich DL, 1997, NEW ENGL J MED, V336, P1356, DOI 10.1056/NEJM199705083361904; Sun G, 2001, J IMMUNOL, V167, P1014, DOI 10.4049/jimmunol.167.2.1014; THEPEN T, 1989, J EXP MED, V170, P499, DOI 10.1084/jem.170.2.499; Tu WC, 2006, J INVERTEBR PATHOL, V92, P73, DOI 10.1016/j.jip.2006.04.002; TWINING SS, 1984, ANAL BIOCHEM, V143, P30, DOI 10.1016/0003-2697(84)90553-0; Van Hove CL, 2007, AM J RESP CELL MOL, V36, P573, DOI 10.1165/rcmb.2006-0385OC; VANROOIJEN N, 1989, J IMMUNOL METHODS, V124, P1, DOI 10.1016/0022-1759(89)90178-6; Vliagoftis H, 2001, J ALLERGY CLIN IMMUN, V107, P679, DOI 10.1067/mai.2001.114245; Wang Q, 2010, J IMMUNOL, V185, P834, DOI 10.4049/jimmunol.0901490; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Yin L, 2001, CELL TISSUE RES, V304, P391, DOI 10.1007/s004410000245; Zhang-Hoover J, 2000, IMMUNOLOGY, V101, P501, DOI 10.1046/j.1365-2567.2000.00143.x	54	13	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47971	10.1371/journal.pone.0047971	http://dx.doi.org/10.1371/journal.pone.0047971			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094102	Green Published, gold, Green Submitted			2022-12-25	WOS:000310050200054
J	Reverberi, M; Punelli, M; Smith, CA; Zjalic, S; Scarpari, M; Scala, V; Cardinali, G; Aspite, N; Pinzari, F; Payne, GA; Fabbri, AA; Fanelli, C				Reverberi, Massimo; Punelli, Marta; Smith, Carrie A.; Zjalic, Slaven; Scarpari, Marzia; Scala, Valeria; Cardinali, Giorgia; Aspite, Nicaela; Pinzari, Flavia; Payne, Gary A.; Fabbri, Anna A.; Fanelli, Corrado			How Peroxisomes Affect Aflatoxin Biosynthesis in Aspergillus Flavus	PLOS ONE			English	Article							OXIDATIVE STRESS; SACCHAROMYCES-CEREVISIAE; BETA-OXIDATION; MYCOTOXIN PRODUCTION; PARASITICUS; PROTEIN; ACID; METABOLISM; FUNGI; LIPOPEROXIDATION	In filamentous fungi, peroxisomes are crucial for the primary metabolism and play a pivotal role in the formation of some secondary metabolites. Further, peroxisomes are important site for fatty acids beta-oxidation, the formation of reactive oxygen species and for their scavenging through a complex of antioxidant activities. Oxidative stress is involved in different metabolic events in all organisms and it occurs during oxidative processes within the cell, including peroxisomal beta-oxidation of fatty acids. In Aspergillus flavus, an unbalance towards an hyper-oxidant status into the cell is a prerequisite for the onset of aflatoxin biosynthesis. In our preliminary results, the use of bezafibrate, inducer of both peroxisomal beta-oxidation and peroxisome proliferation in mammals, significantly enhanced the expression of pex11 and foxA and stimulated aflatoxin synthesis in A. flavus. This suggests the existence of a correlation among peroxisome proliferation, fatty acids beta-oxidation and aflatoxin biosynthesis. To investigate this correlation, A. flavus was transformed with a vector containing P33, a gene from Cymbidium ringspot virus able to induce peroxisome proliferation, under the control of the promoter of the Cu, Zn-sod gene of A. flavus. This transcriptional control closely relates the onset of the antioxidant response to ROS increase, with the proliferation of peroxisomes in A. flavus. The AfP33 transformant strain show an up-regulation of lipid metabolism and an higher content of both intracellular ROS and some oxylipins. The combined presence of a higher amount of substrates (fatty acids-derived), an hyper-oxidant cell environment and of hormone-like signals (oxylipins) enhances the synthesis of aflatoxins in the AfP33 strain. The results obtained demonstrated a close link between peroxisome metabolism and aflatoxin synthesis.	[Reverberi, Massimo; Punelli, Marta; Scarpari, Marzia; Scala, Valeria; Fabbri, Anna A.; Fanelli, Corrado] Univ Roma La Sapienza, Dipartimento Biol Ambientale, Rome, Italy; [Smith, Carrie A.] Oklahoma State Univ, Oklahoma City, OK USA; [Zjalic, Slaven] Univ Zadar, Dept Ecol Agron & Aquaculture, Zadar, Croatia; [Cardinali, Giorgia; Aspite, Nicaela] IFO S Gallicano, Rome, Italy; [Pinzari, Flavia] Minist Beni Culturali, IRCPAL, Rome, Italy; [Payne, Gary A.] N Carolina State Univ, Raleigh, NC 27695 USA	Sapienza University Rome; Oklahoma State University System; Oklahoma State University Center for Health Sciences; Oklahoma State University - Stillwater; University of Zadar; IRCCS Istituti Fisioterapici Ospitalieri (IFO); University of North Carolina; North Carolina State University	Reverberi, M (corresponding author), Univ Roma La Sapienza, Dipartimento Biol Ambientale, Rome, Italy.	massimo.reverberi@uniroma1.it	Pinzari, Flavia/S-1790-2018; Cardinali, Giorgia/H-1814-2016; reverberi, massimo/G-7715-2012	Pinzari, Flavia/0000-0002-1083-8734; Cardinali, Giorgia/0000-0002-7527-9451; reverberi, massimo/0000-0003-3671-6783; scala, valeria/0000-0001-9383-8766; Fanelli, Corrado/0000-0002-0804-3078				Aguirre J, 2005, TRENDS MICROBIOL, V13, P111, DOI 10.1016/j.tim.2005.01.007; Barnett P, 2000, TRENDS BIOCHEM SCI, V25, P227, DOI 10.1016/S0968-0004(00)01579-6; Bartoszewska M, 2011, BIOTECHNOL LETT, V33, P1921, DOI 10.1007/s10529-011-0664-y; Berlot JP, 2000, LIPIDS, V35, P1397, DOI 10.1007/s11745-000-0657-0; Burow GB, 1997, MOL PLANT MICROBE IN, V10, P380, DOI 10.1094/MPMI.1997.10.3.380; Christensen SA, 2010, FUNGAL GENET BIOL, V47, P539; Corpas FJ, 2001, TRENDS PLANT SCI, V6, P145, DOI 10.1016/S1360-1385(01)01898-2; FABBRI AA, 1983, J GEN MICROBIOL, V129, P3447; Fahmy T., 2003, XLSTAT PRO 7 0 XLSTA; FANELLI C, 1989, MYCOPATHOLOGIA, V107, P115, DOI 10.1007/BF00707547; Fanelli C, 1985, Mycotoxin Res, V1, P65, DOI 10.1007/BF03192005; Gao XQ, 2009, TOXIN REV, V28, P79, DOI 10.1080/15569540802420584; Georgianna DR, 2009, FUNGAL GENET BIOL, V46, P113, DOI 10.1016/j.fgb.2008.10.011; Goto T, 2011, J LIPID RES, V52, P873, DOI 10.1194/jlr.M011320; Grant JJ, 2000, PLANT PHYSIOL, V124, P21, DOI 10.1104/pp.124.1.21; Halliwell B., 2007, FREE RADICAL BIO MED, P187; He ZM, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-104; Jayashree T, 2000, FREE RADICAL BIO MED, V29, P981, DOI 10.1016/S0891-5849(00)00398-1; Kiel JAKW, 2005, FUNGAL GENET BIOL, V42, P154, DOI 10.1016/j.fgb.2004.10.010; Kiel JAKW, 2009, FUNCT INTEGR GENOMIC, V9, P167, DOI 10.1007/s10142-009-0110-6; Koo AJK, 2006, J BIOL CHEM, V281, P33511, DOI 10.1074/jbc.M607854200; Lopez-Huertas E, 2000, EMBO J, V19, P6770, DOI 10.1093/emboj/19.24.6770; Maggio-Hall LA, 2005, MOL PLANT MICROBE IN, V18, P783, DOI 10.1094/MPMI-18-0783; Maggio-Hall LA, 2004, MOL MICROBIOL, V54, P1173, DOI 10.1111/j.1365-2958.2004.04340.x; McCartney AW, 2005, PLANT CELL, V17, P3513, DOI 10.1105/tpc.105.036350; Moye-Rowley WS, 2003, EUKARYOT CELL, V2, P381, DOI 10.1128/EC.2.3.381-389.2003; Narasaiah KV, 2006, MYCOPATHOLOGIA, V162, P179, DOI 10.1007/s11046-006-0052-7; Navarro B, 2006, J GEN VIROL, V87, P705, DOI 10.1099/vir.0.81325-0; Navarro B, 2004, J VIROL, V78, P4744, DOI 10.1128/JVI.78.9.4744-4752.2004; Neill S, 2002, CURR OPIN PLANT BIOL, V5, P388, DOI 10.1016/S1369-5266(02)00282-0; Nyathi Y, 2006, BBA-MOL CELL RES, V1763, P1478, DOI 10.1016/j.bbamcr.2006.08.031; PASSI S, 1985, J GEN MICROBIOL, V131, P687; PASSI S, 1984, APPL MICROBIOL BIOT, V19, P186, DOI 10.1007/BF00256452; Reverberi M, 2007, FOOD ADDIT CONTAM A, V24, P1070, DOI 10.1080/02652030701553244; Reverberi M, 2008, EUKARYOT CELL, V7, P988, DOI 10.1128/EC.00228-07; Reverberi M, 2010, APPL MICROBIOL BIOT, V87, P899, DOI 10.1007/s00253-010-2657-5; Reverberi M, 2010, APPL MICROBIOL BIOT, V85, P1935, DOI 10.1007/s00253-009-2220-4; Roze LV, 2011, J BIOL CHEM, V286, P35137, DOI 10.1074/jbc.M111.253468; Roze LV, 2011, FUNGAL GENET BIOL, V48, P35, DOI 10.1016/j.fgb.2010.05.006; Titorenko VI, 2011, TRAFFIC, V12, P252, DOI 10.1111/j.1600-0854.2010.01144.x; Tsitsigiannis DI, 2007, TRENDS MICROBIOL, V15, P109, DOI 10.1016/j.tim.2007.01.005; van Roermund CWT, 2000, J CELL BIOL, V150, P489, DOI 10.1083/jcb.150.3.489; Vasquez M, 2001, MOL CELL BIOCHEM, V216, P71, DOI 10.1023/A:1011060615234; Yessoufou A, 2010, SWISS MED WKLY, V140, P4, DOI 10.4414/smw.2010.13071; Zuo X, 2006, ONCOGENE, V25, P1225, DOI 10.1038/sj.onc.1209160	45	62	64	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e48097	10.1371/journal.pone.0048097	http://dx.doi.org/10.1371/journal.pone.0048097			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094106	Green Published, gold, Green Submitted			2022-12-25	WOS:000310050200058
J	Rufer, ES; Tran, TD; Attridge, MM; Andrzejewski, ME; Flentke, GR; Smith, SM				Rufer, Echoleah S.; Tran, Tuan D.; Attridge, Megan M.; Andrzejewski, Matthew E.; Flentke, George R.; Smith, Susan M.			Adequacy of Maternal Iron Status Protects against Behavioral, Neuroanatomical, and Growth Deficits in Fetal Alcohol Spectrum Disorders	PLOS ONE			English	Article							ETHANOL EXPOSURE; COGNITIVE DEFICITS; CEREBELLAR CORTEX; LIGHT DRINKING; UNITED-STATES; RATS; PREVALENCE; PREGNANCY; CHILDREN; RISK	Fetal alcohol spectrum disorders (FASD) are the leading non-genetic cause of neurodevelopmental disability in children. Although alcohol is clearly teratogenic, environmental factors such as gravidity and socioeconomic status significantly modify individual FASD risk despite equivalent alcohol intake. An explanation for this variability could inform FASD prevention. Here we show that the most common nutritional deficiency of pregnancy, iron deficiency without anemia (ID), is a potent and synergistic modifier of FASD risk. Using an established rat model of third trimester-equivalent binge drinking, we show that ID significantly interacts with alcohol to impair postnatal somatic growth, associative learning, and white matter formation, as compared with either insult separately. For the associative learning and myelination deficits, the ID-alcohol interaction was synergistic and the deficits persisted even after the offsprings' iron status had normalized. Importantly, the observed deficits in the ID-alcohol animals comprise key diagnostic criteria of FASD. Other neurobehaviors were normal, showing the ID-alcohol interaction was selective and did not reflect a generalized malnutrition. Importantly ID worsened FASD outcome even though the mothers lacked overt anemia; thus diagnostics that emphasize hematological markers will not identify pregnancies at-risk. This is the first direct demonstration that, as suggested by clinical studies, maternal iron status has a unique influence upon FASD outcome. While alcohol is unquestionably teratogenic, this ID-alcohol interaction likely represents a significant portion of FASD diagnoses because ID is more common in alcohol-abusing pregnancies than generally appreciated. Iron status may also underlie the associations between FASD and parity or socioeconomic status. We propose that increased attention to normalizing maternal iron status will substantially improve FASD outcome, even if maternal alcohol abuse continues. These findings offer novel insights into how alcohol damages the developing brain.	[Rufer, Echoleah S.; Smith, Susan M.] Univ Wisconsin, Mol & Environm Toxicol Ctr, Madison, WI USA; [Rufer, Echoleah S.; Attridge, Megan M.; Flentke, George R.; Smith, Susan M.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA; [Andrzejewski, Matthew E.; Smith, Susan M.] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Tran, Tuan D.] E Carolina Univ, Dept Psychol, Multidisciplinary Studies Program Neurosci, Greenville, NC 27858 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of North Carolina; East Carolina University	Smith, SM (corresponding author), Univ Wisconsin, Mol & Environm Toxicol Ctr, Madison, WI USA.	suesmith@nutrisci.wisc.edu	Mireku, Michael/D-5262-2016	Andrzejewski, Matthew/0000-0002-3557-3453; Attridge, Megan/0000-0003-1298-6826	National Institutes of Health [T32 ES07015, R37 AA11085, R21 AA17281, P30 HD03352]; Palmer Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA017281, R37AA011085] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Palmer Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by National Institutes of Health grants T32 ES07015 (E.S.R), R37 AA11085 (S.M.S), R21 AA17281 (S.M.S, T.D.T.), and P30 HD03352 (Waisman Center), and the Palmer Fund (S.M.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beard JL, 2006, BEHAV BRAIN RES, V170, P224, DOI 10.1016/j.bbr.2006.02.024; Beard JL, 2003, ANNU REV NUTR, V23, P41, DOI 10.1146/annurev.nutr.23.020102.075739; Beard JL, 2000, AM J CLIN NUTR, V71, p1288S, DOI 10.1093/ajcn/71.5.1288s; Bichenkov E, 2001, DEV BRAIN RES, V128, P9, DOI 10.1016/S0165-3806(01)00142-0; Bodnar LM, 2002, J NUTR, V132, P2298, DOI 10.1093/jn/132.8.2298; Car BD, 2006, AM COLL LAB, P127, DOI 10.1016/B978-012074903-4/50008-X; Carter RC, 2007, PEDIATRICS, V120, P559, DOI 10.1542/peds.2007-0151; Cogswell ME, 2003, J NUTR, V133, p1974S, DOI 10.1093/jn/133.6.1974S; Coyne D, 2006, KIDNEY INT, V69, pS4, DOI 10.1038/sj.ki.5000404; DREOSTI IE, 1993, ANN NY ACAD SCI, V678, P193; *FAO WHO IRON, 2001, HUM VIT MIN REQ, P195; GOODLETT CR, 1990, ALCOHOL, V7, P107, DOI 10.1016/0741-8329(90)90070-S; Harrison-Findik DD, 2006, J BIOL CHEM, V281, P22974, DOI 10.1074/jbc.M602098200; Harthoorn-Lasthuizen EJ, 2000, ACTA OBSTET GYN SCAN, V79, P660, DOI 10.1034/j.1600-0412.2000.079008660.x; Ikonomidou C, 2000, SCIENCE, V287, P1056, DOI 10.1126/science.287.5455.1056; Ioannou GN, 2004, GASTROENTEROLOGY, V126, P1293, DOI 10.1053/j.gastro.2004.01.020; Jacobson SW, 2008, ALCOHOL CLIN EXP RES, V32, P365, DOI 10.1111/j.1530-0277.2007.00585.x; Jacobson SW, 2004, ALCOHOL CLIN EXP RES, V28, P1732, DOI 10.1097/01.ALC.0000145691.81233.FA; Kaharuza FM, 2001, ACTA OBSTET GYN SCAN, V80, P532, DOI 10.1034/j.1600-0412.2001.080006532.x; Keen CL, 2010, BIOFACTORS, V36, P125, DOI 10.1002/biof.89; KEEN CL, 1981, J NUTR, V111, P226, DOI 10.1093/jn/111.2.226; Kelly Y, 2009, INT J EPIDEMIOL, V38, P129, DOI 10.1093/ije/dyn230; Kelly YJ, 2012, J EPIDEMIOL COMMUN H, V66, P41, DOI 10.1136/jech.2009.103002; Klintsova AY, 1998, BRAIN RES, V800, P48, DOI 10.1016/S0006-8993(98)00495-8; Lebel C, 2008, ALCOHOL CLIN EXP RES, V32, P1732, DOI 10.1111/j.1530-0277.2008.00750.x; Lindquist DH, 2007, BRAIN RES, V1150, P155, DOI 10.1016/j.brainres.2007.03.002; Lindsley TL, 2006, BRAIN DEV NORMAL PRO, P230, DOI DOI 10.1523/JNEUROSCI.5067-07.2008; Looker AC, 1997, JAMA-J AM MED ASSOC, V277, P973, DOI 10.1001/jama.277.12.973; Lozoff B, 2006, NUTR REV, V64, pS34, DOI 10.1301/nr.2006.may.S34-S43; Mattson SN, 2010, ALCOHOL CLIN EXP RES, V34, P1640, DOI 10.1111/j.1530-0277.2010.01250.x; May PA, 2005, AM J PUBLIC HEALTH, V95, P1190, DOI 10.2105/AJPH.2003.037093; May PA, 2008, ALCOHOL CLIN EXP RES, V32, P738, DOI 10.1111/j.1530-0277.2008.00634.x; May PA, 2007, DRUG ALCOHOL DEPEN, V88, P259, DOI 10.1016/j.drugalcdep.2006.11.007; May PA, 2009, DEV DISABIL RES REV, V15, P176, DOI 10.1002/ddrr.68; MILLER MW, 1995, J NEUROCHEM, V65, P373; Mostofi A, 2010, J NEUROSCI, V30, P8920, DOI 10.1523/JNEUROSCI.6117-09.2010; National Institute on Alcohol Abuse and Alcoholism, 2009, NIAAA 5 YEAR STRAT P; PHILLIPS DE, 1989, EXP NEUROL, V103, P90, DOI 10.1016/0014-4886(89)90190-8; Rao R, 2007, SEMIN FETAL NEONAT M, V12, P54, DOI 10.1016/j.siny.2006.10.007; Rettmer RL, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.3.e37; Rosato-Siri MV, 2010, J NEUROSCI RES, V88, P1695, DOI 10.1002/jnr.22348; Sampson PD, 1997, TERATOLOGY, V56, P317, DOI 10.1002/(SICI)1096-9926(199711)56:5<317::AID-TERA5>3.0.CO;2-U; Smith LN, 2006, PHARMACOL BIOCHEM BE, V85, P91, DOI 10.1016/j.pbb.2006.07.014; Sowell ER, 2008, J NEUROSCI, V28, P1313, DOI 10.1523/JNEUROSCI.5067-07.2008; Spohr HL, 2007, J PEDIATR-US, V150, P175, DOI 10.1016/j.jpeds.2006.11.044; Spottiswoode BS, 2011, ALCOHOL CLIN EXP RES, V35, P2174, DOI 10.1111/j.1530-0277.2011.01566.x; Stanton ME, 1998, ALCOHOL CLIN EXP RES, V22, P270, DOI 10.1111/j.1530-0277.1998.tb03649.x; Stoltzfus RJ, 2001, J NUTR, V131, p697S, DOI 10.1093/jn/131.2.697S; Stratton K., 1996, FETAL ALCOHOL SYNDRO; STREISSGUTH AP, 1983, ALCOHOL CLIN EXP RES, V7, P227, DOI 10.1111/j.1530-0277.1983.tb05447.x; THOMPSON RF, 1986, SCIENCE, V233, P941, DOI 10.1126/science.3738519; Todorich B, 2009, GLIA, V57, P467, DOI 10.1002/glia.20784; Tran TD, 2007, DEV PSYCHOBIOL, V49, P589, DOI 10.1002/dev.20226; Villarreal RP, 2005, J EXP ANAL BEHAV, V84, P631, DOI 10.1901/jeab.2005.96-04; Wozniak JR, 2009, ALCOHOL CLIN EXP RES, V33, P1825, DOI 10.1111/j.1530-0277.2009.01021.x; Zeisel SH, 2011, MOL NEUROBIOL, V44, P185, DOI 10.1007/s12035-011-8165-5	56	41	41	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47499	10.1371/journal.pone.0047499	http://dx.doi.org/10.1371/journal.pone.0047499			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094056	Green Published, Green Submitted, gold			2022-12-25	WOS:000310050200028
J	Burkhardt, W; Kraft, S; Ochs, M; Proquitte, H; Mense, L; Rudiger, M				Burkhardt, Wolfram; Kraft, Stephan; Ochs, Matthias; Proquitte, Hans; Mense, Lars; Ruediger, Mario			Persurf, a New Method to Improve Surfactant Delivery: A Study in Surfactant Depleted Rats	PLOS ONE			English	Article							PARTIAL LIQUID VENTILATION; RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; EXOGENOUS SURFACTANT; GAS-EXCHANGE; II CELLS; MECHANICAL VENTILATION; NATURAL SURFACTANT; BOVINE SURFACTANT; HEALTHY PIGLETS	Purpose: Exogenous surfactant is not very effective in adults with ARDS, since surfactant does not reach atelectatic alveoli. Perfluorocarbons (PFC) can recruit atelectatic areas but do not replace impaired endogenous surfactant. A surfactant-PFC-mixture could combine benefits of both therapies. The aim of the proof-of-principal-study was to produce a PFC-in-surfactant emulsion (Persurf) and to test in surfactant depleted Wistar rats whether Persurf achieves I.) a more homogenous pulmonary distribution and II.) a more homogenous recruitment of alveoli when compared with surfactant or PFC alone. Methods: Three different PFC were mixed with surfactant and phospholipid concentration in the emulsion was measured. After surfactant depletion, animals either received 30 ml/kg of PF5080, 100 mg/kg of stained (green dye) Curosurf (TM) or 30 ml/kg of Persurf. Lungs were fixated after 1 hour of ventilation and alveolar aeration and surfactant distribution was estimated by a stereological approach. Results: Persurf contained 3 mg/ml phospholipids and was stable for more than 48 hours. Persurf-administration improved oxygenation. Histological evaluation revealed a more homogenous surfactant distribution and alveolar inflation when compared with surfactant treated animals. Conclusions: In surfactant depleted rats administration of PFC-in-surfactant emulsion leads to a more homogenous distribution and aeration of the lung than surfactant alone.	[Burkhardt, Wolfram; Mense, Lars; Ruediger, Mario] Tech Univ Dresden, Dept Neonatol & Pediat Intens Care Med, Klin Kinderheilkunde, Univ Klinikum Carl Gustav Carus,Med Fak, D-01062 Dresden, Germany; [Kraft, Stephan] Klinikum Mutterhaus Borromaerinnen, Dept Pediat Surg, Trier, Germany; [Ochs, Matthias] Hannover Med Sch, Inst Funct & Appl Anat, D-3000 Hannover, Germany; [Proquitte, Hans] Univ Med Berlin, Charite, Clin Neonatol, Berlin, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Hannover Medical School; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rudiger, M (corresponding author), Tech Univ Dresden, Dept Neonatol & Pediat Intens Care Med, Klin Kinderheilkunde, Univ Klinikum Carl Gustav Carus,Med Fak, D-01062 Dresden, Germany.	mario.ruediger@uniklinikum-dresden.de	Mense, Lars/ABB-7080-2021		Deutsche Forschungsgemeinschaft (DFG) [SI 785/3-1, RU 1233/1-2]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The study was supported by grants from the Deutsche Forschungsgemeinschaft (DFG SI 785/3-1 and RU 1233/1-2). No additional fundings received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bendel-Stenzel Ellen M., 2000, Pediatr Crit Care Med, V1, P72, DOI 10.1097/00130478-200007000-00014; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Burkhardt W, 2004, INTENS CARE MED, V30, P315, DOI 10.1007/s00134-003-2090-7; Burkhardt W, 2002, BIOL NEONATE, V82, P250, DOI 10.1159/000065886; Chappell SE, 2001, RESP MED, V95, P612, DOI 10.1053/rmed.2001.1114; Cox PN, 2003, INTENS CARE MED, V29, P2297, DOI 10.1007/s00134-003-1881-1; Diemel RV, 2002, CRIT CARE MED, V30, P1083, DOI 10.1097/00003246-200205000-00020; Doctor A, 2003, J APPL PHYSIOL, V95, P1248, DOI 10.1152/japplphysiol.00598.2002; EDWARDS AD, 1992, PEDIATR RES, V32, P532, DOI 10.1203/00006450-199211000-00007; Espinosa FF, 1999, J APPL PHYSIOL, V86, P391, DOI 10.1152/jappl.1999.86.1.391; Gregory TJ, 1997, AM J RESP CRIT CARE, V155, P1309, DOI 10.1164/ajrccm.155.4.9105072; GUNDERSEN HJG, 1987, J MICROSC-OXFORD, V147, P229, DOI 10.1111/j.1365-2818.1987.tb02837.x; Guthmann F, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-10; Hartog A, 1999, BRIT J ANAESTH, V82, P81, DOI 10.1093/bja/82.1.81; Jeng MJ, 2003, CRIT CARE MED, V31, P1166, DOI 10.1097/01.CCM.0000059312.90697.32; Krause MF, 2000, EUR RESPIR J, V15, P949, DOI 10.1034/j.1399-3003.2000.15e23.x; Krause MF, 2001, PEDIATR RES, V50, P34, DOI 10.1203/00006450-200107000-00009; LACHMANN B, 1980, ACTA ANAESTH SCAND, V24, P231, DOI 10.1111/j.1399-6576.1980.tb01541.x; Lachmann B, 1989, Eur Respir J Suppl, V3, p98s; LEACH CL, 1995, J PEDIATR-US, V126, P412, DOI 10.1016/S0022-3476(95)70461-2; Lewis JE, 2003, ANNU REV PHYSIOL, V65, P613, DOI 10.1146/annurev.physiol.65.092101.142434; Meister JC, 2000, PEDIATR RES, V47, P240, DOI 10.1203/00006450-200002000-00015; MODELL J H, 1970, Chest, V57, P263, DOI 10.1378/chest.57.3.263; Moller JC, 2003, INTENS CARE MED, V29, P437, DOI 10.1007/s00134-003-1650-1; Mrozek JD, 1999, CRIT CARE MED, V27, P1916, DOI 10.1097/00003246-199909000-00033; Ochs M, 2006, J MICROSC-OXFORD, V222, P188, DOI 10.1111/j.1365-2818.2006.01587.x; PETTY TL, 1979, CHEST, V75, P571, DOI 10.1378/chest.75.5.571; PETTY TL, 1977, AM REV RESPIR DIS, V115, P531; ROYALL JA, 1988, J PEDIATR-US, V112, P169, DOI 10.1016/S0022-3476(88)80053-2; Rudiger M, 1998, AM J PHYSIOL-LUNG C, V274, pL143, DOI 10.1152/ajplung.1998.274.1.L143; Rudiger M, 2003, PEDIATR RES, V54, P808, DOI 10.1203/01.PDR.000088070.62177.3A; Rudiger M, 2003, CRIT CARE MED, V31, P1190, DOI 10.1097/01.CCM.0000060008.96029.7D; Rudiger M, 2001, CRIT CARE MED, V29, P1786; Rudiger M, 2001, BIOL NEONATE, V79, P73, DOI 10.1159/000047070; Rudiger M, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-40; Skinner J, 1997, ARCH DIS CHILD-FETAL, V76, pF67, DOI 10.1136/fn.76.2.F67; Walmrath D, 2002, EUR RESPIR J, V19, P805, DOI 10.1183/09031936.02.00243402; Weibel ER, 2007, J APPL PHYSIOL, V102, P459, DOI 10.1152/japplphysiol.00808.2006; Wemhoner A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-52; Wolf S, 2001, BRIT J ANAESTH, V87, P593, DOI 10.1093/bja/87.4.593; Wolfson MR, 1998, J APPL PHYSIOL, V84, P624, DOI 10.1152/jappl.1998.84.2.624	41	6	7	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47923	10.1371/journal.pone.0047923	http://dx.doi.org/10.1371/journal.pone.0047923			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082229	Green Submitted, gold, Green Published			2022-12-25	WOS:000311146900126
J	Choi, K; Cho, SI; Hashizume, M; Kim, H				Choi, Kyunghi; Cho, Sung-il; Hashizume, Masahiro; Kim, Ho			Epidemiological Characteristics of Novel Influenza A (H1N1) in Antiviral Drug Users in Korea	PLOS ONE			English	Article							BODY-MASS INDEX; VIRUS-INFECTION; COHORT	Soon after the first novel influenza A (H1N1) death was documented in Korea on August 15, 2009, prompt treatment with antiviral drugs was recommended when an infection was suspected. Free antiviral drugs were distributed to patients who met the case definition in the treatment guidelines, and patients prescribed the antiviral drugs were included in the Antiviral Drug Surveillance System (ADSS). A total of 2,825,821 patients were reported to the ADSS from September 1 to December 31, 2009. Odds ratios were calculated to compare the risks of severe diseases, as indicated by general hospital admissions or intensive care unit (ICU) admissions according to demographic characteristics, underlying medical conditions, and behavioral factors. Approximately 6% of the total population received antiviral drugs during the study period. Of these, 2,709,611 (95.9%) were outpatients, 114,840 (4.06%) were hospitalized, and 1,370 (0.05%) were admitted to the ICU. Children aged 0-9 yr accounted for 33.94% of all reported cases, whereas only 3.89% of the patients were >= 60 yr. The estimated incidence of novel influenza A (H1N1) during the pandemic was 5.68/100 of all reported cases. Mortality due to influenza A (H1N1) during the pandemic was 0.33/100,000, with the highest mortality of 1.31/100,000 for patients aged >= 60 years. Severe pandemic H1N1 influenza was associated with the presence of one or more underlying medical conditions in elderly aged >= 60 years and with lower economic status. Moreover, influenza A (H1N1) appeared to be age-specific in terms of mortality. Although the incidence and admission rates of influenza A (H1N1) were higher in younger age groups, fatal cases were much more likely to occur in the elderly (>= 60 years). In contrast to earlier influenza A (H1N1) reports, the risks of a severe outcome were elevated among those who were underweight (body mass index, 18.5 kg/m(2)).	[Cho, Sung-il; Kim, Ho] Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea; [Cho, Sung-il; Kim, Ho] Seoul Natl Univ, Inst Hlth & Environm, Seoul, South Korea; [Choi, Kyunghi] Natl Hlth Insurance Cooperat, Dept Insurance Benefits, Seoul, South Korea; [Hashizume, Masahiro] Nagasaki Univ, Inst Trop Med, Nagasaki 852, Japan; [Hashizume, Masahiro] Nagasaki Univ, Global Ctr Excellence Program, Nagasaki 852, Japan	Seoul National University (SNU); Seoul National University (SNU); Nagasaki University; Nagasaki University	Kim, H (corresponding author), Seoul Natl Univ, Grad Sch Publ Hlth, Seoul, South Korea.	hokim@snu.ac.kr	Kim, Ho/AAS-2402-2021; Cho, Sung-il/D-5703-2012	Kim, Ho/0000-0001-7472-3752; Hashizume, Masahiro/0000-0003-4720-1750; Cho, Sung-il/0000-0003-4085-1494	Global Research Lab through the National Research Foundation of Korea (NRF) [K21004000001-10A0500-00710]; Ministry of Education, Science and Technology	Global Research Lab through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	Ho Kim was partially supported by the Global Research Lab (#K21004000001-10A0500-00710) through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Blumentals WA, 2012, INFLUENZA OTHER RESP, V6, P28, DOI 10.1111/j.1750-2659.2011.00262.x; Campbell A, 2010, CAN MED ASSOC J, V182, P349, DOI 10.1503/cmaj.091823; Cao B, 2009, NEW ENGL J MED, V361, P2507, DOI 10.1056/NEJMoa0906612; Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; European Centre for Disease Prevention and Control Working group on influenza A (H1N1) v, 2009, EUROSURVEILLANCE, V14, P19238; Kim JH, 2010, J KOREAN MED SCI, V25, P1109, DOI 10.3346/jkms.2010.25.7.1109; Korea Centre for Disease Control and Prevention, 2010, PUBLIC HEATH WEEKLY, V3, P101; Korea Centre for Disease Control and Prevention, INFL A H1N1 2009 CON; Korea Centre for Disease Control and Prevention, 2009, PUBLIC HEATH WEEKLY, V2, P656; Korea Centre for Disease Control and Prevention, 2009, PRESS B         1020; Korea Centre for Disease Control and Prevention, GUID LAB DIAGN NOV I; Korea Centre for Disease Control and Prevention, 2010, PUBLIC HEATH WEEKLY, V3, P241; Korea Centre for Disease Control and Prevention, 2009, PUBLIC HEATH WEEKLY, V2, P785; Korea Centre for Disease Control and Prevention, 2009, PUBLIC HEATH WEEKLY, V2, P689; Korea Ministry of Health and Welfare, 2009, PRESS B         0922; Korea Ministry of Health and Welfare, 2010, PRESS B         0204; Korea Ministry of Health and Welfare, 2010, PRESS B         0305; Korea National Health Insurance Cooperation, NHIC STAT; Kumakura H, 2010, J VASC SURG, V52, P110, DOI 10.1016/j.jvs.2010.02.008; Miller E, 2010, LANCET, V375, P1100, DOI 10.1016/S0140-6736(09)62126-7; Satpathy HK, 2009, POSTGRAD MED, V121, P106, DOI 10.3810/pgm.2009.11.2080; Vaillant L, 2009, EUROSURVEILLANCE, V14, P2; WHO, 20 WHO; Wilson N, 2009, EUROSURVEILLANCE, V14; Zarychanski R, 2010, CAN MED ASSOC J, V182, P257, DOI 10.1503/cmaj.091884	27	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47634	10.1371/journal.pone.0047634	http://dx.doi.org/10.1371/journal.pone.0047634			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082184	gold, Green Published, Green Submitted			2022-12-25	WOS:000311146900080
J	Zambrano, JL; Sorondo, O; Alcala, A; Vizzi, E; Diaz, Y; Ruiz, MC; Michelangeli, F; Liprandi, F; Ludert, JE				Luis Zambrano, Jose; Sorondo, Orlando; Alcala, Ana; Vizzi, Esmeralda; Diaz, Yuleima; Ruiz, Marie Christine; Michelangeli, Fabian; Liprandi, Ferdinando; Ludert, Juan E.			Rotavirus Infection of Cells in Culture Induces Activation of RhoA and Changes in the Actin and Tubulin Cytoskeleton	PLOS ONE			English	Article							NONSTRUCTURAL GLYCOPROTEIN NSP4; INTESTINAL EPITHELIAL-CELLS; INTRACELLULAR CALCIUM-CONCENTRATION; SPIKE PROTEIN VP4; VIRAL ENTEROTOXIN; SECRETORY PATHWAY; PLASMA-MEMBRANE; MICROTUBULES; EXPRESSION; ENTRY	Rotavirus infection induces an increase in [Ca2+](cyto), which in turn may affect the distribution of the cytoskeleton proteins in the infected cell. Changes in microfilaments, including the formation of stress fibers, were observed starting at 0.5 h.p.i. using fluorescent phalloidin. Western blot analysis indicated that RhoA is activated between 0.5 and 1 h.p.i. Neither the phosphorylation of RhoA nor the formation of stress fibers were observed in cells infected with virions pre-treated with an anti-VP5* non-neutralizing mAb, suggesting that RhoA activation is stimulated by the interaction of the virus with integrins forming the cell receptor complex. In addition, the structure of the tubulin cytoskeleton was also studied. Alterations of the microtubules were evident starting at 3 h.p.i. and by 7 h.p.i. when microtubules were markedly displaced toward the periphery of the cell cytoplasm. Loading of rotavirus-infected cells with either a Ca2+ chelator (BAPTA) or transfection with siRNAs to silence NSP4, reversed the changes observed in both the microfilaments and microtubules distribution, but not the appearance of stress fibers. These results indicate that alterations in the distribution of actin microfilaments are initiated early during infection by the activation of RhoA, and that latter changes in the Ca2+ homeostasis promoted by NSP4 during infection may be responsible for other alterations in the actin and tubulin cytoskeleton.	[Luis Zambrano, Jose; Sorondo, Orlando; Alcala, Ana; Vizzi, Esmeralda; Liprandi, Ferdinando] CMBC, IVIC, Caracas, Venezuela; [Sorondo, Orlando] Cent Univ Venezuela, Escuela Biol, Caracas, Venezuela; [Diaz, Yuleima] Univ Bergen, Bergen, Norway; [Ruiz, Marie Christine; Michelangeli, Fabian] CBB, IVIC, Caracas, Venezuela; [Ludert, Juan E.] Inst Politecn Nacl CINVESTAV IPN, Ctr Invest & Estudios Avanzados, Mexico City, DF, Mexico	Venezuelan Institute Science Research; University of Central Venezuela; University of Bergen; Venezuelan Institute Science Research; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional	Zambrano, JL (corresponding author), CMBC, IVIC, Caracas, Venezuela.	jlzr@ivic.gob.ve; jludert@cinvestav.mx	Vizzi, Esmeralda/AAQ-2362-2021; Zambrano-Rouvier, José Luis/AAZ-6995-2021; Ludert, Juan E./H-5658-2019	Zambrano-Rouvier, José Luis/0000-0001-9884-2940; ALCALA, ANA/0000-0002-6882-4765; Vizzi, Esmeralda/0000-0001-6865-1617; Ludert, Juan Ernesto/0000-0003-4790-7681	IVIC [098, 858, 988]	IVIC	The authors declare financial funding by IVIC, and Venezuelan LOCTI Program (TOTAL VENEZUELA, S.A., Helmerich & Paine and Deloitte Group). This does not alter the authors' adherence to all PLOS ONE policies on sharing data and materials.	Ball JM, 2005, VIRAL IMMUNOL, V18, P27, DOI 10.1089/vim.2005.18.27; Berkova Z, 2006, J VIROL, V80, P6061, DOI 10.1128/JVI.02167-05; Berkova Z, 2003, CELL CALCIUM, V34, P55, DOI 10.1016/S0143-4160(03)00022-8; Berkova Z, 2007, J VIROL, V81, P3545, DOI 10.1128/JVI.01080-06; Birkenfeld J, 2008, TRENDS CELL BIOL, V18, P210, DOI 10.1016/j.tcb.2008.02.006; Bowman GD, 2000, J MOL BIOL, V304, P861, DOI 10.1006/jmbi.2000.4250; Brunet JP, 2000, J VIROL, V74, P10801, DOI 10.1128/JVI.74.22.10801-10806.2000; Brunet JP, 2000, J VIROL, V74, P2323, DOI 10.1128/JVI.74.5.2323-2332.2000; Bugarcic A, 2006, J VIROL, V80, P12343, DOI 10.1128/JVI.01378-06; Cabral-Romero C, 2006, MEM I OSWALDO CRUZ, V101, P603, DOI 10.1590/S0074-02762006000600006; Ruiz MC, 2009, THESCIENTIFICWORLDJO, V9, P1476, DOI 10.1100/tsw.2009.158; Coller KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000702; Cuadras MA, 2006, J VIROL, V80, P3935, DOI 10.1128/JVI.80.8.3935-3946.2006; Diaz Y, 2008, J VIROL, V82, P11331, DOI 10.1128/JVI.00577-08; Diaz Y, 2012, VIRUS RES, V167, P285, DOI 10.1016/j.virusres.2012.05.012; Dickman KG, 2000, AM J PHYSIOL-GASTR L, V279, pG757, DOI 10.1152/ajpgi.2000.279.4.G757; Dong YJ, 1997, P NATL ACAD SCI USA, V94, P3960, DOI 10.1073/pnas.94.8.3960; Estes M. K., 2001, FIELDS VIROLOGY; Gardet A, 2006, J VIROL, V80, P3947, DOI 10.1128/JVI.80.8.3947-3956.2006; Gardet A, 2007, J VIROL, V81, P4892, DOI 10.1128/JVI.02698-06; Gibbons TF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-278; Graham KL, 2003, J VIROL, V77, P9969, DOI 10.1128/JVI.77.18.9969-9978.2003; Guerrero CA, 2000, J VIROL, V74, P9362, DOI 10.1128/JVI.74.20.9362-9371.2000; Huang H, 2004, BIOCHEM J, V380, P723, DOI 10.1042/BJ20031789; Huang H, 2001, BIOCHEMISTRY-US, V40, P4169, DOI 10.1021/bi002346s; Janiak A, 2006, MOL BIOL CELL, V17, P1606, DOI 10.1091/mbc.E05-06-0549; Jourdan N, 1998, J VIROL, V72, P7228, DOI 10.1128/JVI.72.9.7228-7236.1998; KAPIKIAN AZ, 2001, FIELDS VIROLOGY; Kurtoglu M, 2007, ANTIOXID REDOX SIGN, V9, P1383, DOI 10.1089/ars.2007.1714; LIPRANDI F, 1990, J GEN VIROL, V71, P1395, DOI 10.1099/0022-1317-71-6-1395; Lopez S, 2004, TRENDS MICROBIOL, V12, P271, DOI 10.1016/j.tim.2004.04.003; Lopez T, 2005, J VIROL, V79, P184, DOI 10.1128/JVI.79.1.184-192.2005; Lundgren O, 2001, MICROBES INFECT, V3, P1145, DOI 10.1016/S1286-4579(01)01475-7; Martin D, 2010, J VIROL, V84, P2522, DOI 10.1128/JVI.01883-09; MIDTHUN K, 1985, J VIROL, V53, P949, DOI 10.1128/JVI.53.3.949-954.1985; Nejmeddine M, 2000, J VIROL, V74, P3313, DOI 10.1128/JVI.74.7.3313-3320.2000; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; PRASAD BVV, 1988, J MOL BIOL, V199, P269, DOI 10.1016/0022-2836(88)90313-0; Rasband W, IMAGEJ IMAGE PROCESS; RIDLEY AJ, 1994, EMBO J, V13, P2600, DOI 10.1002/j.1460-2075.1994.tb06550.x; Ruiz MC, 2005, VIROLOGY, V333, P54, DOI 10.1016/j.virol.2004.12.032; Seo NS, 2008, P NATL ACAD SCI USA, V105, P8811, DOI 10.1073/pnas.0803934105; Silvestri LS, 2005, J VIROL, V79, P15165, DOI 10.1128/JVI.79.24.15165-15174.2005; Steinberg BE, 2011, ANTIVIR RES, DOI [10.1016/j.antiviral.2011.10.019, DOI 10.1016/J.ANTIVI-RAL.2011.10.019]; Tafazoli F, 2001, J VIROL, V75, P1540, DOI 10.1128/JVI.75.3.1540-1546.2001; TIAN P, 1995, J VIROL, V69, P5763, DOI 10.1128/JVI.69.9.5763-5772.1995; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Wang JG, 2010, MAGNETIC FRINGE FIELDS AND INTERFERENCE IN HIGH INTENSITY ACCELERATORS, P1; WECLEWICZ K, 1994, J GEN VIROL, V75, P3267, DOI 10.1099/0022-1317-75-11-3267; WECLEWICZ K, 1993, J NEUROSCI RES, V36, P173, DOI 10.1002/jnr.490360207; Xu AM, 2000, EMBO J, V19, P6465, DOI 10.1093/emboj/19.23.6465; Yang WM, 2012, VIRUS RES, V163, P269, DOI 10.1016/j.virusres.2011.10.011; Zarnbrano JL, 2008, J VIROL, V82, P5815, DOI 10.1128/JVI.02719-07; Zhang MD, 2000, J VIROL, V74, P11663, DOI 10.1128/JVI.74.24.11663-11670.2000; Zhou H, 2005, J BIOL CHEM, V280, P10624, DOI 10.1074/jbc.M411900200	55	21	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47612	10.1371/journal.pone.0047612	http://dx.doi.org/10.1371/journal.pone.0047612			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082182	Green Published, gold, Green Submitted			2022-12-25	WOS:000311146900078
J	Machado, P; Manco, L; Gomes, C; Mendes, C; Fernandes, N; Salome, G; Sitoe, L; Chibute, S; Langa, J; Ribeiro, L; Miranda, J; Cano, J; Pinto, J; Amorim, A; do Rosario, VE; Arez, AP				Machado, Patricia; Manco, Licinio; Gomes, Claudia; Mendes, Cristina; Fernandes, Natercia; Salome, Graca; Sitoe, Luis; Chibute, Sergio; Langa, Jose; Ribeiro, Leticia; Miranda, Juliana; Cano, Jorge; Pinto, Joao; Amorim, Antonio; do Rosario, Virgilio E.; Arez, Ana Paula			Pyruvate Kinase Deficiency in Sub-Saharan Africa: Identification of a Highly Frequent Missense Mutation (G829A; Glu277Lys) and Association with Malaria	PLOS ONE			English	Article							POPULATION-GENETICS; QUANTITATIVE ASSAY; PREVALENCE; RESISTANCE; PROTECTS; CHINESE; HUMANS	Background: Pyruvate kinase (PK) deficiency, causing hemolytic anemia, has been associated to malaria protection and its prevalence in sub-Saharan Africa is not known so far. This work shows the results of a study undertaken to determine PK deficiency occurrence in some sub-Saharan African countries, as well as finding a prevalent PK variant underlying this deficiency. Materials and Methods: Blood samples of individuals from four malaria endemic countries (Mozambique, Angola, Equatorial Guinea and Sao Tome and Principe) were analyzed in order to determine PK deficiency occurrence and detect any possible high frequent PK variant mutation. The association between this mutation and malaria was ascertained through association studies involving sample groups from individuals showing different malaria infection and outcome status. Results: The percentage of individuals showing a reduced PK activity in Maputo was 4.1% and the missense mutation G829A (Glu277Lys) in the PKLR gene (only identified in three individuals worldwide to date) was identified in a high frequency. Heterozygous carrier frequency was between 6.7% and 2.6%. A significant association was not detected between either PK reduced activity or allele 829A frequency and malaria infection and outcome, although the variant was more frequent among individuals with uncomplicated malaria. Conclusions: This was the first study on the occurrence of PK deficiency in several areas of Africa. A common PKLR mutation G829A (Glu277Lys) was identified. A global geographical co-distribution between malaria and high frequency of PK deficiency seems to occur suggesting that malaria may be a selective force raising the frequency of this 277Lys variant.	[Machado, Patricia; Gomes, Claudia; Mendes, Cristina; Pinto, Joao; do Rosario, Virgilio E.; Arez, Ana Paula] Univ Nova Lisboa, Ctr Malaria & Outras Doencas Tropicais, Unidade Parasitol Med, Inst Higiene & Med Trop, P-1200 Lisbon, Portugal; [Manco, Licinio] Univ Coimbra, CIAS, Coimbra, Portugal; [Fernandes, Natercia; Salome, Graca; Sitoe, Luis; Chibute, Sergio] Univ Eduardo Mondlane, Fac Med, Maputo, Mozambique; [Langa, Jose] Hosp Cent Maputo, Banco Sangue, Maputo, Mozambique; [Ribeiro, Leticia] Ctr Hosp Coimbra, Dept Hematol, Coimbra, Portugal; [Miranda, Juliana] Hosp Pediat David Bernardino, Luanda, Angola; [Cano, Jorge] Inst Salud Carlos III, Ctr Nacl Med Trop, Madrid, Spain; [Amorim, Antonio] Univ Porto IPATIMUP, Inst Patol & Imunol Mol, Oporto, Portugal; [Amorim, Antonio] Univ Porto, Fac Ciencias, P-4100 Oporto, Portugal	Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade de Coimbra; Eduardo Mondlane University; Universidade de Coimbra; Centro Hospitalar e Universitario de Coimbra (CHUC); Instituto de Salud Carlos III; Centro Nacional de Medicina Tropical (CNMT); Universidade do Porto; Universidade do Porto	Arez, AP (corresponding author), Univ Nova Lisboa, Ctr Malaria & Outras Doencas Tropicais, Unidade Parasitol Med, Inst Higiene & Med Trop, P-1200 Lisbon, Portugal.	aparez@ihmt.unl.pt	J., Pinto/H-6177-2019; Amorim, Antonio/A-7938-2008; Cano, Jorge/E-2962-2016; Manco, Licinio/M-4746-2013; Pinto, Joao/C-2208-2012; Arez, Ana Paula/I-1729-2012; Cano, Jorge/AAV-6392-2020	J., Pinto/0000-0001-8572-7708; Amorim, Antonio/0000-0002-7518-6247; Cano, Jorge/0000-0001-9864-5058; Manco, Licinio/0000-0002-2636-0288; Pinto, Joao/0000-0001-8572-7708; Arez, Ana Paula/0000-0002-0497-6532; Cano, Jorge/0000-0001-9864-5058; Gomes, Claudia/0000-0003-3746-1671; Ribeiro, Maria Leticia/0000-0002-5964-5001; Ribeiro, Maria Leticia de/0000-0002-7469-7061	FCT grant [SFRH/BD/28236/2006]; Fundacao para a Ciencia e a Tecnologia; "Fundacao para a Ciencia e Tecnologia/Ministerio da Educacao e Ciencia'', FCT/MEC, Portugal [PTDC/SAU-MET/110323/2009];  [PEst-OE/SAU/LA0018/2011];  [LA0018 2011/2012]	FCT grant(Portuguese Foundation for Science and Technology); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); "Fundacao para a Ciencia e Tecnologia/Ministerio da Educacao e Ciencia'', FCT/MEC, Portugal(Portuguese Foundation for Science and Technology); ; 	This study was supported by PEst-OE/SAU/LA0018/2011 - Proj. Estrategico LA0018 2011/2012 (http://cmdt.ihmt.unl.pt/index.php/pt/) and PTDC/SAU-MET/110323/2009, "Fundacao para a Ciencia e Tecnologia/Ministerio da Educacao e Ciencia'', FCT/MEC (http://alfa.fct.mctes.pt/index.phtml.pt), Portugal. PM holds a FCT grant (SFRH/BD/28236/2006). IPATIMUP is an Associate Laboratory of the Portuguese Ministry of Education and Science, and is partially supported by Fundacao para a Ciencia e a Tecnologia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABUMELHA AM, 1991, ACTA HAEMATOL-BASEL, V85, P192; Akin H, 1997, HUM HERED, V47, P42, DOI 10.1159/000154388; Allison AC, 2009, CURR OPIN IMMUNOL, V21, P499, DOI 10.1016/j.coi.2009.04.001; Alves J, 2010, BLOOD CELL MOL DIS, V44, P62, DOI 10.1016/j.bcmd.2009.09.008; [Anonymous], VERS 1 2R3PRE; Ayi K, 2008, NEW ENGL J MED, V358, P1805, DOI 10.1056/NEJMoa072464; Berghout J, 2012, GENES IMMUN, V13, P98, DOI 10.1038/gene.2011.54; Beutler E, 2000, BLOOD, V95, P3585, DOI 10.1182/blood.V95.11.3585.011k39_3585_3588; Beutler E., 1984, GLUTATHIONE RED CELL; Carey PJ, 2000, BLOOD, V96, P4005, DOI 10.1182/blood.V96.12.4005.h8004000e_4005_4006; CARMONAGARCIA S, 1979, HUM HERED, V29, P310; Durand PM, 2008, HAEMATOLOGICA, V93, P939, DOI 10.3324/haematol.12450; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; FENG CS, 1993, AM J HEMATOL, V43, P271, DOI 10.1002/ajh.2830430408; FUNG RHP, 1969, ARCH DIS CHILD, V44, P373, DOI 10.1136/adc.44.235.373; Hedrick PW, 2011, HEREDITY, V107, P283, DOI 10.1038/hdy.2011.16; JOBLING M, 2004, HUMAN EVOLUTIONARY G, P15253; Loh W P, 1968, J Indiana State Med Assoc, V61, P1651; Machado P, 2010, BRIT J HAEMATOL, V149, P775, DOI 10.1111/j.1365-2141.2010.08165.x; Manco L, 1999, BRIT J HAEMATOL, V105, P591, DOI 10.1046/j.1365-2141.1999.01387.x; Mendes C, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001192; Min-Oo G, 2003, NAT GENET, V35, P357, DOI 10.1038/ng1260; Ministerio da Saude Direccao Geral da Saude Republica de Mocambique, 2002, MOC INV NUTR RED POB; Pinto J, 2000, ACTA TROP, V76, P185, DOI 10.1016/S0001-706X(00)00100-5; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V58, P283, DOI 10.1016/0166-6851(93)90050-8; University Medical Center, 2007, PKLR MUT DAT; Valentini G, 2002, J BIOL CHEM, V277, P23807, DOI 10.1074/jbc.M202107200; Verra F, 2009, PARASITE IMMUNOL, V31, P234, DOI 10.1111/j.1365-3024.2009.01106.x; WHO EMRO, 2011, WHO REG OFF E MED EP; Yavarian M, 2008, BLOOD CELL MOL DIS, V40, P308, DOI 10.1016/j.bcmd.2007.08.008; Zanella A, 2007, BLOOD REV, V21, P217, DOI 10.1016/j.blre.2007.01.001	31	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47071	10.1371/journal.pone.0047071	http://dx.doi.org/10.1371/journal.pone.0047071			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082140	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000311146900035
J	Soberman, RJ; MacKay, CR; Vaine, CA; Ryan, GB; Cerny, AM; Thompson, MR; Nikolic, B; Primo, V; Christmas, P; Sheiffele, P; Aronov, L; Knipe, DM; Kurt-Jones, EA				Soberman, Roy J.; MacKay, Christopher R.; Vaine, Christine A.; Ryan, Glennice Bowen; Cerny, Anna M.; Thompson, Mikayla R.; Nikolic, Boris; Primo, Valeria; Christmas, Peter; Sheiffele, Paul; Aronov, Lisa; Knipe, David M.; Kurt-Jones, Evelyn A.			CD200R1 Supports HSV-1 Viral Replication and Licenses Pro-Inflammatory Signaling Functions of TLR2	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; CENTRAL-NERVOUS-SYSTEM; KAPPA-B; RECEPTOR; HOST; EXPRESSION; RESPONSES; MICE; RECOGNIZES; ACTIVATION	The CD200R1:CD200 axis is traditionally considered to limit tissue inflammation by down-regulating pro-inflammatory signaling in myeloid cells bearing the receptor. We generated CD200R1(-/-) mice and employed them to explore both the role of CD200R1 in regulating macrophage signaling via TLR2 as well as the host response to an in vivo, TLR2-dependent model, herpes simplex virus 1 (HSV-1) infection. CD200R1(-/-) peritoneal macrophages demonstrated a 70-75% decrease in the generation of IL-6 and CCL5 (Rantes) in response to the TLR2 agonist Pam(2)CSK(4) and to HSV-1. CD200R1(-/-) macrophages could neither up-regulate the expression of TLR2, nor assemble a functional inflammasome in response to HSV-1. CD200R1(-/-) mice were protected from HSV-1 infection and exhibited dysfunctional TLR2 signaling. Finally, both CD200R1(-/-) mice and CD200R1(-/-) fibroblasts and macrophages showed a markedly reduced ability to support HSV-1 replication. In summary, our data demonstrate an unanticipated and novel requirement for CD200R1 in "licensing'' pro-inflammatory functions of TLR2 and in limiting viral replication that are supported by ex vivo and in vivo evidence.	[Soberman, Roy J.; Vaine, Christine A.; Nikolic, Boris; Primo, Valeria; Christmas, Peter] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Renal Unit,Dept Med, Charlestown, MA USA; [MacKay, Christopher R.; Ryan, Glennice Bowen; Cerny, Anna M.; Thompson, Mikayla R.; Kurt-Jones, Evelyn A.] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; [Sheiffele, Paul; Aronov, Lisa] InGenious Targeting Lab Inc, Stony Brook, NY USA; [Knipe, David M.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA USA	Harvard University; Massachusetts General Hospital; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School	Soberman, RJ (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Renal Unit,Dept Med, Charlestown, MA USA.	Soberman@helix.mgh.harvard.edu; evelyn.kurt-jones@umassmed.edu	Mackay, Charles R/A-9673-2008	Mackay, Charles R/0000-0002-6338-7340; Vaine, Christine/0000-0003-2645-8223	National Institutes of Health [R01AI068871, R01AI068871-S4, P01 AI083215-01]; Diabetes Endocrinology Research Center [DK32520]; UMass CFAR from the National Institutes of Health [5P30 AI-42845]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI083215, R01AI068871, P30AI042845, T32AI095213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK032520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Endocrinology Research Center; UMass CFAR from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants R01AI068871 (RJS), R01AI068871-S4 (RJS and CV), P01 AI083215-01 (EAK-J and DMK) and UMass CFAR Grant 5P30 AI-42845 (EAK-J) from the National Institutes of Health. Core resources supported by the Diabetes Endocrinology Research Center grant DK32520 were also used. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boudakov I, 2007, TRANSPLANTATION, V84, P251, DOI 10.1097/01.tp.0000269795.04592.cc; Burckstummer T, 2009, NAT IMMUNOL; Carr DJJ, 1999, J NEUROVIROL, V5, P449, DOI 10.3109/13550289909045373; Cook WJ, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-5; Cortez M, 2011, CELL HOST MICROBE, V9, P463, DOI 10.1016/j.chom.2011.04.014; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Davey GM, 2010, J IMMUNOL, V184, P2243, DOI 10.4049/jimmunol.0903013; Deckert M, 2006, ACTA NEUROPATHOL, V111, P548, DOI 10.1007/s00401-006-0062-z; Detje CN, 2009, J IMMUNOL, V182, P2297, DOI 10.4049/jimmunol.0800596; Dunne Aisling, 2003, Sci STKE, V2003, pre3, DOI 10.1126/stke.2003.171.re3; Eidson KM, 2002, J VIROL, V76, P2180, DOI 10.1128/JVI.76.5.2180-2191.2002; Fernandes-Alnemri T, 2009, NATURE; Fields BN, 2001, FIELDS VIROLOGY, Vxix; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Hoek RM, 2000, SCIENCE, V290, P1768, DOI 10.1126/science.290.5497.1768; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Karnam G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002710; Koning N, 2009, J NEUROPATH EXP NEUR, V68, P159, DOI 10.1097/NEN.0b013e3181964113; Kurt-Jones EA, 2005, J INFECT DIS, V191, P746, DOI 10.1086/427339; Kurt-Jones EA, 2004, J ENDOTOXIN RES, V10, P419, DOI 10.1179/096805104225006516; Kurt-Jones EA, 2004, P NATL ACAD SCI USA, V101, P1315, DOI 10.1073/pnas.0308057100; Lund J, 2003, J EXP MED, V198, P513, DOI 10.1084/jem.20030162; Lundberg P, 2008, J VIROL, V82, P7078, DOI 10.1128/JVI.00619-08; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; McGinnes LW, 2011, J VIROL, V85, P366, DOI 10.1128/JVI.01861-10; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; Melchjorsen J, 2003, J GEN VIROL, V84, P2491, DOI 10.1099/vir.0.19159-0; Menachery VD, 2010, J VIROL, V84, P9685, DOI 10.1128/JVI.00706-10; Mihrshahi R, 2010, J IMMUNOL, V185, P7216, DOI 10.4049/jimmunol.1002858; Mihrshahi R, 2009, J IMMUNOL, V183, P4879, DOI 10.4049/jimmunol.0901531; Mott KR, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-56; Mukhopadhyay S, 2010, CELL HOST MICROBE, V8, P236, DOI 10.1016/j.chom.2010.08.005; Muruve DA, 2008, NATURE, V452, P103, DOI 10.1038/nature06664; Perry AK, 2005, CELL RES, V15, P407, DOI 10.1038/sj.cr.7290309; Rathinam VAK, 2010, NAT IMMUNOL, V11, P395, DOI 10.1038/ni.1864; Semmling V, 2010, NAT IMMUNOL, V11, P313, DOI 10.1038/ni.1848; Sheridan BS, 2009, J VIROL, V83, P2237, DOI 10.1128/JVI.01699-08; Shlapatska LM, 2001, J IMMUNOL, V166, P5480, DOI 10.4049/jimmunol.166.9.5480; Shrivastava K, 2012, J COMP NEUROLOGY; Snelgrove RJ, 2008, NAT IMMUNOL, V9, P1074, DOI 10.1038/ni.1637; St Leger AJ, 2011, J IMMUNOL, V186, P3927, DOI 10.4049/jimmunol.1003735; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Taylor TJ, 2003, VIROLOGY, V309, P232, DOI 10.1016/S0042-6822(03)00107-7; van Lint AL, 2010, J VIROL, V84, P10802, DOI 10.1128/JVI.00063-10; Vilela MC, 2009, ANN NY ACAD SCI, V1153, P256, DOI 10.1111/j.1749-6632.2008.03959.x; Vollstedt S, 2001, J VIROL, V75, P9596, DOI 10.1128/JVI.75.20.9596-9600.2001; Wang JP, 2012, J VIROL, V86, P2273, DOI 10.1128/JVI.06010-11; WHITLEY R, 1991, NEW ENGL J MED, V324, P450, DOI 10.1056/NEJM199102143240704; Wright GJ, 2000, IMMUNITY, V13, P233, DOI 10.1016/S1074-7613(00)00023-6; Wright GJ, 2003, J IMMUNOL, V171, P3034, DOI 10.4049/jimmunol.171.6.3034; Young JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029688; Zhang SL, 2004, J IMMUNOL, V173, P6786, DOI 10.4049/jimmunol.173.11.6786	52	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47740	10.1371/journal.pone.0047740	http://dx.doi.org/10.1371/journal.pone.0047740			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082204	Green Published, gold, Green Submitted			2022-12-25	WOS:000311146900101
J	Zhang, W; MacDonald, EM; Koepp, DM				Zhang, Wei; MacDonald, Elizabeth M.; Koepp, Deanna M.			The Stomatin-Like Protein SLP-1 and Cdk2 Interact with the F-Box Protein Fbw7-gamma	PLOS ONE			English	Article							PHOSPHORYLATION-DEPENDENT DEGRADATION; FBW7 UBIQUITIN LIGASE; CYCLIN-E; C-MYC; SUBSTRATE RECOGNITION; TUMOR-SUPPRESSOR; NOTCH; ISOFORM; SEL-10; INHIBITOR	Control of cellular proliferation is critical to cell viability. The F-box protein Fbw7 (hAgo/hCdc4/FBXW7) functions as a specificity factor for the Skp1-Cul1-F-box protein (SCF) ubiquitin ligase complex and targets several proteins required for cellular proliferation for ubiquitin-mediated destruction. Fbw7 exists as three splice variants but the mechanistic role of each is not entirely clear. We examined the regulation of the Fbw7-gamma isoform, which has been implicated in the degradation of c-Myc. We show here that Fbw7-gamma is an unstable protein and that its turnover is proteasome-dependent in transformed cells. Using a two-hybrid screen, we identified a novel interaction partner, SLP-1, which binds the N-terminal domain of Fbw7-gamma. Overexpression of SLP-1 inhibits the degradation of Fbw7-gamma, suggesting that this interaction can happen in vivo. When Fbw7-gamma is stabilized by overexpression of SLP-1, c-Myc protein abundance decreases, suggesting that the SCFFbw7-gamma complex maintains activity. We demonstrate that Cdk2 also binds the N-terminal domain of Fbw7-gamma as well as SLP-1. Interestingly, co-expression of Cdk2 and SLP-1 does not inhibit Fbw7-gamma degradation, suggesting that Cdk2 and SLP-1 may have opposing functions.	[Zhang, Wei; MacDonald, Elizabeth M.; Koepp, Deanna M.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities	Koepp, DM (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA.	koepp015@umn.edu			National Institutes of Health [R01 GM076663]; V Foundation for Cancer Research; Leukemia Research Fund; American Cancer Society Institutional Research Grant at the University of Minnesota; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Foundation for Cancer Research; Leukemia Research Fund; American Cancer Society Institutional Research Grant at the University of Minnesota; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded in part by the National Institutes of Health grant R01 GM076663 to DMK and awards from the V Foundation for Cancer Research (www.jimmyv.org), the Leukemia Research Fund (www.leukemia-research.org) and a sub-award from the American Cancer Society Institutional Research Grant at the University of Minnesota (www.cancer.org). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bai C, 1996, METHOD ENZYMOL, V273, P331; Bonetti P, 2008, J CELL BIOL, V182, P19, DOI 10.1083/jcb.200711040; Brooks TA, 2009, NAT REV CANCER, V9, P849, DOI 10.1038/nrc2733; Cizmecioglu O, 2012, J CELL SCI, V125, P981, DOI 10.1242/jcs.095075; Ganoth D, 2001, NAT CELL BIOL, V3, P321, DOI 10.1038/35060126; Green JB, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-44; Grim JE, 2008, J CELL BIOL, V181, P913, DOI 10.1083/jcb.200802076; Gupta-Rossi N, 2001, J BIOL CHEM, V276, P34371, DOI 10.1074/jbc.M101343200; Hao B, 2007, MOL CELL, V26, P131, DOI 10.1016/j.molcel.2007.02.022; Hayami R, 2005, CANCER RES, V65, P6; Koepp DM, 2001, SCIENCE, V294, P173, DOI 10.1126/science.1065203; Mairhofer M, 2009, J BIOL CHEM, V284, P29218, DOI 10.1074/jbc.M109.014993; Mao JH, 2004, NATURE, V432, P775, DOI 10.1038/nature03155; Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Nateri AS, 2004, SCIENCE, V303, P1374, DOI 10.1126/science.1092880; Oberg C, 2001, J BIOL CHEM, V276, P35847, DOI 10.1074/jbc.M103992200; Olson BL, 2008, GENE DEV, V22, P252, DOI 10.1101/gad.1624208; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Popov N, 2007, NAT CELL BIOL, V9, P765, DOI 10.1038/ncb1601; Punga T, 2006, J BIOL CHEM, V281, P25278, DOI 10.1074/jbc.M604983200; Sangfelt O, 2008, CELL CYCLE, V7, P1075, DOI 10.4161/cc.7.8.5648; Sedensky MM, 2004, AM J PHYSIOL-CELL PH, V287, pC468, DOI 10.1152/ajpcell.00182.2003; Seidel G, 1998, GENE, V225, P23, DOI 10.1016/S0378-1119(98)00532-0; Spruck C, 2001, MOL CELL, V7, P639, DOI 10.1016/S1097-2765(01)00210-6; Spruck CH, 2002, CANCER RES, V62, P4535; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; Tetzlaff MT, 2004, P NATL ACAD SCI USA, V101, P3338, DOI 10.1073/pnas.0307875101; Tsunematsu R, 2004, J BIOL CHEM, V279, P9417, DOI 10.1074/jbc.M312337200; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Welcker M, 2008, NAT REV CANCER, V8, P83, DOI 10.1038/nrc2290; Won KA, 1996, EMBO J, V15, P4182, DOI 10.1002/j.1460-2075.1996.tb00793.x; Wu GY, 2001, MOL CELL BIOL, V21, P7403, DOI 10.1128/MCB.21.21.7403-7415.2001; Yada M, 2004, EMBO J, V23, P2116, DOI 10.1038/sj.emboj.7600217; Ye X, 2004, J BIOL CHEM, V279, P50110, DOI 10.1074/jbc.M409226200; Zhang SF, 2004, CURR BIOL, V14, P1888, DOI 10.1016/j.cub.2004.10.030; Zhang W, 2006, MOL CANCER RES, V4, P935, DOI 10.1158/1541-7786.MCR-06-0253; Zhou PB, 1998, MOL CELL, V2, P571, DOI 10.1016/S1097-2765(00)80156-2	41	3	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47736	10.1371/journal.pone.0047736	http://dx.doi.org/10.1371/journal.pone.0047736			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082202	Green Submitted, Green Published, gold			2022-12-25	WOS:000311146900099
J	Ackerman, SH; Tillier, ER; Gatti, DL				Ackerman, Sharon H.; Tillier, Elisabeth R.; Gatti, Domenico L.			Accurate Simulation and Detection of Coevolution Signals in Multiple Sequence Alignments	PLOS ONE			English	Article							INDEPENDENT COMPONENT ANALYSIS; INVERSE COVARIANCE ESTIMATION; MUTUAL INFORMATION; ALLOSTERIC COMMUNICATION; MOLECULAR COEVOLUTION; COEVOLVING POSITIONS; CORRELATED MUTATIONS; CONTACT PREDICTION; PROTEIN EVOLUTION; RESIDUE CONTACTS	Background: While the conserved positions of a multiple sequence alignment (MSA) are clearly of interest, non-conserved positions can also be important because, for example, destabilizing effects at one position can be compensated by stabilizing effects at another position. Different methods have been developed to recognize the evolutionary relationship between amino acid sites, and to disentangle functional/structural dependencies from historical/phylogenetic ones. Methodology/Principal Findings: We have used two complementary approaches to test the efficacy of these methods. In the first approach, we have used a new program, MSAvolve, for the in silico evolution of MSAs, which records a detailed history of all covarying positions, and builds a global coevolution matrix as the accumulated sum of individual matrices for the positions forced to co-vary, the recombinant coevolution, and the stochastic coevolution. We have simulated over 1600 MSAs for 8 protein families, which reflect sequences of different sizes and proteins with widely different functions. The calculated coevolution matrices were compared with the coevolution matrices obtained for the same evolved MSAs with different coevolution detection methods. In a second approach we have evaluated the capacity of the different methods to predict close contacts in the representative X-ray structures of an additional 150 protein families using only experimental MSAs. Conclusions/Significance: Methods based on the identification of global correlations between pairs were found to be generally superior to methods based only on local correlations in their capacity to identify coevolving residues using either simulated or experimental MSAs. However, the significant variability in the performance of different methods with different proteins suggests that the simulation of MSAs that replicate the statistical properties of the experimental MSA can be a valuable tool to identify the coevolution detection method that is most effective in each case.	[Ackerman, Sharon H.; Gatti, Domenico L.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA; [Gatti, Domenico L.] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI USA; [Tillier, Elisabeth R.] Univ Hlth Network, Univ Toronto, Campbell Family Inst Canc Res, Dept Med Biophys, Toronto, ON, Canada	Wayne State University; Wayne State University; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Gatti, DL (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48202 USA.	dgatti@med.wayne.edu		Tillier, Elisabeth/0000-0003-2194-9058	United States Public Health Service [GM69840, GM48157]; Wayne State University; Natural Sciences and Engineering Research Council of Canada (NSERC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048157, R01GM069840] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Wayne State University; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by United States Public Health Service grants GM69840 to DLG, and GM48157 to SHA, by a Wayne State University Research Enhancement Program in Computational Biology grant to DLG, and by a Natural Sciences and Engineering Research Council of Canada (NSERC) grant to ERT. Funding was used for the purchase and maintenance of the computational hardware and software used in this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229; Brown CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010779; Burger L, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000633; Caporaso JG, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-327; Codoner FM, 2008, EVOL BIOINFORM, V4, P29; Codoner FM, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-106; Dekker JP, 2004, BIOINFORMATICS, V20, P1565, DOI 10.1093/bioinformatics/bth128; Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Erdogmus D, 2004, NEURAL COMPUT, V16, P1235, DOI 10.1162/089976604773717595; Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249; Felsenstein J., 2004, INFERRING PHYLOGENIE, VVolume 2; Fernandes AD, 2010, BIOINFORMATICS, V26, P1135, DOI 10.1093/bioinformatics/btq111; Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; FRITSCH FN, 1980, SIAM J NUMER ANAL, V17, P238, DOI 10.1137/0717021; GASSNER GT, 1995, FASEB J, V9, P1411, DOI 10.1096/fasebj.9.14.7589982; GATTI DL, 1994, SCIENCE, V266, P110, DOI 10.1126/science.7939628; Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e; Gloor GB, 2010, MOL BIOL EVOL, V27, P1181, DOI 10.1093/molbev/msq004; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038; Hopf TA, 2012, CELL, V149, P1607, DOI 10.1016/j.cell.2012.04.012; Horner DS, 2008, BRIEF BIOINFORM, V9, P46, DOI 10.1093/bib/bbm052; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; JUKES T H, 1969, P21; Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Little DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004762; Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295; Ludlam A, 2009, J BIOL CHEM, V284, P17138, DOI 10.1074/jbc.M109.002568; Marks DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028766; Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671; Martin P, 2001, STRUCTURE, V9, P1071, DOI 10.1016/S0969-2126(01)00672-4; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Nugent T, 2012, P NATL ACAD SCI USA, V109, pE1540, DOI 10.1073/pnas.1120036109; Olmea O, 1999, J MOL BIOL, V293, P1221, DOI 10.1006/jmbi.1999.3208; Pang A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-236; Radaev S, 2000, J BIOL CHEM, V275, P9476, DOI 10.1074/jbc.275.13.9476; Reza F. M., 1994, INTRO INFORM THEORY; Russ WP, 2005, NATURE, V437, P579, DOI 10.1038/nature03990; Sigala PA, 2008, J AM CHEM SOC, V130, P13696, DOI 10.1021/ja803928m; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Sukumar N, 2001, BIOCHEMISTRY-US, V40, P9870, DOI 10.1021/bi010938k; Tillier ERM, 2003, BIOINFORMATICS, V19, P750, DOI 10.1093/bioinformatics/btg072; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Wollenberg KR, 2000, P NATL ACAD SCI USA, V97, P3288, DOI 10.1073/pnas.070154797; Zhou TQ, 2000, EMBO J, V19, P4838, DOI 10.1093/emboj/19.17.4838	50	10	10	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47108	10.1371/journal.pone.0047108	http://dx.doi.org/10.1371/journal.pone.0047108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091608	gold, Green Published, Green Submitted			2022-12-25	WOS:000310135800024
J	Khan, S; Jutzy, JMS; Valenzuela, MMA; Turay, D; Aspe, JR; Ashok, A; Mirshahidi, S; Mercola, D; Lilly, MB; Wall, NR				Khan, Salma; Jutzy, Jessica M. S.; Valenzuela, Malyn May A.; Turay, David; Aspe, Jonathan R.; Ashok, Arjun; Mirshahidi, Saied; Mercola, Dan; Lilly, Michael B.; Wall, Nathan R.			Plasma-Derived Exosomal Survivin, a Plausible Biomarker for Early Detection of Prostate Cancer	PLOS ONE			English	Article							RADICAL PROSTATECTOMY; GENE-EXPRESSION; TUMOR-MARKERS; APOPTOSIS; BLOOD; RECURRENCE; RESISTANCE; INHIBITOR; PROTEINS; FUTURE	Background: Survivin is expressed in prostate cancer (PCa), and its downregulation sensitizes PCa cells to chemotherapeutic agents in vitro and in vivo. Small membrane-bound vesicles called exosomes, secreted from the endosomal membrane compartment, contain RNA and protein that they readily transport via exosome internalization into recipient cells. Recent progress has shown that tumor-derived exosomes play multiple roles in tumor growth and metastasis and may produce these functions via immune escape, tumor invasion and angiogenesis. Furthermore, exosome analysis may provide novel biomarkers to diagnose or monitor PCa treatment. Methods: Exosomes were purified from the plasma and serum from 39 PCa patients, 20 BPH patients, 8 prostate cancer recurrent and 16 healthy controls using ultracentrifugation and their quantities and qualities were quantified and visualized from both the plasma and the purified exosomes using ELISA and Western blotting, respectively. Results: Survivin was significantly increased in the tumor-derived samples, compared to those from BPH and controls with virtually no difference in the quantity of Survivin detected in exosomes collected from newly diagnosed patients exhibiting low (six) or high (nine) Gleason scores. Exosome Survivin levels were also higher in patients that had relapsed on chemotherapy compared to controls. Conclusions: These studies demonstrate that Survivin exists in plasma exosomes from both normal, BPH and PCa subjects. The relative amounts of exosomal Survivin in PCa plasma was significantly higher than in those with pre-inflammatory BPH and control plasma. This differential expression of exosomal Survivin was seen with both newly diagnosed and advanced PCa subjects with high or low-grade cancers. Analysis of plasma exosomal Survivin levels may offer a convenient tool for diagnosing or monitoring PCa and may, as it is elevated in low as well as high Gleason scored samples, be used for early detection.	[Khan, Salma; Jutzy, Jessica M. S.; Valenzuela, Malyn May A.; Turay, David; Aspe, Jonathan R.; Ashok, Arjun; Wall, Nathan R.] Loma Linda Univ, Ctr Hlth Dispar & Mol Med, Dept Biochem & Microbiol, Loma Linda, CA 92350 USA; [Mirshahidi, Saied] Loma Linda Univ, Ctr Canc, Loma Linda, CA 92350 USA; [Mirshahidi, Saied] Loma Linda Univ, Dept Microbiol, Loma Linda, CA 92350 USA; [Mirshahidi, Saied] Loma Linda Univ, Biospecimen Lab, Loma Linda, CA 92350 USA; [Lilly, Michael B.] Univ Calif Irvine, Dept Med, Div Hematol Oncol, Irvine, CA 92717 USA; [Mercola, Dan; Lilly, Michael B.] Univ Calif Irvine, Chao Family Comprehens Canc Ctr, Irvine, CA USA; [Mercola, Dan] Univ Calif Irvine, Dept Pathol, Irvine, CA 92717 USA	Loma Linda University; Loma Linda University; Loma Linda University; Loma Linda University; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Wall, NR (corresponding author), Loma Linda Univ, Ctr Hlth Dispar & Mol Med, Dept Biochem & Microbiol, Loma Linda, CA 92350 USA.	nwall@llu.edu	mercola, dan/L-4182-2013; Wall, Nathan R./H-7368-2015	mercola, dan/0000-0002-0281-9840; Wall, Nathan R./0000-0002-3235-4386; Jutzy, Jessica/0000-0001-9699-7957; Khan, Salma/0000-0003-2564-4358	Center for Health Disparities and Molecular Medicine; Loma Linda University; NATIONAL CANCER INSTITUTE [P30CA062203] Funding Source: NIH RePORTER; NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES [P20MD001632] Funding Source: NIH RePORTER	Center for Health Disparities and Molecular Medicine; Loma Linda University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER ON MINORITY HEALTH AND HEALTH DISPARITIES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work has been funded in part from a generous start up fund to the PI (NRW) by the Center for Molecular Biology and Gene Therapy which has since been renamed the Center for Health Disparities and Molecular Medicine and from Loma Linda University. The PI has also contributed funds from his personal account. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altieri DC, 2003, ONCOGENE, V22, P8581, DOI 10.1038/sj.onc.1207113; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Bjartell A, 2011, ACTA ONCOL, V50, P76, DOI 10.3109/0284186X.2010.531284; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Chang R T M, 2012, Practitioner, V256, P13; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; Croswell JM, 2011, ONCOLOGY-NY, V25, P452; Denmeade SR, 1996, PROSTATE, V1, P120; Duijvesz D, 2011, EUR UROL, V59, P823, DOI 10.1016/j.eururo.2010.12.031; El-Attar HA, 2010, ASIAN PAC J CANCER P, V11, P897; Fine SW, 2008, J UROLOGY, V179, P1335, DOI 10.1016/j.juro.2007.11.057; Fiorentino M, 2010, UROL CLIN N AM, V37, P131, DOI 10.1016/j.ucl.2009.11.006; Fradet Y, 2009, CURR OPIN UROL, V19, P243, DOI 10.1097/MOU.0b013e32832a08b5; Freedland SJ, 2005, JAMA-J AM MED ASSOC, V294, P433, DOI 10.1001/jama.294.4.433; Fukuda S, 2006, MOL CANCER THER, V5, P1087, DOI 10.1158/1535-7163.MCT-05-0375; Guo ZY, 2006, CANCER CELL, V10, P309, DOI 10.1016/j.ccr.2006.08.021; Han M, 2003, J UROLOGY, V169, P517, DOI 10.1016/S0022-5347(05)63946-8; Howell SB, 2000, MOL UROL, V4, P225; Iero M, 2008, CELL DEATH DIFFER, V15, P80, DOI 10.1038/sj.cdd.4402237; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Johnstone RM, 2006, BLOOD CELL MOL DIS, V36, P315, DOI 10.1016/j.bcmd.2005.12.001; Khan S, 2009, BRIT J CANCER, V100, P1073, DOI 10.1038/sj.bjc.6604978; Khan S, 2011, APOPTOSIS, V16, P1, DOI 10.1007/s10495-010-0534-4; Kishi H, 2004, J UROLOGY, V171, P1855, DOI 10.1097/01.ju.0000120317.88372.03; Klein EA, 2003, UROL CLIN N AM, V30, P315, DOI 10.1016/S0094-0143(02)00179-9; Koike H, 2008, UROLOGY, V72, P1229, DOI 10.1016/j.urology.2007.12.064; Koumangoye RB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024234; Krajewska M, 1996, AM J PATHOL, V148, P1567; Krajewska M, 2003, CLIN CANCER RES, V9, P4914; Li YW, 2004, NEOPLASIA, V6, P354, DOI 10.1593/neo.03478; Lu S, 1999, MOL ENDOCRINOL, V13, P376, DOI 10.1210/me.13.3.376; Mazzola CRE, 2011, PROG UROL, V21, P1, DOI 10.1016/j.purol.2010.07.004; Mikolajczyk SD, 2004, CLIN BIOCHEM, V37, P519, DOI 10.1016/j.clinbiochem.2004.05.016; Mitchell PJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-4; Nakahara T, 2007, CANCER RES, V67, P8014, DOI 10.1158/0008-5472.CAN-07-1343; Ploussard G, 2010, NAT REV UROL, V7, P101, DOI 10.1038/nrurol.2009.261; Quah BJC, 2005, BLOOD CELL MOL DIS, V35, P94, DOI 10.1016/j.bcmd.2005.05.002; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Shariat SF, 2004, CANCER, V100, P751, DOI 10.1002/cncr.20039; Shariat SF, 2011, ACTA ONCOL, V50, P61, DOI 10.3109/0284186X.2010.542174; Shen JJ, 2009, ACTA BIOCH BIOPH SIN, V41, P223, DOI 10.1093/abbs/gmp005; Sugahara K, 2004, INT J HEMATOL, V80, P52, DOI 10.1532/ijh97.04031; Valenti R, 2007, CANCER RES, V67, P2912, DOI 10.1158/0008-5472.CAN-07-0520; Williams Ryan M, 2010, Front Biosci (Schol Ed), V2, P677; Zhang M, 2005, ONCOGENE, V24, P2474, DOI 10.1038/sj.onc.1208490	46	200	204	4	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e46737	10.1371/journal.pone.0046737	http://dx.doi.org/10.1371/journal.pone.0046737			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091600	Green Published, gold			2022-12-25	WOS:000310135800013
J	Musatovova, O; Kannan, TR; Baseman, JB				Musatovova, Oxana; Kannan, T. R.; Baseman, Joel B.			Mycoplasma pneumoniae Large DNA Repetitive Elements RepMP1 Show Type Specific Organization among Strains	PLOS ONE			English	Article							TUMOR ALVEOLAR RHABDOMYOSARCOMA; TANDEM-REPEAT ANALYSIS; CHROMOSOMAL SEQUENCES; GENE; GENOME; RECOMBINATION; GENITALIUM; NUMBER; PRODUCTS; SUBTYPES	Mycoplasma pneumoniae is the smallest self-replicating bacterium with a streamlined genome of 0.81 Mb. Complete genome analysis revealed the presence of multiple copies of four large repetitive elements (designated RepMP1, RepMP2/3, RepMP4 and RepMP5) that are implicated in creating sequence variations among individual strains. Recently, we described RepMP1-associated sequence variations between reference strain M129 and clinical isolate S1 that involved three RepMP1-genes (i.e. mpn130, mpn137 and mpn138). Using PCR and sequencing we analyze 28 additional M. pneumoniae strains and demonstrate the existence of S1-like sequence variants in nine strains and M129-like variants in the remaining nineteen strains. We propose a series of recombination steps that facilitates transition from M129- to S1-like sequence variants. Next we examined the remaining RepMP1-genes and observed no other rearrangements related to the repeat element. The only other detected difference was varying numbers of the 21-nucleotide tandem repeats within mpn127, mpn137, mpn501 and mpn524. Furthermore, typing of strains through analysis of large RepMPs localized within the adhesin P1 operon revealed that sequence divergence involving RepMP1-genes mpn130, mpn137 and mpn138 is strictly type-specific. Once more our analysis confirmed existence of two highly conserved groups of M. pneumoniae strains.	[Musatovova, Oxana; Kannan, T. R.; Baseman, Joel B.] Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Musatovova, O (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Microbiol & Immunol, San Antonio, TX 78229 USA.	musatovova@gmail.com			National Institutes of Health [AI U19070412]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070412] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health AI U19070412. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARR FG, 1993, NAT GENET, V3, P113, DOI 10.1038/ng0293-113; Baseman J B, 1993, Subcell Biochem, V20, P243; Catrein I, 2004, MICROBIOL-SGM, V150, P3989, DOI 10.1099/mic.0.27506-0; Chalker V, 2011, EURO SURVEILL, V16; CRAVEN RB, 1976, J CLIN MICROBIOL, V4, P225; Degrange S, 2009, J CLIN MICROBIOL, V47, P914, DOI 10.1128/JCM.01935-08; Dorigo-Zetsma JW, 2000, J CLIN MICROBIOL, V38, P965, DOI 10.1128/JCM.38.3.965-970.2000; Dumke R, 2003, INT J MED MICROBIOL, V292, P513, DOI 10.1078/1438-4221-00231; Dumke R, 2011, J MICROBIOL METH, V86, P393, DOI 10.1016/j.mimet.2011.06.008; Forsyth MH, 1996, J BACTERIOL, V178, P917, DOI 10.1128/jb.178.3.917-921.1996; GALILI N, 1993, NAT GENET, V5, P230, DOI 10.1038/ng1193-230; GOULET M, 1995, J CLIN MICROBIOL, V33, P2823, DOI 10.1128/JCM.33.11.2823-2825.1995; Hasselbring BA, 2006, J BACTERIOL, V188, P6335, DOI 10.1128/JB.00698-06; HEDEN LO, 1993, J GEN MICROBIOL, V139, P2067, DOI 10.1099/00221287-139-9-2067; Himmelreich R, 1996, NUCLEIC ACIDS RES, V24, P4420, DOI 10.1093/nar/24.22.4420; HU PC, 1977, J EXP MED, V145, P1328, DOI 10.1084/jem.145.5.1328; INAMINE JM, 1988, GENE, V64, P217, DOI 10.1016/0378-1119(88)90337-X; Iverson-Cabral SL, 2007, MOL MICROBIOL, V66, P55, DOI 10.1111/j.1365-2958.2007.05898.x; Iverson-Cabral SL, 2006, INFECT IMMUN, V74, P3715, DOI 10.1128/IAI.00239-06; Jacobs E, 1996, EUR J CLIN MICROBIOL, V15, P38, DOI 10.1007/BF01586183; Kannan TR, 2011, CLIN INFECT DIS; Kenri T, 2008, J MED MICROBIOL, V57, P469, DOI 10.1099/jmm.0.47634-0; Kenri T, 2012, J BACTERIOL, V194, P1253, DOI 10.1128/JB.06553-11; Kokotovic B, 1999, J CLIN MICROBIOL, V37, P3300, DOI 10.1128/JCM.37.10.3300-3307.1999; Krishnakumar R, 2010, APPL ENVIRON MICROB, V76, P5297, DOI 10.1128/AEM.00024-10; Ma L, 2007, MOL MICROBIOL, V66, P220, DOI 10.1111/j.1365-2958.2007.05911.x; Musatovova O, 2008, INFECT IMMUN, V76, P1639, DOI 10.1128/IAI.01621-07; Nisar N, 2007, POSTGRAD MED J, V83, P100, DOI 10.1136/pgmj.2006.049023; RULAND K, 1994, J BACTERIOL, V176, P5202, DOI 10.1128/JB.176.17.5202-5209.1994; RULAND K, 1990, NUCLEIC ACIDS RES, V18, P6311, DOI 10.1093/nar/18.21.6311; Shak JR, 2009, J BACTERIOL, V191, P6900, DOI 10.1128/JB.00706-09; Shin DH, 2006, PROTEIN SCI, V15, P921, DOI 10.1110/ps.051993506; SPERKER B, 1991, MOL MICROBIOL, V5, P299, DOI 10.1111/j.1365-2958.1991.tb02110.x; SU CJ, 1987, INFECT IMMUN, V55, P3023, DOI 10.1128/IAI.55.12.3023-3029.1987; SU CJ, 1990, J CLIN MICROBIOL, V28, P1538, DOI 10.1128/JCM.28.7.1538-1540.1990; SU CJ, 1990, INFECT IMMUN, V58, P2669, DOI 10.1128/IAI.58.8.2669-2674.1990; URSI D, 1994, J CLIN MICROBIOL, V32, P2873, DOI 10.1128/JCM.32.11.2873-2875.1994; VU AC, 1987, INFECT IMMUN, V55, P1830, DOI 10.1128/IAI.55.8.1830-1836.1987; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; WENZEL R, 1988, NUCLEIC ACIDS RES, V16, P8337, DOI 10.1093/nar/16.17.8337	40	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47625	10.1371/journal.pone.0047625	http://dx.doi.org/10.1371/journal.pone.0047625			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091634	gold, Green Published, Green Submitted			2022-12-25	WOS:000310135800058
J	Sharp, H; Pickles, A; Meaney, M; Marshall, K; Tibu, F; Hill, J				Sharp, Helen; Pickles, Andrew; Meaney, Michael; Marshall, Kate; Tibu, Florin; Hill, Jonathan			Frequency of Infant Stroking Reported by Mothers Moderates the Effect of Prenatal Depression on Infant Behavioural and Physiological Outcomes	PLOS ONE			English	Article							VAGAL REGULATION; MATERNAL-CARE; STRESS; CHILDREN; STIMULATION; TEMPERAMENT; EPIGENETICS; CONFLICT; EXPOSURE	Animal studies find that prenatal stress is associated with increased physiological and emotional reactivity later in life, mediated via fetal programming of the HPA axis through decreased glucocorticoid receptor (GR) gene expression. Postnatal behaviours, notably licking and grooming in rats, cause decreased behavioural indices of fear and reduced HPA axis reactivity mediated via increased GR gene expression. Post-natal maternal behaviours may therefore be expected to modify prenatal effects, but this has not previously been examined in humans. We examined whether, according to self-report, maternal stroking over the first weeks of life modified associations between prenatal depression and physiological and behavioral outcomes in infancy, hence mimicking effects of rodent licking and grooming. From a general population sample of 1233 first time mothers recruited at 20 weeks gestation we drew a stratified random sample of 316 for assessment at 32 weeks based on reported inter-partner psychological abuse, a risk to child development. Of these 271 provided data at 5, 9 and 29 weeks post delivery. Mothers reported how often they stroked their babies at 5 and 9 weeks. At 29 weeks vagal withdrawal to a stressor, a measure of physiological adaptability, and maternal reported negative emotionality were assessed. There was a significant interaction between prenatal depression and maternal stroking in the prediction of vagal reactivity to a stressor (p = .01), and maternal reports of infant anger proneness (p = .007) and fear (p = .043). Increasing maternal depression was associated with decreasing physiological adaptability, and with increasing negative emotionality, only in the presence of low maternal stroking. These initial findings in humans indicate that maternal stroking in infancy, as reported by mothers, has effects strongly resembling the effects of observed maternal behaviours in animals, pointing to future studies of the epigenetic, physiological and behavioral effects of maternal stroking.	[Sharp, Helen] Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England; [Pickles, Andrew] Kings Coll London, Inst Psychiat, Dept Biostat, London WC2R 2LS, England; [Meaney, Michael] McGill Univ, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Marshall, Kate; Tibu, Florin; Hill, Jonathan] Univ Manchester, Mental Hlth & Neurodegenerat Res Grp, Manchester, Lancs, England	University of Liverpool; University of London; King's College London; McGill University; University of Manchester	Sharp, H (corresponding author), Univ Liverpool, Inst Psychol Hlth & Soc, Liverpool L69 3BX, Merseyside, England.	hmsharp@liverpool.ac.uk	Pickles, Andrew/A-9625-2011; Sharp, Helen/G-5754-2016; Meaney, Michael/N-5931-2019; Tibu, Florin/O-9581-2015; Sharp, Helen/GOG-8045-2022	Pickles, Andrew/0000-0003-1283-0346; Tibu, Florin/0000-0003-0873-1097; Sharp, Helen/0000-0002-0988-8718	United Kingdom Medical Research Council [G0400577]; MRC [G0400577] Funding Source: UKRI; Medical Research Council [G0400577] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The study was funded by a grant from the United Kingdom Medical Research Council (G0400577). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker DJP, 2008, NESTLE NUTR WORKS SE, V61, P21, DOI 10.1159/0000113163; Bullinger AF, 2011, DEVELOPMENTAL SCI, V14, P58, DOI 10.1111/j.1467-7687.2010.00952.x; Calkins SD, 2000, J ABNORM CHILD PSYCH, V28, P103, DOI 10.1023/A:1005112912906; Calkins SD, 2007, BIOL PSYCHOL, V74, P144, DOI 10.1016/j.biopsycho.2006.09.005; Cottrell EC, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.019.2009; Cox JL, 1996, J AFFECT DISORDERS, V39, P185, DOI 10.1016/0165-0327(96)00008-0; Davis EP, 2007, J AM ACAD CHILD PSY, V46, P737, DOI 10.1097/chi.0b013e318047b775; de Bruijn ATCE, 2009, DEV PSYCHOBIOL, V51, P553, DOI 10.1002/dev.20393; Del Cerro MCR, 2010, BEHAV BRAIN RES, V208, P593, DOI 10.1016/j.bbr.2010.01.003; El-Sheikh M, 2001, CHILD DEV, V72, P1617, DOI 10.1111/1467-8624.00369; Gagne JR, 2011, DEVELOPMENTAL SCI, V14, P112, DOI 10.1111/j.1467-7687.2010.00969.x; Gartstein MA, 2003, INFANT BEHAV DEV, V26, P64, DOI 10.1016/S0163-6383(02)00169-8; Glover V, 2011, J CHILD PSYCHOL PSYC, V52, P356, DOI 10.1111/j.1469-7610.2011.02371.x; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Kagan J, 1999, DEV PSYCHOPATHOL, V11, P209, DOI 10.1017/S0954579499002023; Kajantie E, 2010, NEUROSCI BIOBEHAV R, V35, P23, DOI 10.1016/j.neubiorev.2009.11.013; Kappeler L, 2010, BIOESSAYS, V32, P818, DOI 10.1002/bies.201000015; Koehl M, 2001, NEUROTOX RES, V3, P65, DOI 10.1007/BF03033231; Lemaire V, 2006, BIOL PSYCHIAT, V59, P786, DOI 10.1016/j.biopsych.2005.11.009; LEVINE S, 1994, ANN NY ACAD SCI, V746, P275, DOI 10.1111/j.1749-6632.1994.tb39245.x; Lloyd, 2004, ENGLISH INDICES DEPR; McElwain NL, 2006, J FAM PSYCHOL, V20, P247, DOI 10.1037/0893-3200.20.2.247; Meaney MJ, 2007, TRENDS MOL MED, V13, P269, DOI 10.1016/j.molmed.2007.05.003; Meaney Michael J, 2005, Dialogues Clin Neurosci, V7, P103; Meaney MJ, 2010, CHILD DEV, V81, P41, DOI 10.1111/j.1467-8624.2009.01381.x; Moffitt TE, 1997, PSYCHOL ASSESSMENT, V9, P47, DOI 10.1037/1040-3590.9.1.47; Moore GA, 2010, DEV PSYCHOPATHOL, V22, P23, DOI 10.1017/S095457940999023X; Moore GA, 2009, CHILD DEV, V80, P209, DOI 10.1111/j.1467-8624.2008.01255.x; MOUSSEAU TA, 1999, MATERNAL EFFECTS ADA; O'Connor TG, 2003, J CHILD PSYCHOL PSYC, V44, P1025, DOI 10.1111/1469-7610.00187; Parade SH, 2008, INFANT BEHAV DEV, V31, P637, DOI 10.1016/j.infbeh.2008.07.009; Porges S. W., 1990, PRINCIPLES PSYCHOPHY, P708; Porges S.W., 1985, U.S. Patent, Patent No. [4,510,944, 4510944, 4:510,944]; Porges SW, 2007, BIOL PSYCHOL, V74, P116, DOI 10.1016/j.biopsycho.2006.06.009; Royston P, 2007, STATA J, V7, P445, DOI 10.1177/1536867X0700700401; SCHANBERG SM, 1987, CHILD DEV, V58, P1431, DOI 10.1111/j.1467-8624.1987.tb03856.x; SCHANBERG SM, 1984, P SOC EXP BIOL MED, V175, P135; Seckl JR, 2007, PROG BRAIN RES, V167, P17, DOI 10.1016/S0079-6123(07)67002-2; Smeekens S, 2007, J ABNORM CHILD PSYCH, V35, P347, DOI 10.1007/s10802-006-9095-y; StataCorp, 2009, STAT STAT SOFTW; TRONICK E, 1978, J AM ACAD CHILD PSY, V17, P1, DOI 10.1016/S0002-7138(09)62273-1; Vallee M, 1999, EUR J NEUROSCI, V11, P2906, DOI 10.1046/j.1460-9568.1999.00705.x; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; Yao M, 2007, ENDOCRINOLOGY, V148, P2518, DOI 10.1210/en.2006-1413	44	87	87	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e45446	10.1371/journal.pone.0045446	http://dx.doi.org/10.1371/journal.pone.0045446			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	024UX	23091594	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000310135800004
J	Vicente, CSL; Nascimento, F; Espada, M; Barbosa, P; Mota, M; Glick, BR; Oliveira, S				Vicente, Claudia S. L.; Nascimento, Francisco; Espada, Margarida; Barbosa, Pedro; Mota, Manuel; Glick, Bernard R.; Oliveira, Solange			Characterization of Bacteria Associated with Pinewood Nematode Bursaphelenchus xylophilus	PLOS ONE			English	Article							WILT DISEASE; POPULATION-DYNAMICS; BIOFILM FORMATION; PATHOGENICITY; EXOPOLYSACCHARIDES; MICROORGANISMS; SIDEROPHORES; INOCULATION; CELLULASES	Pine wilt disease (PWD) is a complex disease integrating three major agents: the pathogenic agent, the pinewood nematode Bursaphelenchus xylophilus; the insect-vector Monochamus spp.; and the host pine tree, Pinus sp. Since the early 80's, the notion that another pathogenic agent, namely bacteria, may play a role in PWD has been gaining traction, however the role of bacteria in PWD is still unknown. The present work supports the possibility that some B. xylophilus-associated bacteria may play a significant role in the development of this disease. This is inferred as a consequence of: (i) the phenotypic characterization of a collection of 35 isolates of B. xylophilus-associated bacteria, in different tests broadly used to test plant pathogenic and plant growth promoting bacteria, and (ii) greenhouse experiments that infer the pathogenicity of these bacteria in maritime pine, Pinus pinaster. The results illustrate the presence of a heterogeneous microbial community associated with B. xylophilus and the traits exhibited by at least, some of these bacteria, appear to be related to PWD symptoms. The inoculation of four specific B. xylophilus-associated bacteria isolates in P. pinaster seedlings resulted in the development of some PWD symptoms suggesting that these bacteria likely play an active role with B. xylophilus in PWD.	[Oliveira, Solange] Univ Evora, ICAAM, Lab Microbiol Solo, Evora, Portugal; [Vicente, Claudia S. L.; Nascimento, Francisco; Espada, Margarida; Barbosa, Pedro; Mota, Manuel] Univ Evora, ICAAM, NemaLab, Evora, Portugal; [Glick, Bernard R.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada	University of Evora; University of Evora; University of Waterloo	Oliveira, S (corresponding author), Univ Evora, ICAAM, Lab Microbiol Solo, Evora, Portugal.	ismo@uevora.pt	Vicente, Claudia/C-6226-2019; Nascimento, Francisco X./F-6537-2016; Vicente, Cláudia SL/X-5058-2019; Mota, Manuel/G-6031-2019; Oliveira, Solange/M-4047-2013	Vicente, Claudia/0000-0002-3865-5358; Nascimento, Francisco X./0000-0003-1184-3794; Vicente, Cláudia SL/0000-0002-3865-5358; Mota, Manuel/0000-0002-4145-5031; Oliveira, Solange/0000-0003-4984-4805; Espada, Margarida/0000-0002-3826-711X	European Project REPHRAME - Development of improved methods for detection, control and eradication of pine wood nematode in support of EU Plant Health policy, European Union Seventh Framework Programme [FP7-KBBE-2010-4]; European Project BioReGent - Biocontrol and Bioremediation agents and their role in Agriculture and Forest health, European Union Seventh Framework Programme [247669]; Operational Programme for Competitiveness Factors - COMPETE; National Funds through FCT - Foundation for Science and Technology [PEst-C/AGR/UI0115/2011]	European Project REPHRAME - Development of improved methods for detection, control and eradication of pine wood nematode in support of EU Plant Health policy, European Union Seventh Framework Programme; European Project BioReGent - Biocontrol and Bioremediation agents and their role in Agriculture and Forest health, European Union Seventh Framework Programme; Operational Programme for Competitiveness Factors - COMPETE; National Funds through FCT - Foundation for Science and Technology	This work was supported by the European Project REPHRAME - Development of improved methods for detection, control and eradication of pine wood nematode in support of EU Plant Health policy, European Union Seventh Framework Programme FP7-KBBE-2010-4 and the European Project BioReGent - Biocontrol and Bioremediation agents and their role in Agriculture and Forest health, European Union Seventh Framework Programme FP7-PEOPLE-2009-IRSES (grant agreement no 247669); and FEDER Funds through the Operational Programme for Competitiveness Factors - COMPETE and National Funds through FCT - Foundation for Science and Technology under the Strategic Project PEst-C/AGR/UI0115/2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER DB, 1991, BIOL FERT SOILS, V12, P39, DOI 10.1007/BF00369386; Andrews JH, 2000, ANNU REV PHYTOPATHOL, V38, P145, DOI 10.1146/annurev.phyto.38.1.145; Bhatt G, 2004, J BACTERIOL, V186, P7896, DOI 10.1128/JB.186.23.7896-7904.2004; deFreitas JR, 1997, BIOL FERT SOILS, V24, P358, DOI 10.1007/s003740050258; Dellagi A, 2009, PLANT PHYSIOL, V150, P1687, DOI 10.1104/pp.109.138636; DWORKIN M, 1958, J BACTERIOL, V75, P592, DOI 10.1128/JB.75.5.592-603.1958; EVANS AAF, 1970, J NEMATOL, V2, P99; Fang ZD, 1998, METHODS RES PLANT DI; Futai K., 1979, Bulletin, Kyoto University Forests, P23; GLICKMANN E, 1995, APPL ENVIRON MICROB, V61, P793, DOI 10.1128/AEM.61.2.793-796.1995; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; Hacker J, 2001, EMBO REP, V2, P376, DOI 10.1093/embo-reports/kve097; Han ZM, 2003, J PHYTOPATHOL, V151, P683, DOI 10.1046/j.1439-0434.2003.00790.x; Jones AM, 2011, J BACTERIOL, V193, P2767, DOI 10.1128/JB.00069-10; Kasana RC, 2008, CURR MICROBIOL, V57, P503, DOI 10.1007/s00284-008-9276-8; Kawazu K, 1998, SCI REPORTS FACULTY; Kikuchi T, 2004, FEBS LETT, V572, P201, DOI 10.1016/j.febslet.2004.07.039; KING EO, 1954, J LAB CLIN MED, V44, P301; Koczan JM, 2009, PHYTOPATHOLOGY, V99, P1237, DOI 10.1094/PHYTO-99-11-1237; Kwon HR, 2010, PEST MANAG SCI, V66, P634, DOI 10.1002/ps.1920; Li H, 2007, THESIS U GHENT; MAMIYA Y, 1983, ANNU REV PHYTOPATHOL, V21, P201, DOI 10.1146/annurev.py.21.090183.001221; Mota M., 2008, PINE WILT DIS WORLDW; Naves P, 2005, J PEST SCI, V78, P57, DOI 10.1007/s10340-004-0068-z; NEILANDS JB, 1995, J BIOL CHEM, V270, P26723, DOI 10.1074/jbc.270.45.26723; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; OKU H, 1980, NATURWISSENSCHAFTEN, V67, P198, DOI 10.1007/BF01086307; Patten CL, 2002, APPL ENVIRON MICROB, V68, P3795, DOI 10.1128/AEM.68.8.3795-3801.2002; Penrose DM, 2003, PHYSIOL PLANTARUM, V118, P10, DOI 10.1034/j.1399-3054.2003.00086.x; Proenca DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015191; Ramey BE, 2004, CURR OPIN MICROBIOL, V7, P602, DOI 10.1016/j.mib.2004.10.014; Rashid S, 2012, APPL SOIL ECOL, V61, P217, DOI 10.1016/j.apsoil.2011.09.011; Roriz M, 2011, EXP PARASITOL, V128, P357, DOI 10.1016/j.exppara.2011.04.008; Ryss A. Yu., 2011, Forestry Studies in China, V13, P132, DOI 10.1007/s11632-011-0205-8; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Stoodley P, 2002, ANNU REV MICROBIOL, V56, P187, DOI 10.1146/annurev.micro.56.012302.160705; Sun YL, 2009, FEMS MICROBIOL LETT, V296, P131, DOI 10.1111/j.1574-6968.2009.01625.x; Sutherland IW, 2001, MICROBIOL-UK, V147, P3, DOI 10.1099/00221287-147-1-3; Togashi K, 2006, POPUL ECOL, V48, P271, DOI 10.1007/s10144-006-0011-7; Urnesha S, 2008, J MICROBIOL METH, V72, P95, DOI 10.1016/j.mimet.2007.11.002; van Geel-Schutten GH, 1998, APPL MICROBIOL BIOT, V50, P697, DOI 10.1007/s002530051353; Vicente C, 2012, EUR J PLANT PATHOL, V133, P89, DOI 10.1007/s10658-011-9924-x; Vicente CSL, 2011, ANTON LEEUW INT J G, V100, P477, DOI 10.1007/s10482-011-9602-1; WALTON JD, 1994, PLANT PHYSIOL, V104, P1113, DOI 10.1104/pp.104.4.1113; Xie LQ, 2008, J PHYTOPATHOL, V156, P385, DOI 10.1111/j.1439-0434.2007.01357.x; YAMADA T, 1993, ANNU REV PHYTOPATHOL, V31, P253, DOI 10.1146/annurev.py.31.090193.001345; Zhao B., 2006, FRONT CHINA, V1, P324, DOI [10.1007/s11461-006-0037-1, DOI 10.1007/S11461-006-0037-1]; Zhao BG, 2003, NEMATOLOGY, V5, P899, DOI 10.1163/156854103773040817; Zhu LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038095	50	48	53	4	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e46661	10.1371/journal.pone.0046661	http://dx.doi.org/10.1371/journal.pone.0046661			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091599	Green Published, gold, Green Submitted			2022-12-25	WOS:000310135800012
J	Zhang, J; Espinoza, LA; Kinders, RJ; Lawrence, SM; Pfister, TD; Zhou, M; Veenstra, TD; Thorgeirsson, SS; Jessup, JM				Zhang, J.; Espinoza, L. A.; Kinders, R. J.; Lawrence, S. M.; Pfister, T. D.; Zhou, M.; Veenstra, T. D.; Thorgeirsson, S. S.; Jessup, J. M.			NANOG modulates stemness in human colorectal cancer	ONCOGENE			English	Article						NANOG; NANOGP8; stemness; colorectal cancer; cancer stem cell	TRANSCRIPTIONAL NETWORK; GENE-EXPRESSION; CELLS; PLURIPOTENCY; SOX2; INHIBITOR; PROGNOSIS; SIGNATURE; PATHWAYS; LUNG	NANOG is a stem cell transcription factor that is essential for embryonic development, reprogramming normal adult cells and malignant transformation and progression. The nearly identical retrogene NANOGP8 is expressed in multiple cancers, but generally not in normal tissues and its function is not well defined. Our postulate is that NANOGP8 directly modulates the stemness of individual human colorectal carcinoma (CRC) cells. Stemness was measured in vitro as the spherogenicity of single CRC cells in serum-free medium and the size of the side population (SP) and in vivo as tumorigenicity and experimental metastatic potential in NOD/SCID mice. We found that 80% of clinical liver metastases express a NANOG with 75% of the positive metastases containing NANOGP8 transcripts. In all, 3-62% of single cells within six CRC lines form spheroids in serum-free medium in suspension. NANOGP8 is translated into protein. The relative expression of a NANOG gene increased 8- to 122-fold during spheroid formation, more than the increase in OCT4 or SOX2 transcripts with NANOGP8 the more prevalent family member. Short hairpin RNA (shRNA) to NANOG not only inhibits spherogenicity but also reduces expression of OCT4 and SOX2, the size of the SP and tumor growth in vivo. Inhibition of NANOG gene expression is associated with inhibition of proliferation and decreased phosphorylation of G2-related cell-cycle proteins. Overexpression of NANOGP8 rescues single-cell spherogenicity when NANOG gene expression is inhibited and increases the SP in CRC. Thus, NANOGP8 can substitute for NANOG in directly promoting stemness in CRC.	[Zhang, J.; Espinoza, L. A.; Thorgeirsson, S. S.; Jessup, J. M.] NCI, Expt Carcinogenesis Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Kinders, R. J.; Lawrence, S. M.; Pfister, T. D.] SAIC Frederick Inc, Lab Human Toxicol & Pharmacol, Appl Dev Res Support Directorate, Frederick Natl Lab Canc Res, Frederick, MD USA; [Zhou, M.; Veenstra, T. D.] SAIC Frederick, Lab Prote & Analyt Technol, Frederick Natl Lab Canc Res, Frederick, MD USA; [Jessup, J. M.] Div Canc Treatment & Diag, Canc Diag Program, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick	Jessup, JM (corresponding author), Canc Diag Program, Diagnost Evaluat Branch, Bethesda, MD 20892 USA.	jessupj@mail.nih.gov			Center for Cancer Research of the NCI [ZIA BC 011199]; Department of Defense [W81XWH-11-1-0327]; NATIONAL CANCER INSTITUTE [ZIABC011199] Funding Source: NIH RePORTER	Center for Cancer Research of the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We acknowledge the valuable advice and support of Drs Elizabeth Conner and Valentina Factor. Also, we gratefully acknowledge the support provided by the Center for Cancer Research of the NCI for Project ZIA BC 011199 and by the Department of Defense for Grant Number W81XWH-11-1-0327. The opinions expressed in this manuscript are those of the authors and do not necessarily represent those of the National Cancer Institute, the National Institutes of Health, the Department of Health and Human Services or the Department of the Army.	Ambady S, 2010, INT J DEV BIOL, V54, P1743, DOI 10.1387/ijdb.103192sa; Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Booth HAF, 2004, GENOMICS, V84, P229, DOI 10.1016/j.ygeno.2004.02.014; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Ding JJ, 2012, CELL RES, V22, P155, DOI 10.1038/cr.2011.179; Dykxhoorn DM, 2006, P NATL ACAD SCI USA, V103, P5953, DOI 10.1073/pnas.0601309103; Eberle I, 2010, NUCLEIC ACIDS RES, V38, P5384, DOI 10.1093/nar/gkq307; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Huang H, 2009, NUCLEIC ACIDS RES, V37, P7560, DOI 10.1093/nar/gkp835; Ishiguro T, 2012, BIOCHEM BIOPH RES CO, V418, P199, DOI 10.1016/j.bbrc.2011.10.123; JESSUP JM, 1989, CANCER RES, V49, P6906; Jeter CR, 2011, ONCOGENE, V30, P3833, DOI 10.1038/onc.2011.114; Jeter CR, 2009, STEM CELLS, V27, P993, DOI 10.1002/stem.29; Ji J, 2010, HUM PATHOL, V41, P1438, DOI 10.1016/j.humpath.2009.11.021; Katoh M, 2011, CURR PHARM BIOTECHNO, V12, P160, DOI 10.2174/138920111794295710; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kinders RJ, 2010, CLIN CANCER RES, V16, P5447, DOI 10.1158/1078-0432.CCR-09-3076; Kong DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012445; Kumar SM, 2012, ONCOGENE, V31, P4898, DOI 10.1038/onc.2011.656; Leis O, 2012, ONCOGENE, V31, P1354, DOI 10.1038/onc.2011.338; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Lin KK, 2006, METHOD ENZYMOL, V420, P255, DOI 10.1016/S0076-6879(06)20011-9; Lu KP, 1996, NATURE, V380, P544; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Meng HM, 2010, CANCER BIOL THER, V9, P295, DOI 10.4161/cbt.9.4.10666; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Miyanari Y, 2012, NATURE, V483, P470, DOI 10.1038/nature10807; Miyoshi N, 2010, P NATL ACAD SCI USA, V107, P40, DOI 10.1073/pnas.0912407107; MULDER JWR, 1994, LANCET, V344, P1470, DOI 10.1016/S0140-6736(94)90290-9; Nishi M, 2011, J BIOL CHEM, V286, P11593, DOI 10.1074/jbc.M110.187989; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Po A, 2010, EMBO J, V29, P2646, DOI 10.1038/emboj.2010.131; Saiki Y, 2009, ANN SURG ONCOL, V16, P2638, DOI 10.1245/s10434-009-0567-5; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Santagata S, 2007, AM J SURG PATHOL, V31, P836, DOI 10.1097/PAS.0b013e31802e708a; Sholl LM, 2010, AM J SURG PATHOL, V34, P1193, DOI 10.1097/PAS.0b013e3181e5e024; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Simkus C, 2009, IMMUNOLOGY, V128, P206, DOI 10.1111/j.1365-2567.2009.03101.x; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; Wang Q, 2009, ANTICANCER RES, V29, P1233; Xu F, 2012, DIGEST DIS SCI, V57, P2340, DOI 10.1007/s10620-012-2182-8; You JS, 2009, CANCER RES, V69, P5716, DOI 10.1158/0008-5472.CAN-08-4953; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zappone MV, 2000, DEVELOPMENT, V127, P2367; Zbinden M, 2010, EMBO J, V29, P2659, DOI 10.1038/emboj.2010.137; Zhang J, 2011, P 102 ANN M AM ASS C; Zhang J, 2010, J CLIN PATHOL, V63, P879, DOI 10.1136/jcp.2009.073593; Zhang JY, 2006, FEBS J, V273, P1723, DOI 10.1111/j.1742-4658.2006.05186.x; Zhang X, 2010, J GASTROINTEST SURG, V14, P1220, DOI 10.1007/s11605-010-1246-3	56	83	89	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 12	2013	32	37					4397	4405		10.1038/onc.2012.461	http://dx.doi.org/10.1038/onc.2012.461			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	218AF	23085761	Green Accepted			2022-12-25	WOS:000324404200008
J	Gautam, M; Benson, CJ				Gautam, Mamta; Benson, Christopher J.			Acid-sensing ion channels (ASICs) in mouse skeletal muscle afferents are heteromers composed of ASIC1a, ASIC2, and ASIC3 subunits	FASEB JOURNAL			English	Article						sensory neurons; muscle pain; exercise	VANILLOID TYPE-1 RECEPTOR; SENSORY NEURONS; ACTIVATED CURRENTS; PRESSOR REFLEX; PH; CONTRIBUTES; H+; HYPERALGESIA; LACTATE; COMBINATIONS	Acid-sensing ion channels (ASICs) are expressed in skeletal muscle afferents, in which they sense extracellular acidosis and other metabolites released during ischemia and exercise. ASICs are formed as homotrimers or heterotrimers of several isoforms (ASIC1a, ASIC1b, ASIC2a, ASIC2b, and ASIC3), with each channel displaying distinct properties. To dissect the ASIC composition in muscle afferents, we used whole-cell patch-clamp recordings to study the properties of acid-evoked currents (amplitude, pH sensitivity, the kinetics of desensitization and recovery from desensitization, and pharmacological modulation) in isolated, labeled mouse muscle afferents from wild-type (C57BL/6J) and specific ASIC(-/-) mice. We found that ASIC-like currents in wild-type muscle afferents displayed fast desensitization, indicating that they are carried by heteromeric channels. Currents from ASIC1a(-/-) muscle afferents were less pH-sensitive and displayed faster recovery, currents from ASIC2(-/-) mice showed diminished potentiation by zinc, and currents from ASIC3(-/-) mice displayed slower desensitization than those from wild-type mice. Finally, ASIC-like currents were absent from triple-null mice lacking ASIC1a, ASIC2a, and ASIC3. We conclude that ASIC1a, ASIC2a, and ASIC3 heteromers are the principle channels in skeletal muscle afferents. These results will help us understand the role of ASICs in exercise physiology and provide a molecular target for potential drug therapies to treat muscle pain.-Gautam, M., Benson, C. J. Acid-sensing ion channels (ASICs) in mouse skeletal muscle afferents are heteromers composed of ASIC1a, ASIC2, and ASIC3 subunits. FASEB J. 27, 793-802 (2013). www.fasebj.org	[Benson, Christopher J.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; Ctr Vet Med, Iowa City, IA USA	University of Iowa	Benson, CJ (corresponding author), Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA.	chris-benson@uiowa.edu		Benson, Christopher/0000-0001-6600-8193	U.S. National Institutes of Health National Heart, Lung, and Blood Institute; U.S. Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107529] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Margaret P. Price and Michael J. Welsh (University of Iowa, Howard Hughes Medical Institute, Iowa City, IA, USA) for providing ASIC double- and triple-null mice and Anne Marie S. Harding for technical support. This work was supported by the U.S. National Institutes of Health National Heart, Lung, and Blood Institute and the U.S. Department of Veterans Affairs.	Alam M, 1937, J PHYSIOL-LONDON, V89, P372, DOI 10.1113/jphysiol.1937.sp003485; Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; BANGSBO J, 1993, J PHYSIOL-LONDON, V462, P115, DOI 10.1113/jphysiol.1993.sp019546; Baron A, 2002, J PHYSIOL-LONDON, V539, P485, DOI 10.1113/jphysiol.2001.014837; Baron A, 2001, J BIOL CHEM, V276, P35361, DOI 10.1074/jbc.M105208200; Benson CJ, 1999, CIRC RES, V84, P921; Benson CJ, 2002, P NATL ACAD SCI USA, V99, P2338, DOI 10.1073/pnas.032678399; Birdsong WT, 2010, NEURON, V68, P739, DOI 10.1016/j.neuron.2010.09.029; Chu XP, 2004, J NEUROSCI, V24, P8678, DOI 10.1523/JNEUROSCI.2844-04.2004; COHEN RD, 1983, DIABETES, V32, P181, DOI 10.2337/diab.32.2.181; Connor M, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-31; Deval E, 2008, EMBO J, V27, P3047, DOI 10.1038/emboj.2008.213; Diochot S, 2004, EMBO J, V23, P1516, DOI 10.1038/sj.emboj.7600177; Donier E, 2008, EUR J NEUROSCI, V28, P74, DOI 10.1111/j.1460-9568.2008.06282.x; Gao ZH, 2006, J APPL PHYSIOL, V100, P421, DOI 10.1152/japplphysiol.00659.2005; Gautam M, 2010, NEUROSCIENCE, V170, P893, DOI 10.1016/j.neuroscience.2010.08.003; Hattori T, 2009, CIRC RES, V105, P279, DOI 10.1161/CIRCRESAHA.109.202036; Hayes SG, 2008, AM J PHYSIOL-HEART C, V295, pH1720, DOI 10.1152/ajpheart.00623.2008; Hayes SG, 2007, J PHYSIOL-LONDON, V581, P1271, DOI 10.1113/jphysiol.2007.129197; Hesselager M, 2004, J BIOL CHEM, V279, P11006, DOI 10.1074/jbc.M313507200; Immke DC, 2001, NAT NEUROSCI, V4, P869, DOI 10.1038/nn0901-869; Jiang Q, 2011, NEUROSCIENCE, V193, P89, DOI 10.1016/j.neuroscience.2011.07.021; Jiang Q, 2010, NEUROSCIENCE, V169, P574, DOI 10.1016/j.neuroscience.2010.05.043; Kaufman MP, 2002, CLIN AUTON RES, V12, P429, DOI 10.1007/s10286-002-0059-1; Li JH, 2004, J APPL PHYSIOL, V97, P1709, DOI 10.1152/japplphysiol.00389.2004; Light AR, 2008, J NEUROPHYSIOL, V100, P1184, DOI 10.1152/jn.01344.2007; Lingueglia E, 1997, J BIOL CHEM, V272, P29778, DOI 10.1074/jbc.272.47.29778; Liu JH, 2010, AM J PHYSIOL-HEART C, V299, pH1357, DOI 10.1152/ajpheart.00612.2010; Lu YJ, 2009, NEURON, V64, P885, DOI 10.1016/j.neuron.2009.11.007; Mamet J, 2002, J NEUROSCI, V22, P10662; Mazzuca M, 2007, NAT NEUROSCI, V10, P943, DOI 10.1038/nn1940; MCCLOSKE.DI, 1972, J PHYSIOL-LONDON, V224, P173, DOI 10.1113/jphysiol.1972.sp009887; Molliver DC, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-35; Poirot O, 2006, J PHYSIOL-LONDON, V576, P215, DOI 10.1113/jphysiol.2006.113035; Price MP, 2000, NATURE, V407, P1007, DOI 10.1038/35039512; Price MP, 2001, NEURON, V32, P1071, DOI 10.1016/S0896-6273(01)00547-5; Sluka KA, 2003, PAIN, V106, P229, DOI 10.1016/S0304-3959(03)00269-0; Sluka KA, 2007, PAIN, V129, P102, DOI 10.1016/j.pain.2006.09.038; Street D, 2001, J PHYSIOL-LONDON, V537, P993; Sugiura T, 2005, J NEUROSCI, V25, P2617, DOI 10.1523/JNEUROSCI.2894-04.2005; Walder RY, 2011, PAIN, V152, P2348, DOI 10.1016/j.pain.2011.06.027; Walder RY, 2010, J PAIN, V11, P210, DOI 10.1016/j.jpain.2009.07.004; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wu LJ, 2004, J BIOL CHEM, V279, P43716, DOI 10.1074/jbc.M403557200; Xie JH, 2002, J NEUROPHYSIOL, V87, P2835, DOI 10.1152/jn.2002.87.6.2835; Xing JH, 2008, J PHYSIOL-LONDON, V586, P3245, DOI 10.1113/jphysiol.2008.154450	47	40	42	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					793	802		10.1096/fj.12-220400	http://dx.doi.org/10.1096/fj.12-220400			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23109675	Green Published			2022-12-25	WOS:000314358000037
J	Dennis, MD; Jefferson, LS; Kimball, SR				Dennis, Michael D.; Jefferson, Leonard S.; Kimball, Scot R.			Role of p70S6K1-mediated Phosphorylation of eIF4B and PDCD4 Proteins in the Regulation of Protein Synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION-FACTOR 4E; RAT SKELETAL-MUSCLE; TRANSLATION INITIATION; EUKARYOTIC TRANSLATION; BINDING-PROTEIN; INHIBITS TRANSLATION; MAMMALIAN TARGET; SUPPRESSOR PDCD4; FACTOR 4A; RAPAMYCIN	Modulation of mRNA binding to the 40 S ribosomal subunit during translation initiation controls not only global rates of protein synthesis but also regulates the pattern of protein expression by allowing for selective inclusion, or exclusion, of mRNAs encoding particular proteins from polysomes. The mRNA binding step is modulated by signaling through a protein kinase known as the mechanistic target of rapamycin complex 1 (mTORC1). mTORC1 directly phosphorylates the translational repressors eIF4E binding proteins (4E-BP) 1 and 2, releasing them from the mRNA cap binding protein eIF4E, thereby promoting assembly of the eIF4E.eIF4G complex. mTORC1 also phosphorylates the 70-kDa ribosomal protein S6 kinase 1 (p70S6K1), which subsequently phosphorylates eIF4B, and programmed cell death 4 (PDCD4), which sequesters eIF4A from the eIF4E.eIF4G complex, resulting in repressed translation of mRNAs with highly structured 5'-untranslated regions. In the present study, we compared the role of the 4E-BPs in the regulation of global rates of protein synthesis to that of eIF4B and PDCD4. We found that maintenance of eIF4E interaction with eIF4G was not by itself sufficient to sustain global rates of protein synthesis in the absence of mTORC1 signaling to p70S6K1; phosphorylation of both eIF4B and PDCD4 was additionally required. We also found that the interaction of eIF4E with eIF4G was maintained in the liver of fasted rats as well as in serum-deprived mouse embryo fibroblasts lacking both 4E-BP1 and 4E-BP2, suggesting that the interaction of eIF4G with eIF4E is controlled primarily through the 4E-BPs.	[Dennis, Michael D.; Jefferson, Leonard S.; Kimball, Scot R.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Kimball, SR (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, H166,500 Univ Dr, Hershey, PA 17033 USA.	skimball@psu.edu		Dennis, Michael/0000-0002-0645-6864	National Institutes of Health [DK13499, DK088416]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK013499, R37DK013499, F32DK088416] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grants DK13499 (to L. S. J.) and DK088416 (to M. D. D.).	Bolster DR, 2004, J NUTR, V134, P1704, DOI 10.1093/jn/134.7.1704; Carriere A, 2011, J BIOL CHEM, V286, P567, DOI 10.1074/jbc.M110.159046; Chang JH, 2009, P NATL ACAD SCI USA, V106, P3148, DOI 10.1073/pnas.0808275106; Dorrello NV, 2006, SCIENCE, V314, P467, DOI 10.1126/science.1130276; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Huang BPH, 2009, AM J PHYSIOL-HEART C, V296, pH505, DOI 10.1152/ajpheart.01105.2008; Huo YL, 2012, BIOCHEM J, V444, P141, DOI 10.1042/BJ20112107; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Kimball SR, 2004, J BIOL CHEM, V279, P54103, DOI 10.1074/jbc.M410755200; Kimball SR, 1997, AM J PHYSIOL-CELL PH, V272, pC754, DOI 10.1152/ajpcell.1997.272.2.C754; Kimball SR, 1998, J BIOL CHEM, V273, P30945, DOI 10.1074/jbc.273.47.30945; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Luo J, 2005, J CELL BIOL, V170, P455, DOI 10.1083/jcb.200503088; Miyazaki M, 2010, FEBS J, V277, P2180, DOI 10.1111/j.1742-4658.2010.07635.x; Nielsen KH, 2011, NUCLEIC ACIDS RES, V39, P2678, DOI 10.1093/nar/gkq1206; Ozes AR, 2011, J MOL BIOL, V412, P674, DOI 10.1016/j.jmb.2011.08.004; Olanich ME, 2011, ONCOGENE, V30, P77, DOI 10.1038/onc.2010.404; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Poulin F, 1998, J BIOL CHEM, V273, P14002, DOI 10.1074/jbc.273.22.14002; Raught B, 2000, EMBO J, V19, P434, DOI 10.1093/emboj/19.3.434; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Sans MD, 2004, BIOCHEM BIOPH RES CO, V319, P144, DOI 10.1016/j.bbrc.2004.04.164; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Suzuki C, 2008, P NATL ACAD SCI USA, V105, P3274, DOI 10.1073/pnas.0712235105; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tuckow AP, 2011, AM J PHYSIOL-ENDOC M, V300, pE564, DOI 10.1152/ajpendo.00383.2010; vonManteuffel SR, 1997, MOL CELL BIOL, V17, P5426, DOI 10.1128/MCB.17.9.5426; Wang XM, 2001, EMBO J, V20, P4370, DOI 10.1093/emboj/20.16.4370; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Winter JN, 2011, AM J PHYSIOL-CELL PH, V300, pC1172, DOI 10.1152/ajpcell.00504.2010; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2004, MOL CELL BIOL, V24, P3894, DOI 10.1128/MCB.24.9.3894-3906.2004; Yoshizawa F, 1998, AM J PHYSIOL-ENDOC M, V275, pE814, DOI 10.1152/ajpendo.1998.275.5.E814	35	90	92	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42890	42899		10.1074/jbc.M112.404822	http://dx.doi.org/10.1074/jbc.M112.404822			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105104	Green Published, hybrid			2022-12-25	WOS:000312501600047
J	Zaarour, N; Demaretz, S; Defontaine, N; Zhu, YY; Laghmani, K				Zaarour, Nancy; Demaretz, Sylvie; Defontaine, Nadia; Zhu, Yingying; Laghmani, Kamel			Multiple Evolutionarily Conserved Di-leucine Like Motifs in the Carboxyl Terminus Control the Anterograde Trafficking of NKCC2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION-CHLORIDE COTRANSPORTERS; CELL-SURFACE EXPRESSION; K-CL COTRANSPORTER; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; ER EXPORT; SECRETORY PATHWAY; ENDOCYTIC PATHWAY; CYTOPLASMIC TAIL; BARTTER-SYNDROME	Mutations in the apical Na-K-2Cl co-transporter, NKCC2, cause type I Bartter syndrome, a life-threatening kidney disease. Yet the mechanisms underlying the regulation of NKCC2 trafficking in renal cells are scarcely known. We previously showed that naturally occurring mutations depriving NKCC2 of its distal COOH-terminal tail and interfering with the (LLV1083)-L-1081 motif result in defects in the ER exit of the co-transporter. Here we show that this motif is necessary but not sufficient for anterograde trafficking of NKCC2. Indeed, we have identified two additional hydrophobic motifs, (LL1039)-L-1038 and (LI1049)-L-1048, that are required for ER exit and surface expression of the co-transporter. Double mutations of (LL1039)-L-1038 or (LI1049)-L-1048 to di-alanines disrupted glycosylation and cell surface expression of NKCC2, independently of the expression system. Pulse-chase analysis demonstrated that the absence of the terminally glycosylated form of NKCC2 was not due to reduced synthesis or increased rates of degradation of mutant co-transporters, but was instead caused by defects in maturation. Co-immunolocalization experiments revealed that (1038)AA(1039) and (1048)AA(1049) were trapped mainly in the ER as indicated by extensive co-localization with the ER marker calnexin. Remarkably, among several analyzed motifs present in the NKCC2 COOH terminus, only those required for ER exit and surface expression of NKCC2 are evolutionarily conserved in all members of the SLC12A family, a group of cation-chloride co-transporters that are targets of therapeutic drugs and mutated in several human diseases. Based upon these data, we propose abnormal anterograde trafficking as a common mechanism associated with mutations depriving NKCC2, and also all other members of the SLC12A family, of their COOH terminus.	[Zaarour, Nancy; Demaretz, Sylvie; Defontaine, Nadia; Zhu, Yingying; Laghmani, Kamel] INSERM, Ctr Rech Cordeliers, UMRS872, Paris, France; [Zaarour, Nancy; Demaretz, Sylvie; Defontaine, Nadia; Zhu, Yingying; Laghmani, Kamel] CNRS, ERL7226, F-75006 Paris, France; [Zaarour, Nancy; Demaretz, Sylvie; Defontaine, Nadia; Zhu, Yingying; Laghmani, Kamel] Univ Paris 06, F-75006 Paris, France; [Zaarour, Nancy; Demaretz, Sylvie; Defontaine, Nadia; Zhu, Yingying; Laghmani, Kamel] Univ Paris 05, Fac Med, F-75006 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Laghmani, K (corresponding author), UMRS 872 Equipe 3 ERL7226, 15 Rue Ecole Med, F-75270 Paris 06, France.	Kamel.Laghmani@crc.jussieu.fr	Laghmani, Kamel/AIE-9621-2022	Laghmani, Kamel/0000-0002-2167-5766	INSERM, Paris, France; Fondation pour la Recherche Medicale (FRM); la Societe de Neprologie	INSERM, Paris, France(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); la Societe de Neprologie	This work was supported by grants from INSERM, Paris, France.; Recipient of a thesis fellowship from Fondation pour la Recherche Medicale (FRM) and from la Societe de Neprologie.	Acuna R, 2011, J HYPERTENS, V29, P475, DOI 10.1097/HJH.0b013e328341d0fd; Adachi M, 2007, ENDOCR J, V54, P1003, DOI 10.1507/endocrj.K06-204; Ares GR, 2011, AM J PHYSIOL-RENAL, V301, pF1143, DOI 10.1152/ajprenal.00396.2011; Bello V, 2001, MOL BIOL CELL, V12, P3004, DOI 10.1091/mbc.12.10.3004; Benziane B, 2007, J BIOL CHEM, V282, P33817, DOI 10.1074/jbc.M700195200; Bermak JC, 2001, NAT CELL BIOL, V3, P492, DOI 10.1038/35074561; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Caplan MJ, 1997, AM J PHYSIOL-RENAL, V272, pF425, DOI 10.1152/ajprenal.1997.272.4.F425; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; Carrel D, 2006, J CELL SCI, V119, P4276, DOI 10.1242/jcs.03189; Delpire E, 2002, ANNU REV PHYSIOL, V64, P803, DOI 10.1146/annurev.physiol.64.081501.155847; Delpire E, 2000, NEWS PHYSIOL SCI, V15, P309, DOI 10.1152/physiologyonline.2000.15.6.309; Delpire E, 1999, NAT GENET, V22, P192, DOI 10.1038/9713; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; Ellgaard L, 1999, SCIENCE, V286, P1882, DOI 10.1126/science.286.5446.1882; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Ferreira PA, 1996, NATURE, V383, P637, DOI 10.1038/383637a0; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gassmann M, 2005, MOL PHARMACOL, V68, P137, DOI 10.1124/mol.104.010256; Gavrikov KE, 2006, P NATL ACAD SCI USA, V103, P18793, DOI 10.1073/pnas.0604551103; Hasdemir B, 2005, J CELL BIOL, V171, P459, DOI 10.1083/jcb.200506005; Howell GJ, 2006, INT REV CYTOL, V252, P1, DOI 10.1016/S0074-7696(06)52005-4; HURTLEY SM, 1989, ANNU REV CELL BIOL, V5, P277, DOI 10.1146/annurev.cb.05.110189.001425; Isenring P, 1998, J BIOL CHEM, V273, P11295, DOI 10.1074/jbc.273.18.11295; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Kalandadze A, 2004, J NEUROSCI, V24, P5183, DOI 10.1523/JNEUROSCI.0839-04.2004; Kaneko H, 2004, J NEUROSCI, V24, P7931, DOI 10.1523/JNEUROSCI.2115-04.2004; Kasai K, 2008, CELL MOL BIOL LETT, V13, P144, DOI 10.2478/s11658-007-0043-9; Kupershmidt S, 2002, J BIOL CHEM, V277, P27442, DOI 10.1074/jbc.M112375200; LETOURNEUR F, 1992, CELL, V69, P1143, DOI 10.1016/0092-8674(92)90636-Q; Li PL, 2011, CIRC RES, V108, P458, DOI 10.1161/CIRCRESAHA.110.227835; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; Ma DK, 2001, SCIENCE, V291, P316, DOI 10.1126/science.291.5502.316; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Miller EA, 2003, CELL, V114, P497, DOI 10.1016/S0092-8674(03)00609-3; Monette MY, 2011, AM J PHYSIOL-RENAL, V300, pF840, DOI 10.1152/ajprenal.00552.2010; Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1; Mount DB, 2006, AM J PHYSIOL-RENAL, V290, pF606, DOI 10.1152/ajprenal.00410.2005; Muth TR, 2003, ANNU REV CELL DEV BI, V19, P333, DOI 10.1146/annurev.cellbio.19.110701.161425; Nezu A, 2009, J BIOL CHEM, V284, P6869, DOI 10.1074/jbc.M804302200; Nickel W, 2008, ANNU REV CELL DEV BI, V24, P287, DOI 10.1146/annurev.cellbio.24.110707.175320; Nufer O, 2002, J CELL SCI, V115, P619; Parvin MN, 2007, BIOCHEMISTRY-US, V46, P9630, DOI 10.1021/bi700881a; Petaja-Repo UE, 2000, J BIOL CHEM, V275, P13727, DOI 10.1074/jbc.275.18.13727; Pietila EM, 2005, J BIOL CHEM, V280, P26622, DOI 10.1074/jbc.M413815200; POND L, 1995, J BIOL CHEM, V270, P19989, DOI 10.1074/jbc.270.34.19989; Reiterer V, 2008, J NEUROSCI, V28, P12453, DOI 10.1523/JNEUROSCI.3451-08.2008; Ren XQ, 2005, J NEUROSCI, V25, P6676, DOI 10.1523/JNEUROSCI.1079-05.2005; Roy G, 2010, MOL BIOL CELL, V21, P597, DOI 10.1091/mbc.E09-05-0427; Russell JM, 2000, PHYSIOL REV, V80, P211, DOI 10.1152/physrev.2000.80.1.211; Sabath E, 2004, AM J PHYSIOL-RENAL, V287, pF195, DOI 10.1152/ajprenal.00044.2004; SANDOVAL IV, 1994, J BIOL CHEM, V269, P6622; Schepetilnikov MV, 2005, J GEN VIROL, V86, P2379, DOI 10.1099/vir.0.80865-0; Schulein R, 1998, MOL PHARMACOL, V54, P525, DOI 10.1124/mol.54.3.525; SHIN J, 1991, P NATL ACAD SCI USA, V88, P1918, DOI 10.1073/pnas.88.5.1918; Simon DB, 1996, NAT GENET, V13, P183, DOI 10.1038/ng0696-183; Theos AC, 2006, MOL BIOL CELL, V17, P3598, DOI 10.1091/mbc.E06-01-0081; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; Valdenaire O, 1999, J CELL SCI, V112, P3115; Valentijn JA, 1998, J BIOL CHEM, V273, P30344, DOI 10.1074/jbc.273.46.30344; Vargas-Poussou R, 1998, AM J HUM GENET, V62, P1332, DOI 10.1086/301872; Vincent MJ, 1998, J BIOL CHEM, V273, P950, DOI 10.1074/jbc.273.2.950; Vitale A, 1999, PLANT CELL, V11, P615, DOI 10.1105/tpc.11.4.615; Wang XD, 2004, J CELL BIOL, V167, P65, DOI 10.1083/jcb.200401035; Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893; Yeaman C, 1999, PHYSIOL REV, V79, P73, DOI 10.1152/physrev.1999.79.1.73; Zaarour N, 2011, J BIOL CHEM, V286, P9489, DOI 10.1074/jbc.M110.166546; Zaarour N, 2009, J BIOL CHEM, V284, P21752, DOI 10.1074/jbc.M109.000679; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhang XP, 2011, J BIOL CHEM, V286, P20525, DOI 10.1074/jbc.M111.222034	71	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42642	42653		10.1074/jbc.M112.399162	http://dx.doi.org/10.1074/jbc.M112.399162			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105100	Green Published, hybrid			2022-12-25	WOS:000312501600025
J	Ruggieri, P; Mangino, G; Fioretti, B; Catacuzzeno, L; Puca, R; Ponti, D; Miscusi, M; Franciolini, F; Ragona, G; Calogero, A				Ruggieri, Paola; Mangino, Giorgio; Fioretti, Bernard; Catacuzzeno, Luigi; Puca, Rosa; Ponti, Donatella; Miscusi, Massimo; Franciolini, Fabio; Ragona, Giuseppe; Calogero, Antonella			The Inhibition of KCa3.1 Channels Activity Reduces Cell Motility in Glioblastoma Derived Cancer Stem Cells	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNEL; HUMAN GLIOMA-CELLS; ACTIVATED POTASSIUM CHANNELS; ACUTE MYELOID-LEUKEMIA; ION CHANNELS; CONDUCTANCE; MIGRATION; EPIDEMIOLOGY; GROWTH; IDENTIFICATION	In the present study we evaluated the expression of the intermediate conductance calcium-activated potassium (KCa3.1) channel in human glioblastoma stem-like cells (CSCs) and investigated its role in cell motility. While the KCa3.1 channel is not expressed in neuronal-and glial-derived tissues of healthy individuals, both the KCa3.1 mRNA and protein are present in the glioblastoma tumor population, and are significantly enhanced in CSCs derived from both established cell line U87MG and a primary cell line, FCN9. Consistent with these data, voltage-independent and TRAM-34 sensitive potassium currents imputable to the KCa3.1 channel were recorded in the murine GL261 cell line and several primary human glioblastoma cells lines. Moreover, a significantly higher KCa3.1 current was recorded in U87MG-CD133 positive cells as compared to the U87MG-CD133 negative subpopulation. Further, we found that the tumor cell motility is strongly associated with KCa3.1 channel expression. Blockade of the KCa3.1 channel with the specific inhibitor TRAM-34 has in fact a greater impact on the motility of CSCs (reduction of 75%), which express a high level of KCa3.1 channel, than on the FCN9 parental population (reduction of 32%), where the KCa3.1 channel is expressed at lower level. Similar results were also observed with the CSCs derived from U87MG. Because invasion of surrounding tissues is one of the main causes of treatment failure in glioblastoma, these findings can be relevant for future development of novel cancer therapeutic drugs.	[Ruggieri, Paola; Mangino, Giorgio; Puca, Rosa; Ponti, Donatella; Miscusi, Massimo; Ragona, Giuseppe; Calogero, Antonella] Univ Roma La Sapienza, Dept Med Surg Sci & Biotechnol, Latina, Italy; [Fioretti, Bernard; Catacuzzeno, Luigi; Franciolini, Fabio] Univ Perugia, Dept Cellular & Environm Biol, I-06100 Perugia, Italy	Sapienza University Rome; University of Perugia	Calogero, A (corresponding author), Univ Roma La Sapienza, Dept Med Surg Sci & Biotechnol, Latina, Italy.	antonella.calogero@uniroma1.it	Fioretti, Bernard/I-6159-2015; Miscusi, Massimo/AAQ-6203-2020; Catacuzzenno, Luigi/M-4637-2014; franciolini, fabio/F-9699-2014; Mangino, Giorgio/C-7310-2009; calogero, antonella/U-5418-2019	Fioretti, Bernard/0000-0002-9570-4195; Miscusi, Massimo/0000-0002-5101-9073; Mangino, Giorgio/0000-0002-8950-9780; calogero, antonella/0000-0002-3322-2916; CATACUZZENO, Luigi/0000-0002-4723-0650; PONTI, Donatella/0000-0003-4764-6223	Fondazione Cassa di Risparmio, Perugia; COFIN-MIUR (Ministero dell'Universita e della Ricerca Scientifica) [812.111]	Fondazione Cassa di Risparmio, Perugia(Fondazione Cassa Risparmio Perugia); COFIN-MIUR (Ministero dell'Universita e della Ricerca Scientifica)	This work was supported by grants from the Fondazione Cassa di Risparmio, Perugia (FF) and from COFIN-MIUR (Ministero dell'Universita e della Ricerca Scientifica) 812.111, 2007 (AC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullaev IF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012304; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bondy ML, 2008, CANCER-AM CANCER SOC, V113, P1953, DOI 10.1002/cncr.23741; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Bouhy D, 2011, J NEUROSCI, V31, P16298, DOI 10.1523/JNEUROSCI.0047-11.2011; Bozzuto G, 2010, ANN I SUPER SANITA, V46, P66, DOI 10.4415/ANN_10_01_09; Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Bubien JK, 1999, AM J PHYSIOL-CELL PH, V276, pC1405, DOI 10.1152/ajpcell.1999.276.6.C1405; Calogero A, 2001, CLIN CANCER RES, V7, P2788; Calogero A, 2004, CANCER CELL INT, V4, DOI 10.1186/1475-2867-4-1; Catacuzzeno L., 2012, J SIGNAL TRANSDUCT, V2012, DOI DOI 10.1155/2012/42; Catacuzzeno L, 2011, J CELL PHYSIOL, V226, P1926, DOI 10.1002/jcp.22523; Cuddapah VA, 2011, AM J PHYSIOL-CELL PH, V301, pC541, DOI 10.1152/ajpcell.00102.2011; D'Onofrio M, 2003, J NEUROCHEM, V84, P1288, DOI 10.1046/j.1471-4159.2003.01633.x; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Engbers JDT, 2012, P NATL ACAD SCI USA, V109, P2601, DOI 10.1073/pnas.1115024109; Fioretti B, 2006, CELL PHYSIOL BIOCHEM, V18, P47, DOI 10.1159/000095135; Fioretti B, 2009, AM J PHYSIOL-CELL PH, V297, pC102, DOI 10.1152/ajpcell.00354.2008; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Heddleston JM, 2010, BRIT J CANCER, V102, P789, DOI 10.1038/sj.bjc.6605551; Huang Z, 2010, PROTEIN CELL, V1, P638, DOI 10.1007/s13238-010-0078-y; Ishii TM, 1997, P NATL ACAD SCI USA, V94, P11651, DOI 10.1073/pnas.94.21.11651; Khanna R, 2001, AM J PHYSIOL-CELL PH, V280, pC796, DOI 10.1152/ajpcell.2001.280.4.C796; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lee EK, 2010, J PROTEOME RES, V9, P5108, DOI 10.1021/pr100378z; Li Gui-Rong, 2011, World J Stem Cells, V3, P19, DOI 10.4252/wjsc.v3.i3.19; Liu XJ, 2002, J NEUROSCI, V22, P1840, DOI 10.1523/JNEUROSCI.22-05-01840.2002; Logsdon NJ, 1997, J BIOL CHEM, V272, P32723, DOI 10.1074/jbc.272.52.32723; Lombari V, 2002, 5 EUR M GLIAL CELL F, pS30; Longden TA, 2011, BRIT J PHARMACOL, V164, P922, DOI 10.1111/j.1476-5381.2011.01447.x; Messina S, 2011, ONCOGENE, V30, P3813, DOI 10.1038/onc.2011.99; Olsen ML, 2004, GLIA, V46, P63, DOI 10.1002/glia.10346; Piechaczek C, 2001, J BIOL REG HOMEOS AG, V15, P101; Qiang L, 2009, CANCER LETT, V279, P13, DOI 10.1016/j.canlet.2009.01.016; Ransom CB, 2001, J NEUROSCI, V21, P7674, DOI 10.1523/JNEUROSCI.21-19-07674.2001; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rooj AK, 2012, J BIOL CHEM, V287, P4053, DOI 10.1074/jbc.M111.311688; Rosen JM, 2009, SCIENCE, V324, P1670, DOI 10.1126/science.1171837; Sanai N, 2008, NEUROSURGERY, V62, P753, DOI 10.1227/01.neu.0000318159.21731.cf; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Schonherr R, 2005, J MEMBRANE BIOL, V205, P175, DOI 10.1007/s00232-005-0782-3; SCHWAB A, 1995, PFLUG ARCH EUR J PHY, V430, P802, DOI 10.1007/BF00386179; Schwartzbaum JA, 2006, NAT CLIN PRACT NEURO, V2, P494, DOI 10.1038/ncpneuro0289; Sciaccaluga M, 2010, AM J PHYSIOL-CELL PH, V299, pC175, DOI 10.1152/ajpcell.00344.2009; Sontheimer H, 2008, EXP BIOL MED, V233, P779, DOI 10.3181/0711-MR-308; Stuhmer W, 2010, FUTURE MED CHEM, V2, P745, DOI 10.4155/FMC.10.24; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; VANRENTERGHEM C, 1995, J NEUROCHEM, V65, P1274; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Weaver AK, 2006, GLIA, V54, P223, DOI 10.1002/glia.20364; Wrensch M, 2002, NEURO-ONCOLOGY, V4, P278, DOI 10.1093/neuonc/4.4.278; Wu CY, 2011, CLIN EXP PHARM PHYSL; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012	57	56	58	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e47825	10.1371/journal.pone.0047825	http://dx.doi.org/10.1371/journal.pone.0047825			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110108	Green Published, gold, Green Submitted			2022-12-25	WOS:000310193400019
J	Nolasco, N; Juarez, C; Morgado, E; Meza, E; Caba, M				Nolasco, Nahum; Juarez, Claudia; Morgado, Elvira; Meza, Enrique; Caba, Mario			A Circadian Clock in the Olfactory Bulb Anticipates Feeding during Food Anticipatory Activity	PLOS ONE			English	Article							SUPRACHIASMATIC NUCLEUS; MAMMARY PHEROMONE; RABBIT PUPS; METABOLIC RHYTHMS; VOMERONASAL ORGAN; LOCUS-COERULEUS; NEWBORN RABBITS; NATURAL MODEL; MALE-MICE; RATS	Rabbit pups ingest food, in this case milk, once a day with circadian periodicity and are a natural model of food anticipatory activity. During nursing, several sensory systems receive information about properties of the food, one of them being the olfactory system, which has received little attention in relation to synchronization by food. In addition, the olfactory bulb has a circadian pacemaker that exhibits rhythms independently of the suprachiasmatic nucleus, but the biological functions of these rhythms are largely unknown. In the present contribution, we hypothesized that circadian suckling of milk synchronizes rhythms in the olfactory bulb. To this aim we explored by immunohistochemistry, rhythms of FOS and PER1 proteins, as indicators of activation and reporter of oscillations, respectively, through a complete 24-h cycle in periglomerular, mitral and granular cell layers of both the main and the accessory olfactory bulb. Subjects were 7-day-old rabbit pups scheduled to nurse during the night (02:00 h) or day (10:00 h), and also fasted subjects, to explore the possible persistence of oscillations. In the three layers of the main olfactory bulb, FOS was high at time of nursing, then further increased 1.5 h afterward, and then decreased to increase again in advance of the next nursing bout. This pattern persisted, without the postprandial increase, in fasted subjects with a shift in subjects nursed at 02:00. PER1 was increased 2-8 h after nursing and this increase persisted in most cell layers, with a shift, in fasted subjects. In the accessory olfactory bulb we only observed a consistent pattern of FOS expression in the mitral cell layer of nursed subjects, similar to that of the main olfactory bulb. We conclude that the main olfactory bulb is synchronized during milk ingestion, but during fasting its oscillations perhaps are modulated by the suprachiasmatic nucleus, as proposed for rodents.	[Juarez, Claudia; Morgado, Elvira; Meza, Enrique; Caba, Mario] Univ Veracruzana, Ctr Invest Biomed, Xalapa 91000, Veracruz, Mexico; [Nolasco, Nahum] Univ Veracruzana, CIB, Xalapa 91000, Veracruz, Mexico	Universidad Veracruzana; Universidad Veracruzana	Caba, M (corresponding author), Univ Veracruzana, Ctr Invest Biomed, Xalapa 91000, Veracruz, Mexico.	mcaba@uv.mx	Caba, Mario/H-7850-2019; Juarez, Claudia/AAZ-5026-2020	Caba, Mario/0000-0001-7475-3441; Meza, Jose Enrique/0000-0001-5232-3926; Juarez Portilla, Claudia/0000-0003-2215-058X	National Institutes of Health (NIH)/Fogarty [R01TW006636]; FOGARTY INTERNATIONAL CENTER [R01TW006636] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/Fogarty; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This research was partially funded by Grant R01TW006636 from National Institutes of Health (NIH)/Fogarty (MC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Acosta-Galvan G, 2011, P NATL ACAD SCI USA, V108, P5813, DOI 10.1073/pnas.1015551108; Amir S, 1999, NEUROSCI LETT, V272, P175, DOI 10.1016/S0304-3940(99)00609-6; Caba M, 2008, EUR J NEUROSCI, V27, P432, DOI 10.1111/j.1460-9568.2008.06017.x; Caba M, 2009, EUR J NEUROSCI, V30, P1697, DOI 10.1111/j.1460-9568.2009.06964.x; Challet E, 2010, CELL TISSUE RES, V341, P1, DOI 10.1007/s00441-010-1001-9; Charra R, 2012, BEHAV BRAIN RES, V226, P179, DOI 10.1016/j.bbr.2011.09.008; COLEMAN GJ, 1990, PHYSIOL BEHAV, V47, P1145, DOI 10.1016/0031-9384(90)90365-B; Coureaud G, 2004, CHEM SENSES, V29, P341, DOI 10.1093/chemse/bjh037; Coureaud G, 2010, J COMP PHYSIOL A, V196, P779, DOI 10.1007/s00359-010-0548-y; Davidson AJ, 2001, PHYSIOL BEHAV, V72, P231, DOI 10.1016/S0031-9384(00)00417-0; Davidson AJ, 2009, EUR J NEUROSCI, V30, P1658, DOI 10.1111/j.1460-9568.2009.06961.x; DISTEL H, 1985, J COMP PHYSIOL A, V157, P599, DOI 10.1007/BF01351354; Feillet CA, 2008, MOL CELL NEUROSCI, V37, P209, DOI 10.1016/j.mcn.2007.09.010; Funk D, 2000, BRAIN RES, V866, P262, DOI 10.1016/S0006-8993(00)02249-6; Granados-Fuentes D, 2004, EUR J NEUROSCI, V19, P898, DOI 10.1111/j.0953-816X.2004.03117.x; Granados-Fuentes D, 2004, J NEUROSCI, V24, P615, DOI 10.1523/JNEUROSCI.4002-03.2004; Granados-Fuentes D, 2006, J NEUROSCI, V26, P12219, DOI 10.1523/JNEUROSCI.3445-06.2006; Granados-Fuentes D, 2011, J BIOL RHYTHM, V26, P552, DOI 10.1177/0748730411420247; Hamada T, 2011, BIOCHEM BIOPH RES CO, V409, P727, DOI 10.1016/j.bbrc.2011.05.076; HUDSON R, 1986, PHYSIOL BEHAV, V37, P123, DOI 10.1016/0031-9384(86)90394-X; Juarez C, 2012, EUR J NEUROSCI, V35, P1458, DOI 10.1111/j.1460-9568.2012.08051.x; Landry GJ, 2007, BRAIN RES, V1141, P108, DOI 10.1016/j.brainres.2007.01.032; Landry GJ, 2007, J BIOL RHYTHM, V22, P467, DOI 10.1177/0748730407307804; Landry GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024187; LEGORATTISANCHEZ MO, 1989, BRAIN RES BULL, V23, P283, DOI 10.1016/0361-9230(89)90210-4; Minana-Solis MC, 2009, CHRONOBIOL INT, V26, P808, DOI 10.1080/07420520903044240; Mistlberger RE, 2011, PHYSIOL BEHAV, V104, P535, DOI 10.1016/j.physbeh.2011.04.015; Mistlberger RE, 1999, BRAIN RES, V842, P73, DOI 10.1016/S0006-8993(99)01836-3; MISTLBERGER RE, 1984, PHYSIOL BEHAV, V33, P227, DOI 10.1016/0031-9384(84)90104-5; MISTLBERGER RE, 1988, J BIOL RHYTHM, V3, P277, DOI 10.1177/074873048800300306; Montigny D, 2006, PHYSIOL BEHAV, V89, P742, DOI 10.1016/j.physbeh.2006.08.022; Montufar-Chaveznava R, 2012, NEUROSCIENCE, V207, P198, DOI 10.1016/j.neuroscience.2012.01.025; Morgado E, 2008, AM J PHYSIOL-REG I, V295, pR690, DOI 10.1152/ajpregu.00162.2008; Morgado E, 2011, EUR J NEUROSCI, V34, P1807, DOI 10.1111/j.1460-9568.2011.07898.x; Morgado E, 2010, HORM BEHAV, V58, P465, DOI 10.1016/j.yhbeh.2010.05.003; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; Mori K, 1999, SCIENCE, V286, P711, DOI 10.1126/science.286.5440.711; Munger SD, 2009, ANNU REV PHYSIOL, V71, P115, DOI 10.1146/annurev.physiol.70.113006.100608; Pankevich DE, 2004, J NEUROSCI, V24, P9451, DOI 10.1523/JNEUROSCI.2376-04.2004; Rieux C, 2002, J BIOL RHYTHM, V17, P121, DOI 10.1177/074873002129002410; Sheck W.H., 1986, ATLAS RABBIT BRAIN S; SHIPLEY MT, 1985, BRAIN RES, V329, P294, DOI 10.1016/0006-8993(85)90537-2; Stephan FK, 2002, J BIOL RHYTHM, V17, P284, DOI 10.1177/074873002129002591; Wang ZS, 2006, J NEUROSCI, V26, P7375, DOI 10.1523/JNEUROSCI.1967-06.2006	44	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47779	10.1371/journal.pone.0047779	http://dx.doi.org/10.1371/journal.pone.0047779			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094084	gold, Green Published, Green Submitted			2022-12-25	WOS:000310050200044
J	Yang, SG; Wang, B; Chen, P; Yu, CB; Deng, M; Yao, J; Zhu, CX; Ren, JJ; Wu, W; Ju, B; Shen, JF; Chen, Y; Li, MD; Ruan, B; Li, LJ				Yang, Shi-gui; Wang, Bing; Chen, Ping; Yu, Cheng-bo; Deng, Min; Yao, Jun; Zhu, Chun-xia; Ren, Jing-jing; Wu, Wei; Ju, Bin; Shen, Jian-feng; Chen, Yu; Li, Ming D.; Ruan, Bing; Li, Lanjuan			Effectiveness of HBV Vaccination in Infants and Prediction of HBV Prevalence Trend under New Vaccination Plan: Findings of a Large-Scale Investigation	PLOS ONE			English	Article							B-VIRUS-INFECTION; HEPATITIS-B; TAIWAN; HIV-1	Background: Hepatitis B virus (HBV) infection remains a severe public health problem. Investigating its prevalence and trends is essential to prevention. Methods: To evaluate the effectiveness of HBV vaccination under the 1992 Intervention Program for infants and predicted HBV prevalence trends under the 2011 Program for all ages. We conducted a community-based investigation of 761,544 residents of 12 counties in Zhejiang Province selected according to their location, population density, and economic development. The HBV prevalence trends were predicted by a time-shifting approach. HBV surface antigen (HBsAg) and alanine amino transferase (ALT) were determined. Results: Of the 761,544 persons screened for HBsAg, 54,132 were positive (adjusted carrier rate 6.13%); 9,455 had both elevated ALT and a positive HBsAg test (standardized rate 1.18%). The standardized HBsAg carrier rate for persons aged <= 20 years was 1.51%. Key factors influencing HBV infection were sex, age, family history, drinking, smoking, employment as a migrant worker, and occupation. With the vaccination program implemented in 2011, we predict that by 2020, the HBsAg carrier rate will be 5.27% and that for individuals aged <= 34 years will reach the 2% upper limit of low prevalence according to the WHO criteria, with a standardized rate of 1.86%. Conclusions: The national HBV vaccination program for infants implemented in 1992 has greatly reduced the prevalence of HBV infection. The 2011 program is likely to reduce HBV infection in Zhejiang Province to a low moderate prevalence, and perinatal transmission is expected to be controlled by 2020.	[Yang, Shi-gui; Wang, Bing; Chen, Ping; Yu, Cheng-bo; Deng, Min; Zhu, Chun-xia; Ren, Jing-jing; Wu, Wei; Chen, Yu; Li, Ming D.; Ruan, Bing; Li, Lanjuan] Zhejiang Univ, Affiliated Hosp 1, Key Lab Infect Dis,Sch Med, State Key Lab Diag & Treatment Infect Dis, Hangzhou, Zhejiang, Peoples R China; [Yao, Jun] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Ju, Bin; Shen, Jian-feng] Zhejiang Prov Hlth Bur Ctr Informat, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Provincial Center for Disease Control & Prevention	Li, MD (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Key Lab Infect Dis,Sch Med, State Key Lab Diag & Treatment Infect Dis, Hangzhou, Zhejiang, Peoples R China.	ml2km@zju.edu.cn; hzruanbing@163.com; ljli@zju.edu.cn	Chen, Yu/Y-3292-2019		Mega-Project for National Science and Technology Development under the "11th and 12th Five-Year Plan of China" [2009ZX10004-901, 2011ZX10004-901]; National Science and Technology Support Program of "11th Five-Year Plan" [2008BAH27B00]; National Natural Science Foundation of China [81001271]	Mega-Project for National Science and Technology Development under the "11th and 12th Five-Year Plan of China"; National Science and Technology Support Program of "11th Five-Year Plan"; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported in part by grants from the Mega-Project for National Science and Technology Development under the "11th and 12th Five-Year Plan of China" (2009ZX10004-901, 2011ZX10004-901), the National Science and Technology Support Program of "11th Five-Year Plan" (2008BAH27B00), and the National Natural Science Foundation of China (81001271). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beasley RP, 2009, JAMA-J AM MED ASSOC, V302, P322, DOI 10.1001/jama.2009.1024; Chen HL, 1996, JAMA-J AM MED ASSOC, V276, P906, DOI 10.1001/jama.276.11.906; Chen YS, 2007, CHIN J EXP CLIN INFE, V1, P5; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; Edmunds WJ, 1996, EPIDEMIOL INFECT, V117, P313, DOI 10.1017/S0950268800001497; Hampton T, 2008, JAMA-J AM MED ASSOC, V300, P2108, DOI 10.1001/jama.2008.573; KANE M, 1995, VACCINE, V13, pS47; Kuehn BM, 2010, JAMA-J AM MED ASSOC, V303, P713, DOI 10.1001/jama.2010.161; Lacerda R, 1997, AIDS, V11, pS15; Lai CL, 2003, LANCET, V362, P2089, DOI 10.1016/S0140-6736(03)15108-2; Lai M, 2007, J HEPATOL, V47, P760, DOI 10.1016/j.jhep.2007.07.022; Launay O, 2011, JAMA-J AM MED ASSOC, V305, P1432, DOI 10.1001/jama.2011.351; Lee WM, 1997, NEW ENGL J MED, V337, P1733, DOI 10.1056/NEJM199712113372406; Liang XF, 2009, VACCINE, V27, P6550, DOI 10.1016/j.vaccine.2009.08.048; Liaw YF, 2009, LANCET, V373, P582, DOI 10.1016/S0140-6736(09)60207-5; Liu J, 2007, LANCET, V369, P1582, DOI 10.1016/S0140-6736(07)60723-5; Mogensen TH, 2004, J VIROL, V78, P5883, DOI 10.1128/JVI.78.11.5883-5890.2004; Muthumani K, 2004, DNA CELL BIOL, V23, P239, DOI 10.1089/104454904773819824; Ni YH, 2007, GASTROENTEROLOGY, V132, P1287, DOI 10.1053/j.gastro.2007.02.055; Razani-Boroujerdi S, 2004, CELL IMMUNOL, V230, P1, DOI 10.1016/j.cellimm.2004.07.007; Statistics ZPBo, 2011, MAIN DAT B 6 NAT CEN; Torpy Janet M, 2011, JAMA, V305, P1500, DOI 10.1001/jama.305.14.1500; Wittet S, 2001, HEPATITIS B VACCINE; World Health Organization, 2008, HEP B; Wu Gui-Ying, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P474; Xia GLL, 1996, INT HEPATOL COMMUN, V5, P12; Xu XQ, 2007, DIS SURVEILLANCE, V22, P3; Yang DB, 2004, S CHINA POPULATION, V19, P5; Yao J, 1997, DIS SURVEILLANCE, V12, P3; Yao J, 2000, CHINESE J VACCINES I, V6, P4; Yuen MF, 2003, ANTIVIR THER, V8, P531; Zhejiang CDC, 2007, PLAN IMPL SUPPL IMM	32	19	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47808	10.1371/journal.pone.0047808	http://dx.doi.org/10.1371/journal.pone.0047808			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094094	gold, Green Submitted, Green Published			2022-12-25	WOS:000310050200049
J	Jacques-Fricke, BT; Roffers-Agarwal, J; Gammill, LS				Jacques-Fricke, Bridget T.; Roffers-Agarwal, Julaine; Gammill, Laura S.			DNA Methyltransferase 3b Is Dispensable for Mouse Neural Crest Development	PLOS ONE			English	Article							DNMT3B; METHYLATION; TRANSITION; EXPRESSION; CELLS; GENERATION; FATE	The neural crest is a population of multipotent cells that migrates extensively throughout vertebrate embryos to form diverse structures. Mice mutant for the de novo DNA methyltransferase DNMT3b exhibit defects in two neural crest derivatives, the craniofacial skeleton and cardiac ventricular septum, suggesting that DNMT3b activity is necessary for neural crest development. Nevertheless, the requirement for DNMT3b specifically in neural crest cells, as opposed to interacting cell types, has not been determined. Using a conditional DNMT3b allele crossed to the neural crest cre drivers Wnt1-cre and Sox10-cre, neural crest DNMT3b mutants were generated. In both neural crest-specific and fully DNMT3b-mutant embryos, cranial neural crest cells exhibited only subtle migration defects, with increased numbers of dispersed cells trailing organized streams in the head. In spite of this, the resulting cranial ganglia, craniofacial skeleton, and heart developed normally when neural crest cells lacked DNMT3b. This indicates that DNTM3b is not necessary in cranial neural crest cells for their development. We conclude that defects in neural crest derivatives in DNMT3b mutant mice reflect a requirement for DNMT3b in lineages such as the branchial arch mesendoderm or the cardiac mesoderm that interact with neural crest cells during formation of these structures.	[Jacques-Fricke, Bridget T.; Roffers-Agarwal, Julaine; Gammill, Laura S.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Gammill, LS (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	gammi001@umn.edu	Gammill, Laura/GXH-9992-2022	Gammill, Laura/0000-0003-3914-5269; Roffers-Agarwal, Julaine/0000-0003-2730-7013	American Cancer Society [IRG-58-001-49-IRG32]; National Institutes of Health Individual Ruth L. Kirschstein National Research Service [F32 DE021651, F32 DE019973]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [F32DE021651] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [F32DE019973] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Institutes of Health Individual Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by American Cancer Society grant #IRG-58-001-49-IRG32 (LSG), and National Institutes of Health Individual Ruth L. Kirschstein National Research Service Awards F32 DE021651 (BJF) and F32 DE019973 (JRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MS, 2008, DEV DYNAM, V237, P1021, DOI 10.1002/dvdy.21513; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Basch ML, 2006, NATURE, V441, P218, DOI 10.1038/nature04684; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; BRONNERFRASER M, 1988, NATURE, V335, P161, DOI 10.1038/335161a0; Carmona-Fontaine C, 2011, DEV CELL, V21, P1026, DOI 10.1016/j.devcel.2011.10.012; Cedar H., 2009, EPIGENETIC SILENCING; Chai Y, 2000, DEVELOPMENT, V127, P1671; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dodge JE, 2005, J BIOL CHEM, V280, P17986, DOI 10.1074/jbc.M413246200; Dumont N, 2008, P NATL ACAD SCI USA, V105, P14867, DOI 10.1073/pnas.0807146105; Ehrlich M, 2003, CLIN IMMUNOL, V109, P17, DOI 10.1016/S1521-6616(03)00201-8; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Gallardo T, 2007, GENESIS, V45, P413, DOI 10.1002/dvg.20310; Gammill LS, 2006, DEVELOPMENT, V133, P99, DOI 10.1242/dev.02187; Haberland M, 2009, GENE DEV, V23, P1625, DOI 10.1101/gad.1809209; Hari L, 2012, DEVELOPMENT, V139, P2107, DOI 10.1242/dev.073064; Hirasawa R, 2009, GENE EXPR PATTERNS, V9, P27, DOI 10.1016/j.gep.2008.09.002; Jiang XB, 2000, DEVELOPMENT, V127, P1607; Katayama KI, 2011, P NATL ACAD SCI USA, V108, P7607, DOI 10.1073/pnas.1101347108; Kaufmann MH, 1992, ATLAS MOUSE DEV; KIRBY ML, 1985, ANAT RECORD, V213, P87, DOI 10.1002/ar.1092130112; KIRBY ML, 1983, SCIENCE, V220, P1059, DOI 10.1126/science.6844926; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Le Douarin NM, 1999, NEURAL CREST, V2; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martins-Taylor K, 2012, EPIGENETICS-US, V7, P71, DOI 10.4161/epi.7.1.18750; Matsuoka T, 2005, NATURE, V436, P347, DOI 10.1038/nature03837; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Mouse Genome Informatics Group, 2003, MGI CDNA CLON LOAD; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Rai K, 2010, J BIOL CHEM, V285, P4110, DOI 10.1074/jbc.M109.073676; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Roffers-Agarwal J, 2009, DEVELOPMENT, V136, P1879, DOI 10.1242/dev.032920; SELLECK MAJ, 1995, DEVELOPMENT, V121, P525; Shafiei F, 2008, ONCOGENE, V27, P2602, DOI 10.1038/sj.onc.1210917; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Strobl-Mazzulla PH, 2010, DEV CELL, V19, P460, DOI 10.1016/j.devcel.2010.08.009; Ueda Y, 2006, DEVELOPMENT, V133, P1183, DOI 10.1242/dev.02293; Watanabe D, 2002, MECH DEVELOP, V118, P187, DOI 10.1016/S0925-4773(02)00242-3; Watanabe D, 2006, NEUROSCIENCE, V142, P727, DOI 10.1016/j.neuroscience.2006.07.053	42	22	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47794	10.1371/journal.pone.0047794	http://dx.doi.org/10.1371/journal.pone.0047794			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094090	Green Published, gold, Green Submitted			2022-12-25	WOS:000312384500025
J	Mackenzie, SM; Raible, DW				Mackenzie, Scott M.; Raible, David W.			Proliferative Regeneration of Zebrafish Lateral Line Hair Cells after Different Ototoxic Insults	PLOS ONE			English	Article							INNER-EAR; SUPPORTING CELL; SENSORY EPITHELIA; DIRECT TRANSDIFFERENTIATION; PROSENSORY PATCHES; LASER-ABLATION; NOTCH ACTIVITY; DEATH; NEUROMASTS; EXPRESSION	Sensory hair cells in the zebrafish lateral line regenerate rapidly and completely after damage. Previous studies have used a variety of ototoxins to kill lateral line hair cells to study different phenomena including mechanisms of hair cell death and regeneration. We sought to directly compare these ototoxins to determine if they differentially affected the rate and amount of hair cell replacement. In addition, previous studies have found evidence of proliferative hair cell regeneration in zebrafish, but both proliferation and non-mitotic direct transdifferentiation have been observed during hair cell regeneration in the sensory epithelia of birds and amphibians. We sought to test whether a similar combination of regenerative mechanisms exist in the fish. We analyzed the time course of regeneration after treatment with different ototoxic compounds and also labeled dividing hair cell progenitors. Certain treatments, including cisplatin and higher concentrations of dissolved copper, significantly delayed regeneration by one or more days. However, cisplatin did not block all regeneration as observed previously in the chick basilar papilla. The particular ototoxin did not appear to affect the mechanism of regeneration, as we observed evidence of recent proliferation in the majority of new hair cells in all cases. Inhibiting proliferation with flubendazole blocked the production of new hair cells and prevented the accumulation of additional precursors, indicating that proliferation has a dominant role during regeneration of lateral line hair cells.	[Mackenzie, Scott M.; Raible, David W.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Mackenzie, Scott M.; Raible, David W.] Univ Washington, Grad Program Neurobiol & Behav, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Raible, DW (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	draible@uw.edu		Raible, David/0000-0002-5342-5841	National Institutes of Health [R01DC011269]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011269] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded by National Institutes of Health grant R01DC011269. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler HJ, 1997, INT J DEV NEUROSCI, V15, P375, DOI 10.1016/S0736-5748(96)00098-6; Adler HJ, 1996, NEUROSCI LETT, V205, P17, DOI 10.1016/0304-3940(96)12367-3; Baird RA, 1996, ANN NY ACAD SCI, V781, P59, DOI 10.1111/j.1749-6632.1996.tb15693.x; BAIRD RA, 1993, HEARING RES, V65, P164, DOI 10.1016/0378-5955(93)90211-I; Baird RA, 2000, P NATL ACAD SCI USA, V97, P11722, DOI 10.1073/pnas.97.22.11722; BALAK KJ, 1990, J NEUROSCI, V10, P2502; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bermingham-McDonogh O, 2003, CURR OPIN NEUROBIOL, V13, P119, DOI 10.1016/S0959-4388(03)00018-7; Brignull HR, 2009, BRAIN RES, V1277, P12, DOI 10.1016/j.brainres.2009.02.028; Burns JC, 2012, J NEUROSCI, V32, P6570, DOI 10.1523/JNEUROSCI.6274-11.2012; Cafaro J, 2007, DEV DYNAM, V236, P156, DOI 10.1002/dvdy.21023; Coffin AB, 2009, HEARING RES, V253, P42, DOI 10.1016/j.heares.2009.03.004; CORWIN JT, 1988, SCIENCE, V240, P1772, DOI 10.1126/science.3381100; Daudet N, 2005, DEVELOPMENT, V132, P541, DOI 10.1242/dev.01589; Daudet N, 2007, DEVELOPMENT, V134, P2369, DOI 10.1242/dev.001842; FORGE A, 1993, SCIENCE, V259, P1616, DOI 10.1126/science.8456284; Forge A, 1998, J COMP NEUROL, V397, P69; Giari L, 2012, J APPL TOXICOL, V32, P293, DOI 10.1002/jat.1691; Go W, 2010, CELL CALCIUM, V48, P302, DOI 10.1016/j.ceca.2010.09.012; Hallam R, 2006, INT J AUDIOL, V45, P715, DOI 10.1080/14992020600957335; Harris JA, 2003, JARO-J ASSOC RES OTO, V4, P219, DOI 10.1007/s10162-002-3022-x; Hartman BH, 2010, P NATL ACAD SCI USA, V107, P15792, DOI 10.1073/pnas.1002827107; Hernandez PP, 2007, DEV NEUROBIOL, V67, P637, DOI 10.1002/dneu.20386; Hernandez PP, 2006, HEARING RES, V213, P1, DOI 10.1016/j.heares.2005.10.015; Itoh M, 2001, MECH DEVELOP, V102, P263, DOI 10.1016/S0925-4773(01)00308-2; Jones JE, 1996, J NEUROSCI, V16, P649; Jorgenson J A, 1991, Hosp Pharm, V26, P609; Jorgenson JA, 1991, HOSP PHARM, V26, P615; Jorgenson JA, 1991, HOSP PHARM, V26, P609; Li L, 1997, INT J DEV NEUROSCI, V15, P433, DOI 10.1016/S0736-5748(96)00102-5; Lin V, 2011, J NEUROSCI, V31, P15329, DOI 10.1523/JNEUROSCI.2057-11.2011; Linbo TL, 2006, ENVIRON TOXICOL CHEM, V25, P597, DOI 10.1897/05-241R.1; LOMBARTE A, 1993, HEARING RES, V64, P166, DOI 10.1016/0378-5955(93)90002-I; Lopez-Schier H, 2006, P NATL ACAD SCI USA, V103, P18615, DOI 10.1073/pnas.0608536103; Ma EY, 2008, J NEUROSCI, V28, P2261, DOI 10.1523/JNEUROSCI.4372-07.2008; Matsuda M, 2010, DEVELOPMENT, V137, P3477, DOI 10.1242/dev.052761; Matsui JI, 2002, J NEUROSCI, V22, P1218, DOI 10.1523/JNEUROSCI.22-04-01218.2002; Millimaki BB, 2010, DEV BIOL, V338, P262, DOI 10.1016/j.ydbio.2009.12.011; Mizoguchi T, 2011, J NEUROSCI, V31, P15522, DOI 10.1523/JNEUROSCI.3948-11.2011; Namdaran P, 2012, J NEUROSCI, V32, P3516, DOI 10.1523/JNEUROSCI.3905-11.2012; Nayak GD, 2007, INT J DEV BIOL, V51, P597, DOI 10.1387/ijdb.072392gn; Nicolson T, 2005, ANNU REV GENET, V39, P9, DOI 10.1146/annurev.genet.39.073003.105049; Olivari FA, 2008, BRAIN RES, V1244, P1, DOI 10.1016/j.brainres.2008.09.050; Ou HC, 2007, HEARING RES, V233, P46, DOI 10.1016/j.heares.2007.07.003; Owens KN, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000020; Owens KN, 2009, HEARING RES, V253, P32, DOI 10.1016/j.heares.2009.03.001; Parinov S, 2004, DEV DYNAM, V231, P449, DOI 10.1002/dvdy.20157; Roberson DW, 1996, AUDIT NEUROSCI, V2, P195; Roberson DW, 2004, J NEUROSCI RES, V78, P461, DOI 10.1002/jnr.20271; ROBERSON DW, 1994, AM J OTOL, V15, P28; RUBEL EW, 1995, SCIENCE, V267, P701, DOI 10.1126/science.7839150; RYALS BM, 1988, SCIENCE, V240, P1774, DOI 10.1126/science.3381101; Seiler C, 1999, J NEUROBIOL, V41, P424, DOI 10.1002/(SICI)1097-4695(19991115)41:3<424::AID-NEU10>3.0.CO;2-G; Slattery EL, 2010, J NEUROSCI, V30, P3473, DOI 10.1523/JNEUROSCI.4316-09.2010; Smith ME, 2006, J EXP BIOL, V209, P4193, DOI 10.1242/jeb.02490; Song JK, 1995, HEARING RES, V91, P63, DOI 10.1016/0378-5955(95)00170-0; Spagnuolo PA, 2010, BLOOD, V115, P4824, DOI 10.1182/blood-2009-09-243055; Stone JS, 2000, J COMP NEUROL, V417, P1, DOI 10.1002/(SICI)1096-9861(20000131)417:1<1::AID-CNE1>3.0.CO;2-E; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Taylor RR, 2005, J COMP NEUROL, V484, P105, DOI 10.1002/cne.20450; Ton C, 2005, HEARING RES, V208, P79, DOI 10.1016/j.heares.2005.05.005; Warchol ME, 1996, J NEUROSCI, V16, P5466; WARCHOL ME, 1993, SCIENCE, V259, P1619, DOI 10.1126/science.8456285; White PM, 2006, NATURE, V441, P984, DOI 10.1038/nature04849; Wibowo I, 2011, DEVELOPMENT, V138, P1143, DOI 10.1242/dev.060566; Williams JA, 2000, HEARING RES, V143, P171, DOI 10.1016/S0378-5955(00)00039-3	66	38	42	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47257	10.1371/journal.pone.0047257	http://dx.doi.org/10.1371/journal.pone.0047257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094043	Green Published, Green Submitted, gold			2022-12-25	WOS:000312384500008
J	Wang, Y; Lane, A; Ding, P				Wang, Yu; Lane, Amanda; Ding, Ping			Sex-Biased Dispersal of a Frog (Odorrana schmackeri) Is Affected by Patch Isolation and Resource Limitation in a Fragmented Landscape	PLOS ONE			English	Article							POPULATION-STRUCTURE; GENETIC-EVIDENCE; PHILOPATRY; SCALE; SALAMANDER; EVOLUTION; SOFTWARE; BIRDS; FLOW	Sex-biased dispersal is widespread in the animal kingdom and is affected by numerous factors including mating system, social factors and environmental conditions. Unlike birds and mammals, there is no common trend in amphibians and explaining the direction and degree of sex-biased dispersal in species-specific cases is difficult. We conducted a study on dispersal of the Chinese piebald odorous frog (Odorrana schmackeri) in a fragmented landscape associated with dam construction. Ten microsatellite loci were used to analyze 382 samples sourced from 14 fragmented 'islands'. Assignment tests indicated a significant pattern of female-biased dispersal on one island with inconsistencies in the strength and direction of this pattern between nearby islands. The effects of four island attributes and two potential impact factors on the pattern of sex-biased dispersal were examined. We found that the extent of isolation from the mainland and the number of breeding sites both showed a negative correlation with female biased dispersal, such that the closer an island is to the mainland the more likely it is to display female biased dispersal, and the more breeding sites on an island the more male immigrants. Based on these results, we conclude that geographic isolation and limited breeding resources are the most likely explanation for the patterns of dispersal observed in this fragmented population of amphibians.	[Wang, Yu; Ding, Ping] Zhejiang Univ, Coll Life Sci, Minist Educ, Key Lab Conservat Biol Endangered Wildlife, Hangzhou 310003, Zhejiang, Peoples R China; [Lane, Amanda] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	Zhejiang University; University of Sydney	Ding, P (corresponding author), Zhejiang Univ, Coll Life Sci, Minist Educ, Key Lab Conservat Biol Endangered Wildlife, Hangzhou 310003, Zhejiang, Peoples R China.	dingping@zju.edu.cn	Ding, Ping/H-1817-2015		National Natural Science Foundation of China [30870315, 31100394]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the National Natural Science Foundation of China (nos. 30870315, 31100394) and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antolin Michael F., 1993, Oxford Surveys in Evolutionary Biology, V9, P239; Austin JD, 2003, MOL ECOL, V12, P3165, DOI 10.1046/j.1365-294X.2003.01948.x; Beebee TJC, 2005, BIOL CONSERV, V125, P271, DOI 10.1016/j.biocon.2005.04.009; Benjamini Y, 2001, ANN STAT, V29, P1165; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cabe PR, 2007, HEREDITY, V98, P53, DOI 10.1038/sj.hdy.6800905; Cano JM, 2008, MOL ECOL, V17, P3234, DOI 10.1111/j.1365-294X.2008.03837.x; DIAMOND JM, 1972, P NATL ACAD SCI USA, V69, P3199, DOI 10.1073/pnas.69.11.3199; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Favre L, 1997, P ROY SOC B-BIOL SCI, V264, P127, DOI 10.1098/rspb.1997.0019; Fei L., 2009, FAUNA SINICA AMPHIBI, V3; Freeland J. R., 2011, MOL ECOLOGY; Funk WC, 2005, MOL ECOL, V14, P483, DOI 10.1111/j.1365-294X.2005.02426.x; Gauffre B, 2009, P R SOC B, V276, P3487, DOI 10.1098/rspb.2009.0881; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477; Handley LJL, 2007, MOL ECOL, V16, P1559, DOI 10.1111/j.1365-294X.2006.03152.x; HOWARD RD, 1983, AM NAT, V122, P301, DOI 10.1086/284137; Hu G, 2011, LANDSCAPE ECOL, V26, P1405, DOI 10.1007/s10980-011-9662-7; Knopp T, 2009, MOL ECOL, V18, P2996, DOI 10.1111/j.1365-294X.2009.04252.x; Lampert KP, 2003, MOL ECOL, V12, P3325, DOI 10.1046/j.1365-294X.2003.02016.x; Lane A, 2011, MOL ECOL, V20, P1870, DOI 10.1111/j.1365-294X.2011.05059.x; LAURANCE WF, 1991, BIOL CONSERV, V55, P77, DOI 10.1016/0006-3207(91)90006-U; Liebgold EB, 2011, MOL ECOL, V20, P249, DOI 10.1111/j.1365-294X.2010.04946.x; Macke E, 2011, SCIENCE, V334, P1127, DOI 10.1126/science.1212177; Marshall TC, 1998, MOL ECOL, V7, P639, DOI 10.1046/j.1365-294x.1998.00374.x; Monsen KJ, 2003, MOL ECOL, V12, P3275, DOI 10.1046/j.1365-294X.2003.02001.x; Mossman CA, 1999, MOL ECOL, V8, P1063, DOI 10.1046/j.1365-294x.1999.00652.x; Neter J., 1996, APPL LINEAR STAT MOD; Nichols J., 2001, DISPERSAL; Nicolaus M, 2012, J ANIM ECOL, V81, P827, DOI 10.1111/j.1365-2656.2012.01959.x; Palo JU, 2004, MOL ECOL, V13, P2865, DOI 10.1111/j.1365-294X.2004.02286.x; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Perrin N, 2000, AM NAT, V155, P116, DOI 10.1086/303296; PUSEY AE, 1987, TRENDS ECOL EVOL, V2, P295, DOI 10.1016/0169-5347(87)90081-4; R Development Core Team, 2012, R LANG ENV STAT COMP; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Sheridan CM, 2010, MOL ECOL, V19, P5497, DOI 10.1111/j.1365-294X.2010.04876.x; Smith MA, 2006, ECOGRAPHY, V29, P649, DOI 10.1111/j.2006.0906-7590.04584.x; Trenham PC, 2005, ECOL APPL, V15, P1158, DOI 10.1890/04-1150; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vieites DR, 2006, MOL ECOL, V15, P1617, DOI 10.1111/j.1365-294X.2006.02874.x; Wang Y, 2009, ANIM CONSERV, V12, P329, DOI 10.1111/j.1469-1795.2009.00257.x; Wang Y, 2009, J ZHEJIANG NORMAL U, V32, P322; Wang Y, 2011, J GENET, V90, pE44; WASER PM, 1986, AM NAT, V128, P529, DOI 10.1086/284585; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; Wu JG, 2003, SCIENCE, V300, P1239, DOI 10.1126/science.1083312	49	17	17	1	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47683	10.1371/journal.pone.0047683	http://dx.doi.org/10.1371/journal.pone.0047683			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094076	Green Submitted, Green Published, gold			2022-12-25	WOS:000312384500019
J	Zhang, MS; Jiao, YM; Wang, SX; Zhang, L; Huang, ZH; Chen, YX; Wu, H; Lu, S				Zhang, Mingshun; Jiao, Yanmei; Wang, Shixia; Zhang, Lu; Huang, Zuhu; Chen, Yuxin; Wu, Hao; Lu, Shan			Serum Neutralizing Activities from a Beijing Homosexual Male Cohort Infected with Different Subtypes of HIV-1 in China	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ENV MOLECULAR CLONES; RATIONAL DESIGN; ANTIBODIES; BROAD; CLADES; PANEL	Protective antibodies play a critical role in an effective HIV vaccine; however, eliciting antibodies to block infection by viruses from diverse genetic subtypes remains a major challenge. As the world's most populous country, China has been under the threat of at least three major subtypes of circulating HIV-1 viruses. Understanding the cross reactivity and specificities of serum antibody responses that mediate broad neutralization of the virus in HIV-1 infected Chinese patients will provide valuable information for the design of vaccines to prevent HIV-1 transmission in China. Sera from a cohort of homosexual men, who have been managed by a major HIV clinical center in Beijing, China, were analyzed for cross-sectional neutralizing activities against pseudotyped viruses expressing Env antigens of the major subtype viruses (AE, BC and B subtypes) circulating in China. Neutralizing activities in infected patients' blood were most capable of neutralizing viruses in the homologous subtype; however, a subset of blood samples was able to achieve broad neutralizing activities across different subtypes. Such cross neutralizing activity took 1-2 years to develop and CD4 binding site antibodies were critical components in these blood samples. Our study confirmed the presence of broadly neutralizing sera in China's HIV-1 patient population. Understanding the specificity and breadth of these neutralizing activities can guide efforts for the development of HIV vaccines against major HIV-1 viruses in China.	[Zhang, Mingshun; Zhang, Lu; Huang, Zuhu; Lu, Shan] Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Key Lab Infect Dis, Nanjing, Jiangsu, Peoples R China; [Zhang, Lu; Huang, Zuhu] Nanjing Med Univ, Affiliated Hosp 1, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China; [Zhang, Mingshun; Wang, Shixia; Zhang, Lu; Huang, Zuhu; Lu, Shan] Nanjing Med Univ, Affiliated Hosp 1, China US Vaccine Res Ctr, Nanjing, Jiangsu, Peoples R China; [Zhang, Mingshun] Nanjing Med Univ, Dept Microbiol & Immunol, Nanjing, Jiangsu, Peoples R China; [Jiao, Yanmei; Wu, Hao] Beijing Youan Hosp, Dept Infect Dis, Beijing, Peoples R China; [Wang, Shixia; Chen, Yuxin; Lu, Shan] Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Nanjing Medical University; Capital Medical University; University of Massachusetts System; University of Massachusetts Worcester	Lu, S (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Jiangsu Prov Key Lab Infect Dis, Nanjing, Jiangsu, Peoples R China.	shan.lu@umassmed.edu	Chen, Yuxin/AFR-3812-2022	Chen, Yuxin/0000-0001-5955-687X	China's National 11-5 Major Infectious Disease Program [2008ZX10001-006, 2008ZX10001-010]; Jiangsu Province Key Laboratory in Infectious Diseases; US NIH/NIAID [R01 AI65250, P01 AI AI082274, U19AI082676]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI082274] Funding Source: NIH RePORTER	China's National 11-5 Major Infectious Disease Program; Jiangsu Province Key Laboratory in Infectious Diseases; US NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by China's National 11-5 Major Infectious Disease Program (2008ZX10001-006 and 2008ZX10001-010), support from Jiangsu Province Key Laboratory in Infectious Diseases and US NIH/NIAID grants R01 AI65250, P01 AI AI082274, and U19AI082676. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Binley JA, 2004, J VIROL, V78, P13232, DOI 10.1128/JVI.78.23.13232-13252.2004; Binley JM, 2008, J VIROL, V82, P11651, DOI 10.1128/JVI.01762-08; Bures R, 2002, J VIROL, V76, P2233, DOI 10.1128/JVI.76.5.2233-2244.2002; Chong HH, 2008, JAIDS-J ACQ IMM DEF, V47, P535, DOI 10.1097/QAI.0b013e3181663967; Douek DC, 2006, CELL, V124, P677, DOI 10.1016/j.cell.2006.02.005; Gray RT, 2011, AIDS RES TREAT, V2011, DOI 10.1155/2011/891593; Han XX, 2010, JAIDS-J ACQ IMM DEF, V53, pS27, DOI 10.1097/QAI.0b013e3181c7d5bf; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Jiao YM, 2010, CURR HIV RES, V8, P515, DOI 10.2174/157016210793499169; Li YX, 2007, NAT MED, V13, P1032, DOI 10.1038/nm1624; Li YX, 2009, J VIROL, V83, P1045, DOI 10.1128/JVI.01992-08; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Mascola JR, 1996, AIDS RES HUM RETROV, V12, P1319, DOI 10.1089/aid.1996.12.1319; Ministry of Health of the People's Republic of China, 2010, CHIN 2010 UNGASS COU; MONTEFIORI DC, 2004, CURRENT PROTOCOLS IM, P1; Moore JP, 1996, J VIROL, V70, P427, DOI 10.1128/JVI.70.1.427-444.1996; Nie JH, 2010, JAIDS-J ACQ IMM DEF, V53, P440, DOI 10.1097/QAI.0b013e3181cb8300; Sather DN, 2009, J VIROL, V83, P757, DOI 10.1128/JVI.02036-08; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Vaine M, 2008, J VIROL; Vaine M, 2010, VACCINE, V28, P2999, DOI 10.1016/j.vaccine.2010.02.006; van Gils MJ, 2010, CURR HIV RES, V8, P579, DOI 10.2174/157016210794088254; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang ST, 2011, VIRUS RES, V155, P137, DOI 10.1016/j.virusres.2010.09.012; Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659; Xu JJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-287; Xu JJ, 2010, SEX TRANSM DIS, V37, P432, DOI 10.1097/OLQ.0b013e3181d13eed; Zhang Y, 2006, PLOS MED, V3, P2065, DOI 10.1371/journal.pmed.0030443	29	1	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47548	10.1371/journal.pone.0047548	http://dx.doi.org/10.1371/journal.pone.0047548			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094060	Green Published, gold			2022-12-25	WOS:000312384500014
J	Robu, ME; Zhang, Y; Rhodes, J				Robu, Mara E.; Zhang, Yong; Rhodes, Jennifer			Rereplication in emi1-Deficient Zebrafish Embryos Occurs through a Cdh1-Mediated Pathway	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; CELL-CYCLE PROGRESSION; DNA-REPLICATION; S-PHASE; PREVENTS REREPLICATION; MITOTIC PROGRESSION; TUMOR SUPPRESSION; EMI1; APC/C; CDC20	Disruption of early mitotic inhibitor 1 (Emi1) interferes with normal cell cycle progression and results in early embryonic lethality in vertebrates. During S and G2 phases the ubiquitin ligase complex APC/C is inhibited by Emi1 protein, thereby enabling the accumulation of Cyclins A and B so they can regulate replication and promote the transition from G2 phase to mitosis, respectively. Depletion of Emi1 prevents mitotic entry and causes rereplication and an increase in cell size. In this study, we show that the developmental and cell cycle defects caused by inactivation of zebrafish emi1 are due to inappropriate activation of APC/C through its cofactor Cdh1. Inhibiting/slowing progression into S-phase by depleting Cdt1, an essential replication licensing factor, partially rescued emi1 deficiency-induced rereplication and the increased cell size. The cell size effect was enhanced by co-depletion of cell survival regulator p53. These data suggest that the increased size of emi1-deficient cells is either directly or indirectly caused by the rereplication defects. Moreover, enforced expression of Cyclin A partially ablated the rereplicating population in emi1-deficient zebrafish embryos, consistent with the role of Cyclin A in origin licensing. Forced expression of Cyclin B partially restored the G1 population, in agreement with the established role of Cyclin B in mitotic progression and exit. However, expression of Cyclin B also partially inhibited rereplication in emi1-deficient embryos, suggesting a role for Cyclin B in regulating replication in this cellular context. As Cyclin A and B are substrates for APC/C-Cdh1 - mediated degradation, and Cdt1 is under control of Cyclin A, these data indicate that emi1 deficiency-induced defects in vivo are due to the dysregulation of an APC/C-Cdh1 molecular axis.	[Robu, Mara E.; Zhang, Yong; Rhodes, Jennifer] Temple Univ Hlth Syst, Immune Cell Dev & Host Def Program, Fox Chase Canc Ctr, Philadelphia, PA USA	Fox Chase Cancer Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Rhodes, J (corresponding author), Temple Univ Hlth Syst, Immune Cell Dev & Host Def Program, Fox Chase Canc Ctr, Philadelphia, PA USA.	jennifer.rhodes@fccc.edu			William J. Avery postdoctoral fellowship	William J. Avery postdoctoral fellowship	This work was supported in part by a William J. Avery postdoctoral fellowship to MER (http://www.fccc.edu/research/postdoc/fellowships/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajoghli B, 2004, DEV BIOL, V271, P416, DOI 10.1016/j.ydbio.2004.04.006; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Di Fiore B, 2007, J CELL BIOL, V177, P425, DOI 10.1083/jcb.200611166; Fang GW, 1998, MOL CELL, V2, P163, DOI 10.1016/S1097-2765(00)80126-4; Garcia-Higuera I, 2008, NAT CELL BIOL, V10, P802, DOI 10.1038/ncb1742; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Gong D, 2010, MOL BIOL CELL, V21, P3149, DOI 10.1091/mbc.E10-05-0393; Gottlieb TM, 1998, SEMIN CANCER BIOL, V8, P359, DOI 10.1006/scbi.1998.0098; Gregory TR, 2001, BIOL REV, V76, P65, DOI 10.1017/S1464793100005595; Grosskortenhaus R, 2002, DEV CELL, V2, P29, DOI 10.1016/S1534-5807(01)00104-6; Guardavaccaro D, 2003, DEV CELL, V4, P799, DOI 10.1016/S1534-5807(03)00154-0; Hansen DV, 2004, MOL BIOL CELL, V15, P5623, DOI 10.1091/mbc.E04-07-0598; HARTWELL LH, 1973, GENETICS, V74, P267; HOFMANN JFX, 1994, EMBO J, V13, P425, DOI 10.1002/j.1460-2075.1994.tb06277.x; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Jackson PK, 2004, TRENDS CELL BIOL, V14, P331, DOI 10.1016/j.tcb.2004.05.005; KANE DA, 1993, DEVELOPMENT, V119, P447; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lee H, 2006, MOL CELL BIOL, V26, P5373, DOI 10.1128/MCB.00043-06; Li M, 2007, MOL CELL BIOL, V27, P3481, DOI 10.1128/MCB.02088-06; Lin JJ, 2010, CANCER RES, V70, P10310, DOI 10.1158/0008-5472.CAN-10-2062; Liu E, 2007, J CELL BIOL, V179, P643, DOI 10.1083/jcb.200704138; Machida YJ, 2007, GENE DEV, V21, P184, DOI 10.1101/gad.1495007; Maiorano D, 2000, NATURE, V404, P622, DOI 10.1038/35007104; Margottin-Goguet F, 2003, DEV CELL, V4, P813, DOI 10.1016/S1534-5807(03)00153-9; Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006; Moshe Y, 2004, P NATL ACAD SCI USA, V101, P7937, DOI 10.1073/pnas.0402442101; Nishitani H, 2000, NATURE, V404, P625, DOI 10.1038/35007110; Nuckolls FJ, 1998, BIOCHEM BIOPH RES CO, V244, P280, DOI 10.1006/bbrc.1998.8205; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006; Pines J, 2011, PHILOS T R SOC B, V366, P3625, DOI 10.1098/rstb.2011.0080; Prokhorova TA, 2003, P NATL ACAD SCI USA, V100, P13241, DOI 10.1073/pnas.2336104100; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Reimann JDR, 2002, NATURE, V416, P850, DOI 10.1038/416850a; Rhodes J, 2009, MOL CELL BIOL, V29, P5911, DOI 10.1128/MCB.00558-09; Riley BB, 2010, DEV DYNAM, V239, P828, DOI 10.1002/dvdy.22227; Sansam CL, 2006, GENE DEV, V20, P3117, DOI 10.1101/gad.1482106; Schwab M, 1997, CELL, V90, P683, DOI 10.1016/S0092-8674(00)80529-2; SETHI N, 1991, MOL CELL BIOL, V11, P5592, DOI 10.1128/MCB.11.11.5592; Sidi S, 2008, CELL, V133, P864, DOI 10.1016/j.cell.2008.03.037; Sivaprasad U, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-8; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Soroldoni Daniele, 2009, V546, P117, DOI 10.1007/978-1-60327-977-2_8; van Leuken R, 2008, BBA-REV CANCER, V1786, P49, DOI 10.1016/j.bbcan.2008.05.002; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Verschuren EW, 2007, MOL CELL BIOL, V27, P7955, DOI 10.1128/MCB.00908-07; Visintin R, 1997, SCIENCE, V278, P460, DOI 10.1126/science.278.5337.460; Westerfield M., 2007, ZEBRAFISH BOOK GUIDE; Wuarin J, 2002, CELL, V111, P419, DOI 10.1016/S0092-8674(02)01042-5; Yam CH, 2002, CELL MOL LIFE SCI, V59, P1317, DOI 10.1007/s00018-002-8510-y; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zhang LX, 2008, DEVELOPMENT, V135, P2065, DOI 10.1242/dev.022673	53	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47658	10.1371/journal.pone.0047658	http://dx.doi.org/10.1371/journal.pone.0047658			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082190	gold, Green Published, Green Submitted			2022-12-25	WOS:000311146900087
J	Yamaoka, M; Maeda, N; Nakamura, S; Kashine, S; Nakagawa, Y; Hiuge-Shimizu, A; Okita, K; Imagawa, A; Matsuzawa, Y; Matsubara, K; Funahashi, T; Shimomura, I				Yamaoka, Masaya; Maeda, Norikazu; Nakamura, Seiji; Kashine, Susumu; Nakagawa, Yasuhiko; Hiuge-Shimizu, Aki; Okita, Kohei; Imagawa, Akihisa; Matsuzawa, Yuji; Matsubara, Ken-ichi; Funahashi, Tohru; Shimomura, Iichiro			A Pilot Investigation of Visceral Fat Adiposity and Gene Expression Profile in Peripheral Blood Cells	PLOS ONE			English	Article							METABOLIC SYNDROME; T-CELLS; CIRCADIAN-RHYTHMS; CLOCK GENES; OBESITY; ADIPOCYTOKINES; ACCUMULATION; INFLAMMATION; STRESS	Evidence suggests that visceral fat accumulation plays a central role in the development of metabolic syndrome. Excess visceral fat causes local chronic low-grade inflammation and dysregulation of adipocytokines, which contribute in the pathogenesis of the metabolic syndrome. These changes may affect the gene expression in peripheral blood cells. This study for the first time examined the association between visceral fat adiposity and gene expression profile in peripheral blood cells. The gene expression profile was analyzed in peripheral blood cells from 28 obese subjects by microarray analysis. Reverse transcription-polymerase chain reaction (RT-PCR) was performed using peripheral blood cells from 57 obese subjects. Obesity was defined as body mass index (BMI) greater than 25 kg/m(2) according to the Japanese criteria, and the estimated visceral fat area (eVFA) was measured by abdominal bioelectrical impedance. Analysis of gene expression profile was carried out with Agilent whole human genome 4644 K oligo-DNA microarray. The expression of several genes related to circadian rhythm, inflammation, and oxidative stress correlated significantly with visceral fat accumulation. Period homolog 1 (PER1) mRNA level in blood cells correlated negatively with visceral fat adiposity. Stepwise multiple regression analysis identified eVFA as a significant determinant of PER1 expression. In conclusion, visceral fat adiposity correlated with the expression of genes related to circadian rhythm and inflammation in peripheral blood cells.	[Yamaoka, Masaya; Maeda, Norikazu; Kashine, Susumu; Nakagawa, Yasuhiko; Hiuge-Shimizu, Aki; Okita, Kohei; Imagawa, Akihisa; Funahashi, Tohru; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka, Japan; [Nakamura, Seiji; Matsubara, Ken-ichi] DNA Chip Res Inc, Yokohama, Kanagawa, Japan; [Matsuzawa, Yuji] Sumitomo Hosp, Osaka, Japan	Osaka University; DNA Chip Research Inc.; Sumitomo Hospital	Maeda, N (corresponding author), Osaka Univ, Grad Sch Med, Dept Metab Med, Suita, Osaka, Japan.	norikazu_maeda@endmet.med.osaka-u.ac.jp			 [22590979];  [22126008]	; 	This work was supported in part by Grants-in-Aid for Scientific Research (C) no. 22590979 (to N.M.) and Scientific Research on Innovative Areas no. 22126008 (to T.F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando H, 2005, ENDOCRINOLOGY, V146, P5631, DOI 10.1210/en.2005-0771; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Dallmann R, 2010, CHRONOBIOL INT, V27, P1317, DOI 10.3109/07420528.2010.489166; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Fukuya H, 2007, BIOCHEM BIOPH RES CO, V354, P924, DOI 10.1016/j.bbrc.2007.01.063; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI20042162S, 10.1172/JCI21625]; Gimble JM, 2011, NAT REV ENDOCRINOL, V7, P98, DOI 10.1038/nrendo.2010.214; Haimovich B, 2010, CRIT CARE MED, V38, P751, DOI 10.1097/CCM.0b013e3181cd131c; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Kohsaka A, 2007, CELL METAB, V6, P414, DOI 10.1016/j.cmet.2007.09.006; Kullo IJ, 2002, AM J CARDIOL, V89, P1441, DOI 10.1016/S0002-9149(02)02366-4; Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380; Matsuzawa Y, 2002, CIRC J, V66, P987, DOI 10.1253/circj.66.987; Maury E, 2010, CIRC RES, V106, P447, DOI 10.1161/CIRCRESAHA.109.208355; Nakatsuji Hideaki, 2010, Diabetes Care, V33, pe110, DOI 10.2337/dc10-0739; Neels JG, 2006, J CLIN INVEST, V116, P33, DOI 10.1172/JCI27280; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Ryo M, 2005, DIABETES CARE, V28, P451, DOI 10.2337/diacare.28.2.451; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Winer DA, 2011, NAT MED, V17, P610, DOI 10.1038/nm.2353; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	25	30	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47377	10.1371/journal.pone.0047377	http://dx.doi.org/10.1371/journal.pone.0047377			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091619	gold, Green Submitted, Green Published			2022-12-25	WOS:000310135800042
J	Wu, QF; Hwang, CK; Zheng, H; Wagley, Y; Lin, HY; Kim, DK; Law, PY; Loh, HH; Wei, LN				Wu, Qifang; Hwang, Cheol Kyu; Zheng, Hui; Wagley, Yadav; Lin, Hong-Yiou; Kim, Do Kyung; Law, Ping-Yee; Loh, Horace H.; Wei, Li-Na			MicroRNA 339 down-regulates mu-opioid receptor at the post-transcriptional level in response to opioid treatment	FASEB JOURNAL			English	Article						fentanyl; morphine; promoter; UTR	ACTIVATED PROTEIN-KINASE; MESSENGER-RNA; UP-REGULATION; PROMOTER; GENE; TRANSCRIPTION; IDENTIFICATION; INVOLVEMENT; FENTANYL; EXPRESSION	mu-Opioid receptor (MOR) level is directly related to the function of opioid drugs, such as morphine and fentanyl. Although agonist treatment generally does not affect transcription of mor, previous studies suggest that morphine can affect the translation efficiency of MOR transcript via microRNAs (miRNAs). On the basis of miRNA microarray analyses of the hippocampal total RNA isolated from mice chronically treated with mu-opioid agonists, we found a miRNA (miR-339-3p) that was consistently and specifically increased by morphine (2-fold) and by fentanyl (3.8-fold). miR-339-3p bound to the MOR 3'-UTR and specifically suppressed reporter activity. Suppression was blunted by adding miR-339-3p inhibitor or mutating the miR-339-3p target site. In cells endogenously expressing MOR, miR-339-3p inhibited the production of MOR protein by destabilizing MOR mRNA. Up-regulation of miR-339-3p by fentanyl (EC50=0.75 nM) resulted from an increase in primary miRNA transcript. Mapping of the miR-339-3p primary RNA and its promoter revealed that the primary miR-339-3p was embedded in a noncoding 3'-UTR region of an unknown host gene and was coregulated by the host promoter. The identified promoter was activated by opioid agonist treatment (10 nM fentanyl or 10 mu M morphine), a specific effect blocked by the opioid antagonist naloxone (10 mu M). Taken together, these results suggest that miR-339-3p may serve as a negative feedback modulator of MOR signals by regulating intracellular MOR biosynthesis.-Wu, Q., Hwang, C. K., Zheng, H., Wagley, Y., Lin, H.-Y., Kim, D. K., Law, P.-Y., Loh, H. H., Wei, L.-N. MicroRNA 339 downregulates mu opioid receptor at the post-transcriptional level in response to opioid treatment. FASEB J. 27, 522-535 (2013). www.fasebj.org	[Wu, Qifang; Hwang, Cheol Kyu; Zheng, Hui; Wagley, Yadav; Lin, Hong-Yiou; Kim, Do Kyung; Law, Ping-Yee; Loh, Horace H.; Wei, Li-Na] Univ Minnesota, Dept Pharmacol, Sch Med, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Hwang, CK (corresponding author), Univ Minnesota, Dept Pharmacol, 6-120 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	hwang025@umn.edu		Zheng, Hui/0000-0001-6801-0529; Law, Ping-Yee/0000-0002-5364-1093	U.S. National Institutes of Health, National Institute of Drug Abuse [DA000564, DA001583, DA011806, DA011190, DA013926]; A&F Stark Fund of the Minnesota Medical Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA011190, R01DA000564, K02DA013926, P50DA011806, R01DA001583, R56DA000564, R37DA001583] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Drug Abuse; A&F Stark Fund of the Minnesota Medical Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank Dr. Tracy Kuhlman and Mr. Bradley J. Stish for editorial assistance with the manuscript. This work was supported by the U.S. National Institutes of Health, National Institute of Drug Abuse (grants DA000564, DA001583, DA011806, DA011190, and DA013926); and by the A&F Stark Fund of the Minnesota Medical Foundation. The authors declare no conflicts of interest.	Afify EA, 2002, MOL BRAIN RES, V106, P83, DOI 10.1016/S0169-328X(02)00414-X; Akan P, 2008, GENE, V410, P165, DOI 10.1016/j.gene.2007.12.011; Binyaminy B, 2008, LIFE SCI, V82, P831, DOI 10.1016/j.lfs.2008.01.015; BRODSKY M, 1995, NEUROREPORT, V6, P725, DOI 10.1097/00001756-199503270-00005; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; CHAKRABARTI S, 1995, MOL BRAIN RES, V30, P269, DOI 10.1016/0169-328X(95)00014-J; Chen HC, 1999, NEUROSCIENCE, V92, P1143, DOI 10.1016/S0306-4522(99)00030-5; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; DUTTAROY A, 1995, ANESTHESIOLOGY, V82, P1226, DOI 10.1097/00000542-199505000-00018; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; He Y, 2010, J NEUROSCI, V30, P10251, DOI 10.1523/JNEUROSCI.2419-10.2010; Huang HY, 2006, NUCLEIC ACIDS RES, V34, pW429, DOI 10.1093/nar/gkl333; Hwang CK, 2007, MOL CELL BIOL, V27, P4720, DOI 10.1128/MCB.00073-07; Hwang CK, 2011, NEUROMETHODS, V60, P49, DOI 10.1007/978-1-61779-179-6_4; Hwang CK, 2010, MOL PHARMACOL, V78, P58, DOI 10.1124/mol.110.064311; Hwang CK, 2009, J CELL MOL MED, V13, P3591, DOI 10.1111/j.1582-4934.2008.00535.x; Hwang CK, 2004, J BIOL CHEM, V279, P19764, DOI 10.1074/jbc.M400755200; Im HJ, 2001, MOL PHARMACOL, V59, P1486, DOI 10.1124/mol.59.6.1486; Jalali A, 2011, J NEUROSCI RES, V89, P299, DOI 10.1002/jnr.22562; Jeal W, 1997, DRUGS, V53, P109, DOI 10.2165/00003495-199753010-00011; Karaji AG, 2005, INT IMMUNOPHARMACOL, V5, P1019, DOI 10.1016/j.intimp.2005.01.012; Kelkar YD, 2010, GENOME BIOL EVOL, V2, P620, DOI 10.1093/gbe/evq046; Kim CS, 2008, BBA-MOL CELL RES, V1783, P1835, DOI 10.1016/j.bbamcr.2008.06.019; Kim DK, 2011, J NEUROCHEM, V116, P1077, DOI 10.1111/j.1471-4159.2010.07163.x; Koch T, 1997, J NEUROCHEM, V69, P1767; Kramer HK, 1999, J NEUROCHEM, V72, P594, DOI 10.1046/j.1471-4159.1999.0720594.x; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Law P.-Y., 2011, OPIATE RECEPTORS, V23; Law PY, 2004, NEUROPHARMACOLOGY, V47, P300, DOI 10.1016/j.neuropharm.2004.07.013; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; MANSOUR A, 1995, TRENDS NEUROSCI, V18, P22, DOI 10.1016/0166-2236(95)93946-U; Mayes S, 2006, ANN PHARMACOTHER, V40, P2178, DOI 10.1345/aph.1H135; MCBURNEY MW, 1988, J NEUROSCI, V8, P1063; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Monteys AM, 2010, RNA, V16, P495, DOI 10.1261/rna.1731910; Pan YX, 2001, P NATL ACAD SCI USA, V98, P14084, DOI 10.1073/pnas.241296098; Pan YX, 2002, GENE, V295, P97, DOI 10.1016/S0378-1119(02)00825-9; Pergolizzi Joseph, 2008, Pain Pract, V8, P287, DOI 10.1111/j.1533-2500.2008.00204.x; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; ROSS J, 1995, MICROBIOL REV, V59, P423, DOI 10.1128/MMBR.59.3.423-450.1995; Schmidt H, 2000, J NEUROCHEM, V74, P414, DOI 10.1046/j.1471-4159.2000.0740414.x; Solovyev VV, 2010, METHODS MOL BIOL, V674, P57, DOI 10.1007/978-1-60761-854-6_5; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; UNTERWALD EM, 1995, MOL BRAIN RES, V33, P351, DOI 10.1016/0169-328X(95)00143-G; van Rooij E, 2011, CIRC RES, V108, P219, DOI 10.1161/CIRCRESAHA.110.227496; Wagley Y, 2007, BIOCHEM BIOPH RES CO, V354, P985, DOI 10.1016/j.bbrc.2007.01.083; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Wei LN, 2011, ANNU REV PHARMACOL, V51, P75, DOI 10.1146/annurev-pharmtox-010510-100605; Wu H, 2010, BIOSTATISTICS, V11, P499, DOI 10.1093/biostatistics/kxq005; Wu QF, 2005, MOL PHARMACOL, V68, P279, DOI 10.1124/mol.105.012567; Wu QF, 2009, MOL PHARMACOL, V75, P744, DOI 10.1124/mol.108.053462; Wu QF, 2008, FASEB J, V22, P4085, DOI 10.1096/fj.08-108175; Xiong HP, 2009, BIOCHEM BIOPH RES CO, V378, P883, DOI 10.1016/j.bbrc.2008.12.010; Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803; Zheng H, 2010, J NEUROSCI, V30, P8102, DOI 10.1523/JNEUROSCI.6069-09.2010; Zheng H, 2010, MOL PHARMACOL, V77, P102, DOI 10.1124/mol.109.060848	61	54	60	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					522	535		10.1096/fj.12-213439	http://dx.doi.org/10.1096/fj.12-213439			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23085997	Green Published			2022-12-25	WOS:000314358000012
J	Destouches, D; Huet, E; Sader, M; Frechault, S; Carpentier, G; Ayoul, F; Briand, JP; Menashi, S; Courty, J				Destouches, Damien; Huet, Eric; Sader, Maha; Frechault, Sophie; Carpentier, Gilles; Ayoul, Florie; Briand, Jean-Paul; Menashi, Suzanne; Courty, Jose			Multivalent Pseudopeptides Targeting Cell Surface Nucleoproteins Inhibit Cancer Cell Invasion through Tissue Inhibitor of Metalloproteinases 3 (TIMP-3) Release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-GROWTH; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; MELANOMA-CELLS; BREAST-CANCER; EXPRESSION; PROTEIN; ANGIOGENESIS; NUCLEOLIN; NEUROBLASTOMA	Blockage of the metastasis process remains a significant clinical challenge, requiring innovative therapeutic approaches. For this purpose, molecules that inhibit matrix metalloproteinases activity or induce the expression of their natural inhibitor, the tissue inhibitor of metalloproteinases (TIMPs), are potentially interesting. In a previous study, we have shown that synthetic ligands binding to cell surface nucleolin/nucleophosmin and known as HB 19 for the lead compound and NucAnt 6L (N6L) for the most potent analog, inhibit both tumor growth and angiogenesis. Furthermore, they prevent metastasis in a RET transgenic mice model which develops melanoma. Here, we investigated the effect of N6L on the invasion capacity of MDA-MB-435 melanoma cells. Our results show that the multivalent pseudopeptide N6L inhibited Matrigel invasion of MDA-MB-435 cells in a modified Boyden chamber model. This was associated with an increase in TIMP-3 in the cell culture medium without a change in TIMP-3 mRNA expression suggesting its release from cell surface and/or extracellular matrix. This may be explained by our demonstrated N6L interaction with sulfated glycosaminoglycans and consequently the controlled bioavailability of glycosaminoglycan-bound TIMP-3. The implication of TIMP-3 in N6L-induced inhibition of cell invasion was evidenced by siRNA silencing experiments showing that the loss of TIMP-3 expression abrogated the effect of N6L. The inhibition of tumor cell invasion by N6L demonstrated in this study, in addition to its previously established inhibitory effect on tumor growth and angiogenesis, suggests that N6L represents a promising anticancer drug candidate warranting further investigation.	[Destouches, Damien; Huet, Eric; Sader, Maha; Frechault, Sophie; Carpentier, Gilles; Ayoul, Florie; Menashi, Suzanne; Courty, Jose] Univ Paris Est, Lab Rech Croissance Cellulaire Reparat & Regenera, CNRS, F-94010 Creteil, France; [Briand, Jean-Paul] CNRS, Inst Biol Mol & Cellulaire, Lab Immunol & Chim Therapeut, UPR 9021, F-67084 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Courty, J (corresponding author), Univ Paris Est, Lab Rech Croissance Cellulaire Reparat & Regenera, CNRS, 61 Ave Gen De Gaulle, F-94010 Creteil, France.	courty@u-pec.fr	Destouches, Damien/R-2430-2018; HUET, Eric/R-3178-2018; Courty, Jose/Q-3702-2018	Destouches, Damien/0000-0003-4959-2580; HUET, Eric/0000-0002-5541-5954; Carpentier, Gilles/0000-0002-3730-7263	Multifunctional Nanotechnology for Selective Detection and Treatment of Cancer (MULTIFUN) program	Multifunctional Nanotechnology for Selective Detection and Treatment of Cancer (MULTIFUN) program	This work has been funded in part by the Multifunctional Nanotechnology for Selective Detection and Treatment of Cancer (MULTIFUN) program.	Ahonen M, 2003, ONCOGENE, V22, P2121, DOI 10.1038/sj.onc.1206292; Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Ara T, 1998, J PEDIATR SURG, V33, P1272, DOI 10.1016/S0022-3468(98)90167-1; Bachman KE, 1999, CANCER RES, V59, P798; Bemis LT, 2000, CANCER RES, V60, P3414; Bian JH, 1996, CARCINOGENESIS, V17, P1805, DOI 10.1093/carcin/17.9.1805; Bourguignon LYW, 2008, SEMIN CANCER BIOL, V18, P251, DOI 10.1016/j.semcancer.2008.03.007; Brew K, 2000, BBA-PROTEIN STRUCT M, V1477, P267, DOI 10.1016/S0167-4838(99)00279-4; Deng XY, 2006, EUR J CANCER, V42, P3267, DOI 10.1016/j.ejca.2006.07.003; Destouches D, 2011, CANCER RES, V71, P3296, DOI 10.1158/0008-5472.CAN-10-3459; Destouches D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002518; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; El Khoury D, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-325; Fariss RN, 1997, AM J PATHOL, V150, P323; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hoe HS, 2007, J NEUROSCI, V27, P10895, DOI 10.1523/JNEUROSCI.3135-07.2007; Huet E, 2002, CLIN EXP METASTAS, V19, P107, DOI 10.1023/A:1014547324918; Joo EJ, 2005, GLYCOBIOLOGY, V15, P1, DOI 10.1093/glycob/cwh132; Kang KH, 2008, CARDIOVASC RES, V79, P150, DOI 10.1093/cvr/cvn072; Krust B, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-333; LECO KJ, 1994, J BIOL CHEM, V269, P9352; Loging WT, 1999, ONCOGENE, V18, P7608, DOI 10.1038/sj.onc.1203135; Ma DHK, 2003, J BIOMED SCI, V10, P526, DOI 10.1159/000072380; Mahller YY, 2008, CANCER RES, V68, P1170, DOI 10.1158/0008-5472.CAN-07-2734; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; PAVLOFF N, 1992, J BIOL CHEM, V267, P17321; Pennie WD, 1999, CELL GROWTH DIFFER, V10, P279; Plumb J, 2005, J NEUROIMMUNOL, V164, P1, DOI 10.1016/j.jneuroim.2005.02.021; Qi JH, 2003, NAT MED, V9, P407, DOI 10.1038/nm846; Rae JM, 2007, BREAST CANCER RES TR, V104, P13, DOI 10.1007/s10549-006-9392-8; Reichsman F, 1996, J CELL BIOL, V135, P819, DOI 10.1083/jcb.135.3.819; Ribatti D, 2001, LIFE SCI, V68, P1161, DOI 10.1016/S0024-3205(00)01030-4; Sahai E, 2007, NAT REV CANCER, V7, P737, DOI 10.1038/nrc2229; Sakakibara M, 1999, CANCER, V85, P231, DOI 10.1002/(SICI)1097-0142(19990101)85:1<231::AID-CNCR31>3.0.CO;2-3; Smith MR, 1997, CYTOKINE, V9, P770, DOI 10.1006/cyto.1997.0233; Soulie P, 2002, J IMMUNOASS IMMUNOCH, V23, P33, DOI 10.1081/IAS-120002273; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; Ueki T, 2000, CANCER RES, V60, P1835; Yu WH, 2000, J BIOL CHEM, V275, P31226, DOI 10.1074/jbc.M000907200	40	36	37	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43685	43693		10.1074/jbc.M112.380402	http://dx.doi.org/10.1074/jbc.M112.380402			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23109338	Green Published, hybrid			2022-12-25	WOS:000312940800048
J	Aragao, AZB; Nogueira, MLC; Granato, DC; Simabuco, FM; Honorato, RV; Hoffman, Z; Yokoo, S; Laurindo, FRM; Squina, FM; Zeri, ACM; Oliveira, PSL; Sherman, NE; Leme, AFP				Aragao, Annelize Z. B.; Nogueira, Maria Luiza C.; Granato, Daniela C.; Simabuco, Fernando M.; Honorato, Rodrigo V.; Hoffman, Zaira; Yokoo, Sami; Laurindo, Francisco R. M.; Squina, Fabio M.; Zeri, Ana Carolina M.; Oliveira, Paulo S. L.; Sherman, Nicholas E.; Paes Leme, Adriana F.			Identification of Novel Interaction between ADAM17 (a Disintegrin and Metalloprotease 17) and Thioredoxin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING-ENZYME; EPIDERMAL-GROWTH-FACTOR; PROTEIN-KINASE-C; TYROSINE KINASE; SHEDDING ACTIVITY; C2C12 CELLS; LIPID RAFTS; RECEPTOR; ACTIVATION; NMR	ADAM17, which is also known as TNF alpha-converting enzyme, is the major sheddase for the EGF receptor ligands and is considered to be one of the main proteases responsible for the ectodomain shedding of surface proteins. How a membrane-anchored proteinase with an extracellular catalytic domain can be activated by inside-out regulation is not completely understood. We characterized thioredoxin-1 (Trx-1) as a partner of the ADAM17 cytoplasmic domain that could be involved in the regulation of ADAM17 activity. We induced the overexpression of the ADAM17 cytoplasmic domain in HEK293 cells, and ligands able to bind this domain were identified by MS after protein immunoprecipitation. Trx-1 was also validated as a ligand of the ADAM17 cytoplasmic domain and full-length ADAM17 recombinant proteins by immunoblotting, immunolocalization, and solid phase binding assay. In addition, using nuclear magnetic resonance, it was shown in vitro that the titration of the ADAM17 cytoplasmic domain promotes changes in the conformation of Trx-1. The MS analysis of the cross-linked complexes showed cross-linking between the two proteins by lysine residues. To further evaluate the functional role of Trx-1, we used a heparin-binding EGF shedding cell model and observed that the overexpression of Trx-1 in HEK293 cells could decrease the activity of ADAM17, activated by either phorbol 12-myristate 13-acetate or EGF. This study identifies Trx-1 as a novel interaction partner of the ADAM17 cytoplasmic domain and suggests that Trx-1 is a potential candidate that could be involved in ADAM17 activity regulation.	[Aragao, Annelize Z. B.; Nogueira, Maria Luiza C.; Granato, Daniela C.; Simabuco, Fernando M.; Honorato, Rodrigo V.; Yokoo, Sami; Zeri, Ana Carolina M.; Oliveira, Paulo S. L.; Paes Leme, Adriana F.] CNPEM, Lab Espectrometria Massas, Lab Nacl Biociencias, LNBio, BR-13083970 Campinas, SP, Brazil; [Hoffman, Zaira; Squina, Fabio M.] CNPEM, Lab Nacl Ciencia & Tecnol Bioetanol, CTBE, BR-13083970 Campinas, SP, Brazil; [Laurindo, Francisco R. M.] Univ Sao Paulo, Inst Coracao, BR-05403000 Sao Paulo, Brazil; [Sherman, Nicholas E.] Univ Virginia, WM Keck Biomed Mass Spectrometry Lab, Charlottesville, VA 22908 USA	Universidade de Sao Paulo; University of Virginia	Leme, AFP (corresponding author), CNPEM, Lab Espectrometria Massas, Lab Nacl Biociencias, LNBio, BR-13083970 Campinas, SP, Brazil.	adriana.paesleme@lnbio.org.br	Oliveira, Paulo/D-5463-2011; Zeri, Ana/AAY-4799-2021; Honorato, Rodrigo/H-9773-2013; Oliveira, Paulo S/K-5588-2013; NOGUEIRA, MARIA LUIZA CALDAS/ABD-4713-2020; Aragão, Annelize Z B/I-6535-2012; Simabuco, Fernando M/GQA-4176-2022; Simabuco, Fernando M/G-8421-2017; Leme, Adriana F Paes/C-9679-2012; Squina, Fabio/J-8130-2012; Honorato, Rodrigo Vargas/AAY-9375-2020	Oliveira, Paulo/0000-0002-1287-8019; Zeri, Ana/0000-0003-4169-4523; Honorato, Rodrigo/0000-0001-5267-3002; NOGUEIRA, MARIA LUIZA CALDAS/0000-0003-2548-6564; Simabuco, Fernando M/0000-0002-1672-9686; Simabuco, Fernando M/0000-0002-1672-9686; Leme, Adriana F Paes/0000-0001-7959-147X; Squina, Fabio/0000-0002-8154-7459; Honorato, Rodrigo Vargas/0000-0001-5267-3002; Yokoo, Sami/0000-0003-4658-9319; Sherman, Nicholas/0000-0003-3206-3113	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2009/54067-3, 2009/18301-1, 2010/15675-5, 2010/19278-0, 2011/02267-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [470567/2009-0, 470549/2011-4]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grants 2009/54067-3, 2009/18301-1, 2010/15675-5, 2010/19278-0, and 2011/02267-9 and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico Grants 470567/2009-0 and 470549/2011-4.	Abram CL, 2003, J BIOL CHEM, V278, P16844, DOI 10.1074/jbc.M300267200; Bass Rosemary, 2010, Biochem J, V428, pe3, DOI 10.1042/BJ20100568; BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Butler Georgina S., 2009, V528, P159, DOI 10.1007/978-1-60327-310-7_12; Canault M, 2006, J CELL PHYSIOL, V208, P363, DOI 10.1002/jcp.20671; Cao Y, 2001, BIOCHEM J, V357, P353, DOI 10.1042/0264-6021:3570353; Chaudhury S, 2010, BIOINFORMATICS, V26, P689, DOI 10.1093/bioinformatics/btq007; Chen K, 2004, J BIOL CHEM, V279, P35079, DOI 10.1074/jbc.M404859200; CHEN XR, 1995, J BIOL CHEM, V270, P18285, DOI 10.1074/jbc.270.31.18285; Collet JF, 2010, ANTIOXID REDOX SIGN, V13, P1205, DOI 10.1089/ars.2010.3114; Dethlefsen SM, 1998, J CELL BIOCHEM, V69, P143, DOI 10.1002/(SICI)1097-4644(19980501)69:2<143::AID-JCB5>3.0.CO;2-S; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; Fan HZ, 1999, EMBO J, V18, P6962, DOI 10.1093/emboj/18.24.6962; Fan HZ, 2003, J BIOL CHEM, V278, P18617, DOI 10.1074/jbc.M300331200; Fischer OM, 2004, MOL CELL BIOL, V24, P5172, DOI 10.1128/MCB.24.12.5172-5183.2004; Gschwind A, 2003, EMBO J, V22, P2411, DOI 10.1093/emboj/cdg231; Hara T, 2007, ANTIOXID REDOX SIGN, V9, P1427, DOI 10.1089/ars.2007.1661; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kang Q, 2001, J BIOL CHEM, V276, P24466, DOI 10.1074/jbc.M101162200; Kang Q, 2000, BIOCHEM J, V352, P883, DOI 10.1042/0264-6021:3520883; Kim J, 2005, J CELL BIOCHEM, V94, P39, DOI 10.1002/jcb.20276; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Le Gall SM, 2010, J CELL SCI, V123, P3913, DOI 10.1242/jcs.069997; Li Monica X, 2002, Methods Mol Biol, V173, P255; Mori S, 2003, J BIOL CHEM, V278, P46029, DOI 10.1074/jbc.M306393200; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Myers TJ, 2009, MOL BIOL CELL, V20, P5236, DOI 10.1091/mbc.E08-12-1256; Nelson KK, 1999, BIOCHEM J, V343, P673, DOI 10.1042/0264-6021:3430673; Oliveira AK, 2010, THROMB HAEMOSTASIS, V104, P485, DOI 10.1160/TH09-12-0855; Pearson KM, 2002, RAPID COMMUN MASS SP, V16, P149, DOI 10.1002/rcm.554; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Sahin U, 2004, J CELL BIOL, V164, P769, DOI 10.1083/jcb.200307137; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schilling B, 2003, J AM SOC MASS SPECTR, V14, P834, DOI 10.1016/S1044-0305(03)00327-1; Scott AJ, 2011, J BIOL CHEM, V286, P35466, DOI 10.1074/jbc.M111.277434; Sundberg C, 2004, J BIOL CHEM, V279, P51601, DOI 10.1074/jbc.M403753200; Suzuki A, 2000, ONCOGENE, V19, P5842, DOI 10.1038/sj.onc.1203986; Tanaka M, 2004, J BIOL CHEM, V279, P41950, DOI 10.1074/jbc.M400086200; Tellier E, 2006, EXP CELL RES, V312, P3969, DOI 10.1016/j.yexcr.2006.08.027; Thorp E, 2011, J BIOL CHEM, V286, P33335, DOI 10.1074/jbc.M111.263020; Wang Y, 2009, J IMMUNOL, V182, P2449, DOI 10.4049/jimmunol.0802770; Watanabe R, 2010, PHARMACOL THERAPEUT, V127, P261, DOI 10.1016/j.pharmthera.2010.04.004; Willems SH, 2010, BIOCHEM J, V428, P439, DOI 10.1042/BJ20100179; Xu H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-133; Xu PL, 2010, MOL CELL, V37, P551, DOI 10.1016/j.molcel.2010.01.034; Zhang Q, 2006, P NATL ACAD SCI USA, V103, P6901, DOI 10.1073/pnas.0509719103; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264; Zhang ZL, 2001, FASEB J, V15, P303; Zheng YF, 2002, J BIOL CHEM, V277, P42463, DOI 10.1074/jbc.M207459200; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b	50	30	30	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43071	43082		10.1074/jbc.M112.364513	http://dx.doi.org/10.1074/jbc.M112.364513			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105116	Green Published, hybrid			2022-12-25	WOS:000312501600063
J	Clapp, KM; Peng, HM; Jenkins, GJ; Ford, MJ; Morishima, Y; Lau, M; Osawa, Y				Clapp, Kelly M.; Peng, Hwei-Ming; Jenkins, Gary J.; Ford, Michael J.; Morishima, Yoshihiro; Lau, Miranda; Osawa, Yoichi			Ubiquitination of Neuronal Nitric-oxide Synthase in the Calmodulin-binding Site Triggers Proteasomal Degradation of the Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; IN-VITRO; PROTEOLYTIC DEGRADATION; CHAPERONE MACHINERY; MASS-SPECTROMETRY; STATISTICAL-MODEL; ELECTRON-TRANSFER; TRIAGE DECISIONS; CHIP; SYSTEM	Nitric-oxide synthase, a cytochrome P450-like hemoprotein enzyme, catalyzes the synthesis of nitric oxide, a critical signaling molecule in a variety of physiological processes. Our laboratory has discovered that certain drugs suicide-inactivate neuronal nitric-oxide synthase (nNOS) and lead to the preferential ubiquitination of the inactivated nNOS by an Hsp70- and CHIP (C terminus of Hsc70-interacting protein)-dependent process. To further understand the process by which altered nNOS is recognized, ubiquitinated, and proteasomally degraded, we examined the sites of ubiquitination on nNOS. We utilized an in vitro ubiquitination system containing purified E1, E2 (UbcH5a), Hsp70, and CHIP that recapitulates the ability of the cells to selectively recognize and ubiquitinate the altered forms of nNOS. LC-MS/MS analysis of the tryptic peptides obtained from the in vitro ubiquitinated nNOS identified 12 ubiquitination sites. Nine of the sites were within the oxygenase domain and two were in the calmodulin-binding site, which links the oxygenase and reductase domains, and one site was in the reductase domain. Mutational analysis of the lysines in the calmodulin-binding site revealed that Lys-739 is a major site for poly-ubiquitination of nNOS in vitro and regulates, in large part, the CHIP-dependent degradation of nNOS in HEK293 cells, as well as in in vitro studies with fraction II. Elucidating the exact site of ubiquitination is an important step in understanding how chaperones recognize and trigger degradation of nNOS.	[Clapp, Kelly M.; Peng, Hwei-Ming; Jenkins, Gary J.; Morishima, Yoshihiro; Lau, Miranda; Osawa, Yoichi] Univ Michigan, Dept Pharmacol, Sch Med, Ann Arbor, MI 48109 USA; [Ford, Michael J.] MS Bioworks, Ann Arbor, MI 48108 USA	University of Michigan System; University of Michigan	Osawa, Y (corresponding author), Univ Michigan, Dept Pharmacol, Sch Med, 1301 Med Sci Res Bldg 3, Ann Arbor, MI 48109 USA.	osawa@umich.edu			National Institutes of Health [GM077430]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077430] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM077430.	Ausubel F. M., 1993, CURRENT PROTOCOLS MO, P911; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Banerjee A, 2000, DRUG METAB DISPOS, V28, P118; Bender AT, 2000, J BIOL CHEM, V275, P17407, DOI 10.1074/jbc.M000155200; Bender AT, 1999, J BIOL CHEM, V274, P1472, DOI 10.1074/jbc.274.3.1472; Clapp KM, 2010, J BIOL CHEM, V285, P33642, DOI 10.1074/jbc.M110.159178; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dittmar KD, 1996, J BIOL CHEM, V271, P12833, DOI 10.1074/jbc.271.22.12833; Dunbar AY, 2006, DRUG METAB DISPOS, V34, P1448, DOI 10.1124/dmd.106.009951; Dunbar AY, 2004, MOL PHARMACOL, V66, P964, DOI 10.1124/mol.104.000125; Garcin ED, 2004, J BIOL CHEM, V279, P37918, DOI 10.1074/jbc.M406204200; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jiang JH, 2003, J BIOL CHEM, V278, P49332, DOI 10.1074/jbc.M304738200; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kolodziejski PJ, 2002, P NATL ACAD SCI USA, V99, P12315, DOI 10.1073/pnas.192345199; Korsmeyer KK, 1999, ARCH BIOCHEM BIOPHYS, V365, P31, DOI 10.1006/abbi.1999.1138; Kuang ZH, 2010, J CELL BIOL, V190, P129, DOI 10.1083/jcb.200912087; Li RF, 2007, J MOL BIOL, V374, P777, DOI 10.1016/j.jmb.2007.09.082; MARLETTA MA, 1994, CELL, V78, P927, DOI 10.1016/0092-8674(94)90268-2; Matter H, 2005, J MED CHEM, V48, P4783, DOI 10.1021/jm050007x; Morishima Y, 2005, BIOCHEMISTRY-US, V44, P16333, DOI 10.1021/bi0515570; Morishima Y, 2008, HUM MOL GENET, V17, P3942, DOI 10.1093/hmg/ddn296; Nakatsuka M, 1998, DRUG METAB DISPOS, V26, P497; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Osawa Y, 2003, J PHARMACOL EXP THER, V304, P493, DOI 10.1124/jpet.102.035055; Peng HM, 2004, J BIOL CHEM, V279, P52970, DOI 10.1074/jbc.M406926200; Peng HM, 2012, J BIOL CHEM, V287, P1556, DOI 10.1074/jbc.M111.323295; Peng HM, 2009, BIOCHEMISTRY-US, V48, P8483, DOI 10.1021/bi901058g; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Pratt WB, 2008, J BIOL CHEM, V283, P22885, DOI 10.1074/jbc.R800023200; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; Song Y, 2001, BIOCHEM J, V355, P357, DOI 10.1042/0264-6021:3550357; Stuehr DJ, 2009, FEBS J, V276, P3959, DOI 10.1111/j.1742-4658.2009.07120.x; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Wang DX, 2005, J PROTEOME RES, V4, P1554, DOI 10.1021/pr050104e; Wang Y., 2012, MOL CELL PROTEOMICS, V11, P1; Wang YQ, 2011, J BIOL CHEM, V286, P9443, DOI 10.1074/jbc.M110.176685; You JX, 2001, J BIOL CHEM, V276, P19871, DOI 10.1074/jbc.M100034200	39	10	10	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42601	42610		10.1074/jbc.M112.412494	http://dx.doi.org/10.1074/jbc.M112.412494			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23109339	hybrid, Green Published			2022-12-25	WOS:000312501600021
J	Peng, GQ; Xu, LQ; Lin, YL; Chen, L; Pasquarella, JR; Holmes, KV; Li, F				Peng, Guiqing; Xu, Liqing; Lin, Yi-Lun; Chen, Lang; Pasquarella, Joseph R.; Holmes, Kathryn V.; Li, Fang			Crystal Structure of Bovine Coronavirus Spike Protein Lectin Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE HEPATITIS-VIRUS; RESPIRATORY SYNDROME CORONAVIRUS; CARCINOEMBRYONIC ANTIGEN FAMILY; SIALIC-ACID; AMINOPEPTIDASE-N; BINDING DOMAIN; HEMAGGLUTININ-ESTERASE; SARS CORONAVIRUS; S-PROTEIN; RECEPTOR	The spike protein N-terminal domains (NTDs) of bovine coronavirus (BCoV) and mouse hepatitis coronavirus (MHV) recognize sugar and protein receptors, respectively, despite their significant sequence homology. We recently determined the crystal structure of MHV NTD complexed with its protein receptor murine carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1), which surprisingly revealed a human galectin (galactose-binding lectin) fold in MHV NTD. Here, we have determined at 1.55 angstrom resolution the crystal structure of BCoV NTD, which also has the human galectin fold. Using mutagenesis, we have located the sugar-binding site in BCoV NTD, which overlaps with the galactose-binding site in human galectins. Using a glycan array screen, we have identified 5-N-acetyl-9-O-acetylneuraminic acid as the preferred sugar substrate for BCoV NTD. Subtle structural differences between BCoV and MHV NTDs, primarily involving different conformations of receptor-binding loops, explain why BCoV NTD does not bind CEACAM1 and why MHV NTD does not bind sugar. These results suggest a successful viral evolution strategy in which coronaviruses stole a galectin from hosts, incorporated it into their spike protein, and evolved it into viral receptor-binding domains with altered sugar specificity in contemporary BCoV or novel protein specificity in contemporary MHV.	[Peng, Guiqing; Xu, Liqing; Lin, Yi-Lun; Chen, Lang; Pasquarella, Joseph R.; Li, Fang] Univ Minnesota, Sch Med, Dept Pharmacol, Minneapolis, MN 55455 USA; [Holmes, Kathryn V.] Univ Colorado, Sch Med, Dept Microbiol, Aurora, CO 80045 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Colorado System; University of Colorado Anschutz Medical Campus	Li, F (corresponding author), Univ Minnesota, Sch Med, Dept Pharmacol, 6-120 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	lifang@umn.edu			National Institutes of Health [R01AI089728]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant R01AI089728 (to F. L.).	Beauchemin N, 1999, EXP CELL RES, V252, P243; CAVANAGH D, 1986, J GEN VIROL, V67, P1443, DOI 10.1099/0022-1317-67-7-1443; Chen L, 2012, P NATL ACAD SCI USA, V109, P17966, DOI 10.1073/pnas.1210123109; COMPTON SR, 1992, J VIROL, V66, P7420, DOI 10.1128/JVI.66.12.7420-7428.1992; DELMAS B, 1993, ADV EXP MED BIOL, V342, P293; DELMAS B, 1992, NATURE, V357, P417, DOI 10.1038/357417a0; Dormitzer PR, 2002, EMBO J, V21, P885, DOI 10.1093/emboj/21.5.885; DVEKSLER GS, 1991, J VIROL, V65, P6881, DOI 10.1128/JVI.65.12.6881-6891.1991; Haselhorst T, 2007, GLYCOBIOLOGY, V17, P68, DOI 10.1093/glycob/cwl051; Hofmann H, 2006, J VIROL, V80, P8639, DOI 10.1128/JVI.00560-06; Kammerer R, 2004, GENE, V339, P99, DOI 10.1016/j.gene.2004.06.023; Krempl C, 1997, J VIROL, V71, P3285, DOI 10.1128/JVI.71.4.3285-3287.1997; KUNKEL F, 1993, VIROLOGY, V195, P195, DOI 10.1006/viro.1993.1360; Langereis MA, 2010, J VIROL, V84, P8970, DOI 10.1128/JVI.00566-10; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li F, 2006, J VIROL, V80, P6794, DOI 10.1128/JVI.02744-05; Li F, 2012, J VIROL, V86, P2856, DOI 10.1128/JVI.06882-11; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li WH, 2006, J VIROL, V80, P4211, DOI 10.1128/JVI.80.9.4211-4219.2006; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohtsuka N, 1996, J GEN VIROL, V77, P1683, DOI 10.1099/0022-1317-77-8-1683; Peng GQ, 2011, P NATL ACAD SCI USA, V108, P10696, DOI 10.1073/pnas.1104306108; Reguera J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002859; SCHULTZE B, 1992, VIROLOGY, V189, P792, DOI 10.1016/0042-6822(92)90608-R; SCHULTZE B, 1991, J VIROL, V65, P6232, DOI 10.1128/JVI.65.11.6232-6237.1991; Vijgen L, 2005, J VIROL, V79, P1595, DOI 10.1128/JVI.79.3.1595-1604.2005; Vijgen L, 2006, J VIROL, V80, P7270, DOI 10.1128/JVI.02675-05; Wessner DR, 1998, J VIROL, V72, P1941, DOI 10.1128/JVI.72.3.1941-1948.1998; WILLIAMS RK, 1991, P NATL ACAD SCI USA, V88, P5533, DOI 10.1073/pnas.88.13.5533; Wu KL, 2009, P NATL ACAD SCI USA, V106, P19970, DOI 10.1073/pnas.0908837106; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0; YEATES TO, 1988, ACTA CRYSTALLOGR A, V44, P142, DOI 10.1107/S0108767387009632; YOKOMORI K, 1991, VIROLOGY, V183, P647, DOI 10.1016/0042-6822(91)90994-M; Zeng QH, 2008, P NATL ACAD SCI USA, V105, P9065, DOI 10.1073/pnas.0800502105; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	36	103	110	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41931	41938		10.1074/jbc.M112.418210	http://dx.doi.org/10.1074/jbc.M112.418210			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23091051	Green Published, hybrid			2022-12-25	WOS:000312103000033
J	Sala, CD; Soler-Bistue, AJC; Korprapun, L; Zorreguieta, A; Tolmasky, ME				Davies Sala, Carol; Soler-Bistue, Alfonso J. C.; Korprapun, Leeann; Zorreguieta, Angeles; Tolmasky, Marcelo E.			Inhibition of Cell Division Induced by External Guide Sequences (EGS Technology) Targeting ftsZ	PLOS ONE			English	Article							ESCHERICHIA-COLI; MESSENGER-RNA; BACTERIAL CYTOKINESIS; PENETRATING PEPTIDE; AMIKACIN RESISTANCE; IN-VITRO; EXPRESSION; GROWTH; GENES; TRANSCRIPTION	EGS (external guide sequence) technology is a promising approach to designing new antibiotics. EGSs are short antisense oligoribonucleotides that induce RNase P-mediated cleavage of a target RNA by forming a precursor tRNA-like complex. The ftsZ mRNA secondary structure was modeled and EGSs complementary to two regions with high probability of being suitable targets were designed. In vitro reactions showed that EGSs targeting these regions bound ftsZ mRNA and elicited RNase P-mediated cleavage of ftsZ mRNA. A recombinant plasmid, pEGSb1, coding for an EGS that targets region "b" under the control of the T7 promoter was generated. Upon introduction of this plasmid into Escherichia coli BL21(DE3)(pLysS) the transformant strain formed filaments when expression of the EGS was induced. Concomitantly, E. coli harboring pEGSb1 showed a modest but significant inhibition of growth when synthesis of the EGSb1 was induced. Our results indicate that EGS technology could be a viable strategy to generate new antimicrobials targeting ftsZ.	[Davies Sala, Carol; Soler-Bistue, Alfonso J. C.; Korprapun, Leeann; Zorreguieta, Angeles] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Consejo Nacl Invest Cientificas & Tecnicas, Inst Invest Bioquim Buenos Aires,Fdn Inst Leloir, Buenos Aires, DF, Argentina; [Soler-Bistue, Alfonso J. C.; Korprapun, Leeann; Tolmasky, Marcelo E.] Calif State Univ Fullerton, Dept Biol Sci, Coll Nat Sci & Math, Ctr Appl Biotechnol Studies, Fullerton, CA 92634 USA	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Buenos Aires; California State University System; California State University Fullerton	Zorreguieta, A (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Consejo Nacl Invest Cientificas & Tecnicas, Inst Invest Bioquim Buenos Aires,Fdn Inst Leloir, Buenos Aires, DF, Argentina.	azorreguieta@leloir.org.ar; mtolmasky@fullerton.edu	Tolmasky, Marcelo/AAC-5316-2020; Soler-Bistué, Alfonso/AAV-3123-2021	Tolmasky, Marcelo/0000-0002-6298-7811; Soler-Bistué, Alfonso/0000-0002-3917-0002	National Institutes of Health [2R15AI047115]; X-240 Universidad de Buenos Aires; CONICET; National Institute on Minority Health and Health Disparities, National Institutes of Health [MHIRT 2T37MD001368]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI047115] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [T37MD001368] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); X-240 Universidad de Buenos Aires(University of Buenos Aires); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); National Institute on Minority Health and Health Disparities, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by a Public Health Service grant 2R15AI047115 (to M. E. T.) from the National Institutes of Health and X-240 Universidad de Buenos Aires (to A.Z.). A.Z. is a career member of Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET). C. D. S. and A.J.C.S.B. were supported by fellowships from CONICET. L. K. was supported by grant MHIRT 2T37MD001368 from the National Institute on Minority Health and Health Disparities, National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman S, 2011, PHILOS T R SOC B, V366, P2936, DOI 10.1098/rstb.2011.0142; Anko M, 2012, BBA-BIOMEMBRANES, V1818, P915, DOI 10.1016/j.bbamem.2011.12.028; Ayala JA., 1994, NEW COMPR BIOCH, V27, P73, DOI [10.1016/S0167-7306(08)60408-1, DOI 10.1016/S0167-7306(08)60408-1]; Benders GA, 2005, J BACTERIOL, V187, P4542, DOI 10.1128/JB.187.13.4542-4551.2005; Bistue AJCS, 2007, ANTIMICROB AGENTS CH, V51, P1918, DOI 10.1128/AAC.01500-06; Boberek JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013745; Cam K, 1996, NUCLEIC ACIDS RES, V24, P3065, DOI 10.1093/nar/24.15.3065; Corbin BD, 2007, J BACTERIOL, V189, P3026, DOI 10.1128/JB.01581-06; Czaplewski LG, 2009, BIOORG MED CHEM LETT, V19, P524, DOI 10.1016/j.bmcl.2008.11.021; de Boer PAJ, 2010, CURR OPIN MICROBIOL, V13, P730, DOI 10.1016/j.mib.2010.09.015; de la Fuente A, 2001, BIOCHIMIE, V83, P109, DOI 10.1016/S0300-9084(00)01212-8; Erickson HP, 2010, MICROBIOL MOL BIOL R, V74, P504, DOI 10.1128/MMBR.00021-10; Eriksson M, 2002, J BIOL CHEM, V277, P7144, DOI 10.1074/jbc.M106624200; Flardh K, 1997, MOL MICROBIOL, V24, P927, DOI 10.1046/j.1365-2958.1997.4001762.x; Gilbert DN, 2010, CLIN INFECT DIS, V50, P1081, DOI 10.1086/652237; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; Goh S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006061; GOLDBLUM K, 1981, J BACTERIOL, V146, P128, DOI 10.1128/JB.146.1.128-132.1981; Goley ED, 2011, MOL MICROBIOL, V80, P1680, DOI 10.1111/j.1365-2958.2011.07677.x; Gopalan V, 2002, J BIOL CHEM, V277, P6759, DOI 10.1074/jbc.R100067200; GUERRIERTAKADA C, 1995, P NATL ACAD SCI USA, V92, P11115, DOI 10.1073/pnas.92.24.11115; GuerrierTakada C, 1997, P NATL ACAD SCI USA, V94, P8468, DOI 10.1073/pnas.94.16.8468; Hassane FS, 2010, CELL MOL LIFE SCI, V67, P715, DOI 10.1007/s00018-009-0186-0; Haydon DJ, 2008, SCIENCE, V321, P1673, DOI 10.1126/science.1159961; Haydon DJ, 2010, J MED CHEM, V53, P3927, DOI 10.1021/jm9016366; Holm T, 2011, METHODS MOL BIOL, V683, P207, DOI 10.1007/978-1-60761-919-2_15; Huang Q, 2007, CURR TOP MED CHEM, V7, P527, DOI 10.2174/156802607780059790; Jaiswal R, 2007, BIOCHEMISTRY-US, V46, P4211, DOI 10.1021/bi602573e; Ko JH, 2008, RNA, V14, P1656, DOI 10.1261/rna.1120508; Lehto T, 2010, J CONTROL RELEASE, V141, P42, DOI 10.1016/j.jconrel.2009.08.028; LI Y, 1992, P NATL ACAD SCI USA, V89, P3185, DOI 10.1073/pnas.89.8.3185; Lundblad EW, 2010, NEW BIOTECHNOL, V27, P212, DOI 10.1016/j.nbt.2010.03.003; Mae M, 2009, J CONTROL RELEASE, V134, P221, DOI 10.1016/j.jconrel.2008.11.025; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; McKinney J, 2001, P NATL ACAD SCI USA, V98, P6605, DOI 10.1073/pnas.121180398; McKinney JS, 2004, NUCLEIC ACIDS RES, V32, P848, DOI 10.1093/nar/gkh219; Mellbye BL, 2010, J ANTIMICROB CHEMOTH, V65, P98, DOI 10.1093/jac/dkp392; Meng JR, 2009, ANTIMICROB AGENTS CH, V53, P2871, DOI 10.1128/AAC.01542-08; Mingorance J, 2010, TRENDS MICROBIOL, V18, P348, DOI 10.1016/j.tim.2010.06.001; Rice LB, 2010, INFECT CONT HOSP EP, V31, pS7, DOI 10.1086/655995; Sambrook J, 2001, MOL CLONING LAB MANU; Sarno R, 2003, ANTIMICROB AGENTS CH, V47, P3296, DOI 10.1128/AAC.47.10.3296-3304.2003; Sass P, 2011, P NATL ACAD SCI USA, V108, P17474, DOI 10.1073/pnas.1110385108; Schaffner-Barbero C, 2012, ACS CHEM BIOL, V7, P268, DOI 10.1021/cb2003626; Selinger DW, 2003, GENOME RES, V13, P216, DOI 10.1101/gr.912603; Shen N, 2009, P NATL ACAD SCI USA, V106, P8163, DOI 10.1073/pnas.0903491106; Bistue AJCS, 2009, P NATL ACAD SCI USA, V106, P13230, DOI 10.1073/pnas.0906529106; Stein CA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp841; STUDIER FW, 1990, METHOD ENZYMOL, V185, P60; Takara K, 2010, INT J PHARMACEUT, V396, P143, DOI 10.1016/j.ijpharm.2010.05.002; Tamura M, 2006, J BACTERIOL, V188, P5145, DOI 10.1128/JB.00367-06; Torres Adrian G, 2011, Artif DNA PNA XNA, V2, P71; Traglia G, 2012, BIORESEARCH IN PRESS; Vicente M, 2006, J BACTERIOL, V188, P19, DOI 10.1128/JB.188.1.19-27.2006; Vicente M, 2006, MOL MICROBIOL, V61, P5, DOI 10.1111/j.1365-2958.2006.05233.x; Vivancos AP, 2010, GENOME RES, V20, P989, DOI 10.1101/gr.094318.109; Wang J, 2003, J BIOL CHEM, V278, P44424, DOI 10.1074/jbc.M307625200; Xiaos GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003719; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595; Zuker M, 1999, NATO ASI 3 HIGH TECH, V70, P11	60	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47690	10.1371/journal.pone.0047690	http://dx.doi.org/10.1371/journal.pone.0047690			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110089	Green Published, gold, Green Submitted			2022-12-25	WOS:000310193600021
J	Greve, B; Bolling, T; Amler, S; Rossler, U; Gomolka, M; Mayer, C; Popanda, O; Dreffke, K; Rickinger, A; Fritz, E; Eckardt-Schupp, F; Sauerland, C; Braselmann, H; Sauter, W; Illig, T; Riesenbeck, D; Konemann, S; Willich, N; Mortl, S; Eich, HT; Schmezer, P				Greve, Burkhard; Boelling, Tobias; Amler, Susanne; Roessler, Ute; Gomolka, Maria; Mayer, Claudia; Popanda, Odilia; Dreffke, Kristin; Rickinger, Astrid; Fritz, Eberhard; Eckardt-Schupp, Friederike; Sauerland, Christina; Braselmann, Herbert; Sauter, Wiebke; Illig, Thomas; Riesenbeck, Dorothea; Koenemann, Stefan; Willich, Normann; Moertl, Simone; Eich, Hans Theodor; Schmezer, Peter			Evaluation of Different Biomarkers to Predict Individual Radiosensitivity in an Inter-Laboratory Comparison-Lessons for Future Studies	PLOS ONE			English	Article							BREAST-CANCER PATIENTS; INDUCED DNA-DAMAGE; NORMAL TISSUE COMPLICATIONS; LYMPHOBLASTOID CELL-LINES; ALKALINE COMET ASSAY; DOUBLE-STRAND BREAKS; H2AX PHOSPHORYLATION; GEL-ELECTROPHORESIS; B-CELLS; RADIATION SENSITIVITY	Radiotherapy is a powerful cure for several types of solid tumours, but its application is often limited because of severe side effects in individual patients. With the aim to find biomarkers capable of predicting normal tissue side reactions we analysed the radiation responses of cells from individual head and neck tumour and breast cancer patients of different clinical radiosensitivity in a multicentric study. Multiple parameters of cellular radiosensitivity were analysed in coded samples of peripheral blood lymphocytes (PBLs) and derived lymphoblastoid cell lines (LCLs) from 15 clinical radio-hypersensitive tumour patients and compared to age-and sex-matched non-radiosensitive patient controls and 15 lymphoblastoid cell lines from age-and sex-matched healthy controls of the KORA study. Experimental parameters included ionizing radiation (IR)-induced cell death (AnnexinV), induction and repair of DNA strand breaks (Comet assay), induction of yH2AX foci (as a result of DNA double strand breaks), and whole genome expression analyses. Considerable inter-individual differences in IR-induced DNA strand breaks and their repair and/or cell death could be detected in primary and immortalised cells with the applied assays. The group of clinically radiosensitive patients was not unequivocally distinguishable from normal responding patients nor were individual overreacting patients in the test system unambiguously identified by two different laboratories. Thus, the in vitro test systems investigated here seem not to be appropriate for a general prediction of clinical reactions during or after radiotherapy due to the experimental variability compared to the small effect of radiation sensitivity. Genome-wide expression analysis however revealed a set of 67 marker genes which were differentially induced 6 h after in vitro-irradiation in lymphocytes from radio-hypersensitive and non-radiosensitive patients. These results warrant future validation in larger cohorts in order to determine parameters potentially predictive for clinical radiosensitivity.	[Greve, Burkhard; Boelling, Tobias; Riesenbeck, Dorothea; Koenemann, Stefan; Willich, Normann; Eich, Hans Theodor] Univ Hosp Muenster, Dept Radiotherapy, Munster, Germany; [Dreffke, Kristin; Fritz, Eberhard] FLI, Leibniz Inst Age Res, Jena, Germany; [Rickinger, Astrid; Eckardt-Schupp, Friederike; Moertl, Simone] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Radiat Biol, Neuherberg, Germany; [Roessler, Ute; Sauerland, Christina] Univ Hosp Muenster, Inst Biostat & Clin Res, Munster, Germany; [Braselmann, Herbert] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Mol Radiat Biol, Neuherberg, Germany; [Sauter, Wiebke; Illig, Thomas] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Epidemiol, Neuherberg, Germany; [Mayer, Claudia; Popanda, Odilia; Schmezer, Peter] German Canc Res Ctr, Div Epigen & Canc Risk Factors, Heidelberg, Germany; [Roessler, Ute; Gomolka, Maria] Fed Off Radiat Protect, Dept Radiat Protect & Hlth, Oberschleissheim, Germany	University of Munster; Friedrich Loeffler Institute; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munster; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; German Cancer Research Center (DKFZ)	Greve, B (corresponding author), Univ Hosp Muenster, Dept Radiotherapy, Munster, Germany.	greveb@uni-muenster.de	Popanda, Odilia/P-6917-2019; Moertl, Simone/M-7353-2014; Fritz, Eberhard/N-6402-2017; Amler, Susanne/B-7611-2013; Sauerland, Maria Cristina/A-4154-2014	Moertl, Simone/0000-0003-0644-0878; Amler, Susanne/0000-0001-6903-2906; 	Federal Ministry for the Environment, Nature Conservation and Nuclear safety [StSch 4467]	Federal Ministry for the Environment, Nature Conservation and Nuclear safety	The project was financed by the Federal Ministry for the Environment, Nature Conservation and Nuclear safety (StSch 4467). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alapetite C, 1999, INT J CANCER, V83, P83, DOI 10.1002/(SICI)1097-0215(19990924)83:1<83::AID-IJC16>3.0.CO;2-8; Alsbeih G, 2010, RADIAT RES, V173, P505, DOI 10.1667/RR1769.1; Andrievski A, 2009, INT J RADIAT BIOL, V85, P369, DOI 10.1080/09553000902781147; Azria D, 2012, CRIT REV ONCOL HEMAT, V84, pE35, DOI 10.1016/j.critrevonc.2010.08.003; Banath JP, 2004, CANCER RES, V64, P7144, DOI 10.1158/0008-5472.CAN-04-1433; BAUMANN M, 1995, LATE SEQUELAE ONCOLO; Bergqvist M, 1998, CANCER LETT, V133, P9, DOI 10.1016/S0304-3835(98)00178-5; Bese NS, 2007, INT J RADIAT ONCOL, V68, P654, DOI 10.1016/j.ijrobp.2007.03.010; BMU, 2008, SCHRIFT STRAHL REAKT; Bordon E, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-4; Cohen JI, 2000, NEW ENGL J MED, V343, P481, DOI 10.1056/NEJM200008173430707; Crompton NEA, 2001, INT J RADIAT ONCOL, V49, P547, DOI 10.1016/S0360-3016(00)01477-2; Crompton NEA, 1999, INT J RADIAT ONCOL, V45, P707, DOI 10.1016/S0360-3016(99)00256-4; Dikomey E, 2003, INT J RADIAT ONCOL, V56, P1194, DOI 10.1016/S0360-3016(03)00188-3; Djuzenova CS, 2006, BRIT J CANCER, V94, P1194, DOI 10.1038/sj.bjc.6603005; Fernet M, 2008, CANCER RADIOTHER, V12, P614, DOI 10.1016/j.canrad.2008.07.013; Greve B, 2009, APOPTOSIS, V14, P226, DOI 10.1007/s10495-008-0294-6; Hamasaki K, 2007, ENVIRON MOL MUTAGEN, V48, P38, DOI 10.1002/em.20273; HENDERSON S, 1993, P NATL ACAD SCI USA, V90, P8479, DOI 10.1073/pnas.90.18.8479; Hernandez LAH, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-17; Klokov D, 2006, RADIOTHER ONCOL, V80, P223, DOI 10.1016/j.radonc.2006.07.026; Lee JM, 2004, J VIROL, V78, P12694, DOI 10.1128/JVI.78.22.12694-12697.2004; Lobrich M, 2005, P NATL ACAD SCI USA, V102, P8984, DOI 10.1073/pnas.0501895102; LOBRICH M, 1994, INT J RADIAT BIOL, V65, P623, DOI 10.1080/09553009414550731; Marples B, 1998, BRIT J CANCER, V77, P1108, DOI 10.1038/bjc.1998.184; Mayer C, 2011, CANCER LETT, V302, P20, DOI 10.1016/j.canlet.2010.12.006; McManus KJ, 2005, MOL BIOL CELL, V16, P5013, DOI 10.1091/mbc.E05-01-0065; Mirzayans R, 2006, INT J RADIAT ONCOL, V66, P1498, DOI 10.1016/j.ijrobp.2006.08.064; National Cancer Institute (NCI), 1988, COMM TOX CRIT; Olive PL, 2008, RADIOTHER ONCOL, V86, P336, DOI 10.1016/j.radonc.2007.09.002; Perez CA, 1993, PRINCIPLES PRACTICE, V2nd, P53; Popanda O, 2003, INT J RADIAT ONCOL, V55, P1216, DOI 10.1016/S0360-3016(02)04415-2; Rajeswari N, 2000, CARCINOGENESIS, V21, P557, DOI 10.1093/carcin/21.4.557; Riesenbeck D, 2005, MULTIPARAMETRISCHE U; Rosenberger A, 2011, DNA REPAIR, V10, P322, DOI 10.1016/j.dnarep.2010.12.003; Rube CE, 2008, CLIN CANCER RES, V14, P6546, DOI 10.1158/1078-0432.CCR-07-5147; Rube CE, 2010, INT J RADIAT ONCOL, V76, P1206, DOI 10.1016/j.ijrobp.2009.10.009; Rzeszowska-Wolny J, 2008, INT J RADIAT BIOL, V84, P635, DOI 10.1080/09553000802087041; Schunck C, 2004, CYTOGENET GENOME RES, V104, P383, DOI 10.1159/000077520; Seegenschmiedt MH., 1998, WHO TOXICITY CRITERI; Severin E, 2006, INT J RADIAT ONCOL, V64, P242, DOI 10.1016/j.ijrobp.2005.06.020; Shahidi M, 2007, CANCER LETT, V257, P263, DOI 10.1016/j.canlet.2007.08.002; Sonis S, 2007, ORAL ONCOL, V43, P289, DOI 10.1016/j.oraloncology.2006.03.014; Starmans MHW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028320; Svensson JP, 2006, PLOS MED, V3, P1904, DOI 10.1371/journal.pmed.0030422; Taneja N, 2004, J BIOL CHEM, V279, P2273, DOI 10.1074/jbc.M310030200; Tucker SL, 1996, RADIOTHER ONCOL, V38, P103, DOI 10.1016/0167-8140(95)01669-4; Twardella D, 2003, RADIOTHER ONCOL, V69, P145, DOI 10.1016/S0167-8140(03)00166-X; Twardella D, 2002, RADIOTHER ONCOL, V62, P249, DOI 10.1016/S0167-8140(01)00491-1; Vasireddy RS, 2010, BRIT J CANCER, V102, P1511, DOI 10.1038/sj.bjc.6605666; Werbrouck J, 2010, ONCOL REP, V23, P571, DOI 10.3892/or_00000671; Williams JR, 2008, INT J RADIAT BIOL, V84, P151, DOI 10.1080/09553000701797021; Wistop A, 2005, STRAHLENTHER ONKOL, V181, P326, DOI 10.1007/s00066-005-1372-0; Zijno A, 2010, MUTAT RES-FUND MOL M, V684, P98, DOI 10.1016/j.mrfmmm.2009.12.008; Zou P, 2007, J VIROL, V81, P10029, DOI 10.1128/JVI.02241-06	55	43	46	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47185	10.1371/journal.pone.0047185	http://dx.doi.org/10.1371/journal.pone.0047185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110060	Green Published, gold, Green Submitted			2022-12-25	WOS:000310193600009
J	Slatnar, A; Jakopic, J; Stampar, F; Veberic, R; Jamnik, P				Slatnar, Ana; Jakopic, Jerneja; Stampar, Franci; Veberic, Robert; Jamnik, Polona			The Effect of Bioactive Compounds on In Vitro and In Vivo Antioxidant Activity of Different Berry Juices	PLOS ONE			English	Article							RADICAL ABSORBING CAPACITY; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; ANTHOCYANINS; FRUITS; POLYPHENOLS; PHENOLICS; YEAST; RIBES; FLAVONOIDS	Background: Berry fruit is known for its high contents of various bioactive compounds. The latter constitute of anthocyanins, flavonols and flavanols and posses high antioxidative activity. The highly dynamic antioxidant system can be evaluated in vitro and in vivo in several model organisms. These measurements represent a good approximation of the real potential of bioactive compounds in the cells of higher eucarions. The aim of the study was thus to determine in vitro and in vivo antioxidant activity of different berry juices, which reportedly contain high amounts of phenolics. Methodology/Principal Findings: Five different berry species were collected from several locations in central Slovenia and juice was extracted from each species separately. Juice was assessed for their in vitro and in vivo antioxidant activity. Phenolic profiles of berries were determined with the use of a HPLC/MS system, in vitro antioxidant activity with the DPPH radical scavenging method and in vivo antioxidative activity using Saccharomyces cerevisiae. The highest diversity of individual phenols was detected for bilberry juice. The highest in vitro antioxidant capacity was determined for blackcurrant juice. A decrease in intracellular oxidation compared to control was observed in the following order: blackcurrant < chokeberry = blueberry < bilberry. The results indicate important differences in antioxidant activity of berry juices between in vitro and in vivo studies. Conclusion/Significance: In addition to the total content of phenolic compounds entering the cells, a key factor determining antioxidative activity of berry juices is also the ratio between the compounds. Where high content levels of anthocyanins and very low content levels of flavonols and hydroxycinnamic acids were measured a lower intracellular oxidation has been detected. Specifically, intracellular oxidation increased with higher consumption of hydroxycinnamic acids and lower consumption of anthocyanins in the cells. Antioxidative activity also increased when the consumption of analyzed phenols was rather low.	[Slatnar, Ana; Jakopic, Jerneja; Stampar, Franci; Veberic, Robert] Biotehn Fac, Dept Agron, Ljubljana, Slovenia; [Jamnik, Polona] Biotehn Fac, Dept Food Sci & Technol, Ljubljana, Slovenia		Slatnar, A (corresponding author), Biotehn Fac, Dept Agron, Ljubljana, Slovenia.	ana.slatnar@bf.uni-lj.si	Veberic, Robert/A-1535-2008	Veberic, Robert/0000-0002-1421-5163; Slatnar, Ana/0000-0002-3231-9927	Slovenian Research Agency (ARRS)	Slovenian Research Agency (ARRS)(Slovenian Research Agency - Slovenia)	This work is part of program Horticulture number P4-0013-0481, funded by the Slovenian Research Agency (ARRS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benvenuti S, 2004, J FOOD SCI, V69, pC164; BRAND-WILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Cao GH, 1997, FREE RADICAL BIO MED, V22, P749, DOI 10.1016/S0891-5849(96)00351-6; Cieslik E, 2006, FOOD CHEM, V94, P135, DOI 10.1016/j.foodchem.2004.11.015; Cigut T, 2011, J AGR FOOD CHEM, V59, P11449, DOI 10.1021/jf2022258; Heinonen M, 2007, MOL NUTR FOOD RES, V51, P684, DOI 10.1002/mnfr.200700006; Jakubowski W, 1997, INT J BIOCHEM CELL B, V29, P1297, DOI 10.1016/S1357-2725(97)00056-3; Knekt P, 1997, AM J EPIDEMIOL, V146, P223, DOI 10.1093/oxfordjournals.aje.a009257; Knekt P, 1996, BRIT MED J, V312, P1480, DOI 10.1136/bmj.312.7044.1480; Ma D, 2001, Prog Drug Res, V57, P117; Marks SC, 2007, J SCI FOOD AGR, V87, P719, DOI 10.1002/jsfa.2778; Menacho-Marquez M, 2007, CLIN TRANSL ONCOL, V9, P221, DOI 10.1007/s12094-007-0043-2; Milivojevic J, 2012, J AGR FOOD CHEM, V60, P2682, DOI 10.1021/jf204627m; Moyer RA, 2002, J AGR FOOD CHEM, V50, P519, DOI 10.1021/jf011062r; Prior RL, 1998, J AGR FOOD CHEM, V46, P2686, DOI 10.1021/jf980145d; Puupponen-Pimia R, 2005, APPL MICROBIOL BIOT, V67, P8, DOI 10.1007/s00253-004-1817-x; Rice-Evans C.A., 1998, FLAVONOIDS HLTH DIS, P199; SHAHIDI F, 1992, CRIT REV FOOD SCI, V32, P67, DOI 10.1080/10408399209527581; Sigler K, 1999, FOLIA MICROBIOL, V44, P587, DOI 10.1007/BF02825650; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Veberic R, 2009, FOOD CHEM, V114, P511, DOI 10.1016/j.foodchem.2008.09.080; Vinson JA, 2001, J AGR FOOD CHEM, V49, P5315, DOI 10.1021/jf0009293; Wang H, 1996, J AGR FOOD CHEM, V44, P701, DOI 10.1021/jf950579y; Wang H, 1997, J AGR FOOD CHEM, V45, P304, DOI 10.1021/jf960421t; Wang SY, 2000, J AGR FOOD CHEM, V48, P140, DOI 10.1021/jf9908345; Wolfe KL, 2007, J AGR FOOD CHEM, V55, P8896, DOI 10.1021/jf0715166; Zakrajsek T, 2011, J PROTEOMICS, V74, P2837, DOI 10.1016/j.jprot.2011.06.026; Zheng W, 2003, J AGR FOOD CHEM, V51, P502, DOI 10.1021/jf020728u	28	60	61	1	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47880	10.1371/journal.pone.0047880	http://dx.doi.org/10.1371/journal.pone.0047880			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110118	gold, Green Published, Green Submitted			2022-12-25	WOS:000310193600033
J	Akbarshahi, H; Menzel, M; Bauden, MP; Rosendahl, A; Andersson, R				Akbarshahi, Hamid; Menzel, Mandy; Bauden, Monika Posaric; Rosendahl, Ann; Andersson, Roland			Enrichment of Murine CD68(+)CCR2(+) and CD68(+)CD206(+) Lung Macrophages in Acute Pancreatitis-Associated Acute Lung Injury	PLOS ONE			English	Article							ALTERNATIVE ACTIVATION; INTERLEUKIN-6; BLOOD	Acute lung injury (ALI) is an important cause of mortality in critically ill patients. Acute pancreatitis (AP) is one of the risk factors for developing this syndrome. Among the inflammatory cells, macrophages have a key role in determining the severity of the acute lung injury. In the lungs, macrophages constitute a heterogeneous cell population distributed in different compartments. Changes in not only the macrophage count, but also in their phenotype have been seen during the course of lung injury. A murine ductal ligation model of acute pancreatitis showed substantial morphological changes in the pancreas and lungs. Immunohistochemistry showed neutrophil recruitment into both organs after 9 hours and later on. F4/80(+) cells in the pancreas increased in the ligated animals, though there was not a significant difference in their number in the lungs as compared to sham operated animals. Flow cytometry analysis of lung macrophages demonstrated an enrichment of F4/80(-) CD68(+)CCR2(+) and F4/80(-) CD68(+)CD206(+) lung macrophages in ligated animals ( AP) as compared to the sham operated group. The level of interleukin-6 in plasma increased 3 hours after ligation compared to the sham operated group, as a first indicator of a systemic inflammatory response. This study suggests a role for F4/80(-) CD68(+) macrophages in the pathogenesis of acute lung injury in acute pancreatitis. Studying lung macrophages for different phenotypic markers, their polarization, activation and recruitment, in the context of acute lung injury, is a novel area to potentially identify interventions which may improve the outcome of acute lung injury.	[Andersson, Roland] Skane Univ Hosp, Clin Sci Lund, Dept Surg, Lund, Sweden; [Akbarshahi, Hamid; Menzel, Mandy; Bauden, Monika Posaric; Rosendahl, Ann] Lund Univ, Dept Surg, Clin Sci Lund, Lund, Sweden	Lund University; Skane University Hospital; Lund University	Andersson, R (corresponding author), Skane Univ Hosp, Clin Sci Lund, Dept Surg, Lund, Sweden.	roland.andersson@med.lu.se	Akbarshahi, Hamid/C-1650-2018	Akbarshahi, Hamid/0000-0001-7748-286X; Menzel, Mandy/0000-0003-1286-2022	Evy and Gunnar Sandberg Foundation, Malmo, Sweden	Evy and Gunnar Sandberg Foundation, Malmo, Sweden	The study was supported by the Evy and Gunnar Sandberg Foundation, Malmo, Sweden. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann C, 2011, AM J PHYSL RENAL PHY; Aoun E, 2009, PANCREATOLOGY, V9, P777, DOI 10.1159/000214191; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Dambach DM, 2002, HEPATOLOGY, V35, P1093, DOI 10.1053/jhep.2002.33162; Fridlender ZG, 2011, AM J RESP CELL MOL, V44, P230, DOI 10.1165/rcmb.2010-0080OC; Frossard JL, 2008, LANCET, V371, P143, DOI 10.1016/S0140-6736(08)60107-5; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Herold S, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00065; Ikei S, 1998, J GASTROEN HEPATOL, V13, P1274, DOI 10.1111/j.1440-1746.1998.tb00617.x; Janssen WJ, 2011, AM J RESP CRIT CARE, V184, P547, DOI 10.1164/rccm.201011-1891OC; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; KOIKE K, 1992, J SURG RES, V52, P656, DOI 10.1016/0022-4804(92)90145-P; Lo CJ, 1998, J SURG RES, V79, P179, DOI 10.1006/jsre.1998.5418; Lund H, 2006, SCAND J GASTROENTERO, V41, P234, DOI 10.1080/00365520510024133; Malleo G, 2007, THESCIENTIFICWORLDJO, V7, P431, DOI 10.1100/tsw.2007.98; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Meyerhotz DK, 2008, AM J SURG, V196, P675, DOI 10.1016/j.amjsurg.2008.07.009; Miyake Y, 2007, J IMMUNOL, V178, P5001, DOI 10.4049/jimmunol.178.8.5001; Pastor CM, 2003, CHEST, V124, P2341, DOI 10.1378/chest.124.6.2341; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Rongione AJ, 1997, GASTROENTEROLOGY, V112, P960, DOI 10.1053/gast.1997.v112.pm9041259; Samuel I, 2010, PANCREATOLOGY, V10, P536, DOI 10.1159/000320776; Shrivastava P, 2010, WORLD J GASTROENTERO, V16, P3995, DOI 10.3748/wjg.v16.i32.3995; Steer ML, 2001, RESP PHYSIOL, V128, P13, DOI 10.1016/S0034-5687(01)00259-6; Su Kim Hue, 2006, HPB (Oxford), V8, P264, DOI 10.1080/13651820500467358; Talamini G, 1999, AM J SURG, V177, P7, DOI 10.1016/S0002-9610(98)00296-7; Thenappan T, 2011, AM J RESP CRIT CARE, V183, P1080, DOI 10.1164/rccm.201008-1303OC; Yadav D, 2006, PANCREAS, V33, P323, DOI 10.1097/01.mpa.0000236733.31617.52	30	23	25	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e42654	10.1371/journal.pone.0042654	http://dx.doi.org/10.1371/journal.pone.0042654			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110041	Green Published, Green Submitted, gold			2022-12-25	WOS:000310193400001
J	Ma, Y; Yang, FZ; Wang, Y; Du, ZY; Liu, DH; Guo, HX; Shen, JK; Peng, HL				Ma, Ying; Yang, Fuzhen; Wang, Ying; Du, Zhiyan; Liu, Daihua; Guo, Hongxia; Shen, Jingkang; Peng, Hongli			CaMKK beta Is Involved in AMP-Activated Protein Kinase Activation by Baicalin in LKB1 Deficient Cell Lines	PLOS ONE			English	Article							SCUTELLARIA-BAICALENSIS GEORGI; LIPID-ACCUMULATION; HEPATIC STEATOSIS; INDUCED APOPTOSIS; OXIDATIVE STRESS; SKELETAL-MUSCLE; UPSTREAM KINASE; CANCER-CELLS; HEPG2 CELLS; PATHWAY	AMP-activated protein kinase (AMPK) plays an important role in mediating energy metabolism and is controlled mainly by two upstream kinases, LKB1 or Ca2+/calmodulin-dependent protein kinase kinase-beta (CaMKK beta). Previously, we found that baicalin, one of the major flavonoids in a traditional Chinese herb medicine, Scutellaria baicalensis, protects against the development of hepatic steatosis in rats feeding with a high-fat diet by the activation of AMPK, but, the underlying mechanism for AMPK activation is unknown. Here we show that in two LKB1-deficient cells, HeLa and A549 cells, baicalin activates AMPK by alpha Thr-172 phosphorylation and subsequent phosphorylation of its downstream target, acetyl CoA carboxylase, at Ser-79, to a similar degree as does in HepG2 cells (that express LKB1). Pharmacologic inhibition of CaMKK beta by its selective inhibitor STO-609 markedly inhibits baicalin-induced AMPK activation in both HeLa and HepG2 cells, indicating that CaMKK beta is the responsible AMPK kinase. We also show that treatment of baicalin causes a larger increase in intracellular Ca2+ concentration ([Ca2+](i)), although the maximal level of [Ca2+](i) is lower in HepG2 cells compared to HeLa cells. Chelation of intracellular free Ca2+ by EDTA and EGTA, or depletion of intracellular Ca2+ stores by the endoplasmic reticulum Ca2+-ATPase inhibitor thapsigargin abrogates baicalin-induced activation of AMPK in HeLa cells. Neither cellular ATP nor the production of reactive oxygen species is altered by baicalin. Finally, in HeLa cells, baicalin treatment no longer decreases intracellular lipid accumulation caused by oleic acid after inhibition of CaMKK beta by STO-609. These results demonstrate that a potential Ca2+/CaMKK beta dependent pathway is involved in the activation of AMPK by baicalin and suggest that CaMKK beta likely acts as an upstream kinase of AMPK in response to baicalin.	[Ma, Ying; Yang, Fuzhen; Wang, Ying; Du, Zhiyan; Liu, Daihua; Guo, Hongxia; Shen, Jingkang; Peng, Hongli] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS	Peng, HL (corresponding author), Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 200031, Peoples R China.	penghl@mail.shcnc.ac.cn			National Natural Science Foundation of China [81172921, 30672467]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China (81172921, 30672467). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Ding DR, 2011, ORG BIOMOL CHEM, V9, P7287, DOI 10.1039/c1ob06094e; Engelman JA, 2010, CANCER PREV RES, V3, P1049, DOI 10.1158/1940-6207.CAPR-10-0178; Guo HX, 2009, ACTA PHARMACOL SIN, V30, P1505, DOI 10.1038/aps.2009.150; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, TRENDS BIOCHEM SCI, V36, P470, DOI 10.1016/j.tibs.2011.06.004; Hardie DG, 2004, J CELL SCI, V117, P5479, DOI 10.1242/jcs.01540; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hou XY, 2008, J BIOL CHEM, V283, P20015, DOI 10.1074/jbc.M802187200; Huang WH, 2006, BIOSCI BIOTECH BIOCH, V70, P2371, DOI 10.1271/bbb.50698; Hurley RL, 2005, J BIOL CHEM, V280, P29060, DOI 10.1074/jbc.M503824200; Hwang JT, 2007, CANCER LETT, V247, P115, DOI 10.1016/j.canlet.2006.03.030; Lee JH, 2008, ANTICANCER RES, V28, P1701; Li CR, 2011, BIOPHARM DRUG DISPOS, V32, P427, DOI 10.1002/bdd.771; Li HT, 2011, PHYTOTHER RES, V25, P189, DOI 10.1002/ptr.3238; Li-Weber M, 2009, CANCER TREAT REV, V35, P57, DOI 10.1016/j.ctrv.2008.09.005; Lin CL, 2007, J LIPID RES, V48, P2334, DOI 10.1194/jlr.M700128-JLR200; Lin YL, 2010, PHYTOMEDICINE, V17, P760, DOI 10.1016/j.phymed.2010.01.003; Liu JF, 2011, PHYTOTHER RES, V25, P588, DOI 10.1002/ptr.3305; Lu HF, 2007, ANTICANCER RES, V27, P117; Mungai PT, 2011, MOL CELL BIOL, V31, P3531, DOI 10.1128/MCB.05124-11; Park KG, 2008, HEPATOLOGY, V48, P1477, DOI 10.1002/hep.22496; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Peng HL, 2010, PFLUG ARCH EUR J PHY, V460, P791, DOI 10.1007/s00424-010-0850-0; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Shin SM, 2009, MOL PHARMACOL, V76, P884, DOI 10.1124/mol.109.058479; Song Z, 2007, AM J PHYSIOL-GASTR L, V293, pG894, DOI 10.1152/ajpgi.00133.2007; Sugden C, 1999, PLANT J, V19, P433, DOI 10.1046/j.1365-313X.1999.00532.x; Tokumitsu H, 2002, J BIOL CHEM, V277, P15813, DOI 10.1074/jbc.M201075200; TOKUMITSU H, 1995, J BIOL CHEM, V270, P19320, DOI 10.1074/jbc.270.33.19320; Tong X, 2012, MOL CARCINOGEN, V51, P268, DOI 10.1002/mc.20793; Toyoda T, 2004, AM J PHYSIOL-ENDOC M, V287, pE166, DOI 10.1152/ajpendo.00487.2003; Woods A, 2003, CURR BIOL, V13, P2004, DOI 10.1016/j.cub.2003.10.031; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xie W, 2011, DIABETES OBES METAB, V13, P289, DOI 10.1111/j.1463-1326.2010.01336.x; Yu X, 2004, DIABETOLOGIA, V47, P2012, DOI 10.1007/s00125-004-1570-9; Yue GGL, 2004, J BIOL CHEM, V279, P39310, DOI 10.1074/jbc.M406787200; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	42	39	41	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e47900	10.1371/journal.pone.0047900	http://dx.doi.org/10.1371/journal.pone.0047900			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110126	Green Published, gold, Green Submitted			2022-12-25	WOS:000310193400022
J	Mi, XS; Feng, Q; Lo, ACY; Chang, RCC; Lin, B; Chung, SK; So, KF				Mi, Xue-Song; Feng, Qian; Lo, Amy Cheuk Yin; Chang, Raymond Chuen-Chung; Lin, Bin; Chung, Sookja Kim; So, Kwok-Fai			Protection of Retinal Ganglion Cells and Retinal Vasculature by Lycium Barbarum Polysaccharides in a Mouse Model of Acute Ocular Hypertension	PLOS ONE			English	Article							AMYLOID PEPTIDE NEUROTOXICITY; ISCHEMIA-REPERFUSION INJURY; GLYCATION END-PRODUCTS; BLOOD-BRAIN-BARRIER; OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; ENDOTHELIAL-CELLS; PRECURSOR PROTEIN; RATS; ACCUMULATION	Acute ocular hypertension (AOH) is a condition found in acute glaucoma. The purpose of this study is to investigate the protective effect of Lycium barbarum polysaccharides (LBP) and its protective mechanisms in the AOH insult. LBP has been shown to exhibit neuroprotective effect in the chronic ocular hypertension (COH) experiments. AOH mouse model was induced in unilateral eye for one hour by introducing 90 mmHg ocular pressure. The animal was fed with LBP solution (1 mg/kg) or vehicle daily from 7 days before the AOH insult till sacrifice at either day 4 or day 7 post insult. The neuroprotective effects of LBP on retinal ganglion cells (RGCs) and blood-retinal-barrier (BRB) were evaluated. In control AOH retina, loss of RGCs, thinning of IRL thickness, increased IgG leakage, broken tight junctions, and decreased density of retinal blood vessels were observed. However, in LBP-treated AOH retina, there was less loss of RGCs with thinning of IRL thickness, IgG leakage, more continued structure of tight junctions associated with higher level of occludin protein and the recovery of the blood vessel density when compared with vehicle-treated AOH retina. Moreover, we found that LBP provides neuroprotection by down-regulating RAGE, ET-1, A beta and AGE in the retina, as well as their related signaling pathways, which was related to inhibiting vascular damages and the neuronal degeneration in AOH insults. The present study suggests that LBP could prevent damage to RGCs from AOH-induced ischemic injury; furthermore, through its effects on blood vessel protection, LBP would also be a potential treatment for vascular-related retinopathy.	[Mi, Xue-Song] Jinan Univ, Affiliated Hosp 1, Dept Ophthalmol, Guangzhou, Guangdong, Peoples R China; [Mi, Xue-Song; Feng, Qian; Chang, Raymond Chuen-Chung; Lin, Bin; Chung, Sookja Kim; So, Kwok-Fai] Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Mi, Xue-Song; Feng, Qian; Chang, Raymond Chuen-Chung; Lin, Bin; Chung, Sookja Kim; So, Kwok-Fai] Univ Hong Kong, Li Ka Shing Fac Med, State Key Lab Brain & Cognit Sci, Hong Kong, Hong Kong, Peoples R China; [So, Kwok-Fai] Univ Hong Kong, Li Ka Shing Fac Med, Res Ctr Heart Brain Hormone & Healthy Aging, Hong Kong, Hong Kong, Peoples R China; [Lo, Amy Cheuk Yin; Lin, Bin] Univ Hong Kong, Li Ka Shing Fac Med, Inst Eye, Hong Kong, Hong Kong, Peoples R China; [So, Kwok-Fai] Jinan Univ, Joint Lab Brain Funct & Hlth BFAH, Hong Kong, Hong Kong, Peoples R China	Jinan University; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong	So, KF (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China.	hrmaskf@hkucc.hku.hk	Chang, Raymond Chuen-Chung/C-1107-2009; Lo, Amy C. Y./C-1195-2009; Lin, Bin/E-9871-2010	Chang, Raymond Chuen-Chung/0000-0001-8538-7993; Lo, Amy C. Y./0000-0003-4239-6851; Lin, Bin/0000-0003-1309-3480; So, Kwok-Fai/0000-0003-4039-4246	Hong Kong Research Grant Council [2011CB707501]; fundamental Research Funds for The Central Universities [21609101]; Azalea Foundation	Hong Kong Research Grant Council(Hong Kong Research Grants Council); fundamental Research Funds for The Central Universities(Fundamental Research Funds for the Central Universities); Azalea Foundation	This study was supported by a GRF (General Research Fund) grant from Hong Kong Research Grant Council (National Basic Research Program of China (2011CB707501)), the fundamental Research Funds for The Central Universities (21609101), and Azalea (1972) Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai-Gaun S, 2004, INVEST OPHTH VIS SCI, V45, P4226, DOI 10.1167/iovs.04-0450; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Bui BV, 2005, INVEST OPHTH VIS SCI, V46, P202, DOI 10.1167/iovs.04-0421; Chan HC, 2007, EXP NEUROL, V203, P269, DOI 10.1016/j.expneurol.2006.05.031; Chen HH, 2011, INVEST OPHTH VIS SCI, V52, P36, DOI 10.1167/iovs.09-5115; Cheung AKH, 2005, DIABETES, V54, P3119, DOI 10.2337/diabetes.54.11.3119; Chi ZL, 2010, HUM MOL GENET, V19, P2606, DOI 10.1093/hmg/ddq146; Chiu Kin, 2009, J Ocul Biol Dis Infor, V2, P127; Chiu K, 2010, J CELL BIOCHEM, V110, P311, DOI 10.1002/jcb.22539; Clark AF, 2003, NAT REV DRUG DISCOV, V2, P448, DOI 10.1038/nrd1106; Cui Q, 2007, NEUROSCIENCE, V146, P986, DOI 10.1016/j.neuroscience.2007.02.034; Da T, 2004, INVEST OPHTH VIS SCI, V45, P4477, DOI 10.1167/iovs.04-0940; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Donello JE, 2001, J PHARMACOL EXP THER, V296, P216; Farrall AJ, 2009, NEUROBIOL AGING, V30, P337, DOI 10.1016/j.neurobiolaging.2007.07.015; FECHTNER RD, 1994, SURV OPHTHALMOL, V39, P23, DOI 10.1016/S0039-6257(05)80042-6; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Fu QL, 2008, INVEST OPHTH VIS SCI, V49, P975, DOI 10.1167/iovs.07-1199; Goldblum D, 2007, INVEST OPHTH VIS SCI, V48, P5085, DOI 10.1167/iovs.06-1249; Hammes HP, 2005, HORM METAB RES, V37, pS39, DOI 10.1055/s-2005-861361; Harada C, 2000, NEUROSCI LETT, V292, P134, DOI 10.1016/S0304-3940(00)01444-0; Ho YS, 2007, BRAIN RES, V1158, P123, DOI 10.1016/j.brainres.2007.04.075; Ho YS, 2009, CELL MOL NEUROBIOL, V29, P1233, DOI 10.1007/s10571-009-9419-x; Huang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021411; Jablonski M, 2011, PHYSIOL RES, V60, pS113, DOI 10.33549/physiolres.932186; Leung JWC, 2009, BRAIN RES, V1266, P121, DOI 10.1016/j.brainres.2009.01.070; Li LL, 2011, NEURAL REGEN RES, V6, P1720, DOI 10.3969/j.issn.1673-5374.2011.22.007; Li RS, 2006, CLIN EXP OPHTHALMOL, V34, P575, DOI 10.1111/j.1442-9071.2006.01279.x; Li SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016380; Lo ACY, 2005, J CEREBR BLOOD F MET, V25, P998, DOI 10.1038/sj.jcbfm.9600108; Maczurek A, 2008, ANN NY ACAD SCI, V1126, P147, DOI 10.1196/annals.1433.026; McKinnon SJ, 2002, INVEST OPHTH VIS SCI, V43, P1077; Murata H, 2008, INVEST OPHTH VIS SCI, V49, P5546, DOI 10.1167/iovs.07-1211; PENG XD, 2002, J NINGXIA MED COLL, V24, P79; Quehenberger P, 2000, DIABETES, V49, P1561, DOI 10.2337/diabetes.49.9.1561; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Sakamoto K, 2009, EXP EYE RES, V88, P974, DOI 10.1016/j.exer.2008.12.011; Shen B, 2010, BRAIN RES, V1342, P118, DOI 10.1016/j.brainres.2010.04.032; Shields MB, 2008, CURR OPIN OPHTHALMOL, V19, P85, DOI 10.1097/ICU.0b013e3282f3919b; SONG Y, 1995, J NINGXIA MED COLL, V17, P12; Stitt AW, 2001, BRIT J OPHTHALMOL, V85, P746, DOI 10.1136/bjo.85.6.746; Takita H, 2003, INVEST OPHTH VIS SCI, V44, P4497, DOI 10.1167/iovs.03-0052; Tezel G, 2007, INVEST OPHTH VIS SCI, V48, P1201, DOI 10.1167/iovs.06-0737; Tombran-Tink J., 2008, MECH GLAUCOMAS DIS P; Wall DS, 2004, INVEST OPHTH VIS SCI, V45, P3704, DOI 10.1167/iovs.03-1410; Whiteley W, 2011, STROKE, V42, P10, DOI 10.1161/STROKEAHA.110.588954; Yamagishi S, 1998, DIABETOLOGIA, V41, P1435, DOI 10.1007/s001250051089; Yang D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033596; Yang LP, 2010, NEURAL REGEN RES, V5, P273, DOI 10.3969/j.issn.1673-5374.2010.04.006; Yu MS, 2007, INT J MOL MED, V20, P261; Yu MS, 2005, EXP GERONTOL, V40, P716, DOI 10.1016/j.exger.2005.06.010; Zheng L, 2007, INVEST OPHTH VIS SCI, V48, P361, DOI 10.1167/iovs.06-0510	53	74	82	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e45469	10.1371/journal.pone.0045469	http://dx.doi.org/10.1371/journal.pone.0045469			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094016	Green Published, Green Submitted, gold			2022-12-25	WOS:000310050200001
J	Gallego, P; Planell, R; Benach, J; Querol, E; Perez-Pons, JA; Reverter, D				Gallego, Pablo; Planell, Raquel; Benach, Jordi; Querol, Enrique; Perez-Pons, Josep A.; Reverter, David			Structural Characterization of the Enzymes Composing the Arginine Deiminase Pathway in Mycoplasma penetrans	PLOS ONE			English	Article							FURIOSUS ORNITHINE CARBAMOYLTRANSFERASE; CARBAMOYL-PHOSPHATE SYNTHETASE; ARCHAEON PYROCOCCUS-FURIOSUS; PSEUDOMONAS-AERUGINOSA; CRYSTAL-STRUCTURE; ENTEROCOCCUS-FAECALIS; AGMATINE DEIMINASE; GROWTH-INHIBITION; ESCHERICHIA-COLI; METABOLISM	The metabolism of arginine towards ATP synthesis has been considered a major source of energy for microorganisms such as Mycoplasma penetrans in anaerobic conditions. Additionally, this pathway has also been implicated in pathogenic and virulence mechanism of certain microorganisms, i.e. protection from acidic stress during infection. In this work we present the crystal structures of the three enzymes composing the gene cluster of the arginine deiminase pathway from M. penetrans: arginine deiminase (ADI), ornithine carbamoyltransferase (OTC) and carbamate kinase (CK). The arginine deiminase (ADI) structure has been refined to 2.3 angstrom resolution in its apo-form, displaying an "open" conformation of the active site of the enzyme in comparison to previous complex structures with substrate intermediates. The active site pocket of ADI is empty, with some of the catalytic and binding residues far from their active positions, suggesting major conformational changes upon substrate binding. Ornithine carbamoyltransferase (OTC) has been refined in two crystal forms at 2.5 angstrom and 2.6 angstrom resolution, respectively, both displaying an identical dodecameric structure with a 23-point symmetry. The dodecameric structure of OTC represents the highest level of organization in this protein family and in M. penetrans it is constituted by a novel interface between the four catalytic homotrimers. Carbamate kinase (CK) has been refined to 2.5 angstrom resolution and its structure is characterized by the presence of two ion sulfates in the active site, one in the carbamoyl phosphate binding site and the other in the beta-phosphate ADP binding pocket of the enzyme. The CK structure also shows variations in some of the elements that regulate the catalytic activity of the enzyme. The relatively low number of metabolic pathways and the relevance in human pathogenesis of Mycoplasma penetrans places the arginine deiminase pathway enzymes as potential targets to design specific inhibitors against this human parasite.	[Gallego, Pablo; Planell, Raquel; Querol, Enrique; Perez-Pons, Josep A.; Reverter, David] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain; [Gallego, Pablo; Planell, Raquel; Querol, Enrique; Perez-Pons, Josep A.; Reverter, David] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain; [Benach, Jordi] ALBA Synchrotron Light Source, Experiments Div, Barcelona, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona	Reverter, D (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain.	david.reverter@uab.cat	Reverter, David/H-5360-2015; Perez Pons, Josep Antoni/F-8622-2016	Reverter, David/0000-0002-5347-0992; Perez Pons, Josep Antoni/0000-0002-5062-2989	"Ministerio de Ciencia e Innovacion" of Spain [BFU2008-0364, BIO2007-67904-C02-01, BFU2010-22209-C02-01]; European Community [MIRG-CT-2007-200346]	"Ministerio de Ciencia e Innovacion" of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Community(European Commission)	This work was supported by grants from the "Ministerio de Ciencia e Innovacion" of Spain, BFU2008-0364 to DR. and BIO2007-67904-C02-01, BFU2010-22209-C02-01 to EQ, and from the European Community MIRG-CT-2007-200346 to DR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELAL AT, 1979, ANNU REV MICROBIOL, V33, P139, DOI 10.1146/annurev.mi.33.100179.001035; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAUR H, 1990, J BIOL CHEM, V265, P14728; BAUR H, 1989, EUR J BIOCHEM, V179, P53, DOI 10.1111/j.1432-1033.1989.tb14520.x; Biagini GA, 2003, MOL BIOCHEM PARASIT, V128, P11, DOI 10.1016/S0166-6851(03)00025-2; Brady BS, 2010, GENE, V462, P18, DOI 10.1016/j.gene.2010.04.007; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Clantin B, 2001, EUR J BIOCHEM, V268, P3937, DOI 10.1046/j.1432-1327.2001.02302.x; CUNIN R, 1986, MICROBIOL REV, V50, P314, DOI 10.1128/MMBR.50.3.314-352.1986; Cusa E, 1999, J BACTERIOL, V181, P7479, DOI 10.1128/JB.181.24.7479-7484.1999; Das K, 2004, STRUCTURE, V12, P657, DOI 10.1016/j.str.2004.02.017; de las Rivas B, 2009, J MOL BIOL, V393, P425, DOI 10.1016/j.jmb.2009.08.002; Diaz-Munoz M, 2010, CURR MED CHEM, V17, P2253, DOI 10.2174/092986710791331031; Dillon Brian J, 2002, Med Sci Monit, V8, pBR248; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FALMAGNE P, 1985, J BACTERIOL, V161, P714, DOI 10.1128/JB.161.2.714-719.1985; Galkin A, 2005, J BIOL CHEM, V280, P34080, DOI 10.1074/jbc.M505471200; Galkin A, 2004, J BIOL CHEM, V279, P14001, DOI 10.1074/jbc.M313410200; Galkin A, 2010, ACTA CRYSTALLOGR F, V66, P386, DOI 10.1107/S1744309110004665; GAMPER M, 1991, J BACTERIOL, V173, P4742, DOI 10.1128/jb.173.15.4742-4750.1991; Griswold AR, 2006, J BACTERIOL, V188, P834, DOI 10.1128/JB.188.3.834-841.2006; HONZATKO RB, 1982, J MOL BIOL, V160, P219, DOI 10.1016/0022-2836(82)90175-9; HOUGHTON JE, 1984, P NATL ACAD SCI-BIOL, V81, P4864, DOI 10.1073/pnas.81.15.4864; Humm A, 1997, EMBO J, V16, P3373, DOI 10.1093/emboj/16.12.3373; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Knodler LA, 1998, J BIOL CHEM, V273, P4470, DOI 10.1074/jbc.273.8.4470; Langley DB, 2000, J BIOL CHEM, V275, P20012, DOI 10.1074/jbc.M000585200; LEGRAIN C, 1977, EUR J BIOCHEM, V80, P401, DOI 10.1111/j.1432-1033.1977.tb11895.x; LINSTEAD D, 1983, MOL BIOCHEM PARASIT, V8, P241, DOI 10.1016/0166-6851(83)90046-4; Llacer JL, 2007, J BACTERIOL, V189, P1254, DOI 10.1128/JB.01216-06; Ludwig RA, 1992, MOL BIOCHEM PARASIT, V51, P29; LUTHI E, 1986, J GEN MICROBIOL, V132, P2667; Marina A, 1998, EUR J BIOCHEM, V253, P280, DOI 10.1046/j.1432-1327.1998.2530280.x; Massant J, 2004, BIOCHEM SOC T, V32, P306, DOI 10.1042/BST0320306; Massant J, 2003, ACTA CRYSTALLOGR D, V59, P2140, DOI 10.1107/S0907444903019231; MIYAZAKI K, 1990, CANCER RES, V50, P4522; Mouz N, 1996, P NATL ACAD SCI USA, V93, P9414, DOI 10.1073/pnas.93.18.9414; Murray-Rust J, 2001, NAT STRUCT BIOL, V8, P679, DOI 10.1038/90387; Nguyen VT, 1996, EUR J BIOCHEM, V236, P283, DOI 10.1111/j.1432-1033.1996.00283.x; Philip R, 2003, BRIT J CANCER, V88, P613, DOI 10.1038/sj.bjc.6600681; Pich OQ, 2006, MICROBIOL-SGM, V152, P519, DOI 10.1099/mic.0.28287-0; Planell R, 2008, THESIS U AUTONOMA BA; Pollack JD, 1997, CRIT REV MICROBIOL, V23, P269, DOI 10.3109/10408419709115140; Pollack JD, 1997, TRENDS MICROBIOL, V5, P413; Ramon-Maique S, 2010, J MOL BIOL, V397, P1261, DOI 10.1016/j.jmb.2010.02.038; Ramon-Maiques S, 2000, J MOL BIOL, V299, P463, DOI 10.1006/jmbi.2000.3779; RAZIN S, 1978, MICROBIOL REV, V42, P414, DOI 10.1128/MMBR.42.2.414-470.1978; Razin S, 1998, MICROBIOL MOL BIOL R, V62, P1094, DOI 10.1128/MMBR.62.4.1094-1156.1998; Ruepp A, 1993, PLANT PHYSIOL, V101, P429; Sankaranarayanan R, 2008, J MOL BIOL, V375, P1052, DOI 10.1016/j.jmb.2007.11.025; SCHOFIELD PJ, 1992, MOL BIOCHEM PARASIT, V51, P29, DOI 10.1016/0166-6851(92)90197-R; Schrodinger L., 2020, PYMOL; SIMON JP, 1982, J BACTERIOL, V152, P676; Smith RS, 2003, CURR OPIN MICROBIOL, V6, P56, DOI 10.1016/S1369-5274(03)00008-0; STALON V, 1967, BIOCHIM BIOPHYS ACTA, V139, P91, DOI 10.1016/0005-2744(67)90115-5; TERAYAMA H, 1982, BIOCHIM BIOPHYS ACTA, V720, P188, DOI 10.1016/0167-4889(82)90011-8; Uriarte M, 1999, J BIOL CHEM, V274, P16295, DOI 10.1074/jbc.274.23.16295; VANDERWAUVEN C, 1986, ARCH MICROBIOL, V145, P386, DOI 10.1007/BF00470876; VANDERWAUVEN C, 1984, J BACTERIOL, V160, P928, DOI 10.1128/JB.160.3.928-934.1984; VILLERET V, 1995, P NATL ACAD SCI USA, V92, P10762, DOI 10.1073/pnas.92.23.10762; Villeret V, 1998, P NATL ACAD SCI USA, V95, P2801, DOI 10.1073/pnas.95.6.2801; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; YARLETT N, 1994, J EUKARYOT MICROBIOL, V41, P554, DOI 10.1111/j.1550-7408.1994.tb01516.x	63	10	17	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47886	10.1371/journal.pone.0047886	http://dx.doi.org/10.1371/journal.pone.0047886			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082227	Green Published, gold, Green Submitted			2022-12-25	WOS:000311146900124
J	Landes, M; van Lettow, M; Chan, AK; Mayuni, I; Schouten, EJ; Bedell, RA				Landes, Megan; van Lettow, Monique; Chan, Adrienne K.; Mayuni, Isabell; Schouten, Erik J.; Bedell, Richard A.			Mortality and Health Outcomes of HIV-Exposed and Unexposed Children in a PMTCT Cohort in Malawi	PLOS ONE			English	Article							UNINFECTED MOTHERS; INFECTED MOTHERS; INFANTS; AFRICA; PREVENTION; TRANSMISSION; TUBERCULOSIS; PREVALENCE; UGANDA; WOMEN	Background: Mortality and morbidity among HIV-exposed children are thought to be high in Malawi. We sought to determine mortality and health outcomes of HIV-exposed and unexposed infants within a PMTCT program. Method: Data were collected as part of a retrospective cohort study in Zomba District, Malawi. HIV-infected mothers were identified via antenatal, delivery and postpartum records with a delivery date 18-20 months prior; the next registered HIV-uninfected mother was identified as a control. By interview and health record review, data on socio-demographic characteristics, service uptake, and health outcomes were collected. HIV-testing was offered to all exposed children. Results: 173 HIV-infected and 214 uninfected mothers were included. 4 stillbirths (1.0%) occurred; among the 383 livebirths, 41 (10.7%) children died by 20 months (32 (18.7%) HIV-exposed and 9 unexposed children (4.3%; p<0.0001)). Risk factors for child death included: HIV-exposure [adjOR2.9(95% CI 1.1-7.2)], low birthweight [adjOR2.5(1.0-6.3)], previous child death (adjOR25.1(6.5-97.5)] and maternal death [adjOR5.3(11.4-20.5)]. At 20 months, HIV-infected children had significantly poorer health outcomes than HIV-unexposed children and HIV-exposed but uninfected children (HIV-EU), including: hospital admissions, delayed development, undernutrition and restrictions in function (Lansky scale); no significant differences were seen between HIV-EU and HIV-unexposed children. Overall, no difference was seen at 20 months among HIV-infected, HIV-EU and HIV-unexposed groups in Z-scores (%<-22.0) for weight, height and BMI. Risk factors for poor functional health status at 20 months included: HIV-infection [adjOR8.9(2.4-32.6)], maternal illness [adjOR2.8(1.5-5.0)] and low birthweight [adjOR2.0(1.0-4.1)]. Conclusion: Child mortality remains high within this context and could be reduced through more effective PMTCT including prioritizing the treatment of maternal HIV infection to address the effect of maternal health and survival on infant health and survival. HIV-infected children demonstrated developmental delays, functional health and nutritional deficits that underscore the need for increased uptake of early infant diagnosis and institution of ART for all infected infants.	[Landes, Megan; van Lettow, Monique; Chan, Adrienne K.; Mayuni, Isabell; Bedell, Richard A.] Dignitas Int, Zomba, Malawi; [Landes, Megan; Chan, Adrienne K.] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada; [van Lettow, Monique; Chan, Adrienne K.; Schouten, Erik J.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Schouten, Erik J.] Management Sci Hlth, Lilongwe, Malawi	University of Toronto; University of Toronto	van Lettow, M (corresponding author), Dignitas Int, Zomba, Malawi.	m.vanlettow@dignitasinternational.org	Bedell, Richard/AAC-2595-2020	Bedell, Richard/0000-0002-5687-8053	Department of Family and Community Medicine, University of Toronto	Department of Family and Community Medicine, University of Toronto(University of Toronto)	ML is supported by a New Investigator Award from the Department of Family and Community Medicine, University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Abubakar A, 2008, TROP MED INT HEALTH, V13, P880, DOI 10.1111/j.1365-3156.2008.02079.x; [Anonymous], 2011, WORLD HLTH STAT; Brahmbhatt H, 2006, JAIDS-J ACQ IMM DEF, V41, P504, DOI 10.1097/01.qai.0000188122.15493.0a; Brahmbhatt H, 2003, AIDS, V17, P879, DOI 10.1097/00002030-200304110-00013; Gupta A, 2007, CLIN INFECT DIS, V45, P241, DOI 10.1086/518974; Hesseling AC, 2009, CLIN INFECT DIS, V48, P108, DOI 10.1086/595012; Kimani-Murage EW, 2001, BMC PEDIATR, V11, P23; Kuhn L, 2005, CLIN INFECT DIS, V41, P1654, DOI 10.1086/498029; Kurewa EN, 2010, J PERINATOL, V30, P88, DOI 10.1038/jp.2009.121; LANSKY SB, 1987, CANCER, V60, P1651, DOI 10.1002/1097-0142(19871001)60:7<1651::AID-CNCR2820600738>3.0.CO;2-J; Liu KC, 2011, J ACQ IMMUN DEF SYND, V6, P1; Madhi SA, 2006, J CLIN VIROL, V36, P215, DOI 10.1016/j.jcv.2006.03.010; Malawi Ministry of Health, 2008, GUID ART PROV; Malawi MOH, 2008, HIV SYPH SER SURV NA; Manda SOM, 1999, SOC SCI MED, V48, P301, DOI 10.1016/S0277-9536(98)00359-1; Marinda E, 2007, PEDIATR INFECT DIS J, V26, P519, DOI 10.1097/01.inf.0000264527.69954.4c; Nalwoga A, 2010, TROP MED INT HEALTH, V15, P414, DOI 10.1111/j.1365-3156.2010.02476.x; Naniche D, 2009, AM J TROP MED HYG, V80, P870, DOI 10.4269/ajtmh.2009.80.870; Ndirangu J, 2012, ANTIVIR THER, V17, P81, DOI 10.3851/IMP1991; Ndirangu J, 2010, AIDS, V24, P593, DOI 10.1097/QAD.0b013e328335cff5; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Newell ML, 2004, AIDS, V18, pS27, DOI 10.1097/00002030-200406002-00004; Patel D, 2010, AIDS, V24, P437, DOI 10.1097/QAD.0b013e3283345f91; Payongayong E., 2006, SIMPLE HOUSEHOLD POV; Schouten EJ, 2011, LANCET, V378, P282, DOI 10.1016/S0140-6736(10)62303-3; Shapiro RL, 2007, J INFECT DIS, V196, P562, DOI 10.1086/519847; UNAIDS, 2010, GLOB REP 2010 REP GL; van Lettow M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-426; Zaba B, 2005, EPIDEMIOLOGY, V16, P275, DOI 10.1097/01.ede.0000155507.47884.43	29	58	58	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47337	10.1371/journal.pone.0047337	http://dx.doi.org/10.1371/journal.pone.0047337			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082157	Green Published, Green Submitted, gold			2022-12-25	WOS:000311146900053
J	Scharer, RM; Patterson, WF; Carlson, JK; Poulakis, GR				Scharer, Rachel M.; Patterson, William F., III; Carlson, John K.; Poulakis, Gregg R.			Age and Growth of Endangered Smalltooth Sawfish (Pristis pectinata) Verified with LA-ICP-MS Analysis of Vertebrae	PLOS ONE			English	Article							CHONDRICHTHYAN FISHES; WESTERN ATLANTIC; UNITED-STATES; FRESH-WATER; SHARK; VALIDATION; PRECISION; CHEMISTRY; STRONTIUM; RECOVERY	Endangered smalltooth sawfish (Pristis pectinata) were opportunistically sampled in south Florida and aged by counting opaque bands in sectioned vertebrae (n = 15). Small sample size precluded traditional age verification, but fish collected in spring and summer had translucent vertebrae margins, while fish collected in winter had opaque margins. Trends in Sr:Ca measured across vertebrae with laser ablation-inductively coupled plasma-mass spectrometry corresponded well to annual salinity trends observed in sawfish estuarine nursery habitats in south Florida, thus serve as a chemical marker verifying annual formation of opaque bands. Based on that finding and assumptions about mean birth date and timing of opaque band formation, estimated age ranged from 0.4 y for a 0.60 m total length (TL) male to 14.0 y for a 4.35 m TL female. Von Bertalanffy growth parameters computed from size at age data were 4.48 m for L-infinity, 0.219 y(-1) for k, and -0.81 y for t(0). Results of this study have important implications for sawfish conservation as well as for inferring habitat residency of euryhaline elasmobranchs via chemical analysis of vertebrae.	[Scharer, Rachel M.; Patterson, William F., III] Univ W Florida, Dept Biol, Pensacola, FL 32514 USA; [Carlson, John K.] SE Fisheries Sci Ctr, Natl Marine Fisheries Serv, Panama City Lab, Panama City Beach, FL USA; [Poulakis, Gregg R.] Fish & Wildlife Res Inst, Florida Fish & Wildlife Conservat Commiss, Charlotte Harbor Field Lab, Port Charlotte, FL USA	State University System of Florida; University of West Florida; National Oceanic Atmospheric Admin (NOAA) - USA; Florida Fish & Wildlife Conservation Commission	Scharer, RM (corresponding author), Univ W Florida, Dept Biol, Pensacola, FL 32514 USA.	rachel.scharer@MyFWC.com			National Marine Fisheries Service Office of Protected Species	National Marine Fisheries Service Office of Protected Species	Funding was provided by that National Marine Fisheries Service Office of Protected Species. Sawfish were obtained under ESA permits #1352 (Mote Marine Laboratory), #1475 (Florida Fish and Wildlife Conservation Commission), and #13330 (NMFS Southeast Fisheries Science Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews AH, 2011, FISH B-NOAA, V109, P454; Baremore IE, 2009, FISH RES, V99, P203, DOI 10.1016/j.fishres.2009.06.006; BEAMISH RJ, 1983, T AM FISH SOC, V112, P735, DOI 10.1577/1548-8659(1983)112<735:TFRFAV>2.0.CO;2; BEAMISH RJ, 1981, CAN J FISH AQUAT SCI, V38, P982, DOI 10.1139/f81-132; Beissinger S. R., 2002, POPULATION VIABILITY; Bethea DM, 2009, NOAA NMFS SMALLTOOTH; Bigelow HB, 1953, MEM SEARS FDN MAR 2; Boivin G, 1996, J BONE MINER RES, V11, P1302; Cailliet GM, 2004, CRC MAR BIOL SER, P399; Cailliet GM, 2006, ENVIRON BIOL FISH, V77, P211, DOI 10.1007/s10641-006-9105-5; Campana SE, 1999, MAR ECOL PROG SER, V188, P263, DOI 10.3354/meps188263; Campana SE, 2001, J FISH BIOL, V59, P197, DOI 10.1006/jfbi.2001.1668; Carlson JK, 2007, BIOL CONSERV, V136, P195, DOI 10.1016/j.biocon.2006.11.013; CHEN C T, 1990, Pacific Science, V44, P156; Cortes E, 2002, CONSERV BIOL, V16, P1048, DOI 10.1046/j.1523-1739.2002.00423.x; DOLAN TJ, 1984, J HYDROL, V74, P355, DOI 10.1016/0022-1694(84)90024-6; Faunce Craig H., 2004, Wetlands Ecology and Management, V12, P377, DOI 10.1007/s11273-004-4823-y; Francis MP, 2007, MAR FRESHWATER RES, V58, P10, DOI 10.1071/MF06069; Hale LF, 2006, ENVIRON BIOL FISH, V77, P317, DOI 10.1007/s10641-006-9124-2; IUCN, 2022, IUCN RED LIST THREAT; Natanson LJ, 2008, MAR ECOL PROG SER, V361, P267, DOI 10.3354/meps07399; National Marine Fisheries Service (NMFS), 2003, US FED REG, V68, P15674; Norton SL, 2012, MAR COAST FISH, V4, P473, DOI 10.1080/19425120.2012.676606; Phelps QE, 2012, CAN J FISH AQUAT SCI, V69, P930, DOI 10.1139/F2012-038; Poulakis GR, 2012, ENV BIOL FISH, V8; Poulakis Gregg R., 2004, Florida Scientist, V67, P27; Poulakis GR, 2011, MAR FRESHWATER RES, V62, P1165, DOI 10.1071/MF11008; Richardson CJ, 2010, WETL ECOL MANAG, V18, P517, DOI 10.1007/s11273-009-9156-4; SAS Institute, 2008, SAS STAT US GUID; Secor DH, 2000, FISH RES, V46, P359, DOI 10.1016/S0165-7836(00)00159-4; Seitz JC, 2006, MAR POLLUT BULL, V52, P1533, DOI 10.1016/j.marpolbul.2006.07.016; Seitz Jason C., 2002, Florida Scientist, V65, P256; Simpfendorfer CA, 2008, J FISH BIOL, V72, P711, DOI 10.1111/j.1095-8649.2007.01764.x; Simpfendorfer CA, 2000, ENVIRON BIOL FISH, V58, P371, DOI 10.1023/A:1007675111597; Simpfendorfer CA, 2002, ENDANGERED SPECIES U, V19, P45; Simpfendorfer CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016918; Tanaka S, 1991, NATURE CULTURE, V3, P71; Tillett BJ, 2011, MAR ECOL PROG SER, V434, P133, DOI 10.3354/meps09222; von BERTALANFFY LUDWIG, 1938, HUMAN BIOL, V10, P181; Wells BK, 2003, T AM FISH SOC, V132, P409, DOI 10.1577/1548-8659(2003)132<0409:RBWOAS>2.0.CO;2; Werry JM, 2011, MAR FRESHWATER RES, V62, P1421, DOI 10.1071/MF11136	41	39	40	0	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47850	10.1371/journal.pone.0047850	http://dx.doi.org/10.1371/journal.pone.0047850			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082225	Green Published, gold, Green Submitted			2022-12-25	WOS:000311146900122
J	Zhao, W; Zheng, XF; Liu, YY; Yang, WL; Amirbekian, V; Diaz, LE; Huang, XD				Zhao, Wen; Zheng, Xiaofeng; Liu, Yuying; Yang, Wenlu; Amirbekian, Vardan; Diaz, Luis E.; Huang, Xudong			An MRI Study of Symptomatic Adhesive Capsulitis	PLOS ONE			English	Article							ROTATOR INTERVAL LESIONS; FROZEN SHOULDER; CORACOHUMERAL LIGAMENT; ARTHROGRAPHY; DIAGNOSIS; ANATOMY; PATHOLOGY; RELEASE; MOTION	Background: Appilication of MR imaging to diagnose Adhesive Capsulitis (AC) has previously been described. However, there is insufficient information available for the MRI analysis of AC. This study is to describe and evaluate the pathomorphology of the shoulder in Asian patients with AC compared to healthy volunteers. Methodology/Principal Findings: 60 Asian patients with clinically diagnosed AC and 60 healthy volunteers without frozen shoulder underwent MRI of the shoulder joint. All subjects who were age- and sex-matched control ones underwent routine MRI scans of the affected shoulder, including axial, oblique coronal, oblique sagittal T1WI SE and coronal oblique T2WI FSE sequences. Significant abnormal findings were observed on MRI, especially at the rotator cuff interval. The coracohumeral ligament (CHL), articular capsule thickness in the rotator cuff interval as well as the fat space under coracoid process were evaluated. MRI showed that patients with adhesive capsulitis had a significantly thickened coracohumeral ligament and articular capsule in the rotator cuff interval compared to the control subjects (4.2 vs. 2.4 mm, 7.2 vs. 4.4 mm; p<0.05). Partial or complete obliteration of the subcoracoid fat triangle was significantly more frequent in patients with adhesive capsulitis compared with control subjects (73% vs. 13%, 26% vs. 1.6%; p<0.001). Synovitis-like abnormality around the long biceps tendon was significantly more common in patients with adhesive capsulitis than in control subjects. With regards to the inter-observer variability, two MR radiologists had an excellent kappa value of 0.86. Conclusions/Significance: MRI can be used to show characteristic findings in diagnosing AC. Thickening of the CHL and the capsule at the rotator cuff interval and complete obliteration of the fat triangle under the coracoid process have been shown to be the most characteristic MR findings seen with AC.	[Huang, Xudong] Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA 02129 USA; [Huang, Xudong] Harvard Univ, Sch Med, Charlestown, MA USA; [Zhao, Wen] Beijing Aerosp Gen Hosp, Dept Orthoped, Beijing, Peoples R China; [Zheng, Xiaofeng] Beijing Aerosp Gen Hosp, Dept Radiol, Beijing, Peoples R China; [Liu, Yuying] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA; [Yang, Wenlu] Shanghai Maritime Univ, Informat Engn Coll, Dept Elect Engn, Shanghai, Peoples R China; [Amirbekian, Vardan] Brigham & Womens Hosp, Dept Radiol, Boston, MA 02115 USA; [Amirbekian, Vardan] Harvard Univ, Sch Med, Boston, MA USA; [Diaz, Luis E.] Boston Univ, Sch Med, Dept Radiol, Boston, MA 02118 USA; [Diaz, Luis E.] VA Boston Healthcare Syst, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Medical University of South Carolina; Shanghai Maritime University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Huang, XD (corresponding author), Massachusetts Gen Hosp, Dept Psychiat, Charlestown, MA 02129 USA.	xhuang3@partners.org	Huang, Xudong/D-9711-2018	Huang, Xudong/0000-0002-4811-1901	Beijing General Aerospace Hospital; Radiology Department of Brigham and Women's Hospital (BWH)	Beijing General Aerospace Hospital; Radiology Department of Brigham and Women's Hospital (BWH)	This study was supported by research funds from the Beijing General Aerospace Hospital. XH is partially supported by the Radiology Department of Brigham and Women's Hospital (BWH). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoretti N, 2006, CLIN IMAG, V30, P254, DOI 10.1016/j.clinimag.2006.01.022; Bennett WF, 2001, ARTHROSCOPY, V17, P173, DOI 10.1053/jars.2001.21239; BUNKER TD, 1995, J BONE JOINT SURG BR, V77, P677, DOI 10.1302/0301-620X.77B5.7559688; Carrillon Y, 1999, REV RHUM, V66, P201; Codman E., 1934, TENDINITIS SHORT ROT; Connell D, 2002, EUR RADIOL, V12, P2100, DOI 10.1007/s00330-002-1349-7; DePalma AF, 2008, CLIN ORTHOP RELAT R, V466, P552, DOI 10.1007/s11999-007-0101-7; EMIG EW, 1995, AM J ROENTGENOL, V164, P1457, DOI 10.2214/ajr.164.6.7754892; Fitzpatrick MJ, 2003, ARTHROSCOPY, V19, P70, DOI 10.1016/j.arthro.2003.09.047; HARRYMAN DT, 1992, J BONE JOINT SURG AM, V74A, P53, DOI 10.2106/00004623-199274010-00008; Holloway GB, 2001, J BONE JOINT SURG AM, V83A, P1682, DOI 10.2106/00004623-200111000-00010; Hulstyn M J, 1993, Orthop Rev, V22, P425; Jung JY, 2006, EUR RADIOL, V16, P791, DOI 10.1007/s00330-005-0020-5; Kim KC, 2009, J SHOULDER ELBOW SUR; Le Huec J C, 1996, J Shoulder Elbow Surg, V5, P41, DOI 10.1016/S1058-2746(96)80029-2; Lee MH, 2003, J COMPUT ASSIST TOMO, V27, P901, DOI 10.1097/00004728-200311000-00012; Lefevre-Colau MM, 2005, EUR RADIOL, V15, P2415, DOI 10.1007/s00330-005-2830-x; Manton GL, 2001, SKELETAL RADIOL, V30, P326, DOI 10.1007/s002560100326; McNally EG, 2007, SKELETAL RADIOL, V36, P1013, DOI 10.1007/s00256-007-0351-1; Mengiardi B, 2004, RADIOLOGY, V233, P486, DOI 10.1148/radiol.2332031219; Mohana-Borges AVR, 2004, RADIOGRAPHICS, V24, P69, DOI 10.1148/rg.241035081; NEER CS, 1992, CLIN ORTHOP RELAT R, P182; Nguyen BD, 2007, CLIN NUCL MED, V32, P535, DOI 10.1097/RLU.0b013e3180646ad3; Omari A, 2001, J SHOULDER ELB SURG, V10, P353, DOI 10.1067/mse.2001.115986; Ozaki J, 1996, ANN CHIR GYNAECOL FE, V85, P156; Rodeo SA, 1997, J ORTHOPAED RES, V15, P427, DOI 10.1002/jor.1100150316; SATTAR MA, 1985, DIABETES CARE, V8, P507, DOI 10.2337/diacare.8.5.507; Shaikh A, 2009, ORTHOPEDICS, V32, P2, DOI 10.3928/01477447-20090101-20; Siegel LB, 1999, AM FAM PHYSICIAN, V59, P1843; Sofka Carolyn M, 2008, HSS J, V4, P164, DOI 10.1007/s11420-008-9088-1; UITVLUGT G, 1993, ARTHROSCOPY, V9, P181, DOI 10.1016/S0749-8063(05)80371-8; WILEY A M, 1991, Arthroscopy, V7, P138, DOI 10.1016/0749-8063(91)90098-I	32	32	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47277	10.1371/journal.pone.0047277	http://dx.doi.org/10.1371/journal.pone.0047277			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082152	Green Published, gold, Green Submitted			2022-12-25	WOS:000311146900048
J	Joshi, S; Saylor, BT; Wang, W; Peck, AB; Khan, SR				Joshi, Sunil; Saylor, Benjamin T.; Wang, Wei; Peck, Ammon B.; Khan, Saeed R.			Apocynin-Treatment Reverses Hyperoxaluria Induced Changes in NADPH Oxidase System Expression in Rat Kidneys: A Transcriptional Study	PLOS ONE			English	Article							RENAL EPITHELIAL-CELLS; VASCULAR SMOOTH-MUSCLE; CALCIUM-OXALATE NEPHROLITHIASIS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; INFLAMMATORY-BOWEL-DISEASE; INDUCED UP-REGULATION; HYDROXY-L-PROLINE; LARGE GENE LISTS; ETHYLENE-GLYCOL; NAD(P)H OXIDASE	Purpose: We have previously shown that production of reactive oxygen species (ROS) is an important contributor to renal injury and inflammation following exposure to oxalate (Ox) or calcium-oxalate (CaOx) crystals. The present study was conducted, utilizing global transcriptome analyses, to determine the effect of Apocynin on changes in the NADPH oxidase system activated in kidneys of rats fed a diet leading to hyperoxaluria and CaOx crystal deposition. Approach: Age-, sex- and weight-matched rats were either fed regular rat chow or regular rat chow supplemented with 5% w/w hydroxy-L-proline (HLP). Half of the rats on the HLP diet were also placed on Apocynin-supplemented H2O. After 28 days, each rat was euthanized, their kidneys freshly explanted and dissected to obtain both cortex and medulla tissues. Total RNA was extracted from each tissue and subjected to genomic microarrays to obtain global transcriptome data. KEGG was used to identify gene clusters with differentially expressed genes. Immunohistochemistry was used to confirm protein expressions of selected genes. Results: Genes encoding both membrane- and cytosolic-NADPH oxidase complex-associated proteins, together with p21rac and Rap1a, were coordinately up-regulated significantly in both renal medulla and cortex tissues in the HLP-fed rats compared to normal healthy untreated controls. Activation of NADPH oxidase appears to occur via the angiotensin-II/angiotensin-II receptor-2 pathway, although the DAG-PKC pathway of neutrophils may also contribute. Immuno histochemical staining confirmed up-regulated gene expressions. Simultaneously, genes encoding ROS scavenger proteins were down-regulated. HLP-fed rats receiving Apocynin had a complete reversal in the differential-expression of the NADPH oxidase system genes, despite showing similar levels of hyperoxaluria. Conclusions: A strong up-regulation of an oxidative/respiratory burst involving the NADPH oxidase system, activated via the angiotensin-II and most likely the DAG-PKC pathways, occurs in kidneys of hyperoxaluric rats. Apocynin treatment reversed this activation without affecting the levels of hyperoxaluria.	[Joshi, Sunil; Wang, Wei; Peck, Ammon B.; Khan, Saeed R.] Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA; [Saylor, Benjamin T.; Peck, Ammon B.] Univ Florida, Coll Dent, Dept Oral Biol, Gainesville, FL 32610 USA; [Peck, Ammon B.] Univ Florida, Coll Vet Med, Dept Infect Dis & Pathol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Khan, SR (corresponding author), Univ Florida, Coll Med, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA.	Khan@pathology.ufl.edu		Joshi, Sunil/0000-0001-8230-980X	National Institutes of Health [RO1-DK078602]; University of Florida Center for the Study of Lithiasis; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078602] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Florida Center for the Study of Lithiasis; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by National Institutes of Health grant #RO1-DK078602 and University of Florida Center for the Study of Lithiasis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ago T, 2004, CIRCULATION, V109, P227, DOI 10.1161/01.CIR.0000105680.92873.70; Banfi B, 2000, SCIENCE, V287, P138, DOI 10.1126/science.287.5450.138; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; BINDER HJ, 1974, GASTROENTEROLOGY, V67, P441; Chabrashvili T, 2002, HYPERTENSION, V39, P269, DOI 10.1161/hy0202.103264; Chamseddine AH, 2003, AM J PHYSIOL-HEART C, V285, pH2284, DOI 10.1152/ajpheart.00459.2003; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Clempus RE, 2007, ARTERIOSCL THROM VAS, V27, P42, DOI 10.1161/01.ATV.0000251500.94478.18; DOBBINS JW, 1977, NEW ENGL J MED, V296, P298, DOI 10.1056/NEJM197702102960602; Ellmark SHM, 2005, CARDIOVASC RES, V65, P495, DOI 10.1016/j.cardiores.2004.10.026; Gao B, 2010, UROL INT, V85, P237, DOI 10.1159/000314947; Geiszt M, 2000, P NATL ACAD SCI USA, V97, P8010, DOI 10.1073/pnas.130135897; Gill PS, 2006, ANTIOXID REDOX SIGN, V8, P1597, DOI 10.1089/ars.2006.8.1597; Gorlach A, 2000, CIRC RES, V87, P26, DOI 10.1161/01.RES.87.1.26; Grewal JS, 2005, BIOCHEM J, V387, P609, DOI 10.1042/BJ20041465; Hanna IR, 2004, FREE RADICAL BIO MED, V37, P1542, DOI 10.1016/j.freeradbiomed.2004.08.011; Helmcke I, 2009, ANTIOXID REDOX SIGN, V11, P1279, DOI [10.1089/ars.2008.2383, 10.1089/ARS.2008.2383]; Hilenski LL, 2004, ARTERIOSCL THROM VAS, V24, P677, DOI 10.1161/01.ATV.0000112024.13727.2c; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang HS, 2006, KIDNEY INT, V70, P699, DOI 10.1038/sj.ki.5001651; Huang HS, 2003, UROLOGY, V62, P1123, DOI 10.1016/S0090-4295(03)00764-7; Huang HS, 2002, J UROLOGY, V167, P2584, DOI 10.1016/S0022-5347(05)65042-2; HYLANDER E, 1978, SCAND J GASTROENTERO, V13, P577, DOI 10.3109/00365527809181767; Iida S, 1999, J AM SOC NEPHROL, V10, P986; JAMES LF, 1972, CLIN TOXICOL, V5, P231, DOI 10.3109/15563657208991002; Khan SR, 2006, KIDNEY INT, V70, P914, DOI 10.1038/sj.ki.5001699; Khan Saeed R, 2004, Clin Exp Nephrol, V8, P75; Khan SR, 2011, NEPHROL DIAL TRANSPL, V26, P1778, DOI 10.1093/ndt/gfq692; Khan SR, 2010, UROL RES, V38, P429, DOI 10.1007/s00240-010-0303-4; Khan SR, 2006, UROL RES, V34, P86, DOI 10.1007/s00240-005-0016-2; Khan SR, 1997, WORLD J UROL, V15, P236, DOI 10.1007/BF01367661; Khan SR, 2005, UROL RES, V33, P349, DOI 10.1007/s00240-005-0492-4; Khan SR, 2004, FRONT BIOSCI-LANDMRK, V9, P1450, DOI 10.2741/1347; Khan SR, 2002, J UROLOGY, V168, P1173, DOI 10.1016/S0022-5347(05)64621-6; KHAN SR, 1995, UROL RES, V23, P71, DOI 10.1007/BF00307936; Kleinman JG, 2004, NEPHRON PHYSIOL, V98, P43, DOI DOI 10.1159/000080263; Koul H, 1996, KIDNEY INT, V50, P1525, DOI 10.1038/ki.1996.467; Koul HK, 2002, J BIOL CHEM, V277, P36845, DOI 10.1074/jbc.M200832200; Koul S, 2008, UROL RES, V36, P1, DOI 10.1007/s00240-007-0130-4; Kuroda J, 2005, GENES CELLS, V10, P1139, DOI 10.1111/j.1365-2443.2005.00907.x; Lassegue B, 2001, CIRC RES, V88, P888, DOI 10.1161/hh0901.090299; LINDSJO M, 1989, SCAND J UROL NEPHROL, V23, P55, DOI 10.1080/00365599.1989.11690431; Marengo SR, 2002, J UROLOGY, V167, P2192, DOI 10.1016/S0022-5347(05)65127-0; Mazzali M, 2002, QJM-INT J MED, V95, P3, DOI 10.1093/qjmed/95.1.3; McConnell N, 2002, BJU INT, V89, P835, DOI 10.1046/j.1464-410X.2002.02739.x; MENON M, 1982, J UROLOGY, V127, P148, DOI 10.1016/S0022-5347(17)53649-6; Morena M, 2002, KIDNEY INT, V61, pS109, DOI 10.1046/j.1523-1755.61.s80.20.x; Schepers MSJ, 2005, KIDNEY INT, V68, P1660, DOI 10.1111/j.1523-1755.2005.00576.x; Shiose A, 2001, J BIOL CHEM, V276, P1417, DOI 10.1074/jbc.M007597200; Shirotake S, 2012, AM J PATHOL, V180, P1008, DOI 10.1016/j.ajpath.2011.11.027; Sorescu GP, 2004, CIRC RES, V95, P773, DOI 10.1161/01.RES.0000145728.22878.45; Sumimoto H, 2005, BIOCHEM BIOPH RES CO, V338, P677, DOI 10.1016/j.bbrc.2005.08.210; Takac I, 2012, CURR HYPERTENS REP, V14, P70, DOI 10.1007/s11906-011-0238-3; Thamilselvan S, 1997, J UROLOGY, V157, P1059, DOI 10.1016/S0022-5347(01)65141-3; Thamilselvan S, 2005, BJU INT, V96, P117, DOI 10.1111/j.1464-410X.2005.05579.x; Umekawa T, 2005, NEPHROL DIAL TRANSPL, V20, P870, DOI 10.1093/ndt/gfh750; Umekawa T, 2004, J AM SOC NEPHROL, V15, P635, DOI 10.1097/01.ASN.0000113321.49771.2D; Umekawa T, 2003, NEPHROL DIAL TRANSPL, V18, P664, DOI 10.1093/ndt/gfg140; Umekawa T, 2002, KIDNEY INT, V61, P105, DOI 10.1046/j.1523-1755.2002.00106.x; UMEKAWA T, 2009, BJU INT; Umekawa T, 2006, BJU INT, V98, P656, DOI 10.1111/j.1464-410X.2006.06334.x; WILLIAMS HE, 1989, J UROLOGY, V141, P742, DOI 10.1016/S0022-5347(17)40999-2; WILLIAMS HE, 1968, AM J MED, V45, P715, DOI 10.1016/0002-9343(68)90207-6; Worcester EM, 2002, ENDOCRIN METAB CLIN, V31, P979, DOI 10.1016/S0889-8529(02)00035-X; Zuo J, 2011, NEPHROL DIAL TRANSPL, V26, P1785, DOI 10.1093/ndt/gfr035	66	31	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47738	10.1371/journal.pone.0047738	http://dx.doi.org/10.1371/journal.pone.0047738			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091645	gold, Green Submitted, Green Published			2022-12-25	WOS:000310135800071
J	Kuzembayeva, M; Chiu, YF; Sugden, B				Kuzembayeva, Malika; Chiu, Ya-Fang; Sugden, Bill			Comparing Proteomics and RISC Immunoprecipitations to Identify Targets of Epstein-Barr Viral miRNAs	PLOS ONE			English	Article							MICRORNA-21 TARGETS; ENCODED MICRORNAS; VIRUS; IDENTIFICATION; GENES; CELLS	Epstein-Barr virus is a gamma-herpes virus that is causally associated with several lymphomas and carcinomas. This virus encodes at least 25 pre-miRNAs, which are expressed in infected cells to yield more than 50 detected mature miRNAs. miRNAs are small, non-coding RNAs that inhibit gene expression by promoting the inhibition of translation or of degradation of mRNAs. Currently, the function of these viral miRNAs and the contribution they provide to EBV's life-cycle remain largely unknown, due to difficulties in identifying cellular and viral genes regulated by these miRNAs. We have compared and contrasted two methods to identify targets of viral miRNAs in order to identify the advantages and limitations of each method to aid in uncovering the functions of EBV's miRNAs.	[Kuzembayeva, Malika; Chiu, Ya-Fang; Sugden, Bill] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Sugden, B (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	sugden@oncology.wisc.edu	Chiu, Ya-Fang/AAS-7536-2020	Chiu, Ya-Fang/0000-0002-7506-9032	National Cancer Institute, National Institutes of Health [P01CA022443, R01CA133027, R01CA070723]; NATIONAL CANCER INSTITUTE [P01CA022443, R01CA133027, R01CA070723] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by grants from the National Cancer Institute, National Institutes of Health (grants P01CA022443, R01CA133027, and R01CA070723). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Chen CZ, 2005, NEW ENGL J MED, V353, P1768, DOI 10.1056/NEJMp058190; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; Dar W. A., 2010, Viral oncology: basic science and clinical applications, P425; Darnell RB, 2010, WIRES RNA, V1, P266, DOI 10.1002/wrna.31; Dolken L, 2010, CELL HOST MICROBE, V7, P324, DOI 10.1016/j.chom.2010.03.008; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; KLEIN G, 1974, P NATL ACAD SCI USA, V71, P3283, DOI 10.1073/pnas.71.8.3283; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104; Marouga R, 2005, ANAL BIOANAL CHEM, V382, P669, DOI 10.1007/s00216-005-3126-3; Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781; Pratt ZL, 2009, VIROLOGY, V386, P387, DOI 10.1016/j.virol.2009.01.006; Riley KJ, 2012, EMBO J, V31, P2207, DOI 10.1038/emboj.2012.63; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rudel S, 2008, RNA, V14, P1244, DOI 10.1261/rna.973808; Schramedei K, 2011, ONCOGENE, V30, P2975, DOI 10.1038/onc.2011.15; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Seto E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001063; Skalsky RL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002484; Thomson DW, 2011, NUCLEIC ACIDS RES, V39, P6845, DOI 10.1093/nar/gkr330; Vollrath AL, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-280; Walz N, 2010, J VIROL, V84, P716, DOI 10.1128/JVI.01302-09; Witkos TM, 2011, CURR MOL MED, V11, P93; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Young LS, 2003, ONCOGENE, V22, P5108, DOI 10.1038/sj.onc.1206556; Zhu SM, 2007, J BIOL CHEM, V282, P14328, DOI 10.1074/jbc.M611393200	29	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47409	10.1371/journal.pone.0047409	http://dx.doi.org/10.1371/journal.pone.0047409			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091622	gold, Green Published, Green Submitted			2022-12-25	WOS:000310135800045
J	Ziebarth, JD; Bhattacharya, A; Cui, Y				Ziebarth, Jesse D.; Bhattacharya, Anindya; Cui, Yan			Integrative Analysis of Somatic Mutations Altering MicroRNA Targeting in Cancer Genomes	PLOS ONE			English	Article							CELL LUNG-CANCER; CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; PROSTATE-CANCER; WIDE ASSOCIATION; LINKING POLYMORPHISMS; POLYMIRTS DATABASE; FUNCTIONAL IMPACT; GENETIC-VARIATION; PERIPHERAL-BLOOD	Determining the functional impact of somatic mutations is crucial to understanding tumorigenesis and metastasis. Recent sequences of several cancers have provided comprehensive lists of somatic mutations across entire genomes, enabling investigation of the functional impact of somatic mutations in non-coding regions. Here, we study somatic mutations in 3'UTRs of genes that have been identified in four cancers and computationally predict how they may alter miRNA targeting, potentially resulting in dysregulation of the expression of the genes harboring these mutations. We find that somatic mutations create or disrupt putative miRNA target sites in the 3'UTRs of many genes, including several genes, such as MITF, EPHA3, TAL1, SCG3, and GSDMA, which have been previously associated with cancer. We also integrate the somatic mutations with germline mutations and results of association studies. Specifically, we identify putative miRNA target sites in the 3'UTRs of BMPR1B, KLK3, and SPRY4 that are disrupted by both somatic and germline mutations and, also, are in linkage disequilibrium blocks with high scoring markers from cancer association studies. The somatic mutation in BMPR1B is located in a target site of miR-125b; germline mutations in this target site have previously been both shown to disrupt regulation of BMPR1B by miR-125b and linked with cancer.	[Ziebarth, Jesse D.; Bhattacharya, Anindya; Cui, Yan] Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN USA; [Ziebarth, Jesse D.; Bhattacharya, Anindya; Cui, Yan] Univ Tennessee, Hlth Sci Ctr, Ctr Integrat & Translat Genom, Memphis, TN USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center	Cui, Y (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Microbiol Immunol & Biochem, Memphis, TN USA.	ycui2@uthsc.edu	Bhattacharya, Anindya/K-3740-2016	Cui, Yan/0000-0002-7577-6845	University of Tennessee Center for Integrative and Translational Genomics	University of Tennessee Center for Integrative and Translational Genomics	This work was partly supported by The University of Tennessee Center for Integrative and Translational Genomics. No additional external funding was received for this study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Bao L, 2007, NUCLEIC ACIDS RES, V35, pD51, DOI 10.1093/nar/gkl797; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bemis LT, 2008, CANCER RES, V68, P1362, DOI 10.1158/0008-5472.CAN-07-2912; Berger MF, 2011, NATURE, V470, P214, DOI 10.1038/nature09744; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Boehm JS, 2011, NAT REV GENET, V12, P487, DOI 10.1038/nrg3013; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Cardoso BA, 2011, LEUKEMIA, V25, P1578, DOI 10.1038/leu.2011.140; Chakravarti N, 2007, CLIN CANCER RES, V13, P4817, DOI 10.1158/1078-0432.CCR-06-3026; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen AX, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002259; Chen KX, 2008, CARCINOGENESIS, V29, P1306, DOI 10.1093/carcin/bgn116; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chin L, 2008, NATURE, V452, P553, DOI 10.1038/nature06914; Chin L, 2011, GENE DEV, V25, P534, DOI 10.1101/gad.2017311; Chin L, 2011, NAT MED, V17, P297, DOI 10.1038/nm.2323; D'Alessandro V, 2008, CELL ONCOL, V30, P291, DOI 10.3233/CLO-2008-0424; Eeles RA, 2008, NAT GENET, V40, P316, DOI 10.1038/ng.90; Ellwanger DC, 2011, BIOINFORMATICS, V27, P1346, DOI 10.1093/bioinformatics/btr149; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Feng NH, 2012, MOL BIOL REP, V39, P369, DOI 10.1007/s11033-011-0747-9; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Fox BP, 2006, BIOCHEM BIOPH RES CO, V342, P1263, DOI 10.1016/j.bbrc.2006.02.099; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Godshalk SE, 2011, ONCOGENE, V30, P1542, DOI 10.1038/onc.2010.536; Greenberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027400; Guo CG, 2008, GENE CHROMOSOME CANC, V47, P939, DOI 10.1002/gcc.20596; Gururaj AE, 2006, P NATL ACAD SCI USA, V103, P6670, DOI 10.1073/pnas.0601989103; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hammell M, 2010, SEMIN CELL DEV BIOL, V21, P738, DOI 10.1016/j.semcdb.2010.01.004; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Jiang JM, 2005, NUCLEIC ACIDS RES, V33, P5394, DOI 10.1093/nar/gki863; Jin Y, 2011, J BIOL CHEM, V286, P40104, DOI 10.1074/jbc.C111.296707; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Jukic DM, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-27; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Leidinger P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-262; Lewis-Tuffin LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013665; Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Medina PP, 2008, CELL CYCLE, V7, P2485, DOI 10.4161/cc.7.16.6453; Moss AC, 2009, CLIN CANCER RES, V15, P274, DOI 10.1158/1078-0432.CCR-08-1163; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Penney KL, 2011, CARCINOGENESIS, V32, P853, DOI 10.1093/carcin/bgr050; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Ramsingh G, 2010, BLOOD, V116, P5316, DOI 10.1182/blood-2010-05-285395; Rapley EA, 2009, NAT GENET, V41, P807, DOI 10.1038/ng.394; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Richardson K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-504; Ruepp A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-1-r6; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Saeki N, 2007, ONCOGENE, V26, P6488, DOI 10.1038/sj.onc.1210475; Saeki N, 2009, GENE CHROMOSOME CANC, V48, P261, DOI 10.1002/gcc.20636; Saetrom P, 2009, CANCER RES, V69, P7459, DOI 10.1158/0008-5472.CAN-09-1201; Saito T, 2010, NEW BIOTECHNOL, V27, P243, DOI 10.1016/j.nbt.2010.02.016; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Sayers EW, 2011, NUCLEIC ACIDS RES, V39, pD38, DOI 10.1093/nar/gkq1172; Schnall-Levin M, 2010, P NATL ACAD SCI USA, V107, P15751, DOI 10.1073/pnas.1006172107; Schotte D, 2009, LEUKEMIA, V23, P313, DOI 10.1038/leu.2008.286; Sethupathy P, 2008, TRENDS GENET, V24, P489, DOI 10.1016/j.tig.2008.07.004; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shi Z, 2011, J MOL BIOL, V413, P495, DOI 10.1016/j.jmb.2011.06.046; Siva K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001202; Stratton MR, 2011, SCIENCE, V331, P1553, DOI 10.1126/science.1204040; Thomas LF, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr414; Tsang WP, 2010, CARCINOGENESIS, V31, P350, DOI 10.1093/carcin/bgp181; Tsuchiya S, 2011, J BIOL CHEM, V286, P420, DOI 10.1074/jbc.M110.170852; Turnbull C, 2010, NAT GENET, V42, P604, DOI 10.1038/ng.607; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Yamamoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017149; Yantiss RK, 2009, AM J SURG PATHOL, V33, P572, DOI 10.1097/PAS.0b013e31818afd6b; Youn A, 2011, BIOINFORMATICS, V27, P175, DOI 10.1093/bioinformatics/btq630; Zeng JP, 2010, GASTROENTEROLOGY, V138, P981, DOI 10.1053/j.gastro.2009.10.004; Zhang L, 2006, P NATL ACAD SCI USA, V103, P9136, DOI 10.1073/pnas.0508889103; Zhang LN, 2011, P NATL ACAD SCI USA, V108, P13653, DOI 10.1073/pnas.1103360108; Ziebarth JD, 2012, NUCLEIC ACIDS RES, V40, pD216, DOI 10.1093/nar/gkr1026	91	29	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47137	10.1371/journal.pone.0047137	http://dx.doi.org/10.1371/journal.pone.0047137			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091610	gold, Green Published, Green Submitted			2022-12-25	WOS:000310135800027
J	Lang, UE; Kocabayoglu, P; Cheng, GZ; Ghiassi-Nejad, Z; Munoz, U; Vetter, D; Eckstein, DA; Hannivoort, RA; Walsh, MJ; Friedman, SL				Lang, U. E.; Kocabayoglu, P.; Cheng, G. Z.; Ghiassi-Nejad, Z.; Munoz, U.; Vetter, D.; Eckstein, D. A.; Hannivoort, R. A.; Walsh, M. J.; Friedman, S. L.			GSK3 beta phosphorylation of the KLF6 tumor suppressor promotes its transactivation of p21	ONCOGENE			English	Article						KLF6; GSK3 beta; p21; phosphorylation	BETA-CATENIN; TRANSCRIPTIONAL ACTIVATION; DOWN-REGULATION; GENE; DEGRADATION; FREQUENT; PROTEIN; TARGET; MOUSE	KLF6, a ubiquitously expressed Kruppel-like transcription factor, is frequently inactivated in human cancer and has significant roles in cellular proliferation, apoptosis, differentiation and development. A key mechanism of KLF6-mediated growth suppression is through p53-independent transactivation of p21. Several cancer-derived KLF6 mutants lead to the loss of p21-mediated growth suppression through an unknown mechanism. Because several colorectal cancer and hepatocellular carcinoma-derived KLF6 mutations affect a glycogen synthase kinase 3 beta (GSK3 beta) phosphorylation consensus site, we investigated the role of GSK3 beta in the regulation of KLF6 function. Based on transient transfection, GSK3 beta augments the transactivation of a p21 promoter luciferase by KLF6. Reciprocal co-immunoprecipitation of hemagglutinin (HA)-GSK3 beta and Flag-KLF6 validated the interaction between these two proteins. KLF6 phosphorylation is augmented in the presence of GSK3 beta based on in vitro and in vivo P-32 incorporation assays. Site-directed mutagenesis of the candidate phosphorylation sites to alanines ('KLF6-4A' phosphomutant) eliminated a higher molecular weight phosphorylated isoform of KLF6 based on western blot. GSK3 beta augmented the transactivation by wild-type KLF6, but not KLF6-4A, towards the p21 promoter, and increased p21 protein. Functionally, GSK3 beta enhanced KLF6-mediated growth suppression, which was abrogated by the KLF6-4A phosphomutant. These data establish that GSK3 beta directly phosphorylates KLF6, which augments its induction of p21 and resultant growth suppression. This interaction may account for the growth-promoting effects of cancer-derived KLF6 mutants that lack tumor suppressor activity.	[Lang, U. E.; Kocabayoglu, P.; Cheng, G. Z.; Ghiassi-Nejad, Z.; Munoz, U.; Vetter, D.; Eckstein, D. A.; Hannivoort, R. A.; Friedman, S. L.] Mt Sinai Sch Med, Div Liver Dis, New York, NY 10029 USA; [Walsh, M. J.] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA; [Walsh, M. J.] Mt Sinai Sch Med, Dept Pediat, New York, NY 10029 USA; [Walsh, M. J.] Mt Sinai Sch Med, Dept Genet & Genom Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Friedman, SL (corresponding author), Mt Sinai Sch Med, Dept Med, Div Liver Dis, 1425 Madison Ave,Room 11-70C,Box 1123, New York, NY 10029 USA.	scott.friedman@mssm.edu	De Cock, Martine/B-8567-2009; MUÑOZ MORON, URSULA/L-4561-2017	De Cock, Martine/0000-0001-7917-0771; MUÑOZ MORON, URSULA/0000-0001-6024-4697	NIH [RO1DK37340, RO1DK 56621, 1K05 AA018408, 1P20 AA017067, 1RO1CA154809-01, T32GM00728]; Deutsche Forschungsgemeinschaft (DFG); Graduate School for Drug Exploration (GUIDE) [KO 4086/11]; Stichting Nicholaas Muleriusfonds, Groningen; Netherlands; Ellison Medical Foundation Senior Scholar Award in Aging [SS-AG2482-1]; Swiss National Fund (SNF); Alonso Martin Escudero foundation; NATIONAL CANCER INSTITUTE [R01CA154809] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL103967] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037340, R01DK056621] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P20AA017067, K05AA018408] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Graduate School for Drug Exploration (GUIDE); Stichting Nicholaas Muleriusfonds, Groningen; Netherlands(Netherlands Government); Ellison Medical Foundation Senior Scholar Award in Aging(Lawrence Ellison Foundation); Swiss National Fund (SNF)(Swiss National Science Foundation (SNSF)); Alonso Martin Escudero foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank Dr Ming-Ming Zhou at the Mount Sinai School of Medicine for his expert advice in protein purification of GST-KLF6. Dr Jin Q Cheng at H Lee Moffitt Cancer Center shared all GSK3b plasmids and contributed technical support for the in vivo kinase assays. We acknowledge funding support from the NIH (to SLF: RO1DK37340, RO1DK 56621, 1K05 AA018408, 1P20 AA017067; to MJW: 1RO1CA154809-01; to UEL and ZGN: T32GM00728), Deutsche Forschungsgemeinschaft (DFG) (to PK) KO 4086/11, Graduate School for Drug Exploration (GUIDE) and the Stichting Nicholaas Muleriusfonds, Groningen, the Netherlands (to RAH), the Ellison Medical Foundation Senior Scholar Award in Aging (SS-AG2482-1) (to MJW), the Swiss National Fund (SNF) (to DV) and the Alonso Martin Escudero foundation (to UM).	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Banck MS, 2006, FEBS LETT, V580, P6981, DOI 10.1016/j.febslet.2006.10.077; Benzeno S, 2004, CANCER RES, V64, P3885, DOI 10.1158/0008-5472.CAN-03-2818; Botella LM, 2002, BLOOD, V100, P4001, DOI 10.1182/blood.V100.12.4001; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Difeo A, 2006, ONCOGENE, V25, P6026, DOI 10.1038/sj.onc.1209611; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Kremer-Tal S, 2004, HEPATOLOGY, V40, P1047, DOI 10.1002/hep.20460; Kremer-Tal S, 2007, J HEPATOL, V46, P645, DOI 10.1016/j.jhep.2006.10.012; Lee UE, 2010, FEBS LETT, V584, P1006, DOI 10.1016/j.febslet.2010.01.049; Li D, 2005, J BIOL CHEM, V280, P26941, DOI 10.1074/jbc.M500463200; Li D, 2005, CANCER RES, V65, P9216, DOI 10.1158/0008-5472.CAN-05-1040; Li D, 2000, HEPATOLOGY, V32, p209A; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Liu N, 2010, J BIOL CHEM, V285, P18858, DOI 10.1074/jbc.M109.099440; Narla G, 2007, ONCOGENE, V26, P4428, DOI 10.1038/sj.onc.1210223; Narla G, 2001, SCIENCE, V294, P2563, DOI 10.1126/science.1066326; Nejak-Bowen KN, 2011, SEMIN CANCER BIOL, V21, P44, DOI 10.1016/j.semcancer.2010.12.010; Pan Xiu-cheng, 2006, J Zhejiang Univ Sci B, V7, P830, DOI 10.1631/jzus.2006.B0830; Reeves HL, 2004, GASTROENTEROLOGY, V126, P1090, DOI 10.1053/j.gastro.2004.01.005; Reeves HL, 2003, HEPATOLOGY, V2002; Rodriguez E, 2010, PLOS ONE, V5, P9; Slavin DA, 2004, ONCOGENE, V23, P8196, DOI 10.1038/sj.onc.1208020; Warke VG, 2003, J BIOL CHEM, V278, P14812, DOI 10.1074/jbc.M300787200; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Zeng CX, 2010, HEPATOLOGY, V52, P1702, DOI 10.1002/hep.23875	28	34	36	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 19	2013	32	38					4557	4564		10.1038/onc.2012.457	http://dx.doi.org/10.1038/onc.2012.457			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	223SW	23085750	Green Accepted			2022-12-25	WOS:000324831300011
J	Bristow, JM; Reno, TA; Jo, M; Gonias, SL; Klemke, RL				Bristow, Jeanne M.; Reno, Theresa A.; Jo, Minji; Gonias, Steven L.; Klemke, Richard L.			Dynamic Phosphorylation of Tyrosine 665 in Pseudopodium-enriched Atypical Kinase 1 (PEAK1) Is Essential for the Regulation of Cell Migration and Focal Adhesion Turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; INTEGRIN ADHESOME; MATRIX ADHESIONS; SRC; PAXILLIN; RECEPTOR; PROTEIN; REVEALS; IDENTIFICATION; CYTOSKELETON	Pseudopodium-enriched atypical kinase 1 (PEAK1) is a recently described tyrosine kinase that associates with the actin cytoskeleton and focal adhesion (FA) in migrating cells. PEAK1 is known to promote cell migration, but the responsible mechanisms remain unclear. Here, we show that PEAK1 controls FA assembly and disassembly in a dynamic pathway controlled by PEAK1 phosphorylation at Tyr-665. Knockdown of endogenous PEAK1 inhibits random cell migration. In PEAK1-deficient cells, FA lifetimes are decreased, FA assembly times are shortened, and FA disassembly times are extended. Phosphorylation of Tyr-665 in PEAK1 is essential for normal PEAK1 localization and its function in the regulation of FAs; however, constitutive phosphorylation of PEAK1 Tyr-665 is also disruptive of its function, indicating a requirement for precise spatiotemporal regulation of PEAK1. Src family kinases are required for normal PEAK1 localization and function. Finally, we provide evidence that PEAK1 promotes cancer cell invasion through Matrigel by a mechanism that requires dynamic regulation of Tyr-665 phosphorylation.	[Klemke, Richard L.] Univ Calif San Diego, Dept Pathol, Moores Canc Ctr, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Klemke, RL (corresponding author), Univ Calif San Diego, Dept Pathol, Moores Canc Ctr, 9500 Gilman Dr,0612, La Jolla, CA 92093 USA.	rklemke@ucsd.edu			National Institutes of Health [CA097022, HL060551]; American Cancer Society [121437-PF-11-276-01-CSM]; NATIONAL CANCER INSTITUTE [R01CA097022] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060551] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA097022 (to R. L. K.) and HL060551 (to S. L. G.).; Supported by American Cancer Society Postdoctoral Fellowship 121437-PF-11-276-01-CSM.	Bach CTT, 2010, CELL ADHES MIGR, V4, P226, DOI 10.4161/cam.4.2.10888; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Bristow JM, 2009, J CELL SCI, V122, P4535, DOI 10.1242/jcs.053728; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Burridge K, 2006, J BIOL CHEM, V281, P15593, DOI 10.1074/jbc.R500030200; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Choi CK, 2011, BIOPHYS J, V100, P583, DOI 10.1016/j.bpj.2010.12.3719; Donato DM, 2010, J BIOL CHEM, V285, P20769, DOI 10.1074/jbc.M109.091207; Feigin ME, 2009, EXP CELL RES, V315, P707, DOI 10.1016/j.yexcr.2008.10.034; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Geiger B, 2002, CELL, V110, P139, DOI 10.1016/S0092-8674(02)00831-0; Goetz JG, 2009, CELL ADHES MIGR, V3, P185, DOI 10.4161/cam.3.2.7295; Hochgrafe F, 2010, CANCER RES, V70, P9391, DOI 10.1158/0008-5472.CAN-10-0911; Holcomb M, 2006, J BIOL CHEM, V281, P2430, DOI 10.1074/jbc.M508454200; Kassenbrock CK, 2004, J BIOL CHEM, V279, P28017, DOI 10.1074/jbc.M404114200; Kelber JA, 2012, CANCER RES, V72, P2554, DOI 10.1158/0008-5472.CAN-11-3552; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Leroy C, 2009, CANCER RES, V69, P2279, DOI 10.1158/0008-5472.CAN-08-2354; Lock JG, 2008, SEMIN CANCER BIOL, V18, P65, DOI 10.1016/j.semcancer.2007.10.001; McEwen DP, 2004, J BIOL CHEM, V279, P16044, DOI 10.1074/jbc.M400856200; Moritz A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000998; Nagaraj NS, 2011, CLIN CANCER RES, V17, P483, DOI 10.1158/1078-0432.CCR-10-1670; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; RESZKA AA, 1992, J CELL BIOL, V117, P1321, DOI 10.1083/jcb.117.6.1321; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Shattil SJ, 2005, TRENDS CELL BIOL, V15, P399, DOI 10.1016/j.tcb.2005.06.005; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Valles AM, 2004, J BIOL CHEM, V279, P44490, DOI 10.1074/jbc.M405144200; Wang YC, 2010, P NATL ACAD SCI USA, V107, P10920, DOI 10.1073/pnas.0914776107; Webb DJ, 2000, J CELL SCI, V113, P123; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Wu Y, 1998, J BIOL CHEM, V273, P5765, DOI 10.1074/jbc.273.10.5765; Xu Y, 2009, BRIT J CANCER, V100, P633, DOI 10.1038/sj.bjc.6604901; Zaidel-Bar R, 2003, J CELL SCI, V116, P4605, DOI 10.1242/jcs.00792; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183	41	26	27	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					123	131		10.1074/jbc.M112.410910	http://dx.doi.org/10.1074/jbc.M112.410910			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23105102	Green Published, hybrid			2022-12-25	WOS:000313197200012
J	Bang, YJ; Oh, MH; Choi, SH				Bang, Ye-Ji; Oh, Man Hwan; Choi, Sang Ho			Distinct Characteristics of Two 2-Cys Peroxiredoxins of Vibrio vulnificus Suggesting Differential Roles in Detoxifying Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVE-SITE CYSTEINE; ALKYLHYDROPEROXIDE REDUCTASE; IDENTIFICATION; PROTEIN; AHPC; OVEROXIDATION; SPECIFICITY; PEROXIDASE; OXIDANTS; SYSTEM	Peroxiredoxins (Prxs) are ubiquitous antioxidant enzymes reducing toxic peroxides. Two distinct 2-Cys Prxs, Prx1 and Prx2, were identified in Vibrio vulnificus, a facultative aerobic pathogen. Both Prxs have two conserved catalytic cysteines, C-P and C-R, but Prx2 is more homologous in amino acid sequences to eukaryotic Prx than to Prx1. Prx2 utilized thioredoxin A as a reductant, whereas Prx1 required AhpF. Prx2 contained GGIG and FL motifs similar to the motifs conserved in sensitive Prxs and exhibited sensitivity to overoxidation. MS analysis and C-P-SO3H specific immunoblotting demonstrated overoxidation of C-P to C-P-SO2H (or C-P-SO3H) in vitro and in vivo, respectively. In contrast, Prx1 was robust and C-P was not overoxidized. Discrete expression of the Prxs implied that Prx2 is induced by trace amounts of H2O2 and thereby residential in cells grown aerobically. In contrast, Prx1 was occasionally expressed only in cells exposed to high levels of H2O2. A mutagenesis study indicated that lack of Prx2 accumulated sufficient H2O2 to induce Prx1. Kinetic properties indicated that Prx2 effectively scavenges low levels of peroxides because of its high affinity to H2O2, whereas Prx1 quickly degrades higher levels of peroxides because of its high turnover rate and more efficient reactivation. This study revealed that the two Prxs are differentially optimized for detoxifying distinct ranges of H2O2, and proposed that Prx2 is a residential scavenger of peroxides endogenously generated, whereas Prx1 is an occasional scavenger of peroxides exogenously encountered. Furthermore, genome sequence database search predicted widespread coexistence of the two Prxs among bacteria.	[Choi, Sang Ho] Seoul Natl Univ, Natl Res Lab Mol Microbiol & Toxicol, Dept Agr Biotechnol, Ctr Food Safety & Toxicol, Seoul 151921, South Korea; Seoul Natl Univ, Ctr Food & Bioconvergence, Seoul 151921, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Choi, SH (corresponding author), Seoul Natl Univ, Natl Res Lab Mol Microbiol & Toxicol, Dept Agr Biotechnol, Ctr Food Safety & Toxicol, Seoul 151921, South Korea.	choish@snu.ac.kr		Bang, Ye-Ji/0000-0003-4009-0824; Choi, Sang Ho/0000-0003-3865-1039	National Research Foundation [2009-0092822, 2012R1A2A1A03009679]; Ministry of Education, Science and Technology; Agriculture Research Center program of the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea	National Research Foundation; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Agriculture Research Center program of the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea	This work was supported by Mid-career Researcher Program Grants 2009-0092822 and 2012R1A2A1A03009679 through the National Research Foundation funded by Ministry of Education, Science and Technology and the Agriculture Research Center program of the Ministry for Food, Agriculture, Forestry and Fisheries, Republic of Korea (to S. H. C.).	Baek WK, 2009, J MICROBIOL, V47, P624, DOI 10.1007/s12275-009-0130-x; Chuang MH, 2006, P NATL ACAD SCI USA, V103, P2552, DOI 10.1073/pnas.0510770103; Cox AG, 2010, METHOD ENZYMOL, V474, P51, DOI 10.1016/S0076-6879(10)74004-0; DALZIEL K, 1957, ACTA CHEM SCAND, V11, P1706, DOI 10.3891/acta.chem.scand.11-1706; Dietz KJ, 2002, J EXP BOT, V53, P1321, DOI 10.1093/jexbot/53.372.1321; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Huang CH, 2010, J BIOCHEM, V147, P661, DOI 10.1093/jb/mvp209; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Jeong W, 2000, J BIOL CHEM, V275, P2924, DOI 10.1074/jbc.275.4.2924; Kim Y, 2010, J BIOL CHEM, V285, P14020, DOI 10.1074/jbc.M109.100248; Lim MS, 2011, J BACTERIOL, V193, P3722, DOI 10.1128/JB.00314-11; Link AJ, 1997, ELECTROPHORESIS, V18, P1259, DOI 10.1002/elps.1150180807; MILLER PH, 1995, J CLIN MICROBIOL, V33, P2388, DOI 10.1128/JCM.33.9.2388-2391.1995; Miller RA, 1997, CLIN MICROBIOL REV, V10, P1; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; Nelson KJ, 2011, PROTEINS, V79, P947, DOI 10.1002/prot.22936; Oh MH, 2008, J MICROBIOL BIOTECHN, V18, P968; Oh MH, 2009, INFECT IMMUN, V77, P1208, DOI 10.1128/IAI.01006-08; Parsonage D, 2008, P NATL ACAD SCI USA, V105, P8209, DOI 10.1073/pnas.0708308105; Parsonage D, 2010, P NATL ACAD SCI USA, V107, P6240, DOI 10.1073/pnas.0910057107; Pascual MB, 2010, J BIOL CHEM, V285, P34485, DOI 10.1074/jbc.M110.160465; Poole LB, 2000, BIOCHEMISTRY-US, V39, P6602, DOI 10.1021/bi000405w; Poole LB, 2005, ARCH BIOCHEM BIOPHYS, V433, P240, DOI 10.1016/j.abb.2004.09.006; Poole Leslie B., 2007, V44, P61; Rhee SG, 2011, ANTIOXID REDOX SIGN, V15, P781, DOI 10.1089/ars.2010.3393; Riddell JR, 2010, J IMMUNOL, V184, P1022, DOI 10.4049/jimmunol.0901945; Sambrook J, 2001, MOL CLONING LAB MANU; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Storz G, 2000, BACTERIAL STRESS RESPONSES, P47; Trujillo Madia, 2007, V44, P83; Wagner E, 2002, BIOCHEM J, V366, P777, DOI 10.1042/BJ20020525; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405	34	19	19	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42516	42524		10.1074/jbc.M112.421214	http://dx.doi.org/10.1074/jbc.M112.421214			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23095744	hybrid, Green Published			2022-12-25	WOS:000312501600013
J	Klein, JM; Busch, JD; Potting, C; Baker, MJ; Langer, T; Schwarz, G				Klein, Julian M.; Busch, Jakob D.; Potting, Christoph; Baker, Michael J.; Langer, Thomas; Schwarz, Guenter			The Mitochondrial Amidoxime-reducing Component (mARC1) Is a Novel Signal-anchored Protein of the Outer Mitochondrial Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-B5-LIKE HEMOPROTEIN; LIVER-MITOCHONDRIA; REDUCTASE; TRANSLOCATION; IMPORT; SYSTEM	The mitochondrial amidoxime-reducing component (mARC) was recently discovered as the fifth eukaryotic molybdenum cofactor-containing enzyme. The human genome encodes two mARC proteins, mARC1 and mARC2, sharing significant homologies with respect to sequence and function. Whereas mARC2 was identified as a mitochondrial enzyme, the subcellular localization of mARC1 has remained uncharacterized, although the similarity of both proteins suggested identical subcellular localizations. In addition, neither mARC1 nor mARC2 could be attributed unambiguously to one of the four mitochondrial subcompartments. Accordingly, mechanisms triggering the subcellular distribution of both enzymes have been unexplored so far. Here, we shed light on the subcellular localization of mARC1 and demonstrate that it is integrated into the outer mitochondrial membrane. The C-terminal catalytic domain of the protein remains exposed to the cytosol and confers an N-(in)-C-(out) membrane orientation of mARC1. This localization is triggered by the N terminus of the enzyme, being composed of a weak N-terminal mitochondrial targeting signal and a downstream transmembrane helix. We demonstrate the transmembrane domain of mARC1 to be sufficient for mitochondrial targeting and the N-terminal targeting signal to function as a supportive receptor for the outer mitochondrial membrane. According to its localization and targeting mechanism, we classify mARC1 as a novel signal-anchored mitochondrial protein. During mitochondrial import, mARC1 is not processed, and membrane integration proceeds membrane potential independently but requires external ATP, which finally results in the assembly of mARC1 into high oligomeric protein complexes.	[Klein, Julian M.; Busch, Jakob D.; Schwarz, Guenter] Univ Cologne, Dept Chem, Inst Biochem, D-50674 Cologne, Germany; [Potting, Christoph; Baker, Michael J.; Langer, Thomas] Univ Cologne, Ctr Mol Med, Inst Genet, D-50674 Cologne, Germany	University of Cologne; University of Cologne	Schwarz, G (corresponding author), Zuelpicher Str 47, D-50674 Cologne, Germany.	gschwarz@uni-koeln.de	Schwarz, Guenter/ABE-9643-2021; Schwarz, Guenter/F-2217-2013	Schwarz, Guenter/0000-0002-2118-9338; Langer, Thomas/0000-0003-1250-1462	Studienstiftung des Deutschen Volkes; German Science Foundation; Fonds der Chemischen Industrie	Studienstiftung des Deutschen Volkes; German Science Foundation(German Research Foundation (DFG)); Fonds der Chemischen Industrie(Fonds der Chemischen IndustrieEuropean Commission)	This work was supported by a grant from the Studienstiftung des Deutschen Volkes (to J. M. K.), the German Science Foundation (to G. S.), and the Fonds der Chemischen Industrie (to G. S.).	Bittner F, 2010, PLANT CELL MONOGR, V17, P119, DOI [10.1016/j.bbamcr.2006.03.013, 10.1007/978-3-642-10613-2_6]; BORGESE N, 1986, BIOCHEM J, V239, P393, DOI 10.1042/bj2390393; Borgese N, 1996, J CELL BIOL, V135, P1501, DOI 10.1083/jcb.135.6.1501; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; COHEN HJ, 1972, J BIOL CHEM, V247, P7759; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; FUJIKI Y, 1982, J CELL BIOL, V93, P97, DOI 10.1083/jcb.93.1.97; FUKUSHIMA K, 1972, J BIOCHEM, V71, P447; Gakh E, 2002, BBA-MOL CELL RES, V1592, P63, DOI 10.1016/S0167-4889(02)00265-3; Gruenewald S, 2008, J MED CHEM, V51, P8173, DOI 10.1021/jm8010417; HAHNE K, 1994, CELL, V79, P829, DOI 10.1016/0092-8674(94)90072-8; Havemeyer A, 2006, J BIOL CHEM, V281, P34796, DOI 10.1074/jbc.M607697200; ITO A, 1980, J BIOCHEM, V87, P63, DOI 10.1093/oxfordjournals.jbchem.a132753; John GB, 2005, MOL BIOL CELL, V16, P1543, DOI 10.1091/mbc.e04-08-0697; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kanaji S, 2000, J CELL BIOL, V151, P277, DOI 10.1083/jcb.151.2.277; Klein J. M., 2012, J CELL SCI, DOI 10.1242; Kotthaus J, 2011, BIOCHEM J, V433, P383, DOI 10.1042/BJ20100960; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; MCBRIDE HM, 1992, J CELL BIOL, V119, P1451, DOI 10.1083/jcb.119.6.1451; NASON A, 1971, P NATL ACAD SCI USA, V68, P3242, DOI 10.1073/pnas.68.12.3242; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Neve EPA, 2012, J BIOL CHEM, V287, P6307, DOI 10.1074/jbc.M111.328237; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schwarz G, 2006, ANNU REV PLANT BIOL, V57, P623, DOI 10.1146/annurev.arplant.57.032905.105437; Schwarz G, 2009, NATURE, V460, P839, DOI 10.1038/nature08302; SHORE GC, 1995, EUR J BIOCHEM, V227, P9, DOI 10.1111/j.1432-1033.1995.tb20354.x; Suzuki H, 2002, J CELL SCI, V115, P1895; WACHTER C, 1994, MOL BIOL CELL, V5, P465, DOI 10.1091/mbc.5.4.465; Wahl B, 2010, J BIOL CHEM, V285, P37847, DOI 10.1074/jbc.M110.169532; Walther DM, 2009, BBA-MOL CELL RES, V1793, P42, DOI 10.1016/j.bbamcr.2008.04.013; Wiese S, 2007, MOL CELL PROTEOMICS, V6, P2045, DOI 10.1074/mcp.M700169-MCP200	32	40	43	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42795	42803		10.1074/jbc.M112.419424	http://dx.doi.org/10.1074/jbc.M112.419424			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23086957	Green Published, hybrid			2022-12-25	WOS:000312501600038
J	Park, HR; Kong, KH; Yu, BP; Mattson, MP; Lee, J				Park, Hee Ra; Kong, Kyoung Hye; Yu, Byung Pal; Mattson, Mark P.; Lee, Jaewon			Resveratrol Inhibits the Proliferation of Neural Progenitor Cells and Hippocampal Neurogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; DIETARY RESTRICTION; DENTATE GYRUS; STEM-CELLS; ADULT MICE; LIFE-SPAN; NEURODEGENERATIVE DISORDERS; STIMULATES PROLIFERATION; MAMMALIAN BRAIN; RED WINE	Resveratrol is a phytoalexin and natural phenol that is present at relatively high concentrations in peanuts and red grapes and wine. Based upon studies of yeast and invertebrate models, it has been proposed that ingestion of resveratrol may also have anti-aging actions in mammals including humans. It has been suggested that resveratrol exerts its beneficial effects on health by activating the same cellular signaling pathways that are activated by dietary energy restriction (DR). Some studies have reported therapeutic actions of resveratrol in animal models of metabolic and neurodegenerative disorders. However, the effects of resveratrol on cell, tissue and organ function in healthy subjects are largely unknown. In the present study, we evaluated the potential effects of resveratrol on the proliferation and survival of neural progenitor cells (NPCs) in culture, and in the hippocampus of healthy young adult mice. Resveratrol reduced the proliferation of cultured mouse multi-potent NPCs, and activated AMP-activated protein kinase (AMPK), in a concentration-dependent manner. Administration of resveratrol to mice (1-10 mg/kg) resulted in activation of AMPK, and reduced the proliferation and survival of NPCs in the dentate gyrus of the hippocampus. Resveratrol down-regulated the levels of the phosphorylated form of cyclic AMP response element-binding protein (pCREB) and brain-derived neurotrophic factor (BDNF) in the hippocampus. Finally, resveratrol-treated mice exhibited deficits in hippocampus-dependent spatial learning and memory. Our findings suggest that resveratrol, unlike DR, adversely affects hippocampal neurogenesis and cognitive function by a mechanism involving activation of AMPK and suppression of CREB and BDNF signaling.	[Park, Hee Ra; Kong, Kyoung Hye; Lee, Jaewon] Pusan Natl Univ, Dept Pharm, Coll Pharm, Pusan 609735, South Korea; [Park, Hee Ra; Kong, Kyoung Hye; Lee, Jaewon] Pusan Natl Univ, Mol Inflammat Res Ctr Aging Intervent, Pusan 609735, South Korea; [Yu, Byung Pal] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Mattson, Mark P.] NIA, Neurosci Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA	Pusan National University; Pusan National University; University of Texas System; University of Texas Health San Antonio; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Lee, J (corresponding author), Pusan Natl Univ, Dept Pharm, Coll Pharm, Pusan 609735, South Korea.	neuron@pusan.ac.kr	Lee, Jaewon/N-9064-2013	Lee, Jaewon/0000-0003-3203-2130	Intramural Research Program of the NIA, National Institutes of Health; National Research Foundation of Korea (NRF); Korea government (MEST) [2009-0083538]; Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A084225]	Intramural Research Program of the NIA, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea	This work was supported, in part, by the Intramural Research Program of the NIA, National Institutes of Health. This research was supported by the National Research Foundation of Korea (NRF) funded by the Korea government (MEST) (Grant no. 2009-0083538). This research was also supported by a grant of the Korea Healthcare Technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea (No. A084225).	Albani D, 2010, BIOFACTORS, V36, P370, DOI 10.1002/biof.118; Anderson MF, 2002, DEV BRAIN RES, V134, P115; Athar M, 2007, TOXICOL APPL PHARM, V224, P274, DOI 10.1016/j.taap.2006.12.025; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Bastianetto S, 2000, BRIT J PHARMACOL, V131, P711, DOI 10.1038/sj.bjp.0703626; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Ben Abdallah NMB, 2010, NEUROBIOL AGING, V31, P151, DOI 10.1016/j.neurobiolaging.2008.03.002; Blander G, 2005, J BIOL CHEM, V280, P9780, DOI 10.1074/jbc.M414080200; Blum R, 2005, PHYSIOLOGY, V20, P70, DOI 10.1152/physiol.00042.2004; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Briand LA, 2010, BRAIN RES, V1314, P219, DOI 10.1016/j.brainres.2009.11.002; Calabrese EJ, 2010, HUM EXP TOXICOL, V29, P980, DOI 10.1177/0960327110383625; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Cheng AW, 2003, DEV BIOL, V258, P319, DOI 10.1016/S0012-1606(03)00120-9; Choi SH, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-52; de la Lastra CA, 2005, MOL NUTR FOOD RES, V49, P405; Della-Morte D, 2009, NEUROSCIENCE, V159, P993, DOI 10.1016/j.neuroscience.2009.01.017; Deng W, 2010, NAT REV NEUROSCI, V11, P339, DOI 10.1038/nrn2822; Fusco S, 2012, P NATL ACAD SCI USA, V109, P621, DOI 10.1073/pnas.1109237109; Harada N, 2011, J NUTR BIOCHEM, V22, P1150, DOI 10.1016/j.jnutbio.2010.09.016; Hirsch C, 2007, EXP CELL RES, V313, P572, DOI 10.1016/j.yexcr.2006.11.002; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huang HM, 2005, ANN NY ACAD SCI, V1042, P349, DOI 10.1196/annals.1338.032; Joe AK, 2002, CLIN CANCER RES, V8, P893; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kang OH, 2009, PHARMACOL RES, V59, P330, DOI 10.1016/j.phrs.2009.01.009; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kim SJ, 2008, J BIOL CHEM, V283, P14497, DOI 10.1074/jbc.M708373200; Kim WR, 2012, BEHAV BRAIN RES, V227, P470, DOI 10.1016/j.bbr.2011.07.012; Kim Young-Ae, 2003, Journal of Medicinal Food, V6, P273; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Le Corre L, 2005, MOL NUTR FOOD RES, V49, P462, DOI 10.1002/mnfr.200400094; Learish RD, 2000, DEV BRAIN RES, V122, P97; Lee J, 2002, J NEUROCHEM, V82, P1367, DOI 10.1046/j.1471-4159.2002.01085.x; Lee J, 2002, J NEUROCHEM, V80, P539, DOI 10.1046/j.0022-3042.2001.00747.x; Lee J, 2000, J MOL NEUROSCI, V15, P99, DOI 10.1385/JMN:15:2:99; Leong CW, 2007, BIOCHEM BIOPH RES CO, V360, P173, DOI 10.1016/j.bbrc.2007.06.025; Liu ML, 2010, J BIOL CHEM, V285, P36387, DOI 10.1074/jbc.M110.169284; Lu KT, 2008, J AGR FOOD CHEM, V56, P6910, DOI 10.1021/jf8007212; Marambaud P, 2005, J BIOL CHEM, V280, P37377, DOI 10.1074/jbc.M508246200; Markus MA, 2008, CLIN INTERV AGING, V3, P331; Moriya J, 2011, BIOL PHARM BULL, V34, P354, DOI 10.1248/bpb.34.354; Niles LP, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-41; Oh YC, 2009, AM J CHINESE MED, V37, P1203, DOI 10.1142/S0192415X09007600; Orallo F, 2008, CURR MED CHEM, V15, P1887, DOI 10.2174/092986708785132951; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Palazuelos J, 2012, J BIOL CHEM, V287, P1198, DOI 10.1074/jbc.M111.291294; Park M, 2009, NEUROSCI LETT, V449, P201, DOI 10.1016/j.neulet.2008.11.007; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Ramprasath VR, 2010, EUR J CLIN NUTR, V64, P660, DOI 10.1038/ejcn.2010.77; Rattan R, 2005, J BIOL CHEM, V280, P39582, DOI 10.1074/jbc.M507443200; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Shukitt-Hale B, 2007, NEUROBIOL AGING, V28, P1187, DOI 10.1016/j.neurobiolaging.2006.05.031; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Valenzano DR, 2006, CURR BIOL, V16, P296, DOI 10.1016/j.cub.2005.12.038; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Vingtdeux V, 2010, J BIOL CHEM, V285, P9100, DOI 10.1074/jbc.M109.060061; Wang QL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017234; Whitney NP, 2009, J NEUROCHEM, V108, P1343, DOI 10.1111/j.1471-4159.2009.05886.x; Yang Y, 2006, NEUROREPORT, V17, P235, DOI 10.1097/01.wnr.0000199470.29357.8f; Zang Y, 2008, J BIOL CHEM, V283, P6201, DOI 10.1074/jbc.M708619200; Zang Y, 2009, J BIOL CHEM, V284, P6175, DOI 10.1074/jbc.M806887200; Zhang F, 2013, PHYTOTHER RES, V27, P344, DOI 10.1002/ptr.4734; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhou R, 2009, BRIT J PHARMACOL, V158, P462, DOI 10.1111/j.1476-5381.2009.00268.x	70	71	77	1	30	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42588	42600		10.1074/jbc.M112.406413	http://dx.doi.org/10.1074/jbc.M112.406413			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105098	Green Published, hybrid			2022-12-25	WOS:000312501600020
J	Dong, Q; Ji, YS; Cai, C; Chen, ZY				Dong, Qing; Ji, Yun-Song; Cai, Chang; Chen, Zhe-Yu			LIM Kinase 1 (LIMK1) Interacts with Tropomyosin-related Kinase B (TrkB) and Mediates Brain-derived Neurotrophic Factor (BDNF)-induced Axonal Elongation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; HIPPOCAMPAL-NEURONS; NEURITE EXTENSION; BDNF; RECEPTORS; PHOSPHORYLATION; MORPHOLOGY; SLINGSHOT; OUTGROWTH; DYNAMICS	BDNF/TrkB signaling plays critical roles in axonal outgrowth of neurons, the process of which requires the remodeling of the cytoskeleton structure, including microtubules and filamentous actin. However, the mechanism by which BDNF/TrkB signaling regulates cytoskeleton reorganization is still unclear. Here, we identified a novel interaction between LIMK1 and TrkB, which is required for the BDNF-induced axonal elongation. We demonstrated that BDNF-induced TrkB dimerization led to LIMK1 dimerization and transphosphorylation independent of TrkB kinase activity, which could further enhance the activation and stabilization of LIMK1. Moreover, activated LIMK1 translocated to the membrane fraction and phosphorylated its substrate cofilin, thus promoting actin polymerization and axonal elongation. Our findings provided evidence of a novel mechanism for the BDNF-mediated signal transduction leading to axonal elongation.	[Dong, Qing; Ji, Yun-Song; Cai, Chang; Chen, Zhe-Yu] Shandong Univ, Dept Neurobiol, Sch Med, Shandong Prov Key Lab Mental Disorders, Jinan 250012, Shandong, Peoples R China	Shandong University	Chen, ZY (corresponding author), Shandong Univ, Dept Neurobiol, Sch Med, Shandong Prov Key Lab Mental Disorders, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	zheyuchen@sdu.edu.cn			National Natural Science Foundation of China [31071254, 31130026]; National 973 Basic Research Program of China [2012CB911000, 2009CB941403]; State Program of National Natural Science Foundation of China for Innovative Research Group [81021001]; Independent Innovation Foundation of Shandong University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Basic Research Program of China(National Basic Research Program of China); State Program of National Natural Science Foundation of China for Innovative Research Group(National Natural Science Foundation of China (NSFC)); Independent Innovation Foundation of Shandong University	This work was supported by National Natural Science Foundation of China Grants 31071254 and 31130026, National 973 Basic Research Program of China Grants 2012CB911000 and 2009CB941403, State Program of National Natural Science Foundation of China for Innovative Research Group Grant 81021001, and the Independent Innovation Foundation of Shandong University.	Bagheri-Yarmand R, 2006, INT J CANCER, V118, P2703, DOI 10.1002/ijc.21650; Bartkowska K, 2010, ACTA NEUROBIOL EXP, V70, P454; BERNARD O, 1994, CELL GROWTH DIFFER, V5, P1159; Bernard O, 2007, INT J BIOCHEM CELL B, V39, P1071, DOI 10.1016/j.biocel.2006.11.011; Birkenfeld J, 2001, J NEUROCHEM, V78, P924, DOI 10.1046/j.1471-4159.2001.00500.x; Buchan AMJ, 2002, J BIOL CHEM, V277, P28431, DOI 10.1074/jbc.M201261200; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Cheng PL, 2011, P NATL ACAD SCI USA, V108, P18430, DOI 10.1073/pnas.1115907108; Claus C, 2011, J VIROL, V85, P3881, DOI 10.1128/JVI.02492-10; Cosker KE, 2008, J CELL SCI, V121, P796, DOI 10.1242/jcs.019166; Cunha C, 2010, FRONT MOL NEUROSCI, V3, DOI 10.3389/neuro.02.001.2010; Danzer SC, 2002, J NEUROSCI, V22, P9754; Endo M, 2003, J NEUROSCI, V23, P2527; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; Gehler S, 2004, J NEUROSCI, V24, P4363, DOI 10.1523/JNEUROSCI.0404-04.2004; Goldberg JL, 2003, GENE DEV, V17, P941, DOI 10.1101/gad.1062303; Goldberg JL, 2002, NEURON, V33, P689, DOI 10.1016/S0896-6273(02)00602-5; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Heitz F, 2009, BRIT J PHARMACOL, V157, P195, DOI 10.1111/j.1476-5381.2009.00057.x; Horita Y, 2008, J BIOL CHEM, V283, P6013, DOI 10.1074/jbc.M706538200; Huang SH, 2011, J NEUROSCI, V31, P10602, DOI 10.1523/JNEUROSCI.0436-11.2011; Labelle C, 2000, DEV BRAIN RES, V123, P1, DOI 10.1016/S0165-3806(00)00069-9; Li R, 2006, FASEB J, V20, P1218, DOI 10.1096/fj.05-5258fje; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Luikart BW, 2005, J NEUROSCI, V25, P3774, DOI 10.1523/JNEUROSCI.0041-05.2005; Matsui S, 2002, J BIOL CHEM, V277, P544, DOI 10.1074/jbc.M110153200; Meng YH, 2002, NEURON, V35, P121, DOI 10.1016/S0896-6273(02)00758-4; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Miyamoto Y, 2006, P NATL ACAD SCI USA, V103, P10444, DOI 10.1073/pnas.0603914103; Namekata K, 2010, P NATL ACAD SCI USA, V107, P7586, DOI 10.1073/pnas.0914514107; Nishimura Y, 2006, HISTOCHEM CELL BIOL, V126, P627, DOI 10.1007/s00418-006-0198-x; Ohira K, 2009, CURR NEUROPHARMACOL, V7, P276, DOI 10.2174/157015909790031210; PROSCHEL C, 1995, ONCOGENE, V11, P1271; Purcell AL, 2003, TRENDS NEUROSCI, V26, P625, DOI 10.1016/j.tins.2003.09.005; Rex CS, 2007, J NEUROSCI, V27, P3017, DOI 10.1523/JNEUROSCI.4037-06.2007; Rosso S, 2004, MOL BIOL CELL, V15, P3433, DOI 10.1091/mbc.E03-05-0328; Santos AR, 2010, PROG NEUROBIOL, V92, P505, DOI 10.1016/j.pneurobio.2010.08.004; Schecterson LC, 2010, DEV NEUROBIOL, V70, P332, DOI 10.1002/dneu.20767; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Shen K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001842; Tahirovic S, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001644; Takahashi H, 1998, BIOCHEM BIOPH RES CO, V249, P138, DOI 10.1006/bbrc.1998.9094; Toda S, 2006, J NEUROSCI, V26, P1579, DOI 10.1523/JNEUROSCI.4132-05.2006; Tucker KL, 2002, PANMINERVA MED, V44, P325; Tursun B, 2005, GENE DEV, V19, P2307, DOI 10.1101/gad.1340605; Tyler WJ, 2002, LEARN MEMORY, V9, P224, DOI 10.1101/lm.51202; Yin YX, 2010, J NEUROCHEM, V114, P110, DOI 10.1111/j.1471-4159.2010.06745.x; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zhao L, 2009, J CELL SCI, V122, P3123, DOI 10.1242/jcs.047712	50	24	25	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41720	41731		10.1074/jbc.M112.405415	http://dx.doi.org/10.1074/jbc.M112.405415			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086941	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000312103000014
J	Kaneiwa, T; Miyazaki, A; Kogawa, R; Mizumoto, S; Sugahara, K; Yamada, S				Kaneiwa, Tomoyuki; Miyazaki, Anzu; Kogawa, Ryo; Mizumoto, Shuji; Sugahara, Kazuyuki; Yamada, Shuhei			Identification of Amino Acid Residues Required for the Substrate Specificity of Human and Mouse Chondroitin Sulfate Hydrolase (Conventional Hyaluronidase-4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL-CORD-INJURY; DERMATAN SULFATE; PROTEOGLYCANS; EXPRESSION; GENES; FRAGMENTS; ENZYMES; BIOLOGY; PROTEIN; SYSTEM	Human hyaluronidase-4 (hHYAL4), a member of the hyaluronidase family, has no hyaluronidase activity, but is a chondroitin sulfate (CS)-specific endo-beta-N-acetylgalactosaminidase. The expression of hHYAL4 is not ubiquitous but restricted to placenta, skeletal muscle, and testis, suggesting that hHYAL4 is not involved in the systemic catabolism of CS, but rather has specific functions in particular organs or tissues. To elucidate the function of hyaluronidase-4 in vivo, mouse hyaluronidase-4 (mHyal4) was characterized. mHyal4 was also demonstrated to be a CS-specific endo-beta-N-acetylgalactosaminidase. However, mHyal4 and hHYAL4 differed in the sulfate groups they recognized. Although hHYAL4 strongly preferred GlcUA(2-O-sulfate)- GalNAc(6-O-sulfate)-containing sequences typical in CSD, where GlcUA represents D-glucuronic acid, mHyal4 depolymerized various CS isoforms to a similar extent, suggesting broad substrate specificity. To identify the amino acid residues responsible for this difference, a series of human/mouse HYAL4 chimeric proteins and HYAL4 point mutants were generated, and their preference for substrates was investigated. A combination of the amino acid residues at 261-265 and glutamine at 305 was demonstrated to be essential for the enzymatic activity as well as substrate specificity of mHyal4.	[Yamada, Shuhei] Meijo Univ, Fac Pharm, Dept Pathobiochem, Tempaku Ku, Nagoya, Aichi 4688503, Japan; [Kaneiwa, Tomoyuki; Miyazaki, Anzu; Kogawa, Ryo; Mizumoto, Shuji; Sugahara, Kazuyuki; Yamada, Shuhei] Hokkaido Univ, Grad Sch Life Sci, Lab Proteoglycan Signaling & Therapeut, Sapporo, Hokkaido 0010021, Japan	Meijo University; Hokkaido University	Yamada, S (corresponding author), Meijo Univ, Fac Pharm, Dept Pathobiochem, Tempaku Ku, 150 Yagotoyama, Nagoya, Aichi 4688503, Japan.	shuheiy@meijo-u.ac.jp	Mizumoto, Shuji/F-8313-2018	Mizumoto, Shuji/0000-0002-4641-1505	Matching Program for Innovations in Future Drug Discovery and Medical Care from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); Mizutani Foundation for Glycoscience Tokyo, Japan;  [C-24590071]	Matching Program for Innovations in Future Drug Discovery and Medical Care from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT); Mizutani Foundation for Glycoscience Tokyo, Japan; 	This work was supported in part by Grant-in-aid for Scientific Research C-24590071 (to S.Y.) and the Matching Program for Innovations in Future Drug Discovery and Medical Care (to K.S.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT), and the Mizutani Foundation for Glycoscience (to S.Y.), Tokyo, Japan.	Achur RN, 2000, J BIOL CHEM, V275, P40344, DOI 10.1074/jbc.M006398200; Akatsu C, 2011, GLYCOBIOLOGY, V21, P565, DOI 10.1093/glycob/cwq208; Alilain WJ, 2011, NATURE, V475, P196, DOI 10.1038/nature10199; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Couchman JR, 2010, ANNU REV CELL DEV BI, V26, P89, DOI 10.1146/annurev-cellbio-100109-104126; Csoka AB, 1999, GENOMICS, V60, P356, DOI 10.1006/geno.1999.5876; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Kaneiwa T, 2008, J BIOL CHEM, V283, P14971, DOI 10.1074/jbc.M709236200; Kaneiwa T, 2010, GLYCOBIOLOGY, V20, P300, DOI 10.1093/glycob/cwp174; Kawashima H, 2002, J BIOL CHEM, V277, P12921, DOI 10.1074/jbc.M200396200; Kim E, 2005, P NATL ACAD SCI USA, V102, P18028, DOI 10.1073/pnas.0506825102; Kinoshita A, 1999, ANAL BIOCHEM, V269, P367, DOI 10.1006/abio.1999.4027; KOOPMAN P, 1990, NATURE, V348, P450, DOI 10.1038/348450a0; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; LIN Y, 1994, J CELL BIOL, V125, P1157, DOI 10.1083/jcb.125.5.1157; Lokeshwar VB, 2001, J BIOL CHEM, V276, P11922, DOI 10.1074/jbc.M008432200; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; Rauch U, 2006, ADV PHARMACOL, V53, P337, DOI 10.1016/S1054-3589(05)53016-3; Stern R, 2006, CHEM REV, V106, P818, DOI 10.1021/cr050247k; Stern R, 2008, SEMIN CANCER BIOL, V18, P275, DOI 10.1016/j.semcancer.2008.03.017; Stern R, 2006, EUR J CELL BIOL, V85, P699, DOI 10.1016/j.ejcb.2006.05.009; Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011; Sugahara K, 2000, TRENDS GLYCOSCI GLYC, V12, P321, DOI 10.4052/tigg.12.321; Sugahara KN, 2008, CANCER RES, V68, P7191, DOI 10.1158/0008-5472.CAN-07-6198; Uyama T., 2007, COMPR GLYCOSCI, V3, P79; VLODAVSKY I, 1990, CANCER METAST REV, V9, P203, DOI 10.1007/BF00046361; Yamada Shuhei, 2008, Curr Drug Discov Technol, V5, P289; Zhang L, 2009, J BIOL CHEM, V284, P9433, DOI 10.1074/jbc.M900210200	33	23	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42119	42128		10.1074/jbc.M112.360693	http://dx.doi.org/10.1074/jbc.M112.360693			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086929	Green Published, hybrid			2022-12-25	WOS:000312103000050
J	Liu, Z; Tian, YJ; Machida, K; Lai, MMC; Luo, GX; Foung, SKH; Ou, JHJ				Liu, Zhe; Tian, Yongjun; Machida, Keigo; Lai, Michael M. C.; Luo, Guangxiang; Foung, Steven K. H.; Ou, Jing-Hsiung James			Transient Activation of the PI3K-AKT Pathway by Hepatitis C Virus to Enhance Viral Entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR CLASS-B; HIGH-DENSITY-LIPOPROTEIN; MICROVILLAR CHANNEL FORMATION; I SR-BI; SCAVENGER RECEPTOR; SIGNALING PATHWAY; INSULIN-RESISTANCE; PI3K/AKT PATHWAY; PLASMA-MEMBRANE; CELL-CULTURE	The PI3K-AKT signaling pathway plays an important role in cell growth and metabolism. Here we report that hepatitis C virus (HCV) transiently activates the PI3K-AKT pathway. This activation was observed as early as 15 min postinfection, peaked by 30 min, and became undetectable at 24 h postinfection. The activation of AKT could also be mediated by UV-inactivated HCV, HCV pseudoparticle, and the ectodomain of the HCV E2 envelope protein. Because antibodies directed against CD81 and claudin-1, but not antibodies directed against scavenger receptor class B type I or occludin, could also activate AKT, the interaction between HCV E2 and its two co-receptors CD81 and claudin-1 probably triggered the activation of AKT. This activation of AKT by HCV was important for HCV infectivity, because the silencing of AKT by siRNA or the treatment of cells with its inhibitors or with the inhibitor of its upstream regulator PI3K significantly inhibited HCV infection, whereas the expression of constitutively active AKT enhanced HCV infection. The PI3K-AKT pathway is probably involved in HCV entry, because the inhibition of this pathway could inhibit the entry of HCV pseudoparticle but not the VSV pseudoparticle into cells. Furthermore, the treatment of cells with the AKT inhibitor AKT-V prior to HCV infection inhibited HCV infection, whereas the treatment after HCV infection had no obvious effect. Taken together, our studies indicated that HCV transiently activates the PI3K-AKT pathway to facilitate its entry. These results provide important information for understanding HCV replication and pathogenesis and raised the possibility of targeting this cellular pathway to treat HCV patients.	[Liu, Zhe; Tian, Yongjun; Machida, Keigo; Lai, Michael M. C.; Ou, Jing-Hsiung James] Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90033 USA; [Luo, Guangxiang] Univ Kentucky, Coll Med, Dept Microbiol Immunol & Mol Genet, Lexington, KY 40506 USA; [Foung, Steven K. H.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA	University of Southern California; University of Kentucky; Stanford University	Ou, JHJ (corresponding author), Univ So Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, 2011 Zonal Ave,HMR-401, Los Angeles, CA 90033 USA.	jamesou@hsc.usc.edu	Lai, Michael M. C./I-7001-2012; Tian, Yongjun/F-8007-2011	Foung, Steven/0000-0001-7149-6160	National Institutes of Health [DK094652, AI083025]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083025, R01AI091953, R01AI097318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK094652 and AI083025.	Agarwal V, 2009, J BIOL CHEM, V284, P19427, DOI 10.1074/jbc.M109.003442; Banerjee S, 2008, J VIROL, V82, P2606, DOI 10.1128/JVI.01672-07; Bartenschlager R, 2004, ADV VIRUS RES, V63, P71, DOI 10.1016/S0065-3527(04)63002-8; Bartenschlager R, 2007, VIRUS RES, V127, P195, DOI 10.1016/j.virusres.2007.02.022; Benedicto I, 2009, J VIROL, V83, P8012, DOI 10.1128/JVI.00038-09; Bertaux C, 2006, J VIROL, V80, P4940, DOI 10.1128/JVI.80.10.4940-4948.2006; Bose SK, 2012, J VIROL, V86, P6315, DOI 10.1128/JVI.00050-12; Brass Volker, 2006, Int J Med Sci, V3, P29; COORAY S, 2007, APOPTOSIS CELL SIGNA, P57; Esfandiarei M, 2004, J VIROL, V78, P4289, DOI 10.1128/JVI.78.8.4289-4298.2004; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Farquhar MJ, 2008, J VIROL, V82, P8797, DOI 10.1128/JVI.00592-08; Feng SZ, 2011, J GEN VIROL, V92, P1688, DOI 10.1099/vir.0.030866-0; Flint M, 2006, J VIROL, V80, P11331, DOI 10.1128/JVI.00104-06; Gastaminza P, 2008, J VIROL, V82, P2120, DOI 10.1128/JVI.02053-07; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Guo HT, 2007, J VIROL, V81, P10072, DOI 10.1128/JVI.00541-07; Harris HJ, 2010, J BIOL CHEM, V285, P21092, DOI 10.1074/jbc.M110.104836; Huang ZH, 2003, BIOCHEMISTRY-US, V42, P3949, DOI 10.1021/bi0269207; Jiang JY, 2012, J VIROL, V86, P8987, DOI 10.1128/JVI.00004-12; Jiang JY, 2012, J VIROL, V86, P7256, DOI 10.1128/JVI.07222-11; Juntilla MM, 2010, BLOOD, V115, P4030, DOI 10.1182/blood-2009-09-241000; Keck ZY, 2007, J VIROL, V81, P1043, DOI 10.1128/JVI.01710-06; Keck ZY, 2011, J VIROL, V85, P10451, DOI 10.1128/JVI.05259-11; Kellner-Weibel G, 2000, BIOCHEMISTRY-US, V39, P221, DOI 10.1021/bi991666c; Kohaar I, 2010, J VIROL, V84, P6987, DOI 10.1128/JVI.00196-10; Lin KYK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001148; Liu SF, 2009, J VIROL, V83, P2011, DOI 10.1128/JVI.01888-08; LO SY, 1995, VIROLOGY, V213, P455, DOI 10.1006/viro.1995.0018; Patel RK, 2012, J VIROL, V86, P3595, DOI 10.1128/JVI.06625-11; Peng Y, 2004, MOL BIOL CELL, V15, P384, DOI 10.1091/mbc.e03-06-0445; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Rahaus M, 2007, CELL SIGNAL, V19, P312, DOI 10.1016/j.cellsig.2006.07.003; Reaven E, 1998, ENDOCRINOLOGY, V139, P2847, DOI 10.1210/en.139.6.2847; Reaven E, 2001, P NATL ACAD SCI USA, V98, P1613, DOI 10.1073/pnas.98.4.1613; Reaven E, 2000, J LIPID RES, V41, P343; Rigotti A, 1996, J BIOL CHEM, V271, P33545, DOI 10.1074/jbc.271.52.33545; Saeed MF, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000141; Sanchez EG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002754; Scarselli E, 2002, EMBO J, V21, P5017, DOI 10.1093/emboj/cdf529; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shin YK, 2007, J GEN VIROL, V88, P942, DOI 10.1099/vir.0.82483-0; Singh AB, 2011, GASTROENTEROLOGY, V141, P2140, DOI 10.1053/j.gastro.2011.08.038; Street A, 2005, J VIROL, V79, P5006, DOI 10.1128/JVI.79.8.5006-5016.2005; Street A, 2004, J BIOL CHEM, V279, P12232, DOI 10.1074/jbc.M312245200; Toker A, 1997, NATURE, V387, P673, DOI 10.1038/42648; Urata S, 2012, J VIROL, V86, P4578, DOI 10.1128/JVI.06604-11; Williams DL, 2002, J LIPID RES, V43, P544; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Ye J, 2007, PLOS PATHOG, V3, P1017, DOI 10.1371/journal.ppat.0030108; Yu YJ, 2002, J VIROL, V76, P3731, DOI 10.1128/JVI.76.8.3731-3738.2002; Zeisel MB, 2011, J HEPATOL, V54, P566, DOI 10.1016/j.jhep.2010.10.014; Zhang C, 2005, MOL CELL BIOL, V25, P6899, DOI 10.1128/MCB.25.16.6899-6911.2005	55	68	68	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41922	41930		10.1074/jbc.M112.414789	http://dx.doi.org/10.1074/jbc.M112.414789			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23095753	Green Published, hybrid			2022-12-25	WOS:000312103000032
J	Alten, L; Schuster-Gossler, K; Eichenlaub, MP; Wittbrodt, B; Wittbrodt, J; Gossler, A				Alten, Leonie; Schuster-Gossler, Karin; Eichenlaub, Michael P.; Wittbrodt, Beate; Wittbrodt, Joachim; Gossler, Achim			A Novel Mammal-Specific Three Partite Enhancer Element Regulates Node and Notochord-Specific Noto Expression	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; WHOLE-GENOME DATA; GENE-EXPRESSION; HPRT LOCUS; KUPFFERS VESICLE; MOUSE; ORGANIZER; INDUCTION; PLATE; NODE/NOTOCHORD	The vertebrate organizer and notochord have conserved, essential functions for embryonic development and patterning. The restricted expression of developmental regulators in these tissues is directed by specific cis-regulatory modules (CRMs) whose sequence conservation varies considerably. Some CRMs have been conserved throughout vertebrates and likely represent ancestral regulatory networks, while others have diverged beyond recognition but still function over a wide evolutionary range. Here we identify and characterize a mammalian-specific CRM required for node and notochord specific (NNC) expression of NOTO, a transcription factor essential for node morphogenesis, nodal cilia movement and establishment of laterality in mouse. A 523 bp enhancer region (NOCE) upstream the Noto promoter was necessary and sufficient for NNC expression from the endogenous Noto locus. Three subregions in NOCE together mediated full activity in vivo. Binding sites for known transcription factors in NOCE were functional in vitro but dispensable for NOCE activity in vivo. A FOXA2 site in combination with a novel motif was necessary for NOCE activity in vivo. Strikingly, syntenic regions in non-mammalian vertebrates showed no recognizable sequence similarities. In contrast to its activity in mouse NOCE did not drive NNC expression in transgenic fish. NOCE represents a novel, mammal-specific CRM required for the highly restricted Noto expression in the node and nascent notochord and thus regulates normal node development and function.	[Alten, Leonie; Schuster-Gossler, Karin; Gossler, Achim] Hannover Med Sch, Inst Mol Biol, Hannover, Germany; [Eichenlaub, Michael P.; Wittbrodt, Beate; Wittbrodt, Joachim] Univ Heidelberg, Ctr Organismal Studies, Heidelberg, Germany	Hannover Medical School; Ruprecht Karls University Heidelberg	Gossler, A (corresponding author), Hannover Med Sch, Inst Mol Biol, Hannover, Germany.	Gossler.Achim@mh-hannover.de	Wittbrodt, Joachim/D-4735-2014	Wittbrodt, Joachim/0000-0001-8550-7377	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation); DFG; EU FP7 CISSEM; DFG collaborative research center [SFB 488]; DFG-Project "Open Access Publizieren"	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); EU FP7 CISSEM; DFG collaborative research center(German Research Foundation (DFG)); DFG-Project "Open Access Publizieren"(German Research Foundation (DFG))	This work was financially supported by funding in the "Normalverfahren" from the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation), by the DFG funded Cluster of Excellence REBIRTH (From Regenerative Biology to Reconstructive Therapy) (AG), and by the EU FP7 CISSEM and the DFG collaborative research center SFB 488 (JW). Publication costs were supported by the DFG-Project "Open Access Publizieren." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkhalek Hanaa Ben, 2004, Genes Dev, V18, P1725; Alten L, 2012, DEVELOPMENT; ANG SL, 1994, CELL, V78, P561, DOI 10.1016/0092-8674(94)90522-3; Bagheri-Fam S, 2006, DEV BIOL, V291, P382, DOI 10.1016/j.ydbio.2005.11.013; Beckers A, 2007, P NATL ACAD SCI USA, V104, P15765, DOI 10.1073/pnas.0704344104; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Blechinger SR, 2002, MECH DEVELOP, V112, P213, DOI 10.1016/S0925-4773(01)00652-9; Blum M, 2007, DIFFERENTIATION, V75, P133, DOI 10.1111/j.1432-0436.2006.00124.x; Bronson SK, 1996, P NATL ACAD SCI USA, V93, P9067, DOI 10.1073/pnas.93.17.9067; Camus A, 1999, CURR TOP DEV BIOL, V45, P117, DOI 10.1016/S0070-2153(08)60315-4; Cvetkovic B, 2000, J BIOL CHEM, V275, P1073, DOI 10.1074/jbc.275.2.1073; De Robertis EM, 2006, NAT REV MOL CELL BIO, V7, P296, DOI 10.1038/nrm1855; Essner JJ, 2005, DEVELOPMENT, V132, P1247, DOI 10.1242/dev.01663; Essner JJ, 2002, NATURE, V418, P37, DOI 10.1038/418037a; Evans V, 2000, PHYSIOL GENOMICS, V2, P67, DOI 10.1152/physiolgenomics.2000.2.2.67; GOSSLER A, 1989, SCIENCE, V244, P463, DOI 10.1126/science.2497519; Grabher C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S10; Halpern ME, 1995, DEVELOPMENT, V121, P4257; Heaney JD, 2004, GENOMICS, V83, P1072, DOI 10.1016/j.ygeno.2003.12.015; HOOPER M, 1987, NATURE, V326, P292, DOI 10.1038/326292a0; Iwamatsu T, 2004, MECH DEVELOP, V121, P605, DOI 10.1016/j.mod.2004.03.012; Kaestner KH, 2006, CELL MOL LIFE SCI; Knezevic V, 2001, GENESIS, V30, P264, DOI 10.1002/gene.1073; Kramer-Zucker AG, 2005, DEVELOPMENT, V132, P1907, DOI 10.1242/dev.01772; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Martin BL, 2008, DEV CELL, V15, P121, DOI 10.1016/j.devcel.2008.04.013; Melby AE, 1996, DEVELOPMENT, V122, P2225; Melby AE, 1997, DEV DYNAM, V209, P156; Merrill BJ, 2004, DEVELOPMENT, V131, P263, DOI 10.1242/dev.00935; Mongin E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019747; Nakaya MA, 2005, DEVELOPMENT, V132, P5425, DOI 10.1242/dev.02149; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; Nishizaki Y, 2001, MECH DEVELOP, V102, P57, DOI 10.1016/S0925-4773(01)00281-7; Passamaneck YJ, 2009, DEVELOPMENT, V136, P3679, DOI 10.1242/dev.038141; Plouhinec JL, 2004, GENE EXPR PATTERNS, V5, P11, DOI 10.1016/j.modgep.2004.06.010; Raney BJ, 2011, NUCLEIC ACIDS RES, V39, pD871, DOI 10.1093/nar/gkq1017; Rastegar S, 2008, DEV BIOL, V318, P366, DOI 10.1016/j.ydbio.2008.03.034; Rembold M, 2006, NAT PROTOC, V1, P1133, DOI 10.1038/nprot.2006.165; Rosenbloom KR, 2012, NUCLEIC ACIDS RES, V40, pD912, DOI 10.1093/nar/gkr1012; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sasaki H, 1996, GENES CELLS, V1, P59, DOI 10.1046/j.1365-2443.1996.04004.x; Sawada A, 2005, DEVELOPMENT, V132, P4719, DOI 10.1242/dev.02059; SCHUSTERGOSSLER K, 1994, TRANSGENICS, V1, P281; Schweickert A, 2010, CURR BIOL, V20, P738, DOI 10.1016/j.cub.2010.02.061; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; STEIN S, 1995, MECH DEVELOP, V49, P37, DOI 10.1016/0925-4773(94)00300-C; Stemple DL, 2005, DEVELOPMENT, V132, P2503, DOI 10.1242/dev.01812; SULIK K, 1994, DEV DYNAM, V201, P260, DOI 10.1002/aja.1002010309; TALBOT WS, 1995, NATURE, V378, P150, DOI 10.1038/378150a0; Tam P. P. L., 2004, GASTRULATION CELLS E, P233; Tamplin OJ, 2011, DEV BIOL, V360, P415, DOI 10.1016/j.ydbio.2011.10.002; Touw K, 2006, AM J PHYSL CELL PHYS; Viebahn C, 2001, GENESIS, V29, P96, DOI 10.1002/1526-968X(200102)29:2<96::AID-GENE1010>3.0.CO;2-H; VONDASSOW G, 1993, GENE DEV, V7, P355, DOI 10.1101/gad.7.3.355; Zachgo J, 1994, MOL ANAL MAMMALIAN D	56	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e47785	10.1371/journal.pone.0047785	http://dx.doi.org/10.1371/journal.pone.0047785			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110100	Green Submitted, Green Published, gold			2022-12-25	WOS:000310193400017
J	An, FM; Yamanaka, S; Allen, S; Roberts, LR; Gores, GJ; Pawlik, TM; Xie, Q; Ishida, M; Mezey, E; Ferguson-Smith, AC; Mori, Y; Selaru, FM				An, Fangmei; Yamanaka, Sumitaka; Allen, Sarah; Roberts, Lewis R.; Gores, Gregory J.; Pawlik, Timothy M.; Xie, Qing; Ishida, Masaharu; Mezey, Esteban; Ferguson-Smith, Anne C.; Mori, Yuriko; Selaru, Florin M.			Silencing of miR-370 in Human Cholangiocarcinoma by Allelic Loss and Interleukin-6 Induced Maternal to Paternal Epigenotype Switch	PLOS ONE			English	Article							INTRAHEPATIC CHOLANGIOCARCINOMA; EPIGENETIC ALTERATIONS; GENE-EXPRESSION; COLON-CANCER; GROWTH; PATHWAY; MICE; CHOLANGIOCYTES; METHYLATION; RELAXATION	Cholangiocarcinoma (CCA) is a highly lethal malignant tumor arising from the biliary tract epithelium. Interleukin-6 (IL-6) is a major mediator of inflammation and contributor to carcinogenesis within the biliary tree. Previous studies suggested that enforced IL-6 contributes to cholangiocarcinogenesis through hypermethylation of several genes implicated in CCA. However, the precise mechanisms of IL-6 effects in CCA remain unclear. We now demonstrate that microRNA (miR)-370 is underexpressed in a large cohort of human CCA vs. normal liver tissues. In addition, we show that IL-6 induces a time-dependent silencing of miR-370. In addition, demethylation of CCA cells results in upregulation of miR-370. Furthermore, we demonstrate that miR-370 is imprinted, and that the Intergenic Differentially Methylated Region (IG-DMR) responsible for imprinting regulation of this genomic locus is hypermethylated in response to IL-6 treatment. In addition, the IG-DMR is hypermethylated in human CCA specimens compared to normal matched controls, in the same location as the IL-6 induced hypermethylation. Finally, miR-370 was found to regulate WNT10B in luciferase as well as western blotting experiments. Our data indicate that the paternal allele of miR-370 is normally silenced through genomic imprinting and that the overexpression of IL-6 in CCA effectively suppresses the expression of miR-370 from the maternal allele, lending support to the theory that miR-370 silencing in human CCA follows a classic two-hit mechanism.	[An, Fangmei; Yamanaka, Sumitaka; Pawlik, Timothy M.; Ishida, Masaharu; Mezey, Esteban; Mori, Yuriko; Selaru, Florin M.] Johns Hopkins Univ Hosp, Div Gastroenterol & Hepatol, Baltimore, MD 21287 USA; [An, Fangmei; Xie, Qing] Shanghai Jiao Tong Univ, Sch Med, Dept Infect Dis, Ruijin Hosp, Shanghai 200030, Peoples R China; [An, Fangmei] Nanjing Med Univ, Wuxi Peoples Hosp, Dept Gastroenterol, Wuxi, Jiangsu, Peoples R China; [Allen, Sarah; Ferguson-Smith, Anne C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Roberts, Lewis R.; Gores, Gregory J.] Mayo Clin, Coll Med, Div Gastroenterol, Rochester, MN USA; [Roberts, Lewis R.; Gores, Gregory J.] Mayo Clin, Coll Med, Div Hepatol, Rochester, MN USA	Johns Hopkins University; Johns Hopkins Medicine; Shanghai Jiao Tong University; Jiangnan University; Nanjing Medical University; University of Cambridge; Mayo Clinic; Mayo Clinic	Selaru, FM (corresponding author), Johns Hopkins Univ Hosp, Div Gastroenterol & Hepatol, Baltimore, MD 21287 USA.	fselaru1@jhmi.edu	An, Fangmei/AAV-6977-2021; Pawlik, Timothy/AAO-9335-2020	Selaru, Florin/0000-0001-7990-8238; Roberts, Lewis/0000-0001-7885-8574; Ferguson-Smith, Anne/0000-0002-7608-5894	Wendy Will Case Cancer Fund; Biotechnology and Biological Sciences Research Council (BBSRC) studentship; National Institutes of Health (NIH) [AA000626]; American Gastroenterological Association grant; Flight Attendants Medical Research Institute (FAMRI) grant [072119_YCSA]; Johns Hopkins Clinician Scientist Award; Pilot Project from the The Hopkins Conte Digestive Diseases Basic and Translational Research Core Center; NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK089502, K08DK090154] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA000626] Funding Source: NIH RePORTER	Wendy Will Case Cancer Fund; Biotechnology and Biological Sciences Research Council (BBSRC) studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Gastroenterological Association grant; Flight Attendants Medical Research Institute (FAMRI) grant; Johns Hopkins Clinician Scientist Award; Pilot Project from the The Hopkins Conte Digestive Diseases Basic and Translational Research Core Center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by the Wendy Will Case Cancer Fund (to Y.M.), by a Biotechnology and Biological Sciences Research Council (BBSRC) studentship to S.A., by an RO1 Award (AA000626) from the National Institutes of Health (NIH) to E. M., by an American Gastroenterological Association grant to F.M.S. (Fellowship to Faculty Transition Award), by a Flight Attendants Medical Research Institute (FAMRI) grant (072119_YCSA) to F. M. S., by the Johns Hopkins Clinician Scientist Award to F.M.S., by a Pilot Project from the The Hopkins Conte Digestive Diseases Basic and Translational Research Core Center to F. M. S., and by a K08 Award (DK090154-01) from the NIH to F.M.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barlow DP, 2011, ANNU REV GENET, V45, P379, DOI 10.1146/annurev-genet-110410-132459; BARLOW DP, 1991, NATURE, V349, P84, DOI 10.1038/349084a0; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Blechacz B, 2008, HEPATOLOGY, V48, P308, DOI 10.1002/hep.22310; Boumber Y, 2011, ONCOLOGY-NY, V25, P220; Brown KW, 1996, HUM MOL GENET, V5, P2027, DOI 10.1093/hmg/5.12.2027; Cazals-Hatem D, 2004, J HEPATOL, V41, P292, DOI 10.1016/j.jhep.2004.04.030; CROUSE HV, 1960, GENETICS, V45, P1429; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; FERGUSONSMITH AC, 1991, NATURE, V351, P667, DOI 10.1038/351667a0; Georgiades P, 2000, DEVELOPMENT, V127, P4719; Harris TM, 1998, ONCOGENE, V16, P203, DOI 10.1038/sj.onc.1201519; Isomoto H, 2009, ONCOL REP, V22, P227, DOI 10.3892/or_00000428; Kagami M, 2008, NAT GENET, V40, P237, DOI 10.1038/ng.2007.56; Kagami M, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000992; Kang YK, 2000, MODERN PATHOL, V13, P627, DOI 10.1038/modpathol.3880108; Khan NI, 2007, BRIT J HAEMATOL, V138, P338, DOI 10.1111/j.1365-2141.2007.06667.x; Lane TF, 1997, ONCOGENE, V15, P2133, DOI 10.1038/sj.onc.1201593; Lee S, 2002, AM J PATHOL, V161, P1015, DOI 10.1016/S0002-9440(10)64262-9; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Liu X, 2008, ONCOGENE, V27, P1478, DOI 10.1038/sj.onc.1210769; Meng F, 2008, ONCOGENE, V27, P378, DOI 10.1038/sj.onc.1210648; Meng F, 2006, J HEPATOL, V44, P1055, DOI 10.1016/j.jhep.2005.10.030; Mori Y, 2004, CANCER RES, V64, P2434, DOI 10.1158/0008-5472.CAN-03-3508; Mori Y, 2006, GASTROENTEROLOGY, V131, P797, DOI 10.1053/j.gastro.2006.06.006; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; Olaru AV, 2011, HEPATOLOGY; RAINIER S, 1993, NATURE, V362, P747, DOI 10.1038/362747a0; Randhawa GS, 1998, BLOOD, V91, P3144, DOI 10.1182/blood.V91.9.3144.3144_3144_3147; Razumilava N, HEPATOLOGY; Schwienbacher C, 2000, P NATL ACAD SCI USA, V97, P5445, DOI 10.1073/pnas.090087497; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Selaru FM, 2009, HEPATOLOGY, V49, P1595, DOI 10.1002/hep.22838; Sirica AE, 2005, HEPATOLOGY, V41, P5, DOI 10.1002/hep.20537; Steg A, 2006, J MOL DIAGN, V8, P76, DOI 10.2353/jmoldx.2006.040402; SUZUKI H, 1994, NAT GENET, V6, P332, DOI 10.1038/ng0494-332; Tischoff I, 2006, J HEPATO-BILIARY-PAN, V13, P274, DOI 10.1007/s00534-005-1055-3; Tsuneyama K, 2000, DIGEST DIS SCI, V45, P366, DOI 10.1023/A:1005429130150; Wehbe H, 2006, CANCER RES, V66, P10517, DOI 10.1158/0008-5472.CAN-06-2130; Yoshikawa H, 2007, MOL BIOL CELL, V18, P4292, DOI 10.1091/mbc.E06-10-0889; Zografos GN, 2011, HEPATOB PANCREAT DIS, V10, P10, DOI 10.1016/S1499-3872(11)60001-5; Zou TT, 2002, ONCOGENE, V21, P4855, DOI 10.1038/sj.onc.1205613; Zweers SJ, 2012, HEPATOLOGY	45	45	49	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e45606	10.1371/journal.pone.0045606	http://dx.doi.org/10.1371/journal.pone.0045606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110045	Green Submitted, Green Published, gold			2022-12-25	WOS:000310193400003
J	Ragnedda, G; Disanto, G; Giovannoni, G; Ebers, GC; Sotgiu, S; Ramagopalan, SV				Ragnedda, Giammario; Disanto, Giulio; Giovannoni, Gavin; Ebers, George C.; Sotgiu, Stefano; Ramagopalan, Sreeram V.			Protein-Protein Interaction Analysis Highlights Additional Loci of Interest for Multiple Sclerosis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LARGE GENE LISTS; SUSCEPTIBILITY LOCI; TYROSINE KINASE; RISK; 4-O-SULFOTRANSFERASES; METAANALYSIS; EXPRESSION; RESOURCES; FAMILY	Genetic factors play an important role in determining the risk of multiple sclerosis (MS). The strongest genetic association in MS is located within the major histocompatibility complex class II region (MHC), but more than 50 MS loci of modest effect located outside the MHC have now been identified. However, the relative candidate genes that underlie these associations and their functions are largely unknown. We conducted a protein-protein interaction (PPI) analysis of gene products coded in loci recently reported to be MS associated at the genome-wide significance level and in loci suggestive of MS association. Our aim was to identify which suggestive regions are more likely to be truly associated, which genes are mostly implicated in the PPI network and their expression profile. From three recent independent association studies, SNPs were considered and divided into significant and suggestive depending on the strength of the statistical association. Using the Disease Association Protein-Protein Link Evaluator tool we found that direct interactions among genetic products were significantly higher than expected by chance when considering both significant regions alone (p<0.0002) and significant plus suggestive (p<0.007). The number of genes involved in the network was 43. Of these, 23 were located within suggestive regions and many of them directly interacted with proteins coded within significant regions. These included genes such as SYK, IL-6, CSF2RB, FCLR3, EIF4EBP2 and CHST12. Using the gene portal BioGPS, we tested the expression of these genes in 24 different tissues and found the highest values among immune-related cells as compared to non-immune tissues (p<0.001). A gene ontology analysis confirmed the immune-related functions of these genes. In conclusion, loci currently suggestive of MS association interact with and have similar expression profiles and function as those significantly associated, highlighting the fact that more common variants remain to be found to be associated to MS.	[Ragnedda, Giammario; Disanto, Giulio; Ebers, George C.; Ramagopalan, Sreeram V.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Ragnedda, Giammario; Disanto, Giulio; Ebers, George C.; Ramagopalan, Sreeram V.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Neurosci Clin Neurol, Oxford OX3 9DU, England; [Ragnedda, Giammario] Univ Sassari, Div Neurol, Dept Clin & Expt Med, I-07100 Sassari, Italy; [Giovannoni, Gavin; Ramagopalan, Sreeram V.] Queen Mary Univ London, Barts & London Sch Med & Dent, Blizard Inst, London, England; [Sotgiu, Stefano] Univ Sassari, Dept Clin & Expt Med, Div Paediat Neuropsychiat, I-07100 Sassari, Italy; [Ramagopalan, Sreeram V.] London Sch Hyg & Trop Med, London WC1, England	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Sassari; University of London; Queen Mary University London; University of Sassari; University of London; London School of Hygiene & Tropical Medicine	Ramagopalan, SV (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	s.ramagopalan@qmul.ac.uk	sotgiu, stefano/M-1011-2017	McKeating, Jane/0000-0002-7229-5886; Ebers, George/0000-0003-4771-4177	Medical Research Council [G0801976]; Wellcome Trust [090532/Z/09/Z]; FISM-Fondazione Italiana Sclerosi Multipla-Cod [2010/B/5]; Bayer Schering Pharma; Multiple Sclerosis Society of the United Kingdom; Multiple Sclerosis Society of Canada Scientific Research Foundation; Medical Research Council [G0801975] Funding Source: researchfish; MRC [G0801975, G0801976] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); FISM-Fondazione Italiana Sclerosi Multipla-Cod(Fondazione Italiana Sclerosi Multipla (FISM)); Bayer Schering Pharma(Bayer AG); Multiple Sclerosis Society of the United Kingdom; Multiple Sclerosis Society of Canada Scientific Research Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by: the Medical Research Council [GRANT NUMBER G0801976]; the Wellcome Trust 090532/Z/09/Z and a research fellowship FISM-Fondazione Italiana Sclerosi Multipla-Cod.: [2010/B/5 to GD] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: GR reports no competing interest. GD reports no competing interest. GG serves on scientific advisory boards for Merck Serono and Biogen Idec and Vertex Pharmaceuticals; served on the editorial board of Multiple Sclerosis; has received speaker honoraria from Bayer Schering Pharma, Merck Serono, Biogen Idec, Pfizer Inc, Teva Pharmaceutical Industries Ltd.-sanofiaventis, Vertex Pharmaceuticals, Genzyme Corporation, Ironwood, and Novartis; has served as a consultant for Bayer Schering Pharma, Biogen Idec, GlaxoSmithKline, Merck Serono, Protein Discovery Laboratories, Teva Pharmaceutical Industries Ltd.-sanofi-aventis, UCB, Vertex Pharmaceuticals, GW Pharma, Novartis, and FivePrime; serves on the speakers bureau for Merck Serono; and has received research support from Bayer Schering Pharma, Biogen Idec, Merck Serono, Novartis, UCB, Merz Pharmaceuticals, LLC, Teva Pharmaceutical Industries Ltd.-sanofi-aventis, GW Pharma, and Ironwood. GCE serves on the editorial boards of the International Multiple Sclerosis Journal and Multiple Sclerosis and as Section Editor for BMC Medical Genetics; has received funding for travel or speaker honoraria from Bayer Schering Pharma, sanofi-aventis, Roche, and UCB; has served as a consultant to Biopartners, Bayer Schering Pharma, Howrey LLP, Heron Health, and Eli Lilly and Company; and receives research support from Bayer Schering Pharma, the Multiple Sclerosis Society of the United Kingdom, and the Multiple Sclerosis Society of Canada Scientific Research Foundation. SS reports no competing interest. SVR reports no competing interest.	Asquith KL, 2008, J IMMUNOL, V180, P1199, DOI 10.4049/jimmunol.180.2.1199; Bahlo M, 2009, NAT GENET, V41, P824, DOI 10.1038/ng.396; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Chen Q, 2008, MOL PSYCHIATR, V13, P930, DOI 10.1038/sj.mp.4002051; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; De Jager PL, 2009, NAT GENET, V41, P776, DOI 10.1038/ng.401; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Dyment DA, 2005, HUM MOL GENET, V14, P2019, DOI 10.1093/hmg/ddi206; Dyment DA, 2004, LANCET NEUROL, V3, P104, DOI 10.1016/S1474-4422(03)00663-X; Ebers GC, 2004, LANCET, V363, P1773, DOI 10.1016/S0140-6736(04)16304-6; EBERS GC, 1995, NATURE, V377, P150, DOI 10.1038/377150a0; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hesslein DGT, 2011, BLOOD, V117, P3087, DOI 10.1182/blood-2010-06-292219; Hiraoka N, 2000, J BIOL CHEM, V275, P20188, DOI 10.1074/jbc.M002443200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Kasper LH, 2010, NEUROLOGY, V74, pS2, DOI 10.1212/WNL.0b013e3181c97c8f; Kerrigan AM, 2011, TRENDS IMMUNOL, V32, P151, DOI 10.1016/j.it.2011.01.002; MADER S, 1995, MOL CELL BIOL, V15, P4990; Mikami T, 2003, J BIOL CHEM, V278, P36115, DOI 10.1074/jbc.M306044200; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; Moskvina V, 2009, MOL PSYCHIATR, V14, P252, DOI 10.1038/mp.2008.133; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Patsopoulos NA, 2011, ANN NEUROL, V70, P897, DOI 10.1002/ana.22609; Ramagopalan SV, 2010, LANCET NEUROL, V9, P727, DOI 10.1016/S1474-4422(10)70094-6; Ramagopalan SV, 2009, GENOME MED, V1, DOI 10.1186/gm105; Rossin EJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001273; Sanna S, 2010, NAT GENET, V42, P495, DOI 10.1038/ng.584; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Wang JH, 2011, GENOME MED, V3, DOI 10.1186/gm217; Weinblatt ME, 2010, NEW ENGL J MED, V363, P1303, DOI 10.1056/NEJMoa1000500; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Yamada T, 1998, J ALLERGY CLIN IMMUN, V101, P677, DOI 10.1016/S0091-6749(98)70177-0	33	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e46730	10.1371/journal.pone.0046730	http://dx.doi.org/10.1371/journal.pone.0046730			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094030	Green Published, gold, Green Submitted			2022-12-25	WOS:000312384500004
J	Kim, T; Kim, HR; Kim, K; Lee, C				Kim, Taekjun; Kim, HyungGoo R.; Kim, Kayeon; Lee, Choongkil			Modulation of V1 Spike Response by Temporal Interval of Spatiotemporal Stimulus Sequence	PLOS ONE			English	Article							PRIMARY VISUAL-CORTEX; LATERAL GENICULATE-NUCLEUS; CLASSICAL RECEPTIVE-FIELD; PRIMARY AUDITORY-CORTEX; SURROUND SUPPRESSION; FEEDBACK CONNECTIONS; GAMMA-OSCILLATIONS; SPATIAL SUMMATION; CORTICAL NETWORKS; MACAQUE MONKEYS	The spike activity of single neurons of the primary visual cortex (V1) becomes more selective and reliable in response to wide-field natural scenes compared to smaller stimuli confined to the classical receptive field (RF). However, it is largely unknown what aspects of natural scenes increase the selectivity of V1 neurons. One hypothesis is that modulation by surround interaction is highly sensitive to small changes in spatiotemporal aspects of RF surround. Such a fine-tuned modulation would enable single neurons to hold information about spatiotemporal sequences of oriented stimuli, which extends the role of V1 neurons as a simple spatiotemporal filter confined to the RF. In the current study, we examined the hypothesis in the V1 of awake behaving monkeys, by testing whether the spike response of single V1 neurons is modulated by temporal interval of spatiotemporal stimulus sequence encompassing inside and outside the RF. We used two identical Gabor stimuli that were sequentially presented with a variable stimulus onset asynchrony (SOA): the preceding one (S1) outside the RF and the following one (S2) in the RF. This stimulus configuration enabled us to examine the spatiotemporal selectivity of response modulation from a focal surround region. Although S1 alone did not evoke spike responses, visual response to S2 was modulated for SOA in the range of tens of milliseconds. These results suggest that V1 neurons participate in processing spatiotemporal sequences of oriented stimuli extending outside the RF.	[Kim, Taekjun; Kim, Kayeon; Lee, Choongkil] Seoul Natl Univ, Dept Psychol, Seoul, South Korea; [Kim, HyungGoo R.; Lee, Choongkil] Seoul Natl Univ, Program Brain Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Lee, C (corresponding author), Seoul Natl Univ, Dept Psychol, Seoul, South Korea.	cklee@snu.ac.kr	Kim, HyungGoo/L-1308-2019	Kim, HyungGoo/0000-0002-9106-4960; Kim, Taekjun/0000-0002-8376-8861; Kim, Kayeon/0000-0002-4565-9429	Korean Ministry of Education, Science and Technology; Seoul National University	Korean Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Seoul National University	This research was supported by the Cognitive Neuroscience Research Program of the Korean Ministry of Education, Science and Technology, and the Brain Fusion Program of the Seoul National University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitto HJ, 2008, NEURON, V57, P135, DOI 10.1016/j.neuron.2007.11.019; ALLMEN M, 1993, CVGIP-IMAG UNDERSTAN, V58, P338, DOI 10.1006/ciun.1993.1046; Alonso JM, 2006, PROG BRAIN RES, V154, P3, DOI 10.1016/S0079-6123(06)54001-4; Angelucci A, 2002, J NEUROSCI, V22, P8633; Angelucci A, 2006, PROG BRAIN RES, V154, P93, DOI 10.1016/S0079-6123(06)54005-1; Bair W, 2003, J NEUROSCI, V23, P7690; Bartos M, 2007, NAT REV NEUROSCI, V8, P45, DOI 10.1038/nrn2044; Benucci A, 2009, NAT NEUROSCI, V12, P1317, DOI 10.1038/nn.2398; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; Brosch M, 2000, CEREB CORTEX, V10, P1155, DOI 10.1093/cercor/10.12.1155; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; Brosch M, 2008, EXP BRAIN RES, V184, P349, DOI 10.1007/s00221-007-1109-7; Buonomano DV, 2009, NAT REV NEUROSCI, V10, P113, DOI 10.1038/nrn2558; BUONOMANO DV, 1995, SCIENCE, V267, P1028, DOI 10.1126/science.7863330; Buonomano DV, 2003, P NATL ACAD SCI USA, V100, P4897, DOI 10.1073/pnas.0736909100; Buonomano DV, 2000, J NEUROSCI, V20, P1129, DOI 10.1523/JNEUROSCI.20-03-01129.2000; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2547, DOI 10.1152/jn.00693.2001; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; Churchland AK, 2007, J NEUROPHYSIOL, V97, P272, DOI 10.1152/jn.00941.2005; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; GRINVALD A, 1994, J NEUROSCI, V14, P2545; Haider B, 2010, NEURON, V65, P107, DOI 10.1016/j.neuron.2009.12.005; Hasenstaub A, 2005, NEURON, V47, P423, DOI 10.1016/j.neuron.2005.06.016; Hedges JH, 2011, CURR BIOL, V21, P2023, DOI 10.1016/j.cub.2011.10.049; HORTON JC, 1991, ARCH OPHTHALMOL-CHIC, V109, P816, DOI 10.1001/archopht.1991.01080060080030; Hupe JM, 2001, J NEUROPHYSIOL, V85, P134, DOI 10.1152/jn.2001.85.1.134; Johnston A, 2006, CURR BIOL, V16, P472, DOI 10.1016/j.cub.2006.01.032; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; Kapadia MK, 1999, P NATL ACAD SCI USA, V96, P12073, DOI 10.1073/pnas.96.21.12073; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; KITANO M, 1995, EXP BRAIN RES, V104, P297; Komatsu H, 2006, NAT REV NEUROSCI, V7, P220, DOI 10.1038/nrn1869; Lee J, 2010, J NEUROPHYSIOL, V104, P2556, DOI 10.1152/jn.01040.2009; Levitt JB, 2002, VISUAL NEUROSCI, V19, P439, DOI 10.1017/S0952523802194065; Lewicki MS, 1998, NETWORK-COMP NEURAL, V9, pR53, DOI 10.1088/0954-898X/9/4/001; Li W, 2006, NEURON, V50, P951, DOI 10.1016/j.neuron.2006.04.035; Marr D., 1982, VISION; Muller JR, 2003, J NEUROPHYSIOL, V90, P822, DOI 10.1152/jn.00005.2003; NELSON SB, 1991, J NEUROSCI, V11, P344; NELSON SB, 1991, J NEUROSCI, V11, P357; Nikolic D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000260; Nishimoto S, 2011, J NEUROSCI, V31, P14551, DOI 10.1523/JNEUROSCI.6801-10.2011; Ozeki H, 2004, J NEUROSCI, V24, P1428, DOI 10.1523/JNEUROSCI.3852-03.2004; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Pena JL, 2001, SCIENCE, V292, P249, DOI 10.1126/science.1059201; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Pouille F, 2009, NAT NEUROSCI, V12, P1577, DOI 10.1038/nn.2441; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Ray S, 2010, NEURON, V67, P885, DOI 10.1016/j.neuron.2010.08.004; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Series P, 2003, J PHYSIOL-PARIS, V97, P453, DOI 10.1016/j.jphysparis.2004.01.023; Series P, 2002, VISION RES, V42, P2781, DOI 10.1016/S0042-6989(02)00302-4; Sohal VS, 2005, P NATL ACAD SCI USA, V102, P18638, DOI 10.1073/pnas.0509291102; Terao M, 2008, NAT NEUROSCI, V11, P541, DOI 10.1038/nn.2111; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; TOVEE MJ, 1993, J NEUROPHYSIOL, V70, P640, DOI 10.1152/jn.1993.70.2.640; VANSANTEN JPH, 1985, J OPT SOC AM A, V2, P300, DOI 10.1364/JOSAA.2.000300; Vinje WE, 2002, J NEUROSCI, V22, P2904, DOI 10.1523/JNEUROSCI.22-07-02904.2002; WAGNER H, 1987, J NEUROSCI, V7, P3105; Walker GA, 1999, J NEUROSCI, V19, P10536; Walker GA, 2000, VISUAL NEUROSCI, V17, P369, DOI 10.1017/S0952523800173055; Yin P, 2008, J NEUROPHYSIOL, V100, P3009, DOI 10.1152/jn.00828.2007; Yoon H, 2011, CHOICE RELATED LFP C, V483, P03	66	6	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47543	10.1371/journal.pone.0047543	http://dx.doi.org/10.1371/journal.pone.0047543			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091631	Green Published, Green Submitted, gold			2022-12-25	WOS:000310135800055
J	Papachristoforou, A; Kagiava, A; Papaefthimiou, C; Termentzi, A; Fokialakis, N; Skaltsounis, AL; Watkins, M; Arnold, G; Theophilidis, G				Papachristoforou, Alexandros; Kagiava, Alexia; Papaefthimiou, Chrisovalantis; Termentzi, Aikaterini; Fokialakis, Nikolas; Skaltsounis, Alexios-Leandros; Watkins, Max; Arnold, Gerard; Theophilidis, George			The Bite of the Honeybee: 2-Heptanone Secreted from Honeybee Mandibles during a Bite Acts as a Local Anaesthetic in Insects and Mammals	PLOS ONE			English	Article							RAT SCIATIC-NERVE; APIS-MELLIFERA-CARNICA; VARROA-DESTRUCTOR; SODIUM-CHANNELS; BEES; LIDOCAINE; BLOCK; NEUROTOXICITY; PHEROMONES; METABOLISM	Honeybees secrete 2-heptanone (2-H) from their mandibular glands when they bite. Researchers have identified several possible functions: 2-H could act as an alarm pheromone to recruit guards and soldiers, it could act as a chemical marker, or it could have some other function. The actual role of 2-H in honeybee behaviour remains unresolved. In this study, we show that 2-H acts as an anaesthetic in small arthropods, such as wax moth larva (WML) and Varroa mites, which are paralysed after a honeybee bite. We demonstrated that honeybee mandibles can penetrate the cuticle of WML, introducing less than one nanolitre of 2-H into the WML open circulatory system and causing instantaneous anaesthetization that lasts for a few minutes. The first indication that 2-H acts as a local anaesthetic was that its effect on larval response, inhibition and recovery is very similar to that of lidocaine. We compared the inhibitory effects of 2-H and lidocaine on voltage-gated sodium channels. Although both compounds blocked the hNav1.6 and hNav1.2 channels, lidocaine was slightly more effective, 2.82 times, on hNav.6. In contrast, when the two compounds were tested using an ex vivo preparation-the isolated rat sciatic nerve-the function of the two compounds was so similar that we were able to definitively classify 2-H as a local anaesthetic. Using the same method, we showed that 2-H has the fastest inhibitory effect of all alkyl-ketones tested, including the isomers 3- and 4-heptanone. This suggests that natural selection may have favoured 2-H over other, similar compounds because of the associated fitness advantages it confers. Our results reveal a previously unknown role of 2-H in honeybee defensive behaviour and due to its minor neurotoxicity show potential for developing a new local anaesthetic from a natural product, which could be used in human and veterinary medicine.	[Papachristoforou, Alexandros; Kagiava, Alexia; Papaefthimiou, Chrisovalantis; Theophilidis, George] Aristotle Univ Thessaloniki, Sch Biol, Physiol Anim Lab, GR-54006 Thessaloniki, Greece; [Papachristoforou, Alexandros; Arnold, Gerard] CNRS, Lab Evolut, Gif Sur Yvette, France; [Papachristoforou, Alexandros; Arnold, Gerard] Univ Paris 11, Orsay, France; [Papachristoforou, Alexandros] Cyprus Univ Technol, Dept Agr Sci Biotechnol & Food Sci, Limassol, Cyprus; [Kagiava, Alexia] Cyprus Inst Neurol & Genet Neurosci, Nicosia, Cyprus; [Termentzi, Aikaterini; Fokialakis, Nikolas; Skaltsounis, Alexios-Leandros] Univ Athens, Fac Pharm, Dept Pharmacognosy & Nat Prod Chem, Athens, Greece; [Watkins, Max] Vita Europe Ltd, Basingstoke, Hants, England	Aristotle University of Thessaloniki; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Cyprus University of Technology; National & Kapodistrian University of Athens	Papachristoforou, A (corresponding author), Aristotle Univ Thessaloniki, Sch Biol, Physiol Anim Lab, GR-54006 Thessaloniki, Greece.	papachri@legs.cnrs-gif.fr	Fokialakis, Nikolas/AAD-1498-2020; Theophilidis, George/AAJ-2273-2020; skaltsounis, alexios leandros/AAE-9617-2019	Fokialakis, Nikolas/0000-0001-7028-1870; Papachristoforou, Alexandros/0000-0001-8123-6848; Kagiava, Alexia/0000-0002-3903-1299	Vita (Europe) Limited, UK; Vita (Europe) Limited; ChanTest Corporation (Cleveland OH, US); Conseil General de l' Essonne	Vita (Europe) Limited, UK; Vita (Europe) Limited; ChanTest Corporation (Cleveland OH, US); Conseil General de l' Essonne	The research was directed and funded by Vita (Europe) Limited, UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors have read the journal's policy and have the following conflicts: the research was funded through Vita (Europe) Limited, a small UK company specialising only in honeybee health. MW works for this company. The original studies examined honeybee behaviour and they discovered the anaesthetisation properties of 2-H in the mammalian peripheral nervous systems as an extension to the honeybee biology work. Vita has now filed a patent on the potential use of 2-heptanone as a local anaesthetic (International Patent Application number: PCT/GB2012/050157). This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. All other authors have declared that no competing interests exist.; We thank the Cypriot Union of Beekeepers for providing the specimens for the trials. We thank Evagelos Gikas for analytical advice, Dimitris Fotaroudis for the statistical support, ChanTest Corporation (Cleveland OH, US) for the support on patch-clamp experiments and Sharilynn Wardrop for reviewing the paper. We thank Anais Carpentier for the support during SEM photography, which benefited from the facilities and expertise of the Imagif Cell Biology Unit of the Gif campus (www.imagif.cnrs.fr) which is supported by the Conseil General de l' Essonne.	ALBRO PW, 1984, CHEM-BIOL INTERACT, V51, P295, DOI 10.1016/0009-2797(84)90155-8; Aumeier P, 2001, APIDOLOGIE, V32, P81, DOI 10.1051/apido:2001113; BOCH R, 1971, J INSECT PHYSIOL, V17, P2277, DOI 10.1016/0022-1910(71)90077-1; BOCH R, 1970, J INSECT PHYSIOL, V16, P17, DOI 10.1016/0022-1910(70)90108-3; Boecking O, 1999, APIDOLOGIE, V30, P141, DOI 10.1051/apido:19990205; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; Couvillon MJ, 2010, J CHEM ECOL, V36, P1306, DOI 10.1007/s10886-010-9881-4; Cummins TR, 2007, J PHYSIOL-LONDON, V582, P11, DOI 10.1113/jphysiol.2007.136671; EISCHEN FA, 1986, ANIM BEHAV, V34, P1070, DOI 10.1016/S0003-3472(86)80166-X; Engels W, 1997, J INSECT PHYSIOL, V43, P307, DOI 10.1016/S0022-1910(96)00110-2; Feyereisen R, 2006, BIOCHEM SOC T, V34, P1252, DOI 10.1042/BST0341252; FREE JB, 1985, J AGR SCI, V105, P255, DOI 10.1017/S0021859600056318; FREE JB, 1968, Z VERGL PHYSIOL, V61, P361, DOI 10.1007/BF00428008; Geronikaki A, 2009, EUR J MED CHEM, V44, P473, DOI 10.1016/j.ejmech.2008.04.006; Hung YC, 2009, REGION ANESTH PAIN M, V34, P333, DOI 10.1097/AAP.0b013e3181ac7f49; IMAOKA S, 1990, J PHARMACOL EXP THER, V255, P1385; Jianguo T, 2009, NEUROTOXICOLOGY, V30, P81; Kagiava A, 2011, ANTI-CANCER DRUG, V22, P273, DOI 10.1097/CAD.0b013e3283425888; Kagiava A, 2008, NEUROTOXICOLOGY, V29, P1100, DOI 10.1016/j.neuro.2008.09.005; KALICHMAN MW, 1988, ACTA NEUROPATHOL, V75, P583, DOI 10.1007/BF00686203; Kanai Y, 2000, ANESTH ANALG, V91, P944, DOI 10.1097/00000539-200010000-00033; Koh YC, 2012, TOXICON, V4, P497; Kroin JS, 2010, REGION ANESTH PAIN M, V35, P343, DOI 10.1097/AAP.0b013e3181e82df0; LAMBERT LA, 1994, ANESTHESIOLOGY, V80, P1082, DOI 10.1097/00000542-199405000-00017; Lensky Y, 1995, BEE WORLD, V76, P119, DOI 10.1080/0005772X.1995.11099258; Leterrier C, 2010, NEUROSCI LETT, V486, P92, DOI 10.1016/j.neulet.2010.08.079; Lewis RJ, 2012, TOXICON, V59, P524, DOI 10.1016/j.toxicon.2011.07.012; Marder E, 2005, CURR BIOL, V15, pR685, DOI 10.1016/j.cub.2005.08.022; MISUMI J, 1984, BRIT J IND MED, V41, P526; Moschou M, 2008, TOXICOL IN VITRO, V22, P267, DOI 10.1016/j.tiv.2007.09.005; MYERS RR, 1986, ANESTHESIOLOGY, V64, P29, DOI 10.1097/00000542-198601000-00006; Nielsen CK, 2005, PAIN, V118, P112, DOI 10.1016/j.pain.2005.08.002; Papachristoforou A, 2011, PESTIC BIOCHEM PHYS, V101, P109, DOI 10.1016/j.pestbp.2011.08.008; Paterson BA, 2010, J EXP BIOL, V213, P2483, DOI 10.1242/jeb.043026; PATTE F, 1989, J INSECT PHYSIOL, V35, P667, DOI 10.1016/0022-1910(89)90086-3; RIETH JP, 1986, J APICULT RES, V25, P78, DOI 10.1080/00218839.1986.11100697; ROBINSON GE, 1985, J INSECT PHYSIOL, V31, P277, DOI 10.1016/0022-1910(85)90003-4; RUTTNER F, 1992, APIDOLOGIE, V23, P173, DOI 10.1051/apido:19920210; SCHMALBRUCH H, 1986, ANAT REC, V215, P71, DOI 10.1002/ar.1092150111; SHEARER DA, 1965, NATURE, V206, P530, DOI 10.1038/206530a0; Sheets PL, 2011, BRIT J PHARMACOL, V164, P719, DOI 10.1111/j.1476-5381.2011.01209.x; SLAMA K, 1984, J COMP PHYSIOL, V154, P635, DOI 10.1007/BF00684418; Song WZ, 2011, INSECT BIOCHEM MOLEC, V41, P36, DOI 10.1016/j.ibmb.2010.09.010; STRUYE MH, 1994, APIDOLOGIE, V25, P384, DOI 10.1051/apido:19940405; VALLET A, 1991, J INSECT PHYSIOL, V37, P789, DOI 10.1016/0022-1910(91)90076-C	45	28	29	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47432	10.1371/journal.pone.0047432	http://dx.doi.org/10.1371/journal.pone.0047432			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091624	Green Published, gold			2022-12-25	WOS:000310135800047
J	Fallone, F; Britton, S; Nieto, L; Salles, B; Muller, C				Fallone, F.; Britton, S.; Nieto, L.; Salles, B.; Muller, C.			ATR controls cellular adaptation to hypoxia through positive regulation of hypoxia-inducible factor 1 (HIF-1) expression	ONCOGENE			English	Article						ATR; PIKK; hypoxia; HIF-1 alpha regulation; translation; replicative stress	DEPENDENT PROTEIN-KINASE; DNA-DAMAGE; MESSENGER-RNA; REQUIRES ATM; CANCER-CELLS; TUMOR-CELLS; PHOSPHORYLATION; HIF-1-ALPHA; INHIBITION; TRANSLATION	Tumor cells adaptation to severe oxygen deprivation (hypoxia) plays a major role in tumor progression. The transcription factor HIF-1 (hypoxia-inducible factor 1), whose alpha-subunit is stabilized under hypoxic conditions is a key component of this process. Recent studies showed that two members of the phosphoinositide 3-kinase-related kinases (PIKKs) family, ATM (ataxia telangiectasia mutated) and DNA-PK (DNA-dependent protein kinase), regulate the hypoxic-dependent accumulation of HIF-1. These proteins initiate cellular stress responses when DNA damage occurs. In addition, it has been demonstrated that extreme hypoxia induces a replicative stress resulting in regions of single-stranded DNA at stalled replication forks and the activation of ATR (ataxia telangiectasia and Rad3 related protein), another member of the PIKKs family. Here, we show that even less severe hypoxia (0.1% O-2) also induces activation of ATR through replicative stress. Importantly, in using either transiently silenced ATR cells, cells expressing an inactive form of ATR or cells exposed to an ATR inhibitor (CGK733), we demonstrate that hypoxic ATR activation positively regulates the key transcription factor HIF-1 independently of the checkpoint kinase Chk1. We show that ATR kinase activity regulates HIF-1 alpha at the translational level and we find that the elements necessary for the regulation of HIF-1 alpha translation are located within the coding region of HIF-1 alpha mRNA. Finally, by using three independent cellular models, we clearly show that the loss of ATR expression and/or kinase activity results in the decrease of HIF-1 DNA binding under hypoxia and consequently affects protein expression levels of two HIF-1 target genes, GLUT-1 and CAIX. Taken together, our data show a new function for ATR in cellular adaptation to hypoxia through regulation of HIF-1 alpha translation. Our work offers new prospect for cancer therapy using ATR inhibitors with the potential to decrease cellular adaptation in hypoxic tumors.	[Fallone, F.; Britton, S.; Nieto, L.; Salles, B.; Muller, C.] CNRS, IPBS, Toulouse, France; [Fallone, F.; Britton, S.; Nieto, L.; Salles, B.; Muller, C.] Univ Toulouse, UPS, IPBS, Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Muller, C (corresponding author), CNRS, UMR5089, IPBS, 205 Route Narbonne,BP 6418231077, Toulouse, France.	muller@ipbs.fr	Nieto, Laurence/AAJ-5703-2021; Britton, Sébastien/AAL-1862-2020; MULLER, Catherine/E-2060-2011; MULLER, Catherine/M-2185-2018	Nieto, Laurence/0000-0002-1006-0168; Britton, Sébastien/0000-0002-7008-5316; 	'Ligue Nationale Contre le Cancer' (Equipe Labelisee); Canceropole GSO; Association contre le Cancer, ARC; Radioprotection Committee of EDF	'Ligue Nationale Contre le Cancer' (Equipe Labelisee)(Ligue nationale contre le cancer); Canceropole GSO; Association contre le Cancer, ARC; Radioprotection Committee of EDF	We thank Catherine Botanch, Emilie Mirey and Christine Bordier for their help, Dr Nathalie Mazure and Dr Delphine Larrieu for critical comments on the manuscript and Aymeric Poizot for English rereading. We acknowledge Dr P Calsou, Dr Y Martineau and Dr S Pyronnet for technical advices and reagents. This work was supported by the 'Ligue Nationale Contre le Cancer' (Equipe Labelisee, BS), the Canceropole GSO (BS and CM), the Association contre le Cancer, ARC (2008-1102, CM) and the Radioprotection Committee of EDF (CM).	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Abraham RT, 2003, CURR TOP MICROBIOL, V279, P299; Adams KE, 2006, ONCOGENE, V25, P3894, DOI 10.1038/sj.onc.1209426; Airley RE, 2003, INT J CANCER, V104, P85, DOI 10.1002/ijc.10904; Bencokova Z, 2009, MOL CELL BIOL, V29, P526, DOI 10.1128/MCB.01301-08; Bouquet F, 2011, J CELL SCI, V124, P1943, DOI 10.1242/jcs.078030; Brahimi-Horn MC, 2007, BIOCHEM PHARMACOL, V73, P450, DOI 10.1016/j.bcp.2006.10.013; Brahimi-Horn MC, 2009, J CELL SCI, V122, P1055, DOI 10.1242/jcs.035022; Cam H, 2010, MOL CELL, V40, P509, DOI 10.1016/j.molcel.2010.10.030; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Crescenzi E, 2008, CLIN CANCER RES, V14, P1877, DOI 10.1158/1078-0432.CCR-07-4298; Cuadrado M, 2006, J EXP MED, V203, P297, DOI 10.1084/jem.20051923; Dolt KS, 2007, GENE, V386, P73, DOI 10.1016/j.gene.2006.08.004; Economopoulou M, 2009, NAT MED, V15, P553, DOI 10.1038/nm.1947; Galban S, 2008, MOL CELL BIOL, V28, P93, DOI 10.1128/MCB.00973-07; Gibson SL, 2005, CANCER RES, V65, P10734, DOI 10.1158/0008-5472.CAN-05-1160; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Hammond EM, 2004, CANCER RES, V64, P6556, DOI 10.1158/0008-5472.CAN-04-1520; Hammond EM, 2003, MUTAT RES-FUND MOL M, V532, P205, DOI 10.1016/j.mrfmmm.2003.08.017; Hammond EM, 2003, J BIOL CHEM, V278, P12207, DOI 10.1074/jbc.M212360200; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Kang MJ, 2008, FEBS J, V275, P5969, DOI 10.1111/j.1742-4658.2008.06725.x; Koh MY, 2008, TRENDS BIOCHEM SCI, V33, P526, DOI 10.1016/j.tibs.2008.08.002; Lang KJD, 2002, MOL BIOL CELL, V13, P1792, DOI 10.1091/mbc.02-02-0017; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Lei Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007629; Lopez-Contreras AJ, 2010, DNA REPAIR, V9, P1249, DOI 10.1016/j.dnarep.2010.09.012; Lou JJW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010522; Lovejoy CA, 2009, DNA REPAIR, V8, P1004, DOI 10.1016/j.dnarep.2009.04.006; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Martin L, 2012, ONCOGENE, V31, P4076, DOI 10.1038/onc.2011.585; Masuda K, 2009, J CELL MOL MED, V13, P2759, DOI 10.1111/j.1582-4934.2009.00842.x; Monferran S, 2004, EMBO J, V23, P3758, DOI 10.1038/sj.emboj.7600403; Monti Elena, 2011, Curr Mol Pharmacol, V4, P62; Moretti F, 2010, RNA, V16, P2493, DOI 10.1261/rna.2384610; Myers JS, 2006, J BIOL CHEM, V281, P9346, DOI 10.1074/jbc.M513265200; Nghiem P, 2001, P NATL ACAD SCI USA, V98, P9092, DOI 10.1073/pnas.161281798; Onnis B, 2009, J CELL MOL MED, V13, P2780, DOI 10.1111/j.1582-4934.2009.00876.x; Ousset M, 2010, CELL CYCLE, V9, P2814, DOI 10.4161/cc.9.14.12253; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Pereg Y, 2005, P NATL ACAD SCI USA, V102, P5056, DOI 10.1073/pnas.0408595102; Rapisarda A, 2007, ONCOGENE, V26, P6875, DOI 10.1038/sj.onc.1210489; Reaper PM, 2011, NAT CHEM BIOL, V7, P428, DOI [10.1038/NCHEMBIO.573, 10.1038/nchembio.573]; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2007, DRUG DISCOV TODAY, V12, P853, DOI 10.1016/j.drudis.2007.08.006; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; van Uden P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001285; Veuger SJ, 2003, CANCER RES, V63, P6008; Wan C, 2010, MUTAT RES-FUND MOL M, V686, P39, DOI 10.1016/j.mrfmmm.2009.12.012; Wang CX, 2011, J GASTROEN HEPATOL, V26, P1630, DOI 10.1111/j.1440-1746.2011.06758.x; Willmore E, 2004, BLOOD, V103, P4659, DOI 10.1182/blood-2003-07-2527; Zhong H, 2000, CANCER RES, V60, P1541; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430; Zundel W, 2000, GENE DEV, V14, P391	56	22	23	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 12	2013	32	37					4387	4396		10.1038/onc.2012.462	http://dx.doi.org/10.1038/onc.2012.462			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	218AF	23085754	Green Published			2022-12-25	WOS:000324404200007
J	Martino, JJ; Wall, BA; Mastrantoni, E; Wilimczyk, BJ; La Cava, SN; Degenhardt, K; White, E; Chen, S				Martino, J. J.; Wall, B. A.; Mastrantoni, E.; Wilimczyk, B. J.; La Cava, S. N.; Degenhardt, K.; White, E.; Chen, S.			Metabotropic glutamate receptor 1 (Grm1) is an oncogene in epithelial cells	ONCOGENE			English	Article						Grm1; glutamatergic signaling; oncogene; cell transformation; kidney epithelial cells; carcinoma	PROTEIN-COUPLED RECEPTORS; SIGNALING PATHWAYS; MALIGNANT-MELANOMA; HUMAN MELANOCYTES; TRANSGENIC MICE; CANCER; GROWTH; GLUTAMATE-RECEPTOR-1; EXPRESSION; TARGETS	Non-neuronal expression of components of the glutamatergic system has been increasingly observed, and our laboratory previously had demonstrated the etiological role of ectopically expressed metabotropic glutamate receptor 1 (Grm1/mGluR1) in mouse models of melanoma. We hypothesize that inappropriate glutamatergic signaling in other cell types can dysregulate growth leading to transformation and tumorigenesis. As most cancers are carcinomas, we selected an immortalized primary baby mouse kidney (iBMK) cell model to assess whether Grm1 can transform epithelial cells. These iBMK cells, engineered to be immortal yet nontumorigenic and retaining normal epithelial characteristics, were used as recipients for exogenous Grm1 cDNA. Several stable Grm1-expressing clones were isolated and the Grm1-receptors were shown to be functional, as evidenced by the accumulation of second messengers in response to Grm1 agonist. Additionally activated by agonist were mitogen-activated protein kinase (MAPK) and AKT/protein kinase B signaling cascades, the major intracellular pathways shown by many investigators to be critical in melanomagenesis and other neoplasms. These Grm1-iBMK cells exhibited enhanced cell proliferation in in vitro methylthiazolyldiphenyl-tetrazolium bromide (MTT) assays and significant tumorigenicity in in vivo allografts. Persistent Grm1 expression was required for the maintenance of the in vivo tumorigenic phenotype as demonstrated by an inducible Grm1-silencing RNA. These are the first results that indicate that Grm1 can be an oncogene in epithelial cells. In addition, relevance to human disease in the corresponding tumor type of renal cell carcinoma (RCC) may be suggested by observed expression of GRM1/mGluR1 in a number of RCC tumor biopsy samples and cell lines, and the effects of GRM1 modulation on tumorigenicity therein. Moreover, RCC cell lines exhibited elevated levels of extracellular glutamate, and some lines responded to drugs, which modulate the glutamatergic system. These findings imply a possible role for glutamate signaling apparatus in RCC cell growth, and that the glutamatergic system may be a therapeutic target in RCC.	[Martino, J. J.; Wall, B. A.; Mastrantoni, E.; Wilimczyk, B. J.; La Cava, S. N.; Chen, S.] Rutgers State Univ, Ernest Mario Sch Pharm, Susan Lehman Cullman Lab Canc Res, Dept Biol Chem, Piscataway, NJ 08854 USA; [Mastrantoni, E.] Univ Rome Sapienze, Dept Physiol & Pharmacol, Rome, Italy; [Degenhardt, K.] Touro Coll Osteopath Med, Dept Basic Biomed Sci, New York, NY USA; [White, E.; Chen, S.] Canc Inst New Jersey, New Brunswick, NJ USA; [White, E.] Rutgers State Univ, Dept Mol & Biochem, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick	Chen, S (corresponding author), Rutgers State Univ, Ernest Mario Sch Pharm, Susan Lehman Cullman Lab Canc Res, Dept Biol Chem, 164 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	suziec@rci.rutgers.edu	White, Eileen/ABD-6745-2021	White, Eileen/0000-0003-2961-3065	Department of Physiology and Pharmacology, University of Rome "Sapienza", Rome, Itally;  [R01CA108720];  [09-1143-CCR-EO]; NATIONAL CANCER INSTITUTE [R01CA108720, R01CA130893, P30CA072720, R01CA074077] Funding Source: NIH RePORTER	Department of Physiology and Pharmacology, University of Rome "Sapienza", Rome, Itally; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants R01CA108720 and 09-1143-CCR-EO (SC) and PhD fellowship from the Department of Physiology and Pharmacology, University of Rome "Sapienza", Rome, Itally (EM). We would like to acknowledge the generosity of Dr WM Linehan (Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA) for RCC lines, Dr Daiya Takai (The University of Tokyo Hospital, Tokyo, Japan) for TetR plasmid components, Dr Tony Kong (Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, USA) for Aperio digital slide scanning/quantification system access and Dr Hao Wu (The Cancer Institute of New Jersey, New Brunswick, NJ, USA) for keen pathological insights.	American Cancer Society, 2012, CANC FACTS FIG; ANGLARD P, 1992, CANCER RES, V52, P348; Bracarda S, 2009, EUR UROL SUPPL, V8, P787, DOI 10.1016/j.eursup.2009.07.007; Carroll FY, 2001, MOL PHARMACOL, V59, P965, DOI 10.1124/mol.59.5.965; Choi KY, 2011, P NATL ACAD SCI USA, V108, P15219, DOI 10.1073/pnas.1107304108; Cicenas J, 2008, INT J BIOL MARKER, V23, P1, DOI 10.1177/172460080802300101; Cohen-Solal KA, 2002, PIGM CELL RES, V15, P282, DOI 10.1034/j.1600-0749.2002.02024.x; D'Onofrio M, 2003, J NEUROCHEM, V84, P1288, DOI 10.1046/j.1471-4159.2003.01633.x; Degenhardt K, 2002, CANCER CELL, V2, P193, DOI 10.1016/S1535-6108(02)00126-5; Degenhardt K, 2002, J BIOL CHEM, V277, P14127, DOI 10.1074/jbc.M109939200; Degenhardt K, 2006, CLIN CANCER RES, V12, P5298, DOI 10.1158/1078-0432.CCR-06-0439; Ferraguti F, 2008, PHARMACOL REV, V60, P536, DOI 10.1124/pr.108.000166; Frati C, 2000, J CELL PHYSIOL, V183, P364, DOI 10.1002/(SICI)1097-4652(200006)183:3<364::AID-JCP9>3.3.CO;2-O; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Genever PG, 1999, J INVEST DERMATOL, V112, P337, DOI 10.1046/j.1523-1747.1999.00509.x; Gill SS, 1999, BRAIN RES BULL, V48, P143, DOI 10.1016/S0361-9230(98)00154-3; GUTKIND JS, 1991, P NATL ACAD SCI USA, V88, P4703, DOI 10.1073/pnas.88.11.4703; Hers I, 2011, CELL SIGNAL, V23, P1515, DOI 10.1016/j.cellsig.2011.05.004; Hoogduijn MJ, 2006, PIGM CELL RES, V19, P58, DOI 10.1111/j.1600-0749.2005.00284.x; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Iacovelli L, 2006, J NEUROSCI, V26, P8388, DOI 10.1523/JNEUROSCI.2285-06.2006; Jong YJI, 2007, J NEUROCHEM, V101, P458, DOI 10.1111/j.1471-4159.2006.04382.x; JULIUS D, 1989, SCIENCE, V244, P1057, DOI 10.1126/science.2727693; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Lappano R, 2011, NAT REV DRUG DISCOV, V10, P47, DOI 10.1038/nrd3320; Le MN, 2010, J INVEST DERMATOL, V130, P2240, DOI 10.1038/jid.2010.126; Lee HJ, 2011, CLIN CANCER RES, V17, P7080, DOI 10.1158/1078-0432.CCR-11-0098; Levine AJ, 2010, SCIENCE, V330, P1340, DOI 10.1126/science.1193494; Machado-Vieira R, 2009, CURR PHARM DESIGN, V15, P1595, DOI 10.2174/138161209788168010; Marin YE, 2006, CELL SIGNAL, V18, P1279, DOI 10.1016/j.cellsig.2005.10.012; Marin YE, 2004, J MOL MED, V82, P735, DOI 10.1007/s00109-004-0566-8; Mathew A, 2002, EUR J CANCER PREV, V11, P171, DOI 10.1097/00008469-200204000-00010; Matsukura S, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng077; Melchiorri D, 2007, NEUROPHARMACOLOGY, V53, P473, DOI 10.1016/j.neuropharm.2007.05.031; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Miller RG, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001447.pub2; Milligan G, 2000, SCIENCE, V288, P65, DOI 10.1126/science.288.5463.65; Morimoto R, 2006, EMBO J, V25, P4175, DOI 10.1038/sj.emboj.7601317; Namkoong J, 2007, CANCER RES, V67, P2298, DOI 10.1158/0008-5472.CAN-06-3665; Nicoletti F, 2007, TRENDS PHARMACOL SCI, V28, P206, DOI 10.1016/j.tips.2007.03.008; Pollock PM, 2003, NAT GENET, V34, P108, DOI 10.1038/ng1148; Prezeau L, 1996, MOL PHARMACOL, V49, P422; Prickett TD, 2011, NAT GENET, V43, P1119, DOI 10.1038/ng.950; Recasens M, 2007, CURR DRUG TARGETS, V8, P651, DOI 10.2174/138945007780618544; Schmid-Wendtner MH, 2001, BRIT J DERMATOL, V145, P981, DOI 10.1046/j.1365-2133.2001.04507.x; Seidlitz EP, 2009, CLIN EXP METASTAS, V26, P781, DOI 10.1007/s10585-009-9277-4; Sharma MK, 2010, BIOCHEM BIOPH RES CO, V391, P91, DOI 10.1016/j.bbrc.2009.10.168; Sharon D, 1997, J GEN PHYSIOL, V109, P477, DOI 10.1085/jgp.109.4.477; Shin SS, 2008, NEUROPHARMACOLOGY, V55, P396, DOI 10.1016/j.neuropharm.2008.04.021; Shin SS, 2010, PIGM CELL MELANOMA R, V23, P103, DOI 10.1111/j.1755-148X.2009.00648.x; Speyer CL, 2012, BREAST CANCER RES TR, V132, P565, DOI 10.1007/s10549-011-1624-x; Steelman LS, 2011, AGING-US, V3, P192, DOI 10.18632/aging.100296; Stepulak A, 2005, P NATL ACAD SCI USA, V102, P15605, DOI 10.1073/pnas.0507679102; Storto M, 2000, HEPATOLOGY, V31, P649, DOI 10.1002/hep.510310315; Storto M, 2006, MOL PHARMACOL, V69, P1234, DOI 10.1124/mol.105.018390; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; Teh Jessica, 2012, Wiley Interdiscip Rev Membr Transp Signal, V1, P211; Thandi S, 2002, J NEUROCHEM, V83, P1139, DOI 10.1046/j.1471-4159.2002.01217.x; Tihan T, 1996, CANCER-AM CANCER SOC, V77, P2325, DOI 10.1002/(SICI)1097-0142(19960601)77:11<2325::AID-CNCR22>3.0.CO;2-Y; Tong QC, 2002, AM J PHYSIOL-ENDOC M, V282, pE1324, DOI 10.1152/ajpendo.00460.2001; Tripathi VB, 2008, CNS NEUROL DISORD-DR, V7, P11; Wangari-Talbot J, MOL CANCER RES, DOI [10.1158/1541-7786.MCR-12-0158, DOI 10.1158/1541-7786.MCR-12-0158)]; WELCH DR, 1991, INT J CANCER, V47, P227, DOI 10.1002/ijc.2910470211; Wieronska JM, 2009, NEUROCHEM INT, V55, P85, DOI 10.1016/j.neuint.2009.02.019; Wu TY, 2012, MOL CARCINOGEN, V51, P761, DOI 10.1002/mc.20841; Yip D, 2009, CLIN CANCER RES, V15, P3896, DOI 10.1158/1078-0432.CCR-08-3303; Young VR, 2000, J NUTR, V130, p892S, DOI 10.1093/jn/130.4.892S; Zhu H, 1999, MOL BRAIN RES, V73, P93, DOI 10.1016/S0169-328X(99)00239-9; Zhu H, 1998, J INVEST DERMATOL, V110, P247, DOI 10.1046/j.1523-1747.1998.00133.x	70	41	42	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 12	2013	32	37					4366	4376		10.1038/onc.2012.471	http://dx.doi.org/10.1038/onc.2012.471			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	218AF	23085756	Green Accepted			2022-12-25	WOS:000324404200005
J	Fernhoff, NB; Derbyshire, ER; Underbakke, ES; Marletta, MA				Fernhoff, Nathaniel B.; Derbyshire, Emily R.; Underbakke, Eric S.; Marletta, Michael A.			Heme-assisted S-Nitrosation Desensitizes Ferric Soluble Guanylate Cyclase to Nitric Oxide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-BASIS; L-ARGININE; NO; ACTIVATION; MECHANISM; OXIDATION; BINDING; HYPERTENSION; INHIBITION; REACTIVITY	Nitric oxide (NO) signaling regulates key processes in cardiovascular physiology, specifically vasodilation, platelet aggregation, and leukocyte rolling. Soluble guanylate cyclase (sGC), the mammalian NO sensor, transduces an NO signal into the classical second messenger cyclic GMP (cGMP). NO binds to the ferrous (Fe2+) oxidation state of the sGC heme cofactor and stimulates formation of cGMP several hundred-fold. Oxidation of the sGC heme to the ferric (Fe3+) state desensitizes the enzyme to NO. The heme-oxidized state of sGC has emerged as a potential therapeutic target in the treatment of cardiovascular disease. Here, we investigate the molecular mechanism of NO desensitization and find that sGC undergoes a reductive nitrosylation reaction that is coupled to the S-nitrosation of sGC cysteines. We further characterize the kinetics of NO desensitization and find that heme-assisted nitrosothiol formation of beta 1Cys-78 and beta 1Cys-122 causes the NO desensitization of ferric sGC. Finally, we provide evidence that the mechanism of reductive nitrosylation is gated by a conformational change of the protein. These results yield insights into the function and dysfunction of sGC in cardiovascular disease.	[Marletta, Michael A.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Fernhoff, Nathaniel B.; Derbyshire, Emily R.; Marletta, Michael A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Underbakke, Eric S.; Marletta, Michael A.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	Scripps Research Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Marletta, MA (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	marletta@scripps.edu		Underbakke, Eric/0000-0003-4269-7339	National Institutes of Health [GM077365]; Bayer Healthcare (Wuppertal, Germany); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066698, R01GM077365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bayer Healthcare (Wuppertal, Germany)(Bayer AGBayer Healthcare Pharmaceuticals); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM077365. This work was also supported by Bayer Healthcare (Wuppertal, Germany).	Basu S, 2010, FREE RADICAL BIO MED, V48, P255, DOI 10.1016/j.freeradbiomed.2009.10.049; Boerrigter G, 2007, HYPERTENSION, V49, P1128, DOI 10.1161/HYPERTENSIONAHA.106.083832; BRANDWEIN HJ, 1981, J BIOL CHEM, V256, P2958; BRAUGHLER JM, 1983, BIOCHEM PHARMACOL, V32, P811, DOI 10.1016/0006-2952(83)90581-6; BULT H, 1990, NATURE, V345, P346, DOI 10.1038/345346a0; Cary SPL, 2005, P NATL ACAD SCI USA, V102, P13064, DOI 10.1073/pnas.0506289102; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Derbyshire ER, 2008, BIOCHEMISTRY-US, V47, P3892, DOI 10.1021/bi7022943; Derbyshire ER, 2007, J BIOL CHEM, V282, P35741, DOI 10.1074/jbc.M705557200; Derbyshire ER, 2011, BIOCHEMISTRY-US, V50, P4281, DOI 10.1021/bi200341b; Derbyshire ER, 2010, J BIOL CHEM, V285, P17471, DOI 10.1074/jbc.M109.098269; Derbyshire ER, 2009, BIOCHEMISTRY-US, V48, P7519, DOI 10.1021/bi900696x; Derbyshire ER, 2005, BIOCHEMISTRY-US, V44, P16257, DOI 10.1021/bi0515671; Erbil WK, 2009, P NATL ACAD SCI USA, V106, P19753, DOI 10.1073/pnas.0911645106; Fernhoff NB, 2009, P NATL ACAD SCI USA, V106, P21602, DOI 10.1073/pnas.0911083106; Friebe A, 2007, P NATL ACAD SCI USA, V104, P7699, DOI 10.1073/pnas.0609778104; Gibb BJ, 2003, BRIT J PHARMACOL, V139, P1032, DOI 10.1038/sj.bjp.0705318; Harrison DG, 1997, CLIN CARDIOL, V20, P11; Herold S, 2004, J BIOL CHEM, V279, P22841, DOI 10.1074/jbc.M313732200; Hoshino M, 1996, J AM CHEM SOC, V118, P5702, DOI 10.1021/ja953311w; Hoshino M, 1999, COORDIN CHEM REV, V187, P75, DOI 10.1016/S0010-8545(98)00228-8; Jaffrey S R, 2001, Sci STKE, V2001, ppl1, DOI 10.1126/stke.2001.86.pl1; Karow DS, 2005, BIOCHEMISTRY-US, V44, P16266, DOI 10.1021/bi051601b; Keilin D., 1937, NATURE, V139, P548; KNOWLES RG, 1989, P NATL ACAD SCI USA, V86, P5159, DOI 10.1073/pnas.86.13.5159; Kojda G, 1999, CARDIOVASC RES, V43, P562, DOI 10.1016/S0008-6363(99)00169-8; Lapp H, 2009, CIRCULATION, V119, P2781, DOI 10.1161/CIRCULATIONAHA.108.800292; Luchsinger BP, 2003, P NATL ACAD SCI USA, V100, P461, DOI 10.1073/pnas.0233287100; Ma XL, 2007, EMBO J, V26, P578, DOI 10.1038/sj.emboj.7601521; MARLETTA MA, 1988, BIOCHEMISTRY-US, V27, P8706, DOI 10.1021/bi00424a003; Maron BA, 2009, J BIOL CHEM, V284, P7665, DOI 10.1074/jbc.M809460200; Miersch S, 2005, CLIN BIOCHEM, V38, P777, DOI 10.1016/j.clinbiochem.2005.05.014; Mitchell DA, 2007, P NATL ACAD SCI USA, V104, P11609, DOI 10.1073/pnas.0704898104; Nioche P, 2004, SCIENCE, V306, P1550, DOI 10.1126/science.1103596; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; Priestley Joseph, 1775, EXPT OBSERVATIONS DI, V2nd; RADOMSKI MW, 1987, LANCET, V2, P1057, DOI 10.1016/S0140-6736(87)91481-4; Ruetten H, 1999, CIRC RES, V85, P534, DOI 10.1161/01.RES.85.6.534; Russwurm M, 2004, EMBO J, V23, P4443, DOI 10.1038/sj.emboj.7600422; SANCIER KM, 1962, SCIENCE, V137, P752, DOI 10.1126/science.137.3532.752; Sayed N, 2007, P NATL ACAD SCI USA, V104, P12312, DOI 10.1073/pnas.0703944104; Schrammel A, 1996, MOL PHARMACOL, V50, P1; Stasch JP, 2006, J CLIN INVEST, V116, P2552, DOI 10.1172/JCI28371; Stasch JP, 2011, CIRCULATION, V123, P2263, DOI 10.1161/CIRCULATIONAHA.110.981738; Stasch JP, 2002, BRIT J PHARMACOL, V136, P773, DOI 10.1038/sj.bjp.0704778; STONE JR, 1994, BIOCHEMISTRY-US, V33, P5636, DOI 10.1021/bi00184a036; STONE JR, 1995, BIOCHEM BIOPH RES CO, V207, P572, DOI 10.1006/bbrc.1995.1226; Stone JR, 1996, BIOCHEMISTRY-US, V35, P1093, DOI 10.1021/bi9519718; Tschudi MR, 1996, HYPERTENSION, V27, P32, DOI 10.1161/01.HYP.27.1.32; Weichsel A, 2005, P NATL ACAD SCI USA, V102, P594, DOI 10.1073/pnas.0406549102; Winger JA, 2007, J BIOL CHEM, V282, P897, DOI 10.1074/jbc.M606327200; Zhao Y, 1999, P NATL ACAD SCI USA, V96, P14753, DOI 10.1073/pnas.96.26.14753; Zhao YD, 2000, BIOCHEMISTRY-US, V39, P10848, DOI 10.1021/bi9929296	54	44	45	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43053	43062		10.1074/jbc.M112.393892	http://dx.doi.org/10.1074/jbc.M112.393892			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23093402	hybrid, Green Published			2022-12-25	WOS:000312501600061
J	Nelson, AD; Hoffmann, MM; Parks, CA; Dasari, S; Schrum, AG; Gil, D				Nelson, Alfreda D.; Hoffmann, Michele M.; Parks, Christopher A.; Dasari, Surendra; Schrum, Adam G.; Gil, Diana			IgG Fab Fragments Forming Bivalent Complexes by a Conformational Mechanism That Is Reversible by Osmolytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-RECEPTOR ENGAGEMENT; RABBIT GAMMA-GLOBULIN; TUMOR-NECROSIS-FACTOR; PROTEIN AGGREGATION; IN-VIVO; ANTIGEN RECOGNITION; CERTOLIZUMAB PEGOL; ANTIBODY STRUCTURE; T-LYMPHOCYTES; FACTOR-ALPHA	Generated by proteolytic cleavage of immunoglobulin, Fab fragments possess great promise as blocking reagents, able to bind receptors or other targets without inducing cross-linking. However, aggregation of Fab preparations is a common occurrence, which generates intrinsic stimulatory capacity and thwarts signal blockade strategies. Using a panel of biochemical approaches, including size exclusion chromatography, SDS-PAGE, mass spectrometry, and cell stimulation followed by flow cytometry, we have measured the oligomerization and acquisition of stimulatory capacity that occurs in four monoclonal IgG Fabs specific for TCR/CD3. Unexpectedly, we observed that all Fabs spontaneously formed complexes that were precisely bivalent, and these bivalent complexes possessed most of the stimulatory activity of each Fab preparation. Fabs composing bivalent complexes were more susceptible to proteolysis than monovalent Fabs, indicating a difference in conformation between the Fabs involved in these two different states of valency. Because osmolytes represent a class of compounds that stabilize protein folding and conformation, we sought to determine the extent to which the amino acid osmolyte L-proline might impact bivalent Fab complexation. We found that L-proline (i) inhibited the adoption of the conformation associated with bivalent complexation, (ii) preserved Fab monovalency, (iii) reversed the conformation of preformed bivalent Fabs to that of monovalent Fabs, and (iv) separated a significant percentage of preformed bivalent complexes into monovalent species. Thus, Fab fragments can adopt a conformation that is compatible with folding or packing of a bivalent complex in a process that can be inhibited by osmolytes.	[Nelson, Alfreda D.; Hoffmann, Michele M.; Parks, Christopher A.; Schrum, Adam G.; Gil, Diana] Mayo Clin, Coll Med, Dept Immunol, Rochester, MN 55905 USA; [Nelson, Alfreda D.; Hoffmann, Michele M.] Mayo Clin, Coll Med, Initiat Maximize Student Divers, Rochester, MN 55905 USA; [Parks, Christopher A.] Mayo Clin, Coll Med, Summer Undergrad Res Fellowship Program, Rochester, MN 55905 USA; [Dasari, Surendra] Mayo Clin, Coll Med, Div Biomed Stat & Informat, Ctr Individualized Med, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Gil, D (corresponding author), Mayo Clin, Coll Med, Dept Immunol, 200 1st St SW,321 Guggenheim Bldg, Rochester, MN 55905 USA.	gilpages.diana@mayo.edu		Parks, Christopher/0000-0002-2772-2965; Schrum, Adam/0000-0001-9276-1859	National Institutes of Health [1R56AI097187-01]; Mayo Foundation; Mayo Clinic Summer Undergraduate Research Fellowship Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI097187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM072474, R25GM055252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation; Mayo Clinic Summer Undergraduate Research Fellowship Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 1R56AI097187-01 (to D. G. and A. G. S.). This work was also supported by the Mayo Foundation (to D. G. and A. G. S.) and the Mayo Clinic Summer Undergraduate Research Fellowship Program (to C. A. P.).	Anderson DE, 2000, NAT MED, V6, P211, DOI 10.1038/72323; Andrew S M, 2001, Curr Protoc Immunol, VChapter 2, DOI [10.1002/0471142735.im0208s21, 10.1002/0471142735.im0209s21, 10.1002/0471142735.im0207s21]; Arakawa T, 2007, AMINO ACIDS, V33, P587, DOI 10.1007/s00726-007-0506-3; AUGENER W, 1970, J IMMUNOL, V105, P1024; Baden EM, 2009, CURR PROTEIN PEPT SC, V10, P500, DOI 10.2174/138920309789351949; Bolen DW, 2001, J MOL BIOL, V310, P955, DOI 10.1006/jmbi.2001.4819; Bolen DW, 2004, METHODS, V34, P312, DOI 10.1016/j.ymeth.2004.03.022; BUCHNER J, 1991, BIO-TECHNOL, V9, P157, DOI 10.1038/nbt0291-157; BUCHNER J, 1991, BIOCHEMISTRY-US, V30, P6922, DOI 10.1021/bi00242a016; Chapman AP, 1999, NAT BIOTECHNOL, V17, P780, DOI 10.1038/11717; Chennamsetty N, 2009, P NATL ACAD SCI USA, V106, P11937, DOI 10.1073/pnas.0904191106; CYSTER JG, 1992, EUR J IMMUNOL, V22, P2565, DOI 10.1002/eji.1830221015; DAMLE NK, 1988, J IMMUNOL, V140, P1753; Dennis MS, 2002, J BIOL CHEM, V277, P35035, DOI 10.1074/jbc.M205854200; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dobson CM, 2001, PHILOS T R SOC B, V356, P133, DOI 10.1098/rstb.2000.0758; Fekade D, 1996, NEW ENGL J MED, V335, P311, DOI 10.1056/NEJM199608013350503; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Gil D, 2005, J EXP MED, V201, P517, DOI 10.1084/jem.20042036; Gil D, 2008, J IMMUNOL, V180, P3900, DOI 10.4049/jimmunol.180.6.3900; Hamidi M, 2006, DRUG DELIV, V13, P399, DOI 10.1080/10717540600814402; Horton S, 2012, EXPERT OPIN BIOL TH, V12, P235, DOI 10.1517/14712598.2012.645533; Ignatova Z, 2006, P NATL ACAD SCI USA, V103, P13357, DOI 10.1073/pnas.0603772103; Kashanian S, 2008, HYBRIDOMA, V27, P99, DOI 10.1089/hyb.2007.0554; Kashanian S, 2008, HYBRIDOMA, V27, P48, DOI 10.1089/hyb.2007.0547; KAYE J, 1984, J EXP MED, V159, P1397, DOI 10.1084/jem.159.5.1397; KAYE J, 1992, J IMMUNOL, V148, P3342; Keane PA, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/483034; KEARNEY ER, 1995, J IMMUNOL, V155, P1032; KIEFHABER T, 1991, BIO-TECHNOL, V9, P825, DOI 10.1038/nbt0991-825; Levy ED, 2008, NATURE, V453, P1262, DOI 10.1038/nature06942; Looareesuwan S, 1999, AM J TROP MED HYG, V61, P26, DOI 10.4269/ajtmh.1999.61.26; Makowski L, 2008, J MOL BIOL, V375, P529, DOI 10.1016/j.jmb.2007.07.075; Marshall H, 2012, ACTA CRYSTALLOGR D, V68, P69, DOI 10.1107/S0907444911050360; Meng FG, 2001, INT J BIOCHEM CELL B, V33, P701, DOI 10.1016/S1357-2725(01)00048-6; Miao HQ, 2006, BIOCHEM BIOPH RES CO, V345, P438, DOI 10.1016/j.bbrc.2006.04.119; Narciso JET, 2011, NEW BIOTECHNOL, V28, P435, DOI 10.1016/j.nbt.2011.03.012; Paul S, 2006, IMMUNOL LETT, V103, P8, DOI 10.1016/j.imlet.2005.10.003; PORTER RR, 1959, BIOCHEM J, V73, P119, DOI 10.1042/bj0730119; PORTER RR, 1958, NATURE, V182, P670, DOI 10.1038/182670a0; POTTER TA, 1989, NATURE, V337, P73, DOI 10.1038/337073a0; Risueno RM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001747; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Samuel D, 2000, PROTEIN SCI, V9, P344; Sandborn WJ, 2003, BEST PRACT RES CL GA, V17, P105, DOI 10.1053/bega.2002.0345; Sapparapu G, 2009, J BIOL CHEM, V284, P24622, DOI 10.1074/jbc.M109.011858; SCHODIN BA, 1993, J BIOL CHEM, V268, P25722; Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046; Sharma V, 2009, J BIOL CHEM, V284, P33079, DOI 10.1074/jbc.M109.036087; Smith LS, 2010, ANN PHARMACOTHER, V44, P333, DOI 10.1345/aph.1M314; Street TO, 2006, P NATL ACAD SCI USA, V103, P13997, DOI 10.1073/pnas.0606236103; van der Merwe PA, 2011, NAT REV IMMUNOL, V11, P47, DOI 10.1038/nri2887; Vanhove B, 2003, BLOOD, V102, P564, DOI 10.1182/blood-2002-08-2480; Veronese FM, 2008, BIODRUGS, V22, P315, DOI 10.2165/00063030-200822050-00004; WALDMANN TA, 1969, PROG ALLERGY, V13, P1, DOI 10.1159/000287491; Wang W, 2007, J PHARM SCI-US, V96, P1, DOI 10.1002/jps.20727; Wang XL, 2010, PHARM RES-DORDR, V27, P1512, DOI 10.1007/s11095-010-0143-5; Yancey PH, 2005, J EXP BIOL, V208, P2819, DOI 10.1242/jeb.01730; YANCEY PH, 1982, SCIENCE, V217, P1214, DOI 10.1126/science.7112124	59	8	8	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42936	42950		10.1074/jbc.M112.410217	http://dx.doi.org/10.1074/jbc.M112.410217			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23109335	Green Published, hybrid			2022-12-25	WOS:000312501600051
J	Sakane, A; Abdallah, AAM; Nakano, K; Honda, K; Ikeda, W; Nishikawa, Y; Matsumoto, M; Matsushita, N; Kitamura, T; Sasaki, T				Sakane, Ayuko; Abdallah, Ahmed Alamir Mahmoud; Nakano, Kiyoshi; Honda, Kazufumi; Ikeda, Wataru; Nishikawa, Yumiko; Matsumoto, Mitsuru; Matsushita, Natsuki; Kitamura, Toshio; Sasaki, Takuya			Rab13 Small G Protein and Junctional Rab13-binding Protein (JRAB) Orchestrate Actin Cytoskeletal Organization during Epithelial Junctional Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL TIGHT JUNCTIONS; CELL-CELL JUNCTIONS; MYOSIN-II MOTOR; APICAL JUNCTIONS; RHO-GTPASES; JRAB/MICAL-L2; ADHESION; POLYMERIZATION; MORPHOGENESIS; EFFICIENT	During epithelial junctional development, both vesicle transport and reorganization of the actin cytoskeleton must be spatiotemporally regulated. Coordination of these cellular functions is especially important, but the precise mechanism remains elusive. Previously, we identified junctional Rab13-binding protein (JRAB)/molecules interacting with CasL-like 2 (MICAL-L2) as an effector of the Rab13 small G protein, and we found that the Rab13-JRAB system may be involved in the formation of cell-cell adhesions via transport of adhesion molecules. Here, we showed that JRAB interacts with two actin-binding proteins, actinin-1 and -4, and filamentous actin via different domains and regulates actin cross-linking and stabilization through these interactions. During epithelial junctional development, JRAB is prominently enriched in the actin bundle at the free border; subsequently, JRAB undergoes a Rab13-dependent conformational change that is required for maturation of cell-cell adhesion sites. These results suggest that Rab13 and JRAB regulate reorganization of the actin cytoskeleton throughout epithelial junctional development from establishment to maturation of cell-cell adhesion.	[Sakane, Ayuko; Abdallah, Ahmed Alamir Mahmoud; Nakano, Kiyoshi; Sasaki, Takuya] Univ Tokushima, Grad Sch, Dept Biochem, Inst Hlth Biosci, Tokushima 7708503, Japan; [Nakano, Kiyoshi] Univ Tokushima, Fac Med, Student Lab, Tokushima 7708503, Japan; [Honda, Kazufumi] Natl Canc Ctr, Res Inst, Div Chemotherapy & Clin Res, Tokyo 1040045, Japan; [Ikeda, Wataru] KAN Res Inst Inc, Kobe, Hyogo 6500047, Japan; [Nishikawa, Yumiko; Matsumoto, Mitsuru] Univ Tokushima, Inst Enzyme Res, Div Mol Immunol, Tokushima 7708503, Japan; [Matsushita, Natsuki] Ehime Univ, Funct Genom Core Lab, Proteomed Res Ctr, Ehime 7910295, Japan; [Kitamura, Toshio] Univ Tokyo, Inst Med Sci, Dept Hematopoiet Factor, Tokyo 1088639, Japan	Tokushima University; Tokushima University; National Cancer Center - Japan; KAN Research Institute; Tokushima University; Ehime University; University of Tokyo	Sasaki, T (corresponding author), Univ Tokushima, Grad Sch, Dept Biochem, Inst Hlth Biosci, Tokushima 7708503, Japan.	sasaki@basic.med.tokushima-u.ac.jp	Abdallah, Ahmed Alamir Mahmoud/ABG-4989-2021; Kitamura, Toshio/AAA-2071-2021; Ikeda, Wataru/V-8531-2019	Ikeda, Wataru/0000-0002-6907-9058	Ministry of Education, Culture, Sports, Science and Technology; Japan Society for the Promotion of Science	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grant-in-aid for Scientific Research on Innovative Areas 2008-2012 from the Ministry of Education, Culture, Sports, Science and Technology (to T. S.), Grant-in-aid for Scientific Research 2009-2012 (to T. S.), and Grant-in-aid for Young Scientists 2008-2012 from the Japan Society for the Promotion of Science (to A. S.).	Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gov N, 2011, NAT MATER, V10, P412, DOI 10.1038/nmat3036; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Ivanov AI, 2005, MOL BIOL CELL, V16, P2636, DOI 10.1091/mbc.E05-01-0043; Ivanov AI, 2004, MOL BIOL CELL, V15, P2639, DOI 10.1091/mbc.E04-02-0163; Ivanov AI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000658; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; James P, 1996, GENETICS, V144, P1425; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Krendel MF, 1999, CELL MOTIL CYTOSKEL, V43, P296, DOI 10.1002/(SICI)1097-0169(1999)43:4<296::AID-CM3>3.0.CO;2-U; Marzesco AM, 2002, MOL BIOL CELL, V13, P1819, DOI 10.1091/mbc.02-02-0029; Morimoto S, 2005, J BIOL CHEM, V280, P2220, DOI 10.1074/jbc.M406906200; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakatsuji H, 2008, MOL CELL BIOL, V28, P3324, DOI 10.1128/MCB.00144-08; Nelson WJ, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000513; Nishimura N, 2009, FRONT BIOSCI-LANDMRK, V14, P2115, DOI 10.2741/3366; Oikonomou KG, 2011, AUTOIMMUN REV, V10, P389, DOI 10.1016/j.autrev.2010.12.009; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Rahajeng Juliati, 2010, World J Biol Chem, V1, P254, DOI 10.4331/wjbc.v1.i8.254; Sakane A, 2010, MOL CELL BIOL, V30, P1077, DOI 10.1128/MCB.01067-09; Samarin SN, 2007, MOL BIOL CELL, V18, P3429, DOI 10.1091/mbc.E07-04-0315; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Terai T, 2006, MOL BIOL CELL, V17, P2465, DOI 10.1091/mbc.E05-09-0826; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Tsukita Shoichiro, 1992, Current Opinion in Cell Biology, V4, P834, DOI 10.1016/0955-0674(92)90108-O; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Yamamura R, 2008, MOL BIOL CELL, V19, P971, DOI 10.1091/mbc.E07-06-0551; YONEMURA S, 1995, J CELL SCI, V108, P127; ZAHRAOUI A, 1994, J CELL BIOL, V124, P101, DOI 10.1083/jcb.124.1.101; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang JK, 2005, J CELL SCI, V118, P5549, DOI 10.1242/jcs.02639	39	34	36	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42455	42468		10.1074/jbc.M112.383653	http://dx.doi.org/10.1074/jbc.M112.383653			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23100251	Green Published, hybrid			2022-12-25	WOS:000312501600008
J	Vollers, SS; Carruthers, A				Vollers, Sabrina S.; Carruthers, Anthony			Sequence Determinants of GLUT1-mediated Accelerated-exchange Transport ANALYSIS BY HOMOLOGY-SCANNING MUTAGENESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUT1 GLUCOSE-TRANSPORTER; SUBSTITUTED CYSTEINE ACCESSIBILITY; SELECTIVE BIOLOGICAL TRANSPORT; MAJOR FACILITATOR SUPERFAMILY; ERYTHROCYTE SUGAR-TRANSPORT; CYTOCHALASIN-B; 3-ORTHO-METHYL-D-GLUCOSE TRANSPORT; 3-O-METHYLGLUCOSE TRANSPORT; 2-DEOXYGLUCOSE TRANSPORT; OLIGOMERIC STRUCTURE	The class 1 equilibrative glucose transporters GLUT1 and GLUT4 are structurally similar but catalyze distinct modes of transport. GLUT1 exhibits trans-acceleration, in which the presence of intracellular sugar stimulates the rate of unidirectional sugar uptake. GLUT4-mediated uptake is unaffected by intracellular sugar. Using homology-scanning mutagenesis in which domains of GLUT1 are substituted with equivalent domains from GLUT4 and vice versa, we show that GLUT1 transmembrane domain 6 is both necessary and sufficient for trans-acceleration. This region is not directly involved in GLUT1 binding of substrate or inhibitors. Rather, transmembrane domain 6 is part of two putative scaffold domains, which coordinate membrane-spanning amphipathic helices that form the sugar translocation pore. We propose that GLUT1 transmembrane domain 6 restrains import when intracellular sugar is absent by slowing transport-associated conformational changes.	[Vollers, Sabrina S.; Carruthers, Anthony] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Carruthers, A (corresponding author), 364 Plantat St,LRB Room 926, Worcester, MA 01605 USA.	anthony.carruthers@umassmed.edu		Vollers, Sabrina/0000-0002-6772-0155	National Institutes of Health [DK 36081, DK 44888]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK036081, R01DK036081, R01DK044888] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK 36081 and DK 44888.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Al-Hasani H, 2002, J CELL SCI, V115, P131; BACHELARD HS, 1972, BIOCHEM J, V127, pP83; BAKER GF, 1973, J PHYSIOL-LONDON, V231, P143, DOI 10.1113/jphysiol.1973.sp010225; BAKER GF, 1979, BIOCHIM BIOPHYS ACTA, V550, P474, DOI 10.1016/0005-2736(79)90150-0; BAKER PF, 1981, J PHYSIOL-LONDON, V316, P503, DOI 10.1113/jphysiol.1981.sp013803; BALDWIN SA, 1979, BIOCHIM BIOPHYS ACTA, V552, P183, DOI 10.1016/0005-2736(79)90257-8; Bissonnette P, 1996, AM J PHYSIOL-GASTR L, V270, pG153, DOI 10.1152/ajpgi.1996.270.1.G153; Blodgett DM, 2007, J GEN PHYSIOL, V130, P157, DOI 10.1085/jgp.200709818; CARRUTHERS A, 1989, BIOCHEMISTRY-US, V28, P8337, DOI 10.1021/bi00447a011; Cloherty EK, 2001, BIOCHEMISTRY-US, V40, P15549, DOI 10.1021/bi015586w; Cloherty EK, 1996, BIOCHEMISTRY-US, V35, P10411, DOI 10.1021/bi953077m; CORVERA S, 1994, J CELL BIOL, V126, P979, DOI 10.1083/jcb.126.4.979; CRAIK JD, 1979, BIOCHEM J, V182, P503, DOI 10.1042/bj1820503; Craik JD, 1998, AM J PHYSIOL-REG I, V274, pR112, DOI 10.1152/ajpregu.1998.274.1.R112; Cura AJ, 2012, COMPR PHYSIOL, V2, P863, DOI 10.1002/cphy.c110024; Cura AJ, 2010, J BIOL CHEM, V285, P15430, DOI 10.1074/jbc.M110.110593; CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758; GORGA FR, 1982, BIOCHEMISTRY-US, V21, P1905, DOI 10.1021/bi00537a031; HANSEN P, 1995, AM J PHYSIOL-CELL PH, V268, pC30, DOI 10.1152/ajpcell.1995.268.1.C30; HARIK SI, 1990, J NEUROSCI, V10, P3862, DOI 10.1523/JNEUROSCI.10-12-03862.1990; HEBERT DN, 1992, J BIOL CHEM, V267, P23829; HELGERSON AL, 1989, BIOCHEMISTRY-US, V28, P6410, DOI 10.1021/bi00441a038; HELGERSON AL, 1989, BIOCHEMISTRY-US, V28, P4580, DOI 10.1021/bi00437a012; HELLWIG B, 1991, MOL PHARMACOL, V40, P383; Holyoake J, 2006, BIOPHYS J, V91, pL84, DOI 10.1529/biophysj.106.093971; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; JAY TM, 1990, J NEUROCHEM, V55, P989, DOI 10.1111/j.1471-4159.1990.tb04588.x; Joost HG, 2002, AM J PHYSIOL-ENDOC M, V282, pE974, DOI 10.1152/ajpendo.00407.2001; KRUPKA RM, 1981, J BIOL CHEM, V256, P5410; Lemieux MJ, 2007, MOL MEMBR BIOL, V24, P333, DOI 10.1080/09687680701496507; Levine KB, 2005, BIOCHEMISTRY-US, V44, P5606, DOI 10.1021/bi0477541; Levine KB, 2002, BIOCHEMISTRY-US, V41, P12629, DOI 10.1021/bi0258997; LIEB WR, 1974, BIOCHIM BIOPHYS ACTA, V373, P178, DOI 10.1016/0005-2736(74)90144-8; LIEB WR, 1974, BIOCHIM BIOPHYS ACTA, V373, P165, DOI 10.1016/0005-2736(74)90143-6; Liu Q, 2001, BIOCHEMISTRY-US, V40, P7874, DOI 10.1021/bi002850x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maher F, 1996, BIOCHEM J, V315, P827, DOI 10.1042/bj3150827; Mann GE, 2003, PHYSIOL REV, V83, P183, DOI 10.1152/physrev.00022.2002; MILLER DM, 1968, BIOPHYS J, V8, P1339, DOI 10.1016/S0006-3495(68)86560-9; MILLER DM, 1968, BIOPHYS J, V8, P1329, DOI 10.1016/S0006-3495(68)86559-2; Mueckler M, 2002, J BIOL CHEM, V277, P3498, DOI 10.1074/jbc.M109157200; MUECKLER M, 1985, SCIENCE, V229, P941, DOI 10.1126/science.3839598; Mueckler M, 2005, J BIOL CHEM, V280, P39562, DOI 10.1074/jbc.M509050200; Mueckler M, 2008, J BIOL CHEM, V283, P11550, DOI 10.1074/jbc.M708896200; Mueckler M, 2009, BIOCHEMISTRY-US, V48, P5934, DOI 10.1021/bi900521n; Naftalin RJ, 2008, BIOPHYS J, V95, P4300, DOI 10.1529/biophysj.108.136366; NAFTALIN RJ, 1988, BIOCHIM BIOPHYS ACTA, V946, P431, DOI 10.1016/0005-2736(88)90420-8; NAFTALIN RJ, 1991, BIOCHIM BIOPHYS ACTA, V1064, P37, DOI 10.1016/0005-2736(91)90409-2; NAFTALIN RJ, 1977, MEMBRANE TRANSPORT R, P257; NISHIMURA H, 1993, J BIOL CHEM, V268, P8514; PIPER RC, 1993, J CELL BIOL, V121, P1221, DOI 10.1083/jcb.121.6.1221; Salas-Burgos A, 2004, BIOPHYS J, V87, P2990, DOI 10.1529/biophysj.104.047886; Seatter MJ, 1998, BIOCHEMISTRY-US, V37, P1322, DOI 10.1021/bi972322u; SOGIN DC, 1980, BIOCHEMISTRY-US, V19, P5417, DOI 10.1021/bi00564a041; Stein W., 2012, TRANSPORT DIFFUSION; TAYLOR LP, 1981, BIOCHIM BIOPHYS ACTA, V642, P325, DOI 10.1016/0005-2736(81)90449-1; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; TOYODA N, 1987, J BIOL CHEM, V262, P2737; VERHEY KJ, 1994, J BIOL CHEM, V269, P2353; WIDDAS WF, 1952, J PHYSIOL-LONDON, V118, P23, DOI 10.1113/jphysiol.1952.sp004770; Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187; ZOTTOLA RJ, 1995, BIOCHEMISTRY-US, V34, P9734, DOI 10.1021/bi00030a011	65	16	18	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42533	42544		10.1074/jbc.M112.369587	http://dx.doi.org/10.1074/jbc.M112.369587			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23093404	Green Published, hybrid			2022-12-25	WOS:000312501600015
J	Arat, NO; Griffith, JD				Arat, N. Oezlem; Griffith, Jack D.			Human Rap1 Interacts Directly with Telomeric DNA and Regulates TRF2 Localization at the Telomere	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR BRCA1; MAMMALIAN TELOMERE; HOLLIDAY JUNCTIONS; REPLICATION FORK; STRAND BREAKS; BINDING; END; PROTECTION; COMPLEX; PROTEINS	The TRF2-Rap1 complex suppresses non-homologous end joining and interacts with DNAPK-C to prevent end joining. We previously demonstrated that hTRF2 is a double strand telomere binding protein that forms t-loops in vitro and recognizes three- and four-way junctions independent of DNA sequence. How the DNA binding characteristics of hTRF2 to DNA is altered in the presence of hRap1 however is not known. Here we utilized EM and quantitative gel retardation to characterize the DNA binding properties of hRap1 and the TRF2-Rap1 complex. Both gel filtration chromatography and mass analysis from two-dimensional projections showed that the TRF2-Rap1 complex exists in solution and binds to DNA as a complex consisting of four monomers each of hRap1 and hTRF2. EM revealed for the first time that hRap1 binds to DNA templates in the absence of hTRF2 with a preference for double strand-single strand junctions in a sequence independent manner. When hTRF2 and hRap1 are in a complex, its affinity for ds telomeric sequences is 2-fold higher than TRF2 alone and more than 10-fold higher for telomeric 3' ends. This suggests that as hTRF2 recruits hRap1 to telomeric sequences, hRap1 alters the affinity of hTRF2 and its binding preference on telomeric DNA. Moreover, the TRF2-Rap1 complex has higher ability to re-model telomeric DNA than either component alone. This finding underlies the importance of complex formation between hRap1 and hTRF2 for telomere function and end protection.	[Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem, Chapel Hill, NC 27599 USA; [Arat, N. Oezlem; Griffith, Jack D.] Univ N Carolina, Dept Biophys, Chapel Hill, NC 27599 USA; [Griffith, Jack D.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Griffith, JD (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem, 450 W Dr, Chapel Hill, NC 27599 USA.	jdg@med.unc.edu			National Institutes of Health [GM31819, ES3773]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM31819 and ES3773 (to J. D. G.).	Bae NS, 2007, MOL CELL, V26, P323, DOI 10.1016/j.molcel.2007.03.023; Bianchi A, 1999, EMBO J, V18, P5735, DOI 10.1093/emboj/18.20.5735; Bianchi A, 1997, EMBO J, V16, P1785, DOI 10.1093/emboj/16.7.1785; Bombarde O, 2010, EMBO J, V29, P1573, DOI 10.1038/emboj.2010.49; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Capper R, 2007, GENE DEV, V21, P2495, DOI 10.1101/gad.439107; Celli GB, 2005, NAT CELL BIOL, V7, P712, DOI 10.1038/ncb1275; Chen Y, 2011, NAT STRUCT MOL BIOL, V18, P213, DOI 10.1038/nsmb.1974; Chow TT, 2012, GENE DEV, V26, P1167, DOI 10.1101/gad.187211.112; Compton SA, 2010, J BIOL CHEM, V285, P13349, DOI 10.1074/jbc.M109.074286; Compton SA, 2008, J BIOL CHEM, V283, P24478, DOI 10.1074/jbc.M803370200; Court R, 2005, EMBO REP, V6, P39, DOI 10.1038/sj.embor.7400314; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Fouche N, 2006, J BIOL CHEM, V281, P37486, DOI 10.1074/jbc.M608778200; GRIFFITH JD, 1995, J MOL BIOL, V246, P576, DOI 10.1016/S0022-2836(05)80107-X; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Hanaoka S, 2005, PROTEIN SCI, V14, P119, DOI 10.1110/ps.04983705; Hanaoka S, 2001, J MOL BIOL, V312, P167, DOI 10.1006/jmbi.2001.4924; Hsu HL, 2000, GENE DEV, V14, P2807, DOI 10.1101/gad.844000; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kobayashi M, 2006, J BIOL CHEM, V281, P4308, DOI 10.1074/jbc.M511090200; Konishi A, 2008, GENE DEV, V22, P1221, DOI 10.1101/gad.1634008; Lee SM, 1997, J BIOL CHEM, V272, P7532, DOI 10.1074/jbc.272.11.7532; Li BB, 2000, CELL, V101, P471, DOI 10.1016/S0092-8674(00)80858-2; Li BB, 2003, MOL BIOL CELL, V14, P5060, DOI 10.1091/mbc.e03-06-0403; Liu D, 2004, J BIOL CHEM, V279, P51338, DOI 10.1074/jbc.M409293200; Mao ZY, 2007, P NATL ACAD SCI USA, V104, P13068, DOI 10.1073/pnas.0702410104; Martinez P, 2011, NAT REV CANCER, V11, P161, DOI 10.1038/nrc3025; O'Connor MS, 2004, J BIOL CHEM, V279, P28585, DOI 10.1074/jbc.M312913200; Oganesian L, 2011, MOL CELL, V42, P224, DOI 10.1016/j.molcel.2011.03.015; Opresko PL, 2004, MOL CELL, V14, P763, DOI 10.1016/j.molcel.2004.05.023; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Sarthy J, 2009, EMBO J, V28, P3390, DOI 10.1038/emboj.2009.275; Sfeir A, 2010, SCIENCE, V327, P1657, DOI 10.1126/science.1185100; Stansel RM, 2001, EMBO J, V20, P5532; Subramanian D, 2005, J BIOL CHEM, V280, P42568, DOI 10.1074/jbc.M506348200; Takai KK, 2010, J BIOL CHEM, V285, P1457, DOI 10.1074/jbc.M109.038026; Tarsounas M, 2004, CELL, V117, P337, DOI 10.1016/S0092-8674(04)00337-X; van Steensel B, 1998, CELL, V92, P401, DOI 10.1016/S0092-8674(00)80932-0; Xu L, 2007, MOL CELL, V28, P315, DOI 10.1016/j.molcel.2007.10.005; Yamane K, 1999, ONCOGENE, V18, P5194, DOI 10.1038/sj.onc.1202922; Yamane K, 2000, BIOCHEM BIOPH RES CO, V279, P678, DOI 10.1006/bbrc.2000.3983; Yang D, 2011, CELL RES, V21, P1013, DOI 10.1038/cr.2011.39; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139; Zhu XD, 2003, MOL CELL, V12, P1489, DOI 10.1016/S1097-2765(03)00478-7	48	49	49	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41583	41594		10.1074/jbc.M112.415984	http://dx.doi.org/10.1074/jbc.M112.415984			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086976	Green Published, hybrid			2022-12-25	WOS:000312103000003
J	Cohen, SP; Buckley, BK; Kosloff, M; Garland, AL; Bosch, DE; Cheng, JG; Radhakrishna, H; Brown, MD; Willard, FS; Arshavsky, VY; Tarran, R; Siderovski, DP; Kimple, AJ				Cohen, Staci P.; Buckley, Brian K.; Kosloff, Mickey; Garland, Alaina L.; Bosch, Dustin E.; Cheng, JrGang; Radhakrishna, Harish; Brown, Michael D.; Willard, Francis S.; Arshavsky, Vadim Y.; Tarran, Robert; Siderovski, David P.; Kimple, Adam J.			Regulator of G-protein Signaling-21 (RGS21) Is an Inhibitor of Bitter Gustatory Signaling Found in Lingual and Airway Epithelia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEINS; HETEROTRIMERIC G-PROTEINS; G-ALPHA-INTERACTION; TASTE BUD CELLS; STRUCTURAL DETERMINANTS; HIGH-THROUGHPUT; RECEPTOR-CELLS; ACESULFAME-K; P115 RHOGEF; UMAMI TASTE	The gustatory system detects tastants and transmits signals to the brain regarding ingested substances and nutrients. Although tastant receptors and taste signaling pathways have been identified, little is known about their regulation. Because bitter, sweet, and umami taste receptors are G protein-coupled receptors (GPCRs), we hypothesized that regulators of G protein signaling (RGS) proteins may be involved. The recent cloning of RGS21 from taste bud cells has implicated this protein in the regulation of taste signaling; however, the exact role of RGS21 has not been precisely defined. Here, we sought to determine the role of RGS21 in tastant responsiveness. Biochemical analyses confirmed in silico predictions that RGS21 acts as a GTPase-accelerating protein (GAP) for multiple G protein alpha subunits, including adenylyl cyclase-inhibitory (G alpha(i)) subunits and those thought to be involved in tastant signal transduction. Using a combination of in situ hybridization, RT-PCR, immunohistochemistry, and immunofluorescence, we demonstrate that RGS21 is not only endogenously expressed in mouse taste buds but also in lung airway epithelial cells, which have previously been shown to express components of the taste signaling cascade. Furthermore, as shown by reverse transcription-PCR, the immortalized human airway cell line 16HBE was found to express transcripts for tastant receptors, RGS21, and down-stream taste signaling components. Over- and underexpression of RGS21 in 16HBE cells confirmed that RGS21 acts to oppose bitter tastant signaling to cAMP and calcium second messenger changes. Our data collectively suggests that RGS21 modulates bitter taste signal transduction.	[Cohen, Staci P.; Buckley, Brian K.; Bosch, Dustin E.; Willard, Francis S.; Siderovski, David P.; Kimple, Adam J.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Garland, Alaina L.; Tarran, Robert] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Tarran, Robert] Univ N Carolina, CF Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA; [Cheng, JrGang] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27599 USA; [Kosloff, Mickey; Arshavsky, Vadim Y.] Duke Univ, Duke Eye Ctr, Med Ctr, Durham, NC 27710 USA; [Kosloff, Mickey] Univ Haifa, Dept Biol, Fac Nat Sci, IL-31905 Haifa, Israel; [Radhakrishna, Harish; Brown, Michael D.] Coca Cola Co, Dept Biosci, Atlanta, GA 30313 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Duke University; University of Haifa; The Coca-Cola Company	Siderovski, DP (corresponding author), Robert C Byrd Hlth Sci Ctr, 3051A Hlth Sci N,1 Med Ctr Dr, Morgantown, WV 26506 USA.	dpsiderovski@hsc.wvu.edu	Siderovski, David Peter/AAA-9603-2019; Kosloff, Mickey/B-5962-2008	Siderovski, David Peter/0000-0002-0688-8210; Kosloff, Mickey/0000-0003-1807-4000; Bosch, Dustin/0000-0002-7430-2939; Kimple, Adam/0000-0003-1670-8401	National Institutes of Health [R01 GM082892, R01 HL108927, R01 EY012859]; National Institutes of Health/NIDCD Ruth L. Kirschstein NRSA Fellowship [F32 DC011670]; NATIONAL EYE INSTITUTE [R01EY012859, P30EY005722] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL108927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK091978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082892] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC011670] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health/NIDCD Ruth L. Kirschstein NRSA Fellowship; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM082892 (to D. P. S.), R01 HL108927 (to R. T.), R01 EY012859 (to V. Y. A.), and National Institutes of Health/NIDCD Ruth L. Kirschstein NRSA Fellowship F32 DC011670 (to S. P. C.).	Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Arshavsky VY, 1998, NEURON, V20, P11, DOI 10.1016/S0896-6273(00)80430-4; Bansal G, 2007, PHARMACOL THERAPEUT, V116, P473, DOI 10.1016/j.pharmthera.2007.09.005; Behrens M, 2006, J BIOL CHEM, V281, P20650, DOI 10.1074/jbc.M513637200; Berman DM, 1996, CELL, V86, P445, DOI 10.1016/S0092-8674(00)80117-8; Bosch D. E., 2012, CURR PROTOC PHARM, V56; Bourne HR, 1997, CURR OPIN CELL BIOL, V9, P134, DOI 10.1016/S0955-0674(97)80054-3; Castellone MD, 2005, SCIENCE, V310, P1504, DOI 10.1126/science.1116221; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Damak S, 2006, CHEM SENSES, V31, P253, DOI 10.1093/chemse/bjj027; Dascal N, 2001, TRENDS ENDOCRIN MET, V12, P391, DOI 10.1016/S1043-2760(01)00475-1; De Vries L, 2000, ANNU REV PHARMACOL, V40, P235, DOI 10.1146/annurev.pharmtox.40.1.235; Druey KM, 1996, NATURE, V379, P742, DOI 10.1038/379742a0; Fenech C, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.011.2009; Ford CE, 1998, SCIENCE, V280, P1271, DOI 10.1126/science.280.5367.1271; Fukuhara S, 2000, FEBS LETT, V485, P183, DOI 10.1016/S0014-5793(00)02224-9; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; He W, 2004, J NEUROSCI, V24, P7674, DOI 10.1523/JNEUROSCI.2441-04.2004; Heximer SP, 1997, P NATL ACAD SCI USA, V94, P14389, DOI 10.1073/pnas.94.26.14389; Horne J, 2002, CHEM SENSES, V27, P31, DOI 10.1093/chemse/27.1.31; Hutsell SQ, 2010, METHODS MOL BIOL, V627, P75, DOI 10.1007/978-1-60761-670-2_4; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Johnston CA, 2006, BIOCHEMISTRY-US, V45, P11390, DOI 10.1021/bi0613832; Kimple AJ, 2008, COMB CHEM HIGH T SCR, V11, P396, DOI 10.2174/138620708784534770; Kimple AJ, 2007, BBA-PROTEINS PROTEOM, V1774, P1213, DOI 10.1016/j.bbapap.2007.06.002; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Kimple AJ, 2010, METHODS MOL BIOL, V627, P91, DOI 10.1007/978-1-60761-670-2_5; Kimple AJ, 2009, J BIOL CHEM, V284, P19402, DOI 10.1074/jbc.M109.024711; Kinnamon SC, 2012, ACTA PHYSIOL, V204, P158, DOI 10.1111/j.1748-1716.2011.02308.x; Koelle MR, 1996, CELL, V84, P115, DOI 10.1016/S0092-8674(00)80998-8; Kosloff M, 2011, NAT STRUCT MOL BIOL, V18, P846, DOI 10.1038/nsmb.2068; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Kuhn C, 2004, J NEUROSCI, V24, P10260, DOI 10.1523/JNEUROSCI.1225-04.2004; Kusakabe Y, 2000, CHEM SENSES, V25, P525, DOI 10.1093/chemse/25.5.525; Lambert NA, 2010, P NATL ACAD SCI USA, V107, P7066, DOI 10.1073/pnas.0912934107; Lan KL, 1998, J BIOL CHEM, V273, P12794, DOI 10.1074/jbc.273.21.12794; Lefkowitz RJ, 2007, ACTA PHYSIOL, V190, P9, DOI 10.1111/j.1365-201X.2007.01693.x; Li X, 2005, ACTA BIOCHIM POL, V52, P943; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockhart IA, 2009, DEMENT GERIATR COGN, V28, P389, DOI 10.1159/000255578; Mall MA, 2010, J BIOL CHEM, V285, P26945, DOI 10.1074/jbc.M110.151803; Matsui Doreen, 2007, Paediatr Drugs, V9, P283; MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0; Mennella JA, 2008, CLIN THER, V30, P2120, DOI 10.1016/j.clinthera.2008.11.018; Meyerhof W, 2005, REV PHYSIOL BIOCH P, V154, P37, DOI 10.1007/s10254-005-0041-0; Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nishiyama M, 2011, ZOOL SCI, V28, P623, DOI 10.2108/zsj.28.623; Popov S, 1997, P NATL ACAD SCI USA, V94, P7216, DOI 10.1073/pnas.94.14.7216; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Renwick W, 2009, BIODRUGS, V23, P175, DOI 10.2165/00063030-200923030-00004; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Saito M, 1999, BIOL PHARM BULL, V22, P997; Shah AS, 2009, SCIENCE, V325, P1131, DOI 10.1126/science.1173869; Shah PP, 2010, PHARM DEV TECHNOL, V15, P276, DOI 10.3109/10837450903188485; Shaner NC, 2008, NAT METHODS, V5, P545, DOI 10.1038/nmeth.1209; Siderovski DP, 1996, CURR BIOL, V6, P211, DOI 10.1016/S0960-9822(02)00454-2; Sinnarajah S, 2001, NATURE, V409, P1051, DOI 10.1038/35059104; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138; Sobolev V, 2005, NUCLEIC ACIDS RES, V33, pW39, DOI 10.1093/nar/gki398; Soundararajan M, 2008, P NATL ACAD SCI USA, V105, P6457, DOI 10.1073/pnas.0801508105; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Strachan RT, 2009, J BIOL CHEM, V284, P5557, DOI 10.1074/jbc.M805705200; Ueda T, 2003, J NEUROSCI, V23, P7376; von Buchholtz L, 2004, EUR J NEUROSCI, V19, P1535, DOI 10.1111/j.1460-9568.2004.03257.x; Willard FS, 2005, ANAL BIOCHEM, V340, P341, DOI 10.1016/j.ab.2005.02.015; Wong GT, 1996, NATURE, V381, P796, DOI 10.1038/381796a0; Worthington EN, 2011, METHODS MOL BIOL, V742, P77, DOI 10.1007/978-1-61779-120-8_5; Wu SV, 2005, PHYSIOL GENOMICS, V22, P139, DOI 10.1152/physiolgenomics.00030.2005; Wu SV, 2002, P NATL ACAD SCI USA, V99, P2392, DOI 10.1073/pnas.042617699; Xu X, 1999, J BIOL CHEM, V274, P3549, DOI 10.1074/jbc.274.6.3549; YAMANAKA G, 1985, BIOCHEMISTRY-US, V24, P8094, DOI 10.1021/bi00348a039; Yan WT, 2001, AM J PHYSIOL-CELL PH, V280, pC742, DOI 10.1152/ajpcell.2001.280.4.C742; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zheng B, 2001, SCIENCE, V294, P1939, DOI 10.1126/science.1064757	82	24	24	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41706	41719		10.1074/jbc.M112.423806	http://dx.doi.org/10.1074/jbc.M112.423806			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23095746	Green Published, hybrid			2022-12-25	WOS:000312103000013
J	Golubkov, VS; Strongin, AY				Golubkov, Vladislav S.; Strongin, Alex Y.			Insights into Ectodomain Shedding and Processing of Protein-tyrosine Pseudokinase 7 (PTK7)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-TYPE-1 MATRIX-METALLOPROTEINASE; ALPHA-CONVERTING-ENZYME; EXTRACELLULAR-MATRIX; TISSUE INHIBITOR; CELL POLARITY; KINASE FAMILY; CANCER-CELLS; OFF-TRACK; MT1-MMP; PROTEOLYSIS	The membrane PTK7 pseudokinase, a component of both the canonical and noncanonical/planar cell polarity Wnt pathways, modulates cell polarity and motility in biological processes as diverse as embryo development and cancer cell invasion. To determine the individual proteolytic events and biological significance of the ectodomain shedding in the PTK7 function, we used highly invasive fibrosarcoma HT1080 cells as a model system. Current evidence suggested a likely link between PTK7 shedding and cell invasion in our HT1080 cell model system. We also demonstrated that in HT1080 cells the cleavage of the PTK7 ectodomain by an ADAM proteinase was coupled with the membrane type-1 matrix metalloproteinase (MT1-MMP) cleavage of the PKP621 down arrow LI site in the seventh Ig-like domain of PTK7. Proteolytic cleavages led to the generation of two soluble, N-terminal and two matching C-terminal, cell-associated fragments of PTK7. This proteolysis was a prerequisite for the intramembrane cleavage of the C-terminal fragments of PTK7 by gamma-secretase. gamma-Secretase cleavage was predominantly followed by the efficient decay of the resulting C-terminal PTK7 fragment via the proteasome. In contrast, in HT1080 cells, which overexpressed the C-terminal PTK7 fragment, the latter readily entered the nucleus. Our data imply that therapeutic inhibition of PTK7 shedding may be used to slow cancer progression.	[Golubkov, Vladislav S.; Strongin, Alex Y.] Sanford Burnham Inst Med Res, Canc Res Ctr, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Golubkov, VS (corresponding author), Sanford Burnham Inst Med Res, Canc Res Ctr, La Jolla, CA 92037 USA.	vgolubkov@sanfordburnham.org; strongin@sanfordburnham.org	Strongin, Alex/R-6609-2019; Golubkov, Vladislav/L-6828-2017	Strongin, Alex/0000-0003-3765-3016; 	National Institutes of Health [CA77470, CA83017, CA157328]; NATIONAL CANCER INSTITUTE [R01CA083017, R01CA077470, R01CA157328] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA77470, CA83017, and CA157328 (to A. Y. S.).	Amour A, 2000, FEBS LETT, V473, P275, DOI 10.1016/S0014-5793(00)01528-3; Amour A, 2002, FEBS LETT, V524, P154, DOI 10.1016/S0014-5793(02)03047-8; Baudrier-Regnier A, 2000, CANCER GENET CYTOGEN, V119, P80, DOI 10.1016/S0165-4608(99)00215-0; Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; Bigg HF, 2001, CANCER RES, V61, P3610; Brew K, 2010, BBA-MOL CELL RES, V1803, P55, DOI 10.1016/j.bbamcr.2010.01.003; Deryugina EI, 2002, J BIOL CHEM, V277, P9749, DOI 10.1074/jbc.M110269200; Duffy Michael J, 2011, Clin Proteomics, V8, P9, DOI 10.1186/1559-0275-8-9; Duffy MJ, 2009, CLIN CANCER RES, V15, P1140, DOI 10.1158/1078-0432.CCR-08-1585; Easty DJ, 1997, INT J CANCER, V71, P1061, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1061::AID-IJC24>3.0.CO;2-F; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Endoh H, 2004, J CLIN ONCOL, V22, P811, DOI 10.1200/JCO.2004.04.109; Fenteany G, 1998, J BIOL CHEM, V273, P8545, DOI 10.1074/jbc.273.15.8545; Fridman JS, 2007, CLIN CANCER RES, V13, P1892, DOI 10.1158/1078-0432.CCR-06-2116; Golubkov VS, 2006, CANCER RES, V66, P10460, DOI 10.1158/0008-5472.CAN-06-2997; Golubkov VS, 2011, J BIOL CHEM, V286, P20970, DOI 10.1074/jbc.M111.237669; Golubkov VS, 2010, J BIOL CHEM, V285, P35740, DOI 10.1074/jbc.M110.165159; Golubkov VS, 2005, J BIOL CHEM, V280, P25079, DOI 10.1074/jbc.M502779200; Gorringe KL, 2005, GENE CHROMOSOME CANC, V42, P247, DOI 10.1002/gcc.20136; Guo SC, 2011, BBA-REV CANCER, V1815, P197, DOI 10.1016/j.bbcan.2010.12.002; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Holmbeck K, 2004, J CELL PHYSIOL, V200, P11, DOI 10.1002/jcp.20065; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Itoh Y, 2006, J CELL PHYSIOL, V206, P1, DOI 10.1002/jcp.20431; Jones GC, 2005, ARTHRITIS RES THER, V7, P160, DOI 10.1186/ar1783; Jung JW, 2002, BBA-GENE STRUCT EXPR, V1579, P153, DOI 10.1016/S0167-4781(02)00536-5; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Killar L, 1999, ANN NY ACAD SCI, V878, P442, DOI 10.1111/j.1749-6632.1999.tb07701.x; Kohutek ZA, 2009, J NEUROSCI, V29, P4605, DOI 10.1523/JNEUROSCI.5126-08.2009; Kveiborg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017168; Kwak HI, 2009, MATRIX BIOL, V28, P470, DOI 10.1016/j.matbio.2009.07.007; Le Gall SM, 2003, J BIOL CHEM, V278, P45255, DOI 10.1074/jbc.M307745200; Lee MH, 2005, J BIOL CHEM, V280, P15967, DOI 10.1074/jbc.M500897200; Lhoumeau AC, 2011, CELL CYCLE, V10, P1233, DOI 10.4161/cc.10.8.15368; Lichtenthaler SF, 2011, J NEUROCHEM, V117, P779, DOI 10.1111/j.1471-4159.2011.07248.x; Lim NH, 2010, BIOCHEM J, V431, P113, DOI 10.1042/BJ20100725; Lin EA, 2010, PROTEIN CELL, V1, P33, DOI 10.1007/s13238-010-0002-5; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Mochizuki S, 2007, CANCER SCI, V98, P621, DOI 10.1111/j.1349-7006.2007.00434.x; Montes de Oca-B Pavel, 2010, Central Nervous System Agents in Medicinal Chemistry, V10, P337; Morrison CJ, 2009, CURR OPIN CELL BIOL, V21, P645, DOI 10.1016/j.ceb.2009.06.006; MOSSIE K, 1995, ONCOGENE, V11, P2179; Muller-Tidow C, 2004, CLIN CANCER RES, V10, P1241, DOI 10.1158/1078-0432.CCR-0954-03; Murphy G, 2009, SEMIN CELL DEV BIOL, V20, P138, DOI 10.1016/j.semcdb.2008.09.004; Na HW, 2012, J BIOL CHEM, V287, P25001, DOI 10.1074/jbc.M112.348904; Peradziryi H, 2011, EMBO J, V30, P3729, DOI 10.1038/emboj.2011.236; Piao Z, 2001, GENE CHROMOSOME CANC, V30, P113, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1069>3.3.CO;2-Y; Puppo F, 2011, EMBO REP, V12, P43, DOI 10.1038/embor.2010.185; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Rowe RG, 2009, J CELL BIOL, V184, P399, DOI 10.1083/jcb.200810113; Rozanov DV, 2008, CANCER RES, V68, P4086, DOI 10.1158/0008-5472.CAN-07-6458; Sabeh F, 2004, J CELL BIOL, V167, P769, DOI 10.1083/jcb.200408028; Seiki M, 2003, CANCER METAST REV, V22, P129, DOI 10.1023/A:1023087113214; Shnitsar I, 2008, DEVELOPMENT, V135, P4015, DOI 10.1242/dev.023556; Sounnil NE, 2010, INT J CANCER, V126, P1067, DOI 10.1002/ijc.24690; STOCKER W, 1995, PROTEIN SCI, V4, P823; Su YA, 2010, J CANCER, V1, P38; Sundberg C, 2004, J BIOL CHEM, V279, P51601, DOI 10.1074/jbc.M403753200; Szabova L, 2008, ONCOGENE, V27, P3274, DOI 10.1038/sj.onc.1210982; Toyofuku T, 2004, NAT CELL BIOL, V6, P1204, DOI 10.1038/ncb1193; Wehner P, 2011, DEVELOPMENT, V138, P1321, DOI 10.1242/dev.056291; Whitford KL, 2001, NEURON, V32, P1, DOI 10.1016/S0896-6273(01)00459-7; Winberg ML, 2001, NEURON, V32, P53, DOI 10.1016/S0896-6273(01)00446-9; Yanez-Mo M, 2011, BIOCHEM SOC T, V39, P541, DOI 10.1042/BST0390541; Yen WW, 2009, DEVELOPMENT, V136, P2039, DOI 10.1242/dev.030601; Zhao HR, 2004, J BIOL CHEM, V279, P8592, DOI 10.1074/jbc.M308708200; Zhou BBS, 2006, CANCER CELL, V10, P39, DOI 10.1016/j.ccr.2006.05.024; Zolkiewska A, 2008, CELL MOL LIFE SCI, V65, P2056, DOI 10.1007/s00018-008-7586-4	70	23	25	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42009	42018		10.1074/jbc.M112.371153	http://dx.doi.org/10.1074/jbc.M112.371153			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23095747	Green Published, hybrid			2022-12-25	WOS:000312103000040
J	Ryall, KA; Holland, DO; Delaney, KA; Kraeutler, MJ; Parker, AJ; Saucerman, JJ				Ryall, Karen A.; Holland, David O.; Delaney, Kyle A.; Kraeutler, Matthew J.; Parker, Audrey J.; Saucerman, Jeffrey J.			Network Reconstruction and Systems Analysis of Cardiac Myocyte Hypertrophy Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; KINASE; ACTIVATION; ENDOTHELIN-1; MECHANISMS; INHIBITORS; APOPTOSIS; PATHWAY; MODELS; GROWTH	Cardiac hypertrophy is managed by a dense web of signaling pathways with many pathways influencing myocyte growth. A quantitative understanding of the contributions of individual pathways and their interactions is needed to better understand hypertrophy signaling and to develop more effective therapies for heart failure. We developed a computational model of the cardiac myocyte hypertrophy signaling network to determine how the components and network topology lead to differential regulation of transcription factors, gene expression, and myocyte size. Our computational model of the hypertrophy signaling network contains 106 species and 193 reactions, integrating 14 established pathways regulating cardiac myocyte growth. 109 of 114 model predictions were validated using published experimental data testing the effects of receptor activation on transcription factors and myocyte phenotypic outputs. Network motif analysis revealed an enrichment of bifan and biparallel cross-talk motifs. Sensitivity analysis was used to inform clustering of the network into modules and to identify species with the greatest effects on cell growth. Many species influenced hypertrophy, but only a few nodes had large positive or negative influences. Ras, a network hub, had the greatest effect on cell area and influenced more species than any other protein in the network. We validated this model prediction in cultured cardiac myocytes. With this integrative computational model, we identified the most influential species in the cardiac hypertrophy signaling network and demonstrate how different levels of network organization affect myocyte size, transcription factors, and gene expression.	[Ryall, Karen A.; Holland, David O.; Delaney, Kyle A.; Kraeutler, Matthew J.; Parker, Audrey J.; Saucerman, Jeffrey J.] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA	University of Virginia	Saucerman, JJ (corresponding author), Univ Virginia, Dept Biomed Engn, POB 800759, Charlottesville, VA 22908 USA.	jsaucerman@virginia.edu		Saucerman, Jeffrey/0000-0001-9464-8374	National Institutes of Health [HL094476]; National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094476, R01HL105242] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL094476 (to J.S.) and a National Science Foundation graduate fellowship (to K.R.).	Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Assenov Y, 2008, BIOINFORMATICS, V24, P282, DOI 10.1093/bioinformatics/btm554; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bonneau R, 2007, CELL, V131, P1354, DOI 10.1016/j.cell.2007.10.053; Chavali AK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.15; Cooling M, 2007, BIOPHYS J, V93, P3421, DOI 10.1529/biophysj.107.110031; Ferro A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-58; Fuller SJ, 1998, J BIOL CHEM, V273, P18146, DOI 10.1074/jbc.273.29.18146; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Hung WC, 1998, INT J ONCOL, V12, P137; Ibarra RU, 2002, NATURE, V420, P186, DOI 10.1038/nature01149; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kalir S, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100010; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kraeutler MJ, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-157; Lusis AJ, 2010, CIRCULATION, V121, P157, DOI 10.1161/CIRCULATIONAHA.108.847699; Mangan S, 2003, P NATL ACAD SCI USA, V100, P11980, DOI 10.1073/pnas.2133841100; Morgan MA, 2001, BLOOD, V97, P1823, DOI 10.1182/blood.V97.6.1823; Mudd JO, 2008, NATURE, V451, P919, DOI 10.1038/nature06798; Omura T, 2002, HYPERTENSION, V39, P81, DOI 10.1161/hy0102.100783; Prasad KMR, 2011, GENE THER, V18, P43, DOI 10.1038/gt.2010.105; Rose BA, 2010, PHYSIOL REV, V90, P1507, DOI 10.1152/physrev.00054.2009; Ryall KA, 2012, J MOL CELL CARDIOL, V53, P282, DOI 10.1016/j.yjmcc.2012.04.016; Sanbe A, 2003, CIRC RES, V92, P609, DOI 10.1161/01.RES.0000065442.64694.9F; Saucerman JJ, 2004, CIRC RES, V95, P1216, DOI 10.1161/01.RES.0000150055.06226.4e; Saucerman JJ, 2003, J BIOL CHEM, V278, P47997, DOI 10.1074/jbc.M308362200; Schaub MC, 1997, J MOL MED, V75, P901, DOI 10.1007/s001090050182; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shin SY, 2006, FEBS LETT, V580, P5965, DOI 10.1016/j.febslet.2006.09.064; Ueyama T, 2000, J MOL CELL CARDIOL, V32, P947, DOI 10.1006/jmcc.2000.1135; Wang YB, 1998, J BIOL CHEM, V273, P5423, DOI 10.1074/jbc.273.10.5423; Yue TL, 2000, J BIOL CHEM, V275, P37895, DOI 10.1074/jbc.M007037200; Zechner D, 1997, J CELL BIOL, V139, P115, DOI 10.1083/jcb.139.1.115	37	50	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42259	42268		10.1074/jbc.M112.382937	http://dx.doi.org/10.1074/jbc.M112.382937			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23091058	hybrid, Green Published			2022-12-25	WOS:000312103000061
J	Zhang, S; Li, W; Zhu, CC; Wang, XH; Li, Z; Zhang, JS; Zhao, J; Hu, J; Li, T; Zhang, YQ				Zhang, Shun; Li, Wei; Zhu, Chuchao; Wang, Xiaohong; Li, Zhen; Zhang, Jinshan; Zhao, Jie; Hu, Jing; Li, Teng; Zhang, Yuanqiang			Sertoli Cell-specific Expression of Metastasis-associated Protein 2 (MTA2) Is Required for Transcriptional Regulation of the Follicle-stimulating Hormone Receptor (FSHR) Gene during Spermatogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITOR TRICHOSTATIN-A; HISTONE-DEACETYLASE; ANDROGEN RECEPTOR; ESTROGEN-RECEPTOR; MALE-INFERTILITY; MOUSE TESTIS; LEYDIG; CANCER; RAT; ACETYLATION	The effect of follicle-stimulating hormone (FSH) on spermatogenesis is modulated at a fundamental level by controlling the number of competent receptors present at the surface of Sertoli cells (SCs). One underlying mechanism is the down-regulation of the expression levels of the FSH receptor (FSHR) gene after exposure to FSH. Here we report that metastasis-associated protein 2 (MTA2), a component of histone deacetylase and nucleosome-remodeling complexes, as a gene product induced directly by testosterone or indirectly by FSH, is exclusively expressed in SCs. Stimulation of SCs with FSH is accompanied by up-regulation of MTA2 expression and enhancement of deacetylase activity. This effect requires the integrity of functional androgen receptor. Furthermore, MTA2 is a potent corepressor of FSHR transcription, because it can recruit histone deacetylase-1 onto the FSHR promoter and participates in the down-regulation of FSHR expression upon FSH treatment. Abolishment of endogenous MTA2 by siRNA treatment disrupted the desensitization of the FSH response and thereafter impaired the FSH-dependent secretory function of SCs. From a clinical standpoint, deregulated expression of MTA2 in SCs of human pathological testes negatively correlates to the deregulated level of serum FSH. Overall, our present results provide the first evidence that the FSH/androgen receptor/MTA2 cascade may serve as an indispensable negative feedback mechanism to modulate the transduction events of SCs in response to FSH. These data also underscore an unexpected reproductive facet of MTA2,	[Zhang, Shun; Li, Wei; Zhu, Chuchao; Li, Zhen; Zhang, Jinshan; Zhao, Jie; Hu, Jing; Li, Teng; Zhang, Yuanqiang] Fourth Mil Med Univ, Dept Human Anat Histol & Embryol, Xian 710032, Peoples R China; [Zhang, Shun; Wang, Xiaohong] Fourth Mil Med Univ, Reprod Med Ctr, Dept Gynecol & Obstet, Tangdu Hosp, Xian 710038, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Li, W (corresponding author), Fourth Mil Med Univ, Dept Human Anat Histol & Embryol, Xian 710032, Peoples R China.	liweipepeyato@yahoo.com.cn; zhangyq@fmmu.edu.cn			National Natural Science Foundation of China [31271248, 30800395, 31171154]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China Grants 31271248, 30800395, and 31171154.	Chamkhia N, 2006, TOXICOL IND HEALTH, V22, P349, DOI 10.1177/0748233706071739; Chang YF, 2011, BIOTECHNIQUES, V51, P341, DOI 10.2144/000113764; Cheng J, 2007, ENDOCRINOLOGY, V148, P2066, DOI 10.1210/en.2006-1465; Chuang CK, 2007, BIOSCIENCE REP, V27, P403, DOI 10.1007/s10540-007-9063-y; Cui YK, 2006, MOL ENDOCRINOL, V20, P2020, DOI 10.1210/me.2005-0063; Devi YS, 2006, J CLIN ENDOCR METAB, V91, P1062, DOI 10.1210/jc.2005-2072; Faure AK, 2003, MOL HUM REPROD, V9, P757, DOI 10.1093/molehr/gag101; Fenic I, 2004, J ANDROL, V25, P811; Fenic I, 2008, J ANDROL, V29, P172, DOI 10.2164/jandrol.107.003848; Foxley GL, 2001, ENDOCRINE, V15, P193, DOI 10.1385/ENDO:15:2:193; George JW, 2011, BIOL REPROD, V84, P7, DOI 10.1095/biolreprod.110.085043; Grinspon RP, 2010, HORM RES PAEDIAT, V73, P81, DOI 10.1159/000277140; Griswold MD, 2001, MOL CELL ENDOCRINOL, V173, P95, DOI 10.1016/S0303-7207(00)00412-3; Hazzouri M, 2000, EUR J CELL BIOL, V79, P950, DOI 10.1078/0171-9335-00123; Heckert LL, 1998, MOL ENDOCRINOL, V12, P1499, DOI 10.1210/me.12.10.1499; Hermann BP, 2008, ENDOCRINOLOGY, V149, P5297, DOI 10.1210/en.2007-1199; Hou W., 2012, J ANDROL IN PRESS; Huang WQ, 2004, J MOL HISTOL, V35, P47, DOI 10.1023/B:HIJO.0000021063.86024.48; Kim DH, 2005, EXP MOL MED, V37, P492, DOI 10.1038/emm.2005.61; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Lardone MC, 2011, MOL HUM REPROD, V17, P739, DOI 10.1093/molehr/gar051; Li WB, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0026013, 10.1371/journal.pone.0021082]; Loss ES, 2007, HORM METAB RES, V39, P806, DOI 10.1055/s-2007-991167; Lu XD, 2008, J BIOL CHEM, V283, P13825, DOI 10.1074/jbc.M801275200; Ma L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015439; Ma PP, 2010, BIOL REPROD, V83, P1027, DOI 10.1095/biolreprod.110.086397; Maguire SM, 1997, BIOL REPROD, V56, P1106, DOI 10.1095/biolreprod56.5.1106; Manavathi Bramanandam, 2007, Nucl Recept Signal, V5, pe010, DOI 10.1621/nrs.05010; Manavathi B, 2007, P NATL ACAD SCI USA, V104, P13128, DOI 10.1073/pnas.0705878104; Mazumdar A, 2001, NAT CELL BIOL, V3, P30, DOI 10.1038/35050532; Mendis SHS, 2011, BIOL REPROD, V84, P379, DOI 10.1095/biolreprod.110.086231; O'Shaughnessy PJ, 2008, REPRODUCTION, V135, P851, DOI 10.1530/REP-07-0529; Petersen C, 2006, HORM RES, V66, P153, DOI 10.1159/000094142; Popov VM, 2007, STEROIDS, V72, P221, DOI 10.1016/j.steroids.2006.12.001; Saito M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015541; Toh Y, 2009, CLIN EXP METASTAS, V26, P215, DOI 10.1007/s10585-008-9233-8; Walker WH, 2005, REPRODUCTION, V130, P15, DOI 10.1530/rep.1.00358; Wu XF, 2010, REPRODUCTION, V140, P113, DOI 10.1530/REP-09-0349; Yao YL, 2003, J BIOL CHEM, V278, P42560, DOI 10.1074/jbc.M302955200; Yong EL, 2003, HUM REPROD UPDATE, V9, P1, DOI 10.1093/humupd/dmg003	40	57	59	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 23	2012	287	48					40471	40483		10.1074/jbc.M112.383802	http://dx.doi.org/10.1074/jbc.M112.383802			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	042CM	23086931	hybrid, Green Published			2022-12-25	WOS:000311448800038
J	Dowd, KP; Harrington, DM; Donnelly, AE				Dowd, Kieran P.; Harrington, Deirdre M.; Donnelly, Alan E.			Criterion and Concurrent Validity of the activPAL (TM) Professional Physical Activity Monitor in Adolescent Females	PLOS ONE			English	Article							ACCELEROMETER OUTPUT; SEDENTARY BEHAVIOR; UNITED-STATES; CALIBRATION; TIME; VALIDATION; INACTIVITY; ACTIGRAPH; PATTERNS; CHILDREN	Background: The activPAL has been identified as an accurate and reliable measure of sedentary behaviour. However, only limited information is available on the accuracy of the activPAL activity count function as a measure of physical activity, while no unit calibration of the activPAL has been completed to date. This study aimed to investigate the criterion validity of the activPAL, examine the concurrent validity of the activPAL, and perform and validate a value calibration of the activPAL in an adolescent female population. The performance of the activPAL in estimating posture was also compared with sedentary thresholds used with the ActiGraph accelerometer. Methodologies: Thirty adolescent females (15 developmental; 15 cross-validation) aged 15-18 years performed 5 activities while wearing the activPAL, ActiGraph GT3X, and the Cosmed K4B2. A random coefficient statistics model examined the relationship between metabolic equivalent (MET) values and activPAL counts. Receiver operating characteristic analysis was used to determine activity thresholds and for cross-validation. The random coefficient statistics model showed a concordance correlation coefficient of 0.93 (standard error of the estimate = 1.13). An optimal moderate threshold of 2997 was determined using mixed regression, while an optimal vigorous threshold of 8229 was determined using receiver operating statistics. The activPAL count function demonstrated very high concurrent validity (r = 0.96, p<0.01) with the ActiGraph count function. Levels of agreement for sitting, standing, and stepping between direct observation and the activPAL and ActiGraph were 100%, 98.1%, 99.2% and 100%, 0%, 100%, respectively. Conclusions: These findings suggest that the activPAL is a valid, objective measurement tool that can be used for both the measurement of physical activity and sedentary behaviours in an adolescent female population.	[Dowd, Kieran P.; Donnelly, Alan E.] Univ Limerick, Dept Phys Educ & Sport Sci, Limerick, Ireland; [Harrington, Deirdre M.] Pennington Biomed Res Ctr, Baton Rouge, LA USA	University of Limerick; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Dowd, KP (corresponding author), Univ Limerick, Dept Phys Educ & Sport Sci, Limerick, Ireland.	kieran.dowd@ul.ie	Donnelly, Alan E/D-9244-2012; Dowd, Kieran/L-5810-2016	Dowd, Kieran/0000-0002-1841-1604; Donnelly, Alan/0000-0002-6874-0991; Harrington, Deirdre/0000-0003-0278-6812	Irish Research Council for Science, Engineering and Technology (IRCSET)	Irish Research Council for Science, Engineering and Technology (IRCSET)(Irish Research Council for Science, Engineering and Technology)	KD is supported by a studentship from the Irish Research Council for Science, Engineering and Technology (IRCSET), Shelbourne Rd., Dublin 4, Ireland. These funders had no role in the study design, collection, analysis and interpretation of the data, in the writing of the article and in the decision to submit the paper for publication.	Barnes J, 2012, APPL PHYSIOL NUTR ME, V37, P540, DOI [10.1139/H2012-024, 10.1139/h2012-024]; Bassett DR, 2012, MED SCI SPORT EXER, V44, pS32, DOI 10.1249/MSS.0b013e3182399cf7; Bassett DR, 2010, EXERC SPORT SCI REV, V38, P101, DOI 10.1097/JES.0b013e3181e373ee; Berghofer A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-200; Bey L, 2003, J PHYSIOL-LONDON, V551, P673, DOI 10.1113/jphysiol.2003.045591; Butte NF, 2012, MED SCI SPORT EXER, V44, pS5, DOI 10.1249/MSS.0b013e3182399c0e; Chastin SFM, 2009, EUR J APPL PHYSIOL, V106, P893, DOI 10.1007/s00421-009-1090-x; Colley R., 2011, HLTH REP, V22, P4; Department of Transport, 2009, NAT CYCL POL FRAM; Esliger DW, 2011, MED SCI SPORT EXER, V43, P1085, DOI 10.1249/MSS.0b013e31820513be; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Godfrey A, 2007, MED ENG PHYS, V29, P930, DOI 10.1016/j.medengphy.2006.10.001; Grant PM, 2006, BRIT J SPORT MED, V40, P992, DOI 10.1136/bjsm.2006.030262; Hamilton MT, 2007, DIABETES, V56, P2655, DOI 10.2337/db07-0882; Hamilton MT, 2008, CURR CARDIOVASC RISK, V2, P292, DOI 10.1007/s12170-008-0054-8; Harrington DM, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-120; Harrington DM, 2011, J SPORT SCI, V29, P627, DOI 10.1080/02640414.2010.549499; Hart TL, 2011, MED SCI SPORT EXER, V43, P449, DOI 10.1249/MSS.0b013e3181ef5a93; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Jago R, 2007, J SPORT SCI, V25, P937, DOI 10.1080/02640410600908027; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Kozey SL, 2010, MED SCI SPORT EXER, V42, P1776, DOI 10.1249/MSS.0b013e3181d479f2; Kozey-Keadle S, 2011, MED SCI SPORT EXER, V43, P1561, DOI 10.1249/MSS.0b013e31820ce174; Martin A, 2011, PEDIATR EXERC SCI, V23, P468, DOI 10.1123/pes.23.4.468; Martinez-Gomez D, 2010, REV ESP CARDIOL, V63, P277, DOI 10.1016/S0300-8932(10)70086-5; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; Owen N, 2010, EXERC SPORT SCI REV, V38, P105, DOI 10.1097/JES.0b013e3181e373a2; Pate RR, 2008, EXERC SPORT SCI REV, V36, P173, DOI 10.1097/JES.0b013e3181877d1a; POOLE DC, 1991, J APPL PHYSIOL, V71, P1245, DOI 10.1152/jappl.1991.71.4.1245; Riddoch CJ, 2004, MED SCI SPORT EXER, V36, P86, DOI 10.1249/01.MSS.0000106174.43932.92; Ridgers ND, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-15; Rowlands AV, 2007, PEDIATR EXERC SCI, V19, P252, DOI 10.1123/pes.19.3.252; Ryan CG, 2006, BRIT J SPORT MED, V40, P779, DOI 10.1136/bjsm.2006.027276; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2005, MED SCI SPORT EXER, V37, pS531, DOI 10.1249/01.mss.0000185657.86065.98; Trost SG, 2007, PEDIATR EXERC SCI, V19, P145, DOI 10.1123/pes.19.2.145; Vonesh EF, 1996, BIOMETRICS, V52, P572, DOI 10.2307/2532896; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Welk GJ, 2005, MED SCI SPORT EXER, V37, pS501, DOI 10.1249/01.mss.0000185660.38335.de; ZWEIG MH, 1993, CLIN CHEM, V39, P561	43	75	76	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47633	10.1371/journal.pone.0047633	http://dx.doi.org/10.1371/journal.pone.0047633			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094069	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000310050200036
J	Mendes, YS; Alves, NS; Souza, TLF; Sousa, IP; Bianconi, ML; Bernardi, RC; Pascutti, PG; Silva, JL; Gomes, AMO; Oliveira, AC				Mendes, Ygara S.; Alves, Nathalia S.; Souza, Theo L. F.; Sousa, Ivanildo P., Jr.; Lucia Bianconi, M.; Bernardi, Rafael C.; Pascutti, Pedro G.; Silva, Jerson L.; Gomes, Andre M. O.; Oliveira, Andrea C.			The Structural Dynamics of the Flavivirus Fusion Peptide-Membrane Interaction	PLOS ONE			English	Article							BORNE ENCEPHALITIS-VIRUS; PH-DEPENDENT FUSION; MOLECULAR-DYNAMICS; SYNTHETIC PEPTIDES; GLYCOPROTEIN; PROTEINS; MODEL; SIMULATIONS	Membrane fusion is a crucial step in flavivirus infections and a potential target for antiviral strategies. Lipids and proteins play cooperative roles in the fusion process, which is triggered by the acidic pH inside the endosome. This acidic environment induces many changes in glycoprotein conformation and allows the action of a highly conserved hydrophobic sequence, the fusion peptide (FP). Despite the large volume of information available on the virus-triggered fusion process, little is known regarding the mechanisms behind flavivirus-cell membrane fusion. Here, we evaluated the contribution of a natural single amino acid difference on two flavivirus FPs, FLA(G) ((98)DRGWGNGCGLFGK(110)) and FLA(H) ((98)DRGWGNHCGLFGK(110)), and investigated the role of the charge of the target membrane on the fusion process. We used an in silico approach to simulate the interaction of the FPs with a lipid bilayer in a complementary way and used spectroscopic approaches to collect conformation information. We found that both peptides interact with neutral and anionic micelles, and molecular dynamics (MD) simulations showed the interaction of the FPs with the lipid bilayer. The participation of the indole ring of Trp appeared to be important for the anchoring of both peptides in the membrane model, as indicated by MD simulations and spectroscopic analyses. Mild differences between FLA(G) and FLA(H) were observed according to the pH and the charge of the target membrane model. The MD simulations of the membrane showed that both peptides adopted a bend structure, and an interaction between the aromatic residues was strongly suggested, which was also observed by circular dichroism in the presence of micelles. As the FPs of viral fusion proteins play a key role in the mechanism of viral fusion, understanding the interactions between peptides and membranes is crucial for medical science and biology and may contribute to the design of new antiviral drugs.	[Mendes, Ygara S.; Alves, Nathalia S.; Lucia Bianconi, M.; Silva, Jerson L.; Gomes, Andre M. O.; Oliveira, Andrea C.] Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Estrutural, Rio De Janeiro, Brazil; [Mendes, Ygara S.; Alves, Nathalia S.; Lucia Bianconi, M.; Silva, Jerson L.; Gomes, Andre M. O.; Oliveira, Andrea C.] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Rio De Janeiro, Brazil; [Souza, Theo L. F.] Univ Fed Rio de Janeiro, Fac Farm, Rio De Janeiro, Brazil; [Sousa, Ivanildo P., Jr.] Fundacao Oswaldo Cruz, Inst Tecnol Imunobiol, Programa Vacinas Virais, Rio De Janeiro, Brazil; [Bernardi, Rafael C.; Pascutti, Pedro G.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, BR-21941 Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Oliveira, AC (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med, Programa Biol Estrutural, Rio De Janeiro, Brazil.	cheble@bioqmed.ufrj.br	Pascutti, Pedro/AAP-7752-2020; Gomes, Andre M.O./C-4009-2014; SILVA, JERSON Lima/GRF-1442-2022; Silva, Jerson/J-8984-2014; Oliveira, Andrea C/O-6695-2018; Sousa, Ivanildo/HCH-7825-2022; de Souza, Theo LF/E-1705-2017; Sousa, ivanildo/ABC-1067-2020	Gomes, Andre M.O./0000-0003-1052-8004; SILVA, JERSON Lima/0000-0001-9523-9441; Silva, Jerson/0000-0001-9523-9441; Sousa, Ivanildo/0000-0003-1840-3302; de Souza, Theo LF/0000-0002-0109-0357; Pascutti, Pedro/0000-0002-5454-560X	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Fundacao Universitaria Jose Bonifacio (FUJB); Instituto Milenio de Biologia Estrutural em Biomedicina e Biotecnologia (IMBEBB); Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (INBEB); Programa de Apoio a Nucleos de Excelencia (PRONEX)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Fundacao Universitaria Jose Bonifacio (FUJB); Instituto Milenio de Biologia Estrutural em Biomedicina e Biotecnologia (IMBEBB); Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (INBEB); Programa de Apoio a Nucleos de Excelencia (PRONEX)	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ), Fundacao Universitaria Jose Bonifacio (FUJB), Instituto Milenio de Biologia Estrutural em Biomedicina e Biotecnologia (IMBEBB), Instituto Nacional de Ciencia e Tecnologia de Biologia Estrutural e Bioimagem (INBEB), and Programa de Apoio a Nucleos de Excelencia (PRONEX) to JLS, AMOG, and ACO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; EIDELMAN O, 1984, J BIOL CHEM, V259, P4622; EPAND RM, 1992, BIOPOLYMERS, V32, P309, DOI 10.1002/bip.360320403; Freitas MS, 2007, J BIOL CHEM, V282, P27306, DOI 10.1074/jbc.M611864200; Freitas MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015756; Fritz R, 2008, J CELL BIOL, V183, P353, DOI 10.1083/jcb.200806081; Gaus K, 2006, MOL MEMBR BIOL, V23, P41, DOI 10.1080/09687860500466857; Gray C, 1996, BIOPHYS J, V70, P2275, DOI 10.1016/S0006-3495(96)79793-X; GRISHINA IB, 1994, FARADAY DISCUSS, V99, P245, DOI 10.1039/fd9949900245; Gubler D.J., 2007, FIELDS VIROLOGY, VVolume 1; Heinz FX, 2000, ADV VIRUS RES, V55, P231, DOI 10.1016/S0065-3527(00)55005-2; Huang CYH, 2010, VIROLOGY, V396, P305, DOI 10.1016/j.virol.2009.10.027; Jing W, 2003, J PEPT RES, V61, P219, DOI 10.1034/j.1399-3011.2003.00050.x; Kandt C, 2007, METHODS, V41, P475, DOI 10.1016/j.ymeth.2006.08.006; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Larios C, 2005, LUMINESCENCE, V20, P279, DOI 10.1002/bio.850; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Marrink SJ, 1996, FARADAY DISCUSS, V103, P191, DOI 10.1039/fd9960300191; Melo MN, 2009, J MOL BIOL, V392, P736, DOI 10.1016/j.jmb.2009.07.035; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Nieva JL, 2003, BBA-BIOMEMBRANES, V1614, P104, DOI 10.1016/S0005-2736(03)00168-8; Pan JH, 2010, BIOCHEMISTRY-US, V49, P287, DOI 10.1021/bi9017895; PARASASSI T, 1990, BIOPHYS J, V57, P1179, DOI 10.1016/S0006-3495(90)82637-0; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pecheur EI, 1999, J MEMBRANE BIOL, V167, P1, DOI 10.1007/s002329900466; RAFALSKI M, 1990, BIOCHEMISTRY-US, V29, P7917, DOI 10.1021/bi00486a020; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; ROEHRIG JT, 1989, VIROLOGY, V171, P49, DOI 10.1016/0042-6822(89)90509-6; Sanchez SA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029278; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Seelig J, 2004, BBA-BIOMEMBRANES, V1666, P40, DOI 10.1016/j.bbamem.2004.08.004; Seligman SJ, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-27; Sousa IP, 2011, J BIOL CHEM, V286, P1730, DOI 10.1074/jbc.M110.198002; Stauffer F, 2008, MOL MEMBR BIOL, V25, P128, DOI 10.1080/09687680701633091; Takekiyo T, 2009, BIOCHEMISTRY-US, V48, P1543, DOI 10.1021/bi8019838; Tamm LK, 2000, BIOSCIENCE REP, V20, P501, DOI 10.1023/A:1010406920417; Tieleman DP, 1996, J CHEM PHYS, V105, P4871, DOI 10.1063/1.472323; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; WHITE J, 1980, P NATL ACAD SCI-BIOL, V77, P3273, DOI 10.1073/pnas.77.6.3273; WHITE JM, 1990, ANNU REV PHYSIOL, V52, P675, DOI 10.1146/annurev.ph.52.030190.003331; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319	45	16	18	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47596	10.1371/journal.pone.0047596	http://dx.doi.org/10.1371/journal.pone.0047596			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094066	Green Published, Green Submitted, gold			2022-12-25	WOS:000310050200033
J	Makino, CL; Wen, XH; Olshevskaya, EV; Peshenko, IV; Savchenko, AB; Dizhoor, AM				Makino, Clint L.; Wen, Xiao-Hong; Olshevskaya, Elena V.; Peshenko, Igor V.; Savchenko, Andrey B.; Dizhoor, Alexander M.			Enzymatic Relay Mechanism Stimulates Cyclic GMP Synthesis in Rod Photoresponse: Biochemical and Physiological Study in Guanylyl Cyclase Activating Protein 1 Knockout Mice	PLOS ONE			English	Article							OUTER SEGMENTS; DIFFUSION-COEFFICIENT; IN-VIVO; PHOTORECEPTORS; CALCIUM; EXPRESSION; RETGC; GCAPS; PHOTOTRANSDUCTION; CLONING	Regulation of cGMP synthesis by retinal membrane guanylyl cyclase isozymes (RetGC1 and RetGC2) in rod and cone photoreceptors by calcium-sensitive guanylyl cyclase activating proteins (GCAP1 and GCAP2) is one of the key molecular mechanisms affecting the response to light and is involved in congenital retinal diseases. The objective of this study was to identify the physiological sequence of events underlying RetGC activation in vivo, by studying the electrophysiological and biochemical properties of mouse rods in a new genetic model lacking GCAP1. The GCAP1(-/-) retinas expressed normal levels of RetGC isozymes and other phototransduction proteins, with the exception of GCAP2, whose expression was elevated in a compensatory fashion. RetGC activity in GCAP1(-/-) retinas became more sensitive to Ca2+ and slightly increased. The bright flash response in electroretinogram (ERG) recordings recovered quickly in GCAP1(-/-), as well as in RetGC1(-/-) GCAP1(-/-), and RetGC2(-/-) GCAP1(-/-) hybrid rods, indicating that GCAP2 activates both RetGC isozymes in vivo. Individual GCAP1(-/-) rod responses varied in size and shape, likely reflecting variable endogenous GCAP2 levels between different cells, but single-photon response (SPR) amplitude and time-to-peak were typically increased, while recovery kinetics remained faster than in wild type. Recovery from bright flashes in GCAP1(-/-) was prominently biphasic, because rare, aberrant SPRs producing the slower tail component were magnified. These data provide strong physiological evidence that rod photoresponse recovery is shaped by the sequential recruitment of RetGC isozyme activation by GCAPs according to the different GCAP sensitivities for Ca2+ and specificities toward RetGC isozymes. GCAP1 is the 'first-response' sensor protein that stimulates RetGC1 early in the response and thus limits the SPR amplitude, followed by activation of GCAP2 that adds stimulation of both RetGC1 and RetGC2 to speed-up photoreceptor recovery.	[Olshevskaya, Elena V.; Peshenko, Igor V.; Savchenko, Andrey B.; Dizhoor, Alexander M.] Salus Univ, Dept Basic Sci, Elkins Pk, PA USA; [Olshevskaya, Elena V.; Peshenko, Igor V.; Savchenko, Andrey B.; Dizhoor, Alexander M.] Salus Univ, Penn Coll Optometry, Elkins Pk, PA USA; [Makino, Clint L.; Wen, Xiao-Hong] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA; [Makino, Clint L.; Wen, Xiao-Hong] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Harvard Medical School	Dizhoor, AM (corresponding author), Salus Univ, Dept Basic Sci, Elkins Pk, PA USA.	adizhoor@salus.edu	Makino, Clint Lawrence/H-8428-2019	Makino, Clint Lawrence/0000-0002-6005-9069; Dizhoor, Alexander/0000-0001-6770-9186	National Institutes of Health [EY11522, EY011358, EY014104]; Lion's of Massachusetts; Pennsylvania Department of Health Formula Grant; NATIONAL EYE INSTITUTE [P30EY014104, R01EY011358, R01EY011522, R29EY011358] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lion's of Massachusetts; Pennsylvania Department of Health Formula Grant; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by National Institutes of Health grants EY11522 (AMD) and EY011358, EY014104 (CLM), Lion's of Massachusetts, and Pennsylvania Department of Health Formula Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baehr W, 2007, J BIOL CHEM, V282, P8837, DOI 10.1074/jbc.M610369200; BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518; BIRCH DG, 1995, INVEST OPHTH VIS SCI, V36, P1603; Burns ME, 2002, NEURON, V36, P81, DOI 10.1016/S0896-6273(02)00911-X; Calvert PD, 1998, J GEN PHYSIOL, V111, P39, DOI 10.1085/jgp.111.1.39; Chen CK, 1999, P NATL ACAD SCI USA, V96, P3718, DOI 10.1073/pnas.96.7.3718; CHEN J, 1995, SCIENCE, V267, P374, DOI 10.1126/science.7824934; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; Dizhoor AM, 1998, J BIOL CHEM, V273, P17311, DOI 10.1074/jbc.273.28.17311; DIZHOOR AM, 1995, J BIOL CHEM, V270, P25200, DOI 10.1074/jbc.270.42.25200; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; GORCZYCA WA, 1995, J BIOL CHEM, V270, P22029, DOI 10.1074/jbc.270.37.22029; Haeseleer F, 1999, J BIOL CHEM, V274, P6526, DOI 10.1074/jbc.274.10.6526; Howes KA, 2002, EMBO J, V21, P1545, DOI 10.1093/emboj/21.7.1545; Hwang JY, 2003, EUR J BIOCHEM, V270, P3814, DOI 10.1046/j.1432-1033.2003.03770.x; Imanishi Y, 2004, J MOL EVOL, V59, P204, DOI 10.1007/s00239-004-2614-y; Jeon CJ, 1998, J NEUROSCI, V18, P8936; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KOCH KW, 1991, J BIOL CHEM, V266, P8634; KOCH KW, 2006, CALCIUM BINDING PROT, V1, P3; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; LEM J, 1991, NEURON, V6, P201, DOI 10.1016/0896-6273(91)90356-5; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; Lyubarsky AL, 1996, J NEUROSCI, V16, P563, DOI 10.1523/jneurosci.16-02-00563.1996; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; Mendez A, 2001, P NATL ACAD SCI USA, V98, P9948, DOI 10.1073/pnas.171308998; Nakatani K, 2002, BIOPHYS J, V82, P728, DOI 10.1016/S0006-3495(02)75435-0; Olshevskaya EV, 2012, J NEUROSCI, V32, P7208, DOI 10.1523/JNEUROSCI.0976-12.2012; Olshevskaya EV, 1997, J BIOL CHEM, V272, P14327, DOI 10.1074/jbc.272.22.14327; OLSON A, 1993, BIOPHYS J, V65, P1335, DOI 10.1016/S0006-3495(93)81177-9; PALCZEWSKI K, 1994, NEURON, V13, P395, DOI 10.1016/0896-6273(94)90355-7; PEPPERBERG DR, 1992, VISUAL NEUROSCI, V8, P9, DOI 10.1017/S0952523800006441; Peshenko IV, 2007, J BIOL CHEM, V282, P21645, DOI 10.1074/jbc.M702368200; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Peshenko IV, 2004, J BIOL CHEM, V279, P16903, DOI 10.1074/jbc.C400065200; Pugh EN, 1997, BIOSCIENCE REP, V17, P429; RAPORT CJ, 1994, INVEST OPHTH VIS SCI, V35, P2932; Sakurai K, 2011, J NEUROSCI, V31, P7991, DOI 10.1523/JNEUROSCI.6650-10.2011; Scholten A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023117; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; TYBULEWICZ VLJ, 1991, CELL, V65, P1153, DOI 10.1016/0092-8674(91)90011-M; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; Yang RB, 1999, J NEUROSCI, V19, P5889, DOI 10.1523/JNEUROSCI.19-14-05889.1999; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602	46	43	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47637	10.1371/journal.pone.0047637	http://dx.doi.org/10.1371/journal.pone.0047637			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082185	Green Published, Green Submitted, gold			2022-12-25	WOS:000311146900081
J	Pereira, MB; Zanetta, DMT; Abdulkader, RCRM				Pereira, Mariana B.; Zanetta, Dirce M. T.; Abdulkader, Regina C. R. M.			The Real Importance of Pre-Existing Comorbidities on Long-Term Mortality after Acute Kidney Injury	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; ACUTE MYOCARDIAL-INFARCTION; REPLACEMENT THERAPY; PERITUBULAR CAPILLARIES; CHRONIC DIALYSIS; RISK-FACTOR; OUTCOMES; DEATH; SURVIVAL; DISEASE	Background: The causes of death on long-term mortality after acute kidney injury (AKI) have not been well studied. The purpose of the study was to evaluate the role of comorbidities and the causes of death on the long-term mortality after AKI. Methodology/Principal Findings: We retrospectively studied 507 patients who experienced AKI in 2005-2006 and were discharged free from dialysis. In June 2008 (median: 21 months after AKI), we found that 193 (38%) patients had died. This mortality is much higher than the mortality of the population of Sao Paulo City, even after adjustment for age. A multiple survival analysis was performed using Cox proportional hazards regression model and showed that death was associated with Khan's index indicating high risk [adjusted hazard ratio 2.54 (1.38-4.66)], chronic liver disease [1.93 (1.15-3.22)], admission to non-surgical ward [1.85 (1.30-2.61)] and a second AKI episode during the same hospitalization [1.74 (1.12-2.71)]. The AKI severity evaluated either by the worst stage reached during AKI (P=0.20) or by the need for dialysis (P=0.12) was not associated with death. The causes of death were identified by a death certificate in 85% of the non-survivors. Among those who died from circulatory system diseases (the main cause of death), 59% had already suffered from hypertension, 34% from diabetes, 47% from heart failure, 38% from coronary disease, and 66% had a glomerular filtration rate <60 previous to the AKI episode. Among those who died from neoplasms, 79% already had the disease previously. Conclusions: Among AKI survivors who were discharged free from dialysis the increased long-term mortality was associated with their pre-existing chronic conditions and not with the severity of the AKI episode. These findings suggest that these survivors should have a medical follow-up after hospital discharge and that all efforts should be made to control their comorbidities.	[Pereira, Mariana B.; Abdulkader, Regina C. R. M.] Univ Sao Paulo, Sch Med, Div Nephrol, Sao Paulo, Brazil; [Zanetta, Dirce M. T.] Univ Sao Paulo, Sch Publ Hlth, Dept Epidemiol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Pereira, MB (corresponding author), Univ Sao Paulo, Sch Med, Div Nephrol, Sao Paulo, Brazil.	marianabpereira@yahoo.com.br	Zanetta, Dirce M T/G-4950-2013	Zanetta, Dirce Maria/0000-0002-7273-5087	CAPES ("Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior'')	CAPES ("Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior'')(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Mariana B Pereira received a Grant from CAPES ("Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior''). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlstrom A, 2005, INTENS CARE MED, V31, P1222, DOI 10.1007/s00134-005-2681-6; Ali T, 2007, J AM SOC NEPHROL, V18, P1292, DOI 10.1681/ASN.2006070756; Bagshaw SM, 2006, AM J KIDNEY DIS, V48, P402, DOI 10.1053/j.ajkd.2006.06.002; Bagshaw SM, 2009, NEPHROL DIAL TRANSPL, V24, P2739, DOI 10.1093/ndt/gfp159; Barretti P, 1997, RENAL FAILURE, V19, P253, DOI 10.3109/08860229709026285; Basile DP, 2004, CURR OPIN NEPHROL HY, V13, P1, DOI 10.1097/00041552-200401000-00001; Basile DP, 2001, AM J PHYSIOL-RENAL, V281, pF887, DOI 10.1152/ajprenal.0050.2001; Bihorac A, 2009, ANN SURG, V249, P851, DOI 10.1097/SLA.0b013e3181a40a0b; Brown JR, 2010, ANN THORAC SURG, V90, P1142, DOI 10.1016/j.athoracsur.2010.04.039; Cerda J, 2008, CLIN J AM SOC NEPHRO, V3, P881, DOI 10.2215/CJN.04961107; Choi AI, 2010, KIDNEY INT, V78, P478, DOI 10.1038/ki.2010.171; Coca SG, 2010, KIDNEY INT, V78, P926, DOI 10.1038/ki.2010.259; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Deshpande P, 2011, HEPATOL INT, V5, P751, DOI 10.1007/s12072-011-9269-8; Franca E, 2008, INT J EPIDEMIOL, V37, P891, DOI 10.1093/ije/dyn121; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Goldberg A, 2009, KIDNEY INT, V76, P900, DOI 10.1038/ki.2009.295; Goldberg R, 2008, ADV CHRONIC KIDNEY D, V15, P297, DOI 10.1053/j.ackd.2008.04.009; Hobson CE, 2009, CIRCULATION, V119, P2444, DOI 10.1161/CIRCULATIONAHA.108.800011; James MT, 2011, CIRCULATION, V123, P409, DOI 10.1161/CIRCULATIONAHA.110.970160; Kelly KJ, 2003, J AM SOC NEPHROL, V14, P1549, DOI 10.1097/01.ASN.0000064946.94590.46; KHAN IH, 1993, LANCET, V341, P415, DOI 10.1016/0140-6736(93)93003-J; Khan IH, 1997, QJM-MON J ASSOC PHYS, V90, P781; Khosla N, 2009, CLIN J AM SOC NEPHRO, V4, P1914, DOI 10.2215/CJN.01690309; Kramer AA, 1999, KIDNEY INT, V55, P2362, DOI 10.1046/j.1523-1755.1999.00460.x; Lafrance JP, 2010, AM J KIDNEY DIS, V56, P651, DOI 10.1053/j.ajkd.2010.05.011; Lafrance JP, 2010, J AM SOC NEPHROL, V21, P345, DOI 10.1681/ASN.2009060636; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Liano F, 2007, KIDNEY INT, V71, P679, DOI 10.1038/sj.ki.5002086; Liano F, 2010, CLIN NEPHROL, V74, pS89; Loef BG, 2005, J AM SOC NEPHROL, V16, P195, DOI 10.1681/ASN.2003100875; Lopes JA, 2010, BMC NEPHROL, V11, DOI 10.1186/1471-2369-11-9; Macedo E, 2008, CURR OPIN CRIT CARE, V14, P660, DOI 10.1097/MCC.0b013e328317ee6e; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Mehta RH, 2010, AM J CARDIOL, V106, P1728, DOI 10.1016/j.amjcard.2010.07.045; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Nair S, 2002, HEPATOLOGY, V35, P1179, DOI 10.1053/jhep.2002.33160; Parikh CR, 2008, ARCH INTERN MED, V168, P987, DOI 10.1001/archinte.168.9.987; Pechman KR, 2009, AM J PHYSIOL-REG I, V297, pR1358, DOI 10.1152/ajpregu.91022.2008; Ponce D, 2011, NEPHROL DIAL TRANSPL, V26, P3202, DOI 10.1093/ndt/gfr359; Schiffl H, 2011, INT UROL NEPHROL; Schiffl H, 2008, NEPHROL DIAL TRANSPL, V23, P2235, DOI 10.1093/ndt/gfn182; Siew ED, 2010, KIDNEY INT, V77, P536, DOI 10.1038/ki.2009.479; Singh P, 2010, CLIN J AM SOC NEPHRO, V5, P1690, DOI 10.2215/CJN.00830110; Thakar CV, 2009, CRIT CARE MED, V37, P2552, DOI 10.1097/CCM.0b013e3181a5906f; Wald R, 2012, AM J MED, V125, P585, DOI 10.1016/j.amjmed.2012.01.016; Wald R, 2009, JAMA-J AM MED ASSOC, V302, P1179, DOI 10.1001/jama.2009.1322; WOODROW G, 1992, NEPHROL DIAL TRANSPL, V7, P230, DOI 10.1093/oxfordjournals.ndt.a092111	48	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47746	10.1371/journal.pone.0047746	http://dx.doi.org/10.1371/journal.pone.0047746			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082206	Green Submitted, Green Published, gold			2022-12-25	WOS:000311146900103
J	Sinha, N; Pilder, S; Vijayaraghavan, S				Sinha, Nilam; Pilder, Stephen; Vijayaraghavan, Srinivasan			Significant Expression Levels of Transgenic PPP1CC2 in Testis and Sperm Are Required to Overcome the Male Infertility Phenotype of Ppp1cc Null Mice	PLOS ONE			English	Article							SERINE/THREONINE PROTEIN PHOSPHATASES; GLYCOGEN-SYNTHASE KINASE-3; DIFFERENTIAL EXPRESSION; EPIDIDYMAL SPERM; GENE; MOTILITY; FERTILITY; ISOFORMS; CELLS; RAT	PPP1CC2, one of four isoforms of the ser/thr protein phosphatase PP1, is a mammalian-specific splice variant of the Ppp1cc gene, and the only isoform whose expression is confined almost completely to spermatogenic cells. Additionally, PPP1CC2 is the sole isoform found in mammalian spermatozoa. Although PPP1CC1, the other Ppp1cc product, is expressed in many tissues including testis, the only phenotype resulting from deletion of Ppp1cc gene is male infertility. To determine which of the products of Ppp1cc is essential for male fertility, we created two PPP1CC2 transgenes, eTg-G2 and pTg-G2, where Ppp1cc2 expression was driven by the putative endogenous promoter of Ppp1cc or by the testis specific human Pgk2 promoter, respectively. Our results demonstrate that the 2.6-kb genomic region directly upstream of the Ppp1cc structural gene can drive expression of Ppp1cc2, and recapitulate the wild-type tissue specificity of PPP1CC2 in transgenic mice. More importantly, we show that expression of PPP1CC2 alone, via either promoter, is able not only to restore normal spermatogenesis, but the fertility of Ppp1cc null mice as well, provided that transgenic PPP1CC2 expression in testis reaches at least a lower threshold level equivalent to approximately 50% of its expression by a Ppp1cc +/- male. We conclude that the endogenous Ppp1cc promoter normally functions in the testis to maintain a sufficient level of PPP1CC2 expression for normal spermatogenesis to occur, and that production of spermatozoa capable of fertilization in vivo can take place in the complete absence of PPP1CC1 expression.	[Sinha, Nilam; Vijayaraghavan, Srinivasan] Kent State Univ, Dept Biol Sci, Kent, OH 44242 USA; [Pilder, Stephen] Temple Univ, Dept Anat & Cell Biol, Sch Med, Philadelphia, PA 19122 USA	University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Sinha, N (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA.	nilams@vet.upenn.edu; svijayar@kent.edu			National Institutes of Health [R01HD038520-08]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the National Institutes of Health grant R01HD038520-08. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARKER HM, 1993, BIOCHIM BIOPHYS ACTA, V1178, P228, DOI 10.1016/0167-4889(93)90014-G; BARTOOV B, 1993, HUM REPROD, V8, P65, DOI 10.1093/oxfordjournals.humrep.a137876; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Burton KA, 2006, MOL ENDOCRINOL, V20, P2504, DOI 10.1210/me.2006-0060; Chakrabarti R, 2007, BIOL REPROD, V76, P992, DOI 10.1095/biolreprod.106.058610; Cheng L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004861; Cohen PTW, 2002, J CELL SCI, V115, P241; Foster D L., 1994, PHYSL REPROD, V2; Garcia A, 2003, BIOCHIMIE, V85, P721, DOI 10.1016/j.biochi.2003.09.004; Gibbons JA, 2007, J BIOL CHEM, V282, P21838, DOI 10.1074/jbc.M701272200; Goodson SG, 2011, BIOL REPROD, V84, P1207, DOI 10.1095/biolreprod.110.088989; Hirano K, 1996, FEBS LETT, V389, P191, DOI 10.1016/0014-5793(96)00577-7; Huang ZH, 2004, BIOL REPROD, V70, P439, DOI 10.1095/biolreprod.103.020024; KITAGAWA Y, 1990, BIOCHEM BIOPH RES CO, V171, P230, DOI 10.1016/0006-291X(90)91381-2; Lin Q, 1999, MOL PHYLOGENET EVOL, V12, P57, DOI 10.1006/mpev.1998.0560; Okano K, 1997, GENOMICS, V45, P211, DOI 10.1006/geno.1997.4907; ORGEBINCRIST MC, 1967, NATURE, V216, P816, DOI 10.1038/216816a0; ORGEBINCRIST MC, 1977, BIOL REPROD, V16, P358, DOI 10.1095/biolreprod16.3.358; Russell L. D., 1990, HISTOLOGICAL HISTOPA; San Agustin JT, 2001, BIOL REPROD, V65, P151, DOI 10.1095/biolreprod65.1.151; San Agustin JT, 2000, MOL BIOL CELL, V11, P3031, DOI 10.1091/mbc.11.9.3031; SASAKI K, 1990, JPN J CANCER RES, V81, P1272, DOI 10.1111/j.1349-7006.1990.tb02690.x; SHIMA H, 1993, BIOCHEM BIOPH RES CO, V194, P930, DOI 10.1006/bbrc.1993.1910; SILVA EFDE, 1995, J NEUROSCI, V15, P3375; Smith GD, 1996, BIOL REPROD, V54, P719, DOI 10.1095/biolreprod54.3.719; Smith GD, 1999, J ANDROL, V20, P47; Soler DC, 2009, BIOL REPROD, V81, P343, DOI 10.1095/biolreprod.109.076398; Varmuza S, 1999, DEV BIOL, V205, P98, DOI 10.1006/dbio.1998.9100; Vijayaraghavan S, 1996, BIOL REPROD, V54, P709, DOI 10.1095/biolreprod54.3.709; Zhang LP, 1999, BIOL REPROD, V60, P1329, DOI 10.1095/biolreprod60.6.1329	30	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47623	10.1371/journal.pone.0047623	http://dx.doi.org/10.1371/journal.pone.0047623			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082183	Green Published, Green Submitted, gold			2022-12-25	WOS:000311146900079
J	Chiang, CW; Chen, YC; Lu, JC; Hsiao, YT; Chang, CW; Huang, PC; Chang, YT; Chang, PY; Wang, CT				Chiang, Chung-Wei; Chen, Yu-Chieh; Lu, Juu-Chin; Hsiao, Yu-Tien; Chang, Che-Wei; Huang, Pin-Chien; Chang, Yu-Tzu; Chang, Payne Y.; Wang, Chih-Tien			Synaptotagmin I Regulates Patterned Spontaneous Activity in the Developing Rat Retina via Calcium Binding to the C2AB Domains	PLOS ONE			English	Article							VISUAL-SYSTEM DEVELOPMENT; DENSE-CORE VESICLES; MAMMALIAN RETINA; RETINOGENICULATE PROJECTIONS; CA2+-TRIGGERED EXOCYTOSIS; NEUROTRANSMITTER RELEASE; TRANSMITTER RELEASE; BURSTING ACTIVITY; PLASMA-MEMBRANE; MOUSE RETINA	Background: In neonatal binocular animals, the developing retina displays patterned spontaneous activity termed retinal waves, which are initiated by a single class of interneurons (starburst amacrine cells, SACs) that release neurotransmitters. Although SACs are shown to regulate wave dynamics, little is known regarding how altering the proteins involved in neurotransmitter release may affect wave dynamics. Synaptotagmin (Syt) family harbors two Ca2+-binding domains (C2A and C2B) which serve as Ca2+ sensors in neurotransmitter release. However, it remains unclear whether SACs express any specific Syt isoform mediating retinal waves. Moreover, it is unknown how Ca2+ binding to C2A and C2B of Syt affects wave dynamics. Here, we investigated the expression of Syt I in the neonatal rat retina and examined the roles of C2A and C2B in regulating wave dynamics. Methodology/Principal Findings: Immunostaining and confocal microscopy showed that Syt I was expressed in neonatal rat SACs and cholinergic synapses, consistent with its potential role as a Ca2+ sensor mediating retinal waves. By combining a horizontal electroporation strategy with the SAC-specific promoter, we specifically expressed Syt I mutants with weakened Ca2+-binding ability in C2A or C2B in SACs. Subsequent live Ca2+ imaging was used to monitor the effects of these molecular perturbations on wave-associated spontaneous Ca2+ transients. We found that targeted expression of Syt I C2A or C2B mutants in SACs significantly reduced the frequency, duration, and amplitude of wave-associated Ca2+ transients, suggesting that both C2 domains regulate wave temporal properties. In contrast, these C2 mutants had relatively minor effects on pairwise correlations over distance for wave-associated Ca2+ transients. Conclusions/Significance: Through Ca2+ binding to C2A or C2B, the Ca2+ sensor Syt I in SACs may regulate patterned spontaneous activity to shape network activity during development. Hence, modulating the releasing machinery in presynaptic neurons (SACs) alters wave dynamics.	[Chiang, Chung-Wei; Chen, Yu-Chieh; Hsiao, Yu-Tien; Chang, Che-Wei; Huang, Pin-Chien; Wang, Chih-Tien] Natl Taiwan Univ, Inst Mol & Cell Biol, Taipei 10764, Taiwan; [Chiang, Chung-Wei; Chen, Yu-Chieh; Wang, Chih-Tien] Natl Taiwan Univ, Dept Life Sci, Taipei 10764, Taiwan; [Wang, Chih-Tien] Natl Taiwan Univ, Neurobiol & Cognit Sci Ctr, Taipei 10764, Taiwan; [Wang, Chih-Tien] Natl Taiwan Univ, Genome & Syst Biol Degree Program, Taipei 10764, Taiwan; [Lu, Juu-Chin; Chang, Yu-Tzu] Chang Gung Univ, Coll Med, Dept Physiol & Pharmacol, Tao Yuan, Taiwan; [Chang, Payne Y.] Univ Texas Austin, Ctr Learning & Memory, Austin, TX 78712 USA	National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University; Chang Gung University; University of Texas System; University of Texas Austin	Wang, CT (corresponding author), Natl Taiwan Univ, Inst Mol & Cell Biol, Taipei 10764, Taiwan.	chihtienwang@ntu.edu.tw	Lu, Juu-Chin/ABB-3198-2020; Chen, Yu-Chieh David/AAB-2927-2019; Wang, Chih-Tien/GRE-8232-2022	Lu, Juu-Chin/0000-0001-8523-6992; Chen, Yu-Chieh David/0000-0002-2597-7577; Wang, Chih-Tien/0000-0001-7639-7508; Chiang, Chung-Wei/0000-0002-9443-914X	NTU startup fund, National Science Council [NSC-100-2321-B-002-001, NSC-100-2311-B-002-010, NSC-97-2311-B-002-007-MY3]; National Health Research Institutes Grant [NHRI-EX100-9718NC]; NSC college student research fellowship [NSC-97-2815-C-002-042-B]	NTU startup fund, National Science Council; National Health Research Institutes Grant; NSC college student research fellowship	Funding was provided by NTU startup fund, National Science Council Grants (NSC-100-2321-B-002-001, NSC-100-2311-B-002-010 & NSC-97-2311-B-002-007-MY3), and National Health Research Institutes Grant (NHRI-EX100-9718NC) to CT Wang. CW Chiang received a NSC college student research fellowship (NSC-97-2815-C-002-042-B). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREASEN NC, 1994, SCIENCE, V266, P294, DOI 10.1126/science.7939669; Bai JH, 2004, NEURON, V41, P929, DOI 10.1016/S0896-6273(04)00117-5; Bai JH, 2004, TRENDS BIOCHEM SCI, V29, P143, DOI 10.1016/j.tibs.2004.01.008; Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; Blankenship AG, 2010, NAT REV NEUROSCI, V11, P18, DOI 10.1038/nrn2759; BORGES S, 1995, P NATL ACAD SCI USA, V92, P6896, DOI 10.1073/pnas.92.15.6896; Chalupa LM, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-25; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Cormack B, 1994, CURRENT PROTOCOLS MO; Craxton M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-43; Dean C, 2009, NAT NEUROSCI, V12, P767, DOI 10.1038/nn.2315; Donovan SL, 2006, NAT PROTOC, V1, P2710, DOI 10.1038/nprot.2006.454; Dunn TA, 2006, J NEUROSCI, V26, P12807, DOI 10.1523/JNEUROSCI.3238-06.2006; Feller MB, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-24; Feller MB, 1996, SCIENCE, V272, P1182, DOI 10.1126/science.272.5265.1182; Feller MB, 2002, J NEUROBIOL, V53, P556, DOI 10.1002/neu.10140; Firth SI, 2005, CELL CALCIUM, V37, P425, DOI 10.1016/j.ceca.2005.01.010; Ford KJ, 2012, J NEUROSCI, V32, P850, DOI 10.1523/JNEUROSCI.5309-12.2012; Greenlee MHW, 2001, J COMP NEUROL, V430, P306, DOI 10.1002/1096-9861(20010212)430:3<306::AID-CNE1032>3.0.CO;2-B; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; Jackson MB, 2008, NAT STRUCT MOL BIOL, V15, P684, DOI 10.1038/nsmb.1449; Kochubey O, 2011, TRENDS NEUROSCI, V34, P237, DOI 10.1016/j.tins.2011.02.006; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Mackler JM, 2002, NATURE, V418, P340, DOI 10.1038/nature00846; Martinez A, 2008, J NEUROSCI, V28, P7492, DOI 10.1523/JNEUROSCI.1852-08.2008; McLaughlin T, 2003, NEURON, V40, P1147, DOI 10.1016/S0896-6273(03)00790-6; Nishiki T, 2004, J NEUROSCI, V24, P8542, DOI 10.1523/JNEUROSCI.2545-04.2004; Pang ZPP, 2010, CURR OPIN CELL BIOL, V22, P496, DOI 10.1016/j.ceb.2010.05.001; Patterson PH, 2007, SCIENCE, V318, P576, DOI 10.1126/science.1150196; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Pham TA, 2001, NEURON, V31, P409, DOI 10.1016/S0896-6273(01)00381-6; Sherry DM, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-54; Sherry DM, 2003, MOL VIS, V9, P673; Singer JH, 2001, J NEUROSCI, V21, P8514, DOI 10.1523/JNEUROSCI.21-21-08514.2001; Soda T, 2003, J NEUROSCI, V23, P6272; Stafford BK, 2009, NEURON, V64, P200, DOI 10.1016/j.neuron.2009.09.021; Torborg C, 2004, VISION RES, V44, P3347, DOI 10.1016/j.visres.2004.08.015; Torborg CL, 2005, NAT NEUROSCI, V8, P72, DOI 10.1038/nn1376; Ubach J, 1998, EMBO J, V17, P3921, DOI 10.1093/emboj/17.14.3921; Wang CT, 2007, J NEUROSCI, V27, P9130, DOI 10.1523/JNEUROSCI.1293-07.2007; Wang CT, 2006, J PHYSIOL-LONDON, V570, P295, DOI 10.1113/jphysiol.2005.097378; Wang CT, 2003, NATURE, V424, P943, DOI 10.1038/nature01857; Wang CT, 2001, SCIENCE, V294, P1111, DOI 10.1126/science.1064002; Watanabe D, 1998, CELL, V95, P17, DOI 10.1016/S0092-8674(00)81779-1; Wong ROL, 1996, NEURON, V16, P1087, DOI 10.1016/S0896-6273(00)80135-X; WONG ROL, 1993, NEURON, V11, P923, DOI 10.1016/0896-6273(93)90122-8; Wong ROL, 1999, ANNU REV NEUROSCI, V22, P29, DOI 10.1146/annurev.neuro.22.1.29; Wu Y, 2003, P NATL ACAD SCI USA, V100, P2082, DOI 10.1073/pnas.0435872100; Xu HP, 2011, NEURON, V70, P1115, DOI 10.1016/j.neuron.2011.04.028; Zhang JY, 2012, NAT NEUROSCI, V15, P298, DOI 10.1038/nn.3007; Zhang Z, 2011, MOL BIOL CELL, V22, P2324, DOI 10.1091/mbc.E11-02-0159; Zhang Z, 2010, MOL BIOL CELL, V21, P2821, DOI 10.1091/mbc.E10-04-0285; Zhang ZJ, 2009, NAT NEUROSCI, V12, P163, DOI 10.1038/nn.2252; Zheng JJ, 2006, NAT NEUROSCI, V9, P363, DOI 10.1038/nn1644; Zheng JJ, 2004, NEURON, V44, P851, DOI 10.1016/j.neuron.2004.11.015	55	11	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47465	10.1371/journal.pone.0047465	http://dx.doi.org/10.1371/journal.pone.0047465			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091625	Green Submitted, Green Published, gold			2022-12-25	WOS:000310135800048
J	Zhuang, JH; Peng, WH; Li, HL; Wang, W; Wei, YD; Li, WM; Xu, YW				Zhuang, Jianhui; Peng, Wenhui; Li, Hailing; Wang, Wei; Wei, Yidong; Li, Weiming; Xu, Yawei			Methylation of p15(INK4b) and Expression of ANRIL on Chromosome 9p21 Are Associated with Coronary Artery Disease	PLOS ONE			English	Article							DNA METHYLATION; CARDIOVASCULAR-DISEASE; NONCODING RNA; ANTISENSE RNA; POLYCOMB CBX7; HEART-DISEASE; LOCUS; ATHEROSCLEROSIS; RISK; HYPERMETHYLATION	Background: Genome-wide association studies have identified that multiple single nucleiotide polymorphisms on chromosome 9p21 are tightly associated with coronary artery disease (CAD). However, the mechanism linking this risk locus to CAD remains unclear. Methodology/Principal Findings: The methylation status of six candidate genes (BAX, BCL-2, TIMP3, p14(ARF), p15(INK4b) and p16(INK4a)) in 205 patients and controls who underwent coronary angiography were analyzed by quantitative MethyLight assay. Rs10757274 was genotyped and expression of INK4/ARF and antisense non-coding RNA in the INK4 locus (ANRIL) was determined by real-time RT-PCR. Compared with controls, DNA methylation levels at p15(INK4b) significantly increased in CAD patients (p = 0.006). To validate and dissect the methylation percentage of each target CpG site at p15(INK4b), pyrosequencing was performed, finding CpG + 314 and + 332 remarkably hypermethylated in CAD patients. Further investigation determined that p15(INK4b) hypermethylation prevalently emerged in lymphocytes of CAD patients (p = 0.013). The rs10757274 genotype was significantly associated with CAD (p = 0.003) and GG genotype carriers had a higher level of ANRIL exon 1-5 expression compared among three genotypes (p = 0.009). There was a stepwise increase in p15(INK4b) and p16(INK4a) methylation as ANRIL exon 1-5 expression elevated (r = 0.23, p = 0.001 and r = 0.24, p = 0.001, respectively), although neither of two loci methylation was directly linked to rs10757274 genotype. Conclusions/Significance: p15(INK4b) methylation is associated with CAD and ANRIL expression. The epigenetic changes in p15(INK4b) methylation and ANRIL expression may involve in the mechanisms of chromosome 9p21 on CAD development.	[Zhuang, Jianhui; Peng, Wenhui; Li, Hailing; Wei, Yidong; Li, Weiming; Xu, Yawei] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Cardiol, Shanghai 200092, Peoples R China; [Wang, Wei] Rockefeller Univ, Lab Blood & Vasc Biol, New York, NY 10021 USA	Tongji University; Rockefeller University	Peng, WH (corresponding author), Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Cardiol, Shanghai 200092, Peoples R China.	pwenhui@tongji.edu.cn; xuyawei@tongji.edu.cn	黎, 伟/GXM-4040-2022; li, wj/HGD-7322-2022		National Natural Science Foundation of China [30900520, 81070107]; Shanghai Rising-Star Program [10QA1405500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program	This work was supported by grants from National Natural Science Foundation of China No. 30900520 and No. 81070107, and a grant from Shanghai Rising-Star Program No. 10QA1405500. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccarelli A, 2010, CIRC-CARDIOVASC GENE, V3, P567, DOI 10.1161/CIRCGENETICS.110.958744; Ballestar E, 2011, NAT REV RHEUMATOL, V7, P264, DOI 10.1038/nrrheum.2011.16; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Burd CE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001233; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Congrains A, 2012, ATHEROSCLEROSIS, V220, P449, DOI 10.1016/j.atherosclerosis.2011.11.017; Cunnington MS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000899; Eads CA, 2001, CANCER RES, V61, P3410; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Folkersen L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007677; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Gonzalez-Navarro H, 2010, J AM COLL CARDIOL, V55, P2258, DOI 10.1016/j.jacc.2010.01.026; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Holdt LM, 2012, ARTERIOSCL THROM VAS, V32, P196, DOI 10.1161/ATVBAHA.111.232678; Holdt LM, 2010, ARTERIOSCL THROM VAS, V30, P620, DOI 10.1161/ATVBAHA.109.196832; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; Kim M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009692; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Kuo CL, 2011, ARTERIOSCL THROM VAS, V31, P2483, DOI 10.1161/ATVBAHA.111.234492; Li HL, 2011, CLIN CHEM LAB MED, V49, P1547, DOI 10.1515/CCLM.2011.236; Ling C, 2009, DIABETES, V58, P2718, DOI 10.2337/db09-1003; Liu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005027; Makar KW, 2004, J IMMUNOL, V173, P4402, DOI 10.4049/jimmunol.173.7.4402; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Mitra S, 2011, AM J PHYSIOL-HEART C, V301, pH506, DOI 10.1152/ajpheart.00252.2011; Mohammad HP, 2009, CANCER RES, V69, P6322, DOI 10.1158/0008-5472.CAN-09-0065; Nanayakkara PWB, 2008, NEPHROL DIAL TRANSPL, V23, P2586, DOI 10.1093/ndt/gfn040; Ogino S, 2006, J MOL DIAGN, V8, P209, DOI 10.2353/jmoldx.2006.050135; Ordovas JM, 2010, NAT REV CARDIOL, V7, P510, DOI 10.1038/nrcardio.2010.104; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Paul TA, 2010, BLOOD, V115, P3098, DOI 10.1182/blood-2009-07-233858; Peng WH, 2009, CLIN CHEM LAB MED, V47, P917, DOI 10.1515/CCLM.2009.215; Preuss M, 2010, CIRC-CARDIOVASC GENE, V3, P475, DOI 10.1161/CIRCGENETICS.109.899443; Reynolds PA, 2006, J BIOL CHEM, V281, P24790, DOI 10.1074/jbc.M604175200; Sharma P, 2008, DNA CELL BIOL, V27, P357, DOI 10.1089/dna.2007.0694; Silander K, 2009, GENOME MED, V1, DOI 10.1186/gm51; Stenvinkel P, 2007, J INTERN MED, V261, P488, DOI 10.1111/j.1365-2796.2007.01777.x; Tufarelli C, 2003, NAT GENET, V34, P157, DOI 10.1038/ng1157; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zhong CL, 2009, CLIN CANCER RES, V15, P2675, DOI 10.1158/1078-0432.CCR-08-1954; Zhou L, 2008, ARTERIOSCL THROM VAS, V28, P2085, DOI 10.1161/ATVBAHA.108.176065	48	67	73	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47193	10.1371/journal.pone.0047193	http://dx.doi.org/10.1371/journal.pone.0047193			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091611	gold, Green Published			2022-12-25	WOS:000310135800030
J	Ruggieri, V; Pin, E; Russo, MT; Barone, F; Degan, P; Sanchez, M; Quaia, M; Minoprio, A; Turco, E; Mazzei, F; Viel, A; Bignami, M				Ruggieri, V.; Pin, E.; Russo, M. T.; Barone, F.; Degan, P.; Sanchez, M.; Quaia, M.; Minoprio, A.; Turco, E.; Mazzei, F.; Viel, A.; Bignami, M.			Loss of MUTYH function in human cells leads to accumulation of oxidative damage and genetic instability	ONCOGENE			English	Article						MUTYH variants; 8-oxodG; PIG-A; MUTYH-associated polyposis; DNA glycosylase activity	BASE-EXCISION-REPAIR; ADENOMATOUS POLYPOSIS; COLORECTAL-CANCER; DNA-DAMAGE; GLYCOSYLASE ACTIVITY; GERMLINE MUTATIONS; HUMAN HOMOLOG; MYH; HMYH; DEFICIENT	The DNA glycosylase MUTYH (mutY homolog (Escherichia coli)) counteracts the mutagenic effects of 8-oxo-7,8-dihydroguanine (8-oxodG) by removing adenine (A) misincorporated opposite the oxidized purine. Biallelic germline mutations in MUTYH cause the autosomal recessive MUTYH-associated adenomatous polyposis (MAP). Here we designed new tools to investigate the biochemical defects and biological consequences associated with different MUTYH mutations in human cells. To identify phenotype(s) associated with MUTYH mutations, lymphoblastoid cell lines (LCLs) were derived from seven MAP patients harboring missense as well as truncating mutations in MUTYH. These included homozygous p. Arg245His, p. Gly264TrpfsX7 or compound heterozygous variants (p. Gly396Asp/Arg245Cys, p. Gly396Asp/Tyr179Cys, p. Gly396Asp/Glu410GlyfsX43, p. Gly264TrpfsX7/Ala385ProfsX23 and p. Gly264TrpfsX7/ Glu480del). DNA glycosylase assays of MAP LCL extracts confirmed that all these variants were defective in removing A from an 8-oxoG: A DNA substrate, but retained wild-type OGG1 activity. As a consequence of this defect, MAP LCLs accumulated DNA 8-oxodG in their genome and exhibited a fourfold increase in spontaneous mutagenesis at the PIG-A gene compared with LCLs from healthy donors. They were also hypermutable by KBrO3-a source of DNA 8-oxodG-indicating that the relatively modest spontaneous mutator phenotype associated with MUTYH loss can be significantly enhanced by conditions of oxidative stress. These observations identify accumulation of DNA 8-oxodG and a mutator phenotype as likely contributors to the pathogenesis of MUTYH variants.	[Ruggieri, V.; Russo, M. T.; Barone, F.; Minoprio, A.; Turco, E.; Mazzei, F.; Bignami, M.] Ist Super Sanita, Dept Environm & Primary Prevent, I-00161 Rome, Italy; [Pin, E.; Quaia, M.; Viel, A.] IRCCS, Ctr Riferimento Oncol, Div Expt Oncol 1, Aviano, Italy; [Degan, P.] Ist Nazl Ric Cancro IST CBA, Dept Translat Oncol, Genoa, Italy; [Sanchez, M.] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy	Istituto Superiore di Sanita (ISS); IRCCS Aviano (CRO); University of Genoa; IRCCS AOU San Martino IST; Istituto Superiore di Sanita (ISS)	Bignami, M (corresponding author), Ist Super Sanita, Dept Environm & Primary Prevent, Viale Regina Elena 299, I-00161 Rome, Italy.	bignami@iss.it	Ruggieri, Vitalba/J-7847-2016; degan, paolo/AAB-6713-2019; Barone, Flavia/N-6983-2017; QUAIA, MICHELE/AAZ-2990-2020; degan, paolo/AAB-4093-2019; Sanchez, Massimo/AAD-1746-2021; Viel, Alessandra/J-7116-2018	Ruggieri, Vitalba/0000-0003-0860-3415; degan, paolo/0000-0003-0855-8896; Barone, Flavia/0000-0002-8929-7749; QUAIA, MICHELE/0000-0002-6656-2597; Sanchez, Massimo/0000-0003-3696-7582; Viel, Alessandra/0000-0003-2804-0840; Turco, Eleonora/0000-0002-5266-4592; PIN, ELISA/0000-0002-2158-2674	NIH/ISS, AIRC; Ministero della Salute Alleanza contro il Cancro	NIH/ISS, AIRC; Ministero della Salute Alleanza contro il Cancro	The authors are grateful to Drs M Fornasarig and D Barana for patient recruitment. This work has been supported by grants to MB from NIH/ISS, AIRC and by Ministero della Salute Alleanza contro il Cancro to AV and MB.	Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Alhopuro Pia, 2005, Hum Mutat, V26, P393, DOI 10.1002/humu.9368; Ali M, 2008, GASTROENTEROLOGY, V135, P499, DOI 10.1053/j.gastro.2008.04.035; Araten DJ, 2005, CANCER RES, V65, P8111, DOI 10.1158/0008-5472.CAN-04-1198; Bai HB, 2007, CANCER LETT, V250, P74, DOI 10.1016/j.canlet.2006.09.016; Bignami M, 2000, MUTAT RES-REV MUTAT, V462, P71, DOI 10.1016/S1383-5742(00)00016-8; Cardoso J, 2006, CANCER RES, V66, P2514, DOI 10.1158/0008-5472.CAN-05-2407; Cheadle JP, 2007, DNA REPAIR, V6, P274, DOI 10.1016/j.dnarep.2006.11.001; Chiera F, 2008, FREE RADICAL BIO MED, V44, P332, DOI 10.1016/j.freeradbiomed.2007.09.018; Cleary SP, 2009, GASTROENTEROLOGY, V136, P1251, DOI 10.1053/j.gastro.2008.12.050; D'Agostino VG, 2010, DNA REPAIR, V9, P700, DOI 10.1016/j.dnarep.2010.03.008; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Farrington SM, 2005, AM J HUM GENET, V77, P112, DOI 10.1086/431213; Gismondi V, 2004, INT J CANCER, V109, P680, DOI 10.1002/ijc.20054; Glaab WE, 1998, CARCINOGENESIS, V19, P1931, DOI 10.1093/carcin/19.11.1931; Goto M, 2010, HUM MUTAT, V31, pE1861, DOI 10.1002/humu.21363; Gu YS, 2001, NUCLEIC ACIDS RES, V29, P2666, DOI 10.1093/nar/29.12.2666; Hirano S, 2003, J BIOL CHEM, V278, P38121, DOI 10.1074/jbc.C300316200; Isidro Gloria, 2004, Hum Mutat, V24, P353, DOI 10.1002/humu.9282; Jasperson KW, 2010, GASTROENTEROLOGY, V138, P2044, DOI 10.1053/j.gastro.2010.01.054; Jones S, 2002, HUM MOL GENET, V11, P2961, DOI 10.1093/hmg/11.23.2961; Kundu S, 2009, DNA REPAIR, V8, P1400, DOI 10.1016/j.dnarep.2009.09.009; Lipton L, 2003, CANCER RES, V63, P7595; Molatore S, 2010, HUM MUTAT, V31, P159, DOI 10.1002/humu.21158; Oka S, 2011, CANCER SCI, V102, P677, DOI 10.1111/j.1349-7006.2011.01869.x; Out AA, 2010, HUM MUTAT, V31, P1205, DOI 10.1002/humu.21343; Parker AR, 2005, CARCINOGENESIS, V26, P2010, DOI 10.1093/carcin/bgi166; Peruzzi B, 2010, MUTAT RES-REV MUTAT, V705, P3, DOI 10.1016/j.mrrev.2009.12.004; Pin E, INT J CANCER, DOI [10.1002/ijc.27761, DOI 10.1002/IJC.27761)]; Poulsen MLM, 2008, CURR GENOMICS, V9, P420, DOI 10.2174/138920208785699562; Russo MT, 2009, CANCER RES, V69, P4372, DOI 10.1158/0008-5472.CAN-08-3292; Sansom OJ, 2003, DNA REPAIR, V2, P1029, DOI 10.1016/S1568-7864(03)00111-3; Shi GL, 2006, BIOCHEM J, V400, P53, DOI 10.1042/BJ20060774; Sieber OM, 2003, NEW ENGL J MED, V348, P791, DOI 10.1056/NEJMoa025283; Slupska MM, 1999, J BACTERIOL, V181, P6210, DOI 10.1128/JB.181.19.6210-6213.1999; van Loon B, 2010, DNA REPAIR, V9, P604, DOI 10.1016/j.dnarep.2010.03.004; van Puijenbroek M, 2008, CLIN CANCER RES, V14, P139, DOI 10.1158/1078-0432.CCR-07-1705; Wang L, 2004, GASTROENTEROLOGY, V127, P9, DOI 10.1053/j.gastro.2004.03.070; Xu XXS, 2001, CANCER RES, V61, P3775; Yanaru-Fujisawa R, 2008, CLIN GENET, V73, P545, DOI 10.1111/j.1399-0004.2008.00998.x; Yi FM, 2009, VIROLOGY, V388, P236, DOI 10.1016/j.virol.2009.03.027	41	27	28	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 19	2013	32	38					4500	4508		10.1038/onc.2012.479	http://dx.doi.org/10.1038/onc.2012.479			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	223SW	23108399				2022-12-25	WOS:000324831300005
J	Dobruk-Serkowska, A; Caccamo, M; Rodriguez-Castaneda, F; Wu, MY; Bryce, K; Ng, I; Schumacher, MA; Barilla, D; Hayes, F				Dobruk-Serkowska, Aneta; Caccamo, Marisa; Rodriguez-Castaneda, Fernando; Wu, Meiyi; Bryce, Kerstyn; Ng, Irene; Schumacher, Maria A.; Barilla, Daniela; Hayes, Finbarr			Uncoupling of Nucleotide Hydrolysis and Polymerization in the ParA Protein Superfamily Disrupts DNA Segregation Dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL CHROMOSOME SEGREGATION; PLASMID-PARTITION; STRUCTURAL BIOLOGY; NONSPECIFIC DNA; ATP-BINDING; SOPA; SEGROSOME; MECHANISM; COMPLEX; MOTIF	DNA segregation in bacteria is mediated most frequently by proteins of the ParA superfamily that transport DNA molecules attached via the segrosome nucleoprotein complex. Segregation is governed by a cycle of ATP-induced polymerization and subsequent depolymerization of the ParA factor. Here, we establish that hyperactive ATPase variants of the ParA homolog ParF display altered segrosome dynamics that block accurate DNA segregation. An arginine finger-like motif in the ParG centromere-binding factor augments ParF ATPase activity but is ineffective in stimulating nucleotide hydrolysis by the hyperactive proteins. Moreover, whereas polymerization of wild-type ParF is accelerated by ATP and inhibited by ADP, filamentation of the mutated proteins is blocked indiscriminately by nucleotides. The mutations affect a triplet of conserved residues that are situated neither in canonical nucleotide binding and hydrolysis motifs in the ParF tertiary structure nor at interfaces implicated in ParF polymerization. Instead the residues are involved in shaping the contours of the binding pocket so that nucleotide binding locks the mutant proteins into a configuration that is refractory to polymerization. Thus, the architecture of the pocket not only is crucial for optimal ATPase kinetics but also plays a key role in the polymerization dynamics of ParA proteins that drive DNA segregation ubiquitously in procaryotes.	[Dobruk-Serkowska, Aneta; Caccamo, Marisa; Wu, Meiyi; Hayes, Finbarr] Univ Manchester, Manchester Inst Biotechnol, Manchester M1 7DN, Lancs, England; [Dobruk-Serkowska, Aneta; Caccamo, Marisa; Wu, Meiyi; Bryce, Kerstyn; Hayes, Finbarr] Univ Manchester, Fac Life Sci, Manchester M1 7DN, Lancs, England; [Rodriguez-Castaneda, Fernando; Ng, Irene; Barilla, Daniela] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Schumacher, Maria A.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	University of Manchester; University of Manchester; University of York - UK; Duke University	Hayes, F (corresponding author), Univ Manchester, Manchester Inst Biotechnol, 131 Princess St, Manchester M1 7DN, Lancs, England.	finbarr.hayes@manchester.ac.uk		Barilla, Daniela/0000-0002-3486-7492	Biotechnology and Biological Sciences Research Council [G003114]; Medical Research Council [G0801162]; National Institutes of Health [GM074815]; M.D. Anderson Trust Fellowship; Burroughs Wellcome Career Development Award; Overseas Research Student Awards Scheme; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074815] Funding Source: NIH RePORTER; BBSRC [BB/G003114/1] Funding Source: UKRI; MRC [G0801162] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G003114/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); M.D. Anderson Trust Fellowship; Burroughs Wellcome Career Development Award(Burroughs Wellcome Fund); Overseas Research Student Awards Scheme; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported, in whole or in part, by Biotechnology and Biological Sciences Research Council Grant G003114 (to F. H.). This work was also supported by Medical Research Council Grant G0801162 (to D. B.) and by National Institutes of Health Grant GM074815, an M.D. Anderson Trust Fellowship, and a Burroughs Wellcome Career Development Award (to M. A. S.).; Supported in part by a scholarship from the Overseas Research Student Awards Scheme.	Adachi S, 2006, J MOL BIOL, V356, P850, DOI 10.1016/j.jmb.2005.11.088; Anand SP, 2008, MOL MICROBIOL, V67, P881, DOI 10.1111/j.1365-2958.2007.06100.x; Barilla D, 2005, EMBO J, V24, P1453, DOI 10.1038/sj.emboj.7600619; Barilla D, 2003, MOL MICROBIOL, V49, P487, DOI 10.1046/j.1365-2958.2003.03564.x; Barilla D, 2007, P NATL ACAD SCI USA, V104, P1811, DOI 10.1073/pnas.0607216104; Bloom K, 2010, NATURE, V463, P446, DOI 10.1038/nature08912; Bouet JY, 2007, MOL MICROBIOL, V63, P468, DOI 10.1111/j.1365-2958.2006.05537.x; Carmelo E, 2005, J BIOL CHEM, V280, P28683, DOI 10.1074/jbc.M501173200; Castaing JP, 2008, MOL MICROBIOL, V70, P1000, DOI 10.1111/j.1365-2958.2008.06465.x; Drew KRP, 2011, P NATL ACAD SCI USA, V108, P11075, DOI 10.1073/pnas.1018724108; Fogel MA, 2006, GENE DEV, V20, P3269, DOI 10.1101/gad.1496506; Garner EC, 2007, SCIENCE, V315, P1270, DOI 10.1126/science.1138527; Gerdes K, 2010, CELL, V141, P927, DOI 10.1016/j.cell.2010.05.033; Golovanov AP, 2003, MOL MICROBIOL, V50, P1141, DOI 10.1046/j.1365-2958.2003.03750.x; Havey JC, 2012, NUCLEIC ACIDS RES, V40, P801, DOI 10.1093/nar/gkr747; Hayes F, 2006, NAT REV MICROBIOL, V4, P133, DOI 10.1038/nrmicro1342; Hayes F, 1998, J BACTERIOL, V180, P6415; Hayes F, 2000, MOL MICROBIOL, V37, P528, DOI 10.1046/j.1365-2958.2000.02030.x; Hayes F, 2006, TRENDS BIOCHEM SCI, V31, P247, DOI 10.1016/j.tibs.2006.03.002; Hayes F, 2010, BACTERIAL CHROMATIN, P49, DOI 10.1007/978-90-481-3473-1_4; HE L, 1993, MOL MICROBIOL, V9, P1131, DOI 10.1111/j.1365-2958.1993.tb01243.x; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kim KS, 2005, J BIOL CHEM, V280, P34667, DOI 10.1074/jbc.M505005200; KOONIN EV, 1993, J MOL BIOL, V229, P1165, DOI 10.1006/jmbi.1993.1115; Larsen RA, 2007, GENE DEV, V21, P1340, DOI 10.1101/gad.1546107; Lim GE, 2005, P NATL ACAD SCI USA, V102, P17658, DOI 10.1073/pnas.0507222102; LUDTKE DN, 1989, J MOL BIOL, V209, P393, DOI 10.1016/0022-2836(89)90005-3; Machon C, 2007, J MOL BIOL, V374, P1, DOI 10.1016/j.jmb.2007.09.025; MOTALLEBIVESHAREH M, 1990, MOL MICROBIOL, V4, P1455, DOI 10.1111/j.1365-2958.1990.tb02056.x; Ni LS, 2010, P NATL ACAD SCI USA, V107, P11763, DOI 10.1073/pnas.1003817107; Possoz C, 2012, FRONT BIOSCI-LANDMRK, V17, P1020, DOI 10.2741/3971; Pratto F, 2008, NUCLEIC ACIDS RES, V36, P3676, DOI 10.1093/nar/gkn170; Ptacin JL, 2010, NAT CELL BIOL, V12, P791, DOI 10.1038/ncb2083; Ringgaard S, 2009, P NATL ACAD SCI USA, V106, P19369, DOI 10.1073/pnas.0908347106; SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F; Schumacher MA, 2008, BIOCHEM J, V412, P1, DOI 10.1042/BJ20080359; Schumacher MA, 2007, CURR OPIN STRUC BIOL, V17, P103, DOI 10.1016/j.sbi.2006.11.005; Schumacher MA, 2012, J BIOL CHEM, V287, P26146, DOI 10.1074/jbc.M112.373696; Schumacher MA, 2012, CURR OPIN STRUC BIOL, V22, P72, DOI 10.1016/j.sbi.2011.11.001; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; WOODCOCK DM, 1989, NUCLEIC ACIDS RES, V17, P3469, DOI 10.1093/nar/17.9.3469; Wu MY, 2011, NUCLEIC ACIDS RES, V39, P5082, DOI 10.1093/nar/gkr115	42	8	8	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42545	42553		10.1074/jbc.M112.410324	http://dx.doi.org/10.1074/jbc.M112.410324			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23093445	Green Published, hybrid			2022-12-25	WOS:000312501600016
J	Sun, HY; Hunter, T				Sun, Huaiyu; Hunter, Tony			Poly-Small Ubiquitin-like Modifier (PolySUMO)-binding Proteins Identified through a String Search	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMINE-DNA GLYCOSYLASE; PROMYELOCYTIC LEUKEMIA PROTEIN; FAS-BINDING-PROTEIN; SUMO MODIFICATION; CRYSTAL-STRUCTURE; NUCLEAR-BODIES; C-MYB; FLASH; TRANSCRIPTION; MOTIF	Polysumoylation is a crucial cellular response to stresses against genomic integrity or proteostasis. Like the small ubiquitin-like modifier (SUMO)-targeted ubiquitin ligase RNF4, proteins with clustered SUMO-interacting motifs (SIMs) can be important signal transducers downstream of polysumoylation. To identify novel polySUMO-binding proteins, we conducted a computational string search with a custom Python script. We found clustered SIMs in another RING domain protein Arkadia/RNF111. Detailed biochemical analysis of the Arkadia SIMs revealed that dominant SIMs in a SIM cluster often contain a pentameric VIDLT ((V/I/L/F/Y)(V/I)DLT) core sequence that is also found in the SIMs in PIAS family E3s and is likely the best-fitted structure for SUMO recognition. This idea led to the identification of additional novel SIM clusters in FLASH/CASP8AP2, C5orf25, and SOBP/JXC1. We suggest that the clustered SIMs in these proteins form distinct SUMO binding domains to recognize diverse forms of protein sumoylation.	[Sun, Huaiyu; Hunter, Tony] Salk Inst Biol Studies, Mol & Cell Biol Lab, La Jolla, CA 92037 USA	Salk Institute	Sun, HY (corresponding author), Salk Inst Biol Studies, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hsun@salk.edu; hunter@salk.edu			National Institutes of Health [CA14195, CA80100, CA82683]; NATIONAL CANCER INSTITUTE [R01CA080100, R01CA082683, P30CA014195] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA14195, CA80100, and CA82683 (to T.H.).	Alm-Kristiansen AH, 2008, ONCOGENE, V27, P4644, DOI 10.1038/onc.2008.105; Alm-Kristiansen AH, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-21; Alm-Kristiansen AH, 2009, BIOCHEM BIOPH RES CO, V387, P494, DOI 10.1016/j.bbrc.2009.07.053; Almo Steven C., 2007, Journal of Structural and Functional Genomics, V8, P121, DOI 10.1007/s10969-007-9036-1; Armstrong AA, 2012, NATURE, V483, P59, DOI 10.1038/nature10883; Baba D, 2005, NATURE, V435, P979, DOI 10.1038/nature03634; Barcaroli D, 2006, P NATL ACAD SCI USA, V103, P14802, DOI 10.1073/pnas.0604225103; Barcaroli D, 2006, P NATL ACAD SCI USA, V103, P14808, DOI 10.1073/pnas.0604227103; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Birk E, 2010, AM J HUM GENET, V87, P694, DOI 10.1016/j.ajhg.2010.10.005; Boddy MN, 1996, ONCOGENE, V13, P971; Bruderer R, 2011, EMBO REP, V12, P142, DOI 10.1038/embor.2010.206; Chen Z, 2008, J NEUROSCI, V28, P6633, DOI 10.1523/JNEUROSCI.1280-08.2008; Cho G, 2009, J BIOL CHEM, V284, P19592, DOI 10.1074/jbc.M109.010181; Creton S, 2010, CELL, V143, P848, DOI 10.1016/j.cell.2010.11.026; Episkopou V, 2001, NATURE, V410, P825, DOI 10.1038/35071095; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Hakli M, 2005, EXP CELL RES, V304, P224, DOI 10.1016/j.yexcr.2004.10.029; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Hsu YHR, 2006, J BIOL CHEM, V281, P33008, DOI 10.1074/jbc.M604380200; Imai Y, 1999, NATURE, V398, P777, DOI 10.1038/19709; Jian OY, 2009, MOL CELL, V34, P145, DOI 10.1016/j.molcel.2009.03.013; Kagawa W, 2002, MOL CELL, V10, P359, DOI 10.1016/S1097-2765(02)00587-7; Koinuma D, 2003, EMBO J, V22, P6458, DOI 10.1093/emboj/cdg632; Koonin EV, 1999, NATURE, V401, P662, DOI 10.1038/44317; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Lee PSW, 2003, J BIOL CHEM, V278, P27853, DOI 10.1074/jbc.M301755200; Levy L, 2007, MOL CELL BIOL, V27, P6068, DOI 10.1128/MCB.00664-07; Li YJ, 2012, P NATL ACAD SCI USA, V109, P4092, DOI 10.1073/pnas.1109131109; Liew CW, 2010, BIOCHEM J, V431, P23, DOI 10.1042/BJ20100957; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; Lin X, 2003, J BIOL CHEM, V278, P18714, DOI 10.1074/jbc.M302243200; Liu W, 2006, EMBO J, V25, P1646, DOI 10.1038/sj.emboj.7601057; Matic I, 2008, MOL CELL PROTEOMICS, V7, P132, DOI 10.1074/mcp.M700173-MCP200; Matic I, 2010, MOL CELL, V39, P641, DOI 10.1016/j.molcel.2010.07.026; Matunis MJ, 2006, DEV CELL, V11, P596, DOI 10.1016/j.devcel.2006.10.011; Meulmeester E, 2008, MOL CELL, V30, P610, DOI 10.1016/j.molcel.2008.03.021; Meulmeester E, 2008, NATURE, V452, P709, DOI 10.1038/452709a; Milovic-Holm K, 2007, EMBO J, V26, P391, DOI 10.1038/sj.emboj.7601504; Minty A, 2000, J BIOL CHEM, V275, P36316, DOI 10.1074/jbc.M004293200; Miteva M, 2010, SUBCELL BIOCHEM, V54, P195, DOI 10.1007/978-1-4419-6676-6_16; Namanja AT, 2012, J BIOL CHEM, V287, P3231, DOI 10.1074/jbc.M111.293118; Niederlander C, 2001, NATURE, V410, P830, DOI 10.1038/35071103; Ogawa H, 2009, MOL BIOL CELL, V20, P4235, DOI 10.1091/mbc.E08-12-1247; Okura T, 1996, J IMMUNOL, V157, P4277; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Plechanovova A, 2011, NAT STRUCT MOL BIOL, V18, P1052, DOI 10.1038/nsmb.2108; Pype S, 2000, J BIOL CHEM, V275, P18586, DOI 10.1074/jbc.M000531200; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Ryu SW, 2000, BIOCHEM BIOPH RES CO, V279, P6, DOI 10.1006/bbrc.2000.3882; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Shen ZY, 1996, GENOMICS, V37, P183, DOI 10.1006/geno.1996.0540; Shen ZY, 1996, GENOMICS, V36, P271, DOI 10.1006/geno.1996.0462; Sims JJ, 2009, MOL CELL, V33, P775, DOI 10.1016/j.molcel.2009.02.011; Singleton MR, 2002, P NATL ACAD SCI USA, V99, P13492, DOI 10.1073/pnas.212449899; Song AX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013202; Song J, 2005, J BIOL CHEM, V280, P40122, DOI 10.1074/jbc.M507059200; Song J, 2004, P NATL ACAD SCI USA, V101, P14373, DOI 10.1073/pnas.0403498101; Street AG, 1999, P NATL ACAD SCI USA, V96, P9074, DOI 10.1073/pnas.96.16.9074; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Takahashi H, 2005, J BIOL CHEM, V280, P5611, DOI 10.1074/jbc.M408130200; Tanaka N, 2010, BIOSCI BIOTECH BIOCH, V74, P1302, DOI 10.1271/bbb.100082; Tatham MH, 2001, J BIOL CHEM, V276, P35368, DOI 10.1074/jbc.M104214200; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Uchimura Y, 2006, J BIOL CHEM, V281, P23180, DOI 10.1074/jbc.M602280200; Ulrich HD, 2008, MOL CELL, V32, P301, DOI 10.1016/j.molcel.2008.10.010; Uwada J, 2010, BIOCHEM BIOPH RES CO, V391, P407, DOI 10.1016/j.bbrc.2009.11.071; Vogt B, 2012, METHODS MOL BIOL, V832, P249, DOI 10.1007/978-1-61779-474-2_18; Weatheritt RJ, 2012, TRENDS BIOCHEM SCI, V37, P333, DOI 10.1016/j.tibs.2012.05.001; Yaffe MB, 2001, NAT BIOTECHNOL, V19, P348, DOI 10.1038/86737; Yang SH, 2010, MOL CELL BIOL, V30, P2193, DOI 10.1128/MCB.01510-09; Yang XC, 2009, MOL CELL, V36, P267, DOI 10.1016/j.molcel.2009.08.016; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Yousef AF, 2010, ONCOGENE, V29, P4693, DOI 10.1038/onc.2010.226; Zhu JM, 2008, J BIOL CHEM, V283, P29405, DOI 10.1074/jbc.M803632200	78	71	77	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42071	42083		10.1074/jbc.M112.410985	http://dx.doi.org/10.1074/jbc.M112.410985			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086935	Green Published, hybrid			2022-12-25	WOS:000312103000046
J	Haraguchi, H; Noda, T; Kawaoka, Y; Morikawa, Y				Haraguchi, Hiyori; Noda, Takeshi; Kawaoka, Yoshihiro; Morikawa, Yuko			A Large Extension to HIV-1 Gag, Like Pol, Has Negative Impacts on Virion Assembly	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; ROUS-SARCOMA-VIRUS; MEMBRANE-BINDING; PLASMA-MEMBRANE; PRIMARY MACROPHAGES; VIRAL INFECTIVITY; PARTICLE RELEASE; MATRIX PROTEIN; IN-VITRO; DOMAIN	The GagPol protein of HIV-1 harbors viral enzymes, such as protease (PR), reverse transcriptase, and integrase, that are all crucial for virion infectivity. Previous studies have suggested that expression of GagPol alone does not produce viral particles and that the budding defect is caused by the presence of the Pol region. However, it has remained unknown why GagPol fails to produce viral particles. We show here that HIV-1 GagPol is incapable of membrane binding and subsequent particle assembly. Our confocal data indicated that, despite full N-myristoylation, GagPol protein failed to target plasma membrane with diffuse distribution in the cytoplasm. Membrane flotation analysis confirmed these findings. Progressive C-terminal truncation of GagPol to give GagPR allowed for plasma membrane targeting but still not for particle production. Conversely, the C-terminal addition of a noncognate protein, such as beta-galactosidase or 4 tandem GFP, to Gag impaired the membrane affinity, indicating that the Pol region, a large extension to Gag, inhibits membrane binding in the context of GagPol. The addition of the 10 N-terminal amino acids of Fyn kinase [Fyn(10)], a tight membrane-binding signal, conferred plasma membrane targeting on GagPol, but the Fyn(10) GagPol did not produce viral particles. The defect in particle budding was not rescued by the introduction of the PTAP motif, which is responsible for a late stage of viral particle budding. Rather, electron microscopy suggested that the budding defect of GagPR occurred at an early stage of particle morphogenesis. Our data, which were consistent with previous observations, demonstrate the defects of GagPol in membrane binding and particle assembly.	[Haraguchi, Hiyori; Morikawa, Yuko] Kitasato Univ, Kitasato Inst Life Sci, Minato Ku, Tokyo, Japan; [Noda, Takeshi; Kawaoka, Yoshihiro] Univ Tokyo, Inst Med Sci, Minato Ku, Tokyo, Japan; [Kawaoka, Yoshihiro] Japan Sci & Technol Agcy, Infect Induced Host Responses Project, ERATO, Saitama, Japan; [Kawaoka, Yoshihiro] Univ Wisconsin, Dept Pathol Sci, Influenza Res Inst, Madison, WI USA	Kitasato University; University of Tokyo; Japan Science & Technology Agency (JST); University of Wisconsin System; University of Wisconsin Madison	Morikawa, Y (corresponding author), Kitasato Univ, Kitasato Inst Life Sci, Minato Ku, Tokyo, Japan.	morikawa@lisci.kitasato-u.ac.jp			Health Labour Sciences Research grant, Research on HIV/AIDS [22390091]	Health Labour Sciences Research grant, Research on HIV/AIDS	This study was funded by Grant-in-Aid for Scientific Research (B) 22390091 (http://www.jsps.go.jp/index.html), Health Labour Sciences Research grant, Research on HIV/AIDS (http://www.mhlw.go.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfadhli A, 2009, J VIROL, V83, P12196, DOI 10.1128/JVI.01197-09; BENNETT RP, 1991, J VIROL, V65, P272, DOI 10.1128/JVI.65.1.272-280.1991; BRYANT M, 1990, P NATL ACAD SCI USA, V87, P523, DOI 10.1073/pnas.87.2.523; Campbell S, 1999, J VIROL, V73, P2270, DOI 10.1128/JVI.73.3.2270-2279.1999; CAMPBELL S, 1995, J VIROL, V69, P6487, DOI 10.1128/JVI.69.10.6487-6497.1995; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; Chukkapalli V, 2010, P NATL ACAD SCI USA, V107, P1600, DOI 10.1073/pnas.0908661107; Dalton AK, 2007, J VIROL, V81, P6434, DOI 10.1128/JVI.02757-06; Datta SAK, 2007, J MOL BIOL, V365, P812, DOI 10.1016/j.jmb.2006.10.073; Datta SAK, 2011, J MOL BIOL, V406, P205, DOI 10.1016/j.jmb.2010.11.051; Demirov DG, 2002, P NATL ACAD SCI USA, V99, P955, DOI 10.1073/pnas.032511899; Demirov DG, 2004, VIRUS RES, V106, P87, DOI 10.1016/j.virusres.2004.08.007; Denek M, 2007, J CELL BIOL, V177, P329, DOI 10.1083/jcb.200609050; FELSENSTEIN KM, 1988, J VIROL, V62, P2179, DOI 10.1128/JVI.62.6.2179-2182.1988; Finzi A, 2007, J VIROL, V81, P7476, DOI 10.1128/JVI.00308-07; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Gan X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029421; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; GOTTLINGER HG, 1989, P NATL ACAD SCI USA, V86, P5781, DOI 10.1073/pnas.86.15.5781; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; Grigorov B, 2006, J MOL BIOL, V359, P848, DOI 10.1016/j.jmb.2006.04.017; Haraguchi H, 2010, MICROBIOL IMMUNOL, V54, P734, DOI 10.1111/j.1348-0421.2010.00276.x; Hogue IB, 2009, J VIROL, V83, P7322, DOI 10.1128/JVI.02545-08; HUANG MJ, 1995, J VIROL, V69, P6810, DOI 10.1128/JVI.69.11.6810-6818.1995; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; Johnson MC, 2001, J VIROL, V75, P4407, DOI 10.1128/JVI.75.9.4407-4412.2001; Jouve M, 2007, CELL HOST MICROBE, V2, P85, DOI 10.1016/j.chom.2007.06.011; Jouvenet N, 2008, NATURE, V454, P236, DOI 10.1038/nature06998; Jouvenet N, 2006, PLOS BIOL, V4, P2296, DOI 10.1371/journal.pbio.0040435; KARACOSTAS V, 1993, VIROLOGY, V193, P661, DOI 10.1006/viro.1993.1174; Khorchid A, 2002, J VIROL, V76, P4131, DOI 10.1128/JVI.76.8.4131-4137.2002; KRAUSSLICH HG, 1991, P NATL ACAD SCI USA, V88, P3213, DOI 10.1073/pnas.88.8.3213; Li H, 2007, J VIROL, V81, P12899, DOI 10.1128/JVI.01280-07; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Lindwasser OW, 2001, J VIROL, V75, P7913, DOI 10.1128/JVI.75.17.7913-7924.2001; Martin-Serrano J, 2003, J VIROL, V77, P4794, DOI 10.1128/JVI.77.8.4794-4804.2003; Mulgrew-Nesbitt A, 2006, BBA-MOL CELL BIOL L, V1761, P812, DOI 10.1016/j.bbalip.2006.07.002; Murray PS, 2005, STRUCTURE, V13, P1521, DOI 10.1016/j.str.2005.07.010; Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200; Nydegger S, 2003, TRAFFIC, V4, P902, DOI 10.1046/j.1600-0854.2003.00145.x; Nydegger S, 2006, J CELL BIOL, V173, P795, DOI 10.1083/jcb.200508165; Ono A, 2000, J VIROL, V74, P5142, DOI 10.1128/JVI.74.11.5142-5150.2000; Ono A, 2007, VIROLOGY, V360, P27, DOI 10.1016/j.virol.2006.10.011; PARK J, 1992, J VIROL, V66, P6304, DOI 10.1128/JVI.66.11.6304-6313.1992; PARK JS, 1991, J VIROL, V65, P5111, DOI 10.1128/JVI.65.9.5111-5117.1991; PEITZSCH RM, 1993, BIOCHEMISTRY-US, V32, P10436, DOI 10.1021/bi00090a020; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Perlman M, 2006, TRAFFIC, V7, P731, DOI 10.1111/j.1398-9219.2006.00428.x; Raposo G, 2002, TRAFFIC, V3, P718, DOI 10.1034/j.1600-0854.2002.31004.x; Royer M, 1997, J GEN VIROL, V78, P131, DOI 10.1099/0022-1317-78-1-131; Saad JS, 2007, J MOL BIOL, V366, P574, DOI 10.1016/j.jmb.2006.11.068; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Sandefur S, 1998, J VIROL, V72, P2723, DOI 10.1128/JVI.72.4.2723-2732.1998; Shehu-Xhilaga M, 2001, J VIROL, V75, P1834, DOI 10.1128/JVI.75.4.1834-1841.2001; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; SMITH AJ, 1993, J VIROL, V67, P2266, DOI 10.1128/JVI.67.4.2266-2275.1993; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; Tsunetsugu-Yokota Y, 2007, AIDS RES HUM RETROV, V23, P278, DOI 10.1089/aid.2006.0098; VerPlank L, 2001, P NATL ACAD SCI USA, V98, P7724, DOI 10.1073/pnas.131059198; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; WEAVER TA, 1990, J VIROL, V64, P2642, DOI 10.1128/JVI.64.6.2642-2652.1990; WILSON W, 1988, CELL, V55, P1159, DOI 10.1016/0092-8674(88)90260-7; ZHOU WJ, 1994, J VIROL, V68, P2556, DOI 10.1128/JVI.68.4.2556-2569.1994	63	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47828	10.1371/journal.pone.0047828	http://dx.doi.org/10.1371/journal.pone.0047828			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110110	Green Published, gold, Green Submitted			2022-12-25	WOS:000310193600030
J	van der Veen, DR; Shao, JP; Xi, Y; Li, L; Duffield, GE				van der Veen, Daan R.; Shao, Jinping; Xi, Yang; Li, Lei; Duffield, Giles E.			Cardiac Atrial Circadian Rhythms in PERIOD2::LUCIFERASE and per1:luc Mice: Amplitude and Phase Responses to Glucocorticoid Signaling and Medium Treatment	PLOS ONE			English	Article							CLOCK GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; INDIVIDUAL FIBROBLASTS; PLASMA-CORTICOSTERONE; REVEALS PERSISTENT; PERIPHERAL-TISSUES; BLOOD-PRESSURE; HEART-RATE; TIME; METABOLISM	Circadian rhythms in cardiac function are apparent in e. g., blood pressure, heart rate, and acute adverse cardiac events. A circadian clock in heart tissue has been identified, but entrainment pathways of this clock are still unclear. We cultured tissues of mice carrying bioluminescence reporters of the core clock genes, period 1 or 2 (per1(luc) or PER2(LUC)) and compared in vitro responses of atrium to treatment with medium and a synthetic glucocorticoid (dexamethasone [DEX]) to that of the suprachiasmatic nucleus (SCN) and liver. We observed that PER2(LUC), but not per1(luc) is rhythmic in atrial tissue, while both per1(luc) and PER2(LUC) exhibit rhythmicity in other cultured tissues. In contrast to the SCN and liver, both per1(luc) and PER2(LUC) bioluminescence amplitudes were increased in response to DEX treatment, and the PER2(LUC) amplitude response was dependent on the time of treatment. Large phase-shift responses to both medium and DEX treatments were observed in the atrium, and phase responses to medium treatment were not attributed to serum content but the treatment procedure itself. The phase-response curves of atrium to both DEX and medium treatments were found to be different to the liver. Moreover, the time of day of the culturing procedure itself influenced the phase of the circadian clock in each of the cultured tissues, but the magnitude of this response was uniquely large in atrial tissue. The current data describe novel entrainment signals for the atrial circadian clock and specifically highlight entrainment by mechanical treatment, an intriguing observation considering the mechanical nature of cardiac tissue.	[van der Veen, Daan R.; Shao, Jinping; Xi, Yang; Li, Lei; Duffield, Giles E.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [van der Veen, Daan R.] Univ Surrey, Fac Hlth & Med Sci, Dept Biochem & Physiol, Guildford GU2 5XH, Surrey, England; [Shao, Jinping; Xi, Yang; Li, Lei] Nankai Univ, Dept Physiol, Sch Med, Tianjin 300071, Peoples R China	University of Notre Dame; University of Surrey; Nankai University	Duffield, GE (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	duffield.2@nd.edu	Li, Lei/F-5722-2015; van der Veen, Daan R/T-1013-2017	Li, Lei/0000-0001-9703-2102; van der Veen, Daan R/0000-0001-8037-1407; Xi, Yang/0000-0002-5990-2549	American Heart Association [10SDG4030011]; National Institute of General Medical Sciences [R01-GM087508, R01-GM083336]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083336, R01GM087508] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported from grants to GED from the American Heart Association (Scientist Development Grant 10SDG4030011) and the National Institute of General Medical Sciences (R01-GM087508), and R01-GM083336. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABE K, 1979, NEUROENDOCRINOLOGY, V29, P119, DOI 10.1159/000122913; Akashi M, 2000, GENE DEV, V14, P645; Akashi M, 2008, J NEUROSCI, V28, P4619, DOI 10.1523/JNEUROSCI.3410-07.2008; Allen G, 2001, J NEUROSCI, V21, P7937, DOI 10.1523/JNEUROSCI.21-20-07937.2001; Anderson RM, 2012, GROSS PHYSL CARDIOVA; Balsalobre A, 2000, CURR BIOL, V10, P1291, DOI 10.1016/S0960-9822(00)00758-2; Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bray MS, 2008, AM J PHYSIOL-HEART C, V294, pH1036, DOI 10.1152/ajpheart.01291.2007; Butcher GQ, 2005, J NEUROSCI, V25, P5305, DOI 10.1523/JNEUROSCI.4361-04.2005; Davidson AJ, 2005, CLIN EXP HYPERTENS, V27, P307, DOI 10.1081/CEH-200048933; Dietz JR, 2005, CARDIOVASC RES, V68, P8, DOI 10.1016/j.cardiores.2005.06.008; Duffield GE, 2002, CURR BIOL, V12, P551, DOI 10.1016/S0960-9822(02)00765-0; Durgan DJ, 2005, AM J PHYSIOL-HEART C, V289, pH1530, DOI 10.1152/ajpheart.00406.2005; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Guo HN, 2005, P NATL ACAD SCI USA, V102, P3111, DOI 10.1073/pnas.0409734102; Habeler W, 2009, ORGANOGENESIS, V5, P62, DOI 10.4161/org.5.2.9091; Hu K, 2004, P NATL ACAD SCI USA, V101, P18223, DOI 10.1073/pnas.0408243101; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Kalsbeek A, 2012, MOL CELL ENDOCRINOL, V349, P20, DOI 10.1016/j.mce.2011.06.042; Kerkela R, 2011, AM J PHYSIOL-REG I, V300, pR140, DOI 10.1152/ajpregu.00853.2009; Klein D.C., 1991, SUPRACHIASMATIC NUCL; Kornmann B, 2007, COLD SPRING HARB SYM, V72, P319, DOI 10.1101/sqb.2007.72.041; Kornmann B, 2007, PLOS BIOL, V5, P179, DOI 10.1371/journal.pbio.0050034; Lee C, 2001, CELL, V107, P855, DOI 10.1016/S0092-8674(01)00610-9; Li P, 1999, AM J PHYSIOL-REG I, V276, pR500, DOI 10.1152/ajpregu.1999.276.2.R500; Marquez S, 2004, FASEB J, V18, P519, DOI 10.1096/fj.03-0417fje; Martino T, 2004, J MOL MED, V82, P256, DOI 10.1007/s00109-003-0520-1; Martino TA, 2008, AM J PHYSIOL-REG I, V294, pR1675, DOI 10.1152/ajpregu.00829.2007; Menger GJ, 2007, PHYSIOL GENOMICS, V29, P280, DOI 10.1152/physiolgenomics.00199.2006; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Oster H, 2006, CELL METAB, V4, P163, DOI 10.1016/j.cmet.2006.07.002; Peirson SN, 2006, BIOCHEM BIOPH RES CO, V351, P800, DOI 10.1016/j.bbrc.2006.10.118; Pendergast JS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008552; Reddy AB, 2002, J NEUROSCI, V22, P7326; Reilly DF, 2007, ARTERIOSCL THROM VAS, V27, P1694, DOI 10.1161/ATVBAHA.107.144923; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Ripperger JA, 2011, FEBS LETT, V585, P1384, DOI 10.1016/j.febslet.2011.02.027; Schroeder A, 2011, AM J PHYSIOL-HEART C, V300, pH241, DOI 10.1152/ajpheart.00190.2010; Sheward WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009783; So AYL, 2009, P NATL ACAD SCI USA, V106, P17582, DOI 10.1073/pnas.0909733106; Son GH, 2008, P NATL ACAD SCI USA, V105, P20970, DOI 10.1073/pnas.0806962106; Spies CM, 2011, BEST PRACT RES CL RH, V25, P891, DOI 10.1016/j.berh.2011.11.002; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; Tsuchiya Y, 2003, GENES CELLS, V8, P713, DOI 10.1046/j.1365-2443.2003.00669.x; Ulrich-Lai YM, 2006, AM J PHYSIOL-REG I, V290, pR1128, DOI 10.1152/ajpregu.00042.2003; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Welsh DK, 2004, CURR BIOL, V14, P2289, DOI 10.1016/j.cub.2004.11.057; Willich SN, 1999, VASC MED, V4, P41, DOI 10.1191/135886399670596924; Wilsbacher LD, 2002, P NATL ACAD SCI USA, V99, P489, DOI 10.1073/pnas.012248599; Yamamoto T, 2005, J BIOL CHEM, V280, P42036, DOI 10.1074/jbc.M509600200; Yamazaki S, 2005, METHOD ENZYMOL, V393, P288, DOI 10.1016/S0076-6879(05)93012-7; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Yoshikawa T, 2005, J BIOL RHYTHM, V20, P500, DOI 10.1177/0748730405280775; Young ME, 2006, AM J PHYSIOL-HEART C, V290, pH1, DOI 10.1152/ajpheart.00582.2005	57	21	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47692	10.1371/journal.pone.0047692	http://dx.doi.org/10.1371/journal.pone.0047692			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110090	Green Submitted, Green Published, gold			2022-12-25	WOS:000310193600022
J	Mestre, G; Berbel, C; Tortajada, P; Alarcia, M; Coca, R; Gallemi, G; Garcia, I; Fernandez, MM; Aguilar, MC; Martinez, JA; Rodriguez-Bano, J				Mestre, Gabriel; Berbel, Cristina; Tortajada, Purificacion; Alarcia, Margarita; Coca, Roser; Gallemi, Gema; Garcia, Irene; Mar Fernandez, Mari; Carmen Aguilar, Mari; Antonio Martinez, Jose; Rodriguez-Bano, Jesus			"The 3/3 Strategy'': A Successful Multifaceted Hospital Wide Hand Hygiene Intervention Based on WHO and Continuous Quality Improvement Methodology	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; STATISTICAL PROCESS-CONTROL; PROCESS-CONTROL CHARTS; HEALTH-CARE WORKERS; INFECTION-CONTROL; PROGRAM; IMPACT; EPIDEMIOLOGY; PERFORMANCE; GUIDELINES	Background: Only multifaceted hospital wide interventions have been successful in achieving sustained improvements in hand hygiene (HH) compliance. Methodology/Principal Findings: Pre-post intervention study of HH performance at baseline (October 2007-December 2009) and during intervention, which included two phases. Phase 1 (2010) included multimodal WHO approach. Phase 2 (2011) added Continuous Quality Improvement (CQI) tools and was based on: a) Increase of alcohol hand rub (AHR) solution placement (from 0.57 dispensers/bed to 1.56); b) Increase in frequency of audits (three days every three weeks: "3/3 strategy''); c) Implementation of a standardized register form of HH corrective actions; d) Statistical Process Control (SPC) as time series analysis methodology through appropriate control charts. During the intervention period we performed 819 scheduled direct observation audits which provided data from 11,714 HH opportunities. The most remarkable findings were: a) significant improvements in HH compliance with respect to baseline (25% mean increase); b) sustained high level (82%) of HH compliance during intervention; c) significant increase in AHRs consumption over time; c) significant decrease in the rate of healthcare-acquired MRSA; d) small but significant improvements in HH compliance when comparing phase 2 to phase 1 [79.5% (95% CI: 78.2-80.7) vs 84.6% (95% CI: 83.8-85.4), p, 0.05]; e) successful use of control charts to identify significant negative and positive deviations (special causes) related to the HH compliance process over time ("positive'': 90.1% as highest HH compliance coinciding with the "World hygiene day''; and "negative'': 73.7% as lowest HH compliance coinciding with a statutory lay-off proceeding). Conclusions/Significance: CQI tools may be a key addition to WHO strategy to maintain a good HH performance over time. In addition, SPC has shown to be a powerful methodology to detect special causes in HH performance (positive and negative) and to help establishing adequate feedback to healthcare workers.	[Mestre, Gabriel; Berbel, Cristina; Tortajada, Purificacion] Delfos Med Ctr, Nosocomial Infect Control Unit, Barcelona, Catalonia, Spain; [Alarcia, Margarita; Coca, Roser; Gallemi, Gema; Garcia, Irene; Mar Fernandez, Mari; Carmen Aguilar, Mari] Delfos Med Ctr, Supervisor Nursing Dept, Barcelona, Catalonia, Spain; [Antonio Martinez, Jose] Hosp Clin Barcelona, Infect Dis Unit, Barcelona, Catalonia, Spain; [Rodriguez-Bano, Jesus] Univ Hosp Virgen Macarena, Infect Dis & Microbiol Unit, Seville, Spain	University of Barcelona; Hospital Clinic de Barcelona; Hospital Universitario Virgen Macarena	Mestre, G (corresponding author), Delfos Med Ctr, Nosocomial Infect Control Unit, Barcelona, Catalonia, Spain.	mestre.ucin@centromedicodelfos.es	Rodríguez-Baño, Jesús/F-2453-2011	Rodríguez-Baño, Jesús/0000-0001-6732-9001	Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III; European Development Regional Fund "A way to achieve Europe'' ERDF, Spanish Network for the Research in Infectious Diseases [REIPI RD06/0008]	Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government); European Development Regional Fund "A way to achieve Europe'' ERDF, Spanish Network for the Research in Infectious Diseases	In January 2011, Lab HARTMANN S.A, provided 200 bottles of hydroalcoholic gel and gel dispensers as an unrestricted collaboration for an educational program in infection control in Delfos Medical Center. GMR provides part-time consultancy activities for Lab HARTMANN S.A since April 2011. JRB received funding for research from Ministerio de Ciencia e Innovacion, Instituto de Salud Carlos III - co-financed by European Development Regional Fund "A way to achieve Europe'' ERDF, Spanish Network for the Research in Infectious Diseases (REIPI RD06/0008). The other authors declare no conflicts of interest. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data. The funders had no role in the design of the study, analysis of the data, writing of the manuscript, or decision to publish.	Aboumatar H, 2012, INFECT CONT HOSP EP, V33, P144, DOI 10.1086/663707; Allegranzi B, 2009, J HOSP INFECT, V73, P305, DOI 10.1016/j.jhin.2009.04.019; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Benneyan JC, 1998, INFECT CONT HOSP EP, V19, P265; Benneyan JC, 1998, INFECT CONT HOSP EP, V19, P194; Bero LA, 1998, BMJ-BRIT MED J, V317, P465; Boyce JM, 2011, INFECT CONT HOSP EP, V32, P1016, DOI 10.1086/662015; Carey R.G., 2003, IMPROVING HEALTHCARE; Cockburn J, 2004, MED J AUSTRALIA, V180, pS66; Cohen AL, 2008, INFECT CONT HOSP EP, V29, P901, DOI 10.1086/591741; Cummings KL, 2010, INFECT CONT HOSP EP, V31, P357, DOI 10.1086/651096; Curran E, 2008, J HOSP INFECT, V70, P127, DOI 10.1016/j.jhin.2008.06.013; D'Agata EMC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030170; Ebnother C, 2008, INFECT CONT HOSP EP, V29, P38, DOI 10.1086/524330; Eckmanns T, 2006, INFECT CONT HOSP EP, V27, P931, DOI 10.1086/507294; Erasmus V, 2009, INFECT CONT HOSP EP, V30, P415, DOI 10.1086/596773; Erasmus V, 2010, INFECT CONT HOSP EP, V31, P283, DOI 10.1086/650451; Gill AW, 2011, J HOSP INFECT, V78, P20, DOI 10.1016/j.jhin.2010.12.018; Gould DJ, 2007, J HOSP INFECT, V66, P109, DOI 10.1016/j.jhin.2007.02.009; Gould DJ, 2011, J HOSP INFECT, V77, P290, DOI 10.1016/j.jhin.2010.12.011; Grayson ML, 2008, MED J AUSTRALIA, V188, P633, DOI 10.5694/j.1326-5377.2008.tb01820.x; Hysong SJ, 2009, MED CARE, V47, P356, DOI 10.1097/MLR.0b013e3181893f6b; Jang JH, 2010, INFECT CONT HOSP EP, V31, P144, DOI 10.1086/649792; Johnson PDR, 2005, MED J AUSTRALIA, V183, P509, DOI 10.5694/j.1326-5377.2005.tb07151.x; Kohli E, 2009, INFECT CONT HOSP EP, V30, P222, DOI 10.1086/595692; Kretzer EK, 1998, AM J INFECT CONTROL, V26, P245, DOI 10.1016/S0196-6553(98)80008-4; LAFFEL G, 1989, JAMA-J AM MED ASSOC, V262, P2869, DOI DOI 10.1001/JAMA.1989.03430200113036; Larson EL, 2007, AM J INFECT CONTROL, V35, P666, DOI 10.1016/j.ajic.2006.10.006; Lee TC, 2009, INFECT CONT HOSP EP, V30, P249, DOI 10.1086/596042; MacDonald A, 2004, J HOSP INFECT, V56, P56, DOI 10.1016/S0195-6701(03)00293-7; MAYER JA, 1986, INFECT CONT HOSP EP, V7, P259, DOI 10.1017/S0195941700064171; Mohammed MA, 2008, QUAL SAF HEALTH CARE, V17, P137, DOI 10.1136/qshc.2004.012047; Mohammed MA, 2004, QUAL SAF HEALTH CARE, V13, P243, DOI 10.1136/qshc.2004.011650; Mohammed MA, 2001, LANCET, V357, P463, DOI 10.1016/S0140-6736(00)04019-8; Montgomery DC., 1991, INTRO STAT QUALITY C, V2nd ed.; Morton AP, 2007, J HOSP INFECT, V66, P296, DOI 10.1016/j.jhin.2007.04.019; Moulding NT, 1999, QUAL HEALTH CARE, V8, P177, DOI 10.1136/qshc.8.3.177; O'Boyle CA, 2001, AM J INFECT CONTROL, V29, P352, DOI 10.1067/mic.2001.18405; Pessoa-Silva CL, 2007, PEDIATRICS, V120, pE382, DOI 10.1542/peds.2006-3712; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Pittet D, 2004, ANN INTERN MED, V141, P1, DOI 10.7326/0003-4819-141-1-200407060-00008; Pittet D, 2001, EMERG INFECT DIS, V7, P234, DOI 10.3201/eid0702.010217; Pittet D, 2004, INFECT CONT HOSP EP, V25, P264, DOI 10.1086/502389; Pittet D, 2006, LANCET INFECT DIS, V6, P641, DOI 10.1016/S1473-3099(06)70600-4; Rose Louise, 2009, Intensive Crit Care Nurs, V25, P57, DOI 10.1016/j.iccn.2008.09.002; Sax H, 2007, J HOSP INFECT, V67, P9, DOI 10.1016/j.jhin.2007.06.004; Sax H, 2009, AM J INFECT CONTROL, V37, P827, DOI 10.1016/j.ajic.2009.07.003; SELLICK JA, 1993, INFECT CONT HOSP EP, V14, P649; Shewhart WA., 1931, EC CONTROL QUALITY M; Stewardson A, 2011, INFECT CONT HOSP EP, V32, P1029, DOI 10.1086/662023; Stone SP, 2007, LANCET INFECT DIS, V7, P282, DOI 10.1016/S1473-3099(07)70082-8; Thomas M, 2005, AM J INFECT CONTROL, V33, P368, DOI 10.1016/j.ajic.2005.03.011; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Whitby M, 2007, J HOSP INFECT, V65, P1, DOI 10.1016/j.jhin.2006.09.026; Whitby M, 2006, INFECT CONT HOSP EP, V27, P484, DOI 10.1086/503335; Zerr DM, 2005, PEDIATR INFECT DIS J, V24, P397, DOI 10.1097/01.inf.0000160944.14878.2b	56	31	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e47200	10.1371/journal.pone.0047200	http://dx.doi.org/10.1371/journal.pone.0047200			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110061	Green Published, gold, Green Submitted			2022-12-25	WOS:000310193400007
J	Russo, F; Di Bella, S; Nigita, G; Macca, V; Lagana, A; Giugno, R; Pulvirenti, A; Ferro, A				Russo, Francesco; Di Bella, Sebastiano; Nigita, Giovanni; Macca, Valentina; Lagana, Alessandro; Giugno, Rosalba; Pulvirenti, Alfredo; Ferro, Alfredo			miRandola: Extracellular Circulating MicroRNAs Database	PLOS ONE			English	Article							PAZ DOMAIN; CELLS; PLASMA; DISEASE; CANCER; RNA; COMPLEXES; MECHANISM; BIOMARKER; VESICLES	MicroRNAs are small noncoding RNAs that play an important role in the regulation of various biological processes through their interaction with cellular messenger RNAs. They are frequently dysregulated in cancer and have shown great potential as tissue-based markers for cancer classification and prognostication. microRNAs are also present in extracellular human body fluids such as serum, plasma, saliva, and urine. Most of circulating microRNAs are present in human plasma and serum cofractionate with the Argonaute2 (Ago2) protein. However, circulating microRNAs have been also found in membrane-bound vesicles such as exosomes. Since microRNAs circulate in the bloodstream in a highly stable, extracellular form, they may be used as blood-based biomarkers for cancer and other diseases. A knowledge base of extracellular circulating miRNAs is a fundamental tool for biomedical research. In this work, we present miRandola, a comprehensive manually curated classification of extracellular circulating miRNAs. miRandola is connected to miRo, the miRNA knowledge base, allowing users to infer the potential biological functions of circulating miRNAs and their connections with phenotypes. The miRandola database contains 2132 entries, with 581 unique mature miRNAs and 21 types of samples. miRNAs are classified into four categories, based on their extracellular form: miRNA-Ago2 (173 entries), miRNA-exosome (856 entries), miRNA-HDL (20 entries) and miRNA-circulating (1083 entries). miRandola is available online at: http://atlas.dmi.unict.it/mirandola/index.html.	[Russo, Francesco; Di Bella, Sebastiano; Giugno, Rosalba; Pulvirenti, Alfredo; Ferro, Alfredo] Univ Catania, Dept Clin & Mol Biomed, Catania, Italy; [Nigita, Giovanni; Macca, Valentina] Univ Catania, Dept Math & Comp Sci, Catania, Italy; [Lagana, Alessandro] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Human Genet, Columbus, OH 43210 USA	University of Catania; University of Catania; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Ferro, A (corresponding author), Univ Catania, Dept Clin & Mol Biomed, Catania, Italy.	ferro@dmi.unict.it	Pulvirenti, Alfredo/I-7272-2018; Nigita, Giovanni/AAC-4090-2020; Di Bella, Sebastiano/V-6442-2019; Russo, Francesco/X-3055-2018	Pulvirenti, Alfredo/0000-0002-9764-0295; Nigita, Giovanni/0000-0001-8880-4334; Giugno, Rosalba/0000-0001-9843-7638; Russo, Francesco/0000-0001-9257-4359; Di Bella, Sebastiano/0000-0001-7161-303X	Associazione Sclerosi Tuberosa	Associazione Sclerosi Tuberosa	Valentina Macca has been supported by a fellowship sponsored by "Associazione Sclerosi Tuberosa", A. S. T. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai J, 2010, BIOCHEM BIOPH RES CO, V391, P73, DOI 10.1016/j.bbrc.2009.11.005; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Chen XM, 2009, WORLD J GASTROENTERO, V15, P1665, DOI 10.3748/wjg.15.1665; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Gidlof O, 2011, CARDIOLOGY, V118, P217, DOI 10.1159/000328869; Gupta SK, 2010, CIRC-CARDIOVASC GENE, V3, P484, DOI 10.1161/CIRCGENETICS.110.958363; Hanke Merle, 2010, Urol Oncol, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Hebert SS, 2009, TRENDS NEUROSCI, V32, P199, DOI 10.1016/j.tins.2008.12.003; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Lagana A, 2009, DATABASE-OXFORD, DOI 10.1093/database/bap008; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Mathivanan S, 2012, NUCLEIC ACIDS RES, V40, pD1241, DOI 10.1093/nar/gkr828; Mishima T, 2007, BRAIN RES, V1131, P37, DOI 10.1016/j.brainres.2006.11.035; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mocellin S, 2009, MINI-REV MED CHEM, V9, P70, DOI 10.2174/138955709787001802; Nimmo RA, 2009, CHROMOSOMA, V118, P405, DOI 10.1007/s00412-009-0210-z; Romano P, 2011, BRIEF BIOINFORM, V12, P549, DOI 10.1093/bib/bbr055; Shi Y, 2009, SCI CHINA SER C, V52, P205, DOI 10.1007/s11427-009-0040-5; Siegel SR, 2012, MOL BIOL REP, V39, P6219, DOI 10.1007/s11033-011-1441-7; Silva J, 2011, EUR RESPIR J, V37, P617, DOI 10.1183/09031936.00029610; Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016; Sun BK, 2008, J AM ACAD DERMATOL, V59, P725, DOI 10.1016/j.jaad.2008.08.017; Tomimaru Y, 2012, J HEPATOL, V56, P167, DOI 10.1016/j.jhep.2011.04.026; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zahm AM, 2011, J PEDIATR GASTR NUTR, V53, P26, DOI 10.1097/MPG.0b013e31822200cc	32	120	127	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47786	10.1371/journal.pone.0047786	http://dx.doi.org/10.1371/journal.pone.0047786			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094086	Green Published, gold, Green Submitted			2022-12-25	WOS:000310050200045
J	Cappellari, AR; Rockenbach, L; Dietrich, F; Clarimundo, V; Glaser, T; Braganhol, E; Abujamra, AL; Roesler, R; Ulrich, H; Battastini, AML				Cappellari, Angelica Regina; Rockenbach, Liliana; Dietrich, Fabricia; Clarimundo, Vanessa; Glaser, Talita; Braganhol, Elizandra; Abujamra, Ana Lucia; Roesler, Rafael; Ulrich, Henning; Liveira Battastini, Ana Maria			Characterization of Ectonucleotidases in Human Medulloblastoma Cell Lines: ecto-5 ' NT/CD73 in Metastasis as Potential Prognostic Factor	PLOS ONE			English	Article							CHILDHOOD MEDULLOBLASTOMA; EXTRACELLULAR METABOLISM; ALKALINE-PHOSPHATASE; ATP; INHIBITION; EXPRESSION; ADENOSINE; NUCLEOTIDES; ECTOENZYMES; GROWTH	Medulloblastoma (MB) is the most common malignant brain tumor in children and occurs mainly in the cerebellum. Important intracellular signaling molecules, such those present in the Sonic Hedgehog and Wnt pathways, are involved in its development and can also be employed to determine tumor grade and prognosis. Ectonucleotidases, particularly ecto-5'NT/CD73, are important enzymes in the malignant process of different tumor types regulating extracellular ATP and adenosine levels. Here, we investigated the activity of ectonucleotidases in three malignant human cell lines: Daoy and ONS76, being representative of primary MB, and the D283 cell line, derived from a metastatic MB. All cell lines secreted ATP into the extracellular medium while hydrolyze poorly this nucleotide, which is in agreement with the low expression and activity of pyrophosphate/phosphodiesterase, NTPDases and alkaline phosphatase. The analysis of AMP hydrolysis showed that Daoy and ONS76 completely hydrolyzed AMP, with parallel adenosine production (Daoy) and inosine accumulation (ONS76). On the other hand, D283 cell line did not hydrolyze AMP. Moreover, primary MB tumor cells, Daoy and ONS76 express the ecto-5'NT/CD73 while D283 representative of a metastatic tumor, revealed poor expression of this enzyme, while the ecto-adenosine deaminase showed higher expression in D283 compared to Daoy and ONS76 cells. Nuclear beta-catenin has been suggested as a marker for MB prognosis. Further it can promotes expression of ecto-5'NT/CD73 and suppression of adenosine deaminase. It was observed that Daoy and ONS76 showed greater nuclear beta-catenin immunoreactivity than D283, which presented mainly cytoplasmic immunoreactivity. In summary, the absence of ecto-5'NT/CD73 in the D283 cell line, a metastatic MB phenotype, suggests that high expression levels of this ectonucleotidase could be correlated with a poor prognosis in patients with MB.	[Cappellari, Angelica Regina; Rockenbach, Liliana; Dietrich, Fabricia; Clarimundo, Vanessa; Liveira Battastini, Ana Maria] Univ Fed Rio Grande do Sul, Dept Bioquim, Inst Ciencias Basicas & Saude, Porto Alegre, RS, Brazil; [Glaser, Talita; Ulrich, Henning] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Braganhol, Elizandra] Univ Fed Pelotas, Ctr Ciencias Quim Farmaceut & Alimentos, Pelotas, RS, Brazil; [Abujamra, Ana Lucia; Roesler, Rafael] Univ Fed Rio Grande do Sul, Hosp Clin Porto Alegre, Lab Pesquisa Canc, Porto Alegre, RS, Brazil; [Abujamra, Ana Lucia] ICI RS, Inst Canc Infantil RS, Porto Alegre, RS, Brazil; [Roesler, Rafael] Univ Fed Rio Grande do Sul, Dept Farmacol, Inst Ciencias Basicas & Saude, Porto Alegre, RS, Brazil; [Roesler, Rafael] Univ Fed Rio Grande do Sul, Inst Nacl Ciencia & Tecnol Translac Med, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade de Sao Paulo; Universidade Federal de Pelotas; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Battastini, AML (corresponding author), Univ Fed Rio Grande do Sul, Dept Bioquim, Inst Ciencias Basicas & Saude, Porto Alegre, RS, Brazil.	abattastini@gmail.com	Dietrich, Fabrícia/F-8658-2019; Roesler, Rafael/U-9261-2019; Ulrich, Henning/C-5245-2013; Cappellari, Angélica/V-1481-2019; Braganhol, Elizandra/C-6439-2013; Glaser, Talita/C-3663-2014; Abujamra, Ana Lucia/D-4903-2013; Battastini, Ana M/E-2809-2012	Ulrich, Henning/0000-0002-2114-3815; Abujamra, Ana Lucia/0000-0002-4899-4644; Battastini, Ana M/0000-0001-6068-3278; Cappellari, Angelica Regina/0000-0002-8202-609X; Dietrich, Fabricia/0000-0002-6458-2359; Roesler, Rafael/0000-0001-6016-2261	Brazilian funding agency: CNPq [Proc. 303016/2009-4]; Brazilian funding agency: FIPEHCPA [Proc. 10-01320]; Brazilian funding agency: FAPESP; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Science and Technology Facilities Council [ST/H002456/1] Funding Source: researchfish; STFC [ST/H002456/1] Funding Source: UKRI	Brazilian funding agency: CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian funding agency: FIPEHCPA; Brazilian funding agency: FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This work was supported by the Brazilian funding agencies: CNPq (Proc. 303016/2009-4), FIPEHCPA (Proc. 10-01320), FAPESP (to Henning Ulrich). A. Cappellari was recipient of Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbracchio MP, 2009, TRENDS NEUROSCI, V32, P19, DOI 10.1016/j.tins.2008.10.001; Aerts I, 2011, CLIN NEUROL NEUROSUR, V113, P224, DOI 10.1016/j.clineuro.2010.11.018; Bavaresco L, 2008, MOL CELL BIOCHEM, V319, P61, DOI 10.1007/s11010-008-9877-3; Belcher SM, 2009, ENDOCRINOLOGY, V150, P1112, DOI 10.1210/en.2008-1363; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braganhol E, 2007, BBA-GEN SUBJECTS, V1770, P1352, DOI 10.1016/j.bbagen.2007.06.003; Castellino RC, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-127; CHAN KM, 1986, ANAL BIOCHEM, V157, P375, DOI 10.1016/0003-2697(86)90640-8; Ellison DW, 2005, J CLIN ONCOL, V23, P7951, DOI 10.1200/JCO.2005.01.5479; Fields RD, 2006, NAT REV NEUROSCI, V7, P423, DOI 10.1038/nrn1928; Muoio VMF, 2011, ARQ NEURO-PSIQUIAT, V69, P328, DOI 10.1590/S0004-282X2011000300012; Franco R, 1997, PROG NEUROBIOL, V52, P283, DOI 10.1016/S0301-0082(97)00013-0; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Goding JW, 2003, BBA-MOL BASIS DIS, V1638, P1, DOI 10.1016/S0925-4439(03)00058-9; Grobben B, 1999, J NEUROCHEM, V72, P826, DOI 10.1046/j.1471-4159.1999.0720826.x; Khaw AK, 2007, MUTAT RES-FUND MOL M, V625, P134, DOI 10.1016/j.mrfmmm.2007.06.005; Koeller KK, 2003, RADIOGRAPHICS, V23, P1613, DOI 10.1148/rg.236035168; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Millan Jose Luis, 2006, Purinergic Signal, V2, P335, DOI 10.1007/s11302-005-5435-6; Morrone FB, 2005, J NEURO-ONCOL, V71, P135, DOI 10.1007/s11060-004-1383-1; Morrone FB, 2003, J NEURO-ONCOL, V64, P211, DOI 10.1023/A:1025699932270; Ohkubo S, 2000, BRIT J PHARMACOL, V131, P1667, DOI 10.1038/sj.bjp.0703750; Picher M, 2003, J BIOL CHEM, V278, P13468, DOI 10.1074/jbc.M300569200; Polakis P, 2000, GENE DEV, V14, P1837; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Rodini CO, 2010, ARQ NEURO-PSIQUIAT, V68, P947, DOI 10.1590/S0004-282X2010000600021; Roussel Martine F, 2011, F1000 Biol Rep, V3, P5, DOI 10.3410/B3-5; Sakura H, 1998, THROMB RES, V91, P83, DOI 10.1016/S0049-3848(98)00073-5; Schmidt AL, 2010, CNS NEUROL DISORD-DR, V9, P335, DOI 10.2174/187152710791292602; Spychala J, 2004, EXP CELL RES, V296, P99, DOI 10.1016/j.yexcr.2003.11.001; Spychala J, 2000, PHARMACOL THERAPEUT, V87, P161, DOI 10.1016/S0163-7258(00)00053-X; Stagg J, 2010, ONCOGENE, V29, P5346, DOI 10.1038/onc.2010.292; Stefan C, 2005, TRENDS BIOCHEM SCI, V30, P542, DOI 10.1016/j.tibs.2005.08.005; Stefan Cristiana, 2006, Purinergic Signal, V2, P361, DOI 10.1007/s11302-005-5303-4; Stella J, 2009, UROL ONCOL, V28, P260; Strater Norbert, 2006, Purinergic Signal, V2, P343, DOI 10.1007/s11302-006-9000-8; Villar J, 2007, CANCER RES, V67, P10859, DOI 10.1158/0008-5472.CAN-07-2041; von Bueren AO, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-10; Wink MR, 2003, CANCER LETT, V198, P211, DOI 10.1016/S0304-3835(03)00308-2; Wink MR, 2003, NEUROCHEM INT, V43, P621, DOI 10.1016/S0197-0186(03)00094-9; Yegutkin GG, 2008, BBA-MOL CELL RES, V1783, P673, DOI 10.1016/j.bbamcr.2008.01.024; Zimmermann H, 2000, N-S ARCH PHARMACOL, V362, P299, DOI 10.1007/s002100000309; Zimmermann H, 2012, PURINERG SIGNAL, V8, P437, DOI 10.1007/s11302-012-9309-4	43	35	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47468	10.1371/journal.pone.0047468	http://dx.doi.org/10.1371/journal.pone.0047468			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094051	Green Published, gold, Green Submitted			2022-12-25	WOS:000312384500011
J	Hicks, AN; Lorenzetti, D; Gilley, J; Lu, BS; Andersson, KE; Miligan, C; Overbeek, PA; Oppenheim, R; Bishop, CE				Hicks, Amy N.; Lorenzetti, Diego; Gilley, Jonathan; Lu, Baisong; Andersson, Karl-Erik; Miligan, Carol; Overbeek, Paul A.; Oppenheim, Ronald; Bishop, Colin E.			Nicotinamide Mononucleotide Adenylyltransferase 2 (Nmnat2) Regulates Axon Integrity in the Mouse Embryo	PLOS ONE			English	Article							WALLERIAN DEGENERATION; NEUROMUSCULAR SYNAPSES; SLEEPING-BEAUTY; C57BL/OLA MICE; TRANSPOSON; GENE; DYSFUNCTION; EXPRESSION; SURVIVAL; SYSTEM	Using transposon-mediated gene-trap mutagenesis, we have generated a novel mouse mutant termed Blad (Bloated Bladder). Homozygous mutant mice die perinatally showing a greatly distended bladder, underdeveloped diaphragm and a reduction in total skeletal muscle mass. Wild type and heterozygote mice appear normal. Using PCR, we identified a transposon insertion site in the first intron of Nmnat2 (Nicotinamide mononucleotide adenyltransferase 2). Nmnat2 is expressed predominantly in the brain and nervous system and has been linked to the survival of axons. Expression of this gene is undetectable in Nmnat2(blad/blad) mutants. Examination of the brains of E18.5 Nmnat2(blad/blad) mutant embryos did not reveal any obvious morphological changes. In contrast, E18.5 Nmnat2(blad/blad) homozygotes showed an approximate 60% reduction of spinal motoneurons in the lumbar region and a more than 80% reduction in the sensory neurons of the dorsal root ganglion (DRG). In addition, facial motoneuron numbers were severely reduced, and there was virtually a complete absence of axons in the hind limb. Our observations suggest that during embryogenesis, Nmnat2 plays an important role in axonal growth or maintenance. It appears that in the absence of Nmnat2, major target organs and tissues (e. g., muscle) are not functionally innervated resulting in perinatal lethality. In addition, neither Nmnat1 nor 3 can compensate for the loss of Nmnat2. Whilst there have been recent suggestions that Nmnat2 may be an endogenous modulator of axon integrity, this work represents the first in vivo study demonstrating that Nmnat2 is involved in axon development or survival in a mammal.	[Hicks, Amy N.; Lorenzetti, Diego; Lu, Baisong; Andersson, Karl-Erik; Bishop, Colin E.] Wake Forest Univ, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA; [Gilley, Jonathan] Babraham Inst, Signalling Programme, Cambridge, England; [Miligan, Carol; Oppenheim, Ronald] Wake Forest Univ, Neurosci Program, Winston Salem, NC 27109 USA; [Miligan, Carol; Oppenheim, Ronald] Wake Forest Univ, Dept Neurobiol & Anat, Winston Salem, NC 27109 USA; [Miligan, Carol; Oppenheim, Ronald] Wake Forest Univ, Amyotroph Lateral Sclerosis Ctr, Winston Salem, NC 27109 USA; [Overbeek, Paul A.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Wake Forest University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Wake Forest University; Wake Forest University; Wake Forest University; Baylor College of Medicine	Hicks, AN (corresponding author), Wake Forest Univ, Wake Forest Inst Regenerat Med, Winston Salem, NC 27109 USA.	ahicks@wakehealth.edu	Lu, Baisong/B-5837-2013	Lu, Baisong/0000-0001-9240-558X; Hicks, Amy/0000-0001-7729-4156; Overbeek, Paul/0000-0001-9784-2084	National Institutes of Health (NIH) [U01 HD43421, NS069212]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD043421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069212] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to cite support by National Institutes of Health (NIH) grant type U01 HD43421 to CEB and NS069212 to RO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGULNIK AI, 1994, HUM MOL GENET, V3, P879, DOI 10.1093/hmg/3.6.879; Alano CC, 2010, J NEUROSCI, V30, P2967, DOI 10.1523/JNEUROSCI.5552-09.2010; Ali YO, 2012, HUM MOL GENET, V21, P237, DOI 10.1093/hmg/ddr449; BEERMANN F, 1990, EMBO J, V9, P2819, DOI 10.1002/j.1460-2075.1990.tb07470.x; Berger F, 2005, J BIOL CHEM, V280, P36334, DOI 10.1074/jbc.M508660200; Brandon EP, 2003, J NEUROSCI, V23, P539, DOI 10.1523/JNEUROSCI.23-02-00539.2003; Brunetti L, 2010, PROTEIN SCI, V19, P2440, DOI 10.1002/pro.526; CLARKE PGH, 1995, METHOD CELL BIOL, V46, P277; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Conforti L, 2011, FEBS J, V278, P2666, DOI 10.1111/j.1742-4658.2011.08193.x; Feng Y, 2010, J NEUROSCI RES, V88, P3319, DOI 10.1002/jnr.22498; Feng Y, 2010, PROTEIN CELL, V1, P237, DOI 10.1007/s13238-010-0021-2; Gilley J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000300; GLASS JD, 1993, J NEUROCYTOL, V22, P311, DOI 10.1007/BF01195555; Gould TW, 2007, NEUROSCI BIOBEHAV R, V31, P1073, DOI 10.1016/j.neubiorev.2007.04.015; HALL BK, 1990, J MORPHOL, V206, P45, DOI 10.1002/jmor.1052060105; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; Ivics Z, 2006, CURR GENE THER, V6, P593, DOI 10.2174/156652306778520647; Lau C, 2010, J BIOL CHEM, V285, P18868, DOI 10.1074/jbc.M110.107631; Lin WC, 2000, P NATL ACAD SCI USA, V97, P1299, DOI 10.1073/pnas.97.3.1299; Ljungberg MC, 2012, HUM MOL GENET, V21, P251, DOI 10.1093/hmg/ddr492; Lu BS, 2007, MAMM GENOME, V18, P338, DOI 10.1007/s00335-007-9025-5; Mayer PR, 2010, J BIOL CHEM, V285, P40387, DOI 10.1074/jbc.M110.178913; OPPENHEIM RW, 1986, DEV BIOL, V114, P426, DOI 10.1016/0012-1606(86)90207-1; Oppenheim RW, 2008, FUNDAMENTAL NEUROSCI; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; PERRY VH, 1990, EUR J NEUROSCI, V2, P802, DOI 10.1111/j.1460-9568.1990.tb00472.x; Raffaelli N, 2002, BIOCHEM BIOPH RES CO, V297, P835, DOI 10.1016/S0006-291X(02)02285-4; Raffaelli N, 2001, METHOD ENZYMOL, V331, P281; ROBINSON MO, 1989, P NATL ACAD SCI USA, V86, P8437, DOI 10.1073/pnas.86.21.8437; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Schoenmann Z, 2010, J NEUROSCI, V30, P6375, DOI 10.1523/JNEUROSCI.0922-10.2010; Sorci L, 2007, BIOCHEMISTRY-US, V46, P4912, DOI 10.1021/bi6023379; Wang BP, 2011, DEVELOPMENT, V138, P4487, DOI 10.1242/dev.067264; Winseck AK, 2006, EUR J NEUROSCI, V24, P2105, DOI 10.1111/j.1460-9568.2006.05107.x; Yan TT, 2010, NEUROCHEM INT, V56, P101, DOI 10.1016/j.neuint.2009.09.007; Zhai RG, 2008, NATURE, V452, P887, DOI 10.1038/nature06721; Zhai RG, 2006, PLOS BIOL, V4, P2336, DOI 10.1371/journal.pbio.0040416	38	52	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47869	10.1371/journal.pone.0047869	http://dx.doi.org/10.1371/journal.pone.0047869			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082226	Green Published, gold, Green Submitted			2022-12-25	WOS:000311146900123
J	Jaud, T; Dragon, AC; Garcia, JV; Guinet, C				Jaud, Thomas; Dragon, Anne-Cecile; Garcia, Jade Vacquie; Guinet, Christophe			Relationship between Chlorophyll a Concentration, Light Attenuation and Diving Depth of the Southern Elephant Seal Mirounga leonina	PLOS ONE			English	Article							OCEANOGRAPHIC CONDITIONS; FORAGING STRATEGIES; KERGUELEN ISLANDS; CASE-1 WATERS; OCEAN; BEHAVIOR; TEMPERATURE; MOVEMENTS; PREDATOR; MODELS	Recently, a number of Antarctic marine environmental studies have used oceanographic parameters collected from instrumented top predators for ecological and physical information. Phytoplankton concentration is generally quantified through active measurement of chlorophyll fluorescence. In this study, light absorption coefficient (K-0.75) was used as an indicator of phytoplankton concentration. This measurement, easy to obtain and requiring low electric power, allows for assessing of the fine scale horizontal structuring of phytoplankton. As part of this study, Southern elephant seals (SES) were simultaneously equipped with a fluorometer and a light logger. Along the SES tracks, variations in K-0.75 were strongly correlated with chlorophyll, a concentration measured by the fluorometer within the euphotic layer. With regards to SES foraging behaviour, bottom depth of the seal's dive was highly dependent on light intensity at 150 m, indicating that the vertical distribution of SES's prey such as myctophids is tightly related to light level. Therefore, change in phytoplankton concentration may not only have a direct effect on SES's prey abundance but may also determine their vertical accessibility with likely consequences on SES foraging efficiency.	[Jaud, Thomas; Dragon, Anne-Cecile; Garcia, Jade Vacquie; Guinet, Christophe] Ctr Biol Chize, Marine Predator Dept, Villiers En Bois, France		Jaud, T (corresponding author), Ctr Biol Chize, Marine Predator Dept, Villiers En Bois, France.	jaud.thomas@gmail.com	Guinet, Christophe/AAR-8457-2020	VACQUIE GARCIA, Jade/0000-0002-3126-3423	Centre National d'Etudes Spatiale; Total Foundation; Agence Nationale de la Recherche though the Program ANR-VMC- IPSOS SEAL	Centre National d'Etudes Spatiale; Total Foundation(Total SA); Agence Nationale de la Recherche though the Program ANR-VMC- IPSOS SEAL(French National Research Agency (ANR))	Funding came from the Centre National d'Etudes Spatiale, the Total Foundation and the Agence Nationale de la Recherche though the Program ANR-VMC- IPSOS SEAL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvain S, 2005, DEEP-SEA RES PT I, V52, P1989, DOI 10.1016/j.dsr.2005.06.015; Bailleul F, 2007, PHILOS T R SOC B, V362, P2169, DOI 10.1098/rstb.2007.2109; Bailleul F, 2007, DEEP-SEA RES PT II, V54, P343, DOI 10.1016/j.dsr2.2006.11.005; Bailleul F, 2010, MAR ECOL PROG SER, V408, P251, DOI 10.3354/meps08560; BATTY RS, 1990, MAR BIOL, V107, P383, DOI 10.1007/BF01313419; Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104; Block BA, 2002, OCEANOL ACTA, V25, P255, DOI 10.1016/S0399-1784(02)01212-4; Boehlert GW, 2001, J ATMOS OCEAN TECH, V18, P1882, DOI 10.1175/1520-0426(2001)018<1882:APESUI>2.0.CO;2; Boehme L, 2009, OCEAN SCI; BOYD IL, 1991, POLAR BIOL, V11, P259, DOI 10.1007/BF00238460; Bradshaw CJA, 2004, ICES J MAR SCI, V61, P1014, DOI 10.1016/j.icesjms.2004.07.012; Bricaud A, 1998, J GEOPHYS RES-OCEANS, V103, P31033, DOI 10.1029/98JC02712; Campagna C, 2006, DEEP-SEA RES PT I, V53, P1907, DOI 10.1016/j.dsr.2006.08.015; Catul V, 2011, REV FISH BIOL FISHER, V21, P339, DOI 10.1007/s11160-010-9176-4; Charrassin JB, 2008, P NATL ACAD SCI USA, V105, P11634, DOI 10.1073/pnas.0800790105; Cherel Y, 2008, MAR ECOL PROG SER, V370, P239, DOI 10.3354/meps07673; Croxall J, 1985, J ANIM ECOL, P1; Dragon AC, 2012, HORIZONTAL AREA REST; Dragon AC, 2012, MAR ECOL PROG SER, V447, P243, DOI 10.3354/meps09498; Dragon AC, 2010, PROG OCEANOGR, V87, P61, DOI 10.1016/j.pocean.2010.09.025; Eckert SA, 2001, ENVIRON BIOL FISH, V60, P299, DOI 10.1023/A:1007674716437; Field I, 2001, ANTARCT SCI, V13, P371, DOI 10.1017/S0954102001000529; GORDON HR, 1989, LIMNOL OCEANOGR, V34, P1389, DOI 10.4319/lo.1989.34.8.1389; Gould W.J., 2006, WEATHER, V61, P17, DOI [10.1256/wea.56.05, DOI 10.1256/WEA.56.05, DOI 10.1007/s00338-008-0361-z]; Hense I, 2000, J MARINE SYST, V27, P235, DOI 10.1016/S0924-7963(00)00070-1; Hooker SK, 2003, DEEP-SEA RES PT I, V50, P927, DOI 10.1016/S0967-0637(03)00055-4; Horning M, 1999, P ROY SOC B-BIOL SCI, V266, P1127, DOI 10.1098/rspb.1999.0753; Hulley PA, 1981, RESULTS RES CRUISES; ICHIYE T, 1967, PURE APPL GEOPHYS, V67, P143, DOI 10.1007/BF00880572; Kahru M, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030430; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Klatt O, 2007, J ATMOS OCEAN TECH, V24, P1301, DOI 10.1175/JTECH2026.1; LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876; Levy M, 2008, LECT NOTES PHYS, V744, P219, DOI 10.1007/978-3-540-75215-8_9; Lewis R, 2006, P ROY SOC B-BIOL SCI, V273, P2901, DOI 10.1098/rspb.2006.3642; Liu SH, 2003, J PLANKTON RES, V25, P1069, DOI 10.1093/plankt/25.9.1069; Loots C, 2007, POLAR BIOL, V30, P951, DOI 10.1007/s00300-007-0253-7; Lydersen C, 2004, J MARINE SYST, V46, P99, DOI 10.1016/j.jmarsys.2003.11.019; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; McConnell BJ, 1996, CAN J ZOOL, V74, P1485, DOI 10.1139/z96-163; NELSON DM, 1991, LIMNOL OCEANOGR, V36, P1650, DOI 10.4319/lo.1991.36.8.1650; Rasmus KE, 2004, DEEP-SEA RES PT II, V51, P2583, DOI 10.1016/j.dsr2.2001.01.004; Roquet F, 2011, J ATMOSPHERIC OCEANI; Roquet F, 2009, J MARINE SYST, V78, P377, DOI 10.1016/j.jmarsys.2008.11.017; Sims DW, 2003, MAR ECOL PROG SER, V248, P187, DOI 10.3354/meps248187; [Team RDC Computing RFfS], 2009, COMP RFFS; Teo SLH, 2009, AQUAT BIOL, V5, P195, DOI 10.3354/ab00152; Weimerskirch H, 1999, BIOL CONSERV, V87, P273, DOI 10.1016/S0006-3207(98)00039-1; Xing X, 2011, LIMNOLOGY OCEA UNPUB	49	36	37	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47444	10.1371/journal.pone.0047444	http://dx.doi.org/10.1371/journal.pone.0047444			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082166	Green Submitted, Green Published, gold			2022-12-25	WOS:000311146900062
J	Leung, JY; Nevins, JR				Leung, Janet Y.; Nevins, Joseph R.			E2F6 Associates with BRG1 in Transcriptional Regulation	PLOS ONE			English	Article							CELL-CYCLE; FAMILY-MEMBER; IN-VIVO; GROWTH SUPPRESSION; SWI/SNF COMPLEX; GENE; REPRESSION; ACTIVATION; EXPRESSION; ROLES	The E2F6 protein functions as an Rb-independent repressor of gene transcription. We have previously provided evidence suggesting a role for E2F6 in repression of E2F-responsive genes at S phase. Here, we have identified BRG1, the ATPase subunit of the SWI/SNF chromatin-remodeling complex, as an E2F6 interacting protein. Immunoprecipitation experiments demonstrate that BRG1 binds specifically to E2F6 and E2F4 but not the activator E2Fs. E2F6 was also able to interact with BAF155, a BRG1-associated factor, in the SWI/SNF complex. Chromatin immunoprecipitation assays demonstrate the binding of BRG1 coincident with E2F6 on G1/S gene promoters during S phase. Collectively, our studies suggest that E2F6 may recruit BRG1 in transcriptional regulation of genes important for G1/S phase transition of the cell cycle.	[Leung, Janet Y.; Nevins, Joseph R.] Duke Univ, Med Ctr, Duke Inst Genome Sci & Policy, Durham, NC 27708 USA; [Nevins, Joseph R.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC USA	Duke University; Duke University	Nevins, JR (corresponding author), Duke Univ, Med Ctr, Duke Inst Genome Sci & Policy, Durham, NC 27708 USA.	j.nevins@duke.edu			National Cancer Institute [RO1-CA104663, U54-CA112952]; NATIONAL CANCER INSTITUTE [R01CA106520, U54CA112952, R01CA104663] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants to JRN (RO1-CA104663 and U54-CA112952) from the National Cancer Institute. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attwooll C, 2004, EMBO J, V23, P4709, DOI 10.1038/sj.emboj.7600481; BEIJERSBERGEN RL, 1994, GENE DEV, V8, P2680, DOI 10.1101/gad.8.22.2680; CARLSON M, 1981, GENETICS, V98, P41; CARLSON M, 1981, GENETICS, V98, P25; Cartwright P, 1998, ONCOGENE, V17, P611, DOI 10.1038/sj.onc.1201975; Chi YQ, 2003, J BIOL CHEM, V278, P49806, DOI 10.1074/jbc.M309645200; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Gaubatz S, 1998, P NATL ACAD SCI USA, V95, P9190, DOI 10.1073/pnas.95.16.9190; Giangrande PH, 2003, MOL CELL BIOL, V23, P3707, DOI 10.1128/MCB.23.11.3707-3720.2003; Giangrande PH, 2004, GENE DEV, V18, P2941, DOI 10.1101/gad.1239304; GINSBERG D, 1994, GENE DEV, V8, P2665, DOI 10.1101/gad.8.22.2665; Hallstrom TC, 2003, P NATL ACAD SCI USA, V100, P10848, DOI 10.1073/pnas.1831408100; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Ikeda M, 1996, P NATL ACAD SCI USA, V93, P3215, DOI 10.1073/pnas.93.8.3215; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; KHAVARI PA, 1993, NATURE, V366, P170, DOI 10.1038/366170a0; Leung JY, 2008, ONCOGENE, V27, P4172, DOI 10.1038/onc.2008.55; Li J, 2008, DEV CELL, V14, P62, DOI 10.1016/j.devcel.2007.10.017; Logan N, 2005, ONCOGENE, V24, P5000, DOI 10.1038/sj.onc.1208703; Lukas J, 1996, MOL CELL BIOL, V16, P1047; Maiti B, 2005, J BIOL CHEM, V280, P18211, DOI 10.1074/jbc.M501410200; Moon NS, 2005, DEV CELL, V9, P463, DOI 10.1016/j.devcel.2005.08.015; Morkel M, 1997, NATURE, V390, P567, DOI 10.1038/37507; Nagl NG, 2007, EMBO J, V26, P752, DOI 10.1038/sj.emboj.7601541; NEIGEBORN L, 1984, GENETICS, V108, P845; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; RANDAZZO FM, 1994, DEV BIOL, V161, P229, DOI 10.1006/dbio.1994.1023; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; Reisman D, 2009, ONCOGENE, V28, P1653, DOI 10.1038/onc.2009.4; SARDET C, 1995, P NATL ACAD SCI USA, V92, P2403, DOI 10.1073/pnas.92.6.2403; Storre J, 2002, EMBO REP, V3, P695, DOI 10.1093/embo-reports/kvf141; Takahashi Y, 2000, GENE DEV, V14, P804; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Trimarchi JM, 1998, P NATL ACAD SCI USA, V95, P2850, DOI 10.1073/pnas.95.6.2850; Trimarchi JM, 2001, P NATL ACAD SCI USA, V98, P1519, DOI 10.1073/pnas.041597698; van Oevelen C, 2008, MOL CELL, V32, P359, DOI 10.1016/j.molcel.2008.10.015; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Verona R, 1997, MOL CELL BIOL, V17, P7268, DOI 10.1128/MCB.17.12.7268; Wang S, 2002, EMBO J, V21, P3019, DOI 10.1093/emboj/cdf302; Wang S, 2004, EMBO J, V23, P2293, DOI 10.1038/sj.emboj.7600231; Wang WD, 1996, EMBO J, V15, P5370, DOI 10.1002/j.1460-2075.1996.tb00921.x; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117; Xia W, 2008, CANCER RES, V68, P1667, DOI 10.1158/0008-5472.CAN-07-5276; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	45	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47967	10.1371/journal.pone.0047967	http://dx.doi.org/10.1371/journal.pone.0047967			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082233	gold, Green Submitted, Green Published			2022-12-25	WOS:000311146900130
J	Niu, HX; Chen, X; Gruppo, RA; Li, D; Wang, YH; Zhang, L; Wang, KM; Chai, WR; Sun, YP; Ding, ZR; Gartner, TK; Liu, JL				Niu, Haixia; Chen, Xue; Gruppo, Ralph A.; Li, Ding; Wang, Yanhua; Zhang, Lin; Wang, Kemin; Chai, Weiran; Sun, Yueping; Ding, Zhongren; Gartner, T. Kent; Liu, Junling			Integrin alpha IIb-Mediated PI3K/Akt Activation in Platelets	PLOS ONE			English	Article							IN SIGNAL-TRANSDUCTION; IMMOBILIZED FIBRINOGEN; CYTOPLASMIC DOMAIN; BINDING PROTEIN; CALCIUM-BINDING; THROMBOXANE A2; ALPHA(IIB)BETA(3); AGGREGATION; ADHESION; ALPHA-IIB-BETA-3	Integrin alpha II beta b3 mediated bidirectional signaling plays a critical role in thrombosis and haemostasis. Signaling mediated by the beta 3 subunit has been extensively studied, but alpha IIb mediated signaling has not been characterized. Previously, we reported that platelet granule secretion and TxA2 production induced by aIIb mediated outside-in signaling is negatively regulated by the b3 cytoplasmic domain residues R(724)KEFAKFEEER(734). In this study, we identified part of the signaling pathway utilized by aIIb mediated outside-in signaling. Platelets from humans and gene deficient mice, and genetically modified CHO cells as well as a variety of kinase inhibitors were used for this work. We found that aggregation of TxA2 production and granule secretion by beta 3 Delta 724 human platelets initiated by aIIb mediated outside-in signaling was inhibited by the Src family kinase inhibitor PP2 and the PI3K inhibitor wortmannin, respectively, but not by the MAPK inhibitor U0126. Also, PP2 and wortmannin, and the palmitoylated b3 peptide R(724)KEFAKFEEER(734), each inhibited the phosphorylation of Akt residue Ser473 and prevented TxA2 production and storage granule secretion. Similarly, Akt phosphorylation in mouse platelets stimulated by the PAR4 agonist peptide AYPGKF was alpha IIb beta 3-dependent, and blocked by PP2, wortmannin and the palmitoylated peptide p-RKEFAKFEEER. Akt was also phosphorylated in response to mAb D3 plus Fg treatment of CHO cells in suspension expressing alpha IIb beta 3-Delta 724 or alpha IIb beta 3E(724)AERKFERKFE(734), but not in cells expressing wild type alpha II beta b3. In summary, SFK(s) and PI3K/Akt signaling is utilized by alpha IIb-mediated outside-in signaling to activate platelets even in the absence of all but 8 membrane proximal residues of the beta 3 cytoplasmic domain. Our results provide new insight into the signaling pathway used by alpha IIb-mediated outside-in signaling in platelets.	[Niu, Haixia; Chen, Xue; Li, Ding; Wang, Yanhua; Zhang, Lin; Wang, Kemin; Chai, Weiran; Sun, Yueping; Liu, Junling] Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Tumor Microenvironm & Inflammat, Dept Biochem & Mol Cell Biol, Shanghai 200030, Peoples R China; [Gruppo, Ralph A.] Cincinnati Childrens Hosp, Hematol Oncol Dept, Cincinnati, OH USA; [Ding, Zhongren] Fudan Univ, Shanghai Med Coll, Minist Educ, Key Lab Mol Med, Shanghai 200433, Peoples R China; [Ding, Zhongren] Fudan Univ, Shanghai Med Coll, Dept Biochem & Mol Biol, Shanghai 200433, Peoples R China; [Gartner, T. Kent] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA	Shanghai Jiao Tong University; Cincinnati Children's Hospital Medical Center; Fudan University; Fudan University; University of Memphis	Liu, JL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Key Lab Tumor Microenvironm & Inflammat, Dept Biochem & Mol Cell Biol, Shanghai 200030, Peoples R China.	liujl@shsmu.edu.cn			National Natural Science Foundation of China [81170479]; National Basic Research Program of China (973 Program) [2012CB518001]; Shanghai Committee of Science and Technology [11DZ2260200]; National Institutes of Health [HL63216]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063216] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Shanghai Committee of Science and Technology(Shanghai Science & Technology Committee); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by Program of National Natural Science Foundation of China (81170479 to J.L.), National Basic Research Program of China (973 Program) Grants 2012CB518001 (to J.L.), Shanghai Committee of Science and Technology (11DZ2260200) and the National Institutes of Health grant HL63216 (to T.K.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cho MJ, 2003, J THROMB HAEMOST, V1, P363, DOI 10.1046/j.1538-7836.2003.00055.x; Cho MJ, 2003, BLOOD, V101, P2646, DOI 10.1182/blood-2002-05-1363; COLLER BS, 1980, BLOOD, V55, P169; COLLER BS, 1985, J CLIN INVEST, V76, P101, DOI 10.1172/JCI111931; Derrick JM, 1997, BIOCHEM J, V325, P309, DOI 10.1042/bj3250309; Derrick JM, 2001, THROMB HAEMOSTASIS, V86, P894, DOI 10.1055/s-0037-1616147; Deshmukh L, 2011, J BIOL CHEM, V286, P40943, DOI 10.1074/jbc.M111.231951; Flevaris P, 2007, J CELL BIOL, V179, P553, DOI 10.1083/jcb.200703185; Flevaris P, 2009, BLOOD, V113, P893, DOI 10.1182/blood-2008-05-155978; GARTNER TK, 1993, THROMB RES, V71, P47; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kahn ML, 1998, NATURE, V394, P690, DOI 10.1038/29325; Kahner BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034056; KIEFFER N, 1991, J CELL BIOL, V113, P451, DOI 10.1083/jcb.113.2.451; KOUNS WC, 1990, J BIOL CHEM, V265, P20594; LEFKOVITS J, 1995, NEW ENGL J MED, V332, P1553, DOI 10.1056/NEJM199506083322306; Li RH, 2003, SCIENCE, V300, P795, DOI 10.1126/science.1079441; Li ZY, 2010, ARTERIOSCL THROM VAS, V30, P2341, DOI 10.1161/ATVBAHA.110.207522; Liu J, 2008, J THROMB HAEMOST, V6, P1915, DOI 10.1111/j.1538-7836.2008.03135.x; Liu J, 2004, J THROMB HAEMOST, V2, P2213, DOI 10.1111/j.1538-7836.2004.01023.x; Liu JL, 2005, BLOOD, V105, P4345, DOI 10.1182/blood-2004-07-2718; Liu JL, 2005, BLOOD, V106, P2750, DOI 10.1182/blood-2005-04-1667; Lu CF, 2001, J BIOL CHEM, V276, P14642, DOI 10.1074/jbc.M100600200; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; Ma YQ, 2008, J CELL BIOL, V181, P439, DOI 10.1083/jcb.200710196; Naik MU, 2003, BLOOD, V102, P3629, DOI 10.1182/blood-2003-05-1703; Naik UP, 2003, BLOOD, V102, P1355, DOI 10.1182/blood-2003-02-0591; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Qin J, 2004, PLOS BIOL, V2, P726, DOI 10.1371/journal.pbio.0020169; Rantala JK, 2011, NAT CELL BIOL, V13, P1315, DOI 10.1038/ncb2340; Resendiz JC, 2007, J THROMB HAEMOST, V5, P2484, DOI 10.1111/j.1538-7836.2007.02769.x; Shattil SJ, 2009, J THROMB HAEMOST, V7, P210, DOI 10.1111/j.1538-7836.2009.03397.x; Shattil SJ, 2005, TRENDS CELL BIOL, V15, P399, DOI 10.1016/j.tcb.2005.06.005; Thomas DW, 1998, J CLIN INVEST, V102, P1994, DOI 10.1172/JCI5116; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Wang RG, 1997, J CLIN INVEST, V100, P2393, DOI 10.1172/JCI119780; Weng Z, 2010, BLOOD, V116, P2579, DOI 10.1182/blood-2010-03-277236; Xiang B, 2010, J THROMB HAEMOST, V8, P2032, DOI 10.1111/j.1538-7836.2010.03969.x; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642	43	24	27	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47356	10.1371/journal.pone.0047356	http://dx.doi.org/10.1371/journal.pone.0047356			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082158	Green Published, Green Submitted, gold			2022-12-25	WOS:000311146900054
J	Vallee, B; Doudeau, M; Godin, F; Gombault, A; Tchalikian, A; de Tauzia, ML; Benedetti, H				Vallee, Beatrice; Doudeau, Michel; Godin, Fabienne; Gombault, Aurelie; Tchalikian, Aurelie; de Tauzia, Marie-Ludivine; Benedetti, Helene			Nf1 RasGAP Inhibition of LIMK2 Mediates a New Cross-Talk between Ras and Rho Pathways	PLOS ONE			English	Article							NEUROFIBROMATOSIS TYPE-1 GENE; GTPASE-ACTIVATING PROTEIN; SACCHAROMYCES-CEREVISIAE; ADENYLYL-CYCLASE; DROSOPHILA NF1; GAP; KINASES; BINDING; CELLS; PHOSPHORYLATION	Background: Ras GTPases mediate numerous biological processes through their ability to cycle between an inactive GDP-bound form and an active GTP-bound form. Guanine nucleotide exchange factors (GEFs) favor the formation of the active Ras-GTP, whereas GTPase activating proteins (GAPs) promote the formation of inactive Ras-GDP. Numerous studies have established complex signaling cross-talks between Ras GTPases and other members of the superfamily of small GTPases. GEFs were thought to play a major role in these cross-talks. However, recently GAPs were also shown to play crucial roles in these processes. Among RasGAPs, Nf1 is of special interest. Nf1 is responsible for the genetic disease Neurofibromatosis type I, and recent data strongly suggest that this RasGAP connects different signaling pathways. Methodology/Principal Findings: In order to know if the RasGAP Nf1 might play a role in connecting Ras GTPases to other small GTPase pathways, we systematically looked for new partners of Nf1, by performing a yeast two-hybrid screening on its SecPH domain. LIMK2, a major kinase of the Rho/ROCK/LIMK2/cofilin pathway, was identified in this screening. We confirmed this interaction by co-immunoprecipitation experiments, and further characterized it. We also demonstrated its specificity: the close related homolog of LIMK2, LIMK1, does not interact with the SecPH domain of Nf1. We then showed that SecPH partially inhibits the kinase activity of LIMK2 on cofilin. Our results furthermore suggest a precise mechanism for this inhibition: in fact, SecPH would specifically prevent LIMK2 activation by ROCK, its upstream regulator. Conclusions/Significance: Although previous data had already connected Nf1 to actin cytoskeleton dynamics, our study provides for the first time possible detailed molecular requirements of this involvement. Nf1/LIMK2 interaction and inhibition allows to directly connect neurofibromatosis type I to actin cytoskeleton remodeling, and provides evidence that the RasGAP Nf1 mediates a new cross-talk between Ras and Rho signaling pathways within the superfamily of small GTPases.	[Benedetti, Helene] Univ Orleans, CNRS, Ctr Biophys Mol, Orleans, France; INSERM, Orleans, France	Centre National de la Recherche Scientifique (CNRS); Universite de Orleans; Institut National de la Sante et de la Recherche Medicale (Inserm)	Benedetti, H (corresponding author), Univ Orleans, CNRS, Ctr Biophys Mol, Orleans, France.	helene.benedetti@cnrs-orleans.fr		Vallee, Beatrice/0000-0002-5161-354X	Ligue Nationale contre le cancer; Conseil regional du Centre; Canceropole Grand-Ouest; Association Neurofibromatoses et Recklinghausen	Ligue Nationale contre le cancer(Ligue nationale contre le cancer); Conseil regional du Centre(Region Centre-Val de Loire); Canceropole Grand-Ouest; Association Neurofibromatoses et Recklinghausen	Funding: Ligue Nationale contre le cancer, Conseil regional du Centre, Canceropole Grand-Ouest, and the Association Neurofibromatoses et Recklinghausen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008704; BALLESTER R, 1990, CELL, V63, P851, DOI 10.1016/0092-8674(90)90151-4; Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Bollag G, 1996, NAT GENET, V12, P144, DOI 10.1038/ng0296-144; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Boyanapalli M, 2006, BIOCHEM BIOPH RES CO, V340, P1200, DOI 10.1016/j.bbrc.2005.12.129; Bradley WD, 2006, MOL BIOL CELL, V17, P4827, DOI 10.1091/mbc.E06-02-0132; Brown JA, 2012, MOL CELL NEUROSCI, V49, P13, DOI 10.1016/j.mcn.2011.08.008; CAWTHON RM, 1990, CELL, V62, P193, DOI 10.1016/0092-8674(90)90253-B; Chautard H, 2004, EUKARYOT CELL, V3, P459, DOI 10.1128/EC.3.2.459-470.2004; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Corral T, 2003, J CELL PHYSIOL, V197, P214, DOI 10.1002/jcp.10349; D'Angelo I, 2006, EMBO REP, V7, P174, DOI 10.1038/sj.embor.7400602; Dang I, 2011, NEUROCHEM RES, V36, P1697, DOI 10.1007/s11064-011-0433-2; Dasgupta B, 2003, J NEUROSCI, V23, P8949; FREIDMAN JM, 1999, NEUROFIBROMATOSIS PH; GAUDIN JC, 1995, GENE, V163, P249, DOI 10.1016/0378-1119(95)00388-M; GREGORY PE, 1993, SOMAT CELL MOLEC GEN, V19, P265, DOI 10.1007/BF01233074; Guo HF, 1997, SCIENCE, V276, P795, DOI 10.1126/science.276.5313.795; Guthrie C, 1991, GUIDE YEAST GENETICS; Gutmann DH, 1996, ONCOGENE, V12, P2121; Gutmann DH, 2001, HUM MOL GENET, V10, P747, DOI 10.1093/hmg/10.7.747; Harashima T, 2006, MOL CELL, V22, P819, DOI 10.1016/j.molcel.2006.05.011; Hegedus B, 2007, CELL STEM CELL, V1, P443, DOI 10.1016/j.stem.2007.07.008; Huang Y, 2004, ONCOGENE, V23, P368, DOI 10.1038/sj.onc.1207075; Innocenti M, 2002, J CELL BIOL, V156, P125, DOI 10.1083/jcb.200108035; Ishizaki T, 1997, FEBS LETT, V404, P118, DOI 10.1016/S0014-5793(97)00107-5; Kweh F, 2009, MOL CARCINOGEN, V48, P1005, DOI 10.1002/mc.20552; Lin YL, 2007, J CELL BIOL, V177, P829, DOI 10.1083/jcb.200608121; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; Mangoura D, 2006, ONCOGENE, V25, P735, DOI 10.1038/sj.onc.1209113; Maniatis T., 1989, MOL CLONING LAB MANU; MARTIN GA, 1990, CELL, V63, P843, DOI 10.1016/0092-8674(90)90150-D; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; MORAN MF, 1991, MOL CELL BIOL, V11, P1804, DOI 10.1128/MCB.11.4.1804; Ozawa T, 2005, J BIOL CHEM, V280, P39524, DOI 10.1074/jbc.M503707200; Pamonsinlapatham P, 2009, BIOCHIMIE, V91, P320, DOI 10.1016/j.biochi.2008.10.010; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Riccardi V. M., 1992, NEUROFIBROMATOSIS PH; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Sandsmark DK, 2007, CANCER RES, V67, P4790, DOI 10.1158/0008-5472.CAN-06-4470; Schmandke A, 2007, NEUROSCIENTIST, V13, P454, DOI 10.1177/1073858407303611; Scita G, 2000, EMBO J, V19, P2393, DOI 10.1093/emboj/19.11.2393; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; SETTLEMAN J, 1992, NATURE, V359, P153, DOI 10.1038/359153a0; Shang X, 2007, J BIOL CHEM, V282, P8801, DOI 10.1074/jbc.M609375200; Starinsky-Elbaz S, 2009, MOL CELL NEUROSCI, V42, P278, DOI 10.1016/j.mcn.2009.07.014; Sumi T, 2001, J BIOL CHEM, V276, P670, DOI 10.1074/jbc.M007074200; Takai Y, 2001, PHYSIOL REV, V81, P153, DOI 10.1152/physrev.2001.81.1.153; The I, 1997, SCIENCE, V276, P791, DOI 10.1126/science.276.5313.791; Tong JY, 2002, NAT NEUROSCI, V5, P95, DOI 10.1038/nn792; Turbyville TJ, 2010, MOL CANCER THER, V9, P1234, DOI 10.1158/1535-7163.MCT-09-0834; Upadhyaya MCDN, 1998, NEUROFIBROMATOSIS TY; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; XU GF, 1990, CELL, V63, P835, DOI 10.1016/0092-8674(90)90149-9; Yan JC, 2008, HUM MOL GENET, V17, P936, DOI 10.1093/hmg/ddm366; Yang XY, 2009, ONCOGENE, V28, P1401, DOI 10.1038/onc.2008.498	58	23	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47283	10.1371/journal.pone.0047283	http://dx.doi.org/10.1371/journal.pone.0047283			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082153	gold, Green Published, Green Submitted			2022-12-25	WOS:000311146900049
J	Lauria, V; Attrill, MJ; Pinnegar, JK; Brown, A; Edwards, M; Votier, SC				Lauria, Valentina; Attrill, Martin J.; Pinnegar, John K.; Brown, Andrew; Edwards, Martin; Votier, Stephen C.			Influence of Climate Change and Trophic Coupling across Four Trophic Levels in the Celtic Sea	PLOS ONE			English	Article							HERRING CLUPEA-HARENGUS; NORTH-ATLANTIC OSCILLATION; PLANKTON RECORDER DATA; LONG-TERM CHANGES; BALTIC SEA; C-HELGOLANDICUS; FISH COMMUNITY; SEABIRDS; FLUCTUATIONS; ECOSYSTEMS	Climate change has had profound effects upon marine ecosystems, impacting across all trophic levels from plankton to apex predators. Determining the impacts of climate change on marine ecosystems requires understanding the direct effects on all trophic levels as well as indirect effects mediated by trophic coupling. The aim of this study was to investigate the effects of climate change on the pelagic food web in the Celtic Sea, a productive shelf region in the Northeast Atlantic. Using long-term data, we examined possible direct and indirect 'bottom-up' climate effects across four trophic levels: phytoplankton, zooplankton, mid-trophic level fish and seabirds. During the period 1986-2007, although there was no temporal trend in the North Atlantic Oscillation index (NAO), the decadal mean Sea Surface Temperature (SST) in the Celtic Sea increased by 0.66 +/- 0.02 degrees C. Despite this, there was only a weak signal of climate change in the Celtic Sea food web. Changes in plankton community structure were found, however this was not related to SST or NAO. A negative relationship occurred between herring abundance (0- and 1-group) and spring SST ( 0- group: p = 0.02, slope = -0.30560.125; 1-group: p = 0.04, slope = -0.410 +/- 0.193). Seabird demographics showed complex species-specific responses. There was evidence of direct effects of spring NAO ( on black-legged kittiwake population growth rate: p = 0.03, slope = 0.0314 +/- 0.014) as well as indirect bottom- up effects of lagged spring SST (on razorbill breeding success: p = 0.01, slope = -0.144 +/- 0.05). Negative relationships between breeding success and population growth rate of razorbills and common guillemots may be explained by interactions between mid-trophic level fish. Our findings show that the impacts of climate change on the Celtic Sea ecosystem is not as marked as in nearby regions (e.g. the North Sea), emphasizing the need for more research at regional scales.	[Lauria, Valentina; Votier, Stephen C.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England; [Attrill, Martin J.] Univ Plymouth, Inst Marine, Plymouth PL4 8AA, Devon, England; [Pinnegar, John K.] CEFAS, Lowestoft, Suffolk, England; [Brown, Andrew] Natural England, Peterborough, Cambs, England; [Edwards, Martin] Sir Alister Hardy Fdn Ocean Sci, Plymouth, Devon, England	University of Plymouth; University of Plymouth; Centre for Environment Fisheries & Aquaculture Science	Lauria, V (corresponding author), Natl Univ Ireland, Dept Earth & Ocean Sci, Martin Ryan Inst, Galway, Ireland.	valentina.lauria@nuigalway.ie	Lauria, Valentina/R-9053-2018; Votier, Stephen C/G-2348-2014; Lauria, Valentina/AAG-4906-2021; Pinnegar, John K/C-4400-2012	Lauria, Valentina/0000-0002-4179-9133; Votier, Stephen C/0000-0002-0976-0167; Pinnegar, John/0000-0001-5061-9520; Attrill, Martin/0000-0002-4039-031X	Plymouth University; Natural England; Natural Environment Research Council [SAH01001] Funding Source: researchfish; NERC [SAH01001] Funding Source: UKRI	Plymouth University; Natural England; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was co-financed by Plymouth University and Natural England (PhD studentship). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1993, IBIS, V135, P225, DOI 10.1111/j.1474-919X.1993.tb02838.x; AEBISCHER NJ, 1990, NATURE, V347, P753, DOI 10.1038/347753a0; Ainley DG, 2003, ECOLOGY, V84, P709, DOI 10.1890/0012-9658(2003)084[0709:PRCAGS]2.0.CO;2; Alheit J, 1997, FISH OCEANOGR, V6, P130, DOI 10.1046/j.1365-2419.1997.00035.x; Arrhenius F, 1996, ICES J MAR SCI, V53, P701, DOI 10.1006/jmsc.1996.0089; Attrill MJ, 2002, NATURE, V417, P275, DOI 10.1038/417275a; Beaugrand G, 2000, MAR ECOL PROG SER, V200, P93, DOI 10.3354/meps200093; Beaugrand G, 2002, SCIENCE, V296, P1692, DOI 10.1126/science.1071329; Beaugrand G, 2008, ECOL LETT, V11, P1157, DOI 10.1111/j.1461-0248.2008.01218.x; Beaugrand G, 2009, GLOBAL CHANGE BIOL, V15, P1790, DOI 10.1111/j.1365-2486.2009.01848.x; Benvenuti S, 2001, IBIS, V143, P402, DOI 10.1111/j.1474-919X.2001.tb04941.x; Blaxter JHS, 1982, BIOL CLUPEOID FISHES, P1; Burnham KP, 2002, THEORETIC APPROACH; Cardinale M, 2004, 2004K2001 ICES CM; Carscadden JE, 2002, ICES J MAR SCI, V59, P1027, DOI 10.1006/jmsc.2002.1235; Clarke ED, 2003, J APPL ECOL, V40, P278, DOI 10.1046/j.1365-2664.2003.00802.x; Corten A, 1999, ICES J MAR SCI, V56, P207, DOI 10.1006/jmsc.1998.0429; Cury P, 2000, ICES J MAR SCI, V57, P603, DOI 10.1006/jmsc.2000.0712; DAAN N, 1985, T AM FISH SOC, V114, P499, DOI 10.1577/1548-8659(1985)114<499:PBNSHC>2.0.CO;2; Diamond AW, 2003, ENVIRON MONIT ASSESS, V88, P153, DOI 10.1023/A:1025560805788; Dickey-Collas M, 2007, RESOLVING CLIMATE IM, P18; Durant JM, 2005, ECOL LETT, V8, P952, DOI 10.1111/j.1461-0248.2005.00798.x; Durant JM, 2003, P ROY SOC B-BIOL SCI, V270, P1461, DOI 10.1098/rspb.2003.2397; Edwards M, 2001, ICES J MAR SCI, V58, P39, DOI 10.1006/jmsc.2000.0987; Ellis J. R., 2002, MARINE BIODIVERSITY, P45; Fauchald P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022729; Frederiksen M, 2008, J ANIM ECOL, V77, P1020, DOI 10.1111/j.1365-2656.2008.01422.x; Frederiksen M, 2007, MAR ECOL PROG SER, V350, P137, DOI 10.3354/meps07126; Frederiksen M, 2006, J ANIM ECOL, V75, P1259, DOI 10.1111/j.1365-2656.2006.01148.x; Fromentin JM, 1996, MAR ECOL PROG SER, V134, P111, DOI 10.3354/meps134111; FURNESS R, 2004, SCOTTISH BIRD NEWS, V74, P18; Graham CT, 2009, J FISH BIOL, V74, P1143, DOI 10.1111/j.1095-8649.2009.02180.x; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; Hatch SA, 2000, CONDOR, V102, P145, DOI 10.1650/0010-5422(2000)102[0145:SMAPHU]2.0.CO;2; Henderson PA, 2007, J MAR BIOL ASSOC UK, V87, P589, DOI 10.1017/S0025315407052447; Hinder SL, 2012, NAT CLIM CHANGE, V2, P271, DOI [10.1038/nclimate1388, 10.1038/NCLIMATE1388]; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hunt GL, 2002, DEEP-SEA RES PT II, V49, P5821, DOI 10.1016/S0967-0645(02)00321-1; *ICES, 2007, REP WORK GROUP REG E; [ICES ICES], 2008, ADVICE BOOK, V5, P12; KONARZEWSKI M, 1989, ORNIS SCAND, V20, P112, DOI 10.2307/3676877; Lynam CP, 2011, GLOBAL CHANGE BIOL, V17, P767, DOI 10.1111/j.1365-2486.2010.02352.x; McGinty N, 2011, J EXP MAR BIOL ECOL, V400, P120, DOI 10.1016/j.jembe.2011.02.013; Mitchell PI, 2004, SEABIRD POPULATIONS; OSPAR, 2000, QUAL STAT REP 2000 R, P149; OSPAR, 2002, QUAL STAT REP 2000 R; Osterblom H, 2006, MAR ECOL PROG SER, V323, P233, DOI 10.3354/meps323233; Ottersen G, 2001, OECOLOGIA, V128, P1, DOI 10.1007/s004420100655; Ottersen G, 2004, RESPONSE FISH POPULA, P231; Parent B, 2011, THESIS; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Pinnegar JK, 2002, J APPL ECOL, V39, P377, DOI 10.1046/j.1365-2664.2002.00723.x; Pitois SG, 2006, ICES J MAR SCI, V63, P785, DOI 10.1016/j.icesjms.2006.03.009; Planque B, 1996, MAR ECOL PROG SER, V134, P101, DOI 10.3354/meps134101; Reid PC, 1998, NATURE, V391, P546, DOI 10.1038/35290; Richardson AJ, 2004, SCIENCE, V305, P1609, DOI 10.1126/science.1100958; Richardson AJ, 2006, PROG OCEANOGR, V68, P27, DOI 10.1016/j.pocean.2005.09.011; Rijnsdorp AD, 2009, ICES J MAR SCI, V66, P1570, DOI 10.1093/icesjms/fsp056; Riou S, 2011, MAR ECOL PROG SER, V422, P105, DOI 10.3354/meps08968; Royama T, 1996, ANAL POPULATIONS DYN; Russell F. S., 1976, EGGS PLANKTONIC STAG; Team RDC, 2010, R LANG ENV STAT COMP; Toresen R, 2001, LOWELL WAKEFIELD FIS, P315; Toresen R, 2000, FISH FISH, V1, P231, DOI 10.1111/j.1467-2979.2000.00022.x; Voss R, 2009, OCEANOLOGIA, V51, P117, DOI 10.5697/oc.51-1.117; Votier SC, 2008, J ANIM ECOL, V77, P974, DOI 10.1111/j.1365-2656.2008.01421.x; Votier SC, 2005, ECOL LETT, V8, P1157, DOI 10.1111/j.1461-0248.2005.00818.x; Votier SC, 2009, MAR ECOL PROG SER, V393, P225, DOI 10.3354/meps08258; Wanless S, 2007, PROG OCEANOGR, V72, P30, DOI 10.1016/j.pocean.2006.07.007; [No title captured]	70	25	27	0	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47408	10.1371/journal.pone.0047408	http://dx.doi.org/10.1371/journal.pone.0047408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091621	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000310135800044
J	Higgs, MR; Lerat, H; Pawlotsky, JM				Higgs, M. R.; Lerat, H.; Pawlotsky, J-M			Hepatitis C virus-induced activation of beta-catenin promotes c-Myc expression and a cascade of pro-carcinogenetic events	ONCOGENE			English	Article						hepatitis C virus; hepatocellular carcinoma; c-Myc; oxidative stress; DNA damage; NS5A protein	HEPATOCELLULAR-CARCINOMA; DNA-DAMAGE; MITOCHONDRIAL BIOGENESIS; ROS PRODUCTION; TARGET GENES; PROTEIN; MICE; IDENTIFICATION; NS5A; P53	Chronic infection by hepatitis C virus (HCV) is a major risk factor for the onset and development of hepatocellular carcinoma (HCC), although the underlying mechanisms are unclear. The c-Myc oncogene contributes to the genesis of many types of cancers, including HCC, partly via the induction of genetic damage and the inhibition of the cellular response to genotoxic stress. Here, we show a previously undiscovered mechanistic link between HCV infection and enhanced c-Myc expression. c-Myc expression was augmented in non-tumoral liver tissues from HCV-infected individuals with or without HCC and in hepatocyte cell lines harboring an HCV replicon and the infectious HCV strain JFH1. Increased c-Myc expression was confirmed in vivo in a transgenic murine model expressing the entire HCV open reading frame, demonstrating a direct role for HCV protein expression in c-Myc induction. Mechanistically, activation of Akt by the HCV non-structural protein NS5A, and the subsequent stabilization of the transcription factor beta-catenin, was demonstrated to be responsible for activation of the c-Myc promoter, and for increased c-Myc transcription. beta-Catenin-dependent c-Myc expression in this context led to increased production of reactive oxygen species, mitochondrial perturbation, enhanced DNA damage and aberrant cell-cycle arrest. Together, these data provide a novel insight into the mechanisms involved in HCV-associated HCCs, strongly suggesting that c-Myc has a crucial contributory role in this process.	[Higgs, M. R.; Lerat, H.; Pawlotsky, J-M] Inst Mondor Rech Biomed, INSERM, U955, Creteil, France; [Pawlotsky, J-M] Univ Paris Est, Hop Henri Mondor, Dept Virol, Natl Reference Ctr Viral Hepatitis B C & Delta, Creteil, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Pawlotsky, JM (corresponding author), Hop Henri Mondor, Dept Virol, 51 Ave Marechal de Lattre de Tassigny, F-94010 Creteil, France.	jean-michel.pawlotsky@hmn.aphp.fr	Pawlotsky, Jean-Michel/R-8159-2018; Higgs, Martin/AAK-2108-2021; LERAT, Hervé/D-4331-2019	Higgs, Martin/0000-0002-8218-0089; LERAT, Hervé/0000-0002-8505-378X; Pawlotsky, Jean-Michel/0000-0003-0745-7559	Agence Nationale de Recherche sur le SIDA et les Hepatites Virales (ANRS); ANRS	Agence Nationale de Recherche sur le SIDA et les Hepatites Virales (ANRS)(ANRSFrench National Research Agency (ANR)); ANRS(ANRSFrench National Research Agency (ANR))	This work was supported by a research grant from the Agence Nationale de Recherche sur le SIDA et les Hepatites Virales (ANRS). MH was supported by a postdoctoral fellowship from the ANRS. We thank Aurore Gaudin and Olivier Gouin for technical assistance; Christine Perret and Thomas Decaens for manuscript comments; Czeslaw Wychowski, Bert Vogelstein and Xi He for JFH-1-infected cultures, pDEL1 and DKK1, respectively; Mark Harris for the NS5A antibody; Paulette Bioulac-Sage for patient biopsies; and Ralf Bartenschlager for the HCV genotype 1b subgenomic replicon, established in our laboratory by Abdelhakim Ahmed-Belkacem.	AbouElella A, 1996, MODERN PATHOL, V9, P95; Boyault S, 2007, HEPATOLOGY, V45, P42, DOI 10.1002/hep.21467; Cadoret A, 2001, CANCER RES, V61, P3245; Dang CV, 2005, CELL CYCLE, V4, P1465, DOI 10.4161/cc.4.11.2121; Disson O, 2004, GASTROENTEROLOGY, V126, P859, DOI 10.1053/j.gastro.2003.12.005; El-Serag HB, 2002, HEPATOLOGY, V36, pS74, DOI 10.1053/jhep.2002.36807; Farinati F, 2007, J VIRAL HEPATITIS, V14, P821, DOI 10.1111/1365-2893.2007.00878.x; GAN FY, 1993, J HISTOCHEM CYTOCHEM, V41, P1185, DOI 10.1177/41.8.7687263; Garcia-Mediavilla MV, 2005, J HEPATOL, V43, P606, DOI 10.1016/j.jhep.2005.04.019; Graves JA, 2009, J BIOL CHEM, V284, P6520, DOI 10.1074/jbc.M807564200; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; He YP, 2002, J VIROL, V76, P9207, DOI 10.1128/JVI.76.18.9207-9217.2002; Herold S, 2002, MOL CELL, V10, P509, DOI 10.1016/S1097-2765(02)00633-0; Higgs MR, 2010, CANCER RES, V70, P4901, DOI 10.1158/0008-5472.CAN-09-4554; Hsieh A, 2011, CANCER LETT, V300, P162, DOI 10.1016/j.canlet.2010.09.018; Karlsson A, 2003, P NATL ACAD SCI USA, V100, P9974, DOI 10.1073/pnas.1732638100; Kato J, 2001, CANCER RES, V61, P8697; Kawate S, 1999, ONCOLOGY-BASEL, V57, P157, DOI 10.1159/000012024; Keasler VV, 2006, VIROLOGY, V347, P466, DOI 10.1016/j.virol.2005.11.050; Kim J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001798; Korenaga M, 2005, J BIOL CHEM, V280, P37481, DOI 10.1074/jbc.M506412200; Laurent-Puig P, 2001, GASTROENTEROLOGY, V120, P1763, DOI 10.1053/gast.2001.24798; Legoix P, 1999, ONCOGENE, V18, P4044, DOI 10.1038/sj.onc.1202800; Lerat H, 2002, GASTROENTEROLOGY, V122, P352, DOI 10.1053/gast.2002.31001; Lerat H, 2011, EXPERT REV GASTROENT, V5, P341, DOI [10.1586/egh.11.14, 10.1586/EGH.11.14]; Li F, 2005, MOL CELL BIOL, V25, P6225, DOI 10.1128/MCB.25.14.6225-6234.2005; Li YC, 2007, FASEB J, V21, P2474, DOI 10.1096/fj.06-7345com; Machida K, 2006, J VIROL, V80, P7199, DOI 10.1128/JVI.00321-06; McGivern DR, 2011, ONCOGENE, V30, P1969, DOI 10.1038/onc.2010.594; McGivern DR, 2009, ANNU REV PATHOL-MECH, V4, P399, DOI 10.1146/annurev.pathol.4.110807.092202; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; Menssen A, 2007, CELL CYCLE, V6, P339, DOI 10.4161/cc.6.3.3808; Meuleman P, 2008, ANTIVIR RES, V80, P231, DOI 10.1016/j.antiviral.2008.07.006; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Milward A, 2010, J GEN VIROL, V91, P373, DOI 10.1099/vir.0.015305-0; Mitchell C, 2009, AM J PATHOL, V175, P1929, DOI 10.2353/ajpath.2009.090332; Neiman PE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000132; Nishina S, 2008, GASTROENTEROLOGY, V134, P226, DOI 10.1053/j.gastro.2007.10.011; Nordenstedt H, 2010, DIGEST LIVER DIS, V42, pS206, DOI 10.1016/S1590-8658(10)60507-5; Park CY, 2009, J HEPATOL, V51, P853, DOI 10.1016/j.jhep.2009.06.026; Prochownik EV, 2007, CELL CYCLE, V6, P1024, DOI 10.4161/cc.6.9.4161; RAY RB, 1995, VIRUS RES, V37, P209, DOI 10.1016/0168-1702(95)00034-N; Ray S, 2006, CANCER RES, V66, P6598, DOI 10.1158/0008-5472.CAN-05-3115; Rebouissou S, 2008, J HEPATOL, V48, P163, DOI [10.1016/j.jhep.2007.10.003, 10.1016/j.jhep.2008.02.001]; SAEGUSA M, 1993, J CANCER RES CLIN, V119, P737, DOI 10.1007/BF01195346; Sagun KC, 2006, MUTAT RES-FUND MOL M, V593, P64, DOI 10.1016/j.mrfmmm.2005.06.015; SAITO I, 1990, P NATL ACAD SCI USA, V87, P6547, DOI 10.1073/pnas.87.17.6547; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; Si YH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019967; SIMONETTI RG, 1992, ANN INTERN MED, V116, P97, DOI 10.7326/0003-4819-116-2-97; Simonin Y, 2009, HEPATOLOGY, V50, P1370, DOI 10.1002/hep.23169; Stewart B.W., 2003, WORLD CANC REPORT; Street A, 2005, J VIROL, V79, P5006, DOI 10.1128/JVI.79.8.5006-5016.2005; Street A, 2004, J BIOL CHEM, V279, P12232, DOI 10.1074/jbc.M312245200; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Wierstra I, 2008, ADV CANCER RES, V99, P113, DOI 10.1016/S0065-230X(07)99004-1; Yochum GS, 2007, P NATL ACAD SCI USA, V104, P3324, DOI 10.1073/pnas.0611576104; Yu L, 2009, J ONCOL, V2009, DOI 10.1155/2009/780874; Zhang Y, 2012, HEPATOLOGY IN PRESS	61	60	62	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 26	2013	32	39					4683	4693		10.1038/onc.2012.484	http://dx.doi.org/10.1038/onc.2012.484			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	226YD	23108410				2022-12-25	WOS:000325072200010
J	Bhanumathy, C; da Fonseca, PCA; Morris, EP; Joseph, SK				Bhanumathy, Cunnigaiper; da Fonseca, Paula C. A.; Morris, Edward P.; Joseph, Suresh K.			Identification of Functionally Critical Residues in the Channel Domain of Inositol Trisphosphate Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1,4,5-TRISPHOSPHATE RECEPTOR; LIGAND-BINDING; RYANODINE RECEPTOR; CA2+ RELEASE; S4-S5 LINKER; TRANSMEMBRANE SEQUENCE; CONFORMATIONAL-CHANGES; CRYSTAL-STRUCTURE; VOLTAGE SENSOR; K+ CHANNEL	We have combined alanine mutagenesis and functional assays to identify amino acid residues in the channel domain that are critical for inositol 1,4,5-trisphosphate receptor (IP3R) channel function. The residues selected were highly conserved in all three IP3R isoforms and were located in the cytosolic end of the S6 pore-lining helix and proximal portion of the C-tail. Two adjacent hydrophobic amino acids (Ile-2588 and Ile-2589) at the putative cytosolic interface of the S6 helix inactivated channel function and could be candidates for the channel gate. Of five negatively charged residues mutated, none completely eliminated channel function. Of five positively charged residues mutated, only one inactivated the channel (Arg-2596). In addition to the previously identified role of a pair of cysteines in the C-tail (Cys-2610 and Cys-2613), a pair of highly conserved histidines (His-2630 and His-2635) were also essential for channel function. Expression of the H2630A and H2635A mutants (but not R2596A) produced receptors with destabilized interactions between the N-terminal fragment and the channel domain. A previously unrecognized association between the cytosolic C-tail and the TM 4,5-loop was demonstrated using GST pull-down assays. However, none of the mutations in the C-tail interfered with this interaction or altered the ability of the C-tail to assemble into dimers. Our present findings and recent information on IP3R structure from electron microscopy and crystallography are incorporated into a revised model of channel gating.	[Bhanumathy, Cunnigaiper; Joseph, Suresh K.] Thomas Jefferson Univ, Dept Pathol & Cell Biol, Philadelphia, PA 19107 USA; [da Fonseca, Paula C. A.; Morris, Edward P.] Inst Canc Res, Chester Beatty Labs, London SW3 6JB, England	Jefferson University; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Joseph, SK (corresponding author), Thomas Jefferson Univ, Dept Pathol & Cell Biol, Rm 230A JAH,1020 Locust St, Philadelphia, PA 19107 USA.	suresh.joseph@jefferson.edu		da Fonseca, Paula/0000-0001-8656-5747; Morris, Edward/0000-0003-3544-0041	National Institutes of Health [DK34804]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034804] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK34804.	Anyatonwu G, 2010, J BIOL CHEM, V285, P25085, DOI 10.1074/jbc.M110.123208; Anyatonwu G, 2009, J BIOL CHEM, V284, P8093, DOI 10.1074/jbc.M806932200; Berridge MJ, 2009, BBA-MOL CELL RES, V1793, P933, DOI 10.1016/j.bbamcr.2008.10.005; Boehning D, 2000, J BIOL CHEM, V275, P21492, DOI 10.1074/jbc.M001724200; Boehning D, 2000, EMBO J, V19, P5450, DOI 10.1093/emboj/19.20.5450; Bosanac I, 2005, MOL CELL, V17, P193, DOI 10.1016/j.molcel.2004.11.047; Bosanac I, 2002, NATURE, V420, P696, DOI 10.1038/nature01268; Buguliskis JS, 2007, MOL BIOCHEM PARASIT, V155, P128, DOI 10.1016/j.molbiopara.2007.06.011; Chan J, 2010, J BIOL CHEM, V285, P36092, DOI 10.1074/jbc.M110.140160; Chatelain FC, 2005, NEURON, V47, P833, DOI 10.1016/j.neuron.2005.08.022; Csordas G, 2001, CELL CALCIUM, V29, P249, DOI 10.1054/ceca.2000.0191; da Fonseca PCA, 2003, P NATL ACAD SCI USA, V100, P3936, DOI 10.1073/pnas.0536251100; Decher N, 2004, J BIOL CHEM, V279, P13859, DOI 10.1074/jbc.M313704200; Du GG, 2001, J BIOL CHEM, V276, P31760, DOI 10.1074/jbc.M102751200; Ferrer T, 2006, J BIOL CHEM, V281, P12858, DOI 10.1074/jbc.M513518200; Foskett JK, 2007, PHYSIOL REV, V87, P593, DOI 10.1152/physrev.00035.2006; Galvan DL, 2002, J BIOL CHEM, V277, P48248, DOI 10.1074/jbc.M209990200; Gillespie D, 2005, J PHYS CHEM B, V109, P15598, DOI 10.1021/jp052471j; Hurne AM, 2005, J BIOL CHEM, V280, P36994, DOI 10.1074/jbc.M506441200; Jin TH, 2002, MOL CELL, V10, P469, DOI 10.1016/S1097-2765(02)00659-7; JOSEPH SK, 1995, BIOCHEM J, V307, P859, DOI 10.1042/bj3070859; Khan MT, 2010, J BIOL CHEM, V285, P16912, DOI 10.1074/jbc.M110.114207; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Labro AJ, 2011, J BIOL CHEM, V286, P717, DOI 10.1074/jbc.M110.146977; Labro AJ, 2008, J GEN PHYSIOL, V132, P667, DOI 10.1085/jgp.200810048; Lee EH, 2007, EXP MOL MED, V39, P594, DOI 10.1038/emm.2007.65; Lin CC, 2011, NAT STRUCT MOL BIOL, V18, P1172, DOI 10.1038/nsmb.2112; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Ludtke SJ, 2011, STRUCTURE, V19, P1192, DOI 10.1016/j.str.2011.05.003; MIGNERY GA, 1990, EMBO J, V9, P3893, DOI 10.1002/j.1460-2075.1990.tb07609.x; Ramachandran S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000367; Rojas A, 2007, BBA-BIOMEMBRANES, V1768, P39, DOI 10.1016/j.bbamem.2006.06.027; Rossi AM, 2009, NAT CHEM BIOL, V5, P631, DOI 10.1038/nchembio.195; Sackin H, 2005, BIOPHYS J, V88, P2597, DOI 10.1529/biophysj.104.051474; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Sanderson Michael J, 2008, Proc Am Thorac Soc, V5, P23, DOI 10.1513/pats.200704-050VS; Sato C, 2004, J MOL BIOL, V336, P155, DOI 10.1016/j.jmb.2003.11.024; Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI [10.1074/jbc.M706645200, 10.1074/jbc.M802716200]; Schug ZT, 2006, J BIOL CHEM, V281, P24431, DOI 10.1074/jbc.M604190200; Serysheva II, 2003, J BIOL CHEM, V278, P21319, DOI 10.1074/jbc.C300148200; Steinmann C, 2008, J BIOL CHEM, V283, P13506, DOI 10.1074/jbc.C800029200; Stepanovic SZ, 2009, J PHYSIOL-LONDON, V587, P2555, DOI 10.1113/jphysiol.2008.166694; Stewart R, 2003, BIOCHEM J, V376, P795, DOI 10.1042/BJ20030597; Sugawara H, 1997, EMBO J, V16, P3078, DOI 10.1093/emboj/16.11.3078; Szado T, 2008, P NATL ACAD SCI USA, V105, P2427, DOI 10.1073/pnas.0711324105; Taylor CW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004010; Taylor CW, 2009, IMMUNOL REV, V231, P23, DOI 10.1111/j.1600-065X.2009.00807.x; Uchida K, 2003, J BIOL CHEM, V278, P16551, DOI 10.1074/jbc.M300646200; Wall-Lacelle S, 2011, J BIOL CHEM, V286, P27197, DOI 10.1074/jbc.M111.237412; Wang RW, 2004, J BIOL CHEM, V279, P3635, DOI 10.1074/jbc.M311367200; Wang RW, 2003, J BIOL CHEM, V278, P51557, DOI 10.1074/jbc.M306788200; Xu L, 2006, BIOPHYS J, V90, P443, DOI 10.1529/biophysj.105.072538; Yamazaki H, 2010, J BIOL CHEM, V285, P36081, DOI 10.1074/jbc.M110.140129; Yoshikawa F, 1999, J BIOL CHEM, V274, P316, DOI 10.1074/jbc.274.1.316	54	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43674	43684		10.1074/jbc.M112.415786	http://dx.doi.org/10.1074/jbc.M112.415786			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23086950	Green Published, hybrid			2022-12-25	WOS:000312940800047
J	Bachmann, M; Scheiermann, P; Hardle, L; Pfeilschifter, J; Muhl, H				Bachmann, Malte; Scheiermann, Patrick; Haerdle, Lorena; Pfeilschifter, Josef; Muehl, Heiko			IL-36 gamma/IL-1F9, an Innate T-bet Target in Myeloid Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; DENDRITIC CELLS; IFN-GAMMA; TRANSCRIPTION FACTOR; INTERFERON-GAMMA; FAMILY-MEMBERS; IN-VITRO; EXPRESSION; PSORIASIS; IL-36	By concerted action in dendritic (DC) and T cells, T-box expressed in T cells (T-bet, Tbx21) is pivotal for initiation and perpetuation of Th1 immunity. Identification of novel T-bet-regulated genes is crucial for further understanding the biology of this transcription factor. By combining siRNA technology with genome-wide mRNA expression analysis, we sought to identify new T-bet-regulated genes in predendritic KG1 cells activated by IL-18. One gene robustly dependent on T-bet was IL-36 gamma, a recently described novel IL-1 family member. Promoter analysis revealed a T-bet binding site that, along with a kappa B site, enables efficient IL-36 gamma induction. Using knock-out animals, IL-36 gamma reliance on T-bet was extended to murine DC. IL-36 gamma expression by human myeloid cells was confirmed using monocyte-derived DC and M1 macrophages. The latter model was employed to substantiate dependence of IL-36 gamma on endogenous T-bet in human primary cells. Ectopic expression of T-bet likewise mediated IL-36 gamma production in HaCaT keratinocytes that otherwise lack this transcription factor. Additional experiments furthermore revealed that mature IL-36 gamma has the capability to establish an inflammatory gene expression profile in human primary keratinocytes that displays enhanced mRNA levels for TNF alpha, CCL20, S100A7, inducible NOS, and IL-36 gamma itself. Data presented herein shed further light on involvement of T-bet in innate immunity and suggest that IL-36 gamma, besides IFN gamma, may contribute to functions of this transcription factor in immunopathology.	[Bachmann, Malte; Scheiermann, Patrick; Haerdle, Lorena; Pfeilschifter, Josef; Muehl, Heiko] Goethe Univ Frankfurt, Pharmazentrum Frankfurt ZAFES, Univ Hosp, D-60590 Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital	Muhl, H (corresponding author), Goethe Univ Frankfurt, Pharmazentrum Frankfurt ZAFES, Univ Hosp, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	H.Muehl@em.uni-frankfurt.de		Muhl, Heiko/0000-0002-0429-0127	August Scheidel-Stiftung, Frankfurt, Germany	August Scheidel-Stiftung, Frankfurt, Germany	This work was supported by the August Scheidel-Stiftung, Frankfurt, Germany (to M. B.).	Bachmann M, 2007, MOL CANCER THER, V6, P723, DOI 10.1158/1535-7163.MCT-06-0505; Bachmann M, 2009, J CELL MOL MED, V13, P1987, DOI 10.1111/j.1582-4934.2008.00604.x; Beima KM, 2006, J BIOL CHEM, V281, P11992, DOI 10.1074/jbc.M513613200; Benoit M, 2008, J IMMUNOL, V181, P3733, DOI 10.4049/jimmunol.181.6.3733; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Blumberg H, 2007, J EXP MED, V204, P2603, DOI 10.1084/jem.20070157; Carreira S, 1998, MOL CELL BIOL, V18, P5099, DOI 10.1128/MCB.18.9.5099; Carrier Y, 2011, J INVEST DERMATOL, V131, P2428, DOI 10.1038/jid.2011.234; Cho JY, 2003, INT IMMUNOL, V15, P1149, DOI 10.1093/intimm/dxg113; Debets R, 2001, J IMMUNOL, V167, P1440, DOI 10.4049/jimmunol.167.3.1440; Dinarello CA, 1998, J LEUKOCYTE BIOL, V63, P658, DOI 10.1002/jlb.63.6.658; Dinarello CA, 1996, BLOOD, V87, P2095, DOI 10.1182/blood.V87.6.2095.bloodjournal8762095; Dinarello C, 2010, NAT IMMUNOL, V11, P973, DOI 10.1038/ni1110-973; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Edwards AD, 2003, EUR J IMMUNOL, V33, P827, DOI 10.1002/eji.200323797; Iwamoto S, 2007, J IMMUNOL, V179, P1449, DOI 10.4049/jimmunol.179.3.1449; Jenner RG, 2009, P NATL ACAD SCI USA, V106, P17876, DOI 10.1073/pnas.0909357106; Johnston A, 2011, J IMMUNOL, V186, P2613, DOI 10.4049/jimmunol.1003162; KISPERT A, 1993, EMBO J, V12, P4898, DOI 10.1002/j.1460-2075.1993.tb06179.x; Krakowski M, 1996, EUR J IMMUNOL, V26, P1641, DOI 10.1002/eji.1830260735; Kriegova E, 2011, EUR RESPIR J, V38, P1136, DOI 10.1183/09031936.00089910; Kumar S, 2000, J BIOL CHEM, V275, P10308, DOI 10.1074/jbc.275.14.10308; Lazarevic V, 2011, NAT IMMUNOL, V12, P597, DOI 10.1038/ni.2059; Lazarevic V, 2011, NAT IMMUNOL, V12, P96, DOI 10.1038/ni.1969; Lewis DA, 2006, J INVEST DERMATOL, V126, P1885, DOI 10.1038/sj.jid.5700333; Lexberg MH, 2010, EUR J IMMUNOL, V40, P3017, DOI 10.1002/eji.201040539; Lian LH, 2012, J INVEST DERMATOL, V132, P1346, DOI 10.1038/jid.2011.482; Lighvani AA, 2001, P NATL ACAD SCI USA, V98, P15137, DOI 10.1073/pnas.261570598; Lind H, 2007, CYTOKINE, V38, P43, DOI 10.1016/j.cyto.2007.05.001; Lipscomb MW, 2009, J IMMUNOL, V183, P7250, DOI 10.4049/jimmunol.0901477; Lugo-Villarino G, 2005, P NATL ACAD SCI USA, V102, P13248, DOI 10.1073/pnas.0506638102; Lugo-Villarino G, 2003, P NATL ACAD SCI USA, V100, P7749, DOI 10.1073/pnas.1332767100; Magne D, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1946; ManourySchwartz B, 1997, J IMMUNOL, V158, P5501; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Matsuda JL, 2007, J IMMUNOL, V178, P3457, DOI 10.4049/jimmunol.178.6.3457; Muhl H, 2011, CELL MICROBIOL, V13, P340, DOI 10.1111/j.1462-5822.2010.01559.x; Muhl H, 2004, EUR J PHARMACOL, V500, P63, DOI 10.1016/j.ejphar.2004.07.012; Muhl H, 2003, INT IMMUNOPHARMACOL, V3, P1247, DOI 10.1016/S1567-5769(03)00131-0; Muhr P, 2011, BRIT J DERMATOL, V165, P189, DOI 10.1111/j.1365-2133.2011.10302.x; Mutamba S, 2012, EUR J IMMUNOL, V42, P607, DOI 10.1002/eji.201142035; Paulukat J, 2001, J IMMUNOL, V167, P7038, DOI 10.4049/jimmunol.167.12.7038; Powell N, 2010, MUCOSAL IMMUNOL, V3, P567, DOI 10.1038/mi.2010.53; Ravindran R, 2005, J IMMUNOL, V175, P4603, DOI 10.4049/jimmunol.175.7.4603; Rice KL, 2009, HEMATOL REP, V1, P70, DOI 10.4081/hr.2009.e13; Rutitzky LI, 2009, EUR J IMMUNOL, V39, P2470, DOI 10.1002/eji.200939325; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; St Louis DC, 1999, J IMMUNOL, V162, P3237; Stewart JJ, 2006, J BIOL CHEM, V281, P22665, DOI 10.1074/jbc.M603237200; Sullivan BM, 2005, J IMMUNOL, V175, P4593, DOI 10.4049/jimmunol.175.7.4593; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tada M, 2001, DEV GROWTH DIFFER, V43, P1; Taylor SL, 2002, GENOMICS, V79, P726, DOI 10.1006/geno.2002.6752; Tortola L, 2012, J CLIN INVEST, V122, P3965, DOI 10.1172/JCI63451; Towne JE, 2012, CURR OPIN PHARMACOL, V12, P486, DOI 10.1016/j.coph.2012.02.009; Towne JE, 2004, J BIOL CHEM, V279, P13677, DOI 10.1074/jbc.M400117200; Towne JE, 2011, J BIOL CHEM, V286, P42594, DOI 10.1074/jbc.M111.267922; van de Veerdonk FL, 2012, P NATL ACAD SCI USA, V109, P3001, DOI 10.1073/pnas.1121534109; Vigne S, 2012, BLOOD, V120, P3478, DOI 10.1182/blood-2012-06-439026; Vigne S, 2011, BLOOD, V118, P5813, DOI 10.1182/blood-2011-05-356873; Wang JS, 2006, J CLIN INVEST, V116, P414, DOI 10.1172/JCI26631; Wehner R, 2011, J INNATE IMMUN, V3, P258, DOI 10.1159/000323923	65	51	53	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41684	41696		10.1074/jbc.M112.385443	http://dx.doi.org/10.1074/jbc.M112.385443			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23095752	Green Published, hybrid			2022-12-25	WOS:000312103000011
J	Zhang, YL; Liang, Z; Hsueh, HT; Ploplis, VA; Castellino, FJ				Zhang, Yueling; Liang, Zhong; Hsueh, Hsing-Tse; Ploplis, Victoria A.; Castellino, Francis J.			Characterization of Streptokinases from Group A Streptococci Reveals a Strong Functional Relationship That Supports the Coinheritance of Plasminogen-binding M Protein and Cluster 2b Streptokinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO CAPROIC ACID; ACTIVE-SITE; VIRULENCE; SURFACE; DOMAIN; CONFORMATION; PATHOGENESIS; INFECTIONS; ACTIVATION; EXPRESSION	Group A streptococcus (GAS) strains secrete the protein streptokinase (SK), which functions by activating host human plasminogen (hPg) to plasmin (hPm), thus providing a proteolytic framework for invasive GAS strains. The types of SK secreted by GAS have been grouped into two clusters (SK1 and SK2) and one subcluster (SK2a and SK2b). SKs from cluster 1 (SK1) and cluster 2b (SK2b) display significant evolutionary and functional differences, and attempts to relate these properties to GAS skin or pharynx tropism and invasiveness are of great interest. In this study, using four purified SKs from each cluster, new relationships between plasminogen-binding group A streptococcal M (PAM) protein and SK2b have been revealed. All SK1 proteins efficiently activated hPg, whereas all subclass SK2b proteins only weakly activated hPg in the absence of PAM. Surface plasmon resonance studies revealed that the lower affinity of SK2b to hPg served as the basis for the attenuated activation of hPg by SK2b. Binding of hPg to either human fibrinogen (hFg) or PAM greatly enhanced activation of hPg by SK2b but minimally influenced the already effective activation of hPg by SK1. Activation of hPg in the presence of GAS cells containing PAM demonstrated that PAM is the only factor on the surface of SK2b-expressing cells that enabled the direct activation of hPg by SK2b. As the binding of hPg to PAM is necessary for hPg activation by SK2b, this dependence explains the coinherant relationship between PAM and SK2b and the ability of these particular strains to generate the proteolytic activity that disrupts the innate barriers that limit invasiveness.	[Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Castellino, FJ (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.	fcastell@nd.edu		Zhang, Yueling/0000-0002-5619-8410	National Institutes of Health [HL013423]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL013423, R37HL013423] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL013423.	Beall B, 1996, J CLIN MICROBIOL, V34, P953, DOI 10.1128/JCM.34.4.953-958.1996; Bisno AL, 2003, LANCET INFECT DIS, V3, P191, DOI 10.1016/S1473-3099(03)00576-0; Boxrud PD, 2000, BIOCHEMISTRY-US, V39, P13974, DOI 10.1021/bi000594i; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Castellino F J, 1976, Methods Enzymol, V45, P244; CHIBBER BAK, 1986, J BIOL CHEM, V261, P5289; CHIBBER BAK, 1986, P NATL ACAD SCI USA, V83, P1237, DOI 10.1073/pnas.83.5.1237; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Cunningham MW, 2008, ADV EXP MED BIOL, V609, P29, DOI 10.1007/978-0-387-73960-1_3; DCosta SS, 1997, RES MICROBIOL, V148, P559, DOI 10.1016/S0923-2508(97)88080-1; Iwaki T, 2008, CYTOTECHNOLOGY, V57, P45, DOI 10.1007/s10616-008-9129-0; Kalia A, 2004, J BACTERIOL, V186, P110, DOI 10.1128/JB.186.1.110-121.2004; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lauth X, 2009, J INNATE IMMUN, V1, P202, DOI 10.1159/000203645; Le Hello S, 2010, J CLIN MICROBIOL, V48, P526, DOI 10.1128/JCM.01205-09; Lin LF, 2000, BIOCHEMISTRY-US, V39, P4740, DOI 10.1021/bi992028x; LOTTENBERG R, 1992, J BACTERIOL, V174, P5204, DOI 10.1128/JB.174.16.5204-5210.1992; Loy JA, 2001, BIOCHEMISTRY-US, V40, P14686, DOI 10.1021/bi011309d; Macheboeuf P, 2011, NATURE, V472, P64, DOI 10.1038/nature09967; McArthur JD, 2008, FASEB J, V22, P3146, DOI 10.1096/fj.08-109348; McKay FC, 2004, INFECT IMMUN, V72, P364, DOI 10.1128/IAI.72.1.364-370.2004; McShan WM, 2008, J BACTERIOL, V190, P7773, DOI 10.1128/JB.00672-08; Mitchell TJ, 2003, NAT REV MICROBIOL, V1, P219, DOI 10.1038/nrmicro771; Musser JM, 2009, J CLIN INVEST, V119, P2455, DOI 10.1172/JCI38095; Nilsen SL, 1999, PROTEIN EXPRES PURIF, V16, P136, DOI 10.1006/prep.1999.1045; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Ringdahl U, 1998, J BIOL CHEM, V273, P6424, DOI 10.1074/jbc.273.11.6424; Rios-Steiner JL, 2001, J MOL BIOL, V308, P705, DOI 10.1006/jmbi.2001.4646; ROBBINS KC, 1967, J BIOL CHEM, V242, P2333; Sanderson-Smith ML, 2008, FASEB J, V22, P2715, DOI 10.1096/fj.07-105643; Sanderson-Smith ML, 2007, J BACTERIOL, V189, P1435, DOI 10.1128/JB.01218-06; Sanderson-Smith ML, 2006, J BIOL CHEM, V281, P25965, DOI 10.1074/jbc.M603846200; SCHICK LA, 1974, BIOCHEM BIOPH RES CO, V57, P47, DOI 10.1016/S0006-291X(74)80355-4; Sjogren J, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-120; Smeesters PR, 2010, TRENDS MICROBIOL, V18, P275, DOI 10.1016/j.tim.2010.02.007; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Svensson MD, 1999, INFECT IMMUN, V67, P3915, DOI 10.1128/IAI.67.8.3915-3920.1999; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VIOLAND BN, 1975, ARCH BIOCHEM BIOPHYS, V170, P300, DOI 10.1016/0003-9861(75)90121-6; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006; Ward PN, 2002, J BACTERIOL, V184, P119, DOI 10.1128/JB.184.1.119-125.2002	41	28	29	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42093	42103		10.1074/jbc.M112.417808	http://dx.doi.org/10.1074/jbc.M112.417808			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086939	hybrid, Green Published			2022-12-25	WOS:000312103000048
J	Massengale, M; Lu, B; Pan, JJ; Katz, JN; Solomon, DH				Massengale, Mei; Lu, Bing; Pan, John J.; Katz, Jeffrey N.; Solomon, Daniel H.			Adipokine Hormones and Hand Osteoarthritis: Radiographic Severity and Pain	PLOS ONE			English	Article							KNEE; PROGRESSION; BIOMARKERS; OBESITY; LEPTIN; HIP	Introduction: Obesity's association with hand osteoarthritis cannot be fully explained by mechanical loading. We examined the relationship between adipokines and radiographic hand osteoarthritis severity and pain. Methods: In a pilot study of 44 hand osteoarthritis patients (39 women and 5 men), serum adipokine concentrations and hand x-ray Kallman-scores were analyzed using linear regression models. Secondary analyses examined correlates of hand pain. Results: The cohort had a mean age of 63.5 years for women and 72.6 for men; mean (standard deviation) Kallman-scores were 43.3(17.4) for women and 46.2(10.8) for men. Mean body-mass-index was 30 kg/m(2) for women and men. Mean leptin concentration was 32.2 ng/ml (women) and 18.5 ng/ml (men); mean adiponectin-total was 7.9 ng/ml (women) and 5.3 ng/ml (men); mean resistin was 7.3 ng/ml (women) and 9.4 ng/ml (men). No association was found between Kallman-scores and adipokine concentrations (R-2 = 0.00-0.04 unadjusted analysis, all p-values>0.22). Secondary analyses showed mean visual-analog-scale pain of 4.8(2.4) for women and 6.6(0.9) for men. Leptin, BMI, and history of coronary artery disease were found to be associated with visual-analog-scale scores for chronic hand pain (R-2 = 0.36 unadjusted analysis, p-values <= 0.04). Conclusion: In this pilot study, we found that adipokine serum concentrations were not associated with hand osteoarthritis radiographic severity; the most important correlates of joint damage were age and disease duration. Leptin serum concentration, BMI, and coronary artery disease were associated with the intensity of chronic hand OA pain.	[Massengale, Mei; Lu, Bing; Katz, Jeffrey N.; Solomon, Daniel H.] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Solomon, Daniel H.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA; [Katz, Jeffrey N.] Brigham & Womens Hosp, Dept Orthoped Surg, Boston, MA 02115 USA; [Katz, Jeffrey N.] Brigham & Womens Hosp, Orthopaed & Arthrit Ctr Outcomes Res, Boston, MA 02115 USA; [Katz, Jeffrey N.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Massengale, Mei; Lu, Bing; Katz, Jeffrey N.; Solomon, Daniel H.] Harvard Univ, Sch Med, Boston, MA USA; [Pan, John J.] Brigham & Womens Hosp, Dept Radiol, Div Musculoskeletal Radiol, Boston, MA 02115 USA; [Massengale, Mei] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital	Massengale, M (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.	hmei@partners.org			Harvard Catalyst; Harvard Clinical and Translational Science Center (National Institutes of Health) [UL1 RR 025758]; Harvard University; NIH [T32 AR 055885, K24 AR 055989, P60 AR 47782]; Harvard Catalyst Institutional Award; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR047782, T32AR055885, K24AR055989] Funding Source: NIH RePORTER	Harvard Catalyst; Harvard Clinical and Translational Science Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Catalyst Institutional Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Authors gratefully acknowledge the support from Harvard Catalyst vertical bar The Harvard Clinical and Translational Science Center (National Institutes of Health Award #UL1 RR 025758 and financial contributions from Harvard University and its affiliated academic health care centers). The content is solely the responsibility of the authors and does not necessarily represent the official views of Harvard Catalyst, Harvard University and its affiliated academic health care centers, the National Center for Research Resources, or the National Institutes of Health (NIH). MM was supported by NIH T32 AR 055885 and Harvard Catalyst Institutional Award. DHS's effort on this project was supported by the NIH (K24 AR 055989). DHS and NKK were supported by NIH P60 AR 47782. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN R, 1990, ARTHRITIS RHEUM, V33, P1601, DOI 10.1002/art.1780331101; Choe JY, 2012, JOINT BONE SPINE, V79, P160, DOI 10.1016/j.jbspin.2011.04.009; Denisov LN, 2010, TERAPEVT ARKH, V82, P34; Dumond H, 2003, ARTHRITIS RHEUM, V48, P3118, DOI 10.1002/art.11303; Gandhi R, 2010, CLIN RHEUMATOL, V29, P1223, DOI 10.1007/s10067-010-1429-z; Gentelle-Bonnassies S, 2000, ARTHRIT CARE RES, V13, P280, DOI 10.1002/1529-0131(200010)13:5<280::AID-ANR6>3.0.CO;2-6; Jonsson H, 2009, ANN RHEUM DIS, V68, P1696, DOI 10.1136/ard.2008.096289; KALLMAN DA, 1989, ARTHRITIS RHEUM, V32, P1584, DOI 10.1002/anr.1780321213; Kaplan RC, 2007, CANCER EPIDEM BIOMAR, V16, P1291, DOI 10.1158/1055-9965.EPI-06-1089; Lee SA, 2007, CANCER EPIDEM BIOMAR, V16, P2464, DOI 10.1158/1055-9965.EPI-07-0374; Maheu E, 2007, ANN RHEUM DIS, V66, P464, DOI 10.1136/ard.2006.060277; Murphy LB, 2010, OSTEOARTHR CARTILAGE, V18, P1372, DOI 10.1016/j.joca.2010.08.005; Oliveria SA, 1999, EPIDEMIOLOGY, V10, P161, DOI 10.1097/00001648-199903000-00013; Spacek E, 2004, OSTEOARTHR CARTILAGE, V12, P366, DOI 10.1016/j.joca.2004.01.005; Szebenyi B, 2006, ARTHRITIS RHEUM-US, V54, P230, DOI 10.1002/art.21534; Tian YH, 2011, PAIN, V152, P1263, DOI 10.1016/j.pain.2011.01.054; Yusuf E, 2011, ANN RHEUM DIS, V70, P1282, DOI 10.1136/ard.2010.146282	17	54	56	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47860	10.1371/journal.pone.0047860	http://dx.doi.org/10.1371/journal.pone.0047860			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110114	Green Published, Green Submitted, gold			2022-12-25	WOS:000310262500022
J	Ramirez, F; Navarro, J; Afan, I; Hobson, KA; Delgado, A; Forero, MG				Ramirez, Francisco; Navarro, Joan; Afan, Isabel; Hobson, Keith A.; Delgado, Antonio; Forero, Manuela G.			Adapting to a Changing World: Unraveling the Role of Man-Made Habitats as Alternative Feeding Areas for Slender-Billed Gull (Chroicocephalus genei)	PLOS ONE			English	Article							REPRODUCTIVE OUTPUT; POPULATION-DYNAMICS; STABLE-ISOTOPES; HERRING GULL; DIET; DONANA; GROWTH; FOOD; MANAGEMENT; DELTA-C-13	Current rates of wildlife habitat loss have placed increasing demands on managers to develop, validate and implement tools aimed at improving our ability to evaluate such impacts on wildlife. Here, we present a case study conducted at the Natural Area of Donana (SW Spain) where remote sensing and stable isotope (delta C-13, delta N-15) analyses of individuals were combined to unravel (1) the effect of variations in availability of natural food resources (i.e. from natural marshes) on reproductive performance of a Slender-billed Gull (Chroicocephalus genei) population, and (2) the role of two adjacent, artificial systems (a fish farm and saltmines) as alternate anthropogenic feeding areas. Based on long-term (1983-2004) remote-sensing, we inferred the average extent of flooded area at the marshland (a proxy to natural resource availability) annually. Estimated flooded areas (ranging from extreme drought [ca. 151 ha, 1995] to high moisture [15,049 ha, 2004]) were positively related to reproductive success of gulls (estimated for the 1993-2004 period, and ranging from ca. 0 to 1.7 fledglings per breeding pairs), suggesting that habitat availability played a role in determining their reproductive performance. Based on blood delta C-13 and delta N-15 values of fledglings, 2001-2004, and a Bayesian isotopic mixing model, we conclude that saltmines acted as the main alternative foraging habitat for gulls, with relative contributions increasing as the extent of marshland decreased. Although adjacent, anthropogenic systems have been established as the preferred breeding sites for this gull population, dietary switches towards exploitation of alternative (anthropogenic) food resources negatively affected the reproductive output of this species, thus challenging the perception that these man-made systems are necessarily a reliable buffer against loss of natural feeding habitats. The methodology and results derived from this study could be extended to a large suite of threatened natural communities worldwide, thus providing a useful framework for management and conservation.	[Ramirez, Francisco; Forero, Manuela G.] Estn Biol Donana, Dept Biol Conservac, Seville, Spain; [Navarro, Joan] Inst Ciencias Mar, E-08039 Barcelona, Spain; [Afan, Isabel] Estn Biol Donana, Lab SIG & Teledetecc, Seville, Spain; [Hobson, Keith A.] Environm Canada, Saskatoon, SK, Canada; [Delgado, Antonio] Inst Andaluz Ciencias Tierra, Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Environment & Climate Change Canada; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto Andaluz de Ciencias de la Tierra (IACT)	Ramirez, F (corresponding author), Estn Biol Donana, Dept Biol Conservac, Seville, Spain.	ramirez@ebd.csic.es	Huertas, Antonio Delgado/F-6866-2011; Hobson, Keith/Q-9306-2019; Afán, Isabel/F-4783-2015; Ramírez, Francisco/I-3553-2014; Navarro, Joan/C-2119-2009	Huertas, Antonio Delgado/0000-0002-7240-1570; Afán, Isabel/0000-0003-3874-0461; Ramírez, Francisco/0000-0001-9670-486X; Navarro, Joan/0000-0002-5756-9543	EcoGenes project [264125]; Juan de la Cierva program (Ministerio de Economia y Competividad); Spanish Ministry [REN2002-0045, CGL2009-09801, CGL2006-02247/BOS]; Obra Social/Fundacion Cajasol; Environment Canada	EcoGenes project; Juan de la Cierva program (Ministerio de Economia y Competividad); Spanish Ministry(Spanish Government); Obra Social/Fundacion Cajasol; Environment Canada(CGIAR)	During writing, FR and JN were supported by postdoctoral contracts from FP7-REGPOT 2010-1 (Grant No. 264125 of EcoGenes project) and the Juan de la Cierva program (Ministerio de Economia y Competividad), respectively. Research funds were provided by a grant from the Spanish Ministry REN2002-0045 (CGL2009-09801 and CGL2006-02247/BOS for historical data on inundation levels) and by funds provided by Obra Social/Fundacion Cajasol. KAH benefitted from funds provided by Environment Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso-Alvarez C, 2002, WATERBIRDS, V25, P253, DOI 10.1675/1524-4695(2002)025[0253:CIPBAB]2.0.CO;2; Bustamante J, 2006, P 1 GLOBWETLAND S OR; Bustamante J, 2009, J ENVIRON MANAGE, V90, P2219, DOI 10.1016/j.jenvman.2007.08.021; Carey C, 2001, CONSERV BIOL, V15, P903, DOI 10.1046/j.1523-1739.2001.015004903.x; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cramp S., 1983, BIRDS W PALEARTIC; DeFries R, 2005, ECOL APPL, V15, P19, DOI 10.1890/03-5258; Diaz-Delgado R, 2010, CONSERVATION MONITORING IN FRESHWATER HABITATS: A PRACTICAL GUIDE AND CASE STUDIES, P325, DOI 10.1007/978-1-4020-9278-7_28; Dies Jose Ignacio, 2000, Ardeola, V47, P255; DOLMAN PM, 1995, IBIS, V137, pS38, DOI 10.1111/j.1474-919X.1995.tb08456.x; FASOLA M, 1989, B ZOOL, V56, P61; Figuerola J, 2003, GLOBAL ECOL BIOGEOGR, V12, P427, DOI 10.1046/j.1466-822X.2003.00043.x; HOBSON KA, 1993, MAR ECOL PROG SER, V95, P7, DOI 10.3354/meps095007; HOBSON KA, 1994, J ANIM ECOL, V63, P786, DOI 10.2307/5256; Hoekstra JM, 2005, ECOL LETT, V8, P23, DOI 10.1111/j.1461-0248.2004.00686.x; Jouventin P., 1991, Oxford Ornithology Series, P297; Kerr LA, 2007, MAR ECOL PROG SER, V349, P245, DOI 10.3354/meps07064; KLAASSEN M, 1990, ARDEA, V78, P67; Kloskowski J, 2009, AQUAT CONSERV, V19, P815, DOI 10.1002/aqc.1027; Longoni V, 2010, WATERBIRDS, V33, P83, DOI 10.1675/063.033.s106; Lotze HK, 2006, SCIENCE, V312, P1806, DOI 10.1126/science.1128035; Masero JA, 2003, BIODIVERS CONSERV, V12, P1157, DOI 10.1023/A:1023021320448; MASSIAS A, 1990, ORNIS SCAND, V21, P187, DOI 10.2307/3676778; Moody AT, 2012, J ORNITHOL, V153, P1067, DOI 10.1007/s10336-012-0836-0; MURPHY EC, 1984, AUK, V101, P532, DOI 10.1093/auk/101.3.532; Navarro J, 2010, MAR BIOL, V157, P2453, DOI 10.1007/s00227-010-1509-2; Nehls G, 1996, ARDEA, V84, P23; Norris DR, 2007, J APPL ECOL, V44, P875, DOI 10.1111/j.1365-2664.2007.01329.x; Oro D, 2006, P ROY SOC B-BIOL SCI, V273, P379, DOI 10.1098/rspb.2005.3287; Oro D, 2002, WATERBIRDS, V25, P67, DOI 10.1675/1524-4695(2002)025[0067:BBAPDO]2.0.CO;2; Osborne PE, 2001, J APPL ECOL, V38, P458, DOI 10.1046/j.1365-2664.2001.00604.x; PARNELL A, 2008, STABLE ISOTOPE ANAL; Pedrocchi V, 1996, ORNIS FENNICA, V73, P124; Phillips RA, 1999, BIRD STUDY, V46, P174, DOI 10.1080/00063659909461129; PIEROTTI R, 1982, ECOLOGY, V63, P854, DOI 10.2307/1936804; PIEROTTI R, 1990, BIOSCIENCE, V40, P568, DOI 10.2307/1311297; Pinaud D, 2005, MAR ECOL PROG SER, V298, P295, DOI 10.3354/meps298295; Pons X, 1990, REMOTE SENS ENVIRON, V48, P191; Ramirez F, 2011, ENVIRON SCI TECHNOL, V45, P5118, DOI 10.1021/es200026w; Ramirez F, 2011, ESTUAR COAST SHELF S, V92, P217, DOI 10.1016/j.ecss.2010.12.035; Ramos R, 2011, DIVERS DISTRIB, V17, P338, DOI 10.1111/j.1472-4642.2010.00736.x; Rendon MA, 2008, BIOL CONSERV, V141, P1371, DOI 10.1016/j.biocon.2008.03.006; RUBEGA M, 1994, BIOL CONSERV, V70, P205, DOI 10.1016/0006-3207(94)90164-3; Rutz C, 2006, P ROY SOC B-BIOL SCI, V273, P2069, DOI 10.1098/rspb.2006.3507; Santoro S, 2010, BIRD STUDY, V57, P515, DOI 10.1080/00063657.2010.501371; Sergio F, 2011, OECOLOGIA, V166, P79, DOI 10.1007/s00442-010-1795-x; Serrano L., 2006, LIMNETICA, V25, P11, DOI DOI 10.1016/S1001-6058(15)60453-X; Smedes F, 1999, ANALYST, V124, P1711, DOI 10.1039/a905904k; Stearns S.C., 1992, pi; Sutherland WJ, 1996, P ROY SOC B-BIOL SCI, V263, P1325, DOI 10.1098/rspb.1996.0194; SYDEMAN WJ, 1991, J ANIM ECOL, V60, P135, DOI 10.2307/5450; TAMHANE AC, 1979, J AM STAT ASSOC, V74, P471, DOI 10.2307/2286358; Turner W, 2003, TRENDS ECOL EVOL, V18, P306, DOI 10.1016/S0169-5347(03)00070-3; Verkuil Y, 2003, ARDEA, V91, P71; VITOUSEK PM, 1994, ECOLOGY, V75, P1861, DOI 10.2307/1941591; WALMSLEY JG, 2000, SALTWORKS PRESERVING, P81; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wanless S, 1996, J APPL ECOL, V33, P1420, DOI 10.2307/2404781	58	23	25	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47551	10.1371/journal.pone.0047551	http://dx.doi.org/10.1371/journal.pone.0047551			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094062	Green Published, gold, Green Submitted			2022-12-25	WOS:000310050200030
J	Hayes, CN; Akamatsu, S; Tsuge, M; Miki, D; Akiyama, R; Abe, H; Ochi, H; Hiraga, N; Imamura, M; Takahashi, S; Aikata, H; Kawaoka, T; Kawakami, Y; Ohishi, W; Chayama, K				Hayes, C. Nelson; Akamatsu, Sakura; Tsuge, Masataka; Miki, Daiki; Akiyama, Rie; Abe, Hiromi; Ochi, Hidenori; Hiraga, Nobuhiko; Imamura, Michio; Takahashi, Shoichi; Aikata, Hiroshi; Kawaoka, Tomokazu; Kawakami, Yoshiiku; Ohishi, Waka; Chayama, Kazuaki			Hepatitis B Virus-Specific miRNAs and Argonaute2 Play a Role in the Viral Life Cycle	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; MICRORNA EXPRESSION; CORE PROTEIN; P-BODIES; RNA; REPLICATION; INFECTION; PHOSPHORYLATION; SUPPRESSION; PROGRESSION	Disease-specific serum miRNA profiles may serve as biomarkers and might reveal potential new avenues for therapy. An HBV-specific serum miRNA profile associated with HBV surface antigen (HBsAg) particles has recently been reported, and AGO2 and miRNAs have been shown to be stably associated with HBsAg in serum. We identified HBV-associated serum miRNAs using the Toray 3D array system in 10 healthy controls and 10 patients with chronic hepatitis B virus (HBV) infection. 19 selected miRNAs were then measured by quantitative RT-PCR in 248 chronic HBV patients and 22 healthy controls. MiRNA expression in serum versus liver tissue was also compared using biopsy samples. To examine the role of AGO2 during the HBV life cycle, we analyzed intracellular co-localization of AGO2 and HBV core (HBcAg) and surface (HBsAg) antigens using immunocytochemistry and proximity ligation assays in stably transfected HepG2 cells. The effect of AGO2 ablation on viral replication was assessed using siRNA. Several miRNAs, including miR-122, miR-22, and miR-99a, were up-regulated at least 1.5 fold (P<2E-08) in serum of HBV-infected patients. AGO2 and HBcAg were found to physically interact and co-localize in the ER and other subcellular compartments. HBs was also found to co-localize with AGO2 and was detected in multiple subcellular compartments. Conversely, HBx localized non-specifically in the nucleus and cytoplasm, and no interaction between AGO2 and HBx was detected. SiRNA ablation of AGO2 suppressed production of HBV DNA and HBs antigen in the supernatant. Conclusion: These results suggest that AGO2 and HBV-specific miRNAs might play a role in the HBV life cycle.	[Hayes, C. Nelson; Akamatsu, Sakura; Miki, Daiki; Akiyama, Rie; Abe, Hiromi; Ochi, Hidenori; Hiraga, Nobuhiko; Imamura, Michio; Takahashi, Shoichi; Aikata, Hiroshi; Kawaoka, Tomokazu; Kawakami, Yoshiiku; Chayama, Kazuaki] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Metab, Hiroshima, Japan; [Hayes, C. Nelson; Akamatsu, Sakura; Miki, Daiki; Akiyama, Rie; Abe, Hiromi; Ochi, Hidenori; Hiraga, Nobuhiko; Imamura, Michio; Takahashi, Shoichi; Kawaoka, Tomokazu; Kawakami, Yoshiiku; Chayama, Kazuaki] RIKEN, Ctr Genom Med, Lab Digest Dis, Hiroshima, Japan; [Hayes, C. Nelson; Akamatsu, Sakura; Tsuge, Masataka; Miki, Daiki; Akiyama, Rie; Ochi, Hidenori; Hiraga, Nobuhiko; Imamura, Michio; Aikata, Hiroshi; Kawaoka, Tomokazu; Kawakami, Yoshiiku; Ohishi, Waka; Chayama, Kazuaki] Hiroshima Univ, Liver Res Project Ctr, Hiroshima, Japan; [Tsuge, Masataka] Hiroshima Univ, Nat Sci Ctr Basic Res & Dev, Hiroshima, Japan; [Ohishi, Waka] Radiat Effects Res Fdn, Dept Clin Studies, Hiroshima, Japan	Hiroshima University; RIKEN; Hiroshima University; Hiroshima University; Radiation Effects Research Foundation - Japan	Chayama, K (corresponding author), Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Gastroenterol & Metab, Hiroshima, Japan.	chayama@hiroshima-u.ac.jp	Hayes, C. Nelson N/G-4596-2019; Tsuge, Masataka/G-5246-2019; Miki, Daiki/L-5069-2018; Abe-Chayama, Hiromi/M-8256-2019; Chayama, Kazuaki/B-2493-2016	Tsuge, Masataka/0000-0001-7591-8287; Miki, Daiki/0000-0002-6505-9826; Chayama, Kazuaki/0000-0002-5530-5341	Ministry of Health, Labor and Welfare; Ministry of Education Culture Sports Science and Technology, Government of Japan; Grants-in-Aid for Scientific Research [24659368, 24791023] Funding Source: KAKEN	Ministry of Health, Labor and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education Culture Sports Science and Technology, Government of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by Grants-in-Aid for scientific research and development from the Ministry of Health, Labor and Welfare and Ministry of Education Culture Sports Science and Technology, Government of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bala S, 2009, WORLD J GASTROENTERO, V15, P5633, DOI 10.3748/wjg.15.5633; Bouttier M, 2012, NUCLEIC ACIDS RES, V40, P775, DOI 10.1093/nar/gkr762; Brechot C, 2010, PATHOL BIOL, V58, P278, DOI 10.1016/j.patbio.2010.05.001; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Chen YN, 2011, FASEB J, V25, P4511, DOI 10.1096/fj.11-187781; Chen Y, 2008, PHARM RES-DORDR, V25, P72, DOI 10.1007/s11095-007-9504-0; Cullen BR, 2011, GENE DEV, V25, P1881, DOI 10.1101/gad.17352611; DESMET VJ, 1994, HEPATOLOGY, V19, P1513, DOI 10.1002/hep.1840190629; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Fields B. N., 2007, FIELDS VIROLOGY; Giner A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000996; HEERMANN KH, 1984, J VIROL, V52, P396, DOI 10.1128/JVI.52.2.396-402.1984; Hu J, 2012, PROTEIN CELL, V3, P364, DOI 10.1007/s13238-012-2036-3; Hu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034165; Ji F, 2011, J VIRAL HEPATITIS, V18, pE242, DOI 10.1111/j.1365-2893.2011.01443.x; Jiang RQ, 2011, CLIN CANCER RES, V17, P5593, DOI 10.1158/1078-0432.CCR-10-1734; Johnston M, 2010, MOL BIOL CELL, V21, P1462, DOI 10.1091/mbc.E09-10-0885; Lan YT, 1999, VIROLOGY, V259, P342, DOI 10.1006/viro.1999.9798; Li D, 2011, J BIOL CHEM, V286, P36677, DOI 10.1074/jbc.M111.270561; Li JH, 2011, J VIROL, V85, P6319, DOI 10.1128/JVI.02627-10; Lian SL, 2009, RNA, V15, P804, DOI 10.1261/rna.1229409; Liu AM, 2011, OMICS, V15, P187, DOI 10.1089/omi.2010.0098; McMahon BJ, 2009, HEPATOLOGY, V49, pS45, DOI 10.1002/hep.22898; Murata M, 2009, HEPATOLOGY, V49, P1203, DOI 10.1002/hep.22765; Narbus CM, 2011, J VIROL, V85, P12087, DOI 10.1128/JVI.05843-11; Novellino L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031952; Pare JM, 2009, MOL BIOL CELL, V20, P3273, DOI 10.1091/mbc.E09-01-0082; Patient R, 2007, J VIROL, V81, P3842, DOI 10.1128/JVI.02741-06; Potenza N, 2011, NUCLEIC ACIDS RES, V39, P5157, DOI 10.1093/nar/gkr067; Qi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028486; Qiu LP, 2010, BIOCHEM BIOPH RES CO, V398, P771, DOI 10.1016/j.bbrc.2010.07.021; Ren M, 2012, ANTIVIRAL RES; Rudel S, 2011, NUCLEIC ACIDS RES, V39, P2330, DOI 10.1093/nar/gkq1032; Shimakami T, 2012, P NATL ACAD SCI USA, V109, P941, DOI 10.1073/pnas.1112263109; Sir D, 2010, AUTOPHAGY, V6, P548, DOI 10.4161/auto.6.4.11669; Sir D, 2010, P NATL ACAD SCI USA, V107, P4383, DOI 10.1073/pnas.0911373107; Tsuge M, 2005, HEPATOLOGY, V42, P1046, DOI 10.1002/hep.20892; Turcatel G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031032; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Waidmann O, 2012, J VIRAL HEPATITIS, V19, pE58, DOI 10.1111/j.1365-2893.2011.01536.x; Wang SF, 2012, HEPATOLOGY, V55, P730, DOI 10.1002/hep.24809; Wang Y, 2006, GASTROENTEROLOGY, V130, P883, DOI 10.1053/j.gastro.2005.12.028; Weibrecht I, 2010, EXPERT REV PROTEOMIC, V7, P401, DOI 10.1586/EPR.10.10; Wilson JA, 2011, J VIROL, V85, P2342, DOI 10.1128/JVI.02046-10; Xi YG, 2007, RNA, V13, P1668, DOI 10.1261/rna.642907; Xu D, 2011, J CELL BIOL, V193, P409, DOI 10.1083/jcb.201010100; Zeng Y, 2008, BIOCHEM J, V413, P429, DOI 10.1042/BJ20080599; Zhang GL, 2010, ANTIVIR RES, V88, P169, DOI 10.1016/j.antiviral.2010.08.008; Zhang XY, 2011, HEPATOLOGY, V53, P1476, DOI 10.1002/hep.24195	50	49	51	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47490	10.1371/journal.pone.0047490	http://dx.doi.org/10.1371/journal.pone.0047490			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091627	Green Published, Green Submitted, gold			2022-12-25	WOS:000310135800050
J	Lind, G; Gallentoft, L; Danielsen, N; Schouenborg, J; Pettersson, LME				Lind, Gustav; Gallentoft, Lina; Danielsen, Nils; Schouenborg, Jens; Pettersson, Lina M. E.			Multiple Implants Do Not Aggravate the Tissue Reaction in Rat Brain	PLOS ONE			English	Article							SILICON MICROELECTRODE ARRAYS; FIBRILLARY ACIDIC PROTEIN; SPINAL-CORD-INJURY; SUBVENTRICULAR ZONE; NEURITE OUTGROWTH; NEURAL IMPLANTS; CEREBRAL-CORTEX; ASTROCYTES; EXPRESSION; CELLS	Chronically implanted microelectrodes are an invaluable tool for neuroscientific research, allowing long term recordings in awake and behaving animals. It is known that all such electrodes will evoke a tissue reaction affected by its' size, shape, surface structure, fixation mode and implantation method. However, the possible correlation between tissue reactions and the number of implanted electrodes is not clear. We implanted multiple wire bundles into the brain of rats and studied the correlation between the astrocytic and microglial reaction and the positioning of the electrode in relation to surrounding electrodes. We found that an electrode implanted in the middle of a row of implants is surrounded by a significantly smaller astrocytic scar than single ones. This possible interaction was only seen between implants within the same hemisphere, no interaction with the contralateral hemisphere was found. More importantly, we found no aggravation of tissue reactions as a result of a larger number of implants. These results highlight the possibility of implanting multiple electrodes without aggravating the glial scar surrounding each implant.	[Lind, Gustav; Gallentoft, Lina; Danielsen, Nils; Schouenborg, Jens; Pettersson, Lina M. E.] Lund Univ, Fac Med, Neuronano Res Ctr, Dept Expt Med Sci, Lund, Sweden	Lund University	Lind, G (corresponding author), Lund Univ, Fac Med, Neuronano Res Ctr, Dept Expt Med Sci, Lund, Sweden.	gustav.lind@med.lu.se		Gallentoft, Lina/0000-0003-2686-6446; Danielsen, Nils/0000-0002-4917-8294; Pettersson, Lina/0000-0002-6847-8823; Schouenborg, Jens/0000-0002-2815-6918	Knut and Alice Wallenberg foundation; Swedish Research Council [600012701]; Medical Faculty, Lund University	Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Faculty, Lund University	This work was funded by the Knut and Alice Wallenberg foundation and by a Linneaus grant #600012701 from the Swedish Research Council and the Medical Faculty, Lund University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso G, 2005, GLIA, V49, P318, DOI 10.1002/glia.20121; Andjelkovic AV, 1999, GLIA, V28, P225, DOI 10.1002/(SICI)1098-1136(199912)28:3<225::AID-GLIA6>3.0.CO;2-6; Awan NR, 2009, NEUROSURG FOCUS, V27, DOI 10.3171/2009.4.FOCUS0982; Bao F, 2004, J NEUROCHEM, V88, P1335, DOI 10.1046/j.1471-4159.2003.02240.x; Biran R, 2005, EXP NEUROL, V195, P115, DOI 10.1016/j.expneurol.2005.04.020; Biran R, 2007, J BIOMED MATER RES A, V82A, P169, DOI 10.1002/jbm.a.31138; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Bush TG, 1999, NEURON, V23, P297, DOI 10.1016/S0896-6273(00)80781-3; CAVANAGH JB, 1970, J ANAT, V106, P471; Chojnacki AK, 2009, NAT REV NEUROSCI, V10, P153, DOI 10.1038/nrn2571; Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0; EDELL DJ, 1992, IEEE T BIO-MED ENG, V39, P635, DOI 10.1109/10.141202; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; He W, 2005, BIOMATERIALS, V26, P2983, DOI 10.1016/j.biomaterials.2004.08.021; He W, 2006, J NEURAL ENG, V3, P316, DOI 10.1088/1741-2560/3/4/009; Johansson F, 2009, ACTA BIOMATER, V5, P2230, DOI 10.1016/j.actbio.2009.02.010; Kim S, 2009, BIOMED MICRODEVICES, V11, P453, DOI 10.1007/s10544-008-9251-y; Kipke DR, 2008, J NEUROSCI, V28, P11830, DOI 10.1523/JNEUROSCI.3879-08.2008; Komitova M, 2011, GLIA, V59, P800, DOI 10.1002/glia.21152; Kozai TDY, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046011; Krack P, 2002, MOVEMENT DISORD, V17, pS188, DOI 10.1002/mds.10163; LATOV N, 1979, DEV BIOL, V72, P381, DOI 10.1016/0012-1606(79)90127-1; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Lind G, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/4/046005; Linsmeier CE, 2008, BIOMATERIALS, V29, P4598, DOI 10.1016/j.biomaterials.2008.08.028; Linsmeier CE, 2009, NANO LETT, V9, P4184, DOI 10.1021/nl902413x; Lu Y, 2009, BIOMATERIALS, V30, P4143, DOI 10.1016/j.biomaterials.2009.04.030; McConnell GC, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/5/055005; MCKEON RJ, 1991, J NEUROSCI, V11, P3398; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Rousche PJ, 1998, J NEUROSCI METH, V82, P1, DOI 10.1016/S0165-0270(98)00031-4; Seymour JP, 2007, BIOMATERIALS, V28, P3594, DOI 10.1016/j.biomaterials.2007.03.024; Skousen JL, 2011, PROG BRAIN RES, V194, P167, DOI 10.1016/B978-0-444-53815-4.00009-1; Stice P, 2007, J NEURAL ENG, V4, P42, DOI 10.1088/1741-2560/4/2/005; Szarowski DH, 2003, BRAIN RES, V983, P23, DOI 10.1016/S0006-8993(03)03023-3; Thelin J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016267; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Williams JC, 1999, BRAIN RES PROTOC, V4, P303, DOI 10.1016/S1385-299X(99)00034-3; Williams JC, 2007, J NEURAL ENG, V4, P410, DOI 10.1088/1741-2560/4/4/007; Winslow BD, 2010, BIOMATERIALS, V31, P9163, DOI 10.1016/j.biomaterials.2010.05.050	42	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47509	10.1371/journal.pone.0047509	http://dx.doi.org/10.1371/journal.pone.0047509			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091629	gold, Green Published, Green Submitted			2022-12-25	WOS:000310135800052
J	Lahoz, A; Hall, A				Lahoz, A.; Hall, A.			A tumor suppressor role for srGAP3 in mammary epithelial cells	ONCOGENE			English	Article						srGAP; Rac; tumor suppressor; breast cancer; anchorage-independent growth	F-BAR DOMAIN; BREAST-CANCER; GENE-EXPRESSION; RHO-GTPASES; NEURONAL MIGRATION; RAC; MEMBRANE; PROTEINS; WAVE-1; KINASE	srGAP3, a member of the Slit-Robo sub-family of Rho GTPase-activating proteins (Rho GAPs), controls actin and microtubule dynamics through negative regulation of Rac. Here, we describe a potential role for srGAP3 as a tumor suppressor in mammary epithelial cells. We show that RNAi-mediated depletion of srGAP3 promotes Rac dependent, anchorage-independent growth of partially transformed human mammary epithelial cells (HMECs). Furthermore, srGAP3 expression is absent, or significantly reduced in 7/10 breast cancer cell lines compared with normal HMECs. Re-expression of srGAP3 in a subset of these cell lines inhibits both anchorage-independent growth and cell invasion in a GAP-dependent manner, and this is accompanied by an increase in phosphorylation of the ezrin/radixin/moesin (ERM) family proteins and myosin light chain 2 (MLC2). Inhibition of the Rho regulated kinase, ROCK, reduces ERM and MLC2 phosphorylation and restores invasion. We conclude that srGAP3 has tumor suppressor-like activity in HMECs, likely through its activity as a negative regulator of Rac1.	[Lahoz, A.; Hall, A.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Hall, A (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Programn, 1275 York Ave, New York, NY 10065 USA.	halla@mskcc.org			Fundacion Caja Madrid, Spain; MSKCC Geoffrey Beene Cancer Research Center Grant	Fundacion Caja Madrid, Spain; MSKCC Geoffrey Beene Cancer Research Center Grant	We thank William C Hahn, Dana-Farber Cancer Institute, for providing the cell line HMEC/hTERT/LT/c-myc and John D Scott, University of Washington, for the gift of pCDNA3.1-WRP-V5His and pCDNA3.1-WRP Delta GAP-V5His plasmids. We also thank Memorial Sloan-Kettering Cancer Center Molecular Cytogenetics Core facility for performing the FISH assays, the Bioinformatic Core facility for the analysis of the microarray data and Overholtzer laboratories for critical reading of the manuscript and helpful discussions. This work was supported by Fundacion Caja Madrid, Spain (AL) and by an MSKCC Geoffrey Beene Cancer Research Center Grant (AH).	Aspenstrom P, 2009, INT REV CEL MOL BIO, V272, P1, DOI 10.1016/S1937-6448(08)01601-8; Carlson BR, 2011, J NEUROSCI, V31, P2447, DOI 10.1523/JNEUROSCI.4433-10.2011; Chen K, 2011, CELL MOL NEUROBIOL, V31, P675, DOI 10.1007/s10571-011-9664-7; Counter CM, 1998, ONCOGENE, V16, P1217, DOI 10.1038/sj.onc.1201882; Ellenbroek SIJ, 2007, CLIN EXP METASTAS, V24, P657, DOI 10.1007/s10585-007-9119-1; Endris V, 2002, P NATL ACAD SCI USA, V99, P11754, DOI 10.1073/pnas.162241099; Endris V, 2011, J CELL SCI, V124, P3941, DOI 10.1242/jcs.077081; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Guo YJ, 2002, J BIOL CHEM, V277, P41571, DOI 10.1074/jbc.M201864200; Han J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000684; IKEBE M, 1985, J BIOL CHEM, V260, P27; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kristensen LS, 2009, EUR J PHARMACOL, V625, P131, DOI 10.1016/j.ejphar.2009.10.011; Lazer G, 2011, CELL SIGNAL, V23, P969, DOI 10.1016/j.cellsig.2010.10.022; Lorentzen A, 2011, J CELL SCI, V124, P1256, DOI 10.1242/jcs.074849; Madura T, 2004, MOL BRAIN RES, V123, P76, DOI 10.1016/j.molbrainres.2004.01.002; Matsui T, 1998, J CELL BIOL, V140, P647, DOI 10.1083/jcb.140.3.647; Radvanyi L, 2005, P NATL ACAD SCI USA, V102, P11005, DOI 10.1073/pnas.0500904102; Sander EE, 1999, J CELL BIOL, V147, P1009, DOI 10.1083/jcb.147.5.1009; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Shuib S, 2009, AM J MED GENET A, V149A, P2099, DOI 10.1002/ajmg.a.32824; Soderling SH, 2007, J NEUROSCI, V27, P355, DOI 10.1523/JNEUROSCI.3209-06.2006; Soderling SH, 2003, P NATL ACAD SCI USA, V100, P1723, DOI 10.1073/pnas.0438033100; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; Tang YA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012417; Vega FM, 2008, FEBS LETT, V582, P2093, DOI 10.1016/j.febslet.2008.04.039; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Wong K, 2001, CELL, V107, P209, DOI 10.1016/S0092-8674(01)00530-X; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Yang CF, 2007, BIOCHEM J, V403, P1, DOI 10.1042/bj20061750; Yang Y, 2006, EXP CELL RES, V312, P2379, DOI 10.1016/j.yexcr.2006.04.001; Zajchowski DA, 2001, CANCER RES, V61, P5168; Zhao HJ, 2004, MOL BIOL CELL, V15, P2523, DOI 10.1091/mbc.E03-11-0786; Zhao JJ, 2003, CANCER CELL, V3, P483, DOI 10.1016/S1535-6108(03)00088-6; Zondag GCM, 2000, J CELL BIOL, V149, P775, DOI 10.1083/jcb.149.4.775	38	24	25	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT 3	2013	32	40					4854	4860		10.1038/onc.2012.489	http://dx.doi.org/10.1038/onc.2012.489			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	229NW	23108406				2022-12-25	WOS:000325274700014
J	Berglund, FM; Weerasinghe, NR; Davidson, L; Lim, JC; Eickholt, BJ; Leslie, NR				Berglund, F. M.; Weerasinghe, N. R.; Davidson, L.; Lim, J. C.; Eickholt, B. J.; Leslie, N. R.			Disruption of epithelial architecture caused by loss of PTEN or by oncogenic mutant p110 alpha/PIK3CA but not by HER2 or mutant AKT1	ONCOGENE			English	Article						phosphoinositides; phosphoinositide 3-kinase; epithelia; breast cancer; AKT; cell polarity	LIPID PHOSPHATASE PTEN; CELL-POLARITY; PIK3CA MUTATIONS; BREAST-CANCER; MAMMARY-GLAND; PROLIFERATION; MORPHOGENESIS; TUMORIGENESIS; PATHWAY; EXPRESSION	Genetic changes in HER2, PTEN, PIK3CA and AKT1 are all common in breast cancer and lead to the elevated phosphorylation of downstream targets of the PI3K/AKT signalling pathway. Changes in HER2, PTEN, PIK3CA and AKT have all been reported to lead to both enhanced proliferation and failures in hollow lumen formation in three dimensional epithelial culture models, but it is not clear whether these failures in lumen formation are caused by any failure in the spatial coordination of lumen formation (hollowing) or purely a failure in the apoptosis and clearance of luminal cells (cavitation). Here, we use normal murine mammary gland (NMuMG) epithelial cells, which form a hollow lumen without significant apoptosis, to compare the transformation by these four genetic changes. We find that either mutant PIK3CA expression or PTEN loss, but not mutant AKT1 E17K, cause disrupted epithelial architecture, whereas HER2 overexpression drives strong proliferation without affecting lumen formation in these cells. We also show that PTEN requires both lipid and protein phosphatase activity, its extreme C-terminal PDZ binding sequence and probably Myosin 5A to control lumen formation through a mechanism that does not correlate with its ability to control AKT, but which is selectively lost through mutation in some tumours. These findings correlate AKT-independent signalling activated by mutant PIK3CA or PTEN loss, but not strongly by HER2, with disrupted epithelial architecture and tumour formation.	[Berglund, F. M.; Weerasinghe, N. R.; Davidson, L.; Lim, J. C.; Leslie, N. R.] Univ Dundee, Coll Life Sci, Div Cell Signalling & Immunol, Dundee DD1 5EH, Scotland; [Eickholt, B. J.] Charite, Cluster Excellence NeuroCure, D-13353 Berlin, Germany; [Eickholt, B. J.] Inst Biochem, Berlin, Germany	University of Dundee; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Leslie, NR (corresponding author), Univ Dundee, Coll Life Sci, Div Cell Signalling & Immunol, Dow St, Dundee DD1 5EH, Scotland.	n.r.leslie@dundee.ac.uk	Eickholt, Britta/C-5337-2009	LESLIE, Nicholas/0000-0001-5131-0541; Eickholt, Britta/0000-0001-7873-8687	Association for International Cancer Research; Wellcome Trust; Medical Research Council; DSTT consortium (Astra Zeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck Serono and Pfizer); Medical Research Council [G9403619, G0801865, G0802289] Funding Source: researchfish; MRC [G0802289, G0801865, G9403619] Funding Source: UKRI	Association for International Cancer Research; Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); DSTT consortium (Astra Zeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck Serono and Pfizer); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Jon Backer (Albert Einstein College of Medicine) and Dario Alessi, David Meek, Francis Fuller-Pace, Virginia Appleyard, Alastair Thompson, Emily Davis, John Rouse, Inke Nathke and Paul Crocker (all University of Dundee) for reagents and Peter Downes (University of Dundee) for helpful discussions. We thank Sam Swift, Paul Appleton, Martin Kierans and John James (University of Dundee, CHIPS microscopy facility) for assistance with light and electron microscopy. FB and JCL have been funded by a project grant from the Association for International Cancer Research and NRW is a Wellcome Trust Prize Student. Work in the Inositol Lipid Signalling laboratory is funded by the Medical Research Council, the Association for International Cancer Research and the pharmaceutical companies of the DSTT consortium (Astra Zeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck Serono and Pfizer). We wish to dedicate this work to the memory of Joseph Lim, a valued colleague and friend.	Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Datta A, 2011, CURR BIOL, V21, pR126, DOI 10.1016/j.cub.2010.12.003; Davidson L, 2010, ONCOGENE, V29, P687, DOI 10.1038/onc.2009.384; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Debnath J, 2003, J CELL BIOL, V163, P315, DOI 10.1083/jcb.200304159; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Dillon RL, 2009, CANCER RES, V69, P5057, DOI 10.1158/0008-5472.CAN-08-4287; Dunlap J, 2010, BREAST CANCER RES TR, V120, P409, DOI 10.1007/s10549-009-0406-1; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; Feng W, 2008, J BIOL CHEM, V283, P23440, DOI 10.1074/jbc.M802482200; Gonzalez-Angulo AM, 2009, CLIN CANCER RES, V15, P2472, DOI 10.1158/1078-0432.CCR-08-1763; Han SY, 2000, CANCER RES, V60, P3147; Hogan C, 2009, NAT CELL BIOL, V11, P460, DOI 10.1038/ncb1853; Isakoff SJ, 2005, CANCER RES, V65, P10992, DOI 10.1158/0008-5472.CAN-05-2612; Kang YB, 2004, CELL, V118, P277, DOI 10.1016/j.cell.2004.07.011; Kim JW, 2008, GENE DEV, V22, P3147, DOI 10.1101/gad.1700108; Knobbe CB, 2008, ONCOGENE, V27, P5398, DOI 10.1038/onc.2008.238; Lauring J, 2010, ONCOGENE, V29, P2337, DOI 10.1038/onc.2009.516; Leslie NR, 2008, ONCOGENE, V27, P5464, DOI 10.1038/onc.2008.243; Leslie NR, 2007, CURR BIOL, V17, P115, DOI 10.1016/j.cub.2006.12.026; Leslie NR, 2001, BIOCHEM J, V357, P427, DOI 10.1042/0264-6021:3570427; Leung CT, 2012, NATURE, V482, P410, DOI 10.1038/nature10826; Li G, 2002, DEVELOPMENT, V129, P4159; Lin HH, 1999, KIDNEY INT, V55, P168, DOI 10.1046/j.1523-1755.1999.00249.x; Liu H, 2004, J CELL BIOL, V164, P603, DOI 10.1083/jcb.200306090; Liu PX, 2011, NAT MED, V17, P1116, DOI 10.1038/nm.2402; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maroulakou IG, 2007, CANCER RES, V67, P167, DOI 10.1158/0008-5472.CAN-06-3782; Marsh V, 2008, NAT GENET, V40, P1436, DOI 10.1038/ng.256; Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076; Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051; McCaffrey LM, 2011, TRENDS CELL BIOL, V21, P727, DOI 10.1016/j.tcb.2011.06.005; Meyer DS, 2011, CANCER RES, V71, P4344, DOI 10.1158/0008-5472.CAN-10-3827; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Pang H, 2009, CANCER RES, V69, P8868, DOI 10.1158/0008-5472.CAN-09-1968; Perren A, 1999, AM J PATHOL, V155, P1253, DOI 10.1016/S0002-9440(10)65227-3; Pinal N, 2006, CURR BIOL, V16, P140, DOI 10.1016/j.cub.2005.11.068; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Stemke-Hale K, 2008, CANCER RES, V68, P6084, DOI 10.1158/0008-5472.CAN-07-6854; Stiles B, 2002, MOL CELL BIOL, V22, P3842, DOI 10.1128/MCB.22.11.3842-3851.2002; STOKER M, 1985, J CELL SCI, V77, P209; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Tibarewal P, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002138; van Diepen MT, 2009, NAT CELL BIOL, V11, P1191, DOI 10.1038/ncb1961; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; von Stein W, 2005, DEVELOPMENT, V132, P1675, DOI 10.1242/dev.01720; Weaver VM, 1997, J CELL BIOL, V137, P231, DOI 10.1083/jcb.137.1.231; Welch HCE, 2003, FEBS LETT, V546, P93, DOI 10.1016/S0014-5793(03)00454-X; Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045	53	20	21	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP 12	2013	32	37					4417	4426		10.1038/onc.2012.459	http://dx.doi.org/10.1038/onc.2012.459			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	218AF	23085752	Green Accepted			2022-12-25	WOS:000324404200010
J	Doci, CL; Zhou, G; Lingen, MW				Doci, C. L.; Zhou, G.; Lingen, M. W.			The novel tumor suppressor NOL7 post-transcriptionally regulates thrombospondin-1 expression	ONCOGENE			English	Article						NOL7; TSP-1; angiogenesis; post-transcriptional	ENDOTHELIAL GROWTH-FACTOR; PROMOTES TRANSCRIPTION TERMINATION; NUCLEAR-RNA SURVEILLANCE; ANTI-ANGIOGENIC ISOFORMS; PRE-MESSENGER-RNA; FACTOR-BETA; CCR4-NOT COMPLEX; 3'-UNTRANSLATED REGION; QUALITY-CONTROL; POLYMERASE-I	Thrombospondin-1 (TSP-1) is an endogenous inhibitor of angiogenesis whose expression suppresses tumor growth in vivo. Like many angiogenesis-related genes, TSP-1 expression is tightly controlled by various mechanisms, but there is little data regarding the contribution of post-transcriptional processing to this regulation. NOL7 is a novel tumor suppressor that induces an antiangiogenic phenotype and suppresses tumor growth, in part through upregulation of TSP-1. Here we demonstrate that NOL7 is an mRNA-binding protein that must localize to the nucleoplasm to exert its antiangiogenic and tumor suppressive effects. There, it associates with the RNA-processing machinery and specifically interacts with TSP-1 mRNA through its 3'UTR. Reintroduction of NOL7 into SiHa cells increases luciferase expression through interaction with the TSP-1 3'UTR at both the mRNA and protein levels. NOL7 also increases endogenous TSP-1 mRNA half-life. Further, NOL7 post-transcriptional stabilization is observed in a subset of angiogenesis-related mRNAs, suggesting that the stabilization of TSP-1 may be part of a larger novel mechanism. These data demonstrate that NOL7 significantly alters TSP-1 expression and may be a master regulator that coordinates the post-transcriptional expression of key signaling factors critical for the regulation of the angiogenic phenotype.	Univ Chicago, Dept Pathol Med & Radiat, Chicago, IL 60637 USA; Univ Chicago, Dept Cellular Oncol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Lingen, MW (corresponding author), Univ Chicago, Dept Pathol Med & Radiat, 5841S Maryland Ave MC6101, Chicago, IL 60637 USA.	mark.lingen@uchospitals.edu	Doci, Colleen L/M-4389-2015		Illinois Department of Public Health Penny Severns Cancer Research Fund	Illinois Department of Public Health Penny Severns Cancer Research Fund	We wish to thank Drs Ira Wool and Yuen-Ling Chan for their assistance in sucrose gradient ultracentrifugation. This work was supported in part by Illinois Department of Public Health Penny Severns Cancer Research Fund (MWL).	Anderson JT, 2009, CRIT REV BIOCHEM MOL, V44, P16, DOI [10.1080/10409230802640218 , 10.1080/10409230802640218]; Azzouz N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006760; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bleuel K, 1999, P NATL ACAD SCI USA, V96, P2065, DOI 10.1073/pnas.96.5.2065; Brennan CM, 2000, J CELL BIOL, V151, P1, DOI 10.1083/jcb.151.1.1; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chung JH, 2011, LUNG CANCER, V73, P176, DOI 10.1016/j.lungcan.2010.11.011; Claffey KP, 1998, MOL BIOL CELL, V9, P469, DOI 10.1091/mbc.9.2.469; Collart MA, 2004, PROG NUCLEIC ACID RE, V77, P289, DOI 10.1016/S0079-6603(04)77008-7; de Almeida SF, 2010, NUCLEIC ACIDS RES, V38, P8015, DOI 10.1093/nar/gkq703; Denis CL, 2003, PROG NUCLEIC ACID RE, V73, P221, DOI 10.1016/S0079-6603(03)01007-9; Dibrov A, 2006, GROWTH FACTORS, V24, P1, DOI 10.1080/08977190500365995; Dixon DA, 2001, J CLIN INVEST, V108, P1657, DOI 10.1172/JCI200112973; Doci CL, 2012, INT J GYNECOL PATHOL, V31, P15, DOI 10.1097/PGP.0b013e318220ba16; El Hage A, 2008, GENE DEV, V22, P1069, DOI 10.1101/gad.463708; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; Gallouzi IE, 2000, P NATL ACAD SCI USA, V97, P3073, DOI 10.1073/pnas.97.7.3073; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Glaunsinger BA, 2010, RNA BIOL, V7, P13, DOI 10.4161/rna.7.1.10255; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; Hall-Pogar T, 2005, NUCLEIC ACIDS RES, V33, P2565, DOI 10.1093/nar/gki544; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HARGROVE JL, 1989, FASEB J, V3, P2360, DOI 10.1096/fasebj.3.12.2676679; Harper SJ, 2008, NAT REV CANCER, V8, P880, DOI 10.1038/nrc2505; HashimotoUoshima M, 1997, J CELL SCI, V110, P2271; Hasina R, 2006, ONCOGENE, V25, P588, DOI 10.1038/sj.onc.1209070; He YL, 1999, MOL ENDOCRINOL, V13, P537, DOI 10.1210/me.13.4.537; Heath VL, 2009, NAT REV CLIN ONCOL, V6, P395, DOI 10.1038/nrclinonc.2009.52; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Janz A, 2000, NUCLEIC ACIDS RES, V28, P2268, DOI 10.1093/nar/28.11.2268; Kang JH, 2006, FEBS LETT, V580, P510, DOI 10.1016/j.febslet.2005.12.065; Kanies CL, 2008, MOL CANCER RES, V6, P1124, DOI 10.1158/1541-7786.MCR-07-2095; Kawauchi J, 2008, GENE DEV, V22, P1082, DOI 10.1101/gad.463408; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Laderoute KR, 2000, CLIN CANCER RES, V6, P2941; Ladomery MR, 2007, CANCER LETT, V249, P133, DOI 10.1016/j.canlet.2006.08.015; Lau NC, 2009, BIOCHEM J, V422, P443, DOI 10.1042/BJ20090500; Lawler J, 2004, INT J BIOCHEM CELL B, V36, P1038, DOI 10.1016/j.biocel.2004.01.008; LEVY AP, 1995, J BIOL CHEM, V270, P13333, DOI 10.1074/jbc.270.22.13333; Levy AP, 1996, J BIOL CHEM, V271, P2746, DOI 10.1074/jbc.271.5.2746; Levy NS, 1997, BBA-GENE STRUCT EXPR, V1352, P167, DOI 10.1016/S0167-4781(97)00052-3; Levy NS, 1998, J BIOL CHEM, V273, P6417, DOI 10.1074/jbc.273.11.6417; Lingen MW, 2003, METH MOLEC MED, V78, P337; Lukiw WJ, 1997, J NEUROSCI RES, V50, P937, DOI 10.1002/(SICI)1097-4547(19971215)50:6<937::AID-JNR4>3.0.CO;2-E; Mazan-Mamczarz K, 2008, ONCOGENE, V27, P6151, DOI 10.1038/onc.2008.215; Moore MJ, 2002, CELL, V108, P431, DOI 10.1016/S0092-8674(02)00645-1; Mukherjee D, 2002, EMBO J, V21, P165, DOI 10.1093/emboj/21.1.165; Neugebauer KM, 2002, J CELL SCI, V115, P3865, DOI 10.1242/jcs.00073; Nowak DG, 2008, J CELL SCI, V121, P3487, DOI 10.1242/jcs.016410; Okamoto M, 2002, BBA-GENE STRUCT EXPR, V1574, P24, DOI 10.1016/S0167-4781(01)00345-1; PENTTINEN RP, 1988, P NATL ACAD SCI USA, V85, P1105, DOI 10.1073/pnas.85.4.1105; Phelan MW, 1998, J LAB CLIN MED, V132, P519, DOI 10.1016/S0022-2143(98)90131-7; Qiu Y, 2009, BIOCHEM SOC T, V37, P1207, DOI 10.1042/BST0371207; Quesada AR, 2007, BIOESSAYS, V29, P1159, DOI 10.1002/bies.20655; RASTINEJAD F, 1989, CELL, V56, P345, DOI 10.1016/0092-8674(89)90238-9; Ren B, 2006, BBA-REV CANCER, V1765, P178, DOI 10.1016/j.bbcan.2005.11.002; Rennel ES, 2008, BRIT J CANCER, V98, P1250, DOI 10.1038/sj.bjc.6604309; Richard P, 2009, GENE DEV, V23, P1247, DOI 10.1101/gad.1792809; Robinson CJ, 2001, J CELL SCI, V114, P853; Sengupta S, 2003, J BIOL CHEM, V278, P25227, DOI 10.1074/jbc.M301813200; Sheflin LG, 2004, BIOCHEM BIOPH RES CO, V322, P644, DOI 10.1016/j.bbrc.2004.07.173; Streit M, 1999, AM J PATHOL, V155, P441, DOI 10.1016/S0002-9440(10)65140-1; Teixeira A, 2004, NATURE, V432, P526, DOI 10.1038/nature03032; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Touriol C, 2000, J BIOL CHEM, V275, P19361, DOI 10.1074/jbc.M908431199; Vasudevan S, 2003, CURR OPIN CELL BIOL, V15, P332, DOI 10.1016/S0955-0674(03)00051-6; VOLPERT OV, 1995, BREAST CANCER RES TR, V36, P119, DOI 10.1007/BF00666034; Volpert OV, 2000, CANCER METAST REV, V19, P87, DOI 10.1023/A:1026560618302; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; WEINSTATSASLOW DL, 1994, CANCER RES, V54, P6504; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Yamazaki Y, 2006, MOL DIVERS, V10, P515, DOI 10.1007/s11030-006-9027-3; Zhou GL, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-74; Zorio DAR, 2004, EXP CELL RES, V296, P91, DOI 10.1016/j.yexcr.2004.03.019	79	7	7	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 12	2013	32	37					4377	4386		10.1038/onc.2012.464	http://dx.doi.org/10.1038/onc.2012.464			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	218AF	23085760	Green Accepted			2022-12-25	WOS:000324404200006
J	Yu, SL; Levi, L; Siegel, R; Noy, N				Yu, Shuiliang; Levi, Liraz; Siegel, Ruth; Noy, Noa			Retinoic Acid Induces Neurogenesis by Activating Both Retinoic Acid Receptors (RARs) and Peroxisome Proliferator-activated Receptor beta/delta (PPAR beta/delta)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REV-ERB-ALPHA; EMBRYONAL CARCINOMA; BINDING PROTEINS; NEURONAL DIFFERENTIATION; LIM PROTEIN; EXPRESSION; GENES; RESISTANCE; LIGAND; ROLES	Retinoic acid (RA) regulates gene transcription by activating the nuclear receptors retinoic acid receptor (RAR) and peroxisome proliferator-activated receptor (PPAR) beta/delta and their respective cognate lipid-binding proteins CRABP-II and FABP5. RA induces neuronal differentiation, but the contributions of the two transcriptional pathways of the hormone to the process are unknown. Here, we show that the RA-induced commitment of P19 stem cells to neuronal progenitors is mediated by the CRABP-II/RAR path and that the FABP5/PPAR beta/delta path can inhibit the process through induction of the RAR repressors SIRT1 and Ajuba. In contrast with its inhibitory activity in the early steps of neurogenesis, the FABP5/PPAR beta/delta path promotes differentiation of neuronal progenitors to mature neurons, an activity mediated in part by the PPAR beta/delta target gene PDK1. Hence, RA-induced neuronal differentiation is mediated through RAR in the early stages and through PPAR beta/delta in the late stages of the process. The switch in RA signaling is accomplished by a transient up-regulation of RAR beta concomitantly with a transient increase in the CRABP-II/FABP5 ratio at early stages of differentiation. In accordance with these conclusions, hippocampi of FABP5-null mice display excess accumulation of neuronal progenitor cells and a deficit in mature neurons versus wild-type animals.	[Yu, Shuiliang; Levi, Liraz; Siegel, Ruth; Noy, Noa] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Noy, Noa] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Noy, N (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave W333, Cleveland, OH 44106 USA.	noa.noy@case.edu		Levi, Liraz/0000-0001-7462-2396	National Institutes of Health [RO1 DK060684]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK060684] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 DK060684 (to N. N.).	Berry DC, 2012, DIABETES, V61, P1112, DOI 10.2337/db11-1620; Berry DC, 2010, J BIOL CHEM, V285, P15324, DOI 10.1074/jbc.M110.110635; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Boneva NB, 2010, NEUROSCI RES, V68, P94, DOI 10.1016/j.neures.2010.07.2028; BOYLAN JF, 1991, J CELL BIOL, V112, P965, DOI 10.1083/jcb.112.5.965; BOYLAN JF, 1992, J BIOL CHEM, V267, P21486; Budhu AS, 2002, MOL CELL BIOL, V22, P2632, DOI 10.1128/MCB.22.8.2632-2641.2002; D'Angelo B, 2011, J CELL PHYSIOL, V226, P2170, DOI 10.1002/jcp.22552; Di-Poi N, 2002, MOL CELL, V10, P721, DOI 10.1016/S1097-2765(02)00646-9; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Endo M, 2009, J BIOL CHEM, V284, P5107, DOI 10.1074/jbc.M807745200; Fishwick KJ, 2010, DEV BIOL, V338, P215, DOI 10.1016/j.ydbio.2009.12.001; Fontaine C, 2003, J BIOL CHEM, V278, P37672, DOI 10.1074/jbc.M304664200; Germain P, 2006, PHARMACOL REV, V58, P712, DOI 10.1124/pr.58.4.4; Gervois P, 1999, MOL ENDOCRINOL, V13, P400, DOI 10.1210/me.13.3.400; GILLESPIE MT, 1994, MOL CELL ENDOCRINOL, V100, P143, DOI 10.1016/0303-7207(94)90293-3; Goyal RK, 1999, MOL CELL BIOL, V19, P4379; Hall MG, 2008, PPAR RES, V2008, DOI 10.1155/2008/780452; Hou ZY, 2010, P NATL ACAD SCI USA, V107, P2938, DOI 10.1073/pnas.0908656107; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; Kang MR, 2010, NUCLEIC ACIDS RES, V38, P822, DOI 10.1093/nar/gkp1056; Kumar AP, 2004, J BIOL CHEM, V279, P8300, DOI 10.1074/jbc.M311625200; LAU LF, 1987, P NATL ACAD SCI USA, V84, P1182, DOI 10.1073/pnas.84.5.1182; Liu RZ, 2010, INT J DEV BIOL, V54, P1229, DOI 10.1387/ijdb.092976rl; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Manor D, 2003, CANCER RES, V63, P4426; MCBURNEY MW, 1993, INT J DEV BIOL, V37, P135; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; Means AL, 2000, CELL GROWTH DIFFER, V11, P71; Oishi K, 2009, P NATL ACAD SCI USA, V106, P13064, DOI 10.1073/pnas.0808400106; RINGOLD GM, 1984, P NATL ACAD SCI-BIOL, V81, P3964, DOI 10.1073/pnas.81.13.3964; Saluja I, 2001, GLIA, V33, P191, DOI 10.1002/1098-1136(200103)33:3<191::AID-GLIA1018>3.0.CO;2-M; Schmuth M, 2004, J INVEST DERMATOL, V122, P971, DOI 10.1111/j.0022-202X.2004.22412.x; Schug TT, 2008, P NATL ACAD SCI USA, V105, P7546, DOI 10.1073/pnas.0709981105; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Sessler RJ, 2005, MOL CELL, V18, P343, DOI 10.1016/j.molcel.2005.03.026; Shaw N, 2003, J BIOL CHEM, V278, P41589, DOI 10.1074/jbc.C300368200; Soprano DR, 2007, VITAM HORM, V75, P69, DOI 10.1016/S0083-6729(06)75003-8; Stahel PF, 2008, PPAR RES, V2008, DOI 10.1155/2008/538141; Tan NS, 2002, MOL CELL BIOL, V22, P5114, DOI 10.1128/MCB.22.14.5114-5127.2002; Venkatachalam G, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-S3-S5	41	71	79	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42195	42205		10.1074/jbc.M112.410381	http://dx.doi.org/10.1074/jbc.M112.410381			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23105114	hybrid, Green Published			2022-12-25	WOS:000312103000056
J	Ballenberger, N; Lluis, A; von Mutius, E; Illi, S; Schaub, B				Ballenberger, Nikolaus; Lluis, Anna; von Mutius, Erika; Illi, Sabina; Schaub, Bianca			Novel Statistical Approaches for Non-Normal Censored Immunological Data: Analysis of Cytokine and Gene Expression Data	PLOS ONE			English	Article								Background: For several immune-mediated diseases, immunological analysis will become more complex in the future with datasets in which cytokine and gene expression data play a major role. These data have certain characteristics that require sophisticated statistical analysis such as strategies for non-normal distribution and censoring. Additionally, complex and multiple immunological relationships need to be adjusted for potential confounding and interaction effects. Objective: We aimed to introduce and apply different methods for statistical analysis of non-normal censored cytokine and gene expression data. Furthermore, we assessed the performance and accuracy of a novel regression approach in order to allow adjusting for covariates and potential confounding. Methods: For non-normally distributed censored data traditional means such as the Kaplan-Meier method or the generalized Wilcoxon test are described. In order to adjust for covariates the novel approach named Tobit regression on ranks was introduced. Its performance and accuracy for analysis of non-normal censored cytokine/gene expression data was evaluated by a simulation study and a statistical experiment applying permutation and bootstrapping. Results: If adjustment for covariates is not necessary traditional statistical methods are adequate for non-normal censored data. Comparable with these and appropriate if additional adjustment is required, Tobit regression on ranks is a valid method. Its power, type-I error rate and accuracy were comparable to the classical Tobit regression. Conclusion: Non-normally distributed censored immunological data require appropriate statistical methods. Tobit regression on ranks meets these requirements and can be used for adjustment for covariates and potential confounding in large and complex immunological datasets.	[Ballenberger, Nikolaus; Lluis, Anna; von Mutius, Erika; Illi, Sabina; Schaub, Bianca] Ludwig Maximilians Univ Munchen, Dept Pulm & Allergy, Univ Childrens Hosp Munich, Munich, Germany	University of Munich	Schaub, B (corresponding author), Ludwig Maximilians Univ Munchen, Dept Pulm & Allergy, Univ Childrens Hosp Munich, Munich, Germany.	Bianca.Schaub@med.uni-muenchen.de	Schaub, Bianca/B-9935-2019	Schaub, Bianca/0000-0003-1652-8873; von Mutius, Erika/0000-0002-8893-4515	Comprehensive Pneumology Centre; German Research Association (Deutsche Forschungsgemeinschaft), DFG:Sonderforschungsbereich SBF [TR22, TPA22]	Comprehensive Pneumology Centre; German Research Association (Deutsche Forschungsgemeinschaft), DFG:Sonderforschungsbereich SBF(German Research Foundation (DFG))	Comprehensive Pneumology Centre (BS), German Research Association (Deutsche Forschungsgemeinschaft), DFG:Sonderforschungsbereich SBF TR22 (TPA22, BS, NB, AL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARABMAZAR A, 1982, ECONOMETRICA, V50, P1055, DOI 10.2307/1912776; Austin PC, 2000, QUAL LIFE RES, V9, P901, DOI 10.1023/A:1008938326604; Brodersen Kay H., 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3121, DOI 10.1109/ICPR.2010.764; Buckley TJ, 1997, ENVIRON INT, V23, P705, DOI 10.1016/S0160-4120(97)00071-8; CONOVER W. J, 1980, PRACTICAL NONPARAMET; CONOVER WJ, 1981, AM STAT, V35, P124, DOI 10.2307/2683975; COX DR, 1972, J R STAT SOC B, V34, P187; Genser B, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-27; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Helsel D. R., 2005, NONDETECTS DATA ANAL; Hobbs KE, 2003, ENVIRON POLLUT, V121, P239, DOI 10.1016/S0269-7491(02)00218-X; IMAN RL, 1979, TECHNOMETRICS, V21, P499, DOI 10.2307/1268289; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KRUSKAL WH, 1953, J AM STAT ASSOC, V48, P907, DOI 10.2307/2281082; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lubin JH, 2004, ENVIRON HEALTH PERSP, V112, P1691, DOI 10.1289/ehp.7199; PRENTICE RL, 1978, BIOMETRIKA, V65, P167, DOI 10.1093/biomet/65.1.167; SAS Institute, 2009, SAS 9 2 WIND; Schaub Bianca, 2009, J Allergy Clin Immunol, V123, P774, DOI 10.1016/j.jaci.2009.01.056; TOBIN J, 1958, ECONOMETRICA, V26, P24, DOI 10.2307/1907382; Uh HW, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-59; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269	22	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e46423	10.1371/journal.pone.0046423	http://dx.doi.org/10.1371/journal.pone.0046423			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110049	Green Published, Green Submitted, gold			2022-12-25	WOS:000310262500005
J	Sohni, A; Mulas, F; Ferrazzi, F; Luttun, A; Bellazzi, R; Huylebroeck, D; Ekker, SC; Verfaillie, CM				Sohni, Abhishek; Mulas, Francesca; Ferrazzi, Fulvia; Luttun, Aernout; Bellazzi, Riccardo; Huylebroeck, Danny; Ekker, Stephen C.; Verfaillie, Catherine M.			TGF beta 1-Induced Baf60c Regulates both Smooth Muscle Cell Commitment and Quiescence	PLOS ONE			English	Article							ADULT PROGENITOR CELLS; CHROMATIN-REMODELING COMPLEX; IN-VIVO; STEM-CELLS; TRANSCRIPTION FACTORS; GENE-EXPRESSION; CARG ELEMENTS; DIFFERENTIATION; PROMOTER; MICE	Smooth muscle cells (SMCs) play critical roles in a number of diseases; however, the molecular mechanism underlying their development is unclear. Although the role of TGF beta 1 signaling in SMC development is well established, the downstream molecular signals are not fully understood. We used several rat multipotent adult progenitor cell ((r)MAPC) lines that express levels of Oct4 mRNA similar to hypoblast stem cells (HypoSC), and can differentiate robustly to mesodermal and endodermal cell types. TGF beta 1 alone, or with PDGF-BB, induces differentiation of rMAPCs to SMCs, which expressed structural SMC proteins, including a-smooth muscle actin (alpha SMA), and contribute to the SMC coat of blood vessels in vivo. A genome-wide time-course transcriptome analysis revealed that transcripts of Baf60c, part of the SWI/SNF actin binding chromatin remodeling complex D-3 (SMARCD3/BAF60c), were significantly induced during MAPC-SMC differentiation. We demonstrated that BAF60c is a necessary co-regulator of TGF beta 1 mediated induction of SMC genes. Knock-down of Baf60c decreased SMC gene expression in rMAPCs whereas ectopic expression of Baf60c was sufficient to commit rMAPCs to SMCs in the absence of exogenous cytokines. TGF beta 1 activates Baf60c via the direct binding of SMAD2/3 complexes to the Baf60c promoter region. Chromatin-and co-immunoprecipitation studies demonstrated that regulation of SMC genes by BAF60c is mediated via interaction with SRF binding CArG box-containing promoter elements in SMC genes. We noted that compared with TGF beta 1, Baf60c overexpression in rMAPC yielded SMC with a more immature phenotype. Similarly, Baf60c induced an immature phenotype in rat aortic SMCs marked by increased cell proliferation and decreased contractile marker expression. Thus, Baf60c is important for TGF beta-mediated commitment of primitive stem cells (rMAPCs) to SMCs and is associated with induction of a proliferative state of quiescent SMCs. The MAPC-SMC differentiation system may be useful for identification of additional critical (co-) regulators of SMC development.	[Sohni, Abhishek; Verfaillie, Catherine M.] Katholieke Univ Leuven, Dept Dev & Regenerat, Stem Cell Inst, Louvain, Belgium; [Sohni, Abhishek; Ekker, Stephen C.; Verfaillie, Catherine M.] Univ Minnesota, Minneapolis, MN USA; [Mulas, Francesca; Bellazzi, Riccardo] Univ Pavia, Ctr Tissue Engn, I-27100 Pavia, Italy; [Ferrazzi, Fulvia; Bellazzi, Riccardo] Univ Pavia, Dipartimento Informat & Sistemist, I-27100 Pavia, Italy; [Luttun, Aernout] Katholieke Univ Leuven, Ctr Mol & Vasc Biol, Louvain, Belgium; [Huylebroeck, Danny] Katholieke Univ Leuven, Lab Mol Biol Celgen, Dept Dev & Regenerat, Louvain, Belgium; [Ekker, Stephen C.] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN USA	KU Leuven; University of Minnesota System; University of Minnesota Twin Cities; University of Pavia; University of Pavia; KU Leuven; KU Leuven; Mayo Clinic	Verfaillie, CM (corresponding author), Katholieke Univ Leuven, Dept Dev & Regenerat, Stem Cell Inst, Louvain, Belgium.	Catherine.verfaillie@med.kuleuven.be	Bellazzi, Riccardo/J-6432-2018; Luttun, Aernout/AAZ-6540-2020; Ferrazzi, Fulvia/C-1161-2008; Verfaillie, Catherine/H-5148-2013	Bellazzi, Riccardo/0000-0002-6974-9808; Luttun, Aernout/0000-0001-7902-9524; Ferrazzi, Fulvia/0000-0003-4011-4638; Verfaillie, Catherine/0000-0001-7564-4079; Ekker, Stephen/0000-0003-0726-4212; Huylebroeck, Danny/0000-0003-4862-1079	European Union (STROKEMAP) [FP6-037186]; K.U.Leuven [EIW-B4855-EF/05/11, ETH-C1900-PF, EME-C2161-GOA/11/012]; Fondazione Cariplo grant; FIRB ITALBIONET grant by the Italian Ministry of Research	European Union (STROKEMAP)(European Commission); K.U.Leuven(KU Leuven); Fondazione Cariplo grant(Fondazione Cariplo); FIRB ITALBIONET grant by the Italian Ministry of Research	The work was supported in part by grants from the European Union (STROKEMAP, FP6-037186) to CMV and AL, grants from K.U.Leuven (EIW-B4855-EF/05/11, ETH-C1900-PF) to CMV and K.U.Leuven (EME-C2161-GOA/11/012) to CMV and DH. Fondazione Cariplo grant (2008-2006) "Bioinformatics for Tissue Engineering: Creation of an International Research Group" to RB and FM, and FIRB ITALBIONET grant by the Italian Ministry of Research to RB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aranguren XL, 2007, BLOOD, V109, P2634, DOI 10.1182/blood-2006-06-030411; Bergwerff M, 1998, CIRC RES, V82, P221; CHAMLEYCAMPBELL J, 1979, PHYSIOL REV, V59, P1, DOI 10.1152/physrev.1979.59.1.1; Cheung C, 2012, NAT BIOTECHNOL, V30, P165, DOI 10.1038/nbt.2107; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; DeRuiter MC, 1997, CIRC RES, V80, P444, DOI 10.1161/01.RES.80.4.444; Di Camillo B, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S1-S10; DICKSON MC, 1995, DEVELOPMENT, V121, P1845; Drake CJ, 1998, ANN NY ACAD SCI, V857, P155, DOI 10.1111/j.1749-6632.1998.tb10115.x; Forcales SV, 2012, EMBO J, V31, P301, DOI 10.1038/emboj.2011.391; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Hinson JS, 2007, AM J PHYSIOL-HEART C, V292, pH1170, DOI 10.1152/ajpheart.00864.2006; Jinnin M, 2006, MOL PHARMACOL, V69, P597, DOI 10.1124/mol.105.017483; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; KEMP PR, 1995, BIOCHEM J, V310, P1037, DOI 10.1042/bj3101037; Kume T, 2000, DEVELOPMENT, V127, P1387; Lepore JJ, 2005, ARTERIOSCL THROM VAS, V25, P309, DOI 10.1161/01.ATV.0000152725.76020.3c; Li DY, 1999, SCIENCE, V284, P1534, DOI 10.1126/science.284.5419.1534; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Lo Nigro A, 2012, J MOL CELL BIOL; Mack CP, 1999, CIRC RES, V84, P852; Manabe I, 2001, J CLIN INVEST, V107, P823, DOI 10.1172/JCI11385; Martin JG, 2000, EUR RESPIR J, V16, P349, DOI 10.1034/j.1399-3003.2000.16b25.x; Maschhoff KL, 2003, GENE, V320, P23, DOI 10.1016/j.gene.2003.07.002; Mericskay M, 2000, DEV BIOL, V226, P192, DOI 10.1006/dbio.2000.9865; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; MIN BH, 1990, J BIOL CHEM, V265, P16667; Muchardt C, 2001, ONCOGENE, V20, P3067, DOI 10.1038/sj.onc.1204331; Ochi H, 2008, J BIOL CHEM, V283, P3529, DOI 10.1074/jbc.M708594200; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Paddison PJ, 2004, NAT METHODS, V1, P163, DOI 10.1038/nmeth1104-163; Ponticos M, 2004, MOL CELL BIOL, V24, P6151, DOI 10.1128/MCB.24.14.6151-6161.2004; Roobrouck VD, 2011, STEM CELLS, V29, P871, DOI 10.1002/stem.633; Ross JJ, 2006, J CLIN INVEST, V116, P3139, DOI 10.1172/JCI28184; ROSS R, 1974, P NATL ACAD SCI USA, V71, P1207, DOI 10.1073/pnas.71.4.1207; ROSS R, 1984, AM J PATHOL, V114, P79; Shang YT, 2008, J CELL BIOL, V181, P461, DOI 10.1083/jcb.200711145; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Sinha S, 2004, AM J PHYSIOL-CELL PH, V287, pC1560, DOI 10.1152/ajpcell.00221.2004; Subramanian K, 2010, METHODS MOL BIOL, V636, P55, DOI 10.1007/978-1-60761-691-7_4; Takeuchi JK, 2007, P NATL ACAD SCI USA, V104, P846, DOI 10.1073/pnas.0608118104; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Ulloa-Montoya F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r163; Urness LD, 2000, NAT GENET, V26, P328, DOI 10.1038/81634; Winnier GE, 1999, DEV BIOL, V213, P418, DOI 10.1006/dbio.1999.9382; Yang X, 1999, DEVELOPMENT, V126, P1571; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09; Zhou JL, 2009, ARTERIOSCL THROM VAS, V29, P921, DOI 10.1161/ATVBAHA.109.187229	50	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47629	10.1371/journal.pone.0047629	http://dx.doi.org/10.1371/journal.pone.0047629			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110084	Green Published, gold, Green Submitted			2022-12-25	WOS:000310262500015
J	Caljon, G; De Ridder, K; Stijlemans, B; Coosemans, M; Magez, S; De Baetselier, P; Van den Abbeele, J				Caljon, Guy; De Ridder, Karin; Stijlemans, Benoit; Coosemans, Marc; Magez, Stefan; De Baetselier, Patrick; Van den Abbeele, Jan			Tsetse Salivary Gland Proteins 1 and 2 Are High Affinity Nucleic Acid Binding Proteins with Residual Nuclease Activity	PLOS ONE			English	Article							GLOSSINA-MORSITANS-MORSITANS; SERRATIA-MARCESCENS ENDONUCLEASE; NEUTROPHIL EXTRACELLULAR TRAPS; DUPLEX-SPECIFIC NUCLEASE; FLY SALIVA; PLATELET-AGGREGATION; ESCHERICHIA-COLI; IDENTIFICATION; MECHANISM; HEPATOPANCREAS	Analysis of the tsetse fly salivary gland EST database revealed the presence of a highly enriched cluster of putative endonuclease genes, including tsal1 and tsal2. Tsal proteins are the major components of tsetse fly (G. morsitans morsitans) saliva where they are present as monomers as well as high molecular weight complexes with other saliva proteins. We demonstrate that the recombinant tsetse salivary gland proteins 1&2 (Tsal1&2) display DNA/RNA non-specific, high affinity nucleic acid binding with K-D values in the low nanomolar range and a non-exclusive preference for duplex. These Tsal proteins exert only a residual nuclease activity with a preference for dsDNA in a broad pH range. Knockdown of Tsal expression by in vivo RNA interference in the tsetse fly revealed a partially impaired blood digestion phenotype as evidenced by higher gut nucleic acid, hematin and protein contents.	[Caljon, Guy; De Ridder, Karin; Van den Abbeele, Jan] Inst Trop Med Antwerp ITM, Unit Vet Protozool, Dept Biomed Sci, Antwerp, Belgium; [Caljon, Guy; Stijlemans, Benoit; Magez, Stefan; De Baetselier, Patrick] VUB, Unit Cellular & Mol Immunol, Brussels, Belgium; [Caljon, Guy; Stijlemans, Benoit; Magez, Stefan; De Baetselier, Patrick] VIB, Lab Myeloid Cell Immunol, Brussels, Belgium; [Coosemans, Marc] Inst Trop Med Antwerp ITM, Unit Med Entomol, Dept Biomed Sci, Antwerp, Belgium	Institute of Tropical Medicine (ITM); Vrije Universiteit Brussel; Flanders Institute for Biotechnology (VIB); Institute of Tropical Medicine (ITM)	Caljon, G (corresponding author), Inst Trop Med Antwerp ITM, Unit Vet Protozool, Dept Biomed Sci, Antwerp, Belgium.	gcaljon@itg.be; jvdabbeele@itg.be	Magez, Stefan/AAC-5682-2021; Magez, Stefan/D-9497-2014; De Baetselier, Patrick/D-3866-2014; Caljon, Guy/E-1310-2017; Stijlemans, Benoit/AAD-9122-2021	Magez, Stefan/0000-0003-3760-7968; Magez, Stefan/0000-0003-3760-7968; Caljon, Guy/0000-0002-4870-3202; Stijlemans, Benoit/0000-0003-0082-9751; Van Den Abbeele, Jan/0000-0002-4533-4480	InterUniversity Attraction Poles Programme [IAP] of the Belgian Science Policy; Fonds Wetenschappelijk Onderzoek (FWO) Vlaanderen; ERC starting grant "NANOSYM"; ITM; VUB; IWT PhD grant [IWT1149]	InterUniversity Attraction Poles Programme [IAP] of the Belgian Science Policy; Fonds Wetenschappelijk Onderzoek (FWO) Vlaanderen(FWO); ERC starting grant "NANOSYM"; ITM(Defence Research & Development Organisation (DRDO)); VUB; IWT PhD grant	This work was supported by the InterUniversity Attraction Poles Programme [IAP] of the Belgian Science Policy, the Fonds Wetenschappelijk Onderzoek (FWO) Vlaanderen, the ERC starting grant "NANOSYM", ITM and VUB institutional funding and an IWT PhD grant [IWT1149, Instituut voor de aanmoediging van innovatie door wetenschap en technologie in Vlaanderen]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Silva J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-213; Anderson JM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-52; Anisimova VE, 2008, GENE, V418, P41, DOI 10.1016/j.gene.2008.04.005; BALL TK, 1987, GENE, V57, P183, DOI 10.1016/0378-1119(87)90121-1; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; BROWN RP, 1980, J ENTOMOL SOC S AFR, V43, P195; Caljon G, 2006, INFECT IMMUN, V74, P6324, DOI 10.1128/IAI.01046-06; Caljon G, 2006, INT J PARASITOL, V36, P1025, DOI 10.1016/j.ijpara.2006.05.002; Caljon G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009671; Caljon G, 2009, INSECT BIOCHEM MOLEC, V39, P332, DOI 10.1016/j.ibmb.2009.01.010; Calvo E, 2006, J EXP BIOL, V209, P2651, DOI 10.1242/jeb.02267; Cappello M, 1996, AM J TROP MED HYG, V54, P475, DOI 10.4269/ajtmh.1996.54.475; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; ELLIS JA, 1986, VET PATHOL, V23, P661, DOI 10.1177/030098588602300603; FRIEDHOFF P, 1994, NUCLEIC ACIDS RES, V22, P3280, DOI 10.1093/nar/22.16.3280; Friedhoff P, 1996, NUCLEIC ACIDS RES, V24, P2632, DOI 10.1093/nar/24.14.2632; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Gupta AK, 2010, FEBS LETT, V584, P3193, DOI 10.1016/j.febslet.2010.06.006; Haddow JD, 2002, INSECT BIOCHEM MOLEC, V32, P1045, DOI 10.1016/S0965-1748(02)00042-5; KUNITZ M, 1950, J GEN PHYSIOL, V33, P349, DOI 10.1085/jgp.33.4.349; Li S, 2000, GENE, V252, P83, DOI 10.1016/S0378-1119(00)00226-2; Li S, 2001, INSECT MOL BIOL, V10, P69, DOI 10.1046/j.1365-2583.2001.00240.x; MANT MJ, 1981, BRIT J HAEMATOL, V48, P601, DOI 10.1111/j.1365-2141.1981.00601.x; MILLER MD, 1994, NAT STRUCT BIOL, V1, P461, DOI 10.1038/nsb0794-461; NESTLE M, 1969, J BIOL CHEM, V244, P5219; PEACOCK AJ, 1982, J INSECT PHYSIOL, V28, P553, DOI 10.1016/0022-1910(82)90036-1; Peeters E, 2004, MOL MICROBIOL, V54, P321, DOI 10.1111/j.1365-2958.2004.04274.x; Rangarajan ES, 2001, FEMS MICROBIOL REV, V25, P583, DOI 10.1111/j.1574-6976.2001.tb00593.x; Shagin DA, 2002, GENOME RES, V12, P1935, DOI 10.1101/gr.547002; Shlyapnikov SV, 2000, ACTA CRYSTALLOGR D, V56, P567, DOI 10.1107/S090744490000322X; Valenzuela JG, 2004, J EXP BIOL, V207, P3717, DOI 10.1242/jeb.01185; Van Den Abbeele J, 2007, INSECT BIOCHEM MOLEC, V37, P1075, DOI 10.1016/j.ibmb.2007.06.006; Van Den Abbeele J, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000926; Wang WY, 2000, BIOCHEM J, V346, P799, DOI 10.1042/0264-6021:3460799; WORRALL AF, 1990, J BIOL CHEM, V265, P21889	35	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47233	10.1371/journal.pone.0047233	http://dx.doi.org/10.1371/journal.pone.0047233			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110062	Green Published, gold, Green Submitted			2022-12-25	WOS:000310193600010
J	Yoshida, H; Ashikawa, Y; Itoh, S; Nakagawa, T; Asanuma, A; Tanabe, S; Inoue, Y; Hidaka, H				Yoshida, Hideo; Ashikawa, Yuka; Itoh, Shinsuke; Nakagawa, Takashi; Asanuma, Akimune; Tanabe, Sohei; Inoue, Yoshihiro; Hidaka, Hiroyoshi			K-134, a Phosphodiesterase 3 Inhibitor, Prevents Brain Damage by Inhibiting Thrombus Formation in a Rat Cerebral Infarction Model	PLOS ONE			English	Article							PERIPHERAL ARTERY-DISEASE; THERAPY; STROKE; CLOPIDOGREL	Background: K-134 is a more potent antiplatelet drug with a selective inhibitory effect on phosphodiesterase 3 (PDE3) compared with its analogue, cilostazol. Objectives: This study was performed to compare the ameliorating effects of K-134 and cilostazol on brain damage in an experimental photothrombotic cerebral infarction model. Methods and Results: We investigated the effects of oral preadministration of PDE3 inhibitors in a rat stroke model established by photothrombotic middle cerebral artery (MCA) occlusion. K-134 significantly prolonged MCA occlusion time at doses >10 mg/kg, and reduced cerebral infarct size at 30 mg/kg in the stroke model (n = 12, 87.5 +/- 65.6 vs. 126.8 +/- 67.5 mm(3), P<0.01), indicating its potent antithrombotic effect. On the other hand, the effects of cilostazol on MCA occlusion time and cerebral infarct size are relatively weak even at the high dosage of 300 mg/kg. Furthermore, K-134 blocked rat platelet aggregation more potently than cilostazol in vitro. Also in an arteriovenous shunt thrombosis model, K-134 showed an antithrombotic effect greater than cilostazol. Conclusions: These findings suggest that K-134, which has strong antithrombotic activity, is a promising drug for prevention of cerebral infarction associated with platelet hyperaggregability.	[Yoshida, Hideo; Ashikawa, Yuka; Itoh, Shinsuke; Nakagawa, Takashi; Asanuma, Akimune; Tanabe, Sohei] Kowa Co Ltd, Tokyo New Drug Res Labs, Tokyo, Japan; [Inoue, Yoshihiro; Hidaka, Hiroyoshi] D Western Therapeut Inst Inc, Nagoya, Aichi, Japan	Kowa Company, Ltd.	Yoshida, H (corresponding author), Kowa Co Ltd, Tokyo New Drug Res Labs, Tokyo, Japan.	hiyosida@kowa.co.jp		Itoh, Shinsuke/0000-0001-9567-8188				Albers GW, 2004, CHEST, V126, p483S, DOI 10.1378/chest.126.3_suppl.483S; Bailey EL, 2011, INT J STROKE, V6, P434, DOI 10.1111/j.1747-4949.2011.00659.x; Bramer SL, 1999, CLIN PHARMACOKINET, V37, P1, DOI 10.2165/00003088-199937002-00001; Brass EP, 2012, J VASC SURG, V55, P381, DOI 10.1016/j.jvs.2011.09.004; Furie B, 2005, J CLIN INVEST, V115, P3355, DOI 10.1172/JCI26987; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Honda F, 2006, STROKE, V37, P223, DOI 10.1161/01.STR.0000196977.76702.6d; Ito H, 2010, J CEREBR BLOOD F MET, V30, P343, DOI 10.1038/jcbfm.2009.220; Keravis T, 2012, BRIT J PHARMACOL, V165, P1288, DOI 10.1111/j.1476-5381.2011.01729.x; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; OKUDA Y, 1993, CARDIOVASC DRUG REV, V11, P451, DOI 10.1111/j.1527-3466.1993.tb00200.x; Sasaki Y, 2012, EUR J PHARMACOL, V689, P132, DOI 10.1016/j.ejphar.2012.05.014; Shinohara Y, 2010, LANCET NEUROL, V9, P959, DOI 10.1016/S1474-4422(10)70198-8; Steg PG, 2011, J THROMB HAEMOST, V9, P325, DOI 10.1111/j.1538-7836.2011.04277.x; Sudo T, 2000, BIOCHEM PHARMACOL, V59, P347, DOI 10.1016/S0006-2952(99)00346-9; UMEMURA K, 1995, THROMB RES, V80, P209, DOI 10.1016/0049-3848(95)00169-R; UMEMURA K, 1995, JPN J PHARMACOL, V67, P253, DOI 10.1254/jjp.67.253; WATSON BD, 1987, J NEUROSURG, V66, P748, DOI 10.3171/jns.1987.66.5.0748; Yoshida H, 2012, ATHEROSCLEROSIS, V221, P84, DOI 10.1016/j.atherosclerosis.2011.12.044; Yoslhida H, 2011, THROMB HAEMOSTASIS, V105, P487, DOI 10.1160/TH10-07-0439	22	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e46432	10.1371/journal.pone.0046432	http://dx.doi.org/10.1371/journal.pone.0046432			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110051	gold, Green Published, Green Submitted			2022-12-25	WOS:000310193600003
J	de Oliveira, VL; Keijsers, RRMC; van de Kerkhof, PCM; Seyger, MMB; Fasse, E; Svensson, L; Latta, M; Norsgaard, H; Labuda, T; Hupkens, P; van Erp, PEJ; Joosten, I; Koenen, HJPM				de Oliveira, Vivian L.; Keijsers, Romy R. M. C.; van de Kerkhof, Peter C. M.; Seyger, Marieke M. B.; Fasse, Esther; Svensson, Lars; Latta, Markus; Norsgaard, Hanne; Labuda, Tord; Hupkens, Pieter; van Erp, Piet E. J.; Joosten, Irma; Koenen, Hans J. P. M.			Humanized Mouse Model of Skin Inflammation Is Characterized by Disturbed Keratinocyte Differentiation and Influx of IL-17A Producing T Cells	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; ATOPIC-DERMATITIS; TH17 CELLS; IL-17-PRODUCING CELLS; PSORIATIC EPIDERMIS; IN-VIVO; DISEASE; EXPRESSION; MICE; COMBINATION	Humanized mouse models offer a challenging possibility to study human cell function in vivo. In the huPBL-SCID-huSkin allograft model human skin is transplanted onto immunodeficient mice and allowed to heal. Thereafter allogeneic human peripheral blood mononuclear cells are infused intra peritoneally to induce T cell mediated inflammation and microvessel destruction of the human skin. This model has great potential for in vivo study of human immune cells in (skin) inflammatory processes and for preclinical screening of systemically administered immunomodulating agents. Here we studied the inflammatory skin response of human keratinocytes and human T cells and the concomitant systemic human T cell response. As new findings in the inflamed human skin of the huPBL-SCID-huSkin model we here identified: 1. Parameters of dermal pathology that enable precise quantification of the local skin inflammatory response exemplified by acanthosis, increased expression of human beta-defensin-2, Elafin, K16, Ki67 and reduced expression of K10 by microscopy and immunohistochemistry. 2. Induction of human cytokines and chemokines using quantitative real-time PCR. 3. Influx of inflammation associated IL-17A-producing human CD4+ and CD8+ T cells as well as immunoregulatory CD4+ Foxp3+ cells using immunohistochemistry and -fluorescence, suggesting that active immune regulation is taking place locally in the inflamed skin. 4. Systemic responses that revealed activated and proliferating human CD4+ and CD8+ T cells that acquired homing marker expression of CD62L and CLA. Finally, we demonstrated the value of the newly identified parameters by showing significant changes upon systemic treatment with the T cell inhibitory agents cyclosporine-A and rapamycin. In summary, here we equipped the huPBL-SCID-huSkin humanized mouse model with relevant tools not only to quantify the inflammatory dermal response, but also to monitor the peripheral immune status. This combined approach will gain our understanding of the dermal immunopathology in humans and benefit the development of novel therapeutics for controlling inflammatory skin diseases.	[de Oliveira, Vivian L.; Keijsers, Romy R. M. C.; Fasse, Esther; Joosten, Irma; Koenen, Hans J. P. M.] Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Lab Med Immunol, NL-6525 ED Nijmegen, Netherlands; [Keijsers, Romy R. M. C.; van de Kerkhof, Peter C. M.; Seyger, Marieke M. B.; van Erp, Piet E. J.] Radboud Univ Nijmegen, Med Ctr, Dept Dermatol, NL-6525 ED Nijmegen, Netherlands; [Hupkens, Pieter] Radboud Univ Nijmegen, Med Ctr, Dept Plast Surg, NL-6525 ED Nijmegen, Netherlands; [Svensson, Lars; Latta, Markus] LEO Pharma, Dept Dis Pharmacol, Ballerup, Denmark; [Norsgaard, Hanne; Labuda, Tord] LEO Pharma, Dept Mol Biomed, Ballerup, Denmark	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; LEO Pharma; LEO Pharma	Koenen, HJPM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Lab Med, Lab Med Immunol, NL-6525 ED Nijmegen, Netherlands.	h.koenen@labgk.umcn.nl	Fasse, Esther/K-3794-2016; de Oliveira, Vivian Leite/AAJ-9491-2020; Koenen, Hans J.P.M./A-2852-2014; van Erp, Piet/B-4061-2008; Hupkens, P./L-4400-2015; van de Kerkhof, P.C.M./H-8059-2014; Joosten, Irma/N-4418-2013; Seyger, M.M.B./L-4648-2015	de Oliveira, Vivian Leite/0000-0003-2523-0374; van Erp, Piet/0000-0002-6955-8817; Joosten, Irma/0000-0003-2950-4977; Norsgaard, Hanne/0000-0002-5249-6701	VanderEs Research Foundation; LEO Pharma A/S	VanderEs Research Foundation; LEO Pharma A/S	Part of this work was supported by a research grant from the VanderEs Research Foundation and other part was supported by a research grant from LEO Pharma A/S. The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript. However, they have been involved in a few sample analyses and data discussions in addition to manuscript reviewing.	ALKEMADE JAC, 1994, J CELL SCI, V107, P2335; Clark RA, 2007, BLOOD, V109, P194, DOI 10.1182/blood-2006-02-002873; Clark RA, 2006, J INVEST DERMATOL, V126, P1059, DOI 10.1038/sj.jid.5700199; Clark RA, 2010, J INVEST DERMATOL, V130, P362, DOI 10.1038/jid.2009.247; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; de Jongh GJ, 2005, J INVEST DERMATOL, V125, P1163, DOI 10.1111/j.0022-202X.2005.23935.x; Di Cesare A, 2008, J INVEST DERMATOL, V128, P2569, DOI 10.1038/jid.2008.283; Dudda JC, 2008, J EXP MED, V205, P1559, DOI 10.1084/jem.20072594; Feng G, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002099; Franssen MEJ, 2004, CYTOM PART B-CLIN CY, V57B, P32, DOI 10.1002/cyto.b.10069; Gallo RL, 1998, J INVEST DERMATOL, V111, P739, DOI 10.1046/j.1523-1747.1998.00361.x; Griffiths CEM, 2010, NEW ENGL J MED, V362, P118, DOI 10.1056/NEJMoa0810652; Aspizua SG, 2010, AM J PATHOL, V177, P3112, DOI 10.2353/ajpath.2010.100078; Hollox EJ, 2008, NAT GENET, V40, P23, DOI 10.1038/ng.2007.48; Hueber W, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001107; Igney FH, 2004, TRENDS PHARMACOL SCI, V25, P543, DOI 10.1016/j.tips.2004.08.004; Issa F, 2010, TRANSPLANTATION, V90, P1321, DOI 10.1097/TP.0b013e3181ff8772; Kamsteeg M, 2010, BRIT J DERMATOL, V162, P568, DOI 10.1111/j.1365-2133.2009.09547.x; Koenen HJPM, 2008, BLOOD, V112, P2340, DOI 10.1182/blood-2008-01-133967; Koga C, 2008, J INVEST DERMATOL, V128, P2625, DOI 10.1038/jid.2008.111; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; Langewouters AMG, 2007, J DERMATOL TREAT, V18, P279, DOI 10.1080/09546630701395044; Legrand N, 2009, CELL HOST MICROBE, V6, P5, DOI 10.1016/j.chom.2009.06.006; Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308; Liu LZ, 2006, IMMUNITY, V25, P511, DOI 10.1016/j.immuni.2006.06.019; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; MOSIER DE, 1993, J EXP MED, V177, P191, DOI 10.1084/jem.177.1.191; MUELLER W, 1979, NEW ENGL J MED, V301, P555; MURRAY AG, 1994, P NATL ACAD SCI USA, V91, P9146, DOI 10.1073/pnas.91.19.9146; Murray AG, 1998, AM J PATHOL, V153, P627, DOI 10.1016/S0002-9440(10)65604-0; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Nickoloff BJ, 1999, AM J PATHOL, V155, P145, DOI 10.1016/S0002-9440(10)65109-7; Nograles KE, 2008, BRIT J DERMATOL, V159, P1092, DOI 10.1111/j.1365-2133.2008.08769.x; NONOMURA K, 1994, J INVEST DERMATOL, V103, P88, DOI 10.1111/1523-1747.ep12391802; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Ortega C, 2009, J LEUKOCYTE BIOL, V86, P435, DOI [10.1189/jlb.0109046, 10.1189/JLB.0109046]; Paladini RD, 1996, J CELL BIOL, V132, P381, DOI 10.1083/jcb.132.3.381; Paul C, 2011, J EUR ACAD DERMATOL, V25, P1, DOI 10.1111/j.1468-3083.2011.03989.x; Peric M, 2008, J IMMUNOL, V181, P8504, DOI 10.4049/jimmunol.181.12.8504; Rohrl J, 2010, J BIOL CHEM, V285, P7028, DOI 10.1074/jbc.M109.091090; Sagoo P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002076; Sakaguchi S, 2000, CELL, V101, P455, DOI 10.1016/S0092-8674(00)80856-9; SCHALKWIJK J, 1993, J INVEST DERMATOL, V100, P390, DOI 10.1111/1523-1747.ep12471990; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Sigmundsdottir H, 2001, CLIN EXP IMMUNOL, V126, P365, DOI 10.1046/j.1365-2249.2001.01688.x; Takizawa Y, 1997, ARCH DERMATOL RES, V289, P213, DOI 10.1007/s004030050182; Tesmer LA, 2008, IMMUNOL REV, V223, P87, DOI 10.1111/j.1600-065X.2008.00628.x; Tomura M, 2010, J IMMUNOL, V184, P4646, DOI 10.4049/jimmunol.0903946; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Vukmanovic-Stejic M, 2008, J CLIN INVEST, V118, P3639, DOI 10.1172/JCI35834; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; WroneSmith T, 1996, J CLIN INVEST, V98, P1878, DOI 10.1172/JCI118989; Zaba LC, 2007, J EXP MED, V204, P3183, DOI 10.1084/jem.20071094; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	57	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e45509	10.1371/journal.pone.0045509	http://dx.doi.org/10.1371/journal.pone.0045509			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094018	Green Published, gold, Green Submitted			2022-12-25	WOS:000310050200003
J	Dunham, CM; Chirichella, TJ				Dunham, C. Michael; Chirichella, Thomas J.			Trauma Activation Patients: Evidence for Routine Alcohol and Illicit Drug Screening	PLOS ONE			English	Article								Background: Statistics from the National Trauma Data Bank imply that discretionary blood alcohol and urine drug testing is common. However, there is little evidence to determine which patients are appropriate for routine testing, based on information available at trauma center arrival. In 2002, Langdorf reported alcohol and illicit drug rates in Trauma Activation Patients. Methodology/Principal Findings: This is a retrospective investigation of alcohol and illicit drug rates in consecutive St. Elizabeth Health Center (SEHC) trauma patients. SEHC Trauma Activation Patients are compared with the Langdorf Activation Patients and with the SEHC Trauma Nonactivation Patients. Minimum Rates are positive tests divided by total patients (tested and not tested). Activation patients: The minimum alcohol rates were: SEHC 23.1%, Langdorf 28.2%, combined 24.8%. The minimum illicit drug rates were: SEHC 15.7%, Langdorf 23.5, combined 18.3%. The minimum alcohol and/or illicit drug rates were: SEHC 33.4%, Langdorf 41.8%, combined 36.2%. Nonactivation patients: The SEHC minimum alcohol rate was 4.7% and the minimum illicit drug rate was 6.0%. Conclusions: Alcohol and illicit drug rates were significantly greater for Trauma Activation Patients, when compared to Nonactivation Patients. At minimum, Trauma Activation Patients are likely to have a 1-in-3 positive test for alcohol and/or an illicit drug. This substantial rate suggests that Trauma Activation Patients, a readily discernible group at trauma center arrival, are appropriate for routine alcohol and illicit drug testing. However, discretionary testing is more reasonable for Trauma Nonactivation Patients, because minimum rates are low.	[Dunham, C. Michael; Chirichella, Thomas J.] St Elizabeth Hlth Ctr, Trauma Crit Serv, Youngstown, OH USA		Dunham, CM (corresponding author), St Elizabeth Hlth Ctr, Trauma Crit Serv, Youngstown, OH USA.	dunham.michael@sbcglobal.net		Dunham, C. Michael/0000-0002-7842-9750				American College of Surgeons - Committee on Trauma, 2008, ADV TRAUM LIF SUPP D; Bast RP, 2000, SOUTH MED J, V93, P397; Blondell RD, 2005, J TRAUMA, V58, P561, DOI 10.1097/01.TA.0000152638.54978.53; Blondell RD, 2002, J STUD ALCOHOL, V63, P380, DOI 10.15288/jsa.2002.63.380; Buchfuhrer LA, 1996, J ADDICT DIS, V15, P65, DOI 10.1300/J069v15n01_05; Committee on Trauma American College of Surgeons, 2006, COMM TRAUM AM COLL S; Cowperthwaite Matthew C, 2011, J Trauma Manag Outcomes, V5, P3, DOI 10.1186/1752-2897-5-3; Langdorf M I, 2002, Eur J Emerg Med, V9, P115, DOI 10.1097/00063110-200206000-00003; London JA, 2007, ARCH SURG-CHICAGO, V142, P633, DOI 10.1001/archsurg.142.7.633; Madan AK, 1999, J TRAUMA, V47, P568, DOI 10.1097/00005373-199909000-00026; Soderstrom CA, 2001, J TRAUMA, V51, P557, DOI 10.1097/00005373-200109000-00024; Vitale S, 2006, DRUG ALCOHOL DEPEN, V82, P1, DOI 10.1016/j.drugalcdep.2005.08.017	12	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47999	10.1371/journal.pone.0047999	http://dx.doi.org/10.1371/journal.pone.0047999			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094103	Green Submitted, gold, Green Published			2022-12-25	WOS:000310050200055
J	Sartorius, T; Staiger, H; Ketterer, C; Heni, M; Machicao, F; Guilherme, A; Grallert, H; Schulze, MB; Boeing, H; Stefan, N; Fritsche, A; Czech, MP; Haring, HU				Sartorius, Tina; Staiger, Harald; Ketterer, Caroline; Heni, Martin; Machicao, Fausto; Guilherme, Adilson; Grallert, Harald; Schulze, Matthias B.; Boeing, Heiner; Stefan, Norbert; Fritsche, Andreas; Czech, Michael P.; Haering, Hans-Ulrich			Association of Common Genetic Variants in the MAP4K4 Locus with Prediabetic Traits in Humans	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; ADIPOSE-TISSUE INFLAMMATION; INSULIN-RESISTANCE; C-JUN; RISK; GLUCOSE; MECHANISMS	Mitogen-activated protein kinase kinase kinase kinase 4 (MAP4K4) is expressed in all diabetes-relevant tissues and mediates cytokine-induced insulin resistance. We investigated whether common single nucleotide polymorphisms (SNPs) in the MAP4K4 locus associate with glucose intolerance, insulin resistance, impaired insulin release, or elevated plasma cytokines. The best hit was tested for association with type 2 diabetes. Subjects (N = 1,769) were recruited from the Tubingen Family (TUF) study for type 2 diabetes and genotyped for tagging SNPs. In a subgroup, cytokines were measured. Association with type 2 diabetes was tested in a prospective case-cohort study (N = 2,971) derived from the EPIC-Potsdam study. Three SNPs (rs6543087, rs17801985, rs1003376) revealed nominal and two SNPs (rs11674694, rs11678405) significant associations with 2-hour glucose levels. SNPs rs6543087 and rs11674694 were also nominally associated with decreased insulin sensitivity. Another two SNPs (rs2236936, rs2236935) showed associations with reduced insulin release, driven by effects in lean subjects only. Three SNPs (rs11674694, rs13003883, rs2236936) revealed nominal associations with IL-6 levels. SNP rs11674694 was significantly associated with type 2 diabetes. In conclusion, common variation in MAP4K4 is associated with insulin resistance and beta-cell dysfunction, possibly via this gene's role in inflammatory signalling. This variation's impact on insulin sensitivity may be more important since its effect on insulin release vanishes with increasing BMI.	[Sartorius, Tina; Staiger, Harald; Machicao, Fausto; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich] Univ Tubingen, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis, Tubingen, Germany; [Sartorius, Tina; Staiger, Harald; Ketterer, Caroline; Machicao, Fausto; Grallert, Harald; Schulze, Matthias B.; Boeing, Heiner; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich] German Ctr Diabet Res DZD, Neuherberg, Germany; [Sartorius, Tina; Staiger, Harald; Ketterer, Caroline; Heni, Martin; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich] Univ Tubingen, Dept Internal Med, Div Endocrinol Diabetol Angiol Nephrol & Clin Che, D-7400 Tubingen, Germany; [Guilherme, Adilson; Czech, Michael P.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Grallert, Harald] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Res Unit Mol Epidemiol, Inst Epidemiol, Neuherberg, Germany; [Schulze, Matthias B.] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Epidemiol, Nuthetal, Germany; [Boeing, Heiner] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Fritsche, Andreas] Univ Tubingen, Dept Internal Med, Div Nutr & Prevent Med, D-7400 Tubingen, Germany	Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Eberhard Karls University of Tubingen; University of Massachusetts System; University of Massachusetts Worcester; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Haring, HU (corresponding author), Univ Tubingen, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis, Tubingen, Germany.	hans-ulrich.haering@med.uni-tuebingen.de	Staiger, Harald/N-5871-2014; Schulze, Matthias B/AAH-6906-2021; Grallert, Harald/B-3424-2013	Schulze, Matthias B/0000-0002-0830-5277; Heni, Martin/0000-0002-8462-3832; Staiger, Harald/0000-0002-9507-5333; Stefan, Norbert/0000-0002-2186-9595	German Federal Ministry of Education and Research (BMBF) [01 GI 0925]; BMBF [01 EA 9401]; European Union [SOC 95201408 05F02, SOC 98200769 05F02]; German Cancer Aid [70-2488-Ha I]; German Research Foundation (DFG) [STE 1096/3-1]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); BMBF(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); German Cancer Aid(Deutsche Krebshilfe); German Research Foundation (DFG)(German Research Foundation (DFG))	The present study was supported in part by a grant (01 GI 0925) from the German Federal Ministry of Education and Research (BMBF) to the German Centre for Diabetes Research (DZD e.V.). The recruitment phase of the EPIC-Potsdam study was supported by the BMBF (01 EA 9401) and the European Union (SOC 95201408 05F02). The follow-up of the EPIC-Potsdam study was supported by German Cancer Aid (70-2488-Ha I) and the European Union (SOC 98200769 05F02). N.S. is currently supported by a Heisenberg professorship from the German Research Foundation (DFG, STE 1096/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Boeing H, 1999, ANN NUTR METAB, V43, P195, DOI 10.1159/000012786; Bouzakri K, 2007, J BIOL CHEM, V282, P7783, DOI 10.1074/jbc.M608602200; Bouzakri K, 2011, DIABETES, V60, P1111, DOI 10.2337/db10-1178; Bouzakri K, 2009, J BIOL CHEM, V284, P27892, DOI 10.1074/jbc.M109.048058; Haupt A, 2009, J CLIN ENDOCR METAB, V94, P1775, DOI 10.1210/jc.2008-1876; Herzberg-Schafer SA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014194; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Jin WZ, 2009, CLIN SCI, V116, P99, DOI 10.1042/CS20080090; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Kroder G, 1996, J CLIN INVEST, V97, P1471, DOI 10.1172/JCI118569; MARTIN BC, 1992, LANCET, V340, P925, DOI 10.1016/0140-6736(92)92814-V; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Perry JRB, 2008, CURR OPIN CLIN NUTR, V11, P371, DOI 10.1097/MCO.0b013e32830349a1; Staiger H, 2009, ENDOCR REV, V30, P557, DOI 10.1210/er.2009-0017; Stefan N, 2005, DIABETOLOGIA, V48, P2282, DOI 10.1007/s00125-005-1948-3; Stefan N, 2008, DIABETES, V57, P2762, DOI 10.2337/db08-0538; Tang XQ, 2006, P NATL ACAD SCI USA, V103, P2087, DOI 10.1073/pnas.0507660103; Tesz GJ, 2007, J BIOL CHEM, V282, P19302, DOI 10.1074/jbc.M700665200; Yao ZB, 1999, J BIOL CHEM, V274, P2118, DOI 10.1074/jbc.274.4.2118	27	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47647	10.1371/journal.pone.0047647	http://dx.doi.org/10.1371/journal.pone.0047647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094072	Green Published, Green Submitted, gold			2022-12-25	WOS:000312384500016
J	Garcia, PJ; Carcamo, CP; Garnett, GP; Campos, PE; Holmes, KK				Garcia, Patricia J.; Carcamo, Cesar P.; Garnett, Geoff P.; Campos, Pablo E.; Holmes, King K.			Improved STD Syndrome Management by a Network of Clinicians and Pharmacy Workers in Peru: The PREVEN Network	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; RANDOMIZED CONTROLLED-TRIAL; PRIVATE PHARMACIES; MULTICOMPONENT INTERVENTION; ANTIBIOTICS; NEPAL; COMMUNITY; KNOWLEDGE; DRUGGISTS; THAILAND	Background: Sexually Transmitted diseases (STD) syndrome management has been one cornerstone of STD treatment. Persons with STD symptoms in many countries, especially those with limited resources, often initially seek care in pharmacies. The objective of the study was to develop and evaluate an integrated network of physicians, midwives and pharmacy workers trained in STD syndromic management (The PREVEN Network) as part of a national urban community-randomized trial of sexually transmitted infection prevention in Peru. Methods and Findings: After a comprehensive census of physicians, midwives, and pharmacies in ten intervention and ten control cities, we introduced seminars and workshops for pharmacy workers, and continuing education for physicians and midwives in intervention cities and invited graduates to join the PREVEN Network. "Prevention Salespersons'' visited pharmacies, boticas and clinicians regularly for educational support and collection of information on numbers of cases of STD syndromes seen at pharmacies and by clinicians in intervention cities. Simulated patients evaluated outcomes of training of pharmacy workers with respect to adequate STD syndrome management, recommendations for condom use and for treatment of partners. In intervention cities we trained, certified, and incorporated into the PREVEN Network the workers at 623 (80.6%) of 773 pharmacies and 701 (69.6%) of 1007 physicians and midwives in private practice. Extremely high clinician and pharmacy worker turnover, 13.4% and 44% respectively in the first year, dictated continued training of new pharmacy workers and clinicians. By the end of the intervention the Network included 792 pharmacies and 597 clinicians. Pharmacies reported more cases of STDs than did clinicians. Evaluations by simulated patients showed significant and substantial improvements in the management of STD syndromes at pharmacies in intervention cities but not in control cities. Conclusions: Training pharmacy workers linked to a referral network of clinicians proved feasible and acceptable. High turnover was challenging but over come.	[Garcia, Patricia J.; Carcamo, Cesar P.; Campos, Pablo E.] Univ Peruana Cayetano Heredia, Sch Publ Hlth, STI AIDS Unit, Lima, Peru; [Garnett, Geoff P.] Univ London Imperial Coll Sci Technol & Med, London, England; [Holmes, King K.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Garcia, Patricia J.; Carcamo, Cesar P.; Holmes, King K.] Univ Washington, Dept Med, Seattle, WA USA; [Holmes, King K.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Holmes, King K.] Univ Washington, Ctr AIDS & STD, Seattle, WA 98195 USA	Universidad Peruana Cayetano Heredia; Imperial College London; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Garcia, PJ (corresponding author), Univ Peruana Cayetano Heredia, Sch Publ Hlth, STI AIDS Unit, Lima, Peru.	patricia.garcia@upch.pe	Garnett, Geoffrey P/A-9312-2008; , Holmes/K-6215-2019		Wellcome Trust-Burroughs Wellcome Fund Infectious Disease Initiative [059131/Z/99/Z, 078835/Z/05/Z, 078835/Z/05/B]; National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIAID) STD Cooperative Research Center NIAID [AI31448]; National Institutes of Health (NIH) Fogarty International Center Global Health Framework (A Global Health Demonstration Program in Peru) [PAR-05-050]; NIH Center for AIDS Research [P30-AI27757]; NIH Andean CIPRA [U19 AI053218]; USAID-Peru; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI031448, U01AI031448, U19AI053218, P30AI027757] Funding Source: NIH RePORTER	Wellcome Trust-Burroughs Wellcome Fund Infectious Disease Initiative(Burroughs Wellcome FundWellcome Trust); National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIAID) STD Cooperative Research Center NIAID; National Institutes of Health (NIH) Fogarty International Center Global Health Framework (A Global Health Demonstration Program in Peru); NIH Center for AIDS Research; NIH Andean CIPRA; USAID-Peru(United States Agency for International Development (USAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Supported by the Wellcome Trust-Burroughs Wellcome Fund Infectious Disease Initiative 059131/Z/99/Z, 078835/Z/05/Z, and 078835/Z/05/B; the National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIAID) STD Cooperative Research Center NIAID AI31448, the National Institutes of Health (NIH) Fogarty International Center Global Health Framework (A Global Health Demonstration Program in Peru PAR-05-050), the NIH Center for AIDS Research P30-AI27757 and the NIH Andean CIPRA U19 AI053218; and USAID-Peru. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bavestrello L, 2002, REV MED CHILE, V130, P1265; Bestane W J, 1980, AMB Rev Assoc Med Bras, V26, P2; Bista KP, 2002, SEX TRANSM INFECT, V78, P223, DOI 10.1136/sti.78.3.223; Canchihuaman FA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019318; Chalker J, 2005, SOC SCI MED, V60, P131, DOI 10.1016/j.socscimed.2004.04.019; Chalker J, 2002, TROP MED INT HEALTH, V7, P803, DOI 10.1046/j.1365-3156.2002.00934.x; Chalker J, 2000, SEX TRANSM INFECT, V76, P299, DOI 10.1136/sti.76.4.299; Cooper RJ, 2008, BMC MED EDUC, V8, DOI 10.1186/1472-6920-8-57; Cordova A, 1993, P 9 INT C AIDS 6 11, P840; FERRITER ME, 1991, J AUTOM CHEM, V13, P123, DOI 10.1155/S146392469100024X; Garcia P, 2003, B WORLD HEALTH ORGAN, V81, P806; Garcia PJ, 2007, SEX TRANSM INFECT, V83, P142, DOI 10.1136/sti.2006.022657; Garcia PJ, 1998, SEX TRANSM INFECT, V74, pS153; Garcia PJ, 2012, LANCET; Grigoryan L, 2008, J ANTIMICROB CHEMOTH, V61, P1172, DOI 10.1093/jac/dkn054; Hsieh Evelyn J., 2006, Rev Panam Salud Publica, V20, P223, DOI 10.1590/S1020-49892006000900002; Hsieh EJ, 2008, REV PANAM SALUD PUBL, V24, P271, DOI 10.1590/S1020-49892008001000007; Khan MMH, 2006, INT J QUAL HEALTH C, V18, P66, DOI 10.1093/intqhc/mzi086; Kwena Z A, 2008, East Afr Med J, V85, P419; Lopez R, 1990, MORBILIDAD MEDICAMEN; Mainous AG, 2009, ANN FAM MED, V7, P431, DOI 10.1370/afm.999; Mayta-Tristan P, 2008, LANCET, V371, P1577, DOI 10.1016/S0140-6736(08)60685-6; Organizacion Internacional para las Migraciones Instituto Nacional de Estadistica e Informatica & Direccion General de Migraciones y Naturalizacion, 2008, PER EST MIGR INT PER; Prempree P, 2007, SEX HEALTH, V4, P17, DOI 10.1071/SH06035; Reeves D, 2007, J ANTIMICROB CHEMOTH, V59, P333, DOI 10.1093/jac/dkl502; Rollnick S, 1995, BEHAV COGN PSYCHOTH, V23, P325, DOI DOI 10.1017/S135246580001643X; SOUMERAI SB, 1990, JAMA-J AM MED ASSOC, V263, P549, DOI 10.1001/jama.263.4.549; Stergachis A, 1999, SEX TRANSM DIS, V26, pS44, DOI 10.1097/00007435-199904001-00010; STIGMA, 2019, GUID MAN SEX TRANSM; Tuladhar SM, 1998, AIDS, V12, pS81; Turner AN, 2003, SEX TRANSM INFECT, V79, P224, DOI 10.1136/sti.79.3.224; VANDERGEEST S, 1987, SOC SCI MED, V25, P293, DOI 10.1016/0277-9536(87)90232-2; Ward K, 2003, SEX TRANSM DIS, V30, P609, DOI 10.1097/01.OLQ.0000079521.04451.10	33	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47750	10.1371/journal.pone.0047750	http://dx.doi.org/10.1371/journal.pone.0047750			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082208	Green Published, Green Submitted, gold			2022-12-25	WOS:000311146900105
J	Lai, LM; Zhao, XC; Jiang, LH; Wang, YJ; Luo, LG; Zheng, YR; Chen, X; Rimmington, GM				Lai, Liming; Zhao, Xuechun; Jiang, Lianhe; Wang, Yongji; Luo, Liangguo; Zheng, Yuanrun; Chen, Xi; Rimmington, Glyn M.			Soil Respiration in Different Agricultural and Natural Ecosystems in an Arid Region	PLOS ONE			English	Article							WATER-CONTENT; TEMPERATURE SENSITIVITY; MICROBIAL BIOMASS; CARBON-DIOXIDE; FOREST SOIL; CO2 EFFLUX; LAND-USE; VEGETATION; SALINITY; DEPENDENCE	The variation of different ecosystems on the terrestrial carbon balance is predicted to be large. We investigated a typical arid region with widespread saline/alkaline soils, and evaluated soil respiration of different agricultural and natural ecosystems. Soil respiration for five ecosystems together with soil temperature, soil moisture, soil pH, soil electric conductivity and soil organic carbon content were investigated in the field. Comparing with the natural ecosystems, the mean seasonal soil respiration rates of the agricultural ecosystems were 96%-386% higher and agricultural ecosystems exhibited lower CO2 absorption by the saline/alkaline soil. Soil temperature and moisture together explained 48%, 86%, 84%, 54% and 54% of the seasonal variations of soil respiration in the five ecosystems, respectively. There was a significant negative relationship between soil respiration and soil electrical conductivity, but a weak correlation between soil respiration and soil pH or soil organic carbon content. Our results showed that soil CO2 emissions were significantly different among different agricultural and natural ecosystems, although we caution that this was an observational, not manipulative, study. Temperature at the soil surface and electric conductivity were the main driving factors of soil respiration across the five ecosystems. Care should be taken when converting native vegetation into cropland from the point of view of greenhouse gas emissions.	[Lai, Liming; Zhao, Xuechun; Jiang, Lianhe; Wang, Yongji; Zheng, Yuanrun] Chinese Acad Sci, Key Lab Resource Plants, Beijing Bot Garden, W China Subalpine Bot Garden,Inst Bot, Beijing, Peoples R China; [Zhao, Xuechun] Univ Chinese Acad Sci, Beijing, Peoples R China; [Luo, Liangguo] Chinese Acad Agr Sci, Key Lab Agr Environm, Inst Environm & Sustainable Dev Agr, Minist Agr, Beijing 100193, Peoples R China; [Chen, Xi] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, Urumqi, Xinjiang, Peoples R China; [Rimmington, Glyn M.] Wichita State Univ, Global Learning Coll Engn, Wichita, KS USA	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Agricultural Sciences; Institute of Environment & Sustainable Development in Agriculture, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Wichita State University	Zheng, YR (corresponding author), Chinese Acad Sci, Key Lab Resource Plants, Beijing Bot Garden, W China Subalpine Bot Garden,Inst Bot, Beijing, Peoples R China.	zhengyr@ibcas.ac.cn	liming, lai/HGB-0743-2022		China National Key Basic Research Program [2009CB825103]	China National Key Basic Research Program(National Basic Research Program of China)	This work was supported by China National Key Basic Research Program (2009CB825103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsberry L, 2000, ECOL APPL, V10, P1110, DOI 10.1890/1051-0761(2000)010[1110:CIATEO]2.0.CO;2; Bao S D, 1999, METHODS AGROCHEMICAL, P25; Bond-Lamberty B, 2004, GLOBAL CHANGE BIOL, V10, P1756, DOI 10.1111/j.1365-2486.2004.00816.x; Bond-Lamberty B, 2010, NATURE, V464, P579, DOI 10.1038/nature08930; Boone RD, 1998, NATURE, V396, P570, DOI 10.1038/25119; Borken W, 2002, GLOBAL CHANGE BIOL, V8, P1205, DOI 10.1046/j.1365-2486.2002.00547.x; Bowden RD, 1998, SOIL BIOL BIOCHEM, V30, P1591, DOI 10.1016/S0038-0717(97)00228-9; Brooks PD, 2005, GLOBAL CHANGE BIOL, V11, P231, DOI 10.1111/j.1365-2486.2004.00877.x; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Davidson EA, 2000, BIOGEOCHEMISTRY, V48, P53, DOI 10.1023/A:1006204113917; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Eswaran H, 2000, GLOBAL CLIMATE CHANGE AND PEDOGENIC CARBONATES, P15; HOUGHTON RA, 1995, GLOB CHANGE BIOL, V1, P275, DOI 10.1111/j.1365-2486.1995.tb00026.x; Jia B, 2006, J ARID ENVIRON, V67, P60, DOI 10.1016/j.jaridenv.2006.02.002; Lal R, 2004, ENVIRON MANAGE, V33, P528, DOI 10.1007/s00267-003-9110-9; Lavigne MB, 2004, TREE PHYSIOL, V24, P415, DOI 10.1093/treephys/24.4.415; Lenihan JM, 2003, ECOL APPL, V13, P1667, DOI 10.1890/025295; Litton CM, 2008, GLOBAL CHANGE BIOL, V14, P726, DOI 10.1111/j.1365-2486.2008.01546.x; Liu XZ, 2002, PLANT SOIL, V240, P213, DOI 10.1023/A:1015744126533; LLOYD J, 1994, FUNCT ECOL, V8, P315, DOI 10.2307/2389824; Luo Y., 2006, SOIL RESP ENV, P107; Mahecha MD, 2010, SCIENCE, V329, P838, DOI 10.1126/science.1189587; Mo W, 2005, AGR FOREST METEOROL, V134, P81, DOI 10.1016/j.agrformet.2005.08.015; Nelson PN, 1996, SOIL BIOL BIOCHEM, V28, P433, DOI 10.1016/0038-0717(96)00002-8; Parsons AN, 2004, ECOSYSTEMS, V7, P286, DOI 10.1007/s10021-003-0132-1; Pavelka M, 2007, PLANT SOIL, V292, P171, DOI 10.1007/s11104-007-9213-9; Raich JW, 2000, BIOGEOCHEMISTRY, V48, P71, DOI 10.1023/A:1006112000616; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; Rao DLN, 1996, ARID SOIL RES REHAB, V10, P311, DOI 10.1080/15324989609381446; Rey A, 2002, GLOBAL CHANGE BIOL, V8, P851, DOI 10.1046/j.1365-2486.2002.00521.x; Rietz DN, 2003, SOIL BIOL BIOCHEM, V35, P845, DOI 10.1016/S0038-0717(03)00125-1; Sardinha M, 2003, APPL SOIL ECOL, V23, P237, DOI 10.1016/S0929-1393(03)00027-1; Saviozzi A, 2001, PLANT SOIL, V233, P251, DOI 10.1023/A:1010526209076; Sayer EJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001299; Sotta ED, 2004, GLOBAL CHANGE BIOL, V10, P601, DOI 10.1111/j.1529-8817.2003.00761.x; SPSS, 2000, SPSS WIND VERS 13 0; Thornley JHM, 2001, ANN BOT-LONDON, V87, P591, DOI 10.1006/anbo.2001.1372; Trumbore S, 2006, GLOBAL CHANGE BIOL, V12, P141, DOI 10.1111/j.1365-2486.2006.01067.x; Vincent G, 2006, SOIL BIOL BIOCHEM, V38, P2527, DOI 10.1016/j.soilbio.2006.03.009; Wagai R, 1998, SOIL BIOL BIOCHEM, V30, P1501, DOI 10.1016/S0038-0717(98)00041-8; Wan S, 2007, GLOBAL CHANGE BIOL, V13, P2411, DOI 10.1111/j.1365-2486.2007.01433.x; WEBER MG, 1990, FOREST ECOL MANAG, V31, P1, DOI 10.1016/0378-1127(90)90107-M; Wong VNL, 2008, BIOL FERT SOILS, V44, P943, DOI 10.1007/s00374-008-0279-1; Xie JX, 2009, ENVIRON GEOL, V56, P953, DOI 10.1007/s00254-008-1197-0; Zhang LH, 2010, J ARID ENVIRON, V74, P1200, DOI 10.1016/j.jaridenv.2010.05.031; Zheng Y, 2006, J ARID ENVIRON, V66, P113, DOI 10.1016/j.jaridenv.2005.09.005	46	49	54	10	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e48011	10.1371/journal.pone.0048011	http://dx.doi.org/10.1371/journal.pone.0048011			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082234	Green Published, gold			2022-12-25	WOS:000311146900131
J	Zhu, CT; Rand, DM				Zhu, Chen-Tseh; Rand, David M.			A Hydrazine Coupled Cycling Assay Validates the Decrease in Redox Ratio under Starvation in Drosophila	PLOS ONE			English	Article							NICOTINAMIDE-ADENINE-DINUCLEOTIDE; SINGLE EXTRACTION PROCEDURE; PYRIDINE-NUCLEOTIDES; TRIPHOSPHOPYRIDINE NUCLEOTIDE; GENETIC-VARIATION; NADH; METABOLISM; STATE; VALUES; DEHYDROGENASE	A commonly used enzymatic recycling assay for pyridine nucleotides has been adapted to directly measure the NAD(+)/NADH redox ratio in Drosophila melanogaster. This method is also suitable for quantification of NADP(+) and NADPH. The addition of a coupling reaction removing acetaldehyde produced from the alcohol dehydrogenase (ADH) reaction was shown to improve the linearity of NAD(H) assay. The advantages of this assay method are that it allows the determination of both NAD(+) and NADH simultaneously while keeping enzymatic degradation of pyridine nucleotides minimal and also achieving better sensitivity. This method was used to determine the redox ratio of D. melanogaster and validated substantial decrease of redox ratio during starvation.	[Zhu, Chen-Tseh; Rand, David M.] Brown Univ, Dept Ecol & Evolut Biol, Providence, RI 02912 USA	Brown University	Zhu, CT (corresponding author), Brown Univ, Dept Ecol & Evolut Biol, Providence, RI 02912 USA.	ctzhu@brown.edu	Zhu, Chen-Tseh (Lei)/A-9761-2014		National Institutes of Health [1RO1AG027849, 2RO1GM067862]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067862] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027849] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by grants from the National Institutes of Health: 1RO1AG027849 and 2RO1GM067862, both to D.M.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker BM, 2001, FEMS MICROBIOL REV, V25, P15, DOI 10.1016/S0168-6445(00)00039-5; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; BERNOFSKY C, 1973, ANAL BIOCHEM, V53, P452, DOI 10.1016/0003-2697(73)90094-8; BESSHO M, 1989, ANAL BIOCHEM, V182, P304, DOI 10.1016/0003-2697(89)90599-X; BURCH HB, 1967, J BIOL CHEM, V242, P4546; Candeias LP, 1998, J CHEM SOC PERK T 2, P2333, DOI 10.1039/a806431h; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; de Graef MR, 1999, J BACTERIOL, V181, P2351, DOI 10.1128/JB.181.8.2351-2357.1999; Fulco M, 2003, MOL CELL, V12, P51, DOI 10.1016/S1097-2765(03)00226-0; GLOCK GE, 1955, BIOCHEM J, V61, P381, DOI 10.1042/bj0610381; Hoffmann A, 2001, J CELL PHYSIOL, V188, P33, DOI 10.1002/jcp.1092; KHAN S, 1995, BBA-MOL CELL RES, V1269, P153, DOI 10.1016/0167-4889(95)00112-6; Kohen R, 1997, ARCH GERONTOL GERIAT, V24, P103, DOI 10.1016/S0167-4943(96)00744-3; Lin SJ, 2004, GENE DEV, V18, P12, DOI 10.1101/gad.1164804; Lin SJ, 2003, CURR OPIN CELL BIOL, V15, P241, DOI 10.1016/S0955-0674(03)00006-1; LINKLATER HA, 1985, ANAL BIOCHEM, V148, P44, DOI 10.1016/0003-2697(85)90625-6; LOWRY OH, 1961, J BIOL CHEM, V236, P2756; LOWRY OH, 1961, J BIOL CHEM, V236, P2746; Mayevsky A, 2007, AM J PHYSIOL-CELL PH, V292, pC615, DOI 10.1152/ajpcell.00249.2006; MORK J, 1985, CAN J FISH AQUAT SCI, V42, P1580, DOI 10.1139/f85-198; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; NOY N, 1985, MECH AGEING DEV, V29, P63, DOI 10.1016/0047-6374(85)90047-8; OGATA ES, 1990, PEDIATR RES, V27, P56, DOI 10.1203/00006450-199001000-00017; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; PLACE AR, 1979, P NATL ACAD SCI USA, V76, P2354, DOI 10.1073/pnas.76.5.2354; REISS PD, 1984, ANAL BIOCHEM, V140, P162, DOI 10.1016/0003-2697(84)90148-9; RHODES MJC, 1968, PHYTOCHEMISTRY, V7, P337, DOI 10.1016/S0031-9422(00)90872-0; Sun FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034525; TANFORD C, 1967, J AM CHEM SOC, V89, P729, DOI 10.1021/ja00980a001; TISCHLER ME, 1977, ARCH BIOCHEM BIOPHYS, V184, P222, DOI 10.1016/0003-9861(77)90346-0; Umemura K, 2005, ANAL BIOCHEM, V338, P131, DOI 10.1016/j.ab.2004.10.020; WILLIAMSON DH, 1967, BIOCHEM J, V103, P514, DOI 10.1042/bj1030514; WU JT, 1986, CLIN CHEM, V32, P314; Xu KY, 2008, CELL METAB, V8, P289, DOI 10.1016/j.cmet.2008.09.006; Yamada K, 2006, ANAL BIOCHEM, V352, P282, DOI 10.1016/j.ab.2006.02.017; YAN RT, 1987, ANAL BIOCHEM, V164, P362, DOI 10.1016/0003-2697(87)90505-7; YANCEY PH, 1978, J COMP PHYSIOL, V125, P129, DOI 10.1007/BF00686748; ZEREZ CR, 1987, ANAL BIOCHEM, V164, P367, DOI 10.1016/0003-2697(87)90506-9; Zhang QH, 2002, SCIENCE, V295, P1895	39	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47584	10.1371/journal.pone.0047584	http://dx.doi.org/10.1371/journal.pone.0047584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082179	gold, Green Submitted, Green Published			2022-12-25	WOS:000311146900075
J	Biacchesi, S; Merour, E; Lamoureux, A; Bernard, J; Bremont, M				Biacchesi, Stephane; Merour, Emilie; Lamoureux, Annie; Bernard, Julie; Bremont, Michel			Both STING and MAVS Fish Orthologs Contribute to the Induction of Interferon Mediated by RIG-I	PLOS ONE			English	Article							ANTIVIRAL SIGNALING PROTEIN; INNATE IMMUNE RECOGNITION; NF-KAPPA-B; ADAPTER PROTEIN; RNA HELICASE; JAPANESE FLOUNDER; RAINBOW-TROUT; IFN RESPONSE; GENE; VIRUS	Viral infections are detected in most cases by the host innate immune system through pattern-recognition receptors (PRR), the sensors for pathogen-associated molecular patterns (PAMPs), which induce the production of cytokines, such as type I interferons (IFN). Recent identification in mammalian and teleost fish of cytoplasmic viral RNA sensors, RIG-I-like receptors (RLRs), and their mitochondrial adaptor: the mitochondrial antiviral signaling (MAVS) protein, also called IPS-1, highlight their important role in the induction of IFN at the early stage of a virus infection. More recently, an endoplasmic reticulum (ER) adaptor: the stimulator of interferon genes (STING) protein, also called MITA, ERIS and MPYS, has been shown to play a pivotal role in response to both non-self-cytosolic RNA and dsDNA. In this study, we cloned STING cDNAs from zebrafish and showed that it was an ortholog to mammalian STING. We demonstrated that overexpression of this ER protein in fish cells led to a constitutive induction of IFN and interferon-stimulated genes (ISGs). STING-overexpressing cells were almost fully protected against RNA virus infection with a strong inhibition of both DNA and RNA virus replication. In addition, we found that together with MAVS, STING was an important player in the RIG-I IFN-inducing pathway. This report provides the demonstration that teleost fish possess a functional RLR pathway in which MAVS and STING are downstream signaling molecules of RIG-I. The Sequences presented in this article have been submitted to GenBank under accession numbers: Zebrafish STING (HE856619); EPC STING (HE856620); EPC IRF3 (HE856621); EPC IFN promoter (HE856618).	[Biacchesi, Stephane; Merour, Emilie; Lamoureux, Annie; Bernard, Julie; Bremont, Michel] INRA, CRJ, Unite Virol & Immunol Mol, Jouy En Josas, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay	Biacchesi, S (corresponding author), INRA, CRJ, Unite Virol & Immunol Mol, Jouy En Josas, France.	stephane.biacchesi@jouy.inra.fr	BIACCHESI, STEPHANE/A-6924-2010	BIACCHESI, STEPHANE/0000-0002-7020-2391	animal health department of the Institut National de la Recherche Agronomique (INRA)	animal health department of the Institut National de la Recherche Agronomique (INRA)	This work was supported by the animal health department of the Institut National de la Recherche Agronomique (INRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber GN, 2011, IMMUNOL REV, V243, P99, DOI 10.1111/j.1600-065X.2011.01051.x; Belgnaoui SM, 2011, CURR OPIN IMMUNOL, V23, P564, DOI 10.1016/j.coi.2011.08.001; Bergan V, 2010, MOL IMMUNOL, V47, P2005, DOI 10.1016/j.molimm.2010.04.015; Biacchesi S, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-12; Biacchesi S, 2010, J VIROL, V84, P10038, DOI 10.1128/JVI.00343-10; Biacchesi S, 2009, J VIROL, V83, P7815, DOI 10.1128/JVI.00404-09; Boudinot P, 1999, J VIROL, V73, P1846, DOI 10.1128/JVI.73.3.1846-1852.1999; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Castanier C, 2010, EMBO REP, V11, P133, DOI 10.1038/embor.2009.258; Chang MX, 2011, J VIROL, V85, P8403, DOI 10.1128/JVI.00445-10; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Feng H, 2011, FISH SHELLFISH IMMUN, V30, P1159, DOI 10.1016/j.fsi.2011.03.002; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Gomez-Casado E, 2011, VACCINE, V29, P2657, DOI 10.1016/j.vaccine.2011.01.097; Holland JW, 2008, MOL IMMUNOL, V46, P269, DOI 10.1016/j.molimm.2008.08.265; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Jin L, 2008, MOL CELL BIOL, V28, P5014, DOI 10.1128/MCB.00640-08; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Jones JW, 2010, P NATL ACAD SCI USA, V107, P9771, DOI 10.1073/pnas.1003738107; Kang DC, 2002, P NATL ACAD SCI USA, V99, P637, DOI 10.1073/pnas.022637199; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2005, IMMUNITY, V23, P19, DOI 10.1016/j.immuni.2005.04.010; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawasaki T, 2011, IMMUNOL REV, V243, P61, DOI 10.1111/j.1600-065X.2011.01048.x; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; LANGDON JS, 1986, J FISH DIS, V9, P263, DOI 10.1111/j.1365-2761.1986.tb01011.x; Lauksund S, 2009, DEV COMP IMMUNOL, V33, P1196, DOI 10.1016/j.dci.2009.06.012; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Ohtani M, 2012, DEV COMP IMMUNOL, V36, P697, DOI 10.1016/j.dci.2011.10.008; Ohtani M, 2011, DEV COMP IMMUNOL, V35, P554, DOI 10.1016/j.dci.2010.12.013; Ohtani M, 2010, J IMMUNOL, V185, P7507, DOI 10.4049/jimmunol.1001850; Onoguchi K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001012; Ouyang SY, 2012, IMMUNITY, V36, P1073, DOI 10.1016/j.immuni.2012.03.019; Prantner D, 2010, J IMMUNOL, V184, P2551, DOI 10.4049/jimmunol.0903704; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Sauer JD, 2011, INFECT IMMUN, V79, P688, DOI 10.1128/IAI.00999-10; Schlee M, 2009, IMMUNOL REV, V227, P66, DOI 10.1111/j.1600-065X.2008.00724.x; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2011, IMMUNITY, V35, P194, DOI 10.1016/j.immuni.2011.05.016; Simora RMC, 2010, FISH SHELLFISH IMMUN, V29, P979, DOI 10.1016/j.fsi.2010.08.012; Sullivan C, 2007, J IMMUNOL, V178, P4517, DOI 10.4049/jimmunol.178.7.4517; Sun F, 2011, J IMMUNOL, V187, P2531, DOI 10.4049/jimmunol.1100642; Sun F, 2010, J IMMUNOL, V185, P7573, DOI 10.4049/jimmunol.1002401; Sun L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030802; Sun QM, 2006, IMMUNITY, V24, P633, DOI 10.1016/j.immuni.2006.04.004; Sun WX, 2009, P NATL ACAD SCI USA, V106, P8653, DOI 10.1073/pnas.0900850106; Takaoka A, 2007, NATURE, V448, P501, DOI 10.1038/nature06013; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Winton J, 2010, J FISH DIS, V33, P701, DOI 10.1111/j.1365-2761.2010.01165.x; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x; Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zou J, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-85	63	75	83	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47737	10.1371/journal.pone.0047737	http://dx.doi.org/10.1371/journal.pone.0047737			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091644	Green Published, gold, Green Submitted			2022-12-25	WOS:000310135800070
J	Sobolewski, P; Kandel, J; Eckmann, DM				Sobolewski, Peter; Kandel, Judith; Eckmann, David M.			Air Bubble Contact with Endothelial Cells Causes a Calcium-Independent Loss in Mitochondrial Membrane Potential	PLOS ONE			English	Article							PROTEIN-KINASE-C; LIQUID INTERFACES; GAS EMBOLISM; GLYCOCALYX; MECHANOTRANSDUCTION; PATHOPHYSIOLOGY; ADSORPTION; SYNDECAN-4; KINETICS; LAYER	Objective: Gas microembolism remains a serious risk associated with surgical procedures and decompression. Despite this, the signaling consequences of air bubbles in the vasculature are poorly understood and there is a lack of pharmacological therapies available. Here, we investigate the mitochondrial consequences of air bubble contact with endothelial cells. Methods and Results: Human umbilical vein endothelial cells were loaded with an intracellular calcium indicator (Fluo-4) and either a mitochondrial calcium indicator (X-Rhod-1) or mitochondrial membrane potential indicator (TMRM). Contact with 50-150 mu m air bubbles induced concurrent rises in intracellular and mitochondrial calcium, followed by a loss of mitochondrial membrane potential. Pre-treating cells with 1 mu mol/L ruthenium red, a TRPV family calcium channel blocker, did not protect cells from the mitochondrial depolarization, despite blocking the intracellular calcium response. Mitigating the interactions between the air-liquid interface and the endothelial surface layer with 5% BSA or 0.1% Pluronic F-127 prevented the loss of mitochondrial membrane potential. Finally, inhibiting protein kinase C-alpha (PKC alpha), with 5 mmol/L Go6976, protected cells from mitochondrial depolarization, but did not affect the intracellular calcium response. Conclusions: Our results indicate that air bubble contact with endothelial cells activates a novel, calcium-independent, PKC alpha-dependent signaling pathway, which results in mitochondrial depolarization. As a result, mitochondrial dysfunction is likely to be a key contributor to the pathophysiology of gas embolism injury. Further, this connection between the endothelial surface layer and endothelial mitochondria may also play an important role in vascular homeostasis and disease.	[Sobolewski, Peter; Eckmann, David M.] Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA; [Kandel, Judith; Eckmann, David M.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Eckmann, DM (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, Philadelphia, PA 19104 USA.	eckmanndm@uphs.upenn.edu	Sobolewski, Peter/I-7177-2013; Eckmann, David/O-5472-2016	Sobolewski, Peter/0000-0002-2097-0990; Eckmann, David/0000-0002-8954-8827	Office of Naval Research [N00014-08-1-0436, N00014-10-1-0074]; National Institutes of Health [R01 HL067986]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007954, R01HL067986] Funding Source: NIH RePORTER	Office of Naval Research(Office of Naval Research); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported by: Office of Naval Research N00014-08-1-0436 and N00014-10-1-0074 to D.M.E. National Institutes of Health R01 HL067986 to D.M.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON RH, 1992, J PHYSIOL-LONDON, V445, P473, DOI 10.1113/jphysiol.1992.sp018934; Barak M, 2005, CHEST, V128, P2918, DOI 10.1378/chest.128.4.2918; Davidson SM, 2007, CIRC RES, V100, P1128, DOI 10.1161/01.RES.0000261970.18328.1d; Eckmann DM, 2006, ANN NY ACAD SCI, V1077, P256, DOI 10.1196/annals.1362.039; Franzen CA, 2009, MOL CANCER RES, V7, P1045, DOI 10.1158/1541-7786.MCR-09-0017; GRAHAM DE, 1979, J COLLOID INTERF SCI, V70, P403, DOI 10.1016/0021-9797(79)90048-1; GRAHAM DE, 1979, J COLLOID INTERF SCI, V70, P427, DOI 10.1016/0021-9797(79)90050-X; Hansen FK, 1995, J COLLOID INTERF SCI, V176, P408, DOI 10.1006/jcis.1995.9951; HELPS SC, 1990, STROKE, V21, P94, DOI 10.1161/01.STR.21.1.94; Klinger AL, 2011, INTEGR BIOL-UK, V3, P1033, DOI 10.1039/c1ib00017a; Kobayashi S, 2011, UNDERSEA HYPERBAR M, V38, P27; Koo BK, 2006, J MOL BIOL, V355, P651, DOI 10.1016/j.jmb.2005.09.087; Lampe JW, 2010, LANGMUIR, V26, P2452, DOI 10.1021/la903703u; Liao ZZ, 2011, LANGMUIR, V27, P12775, DOI 10.1021/la203053g; Lou S, 2011, INT J ARTIF ORGANS, V34, P1039, DOI 10.5301/ijao.5000010; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mirski MA, 2007, ANESTHESIOLOGY, V106, P164, DOI 10.1097/00000542-200701000-00026; Moon JJ, 2005, J CELL PHYSIOL, V203, P166, DOI 10.1002/jcp.20220; Multhaupt HAB, 2009, J PHYSIOL PHARMACOL, V60, P31; Oh ES, 1997, J BIOL CHEM, V272, P11805, DOI 10.1074/jbc.272.18.11805; Pries AR, 2000, PFLUG ARCH EUR J PHY, V440, P653, DOI 10.1007/s004240000307; Sobolewski P, 2011, AM J PHYSIOL-CELL PH, V301, pC679, DOI 10.1152/ajpcell.00046.2011; Suzuki A, 2004, ANESTHESIOLOGY, V101, P97, DOI 10.1097/00000542-200407000-00016; Szabadkai G, 2008, PHYSIOLOGY, V23, P84, DOI 10.1152/physiol.00046.2007; Tarbell JM, 2006, J INTERN MED, V259, P339, DOI 10.1111/j.1365-2796.2006.01620.x; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; van Hulst RA, 2003, CLIN PHYSIOL FUNCT I, V23, P237; Vann RD, 2011, LANCET, V377, P153, DOI 10.1016/S0140-6736(10)61085-9; Wang Y, 2006, BIOCHEM PHARMACOL, V72, P881, DOI 10.1016/j.bcp.2006.06.032; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959	30	25	25	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47254	10.1371/journal.pone.0047254	http://dx.doi.org/10.1371/journal.pone.0047254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091614	Green Submitted, Green Published, gold			2022-12-25	WOS:000310135800036
J	Wang, PS; Chen, HC; Wu, HM; Lirng, JF; Wu, YT; Soong, BW				Wang, Po-Shan; Chen, Hung-Chieh; Wu, Hsiu-Mei; Lirng, Jiing-Feng; Wu, Yu-Te; Soong, Bing-Wen			Association between Proton Magnetic Resonance Spectroscopy Measurements and CAG Repeat Number in Patients with Spinocerebellar Ataxias 2, 3, or 6	PLOS ONE			English	Article							MACHADO-JOSEPH-DISEASE; POLYGLUTAMINE-INDUCED NEURODEGENERATION; AGE-OF-ONSET; SCA2; TYPE-6; MODEL; FAMILIES	The aim of this study was to correlate magnetic resonance spectroscopy (MRS) measurements, including that for the N-acetyl aspartate (NAA)/creatine (Cr) ratio in the vermis (denoted V-NAA), right cerebellar hemisphere (R-NAA), and left (L-NAA) cerebellar hemisphere, with the clinical scale for the assessment and rating of ataxia (SARA) score for patients with spinocerebellar ataxia (SCA) types 2, 3, and 6. A total of 24 patients with SCA2, 48 with SCA3, and 16 with SCA6 were recruited; 12 patients with SCA2, 43 with SCA3, and 8 with SCA6 underwent detailed magnetic resonance neuroimaging. Forty-four healthy, age-matched individuals without history of neurologic disease served as control subjects. V-NAA and patient age were used to calculate the predicted age at which a patient with SCA2 or SCA3 would reach an onset V-NAA value. Results showed the following: the NAA/Cr ratio decreased with increasing age in patients with SCA but not in control subjects; the SARA score increased progressively with age and duration of illness; V-NAA showed a better correlation with SARA score than R-NAA in patients with SCA2 or SCA3; the ratio of age to V-NAA correlated well with CAG repeat number; the retrospectively predicted age of onset for SCA2 and SCA3 was consistent with patient-reported age of onset; R-NAA showed a better correlation with SARA score than V-NAA in patients with SCA6; V-NAA and R-NAA correlated with clinical severity (SARA score) in patients with SCA. The correlation between CAG repeat number and age could be expressed as a simple linear function, which might explain previous observations claiming that the greater the CAG repeat number, the earlier the onset of illness and the faster the disease progression. These findings support the use of MRS values to predict age of disease onset and to retrospectively evaluate the actual age of disease onset in SCA.	[Wu, Yu-Te] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Wang, Po-Shan] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Wang, Po-Shan] Municipal Gandau Hosp, Dept Med, Taipei, Taiwan; [Wang, Po-Shan; Chen, Hung-Chieh; Soong, Bing-Wen] Natl Yang Ming Univ, Dept Neurol, Sch Med, Taipei 112, Taiwan; [Wang, Po-Shan; Chen, Hung-Chieh; Soong, Bing-Wen] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan; [Chen, Hung-Chieh; Wu, Hsiu-Mei; Lirng, Jiing-Feng] Taipei Vet Gen Hosp, Dept Radiol, Taipei, Taiwan; [Chen, Hung-Chieh; Wu, Hsiu-Mei; Lirng, Jiing-Feng] Natl Yang Ming Univ, Dept Radiol, Sch Med, Taipei 112, Taiwan; [Wu, Yu-Te] Taipei Vet Gen Hosp, Integrated Brain Res Lab, Dept Med Res & Educ, Taipei, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital	Wu, YT (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan.	yutewu163@163.com; bwsoong@ym.edu.tw	Chen, hung-chieh/AAH-6591-2019	Chen, hung-chieh/0000-0003-3544-5045	Taipei Veterans General Hospital [V99C1-155, V100C-129, VGHUST100-G7-3-2, VGHUST101-G4-2-4]; National Science Council [NSC99-2221-E-075-003, NSC99-2221-E-010-012, NSC100-2221-E-010-009, NSC101-2221-E-010-004-MY2, NSC101-2314-B-733-001-MY2]; NSC; National Central University, Taiwan [NSC100-2911-I-008-001]; Center for Dynamical Biomarkers and Translational Medicine; National Central University, Chungli, Taiwan; Brain Research Center, National Yang-Ming University; Ministry of Education, Aim for the Top University Plansic	Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Science Council(Ministry of Science and Technology, Taiwan); NSC(Ministry of Science and Technology, Taiwan); National Central University, Taiwan; Center for Dynamical Biomarkers and Translational Medicine; National Central University, Chungli, Taiwan; Brain Research Center, National Yang-Ming University; Ministry of Education, Aim for the Top University Plansic	The study was funded in part by the Taipei Veterans General Hospital (V99C1-155, V100C-129, VGHUST100-G7-3-2, VGHUST101-G4-2-4), the National Science Council (NSC99-2221-E-075-003, NSC99-2221-E-010-012, NSC100-2221-E-010-009, NSC101-2221-E-010-004-MY2, NSC101-2314-B-733-001-MY2), NSC supported for the Center for Dynamical Biomarkers and Translational Medicine, National Central University, Taiwan (NSC100-2911-I-008-001), Center for Dynamical Biomarkers and Translational Medicine, National Central University, Chungli, Taiwan and Brain Research Center, National Yang-Ming University and a grant from Ministry of Education, Aim for the Top University Plansic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bettencourt C, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-35; Boesch SM, 2001, J MAGN RESON IMAGING, V13, P553, DOI 10.1002/jmri.1078; Boesch SM, 2007, J MAGN RESON IMAGING, V25, P564, DOI 10.1002/jmri.20846; D'Abreu A, 2010, PARKINSONISM RELAT D, V16, P2, DOI 10.1016/j.parkreldis.2009.08.012; Danielsen ER, 1998, MAGNETIC RESONANCE S; Di Prospero NA, 2005, NAT REV GENET, V6, P756, DOI 10.1038/nrg1690; Dohlinger S, 2008, CEREBELLUM, V7, P204, DOI 10.1007/s12311-008-0025-0; Durr A, 1995, BRAIN, V118, P1573, DOI 10.1093/brain/118.6.1573; Estrada R, 1999, ACTA NEUROPATHOL, V97, P306, DOI 10.1007/s004010050989; Gomez CM, 1997, ANN NEUROL, V42, P933, DOI 10.1002/ana.410420616; Guerrini L, 2004, BRAIN, V127, P1785, DOI 10.1093/brain/awh201; Jiang H, 2005, J NEUROL SCI, V236, P25, DOI 10.1016/j.jns.2005.04.009; Kumar P, 2010, PHARMACOL REP, V62, P1; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; Oz G, 2011, CEREBELLUM, V10, P208, DOI 10.1007/s12311-010-0213-6; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Oz G, 2010, MOVEMENT DISORD, V25, P1253, DOI 10.1002/mds.23067; Oz G, 2010, J NEUROSCI, V30, P3831, DOI 10.1523/JNEUROSCI.5612-09.2010; Schmitz-Hubsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92; Schulz JB, 2010, NEUROIMAGE, V49, P158, DOI 10.1016/j.neuroimage.2009.07.027; Soong BW, 2001, ARCH NEUROL-CHICAGO, V58, P1105, DOI 10.1001/archneur.58.7.1105; Stevanin G, 2002, ADV EXP MED BIOL, V516, P47; Takahashi H, 1998, ACTA NEUROPATHOL, V95, P333, DOI 10.1007/s004010050807; TAKIYAMA Y, 1994, NEUROLOGY, V44, P1302, DOI 10.1212/WNL.44.7.1302; Taroni F, 2004, NAT REV NEUROSCI, V5, P641, DOI 10.1038/nrn1474; Wang PS, 2007, J NEUROL, V254, P838, DOI 10.1007/s00415-006-0383-9; Xia HB, 2004, NAT MED, V10, P816, DOI 10.1038/nm1076; Zu T, 2004, J NEUROSCI, V24, P8853, DOI 10.1523/JNEUROSCI.2978-04.2004	28	14	14	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 11	2012	7	10							e47479	10.1371/journal.pone.0047479	http://dx.doi.org/10.1371/journal.pone.0047479			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	020KP	23094053	gold, Green Published, Green Submitted			2022-12-25	WOS:000309807700085
J	Kitamoto, S; Yokoyama, S; Higashi, M; Yamada, N; Takao, S; Yonezawa, S				Kitamoto, S.; Yokoyama, S.; Higashi, M.; Yamada, N.; Takao, S.; Yonezawa, S.			MUC1 enhances hypoxia-driven angiogenesis through the regulation of multiple proangiogenic factors	ONCOGENE			English	Article						MUC1; hypoxia; pancreatic cancer; angiogenesis; mucin	TISSUE GROWTH-FACTOR; ANTIGEN-EXPRESSION; TUMOR HYPOXIA; CANCER; MUCINS; GENE; OVEREXPRESSION; ACTIVATION; CELLS; CTGF	Pancreatic cancer is one of the most lethal malignancies due to its aggressive growth and rapid development of distant metastases. In this context, mucin 1 (MUC1) overexpression and hypoxia are frequently observed events. However, their functional relationship remains largely unknown. This study provides evidence that MUC1 is overexpressed by hypoxia and contributes to hypoxia-driven angiogenesis. Using the conditioned medium obtained from hypoxia-stressed AsPC1 cells treated with MUC1 siRNAs, we demonstrated that MUC1 enhanced the endothelial tube formation, proliferation and migration ability, which induced by hypoxia-conditioned medium (HCM). In addition, MUC1 was significantly induced by hypoxia, especially in the pancreatic cancer cells derived from metastatic tumors (AsPC1, HPAF2 or Capan1), and MUC1-cytoplasmic tail (MUC1-CT) accumulated in the nucleus under hypoxia. As noted in a previous report, MUC1-CT was recruited to genomic regions upstream of the connective tissue growth factor (CTGF) accompanied with beta-catenin and p53, resulting in the hypoxic induction of CTGF. Moreover, hypoxia-induced MUC1 partially regulated two other hypoxia-inducible proangiogenic factors including vascular endothelial growth factor-A and platelet-derived growth factor-B. The neutralization assay revealed that endothelial tube formation induced by HCM was clearly suppressed by antibodies against these three factors, suggesting the importance of these factors in hypoxia-driven angiogenesis. In summary, this is the first report demonstrating a pivotal role of MUC1 in controlling the hypoxia-driven angiogenesis through the regulation of multiple proangiogenic factors in pancreatic cancer. Our findings provide the novel insights into the understanding of complex interactions between pancreatic cancer cells and tumor microenvironments.	[Kitamoto, S.; Yokoyama, S.; Higashi, M.; Yamada, N.; Yonezawa, S.] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human Pathol, Field Oncol, Kagoshima 8908544, Japan; [Takao, S.] Kagoshima Univ, Frontier Sci Res Ctr, Kagoshima 8908544, Japan	Kagoshima University; Kagoshima University	Kitamoto, S (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Human Pathol, Field Oncol, 8-35-1 Sakuragaoka, Kagoshima 8908544, Japan.	s-kita@m3.kufm.kagoshima-u.ac.jp	Kitamoto, Sho/AAE-4549-2021	Kitamoto, Sho/0000-0003-3597-6647	Princess Takamastu Cancer Research Fund [11-24319]; Ministry of Education, Science, Sports, Culture and Technology, Japan [20014022, 23390085, 20590399]; International Educational Research Support Project for Islands, Environment and Medicine; JSPS [239349]; Pancreas Reserch Foundation of Japan; Kodama Memorial Foundation, Japan; Grants-in-Aid for Scientific Research [24701008] Funding Source: KAKEN	Princess Takamastu Cancer Research Fund; Ministry of Education, Science, Sports, Culture and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); International Educational Research Support Project for Islands, Environment and Medicine; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Pancreas Reserch Foundation of Japan; Kodama Memorial Foundation, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Princess Takamastu Cancer Research Fund (11-24319; S Yonezawa); by the Scientific Research on Priority Areas 20014022 and Scientific Research (B) 23390085 (S Yonezawa) and Scientific Research (C) 20590399 (M Higashi) grants from the Ministry of Education, Science, Sports, Culture and Technology, Japan; by an International Educational Research Support Project for Islands, Environment and Medicine (S Yokoyama); by a JSPS Fellowship Grant-in-Aid (no. 239349; S Kitamoto); by a Pancreas Reserch Foundation of Japan (S Yokoyama) and Kodama Memorial Foundation, Japan (S Kitamoto, S Yokoyama and M Higashi). We would like to express our gratitude to Dr Ming-Sound Tsao for providing us with the immortalized human pancreatic duct epithelial cells. We also thank Mses Izumi Houjou and Yukari Nishimura for their excellent technical assistance.	Aubert S, 2009, CANCER RES, V69, P5707, DOI 10.1158/0008-5472.CAN-08-4905; Behrens ME, 2010, ONCOGENE, V29, P5667, DOI 10.1038/onc.2010.327; Bennewith KL, 2009, CANCER RES, V69, P775, DOI 10.1158/0008-5472.CAN-08-0987; BHASKAR KR, 1992, NATURE, V360, P458, DOI 10.1038/360458a0; Brown JM, 2004, NAT REV CANCER, V4, P437, DOI 10.1038/nrc1367; Carson DD, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.127pe35; Chang Q, 2011, CANCER RES, V71, P3110, DOI 10.1158/0008-5472.CAN-10-4049; Chu CY, 2008, J BIOMED SCI, V15, P675, DOI 10.1007/s11373-008-9264-9; Dewhirst MW, 2008, NAT REV CANCER, V8, P425, DOI 10.1038/nrc2397; Dornhofer N, 2006, CANCER RES, V66, P5816, DOI 10.1158/0008-5472.CAN-06-0081; Furukawa T, 1996, AM J PATHOL, V148, P1763; Giatromanolaki A, 2000, CLIN CANCER RES, V6, P1917; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Higgins DF, 2004, AM J PHYSIOL-RENAL, V287, pF1223, DOI 10.1152/ajprenal.00245.2004; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Hong OY, 2000, AM J PATHOL, V157, P1623, DOI 10.1016/S0002-9440(10)64800-6; Kaira K, 2012, INT J SURG PATHOL, V20, P223, DOI 10.1177/1066896911429296; Kaira K, 2012, PATHOL ONCOL RES, V18, P439, DOI 10.1007/s12253-011-9465-9; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kitamoto S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044108; Kufe DW, 2009, NAT REV CANCER, V9, P874, DOI 10.1038/nrc2761; Levitin F, 2005, J BIOL CHEM, V280, P33374, DOI 10.1074/jbc.M506047200; Linden SK, 2008, MUCOSAL IMMUNOL, V1, P183, DOI 10.1038/mi.2008.5; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Macao B, 2006, NAT STRUCT MOL BIOL, V13, P71, DOI 10.1038/nsmb1035; Mikami Y, 2009, BIOCHEM BIOPH RES CO, V379, P1060, DOI 10.1016/j.bbrc.2009.01.002; Papadopoulos I, 2001, CLIN CANCER RES, V7, P1533; Roy LD, 2011, ONCOGENE, V30, P1449, DOI 10.1038/onc.2010.526; Sahraei M, 2012, ONCOGENE, V31, P4935, DOI 10.1038/onc.2011.651; Sakamoto H, 1997, HUM PATHOL, V28, P1056, DOI 10.1016/S0046-8177(97)90059-9; Semenza GL, 2003, ANNU REV MED, V54, P17, DOI 10.1146/annurev.med.54.101601.152418; Shimo T, 2001, CANCER LETT, V174, P57, DOI 10.1016/S0304-3835(01)00683-8; Vaupel P, 2007, CANCER METAST REV, V26, P225, DOI 10.1007/s10555-007-9055-1; Woo JK, 2012, ONCOGENE, V31, P2187, DOI 10.1038/onc.2011.410; Yao MY, 2011, LUNG, V189, P453, DOI 10.1007/s00408-011-9327-y; Yin L, 2007, J BIOL CHEM, V282, P257, DOI 10.1074/jbc.M610156200; Yonezawa S, 2012, GASTRIC CANCER, DOI [10.1007/S10120-011-0125-2, DOI 10.1007/S10120-011-0125-2)]; Yonezawa S, 2011, PATHOL INT, V61, P697, DOI 10.1111/j.1440-1827.2011.02734.x; Zanetti JS, 2011, VIRCHOWS ARCH, V459, P367, DOI 10.1007/s00428-011-1142-6	40	46	49	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 26	2013	32	39					4614	4621		10.1038/onc.2012.478	http://dx.doi.org/10.1038/onc.2012.478			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	226YD	23108411				2022-12-25	WOS:000325072200003
J	De Franceschi, L; Franco, RS; Bertoldi, M; Brugnara, C; Matte, A; Siciliano, A; Wieschhaus, AJ; Chishti, AH; Joiner, CH				De Franceschi, Lucia; Franco, Robert S.; Bertoldi, Mariarita; Brugnara, Carlo; Matte, Alessandro; Siciliano, Angela; Wieschhaus, Adam J.; Chishti, Athar H.; Joiner, Clinton H.			Pharmacological inhibition of calpain-1 prevents red cell dehydration and reduces Gardos channel activity in a mouse model of sickle cell disease	FASEB JOURNAL			English	Article						peroxiredoxin-2; BDA-410; protease	K-CA CHANNEL; DEPENDENT ACTIVATION; KCL COTRANSPORT; PROTEIN-KINASE; BLOOD-CELLS; INTERMEDIATE CONDUCTANCE; DENSE CELLS; IN-VITRO; SAD MICE; MEMBRANE	Sickle cell disease (SCD) is a globally distributed hereditary red blood cell (RBC) disorder. One of the hallmarks of SCD is the presence of circulating dense RBCs, which are important in SCD-related clinical manifestations. In human dense sickle cells, we found reduced calpastatin activity and protein expression compared to either healthy RBCs or unfractionated sickle cells, suggesting an imbalance between activator and inhibitor of calpain-1 in favor of activator in dense sickle cells. Calpain-1 is a nonlysosomal cysteine proteinase that modulates multiple cell functions through the selective cleavage of proteins. To investigate the relevance of this observation in vivo, we evaluated the effects of the orally active inhibitor of calpain-1, BDA-410 (30 mg/kg/d), on RBCs from SAD mice, a mouse model for SCD. In SAD mice, BDA-410 improved RBC morphology, reduced RBC density (D-20; from 1106 +/- 0.001 to 1100 +/- 0.001 g/ml; P<0.05) and increased RBC-K+ content (from 364 +/- 10 to 429 +/- 12.3 mmol/kg Hb; P<0.05), markedly reduced the activity of the Ca2+-activated K+ channel (Gardos channel), and decreased membrane association of peroxiredoxin-2. The inhibitory effect of calphostin C, a specific inhibitor of protein kinase C (PKC), on the Gardos channel was eliminated after BDA-410 treatment, which suggests that calpain-1 inhibition affects the PKC-dependent fraction of the Gardos channel. BDA-410 prevented hypoxia-induced RBC dehydration and K+ loss in SAD mice. These data suggest a potential role of BDA-410 as a novel therapeutic agent for treatment of SCD.-De Franceschi, L., Franco, R. S., Bertoldi, M., Brugnara, C., Matte, A., Siciliano, A., Wieschhaus, A.J., Chishti, A. H., Joiner, C. H. Pharmacological inhibition of calpain-1 prevents red cell dehydration and reduces Gardos channel activity in a mouse model of sickle cell disease. FASEB J. 27, 750-759 (2013). www.fasebj.org	[De Franceschi, Lucia; Matte, Alessandro; Siciliano, Angela] Univ Verona, Dept Med, Sect Internal Med, I-37134 Verona, Italy; [Bertoldi, Mariarita] Univ Verona, Dept Life & Reprod Sci, Biochem Sect, I-37134 Verona, Italy; [Franco, Robert S.; Joiner, Clinton H.] Univ Cincinnati, Coll Med, Div Hematol Oncol, Cincinnati, OH USA; [Franco, Robert S.; Joiner, Clinton H.] Childrens Hosp, Ctr Comprehens Sickle Cell, Cincinnati, OH 45229 USA; [Brugnara, Carlo] Harvard Univ, Childrens Hosp, Sch Med, Dept Lab Med, Boston, MA 02115 USA; [Brugnara, Carlo] Harvard Univ, Childrens Hosp, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Wieschhaus, Adam J.; Chishti, Athar H.] Tufts Univ, Sch Med, Dept Mol Physiol & Pharmacol, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA	University of Verona; University of Verona; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Tufts University	De Franceschi, L (corresponding author), Univ Verona, Dept Med, Ple L Scuro 10, I-37134 Verona, Italy.	lucia.defranceschi@univr.it	Bertoldi, Mariarita/F-1154-2010; Matte, Alessandro/AAB-3496-2022; DE FRANCESCHI, Lucia/AAB-8652-2022	Bertoldi, Mariarita/0000-0002-2337-9928; DE FRANCESCHI, Lucia/0000-0001-7093-777X	Ministro dell'Istruzione, dell'Universita e della Ricerca (MIUR); University of Verona; U.S. National Institutes of Health [HL089517, HL095050]; Tufts Collaborates grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095050, R01HL089517] Funding Source: NIH RePORTER	Ministro dell'Istruzione, dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR)); University of Verona; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tufts Collaborates grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by ex-40% Ministro dell'Istruzione, dell'Universita e della Ricerca (MIUR), University of Verona, to L. D. F. and by U.S. National Institutes of Health grants HL089517 and HL095050 and a Tufts Collaborates grant to A. H. C. The authors are grateful to Drs. Narihiko Yoshii and Hiroshi Kinoshita. A. H. C. proposed the evaluation of BDA-410 in SCD mice. A. H. C. and C.H.J. served as equal senior authors of the manuscript.	AL ZW, 1993, BIOCHEM J, V296, P675, DOI 10.1042/bj2960675; Battaglia F, 2003, J MOL NEUROSCI, V20, P357, DOI 10.1385/JMN:20:3:357; Bennekou F, 2001, BLOOD, V97, P1451, DOI 10.1182/blood.V97.5.1451; Biondani A, 2008, PROTEOM CLIN APPL, V2, P706, DOI 10.1002/prca.200780058; BOIVIN P, 1990, INT J BIOCHEM, V22, P1479, DOI 10.1016/0020-711X(90)90240-4; BRUGNARA C, 1989, BLOOD, V74, P487; Ciana A, 2004, BIOELECTROCHEMISTRY, V62, P169, DOI 10.1016/j.bioelechem.2003.07.004; De Franceschi L, 2004, HAEMATOLOGICA, V89, P348; de Franceschi L, 2003, BLOOD, V102, P1087, DOI 10.1182/blood-2002-07-2135; De Franceschi L, 1999, BLOOD, V94, P4307, DOI 10.1182/blood.V94.12.4307.424k39_4307_4313; De Franceschi L, 2011, HAEMATOL-HEMATOL J, V96, P1595, DOI 10.3324/haematol.2011.043612; De Franceschi L, 2011, SEMIN THROMB HEMOST, V37, P226, DOI 10.1055/s-0031-1273087; De Franceschi L, 2008, PROTEOMICS, V8, P4695, DOI 10.1002/pmic.200700596; DEFRANCESCHI L, 1995, AM J PHYSIOL-CELL PH, V269, pC899, DOI 10.1152/ajpcell.1995.269.4.C899; duVerle DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019035; Eaton W A, 1990, Adv Protein Chem, V40, P63, DOI 10.1016/S0065-3233(08)60287-9; FALCHETTO R, 1992, PROTEIN SCI, V1, P1613, DOI 10.1002/pro.5560011209; Fanger CM, 1999, J BIOL CHEM, V274, P5746, DOI 10.1074/jbc.274.9.5746; Fathallah H, 1997, AM J PHYSIOL-CELL PH, V273, pC1206, DOI 10.1152/ajpcell.1997.273.4.C1206; Franco RS, 2000, BLOOD, V96, P3610, DOI 10.1182/blood.V96.10.3610.h8003610_3610_3617; Gerlach AC, 2001, J BIOL CHEM, V276, P10963, DOI 10.1074/jbc.M007716200; Hanna RA, 2008, NATURE, V456, P409, DOI 10.1038/nature07451; Hebbel RP, 2008, TRANSFUS CLIN BIOL, V15, P14, DOI 10.1016/j.tracli.2008.03.011; Hebbel RP, 2010, BLOOD, V115, P2483, DOI 10.1182/blood-2009-02-204990; Joiner CH, 2004, BLOOD, V104, P2954, DOI 10.1182/blood-2004-01-0112; Joiner CH, 2007, BLOOD, V109, P1728, DOI 10.1182/blood-2006-04-018630; Joiner WJ, 2001, J BIOL CHEM, V276, P37980; KISHIMOTO A, 1989, J BIOL CHEM, V264, P4088; KISHIMOTO A, 1983, J BIOL CHEM, V258, P1156; Koo KH, 2002, ARCH BIOCHEM BIOPHYS, V397, P312, DOI 10.1006/abbi.2001.2700; Kuchay SM, 2007, MOL CELL BIOL, V27, P6038, DOI 10.1128/MCB.00522-07; Li XR, 2007, MOL BIOCHEM PARASIT, V155, P26, DOI 10.1016/j.molbiopara.2007.05.004; Matarrese P, 2005, FASEB J, V19, P416, DOI 10.1096/fj.04-2450fje; Matte A, 2010, FREE RADICAL BIO MED, V49, P457, DOI 10.1016/j.freeradbiomed.2010.05.003; McGoron AJ, 2000, BLOOD, V95, P2164, DOI 10.1182/blood.V95.6.2164; MEHDI S, 1988, BIOCHEM BIOPH RES CO, V157, P1117, DOI 10.1016/S0006-291X(88)80989-6; Melloni E, 2000, BIOCHEM BIOPH RES CO, V272, P472, DOI 10.1006/bbrc.2000.2796; Melloni E, 1998, J BIOL CHEM, V273, P12827, DOI 10.1074/jbc.273.21.12827; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; Moore RB, 1997, AM J HEMATOL, V56, P100, DOI 10.1002/(SICI)1096-8652(199710)56:2<100::AID-AJH5>3.3.CO;2-M; MOORE RB, 1991, J BIOL CHEM, V266, P18964; OLORUNSOGO OO, 1990, BIOSCIENCE REP, V10, P281, DOI 10.1007/BF01117244; PONTREMOLI S, 1988, BIOCHEM BIOPH RES CO, V151, P590, DOI 10.1016/0006-291X(88)90635-3; Rivera A, 2002, BLOOD, V99, P357, DOI 10.1182/blood.V99.1.357; Rivera A, 1999, AM J PHYSIOL-CELL PH, V277, pC746, DOI 10.1152/ajpcell.1999.277.4.C746; Sabaa N, 2008, J CLIN INVEST, V118, P1924, DOI 10.1172/JCI33308; SAIDO TC, 1994, FASEB J, V8, P814, DOI 10.1096/fasebj.8.11.8070630; SALAMINO F, 1993, BIOCHEM J, V290, P191, DOI 10.1042/bj2900191; Siciliano A, 2011, HAEMATOL-HEMATOL J, V96, P24, DOI 10.3324/haematol.2010.028506; Solovey AA, 2001, BLOOD, V97, P1937, DOI 10.1182/blood.V97.7.1937; Sorimachi H, 1997, BIOCHEM J, V328, P721, DOI 10.1042/bj3280721; Stocker JW, 2003, BLOOD, V101, P2412, DOI 10.1182/blood-2002-05-1433; Syme CA, 2003, J BIOL CHEM, V278, P8476, DOI 10.1074/jbc.M210072200; Trinchese F, 2008, J CLIN INVEST, V118, P2796, DOI 10.1172/JCI34254; WANG KKW, 1989, J MEMBRANE BIOL, V112, P233, DOI 10.1007/BF01870954; Wieschhaus A, 2012, BIOCHEM J, V448, P141, DOI 10.1042/BJ20121008; Woycechowsky KJ, 2003, BIOCHEMISTRY-US, V42, P5387, DOI 10.1021/bi026993q; Yan Y, 2009, CELL, V138, P1209, DOI 10.1016/j.cell.2009.06.042; Yasin Z, 2003, BLOOD, V102, P365, DOI 10.1182/blood-2002-11-3416	59	24	24	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					750	759		10.1096/fj.12-217836	http://dx.doi.org/10.1096/fj.12-217836			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23085996	Green Published			2022-12-25	WOS:000314358000033
J	Thaler, R; Zwerina, J; Rumpler, M; Spitzer, S; Gamsjaeger, S; Paschalis, EP; Klaushofer, K; Varga, F				Thaler, Roman; Zwerina, Jochen; Rumpler, Monika; Spitzer, Silvia; Gamsjaeger, Sonja; Paschalis, Eleftherios P.; Klaushofer, Klaus; Varga, Franz			Homocysteine induces serum amyloid A3 in osteoblasts via unlocking RGD-motifs in collagen	FASEB JOURNAL			English	Article						bone; extracellular matrix; Saa3; MC3T3-E1 cells	ACUTE MYOCARDIAL-INFARCTION; NF-KAPPA-B; BETA-CATENIN; ACUTE-PHASE; TYROSINE PHOSPHORYLATION; RHEUMATOID-ARTHRITIS; DIETARY-CHOLESTEROL; PLASMA HOMOCYSTEINE; ALZHEIMERS-DISEASE; AA-AMYLOIDOSIS	Hyperhomocysteinemia is a risk factor for osteoporotic fractures. Homocysteine (Hcys) inhibits collagen cross-linking and consequently decreases bone extracellular matrix (ECM) quality. Serum amyloid A (A-SAA), an acute-phase protein family, plays an important role in chronic and inflammatory diseases and up-regulates MMP13, which plays an important role in bone development and remodeling. Here, we investigate the effect of Hcys on expression of SAA3, a member of the A-SAA gene family, in osteoblasts characterizing underlying mechanisms and possible consequences on bone metabolism. MC3T3-E1 osteoblast-like cells were cultured up to 21 d with Hcys (low millimolar range) or reseeded onto ECM resulting from untreated or Hcys-treated MC3T3-E1 cells. Fourier-transformed infrared spectroscopy and a discriminative antibody were used to characterize the resulting ECM. Gene expression and signaling pathways were analyzed by gene chip, quantitative RT-PCR, and immunoblotting. Transcriptional regulation of Saa3 was studied by promoter transfection assays, chromatin immunoprecipitation, and immunofluorescence microscopy. Hcys treatment resulted in reduced collagen cross-linking, uncovering of RGD-motifs, and activation of the PTK2-PXN-CTNNB1 pathway followed by RELA activation. These signaling events led to increased SAA3 expression followed by the production of MMP13 and several chemokines, including Ccl5, Ccl2, Cxcl10, and Il6. Our data suggest Saa3 as link between hyperhomocysteinemia and development of osteoporosis.-Thaler, R., Zwerina, J., Rumpler, M., Spitzer, S., Gamsjaeger, S., Paschalis, E. P., Klaushofer, K., Varga, F. Homocysteine induces serum amyloid A3 in osteoblasts via unlocking RGD motifs in collagen. FASEB J. 27, 446-463 (2013). www.fasebj.org	Hanusch Hosp, Ludwig Boltzmann Inst Osteol, Wiener Gebietskrankenkasse WGKK, A-1140 Vienna, Austria; Hanusch Hosp, Dept Med 1, Allgemeine Unfallversicherungsanstalt AUVA Trauma, A-1140 Vienna, Austria	Ludwig Boltzmann Institute; WGKK - Hanusch Hospital; WGKK - Hanusch Hospital	Varga, F (corresponding author), Hanusch Hosp, Dept Med 1, Ludwig Boltzmann Inst Osteol, Heinrich Collin Str 30, A-1140 Vienna, Austria.	franz.varga@osteologie.at	/AAC-1939-2021; Gamsjaeger, Sonja/AAD-3956-2019; Gamsjaeger, Sonja/AAB-6636-2021	Gamsjaeger, Sonja/0000-0002-9543-6530; Gamsjaeger, Sonja/0000-0002-9543-6530	Fonds zur Forderung der Wissenschaftlichen Forschung (FWF; The Austrian Science Fund) [P20646-B11]; Wiener Gebietskrankenkasse (WGKK; Social Health Insurance Vienna); Allgemeine Unfallversicherungsanstalt (AUVA; Austrian Social Insurance for Occupational Risks); Austrian Science Fund (FWF) [P 24370] Funding Source: researchfish	Fonds zur Forderung der Wissenschaftlichen Forschung (FWF; The Austrian Science Fund)(Austrian Science Fund (FWF)); Wiener Gebietskrankenkasse (WGKK; Social Health Insurance Vienna); Allgemeine Unfallversicherungsanstalt (AUVA; Austrian Social Insurance for Occupational Risks); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Fonds zur Forderung der Wissenschaftlichen Forschung (FWF; The Austrian Science Fund) Project P20646-B11, the Wiener Gebietskrankenkasse (WGKK; Social Health Insurance Vienna), and the Allgemeine Unfallversicherungsanstalt (AUVA; Austrian Social Insurance for Occupational Risks). The authors thank E. Schiemel and K. Schiemel for carefully reading the manuscript. The authors declare no conflicts of interest.	BIRAN H, 1986, J CLIN PATHOL, V39, P794, DOI 10.1136/jcp.39.7.794; Blouin S, 2009, BONE, V44, P959, DOI 10.1016/j.bone.2008.12.023; Brustolin S, 2010, BRAZ J MED BIOL RES, V43, P1, DOI 10.1590/S0100-879X2009007500021; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chiba T, 2009, J LIPID RES, V50, P1353, DOI 10.1194/jlr.M900089-JLR200; Chung TF, 2000, AMYLOID, V7, P105, DOI 10.3109/13506120009146246; Connolly M, 2011, ANN RHEUM DIS, V70, P1296, DOI 10.1136/ard.2010.142240; Cunnane G, 2001, CURR OPIN RHEUMATOL, V13, P67, DOI 10.1097/00002281-200101000-00011; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Dionisio N, 2010, CURR MED CHEM, V17, P3109, DOI 10.2174/092986710791959783; Dominguez I, 2001, DEV BIOL, V235, P303, DOI 10.1006/dbio.2001.0317; Fasshauer M, 2004, J ENDOCRINOL, V183, P561, DOI 10.1677/joe.1.05699; Fornoni A, 2008, DIABETOLOGIA, V51, P298, DOI 10.1007/s00125-007-0889-4; Fratzl-Zelman N, 2003, CELL BIOL INT, V27, P459, DOI 10.1016/S1065-6995(03)00037-4; Gjesdal CG, 2007, J BONE MINER RES, V22, P747, DOI 10.1359/JBMR.070210; Gruys E, 1996, LAB ANIM, V30, P28, DOI 10.1258/002367796780745018; Inada M, 2004, P NATL ACAD SCI USA, V101, P17192, DOI 10.1073/pnas.0407788101; Johnson BD, 2004, CIRCULATION, V109, P726, DOI 10.1161/01.CIR.0000115516.54550.B1; Kagan HM, 2003, J CELL BIOCHEM, V88, P660, DOI 10.1002/jcb.10413; Katayama T, 2007, INT HEART J, V48, P45, DOI 10.1536/ihj.48.45; Kelley BP, 2011, J BONE MINER RES, V26, P666, DOI 10.1002/jbmr.250; Kim CG, 2011, BIOCHEM BIOPH RES CO, V410, P637, DOI 10.1016/j.bbrc.2011.06.044; Kim K, 2001, CELL BIOL INT, V25, P421, DOI 10.1006/cbir.2000.0650; Klamer G, 2010, CURR MED CHEM, V17, P2873, DOI 10.2174/092986710792065090; KLUVEBECKERMAN B, 1991, DNA CELL BIOL, V10, P651, DOI 10.1089/dna.1991.10.651; Kovacevic A, 2008, J CELL BIOCHEM, V103, P994, DOI 10.1002/jcb.21472; Kumon Y, 1997, J RHEUMATOL, V24, P14; Lewis KE, 2004, CIRCULATION, V110, P540, DOI 10.1161/01.CIR.0000136819.93989.E1; LI XX, 1991, J BIOL CHEM, V266, P15192; Li YT, 2006, PROTEOMICS, V6, P3426, DOI 10.1002/pmic.200500472; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Liu YC, 2010, J CELL BIOCHEM, V111, P402, DOI 10.1002/jcb.22714; Ludlage E, 2005, VET PATHOL, V42, P117, DOI 10.1354/vp.42-2-117; Maier W, 2005, CIRCULATION, V111, P1355, DOI 10.1161/01.CIR.0000158479.58589.0A; Malle E, 1996, EUR J CLIN INVEST, V26, P427, DOI 10.1046/j.1365-2362.1996.159291.x; Marzocco S, 2004, LIFE SCI, V75, P1491, DOI 10.1016/j.lfs.2004.03.013; Mauney JR, 2006, J BIOMED MATER RES A, V79A, P464, DOI 10.1002/jbm.a.30876; McLean RR, 2004, NEW ENGL J MED, V350, P2042, DOI 10.1056/NEJMoa032739; MEEK RL, 1986, J EXP MED, V164, P2006, DOI 10.1084/jem.164.6.2006; MEEK RL, 1992, P NATL ACAD SCI USA, V89, P7949, DOI 10.1073/pnas.89.17.7949; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Moran AE, 2005, CANCER RES, V65, P1097; Morrison C, 2011, J BIOL CHEM, V286, P34271, DOI 10.1074/jbc.M111.222513; Paschalis EP, 2001, J BONE MINER RES, V16, P1821, DOI 10.1359/jbmr.2001.16.10.1821; Peperkamp NHMT, 1997, VET PATHOL, V34, P271, DOI 10.1177/030098589703400402; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raisz LG, 2004, NEW ENGL J MED, V350, P2089, DOI 10.1056/NEJMe048030; Rauner M, 2012, J BONE MINER RES, V27, P575, DOI 10.1002/jbmr.1488; Reigstad CS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005842; Robich MP, 2010, CIRCULATION, V122, pS142, DOI 10.1161/CIRCULATIONAHA.109.920132; Rucker RB, 1998, AM J CLIN NUTR, V67, p996S, DOI 10.1093/ajcn/67.5.996S; RYGG M, 1993, BIOCHIM BIOPHYS ACTA, V1216, P402, DOI 10.1016/0167-4781(93)90007-Z; Scheja L, 2008, EXP DIABETES RES, DOI 10.1155/2008/230837; SHIMIZU H, 1994, GENE, V149, P305; Sommer G, 2008, J CELL BIOCHEM, V104, P2241, DOI 10.1002/jcb.21782; Subramanian S, 2008, ARTERIOSCL THROM VAS, V28, P685, DOI 10.1161/ATVBAHA.107.157685; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Sun SC, 2008, TRENDS IMMUNOL, V29, P469, DOI 10.1016/j.it.2008.07.003; Taubenberger AV, 2010, BIOMATERIALS, V31, P2827, DOI 10.1016/j.biomaterials.2009.12.051; Thaler R, 2011, J BIOL CHEM, V286, P5578, DOI 10.1074/jbc.M110.166181; Thaler R, 2010, BONE, V46, P703, DOI 10.1016/j.bone.2009.10.038; Thorn CF, 2003, EUR J IMMUNOL, V33, P2630, DOI 10.1002/eji.200323985; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Vallon R, 2001, J IMMUNOL, V166, P2801, DOI 10.4049/jimmunol.166.4.2801; Van Dam F, 2009, ARCH GERONTOL GERIAT, V48, P425, DOI 10.1016/j.archger.2008.03.009; Villa P, 2007, CLIN CHEM LAB MED, V45, P130, DOI 10.1515/CCLM.2007.067; WESTERMARK GT, 1990, AM J PATHOL, V137, P377; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Yamada T, 2000, SCAND J IMMUNOL, V52, P7; Zerega B, 2004, MATRIX BIOL, V23, P35, DOI 10.1016/j.matbio.2004.02.002; Zhang B, 2008, J HERED, V99, P355, DOI 10.1093/jhered/esn015; Zhang H, 2006, J BIOMED MATER RES A, V76A, P120, DOI 10.1002/jbm.a.30491	72	18	19	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					446	463		10.1096/fj.12-208058	http://dx.doi.org/10.1096/fj.12-208058			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23085993				2022-12-25	WOS:000314358000006
J	Mcmahon, C; Studer, SM; Clendinen, C; Dann, GP; Jeffrey, PD; Hughson, FM				Mcmahon, Conor; Studer, Sean M.; Clendinen, Chaevia; Dann, Geoffrey P.; Jeffrey, Philip D.; Hughson, Frederick M.			The Structure of Sec12 Implicates Potassium Ion Coordination in Sar1 Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE-EXCHANGE; CHROMOSOME CONDENSATION RCC1; COPII-COATED VESICLE; ENDOPLASMIC-RETICULUM; CRYSTAL-STRUCTURE; BETA-PROPELLERS; PROTEINS; ER; YEAST; REGULATOR	Coat protein II (COPII)-coated vesicles transport proteins and lipids from the endoplasmic reticulum to the Golgi. Crucial for the initiation of COPII coat assembly is Sec12, a guanine nucleotide exchange factor responsible for activating the small Gprotein Sar1. Once activated, Sar1/GTP binds to endoplasmic reticulum membranes and recruits COPII coat components (Sec23/24 and Sec13/31). Here, we report the 1.36 angstrom resolution crystal structure of the catalytically active, 38-kDa cytoplasmic portion of Saccharomyces cerevisiae Sec12. Sec12 adopts a beta propeller fold. Conserved residues cluster around a loop we term the "K loop," which extends from the N-terminal propeller blade. Structure-guided site-directed mutagenesis, in conjunction with in vitro and in vivo functional studies, reveals that this region of Sec12 is catalytically essential, presumably because it makes direct contact with Sar1. Strikingly, the crystal structure also reveals that a single potassium ion stabilizes the K loop; bound potassium is, moreover, essential for optimum guanine nucleotide exchange activity in vitro. Thus, our results reveal a novel role for a potassium-stabilized loop in catalyzing guanine nucleotide exchange.	[Mcmahon, Conor; Clendinen, Chaevia; Dann, Geoffrey P.; Jeffrey, Philip D.; Hughson, Frederick M.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Studer, Sean M.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA	Princeton University; Scripps Research Institute	Hughson, FM (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	hughson@princeton.edu		McMahon, Conor/0000-0001-9971-7869; Jeffrey, Philip/0000-0002-4351-5341	National Institutes of Health [R01 GM071574]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007388, R01GM071574] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 GM071574 (to F.M.H.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500; Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006; Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Chardin P, 2002, FEBS LETT, V525, P171, DOI 10.1016/S0014-5793(02)03068-5; Ebinu JO, 1998, SCIENCE, V280, P1082, DOI 10.1126/science.280.5366.1082; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Futai E, 2004, EMBO J, V23, P4146, DOI 10.1038/sj.emboj.7600428; Huang MD, 2001, J CELL BIOL, V155, P937, DOI 10.1083/jcb.200106039; Itzen A, 2007, J MOL BIOL, V365, P1359, DOI 10.1016/j.jmb.2006.10.096; Kawasaki H, 1998, P NATL ACAD SCI USA, V95, P13278, DOI 10.1073/pnas.95.22.13278; Lee MCS, 2007, SEMIN CELL DEV BIOL, V18, P424, DOI 10.1016/j.semcdb.2007.06.007; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Matsuoka K, 2001, P NATL ACAD SCI USA, V98, P13705, DOI 10.1073/pnas.241522198; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; Miller EA, 2010, CURR OPIN CELL BIOL, V22, P447, DOI 10.1016/j.ceb.2010.04.003; NAKANO A, 1988, J CELL BIOL, V107, P851, DOI 10.1083/jcb.107.3.851; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page MJ, 2006, PHYSIOL REV, V86, P1049, DOI 10.1152/physrev.00008.2006; Renault L, 1998, NATURE, V392, P97, DOI 10.1038/32204; Renault L, 2001, CELL, V105, P245, DOI 10.1016/S0092-8674(01)00315-4; Shaywitz DA, 1997, J BIOL CHEM, V272, P25413, DOI 10.1074/jbc.272.41.25413; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SIKORSKI RS, 1989, GENETICS, V122, P19; Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024; Stone James C, 2011, Genes Cancer, V2, P320, DOI 10.1177/1947601911408082; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Weissman JT, 2001, TRAFFIC, V2, P465, DOI 10.1034/j.1600-0854.2001.20704.x	36	22	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43599	43606		10.1074/jbc.M112.420141	http://dx.doi.org/10.1074/jbc.M112.420141			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23109340	Green Published, hybrid			2022-12-25	WOS:000312940800040
J	Karch, CM; Jeng, AT; Goate, AM				Karch, Celeste M.; Jeng, Amanda T.; Goate, Alison M.			Extracellular Tau Levels Are Influenced by Variability in Tau That Is Associated with Tauopathies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CEREBROSPINAL-FLUID TAU; MICROTUBULE-ASSOCIATED PROTEIN; ALPHA-SYNUCLEIN; ALZHEIMERS-DISEASE; CELLS; RELEASE; SECRETION; HAPLOTYPE; MEMBRANE; DEMENTIA	Tauopathies are a class of neurodegenerative diseases marked by intracellular aggregates of hyperphosphorylated Tau. These diseases may occur by sporadic mechanisms in which genetic variants represent risk factors for disease, as is the case in Alzheimer disease (AD). In AD, cerebrospinal fluid (CSF) levels of soluble Tau/pTau-181 are higher in cases compared with controls. A subset of frontotemporal dementia (FTD) cases occur by a familial mechanism in which MAPT, the gene that encodes Tau, mutations are dominantly inherited. In symptomatic FTD patients expressing a MAPT mutation, CSF Tau levels are slightly elevated but are significantly lower than in AD patients. We sought to model CSF Tau changes by measuring extracellular Tau in cultured cells. Full-length, monomeric extracellular total Tau and pTau-181 were detectable in human neuroblastoma cells expressing endogenous Tau, in human non-neuronal cells overexpressing wild-type Tau, and in mouse cortical neurons. Tau isoforms influence the rate of Tau release, whereby the N terminus (exons 2/3) and microtubule binding repeat length contribute to Tau release from the cell. Compared with cells overexpressing wild-type Tau, cells overexpressing FTD-associated MAPT mutations produce significantly less extracellular total Tau without altering intracellular total Tau levels. This study demonstrates that cells actively release Tau in the absence of disease or toxicity, and Tau release is modified by changes in the Tau protein that are associated with tauopathies.	Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Goate, AM (corresponding author), 425 S Euclid Ave, St Louis, MO 63110 USA.	goatea@psychiatry.wustl.edu		Karch, Celeste/0000-0002-6854-5547; Goate, Alison/0000-0002-0576-2472	National Institutes of Health [5P01AG003991-29]; AstraZeneca; NATIONAL INSTITUTE ON AGING [P50AG005681, P01AG003991] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AstraZeneca(AstraZeneca); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant 5P01AG003991-29 (to John C. Morris) and AstraZeneca.	Agholme L, 2010, J ALZHEIMERS DIS, V20, P1069, DOI 10.3233/JAD-2010-091363; Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Baker M, 1999, HUM MOL GENET, V8, P711, DOI 10.1093/hmg/8.4.711; Barclay JW, 2005, CELL CALCIUM, V38, P343, DOI 10.1016/j.ceca.2005.06.012; Bhaskar K, 2005, J BIOL CHEM, V280, P35119, DOI 10.1074/jbc.M505895200; Chang HC, 1997, AIDS, V11, P1421, DOI 10.1097/00002030-199712000-00006; CHOI DW, 1987, J NEUROSCI, V7, P369; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; CLEVELAND DW, 1977, J MOL BIOL, V116, P207, DOI 10.1016/0022-2836(77)90213-3; Craig-Schapiro R, 2009, NEUROBIOL DIS, V35, P128, DOI 10.1016/j.nbd.2008.10.003; Cruchaga C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001101; Csernansky JG, 2002, ALZ DIS ASSOC DIS, V16, P144, DOI 10.1097/00002093-200207000-00003; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; Dayanandan R, 1999, FEBS LETT, V446, P228, DOI 10.1016/S0014-5793(99)00222-7; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Emmanouilidou E, 2010, J NEUROSCI, V30, P6838, DOI 10.1523/JNEUROSCI.5699-09.2010; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Galasko D, 1998, ARCH NEUROL-CHICAGO, V55, P937, DOI 10.1001/archneur.55.7.937; Gamblin TC, 2003, P NATL ACAD SCI USA, V100, P10032, DOI 10.1073/pnas.1630428100; Geetha T, 2008, TRAFFIC, V9, P1146, DOI 10.1111/j.1600-0854.2008.00751.x; Gomez-Ramos A, 2008, MOL CELL NEUROSCI, V37, P673, DOI 10.1016/j.mcn.2007.12.010; Gomez-Ramos A, 2009, EUR NEUROPSYCHOPHARM, V19, P708, DOI 10.1016/j.euroneuro.2009.04.006; Green AJE, 1999, NEUROSCI LETT, V259, P133, DOI 10.1016/S0304-3940(98)00904-5; Guo JL, 2011, J BIOL CHEM, V286, P15317, DOI 10.1074/jbc.M110.209296; Hampel H, 2004, DEMENT GERIATR COGN, V17, P350, DOI 10.1159/000077170; Hesse C, 2001, NEUROSCI LETT, V297, P187, DOI 10.1016/S0304-3940(00)01697-9; Horowitz PM, 2004, J NEUROSCI, V24, P7895, DOI 10.1523/JNEUROSCI.1988-04.2004; Houlden H, 2001, NEUROLOGY, V56, P1702, DOI 10.1212/WNL.56.12.1702; JENSEN M, 1995, NEUROSCI LETT, V186, P189, DOI 10.1016/0304-3940(95)11297-A; Karch C. M., 2012, NEUROBIOL A IN PRESS; Kauwe JSK, 2008, P NATL ACAD SCI USA, V105, P8050, DOI 10.1073/pnas.0801227105; Kim W, 2010, FEBS LETT, V584, P3085, DOI 10.1016/j.febslet.2010.05.042; Kim W, 2010, J ALZHEIMERS DIS, V19, P647, DOI 10.3233/JAD-2010-1273; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lee G, 1998, J CELL SCI, V111, P3167; Lee HJ, 2005, J NEUROSCI, V25, P6016, DOI 10.1523/JNEUROSCI.0692-05.2005; LINDSTEDT R, 1993, J BIOL CHEM, V268, P11750; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; MELCHIOR F, 1995, CURR OPIN CELL BIOL, V7, P310, DOI 10.1016/0955-0674(95)80084-0; Mills IG, 2001, J CELL SCI, V114, P1959; Misra UK, 1997, J CELL BIOCHEM, V64, P225, DOI 10.1002/(SICI)1097-4644(199702)64:2<225::AID-JCB6>3.0.CO;2-Z; Myers AJ, 2005, HUM MOL GENET, V14, P2399, DOI 10.1093/hmg/ddi241; Myers AJ, 2007, NEUROBIOL DIS, V25, P561, DOI 10.1016/j.nbd.2006.10.018; Nickel W, 2005, TRAFFIC, V6, P607, DOI 10.1111/j.1600-0854.2005.00302.x; Nickel W, 2009, NAT REV MOL CELL BIO, V10, P148, DOI 10.1038/nrm2617; ONO T, 1995, NEUROCHEM INT, V26, P205, DOI 10.1016/0197-0186(94)00135-H; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Saman S, 2012, J BIOL CHEM, V287, P3842, DOI 10.1074/jbc.M111.277061; Santa-Maria I, 2012, J BIOL CHEM, V287, P20522, DOI 10.1074/jbc.M111.323279; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Simon D, 2012, NEURODEGENER DIS, V10, P73, DOI 10.1159/000334915; Simon D, 2012, FEBS LETT, V586, P47, DOI 10.1016/j.febslet.2011.11.022; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Stutzmann GE, 2005, NEUROSCIENTIST, V11, P110, DOI 10.1177/1073858404270899; TATO RE, 1995, J NEUROL NEUROSUR PS, V59, P280, DOI 10.1136/jnnp.59.3.280; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; VIGOPELFREY C, 1995, NEUROLOGY, V45, P788, DOI 10.1212/WNL.45.4.788; Wang YP, 2007, P NATL ACAD SCI USA, V104, P10252, DOI 10.1073/pnas.0703676104; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011	68	126	129	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42751	42762		10.1074/jbc.M112.380642	http://dx.doi.org/10.1074/jbc.M112.380642			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105105	Green Published, hybrid			2022-12-25	WOS:000312501600034
J	Lera, RF; Burkard, ME				Lera, Robert F.; Burkard, Mark E.			High Mitotic Activity of Polo-like Kinase 1 Is Required for Chromosome Segregation and Genomic Integrity in Human Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEROTELIC KINETOCHORE ORIENTATION; TOPOISOMERASE-II-ALPHA; BOX DOMAIN; MAMMALIAN-CELLS; PLK1; CYTOKINESIS; INHIBITOR; PHOSPHORYLATION; INITIATION; MECHANISM	Protein kinases play key roles in regulating human cell biology, but manifold substrates and functions make it difficult to understand mechanism. We tested whether we could dissect functions of a pleiotropic mitotic kinase, Polo-like kinase 1 (Plk1), via distinct thresholds of kinase activity. We accomplished this by titrating Plk1 activity in RPE1 human epithelial cells using chemical genetics and verifying results in additional lines. We found that distinct activity thresholds are required for known functions of Plk1 including (from low to high activity) bipolar spindle formation, timely mitotic entry, and formation of a cytokinesis cleavage furrow. Subtle losses in Plk1 activity impaired chromosome congression and produced severe anaphase dysfunction characterized by poor separation of chromosome masses. These two phenotypes were separable, suggesting that they stem from distinct phosphorylation events. Impaired chromosome segregation in anaphase was the most sensitive to modest loss in Plk1 activity. Mechanistically, it was associated with unpaired sister chromatids with stretched kinetochores, suggestive of merotelic attachments. The C-terminal Polo box domain of Plk1 was required for its anaphase function, although it was dispensable for forming a bipolar spindle. The ultimate effect of partial inhibition of Plk1 was the formation of micronuclei, an increase in tetraploid progeny, and senescence. These results demonstrate that different thresholds of Plk1 activity can elicit distinct phenotypes, illustrating a general method for separating pleiotropic functions of a protein kinase even when these are executed close in time.	[Burkard, Mark E.] Univ Wisconsin, Dept Med, Madison, WI 53705 USA; Univ Wisconsin, Univ Wisconsin Carbone Canc Ctr, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Burkard, ME (corresponding author), Univ Wisconsin, Dept Med, Madison, WI 53705 USA.	mburkard@wisc.edu		Burkard, Mark/0000-0002-4215-7722; Lera, Robert/0000-0001-8713-4279	National Institutes of Health [R01 GM097245, P30 CA014520]; National Center for Advancing Translational Sciences [9U54TR000021]; Flight Attendant Medical Research Institute [062541_YCSA]; NATIONAL CANCER INSTITUTE [P30CA014520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097245] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Flight Attendant Medical Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM097245 (to M. E. B.) and P30 CA014520 (for R. L.) and Clinical and Translational Science Award 9U54TR000021 from the National Center for Advancing Translational Sciences (K Award to M. E. B.) This work was also supported by Flight Attendant Medical Research Institute Grant 062541_YCSA.	Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Brennan IM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000409; Burkard ME, 2007, P NATL ACAD SCI USA, V104, P4383, DOI 10.1073/pnas.0701140104; Burkard ME, 2012, ACS CHEM BIOL, V7, P978, DOI 10.1021/cb200551p; Burkard ME, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000111; Carmena M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001250; Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777; Cimini D, 2003, J CELL SCI, V116, P4213, DOI 10.1242/jcs.00716; Cimini D, 2002, J CELL SCI, V115, P507; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; CLARKE DJ, 1993, J CELL SCI, V105, P563; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136; Gascoigne KE, 2009, J CELL SCI, V122, P2579, DOI 10.1242/jcs.039719; Gilmartin AG, 2009, CANCER RES, V69, P6969, DOI 10.1158/0008-5472.CAN-09-0945; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; Hauf S, 2005, PLOS BIOL, V3, P419, DOI 10.1371/journal.pbio.0030069; Kishi K, 2009, MOL CELL BIOL, V29, P3134, DOI 10.1128/MCB.01663-08; Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Li H, 2008, J BIOL CHEM, V283, P6209, DOI 10.1074/jbc.M709007200; Liu F, 2012, ACS CHEM BIOL, V7, P805, DOI 10.1021/cb200469a; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Maresca TJ, 2010, J CELL SCI, V123, P825, DOI 10.1242/jcs.064790; Medema RH, 2011, CLIN CANCER RES, V17, P6459, DOI 10.1158/1078-0432.CCR-11-0541; Moutinho-Santos T, 2012, J CELL SCI, V125, P576, DOI 10.1242/jcs.092445; Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557; Oppermann FS, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.O111.012351; Paschal C. R., 2012, CHROMOSOMA, DOI 1007/s00412-012-375-8; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; Randall CL, 2007, CELL CYCLE, V6, P1713, DOI 10.4161/cc.6.14.4501; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schoffski P, 2012, EUR J CANCER, V48, P179, DOI 10.1016/j.ejca.2011.11.001; Spence JM, 2007, J CELL SCI, V120, P3952, DOI 10.1242/jcs.013730; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Wolfe BA, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000110; Yun SM, 2009, NAT STRUCT MOL BIOL, V16, P876, DOI 10.1038/nsmb.1628	42	39	41	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42812	42825		10.1074/jbc.M112.412544	http://dx.doi.org/10.1074/jbc.M112.412544			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105120	hybrid, Green Published			2022-12-25	WOS:000312501600040
J	Liu, YS; Zheng, XH; Mueller, GA; Sobhany, M; DeRose, EF; Zhang, YP; London, RE; Birnbaumer, L				Liu, Yanshun; Zheng, Xunhai; Mueller, Geoffrey A.; Sobhany, Mack; DeRose, Eugene F.; Zhang, Yingpei; London, Robert E.; Birnbaumer, Lutz			Crystal Structure of Calmodulin Binding Domain of Orai1 in Complex with Ca2+center dot Calmodulin Displays a Unique Binding Mode	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATES CRAC CHANNELS; IQ MOTIF; APO-CALMODULIN; CA2+ STORE; STIM1; SYSTEM; OLIGOMERIZATION; PEPTIDE	Orai1 is a plasma membrane protein that in its tetrameric form is responsible for calcium influx from the extracellular environment into the cytosol in response to interaction with the Ca2+-depletion sensor STIM1. This is followed by a fast Ca2+center dot calmodulin (CaM)-dependent inhibition, resulting from CaM binding to an Orai1 region called the calmodulin binding domain (CMBD). The interaction between Orai1 and CaM at the atomic level remains unknown. Here, we report the crystal structure of a CaM center dot Orai1-CMBD complex showing one CMBD bound to the C-terminal lobe of CaM, differing from other CaM-target protein complexes, in which both N- and C-terminal lobes of CaM (CaM-N and CaM-C) are involved in target binding. Orai1-CMBD binds CaM-C mainly through hydrophobic interactions, primarily involving residue Trp(76) of Orai1-CMBD, which interacts with the hydrophobic pocket of CaM-C. However, NMRdata, isothermal titration calorimetry data, and pull-down assays indicated that CaM-N and CaM-C both can bind Orai1-CMBD, with CaM-N having similar to 4 times weaker affinity than CaM-C. Pulldown assays of a Orai1-CMBD(W76E) mutant, gel filtration chromatography data, and NOE signals indicated that CaM-N and CaM-C can each bind one Orai1-CMBD. Thus our studies support an unusual, extended 1: 2 binding mode of CaM to Orai1-CMBDs, and quantify the affinity of Orai1 for CaM. We propose a two-step mechanism for CaM-dependent Orai1 inactivation initiated by binding of the C-lobe of CaM to the CMBD of one Orai1 followed by the binding of the N-lobe of CaM to the CMBD of a neighboring Orai1.	[Liu, Yanshun; Zhang, Yingpei; Birnbaumer, Lutz] NIEHS, Neurobiol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Zheng, Xunhai; Mueller, Geoffrey A.; DeRose, Eugene F.; London, Robert E.] NIEHS, Struct Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Sobhany, Mack] NIEHS, Lab Reprod & Dev Toxicol, NIH, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Liu, YS (corresponding author), 111 TW Alexander Dr, Res Triangle Pk, NC 27709 USA.	liuy3@niehs.nih.gov; birnbau1@niehs.nih.gov	Zheng, Xunhai/G-1187-2015; London, Robert E/F-7990-2019; Mueller, Geoffrey A/I-2909-2017	Zheng, Xunhai/0000-0003-0390-2491; London, Robert E/0000-0001-9108-8463; Mueller, Geoffrey A/0000-0001-8361-5323	National Institutes of Health Intramural Research Program [Z01-ES101684]; Collaborative Crystallography Group NIEHS [Z01 ES102645]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES101643, Z01ES101684] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Collaborative Crystallography Group NIEHS; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Intramural Research Program Grant Z01-ES101684 and Collaborative Crystallography Group NIEHS Grant Z01 ES102645.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ataman ZA, 2007, STRUCTURE, V15, P1603, DOI 10.1016/j.str.2007.10.012; BABU YS, 1988, J MOL BIOL, V204, P191, DOI 10.1016/0022-2836(88)90608-0; Chagot B, 2011, J MOL BIOL, V406, P106, DOI 10.1016/j.jmb.2010.11.046; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Elshorst B, 1999, BIOCHEMISTRY-US, V38, P12320, DOI 10.1021/bi9908235; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feldkamp MD, 2011, STRUCTURE, V19, P733, DOI 10.1016/j.str.2011.02.009; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Hayashi N, 1998, PROTEIN EXPRES PURIF, V12, P25, DOI 10.1006/prep.1997.0807; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Juranic N, 2010, J BIOL CHEM, V285, P4015, DOI 10.1074/jbc.M109.060491; KREBS J, 1984, BIOCHEMISTRY-US, V23, P400, DOI 10.1021/bi00298a002; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; LEE W, 1994, FEBS LETT, V350, P87, DOI 10.1016/0014-5793(94)00740-3; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Mullins FM, 2009, P NATL ACAD SCI USA, V106, P15495, DOI 10.1073/pnas.0906781106; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; PRESS WH, 1989, NUMERICAL RECIPES FO; Putkey JA, 2003, J BIOL CHEM, V278, P49667, DOI 10.1074/jbc.C300372200; Putkey JA, 2008, J BIOL CHEM, V283, P1401, DOI 10.1074/jbc.M703831200; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; TAKEMURA H, 1989, BIOCHEM J, V258, P409, DOI 10.1042/bj2580409; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wang X, 2010, BIOCHEMISTRY-US, V49, P10287, DOI 10.1021/bi100500m; Wu MM, 2007, CELL CALCIUM, V42, P163, DOI 10.1016/j.ceca.2007.03.003; Yap KL, 2003, J MOL BIOL, V328, P193, DOI 10.1016/S0022-2836(03)00271-7; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yuan JP, 2009, NAT CELL BIOL, V11, P337, DOI 10.1038/ncb1842; ZHANG M, 1995, NAT STRUCT BIOL, V2, P758, DOI 10.1038/nsb0995-758; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147	39	51	55	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43030	43041		10.1074/jbc.M112.380964	http://dx.doi.org/10.1074/jbc.M112.380964			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23109337	Green Published, hybrid			2022-12-25	WOS:000312501600059
J	Torres-Bacete, J; Sinha, PK; Sato, M; Patki, G; Kao, MC; Matsuno-Yagi, A; Yagi, T				Torres-Bacete, Jesus; Sinha, Prem Kumar; Sato, Motoaki; Patki, Gaurav; Kao, Mou-Chieh; Matsuno-Yagi, Akemi; Yagi, Takao			Roles of Subunit NuoK (ND4L) in the Energy-transducing Mechanism of Escherichia coli NDH-1 (NADH:Quinone Oxidoreductase)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-QUINONE OXIDOREDUCTASE; RESPIRATORY COMPLEX-I; CONSERVED CHARGED RESIDUES; MEMBRANE DOMAIN; PARACOCCUS-DENITRIFICANS; UBIQUINONE OXIDOREDUCTASE; ATP SYNTHASE; SUBMITOCHONDRIAL PARTICLES; PROTON TRANSLOCATION; PERIPHERAL SUBUNITS	The bacterial H+-translocating NADH: quinone oxidoreductase (NDH-1) catalyzes electron transfer from NADH to quinone coupled with proton pumping across the cytoplasmic membrane. The NuoK subunit (counterpart of the mitochondrial ND4L subunit) is one of the seven hydrophobic subunits in the membrane domain and bears three transmembrane segments (TM1-3). Two glutamic residues located in the adjacent transmembrane helices of NuoK are important for the energy coupled activity of NDH-1. In particular, mutation of the highly conserved carboxyl residue ((K)Glu-36 in TM2) to Ala led to a complete loss of the NDH-1 activities. Mutation of the second conserved carboxyl residue ((K)Glu-72 in TM3) moderately reduced the activities. To clarify the contribution of NuoK to the mechanism of proton translocation, we relocated these two conserved residues. When we shifted (K)Glu-36 along TM2 to positions 32, 38, 39, and 40, the mutants largely retained energy transducing NDH-1 activities. According to the recent structural information, these positions are located in the vicinity of (K)Glu-36, present in the same helix phase, in an immediately before and after helix turn. In an earlier study, a double mutation of two arginine residues located in a short cytoplasmic loop between TM1 and TM2 (loop-1) showed a drastic effect on energy transducing activities. Therefore, the importance of this cytosolic loop of NuoK ((K)Arg-25, (K)Arg-26, and (K)Asn-27) for the energy transducing activities was extensively studied. The probable roles of subunit NuoK in the energy transducing mechanism of NDH-1 are discussed.	[Torres-Bacete, Jesus; Sinha, Prem Kumar; Sato, Motoaki; Patki, Gaurav; Kao, Mou-Chieh; Matsuno-Yagi, Akemi; Yagi, Takao] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute	Yagi, T (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd,MEM256, La Jolla, CA 92037 USA.	yagi@scripps.edu		Torres, Jesus/0000-0003-3410-6930	National Institutes of Health from the United States Public Health Service [GM33712]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM033712] Funding Source: NIH RePORTER	National Institutes of Health from the United States Public Health Service; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM33712 from the United States Public Health Service (to T. Y.).	Amarneh B, 2003, BIOCHEMISTRY-US, V42, P4800, DOI 10.1021/bi0340346; Arkin IT, 2007, SCIENCE, V317, P799, DOI 10.1126/science.1142824; Baranova EA, 2007, J MOL BIOL, V366, P140, DOI 10.1016/j.jmb.2006.11.026; Berrisford JM, 2009, J BIOL CHEM, V284, P29773, DOI 10.1074/jbc.M109.032144; Brandt U, 2006, ANNU REV BIOCHEM, V75, P69, DOI 10.1146/annurev.biochem.75.103004.142539; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Carroll J, 2006, J BIOL CHEM, V281, P32724, DOI 10.1074/jbc.M607135200; Castro-Guerrero N, 2010, BIOCHEMISTRY-US, V49, P10072, DOI 10.1021/bi100885v; DeLano WL., 2020, PYMOL MOL GRAPHICS S; Di Bernardo S, 2000, BIOCHEMISTRY-US, V39, P9411; Drose S, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001128; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Efremov RG, 2010, NATURE, V465, P441, DOI 10.1038/nature09066; Euro L, 2008, BBA-BIOENERGETICS, V1777, P1166, DOI 10.1016/j.bbabio.2008.06.001; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Galkin AS, 2001, BIOCHEMISTRY-MOSCOW+, V66, P435, DOI 10.1023/A:1010257630935; Garczarek F, 2005, P NATL ACAD SCI USA, V102, P3633, DOI 10.1073/pnas.0500421102; Hinchliffe P, 2005, SCIENCE, V309, P771, DOI 10.1126/science.1113988; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Kao MC, 2005, BIOCHEMISTRY-US, V44, P9545, DOI 10.1021/bi050708w; Kao MC, 2005, BIOCHEMISTRY-US, V44, P3562, DOI 10.1021/bi0476477; Kao MC, 2004, J BIOL CHEM, V279, P32360, DOI 10.1074/jbc.M403885200; Kao MC, 2003, BIOCHEMISTRY-US, V42, P4534, DOI 10.1021/bi034166z; Kao MC, 2002, BIOCHEMISTRY-US, V41, P4377, DOI 10.1021/bi025525d; Kervinen M, 2004, BIOCHEMISTRY-US, V43, P773, DOI 10.1021/bi0355903; Langemeyer L, 2007, BBA-BIOENERGETICS, V1767, P998, DOI 10.1016/j.bbabio.2007.05.007; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lu JX, 2009, CELL RES, V19, P802, DOI 10.1038/cr.2009.69; Mathiesen C, 2003, FEBS LETT, V549, P7, DOI 10.1016/S0014-5793(03)00767-1; MATSUSHITA K, 1987, BIOCHEMISTRY-US, V26, P7732, DOI 10.1021/bi00398a029; Michel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017420; MILLER MJ, 1990, P NATL ACAD SCI USA, V87, P4900, DOI 10.1073/pnas.87.13.4900; Murai M, 2009, BIOCHEMISTRY-US, V48, P688, DOI 10.1021/bi8019977; Nakamaru-Ogiso E, 2010, J BIOL CHEM, V285, P39070, DOI 10.1074/jbc.M110.157826; Padan E, 2008, TRENDS BIOCHEM SCI, V33, P435, DOI 10.1016/j.tibs.2008.06.007; Preiss L, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000443; Satoh T, 1996, BBA-BIOENERGETICS, V1273, P21, DOI 10.1016/0005-2728(95)00131-X; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2007, BIOCHEMISTRY-US, V46, P2275, DOI 10.1021/bi602508x; Schuler F, 1999, P NATL ACAD SCI USA, V96, P4149, DOI 10.1073/pnas.96.7.4149; Sharma LK, 2009, CURR MED CHEM, V16, P1266, DOI 10.2174/092986709787846578; SHIMOMURA Y, 1989, ARCH BIOCHEM BIOPHYS, V270, P573, DOI 10.1016/0003-9861(89)90539-0; Shiraishi Y, 2012, BIOCHEMISTRY-US, V51, P1953, DOI 10.1021/bi300047h; Sinha P.K, 2009, CURR TOP BIOCH RES, V11, P79; Sinha PK, 2012, J BIOL CHEM, V287, P17363, DOI 10.1074/jbc.M111.329649; Sinha PK, 2009, J BIOL CHEM, V284, P9814, DOI 10.1074/jbc.M809468200; Steimle S, 2011, BIOCHEMISTRY-US, V50, P3386, DOI 10.1021/bi200264q; Symersky J, 2012, NAT STRUCT MOL BIOL, V19, P485, DOI 10.1038/nsmb.2284; Takano S, 1996, BIOCHEMISTRY-US, V35, P9120, DOI 10.1021/bi9605853; Torres-Bacete J, 2007, J BIOL CHEM, V282, P36914, DOI 10.1074/jbc.M707855200; Torres-Bacete J, 2011, J BIOL CHEM, V286, P34007, DOI 10.1074/jbc.M111.260968; Torres-Bacete J, 2009, J BIOL CHEM, V284, P33062, DOI 10.1074/jbc.M109.059154; Umemoto H, 2009, BIOSCI BIOTECH BIOCH, V73, P965, DOI 10.1271/bbb.80869; Wikstrom M, 2012, P NATL ACAD SCI USA, V109, P4431, DOI 10.1073/pnas.1120949109; YAGI T, 1986, ARCH BIOCHEM BIOPHYS, V250, P302, DOI 10.1016/0003-9861(86)90731-9; YAGI T, 1990, ARCH BIOCHEM BIOPHYS, V281, P305, DOI 10.1016/0003-9861(90)90448-8; Yagi T, 2003, BIOCHEMISTRY-US, V42, P2266, DOI 10.1021/bi027158b; Yagi T, 1998, BBA-BIOENERGETICS, V1364, P125, DOI 10.1016/S0005-2728(98)00023-1; Zickermann V, 1998, BIOCHEMISTRY-US, V37, P11792, DOI 10.1021/bi9810555	60	9	9	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42763	42772		10.1074/jbc.M112.422824	http://dx.doi.org/10.1074/jbc.M112.422824			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105119	hybrid, Green Published			2022-12-25	WOS:000312501600035
J	Yamagami, R; Yamashita, K; Nishimasu, H; Tomikawa, C; Ochi, A; Iwashita, C; Hirata, A; Ishitani, R; Nureki, O; Hori, H				Yamagami, Ryota; Yamashita, Koki; Nishimasu, Hiroshi; Tomikawa, Chie; Ochi, Anna; Iwashita, Chikako; Hirata, Akira; Ishitani, Ryuichiro; Nureki, Osamu; Hori, Hiroyuki			The tRNA Recognition Mechanism of Folate/FAD-dependent tRNA Methyltransferase (TrmFO)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; AEOLICUS TRANSFER-RNA; ACID-SEQUENCE MOTIFS; THERMUS-THERMOPHILUS; AQUIFEX-AEOLICUS; RIBOSOMAL-RNA; M(7)G46 METHYLTRANSFERASE; EVOLUTIONARY IMPLICATIONS; M(5)U METHYLTRANSFERASES; GM18 METHYLTRANSFERASE	The conserved U54 in tRNA is often modified to 5-methyluridine (m(5)U) and forms a reverse Hoogsteen base pair with A58 that stabilizes the L-shaped tRNA structure. In Gram-positive and some Gram-negative eubacteria, m(5)U54 is produced by folate/FAD-dependent tRNA (m(5)U54) methyltransferase (TrmFO). TrmFO utilizes N-5,N-10-methylenetetrahydrofolate (CH2THF) as a methyl donor. We previously reported an in vitro TrmFO assay system, in which unstable [C-14]CH2THF was supplied from [C-14]serine and tetrahydrofolate by serine hydroxymethyltransferase. In the current study, we have improved the TrmFO assay system by optimization of enzyme and substrate concentrations and introduction of a filter assay system. Using this assay, we have focused on the tRNA recognition mechanism of TrmFO. 42 tRNA mutant variants were prepared, and experiments with truncated tRNA and microhelix RNAs revealed that the minimum requirement of TrmFO exists in the T-arm structure. The positive determinants for TrmFO were found to be the U54U55C56 sequence and G53-C61 base pair. The gel mobility shift assay and fluorescence quenching showed that the affinity of TrmFO for tRNA in the initial binding process is weak. The inhibition experiments showed that the methylated tRNA is released before the structural change process. Furthermore, we found that A38 prevents incorrect methylation of U32 in the anticodon loop. Moreover, the m(1)A58 modification clearly accelerates the TrmFO reaction, suggesting a synergistic effect of the m(5)U54, m(1)A58, and s(2)U54 modifications on m(5)s(2)U54 formation in Thermus thermophilus cells. The docking model of TrmFO and the T-arm showed that the G53-C61 base pair is not able to directly contact the enzyme.	[Yamagami, Ryota; Yamashita, Koki; Tomikawa, Chie; Ochi, Anna; Iwashita, Chikako; Hirata, Akira; Hori, Hiroyuki] Ehime Univ, Grad Sch Sci & Engn, Dept Mat Sci & Biotechnol, Matsuyama, Ehime 7908577, Japan; [Nishimasu, Hiroshi; Ishitani, Ryuichiro; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 1130032, Japan; [Hori, Hiroyuki] Ehime Univ, Venture Business Lab, Matsuyama, Ehime 7908577, Japan	Ehime University; University of Tokyo; Ehime University	Hori, H (corresponding author), Ehime Univ, Grad Sch Sci & Engn, Dept Mat Sci & Biotechnol, 3 Bunkyo, Matsuyama, Ehime 7908577, Japan.	hori@eng.ehime-u.ac.jp	Hori, Hiroyuki/AAB-3911-2021; NUREKI, OSAMU/G-4960-2014	Yamagami, Ryota/0000-0002-6947-1906	Japan Society for the Promotion of Science [23350081, 24655156]; Grants-in-Aid for Scientific Research [24655156, 23350081] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-aid for Scientific Research 23350081 (to H. H.) and Grant-in-aid for Exploratory Research 24655156 (to H. H.) from the Japan Society for the Promotion of Science.	Alian A, 2008, P NATL ACAD SCI USA, V105, P6876, DOI 10.1073/pnas.0802247105; Armengod ME, 2012, BIOCHIMIE, V94, P1510, DOI 10.1016/j.biochi.2012.02.019; Auxilien S, 2011, RNA, V17, P45, DOI 10.1261/rna.2323411; Awai T, 2011, J BIOL CHEM, V286, P35236, DOI 10.1074/jbc.M111.253641; Awai T, 2009, J BIOL CHEM, V284, P20467, DOI 10.1074/jbc.M109.020024; BARAT C, 1989, EMBO J, V8, P3279, DOI 10.1002/j.1460-2075.1989.tb08488.x; DAVANLOO P, 1979, NUCLEIC ACIDS RES, V6, P1571, DOI 10.1093/nar/6.4.1571; De Bie LGS, 2003, J BACTERIOL, V185, P3238, DOI 10.1128/JB.185.10.3238-3243.2003; DELK AS, 1980, J BIOL CHEM, V255, P4387; DELK AS, 1976, J BIOL CHEM, V251, P7649; Droogmans L, 2003, NUCLEIC ACIDS RES, V31, P2148, DOI 10.1093/nar/gkg314; Dunin-Horkawicz S, 2006, NUCLEIC ACIDS RES, V34, pD145, DOI 10.1093/nar/gkj084; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GARCIA GR, 1998, MODIFICATION EDITING, P555; GOLD M, 1963, P NATL ACAD SCI USA, V50, P164, DOI 10.1073/pnas.50.1.164; GREENBERG R, 1980, J BIOL CHEM, V255, P8296; GU XG, 1991, BIOCHEMISTRY-US, V30, P2999, DOI 10.1021/bi00226a003; GU XG, 1994, BIOCHEMISTRY-US, V33, P2255, DOI 10.1021/bi00174a036; GU XG, 1992, BIOCHEMISTRY-US, V31, P10295, DOI 10.1021/bi00157a017; Gu XR, 1996, NUCLEIC ACIDS RES, V24, P1059, DOI 10.1093/nar/24.6.1059; Gu XR, 1998, BIOCHEMISTRY-US, V37, P339, DOI 10.1021/bi971590p; Gu XR, 1996, BIOCHEMISTRY-US, V35, P11652, DOI 10.1021/bi9612125; GUSTAFSSON C, 1993, J BIOL CHEM, V268, P1326; Hamdane D, 2011, J BIOL CHEM, V286, P36268, DOI 10.1074/jbc.M111.256966; Hamdane D, 2011, BIOCHEMISTRY-US, V50, P5208, DOI 10.1021/bi1019463; Hori H, 2003, J BIOL CHEM, V278, P25081, DOI 10.1074/jbc.M212577200; Hori H, 2002, GENES CELLS, V7, P259, DOI 10.1046/j.1365-2443.2002.00520.x; Ihsanawati, 2008, J MOL BIOL, V383, P871, DOI 10.1016/j.jmb.2008.08.068; Ishida K, 2011, NUCLEIC ACIDS RES, V39, P2304, DOI 10.1093/nar/gkq1180; Johansson MJO, 2002, RNA, V8, P324, DOI 10.1017/S1355838202027851; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; KEALEY JT, 1991, NUCLEIC ACIDS RES, V19, P6465, DOI 10.1093/nar/19.23.6465; KEALEY JT, 1994, PROTEIN EXPRES PURIF, V5, P149, DOI 10.1006/prep.1994.1023; KIM SH, 1974, P NATL ACAD SCI USA, V71, P4970, DOI 10.1073/pnas.71.12.4970; KOWALAK JA, 1994, BIOCHEMISTRY-US, V33, P7869, DOI 10.1021/bi00191a014; Lamichhane TN, 2011, RNA, V17, P1846, DOI 10.1261/rna.2628611; Leung HCE, 1997, J BIOL CHEM, V272, P13073, DOI 10.1074/jbc.272.20.13073; Meyer S, 2008, J MOL BIOL, V380, P532, DOI 10.1016/j.jmb.2008.04.072; NAKANISHI S, 1994, J BIOL CHEM, V269, P32221; Nishimasu H, 2009, P NATL ACAD SCI USA, V106, P8180, DOI 10.1073/pnas.0901330106; Nordlund ME, 2000, RNA, V6, P844, DOI 10.1017/S1355838200992422; Nureki O, 2004, STRUCTURE, V12, P593, DOI 10.1016/j.str.2004.03.003; NY T, 1980, J BACTERIOL, V142, P371, DOI 10.1128/JB.142.2.371-379.1980; NY T, 1988, EUR J BIOCHEM, V177, P467, DOI 10.1111/j.1432-1033.1988.tb14396.x; Ochi A, 2010, J BIOL CHEM, V285, P9018, DOI 10.1074/jbc.M109.065698; Okamoto H, 2004, J BIOL CHEM, V279, P49151, DOI 10.1074/jbc.M408209200; Osawa T, 2009, STRUCTURE, V17, P713, DOI 10.1016/j.str.2009.03.013; Persson BC, 1997, NUCLEIC ACIDS RES, V25, P4093, DOI 10.1093/nar/25.20.4093; ROBERTUS JD, 1974, NATURE, V250, P546, DOI 10.1038/250546a0; ROMBY P, 1987, J BIOMOL STRUCT DYN, V5, P669, DOI 10.1080/07391102.1987.10506419; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Shigi N, 2006, J BIOL CHEM, V281, P2104, DOI 10.1074/jbc.M510771200; Shigi N, 2002, J BIOL CHEM, V277, P39128, DOI 10.1074/jbc.M207323200; Shigi N, 2008, EMBO J, V27, P3267, DOI 10.1038/emboj.2008.246; Takeda H, 2006, GENES CELLS, V11, P1353, DOI 10.1111/j.1365-2443.2006.01022.x; Tomikawa C, 2010, NUCLEIC ACIDS RES, V38, P942, DOI 10.1093/nar/gkp1059; Urbonavicius J, 2005, NUCLEIC ACIDS RES, V33, P3955, DOI 10.1093/nar/gki703; Urbonavicius J, 2007, METHOD ENZYMOL, V425, P103; Urbonavicius J, 2008, MOL MICROBIOL, V67, P323, DOI 10.1111/j.1365-2958.2007.06047.x; WATANABE K, 1976, BIOCHEM BIOPH RES CO, V72, P1137, DOI 10.1016/S0006-291X(76)80250-1; Watanabe K, 2005, J BIOL CHEM, V280, P10368, DOI 10.1074/jbc.M411209200; Yaremchuk A, 2000, EMBO J, V19, P4745, DOI 10.1093/emboj/19.17.4745	63	33	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42480	42494		10.1074/jbc.M112.390112	http://dx.doi.org/10.1074/jbc.M112.390112			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23095745	Green Published, hybrid			2022-12-25	WOS:000312501600010
J	Dewan, V; Wei, M; Kleiman, L; Musier-Forsyth, K				Dewan, Varun; Wei, Min; Kleiman, Lawrence; Musier-Forsyth, Karin			Dual Role for Motif 1 Residues of Human Lysyl-tRNA Synthetase in Dimerization and Packaging into HIV-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; C-TERMINAL DOMAIN; ESCHERICHIA-COLI; IN-VITRO; TRNA(LYS) INCORPORATION; VIRAL INFECTIVITY; CRYSTAL-STRUCTURE; CYCLOPHILIN-A; GAG; PROTEIN	The primer for reverse transcription in human immunodeficiency virus type 1, human tRNA(Lys, 3), is selectively packaged into the virion along with tRNA(Lys1,2). Human lysyl-tRNA synthetase (hLysRS), the only cellular factor known to interact specifically with all three tRNA(Lys) isoacceptors, is also selectively packaged into HIV-1. We have previously defined a tRNA(Lys) packaging complex that includes the tRNA(Lys) isoacceptors, LysRS, HIV-1 Gag, GagPol, and viral RNA. Numerous studies support the hypothesis that during tRNA(Lys) packaging, a Gag.GagPol complex interacts with a tRNA(Lys). LysRS complex, with Gag interacting specifically with the catalytic domain of LysRS, and GagPol interacting with both Gag and tRNA(Lys). In this work, we have identified residues along one face of the motif 1 dimerization helix (H7) of hLysRS that are critical for packaging of the synthetase into virions. Mutation of these residues affects binding to Gag in vitro, as well as the oligomerization state and aminoacylation activity of the synthetase. Taken together, these data suggest that H7 of LysRS has a dual function. In its canonical role it maintains the synthetase dimer interface, whereas in its function in tRNA primer recruitment, it bridges interactions with HIV-1 Gag.	[Dewan, Varun; Musier-Forsyth, Karin] Ohio State Univ, Dept Chem & Biochem, Ohio State Biochem Program, Ctr RNA Biol, Columbus, OH 43210 USA; [Dewan, Varun; Musier-Forsyth, Karin] Ohio State Univ, Ctr Retroviral Res, Columbus, OH 43210 USA; [Wei, Min; Kleiman, Lawrence] McGill Univ, Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Wei, Min; Kleiman, Lawrence] McGill Univ, Jewish Gen Hosp, McGill AIDS Ctr, Montreal, PQ H3T 1E2, Canada	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Lady Davis Institute; McGill University; McGill University	Musier-Forsyth, K (corresponding author), Ohio State Univ, Dept Chem & Biochem, Ohio State Biochem Program, Ctr RNA Biol, 100 W 18th Ave, Columbus, OH 43210 USA.	musier@chemistry.ohio-state.edu			National Institutes of Health [AI077387]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI077387 (to L.K. and K.M.-F.).	Cen S, 2004, J VIROL, V78, P1595, DOI 10.1128/JVI.78.3.1595-1601.2004; Cen S, 2001, J VIROL, V75, P5043, DOI 10.1128/JVI.75.11.5043-5048.2001; Chu H, 2009, CURR TOP MICROBIOL, V339, P67, DOI 10.1007/978-3-642-02175-6_4; Cusack S, 1996, EMBO J, V15, P6321, DOI 10.1002/j.1460-2075.1996.tb01022.x; Datta Siddhartha A. K., 2009, V485, P197, DOI 10.1007/978-1-59745-170-3_14; Dewan V, 2012, ACS CHEM BIOL, V7, P761, DOI 10.1021/cb200450w; ERIANI G, 1990, NUCLEIC ACIDS RES, V18, P7109, DOI 10.1093/nar/18.23.7109; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Fang PF, 2011, P NATL ACAD SCI USA, V108, P8239, DOI 10.1073/pnas.1100224108; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Gabor J, 2002, J VIROL, V76, P9096, DOI 10.1128/JVI.76.18.9096-9102.2002; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Garrus JE, 2001, CELL, V107, P55, DOI 10.1016/S0092-8674(01)00506-2; Guo F, 2003, J VIROL, V77, P9817, DOI 10.1128/JVI.77.18.9817-9822.2003; Guo M, 2008, P NATL ACAD SCI USA, V105, P2331, DOI 10.1073/pnas.0712072105; Guo M, 2010, J PHYS CHEM B, V114, P16273, DOI 10.1021/jp1082517; Halwani R, 2004, J VIROL, V78, P7553, DOI 10.1128/JVI.78.14.7553-7564.2004; Ivanov D, 2007, P NATL ACAD SCI USA, V104, P4353, DOI 10.1073/pnas.0609477104; Javanbakht H, 2003, J BIOL CHEM, V278, P27644, DOI 10.1074/jbc.M301840200; Javanbakht H, 2002, J BIOL CHEM, V277, P17389, DOI 10.1074/jbc.M112479200; Kaminska M, 2007, J VIROL, V81, P68, DOI 10.1128/JVI.01267-06; Kleiman L, 2004, CURR HIV RES, V2, P163, DOI 10.2174/1570162043484988; Kleiman L, 2010, FEBS LETT, V584, P359, DOI 10.1016/j.febslet.2009.11.038; Kobbi L, 2011, J MOL BIOL, V410, P875, DOI 10.1016/j.jmb.2011.03.005; Kovaleski BJ, 2007, J BIOL CHEM, V282, P32274, DOI 10.1074/jbc.M706256200; Kovaleski BJ, 2006, J BIOL CHEM, V281, P19449, DOI 10.1074/jbc.M601189200; MAK J, 1994, J VIROL, V68, P2065, DOI 10.1128/JVI.68.4.2065-2072.1994; Mak J, 1997, J VIROL, V71, P8087, DOI 10.1128/JVI.71.11.8087-8095.1997; Mascarenhas AP, 2009, FEBS J, V276, P6118, DOI 10.1111/j.1742-4658.2009.07315.x; Nakorn PN, 2011, J THEOR BIOL, V270, P88, DOI 10.1016/j.jtbi.2010.11.010; ONESTI S, 1995, STRUCTURE, V3, P163, DOI 10.1016/S0969-2126(01)00147-2; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Park SG, 2005, P NATL ACAD SCI USA, V102, P6356, DOI 10.1073/pnas.0500226102; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Rein A, 2011, TRENDS BIOCHEM SCI, V36, P373, DOI 10.1016/j.tibs.2011.04.001; Stello T, 1999, NUCLEIC ACIDS RES, V27, P4823, DOI 10.1093/nar/27.24.4823; Strack B, 2003, CELL, V114, P689, DOI 10.1016/S0092-8674(03)00653-6; SWANSTROM R, 1997, SYNTHESIS ASSEMBLY P, P263; THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0; Wei M, 2008, J VIROL, V82, P12049, DOI 10.1128/JVI.01744-08; Yannay-Cohen N, 2009, MOL CELL, V34, P603, DOI 10.1016/j.molcel.2009.05.019; Zimmerman C, 2002, NATURE, V415, P88, DOI 10.1038/415088a	44	15	16	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41955	41962		10.1074/jbc.M112.421842	http://dx.doi.org/10.1074/jbc.M112.421842			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23095741	Green Published, hybrid			2022-12-25	WOS:000312103000035
J	Ge, Q; Huang, N; Wynn, RM; Li, Y; Du, XL; Miller, B; Zhang, H; Uyeda, K				Ge, Qiang; Huang, Nian; Wynn, R. Max; Li, Yang; Du, Xinlin; Miller, Bonnie; Zhang, Hong; Uyeda, Kosaku			Structural Characterization of a Unique Interface between Carbohydrate Response Element-binding Protein (ChREBP) and 14-3-3 beta Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR EXPORT SIGNAL; TRANSCRIPTION FACTOR; EXOENZYME-S; GLUCOSE; PHOSPHORYLATION; LOCALIZATION; LIPOGENESIS; DEFICIENCY; REGULATOR; LIGAND	Carbohydrate response element-binding protein (ChREBP) is an insulin-independent, glucose-responsive transcription factor that is expressed at high levels in liver hepatocytes where it plays a critical role in converting excess carbohydrates to fat for storage. In response to fluctuating glucose levels, hepatic ChREBP activity is regulated in large part by nucleocytoplasmic shuttling of ChREBP protein via interactions with 14-3-3 proteins. The N-terminal ChREBP regulatory region is necessary and sufficient for glucose-responsive ChREBP nuclear import and export. Here, we report the crystal structure of a complex of 14-3-3 beta bound to the N-terminal regulatory region of ChREBP at 2.4 angstrom resolution. The crystal structure revealed that the alpha 2 helix of ChREBP (residues 117-137) adopts a well defined alpha-helical conformation and binds 14-3-3 in a phosphorylation-independent manner that is different from all previously characterized 14-3-3 and target protein-bindingmodes. ChREBP alpha 2 interacts with 14-3-3 through both electrostatic and van der Waals interactions, and the binding is partially mediated by a free sulfate or phosphate. Structure-based mutagenesis and binding assays indicated that disrupting the observed 14-3-3 and ChREBP alpha 2 interface resulted in a loss of complex formation, thus validating the novel protein interaction mode in the 14-3-3 beta. ChREBP alpha 2 complex.	[Ge, Qiang; Wynn, R. Max; Li, Yang; Du, Xinlin; Miller, Bonnie; Zhang, Hong; Uyeda, Kosaku] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Huang, Nian; Zhang, Hong] Univ Texas SW Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Uyeda, Kosaku] Dallas Vet Affairs Med Ctr, Dallas, TX 75216 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, H (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.	zhang@chop.swmed.edu; Kosaku.Uyeda@UTSouthwestern.edu		Wynn, Richard/0000-0002-1879-2136	National Institutes of Health from NIDDK [R01 DK063948]; Veterans Affairs merit review grant; Welch Foundation [I-1720]; American Heart Association [10GRNT4310090]; United States Department of Energy, Office of Biological and Environmental Research [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063948] Funding Source: NIH RePORTER	National Institutes of Health from NIDDK; Veterans Affairs merit review grant(US Department of Veterans Affairs); Welch Foundation(The Welch Foundation); American Heart Association(American Heart Association); United States Department of Energy, Office of Biological and Environmental Research(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK063948 from NIDDK. This work was also supported by a Veterans Affairs merit review grant, Welch Foundation Grant I-1720 (to K.U.), and American Heart Association Grant 10GRNT4310090 (to H.Z.).; We thank Yuh Min Chook for helpful discussions. Results shown in this report are derived from work performed at Argonne National Laboratory, Structural Biology Center at the Advanced Photon Source. Argonne is operated by University of Chicago Argonne, LLC, for the United States Department of Energy, Office of Biological and Environmental Research under Contract DE-AC02-06CH11357.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bricambert J, 2010, J CLIN INVEST, V120, P4316, DOI 10.1172/JCI41624; Denechaud PD, 2008, J CLIN INVEST, V118, P956, DOI 10.1172/JCI34314; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fukasawa M, 2010, BIOCHEM BIOPH RES CO, V391, P1166, DOI 10.1016/j.bbrc.2009.11.115; Ge Q, 2011, J BIOL CHEM, V286, P28119, DOI 10.1074/jbc.M111.237016; Guinez C, 2011, DIABETES, V60, P1399, DOI 10.2337/db10-0452; Havula E, 2012, SEMIN CELL DEV BIOL, V23, P640, DOI 10.1016/j.semcdb.2012.02.007; Horton JD, 1998, P NATL ACAD SCI USA, V95, P5987, DOI 10.1073/pnas.95.11.5987; Iizuka K, 2004, P NATL ACAD SCI USA, V101, P7281, DOI 10.1073/pnas.0401516101; Iizuka K, 2006, AM J PHYSIOL-ENDOC M, V291, pE358, DOI 10.1152/ajpendo.00027.2006; Jeong YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022544; Kabashima T, 2003, P NATL ACAD SCI USA, V100, P5107, DOI 10.1073/pnas.0730817100; Kawaguchi T, 2002, J BIOL CHEM, V277, P3829, DOI 10.1074/jbc.M107895200; Kawaguchi T, 2001, P NATL ACAD SCI USA, V98, P13710, DOI 10.1073/pnas.231370798; Kleppe R, 2011, SEMIN CELL DEV BIOL, V22, P713, DOI 10.1016/j.semcdb.2011.08.008; Li MV, 2008, MOL ENDOCRINOL, V22, P1658, DOI 10.1210/me.2007-0560; Ma L, 2005, J BIOL CHEM, V280, P12019, DOI 10.1074/jbc.M413063200; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; Masters SC, 1999, BIOCHEMISTRY-US, V38, P5216, DOI 10.1021/bi982492m; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Merla G, 2004, HUM MOL GENET, V13, P1505, DOI 10.1093/hmg/ddh163; Obsil T, 2011, SEMIN CELL DEV BIOL, V22, P663, DOI 10.1016/j.semcdb.2011.09.001; Obsilova V, 2008, PHYSIOL RES, V57, pS11, DOI 10.33549/physiolres.931598; Ottmann C, 2007, EMBO J, V26, P902, DOI 10.1038/sj.emboj.7601530; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Postic C, 2007, ANNU REV NUTR, V27, P179, DOI 10.1146/annurev.nutr.27.061406.093618; Rittinger K, 1999, MOL CELL, V4, P153, DOI 10.1016/S1097-2765(00)80363-9; Sakiyama H, 2010, BIOCHEM BIOPH RES CO, V402, P784, DOI 10.1016/j.bbrc.2010.10.113; Sakiyama H, 2008, J BIOL CHEM, V283, P24899, DOI 10.1074/jbc.M804308200; Towle HC, 2005, TRENDS ENDOCRIN MET, V16, P489, DOI 10.1016/j.tem.2005.10.003; Uyeda K, 2006, CELL METAB, V4, P107, DOI 10.1016/j.cmet.2006.06.008; Wang BC, 1999, BIOCHEMISTRY-US, V38, P12499, DOI 10.1021/bi991353h; Yaffe MB, 1997, CELL, V91, P961, DOI 10.1016/S0092-8674(00)80487-0; Yamashita H, 2001, P NATL ACAD SCI USA, V98, P9116, DOI 10.1073/pnas.161284298; Yang XW, 2006, P NATL ACAD SCI USA, V103, P17237, DOI 10.1073/pnas.0605779103; Zhai JB, 2001, J BIOL CHEM, V276, P41318, DOI 10.1074/jbc.M107709200	38	22	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41914	41921		10.1074/jbc.M112.418855	http://dx.doi.org/10.1074/jbc.M112.418855			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086940	Green Published, hybrid			2022-12-25	WOS:000312103000031
J	Mayer-Pinto, M; Ignacio, BL; Szechy, MTM; Viana, MS; Curbelo-Fernandez, MP; Lavrado, HP; Junqueira, AOR; Vilanova, E; Silva, SHG				Mayer-Pinto, Mariana; Ignacio, Barbara L.; Szechy, Maria T. M.; Viana, Mariana S.; Curbelo-Fernandez, Maria P.; Lavrado, Helena P.; Junqueira, Andrea O. R.; Vilanova, Eduardo; Silva, Sergio H. G.			How Much Is Too Little to Detect Impacts? A Case Study of a Nuclear Power Plant	PLOS ONE			English	Article							DIFFERENT SPATIAL SCALES; ENVIRONMENTAL IMPACTS; ASYMMETRICAL ANALYSES; BIOACCUMULATION; ORGANISMS; BACI; CHLORINATION; ZOOPLANKTON; COMMUNITIES; VARIABILITY	Several approaches have been proposed to assess impacts on natural assemblages. Ideally, the potentially impacted site and multiple reference sites are sampled through time, before and after the impact. Often, however, the lack of information regarding the potential overall impact, the lack of knowledge about the environment in many regions worldwide, budgets constraints and the increasing dimensions of human activities compromise the reliability of the impact assessment. We evaluated the impact, if any, and its extent of a nuclear power plant effluent on sessile epibiota assemblages using a suitable and feasible sampling design with no 'before' data and budget and logistic constraints. Assemblages were sampled at multiple times and at increasing distances from the point of the discharge of the effluent. There was a clear and localized effect of the power plant effluent (up to 100 m from the point of the discharge). However, depending on the time of the year, the impact reaches up to 600 m. We found a significantly lower richness of taxa in the Effluent site when compared to other sites. Furthermore, at all times, the variability of assemblages near the discharge was also smaller than in other sites. Although the sampling design used here (in particular the number of replicates) did not allow an unambiguously evaluation of the full extent of the impact in relation to its intensity and temporal variability, the multiple temporal and spatial scales used allowed the detection of some differences in the intensity of the impact, depending on the time of sampling. Our findings greatly contribute to increase the knowledge on the effects of multiple stressors caused by the effluent of a power plant and also have important implications for management strategies and conservation ecology, in general.	[Mayer-Pinto, Mariana; Ignacio, Barbara L.; Szechy, Maria T. M.; Viana, Mariana S.; Curbelo-Fernandez, Maria P.; Lavrado, Helena P.; Junqueira, Andrea O. R.; Vilanova, Eduardo; Silva, Sergio H. G.] Univ Fed Rio de Janeiro, Inst Biol, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro	Mayer-Pinto, M (corresponding author), Univ Sydney, EICC, Sch Biol Sci, Marine Ecol Labs A11, Sydney, NSW 2006, Australia.	mariana.mayer@sydney.edu.au	JUNQUEIRA, ANDREA/G-4705-2014; Ignacio, Barbara Lage/I-5204-2012; Lavrado, Helena P/M-9737-2014	Lavrado, Helena P/0000-0002-7275-7075; Mayer-Pinto, Mariana/0000-0001-9679-7023; OLIVEIRA RIBEIRO JUNQUEIRA, ANDREA/0000-0002-3386-2454; Ignacio, Barbara/0000-0001-6943-7348	National Counsel of Technological and Scientific Development (CNPq)	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by the National Counsel of Technological and Scientific Development (CNPq) to Silva, S. H. G. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABARNOU A, 1992, SCI TOTAL ENVIRON, V126, P173, DOI 10.1016/0048-9697(92)90490-J; Abelson A, 1997, ANNU REV ECOL SYST, V28, P317, DOI 10.1146/annurev.ecolsys.28.1.317; Anderson MJ, 2009, MULTIVARIATE ANAL CO; Benedetti-Cecchi L, 2003, ECOLOGY, V84, P2335, DOI 10.1890/02-8011; Bishop MJ, 2002, MAR ECOL PROG SER, V236, P121, DOI 10.3354/meps236121; CHAPMAN MG, 1995, J EXP MAR BIOL ECOL, V189, P103, DOI 10.1016/0022-0981(95)00017-L; Dias CD, 1999, BRAZ ARCH BIOL TECHN, V42, P223; Downes B.J., 2008, MONITORING ECOLOGICA; FREITAS ACS, 1988, SCI TOTAL ENVIRON, V75, P225, DOI 10.1016/0048-9697(88)90035-6; Glasby TM, 1996, ENVIRON MONIT ASSESS, V42, P241, DOI 10.1007/BF00414371; Glasby TM, 1997, AUST J ECOL, V22, P448, DOI 10.1111/j.1442-9993.1997.tb00696.x; Green R., 1979, SAMPLING DESIGN STAT; GUIMARAES JRD, 1985, MAR ENVIRON RES, V16, P77, DOI 10.1016/0141-1136(85)90010-8; GUIMARAES JRD, 1992, SCI TOTAL ENVIRON, V120, P205, DOI 10.1016/0048-9697(92)90056-X; Helmuth B, 2006, ANNU REV ECOL EVOL S, V37, P373, DOI 10.1146/annurev.ecolsys.37.091305.110149; IBAMA, 2007, EST IMP AMB REL IMP; Lardicci C, 1999, MAR POLLUT BULL, V38, P296, DOI 10.1016/S0025-326X(98)00149-0; Laws E. A., 1993, AQUATIC POLLUTION IN; Mayer-Pinto M, 2010, J EXP MAR BIOL ECOL, V391, P1, DOI 10.1016/j.jembe.2010.06.013; MCCAIN JC, 1975, ENVIRON POLLUT, V9, P63, DOI 10.1016/0013-9327(75)90056-7; Morelissen B, 2007, J EXP MAR BIOL ECOL, V348, P162, DOI 10.1016/j.jembe.2007.04.006; Rajagopal S, 2003, MAR ENVIRON RES, V55, P277, DOI 10.1016/S0141-1136(02)00272-6; Rajagopal S, 1996, MAR ENVIRON RES, V41, P201, DOI 10.1016/0141-1136(95)00012-7; Rajagopal S, 2003, WATER RES, V37, P329, DOI 10.1016/S0043-1354(02)00270-1; Schiel DR, 2004, ECOLOGY, V85, P1833, DOI 10.1890/03-3107; SOUTHWARD AJ, 1995, J THERM BIOL, V20, P127, DOI 10.1016/0306-4565(94)00043-I; Steinbeck JR, 2005, ECOL APPL, V15, P1813, DOI 10.1890/04-1046; SURESH K, 1993, HYDROBIOLOGIA, V268, P109, DOI 10.1007/BF00006881; Terlizzi A, 2005, MAR ECOL PROG SER, V289, P27, DOI 10.3354/meps289027; Thiyagarajan V, 2000, J THERM BIOL, V25, P451, DOI 10.1016/S0306-4565(00)00010-3; THORHAUG A, 1973, Marine Pollution Bulletin, V4, P166, DOI 10.1016/0025-326X(73)90176-8; UNDERWOOD AJ, 1992, J EXP MAR BIOL ECOL, V161, P145, DOI 10.1016/0022-0981(92)90094-Q; UNDERWOOD AJ, 1994, ECOL APPL, V4, P3, DOI 10.2307/1942110; UNDERWOOD AJ, 1991, AUST J MAR FRESH RES, V42, P569, DOI 10.1071/MF9910569; Venugopalan V. P., 2012, OPERATIONAL ENV CONS, P1; Vilanova E., 2004, B MUS I BIOL U GEN, V68, P647; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Winder M, 2004, ECOLOGY, V85, P2100, DOI 10.1890/04-0151	38	12	14	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47871	10.1371/journal.pone.0047871	http://dx.doi.org/10.1371/journal.pone.0047871			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110117	Green Submitted, gold, Green Published			2022-12-25	WOS:000310262500025
J	Nilsson, A; Forngren, B; Bjurstrom, S; Goodwin, RJA; Basmaci, E; Gustafsson, I; Annas, A; Hellgren, D; Svanhagen, A; Andren, PE; Lindberg, J				Nilsson, Anna; Forngren, Benita; Bjurstrom, Sivert; Goodwin, Richard J. A.; Basmaci, Elisa; Gustafsson, Ingela; Annas, Anita; Hellgren, Dennis; Svanhagen, Alexander; Andren, Per E.; Lindberg, Johan			In Situ Mass Spectrometry Imaging and Ex Vivo Characterization of Renal Crystalline Deposits Induced in Multiple Preclinical Drug Toxicology Studies	PLOS ONE			English	Article							LASER CAPTURE MICRODISSECTION; TISSUE-SECTIONS; RAT-BRAIN; MALDI; DISCOVERY; TOXICITY; UTILITY; MS	Drug toxicity observed in animal studies during drug development accounts for the discontinuation of many drug candidates, with the kidney being a major site of tissue damage. Extensive investigations are often required to reveal the mechanisms underlying such toxicological events and in the case of crystalline deposits the chemical composition can be problematic to determine. In the present study, we have used mass spectrometry imaging combined with a set of advanced analytical techniques to characterize such crystalline deposits in situ. Two potential microsomal prostaglandin E synthase 1 inhibitors, with similar chemical structure, were administered to rats over a seven day period. This resulted in kidney damage with marked tubular degeneration/regeneration and crystal deposits within the tissue that was detected by histopathology. Results from direct tissue section analysis by matrix-assisted laser desorption ionization mass spectrometry imaging were combined with data obtained following manual crystal dissection analyzed by liquid chromatography mass spectrometry and nuclear magnetic resonance spectroscopy. The chemical composition of the crystal deposits was successfully identified as a common metabolite, bisulphonamide, of the two drug candidates. In addition, an un-targeted analysis revealed molecular changes in the kidney that were specifically associated with the area of the tissue defined as pathologically damaged. In the presented study, we show the usefulness of combining mass spectrometry imaging with an array of powerful analytical tools to solve complex toxicological problems occurring during drug development.	[Nilsson, Anna; Andren, Per E.] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden; [Forngren, Benita; Bjurstrom, Sivert; Basmaci, Elisa; Gustafsson, Ingela; Annas, Anita; Hellgren, Dennis; Svanhagen, Alexander; Lindberg, Johan] AstraZeneca R&D, Safety Assessment, Sodertalje, Sweden; [Goodwin, Richard J. A.] AstraZeneca R&D, DMPK IM, Global Distribut Imaging, Sodertalje, Sweden	Uppsala University; AstraZeneca; AstraZeneca	Nilsson, A (corresponding author), Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden.	anna.nilsson@farmbio.uu.se		Andren, Per/0000-0002-4062-7743	Swedish Research Council [2008-5597, 2009-6050, 2010-5421]; K&A Wallenberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); K&A Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This study was sponsored by the Swedish Research Council (http://www.vr.se), grant no. 2008-5597, 2009-6050, 2010-5421, and the K&A Wallenberg Foundation (http://www.wallenberg.com/kaw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscripts.	Aberg KM, 2008, J CHROMATOGR A, V1192, P139, DOI 10.1016/j.chroma.2008.03.033; Beckonert O, 2010, NAT PROTOC, V5, P1019, DOI 10.1038/nprot.2010.45; Caprioli RM, 1997, ANAL CHEM, V69, P4751, DOI 10.1021/ac970888i; Cazares LH, 2011, ANAL BIOANAL CHEM, V401, P17, DOI 10.1007/s00216-011-5003-6; Clarke CJ, 2008, TOXICOL PATHOL, V36, P140, DOI 10.1177/0192623307310947; Dieterle F, 2008, CURR OPIN DRUG DISC, V11, P60; Drexler Dieter M., 2007, Journal of Pharmacological and Toxicological Methods, V55, P279, DOI 10.1016/j.vascn.2006.11.004; Drexler DM, 2011, ANAL BIOANAL CHEM, V399, P2645, DOI 10.1007/s00216-010-4370-8; EmmertBuck MR, 1996, SCIENCE, V274, P998, DOI 10.1126/science.274.5289.998; Fernandez JA, 2011, ANAL BIOANAL CHEM, V401, P29, DOI 10.1007/s00216-011-4696-x; Goodsaid FM, 2009, CLIN PHARMACOL THER, V86, P490, DOI 10.1038/clpt.2009.149; Goodwin RJA, 2010, ANAL CHEM, V82, P3868, DOI 10.1021/ac100398y; Goodwin RJA, 2011, ANAL CHEM, V83, P9694, DOI 10.1021/ac202630t; Goodwin RJA, 2010, BIOANALYSIS, V2, P279, DOI 10.4155/BIO.09.180; Guillarme D, 2010, TRAC-TREND ANAL CHEM, V29, P15, DOI 10.1016/j.trac.2009.09.008; Izzedine H, 2005, AM J KIDNEY DIS, V45, P804, DOI 10.1053/j.ajkd.2005.02.010; Khatib-Shahidi S, 2006, ANAL CHEM, V78, P6448, DOI 10.1021/ac060788p; Kuhlmann J, 2006, CURR CLIN PHARMACOL, V1, P185, DOI 10.2174/157488406776872578; MONRO AM, 1990, REGUL TOXICOL PHARM, V12, P137, DOI 10.1016/S0273-2300(05)80055-8; Mustafa Dana, 2008, V428, P159; Nilsson A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011411; Pellegatti M, 2011, EXPERT OPIN DRUG MET, V7, P137, DOI 10.1517/17425255.2011.545053; Perazella MA, 1999, AM J MED, V106, P459, DOI 10.1016/S0002-9343(99)00041-8; Prideaux B, 2010, METHODS MOL BIOL, V656, P405, DOI 10.1007/978-1-60761-746-4_23; Seeley EH, 2011, J BIOL CHEM, V286, P25459, DOI 10.1074/jbc.R111.225854; Solon EG, 2010, AAPS J, V12, P11, DOI 10.1208/s12248-009-9158-4; Stoeckli M, 2001, NAT MED, V7, P493, DOI 10.1038/86573; Sugiura Y, 2010, J NEUROIMMUNE PHARM, V5, P31, DOI 10.1007/s11481-009-9162-6	28	38	39	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47353	10.1371/journal.pone.0047353	http://dx.doi.org/10.1371/journal.pone.0047353			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110069	gold, Green Published, Green Submitted			2022-12-25	WOS:000310193600014
J	Roy, BM; Zhukov, DV; Maynard, JA				Roy, Benjamin M.; Zhukov, Dmitriy V.; Maynard, Jennifer A.			Flanking Residues Are Central to DO11.10 T Cell Hybridoma Stimulation by Ovalbumin 323-339	PLOS ONE			English	Article							MHC CLASS-II; MAJOR HISTOCOMPATIBILITY COMPLEX; MYELIN BASIC-PROTEIN; PEPTIDE-BINDING; ANTIGEN PRESENTATION; KINETIC STABILITY; ANCHOR RESIDUES; HIGH-AFFINITY; TCR BINDING; HLA-DR	T cell activation requires formation of a tri-molecular interaction between a major histocompatibility complex (MHC), peptide, and T cell receptor. In a common model system, the ovalbumin epitope 323-339 binds the murine class II MHC, I-A(d), in at least three distinct registers. The DO11.10 T cell recognizes the least stable of these, as determined by peptide-MHC dissociation rates. Using exogenous peptides and peptide insertions into a carrier protein in combination with IL-2 secretion assays, we show that the alternate registers do not competitively inhibit display of the active register four. In contrast, this weakly binding register is stabilized by the presence of N-terminal flanking residues active in MHC binding. The DO11.10 hybridoma is sensitive to the presence of specific wild-type residues extending to at least the P-3 peptide position. Transfer of the P-4 to P-2 flanking residues to a hen egg lysozyme epitope also presented by I-A(d) increases the activity of that epitope substantially. These results illustrate the inherent complexity in delineating the interaction of multiple registers based on traditional thermodynamic measurements and demonstrate the potential of flanking residue modification for increasing the activity of weakly bound epitopes. The latter technique represents an alternative to substitution of anchor residues within a weakly bound register, which we show can significantly decrease the activity of the epitope to a responding T cell.	[Roy, Benjamin M.; Zhukov, Dmitriy V.; Maynard, Jennifer A.] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Roy, Benjamin M.] Univ Minnesota, Dept Chem Engn, Minneapolis, MN USA	University of Texas System; University of Texas Austin; University of Minnesota System; University of Minnesota Twin Cities	Maynard, JA (corresponding author), Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.	maynard@che.utexas.edu			Packard Foundation; NSF [DBI-0964137]; NIH [1R01GM095638]; Div Of Biological Infrastructure [0964137] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095638] Funding Source: NIH RePORTER	Packard Foundation(The David & Lucile Packard Foundation); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding for this project was provided by the Packard Foundation, NSF DBI-0964137 and NIH 1R01GM095638 to JAM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiru N, 2000, J AUTOIMMUN, V14, P231, DOI 10.1006/jaut.2000.0369; Bakker ABH, 1997, INT J CANCER, V70, P302, DOI 10.1002/(SICI)1097-0215(19970127)70:3<302::AID-IJC10>3.0.CO;2-H; Bankovich AJ, 2004, MOL IMMUNOL, V40, P1033, DOI 10.1016/j.molimm.2003.11.016; Bordner AJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-41; Busch R, 2005, IMMUNOL REV, V207, P242, DOI 10.1111/j.0105-2896.2005.00306.x; Castellino F, 1997, HUM IMMUNOL, V54, P159, DOI 10.1016/S0198-8859(97)00078-5; Chang ST, 2006, BIOINFORMATICS, V22, P2761, DOI 10.1093/bioinformatics/btl479; Chaves FA, 2006, BIOCHEMISTRY-US, V45, P6426, DOI 10.1021/bi060194g; Cole DK, 2010, J IMMUNOL, V185, P2600, DOI 10.4049/jimmunol.1000629; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; DANG LH, 1993, J IMMUNOL, V150, P4206; Dyall R, 1998, J EXP MED, V188, P1553, DOI 10.1084/jem.188.9.1553; Fairchild PJ, 1996, INT IMMUNOL, V8, P1035, DOI 10.1093/intimm/8.7.1035; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; Gervois N, 1996, J EXP MED, V183, P2403, DOI 10.1084/jem.183.5.2403; Godkin AJ, 1998, J IMMUNOL, V161, P850; Godkin AJ, 2001, J IMMUNOL, V166, P6720, DOI 10.4049/jimmunol.166.11.6720; Gunther S, 2010, P NATL ACAD SCI USA, V107, P22219, DOI 10.1073/pnas.1014708107; Jardetzky TS, 1996, P NATL ACAD SCI USA, V93, P734, DOI 10.1073/pnas.93.2.734; Jiang W, 2010, P NATL ACAD SCI USA, V107, P13258, DOI 10.1073/pnas.1006344107; Kersh GJ, 2001, J IMMUNOL, V166, P3345, DOI 10.4049/jimmunol.166.5.3345; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Landais E, 2009, J IMMUNOL, V183, P7949, DOI 10.4049/jimmunol.0902493; Lazarski CA, 2005, IMMUNITY, V23, P29, DOI 10.1016/j.immuni.2005.05.009; Lazarski CA, 2006, J EXP MED, V203, P1319, DOI 10.1084/jem.20060058; Levisetti MG, 2007, J IMMUNOL, V178, P6051, DOI 10.4049/jimmunol.178.10.6051; LIANG MN, 1995, INT IMMUNOL, V7, P1397, DOI 10.1093/intimm/7.9.1397; Lovitch SB, 2006, J IMMUNOL, V176, P2958, DOI 10.4049/jimmunol.176.5.2958; MARTINEAU P, 1992, GENE, V113, P35, DOI 10.1016/0378-1119(92)90667-E; Maverakis E, 2008, J AUTOIMMUN, V31, P59, DOI 10.1016/j.jaut.2008.02.004; McBeth C, 2008, J MOL BIOL, V375, P1306, DOI 10.1016/j.jmb.2007.11.020; McFarland BJ, 1999, BIOCHEMISTRY-US, V38, P16663, DOI 10.1021/bi991393l; McFarland BJ, 2002, MED RES REV, V22, P168, DOI 10.1002/med.10006; Nanda NK, 2000, J EXP MED, V192, P781, DOI 10.1084/jem.192.6.781; NELSON CA, 1992, P NATL ACAD SCI USA, V89, P7380, DOI 10.1073/pnas.89.16.7380; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Nielsen M, 2010, IMMUNOLOGY, V130, P319, DOI 10.1111/j.1365-2567.2010.03268.x; Nielsen M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-296; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; Parkhurst MR, 1996, J IMMUNOL, V157, P2539; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Russell HI, 1999, EUR J IMMUNOL, V29, P905, DOI 10.1002/(SICI)1521-4141(199903)29:03<905::AID-IMMU905>3.0.CO;2-8; Scott CA, 1998, IMMUNITY, V8, P319, DOI 10.1016/S1074-7613(00)80537-3; Seamons A, 2003, J EXP MED, V197, P1391, DOI 10.1084/jem.20022226; Seibel JL, 1997, J EXP MED, V185, P1919, DOI 10.1084/jem.185.11.1919; SHIMONKEVITZ R, 1984, J IMMUNOL, V133, P2067; Slansky JE, 2000, IMMUNITY, V13, P529, DOI 10.1016/S1074-7613(00)00052-2; Stadinski BD, 2010, P NATL ACAD SCI USA, V107, P10978, DOI 10.1073/pnas.1006545107; Sundberg EJ, 2003, STRUCTURE, V11, P1151, DOI 10.1016/S0969-2126(03)00187-4; Valmori D, 1999, INT IMMUNOL, V11, P1971, DOI 10.1093/intimm/11.12.1971; Vogt AB, 1997, HUM IMMUNOL, V54, P170, DOI 10.1016/S0198-8859(97)00077-3; Wang JH, 2001, P NATL ACAD SCI USA, V98, P10799, DOI 10.1073/pnas.191124098; Weaver JM, 2008, J IMMUNOL, V181, P3039, DOI 10.4049/jimmunol.181.5.3039; Weaver JM, 2009, IMMUNOL RES	56	2	2	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47585	10.1371/journal.pone.0047585	http://dx.doi.org/10.1371/journal.pone.0047585			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110081	Green Published, Green Submitted, gold			2022-12-25	WOS:000310193600017
J	Tanskanen, MM; Westerterp, KR; Uusitalo, AL; Atalay, M; Hakkinen, K; Kinnunen, HO; Kyrolainen, H				Tanskanen, Minna M.; Westerterp, Klaas R.; Uusitalo, Arja L.; Atalay, Mustafa; Hakkinen, Keijo; Kinnunen, Hannu O.; Kyrolainen, Heikki			Effects of Easy-to-Use Protein-Rich Energy Bar on Energy Balance, Physical Activity and Performance during 8 Days of Sustained Physical Exertion	PLOS ONE			English	Article							LEAN BODY-MASS; CARBOHYDRATE AVAILABILITY; DIETARY-PROTEIN; EXERCISE; WEIGHT; FIELD; EXPENDITURE; MEN; SLEEP; WATER	Background: Previous military studies have shown an energy deficit during a strenuous field training course (TC). This study aimed to determine the effects of energy bar supplementation on energy balance, physical activity (PA), physical performance and well-being and to evaluate ad libitum fluid intake during wintertime 8-day strenuous TC. Methods: Twenty-six men (age 20 +/- 1 yr.) were randomly divided into two groups: The control group (n = 12) had traditional field rations and the experimental (Ebar) group (n = 14) field rations plus energy bars of 4.1 MJ.day(-1). Energy (EI) and water intake was recorded. Fat-free mass and water loss were measured with deuterium dilution and elimination, respectively. The energy expenditure was calculated using the intake/balance method and energy availability as (EI/estimated basal metabolic rate). PA was monitored using an accelerometer. Physical performance was measured and questionnaires of upper respiratory tract infections (URTI), hunger and mood state were recorded before, during and after TC. Results: Ebar had a higher EI and energy availability than the controls. However, decreases in body mass and fat mass were similar in both groups representing an energy deficit. No differences were observed between the groups in PA, water balance, URTI symptoms and changes in physical performance and fat-free mass. Ebar felt less hunger after TC than the controls and they had improved positive mood state during the latter part of TC while controls did not. Water deficit associated to higher PA. Furthermore, URTI symptoms and negative mood state associated negatively with energy availability and PA. Conclusion: An easy-to-use protein-rich energy bars did not prevent energy deficit nor influence PA during an 8-day TC. The high content of protein in the bars might have induced satiation decreasing energy intake from field rations. PA and energy intake seems to be primarily affected by other factors than energy supplementation such as mood state.	[Tanskanen, Minna M.; Hakkinen, Keijo; Kyrolainen, Heikki] Univ Jyvaskyla, Dept Biol Phys Act, Jyvaskyla, Finland; [Westerterp, Klaas R.] Maastricht Univ, Dept Human Biol, Maastricht, Netherlands; [Uusitalo, Arja L.] Helsinki Univ Hosp, Dept Clin Physiol & Nucl Med, Helsinki, Finland; [Atalay, Mustafa] Univ Eastern Finland, Inst Biomed, Kuopio, Finland; [Kinnunen, Hannu O.] Polar Electro Oy, Kempele, Finland	University of Jyvaskyla; Maastricht University; University of Helsinki; Helsinki University Central Hospital; University of Eastern Finland	Tanskanen, MM (corresponding author), Univ Jyvaskyla, Dept Biol Phys Act, Jyvaskyla, Finland.	minna.m.tanskanen@jyu.fi		Kyrolainen, Heikki/0000-0003-3822-1733; Kinnunen, Hannu/0000-0001-9190-8708	Finnish Ministry of Education; Finnish Cultural Foundation; Polar Electro Oy; Scientific Advisory Board for Defense	Finnish Ministry of Education; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Polar Electro Oy; Scientific Advisory Board for Defense	This study was granted by the Finnish Ministry of Education, Finnish Cultural Foundation, Polar Electro Oy and the Scientific Advisory Board for Defense. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany JA, 2008, J APPL PHYSIOL, V105, P58, DOI 10.1152/japplphysiol.00005.2008; BAHR R, 1991, ACTA PHYSIOL SCAND, V141, P555, DOI 10.1111/j.1748-1716.1991.tb09117.x; Barrett B, 2005, J CLIN EPIDEMIOL, V58, P609, DOI 10.1016/j.jclinepi.2004.11.019; Bell DG, 2002, MIL MED, V167, P692, DOI 10.1093/milmed/167.8.692; BOSCO C, 1983, EUR J APPL PHYSIOL O, V50, P273, DOI 10.1007/BF00422166; Brouwer E., 1965, EAAP PUB, V11, P441, DOI DOI 10.4236/NS.2011.312129; Brugniaux JV, 2010, BRIT J SPORT MED, V44, P245, DOI 10.1136/bjsm.2007.045575; Castell LM, 2010, MIL MED, V175, P158, DOI 10.7205/MILMED-D-09-00065; Cline AD, 2000, AVIAT SPACE ENVIR MD, V71, P37; COOPER KH, 1968, J AMER MED ASSOC, V203, P201, DOI 10.1001/jama.203.3.201; Costa RJS, 2005, INT J SPORTS MED, V26, P880, DOI 10.1055/s-2005-837467; Cox GR, 2010, J APPL PHYSIOL, V109, P126, DOI 10.1152/japplphysiol.00950.2009; de Graaf C, 2005, APPETITE, V44, P23, DOI 10.1016/j.appet.2004.08.008; DELANY JP, 1989, J APPL PHYSIOL, V67, P1922, DOI 10.1152/jappl.1989.67.5.1922; EDWARDS JSA, 1991, MIL MED, V156, P466, DOI 10.1093/milmed/156.9.466; FJELD CR, 1988, AM J CLIN NUTR, V48, P671, DOI 10.1093/ajcn/48.3.671; Flakoll PJ, 2004, J APPL PHYSIOL, V96, P951, DOI 10.1152/japplphysiol.00811.2003; FOGELHOLM M, 1994, SPORTS MED, V18, P249, DOI 10.2165/00007256-199418040-00004; Fortes MB, 2011, APPL PHYSIOL NUTR ME, V36, P967, DOI [10.1139/h11-124, 10.1139/H11-124]; Friedl KE, 2000, J APPL PHYSIOL, V88, P1820, DOI 10.1152/jappl.2000.88.5.1820; Hawley JA, 2010, EXERC SPORT SCI REV, V38, P152, DOI 10.1097/JES.0b013e3181f44dd9; Hirsch ES, 2005, APPETITE, V44, P33, DOI 10.1016/j.appet.2004.04.010; Hodgdon J A, 1991, Arctic Med Res, V50 Suppl 6, P132; HOYT RW, 1991, J APPL PHYSIOL, V71, P16, DOI 10.1152/jappl.1991.71.1.16; JOHNSON MJ, 1994, MED SCI SPORT EXER, V26, P235, DOI 10.1249/00005768-199402000-00015; Kinnunen H, 2009, MED SCI SPORTS EXERC, V40, P172; Knapik JJ, 2004, MIL MED, V169, P45, DOI 10.7205/MILMED.169.1.45; Kyrolainen H, 2008, EUR J APPL PHYSIOL, V102, P539, DOI 10.1007/s00421-007-0619-0; Lieberman HR, 2008, AM J CLIN NUTR, V88, P667, DOI 10.1093/ajcn/88.3.667; Lieberman HR, 2005, BIOL PSYCHIAT, V57, P422, DOI 10.1016/j.biopsych.2004.11.014; Mettler S, 2010, MED SCI SPORT EXER, V42, P326, DOI 10.1249/MSS.0b013e3181b2ef8e; Montain SJ, 2008, MED SCI SPORT EXER, V40, P1970, DOI 10.1249/MSS.0b013e31817f4d58; Montain SJ, 1997, AVIAT SPACE ENVIR MD, V68, P384; Nindl BC, 1997, INT J SPORTS MED, V18, P317, DOI 10.1055/s-2007-972640; Nindl BC, 2002, MED SCI SPORT EXER, V34, P1814, DOI 10.1097/00005768-200211000-00019; PACE N, 1945, J BIOL CHEM, V158, P685; Pikosky MA, 2008, MED SCI SPORT EXER, V40, P505, DOI [10.1249/mss.0b013e31815f6643, 10.1249/MSS.0b013e31815f6643]; POPPER R, 1989, MIL MED, V154, P619; Rintamaki H, 1998, INFLUENCE WATER CARB; ROGNUM TO, 1986, ERGONOMICS, V29, P859, DOI 10.1080/00140138608967198; SCHOELLER DA, 1980, AM J CLIN NUTR, V33, P2686, DOI 10.1093/ajcn/33.12.2686; Schofield W N, 1985, Hum Nutr Clin Nutr, V39 Suppl 1, P5; Spence L, 2007, MED SCI SPORT EXER, V39, P577, DOI 10.1249/mss.0b013e31802e851a; Tanskanen M, 2009, SCAND J MED SCI SPOR, V19, P871, DOI 10.1111/j.1600-0838.2008.00857.x; Tanskanen MM, 2011, J STRENGTH COND RES, V25, P787, DOI 10.1519/JSC.0b013e3181c1fa5d; Tharion WJ, 2005, APPETITE, V44, P47, DOI 10.1016/j.appet.2003.11.010; THOMPSON JL, 1995, MED SCI SPORT EXER, V27, P347; Uusitalo AIT, 1998, INT J SPORTS MED, V19, P532, DOI 10.1055/s-2007-971956; Venkatraman JT, 2002, SPORTS MED, V32, P323, DOI 10.2165/00007256-200232050-00004; VIITASALO JT, 1987, INT J SPORTS MED, V8, P281, DOI 10.1055/s-2008-1025670; Weigle DS, 2005, AM J CLIN NUTR, V82, P41, DOI 10.1093/ajcn/82.1.41; Welsh TT, 2008, INT J SPORTS MED, V29, P45, DOI 10.1055/s-2007-964970; Westerterp KR, 2005, BRIT J NUTR, V93, P199, DOI 10.1079/BJN20041310; WESTERTERP KR, 1995, OBES RES, V3, P49, DOI 10.1002/j.1550-8528.1995.tb00007.x; Westerterp-Plantenga MS, 2006, INT J OBESITY, V30, pS16, DOI 10.1038/sj.ijo.0803487; Witard OC, 2011, MED SCI SPORT EXER, V43, P598, DOI 10.1249/MSS.0b013e3181f684c9; Zachwieja JJ, 2001, INT J SPORTS MED, V22, P310, DOI 10.1055/s-2001-13822	57	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47771	10.1371/journal.pone.0047771	http://dx.doi.org/10.1371/journal.pone.0047771			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094083	Green Published, Green Submitted, gold			2022-12-25	WOS:000312384500021
J	Chen, ZQ; Ding, WH; Xu, K; Tan, J; Sun, CY; Gou, YC; Tong, SJ; Xia, GW; Fang, ZJ; Ding, Q				Chen, Zhongqing; Ding, Weihong; Xu, Ke; Tan, Jun; Sun, Chuanyu; Gou, Yuancheng; Tong, Shijun; Xia, Guowei; Fang, Zujun; Ding, Qiang			The 1973 WHO Classification Is More Suitable than the 2004 WHO Classification for Predicting Prognosis in Non-Muscle- Invasive Bladder Cancer	PLOS ONE			English	Article							PAPILLARY UROTHELIAL NEOPLASMS; GROWTH-FACTOR RECEPTOR-3; IMMUNOHISTOCHEMICAL EXPRESSION; WHO/ISUP CLASSIFICATION; PROGRESSION; TUMORS; RECURRENCE; CARCINOMA; TA; PATHOLOGY	Background: Predicting the recurrence and progression of Non-muscle-invasive bladder cancer(NMIBC) is critical for urologist. Histological grade provides significant prognostic information, especially for prediction of progression. Currently, the 1973 and the 2004 WHO classification co-exist. Which system is better for predicting rumor recurrence and progression still a matter for debate. Methodology/Principal Findings: 348 patients diagnosed with Non-muscle invasive bladder cancer were enrolled in our retrospective study. Paraffin sections were assessed by an experienced urological pathologist according to both the 1973 and 2004 WHO classifications. Tumor recurrence and progression was followed-up in all patients. During follow-up, corresponding 5-year recurrence-free survival rates of G1, G2 and G3 were 82.1%, 55.9%, 32.1% and the 5-year progressionfree survival rates were 95.9%, 84.4% and 43.3%, respectively. The 5-year recurrence-free survival rates of papillary urothelial neoplasm of low malignant potential (PUNLMP), low-grade papillary urothelial carcinoma(LGPUC) and high-grade papillary urothelial carcinoma (HGPUC) were 69.8%, 67.1% and 42.0% respectively and the 5-year progression-free survival rates were 100%, 90.9% and 54.8% respectively. In multivariate analysis, the 1973 WHO classification significantly associated with both tumor recurrence and progression(p = 0.010 and p = 0.022, respectively); the 2004 WHO classification correlated with tumor progression(p = 0.019), while was not proved to be a variable that can predict the risk of recurrence(p = 0.547). Kaplan-Meier plots showed that both the 1973 WHO and the 2004 WHO classifications were significantly associated with progression-free survival (p<0.0001, log-rank test). For prediction of recurrence, significant differences were observed between the tumor grades classified using the 1973 WHO grading system (p<0.0001, log-rank test), while a significant overlap was observed between PUNLMP and LG plots using the 2004 WHO grading system(p = 0.616, log-rank test). Conclusion/Significance: Both the 1973 WHO and the 2004 WHO Classifications are effective in predicting tumor progression in Non-muscle invasive bladder cancer, while the 1973 WHO Classification is more suitable for predicting tumor recurrence.	[Ding, Weihong; Xu, Ke; Sun, Chuanyu; Gou, Yuancheng; Tong, Shijun; Xia, Guowei; Fang, Zujun; Ding, Qiang] Fudan Univ, Huashan Hosp, Dept Urol, Shanghai 200433, Peoples R China; [Chen, Zhongqing] Fudan Univ, Huashan Hosp, Dept Pathol, Shanghai 200433, Peoples R China; [Tan, Jun] Fudan Univ, Sch Publ Hlth, Dept Biostat & Social Med, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Xu, K (corresponding author), Fudan Univ, Huashan Hosp, Dept Urol, Shanghai 200433, Peoples R China.	drkexu@163.com			Health Bureau of Shanghai Municipality [XYQ2011028]	Health Bureau of Shanghai Municipality	This work was made possible due to the generous support of Health Bureau of Shanghai Municipality (XYQ2011028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allard P, 1998, BRIT J UROL, V81, P692; Babjuk M, 2011, EUR UROL, V59, P997, DOI 10.1016/j.eururo.2011.03.017; Barbisan F, 2008, CANCER-AM CANCER SOC, V112, P636, DOI 10.1002/cncr.23212; Bryan RT, 2002, BJU INT, V90, P846, DOI 10.1046/j.1464-410X.2002.03053.x; Campbell PA, 2004, BJU INT, V93, P1228, DOI 10.1111/j.1464-410X.2004.04848.x; Cheng L, 1999, CANCER, V86, P2102, DOI 10.1002/(SICI)1097-0142(19991115)86:10<2102::AID-CNCR31>3.3.CO;2-L; Eble JN, 2004, WHO CLASSIFICATION T, P89; EDGE SB, 2009, AJCC CANC STAGING MA, P447; Epstein JI, 1998, AM J SURG PATHOL, V22, P1435, DOI 10.1097/00000478-199812000-00001; Fernandez-Gomez J, 2008, EUR UROL, V53, P992, DOI 10.1016/j.eururo.2007.10.006; Fujii Y, 2003, BJU INT, V92, P559, DOI 10.1046/j.1464-410X.2003.04415.x; Holmang S, 2001, J UROLOGY, V165, P1124, DOI 10.1016/S0022-5347(05)66443-9; Jones TD, 2006, J UROLOGY, V175, P1995, DOI 10.1016/S0022-5347(06)00267-9; KURTH KH, 1995, EUR J CANCER, V31A, P1840, DOI 10.1016/0959-8049(95)00287-S; Lopez-Beltran A, 2004, EUR UROL, V46, P170, DOI 10.1016/j.eururo.2004.03.017; MacLennan GT, 2007, EUR UROL, V51, P889, DOI 10.1016/j.eururo.2006.10.037; May M, 2010, EUR UROL, V57, P850, DOI 10.1016/j.eururo.2009.03.052; Montironi R, 2008, HISTOPATHOLOGY, V53, P621, DOI 10.1111/j.1365-2559.2008.03025.x; Mostofi FK, 1973, HISTOLOGICAL TYPING; Oosterhuis JWA, 2002, J CLIN PATHOL, V55, P900, DOI 10.1136/jcp.55.12.900; Pan CC, 2010, AM J CLIN PATHOL, V133, P788, DOI 10.1309/AJCP12MRVVHTCKEJ; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pavone-Macaluso M, 2006, BJU INT, V98, P1161, DOI 10.1111/j.1464-410X.2006.06445.x; Soloway MS, 2007, EUR UROL, V52, P1564, DOI 10.1016/j.eururo.2007.07.011; Sylvester RJ, 2006, EUR UROL, V49, P466, DOI 10.1016/j.eururo.2005.12.031; Tosoni I, 2000, BJU INT, V85, P48, DOI 10.1046/j.1464-410x.2000.00356.x; Rhijn BWG, 2010, EUR UROL, V57, P1052, DOI 10.1016/j.eururo.2009.09.022; van Rhijn BWG, 2003, J CLIN ONCOL, V21, P1912, DOI 10.1200/JCO.2003.05.073; van Rhijn BWG, 2002, J PATHOL, V198, P245, DOI 10.1002/path.1202; Yin H, 2004, AM J CLIN PATHOL, V121, P679, DOI 10.1039/0KATYHQBJD5XHQ8J	30	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47199	10.1371/journal.pone.0047199	http://dx.doi.org/10.1371/journal.pone.0047199			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082147	Green Submitted, gold, Green Published			2022-12-25	WOS:000311146900043
J	Wang, Y; Chen, Y; Zhou, Q; Huang, S; Ning, K; Xu, J; Kalin, RM; Rolfe, S; Huang, WE				Wang, Yun; Chen, Yin; Zhou, Qian; Huang, Shi; Ning, Kang; Xu, Jian; Kalin, Robert M.; Rolfe, Stephen; Huang, Wei E.			A Culture-Independent Approach to Unravel Uncultured Bacteria and Functional Genes in a Complex Microbial Community	PLOS ONE			English	Article							CATABOLIC NAG GENES; SP STRAIN U2; RIBOSOMAL-RNA; NAPHTHALENE-DEGRADATION; SYSTEMS MICROBIOLOGY; NUCLEOTIDE-SEQUENCE; METAGENOMICS; DNA; CELL; METABOLISM	Most microorganisms in nature are uncultured with unknown functionality. Sequence-based metagenomics alone answers 'who/what are there?' but not 'what are they doing and who is doing it and how?'. Function-based metagenomics reveals gene function but is usually limited by the specificity and sensitivity of screening strategies, especially the identification of clones whose functional gene expression has no distinguishable activity or phenotypes. A 'biosensor-based genetic transducer' (BGT) technique, which employs a whole-cell biosensor to quantitatively detect expression of inserted genes encoding designated functions, is able to screen for functionality of unknown genes from uncultured microorganisms. In this study, BGT was integrated with Stable isotope probing (SIP)-enabled Metagenomics to form a culture-independent SMB toolbox. The utility of this approach was demonstrated in the discovery of a novel functional gene cluster in naphthalene contaminated groundwater. Specifically, metagenomic sequencing of the C-13-DNA fraction obtained by SIP indicated that an uncultured Acidovorax sp. was the dominant key naphthalene degrader in-situ, although three culturable Pseudomonas sp. degraders were also present in the same groundwater. BGT verified the functionality of a new nag2 operon which coexisted with two other nag and two nah operons for naphthalene biodegradation in the same microbial community. Pyrosequencing analysis showed that the nag2 operon was the key functional operon in naphthalene degradation in-situ, and shared homology with both nag operons in Ralstonia sp. U2 and Polaromonas naphthalenivorans CJ2. The SMB toolbox will be useful in providing deep insights into uncultured microorganisms and unravelling their ecological roles in natural environments.	[Wang, Yun; Huang, Wei E.] Univ Sheffield, Kroto Res Inst, Sheffield, S Yorkshire, England; [Chen, Yin] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Zhou, Qian; Huang, Shi; Ning, Kang; Xu, Jian] Chinese Acad Sci, Key Lab Biofuels, BioEnergy Genome Ctr, Qingdao, Peoples R China; [Zhou, Qian; Huang, Shi; Ning, Kang; Xu, Jian] Chinese Acad Sci, Qingdao Inst BioEnergy & Bioproc Technol, Shandong Key Lab Energy Genet, Qingdao, Peoples R China; [Kalin, Robert M.] Univ Strathclyde, David Livingstone Ctr Sustainabil, Glasgow, Lanark, Scotland; [Rolfe, Stephen] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of Warwick; Chinese Academy of Sciences; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS; University of Strathclyde; University of Sheffield	Huang, WE (corresponding author), Univ Sheffield, Kroto Res Inst, Sheffield, S Yorkshire, England.	w.huang@shef.ac.uk	Xu, Jian/G-8430-2012; Rolfe, Stephen/GQB-3258-2022; Kalin, Robert/E-8620-2011; Chen, Yin/C-2669-2009; Huang, Wei/N-6880-2019; Huang, Shi/X-8824-2019; Ning, Kang/ABD-3446-2020	Xu, Jian/0000-0002-0548-8477; Kalin, Robert/0000-0003-3768-3848; Chen, Yin/0000-0002-0367-4276; Huang, Wei/0000-0003-1302-6528; Huang, Shi/0000-0002-7529-2269; Rolfe, Stephen/0000-0003-2141-4707; Ning, Kang/0000-0003-3325-5387	Chinese Scholarship Council; BBSRC-LINK grant [BRM19108, BRM19109]; Biotechnology and Biological Sciences Research Council [BRM19108] Funding Source: researchfish	Chinese Scholarship Council(China Scholarship Council); BBSRC-LINK grant; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank Chinese Scholarship Council for providing studentship to YW. We are indebted to Professor Wolfgang Hillen (Friedrich-Alexander-Universitat Erlangen Nurnberg) for supplying the plasmid vector pWH1274 and Professor Colin Murrell (the University of Warwick) for advice on DNA-SIP. We also thank BBSRC-LINK grant (references BRM19108 and BRM19109) for site knowledge and samples. We are grateful to Prof Victor de Lorenzo for helpful and critical discussion.	Allen CCR, 1997, APPL ENVIRON MICROB, V63, P151, DOI 10.1128/AEM.63.1.151-155.1997; AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Andam CP, 2011, NAT REV MICROBIOL, V9, P543, DOI 10.1038/nrmicro2593; BAUCHOP T, 1960, J GEN MICROBIOL, V23, P457; Bode HB, 2005, ANGEW CHEM INT EDIT, V44, P6828, DOI 10.1002/anie.200501080; Bosch R, 2000, GENE, V245, P65, DOI 10.1016/S0378-1119(00)00038-X; CANE PA, 1982, J GEN MICROBIOL, V128, P2281; Cardenas E, 2008, CURR OPIN BIOTECH, V19, P544, DOI 10.1016/j.copbio.2008.10.010; Carreno CA, 2010, HDB HYDROCARBON LIPI, P4563; Chen Y, 2010, TRENDS MICROBIOL, V18, P157, DOI 10.1016/j.tim.2010.02.002; Dennis JJ, 2004, J MOL BIOL, V341, P753, DOI 10.1016/j.jmb.2004.06.034; Dietrich JA, 2010, ANNU REV BIOCHEM, V79, P563, DOI 10.1146/annurev-biochem-062608-095938; Falkowski PG, 2008, SCIENCE, V320, P1034, DOI 10.1126/science.1153213; Ferguson AS, 2007, J APPL MICROBIOL, V102, P1227, DOI 10.1111/j.1365-2672.2007.03398.x; Ferrer M, 2009, MICROB BIOTECHNOL, V2, P31, DOI 10.1111/j.1751-7915.2008.00057.x; Fortman JL, 2005, CHEMBIOCHEM, V6, P960, DOI 10.1002/cbic.200400428; Fuchs BM, 1998, APPL ENVIRON MICROB, V64, P4973; Galvao TC, 2005, TRENDS BIOTECHNOL, V23, P497, DOI 10.1016/j.tibtech.2005.08.002; Gillespie DE, 2002, APPL ENVIRON MICROB, V68, P4301, DOI 10.1128/AEM.68.9.4301-4306.2002; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; GRUND E, 1992, APPL ENVIRON MICROB, V58, P1874, DOI 10.1128/AEM.58.6.1874-1877.1992; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Head IM, 1998, MICROB ECOL, V35, P1, DOI 10.1007/s002489900056; Huang WE, 2005, ENVIRON MICROBIOL, V7, P1339, DOI 10.1111/j.1462-5822.2005.00821.x; Huang WE, 2008, ENVIRON MICROBIOL, V10, P1668, DOI 10.1111/j.1462-2920.2008.01583.x; Huang WE, 2009, APPL ENVIRON MICROB, V75, P234, DOI 10.1128/AEM.01861-08; HUNGER M, 1990, GENE, V87, P45, DOI 10.1016/0378-1119(90)90494-C; Ishoey T, 2008, CURR OPIN MICROBIOL, V11, P198, DOI 10.1016/j.mib.2008.05.006; Jeon CO, 2006, APPL ENVIRON MICROB, V72, P1086, DOI 10.1128/AEM.72.2.1086-1095.2006; Jones RM, 2003, J BACTERIOL, V185, P5847, DOI 10.1128/JB.185.19.5847-5853.2003; JUNI E, 1969, J BACTERIOL, V98, P281, DOI 10.1128/JB.98.1.281-288.1969; Lorenz P, 2005, NAT REV MICROBIOL, V3, P510, DOI 10.1038/nrmicro1161; MacLean D, 2009, NAT REV MICROBIOL, V7, P287, DOI [10.1038/nrmicro2088, 10.1038/nrmicro2122]; Manefield M, 2002, APPL ENVIRON MICROB, V68, P5367, DOI 10.1128/AEM.68.11.5367-5373.2002; Moser R, 2001, APPL MICROBIOL BIOT, V55, P609, DOI 10.1007/s002530000489; Murrell JC, 2011, STABLE ISOTOPE PROBING AND RELATED TECHNOLOGIES, P1; Neufeld JD, 2007, NAT PROTOC, V2, P860, DOI 10.1038/nprot.2007.109; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935; Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759; Rothberg JM, 2008, NAT BIOTECHNOL, V26, P1117, DOI 10.1038/nbt1485; Sambrook J., 2002, MOL CLONING LAB MANU; Schloss PD, 2003, CURR OPIN BIOTECH, V14, P303, DOI 10.1016/S0958-1669(03)00067-3; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Song YZ, 2009, ENVIRON SCI TECHNOL, V43, P7931, DOI 10.1021/es901349r; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Torres-Cortes G, 2011, ENVIRON MICROBIOL, V13, P1101, DOI 10.1111/j.1462-2920.2010.02422.x; Uchiyama T, 2005, NAT BIOTECHNOL, V23, P88, DOI 10.1038/nbt1048; Uchiyama T, 2010, APPL ENVIRON MICROB, V76, P7029, DOI 10.1128/AEM.00464-10; Venter JC, 2003, SCIENTIST, V17, P8; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Verberkmoes NC, 2009, ISME J, V3, P179, DOI 10.1038/ismej.2008.108; Vieites JM, 2009, FEMS MICROBIOL REV, V33, P236, DOI 10.1111/j.1574-6976.2008.00152.x; Whitfield J, 2005, SCIENCE, V310, P960, DOI 10.1126/science.310.5750.960; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Williamson LL, 2005, APPL ENVIRON MICROB, V71, P6335, DOI 10.1128/AEM.71.10.6335-6344.2005; YEN KM, 1982, P NATL ACAD SCI-BIOL, V79, P874, DOI 10.1073/pnas.79.3.874; Zhang DY, 2012, MICROB BIOTECHNOL, V5, P87, DOI 10.1111/j.1751-7915.2011.00301.x; Zhang DY, 2011, MICROB BIOTECHNOL, V4, P89, DOI 10.1111/j.1751-7915.2010.00228.x; Zhou NY, 2001, J BACTERIOL, V183, P700, DOI 10.1128/JB.183.2.700-708.2001	61	23	26	6	123	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47530	10.1371/journal.pone.0047530	http://dx.doi.org/10.1371/journal.pone.0047530			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082176	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000311146900072
J	White, SN; Mousel, MR; Herrmann-Hoesing, LM; Reynolds, JO; Leymaster, KA; Neibergs, HL; Lewis, GS; Knowles, DP				White, Stephen N.; Mousel, Michelle R.; Herrmann-Hoesing, Lynn M.; Reynolds, James O.; Leymaster, Kreg A.; Neibergs, Holly L.; Lewis, Gregory S.; Knowles, Donald P.			Genome-Wide Association Identifies Multiple Genomic Regions Associated with Susceptibility to and Control of Ovine Lentivirus	PLOS ONE			English	Article							PROGRESSIVE PNEUMONIA VIRUS; MAEDI-VISNA VIRUS; SMALL RUMINANT LENTIVIRUSES; LINKAGE DISEQUILIBRIUM; CAPRINE ARTHRITIS; POLAR OVERDOMINANCE; ENCEPHALITIS-VIRUS; TOOL SET; SHEEP; BREED	Background: Like human immunodeficiency virus (HIV), ovine lentivirus (OvLV) is macrophage-tropic and causes lifelong infection. OvLV infects one quarter of U. S. sheep and induces pneumonia and body condition wasting. There is no vaccine to prevent OvLV infection and no cost-effective treatment for infected animals. However, breed differences in prevalence and proviral concentration have indicated a genetic basis for susceptibility to OvLV. A recent study identified TMEM154 variants in OvLV susceptibility. The objective here was to identify additional loci associated with odds and/or control of OvLV infection. Methodology/Principal Findings: This genome-wide association study (GWAS) included 964 sheep from Rambouillet, Polypay, and Columbia breeds with serological status and proviral concentration phenotypes. Analytic models accounted for breed and age, as well as genotype. This approach identified TMEM154 (nominal P = 9.2x10(-7); empirical P = 0.13), provided 12 additional genomic regions associated with odds of infection, and provided 13 regions associated with control of infection (all nominal <1x10(-5)). Rapid decline of linkage disequilibrium with distance suggested many regions included few genes each. Genes in regions associated with odds of infection included DPPA2/DPPA4 (empirical P = 0.006), and SYTL3 (P = 0.051). Genes in regions associated with control of infection included a zinc finger cluster (ZNF192, ZSCAN16, ZNF389, and ZNF165; P = 0.001), C19orf42/TMEM38A (P = 0.047), and DLGAP1 (P = 0.092). Conclusions/Significance: These associations provide targets for mutation discovery in sheep susceptibility to OvLV. Aside from TMEM154, these genes have not been associated previously with lentiviral infection in any species, to our knowledge. Further, data from other species suggest functional hypotheses for future testing of these genes in OvLV and other lentiviral infections. Specifically, SYTL3 binds and may regulate RAB27A, which is required for enveloped virus assembly of human cytomegalovirus. Zinc finger transcription factors have been associated with positive selection for repression of retroviral replication. DLGAP1 binds and may regulate DLG1, a known regulator of HIV infectivity.	[White, Stephen N.; Reynolds, James O.; Knowles, Donald P.] ARS, Anim Dis Res Unit, USDA, Pullman, WA USA; [White, Stephen N.; Herrmann-Hoesing, Lynn M.; Knowles, Donald P.] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Mousel, Michelle R.; Lewis, Gregory S.] ARS, US Sheep Expt Stn, USDA, Dubois, IN USA; [Leymaster, Kreg A.] ARS, Genet & Breeding Res Unit, US Meat Anim Res Ctr, USDA, Clay Ctr, NE USA; [Neibergs, Holly L.] Washington State Univ, Dept Anim Sci, Pullman, WA 99164 USA	United States Department of Agriculture (USDA); Washington State University; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); Washington State University	White, SN (corresponding author), ARS, Anim Dis Res Unit, USDA, Pullman, WA USA.	Stephen.White@ars.usda.gov	; Mousel, Michelle/I-6398-2013	White, Stephen N./0000-0001-9255-6054; Mousel, Michelle/0000-0003-1367-7005	USDA-ARS CWA [5348-32000-031-00D]	USDA-ARS CWA(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This research was funded by USDA-ARS CWA No. 5348-32000-031-00D. (http://www.ars.usda.gov/main/main.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Badke YM, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-24; Blacklaws BA, 2012, COMP IMMUNOL MICROB, V35, P259, DOI 10.1016/j.cimid.2011.12.003; Blacklaws BA, 2010, CURR HIV RES, V8, P26, DOI 10.2174/157016210790416406; Boon ACM, 2009, J VIROL, V83, P10417, DOI 10.1128/JVI.00514-09; Caroline L, 2010, CURR HIV RES, V8, P94, DOI 10.2174/157016210790416415; Cockett NE, 1996, SCIENCE, V273, P236, DOI 10.1126/science.273.5272.236; Cortez-Romero C, 2011, REPROD DOMEST ANIM, V46, pe1, DOI 10.1111/j.1439-0531.2010.01608.x; CUTLIP RC, 1986, VET MICROBIOL, V12, P283, DOI 10.1016/0378-1135(86)90057-X; CUTLIP RC, 1992, AM J VET RES, V53, P976; DEBOER GF, 1979, RES VET SCI, V26, P202, DOI 10.1016/S0034-5288(18)32917-5; Du Juan, 2004, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V21, P542; Emerson RO, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000325; Fraile-Ramos A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015318; Freking BA, 2002, GENOME RES, V12, P1496, DOI 10.1101/gr.571002; Fukuda M, 2001, BIOCHEM BIOPH RES CO, V281, P1226, DOI 10.1006/bbrc.2001.4512; GATES NL, 1978, J AM VET MED ASSOC, V173, P1575; Heaton MP, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002467; Heidtman M, 2005, MOL BIOL CELL, V16, P1673, DOI 10.1091/mbc.E04-10-0873; Herrmann LM, 2003, CLIN DIAGN LAB IMMUN, V10, P862, DOI 10.1128/CDLI.10.5.862-865.2003; Herrmann-Hoesing LM, 2007, CLIN VACCINE IMMUNOL, V14, P1274, DOI 10.1128/CVI.00095-07; Herrmann-Hoesing LM, 2009, CLIN VACCINE IMMUNOL, V16, P551, DOI 10.1128/CVI.00459-08; Herrmann-Hoesing LM, 2008, IMMUNOGENETICS, V60, P749, DOI 10.1007/s00251-008-0328-9; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; HOUWERS DJ, 1989, RES VET SCI, V46, P5, DOI 10.1016/S0034-5288(18)31108-1; Hu ZL, 2007, NUCLEIC ACIDS RES, V35, pD604, DOI 10.1093/nar/gkl946; Hu ZL, 2007, MAMM GENOME, V18, P1, DOI 10.1007/s00335-006-0105-8; HULET CV, 1984, J ANIM SCI, V58, P15, DOI 10.2527/jas1984.58115x; InfoSheet, 2003, OIL SEEDS WORLD MARK, P1; Javier RT, 2011, J VIROL, V85, P11544, DOI 10.1128/JVI.05410-11; Keen JE, 1997, PREV VET MED, V30, P81, DOI 10.1016/S0167-5877(96)01121-X; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kim E, 1997, J CELL BIOL, V136, P669, DOI 10.1083/jcb.136.3.669; Kim ES, 2009, ANIM GENET, V40, P279, DOI 10.1111/j.1365-2052.2008.01831.x; Kuroda TS, 2002, J BIOL CHEM, V277, P9212, DOI 10.1074/jbc.M112414200; Madan B, 2009, MOL CELL BIOL, V29, P3186, DOI 10.1128/MCB.01970-08; Marshall K, 2009, ANIM GENET, V40, P262, DOI 10.1111/j.1365-2052.2008.01836.x; Nakamura T, 2011, MOL CELL BIOL, V31, P4366, DOI 10.1128/MCB.05701-11; NARAYAN O, 1988, ANN NEUROL, V23, pS95, DOI 10.1002/ana.410230725; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Perugi F, 2009, MOL BIOL CELL, V20, P498, DOI 10.1091/mbc.E08-02-0189; Peterson K, 2008, THERIOGENOLOGY, V69, P433, DOI 10.1016/j.theriogenology.2007.10.013; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qanbari S, 2010, ANIM GENET, V41, P346, DOI 10.1111/j.1365-2052.2009.02011.x; Reina R, 2009, VET J, V182, P31, DOI 10.1016/j.tvjl.2008.05.008; Satoh K, 1997, GENES CELLS, V2, P415, DOI 10.1046/j.1365-2443.1997.1310329.x; Seldin MF, 2007, CURR OPIN GENET DEV, V17, P177, DOI 10.1016/j.gde.2007.03.002; Slager RE, 2011, EUR RESPIR MONOGR, P82, DOI 10.1183/1025448x.10001010; Slatkin M, 2008, NAT REV GENET, V9, P477, DOI 10.1038/nrg2361; SNOWDER GD, 1990, J AM VET MED ASSOC, V197, P475; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; Takeuchi M, 1997, J BIOL CHEM, V272, P11943, DOI 10.1074/jbc.272.18.11943; Team R. D. C, 2011, R LANG ENV STAT COMP; TERRILL CE, 1958, J ANIM SCI, V17, P944, DOI 10.2527/jas1958.174944x; Thomas JH, 2011, GENOME RES, V21, P1800, DOI 10.1101/gr.121749.111; Torsteinsdottir S, 2007, FRONT BIOSCI-LANDMRK, V12, P1532, DOI 10.2741/2166; Yamazaki D, 2011, CELL METAB, V14, P231, DOI 10.1016/j.cmet.2011.05.011; Yokoyama K, 2011, J BIOL CHEM, V286, P5375, DOI 10.1074/jbc.M110.171702; Zhu YP, 2011, P NATL ACAD SCI USA, V108, P15834, DOI 10.1073/pnas.1101676108	59	37	40	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47829	10.1371/journal.pone.0047829	http://dx.doi.org/10.1371/journal.pone.0047829			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082221	gold, Green Published, Green Submitted			2022-12-25	WOS:000311146900118
J	Zarringhalam, K; Meyer, MM; Dotu, I; Chuang, JH; Clote, P				Zarringhalam, Kourosh; Meyer, Michelle M.; Dotu, Ivan; Chuang, Jeffrey H.; Clote, Peter			Integrating Chemical Footprinting Data into RNA Secondary Structure Prediction	PLOS ONE			English	Article							SELECTIVE 2'-HYDROXYL ACYLATION; SINGLE NUCLEOTIDE RESOLUTION; PRIMER EXTENSION SHAPE; PSEUDOKNOTS; STABILITY; SEQUENCES; SOFTWARE; BACTERIA	Chemical and enzymatic footprinting experiments, such as shape (selective 2'-hydroxyl acylation analyzed by primer extension), yield important information about RNA secondary structure. Indeed, since the 2'-hydroxyl is reactive at flexible (loop) regions, but unreactive at base-paired regions, shape yields quantitative data about which RNA nucleotides are basepaired. Recently, low error rates in secondary structure prediction have been reported for three RNAs of moderate size, by including base stacking pseudo-energy terms derived from shape data into the computation of minimum free energy secondary structure. Here, we describe a novel method, RNAsc (RNA soft constraints), which includes pseudo-energy terms for each nucleotide position, rather than only for base stacking positions. We prove that RNAsc is self-consistent, in the sense that the nucleotide-specific probabilities of being unpaired in the low energy Boltzmann ensemble always become more closely correlated with the input shape data after application of RNAsc. From this mathematical perspective, the secondary structure predicted by RNAsc should be 'correct', in as much as the shape data is 'correct'. We benchmark RNAsc against the previously mentioned method for eight RNAs, for which both shape data and native structures are known, to find the same accuracy in 7 out of 8 cases, and an improvement of 25% in one case. Furthermore, we present what appears to be the first direct comparison of shape data and in-line probing data, by comparing yeast asp-tRNA shape data from the literature with data from in-line probing experiments we have recently performed. With respect to several criteria, we find that shape data appear to be more robust than in-line probing data, at least in the case of asp-tRNA.	[Zarringhalam, Kourosh; Meyer, Michelle M.; Dotu, Ivan; Chuang, Jeffrey H.; Clote, Peter] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA	Boston College	Clote, P (corresponding author), Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA.	peter.clote@bc.edu		Dotu, Ivan/0000-0002-0438-9557; Chuang, Jeffrey/0000-0002-3298-2358	Division Of Mathematical Sciences [1016618] Funding Source: National Science Foundation	Division Of Mathematical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Bailor MH, 2010, SCIENCE, V327, P202, DOI 10.1126/science.1181085; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; BANERJEE AR, 1993, BIOCHEMISTRY-US, V32, P153, DOI 10.1021/bi00052a021; Bellaousov S, 2010, RNA, V16, P1870, DOI 10.1261/rna.2125310; Cho SS, 2009, P NATL ACAD SCI USA, V106, P17349, DOI 10.1073/pnas.0906625106; Dann CE, 2007, CELL, V130, P878, DOI 10.1016/j.cell.2007.06.051; Das R, 2005, RNA, V11, P344, DOI 10.1261/rna.7214405; Deigan KE, 2009, P NATL ACAD SCI USA, V106, P97, DOI 10.1073/pnas.0806929106; Ding Y, 2004, NUCL ACIDS RES, V32, pW135, DOI 10.1093/nar/gkh449; Duncan CDS, 2008, BIOCHEMISTRY-US, V47, P8504, DOI 10.1021/bi800207b; Forties RA, 2010, BIOINFORMATICS, V26, P61, DOI 10.1093/bioinformatics/btp627; Garey MR, 1990, COMPUTERS INTRACTABI; Higgs PG, 1996, PHYS REV LETT, V76, P704, DOI 10.1103/PhysRevLett.76.704; HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163; Kertesz M, 2010, NATURE, V467, P103, DOI 10.1038/nature09322; Kladwang W, 2011, BIOCHEMISTRY-US, V50, P8049, DOI [10.1021/bi4200524n, 10.1021/bi200524n]; Kladwang W, 2011, RNA, V17, P522, DOI 10.1261/rna.2516311; Lucks JB, 2011, P NATL ACAD SCI USA, V108, P11063, DOI 10.1073/pnas.1106501108; Lyngso RB, 2000, J COMPUT BIOL, V7, P409, DOI 10.1089/106652700750050862; Mandal M, 2003, CELL, V113, P577, DOI 10.1016/S0092-8674(03)00391-X; Mathews D, 2000, CURRENT PROTOCOLS NU; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Mathews DH, 2005, BIOINFORMATICS, V21, P2246, DOI 10.1093/bioinformatics/bti349; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; MCCASKILL JS, 1990, BIOPOLYMERS, V29, P1105, DOI 10.1002/bip.360290621; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Meyer MM, 2008, RNA, V14, P685, DOI 10.1261/rna.937308; Novikova IV, 2012, NUCL ACIDS RES; Quarrier S, 2010, RNA, V16, P1108, DOI 10.1261/rna.1988510; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891; Tabaska JE, 1998, BIOINFORMATICS, V14, P691, DOI 10.1093/bioinformatics/14.8.691; Tinoco I, 1999, J MOL BIOL, V293, P271, DOI 10.1006/jmbi.1999.3001; Turner DH, 2010, NUCLEIC ACIDS RES, V38, pD280, DOI 10.1093/nar/gkp892; Washietl S, 2010, METHODS MOL BIOL, V609, P285, DOI 10.1007/978-1-60327-241-4_17; Wilkinson KA, 2005, J AM CHEM SOC, V127, P4659, DOI 10.1021/ja0436749; Wilkinson KA, 2008, PLOS BIOL, V6, P883, DOI 10.1371/journal.pbio.0060096; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; ZUKER M, 1989, SCIENCE, V244, P48, DOI 10.1126/science.2468181; ZUKER M, 1981, NUCLEIC ACIDS RES, V9, P133, DOI 10.1093/nar/9.1.133; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	42	60	61	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e45160	10.1371/journal.pone.0045160	http://dx.doi.org/10.1371/journal.pone.0045160			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091593	Green Submitted, Green Published, gold			2022-12-25	WOS:000310135800003
J	Malatesta, M; Peschiaroli, A; Memmi, EM; Zhang, J; Antonov, A; Green, DR; Barlev, NA; Garabadgiu, AV; Zhou, P; Melino, G; Bernassola, F				Malatesta, M.; Peschiaroli, A.; Memmi, E. M.; Zhang, J.; Antonov, A.; Green, D. R.; Barlev, N. A.; Garabadgiu, A. V.; Zhou, P.; Melino, G.; Bernassola, F.			The Cul4A-DDB1 E3 ubiquitin ligase complex represses p73 transcriptional activity	ONCOGENE			English	Article						apoptosis; p73; protein ubiquitylation	TUMOR-SUPPRESSOR FUNCTIONS; DNA-DAMAGE; PROTEIN; CELLS; DDB1; STABILITY; MDM2; P53; DEGRADATION; INSTABILITY	The Cullin4A (cul4A)-dependent ligase (CDL4A) E3 has been implicated in a variety of biological processes, including cell cycle progression and DNA damage response. Remarkably, CDL4A exerts its function through both proteolytic and non-proteolytic events. Here, we show that the p53 family member p73 is able to interact with the CDL4A complex through its direct binding to the receptor subunit DNA-binding protein 1 (DDB1). As a result, the CDL4A complex is able to monoubiquitylate p73. Modification of p73 by CDL4A-mediated ubiquitylation does not affect p73 protein stability, but negatively regulates p73-dependent transcriptional activity. Indeed, genetic or RNA interference-mediated depletion of DDB1 induces the expression of several p73 target genes in a p53-independent manner. In addition, by exploiting a bioinformatic approach, we found that elevated expression of Cul4A in human breast carcinomas is associated with repression of p73 target genes. In conclusion, our findings add a novel insight into the regulation of p73 by the CDL4A complex, through the inhibition of its transcriptional function.	[Malatesta, M.; Memmi, E. M.; Melino, G.; Bernassola, F.] Univ Roma Tor Vergata, Dept Expt Med & Surg, I-00133 Rome, Italy; [Peschiaroli, A.; Melino, G.] Univ Roma Tor Vergata, IDI IRCCS, Biochem Lab, Dept Expt Med & Surg, I-00133 Rome, Italy; [Peschiaroli, A.] CNR, Inst Cellular Biol & Neurobiol, Dept Biomed, Rome, Italy; [Zhang, J.; Zhou, P.] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA; [Zhang, J.; Zhou, P.] Weill Cornell Grad Sch Med Sci, New York, NY USA; [Antonov, A.; Melino, G.] Univ Leicester, MRC, Toxicol Unit, Leicester, Leics, England; [Green, D. R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Barlev, N. A.; Garabadgiu, A. V.; Melino, G.] St Petersburg State Inst Technol, St Petersburg, Russia; [Barlev, N. A.] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Bernassola, F.] European Inst Oncol, Dept Expt Oncol, Milan, Italy	University of Rome Tor Vergata; IRCCS Istituto Dermopatico dell'Immacolata (IDI); University of Rome Tor Vergata; Consiglio Nazionale delle Ricerche (CNR); Cornell University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Leicester; St Jude Children's Research Hospital; Saint Petersburg State Institute of Technology; University of Leicester; IRCCS European Institute of Oncology (IEO)	Melino, G (corresponding author), Univ Roma Tor Vergata, IDI IRCCS, Biochem Lab, Dept Expt Med & Surg, Via Montpellier 1, I-00133 Rome, Italy.	gerry.melino@uniroma2.it; bernasso@uniroma2.it	Green, Douglas R/N-8083-2018; Barlev, Nikolai A/K-5268-2017	Green, Douglas R/0000-0002-7332-1417; Barlev, Nikolai A/0000-0001-7111-2446; PESCHIAROLI, ANGELO/0000-0001-6311-2382; Garabadjiu, Alexander/0000-0001-9972-8517	MIUR/PRIN [20078P7T3K_001, (20078P7T3K_001)/FIRB, RBIP06LCA9_0023, RBIP06LCA9_0C, 2008MRLSNZ_004]; AIRC [9202, 2008-2010_33-08, 5471]; Medical Research Council, UK; Odysseus, Belgium; VIB, Belgium; Alleanza contro il Cancro [ACC12]; AIRC 5xmille [9979]; Ric Finalizzata [08-GIOV_RIC]; NIH [2R01CA098210, 5R01CA 118085]; RFBS [10-04-01234]; MCB RAS; Russian Federal grants [16.740.11.036, 11.G34.31.0069]; US NIH; Medical Research Council [MC_U132670600] Funding Source: researchfish; MRC [MC_U132670600] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA118085, R01CA098210] Funding Source: NIH RePORTER	MIUR/PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); AIRC(Fondazione AIRC per la ricerca sul cancro); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Odysseus, Belgium; VIB, Belgium; Alleanza contro il Cancro; AIRC 5xmille(Fondazione AIRC per la ricerca sul cancro); Ric Finalizzata; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RFBS; MCB RAS; Russian Federal grants; US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Michele Pagano for fruitful discussions on the topics covered in this article, and to Emre Sayan for providing the His-p73 alpha recombinant protein. This work has been supported by the MIUR/PRIN grant 20078P7T3K_001 and AIRC grant 9202 awarded to FB, the Medical Research Council, UK; Odysseus and VIB, Belgium; grants from 'Alleanza contro il Cancro' (ACC12), MIUR/PRIN (20078P7T3K_001)/FIRB (RBIP06LCA9_0023, RBIP06LCA9_0C), AIRC (2008-2010_33-08) (grant number 5471), AIRC 5xmille (grant number 9979), MIUR/PRIN 2008MRLSNZ_004 to GM, the Ric Finalizzata 08-GIOV_RIC awarded to AP, the NIH grants 2R01CA098210, 5R01CA 118085 and Irma T Hirschl Career Scientist Award to PZ. This work was supported by funding from RFBS (10-04-01234), MCB RAS, Russian Federal grants 16.740.11.036 (to NB) and 11.G34.31.0069 (to GM). DRG was supported by grants from the US NIH.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Banks D, 2006, CELL CYCLE, V5, P1719, DOI 10.4161/cc.5.15.3150; Busuttil V, 2010, P NATL ACAD SCI USA, V107, P18061, DOI 10.1073/pnas.1006163107; Cang Y, 2007, P NATL ACAD SCI USA, V104, P2733, DOI 10.1073/pnas.0611311104; Cang Y, 2006, CELL, V127, P929, DOI 10.1016/j.cell.2006.09.045; Chen LC, 1998, CANCER RES, V58, P3677; Chen XA, 2001, J BIOL CHEM, V276, P48175, DOI 10.1074/jbc.M106808200; Choi SH, 2010, GENE DEV, V24, P1236, DOI 10.1101/gad.1920310; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Greer SF, 2003, NAT IMMUNOL, V4, P1074, DOI 10.1038/ni985; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Hannah J, 2009, DNA REPAIR, V8, P536, DOI 10.1016/j.dnarep.2009.01.011; HERSHKOVITZROKA.O, 2010, PLOS ONE, V5; Higa LA, 2006, NAT CELL BIOL, V8, P1277, DOI 10.1038/ncb1490; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kopanja D, 2009, ONCOGENE, V28, P2456, DOI 10.1038/onc.2009.86; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Li T, 2006, CELL, V124, P105, DOI 10.1016/j.cell.2005.10.033; Liu LR, 2009, MOL CELL, V34, P451, DOI 10.1016/j.molcel.2009.04.020; Melino G, 2004, J BIOL CHEM, V279, P8076, DOI 10.1074/jbc.M307469200; Nag A, 2004, CANCER RES, V64, P8152, DOI 10.1158/0008-5472.CAN-04-2598; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; Peschiaroli A, 2009, ONCOGENE, V28, P3157, DOI 10.1038/onc.2009.177; Rossi M, 2005, EMBO J, V24, P836, DOI 10.1038/sj.emboj.7600444; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Sayan AE, 2005, BIOCHEM BIOPH RES CO, V330, P186, DOI 10.1016/j.bbrc.2005.02.145; Tomasini R, 2008, GENE DEV, V22, P2677, DOI 10.1101/gad.1695308; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469	30	21	21	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP 26	2013	32	39					4721	4726		10.1038/onc.2012.463	http://dx.doi.org/10.1038/onc.2012.463			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	226YD	23085759				2022-12-25	WOS:000325072200014
J	Hamill, KJ; Hopkinson, SB; Skalli, O; Jones, JCR				Hamill, Kevin J.; Hopkinson, Susan B.; Skalli, Omar; Jones, Jonathan C. R.			Actinin-4 in keratinocytes regulates motility via an effect on lamellipodia stability and matrix adhesions	FASEB JOURNAL			English	Article						focal contact; hemidesmosome; laminin; integrin	BULLOUS-PEMPHIGOID ANTIGEN; ALPHA-ACTININ; CELL MOTILITY; COFILIN PHOSPHORYLATION; FOCAL ADHESIONS; DEPOLYMERIZING FACTOR; GENE AMPLIFICATION; BETA-4 INTEGRIN; PROTEIN-KINASE; DYNAMICS	During wound repair, epidermal cells at the edge of an injury establish front-rear polarity through orchestrated changes in their cytoskeleton and adhesion structures. The polarity and directed migration of such cells is determined by the assembly, extension, and stabilization of a lamellipodium. Actinin-4 associates with lamellipodia and has been implicated in regulating lamellipodial structure, function and assembly. To study the functions of actinin-4 in human keratinocytes, we used shRNA to generate knockdown cells and compared their motility behavior and matrix adhesion assembly to scrambled shRNA treated control keratinocytes. Actinin-4 knockdown keratinocytes lack polarity, assemble multiple lamellipodia with a 2 x increased area over controls, display reduced activity of the actin remodeling protein cofilin, and fail to migrate in a directional manner. This motility defect is rescued by plating knockdown cells on preformed laminin-332 matrix. In actinin-4-knockdown keratinocytes, focal contact area is increased by 25%, and hemidesmosome proteins are mislocalized. Specifically, alpha 6 beta 4 integrin localizes to large lamellipodial extensions, displays reduced dynamics, and fails to recruit its bullous pemphigoid antigen binding partners. Together, our data indicate a role for actinin-4 in regulating the steering mechanism of keratinocytes via profound effects on their matrix adhesion sites.-Hamill, K. J., Hopkinson, S. B., Skalli, O., Jones, J. C. R. Actinin-4 in keratinocytes regulates motility via an effect on lamellipodia stability and matrix adhesions. FASEB J. 27, 546-556 (2013). www.fasebj.org	[Hamill, Kevin J.; Hopkinson, Susan B.; Jones, Jonathan C. R.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA; [Skalli, Omar] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA	Northwestern University; Feinberg School of Medicine; University of Memphis	Jones, JCR (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, 303 E Chicago Ave, Chicago, IL 60611 USA.	j-jones3@northwestern.edu	Hamill, Kevin/ABF-9727-2020; Skalli, Omar/D-4980-2013; Jones, Jonathan C R/T-9467-2017	Hamill, Kevin/0000-0002-7852-1944; Jones, Jonathan C R/0000-0002-1496-4922	Dermatology Foundation; U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases [K99AR060242, R01AR054184]; Cancer Center Support grant [NCI CA060553];  [NCI CCSG P30 CA060553]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K99AR060242, P30AR057216, R01AR054184] Funding Source: NIH RePORTER	Dermatology Foundation; U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Cancer Center Support grant; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	A Dermatology Foundation Career Development Award (to K.J.H.), as well as grants K99AR060242 (K.J.H.), and R01AR054184 (J.C.R.J.) from the U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases supported this project. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Arthritis and Musculoskeletal and Skin Diseases or the U. S. National Institutes of Health. Imaging work was performed at the Northwestern University Cell Imaging Facility, generously supported by grant NCI CCSG P30 CA060553, awarded to the Robert H. Lurie Comprehensive Cancer Center. FACS analyses were performed at the Northwestern University Flow Cytometry Facility, supported by a Cancer Center Support grant (NCI CA060553).	AGNEW BJ, 1995, J BIOL CHEM, V270, P17582, DOI 10.1074/jbc.270.29.17582; Barbolina MV, 2008, LAB INVEST, V88, P602, DOI 10.1038/labinvest.2008.25; BARON MD, 1987, J BIOL CHEM, V262, P17623; BEGGS AH, 1992, J BIOL CHEM, V267, P9281; Beningo KA, 2001, J CELL BIOL, V153, P881, DOI 10.1083/jcb.153.4.881; Carlier MF, 1999, J BIOL CHEM, V274, P33827, DOI 10.1074/jbc.274.48.33827; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; CARTER WG, 1990, J CELL BIOL, V111, P3141, DOI 10.1083/jcb.111.6.3141; Dembo M, 1999, BIOPHYS J, V76, P2307, DOI 10.1016/S0006-3495(99)77386-8; Galler AB, 2006, HISTOCHEM CELL BIOL, V125, P457, DOI 10.1007/s00418-005-0091-z; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; GLUCK U, 1994, J CELL SCI, V107, P1773; GLUCK U, 1993, P NATL ACAD SCI USA, V90, P383, DOI 10.1073/pnas.90.2.383; Goldfinger LE, 1998, J CELL BIOL, V141, P255, DOI 10.1083/jcb.141.1.255; Gonzales M, 1999, MOL BIOL CELL, V10, P259, DOI 10.1091/mbc.10.2.259; Gonzalez AM, 2001, J CELL SCI, V114, P4197; Hamill KJ, 2009, MOL BIOL CELL, V20, P2954, DOI 10.1091/mbc.E09-01-0051; Harlow E., 1988, ANTIBODIES LAB MANUA; HASHIMOTO T, 1993, J INVEST DERMATOL, V100, P310, DOI 10.1111/1523-1747.ep12469916; Hinz B, 1999, EXP CELL RES, V251, P234, DOI 10.1006/excr.1999.4541; Honda K, 1998, J CELL BIOL, V140, P1383, DOI 10.1083/jcb.140.6.1383; Honda K, 2005, GASTROENTEROLOGY, V128, P51, DOI 10.1053/j.gastro.2004.10.004; HOPKINSON SB, 1995, J CELL BIOL, V130, P117, DOI 10.1083/jcb.130.1.117; Jovceva E, 2007, J CELL SCI, V120, P1888, DOI 10.1242/jcs.004366; Kikuchi S, 2008, CLIN CANCER RES, V14, P5348, DOI 10.1158/1078-0432.CCR-08-0075; KLATTE DH, 1994, J INVEST DERMATOL, V102, P39, DOI 10.1111/1523-1747.ep12371728; Kligys K, 2007, J BIOL CHEM, V282, P32520, DOI 10.1074/jbc.M707041200; Koizumi T, 2010, UROLOGY, V75, P357, DOI 10.1016/j.urology.2009.09.037; Kos CH, 2003, J CLIN INVEST, V111, P1683, DOI 10.1172/JCI200317988; LANGHOFER M, 1993, J CELL SCI, V105, P753; MILLAKE DB, 1989, NUCLEIC ACIDS RES, V17, P6725, DOI 10.1093/nar/17.16.6725; OTEY CA, 1990, J CELL BIOL, V111, P721, DOI 10.1083/jcb.111.2.721; Ozawa T, 2011, MED MOL MORPHOL, V44, P27, DOI 10.1007/s00795-010-0502-7; Ozawa T, 2010, J INVEST DERMATOL, V130, P1624, DOI 10.1038/jid.2009.439; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pullar CE, 2006, MOL BIOL CELL, V17, P4925, DOI 10.1091/mbc.E06-05-0433; Quick Q, 2010, EXP CELL RES, V316, P1137, DOI 10.1016/j.yexcr.2010.02.011; Rabinovitz I, 1999, J CELL BIOL, V146, P1147, DOI 10.1083/jcb.146.5.1147; Rabinovitz I, 1997, J CELL BIOL, V139, P1873, DOI 10.1083/jcb.139.7.1873; RIDDELLE KS, 1991, J CELL BIOL, V112, P159, DOI 10.1083/jcb.112.1.159; Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; Schafer C, 2010, CELL ADHES MIGR, V4, P215, DOI 10.4161/cam.4.2.10745; Sehgal BU, 2006, J BIOL CHEM, V281, P35487, DOI 10.1074/jbc.M606317200; Sen S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008427; Shao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013921; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Tsuruta D, 2003, CELL MOTIL CYTOSKEL, V54, P122, DOI 10.1002/cm.10089; Tsuruta D, 2002, FASEB J, V16, P866, DOI 10.1096/fj.01-0878fje; Tsuruta D, 2011, J DERMATOL SCI, V62, P1, DOI 10.1016/j.jdermsci.2011.01.005; Vallenius T, 2000, J BIOL CHEM, V275, P11100, DOI 10.1074/jbc.275.15.11100; Xia N, 2008, FASEB J, V22, P1649, DOI 10.1096/fj.07-090571; Yamada S, 2010, INT J ORAL MAX SURG, V39, P61, DOI 10.1016/j.ijom.2009.10.003; Yamaji S, 2004, J CELL BIOL, V165, P539, DOI 10.1083/jcb.200308141; Yamamoto S, 2007, MODERN PATHOL, V20, P1278, DOI 10.1038/modpathol.3800966; Yamamoto S, 2012, HISTOPATHOLOGY, V60, P1073, DOI 10.1111/j.1365-2559.2011.04163.x; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; YOUSSOUFIAN H, 1990, AM J HUM GENET, V47, P62	59	26	26	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					546	556		10.1096/fj.12-217406	http://dx.doi.org/10.1096/fj.12-217406			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23085994	Green Published			2022-12-25	WOS:000314358000014
J	He, LH; Kota, P; Aleksandrov, AA; Cui, LY; Jensen, T; Dokholyan, NV; Riordan, JR				He, Lihua; Kota, Pradeep; Aleksandrov, Andrei A.; Cui, Liying; Jensen, Tim; Dokholyan, Nikolay V.; Riordan, John R.			Correctors of Delta F508 CFTR restore global conformational maturation without thermally stabilizing the mutant protein	FASEB JOURNAL			English	Article						cystic fibrosis; VX-809; domain interactions; molecular docking; anion channel; ABC transporter	TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE-ASSOCIATED MUTATIONS; CYTOPLASMIC LOOP; CHANNEL FUNCTION; IN-VITRO; RESCUE; POTENTIATOR; CYANOQUINOLINES; DEFECTS	Most cystic fibrosis is caused by the deletion of a single amino acid (F508) from CFTR and the resulting misfolding and destabilization of the protein. Compounds identified by high-throughput screening to improve Delta F508 CFTR maturation have already entered clinical trials, and it is important to understand their mechanisms of action to further improve their efficacy. Here, we showed that several of these compounds, including the investigational drug VX-809, caused a much greater increase (5- to 10-fold) in maturation at 27 than at 37 degrees C (<2-fold), and the mature product remained short-lived (T-1/2 similar to 4.5 h) and thermally unstable, even though its overall conformational state was similar to wild type, as judged by resistance to proteolysis and interdomain cross-linking. Consistent with its inability to restore thermodynamic stability, VX-809 stimulated maturation 2-5-fold beyond that caused by several different stabilizing modifications of NBD1 and the NBD1/CL4 interface. The compound also promoted maturation of several disease-associated processing mutants on the CL4 side of this interface. Although these effects may reflect an interaction of VX-809 with this interface, an interpretation supported by computational docking, it also rescued maturation of mutants in other cytoplasmic loops, either by allosteric effects or via additional sites of action. In addition to revealing the capabilities and some of the limitations of this important investigational drug, these findings clearly demonstrate that Delta F508 CFTR can be completely assembled and evade cellular quality control systems, while remaining thermodynamically unstable. He, L., Kota, P., Aleksandrov, A. A., Cui, L., Jensen, T., Dokholyan, N. V., Riordan, J. R. Correctors of Delta F508 CFTR restore global conformational maturation without thermally stabilizing the mutant protein. FASEB J. 27, 536-545 (2013). www.fasebj.org	[He, Lihua; Kota, Pradeep; Aleksandrov, Andrei A.; Cui, Liying; Jensen, Tim; Dokholyan, Nikolay V.; Riordan, John R.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [He, Lihua; Aleksandrov, Andrei A.; Cui, Liying; Jensen, Tim; Riordan, John R.] Univ N Carolina, Cyst Fibrosis Treatment & Res Ctr, Chapel Hill, NC 27599 USA; [Kota, Pradeep; Dokholyan, Nikolay V.] Univ N Carolina, Mol & Cellular Biophys Program, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Riordan, JR (corresponding author), Univ N Carolina, Cyst Fibrosis Treatment & Res Ctr, Dept Biochem & Biophys, 6103 Thurston Bowles Bldg,CB 7248, Chapel Hill, NC 27599 USA.	jack_riordan@med.unc.edu	Dokholyan, Nikolay/D-8081-2018	Dokholyan, Nikolay/0000-0002-8225-4025	U.S. National Institutes of Health [DK051619, GM080742]; Cystic Fibrosis Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051870, R01DK051619] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080742] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the U.S. National Institutes of Health to J.R.R. (DK051619) and N.V.D. (GM080742) and from the Cystic Fibrosis Foundation.	Aleksandrov AA, 2012, J MOL BIOL, V419, P41, DOI 10.1016/j.jmb.2012.03.001; Aleksandrov AA, 2010, J MOL BIOL, V401, P194, DOI 10.1016/j.jmb.2010.06.019; Alexander C, 2009, BIOCHEMISTRY-US, V48, P10078, DOI 10.1021/bi901314c; Bartlett JR, 2009, JAMA-J AM MED ASSOC, V302, P1076, DOI 10.1001/jama.2009.1295; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Cutting GR, 2010, ANN NY ACAD SCI, V1214, P57, DOI 10.1111/j.1749-6632.2010.05879.x; Dalton J, 2012, J CHEM INF MODEL, V52, P1842, DOI 10.1021/ci2005884; deCarvalho ACV, 2002, J BIOL CHEM, V277, P35896, DOI 10.1074/jbc.M205644200; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Ding F, 2010, J CHEM INF MODEL, V50, P1623, DOI 10.1021/ci100218t; Dorfman R, 2009, HUM GENET, V126, P763, DOI 10.1007/s00439-009-0724-8; Du K, 2005, NAT STRUCT MOL BIOL, V12, P17, DOI 10.1038/nsmb882; He LH, 2008, J BIOL CHEM, V283, P26383, DOI 10.1074/jbc.M803894200; He LH, 2010, FASEB J, V24, P3103, DOI 10.1096/fj.09-141788; Hoelen H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015458; Kalid O, 2010, J COMPUT AID MOL DES, V24, P971, DOI 10.1007/s10822-010-9390-0; Knapp JM, 2012, J MED CHEM, V55, P1242, DOI 10.1021/jm201372q; Kopito Ron R., 1999, Physiological Reviews, V79, pS167; Liu X., 2012, BIOCHEMISTR IN PRESS; Liu XH, 2012, BIOCHEMISTRY-US, V51, P5113, DOI 10.1021/bi300018e; Loo TW, 2010, BIOCHEMISTRY-US, V49, P6352, DOI 10.1021/bi100807h; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Mendoza JL, 2012, CELL, V148, P164, DOI 10.1016/j.cell.2011.11.023; Mickle JE, 2000, MED CLIN N AM, V84, P597, DOI 10.1016/S0025-7125(05)70243-1; MITTRE H, 1995, J MED GENET, V32, P577, DOI 10.1136/jmg.32.7.577; Mornon JP, 2009, CELL MOL LIFE SCI, V66, P3469, DOI 10.1007/s00018-009-0133-0; Protasevich I, 2010, PROTEIN SCI, V19, P1917, DOI 10.1002/pro.479; Phuan PW, 2011, MOL PHARMACOL, V80, P683, DOI 10.1124/mol.111.073056; Rabeh WM, 2012, CELL, V148, P150, DOI 10.1016/j.cell.2011.11.024; Schultz BD, 1999, J MEMBRANE BIOL, V170, P51, DOI 10.1007/s002329900537; Scotet Virginie, 2003, Hum Mutat, V22, P105, DOI 10.1002/humu.9158; Seibert FS, 1996, J BIOL CHEM, V271, P27493, DOI 10.1074/jbc.271.44.27493; Seibert FS, 1997, BIOCHEMISTRY-US, V36, P11966, DOI 10.1021/bi9712652; Seibert FS, 1996, J BIOL CHEM, V271, P15139, DOI 10.1074/jbc.271.25.15139; Serohijos AWR, 2008, P NATL ACAD SCI USA, V105, P3256, DOI 10.1073/pnas.0800254105; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; Thibodeau PH, 2010, J BIOL CHEM, V285, P35825, DOI 10.1074/jbc.M110.131623; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Wang W, 2011, J BIOL CHEM, V286, P41937, DOI 10.1074/jbc.M111.296061; Wang XD, 2008, TRAFFIC, V9, P1878, DOI 10.1111/j.1600-0854.2008.00806.x; Yin S, 2008, J CHEM INF MODEL, V48, P1656, DOI 10.1021/ci8001167; Yu HH, 2012, J CYST FIBROS, V11, P237, DOI 10.1016/j.jcf.2011.12.005; Zhang F, 1998, NAT STRUCT BIOL, V5, P180, DOI 10.1038/nsb0398-180	44	101	103	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					536	545		10.1096/fj.12-216119	http://dx.doi.org/10.1096/fj.12-216119			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23104983	Green Published			2022-12-25	WOS:000314358000013
J	Khidhir, KG; Woodward, DF; Farjo, NP; Farjo, BK; Tang, ES; Wang, JW; Picksley, SM; Randall, VA				Khidhir, Karzan G.; Woodward, David F.; Farjo, Nilofer P.; Farjo, Bessam K.; Tang, Elaine S.; Wang, Jenny W.; Picksley, Steven M.; Randall, Valerie A.			The prostamide-related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias	FASEB JOURNAL			English	Article						hair follicle; hair growth; balding; prostaglandins; human organ culture	HAIR-GROWTH; PHARMACOLOGICAL CHARACTERIZATION; FP-RECEPTOR; PATTERN; INDUCTION; AREATA; MEN; PROSTAGLANDIN-F2-ALPHA; IDENTIFICATION; REGENERATION	Balding causes widespread psychological distress but is poorly controlled. The commonest treatment, minoxidil, was originally an antihypertensive drug that promoted unwanted hair. We hypothesized that another serendipitous discovery, increased eyelash growth side-effects of prostamide F-2 alpha-related eyedrops for glaucoma, may be relevant for scalp alopecias. Eyelash hairs and follicles are highly specialized and remain unaffected by androgens that inhibit scalp follicles and stimulate many others. Therefore, we investigated whether non-eyelash follicles could respond to bimatoprost, a prostamide F-2 alpha analog recently licensed for eyelash hypotrichosis. Bimatoprost, at pharmacologically selective concentrations, increased hair synthesis in scalp follicle organ culture and advanced mouse pelage hair regrowth in vivo compared to vehicle alone. A prostamide receptor antagonist blocked isolated follicle growth, confirming a direct, receptor-mediated mechanism within follicles; RT-PCR analysis identified 3 relevant receptor genes in scalp follicles in vivo. Receptors were located in the key follicle regulator, the dermal papilla, by analyzing individual follicular structures and immunohistochemistry. Thus, bimatoprost stimulates human scalp follicles in culture and rodent pelage follicles in vivo, mirroring eyelash behavior, and scalp follicles contain bimatoprost-sensitive prostamide receptors in vivo. This highlights a new follicular signaling system and confirms that bimatoprost offers a novel, low-risk therapeutic approach for scalp alopecias.-Khidhir, K. G., Woodward, D. F., Farjo, N. P., Farjo, B. K., Tang, E. S., Wang, J. W., Picksley, S. M., and Randall, V. A. The prostamide-related glaucoma therapy, bimatoprost, offers a novel approach for treating scalp alopecias. FASEB J. 27, 557-567 (2013). www.fasebj.org	[Khidhir, Karzan G.; Picksley, Steven M.; Randall, Valerie A.] Univ Bradford, Ctr Skin Sci, Bradford BD7 1DP, W Yorkshire, England; [Woodward, David F.; Tang, Elaine S.; Wang, Jenny W.] Allergan, Irvine, CA USA; [Farjo, Nilofer P.; Farjo, Bessam K.] Farjo Med Ctr, Manchester, Lancs, England	University of Bradford; AbbVie; Allergan	Randall, VA (corresponding author), Univ Bradford, Ctr Skin Sci, Sch Life Sci, Bradford BD7 1DP, W Yorkshire, England.	v.a.randall@bradford.ac.uk			Ministry of Higher Education and Scientific Research, Kurdistan, Iraq; Allergan, Inc.	Ministry of Higher Education and Scientific Research, Kurdistan, Iraq; Allergan, Inc.(AbbVieAllergan)	The authors gratefully acknowledge a Research Scholarship from the Ministry of Higher Education and Scientific Research, Kurdistan, Iraq, to support K. G. K. The authors also thank Allergan, Inc. (Irvine, CA, USA) for gifts of bimatoprost and AGN 211336. One of the authors of this article (V. A. R.) has informed The FASEB Journal that she has been asked to be an expert witness for Allergan and their coplaintiff Duke University in a legal matter. V. A. R. has acted as a consultant for Allergan, Inc., and has received unrestricted grants from Allergan, Inc., to support her research. E. S. T., J.W.W., and D. F. W. are Allergan employees.	CASH TF, 1993, J AM ACAD DERMATOL, V29, P568, DOI 10.1016/0190-9622(93)70223-G; Chuong CM, 2012, PHYSIOLOGY, V27, P61, DOI 10.1152/physiol.00028.2011; Colombe L, 2008, EXP DERMATOL, V17, P63, DOI 10.1111/j.1600-0625.2007.00639.x; Colombe L, 2007, EXP DERMATOL, V16, P762, DOI 10.1111/j.1600-0625.2007.00586.x; Curran MP, 2009, DRUG AGING, V26, P1049, DOI 10.2165/11203210-000000000-00000; Garg S, 2009, SEMIN CUTAN MED SURG, V28, P15, DOI 10.1016/j.sder.2008.12.002; Girman CJ, 1998, DERMATOLOGY, V197, P223, DOI 10.1159/000018001; Gulec AT, 2004, INT J DERMATOL, V43, P352, DOI 10.1111/j.1365-4632.2004.02028.x; HAMILTON JB, 1951, ANN NY ACAD SCI, V53, P708, DOI 10.1111/j.1749-6632.1951.tb31971.x; Higgins CA, 2009, EXP DERMATOL, V18, P793, DOI 10.1111/j.1600-0625.2008.00833.x; Inui S, 2003, J INVEST DERM SYMP P, V8, P69, DOI 10.1046/j.1523-1747.2003.12174.x; JAHODA CAB, 1984, NATURE, V311, P560, DOI 10.1038/311560a0; JAHODA CAB, 1992, DEVELOPMENT, V115, P1103; Jansen VAA, 2006, NATURE, V440, P663, DOI 10.1038/nature04387; Kaufman KD, 1998, J AM ACAD DERMATOL, V39, P578, DOI 10.1016/S0190-9622(98)70007-6; KEOGH EV, 1965, NATURE, V207, P877, DOI 10.1038/207877a0; KLIGMAN AM, 1959, J INVEST DERMATOL, V33, P307, DOI 10.1038/jid.1959.156; LEE PY, 1988, INVEST OPHTH VIS SCI, V29, P1474; Liang Y, 2008, BRIT J PHARMACOL, V154, P1079, DOI 10.1038/bjp.2008.142; Liang YB, 2003, J BIOL CHEM, V278, P27267, DOI 10.1074/jbc.M301009200; MARSHALL WA, 1970, ARCH DIS CHILD, V45, P13, DOI 10.1136/adc.45.239.13; McCarey BE, 2004, OPHTHALMOLOGY, V111, P1480, DOI 10.1016/j.ophtha.2003.11.013; Messenger AG, 2004, BRIT J DERMATOL, V150, P186, DOI 10.1111/j.1365-2133.2004.05785.x; Michelet JF, 1997, J INVEST DERMATOL, V108, P205, DOI 10.1111/1523-1747.ep12334249; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Ota T, 2005, INVEST OPHTH VIS SCI, V46, P4159, DOI 10.1167/iovs.05-0494; PHILPOTT MP, 1990, J CELL SCI, V97, P463; Piraccini BM, 2006, CURR DRUG SAF, V1, P301, DOI 10.2174/157488606777934477; Plikus MV, 2008, J INVEST DERMATOL, V128, P1071, DOI 10.1038/sj.jid.5701180; Plikus MV, 2011, SCIENCE, V332, P586, DOI 10.1126/science.1201647; Randall VA, 2001, LANCET, V358, P1922, DOI 10.1016/S0140-6736(01)06943-4; Randall VA, 2008, J ENDOCRINOL, V197, P11, DOI 10.1677/JOE-07-0522; Randall VA, 2008, DERMATOL THER, V21, P314, DOI 10.1111/j.1529-8019.2008.00214.x; Randall VA, 2007, SEMIN CELL DEV BIOL, V18, P274, DOI 10.1016/j.semcdb.2007.02.004; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Reynolds AJ, 1999, NATURE, V402, P33, DOI 10.1038/46938; Rogers NE, 2008, J AM ACAD DERMATOL, V59, P547, DOI 10.1016/j.jaad.2008.07.001; SAITOH M, 1970, J INVEST DERMATOL, V54, P65, DOI 10.1111/1523-1747.ep12551679; Shorter K, 2008, FASEB J, V22, P1725, DOI 10.1096/fj.07-099424; Sotiropoulou PA, 2010, NAT CELL BIOL, V12, P572, DOI 10.1038/ncb2059; Tauchi M, 2010, BRIT J DERMATOL, V162, P1186, DOI 10.1111/j.1365-2133.2010.09685.x; Thibaut S, 2010, BRIT J DERMATOL, V162, P304, DOI 10.1111/j.1365-2133.2009.09487.x; Trueb R M, 2010, Skin Therapy Lett, V15, P5; Whiting DA, 2003, EUR J DERMATOL, V13, P150; WHITING DA, 1993, J AM ACAD DERMATOL, V28, P755, DOI 10.1016/0190-9622(93)70106-4; Woodward DF, 2008, PHARMACOL THERAPEUT, V120, P71, DOI 10.1016/j.pharmthera.2008.08.001; Woodward DF, 2003, J PHARMACOL EXP THER, V305, P772, DOI 10.1124/jpet.102.047837; Woodward FD, 2010, CELL BIO RES PROG, P65	48	35	41	1	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					557	567		10.1096/fj.12-218156	http://dx.doi.org/10.1096/fj.12-218156			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23104985	Green Published, hybrid			2022-12-25	WOS:000314358000015
J	Lu, H; Hu, L; Li, TS; Lahiri, S; Shen, C; Wason, MS; Mukherjee, D; Xie, H; Yu, L; Zhao, JH				Lu, Heng; Hu, Liu; Li, Tianshu; Lahiri, Satadru; Shen, Chao; Wason, Melissa S.; Mukherjee, Debarati; Xie, Hui; Yu, Lin; Zhao, Jihe			A Novel Role of Kruppel-like Factor 8 in DNA Repair in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; CYCLIN D1; KLF8 TRANSCRIPTION; GENOMIC STABILITY; DAMAGE RESPONSE; EXCISION-REPAIR; ACTIVATION; PROTEIN; PARP-1; IDENTIFICATION	Kruppel-like factor 8 (KLF8) regulates critical gene transcription and cellular events associated with cancer. However, the role of KLF8 in cancer remains largely unknown. Here, we report a surprisingly novel role for KLF8 inDNArepair in breast cancer cells. Comet, clonogenic, and WST-1 assays showed that KLF8 expression is required for protecting human breast cancer cells from doxorubicin-induced DNA damage and cell death. Western blotting indicated that overexpression of ectopic KLF8 attenuated the levels of the DNA damage marker gamma H2A.X in doxorubicin-treated PARP-1(+/+) but not PARP-1(-/-) mouse embryonic fibroblasts, whereas the PARP-1-binding-defective KLF8 mutant failed to do so. Interestingly, in response to the DNA damage, KLF8 was phosphorylated by the DNA-dependent protein kinase catalytic subunit and, subsequently, SUMOylated by SUMO E3 ligases protein inhibitors of activated STAT (PIASs), which depends upon the interaction of KLF8 with DNA-dependent protein kinase catalytic subunit, PIASs, and PARP-1 as well as their enzymatic activities. Lastly, we show evidence that KLF8 was recruited to the DNA damage site. These results suggest a novel role and mechanism for KLF8 in the regulation of DNA repair and therapeutic resistance in breast cancer cells.	[Lu, Heng; Hu, Liu; Li, Tianshu; Lahiri, Satadru; Shen, Chao; Wason, Melissa S.; Mukherjee, Debarati; Yu, Lin; Zhao, Jihe] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32827 USA; [Xie, Hui] Florida Hosp, Translat Res Inst Metab & Diabet, Orlando, FL 32804 USA	State University System of Florida; University of Central Florida; Adventist Health Services; AdventHealth	Zhao, JH (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, 6900 Lake Nona Blvd, Orlando, FL 32827 USA.	jihe.zhao@ucf.edu	Lahiri, Satadru/J-3483-2019; Li, Tianshu/L-6426-2014	Li, Tianshu/0000-0002-9972-4644	NCI [CA132977]; Susan G. Komen for the Cure Grants [KG090444, KG080616]; NATIONAL CANCER INSTITUTE [R01CA132977] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G. Komen for the Cure Grants(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NCI Grant CA132977 and Susan G. Komen for the Cure Grants KG090444 and KG080616 (to J. Z.).	Brenner JC, 2011, CANCER CELL, V19, P664, DOI 10.1016/j.ccr.2011.04.010; Cao Q, 2011, MOL CARCINOGEN, V50, P863, DOI 10.1002/mc.20791; Cleaver JE, 2009, NAT REV GENET, V10, P756, DOI 10.1038/nrg2663; Cox BD, 2006, J CELL BIOCHEM, V99, P36, DOI 10.1002/jcb.20956; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Fu WJ, 2010, J CANCER RES CLIN, V136, P1255, DOI 10.1007/s00432-010-0776-0; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Huen MS, 2008, CELL RES, V18, P8, DOI 10.1038/cr.2007.109; Jirawatnotai S, 2011, NATURE, V474, P230, DOI 10.1038/nature10155; Li JC, 2010, GASTROENTEROLOGY, V139, P2146, DOI 10.1053/j.gastro.2010.08.004; Lieber MR, 2010, SUBCELL BIOCHEM, V50, P279, DOI 10.1007/978-90-481-3471-7_14; Liu LL, 2012, TUMOR BIOL, V33, P53, DOI 10.1007/s13277-011-0245-7; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Lu H, 2011, J BIOL CHEM, V286, P20335, DOI 10.1074/jbc.M110.215632; Mehta TS, 2009, CELL RES, V19, P1098, DOI 10.1038/cr.2009.64; Moynahan ME, 2010, NAT REV MOL CELL BIO, V11, P196, DOI 10.1038/nrm2851; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Sajish M, 2012, NAT CHEM BIOL, V8, P547, DOI [10.1038/NCHEMBIO.937, 10.1038/nchembio.937]; Schnell O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030429; Urvalek AM, 2011, AM J TRANSL RES, V3, P121; Urvalek AM, 2010, CELL CYCLE, V9, P601, DOI 10.4161/cc.9.3.10606; Wan WF, 2012, MOL MED REP, V5, P347, DOI 10.3892/mmr.2011.669; Wang X, 2007, ONCOGENE, V26, P456, DOI 10.1038/sj.onc.1209796; Wang X, 2011, ONCOGENE, V30, P1901, DOI 10.1038/onc.2010.563; Wang XH, 2008, J BIOL CHEM, V283, P13934, DOI 10.1074/jbc.M709300200; Wang XH, 2007, CANCER RES, V67, P7184, DOI 10.1158/0008-5472.CAN-06-4729; Wang ZQ, 1997, GENE DEV, V11, P2347, DOI 10.1101/gad.11.18.2347; Wei HJ, 2006, J BIOL CHEM, V281, P16664, DOI 10.1074/jbc.M513135200; Yang SH, 2006, EMBO J, V25, P5083, DOI 10.1038/sj.emboj.7601383; Yang XJ, 2006, MOL CELL, V23, P779, DOI 10.1016/j.molcel.2006.08.009; Yoon JH, 2012, BIOCHEM PHARMACOL, V83, P747, DOI 10.1016/j.bcp.2011.12.029; Zerfaoui M, 2010, J IMMUNOL, V185, P1894, DOI 10.4049/jimmunol.1000646; Zhao J, 2007, CELL MOL LIFE SCI, V64, P3017, DOI 10.1007/s00018-007-7137-4; Zhao J, 2001, MOL BIOL CELL, V12, P4066, DOI 10.1091/mbc.12.12.4066; Zhao JH, 2003, MOL CELL, V11, P1503, DOI 10.1016/S1097-2765(03)00179-5; Zhao J, 2009, CANCER METAST REV, V28, P35, DOI 10.1007/s10555-008-9165-4	37	24	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43720	43729		10.1074/jbc.M112.418053	http://dx.doi.org/10.1074/jbc.M112.418053			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23105099	Green Published, hybrid			2022-12-25	WOS:000312940800051
J	Li, CM; Fan, Y; Lan, TH; Lambert, NA; Wu, GY				Li, Chunman; Fan, Yi; Lan, Tien-Hung; Lambert, Nevin A.; Wu, Guangyu			Rab26 Modulates the Cell Surface Transport of alpha(2)-Adrenergic Receptors from the Golgi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; GTP-BINDING PROTEIN; ANGIOTENSIN-II; ENDOPLASMIC-RETICULUM; CARDIAC MYOCYTES; INTRACELLULAR TRAFFICKING; ANTEROGRADE TRAFFICKING; MEMBRANE TRAFFICKING; RETINITIS-PIGMENTOSA; ADRENERGIC-RECEPTOR	The molecular mechanisms underlying the transport from the Golgi to the cell surface of G protein-coupled receptors remain poorly elucidated. Here we determined the role of Rab26, a Ras-like small GTPase involved in vesicle-mediated secretion, in the cell surface export of alpha(2)-adrenergic receptors. We found that transient expression of Rab26 mutants and siRNA-mediated depletion of Rab26 significantly attenuated the cell surface numbers of alpha(2A)-AR and alpha(2B)-AR, as well as ERK1/2 activation by alpha(2B)-AR. Furthermore, the receptors were extensively arrested in the Golgi by Rab26 mutants and siRNA. Moreover, Rab26 directly and activation-dependently interacted with alpha(2B)-AR, specifically the third intracellular loop. These data demonstrate that the small GTPase Rab26 regulates the Golgi to cell surface traffic of alpha(2)-adrenergic receptors, likely through a physical interaction. These data also provide the first evidence implicating an important function of Rab26 in coordinating plasma membrane protein transport.	[Li, Chunman; Fan, Yi; Lan, Tien-Hung; Lambert, Nevin A.; Wu, Guangyu] Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Wu, GY (corresponding author), Georgia Hlth Sci Univ, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA.	guwu@georgiahealth.edu	Fan, Yi/Q-9252-2018	Fan, Yi/0000-0003-1783-3220	National Institutes of Health [R01GM076167, R01GM096762, R01GM078319]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078319, R01GM076167, R01GM096762] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM076167 (to G. W.) and R01GM096762 and R01GM078319 (to N. A. L.).	Bustos MA, 2012, P NATL ACAD SCI USA, V109, pE2057, DOI 10.1073/pnas.1121173109; Charron AJ, 2000, TRAFFIC, V1, P675, DOI 10.1034/j.1600-0854.2000.010811.x; Cheng KW, 2004, NAT MED, V10, P1251, DOI 10.1038/nm1125; Conn PM, 2007, PHARMACOL REV, V59, P225, DOI 10.1124/pr.59.3.2; Daunt DA, 1997, MOL PHARMACOL, V51, P711, DOI 10.1124/mol.51.5.711; Deretic D, 2005, P NATL ACAD SCI USA, V102, P3301, DOI 10.1073/pnas.0500095102; Dong CM, 2007, CELL SIGNAL, V19, P2388, DOI 10.1016/j.cellsig.2007.07.017; Dong CM, 2007, BBA-BIOMEMBRANES, V1768, P853, DOI 10.1016/j.bbamem.2006.09.008; Dong CM, 2006, J BIOL CHEM, V281, P38543, DOI 10.1074/jbc.M605734200; Dong CM, 2012, TRAFFIC, V13, P857, DOI 10.1111/j.1600-0854.2012.01351.x; Dong CM, 2010, J BIOL CHEM, V285, P20369, DOI 10.1074/jbc.M109.081521; Dong CM, 2010, J PHARMACOL EXP THER, V333, P174, DOI 10.1124/jpet.109.161489; Duvernay MT, 2009, TRAFFIC, V10, P552, DOI 10.1111/j.1600-0854.2009.00890.x; Duvernay MT, 2009, MOL PHARMACOL, V75, P751, DOI 10.1124/mol.108.051623; Filipeanu CM, 2006, MOL PHARMACOL, V69, P1571, DOI 10.1124/mol.105.019984; Filipeanu CM, 2006, J BIOL CHEM, V281, P11097, DOI 10.1074/jbc.M511460200; Filipeanu CM, 2004, J BIOL CHEM, V279, P41077, DOI 10.1074/jbc.M405988200; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukuda M, 2003, J BIOL CHEM, V278, P15373, DOI 10.1074/jbc.M212341200; Gimelbrant AA, 2001, J BIOL CHEM, V276, P7285, DOI 10.1074/jbc.M005433200; Hamelin E, 2005, J BIOL CHEM, V280, P36195, DOI 10.1074/jbc.M503438200; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Kobilka BK, 2011, TRENDS PHARMACOL SCI, V32, P213, DOI 10.1016/j.tips.2011.02.005; Lan TH, 2012, TRAFFIC, V13, P1450, DOI 10.1111/j.1600-0854.2012.01401.x; Luo WB, 2007, J BIOL CHEM, V282, P30246, DOI 10.1074/jbc.M703205200; Madziva MT, 2006, J BIOL CHEM, V281, P12178, DOI 10.1074/jbc.M601357200; Masuda ES, 2000, FEBS LETT, V470, P61, DOI 10.1016/S0014-5793(00)01288-6; Mazelova J, 2009, EMBO J, V28, P183, DOI 10.1038/emboj.2008.267; Menasche G, 2000, NAT GENET, V25, P173, DOI 10.1038/76024; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Morello JP, 2001, ANNU REV PHYSIOL, V63, P607, DOI 10.1146/annurev.physiol.63.1.607; Nashida T, 2006, ARCH ORAL BIOL, V51, P89, DOI 10.1016/j.archoralbio.2005.06.005; Parent A, 2009, BIOCHEM J, V418, P163, DOI 10.1042/BJ20080867; Pereira-Leal JB, 2001, J MOL BIOL, V313, P889, DOI 10.1006/jmbi.2001.5072; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Qin K, 2011, NAT CHEM BIOL, V7, P740, DOI [10.1038/nchembio.642, 10.1038/NCHEMBIO.642]; Sanchez-Laorden BL, 2009, J CELL PHYSIOL, V220, P640, DOI 10.1002/jcp.21804; Seachrist JL, 2002, J BIOL CHEM, V277, P679, DOI 10.1074/jbc.M109022200; Stojanovic A, 2002, RECEPTOR CHANNEL, V8, P33, DOI 10.1080/10606820212137; Tan CM, 2004, ANNU REV PHARMACOL, V44, P559, DOI 10.1146/annurev.pharmtox.44.101802.121558; Themmen APN, 1996, EUR J ENDOCRINOL, V134, P533, DOI 10.1530/eje.0.1340533; Tian XL, 2010, MOL CELL BIOL, V30, P1269, DOI 10.1128/MCB.01328-09; Tsuboi T, 2006, J CELL SCI, V119, P2196, DOI 10.1242/jcs.02962; Venkatesan S, 2002, J BIOL CHEM, V277, P2287, DOI 10.1074/jbc.M108321200; WAGNER ACC, 1995, BIOCHEM BIOPH RES CO, V207, P950, DOI 10.1006/bbrc.1995.1277; Wang GS, 2012, TRENDS PHARMACOL SCI, V33, P28, DOI 10.1016/j.tips.2011.09.002; Wu GY, 1997, J BIOL CHEM, V272, P17836, DOI 10.1074/jbc.272.28.17836; Wu GY, 2003, J BIOL CHEM, V278, P47062, DOI 10.1074/jbc.M305707200; Wu GY, 2001, CIRC RES, V89, P1130, DOI 10.1161/hh2401.100427; Wu GY, 1998, J BIOL CHEM, V273, P7197, DOI 10.1074/jbc.273.13.7197; Xia ZQ, 2003, J BIOL CHEM, V278, P21901, DOI 10.1074/jbc.M301905200; Yoshie S, 2000, HISTOCHEM CELL BIOL, V113, P259, DOI 10.1007/s004180000130; Zhu L, 2006, J BIOL CHEM, V281, P22289, DOI 10.1074/jbc.M602664200; Zhuang XL, 2010, ENDOCRINOLOGY, V151, P5114, DOI 10.1210/en.2010-0422	54	34	39	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42784	42794		10.1074/jbc.M112.410936	http://dx.doi.org/10.1074/jbc.M112.410936			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105096	Green Published, hybrid			2022-12-25	WOS:000312501600037
J	Deliu, E; Brailoiu, GC; Mallilankaraman, K; Wang, H; Madesh, M; Undieh, AS; Koch, WJ; Brailoiu, E				Deliu, Elena; Brailoiu, G. Cristina; Mallilankaraman, Karthik; Wang, Hong; Madesh, Muniswamy; Undieh, Ashiwel S.; Koch, Walter J.; Brailoiu, Eugen			Intracellular Endothelin Type B Receptor-driven Ca2+ Signal Elicits Nitric Oxide Production in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; ANGIOTENSIN-II; VASCULAR ENDOTHELIN; RAT MYOMETRIUM; BLOOD-PRESSURE; CB1 RECEPTORS; IN-VITRO; DISEASE; ACTIVATION; NEURONS	Endothelin-1 exerts its actions via activation of ETA and ETB G(q/11) protein-coupled receptors, located in the plasmalemma, cytoplasm, and nucleus. Although the autocrine/paracrine nature of endothelin-1 signaling has been extensively studied, its intracrine role has been largely attributed to interaction with receptors located on nuclear membranes and the nucleoplasm. Because ETB receptors have been shown to be targeted to endolysosomes, we used intracellular microinjection and concurrent imaging methods to test their involvement in Ca2+ signaling and subsequential NO production. We provide evidence that microinjected endothelin-1 produces a dose-dependent elevation in cytosolic calcium concentration in ETB-transfected cells and endothelial cells; this response is sensitive to ETB but not ETA receptor blockade. In endothelial cells, the endothelin-1-induced Ca2+ response is abolished upon endolysosomal but not Golgi disruption. Moreover, the effect is prevented by inhibition of microautophagy and is sensitive to inhibitors of the phospholipase C and inositol 1,4,5-trisphosphate receptor. Furthermore, intracellular endothelin-1 increases nitric oxide via an ETB-dependent mechanism. Our results indicate for the first time that intracellular endothelin-1 activates endolysosomal ETB receptors and increase cytosolic Ca2+ and nitric oxide production. Endothelin-1 acts in an intracrine fashion on endolysosomal ETB to induce nitric oxide formation, thus modulating endothelial function.	[Mallilankaraman, Karthik; Madesh, Muniswamy; Koch, Walter J.; Brailoiu, Eugen] Temple Univ, Ctr Translat Med, Sch Med, Philadelphia, PA 19140 USA; [Deliu, Elena; Wang, Hong; Koch, Walter J.; Brailoiu, Eugen] Temple Univ, Dept Pharmacol, Sch Med, Philadelphia, PA 19140 USA; [Brailoiu, G. Cristina; Undieh, Ashiwel S.] Thomas Jefferson Univ, Jefferson Sch Pharm, Dept Pharmaceut Sci, Philadelphia, PA 19107 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Jefferson University	Brailoiu, E (corresponding author), Temple Univ, Ctr Translat Med, Sch Med, 3500 N Broad St,Rm 951, Philadelphia, PA 19140 USA.	ebrailou@temple.edu	Deliu, Elena/O-7379-2019; Undieh, Ashiwel/ABG-4004-2020	Undieh, Ashiwel/0000-0003-1823-5230; MALLILANKARAMAN, KARTHIK/0000-0002-9492-9050	National Institutes of Health [RO1HL90804]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117654, R01HL090804, R01HL110764, R01HL077288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1HL90804 (to E. B.).	Abe Y, 2000, J BIOL CHEM, V275, P8664, DOI 10.1074/jbc.275.12.8664; Avedanian L, 2010, CAN J PHYSIOL PHARM, V88, P817, DOI 10.1139/Y10-057; Bagnall AJ, 2006, HYPERTENSION, V48, P286, DOI 10.1161/01.HYP.0000229907.58470.4c; Barton M, 2008, CAN J PHYSIOL PHARM, V86, P485, DOI 10.1139/Y08-059; Benard G, 2012, NAT NEUROSCI, V15, P558, DOI 10.1038/nn.3053; BERG TO, 1994, BIOCHEM J, V300, P229, DOI 10.1042/bj3000229; BETINA V, 1992, FOLIA MICROBIOL, V37, P3, DOI 10.1007/BF02814572; Bkaily G, 2011, AM J PHYSIOL-REG I, V300, pR251, DOI 10.1152/ajpregu.00736.2009; Black SM, 2006, VASC PHARMACOL, V45, P308, DOI 10.1016/j.vph.2006.08.005; Bourque SL, 2011, AM J PHYSIOL-REG I, V300, pR1288, DOI 10.1152/ajpregu.00397.2010; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; Boya P, 2012, ANTIOXID REDOX SIGN, V17, P766, DOI 10.1089/ars.2011.4405; Brailoiu GC, 2012, J NEUROCHEM, V122, P1129, DOI 10.1111/j.1471-4159.2012.07869.x; Brailoiu GC, 2011, J BIOL CHEM, V286, P29166, DOI 10.1074/jbc.M110.217463; Brailoiu GC, 2010, J BIOL CHEM, V285, P37133, DOI 10.1074/jbc.C110.169763; Brailoiu GC, 2009, BIOCHEM J, V419, P91, DOI 10.1042/BJ20081138; Bremnes T, 2000, J BIOL CHEM, V275, P17596, DOI 10.1074/jbc.M000142200; Calebiro D, 2010, J MOL ENDOCRINOL, V45, P1, DOI 10.1677/JME-10-0014; Cook JL, 2012, AM J PHYSIOL-REG I, V302, pR482, DOI 10.1152/ajpregu.00493.2011; Deliu E, 2012, J PAIN, V13, P742, DOI 10.1016/j.jpain.2012.05.011; Deliu E, 2011, AM J PHYSIOL-CELL PH, V301, pC559, DOI 10.1152/ajpcell.00123.2011; den Boon FS, 2012, P NATL ACAD SCI USA, V109, P3534, DOI 10.1073/pnas.1118167109; EGUCHI S, 1995, J CARDIOVASC PHARM, V26, pS279; Filipeanu CM, 2001, EUR J PHARMACOL, V420, P9, DOI 10.1016/S0014-2999(01)01004-4; Foster N, 2003, BBA-MOL CELL RES, V1642, P45, DOI 10.1016/S0167-4889(03)00097-1; Gerasimenko JV, 2009, P NATL ACAD SCI USA, V106, P10758, DOI 10.1073/pnas.0904818106; GRIFFITH OW, 1995, ANNU REV PHYSIOL, V57, P707, DOI 10.1146/annurev.ph.57.030195.003423; Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guse AH, 1997, CELL CALCIUM, V22, P91, DOI 10.1016/S0143-4160(97)90109-3; Haller H, 1996, CIRC RES, V79, P765, DOI 10.1161/01.RES.79.4.765; Jafri F, 2003, ARTERIOSCL THROM VAS, V23, P2192, DOI 10.1161/01.ATV.0000099787.21778.55; Kunz JB, 2004, J BIOL CHEM, V279, P9987, DOI 10.1074/jbc.M307905200; Li WW, 2012, CELL MOL LIFE SCI, V69, P1125, DOI 10.1007/s00018-011-0865-5; Li XC, 2011, AM J PHYSIOL-RENAL, V300, pF1076, DOI 10.1152/ajprenal.00329.2010; Loesch A, 2005, J MOL HISTOL, V36, P25, DOI 10.1007/s10735-004-2912-0; Loesch Andrzej, 2005, Current Vascular Pharmacology, V3, P381, DOI 10.2174/157016105774329381; MATSUZAWA Y, 1980, J BIOL CHEM, V255, P646; Mazzuca MQ, 2012, BIOCHEM PHARMACOL, V84, P147, DOI 10.1016/j.bcp.2012.03.020; Muller G, 2009, ANTIOXID REDOX SIGN, V11, P1711, DOI 10.1089/ARS.2008.2403; NATHAN C, 1994, CELL, V78, P915, DOI 10.1016/0092-8674(94)90266-6; Naylor E, 2009, NAT CHEM BIOL, V5, P220, DOI 10.1038/nchembio.150; OBRIEN RF, 1987, J CELL PHYSIOL, V132, P263, DOI 10.1002/jcp.1041320210; Oksche A, 2000, MOL PHARMACOL, V57, P1104; Patel S, 2010, CELL CALCIUM, V47, P480, DOI 10.1016/j.ceca.2010.05.001; Re RN, 2007, NAT CLIN PRACT CARD, V4, P549, DOI 10.1038/ncpcardio0985; Re RN, 2011, J AM SOC HYPERTENS, V5, P435, DOI 10.1016/j.jash.2011.07.001; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; RUBIN DB, 1989, J APPL PHYSIOL, V67, P1585, DOI 10.1152/jappl.1989.67.4.1585; Russell FD, 1999, CIRC RES, V84, P891; Schiffrin EL, 2005, VASC PHARMACOL, V43, P19, DOI 10.1016/j.vph.2005.03.004; Schneider MP, 2007, ANNU REV PHARMACOL, V47, P731, DOI 10.1146/annurev.pharmtox.47.120505.105134; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Tadevosyan A, 2012, J PHYSIOL-LONDON, V590, P1313, DOI 10.1113/jphysiol.2011.222794; TAKAYANAGI R, 1991, FEBS LETT, V282, P103, DOI 10.1016/0014-5793(91)80454-B; Tang LP, 2007, AM J PHYSIOL-LUNG C, V292, pL1467, DOI 10.1152/ajplung.00446.2006; Tawfeek HAW, 2004, AM J PHYSIOL-ENDOC M, V286, pE704, DOI 10.1152/ajpendo.00404.2003; Tica AA, 2011, AM J PHYSIOL-CELL PH, V301, pC1262, DOI 10.1152/ajpcell.00501.2010; Xiao ZH, 2011, J BIOL CHEM, V286, P20100, DOI 10.1074/jbc.M111.220236; YANAGISAWA M, 1988, NATURE, V332, P411, DOI 10.1038/332411a0; Zhuo JL, 2006, AM J PHYSIOL-RENAL, V290, pF1382, DOI 10.1152/ajprenal.00269.2005	61	16	16	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41023	41031		10.1074/jbc.M112.418533	http://dx.doi.org/10.1074/jbc.M112.418533			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23086942	Green Published, hybrid			2022-12-25	WOS:000311887600020
J	Liu, HY; Le Trinh, T; Dong, HJ; Keith, R; Nelson, D; Liu, C				Liu, Hongyan; Le Trinh, Thu; Dong, Huijia; Keith, Robertson; Nelson, David; Liu, Chen			Iron Regulator Hepcidin Exhibits Antiviral Activity against Hepatitis C Virus	PLOS ONE			English	Article							INTERFERING RNAS; MEDICAL PROGRESS; IN-VIVO; EXPRESSION; CELLS; STAT3; LIVER; REPLICATION; ACTIVATION; INFECTION	Hepatitis C viral infection affects 170 million people worldwide. It causes serious chronic liver diseases. HCV infection has been implicated in iron accumulation in the liver and iron overload has been shown to be a potential cofactor for HCV associated hepatocellular carcinoma progression. The underlying mechanisms are not understood. Human hepcidin, a 25 amino acid peptide mainly produced by hepatocytes, is a key regulator of iron metabolism. Alteration of hepcidin expression levels has been reported in the setting of chronic HCV infection and hepatocellular carcinoma. In this study, we aim to examine the interactions between HCV infection and hepcidin expression in liver cells. We found that hepcidin expression was suppressed in HCV infected cells. The suppressive effect appears to be regulated by histone acetylation but not DNA methylation. Moreover, we found that hepcidin had a direct antiviral activity against HCV replication in cell culture. The antiviral effect is associated with STAT3 activation. In conclusion, hepcidin can induce intracellular antiviral state while HCV has a strategy to suppress hepcidin expression. This may be a novel mechanism by which HCV circumvents hepatic innate antiviral defense.	[Liu, Hongyan; Le Trinh, Thu; Dong, Huijia; Liu, Chen] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA; [Keith, Robertson] Med Coll Georgia, Dept Biochem & Mol Biol, Georgia Canc Ctr, Augusta, GA 30912 USA; [Nelson, David] Univ Florida, Dept Med, Gainesville, FL USA	State University System of Florida; University of Florida; University System of Georgia; Augusta University; State University System of Florida; University of Florida	Liu, C (corresponding author), Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA.	liu@pathology.ufl.edu		Robertson, Keith/0000-0002-7508-3328	University of Florida Open-Access Publishing Fund; Dr. Chen Liu's NIH [NIH RR023976, NIH CA133086]; NATIONAL CANCER INSTITUTE [R01CA133086] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K26RR023976] Funding Source: NIH RePORTER	University of Florida Open-Access Publishing Fund; Dr. Chen Liu's NIH; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Publication of this article was funded in part by the University of Florida Open-Access Publishing Fund. This work was supported by Dr. Chen Liu's NIH grants NIH RR023976 and NIH CA133086. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Elmonem Elhamy, 2009, J Egypt Natl Canc Inst, V21, P333; Alla V, 2005, SEMIN LIVER DIS, V25, P461, DOI 10.1055/s-2005-923317; Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777; Bartolomei G, 2011, J GEN VIROL, V92, P2072, DOI 10.1099/vir.0.032706-0; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Charlton M, 2001, AM J TRANSPLANT, V1, P197, DOI 10.1034/j.1600-6143.2001.001003197.x; Choi SO, 2007, BIOCHEM BIOPH RES CO, V356, P312, DOI 10.1016/j.bbrc.2007.02.137; Falzacappa MVV, 2007, BLOOD, V109, P353, DOI 10.1182/blood-2006-07-033969; Fensterl V., 2001, J INTERFERON CYTOKIN, V31, P71; Fujita N, 2008, J HEPATOL, V49, P702, DOI 10.1016/j.jhep.2008.05.014; Fujita N, 2007, MOL MED, V13, P97, DOI 10.2119/2006-00057.Fujita; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Gardi C, 2002, BIOCHEM PHARMACOL, V64, P1139, DOI 10.1016/S0006-2952(02)01257-1; Guo JT, 2001, J VIROL, V75, P8516, DOI 10.1128/JVI.75.18.8516-8523.2001; Harrison-Findik DD, 2006, J BIOL CHEM, V281, P22974, DOI 10.1074/jbc.M602098200; Hornung V, 2005, NAT MED, V11, P263, DOI 10.1038/nm1191; Judge AD, 2005, NAT BIOTECHNOL, V23, P457, DOI 10.1038/nbt1081; Kariko K, 2004, J IMMUNOL, V172, P6545, DOI 10.4049/jimmunol.172.11.6545; Kijima H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-167; Kim DH, 2004, NAT BIOTECHNOL, V22, P321, DOI 10.1038/nbt940; Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lauth X, 2005, J BIOL CHEM, V280, P9272, DOI 10.1074/jbc.M411154200; Le NTV, 2002, BBA-REV CANCER, V1603, P31, DOI 10.1016/S0304-419X(02)00068-9; Lukavsky PJ, 2009, VIRUS RES, V139, P166, DOI 10.1016/j.virusres.2008.06.004; Miura K, 2008, HEPATOLOGY, V48, P1420, DOI 10.1002/hep.22486; Nairz M, 2008, EUR J IMMUNOL, V38, P1923, DOI 10.1002/eji.200738056; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nishina S, 2008, GASTROENTEROLOGY, V134, P226, DOI 10.1053/j.gastro.2007.10.011; Okada S, 1996, PATHOL INT, V46, P311, DOI 10.1111/j.1440-1827.1996.tb03617.x; Park CH, 2001, J BIOL CHEM, V276, P7806, DOI 10.1074/jbc.M008922200; Pictrangelo A, 2004, NAT CLIN PRACT GASTR, V1, P39, DOI 10.1038/ncpgasthep0019; Pietrangelo A, 2004, NEW ENGL J MED, V350, P2383, DOI 10.1056/NEJMra031573; Pietrangelo A, 2007, AM J HEMATOL, V82, P1142, DOI 10.1002/ajh.21101; Pietrangelo A, 2007, GASTROENTEROLOGY, V132, P294, DOI 10.1053/j.gastro.2006.10.018; Schwarz P., J GASTROENTEROL; She HY, 2002, AM J PHYSIOL-GASTR L, V283, pG719, DOI 10.1152/ajpgi.00108.2002; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Sow FB, 2007, J LEUKOCYTE BIOL, V82, P934, DOI 10.1189/jlb.0407216; Sugimoto R, 2009, HEPATOL RES, V39, P619, DOI 10.1111/j.1872-034X.2009.00497.x; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; Tscherne DM, 2007, J VIROL, V81, P3693, DOI 10.1128/JVI.01748-06; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wallace DF, 2006, BIOCHIMIE, V88, P31, DOI 10.1016/j.biochi.2005.07.003; Wrighting DM, 2006, BLOOD, V108, P3204, DOI 10.1182/blood-2006-06-027631; Yang CH, 1998, P NATL ACAD SCI USA, V95, P5568, DOI 10.1073/pnas.95.10.5568; Zhu HZ, 2003, J VIROL, V77, P5493, DOI 10.1128/JVI.77.9.5493-5498.2003; Zhu HZ, 2004, BIOCHEM BIOPH RES CO, V324, P518, DOI 10.1016/j.bbrc.2004.09.081	49	35	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e46631	10.1371/journal.pone.0046631	http://dx.doi.org/10.1371/journal.pone.0046631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110054	gold, Green Published, Green Submitted			2022-12-25	WOS:000310193400005
J	Alguacil, MD; Torrecillas, E; Torres, P; Garcia-Orenes, F; Roldan, A				del Mar Alguacil, Maria; Torrecillas, Emma; Torres, Pilar; Garcia-Orenes, Fuensanta; Roldan, Antonio			Long-Term Effects of Irrigation with Waste Water on Soil AM Fungi Diversity and Microbial Activities: The Implications for Agro-Ecosystem Resilience	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; COMMUNITY; COLONIZATION; NITROGEN; ECOLOGY	The effects of irrigation with treated urban wastewater (WW) on the arbuscular mycorrhizal fungi (AMF) diversity and soil microbial activities were assayed on a long-term basis in a semiarid orange-tree orchard. After 43 years, the soil irrigated with fresh water (FW) had higher AMF diversity than soils irrigated with WW. Microbial activities were significantly higher in the soils irrigated with WW than in those irrigated with FW. Therefore, as no negative effects were observed on crop vitality and productivity, it seems that the ecosystem resilience gave rise to the selection of AMF species better able to thrive in soils with higher microbial activity and, thus, to higher soil fertility.	[del Mar Alguacil, Maria; Torrecillas, Emma; Roldan, Antonio] CSIC Ctr Edafol & Biol Aplicada Segura, Dept Soil & Water Conservat, Murcia, Spain; [Torres, Pilar] Univ Miguel Hernandez, Area Bot, Dept Biol Aplicada, Alicante, Spain; [Garcia-Orenes, Fuensanta] Univ Miguel Hernandez, Dept Agroquim & Medio Ambiente, Grp Edafol Ambiental, Alicante, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Edafologia y Biologia Aplicada del Segura (CEBAS); Universidad Miguel Hernandez de Elche; Universidad Miguel Hernandez de Elche	Alguacil, MD (corresponding author), CSIC Ctr Edafol & Biol Aplicada Segura, Dept Soil & Water Conservat, Campus Espinardo, Murcia, Spain.	mmalguacil@cebas.csic.es	Roldan, Antonio/F-6241-2013; del Mar Alguacil, Maria/M-3859-2014	del Mar Alguacil, Maria/0000-0001-8495-8707; Garcia-Orenes, Fuensanta/0000-0003-3463-3140; Roldan, Antonio/0000-0002-2610-7784	Ramon and Cajal programme (Ministerio de Educacion y Ciencia, Spain)	Ramon and Cajal programme (Ministerio de Educacion y Ciencia, Spain)(German Research Foundation (DFG))	MM Alguacil was supported by the Ramon and Cajal programme (Ministerio de Educacion y Ciencia, Spain).	Adrover M, 2012, J ENVIRON MANAGE, V95, pS188, DOI 10.1016/j.jenvman.2010.08.017; Chen WP, 2008, J ENVIRON QUAL, V37, pS36, DOI 10.2134/jeq2007.0315; Colwell RK., 2013, STAT ESTIMATION SPEC; Alguacil MD, 2010, SOIL BIOL BIOCHEM, V42, P1114, DOI 10.1016/j.soilbio.2010.03.012; Alguacil MD, 2009, APPL ENVIRON MICROB, V75, P4254, DOI 10.1128/AEM.00316-09; Friedel JK, 2000, BIOL FERT SOILS, V31, P414, DOI 10.1007/s003749900188; Gollotte A, 2004, MYCORRHIZA, V14, P111, DOI 10.1007/s00572-003-0244-7; Gosling P, 2006, AGR ECOSYST ENVIRON, V113, P17, DOI 10.1016/j.agee.2005.09.009; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hamilton AJ, 2007, VADOSE ZONE J, V6, P823, DOI 10.2136/vzj2007.0026; Helgason T, 2009, J EXP BOT, V60, P2465, DOI 10.1093/jxb/erp144; Jumpponen A, 2005, BIOL FERT SOILS, V41, P217, DOI 10.1007/s00374-005-0845-8; Mangkoedihardjo S., 2006, Journal of Applied Sciences, V6, P1409; MURPHY J, 1962, ANAL CHIM ACTA, V26, P31; Oehl F, 2010, SOIL BIOL BIOCHEM, V42, P724, DOI 10.1016/j.soilbio.2010.01.006; Ortega-Larrocea MP, 2007, APPL SOIL ECOL, V37, P129, DOI 10.1016/j.apsoil.2007.06.002; Pawlowska TE, 2004, APPL ENVIRON MICROB, V70, P6643, DOI 10.1128/AEM.70.11.6643-6649.2004; Qadir M, 2007, AGR WATER MANAGE, V87, P2, DOI 10.1016/j.agwat.2006.03.018; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Soil Survey Staff, 2010, KEYS SOIL TAX; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stenberg B, 1999, ACTA AGR SCANDINAV B; Tabatabai M.A., 1982, AGRONOMY, P501; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; ter Braak C.F.J., 2004, CANOCO REFERENCE MAN; Toljander JF, 2008, FEMS MICROBIOL ECOL, V65, P323, DOI 10.1111/j.1574-6941.2008.00512.x; Treseder KK, 2002, NEW PHYTOL, V155, P507, DOI 10.1046/j.1469-8137.2002.00470.x; Trouvelot S, 1999, MYCORRHIZA, V8, P203, DOI 10.1007/s005720050235; van der Heijden MGA, 2007, NEW PHYTOL, V174, P244, DOI 10.1111/j.1469-8137.2007.02041.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Van Tuinen D, 1998, MOL ECOL, V7, P879, DOI 10.1046/j.1365-294x.1998.00410.x; YEOMANS JC, 1988, COMMUN SOIL SCI PLAN, V19, P1467, DOI 10.1080/00103628809368027	32	22	22	3	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47680	10.1371/journal.pone.0047680	http://dx.doi.org/10.1371/journal.pone.0047680			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094075	Green Submitted, Green Published, gold			2022-12-25	WOS:000312384500018
J	Hodgson, JA; Thomas, CD; Dytham, C; Travis, JMJ; Cornell, SJ				Hodgson, Jenny A.; Thomas, Chris D.; Dytham, Calvin; Travis, Justin M. J.; Cornell, Stephen J.			The Speed of Range Shifts in Fragmented Landscapes	PLOS ONE			English	Article							CLIMATE-CHANGE; HABITAT FRAGMENTATION; METAPOPULATION MODELS; CONNECTIVITY; CONSERVATION; DISPERSAL; PERSISTENCE; ADAPTATION; STRATEGIES; MANAGEMENT	Species may be driven extinct by climate change, unless their populations are able to shift fast enough to track regions of suitable climate. Shifting will be faster as the proportion of suitable habitat in the landscape increases. However, it is not known how the spatial arrangement of habitat will affect the speed of range advance, especially when habitat is scarce, as is the case for many specialist species. We develop methods for calculating the speed of advance that are appropriate for highly fragmented, stochastic systems. We reveal that spatial aggregation of habitat tends to reduce the speed of advance throughout a wide range of species parameters: different dispersal distances and dispersal kernel shapes, and high and low extinction probabilities. In contrast, aggregation increases the steady-state proportion of habitat that is occupied (without climate change). Nonetheless, we find that it is possible to achieve both rapid advance and relatively high patch occupancy when the habitat has a "channeled" pattern, resembling corridors or chains of stepping stones. We adapt techniques from electrical circuit theory to predict the rate of advance efficiently for complex, realistic landscape patterns, whereas the rate cannot be predicted by any simple statistic of aggregation or fragmentation. Conservationists are already advocating corridors and stepping stones as important conservation tools under climate change, but they are vaguely defined and have so far lacked a convincing basis in fundamental population biology. Our work shows how to discriminate properties of a landscape's spatial pattern that affect the speed of colonization (including, but not limited to, patterns like corridors and chains of stepping stones), and properties that affect a species' probability of persistence once established. We can therefore point the way to better land use planning approaches, which will provide functional habitat linkages and also maintain local population viability.	[Hodgson, Jenny A.; Thomas, Chris D.; Dytham, Calvin] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Travis, Justin M. J.] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Cornell, Stephen J.] Univ Leeds, Sch Biol, Leeds, W Yorkshire, England	University of York - UK; University of Aberdeen; University of Leeds	Hodgson, JA (corresponding author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	jenny.hodgson@york.ac.uk	Travis, Justin/B-8571-2014; Cornell, Stephen J/D-3955-2009; Thomas, Chris D/A-1460-2014; Thomas, Chris D/A-1894-2012	Travis, Justin/0000-0002-5785-4272; Thomas, Chris D/0000-0003-2822-1334; Thomas, Chris D/0000-0003-2822-1334; Hodgson, Jenny/0000-0003-2297-3631; Dytham, Calvin/0000-0002-4111-9484	Natural Environment Research Council [NE/G006377/1]; NERC [NE/G006377/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	JAH and CDT were funded by Natural Environment Research Council grant NE/G006377/1; www.nerc.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo MB, 2004, GLOBAL CHANGE BIOL, V10, P1618, DOI 10.1111/j.1365-2486.2004.00828.x; Ball F, 2010, MATH BIOSCI, V224, P53, DOI 10.1016/j.mbs.2009.12.003; Burton OJ, 2010, ECOL LETT, V13, P1210, DOI 10.1111/j.1461-0248.2010.01505.x; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Chipperfield JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017040; Collingham YC, 2000, ECOL APPL, V10, P131, DOI 10.1890/1051-0761(2000)010[0131:IOHFAP]2.0.CO;2; Csardi N., 2006, INT J COMP SYST, V1695, P1; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; Dewhirst S, 2009, ECOLOGY, V90, P1338, DOI 10.1890/08-0115.1; Dytham C, 1995, OIKOS, V74, P340, DOI 10.2307/3545665; Early R, 2011, ECOL LETT, V14, P1125, DOI 10.1111/j.1461-0248.2011.01681.x; Frank K, 1998, LANDSCAPE ECOL, V13, P363, DOI 10.1023/A:1008054906030; Hannah L, 2007, FRONT ECOL ENVIRON, V5, P131, DOI 10.1890/1540-9295(2007)5[131:PANIAC]2.0.CO;2; Hanski I, 2000, NATURE, V404, P755, DOI 10.1038/35008063; Hanski I, 1999, OIKOS, V87, P209, DOI 10.2307/3546736; Hanski K, 2003, THEOR POPUL BIOL, V64, P119, DOI 10.1016/S0040-5809(03)00022-4; Hastings A, 2005, ECOL LETT, V8, P91, DOI 10.1111/j.1461-0248.2004.00687.x; Heinz SK, 2005, LANDSCAPE ECOL, V20, P83, DOI 10.1007/s10980-004-0678-0; Hess G, 1996, ECOLOGY, V77, P1617, DOI 10.2307/2265556; Hodgson JA, 2011, CONSERV LETT, V4, P289, DOI 10.1111/j.1755-263X.2011.00177.x; Hodgson JA, 2011, J APPL ECOL, V48, P148, DOI 10.1111/j.1365-2664.2010.01919.x; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Keith DA, 2008, BIOL LETTERS, V4, P560, DOI 10.1098/rsbl.2008.0049; Kinezaki N, 2003, THEOR POPUL BIOL, V64, P291, DOI 10.1016/S0040-5809(03)00091-1; Kinezaki N, 2010, THEOR POPUL BIOL, V78, P298, DOI 10.1016/j.tpb.2010.09.002; Lawler JJ, 2009, ANN NY ACAD SCI, V1162, P79, DOI 10.1111/j.1749-6632.2009.04147.x; Malcolm JR, 2006, CONSERV BIOL, V20, P538, DOI 10.1111/j.1523-1739.2006.00364.x; McInerny G, 2007, ECOL INFORM, V2, P1, DOI 10.1016/j.ecoinf.2006.12.001; Mcrae BH, 2008, ECOLOGY, V89, P2712, DOI 10.1890/07-1861.1; Moilanen A., 2009, SPATIAL CONSERVATION; Mustin K, 2009, OIKOS, V118, P131, DOI 10.1111/j.1600-0706.2008.17025.x; Ovaskainen O, 2001, THEOR POPUL BIOL, V60, P281, DOI 10.1006/tpbi.2001.1548; Pearson RG, 2005, BIOL CONSERV, V123, P389, DOI 10.1016/j.biocon.2004.12.006; Phillips SJ, 2008, ECOL APPL, V18, P1200, DOI 10.1890/07-0507.1; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Schippers P, 2011, ECOGRAPHY, V34, P909, DOI 10.1111/j.1600-0587.2011.06712.x; Travis JMJ, 2010, DIVERS DISTRIB, V16, P877, DOI 10.1111/j.1472-4642.2010.00687.x; Urban DL, 2009, ECOL LETT, V12, P260, DOI 10.1111/j.1461-0248.2008.01271.x; Vos CC, 2010, LANDSCAPE ECOL, V25, P1465, DOI 10.1007/s10980-010-9535-5; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Warren MS, 2001, NATURE, V414, P65, DOI 10.1038/35102054; With KA, 2004, RISK ANAL, V24, P803, DOI 10.1111/j.0272-4332.2004.00480.x; With KA, 1997, OIKOS, V79, P219, DOI 10.2307/3546007	45	58	58	1	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47141	10.1371/journal.pone.0047141	http://dx.doi.org/10.1371/journal.pone.0047141			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082145	Green Submitted, Green Published, gold			2022-12-25	WOS:000311146900040
J	Ma, BW; Bokulich, NA; Castillo, PA; Kananurak, A; Underwood, MA; Mills, DA; Bevins, CL				Ma, Betty W.; Bokulich, Nicholas A.; Castillo, Patricia A.; Kananurak, Anchasa; Underwood, Mark A.; Mills, David A.; Bevins, Charles L.			Routine Habitat Change: A Source of Unrecognized Transient Alteration of Intestinal Microbiota in Laboratory Mice	PLOS ONE			English	Article							FRAGMENT-LENGTH-POLYMORPHISMS; RIBOSOMAL-RNA GENES; GUT MICROBIOTA; MOUSE; HOST; OBESITY; 16S; COMMUNITIES; DATABASE; MODEL	The mammalian intestine harbors a vast, complex and dynamic microbial population, which has profound effects on host nutrition, intestinal function and immune response, as well as influence on physiology outside of the alimentary tract. Imbalance in the composition of the dense colonizing bacterial population can increase susceptibility to various acute and chronic diseases. Valuable insights on the association of the microbiota with disease critically depend on investigation of mouse models. Like in humans, the microbial community in the mouse intestine is relatively stable and resilient, yet can be influenced by environmental factors. An often-overlooked variable in research is basic animal husbandry, which can potentially alter mouse physiology and experimental outcomes. This study examined the effects of common husbandry practices, including food and bedding alterations, as well as facility and cage changes, on the gut microbiota over a short time course of five days using three culture-independent techniques, quantitative PCR, terminal restriction fragment length polymorphism (TRFLP) and next generation sequencing (NGS). This study detected a substantial transient alteration in microbiota after the common practice of a short cross-campus facility transfer, but found no comparable alterations in microbiota within 5 days of switches in common laboratory food or bedding, or following an isolated cage change in mice acclimated to their housing facility. Our results highlight the importance of an acclimation period following even simple transfer of mice between campus facilities, and highlights that occult changes in microbiota should be considered when imposing husbandry variables on laboratory animals.	[Ma, Betty W.; Castillo, Patricia A.; Kananurak, Anchasa; Bevins, Charles L.] Univ Calif Davis, Sch Med, Dept Microbiol & Immunol, Davis, CA 95616 USA; [Ma, Betty W.] Univ Calif Davis, Residency Program Lab Anim Med, Sch Vet Med, Ctr Lab Anim Sci, Davis, CA 95616 USA; [Bokulich, Nicholas A.; Mills, David A.] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [Bokulich, Nicholas A.; Mills, David A.] Univ Calif Davis, Dept Viticulture & Enol, Davis, CA 95616 USA; [Underwood, Mark A.] Univ Calif Davis, Sch Med, Dept Pediat, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Bevins, CL (corresponding author), Univ Calif Davis, Sch Med, Dept Microbiol & Immunol, Davis, CA 95616 USA.	clbevins@ucdavis.edu	Mills, David/GXF-1821-2022; Bevins, Charles L/P-4438-2015; Mills, David Andrew/G-2282-2011	Bevins, Charles L/0000-0003-2725-2622; Mills, David Andrew/0000-0003-1913-9865	National Institutes of Health [HD059127, AI032738, AI099519, AI076246]; Thai Royal Government (The Development and Promotion of Science and Technology Talents Project, Thailand); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059127] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI032738, R21AI099519, R01AI032738, R01AI076246] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Thai Royal Government (The Development and Promotion of Science and Technology Talents Project, Thailand); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	These studies were supported in part by financial support by the National Institutes of Health (HD059127, AI032738, AI099519, and AI076246) and the Thai Royal Government (The Development and Promotion of Science and Technology Talents Project, Thailand). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdo Z, 2006, ENVIRON MICROBIOL, V8, P929, DOI 10.1111/j.1462-2920.2005.00959.x; Backhed F, 2011, ANN NUTR METAB, V58, P44, DOI 10.1159/000328042; Bleich A, 2012, COMP IMMUNOL MICROB, V35, P81, DOI 10.1016/j.cimid.2011.12.006; Bokulich NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035507; Bokulich NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036357; Bokulich NA, 2012, FOOD MICROBIOL, V31, P126, DOI 10.1016/j.fm.2012.02.007; Candela M, 2011, CRIT REV MICROBIOL, V37, P1, DOI 10.3109/1040841X.2010.501760; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chow J, 2011, CURR OPIN IMMUNOL, V23, P473, DOI 10.1016/j.coi.2011.07.010; Chow J, 2010, ADV IMMUNOL, V107, P243, DOI [10.1016/B978-0-12-381300-8.00008-3, 10.1016/S0065-2776(10)07001-X]; Cole JR, 2007, NUCLEIC ACIDS RES, V35, pD169, DOI 10.1093/nar/gkl889; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dumas ME, 2006, P NATL ACAD SCI USA, V103, P12511, DOI 10.1073/pnas.0601056103; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Gonzalez Antonio, 2011, Dialogues Clin Neurosci, V13, P55; Gordon JI, 2011, P NATL ACAD SCI USA, V108, P4513, DOI 10.1073/pnas.1101958108; Gurfein BT, 2012, MOL MED, V18, P606, DOI 10.2119/molmed.2012.00053; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Hill DA, 2012, NAT MED; Hooper LV, 2010, NAT REV IMMUNOL, V10, P159, DOI 10.1038/nri2710; Hooper LV, 2004, TRENDS MICROBIOL, V12, P129, DOI 10.1016/j.tim.2004.01.001; Hufeldt MR, 2010, COMPARATIVE MED, V60, P336; Hurst JL, 2004, BIOESSAYS, V26, P1288, DOI 10.1002/bies.20147; Jennings M, 1998, LAB ANIM-UK, V32, P233, DOI 10.1258/002367798780559301; Koren O, 2011, P NATL ACAD SCI USA, V108, P4592, DOI 10.1073/pnas.1011383107; LaTuga MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027858; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Malakoff D, 2000, SCIENCE, V288, P248, DOI 10.1126/science.288.5464.248; Mathis D, 2012, IMMUNOL REV, V245, P239, DOI 10.1111/j.1600-065X.2011.01084.x; Nell S, 2010, NAT REV MICROBIOL, V8, P564, DOI 10.1038/nrmicro2403; O'Hara AM, 2006, EMBO REP, V7, P688, DOI 10.1038/sj.embor.7400731; Packey CD, 2009, CURR OPIN INFECT DIS, V22, P292, DOI 10.1097/QCO.0b013e32832a8a5d; Palmer C, 2007, PLOS BIOL, V5, P1556, DOI 10.1371/journal.pbio.0050177; Plottel CS, 2011, CELL HOST MICROBE, V10, P324, DOI 10.1016/j.chom.2011.10.003; Rasmussen S, 2011, J AM ASSOC LAB ANIM, V50, P479; Reeb-Whitaker CK, 2001, LAB ANIM-UK, V35, P58, DOI 10.1258/0023677011911381; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Salzman NH, 2010, NAT IMMUNOL, V11, P76, DOI 10.1038/ni.1825; Samuel BS, 2006, P NATL ACAD SCI USA, V103, P10011, DOI 10.1073/pnas.0602187103; Schellinck HM, 2010, ADV STUD BEHAV, V41, P255, DOI 10.1016/S0065-3454(10)41007-4; Scupham AJ, 2006, APPL ENVIRON MICROB, V72, P793, DOI 10.1128/AEM.72.1.793-801.2006; Sekirov I, 2009, J PHYSIOL-LONDON, V587, P4159, DOI 10.1113/jphysiol.2009.172742; Shyu C, 2007, MICROB ECOL, V53, P562, DOI 10.1007/s00248-006-9106-0; SOAVE O, 1991, CORNELL VET, V81, P357; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; TULI JS, 1995, LAB ANIM, V29, P132, DOI 10.1258/002367795780740249; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wen L, 2008, NATURE, V455, P1109, DOI 10.1038/nature07336; Zaneveld J, 2008, CURR OPIN CHEM BIOL, V12, P109, DOI 10.1016/j.cbpa.2008.01.015	58	39	39	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47416	10.1371/journal.pone.0047416	http://dx.doi.org/10.1371/journal.pone.0047416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082164	gold, Green Published, Green Submitted			2022-12-25	WOS:000311146900060
J	Khaidakov, M; Mehta, JL				Khaidakov, Magomed; Mehta, Jawahar L.			Oxidized LDL Triggers Pro-Oncogenic Signaling in Human Breast Mammary Epithelial Cells Partly via Stimulation of MiR-21	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; ENDOTHELIAL-CELLS; CANCER CELLS; SCAVENGER RECEPTOR; POOR-PROGNOSIS; NADPH OXIDASE; EXPRESSION; 12-LIPOXYGENASE; GENE; OBESITY	Dyslipidemia and obesity are primary risk factors for the development of atherosclerosis and are also epidemiologically linked to increased susceptibility to a variety of cancers including breast cancer. One of the prominent features of dyslipidemia is enhanced production of oxidized LDL (ox-LDL), which has been shown to be implicated in key steps of atherogenesis including inflammatory signaling and proliferation of vascular cells. In this study we analyzed the effects of ox-LDL in human mammary epithelial cells (MCF10A). MCF10A cells avidly internalized dil-ox-LDL and exhibited increased proliferative response to ox-LDL within the range of 1-50 mu g/ml in a dose-dependent manner. Treatment of cells with 20 mu g/ml ox-LDL for 2 and 12 hours was associated with upregulation of LOX-1 and CD36 scavenger receptors while MSR1 and CXLC16 receptors did not change. Ox-LDL-treated cells displayed significant upregulation of NADPH oxidases (subunits P22(phox) and P47(phox)), lipoxygenases-12 and -15, and cytoplasmic, but not mitochondrial, SOD. Ox-LDL also triggered phosphorylation of I kappa B alpha coupled with nuclear translocation of NF-kappa B and stimulated p44/42 MAPK, PI3K and Akt while intracellular PTEN (PI3K/Akt pathway inhibitor and target of miR-21) declined. Quantitative PCR revealed increased expression of hsa-miR-21 in ox-LDL treated cells coupled with inhibition of miR-21 target genes. Further, transfection of MCF10A cells with miR-21 inhibitor prevented ox-LDL mediated stimulation of PI3K and Akt. We conclude that, similarly to vascular cells, mammary epithelial cells respond to ox-LDL by upregulation of proliferative and pro-inflammatory signaling. We also report for the first time that part of ox-LDL triggered reactions in MCF10A cells is mediated by oncogenic hsa-miR-21 through inhibition of its target gene PTEN and consequent activation of PI3K/Akt pathway.	[Khaidakov, Magomed; Mehta, Jawahar L.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA; [Khaidakov, Magomed; Mehta, Jawahar L.] Univ Arkansas Med Sci, Little Rock, AR 72205 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences	Khaidakov, M (corresponding author), Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA.	mkhaidakov@uams.edu; MehtaJL@uams.edu	Mehta, jl/AAB-8832-2019; Mehta, JL/AAG-7572-2020	Mehta, jl/0000-0003-0384-2097; 	Department of Veterans Affairs; Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development, Washington, DC	Department of Veterans Affairs(US Department of Veterans Affairs); Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development, Washington, DC(US Department of Veterans Affairs)	The work was funded by grant from the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported in part by funds from the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development, Washington, DC.	Bae YS, 2009, CIRC RES; Bonci Desiree, 2010, Recent Pat Cardiovasc Drug Discov, V5, P156, DOI 10.2174/157489010793351962; Brinkley TE, 2008, OBESITY, V16, P1454, DOI 10.1038/oby.2008.213; Calle EE, 2004, ONCOGENE, V23, P6365, DOI 10.1038/sj.onc.1207751; Chow SE, 2007, J APPL PHYSIOL, V102, P1520, DOI 10.1152/japplphysiol.00881.2006; Cleary MP, 2010, VET PATHOL, V47, P202, DOI 10.1177/0300985809357753; Connolly JM, 1998, CANCER LETT, V132, P107, DOI 10.1016/S0304-3835(98)00171-2; Dandapat A, 2007, ARTERIOSCL THROM VAS, V27, P2435, DOI 10.1161/ATVBAHA.107.152272; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dunn S, 2008, BIOCHEM J, V409, P349, DOI 10.1042/BJ20071196; Furstenberger G, 2006, INT J CANCER, V119, P2247, DOI 10.1002/ijc.22153; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Guo AM, 2011, CANCER CHEMOTH PHARM, V68, P1273, DOI 10.1007/s00280-011-1595-y; Heinloth A, 2000, J AM SOC NEPHROL, V11, P1819, DOI 10.1681/ASN.V11101819; Hirsch HA, 2010, CANCER CELL, V17, P348, DOI 10.1016/j.ccr.2010.01.022; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kelesidis I, 2006, BRIT J CANCER, V94, P1221, DOI 10.1038/sj.bjc.6603051; Khaidakov M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020277; Lee SI, 2011, CANCER METAST REV, V30, P481, DOI 10.1007/s10555-011-9321-0; Li M, 2010, CELL PHYSIOL BIOCHEM, V25, P649, DOI 10.1159/000315084; Lorincz AM, 2006, ENDOCR-RELAT CANCER, V13, P279, DOI 10.1677/erc.1.00729; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Mehta JL, 2004, CAN J CARDIOL, V20, p32B; Monks J, 2005, CELL DEATH DIFFER, V12, P107, DOI 10.1038/sj.cdd.4401517; Natarajan R, 1997, J CLIN ENDOCR METAB, V82, P1790, DOI 10.1210/jc.82.6.1790; Nixon JB, 2004, PROSTAG LEUKOTR ESS, V70, P7, DOI 10.1016/j.plefa.2003.06.001; Oh AS, 2001, MOL ENDOCRINOL, V15, P1344, DOI 10.1210/me.15.8.1344; Park SH, 2011, CLIN CHIM ACTA, V412, P435, DOI 10.1016/j.cca.2010.11.017; PARTHASARATHY S, 1989, P NATL ACAD SCI USA, V86, P1046, DOI 10.1073/pnas.86.3.1046; Piao YS, 2008, CARCINOGENESIS, V29, P440, DOI 10.1093/carcin/bgm274; RANKIN SM, 1991, J LIPID RES, V32, P449; Romieu I, 2009, SALUD PUBLICA MEXICO, V51, pS172, DOI 10.1590/S0036-36342009000800007; Salzman R, 2009, ANTICANCER RES, V29, P4227; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Shureiqi I, 1999, CARCINOGENESIS, V20, P1985, DOI 10.1093/carcin/20.10.1985; Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083; Singh SP, 2005, J PHARMACOL EXP THER, V313, P855, DOI 10.1124/jpet.104.080754; Takahashi Y, 2005, ANTIOXID REDOX SIGN, V7, P425, DOI 10.1089/ars.2005.7.425; Tang SH, 2002, J BIOL CHEM, V277, P16189, DOI 10.1074/jbc.M111936200; Tong WG, 2002, BIOCHEM BIOPH RES CO, V296, P942, DOI 10.1016/S0006-291X(02)02014-4; Vohra RS, 2006, TRENDS CARDIOVAS MED, V16, P60, DOI 10.1016/j.tcm.2005.12.001; Wadsack C, 2003, INT J BIOCHEM CELL B, V35, P441, DOI 10.1016/S1357-2725(02)00272-8; Wang WY, 2010, CARDIOVASC RES, V85, P845, DOI 10.1093/cvr/cvp367; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yin B, 2011, INT J ONCOL, V38, P1041, DOI 10.3892/ijo.2011.901; Yoshinaga M, 2004, PROSTAG OTH LIPID M, V73, P111, DOI 10.1016/j.prostaglandins.2004.01.001; Yu S, 2011, BIOCHEM BIOPH RES CO, V407, P44, DOI 10.1016/j.bbrc.2011.02.096	49	30	31	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e46973	10.1371/journal.pone.0046973	http://dx.doi.org/10.1371/journal.pone.0046973			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091604	Green Published, gold, Green Submitted			2022-12-25	WOS:000310135800019
J	Adnan, M; Malathi, SK				Adnan, Mohammad; Malathi, Siddiqui Krishnamurthy			RNase L Induces Autophagy via c-Jun N-terminal Kinase and Double-stranded RNA-dependent Protein Kinase Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; BCL-X-L; ENCEPHALOMYOCARDITIS VIRUS; BECLIN 1; JNK1-MEDIATED PHOSPHORYLATION; CRYSTAL-STRUCTURE; INTERFERON ACTION; CANCER-CELLS; APOPTOSIS; ACTIVATION	Autophagy is a tightly regulated mechanism that mediates sequestration, degradation, and recycling of cellular proteins, organelles, and pathogens. Several proteins associated with autophagy regulate host responses to viral infections. Ribonuclease L (RNase L) is activated during viral infections and cleaves cellular and viral single-stranded RNAs, including rRNAs in ribosomes. Here we demonstrate that direct activation of RNase L coordinates the activation of c-Jun N-terminal kinase (JNK) and double-stranded RNA-dependent protein kinase (PKR) to induce autophagy with hallmarks as accumulation of autophagic vacuoles, p62(SQSTM1) degradation and conversion of Microtubule-associated Protein Light Chain 3-I (LC3-I) to LC3-II. Accordingly, treatment of cells with pharmacological inhibitors of JNK or PKR and mouse embryonic fibroblasts (MEFs) lacking JNK1/2 or PKR showed reduced autophagy levels. Furthermore, RNase L-induced JNK activity promoted Bcl-2 phosphorylation, disrupted the Beclin1-Bcl-2 complex and stimulated autophagy. Viral infection with Encephalomyocarditis virus (EMCV) or Sendai virus led to higher levels of autophagy in wild-type (WT) MEFs compared with RNase L knock out (KO) MEFs. Inhibition of RNase L-induced autophagy using Bafilomycin A1 or 3-methyladenine suppressed viral growth in initial stages; in later stages autophagy promoted viral replication dampening the antiviral effect. Induction of autophagy by activated RNase L is independent of the paracrine effects of interferon (IFN). Our findings suggest a novel role of RNase L in inducing autophagy affecting the outcomes of viral pathogenesis.	[Adnan, Mohammad; Malathi, Siddiqui Krishnamurthy] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA	University System of Ohio; University of Toledo	Malathi, SK (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	Malathi.Krishnamurthy@utoledo.edu			National Institutes of Health [AI089518]; University of Toledo; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI089518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Toledo; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI089518 (to K. M.) and startup funds from the University of Toledo.	Baltanas FC, 2011, BRAIN PATHOL, V21, P374, DOI 10.1111/j.1750-3639.2010.00461.x; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Cebollero Eduardo, 2012, Int J Cell Biol, V2012, P182834, DOI 10.1155/2012/182834; Chakrabarti A, 2012, J VIROL, V86, P11311, DOI 10.1128/JVI.00270-12; Delgado MA, 2008, EMBO J, V27, P1110, DOI 10.1038/emboj.2008.31; Deretic V, 2012, CURR OPIN IMMUNOL, V24, P21, DOI 10.1016/j.coi.2011.10.006; Dreux M, 2010, CELL CYCLE, V9, P1295, DOI 10.4161/cc.9.7.11109; Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106; Espert L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005787; FLOYDSMITH G, 1981, SCIENCE, V212, P1030, DOI 10.1126/science.6165080; GUSELLA GL, 1995, J IMMUNOL, V154, P345; Hartmann R, 2003, MOL CELL, V12, P1173, DOI 10.1016/S1097-2765(03)00433-7; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; He CC, 2010, CURR OPIN CELL BIOL, V22, P140, DOI 10.1016/j.ceb.2010.01.001; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Iordanov MS, 2000, MOL CELL BIOL, V20, P617, DOI 10.1128/MCB.20.2.617-627.2000; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; KERR IM, 1981, ADV CYCL NUCL RES<D>, V14, P469; Komiya K, 2010, BIOCHEM BIOPH RES CO, V401, P561, DOI 10.1016/j.bbrc.2010.09.101; Kouroku Y, 2007, CELL DEATH DIFFER, V14, P230, DOI 10.1038/sj.cdd.4401984; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Ku B, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040025; Lee HK, 2008, CURR OPIN IMMUNOL, V20, P23, DOI 10.1016/j.coi.2008.01.001; Lei Y, 2012, IMMUNITY, V36, P933, DOI 10.1016/j.immuni.2012.03.025; Li GQ, 2004, J BIOL CHEM, V279, P1123, DOI 10.1074/jbc.M305893200; Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998; MacIntosh GC, 2011, AUTOPHAGY, V7, P662, DOI 10.4161/auto.7.6.15447; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Malathi K, 2005, P NATL ACAD SCI USA, V102, P14533, DOI 10.1073/pnas.0507551102; Malathi K, 2004, CANCER RES, V64, P9144, DOI 10.1158/0008-5472.CAN-04-2226; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; MCKENDRY R, 1991, P NATL ACAD SCI USA, V88, P11455, DOI 10.1073/pnas.88.24.11455; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Nakamura T, 2010, CELL, V140, P338, DOI 10.1016/j.cell.2010.01.001; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Pattingre S, 2009, AUTOPHAGY, V5, P558, DOI 10.4161/auto.5.4.8390; Pattingre S, 2009, J BIOL CHEM, V284, P2719, DOI 10.1074/jbc.M805920200; Rusch L, 2000, J INTERF CYTOK RES, V20, P1091, DOI 10.1089/107999000750053762; Saitoh T, 2010, J CELL BIOL, V189, P925, DOI 10.1083/jcb.201002021; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; Shi CS, 2008, J BIOL CHEM, V283, P33175, DOI 10.1074/jbc.M804478200; Shoji-Kawata S, 2009, BBA-MOL CELL RES, V1793, P1478, DOI 10.1016/j.bbamcr.2009.02.008; SILVERMAN RH, 1983, J VIROL, V46, P1051, DOI 10.1128/JVI.46.3.1051-1055.1983; SILVERMAN RH, 1982, EUR J BIOCHEM, V124, P131, DOI 10.1111/j.1432-1033.1982.tb05915.x; Silverman RH, 2007, J VIROL, V81, P12720, DOI 10.1128/JVI.01471-07; Silverman RH, 2007, CYTOKINE GROWTH F R, V18, P381, DOI 10.1016/j.cytogfr.2007.06.012; Sinha S, 2008, AUTOPHAGY, V4, P989, DOI 10.4161/auto.6803; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Talloczy Z, 2006, AUTOPHAGY, V2, P24, DOI 10.4161/auto.2176; Tanida I, 2008, AUTOPHAGY, V4, P131, DOI 10.4161/auto.5233; Thakur CS, 2007, P NATL ACAD SCI USA, V104, P9585, DOI 10.1073/pnas.0700590104; Wei YJ, 2008, AUTOPHAGY, V4, P949, DOI 10.4161/auto.6788; Wei YJ, 2008, MOL CELL, V30, P678, DOI 10.1016/j.molcel.2008.06.001; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Wong CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009996; WRESCHNER DH, 1981, NUCLEIC ACIDS RES, V9, P1571, DOI 10.1093/nar/9.7.1571; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246; Zhang YN, 2011, AUTOPHAGY, V7, P613, DOI 10.4161/auto.7.6.15267; ZHOU AM, 1993, CELL, V72, P753, DOI 10.1016/0092-8674(93)90403-D; Zhou AM, 1997, EMBO J, V16, P6355, DOI 10.1093/emboj/16.21.6355	65	45	45	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43651	43664		10.1074/jbc.M112.399964	http://dx.doi.org/10.1074/jbc.M112.399964			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23109342	Green Published, hybrid			2022-12-25	WOS:000312940800045
J	Kawahara, R; Saburi, W; Odaka, R; Taguchi, H; Ito, S; Mori, H; Matsui, H				Kawahara, Ryosuke; Saburi, Wataru; Odaka, Rei; Taguchi, Hidenori; Ito, Shigeaki; Mori, Haruhide; Matsui, Hirokazu			Metabolic Mechanism of Mannan in a Ruminal Bacterium, Ruminococcus albus, Involving Two Mannoside Phosphorylases and Cellobiose 2-Epimerase DISCOVERY OF A NEW CARBOHYDRATE PHOSPHORYLASE, beta-1,4-MANNOOLIGOSACCHARIDE PHOSPHORYLASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOTHERMUS-MARINUS JCM9785; CRYSTAL-STRUCTURE; GEOBACILLUS-STEAROTHERMOPHILUS; EVOLUTIONARY RELATIONSHIP; BETA-GLUCOSIDASE; SUBSTRATE; ENZYME; IDENTIFICATION; LEVANSUCRASE; REVEALS	Ruminococcus albus is a typical ruminal bacterium digesting cellulose and hemicellulose. Cellobiose 2-epimerase (CE; EC 5.1.3.11), which converts cellobiose to 4-O-beta-D-glucosyl-D-mannose, is a particularly unique enzyme in R. albus, but its physiological function is unclear. Recently, a new metabolic pathway of mannan involving CE was postulated for another CE-producing bacterium, Bacteroides fragilis. In this pathway, beta-1,4-mannobiose is epimerized to 4-O-beta-D-mannosyl-D-glucose (Man-Glc) by CE, and Man-Glc is phosphorolyzed to alpha-D-mannosyl 1-phosphate (Man1P) and D-glucose by Man-Glc phosphorylase (MP; EC 2.4.1.281). Ruminococcus albus NE1 showed intracellular MP activity, and two MP isozymes, RaMP1 and RaMP2, were obtained from the cell-free extract. These enzymes were highly specific for the mannosyl residue at the non-reducing end of the substrate and catalyzed the phosphorolysis and synthesis of Man-Glc through a sequential Bi Bi mechanism. In a synthetic reaction, RaMP1 showed high activity only toward D-glucose and 6-deoxy-D-glucose in the presence of Man1P, whereas RaMP2 showed acceptor specificity significantly different from RaMP1. RaMP2 acted on D-glucose derivatives at the C2- and C3-positions, including deoxy- and deoxyfluoro-analogues and epimers, but not on those substituted at the C6-position. Furthermore, RaMP2 had high synthetic activity toward the following oligosaccharides: beta-linked glucobioses, maltose, N, N'-diacetylchitobiose, and beta-1,4-mannooligosaccharides. Particularly, beta-1,4-mannooligosaccharides served as significantly better acceptor substrates for RaMP2 than D-glucose. In the phosphorolytic reactions, RaMP2 had weak activity toward beta-1,4-mannobiose but efficiently degraded beta-1,4-mannooligosaccharides longer than beta-1,4-mannobiose. Consequently, RaMP2 is thought to catalyze the phosphorolysis of beta-1,4-mannooligosaccharides longer than beta-1,4-mannobiose to produce Man1P and beta-1,4-mannobiose.	[Kawahara, Ryosuke; Saburi, Wataru; Odaka, Rei; Taguchi, Hidenori; Ito, Shigeaki; Mori, Haruhide; Matsui, Hirokazu] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan	Hokkaido University	Saburi, W (corresponding author), Hokkaido Univ, Res Fac Agr, N-9,W-9, Sapporo, Hokkaido 0608589, Japan.	saburiw@chem.agr.hokudai.ac.jp	Mori, Haruhide/AAV-6374-2021; Saburi, Wataru/A-4271-2012	Mori, Haruhide/0000-0001-7346-9131; Saburi, Wataru/0000-0002-2015-7086	Ministry of Education, Culture, Sports, Science, and Technology of Japan [24780091]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Kakenhi, Grants-in-aid for Young Scientists (B) 24780091, of the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Alberto F, 2004, J BIOL CHEM, V279, P18903, DOI 10.1074/jbc.M313911200; Alhassid A, 2009, BIOCHEM J, V422, P73, DOI 10.1042/BJ20090180; BOCK K, 1974, J CHEM SOC PERK T 2, P293, DOI 10.1039/p29740000293; Brux C, 2006, J MOL BIOL, V359, P97, DOI 10.1016/j.jmb.2006.03.005; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Cartmell A, 2011, J BIOL CHEM, V286, P15483, DOI 10.1074/jbc.M110.215962; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P104, DOI 10.1016/0926-6569(63)90211-6; Dixon M., 1979, ENZYMES, P109; Egloff MP, 2001, STRUCTURE, V9, P689, DOI 10.1016/S0969-2126(01)00626-8; Fujimoto Z, 2010, J BIOL CHEM, V285, P34134, DOI 10.1074/jbc.M110.164251; Hamura K, 2012, BIOSCI BIOTECH BIOCH, V76, P812, DOI 10.1271/bbb.110954; Hidaka M, 2006, BIOCHEM J, V398, P37, DOI 10.1042/BJ20060274; Ito S, 2008, APPL MICROBIOL BIOT, V79, P433, DOI 10.1007/s00253-008-1449-7; Ito S, 2007, BIOCHEM BIOPH RES CO, V360, P640, DOI 10.1016/j.bbrc.2007.06.091; KITAOKA M, 1992, BIOSCI BIOTECH BIOCH, V56, P652, DOI 10.1271/bbb.56.652; Kitaoka M, 2012, BIOSCI BIOTECH BIOCH, V76, P343, DOI 10.1271/bbb.110772; LEATHERW.JM, 1965, APPL MICROBIOL, V13, P771, DOI 10.1128/AEM.13.5.771-775.1965; LOWRY OH, 1946, J BIOL CHEM, V162, P421; Martinez-Fleites C, 2005, BIOCHEM J, V390, P19, DOI 10.1042/BJ20050324; Meng GY, 2003, NAT STRUCT BIOL, V10, P935, DOI 10.1038/nsb974; MIWA I, 1972, CLIN CHIM ACTA, V37, P538, DOI 10.1016/0009-8981(72)90483-4; MOORE S, 1948, J BIOL CHEM, V176, P367; Nagem RAP, 2004, J MOL BIOL, V344, P471, DOI 10.1016/j.jmb.2004.09.024; Nihira T, 2012, APPL MICROBIOL BIOT, V93, P1513, DOI 10.1007/s00253-011-3515-9; Nurizzo D, 2002, NAT STRUCT BIOL, V9, P665, DOI 10.1038/nsb835; OHMIYA K, 1985, J BACTERIOL, V161, P432, DOI 10.1128/JB.161.1.432-434.1985; Ojima T, 2011, BIOSCI BIOTECH BIOCH, V75, P2162, DOI 10.1271/bbb.110456; Rajashekhara E, 2002, BIOSCI BIOTECH BIOCH, V66, P2578, DOI 10.1271/bbb.66.2578; Sato H, 2012, BIOSCI BIOTECH BIOCH, V76, P1584, DOI 10.1271/bbb.120284; Senoura T, 2011, BIOCHEM BIOPH RES CO, V408, P701, DOI 10.1016/j.bbrc.2011.04.095; Senoura T, 2009, BIOSCI BIOTECH BIOCH, V73, P400, DOI 10.1271/bbb.80691; TYLER TR, 1967, ARCH BIOCHEM BIOPHYS, V119, P363, DOI 10.1016/0003-9861(67)90466-3; Wakuta S, 2010, PHYTOCHEMISTRY, V71, P1280, DOI 10.1016/j.phytochem.2010.04.025; Yamaguchi A, 2005, J BIOCHEM, V137, P587, DOI 10.1093/jb/mvi078	34	52	56	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42389	42399		10.1074/jbc.M112.390336	http://dx.doi.org/10.1074/jbc.M112.390336			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23093406	hybrid, Green Published, Green Submitted			2022-12-25	WOS:000312103000074
J	Makedonska, J; Wright, BW; Strait, DS				Makedonska, Jana; Wright, Barth W.; Strait, David S.			The Effect of Dietary Adaption on Cranial Morphological Integration in Capuchins (Order Primates, Genus Cebus)	PLOS ONE			English	Article							DEVELOPMENTAL INTEGRATION; MASTICATORY SYSTEM; BONE-GROWTH; ONTOGENETIC VARIATION; SIGMODON-FULVIVENTER; POSTNATAL-GROWTH; CORTICAL BONE; HUMAN SKULL; IN-VIVO; EVOLUTION	A fundamental challenge of morphology is to identify the underlying evolutionary and developmental mechanisms leading to correlated phenotypic characters. Patterns and magnitudes of morphological integration and their association with environmental variables are essential for understanding the evolution of complex phenotypes, yet the nature of the relevant selective pressures remains poorly understood. In this study, the adaptive significance of morphological integration was evaluated through the association between feeding mechanics, ingestive behavior and craniofacial variation. Five capuchin species were examined, Cebus apella sensu stricto, Cebus libidinosus, Cebus nigritus, Cebus olivaceus and Cebus albifrons. Twenty three-dimensional landmarks were chosen to sample facial regions experiencing high strains during feeding, characteristics affecting muscular mechanical advantage and basicranial regions. Integration structure and magnitude between and within the oral and zygomatic subunits, between and within blocks maximizing modularity and within the face, the basicranium and the cranium were examined using partial-least squares, eigenvalue variance, integration indices compared inter-specifically at a common level of sampled population variance and cluster analyses. Results are consistent with previous findings reporting a relative constancy of facial and cranial correlation patterns across mammals, while covariance magnitudes vary. Results further suggest that food material properties structure integration among functionally-linked facial elements and possibly integration between the face and the basicranium. Hard-object-feeding capuchins, especially C. apella s.s., whose faces experience particularly high biomechanical loads are characterized by higher facial and cranial integration especially compared to C. albifrons, likely because morphotypes compromising feeding performance are selected against in species relying on obdurate fallback foods. This is the first study to report a link between food material properties and facial and cranial integration. Furthermore, results do not identify the consistent presence of cranial modules yielding support to suggestions that despite the distinct embryological imprints of its elements the cranium of placental mammals is not characterized by a modular architecture.	[Makedonska, Jana; Strait, David S.] SUNY Albany, Dept Anthropol, Albany, NY 12222 USA; [Wright, Barth W.] Kansas City Univ Med & Biosci, Dept Anat, Kansas City, MO USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; Kansas City University of Medicine & Biosciences	Makedonska, J (corresponding author), SUNY Albany, Dept Anthropol, Albany, NY 12222 USA.	jmakedonska@gmail.com			National Science Foundation BCS [1028815]; Division Of Behavioral and Cognitive Sci [1028815] Funding Source: National Science Foundation	National Science Foundation BCS(National Science Foundation (NSF)); Division Of Behavioral and Cognitive Sci(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	This research was supported by National Science Foundation BCS 1028815 to JM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abzhanov A, 2004, SCIENCE, V305, P1462, DOI 10.1126/science.1098095; Ackermann RR, 2005, J HUM EVOL, V48, P175, DOI 10.1016/j.jhevol.2004.11.001; Alfaro JWL, 2012, AM J PRIMATOL, V74, P273, DOI 10.1002/ajp.22007; Alfaro JWL, 2012, J BIOGEOGR, V39, P272, DOI 10.1111/j.1365-2699.2011.02609.x; ANAPOL F, 1994, AM J PHYS ANTHROPOL, V94, P239, DOI 10.1002/ajpa.1330940208; Auffray Jean-Christophe, 1999, P309; Bastir M, 2005, AM J PHYS ANTHROPOL, V128, P26, DOI 10.1002/ajpa.20191; Bastir M, 2004, AM J PHYS ANTHROPOL, V123, P340, DOI 10.1002/ajpa.10313; Bastir M, 2008, ANAT REC, V291, P130, DOI 10.1002/ar.20636; Bastir M, 2005, DEV PRIMATOL-PROG PR, P265, DOI 10.1007/0-387-27614-9_12; Bastir M, 2006, J ANAT, V209, P637, DOI 10.1111/j.1469-7580.2006.00644.x; Bastir M, 2006, ARCH ORAL BIOL, V51, P814, DOI 10.1016/j.archoralbio.2006.03.009; Bastir M, 2009, EVOL BIOL, V36, P57, DOI 10.1007/s11692-008-9037-4; Bearder S.K., 1980, International Journal of Primatology, V1, P103, DOI 10.1007/BF02735592; BEECHER RM, 1983, J CRAN GENET DEV BIO, V3, P193; BEECHER RM, 1981, ANGLE ORTHOD, V51, P61; Bentolila V, 1998, BONE, V23, P275, DOI 10.1016/S8756-3282(98)00104-5; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Bookstein FL, 1996, NATO ADV SCI INST SE, V284, P131; Bookstein FL, 2003, J HUM EVOL, V44, P167, DOI 10.1016/S0047-2484(02)00201-4; BOUVIER M, 1981, J MORPHOL, V167, P1, DOI 10.1002/jmor.1051670102; Bouvier M, 1996, ARCH ORAL BIOL, V41, P941, DOI 10.1016/S0003-9969(96)00047-7; Brandt Hartwin, 2007, CONSTANTINO; Brocardo Carlos Rodrigo, 2010, Neotropical Primates, V17, P70; BROWN AD, 1990, FOLIA PRIMATOL, V54, P187, DOI 10.1159/000156443; BURR DB, 1993, J BIOMECH, V26, P613, DOI 10.1016/0021-9290(93)90023-8; BURR DB, 1985, J BIOMECH, V18, P189, DOI 10.1016/0021-9290(85)90204-0; Byron CD, 2009, J HUM EVOL, V57, P649, DOI 10.1016/j.jhevol.2008.11.006; Campbell Christina J., 2011, PRIMATES PERSPECTIVE; Cheverud J.M., 1989, Progress in Zoology, V35, P196; Cheverud J.M., 1988, P94; Cheverud JM, 2004, J EXP ZOOL PART B, V302B, P424, DOI 10.1002/jez.b.21008; CHEVERUD JM, 1982, EVOLUTION, V36, P499, DOI 10.1111/j.1558-5646.1982.tb05070.x; CHEVERUD JM, 1995, AM NAT, V145, P63, DOI 10.1086/285728; Cheverud JM, 1996, AM ZOOL, V36, P44; CHEVERUD JM, 1992, AM J PHYS ANTHROPOL, V88, P323, DOI 10.1002/ajpa.1330880307; CHEVERUD JM, 1992, AM J PHYS ANTHROPOL, V87, P167, DOI 10.1002/ajpa.1330870205; CHEVERUD JM, 1984, J THEOR BIOL, V110, P155, DOI 10.1016/S0022-5193(84)80050-8; COLE TM, 1992, J HUM EVOL, V23, P253, DOI 10.1016/S0047-2484(05)80003-X; CORRUCCINI RS, 1984, J CRAN GENET DEV BIO, V4, P135; DAEGLING DJ, 1992, INT J PRIMATOL, V13, P545, DOI 10.1007/BF02547832; Daegling DJ, 2004, AM J PHYS ANTHROPOL, V124, P346, DOI 10.1002/ajpa.10356; DERUITER JR, 1986, BEHAVIOUR, V98, P240, DOI 10.1163/156853986X00982; DICKINSON C, 1990, AM J PHYS ANTHROPOL, V81, P215; Dryden I., 1998, STAT ANAL SHAPE; Dumont ER, 2003, J EXP BIOL, V206, P2117, DOI 10.1242/jeb.00375; ENLOW DH, 1969, AMER J ORTHODONTICS, V56, P6, DOI 10.1016/0002-9416(69)90254-1; Enlow DH, 1996, ESSENTIALS FACIAL GR; ESCOUFIER Y, 1973, BIOMETRICS, V29, P751, DOI 10.2307/2529140; FELSENSTEIN J, 1988, ANNU REV ECOL SYST, V19, P445, DOI 10.1146/annurev.es.19.110188.002305; Ford SM, 1996, ADAPTIVE RADIATIONS OF NEOTROPICAL PRIMATES, P229; Fragaszy D. M., 2004, COMPLETE CAPUCHIN BI; FRAGASZY DM, 1995, J COMP PSYCHOL, V109, P339, DOI 10.1037/0735-7036.109.4.339; Goswami A, 2006, EVOLUTION, V60, P169; Goswami A, 2006, AM NAT, V168, P270, DOI 10.1086/505758; Goswami A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000995; Hallgrimsson Benedikt, 2007, Novartis Found Symp, V284, P164; Harcourt, 1980, THESIS U WITWATERSRA; Harcourt CS, 1984, THESIS U CAMBRIDGE; Harvati K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024024; Herring Susan W., 1993, P153; Hylander W.L., 1988, P55; HYLANDER WL, 1994, AM J PHYS ANTHROPOL, V94, P523, DOI 10.1002/ajpa.1330940407; HYLANDER WL, 1991, AM J PHYS ANTHROPOL, V86, P1, DOI 10.1002/ajpa.1330860102; HYLANDER WL, 1985, AM ZOOL, V25, P315; HYLANDER WL, 1979, AM J PHYS ANTHROPOL, V51, P433, DOI 10.1002/ajpa.1330510317; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; IZAWA K, 1977, Primates, V18, P773, DOI 10.1007/BF02382930; IZAWA K, 1975, Primates, V16, P295, DOI 10.1007/BF02381557; JANSON CH, 1984, Z TIERPSYCHOL, V65, P177; Jiang XB, 2002, DEV BIOL, V241, P106, DOI 10.1006/dbio.2001.0487; KAY RF, 1981, AM J PHYS ANTHROPOL, V55, P141, DOI 10.1002/ajpa.1330550202; KINZEY WG, 1974, J HUM EVOL, V3, P193, DOI 10.1016/0047-2484(74)90177-8; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Klingenberg CP, 2009, EVOL DEV, V11, P405, DOI 10.1111/j.1525-142X.2009.00347.x; Klingenberg CP, 2003, EVOL DEV, V5, P522, DOI 10.1046/j.1525-142X.2003.03057.x; Klingenberg CP, 2002, EVOLUTION, V56, P1909; Klingenberg CP, 2001, AM NAT, V157, P11, DOI 10.1086/317002; Klingenberg CP, 2000, EVOLUTION, V54, P1273, DOI 10.1111/j.0014-3820.2000.tb00560.x; LANDE R, 1979, EVOLUTION, V33, P402, DOI [10.2307/2407630, 10.1111/j.1558-5646.1979.tb04694.x]; LANDE R, 1984, GENET RES, V44, P309, DOI 10.1017/S0016672300026549; LANDE R, 1980, GENETICS, V94, P203; LANYON LE, 1979, J BIOMECH, V12, P593, DOI 10.1016/0021-9290(79)90079-4; LANYON LE, 1982, J BIOMECH, V15, P141, DOI 10.1016/0021-9290(82)90246-9; Lee TC, 2002, J ANAT, V201, P437, DOI 10.1046/j.1469-7580.2002.00123.x; LEIGH SR, 1992, J HUM EVOL, V23, P27, DOI 10.1016/0047-2484(92)90042-8; Lieberman DE, 2004, J EXP ZOOL PART B, V302B, P284, DOI 10.1002/jez.b.21004; Lieberman DE, 2003, J EXP BIOL, V206, P3125, DOI 10.1242/jeb.00514; Lieberman DE, 2000, YEARB PHYS ANTHROPOL, V43, P117; Ludwig G, 2006, REV BRAS ZOOL, V23, P888, DOI 10.1590/S0101-81752006000300039; Marroig G, 2004, J EVOLUTION BIOL, V17, P144, DOI 10.1046/j.1420-9101.2003.00653.x; Marroig G, 2001, EVOLUTION, V55, P2576; Marshall AJ, 2007, INT J PRIMATOL, V28, P1218, DOI 10.1007/s10764-007-9218-5; Martinez-Abadias N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026425; Masterson TJ, 1997, AM J PHYS ANTHROPOL, V104, P487, DOI 10.1002/(SICI)1096-8644(199712)104:4<487::AID-AJPA5>3.3.CO;2-J; McCarthy RC, 2001, ANAT REC, V264, P247, DOI 10.1002/ar.1167; McFarlin SC, 2008, J ANAT, V213, P308, DOI 10.1111/j.1469-7580.2008.00947.x; Mitteroecker P, 2008, EVOLUTION, V62, P943, DOI 10.1111/j.1558-5646.2008.00321.x; MORI S, 1993, BONE, V14, P103, DOI 10.1016/8756-3282(93)90235-3; Morriss-Kay GM, 2001, J ANAT, V199, P143; MOSS ML, 1957, ANAT REC, V127, P569, DOI 10.1002/ar.1091270307; MOSS ML, 1960, AM J PHYS ANTHROPOL, V18, P281, DOI 10.1002/ajpa.1330180406; MOSS ML, 1975, ARCH ORAL BIOL, V20, P489, DOI 10.1016/0003-9969(75)90209-5; Nash L.T., 1989, Human Evolution, V4, P199, DOI 10.1007/BF02435449; Nash LT, 1998, AM J PRIMATOL, V10, P57; Noden DM, 2005, J ANAT, V207, P575, DOI 10.1111/j.1469-7580.2005.00473.x; NODEN DM, 1988, DEVELOPMENT, V103, P121; Olson E. C., 1958, MORPHOLOGICAL INTEGR; Opperman LA, 2000, DEV DYNAM, V219, P472, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1073>3.0.CO;2-F; Pavlicev M, 2009, EVOL BIOL, V36, P157, DOI 10.1007/s11692-008-9042-7; Pearson OM, 2004, YEARB PHYS ANTHROPOL, V47, P63, DOI 10.1002/ajpa.20155; PERES CA, 1994, BIOTROPICA, V26, P98, DOI 10.2307/2389114; Porto A, 2009, EVOL BIOL, V36, P118, DOI 10.1007/s11692-008-9038-3; Ravosa MJ, 2003, AM J PHYS ANTHROPOL, P175; Richmond BG, 2005, ANAT REC PART A, V283A, P259, DOI 10.1002/ar.a.20169; Rimoli J., 2008, PRIMATOLOGIA NO BRAS, V9, P130; Robinson J.G., 1986, SMITHSONIAN CONTRIBU, V27, P1, DOI DOI 10.5479/SI.00810282.431; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Ross CF, 2001, AM J PHYS ANTHROPOL, V116, P108, DOI 10.1002/ajpa.1106; Roth VL, 1996, AM ZOOL, V36, P14; Shirai LT, 2010, J EXP ZOOL PART B, V314B, P663, DOI 10.1002/jez.b.21367; Sholts SB, 2010, J FORENSIC SCI, V55, P871, DOI 10.1111/j.1556-4029.2010.01380.x; Sholts SB, 2010, INT J OSTEOARCHAEOL, DOI [10.1002/oa.1156, DOI 10.1002/0A.1156]; Sidor CA, 2001, EVOLUTION, V55, P1419; Silva J. S., 2001, THESIS U FEDERAL RIO; Singleton M, 2005, DEV PRIMATOL-PROG PR, P319, DOI 10.1007/0-387-27614-9_15; Slice DE, 2005, DEV PRIMATOL-PROG PR, P1, DOI 10.1007/0-387-27614-9; Spector JA, 2002, PLAST RECONSTR SURG, V109, P645, DOI 10.1097/00006534-200202000-00035; SPENCER MA, 1993, AM J PHYS ANTHROPOL, V91, P1, DOI 10.1002/ajpa.1330910102; Spencer MA, 1998, J HUM EVOL, V34, P25, DOI 10.1006/jhev.1997.0180; Spencer MA, 1999, AM J PHYS ANTHROPOL, V108, P483, DOI 10.1002/(SICI)1096-8644(199904)108:4<483::AID-AJPA7>3.0.CO;2-L; Strait DS, 2009, P NATL ACAD SCI USA, V106, P2124, DOI 10.1073/pnas.0808730106; Strait DS, 2001, AM J PHYS ANTHROPOL, V114, P273, DOI 10.1002/ajpa.1041; Terborgh J, 1983, 5 NEW WORLD PRIMATES; Thompson EN, 2003, J EXP BIOL, V206, P923, DOI 10.1242/jeb.00181; Verborgt O, 2000, J BONE MINER RES, V15, P60, DOI 10.1359/jbmr.2000.15.1.60; Vinyard CJ, 2007, AM J PRIMATOL, V69, P46, DOI 10.1002/ajp.20326; Vinyard CJ, 2003, AM J PHYS ANTHROPOL, V120, P153, DOI 10.1002/ajpa.10129; WAGNER GP, 1984, J MATH BIOL, V21, P77, DOI 10.1007/BF00275224; Wagner GP, 2008, NATURE, V452, P470, DOI 10.1038/nature06756; WEIDENREICH FRANZ, 1941, TRANS AMER PHIL SOC, V31, P321; Wilkie AOM, 2001, NAT REV GENET, V2, P458, DOI 10.1038/35076601; Wood B, 2001, AM J PHYS ANTHROPOL, V116, P13, DOI 10.1002/ajpa.1097; Wright BW, 2009, AM J PHYS ANTHROPOL, V140, P687, DOI 10.1002/ajpa.21116; Wright BW, 2005, J HUM EVOL, V48, P473, DOI 10.1016/j.jhevol.2005.01.006; Yezerinac SM, 1992, SYST BIOL, V421, P734; Young NM, 2006, J ANAT, V209, P623, DOI 10.1111/j.1469-7580.2006.00639.x; Young NM, 2010, P NATL ACAD SCI USA, V107, P3400, DOI 10.1073/pnas.0911856107; Young NM, 2009, EVOL BIOL, V36, P88, DOI 10.1007/s11692-009-9053-z; Young NM, 2005, EVOLUTION, V59, P2691; YOUNG RW, 1959, AM J ANAT, V105, P383, DOI 10.1002/aja.1001050304; Yu JC, 2001, J CRANIOFAC SURG, V12, P391, DOI 10.1097/00001665-200107000-00018; Zelditch M.L., 2004, GEOMETRIC MORPHOMETR, DOI DOI 10.1016/B978-0-12-778460-1.X5000-5; Zelditch ML, 2009, EVOL BIOL, V36, P71, DOI 10.1007/s11692-008-9034-7; ZELDITCH ML, 1988, EVOLUTION, V42, P28, DOI 10.1111/j.1558-5646.1988.tb04105.x; ZELDITCH ML, 1989, EVOLUTION, V43, P814, DOI 10.1111/j.1558-5646.1989.tb05179.x; ZELDITCH ML, 1989, J MAMMAL, V70, P477, DOI 10.2307/1381419	158	28	28	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e40398	10.1371/journal.pone.0040398	http://dx.doi.org/10.1371/journal.pone.0040398			58	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110039	Green Published, gold			2022-12-25	WOS:000310262500001
J	Remington, ED; Osmanski, MS; Wang, XQ				Remington, Evan D.; Osmanski, Michael S.; Wang, Xiaoqin			An Operant Conditioning Method for Studying Auditory Behaviors in Marmoset Monkeys	PLOS ONE			English	Article							MEDIAL BELT REGIONS; SOUND-LOCALIZATION; AWAKE PRIMATES; NEURAL REPRESENTATIONS; CORTICAL CONNECTIONS; COMPLEX SOUNDS; BINAURAL CUES; SPECTRAL CUES; LARGE MAMMALS; CORTEX	The common marmoset (Callithrix jacchus) is a small New World primate that has increasingly been used as a non-human model in the fields of sensory, motor, and cognitive neuroscience. However, little knowledge exists regarding behavioral methods in this species. Developing an understanding of the neural basis of perception and cognition in an animal model requires measurement of both brain activity and behavior. Here we describe an operant conditioning behavioral training method developed to allow controlled psychoacoustic measurements in marmosets. We demonstrate that marmosets can be trained to consistently perform a Go/No-Go auditory task in which a subject licks at a feeding tube when it detects a sound. Correct responses result in delivery of a food reward. Crucially, this operant conditioning task generates little body movement and is well suited for pairing behavior with single-unit electrophysiology. Successful implementation of an operant conditioning behavior opens the door to a wide range of new studies in the field of auditory neuroscience using the marmoset as a model system.	[Remington, Evan D.; Osmanski, Michael S.; Wang, Xiaoqin] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA	Johns Hopkins University	Remington, ED (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	evan.remington@gmail.com		Osmanski, Michael/0000-0003-3458-9215	National Institutes of Health [DC003180, DC005808, DC008578]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003180, R01DC008578, R01DC005808] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health grants DC003180, DC005808, and DC008578 (XW)(http://nih.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour DL, 2003, SCIENCE, V299, P1073, DOI 10.1126/science.1080425; Bartlett EL, 2007, J NEUROPHYSIOL, V97, P1005, DOI 10.1152/jn.00593.2006; Bendor D, 2005, NATURE, V436, P1161, DOI 10.1038/nature03867; Bendor D, 2007, NAT NEUROSCI, V10, P763, DOI 10.1038/nn1888; BENSON DA, 1978, BRAIN RES, V159, P307, DOI 10.1016/0006-8993(78)90537-1; Bouchardet da Fonesca GA, 1984, PRIMATES, V25, P441; BROWN CH, 1980, J ACOUST SOC AM, V68, P127, DOI 10.1121/1.384638; de la Mothe LA, 2006, J COMP NEUROL, V496, P27, DOI 10.1002/cne.20923; de la Mothe LA, 2006, J COMP NEUROL, V496, P72, DOI 10.1002/cne.20924; de la Mothe LA, 2012, ANAT REC, V295, P800, DOI 10.1002/ar.22451; Eliades SJ, 2008, NATURE, V453, P1102, DOI 10.1038/nature06910; Fritz J, 2003, NAT NEUROSCI, V6, P1216, DOI 10.1038/nn1141; Gescheider G. a, 1985, PSYCHOPHYSICAL MEASU, P1; HEFFNER HE, 1984, BEHAV NEUROSCI, V98, P541, DOI 10.1037/0735-7044.98.3.541; HEFFNER RS, 1992, J COMP PSYCHOL, V106, P107, DOI 10.1037/0735-7036.106.2.107; HEFFNER RS, 1988, BEHAV NEUROSCI, V102, P422, DOI 10.1037/0735-7044.102.3.422; HEFFNER RS, 1989, BRAIN BEHAV EVOLUT, V33, P248, DOI 10.1159/000115932; Huang AY, 1996, J ACOUST SOC AM, V100, P1070, DOI 10.1121/1.416293; Kadia SC, 2003, J NEUROPHYSIOL, V89, P1603, DOI 10.1152/jn.00271.2001; Kajikawa Y, 2008, HEARING RES, V239, P107, DOI 10.1016/j.heares.2008.01.015; Lu T, 2001, NAT NEUROSCI, V4, P1131, DOI 10.1038/nn737; Lu T, 2001, J NEUROPHYSIOL, V85, P2364, DOI 10.1152/jn.2001.85.6.2364; MILES RC, 1956, J COMP PHYSIOL PSYCH, V49, P219, DOI 10.1037/h0045088; Miller CT, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00128; Miller CT, 2010, AM J PRIMATOL, V72, P974, DOI 10.1002/ajp.20854; Miller CT, 2009, J COMP PHYSIOL A, V195, P783, DOI 10.1007/s00359-009-0456-1; Miller CT, 2006, J COMP PHYSIOL A, V192, P27, DOI 10.1007/s00359-005-0043-z; Nelson PC, 2009, J NEUROSCI, V29, P2553, DOI 10.1523/JNEUROSCI.5359-08.2009; Osmanski MS, 2011, HEARING RES, V277, P127, DOI 10.1016/j.heares.2011.02.001; Otazu GH, 2009, NAT NEUROSCI, V12, P646, DOI 10.1038/nn.2306; Parsons CH, 1999, J NEUROPHYSIOL, V82, P2294, DOI 10.1152/jn.1999.82.5.2294; Reser DH, 2009, EUR J NEUROSCI, V30, P578, DOI 10.1111/j.1460-9568.2009.06846.x; ROBERTS AC, 1988, Q J EXP PSYCHOL-B, V40, P321; Sadagopan S, 2008, J NEUROSCI, V28, P3415, DOI 10.1523/JNEUROSCI.2743-07.2008; Sadagopan S, 2009, J NEUROSCI, V29, P11192, DOI 10.1523/JNEUROSCI.1286-09.2009; Sasaki E, 2009, NATURE, V459, P523, DOI 10.1038/nature08090; Scott BH, 2007, J NEUROSCI, V27, P6489, DOI 10.1523/JNEUROSCI.0016-07.2007; Seiden HR, 1957, AUDITORY ACUITY MARM; SINNOTT JM, 1985, J ACOUST SOC AM, V78, P1977, DOI 10.1121/1.392654; Wang XQ, 2000, P NATL ACAD SCI USA, V97, P11843, DOI 10.1073/pnas.97.22.11843; Watkins PV, 2008, NAT NEUROSCI, V11, P1259, DOI 10.1038/nn.2201; Watkins PV, 2011, HEARING RES, V275, P30, DOI 10.1016/j.heares.2010.11.011	42	40	40	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 24	2012	7	10							e47895	10.1371/journal.pone.0047895	http://dx.doi.org/10.1371/journal.pone.0047895			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026VC	23110123	gold, Green Published			2022-12-25	WOS:000310310200102
J	Lu, QL; Yao, YH; Yao, YF; Liu, SZ; Huang, Y; Lu, S; Bai, Y; Zhou, BS; Xu, Y; Li, L; Wang, N; Wang, L; Zhang, J; Cheng, X; Qin, GJ; Ma, W; Xu, CQ; Tu, X; Wang, Q				Lu, Qiulun; Yao, Yihong; Yao, Yufeng; Liu, Shizhi; Huang, Yuan; Lu, Shan; Bai, Ying; Zhou, Bisheng; Xu, Yan; Li, Lei; Wang, Nan; Wang, Li; Zhang, Jie; Cheng, Xiang; Qin, Gangjian; Ma, Wei; Xu, Chengqi; Tu, Xin; Wang, Qing			Angiogenic Factor AGGF1 Promotes Therapeutic Angiogenesis in a Mouse Limb Ischemia Model	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; KLIPPEL-TRENAUNAY-SYNDROME; ENDOTHELIAL GROWTH-FACTOR; LOWER-EXTREMITY; GENE-TRANSFER; HINDLIMB ISCHEMIA; CLINICAL-TRIAL; PLASMID DNA; BLOOD-FLOW; SUSCEPTIBILITY	Background: Peripheral arterial disease (PAD) is a common disease accounting for about 12% of the adult population, and causes significant morbidity and mortality. Therapeutic angiogenesis using angiogenic factors has been considered to be a potential treatment option for PAD patients. In this study, we assessed the potential of a new angiogenic factor AGGF1 for therapeutic angiogenesis in a critical limb ischemia model in mice for PAD. Methods and Results: We generated a unilateral hindlimb ischemia model in mice by ligation of the right common iliac artery and femoral artery. Ischemic mice with intrasmuscular administration of DNA for an expression plasmid for human AGGF1 (AGGF1 group) resulted in increased expression of both AGGF1 mRNA and protein after the administration compared with control mice with injection of the empty vector (control group). Color PW Doppler echocardiography showed that the blood flow in ischemic hindlimbs was significantly increased in the AGGF1 group compared to control mice at time points of 7, 14, and 28 days after DNA administration (n = 9/group, P = 0.049, 0.001, and 0.001, respectively). Increased blood flow in the AGGF1 group was correlated to increased density of CD31-positive vessels and decreased necrosis in muscle tissues injected with AGGF1 DNA compared with the control tissue injected with the empty vector. Ambulatory impairment was significantly reduced in the AGGF1 group compared to the control group (P = 0.004). The effect of AGGF1 was dose-dependent. At day 28 after gene transfer, AGGF1 was significantly better in increasing blood flow than FGF-2 (P = 0.034), although no difference was found for tissue necrosis and ambulatory impairment. Conclusions: These data establish AGGF1 as a candidate therapeutic agent for therapeutic angiogenesis to treat PAD.	[Lu, Qiulun; Yao, Yihong; Yao, Yufeng; Liu, Shizhi; Huang, Yuan; Lu, Shan; Bai, Ying; Zhou, Bisheng; Xu, Yan; Li, Lei; Wang, Nan; Wang, Li; Zhang, Jie; Xu, Chengqi; Tu, Xin; Wang, Qing] Huazhong Univ Sci & Technol, Cardio X Inst, Ctr Human Genome Res, Minist Educ,Coll Life Sci & Technol,Key Lab Mol B, Wuhan 430074, Peoples R China; [Cheng, Xiang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Inst Cardiol, Wuhan 430074, Peoples R China; [Qin, Gangjian] Northwestern Univ, Sch Med, Feinberg Cardiovasc Res Inst, Chicago, IL USA; [Xu, Chengqi] First Hosp Wuhan City, Wuhan, Peoples R China; [Wang, Qing] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Ctr Cardiovasc Genet, Cleveland, OH 44106 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Northwestern University; Cleveland Clinic Foundation	Tu, X (corresponding author), Huazhong Univ Sci & Technol, Cardio X Inst, Ctr Human Genome Res, Minist Educ,Coll Life Sci & Technol,Key Lab Mol B, Wuhan 430074, Peoples R China.	xtu@mail.hust.edu.cn; qkwang@mail.hust.edu.cn	Cheng, Xiang/K-2190-2012; Wang, Li/AAM-2454-2021; Zhou, Bisheng/B-6607-2011; Zhou, Bisheng/K-2160-2019; Lu, Qiulun/A-7073-2018; Zhou, Bisheng/M-3143-2016	Wang, Li/0000-0002-8969-7427; Xu, Chengqi/0000-0002-4269-6830; Zhou, Bisheng/0000-0003-1551-0612	Fundamental Research Funds for the Central Universities [2010MS015, 2011TS082]; State Key Laboratory of Freshwater Ecology and Biotechnology [2011FB16]; Hubei Province Natural Science Key Program [2008CDA047]; Key Academic Program Leader Award of Wuhan City [200951830560]; National Natural Science Foundation of China [81070106]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); State Key Laboratory of Freshwater Ecology and Biotechnology(Chinese Academy of Sciences); Hubei Province Natural Science Key Program; Key Academic Program Leader Award of Wuhan City; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the Fundamental Research Funds for the Central Universities (2010MS015, 2011TS082), a grant from the State Key Laboratory of Freshwater Ecology and Biotechnology (2011FB16), a Hubei Province Natural Science Key Program (2008CDA047) and a Key Academic Program Leader Award of Wuhan City (200951830560), and the National Natural Science Foundation of China (81070106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumgartner I, 2000, ANN INTERN MED, V132, P880, DOI 10.7326/0003-4819-132-11-200006060-00005; Bosch-Marce M, 2007, CIRC RES, V101, P1310, DOI 10.1161/CIRCRESAHA.107.153346; Brevetti G, 2010, CIRCULATION, V122, P1862, DOI 10.1161/CIRCULATIONAHA.109.918417; Costantini V, 2002, THROMB RES, V106, pV285, DOI 10.1016/S0049-3848(02)00104-4; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; DAVIS HL, 1993, HUM GENE THER, V4, P733, DOI 10.1089/hum.1993.4.6-733; Dieter RS, 2003, VASC MED, V8, P233, DOI 10.1191/1358863x03vm506ra; Fan C, 2009, J BIOL CHEM, V284, P23331, DOI 10.1074/jbc.M109.036079; Fitzgerald SM, 2007, AM J PHYSIOL-HEART C, V293, pH1072, DOI 10.1152/ajpheart.00072.2007; Gupta R, 2009, CIRC RES, V105, P724, DOI 10.1161/CIRCRESAHA.109.200386; Ha XQ, 2008, NEURAL REGEN RES, V3, P625; Helisch A, 2006, ARTERIOSCL THROM VAS, V26, P520, DOI 10.1161/01.ATV.0000202677.55012.a0; Hiatt WR, 2001, NEW ENGL J MED, V344, P1608, DOI 10.1056/NEJM200105243442108; Hiraoka K, 2003, CIRCULATION, V108, P2689, DOI 10.1161/01.CIR.0000093275.78676.F4; Hirsch AT, 2006, J AM COLL CARDIOL, V47, P1239, DOI 10.1016/j.jacc.2005.10.009; Hu Y, 2008, ANN HUM GENET, V72, P636, DOI 10.1111/j.1469-1809.2008.00458.x; Lange S, 2003, DIABETES CARE, V26, P3357, DOI 10.2337/diacare.26.12.3357; Leng GC, 1996, INT J EPIDEMIOL, V25, P1172, DOI 10.1093/ije/25.6.1172; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Matyas L, 2005, HUM GENE THER, V16, P1202, DOI 10.1089/hum.2005.16.1202; Mughal NA, 2012, BRIT J SURG, V99, P6, DOI 10.1002/bjs.7743; Nikol S, 2008, MOL THER, V16, P972, DOI 10.1038/mt.2008.33; Olin JW, 2010, MAYO CLIN PROC, V85, P678, DOI 10.4065/mcp.2010.0133; Powell RJ, 2004, VASC MED, V9, P193, DOI 10.1191/1358863x04vm557oa; Qi X, 2010, EUR J PHARMACOL, V634, P121, DOI 10.1016/j.ejphar.2010.02.038; Rooke TW, 2011, J AM COLL CARDIOL, V58, P2020, DOI 10.1016/j.jacc.2011.08.023; Schgoer W, 2009, CIRC RES, V105, P994, DOI 10.1161/CIRCRESAHA.109.199513; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Taniyama Y, 2001, GENE THER, V8, P181, DOI 10.1038/sj.gt.3301379; Tian XL, 2004, NATURE, V427, P640, DOI 10.1038/nature02320; Timur AA, 2005, CELL MOL LIFE SCI, V62, P1434, DOI 10.1007/s00018-005-4523-7; Tongers J, 2008, CIRCULATION, V118, P9, DOI 10.1161/CIRCULATIONAHA.108.784371; Tsurumi Y, 1996, CIRCULATION, V94, P3281, DOI 10.1161/01.CIR.94.12.3281; VOGT MT, 1992, J CLIN EPIDEMIOL, V45, P529, DOI 10.1016/0895-4356(92)90102-S; Wang F, 2011, NAT GENET, V43, P345, DOI 10.1038/ng.783; Weitz JI, 1996, CIRCULATION, V94, P3026, DOI 10.1161/01.CIR.94.11.3026; Welten GMJM, 2009, J CARDIOVASC SURG, V50, P109; Welten GMJM, 2008, J AM COLL CARDIOL, V51, P1588, DOI 10.1016/j.jacc.2007.11.077; Wiley SR, 2001, IMMUNITY, V15, P837, DOI 10.1016/S1074-7613(01)00232-1; Wu L, 2008, J BIOL CHEM, V283, P6968, DOI 10.1074/jbc.M709721200; Zhang T, 2008, CIRCULATION, V118, pS461	41	28	29	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e46998	10.1371/journal.pone.0046998	http://dx.doi.org/10.1371/journal.pone.0046998			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110058	Green Published, gold, Green Submitted			2022-12-25	WOS:000310193600007
J	Romao-Dumaresq, AS; de Araujo, WL; Talbot, NJ; Thornton, CR				Romao-Dumaresq, Aline S.; de Araujo, Welington Luiz; Talbot, Nicholas J.; Thornton, Christopher R.			RNA Interference of Endochitinases in the Sugarcane Endophyte Trichoderma virens 223 Reduces Its Fitness as a Biocontrol Agent of Pineapple Disease	PLOS ONE			English	Article							GLIOCLADIUM-VIRENS; BIOLOGICAL-CONTROL; RHIZOCTONIA-SOLANI; ENCODING GENE; EXTRACELLULAR CHITINASE; N-ACETYLGLUCOSAMINIDASE; INCREASED ANTIFUNGAL; MOLECULAR-CLONING; FILAMENTOUS FUNGI; 33-KDA CHITINASE	The sugarcane root endophyte Trichoderma virens 223 holds enormous potential as a sustainable alternative to chemical pesticides in the control of sugarcane diseases. Its efficacy as a biocontrol agent is thought to be associated with its production of chitinase enzymes, including N-acetyl-beta-D-glucosaminidases, chitobiosidases and endochitinases. We used targeted gene deletion and RNA-dependent gene silencing strategies to disrupt N-acetyl-beta-D-glucosaminidase and endochitinase activities of the fungus, and to determine their roles in the biocontrol of soil-borne plant pathogens. The loss of N-acetyl-beta-D-glucosaminidase activities was dispensable for biocontrol of the plurivorous damping-off pathogens Rhizoctonia solani and Sclerotinia sclerotiorum, and of the sugarcane pathogen Ceratocystis paradoxa, the causal agent of pineapple disease. Similarly, suppression of endochitinase activities had no effect on R. solani and S. sclerotiorum disease control, but had a pronounced effect on the ability of T. virens 223 to control pineapple disease. Our work demonstrates a critical requirement for T. virens 223 endochitinase activity in the biocontrol of C. paradoxa sugarcane disease, but not for general antagonism of other soil pathogens. This may reflect its lifestyle as a sugarcane root endophyte.	[Talbot, Nicholas J.; Thornton, Christopher R.] Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England; [de Araujo, Welington Luiz] Univ Sao Paulo, Inst Biol Sci, Dept Microbiol, Sao Paulo, Brazil; [Romao-Dumaresq, Aline S.] Univ Sao Paulo, Escola Super Agr Luiz de Queiroz, Dept Genet, Piracicaba, SP, Brazil	University of Exeter; Universidade de Sao Paulo; Universidade de Sao Paulo	Thornton, CR (corresponding author), Univ Exeter, Coll Life & Environm Sci, Exeter, Devon, England.	C.R.Thornton@exeter.ac.uk	Araújo, Welington/G-4905-2012; Talbot, Nicholas J/I-9584-2014; Talbot, Nicholas J/I-5618-2019	Araújo, Welington/0000-0002-2120-8172; Talbot, Nicholas J/0000-0001-6434-7757; Talbot, Nicholas J/0000-0001-6434-7757	FAPESP [2002/14143-3]; CAPES	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by FAPESP (grant no. 2002/14143-3) and CAPES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek JM, 1999, CURR GENET, V35, P41, DOI 10.1007/s002940050431; Baek JM, 1998, FUNGAL GENET BIOL, V23, P34, DOI 10.1006/fgbi.1997.1025; Bolar JP, 2000, PHYTOPATHOLOGY, V90, P72, DOI 10.1094/PHYTO.2000.90.1.72; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunner K, 2003, CURR GENET, V43, P289, DOI 10.1007/s00294-003-0399-y; Caron J, 1993, ISOLEMENT CARACTERIS; CARSOLIO C, 1994, P NATL ACAD SCI USA, V91, P10903, DOI 10.1073/pnas.91.23.10903; Carsolio C, 1999, APPL ENVIRON MICROB, V65, P929; Catlett N.L., 2003, FUNGAL GENET NEWSL, V50, P9, DOI DOI 10.4148/1941-4765.1150; De Marco JL, 2004, APPL MICROBIOL BIOT, V64, P70, DOI 10.1007/s00253-003-1490-5; DELACRUZ J, 1992, EUR J BIOCHEM, V206, P859, DOI 10.1111/j.1432-1033.1992.tb16994.x; DIPIETRO A, 1993, PHYTOPATHOLOGY, V83, P308, DOI 10.1094/Phyto-83-308; Draborg H, 1995, BIOCHEM MOL BIOL INT, V36, P781; El-Katatny MH, 2001, APPL MICROBIOL BIOT, V56, P137, DOI 10.1007/s002530100646; Emani C, 2003, PLANT BIOTECHNOL J, V1, P321, DOI 10.1046/j.1467-7652.2003.00029.x; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GARCIA I, 1994, CURR GENET, V27, P83, DOI 10.1007/BF00326583; Hanson LE, 2004, PHYTOPATHOLOGY, V94, P171, DOI 10.1094/PHYTO.2004.94.2.171; HARAN S, 1995, MYCOL RES, V99, P441, DOI 10.1016/S0953-7562(09)80642-4; Harman GE, 2004, NAT REV MICROBIOL, V2, P43, DOI 10.1038/nrmicro797; HARMAN GE, 1993, PHYTOPATHOLOGY, V83, P313, DOI 10.1094/Phyto-83-313; HAYES CK, 1994, GENE, V138, P143, DOI 10.1016/0378-1119(94)90797-8; Hollanda E, 2010, TRADE ENV REV, P68; Howell CR, 2006, PHYTOPATHOLOGY, V96, P178, DOI 10.1094/PHYTO-96-0178; Howell CR, 2005, BIOL CONTROL, V33, P217, DOI 10.1016/j.biocontrol.2005.02.003; HOWELL CR, 1982, PHYTOPATHOLOGY, V72, P496, DOI 10.1094/Phyto-72-496; HOWELL CR, 1987, PHYTOPATHOLOGY, V77, P992, DOI 10.1094/Phyto-77-992; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Kim DJ, 2002, CURR GENET, V40, P374, DOI 10.1007/s00294-001-0267-6; Kubicek CP, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r40; Kubicek CP, TRICHODERMA GLIOCLAD, V2, P73; Limon MC, 2004, APPL MICROBIOL BIOT, V64, P675, DOI 10.1007/s00253-003-1538-6; Limon MC, 1999, PHYTOPATHOLOGY, V89, P254, DOI 10.1094/PHYTO.1999.89.3.254; LIMON MC, 1995, CURR GENET, V28, P478, DOI 10.1007/BF00310819; Liu H, 2002, GENETICS, V160, P463; Lopez-Mondejar R, 2009, FEBS J, V276, P5137, DOI 10.1111/j.1742-4658.2009.07211.x; LORITO M, 1994, PHYTOPATHOLOGY, V84, P398, DOI 10.1094/Phyto-84-398; Lu ZX, 2004, APPL ENVIRON MICROB, V70, P3073, DOI 10.1128/AEM.70.5.3073-3081.2004; Mouyna I, 2004, FEMS MICROBIOL LETT, V237, P317, DOI 10.1016/j.femsle.2004.06.048; Nakayashiki H, 2005, FUNGAL GENET BIOL, V42, P275, DOI 10.1016/j.fgb.2005.01.002; Nguyen QB, 2008, MOL MICROBIOL, V68, P1348, DOI 10.1111/j.1365-2958.2008.06242.x; Peberdy J., 1990, BIOCH CELL WALLS MEM, P5, DOI [10.1007/978-3-642-74215-6_2, DOI 10.1007/978-3-642-74215-6_2]; Peterbauer CK, 1996, CURR GENET, V30, P325, DOI 10.1007/s002940050140; RAEDER U, 1985, LETT APPL MICROBIOL, V1, P17, DOI 10.1111/j.1472-765X.1985.tb01479.x; ROBERTS DP, 1990, PHYTOPATHOLOGY, V80, P461, DOI 10.1094/Phyto-80-461; Romao A.S., 2010, ANALISE COMUNIDADE F; Romao AS, 2008, 12 INT C MYC IST TUR; Romao AS, 2007, MICOLOGIA AVANCOS CO, P150; Ryder LS, 2012, MICROBIOL-SGM, V158, P84, DOI 10.1099/mic.0.051854-0; Sambrook J., 2002, MOL CLONING LAB MANU; SCHIRMBOCK M, 1994, APPL ENVIRON MICROB, V60, P4364; Seidl Verena, 2008, Fungal Biology Reviews, V22, P36, DOI 10.1016/j.fbr.2008.03.002; Talukder M. I., 2007, Journal of Agriculture & Rural Development (Gazipur), V5, P79; TU JC, 1980, PHYTOPATHOLOGY, V70, P670, DOI 10.1094/Phyto-70-670; ULHOA CJ, 1992, ENZYME MICROB TECH, V14, P236, DOI 10.1016/0141-0229(92)90072-V; ULHOA CJ, 1991, CURR MICROBIOL, V23, P285, DOI 10.1007/BF02092032; Verma M, 2007, BIOCHEM ENG J, V37, P1, DOI 10.1016/j.bej.2007.05.012; Viterbo A, 2002, CURR GENET, V42, P114, DOI 10.1007/s00294-002-0345-4; Viterbo A, 2001, FEMS MICROBIOL LETT, V200, P169, DOI 10.1111/j.1574-6968.2001.tb10710.x; WILHITE SE, 1994, PHYTOPATHOLOGY, V84, P816, DOI 10.1094/Phyto-84-816; Woo SL, 1999, MOL PLANT MICROBE IN, V12, P419, DOI 10.1094/MPMI.1999.12.5.419; Yedidia I, 2003, APPL ENVIRON MICROB, V69, P7343, DOI 10.1128/AEM.69.12.7343-7353.2003; Zeilinger S, 1999, FUNGAL GENET BIOL, V26, P131, DOI 10.1006/fgbi.1998.1111; ZIMAND G, 1991, Phytoparasitica, V19, P252	65	23	24	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47888	10.1371/journal.pone.0047888	http://dx.doi.org/10.1371/journal.pone.0047888			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110120	gold, Green Published			2022-12-25	WOS:000310193600035
J	Hsu, RJ; Ho, JY; Cha, TL; Yu, DS; Wu, CL; Huang, WP; Chu, PL; Chen, YH; Chen, JT; Yu, CP				Hsu, Ren-Jun; Ho, Jar-Yi; Cha, Tai-Lung; Yu, Dah-Shyong; Wu, Chieh-Lin; Huang, Wei-Ping; Chu, Pauling; Chen, Ying-Hsin; Chen, Jiann-Torng; Yu, Cheng-Ping			WNT10A Plays an Oncogenic Role in Renal Cell Carcinoma by Activating WNT/beta-catenin Pathway	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; PRIMARY GASTRIC-CANCER; SIGNALING PATHWAY; BETA-CATENIN; HEPATOCELLULAR-CARCINOMA; STEM-CELLS; NONCANONICAL WNT; ANTAGONIST GENE; INHIBITS PROLIFERATION	Renal cell carcinoma (RCC) is a malignancy with poor prognosis. WNT/beta-catenin signaling dysregulation, especially beta-catenin overactivation and WNT antagonist silencing, is associated with RCC carcinogenesis and progression. However, the role of WNT ligands in RCC has not yet been determined. We screened 19 WNT ligands from normal kidney and RCC cell lines and tissues and found that WNT10A was significantly increased in RCC cell lines and tissues as compared to that in normal controls. The clinical significance of increase in WNT10A was evaluated by performing an immunohistochemical association study in a 19-year follow-up cohort comprising 284 RCC and 267 benign renal disease (BRD) patients. The results of this study showed that WNT10A was dramatically upregulated in RCC tissues as compared to that in BRD tissues. This result suggests that WNT10A, nuclear beta-catenin, and nuclear cyclin D1 act as independent risk factors for RCC carcinogenesis and progression, with accumulative risk effects. Molecular validation of cell line models with gain- or loss-of-function designs showed that forced WNT10A expression induced RCC cell proliferation and aggressiveness, including higher chemoresistance, cell migration, invasiveness, and cell transformation, due to the activation of beta-catenin-dependent signaling. Conversely, WNT10A siRNA knockdown decreased cell proliferation and aggressiveness of RCC cells. In conclusion, we showed that WNT10A acts as an autocrine oncogene both in RCC carcinogenesis and progression by activating WNT/beta-catenin signaling.	[Hsu, Ren-Jun; Yu, Cheng-Ping] Natl Def Med Ctr, Triserv Gen Hosp, Biobank Management Ctr, Taipei, Taiwan; [Hsu, Ren-Jun; Ho, Jar-Yi; Wu, Chieh-Lin; Huang, Wei-Ping; Yu, Cheng-Ping] Natl Def Med Ctr, Triserv Gen Hosp, Grad Inst Pathol & Parasitol, Taipei, Taiwan; [Ho, Jar-Yi; Cha, Tai-Lung; Yu, Dah-Shyong; Yu, Cheng-Ping] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Cha, Tai-Lung; Yu, Dah-Shyong] Natl Def Med Ctr, Triserv Gen Hosp, Div Urol, Taipei, Taiwan; [Chu, Pauling] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan; [Chen, Ying-Hsin] Natl Def Med Ctr, Triserv Gen Hosp, Dept Emergency Med, Taipei, Taiwan; [Chen, Jiann-Torng] Natl Def Med Ctr, Triserv Gen Hosp, Dept Ophthalmol, Taipei, Taiwan	National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital; National Defense Medical Center; Tri-Service General Hospital	Yu, CP (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Biobank Management Ctr, Taipei, Taiwan.	cpyupath@yahoo.com.tw		Yu, Cheng-Ping/0000-0002-0693-5056; Wu, Chieh-Lin (Stanley)/0000-0002-7090-7172; Ho, Jar-Yi/0000-0001-6933-041X	National Science Council [NSC100-2320-B-016-010-]; Tri-Service General Hospital [TSGH-C98-04, TSGH-C98-10-S01, TSGH-C99-004, TSGH-C99-146, TSGH-C99-009-10-S01, TSGH-C100-135, TSGH-C100-007-009-10-S01]	National Science Council(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital	This work was supported by the National Science Council (NSC100-2320-B-016-010-) and the Tri-Service General Hospital (TSGH-C98-04, TSGH-C98-10-S01, TSGH-C99-004, TSGH-C99-146, TSGH-C99-009-10-S01, TSGH-C100-135 and TSGH-C100-007-009-10-S01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldewijns MML, 2008, BBA-REV CANCER, V1785, P133, DOI 10.1016/j.bbcan.2007.12.002; Banumathy G, 2010, CANCER BIOL THER, V10, P658, DOI 10.4161/cbt.10.7.13247; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bengochea A, 2008, BRIT J CANCER, V99, P143, DOI 10.1038/sj.bjc.6604422; Bilim V, 2000, CLIN CANCER RES, V6, P460; Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Bjorklund P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004243; Bomben R, 2007, BLOOD, V109, P2989, DOI 10.1182/blood-2006-10-051110; Bruder E, 2007, MODERN PATHOL, V20, P1217, DOI 10.1038/modpathol.3800957; Bui TD, 1997, ONCOGENE, V14, P1249, DOI 10.1038/sj.onc.1200936; Carmon KS, 2008, MOL CANCER RES, V6, P1017, DOI 10.1158/1541-7786.MCR-08-0039; Chen K, 2008, PEDIATR BLOOD CANCER, V51, P349, DOI 10.1002/pbc.21595; Cheng XX, 2005, CANCER LETT, V223, P339, DOI 10.1016/j.canlet.2004.11.013; Chien AJ, 2009, P NATL ACAD SCI USA, V106, P1193, DOI 10.1073/pnas.0811902106; Clement G, 2006, ONCOGENE, V25, P3084, DOI 10.1038/sj.onc.1209338; Costa VL, 2010, EPIGENETICS-US, V5, P343, DOI 10.4161/epi.5.4.11749; Dahl E, 2007, ONCOGENE, V26, P5680, DOI 10.1038/sj.onc.1210345; Dai W, 2011, CLIN CANCER RES, V17, P4052, DOI 10.1158/1078-0432.CCR-10-3021; Fu L, 2011, GUT, V60, P1635, DOI 10.1136/gut.2011.241638; Gelebart P, 2008, BLOOD, V112, P5171, DOI 10.1182/blood-2008-02-139212; Guillen-Ahlers H, 2008, CURR DRUG TARGETS, V9, P591, DOI 10.2174/138945008784911813; Gumz ML, 2007, CLIN CANCER RES, V13, P4740, DOI 10.1158/1078-0432.CCR-07-0143; Hirata H, 2011, INT J CANCER, V128, P1793, DOI 10.1002/ijc.25507; Hirata H, 2010, CANCER RES, V70, P1896, DOI 10.1158/0008-5472.CAN-09-3549; Hirata H, 2009, CLIN CANCER RES, V15, P5678, DOI 10.1158/1078-0432.CCR-09-0558; Hirata H, 2009, CANCER-AM CANCER SOC, V115, P4488, DOI 10.1002/cncr.24491; Katoh M, 2001, INT J ONCOL, V19, P1003; Katoh M, 2001, BIOCHEM BIOPH RES CO, V289, P1093, DOI 10.1006/bbrc.2001.6076; Kawakami K, 2011, INT J CANCER, V128, P541, DOI 10.1002/ijc.25357; Kawakami K, 2009, CANCER RES, V69, P8603, DOI 10.1158/0008-5472.CAN-09-2534; Kawamoto K, 2008, INT J CANCER, V123, P535, DOI 10.1002/ijc.23514; Kikuchi A, 2008, CANCER SCI, V99, P202, DOI 10.1111/j.1349-7006.2007.00675.x; Kim M, 2008, J HEPATOL, V48, P780, DOI 10.1016/j.jhep.2007.12.020; Kim YS, 2000, PATHOL INT, V50, P725, DOI 10.1046/j.1440-1827.2000.01111.x; Kirikoshi H, 2001, INT J ONCOL, V19, P997; Kirikoshi H, 2001, BIOCHEM BIOPH RES CO, V283, P798, DOI 10.1006/bbrc.2001.4855; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Kuhl M, 2000, TRENDS GENET, V16, P279, DOI 10.1016/s0168-9525(00)02028-x; KWAN H, 1992, MOL CELL BIOL, V12, P147, DOI 10.1128/MCB.12.1.147; Lane TF, 1997, ONCOGENE, V15, P2133, DOI 10.1038/sj.onc.1201593; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Li ZG, 2008, ONCOGENE, V27, P596, DOI 10.1038/sj.onc.1210694; Lin YC, 2010, J MED SCI, V30, P199; Liu X, 2008, ONCOGENE, V27, P1478, DOI 10.1038/sj.onc.1210769; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Lu DS, 2004, P NATL ACAD SCI USA, V101, P3118, DOI 10.1073/pnas.0308648100; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Mazieres J, 2005, ONCOGENE, V24, P5396, DOI 10.1038/sj.onc.1208568; MCCARTY KS, 1985, ARCH PATHOL LAB MED, V109, P716; Mccoy KE, 2011, DEV DYNAM, V240, P1558, DOI 10.1002/dvdy.22626; Miyakoshi T, 2008, ENDOCR PATHOL, V19, P261, DOI 10.1007/s12022-008-9048-9; Nakamura Y, 2005, AM J PATHOL, V167, P97, DOI 10.1016/S0002-9440(10)62957-4; Nygren MK, 2007, BRIT J HAEMATOL, V136, P400, DOI 10.1111/j.1365-2141.2006.06442.x; Okoye Ujunwa C, 2008, J Mol Signal, V3, P16, DOI 10.1186/1750-2187-3-16; Olson DJ, 1998, EXP CELL RES, V241, P134, DOI 10.1006/excr.1998.4030; Park JK, 2009, NEOPLASMA, V56, P119, DOI 10.4149/neo_2009_02_119; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Pu P, 2009, CANCER GENE THER, V16, P351, DOI 10.1038/cgt.2008.78; Roberts DM, 2007, NAT STRUCT MOL BIOL, V14, P463, DOI 10.1038/nsmb0607-463; Roman-Gomez J, 2007, BLOOD, V109, P3462, DOI 10.1182/blood-2006-09-047043; Saini S, 2011, NAT REV UROL, V8, P690, DOI 10.1038/nrurol.2011.146; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Schmidt-Ott KM, 2008, KIDNEY INT, V74, P1004, DOI 10.1038/ki.2008.322; Serra R, 2011, J MAMMARY GLAND BIOL, V16, P157, DOI 10.1007/s10911-011-9205-5; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sinnberg T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023429; Sugimura R, 2010, BIRTH DEFECTS RES C, V90, P243, DOI 10.1002/bdrc.20195; Sun M, 2011, EUR UROL, V60, P644, DOI 10.1016/j.eururo.2011.06.041; Teissedre B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004537; Thiago LS, 2010, BIOMED PHARMACOTHER, V64, P63, DOI 10.1016/j.biopha.2009.09.005; Tickenbrock L, 2008, INT J ONCOL, V33, P1215, DOI 10.3892/ijo_00000111; Tulac S, 2003, J CLIN ENDOCR METAB, V88, P3860, DOI 10.1210/jc.2003-030494; Uraguchi M, 2004, J DENT RES, V83, P327, DOI 10.1177/154405910408300411; Urakami S, 2006, CLIN CANCER RES, V12, P6989, DOI 10.1158/1078-0432.CCR-06-1194; Uysal-Onganer P, 2012, ACTA PHYSIOL, V204, P52, DOI 10.1111/j.1748-1716.2011.02297.x; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Wang W, 2010, CANCER INVEST, V28, P230, DOI 10.3109/07357900903095698; Wang XH, 2009, CELL CYCLE, V8, P1567, DOI 10.4161/cc.8.10.8489; Wei W, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-16; Wend P, 2010, SEMIN CELL DEV BIOL, V21, P855, DOI 10.1016/j.semcdb.2010.09.004; Yan LQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016515; Ying Y, 2009, EPIGENETICS-US, V4, P307, DOI 10.4161/epi.4.5.9371; You L, 2006, DRUG NEWS PERSPECT, V19, P27, DOI 10.1358/dnp.2006.19.1.965871; You L, 2004, ONCOGENE, V23, P6170, DOI 10.1038/sj.onc.1207844; You L, 2004, CANCER RES, V64, P5385, DOI 10.1158/0008-5472.CAN-04-1227; Yuan FJ, 2010, MOL CELL BIOCHEM, V343, P155, DOI 10.1007/s11010-010-0509-3; Zhang XL, 2010, NEOPLASMA, V57, P545, DOI 10.4149/neo_2010_06_545	90	47	47	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47649	10.1371/journal.pone.0047649	http://dx.doi.org/10.1371/journal.pone.0047649			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094073	Green Published, Green Submitted, gold			2022-12-25	WOS:000310050200038
J	Leguebe, M; Nguyen, C; Capece, L; Hoang, Z; Giorgetti, A; Carloni, P				Leguebe, Michael; Chuong Nguyen; Capece, Luciana; Zung Hoang; Giorgetti, Alejandro; Carloni, Paolo			Hybrid Molecular Mechanics/Coarse-Grained Simulations for Structural Prediction of G-Protein Coupled Receptor/Ligand Complexes	PLOS ONE			English	Article							LOCAL-STRUCTURE MODEL; FORCE-FIELD; MULTISCALE SIMULATIONS; UNFOLDING TRANSITION; GLOBULAR-PROTEINS; RESP MODEL; DYNAMICS; ACTIVATION; RESTRAINTS; SOFTWARE	Understanding how ligands bind to G-protein coupled receptors (GPCRs) provides insights into a myriad of cell processes and is crucial for drug development. Here we extend a hybrid molecular mechanics/coarse-grained (MM/CG) approach applied previously to enzymes to GPCR/ligand complexes. The accuracy of this method for structural predictions is established by comparison with recent atomistic molecular dynamics simulations on the human beta 2 adrenergic receptor, a member of the GPCRs superfamily. The results obtained with the MM/CG methodology show a good agreement with previous all-atom classical dynamics simulations, in particular in the structural description of the ligand binding site. This approach could be used for high-throughput predictions of ligand poses in a variety of GPCRs.	[Leguebe, Michael; Chuong Nguyen; Capece, Luciana; Giorgetti, Alejandro; Carloni, Paolo] German Res Sch Simulat Sci, Julich, Germany; [Leguebe, Michael] Inst Math Bordeaux, INRIA Bordeaux Sud Ouest, Talence, France; [Chuong Nguyen; Capece, Luciana; Giorgetti, Alejandro; Carloni, Paolo] JARA High Performance Comp, Julich, Germany; [Capece, Luciana] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy; [Zung Hoang] Vietnam Natl Univ Ho Chi Minh City, Ho Chi Minh City, Vietnam; [Giorgetti, Alejandro] Univ Verona, Dept Biotechnol, I-37100 Verona, Italy; [Carloni, Paolo] Forschungszentrum Julich, Inst Adv Simulat, Intitute Computat Biomed IAS 5, D-52425 Julich, Germany	Centre National de la Recherche Scientifique (CNRS); Inria; International Center for Genetic Engineering & Biotechnology (ICGEB); Vietnam National University Hochiminh City; University of Verona; Helmholtz Association; Research Center Julich	Giorgetti, A (corresponding author), German Res Sch Simulat Sci, Julich, Germany.	alejandro.giorgetti@univr.it	Carloni, Paolo/H-8736-2013; Nguyen, Chuong/F-3473-2011	Nguyen, Chuong/0000-0001-8373-981X; Carloni, Paolo/0000-0002-9010-0149; Giorgetti, Alejandro/0000-0001-8738-6150; LEGUEBE, Michael/0000-0001-9908-5005	Deutsche Forschungsgemeinschaft [CA 973/6-1]; Vietnam National Foundation for Science and Technology Development [DFG.2011.01]; Project ISS [UPR- 20009-1301355 (CUP I85J08000040005)]; JARA-HPC on RWTH Compute Cluster [jara0023]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Vietnam National Foundation for Science and Technology Development; Project ISS; JARA-HPC on RWTH Compute Cluster	This work has been supported in part by a grant from the Deutsche Forschungsgemeinschaft (CA 973/6-1), by a grant from Vietnam National Foundation for Science and Technology Development (DFG.2011.01), and by a grant from the Project ISS UPR- 20009-1301355 (CUP I85J08000040005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Ursula Rothlisberger for kindly providing the trajectories of the all-atom MD simulations, and Justin Finnerty and Alexander Peyser for comments on the manuscript. Computer resources provided by the Julich Supercomputing Center on JUROPA and by JARA-HPC on RWTH Compute Cluster (project ID jara0023) is greatly acknowledged.	ABE H, 1981, BIOPOLYMERS, V20, P1013, DOI 10.1002/bip.1981.360200512; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Ayton GS, 2007, CURR OPIN STRUC BIOL, V17, P192, DOI 10.1016/j.sbi.2007.03.004; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Berendsen HJC, 1981, INTERMOLECULAR FORCE, P331, DOI [DOI 10.1007/978-94-015-7658-1_21, 10.1007/978-94-015-7658-1_21]; Biarnes X, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012394; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Christen M, 2005, J COMPUT CHEM, V26, P1719, DOI 10.1002/jcc.20303; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Deupi X, 2011, CURR OPIN STRUC BIOL, V21, P541, DOI 10.1016/j.sbi.2011.06.002; GO N, 1981, BIOPOLYMERS, V20, P991, DOI 10.1002/bip.1981.360200511; Hoffmann C, 2004, N-S ARCH PHARMACOL, V369, P151, DOI 10.1007/s00210-003-0860-y; Kalli AC, 2011, P NATL ACAD SCI USA, V108, P11890, DOI 10.1073/pnas.1104505108; Kutzner C, 2007, J COMPUT CHEM, V28, P2075, DOI 10.1002/jcc.20703; Mark P, 2001, J PHYS CHEM A, V105, P9954, DOI 10.1021/jp003020w; Messer BM, 2010, PROTEINS, V78, P1212, DOI 10.1002/prot.22640; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; NADLER W, 1987, P NATL ACAD SCI USA, V84, P7933, DOI 10.1073/pnas.84.22.7933; Neri M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.218102; Neri M, 2008, BIOPHYS J, V94, P71, DOI 10.1529/biophysj.107.116301; Nygaard R, 2010, J BIOL CHEM, V285, P19625, DOI 10.1074/jbc.M110.106021; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; OSHER S, 1988, J COMPUT PHYS, V79, P12, DOI 10.1016/0021-9991(88)90002-2; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Paesani F, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2386157; Rompler H, 2011, NAT COMMUN, V2, P17; Rompler H, 2007, MOL INTERV, V7, P17, DOI 10.1124/mi.7.1.5; Rueda M, 2007, P NATL ACAD SCI USA, V104, P796, DOI 10.1073/pnas.0605534104; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Rzepiela AJ, 2011, PHYS CHEM CHEM PHYS, V13, P10437, DOI 10.1039/c0cp02981e; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sgourakis NG, 2010, J MOL BIOL, V398, P161, DOI 10.1016/j.jmb.2010.02.032; Shi Q, 2006, J PHYS CHEM B, V110, P15045, DOI 10.1021/jp062700h; Taylor MRG, 2007, PHARMACOGENOMICS J, V7, P29, DOI 10.1038/sj.tpj.6500393; Vanni S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001053; Villa E, 2005, P NATL ACAD SCI USA, V102, P6783, DOI 10.1073/pnas.0409387102; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; Yarnitzky T, 2010, CURR OPIN DRUG DISC, V13, P317	38	38	38	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47332	10.1371/journal.pone.0047332	http://dx.doi.org/10.1371/journal.pone.0047332			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094046	Green Published, gold			2022-12-25	WOS:000310050200022
J	Jonas, JB; Jonas, SB; Jonas, RA; Holbach, L; Dai, Y; Sun, XH; Panda-Jonas, S				Jonas, Jost B.; Jonas, Shefali B.; Jonas, Rahul A.; Holbach, Leonhard; Dai, Yi; Sun, Xinghuai; Panda-Jonas, Songhomitra			Parapapillary Atrophy: Histological Gamma Zone and Delta Zone	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; HIGH MYOPIA; NORMAL EYES; GLAUCOMA; NERVE; BETA; HISTOMORPHOMETRY; ANATOMY	Background: To examine histomorphometrically the parapapillary region in human eyes. Methodology/Principal Findings: The histomorphometric study included 65 human globes (axial length: 21-37 mm). On anterior-posterior histological sections, we measured the distance Bruch's membrane end (BME)-optic nerve margin ("Gamma zone"), BME-retinal pigment epithelium (RPE) ("Beta zone"), BME-beginning of non-occluded choriocapillaris, and BME-beginning of photoreceptor layer. "Delta zone" was defined as part of gamma zone in which blood vessels of at least 50 mm diameter were not present over a length of >300 mu m. Beta zone (mean length: 0.35 +/- 0.52 mm) was significantly (P = 0.01) larger in the glaucoma group than in the non-glaucomatous group. It was not significantly (P = 0.28) associated with axial length. Beta zone was significantly (P = 0.004) larger than the region with occluded choriocapillaris. Gamma zone (mean length: 0.63 +/- 1.25 mm) was associated with axial length (P<0.001; r(2) = 0.73) with an increase starting at an axial length of 26.5 mm. It was not significantly (P = 0.24) associated with glaucomatous optic neuropathy. Delta zone (present only in eyes with axial length of >= 27 mm) was associated with axial length (P = 0.001) and scleral flange length (P, 0.001) but not with glaucoma (P = 0.73). Conclusions/Significance: Parapapillary gamma zone (peripapillary sclera without overlying choroid, Bruch's membrane and deep retinal layers) was related with axial globe elongation and was independent of glaucoma. Delta zone (no blood vessels >50 mu m diameter within gamma zone) was present only in highly axially elongated globes and was not related with glaucoma. Beta zone (Bruch's membrane without RPE) was correlated with glaucoma but not with globe elongation. Since the region with occluded choriocapillaris was smaller than beta zone, complete loss of RPE may have occurred before complete choriocapillaris closure.	[Jonas, Jost B.; Jonas, Shefali B.; Jonas, Rahul A.; Panda-Jonas, Songhomitra] Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, D-6900 Heidelberg, Germany; [Holbach, Leonhard] Univ Erlangen Nurnberg, Dept Ophthalmol, Erlangen, Germany; [Dai, Yi; Sun, Xinghuai] Fudan Univ, Shanghai Med Coll, Eye & ENT Hosp, Dept Ophthalmol & Vis Sci, Shanghai 200433, Peoples R China; [Sun, Xinghuai] Fudan Univ, Inst Brain Sci, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China	Ruprecht Karls University Heidelberg; University of Erlangen Nuremberg; Fudan University; Fudan University	Jonas, JB (corresponding author), Heidelberg Univ, Med Fac Mannheim, Dept Ophthalmol, D-6900 Heidelberg, Germany.	Jost.Jonas@umm.de	Dai, Yi/AAX-2979-2021; Jonas, Rahul A/N-9304-2017	Jonas, Rahul/0000-0002-5389-3047				Burgoyne CF, 2001, J GLAUCOMA, V10, pS16, DOI 10.1097/00061198-200110001-00007; FANTES FE, 1989, OPHTHALMOLOGY, V96, P20; Guist G, 1934, COINCIDENT OPHTHALMO; Hayashi K, 2012, INVEST OPHTH VIS SCI, V53, P1499, DOI 10.1167/iovs.11-8572; JONAS JB, 1989, INVEST OPHTH VIS SCI, V30, P908; Jonas JB, 2005, AM J OPHTHALMOL, V139, P346, DOI 10.1016/j.ajo.2004.07.047; JONAS JB, 1992, GRAEF ARCH CLIN EXP, V230, P134, DOI 10.1007/BF00164651; Jonas JB, 2011, AM J OPHTHALMOL, V152, P1021, DOI 10.1016/j.ajo.2011.05.006; Jonas JB, 2010, ACTA OPHTHALMOL, V88, pe317, DOI 10.1111/j.1755-3768.2010.02022.x; KUBOTA T, 1993, BRIT J OPHTHALMOL, V77, P103, DOI 10.1136/bjo.77.2.103; Lee KYC, 2010, INVEST OPHTH VIS SCI, V51, P666, DOI 10.1167/iovs.09-3663; Manjunath V, 2011, OPHTHALMOLOGY, V118, P531, DOI 10.1016/j.ophtha.2010.07.013; Na Jung Hwa, 2010, Korean J Ophthalmol, V24, P353, DOI 10.3341/kjo.2010.24.6.353; Nonaka A, 2011, INVEST OPHTH VIS SCI, V52, P6706, DOI 10.1167/iovs.11-7580; Ohno-Matsui K, 2011, INVEST OPHTH VIS SCI, V52, P9644, DOI 10.1167/iovs.11-8597; Park SC, 2012, OPHTHALMOLOGY, V119, P3, DOI 10.1016/j.ophtha.2011.07.012; Park SC, 2010, INVEST OPHTH VIS SCI, V51, P6408, DOI 10.1167/iovs.09-5100; Reis ASC, 2012, OPHTHALMOLOGY, V119, P738, DOI 10.1016/j.ophtha.2011.09.054; Sigal IA, 2005, INVEST OPHTH VIS SCI, V46, P4189, DOI 10.1167/iovs.05-0541; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050; Xu LA, 2010, ACTA OPHTHALMOL, V88, pe350, DOI 10.1111/j.1755-3768.2009.01770.x	21	158	163	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47237	10.1371/journal.pone.0047237	http://dx.doi.org/10.1371/journal.pone.0047237			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094040	Green Published, gold			2022-12-25	WOS:000312384500006
J	Huser, A; Rohwedder, A; Apostolopoulou, AA; Widmann, A; Pfitzenmaier, JE; Maiolo, EM; Selcho, M; Pauls, D; von Essen, A; Gupta, T; Sprecher, SG; Birman, S; Riemensperger, T; Stocker, RF; Thum, AS				Huser, Annina; Rohwedder, Astrid; Apostolopoulou, Anthi A.; Widmann, Annekathrin; Pfitzenmaier, Johanna E.; Maiolo, Elena M.; Selcho, Mareike; Pauls, Dennis; von Essen, Alina; Gupta, Tripti; Sprecher, Simon G.; Birman, Serge; Riemensperger, Thomas; Stocker, Reinhard F.; Thum, Andreas S.			The Serotonergic Central Nervous System of the Drosophila Larva: Anatomy and Behavioral Function	PLOS ONE			English	Article							MOTH MANDUCA-SEXTA; CONTAINING NEURONS; IMMUNOREACTIVE NEURONS; OLFACTORY MEMORY; DECISION-MAKING; LIGHT-AVOIDANCE; HEAD INVOLUTION; MUSHROOM BODIES; BIOGENIC-AMINES; TERM-MEMORY	The Drosophila larva has turned into a particularly simple model system for studying the neuronal basis of innate behaviors and higher brain functions. Neuronal networks involved in olfaction, gustation, vision and learning and memory have been described during the last decade, often up to the single-cell level. Thus, most of these sensory networks are substantially defined, from the sensory level up to third-order neurons. This is especially true for the olfactory system of the larva. Given the wealth of genetic tools in Drosophila it is now possible to address the question how modulatory systems interfere with sensory systems and affect learning and memory. Here we focus on the serotonergic system that was shown to be involved in mammalian and insect sensory perception as well as learning and memory. Larval studies suggested that the serotonergic system is involved in the modulation of olfaction, feeding, vision and heart rate regulation. In a dual anatomical and behavioral approach we describe the basic anatomy of the larval serotonergic system, down to the single-cell level. In parallel, by expressing apoptosis-inducing genes during embryonic and larval development, we ablate most of the serotonergic neurons within the larval central nervous system. When testing these animals for naive odor, sugar, salt and light perception, no profound phenotype was detectable; even appetitive and aversive learning was normal. Our results provide the first comprehensive description of the neuronal network of the larval serotonergic system. Moreover, they suggest that serotonin per se is not necessary for any of the behaviors tested. However, our data do not exclude that this system may modulate or fine-tune a wide set of behaviors, similar to its reported function in other insect species or in mammals. Based on our observations and the availability of a wide variety of genetic tools, this issue can now be addressed.	[Huser, Annina; Rohwedder, Astrid; Apostolopoulou, Anthi A.; Widmann, Annekathrin; Pfitzenmaier, Johanna E.; Maiolo, Elena M.; von Essen, Alina; Gupta, Tripti; Sprecher, Simon G.; Stocker, Reinhard F.; Thum, Andreas S.] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland; [Selcho, Mareike; Pauls, Dennis] Univ Wurzburg, Bioctr, Theodor Boveri Inst, Wurzburg, Germany; [Birman, Serge] CNRS, ESPCI Neurobiol Unit, Paris, France; [Riemensperger, Thomas] Univ Gottingen, Johann Friedrich Blumenbach Inst Zool & Anthropol, Gottingen, Germany; [Rohwedder, Astrid; Apostolopoulou, Anthi A.; Widmann, Annekathrin; Pfitzenmaier, Johanna E.; Thum, Andreas S.] Univ Konstanz, Dept Biol, Constance, Germany	University of Fribourg; University of Wurzburg; Centre National de la Recherche Scientifique (CNRS); University of Gottingen; University of Konstanz	Thum, AS (corresponding author), Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland.	andreas.thum@uni-konstanz.de	Apostolopoulou, Anthi/AAX-5004-2020; Thum, Andreas S/B-1083-2013; Sprecher, Simon/K-4249-2015	Critelli, Salvatore/0000-0001-7325-0228; Widmann, Annekathrin/0000-0003-1387-6805; Thum, Andreas/0000-0002-3830-6596; Pauls, Dennis/0000-0001-8330-8120; Apostolopoulou, Anthi/0000-0002-8174-4372; Selcho, Mareike/0000-0002-6405-2972; Sprecher, Simon/0000-0001-9060-3750	DFG [TH1584/1-1]; SNF [31003A_132812/1]; Zukunftskolleg of the University Konstanz	DFG(German Research Foundation (DFG)); SNF; Zukunftskolleg of the University Konstanz	This work was supported by DFG grant TH1584/1-1, SNF grant 31003A_132812/1 and the Zukunftskolleg of the University Konstanz to AST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT MK, 1991, GENETICS, V129, P783; ACEVESPINA FO, 1979, SCIENCE, V206, P93, DOI 10.1126/science.206.4414.93; Aso Y, 2010, CURR BIOL, V20, P1445, DOI 10.1016/j.cub.2010.06.048; Becnel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020800; Bicker G, 1999, MICROSC RES TECHNIQ, V44, P166, DOI 10.1002/(SICI)1097-0029(19990115/01)44:2/3<166::AID-JEMT8>3.0.CO;2-T; Blenau W, 2005, ARCH INSECT BIOCHEM, V59, P99, DOI 10.1002/arch.20072; Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240; Bossing T, 1996, MECH DEVELOP, V55, P53, DOI 10.1016/0925-4773(95)00490-4; BRAND AH, 1995, CURR OPIN NEUROBIOL, V5, P572, DOI 10.1016/0959-4388(95)80061-1; BRAND AH, 1993, DEVELOPMENT, V118, P401; BUDNIK V, 1988, J COMP NEUROL, V268, P400, DOI 10.1002/cne.902680309; BUDNIK V, 1989, J NEUROSCI, V9, P2866; Busch S, 2009, J COMP NEUROL, V513, P643, DOI 10.1002/cne.21966; Chen J, 2008, DEV BIOL, V320, P30, DOI 10.1016/j.ydbio.2008.03.038; Colomb J, 2007, J COMP NEUROL, V502, P834, DOI 10.1002/cne.21312; Dacks AM, 2006, J COMP NEUROL, V498, P727, DOI 10.1002/cne.21076; Dasari S, 2006, J COMP PHYSIOL B, V176, P349, DOI 10.1007/s00360-005-0058-3; Diegelmann S, 2002, GENESIS, V34, P95, DOI 10.1002/gene.10112; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Dumstrei K, 2003, J COMP NEUROL, V455, P451, DOI 10.1002/cne.10484; Fiala A, 2002, CURR BIOL, V12, P1877, DOI 10.1016/S0960-9822(02)01239-3; Gerber B, 2004, J EXP BIOL, V207, P179, DOI 10.1242/jeb.00718; Gerber B, 2009, RESULTS PROBL CELL D, V47, P139, DOI 10.1007/400_2008_9; Gerber B, 2007, CHEM SENSES, V32, P65, DOI 10.1093/chemse/bjl030; Giang T, 2011, J NEUROGENET, V25, P17, DOI 10.3109/01677063.2011.553002; Gomez-Marin A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1455; GREEN AR, 1990, ANN NY ACAD SCI, V600, P237; GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694; HEISENBERG M, 1985, J NEUROGENET, V2, P1, DOI 10.3109/01677068509100140; Hendel T, 2005, J COMP PHYSIOL A, V191, P265, DOI 10.1007/s00359-004-0574-8; HOMBERG U, 1989, J COMP NEUROL, V288, P243, DOI 10.1002/cne.902880204; Honjo K, 2005, J NEUROSCI, V25, P7905, DOI 10.1523/JNEUROSCI.2135-05.2005; Ito K, 1998, LEARN MEMORY, V5, P52; Iyengar BG, 2006, J COMP NEUROL, V499, P583, DOI 10.1002/cne.21133; Johnson O, 2011, NEUROSCIENCE, V192, P372, DOI 10.1016/j.neuroscience.2011.06.058; Johnson O, 2009, NEUROSCIENCE, V158, P1292, DOI 10.1016/j.neuroscience.2008.10.055; KAMYSHEV NG, 1983, PHARMACOL BIOCHEM BE, V18, P677, DOI 10.1016/0091-3057(83)90005-9; Keene AC, 2004, NEURON, V44, P521, DOI 10.1016/j.neuron.2004.10.006; Keene AC, 2006, CURR BIOL, V16, P1524, DOI 10.1016/j.cub.2006.06.022; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Keene AC, 2011, J NEUROSCI, V31, P6527, DOI 10.1523/JNEUROSCI.6165-10.2011; KENT KS, 1987, J NEUROBIOL, V18, P451, DOI 10.1002/neu.480180506; Kitamoto T, 2002, P NATL ACAD SCI USA, V99, P13232, DOI 10.1073/pnas.202489099; Krashes MJ, 2009, CELL, V139, P416, DOI 10.1016/j.cell.2009.08.035; Lee PT, 2011, P NATL ACAD SCI USA, V108, P13794, DOI 10.1073/pnas.1019483108; Lee T, 1999, DEVELOPMENT, V126, P4065; Louis M, 2008, J VIS EXP; Lundell MJ, 1996, MOL CELL NEUROSCI, V7, P46, DOI 10.1006/mcne.1996.0004; LUNDELL MJ, 1994, DEV BIOL, V165, P385, DOI 10.1006/dbio.1994.1261; Luo JN, 2012, CELL MOL LIFE SCI, V69, P471, DOI 10.1007/s00018-011-0789-0; Luo LJ, 2010, J NEUROSCI, V30, P4261, DOI 10.1523/JNEUROSCI.4090-09.2010; Mao ZM, 2009, FRONT NEURAL CIRCUIT, V3, DOI 10.3389/neuro.04.005.2009; Michels B, 2005, LEARN MEMORY, V12, P224, DOI 10.1101/lm.92805; Monastirioti M, 1999, MICROSC RES TECHNIQ, V45, P106, DOI 10.1002/(SICI)1097-0029(19990415)45:2<106::AID-JEMT5>3.3.CO;2-V; Moncalvo VGR, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-66; MONTE P, 1989, BEHAV GENET, V19, P267, DOI 10.1007/BF01065910; Nassif C, 2003, J COMP NEUROL, V455, P417, DOI 10.1002/cne.10482; Neckameyer WS, 2007, GENES BRAIN BEHAV, V6, P756, DOI 10.1111/j.1601-183X.2007.00307.x; Neckameyer WS, 2010, DEV NEUROSCI-BASEL, V32, P217, DOI 10.1159/000304888; NECKAMEYER WS, 1992, J BIOL CHEM, V267, P4199; Nichols CD, 2007, DEV NEUROBIOL, V67, P752, DOI 10.1002/dneu.20370; Niewalda T, 2008, CHEM SENSES, V33, P685, DOI 10.1093/chemse/bjn037; NOVAK MG, 1994, J MED ENTOMOL, V31, P600, DOI 10.1093/jmedent/31.4.600; NOVAK MG, 1995, J EXP BIOL, V198, P167; Olivier B, 1995, PHARMACOPSYCHIATRY, V28, P80, DOI 10.1055/s-2007-979624; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Pauls D, 2010, J NEUROSCI, V30, P10655, DOI 10.1523/JNEUROSCI.1281-10.2010; Pauls D, 2010, CHEM SENSES, V35, P335, DOI 10.1093/chemse/bjq023; PRUZAN A, 1977, BEHAV GENET, V7, P457, DOI 10.1007/BF01066781; Rohwedder A, 2012, CHEM SENSES; Roman G, 2004, BIOESSAYS, V26, P1243, DOI 10.1002/bies.20120; Roy B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-20; SALECKER I, 1990, HISTOCHEMISTRY, V94, P463, DOI 10.1007/BF00272608; SawinMcCormack EP, 1995, J NEUROGENET, V10, P119, DOI 10.3109/01677069509083459; Scherer S, 2003, LEARN MEMORY, V10, P217, DOI 10.1101/lm.57903; Schipanski A, 2008, CHEM SENSES, V33, P563, DOI 10.1093/chemse/bjn024; Schleyer M, 2011, LEARN MEMORY, V18, P639, DOI 10.1101/lm.2163411; Schroll C, 2006, CURR BIOL, V16, P1741, DOI 10.1016/j.cub.2006.07.023; Sejourne J, 2011, NAT NEUROSCI, V14, P903, DOI 10.1038/nn.2846; Selcho M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005897; Sitaraman D, 2012, J NEUROGENET; Sitaraman D, 2012, J NEUROGENET, V26, P238, DOI 10.3109/01677063.2012.666298; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Sykes PA, 2005, DEV BIOL, V286, P207, DOI 10.1016/j.ydbio.2005.07.025; TAGHERT PH, 1984, J NEUROSCI, V4, P989; VALLES AM, 1988, J COMP NEUROL, V268, P414, DOI 10.1002/cne.902680310; Venken KJT, 2011, NEURON, V72, P202, DOI 10.1016/j.neuron.2011.09.021; von Essen AMHJ, 2011, BEHAV NEUROSCI, V125, P921, DOI 10.1037/a0025758; von Essen AM, 2011, BEHAV NEUROSCI; Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306; Waddell S, 2000, CELL, V103, P805, DOI 10.1016/S0092-8674(00)00183-5; Wang J, 2004, NEURON, V43, P663, DOI 10.1016/j.neuron.2004.06.033; Westenberg HGM, 1996, J AFFECT DISORDERS, V40, P85, DOI 10.1016/0165-0327(96)00043-2; White K, 1996, SCIENCE, V271, P805, DOI 10.1126/science.271.5250.805; Wilkinson LO, 1991, SEROTONIN RECEPTOR S, P147; Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9; Wu Q, 2003, NEURON, V39, P147, DOI 10.1016/S0896-6273(03)00396-9; Xiang Y, 2010, NATURE, V468, P921, DOI 10.1038/nature09576; Xu J, 2008, NAT NEUROSCI, V11, P676, DOI 10.1038/nn.2119; Younossi-Hartenstein A, 2003, J COMP NEUROL, V455, P435, DOI 10.1002/cne.10483; Yu DH, 2005, CELL, V123, P945, DOI 10.1016/j.cell.2005.09.037; Yuan Q, 2005, NEURON, V47, P115, DOI 10.1016/j.neuron.2005.05.027; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032	103	54	54	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47518	10.1371/journal.pone.0047518	http://dx.doi.org/10.1371/journal.pone.0047518			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082175	Green Published, Green Submitted, Green Accepted, gold			2022-12-25	WOS:000311146900071
J	Regier, DA; Diorio, C; Ethier, MC; Alli, A; Alexander, S; Boydell, KM; Gassas, A; Taylor, J; Kellow, C; Mills, D; Sung, L				Regier, Dean A.; Diorio, Caroline; Ethier, Marie-Chantal; Alli, Amanda; Alexander, Sarah; Boydell, Katherine M.; Gassas, Adam; Taylor, Jonathan; Kellow, Charis; Mills, Denise; Sung, Lillian			Discrete Choice Experiment to Evaluate Factors That Influence Preferences for Antibiotic Prophylaxis in Pediatric Oncology	PLOS ONE			English	Article							MORTALITY	Background: Bacterial and fungal infections in pediatric oncology patients cause morbidity and mortality. The clinical utility of antimicrobial prophylaxis in children is uncertain and the personal utility of these agents is disputed. Objectives were to use a discrete choice experiment to: (1) describe the importance of attributes to parents and healthcare providers when deciding between use and non-use of antibacterial and antifungal prophylaxis; and (2) estimate willingness-to-pay for prophylactic strategies. Methods: Attributes were chances of infection, death and side effects, route of administration and cost of pharmacotherapy. Respondents were randomized to a discrete choice experiment outlining hypothetical treatment options to prevent antibacterial or antifungal infections. Each respondent was presented 16 choice tasks and was asked to choose between two unlabeled treatment options and an opt-out alternative (no prophylaxis). Results: 102 parents and 60 healthcare providers participated. For the antibacterial discrete choice experiment, frequency of administration was significantly associated with utility for parents but not for healthcare providers. Increasing chances of infection, death, side effects and cost were all significantly associated with decreased utility for parents and healthcare providers in both the antibacterial and antifungal discrete choice experiment. Parental willingness-to-pay was higher than healthcare providers for both strategies. Conclusion: Chances of infection, death, side effects and costs were all significantly associated with utility. Parents have higher willingness-to-pay for these strategies compared with healthcare providers. This knowledge can help to develop prophylaxis programs.	[Regier, Dean A.] British Columbia Canc Res Agcy, Canadian Ctr Appl Res Canc Control, Vancouver, BC, Canada; [Diorio, Caroline; Ethier, Marie-Chantal; Alli, Amanda; Taylor, Jonathan; Kellow, Charis; Sung, Lillian] Hosp Sick Children, Program Child Hlth Evaluat Sci, Toronto, ON M5G 1X8, Canada; [Alexander, Sarah; Gassas, Adam; Mills, Denise; Sung, Lillian] Hosp Sick Children, Div Haematol Oncol, Toronto, ON M5G 1X8, Canada; [Boydell, Katherine M.] Hosp Sick Children, Community Hlth Syst Resource Grp, Toronto, ON M5G 1X8, Canada; [Ethier, Marie-Chantal] McMaster Univ, Program Hlth Res Methodol, Hamilton, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University	Sung, L (corresponding author), British Columbia Canc Res Agcy, Canadian Ctr Appl Res Canc Control, Vancouver, BC, Canada.	lillian.sung@sickkids.ca	Boydell, Katherine/AAR-2918-2021	Boydell, Katherine/0000-0002-1464-8532; Regier, Dean/0000-0001-8876-0511; Diorio, Caroline/0000-0002-8005-3836	Canadian Institutes of Health Research [87719]; Pediatric Oncology Group of Ontario Research Unit	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Pediatric Oncology Group of Ontario Research Unit	LS is supported by a New Investigator Award from the Canadian Institutes of Health Research (Grant no. 87719). This research is supported by the Pediatric Oncology Group of Ontario Research Unit. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gafter-Gvili A, 2005, ANN INTERN MED, V142, P979, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00008; Kuderer NM, 2006, CANCER-AM CANCER SOC, V106, P2258, DOI 10.1002/cncr.21847; LANCASTER KJ, 1966, J POLIT ECON, V74, P132, DOI 10.1086/259131; Lehrnbecher T, 2009, BRIT J HAEMATOL, V147, P125, DOI 10.1111/j.1365-2141.2009.07844.x; Louviere J., 2002, STATED CHOICE METHOD; Louviere J. J., 2000, STATED CHOICE METHOD, DOI DOI 10.1017/CBO9780511753831; Regier DA, 2010, AM J HUM GENET, V86, P765, DOI 10.1016/j.ajhg.2010.03.009; Robenshtok E, 2007, J CLIN ONCOL, V25, P5471, DOI 10.1200/JCO.2007.12.3851; Ryan M, 2000, BMJ-BRIT MED J, V320, P1530, DOI 10.1136/bmj.320.7248.1530; SMALL KA, 1981, ECONOMETRICA, V49, P105, DOI 10.2307/1911129; Street D. J., 2007, CONSTRUCTION OPTIMAL; Sung LL, 2007, BLOOD, V110, P3532, DOI 10.1182/blood-2007-05-091942; Telser H, 2002, HEALTH ECON, V11, P129, DOI 10.1002/hec.653	13	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47470	10.1371/journal.pone.0047470	http://dx.doi.org/10.1371/journal.pone.0047470			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038AF	23082169	gold, Green Published, Green Submitted			2022-12-25	WOS:000311146900065
J	All, AH; Bazley, FA; Gupta, S; Pashai, N; Hu, C; Pourmorteza, A; Kerr, C				All, Angelo H.; Bazley, Faith A.; Gupta, Siddharth; Pashai, Nikta; Hu, Charles; Pourmorteza, Amir; Kerr, Candace			Human Embryonic Stem Cell-Derived Oligodendrocyte Progenitors Aid in Functional Recovery of Sensory Pathways following Contusive Spinal Cord Injury	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; SOMATOSENSORY-EVOKED POTENTIALS; NEURAL STEM/PROGENITOR CELLS; LOCOMOTOR RECOVERY; PRECURSOR CELLS; MOUSE MODEL; RAT; BIOLUMINESCENCE; DIFFERENTIATION; TRANSPLANTATION	Background: Transplantations of human stem cell derivatives have been widely investigated in rodent models for the potential restoration of function of neural pathways after spinal cord injury (SCI). Studies have already demonstrated cells survival following transplantation in SCI. We sought to evaluate survival and potential therapeutic effects of transplanted human embryonic stem (hES) cell-derived oligodendrocyte progenitor cells (OPCs) in a contusive injury in rats. Bioluminescence imaging was utilized to verify survivability of cells up to 4 weeks, and somatosensory evoked potential (SSEPs) were recorded at the cortex to monitor function of sensory pathways throughout the 6-week recovery period. Principal Findings: hES cells were transduced with the firefly luciferase gene and differentiated into OPCs. OPCs were transplanted into the lesion epicenter of rat spinal cords 2 hours after inducing a moderate contusive SCI. The hES-treatment group showed improved SSEPs, including increased amplitude and decreased latencies, compared to the control group. The bioluminescence of transplanted OPCs decreased by 97% in the injured spinal cord compared to only 80% when injected into an uninjured spinal cord. Bioluminescence increased in both experimental groups such that by week 3, no statistical difference was detected, signifying that the cells survived and proliferated independent of injury. Post-mortem histology of the spinal cords showed integration of human cells expressing mature oligodendrocyte markers and myelin basic protein without the expression of markers for astrocytes (GFAP) or pluripotent cells (OCT4). Conclusions: hES-derived OPCs transplanted 2 hours after contusive SCI survive and differentiate into OLs that produce MBP. Treated rats demonstrated functional improvements in SSEP amplitudes and latencies compared to controls as early as 1 week post-injury. Finally, the hostile injury microenvironment at 2 hours post-injury initially caused increased cell death but did not affect the long-term cell proliferation or survival, indicating that cells can be transplanted sooner than conventionally accepted.	[All, Angelo H.; Bazley, Faith A.; Gupta, Siddharth; Pashai, Nikta; Hu, Charles; Pourmorteza, Amir] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [All, Angelo H.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Kerr, Candace] Univ Maryland, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore	All, AH (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.	hmn@jhu.edu; ckerr@som.umaryland.edu			Maryland Stem Cell Research Fund (MSCRF) [2007-MSCRFII-0159-00, 2009-MSCRFII-0091-00]; National Institutes of Health (NICHD) [R21HD057487-01A1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD057487] Funding Source: NIH RePORTER	Maryland Stem Cell Research Fund (MSCRF); National Institutes of Health (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors would like to thank the Maryland Stem Cell Research Fund (MSCRF): Grant #2007-MSCRFII-0159-00 (awarded to CK) and Grant #2009-MSCRFII-0091-00 (awarded to AA). We would also like to thank the National Institutes of Health (NICHD): Grant #R21HD057487-01A1 (awarded to CK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abematsu M, 2010, J CLIN INVEST, V120, P3255, DOI 10.1172/JCI42957; AGRAWAL G, 2009, EMBC 2009 ANN INT C, P2086; Agrawal G, 2010, J CLIN NEUROSCI, V17, P1159, DOI 10.1016/j.jocn.2010.02.005; Agrawal G, 2010, SPINE, V35, P1122, DOI 10.1097/BRS.0b013e3181be5fa7; Agrawal G, 2009, J CLIN NEUROSCI, V16, P1052, DOI 10.1016/j.jocn.2008.08.009; All AH, 2010, NEUROL SCI, V31, P595, DOI 10.1007/s10072-010-0329-y; All AH, 2009, J NEUROL SCI, V284, P81, DOI 10.1016/j.jns.2009.04.025; Amit M, 2003, BIOL REPROD, V68, P2150, DOI 10.1095/biolreprod.102.012583; Arnhold S, 2004, INVEST OPHTH VIS SCI, V45, P4251, DOI 10.1167/iovs.03-1108; Bazley FA, 2012, J NEUROSURG IN PRESS; Bazley FA, 2011, IEEE ENG MED BIO, P2005, DOI 10.1109/IEMBS.2011.6090564; BOTTENSTEIN JE, 1979, P NATL ACAD SCI USA, V76, P514, DOI 10.1073/pnas.76.1.514; Curt A, 1998, ARCH PHYS MED REHAB, V79, P81, DOI 10.1016/S0003-9993(98)90213-1; Dietz V, 1998, ELECTROMYOGR MOTOR C, V109, P140, DOI 10.1016/S0924-980X(98)00002-2; Dothager RS, 2009, CURR OPIN BIOTECH, V20, P45, DOI 10.1016/j.copbio.2009.01.007; Einstein O, 2006, EXP NEUROL, V198, P275, DOI 10.1016/j.expneurol.2005.11.007; Erceg S, 2010, STEM CELLS, V28, P1541, DOI 10.1002/stem.489; Faulkner J, 2005, TRANSPL IMMUNOL, V15, P131, DOI 10.1016/j.trim.2005.09.007; Geron, 2010, SAF STUD GRNOPC1 SPI; Hovatta O, 2003, HUM REPROD, V18, P1404, DOI 10.1093/humrep/deg290; Hwang DH, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-117; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kerr CL, 2010, INT J NEUROSCI, V120, P305, DOI 10.3109/00207450903585290; Kumagai G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007706; Letzen BS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010480; Lu HZ, 2010, DIFFERENTIATION, V80, P228, DOI 10.1016/j.diff.2010.09.179; Maybhate A, 2012, CRIT CARE MED, V40, P573, DOI 10.1097/CCM.0b013e318232d97e; Michelini E, 2009, METHODS MOL BIOL, V574, P1, DOI 10.1007/978-1-60327-321-3_1; Moloney TC, 2010, NEUROREHAB NEURAL RE, V24, P645, DOI 10.1177/1545968309357745; Nori S, 2011, P NATL ACAD SCI USA, V108, P16825, DOI 10.1073/pnas.1108077108; Ogawa D, 2009, J NEUROSCI RES, V87, P307, DOI 10.1002/jnr.21843; Okada S, 2005, FASEB J, V19, P1839, DOI 10.1096/fj.05-4082fje; Park S, 2012, CYTOTHERAPY; Rossi SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011852; Sahni V, 2010, NAT REV NEUROL, V6, P363, DOI 10.1038/nrneurol.2010.73; Sharp J, 2010, STEM CELLS, V28, P152, DOI 10.1002/stem.245; Sher F, 2009, STEM CELLS, V27, P1582, DOI 10.1002/stem.76; Su ZD, 2011, J NEUROTRAUM, V28, P1089, DOI 10.1089/neu.2010.1597; Takahashi Y, 2011, CELL TRANSPLANT, V20, P727, DOI 10.3727/096368910X536554; Tsuji O, 2011, NEUROTHERAPEUTICS, V8, P668, DOI 10.1007/s13311-011-0063-z; Walczak P, 2011, GLIA, V59, P499, DOI 10.1002/glia.21119; Wang YP, 2011, J NEUROSCI, V31, P6053, DOI 10.1523/JNEUROSCI.5524-09.2011; Zeng X, 2011, CELL TRANSPLANT, V20, P1881, DOI 10.3727/096368911X566181	43	40	49	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47645	10.1371/journal.pone.0047645	http://dx.doi.org/10.1371/journal.pone.0047645			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091637	Green Published, Green Submitted, gold			2022-12-25	WOS:000310135800062
J	Patil, SS; Gentschev, I; Adelfinger, M; Donat, U; Hess, M; Weibel, S; Nolte, I; Frentzen, A; Szalay, AA				Patil, Sandeep S.; Gentschev, Ivaylo; Adelfinger, Marion; Donat, Ulrike; Hess, Michael; Weibel, Stephanie; Nolte, Ingo; Frentzen, Alexa; Szalay, Aladar A.			Virotherapy of Canine Tumors with Oncolytic Vaccinia Virus GLV-1h109 Expressing an Anti-VEGF Single-Chain Antibody	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; MICROVASCULAR DENSITY; BREAST-TUMORS; NUDE-MICE; PET DOGS; THERAPY; CANCER; MODEL; MICROENVIRONMENT; ANGIOGENESIS	Virotherapy using oncolytic vaccinia virus (VACV) strains is one promising new strategy for cancer therapy. We have previously reported that oncolytic vaccinia virus strains expressing an anti-VEGF (Vascular Endothelial Growth Factor) single-chain antibody (scAb) GLAF-1 exhibited significant therapeutic efficacy for treatment of human tumor xenografts. Here, we describe the use of oncolytic vaccinia virus GLV-1h109 encoding GLAF-1 for canine cancer therapy. In this study we analyzed the virus-mediated delivery and production of scAb GLAF-1 and the oncolytic and immunological effects of the GLV-1h109 vaccinia virus strain against canine soft tissue sarcoma and canine prostate carcinoma in xenograft models. Cell culture data demonstrated that the GLV-1h109 virus efficiently infect, replicate in and destroy both tested canine cancer cell lines. In addition, successful expression of GLAF-1 was demonstrated in virus-infected canine cancer cells and the antibody specifically recognized canine VEGF. In two different xenograft models, the systemic administration of the GLV-1h109 virus was found to be safe and led to anti-tumor and immunological effects resulting in the significant reduction of tumor growth in comparison to untreated control mice. Furthermore, tumor-specific virus infection led to a continued production of functional scAb GLAF-1, resulting in inhibition of angiogenesis. Overall, the GLV-1h109-mediated cancer therapy and production of immunotherapeutic anti-VEGF scAb may open the way for combination therapy concept i.e. vaccinia virus mediated oncolysis and intratumoral production of therapeutic drugs in canine cancer patients.	[Patil, Sandeep S.; Gentschev, Ivaylo; Adelfinger, Marion; Donat, Ulrike; Hess, Michael; Weibel, Stephanie; Szalay, Aladar A.] Univ Wurzburg, Dept Biochem, Wurzburg, Germany; [Gentschev, Ivaylo; Frentzen, Alexa; Szalay, Aladar A.] Genelux Corp, San Diego Sci Ctr, San Diego, CA USA; [Nolte, Ingo] Univ Vet Med, Small Anim Clin, Hannover, Germany; [Szalay, Aladar A.] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, Wurzburg, Germany; [Szalay, Aladar A.] Univ Wurzburg, Inst Mol Infect Biol, Wurzburg, Germany; [Szalay, Aladar A.] Univ Calif San Diego, Moores Canc Ctr, Dept Radiat Oncol, La Jolla, CA 92093 USA	University of Wurzburg; University of Veterinary Medicine Hannover, Foundation; University of Wurzburg; University of Wurzburg; University of California System; University of California San Diego	Szalay, AA (corresponding author), Univ Wurzburg, Dept Biochem, Wurzburg, Germany.	aaszalay@genelux.com	Gentschev, Ivaylo/AAJ-5819-2021; Gentschev, Ivaylo/F-9454-2011	Gentschev, Ivaylo/0000-0003-3743-6329	Research and Development Division of Genelux Corporation, San Diego, USA; Genelux Corp., San Diego, USA; Genelux Corporation; German Excellence Initiative; German Research Foundation (DFG); University of Wuerzburg in the funding programme Open Access Publishing; Genelux	Research and Development Division of Genelux Corporation, San Diego, USA; Genelux Corp., San Diego, USA; Genelux Corporation; German Excellence Initiative; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg in the funding programme Open Access Publishing; Genelux	The research was supported by the Research and Development Division of Genelux Corporation, San Diego, USA, and a Service Grant to the University of Wurzburg, Germany also funded by Genelux Corp., San Diego, USA. IG AF and AAS are employees and shareholders of Genelux. MA, UD, MH and SW were supported by grants of Genelux Corporation. SSP is a graduate fellow and supported by a grant of the German Excellence Initiative to the Graduate School of Life Sciences, University of Wuerzburg. This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; I. Gentschev, A. Frentzen and A. A. Szalay have financial interests in Genelux Corporation, and M. Adelfinger U. Donar, M. Hess and S. Weibel were supported by grants of Genelux Corporation. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. However, no direct financial support was provided by Genelux for the completion of this study.	Arendt M, 2009, VET COMP ONCOL, V7, P153, DOI 10.1111/j.1476-5829.2009.00187.x; Breitbach CJ, 2007, MOL THER, V15, P1686, DOI 10.1038/sj.mt.6300215; de Queiroz GF, 2010, J VET DIAGN INVEST, V22, P105, DOI 10.1177/104063871002200121; FALKNER FG, 1990, J VIROL, V64, P3108, DOI 10.1128/JVI.64.6.3108-3111.1990; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Frentzen A, 2009, P NATL ACAD SCI USA, V106, P12915, DOI 10.1073/pnas.0900660106; Fridlender ZG, 2009, CANCER CELL, V16, P183, DOI 10.1016/j.ccr.2009.06.017; Gentschev I, 2009, CANCER GENE THER, V16, P320, DOI 10.1038/cgt.2008.87; Gentschev I, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/489759; Gentschev I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037239; Gentschev I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022069; Gentschev I, 2010, J ONCOL, V2010, DOI 10.1155/2010/736907; Gerber HP, 2000, CANCER RES, V60, P6253; Gerber HP, 2005, CANCER RES, V65, P671; Gil M, 2011, BRIT J CANCER, V105, P1512, DOI 10.1038/bjc.2011.429; Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583; Hemminki A, 2003, MOL THER, V7, P163, DOI 10.1016/S1525-0016(02)00049-7; Hess M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-172; Jain RK, 2001, ADV DRUG DELIVER REV, V46, P149, DOI 10.1016/S0169-409X(00)00131-9; John LB, 2012, CANCER RES, V72, P1651, DOI 10.1158/0008-5472.CAN-11-2788; Kamstock D, 2007, CANCER IMMUNOL IMMUN, V56, P1299, DOI 10.1007/s00262-007-0282-7; Kelsey JL, 1998, EPIDEMIOL REV, V20, P204, DOI 10.1093/oxfordjournals.epirev.a017981; Liang WC, 2006, J BIOL CHEM, V281, P951, DOI 10.1074/jbc.M508199200; Merlo DF, 2008, J VET INTERN MED, V22, P976, DOI 10.1111/j.1939-1676.2008.0133.x; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Ochando JC, 2012, IMMUNOL RES; Padera TP, 2004, NATURE, V427, P695, DOI 10.1038/427695a; Patil SS, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-3; Patruno R, 2009, J CELL MOL MED, V13, P555, DOI 10.1111/j.1582-4934.2008.00355.x; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Quesada AR, 2007, BIOESSAYS, V29, P1159, DOI 10.1002/bies.20655; Reimann-Berg N, 2011, CYTOGENET GENOME RES, V132, P16, DOI 10.1159/000317077; Ruffell B, 2012, TRENDS IMMUNOL, V33, P119, DOI 10.1016/j.it.2011.12.001; Suter SE, 2005, CLIN CANCER RES, V11, P1579, DOI 10.1158/1078-0432.CCR-04-1944; Weibel S, 2008, CELL MICROBIOL, V10, P1235, DOI 10.1111/j.1462-5822.2008.01122.x; Winkler F, 2004, CANCER CELL, V6, P553, DOI 10.1016/S1535-6108(04)00305-8; Zhang Q, 2007, CANCER RES, V67, P10038, DOI 10.1158/0008-5472.CAN-07-0146; Zizzo N, 2010, LEUKEMIA LYMPHOMA, V51, P291, DOI 10.3109/10428190903452818	39	25	35	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47472	10.1371/journal.pone.0047472	http://dx.doi.org/10.1371/journal.pone.0047472			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091626	Green Published, Green Submitted, gold			2022-12-25	WOS:000310135800049
J	Seehase, M; Collins, JJP; Kuypers, E; Jellema, RK; Ophelders, DRMG; Ospina, OL; Perez-Gil, J; Bianco, F; Garzia, R; Razzetti, R; Kramer, BW				Seehase, Matthias; Collins, Jennifer J. P.; Kuypers, Elke; Jellema, Reint K.; Ophelders, Daan R. M. G.; Ospina, Olga L.; Perez-Gil, J.; Bianco, Federico; Garzia, Raffaella; Razzetti, Roberta; Kramer, Boris W.			New Surfactant with SP-B and C Analogs Gives Survival Benefit after Inactivation in Preterm Lambs	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; IMMATURE NEWBORN RABBITS; PULMONARY SURFACTANT; EXOGENOUS SURFACTANT; NATURAL SURFACTANT; PREMATURE RABBITS; PROTEIN-A; FILMS; INFLAMMATION; INFANTS	Background: Respiratory distress syndrome in preterm babies is caused by a pulmonary surfactant deficiency, but also by its inactivation due to various conditions, including plasma protein leakage. Surfactant replacement therapy is well established, but clinical observations and in vitro experiments suggested that its efficacy may be impaired by inactivation. A new synthetic surfactant (CHF 5633), containing synthetic surfactant protein B and C analogs, has shown comparable effects on oxygenation in ventilated preterm rabbits versus Poractant alfa, but superior resistance against inactivation in vitro. We hypothesized that CHF 5633 is also resistant to inactivation by serum albumin in vivo. Methodology/Principal Findings: Nineteen preterm lambs of 127 days gestational age (term = 150 days) received CHF 5633 or Poractant alfa and were ventilated for 48 hours. Ninety minutes after birth, the animals received albumin with CHF 5633 or Poractant alfa. Animals received additional surfactant if PaO2 dropped below 100 mmHg. A pressure volume curve was done post mortem and markers of pulmonary inflammation, surfactant content and biophysiology, and lung histology were assessed. CHF 5633 treatment resulted in improved arterial pH, oxygenation and ventilation efficiency index. The survival rate was significantly higher after CHF 5633 treatment (5/7) than after Poractant alfa (1/8) after 48 hours of ventilation. Biophysical examination of the surfactant recovered from bronchoalveolar lavages revealed that films formed by CHF 5633-treated animals reached low surface tensions in a wider range of compression rates than films from Poractant alfa-treated animals. Conclusions: For the first time a synthetic surfactant containing both surfactant protein B and C analogs showed significant benefit over animal derived surfactant in an in vivo model of surfactant inactivation in premature lambs.	[Seehase, Matthias; Collins, Jennifer J. P.; Kuypers, Elke; Jellema, Reint K.; Ophelders, Daan R. M. G.; Kramer, Boris W.] Maastricht Univ, Med Ctr, Dept Pediat, Maastricht, Netherlands; [Bianco, Federico; Garzia, Raffaella; Razzetti, Roberta] Chiesi Farmaceutici SpA, Dept Res & Dev, Parma, Italy; [Ospina, Olga L.; Perez-Gil, J.] Univ Complutense, Fac Biol, Dept Biochem, E-28040 Madrid, Spain; [Ospina, Olga L.] Pontificia Univ Javeriana, Dept Phys, Bogota, Colombia	Maastricht University; Chiesi Pharmaceuticals Inc; Complutense University of Madrid; Pontificia Universidad Javeriana	Kramer, BW (corresponding author), Maastricht Univ, Med Ctr, Dept Pediat, Maastricht, Netherlands.	b.kramer@mumc.nl	Ospina-Ramírez, Olga Lucía/AAF-8248-2019; Perez-Gil, Jesus/H-3102-2019; Kramer, Boris/AAO-3183-2021; Jellema, Reint/AAW-1214-2020	Perez-Gil, Jesus/0000-0003-3587-7147; Jellema, Reint/0000-0002-6918-0930; Ophelders, Daan/0000-0001-7410-5102; Collins, Jennifer/0000-0002-7556-0526	VENI from the Dutch Research Council (NWO) [BWK 016.096.1441]; Spanish Ministry of Economy and Competitivity [BIO2009-09694, CSD2007-00010]; Community of Madrid [S2009MAT-1507]; Chiesi Pharmaceutici SpA (Parma, Italy)	VENI from the Dutch Research Council (NWO); Spanish Ministry of Economy and Competitivity(Spanish Government); Community of Madrid(Comunidad de Madrid); Chiesi Pharmaceutici SpA (Parma, Italy)(Chiesi Pharmaceuticals Inc)	BWK is supported by a VENI grant (No. BWK 016.096.141) from the Dutch Research Council (NWO). OLO and JPG are supported by grants from the Spanish Ministry of Economy and Competitivity (BIO2009-09694, CSD2007-00010) and Community of Madrid (S2009MAT-1507). This study was funded by Chiesi Pharmaceutici SpA (Parma, Italy). Preparations of CHF 5633 synthetic surfactant and Curosurf (R) were also supplied by Chiesi Pharmaceutici SpA. FB, RR and RG participated in the interpretation of the data and review of the manuscript, but otherwise the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almlen A, 2008, J APPL PHYSIOL, V104, P1101, DOI 10.1152/japplphysiol.00865.2007; Almlen A, 2010, NEONATOLOGY, V98, P91, DOI 10.1159/000276980; Aman J, 2011, CRIT CARE MED, V39, P89, DOI 10.1097/CCM.0b013e3181feb46a; Been JV, 2007, EUR J PEDIATR, V166, P889, DOI 10.1007/s00431-007-0501-4; Behrman RE, 2007, PRETERM BIRTH CAUSES; Blanco F., 2001, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD000144; Calkovska A, 2008, PULM PHARMACOL THER, V21, P393, DOI 10.1016/j.pupt.2007.10.003; Casals C, 1998, AM J RESP CRIT CARE, V157, P43, DOI 10.1164/ajrccm.157.1.9611106; Davis AJ, 1998, AM J RESP CRIT CARE, V157, P553, DOI 10.1164/ajrccm.157.2.97-08019; Friedrich W, 2000, Eur J Med Res, V5, P277; Gastiasoro-Cuesta E, 2006, PEDIATRICS, V117, P295, DOI 10.1542/peds.2005-0378; Gizzi C, 2010, J MATERN-FETAL NEO M, V23, P41, DOI 10.3109/14767058.2010.509912; Gomez-Gil L, 2009, BIOPHYS J, V97, P2736, DOI 10.1016/j.bpj.2009.08.045; Hilgendorff A, 2006, BIOL NEONATE, V90, P210, DOI 10.1159/000093820; Jobe AH, 2008, NEONATOLOGY, V94, P190, DOI 10.1159/000143721; Johansson J, 2003, J APPL PHYSIOL, V95, P2055, DOI 10.1152/japplphysiol.00153.2003; Koeppen M, 2011, J VIS EXP; Kramer B. W., 2007, Intensivmedizin und Notfallmedizin, V44, P403, DOI 10.1007/s00390-007-0809-3; Kramer BW, 2008, J PERINATOL, V28, pS21, DOI 10.1038/jp.2008.46; Kramer BW, 2001, AM J RESP CRIT CARE, V163, P158, DOI 10.1164/ajrccm.163.1.2005084; Kuronuma K, 2009, J BIOL CHEM, V284, P25488, DOI 10.1074/jbc.M109.040832; Lopez-Rodriguez E, 2011, BIOPHYS J, V100, P646, DOI 10.1016/j.bpj.2010.12.3715; Lu KW, 2011, BBA-BIOMEMBRANES, V1808, P2366, DOI 10.1016/j.bbamem.2011.06.013; Sarrasague MM, 2011, RESP PHYSIOL NEUROBI, V175, P316, DOI 10.1016/j.resp.2010.12.009; Miedema M, 2011, AM J RESP CRIT CARE; MIZUNO K, 1995, PEDIATR RES, V37, P271, DOI 10.1203/00006450-199503000-00004; Nag K, 2010, J COLLOID INTERF SCI, V352, P456, DOI 10.1016/j.jcis.2010.08.058; Numata M, 2010, P NATL ACAD SCI USA, V107, P320, DOI 10.1073/pnas.0909361107; Perez-Gil J, 2008, BBA-BIOMEMBRANES, V1778, P1676, DOI 10.1016/j.bbamem.2008.05.003; Perez-Gil J, 2010, PHYSIOLOGY, V25, P132, DOI 10.1152/physiol.00006.2010; RIDER ED, 1993, AM REV RESPIR DIS, V147, P669, DOI 10.1164/ajrccm/147.3.669; Roggini M, 2010, Minerva Pediatr, V62, P217; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Sato A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039392; Schurch D, 2010, BIOPHYS J, V99, P3290, DOI 10.1016/j.bpj.2010.09.039; Taeusch HW, 2005, BIOPHYS J, V89, P1769, DOI 10.1529/biophysj.105.062620; van Kaam AH, 2011, NEONATOLOGY, V100, P71, DOI 10.1159/000322004; Wirbelauer J, 2009, J PERINATOL, V29, pS18, DOI 10.1038/jp.2009.30; Zuo YY, 2008, BBA-BIOMEMBRANES, V1778, P1947, DOI 10.1016/j.bbamem.2008.03.021	39	64	71	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47631	10.1371/journal.pone.0047631	http://dx.doi.org/10.1371/journal.pone.0047631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091635	Green Published, gold, Green Submitted			2022-12-25	WOS:000310135800059
J	Idigo, WO; Reilly, S; Zhang, MH; Zhang, YH; Jayaram, R; Carnicer, R; Crabtree, MJ; Balligand, JL; Casadei, B				Idigo, Winifred O.; Reilly, Svetlana; Zhang, Mei Hua; Zhang, Yin Hua; Jayaram, Raja; Carnicer, Ricardo; Crabtree, Mark J.; Balligand, Jean-Luc; Casadei, Barbara			Regulation of Endothelial Nitric-oxide Synthase (NOS) S-Glutathionylation by Neuronal NOS EVIDENCE OF A FUNCTIONAL INTERACTION BETWEEN MYOCARDIAL CONSTITUTIVE NOS ISOFORMS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEFICIENT SKELETAL-MUSCLE; XANTHINE OXIDOREDUCTASE; SUPEROXIDE GENERATION; VENTRICULAR MYOCYTES; MUSCULAR-DYSTROPHY; UP-REGULATION; HUMAN HEART; PHOSPHORYLATION; ACTIVATION; BETA(3)-ADRENOCEPTOR	Myocardial constitutive No production depends on the activity of both endothelial and neuronal NOS (eNOS and nNOS, respectively). Stimulation of myocardial beta(3)-adrenergic receptor (beta(3)-AR) produces a negative inotropic effect that is dependent on eNOS. We evaluated whether nNOS also plays a role in beta(3)-AR signaling and found that the beta(3)-AR-mediated reduction in cell shortening and [Ca2+](i) transient amplitude was abolished both in eNOS(-/-) and nNOS(-/-) left ventricular (LV) myocytes and in wild type LV myocytes after nNOS inhibition with S-methyl-L-thiocitrulline. LV superoxide (O-2(radical anion)) production was increased in nNOS(-/-) mice and reduced by L-N-omega-nitroarginine methyl ester (L-NAME), indicating uncoupling of eNOS activity. eNOS S-glutathionylation and Ser-1177 phosphorylation were significantly increased in nNOS(-/-) myocytes, whereas myocardial tetrahydrobiopterin, eNOS Thr-495 phosphorylation, and arginase activity did not differ between genotypes. Although inhibitors of xanthine oxidoreductase (XOR) or NOX2 NADPH oxidase caused a similar reduction in myocardial O-2(radical anion), only XOR inhibition reduced eNOS S-glutathionylation and Ser-1177 phosphorylation and restored both eNOS coupled activity and the negative inotropic and [Ca2+] i transient response to beta(3)-AR stimulation in nNOS(-/-) mice. In summary, our data show that increased O-2(radical anion) production by XOR selectively uncouples eNOS activity and abolishes the negative inotropic effect of beta(3)-AR stimulation in nNOS(-/-) myocytes. These findings provide unequivocal evidence of a functional interaction between the myocardial constitutive NOS isoforms and indicate that aspects of the myocardial phenotype of nNOS(-/-) mice result from disruption of eNOS signaling.	[Idigo, Winifred O.; Reilly, Svetlana; Zhang, Mei Hua; Zhang, Yin Hua; Jayaram, Raja; Carnicer, Ricardo; Crabtree, Mark J.; Casadei, Barbara] Univ Oxford, Dept Cardiovasc Med, John Radcliffe Hosp, Oxford OX3 9DU, England; [Balligand, Jean-Luc] Catholic Univ Louvain, Unit Pharmacol & Therapeut, B-1348 Louvain, Belgium	University of Oxford; Universite Catholique Louvain	Casadei, B (corresponding author), Univ Oxford, Dept Cardiovasc Med, John Radcliffe Hosp, Level 6, Oxford OX3 9DU, England.	barbara.casadei@cardiov.ox.ac.uk	Zhang, Yin Hua/J-2785-2012; JAYARAM, RAJA/O-6068-2019; Balligand, Jean-Luc J/D-7543-2012	Crabtree, Mark/0000-0003-3298-2697; BALLIGAND, Jean-Luc/0000-0002-0522-4156; Reilly, Svetlana/0000-0003-1231-1239; Casadei, Barbara/0000-0002-6801-1617; Carnicer Hijazo, Ricardo/0000-0002-7440-2964; JAYARAM, RAJA/0000-0002-7861-9546	Wellcome Trust; British Heart Foundation; Oxford Biomedical Research Centre; Fondation Leducq; British Heart Foundation [RG/11/15/29375] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); Oxford Biomedical Research Centre; Fondation Leducq(Leducq Foundation); British Heart Foundation(British Heart Foundation)	This work was supported by a Wellcome Trust Prize Studentship (to W. O. I.) and funds from the British Heart Foundation (to Y. H. Z., M. H. Z., R. C., M. J. C., and B. C.), the Oxford Biomedical Research Centre (to R. J. and B. C.), and the Fondation Leducq (to B. C., S. R., and J.-L.B.).	Ashley EA, 2002, CIRCULATION, V105, P3011, DOI 10.1161/01.CIR.0000019516.31040.2D; Au ALS, 2002, J CARDIAC SURG, V17, P465; Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; Bendall JK, 2004, CIRCULATION, V110, P2368, DOI 10.1161/01.CIR.0000145160.04084.AC; Berkowitz DE, 2003, CIRCULATION, V108, P2000, DOI 10.1161/01.CIR.0000092948.04444.C7; Brennan JP, 2006, J BIOL CHEM, V281, P21827, DOI 10.1074/jbc.M603952200; Brixius K, 2004, BRIT J PHARMACOL, V143, P1014, DOI 10.1038/sj.bjp.0705983; Burger DE, 2009, CIRCULATION, V120, P1345, DOI 10.1161/CIRCULATIONAHA.108.846402; Carnicer R, 2012, CIRC RES, V111, P718, DOI 10.1161/CIRCRESAHA.112.274464; Chen CA, 2008, J BIOL CHEM, V283, P27038, DOI 10.1074/jbc.M802269200; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Cheng HJ, 2001, CIRC RES, V89, P599, DOI 10.1161/hh1901.098042; Damy T, 2004, LANCET, V363, P1365, DOI 10.1016/S0140-6736(04)16048-0; Dawson D, 2005, CIRCULATION, V112, P3729, DOI 10.1161/CIRCULATIONAHA.105.539437; Du XL, 2001, J CLIN INVEST, V108, P1341, DOI 10.1172/JCI11235; Dumitrescu C, 2007, P NATL ACAD SCI USA, V104, P15081, DOI 10.1073/pnas.0702986104; Fleming I, 2001, CIRC RES, V88, pE68, DOI 10.1161/hh1101.092677; Gauthier C, 1996, J CLIN INVEST, V98, P556, DOI 10.1172/JCI118823; Gauthier C, 1998, J CLIN INVEST, V102, P1377, DOI 10.1172/JCI2191; Hoshino S, 2005, FREE RADICAL RES, V39, P481, DOI 10.1080/10715760500073840; HUANG PL, 1993, CELL, V75, P1273, DOI 10.1016/0092-8674(93)90615-W; Iyamu EW, 2008, BIOCHEM BIOPH RES CO, V376, P116, DOI 10.1016/j.bbrc.2008.08.102; Khan SA, 2004, P NATL ACAD SCI USA, V101, P15944, DOI 10.1073/pnas.0404136101; Kinugawa S, 2005, CIRC RES, V96, P355, DOI 10.1161/01.RES.0000155331.09458.A7; Lai Y, 2009, J CLIN INVEST, V119, P624, DOI 10.1172/JCI36612; Lin MI, 2003, J BIOL CHEM, V278, P44719, DOI 10.1074/jbc.M302836200; McManaman JL, 1999, ARCH BIOCHEM BIOPHYS, V371, P308, DOI 10.1006/abbi.1999.1432; Mohamed TMA, 2009, J BIOL CHEM, V284, P12091, DOI 10.1074/jbc.M809112200; Moniotte S, 2001, CIRCULATION, V103, P1649, DOI 10.1161/01.CIR.103.12.1649; Nishino T, 1997, J BIOL CHEM, V272, P29859, DOI 10.1074/jbc.272.47.29859; Reilly SN, 2011, CIRCULATION, V124, P1107, DOI 10.1161/CIRCULATIONAHA.111.029223; Sander M, 2000, P NATL ACAD SCI USA, V97, P13818, DOI 10.1073/pnas.250379497; Saraiva RM, 2005, CIRCULATION, V112, P3415, DOI 10.1161/CIRCULATIONAHA.105.557892; Schuhmacher S, 2011, DIABETES, V60, P2608, DOI 10.2337/db10-1395; Sears CE, 2003, CIRC RES, V92, pE52, DOI 10.1161/01.RES.0000064585.95749.6D; Shesely EG, 1996, P NATL ACAD SCI USA, V93, P13176, DOI 10.1073/pnas.93.23.13176; Silberman GA, 2010, CIRCULATION, V121, P519, DOI 10.1161/CIRCULATIONAHA.109.883777; Sun JH, 2006, CIRC RES, V98, P403, DOI 10.1161/01.RES.0000202707.79018.0a; Takimoto E, 2005, J CLIN INVEST, V115, P1221, DOI 10.1172/JCI200521968; Thomas GD, 1998, P NATL ACAD SCI USA, V95, P15090, DOI 10.1073/pnas.95.25.15090; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Venardos K, 2009, INT J BIOCHEM CELL B, V41, P2522, DOI 10.1016/j.biocel.2009.08.008; Wang H, 2008, AM J PHYSIOL-CELL PH, V294, pC1566, DOI 10.1152/ajpcell.00367.2007; Zhang YH, 2008, CIRC RES, V102, P242, DOI 10.1161/CIRCRESAHA.107.164798; Zhang YH, 2012, J MOL CELL CARDIOL, V52, P341, DOI 10.1016/j.yjmcc.2011.09.006; Zou MH, 2002, J BIOL CHEM, V277, P32552, DOI 10.1074/jbc.M204512200	46	37	38	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43665	43673		10.1074/jbc.M112.412031	http://dx.doi.org/10.1074/jbc.M112.412031			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23091050	Green Published, hybrid			2022-12-25	WOS:000312940800046
J	Cai, B; Siminszky, B; Chappell, J; Dewey, RE; Bush, LP				Cai, Bin; Siminszky, Balazs; Chappell, Joseph; Dewey, Ralph E.; Bush, Lowell P.			Enantioselective Demethylation of Nicotine as a Mechanism for Variable Nornicotine Composition in Tobacco Leaf	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-SUSPENSION-CULTURES; ENANTIOMERIC COMPOSITION; N-DEMETHYLATION; ALKALOIDS; BIOSYNTHESIS; TABACUM; GLAUCA; GENE; TRANSFORMATION; DEGRADATION	Nicotine and its N-demethylation product nornicotine are two important alkaloids in Nicotiana tabacum L. (tobacco). Both nicotine and nornicotine have two stereoisomers that differ from each other at 2'-C position on the pyrrolidine ring. (S)-Nicotine is the predominant form in the tobacco leaf, whereas the (R)-enantiomer only accounts for similar to 0.2% of the total nicotine pool. Despite considerable past efforts, a comprehensive understanding of the factors responsible for generating an elevated and variable enantiomer fraction of nornicotine (EFnnic of 0.04 to 0.75) from the consistently low EF observed for nicotine has been lacking. The objective of this study was to determine potential roles of enantioselective demethylation in the formation of the nornicotine EF. Recombinant CYP82E4, CYP82E5v2, and CYP82E10, three known tobacco nicotine demethylases, were expressed in yeast and assayed for their enantioselectivities in vitro. Recombinant CYP82E4, CYP82E5v2, and CYP82E10 demethylated (R)-nicotine 3-, 10-, and 10-fold faster than (S)-nicotine, respectively. The combined enantioselective properties of the three nicotine demethylases can reasonably account for the nornicotine composition observed in tobacco leaves, which was confirmed in planta. Collectively, our studies suggest that an enantioselective mechanism facilitates the maintenance of a reduced (R)-nicotine pool and, depending on the relative abundances of the three nicotine demethylase enzymes, can confer a high (R)-enantiomer percentage within the nornicotine fraction of the leaf.	[Cai, Bin; Siminszky, Balazs; Chappell, Joseph; Bush, Lowell P.] Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40546 USA; [Dewey, Ralph E.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA	University of Kentucky; University of North Carolina; North Carolina State University	Bush, LP (corresponding author), Univ Kentucky, Dept Plant & Soil Sci, Lexington, KY 40546 USA.	lpbush@email.uky.edu		Dewey, Ralph/0000-0003-1924-3777; Cai, Bin/0000-0002-8046-6040	Altria Client Services; Philip Morris International	Altria Client Services; Philip Morris International	The work described in this paper was supported in part by Altria Client Services and Philip Morris International.	Armstrong DW, 1998, CHIRALITY, V10, P587, DOI 10.1002/(SICI)1520-636X(1998)10:7<587::AID-CHIR6>3.3.CO;2-R; Armstrong DW, 1999, CHIRALITY, V11, P82, DOI 10.1002/(SICI)1520-636X(1999)11:1&lt;82::AID-CHIR14&gt;3.0.CO;2-C; Bartholomeusz TA, 2005, PHYTOCHEMISTRY, V66, P1890, DOI 10.1016/j.phytochem.2005.07.012; CHELVARAJAN RL, 1993, J AGR FOOD CHEM, V41, P858, DOI 10.1021/jf00030a003; DAWSON RF, 1951, J AM CHEM SOC, V73, P4218, DOI 10.1021/ja01153a052; DAWSON RF, 1945, AM J BOT, V32, P416, DOI 10.2307/2437360; DeBoer KD, 2009, PLANT MOL BIOL, V69, P299, DOI 10.1007/s11103-008-9425-2; FRIESEN JB, 1990, TETRAHEDRON LETT, V31, P6295; Gavilano LB, 2007, PLANT CELL PHYSIOL, V48, P1567, DOI 10.1093/pcp/pcm128; Hao DY, 1996, PHYTOCHEMISTRY, V41, P477, DOI 10.1016/0031-9422(95)00532-3; Harner T, 2000, ENVIRON SCI TECHNOL, V34, P218, DOI 10.1021/es9906958; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Hecht SS, 2006, LANGENBECK ARCH SURG, V391, P603, DOI 10.1007/s00423-006-0111-z; Kajikawa M, 2011, PLANT PHYSIOL, V155, P2010, DOI 10.1104/pp.110.170878; Kajikawa M, 2009, PLANT MOL BIOL, V69, P287, DOI 10.1007/s11103-008-9424-3; KISAKI T, 1978, BEITR TABAKFORSCH, V9, P308, DOI 10.2478/cttr-2013-0461; KISAKI T, 1966, PHYTOCHEMISTRY, V5, P293; KISAKI T, 1964, AGR BIOL CHEM TOKYO, V28, P492, DOI 10.1080/00021369.1964.10858265; KISAKI T, 1961, ARCH BIOCHEM BIOPHYS, V92, P351, DOI 10.1016/0003-9861(61)90360-5; LEETE E, 1974, PHYTOCHEMISTRY, V13, P1853, DOI 10.1016/0031-9422(74)85101-0; LEETE E, 1972, PHYTOCHEMISTRY, V11, P2751, DOI 10.1016/S0031-9422(00)86508-5; Leete E., 1992, 2 METABOLITE BIOSYNT, P121; Lewis RS, 2010, PHYTOCHEMISTRY, V71, P1988, DOI 10.1016/j.phytochem.2010.09.011; Liu BZ, 2008, J CHROMATOGR B, V865, P13, DOI 10.1016/j.jchromb.2008.01.034; Lochmann H, 2001, J CHROMATOGR A, V917, P311, DOI 10.1016/S0021-9673(01)00627-6; MANN T. J., 1964, CROP SCI, V4, P349, DOI 10.2135/cropsci1964.0011183X000400040003x; MATSUSHIMA S, 1983, AGR BIOL CHEM TOKYO, V47, P507, DOI 10.1080/00021369.1983.10865670; McIntee EJ, 2000, CHEM RES TOXICOL, V13, P192, DOI 10.1021/tx990171l; Mesnard F, 2002, PLANTA, V214, P911, DOI 10.1007/s00425-001-0702-4; Mesnard F, 2001, PLANT SCI, V161, P1011, DOI 10.1016/S0168-9452(01)00509-X; Meunier B, 2004, CHEM REV, V104, P3947, DOI 10.1021/cr020443g; MIZUSAKI S, 1965, AGR BIOL CHEM TOKYO, V29, P78, DOI 10.1080/00021369.1965.10858351; Pogocki D, 2007, EUR J PHARMACOL, V563, P18, DOI 10.1016/j.ejphar.2007.02.038; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Robins Richard J., 2007, Phytochemistry Reviews, V6, P51, DOI 10.1007/s11101-006-9030-4; Siminszky B, 2005, P NATL ACAD SCI USA, V102, P14919, DOI 10.1073/pnas.0506581102; Steppuhn A, 2004, PLOS BIOL, V2, P1074, DOI 10.1371/journal.pbio.0020217; Xu DM, 2007, PHYSIOL PLANTARUM, V129, P307, DOI 10.1111/j.1399-3054.2006.00811.x; Yamanaka H, 2005, DRUG METAB DISPOS, V33, P1811, DOI 10.1124/dmd.105.006254	39	17	18	1	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42804	42811		10.1074/jbc.M112.413807	http://dx.doi.org/10.1074/jbc.M112.413807			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23100254	Green Published, hybrid			2022-12-25	WOS:000312501600039
J	Lew, CR; Tolan, DR				Lew, Carolyn Ritterson; Tolan, Dean R.			Targeting of Several Glycolytic Enzymes Using RNA Interference Reveals Aldolase Affects Cancer Cell Proliferation through a Non-glycolytic Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALDRICH-SYNDROME PROTEIN; NF-KAPPA-B; F-ACTIN; CENTROSOME SEPARATION; PYRUVATE-KINASE; MOTILITY FACTOR; IN-VITRO; BINDING; METABOLISM; GROWTH	In cancer, glucose uptake and glycolysis are increased regardless of the oxygen concentration in the cell, a phenomenon known as the Warburg effect. Several (but not all) glycolytic enzymes have been investigated as potential therapeutic targets for cancer treatment using RNAi. Here, four previously untargeted glycolytic enzymes, aldolase A, glyceraldehyde 3-phosphate dehydrogenase, triose phosphate isomerase, and enolase 1, are targeted using RNAi in Ras-transformed NIH-3T3 cells. Of these enzymes, knockdown of aldolase causes the greatest effect, inhibiting cell proliferation by 90%. This defect is rescued by expression of exogenous aldolase. However, aldolase knockdown does not affect glycolytic flux or intracellular ATP concentration, indicating a non-metabolic cause for the cell proliferation defect. Furthermore, this defect could be rescued with an enzymatically dead aldolase variant that retains the known F-actin binding ability of aldolase. One possible model for how aldolase knockdown may inhibit transformed cell proliferation is through its disruption of actin-cytoskeleton dynamics in cell division. Consistent with this hypothesis, aldolase knockdown cells show increased multinucleation. These results are compared with other studies targeting glycolytic enzymes with RNAi in the context of cancer cell proliferation and suggest that aldolase may be a useful target in the treatment of cancer.	[Lew, Carolyn Ritterson; Tolan, Dean R.] Boston Univ, Dept Biol, Boston, MA 02215 USA	Boston University	Tolan, DR (corresponding author), 5 Cummington St, Boston, MA 02215 USA.	tolan@bu.edu		Tolan, Dean/0000-0002-0598-7241				APPLEMAN LJ, 1995, INT J CANCER, V61, P887, DOI 10.1002/ijc.2910610623; ARNOLD H, 1970, EUR J BIOCHEM, V15, P360, DOI 10.1111/j.1432-1033.1970.tb01016.x; ARNOLD H, 1968, EUR J BIOCHEM, V6, P163, DOI 10.1111/j.1432-1033.1968.tb00434.x; BARON CB, 1995, J BIOL CHEM, V270, P20459, DOI 10.1074/jbc.270.35.20459; BEERNINK PT, 1992, PROTEIN EXPRES PURIF, V3, P332, DOI 10.1016/1046-5928(92)90009-L; BERGMEYER HU, 1974, METHOD ENZYMAT AN, P1205; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROOKS DE, 1976, BIOCHEM J, V156, P527, DOI 10.1042/bj1560527; Buscaglia CA, 2006, J BIOL CHEM, V281, P1324, DOI 10.1074/jbc.M506346200; Calvo MN, 2006, FEBS LETT, V580, P3308, DOI 10.1016/j.febslet.2006.04.093; Chen Z, 2007, J BIOENERG BIOMEMBR, V39, P267, DOI 10.1007/s10863-007-9086-x; Chiaradonna F, 2005, BIOCHEM SOC T, V33, P297, DOI 10.1042/BST0330297; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Dang CV, 1999, TRENDS BIOCHEM SCI, V24, P68, DOI 10.1016/S0968-0004(98)01344-9; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Fell D. A., 1997, UNDERSTANDING CONTRO, P90; Forer A, 2007, PROTOPLASMA, V232, P79, DOI 10.1007/s00709-007-0265-8; Funasaka T, 2007, CANCER RES, V67, P4236, DOI 10.1158/0008-5472.CAN-06-3935; Gapuzan MER, 2005, ONCOGENE, V24, P6574, DOI 10.1038/sj.onc.1208809; Gapuzan MER, 2002, ONCOGENE, V21, P2484, DOI 10.1038/sj.onc.1205333; Gilmore TD, 2003, VIROLOGY, V316, P9, DOI 10.1016/S0042-6822(03)00562-2; GUGUENGUILLOUZO C, 1981, IN VITRO CELL DEV B, V17, P369; Gutman I., 1983, METHOD ENZYMAT AN, P1464; HATTON JD, 1992, CANCER RES, V52, P1933; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ishida A, 2005, ARCH BIOCHEM BIOPHYS, V435, P134, DOI 10.1016/j.abb.2004.11.022; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Kao AW, 1999, J BIOL CHEM, V274, P17742, DOI 10.1074/jbc.274.25.17742; KENG PC, 1984, BRIT J CANCER, V50, P519, DOI 10.1038/bjc.1984.209; Kim JH, 2002, BIOCHEMISTRY-US, V41, P3414, DOI 10.1021/bi015700a; Knight RJ, 1996, CARDIOVASC RES, V32, P1016, DOI 10.1016/S0008-6363(96)00137-X; KUENG W, 1989, ANAL BIOCHEM, V182, P16, DOI 10.1016/0003-2697(89)90710-0; Lee KG, 2007, CELL CYCLE, V6, P1487; Lundmark R, 2004, J BIOL CHEM, V279, P42694, DOI 10.1074/jbc.M407430200; MARKS J, 1986, J CELL SCI, P229; MORRIS AJ, 1993, J BIOL CHEM, V268, P1095; Moulding DA, 2007, J EXP MED, V204, P2213, DOI 10.1084/jem.20062324; OROSZ F, 1988, BIOCHIM BIOPHYS ACTA, V957, P293, DOI 10.1016/0167-4838(88)90286-5; PAGLIARO L, 1992, J CELL BIOL, V118, P859, DOI 10.1083/jcb.118.4.859; Park SJ, 2011, MOL CELLS, V31, P515, DOI 10.1007/s10059-011-2292-8; Peng QP, 2008, CANCER BIOL THER, V7, P1128, DOI 10.4161/cbt.7.7.6199; Pollitt AY, 2009, J CELL SCI, V122, P2575, DOI 10.1242/jcs.023879; Puschner B, 1997, HEARING RES, V114, P102, DOI 10.1016/S0378-5955(97)00163-9; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rosenblatt J, 2004, CELL, V117, P361, DOI 10.1016/S0092-8674(04)00341-1; SHIMIZU K, 1983, P NATL ACAD SCI-BIOL, V80, P2112, DOI 10.1073/pnas.80.8.2112; St-Jean M, 2007, J BIOL CHEM, V282, P14309, DOI 10.1074/jbc.M611505200; Tennant DA, 2010, NAT REV CANCER, V10, P267, DOI 10.1038/nrc2817; Uzbekov R, 2002, BIOL CELL, V94, P275, DOI 10.1016/S0248-4900(02)01202-9; Wang J, 1997, EXP CELL RES, V237, P445, DOI 10.1006/excr.1997.3811; Wang JA, 1996, J BIOL CHEM, V271, P6861, DOI 10.1074/jbc.271.12.6861; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Watanabe H, 1996, CANCER RES, V56, P2960; Withee J, 2004, GENETICS, V167, P1165, DOI 10.1534/genetics.103.025676; Yi W, 2012, SCIENCE, V337, P975, DOI 10.1126/science.1222278	55	64	65	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42554	42563		10.1074/jbc.M112.405969	http://dx.doi.org/10.1074/jbc.M112.405969			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23093405	Green Published, hybrid			2022-12-25	WOS:000312501600017
J	Souza, CM; Davidson, D; Rhee, I; Gratton, JP; Davis, EC; Veillette, A				Souza, Cleiton Martins; Davidson, Dominique; Rhee, Inmoo; Gratton, Jean-Philippe; Davis, Elaine C.; Veillette, Andre			The Phosphatase PTP-PEST/PTPN12 Regulates Endothelial Cell Migration and Adhesion, but Not Permeability, and Controls Vascular Development and Embryonic Viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE-PHOSPHATASE; PTP-PEST; SH3 DOMAIN; ANGIOGENESIS; KINASE; MICE; ASSOCIATION; VASCULOGENESIS; SUBSTRATE; P130(CAS)	Protein-tyrosine phosphatase (PTP)-PEST (PTPN12) is ubiquitously expressed. It is essential for normal embryonic development and embryonic viability in mice. Herein we addressed the involvement of PTP-PEST in endothelial cell functions using a combination of genetic and biochemical approaches. By generating primary endothelial cells from an inducible PTP-PEST-deficient mouse, we found that PTP-PEST is not needed for endothelial cell differentiation and proliferation or for the control of endothelial cell permeability. Nevertheless, it is required for integrin-mediated adhesion and migration of endothelial cells. PTP-PEST-deficient endothelial cells displayed increased tyrosine phosphorylation of Cas, paxillin, and Pyk2, which were previously also implicated in integrin functions. By eliminating PTP-PEST in endothelial cells in vivo, we obtained evidence that expression of PTP-PEST in endothelial cells is required for normal vascular development and embryonic viability. Therefore, PTP-PEST is a key regulator of integrin-mediated functions in endothelial cells seemingly through its capacity to control Cas, paxillin, and Pyk2. This function explains at least in part the essential role of PTP-PEST in embryonic development and viability.	[Souza, Cleiton Martins; Davidson, Dominique; Rhee, Inmoo; Veillette, Andre] Clin Res Inst Montreal, Lab Mol Oncol, Montreal, PQ H2W 1R7, Canada; [Gratton, Jean-Philippe] Clin Res Inst Montreal, Lab Endothelial Cell Biol, Montreal, PQ H2W 1R7, Canada; [Rhee, Inmoo; Veillette, Andre] McGill Univ, Dept Med, Montreal, PQ H3G 1Y6, Canada; [Gratton, Jean-Philippe; Veillette, Andre] Univ Montreal, Dept Med, Montreal, PQ H3T 1J4, Canada; [Davis, Elaine C.] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ H3A 2B2, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McGill University; Universite de Montreal; McGill University	Veillette, A (corresponding author), Clin Res Inst Montreal, Lab Mol Oncol, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	veillea@ircm.qc.ca		Gratton, Jean-Philippe/0000-0001-9877-8520	Canadian Institutes of Health Research; Canadian Cancer Society Research Institute; Angelo Pizzagalli Fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Angelo Pizzagalli Fellowship	This work was supported in part by grants from the Canadian Institutes of Health Research and the Canadian Cancer Society Research Institute (to A. V., J.-P. G., and E. C. D.).; Recipient of the Angelo Pizzagalli Fellowship.	Angers-Loustau A, 1999, J CELL BIOL, V144, P1019, DOI 10.1083/jcb.144.5.1019; Angers-Loustau A, 1999, BIOCHEM CELL BIOL, V77, P493, DOI 10.1139/bcb-77-6-493; Braren R, 2006, J CELL BIOL, V172, P151, DOI 10.1083/jcb.200506184; Carlson TR, 2008, DEVELOPMENT, V135, P2193, DOI 10.1242/dev.016378; Charest A, 1996, J BIOL CHEM, V271, P8424, DOI 10.1074/jbc.271.14.8424; CHAREST A, 1995, BIOCHEM J, V308, P425, DOI 10.1042/bj3080425; Charest A, 1997, ONCOGENE, V14, P1643, DOI 10.1038/sj.onc.1201008; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Cote JF, 2002, J BIOL CHEM, V277, P2973, DOI 10.1074/jbc.M106428200; Davidson D, 2001, EMBO J, V20, P3414, DOI 10.1093/emboj/20.13.3414; Davidson D, 2010, IMMUNITY, V33, P167, DOI 10.1016/j.immuni.2010.08.001; Dejana E, 2009, DEV CELL, V16, P209, DOI 10.1016/j.devcel.2009.01.004; Dominguez MG, 2007, P NATL ACAD SCI USA, V104, P3243, DOI 10.1073/pnas.0611510104; DUMONT DJ, 1994, GENE DEV, V8, P1897, DOI 10.1101/gad.8.16.1897; Garton AJ, 1999, J BIOL CHEM, V274, P3811, DOI 10.1074/jbc.274.6.3811; Garton AJ, 1996, MOL CELL BIOL, V16, P6408; Garton AJ, 1997, ONCOGENE, V15, P877, DOI 10.1038/sj.onc.1201279; Gory-Faure S, 1999, DEVELOPMENT, V126, P2093; Halle M, 2007, CELL CYCLE, V6, P2773, DOI 10.4161/cc.6.22.4926; Honda H, 1998, NAT GENET, V19, P361, DOI 10.1038/1246; Jamieson JS, 2005, J CELL SCI, V118, P5835, DOI 10.1242/jcs.02693; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lyons PD, 2001, J BIOL CHEM, V276, P24422, DOI 10.1074/jbc.M011080200; Ohmori T, 2001, J BIOL CHEM, V276, P5274, DOI 10.1074/jbc.M005405200; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sastry SK, 2006, J BIOL CHEM, V281, P11627, DOI 10.1074/jbc.M600897200; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Shen Y, 1998, J BIOL CHEM, V273, P6474, DOI 10.1074/jbc.273.11.6474; Silva R, 2008, ARTERIOSCL THROM VAS, V28, P1703, DOI 10.1161/ATVBAHA.108.172015; Sirois J, 2006, MECH DEVELOP, V123, P869, DOI 10.1016/j.mod.2006.08.011; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sun TT, 2011, CELL, V144, P703, DOI 10.1016/j.cell.2011.02.003; Tanjore H, 2008, DEV DYNAM, V237, P75, DOI 10.1002/dvdy.21385; Thibeault S, 2010, MOL CELL, V39, P468, DOI 10.1016/j.molcel.2010.07.013; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; Veillette A, 2009, IMMUNOL REV, V228, P312, DOI 10.1111/j.1600-065X.2008.00747.x; Vestweber D, 2009, TRENDS CELL BIOL, V19, P8, DOI 10.1016/j.tcb.2008.10.001; Weis SM, 2008, J CELL BIOL, V181, P43, DOI 10.1083/jcb.200710038; Winderlich M, 2009, J CELL BIOL, V185, P657, DOI 10.1083/jcb.200811159	42	27	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43180	43190		10.1074/jbc.M112.387456	http://dx.doi.org/10.1074/jbc.M112.387456			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105101	Green Published, hybrid			2022-12-25	WOS:000312501600072
J	Vazquez-Cedeira, M; Lazo, PA				Vazquez-Cedeira, Marta; Lazo, Pedro A.			Human VRK2 (Vaccinia-related Kinase 2) Modulates Tumor Cell Invasion by Hyperactivation of NFAT1 and Expression of Cyclooxygenase-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED T-CELLS; TRANSCRIPTION FACTOR NFAT1; BREAST-CANCER METASTASIS; COLON-CARCINOMA CELLS; N-TERMINAL KINASE; NUCLEAR FACTOR; SIGNALING PATHWAY; BINDING-SITE; PHOSPHORYLATION; CALCINEURIN	Human VRK2 (vaccinia-related kinase 2), a kinase that emerged late in evolution, affects different signaling pathways, and some carcinomas express high levels of VRK2. Invasion by cancer cells has been associated with NFAT1 (nuclear factor of activated T cells) activation and expression of the COX-2 (cyclooxygenase 2) gene. We hypothesized that VRK proteins might play a regulatory role in NFAT1 activation in tumor cells. We demonstrate that VRK2 directly interacts and phosphorylates NFAT1 in Ser-32 within its N-terminal transactivation domain. VRK2 increases NFAT1-dependent transcription by phosphorylation, and this effect is only detected following cell phorbol 12-myristate 13-acetate and ionomycin stimulation and calcineurin activation. This NFAT1 hyperactivation by VRK2 increases COX-2 gene expression through the proximal NFAT1 binding site in the COX-2 gene promoter. Furthermore, VRK2A down-regulation by RNA interference reduces COX-2 expression at transcriptional and protein levels. Therefore, VRK2 down-regulation reduces cell invasion by tumor cells, such as MDA-MB-231 and MDA-MB-435, upon stimulation with phorbol 12-myristate 13-acetate plus ionomycin. These findings identify the first reported target and function of human VRK2 as an active kinase playing a role in regulation of cancer cell invasion through the NFAT pathway and COX-2 expression.	[Lazo, Pedro A.] Univ Salamanca, CSIC, Expt Therapeut & Translat Oncol Program, Inst Biol Mol & Celular Canc,IBMCC Ctr Invest Can, E-37007 Salamanca, Spain; [Vazquez-Cedeira, Marta] Hosp Univ Salamanca, Inst Invest Biomed Salamanca, E-37007 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC)	Lazo, PA (corresponding author), Univ Salamanca, CSIC, Expt Therapeut & Translat Oncol Program, Inst Biol Mol & Celular Canc,IBMCC Ctr Invest Can, Campus Miguel de Unamuno, E-37007 Salamanca, Spain.	pedro.lazo@csic.es	Lazo, Pedro A./M-6435-2014	Lazo, Pedro A./0000-0001-8997-3025	Ministerio de Educacion, Ciencia e Innovacion [SAF2010-14935]; Consolider-Ingenio Grant [CSD07-0017]; Junta de Castilla y Leon (Consejeria de Educacion) [CSI-006A11-2]; Fundacion Sandra Ibarra; Kutxa-Fundacion Inbiomed; Junta para Ampliacion de Estudios e Investigaciones Cientificas-Consejo Superior de Investigaciones Cientificas-Fondo Social Europeo fellowship	Ministerio de Educacion, Ciencia e Innovacion; Consolider-Ingenio Grant; Junta de Castilla y Leon (Consejeria de Educacion)(Junta de Castilla y Leon); Fundacion Sandra Ibarra; Kutxa-Fundacion Inbiomed; Junta para Ampliacion de Estudios e Investigaciones Cientificas-Consejo Superior de Investigaciones Cientificas-Fondo Social Europeo fellowship	This work was supported by grants from Ministerio de Educacion, Ciencia e Innovacion Grant SAF2010-14935, Consolider-Ingenio 2010 Grant CSD07-0017, Junta de Castilla y Leon (Consejeria de Educacion, Grant CSI-006A11-2), Fundacion Sandra Ibarra, and Kutxa-Fundacion Inbiomed.; Supported by a Junta para Ampliacion de Estudios e Investigaciones Cientificas-Consejo Superior de Investigaciones Cientificas-Fondo Social Europeo fellowship.	Abbasi S, 2006, J BIOL CHEM, V281, P7717, DOI 10.1074/jbc.M510775200; Abbasi S, 2005, J BIOL CHEM, V280, P36737, DOI 10.1074/jbc.M506493200; Barcia R, 2002, ARCH BIOCHEM BIOPHYS, V399, P1, DOI 10.1006/abbi.2001.2746; Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930; Bergmann C, 2007, CANCER RES, V67, P8865, DOI 10.1158/0008-5472.CAN-07-0767; Blanco S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001660; Blanco S, 2007, MOL CELL BIOL, V27, P7273, DOI 10.1128/MCB.00025-07; Blanco S, 2006, FEBS J, V273, P2487, DOI 10.1111/j.1742-4658.2006.05256.x; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Buchholz M, 2006, EMBO J, V25, P3714, DOI 10.1038/sj.emboj.7601246; Corral RS, 2007, ONCOGENE, V26, P958, DOI 10.1038/sj.onc.1209856; de Gregorio R, 2001, J BIOL CHEM, V276, P27003, DOI 10.1074/jbc.M100885200; Diehn M, 2002, P NATL ACAD SCI USA, V99, P11796, DOI 10.1073/pnas.092284399; Duque J, 2005, J BIOL CHEM, V280, P8686, DOI 10.1074/jbc.M413076200; Fedorov O, 2007, DRUG DISCOV TODAY, V12, P365, DOI 10.1016/j.drudis.2007.03.006; Fernandez IF, 2012, CELL MOL LIFE SCI, V69, P3881, DOI 10.1007/s00018-012-1056-8; Fernandez IF, 2010, MOL CELL BIOL, V30, P4687, DOI 10.1128/MCB.01581-09; Flockhart RJ, 2009, BRIT J CANCER, V101, P1448, DOI 10.1038/sj.bjc.6605277; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Gomez-Casero E, 2007, CELL SIGNAL, V19, P1652, DOI 10.1016/j.cellsig.2007.02.010; Hilioti Z, 2004, GENE DEV, V18, P35, DOI 10.1101/gad.1159204; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Iniguez MA, 2000, J BIOL CHEM, V275, P23627, DOI 10.1074/jbc.M001381200; Jauliac S, 2002, NAT CELL BIOL, V4, P540, DOI 10.1038/ncb816; Jiang XG, 2009, MOL CELL BIOL, V29, P5104, DOI 10.1128/MCB.00465-09; Kang TH, 2008, J CELL SCI, V121, P3035, DOI 10.1242/jcs.026757; Kim HS, 2012, BREAST CANCER RES TR, V132, P51, DOI 10.1007/s10549-011-1521-3; Kim TH, 2009, MOL CANCER RES, V7, P1605, DOI 10.1158/1541-7786.MCR-09-0102; Klerkx EPF, 2009, HISTOL HISTOPATHOL, V24, P749, DOI 10.14670/HH-24.749; Li ZG, 2008, CLIN EXP METASTAS, V25, P389, DOI 10.1007/s10585-007-9117-3; Lopez-Borges S, 2000, ONCOGENE, V19, P3656, DOI 10.1038/sj.onc.1203709; Luo C, 1996, P NATL ACAD SCI USA, V93, P8907, DOI 10.1073/pnas.93.17.8907; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Nezu J, 1997, GENOMICS, V45, P327, DOI 10.1006/geno.1997.4938; Nichols RJ, 2004, J BIOL CHEM, V279, P7934, DOI 10.1074/jbc.M310813200; Ogunwobi OO, 2012, J GASTROEN HEPATOL, V27, P566, DOI 10.1111/j.1440-1746.2011.06980.x; Okamura H, 2004, MOL CELL BIOL, V24, P4184, DOI 10.1128/MCB.24.10.4184-4195.2004; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Ortega-Perez I, 2005, J BIOL CHEM, V280, P20867, DOI 10.1074/jbc.M501898200; Rainio EM, 2002, J IMMUNOL, V168, P1524, DOI 10.4049/jimmunol.168.4.1524; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Ryeom S, 2008, CANCER CELL, V13, P420, DOI 10.1016/j.ccr.2008.02.018; Sanna B, 2006, P NATL ACAD SCI USA, V103, P7327, DOI 10.1073/pnas.0509340103; Santos CR, 2006, MOL CANCER RES, V4, P177, DOI 10.1158/1541-7786.MCR-05-0212; Scheeff ED, 2009, STRUCTURE, V17, P128, DOI 10.1016/j.str.2008.10.018; Serfling E, 2000, BBA-MOL CELL RES, V1498, P1, DOI 10.1016/S0167-4889(00)00082-3; Sevilla A, 2004, ONCOGENE, V23, P8950, DOI 10.1038/sj.onc.1208015; Sevilla A, 2004, J BIOL CHEM, V279, P27458, DOI 10.1074/jbc.M401009200; Sihto H, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2944; Singh B, 2007, ONCOGENE, V26, P3789, DOI 10.1038/sj.onc.1210154; Singh B, 2006, J SURG RES, V131, P267, DOI 10.1016/j.jss.2005.11.582; Singh B, 2005, INT J ONCOL, V26, P1393; Singh B, 2006, J SURG RES, V134, P44, DOI 10.1016/j.jss.2006.03.018; Tsatsanis C, 1998, P NATL ACAD SCI USA, V95, P3827, DOI 10.1073/pnas.95.7.3827; Tuynman JB, 2008, CANCER RES, V68, P1213, DOI 10.1158/0008-5472.CAN-07-5172; Valbuena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001642; Valbuena A, 2006, MOL CELL BIOL, V26, P4782, DOI 10.1128/MCB.00069-06; Valbuena A, 2011, CELL SIGNAL, V23, P1267, DOI 10.1016/j.cellsig.2011.04.002; Valbuena A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017320; Valbuena A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002649; Vazquez-Cedeira M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023235; Vega FM, 2004, MOL CELL BIOL, V24, P10366, DOI 10.1128/MCB.24.23.10366-10380.2004; Vega FM, 2003, FEBS LETT, V544, P176, DOI 10.1016/S0014-5793(03)00501-5; Vinogradova Y, 2011, BRIT J CANCER, V105, P452, DOI 10.1038/bjc.2011.252; Yiu GK, 2006, J BIOL CHEM, V281, P12210, DOI 10.1074/jbc.M600184200; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	68	28	29	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42739	42750		10.1074/jbc.M112.404285	http://dx.doi.org/10.1074/jbc.M112.404285			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105117	Green Published, hybrid			2022-12-25	WOS:000312501600033
J	Watari, R; Yamaguchi, C; Zemba, W; Kubo, Y; Okano, K; Okano, T				Watari, Ryuji; Yamaguchi, Chiaki; Zemba, Wataru; Kubo, Yoko; Okano, Keiko; Okano, Toshiyuki			Light-dependent Structural Change of Chicken Retinal Cryptochrome4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-CLONING; PINEAL; LOCALIZATION; EXPRESSION	Animals have several classes of cryptochromes (CRYs), some of which function as core elements of circadian clockwork, circadian photoreceptors, and/or light-dependent magnetoreceptors. In addition to the circadian clock genes Cry1 and Cry2, nonmammalian vertebrates have the Cry4 gene, the molecular function of which remains unknown. Here we analyzed chicken CRY4 (cCRY4) expression in the retina with in situ hybridization and found that cCRY4 was likely transcribed in the visual pigment cells, cells in the inner nuclear layer, and retinal ganglion cells. We further developed several monoclonal antibodies to the carboxyl-terminal extension of cCRY4 and localized cCRY4 protein with immunohistochemistry. Consistent with the results of in situ hybridization, cCRY4 immunoreactivity was found in visual pigment cells and cells located at the inner nuclear layer and the retinal ganglion cell layer. Among the antibodies, one termed C1-mAb had its epitope within the carboxyl-terminal 14-amino acid sequence (QLTRDDADDPMEMK) and associated with cCRY4 in the retinal soluble fraction more strongly in the dark than under blue light conditions. Immunoprecipitation experiments under various light conditions indicated that cCRY4 from the immunocomplex formed in the dark dissociated from C1-mAb during blue light illumination as weak as 25 mu W/cm(2) and that the release occurred with not only blue but also near UV light. These results suggest that cCRY4 reversibly changes its structure within the carboxyl-terminal region in a light-dependent manner and operates as a photoreceptor or magnetoreceptor with short wavelength sensitivity in the retina.	[Watari, Ryuji; Yamaguchi, Chiaki; Zemba, Wataru; Kubo, Yoko; Okano, Keiko; Okano, Toshiyuki] Waseda Univ, Dept Elect Engn & Biosci, Grad Sch Adv Sci & Engn, Shinjuku Ku, Tokyo 1628480, Japan; [Okano, Toshiyuki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Waseda University; Japan Science & Technology Agency (JST)	Okano, T (corresponding author), Waseda Univ, Dept Elect Engn & Biosci, Grad Sch Adv Sci & Engn, Shinjuku Ku, Wakamatsu Cho 2-2, Tokyo 1628480, Japan.	okano@waseda.jp		Okano, Toshiyuki/0000-0001-6740-6265	Japanese Society for the Promotion of Science [KAKENHI 24657109, 23248033]; Ministry of Education, Culture, Sports, Science & Technology in Japan (MEXT)	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science & Technology in Japan (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported, in part, by Grants-in-aid for Scientific Research KAKENHI 24657109 and 23248033 from the Japanese Society for the Promotion of Science (to T. O.) and the Ministry of Education, Culture, Sports, Science & Technology in Japan (MEXT)-Supported Program for the Strategic Research Foundation at Private Universities.	Akiyama M, 2009, FEBS LETT, V583, P933, DOI 10.1016/j.febslet.2009.02.006; Bayram O, 2010, FUNGAL GENET BIOL, V47, P900, DOI 10.1016/j.fgb.2010.05.008; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Chaurasia SS, 2005, J NEUROCHEM, V92, P158, DOI 10.1111/j.1471-4159.2004.02874.x; Fogle KJ, 2011, SCIENCE, V331, P1409, DOI 10.1126/science.1199702; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Kasahara T, 2000, J NEUROCHEM, V75, P217, DOI 10.1046/j.1471-4159.2000.0750217.x; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; Kubo Y, 2006, J NEUROCHEM, V97, P1155, DOI 10.1111/j.1471-4159.2006.03826.x; Li QH, 2007, PHOTOCHEM PHOTOBIOL, V83, P94, DOI 10.1562/2006-02-28-IR-826; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Mouritsen H, 2004, P NATL ACAD SCI USA, V101, P14294, DOI 10.1073/pnas.0405968101; Niessner C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020091; Ozturk N, 2007, COLD SPRING HARB SYM, V72, P119, DOI 10.1101/sqb.2007.72.015; Okano T, 2003, J BIOCHEM, V134, P791, DOI 10.1093/jb/mvg221; OKANO T, 1994, NATURE, V372, P94, DOI 10.1038/372094a0; Ozturk N, 2011, P NATL ACAD SCI USA, V108, P516, DOI 10.1073/pnas.1017093108; Ozturk N, 2009, BIOCHEMISTRY-US, V48, P8585, DOI 10.1021/bi901043s; PIERCE ME, 1993, NEURON, V10, P579, DOI 10.1016/0896-6273(93)90161-J; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Tu DC, 2004, SCIENCE, V306, P129, DOI 10.1126/science.1101484; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504; Yamamoto K, 2001, NEUROSCI LETT, V313, P13, DOI 10.1016/S0304-3940(01)02227-3; Zoltowski BD, 2011, NATURE, V480, P396, DOI 10.1038/nature10618	24	44	47	0	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42634	42641		10.1074/jbc.M112.395731	http://dx.doi.org/10.1074/jbc.M112.395731			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23095750	hybrid, Green Published			2022-12-25	WOS:000312501600024
J	de la Parra, C; Otero-Franqui, E; Martinez-Montemayor, M; Dharmawardhane, S				de la Parra, Columba; Otero-Franqui, Elisa; Martinez-Montemayor, Michelle; Dharmawardhane, Suranganie			The Soy Isoflavone Equol May Increase Cancer Malignancy via Up-regulation of Eukaryotic Protein Synthesis Initiation Factor eIF4G	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERNAL RIBOSOME ENTRY; ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER; IN-VITRO; S-EQUOL; TRANSLATIONAL CONTROL; CELL-PROLIFERATION; GENE-EXPRESSION; CYCLIN D1; MYC	Dietary soy is thought to be cancer-preventive; however, the beneficial effects of soy on established breast cancer is controversial. We recently demonstrated that dietary daidzein or combined soy isoflavones (genistein, daidzein, and glycitein) increased primary mammary tumor growth and metastasis. Cancer-promoting molecules, including eukaryotic protein synthesis initiation factors (eIF) eIF4G and eIF4E, were up-regulated in mammary tumors from mice that received dietary daidzein. Herein, we show that increased eIF expression in tumor extracts of mice after daidzein diets is associated with protein expression of mRNAs with internal ribosome entry sites (IRES) that are sensitive to eIF4E and eIF4G levels. Results with metastatic cancer cell lines show that some of the effects of daidzein in vivo can be recapitulated by the daidzein metabolite equol. In vitro, equol, but not daidzein, up-regulated eIF4G without affecting eIF4E or its regulator, 4E-binding protein (4E-BP), levels. Equol also increased metastatic cancer cell viability. Equol specifically increased the protein expression of IRES containing cell survival and proliferation-promoting molecules and up-regulated gene and protein expression of the transcription factor c-Myc. Moreover, equol increased the polysomal association of mRNAs for p 120 catenin and eIF4G. The elevated eIF4G in response to equol was not associated with eIF4E or 4E-binding protein in 5' cap co-capture assays or co-immunoprecipitations. In dual luciferase assays, IRES-dependent protein synthesis was increased by equol. Therefore, up-regulation of eIF4G by equol may result in increased translation of pro-cancer mRNAs with IRESs and, thus, promote cancer malignancy.	[de la Parra, Columba; Otero-Franqui, Elisa; Dharmawardhane, Suranganie] Univ Puerto Rico, Sch Med, Dept Biochem, San Juan, PR 00936 USA; [Martinez-Montemayor, Michelle] Univ Cent Caribe, Sch Med, Dept Biochem, Bayamon, PR 00960 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Dharmawardhane, S (corresponding author), POB 365067, San Juan, PR 00936 USA.	su.d@upr.edu	Martínez-Montemayor, Michelle/X-6880-2019	Martínez-Montemayor, Michelle/0000-0002-6933-9905	National Institutes of Health [SC3GM084824]; National Institute of General Medical Sciences [G12RR003035, G12RR035051]; United States Army/BCRP [W81XWH-11-1-0199]; University of Puerto Rico Medical Sciences Campus Biomedical Graduate Program; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM084824] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600, G12MD007583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); United States Army/BCRP; University of Puerto Rico Medical Sciences Campus Biomedical Graduate Program; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Grants SC3GM084824 (NIGMS; to S. D.) and G12RR003035 (National Institute of General Medical Sciences to Universidad Central del Caribe) and National Institute of General Medical Sciences Grant G12RR035051 (to the University of Puerto Rico Medical Sciences Campus), This work was also supported by the United States Army/BCRP W81XWH-11-1-0199 and the University of Puerto Rico Medical Sciences Campus Biomedical Graduate Program (to C. D.).	Anastasiadis PZ, 2007, BBA-MOL CELL RES, V1773, P34, DOI 10.1016/j.bbamcr.2006.08.040; Atkinson C, 2008, AM J CLIN NUTR, V87, P679, DOI 10.1093/ajcn/87.3.679; Bandera EV, 2011, BMC WOMENS HEALTH, V11, DOI 10.1186/1472-6874-11-40; Bauer C, 2002, INT J CANCER, V98, P181, DOI 10.1002/ijc.10180; Braunstein S, 2007, MOL CELL, V28, P501, DOI 10.1016/j.molcel.2007.10.019; Carreau C, 2009, MOL NUTR FOOD RES, V53, P652, DOI 10.1002/mnfr.200800061; Chida D, 1999, BLOOD, V93, P1567, DOI 10.1182/blood.V93.5.1567.405k29_1567_1578; Choi EJ, 2008, MOL MED REP, V1, P239; Choi EJ, 2009, CHEM-BIOL INTERACT, V177, P7, DOI 10.1016/j.cbi.2008.09.031; Dang Chi V, 2010, Genes Cancer, V1, P526; DHARMAWARDHANE S, 1991, CELL MOTIL CYTOSKEL, V20, P279, DOI 10.1002/cm.970200404; Doe MR, 2012, CANCER RES, V72, P949, DOI 10.1158/0008-5472.CAN-11-2371; DUBIK D, 1992, ONCOGENE, V7, P1587; Fukuda S, 2002, BLOOD, V100, P2463, DOI 10.1182/blood.V100.7.2463; Goodman MT, 2009, CANCER PREV RES, V2, P887, DOI 10.1158/1940-6207.CAPR-09-0039; Graff JR, 2008, CANCER RES, V68, P631, DOI 10.1158/0008-5472.CAN-07-5635; Graff JR, 2007, J CLIN INVEST, V117, P2638, DOI 10.1172/JCI32044; Han BG, 2002, MOL CELL BIOL, V22, P7372, DOI 10.1128/MCB.22.21.7372-7384.2002; Haron H, 2011, INT J FOOD SCI NUTR, V62, P642, DOI 10.3109/09637486.2011.570742; Hedlund TE, 2003, PROSTATE, V54, P68, DOI 10.1002/pros.10137; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Jackson RL, 2011, NUTR REV, V69, P432, DOI 10.1111/j.1753-4887.2011.00400.x; Jo OD, 2008, J BIOL CHEM, V283, P23274, DOI 10.1074/jbc.M801185200; Ju YH, 2006, CARCINOGENESIS, V27, P856, DOI 10.1093/carcin/bgi320; Kelly PN, 2011, CELL DEATH DIFFER, V18, P1414, DOI 10.1038/cdd.2011.17; Khan SA, 2012, CANCER PREV RES, V5, P309, DOI 10.1158/1940-6207.CAPR-11-0251; Kim YY, 2009, CANCER RES, V69, P8455, DOI 10.1158/0008-5472.CAN-09-1923; Ko KP, 2010, CANCER EPIDEM BIOMAR, V19, P1292, DOI 10.1158/1055-9965.EPI-09-1004; Krepela E, 2009, INT J ONCOL, V35, P1449, DOI 10.3892/ijo_00000464; Kuhnle GGC, 2008, J AGR FOOD CHEM, V56, P10099, DOI 10.1021/jf801344x; Kumar N, 2004, FRONT BIOSCI-LANDMRK, V9, P2927, DOI 10.2741/1448; Labisso WL, 2012, CELL CYCLE, V11, P1593, DOI 10.4161/cc.20008; Lamartiniere CA, 2002, TOXICOL SCI, V65, P228, DOI 10.1093/toxsci/65.2.228; Lampe JW, 2010, J NUTR, V140, p1369S, DOI 10.3945/jn.109.118323; Lerner RS, 2006, RNA, V12, P775, DOI 10.1261/rna.2318906; Lin CJ, 2009, CANCER RES, V69, P7491, DOI 10.1158/0008-5472.CAN-09-0813; Ling J, 2005, EMBO J, V24, P4094, DOI 10.1038/sj.emboj.7600868; Liu HQ, 2010, J NUTR BIOCHEM, V21, P390, DOI 10.1016/j.jnutbio.2009.01.016; Liu WZ, 2009, J BIOL CHEM, V284, P31336, DOI 10.1074/jbc.M109.049858; Lund TD, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-4; Magee PJ, 2006, NUTR CANCER, V54, P232, DOI 10.1207/s15327914nc5402_10; Magee PJ, 2011, P NUTR SOC, V70, P10, DOI 10.1017/S0029665110003940; Magee PJ, 2004, CANCER LETT, V208, P35, DOI 10.1016/j.canlet.2003.11.012; Martinez-Montemayor MM, 2011, NUTR CANCER, V63, P1085, DOI 10.1080/01635581.2011.601845; Martinez-Montemayor MM, 2010, CLIN EXP METASTAS, V27, P465, DOI 10.1007/s10585-010-9336-x; McMichael-Phillips DF, 1998, AM J CLIN NUTR, V68, p1431S, DOI 10.1093/ajcn/68.6.1431S; McNeil CM, 2006, J STEROID BIOCHEM, V102, P147, DOI 10.1016/j.jsbmb.2006.09.028; Messina M, 2010, J NUTR, V140, p1350S, DOI 10.3945/jn.109.118315; Messina M, 2009, J NUTR, V139, p796S, DOI 10.3945/jn.108.104182; Mezquita P, 2005, ONCOGENE, V24, P889, DOI 10.1038/sj.onc.1208251; Munoz Y, 2009, THROMB RES, V123, P740, DOI 10.1016/j.thromres.2008.07.011; Muthyala RS, 2004, BIOORGAN MED CHEM, V12, P1559, DOI 10.1016/j.bmc.2003.11.035; Onoda A, 2011, FOOD CHEM TOXICOL, V49, P2279, DOI 10.1016/j.fct.2011.06.027; Pieters T, 2012, FRONT BIOSCI-LANDMRK, V17, P760, DOI 10.2741/3956; Ramirez-Valle F, 2008, J CELL BIOL, V181, P293, DOI 10.1083/jcb.200710215; Rice S, 2006, ENDOCR-RELAT CANCER, V13, P995, DOI 10.1677/erc.1.01159; Rivera-Ruiz ME, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-690; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Setchell KDR, 2003, AM J CLIN NUTR, V77, P411, DOI 10.1093/ajcn/77.2.411; Setchell KDR, 2010, J NUTR, V140, p1355S, DOI 10.3945/jn.109.119776; Setchell KDR, 2010, J NUTR, V140, p1363S, DOI 10.3945/jn.109.119784; Sherrill KW, 2004, J BIOL CHEM, V279, P29066, DOI 10.1074/jbc.M402727200; Shi YJ, 2005, J BIOL CHEM, V280, P10964, DOI 10.1074/jbc.M407874200; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Silvera D, 2009, NAT CELL BIOL, V11, P903, DOI 10.1038/ncb1900; Sonenberg N, 2003, CURR OPIN STRUC BIOL, V13, P56, DOI 10.1016/S0959-440X(03)00009-5; Spriggs KA, 2009, MOL CELL BIOL, V29, P1565, DOI 10.1128/MCB.01283-08; Staber PB, 2007, BLOOD, V110, P3374, DOI 10.1182/blood-2007-02-071258; Stoneley M, 2000, MOL CELL BIOL, V20, P1162, DOI 10.1128/MCB.20.4.1162-1169.2000; Stoneley M, 1998, ONCOGENE, V16, P423, DOI 10.1038/sj.onc.1201763; Tonetti DA, 2007, NUTR CANCER, V58, P222, DOI 10.1080/01635580701328545; Van Der Kelen K, 2009, CRIT REV BIOCHEM MOL, V44, P143, DOI 10.1080/10409230902882090; Wang XM, 2007, METHOD ENZYMOL, V431, P113, DOI 10.1016/S0076-6879(07)31007-0; WELSHONS WV, 1987, BREAST CANCER RES TR, V10, P169, DOI 10.1007/BF01810580; Wolfer A, 2011, CANCER RES, V71, P2034, DOI 10.1158/0008-5472.CAN-10-3776; XU X, 1994, J NUTR, V124, P825, DOI 10.1093/jn/124.6.825; Yoon A, 2006, SCIENCE, V312, P902, DOI 10.1126/science.1123835	77	16	17	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41640	41650		10.1074/jbc.M112.393470	http://dx.doi.org/10.1074/jbc.M112.393470			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23095751	Green Published, hybrid			2022-12-25	WOS:000312103000008
J	Zhang, NR; Planer, W; Siuda, ER; Zhao, HC; Stickler, L; Chang, SD; Baird, MA; Cao, YQ; Bruchas, MR				Zhang, Nancy R.; Planer, William; Siuda, Edward R.; Zhao, Hu-Chen; Stickler, Lucy; Chang, Steven D.; Baird, Madison A.; Cao, Yu-Qing; Bruchas, Michael R.			Serine 363 Is Required for Nociceptin/Orphanin FQ Opioid Receptor (NOPR) Desensitization, Internalization, and Arrestin Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; N-TERMINAL KINASE; BETA-ARRESTIN; NONVISUAL ARRESTINS; CALCIUM-CHANNELS; ORL1 RECEPTORS; P38 MAPK; ACTIVATION; PHOSPHORYLATION; COMPLEX	We determined the role of carboxyl-terminal regulation of NOPR (nociceptin, orphanin FQ receptor) signaling and function. We mutated C-terminal serine and threonine residues and examined their role in NOPR trafficking, homologous desensitization, and arrestin-dependent MAPK signaling. The NOPR agonist, nociceptin, caused robust NOPR-YFP receptor internalization, peaking at 30 min. Mutation of serine 337, 346, and 351, had no effect on NOPR internalization. However, mutation of C-terminal threonine 362, serine 363, and threonine 365 blocked nociceptin-induced internalization of NOPR. Furthermore, point mutation of only Ser-363 was sufficient to block NOPR internalization. Homologous desensitization of NOPR-mediated calcium channel blockade and inhibition of cAMP were also shown to require Ser-363. Additionally, NOPR internalization was absent when GRK3, and Arrestin3 were knocked down using siRNA, but not when GRK2 and Arrestin2 were knocked down. We also found that nociceptin-induced NOPR-mediated JNK but not ERK signaling requires Ser-363, GRK3, and Arrestin3. Dominant-positive Arrestin3 but not Arrestin2 was sufficient to rescue NOPR-S363A internalization and JNK signaling. These findings suggest that NOPR function may be regulated by GRK3 phosphorylation of Ser-363 and Arrestin3 and further demonstrates the complex nature of G-protein-dependent and -independent signaling in opioid receptors.	[Zhang, Nancy R.; Planer, William; Siuda, Edward R.; Zhao, Hu-Chen; Stickler, Lucy; Chang, Steven D.; Baird, Madison A.; Cao, Yu-Qing; Bruchas, Michael R.] Washington Univ, Sch Med, Dept Anesthesiol, Basic Res Div, St Louis, MO 63110 USA; [Bruchas, Michael R.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Cao, Yu-Qing; Bruchas, Michael R.] Washington Univ, Sch Med, Pain Ctr, St Louis, MO 63110 USA; [Siuda, Edward R.; Cao, Yu-Qing; Bruchas, Michael R.] Washington Univ, Sch Med, Div Biol & Biomed Sci, Program Neurosci, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Bruchas, MR (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol & Anat Neurobiol, 660 S Euclid Ave, St Louis, MO 63110 USA.	bruchasm@wustl.edu	Bruchas, Michael/G-7616-2012		National Institutes of Health [R00DA034929, T32DA007261]; Howard Hughes Medical Institute SURF Fellowship Program; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007261, R00DA025182, R21DA034929] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute SURF Fellowship Program; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R00DA034929 (to M.R.B.) and T32DA007261 (to S.D.C.) and the Howard Hughes Medical Institute SURF Fellowship Program (to N.Z. and L.S.).	Al-Hasani R, 2011, ANESTHESIOLOGY, V115, P1363, DOI 10.1097/ALN.0b013e318238bba6; Altier C, 2006, NAT NEUROSCI, V9, P31, DOI 10.1038/nn1605; Antoniou X, 2011, J ALZHEIMERS DIS, V24, P633, DOI 10.3233/JAD-2011-091567; Bohn LM, 2004, NEUROMOL MED, V5, P41, DOI 10.1385/NMM:5:1:041; Breitman M, 2012, J BIOL CHEM, V287, P19653, DOI 10.1074/jbc.M112.358192; Bruchas MR, 2007, J NEUROSCI, V27, P11614, DOI 10.1523/JNEUROSCI.3769-07.2007; Bruchas MR, 2006, J BIOL CHEM, V281, P18081, DOI 10.1074/jbc.M513640200; Bruchas MR, 2011, NEURON, V71, P498, DOI 10.1016/j.neuron.2011.06.011; Bruchas MR, 2010, PSYCHOPHARMACOLOGY, V210, P137, DOI 10.1007/s00213-010-1806-y; Carter JM, 2005, J MOL BIOL, V351, P865, DOI 10.1016/j.jmb.2005.06.048; Celver J, 2002, J BIOL CHEM, V277, P9043, DOI 10.1074/jbc.M107400200; Chan ASL, 2000, J PHARMACOL EXP THER, V295, P1094; Connor M, 1996, BRIT J PHARMACOL, V118, P205, DOI 10.1111/j.1476-5381.1996.tb15387.x; Corbani M, 2004, ENDOCRINOLOGY, V145, P2876, DOI 10.1210/en.2004-0062; Davies C, 2012, BIOCHEM SOC T, V40, P85, DOI 10.1042/BST20110641; Goeldner C, 2008, J NEUROSCI, V28, P2190, DOI 10.1523/JNEUROSCI.3711-07.2008; Grecksch G, 2011, J NEUROSCI, V31, P13890, DOI 10.1523/JNEUROSCI.2304-11.2011; Groer CE, 2011, J BIOL CHEM, V286, P31731, DOI 10.1074/jbc.M111.248310; Gurevich VV, 1997, J BIOL CHEM, V272, P28849, DOI 10.1074/jbc.272.46.28849; Land BB, 2009, P NATL ACAD SCI USA, V106, P19168, DOI 10.1073/pnas.0910705106; Lau EK, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001748; LAW PY, 1982, MOL PHARMACOL, V22, P1; Macey TA, 2006, J BIOL CHEM, V281, P34515, DOI 10.1074/jbc.M604278200; Manassero G, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-39; Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3; Marti M, 2004, J NEUROSCI, V24, P6659, DOI 10.1523/JNEUROSCI.0987-04.2004; McLaughlin JP, 2003, J BIOL CHEM, V278, P34631, DOI 10.1074/jbc.M304022200; McLennan GP, 2008, J NEUROCHEM, V107, P1753, DOI 10.1111/j.1471-4159.2008.05745.x; Melief EJ, 2010, P NATL ACAD SCI USA, V107, P11608, DOI 10.1073/pnas.1000751107; Mika J, 2011, NEUROPEPTIDES, V45, P247, DOI 10.1016/j.npep.2011.03.002; Mogil JS, 2001, PHARMACOL REV, V53, P381; MOLLEREAU C, 1994, FEBS LETT, V341, P33, DOI 10.1016/0014-5793(94)80235-1; Murali SS, 2012, J PHYSIOL-LONDON, V590, P1655, DOI 10.1113/jphysiol.2012.228429; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Pan L, 2003, J BIOL CHEM, V278, P11623, DOI 10.1074/jbc.M209532200; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; REINSCHEID RK, 1995, SCIENCE, V270, P792, DOI 10.1126/science.270.5237.792; Rozenfeld R, 2007, FASEB J, V21, P2455, DOI 10.1096/fj.06-7793com; Schmid C, 2008, INT J COMPUT VISION, V76, P105, DOI 10.1007/s11263-007-0073-9; Schmid CL, 2010, J NEUROSCI, V30, P13513, DOI 10.1523/JNEUROSCI.1665-10.2010; Schmid CL, 2009, PHARMACOL THERAPEUT, V121, P285, DOI 10.1016/j.pharmthera.2008.11.005; Seo J, 2011, J BIOL CHEM, V286, P27894, DOI 10.1074/jbc.M111.260448; Shenoy SK, 2011, TRENDS PHARMACOL SCI, V32, P521, DOI 10.1016/j.tips.2011.05.002; Song XF, 2006, J BIOL CHEM, V281, P21491, DOI 10.1074/jbc.M603659200; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Tibbles LA, 1999, CELL MOL LIFE SCI, V55, P1230, DOI 10.1007/s000180050369; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Wolfe BL, 2007, TRAFFIC, V8, P462, DOI 10.1111/j.1600-0854.2007.00551.x; Zhan XZ, 2011, BIOCHEMISTRY-US, V50, P10520, DOI 10.1021/bi201506g; Zhang Z, 1999, J NEUROCHEM, V73, P1502, DOI 10.1046/j.1471-4159.1999.0731502.x	51	31	34	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42019	42030		10.1074/jbc.M112.405696	http://dx.doi.org/10.1074/jbc.M112.405696			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086955	hybrid, Green Published			2022-12-25	WOS:000312103000041
J	Bahuon, C; Despres, P; Pardigon, N; Panthier, JJ; Cordonnier, N; Lowenski, S; Richardson, J; Zientara, S; Lecollinet, S				Bahuon, Celine; Despres, Philippe; Pardigon, Nathalie; Panthier, Jean-Jacques; Cordonnier, Nathalie; Lowenski, Steeve; Richardson, Jennifer; Zientara, Stephan; Lecollinet, Sylvie			IS-98-ST1 West Nile Virus Derived from an Infectious cDNA Clone Retains Neuroinvasiveness and Neurovirulence Properties of the Original Virus	PLOS ONE			English	Article							2',5'-OLIGOADENYLATE SYNTHETASE 1B; AMINO-ACID SUBSTITUTION; VIRULENCE; PROTEIN; INHIBITION; DETERMINANTS; REPLICATION; PHENOTYPE; CONFERS; STRAIN	Infectious clones of West Nile virus (WNV) have previously been generated and used to decipher the role of viral proteins in WNV virulence. The majority of molecular clones obtained to date have been derived from North American, Australian, or African isolates. Here, we describe the construction of an infectious cDNA clone of a Mediterranean WNV strain, IS-98-ST1. We characterized the biological properties of the recovered recombinant virus in cell culture and in mice. The growth kinetics of recombinant and parental WNV were similar in Vero cells. Moreover, the phenotype of recombinant and parental WNV was indistinguishable as regards viremia, viral load in the brain, and mortality in susceptible and resistant mice. Finally, the pathobiology of the infectious clone was examined in embryonated chicken eggs. The capacity of different WNV strains to replicate in embryonated chicken eggs closely paralleled their ability to replicate in mice, suggesting that inoculation of embryonated chicken eggs could provide a practical in vivo model for the study of WNV pathogenesis. In conclusion, the IS-98-ST1 infectious clone will allow assessment of the impact of selected mutations and novel genomic changes appearing in emerging European strains pathogenicity and endemic or epidemic potential. This will be invaluable in the context of an increasing number of outbreaks and enhanced severity of infections in the Mediterranean basin and Eastern Europe.	[Bahuon, Celine; Lowenski, Steeve; Richardson, Jennifer; Zientara, Stephan; Lecollinet, Sylvie] Agence Natl Seurite Sanit Alimentat Environm Trav, UMR VIROLOGIE ANSES INRA ENVA 1161, Maisons Alfort, France; [Despres, Philippe; Pardigon, Nathalie] Inst Pasteur, Dept Virol, Unite Interact Mol Flavivirus Hotes, Paris, France; [Panthier, Jean-Jacques] Inst Pasteur, Mouse Funct Genet, Paris, France; [Cordonnier, Nathalie] Ecole Natl Vet Alfort, Unite Histol & Anat Pathol, Maisons Alfort, France	INRAE; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Ecole Nationale Veterinaire d'Alfort (ENVA)	Bahuon, C (corresponding author), Agence Natl Seurite Sanit Alimentat Environm Trav, UMR VIROLOGIE ANSES INRA ENVA 1161, Maisons Alfort, France.	celine.bahuon@anses.fr	Zientara, Stephan/AAA-7661-2021; Lecollinet, Sylvie/M-1728-2019; Lecollinet, Sylvie/AAV-5276-2021; Zientara, Stephan/A-5336-2016; PANTHIER, Jean-Jacques/I-4366-2014	Zientara, Stephan/0000-0002-6733-8503; Zientara, Stephan/0000-0003-0089-8175; PANTHIER, Jean-Jacques/0000-0002-7966-0663; Lecollinet, Sylvie/0000-0001-8535-2133; Richardson, Jennifer/0000-0002-4137-3984	French agency for food, environmental and occupational health and safety (ANSES)	French agency for food, environmental and occupational health and safety (ANSES)(French National Research Agency (ANR))	This study was funded by the French agency for food, environmental and occupational health and safety (ANSES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No external funding was received for this study.	Abdul-Careem MF, 2007, POULTRY SCI, V86, P1351, DOI 10.1093/ps/86.7.1351; Audsley M, 2011, VIROLOGY, V414, P63, DOI 10.1016/j.virol.2011.03.008; Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005; Beasley DWC, 2002, VIROLOGY, V296, P17, DOI 10.1006/viro.2002.1372; Bondre VP, 2007, J GEN VIROL, V88, P875, DOI 10.1099/vir.0.82403-0; Borisevich V, 2006, VIROLOGY, V349, P371, DOI 10.1016/j.virol.2006.02.013; Botha EM, 2008, EMERG INFECT DIS, V14, P222, DOI 10.3201/eid1402.070457; Brault AC, 2007, NAT GENET, V39, P1162, DOI 10.1038/ng2097; Brnic D, 2012, J VIROL, V86, P2512, DOI 10.1128/JVI.05663-11; Calistri Paolo, 2010, Open Virol J, V4, P29, DOI 10.2174/1874357901004020029; Crespo R, 2009, AVIAN DIS, V53, P608, DOI 10.1637/8829-040209-ResNote.1; Deas TS, 2005, J VIROL, V79, P4599, DOI 10.1128/JVI.79.8.4599-4609.2005; Elghonemy S, 2005, VIROLOGY, V331, P238, DOI 10.1016/j.virol.2004.11.008; Evans JD, 2007, J VIROL, V81, P11809, DOI 10.1128/JVI.00791-07; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; Firth AE, 2011, NUCLEIC ACIDS RES, V39, P6679, DOI 10.1093/nar/gkr224; Fodor E, 1999, J VIROL, V73, P9679, DOI 10.1128/JVI.73.11.9679-9682.1999; Hall RA, 2002, CURR TOP MICROBIOL, V267, P253; Jacobsen ID, 2010, INFECT IMMUN, V78, P2995, DOI 10.1128/IAI.00268-10; Jungreis I, 2011, GENOME RES, V21, P2096, DOI 10.1101/gr.119974.110; Kajaste-Rudnitski A, 2006, J BIOL CHEM, V281, P4624, DOI 10.1074/jbc.M508649200; Khromykh AA, 1997, J VIROL, V71, P1497, DOI 10.1128/JVI.71.2.1497-1505.1997; KHROMYKH AA, 1994, J VIROL, V68, P4580, DOI 10.1128/JVI.68.7.4580-4588.1994; Kinney RM, 2006, J GEN VIROL, V87, P3611, DOI 10.1099/vir.0.82299-0; Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002; Liang QL, 2011, MOL IMMUNOL, V48, P924, DOI 10.1016/j.molimm.2010.12.011; Linke S, 2007, J VIROL METHODS, V146, P355, DOI 10.1016/j.jviromet.2007.05.021; Liu WJ, 2006, J VIROL, V80, P2396, DOI 10.1128/JVI.80.5.2396-2404.2006; Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005; Liu WJ, 2003, J VIROL, V77, P7804, DOI 10.1128/JVI.77.14.7804-7813.2003; Lucas M, 2004, VIROL J, V1, DOI 10.1186/1743-422X-1-9; Ma DL, 2009, ANTIVIR RES, V83, P53, DOI 10.1016/j.antiviral.2009.03.006; Malkinson M, 2002, EMERG INFECT DIS, V8, P392, DOI 10.3201/eid0804.010217; Mashimo T, 2002, P NATL ACAD SCI USA, V99, P11311, DOI 10.1073/pnas.172195399; May FJ, 2011, J VIROL, V85, P2964, DOI 10.1128/JVI.01963-10; Melian EB, 2010, J VIROL, V84, P1641, DOI 10.1128/JVI.01979-09; Mertens E, 2010, VIROLOGY, V399, P176, DOI 10.1016/j.virol.2009.12.036; Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100; Murray KO, 2010, VET RES, V41, DOI 10.1051/vetres/2010039; Papa A, 2010, EUROSURVEILLANCE, V15; Pugachev KV, 2004, J VIROL, V78, P1032, DOI 10.1128/JVI.78.2.1032-1038.2004; Puig-Basagoiti F, 2007, VIROLOGY, V361, P229, DOI 10.1016/j.virol.2006.11.012; Ruggli N, 1999, ADV VIRUS RES, V53, P183, DOI 10.1016/S0065-3527(08)60348-6; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Sambrook J., 2001, MOL CLONING; Samuel MA, 2006, J VIROL, V80, P9349, DOI 10.1128/JVI.01122-06; Schlick P, 2009, J VIROL, V83, P5581, DOI 10.1128/JVI.02653-08; Senne DA, 2000, AVIAN DIS, V44, P642, DOI 10.2307/1593105; Seregin A, 2006, VIROLOGY, V356, P115, DOI 10.1016/j.virol.2006.07.038; Shi PY, 2002, J VIROL, V76, P5847, DOI 10.1128/JVI.76.12.5847-5856.2002; Simon-Chazottes D, 2011, VIROLOGY, V417, P147, DOI 10.1016/j.virol.2011.05.018; Sotelo E, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-11; Sotelo E, 2009, VIROLOGY, V395, P289, DOI 10.1016/j.virol.2009.09.013; Steele KE, 2000, VET PATHOL, V37, P208, DOI 10.1354/vp.37-3-208; Wicker JA, 2006, VIROLOGY, V349, P245, DOI 10.1016/j.virol.2006.03.007; Yamshchikov G, 2004, VIROLOGY, V330, P304, DOI 10.1016/j.virol.2004.09.014; Yamshchikov V, 2001, VIROLOGY, V281, P272, DOI 10.1006/viro.2000.0793; Yamshchikov VF, 2001, VIROLOGY, V281, P294, DOI 10.1006/viro.2000.0795; Yu L, 2008, VACCINE, V26, P5981, DOI 10.1016/j.vaccine.2008.08.064	59	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47666	10.1371/journal.pone.0047666	http://dx.doi.org/10.1371/journal.pone.0047666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110088	Green Submitted, Green Published, gold			2022-12-25	WOS:000310193600020
J	Rieger, AM; Konowalchuk, JD; Grayfer, L; Katzenback, BA; Havixbeck, JJ; Kiemele, MD; Belosevic, M; Barreda, DR				Rieger, Aja M.; Konowalchuk, Jeffrey D.; Grayfer, Leon; Katzenback, Barbara A.; Havixbeck, Jeffrey J.; Kiemele, Moira D.; Belosevic, Miodrag; Barreda, Daniel R.			Fish and Mammalian Phagocytes Differentially Regulate Pro-Inflammatory and Homeostatic Responses In Vivo	PLOS ONE			English	Article							ZYMOSAN-INDUCED PERITONITIS; APOPTOTIC CELLS; B-CELLS; REACTIVE OXYGEN; TGF-BETA; MACROPHAGE; RESOLUTION; EXPRESSION; CLEARANCE; RECEPTOR	Phagocytosis is a cellular mechanism that is important to the early induction of antimicrobial responses and the regulation of adaptive immunity. At an inflammatory site, phagocytes serve as central regulators for both pro-inflammatory and homeostatic anti-inflammatory processes. However, it remains unclear if this is a recent evolutionary development or whether the capacity to balance between these two seemingly contradictory processes is a feature already displayed in lower vertebrates. In this study, we used murine (C57BL/6) and teleost fish (C. auratus) in vitro and in vivo models to assess the evolutionary conservation of this dichotomy at a site of inflammation. At the level of the macrophage, we found that teleost fish already displayed divergent pro-inflammatory and homeostatic responses following internalization of zymosan or apoptotic bodies, respectively, and that these were consistent with those of mice. However, fish and mice displayed significant differences in vivo with regards to the level of responsiveness to zymosan and apoptotic bodies, the identity of infiltrating leukocytes, their rate of infiltration, and the kinetics and strength of resulting antimicrobial responses. Unlike macrophages, significant differences were identified between teleost and murine neutrophilic responses. We report for the first time that activated murine, but not teleost neutrophils, possess the capacity to internalize apoptotic bodies. This internalization translates into reduction of neutrophil ROS production. This may play an important part in the recently identified anti-inflammatory activity that mammalian neutrophils display during the resolution phase of inflammation. Our observations are consistent with continued honing of inflammatory control mechanisms from fish to mammals, and provide added insights into the evolutionary path that has resulted in the integrated, multilayered responses that are characteristic of higher vertebrates.	[Rieger, Aja M.; Konowalchuk, Jeffrey D.; Grayfer, Leon; Katzenback, Barbara A.; Havixbeck, Jeffrey J.; Kiemele, Moira D.; Belosevic, Miodrag; Barreda, Daniel R.] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Belosevic, Miodrag] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Barreda, Daniel R.] Univ Alberta, Dept Agr Forestry & Nutr Sci, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Barreda, DR (corresponding author), Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada.	dan.barreda@ualberta.ca	Belosevic, Miodrag/C-6729-2008; Belosevic, Miodrag/G-9396-2018; Barreda, Daniel/A-2613-2014; Katzenback, Barb/M-1292-2013	Belosevic, Miodrag/0000-0002-6412-8236; Belosevic, Miodrag/0000-0002-6412-8236; Barreda, Daniel/0000-0003-4630-2840; Katzenback, Barb/0000-0001-6171-5040	Natural Sciences and Engineering Council of Canada (NSERC) grants; NSERC Vanier doctoral scholarship; NSERC; Alberta Ingenuity doctoral scholarship; NSERC PGS-D doctoral scholarship	Natural Sciences and Engineering Council of Canada (NSERC) grants; NSERC Vanier doctoral scholarship; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Ingenuity doctoral scholarship; NSERC PGS-D doctoral scholarship	This work was supported by Natural Sciences and Engineering Council of Canada (NSERC) grants to DRB and MB. AMR was supported by NSERC Vanier doctoral scholarship. BAK was supported by NSERC and Alberta Ingenuity doctoral scholarships and LG was supported by NSERC PGS-D doctoral scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson HA, 2002, CELL DEATH DIFFER, V9, P616, DOI 10.1038/sj.cdd.4401013; Ariel A, 2006, NAT IMMUNOL, V7, P1209, DOI 10.1038/ni1392; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Bellingan GJ, 1996, J IMMUNOL, V157, P2577; Bianchi SM, 2008, AM J RESP CRIT CARE, V177, P35, DOI 10.1164/rccm.200612-1804OC; Bittencourt MD, 2001, BLOOD, V98, P224, DOI 10.1182/blood.V98.1.224; Borgeson E, 2011, INFECT IMMUN, V79, P1489, DOI 10.1128/IAI.00777-10; Brown GD, 2002, J EXP MED, V196, P407, DOI 10.1084/jem.20020470; Cash JL, 2009, METHOD ENZYMOL, V461, P379, DOI 10.1016/S0076-6879(09)05417-2; Chadzinska M, 2008, DEV COMP IMMUNOL, V32, P509, DOI 10.1016/j.dci.2007.08.008; Christenson K, J LEUKOC BIOL, V90, P1055; Cuzzocrea S, 1997, SHOCK, V8, P268, DOI 10.1097/00024382-199710000-00006; Duffield JS, 2003, CLIN SCI, V104, P27, DOI 10.1042/CS20020240; Erwig LP, 2007, AM J PATHOL, V171, P2, DOI 10.2353/ajpath.2007.070135; Esmann L, 2010, J IMMUNOL, V184, P391, DOI 10.4049/jimmunol.0900564; Fadeel B, 2010, BIOCHEM BIOPH RES CO, V396, P7, DOI 10.1016/j.bbrc.2010.02.106; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fillatreau S, 2008, NAT REV IMMUNOL, V8, P391, DOI 10.1038/nri2315; Fullard JF, 2009, APOPTOSIS, V14, P1029, DOI 10.1007/s10495-009-0335-9; Gantner BN, 2003, J EXP MED, V197, P1107, DOI 10.1084/jem.20021787; Goodridge HS, 2007, J IMMUNOL, V178, P3107, DOI 10.4049/jimmunol.178.5.3107; Gregory CD, 2004, IMMUNOLOGY, V113, P1, DOI 10.1111/j.1365-2567.2004.01959.x; Herre J, 2004, BLOOD, V104, P4038, DOI 10.1182/blood-2004-03-1140; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Johann AM, 2006, CELL DEATH DIFFER, V13, P1533, DOI 10.1038/sj.cdd.4401832; Katzenback BA, 2012, FISH SHELLFISH IMMUN, V32, P434, DOI 10.1016/j.fsi.2011.12.003; Katzenback BA, 2009, DEV COMP IMMUNOL, V33, P601, DOI 10.1016/j.dci.2008.10.011; Keen D, 2008, J Wound Care, V17, P218; Keen D, 2008, J WOUND CARE, V17, P222; Kim SJ, 2004, IMMUNITY, V21, P643, DOI 10.1016/j.immuni.2004.09.009; Kleinclauss F, 2006, CELL DEATH DIFFER, V13, P41, DOI 10.1038/sj.cdd.4401699; Kolaczkowska E, 2008, INFLAMM RES, V57, P272, DOI 10.1007/s00011-007-7131-1; Leitch AE, 2011, J LEUKOCYTE BIOL, V90, P841, DOI 10.1189/jlb.0511222; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Li J, 2006, NAT IMMUNOL, V7, P1116, DOI 10.1038/ni1389; Maderna P, 2003, BBA-MOL BASIS DIS, V1639, P141, DOI 10.1016/j.bbadis.2003.09.004; Majji S, 2009, DEV COMP IMMUNOL, V33, P224, DOI 10.1016/j.dci.2008.08.010; Martinez-Martin N, 2011, IMMUNITY, V35, P208, DOI 10.1016/j.immuni.2011.06.003; Medzhitov R, 2007, NATURE, V449, P819, DOI 10.1038/nature06246; MILLER NW, 1994, J IMMUNOL, V152, P2180; Munoz LE, 2010, AUTOIMMUN REV, V10, P38, DOI 10.1016/j.autrev.2010.08.015; Nakashima M, 2012, J LEUKOCYTE BIOL, V91, P537, DOI 10.1189/jlb.0411214; Nascimento-Silva V, 2007, THROMB HAEMOSTASIS, V97, P88, DOI 10.1160/TH06-06-0315; Neumann NF, 2000, FISH SHELLFISH IMMUN, V10, P1, DOI 10.1006/fsim.1999.0221; Neumann NF, 1998, DEV COMP IMMUNOL, V22, P417, DOI 10.1016/S0145-305X(98)00023-8; Overland HS, 2010, FISH SHELLFISH IMMUN, V28, P193, DOI 10.1016/j.fsi.2009.10.021; Parra D, 2012, J LEUKOCYTE BIOL, V91, P525, DOI 10.1189/jlb.0711372; Pini M, 2010, J LEUKOCYTE BIOL, V87, P51, DOI 10.1189/jlb.0309188; Poon IKH, 2010, CELL DEATH DIFFER, V17, P381, DOI 10.1038/cdd.2009.195; Potter PK, 2003, J IMMUNOL, V170, P3223, DOI 10.4049/jimmunol.170.6.3223; Reiter I, 1999, J IMMUNOL, V163, P1730; Rieger A, 2008, NAT REV IMMUNOL, V8, P486, DOI 10.1038/nri2315-c1; Rieger AM, 2010, DEV COMP IMMUNOL, V34, P1144, DOI 10.1016/j.dci.2010.06.006; Saas P, 2007, TRANSPLANTATION, V84, pS31, DOI 10.1097/01.tp.0000269113.59857.d6; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serinkan BF, 2005, CELL DEATH DIFFER, V12, P1141, DOI 10.1038/sj.cdd.4401619; Soehnlein O, 2010, NAT REV IMMUNOL, V10, P427, DOI 10.1038/nri2779; Stafford JL, 2001, DEV COMP IMMUNOL, V25, P447, DOI 10.1016/S0145-305X(01)00015-5; Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011; Tassiulas I, 2007, HUM IMMUNOL, V68, P156, DOI 10.1016/j.humimm.2006.12.008; Underhill DM, 2003, J ENDOTOXIN RES, V9, P176, DOI 10.1179/096805103125001586; van Lent PLEM, 2001, J LEUKOCYTE BIOL, V70, P708; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Weigert A, 2009, BIOL CHEM, V390, P379, DOI 10.1515/BC.2009.048; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; Wu Y, 2012, NEUROCHEM RES, V37, P1690, DOI 10.1007/s11064-012-0776-3; Zamboni DS, 2003, INFECT IMMUN, V71, P1225, DOI 10.1128/IAI.71.3.1225-1233.2003; Zhang YA, 2010, NAT IMMUNOL, V11, P827, DOI 10.1038/ni.1913; Zouali M, 2008, FRONT BIOSCI, V13, P4852, DOI 10.2741/3044	69	40	43	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47070	10.1371/journal.pone.0047070	http://dx.doi.org/10.1371/journal.pone.0047070			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110059	Green Published, Green Submitted, gold			2022-12-25	WOS:000310193600008
J	Kothera, L; Godsey, MS; Doyle, MS; Savage, HM				Kothera, Linda; Godsey, Marvin S., Jr.; Doyle, Michael S.; Savage, Harry M.			Characterization of Culex pipiens Complex (Diptera: Culicidae) Populations in Colorado, USA Using Microsatellites	PLOS ONE			English	Article							WEST-NILE-VIRUS; EASTERN UNITED-STATES; CHAIN-REACTION ASSAY; VECTOR COMPETENCE; NORTH-AMERICA; F-STATISTICS; FRONT RANGE; MOSQUITOS; SOFTWARE; QUINQUEFASCIATUS	Mosquitoes such as those in the Culex pipiens complex are important vectors of disease. This study was conducted to genetically characterize Cx. pipiens complex populations in the state of Colorado, USA, and to determine the number of genetic clusters represented by the data. Thirteen populations located among four major river basins were sampled (n = 597 individuals) using a panel of 14 microsatellites. The lowest-elevation sites had the highest Expected Heterozygosity (H-E) values (range 0.54-0.65). AMOVA results indicated the presence of statistically significant amounts of variation within each level when populations were analyzed as one group or when they were grouped either by river basin or by their position on the east or west side of the Rocky Mountains. Most pairwise F-ST values were significant via permutation test (range 0-0.10), with the highest values from comparisons with Lamar, in southeast CO. A neighbor joining tree based on Cavalli-Sforza and Edwards's chord distances was consistent with the geographic locations of populations, as well as with the AMOVA results. There was a significant isolation by distance effect, and the cluster analysis resolved five groups. Individuals were also assayed with an additional microsatellite marker, Cxpq78, proposed to be monomorphic in Cx. pipiens but polymorphic in the closely related but biologically distinct species Cx. quinquefasciatus. Low frequencies (<= 3%) of Cx. quinquefasciatus alleles for this marker were noted, and mostly confined to populations along the Interstate 25 corridor. Pueblo was distinct in that it had 10% Cx. quinquefasciatus alleles, mostly of one allele size. The degree of population genetic structure observed in this study is in contrast with that of Cx. tarsalis, the other major vector of WNV in the western U.S., and likely reflects the two species' different dispersal strategies.	[Kothera, Linda; Godsey, Marvin S., Jr.; Doyle, Michael S.; Savage, Harry M.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA	Centers for Disease Control & Prevention - USA	Kothera, L (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.	lkothera@cdc.gov						Abreu AG, 2012, MOL ECOL RESOUR, V12, P374, DOI 10.1111/j.1755-0998.2011.03109.x; Aspen S, 2003, J AM MOSQUITO CONTR, V19, P115; Barker CM, 2009, J VECTOR ECOL, V34, P276, DOI [10.1111/j.1948-7134.2009.00036.x, 10.3376/038.034.0214]; BARR AR, 1957, AM J TROP MED HYG, V6, P153, DOI 10.4269/ajtmh.1957.6.153; Bataille A, 2010, MOL ECOL, V19, P4491, DOI 10.1111/j.1365-294X.2010.04843.x; Bolling BG, 2007, J AM MOSQUITO CONTR, V23, P37, DOI 10.2987/8756-971X(2007)23[37:ESATCF]2.0.CO;2; Bolling BG, 2009, J MED ENTOMOL, V46, P1519, DOI 10.1603/033.046.0641; CAVALLISFORZA LL, 1967, EVOLUTION, V32, P550; Chapman JW, 2011, ANNU REV ENTOMOL, V56, P337, DOI 10.1146/annurev-ento-120709-144820; CRABTREE MB, 1995, AM J TROP MED HYG, V53, P105, DOI 10.4269/ajtmh.1995.53.105; Darsie R. F., 2005, IDENTIFICATION GEOGR; Edillo FE, 2007, J MED ENTOMOL, V44, P145, DOI 10.1603/0022-2585(2007)44[145:ASOBAM]2.0.CO;2; Edillo F, 2009, AM J TROP MED HYG, V81, P842, DOI 10.4269/ajtmh.2009.08-0605; Eisen L, 2008, J MED ENTOMOL, V45, P800, DOI 10.1603/0022-2585(2008)45[800:MSRCAA]2.0.CO;2; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Fonseca DM, 2004, SCIENCE, V303, P1535, DOI 10.1126/science.1094247; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Huang SM, 2008, AM J TROP MED HYG, V79, P518, DOI 10.4269/ajtmh.2008.79.518; Huang SM, 2011, AM J TROP MED HYG, V85, P434, DOI 10.4269/ajtmh.2011.10-0679; Keyghobadi N, 2004, MOL ECOL NOTES, V4, P20, DOI 10.1046/j.1471-8286.2003.00557.x; Kilpatrick AM, 2010, AM J TROP MED HYG, V83, P607, DOI 10.4269/ajtmh.2010.10-0005; Kothera L, 2010, J MED ENTOMOL, V47, P805, DOI 10.1603/ME10031; Kothera L, 2009, J MED ENTOMOL, V46, P236, DOI 10.1603/033.046.0208; Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160; Lindsey NP, 2008, VECTOR-BORNE ZOONOT, V8, P35, DOI 10.1089/vbz.2007.0137; Merrill SA, 2005, AM J TROP MED HYG, V72, P304, DOI 10.4269/ajtmh.2005.72.304; MITCHELL CJ, 1980, ST LOUIS ENCEPHALITI, P313; Nei M., 1987, MOL EVOLUTIONARY GEN; Pritchard JK, 2000, GENETICS, V155, P945; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reisen W, 2004, EMERG INFECT DIS, V10, P1369, DOI 10.3201/eid1008.040077; Reisen WK, 2008, J MED ENTOMOL, V45, P1126, DOI 10.1603/0022-2585(2008)45[1126:DVICDC]2.0.CO;2; REITER P, 1983, MOSQ NEWS, V43, P496; Richards SL, 2010, AM J TROP MED HYG, V83, P126, DOI 10.4269/ajtmh.2010.09-0776; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Savage HM, 2007, VECTOR-BORNE ZOONOT, V7, P365, DOI 10.1089/vbz.2006.0602; Smith JL, 2005, MOL ECOL NOTES, V5, P697, DOI 10.1111/j.1471-8286.2005.01034.x; TSAI TF, 1988, AM J EPIDEMIOL, V128, P285, DOI 10.1093/oxfordjournals.aje.a114969; Urbanelli S, 1997, J MED ENTOMOL, V34, P116, DOI 10.1093/jmedent/34.2.116; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Venkatesan M, 2010, MOL ECOL, V19, P1573, DOI 10.1111/j.1365-294X.2010.04577.x; Vinogradova EB, 2000, CULEX PIPIENS PIPIEN; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Winters AM, 2008, AM J TROP MED HYG, V78, P654, DOI 10.4269/ajtmh.2008.78.654	49	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47602	10.1371/journal.pone.0047602	http://dx.doi.org/10.1371/journal.pone.0047602			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094068	gold, Green Published			2022-12-25	WOS:000310050200035
J	Branstetter, BK; Finneran, JJ; Fletcher, EA; Weisman, BC; Ridgway, SH				Branstetter, Brian K.; Finneran, James J.; Fletcher, Elizabeth A.; Weisman, Brian C.; Ridgway, Sam H.			Dolphins Can Maintain Vigilant Behavior through Echolocation for 15 Days without Interruption or Cognitive Impairment	PLOS ONE			English	Article							CONTINUOUS AUDITORY VIGILANCE; BOTTLE-NOSED DOLPHINS; TURSIOPS-TRUNCATUS; STENELLA-LONGIROSTRIS; SPINNER DOLPHINS; SHARK PREDATION; CETACEAN SLEEP; HABITAT USE; EVOLUTION; RISK	In dolphins, natural selection has developed unihemispheric sleep where alternating hemispheres of their brain stay awake. This allows dolphins to maintain consciousness in response to respiratory demands of the ocean. Unihemispheric sleep may also allow dolphins to maintain vigilant states over long periods of time. Because of the relatively poor visibility in the ocean, dolphins use echolocation to interrogate their environment. During echolocation, dolphin produce clicks and listen to returning echoes to determine the location and identity of objects. The extent to which individual dolphins are able to maintain continuous vigilance through this active sense is unknown. Here we show that dolphins may continuously echolocate and accurately report the presence of targets for at least 15 days without interruption. During a total of three sessions, each lasting five days, two dolphins maintained echolocation behaviors while successfully detecting and reporting targets. Overall performance was between 75 to 86% correct for one dolphin and 97 to 99% correct for a second dolphin. Both animals demonstrated diel patterns in echolocation behavior. A 15-day testing session with one dolphin resulted in near perfect performance with no significant decrement over time. Our results demonstrate that dolphins can continuously monitor their environment and maintain long-term vigilant behavior through echolocation.	[Branstetter, Brian K.; Ridgway, Sam H.] Natl Marine Mammal Fdn, San Diego, CA USA; [Finneran, James J.; Weisman, Brian C.] USA, Marine Mammal Program, Space & Naval Warfare Syst Ctr Pacific, San Diego, CA USA; [Fletcher, Elizabeth A.] Sci Applicat Int Corp, Maritime Serv Div, San Diego, CA 92121 USA	Naval Information Warfare Center Pacific; Science Applications International Corporation (SAIC)	Branstetter, BK (corresponding author), Natl Marine Mammal Fdn, San Diego, CA USA.	brian.branstetter@nmmpfoundation.org	Branstetter, Brian/ABE-2593-2020	Ridgway, Sam/0000-0001-7474-9880	U.S. Navy Marine Mammal Program	U.S. Navy Marine Mammal Program	This project was funded by the U.S. Navy Marine Mammal Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, LANG ENV STAT COMP; Au W. W., 1993, SONAR DOLPHINS; Au WWL., 1980, ANIMAL SONAR SYSTEMS, P251, DOI DOI 10.1007/978-1-4684-7254-7_10; Aubauer R, 2000, J ACOUST SOC AM, V107, P2750, DOI 10.1121/1.428661; AUDET D, 1990, J MAMMAL, V71, P420, DOI 10.2307/1381955; Bates D., 2009, IME4 LINEAR MIXED EF; Benoit-Bird KJ, 2009, J ACOUST SOC AM, V125, P539, DOI 10.1121/1.2967477; Benoit-Bird KJ, 2009, J ACOUST SOC AM, V125, P125, DOI 10.1121/1.2967480; Benoit-Bird KJ, 2003, BEHAV ECOL SOCIOBIOL, V53, P364, DOI 10.1007/s00265-003-0585-4; COCKCROFT VG, 1989, S AFR J ZOOL, V24, P305; Connor RC, 2001, MG BEH ECOL, P408; Crawley MJ, 2009, MIXED EFFECTS MODEL, P627; Finneran JJ, 2010, J ACOUST SOC AM, V128, P1483, DOI 10.1121/1.3471915; Goley PD, 1999, MAR MAMMAL SCI, V15, P1054, DOI 10.1111/j.1748-7692.1999.tb00877.x; Heithaus MR, 2002, ECOLOGY, V83, P480, DOI 10.1890/0012-9658(2002)083[0480:FAATSP]2.0.CO;2; Heithaus MR, 2001, MAR MAMMAL SCI, V17, P526, DOI 10.1111/j.1748-7692.2001.tb01002.x; Houser DS, 2006, J ACOUST SOC AM, V120, P4090, DOI 10.1121/1.2357993; Jones G, 2007, P R SOC B, V274, P905, DOI 10.1098/rspb.2006.0200; Kloepper LN, 2012, J EXP BIOL, V215, P1306, DOI 10.1242/jeb.066605; Lammers MO, 2003, MAR MAMMAL SCI, V19, P249, DOI 10.1111/j.1748-7692.2003.tb01107.x; Lilly J. C., 1964, HDB PHYSL ENV, P741; Lyamin O, 2007, PHYSIOL BEHAV, V92, P725, DOI 10.1016/j.physbeh.2007.05.064; Lyamin OI, 2008, NEUROSCI BIOBEHAV R, V32, P1451, DOI 10.1016/j.neubiorev.2008.05.023; Moore PW, 2008, J ACOUST SOC AM, V124, P3324, DOI 10.1121/1.2980453; Moss CF, 2001, J ACOUST SOC AM, V110, P2207, DOI 10.1121/1.1398051; Mukhametov L. M., 1984, EXPT BRAIN RES S, P227, DOI [10.1007/978-3-[ 642-69554-4_17spinal, DOI 10.1007/978-3-642-69554-E]; MUKHAMETOV LM, 1988, SLEEP 86, P154; Pillay P, 2004, J SLEEP RES, V13, P353, DOI 10.1111/j.1365-2869.2004.00419.x; Pinheiro J, 2001, MIXED EFFECTS MODELS; Rattenborg NC, 1999, BEHAV BRAIN RES, V105, P163, DOI 10.1016/S0166-4328(99)00070-4; Ridgway S. H., 1991, J ACOUST SOC AM, V90, P2335, DOI [10.1121/1.402199, DOI 10.1121/1.402199]; Ridgway S, 2006, J EXP BIOL, V209, P3621, DOI 10.1242/jeb.02405; Ridgway S, 2009, J EXP BIOL, V212, P1519, DOI 10.1242/jeb.027896; Ridgway SH, 2002, BRAIN BEHAV EVOLUT, V60, P265, DOI 10.1159/000067192; Treves A, 2000, ANIM BEHAV, V60, P711, DOI 10.1006/anbe.2000.1528; Verfuss UK, 2009, J EXP BIOL, V212, P823, DOI 10.1242/jeb.022137	36	23	23	4	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47478	10.1371/journal.pone.0047478	http://dx.doi.org/10.1371/journal.pone.0047478			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082170	gold, Green Submitted, Green Published			2022-12-25	WOS:000311146900066
J	Niska, JA; Meganck, JA; Pribaz, JR; Shahbazian, JH; Lim, E; Zhang, N; Rice, BW; Akin, A; Ramos, RI; Bernthal, NM; Francis, KP; Miller, LS				Niska, Jared A.; Meganck, Jeffrey A.; Pribaz, Jonathan R.; Shahbazian, Jonathan H.; Lim, Ed; Zhang, Ning; Rice, Brad W.; Akin, Ali; Ramos, Romela Irene; Bernthal, Nicholas M.; Francis, Kevin P.; Miller, Lloyd S.			Monitoring Bacterial Burden, Inflammation and Bone Damage Longitudinally Using Optical and mu CT Imaging in an Orthopaedic Implant Infection in Mice	PLOS ONE			English	Article							IN-VIVO; MOUSE MODEL; ARTHROPLASTY; VANCOMYCIN; DIAGNOSIS; BIOFILMS; DISEASES; SURGERY; SITE	Background: Recent advances in non-invasive optical, radiographic and mu CT imaging provide an opportunity to monitor biological processes longitudinally in an anatomical context. One particularly relevant application for combining these modalities is to study orthopaedic implant infections. These infections are characterized by the formation of persistent bacterial biofilms on the implanted materials, causing inflammation, periprosthetic osteolysis, osteomyelitis, and bone damage, resulting in implant loosening and failure. Methodology/Principal Findings: An orthopaedic implant infection model was used in which a titanium Kirshner-wire was surgically placed in femurs of LysEGFP mice, which possess EGFP-fluorescent neutrophils, and a bioluminescent S. aureus strain (Xen29; 1x10(3) CFUs) was inoculated in the knee joint before closure. In vivo bioluminescent, fluorescent, X-ray and mu CT imaging were performed on various postoperative days. The bacterial bioluminescent signals of the S. aureus-infected mice peaked on day 19, before decreasing to a basal level of light, which remained measurable for the entire 48 day experiment. Neutrophil EGFP-fluorescent signals of the S. aureus-infected mice were statistically greater than uninfected mice on days 2 and 5, but afterwards the signals for both groups approached background levels of detection. To visualize the three-dimensional location of the bacterial infection and neutrophil infiltration, a diffuse optical tomography reconstruction algorithm was used to co-register the bioluminescent and fluorescent signals with mu CT images. To quantify the anatomical bone changes on the mu CT images, the outer bone volume of the distal femurs were measured using a semi-automated contour based segmentation process. The outer bone volume increased through day 48, indicating that bone damage continued during the implant infection. Conclusions/Significance: Bioluminescent and fluorescent optical imaging was combined with X-ray and mu CT imaging to provide noninvasive and longitudinal measurements of the dynamic changes in bacterial burden, neutrophil recruitment and bone damage in a mouse orthopaedic implant infection model.	[Shahbazian, Jonathan H.; Ramos, Romela Irene; Miller, Lloyd S.] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA; [Niska, Jared A.; Pribaz, Jonathan R.; Bernthal, Nicholas M.] Univ Calif Los Angeles, David Geffen Sch Med, Orthopaed Hosp Dept Orthopaed Surg, Orthopaed Hosp Res Ctr, Los Angeles, CA 90095 USA; [Meganck, Jeffrey A.; Lim, Ed; Zhang, Ning; Rice, Brad W.; Akin, Ali; Francis, Kevin P.] Caliper, Alameda, CA USA; [Akin, Ali] Novartis Inst BioMed Res Inc, Emeryville, CA USA	Johns Hopkins University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Novartis	Miller, LS (corresponding author), Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA.	lloydmiller@jhmi.edu	Hamblin, Mike/AAB-2511-2022; Hamblin, Michael R/H-2758-2019	Hamblin, Michael R/0000-0001-6431-4605; Miller, Lloyd/0000-0002-8332-2210; Niska, Jared/0000-0002-7779-7949	H & H Lee Surgical Resident Research Scholars Program; National Institutes of Health [R01-AI078910, R24-CA92865]; NATIONAL CANCER INSTITUTE [R24CA092865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078910] Funding Source: NIH RePORTER	H & H Lee Surgical Resident Research Scholars Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by an H & H Lee Surgical Resident Research Scholars Program (to JAN) and National Institutes of Health grants R01-AI078910 (to LSM) and R24-CA92865 (to the UCLA Small Animal Imaging Resource Program). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CS, 2009, J ORTHOP RES, V27, P701, DOI 10.1002/jor.20815; Andreu N, 2011, FEMS MICROBIOL REV, V35, P360, DOI 10.1111/j.1574-6976.2010.00252.x; Archer NK, 2011, VIRULENCE, V2, P445, DOI 10.4161/viru.2.5.17724; Badr CE, 2011, TRENDS BIOTECHNOL, V29, P624, DOI 10.1016/j.tibtech.2011.06.010; Bauer TW, 2006, J BONE JOINT SURG AM, V88A, P869, DOI 10.2106/JBJS.E.01149; Bernthal NM, 2011, J ORTHOP RES, V29, P1621, DOI 10.1002/jor.21414; Bernthal NM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012580; Cho JS, 2011, J INVEST DERMATOL, V131, P907, DOI 10.1038/jid.2010.417; Cook SD, 2009, CLIN ORTHOP RELAT R, V467, P3213, DOI 10.1007/s11999-009-1087-0; Darouiche RO, 2004, NEW ENGL J MED, V350, P1422, DOI 10.1056/NEJMra035415; Deirmengian CA, 2012, J BONE JOINT SURG AM, V94A, P182, DOI 10.2106/JBJS.K.01262; Del Pozo JL, 2009, NEW ENGL J MED, V361, P787, DOI 10.1056/NEJMcp0905029; Dothager RS, 2009, CURR OPIN BIOTECH, V20, P45, DOI 10.1016/j.copbio.2009.01.007; Faust N, 2000, BLOOD, V96, P719; Foster WK, 2011, PHYS MED BIOL, V56, P315, DOI 10.1088/0031-9155/56/2/002; Fulkerson E, 2006, J BONE JOINT SURG AM, V88A, P1231, DOI 10.2106/JBJS.E.00004; Ghanem E, 2008, J BONE JOINT SURG AM, V90A, P1637, DOI 10.2106/JBJS.G.00470; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hutchens M, 2007, CELL MICROBIOL, V9, P2315, DOI 10.1111/j.1462-5822.2007.00995.x; Johnson LC, 2011, BONE, V48, P141, DOI 10.1016/j.bone.2010.05.033; Kadurugamuwa JL, 2003, INFECT IMMUN, V71, P882, DOI 10.1128/IAI.71.2.882-890.2003; Kim MH, 2008, J INVEST DERMATOL, V128, P1812, DOI 10.1038/sj.jid.5701223; Kim MH, 2011, BLOOD, V117, P3343, DOI 10.1182/blood-2010-07-296970; Klinck RJ, 2008, MED ENG PHYS, V30, P888, DOI 10.1016/j.medengphy.2007.11.004; Kuo C, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2717898; Kurtz SM, 2012, J ARTHROPLASTY, V27, P61, DOI 10.1016/j.arth.2012.02.022; Lee J, 2006, J BONE JOINT SURG AM, V88A, P1705, DOI 10.2106/JBJS.E.01156; Luker GD, 2008, J NUCL MED, V49, P1, DOI 10.2967/jnumed.107.045799; Ning XH, 2011, NAT MATER, V10, P602, DOI [10.1038/NMAT3074, 10.1038/nmat3074]; Niska JA, 2012, ANTIMICROB AGENTS CH, V56, P2590, DOI 10.1128/AAC.06291-11; Ntziachristos V, 2005, NAT BIOTECHNOL, V23, P313, DOI 10.1038/nbt1074; Panizzi P, 2011, NAT MED, V17, P1142, DOI 10.1038/nm.2423; Pribaz JR, 2012, J ORTHOP RES, V30, P335, DOI 10.1002/jor.21519; Reumann MK, 2010, TRENDS BIOTECHNOL, V28, P93, DOI 10.1016/j.tibtech.2009.11.004; Sjollema J, 2010, BIOMATERIALS, V31, P1984, DOI 10.1016/j.biomaterials.2009.11.068; Snoeks TJA, 2011, BONE, V48, P106, DOI 10.1016/j.bone.2010.07.027; Zimmerli W, 2004, NEW ENGL J MED, V351, P1645, DOI 10.1056/NEJMra040181; Zimmerli W, 2011, SEMIN IMMUNOPATHOL, V33, P295, DOI 10.1007/s00281-011-0275-7	38	61	64	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47397	10.1371/journal.pone.0047397	http://dx.doi.org/10.1371/journal.pone.0047397			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082163	Green Published, gold, Green Submitted			2022-12-25	WOS:000311146900059
J	Seto, J; Busse, B; Gupta, HS; Schafer, C; Krauss, S; Dunlop, JWC; Masic, A; Kerschnitzki, M; Zaslansky, P; Boesecke, P; Catala-Lehnen, P; Schinke, T; Fratzl, P; Jahnen-Dechent, W				Seto, Jong; Busse, Bjoern; Gupta, Himadri S.; Schaefer, Cora; Krauss, Stefanie; Dunlop, John W. C.; Masic, Admir; Kerschnitzki, Michael; Zaslansky, Paul; Boesecke, Peter; Catala-Lehnen, Philip; Schinke, Thorsten; Fratzl, Peter; Jahnen-Dechent, Willi			Accelerated Growth Plate Mineralization and Foreshortened Proximal Limb Bones in Fetuin-A Knockout Mice	PLOS ONE			English	Article							ANGLE X-RAY; CALCIUM-PHOSPHATE; CALCIPROTEIN PARTICLES; ALPHA-2HS GLYCOPROTEIN; APATITE FORMATION; SERUM; CALCIFICATION; INHIBITION; COMPLEX; NANOBACTERIA	The plasma protein fetuin-A/alpha2-HS-glycoprotein (genetic symbol Ahsg) is a systemic inhibitor of extraskeletal mineralization, which is best underscored by the excessive mineral deposition found in various tissues of fetuin-A deficient mice on the calcification-prone genetic background DBA/2. Fetuin-A is known to accumulate in the bone matrix thus an effect of fetuin-A on skeletal mineralization is expected. We examined the bones of fetuin-A deficient mice maintained on a C57BL/6 genetic background to avoid bone disease secondary to renal calcification. Here, we show that fetuin-A deficient mice display normal trabecular bone mass in the spine, but increased cortical thickness in the femur. Bone material properties, as well as mineral and collagen characteristics of cortical bone were unaffected by the absence of fetuin-A. In contrast, the long bones especially proximal limb bones were severely stunted in fetuin-A deficient mice compared to wildtype littermates, resulting in increased biomechanical stability of fetuin-A deficient femora in three-point-bending tests. Elevated backscattered electron signal intensities reflected an increased mineral content in the growth plates of fetuin-A deficient long bones, corroborating its physiological role as an inhibitor of excessive mineralization in the growth plate cartilage matrix - a site of vigorous physiological mineralization. We show that in the case of fetuin-A deficiency, active mineralization inhibition is a necessity for proper long bone growth.	[Schaefer, Cora; Jahnen-Dechent, Willi] Rhein Westfal TH Aachen, Biointerface Lab, Helmholtz Inst Biomed Engn, Aachen, Germany; [Seto, Jong; Gupta, Himadri S.; Krauss, Stefanie; Dunlop, John W. C.; Masic, Admir; Kerschnitzki, Michael; Zaslansky, Paul; Fratzl, Peter] Max Planck Inst Colloids & Interfaces, Dept Biomat, Potsdam, Germany; [Busse, Bjoern; Catala-Lehnen, Philip; Schinke, Thorsten] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, Hamburg, Germany; [Boesecke, Peter] European Synchrotron Radiat Facil, Beamline ID2, F-38043 Grenoble, France	Helmholtz Association; RWTH Aachen University; Max Planck Society; University of Hamburg; University Medical Center Hamburg-Eppendorf; European Synchrotron Radiation Facility (ESRF)	Jahnen-Dechent, W (corresponding author), Rhein Westfal TH Aachen, Biointerface Lab, Helmholtz Inst Biomed Engn, Aachen, Germany.	willi.jahnen@rwth-aachen.de	Gupta, Himadri S/J-2129-2012; Busse, Björn/AAC-4033-2020; Dunlop, John W C/A-1997-2012; Fratzl, Peter/H-9095-2012; zaslansky, paul/AAB-7322-2021; Busse, Björn/O-8462-2016; Jahnen-Dechent, Willi/A-7608-2011	Busse, Björn/0000-0002-3099-8073; Dunlop, John W C/0000-0003-2741-6383; Fratzl, Peter/0000-0003-4437-7830; zaslansky, paul/0000-0002-8714-4992; Busse, Björn/0000-0002-3099-8073; Gupta, Himadri Shikhar/0000-0003-2201-8933; Catala-Lehnen, Philip/0000-0001-5475-6741; Masic, Admir/0000-0002-1207-4926; Jahnen-Dechent, Willi/0000-0003-1315-4407	Max Planck Society; Deutsche Forschungsgemeinschaft [JA 562/10]; Helmholtz Zentrum Berlin fur Materialien und Energie-BESSY II; EU Marie Curie EST Fellowship on Biomimetic Systems [MEST-CT-2004-504465]	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Helmholtz Zentrum Berlin fur Materialien und Energie-BESSY II; EU Marie Curie EST Fellowship on Biomimetic Systems	Funding for this work is made possible through the Max Planck Society, Deutsche Forschungsgemeinschaft (JA 562/10), and the Helmholtz Zentrum Berlin fur Materialien und Energie-BESSY II. JS was supported by EU Marie Curie EST Fellowship on Biomimetic Systems, MEST-CT-2004-504465. Support from the European Synchrotron Radiation Facility (ESRF) through the allocation of synchrotron beamtime for experiment SC-2301 at beamline ID2 is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHTON BA, 1976, CALC TISS RES, V22, P27; Binkert C, 1999, J BIOL CHEM, V274, P28514, DOI 10.1074/jbc.274.40.28514; Demetriou M, 1996, J BIOL CHEM, V271, P12755, DOI 10.1074/jbc.271.22.12755; DICKSON IR, 1975, NATURE, V256, P430, DOI 10.1038/256430a0; Gupta HS, 2006, P NATL ACAD SCI USA, V103, P17741, DOI 10.1073/pnas.0604237103; Hamano T, 2010, J AM SOC NEPHROL, V21, P1998, DOI 10.1681/ASN.2009090944; Heiss A, 2007, BIOINTERPHASES, V2, P16, DOI 10.1116/1.2714924; Heiss A, 2003, J BIOL CHEM, V278, P13333, DOI 10.1074/jbc.M210868200; Heiss A, 2008, J BIOL CHEM, V283, P14815, DOI 10.1074/jbc.M709938200; Heiss A, 2010, BIOPHYS J, V99, P3986, DOI 10.1016/j.bpj.2010.10.030; Herrmann M, 2012, CIRC RES, V111, P575, DOI 10.1161/CIRCRESAHA.111.261479; ISHIKAWA Y, 1991, J CELL PHYSIOL, V149, P222, DOI 10.1002/jcp.1041490208; Jahnen-Dechent W, 2008, J MOL MED, V86, P379, DOI 10.1007/s00109-007-0294-y; Jahnen-Dechent W, 2011, CIRC RES, V108, P1494, DOI 10.1161/CIRCRESAHA.110.234260; JahnenDechent W, 1997, J BIOL CHEM, V272, P31496, DOI 10.1074/jbc.272.50.31496; Jiang Q, 2010, J INVESTIGATIVE DERM; Kazanci M, 2006, J STRUCT BIOL, V156, P489, DOI 10.1016/j.jsb.2006.06.011; Ketteler M, 2003, LANCET, V361, P827, DOI 10.1016/S0140-6736(03)12710-9; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lee C, 2009, FRONT BIOSCI-LANDMRK, V14, P2911, DOI 10.2741/3422; Lehmann W, 2004, BONE, V35, P1247, DOI 10.1016/j.bone.2004.08.017; Loohuis KMO, 2010, KIDNEY INT, V77, P77, DOI 10.1038/ki.2009.407; Martel J, 2008, P NATL ACAD SCI USA, V105, P5549, DOI 10.1073/pnas.0711744105; MCKEE MD, 1993, J BONE MINER RES, V8, P485; Megens M, 1997, LANGMUIR, V13, P6120, DOI 10.1021/la970422v; Meng HJ, 2007, P NATL ACAD SCI USA, V104, P4530, DOI 10.1073/pnas.0607620104; Nudelman F, 2010, NAT MATER, V9, P1004, DOI 10.1038/NMAT2875; Parfitt AM, 2002, BONE, V30, P337, DOI 10.1016/S8756-3282(01)00668-8; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pasch A, 2012, J AM SOC NEPHROL, P1; Pedersen KO, 1944, NATURE, V154, P575, DOI 10.1038/154575a0; Price P, 2009, J BIOL CHEM; Price PA, 2003, J BIOL CHEM, V278, P22153, DOI 10.1074/jbc.M300739200; Price PA, 2003, J BIOL CHEM, V278, P22144, DOI 10.1074/jbc.M300744200; Raoult D, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040041; Rasband W, IMAGEJ; Reynolds JL, 2005, J AM SOC NEPHROL, V16, P2920, DOI 10.1681/ASN.2004100895; Rochette CN, 2009, CHEMBIOCHEM, V10, P735, DOI 10.1002/cbic.200800719; Roschger P, 2008, BONE, V42, P456, DOI 10.1016/j.bone.2007.10.021; Rothenberg AB, 2007, PEDIATR RADIOL, V37, P1264, DOI 10.1007/s00247-007-0604-0; Schafer C, 2003, J CLIN INVEST, V112, P357, DOI 10.1172/JCI17202; Schinke T, 1996, J BIOL CHEM, V271, P20789, DOI 10.1074/jbc.271.34.20789; Schmidt K, 2005, J CELL BIOL, V168, P899, DOI 10.1083/jcb.200408013; Seitz S, 2010, OSTEOPOROSIS INT, V21, P119, DOI 10.1007/s00198-009-0933-y; Smith ER, 2012, NEPHROL DIAL TRANSPL, V27, P1957, DOI 10.1093/ndt/gfr609; Szweras M, 2002, J BIOL CHEM, V277, P19991, DOI 10.1074/jbc.M112234200; TERMINE JD, 1988, CIBA FDN S, V136, P178; Toroian D, 2008, CALCIFIED TISSUE INT, V82, P116, DOI 10.1007/s00223-007-9085-2; TRIFFITT JT, 1976, NATURE, V262, P226, DOI 10.1038/262226a0; Wald J, 2011, SOFT MATTER, V7, P2869, DOI 10.1039/c0sm01191f; Westenfeld R, 2009, J AM SOC NEPHROL; Westenfeld R, 2007, NEPHROL DIAL TRANSPL, V22, P1537, DOI 10.1093/ndt/gfm094; Woodard JC, 1997, BONE, V21, P171, DOI 10.1016/S8756-3282(97)00099-9; Wu CY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008058; Young J, 2009, BRIT J CRIMINOL, V49, P4, DOI 10.1093/bjc/azn074	56	41	41	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47338	10.1371/journal.pone.0047338	http://dx.doi.org/10.1371/journal.pone.0047338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091616	gold, Green Published, Green Submitted			2022-12-25	WOS:000310135800039
J	Wheeler, APS; Morad, S; Buchholz, N; Knight, MM				Wheeler, Andrew P. S.; Morad, Samir; Buchholz, Noor; Knight, Martin M.			The Shape of the Urine Stream - From Biophysics to Diagnostics	PLOS ONE			English	Article							BENIGN PROSTATIC HYPERPLASIA; HOME UROFLOWMETRY; TRACT SYMPTOMS; FLOW; URETHROTOMY; DILATION; THERAPY; DEVICE; DROP; MEN	We develop a new computational model of capillary-waves in free-jet flows, and apply this to the problem of urological diagnosis in this first ever study of the biophysics behind the characteristic shape of the urine stream as it exits the urethral meatus. The computational fluid dynamics model is used to determine the shape of a liquid jet issuing from a non-axisymmetric orifice as it deforms under the action of surface tension. The computational results are verified with experimental modelling of the urine stream. We find that the shape of the stream can be used as an indicator of both the flow rate and orifice geometry. We performed volunteer trials which showed these fundamental correlations are also observed in vivo for male healthy volunteers and patients undergoing treatment for low flow rate. For healthy volunteers, self estimation of the flow shape provided an accurate estimation of peak flow rate (+/- 2%). However for the patients, the relationship between shape and flow rate suggested poor meatal opening during voiding. The results show that self measurement of the shape of the urine stream can be a useful diagnostic tool for medical practitioners since it provides a non-invasive method of measuring urine flow rate and urethral dilation.	[Wheeler, Andrew P. S.] Univ Southampton, Southampton, Hants, England; [Morad, Samir; Knight, Martin M.] Queen Mary Univ London, Sch Engn & Mat Sci, London, England; [Buchholz, Noor] Newham Univ Hosp, Dept Urol, London, England	University of Southampton; University of London; Queen Mary University London	Wheeler, APS (corresponding author), Univ Southampton, Southampton, Hants, England.	a.wheeler@soton.ac.uk	Wheeler, Andrew/B-4485-2013	Wheeler, Andrew/0000-0001-5526-5266; Knight, Martin/0000-0003-3755-1597				Addla SK, 2010, NEUROUROL URODYNAM, V29, P1301, DOI 10.1002/nau.20846; Boci R, 1999, NEUROUROL URODYNAM, V18, P25, DOI 10.1002/(SICI)1520-6777(1999)18:1<25::AID-NAU5>3.0.CO;2-O; Caffarel J, 2006, NEUROUROL URODYNAM, V25, P632; Caffarel J, 2007, NEUROUROL URODYNAM, V26, P474, DOI 10.1002/nau.20383; Currie RJ, 1998, UROLOGY, V52, P1118, DOI 10.1016/S0090-4295(98)00404-X; delaRosette JJMCH, 1996, BRIT J UROL, V78, P385, DOI 10.1046/j.1464-410X.1996.00115.x; Dietz HP, 2007, INT UROGYNECOL J, V18, P665, DOI 10.1007/s00192-007-0376-y; EGGERS J, 1994, J FLUID MECH, V262, P205, DOI 10.1017/S0022112094000480; Eggers J, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/3/036601; GOLOMB J, 1992, J UROLOGY, V147, P1044, DOI 10.1016/S0022-5347(17)37462-1; Greenwell TJ, 2004, J UROLOGY, V172, P275, DOI 10.1097/01.ju.0000132156.76403.8f; Jonas U, 1996, J UROLOGY, V156, P1040, DOI 10.1016/S0022-5347(01)65695-7; Lin SP, 1998, ANNU REV FLUID MECH, V30, P85, DOI 10.1146/annurev.fluid.30.1.85; Madersbacher S, 2004, EUR UROL, V46, P547, DOI 10.1016/j.eururo.2004.07.016; Neal DE, 1997, LANCET, V350, P305, DOI 10.1016/S0140-6736(05)63382-X; Nitti Victor W, 2005, Rev Urol, V7 Suppl 6, pS14; PAPAGEORGIOU DT, 1995, PHYS FLUIDS, V7, P1529, DOI 10.1063/1.868540; Pel JJM, 2002, NEUROUROL URODYNAM, V21, P48, DOI 10.1002/nau.2112; Rayleigh L, 1878, P LONDON MATH SOC S, P3; Reynard JM, 1996, BRIT J UROL, V77, P813, DOI 10.1046/j.1464-410X.1996.00097.x; Schafer W, 2002, NEUROUROL URODYNAM, V21, P261, DOI 10.1002/nau.10066; Steenkamp JW, 1997, J UROLOGY, V157, P98, DOI 10.1016/S0022-5347(01)65296-0; WASSON JH, 1995, NEW ENGL J MED, V332, P75, DOI 10.1056/NEJM199501123320202; Wiygul J, 2009, CURR OPIN UROL, V19, P3, DOI 10.1097/MOU.0b013e32831a6ec6	24	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47133	10.1371/journal.pone.0047133	http://dx.doi.org/10.1371/journal.pone.0047133			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091609	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000310135800026
J	Arlt, A; Sebens, S; Krebs, S; Geismann, C; Grossmann, M; Kruse, ML; Schreiber, S; Schafer, H				Arlt, A.; Sebens, S.; Krebs, S.; Geismann, C.; Grossmann, M.; Kruse, M-L; Schreiber, S.; Schaefer, H.			Inhibition of the Nrf2 transcription factor by the alkaloid trigonelline renders pancreatic cancer cells more susceptible to apoptosis through decreased proteasomal gene expression and proteasome activity	ONCOGENE			English	Article						chemoresistance; oxidative stress; tumorigenesis; pancreas	COMPONENTS CHLOROGENIC ACID; SIGNALING PATHWAY; OXIDATIVE STRESS; DECAFFEINATED COFFEE; ADAPTIVE RESPONSE; CARCINOMA CELLS; KEAP1 MUTATIONS; ACTIVATION; SUBUNIT; CHEMORESISTANCE	Evidence accumulates that the transcription factor nuclear factor E2-related factor 2 (Nrf2) has an essential role in cancer development and chemoresistance, thus pointing to its potential as an anticancer target and undermining its suitability in chemoprevention. Through the induction of cytoprotective and proteasomal genes, Nrf2 confers apoptosis protection in tumor cells, and inhibiting Nrf2 would therefore be an efficient strategy in anticancer therapy. In the present study, pancreatic carcinoma cell lines (Panc1, Colo357 and MiaPaca2) and H6c7 pancreatic duct cells were analyzed for the Nrf2-inhibitory effect of the coffee alkaloid trigonelline (trig), as well as for its impact on Nrf2-dependent proteasome activity and resistance to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) and anticancer drug-induced apoptosis. Chemoresistant Panc1 and Colo357 cells exhibit high constitutive Nrf2 activity, whereas chemosensitive MiaPaca2 and H6c7 cells display little basal but strong tert-butylhydroquinone (tBHQ)-inducible Nrf2 activity and drug resistance. Trig efficiently decreased basal and tBHQ-induced Nrf2 activity in all cell lines, an effect relying on a reduced nuclear accumulation of the Nrf2 protein. Along with Nrf2 inhibition, trig blocked the Nrf2-dependent expression of proteasomal genes (for example, s5a/psmd4 and alpha 5/psma5) and reduced proteasome activity in all cell lines tested. These blocking effects were absent after treatment with Nrf2 siRNA, a condition in which proteasomal gene expression and proteasome activity were already decreased, whereas siRNA against the related transcription factor Nrf1 did not affect proteasome activity and the inhibitory effect of trig. Depending on both Nrf2 and proteasomal gene expression, the sensitivity of all cell lines to anticancer drugs and TRAIL-induced apoptosis was enhanced by trig. Moreover, greater antitumor responses toward anticancer drug treatment were observed in tumor-bearing mice when receiving trig. In conclusion, representing an efficient Nrf2 inhibitor capable of blocking Nrf2-dependent proteasome activity and thereby apoptosis protection in pancreatic cancer cells, trig might be beneficial in improving anticancer therapy.	[Arlt, A.; Krebs, S.; Geismann, C.; Grossmann, M.; Kruse, M-L; Schreiber, S.; Schaefer, H.] UKSH, Lab Mol Gastroenterol & Hepatol, Dept Internal Med 1, Kiel, Germany; [Sebens, S.] Inst Expt Med, Inflammatory Carcinogenesis Res Grp, Kiel, Germany; [Schreiber, S.] UKSH, Inst Clin Mol Biol, Kiel, Germany	University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital	Schafer, H (corresponding author), Dept Internal Med I, Lab Mol Gastroenterol & Hepatol, Bldg 6,UKSH Campus Kiel,Schittenhelmstr 12, D-24105 Kiel, Germany.	hschaef@1med.uni-kiel.de	Schäfer, Heiner/C-1055-2011; Geismann, Claudia/AAX-8158-2021; Sebens, Susanne/C-1222-2010; Arlt, Alexander/G-7308-2019	Geismann, Claudia/0000-0003-0640-9256; Arlt, Alexander/0000-0002-6160-1059; Schafer, Heiner/0000-0001-6936-9090	German Research Society DFG [SCHA 677/9-1]; Sander Foundation [2010.076.1]; German Cluster of Excellence 'Inflammation-at-Interfaces'	German Research Society DFG(German Research Foundation (DFG)); Sander Foundation; German Cluster of Excellence 'Inflammation-at-Interfaces'	Technical assistance by Frauke Grohmann, Dagmar Leisner and Iris Bauer is acknowledged. The project was funded by the German Research Society DFG (SCHA 677/9-1), the Sander Foundation (2010.076.1) and the German Cluster of Excellence 'Inflammation-at-Interfaces'.	Adam J, 2011, CANCER CELL, V20, P524, DOI 10.1016/j.ccr.2011.09.006; Akhdar H, 2009, EUR J CANCER, V45, P2219, DOI 10.1016/j.ejca.2009.05.017; Arlt A, 2009, ONCOGENE, V28, P3983, DOI 10.1038/onc.2009.264; Arlt A, 2001, ONCOGENE, V20, P859, DOI 10.1038/sj.onc.1204168; Boettler U, 2011, J NUTR BIOCHEM, V22, P426, DOI 10.1016/j.jnutbio.2010.03.011; Chen L, 2005, CANCER RES, V65, P5599, DOI 10.1158/0008-5472.CAN-05-0201; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Du ZX, 2011, J CLIN ENDOCR METAB, V96, pE763, DOI 10.1210/jc.2010-2642; Eades G, 2011, J BIOL CHEM, V286, P40725, DOI 10.1074/jbc.M111.275495; Elangovan M, 2010, BIOCHEM BIOPH RES CO, V396, P425, DOI 10.1016/j.bbrc.2010.04.108; Fritsche P, 2009, GUT, V58, P1399, DOI 10.1136/gut.2009.180711; Geismann C, 2011, INT J ONCOL, V38, P257, DOI 10.3892/ijo_00000846; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Hong YB, 2010, PANCREAS, V39, P463, DOI 10.1097/MPA.0b013e3181c31314; Hu XT, 2009, ONCOL REP, V22, P1247, DOI 10.3892/or_00000561; Hu Y, 2012, MOL BIOL REP, V39, P4743, DOI 10.1007/s11033-011-1266-4; Jiang T, 2010, CANCER RES, V70, P5486, DOI 10.1158/0008-5472.CAN-10-0713; Kannan S, 2006, CANCER RES, V66, P8421, DOI 10.1158/0008-5472.CAN-06-1181; Kapeta S, 2010, J BIOL CHEM, V285, P8171, DOI 10.1074/jbc.M109.031575; Kim J, 2010, MUTAT RES-FUND MOL M, V690, P12, DOI 10.1016/j.mrfmmm.2009.09.007; Kim SK, 2008, FREE RADICAL BIO MED, V45, P537, DOI 10.1016/j.freeradbiomed.2008.05.011; Kim TH, 2011, CANCER RES, V71, P2260, DOI 10.1158/0008-5472.CAN-10-3007; Kim YR, 2010, J PATHOL, V220, P446, DOI 10.1002/path.2653; Kinch L, 2011, CANCER CELL, V20, P418, DOI 10.1016/j.ccr.2011.10.005; Konstantinopoulos PA, 2011, CANCER RES, V71, P5081, DOI 10.1158/0008-5472.CAN-10-4668; Kwak MK, 2006, BIOCHEM BIOPH RES CO, V345, P1350, DOI 10.1016/j.bbrc.2006.05.043; Kwak MK, 2003, MOL CELL BIOL, V23, P8786, DOI 10.1128/MCB.23.23.8786-8794.2003; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Lau A, 2008, PHARMACOL RES, V58, P262, DOI 10.1016/j.phrs.2008.09.003; Lister A, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-37; Muerkoster S, 2005, CANCER RES, V65, P1316, DOI 10.1158/0008-5472.CAN-04-1626; Nguyen T, 2005, J BIOL CHEM, V280, P32485, DOI 10.1074/jbc.M503074200; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Nioi P, 2007, BIOCHEM BIOPH RES CO, V362, P816, DOI 10.1016/j.bbrc.2007.08.051; Niture SK, 2009, J BIOL CHEM, V284, P13856, DOI 10.1074/jbc.M808084200; Olthof MR, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-10; Osburn WO, 2008, MUTAT RES-REV MUTAT, V659, P31, DOI 10.1016/j.mrrev.2007.11.006; Radhakrishnan SK, 2010, MOL CELL, V38, P17, DOI 10.1016/j.molcel.2010.02.029; Ren SR, 2000, ONCOGENE, V19, P1419, DOI 10.1038/sj.onc.1203462; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Rho JH, 2008, J PROTEOME RES, V7, P2959, DOI 10.1021/pr8000892; Schaedler S, 2010, J BIOL CHEM, V285, P41074, DOI 10.1074/jbc.M110.145862; Sebens S, 2011, J BIOL CHEM, V286, P40911, DOI 10.1074/jbc.M111.274902; Shim GS, 2009, FREE RADICAL BIO MED, V47, P1619, DOI 10.1016/j.freeradbiomed.2009.09.006; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Singh A, 2010, ANTIOXID REDOX SIGN, V13, P1627, DOI 10.1089/ars.2010.3219; Singh S, 2010, FREE RADICAL RES, V44, P1267, DOI 10.3109/10715762.2010.507670; Solis LM, 2010, CLIN CANCER RES, V16, P3743, DOI 10.1158/1078-0432.CCR-09-3352; Stathis A, 2010, NAT REV CLIN ONCOL, V7, P163, DOI 10.1038/nrclinonc.2009.236; Steffen J, 2010, MOL CELL, V40, P147, DOI 10.1016/j.molcel.2010.09.012; Taguchi A, 2011, CANCER CELL, V20, P289, DOI 10.1016/j.ccr.2011.08.007; van Dijk AE, 2009, DIABETES CARE, V32, P1023, DOI 10.2337/dc09-0207; Wang R, 2008, BIOCHEM BIOPH RES CO, V373, P151, DOI 10.1016/j.bbrc.2008.06.004; Wang XJ, 2008, CARCINOGENESIS, V29, P1235, DOI 10.1093/carcin/bgn095; Wang XJ, 2007, P NATL ACAD SCI USA, V104, P19589, DOI 10.1073/pnas.0709483104; Xie YM, 2010, CANCER METAST REV, V29, P687, DOI 10.1007/s10555-010-9255-y; Zhang DD, 2010, ANTIOXID REDOX SIGN, V13, P1623, DOI 10.1089/ars.2010.3301; Zhou W, 2007, MOL CELL ENDOCRINOL, V278, P52, DOI 10.1016/j.mce.2007.08.011	59	207	212	5	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	OCT 3	2013	32	40					4825	4835		10.1038/onc.2012.493	http://dx.doi.org/10.1038/onc.2012.493			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	229NW	23108405				2022-12-25	WOS:000325274700011
J	Porsch, H; Bernert, B; Mehic, M; Theocharis, AD; Heldin, CH; Heldin, P				Porsch, H.; Bernert, B.; Mehic, M.; Theocharis, A. D.; Heldin, C-H; Heldin, P.			Efficient TGF beta-induced epithelial-mesenchymal transition depends on hyaluronan synthase HAS2	ONCOGENE			English	Article						EMT; growth factors; TGF beta; hyaluronan synthase 2; migration	GROWTH-FACTOR-BETA; INTRACELLULAR HYALURONAN; CELL-PROLIFERATION; EXPRESSION; RECEPTOR; CLONING; TRAF6; FIBROBLASTS; SUPPRESSES; ACTIVATION	Epithelial-mesenchymal transition (EMT) is a developmental program, which can be adopted by cancer cells to increase their migration and ability to form metastases. Transforming growth factor beta (TGF beta) is a well-studied inducer of EMT. We demonstrate that TGF beta potently stimulates hyaluronan synthesis via upregulation of hyaluronan synthase 2 (HAS2) in NMuMG mammary epithelial cells. This stimulatory effect requires the kinase active type I TGF beta receptor and is dependent on Smad signaling and activation of the p38 mitogen-activated protein kinase. Knockdown of HAS2 inhibited the TGF beta-induced EMT by about 50%, as determined by the phase contrast microscopy and immunostaining using the EMT marker ZO-1. Furthermore, real-time PCR analysis of the EMT markers fibronectin, Snail1 and Zeb1 revealed decreased expressions upon HAS2 suppression, using specific small interfering RNA (siRNA) for HAS2. Removal of the extracellular hyaluronan by Streptomyces hyaluronidase or inhibiting the binding to its cell surface receptor CD44 by blocking antibodies, did not inhibit TGF beta-induced EMT. Interestingly, HAS2 suppression completely abolished the TGF beta-induced cell migration, whereas CD44 knockdown did not. These observations suggest that TGF beta-dependent HAS2 expression, but not extracellular hyaluronan, has an important regulatory role in TGF beta-induced EMT.	[Porsch, H.; Bernert, B.; Mehic, M.; Theocharis, A. D.; Heldin, C-H; Heldin, P.] Uppsala Univ, Biomed Ctr, Sci life Lab, Ludwig Inst Canc Res, SE-75124 Uppsala, Sweden	Ludwig Institute for Cancer Research; Uppsala University	Heldin, P (corresponding author), Uppsala Univ, Biomed Ctr, Sci life Lab, Ludwig Inst Canc Res, Box 595, SE-75124 Uppsala, Sweden.	Evi.Heldin@LICR.uu.se	theocharis, achilleas/F-6903-2010	Theocharis, Achilleas/0000-0001-8611-2297; Mehic, Merima/0000-0001-8249-5526	Swedish Cancer Society; Agnes and Mac Rudberg Foundation; Gurli and Edward Brunnberg Foundation; Mizutani Foundation for Glycoscience	Swedish Cancer Society(Swedish Cancer Society); Agnes and Mac Rudberg Foundation; Gurli and Edward Brunnberg Foundation; Mizutani Foundation for Glycoscience	This work was supported in part by grants from the Swedish Cancer Society, Agnes and Mac Rudberg Foundation, Gurli and Edward Brunnberg Foundation and Mizutani Foundation for Glycoscience. We thank Drs A Moustakas and L van der Heide (Ludwig Institute for Cancer Research, Uppsala, Sweden) for advice.	Anttila MA, 2000, CANCER RES, V60, P150; Auvinen P, 2000, AM J PATHOL, V156, P529, DOI 10.1016/S0002-9440(10)64757-8; Bakkers J, 2004, DEVELOPMENT, V131, P525, DOI 10.1242/dev.00954; Bernert B, 2011, J BIOL CHEM, V286, P42349, DOI 10.1074/jbc.M111.278598; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Boregowda Rajeev K, 2006, J Carcinog, V5, P2, DOI 10.1186/1477-3163-5-2; Brinck J, 1999, EXP CELL RES, V252, P342, DOI 10.1006/excr.1999.4645; Camenisch TD, 2000, J CLIN INVEST, V106, P349, DOI 10.1172/JCI10272; Camenisch TD, 2002, NAT MED, V8, P850, DOI 10.1038/nm742; Evanko SP, 2004, J HISTOCHEM CYTOCHEM, V52, P1525, DOI 10.1369/jhc.4A6356.2004; Evanko SP, 2001, INTRACELLULAR HYALUR; Gal A, 2008, ONCOGENE, V27, P1218, DOI 10.1038/sj.onc.1210741; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; HELDIN P, 1989, BIOCHEM J, V258, P919, DOI 10.1042/bj2580919; Heldin P, 1996, ONCOL REP, V3, P1011; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Itano N, 1996, J BIOL CHEM, V271, P9875, DOI 10.1074/jbc.271.17.9875; Jacobson A, 2000, BIOCHEM J, V348, P29, DOI 10.1042/0264-6021:3480029; Karousou E, 2010, J BIOL CHEM, V285, P23647, DOI 10.1074/jbc.M110.127050; Kowanetz M, 2004, MOL CELL BIOL, V24, P4241, DOI 10.1128/MCB.24.10.4241-4254.2004; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Li LL, 2007, BIOCHEM J, V404, P327, DOI 10.1042/BJ20061757; Li Y, 2001, BRIT J CANCER, V85, P600, DOI 10.1054/bjoc.2001.1922; Li YJ, 2000, AM J RESP CELL MOL, V23, P411, DOI 10.1165/ajrcmb.23.3.4102; Li YJ, 2007, INT J CANCER, V120, P2557, DOI 10.1002/ijc.22550; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Meran S, 2007, J BIOL CHEM, V282, P25687, DOI 10.1074/jbc.M700773200; Moustakas A, 2007, CANCER SCI, V98, P1512, DOI 10.1111/j.1349-7006.2007.00550.x; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Mu YB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1332; Okuda H, 2012, CANCER RES, V72, P537, DOI 10.1158/0008-5472.CAN-11-1678; Olsson M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001332; Sato N, 2004, CANCER RES, V64, P6950, DOI 10.1158/0008-5472.CAN-04-0677; Schiller M, 2010, J BIOL CHEM, V285, P409, DOI 10.1074/jbc.M109.038620; Shyjan AM, 1996, J BIOL CHEM, V271, P23395, DOI 10.1074/jbc.271.38.23395; Simpson RML, 2010, AM J PATHOL, V176, P1215, DOI 10.2353/ajpath.2010.090802; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Spicer AP, 1998, J BIOL CHEM, V273, P1923, DOI 10.1074/jbc.273.4.1923; Spicer AP, 1997, J BIOL CHEM, V272, P8957; Stuhlmeier KM, 2004, J BIOL CHEM, V279, P8753, DOI 10.1074/jbc.M303945200; Takahashi E, 2010, J BIOL CHEM, V285, P4060, DOI 10.1074/jbc.M109.056523; Takebe N, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2876; Tang BW, 2003, J CLIN INVEST, V112, P1116, DOI 10.1172/JCI200318899; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tool BP, 2001, SEMIN CELL DEV BIOL, V12, P79, DOI 10.1006/scdb.2000.0244; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Toole BP, 2008, SEMIN CANCER BIOL, V18, P244, DOI 10.1016/j.semcancer.2008.03.009; Unger K, 2010, ENDOCR-RELAT CANCER, V17, P87, DOI 10.1677/ERC-09-0065; Usui T, 2000, INVEST OPHTH VIS SCI, V41, P3261; Wakefield LM, 2002, CURR OPIN GENET DEV, V12, P22, DOI 10.1016/S0959-437X(01)00259-3; Wang AM, 2011, FEBS J, V278, P1412, DOI 10.1111/j.1742-4658.2011.08069.x; Watanabe K, 1996, J BIOL CHEM, V271, P22945, DOI 10.1074/jbc.271.38.22945; Williams CM, 2008, CANCER RES, V68, P3185, DOI 10.1158/0008-5472.CAN-07-2673; Yamashita M, 2008, MOL CELL, V31, P918, DOI 10.1016/j.molcel.2008.09.002; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	55	98	102	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 12	2013	32	37					4355	4365		10.1038/onc.2012.475	http://dx.doi.org/10.1038/onc.2012.475			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	218AF	23108409	Green Published, hybrid			2022-12-25	WOS:000324404200004
J	Horner, A; Goetz, F; Tampe, R; Klussmann, E; Pohl, P				Horner, Andreas; Goetz, Frank; Tampe, Robert; Klussmann, Enno; Pohl, Peter			Mechanism for Targeting the A-kinase Anchoring Protein AKAP18 delta to the Membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RENAL PRINCIPAL CELLS; FLUORESCENCE CORRELATION SPECTROSCOPY; CYCLIC-AMP; PEPTIDES; AQUAPORIN-2; LOCALIZATION; DIFFUSION; BINDING; AKAP15	A-kinase anchoring proteins (AKAPs) are a family of scaffolding proteins that target PKA and other signaling molecules to cellular compartments and thereby spatiotemporally define cellular signaling events. The AKAP18 family comprises AKAP18 alpha, AKAP18 beta, AKAP18 gamma, and AKAP18 delta. The delta isoform targets PKA and phosphodiesterase PDE4D to AQP2 (aquaporin-2)-bearing vesicles to orchestrate the acute regulation of body water balance. Therefore, AKAP18 delta must adopt a membrane localization that seems at odds with (i) its lack of palmitoylation or myristoylation sites that tailor its isoforms AKAP18 alpha and AKAP18 beta to membrane compartments and (ii) the high sequence identity to the preferentially cytoplasmic AKAP18 gamma. Here, we show that the electrostatic attraction of the positively charged amino acids of AKAP18 delta to negatively charged lipids explains its membrane targeting. As revealed by fluorescence correlation spectroscopy, the binding constant of purified AKAP18 delta fragments to large unilamellar vesicles correlates (i) with the fraction of net negatively charged lipids in the bilayer and (ii) with the total amount of basic residues in the protein. Although distantly located on the sequence, these positively charged residues concentrate in the tertiary structure and form a clear binding surface. Thus, specific recruitment of the AKAP18 delta-based signaling module to membranes such as those of AQP2-bearing vesicles must be achieved by additional mechanisms, most likely compartment-specific protein-protein interactions.	[Horner, Andreas; Pohl, Peter] Johannes Kepler Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Goetz, Frank; Klussmann, Enno] Max Delbruck Ctr Mol Med MDC, D-13125 Berlin, Germany; [Tampe, Robert] Goethe Univ Frankfurt, Inst Biochem, Bioctr, D-60438 Frankfurt, Germany	Johannes Kepler University Linz; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Goethe University Frankfurt	Pohl, P (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Gruberstr 40-42, A-4020 Linz, Austria.	peter.pohl@jku.at	Tampé, Robert/H-2953-2015; Horner, Andreas/F-6427-2013; Pohl, Peter/A-5361-2008	Tampé, Robert/0000-0002-0403-2160; Horner, Andreas/0000-0002-5328-1745; Pohl, Peter/0000-0002-1792-2314	Upper Austrian Government; Deutsche Forschungsgemeinschaft [DFG KL1415/3-2, KL1415/4-2]	Upper Austrian Government; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Upper Austrian Government and Deutsche Forschungsgemeinschaft Grants DFG KL1415/3-2 and KL1415/4-2 (to E. K.).	Arbuzova A, 1998, BBA-REV BIOMEMBRANES, V1376, P369, DOI 10.1016/S0304-4157(98)00011-2; BenTal N, 1996, BIOPHYS J, V71, P561, DOI 10.1016/S0006-3495(96)79280-9; Gadjev Ilya, INT REV CELL MOL BIO, P87, DOI [DOI 10.1016/S1937-6448(10)8305-9, 10.1016/S1937-6448(08)01403-2, DOI 10.1016/S1937-6448(08)01403-2]; Gold MG, 2008, J MOL BIOL, V375, P1329, DOI 10.1016/j.jmb.2007.11.037; Henn V, 2004, J BIOL CHEM, V279, P26654, DOI 10.1074/jbc.M312835200; Horner A, 2009, BIOPHYS J, V96, P2689, DOI 10.1016/j.bpj.2008.12.3931; Hulme JT, 2002, J BIOL CHEM, V277, P4079, DOI 10.1074/jbc.M109814200; Hundsrucker C, 2006, BIOCHEM J, V396, P297, DOI 10.1042/BJ20051970; Kleinschmidt JH, 1997, BIOPHYS J, V73, P2546, DOI 10.1016/S0006-3495(97)78283-3; Klussmann E, 1999, J BIOL CHEM, V274, P4934, DOI 10.1074/jbc.274.8.4934; Lata S, 2006, J AM CHEM SOC, V128, P2365, DOI 10.1021/ja0563105; Lorenz D, 2003, EMBO REP, V4, P88, DOI 10.1038/sj.embor.embor711; Lygren B, 2007, EMBO REP, V8, P1061, DOI 10.1038/sj.embor.7401081; Michel JJC, 2002, ANNU REV PHARMACOL, V42, P235, DOI 10.1146/annurev.pharmtox.42.083101.135801; Nedvetsky Pavel I, 2009, Handb Exp Pharmacol, P133, DOI 10.1007/978-3-540-79885-9_6; Newlon MG, 1999, NAT STRUCT BIOL, V6, P222; Petrasek Z, 2008, BIOPHYS J, V94, P1437, DOI 10.1529/biophysj.107.108811; Pohl EE, 2000, BIOCHEMISTRY-US, V39, P1834, DOI 10.1021/bi9919549; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Rusu L, 2004, BIOPHYS J, V87, P1044, DOI 10.1529/biophysj.104.039958; Stefan E, 2007, J AM SOC NEPHROL, V18, P199, DOI 10.1681/ASN.2006020132; Streb JW, 2005, J BIOL CHEM, V280, P28007, DOI 10.1074/jbc.M414017200; Tao JC, 2006, J BIOL CHEM, V281, P23932, DOI 10.1074/jbc.M601813200; Tibbs VC, 1998, J BIOL CHEM, V273, P25783, DOI 10.1074/jbc.273.40.25783; Trotter KW, 1999, J CELL BIOL, V147, P1481, DOI 10.1083/jcb.147.7.1481; Wruss J, 2009, J AM CHEM SOC, V131, P5478, DOI 10.1021/ja807917t	26	16	16	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42495	42501		10.1074/jbc.M112.414946	http://dx.doi.org/10.1074/jbc.M112.414946			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23095754	hybrid, Green Published			2022-12-25	WOS:000312501600011
J	Zhou, Y; Lee, JY; Lee, CM; Cho, WK; Kang, MJ; Koff, JL; Yoon, PO; Chae, J; Park, HO; Elias, JA; Lee, CG				Zhou, Yang; Lee, Jae-Young; Lee, Chang-Min; Cho, Won-Kyung; Kang, Min-Jong; Koff, Jonathan L.; Yoon, Pyeong-Oh; Chae, Jeiwook; Park, Han-Oh; Elias, Jack A.; Lee, Chun Geun			Amphiregulin, an Epidermal Growth Factor Receptor Ligand, Plays an Essential Role in the Pathogenesis of Transforming Growth Factor-beta-induced Pulmonary Fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED LUNG FIBROSIS; TGF-BETA; FACTOR-ALPHA; MYOFIBROBLAST DIFFERENTIATION; SIGNALING PATHWAY; GENE-EXPRESSION; TRANSGENIC MICE; IN-VIVO; INFLAMMATION; APOPTOSIS	Dysregulated amphiregulin (AR) expression and EGR receptor (EGFR) activation have been described in animal models of pulmonary fibrosis and in patients with idiopathic pulmonary fibrosis. However, the exact role of AR in the pathogenesis of pulmonary fibrosis has not been clearly defined. Here, we show that a potent profibrogenic cytokine TGF-beta 1 significantly induced the expression of AR in lung fibroblasts in vitro and in murine lungs in vivo. AR stimulated NIH3T3 fibroblast cell proliferation in a dose-dependent manner. Silencing of AR expression by siRNA or chemical inhibition of EGFR signaling, utilizing AG1478 and gefitinib, significantly reduced the ability of TGF-beta 1 to stimulate fibroblast proliferation and expression of alpha-smooth muscle actin, collagen, and other extracellular matrix-associated genes. TGF-beta 1-stimulated activation of Akt, ERK, and Smad signaling was also significantly inhibited by these interventions. Consistent with these in vitro findings, AR expression was impressively increased in the lungs of TGF-beta 1 transgenic mice, and either siRNA silencing of AR or chemical inhibition of EGFR signaling significantly reduced TGF-beta 1 stimulated collagen accumulation in the lung. These studies showed a novel regulatory role for AR in the pathogenesis of TGF-beta 1-induced pulmonary fibrosis. In addition, these studies suggest that AR, or AR-activated EGFR signaling, is a potential therapeutic target for idiopathic pulmonary fibrosis associated with TGF-beta 1 activation.	[Zhou, Yang; Lee, Chang-Min; Cho, Won-Kyung; Kang, Min-Jong; Koff, Jonathan L.; Elias, Jack A.; Lee, Chun Geun] Yale Univ, Sch Med, Dept Internal Med, Sect Pulm & Crit Care Med, New Haven, CT 06520 USA; [Lee, Jae-Young] Hallym Univ, Sch Med, Dept Internal Med, Seoul 150030, South Korea; [Yoon, Pyeong-Oh; Chae, Jeiwook; Park, Han-Oh] Bioneer Corp, Taejon 306220, South Korea	Yale University; Hallym University	Lee, CG (corresponding author), 300 Cedar St,TAC S425A, New Haven, CT 06520 USA.	chungeun.lee@yale.edu	Lee, Chun Geun/AAC-2838-2021	Cho, Won-Kyung/0000-0003-1540-545X; Kang, Min-Jong/0000-0003-3245-144X; Lee, Chun Geun/0000-0002-9514-3658				Amendt C, 2002, J CELL SCI, V115, P2189; Avraham R, 2011, NAT REV MOL CELL BIO, V12, P104, DOI 10.1038/nrm3048; Bhandari V, 2006, NAT MED, V12, P1286, DOI 10.1038/nm1494; Borrell-Pages M, 2003, EMBO J, V22, P1114, DOI 10.1093/emboj/cdg111; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Elias JA, 2003, J CLIN INVEST, V111, P291, DOI 10.1172/JCI200317748; Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0; Forsythe B, 2004, DRUG SAFETY, V27, P1081, DOI 10.2165/00002018-200427140-00002; Fukumoto J, 2010, AM J PHYSIOL-LUNG C, V298, pL131, DOI 10.1152/ajplung.90576.2008; Homer RJ, 2011, ARCH PATHOL LAB MED, V135, P780, DOI 10.1043/2010-0296-RA.1; Hu B, 2007, AM J RESP CELL MOL, V36, P78, DOI 10.1165/rcmb.2006-0043OC; Ishii Y, 2006, AM J RESP CRIT CARE, V174, P550, DOI 10.1164/rccm.200509-1534OC; Kang HR, 2007, J EXP MED, V204, P1083, DOI 10.1084/jem.20061273; Kang HR, 2007, J BIOL CHEM, V282, P7723, DOI 10.1074/jbc.M610764200; Kang Hye-Ryun, 2008, Expert Rev Clin Pharmacol, V1, P547, DOI 10.1586/17512433.1.4.547; Kawakami T, 1998, J INVEST DERMATOL, V110, P47, DOI 10.1046/j.1523-1747.1998.00073.x; KHALIL N, 1991, AM J RESP CELL MOL, V5, P155, DOI 10.1165/ajrcmb/5.2.155; Khalil N, 2001, THORAX, V56, P907, DOI 10.1136/thorax.56.12.907; KORFHAGEN TR, 1994, J CLIN INVEST, V93, P1691, DOI 10.1172/JCI117152; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lee CG, 2004, J EXP MED, V200, P377, DOI 10.1084/jem.20040104; Lee CG, 2001, J EXP MED, V194, P809, DOI 10.1084/jem.194.6.809; Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271; Liu M, 2007, AM J RESP CELL MOL, V37, P578, DOI 10.1165/rcmb.2007-0100OC; Madtes DK, 1999, AM J RESP CELL MOL, V20, P924, DOI 10.1165/ajrcmb.20.5.3526; MADTES DK, 1994, AM J RESP CELL MOL, V11, P540, DOI 10.1165/ajrcmb.11.5.7524566; Martinelli M, 2011, MOL BIOL REP, V38, P4613, DOI 10.1007/s11033-010-0594-0; Meran S, 2011, J BIOL CHEM, V286, P17618, DOI 10.1074/jbc.M111.226563; Mundle SD, 1995, ANTICANCER RES, V15, P1895; Nakao A, 1999, J CLIN INVEST, V104, P5, DOI 10.1172/JCI6094; Noble PW, 2004, CLIN CHEST MED, V25, P749, DOI 10.1016/j.ccm.2004.04.003; Perugorria MJ, 2008, HEPATOLOGY, V48, P1251, DOI 10.1002/hep.22437; Roy SG, 2001, INT J BIOCHEM CELL B, V33, P723, DOI 10.1016/S1357-2725(01)00041-3; Samarakoon R, 2008, THROMB HAEMOSTASIS, V100, P976, DOI 10.1160/TH08-05-0273; Scartozzi M, 2007, BRIT J CANCER, V97, P92, DOI 10.1038/sj.bjc.6603847; Schuger L, 1996, DEVELOPMENT, V122, P1759; Seluanov Andrei, 2010, J Vis Exp, DOI 10.3791/2033; Sheppard Dean, 2006, Proc Am Thorac Soc, V3, P413, DOI 10.1513/pats.200601-008AW; SHOYAB M, 1988, P NATL ACAD SCI USA, V85, P6528, DOI 10.1073/pnas.85.17.6528; Siner JM, 2007, FASEB J, V21, P1422, DOI 10.1096/fj.06-6661com; Wang SW, 2005, J ALLERGY CLIN IMMUN, V115, P287, DOI 10.1016/j.jaci.2004.11.037; Ward PA, 1998, AM J RESP CRIT CARE, V157, pS123, DOI 10.1164/ajrccm.157.4.nhlbi-10; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yamasaki M, 2008, AM J RESP CELL MOL, V38, P346, DOI 10.1165/rcmb.2007-0276OC; Yehualaeshet T, 2000, AM J RESP CELL MOL, V23, P204, DOI 10.1165/ajrcmb.23.2.4089	46	95	104	1	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41991	42000		10.1074/jbc.M112.356824	http://dx.doi.org/10.1074/jbc.M112.356824			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086930	hybrid, Green Published			2022-12-25	WOS:000312103000038
J	Bernard, E; Rolain, T; David, B; Andre, G; Dupres, V; Dufrene, YF; Hallet, B; Chapot-Chartier, MP; Hols, P				Bernard, Elvis; Rolain, Thomas; David, Blandine; Andre, Guillaume; Dupres, Vincent; Dufrene, Yves F.; Hallet, Bernard; Chapot-Chartier, Marie-Pierre; Hols, Pascal			Dual Role for the O-Acetyltransferase OatA in Peptidoglycan Modification and Control of Cell Septation in Lactobacillus plantarum	PLOS ONE			English	Article							BACILLUS-SUBTILIS; TEICHOIC-ACIDS; STRUCTURAL-VARIATION; DIVISION-SITE; WALL; LOCALIZATION; ACETYLATION; RESISTANCE; TRANSFORMATION; BIOSYNTHESIS	Until now, peptidoglycan O-acetyl transferases (Oat) were only described for their peptidoglycan O-acetylating activity and for their implication in the control of peptidoglycan hydrolases. In this study, we show that a Lactobacillus plantarum mutant lacking OatA is unable to uncouple cell elongation and septation. Wild-type cells showed an elongation arrest during septation while oatA mutant cells continued to elongate at a constant rate without any observable pause during the cell division process. Remarkably, this defect does not result from a default in peptidoglycan O-acetylation, since it can be rescued by wild-type OatA as well as by a catalytic mutant or a truncated variant containing only the transmembrane domain of the protein. Consistent with a potential involvement in division, OatA preferentially localizes at mid-cell before membrane invagination and remains at this position until the end of septation. Overexpression of oatA or its inactive variants induces septation-specific aberrations, including asymmetrical and dual septum formation. Overproduction of the division inhibitors, MinC or MinD, leads to cell filamentation in the wild type while curved and branched cells are observed in the oatA mutant, suggesting that the Min system acts differently on the division process in the absence of OatA. Altogether, the results suggest that OatA plays a key role in the spatio-temporal control of septation, irrespective of its catalytic activity.	[Bernard, Elvis; Rolain, Thomas; David, Blandine; Hallet, Bernard; Hols, Pascal] Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain, Belgium; [Bernard, Elvis; Chapot-Chartier, Marie-Pierre] AgroParisTech, UMR Micalis, Jouy En Josas, France; [Bernard, Elvis; Chapot-Chartier, Marie-Pierre] INRA, Micalis UMR1319, Jouy En Josas, France; [Andre, Guillaume; Dupres, Vincent; Dufrene, Yves F.] Catholic Univ Louvain, Inst Condensed Matter & Nanosci, B-1348 Louvain, Belgium	Universite Catholique Louvain; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Universite Catholique Louvain	Hols, P (corresponding author), Catholic Univ Louvain, Inst Sci Vie, B-1348 Louvain, Belgium.	pascal.hols@uclouvain.be	Dupres, Vincent/GLQ-5321-2022	Dupres, Vincent/0000-0002-1970-3633; Chapot-Chartier, Marie-Pierre/0000-0002-4947-0519; Dufrene, Yves/0000-0002-7289-4248	National Foundation for Scientific Research (FNRS); Universite catholique de Louvain (Fonds Speciaux de Recherche); Research Department of the Communaute francaise de Belgique (Concerted Research Action); INRA (Jeune Equipe grant); Marie Curie fellowship for Early Stage Research Training (EST) of the FP6 LabHealth project [MEST-CT-2004-514428]; FRIA	National Foundation for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Universite catholique de Louvain (Fonds Speciaux de Recherche); Research Department of the Communaute francaise de Belgique (Concerted Research Action); INRA (Jeune Equipe grant); Marie Curie fellowship for Early Stage Research Training (EST) of the FP6 LabHealth project(European Commission); FRIA(Fonds de la Recherche Scientifique - FNRS)	Work in the teams of Y.F.D. and P. H. was supported by the National Foundation for Scientific Research (FNRS), the Universite catholique de Louvain (Fonds Speciaux de Recherche), and the Research Department of the Communaute francaise de Belgique (Concerted Research Action). Work of M. P. C. C. was supported by INRA (Jeune Equipe grant). E. B. was the recipient of a Marie Curie fellowship for Early Stage Research Training (EST) of the FP6 LabHealth project (MEST-CT-2004-514428). T. R. held a doctoral fellowship from FRIA. V. D., Y.F.D., and P. H. are respectively Scientific Research Worker, Senior Research Associate, and Research Associate of the FNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre G, 2011, ACS CHEM BIOL, V6, P366, DOI 10.1021/cb1003509; Atilano ML, 2010, P NATL ACAD SCI USA, V107, P18991, DOI 10.1073/pnas.1004304107; Aukrust T W, 1995, Methods Mol Biol, V47, P201; Bera A, 2005, MOL MICROBIOL, V55, P778, DOI 10.1111/j.1365-2958.2004.04446.x; Bernard E, 2011, J BIOL CHEM, V286, P23950, DOI 10.1074/jbc.M111.241414; Bhavsar AP, 2004, J BACTERIOL, V186, P7865, DOI 10.1128/JB.186.23.7865-7873.2004; Bramkamp M, 2008, MOL MICROBIOL, V70, P1556, DOI 10.1111/j.1365-2958.2008.06501.x; CASADABAN MJ, 1980, J MOL BIOL, V138, P179, DOI 10.1016/0022-2836(80)90283-1; CLARKE AJ, 1992, CAN J MICROBIOL, V38, P85, DOI 10.1139/m92-014; Crisostomo MI, 2006, MOL MICROBIOL, V61, P1497, DOI 10.1111/j.1365-2958.2006.05340.x; D'Elia MA, 2006, J BACTERIOL, V188, P8313, DOI 10.1128/JB.01336-06; Delcour J, 1999, ANTON LEEUW INT J G, V76, P159, DOI 10.1023/A:1002089722581; DePedro MA, 1997, J BACTERIOL, V179, P2823, DOI 10.1128/jb.179.9.2823-2834.1997; deRuyter PGGA, 1996, J BACTERIOL, V178, P3434, DOI 10.1128/jb.178.12.3434-3439.1996; DOWER WJ, 1988, NUCLEIC ACIDS RES, V16, P6127, DOI 10.1093/nar/16.13.6127; Emirian A, 2009, FEBS LETT, V583, P3033, DOI 10.1016/j.febslet.2009.08.010; Gamba P, 2009, J BACTERIOL, V191, P4186, DOI 10.1128/JB.01758-08; Gregory JA, 2008, GENE DEV, V22, P3475, DOI 10.1101/gad.1732408; Haeusser DP, 2008, CURR OPIN MICROBIOL, V11, P94, DOI 10.1016/j.mib.2008.02.008; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Marston AL, 1999, MOL MICROBIOL, V33, P84, DOI 10.1046/j.1365-2958.1999.01450.x; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Neuhaus FC, 2003, MICROBIOL MOL BIOL R, V67, P686, DOI 10.1128/MMBR.67.4.686-723.2003; Pavan S, 2000, APPL ENVIRON MICROB, V66, P4427, DOI 10.1128/AEM.66.10.4427-4432.2000; Pfeffer JM, 2006, J BACTERIOL, V188, P902, DOI 10.1128/JB.188.3.902-908.2006; Ramamurthi KS, 2009, P NATL ACAD SCI USA, V106, P13541, DOI 10.1073/pnas.0906851106; Sambrook J, 2001, MOL CLONING LAB MANU; Swoboda JG, 2010, CHEMBIOCHEM, V11, P35, DOI 10.1002/cbic.200900557; Veiga P, 2007, J BIOL CHEM, V282, P19342, DOI 10.1074/jbc.M611308200; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P287, DOI 10.1111/j.1574-6976.2007.00088.x; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; Weidenmaier C, 2004, NAT MED, V10, P243, DOI 10.1038/nm991; Yamamoto H, 2008, MOL MICROBIOL, V70, P297, DOI 10.1111/j.1365-2958.2008.06397.x; Young KD, 2003, MOL MICROBIOL, V49, P571, DOI 10.1046/j.1365-2958.2003.03607.x	34	17	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47893	10.1371/journal.pone.0047893	http://dx.doi.org/10.1371/journal.pone.0047893			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110121	Green Submitted, Green Published, gold			2022-12-25	WOS:000310262500026
J	Botia, B; Legastelois, R; Alaux-Cantin, S; Naassila, M				Botia, Beatrice; Legastelois, Remi; Alaux-Cantin, Stephanie; Naassila, Mickael			Expression of Ethanol-Induced Behavioral Sensitization Is Associated with Alteration of Chromatin Remodeling in Mice	PLOS ONE			English	Article							HISTONE DEACETYLASE INHIBITORS; COCAINE; DOPAMINE; AMPHETAMINE; RECEPTORS; RESPONSES; BINDING; INDUCTION; AMYGDALA; RELAPSE	Background: Ethanol-induced behavioral sensitization (EIBS) is proposed to play a role in early and recurring steps of addiction. EIBS does not occur uniformly in all animals even from the same inbred strain. Since recent data demonstrate that epigenetic mechanisms are likely to be involved in the development and the persistence of ethanol-related behaviors, we explored the involvement of epigenetic mechanisms in ethanol response after EIBS development. Methodology: DBA/2J mice were i.p. injected with saline or ethanol (2 g/kg) once a day for 10 consecutive days. At day 17, ethanol-treated mice were split in resistant and sensitized groups. Brains were then removed 30 min after a saline or 2 g/kg ethanol challenge to assess i) gene expression using PCR array targeting 84 epigenetic-related genes and ii) histone deacetylases (HDAC), histone acetylases (HAT) and DNA methyltransferases (DNMT) activities as well as H4K12 acetylation. Principal Findings: Acute ethanol administration decreased dnmt1, esco2 and rps6ka5 genes expression. These genes were similarly altered in sensitized but not in resistant mice after an ethanol challenge, suggesting that resistant mice were tolerant to the transcriptional outcomes of an ethanol challenge. Whereas global HAT or DNMT activity was not affected, global HDAC activity was reduced after an acute ethanol injection. HDAC inhibition occurred in all ethanol-treated mice but with a lesser extent in sensitized animals. As a consequence, H4 acetylation was specifically potentiated in the core of the Nac proportionally to the striatal HDAC activity decrease. Conclusions/Significance: The present study highlights that the contrasted behavioral response to an ethanol challenge between resistant and sensitized mice may be mediated by epigenetic mechanisms occurring specifically in the striatum. Here we show that vulnerability to ethanol dependence and relapse could be, at least in part, due to individual variability in acute ethanol-induced epigenetic response.	[Botia, Beatrice; Legastelois, Remi; Alaux-Cantin, Stephanie; Naassila, Mickael] Univ Picardie Jules Verne, Unite Format & Rech Pharm, Inst Natl Sante & Rech Med, Res Grp Alcohol & Pharmacodependences,ERI 24, Amiens, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Naassila, M (corresponding author), Univ Picardie Jules Verne, Unite Format & Rech Pharm, Inst Natl Sante & Rech Med, Res Grp Alcohol & Pharmacodependences,ERI 24, Amiens, France.	mickael.naassila@inserm.fr	Naassila, Mickael/N-5146-2016	Naassila, Mickael/0000-0002-9788-0918	National Agency for Research; Conseil Regional de Picardie (CRP); Mission interministerielle de lutte contre la drogue et la toxicomanie (Mildt) - Inserm - Institute of Cancer [APE09002ESA]; Institut de France/Fondation NRJ "Biology of addiction"; ERDF Grant/INTERREG IVA program [4096]; Ministere de l'Enseignement superieur et de la Recherche; CRP	National Agency for Research(French National Research Agency (ANR)); Conseil Regional de Picardie (CRP)(Region Hauts-de-France); Mission interministerielle de lutte contre la drogue et la toxicomanie (Mildt) - Inserm - Institute of Cancer; Institut de France/Fondation NRJ "Biology of addiction"; ERDF Grant/INTERREG IVA program; Ministere de l'Enseignement superieur et de la Recherche; CRP	This study was supported by the National Agency for Research (SENSIBALCO grant, SAMENTA 2011), the Conseil Regional de Picardie (CRP), the Mission interministerielle de lutte contre la drogue et la toxicomanie (Mildt) - Inserm - Institute of Cancer (Contract APE09002ESA), Institut de France/Fondation NRJ "Biology of addiction" and ERDF Grant/INTERREG IVA program No4096 "AlcoBinge". RL is supported by a doctoral Fellowship from the Ministere de l'Enseignement superieur et de la Recherche. BB is supported by a post-doctoral fellowship from the CRP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahao KP, 2011, INT J NEUROPSYCHOPH, V14, P175, DOI 10.1017/S1461145710000441; Anier K, 2010, NEUROPSYCHOPHARMACOL, V35, P2450, DOI 10.1038/npp.2010.128; Boudreau AC, 2005, J NEUROSCI, V25, P9144, DOI 10.1523/JNEUROSCI.2252-05.2005; Brami-Cherrier K, 2009, J NEUROCHEM, V108, P1323, DOI 10.1111/j.1471-4159.2009.05879.x; Cadoni C, 2000, EUR J PHARMACOL, V387, pR23, DOI 10.1016/S0014-2999(99)00843-2; CADOR M, 1995, NEUROSCIENCE, V65, P385, DOI 10.1016/0306-4522(94)00524-9; Camarini R, 2000, INT J NEUROPSYCHOPH, V3, P303, DOI 10.1017/S146114570000211X; de Araujo NP, 2009, PHYSIOL BEHAV, V96, P12, DOI 10.1016/j.physbeh.2008.07.029; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Didone V, 2008, PSYCHOPHARMACOLOGY, V201, P249, DOI 10.1007/s00213-008-1266-9; DiRocco DP, 2009, J NEUROSCI, V29, P2393, DOI 10.1523/JNEUROSCI.4356-08.2009; Fee JR, 2007, NEUROSCIENCE, V150, P14, DOI 10.1016/j.neuroscience.2007.08.027; Fuchs RA, 2005, NEUROPSYCHOPHARMACOL, V30, P296, DOI 10.1038/sj.npp.1300579; Gutierrez-Mecinas M, 2011, P NATL ACAD SCI USA, V108, P13806, DOI 10.1073/pnas.1104383108; Harrison SJ, 2009, PSYCHOPHARMACOLOGY, V207, P47, DOI 10.1007/s00213-009-1629-x; Host L, 2011, J PSYCHOPHARMACOL, V25, P222, DOI 10.1177/0269881109348173; Kalda A, 2007, BEHAV BRAIN RES, V181, P76, DOI 10.1016/j.bbr.2007.03.027; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kim AK, 2010, BEHAV BRAIN RES, V207, P441, DOI 10.1016/j.bbr.2009.10.032; Kim BJ, 2008, BIOCHEM BIOPH RES CO, V372, P298, DOI 10.1016/j.bbrc.2008.05.056; Levine AA, 2005, P NATL ACAD SCI USA, V102, P19186, DOI 10.1073/pnas.0509735102; Martin TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034236; MASUR J, 1988, PSYCHOPHARMACOLOGY, V96, P547, DOI 10.1007/BF02180038; Nordquist RE, 2007, EUR NEUROPSYCHOPHARM, V17, P532, DOI 10.1016/j.euroneuro.2006.12.005; O'Brien ES, 2011, NEUROPSYCHOPHARMACOL, V36, P1518, DOI 10.1038/npp.2011.37; Pandey SC, 2008, J NEUROSCI, V28, P3729, DOI 10.1523/JNEUROSCI.5731-07.2008; Pascual M, 2009, J NEUROCHEM, V108, P920, DOI 10.1111/j.1471-4159.2008.05835.x; Pascual M, 2012, NEUROPHARMACOLOGY, V62, P2309, DOI 10.1016/j.neuropharm.2012.01.011; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; PERUGINI M, 1994, J PHARMACOL EXP THER, V270, P690; Quadros IMH, 2002, ADDICT BIOL, V7, P291, DOI 10.1080/13556210220139505; Quadros IMH, 2002, EUR J PHARMACOL, V442, P55, DOI 10.1016/S0014-2999(02)01503-0; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Sakharkar AJ, 2012, ALCOHOL CLIN EXP RES, V36, P61, DOI 10.1111/j.1530-0277.2011.01581.x; Sanchis-Segura C, 2009, NEUROPSYCHOPHARMACOL, V34, P2642, DOI 10.1038/npp.2009.125; Shukla SD, 2008, ALCOHOL CLIN EXP RES, V32, P1525, DOI 10.1111/j.1530-0277.2008.00729.x; Souza-Formigoni MLO, 1999, PSYCHOPHARMACOLOGY, V146, P262, DOI 10.1007/s002130051115; Steketee JD, 2011, PHARMACOL REV, V63, P348, DOI 10.1124/pr.109.001933; Svedruzic ZM, 2011, PROG MOL BIOL TRANSL, V101, P221, DOI 10.1016/B978-0-12-387685-0.00006-8; Tian WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033435; Vanderschuren LJMJ, 2010, CURR TOP BEHAV NEURO, V3, P179, DOI 10.1007/7854_2009_21; Xu CM, 2011, J NEUROCHEM, V118, P126, DOI 10.1111/j.1471-4159.2011.07281.x	42	50	52	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e47527	10.1371/journal.pone.0047527	http://dx.doi.org/10.1371/journal.pone.0047527			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110077	Green Published, gold			2022-12-25	WOS:000310193400011
J	Beloribi, S; Ristorcelli, E; Breuzard, G; Silvy, F; Bertrand-Michel, J; Beraud, E; Verine, A; Lombardo, D				Beloribi, Sadia; Ristorcelli, Elodie; Breuzard, Gilles; Silvy, Francoise; Bertrand-Michel, Justine; Beraud, Evelyne; Verine, Alain; Lombardo, Dominique			Exosomal Lipids Impact Notch Signaling and Induce Death of Human Pancreatic Tumoral SOJ-6 Cells	PLOS ONE			English	Article							CHOLESTEROL ACCUMULATION; ENDOPLASMIC-RETICULUM; GAMMA-SECRETASE; MEMBRANE; APOPTOSIS; RAFTS; PHOSPHORYLATION; TRAFFICKING; ACTIVATION; CERAMIDE	Exosomes are of increasing interest as alternative mode of cell-to-cell communication. We previously reported that exosomes secreted by human SOJ-6 pancreatic tumor cells induce (glyco) protein ligand-independent cell death and inhibit Notch-1 pathway, this latter being particularly active during carcinogenesis and in cancer stem cells. Therefore, we asked whether exosomal lipids were key-elements for cell death and hypothesized that cholesterol-rich membrane microdomains were privileged sites of exosome interactions with tumor cells. To address these questions and based on the lipid composition of exosomes from SOJ-6 cells (Ristorcelli et al. (2008) FASEB J. 22; 3358-3369) enriched in cholesterol and sphingomyelin (lipids forming liquid-ordered phase, Lo) and depleted in phospholipids (lipids forming liquid-disordered phase, Ld), we designed Synthetic Exosome-Like Nanoparticles (SELN) with ratios Lo/Ld from 3.0 to 6.0 framing that of SOJ-6 cell exosomes. SELN decreased tumor cell survival, the higher the Lo/Ld ratio, the lower the cell survival. This decreased survival was due to activation of cell death with inhibition of Notch pathway. FRET analyses indicated fusions/exchanges of SELN with cell membranes. Fluorescent SELN co-localized with the ganglioside GM1 then with Rab5A, markers of lipid microdomains and of early endosomes, respectively. These interactions occurred at lipid microdomains of plasma and/or endosome membranes where the Notch-1 pathway matures. We thus demonstrated a major role for lipids in interactions between SELN and tumor cells, and in the ensued cell death. To our knowledge this is the first report on such effects of lipidic nanoparticles on tumor cell behavior. This may have implications in tumor progression.	[Beloribi, Sadia; Ristorcelli, Elodie; Breuzard, Gilles; Silvy, Francoise; Beraud, Evelyne; Verine, Alain; Lombardo, Dominique] Aix Marseille Univ, CRO2, Marseille, France; [Beloribi, Sadia; Ristorcelli, Elodie; Breuzard, Gilles; Silvy, Francoise; Beraud, Evelyne; Verine, Alain; Lombardo, Dominique] INSERM, UMR 911, F-13258 Marseille, France; [Bertrand-Michel, Justine] CHU Purpan, INSERM IFR BMT MetaToul, Lipid Core Facil, Toulouse, France	UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)	Lombardo, D (corresponding author), Aix Marseille Univ, CRO2, Marseille, France.	dominique.lombardo@univ-amu.fr	breuzard, gilles/C-4735-2013	breuzard, gilles/0000-0001-8178-2080	INSERM (Paris, France); Aix-Marseille Universite (Marseille, France)	INSERM (Paris, France)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Aix-Marseille Universite (Marseille, France)	This work was funded by INSERM (Paris, France) and Aix-Marseille Universite (Marseille, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Chaput N, 2011, SEMIN IMMUNOPATHOL, V33, P419, DOI 10.1007/s00281-010-0233-9; Crescence L, 2012, J IMMUNOL, V189, P3386, DOI 10.4049/jimmunol.1102647; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; del Conde I, 2005, BLOOD, V106, P1604, DOI 10.1182/blood-2004-03-1095; Escrevente C, 2001, BMC CANCER, V27, P108; Fasano C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000612; Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Fujii Y, 1990, Hum Cell, V3, P31; Izquierdo-Useros N, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000740; Kabarowski JHS, 2001, SCIENCE, V293, P702, DOI 10.1126/science.1061781; Laulagnier K, 2005, BLOOD CELL MOL DIS, V35, P116, DOI 10.1016/j.bcmd.2005.05.010; Laulagnier K, 2004, BIOCHEM J, V380, P161, DOI 10.1042/BJ20031594; Levade T, 2002, NEUROCHEM RES, V27, P601, DOI 10.1023/A:1020215815013; Luketic L, 2007, J IMMUNOL, V179, P5024, DOI 10.4049/jimmunol.179.8.5024; Maceyka M, 2002, BBA-MOL CELL BIOL L, V1585, P193, DOI 10.1016/S1388-1981(02)00341-4; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; McGill MA, 2009, J BIOL CHEM, V284, P26427, DOI 10.1074/jbc.M109.014845; Michel V, 2007, BIOL CELL, V99, P129, DOI 10.1042/BC20060051; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Murai T, 2011, J BIOL CHEM, V286, P1999, DOI 10.1074/jbc.M110.184010; Nieuwland R, 2010, THROMB RES, V125, pS49, DOI 10.1016/j.thromres.2010.01.037; Osenkowski P, 2008, J BIOL CHEM, V283, P22529, DOI 10.1074/jbc.M801925200; Panicot-Dubois L, 2004, NEOPLASIA, V6, P713, DOI 10.1593/neo.04298; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Ristorcelli E, 2008, FASEB J, V22, P3358, DOI 10.1096/fj.07-102855; Ristorcelli E, 2009, INT J CANCER, V125, P1016, DOI 10.1002/ijc.24375; Ross AH, 2009, P NATL ACAD SCI USA, V106, P1297, DOI 10.1073/pnas.0812473106; Roy M, 2007, CURR OPIN GENET DEV, V17, P52, DOI 10.1016/j.gde.2006.12.001; Safaei R, 2005, MOL CANCER THER, V4, P1595, DOI 10.1158/1535-7163.MCT-05-0102; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Steinert S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002933; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Subra C, 2007, BIOCHIMIE, V89, P205, DOI 10.1016/j.biochi.2006.10.014; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Tao LW, 2011, STEM CELLS, V29, P119, DOI 10.1002/stem.552; Tellier E, 2006, EXP CELL RES, V312, P3969, DOI 10.1016/j.yexcr.2006.08.027; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; van Niel G, 2006, J BIOCHEM, V140, P13, DOI 10.1093/jb/mvj128; Vo K, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-138; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Wang XZ, 1996, SCIENCE, V272, P1347, DOI 10.1126/science.272.5266.1347; Zakharova L, 2007, J CELL PHYSIOL, V212, P174, DOI 10.1002/jcp.21013	47	57	60	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47480	10.1371/journal.pone.0047480	http://dx.doi.org/10.1371/journal.pone.0047480			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094054	gold, Green Published, Green Submitted			2022-12-25	WOS:000310050200026
J	Lo, MK; Peeples, ME; Bellini, WJ; Nichol, ST; Rota, PA; Spiropoulou, CF				Lo, Michael K.; Peeples, Mark E.; Bellini, William J.; Nichol, Stuart T.; Rota, Paul A.; Spiropoulou, Christina F.			Distinct and Overlapping Roles of Nipah Virus P Gene Products in Modulating the Human Endothelial Cell Antiviral Response	PLOS ONE			English	Article							DEPENDENT INTERFERON INDUCTION; PARAMYXOVIRUS V PROTEINS; TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; SENDAI-VIRUS; MESSENGER-RNA; MEASLES-VIRUS; C-PROTEIN; W-PROTEIN; RIG-I	Nipah virus (NiV) is a highly pathogenic zoonotic paramyxovirus that causes fatal encephalitis in up to 75% of infected humans. Like other paramyxoviruses, NiV employs co-transcriptional mRNA editing during transcription of the phosphoprotein (P) gene to generate additional mRNAs encoding the V and W proteins. The C protein is translated from the P mRNA, but in an alternative reading frame. There is evidence from both in vitro and in vivo studies to show that the P gene products play a role in NiV pathogenesis. We have developed a reverse genetic system to dissect the individual roles of the NiV P gene products in limiting the antiviral response in primary human microvascular lung endothelial cells, which represent important targets in human NiV infection. By characterizing growth curves and early antiviral responses against a number of recombinant NiVs with genetic modifications altering expression of the proteins encoded by the P gene, we observed that multiple elements encoded by the P gene have both distinct and overlapping roles in modulating virus replication as well as in limiting expression of antiviral mediators such as IFN-beta, CXCL10, and CCL5. Our findings corroborate observations from in vivo hamster infection studies, and provide molecular insights into the attenuation and the histopathology observed in hamsters infected with C, V, and W-deficient NiVs. The results of this study also provide an opportunity to verify the results of earlier artificial plasmid expression studies in the context of authentic viral infection.	[Lo, Michael K.; Nichol, Stuart T.; Spiropoulou, Christina F.] Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Atlanta, GA 30329 USA; [Lo, Michael K.; Bellini, William J.; Rota, Paul A.] Ctr Dis Control & Prevent, Measles Mumps Rubella & Herpes Virus Branch, Atlanta, GA USA; [Peeples, Mark E.] Nationwide Childrens Hosp, Res Inst, Columbus, OH USA; [Peeples, Mark E.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Lo, MK (corresponding author), Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Atlanta, GA 30329 USA.	mko2@cdc.gov	Peeples, Mark E./AAX-5193-2021	Peeples, Mark E./0000-0002-4582-317X; Lo, Michael/0000-0002-0409-7896	Centers for Disease Control and Prevention; National Institutes of Health [AI069014]; ASM/CCID Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI069014, R01AI093848] Funding Source: NIH RePORTER	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ASM/CCID Postdoctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by core funding from the Centers for Disease Control and Prevention, and by National Institutes of Health AI069014 to MEP. MKL was supported in part by an ASM/CCID Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI M, 1989, MOL CELL BIOL, V9, P5062, DOI 10.1128/MCB.9.11.5062; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101; Arankalle VA, 2011, EMERG INFECT DIS, V17, P907, DOI 10.3201/eid1705.100968; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Chadha MS, 2006, EMERG INFECT DIS, V12, P235, DOI 10.3201/eid1202.051247; Childs KS, 2009, J VIROL, V83, P1465, DOI 10.1128/JVI.01768-08; Childs K, 2012, J VIROL, V86, P3411, DOI 10.1128/JVI.06405-11; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Chua KB, 2000, SCIENCE, V288, P1432, DOI 10.1126/science.288.5470.1432; Chua KB, 2002, MICROBES INFECT, V4, P145, DOI 10.1016/S1286-4579(01)01522-2; Ciancanelli MJ, 2009, J VIROL, V83, P7828, DOI 10.1128/JVI.02610-08; COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811; Crameri G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008266; CURRAN J, 1990, ENZYME, V44, P244, DOI 10.1159/000468762; CURRAN J, 1991, EMBO J, V10, P3079, DOI 10.1002/j.1460-2075.1991.tb07860.x; Delenda C, 1998, VIROLOGY, V242, P327, DOI 10.1006/viro.1998.9027; Devaux P, 2008, J VIROL, V82, P5359, DOI 10.1128/JVI.00169-08; Fukuhara N, 2002, VIROLOGY, V299, P172, DOI 10.1006/viro.2002.1516; Geisbert TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010690; GIORGI C, 1983, CELL, V35, P829, DOI 10.1016/0092-8674(83)90115-0; Guillaume V, 2004, J VIROL, V78, P834, DOI 10.1128/JVI.78.2.834-840.2004; Gurley ES, 2007, EMERG INFECT DIS, V13, P1031, DOI 10.3201/eid1307.061128; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Hagmaier K, 2006, J GEN VIROL, V87, P3649, DOI 10.1099/vir.0.82261-0; Halpin K, 2004, J GEN VIROL, V85, P701, DOI 10.1099/vir.0.19685-0; Harcourt BH, 2000, VIROLOGY, V271, P334, DOI 10.1006/viro.2000.0340; Hausmann S, 1999, J VIROL, V73, P343, DOI 10.1128/JVI.73.1.343-351.1999; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; Homaira N, 2010, EPIDEMIOL INFECT, P1; Hooper P, 2001, MICROBES INFECT, V3, P315, DOI 10.1016/S1286-4579(01)01385-5; Horikami SM, 1996, VIROLOGY, V222, P383, DOI 10.1006/viro.1996.0435; HOVANESSIAN AG, 1987, EMBO J, V6, P1273, DOI 10.1002/j.1460-2075.1987.tb02364.x; Kato A, 1997, J VIROL, V71, P7266, DOI 10.1128/JVI.71.10.7266-7272.1997; Kato A, 1997, EMBO J, V16, P578, DOI 10.1093/emboj/16.3.578; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Kolakofsky D, 2005, J GEN VIROL, V86, P1869, DOI 10.1099/vir.0.80986-0; Kolakofsky D, 1998, J VIROL, V72, P891, DOI 10.1128/JVI.72.2.891-899.1998; Kulkarni S, 2009, J VIROL; LISTON P, 1995, J VIROL, V69, P6742, DOI 10.1128/JVI.69.11.6742-6750.1995; Lo MK, 2012, EMERG INFECT DIS, V18, P248, DOI 10.3201/eid1802.111492; Lo MK, 2011, BIOLOGY OF PARAMYXOVIRUSES, P211; Lo MK, 2010, VIROLOGY, V404, P78, DOI 10.1016/j.virol.2010.05.005; Lo MK, 2009, J GEN VIROL, V90, P398, DOI 10.1099/vir.0.007294-0; Lo MK, 2008, J CLIN VIROL; Luby SP, 2006, EMERG INFECT DIS, V12, P1888; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; Malykhina O, 2011, J VIROL, V85, P4792, DOI 10.1128/JVI.02399-10; Marianneau P, 2010, EMERG INFECT DIS, V16, P507, DOI 10.3201/eid1603.091346; Mathieu C, 2012, J VIROL; Mathieu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032157; Mathieu C, 2011, J VIROL, V85, P7863, DOI 10.1128/JVI.00549-11; Mattion NM, 1996, J VIROL, V70, P8124, DOI 10.1128/JVI.70.11.8124-8127.1996; Mayo MA, 2002, ARCH VIROL, V147, P1655, DOI 10.1007/s007050200039; Mebatsion T, 2003, J VIROL, V77, P9259, DOI 10.1128/JVI.77.17.9259-9265.2003; Middleton DJ, 2007, J COMP PATHOL, V136, P266, DOI 10.1016/j.jcpa.2007.03.002; Middleton DJ, 2002, J COMP PATHOL, V126, P124, DOI 10.1053/jcpa.2001.0532; Mungall BA, 2006, J VIROL, V80, P12293, DOI 10.1128/JVI.01619-06; Murphy SK, 1998, J VIROL, V72, P10, DOI 10.1128/JVI.72.1.10-19.1998; Nakatsu Y, 2008, J VIROL, V82, P8296, DOI 10.1128/JVI.00108-08; Nakatsu Y, 2006, J VIROL, V80, P11861, DOI 10.1128/JVI.00751-06; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Paladino P, 2006, J IMMUNOL, V177, P8008, DOI 10.4049/jimmunol.177.11.8008; Pallister J, 2009, J VIROL, V83, P11979, DOI 10.1128/JVI.01847-09; Park MS, 2003, J VIROL, V77, P1501, DOI 10.1128/JVI.77.2.1501-1511.2003; Patterson JB, 2000, VIROLOGY, V267, P80, DOI 10.1006/viro.1999.0118; Prescott J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011159; Prescott JB, 2007, J IMMUNOL, V179, P1796, DOI 10.4049/jimmunol.179.3.1796; Rahman MA, 2011, VECTOR BORNE ZOONOTI; Rahman SA, 2010, EMERG INFECT DIS, V16, P1990, DOI 10.3201/eid1612.091790; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reynes JM, 2005, EMERG INFECT DIS, V11, P1042, DOI 10.3201/eid1107.041350; Rodriguez JJ, 2004, J VIROL, V78, P5358, DOI 10.1128/JVI.78.10.5358-5367.2004; Rodriguez JJ, 2002, J VIROL, V76, P11476, DOI 10.1128/JVI.76.22.11476-11483.2002; ROTA PA, 1994, VIROLOGY, V198, P724, DOI 10.1006/viro.1994.1086; SCHALL TJ, 1988, J IMMUNOL, V141, P1018; SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401; Schneider H, 1997, VIROLOGY, V227, P314, DOI 10.1006/viro.1996.8339; Seto J, 2010, J VIROL, V84, P10965, DOI 10.1128/JVI.01335-10; Shaw ML, 2005, J VIROL, V79, P6078, DOI 10.1128/JVI.79.10.6078-6088.2005; Shaw ML, 2004, J VIROL, V78, P5633, DOI 10.1128/JVI.78.11.5633-5641.2004; Sleeman K, 2008, J GEN VIROL, V89, P1300, DOI 10.1099/vir.0.83582-0; Sparrer KMJ, 2012, J VIROL, V86, P796, DOI 10.1128/JVI.05899-11; Sweetman DA, 2001, VIROLOGY, V281, P193, DOI 10.1006/viro.2000.0805; Tapparel C, 1998, J VIROL, V72, P3117, DOI 10.1128/JVI.72.4.3117-3128.1998; Tober C, 1998, J VIROL, V72, P8124, DOI 10.1128/JVI.72.10.8124-8132.1998; Virtue ER, 2011, J VIROL, V85, P4031, DOI 10.1128/JVI.02412-10; von Messling V, 2006, J VIROL, V80, P6084, DOI 10.1128/JVI.00357-06; Wacharapluesadee S, 2005, EMERG INFECT DIS, V11, P1949, DOI 10.3201/eid1112.050613; Walpita P, 2007, J GEN VIROL, V88, P2542, DOI 10.1099/vir.0.83035-0; Weingartl HM, 2006, J VIROL, V80, P7929, DOI 10.1128/JVI.00263-06; Williamson MM, 2001, J COMP PATHOL, V124, P273, DOI 10.1053/jcpa.2001.0464; Wong KT, 2002, AM J PATHOL, V161, P2153, DOI 10.1016/S0002-9440(10)64493-8; Yoneda M, 2006, P NATL ACAD SCI USA, V103, P16508, DOI 10.1073/pnas.0606972103; Yoneda M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012709; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	96	36	37	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47790	10.1371/journal.pone.0047790	http://dx.doi.org/10.1371/journal.pone.0047790			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094089	Green Submitted, Green Published, gold			2022-12-25	WOS:000310050200046
J	Manabe, T; Hanh, TT; Lam, DM; Do, THV; Pham, TPT; Dinh, TTH; Tran, TMP; Minh, DH; Takasaki, J; Chau, NQ; Toan, LQ; Kudo, K				Manabe, Toshie; Tran Thuy Hanh; Doan Manh Lam; Do Thi Hong Van; Pham Thi Phuong Thuy; Dinh Thi Thanh Huyen; Tran Thi Mai Phuong; Dang Hung Minh; Takasaki, Jin; Ngo Quy Chau; Ly Quoc Toan; Kudo, Koichiro			Knowledge, Attitudes, Practices and Emotional Reactions among Residents of Avian Influenza (H5N1) Hit Communities in Vietnam	PLOS ONE			English	Article							A H1N1 VIRUS; HUMAN INFECTION; PNEUMONIA; CAMBODIA; MEXICO	Background: Awareness of individuals' knowledge and predicting their behavior and emotional reactions is crucial when evaluating clinical preparedness for influenza pandemics with a highly pathogenic virus. Knowledge, attitude, and practice (KAP) relating to avian influenza (H5N1) virus infection among residents in communities where H5N1 patients occurred in Vietnam has not been reported. Methods and Principal Findings: Face-to-face interviews including KAP survey were conducted in Bac Kan province, located in the northeast mountainous region of Vietnam. Participants were residents who lived in a community where H5N1 cases have ever been reported (event group, n = 322) or one where cases have not been reported (non-event group, n = 221). Data on emotional reactions of participants and healthcare-seeking behavior after the event in neighboring areas were collected as well as information on demographics and environmental measures, information sources, and KAP regarding H5N1. These data were compared between two groups. Higher environmental risk of H5N1 and improper poultry-handling behaviors were identified in the event group. At the time of the event, over 50% of the event group sought healthcare for flu-like symptoms or because they were scared. Awareness of the event influenced KAP scores. Healthcare-seeking behavior and attention to H5N1 poultry outbreaks diminished in the event group as time passed after the outbreak compared with the non-event group. Factors that motivated participants to seek healthcare sooner were knowledge of early access to healthcare and the risk of eating sick/dead poultry, and perception of the threat of H5N1. Conclusions: Awareness of H5N1 patients in neighboring areas can provoke panic in residents and influence their healthcare-seeking behavior. Periodic education to share experiences on the occurrence of H5N1 patients and provide accurate information may help prevent panic and infection and reduce mortality. Local conditions should be taken into account when emphasizing the need for early access to healthcare.	[Manabe, Toshie; Takasaki, Jin; Kudo, Koichiro] Natl Ctr Global Hlth & Med, Tokyo, Japan; [Tran Thuy Hanh; Dang Hung Minh; Ngo Quy Chau] Bach Mai Hosp, Hanoi, Vietnam; [Pham Thi Phuong Thuy; Dinh Thi Thanh Huyen; Tran Thi Mai Phuong] NCGM BMH Med Collaborat Ctr, Hanoi, Vietnam	National Center for Global Health & Medicine - Japan	Manabe, T (corresponding author), Natl Ctr Global Hlth & Med, Tokyo, Japan.	manabe@dcc.go.jp			Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by the Japan Initiative for Global Research Network on Infectious Diseases from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2010, MED PRIN PRACT, V19, P421, DOI 10.1159/000320299; [Anonymous], 2021, HUM INF AV INFL AH5N; Barennes H, 2007, EMERG INFECT DIS, V13, P1126, DOI 10.3201/eid1307.061197; Bautista E, 2010, NEW ENGL J MED, V362, P1708, DOI 10.1056/NEJMra1000449; Chotpitayasunondh T, 2005, EMERG INFECT DIS, V11, P201, DOI 10.3201/eid1102.041061; Di Giuseppe G, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-36; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; Dominguez-Cherit G, 2010, JAMA-J AM MED ASSOC, V302, P1880; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; Grijalva-Otero I, 2009, ARCH MED RES, V40, P662, DOI 10.1016/j.arcmed.2009.10.010; Hien ND, 2009, EMERG INFECT DIS, V15, P19, DOI 10.3201/eid1501.080073; Hien TT, 2004, NEW ENGL J MED, V350, P1179, DOI 10.1056/NEJMoa040419; Iglesias ALH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021838; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Leslie T, 2008, EMERG INFECT DIS, V14, P1459, DOI 10.3201/eid1409.071382; Mai TQL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003339; Manabe T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030384; Manabe T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023711; Nguyen TL, 2009, CLIN INFECT DIS, V48, P1639, DOI 10.1086/599031; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Vong S, 2008, EMERG INFECT DIS, V14, P1303, DOI 10.3201/eid1408.070912; Vong S, 2009, J INFECT DIS, V199, P1744, DOI 10.1086/599208; WHO, 2010, CUM NUMB CONF HUM CA; World Health Organization, 2010, AV INFL SIT VIETN UP; World Health Organization, 2010, WKLY EPIDEMIOL REC, V86, P161; *WORLD ORG AN HLTH, 2010, OIE DAIL UPD AV INFL; Xiang NJ, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-34; Zarychanski R, 2010, CAN MED ASSOC J, V182, P257, DOI 10.1503/cmaj.091884	28	29	30	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47560	10.1371/journal.pone.0047560	http://dx.doi.org/10.1371/journal.pone.0047560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094063	Green Published, Green Submitted, gold			2022-12-25	WOS:000310050200031
J	Poole, E; Bain, M; Teague, L; Takei, Y; Laskey, R; Sinclair, J				Poole, Emma; Bain, Mark; Teague, Linda; Takei, Yoshinori; Laskey, Ron; Sinclair, John			The Cellular Protein MCM3AP Is Required for Inhibition of Cellular DNA Synthesis by the IE86 Protein of Human Cytomegalovirus	PLOS ONE			English	Article							MINICHROMOSOME MAINTENANCE PROTEINS; IE2 86-KILODALTON PROTEIN; BOX-BINDING-PROTEIN; NF-KAPPA-B; S-PHASE; RETINOBLASTOMA PROTEIN; CYCLE PROGRESSION; GENE-EXPRESSION; NUCLEAR ANTIGEN; REPLICATION	Like all DNA viruses, human cytomegalovirus (HCMV) infection is known to result in profound effects on host cell cycle. Infection of fibroblasts with HCMV is known to induce an advance in cell cycle through the G(0)-G(1) phase and then a subsequent arrest of cell cycle in early S-phase, presumably resulting in a cellular environment optimum for high levels of viral DNA replication whilst precluding replication of cellular DNA. Although the exact mechanisms used to arrest cell cycle by HCMV are unclear, they likely involve a number of viral gene products and evidence points to the ability of the virus to prevent licensing of cellular DNA synthesis. One viral protein known to profoundly alter cell cycle is the viral immediate early 86 (IE86) protein - an established function of which is to initially drive cells into early S phase but then inhibit cellular DNA synthesis. Here we show that, although IE86 interacts with the cellular licensing factor Cdt1, it does not inhibit licensing of cellular origins. Instead, IE86-mediated inhibition of cellular DNA synthesis requires mini-chromosome-maintenance 3 (MCM3) associated protein (MCM3AP), which can cause subsequent inhibition of initiation of cellular DNA synthesis in a licensing-independent manner.	[Poole, Emma; Bain, Mark; Teague, Linda; Sinclair, John] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England; [Takei, Yoshinori; Laskey, Ron] Univ Cambridge, Hutchison MRC Res Ctr, Cambridge CB2 2QQ, England; [Takei, Yoshinori; Laskey, Ron] Univ Cambridge, Dept Zool, Cambridge CB2 2QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Cambridge	Sinclair, J (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England.	js@mole.bio.cam.ac.uk		Poole, Emma/0000-0003-3904-6121	British Medical Research Council [G0701279]; MRC [G0701279, G9202171] Funding Source: UKRI; Medical Research Council [G9202171, G0701279] Funding Source: researchfish	British Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the British Medical Research Council funding (G0701279). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe E, 2000, GENE, V255, P219, DOI 10.1016/S0378-1119(00)00336-X; Ahn JH, 2000, VIROLOGY, V274, P39, DOI 10.1006/viro.2000.0448; BEPPU T, 1994, J HISTOCHEM CYTOCHEM, V42, P1177, DOI 10.1177/42.8.7913107; Biswas N, 2003, J VIROL, V77, P2369, DOI 10.1128/JVI.77.4.2369-2376.2003; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Bonin LR, 1997, J VIROL, V71, P5861, DOI 10.1128/JVI.71.8.5861-5870.1997; Bresnahan WA, 1998, J BIOL CHEM, V273, P22075, DOI 10.1074/jbc.273.34.22075; Bryant LA, 2000, J VIROL, V74, P7230, DOI 10.1128/JVI.74.16.7230-7237.2000; Burgdorf SW, 2011, J VIROL, V85, P11098, DOI 10.1128/JVI.05315-11; CASWELL R, 1993, J GEN VIROL, V74, P2691, DOI 10.1099/0022-1317-74-12-2691; Cook JG, 2004, J BIOL CHEM, V279, P9625, DOI 10.1074/jbc.M311933200; Frouin I, 2003, J BIOL CHEM, V278, P39265, DOI 10.1074/jbc.C300098200; Gill RB, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-9; HAGEMEIER C, 1994, EMBO J, V13, P2897, DOI 10.1002/j.1460-2075.1994.tb06584.x; JUPP R, 1993, J VIROL, V67, P7539, DOI 10.1128/JVI.67.12.7539-7546.1993; Kalejta RF, 2004, J CELL BIOCHEM, V93, P37, DOI 10.1002/jcb.20177; Kapasi AJ, 2008, J VIROL, V82, P394, DOI 10.1128/JVI.01681-07; Kono Y, 2002, GENES CELLS, V7, P821, DOI 10.1046/j.1365-2443.2002.00562.x; KOTHARI S, 1991, NUCLEIC ACIDS RES, V19, P1767, DOI 10.1093/nar/19.8.1767; Kuipers MA, 2011, J CELL BIOL, V192, P29, DOI 10.1083/jcb.201007111; Li CH, 2010, PROTEIN CELL, V1, P227, DOI 10.1007/s13238-010-0032-z; Li X, 1996, EXP CELL RES, V222, P28, DOI 10.1006/excr.1996.0004; Lin DI, 2008, P NATL ACAD SCI USA, V105, P8079, DOI 10.1073/pnas.0800077105; Lu MS, 1999, J VIROL, V73, P676, DOI 10.1128/JVI.73.1.676-683.1999; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Morin J, 1996, J VIROL, V70, P6402, DOI 10.1128/JVI.70.9.6402-6404.1996; Murphy EA, 2000, J VIROL, V74, P7108, DOI 10.1128/JVI.74.15.7108-7118.2000; Noris E, 2002, J VIROL, V76, P12135, DOI 10.1128/JVI.76.23.12135-12148.2002; Pajovic S, 1997, MOL CELL BIOL, V17, P6459, DOI 10.1128/MCB.17.11.6459; Petrik DT, 2006, J VIROL, V80, P3872, DOI 10.1128/JVI.80.8.3872-3883.2006; Petrik DT, 2007, J VIROL, V81, P5807, DOI 10.1128/JVI.02437-06; PLACHTER B, 1993, VIROLOGY, V193, P642, DOI 10.1006/viro.1993.1172; Poma EE, 1996, J VIROL, V70, P7867, DOI 10.1128/JVI.70.11.7867-7877.1996; Poole E, 2006, EMBO J, V25, P4390, DOI 10.1038/sj.emboj.7601287; Poole E, 2011, J GEN VIROL, V92, P1539, DOI 10.1099/vir.0.031377-0; Poole E, 2009, J VIROL, V83, P3581, DOI 10.1128/JVI.02072-08; Prichard MN, 2008, J VIROL, V82, P5054, DOI 10.1128/JVI.02174-07; Qian Z, 2008, PLOS PATHOG, V6; Reeves M, 2006, J VIROL, V80, P9998, DOI 10.1128/JVI.01297-06; Sanchez V, 2008, CURR TOP MICROBIOL, V325, P243; Sato N, 1997, EMBO J, V16, P4340, DOI 10.1093/emboj/16.14.4340; Saxena S, 2004, MOL CELL, V15, P245, DOI 10.1016/j.molcel.2004.06.045; Shechter D, 2004, P NATL ACAD SCI USA, V101, P10845, DOI 10.1073/pnas.0404143101; Shi YL, 2007, J BIOL CHEM, V282, P9236, DOI 10.1074/jbc.M609256200; Sinclair J, 2000, J GEN VIROL, V81, P1553, DOI 10.1099/0022-1317-81-6-1553; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOMMER MH, 1994, J VIROL, V68, P6223, DOI 10.1128/JVI.68.10.6223-6231.1994; Song YJ, 2010, ACTA VIROL, V54, P125, DOI 10.4149/av_2010_02_125; Song YJ, 2005, J VIROL, V79, P2597, DOI 10.1128/JVI.79.4.2597-2603.2005; Song YJ, 2002, P NATL ACAD SCI USA, V99, P2836, DOI 10.1073/pnas.052010099; Stinski MF, 2008, CURR TOP MICROBIOL, V325, P133; Straschewski S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009174; Takei Y, 2002, J BIOL CHEM, V277, P43121, DOI 10.1074/jbc.C200442200; Takei Y, 2001, EMBO REP, V2, P119, DOI 10.1093/embo-reports/kve026; Wickramasinghe VO, 2011, J MOL BIOL, V406, P355, DOI 10.1016/j.jmb.2010.12.035; Wickramasinghe VO, 2010, CURR BIOL, V20, P25, DOI 10.1016/j.cub.2009.10.078; Wiebusch L, 2003, EMBO REP, V4, P42, DOI 10.1038/sj.embor.embor707; Wiebusch L, 2001, EMBO J, V20, P1086, DOI 10.1093/emboj/20.5.1086; Zhou J, 2005, EMBO J, V24, P1406, DOI 10.1038/sj.emboj.7600609	59	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e45686	10.1371/journal.pone.0045686	http://dx.doi.org/10.1371/journal.pone.0045686			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094019	Green Published, Green Submitted, gold			2022-12-25	WOS:000310050200004
J	Ueda, P; Tong, LL; Viedma, C; Chandy, SJ; Marrone, G; Simon, A; Lundborg, CS				Ueda, Peter; Tong, Leilei; Viedma, Cristobal; Chandy, Sujith J.; Marrone, Gaetano; Simon, Anna; Lundborg, Cecilia Stalsby			Food Marketing towards Children: Brand Logo Recognition, Food-Related Behavior and BMI among 3-13-Year-Olds in a South Indian Town	PLOS ONE			English	Article							OBESITY; OVERWEIGHT; KNOWLEDGE; THREAT	Objectives: To assess exposure to marketing of unhealthy food products and its relation to food related behavior and BMI in children aged 3-13, from different socioeconomic backgrounds in a south Indian town. Methods: Child-parent pairs (n = 306) were recruited at pediatric clinics. Exposure to food marketing was assessed by a digital logo recognition test. Children matched 18 logos of unhealthy food (high in fat/sugar/salt) featured in promotion material from the food industry to pictures of corresponding products. Children's nutritional knowledge, food preferences, purchase requests, eating behavior and socioeconomic characteristics were assessed by a digital game and parental questionnaires. Anthropometric measurements were recorded. Results: Recognition rates for the brand logos ranged from 30% to 80%. Logo recognition ability increased with age (p<0.001) and socioeconomic level (p<0.001 comparing children in the highest and lowest of three socioeconomic groups). Adjusted for gender, age and socioeconomic group, logo recognition was associated with higher BMI (p = 0.022) and nutritional knowledge (p<0.001) but not to unhealthy food preferences or purchase requests. Conclusions: Children from higher socioeconomic groups in the region had higher brand logo recognition ability and are possibly exposed to more food marketing. The study did not lend support to a link between exposure to marketing and poor eating behavior, distorted nutritional knowledge or increased purchase requests. The correlation between logo recognition and BMI warrants further investigation on food marketing towards children and its potential role in the increasing burden of non-communicable diseases in this part of India.	[Ueda, Peter; Chandy, Sujith J.; Marrone, Gaetano; Lundborg, Cecilia Stalsby] Karolinska Inst, Div Global Hlth IHCAR, Stockholm, Sweden; [Tong, Leilei] Stockholm Sch Econ, S-11383 Stockholm, Sweden; [Viedma, Cristobal] Royal Inst Technol, Stockholm, Sweden; [Chandy, Sujith J.; Simon, Anna] Christian Med Coll & Hosp, Vellore, Tamil Nadu, India	Karolinska Institutet; Stockholm School of Economics; Royal Institute of Technology; Christian Medical College & Hospital (CMCH) Vellore	Ueda, P (corresponding author), Karolinska Inst, Div Global Hlth IHCAR, Stockholm, Sweden.	peter.ueda@gmail.com	Ueda, Peter/AGH-9915-2022; Ueda, Peter/AAB-8961-2020	Ueda, Peter/0000-0002-3275-8743; Ueda, Peter/0000-0002-3275-8743; Marrone, Gaetano/0000-0002-2991-1663; Stalsby Lundborg, Cecilia/0000-0001-6525-1861	Swedish International Development Cooperation Agency	Swedish International Development Cooperation Agency	The study was funded by the Swedish International Development Cooperation Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, BUSINESS STANDARD; Berkey CS, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.4.e56; Borzekowski DLG, 2001, J AM DIET ASSOC, V101, P42, DOI 10.1016/S0002-8223(01)00012-8; CALFAS KJ, 1991, J DEV BEHAV PEDIATR, V12, P185; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Consumers International, 2008, JUNK FOOD TRAP MARKT; Escelante de Cruz A, 2004, JUNK FOOD GENERATION; FISCHER PM, 1991, JAMA-J AM MED ASSOC, V266, P3145, DOI 10.1001/jama.266.22.3145; Goyal Ramesh K, 2010, J Assoc Physicians India, V58, P151; Gupta R, 2003, J Assoc Physicians India, V51, P470; Harris JL, 2009, ANNU REV PUBL HEALTH, V30, P211, DOI 10.1146/annurev.publhealth.031308.100304; Hastings G., 2003, REV RES EFFECTS FOOD; International Institute for Population Sciences (IIPS) and Macro International, 2008, NAT FAM HLTH SURV NF; Jain Seema, 2010, Indian J Public Health, V54, P158, DOI 10.4103/0019-557X.75740; JEFFREY DB, 1982, HEALTH EDUC QUART, V9, P174; Kaur P., 2006, CHILDREN FAMILY PURC; Kelly J, 2006, BRIT FOOD J, V108, P413, DOI 10.1108/00070700610661376; Kennedy C, 2000, J Pediatr Nurs, V15, P272, DOI 10.1053/jpdn.2000.8676; Kopelman CA, 2007, J PUBLIC HEALTH-UK, V29, P358, DOI 10.1093/pubmed/fdm067; Ludwig DS, 2001, LANCET, V357, P505, DOI 10.1016/S0140-6736(00)04041-1; Ramachandran A, 2010, LANCET, V375, P408, DOI 10.1016/S0140-6736(09)60937-5; Reddy KS, 2007, J AM COLL CARDIOL, V50, P1370, DOI 10.1016/j.jacc.2007.04.097; Reddy KS, 2005, LANCET, V366, P1744, DOI [10.1016/s0140-6736(05)67343-6, 10.1016/S0140-6736(05)67343-6]; Sharma K, 2010, BUSINESS TODAY  1212; STONEMAN Z, 1981, DEV PSYCHOL, V17, P853; Vadehra S, 2010, YOUNG CONSUMERS, V11, P153; *WHO, 2010, SET REC MARK FOODS N; World Diabetes Foundation, 2011, DIAB FACTS; Wright, 1981, J APPL DEV PSYCHOL, V1, P329	29	14	14	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47000	10.1371/journal.pone.0047000	http://dx.doi.org/10.1371/journal.pone.0047000			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038AF	23082137	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000311146900032
J	Buzoianu, SG; Walsh, MC; Rea, MC; O'Donovan, O; Gelencser, E; Ujhelyi, G; Szabo, E; Nagy, A; Ross, RP; Gardiner, GE; Lawlor, PG				Buzoianu, Stefan G.; Walsh, Maria C.; Rea, Mary C.; O'Donovan, Orla; Gelencser, Eva; Ujhelyi, Gabriella; Szabo, Erika; Nagy, Andras; Ross, R. Paul; Gardiner, Gillian E.; Lawlor, Peadar G.			Effects of Feeding Bt Maize to Sows during Gestation and Lactation on Maternal and Offspring Immunity and Fate of Transgenic Material	PLOS ONE			English	Article							GENETICALLY-MODIFIED MAIZE; BACILLUS-THURINGIENSIS; HEALTH-RISKS; NON-GM; SYSTEM; DNA; BIOCHEMISTRY; MECHANISMS; MODELS; SAFETY	Background: We aimed to determine the effect of feeding transgenic maize to sows during gestation and lactation on maternal and offspring immunity and to assess the fate of transgenic material. Methodology/Principal Findings: On the day of insemination, sows were assigned to one of two treatments (n = 12/treatment); 1) non-Bt control maize diet or 2) Bt-MON810 maize diet, which were fed for similar to 143 days throughout gestation and lactation. Immune function was assessed by leukocyte phenotyping, haematology and Cry1Ab-specific antibody presence in blood on days 0, 28 and 110 of gestation and at the end of lactation. Peripheral-blood mononuclear cell cytokine production was investigated on days 28 and 110 of gestation. Haematological analysis was performed on offspring at birth (n = 12/treatment). Presence of the cry1Ab transgene was assessed in sows' blood and faeces on day 110 of gestation and in blood and tissues of offspring at birth. Cry1Ab protein presence was assessed in sows' blood during gestation and lactation and in tissues of offspring at birth. Blood monocyte count and percentage were higher (P<0.05), while granulocyte percentage was lower (P<0.05) in Bt maize-fed sows on day 110 of gestation. Leukocyte count and granulocyte count and percentage were lower (P<0.05), while lymphocyte percentage was higher (P<0.05) in offspring of Bt maize-fed sows. Bt maize-fed sows had a lower percentage of monocytes on day 28 of lactation and of CD4(+)CD8(+) lymphocytes on day 110 of gestation, day 28 of lactation and overall (P<0.05). Cytokine production was similar between treatments. Transgenic material or Cry1Ab-specific antibodies were not detected in sows or offspring. Conclusions/Significance: Treatment differences observed following feeding of Bt maize to sows did not indicate inflammation or allergy and are unlikely to be of major importance. These results provide additional data for Bt maize safety assessment.	[Buzoianu, Stefan G.; Walsh, Maria C.; Lawlor, Peadar G.] TEAGASC, Pig Dev Dept, Anim & Grassland Res & Innovat Ctr, Fermoy, Cork, Ireland; [Buzoianu, Stefan G.; O'Donovan, Orla; Gardiner, Gillian E.] Waterford Inst Technol, Dept Chem & Life Sci, Waterford, Ireland; [Rea, Mary C.; Ross, R. Paul] Teagasc Food Res Ctr, Fermoy, Cork, Ireland; [Rea, Mary C.; Ross, R. Paul] Natl Univ Ireland Univ Coll Cork, Alimentary Pharmabiot Ctr, Cork, Ireland; [Gelencser, Eva; Ujhelyi, Gabriella; Szabo, Erika; Nagy, Andras] Cent Food Res Inst, Budapest, Hungary	Teagasc; South East Technological University (SETU); Teagasc; University College Cork	Lawlor, PG (corresponding author), TEAGASC, Pig Dev Dept, Anim & Grassland Res & Innovat Ctr, Moorepk, Fermoy, Cork, Ireland.	peadar.lawlor@teagasc.ie	Ross, Paul/A-7584-2015; Stefan, Buzoianu/F-3030-2010; Erika, Koppányné Szabó/M-4548-2017; Nagy, András/M-1437-2017; Gelencser, Eva/A-2842-2013; walsh, maria/H-3662-2013	Ross, Paul/0000-0003-4876-8839; Rea, Mary/0000-0003-3782-0232; O' Donovan, Orla/0000-0003-3980-8835	European Union's Seventh Framework Programme [211820]; Teagasc Walsh Fellowship Programme	European Union's Seventh Framework Programme; Teagasc Walsh Fellowship Programme	The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 211820 and the Teagasc Walsh Fellowship Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adel-Patient K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016346; Andersson HC, 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2150; Bailey M, 2006, VET RES, V37, P443, DOI 10.1051/vetres:2006013; Bailey M, 2009, DEV COMP IMMUNOL, V33, P375, DOI 10.1016/j.dci.2008.07.003; Barros E, 2010, PLANT BIOTECHNOL J, V8, P436, DOI 10.1111/j.1467-7652.2009.00487.x; Batista R, 2010, REGUL TOXICOL PHARM, V58, pS8, DOI 10.1016/j.yrtph.2010.08.019; Betz FS, 2000, REGUL TOXICOL PHARM, V32, P156, DOI 10.1006/rtph.2000.1426; Butts CL, 2008, CELL IMMUNOL, V252, P7, DOI 10.1016/j.cellimm.2007.09.009; Chowdhury EH, 2003, J ANIM SCI, V81, P2546; de Vendomois JS, 2010, INT J BIOL SCI, V6, P590; Domingo JL, 2011, ENVIRON INT, V37, P734, DOI 10.1016/j.envint.2011.01.003; Dona A, 2009, CRIT REV FOOD SCI, V49, P164, DOI 10.1080/10408390701855993; EFSA (European Food Safety Authority). S, 2009, EFSA J, V1149, P1, DOI DOI 10.2903/J.EFSA.2009.1149; Egeli AK, 1998, ACTA VET SCAND, V39, P381; Einspanier R, 2004, EUR FOOD RES TECHNOL, V218, P269, DOI 10.1007/s00217-003-0842-9; Einspanier R, 2001, EUR FOOD RES TECHNOL, V212, P129, DOI 10.1007/s002170000248; Feldman BF., 2006, SCHALMS VET HEMATOLO; Finamore A, 2008, J AGR FOOD CHEM, V56, P11533, DOI 10.1021/jf802059w; Fonseca C, 2012, J PROTEOMICS, V75, P2027, DOI 10.1016/j.jprot.2012.01.005; Gaskell G, 2010, EUR24537 EUROPEANS B; GASKELL GSS, 2005, EUROPEANS BIOTECHNOL; Hartnell G. F., 2007, BEST PRACTICES CONDU; Helm RM, 2000, CURR OPIN IMMUNOL, V12, P647, DOI 10.1016/S0952-7915(00)00157-6; Helm RM, 2002, J ALLERGY CLIN IMMUN, V109, P136, DOI 10.1067/mai.2002.120551; HILL M, 1995, EUPHYTICA, V85, P119, DOI 10.1007/BF00023939; Janeway Jr C.A., 2001, IMMUNOBIOLOGY IMMUNE, V5th; KARARLI TT, 1995, BIOPHARM DRUG DISPOS, V16, P351, DOI 10.1002/bdd.2510160502; Lehrer SB, 2009, REGUL TOXICOL PHARM, V54, pS46, DOI 10.1016/j.yrtph.2009.01.001; Lewis AJ., 2001, SWINE NUTR, V2; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Lutz B, 2005, J AGR FOOD CHEM, V53, P1453, DOI 10.1021/jf049222x; Mazza R, 2005, TRANSGENIC RES, V14, P775, DOI 10.1007/s11248-005-0009-5; Moughan P J, 1992, World Rev Nutr Diet, V67, P40; Mukhopadhya I, 2012, NAT REV GASTRO HEPAT, V9, P219, DOI 10.1038/nrgastro.2012.14; Mundry R, 1998, ANIM BEHAV, V56, P256, DOI 10.1006/anbe.1998.0756; Murtaugh MP, 2002, VET IMMUNOL IMMUNOP, V87, P109, DOI 10.1016/S0165-2427(02)00042-9; NRC, 1998, NUTR REQ SWIN, DOI [10.17226/6016, DOI 10.17226/6016]; Osborne J., 2010, PRACTICAL ASSESSMENT, V15; Pappas PA, 2004, SESUG 2004 P SE SAS, V2004, pTU04; Patterson JK, 2008, EXP BIOL MED, V233, P651, DOI 10.3181/0709-MR-262; Poole JA, 2004, CLIN REV ALLERG IMMU, V26, P161, DOI 10.1385/CRIAI:26:3:161; Prescott VE, 2006, PHARMACOL THERAPEUT, V111, P374, DOI 10.1016/j.pharmthera.2005.10.005; Reddy J, 2000, VET IMMUNOL IMMUNOP, V74, P31, DOI 10.1016/S0165-2427(00)00164-1; Rothkotter HJ, 2009, DEV COMP IMMUNOL, V33, P267, DOI 10.1016/j.dci.2008.06.016; SAS Institute Inc, 2010, SAS STAT 9 22 US GUI; Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Snell C, 2012, FOOD CHEM TOXICOL, V50, P1134, DOI 10.1016/j.fct.2011.11.048; Szczepanik M, 2006, J PHYSIOL PHARMACOL, V57, P15; Takeshita H, 2000, BIOCHEM BIOPH RES CO, V269, P481, DOI 10.1006/bbrc.2000.2300; Trabalza-Marinucci M, 2008, LIVEST SCI, V113, P178, DOI 10.1016/j.livsci.2007.03.009; van Haver E, 2008, FOOD CHEM TOXICOL, V46, pS2, DOI 10.1016/j.fct.2008.02.008; Wal JM, 2003, REGUL TOXICOL PHARM, V38, P98, DOI 10.1016/S0273-2300(03)00079-5; Walsh MC, 2008, FEMS MICROBIOL ECOL, V64, P317, DOI 10.1111/j.1574-6941.2008.00454.x; Walsh MC, 2013, BRIT J NUTR, V109, P873, DOI 10.1017/S0007114512002607; Walsh MC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036141; Walsh MC, 2012, BRIT J NUTR, V107, P364, DOI 10.1017/S0007114511003011; Walsh MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027177; Wiedemann S, 2009, MAMM BIOL, V74, P193, DOI 10.1016/j.mambio.2008.07.002	59	25	27	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47851	10.1371/journal.pone.0047851	http://dx.doi.org/10.1371/journal.pone.0047851			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091650	Green Published, Green Submitted, gold			2022-12-25	WOS:000310135800076
J	Dwivedi, OP; Tabassum, R; Chauhan, G; Ghosh, S; Marwaha, RK; Tandon, N; Bharadwaj, D				Dwivedi, Om Prakash; Tabassum, Rubina; Chauhan, Ganesh; Ghosh, Saurabh; Marwaha, Raman K.; Tandon, Nikhil; Bharadwaj, Dwaipayan			Common Variants of FTO Are Associated with Childhood Obesity in a Cross-Sectional Study of 3,126 Urban Indian Children	PLOS ONE			English	Article							BODY-MASS INDEX; CHINESE CHILDREN; GENE; RISK; OVERWEIGHT	Background: FTO variants are robustly associated with obesity and related traits in many population and shown to have variable impact during life course. Although studies have shown association of FTO variants with adiposity in adult Indian, its association in Indian children is yet to be confirmed. Methods: Here we examined association of FTO variants (rs9939609 and rs8050136) with obesity and related anthropometric and biochemical traits in 3,126 Indian children (aged 11-17 years) including 2,230 normal-weight and 896 over-weight/obese children. We also compared effects observed in the present study with that observed in previous studies on South Asian adults and children of other ethnic groups. Results: The variant rs9939609 showed significant association with risk of obesity [OR = 1.21, P = 2.5x10(-3)] and its measures BMI, weight, waist circumference and hip circumference [beta range = 0.11 to 0.14 Z-score units; P range = 1.3x10(-4) to 1.6x10(-7)] in children. The observed effect sizes in Indian children were similar to those reported for European children. Variant rs9939609 explained 0.88% of BMI variance in Indian children. The effect sizes of rs9939609 on BMI and WC were similar to 2 fold higher in children than adults. Interestingly rs9939609 was also associated with serum levels of thyroid stimulating hormone (TSH) [beta = 0.10 Z-score, P = 5.8x10(-3)]. The other variant rs8050136 was in strong linkage disequilibrium with rs9939609 (r(2) = 0.97) and provided similar association results. Conclusion: The study provides first report of association of FTO variants with obesity and related anthropometric traits in Indian children with higher impact in children compared to adults. We also demonstrated association of FTO variant with serum levels of TSH, indicating putative influence of FTO in hypothalamic-pituitary-thyroid axis.	[Tandon, Nikhil] All India Inst Med Sci, Dept Endocrinol, New Delhi, India; [Dwivedi, Om Prakash; Tabassum, Rubina; Chauhan, Ganesh; Bharadwaj, Dwaipayan] CSIR Inst Genom & Integrat Biol, Genom & Mol Med Unit, Delhi, India; [Ghosh, Saurabh] Indian Stat Inst, Human Genet Unit, Kolkata, India; [Marwaha, Raman K.] Inst Nucl Med & Allied Sci, Dept Endocrinol & Thyroid Res, Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Indian Statistical Institute; Indian Statistical Institute Kolkata; Defence Research & Development Organisation (DRDO); Institute of Nuclear Medicine & Allied Sciences (INMAS)	Tandon, N (corresponding author), All India Inst Med Sci, Dept Endocrinol, New Delhi, India.	nikhil_tandon@hotmail.com; db@igib.res.in	Marwaha, Raman/AAQ-7475-2021; CHAUHAN, GANESH/AAI-5110-2021	Tabassum, Rubina/0000-0002-3120-3041; Chauhan, Ganesh/0000-0002-8564-5021; Marwaha, Raman/0000-0002-9698-4280; Bharadwaj, Dwaipayan/0000-0001-5268-8482	Diabetes mellitus-New drug discovery R&D, molecular mechanisms and genetic & epidemiological factors [NWP0032-OB4]; Council of Scientific and Industrial Research (CSIR), Government of India; Fogarty International Center; Eunice Kennedy Shriver National Institute of Child Health and Human Development at the National Institutes of Health [1 D43 HD065249]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [D43HD065249] Funding Source: NIH RePORTER	Diabetes mellitus-New drug discovery R&D, molecular mechanisms and genetic & epidemiological factors; Council of Scientific and Industrial Research (CSIR), Government of India(Council of Scientific & Industrial Research (CSIR) - India); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Eunice Kennedy Shriver National Institute of Child Health and Human Development at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by "Diabetes mellitus-New drug discovery R&D, molecular mechanisms and genetic & epidemiological factors" (NWP0032-OB4), funded by Council of Scientific and Industrial Research (CSIR), Government of India. RT received a postdoctoral fellowship from the Fogarty International Center and the Eunice Kennedy Shriver National Institute of Child Health and Human Development at the National Institutes of Health (1 D43 HD065249). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Biondi B, 2010, J CLIN ENDOCR METAB, V95, P3614, DOI 10.1210/jc.2010-1245; Chauhan G, 2011, J HUM GENET, V56, P720, DOI 10.1038/jhg.2011.87; Chauhan G, 2010, DIABETES, V59, P2068, DOI 10.2337/db09-1386; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Hardy R, 2010, HUM MOL GENET, V19, P545, DOI 10.1093/hmg/ddp504; INdian DIabetes COnsortium, 2011, Hugo J, V5, P65, DOI 10.1007/s11568-011-9157-2; Kilpelainen TO, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001116; Kirkpatrick CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011053; Larder R, 2011, TRENDS ENDOCRIN MET, V22, P53, DOI 10.1016/j.tem.2010.11.001; Li H, 2012, DIABETOLOGIA, V55, P981, DOI 10.1007/s00125-011-2370-7; Loos RJF, 2008, OBES REV, V9, P246, DOI 10.1111/j.1467-789X.2008.00481.x; Loos RJF, 2012, BEST PRACT RES CL EN, V26, P211, DOI 10.1016/j.beem.2011.11.003; Marwaha RK, 2006, INDIAN PEDIATR, V43, P943; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Sonestedt E, 2009, AM J CLIN NUTR, V90, P1418, DOI 10.3945/ajcn.2009.27958; Sovio U, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001307; Speliotes EK, 2010, NAT GENET, V42, P937, DOI 10.1038/ng.686; Tabassum R, 2012, DIABETES, V61, P626, DOI 10.2337/db11-1501; Vasan SK, 2012, OBESITY, V20, P2268, DOI 10.1038/oby.2012.64; Wang J, 2012, INT J OBESITY, V36, P542, DOI 10.1038/ijo.2011.218; Wen WQ, 2012, NAT GENET, V44, P307, DOI 10.1038/ng.1087; Wu LJ, 2010, DIABETES, V59, P3085, DOI 10.2337/db10-0273	27	21	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47772	10.1371/journal.pone.0047772	http://dx.doi.org/10.1371/journal.pone.0047772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091647	Green Published, Green Submitted, gold			2022-12-25	WOS:000310135800073
J	Richardson, SM; Purmessur, D; Baird, P; Ben, P; Freemont, AJ; Hoyland, JA				Richardson, Stephen M.; Purmessur, Devina; Baird, Pauline; Probyn, Ben; Freemont, Anthony J.; Hoyland, Judith A.			Degenerate Human Nucleus Pulposus Cells Promote Neurite Outgrowth in Neural Cells	PLOS ONE			English	Article							HUMAN INTERVERTEBRAL DISC; NERVE GROWTH-FACTOR; HUMAN NEUROBLASTOMA-CELLS; IN-VITRO; NEUROTROPHIC FACTOR; EXPRESSION; INGROWTH; MODEL; PROTEOGLYCAN; REGENERATION	Innervation of nociceptive nerve fibres into the normally aneural nucleus pulposus (NP) of the intervertebral disc (IVD) occurs during degeneration resulting in discogenic back pain. The neurotrophins nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), which are associated with stimulation of axonal outgrowth and nociception by neuronal cells, are both expressed by NP cells, with BDNF levels increasing with disease severity. However the mechanism of interaction between human NP cells and neural cells has yet to be fully elucidated. Therefore the aim of this study was to determine whether non-degenerate or degenerate human NP cells inhibit or stimulate neural outgrowth and whether any outgrowth is mediated by NGF or BDNF. Human NP cells from non-degenerate and degenerate IVD were cultured in alginate beads then co-cultured for 48 hours with human SH-SY5Y neuroblastoma cells. Co-culture of non-degenerate NP cells with neural cells resulted in both an inhibition of neurite outgrowth and reduction in percentage of neurite expressing cells. Conversely co-culture with degenerate NP cells resulted in an increase in both neurite length and percentage of neurite expressing cells. Addition of anti-NGF to the co-culture with degenerate cells resulted in a decrease in percentage of neurite expressing cells, while addition of anti-BDNF resulted in a decrease in both neurite length and percentage of neurite expressing cells. Our findings show that while non-degenerate NP cells are capable of inhibiting neurite outgrowth from human neural cells, degenerate NP cells stimulate outgrowth. Neurotrophin blocking studies demonstrated that both NGF and BDNF, secreted by degenerate NP cells, may play a role in this stimulation with BDNF potentially playing the predominant role. These findings suggest that NP cells are capable of regulating nerve ingrowth and that neoinnervation occurring during IVD degeneration may be stimulated by the NP cells themselves.	[Richardson, Stephen M.; Purmessur, Devina; Baird, Pauline; Probyn, Ben; Freemont, Anthony J.; Hoyland, Judith A.] Univ Manchester, Fac Med & Human Sci, Inst Inflammat & Repair, Ctr Regenerat Med, Manchester, Lancs, England	University of Manchester	Hoyland, JA (corresponding author), Univ Manchester, Fac Med & Human Sci, Inst Inflammat & Repair, Ctr Regenerat Med, Manchester, Lancs, England.	Judith.a.hoyland@manchester.ac.uk	Richardson, Stephen/A-4124-2009; Freemont, Tony J/A-9000-2015; Purmessur (Walter), Devina/J-8821-2015; Hoyland, Judith A/P-5168-2014	Richardson, Stephen/0000-0002-7637-4135; Freemont, Tony J/0000-0002-9780-208X; Hoyland, Judith A/0000-0003-4876-5208	Biotechnology and Biological Sciences Research Council (BBSRC); Pfizer via a BBSRC CASE studentship	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Pfizer via a BBSRC CASE studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by grants from the Biotechnology and Biological Sciences Research Council (BBSRC) and Pfizer via a BBSRC CASE studentship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2007, SPINE, V32, P635, DOI 10.1097/01.brs.0000257556.90850.53; BOGDUK N, 1981, J ANAT, V132, P39; Coppes MH, 1997, SPINE, V22, P2342, DOI 10.1097/00007632-199710150-00005; Freemont AJ, 1997, LANCET, V350, P178, DOI 10.1016/S0140-6736(97)02135-1; Freemont AJ, 2002, J PATHOL, V197, P286, DOI 10.1002/path.1108; Gingras M, 2003, FASEB J, V17, P2124, DOI 10.1096/fj.02-1180fje; Gruber HE, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2456; Hynds DL, 1997, J NEUROSCI RES, V47, P617, DOI 10.1002/(SICI)1097-4547(19970315)47:6<617::AID-JNR7>3.0.CO;2-G; Hynds DL, 1999, EXP NEUROL, V160, P244, DOI 10.1006/exnr.1999.7212; JACKSON HC, 1966, J BONE JOINT SURG AM, VA 48, P1272, DOI 10.2106/00004623-196648070-00002; Johnson WEB, 2002, ARTHRITIS RHEUM-US, V46, P2658, DOI 10.1002/art.10585; Johnson WEB, 2006, SPINE, V31, P1187, DOI 10.1097/01.brs.0000217669.04903.61; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275; Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732; Le Maitre CL, 2004, J PATHOL, V204, P47, DOI 10.1002/path.1608; MARTIN DM, 1993, J CELL PHYSIOL, V155, P290, DOI 10.1002/jcp.1041550210; Melrose J, 2002, SPINE, V27, P1278, DOI 10.1097/00007632-200206150-00007; Moon HJ, 2012, SPINE, V37, P2, DOI 10.1097/BRS.0b013e31820cd2d8; Olmarker K, 2005, SPINE, V30, P1501, DOI 10.1097/01.brs.0000167823.17687.ec; Orita S, 2011, SPINE, V36, P1737, DOI 10.1097/BRS.0b013e31821d7b9f; PAHLMAN S, 1984, CELL DIFFER DEV, V14, P135, DOI 10.1016/0045-6039(84)90038-1; PEREZPOLO JR, 1979, DEV BIOL, V71, P341, DOI 10.1016/0012-1606(79)90174-X; Purmessur D, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2487; Sive JI, 2002, J CLIN PATHOL-MOL PA, V55, P91, DOI 10.1136/mp.55.2.91; Snow DM, 2001, MICROSC RES TECHNIQ, V54, P273, DOI 10.1002/jemt.1140; Tang XQ, 2007, J NEUROSCI, V27, P6068, DOI 10.1523/JNEUROSCI.1442-07.2007; Tolofari SK, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2898; Yamauchi K, 2009, SPINE, V34, P2263, DOI 10.1097/BRS.0b013e3181a5521d	29	45	47	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47735	10.1371/journal.pone.0047735	http://dx.doi.org/10.1371/journal.pone.0047735			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091643	Green Published, Green Submitted, gold			2022-12-25	WOS:000310135800069
J	Yao, R; Ma, YL; Liang, W; Li, HH; Ma, ZJ; Yu, X; Liao, YH				Yao, Rui; Ma, Yu-Lan; Liang, Wei; Li, Huan-Huan; Ma, Zhi-Jun; Yu, Xian; Liao, Yu-Hua			MicroRNA-155 Modulates Treg and Th17 Cells Differentiation and Th17 Cell Function by Targeting SOCS1	PLOS ONE			English	Article							CD4(+) T-CELLS; PREVENTS DEVELOPMENT; SUPPRESSOR; STAT3; INDUCTION; ACTIVATION; EXPRESSION; RECEPTOR; ABSENCE; T(H)17	MicroRNA (miR)-155 is a critical player in both innate and adaptive immune responses. It can influence CD4(+) T cell lineage choice. To clarify the role of miR-155 in CD4(+) CD25(+) regulatory T (Treg)/T helper (Th) 17 cell differentiation and function, as well as the mechanism involved, we performed gain- and loss-of-function analysis by transfection pre-miR-155 and anti-miR155 into purified CD4+T cells. The results showed that miR-155 positively regulated both Treg and Th17 cell differentiation. It also induced the release of interleukin (IL)-17A by Th17 cells, but not the release of IL-10 and transforming growth factor (TGF)-beta 1 by Treg cells. Furthermore, we found that miR-155 reacted through regulating Janus kinase/signal transducer and activator of transcription (JAK/STAT) rather than TGF-beta/mothers against decapentaplegic homolog (SMAD) signaling pathway in the process of Treg and Th17 cells differentiation. This may because suppressors of cytokine signaling (SOCS) 1, the important negative regulator of JAK/STAT signaling pathway, was the direct target of miR-155 in this process, but SMAD2 and SMAD5 were not. Therefore, we demonstrated that miR-155 enhanced Treg and Th17 cells differentiation and IL-17A production by targeting SOCS1.	[Yao, Rui; Ma, Yu-Lan; Liang, Wei; Li, Huan-Huan; Yu, Xian; Liao, Yu-Hua] Huazhong Univ Sci & Technol, Inst Cardiol, Lab Cardiovasc Immunol, Wuhan 430074, Hubei, Peoples R China; [Ma, Zhi-Jun] Huazhong Univ Sci & Technol, Union Hosp, Dept Gen Surg, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Liao, YH (corresponding author), Huazhong Univ Sci & Technol, Inst Cardiol, Lab Cardiovasc Immunol, Wuhan 430074, Hubei, Peoples R China.	liaoyh27@163.com			National Natural Science Foundation of China [81000085]; Doctor and Novo-teacher Foundation of the Chinese National Ministry of Education [20090142120049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctor and Novo-teacher Foundation of the Chinese National Ministry of Education	The work described in this article was supported by the National Natural Science Foundation of China (No. 81000085)(http://www.nsfc.gov.cn/Portal0/default152.htm), Doctor and Novo-teacher Foundation of the Chinese National Ministry of Education (No. 20090142120049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson AS, 2009, CURR OPIN IMMUNOL, V21, P161, DOI 10.1016/j.coi.2009.03.013; Askenasy N, 2008, AUTOIMMUN REV, V7, P370, DOI 10.1016/j.autrev.2008.03.001; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Chan HC, 2010, LUPUS, V19, P696, DOI 10.1177/0961203309357437; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen W, 2002, J EXP MED, V198, P1875; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Durant L, 2010, IMMUNITY, V32, P605, DOI 10.1016/j.immuni.2010.05.003; Faraoni I, 2009, BBA-MOL BASIS DIS, V1792, P497, DOI 10.1016/j.bbadis.2009.02.013; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gomez-Guerrero C, 2004, J IMMUNOL, V172, P6969, DOI 10.4049/jimmunol.172.11.6969; Isomaki P, 2007, RHEUMATOLOGY, V46, P1538, DOI 10.1093/rheumatology/kem198; Jager LD, 2011, J NEUROIMMUNOL, V232, P108, DOI 10.1016/j.jneuroim.2010.10.018; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Kohlhaas S, 2009, J IMMUNOL, V182, P2578, DOI 10.4049/jimmunol.0803162; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Lee TL, 2006, MOL CANCER THER, V5, P8, DOI 10.1158/1535-7163.MCT-05-0069; Liu XB, 2008, J IMMUNOL, V180, P6070, DOI 10.4049/jimmunol.180.9.6070; Louafi F, 2010, J BIOL CHEM, V285, P41328, DOI 10.1074/jbc.M110.146852; Lu CM, 2011, BLOOD, V117, P4293, DOI 10.1182/blood-2010-12-322503; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; McLaren JE, 2009, CYTOKINE GROWTH F R, V20, P125, DOI 10.1016/j.cytogfr.2008.11.003; Mills KHG, 2008, EUR J IMMUNOL, V38, P2636, DOI 10.1002/eji.200838535; Mujtaba MG, 2005, J IMMUNOL, V175, P5077, DOI 10.4049/jimmunol.175.8.5077; Muljo SA, 2005, J EXP MED, V202, P261, DOI 10.1084/jem.20050678; Murugaiyan G, 2011, J IMMUNOL, V187, P2213, DOI 10.4049/jimmunol.1003952; Nahid MA, 2011, J IMMUNOL, V186, P1723, DOI 10.4049/jimmunol.1002311; Numata K, 2007, J IMMUNOL, V178, P3777, DOI 10.4049/jimmunol.178.6.3777; O Flowers L, 2005, ONCOGENE, V24, P2114, DOI 10.1038/sj.onc.1208437; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Ortiz-Munoz G, 2009, ARTERIOSCL THROM VAS, V29, P525, DOI 10.1161/ATVBAHA.108.173781; Rai D, 2010, P NATL ACAD SCI USA, V107, P3111, DOI 10.1073/pnas.0910667107; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Ruggiero T, 2009, FASEB J, V23, P2898, DOI 10.1096/fj.09-131342; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Turka LA, 2008, FRONT BIOSCI-LANDMRK, V13, P1440, DOI 10.2741/2773; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; Wei L, 2008, SEMIN CELL DEV BIOL, V19, P394, DOI 10.1016/j.semcdb.2008.07.011; Weniger MA, 2006, ONCOGENE, V25, P2679, DOI 10.1038/sj.onc.1209151; Xie JJ, 2010, CYTOKINE, V49, P185, DOI 10.1016/j.cyto.2009.09.007; Yu CR, 2011, INVEST OPHTH VIS SCI, V52, P6978, DOI 10.1167/iovs.11-7688; Yu HR, 2003, J LEUKOCYTE BIOL, V74, P952, DOI 10.1189/jlb.0902474; Zhan YF, 2009, IMMUNOL CELL BIOL, V87, P473, DOI 10.1038/icb.2009.23	46	224	249	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e46082	10.1371/journal.pone.0046082	http://dx.doi.org/10.1371/journal.pone.0046082			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091595	Green Published, Green Submitted, gold			2022-12-25	WOS:000310135800005
J	Chen, FQ; Chen, C; Yang, SL; Gong, W; Wang, Y; Cianflone, K; Tang, JR; Wang, DW				Chen, Fuqiong; Chen, Chen; Yang, Shenglan; Gong, Wei; Wang, Yan; Cianflone, Katherine; Tang, Jiarong; Wang, Dao Wen			Let-7b Inhibits Human Cancer Phenotype by Targeting Cytochrome P450 Epoxygenase 2J2	PLOS ONE			English	Article							ARACHIDONIC-ACID EPOXYGENASE; MOLECULAR-CLONING; SIGNALING PATHWAYS; TUMOR-SUPPRESSOR; CELL-GROWTH; MICRORNAS; EXPRESSION; PROLIFERATION; METABOLISM; APOPTOSIS	Background: MicroRNAs (miRNAs) are small, noncoding RNA molecules of 20 to 22 nucleotides that regulate gene expression by binding to their 39 untranslated region (3'UTR). Increasing data implicate altered miRNA participation in the progress of cancer. We previously reported that CYP2J2 epoxygenase promotes human cancer phenotypes. But whether and how CYP2J2 is regulated by miRNA is not understood. Methods and Results: Using bioinformatics analysis, we found potential target sites for miRNA let-7b in 3'UTR of human CYP2J2. Luciferase and western blot assays revealed that CYP2J2 was regulated by let-7b. In addition, let-7b decreased the enzymatic activity of endogenous CYP2J2. Furthermore, let-7b may diminish cell proliferation and promote cell apoptosis of tumor cells via posttranscriptional repression of CYP2J2. Tumor xenografts were induced in nude mice by subcutaneous injection of MDA-MB-435 cells. The let-7b expression vector, pSilencer-let-7b, was injected through tail vein every 3 weeks. Let-7b significantly inhibited the tumor phenotype by targeting CYP2J2. Moreover, quantitative real-time polymerase chain reaction and western blotting were used to determine the expression levels of let-7b and CYP2J2 protein from 18 matched lung squamous cell cancer and adjacent normal lung tissues; the expression level of CYP2J2 was inversely proportional to that of let-7b. Conclusions: Our results demonstrated that the decreased expression of let-7b could lead to the high expression of CYP2J2 protein in cancerous tissues. These findings suggest that miRNA let-7b reduces CYP2J2 expression, which may contribute to inhibiting tumor phenotypes.	[Chen, Fuqiong; Chen, Chen; Yang, Shenglan; Gong, Wei; Wang, Yan; Tang, Jiarong; Wang, Dao Wen] Huazhong Univ Sci & Technol, Dept Internal Med, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Chen, Fuqiong; Chen, Chen; Yang, Shenglan; Gong, Wei; Wang, Yan; Tang, Jiarong; Wang, Dao Wen] Huazhong Univ Sci & Technol, Gene Therapy Ctr, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Cianflone, Katherine] Univ Laval, Ctr Rech, Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ, Canada	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Laval University	Chen, FQ (corresponding author), Huazhong Univ Sci & Technol, Dept Internal Med, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China.	jrtang@tjh.tjmu.edu.cn; dwwang@tjh.tjmu.edu.cn	, Chen/R-4321-2019		National Basic Research Program "973" [2012CB517801]; NSFC [30930039, 81070236]	National Basic Research Program "973"(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC))	This work was supported by grant from the National Basic Research Program "973" (No. 2012CB517801) and NSFC (No. 30930039 and 81070236). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akao Y, 2006, BIOL PHARM BULL, V29, P903, DOI 10.1248/bpb.29.903; Bandi N, 2009, CANCER RES, V69, P5553, DOI 10.1158/0008-5472.CAN-08-4277; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Capdevila JH, 2000, J LIPID RES, V41, P163; Chen C, 2009, J PHARMACOL EXP THER, V329, P908, DOI 10.1124/jpet.109.152017; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Cheng AM, 2005, NUCLEIC ACIDS RES, V33, P1290, DOI 10.1093/nar/gki200; Enayetallah AE, 2004, J HISTOCHEM CYTOCHEM, V52, P447, DOI 10.1177/002215540405200403; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Jiang JG, 2005, CANCER RES, V65, P4707, DOI 10.1158/0008-5472.CAN-04-4173; Jiang JG, 2007, CANCER RES, V67, P6665, DOI 10.1158/0008-5472.CAN-06-3643; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; KARARA A, 1993, J BIOL CHEM, V268, P13565; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Mott JL, 2009, HEPATOLOGY, V50, P630, DOI 10.1002/hep.23010; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Schultz J, 2008, CELL RES, V18, P549, DOI 10.1038/cr.2008.45; Spector AA, 2004, PROG LIPID RES, V43, P55, DOI 10.1016/S0163-7827(03)00049-3; Wang Y, 2005, J PHARMACOL EXP THER, V314, P522, DOI 10.1124/jpet.105.083477; Wu S, 1996, J BIOL CHEM, V271, P3460; Wu S, 1997, J BIOL CHEM, V272, P12551, DOI 10.1074/jbc.272.19.12551; Yang SL, 2007, AM J PHYSIOL-HEART C, V293, pH142, DOI 10.1152/ajpheart.00783.2006; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200; Zhao YC, 2011, BREAST CANCER RES TR, V127, P69, DOI 10.1007/s10549-010-0972-2	28	25	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 25	2012	7	6							e39197	10.1371/journal.pone.0039197	http://dx.doi.org/10.1371/journal.pone.0039197			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	965QG	23082159	Green Published, gold, Green Submitted			2022-12-25	WOS:000305781700022
J	Karpinich, NO; Kechele, DO; Espenschied, ST; Willcockson, HH; Fedoriw, Y; Caron, KM				Karpinich, Natalie O.; Kechele, Daniel O.; Espenschied, Scott T.; Willcockson, Helen H.; Fedoriw, Yuri; Caron, Kathleen M.			Adrenomedullin gene dosage correlates with tumor and lymph node lymphangiogenesis	FASEB JOURNAL			English	Article						cancer; endothelial cells; metastasis; mouse models	GROWTH-FACTOR-C; VEGF-D PROMOTES; MOLECULAR-MECHANISMS; PEPTIDE RECEPTORS; METASTASIS; ANGIOGENESIS; MACROPHAGES; EXPRESSION; CELLS; CANCER	Adrenomedullin (AM) is a potent lymphangiogenic factor that promotes lymphatic endothelial cell (LEC) proliferation through a pharmacologically tractable G-protein-coupled receptor. Numerous types of human cancers have increased levels of AM; however, the functional consequences of this fact have not been characterized. Therefore, we evaluated whether modulating adrenomedullin (Adm) gene dosage within tumor cells affects lymphangiogenesis. Murine Lewis lung carcinoma (LLC) cells that overexpress or underexpress Adm were injected subcutaneously into C57BL/6 mice, and tumors were evaluated for growth and vascularization. A dosage range from similar to 10 to 200% of wild-type Adm expression did not affect LLC proliferation in vitro or in vivo, nor did it affect angiogenesis. Notably, the dosage of Adm markedly and significantly influenced tumor lymphangiogenesis. Reduced Adm expression in tumors decreased the proliferation of LECs and the number of lymphatic vessels, while elevated tumor Adm expression led to enlarged lymphatic vessels. Moreover, overexpression of Adm in tumors induced sentinel lymph node lymphangiogenesis and led to an increased incidence of Ki67-positive foci within the lung. These data show that tumor-secreted AM is a critical factor for driving both tumor and lymph node lymphangiogenesis. Thus, pharmacological targeting of AM signaling may provide a new avenue for inhibition of tumor lymphangiogenesis.-Karpinich, N. O., Kechele, D. O., Espenschied, S. T., Willcockson, H. H., Fedoriw, Y., Caron, K. M. Adrenomedullin gene dosage correlates with tumor and lymph node lymphangiogenesis. FASEB J. 27, 590-600 (2013). www.fasebj.org	[Karpinich, Natalie O.; Kechele, Daniel O.; Espenschied, Scott T.; Willcockson, Helen H.; Caron, Kathleen M.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Fedoriw, Yuri] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Caron, Kathleen M.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Caron, KM (corresponding author), Univ N Carolina, Dept Cell & Mol Physiol, 111 Mason Farm Rd,CB 7545,6330 MBRB, Chapel Hill, NC 27599 USA.	kathleen_caron@med.unc.edu	Espenschied, Scott T./AAO-2900-2020; , Histology Research Core Facility/ABF-6317-2021	Caron, Kathleen/0000-0002-7033-9232; Espenschied, Scott T./0000-0001-8885-7532; Kechele, Daniel/0000-0001-5377-1392	UNC-CH University Cancer Research Innovation Award; U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL091973]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091973] Funding Source: NIH RePORTER	UNC-CH University Cancer Research Innovation Award; U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Kirk McNaughton [University of North Carolina at Chapel Hill (UNC-CH) Histology Research Core] for assistance with tissue sectioning. This work was supported by a UNC-CH University Cancer Research Innovation Award and U.S. National Institutes of Health, National Heart, Lung, and Blood Institute grant HL091973 to K. M. C. The authors declare no conflicts of interest.	Albrecht I, 2011, INT J DEV BIOL, V55, P483, DOI 10.1387/ijdb.103226ia; Banerji S, 1999, J CELL BIOL, V144, P789, DOI 10.1083/jcb.144.4.789; Bono P, 2004, CLIN CANCER RES, V10, P7144, DOI 10.1158/1078-0432.CCR-03-0826; BreitenederGeleff S, 1997, AM J PATHOL, V151, P1141; Cao YH, 2005, NAT REV CANCER, V5, P735, DOI 10.1038/nrc1693; Caron KM, 2001, P NATL ACAD SCI USA, V98, P615, DOI 10.1073/pnas.021548898; Chen PW, 2011, CLIN CANCER RES, V17, P7230, DOI 10.1158/1078-0432.CCR-11-1354; Clasper S, 2008, CANCER RES, V68, P7293, DOI 10.1158/0008-5472.CAN-07-6506; Doods H, 2007, TRENDS PHARMACOL SCI, V28, P580, DOI 10.1016/j.tips.2007.10.005; Dunworth WP, 2008, PEPTIDES, V29, P2243, DOI 10.1016/j.peptides.2008.09.009; Dunworth WP, 2009, ARTERIOSCL THROM VAS, V29, P650, DOI 10.1161/ATVBAHA.109.185066; Fagiani E, 2011, CANCER RES, V71, P5717, DOI 10.1158/0008-5472.CAN-10-4635; Fritz-Six KL, 2008, J CLIN INVEST, V118, P40, DOI 10.1172/JCI33302; Harrell MI, 2007, AM J PATHOL, V170, P774, DOI 10.2353/ajpath.2007.060761; Hay DL, 2011, ENDOCR-RELAT CANCER, V18, pC1, DOI 10.1677/ERC-10-0244; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Hirakawa S, 2007, BLOOD, V109, P1010, DOI 10.1182/blood-2006-05-021758; Holopainen T, 2012, J NATL CANCER I, V104, P461, DOI 10.1093/jnci/djs009; Hu ZY, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-9; Ji RC, 2009, HISTOL HISTOPATHOL, V24, P377, DOI 10.14670/HH-24.377; Jin DH, 2008, CARDIOVASC RES, V80, P339, DOI 10.1093/cvr/cvn228; Karnezis T, 2012, CANCER CELL, V21, P181, DOI 10.1016/j.ccr.2011.12.026; Karpanen T, 2001, CANCER RES, V61, P1786; Kerjaschki D, 2005, J CLIN INVEST, V115, P2316, DOI 10.1172/JCI26354; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; Martinez A, 2002, J NATL CANCER I, V94, P1226; Miller MJ, 1996, J BIOL CHEM, V271, P23345; Nagaya N, 2005, AM J PHYSIOL-REG I, V288, pR1432, DOI 10.1152/ajpregu.00662.2004; NUKI C, 1993, BIOCHEM BIOPH RES CO, V196, P245, DOI 10.1006/bbrc.1993.2241; Padera TP, 2002, SCIENCE, V296, P1883, DOI 10.1126/science.1071420; Petrova TV, 2002, EMBO J, V21, P4593, DOI 10.1093/emboj/cdf470; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Qian CN, 2006, CANCER RES, V66, P10365, DOI 10.1158/0008-5472.CAN-06-2977; Ramachandran V, 2007, CANCER RES, V67, P2666, DOI 10.1158/0008-5472.CAN-06-3362; Ribatti D, 2005, PEPTIDES, V26, P1670, DOI 10.1016/j.peptides.2005.02.017; Roesli C, 2008, FASEB J, V22, P1933, DOI 10.1096/fj.07-100529; Schoppmann SF, 2002, AM J PATHOL, V161, P947, DOI 10.1016/S0002-9440(10)64255-1; Schulz P, 2011, FASEB J, V25, P3325, DOI 10.1096/fj.11-182287; Sharpe J, 2002, SCIENCE, V296, P541, DOI 10.1126/science.1068206; Shields JD, 2007, ONCOGENE, V26, P2997, DOI 10.1038/sj.onc.1210114; Skobe M, 2001, AM J PATHOL, V159, P893, DOI 10.1016/S0002-9440(10)61765-8; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Stacker SA, 2001, NAT MED, V7, P186, DOI 10.1038/84635; SUGIURA K, 1955, CANCER RES, V15, P38; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Thouennon E, 2010, ENDOCR-RELAT CANCER, V17, P637, DOI 10.1677/ERC-10-0109; Wallgard E, 2008, ARTERIOSCL THROM VAS, V28, P1469, DOI 10.1161/ATVBAHA.108.165738; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Zhao B, 2011, J HEPATO-BIL-PAN SCI, V18, P821, DOI 10.1007/s00534-011-0395-4; Zudaire E, 2003, REGUL PEPTIDES, V112, P175, DOI 10.1016/S0167-0115(03)00037-5	51	27	27	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					590	600		10.1096/fj.12-214080	http://dx.doi.org/10.1096/fj.12-214080			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23099649	Green Published			2022-12-25	WOS:000314358000018
J	Alapatt, P; Guo, FJ; Komanetsky, SM; Wang, SP; Cai, JJ; Sargsyan, A; Diaz, ER; Bacon, BT; Aryal, P; Graham, TE				Alapatt, Philomena; Guo, Fangjian; Komanetsky, Susan M.; Wang, Shuping; Cai, Jinjin; Sargsyan, Ashot; Diaz, Eduardo Rodriguez; Bacon, Brandon T.; Aryal, Pratik; Graham, Timothy E.			Liver Retinol Transporter and Receptor for Serum Retinol-binding Protein (RBP4)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATTHEW-WOOD-SYNDROME; VITAMIN-A; GENE-EXPRESSION; CELLULAR UPTAKE; RETINOL-BINDING-PROTEIN-4 LEVELS; SYNERGISTIC INDUCTION; INSULIN-RESISTANCE; GLUCOSE-TRANSPORT; MEMBRANE-RECEPTOR; ACID	Vitamin A (retinol) is absorbed in the small intestine, stored in liver, and secreted into circulation bound to serum retinol-binding protein (RBP4). Circulating retinol may be taken up by extrahepatic tissues or recycled back to liver multiple times before it is finally metabolized or degraded. Liver exhibits high affinity binding sites for RBP4, but specific receptors have not been identified. The only known high affinity receptor for RBP4, Stra6, is not expressed in the liver. Here we report discovery of RBP4 receptor-2 (RBPR2), a novel retinol transporter expressed primarily in liver and intestine and induced in adipose tissue of obese mice. RBPR2 is structurally related to Stra6 and highly conserved in vertebrates, including humans. Expression of RBPR2 in cultured cells confers high affinity RBP4 binding and retinol transport, and RBPR2 knockdown reduces RBP4 binding/retinol transport. RBPR2 expression is suppressed by retinol and retinoic acid and correlates inversely with liver retinol stores in vivo. We conclude that RBPR2 is a novel retinol transporter that potentially regulates retinol homeostasis in liver and other tissues. In addition, expression of RBPR2 in liver and fat suggests a possible role in mediating established metabolic actions of RBP4 in those tissues.	[Graham, Timothy E.] Univ Utah, Program Mol Med, Eccles Inst Human Genet, Salt Lake City, UT 84112 USA; [Alapatt, Philomena; Guo, Fangjian; Komanetsky, Susan M.; Wang, Shuping; Cai, Jinjin; Sargsyan, Ashot; Diaz, Eduardo Rodriguez; Bacon, Brandon T.; Graham, Timothy E.] Univ Utah, Dept Med, Div Endocrinol Metab & Diabet, Salt Lake City, UT 84112 USA; [Alapatt, Philomena; Guo, Fangjian; Komanetsky, Susan M.; Wang, Shuping; Cai, Jinjin; Sargsyan, Ashot; Diaz, Eduardo Rodriguez; Bacon, Brandon T.; Graham, Timothy E.] George E Wahlen Dept Vet Affairs Med Ctr, Salt Lake City, UT 84148 USA; [Aryal, Pratik] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Harvard University; Beth Israel Deaconess Medical Center	Graham, TE (corresponding author), Univ Utah, Program Mol Med, Eccles Inst Human Genet, Rm 3110A,15 N 2030 E, Salt Lake City, UT 84112 USA.	tgraham@u2m2.utah.edu	Guo, Fangjian/B-7705-2015; cai, jinjin/I-7005-2012; Sargsyan, Ashot/AAH-3724-2021	Guo, Fangjian/0000-0003-3729-2724; Sargsyan, Ashot/0000-0003-1662-7548; Bacon, Brandon/0000-0002-3793-0549; Aryal, Pratik/0000-0001-6443-8974	National Institutes of Health [R03 DK080195]; Bio-medical Laboratory Research and Development Merit Review Award from the Department of Veterans Affairs [01BX000937]; Physician Scientist Early Career Award from the Howard Hughes Medical Institute; Clinical Scientist Development Award from the Doris Duke Charitable Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R03DK080195] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bio-medical Laboratory Research and Development Merit Review Award from the Department of Veterans Affairs(US Department of Veterans Affairs); Physician Scientist Early Career Award from the Howard Hughes Medical Institute; Clinical Scientist Development Award from the Doris Duke Charitable Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by National Institutes of Health Grant R03 DK080195 (to T. E. G.). This work was also supported by a Bio-medical Laboratory Research and Development Merit Review Award from the Department of Veterans Affairs (01BX000937) (to T. E. G.) and a Physician Scientist Early Career Award from the Howard Hughes Medical Institute (to T. E. G.). Cloning of human RBPR2 orthologues (and no animal-related work) was supported by a Clinical Scientist Development Award from the Doris Duke Charitable Foundation (to T. E. G.).	Ahmad B, 1930, BIOCHEM J, V24, P27, DOI 10.1042/bj0240027; Amengual J, 2012, J BIOL CHEM, V287, P24216, DOI 10.1074/jbc.M112.353979; [Anonymous], 1990, Methods Enzymol, V189, P3; BERNHARD HP, 1973, DEV BIOL, V35, P83, DOI 10.1016/0012-1606(73)90008-0; Berry DC, 2012, BBA-MOL CELL BIOL L, V1821, P168, DOI 10.1016/j.bbalip.2011.07.002; Berry DC, 2011, P NATL ACAD SCI USA, V108, P4340, DOI 10.1073/pnas.1011115108; Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; BLANER WS, 1989, ENDOCR REV, V10, P308, DOI 10.1210/edrv-10-3-308; BLOMHOFF R, 1985, J BIOL CHEM, V260, P3571; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; Capper NS, 1930, BIOCHEM J, V24, P980, DOI 10.1042/bj0240980; CHAM BE, 1976, J LIPID RES, V17, P176; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chassaing N, 2009, HUM MUTAT, V30, pE673, DOI 10.1002/humu.21023; CHEN CC, 1977, J BIOL CHEM, V252, P5216; Chitayat D, 2007, AM J MED GENET A, V143A, P1268, DOI 10.1002/ajmg.a.31788; Cifelli CJ, 2008, J NUTR, V138, P971, DOI 10.1093/jn/138.5.971; de Vries WN, 2000, GENESIS, V26, P110, DOI 10.1002/(SICI)1526-968X(200002)26:2<110::AID-GENE2>3.0.CO;2-8; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; FARAONIO R, 1993, EUR J BIOCHEM, V211, P835, DOI 10.1111/j.1432-1033.1993.tb17616.x; Ganguly J., 1989, BIOCH VITAMIN A, P63; GJOEN T, 1987, J BIOL CHEM, V262, P10926; Golzio C, 2007, AM J HUM GENET, V80, P1179, DOI 10.1086/518177; GOODMAN DS, 1972, J LIPID RES, V13, P338; Graham TE, 2007, HORM METAB RES, V39, P717, DOI 10.1055/s-2007-985879; Graham TE, 2006, NEW ENGL J MED, V355, P1394; Hahn S, 2007, EUR J ENDOCRINOL, V157, P201, DOI 10.1530/EJE-07-0143; Isken A, 2008, CELL METAB, V7, P258, DOI 10.1016/j.cmet.2008.01.009; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; Kawaguchi R, 2008, BIOCHEMISTRY-US, V47, P5387, DOI 10.1021/bi8002082; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kawaguchi R, 2012, J MEMBRANE BIOL, V245, P731, DOI 10.1007/s00232-012-9463-1; Kawaguchi R, 2011, ACS CHEM BIOL, V6, P1041, DOI 10.1021/cb200178w; Kloeting N, 2007, CELL METAB, V6, P79, DOI 10.1016/j.cmet.2007.06.002; Kovacs P, 2007, DIABETES, V56, P3095, DOI 10.2337/db06-1647; LEID M, 1992, TRENDS BIOCHEM SCI, V17, P427, DOI 10.1016/0968-0004(92)90014-Z; LEWIS KC, 1990, J LIPID RES, V31, P1535; MATSUURA T, 1993, ARCH BIOCHEM BIOPHYS, V301, P221, DOI 10.1006/abbi.1993.1137; McGrane MM, 2007, J NUTR BIOCHEM, V18, P497, DOI 10.1016/j.jnutbio.2006.10.006; Mendoza-Parra MA, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.73; Munkhtulga L, 2007, HUM GENET, V120, P879, DOI 10.1007/s00439-006-0264-4; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; NORUM KR, 1992, AM J CLIN NUTR, V56, P735, DOI 10.1093/ajcn/56.4.735; Ost A, 2007, FASEB J, V21, P3696, DOI 10.1096/fj.07-8173com; Paschaki M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032447; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; PITOT H. C., 1964, NAT CANCER INST MONOGR, V13, P229; Qi QB, 2007, J CLIN ENDOCR METAB, V92, P4827, DOI 10.1210/jc.2007-1219; Quadro L, 2004, J LIPID RES, V45, P1975, DOI 10.1194/jlr.M400137-JLR200; RANDOLPH RK, 1991, J LIPID RES, V32, P809; Rhinn M, 2012, DEVELOPMENT, V139, P843, DOI 10.1242/dev.065938; Robinson JF, 2012, TOXICOL SCI, V126, P242, DOI 10.1093/toxsci/kfr342; Schnitzer Jay J, 2004, Semin Pediatr Surg, V13, P37, DOI 10.1053/j.sempedsurg.2003.09.006; Senoo H, 2007, VITAM HORM, V75, P131, DOI 10.1016/S0083-6729(06)75006-3; SHEPHERD PR, 1993, J BIOL CHEM, V268, P22243; Shirakami Y, 2012, BBA-MOL CELL BIOL L, V1821, P124, DOI 10.1016/j.bbalip.2011.06.023; SIVAPRASADARAO A, 1988, BIOCHEM J, V255, P571; Slavotinek AM, 2011, MOL GENET METAB, V104, P448, DOI 10.1016/j.ymgme.2011.09.029; SMELAND S, 1995, BIOCHEM J, V305, P419, DOI 10.1042/bj3050419; STGEORGE S, 1954, SCIENCE, V120, P463; Sun H, 2011, INT REV CEL MOL BIO, V288, P1, DOI 10.1016/B978-0-12-386041-5.00001-7; Szeto W, 2001, CANCER RES, V61, P4197; Tanumihardjo SA, 2011, AM J CLIN NUTR, V94, p658S, DOI 10.3945/ajcn.110.005777; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tice DA, 2002, J BIOL CHEM, V277, P14329, DOI 10.1074/jbc.M200334200; TSUTSUMI C, 1992, J BIOL CHEM, V267, P1805; van Hoek M, 2008, DIABETOLOGIA, V51, P1423, DOI 10.1007/s00125-008-1042-8; Venable CL, 2000, J BIOL CHEM, V275, P18318, DOI 10.1074/jbc.M908392199; Vogel S, 2000, J LIPID RES, V41, P882; Wang YP, 2002, ARCH BIOCHEM BIOPHYS, V401, P235, DOI 10.1016/S0003-9861(02)00043-7; Wu Y, 2009, J LIPID RES, V50, P1479, DOI 10.1194/jlr.P900014-JLR200; Yamamoto Y, 1997, EXP CELL RES, V234, P373, DOI 10.1006/excr.1997.3642; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zanotti G, 2004, VITAM HORM, V69, P271, DOI 10.1016/S0083-6729(04)69010-8	76	81	85	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 11	2013	288	2					1250	1265		10.1074/jbc.M112.369132	http://dx.doi.org/10.1074/jbc.M112.369132			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	071ES	23105095	hybrid, Green Published			2022-12-25	WOS:000313570300045
J	Dobierzewska, A; Shi, LH; Karakashian, AA; Nikolova-Karakashian, MN				Dobierzewska, Aneta; Shi, Lihua; Karakashian, Alexander A.; Nikolova-Karakashian, Mariana N.			Interleukin 1 beta Regulation of FoxO1 Protein Content and Localization EVIDENCE FOR A NOVEL CERAMIDE-DEPENDENT MECHANISM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR SUBSTRATE-1; PLECKSTRIN HOMOLOGY DOMAIN; TRANSCRIPTION FACTOR FOXO1; NEUTRAL SPHINGOMYELINASE-2; OXIDATIVE STRESS; LIFE-SPAN; PKC-ZETA; JNK; PHOSPHORYLATION; RESISTANCE	FoxO1 transcription factor controls the glucose and lipid metabolism, as well as cell proliferation and stress response. Akt, activated by insulin and other growth factors, phosphorylates FoxO1 causing its nuclear export and activity suppression. In this manuscript, we show that IL-1 beta, a pro-inflammatory cytokine, has the opposite effects on FoxO1. IL-1 beta stimulation of primary rat hepatocytes and HEK293 cells overexpressing the IL-1 beta receptor (293-IL-1RI) results in increased nuclear and cytosolic FoxO1 protein but not mRNA levels. IL-1 beta stimulation also elevates the levels of a mutant FoxO1 that is resistant to Akt phosphorylation. This suggests that an Akt-independent mechanism is involved. Co-stimulation with insulin does not affect the IL-1 beta induction of FoxO1. The IL-1 beta effects on FoxO1 are counteracted, however, by the silencing or inhibition of neutral sphingomyelinase 2 (nSMase-2) using shRNAi, scyphostatin, or GW4869, as well as by the pharmacological inhibition of JNK and ERK. Reversely, the overexpression of nSMase-2 through adenovirus-mediated gene transfer potentiates, in a JNK- and ERK-dependent manner, the IL-1 beta effects. We also show that transcription of insulin-like growth factor-binding protein-1 mRNA, which requires active FoxO1, is stimulated by IL-1 beta and is suppressed by the inhibition of nSMase-2 and JNK. In conclusion, we propose that IL-1 beta regulates FoxO1 activity through a novel nSMase-2-dependent pathway.	[Nikolova-Karakashian, Mariana N.] Univ Kentucky, Coll Med, AB Chandler Med Ctr, Dept Physiol, Lexington, KY 40536 USA	University of Kentucky	Nikolova-Karakashian, MN (corresponding author), Univ Kentucky, Coll Med, AB Chandler Med Ctr, Dept Physiol, 800 Rose St, Lexington, KY 40536 USA.	mnikolo@uky.edu			National Institutes of Health [AG019223]; NATIONAL INSTITUTE ON AGING [R56AG019223, R01AG019223, R01AG026711] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grant AG019223 (to M. N. K.).	Arboleda G, 2007, EUR J NEUROSCI, V25, P3030, DOI 10.1111/j.1460-9568.2007.05557.x; Bartolome N, 2008, INNATE IMMUN-LONDON, V14, P255, DOI 10.1177/1753425908094718; Chen YJ, 2007, J BIOL CHEM, V282, P27215, DOI 10.1074/jbc.M700264200; Cheng ZY, 2011, ANTIOXID REDOX SIGN, V14, P649, DOI 10.1089/ars.2010.3370; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Dobierzewska A, 2011, J BIOL CHEM, V286, P32064, DOI 10.1074/jbc.M111.238030; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Fox TE, 2007, J BIOL CHEM, V282, P12450, DOI 10.1074/jbc.M700082200; Giltiay NV, 2005, J LIPID RES, V46, P2497, DOI 10.1194/jlr.M500337-JLR200; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hajduch E, 2008, BIOCHEM J, V410, P369, DOI 10.1042/BJ20070936; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Jager J, 2007, ENDOCRINOLOGY, V148, P241, DOI 10.1210/en.2006-0692; Jia GH, 2011, EXP MOL PATHOL, V90, P1, DOI 10.1016/j.yexmp.2010.11.001; Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JCI32914, 10.1172/JC132914]; KANETY H, 1995, J BIOL CHEM, V270, P23780, DOI 10.1074/jbc.270.40.23780; Karakashian AA, 2004, FASEB J, V18, P968, DOI 10.1096/fj.03-0875fje; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; Kim JA, 2005, J BIOL CHEM, V280, P23173, DOI 10.1074/jbc.M501439200; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; NikolovaKarakashian M, 1997, J BIOL CHEM, V272, P18718, DOI 10.1074/jbc.272.30.18718; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Rutkute K, 2007, J LIPID RES, V48, P2443, DOI 10.1194/jlr.M700227-JLR200; Rutkute K, 2007, HEPATOLOGY, V46, P1166, DOI 10.1002/HEP.21777; Rutkute K, 2007, BIOCHEM BIOPH RES CO, V361, P263, DOI 10.1016/j.bbrc.2007.06.079; SANDBERG JO, 1994, BIOCHEM BIOPH RES CO, V202, P543, DOI 10.1006/bbrc.1994.1962; Sauter NS, 2008, ENDOCRINOLOGY, V149, P2208, DOI 10.1210/en.2007-1059; Senf SM, 2011, AM J PHYSIOL-CELL PH, V300, pC1490, DOI 10.1152/ajpcell.00255.2010; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; Stratford S, 2001, BIOCHEM J, V354, P359, DOI 10.1042/0264-6021:3540359; Sunayama J, 2005, J CELL BIOL, V170, P295, DOI 10.1083/jcb.200409117; Tsuruta F, 2004, EMBO J, V23, P1889, DOI 10.1038/sj.emboj.7600194; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Werner ED, 2004, J BIOL CHEM, V279, P35298, DOI 10.1074/jbc.M405203200; Wesche H, 1997, IMMUNITY, V7, P837, DOI 10.1016/S1074-7613(00)80402-1; Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200; Yoshida K, 2005, NAT CELL BIOL, V7, P278, DOI 10.1038/ncb1228; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620	44	14	15	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44749	44760		10.1074/jbc.M112.378836	http://dx.doi.org/10.1074/jbc.M112.378836			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23105097	hybrid, Green Published			2022-12-25	WOS:000312938600069
J	Goksenin, AY; Zahurancik, W; LeCompte, KG; Taggart, DJ; Suo, Z; Pursell, ZF				Goeksenin, A. Yasemin; Zahurancik, Walter; LeCompte, Kimberly G.; Taggart, David J.; Suo, Zucai; Pursell, Zachary F.			Human DNA Polymerase epsilon Is Able to Efficiently Extend from Multiple Consecutive Ribonucleotides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AICARDI-GOUTIERES-SYNDROME; YEAST REPLICATIVE POLYMERASES; SACCHAROMYCES-CEREVISIAE; RNA-POLYMERASE; MITOCHONDRIAL-DNA; GENOME INTEGRITY; MISMATCH REPAIR; TOPOISOMERASE 1; IN-VIVO; DISCRIMINATION	Replicative DNA polymerases (Pols) help to maintain the high fidelity of replication in large part through their strong selectivity against mispaired deoxyribonucleotides. It has recently been demonstrated that several replicative Pols from yeast have surprisingly low selectivity for deoxyribonucleotides over their analogous ribonucleotides. In human cells, ribonucleotides are found in great abundance over deoxyribonucleotides, raising the possibility that ribonucleotides are incorporated in the human genome at significant levels during normal cellular functions. To address this possibility, the ability of human DNA polymerase epsilon to incorporate ribonucleotides was tested. At physiological concentrations of nucleotides, human Pol epsilon readily inserts and extends from incorporated ribonucleotides. Almost half of inserted ribonucleotides escape proofreading by 3' -> 5' exonuclease-proficient Pol epsilon, indicating that ribonucleotide incorporation by Pol epsilon is likely a significant event in human cells. Human Pol epsilon is also efficient at extending from primers terminating in up to five consecutive ribonucleotides. This efficient extension appears to result from reduced exonuclease activity on primers containing consecutive 3'-terminal ribonucleotides. These biochemical properties suggest that Pol epsilon is a likely source of ribonucleotides in human genomic DNA.	[Goeksenin, A. Yasemin; LeCompte, Kimberly G.; Pursell, Zachary F.] Tulane Univ, Dept Biochem & Mol Biol, Sch Med, New Orleans, LA 70112 USA; [Goeksenin, A. Yasemin; LeCompte, Kimberly G.; Pursell, Zachary F.] Tulane Univ, Tulane Canc Ctr, Sch Med, New Orleans, LA 70112 USA; [Zahurancik, Walter; Taggart, David J.; Suo, Zucai] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA	Tulane University; Tulane University; University System of Ohio; Ohio State University	Pursell, ZF (corresponding author), Tulane Univ, Dept Biochem & Mol Biol, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA.	zpursell@tulane.edu		Goksenin, Alexandra Yasemin/0000-0002-1120-1356; Pursell, Zachary/0000-0001-5871-7192; Zahurancik, Walter/0000-0002-0084-3644	National Institutes of Health [ES016780, RR020152, GM079403]; Tulane University; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020152] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R00ES016780] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079403, P20GM103518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tulane University; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants ES016780 and RR020152 (to Z. F. P.) and GM079403 (to Z. S.). This work was also supported by Tulane University start-up funds (to Z. F. P.).	Albertson TM, 2009, P NATL ACAD SCI USA, V106, P17101, DOI 10.1073/pnas.0907147106; Bonnin A, 1999, J MOL BIOL, V290, P241, DOI 10.1006/jmbi.1999.2900; Brown JA, 2011, BIOCHEMISTRY-US, V50, P1135, DOI 10.1021/bi101915z; Brown JA, 2010, J MOL BIOL, V395, P282, DOI 10.1016/j.jmb.2009.11.003; Bubeck D, 2011, NUCLEIC ACIDS RES, V39, P3652, DOI 10.1093/nar/gkq980; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Cavanaugh NA, 2010, J BIOL CHEM, V285, P24457, DOI 10.1074/jbc.M110.132407; Chabes A, 2003, CELL, V112, P391, DOI 10.1016/S0092-8674(03)00075-8; Chen JJZ, 2000, NUCLEIC ACIDS RES, V28, P3649, DOI 10.1093/nar/28.18.3649; Clark AB, 2011, DNA REPAIR, V10, P476, DOI 10.1016/j.dnarep.2011.02.001; CLAYTON DA, 1982, CELL, V28, P693, DOI 10.1016/0092-8674(82)90049-6; Coffin SR, 2011, J BIOL CHEM, V286, P16984, DOI 10.1074/jbc.M111.228833; Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842; EDER PS, 1991, J BIOL CHEM, V266, P6472; Ferraro P, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1141; Frank P, 1998, BIOL CHEM, V379, P1407, DOI 10.1515/bchm.1998.379.12.1407; Fuste JM, 2010, MOL CELL, V37, P67, DOI 10.1016/j.molcel.2009.12.021; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; Hiller B, 2012, J EXP MED, V209, P1419, DOI 10.1084/jem.20120876; Jeong HS, 2004, NUCLEIC ACIDS RES, V32, P407, DOI 10.1093/nar/gkh209; Joyce CM, 1997, P NATL ACAD SCI USA, V94, P1619, DOI 10.1073/pnas.94.5.1619; Kasiviswanathan R, 2011, J BIOL CHEM, V286, P31490, DOI 10.1074/jbc.M111.252460; Kim N, 2011, SCIENCE, V332, P1561, DOI 10.1126/science.1205016; Kleczkowska HE, 2001, GENE DEV, V15, P724, DOI 10.1101/gad.191201; Kokoska RJ, 2003, J BIOL CHEM, V278, P50537, DOI 10.1074/jbc.M308515200; Korona DA, 2011, NUCLEIC ACIDS RES, V39, P1763, DOI 10.1093/nar/gkq1034; Kumar D, 2011, NUCLEIC ACIDS RES, V39, P1360, DOI 10.1093/nar/gkq829; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Kunkel TA, 2008, TRENDS CELL BIOL, V18, P521, DOI 10.1016/j.tcb.2008.08.005; Kunkel TA, 2011, CURR OPIN CHEM BIOL, V15, P620, DOI 10.1016/j.cbpa.2011.07.025; Lin TC, 2001, BIOCHEMISTRY-US, V40, P8749, DOI 10.1021/bi0105936; Lippert MJ, 2011, P NATL ACAD SCI USA, V108, P698, DOI 10.1073/pnas.1012363108; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P21070, DOI 10.1073/pnas.1013048107; McElhinny SAN, 2010, NAT CHEM BIOL, V6, P774, DOI [10.1038/NCHEMBIO.424, 10.1038/nchembio.424]; McElhinny SAN, 2010, P NATL ACAD SCI USA, V107, P4949, DOI 10.1073/pnas.0914857107; Moon AF, 2007, DNA REPAIR, V6, P1709, DOI 10.1016/j.dnarep.2007.05.009; Pavlov YI, 2001, GENETICS, V159, P47; Perrino FW, 2009, J MOL MED-JMM, V87, P25, DOI 10.1007/s00109-008-0422-3; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; Qiu JZ, 1999, MOL CELL BIOL, V19, P8361, DOI 10.1128/mcb.19.12.8361; Reijns MAM, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.011; Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373; Ruiz JF, 2003, NUCLEIC ACIDS RES, V31, P4441, DOI 10.1093/nar/gkg637; SYVAOJA J, 1990, P NATL ACAD SCI USA, V87, P6664, DOI 10.1073/pnas.87.17.6664; Takahashi T, 2011, P NATL ACAD SCI USA, V108, P692, DOI 10.1073/pnas.1012582108; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Watt DL, 2011, DNA REPAIR, V10, P897, DOI 10.1016/j.dnarep.2011.05.009; Williams JS, 2012, DNA REPAIR, V11, P649, DOI 10.1016/j.dnarep.2012.05.004; Zenkin N, 2008, CELL MOL LIFE SCI, V65, P2280, DOI 10.1007/s00018-008-8020-7	49	44	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42675	42684		10.1074/jbc.M112.422733	http://dx.doi.org/10.1074/jbc.M112.422733			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23093410	Green Published, hybrid			2022-12-25	WOS:000312501600028
J	Sapio, MR; Salzmann, A; Vessaz, M; Crespel, A; Lyons, PJ; Malafosse, A; Fricker, LD				Sapio, Matthew R.; Salzmann, Annick; Vessaz, Monique; Crespel, Arielle; Lyons, Peter J.; Malafosse, Alain; Fricker, Lloyd D.			Naturally Occurring Carboxypeptidase A6 Mutations EFFECT ON ENZYME FUNCTION AND ASSOCIATION WITH EPILEPSY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FEBRILE SEIZURES-PLUS; LOBE EPILEPSY; SCN1A; GENE; VARIANT; IDENTIFICATION; POPULATION; PREVALENCE	Carboxypeptidase A6 (CPA6) is a member of the A/B subfamily of M14 metallocarboxypeptidases that is expressed in brain and many other tissues during development. Recently, two mutations in human CPA6 were associated with febrile seizures and/or temporal lobe epilepsy. In this study we screened for additional CPA6 mutations in patients with febrile seizures and focal epilepsy, which encompasses the temporal lobe epilepsy subtype. Mutations found from this analysis as well as CPA6 mutations reported in databases of single nucleotide polymorphisms were further screened by analysis of the modeled proCPA6 protein structure and the functional role of the mutated amino acid. The point mutations predicted to affect activity and/or protein folding were tested by expression of the mutant in HEK293 cells and analysis of the resulting CPA6 protein. Common polymorphisms in CPA6 were also included in this analysis. Several mutations resulted in reduced enzyme activity or CPA6 protein levels in the extracellular matrix. The mutants with reduced extracellular CPA6 protein levels showed normal levels of 50-kDa proCPA6 in the cell, and this could be converted into 37-kDa CPA6 by trypsin, suggesting that protein folding was not greatly affected by the mutations. Interestingly, three of the mutations that reduced extracellular CPA6 protein levels were found in patients with epilepsy. Taken together, these results provide further evidence for the involvement of CPA6 mutations in human epilepsy and reveal additional rare mutations that inactivate CPA6 and could, therefore, also be associated with epileptic phenotypes.	[Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Sapio, Matthew R.; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Salzmann, Annick; Malafosse, Alain] Univ Geneva, Dept Psychiat, CH-1205 Geneva, Switzerland; [Vessaz, Monique; Malafosse, Alain] Univ Hosp Geneva, Dept Genet Med & Lab, CH-1205 Geneva, Switzerland; [Crespel, Arielle] Montpellier Univ Hosp, Dept Neurol, Montpellier, France; [Lyons, Peter J.] Andrews Univ, Dept Biol, Berrien Springs, MI 49104 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Geneva; University of Geneva; Universite de Montpellier; CHU de Montpellier; Andrews University	Fricker, LD (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	lloyd.fricker@einstein.yu.edu	Sapio, Matthew R/J-5096-2016	Sapio, Matthew R/0000-0002-8855-5419; Lyons, Peter/0000-0001-5214-5445; Salzmann, Annick/0000-0003-0571-251X	National Institutes of Health [DA-004494]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grant DA-004494 (to L. D. F.)	[Anonymous], 1980, PEDIATRICS, V66, P1009; [Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Baulac S, 2004, LANCET NEUROL, V3, P421, DOI 10.1016/S1474-4422(04)00808-7; Chen H, 2001, HUM MUTAT, V18, P120, DOI 10.1002/humu.1161; Desmet FO, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp215; Dibbens LM, 2010, ANN NEUROL, V67, P542, DOI 10.1002/ana.21909; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P360, DOI 10.1002/gepi.10264; Escayg A, 2010, EPILEPSIA, V51, P1650, DOI 10.1111/j.1528-1167.2010.02640.x; FALCONER MA, 1964, ARCH NEUROL-CHICAGO, V10, P233, DOI 10.1001/archneur.1964.00460150003001; Fontenele-Neto JD, 2005, MOL BRAIN RES, V137, P132, DOI 10.1016/j.molbrainres.2005.02.026; Hauser WA, 1996, MAYO CLIN PROC, V71, P576, DOI 10.4065/71.6.576; HAUSER WA, 1994, EPILEPSIA, V35, pS1, DOI 10.1111/j.1528-1157.1994.tb05932.x; Kang JQ, 2009, J NEUROSCI, V29, P2845, DOI 10.1523/JNEUROSCI.4772-08.2009; Kim YH, 2001, PROTEIN ENG, V14, P343, DOI 10.1093/protein/14.5.343; Le Gal F, 2011, EPILEPSIA, V52, pE135, DOI 10.1111/j.1528-1167.2011.03164.x; Liao WP, 2010, EPILEPSIA, V51, P1669, DOI 10.1111/j.1528-1167.2010.02645.x; Lossin C, 2009, BRAIN DEV-JPN, V31, P114, DOI 10.1016/j.braindev.2008.07.011; Lyons PJ, 2008, J BIOL CHEM, V283, P7054, DOI 10.1074/jbc.M707680200; Lyons PJ, 2010, J BIOL CHEM, V285, P38234, DOI 10.1074/jbc.M110.158626; Lyons PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012967; Montgomery J, 2007, NAT PROTOC, V2, P59, DOI 10.1038/nprot.2007.10; Moulard B, 2001, BRAIN RES REV, V36, P275, DOI 10.1016/S0165-0173(01)00104-7; Mulley JC, 2005, HUM MOL GENET, V14, pR243, DOI 10.1093/hmg/ddi355; Nakayama J, 2009, BRAIN DEV-JPN, V31, P359, DOI 10.1016/j.braindev.2008.11.014; OTTMAN R, 1989, EPILEPSIA, V30, P107, DOI 10.1111/j.1528-1157.1989.tb05290.x; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Phillips MA, 1996, BIOCHEMISTRY-US, V35, P6771, DOI 10.1021/bi960113o; Pizzuti A, 2002, INVEST OPHTH VIS SCI, V43, P3609; RICH SS, 1987, AM J HUM GENET, V41, P249; Roshal D, 2011, EPILEPSY BEHAV, V21, P206, DOI 10.1016/j.yebeh.2011.03.003; Salzmann Annick, 2012, Epilepsy Res Treat, V2012, P863702, DOI 10.1155/2012/863702; Salzmann A, 2012, HUM MUTAT, V33, P124, DOI 10.1002/humu.21613; SANDER JWAS, 1990, LANCET, V336, P1267, DOI 10.1016/0140-6736(90)92959-L; Schlachter K, 2009, NEUROLOGY, V72, P974, DOI 10.1212/01.wnl.0000344401.02915.00; Stern Curt, 1943, SCIENCE, V97, P137, DOI 10.1126/science.97.2510.137; Taylor CF, 2009, BIOCHEM SOC T, V37, P433, DOI 10.1042/BST0370433; Tzoulis C, 2006, BRAIN, V129, P1685, DOI 10.1093/brain/awl097; Vendrell J, 2000, BBA-PROTEIN STRUCT M, V1477, P284, DOI 10.1016/S0167-4838(99)00280-0; Volkers L, 2011, EUR J NEUROSCI, V34, P1268, DOI 10.1111/j.1460-9568.2011.07826.x; Wallace H, 1998, LANCET, V352, P1970, DOI 10.1016/S0140-6736(98)04512-7; Wei SW, 2002, J BIOL CHEM, V277, P14954, DOI 10.1074/jbc.M112254200; Winterthun S, 2005, NEUROLOGY, V64, P1204, DOI 10.1212/01.WNL.0000156516.77696.5A; Wojdacz TK, 2008, NAT PROTOC, V3, P1903, DOI 10.1038/nprot.2008.191; Gomis-Ruth FX, 2008, CRIT REV BIOCHEM MOL, V43, P319, DOI 10.1080/10409230802376375 ; Gomis-Ruth FX, 2012, BBA-PROTEINS PROTEOM, V1824, P157, DOI 10.1016/j.bbapap.2011.04.014	45	15	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42900	42909		10.1074/jbc.M112.414094	http://dx.doi.org/10.1074/jbc.M112.414094			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105115	Green Published, hybrid			2022-12-25	WOS:000312501600048
J	Tashiro, Y; Urushitani, M; Inoue, H; Koike, M; Uchiyama, Y; Komatsu, M; Tanaka, K; Yamazaki, M; Abe, M; Misawa, H; Sakimura, K; Ito, H; Takahashi, R				Tashiro, Yoshitaka; Urushitani, Makoto; Inoue, Haruhisa; Koike, Masato; Uchiyama, Yasuo; Komatsu, Masaaki; Tanaka, Keiji; Yamazaki, Maya; Abe, Manabu; Misawa, Hidemi; Sakimura, Kenji; Ito, Hidefumi; Takahashi, Ryosuke			Motor Neuron-specific Disruption of Proteasomes, but Not Autophagy, Replicates Amyotrophic Lateral Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; DNA-BINDING PROTEIN; SUPEROXIDE-DISMUTASE; PARKINSONS-DISEASE; NEURODEGENERATIVE DISEASE; MOUSE MODEL; CRE RECOMBINASE; TRANSGENIC MICE; CELL-DEATH; TDP-43	Evidence suggests that protein misfolding is crucially involved in the pathogenesis of amyotrophic lateral sclerosis (ALS). However, controversy still exists regarding the involvement of proteasomes or autophagy in ALS due to previous conflicting results. Here, we show that impairment of the ubiquitin-proteasome system, but not the autophagy-lysosome system in motor neurons replicates ALS in mice. Conditional knock-out mice of the proteasome subunit Rpt3 in a motor neuron-specific manner (Rpt3-CKO) showed locomotor dysfunction accompanied by progressive motor neuron loss and gliosis. Moreover, diverse ALS-linked proteins, including TAR DNA-binding protein 43 kDa (TDP-43), fused in sarcoma (FUS), ubiquilin 2, and optineurin were mislocalized or accumulated in motor neurons, together with other typical ALS hallmarks such as basophilic inclusion bodies. On the other hand, motor neuron-specific knock-out of Atg7, a crucial component for the induction of autophagy (Atg7-CKO), only resulted in cytosolic accumulation of ubiquitin and p62, and no TDP-43 or FUS pathologies or motor dysfunction was observed. These results strongly suggest that proteasomes, but not autophagy, fundamentally govern the development of ALS in which TDP-43 and FUS proteinopathy may play a crucial role. Enhancement of proteasome activity may be a promising strategy for the treatment of ALS.	[Ito, Hidefumi] Wakayama Med Univ, Dept Neurol, Grad Sch Med, Wakayama 6418510, Japan; [Tashiro, Yoshitaka; Takahashi, Ryosuke] Kyoto Univ, Dept Neurol, Grad Sch Med, Kyoto 6068507, Japan; [Urushitani, Makoto] Shiga Univ Med Sci, Mol Neurosci Res Ctr, Unit Neurobiol & Therapeut, Shiga 5202192, Japan; [Inoue, Haruhisa] Kyoto Univ, Inst Integrated Cell Mat Sci, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan; [Koike, Masato; Uchiyama, Yasuo] Juntendo Univ, Dept Cell Biol & Neurosci, Grad Sch Med, Tokyo 1138421, Japan; [Komatsu, Masaaki] Tokyo Metropolitan Inst Med Sci, Protein Metab Project, Tokyo 1568506, Japan; [Yamazaki, Maya; Abe, Manabu; Sakimura, Kenji] Niigata Univ, Brain Res Inst, Dept Cellular Neurobiol, Niigata 9518585, Japan; [Misawa, Hidemi] Keio Univ, Dept Pharmacol, Fac Pharm, Tokyo 1058512, Japan; [Takahashi, Ryosuke] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol CREST, Saitama 3320012, Japan	Wakayama Medical University; Kyoto University; Shiga University of Medical Science; Kyoto University; Juntendo University; Tokyo Metropolitan Institute of Medical Science; Niigata University; Keio University; Japan Science & Technology Agency (JST)	Ito, H (corresponding author), Wakayama Med Univ, Dept Neurol, Grad Sch Med, 811-1 Kimiidera, Wakayama 6418510, Japan.	ito@wakayama-med.ac.jp; ryosuket@kuhp.kyoto-u.ac.jp	Koike, Masato/F-9584-2010; Yamazaki, Maya/C-6952-2012; Komatsu, Masaaki/B-8321-2011	Koike, Masato/0000-0002-3174-5684; Komatsu, Masaaki/0000-0001-7672-7722; Urushitani, Makoto/0000-0003-2773-9836; Inoue, Haruhisa/0000-0003-4736-9537	Japan Society for the Promotion of Science [21500336, 24300132]; Ministry of Education, Culture, Sports, Science and Technology of Japan [22110007, 23111002]; Funding Program for Next Generation World-Leading Researchers [L132]; Japan Science and Technology Agency [AS2211173G]; Research Committee of CNS Degenerative Diseases and Comprehensive Research on Disability Health and Welfare, the Ministry of Health, Labour and Welfare of Japan; Japan Science and Technology Agency; Core Research for Evolutional Science and Technology; Grants-in-Aid for Scientific Research [23300131] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Funding Program for Next Generation World-Leading Researchers(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Research Committee of CNS Degenerative Diseases and Comprehensive Research on Disability Health and Welfare, the Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for scientific research from the Japan Society for the Promotion of Science (21500336 and 24300132), Grants-in-Aid for scientific research on Innovative Areas Foundation of Synapse and Neurocircuit Pathology (22110007), Brain Environment (23111002), and Comprehensive Brain Science Network) from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Funding Program for Next Generation World-Leading Researchers (L132), the Japan Science and Technology Agency (AS2211173G), the Research Committee of CNS Degenerative Diseases and Comprehensive Research on Disability Health and Welfare, the Ministry of Health, Labour and Welfare of Japan, Japan Science and Technology Agency, and Core Research for Evolutional Science and Technology.	Aquilano K, 2003, J NEUROCHEM, V85, P1324, DOI 10.1046/j.1471-4159.2003.01783.x; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Bentmann E, 2012, J BIOL CHEM, V287, P23079, DOI 10.1074/jbc.M111.328757; Bhattacharya A, 2012, NEUROBIOL AGING, V33, P1829, DOI 10.1016/j.neurobiolaging.2011.06.002; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Casciati A, 2002, J NEUROCHEM, V83, P1019, DOI 10.1046/j.1471-4159.2002.01232.x; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Da Cruz S, 2011, CURR OPIN NEUROBIOL, V21, P904, DOI 10.1016/j.conb.2011.05.029; DEMARTINO GN, 1994, J BIOL CHEM, V269, P20878; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Droggiti A, 2011, J NEUROCHEM, V119, P630, DOI 10.1111/j.1471-4159.2011.07444.x; Fornai F, 2008, P NATL ACAD SCI USA, V105, P2052, DOI 10.1073/pnas.0708022105; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Hadano S, 2001, NAT GENET, V29, P166, DOI 10.1038/ng1001-166; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harris H, 2012, NAT REV NEUROL, V8, P108, DOI 10.1038/nrneurol.2011.200; Kabuta T, 2006, J BIOL CHEM, V281, P30524, DOI 10.1074/jbc.M603337200; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kim SH, 2010, J BIOL CHEM, V285, P34097, DOI 10.1074/jbc.M110.154831; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Koike M, 2008, AM J PATHOL, V172, P454, DOI 10.2353/ajpath.2008.070876; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lang-Rollin I, 2005, APOPTOSIS, V10, P809, DOI 10.1007/s10495-005-0378-5; Lang-Rollin I, 2004, J NEUROCHEM, V90, P1511, DOI 10.1111/j.1471-4159.2004.02684.x; Lee J.A., 2012, EXP NEUROBIOL, V21, P1, DOI DOI 10.5607/EN.2012.21.1.1; Lee M, 2001, FREE RADICAL BIO MED, V31, P1550, DOI 10.1016/S0891-5849(01)00633-5; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; Matsui H, 2010, J NEUROCHEM, V115, P178, DOI 10.1111/j.1471-4159.2010.06918.x; McNaught KSP, 2002, NEUROSCI LETT, V326, P155, DOI 10.1016/S0304-3940(02)00296-3; Misawa H, 2003, GENESIS, V37, P44, DOI 10.1002/gene.10224; Mishina M, 2007, NEUROSCI RES, V58, P105, DOI 10.1016/j.neures.2007.01.004; MIZUSAWA H, 1989, ACTA NEUROPATHOL, V79, P37, DOI 10.1007/BF00308955; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; OKAMOTO K, 1991, ACTA NEUROPATHOL, V81, P610, DOI 10.1007/BF00296370; Papadeas ST, 2011, P NATL ACAD SCI USA, V108, P17803, DOI 10.1073/pnas.1103141108; Rideout HJ, 2005, J NEUROCHEM, V93, P1304, DOI 10.1111/j.1471-4159.2005.03124.x; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; Sakao Y, 2000, GENOMICS, V67, P1, DOI 10.1006/geno.2000.6231; Takeuchi T, 2002, BIOCHEM BIOPH RES CO, V293, P953, DOI 10.1016/S0006-291X(02)00321-2; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Tsvetkov AS, 2010, P NATL ACAD SCI USA, V107, P16982, DOI 10.1073/pnas.1004498107; Urushitani M, 2002, J NEUROCHEM, V83, P1030, DOI 10.1046/j.1471-4159.2002.01211.x; Urushitani M, 2007, P NATL ACAD SCI USA, V104, P2495, DOI 10.1073/pnas.0606201104; Urushitani M, 2010, J NEUROSCI RES, V88, P784, DOI 10.1002/jnr.22243; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vlug AS, 2004, AMYOTROPH LATERAL SC, V5, P16, DOI 10.1080/14660820310016804; Wahl C, 2008, J NEURAL TRANSM, V115, P1141, DOI 10.1007/s00702-008-0054-3; Wang HQ, 2008, J NEUROCHEM, V107, P171, DOI 10.1111/j.1471-4159.2008.05607.x; Wang IF, 2012, P NATL ACAD SCI USA, V109, P15024, DOI 10.1073/pnas.1206362109; Wang XJ, 2010, NEUROSCI LETT, V469, P112, DOI 10.1016/j.neulet.2009.11.055; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zhang XJ, 2011, AUTOPHAGY, V7, P412, DOI 10.4161/auto.7.4.14541	61	129	131	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42984	42994		10.1074/jbc.M112.417600	http://dx.doi.org/10.1074/jbc.M112.417600			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23095749	Green Published, hybrid, Green Submitted			2022-12-25	WOS:000312501600055
J	Baaklini, I; Wong, MJH; Hantouche, C; Patel, Y; Shrier, A; Young, JC				Baaklini, Imad; Wong, Michael J. H.; Hantouche, Christine; Patel, Yogita; Shrier, Alvin; Young, Jason C.			The DNAJA2 Substrate Release Mechanism Is Essential for Chaperone-mediated Folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FINGER-LIKE REGION; I HSP40; POTASSIUM CHANNEL; CRYSTAL-STRUCTURE; HSP70 CHAPERONES; YEAST HSP40; PROTEIN; YDJ1; BINDING; HSC70	DNAJA1 (DJA1/Hdj2) and DNAJA2 (DJA2) are the major J domain partners of human Hsp70/Hsc70 chaperones. Although they have overall similarity with the well characterized type I co-chaperones from yeast and bacteria, they are biologically distinct, and their functional mechanisms are poorly characterized. We identified DJA2-specific activities in luciferase folding and repression of human ether-a-go-go-related gene (HERG) trafficking that depended on its expression levels in cells. Mutations in different internal domains of DJA2 abolished these effects. Using purified proteins, we addressed the mechanistic defects. A mutant lacking the region between the zinc finger motifs (DJA2-Delta m2) was able to bind substrate similar to wild type but was incapable of releasing substrate during its transfer to Hsc70. The equivalent mutation in DJA1 also abolished its substrate release. A DJA2 mutant (DJA-221), which had its C-terminal dimerization region replaced by that of DJA1, was inactive but retained its ability to release substrate. The release mechanism required the J domain and ATP hydrolysis by Hsc70, although the nucleotide dependence diverged between DJA2 and DJA1. Limited proteolysis suggested further conformational differences between the two wild-type co-chaperones and the mutants. Our results demonstrate an essential role of specific DJA domains in the folding mechanism of Hsc70.	[Baaklini, Imad; Wong, Michael J. H.; Patel, Yogita; Young, Jason C.] McGill Univ, Dept Biochem, Montreal, PQ H3G 0B1, Canada; [Hantouche, Christine; Shrier, Alvin] McGill Univ, Dept Physiol, Montreal, PQ H3G 0B1, Canada; Grp Rech Axe Struct Prot, Montreal, PQ H3G 0B1, Canada	McGill University; McGill University	Young, JC (corresponding author), McGill Univ, Dept Biochem, 3649 Promenade Sir William Osler, Montreal, PQ H3G 0B1, Canada.	jason.young2@mcgill.ca			Canadian Institutes of Health Research; Groupe de Recherche Axe sur la Structure des Proteines; McGill Training Program in Systems Biology	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Groupe de Recherche Axe sur la Structure des Proteines; McGill Training Program in Systems Biology	This work was supported in part by the Canadian Institutes of Health Research.; Supported by a fellowship from Groupe de Recherche Axe sur la Structure des Proteines.; Supported by a scholarship from the McGill Training Program in Systems Biology.	Akhavan A, 2005, J CELL SCI, V118, P2803, DOI 10.1242/jcs.02423; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Banecki B, 1996, J BIOL CHEM, V271, P14840, DOI 10.1074/jbc.271.25.14840; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Bhangoo MK, 2007, MOL BIOL CELL, V18, P3414, DOI 10.1091/mbc.E07-01-0088; Borges JC, 2005, J BIOL CHEM, V280, P13671, DOI 10.1074/jbc.M408349200; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI 10.1016/j.febsiet.2007.05.039; Fan CY, 2005, J BIOL CHEM, V280, P695, DOI 10.1074/jbc.M410645200; Fewell SW, 2004, J BIOL CHEM, V279, P51131, DOI 10.1074/jbc.M404857200; Ficker E, 2003, CIRC RES, V92, pE87, DOI 10.1161/01.RES.0000079028.31393.15; Flom GA, 2008, MOL BIOL CELL, V19, P5249, DOI 10.1091/mbc.E08-04-0435; Hageman J, 2011, BIOCHEM J, V435, P127, DOI 10.1042/BJ20101247; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Inobe T, 2003, J MOL BIOL, V329, P121, DOI 10.1016/S0022-2836(03)00409-1; Jiang JW, 2005, MOL CELL, V20, P513, DOI 10.1016/j.molcel.2005.09.028; Jin Y, 2008, EMBO J, V27, P2873, DOI 10.1038/emboj.2008.207; Johnson JL, 2001, J CELL BIOL, V152, P851, DOI 10.1083/jcb.152.4.851; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kota P, 2009, P NATL ACAD SCI USA, V106, P11073, DOI 10.1073/pnas.0900746106; Li JZ, 2003, STRUCTURE, V11, P1475, DOI 10.1016/j.str.2003.10.012; Linke K, 2003, J BIOL CHEM, V278, P44457, DOI 10.1074/jbc.M307491200; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Michels AA, 1997, J BIOL CHEM, V272, P33283, DOI 10.1074/jbc.272.52.33283; MILARSKI KL, 1989, J CELL BIOL, V109, P1947, DOI 10.1083/jcb.109.5.1947; OBrien MC, 1996, J BIOL CHEM, V271, P15874, DOI 10.1074/jbc.271.27.15874; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Petrova K, 2008, EMBO J, V27, P2862, DOI 10.1038/emboj.2008.199; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Ramos CHI, 2008, J MOL BIOL, V383, P155, DOI 10.1016/j.jmb.2008.08.019; Rosales-Hernandez A, 2009, CELL STRESS CHAPERON, V14, P71, DOI 10.1007/s12192-008-0056-y; Schneider C, 1996, P NATL ACAD SCI USA, V93, P14536, DOI 10.1073/pnas.93.25.14536; Smith CA, 1996, BIOCHEMISTRY-US, V35, P5404, DOI 10.1021/bi952633+; Summers DW, 2009, J BIOL CHEM, V284, P3628, DOI 10.1074/jbc.M807369200; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Terada K, 2000, J BIOL CHEM, V275, P24728, DOI 10.1074/jbc.M002021200; Terada K, 2010, J BIOL CHEM, V285, P16789, DOI 10.1074/jbc.M110.101501; Tzankov S, 2008, J BIOL CHEM, V283, P27100, DOI 10.1074/jbc.M803923200; Walker VE, 2007, J BIOL CHEM, V282, P23509, DOI 10.1074/jbc.M701006200; Walker VE, 2010, J BIOL CHEM, V285, P3319, DOI 10.1074/jbc.M109.024000; Wu YK, 2005, J MOL BIOL, V346, P1005, DOI 10.1016/j.jmb.2004.12.040; Young JC, 2010, BIOCHEM CELL BIOL, V88, P291, DOI [10.1139/o09-175, 10.1139/O09-175]	42	29	30	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41939	41954		10.1074/jbc.M112.413278	http://dx.doi.org/10.1074/jbc.M112.413278			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23091061	Green Published, hybrid			2022-12-25	WOS:000312103000034
J	Tu-Sekine, B; Raben, DM				Tu-Sekine, Becky; Raben, Daniel M.			Dual Regulation of Diacylglycerol Kinase (DGK)-theta POLYBASIC PROTEINS PROMOTE ACTIVATION BY PHOSPHOLIPIDS AND INCREASE SUBSTRATE AFFINITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDIC-ACID; PLASMA-MEMBRANE; ALPHA; THETA; RAS; ORGANIZATION; ENDOCYTOSIS; RECEPTORS; PEPTIDES; FAMILY	Diacylglycerol kinases are important mediators of lipid signaling cascades, and insight into their regulation is of increasing interest. Using purified DGK-theta, we show that this isoform is subject to dual regulation and that the previously characterized stimulation by acidic phospholipids is dependent on the presence of a positively charged protein or peptide. Polybasic cofactors lowered the K-m for diacylglycerol at the membrane surface (K-m(surf)), and worked synergistically with acidic phospholipids to increase activity 10- to 30-fold, suggesting that the purified enzyme is autoinhibited. Vesicle pulldown studies showed that acidic phospholipids recruit polybasic cofactors to the vesicle surface but have little effect on the membrane association of DGK-theta, suggesting that a triad of enzyme, acidic lipid and basic protein are necessary for interfacial activity. Importantly, these data demonstrate that the interfacial association and catalytic activity of DGK-theta are independently regulated. Finally, we show that DGK-theta directly interacts with, and is activated by, basic proteins such as histone H1 and Tau with nM affinity, consistent with a potential role for a polybasic protein or protein domain in the activation of this enzyme.	[Tu-Sekine, Becky; Raben, Daniel M.] Johns Hopkins Sch Med, Dept Biol Chem, Baltimore, MD 20120 USA	Johns Hopkins University; Johns Hopkins Medicine	Raben, DM (corresponding author), Johns Hopkins Sch Med, Dept Biol Chem, 725 N Wolfe St, Baltimore, MD 20120 USA.	draben@jhmi.edu			National Institutes of Health [GM059251]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059251] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077923] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by Grant GM059251 from the National Institutes of Health (to D. M. R.).	Allen D, 2007, J NEUROSCI, V27, P2369, DOI 10.1523/JNEUROSCI.3565-06.2007; Brose N, 2004, CURR OPIN NEUROBIOL, V14, P328, DOI 10.1016/j.conb.2004.05.006; de Turco EBR, 2001, P NATL ACAD SCI USA, V98, P4740, DOI 10.1073/pnas.081536298; Flores I, 1996, J BIOL CHEM, V271, P10334, DOI 10.1074/jbc.271.17.10334; Fuchs B, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-20; Golebiewska U, 2006, BIOPHYS J, V91, P588, DOI 10.1529/biophysj.106.081562; Hasegawa H, 2008, J CELL BIOCHEM, V105, P756, DOI 10.1002/jcb.21873; Houssa B, 1999, J BIOL CHEM, V274, P6820, DOI 10.1074/jbc.274.11.6820; Jones DR, 2000, FEBS LETT, V476, P160, DOI 10.1016/S0014-5793(00)01702-6; Kawasaki T, 2008, BIOCHEM J, V409, P471, DOI 10.1042/BJ20070755; Kiselev VY, 2011, BIOPHYS J, V100, P1261, DOI 10.1016/j.bpj.2011.01.025; Leach NT, 2007, AM J HUM GENET, V80, P792, DOI 10.1086/513019; Los AP, 2006, J BIOL CHEM, V281, P858, DOI 10.1074/jbc.M502693200; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McMullan R, 2006, GENE DEV, V20, P65, DOI 10.1101/gad.359706; MEGGIO F, 1994, BIOCHEMISTRY-US, V33, P4336, DOI 10.1021/bi00180a030; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Mills JC, 1998, J CELL SCI, V111, P625; Perez-Victoria I, 2011, BBA-BIOMEMBRANES, V1808, P717, DOI 10.1016/j.bbamem.2010.11.031; Rainero E, 2012, J CELL BIOL, V196, P277, DOI 10.1083/jcb.201109112; Regier DS, 2005, P NATL ACAD SCI USA, V102, P7595, DOI 10.1073/pnas.0500663102; Rincon E, 2007, MOL CELL PROTEOMICS, V6, P1073, DOI 10.1074/mcp.M700047-MCP200; Royle SJ, 2005, J CELL SCI, V118, P3073, DOI 10.1242/jcs.02451; Tabellini G, 2003, EXP CELL RES, V287, P143, DOI 10.1016/S0014-4827(03)00115-0; Topham MK, 2009, BBA-GEN SUBJECTS, V1790, P416, DOI 10.1016/j.bbagen.2009.01.010; Tu-Sekine B, 2007, BIOCHEMISTRY-US, V46, P924, DOI 10.1021/bi061170c; Tu-Sekine B, 2011, CRIT REV BIOCHEM MOL, V46, P353, DOI 10.3109/10409238.2011.577761; van Baal J, 2005, J BIOL CHEM, V280, P9870, DOI 10.1074/jbc.M409301200; Walker AJ, 2001, BIOCHEM J, V353, P129, DOI 10.1042/bj3530129; Watanabe H, 2010, J NEUROSCI, V30, P655, DOI 10.1523/JNEUROSCI.3214-09.2010; Williams CL, 2003, CELL SIGNAL, V15, P1071, DOI 10.1016/S0898-6568(03)00098-6; Yang J, 2011, EMBO J, V30, P165, DOI 10.1038/emboj.2010.286; Zha YY, 2006, NAT IMMUNOL, V7, P1166, DOI 10.1038/ni1394	33	10	13	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41619	41627		10.1074/jbc.M112.404855	http://dx.doi.org/10.1074/jbc.M112.404855			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23091060	Green Published, hybrid			2022-12-25	WOS:000312103000006
J	Igo, RP; Kopplin, LJ; Joseph, P; Truitt, B; Fondran, J; Bardenstein, D; Aldave, AJ; Croasdale, CR; Price, MO; Rosenwasser, M; Lass, JH; Iyengar, SK				Igo, Robert P., Jr.; Kopplin, Laura J.; Joseph, Peronne; Truitt, Barbara; Fondran, Jeremy; Bardenstein, David; Aldave, Anthony J.; Croasdale, Christopher R.; Price, Marianne O.; Rosenwasser, Miriam; Lass, Jonathan H.; Iyengar, Sudha K.		FECD Genetics Multi-Ctr Study Grp	Differing Roles for TCF4 and COL8A2 in Central Corneal Thickness and Fuchs Endothelial Corneal Dystrophy	PLOS ONE			English	Article							MISSENSE MUTATIONS; SLC4A11 MUTATIONS; GENE; COLLAGEN; POLYMORPHISMS; ASSOCIATION; LOCUS; HERITABILITY; VARIANTS; PROTEIN	Fuchs endothelial corneal dystrophy (FECD) is the most common late-onset, vision-threatening corneal dystrophy in the United States, affecting about 4% of the population. Advanced FECD involves a thickening of the cornea from stromal edema and changes in Descemet membrane. To understand the relationship between FECD and central corneal thickness (CCT), we characterized common genetic variation in COL8A2 and TCF4, genes previously implicated in CCT and/or FECD. Other genes previously associated with FECD (PITX2, ZEB1, SLC4A11), and genes only known to affect CCT (COL5A1, FOXO1, AVGR8, ZNF469) were also interrogated. FECD probands, relatives and controls were recruited from 32 clinical sites; a total of 532 cases and 204 controls were genotyped and tested for association of FECD case/control status, a 7-step FECD severity scale and CCT, adjusting for age and sex. Association of FECD grade with TCF4 was highly significant (OR = 6.01 at rs613872; p = 4.8 x 10(-25)), and remained significant when adjusted for changes in CCT (OR = 4.84; p = 2.2 x 10(-16)). Association of CCT with TCF4 was also significant (p = 6.1 x 10(-7)), but was abolished with adjustment for FECD grade (p = 0.92). After adjusting for FECD grade, markers in other genes examined were modestly associated (p similar to 0.001) with FECD and/or CCT. Thus, common variants in TCF4 appear to influence FECD directly, and CCT secondarily via FECD. Additionally, changes in corneal thickness due to the effect of other loci may modify disease severity, age-at-onset, or other biomechanical characteristics.	[Igo, Robert P., Jr.; Joseph, Peronne; Truitt, Barbara; Fondran, Jeremy; Lass, Jonathan H.; Iyengar, Sudha K.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Kopplin, Laura J.] Casey Eye Inst, Dept Ophthalmol, Portland, OR USA; [Kopplin, Laura J.; Bardenstein, David; Lass, Jonathan H.; Iyengar, Sudha K.] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44106 USA; [Kopplin, Laura J.; Bardenstein, David; Lass, Jonathan H.; Iyengar, Sudha K.] Univ Hosp Cleveland, Inst Eye, Cleveland, OH 44106 USA; [Aldave, Anthony J.] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Aldave, Anthony J.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Croasdale, Christopher R.] David Duehr Dean Clin, Madison, WI USA; [Price, Marianne O.] Price Vis Grp, Indianapolis, IN USA; [Rosenwasser, Miriam] Cent Penn Eye Inst, Hershey, PA USA; [Iyengar, Sudha K.] Case Western Reserve Univ, Dept Genet, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Case Western Reserve University	Iyengar, SK (corresponding author), Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA.	ski@case.edu	Igo, Rob/P-3438-2019; /S-1190-2019	Igo, Rob/0000-0002-0024-1993; /0000-0001-7488-250X; Price, Marianne/0000-0002-6652-534X	National Eye Institute [R01EY16482, R21 EY015145, P30 EY11373]; Research to Prevent Blindness; Ohio Lions Eye Research Foundation; U.S. Public Health Service Resource Grant from the National Center for Research Resources [RR03655]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR003655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016482, R21EY015145, P30EY011373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007250] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Ohio Lions Eye Research Foundation; U.S. Public Health Service Resource Grant from the National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Eye Institute (grant numbers R01EY16482, R21 EY015145, P30 EY11373), Research to Prevent Blindness and the Ohio Lions Eye Research Foundation. Some of the results of this paper were obtained by using the program package S.A.G.E., which is supported by a U.S. Public Health Service Resource Grant (RR03655) from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu A, 2008, AM J HUM GENET, V82, P1217, DOI 10.1016/j.ajhg.2008.04.001; Afshari NA, 2009, INVEST OPHTH VIS SCI, V50, P1093, DOI 10.1167/iovs.08-1839; Aldave AJ, 2007, AM J MED GENET A, V143A, P2549, DOI 10.1002/ajmg.a.31978; Aldave AJ, 2006, INVEST OPHTH VIS SCI, V47, P3787, DOI 10.1167/iovs.05-1635; ALSBIRK PH, 1978, ACTA OPHTHALMOL, V56, P105; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Asai-Coakwell M, 2006, INVEST OPHTH VIS SCI, V47, P4905, DOI 10.1167/iovs.06-0457; Baratz KH, 2010, NEW ENGL J MED, V363, P1016, DOI 10.1056/NEJMoa1007064; Biswas S, 2001, HUM MOL GENET, V10, P2415, DOI 10.1093/hmg/10.21.2415; Bohnsack BL, 2012, INVEST OPHTH VIS SCI, V53, P7, DOI 10.1167/iovs.11-8494; Charlesworth J, 2010, INVEST OPHTH VIS SCI, V50, P4087; Chen MH, 2010, BIOINFORMATICS, V26, P580, DOI 10.1093/bioinformatics/btp710; Chen W, 2010, P NATL ACAD SCI USA, V107, P7401, DOI 10.1073/pnas.0912702107; de Bakker PIW, 2005, NAT GENET, V37, P1217, DOI 10.1038/ng1669; Desir J, 2007, J MED GENET, V44, P322, DOI 10.1136/jmg.2006.046904; Desronvil T, 2010, MOL VIS, V16, P2185; Ehlers N, 1998, ACTA OPHTHALMOL SCAN, V76, P314, DOI 10.1034/j.1600-0420.1998.760312.x; Eye Bank Association of America, 2010, STAT REP; Gottsch JD, 2006, CORNEA, V25, P485, DOI 10.1097/01.ico.0000178726.11693.14; Gottsch JD, 2005, INVEST OPHTH VIS SCI, V46, P4504, DOI 10.1167/iovs.05-0497; Gottsch JD, 2005, INVEST OPHTH VIS SCI, V46, P1934, DOI 10.1167/iovs.04-0937; Gutti V, 2010, OCULAR DIS MECH MANA; Hemadevi B, 2010, BMC OPHTHALMOL, V10, DOI 10.1186/1471-2415-10-3; Hopfer U, 2005, FASEB J, V19, P1232, DOI 10.1096/fj.04-3019com; Jiao XD, 2007, J MED GENET, V44, P64, DOI 10.1136/jmg.2006.044644; Jostins L, 2011, HUM MOL GENET, V20, pR182, DOI 10.1093/hmg/ddr378; Jun AS, 2012, HUM MOL GENET, V21, P384, DOI 10.1093/hmg/ddr473; Kniestedt C, 2006, OPHTHALMOLOGY, V113, P1791, DOI 10.1016/j.ophtha.2006.05.017; Kobayashi A, 2004, JPN J OPHTHALMOL, V48, P195, DOI 10.1007/s10384-003-0063-6; Kopplin LJ, 2012, ARCH OPHTHALMOL-CHIC, V130, P433, DOI 10.1001/archopthalmol.2011.1626; KRACHMER JH, 1978, ARCH OPHTHALMOL-CHIC, V96, P2036, DOI 10.1001/archopht.1978.03910060424004; Krafchak CM, 2005, AM J HUM GENET, V77, P694, DOI 10.1086/497348; Kuot A, 2012, EUR J HUM GENET, V20, P632, DOI 10.1038/ejhg.2011.248; Landers JA, 2009, INVEST OPHTH VIS SCI, V50, P4087, DOI 10.1167/iovs.08-3271; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Li YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018044; Liskova P, 2007, HUM MUTAT, V28, DOI 10.1002/humu.9495; Liskova P, 2010, OPHTHALMIC GENET, V31, P230, DOI 10.3109/13816810.2010.518577; Louttit MD, 2012, CORNEA, V31, P26, DOI 10.1097/ICO.0b013e31821c9b8f; Lu R, 2012, STEM CELLS, V30, P753, DOI 10.1002/stem.1032; Lu Y, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000947; Mackey DA, 2012, CORNEA, V31, P162, DOI 10.1097/ICO.0b013e318226155f; Mehta JS, 2008, INVEST OPHTH VIS SCI, V49, P184, DOI 10.1167/iovs.07-0847; Mok JW, 2009, EYE, V23, P895, DOI 10.1038/eye.2008.116; Musch DC, 2011, INVEST OPHTH VIS SCI, V52, P6959, DOI 10.1167/iovs.11-7771; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Puk O, 2009, INVEST OPHTH VIS SCI, V50, P5653, DOI 10.1167/iovs.09-3550; Ramprasad Vedam L, 2007, Hum Mutat, V28, P522, DOI 10.1002/humu.9487; Riazuddin SA, 2012, AM J HUM GENET, V90, P533, DOI 10.1016/j.ajhg.2012.01.013; Riazuddin SA, 2011, INVEST OPHTH VIS SCI, V52, P2825, DOI 10.1167/iovs.10-6497; Riazuddin SA, 2010, HUM MUTAT, V31, P1261, DOI 10.1002/humu.21356; Riazuddin SA, 2010, AM J HUM GENET, V86, P45, DOI 10.1016/j.ajhg.2009.12.001; S.A.G.E, 2011, STAT ANAL GENETIC EP; Sanchez-Tillo E, 2011, P NATL ACAD SCI USA, V108, P19204, DOI 10.1073/pnas.1108977108; Schaid DJ, 2004, GENET EPIDEMIOL, V27, P348, DOI 10.1002/gepi.20037; Shimizu S, 2004, AM J MED GENET A, V130A, P372, DOI 10.1002/ajmg.a.30267; Sundin OH, 2006, INVEST OPHTH VIS SCI, V47, P3919, DOI 10.1167/iovs.05-1619; Thalamuthu A, 2011, INVEST OPHTH VIS SCI, V52, P5573, DOI 10.1167/iovs.11-7568; Toh TY, 2005, INVEST OPHTH VIS SCI, V46, P3718, DOI 10.1167/iovs.04-1497; Vincent AL, 2009, MOL VIS, V15, P2544; Vitart V, 2010, HUM MOL GENET, V19, P4304, DOI 10.1093/hmg/ddq349; Vithana EN, 2008, HUM MOL GENET, V17, P656, DOI 10.1093/hmg/ddm337; Vithana EN, 2006, NAT GENET, V38, P755, DOI 10.1038/ng1824; Vithana EN, 2011, HUM MOL GENET, V20, P649, DOI 10.1093/hmg/ddq511; WILSON SE, 1988, AM J OPHTHALMOL, V106, P270, DOI 10.1016/0002-9394(88)90360-1; Wright EMMB, 2011, AM J HUM GENET, V88, P767, DOI 10.1016/j.ajhg.2011.05.007; Zheng YF, 2008, INVEST OPHTH VIS SCI, V49, P4303, DOI 10.1167/iovs.08-1934	67	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e46742	10.1371/journal.pone.0046742	http://dx.doi.org/10.1371/journal.pone.0046742			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110055	Green Submitted, Green Published, gold			2022-12-25	WOS:000310193600005
J	Oh, MC; Kim, JM; Safaee, M; Kaur, G; Sun, MZ; Kaur, R; Celli, A; Mauro, TM; Parsa, AT				Oh, Michael C.; Kim, Joseph M.; Safaee, Michael; Kaur, Gurvinder; Sun, Matthew Z.; Kaur, Rajwant; Celli, Anna; Mauro, Theodora M.; Parsa, Andrew T.			Overexpression of Calcium-Permeable Glutamate Receptors in Glioblastoma Derived Brain Tumor Initiating Cells	PLOS ONE			English	Article							NEWLY-DIAGNOSED GLIOBLASTOMA; CANCER STEM-CELLS; AMPA RECEPTORS; DIFFERENTIAL EXPRESSION; MOLECULAR-MECHANISMS; MESSENGER-RNA; GLUR2 SUBUNIT; GLIOMA-CELLS; RAT-BRAIN; GROWTH	Glioblastoma multiforme is the most malignant type of primary brain tumor with a poor prognosis. These tumors consist of a heterogeneous population of malignant cells, including well-differentiated tumor cells and less differentiated cells with stem cell properties. These cancer stem cells, known as brain tumor initiating cells, likely contribute to glioma recurrence, as they are highly invasive, mobile, resistant to radiation and chemotherapy, and have the capacity to self-renew. Glioblastoma tumor cells release excitotoxic levels of glutamate, which may be a key process in the death of peritumoral neurons, formation of necrosis, local inflammation, and glioma-related seizures. Moreover, elevated glutamate levels in the tumor may act in paracrine and autocrine manner to activate glutamate receptors on glioblastoma tumor cells, resulting in proliferation and invasion. Using a previously described culturing condition that selectively promotes the growth of brain tumor initiating cells, which express the stem cell markers nestin and SOX-2, we characterize the expression of alpha-amino-3-hydroxy-5-methyl-4-isozolepropionic acid (AMPA)-type glutamate receptor subunits in brain tumor initiating cells derived from glioblastomas. Here we show for the first time that glioblastoma brain tumor initiating cells express high concentrations of functional calcium-permeable AMPA receptors, compared to the differentiated tumor cultures consisting of non-stem cells. Up-regulated calcium-permeable AMPA receptor expression was confirmed by immunoblotting, immunocytochemistry, and intracellular calcium imaging in response to specific agonists. Our findings raise the possibility that glutamate secretion in the GBM tumor microenvironment may stimulate brain tumor derived cancer stem cells.	[Oh, Michael C.; Kim, Joseph M.; Safaee, Michael; Kaur, Gurvinder; Sun, Matthew Z.; Kaur, Rajwant; Parsa, Andrew T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Celli, Anna; Mauro, Theodora M.] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Parsa, AT (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	ParsaA@Neurosurg.UCSF.edu		Kim, Joseph/0000-0002-1108-2625	National Research Service Award from the National Institutes of Health [F32NS073326-01]; Neurosurgery Research and Education Foundation (NREF) Whelan Neuro-oncology Research Fellowship; Reza and Georgianna Khatib Endowed Chair in Skull Base Tumor Surgery; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS073326] Funding Source: NIH RePORTER	National Research Service Award from the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Neurosurgery Research and Education Foundation (NREF) Whelan Neuro-oncology Research Fellowship; Reza and Georgianna Khatib Endowed Chair in Skull Base Tumor Surgery; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Dr. Oh received a National Research Service Award from the National Institutes of Health (F32NS073326-01) and the Neurosurgery Research and Education Foundation (NREF) Whelan Neuro-oncology Research Fellowship. Dr. Parsa was partially funded by the Reza and Georgianna Khatib Endowed Chair in Skull Base Tumor Surgery. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Behrens PF, 2000, J NEURO-ONCOL, V47, P11, DOI 10.1023/A:1006426917654; Beretta F, 2009, EUR J NEUROSCI, V30, P25, DOI 10.1111/j.1460-9568.2009.06804.x; Blazek ER, 2007, INT J RADIAT ONCOL, V67, P1, DOI 10.1016/j.ijrobp.2006.09.037; Brocke Katja S, 2010, Cancer Biol Ther, V9, P455, DOI 10.4161/cbt.9.6.10898; Buckingham SC, 2011, NAT MED, V17, P1269, DOI 10.1038/nm.2453; Celli A, 2010, BIOPHYS J, V98, P911, DOI 10.1016/j.bpj.2009.10.055; Chang CJ, 2009, BIOCHEM BIOPH RES CO, V380, P236, DOI 10.1016/j.bbrc.2009.01.040; de Groot J, 2011, GLIA, V59, P1181, DOI 10.1002/glia.21113; De Groot JF, 2008, J NEURO-ONCOL, V88, P121, DOI 10.1007/s11060-008-9552-2; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; Digman MA, 2008, BIOPHYS J, V94, pL14, DOI 10.1529/biophysj.107.120154; Giese A, 2003, J CLIN ONCOL, V21, P1624, DOI 10.1200/JCO.2003.05.063; Grossman SA, 2010, CLIN CANCER RES, V16, P2443, DOI 10.1158/1078-0432.CCR-09-3106; Grossman SA, 2009, J CLIN ONCOL, V27, P4155, DOI 10.1200/JCO.2008.21.6895; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Ishiuchi S, 2002, NAT MED, V8, P971, DOI 10.1038/nm746; Ishiuchi S, 2007, J NEUROSCI, V27, P7987, DOI 10.1523/JNEUROSCI.2180-07.2007; Iwamoto FM, 2010, CANCER-AM CANCER SOC, V116, P1776, DOI 10.1002/cncr.24957; Labrakakis C, 1998, EUR J NEUROSCI, V10, P2153, DOI 10.1046/j.1460-9568.1998.00226.x; Lefranc F, 2005, J CLIN ONCOL, V23, P2411, DOI 10.1200/JCO.2005.03.089; LEHRE KP, 1995, J NEUROSCI, V15, P1835; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Lo M, 2008, J CELL PHYSIOL, V215, P593, DOI 10.1002/jcp.21366; Lyons SA, 2007, CANCER RES, V67, P9463, DOI 10.1158/0008-5472.CAN-07-2034; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Marcus HJ, 2010, J NEURO-ONCOL, V97, P11, DOI 10.1007/s11060-009-9990-5; MATUTE C, 1992, P NATL ACAD SCI USA, V89, P3399, DOI 10.1073/pnas.89.8.3399; Noch E, 2009, CANCER BIOL THER, V8, P1791, DOI 10.4161/cbt.8.19.9762; Oh MC, 2005, NAT NEUROSCI, V8, P853, DOI 10.1038/nn1476; Piao YJ, 2009, NEURO-ONCOLOGY, V11, P260, DOI 10.1215/15228517-2008-094; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Roslin M, 2003, J NEURO-ONCOL, V61, P151, DOI 10.1023/A:1022106910017; Rzeski W, 2002, BIOCHEM PHARMACOL, V64, P1195, DOI 10.1016/S0006-2952(02)01218-2; Rzeski W, 2001, P NATL ACAD SCI USA, V98, P6372, DOI 10.1073/pnas.091113598; Sanchez S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021127; Schunemann DP, 2010, PATHOL ONCOL RES, V16, P285, DOI 10.1007/s12253-009-9223-4; Simon M, 2011, NAT MED, V17, P1190, DOI 10.1038/nm.2510; Singh SK, 2004, ONCOGENE, V23, P7267, DOI 10.1038/sj.onc.1207946; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sontheimer H, 2004, MOL NEUROBIOL, V29, P61, DOI 10.1385/MN:29:1:61; Sontheimer H, 2008, J NEUROCHEM, V105, P287, DOI 10.1111/j.1471-4159.2008.05301.x; Sontheimer H, 2011, ONCOTARGET, V2, P823; Stepulak A, 2009, HISTOCHEM CELL BIOL, V132, P435, DOI 10.1007/s00418-009-0613-1; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Takano T, 2001, NAT MED, V7, P1010, DOI 10.1038/nm0901-1010; TORP R, 1994, EUR J NEUROSCI, V6, P936, DOI 10.1111/j.1460-9568.1994.tb00587.x; van Vuurden DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005953; Ye ZC, 1999, CANCER RES, V59, P4383; Ye ZC, 1999, J NEUROSCI, V19, P10767, DOI 10.1523/JNEUROSCI.19-24-10767.1999; Yoshida Y, 2006, PATHOL INT, V56, P262, DOI 10.1111/j.1440-1827.2006.01954.x	53	41	43	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47846	10.1371/journal.pone.0047846	http://dx.doi.org/10.1371/journal.pone.0047846			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110111	Green Published, Green Submitted, gold			2022-12-25	WOS:000310193600031
J	Servos, P; Boyd, A				Servos, Philip; Boyd, Allison			Probing the Neural Basis of Perceptual Phenomenology with the Touch-Induced Visual Illusion	PLOS ONE			English	Article							DECISION-MAKING; CORTEX; FMRI; OWNERSHIP; REFLECTS; NEURONS; AREAS; SHAPE; HAND	Using the touch-induced visual illusion we examine whether the brain regions involved in coding sensory information are dissociable from those that contain decision information. Activity in the intraparietal sulcus, as measured by functional magnetic resonance imaging, was associated with the illusion suggesting a sensory coding role whereas activity in the middle occipital gyrus differentially modulated activity according to the decisions made by subjects consistent with their reported perceptual phenomenology.	[Servos, Philip; Boyd, Allison] Wilfrid Laurier Univ, Dept Psychol, Waterloo, ON N2L 3C5, Canada	Wilfrid Laurier University	Servos, P (corresponding author), Wilfrid Laurier Univ, Dept Psychol, Waterloo, ON N2L 3C5, Canada.	pservos@wlu.ca			Canada Research Chairs program; NSERC	Canada Research Chairs program(Canada Research Chairs); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by the Canada Research Chairs program and NSERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benoit MM, 2010, HUM BRAIN MAPP, V31, P526, DOI 10.1002/hbm.20884; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Grefkes C, 2002, NEURON, V35, P173, DOI 10.1016/S0896-6273(02)00741-9; Hayashi T, 2007, BRAIN RES, V1163, P72, DOI 10.1016/j.brainres.2007.05.073; Heekeren HR, 2008, NAT REV NEUROSCI, V9, P467, DOI 10.1038/nrn2374; Jehee JFM, 2007, BRAIN RES, V1157, P167, DOI 10.1016/j.brainres.2007.03.090; Kim JN, 1999, NAT NEUROSCI, V2, P176, DOI 10.1038/5739; Murray MM, 2002, J NEUROSCI, V22, P5055, DOI 10.1523/JNEUROSCI.22-12-05055.2002; Nienborg H, 2009, NATURE, V459, P89, DOI 10.1038/nature07821; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Parker AJ, 1998, ANNU REV NEUROSCI, V21, P227, DOI 10.1146/annurev.neuro.21.1.227; Piazza M, 2002, NEUROIMAGE, V15, P435, DOI 10.1006/nimg.2001.0980; Pinkerton RG, 2007, INT SOC MAGN RES MED; Reddy L, 2011, HUM BRAIN MAPP, V32, P163, DOI 10.1002/hbm.21007; Romo R, 2002, NAT NEUROSCI, V5, P1217, DOI 10.1038/nn950; Servos P, 2002, CEREB CORTEX, V12, P772, DOI 10.1093/cercor/12.7.772; Stein BE, 2009, EXP BRAIN RES, V198, P113, DOI 10.1007/s00221-009-1880-8; Stein BE., 1993, MERGING SENSES; Stilla R, 2008, HUM BRAIN MAPP, V29, P1123, DOI 10.1002/hbm.20456; Talairach J., 1988, COPLANAR STEREOTAXIC; Violentyev A, 2005, NEUROREPORT, V16, P1107, DOI 10.1097/00001756-200507130-00015	23	1	1	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47788	10.1371/journal.pone.0047788	http://dx.doi.org/10.1371/journal.pone.0047788			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110101	Green Published, gold, Green Submitted			2022-12-25	WOS:000310193600026
J	Goodison, S; Chang, MR; Dai, YF; Urquidi, V; Rosser, CJ				Goodison, Steve; Chang, Myron; Dai, Yunfeng; Urquidi, Virginia; Rosser, Charles J.			A Multi-Analyte Assay for the Non-Invasive Detection of Bladder Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; URINARY INTERLEUKIN-8; APOLIPOPROTEIN-E; BIOMARKER; TERE1	Accurate urinary assays for bladder cancer (BCa) detection would benefit both patients and healthcare systems. Through genomic and proteomic profiling of urine components, we have previously identified a panel of biomarkers that can outperform current urine-based biomarkers for the non-invasive detection of BCa. Herein, we report the diagnostic utility of various multivariate combinations of these biomarkers. We performed a case-controlled validation study in which voided urines from 127 patients (64 tumor bearing subjects) were analyzed. The urinary concentrations of 14 biomarkers (IL-8, MMP-9, MMP-10, SDC1, CCL18, PAI-1, CD44, VEGF, ANG, CA9, A1AT, OPN, PTX3, and APOE) were assessed by enzyme-linked immunosorbent assay (ELISA). Diagnostic performance of each biomarker and multivariate models were compared using receiver operating characteristic curves and the chi-square test. An 8-biomarker model achieved the most accurate BCa diagnosis (sensitivity 92%, specificity 97%), but a combination of 3 of the 8 biomarkers (IL-8, VEGF, and APOE) was also highly accurate (sensitivity 90%, specificity 97%). For comparison, the commercial BTA-Trak ELISA test achieved a sensitivity of 79% and a specificity of 83%, and voided urine cytology detected only 33% of BCa cases in the same cohort. These datashow that a multivariate urine-based assay can markedly improve the accuracy of non-invasive BCa detection. Further validation studies are under way to investigate the clinical utility of this panel of biomarkers for BCa diagnosis and disease monitoring.	[Rosser, Charles J.] Univ Texas MD Anderson Canc Ctr, Sect Urol Oncol, Orlando, FL USA; [Goodison, Steve; Urquidi, Virginia] Univ Texas MD Anderson Canc Ctr, Canc Res Inst, Orlando, FL USA; [Chang, Myron; Dai, Yunfeng] Univ Florida, Dept Biostat, Gainesville, FL USA; [Urquidi, Virginia; Rosser, Charles J.] Nonagen Biosci Corp, Orlando, FL USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; State University System of Florida; University of Florida	Rosser, CJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Sect Urol Oncol, Orlando, FL USA.	Charles.rosser@orlandohealth.com			Flight Attendant Medical Research Institute; Florida Department of Health James and Esther King Team Science Award [10KT-01]; National Cancer Institute [RO1 CA116161]; NATIONAL CANCER INSTITUTE [R01CA116161] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000064] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; Florida Department of Health James and Esther King Team Science Award; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by research grants from Flight Attendant Medical Research Institute (CJR), Florida Department of Health James and Esther King Team Science Award 10KT-01 (CJR), and National Cancer Institute RO1 CA116161 (SG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2004, AM STAT, V58, P131, DOI 10.1198/0003130043277; Banos JLG, 2001, UROLOGY, V57, P685, DOI 10.1016/S0090-4295(00)01090-6; Bian W, 2007, INT J UROL, V14, P108, DOI 10.1111/j.1442-2042.2007.01670.x; Bossuyt PM, 2004, FAM PRACT, V21, P4, DOI 10.1093/fampra/cmh103; Chen JL, 2011, P NATL ACAD SCI USA, V108, P14813, DOI 10.1073/pnas.1106420108; Crew JP, 1999, J UROLOGY, V161, P799, DOI 10.1016/S0022-5347(01)61772-5; Eissa Sanaa, 2007, Cancer Biomarkers, V3, P275; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Fredericks WJ, 2011, DNA CELL BIOL, V30, P851, DOI 10.1089/dna.2011.1315; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Grossman HB, 2005, JAMA-J AM MED ASSOC, V293, P810, DOI 10.1001/jama.293.7.810; Ho YY, 2001, J BIOL CHEM, V276, P43455, DOI 10.1074/jbc.M105325200; Jeon SH, 2001, ONCOL REP, V8, P1265; Kocak H, 2004, CLIN BIOCHEM, V37, P673, DOI 10.1016/j.clinbiochem.2004.02.005; Leon LF, 1998, BIOMETRICS, V54, P1165, DOI 10.2307/2533866; Linden M, 2012, PROTEOMICS, V12, P135, DOI 10.1002/pmic.201000810; Lokeshwar VB, 2005, UROLOGY, V66, P35, DOI 10.1016/j.urology.2005.08.064; McGarvey TW, 2005, J CELL BIOCHEM, V95, P419, DOI 10.1002/jcb.20432; Mian BM, 2003, CLIN CANCER RES, V9, P3167; Montironi R, 2005, INT J SURG PATHOL, V13, P143, DOI 10.1177/106689690501300203; Rosser CJ, 2009, CANCER EPIDEM BIOMAR, V18, P444, DOI 10.1158/1055-9965.EPI-08-1002; Sheryka E, 2003, UROLOGY, V62, P162, DOI 10.1016/S0090-4295(03)00134-1; Urquidi V, 2012, J UROLOGY, V188, P2211; Urquidi V, 2012, BMC UROL, V12, DOI 10.1186/1471-2490-12-12; Urquidi V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037797; Urquidi V, 2012, UROLOGY, V79, DOI 10.1016/j.urology.2012.01.016; Yang N, 2011, CLIN CANCER RES, V17, P3349, DOI 10.1158/1078-0432.CCR-10-3121	27	74	79	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47469	10.1371/journal.pone.0047469	http://dx.doi.org/10.1371/journal.pone.0047469			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094052	Green Submitted, Green Published, gold			2022-12-25	WOS:000310050200025
J	Bertelsen, K; Dorosz, J; Hansen, SK; Nielsen, NC; Vosegaard, T				Bertelsen, Kresten; Dorosz, Jerzy; Hansen, Sara Krogh; Nielsen, Niels Chr.; Vosegaard, Thomas			Mechanisms of Peptide-Induced Pore Formation in Lipid Bilayers Investigated by Oriented P-31 Solid-State NMR Spectroscopy	PLOS ONE			English	Article							NUCLEAR-MAGNETIC-RESONANCE; ANTIMICROBIAL PEPTIDE; MEMBRANE-PROTEINS; ROTATIONAL DIFFUSION; PHOSPHOLIPID-BILAYERS; MOLECULAR-DYNAMICS; ALAMETHICIN; MODEL; N-15; CONFORMATION	There is a considerable interest in understanding the function of antimicrobial peptides (AMPs), but the details of their mode of action is not fully understood. This motivates extensive efforts in determining structural and mechanistic parameters for AMP's interaction with lipid membranes. In this study we show that oriented-sample P-31 solid-state NMR spectroscopy can be used to probe the membrane perturbations and -disruption by AMPs. For two AMPs, alamethicin and novicidin, we observe that the majority of the lipids remain in a planar bilayer conformation but that a number of lipids are involved in the peptide anchoring. These lipids display reduced dynamics. Our study supports previous studies showing that alamethicin adopts a transmembrane arrangement without significant disturbance of the surrounding lipids, while novicidin forms toroidal pores at high concentrations leading to more extensive membrane disturbance.	[Bertelsen, Kresten; Dorosz, Jerzy; Hansen, Sara Krogh; Nielsen, Niels Chr.; Vosegaard, Thomas] Univ Aarhus, Dept Chem, Interdisciplinary Nanosci Ctr INANO, Ctr Insoluble Prot Struct InSPIN, Aarhus, Denmark; [Vosegaard, Thomas] Univ Aarhus, Sch Engn, Dept Engn, Aarhus, Denmark	Aarhus University; Aarhus University	Nielsen, NC (corresponding author), Univ Aarhus, Dept Chem, Interdisciplinary Nanosci Ctr INANO, Ctr Insoluble Prot Struct InSPIN, Aarhus, Denmark.	ncn@inano.au.dk; tv@chem.au.dk		Nielsen, Niels Chr./0000-0003-2978-4366; Vosegaard, Thomas/0000-0001-5414-4550	Danish National Research Foundation; Danish Natural Science Research Council, Lundbeckfonden; Danish Center for Scientific Computing (DCSC); Danish Biotechnology Instrument Centre (DABIC)	Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Natural Science Research Council, Lundbeckfonden(Danish Natural Science Research CouncilLundbeckfonden); Danish Center for Scientific Computing (DCSC); Danish Biotechnology Instrument Centre (DABIC)	Support from the Danish National Research Foundation, the Danish Natural Science Research Council, Lundbeckfonden, the Danish Center for Scientific Computing (DCSC), and the Danish Biotechnology Instrument Centre (DABIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aisenbrey C, 2004, J AM CHEM SOC, V126, P16676, DOI 10.1021/ja0468675; Bak M, 2000, J MAGN RESON, V147, P296, DOI 10.1006/jmre.2000.2179; Bak M, 2001, BIOPHYS J, V81, P1684, DOI 10.1016/S0006-3495(01)75822-5; Bechinger B, 2001, BIOCHEMISTRY-US, V40, P9428, DOI 10.1021/bi010162n; Bertelsen K, 2007, J AM CHEM SOC, V129, P14717, DOI 10.1021/ja0749690; Bertelsen K, 2011, J PHYS CHEM B, V115, P1767, DOI 10.1021/jp110866g; Bertelsen K, 2009, J AM CHEM SOC, V131, P18335, DOI 10.1021/ja908604u; BROWN MF, 1978, BIOPHYS J, V21, pA205; Cady SD, 2007, J AM CHEM SOC, V129, P5719, DOI 10.1021/ja070305e; CAFISO DS, 1994, ANNU REV BIOPH BIOM, V23, P141, DOI 10.1146/annurev.bb.23.060194.001041; DAVIS JH, 1983, BIOCHIM BIOPHYS ACTA, V737, P117, DOI 10.1016/0304-4157(83)90015-1; Dittmer J, 2009, J PHYS CHEM B, V113, P6928, DOI 10.1021/jp811494p; Dubos RJ, 1941, J EXP MED, V73, P629, DOI 10.1084/jem.73.5.629; FENSKE DB, 1991, BIOPHYS J, V59, P55, DOI 10.1016/S0006-3495(91)82198-1; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; FOX RO, 1982, NATURE, V300, P325, DOI 10.1038/300325a0; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; GIBSON TR, 1985, PEPTIDES, V6, P615, DOI 10.1016/0196-9781(85)90162-7; Glaubitz C, 1998, J MAGN RESON, V130, P305, DOI 10.1006/jmre.1997.1344; GRIFFIN RG, 1976, J AM CHEM SOC, V98, P851, DOI 10.1021/ja00419a044; Hallock KJ, 2003, BIOPHYS J, V84, P3052, DOI 10.1016/S0006-3495(03)70031-9; Haney EF, 2010, CHEM PHYS LIPIDS, V163, P82, DOI 10.1016/j.chemphyslip.2009.09.002; He K, 1996, BIOPHYS J, V71, P2669, DOI 10.1016/S0006-3495(96)79458-4; HE K, 1995, BIOCHEMISTRY-US, V34, P15614, DOI 10.1021/bi00048a002; HERZFELD J, 1978, BIOCHEMISTRY-US, V17, P2711, DOI 10.1021/bi00607a003; Hong M, 2006, CHEM PHYS LETT, V432, P296, DOI 10.1016/j.cplett.2006.10.067; Ludtke SJ, 1996, BIOCHEMISTRY-US, V35, P13723, DOI 10.1021/bi9620621; Maragakis LL, 2008, EXPERT REV ANTI-INFE, V6, P751, DOI 10.1586/14787210.6.5.751; MARTIN DR, 1976, BIOCHEM J, V153, P181, DOI 10.1042/bj1530181; MathWorks Inc, MATLAB; Matsuzaki K, 1996, BIOCHEMISTRY-US, V35, P11361, DOI 10.1021/bi960016v; Matsuzaki K, 1998, BBA-REV BIOMEMBRANES, V1376, P391, DOI 10.1016/S0304-4157(98)00014-8; MOHR H, 1978, BIOCHIM BIOPHYS ACTA, V526, P375, DOI 10.1016/0005-2744(78)90129-8; NIELSEN NC, 1995, J BIOMOL NMR, V5, P311, DOI 10.1007/BF00211758; Nielsen SB, 2010, J COLLOID INTERF SCI, V345, P248, DOI 10.1016/j.jcis.2010.01.065; Opella SJ, 2004, CHEM REV, V104, P3587, DOI 10.1021/cr0304121; Oren Z, 1998, BIOPOLYMERS, V47, P451; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Park SH, 2006, J AM CHEM SOC, V128, P7402, DOI 10.1021/ja0606632; Park SH, 2006, J MAGN RESON, V178, P162, DOI 10.1016/j.jmr.2005.08.008; Picard F, 1996, BIOPHYS J, V70, P1737, DOI 10.1016/S0006-3495(96)79736-9; Prenner EJ, 1997, BIOCHEMISTRY-US, V36, P7906, DOI 10.1021/bi962785k; PRIMOR N, 1980, BIOCHIM BIOPHYS ACTA, V626, P299, DOI 10.1016/0005-2795(80)90124-5; Prongidi-Fix L, 2007, J AM CHEM SOC, V129, P8430, DOI 10.1021/ja072668k; Saint-Laurent A, 1998, BIOCHEM CELL BIOL, V76, P465; Salnikov ES, 2009, BIOPHYS J, V96, P86, DOI 10.1529/biophysj.108.136242; Sani MA, 2011, BIOPHYS J, V100, pL40, DOI 10.1016/j.bpj.2011.03.005; SANSOM MSP, 1993, EUR BIOPHYS J BIOPHY, V22, P105, DOI 10.1007/BF00196915; SEELIG J, 1978, BIOCHIM BIOPHYS ACTA, V515, P105, DOI 10.1016/0304-4157(78)90001-1; SEELIG J, 1977, Q REV BIOPHYS, V10, P353, DOI 10.1017/S0033583500002948; SMITH SO, 1992, ANNU REV BIOPH BIOM, V21, P25, DOI 10.1146/annurev.bb.21.060192.000325; Soong R, 2010, J AM CHEM SOC, V132, P5779, DOI 10.1021/ja910807e; Soubias O, 2005, BIOPHYS J, V89, P1120, DOI 10.1529/biophysj.105.059857; Strandberg E, 2009, BIOPHYS J, V96, P3223, DOI 10.1016/j.bpj.2009.02.040; Thogersen L, 2008, BIOPHYS J, V95, P4337, DOI 10.1529/biophysj.108.133330; Tieleman DP, 1998, FARADAY DISCUSS, V111, P209; Toraya S, 2004, BIOPHYS J, V87, P3323, DOI 10.1529/biophysj.104.046102; Tosner Z, 2009, J MAGN RESON, V197, P120, DOI 10.1016/j.jmr.2008.11.020; Vad B, 2010, BBA-PROTEINS PROTEOM, V1804, P806, DOI 10.1016/j.bbapap.2009.12.006; Vosegaard T, 2002, MONATSH CHEM, V133, P1555, DOI 10.1007/s00706-002-0519-2; Vosegaard T, 2008, J AM CHEM SOC, V130, P5028, DOI 10.1021/ja8000612; Wi S, 2008, J PHYS CHEM B, V112, P11402, DOI 10.1021/jp801825k; Yount NY, 2006, BIOPOLYMERS, V84, P435, DOI 10.1002/bip.20543; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	64	32	32	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47745	10.1371/journal.pone.0047745	http://dx.doi.org/10.1371/journal.pone.0047745			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094079	Green Published, gold, Green Submitted			2022-12-25	WOS:000312384500020
J	Carter, EJ; Williams, DL; Minshew, NJ; Lehman, JF				Carter, Elizabeth J.; Williams, Diane L.; Minshew, Nancy J.; Lehman, Jill F.			Is He Being Bad? Social and Language Brain Networks during Social Judgment in Children with Autism	PLOS ONE			English	Article							FUSIFORM FACE AREA; ASPERGER-SYNDROME; SPECTRUM DISORDERS; PEER INTERACTION; WORKING-MEMORY; MIND REGIONS; FMRI; COMPREHENSION; ADOLESCENTS; ACTIVATION	Individuals with autism often violate social rules and have lower accuracy in identifying and explaining inappropriate social behavior. Twelve children with autism (AD) and thirteen children with typical development (TD) participated in this fMRI study of the neurofunctional basis of social judgment. Participants indicated in which of two pictures a boy was being bad (Social condition) or which of two pictures was outdoors (Physical condition). In the within-group Social-Physical comparison, TD children used components of mentalizing and language networks [bilateral inferior frontal gyrus (IFG), bilateral medial prefrontal cortex (mPFC), and bilateral posterior superior temporal sulcus (pSTS)], whereas AD children used a network that was primarily right IFG and bilateral pSTS, suggesting reduced use of social and language networks during this social judgment task. A direct group comparison on the Social-Physical contrast showed that the TD group had greater mPFC, bilateral IFG, and left superior temporal pole activity than the AD group. No regions were more active in the AD group than in the group with TD in this comparison. Both groups successfully performed the task, which required minimal language. The groups also performed similarly on eyetracking measures, indicating that the activation results probably reflect the use of a more basic strategy by the autism group rather than performance disparities. Even though language was unnecessary, the children with TD recruited language areas during the social task, suggesting automatic encoding of their knowledge into language; however, this was not the case for the children with autism. These findings support behavioral research indicating that, whereas children with autism may recognize socially inappropriate behavior, they have difficulty using spoken language to explain why it is inappropriate. The fMRI results indicate that AD children may not automatically use language to encode their social understanding, making expression and generalization of this knowledge more difficult.	[Carter, Elizabeth J.] Carnegie Mellon Univ, Inst Robot, Pittsburgh, PA 15213 USA; [Carter, Elizabeth J.] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Williams, Diane L.] Duquesne Univ, Dept Speech Language Pathol, Pittsburgh, PA 15219 USA; [Minshew, Nancy J.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Minshew, Nancy J.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Lehman, Jill F.] Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA 15213 USA	Carnegie Mellon University; Carnegie Mellon University; Duquesne University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Carnegie Mellon University	Carter, EJ (corresponding author), Carnegie Mellon Univ, Inst Robot, Pittsburgh, PA 15213 USA.	ejcarter@gmail.com	Williams, Diane L/B-4128-2017	Williams, Diane L/0000-0001-7135-9019; Carter, Elizabeth J./0000-0002-2735-148X	National Institute of Child Health and Human Development Autism Center of Excellence [P50HD055748]; National Institute on Deafness and Other Communication Disorders [DC006691]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K23DC006691] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development Autism Center of Excellence; National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a National Institute of Child Health and Human Development Autism Center of Excellence grant (P50HD055748, PI: NJM) and a National Institute on Deafness and Other Communication Disorders K23 award (DC006691, PI: DLW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; ANDO H, 1979, CHILD PSYCHIAT HUM D, V9, P131, DOI 10.1007/BF01433475; Bachevalier J, 2006, NEUROSCI BIOBEHAV R, V30, P97, DOI 10.1016/j.neubiorev.2005.07.002; Baron-Cohen S, 1999, J AUTISM DEV DISORD, V29, P407, DOI 10.1023/A:1023035012436; Baron-Cohen S., 2001, J DEV LEARNING DISOR, V5, P47, DOI DOI 10.1111/J.1467-7687.2008.00720.X; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; BARONCOHEN S, 1986, BRIT J DEV PSYCHOL, V4, P113, DOI 10.1111/j.2044-835X.1986.tb01003.x; Bauminger N, 2003, J AUTISM DEV DISORD, V33, P489, DOI 10.1023/A:1025827427901; Berthoz S, 2002, BRAIN, V125, P1696, DOI 10.1093/brain/awf190; BOUCHER J, 1981, J AUTISM DEV DISORD, V11, P293, DOI 10.1007/BF01531512; Bronsard G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014358; Carrington SJ, 2009, HUM BRAIN MAPP, V30, P2313, DOI 10.1002/hbm.20671; Carter EJ, 2011, NEUROIMAGE, V54, P1634, DOI 10.1016/j.neuroimage.2010.08.077; Castelli F, 2000, NEUROIMAGE, V12, P314, DOI 10.1006/nimg.2000.0612; Castelli F, 2002, BRAIN, V125, P1839, DOI 10.1093/brain/awf189; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; Dominick KC, 2007, RES DEV DISABIL, V28, P145, DOI 10.1016/j.ridd.2006.02.003; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; FLETCHER PC, 1995, COGNITION, V57, P109, DOI 10.1016/0010-0277(95)00692-R; Forbes CE, 2010, ANNU REV NEUROSCI, V33, P299, DOI 10.1146/annurev-neuro-060909-153230; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Frith U, 2003, PHILOS T R SOC B, V358, P459, DOI 10.1098/rstb.2002.1218; Gazzaniga MS, 2000, BRAIN, V123, P1293, DOI 10.1093/brain/123.7.1293; Grandin T., 1995, THINKING PICTURES; Grant CM, 2005, AUTISM, V9, P317, DOI 10.1177/1362361305055418; Gray C.A., 2010, NEW SOCIAL STORY BOO, V10th ed; Grezes J, 2009, NEUROPSYCHOLOGIA, V47, P1816, DOI 10.1016/j.neuropsychologia.2009.02.021; Groen WB, 2010, CEREB CORTEX, V20, P1937, DOI 10.1093/cercor/bhp264; Happe F, 1996, NEUROREPORT, V8, P197, DOI 10.1097/00001756-199612200-00040; Harris GJ, 2006, BRAIN COGNITION, V61, P54, DOI 10.1016/j.bandc.2005.12.015; Heekeren HR, 2003, NEUROREPORT, V14, P1215, DOI 10.1097/00001756-200307010-00005; Humphrey N, 2011, AUTISM, V15, P397, DOI 10.1177/1362361310387804; HURLBURT RT, 1994, PSYCHOL MED, V24, P385, DOI 10.1017/S0033291700027367; Jellema T, 2009, AUTISM RES, V2, P192, DOI 10.1002/aur.83; Just MA, 2004, BRAIN, V127, P1811, DOI 10.1093/brain/awh199; Kana RK, 2009, SOC NEUROSCI-UK, V4, P135, DOI 10.1080/17470910802198510; Kanner L, 1943, NERV CHILD, V2, P217; Kanwisher N, 1997, J NEUROSCI, V17, P4302; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Kim JW, 2005, COGNITIVE BRAIN RES, V25, P659, DOI 10.1016/j.cogbrainres.2005.08.018; Koshino H, 2005, NEUROIMAGE, V24, P810, DOI 10.1016/j.neuroimage.2004.09.028; Koshino H, 2008, CEREB CORTEX, V18, P289, DOI 10.1093/cercor/bhm054; Kuchinke L, 2011, NEUROPSYCHOLOGIA, V49, P331, DOI 10.1016/j.neuropsychologia.2010.12.026; Laurent AC, 2004, TOP LANG DISORD, V24, P286, DOI 10.1097/00011363-200410000-00006; Lombardo MV, 2011, NEUROIMAGE, V56, P1832, DOI 10.1016/j.neuroimage.2011.02.067; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Loveland KA, 2001, J AUTISM DEV DISORD, V31, P367, DOI 10.1023/A:1010608518060; Mason R.A., 2006, HDB PSYCHOLINGUISTIC, P765, DOI [10.1016/B978-012369374-7/50020-1, DOI 10.1016/B978-012369374-7/50020-1]; Mason RA, 2008, NEUROPSYCHOLOGIA, V46, P269, DOI 10.1016/j.neuropsychologia.2007.07.018; Mitchell JP, 2002, P NATL ACAD SCI USA, V99, P15238, DOI 10.1073/pnas.232395699; Moll J, 2002, NEUROIMAGE, V16, P696, DOI 10.1006/nimg.2002.1118; Moll J, 2002, J NEUROSCI, V22, P2730, DOI 10.1523/JNEUROSCI.22-07-02730.2002; Myers GC, 1994, GOOFUS GALLANT; Nah YH, 2011, AUTISM, V15, P185, DOI 10.1177/1362361309353616; Ohnishi T, 2004, NEUROREPORT, V15, P1483, DOI 10.1097/01.wnr.0000127464.17770.1f; Ohnishi T, 2000, BRAIN, V123, P1838, DOI 10.1093/brain/123.9.1838; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; PERNER J, 1989, CHILD DEV, V60, P689, DOI 10.2307/1130734; Pierce K, 1997, J AUTISM DEV DISORD, V27, P265, DOI 10.1023/A:1025898314332; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Quirmbach LM, 2009, J AUTISM DEV DISORD, V39, P299, DOI 10.1007/s10803-008-0628-9; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rutter M, 2001, AUTISM DIAGNOSTIC IN; Sahyoun CP, 2010, NEUROPSYCHOLOGIA, V48, P86, DOI 10.1016/j.neuropsychologia.2009.08.013; Schultz RT, 2003, PHILOS T R SOC B, V358, P415, DOI 10.1098/rstb.2002.1208; Schwarzlose RF, 2005, J NEUROSCI, V25, P11055, DOI 10.1523/JNEUROSCI.2621-05.2005; Senju A, 2010, DEV PSYCHOPATHOL, V22, P353, DOI 10.1017/S0954579410000106; Silani G, 2008, SOC NEUROSCI-UK, V3, P97, DOI 10.1080/17470910701577020; Spencer MD, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.18; Takahashi H, 2004, NEUROIMAGE, V23, P967, DOI 10.1016/j.neuroimage.2004.07.054; van Wassenhove V, 2005, P NATL ACAD SCI USA, V102, P1181, DOI 10.1073/pnas.0408949102; Vollm BA, 2006, NEUROIMAGE, V29, P90, DOI 10.1016/j.neuroimage.2005.07.022; Wang AT, 2007, ARCH GEN PSYCHIAT, V64, P698, DOI 10.1001/archpsyc.64.6.698; Wechsler D., 1999, WECHSLER ABBREVIATED; Williams DL, 2005, ARCH CLIN NEUROPSYCH, V20, P1, DOI 10.1016/j.acn.2002.08.001; Wolford G, 2000, J NEUROSCI, V20, part. no.; Young L, 2007, P NATL ACAD SCI USA, V104, P8235, DOI 10.1073/pnas.0701408104	80	16	16	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47241	10.1371/journal.pone.0047241	http://dx.doi.org/10.1371/journal.pone.0047241			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038AF	23082151	Green Published, Green Accepted, gold			2022-12-25	WOS:000311146900047
J	Malaza, A; Mossong, J; Barnighausen, T; Newell, ML				Malaza, Abraham; Mossong, Joel; Baernighausen, Till; Newell, Marie-Louise			Hypertension and Obesity in Adults Living in a High HIV Prevalence Rural Area in South Africa	PLOS ONE			English	Article							DEVELOPING-COUNTRIES; SOCIOECONOMIC-STATUS; COHORT PROFILE; HEALTH SURVEY; POPULATION; DISEASE; MORTALITY; EPIDEMIC; WEIGHT; BURDEN	Hypertension and excess body weight are major risk factors of cardiovascular morbidity and mortality in developing countries. In countries with a high HIV prevalence, it is unknown how increased antiretroviral treatment and care (ART) coverage has affected the prevalence of overweight, obesity, and hypertension. We conducted a health survey in 2010 based on the WHO STEPwise approach in 14,198 adult resident participants of a demographic surveillance area in rural South Africa to investigate factors associated with hypertension and excess weight including HIV infection and ART status. Women had a significantly higher median body mass index (BMI) than men (26.4 vs. 21.2 kg/m(2), p<0.001). The prevalence of obesity (BMI >= 30 kg/m(2)) in women (31.3%, 95% confidence interval (CI) 30.2-32.4) was 6.5 times higher than in men (4.9%, 95% CI 4.1-5.7), whereas prevalence of hypertension (systolic or diastolic blood pressure >= 140 or 90 mm Hg, respectively) was 1.4 times higher in women than in men (28.5% vs 20.8%, p<0.001). In multivariable regression analysis, both hypertension and obesity were significantly associated with sex, age, HIV and ART status. The BMI of women and men on ART was on average 3.8 (95% CI 3.2-3.8) and 1.7 (95% CI 0.9-2.5) kg/m(2) lower than of HIV-negative women and men, respectively. The BMI of HIV-infected women and men not on ART was on average 1.2 (95% CI 0.8-1.6) and 0.4 (95% CI -0.1-0.9) kg/m(2) lower than of HIV-negative women and men, respectively. Obesity was a bigger risk factor for hypertension in men (adjusted odds ratio (aOR) 2.99, 95% CI 2.00-4.48) than in women (aOR 1.64, 95% CI 1.39-1.92) and overweight (25 <= BMI<30) was a significant risk factor for men only (aOR 1.53 95% CI 1.14-2.06). Our study suggests that, cardiovascular risk factors of hypertension and obesity differ substantially between women and men in rural South Africa.	[Malaza, Abraham; Mossong, Joel; Baernighausen, Till; Newell, Marie-Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, Kwazulu Natal, South Africa; [Baernighausen, Till] Harvard Univ, Harvard Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Newell, Marie-Louise] UCL, Inst Child Hlth, Ctr Paediat Epidemiol & Biostat, London, England	University of Kwazulu Natal; Harvard University; Harvard T.H. Chan School of Public Health; University of London; University College London	Mossong, J (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, Kwazulu Natal, South Africa.	jmossong@africacentre.ac.za	Mossong, Joël/D-4998-2009; Bärnighausen, Till/Y-2388-2019; Newell, Marie-Louise/AAE-8222-2019	Mossong, Joël/0000-0003-0717-9835; Newell, Marie-Louise/0000-0002-1074-7699	Wellcome Trust [050534]; German government through the Centre for International Migration and Development (CIM)	Wellcome Trust(Wellcome TrustEuropean Commission); German government through the Centre for International Migration and Development (CIM)	This study was funded by the Wellcome Trust core grant (#050534) including the household and individual health surveillance. JM received partial financial support from the German government through the Centre for International Migration and Development (CIM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MA, 2009, SAMJ S AFR MED J, V99, P661; [Anonymous], 2003, J HYPERTENS, V21, P1011; Barnighausen T, 2008, J HUM HYPERTENS, V22, P236, DOI 10.1038/sj.jhh.1002308; Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Case A, 2009, ECON HUM BIOL, V7, P271, DOI 10.1016/j.ehb.2009.07.002; Chimbindi N, 2012, 19 INT AIDS C WASH U; DEVILLIERS MA, 1988, S AFR J SCI, V84, P601; Filmer D, 2001, DEMOGRAPHY, V38, P115, DOI 10.1353/dem.2001.0003; Gaziano TA, 2006, LANCET, V368, P679, DOI 10.1016/S0140-6736(06)69252-0; Herbst AJ, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-47; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; Houlihan CF, 2011, INT J EPIDEMIOL, V40, P318, DOI 10.1093/ije/dyp402; Islam FM, 2012, HIV MED; Joint United Nations Programme on HIV/AIDS, 2010, GLOB REP UNAIDS REP; Joubert J, 2007, SAMJ S AFR MED J, V97, P683; Kruger HS, 2007, PUBLIC HLTH NUTR, V8; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Mufunda J, 2006, J HUM HYPERTENS, V20, P59, DOI 10.1038/sj.jhh.1001924; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Puoane T, 2002, OBES RES, V10, P1038, DOI 10.1038/oby.2002.141; Rodgers A, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P851; Shisana O., 2009, S AFRICAN HIV PREVAL; Steyn K, 2001, J HYPERTENS, V19, P1717, DOI 10.1097/00004872-200110000-00004; Swinburn BA, LANCET, V378, P804; Tanser F, 2012, C RETR OPP INF CROI; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; Thomas F, 2005, HYPERTENSION, V46, P654, DOI 10.1161/01.HYP.0000184282.51550.00; van der Merwe MT, 2006, OBES REV, V7, P315, DOI 10.1111/j.1467-789X.2006.00237.x; Walker ARP, 2001, PUBLIC HEALTH, V115, P368, DOI 10.1038/sj.ph.1900790; Wanke CA, 2000, CLIN INFECT DIS, V31, P803, DOI 10.1086/314027; WHO, 2000, OB PREV MAN GLOB EP; WHO, 2011, GLOB STAT REP NONC D; WHO, 2003, STEPS FRAM SURV WHO; World Health Organization, 2010, UN ACC SCAL PRIOR HI	37	86	87	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47761	10.1371/journal.pone.0047761	http://dx.doi.org/10.1371/journal.pone.0047761			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082211	Green Published, gold, Green Submitted			2022-12-25	WOS:000311146900108
J	O'Connell, NE; Cossar, J; Marston, L; Wand, BM; Bunce, D; Moseley, GL; De Souza, LH				O'Connell, Neil E.; Cossar, John; Marston, Louise; Wand, Benedict M.; Bunce, David; Moseley, G. Lorimer; De Souza, Lorraine H.			Rethinking Clinical Trials of Transcranial Direct Current Stimulation: Participant and Assessor Blinding Is Inadequate at Intensities of 2mA	PLOS ONE			English	Article							PREFRONTAL CORTEX; PAIN; DEPRESSION; MODULATION	Background: Many double-blind clinical trials of transcranial direct current stimulation (tDCS) use stimulus intensities of 2 mA despite the fact that blinding has not been formally validated under these conditions. The aim of this study was to test the assumption that sham 2 mA tDCS achieves effective blinding. Methods: A randomised double blind crossover trial. 100 tDCS-naive healthy volunteers were incorrectly advised that they there were taking part in a trial of tDCS on word memory. Participants attended for two separate sessions. In each session, they completed a word memory task, then received active or sham tDCS (order randomised) at 2 mA stimulation intensity for 20 minutes and then repeated the word memory task. They then judged whether they believed they had received active stimulation and rated their confidence in that judgement. The blinded assessor noted when red marks were observed at the electrode sites post-stimulation. Results: tDCS at 2 mA was not effectively blinded. That is, participants correctly judged the stimulation condition greater than would be expected to by chance at both the first session (kappa level of agreement (kappa) 0.28, 95% confidence interval (CI) 0.09 to 0.47 p = 0.005) and the second session (kappa = 0.77, 95% CI 0.64 to 0.90), p = <0.001) indicating inadequate participant blinding. Redness at the reference electrode site was noticeable following active stimulation more than sham stimulation (session one, kappa = 0.512, 95% CI 0.363 to 0.66, p<0.001; session two, kappa = 0.677, 95%CI 0.534 to 0.82) indicating inadequate assessor blinding. Conclusions: Our results suggest that blinding in studies using tDCS at intensities of 2 mA is inadequate. Positive results from such studies should be interpreted with caution.	[O'Connell, Neil E.; Cossar, John; De Souza, Lorraine H.] Brunel Univ, Sch Hlth Sci & Social Care, Rehabil Res Ctr, London, England; [Marston, Louise] UCL, Res Dept Primary Care & Populat Hlth, London, England; [Wand, Benedict M.] Univ Notre Dame Australia, Sch Physiotherapy, Fremantle, WA, Australia; [Bunce, David] Brunel Univ, Ctr Cognit & Neuroimaging, London, England; [Moseley, G. Lorimer] Univ S Australia, Sansom Inst Hlth Res, Adelaide, SA 5001, Australia; [Moseley, G. Lorimer] Neurosci Res Australia, Sydney, NSW, Australia	Brunel University; University of London; University College London; University of Notre Dame Australia; Brunel University; University of South Australia; Neuroscience Research Australia	O'Connell, NE (corresponding author), Brunel Univ, Sch Hlth Sci & Social Care, Rehabil Res Ctr, London, England.	neil.oconnell@brunel.ac.uk	Marston, Louise/A-8535-2012; Moseley, Lorimer/A-7095-2009; Wand, Benedict/C-3341-2011; O'CONNELL, NEIL/A-6907-2014	Marston, Louise/0000-0002-9973-1131; Moseley, Lorimer/0000-0002-3750-4945; O'CONNELL, NEIL/0000-0003-1989-4537; Bunce, David/0000-0003-3265-2700; Wand, Benedict/0000-0002-0297-0292	National Health & Medical Research Council of Australia [571090]	National Health & Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	GLM is supported by the National Health & Medical Research Council of Australia ID 571090. This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No corporate funding or sponsorship was received for the conduct of this study. No government or institutional funding was received for the conduct of this study.	Altman D.G., 1991, PRACTICAL STATISTIC; Ambrus GG, 2012, BRAIN STIMUL, V5, P499, DOI 10.1016/j.brs.2011.12.001; Bartley EJ, 2012, ANN BEHAV MED, V43, P343, DOI 10.1007/s12160-012-9345-x; Bastani A, 2012, CLIN NEUROPHYSIOL, V123, P644, DOI 10.1016/j.clinph.2011.08.029; Berger VW., 2003, J MODERN APPL STAT M, V2, P8, DOI [10.22237/jmasm/1051747680, DOI 10.22237/JMASM/1051747680]; Berger VW, 2012, J CLIN EPID IN PRESS; Boggio PS, 2008, DRUG ALCOHOL DEPEN, V92, P55, DOI 10.1016/j.drugalcdep.2007.06.011; Boggio PS, 2009, CLIN J PAIN, V25, P691, DOI 10.1097/AJP.0b013e3181af1414; Brunoni AR, 2012, BRAIN STIMUL, V5, P175, DOI 10.1016/j.brs.2011.03.002; Brunoni AR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004824; Butler DS, 2003, EXPLAIN PAIN, V2nd; Fregni F, 2008, J CLIN PSYCHIAT, V69, P32, DOI 10.4088/JCP.v69n0105; Fregni F, 2006, ARTHRITIS RHEUM-US, V54, P3988, DOI 10.1002/art.22195; Fregni F, 2006, PAIN, V122, P197, DOI 10.1016/j.pain.2006.02.023; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Goldman RL, 2011, APPETITE, V56, P741, DOI 10.1016/j.appet.2011.02.013; Hopewell S, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.MR000006.pub3; Hrobjartsson A, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003974.pub3; Klatzkin RR, 2010, EUR J PAIN, V14, P77, DOI 10.1016/j.ejpain.2009.01.002; Loo CK, 2012, BRIT J PSYCHIAT, V200, P52, DOI 10.1192/bjp.bp.111.097634; Loo CK, 2010, INT J NEUROPSYCHOPH, V13, P61, DOI 10.1017/S1461145709990411; McFadden JL, 2011, BRAIN STIMUL, V4, P38, DOI 10.1016/j.brs.2010.05.002; Montenegro RA, 2012, APPETITE, V58, P333, DOI 10.1016/j.appet.2011.11.008; Mori F, 2010, J PAIN, V11, P436, DOI 10.1016/j.jpain.2009.08.011; Nitsche MA, 2009, EXP NEUROL, V219, P14, DOI 10.1016/j.expneurol.2009.03.038; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; Nuesch E, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3515; O'Connell NE, 2010, COCHRANE DB SYST REV, V9; O'Connell NE, 2011, CLIN J PAIN IN PRESS; Priori A, 2009, BRAIN STIMUL, V2, P241, DOI 10.1016/j.brs.2009.02.004; Rezaii T, 2012, J PAIN, V13, P646, DOI 10.1016/j.jpain.2012.04.002; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	32	182	183	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47514	10.1371/journal.pone.0047514	http://dx.doi.org/10.1371/journal.pone.0047514			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082174	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000311146900070
J	van den Bergh, MR; Biesbroek, G; Rossen, JWA; Piters, WAAD; Bosch, AATM; van Gils, EJM; Wang, XH; Boonacker, CWB; Veenhoven, RH; Bruin, JP; Bogaert, D; Sanders, EAM				van den Bergh, Menno R.; Biesbroek, Giske; Rossen, John W. A.; Piters, Wouter A. A. de Steenhuijsen; Bosch, Astrid A. T. M.; van Gils, Elske J. M.; Wang, Xinhui; Boonacker, Chantal W. B.; Veenhoven, Reinier H.; Bruin, Jacob P.; Bogaert, Debby; Sanders, Elisabeth A. M.			Associations between Pathogens in the Upper Respiratory Tract of Young Children: Interplay between Viruses and Bacteria	PLOS ONE			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; RANDOMIZED CONTROLLED-TRIAL; STREPTOCOCCUS-PNEUMONIAE; STAPHYLOCOCCUS-AUREUS; HAEMOPHILUS-INFLUENZAE; SYNCYTIAL VIRUS; MICROBIOTA; COLONIZATION; COMMUNITY; CARRIAGE	Background: High rates of potentially pathogenic bacteria and respiratory viruses can be detected in the upper respiratory tract of healthy children. Investigating presence of and associations between these pathogens in healthy individuals is still a rather unexplored field of research, but may have implications for interpreting findings during disease. Methodology/Principal Findings: We selected 986 nasopharyngeal samples from 433 6- to 24-month-old healthy children that had participated in a randomized controlled trial. We determined the presence of 20 common respiratory viruses using real-time PCR. Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and Staphylococcus aureus were identified by conventional culture methods. Information on risk factors was obtained by questionnaires. We performed multivariate logistic regression analyses followed by partial correlation analysis to identify the overall pattern of associations. S. pneumoniae colonization was positively associated with the presence of H. influenzae (adjusted odds ratio 1.60, 95% confidence interval 1.18-2.16), M. catarrhalis (1.78, 1.29-2.47), human rhinoviruses (1.63, 1.19-2.22) and enteroviruses (1.97, 1.26-3.10), and negatively associated with S. aureus presence (0.59, 0.35-0.98). H. influenzae was positively associated with human rhinoviruses (1.63, 1.22-2.18) and respiratory syncytial viruses (2.78, 1.06-7.28). M. catarrhalis colonization was positively associated with coronaviruses (1.99, 1.01-3.93) and adenoviruses (3.69, 1.29-10.56), and negatively with S. aureus carriage (0.42, 0.25-0.69). We observed a strong positive association between S. aureus and influenza viruses (4.87, 1.59-14.89). In addition, human rhinoviruses and enteroviruses were positively correlated (2.40, 1.66-3.47), as were enteroviruses and human bocavirus, WU polyomavirus, parainfluenza viruses, and human parechovirus. A negative association was observed between human rhinoviruses and coronaviruses. Conclusions/Significance: Our data revealed high viral and bacterial prevalence rates and distinct bacterial-bacterial, viral-bacterial and viral-viral associations in healthy children, hinting towards the complexity and potential dynamics of microbial communities in the upper respiratory tract. This warrants careful consideration when associating microbial presence with specific respiratory diseases.	[van den Bergh, Menno R.; Biesbroek, Giske; Piters, Wouter A. A. de Steenhuijsen; Bosch, Astrid A. T. M.; van Gils, Elske J. M.; Wang, Xinhui; Bogaert, Debby; Sanders, Elisabeth A. M.] Univ Med Ctr Utrecht, Dept Pediat Immunol & Infect Dis, Wilhelmina Childrens Hosp, Utrecht, Netherlands; [van den Bergh, Menno R.; van Gils, Elske J. M.; Veenhoven, Reinier H.] Spaarne Hosp, Res Ctr, Linnaeus Inst, Hoofddorp, Netherlands; [Rossen, John W. A.] St Elizabeth Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands; [Boonacker, Chantal W. B.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Bruin, Jacob P.] Reg Publ Hlth Lab, Haarlem, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Spaarne Hospital; Elisabeth-TweeSteden Ziekenhuis (ETZ); Utrecht University; Utrecht University Medical Center	Bogaert, D (corresponding author), Univ Med Ctr Utrecht, Dept Pediat Immunol & Infect Dis, Wilhelmina Childrens Hosp, Utrecht, Netherlands.	d.bogaert@umcutrecht.nl	Rossen, John W/G-7564-2011; de Steenhuijsen Piters, Wouter/AAI-9952-2020	Rossen, John W/0000-0002-7167-8623; de Steenhuijsen Piters, Wouter/0000-0002-1144-4067; Bogaert, Debby/0000-0003-2651-7000	Netherlands Organisation for Scientific Research through NWO-VENI [91610121]; ZonMW [91209010]; Dutch Ministry of Health; Pfizer; Baxter; GlaxoSmithKline	Netherlands Organisation for Scientific Research through NWO-VENI; ZonMW(Netherlands Organization for Health Research and Development); Dutch Ministry of Health; Pfizer(Pfizer); Baxter; GlaxoSmithKline(GlaxoSmithKline)	This work was supported by The Netherlands Organisation for Scientific Research through NWO-VENI Grant 91610121, ZonMW Grant 91209010 and the Dutch Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; DB declares to have received consulting fees from Pfizer. EAMS declares to have received unrestricted research support from Pfizer and Baxter, consulting fees from Pfizer and GlaxoSmithKline, lecturing fees from Pfizer, and grant support for vaccine studies from Pfizer and GlaxoSmithKline. RHV declares to have received research support from GlaxoSmithKline and Pfizer for vaccine studies and consulting fees from GlaxoSmithKline. None of the fees or grants listed here were received for the research described in this paper. For all other authors no conflicts of interest were declared. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	[Anonymous], 2001, ENCY MATH; Avadhanula V, 2006, J VIROL, V80, P1629, DOI 10.1128/JVI.80.4.1629-1636.2006; Biesbroek G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032942; Blaser MJ, 2009, NAT REV MICROBIOL, V7, P887, DOI 10.1038/nrmicro2245; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Bogaert D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017035; Brogden KA, 2005, LANCET, V365, P253, DOI 10.1016/S0140-6736(05)70155-0; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Donders ART, 2006, J CLIN EPIDEMIOL, V59, P1087, DOI 10.1016/j.jclinepi.2006.01.014; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; HUEBNER RJ, 1957, ANN NY ACAD SCI, V67, P430, DOI 10.1111/j.1749-6632.1957.tb46066.x; Ishizuka S, 2003, J INFECT DIS, V188, P1928, DOI 10.1086/379833; Iverson AR, 2011, J INFECT DIS, V203, P880, DOI 10.1093/infdis/jiq113; Jacoby P, 2007, VACCINE, V25, P2458, DOI 10.1016/j.vaccine.2006.09.020; Jansen AGSC, 2008, EPIDEMIOL INFECT, V136, P1448, DOI 10.1017/S0950268807000271; Jansen RR, 2011, J CLIN MICROBIOL, V49, P2631, DOI 10.1128/JCM.02094-10; Kane M, 2011, SCIENCE, V334, P245, DOI 10.1126/science.1210718; Klugman KP, 2007, SCIENCE, V316, P49; Koon K, 2010, EMERG INFECT DIS, V16, P1976, DOI 10.3201/eid1612.091697; Kuss SK, 2011, SCIENCE, V334, P249, DOI 10.1126/science.1211057; Madhi SA, 2004, NAT MED, V10, P811, DOI 10.1038/nm1077; Margolis E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-59; O'Brien KL, 2003, PEDIATR INFECT DIS J, V22, P133, DOI [10.1097/00006454-200302000-00009, 10.1097/00006454-200302000-00010]; Peltola V, 2011, PEDIATR INFECT DIS J, V30, P456, DOI 10.1097/INF.0b013e318208ee82; Pericone CD, 2000, INFECT IMMUN, V68, P3990, DOI 10.1128/IAI.68.7.3990-3997.2000; Regev-Yochay G, 2004, JAMA-J AM MED ASSOC, V292, P716, DOI 10.1001/jama.292.6.716; Rivers TM, 1937, J BACTERIOL, V33, P1; Selva L, 2009, P NATL ACAD SCI USA, V106, P1234, DOI 10.1073/pnas.0809600106; Singeton RJ, 2010, J MED VIROL, V82, P1282, DOI 10.1002/jmv.21790; van de Pol AC, 2006, CRIT CARE, V10, DOI 10.1186/cc4895; van de Pol AC, 2007, J CLIN MICROBIOL, V45, P2260, DOI 10.1128/JCM.00848-07; van de Pol AC, 2009, EMERG INFECT DIS, V15, P454, DOI 10.3201/eid1503.081203; van Gils EJM, 2011, VACCINE, V29, P7595, DOI 10.1016/j.vaccine.2011.08.049; van Gils EJM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020229; van Gils EJM, 2009, JAMA-J AM MED ASSOC, V302, P159, DOI 10.1001/jama.2009.975; Wiertsema SP, 2011, J MED VIROL, V83, P2008, DOI 10.1002/jmv.22221; Willing BP, 2011, NAT REV MICROBIOL, V9, P233, DOI 10.1038/nrmicro2536; ZEGER SL, 1988, BIOMETRICS, V44, P1049, DOI 10.2307/2531734	40	141	145	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47711	10.1371/journal.pone.0047711	http://dx.doi.org/10.1371/journal.pone.0047711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082199	Green Submitted, Green Published, gold			2022-12-25	WOS:000311146900096
J	Ying, HY; Shen, X; Yue, BYJT				Ying, Hongyu; Shen, Xiang; Yue, Beatrice Y. J. T.			Establishment of Inducible Wild Type and Mutant Myocilin-GFP-Expressing RGC5 Cell Lines	PLOS ONE			English	Article							OPEN-ANGLE GLAUCOMA; OLFACTOMEDIN-HOMOLOGY DOMAIN; RETINAL GANGLION-CELLS; TRABECULAR MESHWORK; EXTRACELLULAR-MATRIX; RHO-GTPASES; PROTEIN INTERACTIONS; BARRIER INTEGRITY; GENE MYOCILIN; NON-SECRETION	Background: Myocilin is gene linked directly to juvenile- and adult-onset open angle glaucoma. Mutations including Gln368stop (Q368X) and Pro370Leu (P370L) have been identified in patients. The exact role of myocilin and its functional association with glaucoma are still unclear. In the present study, we established tetracycline-inducible (Tet-on) wild type and mutant myocilin-green fluorescence protein (GFP) expressing RGC5 stable cell lines and studied the changes in cell migration and barrier function upon induction. Methodology/Principal Findings: After several rounds of selection, clones that displayed low, moderate, or high expression of wild type, Q368X or P370L myocilin-GFP upon doxycycline (Dox) induction were obtained. The levels of wild type and mutant myocilin-GFP in various clones were confirmed by Western blotting. Compared to non-induced controls, the cell migration was retarded, the actin stress fibers were fewer and shorter, and the trypsinization time needed for cells to round up was reduced when wild type or mutant myocilin was expressed. The barrier function was in addition aberrant following induced expression of wild type, Q368X or P370L myocilin. Immunoblotting further showed that tight junction protein occludin was downregulated in induced cells. Conclusions/Significance: Tet-on inducible, stable RGC5 cell lines were established. These cell lines, expressing wild type or mutant (Q368X or P370L) myocilin-GFP upon Dox induction, are valuable in facilitating studies such as proteomics, as well as functional and pathogenesis investigations of disease-associated myocilin mutants. The barrier function was found impaired and the migration of cells was hindered with induced expression of wild type and mutant myocilin in RGC5 cell lines. The reduction in barrier function might be related to the declined level of occludin. The retarded cell migration was consistent with demonstrated myocilin phenotypes including the loss of actin stress fibers, lowered RhoA activities and compromised cell-matrix adhesiveness.	[Ying, Hongyu; Shen, Xiang; Yue, Beatrice Y. J. T.] Univ Illinois, Coll Med, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Yue, BYJT (corresponding author), Univ Illinois, Coll Med, Dept Ophthalmol & Visual Sci, Chicago, IL 60607 USA.	Beatyue@uic.edu			National Eye Institute, National Institutes of Health, Bethesda, Maryland [EY018828, EY01792]; Cless Family Foundation, Northbrook; NATIONAL EYE INSTITUTE [R01EY005628, P30EY001792, R01EY018828] Funding Source: NIH RePORTER	National Eye Institute, National Institutes of Health, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Cless Family Foundation, Northbrook; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute, National Institutes of Health, Bethesda, Maryland (grant EY018828 to B.Y.J.T.Y. and core grant EY01792) and by the Cless Family Foundation, Northbrook. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam MF, 1997, HUM MOL GENET, V6, P2091, DOI 10.1093/hmg/6.12.2091; Allingham RR, 2009, EXP EYE RES, V88, P837, DOI 10.1016/j.exer.2008.11.003; Aroca-Aguilar JD, 2005, J BIOL CHEM, V280, P21043, DOI 10.1074/jbc.M501340200; Aroca-Aguilar JD, 2011, INVEST OPHTH VIS SCI, V52, P179, DOI 10.1167/iovs.09-4866; Baumer Y, 2008, HISTOCHEM CELL BIOL, V129, P179, DOI 10.1007/s00418-007-0358-7; BILL A, 1975, INVEST OPHTH VISUAL, V14, P1; Birukova AA, 2004, MICROVASC RES, V67, P64, DOI 10.1016/j.mvr.2003.09.007; Caballero M, 2000, BBA-MOL BASIS DIS, V1502, P447, DOI 10.1016/S0925-4439(00)00068-5; Choi J, 2005, INVEST OPHTH VIS SCI, V46, P214, DOI 10.1167/iovs.04-0765; Clark AF, 2001, FASEB J, V15, P1251, DOI 10.1096/fj.00-0663fje; Cummins PM, 2012, MOL CELL BIOL, V32, P242, DOI 10.1128/MCB.06029-11; CUNHAVAZ J, 1979, SURV OPHTHALMOL, V23, P279, DOI 10.1016/0039-6257(79)90158-9; Ezzat MK, 2008, EXP EYE RES, V87, P376, DOI 10.1016/j.exer.2008.07.002; Fan BJ, 2006, CLIN BIOCHEM, V39, P249, DOI 10.1016/j.clinbiochem.2005.11.001; Fautsch MP, 2006, EXP EYE RES, V82, P1046, DOI 10.1016/j.exer.2005.09.016; Filla MS, 2002, INVEST OPHTH VIS SCI, V43, P151; Fingert JH, 2011, EYE, V25, P587, DOI 10.1038/eye.2011.97; Fingert JH, 1998, GENOME RES, V8, P377, DOI 10.1101/gr.8.4.377; Fingert JH, 1999, HUM MOL GENET, V8, P899, DOI 10.1093/hmg/8.5.899; Frassetto LJ, 2006, INVEST OPHTH VIS SCI, V47, P427, DOI 10.1167/iovs.05-0340; Garcia JGN, 1997, AM J PHYSIOL-LUNG C, V273, pL172, DOI 10.1152/ajplung.1997.273.1.L172; Gobeil S, 2006, EXP EYE RES, V82, P1017, DOI 10.1016/j.exer.2005.11.002; Goldwich A, 2009, HISTOCHEM CELL BIOL, V131, P167, DOI 10.1007/s00418-008-0518-4; Gould DB, 2004, MOL CELL BIOL, V24, P9019, DOI 10.1128/MCB.24.20.9019-9025.2004; Harvey R, 2007, INVEST OPHTH VIS SCI, V48, P1884, DOI 10.1167/iovs.06-0990; Jacobson N, 2001, HUM MOL GENET, V10, P117, DOI 10.1093/hmg/10.2.117; Joe MK, 2005, BIOCHEM BIOPH RES CO, V336, P1201, DOI 10.1016/j.bbrc.2005.09.006; Jurynec MJ, 2003, MOL CELL NEUROSCI, V23, P69, DOI 10.1016/S1044-7431(03)00019-8; Kameda T, 2012, INVEST OPHTH VIS SCI, V53, P3092, DOI 10.1167/iovs.11-8018; Karali A, 2000, INVEST OPHTH VIS SCI, V41, P729; Kim BS, 2001, MOL CELL BIOL, V21, P7707, DOI 10.1128/MCB.21.22.7707-7713.2001; Koga T, 2010, AM J PATHOL, V176, P343, DOI 10.2353/ajpath.2010.090194; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Kwon HS, 2009, MOL CELL BIOL, V29, P2139, DOI 10.1128/MCB.01274-08; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Lee JG, 2009, INVEST OPHTH VIS SCI, V50, P2067, DOI 10.1167/iovs.08-3135; Lee OT, 2008, CURR EYE RES, V33, P849, DOI 10.1080/02713680802429210; Li YX, 2006, BIOCHEM BIOPH RES CO, V339, P797, DOI 10.1016/j.bbrc.2005.11.082; Liu YH, 2004, HUM MOL GENET, V13, P1193, DOI 10.1093/hmg/ddh128; Liu YT, 2011, EXP EYE RES, V93, P331, DOI 10.1016/j.exer.2011.08.007; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Nusrat A, 2000, J BIOL CHEM, V275, P29816, DOI 10.1074/jbc.M002450200; Park BC, 2007, GENES CELLS, V12, P969, DOI 10.1111/j.1365-2443.2007.01102.x; Polansky JR, 1997, OPHTHALMOLOGICA, V211, P126, DOI 10.1159/000310780; Rao PV, 2000, EXP EYE RES, V71, P637, DOI 10.1006/exer.2000.0920; Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901; Rozsa F W, 1998, Mol Vis, V4, P20; Runkle EA, 2011, METHODS MOL BIOL, V686, P133, DOI 10.1007/978-1-60761-938-3_5; Russell P, 2001, INVEST OPHTH VIS SCI, V42, P983; Sakai H, 2007, J CELL PHYSIOL, V213, P775, DOI 10.1002/jcp.21147; Sakai H, 2006, INVEST OPHTH VIS SCI, V47, P4427, DOI 10.1167/iovs.06-0047; Sanchez-Sanchez F, 2007, J BIOL CHEM, V282, P27810, DOI 10.1074/jbc.M609608200; Sarfarazi M, 1998, AM J HUM GENET, V62, P641, DOI 10.1086/301767; Schwechter BR, 2007, INVEST OPHTH VIS SCI, V48, P2845, DOI 10.1167/iovs.06-1364; Senatorov V, 2006, J NEUROSCI, V26, P11903, DOI 10.1523/JNEUROSCI.3020-06.2006; SHEFFIELD VC, 1993, NAT GENET, V4, P47, DOI 10.1038/ng0593-47; Shen X, 2008, J BIOL CHEM, V283, P603, DOI 10.1074/jbc.M708250200; Shimizu S, 2000, AM J OPHTHALMOL, V130, P165, DOI 10.1016/S0002-9394(00)00536-5; Shivanna M, 2010, J OCUL PHARMACOL TH, V26, P1, DOI 10.1089/jop.2009.0025; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; Srinivas SP, 2012, EXP EYE RES, V95, P8, DOI 10.1016/j.exer.2011.09.009; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Swiderski RE, 2000, INVEST OPHTH VIS SCI, V41, P3420; Takahashi H, 1998, BIOCHEM BIOPH RES CO, V248, P104, DOI 10.1006/bbrc.1998.8917; Tamm ER, 2002, PROG RETIN EYE RES, V21, P395, DOI 10.1016/S1350-9462(02)00010-1; Torrado M, 2002, HUM MOL GENET, V11, P1291, DOI 10.1093/hmg/11.11.1291; Ueda J, 2002, INVEST OPHTH VIS SCI, V43, P1068; Underwood JL, 1999, AM J PHYSIOL-CELL PH, V277, pC330, DOI 10.1152/ajpcell.1999.277.2.C330; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; Wentz-Hunter K, 2004, EXP CELL RES, V297, P39, DOI 10.1016/j.yexcr.2004.02.024; Wentz-Hunter K, 2002, INVEST OPHTH VIS SCI, V43, P176; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Yam GHF, 2007, AM J PATHOL, V170, P100, DOI 10.2353/ajpath.2007.060806; Yang C, 2009, INVEST OPHTH VIS SCI, V50, P1290, DOI 10.1167/iovs.08-1920; Ying HY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009168; Yue BYJT, 1996, SURV OPHTHALMOL, V40, P379; Zhou Y, 2008, INVEST OPHTH VIS SCI, V49, P1932, DOI 10.1167/iovs.07-1339; Zhuo YH, 2010, MOL VIS, V16, P61	78	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47307	10.1371/journal.pone.0047307	http://dx.doi.org/10.1371/journal.pone.0047307			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082156	Green Published, gold			2022-12-25	WOS:000311146900052
J	Nienhaus, U; Aegerter-Wilmsen, T; Aegerter, CM				Nienhaus, Ulrike; Aegerter-Wilmsen, Tinri; Aegerter, Christof M.			In-Vivo Imaging of the Drosophila Wing Imaginal Disc over Time: Novel Insights on Growth and Boundary Formation	PLOS ONE			English	Article							MORPHOGEN GRADIENT; GENE-EXPRESSION; DYNAMICS; PROLIFERATION; MECHANISM; PROTEIN; NOTCH; VEIN; SIZE	In developmental biology, the sequence of gene induction and pattern formation is best studied over time as an organism develops. However, in the model system of Drosophila larvae this oftentimes proves difficult due to limitations in imaging capabilities. Using the larval wing imaginal disc, we show that both overall growth, as well as the creation of patterns such as the distinction between the anterior(A) and posterior(P) compartments and the dorsal(D) and ventral(V) compartments can be studied directly by imaging the wing disc as it develops inside a larva. Imaged larvae develop normally, as can be seen by the overall growth curve of the wing disc. Yet, the fact that we can follow the development of individual discs through time provides the opportunity to simultaneously assess individual variability. We for instance find that growth rates can vary greatly over time. In addition, we observe that mechanical forces act on the wing disc within the larva at times when there is an increase in growth rates. Moreover, we observe that A/P boundary formation follows the established sequence and a smooth boundary is present from the first larval instar on. The division of the wing disc into a dorsal and a ventral compartment, on the other hand, develops quite differently. Contrary to expectation, the specification of the dorsal compartment starts with only one or two cells in the second larval instar and a smooth boundary is not formed until the third larval instar.	[Nienhaus, Ulrike; Aegerter, Christof M.] Univ Zurich, Inst Phys, Zurich, Switzerland; [Aegerter-Wilmsen, Tinri] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland	University of Zurich; University of Zurich	Aegerter, CM (corresponding author), Univ Zurich, Inst Phys, Zurich, Switzerland.	aegerter@physik.uzh.ch		Aegerter, Christof/0000-0002-7200-7987	Swiss National Science Foundation; Forschungskredit of UZH; SystemsX.ch as part of the RTD WingX	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Forschungskredit of UZH; SystemsX.ch as part of the RTD WingX	This work was supported by the Swiss National Science Foundation (www.snf.ch), the Forschungskredit of UZH as well as SystemsX.ch as part of the RTD WingX, www.systemsx.ch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aegerter-Wilmsen T, 2007, MECH DEVELOP, V124, P318, DOI 10.1016/j.mod.2006.12.005; Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166; Aldaz S, 2010, P NATL ACAD SCI USA, V107, P14217, DOI 10.1073/pnas.1008623107; Ben-Zvi D, 2011, CURR BIOL, V21, P1391, DOI 10.1016/j.cub.2011.07.015; Bialek W, 2004, SCIENCE, V303, P788, DOI 10.1126/science.1095480; Bittig T, 2009, EUR PHYS J E, V30, P93, DOI 10.1140/epje/i2009-10507-6; BLAIR SS, 1994, DEVELOPMENT, V120, P1805; BROWER DL, 1984, NATURE, V310, P496, DOI 10.1038/310496a0; BROWER DL, 1986, EMBO J, V5, P2649, DOI 10.1002/j.1460-2075.1986.tb04547.x; Dahmann C, 2000, CELL, V100, P411, DOI 10.1016/S0092-8674(00)80677-7; DAMBLYCHAUDIERE C, 1986, DEV BIOL, V113, P288, DOI 10.1016/0012-1606(86)90164-8; Donaldson T, 2004, GENETICS, V167, P687, DOI 10.1534/genetics.103.019588; Fuger P, 2007, NAT PROTOC, V2, P3285, DOI 10.1038/nprot.2007.472; Garcia-Bellido A, 1998, GENETICS, V148, P539; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Hamaratoglu F, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001182; Hufnagel L, 2007, P NATL ACAD SCI USA, V104, P3835, DOI 10.1073/pnas.0607134104; Kanodia J, 2009, P NATL ACAD SCI USA, V106, P1087; Kicheva A, 2007, SCIENCE, V315, P521, DOI 10.1126/science.1135774; Landsberg KP, 2009, CURR BIOL, V19, P1950, DOI 10.1016/j.cub.2009.10.021; MADHAVAN MM, 1977, ROUX ARCH DEV BIOL, V183, P269, DOI 10.1007/BF00848459; Mao YL, 2011, GENE DEV, V25, P131, DOI 10.1101/gad.610511; Milan M, 1996, P NATL ACAD SCI USA, V93, P640, DOI 10.1073/pnas.93.2.640; Milan M, 2005, DEV DYNAM, V233, P804, DOI 10.1002/dvdy.20384; Milan M, 2003, DEVELOPMENT, V130, P553, DOI 10.1242/dev.00276; Milan M, 1999, MOL CELL, V4, P1073, DOI 10.1016/S1097-2765(00)80235-X; Ng M, 1996, NATURE, V381, P316, DOI 10.1038/381316a0; Nienhaus U, 2009, MECH DEVELOP, V126, P942, DOI 10.1016/j.mod.2009.09.002; Oda H, 2001, J CELL SCI, V114, P493; Rasse TM, 2005, NAT NEUROSCI, V8, P898, DOI 10.1038/nn1484; Schnepp B, 1996, GENE DEV, V10, P2302, DOI 10.1101/gad.10.18.2302; Shraiman BI, 2005, P NATL ACAD SCI USA, V102, P3318, DOI 10.1073/pnas.0404782102; TABATA T, 1995, DEVELOPMENT, V121, P3359; Teleman AA, 2000, CELL, V103, P971, DOI 10.1016/S0092-8674(00)00199-9; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Wang SH, 2000, GENE DEV, V14, P2271, DOI 10.1101/gad.827000; Wartlick O, 2011, SCIENCE, V331, P1154, DOI 10.1126/science.1200037; Weihe U, 2001, DEVELOPMENT, V128, P4615; Wessells RJ, 1999, DEV BIOL, V216, P243, DOI 10.1006/dbio.1999.9459; Zecca M, 2002, DEVELOPMENT, V129, P1357; Zecca M, 2002, DEVELOPMENT, V129, P1369; Zito K, 1999, NEURON, V22, P719, DOI 10.1016/S0896-6273(00)80731-X	42	25	26	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47594	10.1371/journal.pone.0047594	http://dx.doi.org/10.1371/journal.pone.0047594			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091633	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000310135800057
J	Hagemann, N; Ackermann, N; Christmann, J; Brier, S; Yu, F; Erdmann, KS				Hagemann, N.; Ackermann, N.; Christmann, J.; Brier, S.; Yu, F.; Erdmann, K. S.			The serologically defined colon cancer antigen-3 interacts with the protein tyrosine phosphatase PTPN13 and is involved in the regulation of cytokinesis	ONCOGENE			English	Article						endosome; cytokinesis; Arf6; colon; vesicular trafficking; protein tyrosine phosphatase	FAS-MEDIATED APOPTOSIS; FERM DOMAIN; CELL-SURFACE; KINASE; FAP-1; TUMORIGENESIS; BL; AGGRESSIVENESS; TRAFFICKING; ANEUPLOIDY	Cytokinesis is the final step of cell division. Increasing evidence suggests failure of cytokinesis might contribute to the development of cancer. Here, we demonstrate that the serologically defined colon cancer antigen-3 (SDCCAG3) forms a complex with PTPN13, a protein tyrosine phosphatase known to be involved in the regulation of cytokinesis, carcinogenesis and tumor aggressiveness. We show that SDCCAG3 is a novel endosomal protein, primarily localized at the early/recycling endosomal compartment. SDCCAG3 undergoes dynamic localization during cell division with strong accumulation at the midbody during cytokinesis. Overexpression as well as downregulation correlates with the generation of multinucleate cells. Furthermore, we show interaction of SDCCAG3 with the Arf GTPase activating protein GIT1 (G protein-coupled receptor kinase interactor-1). Overexpression of an ArfGAP-negative version of GIT1 also results in an increased number of multinucleate cells suggesting regulation of Arf-mediated vesicular trafficking or signaling via SDCCAG3. Finally, we demonstrate that SDCCAG3 expression levels are elevated in colon cancers. In summary, we have established SDCCAG3 as a novel endosomal protein, which is involved in the regulation of cytokinesis.	[Hagemann, N.; Ackermann, N.; Christmann, J.; Brier, S.; Yu, F.; Erdmann, K. S.] Ruhr Univ Bochum, Dept Biochem 2, D-44780 Bochum, Germany	Ruhr University Bochum	Erdmann, KS (corresponding author), Univ Sheffield, Dept Biomed Sci, Ctr Membrane Interact & Dynam, Sheffield S10 2TN, S Yorkshire, England.	k.erdmann@sheffield.ac.uk	Brier, Sebastien/L-7787-2019	Brier, Sebastien/0000-0003-1758-8237; Christmann, Jens/0000-0002-8625-2991	German research foundation [SFB642]	German research foundation(German Research Foundation (DFG))	We would like to thank Rolf Heumann for longstanding support. This work was supported by a grant from the German research foundation (SFB642) to KSE.	Abaan OD, 2005, ONCOGENE, V24, P2715, DOI 10.1038/sj.onc.1208247; Ai Erkang, 2009, Communicative & Integrative Biology, V2, P444; Bompard G, 2003, J CELL SCI, V116, P2519, DOI 10.1242/jcs.00448; Chesneau L, 2012, CURR BIOL, V22, P147, DOI 10.1016/j.cub.2011.11.058; Claing A, 2000, P NATL ACAD SCI USA, V97, P1119, DOI 10.1073/pnas.97.3.1119; Cuppen E, 1999, J CELL SCI, V112, P3299; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Echard A, 2008, BIOCHEM SOC T, V36, P395, DOI 10.1042/BST0360395; Erdmann KS, 2003, EUR J BIOCHEM, V270, P4789, DOI 10.1046/j.1432-1033.2003.03895.x; Freiss G, 2011, ANTI-CANCER AGENT ME, V11, P78, DOI 10.2174/187152011794941262; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Glondu-Lassis M, 2010, CANCER RES, V70, P5116, DOI 10.1158/0008-5472.CAN-09-4368; Gross C, 2001, FEBS LETT, V496, P101, DOI 10.1016/S0014-5793(01)02401-2; Hamada K, 2000, EMBO J, V19, P4449, DOI 10.1093/emboj/19.17.4449; Hendriks W, 1995, J CELL BIOCHEM, V59, P418, DOI 10.1002/jcb.240590403; Herrmann L, 2003, MOL BIOL CELL, V14, P230, DOI 10.1091/mbc.E02-04-0191; Hoover AC, 2009, ONCOGENE, V28, P3960, DOI 10.1038/onc.2009.251; Ivanov VN, 2003, MOL CELL BIOL, V23, P3623, DOI 10.1128/MCB.23.10.3623-3635.2003; Kouranti I, 2006, CURR BIOL, V16, P1719, DOI 10.1016/j.cub.2006.07.020; Lahuna O, 2005, EMBO J, V24, P1364, DOI 10.1038/sj.emboj.7600616; Li Y, 2000, INT J CANCER, V87, P473, DOI 10.1002/1097-0215(20000815)87:4<473::AID-IJC3>3.0.CO;2-1; Montagnac G, 2008, CURR OPIN CELL BIOL, V20, P454, DOI 10.1016/j.ceb.2008.03.011; Montagnac G, 2009, CURR BIOL, V19, P184, DOI 10.1016/j.cub.2008.12.043; Neto H, 2011, BIOCHEM J, V437, P13, DOI 10.1042/BJ20110153; Neznanov N, 2005, DNA CELL BIOL, V24, P777, DOI 10.1089/dna.2005.24.777; Prekeris R, 2008, J CELL SCI, V121, P1569, DOI 10.1242/jcs.018770; Premont RT, 2000, J BIOL CHEM, V275, P22373, DOI 10.1074/jbc.275.29.22373; Premont RT, 1998, P NATL ACAD SCI USA, V95, P14082, DOI 10.1073/pnas.95.24.14082; SATO T, 1995, SCIENCE, V268, P411, DOI 10.1126/science.7536343; Scanlan MJ, 1998, INT J CANCER, V76, P652, DOI 10.1002/(SICI)1097-0215(19980529)76:5<652::AID-IJC7>3.3.CO;2-9; Schickel R, 2010, MOL CELL, V38, P908, DOI 10.1016/j.molcel.2010.05.018; Schmidt A, 2007, EMBO J, V26, P1624, DOI 10.1038/sj.emboj.7601637; Schweitzer JK, 2005, EXP CELL RES, V311, P74, DOI 10.1016/j.yexcr.2005.07.033; Scrima M, 2012, AM J PATHOL, V180, P1202, DOI 10.1016/j.ajpath.2011.11.038; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Ungefroren H, 2001, J CELL SCI, V114, P2735; Ungefroren H, 1998, CANCER RES, V58, P1741; Wang ZH, 2004, SCIENCE, V304, P1164, DOI 10.1126/science.1096096; Weaver BAA, 2007, CANCER RES, V67, P10103, DOI 10.1158/0008-5472.CAN-07-2266; Zhao ZS, 2005, MOL CELL, V20, P237, DOI 10.1016/j.molcel.2005.08.035; Zhu JH, 2008, ONCOGENE, V27, P2525, DOI 10.1038/sj.onc.1210922	43	23	28	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP 26	2013	32	39					4602	4613		10.1038/onc.2012.485	http://dx.doi.org/10.1038/onc.2012.485			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	226YD	23108400				2022-12-25	WOS:000325072200002
J	De La Vega-Beltran, JL; Sanchez-Cardenas, C; Krapf, D; Hernandez-Gonzalez, EO; Wertheimer, E; Trevino, CL; Visconti, PE; Darszon, A				Luis De La Vega-Beltran, Jose; Sanchez-Cardenas, Claudia; Krapf, Dario; Hernandez-Gonzalez, Enrique O.; Wertheimer, Eva; Trevino, Claudia L.; Visconti, Pablo E.; Darszon, Alberto			Mouse Sperm Membrane Potential Hyperpolarization Is Necessary and Sufficient to Prepare Sperm for the Acrosome Reaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; PROTEIN-TYROSINE PHOSPHORYLATION; SPERMATOGENIC CELLS; CA2+ CHANNELS; ZONA-PELLUCIDA; CALCIUM-CHANNELS; MAMMALIAN SPERM; MALE-FERTILITY; K+ CURRENT; CAPACITATION	Mammalian sperm are unable to fertilize the egg immediately after ejaculation; they acquire this capacity during migration in the female reproductive tract. This maturational process is called capacitation and in mouse sperm it involves a plasma membrane reorganization, extensive changes in the state of protein phosphorylation, increases in intracellular pH (pH(i)) and Ca2+ ([Ca2+](i)), and the appearance of hyperactivated motility. In addition, mouse sperm capacitation is associated with the hyperpolarization of the cell membrane potential. However, the functional role of this process is not known. In this work, to dissect the role of this membrane potential change, hyperpolarization was induced in noncapacitated sperm using either the ENaC inhibitor amiloride, the CFTR agonist genistein or the K+ ionophore valinomycin. In this experimental setting, other capacitation-associated processes such as activation of a cAMP-dependent pathway and the consequent increase in protein tyrosine phosphorylation were not observed. However, hyperpolarization was sufficient to prepare sperm for the acrosome reaction induced either by depolarization with high K+ or by addition of solubilized zona pellucida (sZP). Moreover, K+ and sZP were also able to increase [Ca2+](i) in non-capacitated sperm treated with these hyperpolarizing agents but not in untreated cells. On the other hand, in conditions that support capacitation-associated processes blocking hyperpolarization by adding valinomycin and increasing K+ concentrations inhibited the agonist-induced acrosome reaction as well as the increase in [Ca2+](i). Altogether, these results suggest that sperm hyperpolarization by itself is key to enabling mice sperm to undergo the acrosome reaction.	[Luis De La Vega-Beltran, Jose; Sanchez-Cardenas, Claudia; Trevino, Claudia L.; Darszon, Alberto] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Genet Desarrollo & Fisiol Mol, Cuernavaca 62210, Morelos, Mexico; [Krapf, Dario] Univ Nacl Rosario, CONICET, Inst Biol Mol & Celular Rosario, RA-2000 Rosario, Santa Fe, Argentina; [Hernandez-Gonzalez, Enrique O.] CINVESTAV, IPN, Dept Biol Celular, Mexico City 07360, DF, Mexico; [Wertheimer, Eva; Visconti, Pablo E.] Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA	Universidad Nacional Autonoma de Mexico; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; University of Massachusetts System; University of Massachusetts Amherst	Visconti, PE (corresponding author), Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA.	pvisconti@vasci.umass.edu; darszon@ibt.unam.mx	Hernández-González, Enrique/AAU-8526-2020	Trevino, Claudia L/0000-0002-7281-0534; Krapf, Dario/0000-0001-7607-1954; Darszon, Alberto/0000-0002-2502-0505	National Institutes of Health [R01 HD44044, HD038082]; CONACyT-Mexico [49113, 128566, 47011, 99333]; DGAPA/UNAM [IN211809, IN225406, IN204109, IN202212-3]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD044044, R01HD038082] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA/UNAM(Universidad Nacional Autonoma de Mexico); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 HD44044 and HD038082 (to P. E. V.), CONACyT-Mexico, (49113 and 128566, to A. D., 47011 and 99333, to C. T.), DGAPA/UNAM (IN211809 and IN225406, to A. D., IN204109 and IN202212-3, to C. T.).	Acevedo JJ, 2006, DEV BIOL, V289, P395, DOI 10.1016/j.ydbio.2005.11.002; Arnoult C, 1999, P NATL ACAD SCI USA, V96, P6757, DOI 10.1073/pnas.96.12.6757; Arnoult C, 1996, P NATL ACAD SCI USA, V93, P13004, DOI 10.1073/pnas.93.23.13004; Arnoult C, 1998, MOL PHARMACOL, V53, P1104; Bello OD, 2012, EXP CELL RES, V318, P478, DOI 10.1016/j.yexcr.2012.01.002; Bennett JC, 2010, J BIOL CHEM, V285, P26269, DOI 10.1074/jbc.M109.095752; Chang HX, 2010, BIOL REPROD, V83, P507, DOI 10.1095/biolreprod.109.083113; Chavez JC, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094037; Chen JH, 2009, J BIOL CHEM, V284, P35495, DOI 10.1074/jbc.M109.072678; Chen WY, 2009, BIOL REPROD, V80, P115, DOI 10.1095/biolreprod.108.068528; Darszon A, 2006, CELL CALCIUM, V40, P241, DOI 10.1016/j.ceca.2006.04.028; Darszon A, 2011, PHYSIOL REV, V91, P1305, DOI 10.1152/physrev.00028.2010; Demarco IA, 2003, J BIOL CHEM, V278, P7001, DOI 10.1074/jbc.M206284200; Escoffier J, 2007, J CELL PHYSIOL, V212, P753, DOI 10.1002/jcp.21075; Escoffier J, 2012, J CELL SCI, V125, P473, DOI 10.1242/jcs.093344; ESPINOSA F, 1995, FEBS LETT, V372, P119, DOI 10.1016/0014-5793(95)00962-9; Espinosa F, 1998, FEBS LETT, V426, P47, DOI 10.1016/S0014-5793(98)00305-6; Fierro D. F., 2012, J CELL PHYS IN PRESS; FLORMAN HM, 1992, DEV BIOL, V152, P304, DOI 10.1016/0012-1606(92)90137-6; Florman HM, 1998, BIOL REPROD, V59, P12, DOI 10.1095/biolreprod59.1.12; Hernandez-Gonzalez EO, 2007, J BIOL CHEM, V282, P24397, DOI 10.1074/jbc.M701603200; Hernandez-Gonzalez EO, 2006, J BIOL CHEM, V281, P5623, DOI 10.1074/jbc.M508172200; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Lievano A, 1996, FEBS LETT, V388, P150, DOI 10.1016/0014-5793(96)00515-7; Lishko PV, 2012, ANNU REV PHYSIOL, V74, P453, DOI 10.1146/annurev-physiol-020911-153258; Lishko PV, 2011, NATURE, V471, P387, DOI 10.1038/nature09767; Lopez-Gonzalez I, 2001, DEV BIOL, V236, P210, DOI 10.1006/dbio.2001.0314; Luke T, 2012, AM J PHYSIOL-LUNG C, V302, pL1128, DOI 10.1152/ajplung.00396.2011; Martinez-Lopez P, 2009, BIOCHEM BIOPH RES CO, V381, P204, DOI 10.1016/j.bbrc.2009.02.008; Mayorga LS, 2007, IUBMB LIFE, V59, P286, DOI 10.1080/15216540701222872; McPartlin LA, 2011, BIOL REPROD, V85, P179, DOI 10.1095/biolreprod.110.085555; MOORE GD, 1994, DEVELOPMENT, V120, P3313; Munoz-Garay C, 2001, DEV BIOL, V234, P261, DOI 10.1006/dbio.2001.0196; Navarro B, 2007, P NATL ACAD SCI USA, V104, P7688, DOI 10.1073/pnas.0702018104; Nisihigaki T., 2006, BIOTECHNIQUES, V41, P191; Okunande GW, 2004, J BIOL CHEM, V279, P33742, DOI 10.1074/jbc.M404628200; Reddy MM, 2009, J MEMBRANE BIOL, V231, P65, DOI 10.1007/s00232-009-9205-1; Ren DJ, 2010, PHYSIOLOGY, V25, P165, DOI 10.1152/physiol.00049.2009; Rode B, 2012, HUM MOL GENET, V21, P1287, DOI 10.1093/hmg/ddr558; Samak G, 2011, J BIOL CHEM, V286, P30232, DOI 10.1074/jbc.M111.240358; Santi CM, 2010, FEBS LETT, V584, P1041, DOI 10.1016/j.febslet.2010.02.005; Santi CM, 1996, AM J PHYSIOL-CELL PH, V271, pC1583, DOI 10.1152/ajpcell.1996.271.5.C1583; Saponara S, 2011, BRIT J PHARMACOL, V164, P1684, DOI 10.1111/j.1476-5381.2011.01476.x; Schaefer AT, 2003, BIOPHYS J, V84, P3508, DOI 10.1016/S0006-3495(03)75086-3; Schuh K, 2004, J BIOL CHEM, V279, P28220, DOI 10.1074/jbc.M312599200; Trevino CL, 2004, FEBS LETT, V563, P87, DOI 10.1016/S0014-5793(04)00257-1; Trevino CL, 2001, FEBS LETT, V509, P119, DOI 10.1016/S0014-5793(01)03134-9; Visconti PE, 2011, ASIAN J ANDROL, V13, P395, DOI 10.1038/aja.2010.69; Visconti PE, 2009, P NATL ACAD SCI USA, V106, P667, DOI 10.1073/pnas.0811895106; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; Visconti PE, 1999, J BIOL CHEM, V274, P3235, DOI 10.1074/jbc.274.5.3235; VISCONTI PE, 1995, DEVELOPMENT, V121, P1129; Wang D, 2003, NAT CELL BIOL, V5, P1117, DOI 10.1038/ncb1072; WARD CR, 1992, J BIOL CHEM, V267, P14061; Xia JS, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-119; Xia JS, 2009, BIOL REPROD, V80, P1092, DOI 10.1095/biolreprod.108.074039; Xu WM, 2007, P NATL ACAD SCI USA, V104, P9816, DOI 10.1073/pnas.0609253104; Zeng XH, 2011, P NATL ACAD SCI USA, V108, P5879, DOI 10.1073/pnas.1100240108; ZENG Y, 1995, DEV BIOL, V171, P554, DOI 10.1006/dbio.1995.1304	60	65	67	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44384	44393		10.1074/jbc.M112.393488	http://dx.doi.org/10.1074/jbc.M112.393488			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23095755	Green Published, hybrid			2022-12-25	WOS:000312938600035
J	Banerjee, A; Qian, PX; Wu, ZS; Ren, XG; Steiner, M; Bougen, NM; Liu, SL; Liu, DX; Zhu, T; Lobie, PE				Banerjee, Arindam; Qian, PengXu; Wu, Zheng-Sheng; Ren, Xiaoge; Steiner, Michael; Bougen, Nicola M.; Liu, Suling; Liu, Dong-Xu; Zhu, Tao; Lobie, Peter E.			Artemin Stimulates Radio- and Chemo-resistance by Promoting TWIST1-BCL-2-dependent Cancer Stem Cell-like Behavior in Mammary Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BREAST-CANCER; GENE-EXPRESSION; ALDEHYDE DEHYDROGENASE; THERAPEUTIC TARGET; ESTROGEN-RECEPTOR; UP-REGULATION; GDNF FAMILY; CLAUDIN-LOW; BCL-2	Artemin (ARTN) has been reported to promote a TWIST1-dependent epithelial to mesenchymal transition of estrogen receptor negative mammary carcinoma (ER-MC) cells associated with metastasis and poor survival outcome. We therefore examined a potential role of ARTN in the promotion of the cancer stem cell (CSC)-like phenotype in mammary carcinoma cells. Acquired resistance of ER-MC cells to either ionizing radiation (IR) or paclitaxel was accompanied by increased ARTN expression. Small interfering RNA (siRNA)-mediated depletion of ARTN in either IR- or paclitaxel-resistant ER-MC cells restored cell sensitivity to IR or paclitaxel. Expression of ARTN was enriched in ER-MC cells grown in mammospheric compared with monolayer culture and was also enriched along with BMI1, TWIST1, and DVL1 in mammospheric and ALDH1+ populations. ARTN promoted mammospheric growth and self-renewal of ER-MC cells and increased the ALDH1+ population, whereas siRNA-mediated depletion of ARTN diminished these CSC-like cell behaviors. Furthermore, increased ARTN expression was significantly correlated with ALDH1 expression in a cohort of ER-MC patients. Forced expression of ARTN also dramatically enhanced tumor initiating capacity of ER-MC cells in xenograft models at low inoculum. ARTN promotion of the CSC-like cell phenotype was mediated by TWIST1 regulation of BCL-2 expression. ARTN also enhanced mammosphere formation and the ALDH1 + population in estrogen receptor-positive mammary carcinoma (ER + MC) cells. Increased expression of ARTN and the functional consequences thereof may be one common adaptive mechanism used by mammary carcinoma cells to promote cell survival and renewal in hostile tumor microenvironments.	[Qian, PengXu; Wu, Zheng-Sheng; Liu, Suling; Zhu, Tao] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China; [Qian, PengXu; Wu, Zheng-Sheng; Liu, Suling; Zhu, Tao] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Anhui, Peoples R China; [Banerjee, Arindam; Ren, Xiaoge; Steiner, Michael; Liu, Dong-Xu; Lobie, Peter E.] Univ Auckland, Liggins Inst, Auckland 1023, New Zealand; [Wu, Zheng-Sheng] Anhui Med Univ, Dept Pathol, Hefei, Anhui, Peoples R China; [Wu, Zheng-Sheng] Fudan Univ, Shanghai Med Coll, Dept Pathol, Shanghai 200433, Peoples R China; [Bougen, Nicola M.; Lobie, Peter E.] Natl Univ Singapore, Canc Sci Inst Singapore, Singapore 117599, Singapore; [Bougen, Nicola M.; Lobie, Peter E.] Natl Univ Singapore, Dept Pharmacol, Singapore 117599, Singapore	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; University of Auckland; Anhui Medical University; Fudan University; National University of Singapore; National University of Singapore	Zhu, T (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Hefei 230027, Anhui, Peoples R China.	zhut@ustc.edu.cn; csipel@nus.edu.sg	Liu, Suling/N-2796-2013; liu, suling/AAF-5249-2019; Qian, Pengxu/B-9376-2016	Liu, Suling/0000-0002-0475-0242; liu, suling/0000-0002-0475-0242; Qian, Pengxu/0000-0001-5636-6704; Bougen-Zhukov, Nicola/0000-0001-9535-1150	Breast Cancer Research Trust (New Zealand); Dick Roberts Trust (New Zealand); Cancer Science Institute (Singapore); National Key Scientific Programme of China [2012CB934002, 2010CB912804]; Chinese Academy of Sciences [XDA1040410]; National Natural Science Foundation of China [30971492, 81101597]; Chinese Academy of Sciences Visiting Professorship for Senior International Scientists [2010T2S03]; Saratan Therapeutics Ltd.	Breast Cancer Research Trust (New Zealand); Dick Roberts Trust (New Zealand); Cancer Science Institute (Singapore); National Key Scientific Programme of China; Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences Visiting Professorship for Senior International Scientists; Saratan Therapeutics Ltd.	This work was funded by the Breast Cancer Research Trust (New Zealand), The Dick Roberts Trust (New Zealand), Cancer Science Institute (Singapore), The National Key Scientific Programme of China (2012CB934002 and 2010CB912804), Chinese Academy of Sciences (XDA1040410), National Natural Science Foundation of China (30971492 and 81101597), and the Chinese Academy of Sciences Visiting Professorship for Senior International Scientists (2010T2S03). D.-X. L. and P. E. L. are inventors of PCT/NZ2008/000152 and derivatives thereof. P. E. L. is an inventor of PCT/NZ2010/000207 and derivatives thereof. Z. T. and P. E. L. received consultancies from Saratan Therapeutics Ltd (a biotech company formed around the potential to use Artemin as a target for breast cancer). Salaries of D.-X. L. and A. B. were supported in part by Saratan Therapeutics Ltd.	Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Ansieau S, 2010, ONCOGENE, V29, P3173, DOI 10.1038/onc.2010.92; Arpino G, 2008, ENDOCR REV, V29, P217, DOI 10.1210/er.2006-0045; Baloh RH, 1998, P NATL ACAD SCI USA, V95, P5801, DOI 10.1073/pnas.95.10.5801; Banerjee A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3054; Baumann M, 2008, NAT REV CANCER, V8, P545, DOI 10.1038/nrc2419; Bespalov MM, 2007, TRENDS PHARMACOL SCI, V28, P68, DOI 10.1016/j.tips.2006.12.005; Bespalov MM, 2011, J CELL BIOL, V192, P153, DOI 10.1083/jcb.201009136; Bjorklund A, 2010, PROG BRAIN RES, V184, P237, DOI 10.1016/S0079-6123(10)84013-0; Boulay A, 2008, CANCER RES, V68, P3743, DOI 10.1158/0008-5472.CAN-07-5100; Bratton MR, 2010, INT J ONCOL, V37, P541, DOI 10.3892/ijo_00000703; Chen JQ, 2009, BBA-REV CANCER, V1796, P162, DOI 10.1016/j.bbcan.2009.06.003; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Croker AK, 2009, J CELL MOL MED, V13, P2236, DOI 10.1111/j.1582-4934.2008.00455.x; Dawson SJ, 2010, BRIT J CANCER, V103, P668, DOI 10.1038/sj.bjc.6605736; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Deans AJ, 2006, CANCER RES, V66, P8219, DOI 10.1158/0008-5472.CAN-05-3945; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Eckert MA, 2011, CANCER CELL, V19, P372, DOI 10.1016/j.ccr.2011.01.036; Foubert E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2585; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; Gao MQ, 2010, ONCOGENE, V29, P2672, DOI 10.1038/onc.2010.35; Gazitt Y, 1998, INT J ONCOL, V13, P839; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hofmann MC, 2008, MOL CELL ENDOCRINOL, V288, P95, DOI 10.1016/j.mce.2008.04.012; Jameel JKA, 2004, BREAST, V13, P452, DOI 10.1016/j.breast.2004.08.004; Kallergi G, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2896; Kang J, 2010, ONCOGENE, V29, P3228, DOI 10.1038/onc.2010.71; Kang J, 2009, ONCOGENE, V28, P2034, DOI 10.1038/onc.2009.66; Karimi-Busheri F, 2010, CRYOBIOLOGY, V60, P308, DOI 10.1016/j.cryobiol.2010.02.005; Kerr Daniel Alan II, 2011, Hormones & Cancer, V2, P261, DOI 10.1007/s12672-011-0080-8; Korkaya H, 2008, ONCOGENE, V27, P6120, DOI 10.1038/onc.2008.207; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Kwok WK, 2005, CANCER RES, V65, P5153, DOI 10.1158/0008-5472.CAN-04-3785; Lang JY, 2011, CANCER CELL, V20, P341, DOI 10.1016/j.ccr.2011.07.017; Liu DX, 2007, CELL DEATH DIFFER, V14, P1893, DOI 10.1038/sj.cdd.4402209; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu SL, 2005, BREAST CANCER RES, V7, P86, DOI 10.1186/bcr1021; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; May CD, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2789; Morimoto K, 2009, CANCER SCI, V100, P1062, DOI 10.1111/j.1349-7006.2009.01151.x; Morrison R, 2011, J ONCOL, V2011, DOI 10.1155/2011/941876; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Pandey V, 2010, TRANSL ONCOL, V3, P218, DOI 10.1593/tlo.09325; Patel N, 2010, P NATL ACAD SCI USA, V107, P2503, DOI 10.1073/pnas.0910649107; Pearce AG, 2001, RADIAT RES, V156, P739, DOI 10.1667/0033-7587(2001)156[0739:TGACOA]2.0.CO;2; Pidgeon GP, 2001, BRIT J CANCER, V85, P273, DOI 10.1054/bjoc.2001.1876; Pisconti A, 2010, J CELL BIOL, V190, P427, DOI 10.1083/jcb.201003081; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Samuel S, 2010, MOL THER, V18, P2094, DOI 10.1038/mt.2010.188; Scheel C, 2011, CELL, V145, P926, DOI 10.1016/j.cell.2011.04.029; Song J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011456; Spinnler K, 2010, HUM REPROD, V25, P2181, DOI 10.1093/humrep/deq170; Takahashi-Yanaga F, 2010, CLIN CANCER RES, V16, P3153, DOI 10.1158/1078-0432.CCR-09-2943; Tang JZ, 2010, MOL CANCER THER, V9, P1697, DOI 10.1158/1535-7163.MCT-09-1077; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tawfik K, 2012, HUM PATHOL, V43, P23, DOI 10.1016/j.humpath.2011.04.011; Yang MH, 2010, NAT CELL BIOL, V12, P982, DOI 10.1038/ncb2099; Yang QF, 2009, BREAST CANCER RES TR, V115, P343, DOI 10.1007/s10549-008-0068-4; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	62	39	43	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42502	42515		10.1074/jbc.M112.365163	http://dx.doi.org/10.1074/jbc.M112.365163			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23095743	Green Published, hybrid			2022-12-25	WOS:000312501600012
J	Hayashi, T; Hayashi, E; Fujimoto, M; Sprong, H; Su, TP				Hayashi, Teruo; Hayashi, Eri; Fujimoto, Michiko; Sprong, Hein; Su, Tsung-Ping			The Lifetime of UDP-galactose: Ceramide Galactosyltransferase Is Controlled by a Distinct Endoplasmic Reticulum-associated Degradation (ERAD) Regulated by Sigma-1 Receptor Chaperones	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OLIGODENDROCYTE DIFFERENTIATION; BINDING-SITE; PROTEIN; EXPRESSION; CELLS; MICE; GLYCOSPHINGOLIPIDS; GALACTOSYLCERAMIDE; IDENTIFICATION; PURIFICATION	The glycosphingolipid biosynthesis is initiated by monoglycosylation of ceramides, the action of which is catalyzed either by UDP-glucose: ceramide glucosyltransferase or by UDP-galactose: ceramide galactosyltransferase (CGalT). CGalT is expressed predominantly at the endoplasmic reticulum (ER) of oligodendrocytes and is responsible for synthesizing galactosylceramides (GalCer) that play an important role in regulation of axon conductance. However, despite the importance of ceramide monoglycosylation enzymes in a spectrum of cellular functions, the mechanism that fine tunes activities of those enzymes is largely unknown. In the present study, we demonstrated that the sigma-1 receptor (Sig-1R) chaperone, the mammalian homologue of a yeast C8-C7 sterol isomerase, controls the protein level and activity of the CGalT enzyme via a distinct ER-associated degradation system involving Insig. The Sig-1R forms a complex with Insig via its transmembrane domain partly in a sterol-dependent manner and associates with CGalT at the ER. The knockdown of Sig-1Rs dramatically prolonged the lifetime of CGalT without affecting the trimming of N-linked oligosaccharides at CGalT. The increased lifetime leads to the up-regulation of CGalT protein as well as elevated enzymatic activity in CHO cells stably expressing CGalT. Knockdown of Sig-1Rs also decreased CGalT degradation endogenously expressed in D6P2T-schwannoma cells. Our data suggest that Sig-1Rs negatively regulate the activity of GalCer synthesis under physiological conditions by enhancing the degradation of CGalT through regulation of the dynamics of Insig in the lipid-activated ER-associated degradation system. The GalCer synthesis may thus be influenced by sterols at the ER.	[Hayashi, Teruo; Hayashi, Eri; Fujimoto, Michiko] NIDA, Cellular Stress Signaling Unit, NIH, Baltimore, MD 21224 USA; [Su, Tsung-Ping] NIDA, Cellular Pathobiol Sect, Integrat Neurosci Branch, Intramural Res Program,NIH, Baltimore, MD 21224 USA; [Sprong, Hein] Natl Inst Publ Hlth & Environm, Lab Zoonoses & Environm Microbiol, NL-3720 BA Bilthoven, Netherlands	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA); Netherlands National Institute for Public Health & the Environment	Hayashi, T (corresponding author), Seiwakai Nishikawa Hosp, 293-2 Minato Machi, Hamada, Shimane 6970052, Japan.	thayashi2r@gmail.com; tsu@intra.nida.nih.gov		Sprong, Hein/0000-0002-0218-4320	National Institutes of Health, NIDA, Intramural Research Program; NATIONAL INSTITUTE ON DRUG ABUSE [ZIADA000206] Funding Source: NIH RePORTER	National Institutes of Health, NIDA, Intramural Research Program; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by the National Institutes of Health, NIDA, Intramural Research Program.	Bansal R, 1999, J NEUROSCI, V19, P7913; Baulieu EE, 2001, INT REV NEUROBIOL, V46, P1; Bernasconi R, 2011, CURR OPIN CELL BIOL, V23, P176, DOI 10.1016/j.ceb.2010.10.002; Bernasconi R, 2010, J CELL BIOL, V188, P223, DOI 10.1083/jcb.200910042; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boggs JA, 2008, BBA-GEN SUBJECTS, V1780, P445, DOI 10.1016/j.bbagen.2007.10.015; Bowen W D, 2000, Pharm Acta Helv, V74, P211; Coetzee T, 1996, CELL, V86, P209, DOI 10.1016/S0092-8674(00)80093-8; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; Fewou SN, 2005, J NEUROCHEM, V94, P469, DOI 10.1111/j.1471-4159.2005.03221.x; Fontanilla D, 2009, SCIENCE, V323, P934, DOI 10.1126/science.1166127; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Hakomori SI, 2008, BBA-GEN SUBJECTS, V1780, P325, DOI 10.1016/j.bbagen.2007.08.015; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hanner M, 1996, P NATL ACAD SCI USA, V93, P8072, DOI 10.1073/pnas.93.15.8072; Hashimoto Kenji, 2009, Central Nervous System Agents in Medicinal Chemistry, V9, P197; Hayashi T, 2004, P NATL ACAD SCI USA, V101, P14949, DOI 10.1073/pnas.0402890101; Hayashi T, 2001, P NATL ACAD SCI USA, V98, P491, DOI 10.1073/pnas.021413698; Hayashi T, 2007, CELL, V131, P596, DOI 10.1016/j.cell.2007.08.036; Hayashi T, 2011, EXPERT OPIN THER TAR, V15, P557, DOI 10.1517/14728222.2011.560837; Hayashi T, 2010, MOL PHARMACOL, V77, P517, DOI 10.1124/mol.109.062539; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Iyanagi T, 2007, INT REV CYTOL, V260, P35, DOI 10.1016/S0074-7696(06)60002-8; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kim FJ, 2010, MOL PHARMACOL, V77, P695, DOI 10.1124/mol.109.057083; Kohyama-Koganeya A, 2004, J BIOL CHEM, V279, P35995, DOI 10.1074/jbc.M400444200; Lopez PHH, 2009, CURR OPIN STRUC BIOL, V19, P549, DOI 10.1016/j.sbi.2009.06.001; Matsumoto RR, 2002, NEUROPHARMACOLOGY, V42, P1043, DOI 10.1016/S0028-3908(02)00056-4; Maurice T, 1998, NEUROSCIENCE, V83, P413, DOI 10.1016/S0306-4522(97)00405-3; Meunier J, 2006, BRIT J PHARMACOL, V149, P998, DOI 10.1038/sj.bjp.0706927; Meunier J, 2010, J PHARMACOL EXP THER, V332, P388, DOI 10.1124/jpet.109.160960; Nuwayhid SJ, 2003, J PHARMACOL EXP THER, V304, P364, DOI 10.1124/jpet.102.043398; Pal A, 2007, MOL PHARMACOL, V72, P921, DOI 10.1124/mol.107.038307; Palacios G, 2003, BRAIN RES, V961, P92, DOI 10.1016/S0006-8993(02)03892-1; Ramachandran S, 2009, EUR J PHARMACOL, V609, P19, DOI 10.1016/j.ejphar.2009.03.003; Sabino V, 2009, NEUROPSYCHOPHARMACOL, V34, P1482, DOI 10.1038/npp.2008.192; SCHULTE S, 1993, P NATL ACAD SCI USA, V90, P10265, DOI 10.1073/pnas.90.21.10265; Sever N, 2004, J BIOL CHEM, V279, P43136, DOI 10.1074/jbc.M406406200; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Smith MH, 2011, SCIENCE, V334, P1086, DOI 10.1126/science.1209235; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; Sot J, 2005, BIOPHYS J, V88, P3368, DOI 10.1529/biophysj.104.057851; Sprong H, 2003, MOL BIOL CELL, V14, DOI 10.1091/mbc.E03-03-0130; Sprong H, 1998, J BIOL CHEM, V273, P25880, DOI 10.1074/jbc.273.40.25880; Sprong H, 2001, NAT REV MOL CELL BIO, V2, P504, DOI 10.1038/35080071; Sprong H, 2001, J CELL BIOL, V155, P369, DOI 10.1083/jcb.200106104; SU TP, 1988, SCIENCE, V240, P219, DOI 10.1126/science.2832949; Suchanek M, 2005, NAT METHODS, V2, P261, DOI 10.1038/NMETH752; van Meer G, 2000, BBA-MOL CELL BIOL L, V1486, P145, DOI 10.1016/S1388-1981(00)00054-8; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Xu JB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1386	52	37	38	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43156	43169		10.1074/jbc.M112.380444	http://dx.doi.org/10.1074/jbc.M112.380444			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105111	hybrid, Green Published			2022-12-25	WOS:000312501600070
J	Hirano, Y; Hizume, K; Kimura, H; Takeyasu, K; Haraguchi, T; Hiraoka, Y				Hirano, Yasuhiro; Hizume, Kohji; Kimura, Hiroshi; Takeyasu, Kunio; Haraguchi, Tokuko; Hiraoka, Yasushi			Lamin B Receptor Recognizes Specific Modifications of Histone H4 in Heterochromatin Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE PROTEIN LBR; ENVELOPE INNER MEMBRANE; NUCLEAR-ENVELOPE; CHROMODOMAIN PROTEINS; INTEGRAL PROTEIN; TUDOR DOMAIN; DNA-DAMAGE; CHROMATIN; BINDING; METHYLATION	Inner nuclear membrane proteins provide a structural framework for chromatin, modulating transcription beneath the nuclear envelope. Lamin B receptor (LBR) is a classical inner nuclear membrane protein that associates with heterochromatin, and its mutations are known to cause Pelger-Huet anomaly in humans. However, the mechanisms by which LBR organizes heterochromatin remain to be elucidated. Here, we show that LBR represses transcription by binding to chromatin regions that are marked by specific histone modifications. The tudor domain (residues 1-62) of LBR primarily recognizes histone H4 lysine 20 dimethylation and is essential for chromatin compaction, whereas the whole nucleoplasmic region (residues 1-211) is required for transcriptional repression. We propose a model in which the nucleoplasmic domain of LBR tethers epigenetically marked chromatin to the nuclear envelope and transcriptional repressors are loaded onto the chromatin through their interaction with LBR.	[Hirano, Yasuhiro; Kimura, Hiroshi; Haraguchi, Tokuko; Hiraoka, Yasushi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Hizume, Kohji] Natl Inst Genet, Div Microbial Genet, Mishima, Shizuoka 4118540, Japan; [Takeyasu, Kunio] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068501, Japan; [Haraguchi, Tokuko; Hiraoka, Yasushi] Natl Inst Informat & Communicat Technol, Adv ICT Res Inst Kobe, Kobe, Hyogo 6512492, Japan	Osaka University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Kyoto University; National Institute of Information & Communications Technology (NICT) - Japan	Hiraoka, Y (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Yamadaoka 1-3, Suita, Osaka 5650871, Japan.	hiraoka@fbs.osaka-u.ac.jp	Hirano, Yasuhiro/AAN-4617-2021; Hizume, Kohji/L-6661-2019; Hiraoka, Yasushi/B-5111-2009; Kimura, Hiroshi/B-9524-2015	Hiraoka, Yasushi/0000-0001-9407-8228; Kimura, Hiroshi/0000-0003-0854-083X; Hizume, Kohji/0000-0001-9091-9173; Hirano, Yasuhiro/0000-0001-7339-4053; Kimura, Hiroshi/0000-0002-4968-7144	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [24770157] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research on innovative areas (to Y. Hiraoka, H. K., and T. H.) and a grant-in-aid for scientific research on priority areas (to K. T.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), and a grant-in-aid for research activity start-up (to Y. Hirano) from the Japan Society for the Promotion of Science.	Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bock I, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-48; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Duband-Goulet I, 2000, BIOCHEMISTRY-US, V39, P6483, DOI 10.1021/bi992908b; Greeson NT, 2008, J BIOL CHEM, V283, P33168, DOI 10.1074/jbc.M806857200; Guarda A, 2009, EXP CELL RES, V315, P1895, DOI 10.1016/j.yexcr.2009.01.019; Haraguchi T, 2000, J CELL SCI, V113, P779; HAYES JJ, 1991, P NATL ACAD SCI USA, V88, P6829, DOI 10.1073/pnas.88.15.6829; Hirano Y, 2008, PFLUG ARCH EUR J PHY, V456, P139, DOI 10.1007/s00424-007-0431-z; Hirano Y, 2009, GENES CELLS, V14, P155, DOI 10.1111/j.1365-2443.2008.01262.x; Hizume K, 2005, BIOCHEMISTRY-US, V44, P12978, DOI 10.1021/bi050623v; Hizume K, 2007, NUCLEIC ACIDS RES, V35, P2787, DOI 10.1093/nar/gkm116; Hoffmann K, 2002, NAT GENET, V31, P410, DOI 10.1038/ng925; Hoffmann K, 2007, CHROMOSOMA, V116, P227, DOI 10.1007/s00412-007-0094-8; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Lee J, 2008, NAT STRUCT MOL BIOL, V15, P109, DOI 10.1038/nsmb1326; Liokatis S, 2012, J BIOL CHEM, V287, P1032, DOI 10.1074/jbc.M111.281303; Ma Y, 2007, J CELL SCI, V120, P520, DOI 10.1242/jcs.03355; Makatsori D, 2004, J BIOL CHEM, V279, P25567, DOI 10.1074/jbc.M313606200; Martins SB, 2000, J CELL SCI, V113, P3703; Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155; Ohniwa RL, 2007, GENES CELLS, V12, P1141, DOI 10.1111/j.1365-2443.2007.01125.x; Ostlund C, 2006, BIOCHEMISTRY-US, V45, P1374, DOI 10.1021/bi052156n; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Pesavento JJ, 2008, MOL CELL BIOL, V28, P468, DOI 10.1128/MCB.01517-07; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Polioudaki H, 2001, EMBO REP, V2, P920, DOI 10.1093/embo-reports/kve199; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Shaklai S, 2007, FEBS J, V274, P1383, DOI 10.1111/j.1742-4658.2007.05697.x; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Takano M, 2002, EUR J BIOCHEM, V269, P943, DOI 10.1046/j.0014-2956.2001.02730.x; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Towbin BD, 2009, CURR OPIN GENET DEV, V19, P180, DOI 10.1016/j.gde.2009.01.006; Tsuchiya M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025694; WORMAN HJ, 1988, P NATL ACAD SCI USA, V85, P8531, DOI 10.1073/pnas.85.22.8531; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Ye Q, 1996, J BIOL CHEM, V271, P14653, DOI 10.1074/jbc.271.25.14653; YE Q, 1994, J BIOL CHEM, V269, P11306; Ye QA, 1997, J BIOL CHEM, V272, P14983, DOI 10.1074/jbc.272.23.14983; Zwerger M, 2008, EXP HEMATOL, V36, P977, DOI 10.1016/j.exphem.2008.03.003	42	81	84	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42654	42663		10.1074/jbc.M112.397950	http://dx.doi.org/10.1074/jbc.M112.397950			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23100253	hybrid, Green Published			2022-12-25	WOS:000312501600026
J	Ding, WX; Li, M; Biazik, JM; Morgan, DG; Guo, FL; Ni, HM; Goheen, M; Eskelinen, EL; Yin, XM				Ding, Wen-Xing; Li, Min; Biazik, Joanna M.; Morgan, David G.; Guo, Fengli; Ni, Hong-Min; Goheen, Michael; Eskelinen, Eeva-Liisa; Yin, Xiao-Ming			Electron Microscopic Analysis of a Spherical Mitochondrial Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DEATH; MITOPHAGY; PARKIN; AUTOPHAGY; MEMBRANE; DISEASE; STRESS; FUSION; PINK1	Mitochondria undergo dynamic structural alterations to meet changing needs and to maintain homeostasis. We report here a novel mitochondrial structure. Conventional transmission electron microscopic examination of murine embryonic fibroblasts treated with carbonyl cyanide m-chlorophenylhydrazone (CCCP), a mitochondrial uncoupler, found that more than half of the mitochondria presented a ring-shaped or C-shaped morphology. Many of these mitochondria seemed to have engulfed various cytosolic components. Serial sections through individual mitochondria indicated that they formed a ball-like structure with an internal lumen surrounded by the membranes and containing cytosolic materials. Notably, the lumen was connected to the external cytoplasm through a small opening. Electron tomographic reconstruction of the mitochondrial spheroids demonstrated the membrane topology and confirmed the vesicular configuration of this mitochondrial structure. The outside periphery and the lumen were defined by the outer membranes, which were lined with the inner membranes. Matrix and cristae were retained but distributed unevenly with less being kept near the luminal opening. Mitochondrial spheroids seem to form in response to oxidative mitochondrial damage independently of mitophagy. The structural features of the mitochondrial spheroids thus represent a novel mitochondrial dynamics.	[Ding, Wen-Xing; Ni, Hong-Min] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA; [Li, Min; Goheen, Michael; Yin, Xiao-Ming] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Biazik, Joanna M.; Eskelinen, Eeva-Liisa] Univ Helsinki, Dept Biosci, Div Biochem & Biotechnol, FIN-00014 Helsinki, Finland; [Morgan, David G.] Indiana Univ, Cryotransmiss Electron Microscopy Facil, Bloomington, IN 47405 USA; [Guo, Fengli] Stowers Inst Med Res, Kansas City, MO 64110 USA	University of Kansas; University of Kansas Medical Center; Indiana University System; Indiana University Bloomington; University of Helsinki; Indiana University System; Indiana University Bloomington; Stowers Institute for Medical Research	Ding, WX (corresponding author), Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, MS 1018,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	wxding@kumc.edu; xmyin@iupui.edu	Li, Min/B-1281-2011; Eskelinen, Eeva-Liisa/AAF-3496-2019; Morgan, David Gene/W-3429-2019	Eskelinen, Eeva-Liisa/0000-0003-0006-7785; Biazik-Richmond, Joanna/0000-0002-5855-0457	National Institutes of Health [R01 AA020518-01, R21AA017421, P20 RR021940, P20 RR016475, R01CA111456, R01CA83817]; NATIONAL CANCER INSTITUTE [R01CA083817, R01CA111456] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475, P20RR021940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103418] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA017421, R37AA020518, R01AA020518] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AA020518-01, R21AA017421, P20 RR021940, and P20 RR016475 (to W.-X. D.) and R01CA111456 and R01CA83817 (to X.-M.Y.).	Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chan NC, 2011, HUM MOL GENET, V20, P1726, DOI 10.1093/hmg/ddr048; CHRISTENSEN AK, 1959, EXP CELL RES, V18, P576, DOI 10.1016/0014-4827(59)90323-4; Cui M, 2010, J BIOL CHEM, V285, P11740, DOI 10.1074/jbc.M109.066662; Ding WX, 2012, J BIOL CHEM, V287, P42379, DOI 10.1074/jbc.M112.413682; Ding WX, 2010, J BIOL CHEM, V285, P27879, DOI 10.1074/jbc.M110.119537; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; KIESSLING KH, 1964, EXP CELL RES, V33, P350, DOI 10.1016/S0014-4827(64)81040-5; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; LAUBER JK, 1983, CURR EYE RES, V2, P855, DOI 10.3109/02713688209020022; Lee JY, 2010, J CELL BIOL, V189, P671, DOI 10.1083/jcb.201001039; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Liu X, 2011, CELL DEATH DIFFER, V18, P1561, DOI 10.1038/cdd.2011.13; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Matsuda N, 2010, J CELL BIOL, V189, P211, DOI 10.1083/jcb.200910140; Messerschmitt M, 2003, J CELL BIOL, V160, P553, DOI 10.1083/jcb.200211113; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Ricci JE, 2003, CELL DEATH DIFFER, V10, P488, DOI 10.1038/sj.cdd.4401225; Scheffler I.E., 1999, MITOCHONDRIA, p[15, 145]; SETOGUTI T, 1977, AM J ANAT, V148, P65, DOI 10.1002/aja.1001480107; Wallace DC, 2010, ANNU REV PATHOL-MECH, V5, P297, DOI 10.1146/annurev.pathol.4.110807.092314; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Yoshii SR, 2011, J BIOL CHEM, V286, P19630, DOI 10.1074/jbc.M110.209338; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028	26	72	72	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42373	42378		10.1074/jbc.M112.413674	http://dx.doi.org/10.1074/jbc.M112.413674			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23093403	Green Published, hybrid			2022-12-25	WOS:000312103000072
J	Raj, N; Zhang, L; Wei, YL; Arnosti, DN; Henry, RW				Raj, Nitin; Zhang, Liang; Wei, Yiliang; Arnosti, David N.; Henry, R. William			Ubiquitination of Retinoblastoma Family Protein 1 Potentiates Gene-specific Repression Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; ECTOPIC EXPRESSION; ACTIVATION DOMAIN; E2F; BINDING; RB; PHOSPHORYLATION; TRANSCRIPTION; MECHANISM; PRB	The retinoblastoma (RB) tumor suppressor family functions as a regulatory node governing cell cycle progression, differentiation, and apoptosis. Post-translational modifications play a critical role in modulating RB activity, but additional levels of control, including protein turnover, are also essential for proper function. The Drosophila RB homolog Rbf1 is subjected to developmentally cued proteolysis mediated by an instability element (IE) present in the C terminus of this protein. Paradoxically, instability mediated by the IE is also linked to Rbf1 repression potency, suggesting that proteolytic machinery may also be directly involved in transcriptional repression. We show that the Rbf1 IE is an autonomous degron that stimulates both Rbf1 ubiquitination and repression potency. Importantly, Rbf1 IE function is promoter-specific, contributing to repression of cell cycle responsive genes but not to repression of cell signaling genes. The multifunctional IE domain thus provides Rbf1 flexibility for discrimination between target genes embedded in divergent cellular processes.	[Wei, Yiliang; Arnosti, David N.; Henry, R. William] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Raj, Nitin] Michigan State Univ, Genet Program, E Lansing, MI 48824 USA; [Zhang, Liang] Michigan State Univ, Cell & Mol Biol Program, E Lansing, MI 48824 USA	Michigan State University; Michigan State University; Michigan State University	Arnosti, DN (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	arnosti@msu.edu; henryrw@msu.edu	Wei, Yiliang/S-7723-2018	Wei, Yiliang/0000-0001-8956-2955; Raj, Nitin/0000-0001-7678-3855	National Institutes of Health [1R01GM079098, 1R01CA142644]; Michigan State University Gene Expression in Development and Disease Group; NATIONAL CANCER INSTITUTE [R01CA142644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079098] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michigan State University Gene Expression in Development and Disease Group; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R01GM079098 (to R.W.H. and D.N.A.) and 1R01CA142644 (to J.J. Tepe and R.W.H.). This work was also supported by the Michigan State University Gene Expression in Development and Disease Group.	Acharya P., 2012, GENES GENOM IN PRESS; Acharya P, 2010, MOL BIOL CELL, V21, P3890, DOI 10.1091/mbc.E10-06-0520; Barbash O, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-2; Bech-Otschir D, 2002, J CELL SCI, V115, P467; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Chamovitz DA, 2002, CURR BIOL, V12, pR232, DOI 10.1016/S0960-9822(02)00775-3; CHEN PL, 1989, CELL, V58, P1193, DOI 10.1016/0092-8674(89)90517-5; Delston RB, 2011, ONCOGENE, V30, P588, DOI 10.1038/onc.2010.442; Delston RB, 2006, CURR MOL MED, V6, P713; Deroo BJ, 2002, J BIOL CHEM, V277, P20120, DOI 10.1074/jbc.C200173200; Du W, 1996, EMBO J, V15, P3684, DOI 10.1002/j.1460-2075.1996.tb00738.x; Du W, 1999, EMBO J, V18, P916, DOI 10.1093/emboj/18.4.916; Du W, 1996, GENE DEV, V10, P1206, DOI 10.1101/gad.10.10.1206; Geng FQ, 2012, ANNU REV BIOCHEM, V81, P177, DOI 10.1146/annurev-biochem-052110-120012; Genovese C, 2006, ONCOGENE, V25, P5201, DOI 10.1038/sj.onc.1209652; Hammond-Martel I, 2012, CELL SIGNAL, V24, P410, DOI 10.1016/j.cellsig.2011.10.009; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HINDS PW, 1992, CELL, V70, P993, DOI 10.1016/0092-8674(92)90249-C; Horwitz AA, 2007, P NATL ACAD SCI USA, V104, P6614, DOI 10.1073/pnas.0610481104; KATO J, 1993, GENE DEV, V7, P331; Keller SA, 2005, GENE EXPR PATTERNS, V5, P411, DOI 10.1016/j.modgep.2004.09.005; Knudsen ES, 1998, GENE DEV, V12, P2278, DOI 10.1101/gad.12.15.2278; Korenjak M, 2012, MOL CELL BIOL, V32, P4375, DOI 10.1128/MCB.00536-12; Kurosu T, 2004, CURR BIOL, V14, P1112, DOI 10.1016/j.cub.2004.06.020; LIN BTY, 1992, CIBA F SYMP, V170, P227; Morris EJ, 2001, ADV CANCER RES, V82, P1, DOI 10.1016/S0065-230X(01)82001-7; Nguyen DX, 2005, J CELL BIOCHEM, V94, P870, DOI 10.1002/jcb.20375; Raj N, 2012, CELL CYCLE, V11, P3731, DOI 10.4161/cc.21665; Rubin SM, 2005, CELL, V123, P1093, DOI 10.1016/j.cell.2005.09.044; Ryu JR, 2003, NUCLEIC ACIDS RES, V31, P4654, DOI 10.1093/nar/gkg491; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Salghetti SE, 1999, EMBO J, V18, P717, DOI 10.1093/emboj/18.3.717; Salghetti SE, 2000, P NATL ACAD SCI USA, V97, P3118, DOI 10.1073/pnas.050007597; Sdek P, 2004, J BIOL CHEM, V279, P53317, DOI 10.1074/jbc.M406062200; Skapek SX, 2006, ONCOGENE, V25, P5268, DOI 10.1038/sj.onc.1209710; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Uchida CH, 2005, EMBO J, V24, P160, DOI 10.1038/sj.emboj.7600486; Ullah Z, 2007, MOL BIOL CELL, V18, P1179, DOI 10.1091/mbc.E06-09-0790; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000; Wells J, 2003, ONCOGENE, V22, P1445, DOI 10.1038/sj.onc.1206264; Wikenheiser-Brokamp KA, 2006, CELL MOL LIFE SCI, V63, P767, DOI 10.1007/s00018-005-5487-3; Ying HQ, 2006, CELL CYCLE, V5, P506, DOI 10.4161/cc.5.5.2515	42	7	7	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41835	41843		10.1074/jbc.M112.422428	http://dx.doi.org/10.1074/jbc.M112.422428			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086928	Green Published, hybrid			2022-12-25	WOS:000312103000024
J	Kandiyil, N; Altaf, N; Hosseini, AA; MacSweeney, ST; Auer, DP				Kandiyil, Neghal; Altaf, Nishath; Hosseini, Akram A.; MacSweeney, Shane T.; Auer, Dorothee P.			Lower Prevalence of Carotid Plaque Hemorrhage in Women, and Its Mediator Effect on Sex Differences in Recurrent Cerebrovascular Events	PLOS ONE			English	Article							TRANSIENT ISCHEMIC ATTACK; INTRAPLAQUE HEMORRHAGE; RISK-FACTORS; SYMPTOMATIC PATIENTS; ARTERY STENOSIS; ENDARTERECTOMY; STROKE; ASSOCIATION; DISEASE; SURGERY	Background and Purpose: Women are at lower risk of stroke, and appear to benefit less from carotid endarterectomy (CEA) than men. We hypothesised that this is due to more benign carotid disease in women mediating a lower risk of recurrent cerebrovascular events. To test this, we investigated sex differences in the prevalence of MRI detectable plaque hemorrhage (MRI PH) as an index of plaque instability, and secondly whether MRI PH mediates sex differences in the rate of cerebrovascular recurrence. Methods: Prevalence of PH between sexes was analysed in a single centre pooled cohort of 176 patients with recently symptomatic, significant carotid stenosis (106 severe [>= 70%], 70 moderate [50-69%]) who underwent prospective carotid MRI scanning for identification of MRI PH. Further, a meta-analysis of published evidence was undertaken. Recurrent events were noted during clinical follow up for survival analysis. Results: Women with symptomatic carotid stenosis (50%>=) were less likely to have plaque hemorrhage (PH) than men (46% vs. 70%) with an adjusted OR of 0.23 [95% CI 0.10-0.50, P<0.0001] controlling for other known vascular risk factors. This negative association was only significant for the severe stenosis subgroup (adjusted OR 0.18, 95% CI 0.067-0.50) not the moderate degree stenosis. Female sex in this subgroup also predicted a longer time to recurrent cerebral ischemic events (HR 0.38 95% CI 0.15-0.98, P = 0.045). Further addition of MRI PH or smoking abolished the sex effects with only MRI PH exerting a direct effect. Meta-analysis confirmed a protective effect of female sex on development of PH: unadjusted OR for presence of PH = 0.54 (95% CI 0.45-0.67, p<0.00001). Conclusions: MRI PH is significantly less prevalent in women. Women with MRI PH and severe stenosis have a similar risk as men for recurrent cerebrovascular events. MRI PH thus allows overcoming the sex bias in selection for CEA.	[Kandiyil, Neghal; Altaf, Nishath; Hosseini, Akram A.; Auer, Dorothee P.] Univ Nottingham, Div Radiol & Imaging Sci, Nottingham NG7 2RD, England; [Kandiyil, Neghal; Altaf, Nishath; MacSweeney, Shane T.] Univ Nottingham Hosp, Nottingham NG7 2UH, England	University of Nottingham; University of Nottingham	Auer, DP (corresponding author), Univ Nottingham, Div Radiol & Imaging Sci, Nottingham NG7 2RD, England.	dorothee.auer@nottingham.ac.uk		Auer, Dorothee P./0000-0002-4745-3635	Department of Health [PB-PG-0107-11438] Funding Source: Medline; National Institute for Health Research [PB-PG-0107-11438] Funding Source: researchfish	Department of Health; National Institute for Health Research(National Institute for Health Research (NIHR))		Alamowitch S, 2005, STROKE, V36, P27, DOI 10.1161/01.STR.0000149622.12636.1f; Altaf N, 2008, RADIOLOGY, V248, P202, DOI 10.1148/radiol.2481070300; Altaf N, 2008, J VASC SURG, V47, P337, DOI 10.1016/j.jvs.2007.09.064; Altaf N, 2007, STROKE, V38, P1633, DOI 10.1161/STROKEAHA.106.473066; AS Aghi M, 2001, INITIATION MAINTENAN, V1, P49; Bitar R, 2008, RADIOLOGY, V249, P259, DOI 10.1148/radiol.2491071517; Bond R, 2005, CEREBROVASC DIS, V20, P69, DOI 10.1159/000086509; Cheung HMC, 2011, RADIOLOGY, V260, P841, DOI 10.1148/radiol.11101652; Derksen WJM, 2011, ATHEROSCLEROSIS, V214, P139, DOI 10.1016/j.atherosclerosis.2010.10.022; Di Carlo A, 2003, STROKE, V34, P1114, DOI 10.1161/01.STR.0000068410.07397.D7; DiBardino D, 2000, ANN VASC SURG, V14, P340, DOI 10.1007/s100169910078; Farrell B, 1998, LANCET, V351, P1379, DOI 10.1016/s0140-6736(97)09292-1; Furie KL, 2011, STROKE, V42, P227, DOI 10.1161/STR.0b013e3181f7d043; Goode NA, 2007, EUR STROK C GLASG UK; Hellings WE, 2007, J VASC SURG, V45, P289, DOI 10.1016/j.jvs.2006.09.051; Hellings WE, 2010, CIRCULATION, V121, P1941, DOI 10.1161/CIRCULATIONAHA.109.887497; Kurosaki Y, 2011, NEUROSURGERY, V68, P62, DOI 10.1227/NEU.0b013e3181fc60a8; Kwee RM, 2010, STROKE, V41, P1389, DOI 10.1161/STROKEAHA.109.575670; Meese SR, 2004, J NEUROL NEUROSUR PS, V75, P1759, DOI 10.1136/jnnp.2003.030486; Murphy RE, 2003, CIRCULATION, V107, P3053, DOI 10.1161/01.CIR.0000074204.92443.37; Qiao Y, 2012, AM J NEURORADIOL, V33, P755, DOI 10.3174/ajnr.A2863; Redgrave JNE, 2006, CIRCULATION, V113, P2320, DOI 10.1161/CIRCULATIONAHA.105.589044; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rothwell PM, 2004, LANCET, V363, P915, DOI 10.1016/S0140-6736(04)15785-1; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Rothwell PM, 2004, STROKE, V35, P2855, DOI 10.1161/01.STR.0000147040.20446.f6; Sidhu PS, 1997, CLIN RADIOL, V52, P654, DOI 10.1016/S0009-9260(97)80027-X; Turc G, 2012, ARTERIOSCL THROM VAS, V32, P492, DOI 10.1161/ATVBAHA.111.239335	28	15	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47319	10.1371/journal.pone.0047319	http://dx.doi.org/10.1371/journal.pone.0047319			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110067	Green Published, Green Submitted, gold			2022-12-25	WOS:000310262500008
J	Loddenkemper, T; Syed, TU; Ramgopal, S; Gulati, D; Thanaviratananich, S; Kothare, SV; Alshekhlee, A; Koubeissi, MZ				Loddenkemper, Tobias; Syed, Tanvir U.; Ramgopal, Sriram; Gulati, Deepak; Thanaviratananich, Sikawat; Kothare, Sanjeev V.; Alshekhlee, Amer; Koubeissi, Mohamad Z.			Risk Factors Associated with Death in In-Hospital Pediatric Convulsive Status Epilepticus	PLOS ONE			English	Article							REFRACTORY STATUS EPILEPTICUS; CONTINUOUS MIDAZOLAM; CLINICAL-FEATURES; TERM MORTALITY; UNITED-STATES; 1ST EPISODE; CHILDREN; EPILEPSY; CHILDHOOD; EFFICACY	Objective: To evaluate in-patient mortality and predictors of death associated with convulsive status epilepticus (SE) in a large, multi-center, pediatric cohort. Patients and Methods: We identified our cohort from the KID Inpatient Database for the years 1997, 2000, 2003 and 2006. We queried the database for convulsive SE, associated diagnoses, and for inpatient death. Univariate logistic testing was used to screen for potential risk factors. These risk factors were then entered into a stepwise backwards conditional multivariable logistic regression procedure. P-values less than 0.05 were taken as significant. Results: We identified 12,365 (5,541 female) patients with convulsive SE aged 0-20 years (mean age 6.2 years, standard deviation 5.5 years, median 5 years) among 14,965,571 pediatric inpatients (0.08%). Of these, 117 died while in the hospital (0.9%). The most frequent additional admission ICD-9 code diagnoses in addition to SE were cerebral palsy, pneumonia, and respiratory failure. Independent risk factors for death in patients with SE, assessed by multivariate calculation, included near drowning (Odds ratio [OR] 43.2; Confidence Interval [CI] 4.4-426.8), hemorrhagic shock (OR 17.83; CI 6.5-49.1), sepsis (OR 10.14; CI 4.0-25.6), massive aspiration (OR 9.1; CI 1.8-47), mechanical ventilation >96 hours (OR9; 5.6-14.6), transfusion (OR 8.25; CI 4.3-15.8), structural brain lesion (OR7.0; CI 3.1-16), hypoglycemia (OR5.8; CI 1.75-19.2), sepsis with liver failure (OR 14.4; CI 5-41.9), and admission in December (OR3.4; CI 1.6-4.1). African American ethnicity (OR 0.4; CI 0.2-0.8) was associated with a decreased risk of death in SE. Conclusion: Pediatric convulsive SE occurs in up to 0.08% of pediatric inpatient admissions with a mortality of up to 1%. There appear to be several risk factors that can predict mortality. These may warrant additional monitoring and aggressive management.	[Loddenkemper, Tobias; Ramgopal, Sriram; Kothare, Sanjeev V.] Childrens Hosp Boston, Dept Neurol, Boston, MA USA; [Loddenkemper, Tobias; Ramgopal, Sriram; Kothare, Sanjeev V.] Harvard Univ, Sch Med, Boston, MA USA; [Syed, Tanvir U.; Gulati, Deepak; Thanaviratananich, Sikawat; Koubeissi, Mohamad Z.] Case Western Reserve Univ & Univ Hosp, Dept Neurol, Cleveland, OH USA; [Alshekhlee, Amer] St Louis Univ, Dept Neurol, St Louis, MO 63103 USA; [Koubeissi, Mohamad Z.] George Washington Univ, Dept Neurol, Washington, DC USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Case Western Reserve University; Case Western Reserve University Hospital; Saint Louis University; George Washington University	Ramgopal, S (corresponding author), Childrens Hosp Boston, Dept Neurol, Boston, MA USA.	Sriram.ramgopal@childrens.harvard.edu		thanaviratananich, sikawat/0000-0001-8773-9470; Ramgopal, Sriram/0000-0002-1389-5726; Loddenkemper, Tobias/0000-0003-2074-0674; Kothare, Sanjeev/0000-0001-7849-6649	National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) [1R21NS076859-01]; Career Development Fellowship Award from Harvard Medical School; Children's Hospital Boston; Program for Quality and Safety at Children's Hospital Boston; Payer Provider Quality Initiative; Translational Research Project at Children's Hospital Boston; Epilepsy Foundation of America [EF-213583, EF-213882]; Center for Integration of Medicine & Innovative Technology (CIMIT/DoD); National Institute of Health [1 RC1 HL099749-01 (R21), RFA-HL-09-001]; Harvard Catalyst; Coulter Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL009001, RC1HL099749] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS076859] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Career Development Fellowship Award from Harvard Medical School; Children's Hospital Boston; Program for Quality and Safety at Children's Hospital Boston; Payer Provider Quality Initiative; Translational Research Project at Children's Hospital Boston; Epilepsy Foundation of America; Center for Integration of Medicine & Innovative Technology (CIMIT/DoD); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Catalyst; Coulter Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	TL serves on the Laboratory Accreditation Board for Long Term (Epilepsy and ICU) Monitoring (ABRET), serves as an Associate Editor for Seizure, serves on the American Board of Clinical Neurophysiology, and on the Council of the American Clinical Neurophysiology Society, performs Video EEG longterm monitoring, EEGs, and other electrophysiological studies at Children's Hospital Boston and bills for these procedures (20%), receives support from National Institutes of Health (NIH)/National Institute of Neurological Disorders and Stroke (NINDS) 1R21NS076859-01 (2011-2013), is supported by a Career Development Fellowship Award from Harvard Medical School and Children's Hospital Boston, by the Program for Quality and Safety at Children's Hospital Boston, from the Payer Provider Quality Initiative, the Translational Research Project at Children's Hospital Boston, receives funding from the Epilepsy Foundation of America (EF-213583 & EF-213882), and from the Center for Integration of Medicine & Innovative Technology (CIMIT/DoD), and received investigator initiated research support from Eisai and Lundbeck. Drs. TS, SR, DG, and ST have nothing to disclose. Dr. SK performs Video EEG longterm monitoring, EEGs, and other electrophysiological studies at Children's Hospital Boston and bills for these procedures, is interim medical director of the Center for Pediatric Sleep Disorders at Children's Hospital Boston, and has received research support from National Institute of Health (1 RC1 HL099749-01 (R21) (2009-12), and RFA-HL-09-001 (2010-14) and the Harvard Catalyst (2010-11). He also serves on the editorial board of the journal Pediatric Neurology. Dr. AA has nothing to disclose. Dr. MK has no conflict of interest related to the current work, has received grant support from the Coulter Foundation, and is on the Speakers' Bureaus of UCB and Pfizer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2011, OV KIDS INP DAT KID; Ahmad S, 2006, LANCET, V367, P1591, DOI 10.1016/S0140-6736(06)68696-0; AICARDI J, 1970, EPILEPSIA, V11, P187, DOI 10.1111/j.1528-1157.1970.tb03880.x; Asadi-Pooya AA, 2005, EPILEPSY BEHAV, V7, P502, DOI 10.1016/j.yebeh.2005.07.005; Banerjee P, 2007, EPILEPSY COMPREHENSI, V1, P45; Barnard C, 1999, J CHILD NEUROL, V14, P787, DOI 10.1177/088307389901401204; Berg AT, 2004, NEUROLOGY, V63, P1027, DOI 10.1212/01.WNL.0000138425.54223.DC; Berg AT, 2001, NEUROLOGY, V56, P1445, DOI 10.1212/WNL.56.11.1445; Brevoord JCD, 2005, J CHILD NEUROL, V20, P476, DOI 10.1177/088307380502000602; Callenbach PMC, 2001, PEDIATRICS, V107, P1259, DOI 10.1542/peds.107.6.1259; Chen L, 2009, EUR J NEUROL, V16, P444, DOI 10.1111/j.1468-1331.2008.02404.x; CHEVRIE JJ, 1979, EPILEPSIA, V20, P643, DOI 10.1111/j.1528-1157.1979.tb04848.x; Chin RFM, 2004, J NEUROL NEUROSUR PS, V75, P1584, DOI 10.1136/jnnp.2003.032797; Day JF, 2009, J MED ENTOMOL, V46, P1498, DOI 10.1603/033.046.0638; de Pont ACJM, 2011, NETH J MED, V69, P196; DELORENZO RJ, 1992, EPILEPSIA, V33, pS15; DeLorenzo RJ, 1996, NEUROLOGY, V46, P1029, DOI 10.1212/WNL.46.4.1029; DODSON WE, 1993, JAMA-J AM MED ASSOC, V270, P854; DUNN DW, 1988, J CHILD NEUROL, V3, P167, DOI 10.1177/088307388800300303; Gulati Sheffali, 2005, Indian Journal of Pediatrics, V72, P105, DOI 10.1007/BF02760691; Hayashi K, 2007, PEDIATR NEUROL, V36, P366, DOI 10.1016/j.pediatrneurol.2007.02.012; Kang Du Cheol, 2005, Yonsei Medical Journal, V46, P27; Karasalihoglu S, 2003, PEDIATR INT, V45, P429, DOI 10.1046/j.1442-200X.2003.01758.x; Kim SJ, 2001, PEDIATR NEUROL, V25, P217, DOI 10.1016/S0887-8994(01)00311-3; Knake S, 2001, EPILEPSIA, V42, P714, DOI 10.1046/j.1528-1157.2001.01101.x; KONRAD F, 1994, CHEST, V105, P237, DOI 10.1378/chest.105.1.237; Koubeissi M, 2007, NEUROLOGY, V69, P886, DOI 10.1212/01.wnl.0000269791.96189.70; Kramer U, 2005, J CHILD NEUROL, V20, P184, DOI 10.1177/08830738050200030301; Li JM, 2009, EPILEPSY BEHAV, V14, P146, DOI 10.1016/j.yebeh.2008.09.005; Lin KL, 2009, PEDIATR NEUROL, V41, P413, DOI 10.1016/j.pediatrneurol.2009.06.004; Logroscino G, 2005, EPILEPSIA, V46, P46, DOI 10.1111/j.1528-1167.2005.00409.x; Logroscino G, 2002, NEUROLOGY, V58, P537, DOI 10.1212/WNL.58.4.537; Logroscino G, 1997, EPILEPSIA, V38, P1344, DOI 10.1111/j.1528-1157.1997.tb00073.x; Lowenstein DH, 1999, EPILEPSIA, V40, P120, DOI 10.1111/j.1528-1157.1999.tb02000.x; Maegaki Y, 2005, NEUROPEDIATRICS, V36, P186, DOI 10.1055/s-2005-865611; Mah JK, 1999, PEDIATR NEUROL, V20, P364, DOI 10.1016/S0887-8994(99)00012-0; MAYTAL J, 1989, PEDIATRICS, V83, P323; Molinero MR, 2009, EPILEPSIA, V50, P2314, DOI 10.1111/j.1528-1167.2009.02266.x; Morrison G, 2006, INTENS CARE MED, V32, P2070, DOI 10.1007/s00134-006-0362-8; Mpimbaza A, 2008, PEDIATRICS, V121, pE58, DOI 10.1542/peds.2007-0930; Muchohi SN, 2008, BRIT J CLIN PHARMACO, V65, P12, DOI 10.1111/j.1365-2125.2007.02966.x; Ogutu BR, 2002, BRIT J CLIN PHARMACO, V53, P49, DOI 10.1046/j.0306-5251.2001.01529.x; Ozdemir D, 2005, SEIZURE-EUR J EPILEP, V14, P129, DOI 10.1016/j.seizure.2004.12.005; Prasad K, 2007, BRIT J CLIN PHARMACO, V63, P640, DOI 10.1111/j.1365-2125.2007.02931.x; RYAN CA, 1993, CAN MED ASSOC J, V148, P781; Sahin M, 2001, EPILEPSIA, V42, P1461, DOI 10.1046/j.1528-1157.2001.21301.x; Scholtes FBJ, 1996, SEIZURE-EUR J EPILEP, V5, P177, DOI 10.1016/S1059-1311(96)80033-1; Sharip A, 2006, PEDIATR INFECT DIS J, V25, P191, DOI 10.1097/01.inf.0000202065.03366.0c; Siddiqui Tahir Saeed, 2008, J Ayub Med Coll Abbottabad, V20, P51; Sillanpaa M, 2002, ANN NEUROL, V52, P303, DOI 10.1002/ana.10286; Singhi S, 2002, J CHILD NEUROL, V17, P106, DOI 10.1177/088307380201700203; Sodarangani M, 2008, LANCET NEUROL, V7, P145, DOI [10.1016/SI474-4422(07)70331-9, 10.1016/S1474-4422(07)70331-9]; Tabarki B, 2001, SEIZURE-EUR J EPILEP, V10, P365, DOI 10.1053/seiz.2000.0495; Waterhouse EJ, 1999, EPILEPSIA, V40, P752, DOI 10.1111/j.1528-1157.1999.tb00774.x; Wilson FC, 2003, NEUROREHABILITATION, V18, P291; Wu YW, 2002, NEUROLOGY, V58, P1070, DOI 10.1212/WNL.58.7.1070	56	35	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47474	10.1371/journal.pone.0047474	http://dx.doi.org/10.1371/journal.pone.0047474			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110074	Green Published, gold			2022-12-25	WOS:000310262500012
J	Dhurandhar, EJ; Krishnapuram, R; Hegde, V; Dubuisson, O; Tao, RY; Dong, XC; Ye, JP; Dhurandhar, NV				Dhurandhar, Emily J.; Krishnapuram, Rashmi; Hegde, Vijay; Dubuisson, Olga; Tao, Rongya; Dong, X. Charlie; Ye, Jianping; Dhurandhar, Nikhil V.			E4orf1 Improves Lipid and Glucose Metabolism in Hepatocytes: A Template to Improve Steatosis & Hyperglycemia	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; HEPATIC INSULIN-RESISTANCE; HUMAN ADENOVIRUS TYPE-36; ADIPOSE-TISSUE; DISEASE; OBESITY; MUSCLE; ASSOCIATION; PROTEIN; CELLS	Hepatic steatosis often accompanies obesity and insulin resistance. The cornerstones of steatosis treatment include reducing body weight and dietary fat intake, which are marginally successful over the long term. Ad36, a human adenovirus, may offer a template to overcome these limitations. In vitro and in vivo studies collectively indicate that via its E4orf1 protein, Ad36 improves hyperglycemia, and attenuates hepatic steatosis, despite a high fat diet and without weight loss. Considering that hepatic insulin sensitivity, or the synthesis, oxidation, or export of fatty acid by hepatocytes are the key determinant of hepatic lipid storage, we determined the role of E4orf1 protein in modulating these physiological pathways. For this study, HepG2 cells, or mouse primary hepatocytes were transfected with E4orf1 or the null vector. Glucose output by hepatocytes was determined under gluconeogenic conditions (cAMP and dexamethasone, or glucagon exposure). Also, de-novo lipogenesis, palmitate oxidation, and lipid export as determined by apoB secretion were measured 48 h post transfection. Results show that compared to null vector transfected cells, E4orf1 significantly reduced glucose output in basal and gluconeogenic conditions. E4orf1 reduced de-novo lipogenesis by about 35%, increased complete fatty acid oxidation 2-fold (p<0.0001), and apoB secretion 1.5 fold(p<0.003). Response of key signaling molecules to E4orf1 transfection was in agreement with these findings. Thus, E4orf1 offers a valuable template to exogenously modulate hepatic glucose and lipid metabolism. Elucidating the underlying molecular mechanism may help develop therapeutic approaches for treating diabetes or non-alcoholic fatty liver disease(NAFLD).	[Dhurandhar, Emily J.; Krishnapuram, Rashmi; Hegde, Vijay; Dubuisson, Olga; Ye, Jianping; Dhurandhar, Nikhil V.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA; [Tao, Rongya; Dong, X. Charlie] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Indiana University System; Indiana University Bloomington	Dhurandhar, NV (corresponding author), Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA.	Nikhil.Dhurandhar@PBRC.edu	Ye, Jianping/N-1998-2017; tao, rongya/B-8042-2014	Ye, Jianping/0000-0003-3875-365X; tao, rongya/0000-0002-3316-5587	American Diabetes Association [1-09-IN-13]; Mathile Institute for the Advancement of Human Nutrition; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R00DK077505, T32DK062710] Funding Source: NIH RePORTER	American Diabetes Association(American Diabetes Association); Mathile Institute for the Advancement of Human Nutrition; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was funded in part by the American Diabetes Association 1-09-IN-13, and The Mathile Institute for the Advancement of Human Nutrition, awarded to NVD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adiels M, 2006, DIABETOLOGIA, V49, P755, DOI 10.1007/s00125-005-0125-z; Bugianesi E, 2005, DIABETOLOGIA, V48, P634, DOI 10.1007/s00125-005-1682-x; Chitturi S, 2002, HEPATOLOGY, V35, P373, DOI 10.1053/jhep.2002.30692; Clark JM, 2006, J CLIN GASTROENTEROL, V40, pS39; Dhurandhar EJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023394; Diraison F, 2003, DIABETES METAB, V29, P478, DOI 10.1016/S1262-3636(07)70061-7; Erion DM, 2009, CELL METAB, V10, P499, DOI 10.1016/j.cmet.2009.10.007; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Fabbrini E, 2009, P NATL ACAD SCI USA, V106, P15430, DOI 10.1073/pnas.0904944106; Korenblat KM, 2008, GASTROENTEROLOGY, V134, P1369, DOI 10.1053/j.gastro.2008.01.075; Krishnapuram R, 2011, AM J PHYSIOL-ENDOC M, V300, pE779, DOI 10.1152/ajpendo.00703.2010; Lam Brian, 2010, Therap Adv Gastroenterol, V3, P121, DOI 10.1177/1756283X09359964; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Rogers PM, 2008, DIABETES, V57, P2321, DOI 10.2337/db07-1311; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Seppala-Lindroos A, 2002, J CLIN ENDOCR METAB, V87, P3023, DOI 10.1210/jc.87.7.3023; TAL M, 1992, P NATL ACAD SCI USA, V89, P5744, DOI 10.1073/pnas.89.13.5744; Trovato GM, 2010, LIVER INT, V30, P184, DOI 10.1111/j.1478-3231.2009.02127.x; Vega GL, 2007, HEPATOLOGY, V46, P716, DOI 10.1002/hep.21727; Wang ZQ, 2008, DIABETES, V57, P1805, DOI 10.2337/db07-1313; Yellaturu CR, 2009, J BIOL CHEM, V284, P7518, DOI 10.1074/jbc.M805746200; Younossi ZM, 2004, CLIN GASTROENTEROL H, V2, P262, DOI 10.1016/S1542-3565(04)00014-X; Zhang DY, 2007, P NATL ACAD SCI USA, V104, P17075, DOI 10.1073/pnas.0707060104	23	29	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47813	10.1371/journal.pone.0047813	http://dx.doi.org/10.1371/journal.pone.0047813			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110104	Green Submitted, Green Published, gold			2022-12-25	WOS:000310193600027
J	Ortega-Martorell, S; Lisboa, PJG; Vellido, A; Simoes, RV; Pumarola, M; Julia-Sape, M; Arus, C				Ortega-Martorell, Sandra; Lisboa, Paulo J. G.; Vellido, Alfredo; Simoes, Rui V.; Pumarola, Marti; Julia-Sape, Margarida; Arus, Carles			Convex Non-Negative Matrix Factorization for Brain Tumor Delimitation from MRSI Data	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; INDEPENDENT COMPONENT ANALYSIS; IN-VIVO; MOUSE GLIOMA; CLASSIFICATION; PERTURBATION; PATTERN; SEGMENTATION; TEMOZOLOMIDE; ALGORITHMS	Background: Pattern Recognition techniques can provide invaluable insights in the field of neuro-oncology. This is because the clinical analysis of brain tumors requires the use of non-invasive methods that generate complex data in electronic format. Magnetic Resonance (MR), in the modalities of spectroscopy (MRS) and spectroscopic imaging (MRSI), has been widely applied to this purpose. The heterogeneity of the tissue in the brain volumes analyzed by MR remains a challenge in terms of pathological area delimitation. Methodology/Principal Findings: A pre-clinical study was carried out using seven brain tumor-bearing mice. Imaging and spectroscopy information was acquired from the brain tissue. A methodology is proposed to extract tissue type-specific sources from these signals by applying Convex Non-negative Matrix Factorization (Convex-NMF). Its suitability for the delimitation of pathological brain area from MRSI is experimentally confirmed by comparing the images obtained with its application to selected target regions, and to the gold standard of registered histopathology data. The former showed good accuracy for the solid tumor region (proliferation index (PI) > 30%). The latter yielded (i) high sensitivity and specificity in most cases, (ii) acquisition conditions for safe thresholds in tumor and non-tumor regions (PI > 30% for solid tumoral region; <= 5% for non-tumor), and (iii) fairly good results when borderline pixels were considered. Conclusions/Significance: The unsupervised nature of Convex-NMF, which does not use prior information regarding the tumor area for its delimitation, places this approach one step ahead of classical label-requiring supervised methods for discrimination between tissue types, minimizing the negative effect of using mislabeled voxels. Convex-NMF also relaxes the non-negativity constraints on the observed data, which allows for a natural representation of the MRSI signal. This should help radiologists to accurately tackle one of the main sources of uncertainty in the clinical management of brain tumors, which is the difficulty of appropriately delimiting the pathological area.	[Ortega-Martorell, Sandra; Julia-Sape, Margarida; Arus, Carles] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Cerdanyola Del Valles, Spain; [Ortega-Martorell, Sandra; Julia-Sape, Margarida; Arus, Carles] Ctr Invest Biomed Red Bioingenieria Biomat & Nano, Cerdanyola Del Valles, Spain; [Ortega-Martorell, Sandra; Julia-Sape, Margarida; Arus, Carles] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Cerdanyola Del Valles, Spain; [Lisboa, Paulo J. G.] Liverpool John Moores Univ, Dept Math & Stat, Liverpool L3 5UX, Merseyside, England; [Vellido, Alfredo] Univ Politecn Cataluna, Dept Comp Languages & Syst, Barcelona, Spain; [Simoes, Rui V.] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Pumarola, Marti] Univ Autonoma Barcelona, Murine Pathol Unit, Ctr Biotecnol Anim & Terapia Genica, Dept Med & Cirurg Anim, Cerdanyola Del Valles, Spain	Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Autonomous University of Barcelona; Liverpool John Moores University; Universitat Politecnica de Catalunya; Memorial Sloan Kettering Cancer Center; Autonomous University of Barcelona	Arus, C (corresponding author), Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Cerdanyola Del Valles, Spain.	Carles.Arus@uab.cat	Vellido, Alfredo/AAH-2654-2019; Simoes, Rui Vasco/AAB-3303-2020; Ortega-Martorell, Sandra/F-5345-2012; Ortega-Martorell, Sandra/O-7805-2019; Arus, Carles/C-2361-2009; Julià-Sapé, Margarida/A-4003-2009; Julià-Sapé, Margarida/AIC-9348-2022	Simoes, Rui Vasco/0000-0001-7574-4723; Ortega-Martorell, Sandra/0000-0001-9927-3209; Arus, Carles/0000-0003-2510-2671; Julià-Sapé, Margarida/0000-0002-3316-9027; Julià-Sapé, Margarida/0000-0002-3316-9027; Pumarola Batlle, Marti/0000-0002-0935-7941; Vellido, Alfredo/0000-0002-9843-1911	Spanish MICINN [TIN2009-13895-C02-01]; CIBER-BBN; VI National RDI Plan; CIBER Actions; Instituto de Salud Carlos III; Ministerio de Ciencia e Innovacion [SAF2008-03323]; MARESCAN from Ministerio de Economia y Competitividad, in Spain [SAF2011-23870]; Generalitat de Catalunya (FI-DGR)	Spanish MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); CIBER-BBN; VI National RDI Plan; CIBER Actions; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); MARESCAN from Ministerio de Economia y Competitividad, in Spain; Generalitat de Catalunya (FI-DGR)(Generalitat de Catalunya)	This research is partially supported by the Spanish MICINN under grant TIN2009-13895-C02-01; also partially funded by CIBER-BBN, which is an initiative of the VI National R&D&I Plan 2008-2011, CIBER Actions and financed by the Instituto de Salud Carlos III with assistance from the European Regional Development Fund; and by projects PHENOIMA: SAF2008-03323, from Ministerio de Ciencia e Innovacion and MARESCAN: SAF2011-23870 from Ministerio de Economia y Competitividad, in Spain. Ms. Ortega-Martorell holds a predoctoral fellowship from Generalitat de Catalunya (FI-DGR 2010), and a short-stage funding for visiting Prof. Lisboa's lab. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bishop C. M., 2006, J ELECT IMAG, V16, P140; Bitar R, 2006, RADIOGRAPHICS, V26, P513, DOI 10.1148/rg.262055063; CARDOSO JF, 1993, IEE PROC-F, V140, P362, DOI 10.1049/ip-f-2.1993.0054; Chaumeil MM, 2012, NEUROIMAGE, V59, P193, DOI 10.1016/j.neuroimage.2011.07.034; Coons SW, 1997, CANCER, V79, P1381, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1381::AID-CNCR16>3.0.CO;2-W; De Edeleny FS, 2000, NAT MED, V6, P1287, DOI 10.1038/81401; de Edelenyi FS, 2005, ANAL CHIM ACTA, V544, P36, DOI 10.1016/j.aca.2005.04.007; De Vos M, 2007, J MAGN RESON, V184, P292, DOI 10.1016/j.jmr.2006.10.017; Devos A, 2004, J MAGN RESON, V170, P164, DOI 10.1016/j.jmr.2004.06.010; Ding C, 2010, IEEE T PATTERN ANAL, V32, P45, DOI 10.1109/TPAMI.2008.277; Du SY, 2008, NMR BIOMED, V21, P33, DOI 10.1002/nbm.1151; Duda R.O., 2006, PATTERN CLASSIFICATI; ElDeredy W, 1997, NMR BIOMED, V10, P99, DOI 10.1002/(SICI)1099-1492(199705)10:3<99::AID-NBM461>3.0.CO;2-#; Ellison DW, 2011, J NEGAT RESULTS BIOM, V10, DOI 10.1186/1477-5751-10-7; Gadian D. G., 1995, NMR ITS APPL LIVING; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Garcia-Gomez JM, 2009, MAGN RESON MATER PHY, V22, P5, DOI 10.1007/s10334-008-0146-y; Glass R, 2005, J NEUROSCI, V25, P2637, DOI 10.1523/JNEUROSCI.5118-04.2005; Hassibi B, 1993, ADV NEURAL INFORMATI, P164; Howe FA, 2003, NMR BIOMED, V16, P123, DOI 10.1002/nbm.822; Hyvarinen A, 1999, IEEE T NEURAL NETWOR, V10, P626, DOI 10.1109/72.761722; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; IMM Technical University of Denmark, 2006, NMF DTU TOOLB COLL N; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Johannessen AL, 2006, PATHOL ONCOL RES, V12, P143, DOI 10.1007/BF02893360; JUTTEN C, 1991, SIGNAL PROCESS, V24, P1, DOI 10.1016/0165-1684(91)90079-X; Kros JM, 2011, J NEUROPATH EXP NEUR, V70, P101, DOI 10.1097/NEN.0b013e31820681aa; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lee J, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-9; Lin CJ, 2007, NEURAL COMPUT, V19, P2756, DOI 10.1162/neco.2007.19.10.2756; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Luts J, 2009, NMR BIOMED, V22, P374, DOI 10.1002/nbm.1347; McKnight TR, 2002, J NEUROSURG, V97, P794, DOI 10.3171/jns.2002.97.4.0794; Nelson SJ, 2011, NMR BIOMED, V24, P734, DOI 10.1002/nbm.1669; Nelson SJ, 2002, J MAGN RESON IMAGING, V16, P464, DOI 10.1002/jmri.10183; Ortega-Martorell S, 2011, 2011 INTERNATIONAL JOINT CONFERENCE ON NEURAL NETWORKS (IJCNN), P3279, DOI 10.1109/IJCNN.2011.6033656; OSTERTAG CB, 1987, ACTA NEUROCHIR, V89, P117, DOI 10.1007/BF01560376; PAATERO P, 1994, ENVIRONMETRICS, V5, P111, DOI 10.1002/env.3170050203; Park I, 2011, J MAGN RESON IMAGING, V33, P1284, DOI 10.1002/jmri.22563; Pirzkall A, 2004, INT J RADIAT ONCOL, V59, P126, DOI 10.1016/j.ijrobp.2003.08.023; Preul MC, 1996, NAT MED, V2, P323, DOI 10.1038/nm0396-323; Sajda P, 2004, IEEE T MED IMAGING, V23, P1453, DOI 10.1109/TMI.2004.834626; Sava ARC, 2011, NMR BIOMED, V24, P824, DOI 10.1002/nbm.1628; SEGEBARTH CM, 1990, MAGN RESON MED, V13, P62, DOI 10.1002/mrm.1910130108; Simoes RV, 2008, NMR BIOMED, V21, P251, DOI 10.1002/nbm.1188; Simoes RV, 2010, NMR BIOMED, V23, P23, DOI 10.1002/nbm.1421; Simoes RV, 2009, P EUR SOC MAGN RES M, P195; Simoes RV, 2012, IN VIVO MAG IN PRESS; Simonetti AW, 2003, ANAL CHEM, V75, P5352, DOI 10.1021/ac034541t; Su YZ, 2008, NMR BIOMED, V21, P1030, DOI 10.1002/nbm.1271; Usenius JP, 1996, NEUROREPORT, V7, P1597, DOI 10.1097/00001756-199607080-00013; Simoes RV, 2012, INTEGR BIOL-UK, V4, P183, DOI 10.1039/c2ib00079b; Vellido A, 2012, NMR BIOMED, V25, P819, DOI 10.1002/nbm.1797; Xiaoyu Ding, 2011, Proceedings of the 2011 International Conference on Machine Learning and Cybernetics (ICMLC 2011), P338, DOI 10.1109/ICMLC.2011.6016680; Zhai HY, 2011, J NEUROSCI, V31, P14346, DOI 10.1523/JNEUROSCI.3299-11.2011; Zhou QY, 2009, NEURO-ONCOLOGY, V11, P301, DOI 10.1215/15228517-2008-088	56	35	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47824	10.1371/journal.pone.0047824	http://dx.doi.org/10.1371/journal.pone.0047824			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110107	Green Published, gold			2022-12-25	WOS:000310193600029
J	Cryan, PM; Jameson, JW; Baerwald, EF; Willis, CKR; Barclay, RMR; Snider, EA; Crichton, EG				Cryan, Paul M.; Jameson, Joel W.; Baerwald, Erin F.; Willis, Craig K. R.; Barclay, Robert M. R.; Snider, E. Apple; Crichton, Elizabeth G.			Evidence of Late-Summer Mating Readiness and Early Sexual Maturation in Migratory Tree-Roosting Bats Found Dead at Wind Turbines	PLOS ONE			English	Article							FEMALE REPRODUCTIVE-TRACT; LONG-EARED BATS; PLECOTUS-AURITUS; PENILE SPINES; GLANS-PENIS; FATALITIES; CHIROPTERA; PATTERNS; SPERMATOZOA; SURVIVAL	Understanding animal mating systems is an important component of their conservation, yet the precise mating times for many species of bats are unknown. The aim of this study was to better understand the details and timing of reproductive events in species of bats that die most frequently at wind turbines in North America, because such information can help inform conservation strategies. We examined the reproductive anatomy of hoary bats (Lasiurus cinereus), eastern red bats (L. borealis), and silver-haired bats (Lasionycteris noctivagans) found dead beneath industrial-scale wind turbines to learn more about when they mate. We evaluated 103 L. cinereus, 18 L. borealis, and 47 Ln. noctivagans from wind energy facilities in the United States and Canada. Histological analysis revealed that most male L. cinereus and L. borealis, as well as over half the Ln. noctivagans examined had sperm in the caudae epididymides by late August, indicating readiness to mate. Testes regression in male hoary bats coincided with enlargement of seminal vesicles and apparent growth of keratinized spines on the glans penis. Seasonality of these processes also suggests that mating could occur during August in L. cinereus. Spermatozoa were found in the uterus of an adult female hoary bat collected in September, but not in any other females. Ovaries of all females sampled had growing secondary or tertiary follicles, indicating sexual maturity even in first-year females. Lasiurus cinereus, L. borealis, and Ln. noctivagans are the only North American temperate bats in which most first-year young of both sexes are known to sexually mature in their first autumn. Our findings provide the first detailed information published on the seasonal timing of mating readiness in these species most affected by wind turbines.	[Cryan, Paul M.; Snider, E. Apple] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA; [Jameson, Joel W.; Willis, Craig K. R.] Univ Winnipeg, Dept Biol, Winnipeg, MB R3B 2E9, Canada; [Jameson, Joel W.; Willis, Craig K. R.] Univ Winnipeg, Ctr Forest Interdisciplinary Res, Winnipeg, MB R3B 2E9, Canada; [Baerwald, Erin F.; Barclay, Robert M. R.] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada; [Snider, E. Apple] US Forest Serv, Steamboat Springs, CO USA; [Crichton, Elizabeth G.] Univ Queensland, Gatton, Qld, Australia	United States Department of the Interior; United States Geological Survey; University of Winnipeg; University of Winnipeg; University of Calgary; United States Department of Agriculture (USDA); United States Forest Service; University of Queensland	Cryan, PM (corresponding author), US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO USA.	cryanp@usgs.gov	Willis, Craig K.R./F-5218-2013	Baerwald, Erin/0000-0002-6399-4749; Willis, Craig/0000-0002-0985-8607; Cryan, Paul/0000-0002-2915-8894	U.S. Fish and Wildlife Service; United States Geological Survey; Sustainable Development Innovation Fund of Manitoba Conservation; Natural Science and Engineering Research Council (NSERC, Canada); Bat Conservation International; University of Calgary's Institute for Sustainable Energy, Environment and Economy; Alberta Wind Energy; TransAlta; Enmax; Suncor	U.S. Fish and Wildlife Service(US Fish & Wildlife Service); United States Geological Survey(United States Geological Survey); Sustainable Development Innovation Fund of Manitoba Conservation; Natural Science and Engineering Research Council (NSERC, Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Bat Conservation International; University of Calgary's Institute for Sustainable Energy, Environment and Economy; Alberta Wind Energy; TransAlta; Enmax; Suncor	This research was funded in part by the U.S. Fish and Wildlife Service, the United States Geological Survey, grants to CW from the Sustainable Development Innovation Fund of Manitoba Conservation, grants to CW and RB from the Natural Science and Engineering Research Council (NSERC, Canada), and funding to RB and EB from Bat Conservation International, the University of Calgary's Institute for Sustainable Energy, Environment and Economy, TransAlta, Enmax, Suncor, and Alberta Wind Energy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altringham JD, 2011, BATS: FROM EVOLUTION TO CONSERVATION, 2ND EDITION, P1; Arnett EB, 2008, J WILDLIFE MANAGE, V72, P61, DOI 10.2193/2007-221; ARONSON LR, 1967, ANAT REC, V157, P71, DOI 10.1002/ar.1091570111; Arteaga-Silva M, 2008, PHYSIOL BEHAV, V94, P412, DOI 10.1016/j.physbeh.2008.02.007; Baerwald EF, 2008, CURR BIOL, V18, pR695, DOI 10.1016/j.cub.2008.06.029; Baerwald EF, 2011, J WILDLIFE MANAGE, V75, P1103, DOI 10.1002/jwmg.147; Baerwald EF, 2009, J WILDLIFE MANAGE, V73, P1077, DOI 10.2193/2008-233; Barbour R.W., 1969, BATS AM; Barclay RMR, 2003, BAT ECOLOGY, P209; Brunet-Rossinni Anja K., 2009, P315; Cockrum E. L., 1955, Transactions of the Kansas Academy of Science, V58, P487, DOI 10.2307/3626410; Crichton Elizabeth G., 2000, P295, DOI 10.1016/B978-012195670-7/50008-4; Cryan P. M., 2011, ENVIRON LAW, V41, P355; Cryan PM, 2008, J WILDLIFE MANAGE, V72, P845, DOI 10.2193/2007-371; Cryan PM, 2007, BIOL CONSERV, V139, P1, DOI 10.1016/j.biocon.2007.05.019; Cryan PM, 2009, J MAMMAL, V90, P1330, DOI 10.1644/09-MAMM-S-076R1.1; Cryan PM, 2003, J MAMMAL, V84, P579, DOI 10.1644/1545-1542(2003)084<0579:SDOMTB>2.0.CO;2; DIXSON AF, 1991, PHYSIOL BEHAV, V49, P557, DOI 10.1016/0031-9384(91)90280-2; Druecker JD, 1972, ASPECTS REPROD MYOTI; Encarnacao JA, 2006, J MAMMAL, V87, P93, DOI 10.1644/04-MAMM-A-141R2.1; Entwistle AC, 1998, J ZOOL, V244, P63, DOI 10.1017/S0952836998001071; FENTON MB, 1969, CAN J ZOOLOG, V47, P597, DOI 10.1139/z69-103; Fleming TH, 2003, BAT ECOLOGY, P156; GUSTAFSON AW, 1979, J REPROD FERTIL, V56, P317; GUTHRIE MARY J., 1933, JOUR MAMMAL, V14, P199, DOI 10.2307/1373819; HOOPER EMMET T., 1959, OCCAS PAPERS MUS ZOOL UNIV MICHIGAN, V613, P1; KERMOTT LH, 1988, J ZOOL, V214, P519, DOI 10.1111/j.1469-7998.1988.tb03757.x; Kleiman D. G., 1969, Lynx, VNo. 10, P65; Kokurewicz Tomasz, 1992, Myotis, V30, P95; KRUTZSCH PH, 1975, AM J ANAT, V143, P163, DOI 10.1002/aja.1001430203; Krutzsch PH, 1987, AM J ANAT, V178, P617; Krutzsch Philip H., 2000, P91, DOI 10.1016/B978-012195670-7/50005-9; Krutzsch PH, 2009, ACTA CHIROPTEROL, V11, P89, DOI 10.3161/150811009X465712; Kunz TH, 2007, FRONT ECOL ENVIRON, V5, P315, DOI 10.1890/1540-9295(2007)5[315:EIOWED]2.0.CO;2; Lane JE, 2011, ANIM BEHAV, V81, P909, DOI 10.1016/j.anbehav.2011.02.003; Lupold S, 2004, BIOL J LINN SOC, V83, P497, DOI 10.1111/j.1095-8312.2004.00407.x; McCracken Gary F., 2000, P321, DOI 10.1016/B978-012195670-7/50009-6; Myers P., 1977, University Calif. Publs Zool., VNo. 107, P1; OXBERRY BA, 1979, J REPROD FERTIL, V56, P359; PEARSON OP, 1952, J MAMMAL, V33, P273, DOI 10.2307/1375769; Polak M, 2010, P ROY SOC B-BIOL SCI, V277, P1371, DOI 10.1098/rspb.2009.1720; RACEY PA, 1979, J REPROD FERTIL, V56, P391; RACEY PA, 1974, J REPROD FERTIL, V41, P169; Racey Paul A., 2000, P363, DOI 10.1016/B978-012195670-7/50010-2; Rasweiler John J., 2000, P157, DOI 10.1016/B978-012195670-7/50006-0; RYAN JM, 1991, J MAMMAL, V72, P658, DOI 10.2307/1381827; SACHS BD, 1984, ANAT REC, V210, P45, DOI 10.1002/ar.1092100108; Solick Donald I., 2012, Bat Research News, V53, P15; SPEAKMAN JR, 1986, J ZOOL, V210, P515; Tuttle M.D., 1982, P105; Wimsatt WA, 1944, ANAT REC, V88, P193, DOI 10.1002/ar.1090880206; WIMSATT WA, 1945, J MAMMAL, V26, P23, DOI 10.2307/1375029; WIMSATT WA, 1966, AM J ANAT, V119, P25, DOI 10.1002/aja.1001190104; Wimsatt WA, 1960, B MUS COMP ZOOL HARV, V124, P259	54	48	49	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47586	10.1371/journal.pone.0047586	http://dx.doi.org/10.1371/journal.pone.0047586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094065	Green Submitted, Green Published, gold			2022-12-25	WOS:000310050200032
J	Rombach, SM; Aerts, JMFG; Poorthuis, BJHM; Groener, JEM; Donker-Koopman, W; Hendriks, E; Mirzaian, M; Kuiper, S; Wijburg, FA; Hollak, CEM; Linthorst, GE				Rombach, Saskia M.; Aerts, Johannes M. F. G.; Poorthuis, Ben J. H. M.; Groener, Johanna E. M.; Donker-Koopman, Wilma; Hendriks, Erik; Mirzaian, Mina; Kuiper, Sijmen; Wijburg, Frits A.; Hollak, Carla E. M.; Linthorst, Gabor E.			Long-Term Effect of Antibodies against Infused Alpha-Galactosidase A in Fabry Disease on Plasma and Urinary (lyso)Gb3 Reduction and Treatment Outcome	PLOS ONE			English	Article							ENZYME REPLACEMENT THERAPY; AGALSIDASE-BETA THERAPY; GLOBOTRIAOSYLSPHINGOSINE; GLOBOTRIAOSYLCERAMIDE; CERAMIDE; EFFICACY	Introduction: Enzyme replacement therapy (ERT) with alpha-Galactosidase A (aGal A) may cause antibody (AB) formation against aGal A in males with Fabry disease (FD). Anti agalsidase ABs negatively influence globotriaosylceramide (Gb3) reduction. We investigated the impact of agalsidase AB on Gb3 and lysoGb3 and clinical outcome in Fabry patients on ERT. Methods: Adult male and female patients on ERT for at least one year were included. Urinary Gb3 was measured by HPLC, plasma lysoGb3 by LC-ESI-MS/MS and AB with a neutralization assay. Results: Of the 59 patients evaluable patients, 0/30 females and 17/29 males developed anti-agalsidase antibodies (AB+). Only 3/17 males had transient (low) titers (tolerized). All AB+ patients developed antibodies during the first year of treatment. Change of agalsidase preparation (or dose) did not induce antibody formation. AB+ males had significant less decline in plasma lysoGb3 compared to AB- males (p = 0.04). Urinary Gb3 levels decreased markedly in AB- but remained comparable to baseline in AB+ males (p<0.01). (Lyso) Gb3 reduction in plasma and urine on ERT was correlated with LVmass reduction in females and development white matter lesions and stroke. Conclusion: In male patients antibodies against aGal A remained present up to 10 years of ERT. The presence of these antibodies is associated with a less robust decrease in plasma lysoGb3 and a profound negative effect on urinary Gb3 reduction, which may reflect worse treatment outcome.	[Rombach, Saskia M.; Hollak, Carla E. M.; Linthorst, Gabor E.] Univ Amsterdam, Acad Med Ctr, Div Internal Med, Dept Endocrinol & Metab, NL-1105 AZ Amsterdam, Netherlands; [Aerts, Johannes M. F. G.; Poorthuis, Ben J. H. M.; Groener, Johanna E. M.; Donker-Koopman, Wilma; Hendriks, Erik; Mirzaian, Mina; Kuiper, Sijmen; Wijburg, Frits A.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1105 AZ Amsterdam, Netherlands; Univ Amsterdam, Acad Med Ctr, Dept Pediat, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Linthorst, GE (corresponding author), Univ Amsterdam, Acad Med Ctr, Div Internal Med, Dept Endocrinol & Metab, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	g.e.linthorst@amc.nl	Aerts, Johannes/A-1028-2009	Aerts, Johannes/0000-0001-8168-2565; Hollak, Carla/0000-0003-0464-1078; Mirzaian, Mina/0000-0001-9404-2903; Wijburg, Frits/0000-0002-0950-1368	Netherlands Organization for Health Research and Development (ZON-MW)	Netherlands Organization for Health Research and Development (ZON-MW)(Netherlands Organization for Health Research and Development)	This study was funded by The Netherlands Organization for Health Research and Development (ZON-MW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts JM, 2008, P NATL ACAD SCI USA, V105, P2812, DOI 10.1073/pnas.0712309105; Banikazemi M, 2007, ANN INTERN MED, V146, P77, DOI 10.7326/0003-4819-146-2-200701160-00148; Bekri Soumeya, 2006, Cardiovascular & Hematological Agents in Medicinal Chemistry, V4, P289, DOI 10.2174/187152506778520718; Benichou B, 2009, MOL GENET METAB, V96, P4, DOI 10.1016/j.ymgme.2008.10.004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Breunig F, 2006, KIDNEY INT, V69, P1216, DOI 10.1038/sj.ki.5000208; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Garman RD, 2004, CLIN EXP IMMUNOL, V137, P496, DOI 10.1111/j.1365-2249.2004.02567.x; Germain DP, 2007, J AM SOC NEPHROL, V18, P1547, DOI 10.1681/ASN.2006080816; Groener JEM, 2007, CLIN CHEM, V53, P742, DOI 10.1373/clinchem.2006.079012; Hollak CEM, 2009, MOL GENET METAB, V96, P1, DOI 10.1016/j.ymgme.2008.10.013; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Linthorst GE, 2004, KIDNEY INT, V66, P1589, DOI 10.1111/j.1523-1755.2004.00924.x; Lubanda JC, 2009, GENET MED, V11, P256, DOI 10.1097/GIM.0b013e3181981d82; Mendelsohn NJ, 2009, NEW ENGL J MED, V360, P194, DOI 10.1056/NEJMc0806809; Rombach SM, 2010, BBA-MOL BASIS DIS, V9, P1; Sanchez-Nino MD, 2011, NEPHROL DIAL TRANSPL, V26, P1797, DOI 10.1093/ndt/gfq306; Schellekens H, 2008, CLIN THER, V30, pS50, DOI 10.1016/S0149-2918(08)80041-0; Schiffmann R, 2001, JAMA-J AM MED ASSOC, V285, P2743, DOI 10.1001/jama.285.21.2743; Schiffmann R, 2009, NEPHROL DIAL TRANSPL, V24, P2102, DOI 10.1093/ndt/gfp031; Smid BE, 2011, ORPHANET J RARE DIS, V6, DOI 10.1186/1750-1172-6-69; van Breemen MJ, 2011, BBA-MOL BASIS DIS, V1812, P70, DOI 10.1016/j.bbadis.2010.09.007; Vedder AC, 2007, J INHERIT METAB DIS, V30, P68, DOI 10.1007/s10545-006-0484-8; Vedder AC, 2008, MOL GENET METAB, V94, P319, DOI 10.1016/j.ymgme.2008.03.003; Vedder AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000598; Weidemann F, 2009, CIRCULATION, V119, P524, DOI 10.1161/CIRCULATIONAHA.108.794529; Wilcox WR, 2012, MOL GENET METAB, V105, P443, DOI 10.1016/j.ymgme.2011.12.006; Young E, 2005, ACTA PAEDIATR, V94, P51, DOI 10.1080/08035320510028111	29	84	86	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47805	10.1371/journal.pone.0047805	http://dx.doi.org/10.1371/journal.pone.0047805			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094092	gold, Green Published, Green Submitted			2022-12-25	WOS:000310050200048
J	Cong, WN; Cai, H; Wang, R; Daimon, CM; Maudsley, S; Raber, K; Canneva, F; von Horsten, S; Martin, B				Cong, Wei-na; Cai, Huan; Wang, Rui; Daimon, Caitlin M.; Maudsley, Stuart; Raber, Kerstin; Canneva, Fabio; von Hoersten, Stephan; Martin, Bronwen			Altered Hypothalamic Protein Expression in a Rat Model of Huntington's Disease	PLOS ONE			English	Article							EXPANDED CAG REPEAT; NEUROENDOCRINE CHANGES; GLUCOSE-HOMEOSTASIS; ALZHEIMERS-DISEASE; STRIATAL ATROPHY; RODENT MODELS; BODY-WEIGHT; WHOLE-BODY; BRAIN; MICE	Huntington's disease (HD) is a neurodegenerative disorder, which is characterized by progressive motor impairment and cognitive alterations. Changes in energy metabolism, neuroendocrine function, body weight, euglycemia, appetite function, and circadian rhythm can also occur. It is likely that the locus of these alterations is the hypothalamus. We used the HD transgenic (tg) rat model bearing 51 CAG repeats, which exhibits similar HD symptomology as HD patients to investigate hypothalamic function. We conducted detailed hypothalamic proteome analyses and also measured circulating levels of various metabolic hormones and lipids in pre-symptomatic and symptomatic animals. Our results demonstrate that there are significant alterations in HD rat hypothalamic protein expression such as glial fibrillary acidic protein (GFAP), heat shock protein-70, the oxidative damage protein glutathione peroxidase (Gpx4), glycogen synthase1 (Gys1) and the lipid synthesis enzyme acylglycerol-3-phosphate O-acyltransferase 1 (Agpat1). In addition, there are significant alterations in various circulating metabolic hormones and lipids in pre-symptomatic animals including, insulin, leptin, triglycerides and HDL, before any motor or cognitive alterations are apparent. These early metabolic and lipid alterations are likely prodromal signs of hypothalamic dysfunction. Gaining a greater understanding of the hypothalamic and metabolic alterations that occur in HD, could lead to the development of novel therapeutics for early interventional treatment of HD.	[Cong, Wei-na; Cai, Huan; Wang, Rui; Daimon, Caitlin M.; Martin, Bronwen] NIA, Metab Unit, NIH, Baltimore, MD 21224 USA; [Maudsley, Stuart] NIA, Receptor Pharmacol Unit, NIH, Baltimore, MD 21224 USA; [Raber, Kerstin; Canneva, Fabio; von Hoersten, Stephan] Univ Erlangen Nurnberg, Dept Expt Therapy, D-91054 Erlangen, Germany	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of Erlangen Nuremberg	Martin, B (corresponding author), NIA, Metab Unit, NIH, Baltimore, MD 21224 USA.	martinbro@mail.nih.gov	Maudsley, Stuart/Q-4782-2019; von Hörsten, Stephan/G-9005-2015; Maudsley, Stuart/AAV-9929-2021; Cai, Huan/B-6578-2016; Wang, Rui/I-5643-2019	von Hörsten, Stephan/0000-0001-6409-0664; Maudsley, Stuart/0000-0002-1868-184X; Cai, Huan/0000-0001-7731-8891; Wang, Rui/0000-0001-7015-0272; Martin, Bronwen/0000-0002-9185-6925	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Aylward EH, 2004, NEUROLOGY, V63, P66, DOI 10.1212/01.WNL.0000132965.14653.D1; Aziz NA, 2010, CLIN ENDOCRINOL, V73, P206, DOI 10.1111/j.1365-2265.2009.03661.x; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; BAMFORD KA, 1995, NEUROLOGY, V45, P1867, DOI 10.1212/WNL.45.10.1867; Bellinger FP, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-8; Bjorkqvist M, 2007, MOVEMENT DISORD, V22, P1952, DOI 10.1002/mds.21447; Boey D, 2007, PEPTIDES, V28, P390, DOI 10.1016/j.peptides.2006.07.031; BRANDT J, 1988, ANN NEUROL, V23, P555, DOI 10.1002/ana.410230605; Braunstein KE, 2010, HUM MOL GENET, V19, P4385, DOI 10.1093/hmg/ddq361; Cai H, 2012, CURR ALZHEIMER RES, V9, P5, DOI 10.2174/156720512799015064; CHADWICK W, 2010, INT J ALZHEIMERS DIS, DOI DOI 10.4061/2010/604792; Chadwick W, 2011, J SIGNAL TRANSDUCT, V2011; Chadwick W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036975; Chadwick W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021638; Chadwick W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014352; De Sandre-Giovannoli A, 2002, AM J HUM GENET, V70, P726, DOI 10.1086/339274; DEWHURST K, 1970, EUR NEUROL, V3, P278, DOI 10.1159/000113980; Ding WG, 1997, DIABETES, V46, P615, DOI 10.2337/diabetes.46.4.615; Djousse L, 2002, NEUROLOGY, V59, P1325, DOI 10.1212/01.WNL.0000031791.10922.CF; Faivre E, 2012, EUR J PHARMACOL, V674, P294, DOI 10.1016/j.ejphar.2011.11.007; FARRER LA, 1985, CLIN GENET, V27, P62; Field BCT, 2010, NAT REV ENDOCRINOL, V6, P444, DOI 10.1038/nrendo.2010.93; Gabery S, 2010, ACTA NEUROPATHOL, V120, P777, DOI 10.1007/s00401-010-0742-6; Griffiths SD, 2007, MOL BIOTECHNOL, V36, P81, DOI 10.1007/s12033-007-0005-5; Hamilton JM, 2004, J NEUROL NEUROSUR PS, V75, P209, DOI 10.1136/jnnp.2003.017822; Hashimoto K-I, 2012, CLIN ENDOCRINOL META; Holness MJ, 2003, BIOCHEM J, V369, P687, DOI 10.1042/BJ20021509; Hult S, 2011, CELL METAB, V13, P428, DOI 10.1016/j.cmet.2011.02.013; Hult S, 2010, CURR DRUG TARGETS, V11, P1237, DOI 10.2174/1389450111007011237; Hurlbert MS, 1999, DIABETES, V48, P649, DOI 10.2337/diabetes.48.3.649; Irimia JM, 2010, J BIOL CHEM, V285, P12851, DOI 10.1074/jbc.M110.106534; Kipps CM, 2005, J NEUROL NEUROSUR PS, V76, P650, DOI 10.1136/jnnp.2004.047993; KREMER HPH, 1989, J NEUROL SCI, V90, P335, DOI 10.1016/0022-510X(89)90120-2; Lalic NM, 2008, ARCH NEUROL-CHICAGO, V65, P476, DOI 10.1001/archneur.65.4.476; Lalli G, 2009, J CELL SCI, V122, P1499, DOI 10.1242/jcs.044339; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; Leoni V, 2011, NEUROSCI LETT, V494, P245, DOI 10.1016/j.neulet.2011.03.025; Li SH, 2004, NEUROSCIENTIST, V10, P467, DOI 10.1177/1073858404266777; Lopez M, 2008, CURR OPIN CLIN NUTR, V11, P483, DOI 10.1097/MCO.0b013e328302f3d8; Lotz GP, 2010, J BIOL CHEM, V285, P38183, DOI 10.1074/jbc.M110.160218; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; Martin B, 2008, HISTOL HISTOPATHOL, V23, P237, DOI 10.14670/HH-23.237; Martin B, 2007, ENDOCRINOLOGY, V148, P4318, DOI 10.1210/en.2007-0161; Martin B, 2010, DIABETES, V59, P1143, DOI 10.2337/db09-0807; Martin B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004146; Martin B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002750; Martin B, 2009, DIABETES, V58, P318, DOI 10.2337/db08-0799; Martin B, 2009, J BIOL CHEM, V284, P2493, DOI 10.1074/jbc.M804545200; Mayers RM, 2005, BIOCHEM SOC T, V33, P367, DOI 10.1042/BST0330367; McBride JL, 2006, P NATL ACAD SCI USA, V103, P9345, DOI 10.1073/pnas.0508875103; Middeldorp J, 2011, PROG NEUROBIOL, V93, P421, DOI 10.1016/j.pneurobio.2011.01.005; Morton AJ, 2005, J NEUROSCI, V25, P157, DOI 10.1523/JNEUROSCI.3842-04.2005; Nguyen HP, 2006, HUM MOL GENET, V15, P3177, DOI 10.1093/hmg/ddl394; Paulsen JS, 2006, BIOL PSYCHIAT, V59, P57, DOI 10.1016/j.biopsych.2005.06.003; Petersen A, 2009, NEURODEGENER DIS, V6, P154, DOI 10.1159/000225377; Phan J, 2009, HUM MOL GENET, V18, P1006, DOI 10.1093/hmg/ddn428; PODOLSKY S, 1977, GERONTOLOGY, V23, P55, DOI 10.1159/000212174; Pohl R, 2004, P NUTR SOC, V63, P259, DOI 10.1079/PNS2004341; Popovic V, 2004, EUR J ENDOCRINOL, V151, P451, DOI 10.1530/eje.0.1510451; Raza H, 2011, FEBS J, V278, P4243, DOI 10.1111/j.1742-4658.2011.08358.x; Rosas HD, 2005, NEUROLOGY, V65, P745, DOI 10.1212/01.wnl.0000174432.87383.87; Rothman SM, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.07.005; Salvatore E, 2011, J NEUROL NEUROSUR PS, V82, P543, DOI 10.1136/jnnp.2010.208553; SANBERG PR, 1981, MED J AUSTRALIA, V1, P407, DOI 10.5694/j.1326-5377.1981.tb135681.x; Sawiak SJ, 2009, NEUROBIOL DIS, V33, P20, DOI 10.1016/j.nbd.2008.09.016; Scherbaum WA, 1998, EXP CLIN ENDOCR DIAB, V106, P97, DOI 10.1055/s-0029-1211958; SCHWARTZ TW, 1978, J CLIN INVEST, V61, P781, DOI 10.1172/JCI108992; SHIWACH R, 1994, ACTA PSYCHIAT SCAND, V90, P241, DOI 10.1111/j.1600-0447.1994.tb01587.x; Soneson C, 2010, NEUROBIOL DIS, V40, P531, DOI 10.1016/j.nbd.2010.07.013; Spoden GA, 2009, EXP CELL RES, V315, P2765, DOI 10.1016/j.yexcr.2009.06.024; Stranahan AM, 2010, NEUROBIOL AGING, V31, P1937, DOI 10.1016/j.neurobiolaging.2008.10.016; Takeuchi K, 2009, AM J PHYSIOL-ENDOC M, V296, pE1195, DOI 10.1152/ajpendo.90958.2008; Tomita T, 2011, ISLETS, V3, P166, DOI 10.4161/isl.3.4.15875; Trejo A, 2004, NUTRITION, V20, P192, DOI 10.1016/j.nut.2003.10.007; Valenza M, 2010, J NEUROSCI, V30, P10844, DOI 10.1523/JNEUROSCI.0917-10.2010; van der Burg JMM, 2009, LANCET NEUROL, V8, P765, DOI 10.1016/S1474-4422(09)70178-4; von Horsten S, 2003, HUM MOL GENET, V12, P617, DOI 10.1093/hmg/ddg075; WHITTIER JR, 1976, JAMA-J AM MED ASSOC, V235, P1423, DOI 10.1001/jama.1976.03260400011003; Wolf RC, 2007, BRAIN, V130, P2845, DOI 10.1093/brain/awm210; Zhao WQ, 2007, J NEUROCHEM, V100, P1211, DOI 10.1111/j.1471-4159.2006.04311.x	82	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47240	10.1371/journal.pone.0047240	http://dx.doi.org/10.1371/journal.pone.0047240			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094041	Green Submitted, gold, Green Published			2022-12-25	WOS:000312384500007
J	Masino, MA; Abbinanti, MD; Eian, J; Harris-Warrick, RM				Masino, Mark A.; Abbinanti, Matthew D.; Eian, John; Harris-Warrick, Ronald M.			TTX-Resistant NMDA Receptor-Mediated Membrane Potential Oscillations in Neonatal Mouse Hb9 Interneurons	PLOS ONE			English	Article							RAT SPINAL-CORD; METHYL-D-ASPARTATE; CENTRAL PATTERN GENERATORS; CAT NEOCORTICAL NEURONS; LOCOMOTOR-LIKE ACTIVITY; FICTIVE LOCOMOTION; VOLTAGE OSCILLATIONS; IN-VITRO; LUMBAR MOTONEURONS; COMMISSURAL INTERNEURONS	Conditional neuronal membrane potential oscillations have been identified as a potential mechanism to help support or generate rhythmogenesis in neural circuits. A genetically identified population of ventromedial interneurons, called Hb9, in the mouse spinal cord has been shown to generate TTX-resistant membrane potential oscillations in the presence of NMDA, serotonin and dopamine, but these oscillatory properties are not well characterized. Hb9 interneurons are rhythmically active during fictive locomotor-like behavior. In this study, we report that exogenous N-Methyl-D-Aspartic acid (NMDA) application is sufficient to produce membrane potential oscillations in Hb9 interneurons. In contrast, exogenous serotonin and dopamine application, alone or in combination, are not sufficient. The properties of NMDA-induced oscillations vary among the Hb9 interneuron population; their frequency and amplitude increase with increasing NMDA concentration. NMDA does not modulate the T-type calcium current (I-Ca(T)), which is thought to be important in generating locomotor-like activity, in Hb9 neurons. These results suggest that NMDA receptor activation is sufficient for the generation of TTX-resistant NMDA-induced membrane potential oscillations in Hb9 interneurons. Citation: Masino MA, Abbinanti MD, Eian J, Harris-Warrick RM (2012) TTX-Resistant NMDA Receptor-Mediated Membrane Potential Oscillations in Neonatal Mouse Hb9 Interneurons. PLoS ONE 7(10): e47940. doi: 10.1371/journal.pone.0047940	[Masino, Mark A.; Eian, John] Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA; [Abbinanti, Matthew D.; Harris-Warrick, Ronald M.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA	University of Minnesota System; University of Minnesota Twin Cities; Cornell University	Masino, MA (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	masino@umn.edu		Harris-Warrick, Ronald/0000-0002-7668-6075	National Institutes of Health [R01-NS065054, R01-NS35631, R01-NS17323]; Minnesota Medical Foundation Grant [4052-9238-11]; Office of the Dean of the Graduate School of the University of Minnesota [21934]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035631, R01NS065054, R01NS017323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Medical Foundation Grant; Office of the Dean of the Graduate School of the University of Minnesota(University of Minnesota System); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants R01-NS065054 (MAM) and R01-NS35631 and R01-NS17323 (to RMHW), Minnesota Medical Foundation Grant 4052-9238-11 (MAM) and Office of the Dean of the Graduate School of the University of Minnesota (Grant-in-Aid of Research, Artistry and Scholarship 21934 (MAM)). NIH: www.nih.gov MMF: www.mmf.umn.edu GIA: www.research.umn.edu/advance/gia.html#.T_2YrGDcFBw. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbinanti MD, 2012, J NEUROPHYSIOL, V107, P2212, DOI 10.1152/jn.00768.2011; Anderson TM, 2012, J NEUROPHYSIOL, V107, P103, DOI 10.1152/jn.00583.2011; Arshavsky YI, 1997, CURR OPIN NEUROBIOL, V7, P781, DOI 10.1016/S0959-4388(97)80136-5; Beato M, 1997, P ROY SOC B-BIOL SCI, V264, P877, DOI 10.1098/rspb.1997.0122; Brownstone RM, 2008, BRAIN RES REV, V57, P64, DOI 10.1016/j.brainresrev.2007.06.025; CALABRESE RL, 1997, COMPUT NEUR, P119; CAZALETS JR, 1995, J NEUROSCI, V15, P4943; CAZALETS JR, 1992, J PHYSIOL-LONDON, V455, P187, DOI 10.1113/jphysiol.1992.sp019296; Cowley KC, 2005, J NEUROPHYSIOL, V94, P3805, DOI 10.1152/jn.00016.2005; Cowley KC, 1997, J NEUROPHYSIOL, V77, P247, DOI 10.1152/jn.1997.77.1.247; Crone SA, 2008, NEURON, V60, P70, DOI 10.1016/j.neuron.2008.08.009; Crone SA, 2009, J NEUROSCI, V29, P7098, DOI 10.1523/JNEUROSCI.1206-09.2009; Diaz-Rios M, 2007, J NEUROPHYSIOL, V98, P2157, DOI 10.1152/jn.00430.2007; FLATMAN JA, 1983, BRAIN RES, V266, P169, DOI 10.1016/0006-8993(83)91323-9; FLATMAN JA, 1986, BRAIN RES, V363, P62, DOI 10.1016/0006-8993(86)90659-1; Fouad K, 2010, J NEUROPHYSIOL, V104, P2975, DOI 10.1152/jn.00499.2010; Gabbay H, 2002, J NEUROPHYSIOL, V88, P732, DOI 10.1152/jn.2002.88.2.732; GETTING PA, 1989, ANNU REV NEUROSCI, V12, P185, DOI 10.1146/annurev.neuro.12.1.185; Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545; GRILLNER S, 1979, EXP BRAIN RES, V34, P241; Han P, 2007, J NEUROSCI, V27, P13192, DOI 10.1523/JNEUROSCI.1279-07.2007; Harris-Warrick RM, 2002, CURR OPIN NEUROBIOL, V12, P646, DOI 10.1016/S0959-4388(02)00377-X; HarrisWarrick RM, 1995, CURR OPIN NEUROBIOL, V5, P721, DOI 10.1016/0959-4388(95)89098-R; HERNANDEZ P, 1991, EXP BRAIN RES, V85, P66; Hinckley CA, 2006, J NEUROSCI, V26, P8477, DOI 10.1523/JNEUROSCI.0395-06.2006; HOCHMAN S, 1994, J NEUROPHYSIOL, V72, P2559, DOI 10.1152/jn.1994.72.5.2559; HOCHMAN S, 1994, J NEUROPHYSIOL, V72, P565, DOI 10.1152/jn.1994.72.2.565; Jiang ZY, 1999, BRAIN RES, V816, P493, DOI 10.1016/S0006-8993(98)01199-8; Juvin L, 2005, J NEUROSCI, V25, P6025, DOI 10.1523/JNEUROSCI.0696-05.2005; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kjaerulff O, 1996, J NEUROSCI, V16, P5777; Kremer E, 1997, J NEUROPHYSIOL, V77, P1155, DOI 10.1152/jn.1997.77.3.1155; KUDO N, 1987, NEUROSCI LETT, V75, P43, DOI 10.1016/0304-3940(87)90072-3; Kwan AC, 2010, J NEUROPHYSIOL, V104, P3323, DOI 10.1152/jn.00679.2010; Kwan AC, 2009, J NEUROSCI, V29, P11601, DOI 10.1523/JNEUROSCI.1612-09.2009; LERESCHE N, 1991, J PHYSIOL-LONDON, V441, P155, DOI 10.1113/jphysiol.1991.sp018744; LERESCHE N, 1990, NEUROSCI LETT, V113, P72, DOI 10.1016/0304-3940(90)90497-W; MacLean JN, 1997, EUR J NEUROSCI, V9, P2702, DOI 10.1111/j.1460-9568.1997.tb01699.x; MacLean JN, 2001, J NEUROPHYSIOL, V86, P1131, DOI 10.1152/jn.2001.86.3.1131; MacLean JN, 1998, J NEUROPHYSIOL, V79, P2804, DOI 10.1152/jn.1998.79.5.2804; Marder E, 2001, CURR BIOL, V11, pR986, DOI 10.1016/S0960-9822(01)00581-4; MARDER E, 1984, J NEUROPHYSIOL, V51, P1362, DOI 10.1152/jn.1984.51.6.1362; MULLONEY B, 1981, BRAIN RES, V229, P25, DOI 10.1016/0006-8993(81)90742-3; Pena F, 2004, J NEUROSCI, V24, P7549, DOI 10.1523/JNEUROSCI.1871-04.2004; PERKEL DH, 1974, SCIENCE, V185, P181, DOI 10.1126/science.185.4146.181; Plouffe B, 2010, METHOD ENZYMOL, V484, P295, DOI [10.1016/B978-0-12-381298-8.00016-2, 10.1016/S0076-6879(10)84016-9]; ROBERTS A, 1995, J NEUROPHYSIOL, V73, P485, DOI 10.1152/jn.1995.73.2.485; Schmidt BJ, 1998, ANN NY ACAD SCI, V860, P189, DOI 10.1111/j.1749-6632.1998.tb09049.x; SCHWINDT P, 1977, BRAIN RES, V120, P173, DOI 10.1016/0006-8993(77)90510-8; SCHWINDT PC, 1980, J NEUROPHYSIOL, V43, P1700, DOI 10.1152/jn.1980.43.6.1700; SIGVARDT KA, 1985, BRAIN RES, V336, P390, DOI 10.1016/0006-8993(85)90676-6; SILLAR KT, 1994, EUR J MORPHOL, V32, P293; SMITH JC, 1988, FASEB J, V2, P2283, DOI 10.1096/fasebj.2.7.2450802; SMITH JC, 1987, J NEUROSCI METH, V21, P321, DOI 10.1016/0165-0270(87)90126-9; Tazerart S, 2008, J NEUROSCI, V28, P8577, DOI 10.1523/JNEUROSCI.1437-08.2008; Tresch MC, 2000, NAT NEUROSCI, V3, P593, DOI 10.1038/75768; WALLEN P, 1987, J NEUROSCI, V7, P2745; WALLEN P, 1985, NEUROSCI LETT, V56, P87, DOI 10.1016/0304-3940(85)90112-0; Whelan P, 2000, J NEUROPHYSIOL, V84, P2821, DOI 10.1152/jn.2000.84.6.2821; Wilson JM, 2007, J NEUROPHYSIOL, V98, P2370, DOI 10.1152/jn.00338.2007; Wilson JM, 2010, J NEUROSCI, V30, P1137, DOI 10.1523/JNEUROSCI.1401-09.2010; Wilson JM, 2005, J NEUROSCI, V25, P5710, DOI 10.1523/JNEUROSCI.0274-05.2005; WILSON WA, 1974, SCIENCE, V186, P932, DOI 10.1126/science.186.4167.932; Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027; Zhong GS, 2007, J NEUROSCI, V27, P4507, DOI 10.1523/JNEUROSCI.0124-07.2007; Ziskind-Conhaim L, 2008, J NEUROPHYSIOL, V100, P2254, DOI 10.1152/jn.90437.2008; Ziskind-Conhaim L, 2010, ANN NY ACAD SCI, V1198, P72, DOI 10.1111/j.1749-6632.2010.05533.x	67	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47940	10.1371/journal.pone.0047940	http://dx.doi.org/10.1371/journal.pone.0047940			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094101	gold, Green Published			2022-12-25	WOS:000312384500029
J	Ramos, CG; da Costa, PJP; Doring, G; Leitao, JH				Ramos, Christian G.; da Costa, Paulo J. P.; Doering, Gerd; Leitao, Jorge H.			The Novel Cis-Encoded Small RNA h2cR Is a Negative Regulator of hfq2 in Burkholderia cenocepacia	PLOS ONE			English	Article							MESSENGER-RNA; GENE-EXPRESSION; BINDING; PROTEIN; RPOS; IDENTIFICATION; PREDICTION; VIRULENCE; CEPACIA; DSRA	Small non-coding regulatory RNAs (sRNAs) post-transcriptionally affect multiple phenotypes in prokaryotes and eukaryotes, yet most of the underlying regulatory mechanisms and the nature of the target mRNAs remain unclear. Here we report the identification and functional analysis of the novel cis-encoded sRNA h2cR, from the human opportunistic pathogen Burkholderia cenocepacia J2315. The sRNA was found to negatively regulate the hfq2 mRNA, through binding to part of the 5'-UTR region of the hfq2 mRNA, resulting in accelerated hfq2 mRNA decay and reduced protein levels in exponentially growing cells. Both the h2cR transcript and the hfq2 mRNA are stabilized by the other B. cenocepacia RNA chaperone, Hfq. Infection experiments using the nematode Caenorhabditis elegans revealed that down-regulation of Hfq2 by h2cR decreases the B. cenocepacia ability to colonize and persist within the nematode, suggesting a role for h2cR on bacterial persistence in the host.	[Leitao, Jorge H.] Univ Tecn Lisboa, Inst Super Tecn, Dept Bioengn, P-1096 Lisbon, Portugal; [Ramos, Christian G.; da Costa, Paulo J. P.; Leitao, Jorge H.] Univ Tecn Lisboa, Inst Super Tecn, Inst Biotechnol & Bioengn, P-1096 Lisbon, Portugal; [Doering, Gerd] Univ Tubingen, Inst Med Mikrobiol & Hyg, Tubingen, Germany	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Leitao, JH (corresponding author), Univ Tecn Lisboa, Inst Super Tecn, Dept Bioengn, P-1096 Lisbon, Portugal.	jorgeleitao@ist.utl.pt	Leitão, Jorge H./A-5122-2012; Ramos, Christian G/A-8588-2010; Ramos, Christian Gomes/H-5855-2019	Leitão, Jorge H./0000-0001-8850-274X; Ramos, Christian G/0000-0003-0970-7750; Ramos, Christian Gomes/0000-0003-0970-7750	Fundacao Ciencia e a Tecnologia, Portugal [PTDC/BIA-MIC/119091/2010]	Fundacao Ciencia e a Tecnologia, Portugal	This work was partially supported by Fundacao Ciencia e a Tecnologia, Portugal (contract PTDC/BIA-MIC/119091/2010), a Post-Doc grant to CGR and a research grant to JP da Costa. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beich-Frandsen M, 2011, NUCLEIC ACIDS RES, V39, P4900, DOI 10.1093/nar/gkq1346; Bejerano-Sagie M, 2007, CURR OPIN MICROBIOL, V10, P189, DOI 10.1016/j.mib.2007.03.009; Bohn C, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-10; Brantl S, 2007, CURR OPIN MICROBIOL, V10, P102, DOI 10.1016/j.mib.2007.03.012; Chao YJ, 2010, CURR OPIN MICROBIOL, V13, P24, DOI 10.1016/j.mib.2010.01.001; Coenye T, 2007, FEMS MICROBIOL LETT, V276, P83, DOI 10.1111/j.1574-6968.2007.00916.x; Coenye T, 2011, ANTIMICROB AGENTS CH, V55, P1912, DOI 10.1128/AAC.01571-10; Folichon M, 2003, NUCLEIC ACIDS RES, V31, P7302, DOI 10.1093/nar/gkg915; Gottesman S, 2006, COLD SPRING HARB SYM, V71, P1, DOI 10.1101/sqb.2006.71.016; Gottesman S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003798; Hwang W, 2011, NUCLEIC ACIDS RES, V39, P5131, DOI 10.1093/nar/gkr075; KAJITANI M, 1994, J BACTERIOL, V176, P531, DOI 10.1128/JB.176.2.531-534.1994; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Lefebre MD, 2002, APPL ENVIRON MICROB, V68, P5956, DOI 10.1128/AEM.68.12.5956-5964.2002; Liu JM, 2010, CURR OPIN MICROBIOL, V13, P18, DOI 10.1016/j.mib.2009.11.004; Majdalani N, 2005, CRIT REV BIOCHEM MOL, V40, P93, DOI 10.1080/10409230590918702; Markowitz VM, 2010, NUCLEIC ACIDS RES, V38, pD382, DOI 10.1093/nar/gkp887; Marsh EK, 2012, APPL ENVIRON MICROB, V78, P2075, DOI 10.1128/AEM.07486-11; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; McNealy TL, 2005, J BACTERIOL, V187, P1527, DOI 10.1128/JB.187.4.1527-1532.2005; Moll I, 2003, RNA, V9, P1308, DOI 10.1261/rna.5850703; Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1; Munch R, 2005, BIOINFORMATICS, V21, P4187, DOI 10.1093/bioinformatics/bti635; Olsen AS, 2010, J MOL BIOL, V404, P173, DOI 10.1016/j.jmb.2010.09.038; Papenfort K, 2010, CELL HOST MICROBE, V8, P116, DOI 10.1016/j.chom.2010.06.008; Peeters E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-90; Rajkowitsch L, 2007, RNA, V13, P2053, DOI 10.1261/rna.671807; Ramos CG, 2011, J BACTERIOL, V193, P1515, DOI 10.1128/JB.01375-10; Ramos CG, 2010, MICROB PATHOGENESIS, V48, P168, DOI 10.1016/j.micpath.2010.02.006; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Roberts SA, 2007, MOL MICROBIOL, V66, P1506, DOI 10.1111/j.1365-2958.2007.06015.x; Salgado-Garrido J, 1999, EMBO J, V18, P3451, DOI 10.1093/emboj/18.12.3451; Sobrero P, 2011, ARCH MICROBIOL, V193, P629, DOI 10.1007/s00203-011-0701-1; Soper TJ, 2008, RNA, V14, P1907, DOI 10.1261/rna.1110608; Sousa SA, 2011, INT J MICROBIOL; Sousa SA, 2010, MICROBIOL-SGM, V156, P896, DOI 10.1099/mic.0.035139-0; Sousa SA, 2008, MICROB PATHOGENESIS, V45, P331, DOI 10.1016/j.micpath.2008.08.002; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Uehlinger S, 2009, INFECT IMMUN, V77, P4102, DOI 10.1128/IAI.00398-09; Updegrove T, 2008, BIOCHEMISTRY-US, V47, P11184, DOI 10.1021/bi800479p; Vandamme P, 2003, RES MICROBIOL, V154, P91, DOI 10.1016/S0923-2508(03)00026-3; Vecerek B, 2005, RNA, V11, P976, DOI 10.1261/rna.2360205; Vecerek B, 2008, NUCLEIC ACIDS RES, V36, P133, DOI 10.1093/nar/gkm985; Wassarman KM, 2002, CELL, V109, P141, DOI 10.1016/S0092-8674(02)00717-1; Winsor GL, 2008, BIOINFORMATICS, V24, P2803, DOI 10.1093/bioinformatics/btn524; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	46	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47896	10.1371/journal.pone.0047896	http://dx.doi.org/10.1371/journal.pone.0047896			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082228	Green Submitted, gold, Green Published			2022-12-25	WOS:000311146900125
J	Ren, JN; Zhao, YZ; Yuan, YJ; Han, G; Li, WQ; Huang, Q; Tong, ZH; Li, JS				Ren, Jianan; Zhao, Yunzhao; Yuan, Yujie; Han, Gang; Li, Weiqin; Huang, Qian; Tong, Zhihui; Li, Jieshou			Complement Depletion Deteriorates Clinical Outcomes of Severe Abdominal Sepsis: A Conspirator of Infection and Coagulopathy in Crime?	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INTENSIVE-CARE-UNIT; INFLAMMATORY RESPONSE; SERUM PROCALCITONIN; SCORING SYSTEM; SEPTIC SHOCK; PLASMA; COAGULATION; PERITONITIS; ACTIVATION	Background: The complement depletion commonly occurred during sepsis, but it was often underestimated compared with severe infection or coagulation dysfunction. Objective: This study was designed to investigate the alteration of complement system in patients with severe abdominal sepsis and evaluate the role of complement depletion in prognosis of such patients. The relationship between complement depletion and infection or coagulopathy was also explored. Methods: Forty-five patients with severe abdominal sepsis were prospectively conducted among individuals referral to SICU. Currently recommended treatments, such as early goal-directed resuscitation, source control and antibiotics therapy, were performed. Acute physiology and chronic health evaluation II (APACHE II) and sepsis related organ failure assessment (SOFA) scores were employed to evaluate severity. Plasma levels of C3, C4, CRP, PCT, D-dimer and other parameters were detected within eight times of observation. The 28-day mortality, length of stay, and postoperative complications were compared between complement depletion and non-complement depletion groups. Results: Within the study period, eight (17.8%) patients died, five of them suffering from complement depletion. The overall incidence of complement depletion was 64.4%. At admission, mean complement C3 and C4 levels were 0.70 and 0.13 mg/mL, respectively. Using ROC analysis for mortality prediction, the area under the curve of C3 was 0.926 (95% CI, 0.845-0.998, P<0.001), with optimal cutpoint value of 0.578 mg/mL. Complement C3 depletion was shown to be no correlation to severity scores, however, strongly correlated with elevated D-dimer, PCT concentrations and increased postoperative complications. Conclusions: Complement C3 depletion was found to be connected to poor prognosis in severe abdominal sepsis. This depletion seems to be associated with coagulopathy and aggravated infection during sepsis, which should be paid close attention in critical care.	[Ren, Jianan; Zhao, Yunzhao; Yuan, Yujie; Han, Gang; Li, Weiqin; Huang, Qian; Tong, Zhihui; Li, Jieshou] Nanjing Univ, Sch Med, Jingling Hosp, Dept Surg, Nanjing, Jiangsu, Peoples R China	Nanjing University	Ren, JN (corresponding author), Nanjing Univ, Sch Med, Jingling Hosp, Dept Surg, Nanjing, Jiangsu, Peoples R China.	JiananR@gmail.com	Li, jie/GXG-4583-2022; ZHAO, YUAN/HCI-5831-2022; Yuan, Yujie/O-9873-2018; zhao, YZ/GXH-6401-2022	Yuan, Yujie/0000-0001-5786-4377; Ren, Jianan/0000-0002-7978-8093	Natural Science Foundation of Jiangsu Province for Distinguished Scholars [BK2010017]; High-Level Personnel Training Project, Jiangsu, China [BRA2011232]	Natural Science Foundation of Jiangsu Province for Distinguished Scholars; High-Level Personnel Training Project, Jiangsu, China	This study was supported by grants from the Climbing Program in Natural Science Foundation of Jiangsu Province for Distinguished Scholars (No. BK2010017) and the High-Level Personnel Training Project, Jiangsu, China (BRA2011232). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; ASSICOT M, 1993, LANCET, V341, P515, DOI 10.1016/0140-6736(93)90277-N; Bearfield P, 2010, CRITICAL CARE, V14, pP223; Bee TK, 2008, J TRAUMA, V65, P337, DOI 10.1097/TA.0b013e31817fa451; CHAPMAN R, 1964, AM J SURG, V108, P157, DOI 10.1016/0002-9610(64)90005-4; Delibegovic Samir, 2011, Med Arh, V65, P82; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Ehrnthaller C, 2011, MOL MED, V17, P317, DOI 10.2119/molmed.2010.00149; Iakovleva I I, 1999, Anesteziol Reanimatol, P23; Jones AE, 2009, CRIT CARE MED, V37, P1649, DOI 10.1097/CCM.0b013e31819def97; Ke L, 2012, J HEPATO-BIL-PAN SCI, V19, P259, DOI 10.1007/s00534-011-0414-5; Kulkarni SV, 2007, AM J SURG, V194, P549, DOI 10.1016/j.amjsurg.2007.01.031; Kupreishvili K, 2011, J HEART VALVE DIS, V20, P29; Lambris John D, 2012, Adv Exp Med Biol, V946, pv; Leendertse M, 2010, J INFECT DIS, V201, P544, DOI 10.1086/650341; LIN RY, 1993, CLIN IMMUNOL IMMUNOP, V69, P136, DOI 10.1006/clin.1993.1161; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Martinez JL, 2012, J GASTROINTEST SURG, V16, P156, DOI 10.1007/s11605-011-1703-7; Muller B, 2001, J CLIN ENDOCR METAB, V86, P396, DOI 10.1210/jc.86.1.396; OH TE, 1993, CRIT CARE MED, V21, P698, DOI 10.1097/00003246-199305000-00013; Oikonomopoulou K, 2012, SEMIN IMMUNOPATHOL, V34, P151, DOI 10.1007/s00281-011-0280-x; Peng ZY, 2010, CONTRIB NEPHROL, V165, P322, DOI 10.1159/000313773; Selberg O, 2000, CRIT CARE MED, V28, P2793, DOI 10.1097/00003246-200008000-00019; Semeraro N, 2012, THROMB RES, V129, P290, DOI 10.1016/j.thromres.2011.10.013; Silasi-Mansat R, 2010, BLOOD, V116, P1002, DOI 10.1182/blood-2010-02-269746; Silvester W, 1997, AM J KIDNEY DIS, V30, pS38, DOI 10.1016/S0272-6386(97)90541-2; SIRIO CA, 1992, CRIT CARE MED, V20, P1207, DOI 10.1097/00003246-199209000-00006; Taylor R, 2007, LANCET ONCOL, V8, P370, DOI 10.1016/S1470-2045(07)70114-6; Ward PA, 2009, J CELL MOL MED, V13, P4154, DOI 10.1111/j.1582-4934.2009.00893.x; Wolbink GJ, 1998, J INFECT DIS, V177, P81, DOI 10.1086/513803; WONG DT, 1995, CRIT CARE MED, V23, P1177, DOI 10.1097/00003246-199507000-00005; Yalcindag A, 2006, J ALLERGY CLIN IMMUN, V117, P1455, DOI 10.1016/j.jaci.2006.01.048; Yealy DM, 2009, JAMA-J AM MED ASSOC, V302, P1115, DOI 10.1001/jama.2009.1318; Younger JG, 2010, ACAD EMERG MED, V17, P353, DOI 10.1111/j.1553-2712.2010.00713.x; Yuan SM, 2011, REV BRAS CIR CARDIOV, V26, P573, DOI 10.5935/1678-9741.20110047; Yuan YJ, 2012, INT IMMUNOPHARMACOL, V12, P271, DOI 10.1016/j.intimp.2011.11.022; Yuan YJ, 2011, J SURG RES, V168, pE87, DOI 10.1016/j.jss.2011.01.062; ZIMMERMAN JE, 1988, CRIT CARE MED, V16, P318, DOI 10.1097/00003246-198804000-00003	38	27	31	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47095	10.1371/journal.pone.0047095	http://dx.doi.org/10.1371/journal.pone.0047095			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091606	Green Submitted, Green Published, gold			2022-12-25	WOS:000310135800022
J	Lin, S; Tian, L; Shen, H; Gu, Y; Li, JL; Chen, Z; Sun, X; You, MJ; Wu, L				Lin, S.; Tian, L.; Shen, H.; Gu, Y.; Li, J-L; Chen, Z.; Sun, X.; You, M. James; Wu, L.			DDX5 is a positive regulator of oncogenic NOTCH1 signaling in T cell acute lymphoblastic leukemia	ONCOGENE			English	Article						NOTCH; MAML1; DDX5; T-ALL; leukemia	RNA HELICASES P68; TRANSCRIPTIONAL COACTIVATOR; SOLID TUMORS; MASTERMIND; PROTEINS; CANCER; IDENTIFICATION; ACTIVATION; DIFFERENTIATION; COREGULATORS	Notch signaling is a highly conserved cell-cell communication pathway regulating normal development and tissue homeostasis. Aberrant Notch signaling represents an important oncogenic mechanism for T cell acute lymphoblastic leukemia (T-ALL), an aggressive subset of the most common malignant childhood cancer ALL. Therefore, understanding the molecular regulation of Notch signaling is critical to identify new approaches to block aberrant Notch oncogenic activity. The family of three MAML transcriptional coactivators is crucial for Notch signaling activation. The prototypic member MAML1 is the major coactivator that regulates Notch oncogenic activities in leukemic cells. However, the molecular basis underlying MAML1 coactivator function that contributes to Notch signaling remains unclear. In this study, we performed proteomic studies and identified DDX5, an ATP-dependent DEAD-box RNA helicase, as a component of the MAML1 protein complex. DDX5 interacts with MAML1 in vitro and in vivo, and is associated with the endogenous NOTCH1 transcription activation complex in human T-ALL leukemic cells. Lentivirus-mediated short-hairpin RNA knock-down of DDX5 resulted in decreased expression of Notch target genes, reduced cell proliferation and increased apoptosis in cultured human leukemic cells with constitutive activation of Notch signaling. Also, DDX5 depletion inhibited the growth of human leukemia xenograft in nude mice. Moreover, DDX5 is highly expressed in primary human T-ALL leukemic cells based on the analyses of Oncomine and GEO databases, and Immunohistochemical staining. Our overall findings revealed a critical role of DDX5 in promoting efficient Notch-mediated transcription in leukemic cells, suggesting that DDX5 might be critical for NOTCH1-mediated T-ALL pathogenesis and thus is a potential new target for modulating the Notch signaling in leukemia.	[Lin, S.; Tian, L.; Shen, H.; Gu, Y.; Chen, Z.; Wu, L.] Univ Florida, Dept Mol Genet & Microbiol, Shands Canc Ctr, Gainesville, FL 32610 USA; [Tian, L.; Shen, H.] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Li, J-L] Sanford Burnham Med Res Inst Lake Nona, Orlando, FL USA; [Sun, X.; You, M. James] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	State University System of Florida; University of Florida; Sun Yat Sen University; Sanford Burnham Prebys Medical Discovery Institute; University of Texas System; UTMD Anderson Cancer Center	Wu, L (corresponding author), Univ Florida, Dept Mol Genet & Microbiol, Shands Canc Ctr, 2033 Mowry Rd, Gainesville, FL 32610 USA.	lzwu@ufl.edu	Li, J L/E-6100-2018; chen, zirong/S-4042-2016; Li, Jian-Liang/AAE-9315-2019	Li, J L/0000-0002-6487-081X; chen, zirong/0000-0002-0589-4619; Li, Jian-Liang/0000-0002-6487-081X	University of Florida Shands Cancer Center Startup fund; STOP! Children's Cancer, Inc.; Florida Bankhead Coley Cancer Research Program [2BB11, 1BF04]; National Natural Science Foundation of China [81170891]; NIH/NCI [RO1 CA164346]; Developmental Research Awards in Leukemia SPORE [CA100632]; UT MDACC Physician Scientist Award; American Cancer Society IRG; UT MDACC IRG; Ladies Leukemia League; NATIONAL CANCER INSTITUTE [R01CA164346, P30CA016672, P50CA100632] Funding Source: NIH RePORTER	University of Florida Shands Cancer Center Startup fund; STOP! Children's Cancer, Inc.; Florida Bankhead Coley Cancer Research Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Developmental Research Awards in Leukemia SPORE; UT MDACC Physician Scientist Award; American Cancer Society IRG(American Cancer Society); UT MDACC IRG; Ladies Leukemia League; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Vittorio Sartorelli for kindly providing us with DDX5 expression constructs, Marda Jorgensen for helping with immunohistochemical staining and Jameson Kuang for careful reading of the manuscript. This work was supported by the University of Florida Shands Cancer Center Startup fund, STOP! Children's Cancer, Inc., and Florida Bankhead Coley Cancer Research Program (2BB11 and 1BF04 to LW). HS was supported by the National Natural Science Foundation of China (81170891). MJY was supported by NIH/NCI RO1 CA164346, Developmental Research Awards in Leukemia SPORE CA100632, UT MDACC Physician Scientist Award, American Cancer Society IRG, UT MDACC IRG and Ladies Leukemia League.	Artayanis-Tsakonas S, 2010, CURR TOP DEV BIOL, V92, P1, DOI 10.1016/S0070-2153(10)92001-2; Aster JC, 2011, J PATHOL, V223, P262, DOI 10.1002/path.2789; Caretti G, 2007, CELL CYCLE, V6, P1172, DOI 10.4161/cc.6.10.4228; Caretti G, 2006, DEV CELL, V11, P547, DOI 10.1016/j.devcel.2006.08.003; Chiang MY, 2008, J CLIN INVEST, V118, P3181, DOI 10.1172/JCI35090; Clark EL, 2008, CANCER RES, V68, P7938, DOI 10.1158/0008-5472.CAN-08-0932; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Endoh H, 1999, MOL CELL BIOL, V19, P5363; FORD MJ, 1988, NATURE, V332, P736, DOI 10.1038/332736a0; Fryer CJ, 2004, MOL CELL, V16, P509, DOI 10.1016/j.molcel.2004.10.014; Fryer CJ, 2002, GENE DEV, V16, P1397, DOI 10.1101/gad.991602; Fuller-Pace FV, 2008, BIOCHEM SOC T, V36, P609, DOI 10.1042/BST0360609; Fuller-Pace FV, 2011, FUTURE ONCOL, V7, P239, DOI 10.2217/FON.11.1; Germann S, 2012, ONCOGENE, V31, P4536, DOI 10.1038/onc.2011.618; Gu Y, 2012, ONCOGENE, V31, P469, DOI 10.1038/onc.2011.247; Guo DM, 2009, LEUKEMIA RES, V33, P678, DOI 10.1016/j.leukres.2008.10.026; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Hansson ML, 2009, NUCLEIC ACIDS RES, V37, P2996, DOI 10.1093/nar/gkp163; HIRLING H, 1989, NATURE, V339, P562, DOI 10.1038/339562a0; Homminga I, 2011, CANCER CELL, V19, P484, DOI 10.1016/j.ccr.2011.02.008; Janknecht R, 2010, AM J TRANSL RES, V2, P223; Jensen ED, 2008, J CELL BIOCHEM, V103, P1438, DOI 10.1002/jcb.21526; Koch U, 2010, CURR TOP DEV BIOL, V92, P411, DOI 10.1016/S0070-2153(10)92013-9; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lin SE, 2002, J BIOL CHEM, V277, P50612, DOI 10.1074/jbc.M209529200; McElhinny AS, 2008, ONCOGENE, V27, P5138, DOI 10.1038/onc.2008.228; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Nicol SM, 2010, METHODS MOL BIOL, V587, P265, DOI 10.1007/978-1-60327-355-8_19; Paganin M, 2011, BLOOD REV, V25, P83, DOI 10.1016/j.blre.2010.09.004; Ranganathan P, 2011, NAT REV CANCER, V11, P338, DOI 10.1038/nrc3035; Ribeiro MSJ, 2009, NUCLEIC ACIDS RES, V37, P6691, DOI 10.1093/nar/gkp724; Van Vlierberghe P, 2011, J EXP MED, V208, P2571, DOI 10.1084/jem.20112239; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Yang L, 2007, ONCOGENE, V26, P6082, DOI 10.1038/sj.onc.1210427	37	64	71	1	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 3	2013	32	40					4845	4853		10.1038/onc.2012.482	http://dx.doi.org/10.1038/onc.2012.482			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	229NW	23108395	Green Accepted			2022-12-25	WOS:000325274700013
J	Can, G; Akpinar, B; Baran, Y; Zhivotovsky, B; Olsson, M				Can, G.; Akpinar, B.; Baran, Y.; Zhivotovsky, B.; Olsson, M.			5-Fluorouracil signaling through a calcium-calmodulin-dependent pathway is required for p53 activation and apoptosis in colon carcinoma cells	ONCOGENE			English	Article						apoptosis; 5-fluorouracil; calcium; calmodulin; p53; DR5	DNA-DAMAGE; CANCER-CELLS; RIBOSOME BIOGENESIS; C-FLIP; CHECKPOINT; PROTEIN; AGENTS; DEATH; PHOSPHORYLATION; CHEMOTHERAPY	5-Fluorouracil (5-FU) is an anti-metabolite that is in clinical use for treatment of several cancers. In cells, it is converted into three distinct fluoro-based nucleotide analogs, which interfere with DNA synthesis and repair, leading to genome impairment and, eventually, apoptotic cell death. Current knowledge states that in certain cell types, 5-FU-induced stress is signaling through a p53-dependent induction of tumor necrosis factor-receptor oligomerization required for death-inducing signaling complex formation and caspase-8 activation. Here we establish a role of calcium (Ca2+) as a messenger for p53 activation in response to 5-FU. Using a combination of pharmacological and genetic approaches, we show that treatment of colon carcinoma cells stimulates entry of extracellular Ca2+ through long lasting-type plasma membrane channels, which further directs posttranslational phosphorylation of at least three p53 serine residues (S15, S33 and S37) by means of calmodulin (CaM) activity. Obstructing this pathway by the Ca2+-chelator BAPTA (1,2-bis(o-aminophenoxy) ethane-N, N, N', N'-tetraacetic acid) or by inhibitors of CaM efficiently reduces 5-FU-induced caspase activities and subsequent cell death. Moreover, ectopic expression of p53 S15A in HCT116 p53(-/-) cells confirmed the importance of a Ca2+-CaM-p53 axis in 5-FU-induced extrinsic apoptosis. The fact that a widely used therapeutic drug, such as 5-FU, is operating via this pathway could provide new therapeutic intervention points, or specify new combinatorial treatment regimes.	[Can, G.; Akpinar, B.; Zhivotovsky, B.; Olsson, M.] Karolinska Inst, Inst Environm Med, Div Toxicol, SE-17177 Stockholm, Sweden; [Baran, Y.] Izmir Inst Technol, Dept Mol Biol & Genet, Canc Genet & Mol Hematol Lab, Izmir, Turkey	Karolinska Institutet; Izmir Institute of Technology	Zhivotovsky, B (corresponding author), Karolinska Inst, Inst Environm Med, Div Toxicol, SE-17177 Stockholm, Sweden.	Boris.Zhivotovsky@ki.se	Zhivotovsky, Boris/A-4346-2014; Can, Geylani/B-6667-2012; Can, Geylani/M-5538-2019; Olsson, Magnus/E-3140-2012	Zhivotovsky, Boris/0000-0002-2238-3482; Can, Geylani/0000-0002-1716-7830; Can, Geylani/0000-0002-1716-7830; Olsson, Magnus/0000-0002-6370-8423	Swedish Science Foundation; Swedish and Stockholm Cancer Societies; Swedish Childhood Cancer Foundation; EC-FP-6 (Chemores); EC-FP-7 (APO-SYS)	Swedish Science Foundation; Swedish and Stockholm Cancer Societies; Swedish Childhood Cancer Foundation(European Commission); EC-FP-6 (Chemores); EC-FP-7 (APO-SYS)(European CommissionEuropean Commission Joint Research Centre)	We thank Professors Bert Vogelstein, Peter H Krammer, Ladislav Andera, Moshe Oren and Dr Inna Lavrik for their contribution of cells, antibodies and vectors. This study was supported by grants from the Swedish Science Foundation, the Swedish and Stockholm Cancer Societies, the Swedish Childhood Cancer Foundation and the EC-FP-6 (Chemores) and EC-FP-7 (APO-SYS). MO is a fellow of the Swedish Society of Medical Research.	Abdulghani J, 2010, EXPERT OPIN THER TAR, V14, P1091, DOI 10.1517/14728222.2010.519701; Bagnoli M, 2010, INT J BIOCHEM CELL B, V42, P210, DOI 10.1016/j.biocel.2009.11.015; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Berridge MJ, 2002, CELL CALCIUM, V32, P235, DOI 10.1016/S0143416002001823; Borralho PM, 2007, BBA-MOL BASIS DIS, V1772, P40, DOI 10.1016/j.bbadis.2006.09.005; Bunz F, 1999, J CLIN INVEST, V104, P263, DOI 10.1172/JCI6863; Burger K, 2010, J BIOL CHEM, V285, P12416, DOI 10.1074/jbc.M109.074211; Coutinho I, 2009, FEBS LETT, V583, P3582, DOI 10.1016/j.febslet.2009.10.030; Craig AL, 2007, MOL CELL BIOL, V27, P3542, DOI 10.1128/MCB.01595-06; de la Cruz-Morcillo MA, 2012, ONCOGENE, V31, P1073, DOI 10.1038/onc.2011.321; Derheimer FA, 2007, P NATL ACAD SCI USA, V104, P12778, DOI 10.1073/pnas.0705317104; Galligan L, 2005, MOL CANCER THER, V4, P2026, DOI 10.1158/1535-7163.MCT-05-0262; GLAZER RI, 1982, MOL PHARMACOL, V21, P468; Harr MW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a005579; Henry RE, 2012, EMBO J, V31, P1266, DOI 10.1038/emboj.2011.498; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Kaeser MD, 2004, J BIOL CHEM, V279, P7598, DOI 10.1074/jbc.M311732200; Kim HD, 2011, ONCOGENE, V30, P3317, DOI 10.1038/onc.2011.47; KUFE DW, 1981, J BIOL CHEM, V256, P9802; Kumar S K, 2001, Curr Oncol Rep, V3, P94, DOI 10.1007/s11912-001-0007-6; Lamprecht SA, 2003, NAT REV CANCER, V3, P601, DOI 10.1038/nrc1144; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Li Y, 2010, MOL CANCER THER, V9, P113, DOI 10.1158/1535-7163.MCT-08-1189; Longley DB, 2006, ONCOGENE, V25, P838, DOI 10.1038/sj.onc.1209122; Longley DB, 2004, CLIN CANCER RES, V10, P3562, DOI 10.1158/1078-0432.CCR-03-0532; Longley DB, 2003, NAT REV CANCER, V3, P330, DOI 10.1038/nrc1074; MacLaine NJ, 2011, CELL CYCLE, V10, P916, DOI 10.4161/cc.10.6.15076; Matuo R, 2009, J APPL TOXICOL, V29, P308, DOI 10.1002/jat.1411; Naka T, 2002, CANCER RES, V62, P5800; Oberle C, 2010, CELL DEATH DIFFER, V17, P1167, DOI 10.1038/cdd.2009.214; OConnor PM, 1997, CANCER RES, V57, P4285; Olsson M, 2011, CELL DEATH DIFFER, V18, P1441, DOI 10.1038/cdd.2011.30; Olsson M, 2009, ONCOGENE, V28, P1949, DOI 10.1038/onc.2009.36; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Perraud A, 2011, ONCOL REP, V26, P1091, DOI 10.3892/or.2011.1404; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Pospisilova S, 2004, BIOCHEM J, V378, P939, DOI 10.1042/BJ20030662; Raveh T, 2001, NAT CELL BIOL, V3, P1, DOI 10.1038/35050500; Seiple L, 2006, NUCLEIC ACIDS RES, V34, P140, DOI 10.1093/nar/gkj430; Stagni V, 2010, CARCINOGENESIS, V31, P1956, DOI 10.1093/carcin/bgq193; Takeda K, 2004, EMBO REP, V5, P161, DOI 10.1038/sj.embor.7400072; Wang SL, 2004, CANCER RES, V64, P6666, DOI 10.1158/0008-5472.CAN-04-1734	43	37	39	0	27	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP 19	2013	32	38					4529	4538		10.1038/onc.2012.467	http://dx.doi.org/10.1038/onc.2012.467			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	223SW	23108402	Green Published			2022-12-25	WOS:000324831300008
J	Lainey, E; Wolfromm, A; Marie, N; Enot, D; Scoazec, M; Bouteloup, C; Leroy, C; Micol, JB; De Botton, S; Galluzzi, L; Fenaux, P; Kroemer, G				Lainey, E.; Wolfromm, A.; Marie, N.; Enot, D.; Scoazec, M.; Bouteloup, C.; Leroy, C.; Micol, J-B; De Botton, S.; Galluzzi, L.; Fenaux, P.; Kroemer, G.			Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia	ONCOGENE			English	Article						ATPase-binding cassette (ABC) transporters; ABT-263; MG-132; MOLM-13; obatoclax; SKM1	ACUTE MYELOGENOUS LEUKEMIA; CELL LUNG-CANCER; MITOCHONDRIAL-MEMBRANE PERMEABILIZATION; KINASE INHIBITOR; DOWN-REGULATION; MYELODYSPLASTIC SYNDROMES; APOPTOSIS RESISTANCE; SIGNALING PATHWAYS; DRUG-RESISTANCE; MCL-1	The term myelodysplastic syndrome (MDS) identifies a heterogeneous group of clonal disorders originating from bone marrow stem cells that often progress to acute myeloid leukemia (AML). The reference treatments for MDS include the DNA methyltransferase inhibitors azacytidine and decitabine. Recently, the epidermal growth factor receptor (EGFR) inhibitor erlotinib has been shown to exert antileukemic activity in vitro and in vivo, independent of the EGFR. Thanks to this feature, erlotinib is currently being tested as an antileukemic drug in clinical trials. Here, we report that azacytidine and erlotinib mediate synergistic antineoplastic effects in several primary or secondary (post-MDS) AML cell lines. The combination of azacytidine and erlotinib blocked cell-cycle progression and induced caspase-dependent apoptosis more consistently than either of the two agents alone. These effects were not a consequence of cellular differentiation and could be discriminated from each other, as the former depended on caspases whereas the latter did not. The synergy between azacitidine and erlotinib, which involved the proteasomal degradation of the anti-apoptotic Bcl-2 family members MCL-1 and BCL2L10 and the upregulation of their pro-apoptotic counterpart PUMA, was abolished when azacytidine was replaced by decitabine but persisted when erlotinib was substituted with gefitinib, another EGFR inhibitor. Of note, the intracellular accumulation of azacytidine was exacerbated by both erlotinib and gefitinib, pointing to a pharmacokinetic mechanism of synergy. In approximately half of the cases studied, marrow and circulating blasts from MDS and AML patients, respectively, exhibited hyperadditive cytotoxic responses to the combination of azacytidine and erlotinib. These results strongly suggest that the combination of azacytidine and erlotinib may exert clinically relevant antileukemic effects.	[Lainey, E.; Wolfromm, A.; Enot, D.; Scoazec, M.; Bouteloup, C.; Leroy, C.; Fenaux, P.; Kroemer, G.] INSERM, U848, Villejuif, France; [Lainey, E.; Wolfromm, A.; Enot, D.; Scoazec, M.; Bouteloup, C.; Leroy, C.; Galluzzi, L.; Kroemer, G.] Inst Gustave Roussy, F-94805 Villejuif, France; [Lainey, E.] Hop Robert Debre, AP HP, F-75019 Paris, France; [Wolfromm, A.] Univ Paris 07, Paris, France; [Marie, N.] CNRS, UMR8206, Paris, France; [Marie, N.] INSERM, U705, Paris, France; [Marie, N.] Inst Medicament Toxicol Chim Environm, Lab Neuropsychopharmacol Addict, Paris, France; [Micol, J-B; De Botton, S.] Inst Gustave Roussy, Serv Hematol Clin, F-94805 Villejuif, France; [Galluzzi, L.; Kroemer, G.] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Fenaux, P.] Hop Avicenne, AP HP, Serv Hematol Clin, F-93009 Bobigny, France; [Kroemer, G.] Ctr Rech Cordeliers, Paris, France; [Kroemer, G.] Hop Europeen Georges Pompidou, AP HP, Pole Biol, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Kroemer, G (corresponding author), Inst Gustave Roussy, INSERM, U848, PR1, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.	kroemer@orange.fr	Kroemer, Guido/AAY-9859-2020; Marie, Nicolas/I-9129-2014; Galluzzi, Lorenzo/AAG-6432-2019; Galluzzi, Lorenzo/AAG-6294-2019; KROEMER, Guido/B-4263-2013; Galluzzi, Lorenzo/AAH-3286-2021	Marie, Nicolas/0000-0002-6491-9898; KROEMER, Guido/0000-0002-9334-4405; 	Ligue Nationale contre le Cancer (Equipe labellisee); Agence Nationale pour la Recherche (ANR AUTOPH, ANR Emergence); European Commission (ChemoRes, ArtForce); Fondation de France; Institut National du Cancer (INCa); Canceropole Ile-de-France; Fondation Bettencourt-Schueller; LabEx Immuno-Oncology; Institut National de la Sante et de la recherche Medicale; Association de recherche sur le cancer (ARC); Fondation de la Recherche Medicale (FRM)	Ligue Nationale contre le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); Agence Nationale pour la Recherche (ANR AUTOPH, ANR Emergence)(French National Research Agency (ANR)); European Commission (ChemoRes, ArtForce); Fondation de France(Fondation de France); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Canceropole Ile-de-France(Region Ile-de-France); Fondation Bettencourt-Schueller; LabEx Immuno-Oncology; Institut National de la Sante et de la recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Association de recherche sur le cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Fondation de la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	GK is supported by the Ligue Nationale contre le Cancer (Equipe labellisee), Agence Nationale pour la Recherche (ANR AUTOPH, ANR Emergence), European Commission (ChemoRes, ArtForce), Fondation de France, Institut National du Cancer (INCa), Canceropole Ile-de-France, Fondation Bettencourt-Schueller and the LabEx Immuno-Oncology. EL receives a PhD fellowship from Institut National de la Sante et de la recherche Medicale, AW is supported by a fellowship from Association de recherche sur le cancer (ARC) and MS by Fondation de la Recherche Medicale (FRM).	Aimiuwu J, 2012, BLOOD, V119, P5229, DOI 10.1182/blood-2011-11-382226; Boehrer S, 2008, BLOOD, V111, P2170, DOI 10.1182/blood-2007-07-100362; Boehrer S, 2011, CELL CYCLE, V10, P3168, DOI 10.4161/cc.10.18.16599; Boehrer S, 2008, BIOCHEM PHARMACOL, V76, P1417, DOI 10.1016/j.bcp.2008.05.024; Chan G, 2007, BLOOD, V110, P1079, DOI 10.1182/blood-2007-01-069856; Chapuis N, 2010, CLIN CANCER RES, V16, P5424, DOI 10.1158/1078-0432.CCR-10-1102; Chen LS, 2011, BLOOD, V118, P693, DOI 10.1182/blood-2010-12-323022; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Cluzeau T, 2012, ONCOTARGET, V3, P490; Criollo A, 2007, APOPTOSIS, V12, P3, DOI 10.1007/s10495-006-0328-x; Eghtedar A, 2012, BLOOD, V119, P4614, DOI 10.1182/blood-2011-12-400051; Fabiani E, 2010, LEUKEMIA LYMPHOMA, V51, P2275, DOI 10.3109/10428194.2010.528093; Fabre C, 2008, CELL CYCLE, V7, P2139, DOI 10.4161/cc.7.14.6268; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Galluzzi L, 2007, APOPTOSIS, V12, P803, DOI 10.1007/s10495-007-0720-1; Galluzzi L, 2012, NAT REV DRUG DISCOV, V11, P215, DOI 10.1038/nrd3626; Galluzzi L, 2010, CANCER RES, V70, P1793, DOI 10.1158/0008-5472.CAN-09-3112; Glaser SP, 2012, GENE DEV, V26, P120, DOI 10.1101/gad.182980.111; Hoffmann J, 2008, CANCER RES, V68, P5301, DOI 10.1158/0008-5472.CAN-08-0237; Huber S, 2011, LEUKEMIA, V25, P838, DOI 10.1038/leu.2011.2; Jemaa M, 2012, EMBO MOL MED, V4, P500, DOI 10.1002/emmm.201200228; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Kimura S, 2012, ANTICANCER RES, V32, P795; Klimek VM, 2012, LEUKEMIA RES, V36, P1093, DOI 10.1016/j.leukres.2012.04.025; Komrokji RS, 2010, BLOOD, V116; Kornblau SM, 2006, BLOOD, V108, P2358, DOI 10.1182/blood-2006-02-003475; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Lainey E, 2011, BIOCHEM PHARMACOL, V82, P1457, DOI 10.1016/j.bcp.2011.05.011; Lee JJ, 2009, STAT BIOPHARM RES, V1, P4, DOI 10.1198/sbr.2009.0001; Meng XW, 2007, J BIOL CHEM, V282, P29831, DOI 10.1074/jbc.M706110200; Noguchi K, 2009, CANCER SCI, V100, P1701, DOI 10.1111/j.1349-7006.2009.01213.x; Pitini V, 2008, J CLIN ONCOL, V26, P3645, DOI 10.1200/JCO.2008.17.0357; Rahmani M, 2005, J BIOL CHEM, V280, P35217, DOI 10.1074/jbc.M506551200; Rahmani M, 2012, BLOOD, V119, P6089, DOI 10.1182/blood-2011-09-378141; Rosen DB, 2012, LEUKEMIA RES, V36, P900, DOI 10.1016/j.leukres.2012.02.022; Rouge TD, 2007, CANCER RES, V67, P6253, DOI 10.1158/0008-5472.CAN-07-0538; Sansonetti A, 2012, LEUKEMIA RES, V36, P358, DOI 10.1016/j.leukres.2011.09.022; Scholl C, 2008, SEMIN ONCOL, V35, P336, DOI 10.1053/j.seminoncol.2008.04.004; Shi Z, 2007, CANCER RES, V67, P11012, DOI 10.1158/0008-5472.CAN-07-2686; Stegmaier K, 2005, BLOOD, V106, P2841, DOI 10.1182/blood-2005-02-0488; Tefferi A, 2009, NAT REV CLIN ONCOL, V6, P627, DOI 10.1038/nrclinonc.2009.149; van Stijn A, 2003, HAEMATOLOGICA, V88, P497; Weber C, 2012, J PROTEOMICS, V75, P1343, DOI 10.1016/j.jprot.2011.11.004; Weisberg E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025351; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Yu CR, 2005, ONCOGENE, V24, P6861, DOI 10.1038/sj.onc.1208841; Zantl N, 2007, ONCOGENE, V26, P7038, DOI 10.1038/sj.onc.1210510	48	33	35	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP 12	2013	32	37					4331	4342		10.1038/onc.2012.469	http://dx.doi.org/10.1038/onc.2012.469			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	218AF	23085751				2022-12-25	WOS:000324404200002
J	Lee, YJ; Kim, KJ; Kang, HY; Kim, HR; Maeng, PJ				Lee, Yong Joo; Kim, Kyung Jin; Kang, Hong Yong; Kim, Hye-Rim; Maeng, Pil Jae			Involvement of GDH3-encoded NADP(+)-dependent Glutamate Dehydrogenase in Yeast Cell Resistance to Stress-induced Apoptosis in Stationary Phase Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; INSULIN-RELEASE; GLUTATHIONE; GENE; METABOLISM; EXPRESSION; BIOSYNTHESIS; PURIFICATION; SUPEROXIDE	Glutamate metabolism is linked to a number of fundamental metabolic pathways such as amino acid metabolism, the TCA cycle, and glutathione (GSH) synthesis. In the yeast Saccharomyces cerevisiae, glutamate is synthesized from alpha-ketoglutarate by two NADP(+)-dependent glutamate dehydrogenases (NADP-GDH) encoded by GDH1 and GDH3. Here, we report the relationship between the function of the NADP-GDH and stress-induced apoptosis. Gdh3-null cells showed accelerated chronological aging and hypersusceptibility to thermal and oxidative stress during stationary phase. Upon exposure to oxidative stress, Gdh3-null strains displayed a rapid loss in viability associated with typical apoptotic hallmarks, i.e. reactive oxygen species accumulation, nuclear fragmentation, DNA breakage, and phosphatidylserine translocation. In addition, Gdh3-null cells, but not Gdh1-null cells, had a higher tendency toward GSHdepletion and subsequent reactive oxygen species accumulation than did WT cells. GSH depletion was rescued by exogenous GSH or glutamate. The hypersusceptibility of stationary phase Gdh3-null cells to stress-induced apoptosis was suppressed by deletion of GDH2. Promoter swapping and site-directed mutagenesis of GDH1 and GDH3 indicated that the necessity of GDH3 for the resistance to stress-induced apoptosis and chronological aging is due to the stationary phase-specific expression of GDH3 and concurrent degradation of Gdh1 in which the Lys-426 residue plays an essential role.	[Lee, Yong Joo; Kim, Kyung Jin; Kang, Hong Yong; Kim, Hye-Rim; Maeng, Pil Jae] Chungnam Natl Univ, Dept Microbiol & Mol Biol, Taejon 305764, South Korea	Chungnam National University	Maeng, PJ (corresponding author), Chungnam Natl Univ, Dept Microbiol & Mol Biol, Taejon 305764, South Korea.	pjmaeng@cnu.ac.kr		Maeng, Pil Jae/0000-0002-7677-3208	National Research Foundation of Korea [2009-0077095]; Ministry of Education, Science, and Technology (MEST)	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science, and Technology (MEST)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by Grant 2009-0077095 from the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (MEST).	ANDERSON ME, 1985, METHOD ENZYMOL, V113, P548; Armstrong JS, 2002, CELL DEATH DIFFER, V9, P252, DOI 10.1038/sj.cdd.4400959; Avendano A, 2005, MOL MICROBIOL, V57, P291, DOI 10.1111/j.1365-2958.2005.04689.x; Avendano A, 1997, J BACTERIOL, V179, P5594, DOI 10.1128/jb.179.17.5594-5597.1997; Avery AM, 2001, J BIOL CHEM, V276, P33730, DOI 10.1074/jbc.M105672200; BENJAMIN PM, 1989, MOL GEN GENET, V217, P370, DOI 10.1007/BF02464906; BERMINGHAMMCDONOGH O, 1988, P NATL ACAD SCI USA, V85, P4789, DOI 10.1073/pnas.85.13.4789; Catic A, 2004, BIOINFORMATICS, V20, P3302, DOI 10.1093/bioinformatics/bth407; COGONI C, 1995, J BACTERIOL, V177, P792, DOI 10.1128/jb.177.3.792-798.1995; COOPER AJL, 1987, PHYSIOL REV, V67, P440, DOI 10.1152/physrev.1987.67.2.440; Cox KH, 2002, J BIOL CHEM, V277, P37559, DOI 10.1074/jbc.M204879200; DeLuna A, 2001, J BIOL CHEM, V276, P43775, DOI 10.1074/jbc.M107986200; Doherty D., 1970, METHODS ENZYMOLOGY A, V17, P850; Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002; Fabrizio P, 2003, AGING CELL, V2, P73, DOI 10.1046/j.1474-9728.2003.00033.x; FAHIEN LA, 1988, J BIOL CHEM, V263, P13610; Filetici P, 1996, YEAST, V12, P1359, DOI 10.1002/(SICI)1097-0061(199610)12:13<1359::AID-YEA3>3.0.CO;2-5; GALIAZZO F, 1987, BIOCHEM BIOPH RES CO, V147, P1200, DOI 10.1016/S0006-291X(87)80197-3; Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x; Grant CM, 1996, CURR GENET, V29, P511, DOI 10.1007/BF02426954; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Herman PK, 2002, CURR OPIN MICROBIOL, V5, P602, DOI 10.1016/S1369-5274(02)00377-6; HUDSON RC, 1993, COMP BIOCHEM PHYS B, V106, P767, DOI 10.1016/0305-0491(93)90031-Y; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Lauber K, 2001, J BIOL CHEM, V276, P29772, DOI 10.1074/jbc.M101524200; Lee YJ, 2007, MOL BIOL CELL, V18, P3556, DOI 10.1091/mbc.E07-02-0118; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757; Mates JM, 2002, INT J BIOCHEM CELL B, V34, P439, DOI 10.1016/S1357-2725(01)00143-1; MAVROTHALASSITIS G, 1988, P NATL ACAD SCI USA, V85, P3494, DOI 10.1073/pnas.85.10.3494; Mayor T, 2005, METHOD ENZYMOL, V399, P385, DOI 10.1016/S0076-6879(05)99026-5; Mayor T, 2005, MOL CELL PROTEOMICS, V4, P741, DOI 10.1074/mcp.M400220-MCP200; MAZON MJ, 1979, J BACTERIOL, V139, P686; McKenna MC, 1996, J NEUROCHEM, V66, P386; MILLER SM, 1990, J BACTERIOL, V172, P4927, DOI 10.1128/jb.172.9.4927-4935.1990; Paz I, 2001, J BACTERIOL, V183, P4477, DOI 10.1128/JB.183.15.4477-4483.2001; Plaitakis A, 2000, J NEUROCHEM, V75, P1862, DOI 10.1046/j.1471-4159.2000.0751862.x; Plaitakis A, 2001, J NEUROSCI RES, V66, P899, DOI 10.1002/jnr.10054; Plaitakis A, 2011, NEUROCHEM INT, V59, P495, DOI 10.1016/j.neuint.2011.03.015; Riego L, 2002, BIOCHEM BIOPH RES CO, V293, P79, DOI 10.1016/S0006-291X(02)00174-2; Savolainen KM, 1995, TOXICOL LETT, V82-3, P399; SENER A, 1981, P NATL ACAD SCI-BIOL, V78, P5460, DOI 10.1073/pnas.78.9.5460; Shashidharan P, 1997, J NEUROCHEM, V68, P1804; SHASHIDHARAN P, 1994, J BIOL CHEM, V269, P16971; Stanley CA, 1998, NEW ENGL J MED, V338, P1352, DOI 10.1056/NEJM199805073381904; Wang XF, 2000, J NEUROCHEM, V74, P1434, DOI 10.1046/j.1471-4159.2000.0741434.x; WernerWashburne M, 1996, MOL MICROBIOL, V19, P1159, DOI 10.1111/j.1365-2958.1996.tb02461.x; WERNERWASHBURNE M, 1993, MICROBIOL REV, V57, P383, DOI 10.1128/MMBR.57.2.383-401.1993; Wu CY, 2007, J BIOL CHEM, V282, P2184, DOI 10.1074/jbc.M606639200; Zaganas I, 2009, NEUROCHEM INT, V55, P52, DOI 10.1016/j.neuint.2009.03.001	51	20	20	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 28	2012	287	53					44221	44233		10.1074/jbc.M112.375360	http://dx.doi.org/10.1074/jbc.M112.375360			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062RI	23105103	Green Published, hybrid			2022-12-25	WOS:000312938600021
J	Han, D; Ybanez, MD; Johnson, HS; McDonald, JN; Mesropyan, L; Sancheti, H; Martin, G; Martin, A; Lim, AM; Dara, L; Cadenas, E; Tsukamoto, H; Kaplowitz, N				Han, Derick; Ybanez, Maria D.; Johnson, Heather S.; McDonald, Jeniece N.; Mesropyan, Lusine; Sancheti, Harsh; Martin, Gary; Martin, Alanna; Lim, Atalie M.; Dara, Lily; Cadenas, Enrique; Tsukamoto, Hidekazu; Kaplowitz, Neil			Dynamic Adaptation of Liver Mitochondria to Chronic Alcohol Feeding in Mice BIOGENESIS, REMODELING, AND FUNCTIONAL ALTERATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE MITOCHONDRIA; CHRONIC ETHANOL TREATMENT; RAT-LIVER; ENERGY-METABOLISM; SUPEROXIDE ANION; SWIFT INCREASE; NECROSIS; EXERCISE; PROTEIN; STRESS	Liver mitochondria undergo dynamic alterations following chronic alcohol feeding to mice. Intragastric alcohol feeding to mice resulted in 1) increased state III respiration (109% compared with control) in isolated liver mitochondria, probably due to increased levels of complexes I, IV, and V being incorporated into the respiratory chain; 2) increased mitochondrial NAD(+) and NADH levels (similar to 2-fold), with no change in the redox status; 3) alteration in mitochondrial morphology, with increased numbers of elongated mitochondria; and 4) enhanced mitochondrial biogenesis in the liver, which corresponded with an up-regulation of PGC-1 alpha (peroxisome proliferator-activated receptor gamma coactivator-1 alpha). Oral alcohol feeding to mice, which is associated with less liver injury and steatosis, slightly enhanced respiration in isolated liver mitochondria (30.8% compared with control), lower than the striking increase caused by intragastric alcohol feeding. Mitochondrial respiration increased with both oral and intragastric alcohol feeding despite extensive N-acetylation of mitochondrial proteins. The alcohol-induced mitochondrial alterations are probably an adaptive response to enhance alcohol metabolism in the liver. Isolated liver mitochondria from alcohol-treated mice had a greater rate of acetaldehyde metabolism and respiration when treated with acetaldehyde than control. Aldehyde dehydrogenase-2 levels were unaltered in response to alcohol, suggesting that the greater acetaldehyde metabolism by isolated mitochondria from alcohol-treated mice was due to increased mitochondrial respiration that regenerated NAD(+), the rate-limiting substrate in alcohol/acetaldehyde metabolism. Overall, our work suggests that mitochondrial plasticity in the liver may be an important adaptive response to the metabolic stress caused by alcohol intake and could potentially play a role in many other vital functions performed by the liver.	[Han, Derick; Lim, Atalie M.; Dara, Lily; Kaplowitz, Neil] Univ So Calif, Keck Sch Med, Res Ctr Liver Dis, Los Angeles, CA 90089 USA; [Lim, Atalie M.; Dara, Lily; Kaplowitz, Neil] Univ So Calif, Keck Sch Med, So Calif Res Ctr Alcohol Liver & Pancreat Dis, Los Angeles, CA 90089 USA; [Sancheti, Harsh; Cadenas, Enrique] Univ So Calif, Sch Pharm, Dept Pharmacol & Pharmaceut Sci, Los Angeles, CA 90089 USA; [Martin, Gary; Martin, Alanna] Occidental Coll, Dept Biol, Los Angeles, CA 90041 USA; [Tsukamoto, Hidekazu] Univ So Calif, Keck Sch Med, So Calif Res Ctr Alcohol Liver & Pancreat Dis & C, Los Angeles, CA 90089 USA; [Tsukamoto, Hidekazu] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90089 USA; [Tsukamoto, Hidekazu] Greater Los Angeles Vet Affairs Healthcare Syst, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California; University of Southern California; Occidental College; University of Southern California; University of Southern California; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Han, D (corresponding author), Univ So Calif, Keck Sch Med, Res Ctr Liver Dis, 2011 Zonal Ave,HMR 101, Los Angeles, CA 90089 USA.	derickh@usc.edu	Dara, Lily/S-2444-2019	Dara, Lily/0000-0002-0121-7186; Sancheti, Harsh/0000-0001-8084-4550	National Institutes of Health Grant [AA016911, AA14428, P50AA11999]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK048522] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [P50AA011999, K01AA016911, R01AA014428] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in whole or in part, by National Institutes of Health Grant AA016911 (to D. H.), AA14428 (to N. K.), and P50AA11999 (to H. T.).	Adhihetty PJ, 2003, EXP PHYSIOL, V88, P99, DOI 10.1113/eph8802505; Arteel GE, 2010, DIGEST DIS, V28, P729, DOI 10.1159/000324280; Arteel GE, 2003, GASTROENTEROLOGY, V124, P778, DOI 10.1053/gast.2003.50087; Arteel GE, 1997, HEPATOLOGY, V25, P920, DOI 10.1002/hep.510250422; Baar K, 2002, FASEB J, V16, P1879, DOI 10.1096/fj.02-0367com; Bailey SM, 2002, FREE RADICAL BIO MED, V32, P11, DOI 10.1016/S0891-5849(01)00769-9; BARAONA E, 1977, J CLIN INVEST, V60, P546, DOI 10.1172/JCI108806; BARAONA E, 1982, ANNU REV MED, V33, P281, DOI 10.1146/annurev.me.33.020182.001433; BERNSTEIN JD, 1978, BIOCHEM PHARMACOL, V27, P2337, DOI 10.1016/0006-2952(78)90141-7; Bradford BU, 2005, ALCOHOL, V35, P13, DOI 10.1016/j.alcohol.2004.12.001; Campian JL, 2007, J BIOL CHEM, V282, P12430, DOI 10.1074/jbc.M604547200; CEDERBAUM AI, 1974, ARCH BIOCHEM BIOPHYS, V165, P560, DOI 10.1016/0003-9861(74)90283-5; CUNNINGHAM CC, 1990, ALCOHOL ALCOHOLISM, V25, P127, DOI 10.1093/oxfordjournals.alcalc.a044987; Ding WX, 2010, GASTROENTEROLOGY, V139, P1740, DOI 10.1053/j.gastro.2010.07.041; FRENCH SW, 1984, HEPATOLOGY, V4, P912, DOI 10.1002/hep.1840040521; Fritz KS, 2012, J PROTEOME RES, V11, P1633, DOI 10.1021/pr2008384; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Garcia J, 2010, J BIOL CHEM, V285, P39646, DOI 10.1074/jbc.M110.164160; Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Han D, 2001, BIOCHEM J, V353, P411, DOI 10.1042/0264-6021:3530411; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; HASUMURA Y, 1976, J BIOL CHEM, V251, P4908; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; HOLLOSZY JO, 1976, ANNU REV PHYSIOL, V38, P273, DOI 10.1146/annurev.ph.38.030176.001421; Hoppeler H, 2003, MED SCI SPORT EXER, V35, P95, DOI 10.1097/00005768-200301000-00016; ISRAEL Y, 1975, P NATL ACAD SCI USA, V72, P1137, DOI 10.1073/pnas.72.3.1137; Israel Y, 1984, Recent Dev Alcohol, V2, P119; ITURRIAGA H, 1980, EUR J CLIN INVEST, V10, P211, DOI 10.1111/j.1365-2362.1980.tb00022.x; Ji C, 2006, J HEPATOL, V45, P717, DOI 10.1016/j.jhep.2006.05.009; JI SC, 1982, P NATL ACAD SCI-BIOL, V79, P5415, DOI 10.1073/pnas.79.17.5415; KLAIDMAN LK, 1995, ANAL BIOCHEM, V228, P312, DOI 10.1006/abio.1995.1356; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; MOLE PA, 1971, J CLIN INVEST, V50, P2323, DOI 10.1172/JCI106730; Nisoli E, 2005, SCIENCE, V310, P314, DOI 10.1126/science.1117728; Oliva J, 2008, EXP MOL PATHOL, V85, P155, DOI 10.1016/j.yexmp.2008.08.002; Otera H, 2011, J BIOCHEM, V149, P241, DOI 10.1093/jb/mvr002; Picklo MJ, 2008, BIOCHEM BIOPH RES CO, V376, P615, DOI 10.1016/j.bbrc.2008.09.039; Reddy PH, 2011, BRAIN RES REV, V67, P103, DOI 10.1016/j.brainresrev.2010.11.004; Saggerson D, 2008, ANNU REV NUTR, V28, P253, DOI 10.1146/annurev.nutr.28.061807.155434; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Schagger H, 2001, J BIOL CHEM, V276, P37861; Shinohara M, 2010, HEPATOLOGY, V51, P796, DOI 10.1002/hep.23391; SPACH PI, 1987, BIOCHIM BIOPHYS ACTA, V894, P460, DOI 10.1016/0005-2728(87)90125-3; THURMAN RG, 1982, J PHARMACOL EXP THER, V223, P45; TOBON F, 1971, J LAB CLIN MED, V77, P110; TSUKAMOTO H, 1985, HEPATOLOGY, V5, P224, DOI 10.1002/hep.1840050212; TSUKAMOTO H, 1986, HEPATOLOGY, V6, P814, DOI 10.1002/hep.1840060503; Venkatraman A, 2004, HEPATOLOGY, V40, P565, DOI 10.1002/hep.20326; Venkatraman A, 2004, J BIOL CHEM, V279, P22092, DOI 10.1074/jbc.M402245200; Verdin E, 2010, TRENDS BIOCHEM SCI, V35, P669, DOI 10.1016/j.tibs.2010.07.003; VIDELA L, 1970, BIOCHEM J, V118, P275, DOI 10.1042/bj1180275; VIDELA L, 1973, BIOCHEM J, V134, P507, DOI 10.1042/bj1340507; Vinogradov AD, 2008, BBA-BIOENERGETICS, V1777, P729, DOI 10.1016/j.bbabio.2008.04.014; Yap LP, 2009, ADV DRUG DELIVER REV, V61, P1283, DOI 10.1016/j.addr.2009.07.015; Zhang XY, 2010, HEPATOLOGY, V52, P2137, DOI 10.1002/hep.23909	57	52	53	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42165	42179		10.1074/jbc.M112.377374	http://dx.doi.org/10.1074/jbc.M112.377374			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086958	hybrid, Green Published			2022-12-25	WOS:000312103000054
J	Pusapati, GV; Luchetti, G; Pfeffer, SR				Pusapati, Ganesh V.; Luchetti, Giovanni; Pfeffer, Suzanne R.			Ric1-Rgp1 Complex Is a Guanine Nucleotide Exchange Factor for the Late Golgi Rab6A GTPase and an Effector of the Medial Golgi Rab33B GTPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-GOLGI; LOCALIZATION; TRAFFICKING; MAINTENANCE; ENDOSOMES; PROTEINS; VESICLES; PATHWAY; CASCADE; GCC185	Rab GTPases are master regulators of membrane trafficking events and template the directionality of protein transport through the secretory and endocytic pathways. Certain Rabs recruit the guanine nucleotide exchange factor (GEF) that activates a subsequent acting Rab protein in a given pathway; this process has been termed a Rab cascade. We show here that the medial Golgi-localized Rab33B GTPase has the potential to link functionally to the late Golgi, Rab6 GTPase, by its capacity for association with Ric1 and Rgp1 proteins. In yeast, Ric1p and Rgp1p form a complex that catalyzes guanine nucleotide exchange by Ypt6p, the Rab6 homolog. Human Ric1 and Rgp1 both bind Rab6A with preference for the GDP-bound conformation, characteristic of a GEF. Nevertheless, both Ric1 and Rgp1 proteins are needed to catalyze nucleotide exchange on Rab6A protein. Ric1 and Rgp1 form a complex, but unlike their yeast counterparts, most of the subunits are not associated, and most of the proteins are cytosolic. Loss of Ric1 or Rgp1 leads to destabilization of Rab6, concomitant with a block in Rab6-dependent retrograde transport of mannose 6-phosphate receptors to the Golgi. The C terminus of Ric1 protein contains a distinct binding site for Rab33B-GTP, supporting the existence of a Rab cascade between the medial and trans Golgi. This study thus identifies a GEF for Rab6A in human cells.	[Pusapati, Ganesh V.; Luchetti, Giovanni; Pfeffer, Suzanne R.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA	Stanford University	Pfeffer, SR (corresponding author), Stanford Univ, Dept Biochem, Sch Med, 279 Campus Dr B400, Stanford, CA 94305 USA.	pfeffer@stanford.edu		Pusapati, Ganesh/0000-0002-1406-2566	National Institutes of Health Grant [DK37332]; National Institutes of Health Training Grant [GM007276]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK037332, R56DK037332, R37DK037332] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK37332 (to S.R.P.).; Supported by National Institutes of Health Training Grant GM007276.	Aivazian D, 2006, J CELL BIOL, V173, P917, DOI 10.1083/jcb.200510010; Akiyama M, 2005, BIOCHEM BIOPH RES CO, V335, P1264, DOI 10.1016/j.bbrc.2005.08.019; Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Barr FA, 2009, SEMIN CELL DEV BIOL, V20, P780, DOI 10.1016/j.semcdb.2009.03.007; Barrowman J, 2010, NAT REV MOL CELL BIO, V11, P759, DOI 10.1038/nrm2999; Bensen ES, 2001, MOL BIOL CELL, V12, P13, DOI 10.1091/mbc.12.1.13; Brown FC, 2011, J CELL BIOL, V194, P779, DOI 10.1083/jcb.201104019; Burguete AS, 2008, CELL, V132, P286, DOI 10.1016/j.cell.2007.11.048; Diaz E., 1997, J CELL BIOL, V138, P283; DIRACSVEJSTRUP AB, 1994, J BIOL CHEM, V269, P15427; Field MC, 2011, J CELL BIOL, V193, P963, DOI 10.1083/jcb.201102042; Ganley IG, 2008, J CELL BIOL, V180, P159, DOI 10.1083/jcb.200707136; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Mizuno-Yamasaki E, 2012, ANNU REV BIOCHEM, V81, P637, DOI 10.1146/annurev-biochem-052810-093700; Nordmann M, 2010, CURR BIOL, V20, P1654, DOI 10.1016/j.cub.2010.08.002; Nottingham RM, 2011, J BIOL CHEM, V286, P33213, DOI 10.1074/jbc.M111.261115; Ortiz D, 2002, J CELL BIOL, V157, P1005, DOI 10.1083/jcb.200201003; Pfeffer SR, 2010, P NATL ACAD SCI USA, V107, P19614, DOI 10.1073/pnas.1011016107; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rivera-Molina FE, 2009, P NATL ACAD SCI USA, V106, P14408, DOI 10.1073/pnas.0906536106; Siniossoglou S, 2000, EMBO J, V19, P4885, DOI 10.1093/emboj/19.18.4885; Starr T, 2010, TRAFFIC, V11, P626, DOI 10.1111/j.1600-0854.2010.01051.x; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Storrie B, 2012, TRAFFIC, V13, P727, DOI 10.1111/j.1600-0854.2012.01343.x	25	39	42	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42129	42137		10.1074/jbc.M112.414565	http://dx.doi.org/10.1074/jbc.M112.414565			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23091056	Green Published, hybrid			2022-12-25	WOS:000312103000051
J	Miyamoto, T; Nakayama, EE; Yokoyama, M; Ibe, S; Takehara, S; Kono, K; Yokomaku, Y; Pizzato, M; Luban, J; Sugiura, W; Sato, H; Shioda, T				Miyamoto, Tadashi; Nakayama, Emi E.; Yokoyama, Masaru; Ibe, Shiro; Takehara, Shunpei; Kono, Ken; Yokomaku, Yoshiyuki; Pizzato, Massimo; Luban, Jeremy; Sugiura, Wataru; Sato, Hironori; Shioda, Tatsuo			The Carboxyl-Terminus of Human Immunodeficiency Virus Type 2 Circulating Recombinant form 01_AB Capsid Protein Affects Sensitivity to Human TRIM5 alpha	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY; RESTRICTION FACTOR; CYNOMOLGUS MONKEY; HIV-1 INFECTION; RHESUS-MONKEY; WEST-AFRICA; HUMAN-CELLS; AMINO-ACID; SIMULATIONS; DYNAMICS	Human immunodeficiency virus (HIV) type 2 shows limited geographical distribution compared with HIV type 1. Although 8 genetic groups of HIV type 2 (HIV-2) have been described, recombinant viruses between these groups are rarely observed. Recently, three HIV-2 patients in Japan were described with rapidly progressive, acquired immunodeficiency. These patients were infected with an A/B inter-group recombinant designated CRF01_AB. Here, we characterize the capsid protein (CA) encoded by the viruses from these patients. HIV-2 CRF01_AB CA showed unique amino acid sequence almost equally distinct from group A and group B viruses. Notably, HIV-2 CRF01_AB CA showed potent resistance to human TRIM5 alpha. In addition to the previously identified amino acid position 119 in the N-terminal domain of CA, we found that HIV-2 CRF01_AB-specific amino acid substitutions in the C-terminal domain also were necessary for resistance to human TRIM5 alpha. These results indicate that retroviruses can evade TRIM5 alpha by substitution at residues within the C-terminal domain of CA.	[Miyamoto, Tadashi; Nakayama, Emi E.; Takehara, Shunpei; Kono, Ken; Shioda, Tatsuo] Osaka Univ, Microbial Dis Res Inst, Dept Viral Infect, Suita, Osaka 565, Japan; [Yokoyama, Masaru; Sato, Hironori] Natl Inst Infect Dis, Lab Viral Genom, Pathogen Genom Ctr, Tokyo, Japan; [Ibe, Shiro; Yokomaku, Yoshiyuki; Sugiura, Wataru] Nagoya Med Ctr, Natl Hosp Org, Clin Res Ctr, Dept Infect & Immunol,Naka Ku, Nagoya, Aichi, Japan; [Pizzato, Massimo; Luban, Jeremy] Univ Geneva, Dept Microbiol & Mol Med, Geneva, Switzerland	Osaka University; National Institute of Infectious Diseases (NIID); Nagoya Medical Center; University of Geneva	Shioda, T (corresponding author), Osaka Univ, Microbial Dis Res Inst, Dept Viral Infect, Suita, Osaka 565, Japan.	shioda@biken.osaka-u.ac.jp	Pizzato, Massimo/AFL-0051-2022	Pizzato, Massimo/0000-0002-9491-1483; Luban, Jeremy/0000-0001-5650-4054	Health Science Foundation; Ministry of Education, Culture, Sports, Science, and Technology, Japan [23590541, 23390111]; Ministry of Health, Labour, and Welfare, Japan [H22-AIDS-003]; Swiss National Fund [3100A0-128655]; NIH [RO1AI59159]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059159] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23390111] Funding Source: KAKEN	Health Science Foundation; Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour, and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan); Swiss National Fund(Swiss National Science Foundation (SNSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Health Science Foundation; the Ministry of Education, Culture, Sports, Science, and Technology, Japan (23590541 to EEN, 23390111 to TS), the Ministry of Health, Labour, and Welfare, Japan (H22-AIDS-003 to HS), Swiss National Fund grant 3100A0-128655 to JL, and NIH grant RO1AI59159 to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JL, 2006, J VIROL, V80, P9754, DOI 10.1128/JVI.01052-06; Bailey GD, 2012, J MOL BIOL, V417, P212, DOI 10.1016/j.jmb.2012.01.014; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Case D, 2006, AMBER 9; Damond F, 2004, AIDS RES HUM RETROV, V20, P666, DOI 10.1089/0889222041217392; Dodson GG, 2008, EMBO REP, V9, P144, DOI 10.1038/sj.embor.7401160; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; GAO F, 1992, NATURE, V358, P495, DOI 10.1038/358495a0; Gottlieb GS, 2002, J INFECT DIS, V185, P905, DOI 10.1086/339295; Hatziioannou T, 2004, P NATL ACAD SCI USA, V101, P10774, DOI 10.1073/pnas.0402361101; HILLIS DM, 1993, SYST BIOL, V42, P182, DOI 10.2307/2992540; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; HUET T, 1990, NATURE, V345, P356, DOI 10.1038/345356a0; Ibe S, 2010, JAIDS-J ACQ IMM DEF, V54, P241, DOI 10.1097/QAI.0b013e3181dc98c1; Inagaki N, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-90; Keckesova Z, 2004, P NATL ACAD SCI USA, V101, P10780, DOI 10.1073/pnas.0402474101; Kinomoto M, 2005, J VIROL, V79, P5996, DOI 10.1128/JVI.79.10.5996-6004.2005; Kono K, 2008, VIROLOGY, V373, P447, DOI 10.1016/j.virol.2007.12.022; Kono K, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-72; LASFARGUES EY, 1976, CANCER RES, V36, P67; Lee K, 2001, ANTIMICROB AGENTS CH, V45, P138, DOI 10.1128/AAC.45.1.138-144.2001; MARLINK R, 1994, SCIENCE, V265, P1587, DOI 10.1126/science.7915856; Miyamoto T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022779; Nakayama EE, 2005, J VIROL, V79, P8870, DOI 10.1128/JVI.79.14.8870-8877.2005; Nakayama EE, 2010, REV MED VIROL, V20, P77, DOI 10.1002/rmv.637; Onyango CO, 2010, VACCINE, V28, pB60, DOI 10.1016/j.vaccine.2009.08.060; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Perron MJ, 2004, P NATL ACAD SCI USA, V101, P11827, DOI 10.1073/pnas.0403364101; Pertel T, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-49; Pertel T, 2011, NATURE, V472, P361, DOI 10.1038/nature09976; Ponder JW, 2003, ADV PROTEIN CHEM, V66, P27; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Price AJ, 2009, NAT STRUCT MOL BIOL, V16, P1036, DOI 10.1038/nsmb.1667; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Rowland-Jones SL, 2007, NAT IMMUNOL, V8, P329, DOI 10.1038/ni0407-329; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sebastian S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-40; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shirakawa K, 2008, NAT STRUCT MOL BIOL, V15, P1184, DOI 10.1038/nsmb.1497; Sokolskaja E, 2006, J VIROL, V80, P2855, DOI 10.1128/JVI.80.6.2855-2862.2006; Song H, 2007, J VIROL, V81, P7280, DOI 10.1128/JVI.00406-07; Stremlau M, 2006, P NATL ACAD SCI USA, V103, P5514, DOI 10.1073/pnas.0509996103; Stremlau M, 2004, NATURE, V427, P848, DOI 10.1038/nature02343; Wu XL, 2006, P NATL ACAD SCI USA, V103, P7465, DOI 10.1073/pnas.0510483103	46	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47757	10.1371/journal.pone.0047757	http://dx.doi.org/10.1371/journal.pone.0047757			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094081	Green Published, gold, Green Submitted			2022-12-25	WOS:000310050200042
J	Euser, SM; Nagelkerke, NJ; Schuren, F; Jansen, R; Den Boer, JW				Euser, Sjoerd M.; Nagelkerke, Nico J.; Schuren, Frank; Jansen, Ruud; Den Boer, Jeroen W.			Genome Analysis of Legionella pneumophila Strains Using a Mixed-Genome Microarray	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; LEGIONNAIRES-DISEASE; SEQUENCE TYPES; PATHOGENS; VIRULENCE; CLASSIFICATION; SEROGROUPS; EPIDEMIC; OUTBREAK; FEATURES	Background: Legionella, the causative agent for Legionnaires' disease, is ubiquitous in both natural and man-made aquatic environments. The distribution of Legionella genotypes within clinical strains is significantly different from that found in environmental strains. Developing novel genotypic methods that offer the ability to distinguish clinical from environmental strains could help to focus on more relevant (virulent) Legionella species in control efforts. Mixed-genome microarray data can be used to perform a comparative-genome analysis of strain collections, and advanced statistical approaches, such as the Random Forest algorithm are available to process these data. Methods: Microarray analysis was performed on a collection of 222 Legionella pneumophila strains, which included patient-derived strains from notified cases in the Netherlands in the period 2002-2006 and the environmental strains that were collected during the source investigation for those patients within the Dutch National Legionella Outbreak Detection Programme. The Random Forest algorithm combined with a logistic regression model was used to select predictive markers and to construct a predictive model that could discriminate between strains from different origin: clinical or environmental. Results: Four genetic markers were selected that correctly predicted 96% of the clinical strains and 66% of the environmental strains collected within the Dutch National Legionella Outbreak Detection Programme. Conclusions: The Random Forest algorithm is well suited for the development of prediction models that use mixed-genome microarray data to discriminate between Legionella strains from different origin. The identification of these predictive genetic markers could offer the possibility to identify virulence factors within the Legionella genome, which in the future may be implemented in the daily practice of controlling Legionella in the public health environment.	[Euser, Sjoerd M.; Jansen, Ruud; Den Boer, Jeroen W.] Reg Publ Hlth Lab Kennemerland, Haarlem, Netherlands; [Nagelkerke, Nico J.] United Arab Emirates Univ, Dept Community Med, Al Ain, U Arab Emirates; [Schuren, Frank] TNO Microbiol & Syst Biol, Zeist, Netherlands	United Arab Emirates University; Netherlands Organization Applied Science Research	Euser, SM (corresponding author), Reg Publ Hlth Lab Kennemerland, Haarlem, Netherlands.	s.euser@streeklabhaarlem.nl			Vitens water supply company	Vitens water supply company	This study was supported by a grant from Vitens water supply company (www.vitens.nl). This company had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alli OAT, 2003, MICROBIOL-SGM, V149, P631, DOI 10.1099/mic.0.25980-0; Amaro F, 2012, J BACTERIOL, V194, P1613, DOI 10.1128/JB.06626-11; [Anonymous], JAARR SURV RESP INF; Blasi F, 2004, EUR RESPIR J, V24, P171, DOI 10.1183/09031936.04.00135703; BOLLIN GE, 1985, J CLIN MICROBIOL, V21, P674, DOI 10.1128/JCM.21.5.674-677.1985; Borchardt J, 2008, EUR J CLIN MICROBIOL, V27, P29, DOI 10.1007/s10096-007-0392-3; Braun J J, 2004, Ned Tijdschr Geneeskd, V148, P836; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Cazalet C, 2008, GENOME RES, V18, P431, DOI 10.1101/gr.7229808; Cazalet C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000851; Chiarini A, 2008, NEW MICROBIOL, V31, P217; Chien MC, 2004, SCIENCE, V305, P1966, DOI 10.1126/science.1099776; D'Auria G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-181; Den Boer JW, 2008, CLIN MICROBIOL INFEC, V14, P459, DOI 10.1111/j.1469-0691.2008.01973.x; Den Boer JW, 2007, INT J HYG ENVIR HEAL, V210, P1, DOI 10.1016/j.ijheh.2006.07.002; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Doleans A, 2004, J CLIN MICROBIOL, V42, P458, DOI 10.1128/JCM.42.1.458-460.2004; Dominguez A, 2009, INT J TUBERC LUNG D, V13, P407; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; Fry Norman K., 1999, Clin Microbiol Infect, V5, P462, DOI 10.1111/j.1469-0691.1999.tb00176.x; Gomez-Valero L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-536; Harrison TG, 2009, EUR J CLIN MICROBIOL, V28, P781, DOI 10.1007/s10096-009-0705-9; Hoffmann K, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-229; Huang TD, 2010, J CLIN MICROBIOL, V48, P2091, DOI 10.1128/JCM.02342-09; Joseph C. A., 2010, EUROSURVEILLANCE, V15, P1; Kool JL, 2000, EPIDEMIOL INFECT, V125, P599, DOI 10.1017/S095026880000474X; Schroeder GN, 2010, J BACTERIOL, V192, P6001, DOI 10.1128/JB.00778-10; Schwender H, 2008, BIOMETRICAL J, V50, P911, DOI 10.1002/bimj.200810475; Steinert M, 2007, INT J MED MICROBIOL, V297, P577, DOI 10.1016/j.ijmm.2007.03.009; Wolk DM, 2009, J CLIN MICROBIOL, V47, P758, DOI 10.1128/JCM.01714-08; Woodhead M, 2002, EUR RESPIR J, V20, p20S, DOI 10.1183/09031936.02.00702002; Yu VL, 2002, J INFECT DIS, V186, P127, DOI 10.1086/341087; Yzerman E, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-433	33	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47437	10.1371/journal.pone.0047437	http://dx.doi.org/10.1371/journal.pone.0047437			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094048	Green Published, gold, Green Submitted			2022-12-25	WOS:000312384500010
J	Wubet, T; Christ, S; Schoning, I; Boch, S; Gawlich, M; Schnabel, B; Fischer, M; Buscot, F				Wubet, Tesfaye; Christ, Sabina; Schoening, Ingo; Boch, Steffen; Gawlich, Melanie; Schnabel, Beatrix; Fischer, Markus; Buscot, Francois			Differences in Soil Fungal Communities between European Beech (Fagus sylvatica L.) Dominated Forests Are Related to Soil and Understory Vegetation	PLOS ONE			English	Article							MICROBIAL DIVERSITY; MYCORRHIZAL FUNGI; RARE BIOSPHERE; BACTERIAL; REVEAL; RUSSULALES	Fungi are important members of soil microbial communities with a crucial role in biogeochemical processes. Although soil fungi are known to be highly diverse, little is known about factors influencing variations in their diversity and community structure among forests dominated by the same tree species but spread over different regions and under different managements. We analyzed the soil fungal diversity and community composition of managed and unmanaged European beech dominated forests located in three German regions, the Schwa "bische Alb in Southwestern, the Hainich-Dun in Central and the Schorfheide Chorin in the Northeastern Germany, using internal transcribed spacer (ITS) rDNA pyrotag sequencing. Multiple sequence quality filtering followed by sequence data normalization revealed 1655 fungal operational taxonomic units. Further analysis based on 722 abundant fungal OTUs revealed the phylum Basidiomycota to be dominant (54%) and its community to comprise 71.4% of ectomycorrhizal taxa. Fungal community structure differed significantly (p <= 0.001) among the three regions and was characterized by non-random fungal OTUs co-occurrence. Soil parameters, herbaceous understory vegetation, and litter cover affected fungal community structure. However, within each study region we found no difference in fungal community structure between management types. Our results also showed region specific significant correlation patterns between the dominant ectomycorrhizal fungal genera. This suggests that soil fungal communities are region-specific but nevertheless composed of functionally diverse and complementary taxa.	[Wubet, Tesfaye; Gawlich, Melanie; Schnabel, Beatrix; Buscot, Francois] UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Saale, Germany; [Christ, Sabina] Fraunhofer Inst Cell Therapy & Immunol, Dept Diagnost, Leipzig, Germany; [Buscot, Francois] Univ Leipzig, Inst Biol, Chair Soil Ecol, Leipzig, Germany; [Schoening, Ingo] Max Planck Inst Biogeochem, Dept Biogeochem Proc, Jena, Germany; [Boch, Steffen; Fischer, Markus] Univ Bern, Inst Plant Sci & Bot Garden, Bern, Switzerland	Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Fraunhofer Gesellschaft; Leipzig University; Max Planck Society; University of Bern	Wubet, T (corresponding author), UFZ Helmholtz Ctr Environm Res, Dept Soil Ecol, Halle, Saale, Germany.	tesfaye.wubet@ufz.de	Buscot, Francois/A-4125-2016; Boch, Steffen/L-5436-2016; Wubet, Tesfaye/C-6241-2012; Fischer, Markus/C-6411-2008; Schöning, Ingo/D-3341-2009	Buscot, Francois/0000-0002-2364-0006; Wubet, Tesfaye/0000-0001-8572-4486; Fischer, Markus/0000-0002-5589-5900; Schöning, Ingo/0000-0002-9830-5026; Christ, Sabina/0000-0001-6886-8154	DFG [1374, BU-941/18-1, Fi-1246/6-1, SCHR1181/1-1]	DFG(German Research Foundation (DFG))	The work has been funded by the DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (BU-941/18-1, Fi-1246/6-1 and SCHR1181/1-1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agerer R, 2006, MYCOL PROG, V5, P67, DOI 10.1007/s11557-006-0505-x; Aponte C, 2010, SOIL BIOL BIOCHEM, V42, P788, DOI 10.1016/j.soilbio.2010.01.014; Bonfante P, 2009, ANNU REV MICROBIOL, V63, P363, DOI 10.1146/annurev.micro.091208.073504; Buee M, 2005, MYCORRHIZA, V15, P235, DOI 10.1007/s00572-004-0313-6; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Burke DJ, 2009, APPL ENVIRON MICROB, V75, P7639, DOI 10.1128/AEM.01648-09; Buscot F, 2005, SOIL BIOL, V3, P3; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Christ S, 2011, SOIL BIOL BIOCHEM, V43, P1292, DOI 10.1016/j.soilbio.2011.02.022; Danzeisen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027949; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Geml J, 2010, NEW PHYTOL, V187, P494, DOI 10.1111/j.1469-8137.2010.03283.x; Geml J, 2009, MOL ECOL, V18, P2213, DOI 10.1111/j.1365-294X.2009.04192.x; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; Gotelli NJ, 2000, ECOSIM NULL MODELS S; Gottel NR, 2011, APPL ENVIRON MICROB, V77, P5934, DOI 10.1128/AEM.05255-11; Green J, 2006, TRENDS ECOL EVOL, V21, P501, DOI 10.1016/j.tree.2006.06.012; Green JL, 2004, NATURE, V432, P747, DOI 10.1038/nature03034; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Jumpponen A, 2010, MOL ECOL, V19, P41, DOI 10.1111/j.1365-294X.2009.04483.x; Kasel S, 2008, SOIL BIOL BIOCHEM, V40, P1724, DOI 10.1016/j.soilbio.2008.02.011; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Koide RT, 2011, ANN FOREST SCI, V68, P45, DOI 10.1007/s13595-010-0006-6; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lim YW, 2010, J MICROBIOL, V48, P284, DOI 10.1007/s12275-010-9369-5; Lindahl BD, 2007, NEW PHYTOL, V173, P611, DOI 10.1111/j.1469-8137.2006.01936.x; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Opik M, 2009, NEW PHYTOL, V184, P424, DOI 10.1111/j.1469-8137.2009.02920.x; Oksanen J., 2011, VEGAN COMMUNITY ECOL; Pandey Ram Vinay, 2010, BMC Res Notes, V3, P3, DOI 10.1186/1756-0500-3-3; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Reeder J, 2009, NAT METHODS, V6, P636, DOI 10.1038/nmeth0909-636; Revelle W., 2011, PSYCH PROCEDURES PSY; Rinaldi AC, 2008, FUNGAL DIVERS, V33, P1; Roberts D.W., 2010, LABDSV ORDINATION MU; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P1; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Taylor LL, 2009, GEOBIOLOGY, V7, P171, DOI 10.1111/j.1472-4669.2009.00194.x; Team R. D. C, 2011, R LANG ENV STAT COMP; Tedersoo L, 2008, NEW PHYTOL, V180, P479, DOI 10.1111/j.1469-8137.2008.02561.x; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; White T., 1990, PCR PROTOCOLS GUIDE, P315; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10	50	78	82	3	118	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47500	10.1371/journal.pone.0047500	http://dx.doi.org/10.1371/journal.pone.0047500			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094057	Green Submitted, Green Published, gold			2022-12-25	WOS:000312384500012
J	Holland, D; McEvoy, LK; Desikan, RS; Dale, AM				Holland, Dominic; McEvoy, Linda K.; Desikan, Rahul S.; Dale, Anders M.		Alzheimer's Dis Neuroimaging	Enrichment and Stratification for Predementia Alzheimer Disease Clinical Trials	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; BRAIN ATROPHY RATES; CEREBROSPINAL-FLUID; CSF BIOMARKERS; PHOSPHORYLATED-TAU; OLDER-ADULTS; NEUROFIBRILLARY PATHOLOGY; NATIONAL INSTITUTE; STRUCTURAL MRI; AMYLOID BURDEN	The tau and amyloid pathobiological processes underlying Alzheimer disease (AD) progresses slowly over periods of decades before clinical manifestation as mild cognitive impairment (MCI), then more rapidly to dementia, and eventually to end-stage organ failure. The failure of clinical trials of candidate disease modifying therapies to slow disease progression in patients already diagnosed with early AD has led to increased interest in exploring the possibility of early intervention and prevention trials, targeting MCI and cognitively healthy (HC) populations. Here, we stratify MCI individuals based on cerebrospinal fluid (CSF) biomarkers and structural atrophy risk factors for the disease. We also stratify HC individuals into risk groups on the basis of CSF biomarkers for the two hallmark AD pathologies. Results show that the broad category of MCI can be decomposed into subsets of individuals with significantly different average regional atrophy rates. By thus selectively identifying individuals, combinations of these biomarkers and risk factors could enable significant reductions in sample size requirements for clinical trials of investigational AD-modifying therapies, and provide stratification mechanisms to more finely assess response to therapy. Power is sufficiently high that detecting efficacy in MCI cohorts should not be a limiting factor in AD therapeutics research. In contrast, we show that sample size estimates for clinical trials aimed at the preclinical stage of the disorder (HCs with evidence of AD pathology) are prohibitively large. Longer natural history studies are needed to inform design of trials aimed at the presymptomatic stage.	[Holland, Dominic; Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [McEvoy, Linda K.; Desikan, Rahul S.; Dale, Anders M.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Holland, D (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	dominic.holland@gmail.com			National Institutes of Health (NIH) [R01AG031224, R01AG22381, U54NS056883, P50NS22343, P50MH081755]; NIA [K01AG029218]; NIH-NIBIB [T32 EB005970]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB005970] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH081755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS022343, U54NS056883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG022381, R01AG031224, K01AG029218] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH-NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by National Institutes of Health (NIH) grants R01AG031224, R01AG22381, U54NS056883, P50NS22343, and P50MH081755 (A. M. D.); NIA K01AG029218 (LKM)); NIH-NIBIB T32 EB005970 (RSD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arai T, 2001, ACTA NEUROPATHOL, V101, P167; Bakkour A, 2009, NEUROLOGY, V72, P1048, DOI 10.1212/01.wnl.0000340981.97664.2f; Bateman RJ, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt59; Becker JA, 2011, ANN NEUROL, V69, P1032, DOI 10.1002/ana.22333; Bonk J, 2010, J AM GERIATR SOC, V58, pS303, DOI 10.1111/j.1532-5415.2010.02937.x; Bourgeat P, 2010, NEUROLOGY, V74, P121, DOI 10.1212/WNL.0b013e3181c918b5; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Braak H, 2006, ACTA NEUROPATHOL, V112, P389, DOI 10.1007/s00401-006-0127-z; Braak H, 2012, ALZHEIMERS DEMENT, V8, P227, DOI 10.1016/j.jalz.2012.01.011; Braak H, 2011, J NEUROPATH EXP NEUR, V70, P960, DOI 10.1097/NEN.0b013e318232a379; Brookmeyer R, 2011, ALZHEIMERS DEMENT, V7, P61, DOI 10.1016/j.jalz.2010.11.007; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Buerger K, 2006, BRAIN, V129, P3035, DOI 10.1093/brain/awl269; Bulic B, 2010, NEUROPHARMACOLOGY, V59, P276, DOI 10.1016/j.neuropharm.2010.01.016; Cardenas VA, 2011, NEUROBIOL AGING, V32, P572, DOI 10.1016/j.neurobiolaging.2009.04.011; Cedarbaum JM, 2012, ALZHEIMERS DEMENT; Chan D, 2003, LANCET, V362, P1121, DOI 10.1016/S0140-6736(03)14469-8; Chetelat G, 2012, NEUROLOGY, V78, P477, DOI 10.1212/WNL.0b013e318246d67a; Craig-Schapiro R, 2009, NEUROBIOL DIS, V35, P128, DOI 10.1016/j.nbd.2008.10.003; Cummings Jeffrey L, 2011, Alzheimers Dement, V7, pe13, DOI 10.1016/j.jalz.2010.06.004; de Leon MJ, 2007, ANN NY ACAD SCI, V1097, P114, DOI 10.1196/annals.1379.012; Delrieu J, 2012, J NEUROCHEM, V120, P186, DOI 10.1111/j.1471-4159.2011.07458.x; Desikan RS, 2011, ANN NEUROL, V70, P657, DOI 10.1002/ana.22509; Desikan RS, 2012, ARCH NEUROL; Dickerson BC, 2012, NEUROLOGY, V78, P84, DOI 10.1212/WNL.0b013e31823efc6c; Duyckaerts C, 2011, ACTA NEUROPATHOL, V121, P145, DOI 10.1007/s00401-010-0794-7; Fagan AM, 2006, ANN NEUROL, V59, P512, DOI 10.1002/ana.20730; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fennema-Notestine C, 2009, HUM BRAIN MAPP, V30, P3238, DOI 10.1002/hbm.20744; Fjell AM, 2010, CEREB CORTEX, V20, P2069, DOI 10.1093/cercor/bhp279; Fjell AM, 2010, J NEUROSCI, V30, P2088, DOI 10.1523/JNEUROSCI.3785-09.2010; Fjell AM, 2009, J NEUROSCI, V29, P15223, DOI 10.1523/JNEUROSCI.3252-09.2009; Fox NC, 2000, ARCH NEUROL-CHICAGO, V57, P339, DOI 10.1001/archneur.57.3.339; Fox NC, 2011, NEUROIMAGE, V57, P15, DOI 10.1016/j.neuroimage.2011.01.077; Ghidoni R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/697036; Goedert M, 2004, SEMIN CELL DEV BIOL, V15, P45, DOI 10.1016/j.semcdb.2003.12.015; Gold M, 2010, DEMENT GERIATR COGN, V30, P131, DOI 10.1159/000318845; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Gravitz L, 2011, NATURE, V475, pS9, DOI 10.1038/475S9a; Grill JD, 2012, NEUROBIOL AGING; Gunnarsson MD, 2007, DEMENT GERIATR COGN, V24, P247, DOI 10.1159/000107099; Hansson O, 2006, LANCET NEUROL, V5, P228, DOI 10.1016/S1474-4422(06)70355-6; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heister D, 2011, NEUROLOGY, V77, P1619, DOI 10.1212/WNL.0b013e3182343314; Herrmann N, 2011, DRUGS, V71, P2031, DOI 10.2165/11595870-000000000-00000; Holland D., 2011, HUM BRAIN MAPP; Holland D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042325; Holland D, 2011, MED IMAGE ANAL, V15, P489, DOI 10.1016/j.media.2011.02.005; Holland D, 2009, P NATL ACAD SCI USA, V106, P20954, DOI 10.1073/pnas.0906053106; Hua X, 2011, NEUROIMAGE, V57, P5, DOI 10.1016/j.neuroimage.2011.01.079; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Hyman BT, 2011, ARCH NEUROL-CHICAGO, V68, P1062, DOI 10.1001/archneurol.2011.70; HYMAN BT, 1993, J NEUROPATH EXP NEUR, V52, P594, DOI 10.1097/00005072-199311000-00006; Imbimbo BP, 2011, CURR TOP MED CHEM, V11, P1555; Jack CR, 2012, RADIOLOGY, V263, P343, DOI 10.1148/radiol.12110433; Jack CR, 2011, ARCH NEUROL-CHICAGO, V68, P1526, DOI 10.1001/archneurol.2011.183; Jack CR, 2011, ALZHEIMERS DEMENT, V7, P474, DOI 10.1016/j.jalz.2011.04.007; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Jack CR, 2005, NEUROLOGY, V65, P1227, DOI 10.1212/01.wnl.0000180958.22678.91; Jack CR, 2003, NEUROLOGY, V60, P253, DOI 10.1212/01.WNL.0000042480.86872.03; Johnson KA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006213; Koikkalainen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031112; Lee GJ, 2012, BIOL PSYCHIAT, V71, P814, DOI 10.1016/j.biopsych.2011.12.024; Lemere CA, 2010, NAT REV NEUROL, V6, P108, DOI 10.1038/nrneurol.2009.219; Leung KK, 2012, NEUROIMAGE, V59, P3995, DOI 10.1016/j.neuroimage.2011.10.068; Leung KK, 2010, NEUROIMAGE, V51, P1345, DOI 10.1016/j.neuroimage.2010.03.018; Leung KK, 2010, NEUROIMAGE, V50, P516, DOI 10.1016/j.neuroimage.2009.12.059; Leuzy A, 2012, EXPERT REV NEUROTHER, V12, P557, DOI [10.1586/ern.12.38, 10.1586/ERN.12.38]; Lorenzi M, 2010, NEUROBIOL AGING, V31, P1443, DOI 10.1016/j.neurobiolaging.2010.04.036; Markesbery WR, 2006, ARCH NEUROL-CHICAGO, V63, P38, DOI 10.1001/archneur.63.1.38; Mattsson N, 2012, J ALZHEIMERS DIS, V30, P767, DOI 10.3233/JAD-2012-120019; Mattsson N, 2009, JAMA-J AM MED ASSOC, V302, P385, DOI 10.1001/jama.2009.1064; McDonald CR, 2009, NEUROLOGY, V73, P457, DOI 10.1212/WNL.0b013e3181b16431; McEvoy LK, 2010, EXPERT REV NEUROTHER, V10, P1675, DOI 10.1586/ERN.10.162; McEvoy LK, 2010, ALZ DIS ASSOC DIS, V24, P269, DOI 10.1097/WAD.0b013e3181d1b814; McEvoy LK, 2009, RADIOLOGY, V251, P195, DOI 10.1148/radiol.2511080924; McMurdo MET, 2011, AGE AGEING, V40, P659, DOI 10.1093/ageing/afr115; Mintun MA, 2006, NEUROLOGY, V67, P446, DOI 10.1212/01.wnl.0000228230.26044.a4; Mody L, 2008, J AM GERIATR SOC, V56, P2340, DOI 10.1111/j.1532-5415.2008.02015.x; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morris JC, 2010, ANN NEUROL, V67, P122, DOI 10.1002/ana.21843; Morris JC, 2009, ARCH NEUROL-CHICAGO, V66, P1469, DOI 10.1001/archneurol.2009.269; Murphy EA, 2010, NEUROIMAGE, V53, P1310, DOI 10.1016/j.neuroimage.2010.07.016; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Olsson A, 2005, CLIN CHEM, V51, P336, DOI 10.1373/clinchem.2004.039347; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Pimplikar SW, 2009, INT J BIOCHEM CELL B, V41, P1261, DOI 10.1016/j.biocel.2008.12.015; Poulin SP, 2011, PSYCHIAT RES-NEUROIM, V194, P7, DOI 10.1016/j.pscychresns.2011.06.014; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Reuter M, 2012, NEUROIMAGE; Ridha BH, 2008, J NEUROL, V255, P567, DOI 10.1007/s00415-008-0750-9; Rosner B, 2011, FUNDAMENTALS BIOSTAT, Vxvii; Sancesario GM, 2012, J ALZHEIMERS DIS, V31, P865, DOI 10.3233/JAD-2012-120211; Saykin AJ, 2006, NEUROLOGY, V67, P834, DOI 10.1212/01.wnl.0000234032.77541.a2; Schott JM, 2010, NEUROBIOL AGING, V31, P1452, DOI 10.1016/j.neurobiolaging.2010.04.011; Schott JM, 2010, ANN NEUROL, V68, P825, DOI 10.1002/ana.22315; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sperling RA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002609; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Storandt M, 2012, NEUROBIOL AGING, V33, P2262, DOI 10.1016/j.neurobiolaging.2011.11.029; Thompson WK, 2011, NEUROIMAGE, V57, P1, DOI 10.1016/j.neuroimage.2010.11.092; Tondelli M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.05.018; Vellas B, 2011, PROG NEUROBIOL, V95, P594, DOI 10.1016/j.pneurobio.2011.08.014; Vemuri P, 2009, NEUROLOGY, V73, P294, DOI 10.1212/WNL.0b013e3181af79fb; Vemuri P, 2008, NEUROIMAGE, V42, P559, DOI 10.1016/j.neuroimage.2008.05.012; Vos S, 2012, NEUROBIOL AGING; Weiner Michael W, 2012, Alzheimers Dement, V8, pS1, DOI [10.1016/j.jalz.2013.05.1769, 10.1016/j.jalz.2011.09.172]; West MJ, 2004, NEUROBIOL AGING, V25, P1205, DOI 10.1016/j.neurobiolaging.2003.12.005; Whitwell JL, 2008, NEUROLOGY, V71, P743, DOI 10.1212/01.wnl.0000324924.91351.7d; Whitwell JL, 2008, NEUROLOGY, V70, P512, DOI 10.1212/01.wnl.0000280575.77437.a2; Williams MM, 2012, ALZHEIMERS DEMENT; Wisniewski H M, 1982, Exp Brain Res, VSuppl 5, P3; Witham MD, 2007, DRUG AGING, V24, P187, DOI 10.2165/00002512-200724030-00002	116	54	54	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47739	10.1371/journal.pone.0047739	http://dx.doi.org/10.1371/journal.pone.0047739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082203	Green Published, gold			2022-12-25	WOS:000311146900100
J	Kumar, T; Jha, SK				Kumar, Tankesh; Jha, Sushil K.			Sleep Deprivation Impairs Consolidation of Cued Fear Memory in Rats	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PARADOXICAL SLEEP; CIRCADIAN MODULATION; SYNAPTIC PLASTICITY; AVOIDANCE-BEHAVIOR; LATERAL AMYGDALA; STRESS-DISORDER; REM-SLEEP; EXPRESSION; RHYTHM	Post-learning sleep facilitates negative memory consolidation and also helps preserve it over several years. It is believed, therefore, that sleep deprivation may help prevent consolidation of fearful memory. Its effect, however, on consolidation of negative/frightening memories is not known. Cued fear-conditioning (CuFC) is a widely used model to understand the neural basis of negative memory associated with anxiety disorders. In this study, we first determined the suitable circadian timing for consolidation of CuFC memory and changes in sleep architecture after CuFC. Thereafter, we studied the effect of sleep deprivation on CuFC memory consolidation. Three sets of experiments were performed in male Wistar rat (n = 51). In experiment-I, animals were conditioned to cued-fear by presenting ten tone-shock paired stimuli during lights-on (7 AM) (n = 9) and lights-off (7 PM) (n = 9) periods. In experiment-II, animals were prepared for polysomnographic recording (n = 8) and changes in sleep architecture after CuFC was determined. Further in experiment-III, animals were cued fear-conditioned during the lights-off period and were randomly divided into four groups: Sleep-Deprived (SD) (n = 9), Non-Sleep Deprived (NSD) (n = 9), Stress Control (SC) (n = 9) and Tone Control (n = 7). Percent freezing amount, a hallmark of fear, was compared statistically in these groups. Rats trained during the lights-off period exhibited significantly more freezing compared to lights-on period. In CuFC trained animals, total sleep amount did not change, however, REM sleep decreased significantly. Further, out of total sleep time, animals spent proportionately more time in NREM sleep. Nevertheless, SD animals exhibited significantly less freezing compared to NSD and SC groups. These data suggest that sleep plays an important role in the consolidation of cued fear-conditioned memory.	[Kumar, Tankesh; Jha, Sushil K.] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Jawaharlal Nehru University, New Delhi	Jha, SK (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	sushilkjha@mail.jnu.ac.in	Jha, Sushil/R-3059-2019	Jha, Sushil/0000-0001-8638-898X	Council of Scientific and Industrial Research (CSIR), New Delhi, India; Department of Science & Technology (DST); DST-PURSE; Capacity Build-up funds; University Grants Commission UGC-RNW; UGC-CAS	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); Department of Science & Technology (DST)(Department of Science & Technology (India)); DST-PURSE; Capacity Build-up funds; University Grants Commission UGC-RNW(University Grants Commission, India); UGC-CAS(University Grants Commission, IndiaChinese Academy of Sciences)	Funding to SKJ from Council of Scientific and Industrial Research (CSIR), New Delhi, India is highly acknowledged. Funding from other sources such as Department of Science & Technology (DST), DST-PURSE, Capacity Build-up funds, University Grants Commission UGC-RNW and UGC-CAS is also acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aton SJ, 2009, NEURON, V61, P454, DOI 10.1016/j.neuron.2009.01.007; Backhaus J, 2006, BIOL PSYCHIAT, V60, P1324, DOI 10.1016/j.biopsych.2006.03.051; Bjorness TE, 2005, LEARN MEMORY, V12, P352, DOI 10.1101/lm.84805; Blair HT, 2001, LEARN MEMORY, V8, P229, DOI 10.1101/lm.30901; Campbell IG, 2002, J NEUROPHYSIOL, V88, P1073, DOI 10.1152/jn.2002.88.2.1073; CATALA MD, 1985, PHYSIOL BEHAV, V34, P327, DOI 10.1016/0031-9384(85)90191-X; Chaudhury D, 2002, BEHAV BRAIN RES, V133, P95, DOI 10.1016/S0166-4328(01)00471-5; Chowdhury A, 2011, NEUROBIOL LEARN MEM, V95, P355, DOI 10.1016/j.nlm.2011.01.009; DAVIES JA, 1973, PSYCHOPHARMACOLOGIA, V32, P211, DOI 10.1007/BF00428692; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3; Gais S, 2000, NAT NEUROSCI, V3, P1335, DOI 10.1038/81881; Gerstner JR, 2010, NAT REV NEUROSCI, V11, P577, DOI 10.1038/nrn2881; Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803; Hale MW, 2006, BRAIN RES BULL, V71, P174, DOI 10.1016/j.brainresbull.2006.09.001; Hennevin E, 1998, BEHAV NEUROSCI, V112, P839, DOI 10.1037/0735-7044.112.4.839; HENNEVIN E, 1995, BEHAV BRAIN RES, V69, P125, DOI 10.1016/0166-4328(95)00013-J; Hill S, 2008, BRAIN RES BULL, V76, P605, DOI 10.1016/j.brainresbull.2008.02.024; Holland P, 2007, CURR BIOL, V17, pR179, DOI 10.1016/j.cub.2006.12.033; Ishikawa A, 2006, EUR J NEUROSCI, V24, P243, DOI 10.1111/j.1460-9568.2006.04874.x; Jha SK, 2005, J NEUROSCI, V25, P9266, DOI 10.1523/JNEUROSCI.2722-05.2005; Jha SK, 2005, EUR J NEUROSCI, V21, P1077, DOI 10.1111/j.1460-9568.2005.03920.x; Knight DC, 2009, NEUROIMAGE, V45, P208, DOI 10.1016/j.neuroimage.2008.11.015; Kuriyama K, 2010, BIOL PSYCHIAT, V68, P991, DOI 10.1016/j.biopsych.2010.08.015; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Liu DLJ, 2008, NEUROBIOL LEARN MEM, V89, P36, DOI 10.1016/j.nlm.2007.09.001; Loh DH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012546; Lyon LC, 2005, P NATL ACAD SCI USA, V102, P12589, DOI 10.1073/pnas.0503847102; Madan V, 2008, INT J LIFE SCI TECHN, V1, P9; Madan V, 2008, SLEEP, V31, P497, DOI 10.1093/sleep/31.4.497; Mahan AL, 2012, TRENDS NEUROSCI, V35, P24, DOI 10.1016/j.tins.2011.06.007; McDonald RJ, 2002, LEARN MOTIV, V33, P230, DOI 10.1006/lmot.2001.1111; Narayanan RT, 2007, EUR J NEUROSCI, V25, P1823, DOI 10.1111/j.1460-9568.2007.05437.x; Pape HC, 2010, PHYSIOL REV, V90, P419, DOI 10.1152/physrev.00037.2009; Pawlyk AC, 2005, BIOL PSYCHIAT, V57, P268, DOI 10.1016/j.biopsych.2004.11.008; Payne JD, 2011, J COGNITIVE NEUROSCI, V23, P1285, DOI 10.1162/jocn.2010.21526; PITMAN RK, 1989, BIOL PSYCHIAT, V26, P221, DOI 10.1016/0006-3223(89)90033-4; Popa D, 2010, P NATL ACAD SCI USA, V107, P6516, DOI 10.1073/pnas.0913016107; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Ruskin DN, 2004, EUR J NEUROSCI, V19, P3121, DOI 10.1111/j.0953-816X.2004.03426.x; Sanford LD, 2003, BEHAV BRAIN RES, V147, P193, DOI 10.1016/S0166-4328(03)00180-3; Sanford LD, 2003, BEHAV GENET, V33, P43, DOI 10.1023/A:1021051516829; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007; Smith Carlyle, 1996, Physiology and Behavior, V59, P93, DOI 10.1016/0031-9384(95)02054-3; Valentinuzzi VS, 2001, ANIM LEARN BEHAV, V29, P133, DOI 10.3758/BF03192822; Vecsey CG, 2009, NATURE, V461, P1122, DOI 10.1038/nature08488; Wagner U, 2006, BIOL PSYCHIAT, V60, P788, DOI 10.1016/j.biopsych.2006.03.061; Walker MP, 2003, LEARN MEMORY, V10, P275, DOI 10.1101/lm.58503; Wang LMC, 2009, ASN NEURO, V1, DOI 10.1042/AN20090020; WITTING W, 1993, BRAIN RES BULL, V30, P157, DOI 10.1016/0361-9230(93)90053-E	52	51	53	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47042	10.1371/journal.pone.0047042	http://dx.doi.org/10.1371/journal.pone.0047042			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082139	gold, Green Published, Green Submitted			2022-12-25	WOS:000311146900034
J	Xie, XB; Yin, JQ; Wen, LL; Gao, ZH; Zou, CY; Wang, J; Huang, G; Tang, QL; Colombo, C; He, WL; Jia, Q; Shen, JN				Xie, Xian-biao; Yin, Jun-qiang; Wen, Li-li; Gao, Zhen-hua; Zou, Chang-ye; Wang, Jin; Huang, Gang; Tang, Qing-lian; Colombo, Chiara; He, Wei-ling; Jia, Qiang; Shen, Jing-nan			Critical Role of Heat Shock Protein 27 in Bufalin-Induced Apoptosis in Human Osteosarcomas: A Proteomic-Based Research	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; HIGH-GRADE OSTEOSARCOMA; AKT ACTIVATION; CYTOCHROME-C; HSP27; LEUKEMIA; LINES; METHOTREXATE; CINOBUFAGIN; INHIBITION	Bufalin is the primary component of the traditional Chinese herb "Chan Su''. Evidence suggests that this compound possesses potent anti-tumor activities, although the exact molecular mechanism(s) is unknown. Our previous study showed that bufalin inhibited growth of human osteosarcoma cell lines U2OS and U2OS/MTX300 in culture. Therefore, this study aims to further clarify the in vitro and in vivo anti-osteosarcoma effects of bufalin and its molecular mechanism of action. We found bufalin inhibited both methotrexate (MTX) sensitive and resistant human osteosarcoma cell growth and induced G2/M arrest and apoptosis. Using a comparative proteomics approach, 24 differentially expressed proteins following bufalin treatment were identified. In particular, the level of an anti-apoptotic protein, heat shock protein 27 (Hsp27), decreased remarkably. The down-regulation of Hsp27 and alterations of its partner signaling molecules (the decrease in p-Akt, nuclear NF-kappa B p65, and co-immunoprecipitated cytochrome c/Hsp27) were validated. Hsp27 over-expression protected against bufalin-induced apoptosis, reversed the dephosphorylation of Akt and preserved the level of nuclear NF-kappa B p65 and co-immunoprecipitated Hsp27/cytochrome c. Moreover, bufalin inhibited MTX-resistant osteosarcoma xenograft growth, and a down-regulation of Hsp27 in vivo was observed. Taken together, bufalin exerted potent anti-osteosarcoma effects in vitro and in vivo, even in MTX resistant osteosarcoma cells. The down-regulation of Hsp27 played a critical role in bufalin-induced apoptosis in osteosarcoma cells. Bufalin may have merit to be a potential chemotherapeutic agent for osteosarcoma, particularly in MTX-resistant groups.	[Jia, Qiang] Guizhou Acad Sci, Inst Biol, Guiyang, Peoples R China; [Xie, Xian-biao; Yin, Jun-qiang; Gao, Zhen-hua; Zou, Chang-ye; Wang, Jin; Huang, Gang; Tang, Qing-lian; He, Wei-ling; Shen, Jing-nan] Sun Yat Sen Univ, Affiliated Hosp 1, Bone & Soft Tissue Tumor Ctr, Guangzhou 510275, Guangdong, Peoples R China; [Wen, Li-li] Sun Yat Sen Univ, Ctr Canc, Dept Anesthesiol, Guangzhou 510275, Guangdong, Peoples R China; [Colombo, Chiara] Ist Nazl Tumori, Dept Surg, I-20133 Milan, Italy	Sun Yat Sen University; Sun Yat Sen University; Fondazione IRCCS Istituto Nazionale Tumori Milan	Jia, Q (corresponding author), Guizhou Acad Sci, Inst Biol, Guiyang, Peoples R China.	ytjq0629_cn@sina.com; shenjingnan@21cn.com	Colombo, Chiara/C-4303-2017	Colombo, Chiara/0000-0001-8031-5528	National Natural Science Foundation of China [30973504, 81102040]; Natural Science Foundation of Guangdong Province [8251008901000019]; Ministry of Science and Technology of Guizhou Province, China [G[2009]4013, NY[2009]3021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Ministry of Science and Technology of Guizhou Province, China	This work was supported by grants from National Natural Science Foundation of China (No 30973504, No 81102040); Natural Science Foundation of Guangdong Province (No 8251008901000019); and the Ministry of Science and Technology of Guizhou Province, China (G[2009]4013 and NY[2009]3021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benini S, 1999, INT J CANCER, V80, P581, DOI 10.1002/(SICI)1097-0215(19990209)80:4<581::AID-IJC16>3.3.CO;2-F; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Bruey JM, 2000, NAT CELL BIOL, V2, P645, DOI 10.1038/35023595; Charette SJ, 2000, MOL CELL BIOL, V20, P7602, DOI 10.1128/MCB.20.20.7602-7612.2000; Chiu PH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031648; Ciocca DR, 2005, CELL STRESS CHAPERON, V10, P86, DOI 10.1379/CSC-99r.1; Concannon CG, 2003, APOPTOSIS, V8, P61, DOI 10.1023/A:1021601103096; Delepine N, 1996, CANCER-AM CANCER SOC, V78, P2127, DOI 10.1002/(SICI)1097-0142(19961115)78:10<2127::AID-CNCR13>3.3.CO;2-Z; Dong YH, 2011, APOPTOSIS, V16, P394, DOI 10.1007/s10495-011-0573-5; Ferguson WS, 2001, CANCER INVEST, V19, P292, DOI 10.1081/CNV-100102557; Gibert B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029719; Guo K, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-100; Guo QC, 2007, ACTA PHARMACOL SIN, V28, P850, DOI 10.1111/j.1745-7254.2007.00603.x; Han KQ, 2007, WORLD J GASTROENTERO, V13, P3374, DOI 10.3748/wjg.v13.i24.3374; Hsu HS, 2011, CANCER-AM CANCER SOC, V117, P1516, DOI 10.1002/cncr.25599; Jiang YT, 2010, CYTOTECHNOLOGY, V62, P573, DOI 10.1007/s10616-010-9310-0; Kawazoe N, 1999, ONCOGENE, V18, P2413, DOI 10.1038/sj.onc.1202555; Krenn L, 1998, PHYTOCHEMISTRY, V48, P1, DOI 10.1016/S0031-9422(97)00426-3; Na L, 2006, CARCINOGENESIS, V27, P1222, DOI 10.1093/carcin/bgi306; Moon A, 2010, PATHOLOGY, V42, P421, DOI 10.3109/00313025.2010.493866; Mumby M, 2007, CELL, V130, P21, DOI 10.1016/j.cell.2007.06.034; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; NUMAZAWA S, 1994, J CELL PHYSIOL, V160, P113, DOI 10.1002/jcp.1041600114; Parcellier A, 2003, MOL CELL BIOL, V23, P5790, DOI 10.1128/MCB.23.16.5790-5802.2003; Paul C, 2002, MOL CELL BIOL, V22, P816, DOI 10.1128/MCB.22.3.816-834.2002; Picci P, 2010, ANN ONCOL, V21, P1366, DOI 10.1093/annonc/mdp502; Qi FH, 2011, CANCER SCI, V102, P951, DOI 10.1111/j.1349-7006.2011.01900.x; Rane MJ, 2003, J BIOL CHEM, V278, P27828, DOI 10.1074/jbc.M303417200; Rho SB, 2011, FEBS LETT, V585, P29, DOI 10.1016/j.febslet.2010.11.014; SERRA M, 1993, ANTICANCER RES, V13, P323; SIROTNAK FM, 1978, CANCER RES, V38, P345; Uozaki H, 2000, PATHOL RES PRACT, V196, P665, DOI 10.1016/S0344-0338(00)80118-1; Watabe M, 1998, ONCOGENE, V16, P779, DOI 10.1038/sj.onc.1201592; Whelan JS, 2011, ANN ONCOL; Xie XB, 2011, CLIN CANCER RES, V17, P5901, DOI 10.1158/1078-0432.CCR-11-0660; Yeh JY, 2003, PROSTATE, V54, P112, DOI 10.1002/pros.10172; Yin JQ, 2007, ACTA PHARMACOL SIN, V28, P712, DOI 10.1111/j.1745-7254.2007.00559.x; Zhang Y, 2007, CLIN CANCER RES, V13, P2855, DOI 10.1158/1078-0432.CCR-06-2090	38	37	43	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47375	10.1371/journal.pone.0047375	http://dx.doi.org/10.1371/journal.pone.0047375			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091618	Green Published, gold, Green Submitted			2022-12-25	WOS:000310135800041
J	del Pino, J; Jimenez, JL; Ventoso, I; Castello, A; Munoz-Fernandez, MA; de Haro, C; Berlanga, JJ				del Pino, Javier; Luis Jimenez, Jose; Ventoso, Ivan; Castello, Alfredo; Angeles Munoz-Fernandez, Ma; de Haro, Cesar; Jose Berlanga, Juan			GCN2 Has Inhibitory Effect on Human Immunodeficiency Virus-1 Protein Synthesis and Is Cleaved upon Viral Infection	PLOS ONE			English	Article							FACTOR 2-ALPHA KINASE; INITIATION-FACTOR 4G; POLY(A)-BINDING PROTEIN; HIV-1 PROTEASE; POLY(A)-DEPENDENT TRANSLATION; DROSOPHILA-MELANOGASTER; EFFICIENT CLEAVAGE; MAMMALIAN-CELLS; BINDING-PROTEIN; GENE-EXPRESSION	The reversible phosphorylation of the alpha-subunit of eukaryotic translation initiation factor 2 (eIF2alpha) is a well-characterized mechanism of translational control in response to a wide variety of cellular stresses, including viral infection. Beside PKR, the eIF2alpha kinase GCN2 participates in the cellular response against viral infection by RNA viruses with central nervous system tropism. PKR has also been involved in the antiviral response against HIV-1, although this antiviral effect is very limited due to the distinct mechanisms evolved by the virus to counteract PKR action. Here we report that infection of human cells with HIV-1 conveys the proteolytic cleavage of GCN2 and that purified HIV-1 and HIV-2 proteases produce direct proteolysis of GCN2 in vitro, abrogating the activation of GCN2 by HIV-1 RNA. Transfection of distinct cell lines with a plasmid encoding an HIV-1 cDNA clone competent for a single round of replication resulted in the activation of GCN2 and the subsequent eIF2alpha phosphorylation. Moreover, transfection of GCN2 knockout cells or cells with low levels of phosphorylated eIF2alpha with the same HIV-1 cDNA clone resulted in a marked increase of HIV-1 protein synthesis. Also, the over-expression of GCN2 in cells led to a diminished viral protein synthesis. These findings suggest that viral RNA produced during HIV-1 infection activates GCN2 leading to inhibition of viral RNA translation, and that HIV-1 protease cleaves GCN2 to overcome its antiviral effect.	[del Pino, Javier; Ventoso, Ivan; Castello, Alfredo; de Haro, Cesar; Jose Berlanga, Juan] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain; [Luis Jimenez, Jose] Hosp Gen Univ Gregorio Maranon, Plataforma Lab, Madrid, Spain; [Angeles Munoz-Fernandez, Ma] Hosp Gen Univ Gregorio Maranon, Lab Mol Immunobiol, Madrid, Spain	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); General University Gregorio Maranon Hospital; General University Gregorio Maranon Hospital	Berlanga, JJ (corresponding author), Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain.	jberlanga@cbm.uam.es	Jiménez, José Luis/AAK-6193-2020; Ventoso, Iván/N-4018-2014; Castello, Alfredo/U-6317-2018; Palomares, Alfredo Castello/K-8062-2019; Berlanga, Juan José/N-1718-2015	Jiménez, José Luis/0000-0001-6187-6223; Ventoso, Iván/0000-0001-7887-3520; Castello, Alfredo/0000-0002-1499-4662; Palomares, Alfredo Castello/0000-0002-1499-4662; Berlanga, Juan José/0000-0002-2408-6561; Munoz-Fernandez/0000-0002-0813-4500	Direccion General de Investigacion Cientifica y Tecnica (DGICYT) [BFU2007-62987, BFU2006-12822]; Fundacion Ramon Areces; Universidad Autonoma de Madrid and the Government of Madrid [PS09-02029, RD06-0006-0035]; Fondo de Investigaciones Sanitarias [PS09-02029, RD06-0006-0035, PI081495]; Ministerio de Ciencia y Tecnologia (Government of Spain); Programa de Investigacion de la Consejeria de Sanidad de la Comunidad de Madrid	Direccion General de Investigacion Cientifica y Tecnica (DGICYT)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces; Universidad Autonoma de Madrid and the Government of Madrid; Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); Ministerio de Ciencia y Tecnologia (Government of Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Programa de Investigacion de la Consejeria de Sanidad de la Comunidad de Madrid	This work was supported in part by grants BFU2007-62987 (to CDH) BFU2006-12822 and BFU2009-09469 (to JJB) from the Direccion General de Investigacion Cientifica y Tecnica (DGICYT), a grant from the Fundacion Ramon Areces (to CDH), a grant from Universidad Autonoma de Madrid and the Government of Madrid (to JJB), grants PS09-02029 and RD06-0006-0035 (to MAM-F) and PI081495 (to JLJ) from Fondo de Investigaciones Sanitarias, and an institutional grant from the Fundacion Ramon Areces to the Centro de Biologia Molecular Severo Ochoa. JDP was supported by a Ph.D. fellowship from the Ministerio de Ciencia y Tecnologia (Government of Spain). JLJ is supported by Programa de Investigacion de la Consejeria de Sanidad de la Comunidad de Madrid. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDABE R, 1995, BIOCHEM BIOPH RES CO, V215, P928, DOI 10.1006/bbrc.1995.2553; Alvarez E, 2006, BIOCHEM J, V396, P219, DOI 10.1042/BJ20060108; Alvarez E, 2003, J VIROL, V77, P12392, DOI 10.1128/JVI.77.23.12392-12400.2003; Balvay L, 2007, NAT REV MICROBIOL, V5, P128, DOI 10.1038/nrmicro1599; Benkirane M, 1997, EMBO J, V16, P611, DOI 10.1093/emboj/16.3.611; Berlanga JJ, 1998, J BIOL CHEM, V273, P32340, DOI 10.1074/jbc.273.48.32340; Berlanga JJ, 1999, EUR J BIOCHEM, V265, P754, DOI 10.1046/j.1432-1327.1999.00780.x; Berlanga JJ, 2006, EMBO J, V25, P1730, DOI 10.1038/sj.emboj.7601073; Castello A, 2006, J MOL BIOL, V355, P942, DOI 10.1016/j.jmb.2005.11.024; Castello A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007997; CHEN JJ, 1995, TRENDS BIOCHEM SCI, V20, P105, DOI 10.1016/S0968-0004(00)88975-6; Chonco L, 2012, J CONTROL RELEASE, V161, P949, DOI 10.1016/j.jconrel.2012.04.050; Clerzius G, 2011, REV MED VIROL, V21, P42, DOI 10.1002/rmv.674; Clerzius G, 2009, J VIROL, V83, P10119, DOI 10.1128/JVI.02457-08; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; deHaro C, 1996, FASEB J, V10, P1378, DOI 10.1096/fasebj.10.12.8903508; Deng J, 2002, CURR BIOL, V12, P1279, DOI 10.1016/S0960-9822(02)01037-0; ELROYSTEIN O, 1989, P NATL ACAD SCI USA, V86, P6126, DOI 10.1073/pnas.86.16.6126; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Garcia-Merino I, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-27; Gelinas JF, 2011, J VIROL, V85, P8460, DOI 10.1128/JVI.00240-11; Gordon-Alonso M, 2012, J IMMUNOL, V189, P689, DOI 10.4049/jimmunol.1103708; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Hinnebusch AG, 1997, J BIOL CHEM, V272, P21661, DOI 10.1074/jbc.272.35.21661; Imataka H, 1998, EMBO J, V17, P7480, DOI 10.1093/emboj/17.24.7480; Joachims M, 1999, J VIROL, V73, P718, DOI 10.1128/JVI.73.1.718-727.1999; Khaleghpour K, 2001, MOL CELL BIOL, V21, P5200, DOI 10.1128/MCB.21.15.5200-5213.2001; Kuyumcu-Martinez NM, 2002, J VIROL, V76, P2062, DOI 10.1128/JVI.76.5.2062-2074.2002; Li XH, 2010, MOL CELL BIOCHEM, V339, P127, DOI 10.1007/s11010-009-0376-y; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MAITRA RK, 1994, VIROLOGY, V204, P823, DOI 10.1006/viro.1994.1601; Ohlmann T, 2002, J MOL BIOL, V318, P9, DOI 10.1016/S0022-2836(02)00070-0; Perez MAS, 2010, J PHYS CHEM B, V114, P2525, DOI 10.1021/jp910958u; Pomar N, 2003, EUR J BIOCHEM, V270, P293, DOI 10.1046/j.1432-1033.2003.03383.x; Prevot D, 2003, BIOL CELL, V95, P141, DOI 10.1016/S0248-4900(03)00031-5; PROUD CG, 1995, TRENDS BIOCHEM SCI, V20, P241, DOI 10.1016/S0968-0004(00)89025-8; RATNER L, 1985, NATURE, V313, P277, DOI 10.1038/313277a0; RITTENHOUSE J, 1990, BIOCHEM BIOPH RES CO, V171, P60, DOI 10.1016/0006-291X(90)91356-W; Santoyo J, 1997, J BIOL CHEM, V272, P12544, DOI 10.1074/jbc.272.19.12544; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Ventoso I, 2001, P NATL ACAD SCI USA, V98, P12966, DOI 10.1073/pnas.231343498; Ventoso I, 2010, J VIROL, V84, P5043, DOI 10.1128/JVI.02188-09; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Zhan K, 2002, MOL CELL BIOL, V22, P7134, DOI 10.1128/MCB.22.20.7134-7146.2002	49	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47272	10.1371/journal.pone.0047272	http://dx.doi.org/10.1371/journal.pone.0047272			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110064	Green Accepted, Green Published, Green Submitted, gold			2022-12-25	WOS:000310193600011
J	Qiu, YF; Davis, MJ; Dayrit, JK; Hadd, Z; Meister, DL; Osterholzer, JJ; Williamson, PR; Olszewski, MA				Qiu, Yafeng; Davis, Michael J.; Dayrit, Jeremy K.; Hadd, Zachary; Meister, Daniel L.; Osterholzer, John J.; Williamson, Peter R.; Olszewski, Michal A.			Immune Modulation Mediated by Cryptococcal Laccase Promotes Pulmonary Growth and Brain Dissemination of Virulent Cryptococcus neoformans in Mice	PLOS ONE			English	Article							INTERFERON-GAMMA; MACROPHAGE ACTIVATION; HOST-RESISTANCE; AFFERENT PHASE; T-CELLS; INFECTION; INTERLEUKIN-4; INFLAMMATION; EXPRESSION; CD4(+)	C. neoformans is a leading cause of fatal mycosis linked to CNS dissemination. Laccase, encoded by the LAC1 gene, is an important virulence factor implicated in brain dissemination yet little is known about the mechanism(s) accounting for this observation. Here, we investigated whether the presence or absence of laccase altered the local immune response in the lungs by comparing infections with the highly virulent strain, H99 (which expresses laccase) and mutant strain of H99 deficient in laccase (lac1 Delta) in a mouse model of pulmonary infection. We found that LAC1 gene deletion decreased the pulmonary fungal burden and abolished CNS dissemination at weeks 2 and 3. Furthermore, LAC1 deletion lead to: 1) diminished pulmonary eosinophilia; 2) increased accumulation of CD4+ and CD8+ T cells; 3) increased Th1 and Th17 cytokines yet decreased Th2 cytokines; and 4) lung macrophage shifting of the lung macrophage phenotype from M2-towards M1-type activation. Next, we used adoptively transferred CD4+ T cells isolated from pulmonary lymph nodes of mice infected with either lac1 Delta or H99 to evaluate the role of laccase-induced immunomodulation on CNS dissemination. We found that in comparison to PBS treated mice, adoptively transferred CD4+ T cells isolated from lac1 Delta-infected mice decreased CNS dissemination, while those isolated from H99-infected mice increased CNS dissemination. Collectively, our findings reveal that immune modulation away from Th1/Th17 responses and towards Th2 responses represents a novel mechanism through which laccase can contribute to cryptococcal virulence. Furthermore, our data support the hypothesis that laccase-induced changes in polarization of CD4+ T cells contribute to CNS dissemination.	[Qiu, Yafeng; Davis, Michael J.; Dayrit, Jeremy K.; Osterholzer, John J.; Olszewski, Michal A.] Vet Adm Ann Arbor Hlth Syst, Res Serv, Ann Arbor, MI USA; [Qiu, Yafeng; Davis, Michael J.; Dayrit, Jeremy K.; Hadd, Zachary; Meister, Daniel L.; Osterholzer, John J.; Olszewski, Michal A.] Univ Michigan, Sch Med, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI USA; [Williamson, Peter R.] NIAID, Lab Clin Infect Dis, NIH, Bethesda, MD 20892 USA; [Williamson, Peter R.] Univ Illinois, Coll Med, Sect Infect Dis Immunol & Int Med, Chicago, IL USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; University of Michigan System; University of Michigan; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Olszewski, MA (corresponding author), Vet Adm Ann Arbor Hlth Syst, Res Serv, Ann Arbor, MI USA.	olszewsm@umich.edu		OLSZEWSKI, MICHAL/0000-0001-7474-0843; Davis, Michael/0000-0002-3970-2208	VA [1I01BX000656-01A1]; VA CDA-2; Multidisciplinary Training Program in Pulmonary Diseases [PHS T32-HL07749-19]; Intramural Research Program of the NIH, NIAID; Undergraduate Research Opportunity Program at the University of Michigan; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007749] Funding Source: NIH RePORTER	VA(US Department of Veterans Affairs); VA CDA-2; Multidisciplinary Training Program in Pulmonary Diseases; Intramural Research Program of the NIH, NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Undergraduate Research Opportunity Program at the University of Michigan(University of Michigan System); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This Research has been supported by VA Merit Review funding (1I01BX000656-01A1, MAO), VA CDA-2 funding (JJO), and the Multidisciplinary Training Program in Pulmonary Diseases (MJD, PHS T32-HL07749-19). This research was also supported, in part, by the Intramural Research Program of the NIH, NIAID (PRW). Undergraduate Research Opportunity Program at the University of Michigan supported undergraduate students (DLM, ZH) during their work in the authors' laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alanio A, 2011, MBIO, V2, DOI 10.1128/mBio.00158-11; Arora S, 2005, J IMMUNOL, V174, P6346, DOI 10.4049/jimmunol.174.10.6346; Arora S, 2011, INFECT IMMUN, V79, P1915, DOI 10.1128/IAI.01270-10; Blackstock R, 2004, AM J RESP CELL MOL, V30, P109, DOI 10.1165/rcmb.2003-0156OC; Blackstock R, 1999, MYCOPATHOLOGIA, V147, P1, DOI 10.1023/A:1007041401743; Buchanan KL, 2000, INFECT IMMUN, V68, P456, DOI 10.1128/IAI.68.2.456-462.2000; Chen GH, 2008, INFECT IMMUN, V76, P2379, DOI 10.1128/IAI.01143-07; CHUCK SL, 1989, NEW ENGL J MED, V321, P794, DOI 10.1056/NEJM198909213211205; Classen Andrea, 2009, V531, P29, DOI 10.1007/978-1-59745-396-7_3; Eisenman HC, 2007, MICROBIOL-SGM, V153, P3954, DOI 10.1099/mic.0.2007/011049-0; Erb-Downward JR, 2008, MOL MICROBIOL, V68, P1428, DOI 10.1111/j.1365-2958.2008.06245.x; Erb-Downward JR, 2007, EUKARYOT CELL, V6, P346, DOI 10.1128/EC.00336-06; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hardison SE, 2010, AM J PATHOL, V176, P774, DOI 10.2353/ajpath.2010.090634; Hofford JM, 1996, J LAB CLIN MED, V128, P545, DOI 10.1016/S0022-2143(96)90126-2; Huffnagle GB, 1996, J IMMUNOL, V157, P4529; HUFFNAGLE GB, 1995, J IMMUNOL, V155, P3507; HUFFNAGLE GB, 1994, J LEUKOCYTE BIOL, V55, P35, DOI 10.1002/jlb.55.1.35; HUFFNAGLE GB, 1991, INFECT IMMUN, V59, P1423, DOI 10.1128/IAI.59.4.1423-1433.1991; HUFFNAGLE GB, 1991, J EXP MED, V173, P793, DOI 10.1084/jem.173.4.793; Jain AV, 2009, INFECT IMMUN, V77, P5389, DOI 10.1128/IAI.00809-09; Jarvis JN, 2007, AIDS, V21, P2119, DOI 10.1097/QAD.0b013e3282a4a64d; Kawakami K, 1996, FEMS IMMUNOL MED MIC, V13, P123, DOI 10.1016/0928-8244(95)00093-3; Kawakami K, 1999, CELL IMMUNOL, V197, P55, DOI 10.1006/cimm.1999.1557; Kleinschek MA, 2006, J IMMUNOL, V176, P1098, DOI 10.4049/jimmunol.176.2.1098; Kronstad JW, 2011, NAT REV MICROBIOL, V9, P193, DOI 10.1038/nrmicro2522; Liu L, 1999, INFECT IMMUN, V67, P6034, DOI 10.1128/IAI.67.11.6034-6039.1999; MODY CH, 1993, J LAB CLIN MED, V121, P765; Muller U, 2007, J IMMUNOL, V179, P5367, DOI 10.4049/jimmunol.179.8.5367; Noverr MC, 2004, INFECT IMMUN, V72, P1693, DOI 10.1128/IAI.72.3.1693-1699.2004; Noverr MC, 2003, INFECT IMMUN, V71, P1538, DOI 10.1128/IAI.71.3.1538-1547.2003; Olszewski MA, 2000, J IMMUNOL, V165, P6429, DOI 10.4049/jimmunol.165.11.6429; Olszewski MA, 2001, INFECT IMMUN, V69, P6256, DOI 10.1128/IAI.69.10.6256-6263.2001; Olszewski MA, 2010, FUTURE MICROBIOL, V5, P1269, DOI [10.2217/fmb.10.93, 10.2217/FMB.10.93]; Osterholzer JJ, 2009, AM J PATHOL, V174, P932, DOI 10.2353/ajpath.2009.080673; Panepinto JC, 2006, FEMS YEAST RES, V6, P489, DOI 10.1111/j.1567-1364.2006.00078.x; Pappas PG, 2001, CLIN INFECT DIS, V33, P690, DOI 10.1086/322597; Pukkila-Worley R, 2005, EUKARYOT CELL, V4, P190, DOI 10.1128/EC.4.1.190-201.2005; Salas SD, 1996, J EXP MED, V184, P377, DOI 10.1084/jem.184.2.377; Shreiner AB, 2012, INFECT IMMUN, V80, P388, DOI 10.1128/IAI.05530-11; Traynor TR, 2000, J IMMUNOL, V164, P2021, DOI 10.4049/jimmunol.164.4.2021; Valdez PA, 2012, IMMUNITY, V36, P668, DOI 10.1016/j.immuni.2012.02.013; Wormley FL, 2007, INFECT IMMUN, V75, P1453, DOI 10.1128/IAI.00274-06; Wozniak KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017204; Zhang YM, 2009, AM J PATHOL, V175, P2489, DOI 10.2353/ajpath.2009.090530	45	53	55	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e47853	10.1371/journal.pone.0047853	http://dx.doi.org/10.1371/journal.pone.0047853			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110112	Green Published, gold, Green Submitted			2022-12-25	WOS:000310193400020
J	Matulova, M; Rajova, J; Vlasatikova, L; Volf, J; Stepanova, H; Havlickova, H; Sisak, F; Rychlik, I				Matulova, Marta; Rajova, Jana; Vlasatikova, Lenka; Volf, Jiri; Stepanova, Hana; Havlickova, Hana; Sisak, Frantisek; Rychlik, Ivan			Characterization of Chicken Spleen Transcriptome after Infection with Salmonella enterica Serovar Enteritidis	PLOS ONE			English	Article							SUPEROXIDE-DISMUTASE PLAYS; IMMUNE-RESPONSE; CELL-SURFACE; EXPRESSION; TYPHIMURIUM; LIPOCALIN; RECEPTOR; AVIDIN; GENE; MACROPHAGES	In this study we were interested in identification of new markers of chicken response to Salmonella Enteritidis infection. To reach this aim, gene expression in the spleens of naive chickens and those intravenously infected with S. Enteritidis with or without previous oral vaccination was determined by 454 pyrosequencing of splenic mRNA/cDNA. Forty genes with increased expression at the level of transcription were identified. The most inducible genes encoded avidin (AVD), extracellular fatty acid binding protein (EXFABP), immune responsive gene 1 (IRG1), chemokine ah221 (AH221), trappin-6-like protein (TRAP6) and serum amyloid A (SAA). Using cDNA from sorted splenic B-lymphocytes, macrophages, CD4, CD8 and gamma delta T-lymphocytes, we found that the above mentioned genes were preferentially expressed in macrophages. AVD, EXFABP, IRG1, AH221, TRAP6 and SAA were induced also in the cecum of chickens orally infected with S. Enteritidis on day 1 of life or day 42 of life. Unusual results were obtained for the immunoglobulin encoding transcripts. Prior to the infection, transcripts coding for the constant parts of IgM, IgY, IgA and Ig light chain were detected in B-lymphocytes. However, after the infection, immunoglobulin encoding transcripts were expressed also by T-lymphocytes and macrophages. Expression of AVD, EXFABP, IRG1, AH221, TRAP6, SAA and all immunoglobulin genes can be therefore used for the characterization of the course of S. Enteritidis infection in chickens.	[Matulova, Marta; Rajova, Jana; Vlasatikova, Lenka; Volf, Jiri; Stepanova, Hana; Havlickova, Hana; Sisak, Frantisek; Rychlik, Ivan] Vet Res Inst, CS-62132 Brno, Czech Republic	Czech Veterinary Research Institute	Rychlik, I (corresponding author), Vet Res Inst, CS-62132 Brno, Czech Republic.	rychlik@vri.cz	Štěpánová, Hana/GPG-3735-2022; , Ivan/GPS-9674-2022	, Ivan/0000-0001-7995-6483	Czech Ministry of Agriculture [MZE0002716202]; Czech Ministry of Education [CZ.1.05/2.1.00/01.0006-ED0006/01/01]; Czech Science Foundation [P502/12/0303]	Czech Ministry of Agriculture(Ministry of Agriculture, Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic)	This work has been supported by the project MZE0002716202 of the Czech Ministry of Agriculture, AdmireVet project CZ.1.05/2.1.00/01.0006-ED0006/01/01 from the Czech Ministry of Education and Czech Science Foundation project P502/12/0303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basler T, 2006, J LEUKOCYTE BIOL, V79, P628, DOI 10.1189/jlb.0905520; Beal RK, 2006, INFECT IMMUN, V74, P1442, DOI 10.1128/IAI.74.2.1442-1444.2006; Beal RK, 2004, VET IMMUNOL IMMUNOP, V100, P151, DOI 10.1016/j.vetimm.2004.04.005; Beal RK, 2004, AVIAN PATHOL, V33, P25, DOI 10.1080/03079450310001636282; Berndt A, 2007, INFECT IMMUN, V75, P5993, DOI 10.1128/IAI.00695-07; Boes M, 1998, J EXP MED, V188, P2381, DOI 10.1084/jem.188.12.2381; Campbell EJ, 2000, J IMMUNOL, V165, P3366, DOI 10.4049/jimmunol.165.6.3366; Cancedda FD, 1996, J BIOL CHEM, V271, P20163, DOI 10.1074/jbc.271.33.20163; Cancedda FD, 2002, MOL CELL BIOCHEM, V239, P221, DOI 10.1023/A:1020548118241; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; COOK GP, 1995, INT IMMUNOL, V7, P89, DOI 10.1093/intimm/7.1.89; Correnti C, 2011, STRUCTURE, V19, P1796, DOI 10.1016/j.str.2011.09.019; Coudevylle N, 2011, BIOCHEMISTRY-US, V50, P9192, DOI 10.1021/bi201115q; Coudevylle N, 2010, J BIOL CHEM, V285, P41646, DOI 10.1074/jbc.M110.123331; Crhanova M, 2011, INFECT IMMUN, V79, P2755, DOI 10.1128/IAI.01375-10; Di Marco E, 2003, J CELL PHYSIOL, V196, P464, DOI 10.1002/jcp.10310; Divanovic S, 2005, NAT IMMUNOL, V6, P571, DOI 10.1038/ni1198; DOZIN B, 1992, J BIOL CHEM, V267, P2979; ELO HA, 1980, EXPERIENTIA, V36, P312, DOI 10.1007/BF01952296; Furutani Y, 1998, J BIOCHEM-TOKYO, V124, P491, DOI 10.1093/oxfordjournals.jbchem.a022140; Gruys E, 2005, J Zhejiang Univ Sci B, V6, P1045, DOI 10.1631/jzus.2005.B1045; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; KEMP DJ, 1980, P NATL ACAD SCI-BIOL, V77, P2876, DOI 10.1073/pnas.77.5.2876; KORPELA J, 1984, EUR J CELL BIOL, V33, P105; Marikovsky M, 2003, J IMMUNOL, V170, P2993, DOI 10.4049/jimmunol.170.6.2993; Marikovsky M, 2002, INT J CANCER, V97, P34, DOI 10.1002/ijc.1565; Matulova M, 2012, VACCINE, V30, P2090, DOI 10.1016/j.vaccine.2012.01.050; Matulova M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032346; Miura Y, 1998, BLOOD, V92, P2815, DOI 10.1182/blood.V92.8.2815.420k09_2815_2822; Nagai Y, 2002, BLOOD, V99, P1699, DOI 10.1182/blood.V99.5.1699; Ogata H, 2000, J EXP MED, V192, P23, DOI 10.1084/jem.192.1.23; Owen CA, 1999, J LEUKOCYTE BIOL, V65, P137, DOI 10.1002/jlb.65.2.137; Pasare C, 1999, EUR J IMMUNOL, V29, P1219, DOI 10.1002/(SICI)1521-4141(199904)29:04&lt;1219::AID-IMMU1219&gt;3.0.CO;2-H; Raffatellu M, 2009, CELL HOST MICROBE, V5, P476, DOI 10.1016/j.chom.2009.03.011; Rozen S, 2000, Methods Mol Biol, V132, P365; Shi SP, 2005, J IMMUNOL, V175, P3318, DOI 10.4049/jimmunol.175.5.3318; STAVNEZER J, 1986, J IMMUNOL, V137, P3978; Tremblay GM, 2002, CHEST, V121, P582, DOI 10.1378/chest.121.2.582; Zerega B, 2004, MATRIX BIOL, V23, P35, DOI 10.1016/j.matbio.2004.02.002; Zerega B, 2001, J CELL SCI, V114, P1473	40	58	60	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e48101	10.1371/journal.pone.0048101	http://dx.doi.org/10.1371/journal.pone.0048101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094107	Green Published, Green Submitted, gold			2022-12-25	WOS:000310050200059
J	Zhou, WZ; Quah, ST; Verma, CS; Liu, Y; Lane, DP; Brown, CJ				Zhou, Weizhuang; Quah, Soo T.; Verma, Chandra S.; Liu, Yun; Lane, David P.; Brown, Christopher J.			Improved eIF4E Binding Peptides by Phage Display Guided Design: Plasticity of Interacting Surfaces Yield Collective Effects	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; AMINO-ACIDS; CAP; INITIATION; CANCER; CRYSTALLOGRAPHY; REFINEMENT; EXPRESSION; PROTEINS	Eukaryotic initiation factor (eIF)4E is over-expressed in many types of cancer such as breast, head and neck, and lung. A consequence of increased levels of eIF4E is the preferential translation of pro-tumorigenic proteins (e.g. c-Myc and vascular endothelial growth factor) and as a result is regarded as a potential therapeutic target. In this work a novel phage display peptide has been isolated against eIF4E. From the phage sequence two amino acids were delineated which improved binding when substituted into the eIF4G1 sequence. Neither of these substitutions were involved in direct interactions with eIF4E and acted either via optimization of the helical capping motif or restricting the conformational flexibility of the peptide. In contrast, substitutions of the remaining phage derived amino acids into the eIF4G1 sequence disrupted binding of the peptide to eIF4E. Interestingly when some of these disruptive substitutions were combined with key mutations from the phage peptide, they lead to improved affinities. Atomistic computer simulations revealed that the phage and the eIF4G1 derivative peptide sequences differ subtly in their interaction sites on eIF4E. This raises the issue, especially in the context of planar interaction sites such as those exhibited by eIF4E, that given the intricate plasticity of protein surfaces, the construction of structure-activity relationships should account for the possibility of significant movement in the spatial positioning of the peptide binding interface, including significant librational motions of the peptide.	[Zhou, Weizhuang; Verma, Chandra S.; Liu, Yun] ASTAR, Bioinformat Inst, Singapore, Singapore; [Quah, Soo T.; Lane, David P.; Brown, Christopher J.] ASTAR, Lab P53, Singapore, Singapore; [Verma, Chandra S.] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore; [Verma, Chandra S.] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Agency for Science Technology & Research (A*STAR); National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Verma, CS (corresponding author), ASTAR, Bioinformat Inst, Singapore, Singapore.	chandra@bii.a-star.edu.sg; cjbrown@p53lab.a-star.edu.sg		Liu, Yun/0000-0003-4079-8275; Zhou, Weizhuang/0000-0003-4228-8201; Lane, David/0000-0003-0551-3545				Blagden SP, 2011, NAT REV CLIN ONCOL, V8, P280, DOI 10.1038/nrclinonc.2011.16; Bolhassani A, 2011, BBA-REV CANCER, V1816, P232, DOI 10.1016/j.bbcan.2011.07.006; Brown CJ, 2011, J MOL BIOL, V405, P736, DOI 10.1016/j.jmb.2010.10.045; Brown CJ, 2009, CELL CYCLE, V8, P1905, DOI 10.4161/cc.8.12.8742; Case D. A., 2010, AMBERTOOLS15 AMBER; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Daniels TR, 2011, BIOCH BIOPHYS ACTA; Dastidar SG, 2008, J AM CHEM SOC, V130, P13514, DOI 10.1021/ja804289g; Doig AJ, 1997, PROTEIN SCI, V6, P147; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Graff JR, 2007, J CLIN INVEST, V117, P2638, DOI 10.1172/JCI32044; Graff JR, 2003, CLIN EXP METASTAS, V20, P265, DOI 10.1023/A:1022943419011; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kentsis A, 2004, P NATL ACAD SCI USA, V101, P18105, DOI 10.1073/pnas.0406927102; Kim YW, 2011, NAT PROTOC, V6, P761, DOI 10.1038/nprot.2011.324; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Macias AT, 2005, J COMPUT CHEM, V26, P1452, DOI 10.1002/jcc.20281; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Montanaro L, 2004, CELL CYCLE, V3, P1387, DOI 10.4161/cc.3.11.1251; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Schroeder A, 2012, NAT REV CANCER, V12, P39, DOI 10.1038/nrc3180; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sillerud LO, 2005, CURR PROTEIN PEPT SC, V6, P151, DOI 10.2174/1389203053545462; Topisirovic I, 2011, WIRES RNA, V2, P277, DOI 10.1002/wrna.52; Verdine GL, 2007, CLIN CANCER RES, V13, P7264, DOI 10.1158/1078-0432.CCR-07-2184; Worth CL, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-161	31	19	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47235	10.1371/journal.pone.0047235	http://dx.doi.org/10.1371/journal.pone.0047235			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094039	Green Published, gold			2022-12-25	WOS:000310050200018
J	Faget, DV; Lucena, PI; Robbs, BK; Viola, JPB				Faget, Douglas V.; Lucena, Pedro I.; Robbs, Bruno K.; Viola, Joao P. B.			NFAT1 C-Terminal Domains Are Necessary but Not Sufficient for Inducing Cell Death	PLOS ONE			English	Article							ACTIVATED T-CELLS; TRANSCRIPTION FACTOR NFATP; ATP-DEFICIENT MICE; NUCLEAR FACTOR; GENE-EXPRESSION; NF-ATC; PROTEINS; FAMILY; REGION; APOPTOSIS	The proteins belonging to the nuclear factor of activated T cells (NFAT) family of transcription factors are expressed in several cell types and regulate genes involved in differentiation, cell cycle and apoptosis. NFAT proteins share two conserved domains, the NFAT-homology region (NHR) and a DNA-binding domain (DBD). The N- and C-termini display two transactivation domains (TAD-N and TAD-C) that have low sequence similarity. Due to the high sequence conservation in the NHR and DBD, NFAT members have some overlapping roles in gene regulation. However, several studies have shown distinct roles for NFAT proteins in the regulation of cell death. The TAD-C shows low sequence similarity among NFAT family members, but its contribution to specific NFAT1-induced phenotypes is poorly understood. Here, we described at least two regions of NFAT1 TAD-C that confer pro-apoptotic activity to NFAT1. These regions extend from amino acids 699 to 734 and 819 to 850 of NFAT1. We also showed that the NFAT1 TAD-C is unable to induce apoptosis by itself and requires a functional DBD. Furthermore, we showed that when fused to NFAT1 TAD-C, NFAT2, which is associated with cell transformation, induces apoptosis in fibroblasts. Together, these results suggest that the NFAT1 TAD-C includes NFAT death domains that confer to different NFAT members the ability to induce apoptosis.	[Faget, Douglas V.; Lucena, Pedro I.; Robbs, Bruno K.; Viola, Joao P. B.] Brazilian Natl Canc Inst INCA, Program Cellular Biol, Rio De Janeiro, Brazil	National Cancer Institute (Inca)	Viola, JPB (corresponding author), Brazilian Natl Canc Inst INCA, Program Cellular Biol, Rio De Janeiro, Brazil.	jpviola@inca.gov.br	Robbs, Bruno/H-5553-2013; Viola, Joao P.B./AAP-4125-2020	Viola, Joao P.B./0000-0002-0698-3146; Robbs, Bruno Kaufmann/0000-0002-3972-5530; Faget, Douglas/0000-0002-2452-0962	International Centre for Genetic Engineering and Biotechnology [CRP/BRA09-01]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [478780/2010-9]; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro [102.357/2009]; Instituto Nacional de Ciencia e Tecnologia em Cancer [573806/2008-0, 170.026/2008]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro	International Centre for Genetic Engineering and Biotechnology; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Instituto Nacional de Ciencia e Tecnologia em Cancer; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants to J.P.B.V. from the International Centre for Genetic Engineering and Biotechnology (CRP/BRA09-01), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (478780/2010-9), Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (102.357/2009) and Instituto Nacional de Ciencia e Tecnologia em Cancer (573806/2008-0 and 170.026/2008). D. V. F. and B. K. R. were supported by a fellowship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior and P.I.L. was supported by a fellowship from the Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baksh S, 2002, MOL CELL, V10, P1071, DOI 10.1016/S1097-2765(02)00701-3; Caetano MS, 2002, FASEB J, V16, P1940, DOI 10.1096/fj.02-0282fje; Carneiro FRG, 2011, MOL CELL BIOL, V31, P2889, DOI 10.1128/MCB.00974-10; Carvalho LDS, 2007, CELL CYCLE, V6, P1789, DOI 10.4161/cc.6.14.4473; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; ETTINGER R, 1995, J IMMUNOL, V154, P4302; Garcia-Rodriguez C, 1998, J EXP MED, V187, P2031, DOI 10.1084/jem.187.12.2031; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HO AM, 1994, J BIOL CHEM, V269, P28181; Hodge MR, 1996, IMMUNITY, V4, P397, DOI 10.1016/S1074-7613(00)80253-8; HOEY T, 1995, IMMUNITY, V2, P461, DOI 10.1016/1074-7613(95)90027-6; Holtz-Heppelmann CJ, 1998, J BIOL CHEM, V273, P4416, DOI 10.1074/jbc.273.8.4416; Horsley V, 2002, J CELL BIOL, V156, P771, DOI 10.1083/jcb.200111073; JAIN JN, 1995, J BIOL CHEM, V270, P4138, DOI 10.1074/jbc.270.8.4138; Kaminuma O, 2008, J IMMUNOL, V180, P319, DOI 10.4049/jimmunol.180.1.319; Latinis KM, 1997, J BIOL CHEM, V272, P31427, DOI 10.1074/jbc.272.50.31427; Lin BZ, 2004, CELL, V116, P527, DOI 10.1016/S0092-8674(04)00162-X; LIU ZG, 1994, NATURE, V367, P281, DOI 10.1038/367281a0; Luo C, 1996, J EXP MED, V184, P141, DOI 10.1084/jem.184.1.141; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Mancini M, 2009, NAT REV CANCER, V9, P810, DOI 10.1038/nrc2735; Mariani SM, 1998, EUR J IMMUNOL, V28, P1492, DOI 10.1002/(SICI)1521-4141(199805)28:05<1492::AID-IMMU1492>3.0.CO;2-X; MCCAFFREY PG, 1994, J BIOL CHEM, V269, P30445; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; Neal JW, 2003, J BIOL CHEM, V278, P17246, DOI 10.1074/jbc.M300528200; Nguyen TN, 2010, MOL IMMUNOL, V47, P2314, DOI 10.1016/j.molimm.2010.05.287; Okamura H, 2000, MOL CELL, V6, P539, DOI 10.1016/S1097-2765(00)00053-8; Park JC, 1996, J BIOL CHEM, V271, P20914, DOI 10.1074/jbc.271.34.20914; Ranger AM, 2000, J EXP MED, V191, P9, DOI 10.1084/jem.191.1.9; Ranger AM, 1998, IMMUNITY, V8, P125, DOI 10.1016/S1074-7613(00)80465-3; Ranger AM, 1998, NATURE, V392, P186, DOI 10.1038/32426; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Robbs BK, 2008, MOL CELL BIOL, V28, P7168, DOI 10.1128/MCB.00256-08; Schuh K, 1998, EUR J IMMUNOL, V28, P2456, DOI 10.1002/(SICI)1521-4141(199808)28:08<2456::AID-IMMU2456>3.0.CO;2-9; TAMM I, 1991, J CELL PHYSIOL, V148, P85, DOI 10.1002/jcp.1041480111; Teixeira LK, 2005, J IMMUNOL, V175, P5931, DOI 10.4049/jimmunol.175.9.5931; Wang DZ, 1995, ANN NY ACAD SCI, V766, P182, DOI 10.1111/j.1749-6632.1995.tb26661.x; Wang QD, 2000, BIOCHEM BIOPH RES CO, V276, P466, DOI 10.1006/bbrc.2000.3512; Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892; Yang H, 2010, BIOCHEM PHARMACOL, V79, P948, DOI 10.1016/j.bcp.2009.11.004; Youn HD, 2000, EMBO J, V19, P4323, DOI 10.1093/emboj/19.16.4323; Yu H, 2007, CANCER BIOL THER, V6, P405, DOI 10.4161/cbt.6.3.3755	43	11	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47868	10.1371/journal.pone.0047868	http://dx.doi.org/10.1371/journal.pone.0047868			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110116	Green Submitted, Green Published, gold			2022-12-25	WOS:000310262500024
J	Lee, AY; Gregorius, J; Kerlan, RK; Gordon, RL; Fidelman, N				Lee, Andrew Y.; Gregorius, John; Kerlan, Robert K., Jr.; Gordon, Roy L.; Fidelman, Nicholas			Percutaneous Transhepatic Balloon Dilation of Biliary-Enteric Anastomotic Strictures after Surgical Repair of Iatrogenic Bile Duct Injuries	PLOS ONE			English	Article							LAPAROSCOPIC CHOLECYSTECTOMY; MANAGEMENT; HEPATICOJEJUNOSTOMY; EXPERIENCE; SURVIVAL; SURGERY	Purpose: To evaluate the efficacy of percutaneous balloon dilation of biliary-enteric anastomotic strictures resulting from surgical repair of laparoscopic cholecystectomy-related bile duct injuries. Material and Methods: A total of 61 patients were referred to our institution from 1995 to 2010 for treatment of obstruction at the biliary-enteric anastomosis following surgical repair of laparoscopic cholecystectomy-related bile duct injuries. Of these 61 patients, 27 underwent surgical revision upon stricture diagnosis, and 34 patients were managed using balloon dilation. Of these 34 patients, 2 were lost to follow up, leaving 32 patients for analysis. The primary study objective was to determine the clinical success rate of balloon dilation of biliary-enteric anastomotic strictures. Secondary study objectives included determining anastomosis patency, rates of stricture recurrence following treatment, and morbidity. Results: Balloon dilation of biliary-enteric anastomotic strictures was clinically successful in 21 of 32 patients (66%). Anastomotic stricture recurred in one of 21 patients (5%) after an average of 13.1 years of follow-up. Patients who were unsuccessfully managed with balloon dilation required significantly more invasive procedures (6.8 v. 3.4; p = 0.02) and were left with an indwelling biliary catheter for a significantly longer period of time (8.8 v. 2.0 months; p = 0.02) than patients whose strictures could be resolved by balloon dilation. No significant differences in the number of balloon dilations performed (p = 0.17) or in the maximum balloon diameter used (p = 0.99) were demonstrated for patients with successful or unsuccessful balloon dilation outcomes. Conclusion: Percutaneous balloon dilation of anastomotic biliary strictures following surgical repair of laparoscopic cholecystectomy-related injuries may result in lasting patency of the biliary-enteric anastomosis.	[Lee, Andrew Y.; Gregorius, John; Kerlan, Robert K., Jr.; Gordon, Roy L.; Fidelman, Nicholas] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Fidelman, N (corresponding author), Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94143 USA.	Nicholas.Fidelman@ucsf.edu	Lee, Andrew/GVU-2817-2022					Archer SB, 2001, ANN SURG, V234, P549, DOI 10.1097/00000658-200110000-00014; BISMUTH H, 1982, BILIARY TRACT, V5, P209; Chaudhary A, 2002, DIGEST SURG, V19, P22, DOI 10.1159/000052001; DAVIDS PHP, 1993, ANN SURG, V217, P237, DOI 10.1097/00000658-199303000-00004; de Reuver PR, 2007, SURGERY, V142, P1, DOI 10.1016/j.surg.2007.03.004; DEZIEL DJ, 1993, AM J SURG, V165, P9, DOI 10.1016/S0002-9610(05)80397-6; Fischer CP, 2009, HPB, V11, P32, DOI 10.1111/j.1477-2574.2008.00002.x; Flum DR, 2003, JAMA-J AM MED ASSOC, V290, P2168, DOI 10.1001/jama.290.16.2168; Goykhman Y, 2008, J GASTROINTEST SURG, V12, P1412, DOI 10.1007/s11605-008-0538-3; Johnson SR, 2000, SURGERY, V128, P668, DOI 10.1067/msy.2000.108422; Kocher M, 2007, EUR J RADIOL, V62, P170, DOI 10.1016/j.ejrad.2007.01.032; Lillemoe KD, 2000, ANN SURG, V232, P430, DOI 10.1097/00000658-200009000-00015; MacFadyen BV, 1998, SURG ENDOSC-ULTRAS, V12, P315, DOI 10.1007/s004649900661; Misra S, 2004, J AM COLL SURGEONS, V198, P218, DOI 10.1016/j.jamcollsurg.2003.09.020; PELLEGRINI CA, 1984, AM J SURG, V147, P175, DOI 10.1016/0002-9610(84)90054-0; PITT HA, 1982, AM J SURG, V144, P14, DOI 10.1016/0002-9610(82)90595-5; Stewart L, 2004, J GASTROINTEST SURG, V8, P523, DOI 10.1016/j.gassur.2004.02.010; STEWART L, 1995, ARCH SURG-CHICAGO, V130, P1123; TERBLANCHE J, 1990, SURGERY, V108, P828; Walsh RM, 2004, J AM COLL SURGEONS, V199, P192, DOI 10.1016/j.jamcollsurg.2004.02.029; Yan JQ, 2007, WORLD J GASTROENTERO, V13, P6598, DOI 10.3748/wjg.13.6598	21	17	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e46478	10.1371/journal.pone.0046478	http://dx.doi.org/10.1371/journal.pone.0046478			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110053	Green Submitted, gold, Green Published			2022-12-25	WOS:000310262500007
J	Boianelli, A; Bidossi, A; Gualdi, L; Mulas, L; Mocenni, C; Pozzi, G; Vicino, A; Oggioni, MR				Boianelli, Alessandro; Bidossi, Alessandro; Gualdi, Luciana; Mulas, Laura; Mocenni, Chiara; Pozzi, Gianni; Vicino, Antonio; Oggioni, Marco R.			A Non-Linear Deterministic Model for Regulation of Diauxic Lag on Cellobiose by the Pneumococcal Multidomain Transcriptional Regulator CelR	PLOS ONE			English	Article							PNEUMONIAE VIRULENCE FACTORS; STREPTOCOCCUS-PNEUMONIAE; ESCHERICHIA-COLI; METABOLISM; GROWTH; GENE; TRANSFORMATION; COLONIZATION; SUBSTRATE; LACTOSE	When grown on glucose and beta-glucosides, S. pneumoniae shows sequential use of sugars resulting in diauxic growth with variable time extent of the lag phase separating the biphasic growth curve. The pneumococcal beta-glucoside uptake locus containing the PTS transporter spr0276-82, is regulated by a multi-domain transcriptional regulator CelR. In this work, we address the contribution of phosphorylation of the phosphorylable cysteine in the EIIB domain of CelR to diauxic lag. Utilising site-directed mutagenesis of the phosphorylable amino acids in the EIIB and EIIA domains of CelR, we show that the EIIB domain activation is linked to the duration of the lag phase. Analysis of mutants for other PTS systems indicates that a second beta-glucoside PTS (spr0505), not able to support growth on cellobiose, is responsible for the lag during diauxic growth. A mathematical model of the process is devised together with a nonlinear identification procedure which provides model parameter estimates characterizing the single phases of bacterial growth. Parameter identification performed on data recorded in appropriate experiments on mutants allows for establishing a relationship between a specific model parameter, the EIIB domain and the time extent of the diauxic lag. The experimental results and the related insights provided by the mathematical model provide evidence that the conflicting activation of the CelR regulator is at the origin of the lag phase during sequential growth on glucose and cellobiose. This data is the first description of diauxic lag regulation involving two PTS and a multidomain regulator and could serve as a promising approach for studying the S. pneumoniae growth process on complex carbon sources as possibly encountered in the human host.	[Bidossi, Alessandro; Gualdi, Luciana; Mulas, Laura; Pozzi, Gianni; Oggioni, Marco R.] Univ Siena, Dept Biotechnol, LAMMB, I-53100 Siena, Italy; [Boianelli, Alessandro; Mocenni, Chiara; Vicino, Antonio] Univ Siena, Dept Informat Engn, Ctr Complex Syst Studies CSC, I-53100 Siena, Italy; [Pozzi, Gianni; Oggioni, Marco R.] Azienda Osped Univ Senese, UOC Batteriol, Siena, Italy	University of Siena; University of Siena; University of Siena; University Hospital of Siena	Oggioni, MR (corresponding author), Univ Siena, Dept Biotechnol, LAMMB, Via Laterina 8, I-53100 Siena, Italy.	oggioni@unisi.it	Pozzi, Gianni/Q-2713-2018; Mocenni, Chiara/X-4424-2019; Mocenni, Chiara/AAU-5018-2021; Oggioni, Marco Rinaldo/K-3839-2016	Pozzi, Gianni/0000-0002-9557-4714; Mocenni, Chiara/0000-0002-1259-6003; Oggioni, Marco Rinaldo/0000-0003-4117-793X; VICINO, Antonio/0000-0002-7969-4054	European Commission [PNEUMOPATH FP7-HEALTH-222983, ADITECH FP7-HEALTH-280873]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The work was in part funded by the European Commission grants PNEUMOPATH FP7-HEALTH-222983 and ADITECH FP7-HEALTH-280873. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bidossi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033320; Boianelli A, 2011, P 18 WORLD C INT FED, V44, P11773, DOI [10.3182/20110828-6-IT-1002.02372., DOI 10.3182/20110828-6-IT-1002.02372]; Carvalho SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026707; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Dopazo J, 2001, MICROB DRUG RESIST, V7, P99, DOI 10.1089/10766290152044995; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Fu WG, 1999, BIOCHEM ENG J, V3, P163, DOI 10.1016/S1369-703X(99)00014-5; GUILD WR, 1976, J BACTERIOL, V125, P125, DOI 10.1128/JB.125.1.125-135.1976; Hava DL, 2003, MOL MICROBIOL, V50, P1103, DOI 10.1046/j.1365-2958.2003.03764.x; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; Iannelli F, 2004, MOL BIOTECHNOL, V26, P81, DOI 10.1385/MB:26:1:81; Inada T, 1996, GENES CELLS, V1, P293, DOI 10.1046/j.1365-2443.1996.24025.x; Iyer R, 2007, MOL MICROBIOL, V66, P1, DOI 10.1111/j.1365-2958.2007.05878.x; Joyet P, 2010, MOL MICROBIOL, V76, P1279, DOI 10.1111/j.1365-2958.2010.07175.x; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; KOMPALA DS, 1986, BIOTECHNOL BIOENG, V28, P1044, DOI 10.1002/bit.260280715; Kovarova-Kovar K, 1998, MICROBIOL MOL BIOL R, V62, P646; McKessar SJ, 2007, J BACTERIOL, V189, P1342, DOI 10.1128/JB.01170-06; Monod J, 1942, THESIS U PARIS FRANC; Narang A, 1997, CHEM ENG SCI, V52, P2567, DOI 10.1016/S0009-2509(97)00073-0; Pozzi G, 1996, J BACTERIOL, V178, P6087, DOI 10.1128/jb.178.20.6087-6090.1996; SALLES C, 1992, NUCLEIC ACIDS RES, V20, P6103, DOI 10.1093/nar/20.22.6103; Shafeeq S, 2011, MICROBIOL-SGM, V157, P2854, DOI 10.1099/mic.0.051359-0; Sung CK, 2001, APPL ENVIRON MICROB, V67, P5190, DOI 10.1128/AEM.67.11.5190-5196.2001; Trappetti C, 2009, J INFECT DIS, V199, P1497, DOI 10.1086/598483; Zeng L, 2009, J BACTERIOL, V191, P2153, DOI 10.1128/JB.01641-08	26	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e47393	10.1371/journal.pone.0047393	http://dx.doi.org/10.1371/journal.pone.0047393			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110070	Green Submitted, Green Published, gold			2022-12-25	WOS:000310193400009
J	Sathiamoorthy, S; Shin, JA				Sathiamoorthy, Sarmitha; Shin, Jumi A.			Boundaries of the Origin of Replication: Creation of a pET-28a-Derived Vector with p15A Copy Control Allowing Compatible Coexistence with pET Vectors	PLOS ONE			English	Article							HIGH-LEVEL EXPRESSION; NUCLEOTIDE-SEQUENCE; CLONING VEHICLES; GENE-PRODUCT; COLE1 DNA; RNA-I; PLASMID; NUMBER; PRIMER; CONSTRUCTION	During our studies involving protein-DNA interactions, we constructed plasmid pSAM to fulfill two requirements: 1) to facilitate transfer of cloned sequences from widely used expression vector pET-28a(+), and 2) to provide a vector compatible with pBR322-derived plasmids for use in cells harboring two different plasmids. Vector pSAM is a pET-28a(+)-derived plasmid with the p15A origin of replication (ori); pET-28a(+) contains the pBR322 replicon that is incompatible with other pBR322-derived plasmids. By replacing the original pET-28a(+) replicon-comprising the ori, RNAI, RNAII, and Rom-with the p15A replicon, we generated pSAM, which contains the pET-28a(+) multiple cloning site and is now compatible with pBR322-derived vectors. Plasmid copy number was assessed using quantitative PCR: pSAM copy number was maintained at 18 +/- 4 copies per cell, consistent with that of other p15A-type vectors. Compatibility with pBR322-derived vectors was tested with pGEX-6p-1 and pSAM, which maintained their copy numbers of 49 +/- 10 and 14 +/- 4, respectively, when both were present within the same cell. Swapping of the ori is a common practice; however, it is vital that all regions of the original replicon be removed. Additional vector pSAMRNAI illustrated that incompatibility remains when portions of the replicon, such as RNAI and/or Rom, are retained; pSAMRNAI, which contains the intact RNAI but not ROM, lowered the copy number of pGEX-6p-1 to 18 +/- 2 in doubly transformed cells due to retention of the pET-28a(+)-derived RNAI. Thus, pSAMRNAI is incompatible with vectors controlled by the pBR322 replicon and further demonstrates the need to remove all portions of the original replicon and to quantitatively assess copy number, both individually and in combination, to ensure vector compatibility. To our knowledge, this is the first instance where the nascent vector has been quantitatively assessed for both plasmid copy number and compatibility. New vector pSAM provides ease of transferring sequences from commonly used pET-28a(+) into a vector compatible with the pBR322 family of plasmids. This essential need is currently not filled.	[Sathiamoorthy, Sarmitha; Shin, Jumi A.] Univ Toronto, Dept Chem, Mississauga, ON L5L 1C6, Canada; [Shin, Jumi A.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada	University of Toronto; University Toronto Mississauga; University of Toronto	Shin, JA (corresponding author), Univ Toronto, Dept Chem, Mississauga, ON L5L 1C6, Canada.	jumi.shin@utoronto.ca			Collaborative Health Research Project Grant [CHRP 385829]; National Sciences and Engineering Research Council Discovery Grant (NSERC); Canadian Foundation for Innovation/Ontario Innovation Trust New Opportunities Grant [CFI/OIT 7856]; University of Toronto	Collaborative Health Research Project Grant; National Sciences and Engineering Research Council Discovery Grant (NSERC); Canadian Foundation for Innovation/Ontario Innovation Trust New Opportunities Grant; University of Toronto(University of Toronto)	This work was supported by a Collaborative Health Research Project Grant (CHRP 385829, http://www.cihr-irsc.gc.ca/), National Sciences and Engineering Research Council Discovery Grant (NSERC, http://www.nserc-crsng.gc.ca/), Canadian Foundation for Innovation/Ontario Innovation Trust New Opportunities Grant (CFI/OIT 7856), and the University of Toronto. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balbas Paulina, 2004, Methods Mol Biol, V267, P77; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; Burgos JS, 2002, MOL CELL PROBE, V16, P257, DOI 10.1006/mcpr.2002.0419; Camps Manel, 2010, Recent Pat DNA Gene Seq, V4, P58; Carapuca E, 2007, MOL BIOTECHNOL, V37, P120, DOI 10.1007/s12033-007-0007-3; CESARENI G, 1982, P NATL ACAD SCI-BIOL, V79, P6313, DOI 10.1073/pnas.79.20.6313; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; CHEN ST, 1987, J BACTERIOL, V169, P913, DOI 10.1128/jb.169.2.913-916.1987; CHIANG CS, 1991, PLASMID, V26, P186, DOI 10.1016/0147-619X(91)90042-U; CORDINGLEY MG, 1990, J BIOL CHEM, V265, P9062; DUBENDORFF JW, 1991, J MOL BIOL, V219, P45, DOI 10.1016/0022-2836(91)90856-2; Finkelstein J, 2003, ANAL BIOCHEM, V319, P78, DOI 10.1016/S0003-2697(03)00273-2; Fujimura H, 1996, BIOLOGICALS, V24, P67, DOI 10.1006/biol.1996.0007; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hahn FM, 2001, J BACTERIOL, V183, P1, DOI 10.1128/JB.183.1.1-11.2001; Held D., 2003, INNOVATIONS; Hiszczynska-Sawicka E, 1997, PLASMID, V38, P174, DOI 10.1006/plas.1997.1307; HORINOUCHI S, 1982, J BACTERIOL, V150, P815, DOI 10.1128/JB.150.2.815-825.1982; ITOH T, 1980, P NATL ACAD SCI-BIOL, V77, P2450, DOI 10.1073/pnas.77.5.2450; LACATENA RM, 1981, NATURE, V294, P623, DOI 10.1038/294623a0; Lee C, 2006, J BIOTECHNOL, V123, P273, DOI 10.1016/j.jbiotec.2005.11.014; MAYER MP, 1995, GENE, V163, P41, DOI 10.1016/0378-1119(95)00389-N; MOSER DR, 1983, J BACTERIOL, V154, P809, DOI 10.1128/JB.154.2.809-818.1983; NORDSTROM K, 1990, CELL, V63, P1121, DOI 10.1016/0092-8674(90)90405-4; NOVICK RP, 1987, MICROBIOL REV, V51, P381, DOI 10.1128/MMBR.51.4.381-395.1987; OKA A, 1981, J MOL BIOL, V147, P217, DOI 10.1016/0022-2836(81)90438-1; PROJAN SJ, 1983, PLASMID, V9, P182, DOI 10.1016/0147-619X(83)90019-7; Pushnova EA, 2000, ANAL BIOCHEM, V284, P70, DOI 10.1006/abio.2000.4668; Schmidt T, 1996, J BIOTECHNOL, V49, P219, DOI 10.1016/0168-1656(96)01519-2; Shahravan SH, 2011, ANAL CHEM, V83, P9643, DOI 10.1021/ac2024602; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; TAMM J, 1985, P NATL ACAD SCI USA, V82, P2257, DOI 10.1073/pnas.82.8.2257; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Zeng JM, 2010, PROTEIN EXPRES PURIF, V69, P47, DOI 10.1016/j.pep.2009.09.002	34	11	12	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e47259	10.1371/journal.pone.0047259	http://dx.doi.org/10.1371/journal.pone.0047259			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110063	Green Published, Green Submitted, gold			2022-12-25	WOS:000310193400008
J	Cardoso, AA; Jiang, YL; Luo, MH; Reed, AM; Shahda, S; He, Y; Maitra, A; Kelley, MR; Fishel, ML				Cardoso, Angelo A.; Jiang, Yanlin; Luo, Meihua; Reed, April M.; Shahda, Safi; He, Ying; Maitra, Anirban; Kelley, Mark R.; Fishel, Melissa L.			APE1/Ref-1 Regulates STAT3 Transcriptional Activity and APE1/Ref-1-STAT3 Dual-Targeting Effectively Inhibits Pancreatic Cancer Cell Survival	PLOS ONE			English	Article							SIGNALING PROTEIN APE1/REF-1; SMALL-MOLECULE INHIBITOR; DNA-REPAIR ENZYME; APURINIC/APYRIMIDINIC ENDONUCLEASE-1; ENHANCED SENSITIVITY; REDOX FUNCTION; TUMOR-GROWTH; ACTIVATION; EXPRESSION; TRANSDUCER	Pancreatic cancer is a largely incurable disease, and increasing evidence supports strategies targeting multiple molecular mediators of critical functions of pancreatic ductal adenocarcinoma cells. Intracellular redox state modulates the activity of various signal transduction pathways and biological processes, including cell survival, drug resistance and responsiveness to microenvironmental factors. Recently, it has been shown that the transcription factor STAT3 is under redox control, but the mechanisms involved in its regulation are unknown. Here, we demonstrate for the first time that STAT3 DNA binding and transcriptional activity is directly regulated by the redox function of the APE1/Ref-1 endonuclease, using overexpression and redox-specific mutational strategies, and gene knockdown. Also, pharmacological blockade of APE1/Ref-1 by the redox-selective inhibitor E3330 abrogates STAT3 DNA binding. Since APE1/Ref-1 also exerts redox control on other cancer-associated transcription factors, we assessed the impact of dual-targeting of STAT3 signaling and APE1/Ref-1 redox on pancreatic cancer cell functions. We observed that disruption of APE1/Ref-1 redox activity synergizes with STAT3 blockade to potently inhibit the proliferation and viability of human PDAC cells. Mechanistically, we show that STAT3-APE1/Ref-1 dual targeting promotes marked tumor cell apoptosis, with engagement of caspase-3 signaling, which are significantly increased in comparison to the effects triggered by single target blockade. Also, we show that STAT3-APE1/Ref-1 dual blockade results in significant inhibition of tumor cell migration. Overall, this work demonstrates that the transcriptional activity of STAT3 is directly regulated by the redox function of APE1/Ref-1, and that concurrent blockade of STAT3 and APE1/Ref-1 redox synergize effectively inhibit critical PDAC cell functions.	[Jiang, Yanlin; Luo, Meihua; Reed, April M.; He, Ying; Kelley, Mark R.; Fishel, Melissa L.] Herman B Wells Ctr Pediat Res, Dept Pediat, Sect Hematol Oncol, Indianapolis, IN USA; [Cardoso, Angelo A.; Shahda, Safi] Indiana Univ Sch Med, Dept Med, Div Hematol Oncol, Indianapolis, IN USA; [Maitra, Anirban] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Kelley, Mark R.; Fishel, Melissa L.] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN USA; [Kelley, Mark R.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington; Johns Hopkins University; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Fishel, ML (corresponding author), Herman B Wells Ctr Pediat Res, Dept Pediat, Sect Hematol Oncol, Indianapolis, IN USA.	mfishel@iupui.edu	Fishel, Melissa L./AAH-6608-2020	Fishel, Melissa L./0000-0002-9436-6382; Kelley, Mark/0000-0002-6120-9532	National Institutes of Health National Cancer Institute (NCI) [CA121168, CA114571, CA121168S1, CA122298, CA113669, CA134292, CA134767]; Riley Children's Foundation; Ralph W. and Grace M. Showalter Research Trust; NATIONAL CANCER INSTITUTE [R01CA121168, R01CA113669, R01CA114571, P01CA134292, R01CA134767, R21CA122298, R01CA167291] Funding Source: NIH RePORTER	National Institutes of Health National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Riley Children's Foundation; Ralph W. and Grace M. Showalter Research Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Financial support for this work was provided by the National Institutes of Health National Cancer Institute (NCI) CA121168, CA114571, and CA121168S1 (MRK), CA122298 (MLF), CA113669, CA134292 and CA134767 (AM) the Riley Children's Foundation (MRK) www.rileykids.org/and the Ralph W. and Grace M. Showalter Research Trust Fund (MLF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astsaturov I, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001083; Bapat A, 2010, J PHARMACOL EXP THER, V334, P988, DOI 10.1124/jpet.110.169128; Bhakat KK, 2009, ANTIOXID REDOX SIGN, V11, P621, DOI [10.1089/ars.2008.2198, 10.1089/ARS.2008.2198]; Brantley EC, 2008, MOL CANCER RES, V6, P675, DOI 10.1158/1541-7786.MCR-07-2180; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Cummins EP, 2005, PFLUG ARCH EUR J PHY, V450, P363, DOI 10.1007/s00424-005-1413-7; Fan ZS, 2003, NAT IMMUNOL, V4, P145, DOI 10.1038/ni885; Ferbeyre G, 2011, BBA-REV CANCER, V1815, P104, DOI 10.1016/j.bbcan.2010.10.004; Fishel ML, 2008, DNA REPAIR, V7, P177, DOI 10.1016/j.dnarep.2007.09.008; Fishel ML, 2007, MOL ASPECTS MED, V28, P375, DOI 10.1016/j.mam.2007.04.005; Fishel ML, 2011, MOL CANCER THER, V10, P1698, DOI 10.1158/1535-7163.MCT-11-0107; Fishel ML, 2010, EXP HEMATOL, V38, P1178, DOI 10.1016/j.exphem.2010.08.011; Georgiadis MM, 2008, MUTAT RES-FUND MOL M, V643, P54, DOI 10.1016/j.mrfmmm.2008.04.008; Gray MJ, 2005, ONCOGENE, V24, P3110, DOI 10.1038/sj.onc.1208513; Greten FR, 2002, GASTROENTEROLOGY, V123, P2052, DOI 10.1053/gast.2002.37075; Grivennikov SI, 2010, CYTOKINE GROWTH F R, V21, P11, DOI 10.1016/j.cytogfr.2009.11.005; Groner B, 2008, SEMIN CELL DEV BIOL, V19, P341, DOI 10.1016/j.semcdb.2008.06.005; HOLMGREN A, 1995, STRUCTURE, V3, P239, DOI 10.1016/S0969-2126(01)00153-8; Jackson MW, 2006, J BIOL CHEM, V281, P16814, DOI 10.1074/jbc.M511617200; Jaganathan S, 2010, J PHARMACOL EXP THER, V333, P373, DOI 10.1124/jpet.109.162669; Jiang YL, 2010, CANCER INVEST, V28, P885, DOI 10.3109/07357907.2010.512816; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jordan BF, 2005, CLIN CANCER RES, V11, P529; Kelley MR, 2010, CANCER DRUG DISCOV D, P133, DOI 10.1007/978-1-4419-6615-5_7; Kramer OH, 2010, MOL CELL ENDOCRINOL, V315, P40, DOI 10.1016/j.mce.2009.10.007; Li L, 2004, BIOCHEM BIOPH RES CO, V322, P1005, DOI 10.1016/j.bbrc.2004.08.014; Li L, 2010, CANCER RES, V70, P8222, DOI 10.1158/0008-5472.CAN-10-0894; Liby KT, 2010, CANCER PREV RES, V3, P1427, DOI 10.1158/1940-6207.CAPR-10-0197; Luo M, 2008, ANTIOXID REDOX SIGN, V10, P1853, DOI 10.1089/ars.2008.2120; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Preston IR, 2005, CIRCULATION, V111, P782, DOI 10.1161/01.CIR.0000155254.86840.47; Qiu ZJ, 2007, CANCER SCI, V98, P1099, DOI 10.1111/j.1349-7006.2007.00485.x; Rabik CA, 2008, J PHARMACOL EXP THER, V327, P442, DOI 10.1124/jpet.108.141291; Ramanathan RK, 2011, CANCER CHEMOTH PHARM, V67, P503, DOI 10.1007/s00280-010-1343-8; Ray S, 2010, MOL ENDOCRINOL, V24, P391, DOI 10.1210/me.2009-0319; Redell MS, 2005, CURR PHARM DESIGN, V11, P2873, DOI 10.2174/1381612054546699; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Simon AR, 1998, AM J PHYSIOL-CELL PH, V275, pC1640, DOI 10.1152/ajpcell.1998.275.6.C1640; Singh-Gupta V, 2009, INT J CANCER, V124, P1675, DOI 10.1002/ijc.24015; Su DA, 2011, BIOCHEMISTRY-US, V50, P82, DOI 10.1021/bi101248s; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; Turkson J, 2004, EXPERT OPIN THER TAR, V8, P409, DOI 10.1517/14728222.8.5.409; Wang D, 2004, MOL CANCER THER, V3, P679; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x; Xie KP, 2006, CYTOKINE GROWTH F R, V17, P147, DOI 10.1016/j.cytogfr.2006.01.002; Yang G, 2009, WORLD J GASTROENTERO, V15, P3757, DOI 10.3748/wjg.15.3757; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yu H, 2009, NAT REV CANCER, V9, P798, DOI 10.1038/nrc2734	50	70	72	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47462	10.1371/journal.pone.0047462	http://dx.doi.org/10.1371/journal.pone.0047462			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094050	Green Published, gold, Green Submitted			2022-12-25	WOS:000310050200024
J	Matthews, PC; Listgarten, J; Carlson, JM; Payne, R; Huang, KHG; Frater, J; Goedhals, D; Steyn, D; van Vuuren, C; Paioni, P; Jooste, P; Ogwu, A; Shapiro, R; Mncube, Z; Ndung'u, T; Walker, BD; Heckerman, D; Goulder, PJR				Matthews, Philippa C.; Listgarten, Jennifer; Carlson, Jonathan M.; Payne, Rebecca; Huang, Kuan-Hsiang Gary; Frater, John; Goedhals, Dominique; Steyn, Dewald; van Vuuren, Cloete; Paioni, Paolo; Jooste, Pieter; Ogwu, Anthony; Shapiro, Roger; Mncube, Zenele; Ndung'u, Thumbi; Walker, Bruce D.; Heckerman, David; Goulder, Philip J. R.			Co-Operative Additive Effects between HLA Alleles in Control of HIV-1	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELL RESPONSES; DISEASE PROGRESSION; IMMUNE CONTROL; SELECTION PRESSURE; VIRAL LOAD; NK CELLS; INFECTION; VIREMIA; ASSOCIATION	Background: HLA class I genotype is a major determinant of the outcome of HIV infection, and the impact of certain alleles on HIV disease outcome is well studied. Recent studies have demonstrated that certain HLA class I alleles that are in linkage disequilibrium, such as HLA-A*74 and HLA-B*57, appear to function co-operatively to result in greater immune control of HIV than mediated by either single allele alone. We here investigate the extent to which HLA alleles - irrespective of linkage disequilibrium - function co-operatively. Methodology/Principal Findings: We here refined a computational approach to the analysis of >2000 subjects infected with C-clade HIV first to discern the individual effect of each allele on disease control, and second to identify pairs of alleles that mediate 'co-operative additive' effects, either to improve disease suppression or to contribute to immunological failure. We identified six pairs of HLA class I alleles that have a co-operative additive effect in mediating HIV disease control and four hazardous pairs of alleles that, occurring together, are predictive of worse disease outcomes (q<0.05 in each case). We developed a novel 'sharing score' to quantify the breadth of CD8+ T cell responses made by pairs of HLA alleles across the HIV proteome, and used this to demonstrate that successful viraemic suppression correlates with breadth of unique CD8+ T cell responses (p = 0.03). Conclusions/Significance: These results identify co-operative effects between HLA Class I alleles in the control of HIV-1 in an extended Southern African cohort, and underline complementarity and breadth of the CD8+ T cell targeting as one potential mechanism for this effect.	[Matthews, Philippa C.; Payne, Rebecca; Paioni, Paolo; Goulder, Philip J. R.] Univ Oxford, Dept Paediat, Oxford, England; [Listgarten, Jennifer; Carlson, Jonathan M.; Heckerman, David] Microsoft Res, ESci Grp, Los Angeles, CA USA; [Huang, Kuan-Hsiang Gary; Frater, John] Univ Oxford, Nuffield Dept Med, Oxford, England; [Goedhals, Dominique] Univ Orange Free State, Dept Med Microbiol & Virol, Natl Hlth Lab Serv, Bloemfontein, South Africa; [Steyn, Dewald; van Vuuren, Cloete] Univ Orange Free State, Dept Internal Med, Bloemfontein, South Africa; [Jooste, Pieter] Univ Orange Free State, Kimberley Hosp, Dept Paediat, Kimberley, Northern Cape, South Africa; [Ogwu, Anthony; Shapiro, Roger] Botswana Harvard AIDS Inst Partnership, Gaborone, Botswana; [Shapiro, Roger] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Mncube, Zenele; Ndung'u, Thumbi; Walker, Bruce D.; Goulder, Philip J. R.] Univ KwaZulu Natal, Doris Duke Med Res Inst, HIV Pathogenesis Programme, Durban, South Africa; [Ndung'u, Thumbi; Walker, Bruce D.] Massachusetts Gen Hosp, Ragon Inst, Boston, MA 02114 USA	University of Oxford; Microsoft; University of Oxford; University of the Free State; University of the Free State; Botswana-Harvard AIDS Institute Partnership; Harvard University; Harvard T.H. Chan School of Public Health; University of Kwazulu Natal; Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Matthews, PC (corresponding author), Univ Oxford, Dept Paediat, Oxford, England.	p.matthews@doctors.org.uk	Matthews, Philippa/P-7810-2019; Payne, Rebecca/AAC-4783-2022	Matthews, Philippa/0000-0002-4036-4269; Payne, Rebecca/0000-0002-9037-7367; Frater, John/0000-0001-7163-7277; Paioni, Paolo/0000-0002-3904-1606; Ndung'u, Thumbi/0000-0003-2962-3992; van Vuuren, Cloete/0000-0002-9095-0039	UK Medical Research Council; Oxford Radcliffe Hospitals Medical Research Fund; Wellcome Trust; National Institutes of Health; Bill and Melinda Gates Foundation; South African AIDS Vaccine Initiative; MRC [G108/626] Funding Source: UKRI; Medical Research Council [G108/626] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046995, P30AI060354] Funding Source: NIH RePORTER	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Oxford Radcliffe Hospitals Medical Research Fund; Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); South African AIDS Vaccine Initiative; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	PM was funded by the UK Medical Research Council and Oxford Radcliffe Hospitals Medical Research Fund. PG was funded by Wellcome Trust and is an Elizabeth Glaser Paediatric AIDS Foundation Scientist. TN holds the South African Department of Science and Technology/National Research Foundation Research Chair in Systems Biology of HIV/AIDS. The Durban cohort was funded by grants from the Wellcome Trust, The National Institutes of Health, The Bill and Melinda Gates Foundation and the South African AIDS Vaccine Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2009, J INTERN MED, V265, P29, DOI 10.1111/j.1365-2796.2008.02045.x; Alter G, 2009, J VIROL, V83, P6798, DOI 10.1128/JVI.00256-09; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; Brumme ZL, 2007, PLOS PATHOG, V3, P913, DOI 10.1371/journal.ppat.0030094; Carlson J.M., 2009, MSRTR200953; Carlson J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000591; Carlson JM, 2012, J VIROL, V86, P5230, DOI 10.1128/JVI.06728-11; Carrington M, 1999, SCIENCE, V283, P1748, DOI 10.1126/science.283.5408.1748; Fellay J, 2007, SCIENCE, V317, P944, DOI 10.1126/science.1143767; Fellay J, 2011, J INFECT DIS, V203, P773, DOI 10.1093/infdis/jiq125; Frater AJ, 2007, J VIROL, V81, P6742, DOI 10.1128/JVI.00022-07; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Goulder PJR, 1996, AIDS RES HUM RETROV, V12, P1691, DOI 10.1089/aid.1996.12.1691; Honeyborne I, 2007, J VIROL, V81, P3667, DOI 10.1128/JVI.02689-06; Honeyborne I, 2010, J VIROL, V84, P11279, DOI 10.1128/JVI.01144-10; Huang KHG, 2009, ANTIVIR THER, V14, P975, DOI 10.3851/IMP1416; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kiepiela P, 2004, NATURE, V432, P769, DOI 10.1038/nature03113; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kloverpris HN, 2012, J VIROL, V86, P919, DOI 10.1128/JVI.06150-11; Koehler RN, 2010, J INFECT DIS, V202, P1562, DOI 10.1086/656913; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Leslie A, 2010, J VIROL, V84, P9879, DOI 10.1128/JVI.00320-10; Listgarten J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000016; Matthews PC, 2008, J VIROL, V82, P8548, DOI 10.1128/JVI.00580-08; Matthews PC, 2011, J IMMUNOL, V186, P5675, DOI 10.4049/jimmunol.1003711; Ngumbela KC, 2008, AIDS RES HUM RETROV, V24, P72, DOI 10.1089/aid.2007.0124; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Shapiro RL, 2010, NEW ENGL J MED, V362, P2282, DOI 10.1056/NEJMoa0907736; Sidney J, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-1; Song W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023469; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100	33	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47799	10.1371/journal.pone.0047799	http://dx.doi.org/10.1371/journal.pone.0047799			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094091	gold, Green Published, Green Submitted			2022-12-25	WOS:000310050200047
J	Andersson, SEM; Svensson, MND; Erlandsson, MC; Dehlin, M; Andersson, KME; Bokarewa, MI				Andersson, Sofia E. M.; Svensson, Mattias N. D.; Erlandsson, Malin C.; Dehlin, Mats; Andersson, Karin M. E.; Bokarewa, Maria I.			Activation of Fms-Like Tyrosine Kinase 3 Signaling Enhances Survivin Expression in a Mouse Model of Rheumatoid Arthritis	PLOS ONE			English	Article							DENDRITIC CELL-DEVELOPMENT; FLT3 LIGAND; PROGENITOR CELLS; EXTRACELLULAR SURVIVIN; HEMATOPOIETIC STEM; COLORECTAL-CANCER; IN-VIVO; APOPTOSIS; INHIBITOR; RECEPTOR	Survivin is known as an inhibitor of apoptosis and a positive regulator of cell division. We have recently identified survivin as a predictor of joint destruction in patients with rheumatoid arthritis (RA). Flt3 ligand (Flt3L) is expressed in the inflamed joints and has adjuvant properties in arthritis. Studies on 90 RA patients (median age 60.5 years [range, 24-87], disease duration 10.5 years [range, 0-35]) show a strong positive association between the levels of survivin and Flt3L in blood. Here, we present experimental evidence connecting survivin and Flt3L signaling. Treatment of BALB/c mice with Flt3L led to an increase of survivin in the bone marrow and in splenic dendritic cells. Flt3L changed the profile of survivin splice variants, increasing transcription of the short survivin40 in the bone marrow. Treatment with an Flt3 inhibitor reduced total survivin expression in bone marrow and in the dendritic cell population in spleen. Inhibition of survivin transcription in mice, by shRNA lentiviral constructs, reduced the gene expression of Flt3L. We conclude that expression of survivin is a downstream event of Flt3 signaling, which serves as an essential mechanism supporting survival of leukocytes during their differentiation, and maturation of dendritic cells, in RA.	[Andersson, Sofia E. M.; Svensson, Mattias N. D.; Erlandsson, Malin C.; Dehlin, Mats; Andersson, Karin M. E.; Bokarewa, Maria I.] Univ Goteborg, Dept Rheumatol & Inflammat Res, Sahlgrenska Univ Hosp, Gothenburg, Sweden	Sahlgrenska University Hospital; University of Gothenburg	Andersson, SEM (corresponding author), Univ Goteborg, Dept Rheumatol & Inflammat Res, Sahlgrenska Univ Hosp, Gothenburg, Sweden.	sofia.andersson@rheuma.gu.se	Svensson, Mattias N.D./A-9827-2012; Bokarewa, Maria I/A-8114-2019	Svensson, Mattias N.D./0000-0001-8077-9824; Bokarewa, Maria I/0000-0001-9424-5145; Erlandsson, Malin/0000-0003-1100-7577; Andersson, Sofia/0000-0003-2933-7339; Andersson, Karin/0000-0002-9475-3040	Medical Society of Goteborg; Swedish Association against Rheumatism; King Gustaf V:s 80-year Foundation; Commission of European Union [HEALTH-F2-2010-261460]; Swedish Research Council; IngaBritt and Arne Lundberg Foundation; Professor Nanna Swartz Foundation; Torsten Soderberg Foundation; AME Wolff Foundation; Rune and Ulla Amlovs Trust; Swedish Research Agency for Innovation Systems (VINNOVA); Swedish Foundation for Strategic Research; Pharmacist Hedberg's Foundation; Magnus Bergwall Foundation; University of Goteborg; Family Tholen and Kristlers Foundation; Western Gotaland county council; University of Goteborg (LUA/ALF)	Medical Society of Goteborg; Swedish Association against Rheumatism; King Gustaf V:s 80-year Foundation; Commission of European Union(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); IngaBritt and Arne Lundberg Foundation; Professor Nanna Swartz Foundation; Torsten Soderberg Foundation; AME Wolff Foundation; Rune and Ulla Amlovs Trust; Swedish Research Agency for Innovation Systems (VINNOVA)(Vinnova); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Pharmacist Hedberg's Foundation; Magnus Bergwall Foundation; University of Goteborg; Family Tholen and Kristlers Foundation; Western Gotaland county council; University of Goteborg (LUA/ALF)	This work was funded by grants from the Medical Society of Goteborg, the Swedish Association against Rheumatism, the King Gustaf V:s 80-year Foundation, the Commission of European Union (HEALTH-F2-2010-261460), the Swedish Research Council, IngaBritt and Arne Lundberg Foundation, Professor Nanna Swartz Foundation, Torsten Soderberg Foundation, AME Wolff Foundation, Rune and Ulla Amlovs Trust, the Swedish Research Agency for Innovation Systems (VINNOVA), the Swedish Foundation for Strategic Research, the Pharmacist Hedberg's Foundation, Magnus Bergwall Foundation, the University of Goteborg, the Family Tholen and Kristlers Foundation, the Regional agreement on medical training and clinical research between the Western Gotaland county council and the University of Goteborg (LUA/ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JK, 2010, INFLAMMATION, V33, P381, DOI 10.1007/s10753-010-9196-1; Altieri DC, 2010, BIOCHEM J, V430, P199, DOI 10.1042/BJ20100814; Altznauer F, 2004, J EXP MED, V199, P1343, DOI 10.1084/jem.20032033; Aoki Y, 2003, BLOOD, V101, P1535, DOI 10.1182/blood-2002-07-2130; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baran M, 2009, J CELL MOL MED, V13, P3797, DOI 10.1111/j.1582-4934.2009.00721.x; Bigley V, 2011, J EXP MED, V208, P227, DOI 10.1084/jem.20101459; Bokarewa M, 2005, ARTHRITIS RES THER, V7, pR349, DOI 10.1186/ar1498; Boyer SW, 2011, CELL STEM CELL, V9, P64, DOI 10.1016/j.stem.2011.04.021; Carter BZ, 2001, BLOOD, V97, P2784, DOI 10.1182/blood.V97.9.2784; Chklovskaia E, 2001, BLOOD, V97, P1027, DOI 10.1182/blood.V97.4.1027; Conway EM, 2000, BLOOD, V95, P1435, DOI 10.1182/blood.V95.4.1435.004k01_1435_1442; Deane KD, 2010, ARTHRITIS RHEUM-US, V62, P3161, DOI 10.1002/art.27638; Dehlin M, 2011, J LEUKOCYTE BIOL, V90, P811, DOI 10.1189/jlb.1110640; Dehlin M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003633; Dharmapatni AASSK, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2603; Fukuda S, 2001, BLOOD, V98, P2091, DOI 10.1182/blood.V98.7.2091; Fukuda S, 2009, BLOOD, V114, P394, DOI 10.1182/blood-2008-11-188714; Gu LB, 2007, EXP HEMATOL, V35, P957, DOI 10.1016/j.exphem.2007.03.007; Horiuchi K, 2009, J IMMUNOL, V182, P7408, DOI 10.4049/jimmunol.0801931; Isgren A, 2012, SEMIN ARTHRITIS RHEU, V41, P652, DOI 10.1016/j.semarthrit.2011.08.005; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Kang BH, 2011, J BIOL CHEM, V286, P16758, DOI 10.1074/jbc.M110.210120; Karsunky H, 2003, J EXP MED, V198, P305, DOI 10.1084/jem.20030323; Kim PJ, 2003, LANCET, V362, P205, DOI 10.1016/S0140-6736(03)13910-4; Kornacker M, 2001, IMMUNOL LETT, V76, P169, DOI 10.1016/S0165-2478(01)00186-9; Kuttler F, 2002, LEUKEMIA, V16, P726, DOI 10.1038/sj.leu.2402427; Leung CG, 2007, J EXP MED, V204, P1603, DOI 10.1084/jem.20062395; Li FZ, 2010, AM J PATHOL, V176, P1629, DOI 10.2353/ajpath.2010.090414; MACKAREHTSCHIAN K, 1995, IMMUNITY, V3, P147, DOI 10.1016/1074-7613(95)90167-1; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; McKenna HJ, 2000, BLOOD, V95, P3489, DOI 10.1182/blood.V95.11.3489; Mera S, 2008, J LEUKOCYTE BIOL, V83, P149, DOI 10.1189/jlb.0507287; Morgillo F, 2006, CANCER RES, V66, P10100, DOI 10.1158/0008-5472.CAN-06-1684; Noton EA, 2006, J BIOL CHEM, V281, P1286, DOI 10.1074/jbc.M508773200; Okada H, 2004, J EXP MED, V199, P399, DOI 10.1084/jem.20032092; Petrarca CR, 2011, CLIN BREAST CANCER, V11, P129, DOI 10.1016/j.clbc.2011.03.002; Rozen S, 2000, Methods Mol Biol, V132, P365; Schmid MA, 2010, IMMUNOL REV, V234, P32, DOI 10.1111/j.0105-2896.2009.00877.x; Small Donald, 2006, Hematology Am Soc Hematol Educ Program, P178; Smith MD, 2010, RHEUMATOLOGY, V49, P862, DOI 10.1093/rheumatology/kep467; Song JX, 2005, IMMUNITY, V22, P621, DOI 10.1016/j.immuni.2005.03.012; Svensson B, 2010, ANN MED, V42, P45, DOI 10.3109/07853890903376280; Takahashi R, 1998, J BIOL CHEM, V273, P7787, DOI 10.1074/jbc.273.14.7787; Tran J, 2002, P NATL ACAD SCI USA, V99, P4349, DOI 10.1073/pnas.072586399; Tussiwand R, 2005, J IMMUNOL, V175, P3674, DOI 10.4049/jimmunol.175.6.3674; Williams NS, 2003, CLIN CANCER RES, V9, P931; Xia F, 2006, CANCER RES, V66, P3392, DOI 10.1158/0008-5472.CAN-05-4537; Xing Z, 2004, J EXP MED, V199, P69, DOI 10.1084/jem.20031588; Zhou JB, 2009, BLOOD, V113, P4052, DOI 10.1182/blood-2008-05-156422	50	31	31	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47668	10.1371/journal.pone.0047668	http://dx.doi.org/10.1371/journal.pone.0047668			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082191	Green Submitted, gold, Green Published			2022-12-25	WOS:000311146900088
J	Dzunkova, M; D'Auria, G; Perez-Villarroya, D; Moya, A				Dzunkova, Maria; D'Auria, Giuseppe; Perez-Villarroya, David; Moya, Andres			Hybrid Sequencing Approach Applied to Human Fecal Metagenomic Clone Libraries Revealed Clones with Potential Biotechnological Applications	PLOS ONE			English	Article							ARGININE DEIMINASE; PROTEIN FAMILIES; DOMAIN-STRUCTURE; ALGINATE LYASE; PHASE-I; GENE; IDENTIFICATION; DATABASE; THERAPY; HOMOCYSTINURIA	Natural environments represent an incredible source of microbial genetic diversity. Discovery of novel biomolecules involves biotechnological methods that often require the design and implementation of biochemical assays to screen clone libraries. However, when an assay is applied to thousands of clones, one may eventually end up with very few positive clones which, in most of the cases, have to be "domesticated'' for downstream characterization and application, and this makes screening both laborious and expensive. The negative clones, which are not considered by the selected assay, may also have biotechnological potential; however, unfortunately they would remain unexplored. Knowledge of the clone sequences provides important clues about potential biotechnological application of the clones in the library; however, the sequencing of clones one-by-one would be very time-consuming and expensive. In this study, we characterized the first metagenomic clone library from the feces of a healthy human volunteer, using a method based on 454 pyrosequencing coupled with a clone-by-clone Sanger end-sequencing. Instead of whole individual clone sequencing, we sequenced 358 clones in a pool. The medium-large insert (7-15 kb) cloning strategy allowed us to assemble these clones correctly, and to assign the clone ends to maintain the link between the position of a living clone in the library and the annotated contig from the 454 assembly. Finally, we found several open reading frames (ORFs) with previously described potential medical application. The proposed approach allows planning ad-hoc biochemical assays for the clones of interest, and the appropriate sub-cloning strategy for gene expression in suitable vectors/hosts.	[Dzunkova, Maria; D'Auria, Giuseppe; Perez-Villarroya, David; Moya, Andres] Univ Valencia, Joint Unit Res Genom & Hlth, Ctr Publ Hlth Res CSISP, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain; [Dzunkova, Maria; D'Auria, Giuseppe; Moya, Andres] CIBER Epidemiol & Salud Publ CIBEResp, Madrid, Spain	University of Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP	D'Auria, G (corresponding author), Univ Valencia, Joint Unit Res Genom & Hlth, Ctr Publ Hlth Res CSISP, Cavanilles Inst Biodivers & Evolutionary Biol, Valencia, Spain.	dauria_giu@gva.es	Moya, Andrés/A-8190-2008; D'Auria, Giuseppe/E-6583-2010; Dzunkova, Maria/AAE-3093-2022	Moya, Andrés/0000-0002-2867-1119; Dzunkova, Maria/0000-0002-1765-0697; D'Auria, Giuseppe/0000-0003-0672-2541	Miguel Servet, Instituto de Salud Carlos III, Spain [CP09/00049]; Spanish Ministry for Science and Innovation (MCINN) [SAF2009-13032-C02-01, FU2008-04501-E]; Conselleria D'Educacio Generalitat Valenciana, Spain [Prometeo/2009/092]; Spanish Ministry of Education [FPU2010]	Miguel Servet, Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Spanish Ministry for Science and Innovation (MCINN); Conselleria D'Educacio Generalitat Valenciana, Spain(Center for Forestry Research & Experimentation (CIEF)); Spanish Ministry of Education(Spanish Government)	This work was funded by grant CP09/00049 Miguel Servet, Instituto de Salud Carlos III, Spain to GD; by projects SAF2009-13032-C02-01 from the Spanish Ministry for Science and Innovation (MCINN), FU2008-04501-E from Spanish Ministry for Science and Innovation (MCINN) in the frame of ERA-Net PathoGenoMics and Prometeo/2009/092 from Conselleria D'Educacio Generalitat Valenciana, Spain, to AM. MD is recipient of a fellowship from Spanish Ministry of Education FPU2010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkawash MA, 2006, APMIS, V114, P131, DOI 10.1111/j.1600-0463.2006.apm_356.x; Ausubel F. M., 1992, CURRENT PROTOCOLS MO, P211; Bateman A, 2000, NUCLEIC ACIDS RES, V28, P263, DOI 10.1093/nar/28.1.263; Brady SF, 2009, NAT PROD REP, V26, P1488, DOI 10.1039/b817078a; Cason AL, 2003, EUR J HUM GENET, V11, P937, DOI 10.1038/sj.ejhg.5201072; Chevreux B, 1999, GERMAN C BIOINFORMAT, V99, P45, DOI DOI 10.1.1.23/7465; Cieslinski H, 2009, POL J MICROBIOL, V58, P199; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Corpet F, 2000, NUCLEIC ACIDS RES, V28, P267, DOI 10.1093/nar/28.1.267; Crystal RG, 1997, HUM GENE THER, V8, P985, DOI 10.1089/hum.1997.8.8-985; DAHER GC, 1990, PHARMACOL THERAPEUT, V48, P189, DOI 10.1016/0163-7258(90)90080-L; Daniel R, 2005, NAT REV MICROBIOL, V3, P470, DOI 10.1038/nrmicro1160; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; DeLong EE, 2005, NAT REV MICROBIOL, V3, P459, DOI 10.1038/nrmicro1158; Duan CJ, 2009, J APPL MICROBIOL, V107, P245, DOI 10.1111/j.1365-2672.2009.04202.x; Elend C, 2006, APPL ENVIRON MICROB, V72, P3637, DOI 10.1128/AEM.72.5.3637-3645.2006; Ensor CM, 2002, CANCER RES, V62, P5443; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Greco O, 2001, J CELL PHYSIOL, V187, P22, DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1060>3.0.CO;2-H; Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128; Harvey A, 2000, DRUG DISCOV TODAY, V5, P294, DOI 10.1016/S1359-6446(00)01511-7; HEALY FG, 1995, APPL MICROBIOL BIOT, V43, P667, DOI [10.1007/s002530050468, 10.1007/BF00164771]; Heath C, 2009, APPL ENVIRON MICROB, V75, P4657, DOI 10.1128/AEM.02597-08; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Henne A, 2000, APPL ENVIRON MICROB, V66, P3113, DOI 10.1128/AEM.66.7.3113-3116.2000; Hjort K, 2010, FEMS MICROBIOL ECOL, V71, P197, DOI 10.1111/j.1574-6941.2009.00801.x; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; Hunter S, 2012, NUCLEIC ACIDS RES, V40, pD306, DOI 10.1093/nar/gkr948; Islam MR, 2007, PLANT MOL BIOL, V63, P465, DOI 10.1007/s11103-006-9101-3; Izzo F, 2007, J GASTROEN HEPATOL, V22, P86, DOI 10.1111/j.1440-1746.2006.04463.x; Jukic LV, 2008, J BIOMED SCI, V15, P205, DOI 10.1007/s11373-007-9224-9; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; Lima T, 2009, NUCLEIC ACIDS RES, V37, pD471, DOI 10.1093/nar/gkn661; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; McHutchison JG, 1998, NEW ENGL J MED, V339, P1485, DOI 10.1056/NEJM199811193392101; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; MUDD SH, 1964, SCIENCE, V143, P1443, DOI 10.1126/science.143.3613.1443; MUDD SH, 1970, J CLIN INVEST, V49, P1762, DOI 10.1172/JCI106394; Ni Y, 2008, CANCER LETT, V261, P1, DOI 10.1016/j.canlet.2007.11.038; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; Niethammer AG, 2002, NAT MED, V8, P1369, DOI 10.1038/nm794; Oh HJ, 2004, MOL THER, V9, pS69; Pandha HS, 1999, J CLIN ONCOL, V17, P2180, DOI 10.1200/JCO.1999.17.7.2180; Pearl F, 2005, NUCLEIC ACIDS RES, V33, pD247, DOI 10.1093/nar/gki024; Pereira DIA, 2002, CRIT REV BIOCHEM MOL, V37, P259, DOI 10.1080/10409230290771519; Peris-Bondia F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022448; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Rhee JK, 2005, APPL ENVIRON MICROB, V71, P817, DOI 10.1128/AEM.71.2.817-825.2005; Riesenfeld CS, 2004, ENVIRON MICROBIOL, V6, P981, DOI 10.1111/j.1462-2920.2004.00664.x; Scheer M, 2011, NUCLEIC ACIDS RES, V39, pD670, DOI 10.1093/nar/gkq1089; Scordis P, 1999, BIOINFORMATICS, V15, P799, DOI 10.1093/bioinformatics/15.10.799; Simon C, 2011, APPL ENVIRON MICROB, V77, P1153, DOI 10.1128/AEM.02345-10; Simon C, 2009, APPL MICROBIOL BIOT, V85, P265, DOI 10.1007/s00253-009-2233-z; Simon C, 2009, APPL ENVIRON MICROB, V75, P2964, DOI 10.1128/AEM.02644-08; SIZEMORE DR, 1995, SCIENCE, V270, P299, DOI 10.1126/science.270.5234.299; Staden R, 2000, Methods Mol Biol, V132, P115; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Stein JL, 1996, J BACTERIOL, V178, P591, DOI 10.1128/jb.178.3.591-599.1996; Strohl WR, 2000, DRUG DISCOV TODAY, V5, P39, DOI 10.1016/S1359-6446(99)01443-9; TAKAKU H, 1995, JPN J CANCER RES, V86, P840, DOI 10.1111/j.1349-7006.1995.tb03094.x; Vassaux G, 2006, J PATHOL, V208, P290, DOI 10.1002/path.1865; Wang XJ, 2004, J BIOL CHEM, V279, P51370, DOI 10.1074/jbc.M410471200; Waschkowitz T, 2009, APPL ENVIRON MICROB, V75, P2506, DOI 10.1128/AEM.02136-08; Wells J, 2011, ANNU REV FOOD SCI T, V2, P423, DOI 10.1146/annurev-food-022510-133640; Wong TY, 2000, ANNU REV MICROBIOL, V54, P289, DOI 10.1146/annurev.micro.54.1.289; Wu CH, 2003, NUCLEIC ACIDS RES, V31, P345, DOI 10.1093/nar/gkg040; Yu HH, 2008, J NEUROSCI RES, V86, P2963, DOI 10.1002/jnr.21740; Yun J, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-8	72	3	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47654	10.1371/journal.pone.0047654	http://dx.doi.org/10.1371/journal.pone.0047654			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082187	gold, Green Published, Green Submitted			2022-12-25	WOS:000311146900084
J	Sanchez-Quinto, F; Botigue, LR; Civit, S; Arenas, C; Avila-Arcos, MC; Bustamante, CD; Comas, D; Lalueza-Fox, C				Sanchez-Quinto, Federico; Botigue, Laura R.; Civit, Sergi; Arenas, Conxita; Avila-Arcos, Maria C.; Bustamante, Carlos D.; Comas, David; Lalueza-Fox, Carles			North African Populations Carry the Signature of Admixture with Neandertals	PLOS ONE			English	Article							EUROPE; JACKKNIFE; ANCESTRY; ORIGINS; HISTORY; ASIA	One of the main findings derived from the analysis of the Neandertal genome was the evidence for admixture between Neandertals and non-African modern humans. An alternative scenario is that the ancestral population of non-Africans was closer to Neandertals than to Africans because of ancient population substructure. Thus, the study of North African populations is crucial for testing both hypotheses. We analyzed a total of 780,000 SNPs in 125 individuals representing seven different North African locations and searched for their ancestral/derived state in comparison to different human populations and Neandertals. We found that North African populations have a significant excess of derived alleles shared with Neandertals, when compared to sub-Saharan Africans. This excess is similar to that found in non-African humans, a fact that can be interpreted as a sign of Neandertal admixture. Furthermore, the Neandertal's genetic signal is higher in populations with a local, pre-Neolithic North African ancestry. Therefore, the detected ancient admixture is not due to recent Near Eastern or European migrations. Sub-Saharan populations are the only ones not affected by the admixture event with Neandertals.	[Sanchez-Quinto, Federico; Botigue, Laura R.; Comas, David; Lalueza-Fox, Carles] CSIC Univ Pompeu Fabra, Inst Biol Evolut, Barcelona, Spain; [Bustamante, Carlos D.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Civit, Sergi; Arenas, Conxita] Univ Barcelona, Dept Estadist, Barcelona, Spain; [Avila-Arcos, Maria C.] Univ Copenhagen, Nat Hist Museum Denmark, Ctr GeoGenet, Copenhagen, Denmark	Pompeu Fabra University; Stanford University; University of Barcelona; University of Copenhagen	Lalueza-Fox, C (corresponding author), CSIC Univ Pompeu Fabra, Inst Biol Evolut, Barcelona, Spain.	carles.lalueza@upf.edu	Ávila-Arcos, Maria C./AGZ-3897-2022; Comas, David/D-5382-2014; Botigue, Laura/AAF-8895-2019; Sánchez-Quinto, Federico/AAV-8927-2020; civit-vives, sergi/N-4287-2015; Arenas, Concepcion/H-5579-2015; LALUEZA-FOX, CARLES/AAG-5341-2020	Ávila-Arcos, Maria C./0000-0003-1691-1696; Comas, David/0000-0002-5075-0956; Botigue, Laura/0000-0001-7114-5168; Sánchez-Quinto, Federico/0000-0002-0201-6204; civit-vives, sergi/0000-0002-2511-4579; Arenas, Concepcion/0000-0002-6489-4934; LALUEZA-FOX, CARLES/0000-0002-1730-5914; Bustamante, Carlos D./0000-0002-4187-7920	Ministerio de Ciencia e Innovacion of Spain [BFU2009-06974, CGL2010-14944/BOS]	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	FS-Q, SC, CA and CL-F are supported by a grant from the Ministerio de Ciencia e Innovacion of Spain (BFU2009-06974) and CGL2010-14944/BOS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Rached L, 2011, SCIENCE, V334, P89, DOI 10.1126/science.1209202; Albrechtsen A, 2010, MOL BIOL EVOL, V27, P2534, DOI 10.1093/molbev/msq148; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Balter M, 2011, SCIENCE, V331, P20, DOI 10.1126/science.331.6013.20; Barton RNE, 2009, QUATERNARY SCI REV, V28, P1914, DOI 10.1016/j.quascirev.2009.03.010; Bouzouggar A, 2007, P NATL ACAD SCI USA, V104, P9964, DOI 10.1073/pnas.0703877104; Busing FMTA, 1999, STAT COMPUT, V9, P3, DOI 10.1023/A:1008800423698; Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048; Eriksson A, 2012, P NATL ACAD SCI USA, V109, P13956, DOI 10.1073/pnas.1200567109; Garcea E., 2010, S E MED PEOPLES 130, P192; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hammer MF, 2011, P NATL ACAD SCI USA, V108, P15123, DOI 10.1073/pnas.1109300108; Harvati K, 2012, MODERN ORIGINS N AFR; Henn BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002397; Hublin J-J, 2012, MODERN ORIGINS N AFR; Hunter-Zinck H, 2010, AM J HUM GENET, V87, P17, DOI 10.1016/j.ajhg.2010.05.018; Kuhner MK, 2000, GENETICS, V156, P439; KUNSCH HR, 1989, ANN STAT, V17, P1217, DOI 10.1214/aos/1176347265; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Meyer M, 2012, SCIENCE         0831; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Osborne AH, 2008, P NATL ACAD SCI USA, V105, P16444, DOI 10.1073/pnas.0804472105; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Reich D, 2011, AM J HUM GENET, V89, P516, DOI 10.1016/j.ajhg.2011.09.005; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Sankararaman S, 2012, ARXIV12082238V1; Skoglund P, 2012, SCIENCE, V336, P466, DOI 10.1126/science.1216304; Skoglund P, 2011, P NATL ACAD SCI USA, V108, P18301, DOI 10.1073/pnas.1108181108; Yang MA, 2012, MOL BIOL EVOL; Yotova V, 2011, MOL BIOL EVOL, V28, P1957, DOI 10.1093/molbev/msr024	32	54	56	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47765	10.1371/journal.pone.0047765	http://dx.doi.org/10.1371/journal.pone.0047765			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082212	Green Published, gold			2022-12-25	WOS:000311146900109
J	Sperduti, A; Crivellaro, F; Rossi, PF; Bondioli, L				Sperduti, Alessandra; Crivellaro, Federica; Rossi, Paola Francesca; Bondioli, Luca			"Do Octopuses Have a Brain?" Knowledge, Perceptions and Attitudes towards Neuroscience at School	PLOS ONE			English	Article							SCIENCE; NEUROETHICS; SOCIETY; DECADE; WANT	The present study contributes to the question of school literacy about the brain, with an original survey conducted on Italian students from the 3rd to 10th grades (n = 508). The main goal was to test student's knowledge, attitudes, and interests about neuroscience, to assess needs, prospects, and difficulties in teaching about the brain from elementary to high school. A written questionnaire, maintaining anonymity, asked 12 close-ended multiple choice questions on topics related to human and animal brains, plus one facultative open-ended question about interests and curiosities on brain topics. The results show that respondents have a fragmentary level of basic knowledge about the brain, with aspects related to brain functions and consciousness the most challenging. As expected, degrees of performance improve with school level; elementary school students answered correctly an average number of 5.3 questions, middle school 6.5, and high school 7.4. Overall, students show great interest in the brain, as shown by the large number of questions gathered through the open-ended question (n = 384). Other topics are addressed, mostly related to brain structure/functions and the role of the brain in the everyday life. The survey indicates the need of more thorough school programs on this subject, reinforced by interdisciplinary teaching where comparative anatomy and evolutionary aspects of brain development are covered.	[Sperduti, Alessandra; Crivellaro, Federica; Rossi, Paola Francesca; Bondioli, Luca] Natl Museum Prehist & Ethnog L Pigorini, Sect Anthropol, Rome, Italy		Sperduti, A (corresponding author), Natl Museum Prehist & Ethnog L Pigorini, Sect Anthropol, Rome, Italy.	alesandra.sperduti@beniculturali.it	Sperduti, Alessandra/AAP-8192-2020	Bondlioli, Luca/0000-0002-8511-7667; Sperduti, Alessandra/0000-0001-9338-5891; Crivellaro, Federica/0000-0003-1656-8605	Italian Ministero dell'Istruzione, Universita e Ricerca (MIUR)	Italian Ministero dell'Istruzione, Universita e Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This research was performed with the contribution of the Italian Ministero dell'Istruzione, Universita e Ricerca (MIUR) grant for the Scientific Culture Dissemination (year 2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abi-Rached JM, 2008, EMBO REP, V9, P1158, DOI 10.1038/embor.2008.211; Ausubel D.P., 1968, ED PSYCHOL COGNITIVE; Cameron W, 2003, NAT REV NEUROSCI, V4, P763, DOI 10.1038/nrn1200; Cameron William E, 2006, CBE Life Sci Educ, V5, P91, DOI 10.1187/cbe.06-03-0151; Carlson BA, 2012, ARCH NEUROL-CHICAGO, V69, P987, DOI 10.1001/archneurol.2012.77; Celone K, 2009, AM J BIOETHICS, V9, P28, DOI 10.1080/15265160802617985; Chudler EH, 2010, SCIENCE, V328, P1648, DOI 10.1126/science.1186935; D'Antona M, 2001, DIDATTICA BIOL; Dehaene S., 2005, MONKEY BRAIN HUMAN B; Della Sala S, 1999, MIND MYTHS EXPLORING; Dominici G, 2008, TUTTOSCUOLA, V480, P46; Falchetti E, 2007, PUBLIC UNDERST SCI, V16, P489, DOI 10.1177/0963662505063797; Foy Judith G, 2006, CBE Life Sci Educ, V5, P128, DOI 10.1187/cbe.05-08-0107; Frantz Kyle J, 2006, CBE Life Sci Educ, V5, P175, DOI 10.1187/cbe.05-09-0119; Frazzetto G, 2009, NAT REV NEUROSCI, V10, P815, DOI 10.1038/nrn2736; Herculano-Houzel S, 2003, NAT NEUROSCI, V6, P325, DOI 10.1038/nn0403-325; Herculano-Houzel S, 2002, NEUROSCIENTIST, V8, P98, DOI 10.1177/107385840200800206; Herculano-Houzel S, 2011, ANN NY ACAD SCI, V1225, P191, DOI 10.1111/j.1749-6632.2011.05976.x; Holloway R. L., 2009, ENCY NEUROSCIENCE, P1326; Hughes V, 2010, NATURE, V464, P340, DOI 10.1038/464340a; Illes J, 2005, NAT REV NEUROSCI, V6, P977, DOI 10.1038/nrn1808; Illes J, 2006, TRENDS NEUROSCI, V29, P511, DOI 10.1016/j.tins.2006.07.002; Illes J, 2010, NAT REV NEUROSCI, V11, P61, DOI 10.1038/nrn2773; Jenkins E. W., 2006, STUD SCI EDUC, V42, P49, DOI DOI 10.1080/03057260608560220; Kawade S., 2011, P IEEE GLOB TEL C GL, P1; Labriole M, 2010, CEREBRUM; Liu Dennis, 2006, CBE Life Sci Educ, V5, P94, DOI 10.1187/cbe.06-02-0147; Longo C, 2001, DIDATTICA BIOL; McLennan DA, 2010, EVOLUTION N Y, V3, P548; Miller L, 2002, NEUROSCIENTIST, V8, P16, DOI 10.1177/107385840200800106; Miller Leslie, 2006, CBE Life Sci Educ, V5, P137, DOI 10.1187/cbe.05-08-0115; O'Brien D. T., 2011, EVOLUTION ED OUTREAC, V4, P107, DOI [10.1007/s12052-010-0305-2, DOI 10.1007/S12052-010-0305-2]; O'Connor C, 2012, NEURON, V74, P220, DOI 10.1016/j.neuron.2012.04.004; R Development Core Team, 2012, R LANG ENV STAT COMP; Ramani D, 2009, J CLIN OUTCOMES MANA, P8; Roseman JE, 2010, CEREBRUM; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Sperduti A, 2010, MUSEOLOGIA SCI MEMOR, V6, P231; Tanner KD, 2006, CBE-LIFE SCI EDUC, P5; Valente A, 2008, 22 CNR; Wardlaw JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025829; Yandell BS, 1997, PRACTICAL DATA ANAL; Zardetto-Smith AM, 2000, NEUROSCIENTIST, V6, P159, DOI 10.1177/107385840000600307; Zardetto-Smith AM, 2002, NEUROSCIENTIST, V8, P396, DOI 10.1177/107385802236965	44	14	14	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47943	10.1371/journal.pone.0047943	http://dx.doi.org/10.1371/journal.pone.0047943			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082231	Green Published, Green Submitted, gold			2022-12-25	WOS:000311146900128
J	Ong, WD; Voo, LYC; Kumar, VS				Ong, Wen Dee; Voo, Lok-Yung Christopher; Kumar, Vijay Subbiah			De Novo Assembly, Characterization and Functional Annotation of Pineapple Fruit Transcriptome through Massively Parallel Sequencing	PLOS ONE			English	Article							GENES; IDENTIFICATION; FOLATE; BIOCHEMISTRY; GENERATION; HEALTH; ESTS; TAGS	Background: Pineapple (Ananas comosus var. comosus), is an important tropical non-climacteric fruit with high commercial potential. Understanding the mechanism and processes underlying fruit ripening would enable scientists to enhance the improvement of quality traits such as, flavor, texture, appearance and fruit sweetness. Although, the pineapple is an important fruit, there is insufficient transcriptomic or genomic information that is available in public databases. Application of high throughput transcriptome sequencing to profile the pineapple fruit transcripts is therefore needed. Methodology/Principal Findings: To facilitate this, we have performed transcriptome sequencing of ripe yellow pineapple fruit flesh using Illumina technology. About 4.7 millions Illumina paired-end reads were generated and assembled using the Velvet de novo assembler. The assembly produced 28,728 unique transcripts with a mean length of approximately 200 bp. Sequence similarity search against non-redundant NCBI database identified a total of 16,932 unique transcripts (58.93%) with significant hits. Out of these, 15,507 unique transcripts were assigned to gene ontology terms. Functional annotation against Kyoto Encyclopedia of Genes and Genomes pathway database identified 13,598 unique transcripts (47.33%) which were mapped to 126 pathways. The assembly revealed many transcripts that were previously unknown. Conclusions: The unique transcripts derived from this work have rapidly increased of the number of the pineapple fruit mRNA transcripts as it is now available in public databases. This information can be further utilized in gene expression, genomics and other functional genomics studies in pineapple.	[Ong, Wen Dee; Voo, Lok-Yung Christopher; Kumar, Vijay Subbiah] Univ Malaysia Sabah, Biotechnol Res Inst, Kota Kinabalu, Sabah, Malaysia	Universiti Malaysia Sabah	Kumar, VS (corresponding author), Univ Malaysia Sabah, Biotechnol Res Inst, Kota Kinabalu, Sabah, Malaysia.	vijay@ume.edu.my	Kumar, Vijay S./G-4290-2011; Voo, Christopher/I-6880-2016	Kumar, Vijay S./0000-0002-0384-1580; 	Ministry of Science, Technology and Innovation, Malaysia [02-01-10-SF0026]	Ministry of Science, Technology and Innovation, Malaysia(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia)	This study was supported by the ScienceFund grant (02-01-10-SF0026) from the Ministry of Science, Technology and Innovation, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Beldade P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-130; Bevan M, 2005, GENOME RES, V15, P1632, DOI 10.1101/gr.3723405; Bombarely A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-503; Collins LJ, 2008, GENOME INFORM SER, V21, P3; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Costa GGL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-462; Crowhurst RN, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-351; de La Garza RID, 2007, P NATL ACAD SCI USA, V104, P4218, DOI 10.1073/pnas.0700409104; Dudareva N, 2004, PLANT PHYSIOL, V135, P1893, DOI 10.1104/pp.104.049981; Dudareva N, 2008, CURR OPIN BIOTECH, V19, P181, DOI 10.1016/j.copbio.2008.02.011; Elss S, 2005, LWT-FOOD SCI TECHNOL, V38, P263, DOI 10.1016/j.lwt.2004.07.014; Giovannoni JJ, 2007, CURR OPIN PLANT BIOL, V10, P283, DOI 10.1016/j.pbi.2007.04.008; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Hegedus Z, 2009, MOL IMMUNOL, V46, P2918, DOI 10.1016/j.molimm.2009.07.002; Li JH, 2006, BIOTECHNOL LETT, V28, P1193, DOI 10.1007/s10529-006-9074-y; Liu Q, 2009, J EXP BOT, V60, P801, DOI 10.1093/jxb/ern329; Lokanathan Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-76; Meyer E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-219; Moyle R, 2005, J EXP BOT, V56, P101, DOI 10.1093/jxb/eri015; Negri AS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-378; Newcomb RD, 2006, PLANT PHYSIOL, V141, P147, DOI 10.1104/pp.105.076208; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Parchman TL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-180; Park S, 2006, PLANT PHYSIOL, V141, P811, DOI 10.1104/pp.106.080994; Pop M, 2008, TRENDS GENET, V24, P142, DOI 10.1016/j.tig.2007.12.006; Quilang J, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-157; Rosenkranz R, 2008, GENOMICS, V92, P187, DOI 10.1016/j.ygeno.2008.05.011; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Smith AG, 2007, CURR OPIN PLANT BIOL, V10, P266, DOI 10.1016/j.pbi.2007.04.009; Stover PJ, 2004, NUTR REV, V62, pS3, DOI 10.1111/j.1753-4887.2004.tb00070.x; Vahteristo L, 1997, FOOD CHEM, V59, P589, DOI 10.1016/S0308-8146(96)00318-4; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang W, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-465; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; Wang ZY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-726; WHETTEN R, 1995, PLANT CELL, V7, P1001, DOI 10.2307/3870053; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhou YC, 2003, FOOD CHEM, V80, P565, DOI 10.1016/S0308-8146(02)00375-8	41	36	38	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e46937	10.1371/journal.pone.0046937	http://dx.doi.org/10.1371/journal.pone.0046937			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091603	gold, Green Submitted, Green Published			2022-12-25	WOS:000310135800018
J	Serranova, T; Jech, R; Marti, MJ; Modreanu, R; Valldeoriola, F; Sieger, T; Ruzicka, E; Valls-Sole, J				Serranova, Tereza; Jech, Robert; Jose Marti, Maria; Modreanu, Raluca; Valldeoriola, Francesc; Sieger, Tomas; Ruzicka, Evzen; Valls-Sole, Josep			A Loud Auditory Stimulus Overcomes Voluntary Movement Limitation in Cervical Dystonia	PLOS ONE			English	Article							SPASMODIC TORTICOLLIS; PARADOXICAL KINESIA; ARM MOVEMENTS; REACTION-TIME; STARTLE; PATHOPHYSIOLOGY; EXCITABILITY; HUMANS; STIMULATION; DISORDERS	Background: Patients with cervical dystonia (CD) present with an impaired performance of voluntary neck movements, which are usually slow and limited. We hypothesized that such abnormality could involve defective preparation for task execution. Therefore, we examined motor preparation in CD patients using the StartReact method. In this test, a startling auditory stimulus (SAS) is delivered unexpectedly at the time of the imperative signal (IS) in a reaction time task to cause a faster execution of the prepared motor programme. We expected that CD patients would show an abnormal StartReact phenomenon. Methods: Fifteen CD patients and 15 age matched control subjects (CS) were asked to perform a rotational movement (RM) to either side as quick as possible immediately after IS perception (a low intensity electrical stimulus to the II finger). In randomly interspersed test trials (25%) a 130 dB SAS was delivered simultaneously with the IS. We recorded RMs in the horizontal plane with a high speed video camera (2.38 ms per frame) in synchronization with the IS. The RM kinematic-parameters (latency, velocity, duration and amplitude) were analyzed using video-editing software and screen protractor. Patients were asked to rate the difficulty of their RMs in a numerical rating scale. Results: In control trials, CD patients executed slower RMs (repeated measures ANOVA, p<0.10(-5)), and reached a smaller final head position angle relative to the midline (p<0.05), than CS. In test trials, SAS improved all RMs in both groups (p<0.10(-14)). In addition, patients were more likely to reach beyond their baseline RM than CS (chi(2), p<0.001) and rated their performance better than in control trials (t-test, p<0.01). Conclusion: We found improvement of kinematic parameters and subjective perception of motor performance in CD patients with StartReact testing. Our results suggest that CD patients reach an adequate level of motor preparation before task execution.	[Serranova, Tereza; Jech, Robert; Sieger, Tomas; Ruzicka, Evzen] Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic; [Serranova, Tereza; Jech, Robert; Sieger, Tomas; Ruzicka, Evzen] Charles Univ Prague, Fac Med 1, Ctr Clin Neurosci, Prague, Czech Republic; [Jose Marti, Maria; Modreanu, Raluca; Valldeoriola, Francesc] Univ Barcelona, Hosp Clin, Parkinsons Dis & Movement Disorders Unit,Inst Inv, Ctr Invest Red Enfermedades Neurodegenerat CIBERN, Barcelona, Spain; [Sieger, Tomas] Czech Tech Univ, Fac Elect Engn, Dept Cybernet, CR-16635 Prague, Czech Republic; [Valls-Sole, Josep] Univ Barcelona, Fac Med, Hosp Clin, Dept Neurol,EMG & Motor Control Unit,Inst Invest, Barcelona 7, Spain	Charles University Prague; Charles University Prague; University of Barcelona; Czech Technical University Prague; University of Barcelona	Serranova, T (corresponding author), Charles Univ Prague, Fac Med 1, Dept Neurol, Prague, Czech Republic.	tereza.serranova@gmail.com	Jech, Robert/HHY-7342-2022; Sieger, Tomas/AAD-9342-2019; Serranová, Tereza/AAY-2386-2021	Jech, Robert/0000-0002-9732-8947; Serranová, Tereza/0000-0001-6525-3971; Sieger, Tomas/0000-0003-4960-1934; Ruzicka, Evzen/0000-0002-4893-9661	Czech Ministry of Health [IGA MZ CR NT12282-5/2011]; Czech Ministry of Education [MSM 0021620849]; Charles University in Prague [PRVOUK-P26/LF1/4]; Marato TV3 [PI110930]; European Neurological Society	Czech Ministry of Health(Ministry of Health, Czech Republic); Czech Ministry of Education(Ministry of Education, Youth & Sports - Czech Republic); Charles University in Prague; Marato TV3; European Neurological Society	This work was supported by the Czech Ministry of Health: IGA MZ CR NT12282-5/2011, the Czech Ministry of Education: research project MSM 0021620849, by the Charles University in Prague: research project PRVOUK-P26/LF1/4 and by a grant from Marato TV3 (PI110930) to JVS. TS was supported by Fellowship of the European Neurological Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibiglou L, 2012, J PHYSIOL-LONDON, V590, DOI 10.1113/jphysiol.2011.219592; Anzak A, 2011, EUR J NEUROSCI, V34, P124, DOI 10.1111/j.1460-9568.2011.07735.x; Anzak A, 2011, EXP BRAIN RES, V208, P237, DOI 10.1007/s00221-010-2474-1; Berardelli A, 1996, BRAIN, V119, P661, DOI 10.1093/brain/119.2.661; Berardelli A, 1998, BRAIN, V121, P1195, DOI 10.1093/brain/121.7.1195; Boccagni C, 2008, NEUROL SCI, V29, P375, DOI 10.1007/s10072-008-1033-z; Bonanni L, 2010, MOVEMENT DISORD, V25, P1302, DOI 10.1002/mds.23075; Carboncini MC, 2004, ARCH ITAL BIOL, V142, P113; Carlsen AN, 2004, EXP BRAIN RES, V159, P301, DOI 10.1007/s00221-004-1924-z; CHAN J, 1991, MOVEMENT DISORD, V6, P119, DOI 10.1002/mds.870060206; Comella CL, 1997, MOVEMENT DISORD, V12, P570, DOI 10.1002/mds.870120414; Curra A, 2000, MOVEMENT DISORD, V15, P103, DOI 10.1002/1531-8257(200001)15:1<103::AID-MDS1016>3.0.CO;2-3; Dauer WT, 1998, BRAIN, V121, P547, DOI 10.1093/brain/121.4.547; FAHN S, 1987, CLASSIFICATION INVES, P332; Gregori B, 2008, CLIN NEUROPHYSIOL, V119, P273, DOI 10.1016/j.clinph.2007.10.007; Hallett M, 2006, J NEURAL TRANSM-SUPP, P485; HALLETT M, 1975, J NEUROL NEUROSUR PS, V38, P1154, DOI 10.1136/jnnp.38.12.1154; Hamani C, 2007, CURR OPIN NEUROL, V20, P470, DOI 10.1097/WCO.0b013e32825ea69d; Henderson L, 1998, BRIT J PSYCHOL, V89, P531, DOI 10.1111/j.2044-8295.1998.tb02702.x; MacKinnon CD, 2000, J PHYSIOL-LONDON, V528, P633, DOI 10.1111/j.1469-7793.2000.00633.x; MacKinnon CD, 2004, MOVEMENT DISORD, V19, P273, DOI 10.1002/mds.20017; Muller J, 2003, MOVEMENT DISORD, V18, P1522, DOI 10.1002/mds.10609; Munchau A, 2001, BRAIN, V124, P47, DOI 10.1093/brain/124.1.47; NAKASHIMA K, 1989, NEUROLOGY, V39, P1354, DOI 10.1212/WNL.39.10.1354; NAKASHIMA K, 1989, BRAIN, V112, P681, DOI 10.1093/brain/112.3.681; Queralt A, 2008, J PHYSIOL-LONDON, V586, P4453, DOI 10.1113/jphysiol.2008.156042; Reynolds RF, 2007, J PHYSIOL-LONDON, V583, P1107, DOI 10.1113/jphysiol.2007.136192; Rothwell J C, 1988, Adv Neurol, V50, P133; Sanegre MT, 2004, EXP BRAIN RES, V155, P527, DOI 10.1007/s00221-004-1849-6; Schlesinger I, 2007, MOVEMENT DISORD, V22, P2394, DOI 10.1002/mds.21739; TOLOSA E, 1988, MOVEMENT DISORD, V3, P61, DOI 10.1002/mds.870030108; Valldeoriola F, 1998, NEUROLOGY, V51, P1315, DOI 10.1212/WNL.51.5.1315; Valls-Sole J, 1999, J PHYSIOL-LONDON, V516, P931, DOI 10.1111/j.1469-7793.1999.0931u.x; Valls-Sole Josep, 2004, Suppl Clin Neurophysiol, V57, P554; Valls-Sole J, 2008, EXP BRAIN RES, V187, P497, DOI 10.1007/s00221-008-1402-0; VANDERKAMP W, 1989, J NEUROL NEUROSUR PS, V52, P1043, DOI 10.1136/jnnp.52.9.1043; Vitek JL, 2002, MOVEMENT DISORD, V17, pS49, DOI 10.1002/mds.10142	37	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e46586	10.1371/journal.pone.0046586	http://dx.doi.org/10.1371/journal.pone.0046586			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091598	Green Published, Green Submitted, gold			2022-12-25	WOS:000310135800010
J	Zhou, HC; Dong, XY; Kabarriti, R; Chen, Y; Avsar, Y; Wang, X; Ding, JQ; Liu, LB; Fox, IJ; Roy-Chowdhury, J; Roy-Chowdhury, N; Guha, C				Zhou, Hongchao; Dong, Xinyuan; Kabarriti, Rafi; Chen, Yong; Avsar, Yesim; Wang, Xia; Ding, Jianqiang; Liu, Laibin; Fox, Ira J.; Roy-Chowdhury, Jayanta; Roy-Chowdhury, Namita; Guha, Chandan			Single Liver Lobe Repopulation with Wildtype Hepatocytes Using Regional Hepatic Irradiation Cures Jaundice in Gunn Rats	PLOS ONE			English	Article							EXTERNAL-BEAM RADIOTHERAPY; PREPARATIVE REGIMEN; PARTIAL-HEPATECTOMY; TRANSPLANTATION; RADIATION; DISEASE; MODEL; BILIRUBIN; TYPE-1; VIVO	Background and Aims: Preparative hepatic irradiation (HIR), together with mitotic stimulation of hepatocytes, permits extensive hepatic repopulation by transplanted hepatocytes in rats and mice. However, whole liver HIR is associated with radiation-induced liver disease (RILD), which limits its potential therapeutic application. In clinical experience, restricting HIR to a fraction of the liver reduces the susceptibility to RILD. Here we test the hypothesis that repopulation of selected liver lobes by regional HIR should be sufficient to correct some inherited metabolic disorders. Methods: Hepatocytes (10(7)) isolated from wildtype F344 rats or Wistar-RHA rats were engrafted into the livers of congeneic dipeptidylpeptidase IV deficient (DPPIV-) rats or uridinediphosphoglucuronateglucuronosyltransferase-1A1-deficient jaundiced Gunn rats respectively by intrasplenic injection 24 hr after HIR (50 Gy) targeted to the median lobe, or median plus left liver lobes. An adenovector expressing hepatocyte growth factor (10(11) particles) was injected intravenously 24 hr after transplantation. Results: Three months after hepatocyte transplantation in DPPIV- rats, 30-60% of the recipient hepatocytes were replaced by donor cells in the irradiated lobe, but not in the nonirradiated lobes. In Gunn rats receiving median lobe HIR, serum bilirubin declined from pretreatment levels of 5.17 +/- 0.78 mg/dl to 0.96 +/- 0.30 mg/dl in 8 weeks and remained at this level throughout the 16 week observation period. A similar effect was observed in the group, receiving median plus left lobe irradiation. Conclusions: As little as 20% repopulation of 30% of the liver volume was sufficient to correct hyperbilirubinemia in Gunn rats, highlighting the potential of regiospecific HIR in hepatocyte transplantation-based therapy of inherited metabolic liver diseases.	[Chen, Yong; Avsar, Yesim; Wang, Xia; Ding, Jianqiang; Roy-Chowdhury, Jayanta; Roy-Chowdhury, Namita] Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA; [Zhou, Hongchao; Dong, Xinyuan; Kabarriti, Rafi; Liu, Laibin; Guha, Chandan] Albert Einstein Coll Med, Dept Radiat Oncol, Bronx, NY 10467 USA; [Zhou, Hongchao; Dong, Xinyuan; Kabarriti, Rafi; Liu, Laibin; Guha, Chandan] Montefiore Med Ctr, Bronx, NY 10467 USA; [Fox, Ira J.] Univ Pittsburgh, Childrens Hosp Pittsburgh UPMC, Sch Med, Dept Surg, Pittsburgh, PA USA; [Fox, Ira J.] McGowan Inst Regenerat Med, Pittsburgh, PA USA; [Chen, Yong; Avsar, Yesim; Wang, Xia; Ding, Jianqiang; Roy-Chowdhury, Jayanta; Roy-Chowdhury, Namita] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Zhou, Hongchao; Dong, Xinyuan; Kabarriti, Rafi; Liu, Laibin] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Roy-Chowdhury, N (corresponding author), Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA.	Namita.Roychowdhury@Einstein.YU.edu; cguha@montefiore.org		Ding, Jianqiang/0000-0003-1964-1513	National Institutes of Health [RO1 DK 46057, RO1 DK 67440]; NY Stem [CO24346, DK RO1 079017]; Oxalosis and Hyperoxaluria Foundation [R01 DK64670, R21/R33 CA121051]; NATIONAL CANCER INSTITUTE [R21CA121051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064670, R01DK046057, R01DK067440, R01DK079017] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NY Stem; Oxalosis and Hyperoxaluria Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health grants: RO1 DK 46057 and RO1 DK 67440, NY Stem CO24346 (to JRC); DK RO1 079017 (NRC), Oxalosis and Hyperoxaluria Foundation (to NRC); R01 DK64670 and R21/R33 CA121051 (to CG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosino G, 2005, CELL TRANSPLANT, V14, P151, DOI 10.3727/000000005783983250; CHOWDHURY J R, 1981, Hepatology, V1, P622; Chowdury NR, 2009, LIVER BIOL PATHOBIOL, P251; Christiansen H, 2006, INT J RADIAT ONCOL, V65, P509, DOI 10.1016/j.ijrobp.2006.01.040; Dawson LA, 2005, SEMIN RADIAT ONCOL, V15, P279, DOI 10.1016/j.semradonc.2005.04.005; Dawson LA, 2002, INT J RADIAT ONCOL, V53, P810, DOI 10.1016/S0360-3016(02)02846-8; Dhawan A, 2006, J INHERIT METAB DIS, V29, P431, DOI 10.1007/s10545-006-0245-8; Dhawan A, 2010, METHODS MOL BIOL, V640, P525, DOI 10.1007/978-1-60761-688-7_29; FEVERY J, 1977, J CLIN INVEST, V60, P970, DOI 10.1172/JCI108877; Fisher RA, 2006, TRANSPLANTATION, V82, P441, DOI 10.1097/01.tp.0000231689.44266.ac; Fox IJ, 1998, NEW ENGL J MED, V338, P1422, DOI 10.1056/NEJM199805143382004; Grompe M, 1999, SEMIN LIVER DIS, V19, P7, DOI 10.1055/s-2007-1007093; Guha C, 2005, AM J NEPHROL, V25, P161, DOI 10.1159/000085408; Guha C, 2002, HEPATOLOGY, V36, P354, DOI 10.1053/jhep.2002.34516; Guha C, 2001, INT J RADIAT ONCOL, V49, P451, DOI 10.1016/S0360-3016(00)01495-4; Guha C, 1999, CANCER RES, V59, P5871; Gupta S, 1999, HEPATOLOGY, V29, P509, DOI 10.1002/hep.510290213; Gupta S, 1999, SEMIN LIVER DIS, V19, P15, DOI 10.1055/s-2007-1007094; Horslen SP, 2003, PEDIATRICS, V111, P1262, DOI 10.1542/peds.111.6.1262; Jiang JL, 2008, TRANSPLANTATION, V85, P1253, DOI 10.1097/TP.0b013e31816de49e; Krause P, 2011, INT J RADIAT ONCOL, V80, P1214, DOI 10.1016/j.ijrobp.2011.02.035; Laconi E, 1998, AM J PATHOL, V153, P319, DOI 10.1016/S0002-9440(10)65574-5; Lake JR, 1998, NEW ENGL J MED, V338, P1463, DOI 10.1056/NEJM199805143382012; Legido-Quigley C, 2009, BIOANALYSIS, V1, P1527, DOI [10.4155/bio.09.112, 10.4155/BIO.09.112]; NEUFELD DS, 1997, ISOLATION RAT HEPATO; Oertel M, 2006, GASTROENTEROLOGY, V130, P507, DOI 10.1053/j.gastro.2005.10.049; Overturf K, 1996, NAT GENET, V12, P266, DOI 10.1038/ng0396-266; PIAZZA GA, 1989, BIOCHEM J, V262, P327, DOI 10.1042/bj2620327; Soltys KA, 2010, J HEPATOL, V53, P769, DOI 10.1016/j.jhep.2010.05.010; Waelzlein JH, 2009, CURR OPIN NEPHROL HY, V18, P481, DOI 10.1097/MNH.0b013e3283318e1c; Wang Xia, 2009, V481, P117, DOI 10.1007/978-1-59745-201-4_11; Yamanouchi K, 2009, HEPATOLOGY, V49, P258, DOI 10.1002/hep.22573	32	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e46775	10.1371/journal.pone.0046775	http://dx.doi.org/10.1371/journal.pone.0046775			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091601	Green Published, Green Submitted, gold			2022-12-25	WOS:000310135800014
J	He, Y; Wang, H; Qian, BD; McConkey, B; DePauw, R				He, Yong; Wang, Hong; Qian, Budong; McConkey, Brian; DePauw, Ron			How Early Can the Seeding Dates of Spring Wheat Be under Current and Future Climate in Saskatchewan, Canada?	PLOS ONE			English	Article							GRAIN-YIELD; CERES-WHEAT; TEMPERATURE; GROWTH; PREDICTION; MODELS; PRECIPITATION; SIMULATION; MANAGEMENT; ALBERTA	Background: Shorter growing season and water stress near wheat maturity are the main factors that presumably limit the yield potential of spring wheat due to late seeding in Saskatchewan, Canada. Advancing seeding dates can be a strategy to help producers mitigate the impact of climate change on spring wheat. It is unknown, however, how early farmers can seed while minimizing the risk of spring frost damage and the soil and machinery constraints. Methodology/principal findings: This paper explores early seeding dates of spring wheat on the Canadian Prairies under current and projected future climate. To achieve this, (i) weather records from 1961 to 1990 were gathered at three sites with different soil and climate conditions in Saskatchewan, Canada; (ii) four climate databases that included a baseline (treated as historic weather climate during the period of 1961-1990) and three climate change scenarios (2040-2069) developed by the Canadian global climate model (GCM) with the forcing of three greenhouse gas (GHG) emission scenarios (A2, A1B and B1); (iii) seeding dates of spring wheat (Triticum aestivum L.) under baseline and projected future climate were predicted. Compared with the historical record of seeding dates, the predicted seeding dates were advanced under baseline climate for all sites using our seeding date model. Driven by the predicted temperature increase of the scenarios compared with baseline climate, all climate change scenarios projected significantly earlier seeding dates than those currently used. Compared to the baseline conditions, there is no reduction in grain yield because precipitation increases during sensitive growth stages of wheat, suggesting that there is potential to shift seeding to an earlier date. The average advancement of seeding dates varied among sites and chosen scenarios. The Swift Current (south-west) site has the highest potential for earlier seeding (7 to 11 days) whereas such advancement was small in the Melfort (north-east, 2 to 4 days) region. Conclusions/significance: The extent of projected climate change in Saskatchewan indicates that growers in this region have the potential of earlier seeding. The results obtained in this study may be used for adaptation assessments of seeding dates under possible climate change to mitigate the impact of potential warming.	[He, Yong; Wang, Hong; McConkey, Brian; DePauw, Ron] Agr & Agri Food Canada, Semiarid Prairie Agr Res Ctr, Swift Current, SK, Canada; [He, Yong] China Agr Univ, Dept Soil & Water Sci, Beijing 100094, Peoples R China; [Qian, Budong] Agr & Agri Food Canada, Eastern Cereal & Oilseed Res Ctr, Ottawa, ON, Canada	Agriculture & Agri Food Canada; China Agricultural University; Agriculture & Agri Food Canada	Wang, H (corresponding author), Agr & Agri Food Canada, Semiarid Prairie Agr Res Ctr, Swift Current, SK, Canada.	hong.wang@agr.gc.ca		Qian, Budong/0000-0001-5413-3114; He, Yong/0000-0003-4062-9201	Agriculture and Agri-Food Canada [96]; Visiting Fellowships in Canadian Government Laboratories Program	Agriculture and Agri-Food Canada(Agriculture & Agri Food Canada); Visiting Fellowships in Canadian Government Laboratories Program	This study was funded by Agriculture and Agri-Food Canada (Abase project #96). The authors gratefully acknowledge support for this research from the Visiting Fellowships in Canadian Government Laboratories Program, managed by the Natural Science and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov VA, 2000, THEOR APPL CLIMATOL, V67, P45, DOI 10.1007/s007040070015; Anderson WK, 1996, AUST J EXP AGR, V36, P203, DOI 10.1071/EA9960203; [Anonymous], 2000, SPECIAL REPORT EMISS; Bannayan M, 2003, AGRON J, V95, P114, DOI 10.2134/agronj2003.0114; Barklacich M, 1995, SPECIAL PUBLICATION, P147; BOOTSMA A, 1988, CAN J PLANT SCI, V68, P513, DOI 10.4141/cjps88-062; BOOTSMA A, 1986, CAN J PLANT SCI, V66, P789, DOI 10.4141/cjps86-097; BOOTSMA A, 1993, CAN J PLANT SCI, V73, P389, DOI 10.4141/cjps93-058; BOOTSMA A, 1994, CLIMATIC CHANGE, V26, P65, DOI 10.1007/BF01094009; Chipanshi AC, 1999, AGR SYST, V59, P57, DOI 10.1016/S0308-521X(98)00082-1; DEJONG R, 1984, CAN J SOIL SCI, V64, P667, DOI 10.4141/cjss84-067; *ENV CAN, 1993, CAN CLIM NORM; Gan YT, 2000, RES LETT; Hassan AE, 1975, CAN AGR ENG, V17, P124; HUNT LA, 1993, AGRON J, V85, P1090, DOI 10.2134/agronj1993.00021962008500050025x; Jame YW, 2004, AGR FOREST METEOROL, V124, P207, DOI 10.1016/j.agrformet.2004.01.012; Jamieson PD, 1998, FIELD CROP RES, V55, P23, DOI 10.1016/S0378-4290(97)00060-9; Jones JW, 2003, EUR J AGRON, V18, P235, DOI 10.1016/S1161-0301(02)00107-7; KERR NJ, 1992, AUST J EXP AGR, V32, P717, DOI 10.1071/EA9920717; Khan M, 1996, WEED SCI, V44, P362, DOI 10.1017/S0043174500094017; Kim SJ, 2003, CLIM DYNAM, V20, P635, DOI 10.1007/s00382-002-0292-2; Kim SJ, 2002, CLIM DYNAM, V19, P515, DOI 10.1007/s00382-002-0243-y; Lin E., 2007, PHYS SCI BASIS WORKI, V3, P6; MACDOWALL FD, 1974, CAN J BOT, V52, P151, DOI 10.1139/b74-017; Major DJ, 1996, CAN J PLANT SCI, V76, P59, DOI 10.4141/cjps96-010; McCaig TN, 1997, CAN J PLANT SCI, V77, P215, DOI 10.4141/P96-144; McGinn SM, 1999, OUTLOOK AGR, V28, P19, DOI 10.1177/003072709902800104; MOGENSEN VO, 1985, ACTA AGR SCAND, V35, P353; MOULIN AP, 1993, CAN J PLANT SCI, V73, P713, DOI 10.4141/cjps93-093; Nangia V, 2008, J ENVIRON QUAL, V37, P296, DOI 10.2134/jeq2007.0224; Prasad PVV, 2011, J AGRON CROP SCI, V197, P430, DOI 10.1111/j.1439-037X.2011.00477.x; Qian BD, 2004, CLIM RES, V26, P175, DOI 10.3354/cr026175; Qian BD, 2011, AGR FOREST METEOROL, V151, P1781, DOI 10.1016/j.agrformet.2011.07.016; Quiring SM, 2003, AGR FOREST METEOROL, V118, P49, DOI 10.1016/S0168-1923(03)00072-8; Richards JH, 1969, ATLAS SASKATCHEWAN; SAS Institute Inc, 1999, SAS PRC GUID VERS 8; SIONIT N, 1980, PHYSIOL PLANTARUM, V50, P11, DOI 10.1111/j.1399-3054.1980.tb02675.x; Smith C.W., 1995, CROP PRODUCTION EVOL; Thornton PE, 2000, AGR FOREST METEOROL, V104, P255, DOI 10.1016/S0168-1923(00)00170-2; Wang H, 2009, NJAS-WAGEN J LIFE SC, V57, P65, DOI 10.1016/j.njas.2009.07.003; Wang H, 2010, CAN J SOIL SCI, V90, P37, DOI 10.4141/CJSS08084; Willmott C.J., 1981, PHYS GEOGR, V2, P184, DOI [10.1080/02723646.1981.10642213, DOI 10.1080/02723646.1981.10642213]; Zentner RP, 2003, CAN J PLANT SCI, V83, P667, DOI 10.4141/P02-160	43	21	22	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 10	2012	7	10							e45153	10.1371/journal.pone.0045153	http://dx.doi.org/10.1371/journal.pone.0045153			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZU	23094015	gold, Green Published, Green Submitted			2022-12-25	WOS:000312385200006
J	Liu, L; Alonso, V; Guo, L; Tourkova, I; Henderson, SE; Almarza, AJ; Friedman, PA; Blair, HC				Liu, Li; Alonso, Veronica; Guo, Lida; Tourkova, Irina; Henderson, Sarah E.; Almarza, Alejandro J.; Friedman, Peter A.; Blair, Harry C.			Na+/H+ Exchanger Regulatory Factor 1 (NHERF1) Directly Regulates Osteogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; PROTEIN-COUPLED-RECEPTORS; PARATHYROID-HORMONE; BONE; MOUSE; PHOSPHORYLATION; COTRANSPORTERS; DETERIORATION; ASSOCIATION; INHIBITION	Bone formation requires synthesis, secretion, and mineralization of matrix. Deficiencies in these processes produce bone defects. The absence of the PDZ domain protein Na+/H+ exchange regulatory factor 1 (NHERF1) in mice, or its mutation in humans, causes osteomalacia believed to reflect renal phosphate wasting. We show that NHERF1 is expressed by mineralizing osteoblasts and organizes Na+/H+ exchangers (NHEs) and thePTHreceptor. NHERF1-null mice display reduced bone formation and wide mineralizing fronts despite elimination of phosphate wasting by dietary supplementation. Bone mass was normal, reflecting coordinated reduction of bone resorption and formation. NHERF1-null bone had decreased strength, consistent with compromised matrix quality. Mesenchymal stem cells from NHERF1-null mice showed limited osteoblast differentiation but enhanced adipocyte differentiation. PTH signaling and Na+/H+ exchange were dysregulated in these cells. Osteoclast differentiation from monocytes was unaffected. Thus, NHERF1 is required for normal osteoblast differentiation and matrix synthesis. In its absence, compensatory mechanisms maintain bone mass, but bone strength is reduced.	[Liu, Li; Guo, Lida; Tourkova, Irina; Blair, Harry C.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15261 USA; [Liu, Li; Guo, Lida; Tourkova, Irina; Blair, Harry C.] Univ Pittsburgh, Sch Med, Dept Physiol & Cell Biol, Pittsburgh, PA 15261 USA; [Alonso, Veronica; Friedman, Peter A.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA; [Henderson, Sarah E.; Almarza, Alejandro J.] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol & Bioengn, Pittsburgh, PA 15261 USA; [Henderson, Sarah E.; Almarza, Alejandro J.] Univ Pittsburgh, Sch Engn, Dept Oral Biol & Bioengn, Pittsburgh, PA 15261 USA; [Blair, Harry C.] Pittsburgh Vet Affairs Med Ctr, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Blair, HC (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, S705 Scaife Hall, Pittsburgh, PA 15261 USA.	hcblair@imap.pitt.edu	RODRIGUEZ, VERONICA ALONSO/F-3364-2017	Alonso, Veronica/0000-0002-2813-3257	National Institutes of Health [AR053976, DK069998, AR055208]; Department of Veteran's Affairs; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053976, R01AR055208] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069998] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veteran's Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AR053976, DK069998, and AR055208. This work was also supported by the Department of Veteran's Affairs.	Ardura JA, 2011, J BIOL CHEM, V286, P35020, DOI 10.1074/jbc.M111.264978; Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Blair HC, 2011, BIOFACTORS, V37, P159, DOI 10.1002/biof.143; Brownstein CA, 2010, ENDOCRINOLOGY, V151, P492, DOI 10.1210/en.2009-0564; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Datta NS, 2009, CELL SIGNAL, V21, P1245, DOI 10.1016/j.cellsig.2009.02.012; Feng X, 2011, ANNU REV PATHOL-MECH, V6, P121, DOI 10.1146/annurev-pathol-011110-130203; Fratzl-Zelman N, 2004, J CLIN ENDOCR METAB, V89, P1538, DOI 10.1210/jc.2003-031055; Fratzl-Zelman N, 2011, CALCIFIED TISSUE INT, V88, P378, DOI 10.1007/s00223-011-9466-4; Gupta A, 2001, BONE, V29, P467, DOI 10.1016/S8756-3282(01)00601-9; Hartmann C, 2006, TRENDS CELL BIOL, V16, P151, DOI 10.1016/j.tcb.2006.01.001; Hasegawa K, 2008, J BONE MINER METAB, V26, P394, DOI 10.1007/s00774-007-0827-z; Hernando N, 2002, P NATL ACAD SCI USA, V99, P11957, DOI 10.1073/pnas.182412699; Hosogane N, 2010, INT J BIOCHEM CELL B, V42, P1132, DOI 10.1016/j.biocel.2010.03.020; Jamsa T, 1998, BONE, V23, P155, DOI 10.1016/S8756-3282(98)00076-3; Karim Z, 2008, NEW ENGL J MED, V359, P1128, DOI 10.1056/NEJMc086284; Khadeer MA, 2003, AM J PHYSIOL-CELL PH, V284, pC1633, DOI 10.1152/ajpcell.00580.2002; Li BZ, 2007, STEM CELLS DEV, V16, P921, DOI 10.1089/scd.2007.0074; Liu L, 2011, J CELL PHYSIOL, V226, P1702, DOI 10.1002/jcp.22501; Mannstadt M, 1999, AM J PHYSIOL-RENAL, V277, pF665, DOI 10.1152/ajprenal.1999.277.5.F665; Manoharan R, 1996, SPECTROCHIM ACTA A, V52, P215, DOI 10.1016/0584-8539(95)01573-6; Mistry PK, 2010, P NATL ACAD SCI USA, V107, P19473, DOI 10.1073/pnas.1003308107; Murrills RJ, 2009, J CELL BIOCHEM, V106, P887, DOI 10.1002/jcb.22057; Prie D, 2004, CURR OPIN NEPHROL HY, V13, P675, DOI 10.1097/00041552-200411000-00015; ROBERTS S, 1993, J ORTHOP RES, V11, P747, DOI 10.1002/jor.1100110517; Romero G, 2010, J BIOL CHEM, V285, P14756, DOI 10.1074/jbc.M110.102970; Saeed H, 2011, J BONE MINER RES, V26, P1494, DOI 10.1002/jbmr.349; Saito M, 2006, CALCIFIED TISSUE INT, V79, P160, DOI 10.1007/s00223-006-0035-1; Seeman E, 2010, J BONE MINER RES, V25, P1886, DOI 10.1002/jbmr.81; Shenolikar S, 2004, PHYSIOLOGY, V19, P362, DOI 10.1152/physiol.00020.2004; Shenolikar S, 2002, P NATL ACAD SCI USA, V99, P11470, DOI 10.1073/pnas.162232699; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Tobimatsu T, 2006, ENDOCRINOLOGY, V147, P2583, DOI 10.1210/en.2005-1627; Tropel P, 2004, EXP CELL RES, V295, P395, DOI 10.1016/j.yexcr.2003.12.030; Wang B, 2007, J BIOL CHEM, V282, P36214, DOI 10.1074/jbc.M707263200; Wang B, 2012, J BIOL CHEM, V287, P24148, DOI 10.1074/jbc.M112.369405; Wang B, 2009, MOL PHARMACOL, V75, P1189, DOI 10.1124/mol.108.054486; Weinman EJ, 2000, BIOCHEMISTRY-US, V39, P6123, DOI 10.1021/bi000064m; Weinman EJ, 2006, ANNU REV PHYSIOL, V68, P491, DOI 10.1146/annurev.physiol.68.040104.131050; WEINMAN EJ, 1993, J CLIN INVEST, V92, P1781, DOI 10.1172/JCI116767; Weinstein RS, 2010, ENDOCRINOLOGY, V151, P2641, DOI 10.1210/en.2009-1488; Wheeler DS, 2011, ONCOGENE, V30, P32, DOI 10.1038/onc.2010.389; Wheeler D, 2007, J BIOL CHEM, V282, P25076, DOI 10.1074/jbc.M701544200; Williams BO, 2009, J BONE MINER RES, V24, P171, DOI [10.1359/JBMR.081235, 10.1359/jbmr.081235]	44	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43312	43321		10.1074/jbc.M112.422766	http://dx.doi.org/10.1074/jbc.M112.422766			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23109343	hybrid, Green Published			2022-12-25	WOS:000312940800012
J	Rainczuk, AK; Yamaryo-Botte, Y; Brammananth, R; Stinear, TP; Seemann, T; Coppel, RL; McConville, MJ; Crellin, PK				Rainczuk, Arek K.; Yamaryo-Botte, Yoshiki; Brammananth, Rajini; Stinear, Timothy P.; Seemann, Torsten; Coppel, Ross L.; McConville, Malcolm J.; Crellin, Paul K.			The Lipoprotein LpqW Is Essential for the Mannosylation of Periplasmic Glycolipids in Corynebacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WALL ARABINAN BIOSYNTHESIS; MYCOBACTERIUM-TUBERCULOSIS; PHOSPHATIDYLINOSITOL MANNOSIDES; LIPOARABINOMANNAN BIOSYNTHESIS; MONOPHOSPHOMANNOSE SYNTHASE; DEFICIENT MUTANT; CLONING VECTORS; CONSERVED GENE; MYCOLIC ACIDS; EMB PROTEINS	Phosphatidylinositol mannosides (PIM), lipomannan (LM), and lipoarabinomannan (LAM) are essential components of the cell wall and plasma membrane of mycobacteria, including the human pathogen Mycobacterium tuberculosis, as well as the related Corynebacterineae. We have previously shown that the lipoprotein, LpqW, regulates PIM and LM/LAM biosynthesis in mycobacteria. Here, we provide direct evidence that LpqW regulates the activity of key mannosyltransferases in the periplasmic leaflet of the cell membrane. Inactivation of the Corynebacterium glutamicum lpqW ortholog, NCgl1054, resulted in a slow growth phenotype and a global defect in lipoglycan biosynthesis. The NCgl1054 mutant lacked LAMs and was defective in the elongation of the major PIM species, AcPIM2, as well as a second glycolipid, termed Gl-X (mannose-alpha 1-4-glucuronic acid-alpha 1-diacylglycerol), which function as membrane anchors for LM-A and LM-B, respectively. Elongation of AcPIM2 and Gl-X was found to be dependent on expression of polyprenol phosphomannose (ppMan) synthase. However, the Delta NCgl1054 mutant synthesized normal levels of ppMan, indicating that LpqW is not required for synthesis of this donor. A spontaneous suppressor strain was isolated in which lipoglycan synthesis in the Delta NCgl1054 mutant was partially restored. Genome-wide sequencing indicated that a single amino acid substitution within the ppMan-dependent mannosyltransferase MptB could bypass the need for LpqW. Further evidence of an interaction is provided by the observation that MptB activity in cell-free extracts was significantly reduced in the absence of LpqW. Collectively, our results suggest that LpqW may directly activate MptB, highlighting the role of lipoproteins in regulating key cell wall biosynthetic pathways in these bacteria.	[Rainczuk, Arek K.; Brammananth, Rajini; Coppel, Ross L.; Crellin, Paul K.] Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia; [Rainczuk, Arek K.; Brammananth, Rajini; Seemann, Torsten; Coppel, Ross L.; Crellin, Paul K.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia; [Yamaryo-Botte, Yoshiki; McConville, Malcolm J.] Univ Melbourne, Inst Mol Sci & Biotechnol Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Stinear, Timothy P.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3010, Australia; [Seemann, Torsten; Coppel, Ross L.] Monash Univ, Victorian Bioinformat Consortium, Clayton, Vic 3800, Australia	Monash University; Monash University; University of Melbourne; University of Melbourne; Monash University	Crellin, PK (corresponding author), Monash Univ, Australian Res Council, Ctr Excellence Struct & Funct Microbial Genom, Clayton, Vic 3800, Australia.	paul.crellin@monash.edu	Coppel, Ross L/A-6626-2008; Seemann, Torsten/B-2318-2010	Coppel, Ross L/0000-0002-4476-9124; Seemann, Torsten/0000-0001-6046-610X; Crellin, Paul K/0000-0002-2017-4935; Yamaryo-Botte, Yoshiki/0000-0002-9349-4411; Stinear, Timothy/0000-0003-0150-123X	Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics [COE562063]; National Health and Medical Research Council of Australia [ID1007676]	Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian Research Council Centre of Excellence in Structural and Functional Microbial Genomics (COE562063) and the National Health and Medical Research Council of Australia (Project Grant ID1007676).	Alderwick LJ, 2005, J BIOL CHEM, V280, P32362, DOI 10.1074/jbc.M506339200; Alderwick LJ, 2006, J BIOL CHEM, V281, P15653, DOI 10.1074/jbc.M600045200; Alderwick LJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001299; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; Bansal-Mutalik R, 2011, P NATL ACAD SCI USA, V108, P15360, DOI 10.1073/pnas.1112572108; BARKSDALE L, 1970, Bacteriological Reviews, V34, P378; Barry CE, 1996, TRENDS MICROBIOL, V4, P275, DOI 10.1016/0966-842X(96)10031-7; Barry CE, 1998, PROG LIPID RES, V37, P143, DOI 10.1016/S0163-7827(98)00008-3; Besra GS, 1997, J BIOL CHEM, V272, P18460, DOI 10.1074/jbc.272.29.18460; Birch HL, 2008, MOL MICROBIOL, V69, P1191, DOI 10.1111/j.1365-2958.2008.06354.x; Chatterjee D, 1998, GLYCOBIOLOGY, V8, P113, DOI 10.1093/glycob/8.2.113; Crellin PK, 2008, J BACTERIOL, V190, P3690, DOI 10.1128/JB.00200-08; David M, 2011, BIOINFORMATICS, V27, P1011, DOI 10.1093/bioinformatics/btr046; Gande R, 2004, J BIOL CHEM, V279, P44847, DOI 10.1074/jbc.M408648200; Gibson KJC, 2003, J BIOL CHEM, V278, P40842, DOI 10.1074/jbc.M307988200; Guerin ME, 2009, J BIOL CHEM, V284, P25687, DOI 10.1074/jbc.M109.030593; Gurcha SS, 2002, BIOCHEM J, V365, P441, DOI 10.1042/BJ20020107; Haites RE, 2005, J BIOL CHEM, V280, P10981, DOI 10.1074/jbc.M413443200; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Kalscheuer R, 2010, P NATL ACAD SCI USA, V107, P21761, DOI 10.1073/pnas.1014642108; Kaur D, 2007, J BIOL CHEM, V282, P27133, DOI 10.1074/jbc.M703389200; Kaur D, 2006, P NATL ACAD SCI USA, V103, P13664, DOI 10.1073/pnas.0603049103; Kaur D, 2008, P NATL ACAD SCI USA, V105, P17973, DOI 10.1073/pnas.0807761105; Kordulakova J, 2003, J BIOL CHEM, V278, P36285, DOI 10.1074/jbc.M303639200; Kordulakova J, 2002, J BIOL CHEM, V277, P31335, DOI 10.1074/jbc.M204060200; Kovacevic S, 2006, J BIOL CHEM, V281, P9011, DOI 10.1074/jbc.M511709200; Lea-Smith DJ, 2008, J BIOL CHEM, V283, P6773, DOI 10.1074/jbc.M707139200; Lea-Smith DJ, 2007, J BIOL CHEM, V282, P11000, DOI 10.1074/jbc.M608686200; Marland Z, 2006, J MOL BIOL, V359, P983, DOI 10.1016/j.jmb.2006.04.012; MCCONVILLE MJ, 1990, J BIOL CHEM, V265, P7385; McKean S, 2005, MICROBES INFECT, V7, P1352, DOI 10.1016/j.micinf.2005.05.002; Mishra AK, 2008, MOL MICROBIOL, V68, P1595, DOI 10.1111/j.1365-2958.2008.06265.x; Mishra AK, 2008, ANTON LEEUW INT J G, V94, P277, DOI 10.1007/s10482-008-9243-1; Mishra AK, 2007, MOL MICROBIOL, V65, P1503, DOI 10.1111/j.1365-2958.2007.05884.x; Mishra AK, 2011, FEMS MICROBIOL REV, V35, P1126, DOI 10.1111/j.1574-6976.2011.00276.x; Mishra AK, 2009, J BACTERIOL, V191, P4465, DOI 10.1128/JB.01729-08; Morita YS, 2006, J BIOL CHEM, V281, P25143, DOI 10.1074/jbc.M604214200; Morita YS, 2005, J BIOL CHEM, V280, P21645, DOI 10.1074/jbc.m414181200; Morita YS, 2004, BIOCHEM J, V378, P589, DOI 10.1042/BJ20031372; Newton GL, 2006, PROTEIN EXPRES PURIF, V47, P542, DOI 10.1016/j.pep.2006.03.003; Nigou J, 2002, MICROBES INFECT, V4, P945, DOI 10.1016/S1286-4579(02)01621-0; Paradis-Bleau C, 2010, CELL, V143, P1110, DOI 10.1016/j.cell.2010.11.037; Reyrat JM, 2001, TRENDS MICROBIOL, V9, P472, DOI 10.1016/S0966-842X(01)02168-0; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Seidel M, 2007, J BIOL CHEM, V282, P14729, DOI 10.1074/jbc.M700271200; Seidel M, 2007, GLYCOBIOLOGY, V17, P210, DOI 10.1093/glycob/cwl066; Sena CBC, 2010, J BIOL CHEM, V285, P13326, DOI 10.1074/jbc.M109.077297; Skovierova H, 2009, GLYCOBIOLOGY, V19, P1235, DOI 10.1093/glycob/cwp116; Strohmeier GR, 1999, MICROBES INFECT, V1, P709, DOI 10.1016/S1286-4579(99)80072-0; Tatituri RVV, 2007, J BIOL CHEM, V282, P4561, DOI 10.1074/jbc.M608695200; Thanky NR, 2007, TUBERCULOSIS, V87, P231, DOI 10.1016/j.tube.2006.10.004; Typas A, 2012, NAT REV MICROBIOL, V10, P123, DOI 10.1038/nrmicro2677; Typas A, 2010, CELL, V143, P1097, DOI 10.1016/j.cell.2010.11.038; van der Rest ME, 1999, APPL MICROBIOL BIOT, V52, P541, DOI 10.1007/s002530051557; Vercellone A, 1998, FRONT BIOSCI-LANDMRK, V3, pE149; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhang N, 2003, MOL MICROBIOL, V50, P69, DOI 10.1046/j.1365-2958.2003.03681.x	59	17	17	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42726	42738		10.1074/jbc.M112.373415	http://dx.doi.org/10.1074/jbc.M112.373415			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23091062	Green Published, hybrid			2022-12-25	WOS:000312501600032
J	Wang, W; Guo, MX; Hu, L; Cai, JY; Zeng, Y; Luo, J; Shu, ZQ; Li, WX; Huang, Z				Wang, Wei; Guo, Mingxiong; Hu, Li; Cai, Jinyang; Zeng, Yan; Luo, Jun; Shu, Zhiqiang; Li, Wenxin; Huang, Zan			The Zinc Finger Protein ZNF268 Is Overexpressed in Human Cervical Cancer and Contributes to Tumorigenesis via Enhancing NF-kappa B Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; CELL-CYCLE; HUMAN-PAPILLOMAVIRUS; SPLICE VARIANTS; MESSENGER-RNA; UP-REGULATION; GENE ZNF268; TRANSCRIPTION; EXPRESSION; IDENTIFICATION	Cervical cancer is one of the most common tumors affecting women's health worldwide. Although human papillomavirus can be detected in nearly all cases, the mechanism of cervical carcinogenesis remains to be further addressed. Here, we demonstrated that ZNF268, a Kruppel-associated box-containing zinc finger protein, might contribute to the development of cervical cancer. We found that ZNF268b2, an isoform of ZNF268, was overexpressed in human squamous cervical cancer specimens. Knockdown of ZNF268 in cervical cancer cells caused cell cycle arrest at the G(0)/G(1) phase, reduced colony formation, and increased sensitivity to TNF alpha-induced apoptosis. In addition, HeLa cell growth in xenograft nude mice was suppressed by ZNF268 knockdown, with increased apoptosis. Furthermore, ZNF268b2 was shown to increase NF-kappa B signaling in vitro and in vivo. Reconstitution of NF-kappa B activity restored proliferation in ZNF268 knockdown HeLa cells. Of note, we observed a high frequency of NF-kappa B activation in ZNF268-overexpressing cervical cancer tissues, suggesting a pathological coincidence of ZNF268b2 overexpression and NF-kappa B activation. Taken together, our results reveal a novel role of ZNF268b2 that contributes to cervical carcinogenesis in part through enhancing NF-kappa B signaling.	[Wang, Wei; Guo, Mingxiong; Hu, Li; Cai, Jinyang; Zeng, Yan; Shu, Zhiqiang; Li, Wenxin] Wuhan Univ, Zhongnan Hosp, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China; [Wang, Wei; Guo, Mingxiong; Hu, Li; Cai, Jinyang; Zeng, Yan; Shu, Zhiqiang; Li, Wenxin; Huang, Zan] Wuhan Univ, Zhongnan Hosp, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Luo, Jun] Wuhan Univ, Zhongnan Hosp, Dept Pathol, Wuhan 430072, Hubei, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Li, WX (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan 430072, Hubei, Peoples R China.	liwxlab@whu.edu.cn; z-huang@whu.edu.cn	Cai, Jinyang/HCH-0290-2022	Huang, Zan/0000-0001-5623-6950; Wang, Wei/0000-0002-6179-4188; Cai, Jinyang/0000-0002-7385-8281; Wang, Wei/0000-0001-7429-1013	National High Technology Research and Development Program of China (863 Program) [2006AA02A306]; National Natural Science Foundation of China [30871245, 31271511, 30700412, 81070406]; Specialized Research Fund for the Doctoral Program of Higher Education of China [200804861004]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by National High Technology Research and Development Program of China (863 Program) Grant 2006AA02A306 (to W. L.), National Natural Science Foundation of China Grants 30871245 and 31271511 (to M. G.) and 30700412 and 81070406 (to Z. H.), and Specialized Research Fund for the Doctoral Program of Higher Education of China Grant 200804861004 (to M. G.).	BALDIN V, 1993, GENE DEV, V7, P812, DOI 10.1101/gad.7.5.812; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; Branca M, 2006, DIAGN CYTOPATHOL, V34, P555, DOI 10.1002/dc.20514; Brinkman BMN, 2004, CLIN BIOCHEM, V37, P584, DOI 10.1016/j.clinbiochem.2004.05.015; Chen C, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/9/095101; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Chun JN, 2008, MOL CELLS, V26, P175; Engelmark MT, 2006, HUM MOL GENET, V15, P3351, DOI 10.1093/hmg/ddl411; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Gou DM, 2001, BBA-GENE STRUCT EXPR, V1518, P306, DOI 10.1016/S0167-4781(01)00194-4; Guo MX, 2006, J BIOL CHEM, V281, P24623, DOI 10.1074/jbc.M602753200; Guttridge DC, 1999, MOL CELL BIOL, V19, P5785; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Krackhardt AM, 2002, BLOOD, V100, P2123, DOI 10.1182/blood-2002-02-0513; Lee HH, 1999, P NATL ACAD SCI USA, V96, P9136, DOI 10.1073/pnas.96.16.9136; Looman C, 2002, MOL BIOL EVOL, V19, P2118, DOI 10.1093/oxfordjournals.molbev.a004037; Magnusson PKE, 2000, INT J CANCER, V88, P698, DOI 10.1002/1097-0215(20001201)88:5<698::AID-IJC3>3.0.CO;2-J; Moore RJ, 1999, NAT MED, V5, P828, DOI 10.1038/10552; Nair A, 2003, ONCOGENE, V22, P50, DOI 10.1038/sj.onc.1206043; Philip M, 2004, SEMIN CANCER BIOL, V14, P433, DOI 10.1016/j.semcancer.2004.06.006; Ran RQ, 2004, GENE DEV, V18, P1466, DOI 10.1101/gad.1188204; Rosenberger S, 2010, P NATL ACAD SCI USA, V107, P7006, DOI 10.1073/pnas.1002620107; Shao HJ, 2006, INT J MOL MED, V18, P457; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Suganuma M, 1999, CANCER RES, V59, P4516; Sun Y, 2004, INT J MOL MED, V14, P971; Sun Y, 2003, IUBMB LIFE, V55, P127, DOI 10.1080/1521654031000110208; Tjiong MY, 2001, CYTOKINE, V14, P357, DOI 10.1006/cyto.2001.0909; Urrutia R, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-231; Van Waes C, 2007, CLIN CANCER RES, V13, P1076, DOI 10.1158/1078-0432.CCR-06-2221; Vieira KBL, 1996, CANCER RES, V56, P2452; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Wang D, 2008, J BIOL CHEM, V283, P16299, DOI 10.1074/jbc.M706426200; Wang SC, 2005, ANN NY ACAD SCI, V1059, P11, DOI 10.1196/annals.1339.002; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wilting SM, 2008, GENE CHROMOSOME CANC, V47, P890, DOI 10.1002/gcc.20590; Woerner SM, 1995, CLIN CANCER RES, V1, P1125; Zeng Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029518	41	25	31	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42856	42866		10.1074/jbc.M112.399923	http://dx.doi.org/10.1074/jbc.M112.399923			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23091055	hybrid, Green Published			2022-12-25	WOS:000312501600044
J	Zhang, WS; Prakash, C; Sum, C; Gong, Y; Li, YH; Kwok, JJT; Thiessen, N; Pettersson, S; Jones, SJM; Knapp, S; Yang, H; Chin, KC				Zhang, Weishi; Prakash, Celine; Sum, Calvin; Gong, Yue; Li, Yinghui; Kwok, Jeffrey J. T.; Thiessen, Nina; Pettersson, Sven; Jones, Steven J. M.; Knapp, Stefan; Yang, Henry; Chin, Keh-Chuang			Bromodomain-containing Protein 4 (BRD4) Regulates RNA Polymerase II Serine 2 Phosphorylation in Human CD4+T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOCUS-CONTROL REGION; NF-KAPPA-B; GENE-EXPRESSION; HUMAN GENOME; TRANSCRIPTIONAL ELONGATION; P-TEFB; TERMINAL DOMAIN; C-MYC; CHROMATIN; ENHANCERS	Transcriptional elongation by RNA polymerase II (Pol II) is regulated by positive transcription elongation factor b (P-TEFb) in association with bromodomain-containing protein 4 (BRD4). We used genome-wide chromatin immunoprecipitation sequencing in primary human CD4+ T cells to reveal that BRD4 co-localizes with Ser-2-phosphorylated Pol II (Pol II Ser-2) at both enhancers and promoters of active genes. Disruption of bromodomain-histone acetylation interactions by JQ1, a small-molecule bromodomain inhibitor, resulted in decreased BRD4 binding, reduced Pol II Ser-2, and reduced expression of lineage-specific genes in primary human CD4+ T cells. A large number of JQ1-disrupted BRD4 binding regions exhibited diacetylated H4 (lysine 5 and -8) and H3K27 acetylation (H3K27ac), which correlated with the presence of histone acetyltransferases and deacetylases. Genes associated with BRD4/H3K27ac co-occupancy exhibited significantly higher activity than those associated with H3K27ac or BRD4 binding alone. Comparison of BRD4 binding in T cells and in human embryonic stem cells revealed that enhancer BRD4 binding sites were predominantly lineage-specific. Our findings suggest that BRD4-driven Pol II phosphorylation at serine 2 plays an important role in regulating lineage-specific gene transcription in human CD4+ T cells.	[Zhang, Weishi; Prakash, Celine; Sum, Calvin; Gong, Yue; Li, Yinghui; Kwok, Jeffrey J. T.; Chin, Keh-Chuang] ASTAR, Lab Gene Regulat & Inflammat, Singapore Immunol Network SIgN, Biopolis, Singapore 138648, Singapore; [Pettersson, Sven] Karolinska Inst, Dept Microbiol Cell & Tumor Biol, S-17177 Stockholm, Sweden; [Thiessen, Nina; Jones, Steven J. M.] Canadas Michael Smith Genome Sci Ctr, Bioinformat Lab, Vancouver, BC V5Z 1L3, Canada; [Knapp, Stefan] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Yang, Henry] ASTAR, Bioinformat Grp, Singapore Immunol Network SIgN, Biopolis, Singapore 138648, Singapore; [Chin, Keh-Chuang] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117573, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Karolinska Institutet; University of Oxford; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore	Chin, KC (corresponding author), ASTAR, Lab Gene Regulat & Inflammat, Singapore Immunol Network SIgN, Biopolis, Immunos 04-00,8A Biomed Grove, Singapore 138648, Singapore.	kehchuang_chin@immunol.a-star.edu.sg	Li, Yinghui/K-8253-2018; Knapp, Stefan/AAG-2347-2019; Pettersson, Sven/F-9511-2015; Jones, Steven J/C-3621-2009	Knapp, Stefan/0000-0001-5995-6494; Jones, Steven J/0000-0003-3394-2208; Li, Yinghui/0000-0002-9023-9466; Sum, Calvin/0000-0002-7713-2752; Prakash, Celine/0000-0002-3905-5768	SIgN (A*STAR, Singapore)	SIgN (A*STAR, Singapore)	This work was supported by SIgN (A*STAR, Singapore).	Barboric M, 2001, MOL CELL, V8, P327, DOI 10.1016/S1097-2765(01)00314-8; Barski A, 2010, NAT STRUCT MOL BIOL, V17, P629, DOI 10.1038/nsmb.1806; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Devaiah BN, 2012, P NATL ACAD SCI USA, V109, P6927, DOI 10.1073/pnas.1120422109; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Fejes AP, 2008, BIOINFORMATICS, V24, P1729, DOI 10.1093/bioinformatics/btn305; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hirose Y, 2007, J BIOCHEM, V141, P601, DOI 10.1093/jb/mvm090; Hochheimer A, 2003, GENE DEV, V17, P1309, DOI 10.1101/gad.1099903; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Johnson KD, 2003, MOL CELL BIOL, V23, P6484, DOI 10.1128/MCB.23.18.6484-6493.2003; Johnson KD, 2001, MOL CELL, V8, P465, DOI 10.1016/S1097-2765(01)00309-4; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Legube G, 2003, EMBO REP, V4, P944, DOI 10.1038/sj.embor.embor941; Lian Z, 2008, GENOME RES, V18, P1224, DOI 10.1101/gr.075804.107; Lim CA, 2007, MOL CELL, V27, P622, DOI 10.1016/j.molcel.2007.06.038; Louie MC, 2003, P NATL ACAD SCI USA, V100, P2226, DOI 10.1073/pnas.0437824100; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Pekowska A, 2011, EMBO J, V30, P4198, DOI 10.1038/emboj.2011.295; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Reith W, 2005, NAT REV IMMUNOL, V5, P793, DOI 10.1038/nri1708; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Szutorisz H, 2005, TRENDS BIOCHEM SCI, V30, P593, DOI 10.1016/j.tibs.2005.08.006; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wu SY, 2007, J BIOL CHEM, V282, P13141, DOI 10.1074/jbc.R700001200; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Zippo A, 2009, CELL, V138, P1122, DOI 10.1016/j.cell.2009.07.031	44	128	162	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43137	43155		10.1074/jbc.M112.413047	http://dx.doi.org/10.1074/jbc.M112.413047			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23086925	hybrid, Green Published			2022-12-25	WOS:000312501600069
J	Drott, CJ; Olerud, J; Emanuelsson, H; Christoffersson, G; Carlsson, PO				Drott, Carl Johan; Olerud, Johan; Emanuelsson, Hanna; Christoffersson, Gustav; Carlsson, Per-Ola			Sustained Beta-Cell Dysfunction but Normalized Islet Mass in Aged Thrombospondin-1 Deficient Mice	PLOS ONE			English	Article							MOUSE PANCREATIC-ISLETS; ENDOTHELIAL-CELLS; BLOOD-FLOW; IN-VITRO; REVASCULARIZATION; VASCULARIZATION; HYPERGLYCEMIA; INHIBITION; MATRIX; GROWTH	Pancreatic islet endothelial cells have in recent years been shown to support beta-cell mass and function by paracrine interactions. Recently, we identified an islets endothelial-specific glycoprotein, thrombospondin-1 (TSP-1), that showed to be of importance for islet angiogenesis and beta-cell function in young mice. The present study aimed to investigate long-term consequences for islet morphology and beta-cell function of TSP-1 deficiency. Islet and beta-cell mass were observed increased at 10-12 weeks of age in TSP-1 deficient mice, but were normalized before 16 weeks of age when compared to wild-type controls. Islet vascularity was normal in 10-12 and 16-week-old TSP-1 deficient animals, whereas islets of one-year-old animals lacking TSP-1 were hypervascular. Beta-cell dysfunction in TSP-1 deficient animals was present at similar magnitudes between 10-12 and 52 weeks of age, as evaluated by glucose tolerance tests. The insulin secretion capacity in vivo of islets in one-year-old TSP-1 deficient animals was only similar to 15% of that in wild-type animals. Using a transplantation model, we reconstituted TSP-1 in adult TSP-deficient islets. In contrast to neonatal TSP-1 deficient islets that we previously reported to regain function after TSP-1 reconstitution, adult islets failed to recover. We conclude that TSP-1 deficiency in islets causes changing vascular and endocrine morphological alterations postnatally, but is coupled to a chronic beta-cell dysfunction. The beta-cell dysfunction induced by TSP-1 deficiency is irreversible if not substituted early in life.	[Drott, Carl Johan; Emanuelsson, Hanna; Christoffersson, Gustav; Carlsson, Per-Ola] Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden; [Olerud, Johan] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden; [Carlsson, Per-Ola] Uppsala Univ, Dept Med Sci, Uppsala, Sweden	Uppsala University; Uppsala University; Uppsala University	Carlsson, PO (corresponding author), Uppsala Univ, Dept Med Cell Biol, Uppsala, Sweden.	Per-Ola.Carlsson@mcb.uu.se	Christoffersson, Gustaf/ABC-7939-2020	Drott, Carl Johan/0000-0003-2829-8999; Christoffersson, Gustaf/0000-0002-9640-9702	Swedish Research Council; Juvenile Diabetes Research Foundation; European Foundation for the Study of Diabetes/Novo Nordisk Programme; Novo Nordisk Foundation; AFA Insurance; Diabetes Wellness Sweden; Swedish Diabetes Association; Family Ernfors Fund	Swedish Research Council(Swedish Research CouncilEuropean Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); European Foundation for the Study of Diabetes/Novo Nordisk Programme; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); AFA Insurance; Diabetes Wellness Sweden; Swedish Diabetes Association; Family Ernfors Fund	This work was supported by grants from the Swedish Research Council, the Juvenile Diabetes Research Foundation, the European Foundation for the Study of Diabetes/Novo Nordisk Programme 2010, the Novo Nordisk Foundation, AFA Insurance, Diabetes Wellness Sweden, the Swedish Diabetes Association and the Family Ernfors Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON A, 1978, DIABETOLOGIA, V14, P397, DOI 10.1007/BF01228134; BONNERWEIR S, 1988, DIABETES, V37, P616, DOI 10.2337/diabetes.37.5.616; Brissova M, 2006, DIABETES, V55, P2974, DOI 10.2337/db06-0690; Carlsson PO, 2002, J CLIN ENDOCR METAB, V87, P5418, DOI 10.1210/jc.2002-020728; Carlsson PO, 1996, AM J PHYSIOL-ENDOC M, V271, pE990, DOI 10.1152/ajpendo.1996.271.6.E990; Carlsson PO, 1998, AM J PHYSIOL-ENDOC M, V275, pE594, DOI 10.1152/ajpendo.1998.275.4.E594; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; GOOD DJ, 1990, P NATL ACAD SCI USA, V87, P6624, DOI 10.1073/pnas.87.17.6624; JANSSON L, 1981, ACTA PHYSIOL SCAND, V113, P371, DOI 10.1111/j.1748-1716.1981.tb06909.x; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Johansson A, 2009, DIABETOLOGIA, V52, P2385, DOI 10.1007/s00125-009-1485-6; Johansson M, 2006, ENDOCRINOLOGY, V147, P2315, DOI 10.1210/en.2005-0997; Johansson M, 2006, J ANAT, V208, P191, DOI 10.1111/j.1469-7580.2006.00520.x; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; Kayali AG, 2007, DIABETES, V56, P703, DOI 10.2337/db06-1545; KORSGREN O, 1990, J CLIN INVEST, V86, P2161, DOI 10.1172/JCI114955; Lammert E, 2003, CURR BIOL, V13, P1070, DOI 10.1016/S0960-9822(03)00378-6; LEE MS, 1995, AM J PATHOL, V147, P42; Mattsson G, 2002, DIABETES, V51, P1362, DOI 10.2337/diabetes.51.5.1362; Mattsson G, 2002, PANCREATOLOGY, V2, P155, DOI 10.1159/000055906; Miralles F, 1998, J CELL BIOL, V143, P827, DOI 10.1083/jcb.143.3.827; Nyqvist D, 2005, DIABETES, V54, P2287, DOI 10.2337/diabetes.54.8.2287; Olerud J, 2008, DIABETES, V57, P1870, DOI 10.2337/db07-0724; Olerud J, 2011, DIABETES, V60, P1946, DOI 10.2337/db10-0277; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Rodriguez-Manzaneque JC, 2001, P NATL ACAD SCI USA, V98, P12485, DOI 10.1073/pnas.171460498; SJOHOLM A, 1991, AM J PHYSIOL, V260, pC1046, DOI 10.1152/ajpcell.1991.260.5.C1046; Svensson JE, 2010, DIABETOLOGIA, V53, pS197; Weibel E.R, 1979, STEREOLOGICAL METHOD	29	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47451	10.1371/journal.pone.0047451	http://dx.doi.org/10.1371/journal.pone.0047451			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094049	Green Published, Green Submitted, gold			2022-12-25	WOS:000310050200023
J	Li, NC; Lu, J; Willars, GB				Li, Naichang; Lu, Jing; Willars, Gary B.			Allosteric Modulation of the Activity of the Glucagon-like Peptide-1 (GLP-1) Metabolite GLP-1 9-36 Amide at the GLP-1 Receptor	PLOS ONE			English	Article							GASTRIC-INHIBITORY POLYPEPTIDE; TYPE-2 DIABETES-MELLITUS; SMALL-MOLECULE AGONISTS; HEALTHY-SUBJECTS; IN-VIVO; CELLS; ACTIVATION; DEGRADATION; SECRETION; PATHWAYS	Glucagon-like peptide-1 (GLP-1) released from intestinal L cells in response to nutrients has many physiological effects but particularly enhances glucose-dependent insulin release through the GLP-1 receptor (GLP-1R). GLP-1 7-36 amide, the predominant circulating active form of GLP-1, is rapidly truncated by dipeptidyl peptidase-4 to GLP-1 9-36 amide, which is generally considered inactive. Given its physiological roles, the GLP-1R is targeted for treatment of type 2 diabetes. Recently 'compound 2' has been described as both an agonist and positive allosteric modulator of GLP-1 7-36 amide affinity, but not potency, at the GLP-1R. Importantly, we demonstrated previously that exendin 9-39, generally considered a GLP-1R antagonist, enhances compound 2 efficacy (or vice versa) at the GLP-1R. Given that GLP-1 9-36 amide is the major circulating form of GLP-1 post-prandially and is a low affinity weak partial agonist or antagonist at the GLP-1R, we investigated interaction between this metabolite and compound 2 in a cell line with recombinant expression of the human GLP-1R and the rat insulinoma cell line, INS-1E, with native expression of the GLP-1R. We show compound 2 markedly enhances efficacy and potency of GLP-1 9-36 amide for key cellular responses including AMP generation, Ca2+ signaling and extracellular signal-regulated kinase. Thus, metabolites of peptide hormones including GLP-1 that are often considered inactive may provide a means of manipulating key aspects of receptor function and a novel therapeutic strategy.	[Li, Naichang; Lu, Jing; Willars, Gary B.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Li, Naichang] Tianjin Med Univ, Dept Biochem, Tianjin, Peoples R China	University of Leicester; Tianjin Medical University	Willars, GB (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England.	gbw2@le.ac.uk			University of Leicester	University of Leicester	This work was funded by the University of Leicester. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aroda VR, 2012, CLIN THER, V34, P1247, DOI 10.1016/j.clinthera.2012.04.013; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bavec A, 2003, REGUL PEPTIDES, V111, P137, DOI 10.1016/S0167-0115(02)00282-3; Bootman MD, 2011, METHODS MOL BIOL, V746, P277, DOI 10.1007/978-1-61779-126-0_15; BROWN BL, 1971, BIOCHEM J, V121, P561, DOI 10.1042/bj1210561; Cheong YH, 2012, BIOCHEM BIOPH RES CO, V417, P558, DOI 10.1016/j.bbrc.2011.12.004; Coopman K, 2011, MOL ENDOCRINOL, V25, P1804, DOI 10.1210/me.2011-1160; Coopman K, 2010, J PHARMACOL EXP THER, V334, P795, DOI 10.1124/jpet.110.166009; Deacon CF, 2002, AM J PHYSIOL-ENDOC M, V282, pE873, DOI 10.1152/ajpendo.00452.2001; DEACON CF, 1995, DIABETES, V44, P1126, DOI 10.2337/diabetes.44.9.1126; DEACON CF, 1995, J CLIN ENDOCR METAB, V80, P952, DOI 10.1210/jc.80.3.952; DIMITRIADIS GD, 1991, BIOCHEM J, V278, P587, DOI 10.1042/bj2780587; Donnelly D, 2012, BRIT J PHARMACOL, V166, P27, DOI 10.1111/j.1476-5381.2011.01687.x; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Erdogdu O, 2010, MOL CELL ENDOCRINOL, V325, P26, DOI 10.1016/j.mce.2010.04.022; Flatt PR, 2008, FRONT BIOSCI-LANDMRK, V13, P3648, DOI 10.2741/2956; Friedrichsen BN, 2006, J ENDOCRINOL, V188, P481, DOI 10.1677/joe.1.06160; Hallbrink M, 2001, BBA-PROTEIN STRUCT M, V1546, P79, DOI 10.1016/S0167-4838(00)00270-3; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Holst JJ, 2009, MOL CELL ENDOCRINOL, V297, P127, DOI 10.1016/j.mce.2008.08.012; Huang Y, 2010, BRIT J PHARMACOL, V159, P237, DOI 10.1111/j.1476-5381.2009.00517.x; Karagiannis T, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1369; Kenakin T, 2010, J RECEPT SIG TRANSD, V30, P313, DOI 10.3109/10799893.2010.503964; Knudsen LB, 1996, EUR J PHARMACOL, V318, P429, DOI 10.1016/S0014-2999(96)00795-9; Knudsen LB, 2007, P NATL ACAD SCI USA, V104, P937, DOI 10.1073/pnas.0605701104; Knudsen LB, 2012, REGUL PEPTIDES, V175, P21, DOI 10.1016/j.regpep.2011.12.006; Koole C, 2010, MOL PHARMACOL, V78, P456, DOI 10.1124/mol.110.065664; Kurian N, 2009, J PHARMACOL EXP THER, V330, P502, DOI 10.1124/jpet.109.153619; Meier JJ, 2005, DIABETES-METAB RES, V21, P91, DOI 10.1002/dmrr.538; Meier JJ, 2004, DIABETES, V53, P654, DOI 10.2337/diabetes.53.3.654; MENTLEIN R, 1993, EUR J BIOCHEM, V214, P829, DOI 10.1111/j.1432-1033.1993.tb17986.x; Miller LJ, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.217901; Montrose-Rafizadeh C, 1999, ENDOCRINOLOGY, V140, P1132, DOI 10.1210/en.140.3.1132; MontroseRafizadeh C, 1997, J BIOL CHEM, V272, P21201, DOI 10.1074/jbc.272.34.21201; ORSKOV C, 1993, DIABETES, V42, P658, DOI 10.2337/diabetes.42.5.658; ORSKOV C, 1994, DIABETES, V43, P535, DOI 10.2337/diabetes.43.4.535; Theander S, 2004, ENDOCRINOLOGY, V145, P667; THORENS B, 1992, P NATL ACAD SCI USA, V89, P8641, DOI 10.1073/pnas.89.18.8641; Tomas E, 2010, TRENDS ENDOCRIN MET, V21, P59, DOI 10.1016/j.tem.2009.11.007; Willard FS, 2012, EXP DIABETES RES, DOI 10.1155/2012/709893; WILLARS GB, 1995, BRIT J PHARMACOL, V114, P1133, DOI 10.1111/j.1476-5381.1995.tb13325.x; Yamasaki-Mann M, 2009, CELL CALCIUM, V45, P293, DOI 10.1016/j.ceca.2008.11.008; Zhou J, 1999, DIABETES, V48, P2358, DOI 10.2337/diabetes.48.12.2358	43	24	24	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47936	10.1371/journal.pone.0047936	http://dx.doi.org/10.1371/journal.pone.0047936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094100	Green Published, Green Submitted, gold			2022-12-25	WOS:000310050200053
J	Li, YF; Huang, J; Amos, CI				Li, Yafang; Huang, Jian; Amos, Christopher I.			Genetic Association Analysis of Complex Diseases Incorporating Intermediate Phenotype Information	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; OBSTRUCTIVE PULMONARY-DISEASE; LUNG-CANCER; SUSCEPTIBILITY LOCUS; CHROMOSOME 3P; TGFB1 GENE; METAANALYSIS; VARIANTS; SMOKING; 15Q25	Genetic researchers often collect disease related quantitative traits in addition to disease status because they are interested in understanding the pathophysiology of disease processes. In genome-wide association (GWA) studies, these quantitative phenotypes may be relevant to disease development and serve as intermediate phenotypes or they could be behavioral or other risk factors that predict disease risk. Statistical tests combining both disease status and quantitative risk factors should be more powerful than case-control studies, as the former incorporates more information about the disease. In this paper, we proposed a modified inverse-variance weighted meta-analysis method to combine disease status and quantitative intermediate phenotype information. The simulation results showed that when an intermediate phenotype was available, the inverse-variance weighted method had more power than did a case-control study of complex diseases, especially in identifying susceptibility loci having minor effects. We further applied this modified meta-analysis to a study of imputed lung cancer genotypes with smoking data in 1154 cases and 1137 matched controls. The most significant SNPs came from the CHRNA3-CHRNA5-CHRNB4 region on chromosome 15q24-25.1, which has been replicated in many other studies. Our results confirm that this CHRNA region is associated with both lung cancer development and smoking behavior. We also detected three significant SNPs-rs1800469, rs1982072, and rs2241714-in the promoter region of the TGFB1 gene on chromosome 19 (p=1.46x10(-5), 1.18x10(-5), and 6.57x10(-5), respectively). The SNP rs1800469 is reported to be associated with chronic obstructive pulmonary disease and lung cancer in cigarette smokers. The present study is the first GWA study to replicate this result. Signals in the 3q26 region were also identified in the meta-analysis. We demonstrate the intermediate phenotype can potentially enhance the power of complex disease association analysis and the modified meta-analysis method is robust to incorporate intermediate phenotype or other quantitative risk factor in the analysis.	[Li, Yafang; Amos, Christopher I.] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Huang, Jian] Univ Iowa, Dept Stat & Actuarial Sci, Iowa City, IA 52242 USA; [Amos, Christopher I.] Dartmouth Coll, Geisel Coll Med, Dept Community & Family Med, Hanover, NH 03755 USA	University of Texas System; UTMD Anderson Cancer Center; University of Iowa; Dartmouth College	Amos, CI (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.	Christopher.I.Amos@Dartmouth.edu		HUANG, Jian/0000-0002-5218-9269	National Institutes of Health [P50CA70907, RO1CA121197, P30CA016772, U19 CA148127]; NATIONAL CANCER INSTITUTE [P50CA070907, R01CA121197, U19CA148127] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was partially supported by National Institutes of Health grants P50CA70907, RO1CA121197, P30CA016772 and U19 CA148127. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Boyd NF, 2005, LANCET ONCOL, V6, P798, DOI 10.1016/S1470-2045(05)70390-9; Braga E, 2002, INT J CANCER, V100, P534, DOI 10.1002/ijc.10511; Celedon JC, 2004, HUM MOL GENET, V13, P1649, DOI 10.1093/hmg/ddh171; Chan RCK, 2009, SCHIZOPHR B, V36, P1089, DOI [10.1093/schbul/sbp011, DOI 10.1093/SCHBUL/SBP011]; Cooper JD, 2008, NAT GENET, V40, P1399, DOI 10.1038/ng.249; Dasgupta S, 2003, J CLIN PATHOL-MOL PA, V56, P263, DOI 10.1136/mp.56.5.263; Eichler EE, 2010, NAT REV GENET, V11, P446, DOI 10.1038/nrg2809; Fisher R. A., 1919, Transactions of the Royal Society of Edinburgh, V52; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Greenwood TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029630; Guest editorial, 2008, MOL PSYCHIATR, V13, P233; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Lindstrom S, 2011, NAT GENET, V43, P185, DOI 10.1038/ng.760; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; Lynch M., 1998, GENETICS ANAL QUANTI; Marchini J, 2010, NAT REV GENET, V11, P499, DOI 10.1038/nrg2796; Munafo MR, 2012, JNCI-J NATL CANCER I, V104, P740, DOI 10.1093/jnci/djs191; Neelam K, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-139; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Park KH, 2006, CANCER GENET CYTOGEN, V169, P39, DOI 10.1016/j.cancergencyto.2006.03.012; Shulman JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011244; Simons CJ, 2012, SCHIZOPHR B; Spencer CCA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000477; Spitz Margaret R, 2008, J Natl Cancer Inst, V100, P1552, DOI 10.1093/jnci/djn363; Spitz MR, 2012, J NATL CANCER I, V104, P720, DOI 10.1093/jnci/djs211; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Timofeeva MN, 2011, CANCER EPIDEM BIOMAR, V20, P2250, DOI 10.1158/1055-9965.EPI-11-0496; VanderWeele TJ, 2012, AM J EPIDEMIOL, V175, P1013, DOI 10.1093/aje/kwr467; Wang JA, 2010, CANCER-AM CANCER SOC, V116, P3458, DOI 10.1002/cncr.25085; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340	36	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e46612	10.1371/journal.pone.0046612	http://dx.doi.org/10.1371/journal.pone.0046612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094028	Green Published, gold, Green Submitted			2022-12-25	WOS:000310050200012
J	Palagani, V; El Khatib, M; Kossatz, U; Bozko, P; Muller, MR; Manns, MP; Krech, T; Malek, NP; Plentz, RR				Palagani, Vindhya; El Khatib, Mona; Kossatz, Uta; Bozko, Przemyslaw; Mueller, Martin R.; Manns, Michael P.; Krech, Till; Malek, Nisar P.; Plentz, Ruben R.			Epithelial Mesenchymal Transition and Pancreatic Tumor Initiating CD44+/EpCAM+ Cells Are Inhibited by gamma-Secretase Inhibitor IX	PLOS ONE			English	Article							CANCER STEM-CELLS; INTRAEPITHELIAL NEOPLASIA; CADHERIN EXPRESSION; SIGNALING PATHWAY; NOTCH; IDENTIFICATION; GEMCITABINE; PROGRESSION; RESISTANCE; PHENOTYPE	Pancreatic ductal adenocarcinoma (PDAC) is an aggressive disease with a high rate of metastasis. Recent studies have indicated that the Notch signalling pathway is important in PDAC initiation and maintenance, although the specific cell biological roles of the pathway remain to be established. Here we sought to examine this question in established pancreatic cancer cell lines using the gamma-secretase inhibitor IX (GSI IX) to inactivate Notch. Based on the known roles of Notch in development and stem cell biology, we focused on effects on epithelial mesenchymal transition (EMT) and on pancreatic tumor initiating CD44+/EpCAM+ cells. We analyzed the effect of the GSI IX on growth and epithelial plasticity of human pancreatic cancer cell lines, and on the tumorigenicity of pancreatic tumor initiating CD44+/EpCAM+ cells. Notably, apoptosis was induced after GSI IX treatment and EMT markers were selectively targeted. Furthermore, under GSI IX treatment, decline in the growth of pancreatic tumor initiating CD44+/EpCAM+ cells was observed in vitro and in a xenograft mouse model. This study demonstrates a central role of Notch signalling pathway in pancreatic cancer pathogenesis and identifies an effective approach to inhibit selectively EMT and suppress tumorigenesis by eliminating pancreatic tumor initiating CD44+/EpCAM+ cells.	[Palagani, Vindhya; El Khatib, Mona; Kossatz, Uta; Bozko, Przemyslaw; Malek, Nisar P.; Plentz, Ruben R.] Med Univ Hosp, Dept Internal Med 1, Tubingen, Germany; [Mueller, Martin R.] Med Univ Hosp, Dept Internal Med 2, Tubingen, Germany; [Manns, Michael P.] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany; [Krech, Till] Hannover Med Sch, Inst Pathol, D-3000 Hannover, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Hannover Medical School; Hannover Medical School	Plentz, RR (corresponding author), Med Univ Hosp, Dept Internal Med 1, Tubingen, Germany.	Ruben.Plentz@med.uni-tuebingen.de	Udhane, Vindhya/Z-5947-2019	Kossatz, Uta/0000-0002-9092-7154	Deutsche Forschungsgemeinschaft [DFG PL 468/4-1]; TUI Stiftung [TUI AZ68/09]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); TUI Stiftung	The work was supported by Deutsche Forschungsgemeinschaft (DFG PL 468/4-1) and TUI Stiftung (TUI AZ68/09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bao B, 2011, CANCER LETT, V307, P26, DOI 10.1016/j.canlet.2011.03.012; Bednar F, 2011, J GASTROENTEROL; Buchler P, 2005, ANN SURG, V242, P791, DOI 10.1097/01.sla.0000189115.94847.f1; Cano C, 2010, THESCIENTIFICWORLDJO, V10, P1947, DOI 10.1100/tsw.2010.183; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Feldmann G, 2007, CANCER RES, V67, P2187, DOI 10.1158/0008-5472.CAN-06-3281; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hansel DE, 2003, ANNU REV GENOM HUM G, V4, P237, DOI 10.1146/annurev.genom.4.070802.110341; Hermann PC, 2008, CELL CYCLE, V7, P188, DOI 10.4161/cc.7.2.5326; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Hong SM, 2011, MODERN PATHOL, V24, P1237, DOI 10.1038/modpathol.2011.74; Hong SP, 2009, INT J CANCER, V125, P2323, DOI 10.1002/ijc.24573; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; IKEDA Y, 1990, JPN J CANCER RES, V81, P987, DOI 10.1111/j.1349-7006.1990.tb03336.x; Ischehko I, 2009, SURGERY, V146, P430, DOI 10.1016/j.surg.2009.05.003; Jean-Paul D, 2008, P NATL ACAD SCI USA, V105, P18907, DOI 10.1073/pnas.0810111105; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Ji Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006816; Jing YY, 2011, CELL BIOSCI, V1, DOI 10.1186/2045-3701-1-29; Joo YE, 2002, PANCREATOLOGY, V2, P129, DOI 10.1159/000055903; Koch U, 2010, CURR TOP DEV BIOL, V92, P411, DOI 10.1016/S0070-2153(10)92013-9; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Li CW, 2011, GASTROENTEROLOGY, V141, P2218, DOI 10.1053/j.gastro.2011.08.009; Lonardo E, 2010, MOL ONCOL, V4, P431, DOI 10.1016/j.molonc.2010.06.002; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Mazur PK, 2010, P NATL ACAD SCI USA, V107, P13438, DOI 10.1073/pnas.1002423107; Meng RD, 2009, CANCER RES, V69, P573, DOI 10.1158/0008-5472.CAN-08-2088; Miyamoto Y, 2003, CANCER CELL, V3, P565, DOI 10.1016/S1535-6108(03)00140-5; Mueller MT, 2009, GASTROENTEROLOGY, V137, P1102, DOI 10.1053/j.gastro.2009.05.053; Mullendore ME, 2009, CLIN CANCER RES, V15, P2291, DOI 10.1158/1078-0432.CCR-08-2004; Nakajima S, 2004, CLIN CANCER RES, V10, P4125, DOI 10.1158/1078-0432.CCR-0578-03; Ni X, 2011, J CELL MOL MED; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Plentz R, 2009, GASTROENTEROLOGY, V136, P1741, DOI 10.1053/j.gastro.2009.01.008; Rachagani S, 2011, BRIT J CANCER, V104, P1038, DOI 10.1038/bjc.2011.31; Rozenblum E, 1997, CANCER RES, V57, P1731; Stathis A, 2010, NAT REV CLIN ONCOL, V7, P163, DOI 10.1038/nrclinonc.2009.236; Takebe N, 2011, NAT REV CLIN ONCOL, V8, P97, DOI 10.1038/nrclinonc.2010.196; TAN MH, 1986, CANCER INVEST, V4, P15, DOI 10.3109/07357908609039823; Vincent A, 2011, LANCET, V378, P607, DOI 10.1016/S0140-6736(10)62307-0; Wang YH, 2009, NEOPLASMA, V56, P371, DOI 10.4149/neo_2009_05_371; Wang ZW, 2011, ANTICANCER RES, V31, P1105; Wang ZW, 2006, MOL CANCER THER, V5, P483, DOI 10.1158/1535-7163.MCT-05-0299; Yin T, 2011, INT J MOL SCI, V12, P1595, DOI 10.3390/ijms12031595	49	36	36	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e46514	10.1371/journal.pone.0046514	http://dx.doi.org/10.1371/journal.pone.0046514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094026	Green Published, Green Submitted, gold			2022-12-25	WOS:000310050200010
J	Lee, YJ; Johnson, KR; Hallenbeck, JM				Lee, Yang-ja; Johnson, Kory R.; Hallenbeck, John M.			Global Protein Conjugation by Ubiquitin-Like-Modifiers during Ischemic Stress Is Regulated by MicroRNAs and Confers Robust Tolerance to Ischemia	PLOS ONE			English	Article							ARCTIC GROUND-SQUIRRELS; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; DOWN-REGULATION; CELLS; INVASION; SUPPRESSION; TORPOR; SYSTEM; TISSUE	Hibernation torpor provides an excellent model of natural tolerance to ischemia. We have previously shown that massive global SUMOylation occurs during hibernation torpor in ground squirrels. We have also shown that overexpression of Ubc9, SUMO-1, or SUMO-2/3 provides protection against ischemic damage in cell lines and cortical neurons exposed to oxygen/glucose deprivation, and in mice exposed to middle cerebral artery occlusion. We have now extended our study to other Ubiquitin-Like-Modifiers (ULMs), which have multiple cellular functions during stress, in order to assess the possibility that they also have roles in tolerance to ischemia. We found that not only SUMO conjugation, but also global protein conjugation by other ULMs including NEDD8, ISG15, UFM1 and FUB1 were significantly increased in the brains of hibernating ground squirrels during torpor. By means of miRNA microarrays of ground squirrel brain samples (from active and torpor phase) we found that the miR-200 family (miR-200a,b,c/miR-141/miR-429) and the miR-182 family (miR-182/miR-183/miR-96) were among the most consistently depressed miRNAs in the brain during the torpor phase as compared to active animals. In addition, we showed that these miRNAs are involved in the expression of various ULM proteins and their global conjugation to proteins. We observed that inhibition of the miR-200 family and/or miR-182 family miRNA activities in SHSY5Y cells increases global protein conjugation by the above ULMs and makes these cells more tolerant to OGD-induced cell death. This is the first report to describe that the natural tolerance to brain ischemia in hibernators is linked to regulation by microRNAs of a broad range of ubiquitin-like modifiers.	[Lee, Yang-ja; Hallenbeck, John M.] NINDS, Stroke Branch, NIH, Bethesda, MD 20892 USA; [Johnson, Kory R.] NINDS, Bioinformat Sect, Informat Technol & Bioinformat Program, DIR,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Hallenbeck, JM (corresponding author), NINDS, Stroke Branch, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	hallenbj@ninds.nih.gov			National Institute of Neurological Disorders and Stroke/National Institutes of Health; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002856] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by the Intramural Research Program of the National Institute of Neurological Disorders and Stroke/National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chen RX, 2012, MOL MED REP, V5, P800, DOI 10.3892/mmr.2011.695; Dharap A, 2010, J NEUROCHEM, V113, P1685, DOI 10.1111/j.1471-4159.2010.06735.x; Frerichs KU, 1998, J CEREBR BLOOD F MET, V18, P168, DOI 10.1097/00004647-199802000-00007; Gravgaard KH, 2012, BREAST CANC RES TREA; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; HAAS AL, 1987, J BIOL CHEM, V262, P11315; Herrmann J, 2007, CIRC RES, V100, P1276, DOI 10.1161/01.RES.0000264500.11888.f0; Hur K, 2012, GUT; Jeon YJ, 2010, BBA-MOL BASIS DIS, V1802, P485, DOI 10.1016/j.bbadis.2010.02.006; Komatsu M, 2004, EMBO J, V23, P1977, DOI 10.1038/sj.emboj.7600205; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; KUMAR S, 1993, BIOCHEM BIOPH RES CO, V195, P393, DOI 10.1006/bbrc.1993.2056; Lee ST, 2010, STROKE, V41, P1646, DOI 10.1161/STROKEAHA.110.579649; Lee Y, 2007, J CEREBR BLOOD F MET, V27, P950, DOI 10.1038/sj.jcbfm.9600395; Lee YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025852; Lee YJ, 2009, J NEUROCHEM, V109, P257, DOI 10.1111/j.1471-4159.2009.05957.x; Lemaire K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018517; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Liu S, 2012, ANN SURG ONCOL; Liu YT, 2010, PHYSIOL GENOMICS, V42A, P39, DOI 10.1152/physiolgenomics.00054.2010; Liu Z, 2012, J PATHOL; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magenta A, 2011, CELL DEATH DIFFER, V18, P1628, DOI 10.1038/cdd.2011.42; Mihelich BL, 2011, J BIOL CHEM, V286, P44503, DOI 10.1074/jbc.M111.262915; Morin PJ, 2008, BBA-GENE REGUL MECH, V1779, P628, DOI 10.1016/j.bbagrm.2008.07.011; Moskwa P, 2011, MOL CELL, V41, P210, DOI 10.1016/j.molcel.2010.12.005; Nakamura M, 2006, J BIOL CHEM, V281, P16861, DOI 10.1074/jbc.M509907200; Nakka VP, 2011, J CEREBR BLOOD F MET, V31, P2375, DOI 10.1038/jcbfm.2011.103; Oved S, 2006, J BIOL CHEM, V281, P21640, DOI 10.1074/jbc.M513034200; Shao CX, 2010, MOL CELL PROTEOMICS, V9, P313, DOI 10.1074/mcp.M900260-MCP200; Sossey-Alaoui K, 2009, J BIOL CHEM, V284, P33019, DOI 10.1074/jbc.M109.034553; Suzuki K, 1996, IMMUNOBIOLOGY, V195, P187, DOI 10.1016/S0171-2985(96)80038-6; Tateishi K, 2001, J CELL BIOL, V155, P571, DOI 10.1083/jcb.200104035; Wang J, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-227; Yan J, 2006, PHYSIOL GENOMICS, V25, P346, DOI 10.1152/physiolgenomics.00260.2005; Zhang LF, 2011, INT J MOL MED, V28, P381, DOI 10.3892/ijmm.2011.679; Zhu JF, 2012, AM J PATHOL, V180, P2440, DOI 10.1016/j.ajpath.2012.02.023	38	47	50	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47787	10.1371/journal.pone.0047787	http://dx.doi.org/10.1371/journal.pone.0047787			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094087	Green Published, gold, Green Submitted			2022-12-25	WOS:000312384500023
J	Oikonomou, G; Machado, VS; Santisteban, C; Schukken, YH; Bicalho, RC				Oikonomou, Georgios; Machado, Vinicius Silva; Santisteban, Carlos; Schukken, Ynte Hein; Bicalho, Rodrigo Carvalho			Microbial Diversity of Bovine Mastitic Milk as Described by Pyrosequencing of Metagenomic 16s rDNA	PLOS ONE			English	Article							COAGULASE-NEGATIVE STAPHYLOCOCCI; POLYMERASE-CHAIN-REACTION; SUBCLINICAL MASTITIS; HELCOCOCCUS-OVIS; IDENTIFICATION; PATHOGENS; ENDOCARDITIS; SEQUENCES; BACTERIA; CULTURE	Dairy cow mastitis is an important disease in the dairy industry. Different microbial species have been identified as causative agents in mastitis, and are traditionally diagnosed by bacterial culture. The objective of this study was to use metagenomic pyrosequencing of bacterial 16S rRNA genes to investigate bacterial DNA diversity in milk samples of mastitic and healthy dairy cows and compare the results with those obtained by classical bacterial culture. One hundred and thirty-six milk samples were collected from cows showing signs of mastitis and used for microbiological culture. Additionally, 20 milk samples were collected from healthy quarters. Bacterial DNA was isolated from the same milk samples and the 16S rRNA genes were individually amplified and pyrosequenced. Discriminant analysis showed that the groups of samples that were most clearly different from the rest and thus easily discriminated were the normal milk samples from healthy cows and those characterised by culture as Trueperella pyogenes and Streptococcus spp. The mastitis pathogens identified by culture were generally among the most frequent organisms detected by pyrosequencing, and in some cases (Escherichia coli, Klebsiella spp. and Streptococcus uberis mastitis) the single most prevalent microorganism. Trueperella pyogenes sequences were the second most prevalent sequences in mastitis cases diagnosed as Trueperella pyogenes by culture, Streptococcus dysgalactiae sequences were the second most prevalent sequences in mastitis cases diagnosed as Streptococcus dysgalactiae by culture, and Staphyloccocus aureus sequences were the third most prevalent in mastitis cases diagnosed as Staphylococcus aureus by culture. In samples that were aerobic culture negative, pyrosequencing identified DNA of bacteria that are known to cause mastitis, DNA of bacteria that are known pathogens but have so far not been associated with mastitis, and DNA of bacteria that are currently not known to be pathogens. A possible role of anaerobic pathogens in bovine mastitis is also suggested.	[Oikonomou, Georgios; Machado, Vinicius Silva; Santisteban, Carlos; Schukken, Ynte Hein; Bicalho, Rodrigo Carvalho] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	Cornell University	Bicalho, RC (corresponding author), Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA.	rcb28@cornell.edu	Schukken, Ynte H/C-3405-2008; Schukken, Ynte/ABD-3352-2021	Schukken, Ynte H/0000-0002-8250-4194; Schukken, Ynte/0000-0002-8250-4194	United States Department of Agriculture/National Institute of Food and Agriculture Federal Formula Funds [NE-1028]	United States Department of Agriculture/National Institute of Food and Agriculture Federal Formula Funds	Funding was partially provided by the United States Department of Agriculture/National Institute of Food and Agriculture Federal Formula Funds project NE-1028. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bexiga R, 2011, J DAIRY RES, V78, P49, DOI 10.1017/S0022029910000725; Bhatt VD, 2012, J APPL MICROBIOL, V112, P639, DOI 10.1111/j.1365-2672.2012.05244.x; Bicalho ML, 2011, VET MICROBIOL; CANTOR CR, 1966, P NATL ACAD SCI USA, V56, P177, DOI 10.1073/pnas.56.1.177; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Collins MD, 1999, INT J SYST BACTERIOL, V49, P1429, DOI 10.1099/00207713-49-4-1429; Drummond GB, 2012, J PHYSIOL-LONDON, V590, P1303, DOI 10.1113/jphysiol.2012.229856; Elad D, 2004, EMERG INFECT DIS, V10, P505, DOI 10.3201/eid1003.020592; Fessler AT, 2010, J ANTIMICROB CHEMOTH, V65, P1576, DOI 10.1093/jac/dkq172; Halasa T, 2007, VET QUART, V29, P18, DOI 10.1080/01652176.2007.9695224; Herrero IA, 2002, J CLIN MICROBIOL, V40, P3848, DOI 10.1128/JCM.40.10.3848-3850.2002; Hunt KM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021313; Kolbert CP, 1999, CURR OPIN MICROBIOL, V2, P299, DOI 10.1016/S1369-5274(99)80052-6; Koskinen MT, 2010, J DAIRY SCI, V93, P5707, DOI 10.3168/jds.2010-3167; Kuang Y, 2009, BIOCHEM ENG J, V45, P76, DOI 10.1016/j.bej.2009.02.010; Kutzer P, 2008, J CLIN MICROBIOL, V46, P3291, DOI 10.1128/JCM.00867-08; Luthje P, 2006, J ANTIMICROB CHEMOTH, V57, P966, DOI 10.1093/jac/dk1061; Nagaraja TG, 2005, ANAEROBE, V11, P239, DOI 10.1016/j.anaerobe.2005.01.007; Nawrocki EP, 2007, PLOS COMPUT BIOL, V3, P540, DOI 10.1371/journal.pcbi.0030056; PYORALA S, 1992, BRIT VET J, V148, P54, DOI 10.1016/0007-1935(92)90067-B; Pyorala S, 2009, VET MICROBIOL, V134, P3, DOI 10.1016/j.vetmic.2008.09.015; Rozen S, 2000, Methods Mol Biol, V132, P365; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santos TMA, 2011, J DAIRY SCI, V94, P291, DOI 10.3168/jds.2010-3668; Schaechter M., 2009, ENCY MICROBIOLOGY, P57; Schukken YH, 2009, VET MICROBIOL, V134, P9, DOI 10.1016/j.vetmic.2008.09.014; Schwaiger K, 2012, J DAIRY SCI, V95, P98, DOI 10.3168/jds.2011-4700; Shome BR, 2011, J APPL MICROBIOL, V111, P1349, DOI 10.1111/j.1365-2672.2011.05169.x; Sun YJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq872; Taponen S, 2009, J DAIRY SCI, V92, P2610, DOI 10.3168/jds.2008-1729; Tsakalidou E, 1998, INT J SYST BACTERIOL, V48, P519, DOI 10.1099/00207713-48-2-519; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07	33	110	117	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47671	10.1371/journal.pone.0047671	http://dx.doi.org/10.1371/journal.pone.0047671			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082192	gold, Green Published			2022-12-25	WOS:000311146900089
J	Sabag-Daigle, A; Ahmer, BMM				Sabag-Daigle, Anice; Ahmer, Brian M. M.			ExpI and PhzI Are Descendants of the Long Lost Cognate Signal Synthase for SdiA	PLOS ONE			English	Article							FISCHERI LUXR PROTEIN; PSEUDOMONAS-AERUGINOSA; ACYLHOMOSERINE LACTONE; SALMONELLA-ENTERICA; TERMINAL REGION; QUORUM; AUTOINDUCER; REGULATORS; BACTERIA; EXPRESSION	SdiA of E. coli and Salmonella is a LuxR homolog that detects N-acyl homoserine lactones (AHLs). Most LuxR homologs function together with a cognate AHL synthase (a LuxI homolog), but SdiA does not. Instead, SdiA detects AHLs produced by other bacterial species. In this report, we performed a phylogenetic analysis of SdiA. The results suggest that one branch of the Enterobacteriaceae obtained a rhlR/rhlI pair by horizontal transfer. The Erwinia and Pantoea branches still contain the complete pair where it is known as expR/expI and phzR/phzI, respectively. A deletion event removed the luxI homolog from the remainder of the group, leaving just the luxR homolog known as sdiA. Thus ExpR and PhzR are SdiA orthologs and ExpI and PhzI are descendants of the long lost cognate signal synthase of SdiA.	[Sabag-Daigle, Anice; Ahmer, Brian M. M.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Sabag-Daigle, Anice; Ahmer, Brian M. M.] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Ahmer, BMM (corresponding author), Ohio State Univ, Dept Microbiol, 484 W 12Th Ave, Columbus, OH 43210 USA.	ahmer.1@osu.edy	Ahmer, Brian M. M./F-2228-2010	Ahmer, Brian M. M./0000-0002-4267-7322	National Institute of Allergy and Infectious Diseases [R01AI073971, R01AI097116]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073971, R01AI097116] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by Award Numbers R01AI073971 and R01AI097116 from the National Institute of Allergy and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson S, 2009, J R SOC INTERFACE, V6, P959, DOI 10.1098/rsif.2009.0203; CHOI SH, 1992, J BACTERIOL, V174, P4064, DOI 10.1128/jb.174.12.4064-4069.1992; CHOI SH, 1991, P NATL ACAD SCI USA, V88, P11115, DOI 10.1073/pnas.88.24.11115; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Drummond A., 2011, GENEIOUS V5 5; Dyszel JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008946; Dyszel JL, 2010, J BACTERIOL, V192, P29, DOI 10.1128/JB.01139-09; Evans K, 1998, J BACTERIOL, V180, P5443, DOI 10.1128/JB.180.20.5443-5447.1998; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Gillespie JJ, 2011, INFECT IMMUN, V79, P4286, DOI 10.1128/IAI.00207-11; Gray KM, 2001, MICROBIOL-SGM, V147, P2379, DOI 10.1099/00221287-147-8-2379; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; HANZELKA BL, 1995, J BACTERIOL, V177, P815, DOI 10.1128/jb.177.3.815-817.1995; Hoang TT, 1999, GENE, V237, P361, DOI 10.1016/S0378-1119(99)00331-5; Hoang TT, 2002, MICROBIOL-SGM, V148, P3849, DOI 10.1099/00221287-148-12-3849; Janssens JCA, 2007, APPL ENVIRON MICROB, V73, P535, DOI 10.1128/AEM.01451-06; KAPLAN HB, 1985, J BACTERIOL, V163, P1210, DOI 10.1128/JB.163.3.1210-1214.1985; Lerat E, 2004, MOL BIOL EVOL, V21, P903, DOI 10.1093/molbev/msh097; Lindsay A, 2005, J BACTERIOL, V187, P5054, DOI 10.1128/JB.187.14.5054-5058.2005; Michael B, 2001, J BACTERIOL, V183, P5733, DOI 10.1128/JB.183.19.5733-5742.2001; Minagawa S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-70; More MI, 1996, SCIENCE, V272, P1655, DOI 10.1126/science.272.5268.1655; Morohoshi T, 2007, J BACTERIOL, V189, P8333, DOI 10.1128/JB.01054-07; Ng WL, 2009, ANNU REV GENET, V43, P197, DOI 10.1146/annurev-genet-102108-134304; Parsek MR, 1999, P NATL ACAD SCI USA, V96, P4360, DOI 10.1073/pnas.96.8.4360; Patankar AV, 2009, FEMS MICROBIOL REV, V33, P739, DOI 10.1111/j.1574-6976.2009.00163.x; Pearson JP, 1999, J BACTERIOL, V181, P1203, DOI 10.1128/JB.181.4.1203-1210.1999; Raychaudhuri A, 2005, BIOCHEMISTRY-US, V44, P2974, DOI 10.1021/bi048005m; Reading NC, 2006, FEMS MICROBIOL LETT, V254, P1, DOI 10.1111/j.1574-6968.2005.00001.x; Smith JN, 2003, J BACTERIOL, V185, P1357, DOI 10.1128/JB.185.4.1357-1366.2003; Soares JA, 2011, CURR OPIN MICROBIOL, V14, P188, DOI 10.1016/j.mib.2011.01.006; Sperandio V, 2010, GUT MICROBES, V1, P432, DOI 10.4161/gmic.1.6.14177; Subramoni S, 2009, MICROBIOL-SGM, V155, P1377, DOI 10.1099/mic.0.026849-0; Venturi V, 2004, FEMS MICROBIOL LETT, V241, P179, DOI 10.1016/j.femsle.2004.10.015	34	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47720	10.1371/journal.pone.0047720	http://dx.doi.org/10.1371/journal.pone.0047720			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082201	Green Published, gold, Green Submitted			2022-12-25	WOS:000311146900098
J	Trancikova, A; Mamais, A; Webber, PJ; Stafa, K; Tsika, E; Glauser, L; West, AB; Bandopadhyay, R; Moore, DJ				Trancikova, Alzbeta; Mamais, Adamantios; Webber, Philip J.; Stafa, Klodjan; Tsika, Elpida; Glauser, Liliane; West, Andrew B.; Bandopadhyay, Rina; Moore, Darren J.			Phosphorylation of 4E-BP1 in the Mammalian Brain Is Not Altered by LRRK2 Expression or Pathogenic Mutations	PLOS ONE			English	Article							DISEASE-ASSOCIATED MUTATIONS; PARKINSONS-DISEASE; KINASE-ACTIVITY; PROTEIN-KINASE; GTP-BINDING; DOPAMINERGIC NEURON; ACTIVATION; LINK	Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are a common cause of autosomal dominant familial Parkinson's disease (PD). LRRK2 encodes a multi-domain protein containing GTPase and kinase enzymatic domains. Disease-associated mutations in LRRK2 variably influence enzymatic activity with the common G2019S variant leading to enhanced kinase activity. Mutant LRRK2 induces neuronal toxicity through a kinase-dependent mechanism suggesting that kinase activity is important for mediating the pathogenic effects of LRRK2 mutations. A number of LRRK2 kinase substrates have been identified in vitro but whether they represent authentic physiological substrates in mammalian cells or tissues is not yet clear. The eukaryotic initiation factor 4E (eIF4E)-binding protein, 4E-BP1, was recently identified as a potential substrate of LRRK2 kinase activity in vitro and in Drosophila with phosphorylation occurring at Thr37 and Thr46. Here, we explore a potential interaction of LRRK2 and 4E-BP1 in mammalian cells and brain. We find that LRRK2 can weakly phosphorylate 4E-BP1 in vitro but LRRK2 overexpression is not able to alter endogenous 4E-BP1 phosphorylation in mammalian cells. In mammalian neurons LRRK2 and 4E-BP1 display minimal co-localization, whereas the subcellular distribution, protein complex formation and covalent post-translational modification of endogenous 4E-BP1 are not altered in the brains of LRRK2 knockout or mutant LRRK2 transgenic mice. In the brain, the phosphorylation of 4E-BP1 at Thr37 and Thr46 does not change in LRRK2 knockout or mutant LRRK2 transgenic mice, nor is 4E-BP1 phosphorylation altered in idiopathic or G2019S mutant PD brains. Collectively, our results suggest that 4E-BP1 is neither a major nor robust physiological substrate of LRRK2 in mammalian cells or brain.	[Trancikova, Alzbeta; Stafa, Klodjan; Tsika, Elpida; Glauser, Liliane; Moore, Darren J.] Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lausanne, Switzerland; [Mamais, Adamantios; Bandopadhyay, Rina] UCL, Inst Neurol, Reta Lila Weston Inst Neurol Dis, London, England; [Webber, Philip J.; West, Andrew B.] Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of London; University College London; University of Alabama System; University of Alabama Birmingham	Moore, DJ (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, Brain Mind Inst, Lausanne, Switzerland.	darren.moore@epfl.ch	Trancikova, Alzbeta Kralova/X-7402-2018; Bandopadhyay, Rina/C-7926-2009	Trancikova, Alzbeta Kralova/0000-0002-4743-4952; Moore, Darren/0000-0003-2359-5679; West, Andrew/0000-0002-3034-4061; Tsika, Elpida/0000-0003-4189-4234; Mamais, Adamantios/0000-0002-5546-7084	Michael J. Fox Foundation for Parkinson's Research; Swiss National Science Foundation [310030_127478]; Ecole Polytechnique Federale de Lausanne; Reta Lila Weston Trust; National Institutes of Health [R01 NS064934]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064934] Funding Source: NIH RePORTER	Michael J. Fox Foundation for Parkinson's Research; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ecole Polytechnique Federale de Lausanne; Reta Lila Weston Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funding from the Michael J. Fox Foundation for Parkinson's Research (DJM), Swiss National Science Foundation (grant no. 310030_127478 to DJM), Ecole Polytechnique Federale de Lausanne (DJM), Reta Lila Weston Trust (RB and AM) and National Institutes of Health grant R01 NS064934 (ABW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasly JO, 2010, MOVEMENT DISORD, V25, P2156, DOI 10.1002/mds.23265; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Biskup S, 2009, BBA-MOL BASIS DIS, V1792, P625, DOI 10.1016/j.bbadis.2008.09.015; Dusonchet J, 2011, J NEUROSCI, V31, P907, DOI 10.1523/JNEUROSCI.5092-10.2011; Gasser T, 2009, BBA-MOL BASIS DIS, V1792, P587, DOI 10.1016/j.bbadis.2008.12.007; Giasson BI, 2006, ANN NEUROL, V59, P315, DOI 10.1002/ana.20791; Gillardon F, 2009, J NEUROCHEM, V110, P1514, DOI 10.1111/j.1471-4159.2009.06235.x; Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422; Glauser L, 2011, J NEUROCHEM, V118, P636, DOI 10.1111/j.1471-4159.2011.07318.x; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Hallett Penelope J, 2008, Curr Protoc Neurosci, VChapter 1, DOI 10.1002/0471142301.ns0116s42; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Herzig MC, 2011, HUM MOL GENET, V20, P4209, DOI 10.1093/hmg/ddr348; Hsu CH, 2010, J NEUROCHEM, V112, P1593, DOI 10.1111/j.1471-4159.2010.06568.x; Imai Y, 2008, EMBO J, V27, P2432, DOI 10.1038/emboj.2008.163; Ito G, 2007, BIOCHEMISTRY-US, V46, P1380, DOI 10.1021/bi061960m; Jaleel M, 2007, BIOCHEM J, V405, P307, DOI 10.1042/BJ20070209; Kamikawaji S, 2009, BIOCHEMISTRY-US, V48, P10963, DOI 10.1021/bi9011379; Kanao T, 2010, HUM MOL GENET, V19, P3747, DOI 10.1093/hmg/ddq289; Kumar A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008730; Lewis PA, 2007, BIOCHEM BIOPH RES CO, V357, P668, DOI 10.1016/j.bbrc.2007.04.006; Li XT, 2007, J NEUROCHEM, V103, P238, DOI 10.1111/j.1471-4159.2007.04743.x; LIN TA, 1994, SCIENCE, V266, P653, DOI 10.1126/science.7939721; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Ng Philip, 2002, Methods Mol Med, V69, P389; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Ramonet D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018568; Ross OA, 2006, ANN NEUROL, V59, P388, DOI 10.1002/ana.20731; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Stafa K, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002526; Tain LS, 2009, NAT NEUROSCI, V12, P1129, DOI 10.1038/nn.2372; Tsika E, 2012, CURR NEUROL NEUROSCI, V12, P251, DOI 10.1007/s11910-012-0265-8; Webber PJ, 2011, J MOL BIOL, V412, P94, DOI 10.1016/j.jmb.2011.07.033; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Xiong YL, 2012, J NEUROSCI, V32, P3877, DOI 10.1523/JNEUROSCI.4566-11.2012; Xiong YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000902; Young SM, 2009, NEURON, V63, P482, DOI 10.1016/j.neuron.2009.07.028; Zhou HS, 2000, VIROLOGY, V275, P348, DOI 10.1006/viro.2000.0515; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	46	36	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47784	10.1371/journal.pone.0047784	http://dx.doi.org/10.1371/journal.pone.0047784			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082216	Green Published, gold, Green Submitted			2022-12-25	WOS:000311146900113
J	Xu, Q; Zhang, L; Li, T; Zhang, L; He, L; Dong, K; Liu, NN				Xu, Qiang; Zhang, Lee; Li, Ting; Zhang, Lan; He, Lin; Dong, Ke; Liu, Nannan			Evolutionary Adaptation of the Amino Acid and Codon Usage of the Mosquito Sodium Channel following Insecticide Selection in the Field Mosquitoes	PLOS ONE			English	Article							KNOCKDOWN RESISTANCE KDR; PYRETHROID-RESISTANT; CULEX-QUINQUEFASCIATUS; POINT MUTATIONS; CROSS-RESISTANCE; GENE; IDENTIFICATION; EXPRESSION; DROSOPHILA; SITE	Target site insensitivity resulting from point mutations within the voltage-gated sodium channel of the insect nervous system is known to be of primary importance in the development of resistance to pyrethroid insecticides. This study shifts current research paradigms by conducting, for the first time, a global analysis of all the naturally occurring mutations, both nonsynonymous and synonymous mutations, as well as mutation combinations in the entire mosquito sodium channel of Culex quinquefasciatus and analyzing their evolutionary and heritable feature and roles in insecticide resistance. Through a systematic analysis of comparing nucleotide polymorphisms in the entire sodium channel cDNAs of individuals between susceptible and resistant mosquito strains, between field parental mosquitoes and their permethrin selected offspring, and among different mosquito groups categorized by their levels of tolerance to specific permethrin concentrations within and among the mosquito strains of the field parental strains and their permethrin selected offspring, 3 nonsynonymous (A(109)S, (LF)-F-982, and (WR)-R-1573) and 6 synonymous (L-852, G(891), A(1241), D-1245, P-1249, and G(1733)) mutations were identified. The co-existence of all 9 mutations, both nonsynonymous and synonymous, and their homozygousity were found to be important factors for high levels of resistance. Our study, for the first time, provide a strong case demonstrating the co-existence of both nonsynonymous and synonymous mutations in the sodium channel of resistant mosquitoes in response to insecticide resistance and the inheritance of these mutations in the offspring of field mosquito strains following insecticide selection.	[Xu, Qiang; Li, Ting; Zhang, Lan; He, Lin; Liu, Nannan] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA; [Zhang, Lee] Auburn Univ, Genom Lab, Auburn, AL 36849 USA; [Dong, Ke] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA	Auburn University System; Auburn University; Auburn University System; Auburn University; Michigan State University	Liu, NN (corresponding author), Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA.	liunann@auburn.edu	Li, Ting/L-2400-2016; Li, Ting/D-5181-2015; Li, Ting/ABG-2699-2021	Li, Ting/0000-0002-6004-4617; 	National Institute Of Allergy And Infectious Diseases [R21AI090303]; AAES [ALA08-045, ALA015-1-10026]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI090303] Funding Source: NIH RePORTER	National Institute Of Allergy And Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AAES; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project described was supported by Award Number R21AI090303 from the National Institute Of Allergy And Infectious Diseases, and AAES Hatch/Multistate Grants ALA08-045 and ALA015-1-10026 to N.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x; Burton MJ, 2011, INSECT BIOCHEM MOLEC, V41, P723, DOI 10.1016/j.ibmb.2011.05.004; Chapman J, 2008, GENET EPIDEMIOL, V32, P560, DOI 10.1002/gepi.20330; Davies TGE, 2007, IUBMB LIFE, V59, P151, DOI 10.1080/15216540701352042; Davies TGE, 2008, PEST MANAG SCI, V64, P1126, DOI 10.1002/ps.1617; Dong Ke, 2007, Invertebrate Neuroscience, V7, P17, DOI 10.1007/s10158-006-0036-9; Du Y, 2009, TOXICOL APPL PHARM, V234, P266, DOI 10.1016/j.taap.2008.10.006; Eleftherianos I, 2008, B ENTOMOL RES, V98, P183, DOI 10.1017/S0007485307005524; Goeman JJ, 2006, J ROY STAT SOC B, V68, P477, DOI 10.1111/j.1467-9868.2006.00551.x; Guerrero FD, 1997, INSECT BIOCHEM MOLEC, V27, P745, DOI 10.1016/S0965-1748(97)00057-X; Gupta SK, 2000, BIOCHEM BIOPH RES CO, V269, P692, DOI 10.1006/bbrc.2000.2351; Hanrahan CJ, 2000, GENETICS, V155, P1149; Head DJ, 1998, INSECT MOL BIOL, V7, P191, DOI 10.1046/j.1365-2583.1998.72061.x; Hemingway J, 2002, SCIENCE, V298, P96, DOI 10.1126/science.1078052; Ingles PJ, 1996, INSECT BIOCHEM MOLEC, V26, P319, DOI 10.1016/0965-1748(95)00093-3; Kawada H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024323; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Liu HQ, 2004, J MED ENTOMOL, V41, P408, DOI 10.1603/0022-2585-41.3.408; Liu NN, 2007, GENE, V394, P61, DOI 10.1016/j.gene.2007.01.032; Liu NN, 2009, J MED ENTOMOL, V46, P1424, DOI 10.1603/033.046.0625; Liu NN, 2002, INSECT BIOCHEM MOLEC, V32, P755, DOI 10.1016/S0965-1748(01)00158-8; Liu ZQ, 2000, INSECT BIOCHEM MOLEC, V30, P991, DOI 10.1016/S0965-1748(00)00074-6; Martinez-Torres D, 1999, PESTIC SCI, V55, P1012, DOI 10.1002/(SICI)1096-9063(199910)55:10&lt;1012::AID-PS39&gt;3.0.CO;2-5; Miyazaki M, 1996, MOL GEN GENET, V252, P61, DOI 10.1007/BF02173205; MOORMAN JR, 1990, SCIENCE, V250, P688; Morin S, 2002, INSECT BIOCHEM MOLEC, V32, P1781, DOI 10.1016/S0965-1748(02)00137-6; Palladino MJ, 2000, CELL, V102, P437, DOI 10.1016/S0092-8674(00)00049-0; PATTON DE, 1992, P NATL ACAD SCI USA, V89, P10905, DOI 10.1073/pnas.89.22.10905; Sanchez G, 2012, ASSOTESTER STAT TEST; Soderlund D.M., 2005, P1; Soderlund D. M., 1990, PESTICIDE RESISTANCE, P58; Sonoda S, 2008, ARCH INSECT BIOCHEM, V69, P1, DOI 10.1002/arch.20246; Ting L, 2010, J MED ENTOMOL, V47, P1127; Toda S, 2009, J ECON ENTOMOL, V102, P2296, DOI 10.1603/029.102.0635; Tran HTT, 2005, MOL GENET METAB, V85, P213, DOI 10.1016/j.ymgme.2005.03.006; Tsagkarakou A, 2009, INSECT MOL BIOL, V18, P583, DOI 10.1111/j.1365-2583.2009.00900.x; Usherwood PNR, 2007, FEBS LETT, V581, P5485, DOI 10.1016/j.febslet.2007.10.057; VASSILEV PM, 1988, SCIENCE, V241, P1658, DOI 10.1126/science.2458625; Wang DX, 2005, PHARMACOGENET GENOM, V15, P693, DOI 10.1097/01.fpc.0000178311.02878.83; Wang RW, 2002, J APICULT RES, V41, P17, DOI 10.1080/00218839.2002.11101064; *WHO, 1957, WHO TECH RPT SER; Williamson MS, 1996, MOL GEN GENET, V252, P51, DOI 10.1007/BF02173204; Xu Q, 2005, PEST MANAG SCI, V61, P1096, DOI 10.1002/ps.1090; Xu QA, 2006, GENE, V379, P62, DOI 10.1016/j.gene.2006.04.013; Xu Q, 2006, BIOCHEM BIOPH RES CO, V345, P774, DOI 10.1016/j.bbrc.2006.04.155; Xu Q, 2011, BIOCHEM BIOPH RES CO, V407, P645, DOI 10.1016/j.bbrc.2011.03.060	46	22	23	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47609	10.1371/journal.pone.0047609	http://dx.doi.org/10.1371/journal.pone.0047609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082181	Green Published, Green Submitted, gold			2022-12-25	WOS:000311146900077
J	Zhang, WL; Chen, Y; Yang, XM; Fan, JY; Mi, XN; Wang, JZ; Zhang, CN; Hu, FB; Hui, RT				Zhang, Weili; Chen, Yu; Yang, Xiaomin; Fan, Jingyao; Mi, Xuenan; Wang, Jizheng; Zhang, Channa; Hu, Frank B.; Hui, Rutai			Functional Haplotypes of the hTERT Gene, Leukocyte Telomere Length Shortening, and the Risk of Peripheral Arterial Disease	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CORONARY-HEART-DISEASE; ANKLE-BRACHIAL INDEX; COMMON VARIANTS; LOCUS; POLYMORPHISM; MORTALITY; PROMOTER; TERC; ATHEROSCLEROSIS	Background: The development of peripheral arterial disease (PAD) is heterogeneous even in the presence of similar risk factors. Our aim was to determine whether inter-individual differences in leukocyte telomere length contribute to the susceptibility of PAD. Methods: A total of 485 patients with PAD (defined by the ankle-brachial index) and 970 age-and gender-matched controls were recruited from seven rural communities in Henan Province in China. The relative leukocyte telomere length was determined by a quantitative PCR-based method. Two common promoter variants of the hTERT gene were genotyped to assess their effects on telomere length and the risk of PAD. In vivo luciferase assay was performed to study the transcriptional activity. Results: After adjustment for vascular risk factors and genetic variants in the hTERT gene, individuals in the lowest and middle tertiles of telomere length had a significantly higher risk of PAD than did those in the highest tertile (odds ratio [OR] 1.73, 95% confidence interval [CI] 1.29-2.49 in the middle tertile; 3.15, 95%CI 2.31-4.29 in the lowest tertile). Haplotype analysis using the 2 variants (rs2735940 and rs2853669) showed that subjects with the at-risk C-C haplotype had shorter telomere length than those individuals with the T-T haplotype and consistently had 1.30-fold (OR 1.30, 95%CI 1.06-1.58; P = 0.005) increased risk for PAD. The C-C haplotype had 43% lowered transcription activity of hTERT promoter (P<0.001). Conclusion: The associations between the functional haplotype of hTERT gene and telomere length and the risk of atherosclerotic PAD suggested that mean leukocyte telomere length may independently serve as a potential predictor of PAD.	[Zhang, Weili; Chen, Yu; Fan, Jingyao; Mi, Xuenan; Wang, Jizheng; Zhang, Channa; Hui, Rutai] Chinese Acad Med Sci, Sino German Lab Mol Med, State Key Lab Cardiovasc Dis, FuWai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Zhang, Weili; Chen, Yu; Fan, Jingyao; Mi, Xuenan; Wang, Jizheng; Zhang, Channa; Hui, Rutai] Peking Union Med Coll, Beijing 100021, Peoples R China; [Yang, Xiaomin] Baotou Med Coll, Affiliated Hosp 2, Baotou City, Peoples R China; [Hu, Frank B.] Harvard Univ, Sch Publ Hlth, Dept Nutr & Epidemiol, Boston, MA 02115 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Baotou Medical College; Harvard University; Harvard T.H. Chan School of Public Health	Zhang, WL (corresponding author), Chinese Acad Med Sci, Sino German Lab Mol Med, State Key Lab Cardiovasc Dis, FuWai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China.	zhangwl1747@yahoo.com.cn			Ministry of Science and Technology of China [2011CB503901]; National Natural Science Foundation [81070172]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the grants to Dr. Hui (2011CB503901) from the Ministry of Science and Technology of China and to Dr. Zhang (81070172) from the National Natural Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew T, 2006, AM J HUM GENET, V78, P480, DOI 10.1086/500052; Belch JJF, 2003, ARCH INTERN MED, V163, P884, DOI 10.1001/archinte.163.8.884; Bischoff C, 2005, TWIN RES HUM GENET, V8, P433, DOI 10.1375/twin.8.5.433; Blackburn EH, 1991, CIRCULATION, V350, P569; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Brevetti G, 2004, ATHEROSCLEROSIS, V175, P131, DOI 10.1016/j.atherosclerosis.2004.03.009; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Calado RT, 2009, NEW ENGL J MED, V361, P2353, DOI 10.1056/NEJMra0903373; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Codd V, 2010, NAT GENET, V42, P197, DOI 10.1038/ng.532; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; Ducrest AL, 2002, ONCOGENE, V21, P541, DOI 10.1038/sj.onc.1205081; Fehrer C, 2006, EXP GERONTOL, V41, P648, DOI 10.1016/j.exger.2006.03.016; Gauderman WJ, 2006, QUANTO 1 1 COMPUTER; Greenland P, 2000, CIRCULATION, V101, P723; Gu JA, 2011, CANCER PREV RES, V4, P514, DOI 10.1158/1940-6207.CAPR-11-0063; Hasimu B, 2006, HYPERTENS RES, V29, P23, DOI 10.1291/hypres.29.23; Hayoz D, 2005, J INTERN MED, V258, P238, DOI 10.1111/j.1365-2796.2005.01536.x; Hooi JD, 2004, J CLIN EPIDEMIOL, V57, P294, DOI 10.1016/j.jclinepi.2003.09.003; Horikawa I, 1999, CANCER RES, V59, P826; Hsu CP, 2006, EUR J CANCER, V42, P1466, DOI 10.1016/j.ejca.2006.02.014; Ju ZY, 2007, NAT MED, V13, P742, DOI 10.1038/nm1578; Kilian A, 1997, HUM MOL GENET, V6, P2011, DOI 10.1093/hmg/6.12.2011; Knowles JW, 2007, ARTERIOSCL THROM VAS, V27, P2068, DOI 10.1161/01.ATV.0000282199.66398.8c; Lansdorp PM, 1996, HUM MOL GENET, V5, P685, DOI 10.1093/hmg/5.5.685; Levy D, 2010, P NATL ACAD SCI USA, V107, P9293, DOI 10.1073/pnas.0911494107; Mangino M, 2009, J MED GENET, V46, P451, DOI 10.1136/jmg.2008.064956; Mangino M, 2008, HUM MOL GENET, V17, P2518, DOI 10.1093/hmg/ddn152; Matsubara Y, 2006, BIOCHEM BIOPH RES CO, V348, P669, DOI 10.1016/j.bbrc.2006.07.103; McDermott MM, 2009, J AM COLL CARDIOL, V54, P1228, DOI 10.1016/j.jacc.2009.04.081; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; Newman AB, 1999, ARTERIOSCL THROM VAS, V19, P538, DOI 10.1161/01.ATV.19.3.538; Nordfjall K, 2007, BIOCHEM BIOPH RES CO, V358, P215, DOI 10.1016/j.bbrc.2007.04.099; O'Hare MJ, 2001, P NATL ACAD SCI USA, V98, P646, DOI 10.1073/pnas.98.2.646; Prescott J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019635; Samani NJ, 2001, LANCET, V358, P472, DOI 10.1016/S0140-6736(01)05633-1; Shen Q, 2011, EUR J HUM GENET, V19, P721, DOI 10.1038/ejhg.2011.4; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; Soerensen M, 2012, AGING CELL, V11, P223, DOI 10.1111/j.1474-9726.2011.00775.x; Takakura M, 1999, CANCER RES, V59, P551; Tregouet DA, 2004, ANN HUM GENET, V68, P165, DOI 10.1046/j.1529-8817.2003.00085.x; Vasa-Nicotera M, 2005, AM J HUM GENET, V76, P147, DOI 10.1086/426734; Yang JW, 1999, J BIOL CHEM, V274, P26141, DOI 10.1074/jbc.274.37.26141; Yang XM, 2007, J VASC SURG, V46, P296, DOI 10.1016/j.jvs.2007.03.034; Zee RYL, 2011, CLIN CHIM ACTA, V412, P199, DOI 10.1016/j.cca.2010.10.003; Zheng ZJ, 1997, ATHEROSCLEROSIS, V131, P115, DOI 10.1016/S0021-9150(97)06089-9	46	22	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47029	10.1371/journal.pone.0047029	http://dx.doi.org/10.1371/journal.pone.0047029			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082138	Green Published, Green Submitted, gold			2022-12-25	WOS:000311146900033
J	de Boer, BA; van den Berg, G; Soufan, AT; de Boer, PAJ; Hagoort, J; van den Hoff, MJB; Moorman, AFM; Ruijter, JM				de Boer, Bouke A.; van den Berg, Gert; Soufan, Alexandre T.; de Boer, Piet A. J.; Hagoort, Jaco; van den Hoff, Maurice J. B.; Moorman, Antoon F. M.; Ruijter, Jan M.			Measurement and 3D-Visualization of Cell-Cycle Length Using Double Labelling with Two Thymidine Analogues Applied in Early Heart Development	PLOS ONE			English	Article							CHICK-EMBRYO; PROLIFERATION; GROWTH; BROMODEOXYURIDINE; RECONSTRUCTION; TUBE	Organ development is a complex spatial process in which local differences in cell proliferation rate play a key role. Understanding this role requires the measurement of the length of the cell cycle at every position of the three-dimensional (3D) structure. This measurement can be accomplished by exposing the developing embryo to two different thymidine analogues for two different durations immediately followed by tissue fixation. This paper presents a method and a dedicated computer program to measure the resulting labelling indices and subsequently calculate and visualize local cell cycle lengths within the 3D morphological context of a developing organ. By applying this method to the developing heart, we show a large difference in cell cycle lengths between the early heart tube and the adjacent mesenchyme of the pericardial wall. Later in development, a local increase in cell size was found to be associated with a decrease in cell cycle length in the region where the chamber myocardium starts to develop. The combined application of halogenated-thymidine double exposure and image processing enables the automated study of local cell cycle parameters in single specimens in a full 3D context. It can be applied in a wide range of research fields ranging from embryonic development to tissue regeneration and cancer research.	[de Boer, Bouke A.; van den Berg, Gert; Soufan, Alexandre T.; de Boer, Piet A. J.; Hagoort, Jaco; van den Hoff, Maurice J. B.; Moorman, Antoon F. M.; Ruijter, Jan M.] Univ Amsterdam, Acad Med Ctr, Dept Anat Embryol & Physiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Ruijter, JM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Anat Embryol & Physiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	j.m.ruijter@amc.uva.nl		van den Hoff, Maurice/0000-0002-3837-8055	EU [Health-F2-2008-223040]; Netherlands Heart foundation [NHS1996M002]	EU(European Commission); Netherlands Heart foundation(Netherlands Heart Foundation)	BAdB was supported by the EU seventh framework program project CHeartED (Health-F2-2008-223040). GvdB was supported by the Netherlands Heart foundation (NHS1996M002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiades MR, 1996, DEV DYNAM, V205, P293, DOI 10.1002/(SICI)1097-0177(199603)205:3<293::AID-AJA9>3.0.CO;2-D; [Anonymous], 1979, STEREOLOGICAL METHOD; ATEN JA, 1992, HISTOCHEM J, V24, P251, DOI 10.1007/BF01046839; Boehm B, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000420; Cai L, 1997, J NEUROSCI, V17, P2079; de Boer BA, 2012, DEV BIOL, V368, P203, DOI 10.1016/j.ydbio.2012.05.001; de Boer BA, 2011, DEVELOPMENT, V138, P159, DOI 10.1242/dev.051086; GERDES J, 1984, J IMMUNOL, V133, P1710; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; MACAULEY A, 1993, DEVELOPMENT, V117, P873; Martynoga B, 2005, DEV BIOL, V283, P113, DOI 10.1016/j.ydbio.2005.04.005; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; SANDERS EJ, 1993, DEVELOPMENT, V118, P389; SHIBUI S, 1989, J HISTOCHEM CYTOCHEM, V37, P1007, DOI 10.1177/37.7.2659659; SISSMAN NJ, 1966, NATURE, V210, P504, DOI 10.1038/210504a0; Soufan AT, 2007, J MICROSC-OXFORD, V225, P269, DOI 10.1111/j.1365-2818.2007.01742.x; Soufan AT, 2006, CIRC RES, V99, P545, DOI 10.1161/01.RES.0000239407.45137.97; Soufan AT, 2003, PHYSIOL GENOMICS, V13, P187, DOI 10.1152/physiolgenomics.00182.2002; STALSBERG H, 1969, DEV BIOL, V20, P18, DOI 10.1016/0012-1606(69)90003-7; van den Berg G, 2009, CIRC RES, V104, P179, DOI 10.1161/CIRCRESAHA.108.185843; Vega CJ, 2005, NAT METHODS, V2, P167, DOI 10.1038/NMETH741; Vincent L, 1993, IEEE T IMAGE PROCESS, V2, P176, DOI 10.1109/83.217222; VOIT EO, 1988, J THEOR BIOL, V131, P435, DOI 10.1016/S0022-5193(88)80039-0; WIMBER DE, 1963, EXP CELL RES, V30, P8, DOI 10.1016/0014-4827(63)90209-X	25	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47719	10.1371/journal.pone.0047719	http://dx.doi.org/10.1371/journal.pone.0047719			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091641	Green Published, gold, Green Submitted			2022-12-25	WOS:000310135800067
J	Knox, PC; Amatya, N; Jiang, XY; Gong, Q				Knox, Paul C.; Amatya, Nabin; Jiang, Xiaoyu; Gong, Qyong			Performance Deficits in a Voluntary Saccade Task in Chinese "Express Saccade Makers"	PLOS ONE			English	Article							DORSOLATERAL PREFRONTAL CORTEX; SUPERIOR COLLICULUS; ANTISACCADE TASK; PREPARATORY SET; REACTION-TIMES; ANTI-SACCADES; RESEARCH TOOL; EYE-MOVEMENT; REFLEXIVE; MONKEY	Differences in behaviour and cognition have been observed in different human populations. It has been reported that in various types of complex visual task, eye movement patterns differ systematically between Chinese and non-Chinese participants, an observation that has been related to differences in culture between groups. However, we confirm here that, in healthy, naive adult Chinese participants, a far higher proportion (22%) than expected (1-5%) exhibit a pattern of reflexive eye movement behaviour (high numbers of low latency express saccades) in circumstances designed to inhibit such responses (prosaccade overlap tasks). These participants are defined as "express saccade makers'' (ESMs). We then show using the antisaccade paradigm, which requires the inhibition of reflexive responses and the programming and execution of voluntary saccades, that the performance of ESMs is compromised; they have higher antisaccade directional error rates, and the latency distributions of their error saccades again exhibit a higher proportion of low latency express saccade errors consistent with a reduced ability to inhibit reflexive responses. These results are difficult to reconcile with a cultural explanation as they relate to important and specific performance differences within a particular population. They suggest a potential unexpected confound relevant to those studies of Chinese versus other groups which have investigated group differences using oculomotor measures, and explained them in terms of culture. The confirmation of higher numbers of ESMs among Chinese participants provides new opportunities for examining oculomotor control.	[Knox, Paul C.] Univ Liverpool, Inst Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England; [Amatya, Nabin; Jiang, Xiaoyu; Gong, Qyong] Sichuan Univ, W China Hosp, Ctr Med Imaging, Huaxi MR Res Ctr,Ctr Med Imaging, Chengdu 610064, Peoples R China	University of Liverpool; Sichuan University	Knox, PC (corresponding author), Univ Liverpool, Inst Ageing & Chron Dis, Liverpool L69 3BX, Merseyside, England.	pcknox@liv.ac.uk	Knox, Paul/Q-1920-2019; Gong, Qiyong/W-3052-2019	Knox, Paul/0000-0002-2578-7335; Gong, Qiyong/0000-0002-5912-4871	National Natural Science Foundation of China [81030027]; UK Royal Society [30711130226]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); UK Royal Society(Royal Society of London)	This study was supported by the National Natural Science Foundation of China (Grant No. 81030027) and a UK Royal Society International Joint Project grant (Grant No. 30711130226). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatya N, 2011, EXP BRAIN RES, V210, P117, DOI 10.1007/s00221-011-2609-z; Biscaldi M, 1996, J NEUROPHYSIOL, V76, P199, DOI 10.1152/jn.1996.76.1.199; Bohns VK, 2011, J EXP SOC PSYCHOL, V47, P676, DOI 10.1016/j.jesp.2011.01.001; CARPENTER RHS, 1995, NATURE, V377, P59, DOI 10.1038/377059a0; Cavegn D, 1996, EXP BRAIN RES, V109, P101; Chua HF, 2005, P NATL ACAD SCI USA, V102, P12629, DOI 10.1073/pnas.0506162102; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; Crawford TJ, 2011, EXP BRAIN RES, V208, P385, DOI 10.1007/s00221-010-2488-8; Cutsuridis V, 2007, NEURAL NETWORKS, V20, P690, DOI 10.1016/j.neunet.2007.01.004; Delinte A, 2002, NEUROSCI RES, V42, P21, DOI 10.1016/S0168-0102(01)00300-5; Dorris MC, 1998, J NEUROSCI, V18, P7015; Dorris MC, 1997, J NEUROSCI, V17, P8566; Edelman JA, 1996, J NEUROPHYSIOL, V76, P908, DOI 10.1152/jn.1996.76.2.908; Evdokimidis I, 2002, EXP BRAIN RES, V147, P45, DOI 10.1007/s00221-002-1208-4; Everling S, 1998, NEUROPSYCHOLOGIA, V36, P885, DOI 10.1016/S0028-3932(98)00020-7; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; Everling S, 1999, J NEUROSCI, V19, P2740; Everling S, 1998, J NEUROPHYSIOL, V79, P511, DOI 10.1152/jn.1998.79.2.511; Fischer B, 1997, EXP BRAIN RES, V116, P191, DOI 10.1007/PL00005749; FISCHER B, 1993, EXP BRAIN RES, V92, P528; Fischer B, 1997, BRAIN RES, V754, P285, DOI 10.1016/S0006-8993(97)00094-2; FISCHER B, 1984, EXP BRAIN RES, V57, P191; Goh JO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008238; GUITTON D, 1985, EXP BRAIN RES, V58, P455; HALLETT PE, 1978, VISION RES, V18, P1279, DOI 10.1016/0042-6989(78)90218-3; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; Harwood MR, 2008, J NEUROPHYSIOL, V99, P1743, DOI 10.1152/jn.00589.2007; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Hutton SB, 2006, PSYCHOPHYSIOLOGY, V43, P302, DOI 10.1111/j.1469-8986.2006.00403.x; Ji LJ, 2000, J PERS SOC PSYCHOL, V78, P943, DOI 10.1037/0022-3514.78.5.943; Kelly DJ, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00095; KINGSTONE A, 1993, PERCEPT PSYCHOPHYS, V54, P260, DOI 10.3758/BF03211762; Kitayama S, 2003, PSYCHOL SCI, V14, P201, DOI 10.1111/1467-9280.02432; Kobayashi C, 2006, BRAIN LANG, V98, P210, DOI 10.1016/j.bandl.2006.04.013; Koval MJ, 2011, J NEUROSCI, V31, P8659, DOI 10.1523/JNEUROSCI.1258-11.2011; Leigh RJ, 2004, BRAIN, V127, P460, DOI 10.1093/brain/awh035; Massen C, 2004, Q J EXP PSYCHOL-A, V57, P475, DOI 10.1080/02724980343000341; McKone E, 2010, VISION RES, V50, P1540, DOI 10.1016/j.visres.2010.05.010; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; Munoz DP, 1998, EXP BRAIN RES, V121, P391, DOI 10.1007/s002210050473; Nagel M, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-89; Nyffeler T, 2007, EUR J NEUROSCI, V26, P1381, DOI 10.1111/j.1460-9568.2007.05758.x; Ploner CJ, 2005, BIOL PSYCHIAT, V57, P1159, DOI 10.1016/j.biopsych.2005.02.017; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; SCHILLER PH, 1987, J NEUROPHYSIOL, V57, P1033, DOI 10.1152/jn.1987.57.4.1033; Trappenberg TP, 2001, J COGNITIVE NEUROSCI, V13, P256, DOI 10.1162/089892901564306; Walker R, 1998, NEUROPSYCHOLOGIA, V36, P1141, DOI 10.1016/S0028-3932(98)00004-9; Wang Q, 2009, COGNITION, V111, P123, DOI 10.1016/j.cognition.2009.01.004; Wegener SP, 2008, EXP BRAIN RES, V190, P463, DOI 10.1007/s00221-008-1488-4; Wu SL, 2007, PSYCHOL SCI, V18, P600, DOI 10.1111/j.1467-9280.2007.01946.x	51	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47688	10.1371/journal.pone.0047688	http://dx.doi.org/10.1371/journal.pone.0047688			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	024UX	23091639	Green Published, Green Submitted, gold			2022-12-25	WOS:000310135800064
J	Huang, WH; Chang, MC; Tsai, KS; Hung, MC; Chen, HL; Hung, SC				Huang, W-H; Chang, M-C; Tsai, K-S; Hung, M-C; Chen, H-L; Hung, S-C			Mesenchymal stem cells promote growth and angiogenesis of tumors in mice	ONCOGENE			English	Article						mesenchymal stem cells; cancer cells; endothelial cells; IL-6; endothelian-1; angiogenesis	STROMAL FIBROBLASTS; EXPANSION; RELEASE; PATHWAY	Though the early integration of mesenchymal stem cells (MSCs) into tumor-associated stroma of cancer has been demonstrated, the functional contributions and underlying mechanisms of these cells to tumor growth and angiogenesis remain to be clarified. Using a xenograft model, human colorectal cancer cells, MSCs, and their cell mixture were introduced to a subcutaneous site of immunodeficient mice. The tumor growth rate and angiogenesis of each transplantation was then compared. We demonstrate that a variety of colorectal cancer cells, when mixed with otherwise non-tumorigenic MSCs, increase the tumor growth rate and angiogenesis more than that when mixed with carcinoma-associated fibroblasts or normal colonic fibroblasts. The secretion of interleukin-6 (IL-6) from MSCs increases the secretion of endothelin-1 (ET-1) in cancer cells, which induces the activation of Akt and ERK in endothelial cells, thereby enhancing their capacities for recruitment and angiogenesis to tumor. The IL-6/ET-1/Akt or ERK pathway of tumor-stroma interaction can be targeted by an antibody against IL-6 or Lentiviral-mediated RNAi against IL-6 in MSCs, by inhibition or knockdown of ET-1 in cancer cells, or by inhibition of ERK and Akt in host endothelial cells. These demonstrate that attempts to interrupt the interaction of MSCs and cancer cells help to abrogate angiogenesis and inhibit tumor growth in tumors formed by cancer cells admixed with MSCs. These data demonstrate that the tumor microenvironment, namely, MSCs-secreted IL-6, may enrich the proangiognic factors secreted by cancer cells to increase angiogenesis and tumor growth and that targeting this interaction may lead to novel therapeutic and preventive strategies.	[Huang, W-H; Chen, H-L] Natl Yang Ming Univ, Inst Oral Biol, Dept Dent, Taipei 112, Taiwan; [Chang, M-C; Tsai, K-S] Natl Yang Ming Univ, Inst Anat & Cell Biol, Dept Dent, Taipei 112, Taiwan; [Chang, M-C; Hung, S-C] Taipei Vet Gen Hosp, Dept Orthopaed & Traumatol, Taipei, Taiwan; [Tsai, K-S; Hung, S-C] Taipei Vet Gen Hosp, Dept Med Res & Educ, Stem Cell Lab, Taipei, Taiwan; [Hung, M-C] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Hung, M-C] China Med Univ & Hosp, Coll Med, Grad Inst Canc Biol, Taichung, Taiwan; [Hung, M-C] China Med Univ & Hosp, Ctr Mol Med, Taichung, Taiwan; [Hung, S-C] Natl Yang Ming Univ, Inst Clin Med, Dept Dent, Taipei 112, Taiwan; [Hung, S-C] Natl Yang Ming Univ, Inst Pharmacol, Dept Dent, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei Veterans General Hospital; Taipei Veterans General Hospital; University of Texas System; UTMD Anderson Cancer Center; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Chen, HL (corresponding author), Natl Yang Ming Univ, Inst Oral Biol, Dept Dent, 155,Sect 2,Li Ron St, Taipei 112, Taiwan.	hlchen2@ym.edu.tw; hungsc@vghtpe.gov.tw	Hung, Mien-Chie/ABD-5911-2021	Hung, Mien-Chie/0000-0003-4317-4740	National Science Council [99-3111-B-010-005-, 100-2321-B-010-022-]; Taipei Veterans General Hospital [V99E1-011]; National Yang-Ming University, Ministry of Education	National Science Council(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital(Taipei Veterans General Hospital); National Yang-Ming University, Ministry of Education	National Science Council (99-3111-B-010-005-; 100-2321-B-010-022-), Taipei Veterans General Hospital (V99E1-011) and National Yang-Ming University, Ministry of Education. The study sponsors do not have a role in the study design, collection, analysis and interpretation of date.	Basile JR, 2007, J BIOL CHEM, V282, P6899, DOI 10.1074/jbc.M609570200; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Coffelt SB, 2009, P NATL ACAD SCI USA, V106, P3806, DOI 10.1073/pnas.0900244106; Dwyer RM, 2007, CLIN CANCER RES, V13, P5020, DOI 10.1158/1078-0432.CCR-07-0731; Eldesoky A, 2011, SAUDI J GASTROENTERO, V17, P170, DOI 10.4103/1319-3767.80378; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; FOLKMAN J, 1973, J EXP MED, V138, P745, DOI 10.1084/jem.138.4.745; Hung SC, 2005, CLIN CANCER RES, V11, P7749, DOI 10.1158/1078-0432.CCR-05-0876; Hung SC, 2007, STEM CELLS, V25, P2363, DOI 10.1634/stemcells.2006-0686; Joyce JA, 2005, CANCER CELL, V7, P513, DOI 10.1016/j.ccr.2005.05.024; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Lis R, 2011, INT J CANCER, V128, P715, DOI 10.1002/ijc.25619; Liu Y, 2011, J BIOL CHEM, V286, P25007, DOI 10.1074/jbc.M110.213108; Mishra PJ, 2008, CANCER RES, V68, P4331, DOI 10.1158/0008-5472.CAN-08-0943; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Nelson J, 2003, NAT REV CANCER, V3, P110, DOI 10.1038/nrc990; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Patel SA, 2010, J IMMUNOL, V184, P5885, DOI 10.4049/jimmunol.0903143; Piperi C, 2011, CYTOKINE, V55, P387, DOI 10.1016/j.cyto.2011.05.012; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Quante M, 2011, CANCER CELL, V19, P257, DOI 10.1016/j.ccr.2011.01.020; Roodhart JML, 2011, CANCER CELL, V20, P370, DOI 10.1016/j.ccr.2011.08.010; Sekiya I, 2002, STEM CELLS, V20, P530, DOI 10.1634/stemcells.20-6-530; Shinagawa K, 2010, INT J CANCER, V127, P2323, DOI 10.1002/ijc.25440; Shojaei F, 2008, CANCER RES, V68, P5501, DOI 10.1158/0008-5472.CAN-08-0925; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Stagg J, 2008, STEM CELL REV, V4, P119, DOI 10.1007/s12015-008-9030-4; Tsai KS, 2011, GASTROENTEROLOGY, V141, P1046, DOI 10.1053/j.gastro.2011.05.045; Yamanashi T, 2009, ONCOLOGY-BASEL, V77, P53, DOI 10.1159/000226112	29	146	151	3	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 12	2013	32	37					4343	4354		10.1038/onc.2012.458	http://dx.doi.org/10.1038/onc.2012.458			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	218AF	23085755				2022-12-25	WOS:000324404200003
J	Dalvai, M; Bellucci, L; Fleury, L; Lavigne, AC; Moutahir, F; Bystricky, K				Dalvai, M.; Bellucci, L.; Fleury, L.; Lavigne, A-C; Moutahir, F.; Bystricky, K.			H2A.Z-dependent crosstalk between enhancer and promoter regulates Cyclin D1 expression	ONCOGENE			English	Article						H2A.Z; chromatin; acetylation; enhancer; intragenic loop; cyclin D1	BREAST-CANCER CELLS; ESTROGEN-RECEPTOR-ALPHA; RNA-POLYMERASE-II; BETA-GLOBIN LOCUS; GENE-EXPRESSION; HISTONE H2A.Z; TRANSCRIPTIONAL ACTIVATION; CHROMOSOME CONFORMATION; CHROMATIN DYNAMICS; IN-VIVO	H2A.Z association with specific genomic loci is thought to contribute to a chromatin structure that promotes transcription activation. Acetylation of H2A.Z at promoters of oncogenes has been linked to tumorigenesis. The mechanism is unknown. Here, we show that in triple negative breast cancer cells, H2A.Z bound to the promoter of the constitutively, weakly expressed cyclin D1 oncogene (CCND1), a key regulator of cellular proliferation. Depleting the pool of H2A.Z stimulated transcription of CCND1 in the absence of its cognate transcription factor, the estrogen receptor (ER). During activation of CCND1, H2A.Z was released from the transcription start site (TSS) and downstream enhancer (enh2) sequences. Concurrently, acetylation of H2A.Z, H3 and H4 at the TSS was increased but only H2A.Z was acetylated at enh2. Acetylation of H2A.Z required the Tip60 acetyltransferase to be associated with the activated CCND1 on both TSS and enh2 sites. Depletion of Tip60 prevented CCND1 activation. Chromosome conformation capture experiments (3C) revealed specific contacts between the TSS and enh2 chromatin regions. These results suggest that release of a histone H2A.Z-mediated repression loop activates CCND1 for transcription. Our findings open new avenues for controlling and understanding aberrant gene expression associated with tumorigenesis.	[Dalvai, M.; Bellucci, L.; Fleury, L.; Lavigne, A-C; Moutahir, F.; Bystricky, K.] Univ Toulouse, LBME, F-31062 Toulouse, France; [Dalvai, M.; Bellucci, L.; Fleury, L.; Lavigne, A-C; Moutahir, F.; Bystricky, K.] CNRS, LBME, UMR 5099, Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Bystricky, K (corresponding author), Univ Toulouse, LBME, 118 Route Narbonne, F-31062 Toulouse, France.	kerstin@biotoul.fr	Lavigne, Anne-Claire/O-8805-2015; Bystricky, Kerstin/AAA-3003-2020; BYSTRICKY, Kerstin/B-8670-2009	Bystricky, Kerstin/0000-0001-6717-3721; BYSTRICKY, Kerstin/0000-0001-6717-3721	Ligue Nationale Contre le Cancer; Institut National du Cancer (INCa) [34696]; Fondation pour la Recherche Medicale (FRM)	Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	We would like to thank Dr Didier Trouche for the Tip60 expressing vector and insightful discussions, J Eeckhoute, Lille for sharing unpublished work, and David Laperriere, IRIC, Montreal, for expert advice on genome database use. This work was supported by the Ligue Nationale Contre le Cancer (fellowship to LB), the Institut National du Cancer (INCa grant no. 34696) and the Fondation pour la Recherche Medicale (FRM, fellowship to MD).	Adam M, 2001, MOL CELL BIOL, V21, P6270, DOI 10.1128/MCB.21.18.6270-6279.2001; Altaf M, 2009, BIOCHEM CELL BIOL, V87, P35, DOI 10.1139/O08-140; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BARTKOVA J, 1994, J PATHOL, V172, P237, DOI 10.1002/path.1711720303; Barzily-Rokni M, 2011, NUCLEIC ACIDS RES, V39, P1326, DOI 10.1093/nar/gkq994; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Boulon S, 2002, MOL CELL BIOL, V22, P7769, DOI 10.1128/MCB.22.22.7769-7779.2002; Bray F, 2002, EUR J CANCER, V38, P99, DOI 10.1016/S0959-8049(01)00350-1; Brookes E, 2009, EMBO REP, V10, P1213, DOI 10.1038/embor.2009.221; Bruzzese F, 2011, J CELL PHYSIOL, V226, P2378, DOI 10.1002/jcp.22574; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chambeyron S, 2004, CURR OPIN CELL BIOL, V16, P256, DOI 10.1016/j.ceb.2004.03.004; Chu S, 1997, MOL CELL ENDOCRINOL, V132, P195, DOI 10.1016/S0303-7207(97)00133-0; Dalvai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011011; Dalvai M, 2010, J MAMMARY GLAND BIOL, V15, P19, DOI 10.1007/s10911-010-9167-z; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Deschenes J, 2007, J BIOL CHEM, V282, P17335, DOI 10.1074/jbc.C700030200; Eeckhoute J, 2006, GENE DEV, V20, P2513, DOI 10.1101/gad.1446006; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Farris SD, 2005, J BIOL CHEM, V280, P25298, DOI 10.1074/jbc.M501784200; Fleury L, 2008, ONCOGENE, V27, P4075, DOI 10.1038/onc.2008.41; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gamble MJ, 2010, GENE DEV, V24, P21, DOI 10.1101/gad.1876110; Gevry N, 2009, GENE DEV, V23, P1522, DOI 10.1101/gad.1787109; Giamarchi C, 1999, ONCOGENE, V18, P533, DOI 10.1038/sj.onc.1202317; Guillemette B, 2005, PLOS BIOL, V3, P2100, DOI 10.1371/journal.pbio.0030384; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Henikoff S, 2005, ANNU REV CELL DEV BI, V21, P133, DOI 10.1146/annurev.cellbio.21.012704.133518; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Ikura T, 2007, MOL CELL BIOL, V27, P7028, DOI 10.1128/MCB.00579-07; JENSEN EV, 1967, ARCH ANAT MICROSC MO, V56, P547; Jeong KW, 2011, NAT STRUCT MOL BIOL, V18, P1358, DOI 10.1038/nsmb.2153; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Jin FL, 2011, P NATL ACAD SCI USA, V108, P5290, DOI 10.1073/pnas.1017214108; Keogh MC, 2006, GENE DEV, V20, P660, DOI 10.1101/gad.1388106; Kimura A, 1998, GENES CELLS, V3, P789, DOI 10.1046/j.1365-2443.1998.00229.x; Kocanova S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000922; Lee S, 2010, J BIOL CHEM, V285, P21399, DOI 10.1074/jbc.M110.128413; Legube G, 2004, J BIOL CHEM, V279, P44825, DOI 10.1074/jbc.M407478200; Lehn S, 2010, AM J PATHOL, V177, P2886, DOI 10.2353/ajpath.2010.100303; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; Ma XJ, 2009, DRUGS, V69, P1911, DOI 10.2165/11315680-000000000-00000; March-Diaz R, 2008, PLANT J, V53, P475, DOI 10.1111/j.1365-313X.2007.03361.x; Mattera L, 2009, ONCOGENE, V28, P1506, DOI 10.1038/onc.2008.499; Mattera L, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000983; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Metivier R, 2002, MOL CELL, V10, P1019, DOI 10.1016/S1097-2765(02)00746-3; Millar CB, 2006, GENE DEV, V20, P711, DOI 10.1101/gad.1395506; Noordermeer D, 2011, NAT CELL BIOL, V13, P944, DOI 10.1038/ncb2278; Ogawa S, 1998, NUCLEIC ACIDS RES, V26, P3505, DOI 10.1093/nar/26.15.3505; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; OTTAVIANO YL, 1994, CANCER RES, V54, P2552; Planas-Silva MD, 1999, CANCER RES, V59, P4788; Ptashne M, 1997, NATURE, V386, P569, DOI 10.1038/386569a0; Serandour AA, 2011, GENOME RES, V21, P555, DOI 10.1101/gr.111534.110; Shia WJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-217; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Soulez M, 2001, J MOL ENDOCRINOL, V27, P259, DOI 10.1677/jme.0.0270259; Splinter E, 2004, METHOD ENZYMOL, V375, P493; Stadhouders R, 2012, EMBO J, V31, P986, DOI 10.1038/emboj.2011.450; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suganuma T, 2008, CELL, V135, P604, DOI 10.1016/j.cell.2008.10.036; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; THOMPSON EW, 1992, J CELL PHYSIOL, V150, P534, DOI 10.1002/jcp.1041500314; Tobin NP, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-417; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; TOUITOU I, 1991, J STEROID BIOCHEM, V40, P231, DOI 10.1016/0960-0760(91)90187-A; Updike DL, 2006, PLOS GENET, V2, P1500, DOI 10.1371/journal.pgen.0020161; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Valdes-Mora F, 2012, GENOME RES, V22, P307, DOI 10.1101/gr.118919.110; Vigushin DM, 2001, CLIN CANCER RES, V7, P971; Vogelmann J, 2011, NUCLEUS-PHILA, V2, P358, DOI 10.4161/nucl.2.5.17860; Voss TC, 2011, CELL, V146, P544, DOI 10.1016/j.cell.2011.07.006; Yamamoto T, 1997, J BIOL CHEM, V272, P30595, DOI 10.1074/jbc.272.49.30595; Yang XW, 2001, CANCER RES, V61, P7025; Yun MY, 2011, CELL RES, V21, P564, DOI 10.1038/cr.2011.42	79	28	28	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 5	2013	32	36					4243	4251		10.1038/onc.2012.442	http://dx.doi.org/10.1038/onc.2012.442			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	214WL	23108396				2022-12-25	WOS:000324168000006
J	Otazo, MRD; Lorenzo, J; Tort, O; Aviles, FX; Bautista, JM				de la Vega Otazo, Monica Rodriguez; Lorenzo, Julia; Tort, Olivia; Aviles, Francesc X.; Bautista, Jose M.			Functional segregation and emerging role of cilia-related cytosolic carboxypeptidases (CCPs)	FASEB JOURNAL			English	Article						basal bodies; microtubules; tubulin modifications; polyglutamylation; detyrosination	PURKINJE-CELL DEGENERATION; TUBULIN POLYGLUTAMYLASE; EVOLUTION; ORIGIN; PROTEINS; MOUSE; DEGLUTAMYLASE; CILIOGENESIS; MECHANISMS; TRANSPORT	Recent experimental data indicating axonal regeneration, axogenesis, dendritogenesis, and ciliary axoneme assembly and wellness have linked the role of cytosolic metallocarboxypeptidase 1 (CCP1/AGTPBP1/Nna1) to the microtubule network. In addition, 5 of the 6 mammalian ccp genes have been shown to participate in post-translational modifications of tubulin, which occur in the microtubules of neurons, mitotic spindles, cilia, and basal bodies. Here, we compile evidence for the idea that the occurrence of CCPs strongly correlates with the presence of cilia, suggesting that CCP functions might be primarily related to cilia and basal bodies (CBBs). In agreement with this hypothesis, CCPs were localized in centrioles, basal bodies, and mitotic spindles in HeLa cells by confocal microscopy. By reconstructing the evolutionary history of CCPs, we show their presence in the last eukaryotic common ancestor and relate each group of CCP orthologs to specific roles in CBBs. The clues presented in this study suggest that during the evolution of eukaryotes, mechanisms mediated by CCPs through tubulin post-translational modifications controlling assembly, trafficking, and signaling in the microtubules, were transferred from cilia to cell and axon microtubules.-Rodriguez de la Vega Otazo, M., Lorenzo, J., Tort, O., Aviles, F. X., Bautista, J. M. Functional segregation and emerging role of cilia-related cytosolic carboxypeptidases (CCPs). FASEB J. 27, 424-431 (2013). www.fasebj.org	[de la Vega Otazo, Monica Rodriguez; Lorenzo, Julia; Tort, Olivia; Aviles, Francesc X.] Univ Autonoma Barcelona, Inst Biotechnol & Biomed, Barcelona, Spain; [de la Vega Otazo, Monica Rodriguez; Lorenzo, Julia; Tort, Olivia; Aviles, Francesc X.] Univ Autonoma Barcelona, Dept Biochem & Mol Biol, Barcelona, Spain; [Bautista, Jose M.] Univ Complutense Madrid, Dept Biochem & Mol Biol 4, Fac Vet, E-28040 Madrid, Spain; [Bautista, Jose M.] Univ Complutense Madrid, Inst Invest Hosp Octubre 12, E-28040 Madrid, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Complutense University of Madrid; Complutense University of Madrid; Hospital Universitario 12 de Octubre	Bautista, JM (corresponding author), Univ Complutense Madrid, Dept Biochem & Mol Biol 4, Ciudad Univ, E-28040 Madrid, Spain.	francescxavier.aviles@uab.es; jmbau@vet.ucm.es	Lorenzo, Julia/E-9015-2011; Avilés, Francesc Xavier/A-2664-2015; Rodriguez de la Vega Otazo, Monica Margarita/H-7008-2015; Aviles, Francesc Xavier/F-3482-2019; Bautista, José M./B-7899-2013; Tort, Olivia/P-1828-2015	Lorenzo, Julia/0000-0001-5659-6008; Avilés, Francesc Xavier/0000-0002-1399-6789; Rodriguez de la Vega Otazo, Monica Margarita/0000-0002-1061-3471; Aviles, Francesc Xavier/0000-0002-1399-6789; Bautista, José M./0000-0001-8926-881X; Tort, Olivia/0000-0002-1841-125X	Spanish Ministry of Science and Innovation [BIO2010-22321, BIO2010-17039]; Network of Excellence of the Generalitat de Catalunya (Xarxa de Referencia en Biotecnologia; Spain); Iberoamerican Ciencia y Tecnologia Para el Desarrollo (CYTED) network [210RT0398]; Consolidated Research Teams of the Universidad Complutense de Madrid (Comunidad de Madrid, Spain) [920267]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Network of Excellence of the Generalitat de Catalunya (Xarxa de Referencia en Biotecnologia; Spain)(Generalitat de Catalunya); Iberoamerican Ciencia y Tecnologia Para el Desarrollo (CYTED) network; Consolidated Research Teams of the Universidad Complutense de Madrid (Comunidad de Madrid, Spain)	The authors thank Dr. Luis Serrano (Centre de Regulacio Genomica, Barcelona, Spain), Jesus Avila (Centro de Biologia Molecular-Consejo Superior de Investigaciones Cientificas, Madrid, Spain), and Oscar Yanes (Universitat Rovira i Virgili, Tarragona, Spain) for discussions and reading of the manuscript; M. Roldan and N. Barba for technical assistance with confocal microscopy imaging and analyses; and F. Cortes for technical support in cell culturing. This work was funded by grants from the Spanish Ministry of Science and Innovation (BIO2010-22321 and BIO2010-17039), by the Network of Excellence of the Generalitat de Catalunya (Xarxa de Referencia en Biotecnologia; Spain), by the Iberoamerican Ciencia y Tecnologia Para el Desarrollo (CYTED) network (210RT0398), and by the Program of Consolidated Research Teams of the Universidad Complutense de Madrid (J.M.B., Research Team 920267; Comunidad de Madrid, Spain).	Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; BARRA HS, 1988, MOL NEUROBIOL, V2, P133, DOI 10.1007/BF02935343; Berezniuk I, 2012, J BIOL CHEM, V287, P6503, DOI 10.1074/jbc.M111.309138; Berger L, 2005, DIS AQUAT ORGAN, V68, P51, DOI 10.3354/dao068051; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bornens M, 2007, ADV EXP MED BIOL, V607, P119; Carvalho-Santos Z, 2010, J CELL SCI, V123, P1414, DOI 10.1242/jcs.064931; Collins TJ, 2007, BIOTECHNIQUES, V43, P25, DOI 10.2144/000112517; de la Vega MR, 2007, FASEB J, V21, P851, DOI 10.1096/fj.06-7330com; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Dolan MF, 2002, ANAT REC, V268, P290, DOI 10.1002/ar.10161; DOPAZO J, 1994, J MOL EVOL, V38, P300, DOI 10.1007/BF00176092; Escalier D, 2006, HUM REPROD UPDATE, V12, P449, DOI 10.1093/humupd/dml013; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fernandez-Gonzalez A, 2002, SCIENCE, V295, P1904, DOI 10.1126/science.1068912; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; Fritz-Laylin LK, 2010, EUKARYOT CELL, V9, P860, DOI 10.1128/EC.00381-09; Gupta RS, 1996, TRENDS BIOCHEM SCI, V21, P166, DOI 10.1016/0968-0004(96)20013-1; Gupta RS, 2005, MICROBIAL PHYLOGENY, P160; Harris A, 2000, MOL CELL NEUROSCI, V16, P578, DOI 10.1006/mcne.2000.0900; Hodges ME, 2010, J CELL SCI, V123, P1407, DOI 10.1242/jcs.064873; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Janke C, 2005, SCIENCE, V308, P1758, DOI 10.1126/science.1113010; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Kalinina E, 2007, FASEB J, V21, P836, DOI 10.1096/fj.06-7329com; Kim J, 2010, NATURE, V464, P1048, DOI 10.1038/nature08895; Kimura Y, 2010, J BIOL CHEM, V285, P22934, DOI 10.1074/jbc.C110.128280; Lalle M, 2011, J BIOL CHEM, V286, P4471, DOI 10.1074/jbc.M110.181511; Le Bot N, 1998, J CELL BIOL, V143, P1559, DOI 10.1083/jcb.143.6.1559; Moreira D, 1998, J MOL EVOL, V47, P517, DOI 10.1007/PL00006408; MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; O'Hagan R, 2011, CURR BIOL, V21, P1685, DOI 10.1016/j.cub.2011.08.049; Otero A, 2012, FASEB J, V26, P3754, DOI 10.1096/fj.12-209601; PICKETTHEAPS JD, 1978, CELL, V14, P455, DOI 10.1016/0092-8674(78)90232-5; Regnard C, 1999, J CELL SCI, V112, P4281; Rogowski K, 2010, CELL, V143, P564, DOI 10.1016/j.cell.2010.10.014; Rogowski K, 2009, CELL, V137, P1076, DOI 10.1016/j.cell.2009.05.020; RZHETSKY A, 1992, J MOL EVOL, V35, P367, DOI 10.1007/BF00161174; Sahab ZJ, 2011, CANCER RES, V71, P1219, DOI 10.1158/0008-5472.CAN-10-2294; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Suryavanshi S, 2010, CURR BIOL, V20, P435, DOI 10.1016/j.cub.2009.12.062; TACHI S, 1974, BIOL REPROD, V10, P391, DOI 10.1095/biolreprod10.4.391; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Vaisberg EA, 1996, J CELL BIOL, V133, P831, DOI 10.1083/jcb.133.4.831; Valero J, 2006, MOL CELL NEUROSCI, V33, P283, DOI 10.1016/j.mcn.2006.08.002; van Dijk J, 2007, MOL CELL, V26, P437, DOI 10.1016/j.molcel.2007.04.012; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727; Woodland HR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003778; Wu HY, 2012, FASEB J, V26, P4468, DOI 10.1096/fj.12-205047; ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4	50	21	24	0	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					424	431		10.1096/fj.12-209080	http://dx.doi.org/10.1096/fj.12-209080			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23085998				2022-12-25	WOS:000314358000003
J	Saavedra, YGL; Day, R; Seidah, NG				Saavedra, Yascara Grisel Luna; Day, Robert; Seidah, Nabil G.			The M2 Module of the Cys-His-rich Domain (CHRD) of PCSK9 Protein Is Needed for the Extracellular Low-density Lipoprotein Receptor (LDLR) Degradation Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; PROPROTEIN CONVERTASE PCSK9; FAMILIAL HYPERCHOLESTEROLEMIA; LIVER-REGENERATION; MOUSE-LIVER; CHOLESTEROL; MUTATIONS; MICE; ANTIBODY; MUTANTS	PCSK9 enhances the cellular degradation of the LDL receptor (LDLR), leading to increased plasma LDL cholesterol. This multidomain protein contains a prosegment, a catalytic domain, a hinge region, and a cysteine-histidine rich domain (CHRD) composed of three tightly packed modules named M1, M2, and M3. The CHRD is required for the activity of PCSK9, but the mechanism behind this remains obscure. To define the contribution of each module to the function of PCSK9, we dissected the CHRD structure. Six PCSK9 deletants were generated by mutagenesis, corresponding to the deletion of only one (Delta M1, Delta M2, Delta M3) or two (Delta M12, Delta M13, Delta M23) modules. Transfection of HEK293 cells showed that all deletants were well processed and expressed compared with the parent PCSK9 but that only those lacking the M2 module were secreted. HepG2 cells lacking endogenous PCSK9 (HepG2/shPCSK9) were used for the functional analysis of the extracellular or intracellular activity of PCSK9 and its deletants. To analyze the ability of the deletants to enhance the LDLR degradation by the intracellular pathway, cellular expressions revealed that only the Delta M2 deletant retains a comparable total LDLR-degrading activity to full-length PCSK9. To probe the extracellular pathway, HepG2/shPCSK9 cells were incubated with conditioned media from transfected HEK293 or HepG2/shPCSK9 cells, and cell surface LDLR levels were analyzed by FACS. The results showed no activity of any secreted deletant compared with PCSK9. Thus, although M2 is dispensable for secretion, its presence is required for the extracellular activity of PCSK9 on cell surface LDLR.	[Saavedra, Yascara Grisel Luna; Seidah, Nabil G.] Univ Montreal, IRCM, Biochem Neuroendocrinol Lab, Montreal, PQ H2W 1R7, Canada; [Day, Robert] Univ Sherbrooke, Inst Pharmacol Sherbrooke, Sherbrooke, PQ J1H 5N4, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of Sherbrooke	Seidah, NG (corresponding author), Univ Montreal, IRCM, Biochem Neuroendocrinol Lab, 110 Pine Ave W, Montreal, PQ H2W 1R7, Canada.	seidahn@ircm.qc.ca	Seidah, Nabil/I-3596-2013	Seidah, Nabil/0000-0001-6503-9342	Canadian Institute of Health Research [MOP-102741, CTP 82946]; Bristol-Myers Squibb; Strauss Foundation; Canada Chair [216684]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Bristol-Myers Squibb(Bristol-Myers Squibb); Strauss Foundation; Canada Chair	This research was supported by Canadian Institute of Health Research Grants MOP-102741 and CTP 82946, a Bristol-Myers Squibb collaborative agreement grant, a Strauss Foundation grant, and Canada Chair no. 216684.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Benjannet S, 2004, J BIOL CHEM, V279, P48865, DOI 10.1074/jbc.M409699200; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Benjannet S, 2010, J BIOL CHEM, V285, P40965, DOI 10.1074/jbc.M110.154815; Cameron J, 2006, HUM MOL GENET, V15, P1551, DOI 10.1093/hmg/ddl077; Cariou B, 2011, ATHEROSCLEROSIS, V216, P258, DOI 10.1016/j.atherosclerosis.2011.04.018; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cunningham D, 2007, NAT STRUCT MOL BIOL, V14, P413, DOI 10.1038/nsmb1235; David J.-P, 2007, Proceedings of the 8th European Conference on Radiation and its Effects on Components and Systems, P1; Davignon J, 2010, CURR ATHEROSCLER REP, V12, P308, DOI 10.1007/s11883-010-0123-6; Denis M, 2012, CIRCULATION, V125, P894, DOI 10.1161/CIRCULATIONAHA.111.057406; Du F, 2011, J BIOL CHEM, V286, P43054, DOI 10.1074/jbc.M111.273474; Dubuc G, 2010, J LIPID RES, V51, P140, DOI 10.1194/jlr.M900273-JLR200; Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104; Hampton EN, 2007, P NATL ACAD SCI USA, V104, P14604, DOI 10.1073/pnas.0703402104; Holla OL, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-9; Holla OL, 2011, J LIPID RES, V52, P1787, DOI 10.1194/jlr.M018093; Holla OL, 2011, BIOCHEM BIOPH RES CO, V406, P234, DOI 10.1016/j.bbrc.2011.02.023; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Kotowski IK, 2006, AM J HUM GENET, V78, P410, DOI 10.1086/500615; Kwon HJ, 2008, P NATL ACAD SCI USA, V105, P1820, DOI 10.1073/pnas.0712064105; Lo Surdo P, 2011, EMBO REP, V12, P1300, DOI 10.1038/embor.2011.205; Marduel M, 2013, HUM MUTAT, V34, P83, DOI 10.1002/humu.22215; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Naureckiene S, 2003, ARCH BIOCHEM BIOPHYS, V420, P55, DOI 10.1016/j.abb.2003.09.011; Ni YG, 2010, J BIOL CHEM, V285, P12882, DOI 10.1074/jbc.M110.113035; Park SW, 2004, J BIOL CHEM, V279, P50630, DOI 10.1074/jbc.M410077200; Piper DE, 2007, STRUCTURE, V15, P545, DOI 10.1016/j.str.2007.04.004; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Poirier S, 2009, J BIOL CHEM, V284, P28856, DOI 10.1074/jbc.M109.037085; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Sikka P, 2011, J POSTGRAD MED, V57, P321, DOI 10.4103/0022-3859.90085; Stein EA, 2012, LANCET, V380, P29, DOI 10.1016/S0140-6736(12)60771-5; Strom TB, 2010, MOL GENET METAB, V101, P76, DOI 10.1016/j.ymgme.2010.05.003; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354; Zhang DW, 2008, P NATL ACAD SCI USA, V105, P13045, DOI 10.1073/pnas.0806312105; Zhang DW, 2007, J BIOL CHEM, V282, P18602, DOI 10.1074/jbc.M702027200	42	48	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43492	43501		10.1074/jbc.M112.394023	http://dx.doi.org/10.1074/jbc.M112.394023			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23105118	hybrid, Green Published			2022-12-25	WOS:000312940800030
J	Bauer, I; Grozio, A; Lasiglie, D; Basile, G; Sturla, L; Magnone, M; Sociali, G; Soncini, D; Caffa, I; Poggi, A; Zoppoli, G; Cea, M; Feldmann, G; Mostoslavsky, R; Ballestrero, A; Patrone, F; Bruzzone, S; Nencioni, A				Bauer, Inga; Grozio, Alessia; Lasiglie, Denise; Basile, Giovanna; Sturla, Laura; Magnone, Mirko; Sociali, Giovanna; Soncini, Debora; Caffa, Irene; Poggi, Alessandro; Zoppoli, Gabriele; Cea, Michele; Feldmann, Georg; Mostoslavsky, Raul; Ballestrero, Alberto; Patrone, Franco; Bruzzone, Santina; Nencioni, Alessio			The NAD(+)-dependent Histone Deacetylase SIRT6 Promotes Cytokine Production and Migration in Pancreatic Cancer Cells by Regulating Ca2+ Responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC ADP-RIBOSE; GENE-EXPRESSION; TRANSCRIPTION FACTOR; PROTEIN-SYNTHESIS; CALCIUM; INFLAMMATION; CARCINOMA; MECHANISM; CHANNEL; NAD(+)	Cytokine secretion by cancer cells contributes to cancer-induced symptoms and angiogenesis. Studies show that the sirtuin SIRT6 promotes inflammation by enhancing TNF expression. Here, we aimed to determine whether SIRT6 is involved in conferring an inflammatory phenotype to cancer cells and to define the mechanisms linking SIRT6 to inflammation. We show that SIRT6 enhances the expression of pro-inflammatory cyto-/chemokines, such as IL8 and TNF, and promotes cell migration in pancreatic cancer cells by enhancing Ca2+ responses. Via its enzymatic activity, SIRT6 increases the intracellular levels of ADP-ribose, an activator of the Ca2+ channel TRPM2. In turn, TRPM2 and Ca2+ are shown to be involved in SIRT6-induced TNF and IL8 expression. SIRT6 increases the nuclear levels of the Ca2+-dependent transcription factor, nuclear factor of activated T cells (NFAT), and cyclosporin A, a calcineurin inhibitor that reduces NFAT activity, reduces TNF and IL8 expression in SIRT6-overexpressing cells. These results implicate a role for SIRT6 in the synthesis of Ca2+-mobilizing second messengers, in the regulation of Ca2+-dependent transcription factors, and in the expression of pro-inflammatory, pro-angiogenic, and chemotactic cytokines. SIRT6 inhibition may help combat cancer-induced inflammation, angiogenesis, and metastasis.	[Grozio, Alessia; Basile, Giovanna; Sturla, Laura; Magnone, Mirko; Sociali, Giovanna; Bruzzone, Santina] Univ Genoa, Dept Expt Med, Biochem Sect, I-16132 Genoa, Italy; [Bauer, Inga; Lasiglie, Denise; Soncini, Debora; Caffa, Irene; Zoppoli, Gabriele; Cea, Michele; Ballestrero, Alberto; Patrone, Franco; Nencioni, Alessio] Univ Genoa, Dept Internal Med, I-16132 Genoa, Italy; [Grozio, Alessia; Basile, Giovanna; Sturla, Laura; Magnone, Mirko; Sociali, Giovanna; Bruzzone, Santina] Univ Genoa, CEBR, I-16132 Genoa, Italy; [Poggi, Alessandro] IRCCS Azienda Osped Univ San Martino IST Natl Ins, Unit Mol Oncol & Angiogenesis, I-16132 Genoa, Italy; [Cea, Michele] Harvard Univ, Sch Med, LeBow Inst Myeloma Therapeut, Dana Farber Canc Inst 02215, Boston, MA USA; [Cea, Michele] Harvard Univ, Sch Med, Jerome Lipper Ctr Multiple Myeloma Res, Dana Farber Canc Inst 02215, Boston, MA USA; [Feldmann, Georg] Univ Bonn, Dept Internal Med 3, Ctr Integrated Oncol Cologne Bonn, D-53127 Bonn, Germany; [Mostoslavsky, Raul] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA	University of Genoa; University of Genoa; University of Genoa; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Bonn; Harvard University; Harvard Medical School; Massachusetts General Hospital	Bruzzone, S (corresponding author), Univ Genoa, Dept Expt Med, Biochem Sect, Viale Benedetto 15,1, I-16132 Genoa, Italy.	santina.bruzzone@unige.it	Poggi, Alessandro/K-6664-2016; Caffa, Irene/J-9835-2016; Soncini, Debora/AAB-2230-2019; Bruzzone, Santina/A-4264-2015; cea, Michele/K-3863-2018; Zoppoli, Gabriele/B-6935-2016; Nencioni, Alessio/K-3692-2018; Ballestrero, Alberto/K-7546-2016; Zoppoli, Gabriele/B-6935-2016	Poggi, Alessandro/0000-0002-1860-430X; Caffa, Irene/0000-0003-1111-9915; Soncini, Debora/0000-0001-5156-498X; Bruzzone, Santina/0000-0003-2034-3716; cea, Michele/0000-0002-1530-6729; Zoppoli, Gabriele/0000-0003-3890-5588; Ballestrero, Alberto/0000-0002-2601-7711; NENCIONI, ALESSIO/0000-0001-5068-8884; Zoppoli, Gabriele/0000-0002-1619-1708	Associazione Italiana per la Ricerca sul Cancro (AIRC) [6108]; European Seventh Framework Program [256986]; Ministero della Salute [GR-2008-1135635]; Fondazione CARIGE; Compagnia di San Paolo; University of Genoa	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); European Seventh Framework Program; Ministero della Salute(Ministry of Health, Italy); Fondazione CARIGE(Fondazione Carige); Compagnia di San Paolo(Compagnia di San Paolo); University of Genoa	This work was supported in part by the Associazione Italiana per la Ricerca sul Cancro (AIRC, Code 6108) (to A. N.), by the European Seventh Framework Program (Project 256986, PANACREAS) (to A. N.), by Ministero della Salute Grant GR-2008-1135635 (to A. N.), by the Fondazione CARIGE, by the Compagnia di San Paolo, and by the University of Genoa.	ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Argiles Josep M, 2009, Curr Opin Support Palliat Care, V3, P263, DOI 10.1097/SPC.0b013e3283311d09; Badea L, 2008, HEPATO-GASTROENTEROL, V55, P2016; Balkwill FR, 2012, SEMIN CANCER BIOL, V22, P33, DOI 10.1016/j.semcancer.2011.12.005; Basile G, 2005, P NATL ACAD SCI USA, V102, P14509, DOI 10.1073/pnas.0503691102; Bruzzone S, 2003, BIOCHEM J, V375, P395, DOI 10.1042/BJ20030556; Bruzzone S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007897; Busso N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002267; Chan DA, 2009, CANCER CELL, V15, P527, DOI 10.1016/j.ccr.2009.04.010; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Ebrahimi B, 2004, CANCER-AM CANCER SOC, V101, P2727, DOI 10.1002/cncr.20672; Egberts JH, 2008, CANCER RES, V68, P1443, DOI 10.1158/0008-5472.CAN-07-5704; Fernando RI, 2011, CANCER RES, V71, P5296, DOI 10.1158/0008-5472.CAN-11-0156; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Fliegert R, 2007, BIOCHEM SOC T, V35, P109, DOI 10.1042/BST0350109; Grahnert A, 2011, INNATE IMMUN-LONDON, V17, P212, DOI 10.1177/1753425910361989; Grubisha O, 2006, J BIOL CHEM, V281, P14057, DOI 10.1074/jbc.M513741200; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hasmann M, 2003, CANCER RES, V63, P7436; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Ishikawa M, 2005, CANCER SCI, V96, P387, DOI 10.1111/j.1349-7006.2005.00064.x; Jackson AD, 2002, J BIOL CHEM, V277, P18535, DOI 10.1074/jbc.M200671200; Kaidi A, 2010, SCIENCE, V329, P1348, DOI 10.1126/science.1192049; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kiefer F, 2011, CELL MOL LIFE SCI, V68, P2811, DOI 10.1007/s00018-011-0677-7; Knowles H, 2011, P NATL ACAD SCI USA, V108, P11578, DOI 10.1073/pnas.1010678108; Kurzrock R, 2001, CANCER, V92, P1684, DOI 10.1002/1097-0142(20010915)92:6+<1684::AID-CNCR1497>3.0.CO;2-Z; Lee HC, 2011, SCI CHINA LIFE SCI, V54, P699, DOI 10.1007/s11427-011-4197-3; Lee KM, 2003, BIOCHEM BIOPH RES CO, V301, P1038, DOI 10.1016/S0006-291X(03)00086-X; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Lund FE, 2006, MOL MED, V12, P328, DOI 10.2119/2006-00099.Lund; Magnone M, 2012, J BIOL CHEM, V287, P21067, DOI 10.1074/jbc.M111.324269; Mantovani A, 2010, CURR MOL MED, V10, P369, DOI 10.2174/156652410791316968; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Matsuo Y, 2009, INT J CANCER, V124, P853, DOI 10.1002/ijc.24040; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Montecucco F., 2012, ANTIOXID RE IN PRESS; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Muller MR, 2010, NAT REV IMMUNOL, V10, P645, DOI 10.1038/nri2818; MUKAIDA N, 1989, J IMMUNOL, V143, P1366; Pan PW, 2011, J BIOL CHEM, V286, P14575, DOI 10.1074/jbc.M111.218990; Pei HD, 2009, CANCER CELL, V16, P259, DOI 10.1016/j.ccr.2009.07.016; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Peterson FC, 2011, J BIOL CHEM, V286, P35955, DOI 10.1074/jbc.M111.276238; PREISS J, 1958, J BIOL CHEM, V233, P493; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Robert F, 2012, CANCER RES, V72, P747, DOI 10.1158/0008-5472.CAN-11-2739; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Shi Q, 1999, CLIN CANCER RES, V5, P3711; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Slade D, 2011, NATURE, V477, P616, DOI 10.1038/nature10404; STEFFAN NM, 1995, J IMMUNOL, V155, P4685; SUNG SSJ, 1991, J IMMUNOL, V147, P2047; Suzuki YJ, 2011, CELL SIGNAL, V23, P1094, DOI 10.1016/j.cellsig.2011.02.007; Tennen RI, 2010, MECH AGEING DEV, V131, P185, DOI 10.1016/j.mad.2010.01.006; Tong L, 2010, BBA-PROTEINS PROTEOM, V1804, P1617, DOI 10.1016/j.bbapap.2010.02.007; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; Yamamoto S, 2008, NAT MED, V14, P738, DOI 10.1038/nm1758; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zhu X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0017783, 10.1371/journal.pone.0027081]	62	129	134	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					40924	40937		10.1074/jbc.M112.405837	http://dx.doi.org/10.1074/jbc.M112.405837			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23086953	hybrid, Green Published			2022-12-25	WOS:000311887600012
J	Nagpal, P; Plant, PJ; Correa, J; Bain, A; Takeda, M; Kawabe, H; Rotin, D; Bain, JR; Batt, JAE				Nagpal, Preena; Plant, Pamela J.; Correa, Judy; Bain, Alexandra; Takeda, Michiko; Kawabe, Hiroshi; Rotin, Daniela; Bain, James R.; Batt, Jane A. E.			The Ubiquitin Ligase Nedd4-1 Participates in Denervation-Induced Skeletal Muscle Atrophy in Mice	PLOS ONE			English	Article							PROTEASOME PATHWAY; MYOFIBRILLAR PROTEINS; CELL ACTIVATION; NOTCH; DEGRADATION; TARGET; GROWTH; SPECIFICITY; PHOSPHATASE; SARCOPENIA	Skeletal muscle atrophy is a consequence of muscle inactivity resulting from denervation, unloading and immobility. It accompanies many chronic disease states and also occurs as a pathophysiologic consequence of normal aging. In all these conditions, ubiquitin-dependent proteolysis is a key regulator of the loss of muscle mass, and ubiquitin ligases confer specificity to this process by interacting with, and linking ubiquitin moieties to target substrates through protein: protein interaction domains. Our previous work suggested that the ubiquitin-protein ligase Nedd4-1 is a potential mediator of skeletal muscle atrophy associated with inactivity (denervation, unloading and immobility). Here we generated a novel tool, the Nedd4-1 skeletal muscle-specific knockout mouse (myo Cre; Nedd4-1 flox/flox) and subjected it to a well validated model of denervation induced skeletal muscle atrophy. The absence of Nedd4-1 resulted in increased weights and cross-sectional area of type II fast twitch fibres of denervated gastrocnemius muscle compared with wild type littermates controls, at seven and fourteen days following tibial nerve transection. These effects are not mediated by the Nedd4-1 substrates MTMR4, FGFR1 and Notch-1. These results demonstrate that Nedd4-1 plays an important role in mediating denervation-induced skeletal muscle atrophy in vivo.	[Nagpal, Preena; Plant, Pamela J.; Correa, Judy; Batt, Jane A. E.] St Michaels Hosp, Keenan Res Ctr, LiKaShing Knowledge Inst, Toronto, ON M5B 1W8, Canada; [Nagpal, Preena; Bain, Alexandra; Batt, Jane A. E.] Univ Toronto, Dept Med, Div Clin Sci, Toronto, ON, Canada; [Takeda, Michiko; Kawabe, Hiroshi] Max Planck Inst Expt Med, Dept Mol Neurobiol, D-3400 Gottingen, Germany; [Rotin, Daniela] Hosp Sick Children, Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Bain, James R.] McMaster Univ, Dept Surg, Hamilton, ON L8S 4L8, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Max Planck Society; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University	Batt, JAE (corresponding author), St Michaels Hosp, Keenan Res Ctr, LiKaShing Knowledge Inst, 30 Bond St, Toronto, ON M5B 1W8, Canada.	jane.batt@utoronto.ca	Kawabe, Hiroshi/U-7325-2018	Kawabe, Hiroshi/0000-0001-5650-8696	Neuromuscular Research Partnership (Canadian Institutes of Health Research (CIHR)/Amyotrophic Lateral Sclerosis Society of Canada/Muscular Dystrophy Canada) [JNM - 90959]; German Research Foundation [SPP1365/KA3423/1-1]; Fritz Thyssen Foundation; CIHR Clinical Research Initiative - New Investigator Award	Neuromuscular Research Partnership (Canadian Institutes of Health Research (CIHR)/Amyotrophic Lateral Sclerosis Society of Canada/Muscular Dystrophy Canada)(Canadian Institutes of Health Research (CIHR)); German Research Foundation(German Research Foundation (DFG)); Fritz Thyssen Foundation; CIHR Clinical Research Initiative - New Investigator Award(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Neuromuscular Research Partnership (Canadian Institutes of Health Research (CIHR)/Amyotrophic Lateral Sclerosis Society of Canada/Muscular Dystrophy Canada, # JNM - 90959; to JAEB), the German Research Foundation (SPP1365/KA3423/1-1; to HK) and the Fritz Thyssen Foundation (to HK). JAEB was supported by a CIHR Clinical Research Initiative - New Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Argiles JM, 2011, SARCOPENIA-AGE-RELATED MUSCLE WASTING AND WEAKNESS: MECHANISMS AND TREATMENTS, P9, DOI 10.1007/978-90-481-9713-2_2; Bain JR, 2001, NEUROSCIENCE, V103, P503, DOI 10.1016/S0306-4522(00)00577-7; Batt J, 2005, FASEB J, V19, P115, DOI 10.1096/fj.04-3640fje; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Buj-Bello A, 2008, HUM MOL GENET, V17, P2132, DOI 10.1093/hmg/ddn112; Cao CH, 2008, MOL BIOL CELL, V19, P3334, DOI 10.1091/mbc.E08-04-0367; Cao XR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160940; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Decramer M, 1997, EUR RESPIR J, V10, P417, DOI 10.1183/09031936.97.10020417; Eash J, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-32; Eddins MJ, 2011, CELL BIOCHEM BIOPHYS, V60, P113, DOI 10.1007/s12013-011-9175-7; Fouladkou F, 2010, J BIOL CHEM, V285, P6770, DOI 10.1074/jbc.M109.082347; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gomes MD, 2001, P NATL ACAD SCI USA, V98, P14440, DOI 10.1073/pnas.251541198; Henry PC, 2003, J BIOL CHEM, V278, P20019, DOI 10.1074/jbc.M211153200; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Ing B, 2007, MOL CELL BIOL, V27, P481, DOI 10.1128/MCB.00463-06; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Janssen I, 2004, J AM GERIATR SOC, V52, P80, DOI 10.1111/j.1532-5415.2004.52014.x; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Jejurikar SS, 2003, APOPTOSIS, V8, P573, DOI 10.1023/A:1026127307457; Jejurikar SS, 2002, PLAST RECONSTR SURG, V110, P160, DOI 10.1097/00006534-200207000-00027; Kamynina E, 2001, AM J PHYSIOL-RENAL, V281, pF469, DOI 10.1152/ajprenal.2001.281.3.F469; Kamynina E, 2001, FASEB J, V15, P204, DOI 10.1096/fj.00-0191com; Kawabe H, 2010, NEURON, V65, P358, DOI 10.1016/j.neuron.2010.01.007; Kedar V, 2004, P NATL ACAD SCI USA, V101, P18135, DOI 10.1073/pnas.0404341102; Koncarevic A, 2007, FASEB J, V21, P427, DOI 10.1096/fj.06-6665com; Kuschel R, 1999, J HISTOCHEM CYTOCHEM, V47, P1375, DOI 10.1177/002215549904701104; Lagirand-Cantaloube J, 2008, EMBO J, V27, P1266, DOI 10.1038/emboj.2008.52; Laporte J, 2003, HUM MOL GENET, V12, pR285, DOI 10.1093/hmg/ddg273; Lecker SH, 1999, J NUTR, V129, p227S, DOI 10.1093/jn/129.1.227S; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Lipkowitz S, 2011, NAT REV CANCER, V11, P629, DOI 10.1038/nrc3120; Liu XH, 2011, BIOCHEM BIOPH RES CO, V414, P165, DOI 10.1016/j.bbrc.2011.09.048; Liu Y, 2009, DEV BIOL, V330, P153, DOI 10.1016/j.ydbio.2009.03.023; Luo D, 2005, SEMIN CELL DEV BIOL, V16, P612, DOI 10.1016/j.semcdb.2005.07.002; MCGEACHIE J, 1978, CELL TISSUE RES, V193, P259; Mostert R, 2000, RESP MED, V94, P859, DOI 10.1053/rmed.2000.0829; Persaud A, 2011, EMBO J, V30, P3259, DOI 10.1038/emboj.2011.234; Plant PJ, 2010, AM J RESP CELL MOL, V42, P461, DOI 10.1165/rcmb.2008-0382OC; Plant PJ, 2009, BIOCHEM J, V419, P57, DOI 10.1042/BJ20081866; Solomon V, 1996, J BIOL CHEM, V271, P26690, DOI 10.1074/jbc.271.43.26690; Stevenson EJ, 2003, J PHYSIOL-LONDON, V551, P33, DOI 10.1113/jphysiol.2003.044701; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Viguie CA, 1997, ANAT REC, V248, P346; Witt SH, 2005, J MOL BIOL, V350, P713, DOI 10.1016/j.jmb.2005.05.021; Yang B, 2010, CELL DEATH DIFFER, V17, P68, DOI 10.1038/cdd.2009.84; Zanotti S, 2010, MOL CELL BIOL, V30, P886, DOI 10.1128/MCB.01285-09; Zhao RX, 2001, EXP CELL RES, V265, P329, DOI 10.1006/excr.2001.5185	52	49	51	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e46427	10.1371/journal.pone.0046427	http://dx.doi.org/10.1371/journal.pone.0046427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110050	Green Published, Green Submitted, gold			2022-12-25	WOS:000310262500006
J	Sukumar, D; Rengaswamy, M; Chakravarthy, VS				Sukumar, Deepika; Rengaswamy, Maithreye; Chakravarthy, V. Srinivasa			Modeling the Contributions of Basal Ganglia and Hippocampus to Spatial Navigation Using Reinforcement Learning	PLOS ONE			English	Article							MULTIPLE MEMORY-SYSTEMS; CAUDATE-NUCLEUS LESIONS; COMPUTATIONAL MODEL; SYNAPTIC-TRANSMISSION; PARKINSONS-DISEASE; FUNCTIONAL-ANATOMY; PREFRONTAL CORTEX; PATH-INTEGRATION; ACTION SELECTION; DORSAL STRIATUM	A computational neural model that describes the competing roles of Basal Ganglia and Hippocampus in spatial navigation is presented. Model performance is evaluated on a simulated Morris water maze explored by a model rat. Cue-based and place-based navigational strategies, thought to be subserved by the Basal ganglia and Hippocampus respectively, are described. In cue-based navigation, the model rat learns to directly head towards a visible target, while in place-based navigation the target position is represented in terms of spatial context provided by an array of poles placed around the pool. Learning is formulated within the framework of Reinforcement Learning, with the nigrostriatal dopamine signal playing the role of Temporal Difference Error. Navigation inherently involves two apparently contradictory movements: goal oriented movements vs. random, wandering movements. The model hypothesizes that while the goal-directedness is determined by the gradient in Value function, randomness is driven by the complex activity of the SubThalamic Nucleus (STN)-Globus Pallidus externa (GPe) system. Each navigational system is associated with a Critic, prescribing actions that maximize value gradients for the corresponding system. In the integrated system, that incorporates both cue-based and place-based forms of navigation, navigation at a given position is determined by the system whose value function is greater at that position. The proposed model describes the experimental results of [ 1], a lesion-study that investigates the competition between cue-based and place-based navigational systems. The present study also examines impaired navigational performance under Parkinsonian-like conditions. The integrated navigational system, operated under dopamine-deficient conditions, exhibits increased escape latency as was observed in experimental literature describing MPTP model rats navigating a water maze.	[Rengaswamy, Maithreye; Chakravarthy, V. Srinivasa] Indian Inst Technol Madras, Dept Biotechnol, Madras, Tamil Nadu, India; [Sukumar, Deepika] Cognizant Technol Solut, Bangalore, Karnataka, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Chakravarthy, VS (corresponding author), Indian Inst Technol Madras, Dept Biotechnol, Madras, Tamil Nadu, India.	schakra@ee.iitm.ac.in		Chakravarthy, Srinivasa/0000-0002-2453-1637	Department of Biotechnology, India	Department of Biotechnology, India(Department of Biotechnology (DBT) India)	The research described in this study was funded by the Department of Biotechnology, India (http://dbtindia.nic.in/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1985, J NEUROPHYSIOL, V53, P1417, DOI 10.1152/jn.1985.53.6.1417; Amaral D G, 1993, Curr Opin Neurobiol, V3, P225, DOI 10.1016/0959-4388(93)90214-J; Arleo Angelo, 2007, Journal of Integrative Neuroscience, V6, P327, DOI 10.1142/S0219635207001593; Banquet JP, 2005, NEURAL COMPUT, V17, P1339, DOI 10.1162/0899766053630369; Bolam JP, 2000, J ANAT, V196, P527, DOI 10.1046/j.1469-7580.2000.19640527.x; Bourdaud N, 2008, IEEE T NEUR SYS REH, V16, P549, DOI 10.1109/TNSRE.2008.926712; BURGESS N, 1994, NEURAL NETWORKS, V7, P1065, DOI 10.1016/S0893-6080(05)80159-5; Chakravarthy VS, 2010, BIOL CYBERN, V103, P237, DOI 10.1007/s00422-010-0401-y; Chavarriaga R, 2005, NEUROINFORMATICS, V3, P223, DOI 10.1385/NI:3:3:223; Cohen J, 2002, CURR OPIN NEUROBIOL, V12, P223, DOI 10.1016/S0959-4388(02)00314-8; Costa C, 2012, BRAIN, V135, P1884, DOI 10.1093/brain/aws101; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Dayan P., 2001, THEORETICAL NEUROSCI; Devan BD, 1999, J NEUROSCI, V19, P2789; Dolle L, 2010, BIOL CYBERN, V103, P299, DOI 10.1007/s00422-010-0400-z; Doshay LJ, 1960, PARKINSONS DIS ITS M; Dreher JC, 2002, NEURAL NETWORKS, V15, P583, DOI 10.1016/S0893-6080(02)00051-5; Foerde K, 2006, P NATL ACAD SCI USA, V103, P11778, DOI 10.1073/pnas.0602659103; Foster DJ, 2000, HIPPOCAMPUS, V10, P1, DOI 10.1002/(SICI)1098-1063(2000)10:1<1::AID-HIPO1>3.0.CO;2-1; Fox C, 2009, FRONTIERS NEUROINFOR, V3; Gangadhar G, 2008, NEURAL COMPUT, V20, P2491, DOI 10.1162/neco.2008.03-07-498; GASBARRI A, 1994, BRAIN RES BULL, V33, P445, DOI 10.1016/0361-9230(94)90288-7; Gerfen CR, 1996, HDB CHEM NEUROANATOM, P371, DOI [10.1016/S0924-8196(96)80004-2, DOI 10.1016/S0924-8196(96)80004-2]; GRACE AA, 1991, NEUROSCIENCE, V41, P1, DOI 10.1016/0306-4522(91)90196-U; Gurney K, 2001, BIOL CYBERN, V84, P401, DOI 10.1007/PL00007984; Hartley T, 2003, NEURON, V37, P877, DOI 10.1016/S0896-6273(03)00095-3; Hasselmo ME, 2005, J COGNITIVE NEUROSCI, V17, P1115, DOI 10.1162/0898929054475190; Hornykiewicz O, 1998, NEUROLOGY, V51, pS2, DOI 10.1212/WNL.51.2_Suppl_2.S2; Hsu KS, 1996, J NEUROPHYSIOL, V76, P1887, DOI 10.1152/jn.1996.76.3.1887; Humphries MD, 2006, J NEUROSCI, V26, P12921, DOI 10.1523/JNEUROSCI.3486-06.2006; JOEL D, 1994, NEUROSCIENCE, V63, P363, DOI 10.1016/0306-4522(94)90536-3; Joel D, 2002, NEURAL NETWORKS, V15, P535, DOI 10.1016/S0893-6080(02)00047-3; Joseph D, 2010, NEUROCOMPUTING, V74, P205, DOI 10.1016/j.neucom.2010.03.001; Kalva SK, 2012, NEURAL NETWORKS; Kobayashi K, 2006, EUR J NEUROSCI, V24, P1867, DOI 10.1111/j.1460-9568.2006.05079.x; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Krishnan R, 2011, NEURAL NETWORKS, V24, P801, DOI 10.1016/j.neunet.2011.06.002; Leea AS, 2008, P NATL ACAD SCI USA, V105, P17163, DOI 10.1073/pnas.0807749105; Maaswinkel H, 1999, BEHAV BRAIN RES; Magdoom KN, 2011, NEURAL COMPUT, V23, P477, DOI 10.1162/NECO_a_00073; MANSOUR A, 1992, NEUROSCIENCE, V46, P959, DOI 10.1016/0306-4522(92)90197-A; Martinet LE, 2008, LECT NOTES ARTIF INT, V5248, P39, DOI 10.1007/978-3-540-87601-4_6; Maya MC, 2012, INT J MIND IN PRESS; MCDONALD RJ, 1993, BEHAV NEUROSCI, V107, P3, DOI 10.1037/0735-7044.107.1.3; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Miyoshi E, 2002, BRAIN RES BULL, V58, P41, DOI 10.1016/S0361-9230(02)00754-2; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Niv Y, 2006, ADV NEURAL INF PROCE, V18, P1019; Obeso JA, 2002, NEWS PHYSIOL SCI, V17, P51, DOI 10.1152/rips.01363.2001; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; PACKARD MG, 1992, BEHAV NEUROSCI, V106, P439, DOI 10.1037/0735-7044.106.3.439; PACKARD MG, 1989, J NEUROSCI, V9, P1465; Pearce JM, 1998, NATURE, V396, P75, DOI 10.1038/23941; Pitkanen A, 2002, HIPPOCAMPUS, V12, P186, DOI 10.1002/hipo.1099; Poldrack RA, 2003, NEUROPSYCHOLOGIA, V41, P245, DOI 10.1016/S0028-3932(02)00157-4; Purzner J, 2007, J NEUROSCI, V27, P6029, DOI 10.1523/JNEUROSCI.5441-06.2007; Redish A. D., 1999, COGNITIVE MAP PLACE, DOI DOI 10.1038/nature14445; Rolls ET, 2005, J NEUROSCI, V25, P6167, DOI 10.1523/JNEUROSCI.1481-05.2005; Sakamoto T, 2001, NEUROBIOL LEARN MEM, V76, P192, DOI 10.1006/nlme.2001.4006; Samsonovich A, 1997, J NEUROSCI, V17, P5900; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; SERVANSCHREIBER D, 1990, SCIENCE, V249, P892, DOI 10.1126/science.2392679; SHERRY DF, 1987, PSYCHOL REV, V94, P439, DOI 10.1037/0033-295X.94.4.439; Sridharan D, 2006, INT J NEURAL SYST, V16, P111, DOI 10.1142/S0129065706000548; Standage DI, 2005, NEURAL NETWORKS, V18, P620, DOI 10.1016/j.neunet.2005.06.015; Strosslin T, 2005, NEURAL NETWORKS, V18, P1125, DOI 10.1016/j.neunet.2005.08.012; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Suzuki T, 2001, J NEUROSCI, V21, P6492, DOI 10.1523/JNEUROSCI.21-17-06492.2001; Terman D, 2002, J NEUROSCI, V22, P2963, DOI 10.1523/JNEUROSCI.22-07-02963.2002; Trullier O, 1997, PROG NEUROBIOL, V51, P483, DOI 10.1016/S0301-0082(96)00060-3; WHISHAW IQ, 1987, BEHAV BRAIN RES, V24, P125, DOI 10.1016/0166-4328(87)90250-6	73	15	15	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47467	10.1371/journal.pone.0047467	http://dx.doi.org/10.1371/journal.pone.0047467			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110073	Green Published, gold			2022-12-25	WOS:000310262500011
J	Zhuang, WY; Liu, CY				Zhuang, Wen-Ying; Liu, Chao-Yang			What an rRNA Secondary Structure Tells about Phylogeny of Fungi in Ascomycota with Emphasis on Evolution of Major Types of Ascus	PLOS ONE			English	Article							ANCESTRAL STATE RECONSTRUCTION; CHARACTER STATES; MIXED MODELS; ALIGNMENT; CLASSIFICATION; PEZIZOMYCOTINA; SUBSTITUTION; SEQUENCES; ANATOMY; TAXA	Background: RNA secondary structure is highly conserved throughout evolution. The higher order structure is fundamental in establishing important structure-function relationships. Nucleotide sequences from ribosomal RNA (rRNA) genes have made a great contribution to our understanding of Ascomycota phylogeny. However, filling the gaps between molecular phylogeny and morphological assumptions based on ascus dehiscence modes and type of fruitbodies at the higher level classification of the phylum remains an unfulfilled task faced by mycologists. Methodology/Principal Findings: We selected some major groups of Ascomycota to view their phylogenetic relationships based on analyses of rRNA secondary structure. Using rRNA secondary structural information, here, we converted nucleotide sequences into the structure ones over a 20-symbol code. Our structural analyses together with ancestral character state reconstruction produced reasonable phylogenetic position for the class Geoglossomycetes as opposed to the classic nucleotide analyses. Judging from the secondary structure analyses with consideration of mode of ascus dehiscence and the ability of forming fruitbodies, we draw a clear picture of a possible evolutionary route for fungal asci and some major groups of fungi in Ascomycota. The secondary structure trees show a more reasonable phylogenetic position for the class Geoglossomycetes. Conclusions: Our results illustrate that asci lacking of any dehiscence mechanism represent the most primitive type. Passing through the operculate and Orbilia-type asci, bitunicate asci occurred. The evolution came to the most advanced inoperculate type. The ascus-producing fungi might be derived from groups lacking of the capacity to form fruitbodies, and then evolved multiple times. The apothecial type of fruitbodies represents the ancestral state, and the ostiolar type is advanced. The class Geoglossomycetes is closely related to Leotiomycetes and Sordariomycetes having a similar ascus type other than it was originally placed based on nucleotide sequence analyses.	[Zhuang, Wen-Ying] Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China; [Liu, Chao-Yang] SW Univ Sci & Technol, Sch Life Sci & Engn, Mianyang, Peoples R China	Chinese Academy of Sciences; Institute of Microbiology, CAS; Southwest University of Science & Technology - China	Zhuang, WY (corresponding author), Chinese Acad Sci, Inst Microbiol, State Key Lab Mycol, Beijing, Peoples R China.	zhuangwy@im.ac.cn			National Natural Science Foundation of China [31070015]; Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-J-6]; State 863 Project [2008AA02Z312]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of SciencesKnowledge Innovation Program of the Chinese Academy of Sciences); State 863 Project(National High Technology Research and Development Program of China)	This study was funded by the National Natural Science Foundation of China (31070015), Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-J-6), and State 863 Project (2008AA02Z312) to WYZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth GC, 1973, FUNGI ADV TREATISE A, VIV; Alexopoulos C. J., 1996; [Anonymous], 1973, FUNGI ADV TREATISE; BARR ME, 1983, MYCOLOGIA, V75, P1, DOI 10.2307/3792917; Barr ME, 2001, MYCOTA, V7, P161; BENNY GL, 1978, CAN J BOT, V56, P2006, DOI 10.1139/b78-241; Boudier E, 1885, B SOC MYCOL FRANCE, V1, P91; Boudier E, 1904, ICONES MYCOLOGICAE, V1; Brodo I. M., 2001, LICHENS N AM; BUTLER ELLYS T., 1939, MYCOLOGIA, V31, P612; Caetano-Anolles G, 2002, NUCLEIC ACIDS RES, V30, P2575, DOI 10.1093/nar/30.11.2575; Collins LJ, 2000, J MOL EVOL, V51, P194, DOI 10.1007/s002390010081; de Hoog GS, 2005, STUD MYCOL, P33; Ekman S, 2008, SYST BIOL, V57, P141, DOI 10.1080/10635150801910451; Eriksson O.E., 2003, MYCONET, V9, P91; Eriksson OE, 1997, MYCONET, V1, P1; Eriksson Ove E., 1998, Systema Ascomycetum, V16, P83; Fennel D.I., 1973, FUNGI ADV TREATISE A, V4A, P45; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hansen PV, 2007, MYCOL RES, V111, P592, DOI 10.1016/j.mycres.2007.02.010; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; HONEGGER R, 1978, LICHENOLOGIST, V10, P47, DOI 10.1017/S0024282978000079; Hudelot C, 2003, MOL PHYLOGENET EVOL, V28, P241, DOI 10.1016/S1055-7903(03)00061-7; James TY, 2006, NATURE, V443, P818, DOI 10.1038/nature05110; JOHNSON MS, 1990, J MOL EVOL, V30, P43, DOI 10.1007/BF02102452; Jow H, 2002, MOL BIOL EVOL, V19, P1591, DOI 10.1093/oxfordjournals.molbev.a004221; Katoh K, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-212; Kirk PM, 2008, AINSWORTH BISBYS DIC; KJER KM, 1995, MOL PHYLOGENET EVOL, V4, P314, DOI 10.1006/mpev.1995.1028; Landvik S, 2003, MYCOL RES, V107, P1021, DOI 10.1017/S0953756203008219; Landvik Sara, 1993, Systema Ascomycetum, V11, P107; Liu YJ, 2004, P NATL ACAD SCI USA, V101, P4507, DOI 10.1073/pnas.0400938101; LUTTRELL ES, 1955, MYCOLOGIA, V47, P511, DOI 10.2307/3755666; Luttrell ES, 1973, FUNGI ADV TREATISE, P135; MADDISON WP, 2006, MESQUITE MODULAR SYS; Mittl PRE, 2001, CURR OPIN CHEM BIOL, V5, P402, DOI 10.1016/S1367-5931(00)00221-0; Mugridge NB, 2000, MOL BIOL EVOL, V17, P1842, DOI 10.1093/oxfordjournals.molbev.a026285; Muller E, 1973, FUNGI              A, V4A, P87; Nannfeldt JA, 1932, NOVA ACTA REGIAE SOC, V8, P1; Nylander JAA, 2004, SYST BIOL, V53, P47, DOI 10.1080/10635150490264699; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; RICHARDSON D. H. S., 1964, LICHENOLOGIST, V2, P205, DOI 10.1017/S0024282964000251; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schaferhoff B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-352; Schaffer S, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-246; Schoch CL, 2009, PERSOONIA, V22, P129, DOI 10.3767/003158509X461486; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Seaver FJ, 1928, N AM CUP FUNGI OPERC; Smith AD, 2004, MOL BIOL EVOL, V21, P419; Spatafora JW, 2006, MYCOLOGIA, V98, P1018, DOI 10.3852/mycologia.98.6.1018; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Subbotin SA, 2007, MOL PHYLOGENET EVOL, V43, P881, DOI 10.1016/j.ympev.2006.09.019; Swofford D.L., 2002, PAUP PHYLOGENETIC AN, DOI 10.1111/j.0014-3820.2002.tb00191.x; TAI F. L., 1931, Sinensia, V1, P147; Telford MJ, 2005, MOL BIOL EVOL, V22, P1129, DOI 10.1093/molbev/msi099; Verkley G.J.M., 1995, ASCUS APICAL APPARAT; Wang Z, 2006, MOL PHYLOGENET EVOL, V41, P295, DOI 10.1016/j.ympev.2006.05.031; Zhuang WY, 2004, CHINESE FUNGUS FLORA, V21	59	6	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47546	10.1371/journal.pone.0047546	http://dx.doi.org/10.1371/journal.pone.0047546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110078	gold, Green Published, Green Submitted			2022-12-25	WOS:000310262500014
J	Chadderdon, GL; Neymotin, SA; Kerr, CC; Lytton, WW				Chadderdon, George L.; Neymotin, Samuel A.; Kerr, Cliff C.; Lytton, William W.			Reinforcement Learning of Targeted Movement in a Spiking Neuronal Model of Motor Cortex	PLOS ONE			English	Article							DOPAMINE DEPLETION; DEPENDENT PLASTICITY; BASAL GANGLIA; REWARD; PERFORMANCE; MODULATION; ACQUISITION; ACTIVATION; ERROR; AREA	Sensorimotor control has traditionally been considered from a control theory perspective, without relation to neurobiology. In contrast, here we utilized a spiking-neuron model of motor cortex and trained it to perform a simple movement task, which consisted of rotating a single-joint "forearm'' to a target. Learning was based on a reinforcement mechanism analogous to that of the dopamine system. This provided a global reward or punishment signal in response to decreasing or increasing distance from hand to target, respectively. Output was partially driven by Poisson motor babbling, creating stochastic movements that could then be shaped by learning. The virtual forearm consisted of a single segment rotated around an elbow joint, controlled by flexor and extensor muscles. The model consisted of 144 excitatory and 64 inhibitory event-based neurons, each with AMPA, NMDA, and GABA synapses. Proprioceptive cell input to this model encoded the 2 muscle lengths. Plasticity was only enabled in feedforward connections between input and output excitatory units, using spike-timing-dependent eligibility traces for synaptic credit or blame assignment. Learning resulted from a global 3-valued signal: reward (+1), no learning (0), or punishment (21), corresponding to phasic increases, lack of change, or phasic decreases of dopaminergic cell firing, respectively. Successful learning only occurred when both reward and punishment were enabled. In this case, 5 target angles were learned successfully within 180 s of simulation time, with a median error of 8 degrees. Motor babbling allowed exploratory learning, but decreased the stability of the learned behavior, since the hand continued moving after reaching the target. Our model demonstrated that a global reinforcement signal, coupled with eligibility traces for synaptic plasticity, can train a spiking sensorimotor network to perform goal-directed motor behavior.	[Chadderdon, George L.; Neymotin, Samuel A.; Kerr, Cliff C.; Lytton, William W.] Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA; [Neymotin, Samuel A.] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT USA; [Kerr, Cliff C.] Univ Sydney, Sch Phys, Sydney, NSW 2006, Australia; [Lytton, William W.] Suny Downstate Med Ctr, Dept Neurol, Brooklyn, NY 11203 USA; [Lytton, William W.] Kings Cty Hosp, Brooklyn, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; Yale University; University of Sydney; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Chadderdon, GL (corresponding author), Suny Downstate Med Ctr, Dept Physiol & Pharmacol, Brooklyn, NY 11203 USA.	georgec@neurosim.downstate.edu		Lytton, William/0000-0002-3727-2849; Neymotin, Samuel/0000-0003-3646-5195	Defense Advanced Research Projects Agency (DARPA) [N66001-10-C-2008]	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA))	Research supported by Defense Advanced Research Projects Agency (DARPA) grant N66001-10-C-2008 (http://www.darpa.mil/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almassy N, 1998, CEREB CORTEX, V8, P346, DOI 10.1093/cercor/8.4.346; Baker SN, 1999, EXP BRAIN RES, V128, P109, DOI 10.1007/s002210050825; Bush G, 2002, P NATL ACAD SCI USA, V99, P523, DOI 10.1073/pnas.012470999; Carnevale NT, 2006, NEURON BOOK; Chadderdon G., 2009, THESIS INDIANA U; Cools R, 2006, NEUROSCI BIOBEHAV R, V30, P1, DOI 10.1016/j.neubiorev.2005.03.024; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Daw ND, 2006, NATURE, V441, P876, DOI 10.1038/nature04766; Demiris Y., 2005, MOTOR BABBLING HIERA; Der R, 2006, LECT NOTES COMPUT SC, V4095, P406; Edelman GM, 1987, NEURAL DARWINISM THE; Farries MA, 2007, J NEUROPHYSIOL, V98, P3648, DOI 10.1152/jn.00364.2007; Faure A, 2005, J NEUROSCI, V25, P2771, DOI 10.1523/JNEUROSCI.3894-04.2005; Florian RV, 2007, NEURAL COMPUT, V19, P1468, DOI 10.1162/neco.2007.19.6.1468; Frank MJ, 2006, BEHAV NEUROSCI, V120, P497, DOI 10.1037/0735-7044.120.3.497; Frank MJ, 2004, SCIENCE, V306, P1940, DOI 10.1126/science.1102941; Hecht-Nielsen R., 1989, IEEE T NEURAL NETWOR, V1, P593, DOI [DOI 10.1016/B978-0-12-741252-8.50010-8, DOI 10.1109/IJCNN.1989.118638]; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Hosp JA, 2011, J NEUROSCI, V31, P2481, DOI 10.1523/JNEUROSCI.5411-10.2011; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Joel D, 2002, NEURAL NETWORKS, V15, P535, DOI 10.1016/S0893-6080(02)00047-3; Kao MH, 2005, NATURE, V433, P638, DOI 10.1038/nature03127; Koechlin E, 2007, SCIENCE, V318, P594, DOI 10.1126/science.1142995; KOHONEN T, 1990, P IEEE, V78, P1464, DOI 10.1109/5.58325; Luft AR, 2009, INT J DEV NEUROSCI, V27, P415, DOI 10.1016/j.ijdevneu.2009.05.004; Lytton WW, 2008, NEURAL COMPUT, V20, P2745, DOI 10.1162/neco.2008.10-07-622; Lytton WW, 2008, J NEUROSCI METH, V171, P309, DOI 10.1016/j.jneumeth.2008.03.005; Lytton WW, 2007, J CLIN NEUROPHYSIOL, V24, P175, DOI 10.1097/WNP.0b013e3180336fc0; Lytton WW, 2006, NEUROCOMPUTING, V69, P1160, DOI 10.1016/j.neucom.2005.12.066; Lytton WW, 2005, INT J BIOELECTROMAGN, V7, P47; MAGEE JC, 1995, SCIENCE, V268, P301, DOI 10.1126/science.7716525; Molina-Luna K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007082; MUFSON EJ, 1984, J COMP NEUROL, V225, P31, DOI 10.1002/cne.902250105; Neymotin SA, 2011, FRONT COMPUT NEUROSC, V5, DOI 10.3389/fncom.2011.00019; O'Neill M, 2007, NEUROBIOL LEARN MEM, V88, P75, DOI 10.1016/j.nlm.2007.03.003; Parkinson JA, 2002, BEHAV BRAIN RES, V137, P149, DOI 10.1016/S0166-4328(02)00291-7; Potjans W, 2009, NEURAL COMPUT, V21, P301, DOI 10.1162/neco.2008.08-07-593; Reynolds JNJ, 2002, NEURAL NETWORKS, V15, P507, DOI 10.1016/S0893-6080(02)00045-X; ROBBINS TW, 1990, BEHAV BRAIN RES, V38, P243, DOI 10.1016/0166-4328(90)90179-I; Roberts PD, 2002, BIOL CYBERN, V87, P392, DOI 10.1007/s00422-002-0361-y; Rumelhart DE, 1986, PARALLEL DISTRIBUTED; Sanchez JC, 2011, I IEEE EMBS C NEUR E, P525, DOI 10.1109/NER.2011.5910601; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Seung HS, 2003, NEURON, V40, P1063, DOI 10.1016/S0896-6273(03)00761-X; Shen WX, 2008, SCIENCE, V321, P848, DOI 10.1126/science.1160575; Shima K, 1998, SCIENCE, V282, P1335, DOI 10.1126/science.282.5392.1335; SINGER W, 2003, HDB BRAIN THEORY NEU, P1136; Smith-Roe SL, 2000, J NEUROSCI, V20, P7737; Sober SJ, 2009, NAT NEUROSCI, V12, P927, DOI 10.1038/nn.2336; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Sporns O, 2002, NEURAL NETWORKS, V15, P761, DOI 10.1016/S0893-6080(02)00062-X; Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547; TESAURO G, 1995, COMMUN ACM, V38, P58, DOI 10.1145/203330.203343; Thorndike EL., 1911, ANIMAL INTELLIGENCE, DOI DOI 10.4324/9781351321044; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Tumer EC, 2007, NATURE, V450, P1240, DOI 10.1038/nature06390; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; Wanjerkhede SM, 2008, PROG BRAIN RES, V168, P193, DOI 10.1016/S0079-6123(07)68016-9	60	25	26	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47251	10.1371/journal.pone.0047251	http://dx.doi.org/10.1371/journal.pone.0047251			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094042	gold, Green Submitted, Green Published			2022-12-25	WOS:000310050200019
J	Ording, AG; Garne, JP; Nystrom, PMW; Cronin-Fenton, D; Tarp, M; Sorensen, HT; Lash, TL				Ording, Anne Gulbech; Garne, Jens Peter; Nystrom, Petra Mariann Witt; Cronin-Fenton, Deirdre; Tarp, Maja; Sorensen, Henrik Toft; Lash, Timothy L.			Hospital Recorded Morbidity and Breast Cancer Incidence: A Nationwide Population-Based Case-Control Study	PLOS ONE			English	Article							CHARLSON COMORBIDITY INDEX; IMMUNE-SYSTEM; CO-MORBIDITY; RISK-FACTORS; REGISTRY; PREVENTION; EPIDEMIOLOGY; ESTROGEN; DISEASE; ISSUES	Introduction: Chronic diseases and their complications may increase breast cancer risk through known or still unknown mechanisms, or by shared causes. The association between morbidities and breast cancer risk has not been studied in depth. Methods: Data on all Danish women aged 45 to 85 years, diagnosed with breast cancer between 1994 and 2008 and data on preceding morbidities were retrieved from nationwide medical registries. Odds ratios (OR) and 95% confidence intervals (CI) were estimated using conditional logistic regression associating the Charlson comorbidity score (measured using both the original and an updated Charlson Comorbidity Index (CCI)) with incident breast cancer. Furthermore, we estimated associations between 202 morbidity categories and incident breast cancer, adjusting for multiple comparisons using empirical Bayes (EB) methods. Results: The study included 46,324 cases and 463,240 population controls. Increasing CCI score, up to a score of six, was associated with slightly increased breast cancer risk. Among the Charlson diseases, preceding moderate to severe renal disease (OR = 1.25, 95% CI: 1.06, 1.48), any tumor (OR = 1.17, 95% CI: 1.10, 1.25), moderate to severe liver disease (OR = 1.86, 95% CI: 1.32, 2.62), and metastatic solid tumors (OR = 1.49, 95% CI: 1.17, 1.89), were most strongly associated with subsequent breast cancer. Preceding myocardial infarction (OR = 0.89, 95% CI: 0.81, 0.99), connective tissue disease (OR = 0.87, 95% CI: 0.80, 0.94), and ulcer disease (OR = 0.91, 95% CI: 0.83, 0.99) were most strongly inversely associated with subsequent breast cancer. A history of breast disorders was associated with breast cancer after EB adjustment. Anemias were inversely associated with breast cancer, but the association was near null after EB adjustment. Conclusions: There was no substantial association between morbidity measured with the CCI and breast cancer risk.	[Ording, Anne Gulbech; Cronin-Fenton, Deirdre; Tarp, Maja; Sorensen, Henrik Toft; Lash, Timothy L.] Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark; [Garne, Jens Peter] Aarhus Univ Hosp, Aalborg Hosp, Breast Clin, DK-8000 Aarhus, Denmark; [Nystrom, Petra Mariann Witt] Aarhus Univ Hosp, Aalborg Hosp, Dept Oncol, DK-8000 Aarhus, Denmark; [Nystrom, Petra Mariann Witt] Univ Uppsala Hosp, Dept Oncol, S-75185 Uppsala, Sweden; [Lash, Timothy L.] Wake Forest Sch Med, Dept Epidemiol & Prevent, Winston Salem, NC USA	Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University; Uppsala University; Uppsala University Hospital; Wake Forest University	Ording, AG (corresponding author), Aarhus Univ Hosp, Dept Clin Epidemiol, DK-8000 Aarhus, Denmark.	ao@dce.au.dk	Sorensen, Henrik Toft/Z-6181-2019	Sorensen, Henrik Toft/0000-0003-4299-7040	Clinical Epidemiology Research Foundation; Aarhus University; Karen Elise Jensens Foundation; Arkitekt Holger Hjortenberg og Hustru Dagmar Hjortenbergs Foundation; Inge og Jorgen Larsens Mindelegat Foundation	Clinical Epidemiology Research Foundation; Aarhus University; Karen Elise Jensens Foundation; Arkitekt Holger Hjortenberg og Hustru Dagmar Hjortenbergs Foundation; Inge og Jorgen Larsens Mindelegat Foundation	This study was supported by the Clinical Epidemiology Research Foundation, Aarhus University, Karen Elise Jensens Foundation, Arkitekt Holger Hjortenberg og Hustru Dagmar Hjortenbergs Foundation, and Inge og Jorgen Larsens Mindelegat Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algra AM, 2012, LANCET ONCOL, V13, P518, DOI 10.1016/S1470-2045(12)70112-2; Andersen TF, 1999, DAN MED BULL, V46, P263; Beral V, 2002, BRIT J CANCER, V87, P1234, DOI 10.1038/sj.bjc.6600596; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chung SH, 2010, TRENDS ENDOCRIN MET, V21, P504, DOI 10.1016/j.tem.2010.03.005; Cosman F, 1999, ENDOCR REV, V20, P418, DOI 10.1210/er.20.3.418; *DAN NAT BOARD HLT, 1993, CLASS DIS; *DAN NAT BOARD HLT, 1986, CLASS DIS; De Flora S, 2011, CARCINOGENESIS, V32, P787, DOI 10.1093/carcin/bgr054; Dunn GP, 2004, ANNU REV IMMUNOL, V22, P329, DOI 10.1146/annurev.immunol.22.012703.104803; Ershler WB, 1997, JNCI-J NATL CANCER I, V89, P1489, DOI 10.1093/jnci/89.20.1489; ERSHLER WB, 1993, J GERONTOL, V48, pB3, DOI 10.1093/geronj/48.1.B3; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gjerstorff ML, 2011, SCAND J PUBLIC HEALT, V39, P42, DOI 10.1177/1403494810393562; Janicki SC, 2010, CURR NEUROL NEUROSCI, V10, P359, DOI 10.1007/s11910-010-0122-6; Januel JM, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-194; Jensen AR, 2002, EUR J CANCER PREV, V11, P359, DOI 10.1097/00008469-200208000-00007; Jian JL, 2011, FREE RADICAL BIO MED, V50, P841, DOI 10.1016/j.freeradbiomed.2010.12.028; Key TJ, 2001, LANCET ONCOL, V2, P133, DOI 10.1016/S1470-2045(00)00254-0; Kilkkinen A, 2008, INT J CANCER, V123, P2152, DOI 10.1002/ijc.23622; Kintzel PE, 2001, DRUG SAFETY, V24, P19, DOI 10.2165/00002018-200124010-00003; Lansang MC, 2011, CLEV CLIN J MED, V78, P748, DOI 10.3949/ccjm.78a.10180; Larsson SC, 2007, INT J CANCER, V121, P856, DOI 10.1002/ijc.22717; Latourelle Jeanne C, 2010, Clin Epidemiol, V2, P153; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Nkondjock A, 2004, CANCER LETT, V205, P1, DOI 10.1016/j.canlet.2003.10.005; Pedersen CB, 2006, DAN MED BULL, V53, P441; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Rockhill B, 1998, AM J EPIDEMIOL, V147, P826, DOI 10.1093/oxfordjournals.aje.a009535; Rothman KJ, 2008, MODERN EPIDEMIOLOGY; Sorensen HT, 1998, AM J GASTROENTEROL, V93, P231, DOI 10.1016/S0002-9270(97)00050-6; Steenland K, 2000, CANCER EPIDEM BIOMAR, V9, P895; Storm HH, 1997, DAN MED BULL, V44, P535; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Tinelli A, 2008, ACTA OBSTET GYN SCAN, V87, P1101, DOI 10.1080/00016340802160079; Tirona MT, 2010, CANCER INVEST, V28, P743, DOI 10.3109/07357907.2010.494321; Torti SV, 2011, CANCER RES, V71, P1511, DOI 10.1158/0008-5472.CAN-10-3614; Weiskopf D, 2009, TRANSPL INT, V22, P1041, DOI 10.1111/j.1432-2277.2009.00927.x	38	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47329	10.1371/journal.pone.0047329	http://dx.doi.org/10.1371/journal.pone.0047329			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094045	Green Published, Green Submitted, gold			2022-12-25	WOS:000310050200021
J	Brown, ZZ; Akula, K; Arzumanyan, A; Alleva, J; Jackson, M; Bichenkov, E; Sheffield, JB; Feitelson, MA; Schafmeister, CE				Brown, Zachary Z.; Akula, Kavitha; Arzumanyan, Alla; Alleva, Jennifer; Jackson, Marcus; Bichenkov, Eugeney; Sheffield, Joel B.; Feitelson, Mark A.; Schafmeister, Christian E.			A Spiroligomer alpha-Helix Mimic That Binds HDM2, Penetrates Human Cells and Stabilizes HDM2 in Cell Culture	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; SECONDARY STRUCTURE; BETA-PEPTIDES; P53 PEPTIDE; MDM2; ACTIVATION; MIMETICS; PATHWAY; CANCER; TRANSACTIVATION	We demonstrate functionalized spiroligomers that mimic the HDM2-bound conformation of the p53 activation domain. Spiroligomers are stereochemically defined, functionalized, spirocyclic monomers coupled through pairs of amide bonds to create spiro-ladder oligomers [1]. Two series of spiroligomers were synthesized, one of structural analogs and one of stereochemical analogs, from which we identified compound 1, that binds HDM2 with a Kd value of 400 nM. The spiroligomer 1 penetrates human liver cancer cells through passive diffusion and in a dose-dependent and time-dependent manner increases the levels of HDM2 more than 30-fold in Huh7 cells in which the p53/HDM2 negative feed-back loop is inoperative. This is a biological effect that is not seen with the HDM2 ligand nutlin-3a. We propose that compound 1 modulates the levels of HDM2 by stabilizing it to proteolysis, allowing it to accumulate in the absence of a p53/HDM2 feedback loop.	[Akula, Kavitha; Jackson, Marcus; Schafmeister, Christian E.] Temple Univ, Dept Chem, Philadelphia, PA 19122 USA; [Brown, Zachary Z.; Alleva, Jennifer] Princeton Univ, Dept Chem, Princeton, NJ 08544 USA; [Arzumanyan, Alla; Bichenkov, Eugeney; Sheffield, Joel B.; Feitelson, Mark A.] Temple Univ, Dept Biol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Princeton University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Schafmeister, CE (corresponding author), Temple Univ, Dept Chem, Philadelphia, PA 19122 USA.	meister@temple.edu		Feitelson, Mark/0000-0002-4904-0498	NIH/NIGMS [EUREKA-GM094843-01]; Defense Threat Reduction Agency (DOD-DTRA) [HDTRA1-09-1-0009]; National Science Foundation through TeraGrid resources; NICS [TG-CHE100059]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067866, R01GM094843] Funding Source: NIH RePORTER	NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Defense Threat Reduction Agency (DOD-DTRA)(United States Department of DefenseDefense Threat Reduction Agency); National Science Foundation through TeraGrid resources(National Science Foundation (NSF)); NICS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funders: NIH/NIGMS (EUREKA-GM094843-01) and the Defense Threat Reduction Agency (DOD-DTRA) (HDTRA1-09-1-0009). This research was supported in part by the National Science Foundation through TeraGrid resources provided by NICS under grant number TG-CHE100059. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler MJ, 2011, CURR TOP MICROBIOL, V348, P1, DOI 10.1007/82_2010_91; Appella DH, 1997, NATURE, V387, P381, DOI 10.1038/387381a0; Bernal F, 2007, J AM CHEM SOC, V129, P2456, DOI 10.1021/ja0693587; Brown ZZ, 2008, J AM CHEM SOC, V130, P14382, DOI 10.1021/ja806063k; Brown ZZ, 2011, BIOPOLYMERS, V96, P578, DOI 10.1002/bip.21591; Brown ZZ, 2010, ORG LETT, V12, P1436, DOI 10.1021/ol100048g; Clegg HV, 2008, CELL CYCLE, V7, P287, DOI 10.4161/cc.7.3.5358; Cummings CG, 2010, CURR OPIN CHEM BIOL, V14, P341, DOI 10.1016/j.cbpa.2010.04.001; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Czarna A, 2009, CELL CYCLE, V8, P1176, DOI 10.4161/cc.8.8.8185; Davis JM, 2007, CHEM SOC REV, V36, P326, DOI 10.1039/b608043j; Di Como CJ, 1998, ONCOGENE, V16, P2527; Hailfinger S, 2007, INT J CANCER, V120, P1459, DOI 10.1002/ijc.22519; Hara T, 2006, J AM CHEM SOC, V128, P1995, DOI 10.1021/ja056344c; Harker EA, 2009, BIOORGAN MED CHEM, V17, P2038, DOI 10.1016/j.bmc.2009.01.039; HSU IC, 1993, CARCINOGENESIS, V14, P987, DOI 10.1093/carcin/14.5.987; Joerger AC, 2006, P NATL ACAD SCI USA, V103, P15056, DOI 10.1073/pnas.0607286103; Kritzer JA, 2005, BIOORGAN MED CHEM, V13, P11, DOI 10.1016/j.bmc.2004.09.009; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Liu J, 2008, J AM CHEM SOC, V130, P4334, DOI 10.1021/ja077704u; Michel J, 2009, J AM CHEM SOC, V131, P6356, DOI 10.1021/ja901478e; Murray JK, 2007, BIOPOLYMERS, V88, P657, DOI 10.1002/bip.20741; Patgiri A, 2008, ACCOUNTS CHEM RES, V41, P1289, DOI 10.1021/ar700264k; Ross NT, 2010, PHILOS T R SOC A, V368, P989, DOI 10.1098/rsta.2009.0210; Schafmeister CE, 2000, J AM CHEM SOC, V122, P5891, DOI 10.1021/ja000563a; Schafmeister CE, 2008, ACCOUNTS CHEM RES, V41, P1387, DOI 10.1021/ar700283y; Scrima M, 2010, EUR J ORG CHEM, V2010, P446, DOI 10.1002/ejoc.200901157; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Thompson T, 2004, J BIOL CHEM, V279, P53015, DOI 10.1074/jbc.M410233200; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Veber DF, 2002, J MED CHEM, V45, P2615, DOI 10.1021/jm020017n; Verdine GL, 2007, CLIN CANCER RES, V13, P7264, DOI 10.1158/1078-0432.CCR-07-2184; Yin H, 2005, ANGEW CHEM INT EDIT, V44, P2704, DOI 10.1002/anie.200462316; Zondlo SC, 2006, BIOCHEMISTRY-US, V45, P11945, DOI 10.1021/bi060309g	35	22	30	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e45948	10.1371/journal.pone.0045948	http://dx.doi.org/10.1371/journal.pone.0045948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094022	Green Published, gold, Green Submitted			2022-12-25	WOS:000312384500002
J	Omoyinmi, E; Forabosco, P; Hamaoui, R; Bryant, A; Hinks, A; Ursu, S; Wedderburn, LR; Thomson, W; Lewis, CM; Woo, P				Omoyinmi, Ebun; Forabosco, Paola; Hamaoui, Raja; Bryant, Annette; Hinks, Anne; Ursu, Simona; Wedderburn, Lucy R.; Thomson, Wendy; Lewis, Cathryn M.; Woo, Patricia		Childhood Arthrit Prospective Stud; BSPAR Study Grp; Childhood Arthrit Response Medicat	Association of the IL-10 Gene Family Locus on Chromosome 1 with Juvenile Idiopathic Arthritis (JIA)	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INTERLEUKIN-20; IDENTIFICATION; POLYMORPHISM; EXPRESSION; VARIANTS; IL-20; HAPLOTYPES; IL10; SET	Background: The cytokine IL-10 and its family members have been implicated in autoimmune diseases and we have previously reported that genetic variants in IL-10 were associated with a rare group of diseases called juvenile idiopathic arthritis (JIA). The aim of this study was to fine map genetic variants within the IL-10 cytokine family cluster on chromosome 1 using linkage disequilibrium (LD)-tagging single nucleotide polymorphisms (tSNPs) approach with imputation and conditional analysis to test for disease associations. Methodology/Principal Findings: Fifty-three tSNPs were tested for association between Caucasian paediatric cohorts [219 systemic JIA (sJIA), 187 persistent oligoarticular JIA (pOJIA), and 139 extended OJIA (eOJIA) patients], and controls (Wellcome Trust control cohort, WTCCC2). Significant association with sJIA was detected at rs1400986 in the promoter of IL-20 (odds ratio 1.53; 95% CI 1.21-1.93; p = 0.0004), but in no other subtypes. Imputation analysis identified additional associated SNPs for pOJIA at IL-20 and IL-24, including a rare, functional, missense variant at IL-24 with a p = 0.0002. Penalised logistic regression analysis with HyperLasso and conditional analysis identified several further associations with JIA subtypes. In particular, haplotype analysis refined the sJIA association, with a joint effect at rs1400986 and rs4129024 in intron 1 of MAPKAPK2 (p = 3.2E-5). For pOJIA, a 3-SNP haplotype including rs1878672 in intron 3 of IL-10 showed evidence for association (p = 0.0018). In eOJIA, rs10863962 (3'UTR of FCAMR) and rs12409577 (intron of IL-19) haplotype showed some evidence of association (p = 0.0003). Conclusions: This study supports previous association of IL-20 with sJIA. Haplotype analyses provided stronger association signals than single point analyses, while a penalised logistic regression approach also suggested multiple independent association signals. Replication studies are required to confirm or refute these findings. The results indicate that combined effects with unknown/rare variants remain to be characterised in JIA, and represent a possible example of synthetic association in this region.	[Omoyinmi, Ebun; Hamaoui, Raja; Bryant, Annette; Woo, Patricia] UCL, Dept Immunol & Mol Pathol, London, England; [Forabosco, Paola] CNR, Ist Genet Popolaz, Sassari, Italy; [Hinks, Anne; Thomson, Wendy] Univ Manchester, Manchester Acad Hlth Sci Ctr, Arthrit Res UK Epidemiol Unit, Manchester, Lancs, England; [Ursu, Simona; Wedderburn, Lucy R.] UCL, Inst Child Hlth, Rheumatol Unit, London, England; [Lewis, Cathryn M.] Kings Coll London, Dept Med & Mol Genet, London WC2R 2LS, England; [Lewis, Cathryn M.] Kings Coll London, MRC SGDP Ctr, Inst Psychiat, London WC2R 2LS, England	University of London; University College London; Consiglio Nazionale delle Ricerche (CNR); University of Manchester; University of London; University College London; University of London; King's College London; University of London; King's College London	Omoyinmi, E (corresponding author), UCL, Dept Immunol & Mol Pathol, London, England.	e.omoyinmi@ucl.ac.uk	Hinks, Anne/E-1853-2015; Forabosco, Paola/AAM-5540-2021; Lewis, Cathryn/M-8766-2019; Lewis, Cathryn M/A-5225-2010	Hinks, Anne/0000-0001-8843-3967; Lewis, Cathryn/0000-0002-8249-8476; Lewis, Cathryn M/0000-0002-8249-8476; FORABOSCO, PAOLA/0000-0002-2006-2693; Hyrich, Kimme/0000-0001-8242-9262; Wedderburn, Lucy/0000-0002-7495-1429; Thomson, Wendy/0000-0002-9022-5179	Arthritis Research UK; SPARKS UK [08ICH09, RG/1/010135231]; Great Ormond Street Children's Charity; Wellcome Trust [076113, 085475]; Medical Research Council [G9817803B] Funding Source: researchfish; Versus Arthritis [17287] Funding Source: researchfish; Sparks Charity [08ICH09] Funding Source: researchfish	Arthritis Research UK(Versus Arthritis); SPARKS UK; Great Ormond Street Children's Charity; Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis); Sparks Charity	This work was supported by Arthritis Research UK and by grants from SPARKS UK [08ICH09; the Big Lottery Fund (RG/1/010135231)], and in part by Great Ormond Street Children's Charity. This study makes use of data generated by the Wellcome Trust Case-Control Consortium 2. A full list of the investigators who contributed to the generation of the data is available from www.wtccc.org.uk. Funding for the project was provided by the Wellcome Trust under award 076113 and 085475. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi KR, 2005, NAT GENET, V37, P84, DOI 10.1038/ng1488; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Atan D, 2010, INVEST OPHTH VIS SCI, V51, P4133, DOI 10.1167/iovs.09-4583; Barnes MG, 2009, ARTHRITIS RHEUM-US, V60, P2102, DOI 10.1002/art.24601; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chen WY, 2006, ARTERIOSCL THROM VAS, V26, P2090, DOI 10.1161/01.ATV.0000232502.88144.6f; Cirulli ET, 2010, NAT REV GENET, V11, P415, DOI 10.1038/nrg2779; Crawley E, 1999, ARTHRITIS RHEUM-US, V42, P1101, DOI 10.1002/1529-0131(199906)42:6<1101::AID-ANR6>3.0.CO;2-Y; Crawley E, 2001, RHEUMATOLOGY, V40, P574, DOI 10.1093/rheumatology/40.5.574; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Fife MS, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2041; Hinks A, 2009, ARTHRITIS RHEUM, V60, P258, DOI 10.1002/art.24179; Hoggart CJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000130; Hsieh MY, 2006, GENES IMMUN, V7, P234, DOI 10.1038/sj.gene.6364291; Hsu YH, 2006, ARTHRITIS RHEUM-US, V54, P2722, DOI 10.1002/art.22039; Jones EA, 2005, J IMMUNOL, V175, P7437, DOI 10.4049/jimmunol.175.11.7437; Lard LR, 2003, ARTHRITIS RHEUM-US, V48, P1841, DOI 10.1002/art.11160; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; MALEFYT RD, 1991, J EXP MED, V174, P1209; Nagalakshmi ML, 2004, INT IMMUNOPHARMACOL, V4, P577, DOI 10.1016/j.intimp.2004.01.007; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Otkjaer K, 2007, J INVEST DERMATOL, V127, P1326, DOI 10.1038/sj.jid.5700713; Pascual V, 2005, J EXP MED, V201, P1479, DOI 10.1084/jem.20050473; Petty RE, 2004, J RHEUMATOL, V31, P390; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qian Y, 2010, CURR OPIN OPHTHALMOL, V21, P468, DOI 10.1097/ICU.0b013e32833eab83; Remmers EF, 2010, NAT GENET, V42, P698, DOI 10.1038/ng.625; Romer J, 2003, J INVEST DERMATOL, V121, P1306, DOI 10.1111/j.1523-1747.2003.12626.x; Saraiva M, 2005, J IMMUNOL, V175, P1041, DOI 10.4049/jimmunol.175.2.1041; Scherag A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013967; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Vignal CM, 2011, ANN HUM GENET, V75, P655, DOI 10.1111/j.1469-1809.2011.00670.x; Wei CC, 2005, CLIN IMMUNOL, V117, P65, DOI 10.1016/j.clim.2005.06.012; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Woo P, 2009, BEST PRACT RES CL RH, V23, P589, DOI 10.1016/j.berh.2009.08.001	40	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47673	10.1371/journal.pone.0047673	http://dx.doi.org/10.1371/journal.pone.0047673			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094074	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000312384500017
J	Chaikeeratisak, V; Somboonwiwat, K; Tassanakajon, A				Chaikeeratisak, Vorrapon; Somboonwiwat, Kunlaya; Tassanakajon, Anchalee			Shrimp Alpha-2-Macroglobulin Prevents the Bacterial Escape by Inhibiting Fibrinolysis of Blood Clots	PLOS ONE			English	Article							BLACK TIGER SHRIMP; DIFFERENTIALLY EXPRESSED PROTEINS; LUMINOUS VIBRIO-HARVEYI; MOLECULAR-CLONING; PENAEUS-MONODON; PROTEOMIC ANALYSIS; CYSTEINE PROTEASE; SERINE PROTEINASE; HORSESHOE-CRAB; LYMPHOID ORGAN	Proteomic analysis of the hemocytic proteins of Penaeus monodon (Pm) has previously shown that alpha-2-macroglobulin (A2M) was among the proteins that showed substantially altered expression levels upon Vibrio harveyi infection. Therefore, in this study its potentially important role in the response of shrimp to bacterial infection was further characterized. The yeast two-hybrid system revealed that the receptor binding domain of PmA2M interacted with the carboxyl-terminus of one or both of the transglutaminase type II isoforms, which are key enzymes involved in the shrimp clotting system. In accord with this, PmA2M was found to be localized on the extracellular blood clots and to colocalize with clottable proteins. RNA interference (RNAi)-mediated knockdown of A2M transcript levels reduced the PmA2M transcript levels (similar to 94%) and significantly reduced the bacterial seizing ability of the clotting system, resulting in an up to 3.3-fold higher number of V. harveyi that systemically disseminated into the circulatory system at 5 min post-infection before subsequent clearance by the immune system. Furthermore, an appearance of PmA2M depleted clots in the presence of V. harveyi strikingly demonstrated fibrinolysis zones surrounding the bacteria. This study provides the first evidence of the vital role of PmA2M in enhancing bacterial sequestration by protecting blood clots against fibrinolysis.	[Chaikeeratisak, Vorrapon; Somboonwiwat, Kunlaya; Tassanakajon, Anchalee] Chulalongkorn Univ, Ctr Excellence Mol Biol & Genom Shrimp, Fac Sci, Dept Biochem, Bangkok, Thailand	Chulalongkorn University	Tassanakajon, A (corresponding author), Chulalongkorn Univ, Ctr Excellence Mol Biol & Genom Shrimp, Fac Sci, Dept Biochem, Bangkok, Thailand.	anchalee.k@chula.ac.th	chaikeeratisak, Vorrapon/AFL-6715-2022; chaikeeratisak, Vorrapon/AAG-6852-2022	chaikeeratisak, vorrapon/0000-0003-2793-5394	Thailand National Center for Genetic Engineering and Biotechnology (BIOTEC); National Research University Project of CHE; Ratchadaphiseksomphot Endowment Fund [FW643A]; Royal Golden Jubilee Ph.D. program under the Thailand Research Fund (TRF); TRF; Office of the Higher Education Commission [MRG5280119]; Faculty of Science, Chulalongkorn University [RESA1B1-11]	Thailand National Center for Genetic Engineering and Biotechnology (BIOTEC); National Research University Project of CHE; Ratchadaphiseksomphot Endowment Fund; Royal Golden Jubilee Ph.D. program under the Thailand Research Fund (TRF)(Thailand Research Fund (TRF)); TRF(Thailand Research Fund (TRF)); Office of the Higher Education Commission; Faculty of Science, Chulalongkorn University(Chulalongkorn University)	This research was financially supported by research grants from the Thailand National Center for Genetic Engineering and Biotechnology (BIOTEC), the National Research University Project of CHE and the Ratchadaphiseksomphot Endowment Fund (FW643A). VC received a student fellowship from the Royal Golden Jubilee Ph.D. program under the Thailand Research Fund (TRF) and KS received additional financial support from the TRF, the Office of the Higher Education Commission (Grant No. MRG5280119) and the Faculty of Science, Chulalongkorn University (Grant No. RESA1B1-11). The exchange of scientists (KS) under the JSPS-NRCT Program is also acknowledged, as is the provision of research equipment from the Thai Government Stimulus Package 2 (TKK2555) under the Project for the Establishment of a Comprehensive Center for Innovative Food, Health Products and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amparyup P, 2009, DEV COMP IMMUNOL, V33, P247, DOI 10.1016/j.dci.2008.09.003; Amparyup P, 2012, J BIOL CHEM, V287, P10060, DOI 10.1074/jbc.M111.294744; Armstrong PB, 2010, ISJ-INVERT SURVIV J, V7, P165; ARMSTRONG PB, 1984, THROMB HAEMOSTASIS, V52, P117; Armstrong PB, 1996, J INSECT PHYSIOL, V42, P53, DOI 10.1016/0022-1910(95)00082-8; ARMSTRONG PB, 1985, BIOCHIM BIOPHYS ACTA, V827, P453, DOI 10.1016/0167-4838(85)90232-8; Armstrong PB, 1999, DEV COMP IMMUNOL, V23, P375, DOI 10.1016/S0145-305X(99)00018-X; Armstrong PB, 2003, BIOL BULL-US, V205, P201, DOI 10.2307/1543252; Armstrong PB, 2001, TRENDS IMMUNOL, V22, P47, DOI 10.1016/S1471-4906(00)01803-2; Armstrong PB, 2006, IMMUNOBIOLOGY, V211, P263, DOI 10.1016/j.imbio.2006.01.002; ASPAN A, 1990, INSECT BIOCHEM, V20, P485, DOI 10.1016/0020-1790(90)90030-X; Austin B, 2006, LETT APPL MICROBIOL, V43, P119, DOI 10.1111/j.1472-765X.2006.01989.x; Bidla G, 2005, DEV COMP IMMUNOL, V29, P669, DOI 10.1016/j.dci.2004.11.007; Bourchookarn A, 2008, BBA-PROTEINS PROTEOM, V1784, P504, DOI 10.1016/j.bbapap.2007.12.006; Buresova V, 2009, DEV COMP IMMUNOL, V33, P489, DOI 10.1016/j.dci.2008.09.011; Cerenius L, 2011, J INNATE IMMUN, V3, P3, DOI 10.1159/000322066; Chaikeeratisak V, 2012, MOL BIOL REP, V39, P6367, DOI 10.1007/s11033-012-1458-6; Chen MY, 2005, DEV COMP IMMUNOL, V29, P1003, DOI 10.1016/j.dci.2005.03.012; Chotigeat W, 2007, AQUACULTURE, V271, P112, DOI 10.1016/j.aquaculture.2007.03.019; DORSCH M, 1992, INT J SYST BACTERIOL, V42, P58, DOI 10.1099/00207713-42-1-58; FUKASAWA S, 1988, AGR BIOL CHEM TOKYO, V52, P3009, DOI 10.1080/00021369.1988.10869174; FUKASAWA S, 1988, AGR BIOL CHEM TOKYO, V52, P435; Gollas-Galvan T, 2003, COMP BIOCHEM PHYS C, V134, P431, DOI 10.1016/S1532-0456(03)00002-4; HALL M, 1994, COMP BIOCHEM PHYS B, V108, P65, DOI 10.1016/0305-0491(94)90166-X; Harris LJ, 1999, DIS AQUAT ORGAN, V38, P11, DOI 10.3354/dao038011; Ho PY, 2009, FISH SHELLFISH IMMUN, V26, P459, DOI 10.1016/j.fsi.2009.01.007; Huang CC, 2004, DEV COMP IMMUNOL, V28, P279, DOI 10.1016/j.dci.2003.08.005; Isakova V, 2003, BIOL BULL-US, V205, P203, DOI 10.2307/1543253; Jiravanichpaisal P., 1994, Journal of Aquatic Animal Health, V6, P27, DOI 10.1577/1548-8667(1994)006&lt;0027:HBAPOV&gt;2.3.CO;2; Kanost MR, 1999, DEV COMP IMMUNOL, V23, P291, DOI 10.1016/S0145-305X(99)00012-9; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; Levashina EA, 2001, CELL, V104, P709, DOI 10.1016/S0092-8674(01)00267-7; Lin M, 2002, BLOOD, V99, P1683, DOI 10.1182/blood.V99.5.1683; Lin YC, 2008, DEV COMP IMMUNOL, V32, P317, DOI 10.1016/j.dci.2007.07.002; Lin YC, 2007, MOL IMMUNOL, V44, P1065, DOI 10.1016/j.molimm.2006.08.002; Liu H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706113200; Liu PC, 1999, LETT APPL MICROBIOL, V28, P428, DOI 10.1046/j.1365-2672.1999.00555.x; Liu PC, 1997, CURR MICROBIOL, V35, P32, DOI 10.1007/s002849900207; Ma HM, 2010, DEV COMP IMMUNOL, V34, P677, DOI 10.1016/j.dci.2010.01.014; MARTIN GG, 1985, J MORPHOL, V185, P339, DOI 10.1002/jmor.1051850306; Montero AB, 1999, J FISH DIS, V22, P377, DOI 10.1046/j.1365-2761.1999.00189.x; Pongsomboon S, 2011, FISH SHELLFISH IMMUN, V30, P439, DOI 10.1016/j.fsi.2010.10.015; Ponprateep S, 2009, AQUACULTURE, V289, P219, DOI 10.1016/j.aquaculture.2009.01.026; Prapavorarat A, 2010, J BIOL CHEM, V285, P21467, DOI 10.1074/jbc.M110.130526; Rattanachai A, 2004, FISH SHELLFISH IMMUN, V16, P599, DOI 10.1016/j.fsi.2003.09.011; ROBZYK K, 1992, NUCLEIC ACIDS RES, V20, P3790, DOI 10.1093/nar/20.14.3790; Rojtinnakorn J, 2002, FISH SHELLFISH IMMUN, V13, P69, DOI 10.1006/fsim.2001.0382; Somboonwiwat K, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-39; Theopold U, 2004, TRENDS IMMUNOL, V25, P289, DOI 10.1016/j.it.2004.03.004; Tonganunt M, 2005, J BIOTECHNOL, V120, P135, DOI 10.1016/j.jbiotec.2005.06.006; Vargas-Albores F., 1998, ADV SHRIMP BIOTECHNO, P161; Wang HC, 2007, DEV COMP IMMUNOL, V31, P672, DOI 10.1016/j.dci.2006.11.001; Wang Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000763; Yeh MS, 2007, FISH SHELLFISH IMMUN, V23, P272, DOI 10.1016/j.fsi.2006.10.007; Yeh MS, 2006, BBA-PROTEINS PROTEOM, V1764, P1167, DOI 10.1016/j.bbapap.2006.04.005	55	34	35	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47384	10.1371/journal.pone.0047384	http://dx.doi.org/10.1371/journal.pone.0047384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082160	Green Published, gold, Green Submitted			2022-12-25	WOS:000311146900056
J	Chen, YL; Chang, MC; Chen, CA; Lin, HW; Cheng, WF; Chien, CL				Chen, Yu-Li; Chang, Ming-Cheng; Chen, Chi-An; Lin, Han-Wei; Cheng, Wen-Fang; Chien, Chung-Liang			Depletion of Regulatory T Lymphocytes Reverses the Imbalance between Pro- and Anti-Tumor Immunities via Enhancing Antigen-Specific T Cell Immune Responses	PLOS ONE			English	Article							RNA VACCINE POTENCY; OVARIAN-CANCER; IFN-GAMMA; IMMUNOLOGICAL RESPONSES; PROGNOSTIC-SIGNIFICANCE; TGF-BETA; ENHANCEMENT; GENERATION; RESISTANCE; PHENOTYPE	Background: The regulatory T cells (Tregs) can actively suppress the immune responses. However, literature about detailed changes of host effective and suppressive immunities before and after depletion of Tregs in ovarian carcinomas, is rare. Materials and Methods: Ovarian cancer patients and the ascitogenic animal model were employed. Immunologic profiles with flow cytometric analyses, immunohistochemistric staining, RT-PCR, ELISA, and ELISPOT assays were performed. In vivo depletion of Treg cells with the mAb PC61 was also performed in the animal model. Results: The cytokines, including IL-4 (p = 0.017) and TNF-alpha (p = 0.046), significantly decreased while others such as TGF-beta (p = 0.013), IL-6 (p = 0.016), and IL-10 (p = 0.018) were elevated in ascites of ovarian cancer patients, when the disease progressed to advanced stages. The ratio of CD8(+) T cell/Treg cell in ascites was also lower in advanced diseases than in early diseases (advanced 7.37 +/- 0.64 vs. early 14.25 +/- 3.11, p = 0.037). The kinetic low-dose CD25 Ab depletion group had significantly lower intra-peritoneal tumor weight (0.20 +/- 0.03 g) than the sequential high-dose (0.69 +/- 0.06 g) and sequential low-dose (0.67 +/- 0.07 g) CD25 Ab deletion groups (p = 0.001) after 49 days of tumor challenge in the animal. The kinetic low-dose CD25 Ab depletion group generated the highest number of low-dose, mesothelin-specific T lymphocytes compared to the other groups (p < 0.001). Conclusions: The imbalance between effective and suppressive immunities becomes more severe as a tumor progresses. The depletion of Treg cells can correct the imbalance of immunologic profiles and generate potent anti-tumor effects. Targeting Treg cells can be a new strategy for the immunotherapy of ovarian carcinoma.	[Chen, Yu-Li; Chen, Chi-An; Cheng, Wen-Fang] Natl Taiwan Univ, Coll Med, Dept Obstet & Gynecol, Taipei 10764, Taiwan; [Chen, Yu-Li; Chien, Chung-Liang] Natl Taiwan Univ, Coll Med, Grad Inst Anat & Cell Biol, Taipei 10764, Taiwan; [Chen, Yu-Li] Cathay Gen Hosp, Dept Obstet & Gynecol, Gynecol Canc Ctr, Taipei, Taiwan; [Chang, Ming-Cheng; Lin, Han-Wei; Cheng, Wen-Fang] Natl Taiwan Univ, Coll Med, Grad Inst Oncol, Taipei 10764, Taiwan; [Cheng, Wen-Fang] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Chang, Ming-Cheng] Natl Taiwan Univ, Coll Med, Dept Anesthesiol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; Cathay General Hospital; National Taiwan University; National Taiwan University; National Taiwan University	Cheng, WF (corresponding author), Natl Taiwan Univ, Coll Med, Dept Obstet & Gynecol, Taipei 10764, Taiwan.	wenfangcheng@yahoo.com; chien@ntu.edu.tw		CHIEN, CHUNG-LIANG/0000-0001-9806-486X; CHEN, CHI-AN/0000-0001-6670-7939; CHENG, WEN-FANG/0000-0002-3282-6304	National Science Committee of Taiwan [NSC 98-2628-B-002-083-MY3, 100-2314-B-002-O24]; Department of Medical Research of National Taiwan University Hospital	National Science Committee of Taiwan(Ministry of Science and Technology, Taiwan); Department of Medical Research of National Taiwan University Hospital	The funding for this study was granted by the National Science Committee of Taiwan (NSC 98-2628-B-002-083-MY3 and 100-2314-B-002-O24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by the 2nd and 7th core laboratory facility of the Department of Medical Research of National Taiwan University Hospital.	Agarwal R, 2003, NAT REV CANCER, V3, P502, DOI 10.1038/nrc1123; Annacker O, 2001, J IMMUNOL, V166, P3008, DOI 10.4049/jimmunol.166.5.3008; [Anonymous], 1987, Am J Obstet Gynecol, V156, P263; Baecher-Allan C, 2006, SEMIN CANCER BIOL, V16, P98, DOI 10.1016/j.semcancer.2005.11.003; BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; Chen CA, 2010, MOL THER, V18, P1233, DOI 10.1038/mt.2010.34; Cheng WF, 2007, CANCER-AM CANCER SOC, V110, P420, DOI 10.1002/cncr.22781; Cheng WF, 2005, IMMUNOLOGY, V115, P136, DOI 10.1111/j.1365-2567.2005.02126.x; Cheng WF, 2001, J IMMUNOL, V166, P6218, DOI 10.4049/jimmunol.166.10.6218; Cheng WF, 2001, HUM GENE THER, V12, P235, DOI 10.1089/10430340150218387; Chu CS, 2008, EXPERT REV ANTICANC, V8, P243, DOI 10.1586/14737140.8.2.243; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; den Boer AT, 2005, CANCER RES, V65, P6984, DOI 10.1158/0008-5472.CAN-04-3344; DiSaia PJ, 2003, GYNECOL ONCOL, V90, pS24, DOI 10.1016/S0090-8258(03)00341-X; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Fahlen L, 2005, J EXP MED, V201, P737, DOI 10.1084/jem.20040685; Freeman CM, 2005, J IMMUNOL, V174, P1962, DOI 10.4049/jimmunol.174.4.1962; Ghiringhelli F, 2005, J EXP MED, V202, P1075, DOI 10.1084/jem.20051511; GOLUMBEK PT, 1991, SCIENCE, V254, P713, DOI 10.1126/science.1948050; Gonzalez-Diego P, 2000, EUR J CANCER, V36, P1816, DOI 10.1016/S0959-8049(00)00184-2; Grossman WJ, 2004, IMMUNITY, V21, P589, DOI 10.1016/j.immuni.2004.09.002; Hallermalm K, 2008, J IMMUNOL, V180, P3766, DOI 10.4049/jimmunol.180.6.3766; Imai H, 2007, CANCER SCI, V98, P416, DOI 10.1111/j.1349-7006.2006.00385.x; IOANNIDES CG, 1991, CANCER RES, V51, P4257; Kryczek I, 2007, CANCER RES, V67, P8900, DOI 10.1158/0008-5472.CAN-07-1866; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Larmonier N, 2007, CANCER IMMUNOL IMMUN, V56, P48, DOI 10.1007/s00262-006-0160-8; Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209; Leffers N, 2009, CANCER IMMUNOL IMMUN, V58, P449, DOI 10.1007/s00262-008-0583-5; Lejeune FJ, 2002, J CLIN INVEST, V110, P433, DOI 10.1172/JCI200216493; Li Q, 2003, CANCER RES, V63, P2546; Liao CW, 2005, CANCER RES, V65, P9089, DOI 10.1158/0008-5472.CAN-05-0958; Malmberg KJ, 2002, J CLIN INVEST, V110, P1515, DOI 10.1172/JC1200215564; Miyara M, 2007, TRENDS MOL MED, V13, P108, DOI 10.1016/j.molmed.2007.01.003; Nakamura K, 2004, J IMMUNOL, V172, P834, DOI 10.4049/jimmunol.172.2.834; Nakamura T, 2004, INVEST OPHTH VIS SCI, V45, P93, DOI 10.1167/iovs.03-0752; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; PFLEIDERER A, 1984, J CANCER RES CLIN, V107, P81, DOI 10.1007/BF00399376; Roord STA, 2008, BLOOD, V111, P5233, DOI 10.1182/blood-2007-12-128488; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Shankaran V, 2001, NATURE, V410, P1107, DOI 10.1038/35074122; Tomsova M, 2008, GYNECOL ONCOL, V108, P415, DOI 10.1016/j.ygyno.2007.10.016; Tsuji NM, 2003, INT IMMUNOL, V15, P525, DOI 10.1093/intimm/dxg051; Wolf D, 2005, CLIN CANCER RES, V11, P8326, DOI 10.1158/1078-0432.CCR-05-1244; Workman CJ, 2002, EUR J IMMUNOL, V32, P2255, DOI 10.1002/1521-4141(200208)32:8<2255::AID-IMMU2255>3.0.CO;2-A; Wynn TA, 2005, NAT IMMUNOL, V6, P1069, DOI 10.1038/ni1105-1069; Yigit R, 2010, GYNECOL ONCOL, V117, P366, DOI 10.1016/j.ygyno.2010.01.019; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177	49	24	27	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47190	10.1371/journal.pone.0047190	http://dx.doi.org/10.1371/journal.pone.0047190			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082146	gold, Green Published, Green Submitted			2022-12-25	WOS:000311146900041
J	Chua, BY; Johnson, D; Tan, A; Earnest-Silveira, L; Sekiya, T; Chin, R; Torresi, J; Jackson, DC				Chua, Brendon Y.; Johnson, Douglas; Tan, Amabel; Earnest-Silveira, Linda; Sekiya, Toshiki; Chin, Ruth; Torresi, Joseph; Jackson, David C.			Hepatitis C VLPs Delivered to Dendritic Cells by a TLR2 Targeting Lipopeptide Results in Enhanced Antibody and Cell-Mediated Responses	PLOS ONE			English	Article							VIRUS-LIKE PARTICLES; RESPIRATORY SYNDROME CORONAVIRUS; CD8(+) T-CELL; NEUTRALIZING ANTIBODIES; VACCINE; IMMUNIZATION; INFECTION; BINDING; GLYCOPROTEIN; PROTECTION	Although many studies provide strong evidence supporting the development of HCV virus-like particle (VLP)-based vaccines, the fact that heterologous viral vectors and/or multiple dosing regimes are required to induce protective immunity indicates that it is necessary to improve their immunogenicity. In this study, we have evaluated the use of an anionic self-adjuvanting lipopeptide containing the TLR2 agonist Pam(2)Cys (E(8)Pam(2)Cys) to enhance the immunogenicity of VLPs containing the HCV structural proteins (core, E1 and E2) of genotype 1a. While co-formulation of this lipopeptide with VLPs only resulted in marginal improvements in dendritic cell (DC) uptake, its ability to concomitantly induce DC maturation at very small doses is a feature not observed using VLPs alone or in the presence of an aluminium hydroxide-based adjuvant (Alum). Dramatically improved VLP and E2-specific antibody responses were observed in VLP+E(8)Pam(2)Cys vaccinated mice where up to 3 doses of non-adjuvanted or traditionally alum-adjuvanted VLPs was required to match the antibody titres obtained with a single dose of VLPs formulated with this lipopeptide. This result also correlated with significantly higher numbers of specific antibody secreting cells that was detected in the spleens of VLP+E(8)Pam(2)Cys vaccinated mice and greater ability of sera from these mice to neutralise the binding and uptake of VLPs by Huh7 cells. Moreover, vaccination of HLA-A2 transgenic mice with this formulation also induced better VLP-specific IFN-gamma-mediated responses compared to non-adjuvanted VLPs but comparable levels to that achieved when coadministered with complete freund's adjuvant. These results suggest overall that the immunogenicity of HCV VLPs can be significantly improved by the addition of this novel adjuvant by targeting their delivery to DCs and could therefore constitute a viable vaccine strategy for the treatment of HCV.	[Chua, Brendon Y.; Tan, Amabel; Sekiya, Toshiki; Jackson, David C.] Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia; [Johnson, Douglas; Torresi, Joseph] Austin Hosp, Dept Infect Dis, Heidelberg, Vic 3084, Australia; [Johnson, Douglas; Earnest-Silveira, Linda; Chin, Ruth; Torresi, Joseph] Univ Melbourne, Austin Hosp, Dept Med, Heidelberg, Vic, Australia	University of Melbourne; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne	Chua, BY (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Parkville, Vic 3052, Australia.	bychua@unimelb.edu.au	Chua, Brendon Y/A-9755-2012	Chua, Brendon Y/0000-0001-5654-1293; Jackson, David/0000-0001-7255-270X; Torresi, Joseph/0000-0002-8212-0887	National Health and Medical Research Council of Australia; Australian Centre for HIV and Hepatitis Research; Department of Innovation, Industry, Science and Research, Commonwealth of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Centre for HIV and Hepatitis Research; Department of Innovation, Industry, Science and Research, Commonwealth of Australia	This work was supported by grants from the National Health and Medical Research Council of Australia, The Australian Centre for HIV and Hepatitis Research and from the Department of Innovation, Industry, Science and Research, Commonwealth of Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alphs HH, 2008, P NATL ACAD SCI USA, V105, P5850, DOI 10.1073/pnas.0800868105; Barth H, 2005, BLOOD, V105, P3605, DOI 10.1182/blood-2004-05-1952; Buonaguro L, 2007, VACCINE, V25, P5968, DOI 10.1016/j.vaccine.2007.05.052; Buonaguro L, 2011, EXPERT REV VACCINES, V10, P1569, DOI [10.1586/ERV.11.135, 10.1586/erv.11.135]; Chin R, 2007, J HEPATOL, V47, P325, DOI 10.1016/j.jhep.2007.03.025; CHOO QL, 1994, P NATL ACAD SCI USA, V91, P1294, DOI 10.1073/pnas.91.4.1294; Chua BY, 2008, PEPTIDES, V29, P881, DOI 10.1016/j.peptides.2008.01.025; Chua BY, 2007, VACCINE, V25, P92, DOI 10.1016/j.vaccine.2006.07.012; Chua BY, 2011, J IMMUNOL, V187, P1692, DOI 10.4049/jimmunol.1100486; Deliyannis G, 2006, EUR J IMMUNOL, V36, P770, DOI 10.1002/eji.200535217; Eriksson M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023828; Firat H, 1999, EUR J IMMUNOL, V29, P3112, DOI 10.1002/(SICI)1521-4141(199910)29:10<3112::AID-IMMU3112>3.0.CO;2-Q; Garrone P, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002330; Grebely J, 2006, HEPATOLOGY, V44, P1139, DOI 10.1002/hep.21376; Grollo L, 2006, ANTIVIR THER, V11, P1005; Jackson DC, 2004, P NATL ACAD SCI USA, V101, P15440, DOI 10.1073/pnas.0406740101; Jagu S, 2010, VACCINE, V28, P4478, DOI 10.1016/j.vaccine.2010.04.039; Krey T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000762; Lauer GM, 2005, J VIROL, V79, P12979, DOI 10.1128/JVI.79.20.12979-12988.2005; Law M, 2008, NAT MED, V14, P25, DOI 10.1038/nm1698; Lechmann M, 2001, HEPATOLOGY, V34, P417, DOI 10.1053/jhep.2001.26523; Lindblad EB, 2004, IMMUNOL CELL BIOL, V82, P497, DOI 10.1111/j.0818-9641.2004.01286.x; Liu YV, 2011, VACCINE, V29, P6606, DOI 10.1016/j.vaccine.2011.06.111; Lu BJ, 2010, IMMUNOLOGY, V130, P254, DOI 10.1111/j.1365-2567.2010.03231.x; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Meunier JC, 2008, J VIROL, V82, P966, DOI 10.1128/JVI.01872-07; Middelberg APJ, 2011, VACCINE, V29, P7154, DOI 10.1016/j.vaccine.2011.05.075; Munoz N, 2009, LANCET, V373, P1949, DOI 10.1016/S0140-6736(09)60691-7; Murata K, 2003, P NATL ACAD SCI USA, V100, P6753, DOI 10.1073/pnas.1131929100; Nattermann J, 2005, J HEPATOL, V42, P499, DOI 10.1016/j.jhep.2004.12.018; Pestka JM, 2007, P NATL ACAD SCI USA, V104, P6025, DOI 10.1073/pnas.0607026104; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Puig M, 2006, HEPATOLOGY, V44, P736, DOI 10.1002/hep.21319; Raghuraman S, 2012, J INFECT DIS, V205, P763, DOI 10.1093/infdis/jir835; Rosa D, 1996, P NATL ACAD SCI USA, V93, P1759, DOI 10.1073/pnas.93.5.1759; Sarrazin C, 2012, J HEPATOL, V56, pS88, DOI 10.1016/S0168-8278(12)60010-5; Schneider-Ohrum K, 2011, VACCINE, V29, P9081, DOI 10.1016/j.vaccine.2011.09.051; Smyk-Pearson S, 2006, J INFECT DIS, V194, P454, DOI 10.1086/505714; Steinmann D, 2004, J VIROL, V78, P9030, DOI 10.1128/JVI.78.17.9030-9040.2004; Tarr AW, 2006, HEPATOLOGY, V43, P592, DOI 10.1002/hep.21088; Torresi J, 2007, HEPATOLOGY, V45, P911, DOI 10.1002/hep.21538; Torresi J, 2007, IMMUNOL CELL BIOL, V85, P169, DOI 10.1038/sj.icb.7100021; Velasquez LS, 2010, CLIN VACCINE IMMUNOL, V17, P1850, DOI 10.1128/CVI.00230-10; Visciano ML, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-4; Walpita P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018437; Wang BZ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013972; Zeng WG, 1996, J PEPT SCI, V2, P66	47	43	43	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47492	10.1371/journal.pone.0047492	http://dx.doi.org/10.1371/journal.pone.0047492			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091628	Green Submitted, Green Published, gold			2022-12-25	WOS:000310135800051
J	Shi, T; Gao, ZH; Wang, LJ; Zhang, Z; Zhuang, WB; Sun, HL; Zhong, WJ				Shi, Ting; Gao, Zhihong; Wang, Liangju; Zhang, Zhen; Zhuang, Weibing; Sun, Hailong; Zhong, Wenjun			Identification of Differentially-Expressed Genes Associated with Pistil Abortion in Japanese Apricot by Genome-Wide Transcriptional Analysis	PLOS ONE			English	Article							DIRECTED DNA METHYLATION; FLOWERING-LOCUS-C; ARABIDOPSIS-THALIANA; CELL-WALL; RNA-SEQ; GAMETOPHYTE DEVELOPMENT; PRUNUS-MUME; POLLEN; PROTEINS; MUTANT	The phenomenon of pistil abortion widely occurs in Japanese apricot, and imperfect flowers with pistil abortion seriously decrease the yield in production. Although transcriptome analyses have been extensively studied in the past, a systematic study of differential gene expression has not been performed in Japanese apricot. To investigate genes related to the pistil development of Japanese apricot, high-throughput sequencing technology (Illumina) was employed to survey gene expression profiles from perfect and imperfect Japanese apricot flower buds. 3,476,249 and 3,580,677 tags were sequenced from two libraries constructed from perfect and imperfect flower buds of Japanese apricot, respectively. There were 689 significant differentially-expressed genes between the two libraries. GO annotation revealed that highly ranked genes were those implicated in small molecule metabolism, cellular component organisation or biogenesis at the cellular level and fatty acid metabolism. According to the results, we assumed that late embryogenesis abundant protein (LEA), Dicer-like 3 (DCL3) Xyloglucan endotransglucosylase/hydrolase 2 (XTH2), Pectin lyase-like superfamily protein (PPME1), Lipid transfer protein 3 (LTP3), Fatty acid biosynthesis 1 (FAB1) and Fatty acid desaturase 5 (FAD5) might have relationships with the pistil abortion in Japanese apricot. The expression patterns of 36 differentially expressed genes were confirmed by real-time (RT)-PCR. This is the first report of the Illumina RNA-seq technique being used for the analysis of differentially-expressed gene profiles related to pistil abortion that both computationally and experimentally provides valuable information for the further functional characterisation of genes associated with pistil development in woody plants.	[Shi, Ting; Gao, Zhihong; Wang, Liangju; Zhang, Zhen; Zhuang, Weibing; Sun, Hailong; Zhong, Wenjun] Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Gao, ZH (corresponding author), Nanjing Agr Univ, Coll Hort, Nanjing, Jiangsu, Peoples R China.	gaozhihong@njau.edu.cn		Shi, Ting/0000-0002-0955-016X	Specialized Fund for the Basic Research Operating expenses Program of Central College; National Science Foundation of China [31101526]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Specialized Fund for the Basic Research Operating expenses Program of Central College; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Specialized Fund for the Basic Research Operating expenses Program of Central College 2012, the National Science Foundation of China (31101526) and the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) for funding part of this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-496; Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Anisimov SV, 2008, CURR PHARM BIOTECHNO, V9, P338, DOI 10.2174/138920108785915148; Arathi HS, 1999, AM J BOT, V86, P659, DOI 10.2307/2656574; Asmann YW, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-531; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Barkan L, 2006, PLANT PHYSIOL, V141, P1012, DOI 10.1104/pp.106.080481; Benjamini Y, 2001, ANN STAT, V29, P1165; Beppu K, 2011, J JPN SOC HORTIC SCI, V80, P1, DOI 10.2503/jjshs1.80.1; Boavida LC, 2009, GENETICS, V181, P1369, DOI 10.1534/genetics.108.090852; Borner GHH, 2002, PLANT PHYSIOL, V129, P486, DOI 10.1104/pp.010884; Bosch M, 2005, PLANT CELL, V17, P3219, DOI 10.1105/tpc.105.037473; Bourc'his D, 2010, SCIENCE, V330, P617, DOI 10.1126/science.1194776; Causier B, 2003, PLANT MOL BIOL, V52, P1051, DOI 10.1023/A:1025426016267; Chen WW, 2010, PLANT PHYSIOL, V154, P810, DOI 10.1104/pp.110.161109; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chinnusamy V, 2009, SCI CHINA SER C, V52, P331, DOI 10.1007/s11427-009-0052-1; Chu M.Y., 1999, CHINA FRUIT RECORDS; Chung T, 2009, PLANT PHYSIOL, V151, P1498, DOI 10.1104/pp.109.141705; Ellis CM, 2005, DEVELOPMENT, V132, P4563, DOI 10.1242/dev.02012; Eveland AL, 2010, PLANT PHYSIOL, V154, P1024, DOI 10.1104/pp.110.159673; Gao Z., 2006, JIANGSU AGR SCI, V6, P231; Gao ZH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-371; Gou MY, 2009, PLANT J, V60, P757, DOI 10.1111/j.1365-313X.2009.03995.x; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Habu T, 2012, J JPN SOC HORTIC SCI, V81, P239, DOI 10.2503/jjshs1.81.239; Hao QN, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-525; Heilmann I, 2004, PLANT PHYSIOL, V136, P4237, DOI 10.1104/pp.104.052951; Hou JH, 2011, PLANT MOL BIOL REP, V29, P473, DOI 10.1007/s11105-010-0248-3; Hunt M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-145; Hyodo H, 2003, PLANT MOL BIOL, V52, P473, DOI 10.1023/A:1023904217641; Imoto K, 2005, PLANT MOL BIOL, V58, P177, DOI 10.1007/s11103-005-5344-7; Ji LZ, 2011, PURE APPL MATH Q, V7, P1, DOI 10.1371/journal.pgen.1001358; JOFUKU KD, 1994, PLANT CELL, V6, P1211, DOI 10.1105/tpc.6.9.1211; Kanchiswamy CN, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-97; Kato M, 2004, PLANT PROD SCI, V7, P184, DOI 10.1626/pps.7.184; Klopffleisch K, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.66; Kocsis Marianna, 2008, Acta Biologica Szegediensis, V52, P247; Kokubun M, 2001, CROP SCI, V41, P1517, DOI 10.2135/cropsci2001.4151517x; Kroeger TS, 2009, P NATL ACAD SCI USA, V106, P4537, DOI 10.1073/pnas.0812503106; Kumar R, 2011, MOL GENET GENOMICS, V285, P245, DOI 10.1007/s00438-011-0602-7; Laubinger S, 2008, P NATL ACAD SCI USA, V105, P8795, DOI 10.1073/pnas.0802493105; Li YJ, 2011, FEBS J, V278, P156, DOI 10.1111/j.1742-4658.2010.07941.x; Lim PO, 2010, J EXP BOT, V61, P1419, DOI 10.1093/jxb/erq010; Liu HC, 2000, BBA-MOL CELL BIOL L, V1487, P106, DOI 10.1016/S1388-1981(00)00072-X; Mamidala P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-6; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Maris A, 2011, J EXP BOT, V62, P261, DOI 10.1093/jxb/erq263; Meier I, 2012, BBA-GENE REGUL MECH, V1819, P531, DOI 10.1016/j.bbagrm.2012.01.006; Meisel L, 2005, BIOL RES, V38, P83, DOI 10.4067/S0716-97602005000100010; Menges M, 2008, NEW PHYTOL, V179, P643, DOI 10.1111/j.1469-8137.2008.02552.x; Michaels SD, 2001, PLANT CELL, V13, P935, DOI 10.1105/tpc.13.4.935; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; OKAMOTO G, 1991, J JPN SOC HORTIC SCI, V60, P521, DOI 10.2503/jjshs.60.521; Parre E, 2005, PLANTA, V220, P582, DOI 10.1007/s00425-004-1368-5; Peng SM, 2008, BIOL PLANTARUM, V52, P222, DOI 10.1007/s10535-008-0049-9; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Rapoport HF, 2012, ENVIRON EXP BOT, V77, P227, DOI 10.1016/j.envexpbot.2011.11.021; Reale L, 2009, SEX PLANT REPROD, V22, P109, DOI 10.1007/s00497-009-0096-1; Rockel N, 2008, PLANT J, V53, P133, DOI 10.1111/j.1365-313X.2007.03325.x; Schmitz RJ, 2007, GENETICS, V176, P1359, DOI 10.1534/genetics.107.070649; Shi T, 2012, J PLANT PHYSIOL, V169, P1301, DOI 10.1016/j.jplph.2012.05.009; Shi Ting, 2011, Journal of Plant Resources and Environment, V20, P35; Sivitz A, 2011, PLANT J; Srinivasan A, 1999, FIELD CROP RES, V60, P209, DOI 10.1016/S0378-4290(98)00126-9; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Tong ZG, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-71; Wang HC, 2008, PLANT CELL, V20, P602, DOI 10.1105/tpc.108.058032; Wang QQ, 2010, GENOMICS, V96, P369, DOI 10.1016/j.ygeno.2010.08.009; Wang S., 2008, PRELIMINARY STUDIES; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Whittle CA, 2009, BOTANY, V87, P650, DOI 10.1139/B09-030; Wu JA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-234; Wu T, 2010, J PLANT PHYSIOL, V167, P905, DOI 10.1016/j.jplph.2010.02.004; Xia DZ, 2011, LWT-FOOD SCI TECHNOL, V44, P347, DOI 10.1016/j.lwt.2010.05.017; Xiao LH, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-177; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zhang HM, 2011, CURR OPIN PLANT BIOL, V14, P142, DOI 10.1016/j.pbi.2011.02.003; Zinn KE, 2010, J EXP BOT, V61, P1959, DOI 10.1093/jxb/erq053	80	38	39	0	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47810	10.1371/journal.pone.0047810	http://dx.doi.org/10.1371/journal.pone.0047810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091648	Green Submitted, Green Published, gold			2022-12-25	WOS:000310135800074
J	Ray-David, H; Romeo, Y; Lavoie, G; Deleris, P; Tcherkezian, J; Galan, JA; Roux, PP				Ray-David, H.; Romeo, Y.; Lavoie, G.; Deleris, P.; Tcherkezian, J.; Galan, J. A.; Roux, P. P.			RSK promotes G2 DNA damage checkpoint silencing and participates in melanoma chemoresistance	ONCOGENE			English	Article						MAPK; RSK; Chk1; DNA damage; melanoma; chemoresistance	RIBOSOMAL S6 KINASE; SIGNAL-REGULATED KINASE; PROTEIN-KINASE; CHK1; PHOSPHORYLATION; RAS; INHIBITION; RESISTANCE; SURVIVAL; PATHWAY	The incidence of malignant melanoma is growing rapidly worldwide and there is still no effective therapy for metastatic disease. This type of cancer is highly resistant to conventional DNA-damaging chemotherapeutics, and intense research has been dedicated for understanding the molecular pathways underlying chemoresistance. The Ras/mitogen-activated protein kinase (MAPK) signalling pathway is often deregulated in melanoma, which frequently harbours activating mutations in NRAS or BRAF. Herein, we demonstrate that the MAPK-activated protein kinase RSK (p90 ribosomal S6 kinase) contributes to melanoma chemoresistance by altering their response to chemotherapeutic agents. We find that RSK phosphorylates checkpoint kinase 1 (Chk1) at an inhibitory site, Ser280, both in vitro and in vivo. Our results indicate that RSK is the predominant protein kinase operating downstream of mitogens and oncogenes of the Ras/MAPK pathway, and consistent with this, we find that RSK constitutively phosphorylates Chk1 in melanoma. We show that RSK inhibition increases Chk1 activity in response to DNA-damaging agents, suggesting that the Ras/MAPK pathway modulates Chk1 function and the response to DNA damage. Accordingly, we demonstrate that RSK promotes G2 DNA damage checkpoint silencing in a Chk1-dependent manner, and find that RSK inhibitors sensitize melanoma cells to DNA-damaging agents. Together, our results identify a novel link between the Ras/MAPK pathway and the DNA damage response, and suggest that RSK inhibitors may be used to modulate chemosensitivity, which is one of the major obstacles to melanoma treatment.	[Ray-David, H.; Romeo, Y.; Lavoie, G.; Deleris, P.; Tcherkezian, J.; Galan, J. A.; Roux, P. P.] Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Roux, P. P.] Univ Montreal, Fac Med, Dept Pathol & Cell Biol, Montreal, PQ H3C 3J7, Canada	Universite de Montreal; Universite de Montreal	Roux, PP (corresponding author), Univ Montreal, Inst Res Immunol & Canc, POB 6128,Stn Ctr Ville, Montreal, PQ H3C 3J7, Canada.	philippe.roux@umontreal.ca	Roux, Philippe P./J-3996-2012; Romeo, Yves/AAC-1669-2021	Roux, Philippe P./0000-0002-5962-0250; Galan, Jacob/0000-0003-3304-0474	Canadian Cancer Society Research Institute [700878]; Cancer Research Society [DF121153]; Canadian Institutes of Health Research (CIHR)	Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Cancer Research Society; Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	We thank all the members of our laboratory for their insightful discussions and comments on the manuscript and the data. This work was supported by grants from the Canadian Cancer Society Research Institute (700878) and the Cancer Research Society (DF121153) PP Roux holds a Canada Research Chair in Signal Transduction and Proteomics. JA Galan holds a postdoctoral fellowship from the Canadian Institutes of Health Research (CIHR). IRIC core facilities are supported by the FRSQ.	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Caron E, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.68; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen Y, 2008, FRONT BIOSCI-LANDMRK, V13, P5016; Clark DE, 2005, CANCER RES, V65, P3108; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dhomen N, 2007, CURR OPIN GENET DEV, V17, P31, DOI 10.1016/j.gde.2006.12.005; Eton O, 1998, J CLIN ONCOL, V16, P1103, DOI 10.1200/JCO.1998.16.3.1103; Fecher LA, 2008, CURR OPIN ONCOL, V20, P183, DOI 10.1097/CCO.0b013e3282f5271c; Flaherty KT, 2006, CLIN CANCER RES, V12, p2366S, DOI 10.1158/1078-0432.CCR-05-2505; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Gogas HJ, 2007, CANCER-AM CANCER SOC, V109, P455, DOI 10.1002/cncr.22427; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Johannessen CM, 2010, NATURE, V468, P968, DOI 10.1038/nature09627; Joseph EW, 2010, P NATL ACAD SCI USA, V107, P14903, DOI 10.1073/pnas.1008990107; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; King FW, 2004, CELL CYCLE, V3, P634; Koberle B, 2010, BBA-REV CANCER, V1806, P172, DOI 10.1016/j.bbcan.2010.07.004; Li P, 2012, MOL BIOL CELL, V23, P1582, DOI 10.1091/mbc.E11-10-0883; Liu XS, 2010, PROTEIN CELL, V1, P999, DOI 10.1007/s13238-010-0131-x; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Mamely I, 2006, CURR BIOL, V16, P1950, DOI 10.1016/j.cub.2006.08.026; Markovic SN, 2007, MAYO CLIN PROC, V82, P490, DOI 10.4065/82.4.490; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Michaloglou C, 2008, ONCOGENE, V27, P877, DOI 10.1038/sj.onc.1210704; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Niida H, 2007, MOL CELL BIOL, V27, P2572, DOI 10.1128/MCB.01611-06; Old WM, 2009, MOL CELL, V34, P115, DOI 10.1016/j.molcel.2009.03.007; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Puc J, 2005, CANCER CELL, V7, P193, DOI 10.1016/j.ccr.2005.01.009; Romeo Y, 2012, BIOCHEM J, V441, P553, DOI 10.1042/BJ20110289; Romeo Y, 2011, EXPERT OPIN THER TAR, V15, P5, DOI 10.1517/14728222.2010.531014; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Rubinfeld H, 2005, MOL BIOTECHNOL, V31, P151, DOI 10.1385/MB:31:2:151; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Shtivelman E, 2002, CURR BIOL, V12, P919, DOI 10.1016/S0960-9822(02)00843-6; Smith JA, 2005, CANCER RES, V65, P1027; Soengas MS, 2003, ONCOGENE, V22, P3138, DOI 10.1038/sj.onc.1206454; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; van de Weerdt BCM, 2006, CELL CYCLE, V5, P853, DOI 10.4161/cc.5.8.2692; Walker M, 2009, ONCOGENE, V28, P2314, DOI 10.1038/onc.2009.102; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	49	26	29	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 19	2013	32	38					4480	4489		10.1038/onc.2012.472	http://dx.doi.org/10.1038/onc.2012.472			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	223SW	23108403				2022-12-25	WOS:000324831300003
J	Eberlein, C; Kendrew, J; McDaid, K; Alfred, A; Kang, JS; Jacobs, VN; Ross, SJ; Rooney, C; Smith, NR; Rinkenberger, J; Cao, A; Churchman, A; Marshall, JF; Weir, HM; Bedian, V; Blakey, DC; Foltz, IN; Barry, ST				Eberlein, C.; Kendrew, J.; McDaid, K.; Alfred, A.; Kang, J. S.; Jacobs, V. N.; Ross, S. J.; Rooney, C.; Smith, N. R.; Rinkenberger, J.; Cao, A.; Churchman, A.; Marshall, J. F.; Weir, H. M.; Bedian, V.; Blakey, D. C.; Foltz, I. N.; Barry, S. T.			A human monoclonal antibody 264RAD targeting alpha v beta 6 integrin reduces tumour growth and metastasis, and modulates key biomarkers in vivo	ONCOGENE			English	Article						integrin; alpha v beta 6; alpha v beta 8; beta-6; beta-8; TGF-beta	SQUAMOUS CARCINOMA-CELLS; EPITHELIAL OVARIAN-CANCER; MOUTH-DISEASE VIRUS; FACTOR-BETA; BREAST-CANCER; UP-REGULATION; ACTIVATION; EXPRESSION; FIBROSIS; INVASION	alpha v beta 6 integrin expression is upregulated on a wide range of epithelial tumours, and is thought to play a role in modulating tumour growth. Here we describe a human therapeutic antibody 264RAD, which binds and inhibits alpha v beta 6 integrin function. 264RAD cross-reacts with human, mouse and cynomolgus monkey alpha v beta 6, and inhibits binding to all ligands including the latency-associated peptide of TGF-beta. Screening across a range of integrins revealed that 264RAD also binds and inhibits the related integrin alpha v beta 8, but not the integrins alpha 5 beta 1, alpha v beta 3, alpha v beta 5 and alpha 4 beta 1. In vitro 264RAD inhibited invasion of VB6 and Detroit 562 cells in a Matrigel invasion assay and alpha v beta 6 mediated production of matrix metalloproteinase-9 in Calu-3 cells. It inhibited TGF-beta-mediated activation of dermal skin fibroblasts by preventing local activation of TGF-beta by NCI-H358 tumour cells in a tumour cell - fibroblast co-culture assay. In vivo 264RAD showed dose-dependent inhibition of Detroit 562 tumour growth, regressing established tumours when dosed at 20 mg/kg once weekly. The reduction in growth associated with 264RAD was related to a dose-dependent inhibition of Ki67 and phospho-ERK and a reduction of alpha v beta 6 expression in the tumour cells, coupled to a reduction in fibronectin and alpha smooth muscle actin expression in stromal fibroblasts. 264RAD also reduced the growth and metastasis of orthotopic 4T1 tumours. At 20 mg/kg growth of both the primary tumour and the number of metastatic deposits in lung were reduced. The data support the conclusion that 264RAD is a potent inhibitor of alpha v beta 6 integrin, with some activity against alpha v beta 8 integrin, that reduces both tumour growth and metastasis.	[Eberlein, C.; Kendrew, J.; McDaid, K.; Jacobs, V. N.; Ross, S. J.; Rooney, C.; Smith, N. R.; Weir, H. M.; Blakey, D. C.; Barry, S. T.] AstraZeneca, Oncol iMED, Macclesfield SK10 4TG, Cheshire, England; [Alfred, A.; Kang, J. S.; Rinkenberger, J.; Foltz, I. N.] Amgen Inc, Burnaby, BC, Canada; [Cao, A.; Bedian, V.] AstraZeneca R&D Boston, Oncol iMED, Waltham, MA USA; [Churchman, A.; Marshall, J. F.] Queen Mary Univ London, Barts Canc Inst, London, England	AstraZeneca; AstraZeneca; University of London; Queen Mary University London	Barry, ST (corresponding author), AstraZeneca, Oncol iMED, Alderley Pk, Macclesfield SK10 4TG, Cheshire, England.	Simon.T.Barry@astrazeneca.com		Marshall, John/0000-0002-0494-2295	MRC; MRC [G0800825] Funding Source: UKRI; Medical Research Council [G0800825] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Adrian Churchman was funded by a MRC Pilot Award.	Ahmed N, 2002, ONCOGENE, V21, P1370, DOI 10.1038/sj.onc.1205286; Ahmed N, 2002, J HISTOCHEM CYTOCHEM, V50, P1371, DOI 10.1177/002215540205001010; Ahmed N, 2002, CARCINOGENESIS, V23, P237, DOI 10.1093/carcin/23.2.237; Al-Hazmi N, 2007, EUR J ORAL SCI, V115, P454, DOI 10.1111/j.1600-0722.2007.00481.x; Aluwihare P, 2009, J CELL SCI, V122, P227, DOI 10.1242/jcs.035246; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Arihiro K, 2000, Breast Cancer, V7, P19, DOI 10.1007/BF02967183; Azare J, 2007, MOL CELL BIOL, V27, P4444, DOI 10.1128/MCB.02404-06; Babcook JS, 1996, P NATL ACAD SCI USA, V93, P7843, DOI 10.1073/pnas.93.15.7843; Bates RC, 2005, J CLIN INVEST, V115, P339, DOI 10.1172/JCI200523183; BREUSS JM, 1995, J CELL SCI, V108, P2241; BUSK M, 1992, J BIOL CHEM, V267, P5790; Cambier S, 2005, AM J PATHOL, V166, P1883, DOI 10.1016/S0002-9440(10)62497-2; Cambier S, 2000, CANCER RES, V60, P7084; Culhane AC, 2009, CANCER RES, V69, P7480, DOI 10.1158/0008-5472.CAN-08-3350; DeRose YS, 2011, NAT MED, V17, P1514, DOI 10.1038/nm.2454; DiCara D, 2007, J BIOL CHEM, V282, P9657, DOI 10.1074/jbc.M610461200; Elayadi AN, 2007, CANCER RES, V67, P5889, DOI 10.1158/0008-5472.CAN-07-0245; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Fleming YM, 2009, ONCOGENE, V28, P983, DOI 10.1038/onc.2008.449; Hahm K, 2007, AM J PATHOL, V170, P110, DOI 10.2353/ajpath.2007.060158; Hannigan A, 2010, J CLIN INVEST, V120, P2842, DOI 10.1172/JCI36125; Hedenfalk I, 2001, NEW ENGL J MED, V344, P539, DOI 10.1056/NEJM200102223440801; Horan GS, 2008, AM J RESP CRIT CARE, V177, P56, DOI 10.1164/rccm.200706-805OC; Jenkins RG, 2006, J CLIN INVEST, V116, P1606, DOI 10.1172/JCI27183; Kogelberg H, 2008, J MOL BIOL, V382, P385, DOI 10.1016/j.jmb.2008.07.013; Ludbrook SB, 2003, BIOCHEM J, V369, P311, DOI 10.1042/BJ20020809; Ma LJ, 2003, AM J PATHOL, V163, P1261, DOI 10.1016/S0002-9440(10)63486-4; Marsh D, 2008, CANCER RES, V68, P3295, DOI 10.1158/0008-5472.CAN-08-0174; Mateu MG, 1996, J BIOL CHEM, V271, P12814, DOI 10.1074/jbc.271.22.12814; Morgan MR, 2011, ONCOGENE, V30, P1422, DOI 10.1038/onc.2010.535; Morgan MR, 2004, J BIOL CHEM, V279, P26533, DOI 10.1074/jbc.M401736200; Mu DZ, 2002, J CELL BIOL, V157, P493, DOI 10.1083/jcb.200109100; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Popov Y, 2008, J HEPATOL, V48, P453, DOI 10.1016/j.jhep.2007.11.021; Puthawala K, 2008, AM J RESP CRIT CARE, V177, P82, DOI 10.1164/rccm.200706-806OC; Ramsay AG, 2007, CANCER RES, V67, P5275, DOI 10.1158/0008-5472.CAN-07-0318; Regezi JA, 2002, ORAL ONCOL, V38, P332, DOI 10.1016/S1368-8375(01)00062-8; RONNOVJESSEN L, 1993, LAB INVEST, V68, P696; Ryer EJ, 2006, ARTERIOSCL THROM VAS, V26, P780, DOI 10.1161/01.ATV.0000209517.00220.cd; SHEPPARD D, 1990, J BIOL CHEM, V265, P11502; Sipos B, 2004, HISTOPATHOLOGY, V45, P226, DOI 10.1111/j.1365-2559.2004.01919.x; Su H, 2010, AM J PATHOL, V176, P1018, DOI 10.2353/ajpath.2010.090453; Thomas GJ, 2002, BRIT J CANCER, V87, P859, DOI 10.1038/sj.bjc.6600545; Thomas GJ, 2001, INT J CANCER, V92, P641, DOI 10.1002/1097-0215(20010601)92:5<641::AID-IJC1243>3.0.CO;2-P; Thomas GJ, 2001, J INVEST DERMATOL, V117, P67, DOI 10.1046/j.0022-202x.2001.01379.x; Van Aarsen LAK, 2008, CANCER RES, V68, P561, DOI 10.1158/0008-5472.CAN-07-2307; Yokosaki Y, 1996, J BIOL CHEM, V271, P24144, DOI 10.1074/jbc.271.39.24144; Zhong ZJ, 2010, CLIN CANCER RES, V16, P1191, DOI 10.1158/1078-0432.CCR-09-1634	49	59	64	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP 12	2013	32	37					4406	4416		10.1038/onc.2012.460	http://dx.doi.org/10.1038/onc.2012.460			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	218AF	23108397				2022-12-25	WOS:000324404200009
J	Furuya, H; Wada, M; Shimizu, Y; Yamada, PM; Hannun, YA; Obeid, LM; Kawamori, T				Furuya, Hideki; Wada, Masayuki; Shimizu, Yoshiko; Yamada, Paulette M.; Hannun, Yusuf A.; Obeid, Lina M.; Kawamori, Toshihiko			Effect of sphingosine kinase 1 inhibition on blood pressure	FASEB JOURNAL			English	Article						sphingolipids; cardiovascular functions; chemoprevention; prostacyclin; COX-2; mPGES-1	PROSTAGLANDIN-E SYNTHASE-1; SIGNAL-REGULATED KINASE; II-INDUCED HYPERTENSION; CYCLOOXYGENASE-2 INHIBITOR; OXIDATIVE STRESS; E-2 PROTECTS; 1-PHOSPHATE; DELETION; RECEPTORS; CELECOXIB	Accumulating evidence suggests that sphingosine kinase 1 (SphK1) plays a key role in carcinogenesis by regulating cyclooxygenase-2 (COX-2) expression. Recent clinical studies have revealed that COX-2 inhibitors cause adverse cardiovascular side effects, likely due to inhibition of prostacyclin (PGI(2)). In this work, we investigated the roles of SphK1 inhibition on blood pressure (BP). The results show that lack of SphK1 expression did not exacerbate angiotensin II (Ang II)-induced acute hypertension, whereas celecoxib, a COX-2 inhibitor, augmented and sustained higher BP in mice. Interestingly, SphK1-knockout mice inhibited prostaglandin E-2 (PGE(2)) but not PGI(2) production in response to Ang II, whereas celecoxib blocked both PGE(2) and PGI(2) production. Mechanistically, SphK1 down-regulation by siRNA in human umbilical vein endothelial cells decreased cytokine-induced PGE(2) production primarily through inhibition of microsomal PGE synthase-1 (mPGES-1), not COX-2. SphK1 downregulation also decreased MKK6 expression, which phosphorylates and activates P38 MAPK, which, in turn, regulates early growth response-1 (Egr-1), a transcription factor of mPGES-1. Together, these data indicate that SphK1 regulates PGE(2) production by mPGES-1 expression via the p38 MAPK pathway, independent of COX-2 signaling, in endothelial cells, suggesting that SphK1 inhibition may be a promising strategy for cancer chemoprevention with lack of the adverse cardiovascular side effects associated with coxibs.-Furuya, H., Wada, M., Shimizu, Y., Yamada, P. M., Hannun, Y. A., Obeid, L. M., Kawamori, T. Effect of sphingosine kinase 1 inhibition on blood pressure. FASEB J. 27, 656-664 (2013). www.fasebj.org	[Furuya, Hideki; Shimizu, Yoshiko; Yamada, Paulette M.; Kawamori, Toshihiko] Univ Hawaii, Ctr Canc, Honolulu, HI 96813 USA; [Furuya, Hideki; Wada, Masayuki; Kawamori, Toshihiko] Med Univ S Carolina, Dept Pathol & Lab Med, Charleston, SC 29425 USA; [Hannun, Yusuf A.; Obeid, Lina M.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Shimizu, Yoshiko; Kawamori, Toshihiko] Univ Hawaii Manoa, Dept Mol Biosci & Bioengn, Honolulu, HI 96822 USA; [Obeid, Lina M.] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC USA	Cancer Research Center of Hawaii; University of Hawaii System; Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina; University of Hawaii System; University of Hawaii Manoa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center	Kawamori, T (corresponding author), Univ Hawaii, Ctr Canc, 651 Ilalo St,BSB 222H, Honolulu, HI 96813 USA.	kawamori@cc.hawaii.edu	Furuya, Hideki/AAH-5719-2021	Furuya, Hideki/0000-0002-9536-8662; obeid, lina/0000-0002-0734-0847	U.S. National Institutes of Health (NIH) [R01CA124687, P20RR17677, P01CA97132]; Hollings Cancer Center, MUSC; NIH Extramural Research Facilities Program of the National Center for Research Resources [C06RR015455]; NATIONAL CANCER INSTITUTE [P01CA097132, R01CA124687] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677, C06RR015455] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hollings Cancer Center, MUSC; NIH Extramural Research Facilities Program of the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors thank the Lipidomics Core Facility and Animal Carcinogenesis Core, Hollings Cancer Center, Medical University of South Carolina (MUSC), and Animal Carcinogenesis Shared Resource, University of Hawaii Cancer Center. This work was supported by U.S. National Institutes of Health (NIH) grants (R01CA124687 and P20RR17677 to T. K., P01CA97132 to T. K., Y.A.H., and L.M.O.) and a seed grant to T. K. from the Hollings Cancer Center, MUSC. This work was conducted in a facility constructed with support from the NIH Extramural Research Facilities Program of the National Center for Research Resources (C06RR015455).	Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Ancellin N, 2002, J BIOL CHEM, V277, P6667, DOI 10.1074/jbc.M102841200; Billich A, 2005, CELL SIGNAL, V17, P1203, DOI 10.1016/j.cellsig.2004.12.005; Bresalier RS, 2005, NEW ENGL J MED, V352, P1092, DOI 10.1056/NEJMoa050493; Catella-Lawson F, 1999, J PHARMACOL EXP THER, V289, P735; Cheng Y, 2006, J CLIN INVEST, V116, P1391, DOI 10.1172/JCI27540; Cipollone F, 2008, PHARMACOL THERAPEUT, V118, P161, DOI 10.1016/j.pharmthera.2008.01.002; DIZ DI, 1983, J CLIN INVEST, V72, P466, DOI 10.1172/JCI110994; Dong QG, 1997, ARTERIOSCL THROM VAS, V17, P1599, DOI 10.1161/01.ATV.17.8.1599; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Facemire CS, 2010, HYPERTENSION, V55, P531, DOI 10.1161/HYPERTENSIONAHA.109.145631; FitzGerald G, 2003, NAT REV DRUG DISCOV, V2, P879, DOI 10.1038/nrd1225; FitzGerald GA, 2004, NEW ENGL J MED, V351, P1709, DOI 10.1056/NEJMp048288; Francois H, 2007, J AM SOC NEPHROL, V18, P1466, DOI 10.1681/ASN.2006040343; Hansen-Petrik MB, 2002, CANCER RES, V62, P403; Hemmings DG, 2006, N-S ARCH PHARMACOL, V373, P18, DOI 10.1007/s00210-006-0046-5; JACKSON EK, 1993, HYPERTENSION, V22, P688, DOI 10.1161/01.HYP.22.5.688; Jia ZJ, 2008, HYPERTENSION, V52, P952, DOI 10.1161/HYPERTENSIONAHA.108.111229; Jia ZJ, 2006, CIRC RES, V99, P1243, DOI 10.1161/01.RES.0000251306.40546.08; Jia ZJ, 2010, AM J PHYSIOL-RENAL, V299, pF155, DOI 10.1152/ajprenal.90702.2008; Jia ZJ, 2010, HYPERTENSION, V55, P539, DOI 10.1161/HYPERTENSIONAHA.109.144840; Kaneshiro T, 2009, PROSTAG OTH LIPID M, V90, P31, DOI 10.1016/j.prostaglandins.2009.07.003; Kawamori T, 2003, CARCINOGENESIS, V24, P985, DOI 10.1093/carcin/bgg033; Kawamori T, 1998, CANCER RES, V58, P409; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Kawamori T, 2009, FASEB J, V23, P405, DOI 10.1096/fj.08-117572; Lee OH, 1999, BIOCHEM BIOPH RES CO, V264, P743, DOI 10.1006/bbrc.1999.1586; Levkau B, 2008, CIRC RES, V103, P231, DOI 10.1161/CIRCRESAHA.108.181610; Liu H, 2002, PROG NUCLEIC ACID RE, V71, P493, DOI 10.1016/S0079-6603(02)71049-0; McAdam BF, 1999, P NATL ACAD SCI USA, V96, P272, DOI 10.1073/pnas.96.1.272; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; MURATA S, 1995, STROKE, V26, P650, DOI 10.1161/01.STR.26.4.650; Nakatsugi S, 1997, JPN J CANCER RES, V88, P1117, DOI 10.1111/j.1349-7006.1997.tb00337.x; Naraba H, 2002, J BIOL CHEM, V277, P28601, DOI 10.1074/jbc.M203618200; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Pettus BJ, 2003, FASEB J, V17, P1411, DOI 10.1096/fj.02-1038com; Pettus BJ, 2005, MOL PHARMACOL, V68, P330, DOI 10.1124/mol.104.008722; Qi ZH, 2002, J CLIN INVEST, V110, P61, DOI 10.1172/JCI200214752; Qi ZH, 2006, HYPERTENSION, V48, P323, DOI 10.1161/01.HYP.0000231934.67549.b7; Rani CSS, 1997, J BIOL CHEM, V272, P10777; Sato K, 1999, MOL PHARMACOL, V55, P126, DOI 10.1124/mol.55.1.126; Sato K, 1999, MOL BRAIN RES, V74, P182, DOI 10.1016/S0169-328X(99)00279-X; Shirai K, 2011, CANCER PREV RES, V4, P454, DOI 10.1158/1940-6207.CAPR-10-0299; Shoji Y, 2004, GUT, V53, P1151, DOI 10.1136/gut.2003.028787; Siragy HM, 1999, J CLIN INVEST, V104, P181, DOI 10.1172/JCI6063; Solomon SD, 2005, NEW ENGL J MED, V352, P1071, DOI 10.1056/NEJMoa050405; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; Tsutsumi Y, 1999, J CLIN INVEST, V104, P925, DOI 10.1172/JCI7886; Vascular Research Division Department of Pathology Brigham and Women's Hospital, 2004, IS MOUS LUNG END CEL; Wang M, 2008, CIRCULATION, V117, P1302, DOI 10.1161/CIRCULATIONAHA.107.731398; Wang M, 2006, P NATL ACAD SCI USA, V103, P14507, DOI 10.1073/pnas.0606586103; WU J, 1995, J BIOL CHEM, V270, P11484, DOI 10.1074/jbc.270.19.11484	52	15	15	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					656	664		10.1096/fj.12-219014	http://dx.doi.org/10.1096/fj.12-219014			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23109673	Green Published			2022-12-25	WOS:000314358000024
J	Hochrainer, K; Racchumi, G; Anrather, J				Hochrainer, Karin; Racchumi, Gianfranco; Anrather, Josef			Site-specific Phosphorylation of the p65 Protein Subunit Mediates Selective Gene Expression by Differential NF-kappa B and RNA Polymerase II Promoter Recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR-ALPHA; TRANSCRIPTION FACTOR; PROINFLAMMATORY CYTOKINES; ENDOTHELIAL-CELLS; RESPONSE ELEMENT; IKK-EPSILON; ACTIVATION; KINASE; PROTEOLYSIS; SEQUENCE	Phosphorylation of NF-kappa B plays an important role in modulating transcriptional activity of NF-kappa B independently of inhibitor of kappa B (I kappa B) proteins. For the p65 subunit, multiple phosphorylation sites have been mapped in and adjacent to both the N-terminal Rel homology domain and the C-terminal transactivation domain. Their impact on NF-kappa B-dependent transcription, however, has never been assessed at a broader level. In this study, we evaluate the importance of differential p65 phosphorylation on four serine acceptor sites in the Rel homology domain for the expression of an array of NF-kappa B-dependent genes in endothelial cells. We find that inhibition of p65 phosphorylation on these serine residues targets NF-kappa B activity to distinctive gene subsets in a kappa B enhancer element-specific context. We show that the phosphorylation-dependent alterations in gene and protein expression are reflective of the amount of p65 and phosphorylated RNA polymerase II (p-RNAP II) bound to respective gene promoter regions. Depending on the gene subset, impaired gene expression was either a result of decreased p65 promoter recruitment or of a failure of bound p65 to recruit p-RNAP II. In conclusion, our findings demonstrate that site-specific p65 phosphorylation targets NF-kappa B activity to particular gene subsets on a global level by influencing p65 and p-RNAP II promoter recruitment.	[Hochrainer, Karin; Racchumi, Gianfranco; Anrather, Josef] Weill Cornell Med Coll, Dept Neurol & Neurosci, Div Neurobiol, New York, NY 10065 USA	Cornell University	Anrather, J (corresponding author), Weill Cornell Med Coll, Dept Neurol & Neurosci, Div Neurobiol, 407 E 61st St,RR 409, New York, NY 10065 USA.	joa2006@med.cornell.edu	Hochrainer, Karin/AAN-6145-2020	Hochrainer, Karin/0000-0001-5147-0633	National Institutes of Health [HL077308]; American Heart Association [10SDG2600298]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077308] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL077308 (to J. A.). This work was also supported by American Heart Association Scientist Development Grant 10SDG2600298 (to K.H.).	Anrather J, 2006, J BIOL CHEM, V281, P5657, DOI 10.1074/jbc.M506172200; Anrather J, 1999, J BIOL CHEM, V274, P13594, DOI 10.1074/jbc.274.19.13594; Anrather J, 2005, J BIOL CHEM, V280, P244, DOI 10.1074/jbc.M409344200; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BALDWIN AS, 1988, P NATL ACAD SCI USA, V85, P723, DOI 10.1073/pnas.85.3.723; Barkett M, 1999, ONCOGENE, V18, P6910, DOI 10.1038/sj.onc.1203238; BEG AA, 1995, NATURE, V376, P167, DOI 10.1038/376167a0; Bohuslav J, 2004, J BIOL CHEM, V279, P26115, DOI 10.1074/jbc.M313509200; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Buss H, 2004, J BIOL CHEM, V279, P49571, DOI 10.1074/jbc.C400442200; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dong J, 2008, GENE DEV, V22, P1159, DOI 10.1101/gad.1657408; Drier EA, 1999, GENE DEV, V13, P556, DOI 10.1101/gad.13.5.556; Duran A, 2003, EMBO J, V22, P3910, DOI 10.1093/emboj/cdg370; Geng H, 2009, EMBO REP, V10, P381, DOI 10.1038/embor.2009.10; Ghosh CC, 2010, J IMMUNOL, V185, P3685, DOI 10.4049/jimmunol.0902230; Harant H, 2001, FEBS LETT, V509, P439, DOI 10.1016/S0014-5793(01)03138-6; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; HENKEL T, 1993, NATURE, V365, P182, DOI 10.1038/365182a0; Hochrainer K, 2007, FEBS LETT, V581, P5493, DOI 10.1016/j.febslet.2007.10.056; Hochrainer K, 2012, CELL MOL LIFE SCI, V69, P2057, DOI 10.1007/s00018-011-0912-2; Huang B, 2010, CELL SIGNAL, V22, P1282, DOI 10.1016/j.cellsig.2010.03.017; IADEMARCO MF, 1992, J BIOL CHEM, V267, P16323; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; KUNSCH C, 1992, MOL CELL BIOL, V12, P4412, DOI 10.1128/MCB.12.10.4412; Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007; Moreno R, 2010, NUCLEIC ACIDS RES, V38, P6029, DOI 10.1093/nar/gkq439; NAUMANN M, 1994, EMBO J, V13, P4597, DOI 10.1002/j.1460-2075.1994.tb06781.x; Nowak DE, 2008, MOL CELL BIOL, V28, P3623, DOI 10.1128/MCB.01152-07; O'Shea JM, 2010, BIOCHEM J, V426, P345, DOI 10.1042/BJ20091630; OBRIEN T, 1994, NATURE, V370, P75, DOI 10.1038/370075a0; OHMORI Y, 1993, J BIOL CHEM, V268, P6677; Pan JL, 1998, J BIOL CHEM, V273, P10068, DOI 10.1074/jbc.273.16.10068; Rocha S, 2005, EMBO J, V24, P1157, DOI 10.1038/sj.emboj.7600608; Ryo A, 2003, MOL CELL, V12, P1413, DOI 10.1016/S1097-2765(03)00490-8; Sabatel H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038246; SCHMITZ ML, 1991, EMBO J, V10, P3805, DOI 10.1002/j.1460-2075.1991.tb04950.x; Spencer E, 1999, GENE DEV, V13, P284, DOI 10.1101/gad.13.3.284; Steinbrecher KA, 2005, MOL CELL BIOL, V25, P8444, DOI 10.1128/MCB.25.19.8444-8455.2005; Tanaka Y, 1996, J VIROL, V70, P8508, DOI 10.1128/JVI.70.12.8508-8517.1996; Tian B, 2005, J BIOL CHEM, V280, P17435, DOI 10.1074/jbc.M500437200; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; Vermeulen L, 2003, EMBO J, V22, P1313, DOI 10.1093/emboj/cdg139; Wang D, 2000, J BIOL CHEM, V275, P32592, DOI 10.1074/jbc.M001358200; WIDMER U, 1993, J IMMUNOL, V150, P4996; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	46	54	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 4	2013	288	1					285	293		10.1074/jbc.M112.385625	http://dx.doi.org/10.1074/jbc.M112.385625			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	066CJ	23100252	Green Published, hybrid			2022-12-25	WOS:000313197200028
J	Yang, ZZ; Vild, C; Ju, JY; Zhang, X; Liu, JP; Shen, J; Zhao, B; Lan, WX; Gong, FC; Liu, ML; Cao, CY; Xu, ZH				Yang, Zhongzheng; Vild, Cody; Ju, Jiaying; Zhang, Xu; Liu, Jianping; Shen, Jie; Zhao, Bin; Lan, Wenxian; Gong, Fuchun; Liu, Maili; Cao, Chunyang; Xu, Zhaohui			Structural Basis of Molecular Recognition between ESCRT-III-like Protein Vps60 and AAA-ATPase Regulator Vta1 in the Multivesicular Body Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE ASSOCIATION; CHEMICAL-SHIFT; MACHINERY; NMR; BIOGENESIS; COMPLEXES; VPS4P; CYTOKINESIS; BODIES; SYSTEM	The AAA-ATPase Vps4 is critical for function of the multivesicular body sorting pathway, which impacts cellular phenomena ranging from receptor down-regulation to viral budding to cytokinesis. Vps4 activity is stimulated by the interaction between Vta1 and Vps60, but the structural basis for this interaction is unclear. The fragment Vps60(128-186) was reported to display the full activity of Vps60. Vta1 interacts with Vps60 using its N-terminal domain (Vta1NTD). In this work, the structure of Vps60(128-186) in complex with Vta1NTD was determined using NMR techniques, demonstrating a novel recognition mode of the microtubule-interacting and transport (MIT) domain in which Vps60(128-186) interacts with Vta1NTD through helices alpha 4' and alpha 5', extending over Vta1NTD MIT2 domain helices 1-3. The Vps60 binding does not result in Vta1 conformational changes, further revealing the fact that Vps4 ATPase is enhanced by the interaction between Vta1 and Vps60 in an unanticipated manner.	[Yang, Zhongzheng; Ju, Jiaying; Liu, Jianping; Shen, Jie; Zhao, Bin; Lan, Wenxian; Cao, Chunyang] Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, Shanghai 200032, Peoples R China; [Vild, Cody; Xu, Zhaohui] Univ Michigan, Sch Med, Inst Life Sci, Ann Arbor, MI 48109 USA; [Vild, Cody; Xu, Zhaohui] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Zhang, Xu; Liu, Maili] Chinese Acad Sci, Wuhan Inst Phys & Math, State Key Lab Magnet Resonance & Atom & Mol Phys, Wuhan 430071, Peoples R China; [Liu, Jianping; Gong, Fuchun] Changsha Univ Sci & Technol, Inst Chem & Biochem Engn, Changsha 410076, Hunan, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Organic Chemistry, CAS; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Chinese Academy of Sciences; Wuhan Institute of Physics & Mathematics, CAS; Changsha University of Science & Technology	Cao, CY (corresponding author), Chinese Acad Sci, Shanghai Inst Organ Chem, State Key Lab Bioorgan & Nat Prod Chem, 345 Lingling Rd, Shanghai 200032, Peoples R China.	ccao@mail.sioc.ac.cn; zhaohui@umich.edu	Liu, Maili/A-8543-2011; Zhang, Xu/B-4753-2015	Liu, Maili/0000-0002-9359-915X; 	National Basic Research Program of China [2009CB918600, 2011CB966300]; National Science Foundation of China [30970595, 20921091]; International Cooperation Foundation from the Science and Technology Commission of Shanghai Municipality [09540703800]; Ministry of Health of China [2011ZX09506]; State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, Wuhan Center for Magnetic Resonance, Wuhan Institute of Physics and Mathematics, Chinese Academy of Sciences [T151102]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095769] Funding Source: NIH RePORTER	National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation Foundation from the Science and Technology Commission of Shanghai Municipality; Ministry of Health of China; State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, Wuhan Center for Magnetic Resonance, Wuhan Institute of Physics and Mathematics, Chinese Academy of Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Basic Research Program of China Grants 2009CB918600 and 2011CB966300, National Science Foundation of China Grants 30970595 and 20921091, International Cooperation Foundation Grant 09540703800 from the Science and Technology Commission of Shanghai Municipality, National New Drug Design Program Grant 2011ZX09506 from the Ministry of Health of China, and Grant T151102 from the State Key Laboratory of Magnetic Resonance and Atomic and Molecular Physics, Wuhan Center for Magnetic Resonance, Wuhan Institute of Physics and Mathematics, Chinese Academy of Sciences.	Azmi I, 2006, J CELL BIOL, V172, P705, DOI 10.1083/jcb.200508166; Azmi IF, 2008, DEV CELL, V14, P50, DOI 10.1016/j.devcel.2007.10.021; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Babst M, 2005, TRAFFIC, V6, P2, DOI 10.1111/j.1600-0854.2004.00246.x; Babst M, 2011, TRAFFIC, V12, P1298, DOI 10.1111/j.1600-0854.2011.01230.x; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bieniasz PD, 2009, CELL HOST MICROBE, V5, P550, DOI 10.1016/j.chom.2009.05.015; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dimaano C, 2008, MOL BIOL CELL, V19, P465, DOI 10.1091/mbc.E07-08-0747; Fujii K, 2007, NAT REV MICROBIOL, V5, P912, DOI 10.1038/nrmicro1790; Goddard T. D., 2001, SPARKY 3; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Hurley JH, 2008, CURR OPIN CELL BIOL, V20, P4, DOI 10.1016/j.ceb.2007.12.002; Hurley JH, 2008, DEV CELL, V14, P6, DOI 10.1016/j.devcel.2007.12.013; Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kieffer CC, 2008, PSYCHOANAL INQ, V28, P1, DOI 10.1080/07351690701787077; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lottridge JM, 2006, P NATL ACAD SCI USA, V103, P6202, DOI 10.1073/pnas.0601712103; Morita E, 2004, ANNU REV CELL DEV BI, V20, P395, DOI 10.1146/annurev.cellbio.20.010403.102350; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Saksena S, 2009, BIOCHEM SOC T, V37, P167, DOI 10.1042/BST0370167; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Shestakova A, 2010, MOL BIOL CELL, V21, P1059, DOI 10.1091/mbc.E09-07-0572; Shim S, 2008, MOL BIOL CELL, V19, P2661, DOI 10.1091/mbc.E07-12-1263; Solomons J, 2011, STRUCTURE, V19, P1149, DOI 10.1016/j.str.2011.05.011; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Wang CK, 2011, CELL RES, V21, P1379, DOI 10.1038/cr.2011.123; Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162; Winter V, 2006, TRENDS PLANT SCI, V11, P115, DOI 10.1016/j.tplants.2006.01.008; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Xiao JY, 2008, DEV CELL, V14, P37, DOI 10.1016/j.devcel.2007.10.013; Xiao JY, 2007, J MOL BIOL, V374, P655, DOI 10.1016/j.jmb.2007.09.067; YAMAZAKI T, 1993, J AM CHEM SOC, V115, P11054, DOI 10.1021/ja00076a099; Yang D, 2010, STRUCTURE, V18, P976, DOI 10.1016/j.str.2010.04.014; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512; Yu ZH, 2008, J MOL BIOL, V377, P364, DOI 10.1016/j.jmb.2008.01.009	45	32	32	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43899	43908		10.1074/jbc.M112.390724	http://dx.doi.org/10.1074/jbc.M112.390724			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23105107	Green Published, hybrid			2022-12-25	WOS:000312940800066
J	Molnar, E; Swamy, M; Holzer, M; Beck-Garcia, K; Worch, R; Thiele, C; Guigas, G; Boye, K; Luescher, IF; Schwille, P; Schubert, R; Schamel, WWA				Molnar, Eszter; Swamy, Mahima; Holzer, Martin; Beck-Garcia, Katharina; Worch, Remigiusz; Thiele, Christoph; Guigas, Gernot; Boye, Kristian; Luescher, Immanuel F.; Schwille, Petra; Schubert, Rolf; Schamel, Wolfgang W. A.			Cholesterol and Sphingomyelin Drive Ligand-independent T-cell Antigen Receptor Nanoclustering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE MICRODOMAINS; MULTIVALENT STRUCTURE; CRYSTAL-STRUCTURE; PROTEINS; BINDING; STOICHIOMETRY; ACTIVATION; RAFTS; ORGANIZATION; RECOGNITION	The T-cell antigen receptor (TCR) exists in monomeric and nanoclustered forms independently of antigen binding. Although the clustering is involved in the regulation of T-cell sensitivity, it is unknown how the TCR nanoclusters form. We show that cholesterol is required for TCR nanoclustering in T cells and that this clustering enhances the avidity but not the affinity of the TCR-antigen interaction. Investigating the mechanism of the nanoclustering, we found that radioactive photocholesterol specifically binds to the TCR beta chain in vivo. In order to reduce the complexity of cellular membranes, we used a synthetic biology approach and reconstituted the TCR in liposomes of defined lipid composition. Both cholesterol and sphingomyelin were required for the formation of TCR dimers in phosphatidylcholine-containing large unilamellar vesicles. Further, the TCR was localized in the liquid disordered phase in giant unilamellar vesicles. We propose a model in which cholesterol and sphingomyelin binding to the TCR beta chain causes TCR dimerization. The lipid-induced TCR nanoclustering enhances the avidity to antigen and thus might be involved in enhanced sensitivity of memory compared with naive T cells. Our work contributes to the understanding of the function of specific non-annular lipid-membrane protein interactions.	[Molnar, Eszter; Swamy, Mahima; Beck-Garcia, Katharina; Schamel, Wolfgang W. A.] Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany; [Molnar, Eszter; Swamy, Mahima; Holzer, Martin; Beck-Garcia, Katharina; Schubert, Rolf; Schamel, Wolfgang W. A.] Univ Freiburg, Ctr Biol Signaling Studies BIOSS, D-79104 Freiburg, Germany; [Molnar, Eszter; Beck-Garcia, Katharina; Schamel, Wolfgang W. A.] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Holzer, Martin; Schubert, Rolf] Univ Freiburg, Dept Pharmaceut Technol & Biopharm, Inst Pharmaceut Sci, D-79104 Freiburg, Germany; [Beck-Garcia, Katharina] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79104 Freiburg, Germany; [Worch, Remigiusz; Schwille, Petra] Tech Univ Dresden, Ctr Biotechnol, D-01307 Dresden, Germany; [Thiele, Christoph] Life & Med Sci Inst LIMES, D-53115 Bonn, Germany; [Guigas, Gernot] Univ Bayreuth, D-95447 Bayreuth, Germany; [Boye, Kristian] German Canc Res Ctr, Cellular Biophys Grp, D-69120 Heidelberg, Germany; [Luescher, Immanuel F.] Ludwig Inst Canc Res, Lausanne Branch, CH-1066 Epalinges, Switzerland; [Schamel, Wolfgang W. A.] Univ Clin, CCI, D-79106 Freiburg, Germany	Max Planck Society; University of Freiburg; University of Freiburg; University of Freiburg; University of Freiburg; Technische Universitat Dresden; University of Bonn; University of Bayreuth; Helmholtz Association; German Cancer Research Center (DKFZ); Ludwig Institute for Cancer Research; University of Freiburg	Schamel, WWA (corresponding author), Max Planck Inst Immunobiol & Epigenet, D-79108 Freiburg, Germany.	wolfgang.schamel@biologie.uni-freiburg.de	Swamy, Mahima/J-7046-2019; Schwille, Petra/A-4983-2010	Swamy, Mahima/0000-0003-3977-3425; Boye, Kristian/0000-0002-7135-9577; Worch, Remigiusz/0000-0002-3222-4821; Holzer, Martin/0000-0002-2602-8293	Deutsche Forschungsgemeinschaft [EXC294, SFB620, SCHA 976/2-1]; European Union	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grants EXC294, SFB620, and SCHA 976/2-1 and by the European Union through Grant FP7/2007-2013 (SYBILLA).	Alarcon B, 2006, EMBO REP, V7, P490, DOI 10.1038/sj.embor.7400682; Bjorkbom A, 2011, BBA-BIOMEMBRANES, V1808, P1179, DOI 10.1016/j.bbamem.2011.01.009; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Charrin S, 2003, EUR J IMMUNOL, V33, P2479, DOI 10.1002/eji.200323884; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Contreras FX, 2012, NATURE, V481, P525, DOI 10.1038/nature10742; Contreras FX, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004705; Coskun U, 2011, P NATL ACAD SCI USA, V108, P9044, DOI 10.1073/pnas.1105666108; Davis MM, 1998, ANNU REV IMMUNOL, V16, P523, DOI 10.1146/annurev.immunol.16.1.523; DEMEL RA, 1977, BIOCHIM BIOPHYS ACTA, V465, P1, DOI 10.1016/0005-2736(77)90350-9; Drake DR, 2001, J IMMUNOL, V166, P7009, DOI 10.4049/jimmunol.166.12.7009; Dubey C, 1996, J IMMUNOL, V157, P3280; Essen LO, 1998, P NATL ACAD SCI USA, V95, P11673, DOI 10.1073/pnas.95.20.11673; EXLEY M, 1995, MOL IMMUNOL, V32, P829, DOI 10.1016/0161-5890(95)00046-H; Fahmy TM, 2001, IMMUNITY, V14, P135, DOI 10.1016/S1074-7613(09)00099-5; Fernandez-Miguel G, 1999, P NATL ACAD SCI USA, V96, P1547, DOI 10.1073/pnas.96.4.1547; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; Horejsi V, 2003, IMMUNOL REV, V191, P148, DOI 10.1034/j.1600-065X.2003.00001.x; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huber TB, 2006, P NATL ACAD SCI USA, V103, P17079, DOI 10.1073/pnas.0607465103; Hunte C, 2005, BIOCHEM SOC T, V33, P938, DOI 10.1042/BST0330938; James JR, 2007, P NATL ACAD SCI USA, V104, P17662, DOI 10.1073/pnas.0700411104; James JR, 2011, J BIOL CHEM, V286, P31993, DOI 10.1074/jbc.M111.219212; Kaech SM, 2002, CELL, V111, P837, DOI 10.1016/S0092-8674(02)01139-X; Keefe AD, 2001, PROTEIN EXPRES PURIF, V23, P440, DOI 10.1006/prep.2001.1515; Kumar R, 2011, IMMUNITY, V35, P375, DOI 10.1016/j.immuni.2011.08.010; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; LUESCHER IF, 1995, NATURE, V373, P353, DOI 10.1038/373353a0; Malissen B, 2003, IMMUNOL REV, V191, P7, DOI 10.1034/j.1600-065X.2003.00016.x; Minguet S, 2007, IMMUNITY, V26, P43, DOI 10.1016/j.immuni.2006.10.019; Montixi C, 1998, EMBO J, V17, P5334, DOI 10.1093/emboj/17.18.5334; Rouquette-Jazdanian AK, 2006, CELL SIGNAL, V18, P105, DOI 10.1016/j.cellsig.2005.03.024; Ruprecht JJ, 2004, EMBO J, V23, P3609, DOI 10.1038/sj.emboj.7600374; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Sezgin E, 2012, BBA-BIOMEMBRANES, V1818, P1777, DOI 10.1016/j.bbamem.2012.03.007; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Sieber JJ, 2007, SCIENCE, V317, P1072, DOI 10.1126/science.1141727; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Swamy M., 2006, SCI STKE, V2006, pl4, DOI DOI 10.1126/STKE.3452006PL4.PMID:16868305; Swamy M, 2007, J IMMUNOL METHODS, V324, P74, DOI 10.1016/j.jim.2007.05.003; Swamy M, 2010, CELL COMMUN SIGNAL, V8, DOI 10.1186/1478-811X-8-5; Thiele C, 2000, NAT CELL BIOL, V2, P42, DOI 10.1038/71366; Torchilin V., 2003, LIPOSOMES PRACTICAL; Veiga MP, 2001, BIOCHEMISTRY-US, V40, P2614, DOI 10.1021/bi0019803; Yang JY, 2010, NATURE, V467, P465, DOI 10.1038/nature09357; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	50	99	100	3	37	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42664	42674		10.1074/jbc.M112.386045	http://dx.doi.org/10.1074/jbc.M112.386045			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23091059	Green Published, hybrid			2022-12-25	WOS:000312501600027
J	Ungaro, P; Mirra, P; Oriente, F; Nigro, C; Ciccarelli, M; Vastolo, V; Longo, M; Perruolo, G; Spinelli, R; Formisano, P; Miele, C; Beguinot, F				Ungaro, Paola; Mirra, Paola; Oriente, Francesco; Nigro, Cecilia; Ciccarelli, Marco; Vastolo, Viviana; Longo, Michele; Perruolo, Giuseppe; Spinelli, Rosa; Formisano, Pietro; Miele, Claudia; Beguinot, Francesco			Peroxisome Proliferator-activated Receptor-gamma Activation Enhances Insulin-stimulated Glucose Disposal by Reducing ped/pea-15 Gene Expression in Skeletal Muscle Cells EVIDENCE FOR INVOLVEMENT OF ACTIVATOR PROTEIN-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; PPAR-GAMMA; RESISTANCE; METABOLISM; MECHANISMS; DISEASE; ACID; FAT; DIFFERENTIATION; TROGLITAZONE	The gene network responsible for inflammation-induced insulin resistance remains enigmatic. In this study, we show that, in L6 cells, rosiglitazone-as well as pioglitazone-dependent activation of peroxisome proliferator-activated receptor-gamma (PPAR gamma) represses transcription of the ped/pea-15 gene, whose increased activity impairs glucose tolerance in mice and humans. Rosiglitazone enhanced insulin-induced glucose uptake in L6 cells expressing the endogenous ped/pea-15 gene but not in cells expressing ped/pea-15 under the control of an exogenous promoter. The ability of PPAR gamma to affect ped/pea-15 expression was also lost in cells and in C57BL/6J transgenic mice expressing ped/pea-15 under the control of an exogenous promoter, suggesting that ped/pea-15 repression may contribute to rosiglitazone action on glucose disposal. Indeed, high fat diet mice showed insulin resistance and increased ped/pea-15 levels, although these effects were reduced by rosiglitazone treatment. Both supershift and ChIP assays revealed the presence of the AP-1 component c-JUN at the PED/PEA-15 promoter upon 12-O-tetradecanoylphorbol-13-acetate stimulation of the cells. In these experiments, rosiglitazone treatment reduced c-JUN presence at the PED/PEA-15 promoter. This effect was not associated with a decrease in c-JUN expression. In addition, c-jun silencing in L6 cells lowered ped/pea-15 expression and caused nonresponsiveness to rosiglitazone, although c-jun overexpression enhanced the binding to the ped/pea-15 promoter and blocked the rosiglitazone effect. These results indicate that PPAR gamma regulates ped/pea-15 transcription by inhibiting c-JUN binding at the ped/pea-15 promoter. Thus, ped/pea-15 is downstream of a major PPAR gamma-regulated inflammatory network. Repression of ped/pea-15 transcription might contribute to the PPAR gamma regulation of muscle sensitivity to insulin.	[Ungaro, Paola; Mirra, Paola; Nigro, Cecilia; Vastolo, Viviana; Longo, Michele; Perruolo, Giuseppe; Miele, Claudia; Beguinot, Francesco] Univ Naples Federico II, Ist Endocrinol & Oncol Sperimentale Gaetano Salva, Consiglio Nazl Ric, I-80131 Naples, Italy; [Oriente, Francesco; Ciccarelli, Marco; Vastolo, Viviana; Spinelli, Rosa; Formisano, Pietro; Beguinot, Francesco] Univ Naples Federico II, Dipartimento Biol & Patol Cellulare & Mol, I-80131 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR); University of Naples Federico II; University of Naples Federico II	Ungaro, P (corresponding author), Univ Naples Federico II, Ist Endocrinol & Oncol Sperimentale Gaetano Salva, Consiglio Nazl Ric, I-80131 Naples, Italy.	pungaro@ieos.cnr.it	LONGO, Michele/AAB-9188-2019; NIGRO, Cecilia/AAB-9189-2019; Nigro, Cecilia/K-7338-2016; giuseppe, perruolo/AAW-3869-2021; Longo, Michele/AAB-5972-2020; Formisano, Pietro/J-4237-2018; ORIENTE, Francesco/J-6652-2018	LONGO, Michele/0000-0003-4798-0504; NIGRO, Cecilia/0000-0001-8924-9731; Spinelli, Rosa/0000-0001-7308-4119; ORIENTE, Francesco/0000-0003-4375-4526; Formisano, Pietro/0000-0001-7020-6870; Perruolo, Giuseppe/0000-0003-0479-8729	European Community [201681]; European Foundation for the Study of Diabetes; Associazione Italiana per la Ricerca sul Cancro; Ministero dell'Universita e della Ricerca Scientifica; Fondazione Telethon Funding Source: Custom	European Community(European Commission); European Foundation for the Study of Diabetes; Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Universita e della Ricerca Scientifica(Ministry of Education, Universities and Research (MIUR)); Fondazione Telethon(Fondazione Telethon)	This study was supported in part by European Community FP6 PREPOBEDIA Grant 201681, the European Foundation for the Study of Diabetes, the Associazione Italiana per la Ricerca sul Cancro, and by Ministero dell'Universita e della Ricerca Scientifica Grants PRIN and FIRB-MERIT.	Bandyopadhyay GK, 2005, DIABETES, V54, P2351, DOI 10.2337/diabetes.54.8.2351; Blanquart C, 2003, J STEROID BIOCHEM, V85, P267, DOI 10.1016/S0960-0760(03)00214-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Condorelli G, 2001, DIABETES, V50, P1244, DOI 10.2337/diabetes.50.6.1244; Condorelli G, 1998, EMBO J, V17, P3858, DOI 10.1093/emboj/17.14.3858; Condorelli G, 2002, J BIOL CHEM, V277, P11013, DOI 10.1074/jbc.M110934200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; DuBois RN, 1998, CARCINOGENESIS, V19, P49, DOI 10.1093/carcin/19.1.49; Fiory F, 2009, AM J PHYSIOL-ENDOC M, V297, pE592, DOI 10.1152/ajpendo.00228.2009; Frias JP, 2000, DIABETES CARE, V23, P64, DOI 10.2337/diacare.23.1.64; Gurnell M, 2004, ESSAYS BIOCHEM, V40, P169, DOI 10.1042/bse0400169; Gurnell M, 2000, J BIOL CHEM, V275, P5754, DOI 10.1074/jbc.275.8.5754; Hevener AL, 2003, NAT MED, V9, P1491, DOI 10.1038/nm956; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; JONAT C, 1990, CELL, V62, P1189, DOI 10.1016/0092-8674(90)90395-U; Kintscher U, 2005, AM J PHYSIOL-ENDOC M, V288, pE287, DOI 10.1152/ajpendo.00440.2004; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MEDCALF RL, 1990, J BIOL CHEM, V265, P14618; Miele C, 2007, DIABETES, V56, P622, DOI 10.2337/db06-1260; Miyazaki Y, 2001, DIABETES CARE, V24, P710, DOI 10.2337/diacare.24.4.710; NOLAN JJ, 1994, NEW ENGL J MED, V331, P1188, DOI 10.1056/NEJM199411033311803; Norris AW, 2003, J CLIN INVEST, V112, P608, DOI 10.1172/JCI200317305; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Perfetti A, 2007, J BIOL CHEM, V282, P8648, DOI 10.1074/jbc.M608359200; Raskin P, 2000, DIABETOLOGIA, V43, P278, DOI 10.1007/s001250050045; Ricote M, 2007, BBA-MOL CELL BIOL L, V1771, P926, DOI 10.1016/j.bbalip.2007.02.013; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; SCHLINGENSIEPEN KH, 1993, DEV GENET, V14, P305, DOI 10.1002/dvg.1020140408; SCHULE R, 1991, P NATL ACAD SCI USA, V88, P6092, DOI 10.1073/pnas.88.14.6092; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Tremblay F, 2001, J BIOL CHEM, V276, P38052; Ungaro P, 2010, DIABETOLOGIA, V53, P1482, DOI 10.1007/s00125-010-1732-x; Ungaro P, 2008, J BIOL CHEM, V283, P30970, DOI 10.1074/jbc.M803895200; Valentino R, 2006, DIABETOLOGIA, V49, P3058, DOI 10.1007/s00125-006-0455-5; Vigliotta G, 2004, MOL CELL BIOL, V24, P5005, DOI 10.1128/MCB.24.11.5005-5015.2004; Viparelli F, 2008, J BIOL CHEM, V283, P21769, DOI 10.1074/jbc.M803771200; Way JM, 2001, ENDOCRINOLOGY, V142, P1269, DOI 10.1210/en.142.3.1269; Wheatley KE, 2011, J OBES, V2011, DOI 10.1155/2011/265417; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Zierath JR, 1998, ENDOCRINOLOGY, V139, P5034, DOI 10.1210/en.139.12.5034	44	15	15	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42951	42961		10.1074/jbc.M112.406637	http://dx.doi.org/10.1074/jbc.M112.406637			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105093	hybrid, Green Published			2022-12-25	WOS:000312501600052
J	Kormendi, V; Szyk, A; Piszczek, G; Roll-Mecak, A				Kormendi, Vasilisa; Szyk, Agnieszka; Piszczek, Grzegorz; Roll-Mecak, Antonina			Crystal Structures of Tubulin Acetyltransferase Reveal a Conserved Catalytic Core and the Plasticity of the Essential N Terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLAMYDOMONAS ALPHA-TUBULIN; ACETYLATION; FLAGELLA; MEC-17; SYSTEM; FORM	Tubulin acetyltransferase (TAT) acetylates Lys-40 of alpha-tubulin in the microtubule lumen. TAT is inefficient, and its activity is enhanced when tubulin is incorporated in microtubules. Acetylation is associated with stable microtubules and regulates the binding of microtubule motors and associated proteins. TAT is important in neuronal polarity and mechanosensation, and decreased tubulin acetylation levels are associated with axonal transport defects and neurodegeneration. We present the first structure of TAT in complex with acetyl-CoA (Ac-CoA) at 2.7 angstrom resolution. The structure reveals a conserved stable catalytic core shared with other GCN5 superfamily acetyltransferases consisting of a central beta-sheet flanked by alpha-helices and a C-terminal beta-hairpin unique to TAT. Structure-guided mutagenesis establishes the molecular determinants for Ac-CoA and tubulin substrate recognition. The wild-type TAT construct is a monomer in solution. We identify a metastable interface between the conserved core and N-terminal domain that modulates the oligomerization of TAT in solution and is essential for activity. The 2.45 angstrom resolution structure of an inactive TAT construct with an active site point mutation near this interface reveals a domain-swapped dimer in which the functionally essential N terminus shows evidence of marked structural plasticity. The sequence segment corresponding to this structurally plastic region in TAT has been implicated in substrate recognition in other GCN5 superfamily acetyltransferases. Our structures provide a rational platform for the mechanistic dissection of TAT activity and the design of TAT inhibitors with therapeutic potential in neuronal regeneration.	[Roll-Mecak, Antonina] NINDS, Cell Biol & Biophys Unit, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA; [Piszczek, Grzegorz; Roll-Mecak, Antonina] NHLBI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Roll-Mecak, A (corresponding author), NINDS, Cell Biol & Biophys Unit, Porter Neurosci Res Ctr, NIH, Bldg 35,Rm 3B-203,35 Convent Dr,MSC 3700, Bethesda, MD 20892 USA.	Antonina@mail.nih.gov	Piszczek, Grzegorz/GYU-2029-2022	Roll-Mecak, Antonina/0000-0003-2621-7307	National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL000338] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003122] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by the intramural program of the National Institutes of Health (to A. R. M.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Berndsen CE, 2008, CURR OPIN STRUC BIOL, V18, P682, DOI 10.1016/j.sbi.2008.11.004; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen L, 2012, EMBO J, V31, P3033, DOI 10.1038/emboj.2012.175; Cho Y, 2012, EMBO J, V31, P3063, DOI 10.1038/emboj.2012.160; Cueva JG, 2012, CURR BIOL, V22, P1066, DOI 10.1016/j.cub.2012.05.012; Dyda F, 2000, ANNU REV BIOPH BIOM, V29, P81, DOI 10.1146/annurev.biophys.29.1.81; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friedman JR, 2010, J CELL BIOL, V190, P363, DOI 10.1083/jcb.200911024; GAERTIG J, 1995, J CELL BIOL, V129, P1301, DOI 10.1083/jcb.129.5.1301; Garnham CP, 2012, CYTOSKELETON, V69, P442, DOI 10.1002/cm.21027; Hammond JW, 2010, MOL BIOL CELL, V21, P572, DOI 10.1091/mbc.E09-01-0044; Kolonko EM, 2010, P NATL ACAD SCI USA, V107, P20275, DOI 10.1073/pnas.1009860107; LEDIZET M, 1987, P NATL ACAD SCI USA, V84, P5720, DOI 10.1073/pnas.84.16.5720; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; LHERNAULT SW, 1983, J CELL BIOL, V97, P258, DOI 10.1083/jcb.97.1.258; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Neuwald AF, 1997, TRENDS BIOCHEM SCI, V22, P154, DOI 10.1016/S0968-0004(97)01034-7; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Rojas JR, 1999, NATURE, V401, P93, DOI 10.1038/43487; Santander VS, 2006, MOL CELL BIOCHEM, V291, P167, DOI 10.1007/s11010-006-9212-9; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Steczkiewicz K, 2006, CELL CYCLE, V5, P2927, DOI 10.4161/cc.5.24.3572; Szyk A, 2011, NAT STRUCT MOL BIOL, V18, P1250, DOI 10.1038/nsmb.2148; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Topalidou I, 2012, CURR BIOL, V22, P1057, DOI 10.1016/j.cub.2012.03.066; Trievel RC, 1999, P NATL ACAD SCI USA, V96, P8931, DOI 10.1073/pnas.96.16.8931; Wloga D, 2010, J CELL SCI, V123, P3447, DOI 10.1242/jcs.063727	31	24	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41569	41575		10.1074/jbc.C112.421222	http://dx.doi.org/10.1074/jbc.C112.421222			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23105108	Green Published, hybrid			2022-12-25	WOS:000312103000001
J	Xia, J; Zhang, WX				Xia, Jing; Zhang, Weixiong			Noncanonical MicroRNAs and Endogenous siRNAs in Lytic Infection of Murine Gammaherpesvirus	PLOS ONE			English	Article							SMALL INTERFERING RNAS; BIOGENESIS; HERPESVIRUS; EXPRESSION; PATHWAY; IDENTIFICATION; MECHANISMS; SEQUENCES; DATABASE; UPDATE	MicroRNA (miRNA) and endogenous small interfering RNA (endo-siRNA) are two essential classes of small noncoding RNAs (sncRNAs) in eukaryotes. The class of miRNA is diverse and there exist noncanonical miRNAs that bypass the canonical miRNA biogenesis pathway. In order to identify noncanonical miRNAs and endo-siRNAs responding to virus infection and study their potential function, we sequenced small-RNA species from cells lytically infected with murine gammaherpesvirus 68 (MHV68). In addition to three novel canonical miRNAs in mouse, two antisense miRNAs in virus and 25 novel noncanonical miRNAs, including miRNAs derived from transfer RNAs, small nucleolar RNAs and introns, in the host were identified. These noncanonical miRNAs exhibited features distinct from that of canonical miRNAs in lengths of hairpins, base pairings and first nucleotide preference. Many of the novel miRNAs are conserved in mammals. Besides several known murine endo-siRNAs detected by the sequencing profiling, a novel locus in the mouse genome was identified to produce endo-siRNAs. This novel endo-siRNA locus is comprised of two tandem inverted B4 short interspersed nuclear elements (SINEs). Unexpectedly, the SINE-derived endo-siRNAs were found in a variety of sequencing data and virus-infected cells. Moreover, a murine miRNA was up-regulated more than 35 fold in infected than in mock-treated cells. The putative targets of the viral and the up-regulated murine miRNAs were potentially involved in processes of gene transcription and protein phosphorylation, and localized to membranes, suggesting their potential role in manipulating the host basal immune system during lytic infection. Our results extended the number of noncanonical miRNAs in mammals and shed new light on their potential functions of lytic infection of MHV68.	[Xia, Jing; Zhang, Weixiong] Washington Univ, Dept Comp Sci & Engn, St Louis, MO 63130 USA; [Zhang, Weixiong] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Zhang, WX (corresponding author), Washington Univ, Dept Comp Sci & Engn, St Louis, MO 63130 USA.	weixiong.zhang@wustl.edu		, Weixiong/0000-0002-3898-4223; Zhang, Weixiong/0000-0002-4998-9791	American Recovery and Reinvestment Act (ARRA) [MRCE 2 U54 AI057160]; National Institute of Health [R01GM100364, RC1AR058681]; National Science Foundation [DBI-0743797]; Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [RC1AR058681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100364] Funding Source: NIH RePORTER; Div Of Biological Infrastructure [0743797] Funding Source: National Science Foundation	American Recovery and Reinvestment Act (ARRA); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported in part by the American Recovery and Reinvestment Act (ARRA) administrative supplement MRCE 2 U54 AI057160 (HWV and WZ), National Institute of Health grants R01GM100364 and RC1AR058681 (WZ), National Science Foundation grant DBI-0743797 (WZ), and the Damon Runyon Cancer Research Foundation (TR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babiarz J. E., 2009, STEMBOOK, P1, DOI [10.3824/stembook.1.47.1, DOI 10.3824/STEMBOOK.1.47.1]; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Babiarz JE, 2011, RNA, V17, P1489, DOI 10.1261/rna.2442211; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Berezikov E, 2007, MOL CELL, V28, P328, DOI 10.1016/j.molcel.2007.09.028; Berezikov E, 2011, GENOME RES, V21, P203, DOI 10.1101/gr.116657.110; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Bogerd HP, 2010, MOL CELL, V37, P135, DOI 10.1016/j.molcel.2009.12.016; Brameier M, 2011, NUCLEIC ACIDS RES, V39, P675, DOI 10.1093/nar/gkq776; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; Cullen BR, 2012, P NATL ACAD SCI USA, V109, P2695, DOI 10.1073/pnas.1200328109; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Du P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002176; Ebrahimi B, 2003, J GEN VIROL, V84, P99, DOI 10.1099/vir.0.18639-0; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Enright AJ, 2004, GENOME BIOL, V5; Flynt AS, 2010, MOL CELL, V38, P900, DOI 10.1016/j.molcel.2010.06.014; Fujita PA, 2011, NUCLEIC ACIDS RES, V39, pD876, DOI 10.1093/nar/gkq963; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Jeffery IB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-359; Johnson-Buck AE, 2011, METAL IONS LIFE SCI, V9, P175, DOI 10.1039/978184973251200175; Joyce CE, 2011, HUM MOL GENET, V20, P4025, DOI 10.1093/hmg/ddr331; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; JURKA J, 1988, P NATL ACAD SCI USA, V85, P4775, DOI 10.1073/pnas.85.13.4775; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lena AM, 2008, CELL DEATH DIFFER, V15, P1187, DOI 10.1038/cdd.2008.69; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Nash AA, 2001, PHILOS T R SOC B, V356, P569, DOI 10.1098/rstb.2000.0779; Okamura K, 2008, NAT REV MOL CELL BIO, V9, P673, DOI 10.1038/nrm2479; Okamura K, 2008, NAT STRUCT MOL BIOL, V15, P581, DOI 10.1038/nsmb.1438; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Reese TA, 2010, J VIROL, V84, P10344, DOI 10.1128/JVI.00707-10; Rice P, 2000, SCIENCE, V16, P2; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Stark A, 2008, GENE DEV, V22, P8, DOI 10.1101/gad.1613108; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Umbach JL, 2010, J VIROL, V84, P695, DOI 10.1128/JVI.02013-09; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Virgin HW, 1997, J VIROL, V71, P5894, DOI 10.1128/JVI.71.8.5894-5904.1997; Walz N, 2010, J VIROL, V84, P716, DOI 10.1128/JVI.01302-09; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Yang JS, 2011, MOL CELL, V43, P892, DOI 10.1016/j.molcel.2011.07.024; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yi R, 2009, P NATL ACAD SCI USA, V106, P498, DOI 10.1073/pnas.0810766105; Zeng Y, 2004, NUCLEIC ACIDS RES, V32, P4776, DOI 10.1093/nar/gkh824; Zhang WX, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r81; Zhu JY, 2010, J VIROL, V84, P10266, DOI 10.1128/JVI.01119-10	59	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47863	10.1371/journal.pone.0047863	http://dx.doi.org/10.1371/journal.pone.0047863			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110115	gold, Green Published, Green Submitted			2022-12-25	WOS:000310262500023
J	Li, Q; Zhang, CJ; Li, J; Wang, L; Ren, ZH				Li, Qiang; Zhang, Cunjia; Li, Jing; Wang, Lina; Ren, Zhonghai			Genome-Wide Identification and Characterization of R2R3MYB Family in Cucumis sativus	PLOS ONE			English	Article							TRANSCRIPTION FACTOR SUPERFAMILY; GAMYB-LIKE GENES; MYB GENES; PHYLOGENETIC ANALYSIS; EXPRESSION ANALYSIS; ARABIDOPSIS; EVOLUTION; CELL; DUPLICATION; R2R3-MYB	Background: The R2R3MYB proteins comprise one of the largest families of transcription factors in plants. Although genome-wide analysis of this family has been carried out in some species, little is known about R2R3MYB genes in cucumber (Cucumis sativus L.). Principal Findings: This study has identified 55 R2R3MYB genes in the latest cucumber genome and the CsR2R3MYB family contained the smallest number of identified genes compared to other species that have been studied due to the absence of recent gene duplication events. These results were also supported by genome distribution and gene duplication analysis. Phylogenetic analysis showed that they could be classified into 11 subgroups. The evolutionary relationships and the intron - exon organizations that showed similarities with Arabidopsis, Vitis and Glycine R2R3MYB proteins were also analyzed and suggested strong gene conservation but also the expansions of particular functional genes during the evolution of the plant species. In addition, we found that 8 out of 55 (similar to 14.54%) cucumber R2R3MYB genes underwent alternative splicing events, producing a variety of transcripts from a single gene, which illustrated the extremely high complexity of transcriptome regulation. Tissue-specific expression profiles showed that 50 cucumber R2R3MYB genes were expressed in at least one of the tissues and the other 5 genes showed very low expression in all tissues tested, which suggested that cucumber R2R3MYB genes took part in many cellular processes. The transcript abundance level analysis during abiotic conditions (NaCl, ABA and low temperature treatments) identified a group of R2R3MYB genes that responded to one or more treatments. Conclusions: This study has produced a comparative genomics analysis of the cucumber R2R3MYB gene family and has provided the first steps towards the selection of CsR2R3MYB genes for cloning and functional dissection that can be used in further studies to uncover their roles in cucumber growth and development.	[Li, Qiang; Zhang, Cunjia; Li, Jing; Wang, Lina; Ren, Zhonghai] Shandong Agr Univ, Coll Hort Sci & Engn, Minist Agr,State Key Lab Crop Biol, Key Lab Biol & Genet Improvement Hort Crops Huang, Tai An, Shandong, Peoples R China	Ministry of Agriculture & Rural Affairs; Shandong Agricultural University	Ren, ZH (corresponding author), Shandong Agr Univ, Coll Hort Sci & Engn, Minist Agr,State Key Lab Crop Biol, Key Lab Biol & Genet Improvement Hort Crops Huang, Tai An, Shandong, Peoples R China.	zhren@sdau.edu.cn	Ren, Zhonghai/N-6944-2019	Ren, Zhonghai/0000-0002-0759-3668	National Natural Science Foundation of China [31171977]; Foundation for "Taishan Scholar" from the People's Government of Shandong Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for "Taishan Scholar" from the People's Government of Shandong Province	This study was funded by grant 31171977 from National Natural Science Foundation of China (http://www.nsfc.gov.cn/Portal0/default152.htm) and the Foundation for "Taishan Scholar" from the People's Government of Shandong Province (http://www.sd.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Abe H, 1997, PLANT CELL, V9, P1859, DOI 10.1105/tpc.9.10.1859; Araki S, 2004, J BIOL CHEM, V279, P32979, DOI 10.1074/jbc.M403171200; Bailey-Serres J, 1999, TRENDS PLANT SCI, V4, P142, DOI 10.1016/S1360-1385(99)01386-2; Baudry A, 2004, PLANT J, V39, P366, DOI 10.1111/j.1365-313X.2004.02138.x; Baumann K, 2007, DEVELOPMENT, V134, P1691, DOI 10.1242/dev.02836; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Brownfield L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000430; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chen YH, 2006, PLANT MOL BIOL, V60, P107, DOI 10.1007/s11103-005-2910-y; Cheng H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000440; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Daniel X, 1999, PLANT J, V20, P57, DOI 10.1046/j.1365-313X.1999.00578.x; Dias AP, 2003, PLANT PHYSIOL, V131, P610, DOI 10.1104/pp.012047; Du H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-106; Dubos C, 2010, TRENDS PLANT SCI, V15, P573, DOI 10.1016/j.tplants.2010.06.005; Glover BJ, 1998, DEVELOPMENT, V125, P3497; Gocal GFW, 2001, PLANT PHYSIOL, V127, P1682, DOI 10.1104/pp.010442; Gonzalez A, 2009, DEV BIOL, V325, P412, DOI 10.1016/j.ydbio.2008.10.005; Gonzalez A, 2008, PLANT J, V53, P814, DOI 10.1111/j.1365-313X.2007.03373.x; Grubb CD, 2006, TRENDS PLANT SCI, V11, P89, DOI 10.1016/j.tplants.2005.12.006; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hartmann U, 2005, PLANT MOL BIOL, V57, P155, DOI 10.1007/s11103-004-6910-0; He HS, 2012, PLANT CELL REP, V31, P1199, DOI 10.1007/s00299-012-1241-0; Holub EB, 2001, NAT REV GENET, V2, P516, DOI 10.1038/35080508; Hu LF, 2012, GENOME, V55, P245, DOI [10.1139/G2012-009, 10.1139/g2012-009]; Hu LF, 2011, GENET MOL BIOL, V34, P624, DOI 10.1590/S1415-47572011005000054; Huang SW, 2009, NAT GENET, V41, P1275, DOI 10.1038/ng.475; Ito M, 2001, PLANT CELL, V13, P1891, DOI 10.1105/tpc.13.8.1891; Jakoby MJ, 2008, PLANT PHYSIOL, V148, P1583, DOI 10.1104/pp.108.126979; JANOUDI AK, 1993, J AM SOC HORTIC SCI, V118, P366, DOI 10.21273/JASHS.118.3.366; Jiang CZ, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r46; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Jin HL, 1999, PLANT MOL BIOL, V41, P577, DOI 10.1023/A:1006319732410; Jung C, 2008, PLANT PHYSIOL, V146, P623, DOI 10.1104/pp.107.110981; Kazan K, 2003, TRENDS PLANT SCI, V8, P468, DOI 10.1016/j.tplants.2003.09.001; Keller T, 2006, PLANT CELL, V18, P598, DOI 10.1105/tpc.105.038588; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Klobus G, 2004, PHYSIOL PLANTARUM, V121, P84, DOI 10.1111/j.0031-9317.2004.00306.x; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; Larsen LK, 2002, BIOCHEM J, V366, P767, DOI 10.1042/BJ20011821; Lee MM, 2001, DEVELOPMENT, V128, P1539; Lee SH, 2004, J EXP BOT, V55, P1733, DOI 10.1093/jxb/erh189; Lee SH, 2004, PHYSIOL PLANTARUM, V120, P413, DOI 10.1111/j.0031-9317.2004.00248.x; Lee TH, 2000, BIOCHEM BIOPH RES CO, V270, P356, DOI 10.1006/bbrc.2000.2430; Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808; Li JG, 2006, J EXP BOT, V57, P1263, DOI 10.1093/jxb/erj094; Li Q, 2012, MOL BIOL REP, V39, P4283, DOI 10.1007/s11033-011-1215-2; Li SF, 2009, PLANT CELL, V21, P72, DOI 10.1105/tpc.108.063503; Li XX, 2006, PLANT PHYSIOL, V141, P1167, DOI 10.1104/pp.106.080580; Ling J, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-471; Liu SQ, 2011, GENET MOL RES, V10, P2613, DOI 10.4238/2011.October.25.9; Liu SQ, 2008, THEOR APPL GENET, V117, P927, DOI 10.1007/s00122-008-0832-1; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Locatelli F, 2002, PLANT MOL BIOL, V48, P309, DOI 10.1023/A:1013340004348; Lorkovic ZJ, 2000, TRENDS PLANT SCI, V5, P160, DOI 10.1016/S1360-1385(00)01595-8; Mandaokar A, 2009, PLANT PHYSIOL, V149, P851, DOI 10.1104/pp.108.132597; Matus JT, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-83; Mehan Michael R., 2004, Human Genomics, V1, P335; Mengiste T, 2003, PLANT CELL, V15, P2551, DOI 10.1105/tpc.014167; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Muller D, 2006, PLANT CELL, V18, P586, DOI 10.1105/tpc.105.038745; Nesi N, 2001, PLANT CELL, V13, P2099, DOI 10.1105/tpc.13.9.2099; Nozawa M, 2007, P NATL ACAD SCI USA, V104, P20421, DOI 10.1073/pnas.0709956104; OGATA K, 1994, CELL, V79, P639, DOI 10.1016/0092-8674(94)90549-5; OPPENHEIMER DG, 1991, CELL, V67, P483, DOI 10.1016/0092-8674(91)90523-2; Payne T, 1999, DEVELOPMENT, V126, P671; Rosinski JA, 1998, J MOL EVOL, V46, P74, DOI 10.1007/PL00006285; Schauser L, 2005, J MOL EVOL, V60, P229, DOI 10.1007/s00239-004-0144-2; Serna L, 2006, TRENDS PLANT SCI, V11, P274, DOI 10.1016/j.tplants.2006.04.008; SHARP PA, 1981, CELL, V23, P643, DOI 10.1016/0092-8674(81)90425-6; Shi QH, 2007, PLANT PHYSIOL BIOCH, V45, P542, DOI 10.1016/j.plaphy.2007.05.005; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; URAO T, 1993, PLANT CELL, V5, P1529, DOI 10.1105/tpc.5.11.1529; Urao T, 1996, PLANT J, V10, P1145, DOI 10.1046/j.1365-313X.1996.10061145.x; Wang LJ, 1998, PLANT CELL, V10, P1733, DOI 10.1105/tpc.10.10.1733; Wiese A, 2004, PLANT CELL, V16, P1717, DOI 10.1105/tpc.019349; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Yang CX, 2011, P NATL ACAD SCI USA, V108, P11836, DOI 10.1073/pnas.1100532108; Zhang LC, 2012, J EXP BOT, V63, P203, DOI 10.1093/jxb/err264; Zhu JH, 2005, P NATL ACAD SCI USA, V102, P9966, DOI 10.1073/pnas.0503960102	85	46	50	8	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47576	10.1371/journal.pone.0047576	http://dx.doi.org/10.1371/journal.pone.0047576			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110079	Green Published, gold, Green Submitted			2022-12-25	WOS:000310193600016
J	Schwarz, J; Tome, D; Baars, A; Hooiveld, GJEJ; Muller, M				Schwarz, Jessica; Tome, Daniel; Baars, Annemarie; Hooiveld, Guido J. E. J.; Mueller, Michael			Dietary Protein Affects Gene Expression and Prevents Lipid Accumulation in the Liver in Mice	PLOS ONE			English	Article							HIGH-FAT DIET; INSULIN-RESISTANCE; HEPATIC STEATOSIS; PHYSICAL-ACTIVITY; ADIPOSE-TISSUE; BODY-WEIGHT; LIFE-STYLE; METABOLISM; DISEASE; RATS	Background and Aims: High protein (HP) diets are suggested to positively modulate obesity and associated increased prevalence of non-alcoholic fatty liver (NAFLD) disease in humans and rodents. The aim of our study was to detect mechanisms by which a HP diet affects hepatic lipid accumulation. Methods: To investigate the acute and long term effect of high protein ingestion on hepatic lipid accumulation under both low and high fat (HF) conditions, mice were fed combinations of high (35 energy%) or low (10 energy%) fat and high (50 energy%) or normal (15 energy%) protein diets for 1 or 12 weeks. Effects on body composition, liver fat, VLDL production rate and the hepatic transcriptome were investigated. Results: Mice fed the HP diets displayed a lower body weight, developed less adiposity and decreased hepatic lipid accumulation, which could be attributed to a combination of several processes. Next to an increased hepatic VLDL production rate, increased energy utilisation due to enhanced protein catabolic processes, such as transamination, TCA cycle and oxidative phosphorylation was found upon high protein ingestion. Conclusion: Feeding a HP diet prevented the development of NAFLD by enhancing lipid secretion into VLDL particles and a less efficient use of ingested calories.	[Schwarz, Jessica; Tome, Daniel; Baars, Annemarie; Hooiveld, Guido J. E. J.; Mueller, Michael] Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, Wageningen, Netherlands; [Schwarz, Jessica; Hooiveld, Guido J. E. J.; Mueller, Michael] Netherlands Nutrigenom Ctr, Wageningen, Netherlands; [Tome, Daniel] AgroParisTech, INRA, Nutr Physiol & Ingest Behav UMR914, Paris, France	Wageningen University & Research; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Schwarz, J (corresponding author), Wageningen Univ, Div Human Nutr, Nutr Metab & Genom Grp, Wageningen, Netherlands.	jessica.schwarz@wur.nl	Muller, Michael/B-5795-2008; Hooiveld, Guido JEJ/F-4912-2010; Muller, Michael/M-5724-2019; Schwarz, Jessica/J-3374-2012	Muller, Michael/0000-0002-5930-9905; Hooiveld, Guido JEJ/0000-0003-1954-3542; Muller, Michael/0000-0002-5930-9905; Schwarz, Jessica/0000-0002-2594-2200	Marie Curie European Reintegration Grant within the 7th European Community Framework Programme; Dutch Dairy Organisation (NZO)	Marie Curie European Reintegration Grant within the 7th European Community Framework Programme; Dutch Dairy Organisation (NZO)	This research was supported by a Marie Curie European Reintegration Grant within the 7th European Community Framework Programme and by the Dutch Dairy Organisation (NZO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535; Abete I, 2009, INT J FOOD SCI NUTR, V60, P1, DOI 10.1080/09637480802232625; Aragno M, 2009, FREE RADICAL BIO MED, V47, P1067, DOI 10.1016/j.freeradbiomed.2009.07.016; Baird L, 2011, ARCH TOXICOL, V85, P241, DOI 10.1007/s00204-011-0674-5; Beymer C, 2003, ARCH SURG-CHICAGO, V138, P1240, DOI 10.1001/archsurg.138.11.1240; Bortolotti M., 2010, e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism, V5, pe191; Bortolotti M, 2009, AM J CLIN NUTR, V90, P1002, DOI 10.3945/ajcn.2008.27296; Chalasani N, 2010, GASTROENTEROLOGY, V139, P1567, DOI 10.1053/j.gastro.2010.07.057; Chevalier L, 2010, AM J PHYSIOL-REG I, V299, pR1720, DOI 10.1152/ajpregu.00497.2010; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Wit NJW, 2012, J HEPATOL, V57, P1370, DOI 10.1016/j.jhep.2012.07.003; Do GM, 2011, MOL NUTR FOOD RES, V55, pS173, DOI 10.1002/mnfr.201100064; Dowman JK, 2010, QJM-INT J MED, V103, P71, DOI 10.1093/qjmed/hcp158; Duval C, 2010, DIABETES, V59, P3181, DOI 10.2337/db10-0224; EISENSTEIN RS, 1991, J NUTR, V121, P1581, DOI 10.1093/jn/121.10.1581; Evangelista LS, 2009, J CARDIOVASC NURS, V24, P207, DOI 10.1097/JCN.0b013e31819846b9; Frank JW, 2006, AM J PHYSIOL-ENDOC M, V290, pE225, DOI 10.1152/ajpendo.00351.2005; Fromentin C, 2011, AMINO ACIDS, V40, P1461, DOI 10.1007/s00726-010-0756-3; Gholam PM, 2007, AM J GASTROENTEROL, V102, P399, DOI 10.1111/j.1572-0241.2006.01041.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jean C, 2001, J NUTR, V131, P91, DOI 10.1093/jn/131.1.91; Kantartzis K, 2009, GUT, V58, P1281, DOI 10.1136/gut.2008.151977; Kawasaki T, 2009, J NUTR, V139, P2067, DOI 10.3945/jn.109.105858; Kim S, 2004, GENE, V340, P99, DOI 10.1016/j.gene.2004.06.015; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Krasnoff JB, 2008, HEPATOLOGY, V47, P1158, DOI 10.1002/hep.22137; Lacroix M, 2004, AM J PHYSIOL-REG I, V287, pR934, DOI 10.1152/ajpregu.00100.2004; Lin K, 2011, J INTEGR BIOINFORMAT, V8, DOI 10.2390/biecoll-jib-2011-160; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Morenga LAT, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-40; Muller M, 2010, GENES NUTR, V5, P297, DOI 10.1007/s12263-010-0168-8; Noguchi Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012057; Patsouris D, 2006, ENDOCRINOLOGY, V147, P1508, DOI 10.1210/en.2005-1132; Peter A, 2011, INT J OBES LOND; Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275; Scorletti E, 2011, ENDOCRINE, V40, P332, DOI 10.1007/s12020-011-9530-x; Shertzer HG, 2011, J NUTR, V141, P582, DOI 10.3945/jn.110.133736; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stepien M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014664; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suzuki A, 2005, J HEPATOL, V43, P1060, DOI 10.1016/j.jhep.2005.06.008; Uebanso T, 2009, AM J PHYSIOL-ENDOC M, V297, pE76, DOI 10.1152/ajpendo.00014.2009; Westerbacka J, 2005, J CLIN ENDOCR METAB, V90, P2804, DOI 10.1210/jc.2004-1983; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Yki-Jarvinen H, 2010, CURR OPIN CLIN NUTR, V13, P709, DOI 10.1097/MCO.0b013e32833f4b34; Zelber-Sagi S, 2011, WORLD J GASTROENTERO, V17, P3377, DOI 10.3748/wjg.v17.i29.3377	48	50	61	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47303	10.1371/journal.pone.0047303	http://dx.doi.org/10.1371/journal.pone.0047303			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110065	Green Published, Green Submitted, gold			2022-12-25	WOS:000310193600012
J	Fernandez-Lopez, B; Villar-Cervino, V; Valle-Maroto, SM; Barreiro-Iglesias, A; Anadon, R; Rodicio, MC				Fernandez-Lopez, Blanca; Villar-Cervino, Verona; Valle-Maroto, Silvia M.; Barreiro-Iglesias, Anton; Anadon, Ramon; Celina Rodicio, Maria			The Glutamatergic Neurons in the Spinal Cord of the Sea Lamprey: An In Situ Hybridization and Immunohistochemical Study	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; CENTRAL-NERVOUS-SYSTEM; DORSAL-ROOT GANGLIA; GABA-IMMUNOREACTIVE CELLS; HIPPOCAMPAL GRANULE CELLS; STRETCH-RECEPTOR NEURONS; EXCITATORY INTERNEURONS; SYNAPTIC-INTERACTIONS; PETROMYZON-MARINUS; NEUROTRANSMITTER COLOCALIZATION	Glutamate is the main excitatory neurotransmitter involved in spinal cord circuits in vertebrates, but in most groups the distribution of glutamatergic spinal neurons is still unknown. Lampreys have been extensively used as a model to investigate the neuronal circuits underlying locomotion. Glutamatergic circuits have been characterized on the basis of the excitatory responses elicited in postsynaptic neurons. However, the presence of glutamatergic neurochemical markers in spinal neurons has not been investigated. In this study, we report for the first time the expression of a vesicular glutamate transporter (VGLUT) in the spinal cord of the sea lamprey. We also study the distribution of glutamate in perikarya and fibers. The largest glutamatergic neurons found were the dorsal cells and caudal giant cells. Two additional VGLUT-positive gray matter populations, one dorsomedial consisting of small cells and another one lateral consisting of small and large cells were observed. Some cerebrospinal fluid-contacting cells also expressed VGLUT. In the white matter, some edge cells and some cells associated with giant axons (Muller and Mauthner axons) and the dorsolateral funiculus expressed VGLUT. Large lateral cells and the cells associated with reticulospinal axons are in a key position to receive descending inputs involved in the control of locomotion. We also compared the distribution of glutamate immunoreactivity with that of gamma-aminobutyric acid (GABA) and glycine. Colocalization of glutamate and GABA or glycine was observed in some small spinal cells. These results confirm the glutamatergic nature of various neuronal populations, and reveal new small-celled glutamatergic populations, predicting that some glutamatergic neurons would exert complex actions on postsynaptic neurons.	[Fernandez-Lopez, Blanca; Villar-Cervino, Verona; Valle-Maroto, Silvia M.; Barreiro-Iglesias, Anton; Anadon, Ramon; Celina Rodicio, Maria] Univ Santiago de Compostela, Dept Cell Biol & Ecol, Santiago De Compostela, Spain	Universidade de Santiago de Compostela	Rodicio, MC (corresponding author), Univ Santiago de Compostela, Dept Cell Biol & Ecol, Santiago De Compostela, Spain.	mcelina.rodicio@usc.es	Rodicio, María Celina/K-1883-2014; Barreiro-Iglesias, Antón/G-5281-2010; Villar-Cerviño, Verona/K-6380-2014	Rodicio, María Celina/0000-0002-7267-3285; Barreiro-Iglesias, Antón/0000-0002-7507-080X; Fernandez-Lopez, Blanca/0000-0003-4691-8346; Anadon, Ramon/0000-0003-3260-1209	Spanish Ministry of Education and Science [BFU2007-61056/BFI]; Spanish Ministry of Science and Innovation [BFU2010-17174]	Spanish Ministry of Education and Science(Spanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Spanish Ministry of Education and Science (Grant number: BFU2007-61056/BFI) and Spanish Ministry of Science and Innovation (Grant number: BFU2010-17174). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam AS, 2006, J COMP NEUROL, V498, P266, DOI 10.1002/cne.21056; Adrio F, 2011, J COMP NEUROL, V519, P1115, DOI 10.1002/cne.22556; Barreiro-Iglesias A, 2010, NEUROSCIENCE, V167, P396, DOI 10.1016/j.neuroscience.2010.02.030; Barreiro-Iglesias A, 2009, J ANAT, V215, P601, DOI 10.1111/j.1469-7580.2009.01159.x; Barreiro-Iglesias A, 2009, J ANAT, V215, P435, DOI 10.1111/j.1469-7580.2009.01119.x; BATUEVA IV, 1990, J HIRNFORSCH, V31, P739; BRODIN L, 1990, BRAIN RES, V508, P172, DOI 10.1016/0006-8993(90)91134-3; BRODIN L, 1987, NEUROSCI LETT, V75, P75, DOI 10.1016/0304-3940(87)90078-4; Brumovsky P, 2007, NEUROSCIENCE, V147, P469, DOI 10.1016/j.neuroscience.2007.02.068; Buchanan JT, 2001, PROG NEUROBIOL, V63, P441, DOI 10.1016/S0301-0082(00)00050-2; BUCHANAN JT, 1982, J NEUROPHYSIOL, V47, P961, DOI 10.1152/jn.1982.47.5.961; BUCHANAN JT, 1987, SCIENCE, V236, P312, DOI 10.1126/science.3563512; Rodicio MC, 2008, BRAIN RES BULL, V76, P45, DOI 10.1016/j.brainresbull.2007.10.062; CHRISTENSON J, 1991, NEUROSCI LETT, V134, P93, DOI 10.1016/0304-3940(91)90516-V; DAVANGER S, 1991, J COMP NEUROL, V311, P483, DOI 10.1002/cne.903110404; Dingledine R, 1990, Adv Exp Med Biol, V268, P17; DIPRISCO GV, 1990, BRAIN RES, V530, P161; Dubuc R, 2008, BRAIN RES REV, V57, P172, DOI 10.1016/j.brainresrev.2007.07.016; Dullin JP, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-110; ElManira A, 1996, J COMP NEUROL, V369, P533, DOI 10.1002/(SICI)1096-9861(19960610)369:4<533::AID-CNE4>3.0.CO;2-5; FETCHO JR, 1988, J NEUROSCI, V8, P4192; FONNUM F, 1984, J NEUROCHEM, V42, P1, DOI 10.1111/j.1471-4159.1984.tb09689.x; Gillespie DC, 2005, NAT NEUROSCI, V8, P332, DOI 10.1038/nn1397; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; GRILLNER S, 1984, SCIENCE, V223, P500, DOI 10.1126/science.6691161; Grillner S, 2008, BRAIN RES REV, V57, P2, DOI 10.1016/j.brainresrev.2007.06.027; Grillner Sten, 2007, P129; Gustafsson JS, 2002, J COMP NEUROL, V450, P167, DOI 10.1002/cne.10310; Gutierrez R, 2005, TRENDS NEUROSCI, V28, P297, DOI 10.1016/j.tins.2005.04.005; Gutierrez R, 2003, PROG NEUROBIOL, V71, P337, DOI 10.1016/j.pneurobio.2003.11.004; Gutierrez R, 2006, CURR TOP MED CHEM, V6, P975, DOI 10.2174/156802606777323692; HACK N, 1994, NEUROCHEM INT, V25, P235, DOI 10.1016/0197-0186(94)90067-1; HARPER CE, 1993, PHILOS T ROY SOC B, V340, P141, DOI 10.1098/rstb.1993.0053; Herzog E, 2004, EUR J NEUROSCI, V20, P1752, DOI 10.1111/j.1460-9568.2004.03628.x; Higashijima S, 2004, J COMP NEUROL, V480, P1, DOI 10.1002/cne.20278; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; Joyce MP, 2000, NEUROSCIENCE, V99, P445, DOI 10.1016/S0306-4522(00)00219-0; Kao YH, 2004, J COMP NEUROL, V478, P207, DOI 10.1002/cne.20221; Kiehn O, 2008, BRAIN RES REV, V57, P56, DOI 10.1016/j.brainresrev.2007.07.002; Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910; Kreibich TA, 2004, J NEUROSCI, V24, P7085, DOI 10.1523/JNEUROSCI.0349-04.2004; Landry M, 2004, J COMP NEUROL, V468, P380, DOI 10.1002/cne.10988; Li WC, 2003, J NEUROSCI, V23, P9068; LIU CJ, 1989, HISTOCHEMISTRY, V90, P427, DOI 10.1007/BF00494354; Liu J, 2010, NAT NEUROSCI, V13, P1225, DOI 10.1038/nn.2633; Mahmood R, 2009, NEUROSCIENCE, V164, P1057, DOI 10.1016/j.neuroscience.2009.08.069; MARTIN AR, 1975, J PHYSIOL-LONDON, V251, P409, DOI 10.1113/jphysiol.1975.sp011101; Maxwell DJ, 2007, J PHYSIOL-LONDON, V584, P521, DOI 10.1113/jphysiol.2007.140996; Megias M, 2003, J COMP NEUROL, V455, P72, DOI 10.1002/cne.10473; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Melendez-Ferro M, 2003, J COMP NEUROL, V464, P17, DOI 10.1002/cne.10773; Melendez-Ferro M, 2002, J COMP NEUROL, V446, P360, DOI 10.1002/cne.10209; Melendez-Ferro M, 2001, BRAIN RES, V893, P253, DOI 10.1016/S0006-8993(00)03316-3; Mentel T, 2008, J NEUROSCI, V28, P868, DOI 10.1523/JNEUROSCI.4250-07.2008; Moly PK, 2011, NEUROSCI RES, V70, P251, DOI 10.1016/j.neures.2011.03.003; NIEUWENHUYS R., 1964, PROGR BRAIN RES, V11, P1; Nishimaru H, 2005, P NATL ACAD SCI USA, V102, P5245, DOI 10.1073/pnas.0501331102; Noh J, 2010, NAT NEUROSCI, V13, P232, DOI 10.1038/nn.2478; Oliveira ALR, 2003, SYNAPSE, V50, P117, DOI 10.1002/syn.10249; Ornung G, 1998, EXP BRAIN RES, V118, P517, DOI 10.1007/s002210050308; OTTERSEN OP, 1984, J COMP NEUROL, V229, P374, DOI 10.1002/cne.902290308; Ottersen OP, 1984, HDB CHEM NEUROANATOM, V3, P141; Persson S, 2006, J COMP NEUROL, V497, P683, DOI 10.1002/cne.20987; Platt SR, 2007, VET J, V173, P278, DOI 10.1016/j.tvjl.2005.11.007; REICHENBERGER I, 1994, J COMP NEUROL, V349, P603, DOI 10.1002/cne.903490408; Reichenberger I, 1997, J COMP NEUROL, V377, P149; Reissner E, 1860, ARCH ANAT PHYSL, P545; RINGHAM GL, 1975, J PHYSIOL-LONDON, V251, P395, DOI 10.1113/jphysiol.1975.sp011100; ROBERTS A, 1982, PHILOS T R SOC B, V296, P195, DOI 10.1098/rstb.1982.0002; Roberts A, 1998, ANN NY ACAD SCI, V860, P19, DOI 10.1111/j.1749-6632.1998.tb09036.x; ROBERTS A, 1990, EUR J NEUROSCI, V2, P1051, DOI 10.1111/j.1460-9568.1990.tb00017.x; Robertson B, 2007, J COMP NEUROL, V503, P47, DOI 10.1002/cne.21348; Rodicio MC, 2005, BRAIN RES BULL, V66, P536, DOI 10.1016/j.brainresbull.2004.06.013; RONAN M, 1990, J COMP NEUROL, V291, P491, DOI 10.1002/cne.902910402; ROVAINEN CM, 1974, J COMP NEUROL, V154, P207, DOI 10.1002/cne.901540207; ROVAINEN CM, 1974, J COMP NEUROL, V154, P189, DOI 10.1002/cne.901540206; ROVAINEN CM, 1967, J NEUROPHYSIOL, V30, P1024, DOI 10.1152/jn.1967.30.5.1024; Ruiz Y, 2004, J COMP NEUROL, V470, P151, DOI 10.1002/cne.11032; SANDLER R, 1991, J COMP NEUROL, V303, P177, DOI 10.1002/cne.903030202; Seal RP, 2006, CURR OPIN PHARMACOL, V6, P114, DOI 10.1016/j.coph.2005.12.001; SELZER ME, 1979, BRAIN RES, V163, P181, DOI 10.1016/0006-8993(79)90348-2; Shupliakov O, 1996, ACTA BIOL HUNG, V47, P393; SHUPLIAKOV O, 1992, J NEUROSCI, V12, P3789; Somogyi J, 2001, EUR J NEUROSCI, V14, P219, DOI 10.1046/j.0953-816x.2001.01638.x; Somogyi J, 2006, CURR TOP MED CHEM, V6, P969, DOI 10.2174/156802606777323737; Sun H, 2000, ANAT RECORD, V260, P158, DOI 10.1002/1097-0185(20001001)260:2<158::AID-AR60>3.0.CO;2-V; Todd AJ, 2003, EUR J NEUROSCI, V17, P13, DOI 10.1046/j.1460-9568.2003.02406.x; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Trudeau LE, 2007, MOL INTERV, V7, P138, DOI 10.1124/mi.7.3.5; VESSELKIN NP, 1995, J BRAIN RES, V36, P229; Vigh B, 2004, HISTOL HISTOPATHOL, V19, P607, DOI 10.14670/HH-19.607; Villar-Cervino V, 2008, J COMP NEUROL, V508, P112, DOI 10.1002/cne.21661; Villar-Cervino V, 2008, J COMP NEUROL, V507, P1441, DOI 10.1002/cne.21634; Villar-Cervino V, 2006, J COMP NEUROL, V499, P810, DOI 10.1002/cne.21136; Villar-Cervino V, 2013, J COMP NEUROL, V521, P522, DOI 10.1002/cne.23189; Villar-Cervino V, 2011, J COMP NEUROL, V519, P1712, DOI 10.1002/cne.22597; Villar-Cervino V, 2010, J CHEM NEUROANAT, V40, P71, DOI 10.1016/j.jchemneu.2010.03.009; Villar-Cervino V, 2010, J COMP NEUROL, V518, P1688, DOI 10.1002/cne.22296; Villar-Cervino V, 2009, J COMP NEUROL, V512, P747, DOI 10.1002/cne.21916; Vinay L, 1996, J NEUROPHYSIOL, V76, P1224, DOI 10.1152/jn.1996.76.2.1224; WALBERG F, 1990, EXP BRAIN RES, V79, P547; WHITING HP, 1948, Q J MICROSC SCI, V89, P359; YANG CY, 1994, VISUAL NEUROSCI, V11, P1193, DOI 10.1017/S0952523800006994; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Yasaka T, 2010, PAIN, V151, P475, DOI 10.1016/j.pain.2010.08.008; Yavuzoglu A, 2011, J NEUROSCI, V31, P14424, DOI 10.1523/JNEUROSCI.3529-11.2011; Zander JF, 2010, J NEUROSCI, V30, P7634, DOI 10.1523/JNEUROSCI.0141-10.2010	108	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e47898	10.1371/journal.pone.0047898	http://dx.doi.org/10.1371/journal.pone.0047898			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110124	Green Submitted, Green Published, gold			2022-12-25	WOS:000310193400021
J	Ahamed, M; Chan, B; Jensen, P; Todd, MH				Ahamed, Muneer; Chan, Bun; Jensen, Paul; Todd, Matthew H.			The Outcome of the Oxidations of Unusual Enediamide Motifs Is Governed by the Stabilities of the Intermediate Iminium Ions	PLOS ONE			English	Article							SINGLET OXYGEN; ACID; DELTA(5)-2-OXOPIPERAZINES; CYCLIZATIONS; DERIVATIVES; PRODUCTS; ENAMIDES	We compare the results from the oxidation of two unusual "enediamide'' motifs (3,4-dihydropyrazin-2(1H)-ones), where a double bond is flanked by two amides. In one case the oxidation led to a ring-opened product arising from the cleavage of the double bond, and in the other a rare cis-dioxygenated compound was obtained. Both products have been characterized by X-ray crystallography. The outcomes of the key reactions are rationalized based on calculated free energies of intermediates.	[Ahamed, Muneer; Chan, Bun; Jensen, Paul; Todd, Matthew H.] Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia; [Chan, Bun] ARC Ctr Excellence Free Rad Chem & Biotechnol, Melbourne, Vic, Australia	University of Sydney	Todd, MH (corresponding author), Univ Sydney, Sch Chem, Sydney, NSW 2006, Australia.	matthew.todd@sydney.edu.au	Todd, Matthew/S-2678-2018	Todd, Matthew/0000-0001-7096-4751; Ahamed, Muneer/0000-0002-8204-6875; Ahamed, Muneer/0000-0002-6834-4585; Chan, Bun/0000-0002-0082-5497	University of Sydney; School of Chemistry at The University of Sydney; Wellcome Trust	University of Sydney(University of Sydney); School of Chemistry at The University of Sydney(University of Sydney); Wellcome Trust(Wellcome TrustEuropean Commission)	The authors thank the University of Sydney for a University of Sydney International Fee Scholarship and the School of Chemistry at The University of Sydney for a Lamberton Scholarship (to MA) and the Wellcome Trust for a postdoctoral fellowship (to MHT, 1999-2000, when compound 3 was isolated). The authors thank Professor Leo Radom (The University of Sydney) for a fellowship (to BC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aciro C, 2008, TETRAHEDRON, V64, P9320, DOI 10.1016/j.tet.2008.07.012; Adam W, 2004, J ORG CHEM, V69, P1704, DOI 10.1021/jo035745c; ADAM W, 1995, J AM CHEM SOC, V117, P9690, DOI 10.1021/ja00143a011; BATTISTINI C, 1974, J CHEM SOC CHEM COMM, P712, DOI 10.1039/c39740000712; Cheng JF, 2002, TETRAHEDRON LETT, V43, P6293, DOI 10.1016/S0040-4039(02)01403-X; Frauenrath H, 2001, ANGEW CHEM INT EDIT, V40, P177, DOI 10.1002/1521-3773(20010105)40:1<177::AID-ANIE177>3.0.CO;2-X; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Girard AL, 2011, CHEM-ASIAN J, V6, P1321, DOI 10.1002/asia.201100209; HARAYAMA T, 1986, CHEM PHARM BULL, V34, P2354; HARAYAMA T, 1985, TETRAHEDRON LETT, V26, P3587, DOI 10.1016/S0040-4039(00)89197-2; KIECKONONOWICZ K, 1989, ARCH PHARM, V322, P795, DOI 10.1002/ardp.19893221104; Lee SC, 2007, J COMB CHEM, V9, P828, DOI 10.1021/cc0700492; Marenich AV, 2009, J PHYS CHEM B, V113, P6378, DOI 10.1021/jp810292n; Matsumoto K, 2007, SYNLETT, P3137, DOI 10.1055/s-2007-990911; Merrick JP, 2007, J PHYS CHEM A, V111, P11683, DOI 10.1021/jp073974n; MOLTKELETH C, 1993, ACTA CHEM SCAND, V47, P1117, DOI 10.3891/acta.chem.scand.47-1117; Orsini F, 2004, TETRAHEDRON LETT, V45, P9253, DOI 10.1016/j.tetlet.2004.10.072; RYANG HS, 1978, J AM CHEM SOC, V100, P1302, DOI 10.1021/ja00472a051; SCHREIBER SL, 1984, J AM CHEM SOC, V106, P4186, DOI 10.1021/ja00327a020; STEPHENS PJ, 1994, J PHYS CHEM-US, V98, P11623, DOI 10.1021/j100096a001; Todd MH, 2002, J ORG CHEM, V67, P3985, DOI 10.1021/jo010990m; Wai JS, 2007, BIOORG MED CHEM LETT, V17, P5595, DOI 10.1016/j.bmcl.2007.07.092; Wang W, 2011, J ORG CHEM, V76, P637, DOI 10.1021/jo102058s; Woelfle M, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001260; Xiong H, 2002, TETRAHEDRON LETT, V43, P4449, DOI 10.1016/S0040-4039(02)00849-3; Zhao Y, 2008, THEOR CHEM ACC, V120, P215, DOI 10.1007/s00214-007-0310-x	26	2	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47224	10.1371/journal.pone.0047224	http://dx.doi.org/10.1371/journal.pone.0047224			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094038	Green Submitted, gold, Green Published			2022-12-25	WOS:000310050200017
J	Giang, T; Bell, R; Buchner, A				Giang, Trang; Bell, Raoul; Buchner, Axel			Does Facial Resemblance Enhance Cooperation?	PLOS ONE			English	Article							HUMAN KIN RECOGNITION; SOURCE MEMORY; SAME-SEX; FACES; SIMILARITY; EVOLUTION; NONPATERNITY; ALTRUISM; KINSHIP; HUMANS	Facial self-resemblance has been proposed to serve as a kinship cue that facilitates cooperation between kin. In the present study, facial resemblance was manipulated by morphing stimulus faces with the participants' own faces or control faces (resulting in self-resemblant or other-resemblant composite faces). A norming study showed that the perceived degree of kinship was higher for the participants and the self-resemblant composite faces than for actual first-degree relatives. Effects of facial self-resemblance on trust and cooperation were tested in a paradigm that has proven to be sensitive to facial trustworthiness, facial likability, and facial expression. First, participants played a cooperation game in which the composite faces were shown. Then, likability ratings were assessed. In a source memory test, participants were required to identify old and new faces, and were asked to remember whether the faces belonged to cooperators or cheaters in the cooperation game. Old-new recognition was enhanced for self-resemblant faces in comparison to other-resemblant faces. However, facial self-resemblance had no effects on the degree of cooperation in the cooperation game, on the emotional evaluation of the faces as reflected in the likability judgments, and on the expectation that a face belonged to a cooperator rather than to a cheater. Therefore, the present results are clearly inconsistent with the assumption of an evolved kin recognition module built into the human face recognition system.	[Giang, Trang; Bell, Raoul; Buchner, Axel] Univ Dusseldorf, Dept Expt Psychol, D-40225 Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Giang, T (corresponding author), Univ Dusseldorf, Dept Expt Psychol, D-40225 Dusseldorf, Germany.	Trang.Giang@hhu.de; Raoul.Bell@hhu.de		Bell, Raoul/0000-0002-0592-0362	Deutsche Forschungsgemeinschaft [BE 4311/1-1]; John D. and Catherine T. MacArthur Foundation Research Network on Early Experience and Brain Development	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); John D. and Catherine T. MacArthur Foundation Research Network on Early Experience and Brain Development	The research reported in this article was supported by a grant from the Deutsche Forschungsgemeinschaft (BE 4311/1-1; www.dfg.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Trang Giang, Department of Experimental Psychology, Heinrich Heine University Dusseldorf, Dusseldorf, Germany, Raoul Bell, Department of Experimental Psychology, Heinrich Heine University Dusseldorf, Dusseldorf, Germany and Axel Buchner, Department of Experimental Psychology, Heinrich Heine University Dusseldorf, Dusseldorf, Germany. We declare that no competing interests existed. We thank Lara Schlunder and Marie-Luisa Schaper for their help with stimulus generation and data collection. We thank Daniel Steinmann for allowing us to use his photo for an illustration of the morphing method. Development of the MacBrain Face Stimulus Set was overseen by Nim Tottenham and supported by the John D. and Catherine T. MacArthur Foundation Research Network on Early Experience and Brain Development. Please contact Nim Tottenham at tott0006@tc.umn.edu for more information concerning the stimulus set.	Alvergne A, 2009, J VISION, V9, DOI 10.1167/9.6.23; Anastasi J.S., 2006, N AM J PSYCHOL, V8, P237; Bailenson JN, 2006, POLIT PSYCHOL, V27, P373, DOI 10.1111/j.1467-9221.2006.00505.x; Bailenson JN, 2008, PUBLIC OPIN QUART, V72, P935, DOI 10.1093/poq/nfn064; Barclay P, 2006, HUM NATURE-INT BIOS, V17, P98, DOI 10.1007/s12110-006-1022-y; Bayen UJ, 1996, J EXP PSYCHOL LEARN, V22, P197, DOI 10.1037/0278-7393.22.1.197; Bayen UJ, 2011, J MEM LANG, V64, P1, DOI 10.1016/j.jml.2010.09.001; Bell R, J EXPT PSYC IN PRESS; Bell R, 2012, J EXP PSYCHOL LEARN, V38, P457, DOI 10.1037/a0026017; Bell R, 2011, EMOTION, V11, P249, DOI 10.1037/a0022597; Bell R, 2010, COGNITION, V117, P261, DOI 10.1016/j.cognition.2010.08.020; Berenson KR, 2006, PERS SOC PSYCHOL B, V32, P1509, DOI 10.1177/0146167206291671; Bressan P, 2009, ARCH SEX BEHAV, V38, P657, DOI 10.1007/s10508-008-9350-0; Buchner A, 2009, EVOL HUM BEHAV, V30, P212, DOI 10.1016/j.evolhumbehav.2009.01.004; BURNSTEIN E, 1994, J PERS SOC PSYCHOL, V67, P773, DOI 10.1037/0022-3514.67.5.773; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd ed., DOI DOI 10.4324/9780203771587; DeBruine LM, 2011, P NATL ACAD SCI USA, V108, P11710, DOI 10.1073/pnas.1105919108; DeBruine LM, 2002, P ROY SOC B-BIOL SCI, V269, P1307, DOI 10.1098/rspb.2002.2034; DeBruine LM, 2005, P ROY SOC B-BIOL SCI, V272, P919, DOI 10.1098/rspb.2004.3003; DeBruine LM, 2004, P ROY SOC B-BIOL SCI, V271, P2085, DOI 10.1098/rspb.2004.2824; Ebner NC, 2010, BEHAV RES METHODS, V42, P351, DOI 10.3758/BRM.42.1.351; Erdfelder E, 2009, Z PSYCHOL, V217, P108, DOI 10.1027/0044-3409.217.3.108; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Fraley RC, 2010, PERS SOC PSYCHOL B, V36, P1202, DOI 10.1177/0146167210377180; Fu Yun, 2011, 22 INT JOINT C ART I, DOI DOI 10.5591/978-1-57735-516-8/IJCAI11-422; Greeff JM, 2012, EVOL HUM BEHAV, V33, P268, DOI 10.1016/j.evolhumbehav.2011.10.004; HAMILTON WD, 1963, AM NAT, V97, P354, DOI 10.1086/497114; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Havlicek J, 2009, PSYCHONEUROENDOCRINO, V34, P497, DOI 10.1016/j.psyneuen.2008.10.007; Jackson MC, 2008, J EXP PSYCHOL HUMAN, V34, P556, DOI 10.1037/0096-1523.34.3.556; Kaminski G, 2010, PERCEPTION, V39, P807, DOI 10.1068/p6372; Kircher TTJ, 2001, COGNITION, V78, pB1, DOI 10.1016/S0010-0277(00)00104-9; KLATZKY RL, 1984, MEM COGNITION, V12, P60, DOI 10.3758/BF03196998; Kraus MW, 2010, PSYCHOL SCI, V21, P518, DOI 10.1177/0956797610364949; Kroneisen M, MEMORY IN PRESS; Krupp DB, 2012, J EVOLUTION BIOL, V25, P1472, DOI 10.1111/j.1420-9101.2012.02553.x; Krupp DB, 2008, EVOL HUM BEHAV, V29, P49, DOI 10.1016/j.evolhumbehav.2007.08.002; LANGLOIS JH, 1990, PSYCHOL SCI, V1, P115, DOI 10.1111/j.1467-9280.1990.tb00079.x; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; Lass-Hennemann J, 2011, ARCH SEX BEHAV, V40, P1007, DOI 10.1007/s10508-010-9662-8; Lieberman D, 2007, NATURE, V445, P727, DOI 10.1038/nature05510; Lieberman D, 2012, EVOL HUM BEHAV, V33, P26, DOI 10.1016/j.evolhumbehav.2011.05.002; Lundqvist D., 1998, KAROLINSKA DIRECTED, DOI 10.1037/t27732-000; Maloney LT, 2006, J VISION, V6, P1047, DOI 10.1167/6.10.4; Mehl B, 2008, EVOL HUM BEHAV, V29, P35, DOI 10.1016/j.evolhumbehav.2007.08.001; Meissner CA, 2001, PSYCHOL PUBLIC POL L, V7, P3, DOI 10.1037//1076-8971.7.1.3; Nash RA, 2010, MEMORY, V18, P451, DOI 10.1080/09658211003742706; Park JH, 2008, REV GEN PSYCHOL, V12, P215, DOI 10.1037/1089-2680.12.3.215; Pause BM, 2006, P ROY SOC B-BIOL SCI, V273, P471, DOI 10.1098/rspb.2005.3342; Platek SM, 2003, EVOL HUM BEHAV, V24, P81, DOI 10.1016/S1090-5138(02)00117-4; Platek SM, 2002, EVOL HUM BEHAV, V23, P159, DOI 10.1016/S1090-5138(01)00094-0; PORTER RH, 1981, PHYSIOL BEHAV, V27, P493, DOI 10.1016/0031-9384(81)90337-1; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Sporer SL, 2001, PSYCHOL PUBLIC POL L, V7, P36, DOI 10.1038//1076-8971.7.1.36; Todorov A, 2008, ANN NY ACAD SCI, V1124, P208, DOI 10.1196/annals.1440.012; Tong F, 1999, J EXP PSYCHOL HUMAN, V25, P1016, DOI 10.1037/0096-1523.25.4.1016; Wolf M, 2012, HUM NATURE-INT BIOS, V23, P208, DOI 10.1007/s12110-012-9143-y; Wright DB, 2003, ACTA PSYCHOL, V114, P101, DOI 10.1016/S0001-6918(03)00052-0; Xia S, 2012, IEEE T MULTIMEDIA T	59	19	20	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47809	10.1371/journal.pone.0047809	http://dx.doi.org/10.1371/journal.pone.0047809			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	023QT	23094095	Green Published, Green Submitted, gold			2022-12-25	WOS:000310050200050
J	Li, X; Cai, Y; Wang, YS; Shi, YY; Hou, W; Xu, CS; Wang, HY; Ye, Z; Yao, LB; Zhang, J				Li, Xia; Cai, Yan; Wang, Yu-Sheng; Shi, Yuan-Yuan; Hou, Wei; Xu, Chun-Sheng; Wang, Hai-Yan; Ye, Zi; Yao, Li-Bo; Zhang, Jian			Hyperglycaemia Exacerbates Choroidal Neovascularisation in Mice via the Oxidative Stress-Induced Activation of STAT3 Signalling in RPE Cells	PLOS ONE			English	Article							RETINAL-PIGMENT EPITHELIUM; AGE-RELATED MACULOPATHY; N-ACETYL-CYSTEINE; MACULAR DEGENERATION; RISK-FACTORS; VEGF EXPRESSION; PATHOGENESIS; COMPLICATIONS; EXPOSURE; MODEL	Choroidal neovascularisation (CNV) that occurs as a result of age-related macular degeneration (AMD) causes severe vision loss among elderly patients. The relationship between diabetes and CNV remains controversial. However, oxidative stress plays a critical role in the pathogenesis of both AMD and diabetes. In the present study, we investigated the influence of diabetes on experimentally induced CNV and on the underlying molecular mechanisms of CNV. CNV was induced via photocoagulation in the ocular fundi of mice with streptozotocin-induced diabetes. The effect of diabetes on the severity of CNV was measured. An immunofluorescence technique was used to determine the levels of oxidative DNA damage by anti-8- hydroxy-2-deoxyguanosine (8-OHdG) antibody, the protein expression of phosphorylated signal transducer and activator of transcription 3 (p-STAT3) and vascular endothelial growth factor (VEGF), in mice with CNV. The production of reactive oxygen species (ROS) in retinal pigment epithelial (RPE) cells that had been cultured under high glucose was quantitated using the 2',7'-dichlorofluorescein diacetate (DCFH-DA) method. p-STAT3 expression was examined using Western blot analysis. RT-PCR and ELISA processes were used to detect VEGF expression. Hyperglycaemia exacerbated the development of CNV in mice. Oxidative stress levels and the expression of p-STAT3 and VEGF were highly elevated both in mice and in cultured RPE cells. Treatment with the antioxidant compound N-acetyl-cysteine (NAC) rescued the severity of CNV in diabetic mice. NAC also inhibited the overexpression of p-STAT3 and VEGF in CNV and in RPE cells. The JAK-2/STAT3 pathway inhibitor AG490 blocked VEGF expression but had no effect on the production of ROS in vitro. These results suggest that hyperglycaemia promotes the development of CNV by inducing oxidative stress, which in turn activates STAT3 signalling in RPE cells. Antioxidant supplementation helped attenuate the development of CNV. Thus, our results reveal a potential strategy for the treatment and prevention of diseases involving CNV.	[Li, Xia; Cai, Yan; Wang, Yu-Sheng; Shi, Yuan-Yuan; Wang, Hai-Yan; Ye, Zi] Fourth Mil Med Univ, Xijing Hosp, Dept Ophthalmol, Xian 710032, Shaanxi Provinc, Peoples R China; [Yao, Li-Bo; Zhang, Jian] Fourth Mil Med Univ, Dept Biochem & Mol Biol, State Key Lab Canc Biol, Xian 710032, Shaanxi Provinc, Peoples R China; [Hou, Wei] Fourth Mil Med Univ, Xijing Hosp, Dept Orthoped, Xian 710032, Shaanxi Provinc, Peoples R China; [Xu, Chun-Sheng] Fourth Mil Med Univ, Xijing Hosp, Dept Gastrointestinal Surg, State Key Lab Canc Biol, Xian 710032, Shaanxi Provinc, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Wang, YS (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Ophthalmol, Xian 710032, Shaanxi Provinc, Peoples R China.	wangys003@126.com; biozhangj@yahoo.com.cn			National Natural Science Foundation of China [30872818, 81070748]; National Basic Research Program of China (973 Program) [2011CB510200]; Alexander Von Humboldt Foundation in Germany [V8151/02085]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Alexander Von Humboldt Foundation in Germany(Alexander von Humboldt Foundation)	This work was supported by grants from the National Natural Science Foundation of China (No. 30872818, 81070748) and National Basic Research Program of China (973 Program/No. 2011CB510200). The project was sponsored partly by the equipment donation from the Alexander Von Humboldt Foundation in Germany (to Y.S.W., V8151/02085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktunc E, 2010, CLIN EXP DERMATOL, V35, P902, DOI 10.1111/j.1365-2230.2010.03823.x; Al-Shabrawey M, 2008, INVEST OPHTH VIS SCI, V49, P3231, DOI 10.1167/iovs.08-1754; Awad N, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2011.01.030; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Bertram KM, 2009, AM J PHYSIOL-CELL PH, V297, pC1200, DOI 10.1152/ajpcell.00126.2009; Borrone R, 2008, EUR J OPHTHALMOL, V18, P949, DOI 10.1177/112067210801800615; Brezniceanu ML, 2010, J AM SOC NEPHROL, V21, P943, DOI 10.1681/ASN.2009030242; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Calabrese A, 2011, INVEST OPHTH VIS SCI, V52, P2417, DOI 10.1167/iovs.09-5056; Campa C, 2011, CURR DRUG TARGETS, V12, P173, DOI 10.2174/138945011794182674; Chen Z, 2008, MED RES REV, V28, P185, DOI 10.1002/med.20101; Choi JK, 2011, ARCH OPHTHALMOL-CHIC, V129, P196, DOI 10.1001/archophthalmol.2010.355; Dong A, 2009, J CELL PHYSIOL, V219, P544, DOI 10.1002/jcp.21698; Du YP, 2003, FREE RADICAL BIO MED, V35, P1491, DOI 10.1016/j.freeradbiomed.2003.08.018; Duan YK, 2007, OPHTHALMOLOGY, V114, P732, DOI 10.1016/j.ophtha.2006.07.045; Fraser-Bell S, 2008, AM J OPHTHALMOL, V145, P308, DOI 10.1016/j.ajo.2007.10.007; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Guymer RH, 2006, MED J AUSTRALIA, V184, P455, DOI 10.5694/j.1326-5377.2006.tb00318.x; Hara R, 2010, CURR EYE RES, V35, P1012, DOI 10.3109/02713683.2010.500112; HIDAYAT AA, 1985, OPHTHALMOLOGY, V92, P512; Hou HY, 2008, EXP EYE RES, V86, P983, DOI 10.1016/j.exer.2008.03.018; Hou HY, 2010, MOL THER, V18, P1837, DOI 10.1038/mt.2010.144; Imamura Y, 2006, P NATL ACAD SCI USA, V103, P11282, DOI 10.1073/pnas.0602131103; Izumi-Nagai K, 2007, AM J PATHOL, V170, P2149, DOI 10.2353/ajpath.2007.061018; Jung JE, 2005, FASEB J, V19, P1296, DOI 10.1096/fj.04-3099fje; KLEIN R, 1992, OPHTHALMOLOGY, V99, P1527; Klein R, 2007, AM J OPHTHALMOL, V143, P473, DOI 10.1016/j.ajo.2006.11.058; Lachin JM, 2008, DIABETES, V57, P995, DOI 10.2337/db07-1618; Li QH, 2008, MOL THER, V16, P1688, DOI 10.1038/mt.2008.164; Lyzogubov VV, 2010, INVEST OPHTH VIS SCI, V51; MILLER H, 1990, INVEST OPHTH VIS SCI, V31, P899; Motyl K, 2009, BIOL PROCED ONLINE, V11, P296, DOI 10.1007/s12575-009-9000-5; Pop-Busui R, 2006, DIABETES-METAB RES, V22, P257, DOI 10.1002/dmrr.625; Proctor B, 2007, INVEST OPHTHALMOL VI, V48, P2149; Ryan CM, 2006, DIABETES CARE, V29, P345, DOI 10.2337/diacare.29.02.06.dc05-1626; Sakurai E, 2008, INVEST OPHTH VIS SCI, V49, P540; Shi Y, 2011, INT J INF TECH DECIS, V10, P1, DOI 10.1142/S0219622011004294; Strunnikova N, 2004, INVEST OPHTH VIS SCI, V45, P3767, DOI 10.1167/iovs.04-0311; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; Topouzis F, 2009, BRIT J OPHTHALMOL, V93, P1037, DOI 10.1136/bjo.2008.146316; Wei Michael, 2003, Heart Lung Circ, V12, P44, DOI 10.1046/j.1444-2892.2003.00160.x; Xu Q, 2005, ONCOGENE, V24, P5552, DOI 10.1038/sj.onc.1208719; Yan ML, 2011, CARDIOVASC DRUG THER, V25, P451, DOI 10.1007/s10557-011-6342-4; Yildirim Z, 2011, CLINICS, V66, P743, DOI 10.1590/S1807-59322011000500006; Zarbin MA, 2004, ARCH OPHTHALMOL-CHIC, V122, P598, DOI 10.1001/archopht.122.4.598; Zhang FJ, 2011, TOXICOL SCI, V120, P87, DOI 10.1093/toxsci/kfq364; Zhang LY, 2001, DIABETES CARE, V24, P1275, DOI 10.2337/diacare.24.7.1275; Zhu J, 2009, EXP EYE RES, V88, P910, DOI 10.1016/j.exer.2008.11.034	49	42	44	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47600	10.1371/journal.pone.0047600	http://dx.doi.org/10.1371/journal.pone.0047600			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094067	Green Published, gold, Green Submitted			2022-12-25	WOS:000310050200034
J	Schwaiger, CS; Borjesson, SI; Hess, B; Wallner, B; Elinder, F; Lindahl, E				Schwaiger, Christine S.; Borjesson, Sara I.; Hess, Berk; Wallner, Bjorn; Elinder, Fredrik; Lindahl, Erik			The Free Energy Barrier for Arginine Gating Charge Translation Is Altered by Mutations in the Voltage Sensor Domain	PLOS ONE			English	Article							SHAKER K+ CHANNEL; NUCLEAR MAGNETIC-RESONANCE; POTASSIUM CHANNEL; SOLID-STATE; SODIUM-CHANNELS; RESTING STATE; SIDE-CHAINS; S4 SEGMENT; DYNAMICS; PROTEIN	The gating of voltage-gated ion channels is controlled by the arginine-rich S4 helix of the voltage-sensor domain moving in response to an external potential. Recent studies have suggested that S4 moves in three to four steps to open the conducting pore, thus visiting several intermediate conformations during gating. However, the exact conformational changes are not known in detail. For instance, it has been suggested that there is a local rotation in the helix corresponding to short segments of a 3(10)-helix moving along S4 during opening and closing. Here, we have explored the energetics of the transition between the fully open state (based on the X-ray structure) and the first intermediate state towards channel closing (C-1), modeled from experimental constraints. We show that conformations within 3 angstrom of the X-ray structure are obtained in simulations starting from the C-1 model, and directly observe the previously suggested sliding 3(10)-helix region in S4. Through systematic free energy calculations, we show that the C-1 state is a stable intermediate conformation and determine free energy profiles for moving between the states without constraints. Mutations indicate several residues in a narrow hydrophobic band in the voltage sensor contribute to the barrier between the open and C-1 states, with F233 in the S2 helix having the largest influence. Substitution for smaller amino acids reduces the transition cost, while introduction of a larger ring increases it, largely confirming experimental activation shift results. There is a systematic correlation between the local aromatic ring rotation, the arginine barrier crossing, and the corresponding relative free energy. In particular, it appears to be more advantageous for the F233 side chain to rotate towards the extracellular side when arginines cross the hydrophobic region.	[Schwaiger, Christine S.; Hess, Berk; Lindahl, Erik] Sci Life Lab, Solna, Sweden; [Schwaiger, Christine S.; Hess, Berk; Lindahl, Erik] Royal Inst Technol, Dept Theoret Phys, S-10044 Stockholm, Sweden; [Borjesson, Sara I.; Elinder, Fredrik] Linkoping Univ, Dept Clin & Expt Med, Div Cell Biol, Linkoping, Sweden; [Wallner, Bjorn] Linkoping Univ, Dept Phys Chem & Biol, Linkoping, Sweden; [Wallner, Bjorn] Linkoping Univ, Swedish Esci Res Ctr, Linkoping, Sweden; [Lindahl, Erik] Stockholm Univ, Dept Biochem & Biophys, Ctr Biomembrane Res, S-10691 Stockholm, Sweden	Royal Institute of Technology; Linkoping University; Linkoping University; Linkoping University; Swedish e-Science Research Centre (SeRC); Stockholm University	Lindahl, E (corresponding author), Sci Life Lab, Solna, Sweden.	erik@kth.se	Liin, Sara/I-2941-2012; Wallner, Björn/R-1030-2018; Lindahl, Erik/D-4590-2013	Wallner, Björn/0000-0002-3772-8279; Lindahl, Erik/0000-0002-2734-2794; Hess, Berk/0000-0002-7498-7763; Liin, Sara/0000-0001-8493-0114; Elinder, Fredrik/0000-0001-9125-5583	European Research Council [209825]; Vetenskapsradet [2010-5107]; Swedish Foundation for Strategic Research; Swedish e-Science Research Center	European Research Council(European Research Council (ERC)European Commission); Vetenskapsradet(Swedish Research Council); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish e-Science Research Center	This work was supported by grants from the European Research Council (209825), Vetenskapsradet (2010-5107), the Swedish Foundation for Strategic Research and the Swedish e-Science Research Center. Computing resources were provided by the Swedish National Infrastructure for Computing (SNIC 014/10-31). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; ARMSTRONG CM, 1981, PHYSIOL REV, V61, P644, DOI 10.1152/physrev.1981.61.3.644; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bjelkmar P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000289; Campos FV, 2007, P NATL ACAD SCI USA, V104, P7904, DOI 10.1073/pnas.0702638104; Chen XR, 2010, P NATL ACAD SCI USA, V107, P11352, DOI 10.1073/pnas.1000142107; Cohen BE, 2003, NEURON, V39, P395, DOI 10.1016/S0896-6273(03)00472-0; French RJ, 1996, NEURON, V16, P407, DOI 10.1016/S0896-6273(00)80058-6; FREY MH, 1985, J AM CHEM SOC, V107, P7311, DOI 10.1021/ja00311a016; GALL CM, 1982, P NATL ACAD SCI-BIOL, V79, P101, DOI 10.1073/pnas.79.1.101; Henrion U, 2012, P NATL ACAD SCI US, DOI 101073/pnas1116938109; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hiraoki T, 1998, J MOL STRUCT, V441, P243, DOI 10.1016/S0022-2860(97)00257-3; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HOSHI T, 1994, J GEN PHYSIOL, V103, P249, DOI 10.1085/jgp.103.2.249; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; Islas LD, 2001, J GEN PHYSIOL, V117, P69, DOI 10.1085/jgp.117.1.69; Jensen MO, 2012, SCIENCE, V336, P229, DOI 10.1126/science.1216533; KAMB A, 1988, NEURON, V1, P421, DOI 10.1016/0896-6273(88)90192-4; Khalili-Araghi F, 2010, BIOPHYS J, V98, P2189, DOI 10.1016/j.bpj.2010.02.056; KINSEY RA, 1981, J BIOL CHEM, V256, P9028; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lacroix JJ, 2011, P NATL ACAD SCI USA, V108, P6444, DOI 10.1073/pnas.1103397108; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; LEVY RM, 1983, BIOPHYS J, V41, P217, DOI 10.1016/S0006-3495(83)84422-1; Li-Smerin Y, 2000, J GEN PHYSIOL, V115, P673, DOI 10.1085/jgp.115.6.673; Lin MCA, 2011, J GEN PHYSIOL, V138, P155, DOI 10.1085/jgp.201110642; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Pathak MM, 2007, NEURON, V56, P124, DOI 10.1016/j.neuron.2007.09.023; Pless SA, 2011, NAT CHEM BIOL, V7, P617, DOI [10.1038/nchembio.622, 10.1038/NCHEMBIO.622]; SAITO H, 1990, MACROMOLECULES, V23, P83, DOI 10.1021/ma00203a016; Schoppa NE, 1998, J GEN PHYSIOL, V111, P271, DOI 10.1085/jgp.111.2.271; Schrodinger LLC, 2010, PYM MOL GRAPH SYST V; Schwaiger CS, 2011, BIOPHYS J, V100, P1446, DOI 10.1016/j.bpj.2011.02.003; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Shafrir Y, 2008, BIOPHYS J, V95, P3663, DOI 10.1529/biophysj.108.135335; Swartz KJ, 1997, NEURON, V18, P675, DOI 10.1016/S0896-6273(00)80307-4; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Upadhyay SK, 2009, J PHYSIOL-LONDON, V587, P3851, DOI 10.1113/jphysiol.2009.174730; Vargas E, 2011, NEURON, V72, P713, DOI 10.1016/j.neuron.2011.09.024; Villalba-Galea CA, 2008, P NATL ACAD SCI USA, V105, P17600, DOI 10.1073/pnas.0807387105; YANG NB, 1995, NEURON, V15, P213, DOI 10.1016/0896-6273(95)90078-0; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	49	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e45880	10.1371/journal.pone.0045880	http://dx.doi.org/10.1371/journal.pone.0045880			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094020	Green Published, gold, Green Submitted			2022-12-25	WOS:000310050200005
J	Zhou, K; Michiels, CW; Aertsen, A				Zhou, Kai; Michiels, Chris W.; Aertsen, Abram			Variation of Intragenic Tandem Repeat Tract of tolA Modulates Escherichia coli Stress Tolerance	PLOS ONE			English	Article							FILAMENTOUS PHAGE INFECTION; C-TERMINAL DOMAIN; MICROSATELLITE INSTABILITY; CELL-DIVISION; MUTATIONS; MEMBRANE; COMPLEX; CHROMOSOME; CORECEPTOR; MECHANISMS	In recent work we discovered that the intragenic tandem repeat (TR) region of the tolA gene is highly variable among different Escherichia coli strains. The aim of this study was therefore to investigate the biological function and dynamics of TR variation in E. coli tolA. The biological impact of TR variation was examined by comparing the ability of a set of synthetic tolA variants with in frame repeat copies varying from 2 to 39 to rescue the altered susceptibility of an E. coli Delta tolA mutant to deoxycholic acid, sodium dodecyl sulfate, hyperosmolarity, and infection with filamentous bacteriophage. Interestingly, although each of the TolA variants was able to at least partly rescue the Delta tolA mutant, the extent was clearly dependent on both the repeat number and the type of stress imposed, indicating the existence of opposing selective forces with regard to the optimal TR copy number. Subsequently, TR dynamics in a clonal population were assayed, and we could demonstrate that TR contractions are RecA dependent and enhanced in a DNA repair deficient uvrD background, and can occur at a frequency of 6.9x10(-5).	[Aertsen, Abram] Katholieke Univ Leuven, Fac Biosci Engn, Dept Microbial & Mol Syst M2S, Food Microbiol Lab, Louvain, Belgium; Katholieke Univ Leuven, Fac Biosci Engn, Dept Microbial & Mol Syst M2S, Leuven Food Sci & Nutr Res Ctr LFoRCe, Louvain, Belgium	KU Leuven; KU Leuven	Aertsen, A (corresponding author), Katholieke Univ Leuven, Fac Biosci Engn, Dept Microbial & Mol Syst M2S, Food Microbiol Lab, Louvain, Belgium.	abram.aertsen@biw.kuleuven.be	Michiels, Chris/I-6847-2013	Michiels, Chris/0000-0002-7710-6802; Aertsen, Abram/0000-0002-1897-2305	Research Foundation Flanders [G.0289.06N]	Research Foundation Flanders(FWO)	This work was financially supported by a grant from the Research Foundation Flanders (G.0289.06N); http://www.fwo.be/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begley M, 2005, FEMS MICROBIOL REV, V29, P625, DOI 10.1016/j.femsre.2004.09.003; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bichara M, 2006, MUTAT RES-FUND MOL M, V598, P144, DOI 10.1016/j.mrfmmm.2006.01.020; Bierne H, 1997, MOL MICROBIOL, V26, P557, DOI 10.1046/j.1365-2958.1997.6011973.x; Bouveret E, 1998, MOL MICROBIOL, V27, P143, DOI 10.1046/j.1365-2958.1998.00667.x; Callewaert L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000019; Cooley MB, 2010, APPL ENVIRON MICROB, V76, P3398, DOI 10.1128/AEM.02373-09; Croes E, 2009, J AGR FOOD CHEM, V57, P1029, DOI 10.1021/jf802638n; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dawid S, 1999, P NATL ACAD SCI USA, V96, P1077, DOI 10.1073/pnas.96.3.1077; De Paepe M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002107; DEROUICHE R, 1995, J BIOL CHEM, V270, P11078, DOI 10.1074/jbc.270.19.11078; Deszo EL, 2005, P NATL ACAD SCI USA, V102, P5564, DOI 10.1073/pnas.0407428102; Gemayel R, 2010, ANNU REV GENET, V44, P445, DOI 10.1146/annurev-genet-072610-155046; Gerding MA, 2007, MOL MICROBIOL, V63, P1008, DOI 10.1111/j.1365-2958.2006.05571.x; Hashem VI, 2004, MUTAT RES-FUND MOL M, V554, P95, DOI 10.1016/j.mrfmmm.2004.03.012; Heermann R, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-14; Hernandez SB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002459; Hill TM, 1997, J BACTERIOL, V179, P1931, DOI 10.1128/jb.179.6.1931-1939.1997; Karlsson F, 2003, J BACTERIOL, V185, P2628, DOI 10.1128/JB.185.8.2628-2634.2003; Krachler AM, 2010, J MOL BIOL, V403, P270, DOI 10.1016/j.jmb.2010.08.050; Legendre M, 2007, GENOME RES, V17, P1787, DOI 10.1101/gr.6554007; LEVENGOOD SK, 1991, P NATL ACAD SCI USA, V88, P5939, DOI 10.1073/pnas.88.14.5939; LEVENGOODFREYERMUTH SK, 1993, J BACTERIOL, V175, P222, DOI 10.1128/JB.175.1.222-228.1993; Lubkowski J, 1999, STRUCTURE, V7, P711, DOI 10.1016/S0969-2126(99)80092-6; Luria SE, 1943, GENETICS, V28, P491; Madoff LC, 1996, P NATL ACAD SCI USA, V93, P4131, DOI 10.1073/pnas.93.9.4131; Martin P, 2005, P NATL ACAD SCI USA, V102, P3800, DOI 10.1073/pnas.0406805102; MARVIN DA, 1969, BACTERIOL REV, V33, P172, DOI 10.1007/BF02702778; Merritt ME, 2009, J MED MICROBIOL, V58, P1533, DOI 10.1099/jmm.0.014092-0; Meury J, 1999, BIOL CELL, V91, P67, DOI 10.1016/S0248-4900(99)80032-X; Morel P, 1998, P NATL ACAD SCI USA, V95, P10003, DOI 10.1073/pnas.95.17.10003; Moxon R, 2006, ANNU REV GENET, V40, P307, DOI 10.1146/annurev.genet.40.110405.090442; Raggett EM, 1998, MOL MICROBIOL, V28, P1335, DOI 10.1046/j.1365-2958.1998.00899.x; Rando OJ, 2007, CELL, V128, P655, DOI 10.1016/j.cell.2007.01.023; Riechmann L, 1997, CELL, V90, P351, DOI 10.1016/S0092-8674(00)80342-6; Ritz D, 2001, SCIENCE, V294, P158, DOI 10.1126/science.1063143; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schendel SL, 1997, J BACTERIOL, V179, P3683, DOI 10.1128/jb.179.11.3683-3690.1997; Schofield MJ, 2003, ANNU REV MICROBIOL, V57, P579, DOI 10.1146/annurev.micro.57.030502.090847; Shaver AC, 2003, J BACTERIOL, V185, P6076, DOI 10.1128/JB.185.20.6076-6082.2003; Sheets AJ, 2011, J BACTERIOL, V193, P329, DOI 10.1128/JB.00933-10; VANHAM SM, 1993, CELL, V73, P1187, DOI 10.1016/0092-8674(93)90647-9; Vinces MD, 2009, SCIENCE, V324, P1213, DOI 10.1126/science.1170097; Vines ED, 2005, J BACTERIOL, V187, P3359, DOI 10.1128/JB.187.10.3359-3368.2005; Vogler AJ, 2006, J BACTERIOL, V188, P4253, DOI 10.1128/JB.00001-06; Wagner J, 2000, J BACTERIOL, V182, P4587, DOI 10.1128/JB.182.16.4587-4595.2000; Zhou K, 2012, RES MICROBIOL, V163, P316, DOI 10.1016/j.resmic.2012.05.003	48	3	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47766	10.1371/journal.pone.0047766	http://dx.doi.org/10.1371/journal.pone.0047766			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094082	Green Published, gold, Green Submitted			2022-12-25	WOS:000310050200043
J	Clark, D; Tuor, UI; Thompson, R; Institoris, A; Kulynych, A; Zhang, X; Kinniburgh, DW; Bari, F; Busija, DW; Barber, PA				Clark, Darren; Tuor, Ursula I.; Thompson, Roger; Institoris, Adam; Kulynych, Angela; Zhang, Xu; Kinniburgh, David W.; Bari, Ferenc; Busija, David W.; Barber, Philip A.			Protection against Recurrent Stroke with Resveratrol: Endothelial Protection	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; ISCHEMIA-REPERFUSION; TRANS-RESVERATROL; OXIDATIVE STRESS; RAT-BRAIN; INJURY; CELLS; MODEL; EXPRESSION; DISEASES	Despite increased risk of a recurrent stroke following a minor stroke, information is minimal regarding the interaction between injurious mild cerebral ischemic episodes and the possible treatments which might be effective. The aim of the current study was to investigate recurrent ischemic stroke and whether resveratrol, a nutritive polyphenol with promising cardio-and neuro-protective properties, could ameliorate the associated brain damage. Experiments in adult rats demonstrated that a mild ischemic stroke followed by a second mild cerebral ischemia exacerbated brain damage, and, daily oral resveratrol treatment after the first ischemic insult reduced ischemic cell death with the recurrent insult (P<0.002). Further investigation demonstrated reduction of both inflammatory changes and markers of oxidative stress in resveratrol treated animals. The protection observed with resveratrol treatment could not be explained by systemic effects of resveratrol treatment including effects either on blood pressure or body temperature measured telemetrically. Investigation of resveratrol effects on the blood-brain barrier in vivo demonstrated that resveratrol treatment reduced blood-brain barrier disruption and edema following recurrent stroke without affecting regional cerebral blood flow. Investigation of the mechanism in primary cell culture studies demonstrated that resveratrol treatment significantly protected endothelial cells against an in vitro 'ischemia' resulting in improved viability against oxygen and glucose deprivation (39.6 +/- 6.6% and 81.3 +/- 9.5% in vehicle and resveratrol treated cells, respectively). An inhibition of nitric oxide synthesis did not prevent the improved cell viability following oxygen glucose deprivation but SIRT-1 inhibition with sirtinol partially blocked the protection (P<0.001) suggesting endothelial protection is to some extent SIRT-1 dependent. Collectively, the results support that oral resveratrol treatment provides a low risk strategy to protect the brain from enhanced damage produced by recurrent stroke which is mediated in part by a protective effect of resveratrol on the endothelium of the cerebrovasculature.	[Clark, Darren; Tuor, Ursula I.; Thompson, Roger; Kulynych, Angela; Barber, Philip A.] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Clark, Darren; Tuor, Ursula I.; Thompson, Roger; Kulynych, Angela; Barber, Philip A.] Univ Calgary, Fac Med, Calgary, AB, Canada; [Clark, Darren; Tuor, Ursula I.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Clark, Darren; Tuor, Ursula I.] Univ Calgary, Dept Clin Neurosci, Calgary, AB, Canada; [Clark, Darren; Tuor, Ursula I.] Univ Calgary, Dept Radiol, Calgary, AB, Canada; [Clark, Darren; Bari, Ferenc] Univ Szeged, Dept Med Phys & Informat, Szeged, Hungary; [Institoris, Adam] Univ Szeged, Dept Physiol, Szeged, Hungary; [Busija, David W.] Tulane Univ, Dept Pharmacol, New Orleans, LA 70118 USA; [Zhang, Xu; Kinniburgh, David W.] Univ Calgary, Alberta Ctr Toxicol, Calgary, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Calgary; University of Calgary; Szeged University; Szeged University; Tulane University; University of Calgary	Tuor, UI (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.	utuor@ucalgary.ca	Barber, Philip A/C-7108-2016	Clark, Darren/0000-0002-9152-6539	Canadian Institutes for Health Research [172805, 231136]; Heart and Stroke Foundation; Eli Lilly; OTKA [K81266]; HURO-TRANSMED	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation(Heart & Stroke Foundation of Canada); Eli Lilly(Eli Lilly); OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); HURO-TRANSMED	This work was supported by the Canadian Institutes for Health Research (Grants 172805 and 231136) and a fellowship to DC from the Heart and Stroke Foundation and Eli Lilly. Studies conducted in Hungary were supported by OTKA (K81266) and HURO-TRANSMED. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida L, 2009, MOL NUTR FOOD RES, V53, pS7, DOI 10.1002/mnfr.200800177; Aries MJH, 2010, STROKE, V41, P2697, DOI 10.1161/STROKEAHA.110.594168; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Boocock DJ, 2007, J CHROMATOGR B, V848, P182, DOI 10.1016/j.jchromb.2006.10.017; Borriello A, 2010, NUTR METAB CARDIOVAS, V20, P618, DOI 10.1016/j.numecd.2010.07.004; BUSTO R, 1987, J CEREBR BLOOD F MET, V7, P729, DOI 10.1038/jcbfm.1987.127; Chan V, 2011, CURR PHARM BIOTECHNO, V12, P429, DOI 10.2174/138920111794480552; Chang HC, 2010, J CEREB BLOOD FLOW M; Cheng G, 2009, NEUROSCI LETT, V451, P105, DOI 10.1016/j.neulet.2008.12.045; Dal-Pan Alexandre, 2010, BMC Physiology, V10, P11, DOI 10.1186/1472-6793-10-11; del Zoppo GJ, 2010, ANN NY ACAD SCI, V1207, P46, DOI 10.1111/j.1749-6632.2010.05760.x; Della-Morte D, 2009, NEUROSCIENCE, V159, P993, DOI 10.1016/j.neuroscience.2009.01.017; Domoki F, 2008, AM J PHYSIOL-REG I, V295, pR1099, DOI 10.1152/ajpregu.90430.2008; Dong WP, 2008, J VASC SURG, V48, P709, DOI 10.1016/j.jvs.2008.04.007; Gao DK, 2006, LIFE SCI, V78, P2564, DOI 10.1016/j.lfs.2005.10.030; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; Haynes RL, 2003, J NEUROPATH EXP NEUR, V62, P441, DOI 10.1093/jnen/62.5.441; Kaur J, 2011, J CEREB BLOOD FLOW M; Kis B, 2002, J NEUROENDOCRINOL, V14, P283, DOI 10.1046/j.1365-2826.2002.00778.x; Kiziltepe U, 2004, J VASC SURG, V40, P138, DOI 10.1016/j.jvs.2004.03.032; Kleindorfer D, 2005, STROKE, V36, P720, DOI 10.1161/01.STR.0000158917.59233.b7; Lin YL, 2010, J NUTR, V140, P2187, DOI 10.3945/jn.110.123505; Mayers JR, 2009, FASEB J, V23, P1032, DOI 10.1096/fj.08-115923; Morris KC, 2011, J CEREBR BLOOD F MET, V31, P1003, DOI 10.1038/jcbfm.2010.229; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Qiao M, 2009, J NEUROSCI METH, V184, P244, DOI 10.1016/j.jneumeth.2009.08.010; Qiao M, 2009, INT J DEV NEUROSCI, V27, P691, DOI 10.1016/j.ijdevneu.2009.07.004; Rosenberg GA, 2012, J CEREBR BLOOD F MET, V32, P1139, DOI 10.1038/jcbfm.2011.197; Schmitt CA, 2010, BIOFACTORS, V36, P342, DOI 10.1002/biof.109; Shin JA, 2010, J NEUROIMMUNOL; Sinha K, 2002, LIFE SCI, V71, P655, DOI 10.1016/S0024-3205(02)01691-0; Thandapilly SJ, 2010, AM J HYPERTENS, V23, P192, DOI 10.1038/ajh.2009.228; Tsai SK, 2007, J VASC SURG, V46, P346, DOI 10.1016/j.jvs.2007.04.044; Ungvari Z, 2010, AM J PHYSIOL-HEART C, V299, pH18, DOI 10.1152/ajpheart.00260.2010; Ungvari Z, 2009, AM J PHYSIOL-HEART C, V297, pH1876, DOI 10.1152/ajpheart.00375.2009; Wang CX, 2009, INT J STROKE, V4, P274, DOI 10.1111/j.1747-4949.2009.00317.x; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257; Yenari MA, 2010, STROKE, V41, pS72, DOI 10.1161/STROKEAHA.110.595371	39	61	64	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47792	10.1371/journal.pone.0047792	http://dx.doi.org/10.1371/journal.pone.0047792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082218	Green Submitted, Green Accepted, gold, Green Published			2022-12-25	WOS:000311146900115
J	Golden, CD; Rasolofoniaina, BJR; Benjamin, R; Young, SL				Golden, Christopher D.; Rasolofoniaina, B. J. Rodolph; Benjamin, Rakoto; Young, Sera L.			Pica and Amylophagy Are Common among Malagasy Men, Women and Children	PLOS ONE			English	Article							PREGNANT-WOMEN; GEOPHAGY; IRON; SCHOOLCHILDREN; NUTRITION; ANEMIA; ASSOCIATION; INFECTION; TANZANIA	Pica, the craving and purposive consumption of non-food substances, is of public health concern for its potential deleterious and salubrious health consequences. However, neither its prevalence nor demographic correlates have been well characterized. Therefore, we conducted the first population-based study of pica and amylophagy in Madagascar. From February to December 2009, we surveyed pica and amylophagy behaviors in a random sample of 760 individuals >5 years in 167 households among two ethnic groups in 16 villages in the Makira Protected Area of Madagascar. Of the 760 individuals interviewed, 62.5% were children (5-11 years), 5.4% were adolescents (12-16 years), and 35.1% were adults (>= 17 years). Thirteen non-food items were reported being consumed. Across the entire population in the prior year, the prevalence of geophagy was 53.4%, of amylophagy, 85.2%, and of other pica substances (e.g. charcoal, chalk) was 19.0%. The prevalence of these behaviors was not higher during pregnancy. These findings differ from previous studies in terms of the higher overall prevalence of these behaviors, the high prevalence among men, and the absence of any peak in behaviors during pregnancy. However, there are two categories of substances that elevate our estimates but fall outside the strict definition of pica as a craving: 1) substances consumed for self-medication and 2) substances viewed as food, such as all amylophagic substances in this case. Our results suggest that population-based studies of pica should include males of all ages. Further, the prevalence of the behavior underscores the importance of understanding the etiology and health consequences of these ingestive behaviors (Abstract S1).	[Golden, Christopher D.] Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA; [Golden, Christopher D.; Rasolofoniaina, B. J. Rodolph] Madagascar Hlth & Environm Res MAHERY, Maroantsetra, Madagascar; [Benjamin, Rakoto] Univ Antananarivo, Ecole Super Sci Agron, Dept Agr, Antananarivo, Madagascar; [Young, Sera L.] Cornell Univ, Div Nutr Sci, Ithaca, NY 14853 USA	Harvard University; University Antananarivo; Cornell University	Golden, CD (corresponding author), Harvard Univ, Ctr Environm, Cambridge, MA 02138 USA.	cgolden@fas.harvard.edu		Young, Sera/0000-0002-1763-1218; Golden, Christopher/0000-0002-2258-7493; Golden, Christopher/0000-0002-0358-4625	Margot Marsh Biodiversity Fund [023815]; National Geographic Society Conservation Trust [C135-08]; National Science Foundation Doctoral Dissertation Improvement Grant [DEB- 1011714]	Margot Marsh Biodiversity Fund; National Geographic Society Conservation Trust(National Geographic Society); National Science Foundation Doctoral Dissertation Improvement Grant(National Science Foundation (NSF))	This study was supported by the Margot Marsh Biodiversity Fund #023815, the National Geographic Society Conservation Trust #C135-08, and the National Science Foundation Doctoral Dissertation Improvement Grant- DEB- 1011714. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anell B, 1958, STUD ETHNOGR, V17, P1; BRUHN CM, 1971, J AM DIET ASSOC, V58, P417; Corbett Robin Webb, 2003, MCN Am J Matern Child Nurs, V28, P183; CROSBY WH, 1971, ARCH INTERN MED, V127, P960; DANFORD DE, 1982, ANNU REV NUTR, V2, P303, DOI 10.1146/annurev.nu.02.070182.001511; de Flacourt, 1658, HIST GRANDE ISLE MAD, P209; Diouf S, 2000, Dakar Med, V45, P48; FERGUSON JAMES H., 1950, NEW ORLEANS MED AND SURG JOUR, V103, P81; Furuseth O, 1973, GEOPHAGY E N CAROLIN; Geissler PW, 1998, T ROY SOC TROP MED H, V92, P7, DOI 10.1016/S0035-9203(98)90934-8; Golden CD, 2011, P NATL ACAD SCI USA, V108, P19653, DOI 10.1073/pnas.1112586108; Golden CD, 2009, ORYX, V43, P386, DOI 10.1017/S0030605309000131; Heusinger K, 1852, SOGENANNTE GEOPHAGIE; Hooper D, 1906, MEM ASIATIC SOC BENG, V1, P249; Kawai K, 2009, AM J TROP MED HYG, V80, P36, DOI 10.4269/ajtmh.2009.80.36; KEITH L, 1969, Chicago Medical School Quarterly, V28, P109; KEITH LG, 1969, J AMER MED ASSOC, V208, P535, DOI 10.1001/jama.1969.03160030109024; Laufer B, 1930, FIELD MUSEUM NATURAL, P99; Lopez LB, 2007, INT J GYNECOL OBSTET, V98, P151, DOI 10.1016/j.ijgo.2007.03.038; Luoba AI, 2005, TROP MED INT HEALTH, V10, P220, DOI 10.1111/j.1365-3156.2004.01380.x; MARCHI M, 1990, J AM ACAD CHILD PSY, V29, P112, DOI 10.1097/00004583-199001000-00017; Nchito M, 2004, T ROY SOC TROP MED H, V98, P218, DOI 10.1016/S0035-9203(03)00045-2; Ngudi DD, 2003, FOOD CHEM TOXICOL, V41, P1193, DOI 10.1016/S0278-6915(03)00111-X; Nyaruhucha C N M, 2009, Tanzan J Health Res, V11, P29; Rainville AJ, 1998, J AM DIET ASSOC, V98, P293, DOI 10.1016/S0002-8223(98)00069-8; Saathoff E, 2002, T ROY SOC TROP MED H, V96, P485, DOI 10.1016/S0035-9203(02)90413-X; SAYERS G, 1974, S AFR MED J, V48, P1655; Simpson E, 2000, WESTERN J MED, V173, P20, DOI 10.1136/ewjm.173.1.20; Sule S, 2001, Niger J Med, V10, P25; Tayie FAK., 1999, GHANA MED J, V33, P67; Thompson C.J.S., 1914, P 17 INT C MED, P433; WALKER ARP, 1985, BRIT J OBSTET GYNAEC, V92, P484, DOI 10.1111/j.1471-0528.1985.tb01353.x; Young SL, 2011, Q REV BIOL, V86, P97, DOI 10.1086/659884; Young SL, 2010, ANNU REV NUTR, V30, P403, DOI 10.1146/annurev.nutr.012809.104713; Young SL, 2010, AM J TROP MED HYG, V83, P144, DOI 10.4269/ajtmh.2010.09-0442; Young SL, 2010, J CHEM ECOL, V36, P129, DOI 10.1007/s10886-009-9729-y; Young SL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003147	37	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47129	10.1371/journal.pone.0047129	http://dx.doi.org/10.1371/journal.pone.0047129			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082143	Green Submitted, gold, Green Published			2022-12-25	WOS:000311146900038
J	Majdandzic, J; Bauer, H; Windischberger, C; Moser, E; Engl, E; Lamm, C				Majdandzic, Jasminka; Bauer, Herbert; Windischberger, Christian; Moser, Ewald; Engl, Elisabeth; Lamm, Claus			The Human Factor: Behavioral and Neural Correlates of Humanized Perception in Moral Decision Making	PLOS ONE			English	Article							PREFRONTAL CORTEX; PERSPECTIVE-TAKING; COGNITIVE CONTROL; PERSONAL/IMPERSONAL DISTINCTION; ORBITOFRONTAL CORTEX; NEGATIVE AFFECT; FUNCTIONAL MRI; EMPATHY; JUDGMENT; PAIN	The extent to which people regard others as full-blown individuals with mental states ("humanization'') seems crucial for their prosocial motivation towards them. Previous research has shown that decisions about moral dilemmas in which one person can be sacrificed to save multiple others do not consistently follow utilitarian principles. We hypothesized that this behavior can be explained by the potential victim's perceived humanness and an ensuing increase in vicarious emotions and emotional conflict during decision making. Using fMRI, we assessed neural activity underlying moral decisions that affected fictitious persons that had or had not been experimentally humanized. In implicit priming trials, participants either engaged in mentalizing about these persons (HUMANIZED condition) or not (NEUTRAL condition). In subsequent moral dilemmas, participants had to decide about sacrificing these persons' lives in order to save the lives of numerous others. Humanized persons were sacrificed less often, and the activation pattern during decisions about them indicated increased negative affect, emotional conflict, vicarious emotions, and behavioral control (pgACC/mOFC, anterior insula/IFG, aMCC and precuneus/PCC). Besides, we found enhanced effective connectivity between aMCC and anterior insula, which suggests increased emotion regulation during decisions affecting humanized victims. These findings highlight the importance of others' perceived humanness for prosocial behavior - with aversive affect and other-related concern when imagining harming more "human-like'' persons acting against purely utilitarian decisions.	[Majdandzic, Jasminka; Bauer, Herbert; Engl, Elisabeth; Lamm, Claus] Univ Vienna, Social Cognit & Affect Neurosci Unit, Fac Psychol, Vienna, Austria; [Majdandzic, Jasminka; Windischberger, Christian; Moser, Ewald] Med Univ Vienna, Ctr Med Phys & Biomed Engn, Vienna, Austria	University of Vienna; Medical University of Vienna	Majdandzic, J (corresponding author), Univ Vienna, Social Cognit & Affect Neurosci Unit, Fac Psychol, Vienna, Austria.	jasminka.majdandzic@univie.ac.at; claus.lamm@univie.ac.at	Moser, Ewald/B-3666-2013; Lamm, Claus/B-3357-2014	Moser, Ewald/0000-0001-8278-9583; Lamm, Claus/0000-0002-5422-0653; Engl, Elisabeth/0000-0002-1400-7858; Windischberger, Christian/0000-0002-9944-0190	Austrian Federal Ministry of Defence and Sports, Vienna, Austria	Austrian Federal Ministry of Defence and Sports, Vienna, Austria	This work was supported by a grant from the Austrian Federal Ministry of Defence and Sports, Vienna, Austria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichhorn M, 2009, J COGNITIVE NEUROSCI, V21, P1179, DOI 10.1162/jocn.2009.21082; Allport G., 1979, NATURE PREJUDICE; Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Anderson SW, 1999, NAT NEUROSCI, V2, P1032, DOI 10.1038/14833; BATSON CD, 1995, J PERS SOC PSYCHOL, V68, P1042, DOI 10.1037/0022-3514.68.6.1042; BATSON CD, 1987, J PERS, V55, P19, DOI 10.1111/j.1467-6494.1987.tb00426.x; Batson CD, 1997, PERS SOC PSYCHOL B, V23, P751, DOI 10.1177/0146167297237008; Bechara A, 2005, NAT NEUROSCI, V8, P1458, DOI 10.1038/nn1584; Borg JS, 2006, J COGNITIVE NEUROSCI, V18, P803, DOI 10.1162/jocn.2006.18.5.803; Cauda F, 2011, NEUROIMAGE, V55, P8, DOI 10.1016/j.neuroimage.2010.11.049; Chang LJ, 2008, ADV HEALTH ECON HEAL, V20, P31, DOI 10.1016/S0731-2199(08)20002-6; Cheetham M, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.029.2009; CIALDINI RB, 1987, J PERS SOC PSYCHOL, V52, P749, DOI 10.1037/0022-3514.52.4.749; Ciaramelli E, 2007, SOC COGN AFFECT NEUR, V2, P84, DOI 10.1093/scan/nsm001; Cikara M, 2010, SOC COGN AFFECT NEUR, V5, P404, DOI 10.1093/scan/nsq011; Craig AD, 2010, BRAIN STRUCT FUNCT, V214, P563, DOI 10.1007/s00429-010-0248-y; Cushman F, 2006, PSYCHOL SCI, V17, P1082, DOI 10.1111/j.1467-9280.2006.01834.x; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Decety J, 2003, TRENDS COGN SCI, V7, P527, DOI 10.1016/j.tics.2003.10.004; Decety J., 2005, OTHER MINDS HUMANS B, P143; Decety J, 2007, NEUROSCIENTIST, V13, P580, DOI 10.1177/1073858407304654; Diekhof EK, 2011, NEUROIMAGE, V58, P275, DOI 10.1016/j.neuroimage.2011.05.073; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Farrow TFD, 2001, NEUROREPORT, V12, P2433, DOI 10.1097/00001756-200108080-00029; FLETCHER PC, 1995, NEUROIMAGE, V2, P195, DOI 10.1006/nimg.1995.1025; Friston K. J., 1994, Human Brain Mapping, V2, P189, DOI 10.1002/hbm.460020402; Friston KJ, 1996, NEUROIMAGE, V4, P223, DOI 10.1006/nimg.1996.0074; Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Gallagher HL, 2000, NEUROPSYCHOLOGIA, V38, P11, DOI 10.1016/S0028-3932(99)00053-6; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Greene J, 2002, TRENDS COGN SCI, V6, P517, DOI 10.1016/S1364-6613(02)02011-9; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Greene JD, 2001, SCIENCE, V293, P2105, DOI 10.1126/science.1062872; Greene JD, 2009, J EXP SOC PSYCHOL, V45, P581, DOI 10.1016/j.jesp.2009.01.003; Greene JD, 2009, COGNITION, V111, P364, DOI 10.1016/j.cognition.2009.02.001; Harcourt AH., 1992, COALITIONS ALLIANCES; Harenski CL, 2008, SOC COGN AFFECT NEUR, V3, P313, DOI 10.1093/scan/nsn026; Harenski CL, 2006, NEUROIMAGE, V30, P313, DOI 10.1016/j.neuroimage.2005.09.034; Harris LT, 2006, PSYCHOL SCI, V17, P847, DOI 10.1111/j.1467-9280.2006.01793.x; Haslam N, 2006, PERS SOC PSYCHOL REV, V10, P252, DOI 10.1207/s15327957pspr1003_4; Heekeren HR, 2003, NEUROREPORT, V14, P1215, DOI 10.1097/00001756-200307010-00005; Jackson PL, 2006, NEUROPSYCHOLOGIA, V44, P752, DOI 10.1016/j.neuropsychologia.2005.07.015; Jahoda G., 1999, IMAGES SAVAGES ANCIE; Klein C, 2011, NEUROETHICS-NETH, V4, P143, DOI 10.1007/s12152-010-9077-1; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Lamm C, 2008, CEREB CORTEX, V18, P2369, DOI 10.1093/cercor/bhn006; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Lamm C, 2011, NEUROIMAGE, V54, P2492, DOI 10.1016/j.neuroimage.2010.10.014; Lamm C, 2010, BRAIN STRUCT FUNCT, V214, P579, DOI 10.1007/s00429-010-0251-3; Langner O, 2010, COGNITION EMOTION, V24, P1377, DOI 10.1080/02699930903485076; Leyens JP, 2000, PERS SOC PSYCHOL REV, V4, P186, DOI 10.1207/S15327957PSPR0402_06; Maner JK, 2002, PERS SOC PSYCHOL B, V28, P1601, DOI 10.1177/014616702237586; McGuire J, 2009, J EXP SOC PSYCHOL, V45, P577, DOI 10.1016/j.jesp.2009.01.002; Mercadillo RE, 2011, BRAIN COGNITION, V76, P5, DOI 10.1016/j.bandc.2011.03.019; MESULAM MM, 1982, J COMP NEUROL, V212, P38, DOI 10.1002/cne.902120104; Moll J, 2002, NEUROIMAGE, V16, P696, DOI 10.1006/nimg.2002.1118; Moll J, 2002, J NEUROSCI, V22, P2730, DOI 10.1523/JNEUROSCI.22-07-02730.2002; Moll J, 2001, ARQ NEURO-PSIQUIAT, V59, P657, DOI 10.1590/S0004-282X2001000500001; Moore AB, 2008, PSYCHOL SCI, V19, P549, DOI 10.1111/j.1467-9280.2008.02122.x; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Penny W.D., 2004, HUMAN BRAIN FUNCTION, P843; Picard N, 1996, CEREB CORTEX, V6, P342, DOI 10.1093/cercor/6.3.342; Raine A, 2006, SOC COGN AFFECT NEUR, V1, P203, DOI 10.1093/scan/nsl033; Ridderinkhof KR, 2004, BRAIN COGNITION, V56, P129, DOI 10.1016/j.bandc.2004.09.016; Robertson D, 2006, NEUROPSYCHOLOGIA; Saxe R, 2004, ANNU REV PSYCHOL, V55, P87, DOI 10.1146/annurev.psych.55.090902.142044; Shackman AJ, 2011, NAT REV NEUROSCI, V12, P154, DOI 10.1038/nrn2994; Shenhav A, 2010, NEURON, V67, P667, DOI 10.1016/j.neuron.2010.07.020; Siegal M, 2002, NAT REV NEUROSCI, V3, P463, DOI 10.1038/nrn844; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2009, TRENDS COGN SCI, V13, P334, DOI 10.1016/j.tics.2009.05.001; Singer T, 2009, ANN NY ACAD SCI, V1156, P81, DOI 10.1111/j.1749-6632.2009.04418.x; Sladky R, 2011, NEUROIMAGE, V58, P588, DOI 10.1016/j.neuroimage.2011.06.078; Thomson Judith J, 1976, Monist, V59, P204; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Ugazio G, 2012, EMOTION, V12, P579, DOI 10.1037/a0024611; Valentini E, 2010, J NEUROPHYSIOL, V104, P584, DOI 10.1152/jn.00487.2010; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Vogt BA, 2005, PROG BRAIN RES, V150, P205, DOI 10.1016/S0079-6123(05)50015-3; Wager TD, 2004, AFFECT CONTROL FUNCT; Wallis JD, 2007, ANNU REV NEUROSCI, V30, P31, DOI 10.1146/annurev.neuro.30.051606.094334; Waytz A, 2010, J PERS SOC PSYCHOL, V99, P410, DOI 10.1037/a0020240; Wrangham Richard, 1996, DEMONIC MALES APES O; Young L, 2007, P NATL ACAD SCI USA, V104, P8235, DOI 10.1073/pnas.0701408104; Young L, 2009, J COGNITIVE NEUROSCI, V21, P1396, DOI 10.1162/jocn.2009.21137	92	30	30	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47698	10.1371/journal.pone.0047698	http://dx.doi.org/10.1371/journal.pone.0047698			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	038AF	23082194	Green Published, Green Submitted, gold			2022-12-25	WOS:000311146900091
J	Marutani-Hert, M; Bowman, KD; McCollum, GT; Mirkov, TE; Evens, TJ; Niedz, RP				Marutani-Hert, Mizuri; Bowman, Kim D.; McCollum, Greg T.; Mirkov, T. Erik; Evens, Terence J.; Niedz, Randall P.			A Dark Incubation Period Is Important for Agrobacterium-Mediated Transformation of Mature Internode Explants of Sweet Orange, Grapefruit, Citron, and a Citrange Rootstock	PLOS ONE			English	Article							GENETIC-TRANSFORMATION; SHOOT REGENERATION; PLANT-REGENERATION; STEM SEGMENTS; SINENSIS; GROWTH; TUMEFACIENS; RESISTANCE; CULTURE; TISSUE	Background: Citrus has an extended juvenile phase and trees can take 2-20 years to transition to the adult reproductive phase and produce fruit. For citrus variety development this substantially prolongs the time before adult traits, such as fruit yield and quality, can be evaluated. Methods to transform tissue from mature citrus trees would shorten the evaluation period via the direct production of adult phase transgenic citrus trees. Methodology/Principal Findings: Factors important for promoting shoot regeneration from internode explants from adult phase citrus trees were identified and included a dark incubation period and the use of the cytokinin zeatin riboside. Transgenic trees were produced from four citrus types including sweet orange, citron, grapefruit, and a trifoliate hybrid using the identified factors and factor settings. Significance: The critical importance of a dark incubation period for shoot regeneration was established. These results confirm previous reports on the feasibility of transforming mature tissue from sweet orange and are the first to document the transformation of mature tissue from grapefruit, citron, and a trifoliate hybrid.	[Marutani-Hert, Mizuri; Bowman, Kim D.; McCollum, Greg T.; Evens, Terence J.; Niedz, Randall P.] ARS, US Hort Res Lab, USDA, Ft Pierce, FL USA; [Mirkov, T. Erik] Texas A&M Univ, Texas AgriLIFE Res, Dept Plant Pathol & Microbiol, Weslaco, TX USA	United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station; Texas A&M AgriLife Research; Texas A&M University Kingsville	Niedz, RP (corresponding author), ARS, US Hort Res Lab, USDA, Ft Pierce, FL USA.	randall.niedz@ars.usda.gov			Citrus Research and Development Foundation [144]	Citrus Research and Development Foundation	Research funded by the Citrus Research and Development Foundation (http://www.citrusrdf.org/blog/) under project #144 - Agrobacterium-mediated Genetic Transformation of Mature Citrus Tissue. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida WAB, 2003, PLANT SCI, V164, P203, DOI 10.1016/S0168-9452(02)00401-6; Ananthakrishnan G, 2007, IN VITRO CELL DEV-PL, V43, P593, DOI 10.1007/s11627-007-9059-0; Bassan MM, 2011, PESQUI AGROPECU BRAS, V46, P672, DOI 10.1590/S0100-204X2011000600015; Bove JM, 2006, J PLANT PATHOL, V88, P7; Bowman KD, 2006, HORTSCIENCE, V41, P832, DOI 10.21273/HORTSCI.41.3.832; Cervera M, 1998, TRANSGENIC RES, V7, P51, DOI 10.1023/A:1008855922283; Cervera M, 2008, TREE PHYSIOL, V28, P55, DOI 10.1093/treephys/28.1.55; Curtis IS, 2012, PLANT CELL TISS ORG, V108, P345, DOI 10.1007/s11240-011-0037-1; de Carvalho MHC, 2000, PLANT SCI, V159, P223, DOI 10.1016/S0168-9452(00)00346-0; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; DURANVILA N, 1992, PLANT CELL TISS ORG, V29, P11, DOI 10.1007/BF00036140; Dutt M, 2011, PLANT CELL TISS ORG, V107, P79, DOI 10.1007/s11240-011-9959-x; Enrique R, 2011, PLANT BIOTECHNOL J, V9, P394, DOI 10.1111/j.1467-7652.2010.00555.x; Franche C, 1997, PLANT J, V11, P897, DOI 10.1046/j.1365-313X.1997.11040897.x; Fu XZ, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-55; Geekiyanage S, 2006, PLANT BIOTECHNOL, V23, P431, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.23.431; Ghorbel R, 2001, PHYSIOL MOL PLANT P, V58, P103, DOI 10.1006/pmpp.2000.0318; He YR, 2011, SCI HORTIC-AMSTERDAM, V128, P99, DOI 10.1016/j.scienta.2011.01.002; HIDAKA T, 1990, JPN J BREED, V40, P199; HOOD EE, 1993, TRANSGENIC RES, V2, P208, DOI 10.1007/BF01977351; JEFFERSON RA, 1987, EMBO J, V6, P3901; KANEYOSHI J, 1994, PLANT CELL REP, V13, P541, DOI 10.1007/BF00234507; Khawale RN, 2006, CURR SCI INDIA, V91, P1700; Kobayashi AK, 2003, PLANT CELL TISS ORG, V74, P99, DOI 10.1023/A:1023375526781; Loeza-Kuk E, 2011, AGROCIENCIA-MEXICO, V45, P55; Marutani-Hert M, 2011, PLANT CELL TISS ORG, V106, P81, DOI 10.1007/s11240-010-9896-0; Molinari HBC, 2004, SCI HORTIC-AMSTERDAM, V99, P379, DOI 10.1016/S0304-4238(03)00111-0; MOORE GA, 1992, PLANT CELL REP, V11, P238, DOI 10.1007/BF00235073; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Naik SK, 2003, J PLANT PHYSIOL, V160, P423, DOI 10.1078/0176-1617-00949; Niedz RP, 2011, IN VITRO CELL DEV-PL, V47, P682, DOI 10.1007/s11627-011-9381-4; de Oliveira MLP, 2010, PESQUI AGROPECU BRAS, V45, P654, DOI 10.1590/S0100-204X2010000700004; Pena L, 1997, PLANT CELL REP, V16, P731, DOI 10.1007/s002990050311; PENA L, 1995, PLANT SCI, V104, P183, DOI 10.1016/0168-9452(94)04021-8; Perez-Tornero O, 2010, PLANT CELL TISS ORG, V100, P263, DOI 10.1007/s11240-009-9643-6; Rodriguez A, 2008, PLANT CELL TISS ORG, V93, P97, DOI 10.1007/s11240-008-9347-3; Saini HK, 2010, INDIAN J BIOTECHNOL, V9, P419; Uliaie E D, 2008, Pak J Biol Sci, V11, P2040, DOI 10.3923/pjbs.2008.2040.2043; United States Department of Agriculture, 2010, NOT FRUIT GROW NURS; VANCANNEYT G, 1990, MOL GEN GENET, V220, P245, DOI 10.1007/BF00260489; Xu SX, 2011, PLANT CELL TISS ORG, V104, P199, DOI 10.1007/s11240-010-9819-0; Yang L, 2011, PLANT MOL BIOL, V75, P11, DOI 10.1007/s11103-010-9699-z; Yang ZN, 2000, PLANT CELL REP, V19, P1203, DOI 10.1007/s002990000257	45	20	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47426	10.1371/journal.pone.0047426	http://dx.doi.org/10.1371/journal.pone.0047426			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082165	gold, Green Published, Green Submitted			2022-12-25	WOS:000311146900061
J	Mccoy, MW; Touchon, JC; Landberg, T; Warkentin, KM; Vonesh, JR				McCoy, Michael W.; Touchon, Justin C.; Landberg, Tobias; Warkentin, Karen M.; Vonesh, James R.			Prey Responses to Predator Chemical Cues: Disentangling the Importance of the Number and Biomass of Prey Consumed	PLOS ONE			English	Article							ANTIPREDATOR BEHAVIOR; PHENOTYPIC PLASTICITY; CONSPECIFIC DENSITY; TEMPORAL VARIATION; DOSAGE RESPONSE; OPPOSITE SHIFTS; INDUCED DEFENSE; ALARM CUES; RISK; SIZE	To effectively balance investment in predator defenses versus other traits, organisms must accurately assess predation risk. Chemical cues caused by predation events are indicators of risk for prey in a wide variety of systems, but the relationship between how prey perceive risk in relation to the amount of prey consumed by predators is poorly understood. While per capita predation rate is often used as the metric of relative risk, studies aimed at quantifying predator-induced defenses commonly control biomass of prey consumed as the metric of risk. However, biomass consumed can change by altering either the number or size of prey consumed. In this study we determine whether phenotypic plasticity to predator chemical cues depends upon prey biomass consumed, prey number consumed, or both. We examine the growth response of red-eyed treefrog tadpoles (Agalychnis callidryas) to cues from a larval dragonfly (Anax amazili). Biomass consumed was manipulated by either increasing the number of prey while holding individual prey size constant, or by holding the number of prey constant and varying individual prey size. We address two questions. (i) Do prey reduce growth rate in response to chemical cues in a dose dependent manner? (ii) Does the magnitude of the response depend on whether prey consumption increases via number or size of prey? We find that the phenotypic response of prey is an asymptotic function of prey biomass consumed. However, the asymptotic response is higher when more prey are consumed. Our findings have important implications for evaluating past studies and how future experiments should be designed. A stronger response to predation cues generated by more individual prey deaths is consistent with models that predict prey sensitivity to per capita risk, providing a more direct link between empirical and theoretical studies which are often focused on changes in population sizes not individual biomass.	[McCoy, Michael W.] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA; [McCoy, Michael W.; Vonesh, James R.] Virginia Commonwealth Univ, Dept Biol, Richmond, VA 23284 USA; [Touchon, Justin C.; Warkentin, Karen M.] Smithsonian Trop Res Inst, Balboa, Panama; [Touchon, Justin C.; Landberg, Tobias; Warkentin, Karen M.] Boston Univ, Dept Biol, Boston, MA 02215 USA	University of North Carolina; East Carolina University; Virginia Commonwealth University; Smithsonian Institution; Smithsonian Tropical Research Institute; Boston University	Mccoy, MW (corresponding author), E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.	mccoym@ecu.edu	; Vonesh, James/I-1573-2013	McCoy, Michael/0000-0002-7993-6236; Vonesh, James/0000-0003-2481-9988; Warkentin, Karen/0000-0002-7804-800X	U.S. National Science Foundation [DEB-0717220, DEB-0716923]; Office Of Internatl Science &Engineering [1064566] Funding Source: National Science Foundation	U.S. National Science Foundation(National Science Foundation (NSF)); Office Of Internatl Science &Engineering(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by the U.S. National Science Foundation (DEB-0717220 to JRV and DEB-0716923 to KMW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Abrams Peter A., 1996, P371; Altwegg R, 2003, EVOLUTION, V57, P872; ANHOLT BR, 1995, ECOLOGY, V76, P2230, DOI 10.2307/1941696; Benard MF, 2004, ANNU REV ECOL EVOL S, V35, P651, DOI 10.1146/annurev.ecolsys.35.021004.112426; Bolker B, 2003, ECOLOGY, V84, P1101, DOI 10.1890/0012-9658(2003)084[1101:CTAESO]2.0.CO;2; Bolker B., 2012, BBMLE TOOLS GEN MAXI; Brown GE, 1997, ENVIRON BIOL FISH, V49, P89, DOI 10.1023/A:1007302614292; Brown J., 2000, SCALING BIOL; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Chivers DP, 1998, ECOSCIENCE, V5, P338, DOI 10.1080/11956860.1998.11682471; Dicke M, 2001, ANNU REV ECOL SYST, V32, P1, DOI 10.1146/annurev.ecolsys.32.081501.113951; Fraker ME, 2009, HORM BEHAV, V55, P520, DOI 10.1016/j.yhbeh.2009.01.007; Iyengar EV, 2002, MAR ECOL PROG SER, V225, P205, DOI 10.3354/meps225205; Kats LB, 1998, ECOSCIENCE, V5, P361, DOI 10.1080/11956860.1998.11682468; Laurila A, 1997, BEHAV ECOL SOCIOBIOL, V40, P329, DOI 10.1007/s002650050349; Laurila A, 2004, OIKOS, V107, P90, DOI 10.1111/j.0030-1299.2004.13126.x; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; Lima SL, 1998, ADV STUD BEHAV, V27, P215; Mccoy MW, 2008, J ANIM ECOL, V77, P478, DOI 10.1111/j.1365-2656.2008.01372.x; Mccoy MW, 2007, OECOLOGIA, V153, P871, DOI 10.1007/s00442-007-0795-y; McCoy MW, 2011, AM NAT, V177, P752, DOI 10.1086/659950; MITTELBACH GG, 1981, ECOLOGY, V62, P1370, DOI 10.2307/1937300; Orrock JL, 2004, BEHAV ECOL, V15, P433, DOI 10.1093/beheco/arh031; Pangle KL, 2006, FRESHWATER BIOL, V51, P1070, DOI 10.1111/j.1365-2427.2006.01555.x; Peacor SD, 2004, ISR J ZOOL, V50, P139, DOI 10.1560/KPRR-X1C3-5NHE-QV2N; Peacor SD, 2003, OIKOS, V100, P409, DOI 10.1034/j.1600-0706.2003.12043.x; Preisser EL, 2005, ECOLOGY, V86, P501, DOI 10.1890/04-0719; R Development Core Team, 2006, R LANG ENV STAT COMP; Relyea RA, 2004, ECOLOGY, V85, P172, DOI 10.1890/03-0169; Relyea RA, 2003, ECOLOGY, V84, P1827, DOI 10.1890/0012-9658(2003)084[1827:HPRTCP]2.0.CO;2; Relyea RA, 2003, ECOLOGY, V84, P1840, DOI 10.1890/0012-9658(2003)084[1840:PCAPGT]2.0.CO;2; Relyea RA, 2001, ECOLOGY, V82, P541, DOI 10.1890/0012-9658(2001)082[0541:TRBPRA]2.0.CO;2; Relyea RA, 2001, ECOLOGY, V82, P523, DOI 10.1890/0012-9658(2001)082[0523:MABPOL]2.0.CO;2; RIESSEN HP, 1992, AM NAT, V140, P349, DOI 10.1086/285416; SCHEINER SM, 1993, ANNU REV ECOL SYST, V24, P35, DOI 10.1146/annurev.es.24.110193.000343; Schmidt KA, 2006, OIKOS, V113, P82; Schoeppner NM, 2009, FUNCT ECOL, V23, P1114, DOI 10.1111/j.1365-2435.2009.01578.x; Schoeppner NM, 2005, ECOL LETT, V8, P505, DOI 10.1111/j.1461-0248.2005.00744.x; SEYFARTH RM, 1980, SCIENCE, V210, P801, DOI 10.1126/science.7433999; Storm JJ, 2008, CAN J ZOOL, V86, P1259, DOI 10.1139/Z08-114; Teplitsky C, 2005, OECOLOGIA, V145, P364, DOI 10.1007/s00442-005-0132-2; TOLLRIAN R, 1999, ECOLOGY EVOLUTION IN; Touchon JC, 2008, OIKOS, V117, P634, DOI 10.1111/j.0030-1299.2008.16354.x; Touchon JC, ECOLOGY IN PRESS; Turner AM, 2004, OIKOS, V104, P561, DOI 10.1111/j.0030-1299.2004.12615.x; Van Buskirk J, 2002, ECOLOGY, V83, P1580, DOI 10.2307/3071977; VIA S, 1995, TRENDS ECOL EVOL, V10, P212, DOI 10.1016/S0169-5347(00)89061-8; Vonesh JR, 2006, ECOLOGY, V87, P556, DOI 10.1890/05-0930; Warkentin Karen M., 2009, P177; Warkentin KM, 2005, ANIM BEHAV, V70, P59, DOI 10.1016/j.anbehav.2004.09.019; WERNER EE, 1984, ANNU REV ECOL SYST, V15, P393, DOI 10.1146/annurev.es.15.110184.002141; Werner EE, 2003, ECOLOGY, V84, P1083, DOI 10.1890/0012-9658(2003)084[1083:AROTII]2.0.CO;2; Wiackowski K, 1999, FUNCT ECOL, V13, P59, DOI 10.1046/j.1365-2435.1999.00282.x	54	32	32	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47495	10.1371/journal.pone.0047495	http://dx.doi.org/10.1371/journal.pone.0047495			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082171	Green Published, gold, Green Submitted			2022-12-25	WOS:000311146900067
J	Rueegg, CS; Michel, G; Wengenroth, L; von der Weid, NX; Bergstraesser, E; Kuehni, CE				Rueegg, Corina S.; Michel, Gisela; Wengenroth, Laura; von der Weid, Nicolas X.; Bergstraesser, Eva; Kuehni, Claudia E.		SPOG	Physical Performance Limitations in Adolescent and Adult Survivors of Childhood Cancer and Their Siblings	PLOS ONE			English	Article							QUALITY-OF-LIFE; LONG-TERM SURVIVORS; HEMATOPOIETIC GROWTH-FACTORS; RANDOMIZED CONTROLLED-TRIAL; COST-EFFECTIVENESS; HEALTH-STATUS; EXERCISE; FITNESS; DESIGN; RETINOBLASTOMA	Purpose: This study investigates physical performance limitations for sports and daily activities in recently diagnosed childhood cancer survivors and siblings. Methods: The Swiss Childhood Cancer Survivor Study sent a questionnaire to all survivors (>= 16 years) registered in the Swiss Childhood Cancer Registry, who survived >5 years and were diagnosed 1976-2003 aged <16 years. Siblings received similar questionnaires. We assessed two types of physical performance limitations: 1) limitations in sports; 2) limitations in daily activities (using SF-36 physical function score). We compared results between survivors diagnosed before and after 1990 and determined predictors for both types of limitations by multivariable logistic regression. Results: The sample included 1038 survivors and 534 siblings. Overall, 96 survivors (9.5%) and 7 siblings (1.1%) reported a limitation in sports (Odds ratio 5.5, 95% CI 2.9-10.4, p<0.001), mainly caused by musculoskeletal and neurological problems. Findings were even more pronounced for children diagnosed more recently (OR 4.8, CI 2.4-9.6 and 8.3, CI 3.7-18.8 for those diagnosed <1990 and >= 1990, respectively; p = 0.025). Mean physical function score for limitations in daily activities was 49.6 (CI 48.9-50.4) in survivors and 53.1 (CI 52.5-53.7) in siblings (p<0.001). Again, differences tended to be larger in children diagnosed more recently. Survivors of bone tumors, CNS tumors and retinoblastoma and children treated with radiotherapy were most strongly affected. Conclusion: Survivors of childhood cancer, even those diagnosed recently and treated with modern protocols, remain at high risk for physical performance limitations. Treatment and follow-up care should include tailored interventions to mitigate these late effects in high-risk patients.	[Rueegg, Corina S.; Michel, Gisela; Wengenroth, Laura; Kuehni, Claudia E.] Univ Bern, Inst Social & Prevent Med, Swiss Childhood Canc Registry, Bern, Switzerland; [von der Weid, Nicolas X.] CHU Vaudois, Paediat Hematol Oncol Unit, Lausanne, Switzerland; [Bergstraesser, Eva] Univ Childrens Hosp Zurich, Dept Oncol, Zurich, Switzerland	University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University Children's Hospital Zurich	Kuehni, CE (corresponding author), Univ Bern, Inst Social & Prevent Med, Swiss Childhood Canc Registry, Bern, Switzerland.	kuehni@ispm.unibe.ch	Rueegg, Corina Silvia/H-7128-2019; Michel, Gisela/G-1081-2018	Rueegg, Corina Silvia/0000-0003-3720-4659; Michel, Gisela/0000-0002-9589-0928; Kuehni, Claudia E./0000-0001-8957-2002; Bergstrasser, Eva/0000-0002-0340-1868; Leibundgut, Kurt/0000-0003-2514-6041	Cancer League Zurich; Swiss Bridge; Stiftung zur Krebsbekaempfung; Swiss National Science Foundation [PZ00P3_121682/1, PZ00P3_141722, 3233-069348]; Swiss Paediatric Oncology Group; Kinderkrebshilfe Schweiz; Stiftung fur krebskranke Kinder Regio Basiliensis; Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren; Novartis Oncology Switzerland; Interpharma; Axa Wintherthur; Glaxo Smithkline; Amgen; Bristol Myers Squibb; Swiss Cancer League [KLS-01605-10-2004, KLS-2215-02-2008, KLS-02783-02-2011]; Cancer League Aargau	Cancer League Zurich; Swiss Bridge; Stiftung zur Krebsbekaempfung; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Paediatric Oncology Group; Kinderkrebshilfe Schweiz; Stiftung fur krebskranke Kinder Regio Basiliensis; Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren; Novartis Oncology Switzerland; Interpharma; Axa Wintherthur; Glaxo Smithkline(GlaxoSmithKline); Amgen(Amgen); Bristol Myers Squibb(Bristol-Myers Squibb); Swiss Cancer League; Cancer League Aargau	This study was supported by the Swiss Cancer League (Grant No KLS-01605-10-2004, KLS-2215-02-2008, KLS-02783-02-2011; www.krebsliga.ch), Cancer League Aargau (www.krebsliga-aargau.ch), Cancer League Zurich (www.krebsliga-zh.ch), Swiss Bridge (www.swissbridge.ch) and Stiftung zur Krebsbekaempfung (www.krebsbekaempfung.ch). GM and CEK were funded by the Swiss National Science Foundation (GM: Ambizione Fellowship grant PZ00P3_121682/1 and PZ00P3_141722; CEK:PROSPER grant 3233-069348; www.snf.ch). The work of the Swiss Childhood Cancer Registry is supported by the Swiss Paediatric Oncology Group (www.spog.ch), Kinderkrebshilfe Schweiz (www.kinderkrebshilfe.ch), Stiftung fur krebskranke Kinder Regio Basiliensis (www.krebskrankekinder.ch), Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren (GDK; www.gdk-cds.ch), Novartis Oncology Switzerland (www.novartisoncology.ch), Interpharma (www.interpharma.ch), Axa Wintherthur (www.axa-winterthur.ch), Glaxo Smithkline (www.glaxosmithkline.ch), Amgen (www.amgen.ch) and Bristol Myers Squibb (www.bms.ch). The funders of the Swiss Childhood Cancer Registry support the daily running of the registry and have no role in the scientific projects. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JA, 2007, CURR OPIN PEDIATR, V19, P23, DOI 10.1097/MOP.0b013e328013c89e; Badr H, 2011, J AM DIET ASSOC, V111, P1917, DOI 10.1016/j.jada.2011.09.004; Bekkering WP, 2012, PEDIATR BLOOD CANCER, V58, P978, DOI 10.1002/pbc.23328; Braam KI, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-624; Drabko K, 2012, BONE MARROW TRANSPLA; Ellert U, 1999, Gesundheitswesen, V61 Spec No, pS184; Gatta G, 2009, EUR J CANCER, V45, P992, DOI 10.1016/j.ejca.2008.11.042; Germann U, 2005, EIDGENOSSISCHE VOLKS; Hawkins MM, 2008, PEDIATR BLOOD CANCER, V50, P1018, DOI 10.1002/pbc.21335; Heuser M, 2011, CANCER TREAT RES, V157, P339, DOI 10.1007/978-1-4419-7073-2_19; Huang TT, 2011, INT J PEDIAT, V2011, DOI 10.1155/2011/461512; Hudson MM, 2003, JAMA-J AM MED ASSOC, V290, P1583, DOI 10.1001/jama.290.12.1583; Jarvela LS, 2012, PEDIATR BLOOD CANCER, V59, P155, DOI 10.1002/pbc.24049; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kaneko A, 2003, JPN J CLIN ONCOL, V33, P601, DOI 10.1093/jjco/hyg113; Kelly AKW, 2011, CURR SPORT MED REP, V10, P352, DOI 10.1249/JSR.0b013e318237be40; Kuehni CE, 2011, INT J EPIDEMIOL, DOI [10.1093/ije/dyr1142, DOI 10.1093/IJE/DYR1142]; Kuehni CE, 2012, CANCER-AM CANCER SOC, V118, P1439, DOI 10.1002/cncr.26418; Kunin-Batson A, 2011, PEDIATR BLOOD CANCER, V57, P1197, DOI 10.1002/pbc.22982; Liebherr R, 2010, NEUCHATEL BUNDESAMT; Meadows AT, 2006, J CLIN ONCOL, V24, P5160, DOI 10.1200/JCO.2006.07.3114; Michel G, 2007, SWISS MED WKLY, V137, P502; Moyer-Mileur LJ, 2009, J PEDIAT HEMATOL ONC, V31, P259, DOI 10.1097/MPH.0b013e3181978fd4; Nagarajan R, 2004, BRIT J CANCER, V91, P1858, DOI 10.1038/sj.bjc.6602220; Ness KK, 2008, ARCH PHYS MED REHAB, V89, P128, DOI 10.1016/j.apmr.2007.08.123; Ness KK, 2010, CANCER-AM CANCER SOC, V116, P3034, DOI 10.1002/cncr.25051; Ness KK, 2009, J CLIN ONCOL, V27, P2382, DOI 10.1200/JCO.2008.21.1482; Ness KK, 2005, ANN INTERN MED, V143, P639, DOI 10.7326/0003-4819-143-9-200511010-00007; Oeffinger KC, 2006, NEW ENGL J MED, V355, P1572, DOI 10.1056/NEJMsa060185; Puhalla S, 2012, MOL ONCOL, V6, P237, DOI 10.1016/j.molonc.2012.03.001; Reulen RC, 2007, INT J CANCER, V121, P633, DOI 10.1002/ijc.22658; Reulen RC, 2006, HEALTH QUAL LIFE OUT, P4; Robert RS, 2010, PEDIATR BLOOD CANCER, V54, P990, DOI 10.1002/pbc.22419; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; Rueegg CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034930; Juan AFS, 2011, RECENT RESULTS CANC, V186, P319, DOI 10.1007/978-3-642-04231-7_14; Sheppard L, 2005, CHILD CARE HLTH DEV, V31, P137, DOI 10.1111/j.1365-2214.2005.00498.x; Shields CL, 2010, CURR OPIN OPHTHALMOL, V21, P203, DOI 10.1097/ICU.0b013e328338676a; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Szymlek-Gay EA, 2011, NEW ZEAL MED J, V124, P77; van Waart H, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-673; Velthuis MJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-272; von Hoff K, 2012, CURR TREAT OPTION NE, V14, P416, DOI 10.1007/s11940-012-0183-8; Ware J, 2000, SCORE VERSION 2 SF36; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; Winter C, 2010, PEDIATR BLOOD CANCER, V54, P501, DOI 10.1002/pbc.22271; Zeltzer LK, 2008, CANCER EPIDEM BIOMAR, V17, P435, DOI 10.1158/1055-9965.EPI-07-2541	47	38	39	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47944	10.1371/journal.pone.0047944	http://dx.doi.org/10.1371/journal.pone.0047944			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082232	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000311146900129
J	Tabarean, IV				Tabarean, Iustin V.			Persistent Histamine Excitation of Glutamatergic Preoptic Neurons	PLOS ONE			English	Article							CENTRAL NEURAL PATHWAYS; OPERATED CALCIUM-ENTRY; CATION CHANNEL; TRPC CHANNELS; FLUFENAMIC ACID; NERVOUS-SYSTEM; CA2+ RELEASE; RAT-BRAIN; RECEPTOR; ACTIVATION	Thermoregulatory neurons of the median preoptic nucleus (MnPO) represent a target at which histamine modulates body temperature. The mechanism by which histamine excites a population of MnPO neurons is not known. In this study it was found that histamine activated a cationic inward current and increased the intracellular Ca2+ concentration, actions that had a transient component as well as a sustained one that lasted for tens of minutes after removal of the agonist. The sustained component was blocked by TRPC channel blockers. Single-cell reverse transcription-PCR analysis revealed expression of TRPC1, TRPC5 and TRPC7 subunits in neurons excited by histamine. These studies also established the presence of transcripts for the glutamatergic marker Vglut2 and for the H1 histamine receptor in neurons excited by histamine. Intracellular application of antibodies directed against cytoplasmic sites of the TRPC1 or TRPC5 channel subunits decreased the histamine-induced inward current. The persistent inward current and elevation in intracellular Ca2+ concentration could be reversed by activating the PKA pathway. This data reveal a novel mechanism by which histamine induces persistent excitation and sustained intracellular Ca2+ elevation in glutamatergic MnPO neurons.	Scripps Res Inst, Dept Mol & Integrat Neurosci, La Jolla, CA 92037 USA	Scripps Research Institute	Tabarean, IV (corresponding author), Scripps Res Inst, Dept Mol & Integrat Neurosci, La Jolla, CA 92037 USA.	tabarean@scripps.edu			National Institutes of Health [NS060799]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060799] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant NS060799 (IVT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert AP, 2006, J PHYSIOL-LONDON, V571, P361, DOI 10.1113/jphysiol.2005.102780; Ariano P, 2011, CELL CALCIUM, V49, P387, DOI 10.1016/j.ceca.2011.03.007; Ben-Mabrouk F, 2010, EUR J NEUROSCI, V31, P1219, DOI 10.1111/j.1460-9568.2010.07156.x; Blair NT, 2009, J GEN PHYSIOL, V133, P525, DOI 10.1085/jgp.200810153; Boulay G, 1997, J BIOL CHEM, V272, P29672, DOI 10.1074/jbc.272.47.29672; Chen S, 2011, CELL CALCIUM, V50, P523, DOI 10.1016/j.ceca.2011.08.008; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; COLBOC O, 1982, NEUROPHARMACOLOGY, V21, P45, DOI 10.1016/0028-3908(82)90209-X; Cui NR, 2011, J NEUROPHYSIOL, V105, P2791, DOI 10.1152/jn.00759.2010; Cvetkovic-Lopes V, 2011, PLOS ONE, V5; Dimitrov E., 2011, J NEUROSCI, V518, P4375; DISMUKES K, 1974, BRAIN RES, V78, P467, DOI 10.1016/0006-8993(74)90929-9; Foster RR, 2009, CELL CALCIUM, V45, P384, DOI 10.1016/j.ceca.2009.01.003; Gorelova N, 1996, J NEUROPHYSIOL, V75, P707, DOI 10.1152/jn.1996.75.2.707; GREEN MD, 1976, NEUROPHARMACOLOGY, V15, P321, DOI 10.1016/0028-3908(76)90136-2; Haas H, 2003, NAT REV NEUROSCI, V4, P121, DOI 10.1038/nrn1034; Haas HL, 2008, PHYSIOL REV, V88, P1183, DOI 10.1152/physrev.00043.2007; Harper MT, 2011, CELL CALCIUM, V50, P351, DOI 10.1016/j.ceca.2011.06.005; He LP, 2005, J BIOL CHEM, V280, P10997, DOI 10.1074/jbc.M411797200; Hill K, 2004, NEUROPHARMACOLOGY, V47, P450, DOI 10.1016/j.neuropharm.2004.04.014; Horinouchi T, 2012, J PHARMACOL EXP THER, V340, P143, DOI 10.1124/jpet.111.187500; HOUGH LB, 1984, BRAIN RES, V291, P103, DOI 10.1016/0006-8993(84)90655-3; Ishikawa J, 2003, J IMMUNOL, V170, P4441, DOI 10.4049/jimmunol.170.9.4441; Ju M, 2010, J PHYSIOL-LONDON, V588, P1419, DOI 10.1113/jphysiol.2009.185256; Kim EY, 2012, AM J PHYSIOL-RENAL, V302, pF298, DOI 10.1152/ajprenal.00423.2011; Kim SJ, 2003, NATURE, V426, P285, DOI 10.1038/nature02162; Kinoshita H, 2010, CIRC RES, V106, P1849, DOI 10.1161/CIRCRESAHA.109.208314; Lundius EG, 2010, J NEUROSCI, V30, P4369, DOI 10.1523/JNEUROSCI.0378-10.2010; Malarkey EB, 2008, GLIA, V56, P821, DOI 10.1002/glia.20656; McCormick DA, 2003, CEREB CORTEX, V13, P1219, DOI 10.1093/cercor/bhg104; MCCORMICK DA, 1991, J NEUROSCI, V11, P3188; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Morrison SF, 2011, J APPL PHYSIOL, V110, P1137, DOI 10.1152/japplphysiol.01227.2010; Morrison SF, 2011, FRONT BIOSCI-LANDMRK, V16, P74, DOI 10.2741/3677; MUNAKATA M, 1994, J PHYSIOL-LONDON, V480, P233, DOI 10.1113/jphysiol.1994.sp020356; NORIS G, 1995, ENDOCRINOLOGY, V136, P2967, DOI 10.1210/en.136.7.2967; Olah T, 2011, CELL CALCIUM, V49, P415, DOI 10.1016/j.ceca.2011.03.012; Paxinos G., 2001, MOUSE BRAIN STEREOTA; PORONNIK P, 1992, FEBS LETT, V296, P245, DOI 10.1016/0014-5793(92)80296-S; Qiu J, 2010, J NEUROSCI, V30, P1560, DOI 10.1523/JNEUROSCI.4816-09.2010; REINER PB, 1994, NEUROSCIENCE, V59, P579, DOI 10.1016/0306-4522(94)90178-3; Riccio A, 2002, J BIOL CHEM, V277, P12302, DOI 10.1074/jbc.M112313200; Saada R, 2009, CURR BIOL, V19, P479, DOI 10.1016/j.cub.2009.01.060; Sergeeva OA, 2003, J NEUROCHEM, V85, P1547, DOI 10.1046/j.1471-4159.2003.01806.x; Sethi J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029134; Smith BN, 1996, J PHYSIOL-LONDON, V495, P465, DOI 10.1113/jphysiol.1996.sp021607; Storch U, 2012, J BIOL CHEM, V287, P3530, DOI 10.1074/jbc.M111.283218; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Sung TS, 2011, AM J PHYSIOL-CELL PH, V301, pC823, DOI 10.1152/ajpcell.00351.2010; Tabarean IV, 2012, NEUROPHARMA IN PRESS; Tupone D, 2011, J NEUROSCI, V31, P15944, DOI 10.1523/JNEUROSCI.3909-11.2011; WADA H, 1992, FOLIA PHARMACOL JPN, V99, P63, DOI 10.1254/fpj.99.63; Whyment AD, 2006, J NEUROPHYSIOL, V95, P2492, DOI 10.1152/jn.01135.2004; Williams KW, 2011, J NEUROSCI, V31, P13147, DOI 10.1523/JNEUROSCI.2602-11.2011; Zhou FW, 2008, J NEUROSCI, V28, P473, DOI 10.1523/JNEUROSCI.3978-07.2008; Zhou FW, 2006, J NEUROPHYSIOL, V96, P1581, DOI 10.1152/jn.00148.2006; Zitt C, 2004, J BIOL CHEM, V279, P12427, DOI 10.1074/jbc.M309297200	57	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47700	10.1371/journal.pone.0047700	http://dx.doi.org/10.1371/journal.pone.0047700			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082195	Green Published, gold, Green Submitted			2022-12-25	WOS:000311146900092
J	Rohacek, M; Szucs-Farkas, Z; Pfortmuller, CA; Zimmermann, H; Exadaktylos, A				Rohacek, Martin; Szucs-Farkas, Zsolt; Pfortmueller, Carmen A.; Zimmermann, Heinz; Exadaktylos, Aristomenis			Acute Cardiac Disorder or Pneumonia and Concomitant Presence of Pulmonary Embolism	PLOS ONE			English	Article							VENOUS THROMBOEMBOLISM; D-DIMER; RISK; PROBABILITY; ANGIOGRAPHY; OUTCOMES	Purpose: To determine the frequency of apparent acute pulmonary embolism (PE) and of concomitant disease in computed tomography pulmonary angiography (CTPA); to compare the frequency of PE in patients with pneumonia or acute cardiac disorder (acute coronary syndrome, tachyarrhythmia, acute left ventricular heart failure or cardiogenic shock), with the frequency of PE in patients with none of these alternative chest pathologies (comparison group). Methods: Retrospective analysis of all patients who received a CTPA at the emergency department (ED) within a period of four years and 5 months. Results: Of 1275 patients with CTPA, 28 (2.2%) had PE and concomitant radiologic evidence of another chest disease; 3 more (0.2%) had PE and an acute cardiac disorder without radiological evidence of heart failure. PE was found in 11 of 113 patients (10%) with pneumonia, in 5 of 154 patients (3.3%) with an acute cardiac disorder and in 186 of 1008 patients (18%) in the comparison group. After adjustment for risk factors for thromboembolism and for other relevant patient's characteristics, the proportion of CTPAs with evidence of PE in patients with an acute cardiac disorder or pneumonia was significantly lower than in the comparison group (OR 0.13, 95% CI 0.05-0.33, p < 0.001 for patients with an acute cardiac disorder, and OR 0.45, 95% CI 0.23-0.89, p = 0.021 for patients with pneumonia). Conclusion: The frequency of PE and a concomitant disease that can mimic PE was low. The presence of an acute cardiac disorder or pneumonia was associated with decreased odds of PE.	[Rohacek, Martin; Zimmermann, Heinz; Exadaktylos, Aristomenis] Univ Hosp Bern, Inselspital, Dept Emergency Med, CH-3010 Bern, Switzerland; [Szucs-Farkas, Zsolt] Univ Hosp Bern, Inselspital, Dept Diagnost Intervent & Pediat Radiol, CH-3010 Bern, Switzerland; [Pfortmueller, Carmen A.] Univ Hosp Bern, Inselspital, Dept Internal Med, CH-3010 Bern, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern	Rohacek, M (corresponding author), Univ Hosp Bern, Inselspital, Dept Emergency Med, CH-3010 Bern, Switzerland.	martin.rohacek@gmail.com		Pfortmueller, Carmen/0000-0003-0326-2770				Beemath A, 2006, AM J CARDIOL, V98, P793, DOI 10.1016/j.amjcard.2006.03.064; Carrier M, 2009, THROMB HAEMOSTASIS, V101, P886, DOI 10.1160/TH-08-10-0689; Clayton TC, 2011, INT J EPIDEMIOL, V40, P819, DOI 10.1093/ije/dyr012; Goldhaber SZ, 2012, LANCET, V379, P1835, DOI 10.1016/S0140-6736(11)61904-1; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Kelly J, 2002, ARCH INTERN MED, V162, P747, DOI 10.1001/archinte.162.7.747; Klok FA, 2008, ARCH INTERN MED, V168, P2131, DOI 10.1001/archinte.168.19.2131; Matos MF, 2011, THROMB RES, V128, P216, DOI 10.1016/j.thromres.2011.04.016; Miniati M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030891; Moores LK, 2004, ANN INTERN MED, V141, P866, DOI 10.7326/0003-4819-141-11-200412070-00011; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; Rohacek M, 2012, INTENS CARE MED, V38, P1345, DOI 10.1007/s00134-012-2595-z; Schmidt M, 2012, J INTERN MED, V271, P608, DOI 10.1111/j.1365-2796.2011.02473.x; Spencer FA, 2006, J GEN INTERN MED, V21, P722, DOI 10.1111/j.1525-1497.2006.00458.x; van Beek EJR, 2001, CLIN RADIOL, V56, P838, DOI 10.1053/crad.2001.0778; Venkatesh AK, 2012, ARCH INTERN MED, P1; Wells PS, 2000, THROMB HAEMOSTASIS, V83, P416; Zoller B, 2012, LANCET, V379, P244, DOI 10.1016/S0140-6736(11)61306-8	18	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47418	10.1371/journal.pone.0047418	http://dx.doi.org/10.1371/journal.pone.0047418			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091623	Green Published, Green Submitted, gold			2022-12-25	WOS:000310135800046
J	Sikand, K; Singh, J; Ebron, JS; Shukla, GC				Sikand, Kavleen; Singh, Jagjit; Ebron, Jey Sabith; Shukla, Girish C.			Housekeeping Gene Selection Advisory: Glyceraldehyde-3-Phosphate Dehydrogenase (GAPDH) and beta-Actin Are Targets of miR-644a	PLOS ONE			English	Article							URACIL DNA-GLYCOSYLASE; MESSENGER-RNA LEVELS; CELL-LINES; REAL-TIME; ALZHEIMERS-DISEASE; BREAST-CANCER; RT-PCR; EXPRESSION; MICRORNAS; PROTEIN	Results of overexpression or downregulation of a microRNA (miRNA) on its target mRNA expression are often validated by reverse-transcription and quantitative PCR analysis using an appropriate housekeeping gene as an internal control. The possible direct or indirect effects of a miRNA on the expression of housekeeping genes are often overlooked. Among many housekeeping genes, expressions of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and beta-actin have been used extensively for normalization of gene expression data. Here, we show that GAPDH and beta-actin are direct targets of miR-644a. Our data demonstrate the unsuitability of GAPDH and beta-actin as internal controls in miR-644a functional studies and emphasize the need to carefully consider the choice of a reference gene in miRNA experiments.	[Sikand, Kavleen; Singh, Jagjit; Ebron, Jey Sabith; Shukla, Girish C.] Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA; [Shukla, Girish C.] Cleveland State Univ, Ctr Gene Regulat Hlth & Dis, Cleveland, OH 44115 USA	University System of Ohio; Cleveland State University; University System of Ohio; Cleveland State University	Shukla, GC (corresponding author), Cleveland State Univ, Dept Biol Geol & Environm Sci, Cleveland, OH 44115 USA.	g.shukla@csuohio.edu		Ebron, Jey Sabith/0000-0002-5820-4175; Sikand, Kavleen/0000-0003-0170-2613; Shukla, Girish/0000-0003-1982-2218	National Science Foundation (NSF) [0842606]; DoD Prostate Cancer Research Program; DoD-USAMRAA [W81XWH-11-1-0204]	National Science Foundation (NSF)(National Science Foundation (NSF)); DoD Prostate Cancer Research Program; DoD-USAMRAA(United States Department of Defense)	Research in GCS laboratory is supported by grants from National Science Foundation (NSF) and DoD Prostate Cancer Research Program. JS was supported by NSF grant 0842606 and JSE was supported by DoD-USAMRAA grant W81XWH-11-1-0204. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Barber RD, 2005, PHYSIOL GENOMICS, V21, P389, DOI 10.1152/physiolgenomics.00025.2005; Barroso I, 1999, EUR J ENDOCRINOL, V141, P169, DOI 10.1530/eje.0.1410169; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bas A, 2004, SCAND J IMMUNOL, V59, P566, DOI 10.1111/j.0300-9475.2004.01440.x; BAXI MD, 1995, BIOCHEMISTRY-US, V34, P9700, DOI 10.1021/bi00030a007; BLOMBERG J, 1987, BRIT J HAEMATOL, V65, P83, DOI 10.1111/j.1365-2141.1987.tb06139.x; Cheng C, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-431; Chuang DM, 2005, ANNU REV PHARMACOL, V45, P269, DOI 10.1146/annurev.pharmtox.45.120403.095902; Corbin IR, 2002, CELL PROLIFERAT, V35, P173; de Kok JB, 2005, LAB INVEST, V85, P154, DOI 10.1038/labinvest.3700208; DESPREZ PY, 1992, CANCER LETT, V64, P219, DOI 10.1016/0304-3835(92)90046-X; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Ferreira E, 2012, MOL BIOTECHNOL, V50, P121, DOI 10.1007/s12033-011-9425-3; Glare EM, 2002, THORAX, V57, P765, DOI 10.1136/thorax.57.9.765; GLASER PE, 1995, BIOCHEMISTRY-US, V34, P12193, DOI 10.1021/bi00038a013; Gutala RV, 2004, J NEUROSCI METH, V132, P101, DOI 10.1016/j.jneumeth.2003.09.005; Hara MR, 2006, CELL MOL NEUROBIOL, V26, P527, DOI 10.1007/s10571-006-9011-6; HUITOREL P, 1985, EUR J BIOCHEM, V150, P265, DOI 10.1111/j.1432-1033.1985.tb09016.x; Ishitani R, 1996, P NATL ACAD SCI USA, V93, P9937, DOI 10.1073/pnas.93.18.9937; JABBOUR W, 1992, J NEUROIMMUNOL, V38, P199, DOI 10.1016/0165-5728(92)90013-B; Le PU, 1998, CANCER RES, V58, P1631; Lee PD, 2002, GENOME RES, V12, P292, DOI 10.1101/gr.217802; Lupberger J, 2002, MOL CELL PROBE, V16, P25, DOI 10.1006/mcpr.2001.0392; MATRISIAN LM, 1985, NUCLEIC ACIDS RES, V13, P711, DOI 10.1093/nar/13.3.711; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; MORGENEGG G, 1986, J NEUROCHEM, V47, P54; NAGY E, 1995, J BIOL CHEM, V270, P2755, DOI 10.1074/jbc.270.6.2755; Nowak D, 2005, ACTA BIOCHIM POL, V52, P461; Ostling P, 2011, CANCER RES, V71, P1956, DOI 10.1158/0008-5472.CAN-10-2421; Revillion F, 2000, EUR J CANCER, V36, P1038, DOI 10.1016/S0959-8049(00)00051-4; ROBBINS AR, 1995, J CELL BIOL, V130, P1093, DOI 10.1083/jcb.130.5.1093; Ruan WJ, 2007, CLIN CHIM ACTA, V385, P1, DOI 10.1016/j.cca.2007.07.003; SCHEK N, 1988, CANCER RES, V48, P6354; Schmittgen TD, 2000, J BIOCHEM BIOPH METH, V46, P69, DOI 10.1016/S0165-022X(00)00129-9; Sikand K, 2011, INT J CANCER, V129, P810, DOI 10.1002/ijc.25753; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Szczyrba J, 2010, MOL CANCER RES, V8, P529, DOI 10.1158/1541-7786.MCR-09-0443; Takagi T, 2009, ONCOLOGY-BASEL, V77, P12, DOI 10.1159/000218166; Thorrez L, 2011, GENOME RES, V21, P95, DOI 10.1101/gr.109173.110; Tisdale EJ, 2004, J BIOL CHEM, V279, P54046, DOI 10.1074/jbc.M409472200; Valenti MT, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-49; Xu YZ, 2010, MOL BIOL CELL, V21, P811, DOI 10.1091/mbc.E09-06-0534; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X	46	56	60	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47510	10.1371/journal.pone.0047510	http://dx.doi.org/10.1371/journal.pone.0047510			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091630	Green Submitted, gold, Green Published			2022-12-25	WOS:000310135800053
J	Rodriguez, F; Zanetti, MN; Mayorga, LS; Tomes, CN				Rodriguez, Facundo; Natalia Zanetti, M.; Mayorga, Luis S.; Tomes, Claudia N.			Munc18-1 Controls SNARE Protein Complex Assembly during Human Sperm Acrosomal Exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC VESICLE DOCKING; REGULATES NEUROTRANSMITTER RELEASE; GTP-BINDING PROTEIN; SYNAPTOTAGMIN-VI; ALPHA-SNAP; MAMMALIAN SPERM; RAB3A TRIGGERS; SEC1 HOMOLOG; SYNTAXIN; FUSION	The spermatozoon is a very specialized cell capable of carrying out a limited set of functions with high efficiency. Sperm are then excellent model cells to dissect fundamental processes such as regulated exocytosis. The secretion of the single densecore granule of mammalian spermatozoa relies on the same highly conserved molecules and goes through the same stages as exocytosis in other types of cells. In this study, we describe the presence of Munc18-1 in human sperm and show that this protein has an essential role in acrosomal exocytosis. We observed that inactivation of endogenous Munc18-1 with a specific antibody precluded the stabilization of trans-SNARE complexes and inhibited acrosomal exocytosis. Addition of recombinant Munc18-1 blocked secretion by sequestering monomeric syntaxin, an effect that was rescued by alpha-soluble NSF attachment protein. By electron microscopy, we observed that both the anti-Munc18-1 antibody and recombinant Munc18-1 inhibited the docking of the acrosome to the plasma membrane. In conclusion, our results indicate that Munc18-1 plays a key role in the dynamics of trans-SNARE complex assembly and/or stabilization, a process that is necessary for the docking of the outer acrosomal membrane to the plasma membrane and subsequent fusion pore opening.	[Rodriguez, Facundo; Natalia Zanetti, M.; Mayorga, Luis S.; Tomes, Claudia N.] Univ Nacl Cuyo, Lab Biol & Celular Mol, Inst Histol & Embriol, Consejo Nacl Invest Cient & Tecn,Fac Ciencias Med, RA-5500 Mendoza, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza	Mayorga, LS (corresponding author), Univ Nacl Cuyo, Lab Biol & Celular Mol, Inst Histol & Embriol, Consejo Nacl Invest Cient & Tecn,Fac Ciencias Med, RA-5500 Mendoza, Argentina.	lmayorga@fcm.uncu.edu.ar		Rodriguez Ayala, Juan Facundo/0000-0003-3165-2186; Mayorga, Luis S/0000-0002-5995-0671	National University of Cuyo, Argentina [06/J388, 06/J353 SeCTyP]; CONICET, Argentina [PIP 112-200801-02277]; ANPCyT, Argentina [PICT-2008-1114, PICT-2011-2310, PICT-2006-01036]	National University of Cuyo, Argentina; CONICET, Argentina(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); ANPCyT, Argentina(ANPCyT)	This work was supported by Grants 06/J388 and 06/J353 SeCTyP from National University of Cuyo, Argentina, Grant PIP 112-200801-02277 from CONICET, Argentina, and Grants PICT-2008-1114, PICT-2011-2310, and PICT-2006-01036 from ANPCyT, Argentina.	Alpadi K, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001243; Alvarez L, 2012, J CELL BIOL, V196, P653, DOI 10.1083/jcb.201106096; [Anonymous], MOL BIOL CELL, V22, P4150; Barnard RJO, 1997, J CELL BIOL, V139, P875, DOI 10.1083/jcb.139.4.875; BARROS C, 1967, J CELL BIOL, V34, pC1, DOI 10.1083/jcb.34.3.C1; Bello OD, 2012, EXP CELL RES, V318, P478, DOI 10.1016/j.yexcr.2012.01.002; Berruti Giovanna, 2011, Spermatogenesis, V1, P95; Blengini CS, 2011, ASIAN J ANDROL, V13, P769, DOI 10.1038/aja.2011.27; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; BURGOS MH, 1955, J BIOPHYS BIOCHEM CY, V1, P287, DOI 10.1083/jcb.1.4.287; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Bustos MA, 2012, P NATL ACAD SCI USA, V109, pE2057, DOI 10.1073/pnas.1121173109; Christie MP, 2012, P NATL ACAD SCI USA, V109, P9816, DOI 10.1073/pnas.1116975109; De Blas G, 2002, J BIOL CHEM, V277, P49326, DOI 10.1074/jbc.M208587200; De Blas GA, 2005, PLOS BIOL, V3, P1801, DOI 10.1371/journal.pbio.0030323; de Wit H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000126; Dresbach T, 1998, J NEUROSCI, V18, P2923; Dulubova I, 1999, EMBO J, V18, P4372, DOI 10.1093/emboj/18.16.4372; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Li F, 2007, NAT STRUCT MOL BIOL, V14, P890, DOI 10.1038/nsmb1310; Graham ME, 2004, J BIOL CHEM, V279, P32751, DOI 10.1074/jbc.M400827200; Guerrero A, 2010, DEV BIOL, V344, P52, DOI 10.1016/j.ydbio.2010.04.013; Gulyas-Kovacs A, 2007, J NEUROSCI, V27, P8676, DOI 10.1523/JNEUROSCI.0658-07.2007; Han GYA, 2011, MOL BIOL CELL, V22, P4134, DOI 10.1091/mbc.E11-02-0135; HANSON PI, 1995, J BIOL CHEM, V270, P16955, DOI 10.1074/jbc.270.28.16955; HARRISON SD, 1994, NEURON, V13, P555, DOI 10.1016/0896-6273(94)90025-6; Hickey CM, 2010, MOL BIOL CELL, V21, P2297, DOI 10.1091/mbc.E10-01-0044; Hutt DM, 2005, J BIOL CHEM, V280, P20197, DOI 10.1074/jbc.M412920200; Iida H, 1999, DEV BIOL, V211, P144, DOI 10.1006/dbio.1999.9302; Jorgacevski J, 2011, J NEUROSCI, V31, P9055, DOI 10.1523/JNEUROSCI.0185-11.2011; Lang Thorsten, 2008, V184, P107; Lesich KA, 2008, BIOPHYS J, V95, P472, DOI 10.1529/biophysj.107.127951; Lopez CI, 2007, FASEB J, V21, P4121, DOI 10.1096/fj.06-7716com; Marti-Verdeaux S, 2003, J CELL SCI, V116, P325, DOI 10.1242/jcs.00216; May AP, 2001, J BIOL CHEM, V276, P21991, DOI 10.1074/jbc.R100013200; Mayorga LS, 2007, IUBMB LIFE, V59, P286, DOI 10.1080/15216540701222872; MCMAHON HT, 1995, CELL, V83, P111, DOI 10.1016/0092-8674(95)90239-2; Meijer M, 2012, EMBO J, V31, P2156, DOI 10.1038/emboj.2012.72; MENDOZA C, 1992, J REPROD FERTIL, V95, P755; Michaut M, 2000, P NATL ACAD SCI USA, V97, P9996, DOI 10.1073/pnas.180206197; Michaut M, 2001, DEV BIOL, V235, P521, DOI 10.1006/dbio.2001.0316; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Ramalho-Santos J, 2000, DEV BIOL, V223, P54, DOI 10.1006/dbio.2000.9745; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Rodriguez F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021925; Roggero CM, 2007, J BIOL CHEM, V282, P26335, DOI 10.1074/jbc.M700854200; Roggero CM, 2005, DEV BIOL, V285, P422, DOI 10.1016/j.ydbio.2005.07.007; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shen JS, 2010, J CELL BIOL, V190, P55, DOI 10.1083/jcb.201003148; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tomes C., 2007, MOL MECH EXOCYTOSIS, P117; Tomes CN, 2005, MOL HUM REPROD, V11, P43, DOI 10.1093/molehr/gah126; Tomes CN, 2002, DEV BIOL, V243, P326, DOI 10.1006/dbio.2002.0567; Tsai PSJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032603; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Verhage M, 2008, TRAFFIC, V9, P1414, DOI 10.1111/j.1600-0854.2008.00759.x; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; Ward CR, 1999, MOL REPROD DEV, V53, P413, DOI 10.1002/(SICI)1098-2795(199908)53:4&lt;413::AID-MRD7&gt;3.0.CO;2-W; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimer RM, 2005, CURR TOP DEV BIOL, V65, P83; Weimer RM, 2003, NAT NEUROSCI, V6, P1023, DOI 10.1038/nn1118; Wickner W, 2008, NAT STRUCT MOL BIOL, V15, P658, DOI 10.1038/nsmb.1451; Wu MN, 1999, NEURON, V23, P593, DOI 10.1016/S0896-6273(00)80811-9; Wu MN, 1998, EMBO J, V17, P127, DOI 10.1093/emboj/17.1.127; Xia T, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-19; Xu H, 2010, EMBO J, V29, P1948, DOI 10.1038/emboj.2010.97; Yanagimachi R., 1994, P189; Yunes R, 2000, BIOL REPROD, V62, P1084, DOI 10.1095/biolreprod62.4.1084; Zanetti N, 2009, BIOL REPROD, V81, P396, DOI 10.1095/biolreprod.109.076166; Zarelli VEP, 2009, J BIOL CHEM, V284, P10491, DOI 10.1074/jbc.M807614200; Zhao L, 2007, DEV BIOL, V309, P236, DOI 10.1016/j.ydbio.2007.07.009	76	14	15	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43825	43839		10.1074/jbc.M112.409649	http://dx.doi.org/10.1074/jbc.M112.409649			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23091057	Green Published, hybrid			2022-12-25	WOS:000312940800060
J	Guo, DX; Shi, XL; Arledge, KC; Song, DK; Jiang, LW; Fu, LL; Gong, XQ; Zhang, SY; Wang, XQ; Zhang, LQ				Guo, Dongxing; Shi, Xuanling; Arledge, Kelly C.; Song, Dingka; Jiang, Liwei; Fu, Lili; Gong, Xinqi; Zhang, Senyan; Wang, Xinquan; Zhang, Linqi			A Single Residue within the V5 Region of HIV-1 Envelope Facilitates Viral Escape from the Broadly Neutralizing Monoclonal Antibody VRC01	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CD4 BINDING-SITE; CD4-BINDING SITE; STRUCTURAL BASIS; CELL RESPONSES; POTENT; GP120; GLYCOPROTEIN; RECEPTOR; IMMUNOGENS; COFACTOR	VRC01, a broadly neutralizing monoclonal antibody, is capable of neutralizing a diverse array of HIV-1 isolates by mimicking CD4 binding with the envelope glycoprotein gp120. Nonetheless, resistant strains have been identified. Here, we examined two genetically related and two unrelated envelope clones, derived from CRF08_BC-infected patients, with distinct VRC01 neutralization profiles. A total of 22 chimeric envelope clones was generated by interchanging the loop D and/or V5 regions between the original envelopes or by single alanine substitutions within each region. Analysis of pseudoviruses built from these mutant envelopes showed that interchanging the V5 region between the genetically related or unrelated clones completely swapped their VRC01 sensitivity profiles. Mutagenesis analysis revealed that the asparagine residue at position 460 (Asn-460), a potential N-linked glycosylation site in the V5 region, is a key factor for observed resistance in these strains, which is further supported by our structural modeling. Moreover, changes in resistance were found to positively correlate with deviations in VRC01 binding affinity. Overall, our study indicates that Asn-460 in the V5 region is a critical determinant of sensitivity to VRC01 specifically in these viral strains. The long side chain of Asn-460, and potential glycosylation, may create steric hindrance that lowers binding affinity, thereby increasing resistance to VRC01 neutralization.	[Shi, Xuanling; Arledge, Kelly C.; Song, Dingka; Jiang, Liwei; Fu, Lili; Zhang, Linqi] Tsinghua Univ, Comprehens AIDS Res Ctr, Sch Med, Beijing 100084, Peoples R China; [Shi, Xuanling; Arledge, Kelly C.; Song, Dingka; Jiang, Liwei; Fu, Lili; Zhang, Linqi] Tsinghua Univ, Res Ctr Publ Hlth, Sch Med, Beijing 100084, Peoples R China; [Gong, Xinqi; Zhang, Senyan; Wang, Xinquan] Tsinghua Univ, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China; [Guo, Dongxing; Zhang, Linqi] Peking Union Med Coll, Beijing 100730, Peoples R China; [Guo, Dongxing; Zhang, Linqi] Chinese Acad Med Sci, Inst Pathogen Biol, MOH Key Lab Syst Biol Pathogens, AIDS Res Ctr, Beijing 100730, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Pathogen Biology - CAMS	Zhang, LQ (corresponding author), Tsinghua Univ, Comprehens AIDS Res Ctr, Sch Med, Beijing 100084, Peoples R China.	zhanglinqi@tsinghua.edu.cn	ZHANG, LIN/GYD-9123-2022; zhang, sen/GXH-3513-2022	Song, Dingka/0000-0002-8481-9309	National Science and Technology Major Projects [2012ZX10001-006, 2012ZX10001-009]; National Outstanding Youth Award [30825035]; National Natural Science Funds [U0832604, 81101236]; Tsinghua University Initiative Scientific Research Program; Tsinghua Yue-Yuen Medical Sciences Fund	National Science and Technology Major Projects; National Outstanding Youth Award; National Natural Science Funds(National Natural Science Foundation of China (NSFC)); Tsinghua University Initiative Scientific Research Program; Tsinghua Yue-Yuen Medical Sciences Fund	This work was supported by National Science and Technology Major Projects 2012ZX10001-006 and 2012ZX10001-009, National Outstanding Youth Award 30825035, National Natural Science Funds U0832604 and 81101236, the Tsinghua University Initiative Scientific Research Program, and the Tsinghua Yue-Yuen Medical Sciences Fund.	Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; BARBAS CF, 1992, P NATL ACAD SCI USA, V89, P10164, DOI 10.1073/pnas.89.21.10164; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Corti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008805; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dey B, 2007, J VIROL, V81, P5579, DOI 10.1128/JVI.02500-06; Diskin R, 2011, SCIENCE, V334, P1289, DOI 10.1126/science.1213782; Douagi I, 2010, J VIROL, V84, P1683, DOI 10.1128/JVI.01896-09; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; Falkowska E, 2012, J VIROL, V86, P4394, DOI 10.1128/JVI.06973-11; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Feng Y, 2012, J BIOL CHEM, V287, P5673, DOI 10.1074/jbc.M111.317776; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; Koch M, 2003, VIROLOGY, V313, P387, DOI 10.1016/S0042-6822(03)00294-0; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Li Y, 2006, J VIROL, V80, P1414, DOI 10.1128/JVI.80.3.1414-1426.2006; Li YX, 2011, J VIROL, V85, P8954, DOI 10.1128/JVI.00754-11; Lynch RM, 2012, J VIROL, V86, P7588, DOI 10.1128/JVI.00734-12; Pancera M, 2005, J VIROL, V79, P9954, DOI 10.1128/JVI.79.15.9954-9969.2005; Pantophlet R, 2003, J VIROL, V77, P642, DOI 10.1128/JVI.77.1.642-658.2003; Saha P, 2012, BIOCHEMISTRY-US, V51, P1836, DOI 10.1021/bi300003v; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Shang H, 2011, J BIOL CHEM, V286, P14531, DOI 10.1074/jbc.M111.224527; Song RJ, 2010, J VIROL, V84, P6935, DOI 10.1128/JVI.00453-10; Toma J, 2011, J VIROL, V85, P3872, DOI 10.1128/JVI.02237-10; Visciano ML, 2008, VIROLOGY, V372, P409, DOI 10.1016/j.virol.2007.10.044; Walker LM, 2011, NATURE, V477, P466, DOI 10.1038/nature10373; Walker LM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001028; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109; Wu XL, 2012, J VIROL, V86, P5844, DOI 10.1128/JVI.07139-11; Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532; Wu XL, 2009, J VIROL, V83, P10892, DOI 10.1128/JVI.01142-09; Zhang LQ, 1996, NATURE, V383, P768, DOI 10.1038/383768a0; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819; Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817	40	25	26	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43170	43179		10.1074/jbc.M112.399402	http://dx.doi.org/10.1074/jbc.M112.399402			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23100255	hybrid, Green Published			2022-12-25	WOS:000312501600071
J	Terrasse, R; Tacnet-Delorme, P; Moriscot, C; Perard, J; Schoehn, G; Vernet, T; Thielens, NM; Di Guilmi, AM; Frachet, P				Terrasse, Remi; Tacnet-Delorme, Pascale; Moriscot, Christine; Perard, Julien; Schoehn, Guy; Vernet, Thierry; Thielens, Nicole M.; Di Guilmi, Anne Marie; Frachet, Philippe			Human and Pneumococcal Cell Surface Glyceraldehyde-3-phosphate Dehydrogenase (GAPDH) Proteins Are Both Ligands of Human C1q Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMINOGEN-BINDING-PROTEIN; STREPTOCOCCUS-PNEUMONIAE; MOONLIGHTING PROTEINS; EXTRACELLULAR-MATRIX; BACTERIAL ADHERENCE; COMPLEMENT PATHWAY; RECOGNITION; VIRULENCE; RECEPTOR; TRANSMIGRATION	C1q, a key component of the classical complement pathway, is a major player in the response to microbial infection and has been shown to detect noxious altered-self substances such as apoptotic cells. In this work, using complementary experimental approaches, we identified the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) as a C1q partner when exposed at the surface of human pathogenic bacteria Streptococcus pneumoniae and human apoptotic cells. The membrane-associated GAPDH on HeLa cells bound the globular regions of C1q as demonstrated by pulldown and cell surface co-localization experiments. Pneumococcal strains deficient in surface-exposed GAPDH harbored a decreased level of C1q recognition when compared with the wild-type strains. Both recombinant human and pneumococcal GAPDHs interacted avidly with C1q as measured by surface plasmon resonance experiments (K-D = 0.34-2.17 nM). In addition, GAPDH-C1q complexes were observed by transmission electron microscopy after cross-linking. The purified pneumococcal GAPDH protein activated C1 in an in vitro assay unlike the human form. Deposition of C1q, C3b, and C4b from human serum at the surface of pneumococcal cells was dependent on the presence of surface-exposed GAPDH. This ability of C1q to sense both human and bacterial GAPDHs sheds new insights on the role of this important defense collagen molecule in modulating the immune response.	[Di Guilmi, Anne Marie] Univ Grenoble 1, PG, Inst Biol Struct Jean Pierre Ebel, F-38027 Grenoble 1, France; [Frachet, Philippe] Univ Grenoble 1, IRPAS Grp, ASP Team, Inst Biol Struct Jean Pierre Ebel, F-38027 Grenoble 1, France; [Moriscot, Christine; Schoehn, Guy] Univ Grenoble 1, MEM Grp, F-38027 Grenoble 1, France; [Terrasse, Remi; Tacnet-Delorme, Pascale; Moriscot, Christine; Perard, Julien; Schoehn, Guy; Vernet, Thierry; Thielens, Nicole M.; Di Guilmi, Anne Marie; Frachet, Philippe] CNRS, F-38027 Grenoble, France; [Terrasse, Remi; Tacnet-Delorme, Pascale; Moriscot, Christine; Schoehn, Guy; Vernet, Thierry; Thielens, Nicole M.; Di Guilmi, Anne Marie; Frachet, Philippe] Commissariat Energie Atom, Inst Biol Struct Jean Pierre Ebel, F-38027 Grenoble, France; [Perard, Julien] Univ Grenoble 1, Unit Virus Host Cell Interact, CNRS, European Mol Biol Lab,UJF,UMI 3265, F-38042 Grenoble, France	UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); European Molecular Biology Laboratory (EMBL); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Di Guilmi, AM (corresponding author), Univ Grenoble 1, PG, Inst Biol Struct Jean Pierre Ebel, 41 Rue Jules Horowitz, F-38027 Grenoble 1, France.	anne-marie.di-guilmi@ibs.fr; philippe.frachet@ibs.fr	Thielens, Nicole M/F-2512-2013; Vernet, Thierry/G-1118-2012; frachet, philippe/Q-2869-2019; Frachet, philippe/C-3797-2018	Thielens, Nicole M/0000-0002-7354-0302; frachet, philippe/0000-0002-1658-3859; Frachet, philippe/0000-0002-1658-3859; MORISCOT, Christine/0000-0001-5707-0999; Di Guilmi, Anne Marie/0000-0001-7335-3470; Schoehn, Guy/0000-0002-1459-3201	European Commission [LSHM-CT-2004-512138]; Agence Nationale de la Recherche [PneumoPG, ANR-09-PIRIbio]; University Joseph Fourier-Grenoble	European Commission(European CommissionEuropean Commission Joint Research Centre); Agence Nationale de la Recherche(French National Research Agency (ANR)); University Joseph Fourier-Grenoble	This work was supported in part by European Commission Grant LSHM-CT-2004-512138, Agence Nationale de la Recherche Grants PneumoPG and ANR-09-PIRIbio, and a grant from University Joseph Fourier-Grenoble (to P. F.).	Ali YM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002793; Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; Attali C, 2008, INFECT IMMUN, V76, P466, DOI 10.1128/IAI.01261-07; Bergmann S, 2005, THROMB HAEMOSTASIS, V94, P304, DOI 10.1160/TH05-05-0369; Bergmann S, 2004, INFECT IMMUN, V72, P2416, DOI 10.1128/IAI.72.4.2416-2419.2004; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; Biro A, 2007, MOL IMMUNOL, V44, P1169, DOI 10.1016/j.molimm.2006.06.013; Biro A, 2010, BIOCHEMISTRY-US, V49, P2167, DOI 10.1021/bi9021022; Blanquet-Grossard F, 2005, BIOCHEMISTRY-US, V44, P4349, DOI 10.1021/bi047370a; Boel G, 2005, INFECT IMMUN, V73, P6237, DOI 10.1128/IAI.73.10.6237-6248.2005; Brown JS, 2002, P NATL ACAD SCI USA, V99, P16969, DOI 10.1073/pnas.012669199; Castellano G, 2007, EUR J IMMUNOL, V37, P2803, DOI 10.1002/eji.200636845; Dieudonne-Vatran A, 2009, J IMMUNOL, V182, P7865, DOI 10.4049/jimmunol.0802376; Egea L, 2007, INT J BIOCHEM CELL B, V39, P1190, DOI 10.1016/j.biocel.2007.03.008; Elward K, 2005, J BIOL CHEM, V280, P36342, DOI 10.1074/jbc.M506579200; Ferreira-da-Silva F, 2006, J BIOL CHEM, V281, P33433, DOI 10.1074/jbc.M605267200; Fraser DA, 2010, J NEUROCHEM, V112, P733, DOI 10.1111/j.1471-4159.2009.06494.x; Fraser DA, 2009, J IMMUNOL, V183, P6175, DOI 10.4049/jimmunol.0902232; Henderson B., 2012, CURR TOP MI IN PRESS; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; Jia BL, 2011, EXTREMOPHILES, V15, P337, DOI 10.1007/s00792-011-0365-4; Jin H, 2005, J MOL BIOL, V350, P27, DOI 10.1016/j.jmb.2005.04.063; Jin H, 2011, MBIO, V2, DOI 10.1128/mBio.00068-11; Kang YS, 2006, CELL, V125, P47, DOI 10.1016/j.cell.2006.01.046; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Klein MA, 2001, NAT MED, V7, P488, DOI 10.1038/86567; Kojouharova M, 2010, MOL IMMUNOL, V47, P2154, DOI 10.1016/j.molimm.2010.05.011; Korb LC, 1997, J IMMUNOL, V158, P4525; Laschet JJ, 2004, J NEUROSCI, V24, P7614, DOI 10.1523/JNEUROSCI.0868-04.2004; Lu L, 2008, J IMMUNOL, V181, P7138, DOI 10.4049/jimmunol.181.10.7138; Madureira P, 2007, J IMMUNOL, V178, P1379, DOI 10.4049/jimmunol.178.3.1379; Martin M, 2012, J BIOL CHEM, V287, P33733, DOI 10.1074/jbc.M112.341339; Matta SK, 2010, BBA-PROTEINS PROTEOM, V1804, P2111, DOI 10.1016/j.bbapap.2010.08.004; Mouche F, 2002, J BIOL CHEM, V277, P6743, DOI 10.1074/jbc.M106401200; Navratil JS, 2001, J IMMUNOL, V166, P3231, DOI 10.4049/jimmunol.166.5.3231; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Paidassi H, 2008, FEBS LETT, V582, P3111, DOI 10.1016/j.febslet.2008.08.001; Paidassi H, 2008, J IMMUNOL, V180, P2329, DOI 10.4049/jimmunol.180.4.2329; Paidassi H, 2007, MOL IMMUNOL, V44, P225, DOI 10.1016/j.molimm.2006.07.183; Paidassi H, 2011, J MOL BIOL, V408, P277, DOI 10.1016/j.jmb.2011.02.029; Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Raje CI, 2007, J BIOL CHEM, V282, P3252, DOI 10.1074/jbc.M608328200; Sawa A, 1997, P NATL ACAD SCI USA, V94, P11669, DOI 10.1073/pnas.94.21.11669; Sirover MA, 1997, J CELL BIOCHEM, V66, P133, DOI 10.1002/(SICI)1097-4644(19970801)66:2<133::AID-JCB1>3.3.CO;2-V; Smith BL, 2000, J INFECT DIS, V182, P497, DOI 10.1086/315722; Tacnet-Delorme P, 2001, J IMMUNOL, V167, P6374, DOI 10.4049/jimmunol.167.11.6374; Tarze A, 2007, ONCOGENE, V26, P2606, DOI 10.1038/sj.onc.1210074; Terao Y, 2006, J BIOL CHEM, V281, P14215, DOI 10.1074/jbc.M513408200; Ucker DS, 2012, J BIOL CHEM, V287, P10325, DOI 10.1074/jbc.M111.314971; VELLIEUX FMD, 1995, ACTA CRYSTALLOGR D, V51, P575, DOI 10.1107/S0907444995003015; Yuste J, 2007, PLOS PATHOG, V3, P1208, DOI 10.1371/journal.ppat.0030120; Yuste J, 2008, INFECT IMMUN, V76, P3761, DOI 10.1128/IAI.00291-08	55	42	43	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42620	42633		10.1074/jbc.M112.423731	http://dx.doi.org/10.1074/jbc.M112.423731			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23086952	Green Published, hybrid			2022-12-25	WOS:000312501600023
J	Zhang, J; Wang, SH; Yuan, L; Yang, YX; Zhang, BW; Liu, QB; Chen, L; Yue, W; Li, YH; Pei, XT				Zhang, Jing; Wang, Sihan; Yuan, Lin; Yang, Yinxiang; Zhang, Bowen; Liu, Qingbin; Chen, Lin; Yue, Wen; Li, Yanhua; Pei, Xuetao			Neuron-restrictive Silencer Factor (NRSF) Represses Cocaine- and Amphetamine-regulated Transcript (CART) Transcription and Antagonizes cAMP-response Element-binding Protein Signaling through a Dual NRSE Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESENCHYMAL STEM-CELLS; RAT NUCLEUS-ACCUMBENS; GENE-EXPRESSION; MESSENGER-RNA; GH3 CELLS; PEPTIDE; BRAIN; ACTIVATION; PROMOTER; REST	Cocaine- and amphetamine-regulated transcript (CART) peptide plays a pivotal role in neuroprotection against stroke-related brain injury. However, the regulatory mechanism on CART transcription, especially the repression mechanism, is not fully understood. Here, we show that the transcriptional repressor neuron-restrictive silencer elements (NRSF, also known as REST) represses CART expression through direct binding to two NRSF-binding elements (NRSEs) in the CART promoter and intron 1 (named pNRSE and iNRSE, respectively). EMSA show that NRSF binds to pNRSE and iNRSE directly in vitro. ChIP assays show that NRSF recruits differential co-repressor complexes including CoREST and HDAC1 to these NRSEs. The presence of both NRSEs is required for efficient repression of CART transcription as indicated by reporter gene assays. NRSF overexpression antagonizes forskolin-mediated up-regulation of CART mRNA and protein. Ischemia insult triggered by oxygen-glucose deprivation (OGD) enhances NRSF mRNA levels and then NRSF antagonizes the CREB signaling on CART activation, leading to augmented cell death. Depletion of NRSF in combination with forskolin treatment increases neuronal survival after ischemic insult. These findings reveal a novel dual NRSE mechanism by which NRSF represses CART expression and suggest that NRSF may serve as a therapeutic target for stroke treatment.	[Zhang, Jing; Wang, Sihan; Yang, Yinxiang; Zhang, Bowen; Liu, Qingbin; Chen, Lin; Yue, Wen; Li, Yanhua; Pei, Xuetao] Beijing Inst Transfus Med, Stem Cell & Regenerat Med Lab, Beijing 100850, Peoples R China; [Yuan, Lin] Beijing Inst Radiat Med, State Key Lab Prote, Beijing 100850, Peoples R China	Academy of Military Medical Sciences - China	Pei, XT (corresponding author), Beijing Inst Transfus Med, Stem Cell & Regenerat Med Lab, Beijing 100850, Peoples R China.	peixt@nic.bmi.ac.cn		YUAN, LIN/0000-0001-5449-3435	National High Technology Research and Development Program of China [2006AA02A107]; National Basic Research Program of China [2010CB945500]; Chinese National Natural Science Foundation [81070618]; Beijing Natural Science Foundation [5102036]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China); Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by National High Technology Research and Development Program of China Grant 2006AA02A107, the National Basic Research Program of China Grant 2010CB945500, Chinese National Natural Science Foundation Grant 81070618, and Beijing Natural Science Foundation Grant 5102036.	Ahima RS, 2000, REGUL PEPTIDES, V92, P1, DOI 10.1016/S0167-0115(00)00142-7; Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Balkan B, 2012, BRAIN RES, V1432, P56, DOI 10.1016/j.brainres.2011.11.006; Barrett P, 2002, OBES RES, V10, P1291, DOI 10.1038/oby.2002.175; Bech P, 2008, J CLIN ENDOCR METAB, V93, P1246, DOI 10.1210/jc.2007-1946; Brennan DJ, 2012, ONCOGENE, V31, P3483, DOI 10.1038/onc.2011.519; Broberger C, 1999, P NATL ACAD SCI USA, V96, P13506, DOI 10.1073/pnas.96.23.13506; Chang LL, 2011, BRAIN BEHAV IMMUN, V25, P260, DOI 10.1016/j.bbi.2010.09.017; de Lartigue G, 2007, J NEUROSCI, V27, P2876, DOI 10.1523/JNEUROSCI.5508-06.2007; Dominguez G, 2002, J NEUROCHEM, V80, P885, DOI 10.1046/j.0022-3042.2002.00775.x; Dominguez G, 2006, PEPTIDES, V27, P1913, DOI 10.1016/j.peptides.2006.01.025; DOUGLASS J, 1995, J NEUROSCI, V15, P2471; Gao ZL, 2011, J NEUROSCI, V31, P9772, DOI 10.1523/JNEUROSCI.1604-11.2011; Greco SJ, 2007, J BIOL CHEM, V282, P30039, DOI 10.1074/jbc.M703026200; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Hunter RG, 2006, NEUROPHARMACOLOGY, V50, P858, DOI 10.1016/j.neuropharm.2005.12.007; Jia J, 2008, NEUROPEPTIDES, V42, P653, DOI 10.1016/j.npep.2008.05.006; Jones DC, 2009, NEUROSCIENCE, V160, P339, DOI 10.1016/j.neuroscience.2009.02.051; Jones DC, 2006, J PHARMACOL EXP THER, V317, P454, DOI 10.1124/jpet.105.096123; Kasacka I, 2012, ACTA HISTOCHEM, V114, P695, DOI 10.1016/j.acthis.2011.12.004; Kristensen P, 1998, NATURE, V393, P72, DOI 10.1038/29993; Kuhar MJ, 1999, TRENDS NEUROSCI, V22, P316, DOI 10.1016/S0166-2236(98)01377-0; Kuriyama G, 2004, ENDOCRINOLOGY, V145, P2542, DOI 10.1210/en.2003-0845; Lakatos A, 2002, MOL BRAIN RES, V104, P81, DOI 10.1016/S0169-328X(02)00321-2; Li BW, 2011, STEM CELLS DEV, V20, P1223, DOI 10.1089/scd.2010.0195; Li YH, 2008, J NEUROCHEM, V106, P1314, DOI 10.1111/j.1471-4159.2008.05487.x; Ling F, 2011, DNA CELL BIOL, V30, P91, DOI 10.1089/dna.2010.1101; Liu L, 2012, COMP BIOCHEM PHYS B, V162, P81, DOI 10.1016/j.cbpb.2012.04.005; Liu Z, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-67; Mao PZ, 2007, EUR J NEUROSCI, V26, P624, DOI 10.1111/j.1460-9568.2007.05691.x; Mao PZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029343; Martin D, 2003, J BIOL CHEM, V278, P53082, DOI 10.1074/jbc.M306861200; Rodrigues BC, 2011, NEUROSCIENCE, V195, P201, DOI 10.1016/j.neuroscience.2011.08.036; Rogge GA, 2010, BRAIN RES, V1344, P1, DOI 10.1016/j.brainres.2010.04.069; Sarvari M, 2010, ENDOCRINOLOGY, V151, P1161, DOI 10.1210/en.2009-0911; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; Upadhya MA, 2012, NEUROPHARMACOLOGY, V62, P1823, DOI 10.1016/j.neuropharm.2011.12.004; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Vicentic A, 2004, ENDOCRINOLOGY, V145, P4119, DOI 10.1210/en.2003-1648; Vrang N, 1999, BRAIN RES, V818, P499, DOI 10.1016/S0006-8993(98)01349-3; Wu B, 2006, BIOCHEM BIOPH RES CO, V347, P656, DOI 10.1016/j.bbrc.2006.06.117; Xu Y, 2006, P NATL ACAD SCI USA, V103, P14489, DOI 10.1073/pnas.0602932103; Yang YX, 2008, EXP CELL RES, V314, P2257, DOI 10.1016/j.yexcr.2008.04.008; Yu HB, 2011, GENOME RES, V21, P1284, DOI 10.1101/gr.114488.110; Yuan L, 2012, EMBO REP, V13, P363, DOI 10.1038/embor.2012.10	46	11	12	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42574	42587		10.1074/jbc.M112.376590	http://dx.doi.org/10.1074/jbc.M112.376590			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23086924	hybrid, Green Published			2022-12-25	WOS:000312501600019
J	Davis, ML; Stephens, PA; Willis, SG; Bassi, E; Marcon, A; Donaggio, E; Capitani, C; Apollonio, M				Davis, Miranda L.; Stephens, Philip A.; Willis, Stephen G.; Bassi, Elena; Marcon, Andrea; Donaggio, Emanuela; Capitani, Claudia; Apollonio, Marco			Prey Selection by an Apex Predator: The Importance of Sampling Uncertainty	PLOS ONE			English	Article							CANIS-LUPUS-SIGNATUS; CAPREOLUS-CAPREOLUS; UNGULATE COMMUNITY; CARNIVORE DIET; NATIONAL-PARK; FOOD-HABITS; ROE DEER; WOLF; WOLVES; ECOLOGY	The impact of predation on prey populations has long been a focus of ecologists, but a firm understanding of the factors influencing prey selection, a key predictor of that impact, remains elusive. High levels of variability observed in prey selection may reflect true differences in the ecology of different communities but might also reflect a failure to deal adequately with uncertainties in the underlying data. Indeed, our review showed that less than 10% of studies of European wolf predation accounted for sampling uncertainty. Here, we relate annual variability in wolf diet to prey availability and examine temporal patterns in prey selection; in particular, we identify how considering uncertainty alters conclusions regarding prey selection. Over nine years, we collected 1,974 wolf scats and conducted drive censuses of ungulates in Alpe di Catenaia, Italy. We bootstrapped scat and census data within years to construct confidence intervals around estimates of prey use, availability and selection. Wolf diet was dominated by boar (61.5 +/- 3.90 [SE] % of biomass eaten) and roe deer (33.7 +/- 3.61%). Temporal patterns of prey densities revealed that the proportion of roe deer in wolf diet peaked when boar densities were low, not when roe deer densities were highest. Considering only the two dominant prey types, Manly's standardized selection index using all data across years indicated selection for boar (mean = 0.73 +/- 0.023). However, sampling error resulted in wide confidence intervals around estimates of prey selection. Thus, despite considerable variation in yearly estimates, confidence intervals for all years overlapped. Failing to consider such uncertainty could lead erroneously to the assumption of differences in prey selection among years. This study highlights the importance of considering temporal variation in relative prey availability and accounting for sampling uncertainty when interpreting the results of dietary studies.	[Davis, Miranda L.; Stephens, Philip A.; Willis, Stephen G.] Univ Durham, Sch Biol & Biomed Sci, Durham, England; [Bassi, Elena; Marcon, Andrea; Donaggio, Emanuela; Capitani, Claudia; Apollonio, Marco] Univ Sassari, Dept Nat & Environm Sci, I-07100 Sassari, Sardinia, Italy	Durham University; University of Sassari	Davis, ML (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.	mldavis13@gmail.com	Marcon, Andrea/AAI-8138-2020; Willis, Stephen G/F-8503-2015; Stephens, Philip/B-8397-2008	Marcon, Andrea/0000-0003-3434-1279; Willis, Stephen G/0000-0002-8656-5808; Stephens, Philip/0000-0001-5849-788X; Capitani, Claudia/0000-0002-1899-8679	Durham University Doctoral Fellowship; Regional Government of Tuscany; Provincial Government of Arezzo	Durham University Doctoral Fellowship; Regional Government of Tuscany; Provincial Government of Arezzo	MD is a Ph.D. student funded by a Durham University Doctoral Fellowship. This funder had no role in the study design, data collection and analysis, decision to publish or prepration of the manuscript. Some funding for CC and EB (as students) and additional logistical support of field work for the study was provided by the Regional Government of Tuscany and Provincial Government of Arezzo. These institutions are responsible for managing the study area and are therefore interested in accurate unbiased metrics of the wildlife in the area. The authors worked with these institutions to design monitoring regimes (for wolves, boar, and roe deer) toward this end. These organizations had no other role in the analysis, decision to publish or preparation of the manuscript. Their participation in survey design and data collection has had no impact on the integrity of this study as their only goal was accurate, unbiased monitoring of the resident wildlife.	Aanes R, 1998, EUROPEAN ROE DEER: THE BIOLOGY OF SUCCESS, P139; Abrams PA, 2000, TRENDS ECOL EVOL, V15, P337, DOI 10.1016/S0169-5347(00)01908-X; Ansorge H, 2006, ACTA THERIOL, V51, P99, DOI 10.1007/BF03192661; Apollonio M., 2010, EUROPEAN UNGULATES T; Barja I, 2009, WILDLIFE BIOL, V15, P147, DOI 10.2981/07-096; Barret RH, 1982, HDB CENSUS METHODS T, P243; Berger KM, 2008, ECOLOGY, V89, P818, DOI 10.1890/07-0193.1; Beschta RL, 2009, BIOL CONSERV, V142, P2401, DOI 10.1016/j.biocon.2009.06.015; Bieber C, 2005, J APPL ECOL, V42, P1203, DOI 10.1111/j.1365-2664.2005.01094.x; Boitani Luigi, 2003, P317; Bongi P, 2009, CENSIMENTO CAPRIOLO; Bywater KA, 2010, MAMMAL REV, V40, P212, DOI 10.1111/j.1365-2907.2010.00160.x; Capitani C, 2004, MAMM BIOL, V69, P1, DOI 10.1078/1616-5047-112; Ciucci P, 1996, WILDLIFE BIOL, V2, P37, DOI 10.2981/wlb.1996.006; CUESTA L, 1991, MAMMALIA, V55, P239, DOI 10.1515/mamm.1991.55.2.239; Denno RF, 2005, DIRECT INDIRECT EFFE, P211; Efron B, 2000, J AM STAT ASSOC, V95, P1293, DOI 10.2307/2669773; Elena Bassi, MAMMALIAN B IN PRESS; Environmental Systems Research Institute (ESRI), 2011, ARCGIS DESKT; Fortin D, 2005, ECOLOGY, V86, P1320, DOI 10.1890/04-0953; Garrott RA, 2007, ECOL APPL, V17, P1588, DOI 10.1890/06-1439.1; Gazzola A, 2007, ITAL J ZOOL, V74, P297, DOI 10.1080/11250000701447074; Gazzola A, 2002, ITAL J ZOOL, V69, P157, DOI 10.1080/11250000209356454; Jedrzejewska Bogumila, 2005, P230; JEDRZEJEWSKI W, 1992, OECOLOGIA, V90, P27, DOI 10.1007/BF00317805; Jedrzejewski W, 2000, J MAMMAL, V81, P197, DOI 10.1644/1545-1542(2000)081&lt;0197:PSAPBW&gt;2.0.CO;2; Kauffman MJ, 2007, ECOL LETT, V10, P690, DOI 10.1111/j.1461-0248.2007.01059.x; Linnell JDC, 2000, BIODIVERS CONSERV, V9, P857, DOI 10.1023/A:1008969104618; Macdonald DW, 1980, FOXES VULPES VULPES, P223; Manly B.F.J., 2002, RESOURCE SELECTION A; MANLY BFJ, 1972, AM NAT, V106, P719, DOI 10.1086/282808; Marucco F, 2008, J MAMMAL, V89, P665, DOI 10.1644/07-MAMM-A-005R3.1; Mattioli L, 2004, J ZOOL, V264, P249, DOI 10.1017/S095283690400576X; Mattioli L, 1995, ACTA THERIOL, V40, P387, DOI 10.4098/AT.arch.95-36; Mattioli L, 2011, EUR J WILDLIFE RES, V57, P909, DOI 10.1007/s10344-011-0503-4; Mayle BA, 1998, POPULATION ECOLOGY M, P19; McCullough D.R., 1979, GEORGE RESERVE DEER; Mech L. David, 2003, P131; Melis C, 2009, GLOBAL ECOL BIOGEOGR, V18, P724, DOI 10.1111/j.1466-8238.2009.00480.x; Meriggi A, 2011, ETHOL ECOL EVOL, V23, P195, DOI 10.1080/03949370.2011.577814; Meriggi A, 1996, ECOGRAPHY, V19, P287, DOI 10.1111/j.1600-0587.1996.tb00238.x; MESSIER F, 1994, ECOLOGY, V75, P478, DOI 10.2307/1939551; Messier F, 1995, FUNCTIONAL NUMERICAL, P187; Okarma H, 1995, ACTA THERIOL, V40, P335, DOI 10.4098/AT.arch.95-35; Post E, 1999, NATURE, V401, P905, DOI 10.1038/44814; R Core Development Team, 2011, R LANG ENV STAT COMP; REYNOLDS JC, 1991, MAMMAL REV, V21, P97, DOI 10.1111/j.1365-2907.1991.tb00113.x; SALVADOR A, 1987, MAMMALIA, V51, P45, DOI 10.1515/mamm.1987.51.1.45; Schmidt OJ, 2005, BEHAV PREDATORS PREY, P256; Servanty S, 2009, J ANIM ECOL, V78, P1278, DOI 10.1111/j.1365-2656.2009.01579.x; SMIETANA W, 1993, ACTA THERIOL, V38, P245; Trites AW, 2005, J MAMMAL, V86, P704, DOI 10.1644/1545-1542(2005)086[0704:DAFFSH]2.0.CO;2; Vucetich JA, 2002, ECOLOGY, V83, P3003; WEAVER JL, 1993, J WILDLIFE MANAGE, V57, P534, DOI 10.2307/3809278; Wilmers CC, 2007, J ANIM ECOL, V76, P1037, DOI 10.1111/j.1365-2656.2007.01289.x	55	26	26	3	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47894	10.1371/journal.pone.0047894	http://dx.doi.org/10.1371/journal.pone.0047894			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110122	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000310262500027
J	Theodoric, N; Bechberger, JF; Naus, CC; Sin, WC				Theodoric, Nicolas; Bechberger, John F.; Naus, Christian C.; Sin, Wun-Chey			Role of Gap Junction Protein Connexin43 in Astrogliosis Induced by Brain Injury	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; RAT SPINAL-CORD; FIBRILLARY ACIDIC PROTEIN; FOCAL CEREBRAL-ISCHEMIA; REACTIVE ASTROCYTES; GLIAL SCAR; NESTIN EXPRESSION; CX43 EXPRESSION; UP-REGULATION; STAB WOUNDS	Astrogliosis is a process that involves morphological and biochemical changes associated with astrocyte activation in response to cell damage in the brain. The upregulation of intermediate filament proteins including glial fibrillary acidic protein (GFAP), nestin and vimentin are often used as indicators for astrogliosis. Although connexin43 (Cx43), a channel protein widely expressed in adult astrocytes, exhibits enhanced immunoreactivity in the peri-lesion region, its role in astrogliosis is still unclear. Here, we correlated the temporal and spatial expression of Cx43 to the activation of astrocytes and microglia in response to an acute needle stab wound in vivo. We found large numbers of microglia devoid of Cx43 in the needle wound at 3 days post injury (dpi) while reactive astrocytes expressing Cx43 were present in the peripheral zone surrounding the injury site. A redistribution of Cx43 to the needle site, corresponding to the increased presence of GFAP-positive reactive astrocytes in the region, was only apparent from 6 dpi and sustained until at least 15 dpi. Interestingly, the extent of microglial activation and subsequent astrogliosis in the brain of Cx43 knockout mice was significantly larger than those of wild type, suggesting that Cx43 expression limits the degree of microgliosis. Although Cx43 is not essential for astrogliosis and microglial activation induced by a needle injury, our results demonstrate that Cx43 is a useful marker for injury induced astrogliosis due to its enhanced expression specifically within a small region of the lesion for an extended period. As a channel protein, Cx43 is a potential in vivo diagnostic tool of asymptomatic brain injury.	[Theodoric, Nicolas; Bechberger, John F.; Naus, Christian C.; Sin, Wun-Chey] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	University of British Columbia	Sin, WC (corresponding author), Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	wcsin@mail.ubc.ca			Heart & Stroke Foundation of Canada [20R63496]; Canada Research Chair	Heart & Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This study was supported by a grant from the Heart & Stroke Foundation of Canada (Project grant number: 20R63496) to C.C.N. C.C.N. also holds a Canada Research Chair. The funders have no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Amat JA, 1996, GLIA, V16, P368, DOI 10.1002/(SICI)1098-1136(199604)16:4<368::AID-GLIA9>3.0.CO;2-W; Baklaushev VP, 2011, DRUG DELIV, V18, P331, DOI 10.3109/10717544.2010.549527; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Casper KB, 2006, MOL CELL NEUROSCI, V31, P676, DOI 10.1016/j.mcn.2005.12.006; CAVANAGH JB, 1970, J ANAT, V106, P471; Cerutti SM, 2000, CELL BIOL INT, V24, P35, DOI 10.1006/cbir.1999.0451; Cina C, 2009, J NEUROSCI, V29, P2009, DOI 10.1523/JNEUROSCI.5025-08.2009; Cronin M, 2008, MOL CELL NEUROSCI, V39, P152, DOI 10.1016/j.mcn.2008.06.005; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; DERMIETZEL R, 1993, TRENDS NEUROSCI, V16, P186, DOI 10.1016/0166-2236(93)90151-B; Dobrenis K, 2005, J NEUROSCI RES, V82, P306, DOI 10.1002/jnr.20650; Duffy HS, 2000, J NEUROSCI, V20; Duggal N, 1997, BRAIN RES, V768, P1, DOI 10.1016/S0006-8993(97)00588-X; Eugenin EA, 2001, P NATL ACAD SCI USA, V98, P4190, DOI 10.1073/pnas.051634298; Ezan P, 2012, J CEREB BLOOD FLOW M; Faustmann PM, 2003, GLIA, V42, P101, DOI 10.1002/glia.10141; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fonseca CG, 2002, BRAIN RES, V929, P105, DOI 10.1016/S0006-8993(01)03289-9; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; Froger N, 2010, MOL CELL NEUROSCI, V45, P37, DOI 10.1016/j.mcn.2010.05.007; Garg S, 2005, J NEUROCHEM, V95, P475, DOI 10.1111/j.1471-4159.2005.03384.x; Giaume C, 1996, TRENDS NEUROSCI, V19, P319, DOI 10.1016/0166-2236(96)10046-1; GIORDANA MT, 1994, NEUROPATH APPL NEURO, V20, P163, DOI 10.1111/j.1365-2990.1994.tb01175.x; Goodenough DA, 2003, NAT REV MOL CELL BIO, V4, P285, DOI 10.1038/nrm1072; Hampton DW, 2004, NEUROSCIENCE, V127, P813, DOI 10.1016/j.neuroscience.2004.05.028; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Haupt C, 2007, MOL CELL NEUROSCI, V35, P89, DOI 10.1016/j.mcn.2007.02.005; Hinkerohe D, 2005, GLIA, V52, P85, DOI 10.1002/glia.20223; HOLNESS CL, 1993, BLOOD, V81, P1607; HOSSAIN MZ, 1994, BRAIN RES, V652, P311, DOI 10.1016/0006-8993(94)90242-9; HOSSAIN MZ, 1994, GLIA, V10, P250, DOI 10.1002/glia.440100404; Huang CL, 2012, J NEUROSCI, V32, P3333, DOI 10.1523/JNEUROSCI.1216-11.2012; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Jing RF, 2007, J CELL SCI, V120, P1267, DOI 10.1242/jcs.03423; Kielian T, 2008, J NEUROCHEM, V106, P1000, DOI 10.1111/j.1471-4159.2008.05405.x; Kozoriz MG, 2010, J NEUROPATH EXP NEUR, V69, P196, DOI 10.1097/NEN.0b013e3181cd44df; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kronenberg G, 2005, J CEREBR BLOOD F MET, V25, P1613, DOI 10.1038/sj.jcbfm.9600156; Kunzelmann P, 1999, GLIA, V25, P111, DOI 10.1002/(SICI)1098-1136(19990115)25:2<111::AID-GLIA2>3.0.CO;2-I; Lee IH, 2005, J COMP NEUROL, V489, P1, DOI 10.1002/cne.20567; LEVINE JM, 1994, J NEUROSCI, V14, P4716; Li WEI, 1998, EUR J NEUROSCI, V10, P2444, DOI 10.1046/j.1460-9568.1998.00253.x; LIN RCS, 1995, NEUROBIOL DIS, V2, P79, DOI 10.1006/nbdi.1995.0008; Lovatt D, 2007, J NEUROSCI, V27, P12255, DOI 10.1523/JNEUROSCI.3404-07.2007; Martinez AD, 2002, BRAIN RES, V943, P191, DOI 10.1016/S0006-8993(02)02621-5; McTigue DM, 2001, J NEUROSCI, V21, P3392, DOI 10.1523/JNEUROSCI.21-10-03392.2001; Meme W, 2006, FASEB J, V20, P494, DOI 10.1096/fj.05-4297fje; Nagy JI, 2000, BRAIN RES REV, V32, P29, DOI 10.1016/S0165-0173(99)00066-1; Nagy JI, 1999, NEUROSCIENCE, V88, P447, DOI 10.1016/S0306-4522(98)00191-2; Nakase T, 2004, AM J PATHOL, V164, P2067, DOI 10.1016/S0002-9440(10)63765-0; Nakase T, 2004, BBA-BIOMEMBRANES, V1662, P149, DOI 10.1016/j.bbamem.2004.01.009; Nakase T, 2003, STROKE, V34, P1987, DOI 10.1161/01.STR.0000079814.72027.34; Nakase T, 2006, GLIA, V54, P369, DOI 10.1002/glia.20399; Naus CCG, 2001, CELL COMMUN ADHES, V8, P325, DOI 10.3109/15419060109080747; OCHALSKI PAY, 1995, GLIA, V14, P279, DOI 10.1002/glia.440140405; Oki K, 2010, NEUROSCI RES, V66, P390, DOI 10.1016/j.neures.2009.12.013; Orellana JA, 2009, ANTIOXID REDOX SIGN, V11, P369, DOI 10.1089/ars.2008.2130; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Pekny M, 2004, J PATHOL, V204, P428, DOI 10.1002/path.1645; Retamal MA, 2007, J NEUROSCI, V27, P13781, DOI 10.1523/JNEUROSCI.2042-07.2007; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Rouach N, 2002, BIOL CELL, V94, P457, DOI 10.1016/S0248-4900(02)00016-3; Rozental R, 2000, BRAIN RES REV, V32, P11, DOI 10.1016/S0165-0173(99)00095-8; Sheng JS, 2004, EUR J NEUROSCI, V20, P873, DOI 10.1111/j.1460-9568.2004.03567.x; Simon AM, 1998, TRENDS CELL BIOL, V8, P477, DOI 10.1016/S0962-8924(98)01372-5; Siushansian R, 2001, J COMP NEUROL, V440, P387, DOI 10.1002/cne.1392; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Tamagno I, 2006, J NEURO-ONCOL, V80, P227, DOI 10.1007/s11060-006-9181-6; Tatsumi K, 2008, J NEUROSCI RES, V86, P3494, DOI 10.1002/jnr.21862; Theis M, 2001, CELL COMMUN ADHES, V8, P383, DOI 10.3109/15419060109080758; Theriault E, 1997, J COMP NEUROL, V382, P199; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhao JW, 2009, EUR J NEUROSCI, V29, P1853, DOI 10.1111/j.1460-9568.2009.06736.x; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	80	49	50	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47311	10.1371/journal.pone.0047311	http://dx.doi.org/10.1371/journal.pone.0047311			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110066	Green Published, gold, Green Submitted			2022-12-25	WOS:000310193600013
J	Bae, JC; Suh, S; Park, SE; Rhee, EJ; Park, CY; Oh, KW; Park, SW; Kim, SW; Hur, KY; Kim, JH; Lee, MS; Lee, MK; Kim, KW; Lee, WY				Bae, Ji Cheol; Suh, Sunghwan; Park, Se Eun; Rhee, Eun Jung; Park, Cheol Young; Oh, Ki Won; Park, Sung Woo; Kim, Sun Woo; Hur, Kyu Yeon; Kim, Jae Hyeon; Lee, Myung-Shik; Lee, Moon Kyu; Kim, Kwang-Won; Lee, Won-Young			Regular Exercise Is Associated with a Reduction in the Risk of NAFLD and Decreased Liver Enzymes in Individuals with NAFLD Independent of Obesity in Korean Adults	PLOS ONE			English	Article							NONALCOHOLIC FATTY LIVER; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; WEIGHT-LOSS; CARDIORESPIRATORY FITNESS; NONDIABETIC SUBJECTS; METABOLIC SYNDROME; BODY-COMPOSITION; DISEASE; LIFE	Background: We evaluated the association of regular physical exercise with the presence of non-alcoholic fatty liver disease (NAFLD) and liver enzymes in relation to obesity and insulin resistance. Methodology/Principal Findings: A cross-sectional analysis was conducted in 72,359 healthy Korean adults without diabetes who participated in a comprehensive health check-up. Subjects who have been exercising regularly (more than 3 times per week, at least for 30 minutes each time and for consecutive 3 month) were categorized into exercise group. All subjects were categorized into deciles based on their body mass index (BMI) and we estimated the odds ratios (ORs) for having NAFLD according to exercise regularity in each decile. The diagnosis of NAFLD was based on ultrasonography findings. Individuals with NAFLD (n = 19,921) were analyzed separately to evaluate ORs for having elevated liver enzymes based on regularity of exercise. The risk for NAFLD was significantly reduced in exercise group with age- and sex-adjusted ORs of 0.53-0.72 for all BMI deciles except at BMI categories of < 19.6 and 20.7-21.6 kg/m(2). While no difference was seen in BMI between subjects in exercise and non-exercise group across the BMI deciles, the values of body fat percentage and metabolic risk factors differed. Among NAFLD patients, subjects in exercise group had a lower risk for having elevated liver enzymes with multivariable adjusted OR of 0.85 (95% CI 0.74-0.99, for AST) and 0.74 (95% CI 0.67-0.81, for ALT) than did subjects in non-exercise group. Conclusions/Significance: Regular exercise was associated with a reduced risk for having NAFLD and decreased liver enzymes in patients with NAFLD, and this relationship was also independent of obesity.	[Park, Se Eun; Rhee, Eun Jung; Park, Cheol Young; Oh, Ki Won; Park, Sung Woo; Kim, Sun Woo; Lee, Won-Young] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Internal Med,Div Endocrinol & Metab, Seoul, South Korea; [Bae, Ji Cheol; Suh, Sunghwan; Hur, Kyu Yeon; Kim, Jae Hyeon; Lee, Myung-Shik; Lee, Moon Kyu; Kim, Kwang-Won] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med,Div Endocrinol & Metab, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, WY (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Internal Med,Div Endocrinol & Metab, Seoul, South Korea.	drlwy@hanmail.net	Lee, Myung Shik/C-9606-2011; Rhee, Eun-Jung/M-9294-2015; LEE, WON-YOUNG/C-7249-2018; Park, Cheol-Young/C-6690-2018	Rhee, Eun-Jung/0000-0002-6108-7758; LEE, WON-YOUNG/0000-0002-1082-7592; Suh, Sunghwan/0000-0001-6865-966X; Park, Cheol-Young/0000-0002-9415-9965				Bae JC, 2011, DIABETES CARE, V34, P727, DOI 10.2337/dc10-1991; Bae JC, 2010, AM J GASTROENTEROL, V105, P2389, DOI 10.1038/ajg.2010.275; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Bell LM, 2007, J CLIN ENDOCR METAB, V92, P4230, DOI 10.1210/jc.2007-0779; BLAIR SN, 1993, ANN INTERN MED, V119, P702, DOI 10.7326/0003-4819-119-7_Part_2-199310011-00015; BODEN G, 1993, DIABETES CARE, V16, P728, DOI 10.2337/diacare.16.5.728; Booth FW, 2008, EUR J APPL PHYSIOL, V102, P381, DOI 10.1007/s00421-007-0606-5; Boule NG, 2001, JAMA-J AM MED ASSOC, V286, P1218, DOI 10.1001/jama.286.10.1218; Brodney S, 2001, MED SCI SPORT EXER, V33, P459, DOI 10.1097/00005768-200103000-00020; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Hallsworth K, 2011, GUT, V60, P1278, DOI 10.1136/gut.2011.242073; Harrison SA, 2007, GUT, V56, P1760, DOI 10.1136/gut.2006.112094; Hickman IJ, 2004, GUT, V53, P413, DOI 10.1136/gut.2003.027581; Jeon CY, 2007, DIABETES CARE, V30, P744, DOI 10.2337/dc06-1842; Johnson NA, 2010, HEPATOLOGY, V52, P370, DOI 10.1002/hep.23711; Johnson NA, 2009, HEPATOLOGY, V50, P1105, DOI 10.1002/hep.23129; Kantartzis K, 2009, GUT, V58, P1281, DOI 10.1136/gut.2008.151977; Keating SE, 2012, J HEPATOL, V57, P157, DOI 10.1016/j.jhep.2012.02.023; Kistler KD, 2011, AM J GASTROENTEROL, V106, P460, DOI 10.1038/ajg.2010.488; Longo DL, 2011, HARRISONS PRINCIPLES, V2, P3588; Malavolti M, 2003, ANN HUM BIOL, V30, P380, DOI 10.1080/0301446031000095211; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055; SAVERYMUTTU SH, 1986, BRIT MED J, V292, P13, DOI 10.1136/bmj.292.6512.13; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Sullivan S, 2012, HEPATOLOGY, V55, P1738, DOI 10.1002/hep.25548; Thoma C, 2012, J HEPATOL, V56, P255, DOI 10.1016/j.jhep.2011.06.010; Tiniakos DG, 2010, ANNU REV PATHOL-MECH, V5, P145, DOI 10.1146/annurev-pathol-121808-102132; Ueno T, 1997, J HEPATOL, V27, P103, DOI 10.1016/S0168-8278(97)80287-5; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; Wei YZ, 2008, WORLD J GASTROENTERO, V14, P193, DOI 10.3748/wjg.14.193; Westerbacka J, 2005, J CLIN ENDOCR METAB, V90, P2804, DOI 10.1210/jc.2004-1983; Wong SL, 2004, MED SCI SPORT EXER, V36, P286, DOI 10.1249/01.MSS.0000113665.40775.35; World Health Organization Regional Office for the Western Pacific (WPRO) International Association for the Study of Obesity International Obesity Task Force, 2000, AS PAC PERS RED OB I; Zelber-Sagi S, 2008, HEPATOLOGY, V48, P1791, DOI 10.1002/hep.22525; Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012	38	67	70	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e46819	10.1371/journal.pone.0046819	http://dx.doi.org/10.1371/journal.pone.0046819			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110056	gold, Green Published, Green Submitted			2022-12-25	WOS:000310193400006
J	D'Orazio, M; Pacello, F; Battistoni, A				D'Orazio, Melania; Pacello, Francesca; Battistoni, Andrea			Extracellular Glutathione Decreases the Ability of Burkholderia cenocepacia to Penetrate into Epithelial Cells and to Induce an Inflammatory Response	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; REDUCED GLUTATHIONE; N-ACETYLCYSTEINE; CFTR MUTATION; CEPACIA; INVASION; THIOLS; IMPROVEMENT; SALMONELLA; VIRUS	Background: The airway surface liquid (ASL) of Cystic Fibrosis (CF) patients contains a lower concentration of reduced glutathione (GSH) with respect to healthy people. It is not known whether this defect may favor lung colonization by opportunistic pathogens. Principal Findings: We have analyzed the effects of extracellular GSH on the ability of Burkholderia cenocepacia to penetrate and multiply in epithelial respiratory cells. Extracellular GSH proved to be able to drastically reduce the pathogen ability to adhere and invade airway epithelial cells. This effect is correlated to a GSH-dependent increase in the number of free thiols on the surface of epithelial cells, suggestive of a change in the oxidoreductive status of membrane proteins involved in B. cenocepacia recognition. Moreover, treatments with GSH led to a consistent reduction of the expression of IL-8, TNF-alpha and IL-1 beta in response to B. cenocepacia infection. Conclusions and Significance: Extracellular GSH modulates the interaction between B. cenocepacia and epithelial respiratory cells and inhibits the bacterial invasion into these cells. This suggests that therapies aimed at restoring normal levels of GSH in the ASL might be beneficial to control CF lung infections.	[Pacello, Francesca; Battistoni, Andrea] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [D'Orazio, Melania] Ist Ricovero & Cura Carattere Sci San Raffaele Pi, Rome, Italy	University of Rome Tor Vergata	Battistoni, A (corresponding author), Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.	andrea.battistoni@uniroma2.it	Battistoni, Andrea/A-4778-2016	Battistoni, Andrea/0000-0003-4085-7917	Italian Cystic Fibrosis Research Foundation [11/2008, 15/2010]; Studio Palladio	Italian Cystic Fibrosis Research Foundation(Ministry of Health, ItalyItalian Cystic Fibrosis Research Foundation); Studio Palladio	This work was supported by the Italian Cystic Fibrosis Research Foundation (Grant FFC# 11/2008 and 15#/2010). Following selection, these projects were "adopted" by Studio Palladio 2000, Sandrigo (VI) and of Delegazione FFC Roma 2, respectively, as a form of support to FFC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was partly supported by Studio Palladio 2000. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Bishop C, 2005, CHEST, V127, P308, DOI 10.1378/chest.127.1.308; Buhler T, 1998, J APPL MICROBIOL, V85, P457, DOI 10.1046/j.1365-2672.1998.853501.x; Caldwell CC, 2009, AM J PATHOL, V175, P2473, DOI 10.2353/ajpath.2009.090166; CANTIN AM, 1987, J APPL PHYSIOL, V63, P152, DOI 10.1152/jappl.1987.63.1.152; Dauletbaev N, 2009, EUR J MED RES, V14, P352; Duff C, 2006, MICROB PATHOGENESIS, V41, P183, DOI 10.1016/j.micpath.2006.07.005; ERNST RK, 1990, INFECT IMMUN, V58, P2014, DOI 10.1128/IAI.58.6.2014-2016.1990; Filomeni G, 2002, BIOCHEM PHARMACOL, V64, P1057, DOI 10.1016/S0006-2952(02)01176-0; Ghezzi P, 2011, INT J GEN MED, V4, P105, DOI 10.2147/IJGM.S15618; Gould NS, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-119; Greunert DC, 1988, P NATL ACAD SCI USA, V85, P5951; Griese M, 2004, AM J RESP CRIT CARE, V169, P822, DOI 10.1164/rccm.200308-1104OC; Holden MTG, 2009, J BACTERIOL, V191, P261, DOI 10.1128/JB.01230-08; Hudson VM, 2001, FREE RADICAL BIO MED, V30, P1440, DOI 10.1016/S0891-5849(01)00530-5; Imhoff BR, 2009, BIOCHEM J, V424, P491, DOI 10.1042/BJ20091286; KUNZELMANN K, 1993, AM J RESP CELL MOL, V8, P522, DOI 10.1165/ajrcmb/8.5.522; LEE CA, 1990, P NATL ACAD SCI USA, V87, P4304, DOI 10.1073/pnas.87.11.4304; Martin DW, 2000, INFECT IMMUN, V68, P24, DOI 10.1128/IAI.68.1.24-29.2000; Metcalfe C, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110010; Muller M, 2011, FREE RADICAL BIO MED, V50, P971, DOI 10.1016/j.freeradbiomed.2011.01.012; Nash EF, 2009, COCHRANE DB SYST REV, V21; Nencioni L, 2003, FASEB J, V17, P758, DOI 10.1096/fj.02-0508fje; Nicolis E, 2008, INT IMMUNOPHARMACOL, V8, P1672, DOI 10.1016/j.intimp.2008.08.001; Ou W, 2006, VIROLOGY, V350, P406, DOI 10.1016/j.virol.2006.01.041; Petrucca A, 2003, RES MICROBIOL, V154, P491, DOI 10.1016/S0923-2508(03)00145-1; Pirone L, 2008, ENVIRON MICROBIOL, V10, P2773, DOI 10.1111/j.1462-2920.2008.01697.x; Rada B, 2011, MUCOSAL IMMUNOL, V4, P158, DOI 10.1038/mi.2010.62; Roum JH, 1999, J APPL PHYSIOL, V87, P438, DOI 10.1152/jappl.1999.87.1.438; ROUM JH, 1993, J APPL PHYSIOL, V75, P2419, DOI 10.1152/jappl.1993.75.6.2419; Sajjan U, 2004, INFECT IMMUN, V72, P4188, DOI 10.1128/IAI.72.7.4188-4199.2004; Sajjan U, 2001, J MED MICROBIOL, V50, P535, DOI 10.1099/0022-1317-50-6-535; Sajjan US, 2008, CELL MICROBIOL, V10, P188, DOI 10.1111/j.1462-5822.2007.01029.x; Schwertassek U, 2007, EMBO J, V26, P3086, DOI 10.1038/sj.emboj.7601746; Skalska J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008115; Sokol PA, 1999, INFECT IMMUN, V67, P4443, DOI 10.1128/IAI.67.9.4443-4455.1999; STAAL FJT, 1990, P NATL ACAD SCI USA, V87, P9943, DOI 10.1073/pnas.87.24.9943; Tipper JL, 1998, CLIN MICROBIOL INFEC, V8, P450; Tirouvanziam R, 2006, P NATL ACAD SCI USA, V103, P4628, DOI 10.1073/pnas.0511304103; Vasu VT, 2011, FREE RADICAL RES, V45, P165, DOI 10.3109/10715762.2010.521154; Velsor LW, 2001, AM J PHYSIOL-LUNG C, V281, pL31, DOI 10.1152/ajplung.2001.281.1.L31; Venketaraman V, 2008, MICROB PATHOGENESIS, V44, P255, DOI 10.1016/j.micpath.2007.09.002; Visca A, 2008, J CYST FIBROS, V7, P433, DOI 10.1016/j.jcf.2008.03.006	42	5	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47550	10.1371/journal.pone.0047550	http://dx.doi.org/10.1371/journal.pone.0047550			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094061	Green Published, gold, Green Submitted			2022-12-25	WOS:000310050200029
J	Katsura, Y; Satta, Y				Katsura, Yukako; Satta, Yoko			No Evidence for a Second Evolutionary Stratum during the Early Evolution of Mammalian Sex Chromosomes	PLOS ONE			English	Article							Y-CHROMOSOME; DNA-SEQUENCE; GENE; PLATYPUS; PROTEIN; ORIGIN; MODEL; DEGENERATION; DISTANCE; REGION	Mammalian sex chromosomes originated from a pair of autosomes, and homologous genes on the sex chromosomes (gametologs) differentiated through recombination arrest between the chromosomes. It was hypothesized that this differentiation in eutherians took place in a stepwise fashion and left a footprint on the X chromosome termed "evolutionary strata.'' The evolutionary stratum hypothesis claims that strata 1 and 2 (which correspond to the first two steps of chromosomal differentiation) were generated in the stem lineage of Theria or before the divergence between eutherians and marsupials. However, this prediction relied solely on the molecular clock hypothesis between pairs of human gametologs, and molecular evolution of marsupial sex chromosomal genes has not yet been investigated. In this study, we analyzed the following 7 pairs of marsupial gametologs, together with their eutherian orthologs that reside in stratum 1 or 2: SOX3/SRY, RBMX/Y, RPS4X/Y, HSFX/Y, XKRX/Y, SMCX/Y (KDM5C/D, JARID1C/D), and UBE1X/Y (UBA1/UBA1Y). Phylogenetic analyses and estimated divergence time of these gametologs reveal that they all differentiated at the same time in the therian ancestor. We have also provided strong evidence for gene conversion that occurred in the 39 region of the eutherian stratum 2 genes (SMCX/Y and UBE1X/Y). The results of the present study show that (1) there is no compelling evidence for the second stratum in the stem lineage of Theria; (2) gene conversion, which may have occurred between SMCX/Y and UBE1X/Y in the eutherian lineage, potentially accounts for their apparently lower degree of overall divergence.	[Katsura, Yukako; Satta, Yoko] Grad Univ Adv Studies Sokendai, Dept Evolutionary Study Biosyst, Hayama, Kanagawa, Japan	Graduate University for Advanced Studies - Japan	Satta, Y (corresponding author), Grad Univ Adv Studies Sokendai, Dept Evolutionary Study Biosyst, Hayama, Kanagawa, Japan.	satta@soken.ac.jp	Katsura, Yukako/V-1413-2018	Satta, Yoko/0000-0002-5305-493X	Graduate University for Advanced Studies;  [17018032]	Graduate University for Advanced Studies; 	This work was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas (17018032; http://www.mext.go.jp/english/index.htm) and The Graduate University for Advanced Studies (http://www.soken.ac.jp/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhowmick BK, 2007, GENOME RES, V17, P441, DOI 10.1101/gr.5734907; Calenda G, 2006, GENE, V370, P6, DOI 10.1016/j.gene.2005.10.037; Carvalho-Silva DR, 2004, CHROMOSOME RES, V12, P795, DOI 10.1007/s10577-005-5376-5; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; Charlesworth D, 2005, HEREDITY, V95, P118, DOI 10.1038/sj.hdy.6800697; Deakin JE, 2008, CHROMOSOME RES, V16, P1159, DOI 10.1007/s10577-008-1266-y; Elango N, 2009, BIOL LETTERS, V5, P405, DOI 10.1098/rsbl.2008.0712; FOSTER JW, 1992, NATURE, V359, P531, DOI 10.1038/359531a0; Goodstadt L, 2007, GENOME RES, V17, P969, DOI 10.1101/gr.6093907; Graves JAM, 2006, CELL, V124, P901, DOI 10.1016/j.cell.2006.02.024; Iwase M, 2003, P NATL ACAD SCI USA, V100, P5258, DOI 10.1073/pnas.0635848100; Jegalian K, 1998, NATURE, V394, P776, DOI 10.1038/29522; JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0; JUKES T H, 1969, P21; Katsura Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020365; KIMURA M, 1972, J MOL EVOL, V2, P87, DOI 10.1007/BF01653945; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Makova KD, 2004, GENOME RES, V14, P567, DOI 10.1101/gr.1971104; Makova KD, 2002, NATURE, V416, P624, DOI 10.1038/416624a; Matsunaga S, 2006, GENES GENET SYST, V81, P219, DOI 10.1266/ggs.81.219; Mitchell MJ, 1998, HUM MOL GENET, V7, P429, DOI 10.1093/hmg/7.3.429; MIYATA T, 1987, COLD SPRING HARB SYM, V52, P863, DOI 10.1101/SQB.1987.052.01.094; Muller H. J., 1914, Science New York N S, V39, DOI 10.1126/science.39.1016.906-a; Murtagh VJ, 2012, GENOME RES, V22, P498, DOI 10.1101/gr.120790.111; NEI M, 1969, GENETICS, V63, P669; OHNO S, 1967, SEX CHROMOSOME SEX L; Omoe K, 1996, GENOMICS, V31, P44, DOI 10.1006/geno.1996.0007; Painter TS, 1923, SCIENCE, V58, P247, DOI 10.1126/science.58.1500.247; Pask A, 2000, P NATL ACAD SCI USA, V97, P13198, DOI 10.1073/pnas.230424497; Rens W, 2004, P NATL ACAD SCI USA, V101, P16257, DOI 10.1073/pnas.0405702101; Ross JA, 2008, GENETICS, V179, P2173, DOI 10.1534/genetics.108.088559; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandstedt SA, 2004, GENOME RES, V14, P267, DOI 10.1101/gr.1796204; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; SOURDIS J, 1988, MOL BIOL EVOL, V5, P298; TAKAHATA N, 1991, MOL BIOL EVOL, V8, P494; TAKAHATA N, 1994, IMMUNOGENETICS, V39, P146, DOI 10.1007/BF00188618; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor F, 2006, MOL BIOL EVOL, V23, P565, DOI 10.1093/molbev/msj060; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; van Rheede T, 2006, MOL BIOL EVOL, V23, P587, DOI 10.1093/molbev/msj064; Veyrunes F, 2008, GENOME RES, V18, P965, DOI 10.1101/gr.7101908; Wallis MC, 2007, CHROMOSOME RES, V15, P949, DOI 10.1007/s10577-007-1185-3; Wilkerson AJP, 2008, GENOMICS, V92, P329, DOI 10.1016/j.ygeno.2008.06.012; Wilson MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000568; Woodburne MO, 2003, MOL PHYLOGENET EVOL, V28, P360, DOI 10.1016/S1055-7903(03)00113-1	54	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e45488	10.1371/journal.pone.0045488	http://dx.doi.org/10.1371/journal.pone.0045488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094017	Green Published, Green Submitted, gold			2022-12-25	WOS:000310050200002
J	Dworeck, T; Zimmermann, M				Dworeck, Tamara; Zimmermann, Martin			Site Directed Mutagenesis of Schizosaccharomyces pombe Glutathione Synthetase Produces an Enzyme with Homoglutathione Synthetase Activity	PLOS ONE			English	Article							RAT-KIDNEY; GENE; BIOSYNTHESIS	Three different His-tagged, mutant forms of the fission yeast glutathione synthetase (GSH2) were derived by site-directed mutagenesis. The mutant and wild-type enzymes were expressed in E. coli DH5 alpha and affinity purified in a two-step procedure. Analysis of enzyme activity showed that it was possible to shift the substrate specificity of GSH2 from Gly (k(m) 0,19; wild-type) to beta-Ala or Ser. One mutation (substitution of Ile471, Cy472 to Met and Val and Ala 485 and Thr486 to Leu and Pro) increased the affinity of GSH2 for beta-Ala (k(m) 0,07) and lowered the affinity for Gly (k(m) 0,83), which is a characteristic of the enzyme homoglutathione synthetase found in plants. Substitution of Ala485 and Thr486 to Leu and Pro only, increased instead the affinity of GSH2 for Ser (k(m) 0,23) as a substrate, while affinity to Gly was preserved (k(m) 0,12). This provides a new biosynthetic pathway for hydroxymethyl glutathione, which is known to be synthesized from glutathione and Ser in a reaction catalysed by carboxypeptidase Y. The reported findings provide further insight into how specific amino acids positioned in the GSH2 active site facilitate the recognition of different amino acid substrates, furthermore they support the evolutionary theory that homoglutathione synthetase evolved from glutathione synthetase by a single gene duplication event.	[Zimmermann, Martin] Rhein Westfal TH Aachen, Inst Biol Appl Microbiol 4, Aachen, Germany; [Dworeck, Tamara] Rhein Westfal TH Aachen, Dept Biol, Aachen, Germany	RWTH Aachen University; RWTH Aachen University	Zimmermann, M (corresponding author), Rhein Westfal TH Aachen, Inst Biol Appl Microbiol 4, Aachen, Germany.	Martin.Zimmermann@rwth-aachen.de	Dworeck, Tamara/G-3429-2012	Dworeck, Tamara/0000-0002-8975-7776	RWTH Aachen University	RWTH Aachen University	This work was funded by RWTH Aachen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M. D., 2004, J BIOPHOTONICS INT, V11, P36; Al-Lahham A, 1999, YEAST, V15, P385, DOI 10.1002/(SICI)1097-0061(19990330)15:5<385::AID-YEA382>3.0.CO;2-6; Anderson ME, 1998, CHEM-BIOL INTERACT, V112, P1; Bernhard W R, 1987, Experientia Suppl, V52, P309; Frendo P, 2001, PLANT PHYSIOL, V126, P1706, DOI 10.1104/pp.126.4.1706; HUANG CS, 1995, P NATL ACAD SCI USA, V92, P1232, DOI 10.1073/pnas.92.4.1232; KLAPHECK S, 1992, BOT ACTA, V105, P174, DOI 10.1111/j.1438-8677.1992.tb00284.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACNICOL PK, 1987, PLANT SCI, V53, P229, DOI 10.1016/0168-9452(87)90159-2; MACNICOL PK, 1984, PLANT SCI LETT, V36, P219, DOI 10.1016/0304-4211(84)90172-X; MEISTER A, 1985, METHOD ENZYMOL, V113, P393; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; Okumura R, 2003, BIOSCI BIOTECH BIOCH, V67, P434, DOI 10.1271/bbb.67.434; Penninckx M, 2000, ENZYME MICROB TECH, V26, P737, DOI 10.1016/S0141-0229(00)00165-4; Phlippen N, 2003, J BIOL CHEM, V278, P40152, DOI 10.1074/jbc.M303102200; Polekhina G, 1999, EMBO J, V18, P3204, DOI 10.1093/emboj/18.12.3204; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Skipsey M, 2005, BIOCHEM J, V391, P567, DOI 10.1042/BJ20050718; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40	21	0	0	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e46580	10.1371/journal.pone.0046580	http://dx.doi.org/10.1371/journal.pone.0046580			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091597	Green Published, Green Submitted, gold			2022-12-25	WOS:000310135800009
J	Nicastro, KR; Zardi, GI; McQuaid, CD; Pearson, GA; Serrao, EA				Nicastro, Katy R.; Zardi, Gerardo I.; McQuaid, Christopher D.; Pearson, Gareth A.; Serrao, Ester A.			Love Thy Neighbour: Group Properties of Gaping Behaviour in Mussel Aggregations	PLOS ONE			English	Article							INDIGENOUS PERNA-PERNA; INVASIVE MYTILUS-GALLOPROVINCIALIS; ROCKY INTERTIDAL ZONE; CLIMATE-CHANGE; BODY-TEMPERATURE; WAVE EXPOSURE; SOUTH-AFRICA; ATTACHMENT STRENGTH; SEASONAL-VARIATION; OXYGEN-TENSION	By associating closely with others to form a group, an animal can benefit from a number of advantages including reduced risk of predation, amelioration of environmental conditions, and increased reproductive success, but at the price of reduced resources. Although made up of individual members, an aggregation often displays novel effects that do not manifest at the level of the individual organism. Here we show that very simple behaviour in intertidal mussels shows new effects in dense aggregations but not in isolated individuals. Perna perna and Mytilus galloprovincialis are gaping (periodic valve movement during emersion) and non-gaping mussels respectively. P. perna gaping behaviour had no effect on body temperatures of isolated individuals, while it led to increased humidity and decreased temperatures in dense groups (beds). Gaping resulted in cooler body temperatures for P. perna than M. galloprovincialis when in aggregations, while solitary individuals exhibited the highest temperatures. Gradients of increasing body temperature were detected from the center to edges of beds, but M. galloprovincialis at the edge had the same temperature as isolated individuals. Furthermore, a field study showed that during periods of severe heat stress, mortality rates of mussels within beds of the gaping P. perna were lower than those of isolated individuals or within beds of M. galloprovincialis, highlighting the determinant role of gaping on fitness and group functioning. We demonstrate that new effects of very simple individual behaviour lead to amelioration of abiotic conditions at the aggregation level and that these effects increase mussel resistance to thermal stress.	[Nicastro, Katy R.; Zardi, Gerardo I.; Pearson, Gareth A.; Serrao, Ester A.] Univ Algarve, CCMAR CIMAR Lab Associado, Faro, Portugal; [McQuaid, Christopher D.] Rhodes Univ, Dept Zool & Entomol, ZA-6140 Grahamstown, South Africa	Universidade do Algarve; Rhodes University	Zardi, GI (corresponding author), Univ Algarve, CCMAR CIMAR Lab Associado, Faro, Portugal.	zardi73@yahoo.it	Pearson, Gareth/J-3911-2013; Zardi, Gerardo/M-4026-2013; McQuaid, Christopher/AAT-3725-2020; Nicastro, Katy R/ABI-1531-2020; Serrao, Ester A/C-6686-2012; Nicastro, Katy/AAY-3692-2021; Nicastro, Katy/D-2259-2012	Pearson, Gareth/0000-0002-0768-464X; Zardi, Gerardo/0000-0001-8798-5794; McQuaid, Christopher/0000-0002-3473-8308; Nicastro, Katy R/0000-0002-7071-141X; Serrao, Ester A/0000-0003-1316-658X; Nicastro, Katy/0000-0002-7071-141X	FCT, Portugal; FCT [PTDC/BIA-BEC/103916/2008]; South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; Fundação para a Ciência e a Tecnologia [PTDC/BIA-BEC/103916/2008] Funding Source: FCT	FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; Fundação para a Ciência e a Tecnologia	This research was supported by post-doctoral fellowships from FCT, Portugal (to GIZ) and funded by project PTDC/BIA-BEC/103916/2008 from FCT (to GIZ). This work is based upon research supported by the South African Research Chairs Initiative of the Department of Science and Technology and the National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1983, BIOPHYSICAL PLANT PH; BAYNE BL, 1976, OECOLOGIA, V22, P229, DOI 10.1007/BF00344794; Bownes SJ, 2006, J EXP MAR BIOL ECOL, V338, P140, DOI 10.1016/j.jembe.2006.07.006; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; Bryant SR, 2000, OECOLOGIA, V122, P1, DOI 10.1007/PL00008825; Buhl J, 2006, SCIENCE, V312, P1402, DOI 10.1126/science.1125142; Bulleri F, 2008, PLOS BIOL, V6, P1136, DOI 10.1371/journal.pbio.0060162; Bulleri F, 2009, J ECOL, V97, P1121, DOI 10.1111/j.1365-2745.2009.01567.x; Carrington E, 2002, LIMNOL OCEANOGR, V47, P1723, DOI 10.4319/lo.2002.47.6.1723; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Connell J.H., 1972, Annual Rev Ecol Syst, V3, P169, DOI 10.1146/annurev.es.03.110172.001125; Cote IM, 1999, J EXP MAR BIOL ECOL, V235, P201, DOI 10.1016/S0022-0981(98)00155-5; Davenport J, 2005, MAR ECOL PROG SER, V292, P41, DOI 10.3354/meps292041; de Jager M, 2011, SCIENCE, V332, P1551, DOI 10.1126/science.1201187; FAMME P, 1980, COMP BIOCHEM PHYS A, V66, P161, DOI 10.1016/0300-9629(80)90147-4; FIELDS PA, 1993, TRENDS ECOL EVOL, V8, P361, DOI 10.1016/0169-5347(93)90220-J; Fitzhenry T, 2004, MAR BIOL, V145, P339, DOI 10.1007/s00227-004-1318-6; Gautier P, 2006, BEHAV ECOL SOCIOBIOL, V59, P836, DOI 10.1007/s00265-005-0130-8; Gerlach JD, 2003, ECOL APPL, V13, P167, DOI 10.1890/1051-0761(2003)013[0167:TLHCOI]2.0.CO;2; Gilman SE, 2006, P NATL ACAD SCI USA, V103, P9560, DOI 10.1073/pnas.0510992103; Guinez R, 1999, AM NAT, V154, P341, DOI 10.1086/303234; Guiñez Ricardo, 2005, Rev. biol. mar. oceanogr., V40, P1; Hamner WM, 1997, IS SUM PARTS EQUAL W, P163; HEINRICH B, 1981, SCIENCE, V212, P565, DOI 10.1126/science.212.4494.563; Helmuth B, 2003, LIMNOL OCEANOGR, V48, P1338, DOI 10.4319/lo.2003.48.3.1338; Helmuth B, 2006, ECOL MONOGR, V76, P461, DOI 10.1890/0012-9615(2006)076[0461:MPOTSI]2.0.CO;2; Helmuth BST, 2001, BIOL BULL-US, V201, P374, DOI 10.2307/1543615; Helmuth BST, 1998, ECOL MONOGR, V68, P51, DOI 10.1890/0012-9615(1998)068[0051:IMMPTB]2.0.CO;2; HU SXS, 1995, ECOLOGY, V76, P2278, DOI 10.2307/1941702; Jost J, 2007, BIOL BULL-US, V213, P141, DOI 10.2307/25066630; Krause J, 2002, LIVING GROUPS; Leicht-Young SA, 2007, OECOLOGIA, V154, P273, DOI 10.1007/s00442-007-0839-3; LENT CM, 1969, AM ZOOL, V9, P283; Lourenco Carla R., 2012, Marine Biodiversity Records, V5, pe39, DOI 10.1017/S1755267212000280; Marsden ID, 1998, J EXP MAR BIOL ECOL, V230, P15, DOI 10.1016/S0022-0981(98)00067-7; McKechnie AE, 2001, PHYSIOL BIOCHEM ZOOL, V74, P238, DOI 10.1086/319669; MCMAHON RF, 1983, AM ZOOL, V23, P938; MCQUAID CD, 1979, J THERM BIOL, V4, P47, DOI 10.1016/0306-4565(79)90045-7; Miller LP, 2009, FUNCT ECOL, V23, P756, DOI 10.1111/j.1365-2435.2009.01567.x; Moeser GM, 2006, J EXP BIOL, V209, P1996, DOI 10.1242/jeb.02234; MOON T W, 1970, Journal of Experimental Marine Biology and Ecology, V5, P35, DOI 10.1016/0022-0981(70)90027-4; Nicastro KR, 2007, MAR ECOL PROG SER, V336, P169, DOI 10.3354/meps336169; Nicastro KR, 2010, BIOL INVASIONS, V12, P2165, DOI 10.1007/s10530-009-9619-9; Nicastro KR, 2008, MAR ECOL PROG SER, V372, P119, DOI 10.3354/meps07671; Nicastro Katy R., 2010, BMC Ecology, V10, P17, DOI 10.1186/1472-6785-10-17; Paine R. T., 1994, MARINE ROCKY SHORES; Parrish JK, 1999, SCIENCE, V284, P99, DOI 10.1126/science.284.5411.99; Rius M, 2006, MAR BIOL, V150, P69, DOI 10.1007/s00227-006-0322-4; Robinson TB, 2005, AFR J MAR SCI, V27, P297, DOI 10.2989/18142320509504088; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; Somero GN, 2002, INTEGR COMP BIOL, V42, P780, DOI 10.1093/icb/42.4.780; Stamp NE, 1993, CATERPILLARS ECOLOGI, P5; Stillman JH, 2002, INTEGR COMP BIOL, V42, P790, DOI 10.1093/icb/42.4.790; Underwood A.J., 2002, GMAV 5 WINDOWS ANAL; van de Koppel J, 2008, SCIENCE, V322, P739, DOI 10.1126/science.1163952; Wethey DS, 2008, HYDROBIOLOGIA, V606, P139, DOI 10.1007/s10750-008-9338-8; WIDDOWS J, 1979, COMP BIOCHEM PHYS A, V62, P301, DOI 10.1016/0300-9629(79)90060-4; Zardi G, 2011, OECOLOGIA, P1; Zardi GI, 2008, MAR BIOL, V153, P853, DOI 10.1007/s00227-007-0857-z; Zardi GI, 2006, MAR BIOL, V150, P79, DOI 10.1007/s00227-006-0328-y	60	44	44	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47382	10.1371/journal.pone.0047382	http://dx.doi.org/10.1371/journal.pone.0047382			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091620	Green Submitted, gold, Green Published			2022-12-25	WOS:000310135800043
J	Westengen, OT; Berg, PR; Kent, MP; Brysting, AK				Westengen, Ola T.; Berg, Paul R.; Kent, Matthew P.; Brysting, Anne K.			Spatial Structure and Climatic Adaptation in African Maize Revealed by Surveying SNP Diversity in Relation to Global Breeding and Landrace Panels	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; GENETIC DIVERSITY; DNA MICROSATELLITES; SOUTHERN AFRICA; FLOWERING TIME; INBRED LINES; MAYS L.; ASSOCIATION	Background: Climate change threatens maize productivity in sub-Saharan Africa. To ensure food security, access to locally adapted genetic resources and varieties is an important adaptation measure. Most of the maize grown in Africa is a genetic mix of varieties introduced at different historic times following the birth of the trans-Atlantic economy, and knowledge about geographic structure and local adaptations is limited. Methodology: A panel of 48 accessions of maize representing various introduction routes and sources of historic and recent germplasm introductions in Africa was genotyped with the MaizeSNP50 array. Spatial genetic structure and genetic relationships in the African panel were analysed separately and in the context of a panel of 265 inbred lines representing global breeding material (based on 26,900 SNPs) and a panel of 1127 landraces from the Americas (270 SNPs). Environmental association analysis was used to detect SNPs associated with three climatic variables based on the full 43,963 SNP dataset. Conclusions: The genetic structure is consistent between subsets of the data and the markers are well suited for resolving relationships and admixture among the accessions. The African accessions are structured in three clusters reflecting historical and current patterns of gene flow from the New World and within Africa. The Sahelian cluster reflects original introductions of Meso-American landraces via Europe and a modern introduction of temperate breeding material. The Western cluster reflects introduction of Coastal Brazilian landraces, as well as a Northeast-West spread of maize through Arabic trade routes across the continent. The Eastern cluster most strongly reflects gene flow from modern introduced tropical varieties. Controlling for population history in a linear model, we identify 79 SNPs associated with maximum temperature during the growing season. The associations located in genes of known importance for abiotic stress tolerance are interesting candidates for local adaptations.	[Westengen, Ola T.] Univ Oslo, Ctr Dev & Environm SUM, Oslo, Norway; [Westengen, Ola T.] Nord Genet Resource Ctr, Alnarp, Sweden; [Westengen, Ola T.; Kent, Matthew P.] Univ Oslo, Dept Biol, CEES, Oslo, Norway; [Kent, Matthew P.] Norwegian Univ Life Sci, Dept Anim & Aquacultural Sci, Ctr Integrat Genet CIGENE, As, Norway	University of Oslo; University of Oslo; Norwegian University of Life Sciences	Westengen, OT (corresponding author), Univ Oslo, Ctr Dev & Environm SUM, Oslo, Norway.	ola.westengen@sum.uio.no	Berg, Paul/A-3648-2011; Brysting, Anne Krag/G-5032-2017; Berg, Paul Ragnar/Q-1584-2019	Berg, Paul/0000-0002-4974-8509; Brysting, Anne Krag/0000-0003-0388-4406; Berg, Paul Ragnar/0000-0002-4974-8509	Centre for Development and the Environment, University of Oslo	Centre for Development and the Environment, University of Oslo	This research was supported by the Centre for Development and the Environment, University of Oslo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banziger M, 2006, AGR WATER MANAGE, V80, P212, DOI 10.1016/j.agwat.2005.07.014; Bellon MR, 2011, P NATL ACAD SCI USA, V108, P13432, DOI 10.1073/pnas.1103373108; Bellon MR, 2001, WORLD DEV, V29, P799, DOI 10.1016/S0305-750X(01)00013-4; Bitocchi E, 2009, MOL ECOL, V18, P603, DOI 10.1111/j.1365-294X.2008.04064.x; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Burke MB, 2009, GLOBAL ENVIRON CHANG, V19, P317, DOI 10.1016/j.gloenvcha.2009.04.003; Cook JP, 2012, PLANT PHYSIOL, V158, P824, DOI 10.1104/pp.111.185033; DeVries J, 2001, SECURING HARVEST BIO; Eckert AJ, 2010, GENETICS, V185, P969, DOI 10.1534/genetics.110.115543; Ehrich D, 2006, MOL ECOL NOTES, V6, P603, DOI 10.1111/j.1471-8286.2006.01380.x; Endresen DTF, 2011, CROP SCI, V51, P2036, DOI 10.2135/cropsci2010.12.0717; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Ganal MW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028334; Gibson RW, 2005, ANN APPL BIOL, V147, P153, DOI 10.1111/j.1744-7348.2005.00021.x; Global Crop Diversity Trust (GCDT), 2007, GLOB STRAT EXS CONS; Hamblin MT, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001367; Hancock AM, 2011, SCIENCE, V334, P83, DOI 10.1126/science.1209244; Hao ZF, 2011, J INTEGR PLANT BIOL, V53, P641, DOI 10.1111/j.1744-7909.2011.01051.x; Harlan JR, 1992, CROPS MAN; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; JEFFREYS MDW, 1953, NATURE, V172, P965, DOI 10.1038/172965a0; Jones ES, 2007, THEOR APPL GENET, V115, P361, DOI 10.1007/s00122-007-0570-9; Krill AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009958; Langyintuo AS, 2010, FOOD POLICY, V35, P323, DOI 10.1016/j.foodpol.2010.01.005; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu KJ, 2003, GENETICS, V165, P2117; Lobell DB, 2008, SCIENCE, V319, P607, DOI 10.1126/science.1152339; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Lobell DB, 2011, NAT CLIM CHANGE, V1, P42, DOI [10.1038/nclimate1043, 10.1038/NCLIMATE1043]; Matsuoka Y, 2002, P NATL ACAD SCI USA, V99, P6080, DOI 10.1073/pnas.052125199; McCann JC, 2005, MAIZE GRACE AFRICAS; McCouch SR, 2012, AM J BOT, V99, P407, DOI 10.3732/ajb.1100385; Mirzaei M, 2012, PROTEOMICS, V12, P864, DOI 10.1002/pmic.201100389; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; Nordborg M, 2005, PLOS BIOL, V3, P1289, DOI 10.1371/journal.pbio.0030196; Palusa SG, 2007, PLANT J, V49, P1091, DOI 10.1111/j.1365-313X.2006.03020.x; Pineyro-Nelson A, 2009, MOL ECOL, V18, P750, DOI 10.1111/j.1365-294X.2008.03993.x; Porteres R, 1959, J AGR TROPICALE BOT, V2, P221; Pressoir G, 2004, HEREDITY, V92, P88, DOI 10.1038/sj.hdy.6800387; Pressoir G, 2004, HEREDITY, V92, P95, DOI 10.1038/sj.hdy.6800388; Pritchard JK, 2000, GENETICS, V155, P945; Reif JC, 2004, CROP SCI, V44, P326, DOI 10.2135/cropsci2004.0326; Revilla P, 2003, MAYDICA, V48, P141; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Setter TL, 2011, J EXP BOT, V62, P701, DOI 10.1093/jxb/erq308; Smale M., 2003, MAIZE E SO AFRICA SE; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Tenaillon MI, 2011, CR BIOL, V334, P221, DOI 10.1016/j.crvi.2010.12.015; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; van Heerwaarden J, 2010, HEREDITY, V104, P28, DOI 10.1038/hdy.2009.110; van Heerwaarden J, 2011, P NATL ACAD SCI USA, V108, P1088, DOI 10.1073/pnas.1013011108; Van Inghelandt D, 2010, THEOR APPL GENET, V120, P1289, DOI 10.1007/s00122-009-1256-2; Vigouroux Y, 2008, AM J BOT, V95, P1240, DOI 10.3732/ajb.0800097; Warburton ML, 2008, CROP SCI, V48, P617, DOI 10.2135/cropsci2007.02.0103; Warburton ML, 2011, GENET RESOUR CROP EV, V58, P1243, DOI 10.1007/s10722-010-9658-1; Weir BS., 1996, GENETIC DATA ANAL; WILLETT F, 1962, AFRICA, V32, P1, DOI 10.2307/1157291; Yu JM, 2008, GENETICS, V178, P539, DOI 10.1534/genetics.107.074245; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702	63	14	14	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47832	10.1371/journal.pone.0047832	http://dx.doi.org/10.1371/journal.pone.0047832			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091649	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000310135800075
J	Duran, RV; MacKenzie, ED; Boulahbel, H; Frezza, C; Heiserich, L; Tardito, S; Bussolati, O; Rocha, S; Hall, MN; Gottlieb, E				Duran, R. V.; MacKenzie, E. D.; Boulahbel, H.; Frezza, C.; Heiserich, L.; Tardito, S.; Bussolati, O.; Rocha, S.; Hall, M. N.; Gottlieb, E.			HIF-independent role of prolyl hydroxylases in the cellular response to amino acids	ONCOGENE			English	Article						prolyl hydroxylases; PHD; alpha-ketoglutarate; amino acids; HIF; mTOR	FISSION YEAST; HYPOXIA; GROWTH; MTOR; 4-HYDROXYLASES; DEFICIENCY; EXPRESSION; AUTOPHAGY; PATHWAY; FAMILY	Hypoxia-inducible factor (HIF) prolyl hydroxylases (PHDs) are alpha-ketoglutarate (alpha KG)-dependent dioxygenases that function as cellular oxygen sensors. However, PHD activity also depends on factors other than oxygen, especially aKG, a key metabolic compound closely linked to amino-acid metabolism. We examined the connection between amino-acid availability and PHD activity. We found that amino-acid starvation leads to alpha KG depletion and to PHD inactivation but not to HIF stabilization. Furthermore, pharmacologic or genetic inhibition of PHDs induced autophagy and prevented mammalian target of rapamycin complex 1 (mTORC1) activation by amino acids in a HIF-independent manner. Therefore, PHDs sense not only oxygen but also respond to amino acids, constituting a broad intracellular nutrient-sensing network.	[Duran, R. V.; MacKenzie, E. D.; Boulahbel, H.; Frezza, C.; Heiserich, L.; Tardito, S.; Gottlieb, E.] Beatson Inst Canc Res, Canc Res UK, Apoptosis & Tumour Metab Lab, Glasgow G61 1BD, Lanark, Scotland; [Duran, R. V.; Hall, M. N.] Univ Basel, Biozentrum, Basel, Switzerland; [Tardito, S.; Bussolati, O.] Univ Parma, Dept Expt Med, Unit Gen & Clin Pathol, I-43100 Parma, Italy; [Rocha, S.] Univ Dundee, Coll Life Sci, Wellcome Trust Ctr Gene Regulat & Express, Dundee, Scotland	Beatson Institute; Cancer Research UK; University of Basel; University of Parma; University of Dundee	Gottlieb, E (corresponding author), Beatson Inst Canc Res, Canc Res UK, Apoptosis & Tumour Metab Lab, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	e.gottlieb@beatson.gla.ac.uk	Frezza, Christian/G-2174-2010; Tardito, Saverio/AAJ-7727-2020; Bussolati, Ovidio/B-7589-2013; Gottlieb, Eyal/G-6450-2010; Duran, Raul V./E-4764-2011	Frezza, Christian/0000-0002-3293-7397; Tardito, Saverio/0000-0002-5294-8683; Bussolati, Ovidio/0000-0002-4301-2939; Gottlieb, Eyal/0000-0002-9770-0956; Duran, Raul V./0000-0002-2249-9215; Hall, Michael N/0000-0002-2998-0757	Cancer Research UK; Swiss National Science Foundation; Cancer Research UK [12918] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Cancer Research UK(Cancer Research UK)	PHD2 and PHD3 antibodies were provided by Kevin Gatter. We thank David Sabatini and Fuyuhiko Tamanoi for kindly providing Rag and Rheb plasmids. We thank David Kwiatkowski for TSC2<SUP>+/+</SUP> and TSC2<SUP>-/-</SUP> mouse embryonic fibroblasts. This work was supported by the Cancer Research UK and by the Swiss National Science Foundation.	Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Berra E, 2006, EMBO REP, V7, P41, DOI 10.1038/sj.embor.7400598; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; DalL'Asta V, 1999, AM J PHYSIOL-CELL PH, V276, pC865, DOI 10.1152/ajpcell.1999.276.4.C865; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Frei C, 2004, DEV CELL, V6, P241, DOI 10.1016/S1534-5807(03)00409-X; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Hughes BT, 2008, EMBO J, V27, P1491, DOI 10.1038/emboj.2008.83; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Keskiaho K, 2007, PLANT CELL, V19, P256, DOI 10.1105/tpc.106.042739; Kim J, 2011, ANNU REV BIOCHEM, V80, P1001, DOI 10.1146/annurev-biochem-062209-094414; MacKenzie ED, 2007, MOL CELL BIOL, V27, P3282, DOI 10.1128/MCB.01927-06; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Rocha S, 2003, MOL CELL BIOL, V23, P4713, DOI 10.1128/MCB.23.13.4713-4727.2003; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Selak MA, 2005, CANCER CELL, V7, P77, DOI 10.1016/j.ccr.2004.11.022; SENER A, 1980, NATURE, V288, P187, DOI 10.1038/288187a0; Taylor MS, 2001, GENE, V275, P125, DOI 10.1016/S0378-1119(01)00633-3; Tennant DA, 2009, ONCOGENE, V28, P4009, DOI 10.1038/onc.2009.250; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; West CM, 2007, DEVELOPMENT, V134, P3349, DOI 10.1242/dev.000893; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yuneva M, 2007, J CELL BIOL, V178, P93, DOI 10.1083/jcb.200703099; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000; Zhong H, 2000, CANCER RES, V60, P1541	36	80	84	1	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 19	2013	32	38					4549	4556		10.1038/onc.2012.465	http://dx.doi.org/10.1038/onc.2012.465			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	223SW	23085753	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000324831300010
J	Skeen, VR; Collard, TJ; Southern, SL; Greenhough, A; Hague, A; Townsend, PA; Paraskeva, C; Williams, AC				Skeen, V. R.; Collard, T. J.; Southern, S. L.; Greenhough, A.; Hague, A.; Townsend, P. A.; Paraskeva, C.; Williams, A. C.			BAG-1 suppresses expression of the key regulatory cytokine transforming growth factor beta (TGF-beta 1) in colorectal tumour cells	ONCOGENE			English	Article						BAG-1; TGF-beta 1; colorectal cancer; adenoma; transcriptional repression	HUMAN COLONIC ADENOMA; NF-KAPPA-B; TGF-BETA; GLUCOCORTICOID-RECEPTOR; GENE-EXPRESSION; IN-VIVO; PROGRESSION; INHIBITION; ISOFORMS; BUTYRATE	As colorectal cancer remains the second highest cause of cancer-related deaths in much of the industrialised world, identifying novel strategies to prevent colorectal tumour development remains an important challenge. BAG-1 is a multi-functional protein, the expression of which is up-regulated at relatively early stages in colorectal tumorigenesis. Importantly, BAG-1 is thought to enhance colorectal tumour progression through promoting tumour cell survival. Here, we report for the first time a novel role for BAG-1, establishing it as a suppressor of transforming growth factor beta (TGF-beta 1) expression in colorectal tumour cells. Microarray analysis first highlighted the possibility that BAG-1 may regulate TGF-beta 1 expression, a key cytokine in normal colonic tissue homoeostasis. Q-RT-PCR and ELISA demonstrated TGFB1 mRNA and protein expression to be significantly increased when BAG1 levels were reduced by small interfering RNA; additionally, induction of BAG-1L caused suppression of TGFB1 mRNA in colorectal tumour cells. Using reporter and chromatin immunoprecipitation assays, a direct association of BAG-1 with the TGFB1 gene regulatory region was identified. Immunohistochemistry and Weiser fraction data indicated that the levels of BAG-1 and TGF-beta 1 are inversely correlated in the normal colonic epithelium in vivo, consistent with a role for BAG-1-mediated repression of TGF-beta 1 production. In vitro studies showed that the change in TGF-beta 1 production following manipulation of BAG-1 is functionally relevant; through induction of anchorage-independent growth in TGF-beta 1-dependent normal rat kidney fibroblasts and regulation of SMAD2 phosphorylation in TGF-beta 1-sensitive adenoma cells. Taken together, this study identifies the anti-apoptotic protein BAG-1 as a suppressor of the inhibitory growth factor TGF-beta 1, suggesting that high expression of BAG-1 can impact on a number of the hallmarks of cancer, of potential importance in promoting the early stages of colorectal tumorigenesis. Establishing BAG-1 as a repressor of TGF-beta 1 has important biological implications, and highlights a new role for BAG-1 in colorectal tumorigenesis.	[Skeen, V. R.; Collard, T. J.; Southern, S. L.; Greenhough, A.; Paraskeva, C.; Williams, A. C.] Univ Bristol, Sch Cellular & Mol Med, Bristol BS8 1TD, Avon, England; [Hague, A.] Univ Bristol, Sch Oral & Dent Sci, Bristol BS8 1TD, Avon, England; [Townsend, P. A.] Univ Southampton, Southampton Gen Hosp, Sch Med, Southampton, Hants, England	University of Bristol; University of Bristol; University of Southampton	Williams, AC (corresponding author), Univ Bristol, Sch Cellular & Mol Med, Med Sci Bldg,Univ Walk, Bristol BS8 1TD, Avon, England.	PATownsend@soton.ac.uk; Ann.C.Williams@bristol.ac.uk	Greenhough, Alexander/J-9308-2012; Townsend, Paul/AAF-8234-2020; Greenhough, Alexander/Y-6728-2019	Greenhough, Alexander/0000-0002-8306-811X; Greenhough, Alexander/0000-0002-8306-811X; Townsend, Paul/0000-0001-8956-9508; Williams, Ann/0000-0002-6009-7137	Cancer Research UK programme grant; Citrina Foundation; John James Bristol Foundation; CORE; Cancer Research UK [11975] Funding Source: researchfish	Cancer Research UK programme grant(Cancer Research UK); Citrina Foundation; John James Bristol Foundation; CORE(Luxembourg National Research Fund); Cancer Research UK(Cancer Research UK)	This work was funded by a Cancer Research UK programme grant, the Citrina Foundation, CORE and by the John James Bristol Foundation. We thank members of the CP group for useful discussion.	Arhel NJ, 2003, INT J CANCER, V106, P364, DOI 10.1002/ijc.11257; AVERY A, 1993, BRIT J CANCER, V68, P137, DOI 10.1038/bjc.1993.301; Babyatsky MW, 1996, GASTROENTEROLOGY, V110, P798; BARNARD JA, 1993, GASTROENTEROLOGY, V105, P67, DOI 10.1016/0016-5085(93)90011-Z; BARNARD JA, 1993, CELL GROWTH DIFFER, V4, P495; Barnes JD, 2005, APOPTOSIS, V10, P301, DOI 10.1007/s10495-005-0804-8; Brimmell M, 1999, BRIT J CANCER, V81, P1042, DOI 10.1038/sj.bjc.6690805; Clemo NK, 2008, CARCINOGENESIS, V29, P849, DOI 10.1093/carcin/bgn004; Cutress RI, 2003, ONCOGENE, V22, P4973, DOI 10.1038/sj.onc.1206688; DATTO MB, 1995, P NATL ACAD SCI USA, V92, P5545, DOI 10.1073/pnas.92.12.5545; FRIEDMAN E, 1995, CANCER EPIDEM BIOMAR, V4, P549; Gehring U, 2009, INT J MOL SCI, V10, P906, DOI 10.3390/ijms10030906; Hague A, 1997, GASTROENTEROLOGY, V112, P1036, DOI 10.1053/gast.1997.v112.agast971036; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hong W, 2008, J MOL BIOL, V384, P22, DOI 10.1016/j.jmb.2008.09.010; Hong W, 2009, FEBS LETT, V583, P2451, DOI 10.1016/j.febslet.2009.07.010; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kikuchi R, 2002, BRIT J CANCER, V87, P1136, DOI 10.1038/sj.bjc.6600579; KIM SJ, 1989, J BIOL CHEM, V264, P402; Lampropoulos P, 2012, CANCER LETT, V314, P1, DOI 10.1016/j.canlet.2011.09.041; Lee KY, 2006, J IMMUNOL, V176, P603, DOI 10.4049/jimmunol.176.1.603; MANNING AM, 1991, ONCOGENE, V6, P1471; Mariadason JM, 2005, GASTROENTEROLOGY, V128, P1081, DOI 10.1053/j.gastro.2005.01.054; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; MULDER KM, 1988, BIOCHEM BIOPH RES CO, V150, P711, DOI 10.1016/0006-291X(88)90449-4; Myant K, 2011, EXP CELL RES, V317, P2725, DOI 10.1016/j.yexcr.2011.08.001; Niyaz Y, 2001, J CELL SCI, V114, P1839; Packham G, 1997, BIOCHEM J, V328, P807, DOI 10.1042/bj3280807; PARASKEVA C, 1989, CANCER RES, V49, P1282; Pardali K, 2000, J BIOL CHEM, V275, P29244, DOI 10.1074/jbc.M909467199; Picon A, 1998, CANCER EPIDEM BIOMAR, V7, P497; POLYAK K, 1994, GENE DEV, V8, P9, DOI 10.1101/gad.8.1.9; Sharp Adam, 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404007537; Sharp A, 2009, FEBS LETT, V583, P3405, DOI 10.1016/j.febslet.2009.09.047; Sharp A, 2009, J PHARMACOL EXP THER, V331, P680, DOI 10.1124/jpet.109.153601; Shatkina L, 2003, MOL CELL BIOL, V23, P7189, DOI 10.1128/MCB.23.20.7189-7197.2003; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Skeen VR, 2012, CURR PHARM DESIGN, V18, P3874; Smartt HJM, 2012, GUT, V61, P1306, DOI 10.1136/gutjnl-2011-300817; Strathdee CA, 1999, GENE, V229, P21, DOI 10.1016/S0378-1119(99)00045-1; Takayama S, 1998, CANCER RES, V58, P3116; Townsend PA, 2005, INT J BIOCHEM CELL B, V37, P251, DOI 10.1016/j.biocel.2004.03.016; Tsushima H, 1996, GASTROENTEROLOGY, V110, P375, DOI 10.1053/gast.1996.v110.pm8566583; WANG G, 1992, EXP CELL RES, V198, P27, DOI 10.1016/0014-4827(92)90144-W; Wang XH, 2009, BRIT J CANCER, V100, P1347, DOI 10.1038/sj.bjc.6604985; WILLIAMS AC, 1993, ONCOGENE, V8, P3063; Xu WQ, 2007, EXP MOL PATHOL, V82, P284, DOI 10.1016/j.yexmp.2006.10.011; Zeiner M, 1999, P NATL ACAD SCI USA, V96, P10194, DOI 10.1073/pnas.96.18.10194; Zhang XY, 2011, MOL CELL BIOL, V31, P5037, DOI 10.1128/MCB.06297-11; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328	53	13	15	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 19	2013	32	38					4490	4499		10.1038/onc.2012.480	http://dx.doi.org/10.1038/onc.2012.480			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	223SW	23108401	Green Accepted			2022-12-25	WOS:000324831300004
J	Ho, L; Ferruzzi, MG; Janle, EM; Wang, J; Gong, B; Chen, TY; Lobo, J; Cooper, B; Wu, QL; Talcott, ST; Percival, SS; Simon, JE; Pasinetti, GM				Ho, Lap; Ferruzzi, Mario G.; Janle, Elsa M.; Wang, Jun; Gong, Bing; Chen, Tzu-Ying; Lobo, Jessica; Cooper, Bruce; Wu, Qing Li; Talcott, Stephen T.; Percival, Susan S.; Simon, James E.; Pasinetti, Giulio Maria			Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer's disease	FASEB JOURNAL			English	Article						polyphenol bioavailability; cognitive deterioration; neuroplasticity	LONG-TERM POTENTIATION; RED WINE; MOUSE MODEL; VARIETAL DIFFERENCES; SYNAPTIC PLASTICITY; TRANSGENIC MICE; VITIS-VINIFERA; POLYPHENOLS; QUERCETIN; GRAPES	Epidemiological and preclinical studies indicate that polyphenol intake from moderate consumption of red wines may lower the relative risk for developing Alzheimer's disease (AD) dementia. There is limited information regarding the specific biological activities and cellular and molecular mechanisms by which wine polyphenolic components might modulate AD. We assessed accumulations of polyphenols in the rat brain following oral dosage with a Cabernet Sauvignon red wine and tested brain-targeted polyphenols for potential beneficial AD disease-modifying activities. We identified accumulations of select polyphenolic metabolites in the brain. We demonstrated that, in comparison to vehicle-control treatment, one of the brain-targeted polyphenol metabolites, quercetin-3-O-glucuronide, significantly reduced the generation of beta-amyloid (A beta\) peptides by primary neuron cultures generated from the Tg2576 AD mouse model. Another brain-targeted metabolite, malvidin-3-O-glucoside, had no detectable effect on A beta generation. Moreover, in an in vitro analysis using the photo-induced cross-linking of unmodified proteins (PICUP) technique, we found that quercetin-3-O-glucuronide is also capable of interfering with the initial protein-protein interaction of A beta(1-40) and A beta(1-42) that is necessary for the formation of neurotoxic oligomeric A beta species. Lastly, we found that quercetin-3-O-glucuronide treatment, compared to vehicle-control treatment, significantly improved AD-type deficits in hippocampal formation basal synaptic transmission and long-term potentiation, possibly through mechanisms involving the activation of the c-Jun N-terminal kinases and the mitogen-activated protein kinase signaling pathways. Brain-targeted quercetin-3-O-glucuronide may simultaneously modulate multiple independent AD disease-modifying mechanisms and, as such, may contribute to the benefits of dietary supplementation with red wines as an effective intervention for AD.-Ho, L., Ferruzzi, M. G., Janle, E. M., Wang, J., Gong, B., Chen, T.-Y., Lobo, J., Cooper, B., Wu, Q. L., Talcott, S. T., Percival, S. S., Simon, J. E., Pasinetti, G. M. Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer's disease. FASEB J. 27, 769-781 (2013). www.fasebj.org	[Ho, Lap; Wang, Jun; Gong, Bing; Pasinetti, Giulio Maria] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA; [Pasinetti, Giulio Maria] James J Peters Vet Affairs Med Ctr, Ctr Geriatr Res Educ & Clin, Bronx, NY USA; [Ferruzzi, Mario G.; Lobo, Jessica] Purdue Univ, Dept Food Sci, W Lafayette, IN 47907 USA; [Ferruzzi, Mario G.; Janle, Elsa M.; Chen, Tzu-Ying] Purdue Univ, Dept Nutr Sci, W Lafayette, IN 47907 USA; [Cooper, Bruce] Purdue Univ, Bindley Biosci Ctr, W Lafayette, IN 47907 USA; [Wu, Qing Li; Simon, James E.] Rutgers State Univ, Dept Plant Biol & Plant Pathol, New Brunswick, NJ 08903 USA; [Talcott, Stephen T.] Texas A&M Univ, Dept Nutr & Food Sci, College Stn, TX USA; [Percival, Susan S.] Univ Florida, Dept Food Sci & Human Nutr, Gainesville, FL USA	Icahn School of Medicine at Mount Sinai; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Rutgers State University New Brunswick; Texas A&M University System; Texas A&M University College Station; State University System of Florida; University of Florida	Pasinetti, GM (corresponding author), Mt Sinai Sch Med, Dept Neurol, 1468 Madison Ave,Annenberg Bldg,Rm 20-02, New York, NY 10029 USA.	giulio.pasinetti@mssm.edu		Ferruzzi, Mario/0000-0003-1384-2672; Pasinetti, Giulio/0000-0002-1524-5196	U.S. National Institutes of Health [National Center for Complementary and Alternative Medicine (NCCAM)] [PO1 AT004511]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P01AT004511] Funding Source: NIH RePORTER	U.S. National Institutes of Health [National Center for Complementary and Alternative Medicine (NCCAM)]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine)	These studies were supported by the U.S. National Institutes of Health [grant PO1 AT004511; National Center for Complementary and Alternative Medicine (NCCAM) Project 1 to L. H. and Project 3 to G. M. P.]. The authors thank Dr. Kenjiro Ono (Kanazawa University Graduate School of Medical Science, Takara-Machi, Kanazawa, Japan), for valuable assistance and support with the PICUP analysis.	Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; Alzheimers Assoc, 2012, ALZHEIMERS DEMENT, V8, P131, DOI 10.1016/j.jalz.2012.02.001; Andres-Lacueva C, 2005, NUTR NEUROSCI, V8, P111, DOI 10.1080/10284150500078117; Bartsch D, 1998, CELL, V95, P211, DOI 10.1016/S0092-8674(00)81752-3; Bastianetto S, 2011, CURR ALZHEIMER RES, V8, P445, DOI 10.2174/156720511796391854; Bitan G, 2003, P NATL ACAD SCI USA, V100, P330, DOI 10.1073/pnas.222681699; Bitan G, 2005, AMYLOID, V12, P88, DOI 10.1080/13506120500106958; Bitan G, 2001, J BIOL CHEM, V276, P35176, DOI 10.1074/jbc.M102223200; Bito H, 2003, CELL CALCIUM, V34, P425, DOI 10.1016/S0143-4160(03)00140-4; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Borbalan AMA, 2003, J CHROMATOGR A, V1012, P31, DOI 10.1016/S0021-9673(03)01187-7; Brouillard R, 1997, BIOFACTORS, V6, P403, DOI 10.1002/biof.5520060406; Cantos E, 2002, J AGR FOOD CHEM, V50, P5691, DOI 10.1021/jf0204102; Craggs L, 2011, NEUROREPORT, V22, P1, DOI 10.1097/WNR.0b013e328342741c; Cummings JL, 2004, NEW ENGL J MED, V351, P56, DOI 10.1056/NEJMra040223; Darvesh AS, 2010, EXPERT REV NEUROTHER, V10, P729, DOI [10.1586/ern.10.42, 10.1586/ERN.10.42]; Day AJ, 2003, BIOCHEM PHARMACOL, V65, P1199, DOI 10.1016/S0006-2952(03)00039-X; de Boer VCJ, 2005, J NUTR, V135, P1718, DOI 10.1093/jn/135.7.1718; Dorozynski A, 1997, BRIT MED J, V314, P997; Esteban MA, 2001, J SCI FOOD AGR, V81, P409, DOI 10.1002/1097-0010(200103)81:4&lt;409::AID-JSFA830&gt;3.0.CO;2-H; Fitzjohn SM, 2001, J NEUROSCI, V21, P4691, DOI 10.1523/JNEUROSCI.21-13-04691.2001; Germain S, 2009, J ALZHEIMERS DIS, V17, P105, DOI 10.3233/JAD-2009-1016; German JB, 2000, ANNU REV NUTR, V20, P561, DOI 10.1146/annurev.nutr.20.1.561; Ginjom IR, 2010, J AGR FOOD CHEM, V58, P10133, DOI 10.1021/jf100822n; Gong B, 2004, J CLIN INVEST, V114, P1624, DOI 10.1172/JCI200422831; Gonzalez Elizabeth W, 2011, Issues Ment Health Nurs, V32, P528, DOI 10.3109/01612840.2011.573123; Guedj F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004606; Han X., 2007, INT J MOL SCI, V8, P47; Ho L, 2009, J ALZHEIMERS DIS, V16, P59, DOI 10.3233/JAD-2009-0916; Ho L, 2010, EXPERT REV PROTEOMIC, V7, P579, DOI 10.1586/EPR.10.69; Hou Y, 2010, NEUROPHARMACOLOGY, V58, P911, DOI 10.1016/j.neuropharm.2009.11.002; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hu P, 2008, N-S ARCH PHARMACOL, V378, P43, DOI 10.1007/s00210-008-0301-z; Joseph J, 2009, J NEUROSCI, V29, P12795, DOI 10.1523/JNEUROSCI.3520-09.2009; Kelley KA, 1999, AM J PATHOL, V155, P995, DOI 10.1016/S0002-9440(10)65199-1; Larrieu S, 2004, J Nutr Health Aging, V8, P150; Lee JE, 2009, ANAL CHIM ACTA, V648, P71, DOI 10.1016/j.aca.2009.06.039; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; Luchsinger JA, 2004, J AM GERIATR SOC, V52, P540, DOI 10.1111/j.1532-5415.2004.52159.x; Magrone T, 2011, CURR TOP MED CHEM, V11, P1780, DOI 10.2174/156802611796235116; Manach C, 2004, AM J CLIN NUTR, V79, P727, DOI 10.1093/ajcn/79.5.727; Mandel Silvia A, 2012, Front Biosci (Schol Ed), V4, P581; Masa A, 2007, J CHROMATOGR A, V1164, P291, DOI 10.1016/j.chroma.2007.06.058; Mausbach B. T., 2012, AM J GERIAT PSYCHIAT, DOI [10.1097/JGP.0b013e31824472d5, DOI 10.1097/JGP.0B013E31824472D5]; Meiers S, 2001, J AGR FOOD CHEM, V49, P958, DOI 10.1021/jf0009100; Mohamed S, 2010, AM J GERIAT PSYCHIAT, V18, P917, DOI 10.1097/JGP.0b013e3181d5745d; Moon JH, 2001, FREE RADICAL BIO MED, V30, P1274, DOI 10.1016/S0891-5849(01)00522-6; Ohta K, 2011, BIOCHEM BIOPH RES CO, V416, P362, DOI 10.1016/j.bbrc.2011.11.042; Orgogozo JM, 1997, REV NEUROL-FRANCE, V153, P185; Orts MLD, 2005, J INT SCI VIGNE VIN, V39, P47; Percival SS, 2000, J NUTR, V130, P1091, DOI 10.1093/jn/130.5.1091; Perez-Magarino S, 2004, J AGR FOOD CHEM, V52, P1181, DOI 10.1021/jf035099i; Porat Y, 2006, CHEM BIOL DRUG DES, V67, P27, DOI 10.1111/j.1747-0285.2005.00318.x; Quideau S, 2011, ANGEW CHEM INT EDIT, V50, P586, DOI 10.1002/anie.201000044; Radovanovic BC, 2010, J SCI FOOD AGR, V90, P2455, DOI 10.1002/jsfa.4106; Ramesh BN, 2010, J ALZHEIMERS DIS, V19, P1123, DOI 10.3233/JAD-2010-1312; Rangel-Ordonez L, 2010, PLANTA MED, V76, P1683, DOI 10.1055/s-0030-1249962; Rivera F, 2004, NEUROTOX RES, V6, P543, DOI 10.1007/BF03033450; Scalbert A, 2005, AM J CLIN NUTR, V81, p215S, DOI 10.1093/ajcn/81.1.215S; Shih PH, 2011, J AGR FOOD CHEM, V59, P1683, DOI 10.1021/jf103822h; Shimmyo Y, 2008, BBA-GEN SUBJECTS, V1780, P819, DOI 10.1016/j.bbagen.2008.01.017; Singh M, 2008, J AGR FOOD CHEM, V56, P4855, DOI 10.1021/jf0735073; Spencer JPE, 2003, J BIOL CHEM, V278, P34783, DOI 10.1074/jbc.M305063200; Talcott ST, 2002, J AGR FOOD CHEM, V50, P3186, DOI 10.1021/jf011500u; Tchantchou F, 2009, J ALZHEIMERS DIS, V18, P787, DOI 10.3233/JAD-2009-1189; Thies W, 2011, ALZHEIMERS DEMENT, V7, P175, DOI [10.1016/j.jalz.2011.02.004, 10.1016/j.jalz.2011.02.002]; Thimothe J, 2007, J AGR FOOD CHEM, V55, P10200, DOI 10.1021/jf0722405; Truelsen T, 2002, NEUROLOGY, V59, P1313, DOI 10.1212/01.WNL.0000031421.50369.E7; Urquiaga I, 2000, BIOL RES, V33, P55, DOI 10.4067/s0716-97602000000200004; Vafeiadou K., 2007, Endocrine Metabolic & Immune Disorders-Drug Targets, V7, P211, DOI 10.2174/187153007781662521; Vafeiadou K, 2008, ARCH BIOCHEM BIOPHYS, V478, P195, DOI 10.1016/j.abb.2008.07.014; Wang J, 2006, FASEB J, V20, P2313, DOI 10.1096/fj.06-6281com; Wang J, 2012, J NEUROSCI, V32, P5144, DOI 10.1523/JNEUROSCI.6437-11.2012; Wang J, 2010, J ALZHEIMERS DIS, V22, P653, DOI 10.3233/JAD-2010-101074; Xu Y, 2007, EUR J NEUROSCI, V26, P2931, DOI 10.1111/j.1460-9568.2007.05905.x; Xu YP, 2011, J AGR FOOD CHEM, V59, P10586, DOI 10.1021/jf202438d; Yao Y, 2010, PHYTOTHER RES, V24, P136, DOI 10.1002/ptr.2902; Yokotsuka K, 1999, AM J ENOL VITICULT, V50, P1; Zenebe W, 2002, Bratisl Lek Listy, V103, P159; ZOECKLEIN BW, 1990, PRODUCTION WINE ANAL	80	141	147	2	84	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					769	781		10.1096/fj.12-212118	http://dx.doi.org/10.1096/fj.12-212118			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23097297	Green Published			2022-12-25	WOS:000314358000035
J	Schofield, AV; Steel, R; Bernard, O				Schofield, Alice V.; Steel, Rohan; Bernard, Ora			Rho-associated Coiled-coil Kinase (ROCK) Protein Controls Microtubule Dynamics in a Novel Signaling Pathway That Regulates Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-TUBULIN; LIM-KINASE; PHOSPHORYLATION; ACETYLATION; DEACETYLASE; ACTIVATION; RECEPTOR; HDAC6; ACETYLTRANSFERASE; IDENTIFICATION	The two members of the Rho-associated coiled-coil kinase (ROCK1 and 2) family are established regulators of actin dynamics that are involved in the regulation of the cell cycle as well as cell motility and invasion. Here, we discovered a novel signaling pathway whereby ROCK regulates microtubule (MT) acetylation via phosphorylation of the tubulin polymerization promoting protein 1 (TPPP1/p25). We show that ROCK phosphorylation of TPPP1 inhibits the interaction between TPPP1 and histone deacetylase 6 (HDAC6), which in turn results in increased HDAC6 activity followed by a decrease in MT acetylation. As a consequence, we show that TPPP1 phosphorylation by ROCK increases cell migration and invasion via modulation of cellular acetyl MT levels. We establish here that the ROCK-TPPP1-HDAC6 signaling pathway is important for the regulation of cell migration and invasion.	[Schofield, Alice V.; Bernard, Ora] St Vincents Inst Med Res, Cytoskeleton & Canc Unit, Fitzroy, Vic 3065, Australia; [Schofield, Alice V.; Bernard, Ora] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; [Steel, Rohan] Univ Melbourne, Prot Chem & Metab Unit, Fitzroy, Vic 3065, Australia	St. Vincent's Institute of Medical Research; St Vincent's Hospital Melbourne; University of Melbourne; University of Melbourne	Bernard, O (corresponding author), St Vincents Inst Med Res, Cytoskeleton & Canc Unit, 9 Princes St, Fitzroy, Vic 3065, Australia.	obernard@svi.edu.au		/0000-0002-0423-6120	National Health and Medical Research Council (NHMRC); Australian Research Council (ARC); Cancer Council of Victoria; Victorian Government Operational Infrastructure Support Program; NHMRC; Australian Postgraduate Award; St. Vincent's Institute Foundation Top-up Scholarship	National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council (ARC)(Australian Research Council); Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Victorian Government Operational Infrastructure Support Program; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Postgraduate Award(Australian Government); St. Vincent's Institute Foundation Top-up Scholarship	This research was supported by grants from the National Health and Medical Research Council (NHMRC), the Australian Research Council (ARC), the Cancer Council of Victoria, and in part by the Victorian Government Operational Infrastructure Support Program. This work was also supported by a fellowship from the NHMRC (to O.B.) and by an Australian Postgraduate Award and St. Vincent's Institute Foundation Top-up Scholarship (to A.V.S.).	Acevedo K, 2007, EXP CELL RES, V313, P4091, DOI 10.1016/j.yexcr.2007.08.012; Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Belletti B, 2010, MOL CELL BIOL, V30, P2229, DOI 10.1128/MCB.00723-09; Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com; Creppe C, 2009, CELL, V136, P551, DOI 10.1016/j.cell.2008.11.043; Destaing O, 2005, J CELL SCI, V118, P2901, DOI 10.1242/jcs.02425; Foletta VC, 2003, J CELL BIOL, V162, P1089, DOI 10.1083/jcb.200212060; Harrison BA, 2009, J MED CHEM, V52, P6515, DOI 10.1021/jm901226j; Heng YW, 2012, J CELL SCI, V125, P1579, DOI 10.1242/jcs.096818; Hlavanda E, 2002, BIOCHEMISTRY-US, V41, P8657, DOI 10.1021/bi020140g; Hlavanda E, 2007, J BIOL CHEM, V282, P29531, DOI 10.1074/jbc.M703466200; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Ikegami T, 2005, EUR J NEUROSCI, V22, P3036, DOI 10.1111/j.1460-9568.2005.04492.x; Inada H, 1998, BIOCHEM BIOPH RES CO, V253, P21, DOI 10.1006/bbrc.1998.9732; Kadir S, 2011, J CELL SCI, V124, P2642, DOI 10.1242/jcs.087965; Kang JH, 2007, BIOCHIMIE, V89, P39, DOI 10.1016/j.biochi.2006.08.003; Kang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022699; Katoh K, 2001, AM J PHYSIOL-CELL PH, V280, pC1669, DOI 10.1152/ajpcell.2001.280.6.C1669; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kruger JS, 2003, MOL CANCER RES, V1, P801; Lafarga V, 2012, EMBO J, V31, P856, DOI 10.1038/emboj.2011.466; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; MARUTA H, 1986, J CELL BIOL, V103, P571, DOI 10.1083/jcb.103.2.571; Matsuzawa K, 1997, BIOCHEM BIOPH RES CO, V234, P621, DOI 10.1006/bbrc.1997.6669; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; O'Reilly LA, 1998, BIOTECHNIQUES, V25, P824, DOI 10.2144/98255st03; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; PIPERNO G, 1987, J CELL BIOL, V104, P289, DOI 10.1083/jcb.104.2.289; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Saji S, 2005, ONCOGENE, V24, P4531, DOI 10.1038/sj.onc.1208646; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Sumi T, 2001, J BIOL CHEM, V276, P670, DOI 10.1074/jbc.M007074200; Takesono A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008774; Tirian L, 2003, P NATL ACAD SCI USA, V100, P13976, DOI 10.1073/pnas.2436331100; Tokesi N, 2010, J BIOL CHEM, V285, P17896, DOI 10.1074/jbc.M109.096578; Vincze O, 2006, BIOCHEMISTRY-US, V45, P13818, DOI 10.1021/bi061305e; Wu Y, 2010, J BIOL CHEM, V285, P3554, DOI 10.1074/jbc.M109.063354; Zohrabian VM, 2009, ANTICANCER RES, V29, P119	40	54	56	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43620	43629		10.1074/jbc.M112.394965	http://dx.doi.org/10.1074/jbc.M112.394965			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23093407	Green Published, hybrid			2022-12-25	WOS:000312940800042
J	Skalicky, JJ; Arii, J; Wenzel, DM; Stubblefield, WMB; Katsuyama, A; Uter, NT; Bajorek, M; Myszka, DG; Sundquist, WI				Skalicky, Jack J.; Arii, Jun; Wenzel, Dawn M.; Stubblefield, William-May B.; Katsuyama, Angela; Uter, Nathan T.; Bajorek, Monika; Myszka, David G.; Sundquist, Wesley I.			Interactions of the Human LIP5 Regulatory Protein with Endosomal Sorting Complexes Required for Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AAA-ATPASE VPS4; ESCRT-III COMPLEX; STRUCTURAL BASIS; MULTIVESICULAR BODY; MIT DOMAIN; MEMBRANE ASSOCIATION; CYTOKINESIS; AUTOINHIBITION; MACHINERY; DYNAMICS	The endosomal sorting complex required for transport (ESCRT) pathway remodels membranes during multivesicular body biogenesis, the abscission stage of cytokinesis, and enveloped virus budding. The ESCRT-III and VPS4 ATPase complexes catalyze the membrane fission events associated with these processes, and the LIP5 protein helps regulate their interactions by binding directly to a subset of ESCRT-III proteins and to VPS4. We have investigated the biochemical and structural basis for different LIP5-ligand interactions and show that the first microtubule-interacting and trafficking (MIT) module of the tandem LIP5 MIT domain binds CHMP1B (and other ESCRT-III proteins) through canonical type 1 MIT-interacting motif (MIM1) interactions. In contrast, the second LIP5 MIT module binds with unusually high affinity to a novel MIM element within the ESCRT-III protein CHMP5. A solution structure of the relevant LIP5-CHMP5 complex reveals that CHMP5 helices 5 and 6 and adjacent linkers form an amphipathic "leucine collar" that wraps almost completely around the second LIP5 MIT module but makes only limited contacts with the first MIT module. LIP5 binds MIM1-containing ESCRT-III proteins and CHMP5 and VPS4 ligands independently in vitro, but these interactions are coupled within cells because formation of stable VPS4 complexes with both LIP5 and CHMP5 requires LIP5 to bind both a MIM1-containing ESCRT-III protein and CHMP5. Our studies thus reveal how the tandem MIT domain of LIP5 binds different types of ESCRT-III proteins, promoting assembly of active VPS4 enzymes on the polymeric ESCRT-III substrate.	[Skalicky, Jack J.; Arii, Jun; Wenzel, Dawn M.; Stubblefield, William-May B.; Katsuyama, Angela; Uter, Nathan T.; Bajorek, Monika; Myszka, David G.; Sundquist, Wesley I.] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Sundquist, WI (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	wes@biochem.utah.edu		Bajorek, Monika/0000-0002-0160-4709	National Institutes of Health [AI051174, GM082545]; Japan Herpesvirus Infections Forum; Japan Society for the Promotion of Science; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051174, R37AI051174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082545] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Japan Herpesvirus Infections Forum; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI051174 and GM082545 (to W.I.S.).; Supported by a research fellowship from Japan Herpesvirus Infections Forum and Japan Society for the Promotion of Science.	Agromayor M, 2009, MOL BIOL CELL, V20, P1374, DOI 10.1091/mbc.E08-05-0474; Azmi I, 2006, J CELL BIOL, V172, P705, DOI 10.1083/jcb.200508166; Azmi IF, 2008, DEV CELL, V14, P50, DOI 10.1016/j.devcel.2007.10.021; Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982; Bajorek M, 2009, NAT STRUCT MOL BIOL, V16, P754, DOI 10.1038/nsmb.1621; Bajorek M, 2009, MOL BIOL CELL, V20, P1360, DOI 10.1091/mbc.E08-05-0475; Baumgartel V, 2011, NAT CELL BIOL, V13, P469, DOI 10.1038/ncb2215; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Boura E, 2012, STRUCTURE, V20, P874, DOI 10.1016/j.str.2012.03.008; Caballe A, 2011, TRAFFIC, V12, P1318, DOI 10.1111/j.1600-0854.2011.01244.x; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Ciccarelli FD, 2003, GENOMICS, V81, P437, DOI 10.1016/S0888-7543(03)00011-9; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Davies BA, 2010, MOL BIOL CELL, V21, P3396, DOI 10.1091/mbc.E10-06-0512; Dimaano C, 2008, MOL BIOL CELL, V19, P465, DOI 10.1091/mbc.E07-08-0747; Elia N, 2012, BIOPHYS J, V102, P2309, DOI 10.1016/j.bpj.2012.04.007; Elia N, 2011, P NATL ACAD SCI USA, V108, P4846, DOI 10.1073/pnas.1102714108; Fabrikant G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000575; Fujita H, 2004, J CELL SCI, V117, P2997, DOI 10.1242/jcs.01170; Ghazi-Tabatabai S, 2008, STRUCTURE, V16, P1345, DOI 10.1016/j.str.2008.06.010; Goddard T. D., 2001, SPARKY 3; Gonciarz MD, 2008, J MOL BIOL, V384, P878, DOI 10.1016/j.jmb.2008.09.066; Guntert P, 2009, EUR BIOPHYS J BIOPHY, V38, P129, DOI 10.1007/s00249-008-0367-z; Guizetti J, 2012, TRENDS CELL BIOL, V22, P133, DOI 10.1016/j.tcb.2011.11.007; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Haas TJ, 2007, PLANT CELL, V19, P1295, DOI 10.1105/tpc.106.049346; Hanson PI, 2012, ANNU REV CELL DEV BI, V28, P337, DOI 10.1146/annurev-cellbio-092910-154152; Hartmann C, 2008, J MOL BIOL, V377, P352, DOI 10.1016/j.jmb.2008.01.010; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hill CP, 2012, BBA-MOL CELL RES, V1823, P172, DOI 10.1016/j.bbamcr.2011.08.017; Hurley JH, 2008, DEV CELL, V14, P6, DOI 10.1016/j.devcel.2007.12.013; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Jouvenet N, 2011, J MOL BIOL, V410, P501, DOI 10.1016/j.jmb.2011.04.062; Jouvenet N, 2011, NAT CELL BIOL, V13, P394, DOI 10.1038/ncb2207; Kieffer CC, 2008, PSYCHOANAL INQ, V28, P1, DOI 10.1080/07351690701787077; Kuang ZZ, 2011, J VIROL, V85, P7153, DOI 10.1128/JVI.02610-10; Landsberg MJ, 2009, STRUCTURE, V17, P427, DOI 10.1016/j.str.2008.12.020; Lata S, 2008, J MOL BIOL, V378, P818, DOI 10.1016/j.jmb.2008.03.030; Lata S, 2009, BIOCHEM SOC T, V37, P156, DOI 10.1042/BST0370156; Lin Y, 2005, J BIOL CHEM, V280, P12799, DOI 10.1074/jbc.M413968200; Lottridge JM, 2006, P NATL ACAD SCI USA, V103, P6202, DOI 10.1073/pnas.0601712103; McCullough J., 2012, ANN REV BIO IN PRESS; Merrill SA, 2010, J BIOL CHEM, V285, P35428, DOI 10.1074/jbc.M110.126318; Mu RL, 2012, STRUCTURE, V20, P887, DOI 10.1016/j.str.2012.03.001; Muziol T, 2006, DEV CELL, V10, P821, DOI 10.1016/j.devcel.2006.03.013; Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113; Nickerson DP, 2010, MOL BIOL CELL, V21, P1023, DOI 10.1091/mbc.E09-09-0776; Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171; Pincetic A, 2010, J VIROL, V84, P4725, DOI 10.1128/JVI.02478-09; Popov S, 2009, J VIROL, V83, P7185, DOI 10.1128/JVI.00198-09; Rigden DJ, 2009, FEBS LETT, V583, P872, DOI 10.1016/j.febslet.2009.02.012; Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h; Rue SM, 2008, MOL BIOL CELL, V19, P475, DOI 10.1091/mbc.E07-07-0694; Rusten TE, 2012, NAT CELL BIOL, V14, P38, DOI 10.1038/ncb2381; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Scott A, 2005, P NATL ACAD SCI USA, V102, P13813, DOI 10.1073/pnas.0502165102; Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shestakova A, 2010, MOL BIOL CELL, V21, P1059, DOI 10.1091/mbc.E09-07-0572; Shiflett SL, 2004, J BIOL CHEM, V279, P10982, DOI 10.1074/jbc.M312669200; Shim S, 2008, MOL BIOL CELL, V19, P2661, DOI 10.1091/mbc.E07-12-1263; Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x; Solomons J, 2011, STRUCTURE, V19, P1149, DOI 10.1016/j.str.2011.05.011; Stuchell-Brereton MD, 2007, NATURE, V449, P740, DOI 10.1038/nature06172; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Takasu H, 2005, BIOCHEM BIOPH RES CO, V334, P460, DOI 10.1016/j.bbrc.2005.06.110; Tsang HTH, 2006, GENOMICS, V88, P333, DOI 10.1016/j.ygeno.2006.04.003; Ward DMV, 2005, J BIOL CHEM, V280, P10548, DOI 10.1074/jbc.M413734200; Weiss ER, 2011, J MOL BIOL, V410, P525, DOI 10.1016/j.jmb.2011.04.055; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Xiao JY, 2008, DEV CELL, V14, P37, DOI 10.1016/j.devcel.2007.10.013; Xiao JY, 2007, J MOL BIOL, V374, P655, DOI 10.1016/j.jmb.2007.09.067; Xiao JY, 2009, MOL BIOL CELL, V20, P3514, DOI 10.1091/mbc.E09-05-0403; Yang D, 2010, STRUCTURE, V18, P976, DOI 10.1016/j.str.2010.04.014; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512; Zimmerman DE, 1997, J MOL BIOL, V269, P592, DOI 10.1006/jmbi.1997.1052	79	35	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43910	43926		10.1074/jbc.M112.417899	http://dx.doi.org/10.1074/jbc.M112.417899			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23105106	Green Published, hybrid			2022-12-25	WOS:000312940800067
J	Santos, JS; Asmar-Rovira, GA; Han, GW; Liu, W; Syeda, R; Cherezov, V; Baker, KA; Stevens, RC; Montal, M				Santos, Jose S.; Asmar-Rovira, Guillermo A.; Han, Gye Won; Liu, Wei; Syeda, Ruhma; Cherezov, Vadim; Baker, Kent A.; Stevens, Raymond C.; Montal, Mauricio			Crystal Structure of a Voltage-gated K+ Channel Pore Module in a Closed State in Lipid Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POTASSIUM-CHANNEL; SELECTIVITY FILTER; PROTEINS; RECEPTOR; MESOPHASES; RESOLUTION; SOFTWARE; COMPLEX; DESIGN; SYSTEM	Voltage-gated K+ channels underlie the electrical excitability of cells. Each subunit of the functional tetramer consists of the tandem fusion of two modules, an N-terminal voltage-sensor and a C-terminal pore. To investigate how sensor coupling to the pore generates voltage-dependent channel opening, we solved the crystal structure and characterized the function of a voltage-gated K+ channel pore in a lipid membrane. The structure of a functional channel in a membrane environment at 3.1 angstrom resolution establishes an unprecedented connection between channel structure and function. The structure is unique in delineating an ion-occupied ready to conduct selectivity filter, a confined aqueous cavity, and a closed activation gate, embodying a dynamic entity trapped in an unstable closed state.	[Santos, Jose S.; Syeda, Ruhma; Montal, Mauricio] Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Asmar-Rovira, Guillermo A.; Han, Gye Won; Liu, Wei; Cherezov, Vadim; Baker, Kent A.; Stevens, Raymond C.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	University of California System; University of California San Diego; Scripps Research Institute	Montal, M (corresponding author), Univ Calif San Diego, Neurobiol Sect, Div Biol Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mmontal@ucsd.edu	Han, Gye Won/GLT-1531-2022; Han, Gye Won/GLQ-8724-2022; Cherezov, Vadim/L-9812-2013; Stevens, Raymond/K-7272-2015; Han, Gye Won/GLQ-8673-2022	Han, Gye Won/0000-0003-4107-835X; Cherezov, Vadim/0000-0002-5265-3914; Stevens, Raymond/0000-0002-4522-8725; 	National Institutes of Health [GM-073197, GM-49711]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049711, P50GM073197] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM-073197 and GM-49711. This work was also supported by National Cancer Institute Grant Y1-CO-1020 and National Institute of General Medical Sciences Grant Y1-GM-1104.	Armstrong CM, 2001, BIOPHYS J, V81, P895, DOI 10.1016/S0006-3495(01)75749-9; ARMSTRONG CM, 1972, J GEN PHYSIOL, V59, P388, DOI 10.1085/jgp.59.4.388; Bayley H, 2008, MOL BIOSYST, V4, P1191, DOI 10.1039/b808893d; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Cherezov V, 2004, ACTA CRYSTALLOGR D, V60, P1795, DOI 10.1107/S0907444904019109; Cherezov V, 2009, J R SOC INTERFACE, V6, pS587, DOI 10.1098/rsif.2009.0142.focus; Clayton GM, 2008, P NATL ACAD SCI USA, V105, P1511, DOI 10.1073/pnas.0711533105; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; GOLDSTEIN SAN, 1994, NEURON, V12, P1377, DOI 10.1016/0896-6273(94)90452-9; Heginbotham L, 1999, J GEN PHYSIOL, V114, P551, DOI 10.1085/jgp.114.4.551; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jo S, 2008, NUCLEIC ACIDS RES, V36, pW270, DOI 10.1093/nar/gkn314; Jogini V, 2005, J MOL BIOL, V354, P272, DOI 10.1016/j.jmb.2005.09.031; Lange A, 2006, NATURE, V440, P959, DOI 10.1038/nature04649; Liu Y, 1997, NEURON, V19, P175, DOI 10.1016/S0896-6273(00)80357-8; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; MacKinnon R, 1998, SCIENCE, V280, P106, DOI 10.1126/science.280.5360.106; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MONTAL M, 1990, FASEB J, V4, P2623, DOI 10.1096/fasebj.4.9.1693348; MONTAL M, 1995, ANNU REV BIOPH BIOM, V24, P31, DOI 10.1146/annurev.bb.24.060195.000335; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pauling L., 1960, NATURE CHEMICAL BOND, P513; Petrek M, 2007, STRUCTURE, V15, P1357, DOI 10.1016/j.str.2007.10.007; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Santos JS, 2008, J GEN PHYSIOL, V132, P651, DOI 10.1085/jgp.200810077; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Uysal S, 2009, P NATL ACAD SCI USA, V106, P6644, DOI 10.1073/pnas.0810663106; Zhou M, 2001, NATURE, V411, P657, DOI 10.1038/35079500; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	38	20	21	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43063	43070		10.1074/jbc.M112.415091	http://dx.doi.org/10.1074/jbc.M112.415091			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23095758	Green Published, hybrid			2022-12-25	WOS:000312501600062
J	Calamaras, TD; Lee, C; Lan, F; Ido, Y; Siwik, DA; Colucci, WS				Calamaras, Timothy D.; Lee, Charlie; Lan, Fan; Ido, Yasuo; Siwik, Deborah A.; Colucci, Wilson S.			Post-translational Modification of Serine/Threonine Kinase LKB1 via Adduction of the Reactive Lipid Species 4-Hydroxy-trans-2-nonenal (HNE) at Lysine Residue 97 Directly Inhibits Kinase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; 4-HYDROXYNONENAL HNE; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; RAT-HEART; C-ZETA; PHOSPHORYLATION; ACETYLATION; PRODUCT; MUSCLE	Oxidative stress is pathogenic in a variety of diseases, but the mechanism by which cellular signaling is affected by oxidative species has yet to be fully characterized. Lipid peroxidation, a secondary process that occurs during instances of free radical production, may play an important role in modulating cellular signaling under conditions of oxidative stress. 4-Hydroxy-trans-2-nonenal (HNE) is an electrophilic aldehyde produced during lipid peroxidation that forms covalent adducts on proteins, altering their activity and function. One such target, LKB1, has been reported to be inhibited by HNE adduction. We tested the hypothesis that HNE inhibits LKB1 activity through adduct formation on a specific reactive residue of the protein. To elucidate the mechanism of the inhibitory effect, HEK293T cells expressing LKB1 were treated with HNE (10 mu M for 1 h) and assayed for HNE-LKB1 adduct formation and changes in LKB1 kinase activity. HNE treatment resulted in the formation of HNE-LKB1 adducts and decreased LKB1 kinase activity by 31 +/- 9% (S.E.) but had no effect on the association of LKB1 with its adaptor proteins sterile-20-related adaptor and mouse protein 25. Mutation of LKB1 lysine residue 97 reduced HNE adduct formation and attenuated the effect of HNE on LKB1 activity. Taken together, our results suggest that adduction of LKB1 Lys-97 mediates the inhibitory effect of HNE.	[Calamaras, Timothy D.; Lee, Charlie; Siwik, Deborah A.; Colucci, Wilson S.] Boston Univ, Dept Med, Myocardial Biol Unit, Sch Med, Boston, MA 02118 USA; [Lan, Fan; Ido, Yasuo] Boston Univ, Sch Med, Dept Med, Diabet & Metab Res Unit,Sect Endocrinol, Boston, MA 02118 USA	Boston University; Boston University	Colucci, WS (corresponding author), Boston Univ, Dept Med, Myocardial Biol Unit, Sch Med, 88 E Newton St, Boston, MA 02118 USA.	wilson.colucci@bmc.org		Colucci, Wilson/0000-0002-0576-9420; Ido, Yasuo/0000-0002-3036-9971; /0000-0002-7166-327X	National Institutes of Health [HL-061639, HL-064750]; NHLBI-sponsored Boston University Cardiovascular Proteomics Center [N01-HV-28178]; T32 Cardiovascular Predoctoral Training Grant [HL-007969]; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028178] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL061639, R01HL064750, R01HL028178, T32HL007969] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NHLBI-sponsored Boston University Cardiovascular Proteomics Center; T32 Cardiovascular Predoctoral Training Grant; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-061639 (to W.S.C.) and HL-064750 (to W.S.C.), the NHLBI-sponsored Boston University Cardiovascular Proteomics Center (Contract N01-HV-28178 to W.S.C.), and T32 Cardiovascular Predoctoral Training Grant HL-007969 (to T.D.C.).	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Backos DS, 2011, FREE RADICAL BIO MED, V50, P14, DOI 10.1016/j.freeradbiomed.2010.10.694; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Carbone DL, 2004, FREE RADICAL BIO MED, V37, P1430, DOI 10.1016/j.freeradbiomed.2004.07.016; Chen JJ, 2001, J MOL CELL CARDIOL, V33, P1919, DOI 10.1006/jmcc.2001.1454; Denison FC, 2009, J BIOL CHEM, V284, P67, DOI 10.1074/jbc.M806153200; Dolinsky VW, 2009, CIRCULATION, V119, P1643, DOI 10.1161/CIRCULATIONAHA.108.787440; Dorfman J, 2008, MOL BIOL CELL, V19, P1614, DOI 10.1091/mbc.E07-05-0454; Eaton P, 1999, AM J PHYSIOL-HEART C, V276, pH935, DOI 10.1152/ajpheart.1999.276.3.H935; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fogarty S, 2009, J BIOL CHEM, V284, P77, DOI 10.1074/jbc.M806152200; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hill BG, 2008, BIOCHEM J, V410, P525, DOI 10.1042/BJ20071063; Hurst D, 2005, AM J PHYSIOL-ENDOC M, V289, pE710, DOI 10.1152/ajpendo.00155.2005; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Ji B, 2002, FREE RADICAL BIO MED, V33, P370, DOI 10.1016/S0891-5849(02)00906-1; Ji C, 2001, J BIOL CHEM, V276, P18223, DOI 10.1074/jbc.M101266200; Kimura H, 2005, FREE RADICAL RES, V39, P845, DOI 10.1080/10715760500161546; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lu ZP, 2009, CIRC RES, V105, P830, DOI 10.1161/CIRCRESAHA.109.204974; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; Montine KS, 1997, AM J PATHOL, V150, P437; Nakamura K, 2009, J CARD FAIL, V15, P709, DOI 10.1016/j.cardfail.2009.04.008; Pamplona R, 2008, BBA-BIOENERGETICS, V1777, P1249, DOI 10.1016/j.bbabio.2008.07.003; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Poli G, 2008, MED RES REV, V28, P569, DOI 10.1002/med.20117; Qin FZ, 2012, CIRCULATION, V125, P1757, DOI 10.1161/CIRCULATIONAHA.111.067801; Sampey BP, 2007, MOL PHARMACOL, V71, P871, DOI 10.1124/mol.106.029686; Schaur R. J., 2003, Molecular Aspects of Medicine, V24, P149, DOI 10.1016/S0098-2997(03)00009-8; STROHMAIER H, 1995, J LIPID MEDIAT CELL, V11, P51, DOI 10.1016/0929-7855(94)00027-A; Uchida K, 2003, PROG LIPID RES, V42, P318, DOI 10.1016/S0163-7827(03)00014-6; Vladykovskaya E, 2012, J BIOL CHEM, V287, P11398, DOI 10.1074/jbc.M111.320416; Wagner TM, 2006, J BIOL CHEM, V281, P2598, DOI 10.1074/jbc.M509723200; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Wang ZG, 2012, MOL CELL ENDOCRINOL, V349, P222, DOI 10.1016/j.mce.2011.10.027; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Xie ZL, 2006, J BIOL CHEM, V281, P6366, DOI 10.1074/jbc.M511178200; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	40	16	16	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					42400	42406		10.1074/jbc.M112.385831	http://dx.doi.org/10.1074/jbc.M112.385831			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086944	hybrid, Green Published			2022-12-25	WOS:000312103000075
J	Panigrahi, GB; Slean, MM; Simard, JP; Pearson, CE				Panigrahi, Gagan B.; Slean, Meghan M.; Simard, Jodie P.; Pearson, Christopher E.			Human Mismatch Repair Protein hMutL alpha Is Required to Repair Short Slipped-DNAs of Trinucleotide Repeats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENETIC POLYMORPHISMS; FUNCTIONAL-ANALYSIS; MYOTONIC-DYSTROPHY; NUCLEAR EXTRACTS; MLH1 MUTATIONS; HMLH1 GENE; CAG REPEAT; CANCER; INSTABILITY; EXPRESSION	Mismatch repair (MMR) is required for proper maintenance of the genome by protecting against mutations. The mismatch repair system has also been implicated as a driver of certain mutations, including disease-associated trinucleotide repeat instability. We recently revealed a requirement of hMutS beta in the repair of short slip-outs containing a single CTG repeat unit (1). The involvement of other MMR proteins in short trinucleotide repeat slip-out repair is unknown. Here we show that hMutL alpha is required for the highly efficient in vitro repair of single CTG repeat slip-outs, to the same degree as hMutS beta. HEK293T cell extracts, deficient in hMLH1, are unable to process single-repeat slip-outs, but are functional when complemented with hMutL alpha. The MMR-deficient hMLH1 mutant, T117M, which has a point mutation proximal to the ATP-binding domain, is defective in slip-out repair, further supporting a requirement for hMLH1 in the processing of short slip-outs and possibly the involvement of hMHL1 ATPase activity. Extracts of hPMS2-deficient HEC-1-A cells, which express hMLH1, hMLH3, and hPMS1, are only functional when complemented with hMutL alpha, indicating that neither hMutL beta nor hMutL gamma is sufficient to repair short slip-outs. The resolution of clustered short slip-outs, which are poorly repaired, was partially dependent upon a functional hMutL alpha. The joint involvement of hMutS beta and hMutL alpha suggests that repeat instability may be the result of aberrant outcomes of repair attempts.	[Panigrahi, Gagan B.; Slean, Meghan M.; Simard, Jodie P.; Pearson, Christopher E.] Hosp Sick Children, Dept Genet & Genome Biol, Toronto, ON M5G 1L7, Canada; [Slean, Meghan M.; Pearson, Christopher E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Pearson, CE (corresponding author), TMDT Bldg,101 Coll St,15th Floor,E Tower, Toronto, ON M5G 1L7, Canada.	cepearson.sickkids@gmail.com		Pearson, Christopher/0000-0001-9545-4205	Canadian Institutes of Health Research (CIHR) [MOP-97896]; Muscular Dystrophy Association Canada (Rachel Fund); Tribute Communities; Paul Wellstone Muscular Dystrophy Cooperative Research Center, National Institutes of Health [U54NS48843]; Hospital for Sick Children Research Training Competition; CIHR Collaborative Graduate Training Program in Molecular Medicine; Ontario Graduate Scholarship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS048843] Funding Source: NIH RePORTER	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Muscular Dystrophy Association Canada (Rachel Fund); Tribute Communities; Paul Wellstone Muscular Dystrophy Cooperative Research Center, National Institutes of Health; Hospital for Sick Children Research Training Competition; CIHR Collaborative Graduate Training Program in Molecular Medicine(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by the Canadian Institutes of Health Research (CIHR, MOP-97896), the Muscular Dystrophy Association Canada (Rachel Fund), generous support from Tribute Communities, and the Paul Wellstone Muscular Dystrophy Cooperative Research Center, National Institutes of Health Grant U54NS48843. M.M.S. was supported by studentships from The Hospital for Sick Children Research Training Competition and the CIHR Collaborative Graduate Training Program in Molecular Medicine and by an Ontario Graduate Scholarship.	An Y, 2008, LUNG CANCER, V59, P164, DOI 10.1016/j.lungcan.2007.08.003; Burmester JK, 2004, HUM HERED, V57, P172, DOI 10.1159/000081443; Cannavo E, 2005, CANCER RES, V65, P10759, DOI 10.1158/0008-5472.CAN-05-2528; Castel AL, 2010, NAT REV MOL CELL BIO, V11, P165, DOI 10.1038/nrm2854; Chen PC, 2005, CANCER RES, V65, P8662, DOI 10.1158/0008-5472.CAN-05-0742; Damaraju S, 2006, CLIN CANCER RES, V12, P2545, DOI 10.1158/1078-0432.CCR-05-2703; Dieumegard B, 2000, BRIT J CANCER, V82, P871, DOI 10.1054/bjoc.1999.1014; Flores-Rozas H, 1998, P NATL ACAD SCI USA, V95, P12404, DOI 10.1073/pnas.95.21.12404; Glaab WE, 1998, J BIOL CHEM, V273, P26662, DOI 10.1074/jbc.273.41.26662; Gomes-Pereira M, 2004, HUM MOL GENET, V13, P1815, DOI 10.1093/hmg/ddh186; Harfe BD, 2000, CURR BIOL, V10, P145, DOI 10.1016/S0960-9822(00)00314-6; HOLMES J, 1990, P NATL ACAD SCI USA, V87, P5837, DOI 10.1073/pnas.87.15.5837; Jager AC, 2001, ONCOGENE, V20, P3590, DOI 10.1038/sj.onc.1204467; Kadyrov FA, 2006, CELL, V126, P297, DOI 10.1016/j.cell.2006.05.039; Kondo E, 2003, CANCER RES, V63, P3302; Lee KM, 2005, CLIN CANCER RES, V11, P4620, DOI 10.1158/1078-0432.CCR-04-2534; LI GM, 1995, P NATL ACAD SCI USA, V92, P1950, DOI 10.1073/pnas.92.6.1950; Li GM, 2008, CELL RES, V18, P85, DOI 10.1038/cr.2007.115; Lin YF, 2006, NAT STRUCT MOL BIOL, V13, P179, DOI 10.1038/nsmb1042; Lin YF, 2009, DNA REPAIR, V8, P878, DOI 10.1016/j.dnarep.2009.04.024; LIU B, 1995, NAT GENET, V9, P48, DOI 10.1038/ng0195-48; Manley K, 1999, NAT GENET, V23, P471, DOI 10.1038/70598; Mann A, 2008, EUR J CANCER, V44, P2259, DOI 10.1016/j.ejca.2008.07.010; Mathonnet G, 2003, BRIT J HAEMATOL, V123, P45, DOI 10.1046/j.1365-2141.2003.04551.x; Miret JJ, 1998, P NATL ACAD SCI USA, V95, P12438, DOI 10.1073/pnas.95.21.12438; Miret JJ, 1997, MOL CELL BIOL, V17, P3382, DOI 10.1128/MCB.17.6.3382; Moslein G, 1996, HUM MOL GENET, V5, P1245, DOI 10.1093/hmg/5.9.1245; Panariello L, 1998, Hum Mutat, V12, P216; Panigrahi GB, 2010, P NATL ACAD SCI USA, V107, P12593, DOI 10.1073/pnas.0909087107; Panigrahi GB, 2005, NAT STRUCT MOL BIOL, V12, P654, DOI 10.1038/nsmb959; PARSONS R, 1993, CELL, V75, P1227, DOI 10.1016/0092-8674(93)90331-J; Pearson CE, 1998, NUCLEIC ACIDS RES, V26, P816, DOI 10.1093/nar/26.3.816; Pearson CE, 1996, BIOCHEMISTRY-US, V35, P5041, DOI 10.1021/bi9601013; Pelletier R, 2005, NUCLEIC ACIDS RES, V33, P5667, DOI 10.1093/nar/gki880; Raschle M, 1999, J BIOL CHEM, V274, P32368, DOI 10.1074/jbc.274.45.32368; Richard GF, 1999, MOL GEN GENET, V261, P871, DOI 10.1007/s004380050031; RISINGER JI, 1995, J BIOL CHEM, V270, P18183, DOI 10.1074/jbc.270.31.18183; Risinger JI, 1998, CANCER RES, V58, P2978; Rolfsmeier ML, 2000, MOL CELL, V6, P1501, DOI 10.1016/S1097-2765(00)00146-5; Savouret C, 2003, EMBO J, V22, P2264, DOI 10.1093/emboj/cdg202; Shimodaira H, 1998, NAT GENET, V19, P384, DOI 10.1038/1277; Slean MM, 2008, DNA REPAIR, V7, P1135, DOI 10.1016/j.dnarep.2008.03.014; Smith TR, 2008, CARCINOGENESIS, V29, P2132, DOI 10.1093/carcin/bgn193; Takahashi M, 2007, CANCER RES, V67, P4595, DOI 10.1158/0008-5472.CAN-06-3509; TANNERGARD P, 1995, CANCER RES, V55, P6092; Tome S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000482; Tomer G, 2002, J BIOL CHEM, V277, P21801, DOI 10.1074/jbc.M111342200; Trojan J, 2002, GASTROENTEROLOGY, V122, P211, DOI 10.1053/gast.2002.30296; van den Broek WJAA, 2002, HUM MOL GENET, V11, P191, DOI 10.1093/hmg/11.2.191; Vietri MT, 2009, GENET TEST MOL BIOMA, V13, P193, DOI 10.1089/gtmb.2008.0088; Ward R, 2002, J CANCER RES CLIN, V128, P403, DOI 10.1007/s00432-002-0361-2; Wheeler VC, 2003, HUM MOL GENET, V12, P273, DOI 10.1093/hmg/ddg056; Wu Y, 1997, GENE CHROMOSOME CANC, V18, P269, DOI 10.1002/(SICI)1098-2264(199704)18:4<269::AID-GCC4>3.0.CO;2-Z	53	25	26	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41844	41850		10.1074/jbc.M112.420398	http://dx.doi.org/10.1074/jbc.M112.420398			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086927	Green Published, hybrid			2022-12-25	WOS:000312103000025
J	Sun, F; Wang, XM; Mao, XO; Xie, L; Jin, KL				Sun, Fen; Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Jin, Kunlin			Ablation of Neurogenesis Attenuates Recovery of Motor Function after Focal Cerebral Ischemia in Middle-Aged Mice	PLOS ONE			English	Article							STROKE-INDUCED NEUROGENESIS; SUBVENTRICULAR ZONE; NEUROBLAST MIGRATION; DENTATE GYRUS; ADULT BRAIN; STEM-CELLS; RAT-BRAIN; PROLIFERATION; ANGIOGENESIS; REPLACEMENT	Depletion of neurogenesis worsens functional outcome in young-adult mice after focal cerebral ischemia, but whether a similar effect occurs in older mice is unknown. Using middle-aged (12-month-old) transgenic (DCX-TK(+)) mice that express herpes simplex virus thymidine kinase (HSV-TK) under control of the doublecortin (DCX) promoter, we conditionally depleted DCX-positive cells in the subventricular zone (SVZ) and hippocampus by treatment with ganciclovir (GCV) for 14 days. Focal cerebral ischemia was induced by permanent occlusion of the middle cerebral artery (MCAO) or occlusion of the distal segment of middle cerebral artery (dMCAO) on day 14 of vehicle or GCV treatment and mice were killed 24 hr or 12 weeks later. Increased infarct volume or brain atrophy was found in GCV-compared to vehicle-treated middle-aged DCX-TK(+) mice, both 24 hr after MCAO and 12 weeks after dMCAO. More severe motor deficits were also observed in GCV-treated, middle-aged DCX-TK(+) transgenic mice at both time points. Our results indicate that ischemia-induced newborn neurons contribute to anatomical and functional outcome after experimental stroke in middle-aged mice.	[Sun, Fen; Jin, Kunlin] Univ N Texas, Dept Pharmacol & Neurosci, Inst Aging & Alzheimers Dis Res, Ft Worth, TX USA; [Wang, Xiaomei; Mao, XiaoOu; Xie, Lin; Jin, Kunlin] Buck Inst Res Aging, Novato, CA USA	University of North Texas System; University of North Texas Health Science Center; Buck Institute for Research on Aging	Jin, KL (corresponding author), Univ N Texas, Dept Pharmacol & Neurosci, Inst Aging & Alzheimers Dis Res, Ft Worth, TX USA.	kunlin.jin@UNTHSC.edu		SUN, FEN/0000-0003-2094-9494	US Public Health Service [NS57186, AG21980]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057186] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021980] Funding Source: NIH RePORTER	US Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by US Public Health Service Grants NS57186 and AG21980. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn MY, 1999, BRAIN RES, V837, P169, DOI 10.1016/S0006-8993(99)01645-5; Ameh EA, 2009, SURG INFECT, V10, P105, DOI 10.1089/sur.2007.082; Andersen MB, 1999, PHARMACOL BIOCHEM BE, V62, P673, DOI 10.1016/S0091-3057(98)00204-4; ARNOLD KG, 1981, AGE AGEING, V10, P5, DOI 10.1093/ageing/10.1.5; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Buga AM, 2011, AGING DIS, V2, P64; Burns TC, 2011, EXPERT OPIN BIOL TH, V11, P447, DOI 10.1517/14712598.2011.552883; Darsalia V, 2005, STROKE, V36, P1790, DOI 10.1161/01.STR.0000173151.36031.be; DAVIS M, 1995, STROKE, V26, P1072, DOI 10.1161/01.STR.26.6.1072; Encarnacion A, 2011, J NEUROSCI METH, V196, P247, DOI 10.1016/j.jneumeth.2011.01.010; HOYER S, 1987, GERONTOLOGY, V33, P203, DOI 10.1159/000212877; Jin K, 2003, MOL CELL NEUROSCI, V24, P171, DOI 10.1016/S1044-7431(03)00159-3; Jin KL, 2004, AGING CELL, V3, P373, DOI 10.1111/j.1474-9728.2004.00131.x; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jin KL, 2010, AGING DIS, V1, P72; Jin KL, 2010, P NATL ACAD SCI USA, V107, P7993, DOI 10.1073/pnas.1000154107; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Liu JL, 1998, J NEUROSCI, V18, P7768; Luo J, 2006, AGING CELL, V5, P139, DOI 10.1111/j.1474-9726.2006.00197.x; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Nagayama M, 1999, J CEREBR BLOOD F MET, V19, P661, DOI 10.1097/00004647-199906000-00009; OHLSSON AL, 1995, STROKE, V26, P644, DOI 10.1161/01.STR.26.4.644; Ooboshi H, 2000, BRAIN RES, V884, P23, DOI 10.1016/S0006-8993(00)02861-4; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Popa-Wagner A, 1998, STROKE, V29, P2196, DOI 10.1161/01.STR.29.10.2196; Popa-Wagner A, 2010, STROKE, V41, P1027, DOI 10.1161/STROKEAHA.109.575621; Ramirez-Lassepas M, 1998, GERIATRICS-US, V53, pS44; Sugiura S, 2005, STROKE, V36, P859, DOI 10.1161/01.STR.0000158905.22871.95; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Takagi Y, 1999, BRAIN RES, V831, P283, DOI 10.1016/S0006-8993(99)01411-0; Thored P, 2007, STROKE, V38, P3032, DOI 10.1161/STROKEAHA.107.488445; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Tropepe V, 1997, J NEUROSCI, V17, P7850; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; YAO H, 1991, STROKE, V22, P1414, DOI 10.1161/01.STR.22.11.1414; Zhang L, 2002, J NEUROSCI METH, V117, P207, DOI 10.1016/S0165-0270(02)00114-0; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009	38	51	52	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e46326	10.1371/journal.pone.0046326	http://dx.doi.org/10.1371/journal.pone.0046326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110048	Green Published, Green Submitted, gold			2022-12-25	WOS:000310262500004
J	Yang, JM; Feng, XG; Fu, ZQ; Yuan, CX; Hong, Y; Shi, YJ; Zhang, M; Liu, JM; Li, H; Lu, K; Lin, JJ				Yang, Jianmei; Feng, Xingang; Fu, Zhiqiang; Yuan, Chunxiu; Hong, Yang; Shi, Yaojun; Zhang, Min; Liu, Jinming; Li, Hao; Lu, Ke; Lin, Jiaojiao			Ultrastructural Observation and Gene Expression Profiling of Schistosoma japonicum Derived from Two Natural Reservoir Hosts, Water Buffalo and Yellow Cattle	PLOS ONE			English	Article							PARASITE RELATIONSHIPS; VISUALIZATION; FAMILY; TOOL; EGG	Water buffalo and yellow cattle are the two of the most important natural reservoir hosts for Schistosoma japonicum in endemic areas of China, although their susceptibility differs, with water buffalo being less conducive to the growth and development of S. japonicum. Results from the current study show that the general morphology and ultrastructure of adult schistosomes derived from the two hosts also differed. Using high-throughput microarray technology, we also compared the gene expression profiles of adult schistosomes derived from the two hosts. We identified genes that were differentially expressed in worms from the two natural hosts. Further analysis revealed that genes associated with protein kinase and phosphatase, the stimulus response, and lipid and nucleotide metabolism were overexpressed, whereas genes associated with reproduction, anatomical structure morphogenesis and multifunctional motif were underexpressed in schistosomes from water buffalo. These differentially expressed genes were mainly involved in nucleotide, energy, lipid metabolism, energy metabolism, transcription, transport and signaling pathway. This suggests that they are key molecules affecting the survival and development of schistosomes in different natural host species. The results of this study add to current understanding of the interplay between parasites and their natural hosts, and provide valuable information for the screening of vaccine candidates or new drug targets against schistosomiasis in the natural reservoir hosts in endemic areas.	[Yang, Jianmei; Feng, Xingang; Fu, Zhiqiang; Yuan, Chunxiu; Hong, Yang; Shi, Yaojun; Zhang, Min; Liu, Jinming; Li, Hao; Lu, Ke; Lin, Jiaojiao] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Key Lab Anim Parasitol, Minist Agr China, Shanghai, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Lin, JJ (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Key Lab Anim Parasitol, Minist Agr China, Shanghai, Peoples R China.	qqyangjianmei@163.com			National Science and Technology Major Project [2012ZX10004220-008, 2008ZX10004-011]; National Basic Research Program [2007CB513108]; Special Fund for Agro-scientific Research in the Public Interest [200903036]	National Science and Technology Major Project; National Basic Research Program(National Basic Research Program of China); Special Fund for Agro-scientific Research in the Public Interest	The authors acknowledge financial support of the National Science and Technology Major Project (No.2012ZX10004220-008, No.2008ZX10004-011), the National Basic Research Program (No.2007CB513108), and Special Fund for Agro-scientific Research in the Public Interest (No. 200903036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashton PD, 2001, PARASITOLOGY, V122, P329, DOI 10.1017/S0031182001007351; Brouwers JFHM, 1997, MOL BIOCHEM PARASIT, V88, P175, DOI 10.1016/S0166-6851(97)00091-1; Cavodeassi F, 2001, DEVELOPMENT, V128, P2847; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cox T.F., 2001, MULTIDIMENSIONAL SCA, V2nd; Da'Dara AA, 2008, VACCINE, V26, P3617, DOI 10.1016/j.vaccine.2008.04.080; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Freitas TC, 2007, PLOS PATHOG, V3, P489, DOI 10.1371/journal.ppat.0030052; Gentleman R, 1997, R LANGUAGE; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gobert GN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-128; Grossel MJ, 2006, CELL CYCLE, V5, P266, DOI 10.4161/cc.5.3.2385; GRZYCH JM, 1991, J IMMUNOL, V146, P1322; He Yi-Xun, 1992, Acta Zoologica Sinica, V38, P266; He YX, 2001, TRENDS PARASITOL, V17, P320, DOI 10.1016/S1471-4922(01)01904-3; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Hong Y, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006098; Hu W, 2003, NAT GENET, V35, P139, DOI 10.1038/ng1236; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Krejcova R, 1997, CHEM LISTY, V91, P466; Lee HK, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-269; Lei Zheng-long, 2011, Zhongguo Xuexichongbing Fangzhi Zazhi, V23, P599; Liu F, 2006, PLOS PATHOG, V2, P268, DOI 10.1371/journal.ppat.0020029; Liu SX, 1997, VET PARASITOL, V69, P39, DOI 10.1016/S0304-4017(96)01092-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lockyer AE, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-634; LUO XF, 1988, CHIN J VET SCI TECHN, V8, P42; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; McGarvey ST, 1999, PARASITOL TODAY, V15, P214, DOI 10.1016/S0169-4758(99)01409-X; McManus DP, 2005, PARASITE IMMUNOL, V27, P297, DOI 10.1111/j.1365-3024.2005.00784.x; Morishita H, 2007, CURR OPIN CELL BIOL, V19, P584, DOI 10.1016/j.ceb.2007.09.006; Norberg S, 1998, PEDIATR RES, V44, P233, DOI 10.1203/00006450-199808000-00016; Osman A, 2006, PLOS PATHOG, V2, P536, DOI 10.1371/journal.ppat.0020054; Panganiban G, 2002, DEVELOPMENT, V129, P4371; Parisi M, 2000, CURR BIOL, V10, pR81, DOI 10.1016/S0960-9822(00)00283-9; Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242; Peng JB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-155; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Schluter OM, 2004, J NEUROSCI, V24, P6629, DOI 10.1523/JNEUROSCI.1610-04.2004; Shen W., 1992, CHIN J SCHISTOSOMIAS, V4, P82; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Wang XZ, 2009, MOL BIOCHEM PARASIT, V166, P62, DOI 10.1016/j.molbiopara.2009.02.016; World Health Organization, 2002, TDR TDR STRAT DIR SC; Yang JM, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-25; Zheng Jiang, 2000, Chinese Journal of Zoonoses, V16, P87; Zheng Jiang, 1997, Southeast Asian Journal of Tropical Medicine and Public Health, V28, P291; Zhou Y, 2009, NATURE, V460, P345, DOI 10.1038/nature08140	49	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47660	10.1371/journal.pone.0047660	http://dx.doi.org/10.1371/journal.pone.0047660			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110087	Green Published, gold, Green Submitted			2022-12-25	WOS:000310262500017
J	Yurovsky, D; Hidaka, S; Wu, R				Yurovsky, Daniel; Hidaka, Shohei; Wu, Rachel			Quantitative Linking Hypotheses for Infant Eye Movements	PLOS ONE			English	Article							INDIVIDUAL-DIFFERENCES; MODEL; 6-MONTH-OLD; PERCEPTION; PREFERENCE; PATTERNS; HABITUATION; FAMILIARITY; ATTENTION; INFERENCE	The study of cognitive development hinges, largely, on the analysis of infant looking. But analyses of eye gaze data require the adoption of linking hypotheses: assumptions about the relationship between observed eye movements and underlying cognitive processes. We develop a general framework for constructing, testing, and comparing these hypotheses, and thus for producing new insights into early cognitive development. We first introduce the general framework - applicable to any infant gaze experiment - and then demonstrate its utility by analyzing data from a set of experiments investigating the role of attentional cues in infant learning. The new analysis uncovers significantly more structure in these data, finding evidence of learning that was not found in standard analyses and showing an unexpected relationship between cue use and learning rate. Finally, we discuss general implications for the construction and testing of quantitative linking hypotheses. MATLAB code for sample linking hypotheses can be found on the first author's website.	[Yurovsky, Daniel] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [Hidaka, Shohei] Japan Adv Inst Sci & Technol, Sch Knowledge Sci, Nomi, Ishikawa, Japan; [Wu, Rachel] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY USA	Stanford University; Japan Advanced Institute of Science & Technology (JAIST); University of Rochester	Yurovsky, D (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	yurovsky@stanford.edu		Wu, Rachel/0000-0002-7486-697X; Lauwereyns, Jan/0000-0003-0551-2550	National Science Foundation (NSF); NSF East Asia Pacific Summer Institute Fellowship; BPS Postgraduate Study Visits Awards;  [23300099]; Grants-in-Aid for Scientific Research [23300099] Funding Source: KAKEN	National Science Foundation (NSF)(National Science Foundation (NSF)); NSF East Asia Pacific Summer Institute Fellowship; BPS Postgraduate Study Visits Awards; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by a National Science Foundation (NSF) Graduate Research Fellowship and NSF East Asia Pacific Summer Institute Fellowship to DY, two BPS Postgraduate Study Visits Awards to RW, and Grant-in-Aid for Scientific Research B No. 23300099 to SH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldous D.J., 1985, LECT NOTES MATH, V1117, P1, DOI DOI 10.1007/BFB0099421; Anderson B, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00246; Anderson JR, 1998, J MEM LANG, V38, P341, DOI 10.1006/jmla.1997.2553; Aslin RN, 2000, INFANCY, V1, P463, DOI 10.1207/S15327078IN0104_6; Aslin RN, 2007, DEVELOPMENTAL SCI, V10, P48, DOI 10.1111/j.1467-7687.2007.00563.x; BAILLARGEON R, 1986, COGNITION, V23, P21, DOI 10.1016/0010-0277(86)90052-1; Barr DJ, 2008, J MEM LANG, V59, P457, DOI 10.1016/j.jml.2007.09.002; Brannon EM, 2004, COGNITION, V93, pB59, DOI 10.1016/j.cognition.2004.01.004; Cashon CH, 2000, INFANCY, V1, P429, DOI 10.1207/S15327078IN0104_4; Castelhano MS, 2009, J VISION, V9, DOI 10.1167/9.3.6; Cha SH, 2002, PATTERN RECOGN, V35, P1355, DOI 10.1016/S0031-3203(01)00118-2; Cohen LB, 2004, INFANT CHILD DEV, V13, P349, DOI 10.1002/icd.355; Donkin C, 2012, PSYCHOL SCI, V23, P625, DOI 10.1177/0956797611430961; EDWARDS W, 1963, PSYCHOL REV, V70, P193, DOI 10.1037/h0044139; ESTES WK, 1956, PSYCHOL BULL, V53, P134, DOI 10.1037/h0045156; ESTES WK, 1957, AM PSYCHOL, V12, P609, DOI 10.1037/h0046778; FANTZ RL, 1964, SCIENCE, V146, P668, DOI 10.1126/science.146.3644.668; Farroni T, 2005, P NATL ACAD SCI USA, V102, P17245, DOI 10.1073/pnas.0502205102; Figuerido MAT, 2002, ADV NEURAL INFORM PR, V14, P722; Gallistel CR, 2004, P NATL ACAD SCI USA, V101, P13124, DOI 10.1073/pnas.0404965101; Gilmore RO, 2002, INFANT BEHAV DEV, V25, P399, DOI 10.1016/S0163-6383(02)00142-X; Glymour C, 1998, PHILOS SCI, V65, P1, DOI 10.1086/392624; GOLINKOFF RM, 1987, J CHILD LANG, V14, P23, DOI 10.1017/S030500090001271X; Griffiths TL, 2010, TRENDS COGN SCI, V14, P357, DOI 10.1016/j.tics.2010.05.004; Halberda J, 2003, COGNITION, V87, pB23, DOI 10.1016/S0010-0277(02)00186-5; Hayhoe M, 2005, TRENDS COGN SCI, V9, P188, DOI 10.1016/j.tics.2005.02.009; Houston-Price C, 2004, INFANT CHILD DEV, V13, P341, DOI 10.1002/icd.364; Hunter M.A., 1988, ADV INFANCY RES, V5, P69, DOI DOI 10.1037/0012-1649.19.3.338; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Jackson I, 2009, DEVELOPMENTAL SCI, V12, P670, DOI 10.1111/j.1467-7687.2008.00805.x; Jones M, 2011, BEHAV BRAIN SCI, V34, P215, DOI [10.1017/S0140525X10003134, 10.1017/S0140525X11001439]; Kelly DJ, 2005, DEVELOPMENTAL SCI, V8, pF31, DOI 10.1111/j.1467-7687.2005.0434a.x; Kidd C, 2011, DEVELOPMENTAL SCI, V14, P925, DOI 10.1111/j.1467-7687.2011.01049.x; Kobayashi T, 2005, DEVELOPMENTAL SCI, V8, P409, DOI 10.1111/j.1467-7687.2005.00429.x; Kruschke JK, 2011, PERSPECT PSYCHOL SCI, V6, P299, DOI 10.1177/1745691611406925; Kruschke JK, 2010, TRENDS COGN SCI, V14, P293, DOI 10.1016/j.tics.2010.05.001; Lashley K., 1951, CEREBRAL MECH BEHAV, P112, DOI DOI 10.1093/RFS/HHQ153; Lee MD, 2010, COGNITIVE SCI, V34, P51, DOI 10.1111/j.1551-6709.2009.01063.x; Marchman VA, 2008, DEVELOPMENTAL SCI, V11, pF9, DOI 10.1111/j.1467-7687.2008.00671.x; Mather E, 2010, J EXP CHILD PSYCHOL, V105, P232, DOI 10.1016/j.jecp.2009.11.004; McClelland JL, 2010, TRENDS COGN SCI, V14, P348, DOI 10.1016/j.tics.2010.06.002; McClelland JL, 2009, TOP COGN SCI, V1, P11, DOI 10.1111/j.1756-8765.2008.01003.x; Miller GA, 2003, TRENDS COGN SCI, V7, P141, DOI 10.1016/S1364-6613(03)00029-9; Mix KS, 2002, PSYCHOL BULL, V128, P278, DOI 10.1037//0033-2909.128.2.278; Munakata Y, 2000, INFANCY, V1, P471, DOI 10.1207/S15327078IN0104_7; Navarro DJ, 2006, J MATH PSYCHOL, V50, P101, DOI 10.1016/j.jmp.2005.11.006; Newell A., 1973, YOU CANT PLAY 20 QUE, DOI 10.1016/B978-0-12-170150-5.50012-3; Pelucchi B, 2009, CHILD DEV, V80, P674, DOI 10.1111/j.1467-8624.2009.01290.x; Rasmussen CE, 2000, ADV NEUR IN, V12, P554; Roder BJ, 2000, INFANCY, V1, P491, DOI 10.1207/S15327078IN0104_9; Schoner G, 2006, PSYCHOL REV, V113, P273, DOI 10.1037/0033-295X.113.2.273; Shiffrin RM, 2010, TOP COGN SCI, V2, P736, DOI 10.1111/j.1756-8765.2010.01092.x; SHIFFRIN RM, 1977, PSYCHOL REV, V84, P127, DOI 10.1037/0033-295X.84.2.127; SIEGLER RS, 1987, J EXP PSYCHOL GEN, V116, P250; Sirois S, 2004, J COGNITIVE NEUROSCI, V16, P1352, DOI 10.1162/0898929042304778; Smith L, 2008, COGNITION, V106, P1558, DOI 10.1016/j.cognition.2007.06.010; Spelke ES, 1998, INFANT BEHAV DEV, V21, P181, DOI 10.1016/S0163-6383(98)90002-9; Stager CL, 1997, NATURE, V388, P381, DOI 10.1038/41102; TELLER DY, 1984, VISION RES, V24, P1233, DOI 10.1016/0042-6989(84)90178-0; Torralba A, 2006, PSYCHOL REV, V113, P766, DOI 10.1037/0033-295X.113.4.766; Waxman SR, 1995, COGNITIVE PSYCHOL, V29, P257, DOI 10.1006/cogp.1995.1016; Werker JF, 1998, DEV PSYCHOL, V34, P1289, DOI 10.1037/0012-1649.34.6.1289; Wu R, 2010, J EXP CHILD PSYCHOL, V107, P118, DOI 10.1016/j.jecp.2010.04.014; Xu F, 2000, COGNITION, V74, pB1, DOI 10.1016/S0010-0277(99)00066-9; YOUNGER BA, 1986, CHILD DEV, V57, P803, DOI 10.2307/1130356; Yu C, 2012, INFANCY, V17, P33, DOI 10.1111/j.1532-7078.2011.00095.x; Yu C, 2011, DEVELOPMENTAL SCI, V14, P165, DOI 10.1111/j.1467-7687.2010.00958.x	67	3	3	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47419	10.1371/journal.pone.0047419	http://dx.doi.org/10.1371/journal.pone.0047419			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	026GL	23110071	gold, Green Submitted, Green Published			2022-12-25	WOS:000310262500010
J	Bashiri, G; Perkowski, EF; Turner, AP; Feltcher, ME; Braunstein, M; Baker, EN				Bashiri, Ghader; Perkowski, Ellen F.; Turner, Adrian P.; Feltcher, Meghan E.; Braunstein, Miriam; Baker, Edward N.			Tat-Dependent Translocation of an F-420-Binding Protein of Mycobacterium tuberculosis	PLOS ONE			English	Article							F-420-DEPENDENT GLUCOSE-6-PHOSPHATE-DEHYDROGENASE; SIGNAL PEPTIDES; DRUG CANDIDATE; SIGMA-FACTOR; IDENTIFICATION; COENZYME; PATHWAY; SMEGMATIS; EXPORT; PURIFICATION	F-420 is a unique cofactor present in a restricted range of microorganisms, including mycobacteria. It has been proposed that F-420 has an important role in the oxidoreductive reactions of Mycobacterium tuberculosis, possibly associated with anaerobic survival and persistence. The protein encoded by Rv0132c has a predicted N-terminal signal sequence and is annotated as an F-420-dependent glucose-6-phosphate dehydrogenase. Here we show that Rv0132c protein does not have the annotated activity. It does, however, co-purify with F-420 during expression experiments in M. smegmatis. We also show that the Rv0132c-F-420 complex is a substrate for the Tat pathway, which mediates translocation of the complex across the cytoplasmic membrane, where Rv0132c is anchored to the cell envelope. This is the first report of any F-420-binding protein being a substrate for the Tat pathway and of the presence of F-420 outside of the cytosol in any F-420-producing microorganism. The Rv0132c protein and its Tat export sequence are essentially invariant in the Mycobacterium tuberculosis complex. Taken together, these results show that current understanding of F-420 biology in mycobacteria should be expanded to include activities occurring in the extra-cytoplasmic cell envelope.	[Bashiri, Ghader; Baker, Edward N.] Univ Auckland, Sch Biol Sci, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1, New Zealand; [Perkowski, Ellen F.; Feltcher, Meghan E.; Braunstein, Miriam] Univ N Carolina, Sch Med, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Turner, Adrian P.] Univ Auckland, Sch Biol Sci, Microscopy & Graph Unit, Auckland 1, New Zealand	University of Auckland; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of Auckland	Baker, EN (corresponding author), Univ Auckland, Sch Biol Sci, Maurice Wilkins Ctr Mol Biodiscovery, Auckland 1, New Zealand.	en.baker@auckland.ac.nz	; Bashiri, Ghader/R-4957-2017	Baker, Edward/0000-0003-2456-7661; Bashiri, Ghader/0000-0002-5092-3749; Turner, Adrian/0000-0001-5098-398X	Health Research Council of New Zealand; Foundation for Research, Science and Technology of New Zealand; United States National Institutes of Health [RO1 AI054540]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054540] Funding Source: NIH RePORTER	Health Research Council of New Zealand(Health Research Council of New Zealand); Foundation for Research, Science and Technology of New Zealand(New Zealand Foundation for Research, Science and Technology); United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funded by the Health Research Council of New Zealand, the Foundation for Research, Science and Technology of New Zealand and the United States National Institutes of Health (grant RO1 AI054540). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagos PG, 2010, BIOINFORMATICS, V26, P2811, DOI 10.1093/bioinformatics/btq530; Bashiri G, 2008, J BIOL CHEM, V283, P17531, DOI 10.1074/jbc.M801854200; Bashiri G, 2007, PROTEIN EXPRES PURIF, V54, P38, DOI 10.1016/j.pep.2007.01.014; Bashiri G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015803; Berks BC, 2003, ADV MICROB PHYSIOL, V47, P187, DOI 10.1016/S0065-2911(03)47004-5; Berks BC, 2000, BBA-BIOENERGETICS, V1459, P325, DOI 10.1016/S0005-2728(00)00168-7; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Braunstein M, 2002, METHOD ENZYMOL, V358, P67; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; D'Orazio M, 2001, BIOCHEM J, V359, P17, DOI 10.1042/0264-6021:3590017; DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100; DeMaio J, 1996, P NATL ACAD SCI USA, V93, P2790, DOI 10.1073/pnas.93.7.2790; Dogra M, 2010, BR J PHARM; Duncan K, 2004, CURR OPIN MICROBIOL, V7, P460, DOI 10.1016/j.mib.2004.08.011; Flores AR, 2005, MICROBIOL-SGM, V151, P521, DOI 10.1099/mic.0.27629-0; Geiman DE, 2004, INFECT IMMUN, V72, P1733, DOI 10.1128/IAI.72.3.1733-1745.2004; Gibbons HS, 2007, J BACTERIOL, V189, P5090, DOI 10.1128/JB.00163-07; Gralnick JA, 2006, P NATL ACAD SCI USA, V103, P4669, DOI 10.1073/pnas.0505959103; Gurumurthy M, 2012, FEBS J, V279, P113, DOI 10.1111/j.1742-4658.2011.08404.x; Isabelle D, 2002, APPL ENVIRON MICROB, V68, P5750, DOI 10.1128/AEM.68.11.5750-5755.2002; JACOBSON FS, 1982, J BIOL CHEM, V257, P3385; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Malen H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-132; Manjunatha UH, 2006, P NATL ACAD SCI USA, V103, P431, DOI 10.1073/pnas.0508392103; Marrichi M, 2008, J BIOL CHEM, V283, P35223, DOI 10.1074/jbc.M802660200; McDonough JA, 2005, J BACTERIOL, V187, P7667, DOI 10.1128/JB.187.22.7667-7679.2005; McDonough JA, 2008, J BACTERIOL, V190, P6428, DOI 10.1128/JB.00749-08; Palmer T, 2005, TRENDS MICROBIOL, V13, P175, DOI 10.1016/j.tim.2005.02.002; Purwantini E, 1996, J BACTERIOL, V178, P2861, DOI 10.1128/jb.178.10.2861-2866.1996; Purwantini E, 2009, P NATL ACAD SCI USA, V106, P6333, DOI 10.1073/pnas.0812883106; Selengut JD, 2010, J BACTERIOL, V192, P5788, DOI 10.1128/JB.00425-10; Shi LB, 2005, P NATL ACAD SCI USA, V102, P15629, DOI 10.1073/pnas.0507850102; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Stephenson K, 2005, MOL MEMBR BIOL, V22, P17, DOI 10.1080/09687860500063308; Stover CK, 2000, NATURE, V405, P962, DOI 10.1038/35016103; Sutcliffe IC, 2004, FEMS MICROBIOL REV, V28, P645, DOI 10.1016/j.femsre.2004.06.002; Taylor MC, 2010, MOL MICROBIOL, V78, P561, DOI 10.1111/j.1365-2958.2010.07356.x; THOMPSON BJ, 2010, MOL MICROBIOL; Tullman-Ercek D, 2007, J BIOL CHEM, V282, P8309, DOI 10.1074/jbc.M610507200; Valente FMA, 2007, FEBS LETT, V581, P3341, DOI 10.1016/j.febslet.2007.06.020; Wickner W, 2005, SCIENCE, V310, P1452, DOI 10.1126/science.1113752; Widdick DA, 2011, MOL MICROBIOL, V80, P1395, DOI 10.1111/j.1365-2958.2011.07656.x; World Health Organization, 2010, GLOB TUB CONTR	44	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e45003	10.1371/journal.pone.0045003	http://dx.doi.org/10.1371/journal.pone.0045003			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110042	Green Submitted, Green Published, gold			2022-12-25	WOS:000310193400002
J	Garcia-Gamez, E; Gutierrez-Gil, B; Sahana, G; Sanchez, JP; Bayon, Y; Arranz, JJ				Garcia-Gamez, Elsa; Gutierrez-Gil, Beatriz; Sahana, Goutam; Sanchez, Juan-Pablo; Bayon, Yolanda; Arranz, Juan-Jose			GWA Analysis for Milk Production Traits in Dairy Sheep and Genetic Support for a QTN Influencing Milk Protein Percentage in the LALBA Gene	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SOMATIC-CELL SCORE; ALPHA-LACTALBUMIN; LINKAGE DISEQUILIBRIUM; MISSENSE MUTATION; FERTILITY TRAITS; LOCI; NUCLEOTIDE; CATTLE; YIELD	In this study, we used the Illumina OvineSNP50 BeadChip to conduct a genome-wide association (GWA) analysis for milk production traits in dairy sheep by analyzing a commercial population of Spanish Churra sheep. The studied population consisted of a total of 1,681 Churra ewes belonging to 16 half-sib families with available records for milk yield (MY), milk protein and fat yields (PY and FY) and milk protein and fat contents (PP and FP). The most significant association identified reached experiment-wise significance for PP and FP and was located on chromosome 3 (OAR3). These results confirm the population-level segregation of a previously reported QTL affecting PP and suggest that this QTL has a significant pleiotropic effect on FP. Further associations were detected at the chromosome-wise significance level on 14 other chromosomal regions. The marker on OAR3 showing the highest significant association was located at the third intron of the alpha-lactalbumin (LALBA) gene, which is a functional and positional candidate underlying this association. Sequencing this gene in the 16 Churra rams of the studied resource population identified additional polymorphisms. One out of the 31 polymorphisms identified was located within the coding gene sequence (LALBA_g.242T>C) and was predicted to cause an amino acid change in the protein (Val27Ala). Different approaches, including GWA analysis, a combined linkage and linkage disequilibrium study and a concordance test with the QTL segregating status of the sires, were utilized to assess the role of this mutation as a putative QTN for the genetic effects detected on OAR3. Our results strongly support the polymorphism LALBA_g.242T>C as the most likely causal mutation of the studied OAR3 QTL affecting PP and FP, although we cannot rule out the possibility that this SNP is in perfect linkage disequilibrium with the true causal polymorphism.	[Garcia-Gamez, Elsa; Gutierrez-Gil, Beatriz; Bayon, Yolanda; Arranz, Juan-Jose] Univ Leon, Dept Anim Prod, E-24071 Leon, Spain; [Sahana, Goutam] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Sanchez, Juan-Pablo] IRTA, Lleida, Spain	Universidad de Leon; Aarhus University; IRTA	Arranz, JJ (corresponding author), Univ Leon, Dept Anim Prod, E-24071 Leon, Spain.	jjarrs@unileon.es	Sahana, Goutam/K-7613-2014; Sanchez, Juan Pablo/D-8133-2013; Sahana, Goutam/AAI-7579-2021; Arranz, Juan-Jose/H-1225-2015; Gutierrez, Beatriz/AAU-1711-2021	Sahana, Goutam/0000-0001-7608-7577; Sanchez, Juan Pablo/0000-0001-8639-6146; Sahana, Goutam/0000-0001-7608-7577; Arranz, Juan-Jose/0000-0001-9058-131X; Gutierrez-Gil, Beatriz/0000-0001-7990-5723	Spanish Ministry of Education; Foundation of Supercomputing Center of Castile and Leon (FCSCL); Spanish Ministry of Science [AGL2009-07000]; European Commission	Spanish Ministry of Education(Spanish Government); Foundation of Supercomputing Center of Castile and Leon (FCSCL); Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre)	Elsa Garcia-Gamez has an FPU contract from the Spanish Ministry of Education. The support and availability to the computing facilities of the Foundation of Supercomputing Center of Castile and Leon (FCSCL) (http://www.fcsc.es) is greatly acknowledged.; This work was supported by the Spanish Ministry of Science (Project AGL2009-07000) and by the European Commission by 3SR Project (Sustainable Solutions for Small Ruminants; http://www.3srbreeding.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barillet Francis, 2005, Genet Sel Evol, V37 Suppl 1, pS109, DOI 10.1051/gse:2004033; Becker D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008689; Blott S, 2003, GENETICS, V163, P253; Bolormaa S, 2011, J ANIM SCI, V89, P1684, DOI 10.2527/jas.2010-3079; Boston WS, 2001, J DAIRY SCI, V84, P620, DOI 10.3168/jds.S0022-0302(01)74516-X; Bouwman AC, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-43; Daetwyler HD, 2008, J DAIRY SCI, V91, P3225, DOI 10.3168/jds.2007-0333; Diez-Tascon C, 2001, J DAIRY RES, V68, P389, DOI 10.1017/S0022029901004988; Druet T, 2010, GENETICS, V184, P789, DOI 10.1534/genetics.109.108431; Filangi O, 2010, P 9 WORLD C GEN APPL; Gao XY, 2010, GENET EPIDEMIOL, V34, P100, DOI 10.1002/gepi.20430; Garcia-Fernandez M, 2011, ANIM GENET, V42, P415, DOI 10.1111/j.1365-2052.2010.02162.x; Garcia-Fernandez M, 2009, MOL CELL PROBE, V23, P107, DOI 10.1016/j.mcp.2009.01.001; Garcia-Gamez E, 2012, ANIM GENET, V43, P636, DOI 10.1111/j.1365-2052.2011.02294.x; Garcia-Gamez E, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-43; Garcia-Gamez E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021158; GAYE P, 1987, BIOCHIMIE, V69, P601, DOI 10.1016/0300-9084(87)90179-9; Gonda Y, 2007, GENE EXPR PATTERNS, V7, P431, DOI 10.1016/j.modgep.2006.11.005; Green P, 1990, DOCUMENTATION CRI MA; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Gutierrez-Gil B, 2012, ANIM GENET, V43, P654, DOI 10.1111/j.1365-2052.2012.02322.x; Gutierrez-Gil B, 2009, ANIM GENET, V40, P423, DOI 10.1111/j.1365-2052.2009.01856.x; Gutierrez-Gil B, 2007, J DAIRY SCI, V90, P422, DOI 10.3168/jds.S0022-0302(07)72643-7; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Howard B, 2006, PLOS GENET, V2, P1121, DOI 10.1371/journal.pgen.0020112; Jiang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013661; Legarra A, 2001, ANIM SCI, V73, P407, DOI 10.1017/S1357729800058379; Legarra A, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-43; Lunden A, 1998, P 6 WORLD C GEN APPL, V25; Mai MD, 2010, J ANIM SCI, V88, P3522, DOI 10.2527/jas.2009-2713; Mateescu RG, 2010, ANIM GENET, V41, P460, DOI 10.1111/j.1365-2052.2010.02045.x; Moioli B, 2007, SMALL RUMINANT RES, V68, P179, DOI 10.1016/j.smallrumres.2006.09.008; Mullen Michael Paul, 2011, Frontiers in Genetics, V2, P3, DOI 10.3389/fgene.2011.00003; Olsen HG, 2011, ANIM GENET, V42, P466, DOI 10.1111/j.1365-2052.2011.02179.x; Olsen HG, 2010, ANIM GENET, V41, P273, DOI 10.1111/j.1365-2052.2009.01998.x; Olsen HG, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-32; Othmane MH, 2002, GENET SEL EVOL, V34, P581, DOI [10.1051/gse:2002024, 10.1186/1297-9686-34-5-581]; Pausch H, 2011, GENETICS, V187, P289, DOI 10.1534/genetics.110.124057; Plante Y, 2001, J DAIRY SCI, V84, P1516, DOI 10.3168/jds.S0022-0302(01)70185-3; Raadsma HW, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-45; Ron M, 2007, ANIM GENET, V38, P429, DOI 10.1111/j.1365-2052.2007.01640.x; Sahana G, 2011, J DAIRY SCI, V94, P479, DOI 10.3168/jds.2010-3381; Sahana G, 2010, ANIM GENET, V41, P579, DOI 10.1111/j.1365-2052.2010.02064.x; Schopen GCB, 2011, J DAIRY SCI, V94, P3148, DOI 10.3168/jds.2010-4030; Schulman NF, 2011, ANIM GENET, V42, P263, DOI 10.1111/j.1365-2052.2010.02149.x; Seaton G, 2006, P 8 WORLD C GEN APPL; Seroussi E, 2009, ANIM GENET, V40, P230, DOI 10.1111/j.1365-2052.2008.01809.x; Sharif S, 1998, ANIM GENET, V29, P185, DOI 10.1111/j.1365-2052.1998.00318.x; STINNAKRE MG, 1994, P NATL ACAD SCI USA, V91, P6544, DOI 10.1073/pnas.91.14.6544; Taylor J, 2012, 20 PLANT AN GEN C SA; VANRADEN PM, 1991, J DAIRY SCI, V74, P2737, DOI 10.3168/jds.S0022-0302(91)78453-1; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021739	53	56	59	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47782	10.1371/journal.pone.0047782	http://dx.doi.org/10.1371/journal.pone.0047782			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094085	Green Published, Green Submitted, gold			2022-12-25	WOS:000312384500022
J	Rausch, F; Schicht, M; Paulsen, F; Ngueya, I; Brauer, L; Brandt, W				Rausch, Felix; Schicht, Martin; Paulsen, Friedrich; Ngueya, Ivan; Braeuer, Lars; Brandt, Wolfgang			"SP-G", a Putative New Surfactant Protein - Tissue Localization and 3D Structure	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; LINEAR CONSTRAINT SOLVER; PARTICLE MESH EWALD; PULMONARY SURFACTANT; FORCE-FIELD; NASAL EPITHELIUM; EUSTACHIAN-TUBE; HOST-DEFENSE; I-TASSER; SP-B	Surfactant proteins (SP) are well known from human lung. These proteins assist the formation of a monolayer of surface-active phospholipids at the liquid-air interface of the alveolar lining, play a major role in lowering the surface tension of interfaces, and have functions in innate and adaptive immune defense. During recent years it became obvious that SPs are also part of other tissues and fluids such as tear fluid, gingiva, saliva, the nasolacrimal system, and kidney. Recently, a putative new surfactant protein (SFTA2 or SP-G) was identified, which has no sequence or structural identity to the already know surfactant proteins. In this work, computational chemistry and molecular-biological methods were combined to localize and characterize SP-G. With the help of a protein structure model, specific antibodies were obtained which allowed the detection of SP-G not only on mRNA but also on protein level. The localization of this protein in different human tissues, sequence based prediction tools for posttranslational modifications and molecular dynamic simulations reveal that SP-G has physicochemical properties similar to the already known surfactant proteins B and C. This includes also the possibility of interactions with lipid systems and with that, a potential surface-regulatory feature of SP-G. In conclusion, the results indicate SP-G as a new surfactant protein which represents an until now unknown surfactant protein class.	[Rausch, Felix; Brandt, Wolfgang] Leibniz Inst Plant Biochem, Dept Bioorgan Chem, Halle, Germany; [Schicht, Martin; Paulsen, Friedrich; Ngueya, Ivan; Braeuer, Lars] Univ Erlangen Nurnberg, Inst Anat, Dept 2, D-91054 Erlangen, Germany	Leibniz Institut fur Pflanzenbiochemie; University of Erlangen Nuremberg	Brandt, W (corresponding author), Leibniz Inst Plant Biochem, Dept Bioorgan Chem, Halle, Germany.	wbrandt@ipb-halle.de		Paulsen, Friedrich/0000-0002-0527-0953; Schicht, Martin/0000-0001-5155-5477	Deutsche Forschungsgemeinschaft (DFG) [BR 1329/12-1, BR 3681/2-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This research was supported by the Deutsche Forschungsgemeinschaft (DFG, http://www.dfg.de/index.jsp) given to W.B. (grant: BR 1329/12-1) and L.B. (grant BR 3681/2-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso C, 2004, BIOPHYS J, V87, P4188, DOI 10.1529/biophysj.104.051201; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Baoukina S, 2011, BIOPHYS J, V100, P1678, DOI 10.1016/j.bpj.2011.02.019; Bartlett J, 2011, BIOCHEM SOC T, V39, P1012, DOI 10.1042/BST0391012; Beck DC, 2000, J BIOL CHEM, V275, P3365, DOI 10.1074/jbc.275.5.3365; Beers MF, 2005, ANNU REV PHYSIOL, V67, P663, DOI 10.1146/annurev.physiol.67.040403.101937; Bernhard W, 1997, AM J RESP CELL MOL, V17, P41, DOI 10.1165/ajrcmb.17.1.2594; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Bourbon JR, 2001, COMP BIOCHEM PHYS A, V129, P151, DOI 10.1016/S1095-6433(01)00312-9; Brauer L, 2007, CURR EYE RES, V32, P931, DOI 10.1080/02713680701694369; Braeuer L, 2007, INVEST OPHTH VIS SCI, V48, P3945, DOI 10.1167/iovs.07-0201; Brauer L, 2012, BIOMED ENG-BIOMED TE, V57, P59, DOI 10.1515/bmt-2011-0031; Brauer L, 2009, HISTOCHEM CELL BIOL, V132, P331, DOI 10.1007/s00418-009-0609-x; Brauer L, 2008, J EPITHEL BIOL PHARM, V1, P62; Castrignano T, 2006, NUCLEIC ACIDS RES, V34, pD306, DOI 10.1093/nar/gkj105; Crouch E, 2001, ANNU REV PHYSIOL, V63, P521, DOI 10.1146/annurev.physiol.63.1.521; CURSTEDT T, 1988, EUR J BIOCHEM, V172, P521, DOI 10.1111/j.1432-1033.1988.tb13918.x; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Duncan SL, 2010, BBA-BIOMEMBRANES, V1798, P1632, DOI 10.1016/j.bbamem.2010.04.006; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Ferguson JS, 1999, J IMMUNOL, V163, P312; GLASSER SW, 1988, J BIOL CHEM, V263, P9; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Gustafsson M, 2000, BBA-BIOMEMBRANES, V1466, P169, DOI 10.1016/S0005-2736(00)00198-X; Guttentag S, 2003, AM J RESP CELL MOL, V28, P69, DOI 10.1165/rcmb.2002-0111OC; Hartshorn KL, 1998, AM J PHYSIOL-LUNG C, V274, pL958, DOI 10.1152/ajplung.1998.274.6.L958; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kaleem A, 2011, J CELL BIOCHEM, V112, P138, DOI 10.1002/jcb.22909; Kandasamy SK, 2005, BIOPHYS J, V88, P1577, DOI 10.1529/biophysj.104.038430; Kankavi O, 2003, ACTA BIOCHIM POL, V50, P1057; Kaznessis YN, 2002, J MOL BIOL, V322, P569, DOI 10.1016/S0022-2836(02)00774-X; KHOOR A, 1994, J HISTOCHEM CYTOCHEM, V42, P1187, DOI 10.1177/42.9.8064126; Kiemer L, 2005, BIOINFORMATICS, V21, P1269, DOI 10.1093/bioinformatics/bti130; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Kim JK, 2007, AM J PHYSIOL-LUNG C, V292, pL879, DOI 10.1152/ajplung.00156.2006; KING RJ, 1973, AM J PHYSIOL, V224, P788, DOI 10.1152/ajplegacy.1973.224.4.788; Kishore U, 2006, MOL IMMUNOL, V43, P1293, DOI 10.1016/j.molimm.2005.08.004; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Kukol A, 2009, J CHEM THEORY COMPUT, V5, P615, DOI 10.1021/ct8003468; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LeClair EE, 2001, BIOCHEM BIOPH RES CO, V284, P792, DOI 10.1006/bbrc.2001.5024; Mancia A, 2012, COMP BIOCHEM PHYS C, V155, P136, DOI 10.1016/j.cbpc.2011.04.002; Mittal RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040011; Nakai K, 2000, ADV PROTEIN CHEM, V54, P277, DOI 10.1016/S0065-3233(00)54009-1; NOSE S, 1984, MOL PHYS, V52, P255, DOI 10.1080/00268978400101201; NOSE S, 1983, MOL PHYS, V50, P1055, DOI 10.1080/00268978300102851; NOTTER RH, 1987, CHEM PHYS LIPIDS, V44, P1, DOI 10.1016/0009-3084(87)90002-8; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Paananen R, 2001, AM J PHYSIOL-LUNG C, V280, pL214, DOI 10.1152/ajplung.2001.280.2.L214; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Ren J, 2008, PROTEIN ENG DES SEL, V21, P639, DOI 10.1093/protein/gzn039; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schicht M, 2010, KLIN MONATSBL AUGENH, V227, P864, DOI 10.1055/s-0029-1245609; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Smith GR, 2002, GROMACS USER CONTRIB; Sommer B, 2011, J CHEM INF MODEL, V51, P1165, DOI 10.1021/ci1003619; Ten Brinke A, 2002, BIOCHEM J, V361, P663, DOI 10.1042/0264-6021:3610663; Vallat BK, 2008, PROTEINS, V72, P910, DOI 10.1002/prot.21976; Vallat BK, 2009, PROTEINS, V76, P930, DOI 10.1002/prot.22401; van de Wetering JK, 2004, EUR J BIOCHEM, V271, P1229, DOI 10.1111/j.1432-1033.2004.04040.x; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VANIWAARDEN F, 1990, AM J RESP CELL MOL, V2, P91, DOI 10.1165/ajrcmb/2.1.91; VOORHOUT WF, 1992, AM J PHYSIOL, V263, pL479, DOI 10.1152/ajplung.1992.263.4.L479; Vorbroker DK, 1995, AM J PHYSIOL-LUNG C, V269, pL727, DOI 10.1152/ajplung.1995.269.6.L727; Weaver TE, 1998, BBA-MOL BASIS DIS, V1408, P173, DOI 10.1016/S0925-4439(98)00066-0; Weston WM, 1999, J BIOL CHEM, V274, P13698, DOI 10.1074/jbc.274.19.13698; WHITSETT JA, 1986, PEDIATR RES, V20, P744, DOI 10.1203/00006450-198608000-00009; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; YU SH, 1987, BIOCHIM BIOPHYS ACTA, V921, P437; YU SH, 1990, BIOCHIM BIOPHYS ACTA, V1046, P233, DOI 10.1016/0005-2760(90)90236-Q; Yu SH, 2003, J LIPID RES, V44, P621, DOI 10.1194/jlr.M200380-JLR200; Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702; Zhang ZM, 2004, PROTEIN SCI, V13, P2819, DOI 10.1110/ps.04682504	82	25	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47789	10.1371/journal.pone.0047789	http://dx.doi.org/10.1371/journal.pone.0047789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094088	gold, Green Published, Green Submitted			2022-12-25	WOS:000312384500024
J	Verkade, E; Bergmans, AMC; Budding, AE; van Belkum, A; Savelkoul, P; Buiting, AG; Kluytmans, J				Verkade, Erwin; Bergmans, Anneke M. C.; Budding, Andries E.; van Belkum, Alex; Savelkoul, Paul; Buiting, Anton G.; Kluytmans, Jan			Recent Emergence of Staphylococcus aureus Clonal Complex 398 in Human Blood Cultures	PLOS ONE			English	Article							METHICILLIN-RESISTANT; ST398; AMPLIFICATION; INFECTIONS	Background: Recently, a clone of MRSA with clonal complex 398 (CC398) has emerged that is related to an extensive reservoir in animals, especially pigs and veal calves. It has been reported previously that methicillin-susceptible variants of CC398 circulate among humans at low frequency, and these have been isolated in a few cases of bloodstream infections (BSI). The purpose of this study was to determine the prevalence of S. aureus CC398 in blood cultures taken from patients in a geographic area with a high density of pigs. Methodology/Principal Findings: In total, 612 consecutive episodes of S. aureus BSI diagnosed before and during the emergence of CC398 were included. Three strains (2 MSSA and 1 MRSA) that were isolated from bacteremic patients between 2010-2011 were positive in a CC398 specific PCR. There was a marked increase in prevalence of S. aureus CC398 BSI isolated between 2010-2011 compared to the combined collections that were isolated between 1996-1998 and 2002-2005 (3/157, 1.9% vs. 0/455, 0.0%; p = 0.017). Conclusions/Significance: In conclusion, in an area with a relative high density of pigs, S. aureus CC398 was found as a cause of BSI in humans only recently. This indicates that S. aureus CC398 is able to cause invasive infections in humans and that the prevalence is rising. Careful monitoring of the evolution and epidemiology of S. aureus CC398 in animals and humans is therefore important.	[Verkade, Erwin; Bergmans, Anneke M. C.; Kluytmans, Jan] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [Verkade, Erwin; Buiting, Anton G.; Kluytmans, Jan] St Elizabeth Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands; [Bergmans, Anneke M. C.] Franciscus Hosp, Microbiol Lab, Roosendaal, Netherlands; [Budding, Andries E.; Savelkoul, Paul; Kluytmans, Jan] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands; [van Belkum, Alex] Erasmus MC, Dept Med Microbiol & Infect Dis, Rotterdam, Netherlands; [van Belkum, Alex] BioMerieux, Microbiol R&D, La Balme Les Grottes, France	Amphia Hospital; Elisabeth-TweeSteden Ziekenhuis (ETZ); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Erasmus University Rotterdam; Erasmus MC; bioMerieux	Verkade, E (corresponding author), Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands.	everkade@amphia.nl		Budding, Andries/0000-0001-5128-5411				Armand-Lefevre L, 2005, EMERG INFECT DIS, V11, P711, DOI 10.3201/eid1105.040866; Bhat M, 2009, EMERG INFECT DIS, V15, P285, DOI 10.3201/eid1502.080609; Budding AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013671; Cuny C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006800; de Neeling AJ, 2007, VET MICROBIOL, V122, P366, DOI 10.1016/j.vetmic.2007.01.027; Diederen BMW, 2006, J INFECTION, V52, P157, DOI 10.1016/j.jinf.2005.09.001; DOLZANI L, 1994, FEMS MICROBIOL LETT, V119, P167, DOI 10.1016/0378-1097(94)90409-X; Ekkelenkamp M B, 2006, Ned Tijdschr Geneeskd, V150, P2442; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Kluytmans-VandenBergh MFQ, 2006, CLIN MICROBIOL INFEC, V12, P9, DOI 10.1111/j.1469-0691.2006.01341.x; Melles DC, 2007, J MICROBIOL METH, V69, P371, DOI 10.1016/j.mimet.2007.01.013; Jimenez JN, 2011, EMERG INFECT DIS, V17, P1970, DOI 10.3201/eid1710.110638; National Committee for Clinical Laboratory Standards, 2006, M100S16 NAT COMM CLI; Price LB, 2012, MBIO, V3, DOI 10.1128/mBio.00305-11; Rasigade JP, 2010, EMERG INFECT DIS, V16, P1330, DOI 10.3201/eid1608.100317; Schmitz FJ, 1998, J MED MICROBIOL, V47, P341, DOI 10.1099/00222615-47-4-341; Schmitz FJ, 1997, ZBL HYG UMWELTMED, V200, P172; Uhlemann AC, 2012, MBIO, V3, DOI 10.1128/mBio.00027-12; Valentin-Domelier AS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028369; van Belkum A, 2008, EMERG INFECT DIS, V14, P479, DOI 10.3201/eid1403.070760; Van Den Broek IVF, 2009, EPIDEMIOL INFECT, V137, P700, DOI 10.1017/S0950268808001507; van der Mee-Marquet N, 2011, CLIN INFECT DIS, V52, P152, DOI 10.1093/cid/ciq053; van Loo I, 2007, EMERG INFECT DIS, V13, P1834, DOI 10.3201/eid1312.070384; van Rijen MML, 2008, CLIN INFECT DIS, V46, P261, DOI 10.1086/524672; van Wamel WJB, 2010, EUR J CLIN MICROBIOL, V29, P119, DOI 10.1007/s10096-009-0816-3; Vandenbroucke-Grauls C M J E, 2006, Ned Tijdschr Geneeskd, V150, P1710; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Waldron DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06; Wassenberg MWM, 2011, CLIN MICROBIOL INFEC, V17, P316, DOI 10.1111/j.1469-0691.2010.03260.x	29	33	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e41855	10.1371/journal.pone.0041855	http://dx.doi.org/10.1371/journal.pone.0041855			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094014	gold, Green Published, Green Submitted			2022-12-25	WOS:000312384500001
J	Zhai, K; Hubert, F; Nicolas, V; Ji, GJ; Fischmeister, R; Leblais, V				Zhai, Kui; Hubert, Fabien; Nicolas, Valerie; Ji, Guangju; Fischmeister, Rodolphe; Leblais, Veronique			beta-Adrenergic cAMP Signals Are Predominantly Regulated by Phosphodiesterase Type 4 in Cultured Adult Rat Aortic Smooth Muscle Cells	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; CYCLIC-AMP; SELECTIVE INHIBITOR; ADENYLYL-CYCLASE; NITRIC-OXIDE; EXPRESSION; CGMP; RELAXATION; RECEPTORS; PATHWAYS	Background: We investigated the role of cyclic nucleotide phosphodiesterases (PDEs) in the spatiotemporal control of intracellular cAMP concentrations in rat aortic smooth muscle cells (RASMCs). Methodology/Principal Findings: The rank order of PDE families contributing to global cAMP-PDE activity was PDE4> PDE3 = PDE1. PDE7 mRNA expression but not activity was confirmed. The Fluorescence Resonance Energy Transfer (FRET)-based cAMP sensor, Epac1-camps, was used to monitor the time course of cytosolic cAMP changes. A pulse application of the beta-adrenoceptor (beta-AR) agonist isoproterenol (Iso) induced a transient FRET signal. Both beta(1)- and beta(2)-AR antagonists decreased the signal amplitude without affecting its kinetics. The non-selective PDE inhibitor (IBMX) dramatically increased the amplitude and delayed the recovery phase of Iso response, in agreement with a role of PDEs in degrading cAMP produced by Iso. Whereas PDE1, PDE3 and PDE7 blockades [with MIMX, cilostamide (Cil) and BRL 50481 (BRL), respectively] had no or minor effect on Iso response, PDE4 inhibition [with Ro-20-1724 (Ro)] strongly increased its amplitude and delayed its recovery. When Ro was applied concomitantly with MIMX or Cil (but not with BRL), the Iso response was drastically further prolonged. PDE4 inhibition similarly prolonged both beta(1)- and beta(2)-AR-mediated responses. When a membrane-targeted FRET sensor was used, PDE3 and PDE4 acted in a synergistic manner to hydrolyze the submembrane cAMP produced either at baseline or after beta-AR stimulation. Conclusion/Significance: Our study underlines the importance of cAMP-PDEs in the dynamic control of intracellular cAMP signals in RASMCs, and demonstrates the prominent role of PDE4 in limiting beta-AR responses. PDE4 inhibition unmasks an effect of PDE1 and PDE3 on cytosolic cAMP hydrolyzis, and acts synergistically with PDE3 inhibition at the submembrane compartment. This suggests that mixed PDE4/PDE1 or PDE4/PDE3 inhibitors would be attractive to potentiate cAMP-related functions in vascular cells.	[Zhai, Kui; Ji, Guangju] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China; [Zhai, Kui; Hubert, Fabien; Fischmeister, Rodolphe; Leblais, Veronique] LabEx LERMIT, Inserm UMR S 769, Chatenay Malabry, France; [Zhai, Kui; Hubert, Fabien; Nicolas, Valerie; Fischmeister, Rodolphe; Leblais, Veronique] Univ Paris 11, Fac Pharm, F-92290 Chatenay Malabry, France; [Nicolas, Valerie] IPSIT IFR141, F-92290 Chatenay Malabry, France	Chinese Academy of Sciences; Institute of Biophysics, CAS; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Ji, GJ (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100080, Peoples R China.	gj28@ibp.ac.cn; veronique.leblais@u-psud.fr	LEBLAIS, Véronique/Q-3845-2018; Fischmeister, Rodolphe/L-6061-2018; Hubert, Fabien/ABE-6866-2021	LEBLAIS, Véronique/0000-0001-9934-8944; Fischmeister, Rodolphe/0000-0003-2086-9865; Hubert, Fabien/0000-0003-1360-4092; Zhai, Kui/0000-0003-4725-190X	University Paris-Sud; "Region Ile de France" (SETCI); National Basic Research Program of China [2011CB8091004, 2009CB918701]	University Paris-Sud; "Region Ile de France" (SETCI)(Region Ile-de-France); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from "University Paris-Sud" (Bonus Attractivite Paris-Sud 2009-2012; http://www.u-psud.fr/fr/la_recherche/les_appels_a_projet.html), "Region Ile de France" (SETCI; http://www.iledefrance.fr/appels-a-projets/recherche-enseignement-sup/clos/cotutelle-internationale/) and "National Basic Research Program of China" (2011CB8091004 and 2009CB918701; http://www.973.gov.cn/English/Index.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boess FG, 2004, NEUROPHARMACOLOGY, V47, P1081, DOI 10.1016/j.neuropharm.2004.07.040; Brawley L, 2000, BRIT J PHARMACOL, V129, P637, DOI 10.1038/sj.bjp.0703091; Castro LRV, 2006, CIRCULATION, V113, P2221, DOI 10.1161/CIRCULATIONAHA.105.599241; Degerman E, 1997, J BIOL CHEM, V272, P6823, DOI 10.1074/jbc.272.11.6823; Delpy E, 1996, BRIT J PHARMACOL, V119, P471, DOI 10.1111/j.1476-5381.1996.tb15696.x; Dunkerley HA, 2002, MOL PHARMACOL, V61, P1033, DOI 10.1124/mol.61.5.1033; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; Goncalves RL, 2009, EUR J PHARMACOL, V620, P78, DOI 10.1016/j.ejphar.2009.08.008; Guimaraes S, 2001, PHARMACOL REV, V53, P319; Hoffmann C, 2004, N-S ARCH PHARMACOL, V369, P151, DOI 10.1007/s00210-003-0860-y; Koyama H, 2001, J CELL PHYSIOL, V186, P1; Leblais V, 2008, CARDIOVASC RES, V77, P202, DOI 10.1093/cvr/cvm008; Leroy J, 2008, CIRC RES, V102, P1091, DOI 10.1161/CIRCRESAHA.107.167817; Liu HG, 2000, J BIOL CHEM, V275, P26615, DOI 10.1074/jbc.M001634200; Maurice DH, 2003, MOL PHARMACOL, V64, P533, DOI 10.1124/mol.64.3.533; MCDANIEL NL, 1994, CAN J PHYSIOL PHARM, V72, P1380, DOI 10.1139/y94-199; Mika D, 2012, J MOL CELL CARDIOL, V52, P323, DOI 10.1016/j.yjmcc.2011.08.016; Nausch LWM, 2008, P NATL ACAD SCI USA, V105, P365, DOI 10.1073/pnas.0710387105; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; Nikolaev VO, 2006, PHYSIOLOGY, V21, P86, DOI 10.1152/physiol.00057.2005; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Orallo F, 2004, N-S ARCH PHARMACOL, V370, P452, DOI 10.1007/s00210-004-0994-6; Ostrom RS, 2002, MOL PHARMACOL, V62, P983, DOI 10.1124/mol.62.5.983; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Palmer D, 2000, MOL PHARMACOL, V58, P247, DOI 10.1124/mol.58.2.247; Phillips PG, 2005, AM J PHYSIOL-LUNG C, V288, pL103, DOI 10.1152/ajplung.00095.2004; Piggott LA, 2006, J GEN PHYSIOL, V128, P3, DOI 10.1085/jgp.200509403; Rautureau Y, 2002, BRIT J PHARMACOL, V137, P153, DOI 10.1038/sj.bjp.0704867; Rich TC, 2001, J GEN PHYSIOL, V118, P63, DOI 10.1085/jgp.118.1.63; Richter W, 2008, EMBO J, V27, P384, DOI 10.1038/sj.emboj.7601968; Rose RJ, 1997, BRIT J PHARMACOL, V122, P233, DOI 10.1038/sj.bjp.0701376; ROVNER AS, 1986, J BIOL CHEM, V261, P4740; Rybalkin SD, 1997, J CLIN INVEST, V100, P2611, DOI 10.1172/JCI119805; Sassi Y, 2008, J CLIN INVEST, V118, P2747, DOI 10.1172/JCI35067; Saucerman JJ, 2006, ANN NY ACAD SCI, V1080, P348, DOI 10.1196/annals.1380.026; Smith SJ, 2004, MOL PHARMACOL, V66, P1679, DOI 10.1124/mol.104.002246; Sudo T, 2000, BIOCHEM PHARMACOL, V59, P347, DOI 10.1016/S0006-2952(99)00346-9; THOMPSON WJ, 1971, J BIOL CHEM, V246, P3145; THYBERG J, 1990, ARTERIOSCLEROSIS, V10, P966, DOI 10.1161/01.ATV.10.6.966; Trochu JN, 1999, BRIT J PHARMACOL, V128, P69, DOI 10.1038/sj.bjp.0702797; Vallot O, 2000, ARTERIOSCL THROM VAS, V20, P1225, DOI 10.1161/01.ATV.20.5.1225; von Hayn K, 2010, AM J PHYSIOL-CELL PH, V298, pC324, DOI 10.1152/ajpcell.00197.2009; Wachten S, 2010, J CELL SCI, V123, P95, DOI 10.1242/jcs.058594; WELLS JN, 1988, METHOD ENZYMOL, V159, P489; Xiang YK, 2011, CIRC RES, V109, P231, DOI 10.1161/CIRCRESAHA.110.231340	46	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47826	10.1371/journal.pone.0047826	http://dx.doi.org/10.1371/journal.pone.0047826			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094097	Green Submitted, Green Published, gold			2022-12-25	WOS:000312384500028
J	Kultima, JR; Sunagawa, S; Li, JH; Chen, WN; Chen, H; Mende, DR; Arumugam, M; Pan, Q; Liu, BH; Qin, JJ; Wang, J; Bork, P				Kultima, Jens Roat; Sunagawa, Shinichi; Li, Junhua; Chen, Weineng; Chen, Hua; Mende, Daniel R.; Arumugam, Manimozhiyan; Pan, Qi; Liu, Binghang; Qin, Junjie; Wang, Jun; Bork, Peer			MOCAT: A Metagenomics Assembly and Gene Prediction Toolkit	PLOS ONE			English	Article							SHORT READ ALIGNMENT; SEQUENCES; RESOURCE; LIFE	MOCAT is a highly configurable, modular pipeline for fast, standardized processing of single or paired-end sequencing data generated by the Illumina platform. The pipeline uses state-of-the-art programs to quality control, map, and assemble reads from metagenomic samples sequenced at a depth of several billion base pairs, and predict protein-coding genes on assembled metagenomes. Mapping against reference databases allows for read extraction or removal, as well as abundance calculations. Relevant statistics for each processing step can be summarized into multi-sheet Excel documents and queryable SQL databases. MOCAT runs on UNIX machines and integrates seamlessly with the SGE and PBS queuing systems, commonly used to process large datasets. The open source code and modular architecture allow users to modify or exchange the programs that are utilized in the various processing steps. Individual processing steps and parameters were benchmarked and tested on artificial, real, and simulated metagenomes resulting in an improvement of selected quality metrics. MOCAT can be freely downloaded at http://www.bork.embl.de/mocat/.	[Kultima, Jens Roat; Sunagawa, Shinichi; Mende, Daniel R.; Arumugam, Manimozhiyan; Bork, Peer] European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany; [Li, Junhua; Chen, Weineng; Chen, Hua; Pan, Qi; Liu, Binghang; Qin, Junjie; Wang, Jun] BGI Shenzhen, Dept Sci & Technol, Shenzhen, Guangdong, Peoples R China; [Li, Junhua] S China Univ Technol, Sch Biosci & Biotechnol, Guangzhou, Guangdong, Peoples R China; [Bork, Peer] Max Delbruck Ctr Mol Med, Berlin, Germany	European Molecular Biology Laboratory (EMBL); Beijing Genomics Institute (BGI); South China University of Technology; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Bork, P (corresponding author), European Mol Biol Lab, Struct & Computat Biol Unit, Heidelberg, Germany.	bork@embl.de	Mende, Daniel R/I-3662-2019; Li, Junhua/AAG-3919-2019; Arumugam, Manimozhiyan/E-1211-2011; Arumugam, Manimozhiyan/AAJ-2394-2020; Sunagawa, Shinichi/Q-5950-2019; Wang, Jun/A-7261-2013; Bork, Peer/F-1813-2013; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Mende, Daniel R/0000-0001-6831-4557; Li, Junhua/0000-0001-6784-1873; Arumugam, Manimozhiyan/0000-0002-0886-9101; Arumugam, Manimozhiyan/0000-0002-0886-9101; Sunagawa, Shinichi/0000-0003-3065-0314; Bork, Peer/0000-0002-2627-833X; liu, bh/0000-0002-4948-2835; Wang, Jun/0000-0002-8540-8931; Wang, Jun/0000-0002-2113-5874	European Community [HEALTH-F4-2007-201052]; International Human Microbiome Standards (IHMS) [HEALTH-F4-2010-261376]; Cancerbiome (ERC Advanced Grant) [268985]	European Community(European Commission); International Human Microbiome Standards (IHMS); Cancerbiome (ERC Advanced Grant)	This work was funded by EMBL, the European Community's Seventh Framework Programme via the MetaHIT (HEALTH-F4-2007-201052), International Human Microbiome Standards (IHMS) (HEALTH-F4-2010-261376), and Cancerbiome (ERC Advanced Grant 268985) grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angiuoli SV, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-356; Arumugam M, 2010, BIOINFORMATICS, V26, P2977, DOI 10.1093/bioinformatics/btq536; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Edgar CRC, 2012, INFECT DIS SOC AM, V54, DOI [10.1093/cid/cir977, DOI 10.1093/CID/CIR977]; Gilbert JA, 2010, STAND GENOMIC SCI, V3, P249, DOI 10.4056/sigs.1433550; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Gonzalez A, 2012, CURR OPIN BIOTECH, V23, P64, DOI 10.1016/j.copbio.2011.11.028; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Huson DH, 2011, GENOME RES, V21, P1552, DOI 10.1101/gr.120618.111; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Karsenti E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001177; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD123, DOI 10.1093/nar/gkr975; Mende DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031386; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Schwartz S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016685; Simpson DA, 2011, J MED GENET, V48, P145, DOI 10.1136/jmg.2010.083568; Sun SL, 2011, NUCLEIC ACIDS RES, V39, pD546, DOI 10.1093/nar/gkq1102; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	26	121	127	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47656	10.1371/journal.pone.0047656	http://dx.doi.org/10.1371/journal.pone.0047656			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082188	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000311146900085
J	Lewis, SEM; Rapino, C; Di Tommaso, M; Pucci, M; Battista, N; Paro, R; Simon, L; Lutton, D; Maccarrone, M				Lewis, Sheena E. M.; Rapino, Cinzia; Di Tommaso, Monia; Pucci, Mariangela; Battista, Natalia; Paro, Rita; Simon, Luke; Lutton, Deborah; Maccarrone, Mauro			Differences in the Endocannabinoid System of Sperm from Fertile and Infertile Men	PLOS ONE			English	Article							ACID AMIDE HYDROLASE; FOLLICLE-STIMULATING-HORMONE; TYPE-1 CANNABINOID RECEPTOR; ACROSOME REACTION; MOLECULAR CHARACTERIZATION; MALE REPRODUCTION; SERTOLI-CELLS; CB2 RECEPTORS; SEA-URCHINS; IN-VIVO	Male infertility is a major cause of problems for many couples in conceiving a child. Recently, lifestyle pastimes such as alcohol, tobacco and marijuana have been shown to have further negative effects on male reproduction. The endocannabinoid system (ECS), mainly through the action of anandamide (AEA) and 2-arachidonoylglycerol (2-AG) at cannabinoid (CB1, CB2) and vanilloid (TRPV1) receptors, plays a crucial role in controlling functionality of sperm, with a clear impact on male reproductive potential. Here, sperm from fertile and infertile men were used to investigate content (through LC-ESI-MS), mRNA (through quantitative RT-PCR), protein (through Western Blotting and ELISA) expression, and functionality (through activity and binding assays) of the main metabolic enzymes of AEA and 2-AG (NAPE-PLD and FAAH, for AEA; DAGL and MAGL for 2-AG), as well as of their binding receptors CB1, CB2 and TRPV1. Our findings show a marked reduction of AEA and 2-AG content in infertile seminal plasma, paralleled by increased degradation: biosynthesis ratios of both substances in sperm from infertile versus fertile men. In addition, TRPV1 binding was detected in fertile sperm but was undetectable in infertile sperm, whereas that of CB1 and CB2 receptors was not statistically different in the two groups. In conclusion, this study identified unprecedented alterations of the ECS in infertile sperm, that might impact on capacitation and acrosome reaction, and hence fertilization outcomes. These alterations might also point to new biomarkers to determine male reproductive defects, and identify distinct ECS elements as novel targets for therapeutic exploitation of ECS-oriented drugs to treat male fertility problems.	[Rapino, Cinzia; Di Tommaso, Monia; Pucci, Mariangela; Battista, Natalia; Maccarrone, Mauro] Univ Teramo, Dept Biomed Sci, Teramo, Italy; [Lewis, Sheena E. M.; Paro, Rita; Simon, Luke] Queens Univ Belfast, Sch Med, Ctr Publ Hlth, Inst Clin Sci, Belfast, Antrim, North Ireland; [Lutton, Deborah] Royal Jubilee Matern Serv, Reg Fertil Ctr, Belfast, Antrim, North Ireland; [Maccarrone, Mauro] IRCCS Santa Lucia Fdn, European Ctr Brain Res CERC, Rome, Italy	University of Teramo; Queens University Belfast; IRCCS Santa Lucia	Maccarrone, M (corresponding author), Univ Teramo, Dept Biomed Sci, Teramo, Italy.	mmaccarrone@unite.it	Maccarrone, Mauro/K-5398-2012; Lewis, Sheena E M/ABI-8338-2020; Battista, Natalia/AAC-2529-2019; Pucci, Mariangela/K-6379-2016	Maccarrone, Mauro/0000-0002-3990-2963; Pucci, Mariangela/0000-0003-4657-6075; Battista, Natalia/0000-0002-1936-6710	Ulster Garden Villages, Northern Ireland; Organon Laboratories; Fondazione TERCAS	Ulster Garden Villages, Northern Ireland; Organon Laboratories; Fondazione TERCAS	This investigation was supported by Ulster Garden Villages, Northern Ireland, and Organon Laboratories (to SEML), and by Fondazione TERCAS (grant 2009-2012 to MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 2008, CHEM REV, V108, P1687, DOI 10.1021/cr0782067; Bari M, 2006, MINI-REV MED CHEM, V6, P257, DOI 10.2174/138955706776073466; Bari M, 2011, FRONT BIOSCI-LANDMRK, V16, P498, DOI 10.2741/3701; Bari M, 2011, STEM CELLS DEV, V20, P139, DOI 10.1089/scd.2009.0515; Barratt CLR, 2010, HUM REPROD, V25, P824, DOI 10.1093/humrep/dep465; Battista N, 2008, J NEUROENDOCRINOL, V20, P82, DOI 10.1111/j.1365-2826.2008.01684.x; Battista N, 2012, MOL CELL ENDOCRINOL, V355, P1, DOI 10.1016/j.mce.2012.01.014; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Buffone MG, 2012, MOL REPROD DEV, V79, P4, DOI 10.1002/mrd.21393; Cacciola G, 2008, BIOL REPROD, V79, P758, DOI 10.1095/biolreprod.108.070128; Cacciola G, 2008, MOL CELL ENDOCRINOL, V286, pS24, DOI 10.1016/j.mce.2008.01.004; Catanzaro G, 2011, MOL CELL ENDOCRINOL, V343, P88, DOI 10.1016/j.mce.2011.01.022; CHANG MC, 1993, MOL REPROD DEV, V36, P507, DOI 10.1002/mrd.1080360416; Cobellis G, 2006, BIOL REPROD, V75, P82, DOI 10.1095/biolreprod.106.051730; Cobellis G, 2010, BIOL REPROD, V82, P451, DOI 10.1095/biolreprod.109.079210; Colombo G, 2009, J MOL NEUROSCI, V37, P111, DOI 10.1007/s12031-008-9114-2; Di Marzo V, 2008, REV PHYSIOL BIOCH P, V160, P1, DOI 10.1007/112_0505; Di Marzo V, 2010, CURR MED CHEM, V17, P1430; Dinh TP, 2002, CHEM PHYS LIPIDS, V121, P149, DOI 10.1016/S0009-3084(02)00150-0; El-Talatini MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004579; Fasano S, 2009, ANN NY ACAD SCI, V1163, P112, DOI 10.1111/j.1749-6632.2009.04437.x; Fezza F, 2005, ANAL BIOCHEM, V339, P113, DOI 10.1016/j.ab.2004.12.005; Francavilla F, 2009, ENDOCRINOLOGY, V150, P4692, DOI 10.1210/en.2009-0057; Gasperi V, 2007, CELL MOL LIFE SCI, V64, P219, DOI 10.1007/s00018-006-6445-4; Giuffrida A, 2000, EUR J PHARMACOL, V408, P161, DOI 10.1016/S0014-2999(00)00786-X; Giwercman A, 2010, INT J ANDROL, V33, pE221, DOI 10.1111/j.1365-2605.2009.00995.x; Glanemann C, 2003, APPL MICROBIOL BIOT, V61, P61, DOI 10.1007/s00253-002-1191-5; Gervasi MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016993; Gervasi MG, 2009, REPRODUCTION, V137, P403, DOI 10.1530/REP-08-0204; Grimaldi P, 2009, P NATL ACAD SCI USA, V106, P11131, DOI 10.1073/pnas.0812789106; Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005; Gye MC, 2005, ARCH ANDROLOGY, V51, P247, DOI 10.1080/014850190898845; Habayeb OMH, 2008, JAMA-J AM MED ASSOC, V299, P1135, DOI 10.1001/jama.299.10.1135; Hall W, 1998, LANCET, V352, P1611, DOI 10.1016/S0140-6736(98)05021-1; HERKENHAM M, 1991, J NEUROSCI, V11, P563, DOI 10.1523/jneurosci.11-02-00563.1991; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Howlett AC, 2010, CURR MED CHEM, V17, P1382, DOI 10.2174/092986710790980023; Kaczocha M, 2009, P NATL ACAD SCI USA, V106, P6375, DOI 10.1073/pnas.0901515106; KRUGER TF, 1987, UROLOGY, V30, P248, DOI 10.1016/0090-4295(87)90246-9; Lauckner JE, 2008, P NATL ACAD SCI USA, V105, P2699, DOI 10.1073/pnas.0711278105; Lefievre L, 2007, REPRODUCTION, V133, P675, DOI 10.1530/REP-06-0332; Lewis SEM, 2012, INT J ANDROL, V35, P731, DOI 10.1111/j.1365-2605.2012.01259.x; Lewis SE, 2009, PHARMACOL RES, V60, P126, DOI 10.1016/j.phrs.2009.02.009; Lewis SEM, 2007, REPRODUCTION, V134, P31, DOI 10.1530/REP-07-0152; LINDEMANN CB, 1989, ARCH ANDROLOGY, V23, P1, DOI 10.3109/01485018908986783; LIST A, 1977, DRUG METAB DISPOS, V5, P268; Maccarrone M, 2008, BRIT J PHARMACOL, V153, P189, DOI 10.1038/sj.bjp.0707444; Maccarrone M, 2005, J CELL SCI, V118, P4393, DOI 10.1242/jcs.02536; Maccarrone M, 2003, ENDOCRINOLOGY, V144, P20, DOI 10.1210/en.2002-220544; Maccarrone M, 2002, PROSTAG LEUKOTR ESS, V66, P309, DOI 10.1054/plef.2001.0354; Maccarrone M, 2010, TRENDS BIOCHEM SCI, V35, P601, DOI 10.1016/j.tibs.2010.05.008; Matias I, 2006, INT J OBESITY, V30, pS7, DOI 10.1038/sj.ijo.0803271; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Moriconi A, 2010, CURR MED CHEM, V17, P1411, DOI 10.2174/092986710790980069; Muccioli GG, 2010, DRUG DISCOV TODAY, V15, P474, DOI 10.1016/j.drudis.2010.03.007; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Pasquariello N, 2009, J BIOL CHEM, V284, P29413, DOI 10.1074/jbc.M109.044412; Pertwee RG, 2010, CURR MED CHEM, V17, P1360, DOI 10.2174/092986710790980050; Pierantoni R, 2009, VITAM HORM, V81, P367, DOI 10.1016/S0083-6729(09)81014-5; Ricci G, 2007, GEN COMP ENDOCR, V153, P320, DOI 10.1016/j.ygcen.2007.02.003; Rossato M, 2005, J CLIN ENDOCR METAB, V90, P984, DOI 10.1210/jc.2004-1287; Rossato M, 2008, MOL CELL ENDOCRINOL, V286, pS31, DOI 10.1016/j.mce.2008.02.013; Rossi G, 2007, ENDOCRINOLOGY, V148, P1431, DOI 10.1210/en.2006-0969; Sadeu JC, 2010, CRIT REV TOXICOL, V40, P633, DOI 10.3109/10408444.2010.493552; Schuel H, 2005, BIOL REPROD, V73, P1078, DOI 10.1095/biolreprod.105.043273; Schuel H, 2002, CHEM PHYS LIPIDS, V121, P211, DOI 10.1016/S0009-3084(02)00158-5; SCHUEL H, 1994, P NATL ACAD SCI USA, V91, P7678, DOI 10.1073/pnas.91.16.7678; Schuel H, 2002, MOL REPROD DEV, V63, P376, DOI 10.1002/mrd.90021; SCHUEL H, 1991, PHARMACOL BIOCHEM BE, V40, P609, DOI 10.1016/0091-3057(91)90371-8; Shukla KK, 2012, J ANDROL, V33, P777, DOI 10.2164/jandrol.111.015552; Tambaro S, 2005, EUR J PHARMACOL, V525, P150, DOI 10.1016/j.ejphar.2005.09.058; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Viscomi MT, 2009, J NEUROSCI, V29, P4564, DOI 10.1523/JNEUROSCI.0786-09.2009; Wang HB, 2006, ENDOCR REV, V27, P427, DOI 10.1210/er.2006-0006; Wenger T, 2001, BIOCHEM BIOPH RES CO, V284, P363, DOI 10.1006/bbrc.2001.4977; Whan LB, 2006, FERTIL STERIL, V85, P653, DOI 10.1016/j.fertnstert.2005.08.027; World Health Organization, 2010, WHO LAB MAN EX HUM S; World Health Organization (WHO), 1999, WHO LAB MANUAL EXAMI, V4th; Yanagimachi R, 1988, PHYSL REPROD, V1; Yates ML, 2009, VITAM HORM, V81, P25, DOI 10.1016/S0083-6729(09)81002-9	81	58	60	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47704	10.1371/journal.pone.0047704	http://dx.doi.org/10.1371/journal.pone.0047704			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082196	gold, Green Published			2022-12-25	WOS:000311146900093
J	Randhawa, V; Thakkar, M; Wei, LP				Randhawa, Varunpreet; Thakkar, Megha; Wei, Liping			Applicability of Hydrogen Peroxide in Brown Tide Control - Culture and Microcosm Studies	PLOS ONE			English	Article							HARMFUL ALGAL BLOOMS; AUREOCOCCUS-ANOPHAGEFFERENS; MICROCYSTIN-LR; PHOTOCATALYTIC OXIDATION; TEMPORAL VARIABILITY; NORTH-CAROLINA; KINETIC-MODEL; COASTAL BAYS; PHYTOPLANKTON; TOXICITY	Brown tide algal blooms, caused by the excessive growth of Aureococcus anophagefferens, recur in several northeastern US coastal bays. Direct bloom control could alleviate the ecological and economic damage associated with bloom outbreak. This paper explored the effectiveness and safety of natural chemical biocide hydrogen peroxide (H2O2) for brown tide bloom control. Culture studies showed that H2O2 at 1.6 mg L-1 effectively eradicated high density A. anophagefferens within 24-hr, but caused no significant growth inhibition in the diatoms, prymnesiophytes, green algae and dinoflagellates of >2-3 mu m cell sizes among 12 phytoplankton species tested over 1-week observation. When applied to brown tide bloom prone natural seawater in a microcosm study, this treatment effectively removed the developing brown tide bloom, while the rest of phytoplankton assemblage (quantified via HPLC based marker pigment analyses), particularly the diatoms and green algae, experienced only transient suppression then recovered with total chlorophyll a exceeding that in the controls within 72-hr; cyanobacteria was not eradicated but was still reduced about 50% at 72-hr, as compared to the controls. The action of H2O2 against phytoplankton as a function of cell size and cell wall structure, and a realistic scenario of H2O2 application were discussed.	[Randhawa, Varunpreet; Thakkar, Megha; Wei, Liping] New Jersey Inst Technol, Dept Chem & Environm Sci, Newark, NJ 07102 USA	New Jersey Institute of Technology	Wei, LP (corresponding author), New Jersey Inst Technol, Dept Chem & Environm Sci, Newark, NJ 07102 USA.	liping.wei@njit.edu	Thakkar, Megha/X-3006-2019; wei, li/GSD-3630-2022; Randhawa, Varunpreet/AAA-4303-2020; 黎, 伟/GXM-4040-2022	Thakkar, Megha/0000-0002-9094-5723; 				Ahner BA, 2002, MAR ECOL PROG SER, V232, P93, DOI 10.3354/meps232093; Andersen RA, 1996, DEEP-SEA RES PT II, V43, P517, DOI 10.1016/0967-0645(95)00095-X; Anderson DM, 1997, NATURE, V388, P513, DOI 10.1038/41415; Anderson DM, 2009, OCEAN COAST MANAGE, V52, P342, DOI 10.1016/j.ocecoaman.2009.04.006; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Avery GB, 2005, MAR CHEM, V97, P236, DOI 10.1016/j.marchem.2005.03.006; BALDRY MGC, 1983, J APPL BACTERIOL, V54, P417, DOI 10.1111/j.1365-2672.1983.tb02637.x; Bandala ER, 2004, TOXICON, V43, P829, DOI 10.1016/j.toxicon.2004.03.013; Barrington DJ, 2011, J ENVIRON ENG, V137, P952, DOI 10.1061/(ASCE)EE.1943-7870.0000401; Barrington DJ, 2008, ENVIRON SCI TECHNOL, V42, P8916, DOI 10.1021/es801717y; BARROIN G, 1986, WATER RES, V20, P619, DOI 10.1016/0043-1354(86)90026-6; Boesch DF, 1997, DICISION ANAL SERIES, V10, P1; Boettcher AA, 1997, AQUACULTURE, V148, P247, DOI 10.1016/S0044-8486(96)01421-4; Breuer E, 1999, ESTUARIES, V22, P603, DOI 10.2307/1353048; Bricelj VM, 1997, LIMNOL OCEANOGR, V42, P1023, DOI 10.4319/lo.1997.42.5_part_2.1023; Busenberg E, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2010GC003312; Clark CD, 2010, WATER RES, V44, P2203, DOI 10.1016/j.watres.2009.12.044; COOPER WJ, 1994, ADV CHEM SER, V237, P391; Cornish BJPA, 2000, APPL CATAL B-ENVIRON, V25, P59, DOI 10.1016/S0926-3373(99)00121-6; Crittenden JC, 1999, WATER RES, V33, P2315, DOI 10.1016/S0043-1354(98)00448-5; DeLuca MJ, 2003, WATER RESOURCES DATA; Drabkova M, 2007, PHOTOSYNTHETICA, V45, P363, DOI 10.1007/s11099-007-0062-9; Drabkova M, 2007, ENVIRON SCI TECHNOL, V41, P309, DOI 10.1021/es060746i; Fenton H., 1894, J CHEM SOC T, V65, P899, DOI [10.1039/CT8946500899, DOI 10.1039/CT8946500899]; Gaikowski MP, 1999, AQUACULTURE, V178, P191, DOI 10.1016/S0044-8486(99)00123-4; GARCIAMENDOZA A, 1993, MICROB ECOL HEALTH D, V6, P17, DOI 10.3109/08910609309141557; GARCIAPICHEL F, 1993, APPL ENVIRON MICROB, V59, P163, DOI 10.1128/AEM.59.1.163-169.1993; Gastrich MD, 2004, HARMFUL ALGAE, V3, P305, DOI 10.1016/j.hal.2004.06.003; Gelabert A, 2004, GEOCHIM COSMOCHIM AC, V68, P4039, DOI 10.1016/j.gca.2004.01.011; Gobler CJ, 2011, P NATL ACAD SCI USA, V108, P4352, DOI 10.1073/pnas.1016106108; Gobler CJ, 2005, ESTUARIES, V28, P726, DOI 10.1007/BF02732911; Gobler CJ, 2002, MAR CHEM, V77, P71, DOI 10.1016/S0304-4203(01)00076-7; Hakkinen PJ, 2004, CAN J FISH AQUAT SCI, V61, P1520, DOI 10.1139/F04-098; HALLEGRAEFF GM, 1993, PHYCOLOGIA, V32, P79, DOI 10.2216/i0031-8884-32-2-79.1; HECKY RE, 1973, MAR BIOL, V19, P323, DOI 10.1007/BF00348902; HOSSAIN MA, 1984, PLANT CELL PHYSIOL, V25, P1285; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Jeong HJ, 2002, PHYCOLOGIA, V41, P643, DOI 10.2216/i0031-8884-41-6-643.1; KAY SH, 1984, J AQUAT PLANT MANAGE, V22, P25; Levy JL, 2007, SCI TOTAL ENVIRON, V387, P141, DOI 10.1016/j.scitotenv.2007.07.016; Liu CP, 2001, BOT BULL ACAD SINICA, V42, P207; Liu I, 2003, ENVIRON SCI TECHNOL, V37, P3214, DOI 10.1021/es0201855; Lu CP, 2011, J AGR FOOD CHEM, V59, P11403, DOI 10.1021/jf202874r; Matthijs HCP, 2012, WATER RES, V46, P1460, DOI 10.1016/j.watres.2011.11.016; Meinertz JR, 2008, SCI TOTAL ENVIRON, V392, P225, DOI 10.1016/j.scitotenv.2007.12.015; MILLER WL, 1995, MAR CHEM, V50, P63, DOI 10.1016/0304-4203(95)00027-O; MOFFETT JW, 1990, LIMNOL OCEANOGR, V35, P1221, DOI 10.4319/lo.1990.35.6.1221; MSDEP, 2010, HYDR PER PER AC SOD; Mullaugh KM, 2011, ENVIRON SCI TECHNOL, V45, P9538, DOI 10.1021/es202634s; Neale PJ, 1998, J PHYCOL, V34, P928, DOI 10.1046/j.1529-8817.1998.340928.x; Nicholson RS, 2003, REV SELECTED REFEREN; Noctor G, 2000, PHILOS T R SOC B, V355, P1465, DOI 10.1098/rstb.2000.0707; NYSDEC, 2005, SYN REV TECHN INF RE; O'Sullivan DW, 2005, MAR CHEM, V97, P14, DOI 10.1016/j.marchem.2005.04.003; Olsen PS, 2001, J COASTAL RES, V32, P115; PALENIK B, 1988, LIMNOL OCEANOGR, V33, P1606, DOI 10.4319/lo.1988.33.6_part_2.1606; Pan G, 2006, ENVIRON POLLUT, V141, P206, DOI 10.1016/j.envpol.2005.08.047; Penna TCV, 2001, BMC INFECT DIS, V1, DOI 10.1186/1471-2334-1-16; Petasne RG, 1997, MAR CHEM, V56, P215, DOI 10.1016/S0304-4203(96)00072-2; PRICE N M, 1988, Biological Oceanography, V6, P443; RAVIKUMAR JX, 1994, ENVIRON SCI TECHNOL, V28, P394, DOI 10.1021/es00052a009; Schmidt L.J., 2006, ENV ASSESSMENT USE H; Schrader KK, 1998, AQUACULTURE, V163, P85, DOI 10.1016/S0044-8486(98)00223-3; Sengco MR, 2004, J EUKARYOT MICROBIOL, V51, P169, DOI 10.1111/j.1550-7408.2004.tb00541.x; Shaked Y, 2005, LIMNOL OCEANOGR, V50, P872, DOI 10.4319/lo.2005.50.3.0872; SIEBURTH JM, 1988, J PHYCOL, V24, P416, DOI 10.1111/j.1529-8817.1988.tb00192.x; Srisapoom S, 1999, ACUTE TOXICITY HYDRO, P107; Steigenberger S, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032555; Sym Stuart D., 1993, Progress in Phycological Research, V9, P281; TESTER PA, 1995, MAR ECOL PROG SER, V124, P237, DOI 10.3354/meps124237; Tomas CR, 1997, IDENTIFYING MARINE P; Trice TM, 2004, HARMFUL ALGAE, V3, P295, DOI 10.1016/j.hal.2004.06.010; Van Heukelem L, 2001, J CHROMATOGR A, V910, P31, DOI 10.1016/S0378-4347(00)00603-4; WALLING C, 1975, ACCOUNTS CHEM RES, V8, P125, DOI 10.1021/ar50088a003; Weinbauer MG, 1999, AQUAT MICROB ECOL, V18, P217, DOI 10.3354/ame018217; WOLFE RL, 1989, APPL ENVIRON MICROB, V55, P2230, DOI 10.1128/AEM.55.9.2230-2241.1989; Wolfe-Simon F, 2005, J PHYCOL, V41, P453, DOI 10.1111/j.1529-8817.2005.00086.x; WU JF, 1995, MAR CHEM, V50, P159, DOI 10.1016/0304-4203(95)00033-N; Xenopoulos MA, 1997, PHOTOCHEM PHOTOBIOL, V66, P471, DOI 10.1111/j.1751-1097.1997.tb03175.x; Yuan JC, 2001, DEEP-SEA RES PT II, V48, P2947, DOI 10.1016/S0967-0645(01)00026-1; Zhang XJ, 2008, CHIN J OCEANOL LIMN, V26, P238, DOI 10.1007/s00343-008-0238-6; Zhu CJ, 1997, J APPL PHYCOL, V9, P189, DOI 10.1023/A:1007914806640	82	15	19	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47844	10.1371/journal.pone.0047844	http://dx.doi.org/10.1371/journal.pone.0047844			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082223	Green Published, gold, Green Submitted			2022-12-25	WOS:000311146900120
J	Whiteside, MD; Garcia, MO; Treseder, KK				Whiteside, Matthew D.; Garcia, Maria O.; Treseder, Kathleen K.			Amino Acid Uptake in Arbuscular Mycorrhizal Plants	PLOS ONE			English	Article							ORGANIC NITROGEN; FUNGI; TRANSPORT; HYPHAE; SOIL; DECOMPOSITION; ASSOCIATIONS; DEPLETION; NITRATE	We examined the extent to which arbuscular mycorrhizal (AM) fungi root improved the acquisition of simple organic nitrogen (ON) compounds by their host plants. In a greenhouse-based study, we used quantum dots (fluorescent nanoparticles) to assess uptake of each of the 20 proteinaceous amino acids by AM-colonized versus uncolonized plants. We found that AM colonization increased uptake of phenylalanine, lysine, asparagine, arginine, histidine, methionine, tryptophan, and cysteine; and reduced uptake of aspartic acid. Arbuscular mycorrhizal colonization had the greatest effect on uptake of amino acids that are relatively rare in proteins. In addition, AM fungi facilitated uptake of neutral and positively-charged amino acids more than negatively-charged amino acids. Overall, the AM fungi used in this study appeared to improve access by plants to a number of amino acids, but not necessarily those that are common or negatively-charged.	[Treseder, Kathleen K.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA; [Garcia, Maria O.] Oregon State Univ, Corvallis, OR 97331 USA; [Whiteside, Matthew D.] Univ British Columbia Okanagan, Dept Biol, Kelowna, BC, Canada; [Whiteside, Matthew D.] Univ British Columbia Okanagan, Inst Species Risk & Habitat Studies, Kelowna, BC, Canada	University of California System; University of California Irvine; Oregon State University; University of British Columbia; University of British Columbia Okanagan; University of British Columbia; University of British Columbia Okanagan	Treseder, KK (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.	Treseder@uci.edu	Treseder, Kathleen K/E-5148-2011	Treseder, Kathleen K/0000-0003-2847-6935	National Science Foundation Ecosystems Panel [DEB 1144888]	National Science Foundation Ecosystems Panel	This study was funded by the National Science Foundation Ecosystems Panel (DEB 1144888). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkan N, 2009, MOL PLANT MICROBE IN, V22, P1484, DOI 10.1094/MPMI-22-12-1484; AMES RN, 1983, NEW PHYTOL, V95, P381, DOI 10.1111/j.1469-8137.1983.tb03506.x; Bago B, 1996, NEW PHYTOL, V133, P273, DOI 10.1111/j.1469-8137.1996.tb01894.x; Cappellazzo G, 2008, PLANT PHYSIOL, V147, P429, DOI 10.1104/pp.108.117820; Govindarajulu M, 2005, NATURE, V435, P819, DOI 10.1038/nature03610; Hawkins HJ, 2000, PLANT SOIL, V226, P275, DOI 10.1023/A:1026500810385; HEGGO A, 1990, SOIL BIOL BIOCHEM, V22, P865, DOI 10.1016/0038-0717(90)90169-Z; Hodge A, 2001, NEW PHYTOL, V151, P725, DOI 10.1046/j.0028-646x.2001.00200.x; Hodge A, 2001, NATURE, V413, P297, DOI 10.1038/35095041; Hodge A, 2010, P NATL ACAD SCI USA, V107, P13754, DOI 10.1073/pnas.1005874107; Johnson NC, 1997, NEW PHYTOL, V135, P575, DOI 10.1046/j.1469-8137.1997.00729.x; JONES DL, 1994, PLANT SOIL, V163, P1; Leigh J, 2009, NEW PHYTOL, V181, P199, DOI 10.1111/j.1469-8137.2008.02630.x; LI XL, 1991, NEW PHYTOL, V119, P397, DOI 10.1111/j.1469-8137.1991.tb00039.x; Meharg AA, 2003, MYCOL RES, V107, P1253, DOI 10.1017/S0953756203008608; MOSSE B, 1971, J GEN MICROBIOL, V69, P157, DOI 10.1099/00221287-69-2-157; Nasholm T, 2009, NEW PHYTOL, V182, P31, DOI 10.1111/j.1469-8137.2008.02751.x; Paterson E, 2009, NEW PHYTOL, V184, P19, DOI 10.1111/j.1469-8137.2009.03001.x; Paungfoo-Lonhienne C, 2008, P NATL ACAD SCI USA, V105, P4524, DOI 10.1073/pnas.0712078105; Requena N, 2007, PHYTOCHEMISTRY, V68, P33, DOI 10.1016/j.phytochem.2006.09.036; Rufyikiri G, 2003, NEW PHYTOL, V158, P391, DOI 10.1046/j.1469-8137.2003.00747.x; Schnitzer M, 1986, T 13 C INT SOIL SCI, V3, P473; Seastedt TR, 2008, FRONT ECOL ENVIRON, V6, P547, DOI 10.1890/070046; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Talbot JM, 2010, PEDOBIOLOGIA, V53, P169, DOI 10.1016/j.pedobi.2009.12.001; Tanaka Y, 2005, PLANT CELL ENVIRON, V28, P1247, DOI 10.1111/j.1365-3040.2005.01360.x; TOBAR R, 1994, NEW PHYTOL, V126, P119, DOI 10.1111/j.1469-8137.1994.tb07536.x; Webb MR, 2003, STRUCTURE, V11, P736, DOI 10.1016/S0969-2126(03)00129-1; Whiteside MD, 2012, SOIL BIOL BIOCHEM, V55, P7, DOI 10.1016/j.soilbio.2012.06.001; Whiteside MD, 2009, ECOLOGY, V90, P100, DOI 10.1890/07-2115.1	30	63	67	0	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47643	10.1371/journal.pone.0047643	http://dx.doi.org/10.1371/journal.pone.0047643			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23094070	Green Published, gold			2022-12-25	WOS:000311146900082
J	Xia, HY; Cao, Y; Dai, XM; Marelja, Z; Zhou, D; Mo, R; Al-Mahdawi, S; Pook, MA; Leimkuehler, S; Rouault, TA; Li, KY				Xia, Haiyan; Cao, Yun; Dai, Xiaoman; Marelja, Zvonimir; Zhou, Di; Mo, Ran; Al-Mahdawi, Sahar; Pook, Mark A.; Leimkuehler, Silke; Rouault, Tracey A.; Li, Kuanyu			Novel Frataxin Isoforms May Contribute to the Pathological Mechanism of Friedreich Ataxia	PLOS ONE			English	Article							IN-VIVO; EXTRAMITOCHONDRIAL FRATAXIN; CLUSTER BIOGENESIS; REPEAT EXPANSION; IRON HOMEOSTASIS; SCAFFOLD PROTEIN; MOUSE MODEL; CELLS; COMPLEX; GENE	Friedreich ataxia (FRDA) is an inherited neurodegenerative disease caused by frataxin (FXN) deficiency. The nervous system and heart are the most severely affected tissues. However, highly mitochondria-dependent tissues, such as kidney and liver, are not obviously affected, although the abundance of FXN is normally high in these tissues. In this study we have revealed two novel FXN isoforms (II and III), which are specifically expressed in affected cerebellum and heart tissues, respectively, and are functional in vitro and in vivo. Increasing the abundance of the heart-specific isoform III significantly increased the mitochondrial aconitase activity, while over-expression of the cerebellum-specific isoform II protected against oxidative damage of Fe-S cluster-containing aconitase. Further, we observed that the protein level of isoform III decreased in FRDA patient heart, while the mRNA level of isoform II decreased more in FRDA patient cerebellum compared to total FXN mRNA. Our novel findings are highly relevant to understanding the mechanism of tissue-specific pathology in FRDA.	[Xia, Haiyan; Cao, Yun; Dai, Xiaoman; Zhou, Di; Mo, Ran; Li, Kuanyu] Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China; [Xia, Haiyan; Li, Kuanyu] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing, Jiangsu, Peoples R China; [Marelja, Zvonimir; Leimkuehler, Silke] Univ Potsdam, Inst Biochem & Biol, Potsdam, Germany; [Al-Mahdawi, Sahar; Pook, Mark A.] Brunel Univ, Sch Hlth Sci & Social Care, Div Biosci, Uxbridge UB8 3PH, Middx, England; [Rouault, Tracey A.] NICHHD, Program Mol Med, Bethesda, MD 20892 USA	Nanjing University; Nanjing University; University of Potsdam; Brunel University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Li, KY (corresponding author), Nanjing Univ, Sch Med, Jiangsu Key Lab Mol Med, Nanjing, Jiangsu, Peoples R China.	likuanyu@nju.edu.cn	Marelja, Zvonimir/AAL-3557-2020; Li, Kuanyu/AAL-2051-2020	Leimkuhler, Silke/0000-0003-3238-2122; Marelja, Zvonimir/0000-0002-3702-7528	National Institute of Child Health and Human Development, National Institutes of Health; Friedreich ataxia research association; National Nature Science Foundation of China (NSFC) [31071085]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry; State Key Laboratory of Pharmaceutical Biotechnology [ZZYJ-SN-201006]; Studienstiftung des Deutschen Volkes; Deutscher Akademischer Austauschdienst scholarship; Deutsche Forschungsgemeinschaft [SL1171/5-3]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008814] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Friedreich ataxia research association; National Nature Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); State Key Laboratory of Pharmaceutical Biotechnology; Studienstiftung des Deutschen Volkes; Deutscher Akademischer Austauschdienst scholarship(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the intramural program of the National Institute of Child Health and Human Development, National Institutes of Health, and in part by Friedreich ataxia research association; by the National Nature Science Foundation of China (NSFC) (No. 31071085), by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, and by State Key Laboratory of Pharmaceutical Biotechnology (No. ZZYJ-SN-201006). Zvonimir Marelja was supported by a grant from the Studienstiftung des Deutschen Volkes and by Deutscher Akademischer Austauschdienst scholarship. Additional support was obtained from the Deutsche Forschungsgemeinschaft Grant SL1171/5-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaviva F, 2005, J CELL SCI, V118, P3917, DOI 10.1242/jcs.02516; Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Boehm T, 2011, NEUROL SCI, V32, P327, DOI 10.1007/s10072-010-0326-1; Bradley JL, 2000, HUM MOL GENET, V9, P275, DOI 10.1093/hmg/9.2.275; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Campuzano V, 1997, HUM MOL GENET, V6, P1771, DOI 10.1093/hmg/6.11.1771; Condo I, 2007, HUM MOL GENET, V16, P1534, DOI 10.1093/hmg/ddm102; Condo I, 2006, J BIOL CHEM, V281, P16750, DOI 10.1074/jbc.M511960200; Condo I, 2010, HUM MOL GENET, V19, P1221, DOI 10.1093/hmg/ddp592; Coppola G, 2011, ANN NEUROL, V70, P790, DOI 10.1002/ana.22526; Gakh O, 2010, J BIOL CHEM, V285, P38486, DOI 10.1074/jbc.M110.145144; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Huang J, 2008, J BIOL INORG CHEM, V13, P825, DOI 10.1007/s00775-008-0369-4; Koeppen AH, 2011, J NEUROL SCI, V303, P1, DOI 10.1016/j.jns.2011.01.010; Kumari D, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-2; Land T, 1998, MOL CELL, V2, P807, DOI 10.1016/S1097-2765(00)80295-6; Lauhon CT, 2000, J BIOL CHEM, V275, P20096, DOI 10.1074/jbc.M002680200; Li KY, 2008, HUM MOL GENET, V17, P2265, DOI 10.1093/hmg/ddn127; Li KY, 2006, J BIOL CHEM, V281, P12344, DOI 10.1074/jbc.M600582200; Marelja Z, 2008, J BIOL CHEM, V283, P25178, DOI 10.1074/jbc.M804064200; Marmolino D, 2011, BRAIN RES REV, V67, P311, DOI 10.1016/j.brainresrev.2011.04.001; Marobbio CMT, 2012, MITOCHONDRION, V12, P156, DOI 10.1016/j.mito.2011.07.001; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Michael S, 2006, CEREBELLUM, V5, P257, DOI 10.1080/14734220600913246; Nachbauer W, 2011, MOVEMENT DISORD, V26, P1935, DOI 10.1002/mds.23789; Navarro JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021017; Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3; Pennell DJ, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-45; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Rai M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008825; Ristow M, 2000, P NATL ACAD SCI USA, V97, P12239, DOI 10.1073/pnas.220403797; Rotig A, 1997, NAT GENET, V17, P215, DOI 10.1038/ng1097-215; Schmucker S, 2008, HUM MOL GENET, V17, P3521, DOI 10.1093/hmg/ddn244; Schmucker S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016199; Selak MA, 2011, MITOCHONDRION, V11, P342, DOI 10.1016/j.mito.2010.12.003; Shan YX, 2007, HUM MOL GENET, V16, P929, DOI 10.1093/hmg/ddm038; Stemmler TL, 2010, J BIOL CHEM, V285, P26737, DOI 10.1074/jbc.R110.118679; Tong WH, 2000, EMBO J, V19, P5692, DOI 10.1093/emboj/19.21.5692; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; Velasco-Sanchez D, 2011, CEREBELLUM, V10, P1, DOI 10.1007/s12311-010-0212-7; Yoon T, 2007, J BIOL INORG CHEM, V12, P535, DOI 10.1007/s00775-007-0205-2	44	34	36	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47847	10.1371/journal.pone.0047847	http://dx.doi.org/10.1371/journal.pone.0047847			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082224	gold, Green Submitted, Green Published			2022-12-25	WOS:000311146900121
J	Li, N; Du, ZX; Zong, ZH; Liu, BQ; Li, C; Zhang, Q; Wang, HQ				Li, N.; Du, Z-X; Zong, Z-H; Liu, B-Q; Li, C.; Zhang, Q.; Wang, H-Q			PKC delta-mediated phosphorylation of BAG3 at Ser187 site induces epithelial - mesenchymal transition and enhances invasiveness in thyroid cancer FRO cells	ONCOGENE			English	Article						BAG3; PKC delta; EMT; invasion	PROTEIN-KINASE-C; ACTIVATION MECHANISMS; QUALITY CONTROL; PHORBOL ESTER; BETA-CATENIN; APOPTOSIS; EXPRESSION; MIGRATION; PATHWAY; STRESS	Protein kinase C delta (PKC delta) is a serine (Ser)/threonine kinase, which regulates numerous cellular processes, including proliferation, differentiation, migration and apoptosis. In the current study, Chinese hamster ovary cells were transfected with either a constitutively activated PKCd or a dominant negative PKC delta, phosphoprotein enrichment, two-dimensional difference gel electrophoresis and mass spectrometry was combined to globally identified candidates of PKC delta cascade. We found that Bcl-2 associated athanogene 3 (BAG3) was one of the targets of PKC delta cascade, and BAG3 interacted with PKC delta in vivo. In addition, we clarified that BAG3 was phosphorylate at Ser187 site in a PKC delta-dependent manner in vivo. BAG3 has been implicated in multiple cellular functions, including proliferation, differentiation, apoptosis, migration, invasion, macroautophagy and so on. We generated wild-type (WT)-, Ser187Ala (S187A)- or Ser187Asp (S187D)-BAG3 stably expressing FRO cells, and noticed that phosphorylation state of BAG3 influenced FRO morphology. Finally, for the first time, we showed that BAG3 was implicated in epithelial - mesenchymal transition (EMT) procedure, and phosphorylation state at Ser187 site had a critical role in EMT regulation by BAG3. Collectively, the current study indicates that BAG3 is a novel substrate of PKC delta, and PKC delta-mediated phosphorylation of BAG3 is implicated in EMT and invasiveness of thyroid cancer cells.	[Li, N.; Zong, Z-H; Liu, B-Q; Li, C.; Zhang, Q.; Wang, H-Q] China Med Univ, Dept Biochem & Mol Biol, Shenyang 110001, Liaoning, Peoples R China; [Li, N.; Wang, H-Q] China Med Univ, Minist Publ Hlth, Key Lab Cell Biol, Shenyang 110001, Liaoning, Peoples R China; [Li, N.; Wang, H-Q] China Med Univ, Minist Educ, Key Lab Med Cell Biol, Shenyang 110001, Liaoning, Peoples R China; [Du, Z-X] China Med Univ, Affiliated Hosp 1, Dept Endocrinol & Metab, Shenyang 110001, Liaoning, Peoples R China	China Medical University; China Medical University; China Medical University; China Medical University	Wang, HQ (corresponding author), China Med Univ, Dept Biochem & Mol Biol, 92 Beier, Shenyang 110001, Liaoning, Peoples R China.	wanghq_doctor@hotmail.com			National Natural Science Foundation of China [31070697, 31170727]; Program for LNET [LJQ2011083]; Foundation of Liaoning Educational Committee [L2010561]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for LNET; Foundation of Liaoning Educational Committee	This work was supported by National Natural Science Foundation of China (31070697 and 31170727), Program for LNET (LJQ2011083) and Foundation of Liaoning Educational Committee (L2010561) to H- Q Wang.	Arias AM, 2001, CELL, V105, P425, DOI 10.1016/S0092-8674(01)00365-8; Bozdogan O, 2005, TUMORI J, V91, P539, DOI 10.1177/030089160509100615; Brabletz T, 1998, PATHOL RES PRACT, V194, P701, DOI 10.1016/S0344-0338(98)80129-5; Carra S, 2008, J BIOL CHEM, V283, P1437, DOI 10.1074/jbc.M706304200; Carra S, 2009, AUTOPHAGY, V5, P428, DOI 10.4161/auto.5.3.7894; Carra S, 2009, J BIOL CHEM, V284, P5523, DOI 10.1074/jbc.M807440200; Chiappetta G, 2007, J CLIN ENDOCR METAB, V92, P1159, DOI 10.1210/jc.2006-1712; Doong H, 2002, CANCER LETT, V188, P25, DOI 10.1016/S0304-3835(02)00456-1; Doong H, 2000, ONCOGENE, V19, P4385, DOI 10.1038/sj.onc.1203797; Du ZX, 2008, BIOCHEM BIOPH RES CO, V369, P894, DOI 10.1016/j.bbrc.2008.02.112; Du ZX, 2011, J CLIN ENDOCR METAB, V96, pE763, DOI 10.1210/jc.2010-2642; Du ZX, 2009, J CELL PHYSIOL, V218, P631, DOI 10.1002/jcp.21634; Fan JH, 2006, J INVEST DERMATOL, V126, P1233, DOI 10.1038/sj.jid.5700149; Gamerdinger M, 2011, J MOL MED, V89, P1175, DOI 10.1007/s00109-011-0795-6; Gamerdinger M, 2009, EMBO J, V28, P889, DOI 10.1038/emboj.2009.29; Gavert N, 2007, J CELL BIOCHEM, V102, P820, DOI 10.1002/jcb.21505; Haynes J, MOL BIOL CELL, V22, P4750; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hugo H, 2007, J CELL PHYSIOL, V213, P374, DOI 10.1002/jcp.21223; Humphries MJ, 2006, J BIOL CHEM, V281, P9728, DOI 10.1074/jbc.M507851200; Iwasaki M, 2007, CANCER RES, V67, P10252, DOI 10.1158/0008-5472.CAN-07-0618; Kassis JN, 2006, EXP CELL RES, V312, P2962, DOI 10.1016/j.yexcr.2006.05.023; Kikkawa U, 2002, J BIOCHEM, V132, P831, DOI 10.1093/oxfordjournals.jbchem.a003294; Lee JH, 1999, ONCOGENE, V18, P6183, DOI 10.1038/sj.onc.1203043; Li CH, 2003, FASEB J, V17, P2106, DOI 10.1096/fj.03-0150fje; Liao Q, 2001, FEBS LETT, V503, P151, DOI 10.1016/S0014-5793(01)02728-4; Liu P, 2009, FEBS LETT, V583, P401, DOI 10.1016/j.febslet.2008.12.032; MISCHAK H, 1993, J BIOL CHEM, V268, P20110; Mitsiades CS, 2006, BLOOD, V107, P1092, DOI 10.1182/blood-2005-03-1158; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Pagliuca MG, 2003, FEBS LETT, V541, P11, DOI 10.1016/S0014-5793(03)00274-6; Romano MF, 2003, CANCER BIOL THER, V2, P508, DOI 10.4161/cbt.2.5.524; Romano MF, 2003, CELL DEATH DIFFER, V10, P383, DOI 10.1038/sj.cdd.4401167; Rosati A, 2007, INT J BIOCHEM CELL B, V39, P1337, DOI 10.1016/j.biocel.2007.03.007; Rosati A, 2007, J CELL PHYSIOL, V210, P676, DOI 10.1002/jcp.20865; Shi J, 2008, BLOOD, V111, P1309, DOI 10.1182/blood-2007-03-078535; Steinberg SF, 2004, BIOCHEM J, V384, P449, DOI 10.1042/BJ20040704; Suzuki M, 2011, CANCER LETT, V303, P65, DOI 10.1016/j.canlet.2011.01.019; Takayama S, 1999, J BIOL CHEM, V274, P781, DOI 10.1074/jbc.274.2.781; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; WATANABE T, 1992, P NATL ACAD SCI USA, V89, P10159, DOI 10.1073/pnas.89.21.10159; Yook JI, 2006, NAT CELL BIOL, V8, P1398, DOI 10.1038/ncb1508; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	43	31	33	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	SEP 19	2013	32	38					4539	4548		10.1038/onc.2012.466	http://dx.doi.org/10.1038/onc.2012.466			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	223SW	23108398				2022-12-25	WOS:000324831300009
J	Skeldal, S; Sykes, AM; Glerup, S; Matusica, D; Palstra, N; Autio, H; Boskovic, Z; Madsen, P; Castren, E; Nykjaer, A; Coulson, EJ				Skeldal, Sune; Sykes, Alex M.; Glerup, Simon; Matusica, Dusan; Palstra, Nickless; Autio, Henri; Boskovic, Zoran; Madsen, Peder; Castren, Eero; Nykjaer, Anders; Coulson, Elizabeth J.			Mapping of the Interaction Site between Sortilin and the p75 Neurotrophin Receptor Reveals a Regulatory Role for the Sortilin Intracellular Domain in p75 Neurotrophin Receptor Shedding and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; ACTIVATION; DEATH; LIGAND; PRONGF; PRONEUROTROPHIN-3; TRANSPORT; P75(NTR); CLEAVAGE; SURVIVAL	Neurotrophins comprise a group of neuronal growth factors that are essential for the development and maintenance of the nervous system. However, the immature pro-neurotrophins promote apoptosis by engaging in a complex with sortilin and the p75 neurotrophin receptor (p75(NTR)). To identify the interaction site between sortilin and p75(NTR), we analyzed binding between chimeric receptor constructs and truncated p75(NTR) variants by co-immunoprecipitation experiments, surface plasmon resonance analysis, and FRET. We found that complex formation between sortilin and p75(NTR) relies on contact points in the extracellular domains of the receptors. We also determined that the interaction critically depends on an extracellular juxtamembrane 23-amino acid sequence of p75(NTR). Functional studies further revealed an important regulatory function of the sortilin intracellular domain in p75(NTR)-regulated intramembrane proteolysis and apoptosis. Thus, although the intracellular domain of sortilin does not contribute to p75(NTR) binding, it does regulate the rates of p75(NTR) cleavage, which is required to mediate pro-neurotrophin-stimulated cell death.	[Skeldal, Sune; Glerup, Simon; Madsen, Peder; Nykjaer, Anders; Coulson, Elizabeth J.] Univ Aarhus, Dept Biomed, Lundbeck Fdn Res Ctr MIND, DK-8000 Aarhus C, Denmark; [Skeldal, Sune; Sykes, Alex M.; Matusica, Dusan; Palstra, Nickless; Boskovic, Zoran; Coulson, Elizabeth J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Autio, Henri; Castren, Eero] Univ Helsinki, Neurosci Ctr, FIN-00014 Helsinki, Finland	Aarhus University; Lundbeckfonden; University of Queensland; University of Helsinki	Coulson, EJ (corresponding author), Univ Aarhus, Dept Biomed, Lundbeck Fdn Res Ctr MIND, DK-8000 Aarhus C, Denmark.	an@biokemi.au.dk	Matusica, Dusan/G-8138-2011; Boskovic, Zoran/Y-2764-2018; Coulson, Elizabeth J./C-8766-2009	Matusica, Dusan/0000-0001-6472-7653; Boskovic, Zoran/0000-0002-9867-1827; Coulson, Elizabeth J./0000-0003-3783-6197; Skeldal, Sune/0000-0002-3268-289X; Castren, Eero/0000-0002-1402-2791; Nykjaer, Anders/0000-0001-6422-6736; Sykes, Alex/0000-0001-8981-6652; Madsen, Peder Sondergaard/0000-0002-8845-4802	Lundbeck Foundation; National Health and Medical Research Council of Australia; Finnish Graduate School of Neuroscience; Sigrid Juselius Foundation; Academy of Finland Center of Excellence program	Lundbeck Foundation(Lundbeckfonden); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Finnish Graduate School of Neuroscience; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Academy of Finland Center of Excellence program(Academy of Finland)	This work was supported by the by the Lundbeck Foundation, the National Health and Medical Research Council of Australia, the Finnish Graduate School of Neuroscience, the Sigrid Juselius Foundation, and Academy of Finland Center of Excellence program.	Beattie MS, 2002, NEURON, V36, P375, DOI 10.1016/S0896-6273(02)01005-X; Bronfman FC, 2007, DEV NEUROBIOL, V67, P1183, DOI 10.1002/dneu.20513; Ceni C, 2010, J CELL SCI, V123, P2299, DOI 10.1242/jcs.062612; Coulson EJ, 2000, J BIOL CHEM, V275, P30537, DOI 10.1074/jbc.M005214200; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Frade JM, 1998, BIOESSAYS, V20, P137, DOI 10.1002/(SICI)1521-1878(199802)20:2<137::AID-BIES6>3.0.CO;2-Q; Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101; Hauburger A, 2007, FEBS LETT, V581, P4159, DOI 10.1016/j.febslet.2007.07.063; Hermey G, 2006, BIOCHEM J, V395, P285, DOI 10.1042/BJ20051364; Jacobsen L, 2001, J BIOL CHEM, V276, P22788, DOI 10.1074/jbc.M100857200; Jansen P, 2007, NAT NEUROSCI, V10, P1449, DOI 10.1038/nn2000; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kenchappa RS, 2010, J BIOL CHEM, V285, P20358, DOI 10.1074/jbc.M109.082834; Kenchappa RS, 2006, NEURON, V50, P219, DOI 10.1016/j.neuron.2006.03.011; Kommaddi RP, 2011, FASEB J, V25, P2061, DOI 10.1096/fj.10-173740; Lee R, 2001, SCIENCE, V294, P1945, DOI 10.1126/science.1065057; Meyer BH, 2006, P NATL ACAD SCI USA, V103, P2138, DOI 10.1073/pnas.0507686103; Mohler WA, 1996, P NATL ACAD SCI USA, V93, P12423, DOI 10.1073/pnas.93.22.12423; Nielsen MS, 2001, EMBO J, V20, P2180, DOI 10.1093/emboj/20.9.2180; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Nykjaer A, 2012, TRENDS NEUROSCI, V35, P261, DOI 10.1016/j.tins.2012.01.003; Petersen CM, 1999, EMBO J, V18, P595, DOI 10.1093/emboj/18.3.595; Petersen CM, 1997, J BIOL CHEM, V272, P3599, DOI 10.1074/jbc.272.6.3599; Quistgaard EM, 2009, NAT STRUCT MOL BIOL, V16, P96, DOI 10.1038/nsmb.1543; Schlondorff J, 1999, J CELL SCI, V112, P3603; Skeldal S, 2011, BIOESSAYS, V33, P614, DOI 10.1002/bies.201100036; Sotthibundhu A, 2008, J NEUROSCI, V28, P3941, DOI 10.1523/JNEUROSCI.0350-08.2008; Sykes AM, 2012, J BIOL CHEM, V287, P43810, DOI 10.1074/jbc.M112.382903; Tauris J, 2011, EUR J NEUROSCI, V33, P622, DOI 10.1111/j.1460-9568.2010.07556.x; Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005; Urra S, 2007, J BIOL CHEM, V282, P7606, DOI 10.1074/jbc.M610458200; Vilar M, 2009, NEURON, V62, P72, DOI 10.1016/j.neuron.2009.02.020; Yano H, 2009, J NEUROSCI, V29, P14790, DOI 10.1523/JNEUROSCI.2059-09.2009; Zareen N, 2009, JOVE-J VIS EXP, V23, pe988	34	35	40	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43798	43809		10.1074/jbc.M112.374710	http://dx.doi.org/10.1074/jbc.M112.374710			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23105113	Green Published, hybrid			2022-12-25	WOS:000312940800058
J	Hayes, SD; Liu, H; MacDonald, E; Sanderson, CM; Coulson, JM; Clague, MJ; Urbe, S				Hayes, Sebastian D.; Liu, Han; MacDonald, Ewan; Sanderson, Christopher M.; Coulson, Judy M.; Clague, Michael J.; Urbe, Sylvie			Direct and Indirect Control of Mitogen-activated Protein Kinase Pathway-associated Components, BRAP/IMP E3 Ubiquitin Ligase and CRAF/RAF1 Kinase, by the Deubiquitylating Enzyme USP15	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEUBIQUITINATING ENZYMES; SIGNALING COMPLEXES; T-CELLS; DOMAIN; DEGRADATION; SENSITIVITY; INHIBITORS; KSR1; BRAF; P21	The opposing regulators of ubiquitylation status, E3 ligases and deubiquitylases, are often found to be associated in complexes. Here we report on a novel interaction between the E3 ligase BRAP (also referred to as IMP), a negative regulator of the MAPK scaffold protein KSR, and two closely related deubiquitylases, USP15 and USP4. We map the interaction to the N-terminal DUSP-UBL domain of USP15 and the coiled coil region of BRAP. USP15 as well as USP4 oppose the autoubiquitylation of BRAP, whereas BRAP promotes the ubiquitylation of USP15. Importantly, USP15 but not USP4 depletion destabilizes BRAP by promoting its proteasomal degradation, and BRAP-protein levels can be rescued by reintroducing catalytically active but not inactive mutant USP15. Unexpectedly, USP15 depletion results in a decrease in amplitude of MAPK signaling in response to EGF and PDGF. We provide evidence for a model in which the dominant effect of prolonged USP15 depletion upon signal amplitude is due to a decrease in CRAF levels while allowing for the possibility that USP15 may also function to dampen MAPK signaling through direct stabilization of a negative regulator, the E3 ligase BRAP.	[Hayes, Sebastian D.; Liu, Han; MacDonald, Ewan; Sanderson, Christopher M.; Coulson, Judy M.; Clague, Michael J.; Urbe, Sylvie] Univ Liverpool, Inst Translat Med, Liverpool L69 3BX, Merseyside, England	University of Liverpool	Clague, MJ (corresponding author), Univ Liverpool, Inst Translat Med, Crown St, Liverpool L69 3BX, Merseyside, England.	clague@liv.ac.uk; urbe@liv.ac.uk	Clague, Michael J/A-7199-2008; Urbe, Sylvie/S-1433-2018	Clague, Michael J/0000-0003-3355-9479; Urbe, Sylvie/0000-0003-4735-9814; Liu, Han/0000-0002-0014-4675; MacDonald, Ewan/0000-0001-7594-6552; HAYES, SEBASTIAN/0000-0002-2383-9461; Coulson, Judy/0000-0003-2191-2001	Cancer Research United Kingdom; Wellcome Trust; Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom	Cancer Research United Kingdom(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by a Cancer Research United Kingdom Senior Fellowship.; Recipient of a Wellcome Trust Prize studentship. Present address: Dept. of Cell Biology, Harvard Medical School, Boston, MA 02115.; Recipient of a Biotechnology and Biological Sciences Research Council, Swindon, United Kingdom research studentship.	Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Asada M, 2004, MOL CELL BIOL, V24, P8236, DOI 10.1128/MCB.24.18.8236-8243.2004; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BECK TW, 1990, MOL CELL BIOL, V10, P3325, DOI 10.1128/MCB.10.7.3325; Brooks CL, 2007, ONCOGENE, V26, P7262, DOI 10.1038/sj.onc.1210531; Chen C, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00429.x; Chiu YH, 2009, CHEM REV, V109, P1549, DOI 10.1021/cr800554j; Czyzyk J, 2008, J BIOL CHEM, V283, P23004, DOI 10.1074/jbc.M804084200; de Jong RN, 2006, J BIOL CHEM, V281, P5026, DOI 10.1074/jbc.M510993200; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Elliott PR, 2011, FEBS LETT, V585, P3385, DOI 10.1016/j.febslet.2011.09.040; Faronato M., 2010, USP15 UBIQUITIN SPEC; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Heyninck K, 2005, TRENDS BIOCHEM SCI, V30, P1, DOI 10.1016/j.tibs.2004.11.001; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Inui M, 2011, NAT CELL BIOL, V13, P1368, DOI 10.1038/ncb2346; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Jura N, 2006, MOL CELL, V21, P679, DOI 10.1016/j.molcel.2006.02.011; Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785; Kolch W, 2005, NAT REV MOL CELL BIO, V6, P827, DOI 10.1038/nrm1743; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Lehner B, 2004, GENOME RES, V14, P1315, DOI 10.1101/gr.2122004; Lin J, 2009, MOL CELL BIOL, V29, P2082, DOI 10.1128/MCB.01634-08; Liu H, 2012, SEMIN CELL DEV BIOL, V23, P509, DOI 10.1016/j.semcdb.2012.01.014; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Markson G, 2009, GENOME RES, V19, P1905, DOI 10.1101/gr.093963.109; Matheny SA, 2004, NATURE, V427, P256, DOI 10.1038/nature02237; Matheny SA, 2006, METHOD ENZYMOL, V407, P237, DOI 10.1016/S0076-6879(05)07020-5; Matheny SA, 2009, J BIOL CHEM, V284, P11007, DOI 10.1074/jbc.R800082200; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Poulikakos PI, 2010, NATURE, V464, P427, DOI 10.1038/nature08902; Sacco JJ, 2010, IUBMB LIFE, V62, P140, DOI 10.1002/iub.300; Smith FD, 2002, CURR BIOL, V12, pR32, DOI 10.1016/S0960-9822(01)00646-7; Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Winters BS, 2006, MOL BIOL CELL, V17, P3386, DOI 10.1091/mbc.E05-09-0849; Xu LZ, 2010, CURR BIOL, V20, P1372, DOI 10.1016/j.cub.2010.06.051; Ye Y, 2009, MOL BIOSYST, V5, P1797, DOI 10.1039/b907669g; Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X	42	37	39	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43007	43018		10.1074/jbc.M112.386938	http://dx.doi.org/10.1074/jbc.M112.386938			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23105109	Green Published, hybrid			2022-12-25	WOS:000312501600057
J	Lu, YZ; Li, JZ; Cheng, DM; Parameswaran, B; Zhang, SH; Jiang, ZF; Yew, PR; Peng, JM; Ye, QN; Hu, YF				Lu, Yunzhe; Li, Jiezhi; Cheng, Dongmei; Parameswaran, Balaji; Zhang, Shaohua; Jiang, Zefei; Yew, P. Renee; Peng, Junmin; Ye, Qinong; Hu, Yanfen			The F-box Protein FBXO44 Mediates BRCA1 Ubiquitination and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPORADIC BREAST; OVARIAN-CANCER; BRCA1/BARD1 HETERODIMER; POLYUBIQUITIN CHAINS; TUMOR-SUPPRESSOR; FREQUENT LOSS; E3 LIGASE; EXPRESSION; IDENTIFICATION; COMPLEX	BRCA1 mutations account for a significant proportion of familial breast and ovarian cancers. In addition, reduced BRCA1 protein is associated with sporadic cancer cases in these tissues. At the cellular level, BRCA1 plays a critical role in multiple cellular functions such as DNA repair and cell cycle checkpoint control. Its protein level is regulated in a cell cycle-dependent manner. However, regulation of BRCA1 protein stability is not fully understood. Our earlier study showed that the amino terminus of BRCA1 harbors a degron sequence that is sufficient and necessary for conferring BRCA1 degradation. In the current study, we used mass spectrometry to identify Skp1 that regulates BRCA1 protein stability. Small interfering RNA screening that targets all human F-box proteins uncovered FBXO44 as an important protein that influences BRCA1 protein level. The Skp1-Cul1-F-box-protein44 (SCFFBXO44) complex ubiquitinates full-length BRCA1 in vitro. Furthermore, the N terminus of BRCA1 mediates the interaction between BRCA1 and FBXO44. Overexpression of SCFFBXO44 reduces BRCA1 protein level. Taken together, our work strongly suggests that SCFFBXO44 is an E3 ubiquitin ligase responsible for BRCA1 degradation. In addition, FBXO44 expression pattern in breast carcinomas suggests that SCFFBXO44-mediated BRCA1 degradation might contribute to sporadic breast tumor development.	[Li, Jiezhi; Ye, Qinong] Beijing Inst Biotechnol, Dept Mol Oncol, Beijing 100850, Peoples R China; [Lu, Yunzhe; Parameswaran, Balaji; Yew, P. Renee; Hu, Yanfen] Univ Texas Hlth Sci Ctr San Antonio, Dept Mol Med, Inst Biotechnol, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA; [Li, Jiezhi; Peng, Junmin] Emory Univ, Sch Med, Dept Human Genet, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Zhang, Shaohua; Jiang, Zefei] Acad Mil Med Sci, Hosp 307, Dept Breast Canc, Beijing 100071, Peoples R China	Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio; Emory University; Academy of Military Medical Sciences - China	Ye, QN (corresponding author), Beijing Inst Biotechnol, Dept Mol Oncol, Beijing 100850, Peoples R China.	yeqn66@yahoo.com; huy3@uthscsa.edu	Peng, Junmin/N-2614-2018; zhang, shaohua/GXA-1772-2022	Peng, Junmin/0000-0003-0472-7648; Lu, Yunzhe/0000-0001-7542-6848; Parameswaran, Balaji/0000-0002-1665-4872	National Institutes of Health [R01CA118578]; cancer center support grant from the American Cancer Society [P30CA054174]; American Cancer Society [RSG-09-181-01]; Major State Basic Research Development Program [2011CB504202]; National Natural Science Foundation [81072173]; NATIONAL CANCER INSTITUTE [R01CA118578, P30CA054174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); cancer center support grant from the American Cancer Society; American Cancer Society(American Cancer Society); Major State Basic Research Development Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported, in whole or in part, by National Institutes of Health Grant (to Y. H.) R01CA118578 and the cancer center support grant P30CA054174, a Research Scholar Grant RSG-09-181-01 from the American Cancer Society (to J. P.) and Major State Basic Research Development Program 2011CB504202 and National Natural Science Foundation 81072173 (to Q. Y.).	Baer R, 2002, CURR OPIN GENET DEV, V12, P86, DOI 10.1016/S0959-437X(01)00269-6; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Catteau A, 1999, ONCOGENE, V18, P1957, DOI 10.1038/sj.onc.1202509; Chan KYK, 2002, CANCER RES, V62, P4151; Choudhury AD, 2004, J BIOL CHEM, V279, P33909, DOI 10.1074/jbc.M403646200; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; Glenn KA, 2008, J BIOL CHEM, V283, P12717, DOI 10.1074/jbc.M709508200; Horwitz AA, 2007, P NATL ACAD SCI USA, V104, P6614, DOI 10.1073/pnas.0610481104; Huen MSY, 2010, NAT REV MOL CELL BIO, V11, P138, DOI 10.1038/nrm2831; Ilyin GP, 2002, GENE, V296, P11, DOI 10.1016/S0378-1119(02)00867-3; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Lambie H, 2003, J PATHOL, V200, P207, DOI 10.1002/path.1348; Lu YZ, 2007, MOL ENDOCRINOL, V21, P651, DOI 10.1210/me.2006-0188; MARQUIS ST, 1995, NAT GENET, V11, P17, DOI 10.1038/ng0995-17; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Nishikawa H, 2004, J BIOL CHEM, V279, P3916, DOI 10.1074/jbc.M308540200; Ohta T, 2004, ONCOGENE, V23, P2079, DOI 10.1038/sj.onc.1207371; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Russell PA, 2000, INT J CANCER, V87, P317, DOI 10.1002/1097-0215(20000801)87:3<317::AID-IJC2>3.0.CO;2-B; Strohmaier H, 2001, NATURE, V413, P316, DOI 10.1038/35095076; Winston JT, 1999, CURR BIOL, V9, P1180, DOI 10.1016/S0960-9822(00)80021-4; Wu LJC, 1996, NAT GENET, V14, P430, DOI 10.1038/ng1296-430; Wu WW, 2010, CANCER RES, V70, P6384, DOI 10.1158/0008-5472.CAN-10-1304; Wu-Baer F, 2003, J BIOL CHEM, V278, P34743, DOI 10.1074/jbc.C300249200; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yoshikawa K, 1999, CLIN CANCER RES, V5, P1249; Yoshikawa K, 2000, INT J CANCER, V88, P28, DOI 10.1002/1097-0215(20001001)88:1<28::AID-IJC5>3.0.CO;2-4; Zhang H, 2005, J BIOL CHEM, V280, P43188, DOI 10.1074/jbc.M506598200	30	35	35	2	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 30	2012	287	49					41014	41022		10.1074/jbc.M112.407106	http://dx.doi.org/10.1074/jbc.M112.407106			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	048CK	23086937	Green Published, hybrid			2022-12-25	WOS:000311887600019
J	Ma, K; You, LZ; Liu, JG; Zhang, MX				Ma, Kun; You, Liangzhi; Liu, Junguo; Zhang, Mingxiang			A Hybrid Wetland Map for China: A Synergistic Approach Using Census and Spatially Explicit Datasets	PLOS ONE			English	Article							ECOSYSTEM SERVICES; WATER SECURITY; INVENTORY; GIS	Wetlands play important ecological, economic, and cultural roles in societies around the world. However, wetland degradation has become a serious ecological issue, raising the global sustainability concern. An accurate wetland map is essential for wetland management. Here we used a fuzzy method to create a hybrid wetland map for China through the combination of five existing wetlands datasets, including four spatially explicit wetland distribution data and one wetland census. Our results show the total wetland area is 384,864 km(2), 4.08% of China's national surface area. The hybrid wetland map also shows spatial distribution of wetlands with a spatial resolution of 1 km. The reliability of the map is demonstrated by comparing it with spatially explicit datasets on lakes and reservoirs. The hybrid wetland map is by far the first wetland mapping that is consistent with the statistical data at the national and provincial levels in China. It provides a benchmark map for research on wetland protection and management. The method presented here is applicable for not only wetland mapping but also for other thematic mapping in China and beyond.	[Ma, Kun; You, Liangzhi; Liu, Junguo; Zhang, Mingxiang] Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China; [You, Liangzhi] Int Food Policy Res Inst, Washington, DC 20036 USA; [Liu, Junguo] Int Inst Appl Syst Anal, Ecosyst Serv & Management Program, A-2361 Laxenburg, Austria	Beijing Forestry University; CGIAR; International Food Policy Research Institute (IFPRI); International Institute for Applied Systems Analysis (IIASA)	Liu, JG (corresponding author), Beijing Forestry Univ, Sch Nat Conservat, Beijing, Peoples R China.	water21water@yahoo.com	Liu, Junguo/B-3021-2012	Liu, Junguo/0000-0002-5745-6311	Special Fund for Forestry Scientific Research in the Public Interest [201204204]; National Natural Science Foundation of China [91025009]; Projects of International Cooperation and Exchanges NSFC [41161140353]; New Century Excellent Talents in University [NCET-09-0222]; Fundamental Research Funds for the Central Universities [HJ2010-1]	Special Fund for Forestry Scientific Research in the Public Interest; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Projects of International Cooperation and Exchanges NSFC; New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the Special Fund for Forestry Scientific Research in the Public Interest (201204204), National Natural Science Foundation of China (91025009) and Projects of International Cooperation and Exchanges NSFC (41161140353), New Century Excellent Talents in University (NCET-09-0222), and Fundamental Research Funds for the Central Universities (HJ2010-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari AR, 2011, ENVIRON MONIT ASSESS, V180, P97, DOI 10.1007/s10661-010-1775-y; BFU, 2011, MAPP CHIN WETL BAS 1; Bowen MW, 2010, WETLANDS, V30, P675, DOI 10.1007/s13157-010-0077-z; Carpenter SR, 2011, ANNU REV ENV RESOUR, V36, P75, DOI 10.1146/annurev-environ-021810-094524; Chen LZ, 1998, BIODIVERSITY CURRENT, P197; Chen Y., 2011, ECOSYSTEM SERVICES M; Chopra R, 2001, INT J REMOTE SENS, V22, P89, DOI 10.1080/014311601750038866; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Cyranoski D, 2009, NATURE, V458, P134, DOI 10.1038/458134a; Fritz S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046213; Gong P, 2010, SCI CHINA EARTH SCI, V53, P1036, DOI 10.1007/s11430-010-4002-3; Grenier M, 2007, CAN J REMOTE SENS, V33, pS28, DOI 10.5589/m07-048; Jiang M, 2007, ECOL ECON, V61, P217, DOI 10.1016/j.ecolecon.2006.10.019; JOHNSTON RM, 1993, AUST J MAR FRESH RES, V44, P235, DOI 10.1071/MF9930235; Jung M, 2006, REMOTE SENS ENVIRON, V101, P534, DOI 10.1016/j.rse.2006.01.020; Lehner B, 2004, J HYDROL, V296, P1, DOI 10.1016/j.jhydrol.2004.03.028; Leibowitz SG, 2003, WETLANDS, V23, P517, DOI 10.1672/0277-5212(2003)023[0517:IWATFA]2.0.CO;2; Liu Hong-yu, 2000, Journal of Environmental Sciences (China), V12, P361; Liu J, 2008, HYDROL EARTH SYST SC, V12, P887, DOI 10.5194/hess-12-887-2008; Liu JG, 2008, NATURE, V454, P397, DOI 10.1038/454397a; Millennium EA, 2005, EC HUM WELL BEING WE; *NAT BUR STAT CHIN, 2006, CHIN STAT YB 2006; Niu ZG, 2009, SCI CHINA SER D, V52, P723, DOI 10.1007/s11430-009-0075-2; Ozesmi Stacy L., 2002, Wetlands Ecology and Management, V10, P381, DOI 10.1023/A:1020908432489; Prigent C, 2001, GEOPHYS RES LETT, V28, P4631, DOI 10.1029/2001GL013263; Qu CS, 2011, ECOL MODEL, V222, P287, DOI 10.1016/j.ecolmodel.2010.07.014; Rebelo LM, 2009, J ENVIRON MANAGE, V90, P2144, DOI 10.1016/j.jenvman.2007.06.027; Turner RK, 2000, ECOL ECON, V35, P7, DOI 10.1016/S0921-8009(00)00164-6; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Wang Z, 2011, LOSS FRAGMENTATION M, P1; Woodward RT, 2001, ECOL ECON, V37, P257, DOI 10.1016/S0921-8009(00)00276-7; Yang B. G., 1997, J NATURAL RESOURCES, V12, P307; Yang ZF, 2011, ECOL MODEL, V222, P221, DOI 10.1016/j.ecolmodel.2010.09.039; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248; Zhang JianFeng, 2005, Forestry Studies in China, V7, P15, DOI 10.1007/s11632-005-0015-y	35	14	14	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47814	10.1371/journal.pone.0047814	http://dx.doi.org/10.1371/journal.pone.0047814			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110105	Green Published, Green Submitted, gold, Green Accepted			2022-12-25	WOS:000310193600028
J	Gros, SJ; Kurschat, N; Drenckhan, A; Dohrmann, T; Forberich, E; Effenberger, K; Reichelt, U; Hoffman, RM; Pantel, K; Kaifi, JT; Izbicki, JR				Gros, Stephanie J.; Kurschat, Nina; Drenckhan, Astrid; Dohrmann, Thorsten; Forberich, Evelyn; Effenberger, Katharina; Reichelt, Uta; Hoffman, Robert M.; Pantel, Klaus; Kaifi, Jussuf T.; Izbicki, Jakob R.			Involvement of CXCR4 Chemokine Receptor in Metastastic HER2-Positive Esophageal Cancer	PLOS ONE			English	Article							HUMAN-BREAST-CANCER; C-ERBB-2 ONCOPROTEIN; BARRETTS-ESOPHAGUS; ANTICANCER THERAPY; PROTEIN EXPRESSION; TUMOR-METASTASIS; MESSENGER-RNA; NEU ONCOGENE; OVEREXPRESSION; ADENOCARCINOMA	A functional linkage of the structurally unrelated receptors HER2 and CXCR4 has been suggested for breast cancer but has not been evaluated for esophageal carcinoma. The inhibition of HER2 leads to a reduction of primary tumor growth and metastases in an orthotopic model of esophageal carcinoma. The chemokine receptor CXCR4 has been implicated in metastatic dissemination of various tumors and correlates with poor survival in esophageal carcinoma. The aim of this study was to investigate a correlation between the expression levels of HER2 and CXCR4 and to evaluate the involvemnent of CXCR4-expression in HER2-positive esophageal carcinoma. The effects of HER2-inhibition with trastuzumab and of CXCR4-inhibition with AMD3100 on primary tumor growth, metastatic homing, and receptor expression were evaluated in vitro and in an orthotopic model of metastatic esophageal carcinoma using MRI for imaging. The clinical relevance of HER2- and CXCR4-expression was examined in esophageal carcinoma patients. A significant correlation of HER2- and CXCR4-expression in primary tumor and metastases exists in the orthotopic model. Trastuzumab and AMD3100 treatment led to a significant reduction of primary tumor growth, metastases and micrometastases. HER2-expression was significantly elevated under AMD3100 treatment in the primary tumor and particularly in the metastases. The positive correlation between HER2- and CXCR4-expression was validated in esophageal cancer patients. The correlation of CXCR4- and HER2-expression and the elevation of HER2-expression and reduction of metastases through CXCR4-inhibition suggest a possible functional linkage and a role in tumor dissemination in HER2-positive esophageal carcinoma.	[Gros, Stephanie J.; Kurschat, Nina; Drenckhan, Astrid; Dohrmann, Thorsten; Effenberger, Katharina; Kaifi, Jussuf T.; Izbicki, Jakob R.] Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Hamburg, Germany; [Forberich, Evelyn] Univ Med Ctr Hamburg Eppendorf, Dept Diagnost & Intervent Radiol, Hamburg, Germany; [Effenberger, Katharina; Pantel, Klaus] Univ Med Ctr Hamburg Eppendorf, Dept Tumor Biol, Hamburg, Germany; [Reichelt, Uta] Charite, Dept Pathol, Berlin, Germany; [Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA; [Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Anti Cancer Inc; University of California System; University of California San Diego	Gros, SJ (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Gen Visceral & Thorac Surg, Hamburg, Germany.	sgros@uke.de			Deutsche Forschungsgemeinschaft (DFG) [GR 3484/1-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The work has been supported by grant GR 3484/1-1 of the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamatsu M, 2003, INT J RADIAT ONCOL, V57, P1323, DOI 10.1016/S0360-3016(03)00782-X; ALKASSPOOLES M, 1993, INT J CANCER, V54, P213, DOI 10.1002/ijc.2910540209; Baselga J, 2001, EUR J CANCER, V37, pS16; Bernards R, 2003, NATURE, V425, P247, DOI 10.1038/425247a; Effenberger KE, 2012, INT J CANCER, V131, pE475, DOI 10.1002/ijc.26439; Friess H, 1999, WORLD J SURG, V23, P1010, DOI 10.1007/s002689900616; Gros SJ, 2010, ANTICANCER RES, V30, P3933; Gros SJ, 2010, MOL CANCER THER, V9, P2037, DOI 10.1158/1535-7163.MCT-10-0209; Gros SJ, 2010, INT J CANCER, V126, P2671, DOI 10.1002/ijc.24980; HARDWICK RH, 1994, GUT, V35, P764, DOI 10.1136/gut.35.6.764; Izbicki JR, 2002, SURGERY, V131, P1, DOI 10.1067/msy.2002.114649; Izbicki JR, 1996, J THORAC CARDIOV SUR, V112, P623, DOI 10.1016/S0022-5223(96)70044-2; JANKOWSKI J, 1992, GUT, V33, P1033, DOI 10.1136/gut.33.8.1033; Kaifi JT, 2005, J NATL CANCER I, V97, P1840, DOI 10.1093/jnci/dji431; Koenig AM, 2009, ANN SURG ONCOL, V16, P454, DOI 10.1245/s10434-008-0169-7; Kollmannsberger C, 1999, ANN ONCOL, V10, P1393, DOI 10.1023/A:1008365216323; Lam KY, 1998, EUR J SURG ONCOL, V24, P431, DOI 10.1016/S0748-7983(98)92403-9; Leyland-Jones B, 2002, LANCET ONCOL, V3, P137, DOI 10.1016/S1470-2045(02)00676-9; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Liotta LA, 2001, NATURE, V410, P24, DOI 10.1038/35065180; Locati LD, 2005, ORAL ONCOL, V41, P97, DOI 10.1016/j.oraloncology.2004.03.002; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nakagawa T, 2005, J UROLOGY, V173, P1767, DOI 10.1097/01.ju.0000154632.11824.4d; NAKAMURA T, 1994, CANCER-AM CANCER SOC, V73, P1785, DOI 10.1002/1097-0142(19940401)73:7<1785::AID-CNCR2820730703>3.0.CO;2-0; Pantel K, 1996, CURR TOP MICROBIOL, V213, P1; Pantel K, 2005, BBA-REV CANCER, V1756, P53, DOI 10.1016/j.bbcan.2005.07.002; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Proudfoot AEI, 2002, NAT REV IMMUNOL, V2, P106, DOI 10.1038/nri722; Reichelt U, 2007, MODERN PATHOL, V20, P120, DOI 10.1038/modpathol.3800712; Rossi D, 2000, ANNU REV IMMUNOL, V18, P217, DOI 10.1146/annurev.immunol.18.1.217; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sobin, 2005, TNM ATLAS ILLUSTRATE; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; SUWANAGOOL P, 1993, ASIAN PAC J ALLERGY, V11, P119; Tan M, 1997, CANCER RES, V57, P1199; Tripathy D, 2004, J CLIN ONCOL, V22, P1063, DOI 10.1200/JCO.2004.06.557; Tuma RS, 2005, J NATL CANCER I, V97, P870, DOI 10.1093/jnci/97.12.870; Walch A, 2001, LAB INVEST, V81, P791, DOI 10.1038/labinvest.3780289; Wetzker R, 2003, NAT REV MOL CELL BIO, V4, P651, DOI 10.1038/nrm1173; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; YEATMAN TJ, 1993, SEMIN SURG ONCOL, V9, P256; YU DH, 1991, ONCOGENE, V6, P1991; Yu DH, 1996, ONCOGENE, V13, P1359; Yu DH, 2000, BIOESSAYS, V22, P673, DOI 10.1002/1521-1878(200007)22:7<673::AID-BIES10>3.0.CO;2-A; Zhang DH, 2003, HUM PATHOL, V34, P362, DOI 10.1053/hupa.2003.60	46	38	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47287	10.1371/journal.pone.0047287	http://dx.doi.org/10.1371/journal.pone.0047287			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082154	Green Submitted, Green Published, gold			2022-12-25	WOS:000311146900050
J	Sousa, M; Servidoni, MF; Vinagre, AM; Ramalho, AS; Bonadia, LC; Felicio, V; Ribeiro, MA; Uliyakina, I; Marson, FA; Kmit, A; Cardoso, SR; Ribeiro, JD; Bertuzzo, CS; Sousa, L; Kunzelmann, K; Ribeiro, AF; Amaral, MD				Sousa, Marisa; Servidoni, Maria F.; Vinagre, Adriana M.; Ramalho, Anabela S.; Bonadia, Luciana C.; Felicio, Veronica; Ribeiro, Maria A.; Uliyakina, Inna; Marson, Fernando A.; Kmit, Arthur; Cardoso, Silvia R.; Ribeiro, Jose D.; Bertuzzo, Carmen S.; Sousa, Lisete; Kunzelmann, Karl; Ribeiro, Antonio F.; Amaral, Margarida D.			Measurements of CFTR-Mediated Cl- Secretion in Human Rectal Biopsies Constitute a Robust Biomarker for Cystic Fibrosis Diagnosis and Prognosis	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; NASAL POTENTIAL DIFFERENCE; AIRWAY ION-TRANSPORT; PULMONARY-DISEASE; LUNG-FUNCTION; MUTATION; IDENTIFICATION; CONSENSUS; GENOTYPE; GENE	Background: Cystic Fibrosis (CF) is caused by similar to 1,900 mutations in the CF transmembrane conductance regulator (CFTR) gene encoding for a cAMP-regulated chloride (Cl-) channel expressed in several epithelia. Clinical features are dominated by respiratory symptoms, but there is variable organ involvement thus causing diagnostic dilemmas, especially for non-classic cases. Methodology/Principal Findings: To further establish measurement of CFTR function as a sensitive and robust biomarker for diagnosis and prognosis of CF, we herein assessed cholinergic and cAMP-CFTR-mediated Cl- secretion in 524 freshly excised rectal biopsies from 118 individuals, including patients with confirmed CF clinical diagnosis (n = 51), individuals with clinical CF suspicion (n = 49) and age-matched non-CF controls (n = 18). Conclusive measurements were obtained for 96% of cases. Patients with "Classic CF'', presenting earlier onset of symptoms, pancreatic insufficiency, severe lung disease and low Shwachman-Kulczycki scores were found to lack CFTR-mediated Cl- secretion (<5%). Individuals with milder CF disease presented residual CFTR-mediated Cl- secretion (10-57%) and non-CF controls show CFTR-mediated Cl- secretion >= 30-35% and data evidenced good correlations with various clinical parameters. Finally, comparison of these values with those in "CF suspicion'' individuals allowed to confirm CF in 16/49 individuals (33%) and exclude it in 28/49 (57%). Statistical discriminant analyses showed that colonic measurements of CFTR-mediated Cl- secretion are the best discriminator among Classic/Non-Classic CF and non-CF groups. Conclusions/Significance: Determination of CFTR-mediated Cl- secretion in rectal biopsies is demonstrated here to be a sensitive, reproducible and robust predictive biomarker for the diagnosis and prognosis of CF. The method also has very high potential for (pre-) clinical trials of CFTR-modulator therapies.	[Sousa, Marisa; Ramalho, Anabela S.; Felicio, Veronica; Uliyakina, Inna; Amaral, Margarida D.] Univ Lisbon, BioFIG Ctr Biodivers Funct & Integrat Genom, Fac Sci, P-1699 Lisbon, Portugal; [Sousa, Marisa; Ramalho, Anabela S.; Uliyakina, Inna; Amaral, Margarida D.] Natl Inst Hlth, Dept Genet, Lisbon, Portugal; [Servidoni, Maria F.] Univ Estadual Campinas, Gastroctr, Endoscopy Unit, Campinas, SP, Brazil; [Servidoni, Maria F.; Cardoso, Silvia R.; Ribeiro, Jose D.; Ribeiro, Antonio F.] Univ Estadual Campinas, Dept Pediat, Campinas, SP, Brazil; [Vinagre, Adriana M.; Bonadia, Luciana C.; Marson, Fernando A.; Kmit, Arthur; Ribeiro, Jose D.; Bertuzzo, Carmen S.; Ribeiro, Antonio F.] Univ Estadual Campinas, Fac Med Sci, Campinas, SP, Brazil; [Ribeiro, Maria A.; Ribeiro, Jose D.; Ribeiro, Antonio F.] Univ Estadual Campinas, CIPED Res Ctr Pediat, Campinas, SP, Brazil; [Cardoso, Silvia R.] Univ Hosp Campinas, Endoscopy Unit, Campinas, SP, Brazil; [Sousa, Lisete] Univ Lisbon, CEAUL Ctr Stat & Applicat, P-1699 Lisbon, Portugal; [Sousa, Lisete] Univ Lisbon, Fac Sci, Dept Stat & Operat Res, P-1699 Lisbon, Portugal; [Kunzelmann, Karl] Univ Regensburg, Inst Physiol, Regensburg, Germany	Universidade de Lisboa; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Federal de Sao Paulo (UNIFESP); Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Lisboa; Universidade de Lisboa; University of Regensburg	Amaral, MD (corresponding author), Univ Lisbon, BioFIG Ctr Biodivers Funct & Integrat Genom, Fac Sci, P-1699 Lisbon, Portugal.	mdamaral@fc.ul.pt	Marson, Fernando Augusto Lima/H-1641-2012; Ribeiro, Jose Dirceu D/I-7308-2012; RIBEIRO, ANTONIO FERNANDO AF/F-2786-2014; Kmit, Arthur Henrique Pezzo/E-2296-2018; Amaral, Margarida D/E-5748-2012; Marson, Fernando/AAP-1589-2021; Sousa, Lisete M R/M-1842-2015; Ramalho, Anabela/AAY-4037-2020; Servidoni, Maria de Fátima Correa Pimenta/ABC-6857-2021	Marson, Fernando Augusto Lima/0000-0003-4955-4234; Ribeiro, Jose Dirceu D/0000-0002-3387-5642; Kmit, Arthur Henrique Pezzo/0000-0002-3744-7741; Amaral, Margarida D/0000-0002-0828-8630; Marson, Fernando/0000-0003-4955-4234; Sousa, Lisete M R/0000-0002-2114-720X; Ramalho, Anabela/0000-0002-6480-8725; Felicio, Veronica/0000-0001-6753-323X; SOUSA, MARISA/0000-0003-2305-4813; Kunzelmann, Karl/0000-0002-4583-7037; Uliyakina, Inna/0000-0002-7091-2123; Bertuzzo, Carmen Silvia/0000-0002-2813-2887	TargetScreen2 [EU/FP6/LSH/2005/037365, PIC/IC/83103/2007]; FCT (Portugal) [PEstOE/BIA/UI4046/2011, PEstOE/MAT/UI0006/2011, SFRH/BD/35936/2007, SFRH/BD/69180/2010]; FAPESP (SPRF, Brazil); CNPq, (Brazil) [40.8924/2006/3]; Mukoviszidose e.V. (Germany) [S02/10];  [PTDC/MAT/118335/2010]	TargetScreen2; FCT (Portugal)(Portuguese Foundation for Science and TechnologyEuropean Commission); FAPESP (SPRF, Brazil); CNPq, (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Mukoviszidose e.V. (Germany); 	This work was supported by grants TargetScreen2 (EU/FP6/LSH/2005/037365), PIC/IC/83103/2007; PTDC/MAT/118335/2010; PEstOE/BIA/UI4046/2011 (to BioFIG) and PEstOE/MAT/UI0006/2011 (to CEAUL) from FCT (Portugal); and FAPESP (SPRF, Brazil), CNPq (40.8924/2006/3, Brazil) and Mukoviszidose e.V. S02/10 (Germany). MS and IU are recipients of SFRH/BD/35936/2007 and SFRH/BD/69180/2010 PhD fellowships (FCT, Portugal), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accurso FJ, 2010, NEW ENGL J MED, V363, P1991, DOI 10.1056/NEJMoa0909825; Amaral MD, 2005, PEDIATR PULM, V39, P479, DOI 10.1002/ppul.20168; Amaral MD, 2001, J MED GENET, V38, P777, DOI 10.1136/jmg.38.11.777; Beck S, 1999, HUM MUTAT, V14, P133, DOI 10.1002/(SICI)1098-1004(1999)14:2<133::AID-HUMU5>3.0.CO;2-T; Bobadilla JL, 2002, HUM MUTAT, V19, P575, DOI 10.1002/humu.10041; Bombieri C, 2011, J CYST FIBROS, V10, pS86, DOI 10.1016/S1569-1993(11)60014-3; Bonadia L, 2011, CORRELACAO ENTRE ASP; Boyle MP, 2003, CURR OPIN PULM MED, V9, P498, DOI 10.1097/00063198-200311000-00009; Castellani C, 2008, J CYST FIBROS, V7, P179, DOI 10.1016/j.jcf.2008.03.009; Clancy JP, 2012, THORAX, V67, P12, DOI 10.1136/thoraxjnl-2011-200393; Cleveland RH, 2009, RADIOLOGY, V253, P813, DOI 10.1148/radiol.2533090418; COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392; Correia C, 2005, PREVALENCIA SEIS MUT; De Boeck K, 2006, THORAX, V61, P627, DOI 10.1136/thx.2005.043539; Debray D, 2011, J CYST FIBROS, V10, pS29, DOI 10.1016/S1569-1993(11)60006-4; Derichs N, 2010, THORAX, V65, P594, DOI 10.1136/thx.2009.125088; Farrell PM, 2008, J PEDIATR-US, V153, pS4, DOI 10.1016/j.jpeds.2008.05.005; Felicio V, 2011, ESTUDO CARACTERIZACA; Gavin JR, 1999, DIABETES CARE, V22, pS5; Hirtz S, 2004, GASTROENTEROLOGY, V127, P1085, DOI 10.1053/j.gastro.2004.07.006; Ho LP, 1997, EUR RESPIR J, V10, P2018, DOI 10.1183/09031936.97.10092018; Kanis JA, 2000, OSTEOPOROSIS INT, V11, P192, DOI 10.1007/s001980050281; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; Mall M, 2004, GASTROENTEROLOGY, V126, P32, DOI 10.1053/j.gastro.2003.10.049; Mall M, 2000, AM J PHYSIOL-GASTR L, V278, pG617, DOI 10.1152/ajpgi.2000.278.4.G617; Mall M, 1998, J CLIN INVEST, V102, P15, DOI 10.1172/JCI2729; Mall M, 1998, AM J PHYSIOL-GASTR L, V275, pG1274, DOI 10.1152/ajpgi.1998.275.6.G1274; Mall Marcus, 2004, J Cyst Fibros, V3 Suppl 2, P165, DOI 10.1016/j.jcf.2004.05.035; Noone PG, 2001, RESP RES, V2, P328, DOI 10.1186/rr82; Parad RB, 2005, J PEDIATR-US, V147, pS78, DOI 10.1016/j.jpeds.2005.08.017; Paranjape SM, 2008, CLIN REV ALLERG IMMU, V35, P116, DOI 10.1007/s12016-008-8083-0; Pratha VS, 2000, GASTROENTEROLOGY, V118, P1051, DOI 10.1016/S0016-5085(00)70358-1; Ramalho AS, 2002, AM J RESP CELL MOL, V27, P619, DOI 10.1165/rcmb.2001-0004OC; Ramsey BW, 2011, NEW ENGL J MED, V365, P1663, DOI 10.1056/NEJMoa1105185; RICH DP, 1990, NATURE, V347, P358, DOI 10.1038/347358a0; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Rosenstein BJ, 1998, J PEDIATR-US, V132, P589, DOI 10.1016/S0022-3476(98)70344-0; Roth EK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024445; Rowe SM, 2005, NEW ENGL J MED, V352, P1992, DOI 10.1056/NEJMra043184; Schaedel C, 2002, PEDIATR PULM, V33, P483, DOI 10.1002/ppul.10100; Sermet-Gaudelus I, 2010, THORAX, V65, P539, DOI 10.1136/thx.2009.123422; Shah S, 2011, THORAX, V66, P984, DOI DOI 10.1136/THX.2011.159491; Standaert TA, 2004, PEDIATR PULM, V37, P385, DOI 10.1002/ppul.10448; Taylor CJ, 2009, PAEDIATR RESPIR REV, V10, P220, DOI 10.1016/j.prrv.2009.05.002; van Barneveld A, 2006, BBA-MOL BASIS DIS, V1762, P393, DOI 10.1016/j.bbadis.2006.01.007; van Barneveld A, 2010, BBA-MOL BASIS DIS, V1802, P1062, DOI 10.1016/j.bbadis.2010.08.001; Van Goor F, 2009, P NATL ACAD SCI USA, V106, P18825, DOI 10.1073/pnas.0904709106; Walker LC, 1997, AM J RESP CRIT CARE, V155, P1684, DOI 10.1164/ajrccm.155.5.9154877; Wallace HL, 2003, AM J RESP CRIT CARE, V168, P594, DOI 10.1164/rccm.200211-1302OC; Yu H, 2012, J CYST FIBROS	52	46	46	5	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47708	10.1371/journal.pone.0047708	http://dx.doi.org/10.1371/journal.pone.0047708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082198	Green Published, gold			2022-12-25	WOS:000311146900095
J	van Zanten, GC; Knudsen, A; Roytio, H; Forssten, S; Lawther, M; Blennow, A; Lahtinen, SJ; Jakobsen, M; Svensson, B; Jespersen, L				van Zanten, Gabriella C.; Knudsen, Anne; Roytio, Henna; Forssten, Sofia; Lawther, Mark; Blennow, Andreas; Lahtinen, Sampo J.; Jakobsen, Mogens; Svensson, Birte; Jespersen, Lene			The Effect of Selected Synbiotics on Microbial Composition and Short-Chain Fatty Acid Production in a Model System of the Human Colon	PLOS ONE			English	Article							LACTOBACILLUS-ACIDOPHILUS NCFM; IN-VITRO FERMENTATION; BIFIDOBACTERIUM-LACTIS; GUT MICROBIOTA; DOUBLE-BLIND; FECAL MICROBIOTA; XYLO-OLIGOSACCHARIDES; CONTINUOUS-CULTURE; INFECTION-RATES; BACTERIA	Background: Prebiotics, probiotics and synbiotics can be used to modulate both the composition and activity of the gut microbiota and thereby potentially affecting host health beneficially. The aim of this study was to investigate the effects of eight synbiotic combinations on the composition and activity of human fecal microbiota using a four-stage semicontinuous model system of the human colon. Methods and Findings: Carbohydrates were selected by their ability to enhance growth of the probiotic bacteria Lactobacillus acidophilus NCFM (NCFM) and Bifidobacterium animalis subsp. lactis Bl0-04 (Bl-04) under laboratory conditions. The most effective carbohydrates for each probiotic were further investigated, using the colonic model, for the ability to support growth of the probiotic bacteria, influence the composition of the microbiota and stimulate formation of short-chain fatty acids (SCFA). The following combinations were studied: NCFM with isomaltulose, cellobiose, raffinose and an oat beta-glucan hydrolysate (OBGH) and Bl-04 with melibiose, xylobiose, raffinose and maltotriose. All carbohydrates showed capable of increasing levels of NCFM and Bl-04 during fermentations in the colonic model by 10(3)-10(4) fold and 10-10(2) fold, respectively. Also the synbiotic combinations decreased the modified ratio of Bacteroidetes/Firmicutes (calculated using qPCR results for Bacteroides-Prevotella-Porphyromonas group, Clostridium perfringens cluster I, Clostridium coccoides Eubacterium rectale group and Clostridial cluster XIV) as well as significantly increasing SCFA levels, especially acetic and butyric acid, by three to eight fold, as compared to the controls. The decreases in the modified ratio of Bacteroidetes/Firmicutes were found to be correlated to increases in acetic and butyric acid (p = 0.04 and p = 0.03, respectively). Conclusions: The results of this study show that all synbiotic combinations investigated are able to shift the predominant bacteria and the production of SCFA of fecal microbiota in a model system of the human colon, thereby potentially being able to manipulate the microbiota in a way connected to human health.	[van Zanten, Gabriella C.; Jakobsen, Mogens; Jespersen, Lene] Univ Copenhagen, Fac Life Sci, Dept Food Sci, Frederiksberg, Denmark; [van Zanten, Gabriella C.; Knudsen, Anne; Svensson, Birte] Tech Univ Denmark, Dept Syst Biol, DK-2800 Lyngby, Denmark; [Knudsen, Anne; Blennow, Andreas] Univ Copenhagen, Fac Life Sci, Dept Plant Biol & Biotechnol, Frederiksberg, Denmark; [Roytio, Henna; Forssten, Sofia; Lahtinen, Sampo J.] DuPont Nutr & Hlth, Kantvik, Finland; [Lawther, Mark] Biovelop AS, Kvistgard, Denmark	University of Copenhagen; Technical University of Denmark; University of Copenhagen	van Zanten, GC (corresponding author), Univ Copenhagen, Fac Life Sci, Dept Food Sci, Frederiksberg, Denmark.	gcz@life.ku.dk	Jespersen, Lene/E-1717-2015; van Zanten, Gabriella/M-6000-2014; Jespersen, Lene/AAA-4230-2021; Forssten, Sofia/AAD-1805-2022; Blennow, Andreas/F-7451-2014	Jespersen, Lene/0000-0002-2555-5948; van Zanten, Gabriella/0000-0002-7793-8465; Jespersen, Lene/0000-0002-2555-5948; Svensson, Birte/0000-0002-2993-8196; Blennow, Andreas/0000-0001-6476-9546	Danish Strategic Research Council's Program Committee on Health, Food and Welfare (FoSu)	Danish Strategic Research Council's Program Committee on Health, Food and Welfare (FoSu)	This project was funded by the Danish Strategic Research Council's Program Committee on Health, Food and Welfare (FoSu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams SA, 2007, J PEDIATR-US, V151, P293, DOI 10.1016/j.jpeds.2007.03.043; Andreasen AS, 2010, BRIT J NUTR, V104, P1831, DOI 10.1017/S0007114510002874; Apajalahti JHA, 2002, APPL ENVIRON MICROB, V68, P4986, DOI 10.1128/AEM.68.10.4986-4995.2002; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bartosch S, 2005, CLIN INFECT DIS, V40, P28, DOI 10.1086/426027; Beards E, 2010, BRIT J NUTR, V104, P701, DOI 10.1017/S0007114510001078; Benjamin JL, 2011, GUT, V60, P923, DOI 10.1136/gut.2010.232025; Bjorklund M, 2012, AGE, V34, P987, DOI 10.1007/s11357-011-9294-5; Bolognani F, 2001, EUR J NUTR, V40, P293, DOI 10.1007/s394-001-8359-7; Bouhnik Y, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-8; Brighenti F, 1999, EUR J CLIN NUTR, V53, P726, DOI 10.1038/sj.ejcn.1600841; Collado MC, 2009, CURR DRUG METAB, V10, P68, DOI 10.2174/138920009787048437; De Preter V, 2010, MOL NUTR FOOD RES, V54, P1791, DOI 10.1002/mnfr.201000136; Dinoto A, 2006, APPL ENVIRON MICROB, V72, P784, DOI 10.1128/AEM.72.1.784-792.2006; Donohoe DR, 2011, CELL METAB, V13, P517, DOI 10.1016/j.cmet.2011.02.018; Engelbrektson A, 2009, J MED MICROBIOL, V58, P663, DOI 10.1099/jmm.0.47615-0; Francavilla R, 2010, PEDIATRICS, V126, pE1445, DOI 10.1542/peds.2010-0467; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; GAMET L, 1992, INT J CANCER, V52, P286, DOI 10.1002/ijc.2910520222; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Gobel R., 2010, International Journal of Probiotics and Prebiotics, V5, P53; Griffin IJ, 2002, BRIT J NUTR, V87, pS187, DOI [10.1079/BJN2001503, 10.1079/BJN/2002536]; Hansen MR, 2008, FOOD HYDROCOLLOID, V22, P1551, DOI 10.1016/j.foodhyd.2007.10.010; Heilig HGHJ, 2002, APPL ENVIRON MICROB, V68, P114, DOI 10.1128/AEM.68.1.114-123.2002; Hernandez-Hernandez O, 2011, J AGR FOOD CHEM, V59, P10901, DOI 10.1021/jf202466s; Holben WE, 2002, MICROB ECOL, V44, P175, DOI 10.1007/s00248-002-1011-6; Hughes R, 2000, Curr Issues Intest Microbiol, V1, P51; Hughes R, 2001, CARCINOGENESIS, V22, P43, DOI 10.1093/carcin/22.1.43; Hughes SA, 2008, FEMS MICROBIOL ECOL, V64, P482, DOI 10.1111/j.1574-6941.2008.00478.x; HUNGATE RE, 1950, BACTERIOL REV, V14, P1; Kalliomaki M, 2001, LANCET, V357, P1076, DOI 10.1016/S0140-6736(00)04259-8; Kukkonen K, 2008, PEDIATRICS, V122, P8, DOI 10.1542/peds.2007-1192; Kvist S, Soluble dietary fibre from oat and barley grains, method for producing a fraction rich in &UBeta;-glucan and use of the fraction in foods, pharmaceuticals and cosmetics: Patent Num, Patent No. [WO2005048735-A1, 2005048735]; Larsen N, 2011, FEMS MICROBIOL ECOL, V75, P482, DOI 10.1111/j.1574-6941.2010.01024.x; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Luoto R, 2010, INT J OBESITY, V34, P1531, DOI 10.1038/ijo.2010.50; Macfarlane GT, 1998, MICROB ECOL, V35, P180, DOI 10.1007/s002489900072; Mai V, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-49; Makelainen H., 2010, International Journal of Probiotics and Prebiotics, V5, P203; Makelainen H, 2010, BENEF MICROBES, V1, P139, DOI 10.3920/BM2009.0029; Makelainen H, 2010, BENEF MICROBES, V1, P81, DOI 10.3920/BM2009.0025; Makelainen H, 2009, LETT APPL MICROBIOL, V49, P666, DOI 10.1111/j.1472-765X.2009.02698.x; Makelainen H, 2009, INT DAIRY J, V19, P675, DOI 10.1016/j.idairyj.2009.06.005; Makelainen HS, 2007, J FOOD SCI, V72, pM153, DOI 10.1111/j.1750-3841.2007.00350.x; Makivuokko H, 2005, NUTR CANCER, V52, P94, DOI 10.1207/s15327914nc5201_12; Makivuokko H, 2010, BENEF MICROBES, V1, P131, DOI 10.3920/BM2009.0033; MARSH PD, 1995, J CHEM TECHNOL BIOT, V64, P1, DOI 10.1002/jctb.280640102; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Ouwehand AC, 2009, BRIT J NUTR, V101, P367, DOI 10.1017/S0007114508003097; Paineau D, 2008, FEMS IMMUNOL MED MIC, V53, P107, DOI 10.1111/j.1574-695X.2008.00413.x; Payne AN, 2011, NUTR DIABETES, V1, DOI 10.1038/nutd.2011.8; Quigley EMM, 2010, PHARMACOL RES, V61, P213, DOI 10.1016/j.phrs.2010.01.004; Rafter J, 2007, AM J CLIN NUTR, V85, P488, DOI 10.1093/ajcn/85.2.488; Rayes N, 2007, ANN SURG, V246, P36, DOI 10.1097/01.sla.0000259442.78947.19; Ringel-Kulka T, 2011, J CLIN GASTROENTEROL, V45, P518, DOI 10.1097/MCG.0b013e31820ca4d6; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Riordan Stephen M., 2007, Microbial Ecology in Health and Disease, V19, P7, DOI 10.1080/08910600601178709; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Rosenfeldt V, 2002, PEDIATR INFECT DIS J, V21, P417, DOI 10.1097/00006454-200205000-00013; Rosenfeldt V, 2003, J ALLERGY CLIN IMMUN, V111, P389, DOI 10.1067/mai.2003.389; Roy MJ, 2009, NUTRITION, V25, P1193, DOI 10.1016/j.nut.2009.04.008; Sannasiddappa TH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023227; Sanz ML, 2006, FEMS MICROBIOL ECOL, V56, P383, DOI 10.1111/j.1574-6941.2006.00075.x; Sanz ML, 2005, J AGR FOOD CHEM, V53, P5192, DOI 10.1021/jf050276w; SCHEPPACH W, 1995, EUR J CANCER, V31A, P1077, DOI 10.1016/0959-8049(95)00165-F; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Silk DBA, 2009, ALIMENT PHARM THER, V29, P508, DOI 10.1111/j.1365-2036.2008.03911.x; Snart J, 2006, APPL ENVIRON MICROB, V72, P1925, DOI 10.1128/AEM.72.3.1925-1931.2006; Song YL, 2004, APPL ENVIRON MICROB, V70, P6459, DOI 10.1128/AEM.70.11.6459-6465.2004; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; van den Heuvel EGHM, 2009, NUTR RES, V29, P229, DOI 10.1016/j.nutres.2009.03.005; Ventura M, 2001, APPL ENVIRON MICROB, V67, P2760, DOI 10.1128/AEM.67.6.2760-2765.2001; Walter J, 2001, APPL ENVIRON MICROB, V67, P2578, DOI 10.1128/AEM.67.6.2578-2585.2001; Walton GE, 2012, BRIT J NUTR, V107, P1466, DOI 10.1017/S0007114511004697; Welters CFM, 2002, DIS COLON RECTUM, V45, P621, DOI 10.1007/s10350-004-6257-2; Wickens K, 2008, J ALLERGY CLIN IMMUN, V122, P788, DOI 10.1016/j.jaci.2008.07.011	77	73	74	2	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47212	10.1371/journal.pone.0047212	http://dx.doi.org/10.1371/journal.pone.0047212			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082149	Green Submitted, Green Published, gold			2022-12-25	WOS:000311146900045
J	Gross, EL; Beall, CJ; Kutsch, SR; Firestone, ND; Leys, EJ; Griffen, AL				Gross, Erin L.; Beall, Clifford J.; Kutsch, Stacey R.; Firestone, Noah D.; Leys, Eugene J.; Griffen, Ann L.			Beyond Streptococcus mutans: Dental Caries Onset Linked to Multiple Species by 16S rRNA Community Analysis	PLOS ONE			English	Article							EARLY-CHILDHOOD CARIES; HUMAN CLINICAL SPECIMENS; SALIVARIUS TOVE-R; IN-VITRO; ORAL BACTERIA; MOLECULAR ANALYSIS; VEILLONELLA-ALCALESCENS; ARGININE DEIMINASE; GENUS VEILLONELLA; GNOTOBIOTIC-RATS	Dental caries in very young children may be severe, result in serious infection, and require general anesthesia for treatment. Dental caries results from a shift within the biofilm community specific to the tooth surface, and acidogenic species are responsible for caries. Streptococcus mutans, the most common acid producer in caries, is not always present and occurs as part of a complex microbial community. Understanding the degree to which multiple acidogenic species provide functional redundancy and resilience to caries-associated communities will be important for developing biologic interventions. In addition, microbial community interactions in health and caries pathogenesis are not well understood. The purpose of this study was to investigate bacterial community profiles associated with the onset of caries in the primary dentition. In a combination cross-sectional and longitudinal design, bacterial community profiles at progressive stages of caries and over time were examined and compared to those of health. 16S rRNA gene sequencing was used for bacterial community analysis. Streptococcus mutans was the dominant species in many, but not all, subjects with caries. Elevated levels of S. salivarius, S. sobrinus, and S. parasanguinis were also associated with caries, especially in subjects with no or low levels of S. mutans, suggesting these species are alternative pathogens, and that multiple species may need to be targeted for interventions. Veillonella, which metabolizes lactate, was associated with caries and was highly correlated with total acid producing species. Among children without previous history of caries, Veillonella, but not S. mutans or other acid-producing species, predicted future caries. Bacterial community diversity was reduced in caries as compared to health, as many species appeared to occur at lower levels or be lost as caries advanced, including the Streptococcus mitis group, Neisseria, and Streptococcus sanguinis. This may have implications for bacterial community resilience and the restoration of oral health.	[Kutsch, Stacey R.; Griffen, Ann L.] Ohio State Univ, Coll Dent, Div Pediat Dent & Community Oral Hlth, Columbus, OH 43210 USA; [Gross, Erin L.; Beall, Clifford J.; Firestone, Noah D.; Leys, Eugene J.] Ohio State Univ, Coll Dent, Div Oral Biol, Columbus, OH 43210 USA; [Kutsch, Stacey R.; Griffen, Ann L.] Nationwide Childrens Hosp, Dept Dent, Columbus, OH USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital	Griffen, AL (corresponding author), Ohio State Univ, Coll Dent, Div Pediat Dent & Community Oral Hlth, Columbus, OH 43210 USA.	griffen.1@osu.edu	Griffen, Ann/AAC-5999-2019; Beall, Clifford/D-1035-2012	Beall, Clifford/0000-0002-2198-9124	National Institute of Dental and Craniofacial Research, National Institutes of Health [R01DE016125, T32DE14320, F30DE019339]; OMNII Research Fellowship from the American Academy of Pediatric Dentistry; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE014320] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016125, F30DE019339] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); OMNII Research Fellowship from the American Academy of Pediatric Dentistry; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants R01DE016125, T32DE14320, and F30DE019339 from the National Institute of Dental and Craniofacial Research, National Institutes of Health (www.nidcr.nih.gov), and the OMNII Research Fellowship from the American Academy of Pediatric Dentistry (www.aapd.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas JA, 2008, J CLIN MICROBIOL, V46, P1407, DOI 10.1128/JCM.01410-07; Al-Shalan Thakib A., 1997, Pediatric Dentistry, V19, P37; Alm A, 2007, CARIES RES, V41, P392, DOI 10.1159/000104798; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arif N, 2008, J DENT RES, V87, P278, DOI 10.1177/154405910808700308; Becker MR, 2002, J CLIN MICROBIOL, V40, P1001, DOI 10.1128/JCM.40.3.1001-1009.2002; Beighton D, 2005, COMMUNITY DENT ORAL, V33, P248, DOI 10.1111/j.1600-0528.2005.00232.x; Bergey DH., 2001, BERGEYS MANUAL SYSTE; Bradshaw DJ, 1996, J APPL BACTERIOL, V80, P124, DOI 10.1111/j.1365-2672.1996.tb03199.x; BRADSHAW DJ, 1989, J DENT RES, V68, P1298, DOI 10.1177/00220345890680090101; Bradshaw DJ, 1998, CARIES RES, V32, P456, DOI 10.1159/000016487; Burne RA, 1998, J DENT RES, V77, P445, DOI 10.1177/00220345980770030301; Burne RA, 2000, FEMS MICROBIOL LETT, V193, P1; Byun R, 2004, J CLIN MICROBIOL, V42, P3128, DOI 10.1128/JCM.42.7.3128-3136.2004; Casamassimo PS, 2009, J AM DENT ASSOC, V140, P650, DOI 10.14219/jada.archive.2009.0250; Chen YYM, 1996, FEMS MICROBIOL LETT, V135, P223, DOI 10.1016/0378-1097(95)00454-8; CHESTNUTT IG, 1994, ARCH ORAL BIOL, V39, P589, DOI 10.1016/0003-9969(94)90134-1; Chhour KL, 2005, J CLIN MICROBIOL, V43, P843, DOI 10.1128/JCM.43.2.843-849.2005; Choi EJ, 2009, INT J PAEDIATR DENT, V19, P141, DOI 10.1111/j.1365-263X.2008.00942.x; Corby PM, 2007, TWIN RES HUM GENET, V10, P821, DOI 10.1375/twin.10.6.821; Crielaard W, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-22; Dong YQ, 2002, APPL ENVIRON MICROB, V68, P5549, DOI 10.1128/AEM.68.11.5549-5553.2002; DRUCKER DB, 1984, ARCH ORAL BIOL, V29, P437, DOI 10.1016/0003-9969(84)90024-4; Griffen AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019051; Gross EL, 2010, J CLIN MICROBIOL, V48, P4121, DOI 10.1128/JCM.01232-10; HIROSE H, 1993, CARIES RES, V27, P292, DOI 10.1159/000261553; HORTON WA, 1985, ARCH ORAL BIOL, V30, P777, DOI 10.1016/0003-9969(85)90131-1; HOWELL A, 1961, BACTERIOL REV, V25, P162, DOI 10.1128/MMBR.25.2.162-171.1961; Hughes CV, 2012, PEDIAT DENT, V34, P16; Jiang W, 2011, MICROB ECOL, V61, P342, DOI 10.1007/s00248-010-9753-z; Kanasi E, 2010, J DENT RES, V89, P378, DOI 10.1177/0022034509360010; Kanellis MJ, 2000, J PUBLIC HEALTH DENT, V60, P28; Kawamura Y, 1998, INT J SYST BACTERIOL, V48, P921, DOI 10.1099/00207713-48-3-921; KAWAMURA Y, 1995, INT J SYST BACTERIOL, V45, P406, DOI 10.1099/00207713-45-2-406; KIKUCHI K, 1995, J CLIN MICROBIOL, V33, P1215, DOI 10.1128/JCM.33.5.1215-1222.1995; Kleinberg I, 2002, CRIT REV ORAL BIOL M, V13, P108, DOI 10.1177/154411130201300202; Kumar PS, 2005, J CLIN MICROBIOL, V43, P3944, DOI 10.1128/JCM.43.8.3944-3955.2005; Kuramitsu Howard K, 2006, BMC Oral Health, V6 Suppl 1, pS11; LEYS EJ, 1994, J CLIN MICROBIOL, V32, P1288, DOI 10.1128/JCM.32.5.1288-1294.1994; Li Y, 2007, J CLIN MICROBIOL, V45, P81, DOI 10.1128/JCM.01622-06; Lima KC, 2011, CARIES RES, V45, P21, DOI 10.1159/000322299; Lin X, 2008, J BACTERIOL, V190, P4367, DOI 10.1128/JB.01898-07; Liu JM, 2011, MICROBIOL-SGM, V157, P2433, DOI 10.1099/mic.0.048314-0; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; LOESCHE WJ, 1973, CARIES RES, V7, P201, DOI 10.1159/000259844; Loyola-Rodriguez Juan Pablo, 2008, J Clin Pediatr Dent, V32, P121; Marchandin H, 2003, MICROBIOL-SGM, V149, P1493, DOI 10.1099/mic.0.26132-0; Marchant S, 2001, CARIES RES, V35, P397, DOI 10.1159/000047482; MARGOLIS HC, 1985, J DENT RES, V64, P786, DOI 10.1177/00220345850640050101; Margolis HC, 1999, J DENT RES, V78, P1326, DOI 10.1177/00220345990780070701; Marsh P D, 1994, Adv Dent Res, V8, P263; Marsh PD, 2003, MICROBIOL-SGM, V149, P279, DOI 10.1099/mic.0.26082-0; Mattila ML, 2005, CARIES RES, V39, P85, DOI 10.1159/000083152; MCDERMID AS, 1986, J GEN MICROBIOL, V132, P1205; MIKX FHM, 1975, ARCH ORAL BIOL, V20, P407, DOI 10.1016/0003-9969(75)90224-1; MOORE LVH, 1987, INT J SYST BACTERIOL, V37, P271, DOI 10.1099/00207713-37-3-271; NOORDA WD, 1988, CARIES RES, V22, P342, DOI 10.1159/000261134; Okada M, 2005, J MED MICROBIOL, V54, P661, DOI 10.1099/jmm.0.46069-0; Oksanen J., 2011, COMMUNITY ECOLOGY; Paddick JS, 2005, APPL ENVIRON MICROB, V71, P2467, DOI 10.1128/AEM.71.5.2467-2472.2005; Palmer CA, 2010, J DENT RES, V89, P1224, DOI 10.1177/0022034510376543; Peretz Benjamin, 2003, Pediatr Dent, V25, P114; Preza D, 2008, J CLIN MICROBIOL, V46, P2015, DOI 10.1128/JCM.02411-07; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; ROGOSA M, 1964, J BACTERIOL, V87, P162, DOI 10.1128/JB.87.1.162-170.1964; Seki M, 2006, ORAL MICROBIOL IMMUN, V21, P47, DOI 10.1111/j.1399-302X.2005.00253.x; Tanner ACR, 2011, J CLIN MICROBIOL, V49, P1464, DOI 10.1128/JCM.02427-10; Tanzer J M, 2001, J Dent Educ, V65, P1028; TANZER JM, 1985, INFECT IMMUN, V48, P44, DOI 10.1128/IAI.48.1.44-50.1985; TANZER JM, 1985, INFECT IMMUN, V49, P76, DOI 10.1128/IAI.49.1.76-83.1985; Toro E, 2010, ARCH ORAL BIOL, V55, P249, DOI 10.1016/j.archoralbio.2009.12.007; US Department of Health and Human Services, 2000, OR HLTH AM REP SURG; VANHOUTE J, 1994, J DENT RES, V73, P672, DOI 10.1177/00220345940730031301; Wang BY, 2005, APPL ENVIRON MICROB, V71, P354, DOI 10.1128/AEM.71.1.354-362.2005; WHILEY RA, 1990, FEMS MICROBIOL LETT, V68, P115, DOI 10.1111/j.1574-6968.1990.tb04133.x; WILLCOX MDP, 1988, ARCH ORAL BIOL, V33, P109, DOI 10.1016/0003-9969(88)90053-2; WILLCOX MDP, 1991, ARCH ORAL BIOL, V36, P327, DOI 10.1016/0003-9969(91)90001-B	77	280	294	7	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47722	10.1371/journal.pone.0047722	http://dx.doi.org/10.1371/journal.pone.0047722			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091642	gold, Green Submitted, Green Published			2022-12-25	WOS:000310135800068
J	Mapanga, RF; Rajamani, U; Dlamini, N; Zungu-Edmondson, M; Kelly-Laubscher, R; Shafiullah, M; Wahab, A; Hasan, MY; Fahim, MA; Rondeau, P; Bourdon, E; Essop, MF				Mapanga, Rudo F.; Rajamani, Uthra; Dlamini, Nonkululeko; Zungu-Edmondson, Makhosazane; Kelly-Laubscher, Roisin; Shafiullah, Mohammed; Wahab, Athiq; Hasan, Mohamed Y.; Fahim, Mohamed A.; Rondeau, Philippe; Bourdon, Emmanuel; Essop, M. Faadiel			Oleanolic Acid: A Novel Cardioprotective Agent That Blunts Hyperglycemia-Induced Contractile Dysfunction	PLOS ONE			English	Article							NF-KAPPA-B; HEXOSAMINE BIOSYNTHETIC-PATHWAY; ISCHEMIA-REPERFUSION INJURY; ACUTE MYOCARDIAL-INFARCTION; INDUCED DIABETIC-RATS; NITRIC-OXIDE; OXIDATIVE STRESS; IN-VITRO; MITOCHONDRIAL RESPIRATION; CORONARY-ARTERIOGRAPHY	Diabetes constitutes a major health challenge. Since cardiovascular complications are common in diabetic patients this will further increase the overall burden of disease. Furthermore, stress-induced hyperglycemia in non-diabetic patients with acute myocardial infarction is associated with higher in-hospital mortality. Previous studies implicate oxidative stress, excessive flux through the hexosamine biosynthetic pathway (HBP) and a dysfunctional ubiquitin-proteasome system (UPS) as potential mediators of this process. Since oleanolic acid (OA; a clove extract) possesses antioxidant properties, we hypothesized that it attenuates acute and chronic hyperglycemia-mediated pathophysiologic molecular events (oxidative stress, apoptosis, HBP, UPS) and thereby improves contractile function in response to ischemia-reperfusion. We employed several experimental systems: 1) H9c2 cardiac myoblasts were exposed to 33 mM glucose for 48 hr vs. controls (5 mM glucose); and subsequently treated with two OA doses (20 and 50 mu M) for 6 and 24 hr, respectively; 2) Isolated rat hearts were perfused ex vivo with Krebs-Henseleit buffer containing 33 mM glucose vs. controls (11 mM glucose) for 60 min, followed by 20 min global ischemia and 60 min reperfusion +/- OA treatment; 3) In vivo coronary ligations were performed on streptozotocin treated rats +/- OA administration during reperfusion; and 4) Effects of long-term OA treatment (2 weeks) on heart function was assessed in streptozotocin-treated rats. Our data demonstrate that OA treatment blunted high glucose-induced oxidative stress and apoptosis in heart cells. OA therapy also resulted in cardioprotection, i.e. for ex vivo and in vivo rat hearts exposed to ischemia-reperfusion under hyperglycemic conditions. In parallel, we found decreased oxidative stress, apoptosis, HBP flux and proteasomal activity following ischemia-reperfusion. Long-term OA treatment also improved heart function in streptozotocin-diabetic rats. These findings are promising since it may eventually result in novel therapeutic interventions to treat acute hyperglycemia (in non-diabetic patients) and diabetic patients with associated cardiovascular complications.	[Mapanga, Rudo F.; Rajamani, Uthra; Essop, M. Faadiel] Univ Stellenbosch, Dept Physiol Sci, CMRG, ZA-7600 Stellenbosch, South Africa; [Dlamini, Nonkululeko; Zungu-Edmondson, Makhosazane] Univ KwaZulu Natal, Sch Med Sci, Discipline Physiol, Durban, South Africa; [Kelly-Laubscher, Roisin] Univ Cape Town, Fac Hlth Sci, Dept Human Biol, Observatory, South Africa; [Shafiullah, Mohammed; Wahab, Athiq; Hasan, Mohamed Y.; Fahim, Mohamed A.] United Arab Emirates Univ, Fac Med & Hlth Sci, Al Ain, U Arab Emirates; [Rondeau, Philippe; Bourdon, Emmanuel] Univ Reunion, GEICO, St Denis De La Reunion, France	Stellenbosch University; University of Kwazulu Natal; University of Cape Town; United Arab Emirates University; University of La Reunion	Essop, MF (corresponding author), Univ Stellenbosch, Dept Physiol Sci, CMRG, ZA-7600 Stellenbosch, South Africa.	mfessop@sun.ac.za	Bourdon, Emmanuel/P-8455-2019; rondeau, philippe/F-6755-2015; rondeau, philippe/Q-1967-2019; Kelly-Laubscher, Roisin F/AAC-6012-2019	rondeau, philippe/0000-0002-4652-1376; Kelly-Laubscher, Roisin F/0000-0002-6379-9943; Bourdon, Emmanuel/0000-0003-3731-150X; Essop, Faadiel/0000-0002-8434-4294	South African National Research Foundation; Stellenbosch University; Ministere de l'Enseignement Superieur et de la Recherche; Universite de La Reunion; Conseil Regional de La Reunion; l'Europe	South African National Research Foundation(National Research Foundation - South Africa); Stellenbosch University; Ministere de l'Enseignement Superieur et de la Recherche(Estonian Research CouncilEuropean Commission); Universite de La Reunion; Conseil Regional de La Reunion; l'Europe	This work was supported by the South African National Research Foundation and Stellenbosch University (to MFE). Experimental work conducted at Universite de La Reunion was supported by the Ministere de l'Enseignement Superieur et de la Recherche and the Universite de La Reunion and the Conseil Regional de La Reunion and l'Europe (to EB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MS, 2002, PHYTOCHEMISTRY, V60, P295, DOI 10.1016/S0031-9422(02)00104-8; Arstall MA, 1999, CIRC RES, V85, P829, DOI 10.1161/01.RES.85.9.829; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Bradshaw D, 2007, SAMJ S AFR MED J, V97, P700; Brown GC, 2001, BBA-BIOENERGETICS, V1504, P46, DOI 10.1016/S0005-2728(00)00238-3; Bulteau AL, 2001, J BIOL CHEM, V276, P30057, DOI 10.1074/jbc.M100142200; Cai L, 2002, DIABETES, V51, P1938, DOI 10.2337/diabetes.51.6.1938; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Carvalho G, 2011, J CLIN ENDOCR METAB, V96, P1469, DOI 10.1210/jc.2010-1934; Ceriello A, 2000, METABOLISM, V49, P27, DOI 10.1016/S0026-0495(00)80082-7; Ceriello A, 2002, DIABETES, V51, P1076, DOI 10.2337/diabetes.51.4.1076; Choi CY, 2001, BIOCHEM BIOPH RES CO, V288, P49, DOI 10.1006/bbrc.2001.5727; CROSS HR, 1995, J MOL CELL CARDIOL, V27, P1369, DOI 10.1006/jmcc.1995.0130; D'Amico M, 2001, DIABETOLOGIA, V44, P464, DOI 10.1007/s001250051644; Deuchar GA, 2007, LIFE SCI, V80, P1686, DOI 10.1016/j.lfs.2007.01.040; Du Y, 2006, PLANTA MED, V72, P222, DOI 10.1055/s-2005-916197; Du Y, 2006, MOL CELL BIOCHEM, V288, P135, DOI [10.1007/s11010-006-9129-3, 10.1016/j.molcel.2005.11.014]; EYER KM, 1973, AM HEART J, V86, P428, DOI 10.1016/0002-8703(73)90057-4; Friguet B, 2002, METHOD ENZYMOL, V353, P253; Ge F, 2010, J MED MICROBIOL, V59, P567, DOI 10.1099/jmm.0.014837-0; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GOKHROO R, 1989, INT J CARDIOL, V22, P267, DOI 10.1016/0167-5273(89)90078-8; Gurib-Fakim Ameenah, 2006, Molecular Aspects of Medicine, V27, P1, DOI 10.1016/j.mam.2005.07.008; Han SK, 1997, LIPIDS, V32, P769, DOI 10.1007/s11745-997-0098-9; Harvey CJ, 2009, FREE RADICAL BIO MED, V46, P443, DOI 10.1016/j.freeradbiomed.2008.10.040; Hostettmann K, 1995, CHEM PHARM NATURAL P; Howarth F C, 2001, Arch Physiol Biochem, V109, P200, DOI 10.1076/apab.109.3.200.11598; Ichikawa T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008391; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Jonassen AK, 2001, CIRC RES, V89, P1191, DOI 10.1161/hh2401.101385; Kaiserova K, 2006, J BIOL CHEM, V281, P15110, DOI 10.1074/jbc.M600837200; Kelly RF, 2010, BASIC RES CARDIOL, V105, P763, DOI 10.1007/s00395-010-0125-0; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Mapanga RF, 2009, RENAL FAILURE, V31, P481, DOI 10.1080/08860220902963558; Marfella R, 2009, CARDIOVASC PATHOL, V18, P332, DOI 10.1016/j.carpath.2008.09.008; Marfella R, 2009, J AM COLL CARDIOL, V53, P1425, DOI 10.1016/j.jacc.2009.01.041; Mazzone T, 2008, LANCET, V371, P1800, DOI 10.1016/S0140-6736(08)60768-0; Mehta SR, 2005, JAMA-J AM MED ASSOC, V293, P437; Musabayane CT, 2010, RENAL FAILURE, V32, P832, DOI 10.3109/0886022X.2010.494802; OSWALD GA, 1986, BMJ-BRIT MED J, V293, P917, DOI 10.1136/bmj.293.6552.917; Powell SR, 2008, J MOL CELL CARDIOL, V44, P618, DOI 10.1016/j.yjmcc.2007.12.009; Pye J, 2003, AM J PHYSIOL-HEART C, V284, pH919, DOI 10.1152/ajpheart.00851.2002; Rajamani U, 2011, ACTA PHYSIOL, V202, P151, DOI 10.1111/j.1748-1716.2011.02275.x; Rajamani U, 2010, AM J PHYSIOL-CELL PH, V299, pC139, DOI 10.1152/ajpcell.00020.2010; Requena JR, 2003, AMINO ACIDS, V25, P221, DOI 10.1007/s00726-003-0012-1; Rong ZT, 2011, PHARM BIOL, V49, P78, DOI 10.3109/13880209.2010.499130; Sack MN, 2003, J AM COLL CARDIOL, V41, P1404, DOI 10.1016/S0735-1097(03)00164-5; Senthil S, 2007, TOXICOL PATHOL, V35, P418, DOI 10.1080/01926230701230312; Somova LI, 2003, J ETHNOPHARMACOL, V84, P299, DOI 10.1016/S0378-8741(02)00332-X; Soobrattee MA, 2005, MUTAT RES-FUND MOL M, V579, P200, DOI 10.1016/j.mrfmmm.2005.03.023; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Tang WH, 2010, AM J PHYSIOL-CELL PH, V299, pC643, DOI 10.1152/ajpcell.00137.2010; Van den Berghe G, 2011, J CLIN ENDOCR METAB, V96, P1272, DOI 10.1210/jc.2011-0683; WALKER WJ, 1973, NEW ENGL J MED, V288, P826, DOI 10.1056/NEJM197304192881607; Wang X, 2011, PHYTOTHER RES, V25, P1031, DOI 10.1002/ptr.3385; Wang X, 2010, CHEM-BIOL INTERACT, V184, P328, DOI 10.1016/j.cbi.2010.01.034; Wang XJ, 2011, AM J PHYSIOL-HEART C, V301, pH2207, DOI 10.1152/ajpheart.00714.2011; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Xie YW, 1996, CIRCULATION, V94, P2580, DOI 10.1161/01.CIR.94.10.2580; Yu XC, 2010, CARDIOVASC RES, V85, P312, DOI 10.1093/cvr/cvp309	63	38	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47322	10.1371/journal.pone.0047322	http://dx.doi.org/10.1371/journal.pone.0047322			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091615	Green Published, gold			2022-12-25	WOS:000310135800038
J	Wong, EB; Omar, T; Setlhako, GJ; Osih, R; Feldman, C; Murdoch, DM; Martinson, NA; Bangsberg, DR; Venter, WDF				Wong, Emily B.; Omar, Tanvier; Setlhako, Gosetsemang J.; Osih, Regina; Feldman, Charles; Murdoch, David M.; Martinson, Neil A.; Bangsberg, David R.; Venter, W. D. F.			Causes of Death on Antiretroviral Therapy: A Post-Mortem Study from South Africa	PLOS ONE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; HIV-POSITIVE PATIENTS; SUB-SAHARAN AFRICA; EARLY MORTALITY; AUTOPSY; TUBERCULOSIS; DISEASE; ADULTS; PATHOLOGY; COHORT	Background: Mortality in the first months of antiretroviral therapy (ART) is a significant clinical problem in sub-Saharan Africa. To date, no post-mortem study has investigated the causes of mortality in these patients. Methods: HIV-positive adults who died as in-patients at a Johannesburg academic hospital underwent chart-review and ultrasound-guided needle autopsy for histological and microbiological examination of lung, liver, spleen, kidney, bone marrow, lymph node, skin and cerebrospinal fluid. A clinico-pathologic committee considered all available data and adjudicated immediate and contributing causes of death. Results: Thirty-nine adults were enrolled: 1 14 pre-ART, 15 early-ART (7-90 days), and 10 late-ART (>90 days). Needle sampling yielded adequate specimen in 100% of kidney, skin, heart and cerebrospinal fluid samples, 97% of livers and lungs, 92% of bone marrows, 87% of spleens and 68% of lymph nodes. Mycobacterial infections were implicated in 69% of deaths (26 of 27 of these due to M. tuberculosis), bacterial infections in 33%, fungal infections in 21%, neoplasm in 26%, and non-infectious organ failure in 26%. Immune reconstitution inflammatory syndrome (IRIS) was implicated in 73% of early-ART deaths. Post-mortem investigations revealed previously undiagnosed causes of death in 49% of cases. Multiple pathologies were common with 62% of subjects with mycobacterial infection also having at least one other infectious or neoplastic cause of death. Conclusions: Needle biopsy was efficient and yielded excellent pathology. The large majority of deaths in all three groups were caused by M. tuberculosis suggesting an urgent need for improved diagnosis and expedited treatment prior to and throughout the course of antiretroviral therapy. Complex, unrecognized co-morbidities pose an additional challenge.	[Wong, Emily B.; Setlhako, Gosetsemang J.; Osih, Regina; Venter, W. D. F.] Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa; [Wong, Emily B.] Massachusetts Gen Hosp, Div Infect Dis, Boston, MA 02114 USA; [Wong, Emily B.] Univ KwaZulu Natal, KwaZulu Natal Res Inst TB & HIV, Durban, South Africa; [Omar, Tanvier] Univ Witwatersrand, Fac Hlth Sci, Sch Pathol, Johannesburg, South Africa; [Setlhako, Gosetsemang J.; Feldman, Charles] Univ Witwatersrand, Charlotte Maxeke Johannesburg Acad Hosp, Dept Internal Med, Johannesburg, South Africa; [Murdoch, David M.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Martinson, Neil A.] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa; [Martinson, Neil A.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Bangsberg, David R.] Harvard Univ, Sch Med, Ragon Inst MGH MIT & Harvard, Massachusetts Gen Hosp,Ctr Global Hlth, Boston, MA 02115 USA	University of Witwatersrand; Harvard University; Massachusetts General Hospital; University of Kwazulu Natal; University of Witwatersrand; University of Witwatersrand; Duke University; University of Witwatersrand; Johns Hopkins University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Wong, EB (corresponding author), Univ Witwatersrand, Wits Reprod Hlth & HIV Inst, Johannesburg, South Africa.	emily.wong@k-rith.org	Feldman, Charles/ABF-3315-2020	Feldman, Charles/0000-0002-6881-8314; Venter, Willem/0000-0002-4157-732X	Fogarty International Center at the National Institutes of Health [R24TW007988, RTW007373/0, D43TW000010-21S1]; President's Emergency Plan for AIDS Relief [674-A-00-08-00005-00]; National Research Foundation of South Africa; FOGARTY INTERNATIONAL CENTER [K01TW008005, U2RTW007373, D43TW000010, R24TW007988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI060354, T32AI007387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K24MH087227] Funding Source: NIH RePORTER	Fogarty International Center at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); President's Emergency Plan for AIDS Relief(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Research Foundation of South Africa(National Research Foundation - South Africa); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Fogarty International Center at the National Institutes of Health (www.fic.nih.gov, R24TW007988 supported and provided research training to E. B. W. and G.J.S.; RTW007373/0 supported N.M. and provided research training to W. D. F. V.; and D43TW000010-21S1 provided research training to T.O.), the President's Emergency Plan for AIDS Relief (www.pepfar.gov, 674-A-00-08-00005-00 supported R.O., G.J.S, W. D. F. V.), and the National Research Foundation of South Africa (www.nrf.ac.za, supported C. F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; BAUMGART KW, 1994, PATHOLOGY, V26, P141, DOI 10.1080/00313029400169381; Bisson GP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001725; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Castelnuovo B, 2009, CLIN INFECT DIS, V49, P965, DOI 10.1086/605500; Chakraborty R, 2002, ANN TROP PAEDIATR, V22, P125, DOI 10.1179/027249302125000841; Cohen T, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000296; Cox JA, 2010, AIDS REV, V12, P183; Cury PM, 2003, PATHOL RES PRACT, V199, P811, DOI 10.1078/0344-0338-00500; de Cherif TKS, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-205; Domoua K, 1995, Med Trop (Mars), V55, P252; Etard JF, 2006, AIDS, V20, P1181, DOI 10.1097/01.aids.0000226959.87471.01; Gous N, 2012, J CLIN MICROBIOL, V50, P2100, DOI 10.1128/JCM.00252-12; GREENBERG AE, 1995, AIDS, V9, P1251, DOI 10.1097/00002030-199511000-00006; Guerra I, 2001, PATHOL RES PRACT, V197, P165, DOI 10.1078/0344-0338-00028; Gupta A, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022730, 10.1371/journal.pone.0028691]; Hanzlick R, 1996, ARCH INTERN MED, V156, P25, DOI 10.1001/archinte.156.1.25; Huston BM, 1996, MODERN PATHOL, V9, P1101; Karstaedt A, 2009, CAUSES DEATH PATIENT; Kyeyune R, 2010, JAIDS-J ACQ IMM DEF, V55, P446, DOI 10.1097/QAI.0b013e3181eb611a; Lanjewar DN, 2011, PATHOLOG RES INT, V2011; Lawn SD, 2005, AIDS, V19, P2050, DOI 10.1097/01.aids.0000191232.16111.f9; Lawn SD, 2008, AIDS, V22, P1897, DOI 10.1097/QAD.0b013e32830007cd; Lawn SD, 2008, CURR OPIN HIV AIDS, V3, P425, DOI 10.1097/COH.0b013e3282fe99dc; Lawn SD, 2009, AIDS, V23, P143, DOI 10.1097/QAD.0b013e32831d2a98; Leng K, 2008, INT J STD AIDS, V19, P642, DOI 10.1258/ijsa.2008.008062; LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005; Lucas S, 2012, CURR OPIN INFECT DIS, V25, P36, DOI 10.1097/QCO.0b013e32834ef5c4; MacPherson P, 2009, T ROY SOC TROP MED H, V103, P588, DOI 10.1016/j.trstmh.2008.10.001; Makadzange AT, 2010, CLIN INFECT DIS, V50, P1532, DOI 10.1086/652652; Martinson NA, 2007, AIDS, V21, P2043, DOI 10.1097/QAD.0b013e3282eea47f; Meintjes G, 2009, CLIN INFECT DIS, V48, P667, DOI 10.1086/596764; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; MOHAR A, 1992, AIDS, V6, P467, DOI 10.1097/00002030-199205000-00005; Murdoch DA, 2008, AIDS, V22, P601, DOI 10.1097/QAD.0b013e3282f4a607; Murray J, 2007, AIDS, V21, pS97, DOI 10.1097/01.aids.0000299416.61808.24; Nojilana B, 2009, SAMJ S AFR MED J, V99, P648; Rana FS, 2000, J ACQ IMMUN DEF SYND, V24, P23; Satyanarayana S, 2003, Indian J Pathol Microbiol, V46, P416; Severe P, 2005, NEW ENGL J MED, V353, P2325, DOI 10.1056/NEJMoa051908; Soeiro AD, 2008, CLINICS, V63, P497, DOI 10.1590/S1807-59322008000400014; Wester CW, 2007, JAIDS-J ACQ IMM DEF, V46, P318, DOI 10.1097/QAI.0b013e3181568e3f	42	104	105	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47542	10.1371/journal.pone.0047542	http://dx.doi.org/10.1371/journal.pone.0047542			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23094059	gold, Green Published			2022-12-25	WOS:000310135800054
J	Portal-Celhay, C; Nehrke, K; Blaser, MJ				Portal-Celhay, Cynthia; Nehrke, Keith; Blaser, Martin J.			Effect of Caenorhabditis elegans age and genotype on horizontal gene transfer in intestinal bacteria	FASEB JOURNAL			English	Article						conjugation; mating; in vivo	INFECTIOUS DRUG-RESISTANCE; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; CONJUGAL TRANSFER; LACTOBACILLUS-PLANTARUM; ENTEROCOCCUS-FAECALIS; HELICOBACTER-PYLORI; RHYTHMIC BEHAVIOR; PLASMID; EVOLUTION	Horizontal gene transfer (HGT) between bacteria occurs in the intestinal tract of their animal hosts and facilitates both virulence and antibiotic resistance. A model in which both the pathogen and the host are genetically tractable facilitates developing insight into mechanistic processes enabling or restricting the transfer of antibiotic resistance genes. Here we develop an in vivo experimental system to study HGT in bacteria using Caenorhabditis elegans as a model host. Using a thermosensitive conjugative system, we provide evidence that conjugation between two Escherichia coli strains can take place in the intestinal lumen of N2 wild-type worms at a rate of 10(-3) and 10(-2) per donor. We also show that C. elegans age and genotype are important determinants of the frequency of conjugation. Whereas similar to 1 transconjugant for every 100 donor cells could be recovered from the intestine of N2 C. elegans, for the age-1 and tol-1 mutants, the detected rate of transconjugation (10(-3) and 10(-4) per donor cell, respectively) was significantly lower. This work demonstrates that increased recombination among lumenal microbial populations is a phenotype associated with host aging, and the model provides a framework to study the dynamics of bacterial horizontal gene transfer within the intestinal environment.-Portal-Celhay, C., Nehrke, K., Blaser, M. J. Effect of Caenorhabditis elegans age and genotype on horizontal gene transfer in intestinal bacteria. FASEB J. 27, 760-768 (2013). www.fasebj.org	[Portal-Celhay, Cynthia; Blaser, Martin J.] NYU, Dept Med, Langone Med Ctr, New York, NY 10016 USA; [Portal-Celhay, Cynthia; Blaser, Martin J.] NYU, Dept Microbiol, Langone Med Ctr, New York, NY 10016 USA; [Nehrke, Keith] Univ Rochester, Sch Med & Dent, Rochester, NY USA	New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; University of Rochester	Blaser, MJ (corresponding author), 550 1st Ave,OBV A606, New York, NY 10016 USA.	martin.blaser@nyumc.org		Nehrke, Keith/0000-0001-9697-726X	U.S. National Institutes of Health (NIH) [RO1 GM63270]; National Science Foundation [IOS0919848]; Michael Saperstein Medical Scholars Program; Ellison Medical Foundation; Diane Belfer Program for Human Microbial Ecology; NIH Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063270] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Michael Saperstein Medical Scholars Program; Ellison Medical Foundation(Lawrence Ellison Foundation); Diane Belfer Program for Human Microbial Ecology; NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by U.S. National Institutes of Health (NIH) grant RO1 GM63270 and National Science Foundation grant IOS0919848 (K.N.), the Michael Saperstein Medical Scholars Program, the Ellison Medical Foundation, and the Diane Belfer Program for Human Microbial Ecology. C. elegans strains were provided by the Caenorhabditis Genetic Center (University of Minnesota, Minneapolis, MN, USA), which is funded by the NIH Office of Research Infrastructure Programs (P40 OD010440).	Aballay A, 2000, CURR BIOL, V10, P1539, DOI 10.1016/S0960-9822(00)00830-7; Alegado RA, 2008, CELL MICROBIOL, V10, P1259, DOI 10.1111/j.1462-5822.2008.01124.x; Allman E, 2009, AM J PHYSIOL-CELL PH, V297, pC1071, DOI 10.1152/ajpcell.00284.2009; Alper S, 2007, MOL CELL BIOL, V27, P5544, DOI 10.1128/MCB.02070-06; Arber W, 2009, J BIOTECHNOL, V144, P242, DOI 10.1016/j.jbiotec.2009.05.010; Atherton JC, 2009, J CLIN INVEST, V119, P2475, DOI 10.1172/JCI38605; AVERY L, 1993, GENETICS, V133, P897; Barkay T, 2010, ENVIRON MICROBIOL, V12, P2904, DOI 10.1111/j.1462-2920.2010.02260.x; Blaser MJ, 1997, J PHYSIOL PHARMACOL, V48, P307; Boto L, 2010, P ROY SOC B-BIOL SCI, V277, P819, DOI 10.1098/rspb.2009.1679; Bourgeois-Nicolaos N, 2006, FEMS MICROBIOL LETT, V254, P27, DOI 10.1111/j.1574-6968.2005.00004.x; Dahl KH, 2007, J ANTIMICROB CHEMOTH, V59, P478, DOI 10.1093/jac/dkl530; de Boer P, 2002, MOL MICROBIOL, V44, P351, DOI 10.1046/j.1365-2958.2002.02930.x; Feld L, 2008, J ANTIMICROB CHEMOTH, V61, P845, DOI 10.1093/jac/dkn033; FISHER KW, 1957, J GEN MICROBIOL, V16, P136, DOI 10.1099/00221287-16-1-136; FRETER R, 1983, INFECT IMMUN, V39, P676, DOI 10.1128/IAI.39.2.676-685.1983; Garsin DA, 2001, P NATL ACAD SCI USA, V98, P10892, DOI 10.1073/pnas.191378698; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Jacobsen L, 2007, FEMS MICROBIOL ECOL, V59, P158, DOI 10.1111/j.1574-6941.2006.00212.x; JAROLMEN H, 1969, J BACTERIOL, V99, P487, DOI 10.1128/JB.99.2.487-490.1969; Kassen R, 2004, ANNU REV MICROBIOL, V58, P207, DOI 10.1146/annurev.micro.58.030603.123654; KINGSMAN A, 1978, J MOL BIOL, V122, P287, DOI 10.1016/0022-2836(78)90191-2; Lampkowska J, 2008, INT J FOOD MICROBIOL, V127, P172, DOI 10.1016/j.ijfoodmicro.2008.06.017; Lawley TD, 2002, J BACTERIOL, V184, P2173, DOI 10.1128/JB.184.8.2173-2180.2002; Lester CH, 2004, FEMS MICROBIOL LETT, V235, P385, DOI 10.1016/j.femsle.2004.04.050; Levin BR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000601; Ley RE, 2008, NAT REV MICROBIOL, V6, P776, DOI 10.1038/nrmicro1978; Ley RE, 2008, SCIENCE, V320, P1647, DOI 10.1126/science.1155725; Licht TR, 1999, MICROBIOL-SGM, V145, P2615, DOI 10.1099/00221287-145-9-2615; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Marteau P, 1993, World Rev Nutr Diet, V74, P1; Nagachinta S, 2008, APPL ENVIRON MICROB, V74, P5063, DOI 10.1128/AEM.00517-08; Nehrke K, 2003, J BIOL CHEM, V278, P44657, DOI 10.1074/jbc.M307351200; Pacheco ABF, 1997, J CLIN MICROBIOL, V35, P1521, DOI 10.1128/JCM.35.6.1521-1525.1997; Pang T, 1998, TRENDS MICROBIOL, V6, P131, DOI 10.1016/S0966-842X(98)01236-0; Pfeiffer J, 2008, CURR BIOL, V18, P297, DOI 10.1016/j.cub.2008.01.054; Portal-Celhay C, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-49; Portal-Celhay C, 2012, INFECT IMMUN, V80, P1288, DOI 10.1128/IAI.05522-11; Power EGM, 1996, J HOSP INFECT, V34, P247, DOI 10.1016/S0195-6701(96)90106-1; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; Rae R, 2012, INT J PARASITOL, V42, P747, DOI 10.1016/j.ijpara.2012.05.005; Riddle DL, 1997, C ELEGANS; Roeder T, 2010, DEV COMP IMMUNOL, V34, P203, DOI 10.1016/j.dci.2009.09.010; Rooker MM, 1999, PLASMID, V41, P226, DOI 10.1006/plas.1999.1396; Salyers AA, 2004, TRENDS MICROBIOL, V12, P412, DOI 10.1016/j.tim.2004.07.004; Schjorring S, 2008, J ANTIMICROB CHEMOTH, V62, P1086, DOI 10.1093/jac/dkn323; Sherburne C, 1997, J BACTERIOL, V179, P952, DOI 10.1128/jb.179.3.952-955.1997; Shoemaker NB, 2001, APPL ENVIRON MICROB, V67, P561, DOI 10.1128/AEM.67.2.561-568.2001; Singh V, 2006, P NATL ACAD SCI USA, V103, P13092, DOI 10.1073/pnas.0604050103; SINGLETON P, 1983, APPL ENVIRON MICROB, V46, P291, DOI 10.1128/AEM.46.1.291-292.1983; SINGLETON P, 1981, APPL ENVIRON MICROB, V42, P789, DOI 10.1128/AEM.42.5.789-791.1981; Stiernagle Theresa, 2006, WormBook, P1; Sundin GW, 1996, MOL ECOL, V5, P133, DOI 10.1111/j.1365-294X.1996.tb00299.x; Taylor D. E., 1989, HDB EXPT PHARM, V91; TAYLOR DE, 1980, J GEN MICROBIOL, V116, P475; Tenor JL, 2008, EMBO REP, V9, P103, DOI 10.1038/sj.embor.7401104; Thomas CM, 2005, NAT REV MICROBIOL, V3, P711, DOI 10.1038/nrmicro1234; Vedantam G, 2003, CURR OPIN MICROBIOL, V6, P457, DOI 10.1016/j.mib.2003.09.006; WALTON JR, 1966, LANCET, V2, P1300; WALTON JR, 1967, NATURE, V215, P179, DOI 10.1038/215179a0; Witte W, 2000, INT J ANTIMICROB AG, V14, P321, DOI 10.1016/S0924-8579(00)00144-8; Zaneveld J, 2008, CURR OPIN CHEM BIOL, V12, P109, DOI 10.1016/j.cbpa.2008.01.015	62	8	10	3	49	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2013	27	2					760	768		10.1096/fj.12-218420	http://dx.doi.org/10.1096/fj.12-218420			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	081YG	23085995	Green Published			2022-12-25	WOS:000314358000034
J	Sorensen, L; Andersen, J; Thomsen, M; Hansen, SMR; Zhao, XB; Sandelin, A; Stromgaard, K; Kristensen, AS				Sorensen, Lena; Andersen, Jacob; Thomsen, Mette; Hansen, Stinna M. R.; Zhao, Xiaobei; Sandelin, Albin; Stromgaard, Kristian; Kristensen, Anders S.			Interaction of Antidepressants with the Serotonin and Norepinephrine Transporters MUTATIONAL STUDIES OF THE S1 SUBSTRATE BINDING POCKET	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-AFFINITY RECOGNITION; DOPAMINE TRANSPORTER; BINDING-SITE; NEUROTRANSMITTER TRANSPORTERS; BACTERIAL HOMOLOG; SELECTIVE RECOGNITION; SUBSTRATE; COCAINE; INHIBITION; LEUT	The serotonin transporter (SERT) and the norepinephrine transporter (NET) are sodium-dependent neurotransmitter transporters responsible for reuptake of released serotonin and norepinephrine, respectively, into nerve terminals in the brain. A wide range of inhibitors of SERT and NET are used as treatment of depression and anxiety disorders or as psychostimulant drugs of abuse. Despite their clinical importance, the molecular mechanisms by which various types of antidepressant drugs bind and inhibit SERT and NET are still elusive for the majority of the inhibitors, including the molecular basis for SERT/NET selectivity. Mutational analyses have suggested that a central substrate binding site (denoted the S1 pocket) also harbors an inhibitor binding site. In this study, we determine the effect of mutating six key S1 residues in human SERT (hSERT) and NET (hNET) on the potency of 15 prototypical SERT/NET inhibitors belonging to different drug classes. Analysis of the resulting drug sensitivity profiles provides novel information on drug binding modes in hSERT and hNET and identifies specific S1 residues as important molecular determinants for inhibitor potency and hSERT/hNET selectivity.	[Stromgaard, Kristian; Kristensen, Anders S.] Univ Copenhagen, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark; [Zhao, Xiaobei; Sandelin, Albin] Univ Copenhagen, Biotech Res & Innovat Ctr, DK-2100 Copenhagen, Denmark; [Sandelin, Albin] Univ Copenhagen, Bioinformat Ctr, Dept Biol, DK-2100 Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen	Kristensen, AS (corresponding author), Univ Copenhagen, Dept Drug Design & Pharmacol, DK-2100 Copenhagen, Denmark.	ask@sund.ku.dk	Andersen, Jacob/B-7768-2016; Sandelin, Albin/G-2881-2011; Kristensen, Anders Skov/B-4414-2009; Zhao, Xiaobei/G-3567-2014	Andersen, Jacob/0000-0002-8067-3074; Sandelin, Albin/0000-0002-7109-7378; Kristensen, Anders Skov/0000-0001-8955-6790; Zhao, Xiaobei/0000-0002-5277-0846; Stromgaard, Kristian/0000-0003-2206-4737	Faculty of Pharmaceutical Sciences, University of Copenhagen; H. Lundbeck A/S; Brodrene Hartmanns Foundation; Torben Frimodt and Alice Frimodt Foundation; Lundbeck Foundation; Novo Nordisk Foundation	Faculty of Pharmaceutical Sciences, University of Copenhagen; H. Lundbeck A/S; Brodrene Hartmanns Foundation; Torben Frimodt and Alice Frimodt Foundation; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This work was supported by the Faculty of Pharmaceutical Sciences, University of Copenhagen (Ph.D. stipend to L. S.), H. Lundbeck A/S, Brodrene Hartmanns Foundation, Torben Frimodt and Alice Frimodt Foundation, the Lundbeck Foundation (X. Z. and A. S.) and the Novo Nordisk Foundation (X. Z. and A. S.).	Andersen J, 2011, P NATL ACAD SCI USA, V108, P12137, DOI 10.1073/pnas.1103060108; Andersen J, 2010, J BIOL CHEM, V285, P2051, DOI 10.1074/jbc.M109.072587; Andersen J, 2009, CHEM COMMUN, P3677, DOI 10.1039/b903035m; Andersen J, 2009, J BIOL CHEM, V284, P10276, DOI 10.1074/jbc.M806907200; Apparsundaram S, 2008, J PHARMACOL EXP THER, V327, P982, DOI 10.1124/jpet.108.142315; Barker EL, 1999, J NEUROSCI, V19, P4705; Barker EL, 1998, J BIOL CHEM, V273, P19459, DOI 10.1074/jbc.273.31.19459; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Bisgaard H, 2011, NEUROPHARMACOLOGY, V60, P182, DOI 10.1016/j.neuropharm.2010.08.021; Celik L, 2008, J AM CHEM SOC, V130, P3853, DOI 10.1021/ja076403h; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Claxton DP, 2010, NAT STRUCT MOL BIOL, V17, P822, DOI 10.1038/nsmb.1854; Combs S, 2011, ACS CHEM NEUROSCI, V2, P75, DOI 10.1021/cn100066p; Dar DE, 2005, BIOCHEM PHARMACOL, V70, P461, DOI 10.1016/j.bcp.2005.04.032; Gabrielsen M, 2012, EUR J MED CHEM, V47, P24, DOI 10.1016/j.ejmech.2011.09.056; Gundertofte K., 2007, COMPUTER ASSISTED LE, P443; Han Dawn D., 2006, BMC Pharmacology, V6, P6, DOI 10.1186/1471-2210-6-6; Henry LK, 2006, J BIOL CHEM, V281, P2012, DOI 10.1074/jbc.M505055200; Henry LK, 2003, J BIOL CHEM, V278, P37052, DOI 10.1074/jbc.M305514200; Hill ER, 2011, NEUROPHARMACOLOGY, V61, P112, DOI 10.1016/j.neuropharm.2011.03.014; Indarte M, 2008, PROTEINS, V70, P1033, DOI 10.1002/prot.21598; Jorgensen AM, 2007, CHEMMEDCHEM, V2, P815, DOI 10.1002/cmdc.200600242; Kaufmann KW, 2009, PROTEINS, V74, P630, DOI 10.1002/prot.22178; KITAYAMA S, 1992, P NATL ACAD SCI USA, V89, P7782, DOI 10.1073/pnas.89.16.7782; Koldso H, 2010, J AM CHEM SOC, V132, P1311, DOI 10.1021/ja906923j; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Kristensen AS, 2004, EUR J NEUROSCI, V19, P1513, DOI 10.1111/j.1460-9568.2004.03202.x; Mason JN, 2007, J PHARMACOL EXP THER, V323, P720, DOI 10.1124/jpet.107.125716; Masson J, 1999, PHARMACOL REV, V51, P439; Nencetti S, 2011, EUR J MED CHEM, V46, P825, DOI 10.1016/j.ejmech.2010.12.018; Paczkowski FA, 2007, J BIOL CHEM, V282, P17837, DOI 10.1074/jbc.M610813200; Poulsen A, 2002, J COMPUT AID MOL DES, V16, P273, DOI 10.1023/A:1020220306702; Quick M, 2009, P NATL ACAD SCI USA, V106, P5563, DOI 10.1073/pnas.0811322106; Rupp A, 1994, Pharm Acta Helv, V68, P235, DOI 10.1016/0031-6865(94)90054-X; Sarker S, 2010, MOL PHARMACOL, V78, P1026, DOI 10.1124/mol.110.067538; Schlessinger A, 2011, P NATL ACAD SCI USA, V108, P15810, DOI 10.1073/pnas.1106030108; Shan JF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016350; Shi L, 2008, MOL CELL, V30, P667, DOI 10.1016/j.molcel.2008.05.008; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Sinning S, 2010, J BIOL CHEM, V285, P8363, DOI 10.1074/jbc.M109.045401; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tavoulari S, 2009, J NEUROSCI, V29, P9635, DOI 10.1523/JNEUROSCI.0440-09.2009; Team R.D.C, 2010, R LANG ENV STAT COMP; Tsuruda PR, 2010, J PHARMACOL TOXICOL, V61, P192, DOI 10.1016/j.vascn.2009.12.003; Ukairo OT, 2005, J PHARMACOL EXP THER, V314, P575, DOI 10.1124/jpet.105.085829; Walline CC, 2008, J PHARMACOL EXP THER, V325, P791, DOI 10.1124/jpet.108.136200; Wang WF, 2003, MOL PHARMACOL, V64, P430, DOI 10.1124/mol.64.2.430; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zahniser NR, 2001, PHARMACOL THERAPEUT, V92, P21, DOI 10.1016/S0163-7258(01)00158-9; Zhao YF, 2011, NATURE, V474, P109, DOI 10.1038/nature09971; Zhao YF, 2010, NATURE, V465, P188, DOI 10.1038/nature09057; Zhou FC, 1998, BRAIN RES, V805, P241, DOI 10.1016/S0006-8993(98)00691-X; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614; Zhou Z, 2009, NAT STRUCT MOL BIOL, V16, P652, DOI 10.1038/nsmb.1602	56	62	63	2	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 21	2012	287	52					43694	43707		10.1074/jbc.M112.342212	http://dx.doi.org/10.1074/jbc.M112.342212			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	062SA	23086945	Green Published, hybrid			2022-12-25	WOS:000312940800049
J	Li, YM; Xiao, HJ; de Renty, C; Jaramillo-Lambert, A; Han, ZY; DePamphilis, ML; Brown, KJ; Zhu, WG				Li, Yongming; Xiao, Haijie; de Renty, Christelle; Jaramillo-Lambert, Aimee; Han, Zhiyong; DePamphilis, Melvin L.; Brown, Kristy J.; Zhu, Wenge			The Involvement of Acidic Nucleoplasmic DNA-binding Protein (And-1) in the Regulation of Prereplicative Complex (pre-RC) Assembly in Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-ALPHA; REPLICATION; HELICASE; DOMAIN; CTF4; G1; IDENTIFICATION; ACETYLATION; CTF4/AND-1; INITIATION	DNA replication in all eukaryotes starts with the process of loading the replicative helicase MCM2-7 onto chromatin during late mitosis of the cell cycle. MCM2-7 is a key component of the prereplicative complex (pre-RC), which is loaded onto chromatin by the concerted action of origin recognition complex, Cdc6, and Cdt1. Here, we demonstrate that And-1 is assembled onto chromatin in late mitosis and early G(1) phase before the assembly of pre-RC in human cells. And-1 forms complexes with MCM2-7 to facilitate the assembly of MCM2-7 onto chromatin at replication origins in late mitosis and G(1) phase. We also present data to show that depletion of And-1 significantly reduces the interaction between Cdt1 and MCM7 in G(1) phase cells. Thus, human And-1 facilitates loading of the MCM2-7 helicase onto chromatin during the assembly of pre-RC.	[Li, Yongming; Xiao, Haijie; Jaramillo-Lambert, Aimee; Han, Zhiyong; Zhu, Wenge] George Washington Univ, Sch Med, Dept Biochem & Mol Biol, Washington, DC 20037 USA; [de Renty, Christelle; DePamphilis, Melvin L.] NICHHD, Bethesda, MD 20892 USA; [Brown, Kristy J.] George Washington Univ, Sch Med, Childrens Natl Med Ctr, Dept Integrat Syst Biol,Ctr Genet Med, Washington, DC 20010 USA	George Washington University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Children's National Health System; George Washington University	Zhu, WG (corresponding author), George Washington Univ, Sch Med, Dept Biochem & Mol Biol, 2300 Eye St NW, Washington, DC 20037 USA.	wz6812@gwu.edu	li, yong/HDN-3885-2022	Brown, Kristy/0000-0002-1047-4328; Jaramillo-Lambert, Aimee/0000-0001-7697-8580	National Institutes of Health [CA136555]; National Institutes of Health National Center for Medical Rehabilitation Research/NINDS [2R24HD050846-06]; Intellectual and Developmental Disabilities Research Center [5P30HD040677-10]; National Center for Medical Rehabilitation [UL1RR031988]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health National Center for Medical Rehabilitation Research/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intellectual and Developmental Disabilities Research Center; National Center for Medical Rehabilitation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by National Institutes of Health Grant CA136555 (to W. Z.). This work was also supported in part by National Institutes of Health National Center for Medical Rehabilitation Research/NINDS Core Grants 2R24HD050846-06 (National Center for Medical Rehabilitation Research) and Intellectual and Developmental Disabilities Research Center Grant 5P30HD040677-10 and by National Center for Medical Rehabilitation Research Grant UL1RR031988 (George Washington University, Children's National Medical Center, Clinical and Translational Science Institute).	Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Bermudez VP, 2010, J BIOL CHEM, V285, P9493, DOI 10.1074/jbc.M109.093609; Bochman ML, 2009, MICROBIOL MOL BIOL R, V73, P652, DOI 10.1128/MMBR.00019-09; Bustin M, 1999, MOL CELL BIOL, V19, P5237; Chadha GS, 2010, MOL CELL, V37, P5, DOI 10.1016/j.molcel.2009.12.028; Cook JG, 2004, J BIOL CHEM, V279, P9625, DOI 10.1074/jbc.M311933200; Errico A, 2009, EMBO J, V28, P3681, DOI 10.1038/emboj.2009.304; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Fujita M, 1996, J BIOL CHEM, V271, P4349; Gambus A, 2009, EMBO J, V28, P2992, DOI 10.1038/emboj.2009.226; Grienenberger A, 2002, CURR BIOL, V12, P762, DOI 10.1016/S0960-9822(02)00814-X; GROSSCHEDL R, 1994, TRENDS GENET, V10, P94, DOI 10.1016/0168-9525(94)90232-1; Guilbaud G, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002322; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Herrick J, 2000, P NATL ACAD SCI USA, V97, P222, DOI 10.1073/pnas.97.1.222; Holm M, 2001, EMBO J, V20, P118, DOI 10.1093/emboj/20.1.118; Iizuka M, 2006, MOL CELL BIOL, V26, P1098, DOI 10.1128/MCB.26.3.1098-1108.2006; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Jensen ON, 1999, METH MOL B, V112, P513; Kouprina E. K., 1992, MOL CELL BIOL, V12; LALANDE M, 1990, EXP CELL RES, V186, P332, DOI 10.1016/0014-4827(90)90313-Y; Li Y, 2012, ONCOGENE, V31, P643, DOI 10.1038/onc.2011.261; Li YM, 2011, J BIOL CHEM, V286, P41344, DOI 10.1074/jbc.M111.290767; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Maiorano D, 2005, CELL, V120, P315, DOI 10.1016/j.cell.2004.12.010; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; Miotto B, 2010, MOL CELL, V37, P57, DOI 10.1016/j.molcel.2009.12.012; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Sanjuan R, 2001, MOL BIOL EVOL, V18, P330, DOI 10.1093/oxfordjournals.molbev.a003809; Schwob Etienne, 2009, V521, P673, DOI 10.1007/978-1-60327-817-5_36; Sclafani RA, 2000, J CELL SCI, V113, P2111; Sibani S, 2005, BIOCHEMISTRY-US, V44, P7885, DOI 10.1021/bi047327n; Tanaka S, 2002, NAT CELL BIOL, V4, P198, DOI 10.1038/ncb757; Terret ME, 2009, NATURE, V462, P231, DOI 10.1038/nature08550; Tsutsui Y, 2005, CURR GENET, V48, P34, DOI 10.1007/s00294-005-0584-2; Volkening M, 2005, MOL CELL BIOL, V25, P1560, DOI 10.1128/MCB.25.4.1560-1568.2005; Wang G, 2000, EXP CELL RES, V254, P64, DOI 10.1006/excr.1999.4743; Williams DR, 2002, EUKARYOT CELL, V1, P758, DOI 10.1128/EC.1.5.758-773.2002; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Yoshizawa-Sugata N, 2009, J BIOL CHEM, V284, P20718, DOI 10.1074/jbc.M806711200; Zhu WG, 2007, GENE DEV, V21, P2288, DOI 10.1101/gad.1585607; Zhu WG, 2006, MOL CELL BIOL, V26, P4601, DOI 10.1128/MCB.02141-05; Zhu WG, 2004, MOL CELL BIOL, V24, P7140, DOI 10.1128/MCB.24.16.7140-7150.2004; Zou L, 1998, SCIENCE, V280, P593, DOI 10.1126/science.280.5363.593	46	11	11	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					42469	42479		10.1074/jbc.M112.404277	http://dx.doi.org/10.1074/jbc.M112.404277			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23093411	Green Published, hybrid			2022-12-25	WOS:000312501600009
J	Martins, M; Custodio, R; Camejo, A; Almeida, MT; Cabanes, D; Sousa, S				Martins, Mariana; Custodio, Rafael; Camejo, Ana; Almeida, Maria Teresa; Cabanes, Didier; Sousa, Sandra			Listeria monocytogenes Triggers the Cell Surface Expression of Gp96 Protein and Interacts with Its N Terminus to Support Cellular Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K1; MICROVASCULAR ENDOTHELIAL-CELLS; FOCAL ADHESION KINASE; ENDOPLASMIC-RETICULUM; A RECEPTOR; BINDING-PROTEIN; QUALITY-CONTROL; INVASION; VIRULENCE; GRP94	Listeria monocytogenes is an intracellular food-borne pathogen causing listeriosis in humans. This bacterium deploys an arsenal of virulence factors that act in concert to promote cellular infection. Bacterial surface proteins are of primary importance in the process of host cell invasion. They interact with host cellular receptors, inducing/modulating specific cellular responses. We previously identified Vip, a Listeria surface protein covalently attached to the bacterial cell wall acting as a key virulence factor. We have shown that Vip interacts with Gp96 localized at the surface of host cells during invasion and that this interaction is critical for a successful infection in vivo. To better understand the importance of Vip-Gp96 interaction during infection, we aimed to characterize this interaction at the molecular level. Here we demonstrate that, during infection, L. monocytogenes triggers the cellular redistribution of Gp96, inducing its exposure at the cell surface. Upon infection, Gp96 N-terminal domain is exposed to the extracellular milieu in L2071 fibroblasts and interacts with Vip expressed by Listeria. We identified Gp96 (Asp(1)-Leu(170)) as sufficient to interact with Vip; however, we also showed that the region Tyr(179)-Leu(390) of Gp96 is important for the interaction. Our findings unravel the Listeria-induced surface expression of Gp96 and the topology of its insertion on the plasma membrane and improve our knowledge on the Vip-Gp96 interaction during Listeria infection.	[Martins, Mariana; Custodio, Rafael; Camejo, Ana; Almeida, Maria Teresa; Cabanes, Didier; Sousa, Sandra] Univ Porto, Inst Biol Mol & Celular, Grp Mol Microbiol, P-4150180 Oporto, Portugal	Universidade do Porto	Cabanes, D (corresponding author), Univ Porto, Inst Biol Mol & Celular, Grp Mol Microbiol, Rua Campo Alegre 823, P-4150180 Oporto, Portugal.	didier@ibmc.up.pt; srsousa@ibmc.up.pt	Cabanes, Didier/P-3052-2019; Sousa, Sandra/K-3934-2013; Cabanes, Didier/K-3917-2013; Sousa, Sandra/P-2133-2019; Martins, M. Cristina/J-8284-2013	Cabanes, Didier/0000-0002-4001-1332; Sousa, Sandra/0000-0001-8578-0461; Cabanes, Didier/0000-0002-4001-1332; Sousa, Sandra/0000-0001-8578-0461; Martins, M. Cristina/0000-0002-6574-4794; Martins, Mariana/0000-0002-5677-7068	Fundo Europeu de Desenvolvimento Regional (FEDER)-Programa Operacional Factores de Competitividade (COMPETE); Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC/SAU-MII/65407/2006, FCOMP-01-0124-FEDER-007512, ERA-PTG/0003/2010, PTDC/SAU-MIC/111581/2009FCOMP-01-0124-FEDER-015844]; FCT [BD/29314/2006, BD/43352/2008]; Ciencia Program (COMPETE); Ciencia Program (Programa Operacional Potencial Humano); Ciencia Program (FCT)	Fundo Europeu de Desenvolvimento Regional (FEDER)-Programa Operacional Factores de Competitividade (COMPETE); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Ciencia Program (COMPETE); Ciencia Program (Programa Operacional Potencial Humano); Ciencia Program (FCT)	This work was supported in part by Fundo Europeu de Desenvolvimento Regional (FEDER)-Programa Operacional Factores de Competitividade (COMPETE) and Fundacao para a Ciencia e a Tecnologia (FCT) Grants PTDC/SAU-MII/65407/2006, FCOMP-01-0124-FEDER-007512, ERA-PTG/0003/2010, and PTDC/SAU-MIC/111581/2009FCOMP-01-0124-FEDER-015844.; Supported by FCT Doctoral Fellowships BD/29314/2006 and BD/43352/2008.; Supported by the Ciencia 2008 Program (COMPETE, Programa Operacional Potencial Humano, and FCT). To whom correspondence may be addressed: Group of Molecular Microbiology, Inst. de Biologia Molecular e Celular, Rua do Campo Alegre 823, 4150-180 Porto, Portugal. Tel.: 351226074907; Fax: 351-226099157; E-mail: srsousa@ibmc.up.pt.	Altmeyer A, 1996, INT J CANCER, V69, P340, DOI 10.1002/(SICI)1097-0215(19960822)69:4<340::AID-IJC18>3.0.CO;2-9; Argon Y, 1999, SEMIN CELL DEV BIOL, V10, P495, DOI 10.1006/scdb.1999.0320; Aubry C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033299; Bierne H, 2007, MICROBIOL MOL BIOL R, V71, P377, DOI 10.1128/MMBR.00039-06; Burkholder KM, 2010, INFECT IMMUN, V78, P5062, DOI 10.1128/IAI.00516-10; Cabanes D, 2005, EMBO J, V24, P2827, DOI 10.1038/sj.emboj.7600750; Camejo A, 2011, VIRULENCE, V2, P379, DOI 10.4161/viru.2.5.17703; Cho NH, 2004, MICROBIOL IMMUNOL, V48, P297, DOI 10.1111/j.1348-0421.2004.tb03510.x; Cossart P, 2011, P NATL ACAD SCI USA, V108, P19484, DOI 10.1073/pnas.1112371108; Greenberg HB, 2009, GASTROENTEROLOGY, V136, P1939, DOI 10.1053/j.gastro.2009.02.076; Hilf N, 2002, INT J HYPERTHER, V18, P521, DOI 10.1080/02656730210166177; Hilf N, 2002, BLOOD, V99, P3676, DOI 10.1182/blood.V99.10.3676; Kim G, 2010, BIOCHEM BIOPH RES CO, V397, P100, DOI 10.1016/j.bbrc.2010.05.075; Krishnan S., 2012, CELL MICROB IN PRESS; Krishnan S, 2012, CELL MICROBIOL, V14, P1415, DOI 10.1111/j.1462-5822.2012.01805.x; Lebreton A, 2011, SCIENCE, V331, P1319, DOI 10.1126/science.1200120; Liu B, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1070; Liu YP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002305; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Machata S, 2008, J IMMUNOL, V181, P2028, DOI 10.4049/jimmunol.181.3.2028; Maruvada R, 2008, CELL MICROBIOL, V10, P2326, DOI 10.1111/j.1462-5822.2008.01214.x; Maruvada R, 2008, IMMUNOLOGY, V124, P265, DOI 10.1111/j.1365-2567.2007.02764.x; Marzec M, 2012, BBA-MOL CELL RES, V1823, P774, DOI 10.1016/j.bbamcr.2011.10.013; Mittal R, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1554; Mittal R, 2010, CELL MICROBIOL, V12, P67, DOI 10.1111/j.1462-5822.2009.01379.x; Na X, 2008, INFECT IMMUN, V76, P2862, DOI 10.1128/IAI.00326-08; Prasadarao NV, 2003, INFECT IMMUN, V71, P1680, DOI 10.1128/IAI.71.4.1680-1688.2003; Prasadarao NV, 2002, J IMMUNOL, V169, P6352, DOI 10.4049/jimmunol.169.11.6352; Prasadarao NV, 2002, INFECT IMMUN, V70, P4556, DOI 10.1128/IAI.70.8.4556-4563.2002; Radsak MP, 2003, BLOOD, V101, P2810, DOI 10.1182/blood-2002-07-2261; Rechner C, 2007, CELL HOST MICROBE, V2, P393, DOI 10.1016/j.chom.2007.11.002; Reddy MA, 2000, INFECT IMMUN, V68, P6423, DOI 10.1128/IAI.68.11.6423-6430.2000; Reddy MA, 2000, J BIOL CHEM, V275, P36769, DOI 10.1074/jbc.M007382200; Reis O, 2010, J INFECT DIS, V202, P551, DOI 10.1086/654880; Rolhion N, 2010, GUT, V59, P1355, DOI 10.1136/gut.2010.207456; Soldano KL, 2003, J BIOL CHEM, V278, P48330, DOI 10.1074/jbc.M308661200; Sousa S, 2005, CURR OPIN CELL BIOL, V17, P489, DOI 10.1016/j.ceb.2005.08.013; Stavru F, 2011, IMMUNOL REV, V240, P160, DOI 10.1111/j.1600-065X.2010.00993.x; Swaminathan B, 2007, MICROBES INFECT, V9, P1236, DOI 10.1016/j.micinf.2007.05.011; Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200; Valle J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002843; Wampler JL, 2004, INFECT IMMUN, V72, P931, DOI 10.1128/IAI.72.2.931-936.2004; Xu AM, 1998, J VIROL, V72, P9865, DOI 10.1128/JVI.72.12.9865-9872.1998; Yang Y, 2005, MOL CELLS, V20, P173; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005	45	21	23	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 14	2012	287	51					43083	43093		10.1074/jbc.M112.422568	http://dx.doi.org/10.1074/jbc.M112.422568			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	056OX	23109341	Green Published, hybrid			2022-12-25	WOS:000312501600064
J	Yermolenko, IS; Gorkun, OV; Fuhrmann, A; Podolnikova, NP; Lishko, VK; Oshkadyerov, SP; Lord, ST; Ros, R; Ugarova, TP				Yermolenko, Ivan S.; Gorkun, Oleg V.; Fuhrmann, Alexander; Podolnikova, Nataly P.; Lishko, Valeryi K.; Oshkadyerov, Stanislav P.; Lord, Susan T.; Ros, Robert; Ugarova, Tatiana P.			The Assembly of Nonadhesive Fibrinogen Matrices Depends on the alpha C Regions of the Fibrinogen Molecule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCLONAL-ANTIBODIES; NEUTROPHIL ADHESION; ADSORBED FIBRINOGEN; FLOW CONDITIONS; FRAGMENT-X; HETEROGENEITY; PLATELET; DOMAIN; PLASMINOGEN; PLASMA	Adsorption of fibrinogen on fibrin clots and other surfaces strongly reduces integrin-mediated adhesion of platelets and leukocytes with implications for the surface-mediated control of thrombus growth and blood compatibility of biomaterials. The underlying mechanism of this process is surface-induced aggregation of fibrinogen, resulting in the assembly of a nanoscale multilayered matrix. The matrix is extensible, which makes it incapable of transducing strong mechanical forces via cellular integrins, resulting in insufficient intracellular signaling and weak cell adhesion. To determine the mechanism of the multilayer formation, the physical and adhesive properties of fibrinogen matrices prepared from human plasma fibrinogen (hFg), recombinant normal (rFg), and fibrinogen with the truncated alpha C regions (FgA alpha 251) were compared. Using atomic force microscopy and force spectroscopy, we show that whereas hFg and rFg generated the matrices with a thickness of similar to 8 nm consisting of 7-8 molecular layers, the deposition of FgA alpha 251 was terminated at two layers, indicating that the alpha C regions are essential for the multilayer formation. The extensibility of the matrix prepared from FgA alpha 251 was 2-fold lower than that formed from hFg and rFg. In agreement with previous findings that cell adhesion inversely correlates with the extensibility of the fibrinogen matrix, the less extensible FgA alpha 251 matrix and matrices generated from human fibrinogen variants lacking the alpha C regions supported sustained adhesion of leukocytes and platelets. The persistent adhesiveness of matrices formed from fibrinogen derivatives without the alpha C regions may have implications for conditions in which elevated levels of these molecules are found, including vascular pathologies, diabetes, thrombolytic therapy, and dysfibrinogenemia.	[Yermolenko, Ivan S.; Podolnikova, Nataly P.; Lishko, Valeryi K.; Ugarova, Tatiana P.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA; [Ros, Robert] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Gorkun, Oleg V.; Lord, Susan T.] Univ N Carolina, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Fuhrmann, Alexander] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Yermolenko, Ivan S.; Oshkadyerov, Stanislav P.] Natl Acad Sci Ukraine, Inst Met Phys, UA-03680 Kiev, Ukraine	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego; National Academy of Sciences Ukraine	Ugarova, TP (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.	Tatiana.Ugarova@asu.edu	Ros, Robert/G-2154-2012; Ros, Robert/X-3030-2019	Ros, Robert/0000-0001-9271-4091; GORKUN, OLEG/0000-0002-3068-3389	National Institutes of Health [HL107539]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063199, R01HL107539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL107539 (to T.P.U. and R.R.). This work was also supported by a Predoctoral Fellowship from the American Heart Association (to Y.I.S).	Burton RA, 2006, BIOCHEMISTRY-US, V45, P2257, DOI 10.1021/bi052380c; Cooley BC, 2011, ARTERIOSCL THROM VAS, V31, P1351, DOI 10.1161/ATVBAHA.111.225334; de Maat MPM, 2005, CURR OPIN HEMATOL, V12, P377, DOI 10.1097/01.moh.0000169287.51594.3b; DOOLITTLE RF, 1984, ANNU REV BIOCHEM, V53, P195, DOI 10.1146/annurev.bi.53.070184.001211; Endenburg SC, 1996, ARTERIOSCL THROM VAS, V16, P633, DOI 10.1161/01.ATV.16.5.633; Evans-Nguyen KM, 2006, LANGMUIR, V22, P5115, DOI 10.1021/la053070y; GOLLWITZER R, 1983, THROMB RES, P41; Gorkun OV, 2006, BIOCHEMISTRY-US, V45, P14843, DOI 10.1021/bi061430q; GORKUN OV, 1994, BIOCHEMISTRY-US, V33, P6986, DOI 10.1021/bi00188a031; Gorkun OV, 1998, BIOCHEMISTRY-US, V37, P15434, DOI 10.1021/bi981551t; GROVES HM, 1982, LAB INVEST, V46, P605; GUREWICH V, 1981, THROMB RES, V22, P535, DOI 10.1016/0049-3848(81)90051-7; Hanss M, 2001, ANN NY ACAD SCI, V936, P89; Hayes T, 2002, ARCH PATHOL LAB MED, V126, P1387; HOLM B, 1984, THROMB RES, V35, P279, DOI 10.1016/0049-3848(84)90359-1; HOLM B, 1985, THROMB RES, V37, P165, DOI 10.1016/0049-3848(85)90043-X; Kamocka MM, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3322676; Kollman JM, 2009, BIOCHEMISTRY-US, V48, P3877, DOI 10.1021/bi802205g; Koo J, 2010, J THROMB HAEMOST, V8, P2727, DOI 10.1111/j.1538-7836.2010.04072.x; Kuijper PHM, 1997, BLOOD, V89, P166, DOI 10.1182/blood.V89.1.166.166_166_175; Kuijper PHM, 1997, BLOOD, V89, P2131, DOI 10.1182/blood.V89.6.2131; LIPINSKA I, 1976, AM J CLIN PATHOL, V66, P958; LIPINSKI B, 1977, J LAB CLIN MED, V90, P187; Lishko VK, 2010, J THROMB HAEMOST, V8, P799, DOI 10.1111/j.1538-7836.2010.03778.x; Lishko VK, 2007, BLOOD, V109, P1541, DOI 10.1182/blood-2006-05-022764; Lishko VK, 2002, BIOCHEMISTRY-US, V41, P12942, DOI 10.1021/bi026324c; Litvinov RI, 2007, BIOCHEMISTRY-US, V46, P9133, DOI 10.1021/bi700944j; MILLS D, 1971, BIOCHIM BIOPHYS ACTA, V251, P121, DOI 10.1016/0005-2795(71)90069-9; OWEN J, 1987, J CLIN INVEST, V79, P1642, DOI 10.1172/JCI113001; Podolnikova NP, 2010, BIOCHEMISTRY-US, V49, P68, DOI 10.1021/bi9016022; RUDEE ML, 1981, ULTRAMICROSCOPY, V7, P193, DOI 10.1016/0304-3991(81)90010-3; SCHIELEN WJG, 1989, P NATL ACAD SCI USA, V86, P8951, DOI 10.1073/pnas.86.22.8951; Tsurupa G, 2002, BIOCHEMISTRY-US, V41, P6449, DOI 10.1021/bi025584r; Tsurupa G, 2010, BIOCHEMISTRY-US, V49, P7643, DOI 10.1021/bi1010317; Tsurupa G, 2009, BIOCHEMISTRY-US, V48, P12191, DOI 10.1021/bi901640e; UGAROVA TP, 1993, J BIOL CHEM, V268, P21080; van Ryn J, 2003, THROMB HAEMOSTASIS, V90, P1179, DOI 10.1160/TH03-05-0305; VANAKEN PJ, 1982, ARTERY, V11, P156; VEKLICH YI, 1993, J BIOL CHEM, V268, P13577; Weisel JW, 2005, ADV PROTEIN CHEM, V70, P247, DOI 10.1016/S0065-3233(04)70008-X; Weisel JW, 2001, ANN NY ACAD SCI, V936, P312; WIGREN R, 1991, FEBS LETT, V280, P225, DOI 10.1016/0014-5793(91)80298-H; WRIGHT SD, 1988, P NATL ACAD SCI USA, V85, P7734, DOI 10.1073/pnas.85.20.7734; Yakovlev S, 2000, BIOCHEMISTRY-US, V39, P15730, DOI 10.1021/bi001847a; Yang Z, 2000, P NATL ACAD SCI USA, V97, P14156, DOI 10.1073/pnas.97.26.14156; Yermolenko IS, 2011, BIOMACROMOLECULES, V12, P370, DOI 10.1021/bm101122g; Yermolenko IS, 2010, LANGMUIR, V26, P17269, DOI 10.1021/la101791r; ZAMARRON C, 1990, THROMB HAEMOSTASIS, V64, P41; Zilla P, 2007, BIOMATERIALS, V28, P5009, DOI 10.1016/j.biomaterials.2007.07.017	49	17	17	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 7	2012	287	50					41979	41990		10.1074/jbc.M112.410696	http://dx.doi.org/10.1074/jbc.M112.410696			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	051CT	23086938	Green Published, hybrid			2022-12-25	WOS:000312103000037
J	Sacks-Davis, R; Daraganova, G; Aitken, C; Higgs, P; Tracy, L; Bowden, S; Jenkinson, R; Rolls, D; Pattison, P; Robins, G; Grebely, J; Barry, A; Hellard, M				Sacks-Davis, Rachel; Daraganova, Galina; Aitken, Campbell; Higgs, Peter; Tracy, Lilly; Bowden, Scott; Jenkinson, Rebecca; Rolls, David; Pattison, Philippa; Robins, Garry; Grebely, Jason; Barry, Alyssa; Hellard, Margaret			Hepatitis C Virus Phylogenetic Clustering Is Associated with the Social-Injecting Network in a Cohort of People Who Inject Drugs	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; GLOBAL EPIDEMIOLOGY; USERS; INCARCERATION; HIV; TRANSMISSION; INFECTION; GENOTYPES	It is hypothesized that social networks facilitate transmission of the hepatitis C virus (HCV). We tested for association between HCV phylogeny and reported injecting relationships using longitudinal data from a social network design study. People who inject drugs were recruited from street drug markets in Melbourne, Australia. Interviews and blood tests took place three monthly (during 2005-2008), with participants asked to nominate up to five injecting partners at each interview. The HCV core region of individual isolates was then sequenced and phylogenetic trees were constructed. Genetic clusters were identified using bootstrapping (cut-off: 70%). An adjusted Jaccard similarity coefficient was used to measure the association between the reported injecting relationships and relationships defined by clustering in the phylogenetic analysis (statistical significance assessed using the quadratic assignment procedure). 402 participants consented to participate; 244 HCV infections were observed in 238 individuals. 26 genetic clusters were identified, with 2-7 infections per cluster. Newly acquired infection (AOR = 2.03, 95% CI: 1.04-3.96, p = 0.037, and HCV genotype 3 (vs. genotype 1, AOR = 2.72, 95% CI: 1.48-4.99) were independent predictors of being in a cluster. 54% of participants whose infections were part of a cluster in the phylogenetic analysis reported injecting with at least one other participant in that cluster during the study. Overall, 16% of participants who were infected at study entry and 40% of participants with newly acquired infections had molecular evidence of related infections with at least one injecting partner. Likely transmission clusters identified in phylogenetic analysis correlated with reported injecting relationships (adjusted Jaccard coefficient: 0.300; p<0.001). This is the first study to show that HCV phylogeny is associated with the injecting network, highlighting the importance of the injecting network in HCV transmission.	[Sacks-Davis, Rachel; Aitken, Campbell; Higgs, Peter; Jenkinson, Rebecca; Hellard, Margaret] Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia; [Sacks-Davis, Rachel; Aitken, Campbell; Higgs, Peter; Hellard, Margaret] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Sacks-Davis, Rachel; Aitken, Campbell; Higgs, Peter; Jenkinson, Rebecca; Hellard, Margaret] Burnet Inst, Ctr Res Excellence Injecting Drug Use, Melbourne, Vic, Australia; [Grebely, Jason] Univ New S Wales, Kirby Inst Infect & Immun Soc, Darlinghurst, NSW, Australia; [Tracy, Lilly; Bowden, Scott] Victorian Infect Dis Reference Lab, Melbourne, Vic, Australia; [Barry, Alyssa] Walter & Eliza Hall Inst Med Res, Div Infect & Immun, Parkville, Vic, Australia; [Barry, Alyssa] Univ Melbourne, Dept Med Biol, Parkville, Vic 3052, Australia	Burnet Institute; Monash University; Burnet Institute; University of New South Wales Sydney; Kirby Institute; Victorian Infectious Diseases Reference Laboratory; Walter & Eliza Hall Institute; University of Melbourne	Sacks-Davis, R (corresponding author), Burnet Inst, Ctr Populat Hlth, Melbourne, Vic, Australia.	rachelsd@burnet.edu.au	Rolls, David/C-2886-2012; Higgs, Peter/P-7816-2019; Sacks-Davis, Rachel/H-3277-2019; Higgs, Peter G/L-5939-2013	Rolls, David/0000-0003-0397-9923; Higgs, Peter/0000-0002-5587-5379; Higgs, Peter G/0000-0002-5587-5379; Aitken, Campbell/0000-0002-0923-4837; Pattison, Philippa/0000-0001-9626-2897; Barry, Alyssa/0000-0002-1189-2310; Robins, Garry/0000-0001-7538-5804; Sacks-Davis, Rachel/0000-0003-0860-2762	Australia's National Health and Medical Research Council [331312]; Victorian Department of Health; Australian Centre for HIV and Hepatitis Virology Research [ACH2]; Victorian Operational Infrastructure Support Program; Burnet Institute; Centre for Research Excellence into Injecting Drug Use; Australian Research Council [0987730]	Australia's National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Department of Health; Australian Centre for HIV and Hepatitis Virology Research; Victorian Operational Infrastructure Support Program; Burnet Institute; Centre for Research Excellence into Injecting Drug Use; Australian Research Council(Australian Research Council)	This work was supported by Australia's National Health and Medical Research Council [project grant 331312, postgraduate scholarship to RSD, training fellowship to PH, Senior Research Fellowship to MH, http://www.nhmrc.gov.au/]; the Victorian Department of Health [public health research grant 2008-09, http://www.health.vic.gov.au/]; the Australian Centre for HIV and Hepatitis Virology Research [ACH2, http://www.hiv.edu.au/]; the Victorian Operational Infrastructure Support Program [http://www.business.vic.gov.au/BUSVIC/STANDARD/PC_60698.html]; the Burnet Institute [http://www.burnet.edu.au]; the Centre for Research Excellence into Injecting Drug Use [top-up postgraduate scholarship to RSD, http://www.creidu.edu.au]; and the Australian Research Council [Discovery project grant 0987730, http://www.arc.gov.au/ncgp/dp/dp_default.htm]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceijas C, 2007, INT J DRUG POLICY, V18, P352, DOI 10.1016/j.drugpo.2007.04.004; Aitken CK, 2009, HEPAT MON, V9, P17; Aitken CK, 2008, HEPATOLOGY, V48, P1746, DOI 10.1002/hep.22534; Aitken CK, 2004, J INFECT DIS, V190, P1586, DOI 10.1086/424678; Bernard EJ, 2007, HIV MED, V8, P382, DOI 10.1111/j.1468-1293.2007.00486.x; Borgatti S., 2002, UCINET WINDOWS SOFTW; Borgatti S.P., 2002, NETDRAW GRAPH VISUAL; Brewer DD, 2006, J INFECT DIS, V194, P764, DOI 10.1086/505585; De P, 2007, ADDICTION, V102, P1730, DOI 10.1111/j.1360-0443.2007.01936.x; Dev AT, 2002, HEPATOLOGY, V36, P1259, DOI 10.1053/jhep.2002.36781; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Friedman SR, 2001, J URBAN HEALTH, V78, P411, DOI 10.1093/jurban/78.3.411; Hahn JA, 2009, EPIDEMICS-NETH, V1, P47, DOI 10.1016/j.epidem.2008.10.002; Hennekens C.H., 1987, EPIDEMIOLOGY MED; Jurgens R, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-26; Kuiken C, 2006, HEPATOLOGY, V44, P1355, DOI 10.1002/hep.21377; Latkin C, 2011, DRUG ALCOHOL DEPEN, V117, P50, DOI 10.1016/j.drugalcdep.2011.01.005; Lavanchy D, 1999, J VIRAL HEPATITIS, V6, P35; McCaw R, 1997, J VIRAL HEPATITIS, V4, P351, DOI 10.1046/j.1365-2893.1997.00060.x; Miller ER, 2009, J INFECTION, V58, P375, DOI 10.1016/j.jinf.2009.02.014; Morgenstern B, 2003, BIOINFORMATICS, V19, P425, DOI 10.1093/bioinformatics/btf882; Nei M, 2000, MOL EVOLUTION PHYLOG; Nelson PK, 2011, LANCET, V378, P571, DOI 10.1016/S0140-6736(11)61097-0; Pham ST, 2010, HEPATOLOGY, V52, P1564, DOI 10.1002/hep.23885; Pilon R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022245; Pollini RA, 2009, DRUG ALCOHOL DEPEN, V103, P52, DOI 10.1016/j.drugalcdep.2009.03.005; Rolls DA, 2012, J THEOR BIOL, V297, P73, DOI 10.1016/j.jtbi.2011.12.008; Romano CM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011170; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Seeff LB, 2009, LIVER INT, V29, P89, DOI 10.1111/j.1478-3231.2008.01927.x; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Simpson W, 2001, STATA US 1 N AM M BO; Smith DB, 1997, J GASTROEN HEPATOL, V12, P522, DOI 10.1111/j.1440-1746.1997.tb00477.x; Stumpf MPH, 2002, FEMS MICROBIOL LETT, V214, P143, DOI 10.1111/j.1574-6968.2002.tb11338.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valente TW, 2001, AM J PUBLIC HEALTH, V91, P406, DOI 10.2105/AJPH.91.3.406; Volz E, 2007, P ROY SOC B-BIOL SCI, V274, P2925, DOI 10.1098/rspb.2007.1159; Wood E, 2005, PUBLIC HEALTH REP, V120, P150, DOI 10.1177/003335490512000208; Wylie JL, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-229; Wylie JL, 2007, HEALTH PLACE, V13, P617, DOI 10.1016/j.healthplace.2006.09.002	43	56	56	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47335	10.1371/journal.pone.0047335	http://dx.doi.org/10.1371/journal.pone.0047335			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110068	gold, Green Published, Green Submitted			2022-12-25	WOS:000310262500009
J	Shah, V; Shah, S; Shah, H; Rispoli, FJ; McDonnell, KT; Workeneh, S; Karakoti, A; Kumar, A; Seal, S				Shah, Vishal; Shah, Shreya; Shah, Hirsh; Rispoli, Fred J.; McDonnell, Kevin T.; Workeneh, Selam; Karakoti, Ajay; Kumar, Amit; Seal, Sudipta			Antibacterial Activity of Polymer Coated Cerium Oxide Nanoparticles	PLOS ONE			English	Article							DEXTRAN; NANOCERIA; TOXICITY; INTERNALIZATION; OPTIMIZATION; ANTIOXIDANT; MEDIA; STATE	Cerium oxide nanoparticles have found numerous applications in the biomedical industry due to their strong antioxidant properties. In the current study, we report the influence of nine different physical and chemical parameters: pH, aeration and, concentrations of MgSO4, CaCl2, KCl, natural organic matter, fructose, nanoparticles and Escherichia coli, on the antibacterial activity of dextran coated cerium oxide nanoparticles. A least-squares quadratic regression model was developed to understand the collective influence of the tested parameters on the anti-bacterial activity and subsequently a computer-based, interactive visualization tool was developed. The visualization allows us to elucidate the effect of each of the parameters in combination with other parameters, on the antibacterial activity of nanoparticles. The results indicate that the toxicity of CeO2 NPs depend on the physical and chemical environment; and in a majority of the possible combinations of the nine parameters, non-lethal to the bacteria. In fact, the cerium oxide nanoparticles can decrease the anti-bacterial activity exerted by magnesium and potassium salts.	[Shah, Vishal; Shah, Shreya; Shah, Hirsh] Dowling Coll, Dept Biol, Oakdake, NY USA; [Rispoli, Fred J.; McDonnell, Kevin T.] Dowling Coll, Dept Math & Comp Sci, Oakdake, NY USA; [Workeneh, Selam] Southern Univ, Dept Biol, New Orleans, LA USA; [Karakoti, Ajay; Kumar, Amit; Seal, Sudipta] Univ Cent Florida, Adv Mat Proc Anal Ctr, Nanosci Technol Ctr, Orlando, FL 32816 USA	Southern University System; Southern University New Orleans; State University System of Florida; University of Central Florida	Shah, V (corresponding author), Dowling Coll, Dept Biol, Oakdake, NY USA.	ShahV@dowling.edu; Sudipta.Seal@ucf.edu	Karakoti, Ajay/AGI-8160-2022; Karakoti, Ajay/AAY-5886-2020; Seal, Sudipta/A-7698-2012; Shah, Shreya/HDN-1499-2022; Kumar, Amit/E-9483-2011	KARAKOTI, AJAY/0000-0001-9081-2325	National Science Foundation CBET [0708172, 0930170]; CBET [0966741]; Dowling College	National Science Foundation CBET(National Science Foundation (NSF)); CBET; Dowling College	National Science Foundation CBET grants # 0708172 (NIRT) and 0930170 supported SS and CBET grant # 0966741 supported VS. FR and KM were supported by research funds of Dowling College. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alili L, 2011, BIOMATERIALS, V32, P2918, DOI 10.1016/j.biomaterials.2010.12.056; Berry CC, 2003, BIOMATERIALS, V24, P4551, DOI 10.1016/S0142-9612(03)00237-0; Celardo I, 2011, ACS NANO, V5, P4537, DOI 10.1021/nn200126a; Celardo I, 2011, NANOSCALE, V3, P1411, DOI 10.1039/c0nr00875c; Colon J, 2010, NANOMED-NANOTECHNOL, V6, P698, DOI 10.1016/j.nano.2010.01.010; Colon J, 2009, NANOMED-NANOTECHNOL, V5, P225, DOI 10.1016/j.nano.2008.10.003; Deshpande S, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2061873; Dowding JM, 2012, CHEM COMMUN, V48, P4896, DOI 10.1039/c2cc30485f; Fabrega J, 2009, ENVIRON SCI TECHNOL, V43, P7285, DOI 10.1021/es803259g; Fang XH, 2010, J COLLOID INTERF SCI, V348, P329, DOI 10.1016/j.jcis.2010.04.075; Feng B, 2008, COLLOID SURFACE A, V328, P52, DOI 10.1016/j.colsurfa.2008.06.024; INSELBERG A, 1990, PROCEEDINGS OF THE FIRST IEEE CONFERENCE ON VISUALIZATION - VISUALIZATION 90, P361, DOI 10.1109/VISUAL.1990.146402; Joo JH, 2009, SOLID STATE IONICS, V180, P839, DOI 10.1016/j.ssi.2009.02.006; Karakoti AS, 2008, JOM-US, V60, P33, DOI 10.1007/s11837-008-0029-8; Karakoti AS, 2007, J PHYS CHEM C, V111, P17232, DOI 10.1021/jp076164k; Karakoti AS, 2009, J AM CHEM SOC, V131, P14144, DOI 10.1021/ja9051087; Kuang YS, 2011, J NANOSCI NANOTECHNO, V11, P4103, DOI 10.1166/jnn.2011.3858; Kunzmann A, 2011, TOXICOL APPL PHARM, V253, P81, DOI 10.1016/j.taap.2011.03.011; Li YL, 2009, ANGEW CHEM INT EDIT, V48, P9914, DOI 10.1002/anie.200904260; Liu HL, 2008, IRAN POLYM J, V17, P721; Madero-Visbal RA, 2012, NANOMED NANOTECHNOL; Masui T, 2000, J ALLOY COMPD, V303, P49, DOI 10.1016/S0925-8388(00)00603-4; Pelletier DA, 2010, APPL ENVIRON MICROB, V76, P7981, DOI 10.1128/AEM.00650-10; Perez JM, 2008, SMALL, V4, P552, DOI 10.1002/smll.200700824; Ren SJ, 2004, ECOTOX ENVIRON SAFE, V59, P38, DOI 10.1016/S0147-6513(03)00099-X; Rispoli F, 2008, BIOTECHNOL PROGR, V24, P648, DOI 10.1021/bp070280n; Rispoli F, 2010, J HAZARD MATER, V180, P212, DOI 10.1016/j.jhazmat.2010.04.016; Rispoli FJ, 2010, BIOTECHNOL PROGR, V26, P938, DOI 10.1002/btpr.399; Singh S, 2011, BIOMATERIALS, V32, P6745, DOI 10.1016/j.biomaterials.2011.05.073; Tassa C, 2011, ACCOUNTS CHEM RES, V44, P842, DOI 10.1021/ar200084x; Thill A, 2006, ENVIRON SCI TECHNOL, V40, P6151, DOI 10.1021/es060999b; Tso CP, 2010, WATER SCI TECHNOL, V61, P127, DOI 10.2166/wst.2010.787; Wang ZY, 2011, ENVIRON SCI TECHNOL, V45, P6032, DOI 10.1021/es2010573; Wu WW, 2010, RARE METALS, V29, P149, DOI 10.1007/s12598-010-0026-2; Yu T, 2008, EUR J INORG CHEM, P855, DOI 10.1002/ejic.200700979	35	74	76	2	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e47827	10.1371/journal.pone.0047827	http://dx.doi.org/10.1371/journal.pone.0047827			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110109	Green Published, gold, Green Submitted			2022-12-25	WOS:000310262500021
J	Interlandi, G; Ling, MH; Tu, AY; Chung, DW; Thomas, WE				Interlandi, Gianluca; Ling, Minhua; Tu, An Yue; Chung, Dominic W.; Thomas, Wendy E.			Structural Basis of Type 2A von Willebrand Disease Investigated by Molecular Dynamics Simulations and Experiments	PLOS ONE			English	Article							FACTOR A2 DOMAIN; ANKYRIN REPEAT PROTEINS; BINDING-SITE; VONWILLEBRAND DISEASE; SPACER DOMAIN; ADAMTS13; CLEAVAGE; MUTATIONS; IIA; FORCE	The hemostatic function of von Willebrand factor is downregulated by the metalloprotease ADAMTS13, which cleaves at a unique site normally buried in the A2 domain. Exposure of the proteolytic site is induced in the wild-type by shear stress as von Willebrand factor circulates in blood. Mutations in the A2 domain, which increase its susceptibility to cleavage, cause type 2A von Willebrand disease. In this study, molecular dynamics simulations suggest that the A2 domain unfolds under tensile force progressively through a series of steps. The simulation results also indicated that three type 2A mutations in the C-terminal half of the A2 domain, L1657I, I1628T and E1638K, destabilize the native state fold of the protein. Furthermore, all three type 2A mutations lowered in silico the tensile force necessary to undock the C-terminal helix alpha 6 from the rest of the A2 domain, the first event in the unfolding pathway. The mutations F1520A, I1651A and A1661G were also predicted by simulations to destabilize the A2 domain and facilitate exposure of the cleavage site. Recombinant A2 domain proteins were expressed and cleavage assays were performed with the wild-type and single-point mutants. All three type 2A and two of the three predicted mutations exhibited increased rate of cleavage by ADAMTS13. These results confirm that destabilization of the helix alpha 6 in the A2 domain facilitates exposure of the cleavage site and increases the rate of cleavage by ADAMTS13.	[Interlandi, Gianluca; Tu, An Yue; Thomas, Wendy E.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Ling, Minhua; Chung, Dominic W.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Interlandi, G (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	gianluca@u.washington.edu	Sessum, Rachel/F-7312-2015	Sessum, Rachel/0000-0002-2444-7056; Thomas, Wendy/0000-0001-8602-0819	American Heart Association [0820107Z, AHA09GRNT2230070]; National Institutes of Health research grant [1R01-HL106074]; National Scientist Development grant from the American Heart Association [0735337N]; National Science Foundation through TeraGrid resources [TG-MCB060069N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL106074] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health research grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Scientist Development grant from the American Heart Association; National Science Foundation through TeraGrid resources(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was financially supported by a postdoctoral fellowship from the American Heart Association number 0820107Z to GI, a National Institutes of Health research grant number 1R01-HL106074 to WET, a National Scientist Development grant from the American Heart Association number 0735337N to WET and a grant from the American Heart Association number AHA09GRNT2230070 to DWC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Dr. Jim Pfaendtner for helpful and interesting discussions. The computations were performed on the Abe supercomputer at the National Center for Supercomputing Applications supported by the National Science Foundation and made available to GI and WT through TeraGrid resources under grant number TG-MCB060069N. We would like to specifically thank Susan John for assistance with the allocation and technical help.	Arya M, 2002, BLOOD, V99, P3971, DOI 10.1182/blood-2001-11-0060; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chen JM, 2010, BLOOD, V115, P706, DOI 10.1182/blood-2009-03-213967; Chen W, 2009, CELL MOL BIOENG, V2, P75, DOI 10.1007/s12195-009-0051-0; CHRISTOPHE O, 1994, BLOOD, V83, P3553; Crawley JTB, 2011, BLOOD, V118, P3212, DOI 10.1182/blood-2011-02-306597; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; de Groot R, 2009, BLOOD, V113, P5609, DOI 10.1182/blood-2008-11-187914; DENT JA, 1990, P NATL ACAD SCI USA, V87, P6306, DOI 10.1073/pnas.87.16.6306; Di Stasio E, 2010, BIOPHYS CHEM, V153, P1, DOI 10.1016/j.bpc.2010.07.002; Drews RE, 2010, ANN INTERN MED, V152, P655, DOI 10.7326/0003-4819-152-10-201005180-00244; Enayat MS, 2000, THROMB HAEMOSTASIS, V84, P369; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Franchini M, 2006, ANN HEMATOL, V85, P415, DOI 10.1007/s00277-006-0085-5; Gao WQ, 2008, BLOOD, V112, P1713, DOI 10.1182/blood-2008-04-148759; Gosse C, 2002, BIOPHYS J, V82, P3314, DOI 10.1016/S0006-3495(02)75672-5; Hassenpflug WA, 2006, BLOOD, V107, P2339, DOI 10.1182/blood-2005-04-1758; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IANNUZZI MC, 1991, AM J HUM GENET, V48, P757; Interlandi G, 2008, J MOL BIOL, V375, P837, DOI 10.1016/j.jmb.2007.09.042; Interlandi G, 2010, PROTEINS, V78, P2506, DOI 10.1002/prot.22759; Jakobi AJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1385; Jin SY, 2010, BLOOD, V115, P2300, DOI 10.1182/blood-2009-07-235101; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; Kramer MA, 2010, J MOL BIOL, V404, P381, DOI 10.1016/j.jmb.2010.09.023; Lenting PJ, 2010, THROMB HAEMOSTASIS, V104, P449, DOI 10.1160/TH09-11-0777; Luken BM, 2010, BLOOD, V115, P4910, DOI 10.1182/blood-2009-12-257949; LYONS SE, 1994, BLOOD, V83, P1551; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Matthew Auton MAC, 2007, J MOL BIOL, V366, P966; Mize GJ, 2008, PROTEIN EXPRES PURIF, V57, P280, DOI 10.1016/j.pep.2007.09.018; Nishida H, 2006, BLOOD COAGUL FIBRIN, V17, P203, DOI 10.1097/01.mbc.0000220242.22714.b3; Pos W, 2010, BLOOD, V115, P1640, DOI 10.1182/blood-2009-06-229203; RIBBA AS, 1992, J BIOL CHEM, V267, P23209; Ruggeri Z M, 2004, Hamostaseologie, V24, P1; Sadler JE, 2005, ANNU REV MED, V56, P173, DOI 10.1146/annurev.med.56.082103.104713; Savage B, 1996, CELL, V84, P289, DOI 10.1016/S0092-8674(00)80983-6; SCHNEIDER T, 1978, PHYS REV B, V17, P1302, DOI 10.1103/PhysRevB.17.1302; Sousa SF, 2010, COMB CHEM HIGH T SCR, V13, P442; Sutherland JJ, 2004, J MOL MODEL, V10, P259, DOI 10.1007/s00894-004-0194-9; Tsai HM, 1996, BLOOD, V87, P4235, DOI 10.1182/blood.V87.10.4235.bloodjournal87104235; Willis B.T.M., 1975, THERMAL VIBRATIONS C; Wu JJ, 2006, P NATL ACAD SCI USA, V103, P18470, DOI 10.1073/pnas.0609190103; Wu T, 2010, BLOOD, V115, P370, DOI 10.1182/blood-2009-03-210369; Xu AJ, 2012, P NATL ACAD SCI USA, V109, P3742, DOI 10.1073/pnas.1121261109; Yago T, 2008, J CLIN INVEST, V118, P3195, DOI 10.1172/JCI35754; Zanardelli S, 2009, BLOOD, V114, P2819, DOI 10.1182/blood-2009-05-224915; Zhang Q, 2009, P NATL ACAD SCI USA, V106, P9226, DOI 10.1073/pnas.0903679106; Zhang XH, 2009, SCIENCE, V324, P1330, DOI 10.1126/science.1170905; Zhou MY, 2011, BLOOD, V117, P4623, DOI 10.1182/blood-2010-11-321596	50	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e45207	10.1371/journal.pone.0045207	http://dx.doi.org/10.1371/journal.pone.0045207			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110044	Green Submitted, Green Published, gold			2022-12-25	WOS:000310193600002
J	McConnell, TH; DiBenedetto, JN				McConnell, Thomas H.; DiBenedetto, Joseph N.			Geology of the Early Arikareean Sharps Formation on the Pine Ridge Indian Reservation and Surrounding Areas of South Dakota and Nebraska	PLOS ONE			English	Article							WHITE-RIVER GROUP	Based on geologic mapping, measured sections, and lithologic correlations, the local features of the upper and lower type areas of the Early Arikareean (30.8-20.6 million years ago) Sharps Formation are revised and correlated. The Sharps Formation above the basal Rockyford Member is divided into two members of distinct lithotypes. The upper 233 feet of massive siltstones and sandy siltstones is named the Gooseneck Road Member. The middle member, 161 feet of eolian volcaniclastic siltstones with fluvially reworked volcaniclastic lenses and sandy siltstone sheets, is named the Wolff Camp Member. An ashey zone at the base of the Sharps Formation is described and defined as the Rockyford Ash Zone (RAZ) in the same stratigraphic position as the Nonpareil Ash Zone (NPAZ) in Nebraska. Widespread marker beds of fresh water limestones at 130 feet above the base of the Sharps Formation and a widespread reddish-brown clayey siltstone at 165 feet above the base of the Sharps Formation are described. The Brown Siltstone Beds of Nebraska are shown to be a southern correlative of the Wolff Camp Member and the Rockyford Member of the Sharps Formation. Early attempts to correlate strata in the Great Plains were slow in developing. Recognition of the implications of the paleomagnetic and lithologic correlations of this paper will provide an added datum assisting researchers in future biostratigraphic studies. Based on similar lithologies, the Sharps Formation, currently assigned to the Arikaree Group, should be reassigned to the White River Group.	[McConnell, Thomas H.; DiBenedetto, Joseph N.] United States Forest Serv, Price, UT USA	United States Department of Agriculture (USDA); United States Forest Service	McConnell, TH (corresponding author), United States Forest Serv, Price, UT USA.	thm2086@yahoo.com						Darton NH, 1899, 19 US GEOL SURV AN 4, V19, P719; Harksen JC, 1961, AAPG BULL, V45, P674; Harksen JC, 1969, 99 S DAK GEOL SURV, V99; LaGarry H. E., 1998, GEOL S AM S, P63; Macdonald JR, 1963, B AM MUS NAT HIST, V125, P129; Macdonald JR, 1970, B ANGELES COUNTY MUS, V8, P165; Nicknish JM, 1963, S DAKOTA GEOLOGICAL, V7, P1; Prothero D.R., 1992, EOCENE OLIGOCENE CLI, P46, DOI DOI 10.1515/9781400862924.46; Prothero Donald R., 1998, Geological Society of America Special Paper, V325, P39; PROTHERO DR, 1983, PALAEOGEOGR PALAEOCL, V42, P151, DOI 10.1016/0031-0182(83)90042-1; Schultz CB, 1968, B AM MUSEUM NATURAL, P139; Souders V.L., 1980, 47 U NEBR LINC I AGR; SWINEHART JB, 1985, CENOZOIC PALEOGEOGRA, P209; SWISHER CC, 1990, SCIENCE, V249, P760, DOI 10.1126/science.249.4970.760; Tedford R.H., 1996, TERRESTRIAL EOCENE O; Tedford RH, 1985, DAKOTERRA, V2, P334; Vondra CF, 1969, 18 NEBR GEOL SURV, V18	17	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2012	7	10							e47759	10.1371/journal.pone.0047759	http://dx.doi.org/10.1371/journal.pone.0047759			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MO	23110098	Green Published, Green Submitted, gold			2022-12-25	WOS:000310193600025
J	Molina-Montenegro, MA; Naya, DE				Molina-Montenegro, Marco A.; Naya, Daniel E.			Latitudinal Patterns in Phenotypic Plasticity and Fitness-Related Traits: Assessing the Climatic Variability Hypothesis (CVH) with an Invasive Plant Species	PLOS ONE			English	Article							DANDELIONS TARAXACUM-OFFICINALE; THERMAL TOLERANCE; GEOGRAPHICAL RANGE; LOCAL ADAPTATION; MOUNTAIN PASSES; EVOLUTION; PERFORMANCE; FLEXIBILITY; POPULATIONS; LIMITS	Phenotypic plasticity has been suggested as the main mechanism for species persistence under a global change scenario, and also as one of the main mechanisms that alien species use to tolerate and invade broad geographic areas. However, contrasting with this central role of phenotypic plasticity, standard models aimed to predict the effect of climatic change on species distributions do not allow for the inclusion of differences in plastic responses among populations. In this context, the climatic variability hypothesis (CVH), which states that higher thermal variability at higher latitudes should determine an increase in phenotypic plasticity with latitude, could be considered a timely and promising hypothesis. Accordingly, in this study we evaluated, for the first time in a plant species (Taraxacum officinale), the prediction of the CVH. Specifically, we measured plastic responses at different environmental temperatures (5 and 20 degrees C), in several ecophysiological and fitness-related traits for five populations distributed along a broad latitudinal gradient. Overall, phenotypic plasticity increased with latitude for all six traits analyzed, and mean trait values increased with latitude at both experimental temperatures, the change was noticeably greater at 20 degrees than at 5 degrees C. Our results suggest that the positive relationship found between phenotypic plasticity and geographic latitude could have very deep implications on future species persistence and invasion processes under a scenario of climate change.	[Molina-Montenegro, Marco A.] Univ Catolica Norte, Fac Ciencias Mar, Ctr Estudios Avanzados Zonas Aridas, Coquimbo, Chile; [Naya, Daniel E.] Univ Republica, Fac Ciencias, Dept Ecol & Evolut, Montevideo, Uruguay; [Naya, Daniel E.] Univ Republica, Ctr Univ Reg Este, Montevideo, Uruguay	Universidad Catolica del Norte; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay	Molina-Montenegro, MA (corresponding author), Univ Catolica Norte, Fac Ciencias Mar, Ctr Estudios Avanzados Zonas Aridas, Coquimbo, Chile.	marco.molina@ceaza.cl		Molina-Montenegro, Marco/0000-0001-6801-8942				Addo-Bediako A, 2000, P ROY SOC B-BIOL SCI, V267, P739, DOI 10.1098/rspb.2000.1065; Arroyo Mary T. Kalin, 2000, P385; BRATTSTROM BH, 1968, COMP BIOCHEM PHYSIOL, V24, P93, DOI 10.1016/0010-406X(68)90961-4; BROWN JH, 1971, EVOLUTION, V25, P390, DOI 10.1111/j.1558-5646.1971.tb01893.x; Calosi P, 2008, BIOL LETTERS, V4, P99, DOI 10.1098/rsbl.2007.0408; Chown SL, 2004, FUNCT ECOL, V18, P159, DOI 10.1111/j.0269-8463.2004.00825.x; COUNTS RL, 1993, CAN J BOT, V71, P145, DOI 10.1139/b93-016; Darlington C. D., 1937, RECENT ADV CYTOLOGY; Deutsch CA, 2008, P NATL ACAD SCI USA, V105, P6668, DOI 10.1073/pnas.0709472105; di Castri F., 1989, SCOPE, V37, P1; Duncan RP, 2009, P ROY SOC B-BIOL SCI, V276, P1449, DOI 10.1098/rspb.2008.1801; Ellstrand NC, 2000, P NATL ACAD SCI USA, V97, P7043, DOI 10.1073/pnas.97.13.7043; Fernandez MH, 2005, J BIOGEOGR, V32, P903, DOI 10.1111/j.1365-2699.2004.01188.x; FRANCE R, 1992, AM NAT, V139, P342, DOI 10.1086/285330; Fuller A, 2010, PHYSIOL BIOCHEM ZOOL, V83, P713, DOI 10.1086/652242; Gaston K. J., 2004, BIODIVERSITY INTRO; Gaston KJ, 1999, OIKOS, V84, P309, DOI 10.2307/3546727; Ghalambor CK, 2006, INTEGR COMP BIOL, V46, P5, DOI 10.1093/icb/icj003; Gianoli E, 2004, INT J PLANT SCI, V165, P825, DOI 10.1086/422050; Gianoli E, 2012, BIOL J LINN SOC, V105, P1, DOI 10.1111/j.1095-8312.2011.01793.x; Hoffmann AA, 2011, NATURE, V470, P479, DOI 10.1038/nature09670; Holm L, 1997, NATURAL HIST DISTRIB; HUEY RB, 1978, AM NAT, V112, P225, DOI 10.1086/283262; JANZEN DH, 1967, AM NAT, V101, P233, DOI 10.1086/282487; Jonas CS, 1999, AM J BOT, V86, P333, DOI 10.2307/2656755; Joshi J, 2001, ECOL LETT, V4, P536, DOI 10.1046/j.1461-0248.2001.00262.x; Kellermann V, 2009, SCIENCE, V325, P1244, DOI 10.1126/science.1175443; LETCHER AJ, 1994, AM NAT, V144, P30, DOI 10.1086/285659; Maldonado K, 2012, ZOOLOGY, V115, P128, DOI 10.1016/j.zool.2011.09.005; Maldonado K, 2011, PHYSIOL BIOCHEM ZOOL, V84, P377, DOI 10.1086/660970; Maron JL, 2004, ECOL MONOGR, V74, P261, DOI 10.1890/03-4027; Matesanz S, 2010, ANN NY ACAD SCI, V1206, P35, DOI 10.1111/j.1749-6632.2010.05704.x; Mitchell KA, 2011, FUNCT ECOL, V25, P661, DOI 10.1111/j.1365-2435.2010.01821.x; Molina-Montenegro MA, 2012, BIOL INVASIONS, V14, P21, DOI 10.1007/s10530-011-0055-2; Molina-Montenegro MA, 2012, PLANT ECOL, V213, P133, DOI 10.1007/s11258-011-9964-5; Molina-Montenegro MA, 2010, BIOL INVASIONS, V12, P2277, DOI 10.1007/s10530-009-9638-6; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Mou P, 2013, PLANT SOIL, V364, P373, DOI 10.1007/s11104-012-1336-y; Naya DE, 2008, AM NAT, V172, pE122, DOI 10.1086/590957; Naya DE, 2012, AM NAT, V179, pE172, DOI 10.1086/665646; Naya DE, 2011, EVOL ECOL RES, V13, P647; Neuffer B, 1999, MOL ECOL, V8, P1667, DOI 10.1046/j.1365-294x.1999.00752.x; NOVAK SJ, 1991, AM J BOT, V78, P1150, DOI 10.2307/2444902; Overgaard J, 2011, AM NAT, V178, pS80, DOI 10.1086/661780; PAGEL MD, 1991, AM NAT, V137, P791, DOI 10.1086/285194; Pichancourt JB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032323; PLATENKAMP GAJ, 1990, J ECOL, V78, P772, DOI 10.2307/2260898; Quiroz CL, 2009, ECOL RES, V24, P175, DOI 10.1007/s11284-008-0498-9; Rezende EL, 2004, EVOLUTION, V58, P1361; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Santamaria L, 2003, ECOLOGY, V84, P2454, DOI 10.1890/02-0431; SCHLICHTING CD, 1995, INT J PLANT SCI, V156, P542, DOI 10.1086/297277; Sexton JP, 2002, ECOL APPL, V12, P1652, DOI 10.1890/1051-0761(2002)012[1652:PAGDMA]2.0.CO;2; SNYDER GK, 1975, AM NAT, V109, P93, DOI 10.1086/282976; Speakman JR, 2000, ADV ECOL RES, V30, P177; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; Stillman JH, 2000, PHYSIOL BIOCHEM ZOOL, V73, P200, DOI 10.1086/316738; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; Teplitsky C, 2008, P NATL ACAD SCI USA, V105, P13492, DOI 10.1073/pnas.0800999105; Valladares F, 2006, J ECOL, V94, P1103, DOI 10.1111/j.1365-2745.2006.01176.x; van Baarlen P, 2000, GENOME, V43, P827, DOI 10.1139/gen-43-5-827; van Dijk PJ, 2004, GENETICS, V166, P483, DOI 10.1534/genetics.166.1.483; VANBERKUM FH, 1988, AM NAT, V132, P327, DOI 10.1086/284856; Vasut RJ, 2003, PRESLIA, V75, P311	64	88	88	5	171	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e47620	10.1371/journal.pone.0047620	http://dx.doi.org/10.1371/journal.pone.0047620			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	23110083	gold, Green Published, Green Submitted			2022-12-25	WOS:000310193400013
J	Alam, MS; Getz, M; Safeukui, I; Yi, S; Tamez, P; Shin, J; Velazquez, P; Haldar, K				Alam, Md Suhail; Getz, Michelle; Safeukui, Innocent; Yi, Sue; Tamez, Pamela; Shin, Jenny; Velazquez, Peter; Haldar, Kasturi			Genomic Expression Analyses Reveal Lysosomal, Innate Immunity Proteins, as Disease Correlates in Murine Models of a Lysosomal Storage Disorder	PLOS ONE			English	Article							NIEMANN-PICK-DISEASE; C DISEASE; MOUSE MODEL; CHOLESTEROL ACCUMULATION; MEMBRANE CHOLESTEROL; PROTEOMIC ANALYSIS; NPC1 DEFICIENCY; PLASMA-MEMBRANE; HOST-DEFENSE; IFN-GAMMA	Niemann-Pick Type C (NPC) disease is a rare, genetic, lysosomal disorder with progressive neurodegeneration. Poor understanding of the pathophysiology and a lack of blood-based diagnostic markers are major hurdles in the treatment and management of NPC and several additional, neurological lysosomal disorders. To identify disease severity correlates, we undertook whole genome expression profiling of sentinel organs, brain, liver, and spleen of Balb/c Npc1(-/-) mice relative to Npc1(+/-) at an asymptomatic stage, as well as early- and late-symptomatic stages. Unexpectedly, we found prominent up regulation of innate immunity genes with age-dependent change in their expression, in all three organs. We shortlisted a set of 12 secretory genes whose expression steadily increased with age in both brain and liver, as potential plasma correlates of neurological and/or liver disease. Ten were innate immune genes with eight ascribed to lysosomes. Several are known to be elevated in diseased organs of murine models of other lysosomal diseases including Gaucher's disease, Sandhoff disease and MPSIIIB. We validated the top candidate lysozyme, in the plasma of Npc1(-/-) as well as Balb/c Npc1(nmf164) mice (bearing a point mutation closer to human disease mutants) and show its reduction in response to an emerging therapeutic. We further established elevation of innate immunity in Npc1(-/-) mice through multiple functional assays including inhibition of bacterial infection as well as cellular analysis and immunohistochemistry. These data revealed neutrophil elevation in the Npc1(-/-) spleen and liver (where large foci were detected proximal to damaged tissue). Together our results yield a set of lysosomal, secretory innate immunity genes that have potential to be developed as pan or specific plasma markers for neurological diseases associated with lysosomal storage and where diagnosis is a major problem. Further, the accumulation of neutrophils in diseased organs (hitherto not associated with NPC) suggests their role in pathophysiology and disease exacerbation.	[Alam, Md Suhail; Getz, Michelle; Safeukui, Innocent; Yi, Sue; Tamez, Pamela; Shin, Jenny; Velazquez, Peter; Haldar, Kasturi] Univ Notre Dame, Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA; [Alam, Md Suhail; Getz, Michelle; Safeukui, Innocent; Yi, Sue; Tamez, Pamela; Shin, Jenny; Haldar, Kasturi] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA; [Velazquez, Peter] Indiana Univ Sch Med, Dept Microbiol & Immunol, South Bend, IN USA	University of Notre Dame; University of Notre Dame; Indiana University System; Indiana University South Bend	Haldar, K (corresponding author), Univ Notre Dame, Ctr Rare & Neglected Dis, Notre Dame, IN 46556 USA.	khaldar@nd.edu	Haldar, Kasturi/C-6685-2014	Tamez, Pamela/0000-0001-9005-4560; Shin, Jenny/0000-0002-5650-8044	University of Notre Dame, IN, USA; National Institutes of Health [P01HL078826]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL078826] Funding Source: NIH RePORTER	University of Notre Dame, IN, USA; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the University of Notre Dame, IN, USA and the National Institutes of Health (P01HL078826). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajuebor MN, 2004, EUR J IMMUNOL, V34, P2907, DOI 10.1002/eji.200425071; Baudry M, 2003, EXP NEUROL, V184, P887, DOI 10.1016/S0014-4886(03)00345-5; Beltroy EP, 2005, HEPATOLOGY, V42, P886, DOI 10.1002/hep.20868; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Cluzeau CVM, 2012, HUM MOL GENET, V21, P3632, DOI 10.1093/hmg/dds193; Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; De Windt A, 2007, DNA CELL BIOL, V26, P665, DOI 10.1089/dna.2006.0570; DiRosario J, 2009, J NEUROSCI RES, V87, P978, DOI 10.1002/jnr.21912; Drummond RA, 2011, CURR OPIN MICROBIOL, V14, P392, DOI 10.1016/j.mib.2011.07.001; El Kebir D, 2010, THESCIENTIFICWORLDJO, V10, P1731, DOI 10.1100/tsw.2010.169; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Goluszko P, 2005, INFECT IMMUN, V73, P7791, DOI 10.1128/IAI.73.12.7791-7796.2005; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hofmann E, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-61; Jethwaney D, 2007, PROTEOME SCI, V5, DOI 10.1186/1477-5956-5-12; Jiang Q, 2005, GENE THER, V12, P1761, DOI 10.1038/sj.gt.3302558; Kasten KR, 2010, INFECT IMMUN, V78, P4714, DOI 10.1128/IAI.00456-10; Kumar V, 2010, INT IMMUNOPHARMACOL, V10, P1325, DOI 10.1016/j.intimp.2010.08.012; Lee KH, 2000, J IMMUNOL, V165, P4970, DOI 10.4049/jimmunol.165.9.4970; Li H, 2005, J NEUROPATH EXP NEUR, V64, P323, DOI 10.1093/jnen/64.4.323; Liao GH, 2010, BRAIN RES, V1325, P128, DOI 10.1016/j.brainres.2010.02.019; Liao GH, 2009, BRAIN RES, V1270, P140, DOI 10.1016/j.brainres.2009.03.027; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Lominadze G, 2005, MOL CELL PROTEOMICS, V4, P1503, DOI 10.1074/mcp.M500143-MCP200; Lopez ME, 2012, HUM MOL GENET, DOI 101093/hmg/dds126; Lynn DJ, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.55; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Maue RA, 2012, HUM MOL GENET, V21, P730, DOI 10.1093/hmg/ddr505; Monack DM, 2004, J EXP MED, V199, P231, DOI 10.1084/jem.20031319; Myerowitz R, 2002, HUM MOL GENET, V11, P1343, DOI 10.1093/hmg/11.11.1343; Nakatsuji T, 2011, J INVEST DERMATOL; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Ohmi K, 2009, P NATL ACAD SCI USA, V106, P8332, DOI 10.1073/pnas.0903223106; Parikh SS, 2003, INFECT IMMUN, V71, P6582, DOI 10.1128/IAI.71.11.6582-6590.2003; Parra J, 2011, BIOCHEM BIOPH RES CO, V413, P400, DOI 10.1016/j.bbrc.2011.08.096; Patterson MC, 2007, LANCET NEUROL, V6, P765, DOI 10.1016/S1474-4422(07)70194-1; Porter FD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001417; Pressey SNR, 2012, NEUROBIOL DIS, V45, P1086, DOI 10.1016/j.nbd.2011.12.027; Ramirez CM, 2010, PEDIATR RES, V68, P309, DOI 10.1203/00006450-201011001-00604; Reddy JV, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000019; Repa JJ, 2007, J NEUROSCI, V27, P14470, DOI 10.1523/JNEUROSCI.4823-07.2007; Rimkunas VM, 2008, HEPATOLOGY, V47, P1504, DOI 10.1002/hep.22327; Rimkunas VM, 2009, J LIPID RES, V50, P327, DOI 10.1194/jlr.M800415-JLR200; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Sagiv Y, 2006, J IMMUNOL, V177, P26, DOI 10.4049/jimmunol.177.1.26; Samuel BU, 2001, J BIOL CHEM, V276, P29319, DOI 10.1074/jbc.M101268200; Sayre NL, 2010, J LIPID RES, V51, P2372, DOI 10.1194/jlr.M007211; Schrantz N, 2007, J EXP MED, V204, P841, DOI 10.1084/jem.20061562; Segal AW, 2005, ANNU REV IMMUNOL, V23, P197, DOI 10.1146/annurev.immunol.23.021704.115653; Silva MT, 2011, J LEUKOCYTE BIOL, V89, P675, DOI 10.1189/jlb.0910536; SILVERSTEIN E, 1977, CLIN CHIM ACTA, V74, P21, DOI 10.1016/0009-8981(77)90382-5; Smith D, 2009, NEUROBIOL DIS, V36, P242, DOI 10.1016/j.nbd.2009.07.010; Tang YY, 2009, J VIROL, V83, P7982, DOI 10.1128/JVI.00259-09; Trexler AJ, 2007, CURR PROTEIN PEPT SC, V8, P537, DOI 10.2174/138920307783018659; Tsolis RM, 1999, ADV EXP MED BIOL, V473, P261; Vanier MT, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-16; Vazquez MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028777; Vieira MNN, 2007, J NEUROCHEM, V103, P736, DOI 10.1111/j.1471-4159.2007.04809.x; Vitner EB, 2010, HUM MOL GENET, V19, P3583, DOI 10.1093/hmg/ddq273; Voikar V, 2002, BEHAV BRAIN RES, V132, P1, DOI 10.1016/S0166-4328(01)00380-1; Watarai M, 2002, INFECT IMMUN, V70, P4818, DOI 10.1128/IAI.70.9.4818-4825.2002; Wraith JE, 2009, MOL GENET METAB, V98, P152, DOI 10.1016/j.ymgme.2009.06.008; Xie XF, 2011, P NATL ACAD SCI USA, V108, P15330, DOI 10.1073/pnas.1112751108; Yanjanin NM, 2010, AM J MED GENET B, V153B, P132, DOI 10.1002/ajmg.b.30969	67	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e48273	10.1371/journal.pone.0048273	http://dx.doi.org/10.1371/journal.pone.0048273			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094108	Green Published, Green Submitted, gold			2022-12-25	WOS:000310050200060
J	Mitchell, MD; Cowman, PF; McCormick, MI				Mitchell, Matthew D.; Cowman, Peter F.; McCormick, Mark I.			Chemical Alarm Cues Are Conserved within the Coral Reef Fish Family Pomacentridae	PLOS ONE			English	Article							BEHAVIORAL-RESPONSES; HABITAT UTILIZATION; PREDATOR AVOIDANCE; SKIN EXTRACT; RISK; CONSPECIFICS; RECOGNITION; ENCOUNTERS; SURVIVAL; SIGNALS	Fishes are known to use chemical alarm cues from both conspecifics and heterospecifics to assess local predation risks and enhance predator detection. Yet it is unknown how recognition of heterospecific cues arises for coral reef fishes. Here, we test if naive juvenile fish have an innate recognition of heterospecific alarm cues. We also examine if there is a relationship between the intensity of the antipredator response to these cues and the degree to which species are related to each other. Naive juvenile anemone fish, Amphiprion percula, were tested to see if they displayed antipredator responses to chemical alarm cues from four closely related heterospecific species (family Pomacentridae), a distantly related sympatric species (Asterropteryx semipunctatus) and a saltwater (control). Juveniles displayed significant reductions in foraging rate when exposed to all four confamilial heterospecific species but they did not respond to the distantly related sympatric species or the saltwater control. There was also a strong relationship between the intensity of the antipredator response and the extent to which species were related, with responses weakening as species became more distantly related. These findings demonstrate that chemical alarm cues are conserved within the pomacentrid family, providing juveniles with an innate recognition of heterospecific alarm cues as predicted by the phylogenetic relatedness hypothesis.	[Mitchell, Matthew D.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia; James Cook Univ, Sch Marine & Trop Biol, Townsville, Qld 4811, Australia	James Cook University; James Cook University	Mitchell, MD (corresponding author), James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.	matthew.mitchell1@my.jcu.edu.au	Cowman, Peter Francis/G-9998-2017; McCormick, Mark I/J-8301-2014	Cowman, Peter Francis/0000-0001-5977-5327; McCormick, Mark I/0000-0001-9289-1645	Australian Research Council; ARC Centre of Excellence for Coral Reef Studies [CE0561432]	Australian Research Council(Australian Research Council); ARC Centre of Excellence for Coral Reef Studies(Australian Research Council)	Funding was provided by the Australian Research Council (MIM) and the ARC Centre of Excellence for Coral Reef Studies (Grant No. CE0561432). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almany GR, 2006, CORAL REEFS, V25, P19, DOI 10.1007/s00338-005-0044-y; Berejikian BA, 2003, ENVIRON BIOL FISH, V67, P241, DOI 10.1023/A:1025887015436; BROWN GE, 1995, J FISH BIOL, V47, P387; Brown GE, 2000, J CHEM ECOL, V26, P139, DOI 10.1023/A:1005445629144; Brown Grant E., 2005, P34; Chivers DP, 2007, P ROY SOC B-BIOL SCI, V274, P2611, DOI 10.1098/rspb.2007.0709; CHIVERS DP, 1994, J CHEM ECOL, V20, P1517, DOI 10.1007/BF02059877; Chivers DP, 2002, BEHAVIOUR, V139, P929, DOI 10.1163/156853902320387909; Chivers DP, 2001, CHEM SIGNAL, V9, P277; Commens AM, 1999, J FISH BIOL, V55, P1359, DOI 10.1006/jfbi.1999.1132; Commens-Carson AM, 2007, COPEIA, P838, DOI 10.1643/0045-8511(2007)7[838:ROTDSG]2.0.CO;2; Cowman PF, 2011, J EVOLUTION BIOL, V24, P2543, DOI 10.1111/j.1420-9101.2011.02391.x; Dalesman S, 2007, ECOLOGY, V88, P2462, DOI 10.1890/07-0403.1; Dalesman S, 2010, ANIM BEHAV, V79, P173, DOI 10.1016/j.anbehav.2009.10.024; Depczynski M, 2004, MAR BIOL, V145, P455, DOI 10.1007/s002270004-1342-6; Dixson DL, 2010, ECOL LETT, V13, P68, DOI 10.1111/j.1461-0248.2009.01400.x; ELLIOTT JK, 1995, MAR BIOL, V122, P377, DOI 10.1007/BF00350870; Elliott JK, 2001, MAR BIOL, V138, P23, DOI 10.1007/s002270000441; Fallow PM, 2011, BEHAV ECOL, V22, P401, DOI 10.1093/beheco/arq221; Ferrari MCO, 2010, CAN J ZOOL, V88, P698, DOI 10.1139/Z10-029; Goldman B, 1976, P125; Golub JL, 2005, J FISH BIOL, V66, P1073, DOI 10.1111/j.0022-1112.2005.00658.x; Golub JL, 2003, BEHAV ECOL SOCIOBIOL, V54, P113, DOI 10.1007/s00265-003-0629-9; Graham NAJ, 2003, ENVIRON CONSERV, V30, P200, DOI 10.1017/S0376892903000195; Halbgewachs CF, 2009, BIOL J LINN SOC, V98, P891, DOI 10.1111/j.1095-8312.2009.01328.x; Haney DC, 2001, J FISH BIOL, V59, P810, DOI 10.1006/jfbi.2001.1690; Hartman EJ, 2000, P ROY SOC B-BIOL SCI, V267, P571, DOI 10.1098/rspb.2000.1039; Hazlett BA, 2005, J CHEM ECOL, V31, P671, DOI 10.1007/s10886-005-2054-1; HELFMAN GS, 1989, BEHAV ECOL SOCIOBIOL, V24, P47, DOI 10.1007/BF00300117; Huryn AD, 1999, J CHEM ECOL, V25, P2729, DOI 10.1023/A:1020851524335; Karplus I, 2006, MAR ECOL PROG SER, V319, P215, DOI 10.3354/meps319215; Leahy SM, 2011, BIOL LETTERS, V7, P811, DOI 10.1098/rsbl.2011.0645; Lima SL, 1999, AM NAT, V153, P649, DOI 10.1086/303202; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lonnstedt OM, 2012, P ROY SOC B-BIOL SCI, V279, P2091, DOI 10.1098/rspb.2011.2516; Mariscal R. N., 1970, Univ. Calif. Publs Zool., V91, P1; MATHIS A, 1993, BEHAV ECOL, V4, P260, DOI 10.1093/beheco/4.3.260; McCormick MI, 2006, J FISH BIOL, V68, P969, DOI 10.1111/j.1095-8649.2006.00982.x; MILICICH MJ, 1994, MAR ECOL PROG SER, V110, P121, DOI 10.3354/meps110121; Mirza RS, 2003, BEHAVIOUR, V140, P1359, DOI 10.1163/156853903771980620; Mirza RS, 2001, ETHOLOGY, V107, P989, DOI 10.1046/j.1439-0310.2001.00729.x; Mirza RS, 2001, J CHEM ECOL, V27, P1641, DOI 10.1023/A:1010414426082; Mirza RS, 2001, CHEM SIGNALS VERTEBR, V9; Mitchell MD, 2011, ANIM COGN, V14, P707, DOI 10.1007/s10071-011-0405-6; Mitchell MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015764; Schoeppner NM, 2009, COPEIA, P190, DOI 10.1643/CE-08-041; Schoeppner NM, 2005, ECOL LETT, V8, P505, DOI 10.1111/j.1461-0248.2005.00744.x; Seppanen JT, 2007, ECOLOGY, V88, P1622, DOI 10.1890/06-1757.1; Shriner WM, 1998, ANIM BEHAV, V55, P529, DOI 10.1006/anbe.1997.0623; SMITH RJF, 1991, J CHEM ECOL, V17, P2253, DOI 10.1007/BF00988005; St John J., 1995, THESIS J COOK U N QU; Sullivan AM, 2003, BEHAVIOUR, V140, P553, DOI 10.1163/156853903322127977; THRESHER RE, 1985, ECOLOGY, V66, P1139, DOI 10.2307/1939166; Vadas RL, 2003, MAR ECOL, V24, P100; Vail AL, 2011, BIOL LETTERS, V7, P921, DOI 10.1098/rsbl.2011.0380; Wilson SK, 2008, J ANIM ECOL, V77, P220, DOI 10.1111/j.1365-2656.2007.01341.x	56	42	42	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47428	10.1371/journal.pone.0047428	http://dx.doi.org/10.1371/journal.pone.0047428			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094047	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000312384500009
J	Rangrez, AY; M'Baya-Moutoula, E; Metzinger-Le Meuth, V; Henaut, L; Djelouat, MSE; Benchitrit, J; Massy, ZA; Metzinger, L				Rangrez, Ashraf Yusuf; M'Baya-Moutoula, Eleonore; Metzinger-Le Meuth, Valerie; Henaut, Lucie; Djelouat, Mohamed Seif el Islam; Benchitrit, Joyce; Massy, Ziad A.; Metzinger, Laurent			Inorganic Phosphate Accelerates the Migration of Vascular Smooth Muscle Cells: Evidence for the Involvement of miR-223	PLOS ONE			English	Article							GENE-EXPRESSION; CALCIFICATION; MICRORNA-223; METABOLISM; PHENOTYPE; MIR-145; GROWTH; MICE	Backgound: An elevated serum inorganic phosphate (Pi) level is a major risk factor for kidney disease and downstream vascular complications. We focused on the effect of Pi levels on human aortic vascular smooth muscle cells (VSMCs), with an emphasis on the role of microRNAs (miRNAs). Methodology/Principal Findings: Exposure of human primary VSMCs in vitro to pathological levels of Pi increased calcification, migration rate and concomitantly reduced cell proliferation and the amount of the actin cytoskeleton. These changes were evidenced by significant downregulation of miRNA-143 (miR-143) and miR-145 and concomitant upregulation of their targets and key markers in synthetic VSMCs, such as Kruppel-like factors -4 and -5 and versican. Interestingly, we also found that miR-223 (a marker of muscle damage and a key factor in osteoclast differentiation) is expressed in VSMCs and is significantly upregulated in Pi-treated cells. Over-expressing miR-223 in VSMCs increased proliferation and markedly enhanced VSMC migration. Additionally, we found that the expression of two of the known miR-223 targets, Mef2c and RhoB, was highly reduced in Pi treated as well as miR-223 over-expressing VSMCs. To complement these in vitro findings, we also observed significant downregulation of miR-143 and miR-145 and upregulation of miR-223 in aorta samples collected from ApoE knock-out mice, which display vascular calcification. Conclusions/Significance: Our results suggest that (i) high levels of Pi increase VSMC migration and calcification, (ii) altered expression levels of miR-223 could play a part in this process and (iii) miR-223 is a potential new biomarker of VSMC damage.	[Rangrez, Ashraf Yusuf; M'Baya-Moutoula, Eleonore; Metzinger-Le Meuth, Valerie; Henaut, Lucie; Djelouat, Mohamed Seif el Islam; Benchitrit, Joyce; Massy, Ziad A.; Metzinger, Laurent] INSERM, U1088, Amiens, France; [Rangrez, Ashraf Yusuf; M'Baya-Moutoula, Eleonore; Henaut, Lucie; Djelouat, Mohamed Seif el Islam; Benchitrit, Joyce; Massy, Ziad A.; Metzinger, Laurent] Jules Verne Univ Picardie, Fac Pharm & Med, Amiens, France; [Massy, Ziad A.] Amiens Univ Hosp, Div Pharmacol Nephrol, Amiens, France; [Metzinger-Le Meuth, Valerie] Univ Paris 13, UFR SMBH, Bobigny, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Universite Paris 13	Metzinger, L (corresponding author), INSERM, U1088, Amiens, France.	laurent.metzinger@u-picardie.fr	Meuth, Valérie Metzinger-Le/H-6338-2016; Rangrez, Ashraf/H-4988-2016; Hénaut, Lucie/AAN-6974-2020; metzinger, laurent/AAY-4634-2021; Metzinger, Laurent/B-1426-2016	Meuth, Valérie Metzinger-Le/0000-0003-1718-5083; Rangrez, Ashraf/0000-0003-2630-9754; metzinger, laurent/0000-0002-7636-8480; Metzinger, Laurent/0000-0002-7636-8480	Region Picardie, France	Region Picardie, France(Region Hauts-de-France)	This work was supported by grants from Region Picardie, France ("MARNO-MPCC" and "Modulation des calcifications cardiovasculaires"), including post-doctoral fellowships for AYR and EMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Ella L, 2009, CELL DEATH DIFFER, V16, P1590, DOI 10.1038/cdd.2009.153; Eyholzer M, 2010, LEUKEMIA RES, V34, P672, DOI 10.1016/j.leukres.2009.11.019; FATIGATI V, 1984, J BIOL CHEM, V259, P4383; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Goettsch C, 2011, AM J PATHOL, V179, P1594, DOI 10.1016/j.ajpath.2011.06.016; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; House SJ, 2008, PFLUG ARCH EUR J PHY, V456, P769, DOI 10.1007/s00424-008-0491-8; Ivanovski O, 2009, ATHEROSCLEROSIS, V205, P55, DOI 10.1016/j.atherosclerosis.2008.10.043; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Jono S, 2000, CIRC RES, V87, pE10, DOI 10.1161/01.RES.87.7.e10; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Liu QF, 2011, INT J CANCER, V129, P2662, DOI 10.1002/ijc.25921; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; Lu H, 2010, CARDIOVASC RES, V86, P410, DOI 10.1093/cvr/cvq010; Maizel J, 2009, CIRCULATION, V119, P306, DOI 10.1161/CIRCULATIONAHA.108.797407; Massy ZA, 2005, J AM SOC NEPHROL, V16, P109, DOI 10.1681/ASN.2004060495; Mozar A, 2008, J CELL PHYSIOL, V215, P47, DOI 10.1002/jcp.21283; Mune S, 2009, CLIN EXP NEPHROL, V13, P571, DOI 10.1007/s10157-009-0208-0; Nagai R, 2005, J THROMB HAEMOST, V3, P1569, DOI 10.1111/j.1538-7836.2005.01366.x; Neven E, 2011, CIRC RES, V108, P249, DOI 10.1161/CIRCRESAHA.110.225904; Pagiatakis C, 2012, J BIOL CHEM, V287, P8361, DOI 10.1074/jbc.M111.286203; Quintavalle M, 2010, J CELL BIOL, V189, P13, DOI 10.1083/jcb.200912096; Rangrez AY, 2011, CIRC-CARDIOVASC GENE, V4, P197, DOI 10.1161/CIRCGENETICS.110.958702; ROSS R, 1971, J CELL BIOL, V50, P172, DOI 10.1083/jcb.50.1.172; STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420; Sugatani T, 2007, J CELL BIOCHEM, V101, P996, DOI 10.1002/jcb.21335; Sun G, NUCL ACIDS RES, V38, P239; Tang JR, 2002, BIOCHEM BIOPH RES CO, V290, P1255, DOI 10.1006/bbrc.2002.6336; van Rooij E, 2011, CIRC RES, V108, P219, DOI 10.1161/CIRCRESAHA.110.227496; Wang H, 1998, CIRC RES, V83, P832, DOI 10.1161/01.RES.83.8.832; Wang X, J BIOL CHEM, V285, P23241; Wojciak-Stothard B, 2012, CIRC RES, V110, P1423, DOI 10.1161/CIRCRESAHA.112.264473; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Young EW, 2005, KIDNEY INT, V67, P1179, DOI 10.1111/j.1523-1755.2005.00185.x	37	90	96	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47807	10.1371/journal.pone.0047807	http://dx.doi.org/10.1371/journal.pone.0047807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23094093	Green Published, gold, Green Submitted			2022-12-25	WOS:000312384500026
J	Lindqvist, D; Kaufman, E; Brundin, L; Hall, S; Surova, Y; Hansson, O				Lindqvist, Daniel; Kaufman, Eli; Brundin, Lena; Hall, Sara; Surova, Yulia; Hansson, Oskar			Non-Motor Symptoms in Patients with Parkinson's Disease - Correlations with Inflammatory Cytokines in Serum	PLOS ONE			English	Article							MAJOR DEPRESSION; CEREBROSPINAL-FLUID; DOUBLE-BLIND; TNF-ALPHA; INTERLEUKIN-2; CELECOXIB; METAANALYSIS; ASSOCIATION; DISORDERS; RECEPTOR	Background: Parkinson's Disease (PD) is the second most common neurodegenerative disorder of the central nervous system. Motor symptoms are the focus of pharmacotherapy, yet non-motor features of the disease (e. g. fatigue, mood disturbances, sleep disturbances and symptoms of anxiety) are both common and disabling for the patient. The pathophysiological mechanisms behind the non-motor symptoms in PD are yet to be untangled. The main objective of this study was to investigate associations between pro-inflammatory substances and non-motor symptoms in patients with PD. Methods and Materials: We measured C-reactive protein, interleukin (IL)-6, soluble IL-2 receptor (sIL-2R) and tumor necrosis factor-alpha (TNF-alpha) in blood samples from PD patients (n = 86) and healthy controls (n = 40). Symptoms of fatigue, depression, anxiety and sleeping difficulties were assessed using the Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT), the Hospital Anxiety and Depression Scale (HAD), and the Scales for Outcome in PD-Sleep Scale respectively. Results: IL-6 was significantly higher in PD patients than in healthy controls. Compared to healthy controls, PD patients displayed significantly higher mean scores on HAD and lower scores on FACIT, thus indicating more severe symptoms as measured with these scales. Within the PD sample, high levels of both sIL-2R and TNF-alpha were significantly associated with more severe symptoms assessed by means of FACIT and HAD (depression and anxiety subscales). SIL-2-R levels were able to significantly predict FACIT and HAD scores after the effects of age, gender, anti-parkinsonian medications, and severity of motor symptoms were controlled for. Discussion: We suggest that non-motor symptoms in PD patients, such as fatigue and depressive symptoms, might be generated via inflammatory mechanisms. This knowledge might contribute to the development of novel treatment options in PD, specifically targeting non-motor symptoms.	[Lindqvist, Daniel; Kaufman, Eli; Brundin, Lena] Lund Univ, Dept Clin Sci, Sect Psychiat, Lund, Sweden; [Lindqvist, Daniel] Psychiat Skane, Lund, Sweden; [Brundin, Lena] Michigan State Univ, Dept Translat Sci & Mol Med, Grand Rapids, MI USA; [Hall, Sara; Surova, Yulia; Hansson, Oskar] Skane Univ Hosp, Dept Neurol, Lund, Sweden; [Hansson, Oskar] Lund Univ, Dept Clin Sci, Clin Memory Res Unit, Malmo, Sweden	Lund University; Michigan State University; Lund University; Skane University Hospital; Lund University	Lindqvist, D (corresponding author), Lund Univ, Dept Clin Sci, Sect Psychiat, Lund, Sweden.	Daniel.Lindqvist@med.lu.se	Lindenmayer, David B/P-7183-2017; Hansson, Oskar/A-7134-2013	Lindenmayer, David B/0000-0002-4766-4088; Hansson, Oskar/0000-0001-8467-7286; Brundin, Lena/0000-0002-8327-6242	Swedish Research Council; Sjobring Foundation; OM Persson Foundation; province of Scania state grants (ALF)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Sjobring Foundation; OM Persson Foundation; province of Scania state grants (ALF)	This study was performed with the support of the Swedish Research Council grants, the Sjobring Foundation, OM Persson Foundation and the province of Scania state grants (ALF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarsland D, 2009, MOVEMENT DISORD, V24, P2175, DOI 10.1002/mds.22589; Akhondzadeh S, 2009, DEPRESS ANXIETY, V26, P607, DOI 10.1002/da.20589; Barnum CJ, 2008, NEUROSCIENCE, V156, P30, DOI 10.1016/j.neuroscience.2008.07.016; Barnum CJ, 2012, CURR NEUROL IN PRESS; Bjorklund A, 2010, PROG BRAIN RES, V184, P113, DOI 10.1016/S0079-6123(10)84006-3; BlumDegen D, 1995, NEUROSCI LETT, V202, P17, DOI 10.1016/0304-3940(95)12192-7; CARUSO C, 1993, MEDIAT INFLAMM, V2, P3, DOI 10.1155/S0962935193000018; Cella D, 1997, MANUAL FUNCTIONAL AS; Dantzer R, 2007, BRAIN BEHAV IMMUN, V21, P153, DOI 10.1016/j.bbi.2006.09.006; de Lau LML, 2006, LANCET NEUROL, V5, P525, DOI 10.1016/S1474-4422(06)70471-9; Dinh W, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-58; Dobbs RJ, 1999, ACTA NEUROL SCAND, V100, P34, DOI 10.1111/j.1600-0404.1999.tb00721.x; Findley L, 2003, MOVEMENT DISORD, V18, P1139, DOI 10.1002/mds.10507; Gagne JJ, 2010, NEUROLOGY, V74, P995, DOI 10.1212/WNL.0b013e3181d5a4a3; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Hagell P, 2009, J NEUROL NEUROSUR PS, V80, P489, DOI 10.1136/jnnp.2008.159772; Hou RH, 2012, HUM PSYCHOPHARM CLIN, V27, P6, DOI 10.1002/hup.1259; Jacob EL, 2010, PARKINSONISM RELAT D, V16, P576, DOI 10.1016/j.parkreldis.2010.06.014; KLUTER H, 1995, J NEUROL SCI, V133, P134, DOI 10.1016/0022-510X(95)00180-A; Lindqvist D, 2009, BIOL PSYCHIAT, V66, P287, DOI 10.1016/j.biopsych.2009.01.030; Liu Y., 2011, JFSP RES PROJECT REP, P1; Marinus J, 2003, SLEEP, V26, P1049, DOI 10.1093/sleep/26.8.1049; McKinlay A, 2008, PARKINSONISM RELAT D, V14, P37, DOI 10.1016/j.parkreldis.2007.05.009; Menza M, 2010, PSYCHOSOMATICS, V51, P474, DOI 10.1176/appi.psy.51.6.474; Menza M, 2010, MOVEMENT DISORD, V25, pS117, DOI 10.1002/mds.22788; Muller N, 2006, MOL PSYCHIATR, V11, P680, DOI 10.1038/sj.mp.4001805; Muller T, 1998, ACTA NEUROL SCAND, V98, P142; Nilsson FM, 2002, ACTA PSYCHIAT SCAND, V106, P202, DOI 10.1034/j.1600-0447.2002.02229.x; Ouchi Y, 2009, PARKINSONISM RELAT D, V15, pS200, DOI 10.1016/S1353-8020(09)70814-4; Palhagen S, 2010, J NEUROL, V257, P524, DOI 10.1007/s00415-009-5353-6; Raison CL, 2009, BRAIN BEHAV IMMUN, V23, P327, DOI 10.1016/j.bbi.2008.11.005; Reale M, 2009, BRAIN BEHAV IMMUN, V23, P55, DOI 10.1016/j.bbi.2008.07.003; Rees K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008454.pub2; RUBIN LA, 1990, ANN INTERN MED, V113, P619, DOI 10.7326/0003-4819-113-8-619; Sairam K, 2003, BRAIN RES, V966, P245, DOI 10.1016/S0006-8993(02)04174-4; Scalzo P, 2010, NEUROSCI LETT, V468, P56, DOI 10.1016/j.neulet.2009.10.062; Schiepers OJG, 2005, PROG NEURO-PSYCHOPH, V29, P201, DOI 10.1016/j.pnpbp.2004.11.003; SMITH KA, 1988, SCIENCE, V240, P1169, DOI 10.1126/science.3131876; Soh SE, 2011, PARKINSONISM RELAT D, V17, P1, DOI 10.1016/j.parkreldis.2010.08.012; Teismann P, 2001, SYNAPSE, V39, P167, DOI 10.1002/1098-2396(200102)39:2<167::AID-SYN8>3.0.CO;2-U; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Weintraub D, 2005, MOVEMENT DISORD, V20, P1161, DOI 10.1002/mds.20555; Weintraub D, 2004, J AM GERIATR SOC, V52, P784, DOI 10.1111/j.1532-5415.2004.52219.x; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	44	170	177	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47387	10.1371/journal.pone.0047387	http://dx.doi.org/10.1371/journal.pone.0047387			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082161	gold, Green Published, Green Submitted			2022-12-25	WOS:000311146900057
J	Lopez-Rodriguez, A; Holmgren, M				Lopez-Rodriguez, Angelica; Holmgren, Miguel			Restoration of Proper Trafficking to the Cell Surface for Membrane Proteins Harboring Cysteine Mutations	PLOS ONE			English	Article							NUCLEOTIDE-GATED CHANNELS; SHAKER K+ CHANNEL; RENAL TUBULAR-ACIDOSIS; ION CHANNELS; FUNCTIONAL EXPRESSION; CHEMICAL CHAPERONES; POTASSIUM CHANNEL; COMPLEMENTARY-DNA; GAUCHER-DISEASE; CNGA3 MUTATIONS	A common phenotype for many genetic diseases is that the cell is unable to deliver full-length membrane proteins to the cell surface. For some forms of autism, hereditary spherocytosis and color blindness, the culprits are single point mutations to cysteine. We have studied two inheritable cysteine mutants of cyclic nucleotide-gated channels that produce achromatopsia, a common form of severe color blindness. By taking advantage of the reactivity of cysteine's sulfhydryl group, we modified these mutants with chemical reagents that attach moieties with similar chemistries to the wild-type amino acids' side chains. We show that these modifications restored proper delivery to the cell membrane. Once there, the channels exhibited normal functional properties. This strategy might provide a unique opportunity to assess the chemical nature of membrane protein traffic problems.	[Lopez-Rodriguez, Angelica; Holmgren, Miguel] NINDS, Neurophysiol Sect, Porter Neurosci Res Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Holmgren, M (corresponding author), NINDS, Neurophysiol Sect, Porter Neurosci Res Ctr, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	holmgren@ninds.nih.gov		Lopez-Rodriguez, Angelica/0000-0003-4411-8441	National Institutes of Health, National Institute Neurological Disorders and Stroke; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002993] Funding Source: NIH RePORTER	National Institutes of Health, National Institute Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Intramural Research Program of the National Institutes of Health, National Institute Neurological Disorders and Stroke. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Bartoli M, 2008, HUM MOL GENET, V17, P1214, DOI 10.1093/hmg/ddn029; BONIGK W, 1993, NEURON, V10, P865, DOI 10.1016/0896-6273(93)90202-3; Comoletti D, 2004, J NEUROSCI, V24, P4889, DOI 10.1523/JNEUROSCI.0468-04.2004; Deutsch C, 2003, NEURON, V40, P265, DOI 10.1016/S0896-6273(03)00506-3; DHALLAN RS, 1990, NATURE, V347, P184, DOI 10.1038/347184a0; Dhermy D, 1999, MOL MEMBR BIOL, V16, P305, DOI 10.1080/096876899294526; Dowhan W, 2009, ANNU REV BIOCHEM, V78, P515, DOI 10.1146/annurev.biochem.77.060806.091251; Duricka DL, 2012, BIOCHEM J, V441, P685, DOI 10.1042/BJ20111004; Faillace MP, 2004, J BIOL CHEM, V279, P22643, DOI 10.1074/jbc.M400035200; Flynn GE, 2001, NEURON, V30, P689, DOI 10.1016/S0896-6273(01)00324-5; Holmgren M, 1996, NEUROPHARMACOLOGY, V35, P797, DOI 10.1016/0028-3908(96)00129-3; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; KAUPP UB, 1989, NATURE, V342, P762, DOI 10.1038/342762a0; Koeppen K, 2008, EUR J NEUROSCI, V27, P2391, DOI 10.1111/j.1460-9568.2008.06195.x; Liu CM, 2005, AM J PHYSIOL-CELL PH, V289, pC187, DOI 10.1152/ajpcell.00490.2004; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Mannikko R, 2002, NATURE, V419, P837, DOI 10.1038/nature01038; Matulef K, 1999, NEURON, V24, P443, DOI 10.1016/S0896-6273(00)80857-0; Pages F, 2000, BIOPHYS J, V78, P1227, DOI 10.1016/S0006-3495(00)76680-X; PAPAZIAN DM, 1987, SCIENCE, V237, P749, DOI 10.1126/science.2441470; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; Patel KA, 2005, INVEST OPHTH VIS SCI, V46, P2282, DOI 10.1167/iovs.05-0179; Peng CH, 2004, NEURON, V42, P401, DOI 10.1016/S0896-6273(04)00225-9; Peng CH, 2003, J BIOL CHEM, V278, P34533, DOI 10.1074/jbc.M305102200; Perlmutter DH, 2002, PEDIATR RES, V52, P832, DOI 10.1203/01.PDR.0000036878.28942.14; PEROZO E, 1994, BIOPHYS J, V66, P345, DOI 10.1016/S0006-3495(94)80783-0; Reuter P, 2008, HUM MUTAT, V29, P1228, DOI 10.1002/humu.20790; Rungroj N, 2004, J BIOL CHEM, V279, P13833, DOI 10.1074/jbc.M400188200; Sawkar AR, 2006, ACS CHEM BIOL, V1, P235, DOI 10.1021/cb600187q; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; STRYER L, 1988, COLD SPRING HARB SYM, V53, P283, DOI 10.1101/SQB.1988.053.01.035; Tang YJ, 2002, J BIOL CHEM, V277, P39880, DOI 10.1074/jbc.M206582200; Toye AM, 2006, AM J PHYSIOL-CELL PH, V291, pC788, DOI 10.1152/ajpcell.00094.2006; vanKlompenburg W, 1997, EMBO J, V16, P4261, DOI 10.1093/emboj/16.14.4261; Weitz D, 2002, NEURON, V36, P881, DOI 10.1016/S0896-6273(02)01098-X; Wissinger B, 2001, AM J HUM GENET, V69, P722, DOI 10.1086/323613; Yu ZQ, 2007, FEBS J, V274, P4944, DOI 10.1111/j.1742-4658.2007.06042.x; Zagotta WN, 1996, ANNU REV NEUROSCI, V19, P235, DOI 10.1146/annurev.ne.19.030196.001315; Zheng J, 2004, NEURON, V42, P411, DOI 10.1016/S0896-6273(04)00253-3; Zheng J, 2002, NEURON, V36, P891, DOI 10.1016/S0896-6273(02)01099-1; Zhong HM, 2002, NATURE, V420, P193, DOI 10.1038/nature01201; Zhou ZF, 1999, J BIOL CHEM, V274, P31123, DOI 10.1074/jbc.274.44.31123	43	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47693	10.1371/journal.pone.0047693	http://dx.doi.org/10.1371/journal.pone.0047693			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082193	Green Published, gold, Green Submitted			2022-12-25	WOS:000311146900090
J	van der Donk, CFM; van de Bovenkamp, JHB; De Brauwer, EIGB; De Mol, P; Feldhoff, KH; Kalka-Moll, WM; Nys, S; Thoelen, I; Trienekens, TAM; Stobberingh, EE				van der Donk, Christina F. M.; van de Bovenkamp, Jeroen H. B.; De Brauwer, Els I. G. B.; De Mol, Patrick; Feldhoff, Karl-Heinz; Kalka-Moll, Wiltrud M.; Nys, Sita; Thoelen, Inge; Trienekens, Thera A. M.; Stobberingh, Ellen E.			Antimicrobial Resistance and Spread of Multi Drug Resistant Escherichia coli Isolates Collected from Nine Urology Services in the Euregion Meuse-Rhine	PLOS ONE			English	Article							FIELD GEL-ELECTROPHORESIS; URINARY-TRACT-INFECTIONS; BETA-LACTAMASE GENES; ANTIBIOTIC SUSCEPTIBILITY; SPECTRUM; ENTEROBACTERIACEAE; SURVEILLANCE; CYSTITIS; EUROPE; TRENDS	We determined the prevalence and spread of antibiotic resistance and the characteristics of ESBL producing and/or multi drug resistant (MDR) Escherichia coli isolates collected from urine samples from urology services in the Euregio Meuse-Rhine, the border region of the Netherlands (n = 176), Belgium (n = 126) and Germay (n = 119). Significant differences in resistance between the three regions were observed. Amoxicillin-clavulanic acid resistance ranged from 24% in the Netherlands to 39% in Belgium (p = 0.018), from 20% to 40% (p<0.004) for the fluoroquinolones and from 20% to 40% (p = 0.018) for the folate antagonists. Resistance to nitrofurantoin was less than 5%. The prevalence of ESBL producing isolates varied from 2% among the Dutch isolates to 8% among the German ones (p = 0.012) and were mainly CTX-M 15. The prevalence of MDR isolates among the Dutch, German and Belgian isolates was 11%, 17% and 27%, respectively (p<=0.001 for the Belgian compared with the Dutch isolates). The majority of the MDR and ESBL producing isolates belonged to ST131. This study indicates that most antibiotics used as first choice oral empiric treatment for UTIs (amoxicillin-clavulanic acid, fluoroquinolones and folate antagonists) are not appropriate for this purpose and that MDR strains such as CTX-M producing ST131 have spread in the entire Euregion. Our data stress the importance of ward specific surveillance to optimize empiric treatment. Also, prudent use of antibiotics and further research to alternative agents are warranted.	[van der Donk, Christina F. M.; Stobberingh, Ellen E.] Maastricht Univ, Med Ctr, Dept Med Microbiol, Maastricht, Netherlands; [van der Donk, Christina F. M.; Stobberingh, Ellen E.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Maastricht, Netherlands; [van de Bovenkamp, Jeroen H. B.] PAMM, Lab Med Microbiol, Veldhoven, Netherlands; [De Brauwer, Els I. G. B.] Atrium Med Ctr, Dept Med Microbiol, Heerlen, Netherlands; [De Mol, Patrick] Ctr Hosp Univ Liege, Microbiol Lab, Liege, Belgium; [Feldhoff, Karl-Heinz] Gesundheitsamt Kreises Heinsberg, Heinsberg, Germany; [Kalka-Moll, Wiltrud M.] Med Care Ctr Dr Stein & Colleagues, Monchengladbach, Germany; [Nys, Sita] Jessa Hosp, Dept Biol Clin, Hasselt, Belgium; [Thoelen, Inge] Gen Hosp Vesalius, Dept Biol Clin, Tongeren, Belgium; [Trienekens, Thera A. M.] VieCuri Med Ctr, Dept Med Microbiol, Venlo, Netherlands	Maastricht University; Maastricht University; Atrium Medical Center; University of Liege; VieCuri Medical Center	Stobberingh, EE (corresponding author), Maastricht Univ, Med Ctr, Dept Med Microbiol, Maastricht, Netherlands.	e.stobberingh@mumc.nl			Provincie Limburg - the Netherlands; Ministerium fur Wirtschaft; Energie; Bauen; Wohnen und Verkehr des Landes Nordrhein-Westfalen - Germany; Ministerium der Deutschsprachige Gemeinschaft Belgiens - Belgium; Provincie Limburg - Belgium; Wallonie - Belgium; Rheinland-Westfalen - Germany; Interreg; Euregio Meuse-Rhine; European fund for regional development (EFRO)	Provincie Limburg - the Netherlands; Ministerium fur Wirtschaft; Energie; Bauen; Wohnen und Verkehr des Landes Nordrhein-Westfalen - Germany; Ministerium der Deutschsprachige Gemeinschaft Belgiens - Belgium; Provincie Limburg - Belgium; Wallonie - Belgium; Rheinland-Westfalen - Germany; Interreg; Euregio Meuse-Rhine; European fund for regional development (EFRO)(European Commission)	This project was financially supported by Provincie Limburg - the Netherlands, Ministerium fur Wirtschaft, Energie, Bauen, Wohnen und Verkehr des Landes Nordrhein-Westfalen - Germany, Ministerium der Deutschsprachige Gemeinschaft Belgiens - Belgium, Provincie Limburg - Belgium, Wallonie - Belgium, Rheinland-Westfalen - Germany, Interreg, the Euregio Meuse-Rhine and the European fund for regional development (EFRO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Charalabopoulos K, 2003, CHEMOTHERAPY, V49, P269, DOI 10.1159/000074526; Colodner R, 2008, INFECTION, V36, P41, DOI 10.1007/s15010-007-7083-y; Coque T M, 2008, Euro Surveill, V13; Cullen IM, 2011, BJU INT, P1999; De Backer D, 2008, J ANTIMICROB CHEMOTH, V62, P364, DOI 10.1093/jac/dkn197; den Heijer CDJ, 2010, J ANTIMICROB CHEMOTH, V65, P2128, DOI 10.1093/jac/dkq286; ECDC, 2020, ANN REPORT EUROPEAN; EIS, 2006, EUR MEUSE RHIN FIG; EUCAST, 2011, EUCAST BREAKP TABL I; Gibreel TM, 2012, J ANTIMICROB CHEMOTH, V67, P346, DOI 10.1093/jac/dkr451; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Gupta K, 2011, CLIN INFECT DIS, V52, pE103, DOI [10.1093/cid/ciq257, 10.1093/cid/cir102]; Jans B, 2009, SURVEILLANCE MULTIRE; Lee SS, 2011, J INFECTION, V62, P159, DOI 10.1016/j.jinf.2010.10.009; Naber KG, 2008, EUR UROL, V54, P1164, DOI 10.1016/j.eururo.2008.05.010; Narum SR, 2006, CONSERV GENET, V7, P783, DOI 10.1007/s10592-005-9056-y; NVMM, 2008, ENT; Nys S, 2008, J ANTIMICROB CHEMOTH, V62, P126, DOI 10.1093/jac/dkn151; Overdevest I, 2011, EMERG INFECT DIS, V17, P1216, DOI 10.3201/eid1707.110209; Pallecchi L, 2004, ANTIMICROB AGENTS CH, V48, P4556, DOI 10.1128/AAC.48.12.4556-4561.2004; Pitout JDD, 2009, ANTIMICROB AGENTS CH, V53, P2846, DOI 10.1128/AAC.00247-09; Raz R, 2012, CLIN MICROBIOL INFEC, V18, P4, DOI 10.1111/j.1469-0691.2011.03636.x; Ribot EM, 2006, FOODBORNE PATHOG DIS, V3, P59, DOI 10.1089/fpd.2006.3.59; Rodriguez-Villalobos H, 2011, J ANTIMICROB CHEMOTH, V66, P37, DOI 10.1093/jac/dkq388; Saladin M, 2002, FEMS MICROBIOL LETT, V209, P161, DOI 10.1016/S0378-1097(02)00484-6; SWAB, 2011, NETHM 2011 CONS ANT; SWAB, 2006, RICHTL ANT THER BIJ; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; van der Donk CFM, 2011, J ANTIMICROB CHEMOTH, V66, P855, DOI 10.1093/jac/dkq538; Wagenlehner FME, 2008, INT J ANTIMICROB AG, V31, pS25, DOI 10.1016/j.ijantimicag.2007.07.029; Yagupsky P, 2006, PEDIATR INFECT DIS J, V25, P974, DOI 10.1097/01.inf.0000239270.33190.71	31	25	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 17	2012	7	10							e47707	10.1371/journal.pone.0047707	http://dx.doi.org/10.1371/journal.pone.0047707			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	038AF	23082197	Green Published, gold, Green Submitted			2022-12-25	WOS:000311146900094
J	Yin, LY; Colman, BP; McGill, BM; Wright, JP; Bernhardt, ES				Yin, Liyan; Colman, Benjamin P.; McGill, Bonnie M.; Wright, Justin P.; Bernhardt, Emily S.			Effects of Silver Nanoparticle Exposure on Germination and Early Growth of Eleven Wetland Plants	PLOS ONE			English	Article							DEPENDENT TOXICITY; PHYTOTOXICITY; NANOSILVER; IMPACTS; STRESS; OXYGEN	The increasing commercial production of engineered nanoparticles (ENPs) has led to concerns over the potential adverse impacts of these ENPs on biota in natural environments. Silver nanoparticles (AgNPs) are one of the most widely used ENPs and are expected to enter natural ecosystems. Here we examined the effects of AgNPs on germination and growth of eleven species of common wetland plants. We examined plant responses to AgNP exposure in simple pure culture experiments (direct exposure) and for seeds planted in homogenized field soils in a greenhouse experiment (soil exposure). We compared the effects of two AgNPs-20-nm polyvinylpyrrolidine-coated silver nanoparticles (PVP-AgNPs) and 6-nm gum arabic coated silver nanoparticles (GA-AgNPs)-to the effects of AgNO3 exposure added at equivalent Ag concentrations (1, 10 or 40 mg Ag L-1). In the direct exposure experiments, PVP-AgNP had no effect on germination while 40 mg Ag L-1 GA-AgNP exposure significantly reduced the germination rate of three species and enhanced the germination rate of one species. In contrast, 40 mg Ag L-1 AgNO3 enhanced the germination rate of five species. In general root growth was much more affected by Ag exposure than was leaf growth. The magnitude of inhibition was always greater for GA-AgNPs than for AgNO3 and PVP-AgNPs. In the soil exposure experiment, germination effects were less pronounced. The plant growth response differed by taxa with Lolium multiflorum growing more rapidly under both AgNO3 and GA-AgNP exposures and all other taxa having significantly reduced growth under GA-AgNP exposure. AgNO3 did not reduce the growth of any species while PVP-AgNPs significantly inhibited the growth of only one species. Our findings suggest important new avenues of research for understanding the fate and transport of NPs in natural media, the interactions between NPs and plants, and indirect and direct effects of NPs in mixed plant communities.	[Yin, Liyan] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China; [Yin, Liyan; Colman, Benjamin P.; Bernhardt, Emily S.] Duke Univ, Ctr Environm Implicat Nanotechnol, Durham, NC USA; [Yin, Liyan; Colman, Benjamin P.; McGill, Bonnie M.; Wright, Justin P.; Bernhardt, Emily S.] Duke Univ, Dept Biol, Durham, NC USA	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Duke University; Duke University	Yin, LY (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Aquat Bot & Watershed Ecol, Wuhan, Peoples R China.	lyyin@163.com	Wright, Justin/AAG-6461-2019; Colman, Benjamin/B-5704-2009; Colman, Benjamin P./AGJ-4864-2022; Bernhardt, Emily S/D-9940-2011; Bernhardt, Emily/B-4541-2010; McGill, Bonnie/AAT-7426-2020	Wright, Justin/0000-0002-9102-5347; Colman, Benjamin/0000-0001-6290-3705; Colman, Benjamin P./0000-0001-6290-3705; Bernhardt, Emily S/0000-0003-3031-621X; McGill, Bonnie/0000-0002-5417-3519; Hu, Mengjun/0000-0003-1567-0843	Chinese Academy of Sciences; National Natural Science Foundation of China [31170481]; National Science Foundation (NSF) [29970065]; Environmental Protection Agency (EPA) under NSF, Center for the Environmental Implications of NanoTechnology(CEINT) [EF-0830093]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Foundation (NSF)(National Science Foundation (NSF)); Environmental Protection Agency (EPA) under NSF, Center for the Environmental Implications of NanoTechnology(CEINT)(United States Environmental Protection Agency)	During this work, L.Y. was supported as a visiting scholar at Duke University by a fellowship from the Chinese Academy of Sciences and the National Natural Science Foundation of China (31170481). This material is based upon work supported by the National Science Foundation (NSF)(29970065), and the Environmental Protection Agency (EPA) under NSF Cooperative Agreement EF-0830093, Center for the Environmental Implications of NanoTechnology(CEINT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnaout CL, 2012, ENVIRON SCI TECHNOL, V46, P5387, DOI 10.1021/es204540z; Asharani PV, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/25/255102; Bailey-Serres J, 2010, CURR OPIN PLANT BIOL, V13, P489, DOI 10.1016/j.pbi.2010.08.002; Benn TM, 2008, ENVIRON SCI TECHNOL, V42, P4133, DOI 10.1021/es7032718; Bernhardt ES, 2010, J ENVIRON QUAL, V39, P1954, DOI 10.2134/jeq2009.0479; Blaser SA, 2008, SCI TOTAL ENVIRON, V390, P396, DOI 10.1016/j.scitotenv.2007.10.010; Bradford A, 2009, ENVIRON SCI TECHNOL, V43, P4530, DOI 10.1021/es9001949; Calabrese EJ, 2000, HUM EXP TOXICOL, V19, P2, DOI 10.1191/096032700678815585; CARPITA N, 1979, SCIENCE, V205, P1144, DOI 10.1126/science.205.4411.1144; Choi O, 2008, ENVIRON SCI TECHNOL, V42, P4583, DOI 10.1021/es703238h; Colman BP, 2012, ECOTOXICOLOGY, V21, P1867, DOI 10.1007/s10646-012-0920-5; Dietz KJ, 2011, TRENDS PLANT SCI, V16, P582, DOI 10.1016/j.tplants.2011.08.003; Dinneny JR, 2008, SCIENCE, V320, P942, DOI 10.1126/science.1153795; El Badawy AM, 2011, ENVIRON SCI TECHNOL, V45, P283, DOI 10.1021/es1034188; Elechiguerra Jose Luis, 2005, J Nanobiotechnology, V3, P6; Geisler-Lee J, 2013, NANOTOXICOLOGY, V7, P323, DOI 10.3109/17435390.2012.658094; Glover RD, 2011, ACS NANO, V5, P8950, DOI 10.1021/nn2031319; Gubbins EJ, 2011, ENVIRON POLLUT, V159, P1551, DOI 10.1016/j.envpol.2011.03.002; Jiang HS, 2012, ENVIRON TOXICOL CHEM, V31, P1880, DOI 10.1002/etc.1899; Kahru A, 2010, TOXICOLOGY, V269, P105, DOI 10.1016/j.tox.2009.08.016; Kim J, 2011, NANOTOXICOLOGY, V5, P208, DOI 10.3109/17435390.2010.508137; Kim S, 2009, TOXICOL IN VITRO, V23, P1076, DOI 10.1016/j.tiv.2009.06.001; Kumari M, 2009, SCI TOTAL ENVIRON, V407, P5243, DOI 10.1016/j.scitotenv.2009.06.024; Lin DH, 2007, ENVIRON POLLUT, V150, P243, DOI 10.1016/j.envpol.2007.01.016; Ma JW, 2011, J BIOMED NANOTECHNOL, V7, P263, DOI 10.1166/jbn.2011.1286; Meyer JN, 2010, AQUAT TOXICOL, V100, P140, DOI 10.1016/j.aquatox.2010.07.016; Miao AJ, 2009, ENVIRON POLLUT, V157, P3034, DOI 10.1016/j.envpol.2009.05.047; Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m; Neal AL, 2008, ECOTOXICOLOGY, V17, P362, DOI 10.1007/s10646-008-0217-x; Reinsch BC, 2012, ENVIRON SCI TECHNOL, V46, P6992, DOI 10.1021/es203732x; Ruffini Castiglione M, 2009, CARYOLOGIA, V62, P161, DOI 10.1080/00087114.2004.10589681; Sresty TVS, 1999, ENVIRON EXP BOT, V41, P3, DOI 10.1016/S0098-8472(98)00034-3; Stampoulis D, 2009, ENVIRON SCI TECHNOL, V43, P9473, DOI 10.1021/es901695c; van der Zande M, 2011, TOXICOL LETT, V205, pS289, DOI 10.1016/j.toxlet.2011.05.979; Wierzbicka M, 1998, PLANT SCI, V137, P155, DOI 10.1016/S0168-9452(98)00138-1; Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w; Xiu ZM, 2011, ENVIRON SCI TECHNOL, V45, P9003, DOI 10.1021/es201918f; Yang XY, 2012, ENVIRON SCI TECHNOL, V46, P1119, DOI 10.1021/es202417t; Yin LY, 2011, ENVIRON SCI TECHNOL, V45, P2360, DOI 10.1021/es103995x	39	204	213	5	204	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2012	7	10							e47674	10.1371/journal.pone.0047674	http://dx.doi.org/10.1371/journal.pone.0047674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	024UX	23091638	gold, Green Published, Green Submitted			2022-12-25	WOS:000310135800063
J	Ma, JM; Xu, JQ; Anderson, RN; Jemal, A				Ma, Jiemin; Xu, Jiaquan; Anderson, Robert N.; Jemal, Ahmedin			Widening Educational Disparities in Premature Death Rates in Twenty Six States in the United States, 1993-2007	PLOS ONE			English	Article							CAUSE-SPECIFIC MORTALITY; SOCIOECONOMIC-STATUS; ALL-CAUSE; INEQUALITIES; ADULTS; TRENDS; NORWAY; GAP	Background: Eliminating socioeconomic disparities in health is an overarching goal of the U.S. Healthy People decennial initiatives. We present recent trends in mortality by education among working-aged populations. Methods and Findings: Age-standardized death rates and their average annual percent change for all-cause and five major causes (cancer, heart disease, stroke, diabetes, and accidents) were calculated from 1993 through 2007 for individuals aged 25-64 years by educational attainment as a marker of socioeconomic status, using national vital registration data for 26 states with consistent educational information on the death certificates. Rate ratios and rate differences were used to assess disparities (<= 12 versus >= 16 years of education) for 1993 through 2007. From 1993 through 2007, relative educational disparities in all-cause mortality continued to increase among working-aged men and women in the U. S., due to larger decreases of mortality rates among the most educated coupled with smaller decreases or even worsening trends in the less educated. For example, the rate ratios of all-cause mortality increased from 2.5 (95% confidence interval (CI), 2.4-2.6) in 1993 to 3.6 (95% CI, 3.5-3.7) in 2007 in men and from 1.9 (95% CI, 1.8-2.0) to 3.0 (95% CI, 2.9-3.1) in women. Generally, the rate differences (per 100,000 persons) of all-cause mortality increased from 415.5 (95% CI, 399.1-431.9) in 1993 to 472.7 (95% CI, 460.2-485.2) in 2007 in men and from 165.4 (95% CI, 154.5-176.2) to 256.2 (95% CI, 248.3-264.2) in women. Disparity patterns varied largely across the five specific causes considered in this study, with the largest increases of relative disparities for accidents, especially in women. Conclusions: Relative educational differentials in mortality continued to widen among men and women despite emphasis on reducing disparities in the U. S. Healthy People decennial initiatives.	[Ma, Jiemin; Jemal, Ahmedin] Amer Canc Soc, Surveillance Res Program, Atlanta, GA 30329 USA; [Xu, Jiaquan; Anderson, Robert N.] Ctr Dis Control & Prevent, Mortal Stat Branch, Natl Ctr Hlth Stat, Hyattsville, MD USA	American Cancer Society; Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Ma, JM (corresponding author), Amer Canc Soc, Surveillance Res Program, Atlanta, GA 30329 USA.	jiemin.ma@cancer.org	shen, Guanxin/F-7441-2011	Liu, Hongbo/0000-0002-7187-8115	American Cancer Society and the Centers for Disease Control and Prevention	American Cancer Society and the Centers for Disease Control and Prevention	The American Cancer Society and the Centers for Disease Control and Prevention funded the analysis, interpretation, and compilation of surveillance data. No staff at either agency, other than the authors, was involved in the conduct of the study; collection, management, analysis, and interpretation of the data; or preparation of the manuscript.	Agency for Healthcare Research and Quality, 2010, 2010 NAT HEALTHC DIS; Ahluwalia IB, 2008, J COMMUN HEALTH, V33, P293, DOI 10.1007/s10900-008-9106-8; Albano JD, 2007, JNCI-J NATL CANCER I, V99, P1384, DOI 10.1093/jnci/djm127; Anderson R N, 2001, Natl Vital Stat Rep, V49, P1; Berkman L F, 1997, IARC Sci Publ, P51; Braveman PA, 2005, JAMA-J AM MED ASSOC, V294, P2879, DOI 10.1001/jama.294.22.2879; FELDMAN JJ, 1989, AM J EPIDEMIOL, V129, P919, DOI 10.1093/oxfordjournals.aje.a115225; Hadden WC, 2008, INT J HEALTH SERV, V38, P47, DOI 10.2190/HS.38.1.c; Jemal A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009584; Jemal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002181; Kanjilal S, 2006, ARCH INTERN MED, V166, P2348, DOI 10.1001/archinte.166.21.2348; Kim HJ, 2000, STAT MED, V19, P335, DOI 10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z; Kominski R., 1994, ED ATTAINMENT US MAR, P20; Korhonen N, 2011, INJURY, V42, P885, DOI 10.1016/j.injury.2010.08.033; Krieger N, 2008, PLOS MED, V5, P227, DOI 10.1371/journal.pmed.0050046; Mackenbach JP, 2010, SOC SCI MED, V71, P1249, DOI 10.1016/j.socscimed.2010.07.014; Mackenbach JP, 2003, INT J EPIDEMIOL, V32, P830, DOI 10.1093/ije/dyg209; Meara ER, 2008, HEALTH AFFAIR, V27, P350, DOI 10.1377/hlthaff.27.2.350; Minino A., 2007, NATL VITAL STAT REP, V55, P1; PAPPAS G, 1993, NEW ENGL J MED, V329, P103, DOI 10.1056/NEJM199307083290207; Paulozzi L., 2007, Morbidity and Mortality Weekly Report, V56, P93; Rim Sun Hee, 2011, Morbidity and Mortality Weekly Report, V60, P42; Roger Veronique L, 2011, Circulation, V123, pe18, DOI 10.1161/CIR.0b013e3182009701; Rostron BL, 2010, ED REP CLASS DEATH C, Viii; Rothman KJ., 2008, MODERN EPIDEMIOLOGY; Schalick LM, 2000, INT J HEALTH SERV, V30, P13, DOI 10.2190/8QMH-4FAB-XAWP-VU95; Schwartz CR, 2005, DEMOGRAPHY, V42, P621, DOI 10.1353/dem.2005.0036; Shkolnikov VM, 2012, J EPIDEMIOL COMMUN H, V66, P372, DOI 10.1136/jech.2009.104786; Sorlie PD, 1996, EPIDEMIOLOGY, V7, P437, DOI 10.1097/00001648-199607000-00017; Steenland K, 2004, AM J PUBLIC HEALTH, V94, P1037, DOI 10.2105/AJPH.94.6.1037; Steenland K, 2002, AM J EPIDEMIOL, V156, P11, DOI 10.1093/aje/kwf001; Strand BH, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c654; U.S. Department of Health and Human Services, 2000, HLTH PEOPL 2010 UND; U.S. Department of Health and Human Services, 2010, HLTH PEOPL 2020; U.S. Department of Health and Human Services, 2007, HLTH PEOPL 2010 MIDC; World Health Organization, 1992, INT STAT CLASS DIS R; World Health Organization, 1977, INT STAT CLASS DIS R	37	76	81	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 20	2012	7	7							e41560	10.1371/journal.pone.0041560	http://dx.doi.org/10.1371/journal.pone.0041560			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	977GL	23094023	Green Published, gold, Green Submitted			2022-12-25	WOS:000306644600087
J	Zhao, XW; Zhang, WY; Xu, X; Ma, ZQ; Yin, MH				Zhao, Xiaowei; Zhang, Wenyi; Xu, Xin; Ma, Zhiqiang; Yin, Minghao			Prediction of Protein Phosphorylation Sites by Using the Composition of k-Spaced Amino Acid Pairs	PLOS ONE			English	Article							POSTTRANSLATIONAL MODIFICATIONS; INTRINSIC DISORDER; P38 MAPK; SEQUENCE; DATABASE; UBIQUITYLATION; GLYCOSYLATION; LOCALIZATION; SERVER; TOOL	As one of the most widespread protein post-translational modifications, phosphorylation is involved in many biological processes such as cell cycle, apoptosis. Identification of phosphorylated substrates and their corresponding sites will facilitate the understanding of the molecular mechanism of phosphorylation. Comparing with the labor-intensive and time-consuming experiment approaches, computational prediction of phosphorylation sites is much desirable due to their convenience and fast speed. In this paper, a new bioinformatics tool named CKSAAP_PhSite was developed that ignored the kinase information and only used the primary sequence information to predict protein phosphorylation sites. The highlight of CKSAAP_PhSite was to utilize the composition of k-spaced amino acid pairs as the encoding scheme, and then the support vector machine was used as the predictor. The performance of CKSAAP_PhSite was measured with a sensitivity of 84.81%, a specificity of 86.07% and an accuracy of 85.43% for serine, a sensitivity of 78.59%, a specificity of 82.26% and an accuracy of 80.31% for threonine as well as a sensitivity of 74.44%, a specificity of 78.03% and an accuracy of 76.21% for tyrosine. Experimental results obtained from cross validation and independent benchmark suggested that our method was very promising to predict phosphorylation sites and can be served as a useful supplement tool to the community. For public access, CKSAAP_PhSite is available at http://59.73.198.144/cksaap_phsite/.	[Zhao, Xiaowei; Zhang, Wenyi; Xu, Xin; Ma, Zhiqiang; Yin, Minghao] NE Normal Univ, Coll Comp Sci & Informat Technol, Changchun, Peoples R China	Northeast Normal University - China	Ma, ZQ (corresponding author), NE Normal Univ, Coll Comp Sci & Informat Technol, Changchun, Peoples R China.	zhiqiang.ma967@gmail.com; minghao.yin197@gmail.com	Grosso Jasuktar, Hilary/AGX-7358-2022; Yin, Minghao/E-9611-2015; Yin, Minghao/A-4031-2013	Grosso Jasuktar, Hilary/0000-0002-1441-2191; Yin, Minghao/0000-0002-6226-2394; Mouradian, M. Maral/0000-0002-9937-412X; Ichijo, Hidenori/0000-0002-5005-6438	National Natural Science Foundation of China [60803102, 61070084]; Natural Science Foundation of Jilin Province [20101506, 20110104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jilin Province	This research is partially supported by the National Natural Science Foundation of China under Grant Nos. 60803102, 61070084, and also funded by the Natural Science Foundation of Jilin Province (Nos. 20101506 and 20110104). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Biswas AK, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-273; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Boersema PJ, 2009, J MASS SPECTROM, V44, P861, DOI 10.1002/jms.1599; Bu YH, 2010, J ENDOCRINOL, V206, P271, DOI 10.1677/JOE-10-0064; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Chen K, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-25; Chen K, 2007, BIOCHEM BIOPH RES CO, V355, P764, DOI 10.1016/j.bbrc.2007.02.040; Chen K, 2009, J COMPUT CHEM, V30, P163, DOI 10.1002/jcc.21053; Chen YZ, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-101; Chen Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022930; CHOU KC, 1995, CRIT REV BIOCHEM MOL, V30, P275, DOI 10.3109/10409239509083488; Chou KC, 2008, NAT PROTOC, V3, P153, DOI 10.1038/nprot.2007.494; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250; Gribskov M, 1996, COMPUT CHEM, V20, P25, DOI 10.1016/S0097-8485(96)80004-0; Gsponer J, 2008, SCIENCE, V322, P1365, DOI 10.1126/science.1163581; He B, 2009, CELL RES, V19, P929, DOI 10.1038/cr.2009.87; Heazlewood JL, 2008, NUCLEIC ACIDS RES, V36, pD1015, DOI 10.1093/nar/gkm812; Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772; Hu LL, 2011, BIOPOLYMERS, V95, P763, DOI 10.1002/bip.21645; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Huang JH, 2012, BIOCHIMIE, V94, P1697, DOI 10.1016/j.biochi.2012.03.022; Huang Y, 2010, BIOINFORMATICS, V26, P680, DOI 10.1093/bioinformatics/btq003; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Jensen ON, 2004, CURR OPIN CHEM BIOL, V8, P33, DOI 10.1016/j.cbpa.2003.12.009; Kim SH, 2011, EUR J IMMUNOL, V41, P461, DOI 10.1002/eji.201040668; Meier R, 1997, J BIOL CHEM, V272, P30491, DOI 10.1074/jbc.272.48.30491; Neduva V, 2005, PLOS BIOL, V3, P2090, DOI 10.1371/journal.pbio.0030405; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Pinna LA, 1996, BBA-MOL CELL RES, V1314, P191, DOI 10.1016/S0167-4889(96)00083-3; Plewczynski D, 2005, BIOINFORMATICS, V21, P2525, DOI 10.1093/bioinformatics/bti333; Ressurreicao M, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-6; Russell RB, 2008, FEBS LETT, V582, P1271, DOI 10.1016/j.febslet.2008.02.027; Trost B, 2011, BIOINFORMATICS, V27, P2927, DOI 10.1093/bioinformatics/btr525; Tung CW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-310; Uddin S, 2003, BIOCHEM BIOPH RES CO, V308, P325, DOI 10.1016/S0006-291X(03)01382-2; Uversky VN, 2008, SCIENCE, V322, P1340, DOI 10.1126/science.1167453; Vapnik VN, 1998, STAT LEARNING THEORY, DOI DOI 10.1007/978-1-4419-1428-6_5864; Wang XB, 2009, PROTEIN ENG DES SEL, V22, P707, DOI 10.1093/protein/gzp055; Wang YY, 2010, ACTA PHARMACOL SIN, V31, P160, DOI 10.1038/aps.2009.201; Wood CD, 2009, INT J BIOL SCI, V5, P428; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e; Xue Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-163; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Xue Y, 2010, CURR PROTEIN PEPT SC, V11, P485, DOI 10.2174/138920310791824138; Xue Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011290; Zhao XW, 2011, INT J MOL SCI, V12, P8347, DOI 10.3390/ijms12128347	48	101	108	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2012	7	10							e46302	10.1371/journal.pone.0046302	http://dx.doi.org/10.1371/journal.pone.0046302			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	025MM	22253830	Green Submitted, Green Published, gold			2022-12-25	WOS:000310193400004
J	Villani, A; Frigessi, A; Liljeros, F; Nordvik, MK; de Blasio, BF				Villani, Antonella; Frigessi, Arnoldo; Liljeros, Fredrik; Nordvik, Monica K.; de Blasio, Birgitte Freiesleben			A Characterization of Internet Dating Network Structures among Nordic Men Who Have Sex with Men	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; PARTNERS; ONLINE; RISK; PREFERENCES	Background: The Internet has become an important venue for seeking sexual partners and may facilitate transmission of sexually transmitted infections. Methods: We examined a 64-day data log of flirt messages expressing sexual interest among MSM within the Qruiser. com community. We used logistic regression to analyze characteristics of MSM sending and receiving flirt messages and negative binomial regression to examine individual activity and popularity. The structural properties, including the core structure of the flirt network, were analyzed. Results: The MSM population consisted of approximately 40% homosexuals and 37% bisexuals, while the remaining 23% included men who identified as heterosexual but searched for sex with men and "experimental". MSM were more likely to send flirt messages if they were homosexual and aged 40+ years; young people aged, 30 years were more likely to receive a flirt. Possession of a webcam was strongly associated with both sending flirt messages and being a flirt target. The distributions of flirts sent (max k(out) = 2162) and received (max k(in) = 84) were highly heterogeneous. Members in central cores were more likely homosexuals, singles, and aged 31-40 years. The probability of a matched flirt (flirt returned from target) increased from 1% in the outer core to 18% in the central core (core size = 4). Discussion: The flirt network showed high degree heterogeneity similar to the structural properties of real sexual contact networks with a single central core. Further studies are needed to explore use of webcam for Internet dating.	[Villani, Antonella] Univ Aquila, Dept Math, I-67100 Laquila, Italy; [Frigessi, Arnoldo; de Blasio, Birgitte Freiesleben] Univ Oslo, Inst Basic Med Sci, Dept Biostat, Oslo, Norway; [Liljeros, Fredrik; Nordvik, Monica K.] Stockholm Univ, Dept Sociol, S-10691 Stockholm, Sweden; [Liljeros, Fredrik] Inst Future Studies, Stockholm, Sweden; [Nordvik, Monica K.] Mid Sweden Univ, Dept Social Work, Ostersund, Sweden; [de Blasio, Birgitte Freiesleben] Norwegian Inst Publ Hlth, Dept Infect Dis Epidemiol, Div Infect Dis Control, Oslo, Norway	University of L'Aquila; University of Oslo; Stockholm University; Institute for Futures Studies; Mid-Sweden University; Norwegian Institute of Public Health (NIPH)	Villani, A (corresponding author), Univ Aquila, Dept Math, I-67100 Laquila, Italy.	birgitte.deblasio@basalmed.uio.no	Liljeros, Fredrik G I/I-2667-2018	Liljeros, Fredrik G I/0000-0001-8642-6624; Frigessi, Arnoldo/0000-0001-7103-7589; Norkko, Joanna/0000-0001-9885-8408; Villnas, Anna/0000-0003-3077-929X	Norwegian Research Council [166056/V50]; Riksbankens Jubileumsfond (The Bank of Sweden Tercentenary Foundation)	Norwegian Research Council(Research Council of NorwayEuropean Commission); Riksbankens Jubileumsfond (The Bank of Sweden Tercentenary Foundation)	Birgitte Freiesleben de Blasio was supported by the Norwegian Research Council (Projects 166056/V50). Fredrik Liljeros was supported by Riksbankens Jubileumsfond (The Bank of Sweden Tercentenary Foundation). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no external funding sources for this study.	Al-Tayyib AA, 2009, SEX TRANSM INFECT, V85, P216, DOI 10.1136/sti.2008.032631; Benotsch EG, 2002, ARCH SEX BEHAV, V31, P177, DOI 10.1023/A:1014739203657; Bull SS, 2000, SEX TRANSM DIS, V27, P545, DOI 10.1097/00007435-200010000-00008; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Daneback K, 2005, ARCH SEX BEHAV, V34, P321, DOI 10.1007/s10508-005-3120-z; Daneback K, 2007, CYBERPSYCHOL BEHAV, V10, P100, DOI 10.1089/cpb.2006.9986; de Nooy W, 2005, EXPLORATIVE SOCIAL N; Ellison N, 2006, J COMPUT-MEDIAT COMM, V11; Fiore ART, 2004, THESIS MIT; Ghani AC, 2000, SEX TRANSM DIS, V27, P579, DOI 10.1097/00007435-200011000-00006; Gobrogge KL, 2007, ARCH SEX BEHAV, V36, P717, DOI 10.1007/s10508-007-9216-x; Kim AA, 2001, J ACQ IMMUN DEF SYND, V28, P89; Klausner JD, 2000, JAMA-J AM MED ASSOC, V284, P447, DOI 10.1001/jama.284.4.447; Liljeros F, 2001, NATURE, V411, P907, DOI 10.1038/35082140; McFarlane M, 2000, JAMA-J AM MED ASSOC, V284, P443, DOI 10.1001/jama.284.4.443; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mustanski BS, 2007, AIDS CARE, V19, P822, DOI 10.1080/09540120701237244; Newman MEJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.208701; Ross MW, 2005, CYBERPSYCHOL BEHAV, V8, P131, DOI 10.1089/cpb.2005.8.131; Sautter JM, 2010, SOC SCI QUART, V91, P554, DOI 10.1111/j.1540-6237.2010.00707.x; Silverthorne ZA, 2000, ARCH SEX BEHAV, V29, P67, DOI 10.1023/A:1001886521449; Suler J, 2004, CYBERPSYCHOL BEHAV, V7, P321, DOI 10.1089/1094931041291295	22	34	35	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 13	2012	7	7							e39717	10.1371/journal.pone.0039717	http://dx.doi.org/10.1371/journal.pone.0039717			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	974CF	22808052	Green Submitted, Green Published, gold			2022-12-25	WOS:000306406700011
J	Lee, KW; Zhao, X; Im, JY; Grosso, H; Jang, WH; Chan, TW; Sonsalla, PK; German, DC; Ichijo, H; Junn, E; Mouradian, MM				Lee, Kang-Woo; Zhao, Xin; Im, Joo-Young; Grosso, Hilary; Jang, Won Hee; Chan, Teresa W.; Sonsalla, Patricia K.; German, Dwight C.; Ichijo, Hidenori; Junn, Eunsung; Mouradian, M. Mara			Apoptosis Signal-Regulating Kinase 1 Mediates MPTP Toxicity and Regulates Glial Activation	PLOS ONE			English	Article							MICROGLIAL ACTIVATION; OXIDATIVE STRESS; SUBSTANTIA-NIGRA; DOPAMINERGIC NEURODEGENERATION; MOUSE MODEL; CELL-DEATH; ASK1; DEGENERATION; CYCLOOXYGENASE-2; NEURONS	Apoptosis signal-regulating kinase 1 ASIK1) member of the mitogen-activated protein kinase 3 family, is activated by oxidative stress. The death-signaling pathway mediated by ASK1 is inhibited by DJ 1, which is linked to recessively inherited Parkinson's disease (PD). Considering that DJ-1 deficiency exacerbates the toxicity of the mitochondrial complex I inhibitor 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP), we sought to investigate the direct role and mechanism of ASK1 in MPTP-induced dopamine neuron toxicity. In the present study, we found that MPTP administration to wild-type mice activates ASK1 in the midbrain. In ASK1 null mice, MPTP-induced motor impairment was less profound, and striatal dopamine content and nigral dopamine neuron counts were relatively preserved compared to wild type littermates. Further, microglia and astrocyte activation seen in wild-type mice challenged with MPTP was markedly attenuated in,ASK1(-/-) mice. These data suggest that ASK1 is a key player in MPTP-induced glial activation linking oxidative stress with neuroinflammation, two well recognized pathogenetic factors in PD. These findings demonstrate that ASK1 is an important effector of MPTP-induced toxicity and suggest that inhibiting this kinase is a plausible therapeutic strategy for protecting dopamine neurons in PD.	[Lee, Kang-Woo; Zhao, Xin; Im, Joo-Young; Grosso, Hilary; Chan, Teresa W.; Sonsalla, Patricia K.; Junn, Eunsung; Mouradian, M. Mara] UMDNJ Robert Wood Johnson Med Sch, Dept Neurol, Ctr Neurodegenerat & Neuroimmunol Dis, Piscataway, NJ 08854 USA; [Jang, Won Hee] Inje Univ, Coll Med, Dept Biochem, Pusan, South Korea; [German, Dwight C.] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Ichijo, Hidenori] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Tokyo, Japan	Rutgers State University New Brunswick; Rutgers State University Medical Center; Inje University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Tokyo	Lee, KW (corresponding author), UMDNJ Robert Wood Johnson Med Sch, Dept Neurol, Ctr Neurodegenerat & Neuroimmunol Dis, Piscataway, NJ 08854 USA.	Mouradian@umdnj.edu	Grosso Jasuktar, Hilary/AGX-7358-2022; Yin, Minghao/E-9611-2015; Yin, Minghao/A-4031-2013	Grosso Jasuktar, Hilary/0000-0002-1441-2191; Yin, Minghao/0000-0002-6226-2394; Mouradian, M. Maral/0000-0002-9937-412X; Ichijo, Hidenori/0000-0002-5005-6438	NINDS/NIH [NS059869, NS53517]; American Parkinson Disease Association; Foundation of UMDNJ	NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Parkinson Disease Association; Foundation of UMDNJ	This work was supported by NINDS/NIH grants NS059869 and NS53517 to M.M.M. and by grants from the American Parkinson Disease Association and the Foundation of UMDNJ to E.J. M.M.M. is the William Dow Lovett Professor of Neurology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfinito PD, 2003, J NEUROSCI, V23, P10982; Chang HY, 1998, SCIENCE, V281, P1860, DOI 10.1126/science.281.5384.1860; Cicchetti F, 2002, EUR J NEUROSCI, V15, P991, DOI 10.1046/j.1460-9568.2002.01938.x; Cookson MR, 2005, ANNU REV BIOCHEM, V74, P29, DOI 10.1146/annurev.biochem.74.082803.133400; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Gao HM, 2003, J NEUROSCI, V23, P6181; Guo XL, 2010, EMBO MOL MED, V2, P504, DOI 10.1002/emmm.201000103; Hu XM, 2011, J NEUROSCI, V31, P247, DOI 10.1523/JNEUROSCI.4589-10.2011; Hunot S, 2003, ANN NEUROL, V53, pS49, DOI 10.1002/ana.10481; Hunot S, 2004, P NATL ACAD SCI USA, V101, P665, DOI 10.1073/pnas.0307453101; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Jenner P, 2003, ANN NEUROL, V53, pS26, DOI 10.1002/ana.10483; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Kandil S, 2010, FASEB J, V56, P611; Karunakaran S, 2008, J NEUROSCI, V28, P12500, DOI 10.1523/JNEUROSCI.4511-08.2008; Kim YS, 2007, FASEB J, V21, P179, DOI 10.1096/fj.06-5865com; Kumakura K, 2010, NEUROSCI RES, V66, P313, DOI 10.1016/j.neures.2009.12.003; Langston JW, 1999, ANN NEUROL, V46, P598, DOI 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F; Lee EJ, 2010, J IMMUNOL, V185, P615, DOI 10.4049/jimmunol.0903480; Lee KW, 2011, J NEUROSCI, V31, P6963, DOI 10.1523/JNEUROSCI.6513-10.2011; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Liu H, 2000, MOL CELL BIOL, V20, P2198, DOI 10.1128/MCB.20.6.2198-2208.2000; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; McGeer PL, 2008, MOVEMENT DISORD, V23, P474, DOI 10.1002/mds.21751; Nelson EL, 1996, J COMP NEUROL, V369, P361, DOI 10.1002/(SICI)1096-9861(19960603)369:3<361::AID-CNE3>3.0.CO;2-3; Nishitoh H, 2002, GENE DEV, V16, P1345, DOI 10.1101/gad.992302; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Noguchi T, 2005, J BIOL CHEM, V280, P37033, DOI 10.1074/jbc.M506771200; Saeed U, 2009, NEUROTOX RES, V16, P116, DOI 10.1007/s12640-009-9058-5; Sager TN, 2010, BEHAV BRAIN RES, V208, P444, DOI 10.1016/j.bbr.2009.12.014; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Sedelis M, 2000, BEHAV GENET, V30, P171, DOI 10.1023/A:1001958023096; Song JJ, 2002, J BIOL CHEM, V277, P46566, DOI 10.1074/jbc.M206826200; SONSALLA PK, 1991, J PHARMACOL EXP THER, V256, P506; Su XM, 2008, NEUROBIOL AGING, V29, P1690, DOI 10.1016/j.neurobiolaging.2007.04.006; Sugama S, 2003, BRAIN RES, V964, P288, DOI 10.1016/S0006-8993(02)04085-4; Takeda K, 2000, J BIOL CHEM, V275, P9805, DOI 10.1074/jbc.275.13.9805; Teismann P, 2003, P NATL ACAD SCI USA, V100, P5473, DOI 10.1073/pnas.0837397100; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; UPCHURCH M, 1983, BEHAV NEURAL BIOL, V39, P221, DOI 10.1016/S0163-1047(83)90876-2; Vijitruth R, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-6; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Zeevalk GD, 2007, EXP NEUROL, V203, P512, DOI 10.1016/j.expneurol.2006.09.004; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com	45	101	108	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 10	2012	7	1					242	249	e29935	10.1371/journal.pone.0029935	http://dx.doi.org/10.1371/journal.pone.0029935			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	906OA	22253830	Green Published, Green Submitted, gold			2022-12-25	WOS:000301353900026
J	Ma, JW; Huang, CM; Yao, XX; Shi, C; Sun, LF; Yuan, L; Lei, P; Zhu, HF; Liu, HB; Wu, XW; Ning, Q; Zhou, C; Shen, GX				Ma, Jingwei; Huang, Chunmei; Yao, Xinxin; Shi, Chuan; Sun, Lifang; Yuan, Lu; Lei, Ping; Zhu, Huifen; Liu, Hongbo; Wu, Xiongwen; Ning, Qin; Zhou, Chun; Shen, Guanxin			Inhibition of Hepatitis B Virus and Induction of Hepatoma Cell Apoptosis by ASGPR-Directed Delivery of shRNAs	PLOS ONE			English	Article							SMALL INTERFERING RNAS; ASIALOGLYCOPROTEIN RECEPTOR; INCREASES MIGRATION; NATURAL-HISTORY; PROTEIN-X; SURVIVIN; GENE; EXPRESSION; LIVER; SIRNA	Hepatitis B virus (HBV) infection is a worldwide liver disease and nearly 25% of chronic HBV infections terminate in hepatocellular carcinoma (HCC). Currently, there is no effective therapy to inhibit HBV replication and to eliminate hepatoma cells, making it highly desired to develop novel therapies for these two stages of the HBV-caused detrimental disease. Recently, short hairpin RNA (shRNA) has emerged as a potential therapy for virus-infected disease and cancer. Here, we have generated a shRNA, pGenesil-siHBV4, which effectively inhibits HBV replication in the human hepatoma cell line HepG2.2.15. The inhibitory effects of pGenesil-siHBV4 are manifested by the decrease of both the HBV mRNA level and the protein levels of the secreted HBV surface antigen (HBsAg) and HBV e antigen (HBeAg), and by the reduction of secreted HBV DNA. Using mouse hydrodynamic tail vein injection, we demonstrate that pGenesil-siHBV4 is effective in inhibiting HBV replication in vivo. Because survivin plays a key role in cancer cell escape from apoptosis, we further generated pGenesil-siSurvivin, a survivin-silencing shRNA, and showed its effect of triggering apoptosis of HBV-containing hepatoma cells. To develop targeted shRNA therapy, we have identified that as a specific binder of the asialoglycoprotein receptor (ASGPR), jetPEI-Hepatocyte delivers pGenesil-siHBV4 and pGenesil-siSurvivin specifically to hepatocytes, not other types of cells. Finally, co-transfection of pGenesil-siHBV4 and pGenesil-siSurvivin exerts synergistic effects in inducing hepatoma cell apoptosis, a novel approach to eliminate hepatoma by downregulating survivin via multiple mechanisms. The application of these novel shRNAs with the jetPEI-Hepatocyte targeting strategy demonstrates the proof-of-principle for a promising approach to inhibit HBV replication and eliminate hepatoma cells with high specificity.	[Zhou, Chun] Columbia Univ, Dept Environm Hlth Sci, New York, NY 10027 USA; [Ma, Jingwei; Huang, Chunmei; Yao, Xinxin; Shi, Chuan; Sun, Lifang; Yuan, Lu; Lei, Ping; Zhu, Huifen; Liu, Hongbo; Wu, Xiongwen; Shen, Guanxin] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan 430074, Peoples R China; [Ning, Qin] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Infect Dis, Wuhan 430074, Peoples R China	Columbia University; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Zhou, C (corresponding author), Columbia Univ, Dept Environm Hlth Sci, New York, NY 10027 USA.	cz2132@columbia.edu; guanxin_shen@yahoo.com.cn	shen, Guanxin/F-7441-2011	Liu, Hongbo/0000-0002-7187-8115	Program for Changjiang Scholars and Innovative Research Team in University [IRT1131]; State Project on Major Infectious Diseases Prevention [2012ZX10002006-003]; International Science & Technology Cooperation Program of China [2011DFA31030]	Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); State Project on Major Infectious Diseases Prevention; International Science & Technology Cooperation Program of China	This research work was supported by Program for Changjiang Scholars and Innovative Research Team in University (Grant, No: IRT1131), State Project on Major Infectious Diseases Prevention (Grant 2012ZX10002006-003), and the International Science & Technology Cooperation Program of China (2011DFA31030). The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinc A, 2005, J GENE MED, V7, P657, DOI 10.1002/jgm.696; Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917; Budker VG, 2006, J GENE MED, V8, P874, DOI 10.1002/jgm.920; But DYK, 2008, WORLD J GASTROENTERO, V14, P1652, DOI 10.3748/wjg.14.1652; Chen Y, 2004, WORLD J GASTROENTERO, V10, P82; De Paula D, 2007, RNA, V13, P431, DOI 10.1261/rna.459807; Dykxhoorn DM, 2003, NAT REV MOL CELL BIO, V4, P457, DOI 10.1038/nrm1129; Giladi H, 2003, MOL THER, V8, P769, DOI 10.1016/S1525-0016(03)00244-2; Gong Q, 2011, DNA CELL BIOL, V30, P347, DOI 10.1089/dna.2010.1172; Guan SH, 2007, WORLD J GASTROENTERO, V13, P228, DOI 10.3748/wjg.v13.i2.228; Guo PX, 2010, NAT NANOTECHNOL, V5, P833, DOI [10.1038/nnano.2010.231, 10.1038/NNANO.2010.231]; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Ikeguchi M, 2002, DIAGN MOL PATHOL, V11, P33, DOI 10.1097/00019606-200203000-00007; KANEKO S, 1988, J VIROL, V62, P3979, DOI 10.1128/JVI.62.11.3979-3984.1988; Kew MC, 2010, PATHOL BIOL, V58, P273, DOI 10.1016/j.patbio.2010.01.005; KIM CM, 1991, NATURE, V351, P317, DOI 10.1038/351317a0; Kim EM, 2005, J CONTROL RELEASE, V108, P557, DOI 10.1016/j.jconrel.2005.09.001; Kim SI, 2007, MOL THER, V15, P1145, DOI 10.1038/sj.mt.6300168; Kumar R, 2003, GENOME RES, V13, P2333, DOI 10.1101/gr.1575003; Kuo TC, 2010, BIOCHEM PHARMACOL, V80, P1093, DOI 10.1016/j.bcp.2010.06.003; Li Donghua, 2003, J Huazhong Univ Sci Technolog Med Sci, V23, P383; Li L, 2009, MOL BIOSYST, V5, P1361, DOI 10.1039/b903428e; Liu FJ, 2007, WORLD J GASTROENTERO, V13, P5324, DOI 10.3748/wjg.v13.i40.5324; Liu HY, 2007, CANCER BIOL THER, V6, P697; Liu YQ, 2009, MOL THER, V17, P269, DOI 10.1038/mt.2008.266; Lupberger J, 2007, WORLD J GASTROENTERO, V13, P74, DOI 10.3748/wjg.v13.i1.74; Marusawa H, 2003, EMBO J, V22, P2729, DOI 10.1093/emboj/cdg263; Masiero M, 2007, MOL ASPECTS MED, V28, P143, DOI 10.1016/j.mam.2006.12.004; McCaffrey AP, 2003, NAT BIOTECHNOL, V21, P639, DOI 10.1038/nbt824; McManus MT, 2002, NAT REV GENET, V3, P737, DOI 10.1038/nrg908; McNamara JO, 2006, NAT BIOTECHNOL, V24, P1005, DOI 10.1038/nbt1223; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Nguyen DH, 2008, J CELL PHYSIOL, V216, P289, DOI 10.1002/jcp.21416; NISHIKAWA M, 1995, AM J PHYSIOL-GASTR L, V268, pG849, DOI 10.1152/ajpgi.1995.268.5.G849; O'Driscoll L, 2003, CURR CANCER DRUG TAR, V3, P131, DOI 10.2174/1568009033482038; Pan XF, 2011, MOL IMMUNOL, V48, P1573, DOI 10.1016/j.molimm.2011.03.012; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Shu Y, 2011, MOL THER, V19, P1304, DOI 10.1038/mt.2011.23; Shu Y, 2011, METHODS, V54, P204, DOI 10.1016/j.ymeth.2011.01.008; Song EW, 2005, NAT BIOTECHNOL, V23, P709, DOI 10.1038/nbt1101; STOCKERT RJ, 1995, PHYSIOL REV, V75, P591, DOI 10.1152/physrev.1995.75.3.591; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Uprichard SL, 2005, P NATL ACAD SCI USA, V102, P773, DOI 10.1073/pnas.0409028102; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Wieland SF, 2004, P NATL ACAD SCI USA, V101, P2129, DOI 10.1073/pnas.0308478100; Xia LM, 2009, VIROLOGY, V385, P335, DOI 10.1016/j.virol.2008.11.042; Zhang R, 2010, CANCER GENE THER, V17, P275, DOI 10.1038/cgt.2009.68; Zhang XD, 2005, J MED VIROL, V77, P374, DOI 10.1002/jmv.20466; Zhang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031458; Zhou Y, 2010, J BIOL CHEM, V285, P12159, DOI 10.1074/jbc.M109.067629	50	76	81	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e46096	10.1371/journal.pone.0046096	http://dx.doi.org/10.1371/journal.pone.0046096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23094023	gold, Green Published, Green Submitted			2022-12-25	WOS:000310050200007
J	Xie, T; d' Ario, G; Lamb, JR; Martin, E; Wang, K; Tejpar, S; Delorenzi, M; Bosman, FT; Roth, AD; Yan, P; Bougel, S; Di Narzo, AF; Popovici, V; Budinska, E; Mao, M; Weinrich, SL; Rejto, PA; Hodgson, JG				Xie, Tao; d' Ario, Giovanni; Lamb, John R.; Martin, Eric; Wang, Kai; Tejpar, Sabine; Delorenzi, Mauro; Bosman, Fred T.; Roth, Arnaud D.; Yan, Pu; Bougel, Stephanie; Di Narzo, Antonio Fabio; Popovici, Vlad; Budinska, Eva; Mao, Mao; Weinrich, Scott L.; Rejto, Paul A.; Hodgson, J. Graeme			A Comprehensive Characterization of Genome-Wide Copy Number Aberrations in Colorectal Cancer Reveals Novel Oncogenes and Patterns of Alterations	PLOS ONE			English	Article							ELONGATION-FACTOR EEF1A2; COLON-CANCER; OVARIAN-CANCER; BREAST-CANCER; CELL-LINES; DNA; GENES; HYBRIDIZATION; PROTEIN; TUMORS	To develop a comprehensive overview of copy number aberrations (CNAs) in stage-II/III colorectal cancer (CRC), we characterized 302 tumors from the PETACC-3 clinical trial. Microsatellite-stable (MSS) samples (n = 269) had 66 minimal common CNA regions, with frequent gains on 20 q (72.5%), 7 (41.8%), 8 q (33.1%) and 13 q (51.0%) and losses on 18 (58.6%), 4 q (26%) and 21 q (21.6%). MSS tumors have significantly more CNAs than microsatellite-instable (MSI) tumors: within the MSI tumors a novel deletion of the tumor suppressor WWOX at 16 q23.1 was identified (p<0.01). Focal aberrations identified by the GISTIC method confirmed amplifications of oncogenes including EGFR, ERBB2, CCND1, MET, and MYC, and deletions of tumor suppressors including TP53, APC, and SMAD4, and gene expression was highly concordant with copy number aberration for these genes. Novel amplicons included putative oncogenes such as WNK1 and HNF4A, which also showed high concordance between copy number and expression. Survival analysis associated a specific patient segment featured by chromosome 20 q gains to an improved overall survival, which might be due to higher expression of genes such as EEF1B2 and PTK6. The CNA clustering also grouped tumors characterized by a poor prognosis BRAF-mutant-like signature derived from mRNA data from this cohort. We further revealed non-random correlation between CNAs among unlinked loci, including positive correlation between 20 q gain and 8 q gain, and 20 q gain and chromosome 18 loss, consistent with co-selection of these CNAs. These results reinforce the non-random nature of somatic CNAs in stage-II/III CRC and highlight loci and genes that may play an important role in driving the development and outcome of this disease.	[Xie, Tao; Lamb, John R.; Martin, Eric; Wang, Kai; Mao, Mao; Weinrich, Scott L.; Rejto, Paul A.; Hodgson, J. Graeme] Pfizer Worldwide Res & Dev, Oncol Res, San Diego, CA USA; [d' Ario, Giovanni; Delorenzi, Mauro; Di Narzo, Antonio Fabio; Popovici, Vlad; Budinska, Eva] Swiss Inst Bioinformat, Lausanne, Switzerland; [Tejpar, Sabine] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Louvain, Belgium; [Delorenzi, Mauro; Bosman, Fred T.; Yan, Pu; Bougel, Stephanie] Univ Lausanne, Med Ctr, Lausanne, Switzerland; [Roth, Arnaud D.] Univ Hosp Geneva, Geneva, Switzerland	Pfizer; Swiss Institute of Bioinformatics; KU Leuven; University Hospital Leuven; University of Lausanne; University of Geneva	Xie, T (corresponding author), Pfizer Worldwide Res & Dev, Oncol Res, San Diego, CA USA.	tao.xie@pfizer.com; hodgson.graeme@gmail.com	Whitehall, Vicki L/B-6262-2013; Budinska, Eva/F-2698-2011; Leggett, Barbara A/D-3579-2011; Young, Joanne P/H-7774-2014; Pandeya, Nirmala/F-8054-2010; Young, Joanne P/B-9981-2011; Whitehall, Vicki/E-5414-2019; Rejto, Paul/M-4782-2019; Popovici, Vlad C./C-2039-2008	Whitehall, Vicki L/0000-0002-8285-2391; Budinska, Eva/0000-0002-9004-9187; Pandeya, Nirmala/0000-0003-1462-4968; Popovici, Vlad C./0000-0002-1311-9188; Wang, Kai/0000-0003-0567-3004; /0000-0003-3281-8643	Swiss National Science Foundation [SNF 320030_135421]; Foundation Medic; Krebsforschung Schweiz [KFS 02697-08-2010]; Belgian Federation Against Cancer; Belgian National Cancer Plan	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Foundation Medic; Krebsforschung Schweiz; Belgian Federation Against Cancer; Belgian National Cancer Plan	This work was supported in part by a grant from the Swiss National Science Foundation (SNF 320030_135421) and Foundation Medic and a grant of the Krebsforschung Schweiz (KFS 02697-08-2010) to AR and MD. ST is a senior clinical investigator of the Fund for Scientific Research Flanders and has received research grants from the Belgian Federation Against Cancer and from the Belgian National Cancer Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand N, 2002, NAT GENET, V31, P301, DOI 10.1038/ng904; Andersen CL, 2010, INT J CANC; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; Aubele M, 2007, BRIT J CANCER, V96, P801, DOI 10.1038/sj.bjc.6603613; Aust DE, 2004, SCAND J GASTROENTERO, V39, P766, DOI 10.1080/00365520410003191; Bartos JD, 2007, MUTAT RES-FUND MOL M, V615, P1, DOI 10.1016/j.mrfmmm.2006.09.006; Bouteille N, 2009, ONCOGENE, V28, P2569, DOI 10.1038/onc.2009.120; Brosens RPM, 2010, J PATHOL, V221, P411, DOI 10.1002/path.2724; Camps J, 2006, CARCINOGENESIS, V27, P419, DOI 10.1093/carcin/bgi244; Camps J, 2009, GENE CHROMOSOME CANC, V48, P1002, DOI 10.1002/gcc.20699; Darsigny M, 2010, CANCER RES, V70, P9423, DOI 10.1158/0008-5472.CAN-10-1697; Diep CB, 2006, GENE CHROMOSOME CANC, V45, P31, DOI 10.1002/gcc.20261; Diskin SJ, 2006, GENOME RES, V16, P1149, DOI 10.1101/gr.5076506; Douglas EJ, 2004, CANCER RES, V64, P4817, DOI 10.1158/0008-5472.CAN-04-0328; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Hodgson JG, 2003, BREAST CANCER RES TR, V78, P337, DOI 10.1023/A:1023085825042; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Ji HL, 2006, CANCER RES, V66, P7910, DOI 10.1158/0008-5472.CAN-06-0595; Kazuo M, 2008, ANN SURG ONCOL, V15, P1530, DOI 10.1245/s10434-007-9746-4; Kulkarni G, 2007, BREAST CANCER RES TR, V102, P31, DOI 10.1007/s10549-006-9315-8; Kurashina K, 2008, CANCER SCI, V99, P1835, DOI 10.1111/j.1349-7006.2008.00881.x; Lamb JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020090; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Sayagues JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013752; Martin ES, 2007, CANCER RES, V67, P10736, DOI 10.1158/0008-5472.CAN-07-2742; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Moniz S, 2010, CELL MOL LIFE SCI, V67, P1265, DOI 10.1007/s00018-010-0261-6; Nakao K, 2004, CARCINOGENESIS, V25, P1345, DOI 10.1093/carcin/bgh134; Nakao M, 2009, CANCER GENET CYTOGEN, V188, P70, DOI 10.1016/j.cancergencyto.2008.09.013; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Pinke DE, 2008, GYNECOL ONCOL, V108, P561, DOI 10.1016/j.ygyno.2007.11.019; Platzer P, 2002, CANCER RES, V62, P1134; Popovici V, 2012, J CONTRACEPT FERTIL; Postma C, 2009, ANN ONCOL, V20, P1048, DOI 10.1093/annonc/mdn738; Poulogiannis G, 2010, J PATHOL, V220, P338, DOI 10.1002/path.2640; Reid JF, 2009, GENE CHROMOSOME CANC, V48, P953, DOI 10.1002/gcc.20697; Ried T, 1996, GENE CHROMOSOME CANC, V15, P234, DOI 10.1002/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2; Sabbah M, 2011, MOL CELL BIOL, V31, P1459, DOI 10.1128/MCB.01316-10; Sheffer M, 2009, P NATL ACAD SCI USA, V106, P7131, DOI 10.1073/pnas.0902232106; Speleman F, 2008, CYTOGENET GENOME RES, V123, P176, DOI 10.1159/000184706; Van Cutsem E, 2009, J CLIN ONCOL, V27, P3117, DOI 10.1200/JCO.2008.21.6663; Venkatachalam R, 2008, CYTOGENET GENOME RES, V123, P188, DOI 10.1159/000184708; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Wierzbicki PM, 2009, J PHYSIOL PHARMACOL, V60, P63; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xie T, 2010, OMICS, V14, P91, DOI 10.1089/omi.2009.0114	46	83	87	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 31	2012	7	7							e42001	10.1371/journal.pone.0042001	http://dx.doi.org/10.1371/journal.pone.0042001			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	982LS	23094064	Green Published, Green Submitted, gold			2022-12-25	WOS:000307045600049
J	Zhao, JP; Diao, S; Zhang, BY; Niu, BQ; Wang, QL; Wan, XC; Luo, YQ				Zhao, Jia-Ping; Diao, Shu; Zhang, Bing-Yu; Niu, Bao-Qing; Wang, Qing-Ling; Wan, Xian-Chong; Luo, You-Qing			Phylogenetic Analysis and Molecular Evolution Patterns in the MIR482-MIR1448 Polycistron of Populus L	PLOS ONE			English	Article							RNA SECONDARY STRUCTURE; STRESS-RESPONSIVE MICRORNAS; COMPENSATORY MUTATIONS; TARGET SEQUENCES; SALICACEAE; CONSERVATION; DUPLICATION; BIOGENESIS; PREDICTION; DIVERSE	The microRNAs (miRNAs) miR482 and miR1448 are disease resistance-related miRNAs; the former is ubiquitously distributed in seed plants whereas the latter has only been reported in Populus trichocarpa. The precursor and mature sequences of poplar miR1448 are highly homologous to those of poplar miR482, and these two miRNAs are located in one transcript as a polycistron. Therefore, we hypothesized that the MIR1448 gene may have evolved from the MIR482 gene in poplar. However, the molecular evolution patterns of this process remain unclear. In this study, utilizing cloning and Blast analysis in NCBI ESTs and whole-genome shotgun contigs (WGS) dataset, we determined that the MIR482-MIR1448 polycistron is a family-specific clustered miRNA in Salicaceae. Moreover, phylogenetic analysis illustrated that MIR1448 is the product of a tandem duplication event from MIR482. Nucleotide substitution analysis revealed that both MIR482 and MIR1448 have more rapid evolution ratios than ribosomal DNA (rDNA) genes, and that compensatory mutations that occurred in the stem region of the secondary structure were the main mechanisms that drove the evolution of these MIRNA genes. Furthermore, by comparing the substitution patterns in the miRNA-target complexes of miR482 and miR1448, we inferred that co-evolution between miRNAs and their targets was the major force that drove the "duplicated MIR482" evolve to MIR1448. We propose a novel miRNA-target pairing pattern called the "frameshift targeted mechanism" to explain the gain of target genes by miR1448. The results also imply that the major role of miR482 was in resistance to disease or other stresses via NBS-LRR proteins, whereas the biological functions of miR1448 are more diverse.	[Zhao, Jia-Ping; Wan, Xian-Chong] Chinese Acad Forestry, Inst New Forestry Technol, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China; [Zhao, Jia-Ping; Luo, You-Qing] Beijing Forestry Univ, Minist Educ, Key Lab Silviculture & Conservat, Beijing, Peoples R China; [Diao, Shu; Zhang, Bing-Yu] Chinese Acad Forestry, Res Inst Forestry, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China; [Niu, Bao-Qing; Wang, Qing-Ling] Agr Univ Hebei, Baoding, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry New Technology, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; Beijing Forestry University; Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; Hebei Agricultural University	Zhao, JP (corresponding author), Chinese Acad Forestry, Inst New Forestry Technol, State Key Lab Tree Genet & Breeding, Beijing, Peoples R China.	zhaojiaping@gmail.com; yqluo@bjfu.edu.cn		Yan, Xiaodong/0000-0002-0774-9140; Jia, Gensuo/0000-0001-5950-9555	National Program on Key Basic Research Project of China (973 Program) [2009CB119107]; National Natural Science Foundation of China [30872048]; Chinese Postdoctoral Funding [20110490302]; National Science & Technology Basic Program of China [2009FY210100]	National Program on Key Basic Research Project of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Postdoctoral Funding; National Science & Technology Basic Program of China	This work was financially supported by National Program on Key Basic Research Project of China (973 Program) (No. 2009CB119107), National Natural Science Foundation of China (No. 30872048), Chinese Postdoctoral Funding (No. 20110490302) and National Science & Technology Basic Program of China (No. 2009FY210100). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2004, NAT GENET, V36, P1282, DOI 10.1038/ng1478; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Chakraborty S, 2012, RNA, V18, P1014, DOI 10.1261/rna.031039.111; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; COLLINSON ME, 1992, P ROY SOC EDINB B, V98, P155, DOI 10.1017/S0269727000007521; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; De Felippes FF, 2008, RNA, V14, P2455, DOI 10.1261/rna.1149408; DIXON MT, 1993, MOL BIOL EVOL, V10, P256; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Gazzani S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-62; Guo XY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-454; Hamzeh M, 2004, AM J BOT, V91, P1398, DOI 10.3732/ajb.91.9.1398; HANCOCK JM, 1988, MOL BIOL EVOL, V5, P393; Higgs PG, 2000, Q REV BIOPHYS, V33, P199, DOI 10.1017/S0033583500003620; Kim VN, 2008, CELL, V133, P25, DOI 10.1016/j.cell.2008.03.015; Laubinger S, 2010, P NATL ACAD SCI USA, V107, P17466, DOI 10.1073/pnas.1012891107; Leskinen E, 1999, PLANT SYST EVOL, V215, P209, DOI 10.1007/BF00984656; Li AL, 2007, CELL RES, V17, P212, DOI 10.1038/sj.cr.7310113; Lu SF, 2005, PLANT CELL, V17, P2186, DOI 10.1105/tpc.105.033456; Lu SF, 2008, PLANT J, V55, P131, DOI 10.1111/j.1365-313X.2008.03497.x; Lu SF, 2007, PLANT J, V51, P1077, DOI 10.1111/j.1365-313X.2007.03208.x; Maher C, 2006, GENOME RES, V16, P510, DOI 10.1101/gr.4680506; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Merchan F, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r136; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Piriyapongsa J, 2008, RNA, V14, P814, DOI 10.1261/rna.916708; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Rea PA, 2007, ANNU REV PLANT BIOL, V58, P347, DOI 10.1146/annurev.arplant.57.032905.105406; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Shivaprasad PV, 2012, PLANT CELL, V24, P859, DOI 10.1105/tpc.111.095380; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanzer A, 2004, J MOL BIOL, V339, P327, DOI 10.1016/j.jmb.2004.03.065; Xin MM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-123; Zhang BH, 2006, PLANT J, V46, P243, DOI 10.1111/j.1365-313X.2006.02697.X; Zhang R, 2007, GENOME RES, V17, P612, DOI 10.1101/gr.6146507; Zhang WX, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r81	41	20	23	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47811	10.1371/journal.pone.0047811	http://dx.doi.org/10.1371/journal.pone.0047811			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23144853	gold, Green Published, Green Submitted			2022-12-25	WOS:000312384500027
J	Pratheeshkumar, P; Budhraja, A; Son, YO; Wang, X; Zhang, Z; Ding, SZ; Wang, L; Hitron, A; Lee, JC; Xu, M; Chen, G; Luo, J; Shi, XL				Pratheeshkumar, Poyil; Budhraja, Amit; Son, Young-Ok; Wang, Xin; Zhang, Zhuo; Ding, Songze; Wang, Lei; Hitron, Andrew; Lee, Jeong-Chae; Xu, Mei; Chen, Gang; Luo, Jia; Shi, Xianglin			Quercetin Inhibits Angiogenesis Mediated Human Prostate Tumor Growth by Targeting VEGFR-2 Regulated AKT/mTOR/P70S6K Signaling Pathways	PLOS ONE			English	Article							CANCER PREVENTION; ACTIVATION; APOPTOSIS; INVASION; BIOLOGY; CELLS; MTOR	Angiogenesis is a crucial step in the growth and metastasis of cancers, since it enables the growing tumor to receive oxygen and nutrients. Cancer prevention using natural products has become an integral part of cancer control. We studied the antiangiogenic activity of quercetin using ex vivo, in vivo and in vitro models. Rat aortic ring assay showed that quercetin at non-toxic concentrations significantly inhibited microvessel sprouting and exhibited a significant inhibition in the proliferation, migration, invasion and tube formation of endothelial cells, which are key events in the process of angiogenesis. Most importantly, quercetin treatment inhibited ex vivo angiogenesis as revealed by chicken egg chorioallantoic membrane assay (CAM) and matrigel plug assay. Western blot analysis showed that quercetin suppressed VEGF induced phosphorylation of VEGF receptor 2 and their downstream protein kinases AKT, mTOR, and ribosomal protein S6 kinase in HUVECs. Quercetin (20 mg/kg/d) significantly reduced the volume and the weight of solid tumors in prostate xenograft mouse model, indicating that quercetin inhibited tumorigenesis by targeting angiogenesis. Furthermore, quercetin reduced the cell viability and induced apoptosis in prostate cancer cells, which were correlated with the downregulation of AKT, mTOR and P70S6K expressions. Collectively the findings in the present study suggest that quercetin inhibits tumor growth and angiogenesis by targeting VEGF-R2 regulated AKT/mTOR/P70S6K signaling pathway, and could be used as a potential drug candidate for cancer therapy.	[Pratheeshkumar, Poyil; Budhraja, Amit; Son, Young-Ok; Wang, Xin; Zhang, Zhuo; Ding, Songze; Wang, Lei; Hitron, Andrew; Lee, Jeong-Chae; Shi, Xianglin] Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA; [Xu, Mei; Chen, Gang; Luo, Jia] Univ Kentucky, Coll Med, Dept Internal Med, Lexington, KY USA	University of Kentucky; University of Kentucky	Shi, XL (corresponding author), Univ Kentucky, Coll Med, Grad Ctr Toxicol, Lexington, KY 40536 USA.	xshi5@email.uky.edu	Luo, Jia/E-4674-2012; Wang, Lei/E-3063-2012; Son, Youngok/AAB-1380-2021; Zhang, Zhuo/B-8601-2012; Son, Young-Ok/P-3675-2015	Luo, Jia/0000-0002-6968-3618; Budhraja, Amit/0000-0002-4216-8608; Son, Youngok/0000-0003-0154-4061	National Institutes of Health [1R01ES020870, 5R21ES019249]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020870, R21ES019249] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants: 1R01ES020870 (Shi), and 5R21ES019249 (Shi and Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERGER NA, 1985, BIOCHEMISTRY-US, V24, P4352, DOI 10.1021/bi00337a015; Berger NA, 2010, POLY ADP RIBOSE CELL; Bhat TA, 2008, FOOD CHEM TOXICOL, V46, P1334, DOI 10.1016/j.fct.2007.08.032; Bischoff SC, 2008, CURR OPIN CLIN NUTR, V11, P733, DOI 10.1097/MCO.0b013e32831394b8; Budhraja A, 2012, MOL CANCER THER, V11, P132, DOI 10.1158/1535-7163.MCT-11-0343; Cao YH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.259re1; Chen J, 2002, BIOCHEM PHARMACOL, V64, P1071, DOI 10.1016/S0006-2952(02)01263-7; Dvorak HF, 2005, J THROMB HAEMOST, V3, P1835, DOI 10.1111/j.1538-7836.2005.01361.x; Fasolo A, 2008, MTOR INHIBITORS TREA; Ferrara N, 2001, ACTA HAEMATOL-BASEL, V106, P148, DOI 10.1159/000046610; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Formica JV, 1995, FOOD CHEM TOXICOL, V33, P1061, DOI 10.1016/0278-6915(95)00077-1; KAUFMANN SH, 1993, CANCER RES, V53, P3976; KECK PJ, 1989, SCIENCE, V246, P1309, DOI 10.1126/science.2479987; Kuttan G, 2011, PHARM BIOL, V49, P995, DOI 10.3109/13880209.2011.559476; Li W, 2008, ONCOL REP, V20, P713, DOI 10.3892/or_00000064; Liu LZ, 2008, CANCER RES, V68, P8183, DOI 10.1158/0008-5472.CAN-08-0819; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020858; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McMahon G, 2000, Oncologist, V5 Suppl 1, P3; Murakami A, 2008, CANCER LETT, V269, P315, DOI 10.1016/j.canlet.2008.03.046; Nicholson DW, 1995, IDENTIFICATION INHIB; Pang XF, 2009, CANCER RES, V69, P5893, DOI 10.1158/0008-5472.CAN-09-0755; Patan S, 2004, CANC TREAT, V117, P3; Pratheeshkumar P, 2011, J ENVIRON PATHOL TOX, V30, P33, DOI 10.1615/JEnvironPatholToxicolOncol.v30.i1.40; Pratheeshkumar P, 2012, ANTICANCER AGENTS ME; Pratheeshkumar P, 2011, EUROPEAN J PHARM; Pratheeshkumar P, 2011, DRUG CHEM TOXICOL, V34, P261, DOI 10.3109/01480545.2010.520017; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Roberts WG, 1997, CANCER RES, V57, P765; Seeliger H, 2007, CANCER METAST REV, V26, P611, DOI 10.1007/s10555-007-9077-8; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Tie Jeanne, 2012, Critical Reviews in Oncogenesis, V17, P51; Tufan AC, 2005, CURR CANCER DRUG TAR, V5, P249, DOI 10.2174/1568009054064624; Wang SP, 2011, BOUND VALUE PROBL, DOI 10.1155/2011/901796; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yao H, 2011, J ENVIRON SCI HEAL C, V29, P1, DOI 10.1080/10590501.2011.551317; Yap TA, 2008, CURR OPIN PHARMACOL, V8, P393, DOI 10.1016/j.coph.2008.08.004; Yi TF, 2008, MOL CANCER THER, V7, P1789, DOI 10.1158/1535-7163.MCT-08-0124	40	186	200	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 18	2012	7	10							e47516	10.1371/journal.pone.0047516	http://dx.doi.org/10.1371/journal.pone.0047516			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	054ZN	23300633	Green Published, Green Submitted, gold			2022-12-25	WOS:000312384500013
J	Wang, XM; Zhu, CF; Bao, WG; Zhao, K; Niu, JQ; Yu, XF; Zhang, WY				Wang, Xiaomei; Zhu, Chunfeng; Bao, Wanguo; Zhao, Ke; Niu, Junqi; Yu, Xiao-Fang; Zhang, Wenyan			Characterization of Full-Length Enterovirus 71 Strains from Severe and Mild Disease Patients in Northeastern China	PLOS ONE			English	Article							MOUTH-DISEASE; MOLECULAR EPIDEMIOLOGY; FOOT; HAND; TAIWAN; RECOMBINATION; INFECTION; EVOLUTION; OUTBREAK	Human enterovirus 71 (EV71)-associated hand, foot, and mouth disease (HFMD) has been a leading cause of childhood infection in China since 2008. Epidemic and molecular characteristics of HFMD have been examined in many areas of China, including the central and southern regions. However, clinical and genetic characterization of EV71 in the northeastern region of China is scarce. In this study, a series of analyses were performed on seven full-length EV71 sequences from HFMD patients who had either severe or mild disease. We have determined that these seven circulating EV71 viruses from Changchun, China are actually complex recombinant viruses involving multiple type A human enterovirus (HEV). Classified as EV71 subtype C4 (EV71 C4), these Changchun EV71 viruses contain genetic recombination events between the CA4, CA5, EV71B4 and EV71C1 strains. Most of the structural protein region (P1) of these viruses resembled that of the prototype EV71 C1 strains. The non-structural protein domains (P2 and P3) showed a high degree of similarity with CA4, CA5 and EV71 B4 in different regions. The 5'UTR had unclassified recombination, while partial 3D region of these viruses showed a high degree of similarity to CA16. Phylogenetic analysis of full-length or partial sequences of isolates from severe or mild disease patients in Changchun always formed a single cluster in various phylogenetic analyses of different genomic regions, suggesting that all seven strains originated from one single common ancestor. There was no correlation between viral genomic sequence and virulence. Thus, we found that circulating recombinant forms of EV71 are prevalent among HFMD patients in Northeastern China. The existence of a unique cluster of EV71 related viruses in Northeast China has important implications for vaccine development that would address the increasing prevalence of HFMD.	[Wang, Xiaomei; Zhu, Chunfeng; Zhao, Ke; Yu, Xiao-Fang; Zhang, Wenyan] Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun, Jilin Province, Peoples R China; [Wang, Xiaomei; Niu, Junqi] Jilin Univ, Hosp 1, Dept Hepatol, Changchun, Jilin Province, Peoples R China; [Bao, Wanguo] Jilin Univ, Hosp 1, Dept Infect Dis, Changchun, Jilin Province, Peoples R China	Jilin University; Jilin University; Jilin University	Wang, XM (corresponding author), Jilin Univ, Hosp 1, Inst Virol & AIDS Res, Changchun, Jilin Province, Peoples R China.	junqiniu@yahoo.com.cn; xfyu@jhsph.edu; zhangwenyan@jlu.edu.cn	Li, Yuan/GXV-1310-2022; Pausch, Hubert/U-5934-2019; Wang, Xugao/B-1111-2015; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; li, yong/HDN-3885-2022; Wang, Xiaohui/B-8126-2011; Li, Yang/GWM-7879-2022; Pausch, Hubert/B-7637-2018	Pausch, Hubert/0000-0002-0501-6760; Wang, Xugao/0000-0003-1207-8852; YIN, HANG/0000-0002-9762-4818; Wang, Xiaohui/0000-0002-3415-5612; wang, yizhen/0000-0002-3908-7102; Wang, Jing/0000-0002-2806-6517; Fiorini, Zeno/0000-0001-5218-2502; Comita, Liza/0000-0002-9169-1331; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629	Specialized Research Fund for the Doctoral Program of Higher Education; Jilin University [200903258]; Key Laboratory of Molecular Virology, Jilin Province, China [20102209]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Jilin University(Jilin University); Key Laboratory of Molecular Virology, Jilin Province, China; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported in part by funding from the Specialized Research Fund for the Doctoral Program of Higher Education and Jilin University (No200903258) to Wenyan Zhang, and a grant from the Key Laboratory of Molecular Virology, Jilin Province (20102209), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown BA, 1999, J VIROL, V73, P9969, DOI 10.1128/JVI.73.12.9969-9975.1999; Chan KP, 2003, EMERG INFECT DIS, V9, P78; Chan YF, 2004, EMERG INFECT DIS, V10, P1468; Chan YF, 2010, INFECT GENET EVOL, V10, P404, DOI 10.1016/j.meegid.2009.05.010; Chang GH, 2010, VIRUS RES, V151, P66, DOI 10.1016/j.virusres.2010.04.001; Chen KT, 2007, PEDIATRICS, V120, pE244, DOI 10.1542/peds.2006-3331; CHUMAKOV M, 1979, ARCH VIROL, V60, P329, DOI 10.1007/BF01317504; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Huang SW, 2009, J CLIN MICROBIOL, V47, P3653, DOI 10.1128/JCM.00630-09; Huang SC, 2008, VIRUS RES, V131, P250, DOI 10.1016/j.virusres.2007.10.002; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li RQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026237; Mao LX, 2010, J CLIN VIROL, V49, P100, DOI 10.1016/j.jcv.2010.07.009; SCHMIDT NJ, 1974, J INFECT DIS, V129, P304, DOI 10.1093/infdis/129.3.304; Shi XD, 2011, CENT EUR J MED, V6, P220, DOI 10.2478/s11536-010-0075-9; Shimizu H, 2004, PEDIATR INT, V46, P231, DOI 10.1046/j.1442-200x.2004.01868.x; Solomon T, 2010, LANCET INFECT DIS, V10, P778, DOI 10.1016/S1473-3099(10)70194-8; Tan XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025662; Yoke-Fun C, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-74; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu Z, 2007, BIOMED ENVIRON SCI, V20, P321	22	318	350	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 29	2012	7	3							e32405	10.1371/journal.pone.0050575	http://dx.doi.org/10.1371/journal.pone.0050575			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	948SR	23110176	Green Submitted, Green Published, gold			2022-12-25	WOS:000304523400005
J	Wang, XX; Huang, M; Wang, YZ				Wang, Xinxia; Huang, Ming; Wang, Yizhen			The Effect of Insulin, TNF alpha and DHA on the Proliferation, Differentiation and Lipolysis of Preadipocytes Isolated from Large Yellow Croaker (Pseudosciaena Crocea R.)	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TROUT ONCORHYNCHUS-MYKISS; FATTY-ACID SYNTHASE; INHIBITS ADIPOCYTE DIFFERENTIATION; ADIPOSE TRIGLYCERIDE LIPASE; ACTIVATED RECEPTORS ALPHA; SIGNAL-RELATED KINASE; LPL GENE-EXPRESSION; RAINBOW-TROUT; LIPOPROTEIN-LIPASE	Fish final product can be affected by excessive lipid accumulation. Therefore, it is important to develop strategies to control obesity in cultivated fish to strengthen the sustainability of the aquaculture industry. As in mammals, the development of adiposity in fish depends on hormonal, cytokine and dietary factors. In this study, we investigated the proliferation and differentiation of preadipocytes isolated from the large yellow croaker and examined the effects of critical factors such as insulin, TNF alpha and DHA on the proliferation, differentiation and lipolysis of adipocytes. Preadipocytes were isolated by collagenase digestion, after which their proliferation was evaluated. The differentiation process was optimized by assaying glycerol-3-phosphate dehydrogenase (GPDH) activity. Oil red O staining and electron microscopy were performed to visualize the accumulated triacylglycerol. Gene transcript levels were measured using SYBR green quantitative real-time PCR. Insulin promoted preadipocytes proliferation, stimulated cell differentiation and decreased lipolysis of mature adipocytes. TNF alpha and DHA inhibited cell proliferation and differentiation. While TNF alpha stimulated mature adipocyte lipolysis, DHA showed no lipolytic effect on adipocytes. The expressions of adipose triglyceride lipase (ATGL), fatty acid synthase (FAS), lipoprotein lipase (LPL) and peroxisome proliferator-activated receptor alpha, gamma (PPAR alpha, PPAR gamma) were quantified during preadipocytes differentiation and adipocytes lipolysis to partly explain the regulation mechanisms. In summary, the results of this study indicated that although preadipocytes proliferation and the differentiation process in large yellow croaker are similar to these processes in mammals, the effects of critical factors such as insulin, TNF alpha and DHA on fish adipocytes development are not exactly the same. Our findings fill in the gaps in the basic data regarding the effects of critical factors on adiposity development in fish and will facilitate the further study of molecular mechanism by which these factors act in fish and the application of this knowledge to eventually control obesity in cultured species.	[Wang, Xinxia; Huang, Ming; Wang, Yizhen] Zhejiang Univ, Inst Feed Sci, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Wang, YZ (corresponding author), Zhejiang Univ, Inst Feed Sci, Hangzhou 310003, Zhejiang, Peoples R China.	yzwang@zju.edu.cn	Li, Yuan/GXV-1310-2022; Pausch, Hubert/U-5934-2019; Wang, Xugao/B-1111-2015; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; li, yong/HDN-3885-2022; Wang, Xiaohui/B-8126-2011; Li, Yang/GWM-7879-2022; Pausch, Hubert/B-7637-2018	Pausch, Hubert/0000-0002-0501-6760; Wang, Xugao/0000-0003-1207-8852; YIN, HANG/0000-0002-9762-4818; Wang, Xiaohui/0000-0002-3415-5612; wang, yizhen/0000-0002-3908-7102; Wang, Jing/0000-0002-2806-6517; Fiorini, Zeno/0000-0001-5218-2502; Comita, Liza/0000-0002-9169-1331; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629	NSFC (National Natural Science Foundation of China) [30901104]; China Postdoctoral Science Foundation [2009046138]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	NSFC (National Natural Science Foundation of China)(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by grants from the NSFC (National Natural Science Foundation of China, grant # 30901104), and the China Postdoctoral Science Foundation (grant # 2009046138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albalat A, 2007, COMP BIOCHEM PHYS B, V148, P151, DOI 10.1016/j.cbpb.2007.05.004; Albalat A, 2005, COMP BIOCHEM PHYS A, V142, P347, DOI 10.1016/j.cbpa.2005.08.006; Albalat A, 2005, AM J PHYSIOL-REG I, V289, pR259, DOI 10.1152/ajpregu.00574.2004; Albalat A, 2005, J ENDOCRINOL, V184, P527, DOI 10.1677/joe.1.05940; Albalat A, 2006, GEN COMP ENDOCR, V146, P226, DOI 10.1016/j.ygcen.2005.11.011; [Anonymous], 2011, CHIN FISH STAT YB; Awad AB, 2000, J NUTR BIOCHEM, V11, P153, DOI 10.1016/S0955-2863(99)00087-X; Boney CM, 2000, MOL ENDOCRINOL, V14, P805, DOI 10.1210/me.14.6.805; Boone C, 2000, REPROD NUTR DEV, V40, P325, DOI 10.1051/rnd:2000103; Bouraoui L, 2008, J ENDOCRINOL, V198, P459, DOI 10.1677/JOE-08-0264; Bouraoui L, 2012, COMP BIOCHEM PHYS A, V161, P83, DOI 10.1016/j.cbpa.2011.09.008; Bouraoui L, 2010, AM J PHYSIOL-REG I, V299, pR33, DOI 10.1152/ajpregu.00457.2009; Calviello G, 1999, LIPIDS, V34, P599, DOI 10.1007/s11745-999-0404-6; Capilla E, 2011, GEN COMP ENDOCR, V172, P107, DOI 10.1016/j.ygcen.2011.03.020; Cawthorn WP, 2008, FEBS LETT, V582, P117, DOI 10.1016/j.febslet.2007.11.051; Cersosimo E, 2012, AM J PHYSIOL-CELL PH, V302, pC652, DOI 10.1152/ajpcell.00022.2011; CHAJES V, 1995, BREAST CANCER RES TR, V34, P199, DOI 10.1007/BF00689711; Chamras H, 2002, J NUTR BIOCHEM, V13, P711, DOI 10.1016/S0955-2863(02)00230-9; CHEATHAM B, 1995, ENDOCR REV, V16, P117, DOI 10.1210/er.16.2.117; Choi SM, 2010, MOL CELL BIOL, V30, P5009, DOI 10.1128/MCB.00797-10; Claycombe KJ, 1998, AM J PHYSIOL-REG I, V274, pR1253, DOI 10.1152/ajpregu.1998.274.5.R1253; CORNELIUS P, 1990, J BIOL CHEM, V265, P20506; DANI C, 1990, J CELL BIOCHEM, V43, P103, DOI 10.1002/jcb.240430202; Degerman E, 1998, METHODS, V14, P43, DOI 10.1006/meth.1997.0564; Deiuliis JA, 2008, LIPIDS, V43, P215, DOI 10.1007/s11745-007-3146-1; DOERRLER W, 1994, CYTOKINE, V6, P478, DOI 10.1016/1043-4666(94)90074-4; Forman BM, 1997, P NATL ACAD SCI USA, V94, P4312, DOI 10.1073/pnas.94.9.4312; FRANSEN L, 1986, CELL IMMUNOL, V100, P260, DOI 10.1016/0008-8749(86)90025-0; Garcia-Castillo J, 2004, CELL MOL LIFE SCI, V61, P1331, DOI 10.1007/s00018-004-4068-1; Gasic S, 1999, J BIOL CHEM, V274, P6770, DOI 10.1074/jbc.274.10.6770; Glosli H, 2005, BBA-MOL CELL BIOL L, V1734, P235, DOI 10.1016/j.bbalip.2005.02.011; Goldberg IJ, 1996, J LIPID RES, V37, P693; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Grohmann M, 2005, J LIPID RES, V46, P93, DOI 10.1194/jlr.M400295-JLR200; GRUNFELD C, 1988, J LIPID RES, V29, P1327; Hansen JO, 2008, AQUACULTURE, V284, P159, DOI 10.1016/j.aquaculture.2008.07.043; HARMON JS, 1992, GEN COMP ENDOCR, V87, P214, DOI 10.1016/0016-6480(92)90025-F; Hensler M, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-128; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Khan S, 2002, J LIPID RES, V43, P979; Kim HK, 2006, J NUTR, V136, P409, DOI 10.1093/jn/136.2.409; Kim HK, 2006, J NUTR, V136, P2965, DOI 10.1093/jn/136.12.2965; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Kralisch S, 2005, MOL CELL ENDOCRINOL, V240, P43, DOI 10.1016/j.mce.2005.06.002; Kras KM, 2000, OBES RES, V8, P186, DOI 10.1038/oby.2000.20; Li XF, 2012, FISH PHYSIOL BIOCHEM, V38, P529, DOI 10.1007/s10695-011-9533-9; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LopezSoriano J, 1997, MOL CELL ENDOCRINOL, V132, P93, DOI 10.1016/S0303-7207(97)00125-1; Madsen L, 2005, BBA-MOL BASIS DIS, V1740, P266, DOI 10.1016/j.bbadis.2005.03.001; Montserrat N, 2007, GEN COMP ENDOCR, V150, P462, DOI 10.1016/j.ygcen.2006.11.009; Morrison RF, 1999, J BIOL CHEM, V274, P17088, DOI 10.1074/jbc.274.24.17088; Niemela SM, 2007, J CRANIOFAC SURG, V18, P325, DOI 10.1097/scs.0b013e3180333b6a; Oku H, 2006, COMP BIOCHEM PHYS B, V144, P326, DOI 10.1016/j.cbpb.2006.03.008; Okuno M, 1997, J NUTR, V127, P1752, DOI 10.1093/jn/127.9.1752; PALOMBELLA VJ, 1989, J BIOL CHEM, V264, P18128; PAULAUSKIS JD, 1989, J BIOL CHEM, V264, P574; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Radenne A, 2008, AM J PHYSIOL-ENDOC M, V295, pE884, DOI 10.1152/ajpendo.90438.2008; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; Ramsay TG, 2003, COMP BIOCHEM PHYS B, V136, P245, DOI 10.1016/S1096-4959(02)00261-0; Rieusset J, 1999, DIABETES, V48, P699, DOI 10.2337/diabetes.48.4.699; Ruan H, 2003, J BIOL CHEM, V278, P28181, DOI 10.1074/jbc.M303141200; Ruan H, 2002, DIABETES, V51, P3176, DOI 10.2337/diabetes.51.11.3176; Ryden M, 2007, J INTERN MED, V262, P431, DOI 10.1111/j.1365-2796.2007.01854.x; Sakaguchi Y, 2004, BLOOD, V104, P2728, DOI 10.1182/blood-2003-12-4452; Shalev A, 1996, ENDOCRINOLOGY, V137, P4499, DOI 10.1210/en.137.10.4499; SMITH RA, 1986, J BIOL CHEM, V261, P4871; Sottile V, 2001, ANAL BIOCHEM, V293, P124, DOI 10.1006/abio.2001.5121; Souza SC, 2003, J CELL BIOCHEM, V89, P1077, DOI 10.1002/jcb.10565; Sun C, 2011, MOL BIOL REP, V38, P731, DOI 10.1007/s11033-010-0160-9; Suryawan A, 1997, J ANIM SCI, V75, P105; Todorcevic M, 2008, BBA-MOL CELL BIOL L, V1781, P326, DOI 10.1016/j.bbalip.2008.04.014; van Harmelen V, 2004, METABOLISM, V53, P632, DOI 10.1016/j.metabol.2003.11.012; Vegusdal A, 2003, LIPIDS, V38, P289, DOI 10.1007/s11745-003-1063-3; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang D, 1998, J BIOL CHEM, V273, P25420, DOI 10.1074/jbc.273.39.25420; Wang XX, 2012, AQUAC RES, V43, P281, DOI 10.1111/j.1365-2109.2011.02826.x; Xing H, 1997, ENDOCRINOLOGY, V138, P2776, DOI 10.1210/en.138.7.2776; Xu HY, 1999, J BIOL CHEM, V274, P26287, DOI 10.1074/jbc.274.37.26287; Yoon M, 2009, PHARMACOL RES, V60, P151, DOI 10.1016/j.phrs.2009.02.004; Zhang F, 2004, DRUG NEWS PERSPECT, V17, P661, DOI 10.1358/dnp.2004.17.10.873918; Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929; Zhao ZY, 2008, J FOOD LIPIDS, V15, P534, DOI 10.1111/j.1745-4522.2008.00138.x; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	87	318	350	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2012	7	10							e48069	10.1371/journal.pone.0048069	http://dx.doi.org/10.1371/journal.pone.0048069			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	026GL	23110176	Green Submitted, gold, Green Published			2022-12-25	WOS:000310262500033
J	Wang, XG; Comita, LS; Hao, ZQ; Davies, SJ; Ye, J; Lin, F; Yuan, ZQ				Wang, Xugao; Comita, Liza S.; Hao, Zhanqing; Davies, Stuart J.; Ye, Ji; Lin, Fei; Yuan, Zuoqiang			Local-Scale Drivers of Tree Survival in a Temperate Forest	PLOS ONE			English	Article							TROPICAL TREE; DENSITY-DEPENDENCE; HABITAT ASSOCIATIONS; SHADE TOLERANCE; SPATIAL DISTRIBUTIONS; SIZE DISTRIBUTIONS; SOIL INTERACTIONS; INDIVIDUAL TREES; LONG-TERM; GROWTH	Tree survival plays a central role in forest ecosystems. Although many factors such as tree size, abiotic and biotic neighborhoods have been proposed as being important in explaining patterns of tree survival, their contributions are still subject to debate. We used generalized linear mixed models to examine the relative importance of tree size, local abiotic conditions and the density and identity of neighbors on tree survival in an old-growth temperate forest in northeastern China at three levels (community, guild and species). Tree size and both abiotic and biotic neighborhood variables influenced tree survival under current forest conditions, but their relative importance varied dramatically within and among the community, guild and species levels. Of the variables tested, tree size was typically the most important predictor of tree survival, followed by biotic and then abiotic variables. The effect of tree size on survival varied from strongly positive for small trees (1-20 cm dbh) and medium trees (20-40 cm dbh), to slightly negative for large trees (>40 cm dbh). Among the biotic factors, we found strong evidence for negative density and frequency dependence in this temperate forest, as indicated by negative effects of both total basal area of neighbors and the frequency of conspecific neighbors. Among the abiotic factors tested, soil nutrients tended to be more important in affecting tree survival than topographic variables. Abiotic factors generally influenced survival for species with relatively high abundance, for individuals in smaller size classes and for shade-tolerant species. Our study demonstrates that the relative importance of variables driving patterns of tree survival differs greatly among size classes, species guilds and abundance classes in temperate forest, which can further understanding of forest dynamics and offer important insights into forest management.	[Wang, Xugao; Hao, Zhanqing; Ye, Ji; Lin, Fei; Yuan, Zuoqiang] Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Liaoning Provin, Peoples R China; [Comita, Liza S.] Ohio State Univ, Dept Ecol Evolut & Organismal Biol, Columbus, OH 43210 USA; [Comita, Liza S.] Smithsonian Trop Res Inst, Balboa Ancon, Panama; [Davies, Stuart J.] Harvard Univ, Ctr Trop Forest Sci, Boston, MA 02115 USA; [Davies, Stuart J.] Smithsonian Trop Res Inst, Boston, MA USA	Chinese Academy of Sciences; Shenyang Institute of Applied Ecology, CAS; University System of Ohio; Ohio State University; Smithsonian Institution; Smithsonian Tropical Research Institute; Harvard University; Smithsonian Institution; Smithsonian Tropical Research Institute	Wang, XG (corresponding author), Chinese Acad Sci, Inst Appl Ecol, State Key Lab Forest & Soil Ecol, Shenyang, Liaoning Provin, Peoples R China.	hzq@iae.ac.cn	Li, Yuan/GXV-1310-2022; Pausch, Hubert/U-5934-2019; Wang, Xugao/B-1111-2015; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; li, yong/HDN-3885-2022; Wang, Xiaohui/B-8126-2011; Li, Yang/GWM-7879-2022; Pausch, Hubert/B-7637-2018	Pausch, Hubert/0000-0002-0501-6760; Wang, Xugao/0000-0003-1207-8852; YIN, HANG/0000-0002-9762-4818; Wang, Xiaohui/0000-0002-3415-5612; wang, yizhen/0000-0002-3908-7102; Wang, Jing/0000-0002-2806-6517; Fiorini, Zeno/0000-0001-5218-2502; Comita, Liza/0000-0002-9169-1331; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629	Chinese Academy of Sciences [KSCX2-EW-Z-5, KZCX2-YW-QN402]; National Natural Science Foundation of China [40971286, 31011120470, 31061160188]; Center for Tropical Forest Science of the Smithsonian Tropical Research Institute; HSBC Climate Partnership; National Center for Ecological Analysis and Synthesis; NSF [EF-0553768]; University of California, Santa Barbara; State of California; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Center for Tropical Forest Science of the Smithsonian Tropical Research Institute; HSBC Climate Partnership; National Center for Ecological Analysis and Synthesis; NSF(National Science Foundation (NSF)); University of California, Santa Barbara(University of California System); State of California; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This study was supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-EW-Z-5 and KZCX2-YW-QN402) and the National Natural Science Foundation of China (40971286, 31011120470 and 31061160188). XW acknowledges the support of a fellowship from the Center for Tropical Forest Science of the Smithsonian Tropical Research Institute and the HSBC Climate Partnership. LSC acknowledges the support of a fellowship from the National Center for Ecological Analysis and Synthesis, a center funded by NSF (Grant #EF-0553768), the University of California, Santa Barbara, and the State of California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D., 2009, LME4 LINEAR MIXED EF; Blundell AG, 2001, J ECOL, V89, P608, DOI 10.1046/j.0022-0477.2001.00581.x; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Canham CD, 2006, ECOL APPL, V16, P540, DOI 10.1890/1051-0761(2006)016[0540:NAOCTC]2.0.CO;2; Castagneri D, 2010, ANN FOREST SCI, V67, DOI 10.1051/forest/2009111; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; COLEY PD, 1980, NATURE, V284, P545, DOI 10.1038/284545a0; Comita LS, 2007, J ECOL, V95, P482, DOI 10.1111/j.1365-2745.2007.01229.x; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Comita LS, 2009, J ECOL, V97, P1346, DOI 10.1111/j.1365-2745.2009.01551.x; Comita LS, 2009, ECOLOGY, V90, P2755, DOI 10.1890/08-1482.1; Comita LS, 2009, ECOLOGY, V90, P328, DOI 10.1890/08-0451.1; CONDIT R, 1994, ECOLOGY, V75, P671, DOI 10.2307/1941725; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; CONNELL J H, 1971, P298; Coomes DA, 2007, J ECOL, V95, P27, DOI 10.1111/j.1365-2745.2006.01179.x; Coomes DA, 2006, TRENDS ECOL EVOL, V21, P593, DOI 10.1016/j.tree.2006.09.002; Das A, 2008, ECOLOGY, V89, P1744, DOI 10.1890/07-0524.1; Davies SJ, 2001, ECOLOGY, V82, P920, DOI 10.1890/0012-9658(2001)082[0920:TMAGIS]2.0.CO;2; Ehrenfeld JG, 2005, ANNU REV ENV RESOUR, V30, P75, DOI 10.1146/annurev.energy.30.050504.144212; FILIP GM, 1982, PLANT DIS, V66, P240, DOI 10.1094/PD-66-240; Finzi AC, 1998, ECOL APPL, V8, P447, DOI 10.2307/2641084; Finzi AC, 1998, ECOL APPL, V8, P440, DOI 10.2307/2641083; FRANKLIN JF, 1987, BIOSCIENCE, V37, P550, DOI 10.2307/1310665; Gelman A, DATA ANAL USING REGR; [郝占庆 HAO ZhanQing], 2008, [植物生态学报, Acta Phytoecologica Sinica], V32, P238; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Harrell FE, 2001, REGRESSION MODELING; He FL, 2000, J ECOL, V88, P676, DOI 10.1046/j.1365-2745.2000.00482.x; HIBBS DE, 1983, ECOLOGY, V64, P1394, DOI 10.2307/1937493; HilleRisLambers J, 2002, NATURE, V417, P732, DOI 10.1038/nature00809; Hubbell SP, 2001, ECOL RES, V16, P859, DOI 10.1046/j.1440-1703.2001.00445.x; Imaji A, 2010, OECOLOGIA, V162, P273, DOI 10.1007/s00442-009-1453-3; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; John R, 2007, P NATL ACAD SCI USA, V104, P864, DOI 10.1073/pnas.0604666104; Keane RE, 2001, CLIMATIC CHANGE, V51, P509, DOI 10.1023/A:1012539409854; KENKEL NC, 1988, ECOLOGY, V69, P1017, DOI 10.2307/1941257; Kunstler G, 2009, J ECOL, V97, P685, DOI 10.1111/j.1365-2745.2009.01482.x; Lines ER, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013212; LOEHLE C, 1988, CAN J FOREST RES, V18, P209, DOI 10.1139/x88-032; Lorimer CG, 2001, J ECOL, V89, P960, DOI 10.1111/j.1365-2745.2001.00619.x; Lu R.Q, 1999, SOIL AGRO CHEM ANAL; Lutz JA, 2006, ECOL MONOGR, V76, P257, DOI 10.1890/0012-9615(2006)076[0257:TMDEFD]2.0.CO;2; Maloney PE, 2008, CAN J FOREST RES, V38, P3011, DOI 10.1139/X08-141; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; McCarthy-Neumann S, 2008, ECOLOGY, V89, P1883, DOI 10.1890/07-0211.1; McCarthy-Neumann S, 2010, J ECOL, V98, P408, DOI 10.1111/j.1365-2745.2009.01620.x; Mordecai EA, 2011, ECOL MONOGR, V81, P429, DOI 10.1890/10-2241.1; Muller-Landau HC, 2006, ECOL LETT, V9, P575, DOI 10.1111/j.1461-0248.2006.00904.x; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Nakashizuka T, 2001, TRENDS ECOL EVOL, V16, P205, DOI 10.1016/S0169-5347(01)02117-6; NORBERG RA, 1988, AM NAT, V131, P220, DOI 10.1086/284787; Packer A, 2000, NATURE, V404, P278, DOI 10.1038/35005072; Packer A, 2003, ECOLOGY, V84, P108, DOI 10.1890/0012-9658(2003)084[0108:SPAPSS]2.0.CO;2; Peters HA, 2003, ECOL LETT, V6, P757, DOI 10.1046/j.1461-0248.2003.00492.x; Queenborough SA, 2007, ECOLOGY, V88, P2248, DOI 10.1890/06-0737.1; Queenborough SA, 2009, P ROY SOC B-BIOL SCI, V276, P4197, DOI 10.1098/rspb.2009.0921; R Development Core Team, 2009, R FDN STAT COMP; Reinhart KO, 2009, ECOLOGY, V90, P2984, DOI 10.1890/08-1380.1; Runkle JR, 2000, ECOLOGY, V81, P554, DOI 10.1890/0012-9658(2000)081[0554:CTTIOG]2.0.CO;2; Russo SE, 2005, J ECOL, V93, P879, DOI 10.1111/j.1365-2745.2005.01030.x; Shibata M, 2010, ECOSCIENCE, V17, P137, DOI 10.2980/17-2-3163; Slik JW, 2001, OECOLOGIA, V141, P114; SOMERS RH, 1962, AM SOCIOL REV, V27, P799, DOI 10.2307/2090408; STERNER RW, 1986, J ECOL, V74, P621, DOI 10.2307/2260386; Uriarte M, 2004, ECOL MONOGR, V74, P591, DOI 10.1890/03-4031; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; Wang LiWei, 2011, Biodiversity Science, V19, P260, DOI 10.3724/SP.J.1003.2011.11279; Wang XG, 2008, ACTA OECOL, V33, P345, DOI 10.1016/j.actao.2008.01.005; Wang XG, 2010, CAN J FOREST RES, V40, P1011, DOI 10.1139/X10-056; Wang XG, 2010, J ECOL, V98, P674, DOI 10.1111/j.1365-2745.2010.01644.x; Wang XG, 2009, OIKOS, V118, P25, DOI 10.1111/j.0030-1299.2008.16598.x; WEINER J, 1990, TRENDS ECOL EVOL, V5, P360, DOI 10.1016/0169-5347(90)90095-U; WHITE J, 1970, J ECOL, V58, P467, DOI 10.2307/2258284; Woods KD, 2000, ECOLOGY, V81, P110, DOI 10.2307/177138; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Yao XH, 2001, CAN J FOREST RES, V31, P283, DOI 10.1139/cjfr-31-2-283; Zhang J, 2009, ANN FOREST SCI, V66, DOI 10.1051/forest/2008086; Zhao DH, 2006, ECOL MODEL, V196, P90, DOI 10.1016/j.ecolmodel.2006.02.002; Zuur Alain F., 2009, P1	83	318	350	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 13	2012	7	2							e29469	10.1371/journal.pone.0029469	http://dx.doi.org/10.1371/journal.pone.0029469			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	925BB	23110176	gold, Green Submitted, Green Published			2022-12-25	WOS:000302733900002
J	Wang, XM; Yang, R; Feng, SF; Hou, XQ; Zhang, YQ; Li, Y; Ren, Y				Wang, Xumei; Yang, Rui; Feng, Shifang; Hou, Xiaoqi; Zhang, Yuqu; Li, Yan; Ren, Yi			Genetic Variation in Rheum palmatum and Rheum tanguticum (Polygonaceae), Two Medicinally and Endemic Species in China Using ISSR Markers	PLOS ONE			English	Article							CHLOROPLAST DNA; DIVERSITY; SEQUENCE; EVOLUTION; RHUBARB; DIFFERENTIATION; POPULATIONS; RADIATION; PLATEAU; NUMBER	Aims: Both Rheum palmatum and R. tanguticum are important but endangered medicinal plants endemic to China. In this study, we aimed to (i) investigate the level and pattern of genetic variability within/among populations of those species; (ii) evaluate genetic differentiation between both species and its relationships and ascertain whether both species are consistent with their current taxonomical treatment as separate species; and (iii) discuss the implications for the effective conservation of two species. Methods: Total 574 individuals from 30 populations of R. palmatum and R. tanguticum were collected, covering the entire distribution range of two species in China. The genetic variation within and among 30 populations was evaluated using inter-simple sequence repeat (ISSR) markers. Important Findings: Twelve selected ISSR primers generated a total of 175 fragments, 173 (98.86%) of which were polymorphic. The Nei's gene diversity (H) and Shannon's index (I) of both species were high at species level (H = 0.3107, I = 0.4677 for R. palmatum; H = 0.2848, I = 0.4333 for R. tanguticum). But for both species, the genetic diversity was low at population level, and average within-population diversity of R. palmatum was H = 0.1438, I = 0.2151, and that of R. tanguticum was H = 0.1415, I = 0.2126. The hierarchical AMOVA revealed high levels of among-population genetic differentiation in both species, in line with the gene differentiation coefficient and the limited among-population gene flow (R. palmatum: Phi(st) = 0.592, G(st) = 0.537, N-m = 0.432; R. tanguticum: Phi(st) = 0.567, G(st) = 0.497, N-m = 0.507). By contrast, only 6.52% of the total genetic variance was partitioned between R. palmatum and R. tanguticum. Bayesian analysis, UPGMA cluster analysis, and PCoA analysis all demonstrated the similar results. A significant isolation-by-distance pattern was revealed in R. palmatum (r = 0.547, P = 0.010), but not in R. tanguticum (r = 0.241, P = 0.100). Based on these results, effective conservation strategies were proposed for these two species. The small molecular variance between R. palmatum and R. tanguticum revealed that they had a common ancestor, and we considered that these two species might not be good species.	[Wang, Xumei; Yang, Rui; Li, Yan] Xi An Jiao Tong Univ, Coll Med, Xian 710049, Peoples R China; [Feng, Shifang; Hou, Xiaoqi; Zhang, Yuqu; Ren, Yi] Shaanxi Normal Univ, Coll Life Sci, Xian, Peoples R China	Xi'an Jiaotong University; Shaanxi Normal University	Wang, XM (corresponding author), Xi An Jiao Tong Univ, Coll Med, Xian 710049, Peoples R China.	wangxumei@mail.xjtu.edu.cn	Li, Yuan/GXV-1310-2022; Pausch, Hubert/U-5934-2019; Wang, Xugao/B-1111-2015; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; li, yong/HDN-3885-2022; Wang, Xiaohui/B-8126-2011; Li, Yang/GWM-7879-2022; Pausch, Hubert/B-7637-2018	Pausch, Hubert/0000-0002-0501-6760; Wang, Xugao/0000-0003-1207-8852; YIN, HANG/0000-0002-9762-4818; Wang, Xiaohui/0000-0002-3415-5612; wang, yizhen/0000-0002-3908-7102; Wang, Jing/0000-0002-2806-6517; Fiorini, Zeno/0000-0001-5218-2502; Comita, Liza/0000-0002-9169-1331; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629	National Nature Science Foundation of China [81001602]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported by National Nature Science Foundation of China (No. 81001602). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amel SH, 2004, GENET RESOUR CROP EV, V51, P269, DOI 10.1023/B:GRES.0000024012.59828.6b; [Anonymous], 1984, GARTENFLORA, V23, P305; Bao BJ., 2003, FLORA CHINA, V5, P341; BARRETT SCH, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P3; Chen Da-Xia, 2008, Zhongguo Zhong Yao Za Zhi, V33, P2309; Chen FJ, 2009, BIOCHEM SYST ECOL, V37, P613, DOI 10.1016/j.bse.2009.08.004; Chennaoui-Kourda H, 2007, BIOCHEM SYST ECOL, V35, P682, DOI 10.1016/j.bse.2007.05.005; Chinese Pharmacopoeia Committee, 2010, PHARM PEOPL REP CHIN, P22; Dodd SC, 2002, AM J BOT, V89, P613, DOI 10.3732/ajb.89.4.613; Doyle J. J., 1987, PHYTOCHEMISTRY B, V19, P11, DOI DOI 10.2307/4119796; Esselman EJ, 1999, MOL ECOL, V8, P443, DOI 10.1046/j.1365-294X.1999.00585.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Freeland J. R., 2011, MOL ECOLOGY; Ge XJ, 2005, BIODIVERS CONSERV, V14, P849, DOI 10.1007/s10531-004-0655-6; Ge XJ, 1999, MOL ECOL, V8, P2061, DOI 10.1046/j.1365-294x.1999.00821.x; Goropashnaya AV, 2001, MOL ECOL, V10, P2807, DOI 10.1046/j.1365-294X.2001.t01-1-01410.x; Hamrick J. L., 1990, Plant population genetics, breeding, and genetic resources., P43; Hamrick J. L., 1992, New Forests, V6, P95, DOI 10.1007/BF00120641; Hamrick J. L., 1996, P281; Hamrick JL, 1996, PHILOS T ROY SOC B, V351, P1291, DOI 10.1098/rstb.1996.0112; Hogbin PM, 1999, CONSERV BIOL, V13, P514, DOI 10.1046/j.1523-1739.1999.98182.x; Hu YP, 2010, BIOCHEM SYST ECOL, V38, P264, DOI 10.1016/j.bse.2010.01.006; KARRON JD, 1991, GENETICS AND CONSERVATION OF RARE PLANTS, P87; Knuth P, 1906, HDB FLOWER POLLINATI, V3; Lewontin R.C., 1972, EVOLUTIONARY BIOL, V14, P381, DOI DOI 10.1007/978-1-4684-9063-3_14; Li EX, 2008, MOL PHYLOGENET EVOL, V49, P702, DOI 10.1016/j.ympev.2008.09.012; Li JM, 2007, PLANT SCI, V172, P1048, DOI 10.1016/j.plantsci.2007.02.009; Li PQ, 2010, LIAONING J TRAD CHIN, V37, P136; Lu Jian-ying, 2008, Xibei Shifan Daxue Xuebao (Ziran Kexue Ban), V44, P66; MCDERMOTT JM, 1993, ANNU REV PHYTOPATHOL, V31, P353, DOI 10.1146/annurev.py.31.090193.002033; Miller MP, 1997, TOOLS POPULATION GEN; Moreira RG, 2010, CONSERV GENET, V11, P1247, DOI 10.1007/s10592-009-9953-6; Moreno S, 1998, EUPHYTICA, V101, P117, DOI 10.1023/A:1018379805873; MULLER J, 1981, BOT REV, V47, P1, DOI 10.1007/BF02860537; NEI M, 1974, GENETICS, V76, P379; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pritchard JK, 2000, GENETICS, V155, P945; Rajesh PN, 2003, EUPHYTICA, V129, P15, DOI 10.1023/A:1021567821141; Reddy MP, 2002, EUPHYTICA, V128, P9, DOI 10.1023/A:1020691618797; Song ZQ, 2010, GENETICA, V138, P241, DOI 10.1007/s10709-009-9416-5; Sun YS, 2012, MOL PHYLOGENET EVOL, V63, P150, DOI 10.1016/j.ympev.2012.01.002; Suo FengMei, 2010, Zhongcaoyao = Chinese Traditional and Herbal Drugs, V41, P292; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Wang A. T., 2009, THESIS LANZHOU U; Wang AL, 2005, ANN BOT-LONDON, V96, P489, DOI 10.1093/aob/mci201; Wang XM, 2012, INT J MOL SCI, V13, P3900, DOI 10.3390/ijms13033900; Wang XM, 2010, J MED PLANTS RES, V4, P1865; Wang XM, 2010, J MED PLANTS RES, V4, P904; Wright S, 1931, GENETICS, V16, P0097; Wu JK, 1992, ACTA BOT BOREALI-OCC, V12, P309; Xia T, 2005, BIOCHEM GENET, V43, P87, DOI 10.1007/s10528-005-1502-5; Xiao Su-ping, 2007, Zhongguo Zhong Yao Za Zhi, V32, P195; Yang DY, 2004, BIOL PHARM BULL, V27, P375, DOI 10.1248/bpb.27.375; Yeh F.C., 1997, POPGENE VERSION 1 31	55	318	350	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2012	7	12							e51667	10.1371/journal.pone.0051667	http://dx.doi.org/10.1371/journal.pone.0051667			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	056JC	23110176	gold, Green Published, Green Submitted			2022-12-25	WOS:000312483300022
J	Wang, XH; Fiorini, Z; Smith, C; Zhang, YN; Li, J; Watkins, LR; Yin, H				Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Zhang, Yingning; Li, Jing; Watkins, Linda R.; Yin, Hang			Repositioning Antimicrobial Agent Pentamidine as a Disruptor of the Lateral Interactions of Transmembrane Domain 5 of EBV Latent Membrane Protein 1	PLOS ONE			English	Article							EPSTEIN-BARR-VIRUS; HUMAN CYCLIN A(2); ENDOTHELIAL-CELLS; P-GLYCOPROTEIN; EXPRESSION; BRAIN; ACTIVATION; RESISTANCE; STABILITY; APOPTOSIS	The lateral transmembrane protein-protein interactions (PPI) have been regarded as "undruggable" despite their importance in many essential biological processes. The homo-trimerization of transmembrane domain 5 (TMD-5) of latent membrane protein 1 (LMP-1) is critical for the constitutive oncogenic activation of the Epstein-Barr virus (EBV). Herein we repurpose the antimicrobial agent pentamidine as a regulator of LMP-1 TMD-5 lateral interactions. The results of ToxR assay, tryptophan fluorescence assay, courmarin fluorescence dequenching assay, and Bis-Tris sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) consistently show pentamidine disrupts LMP-1 TMD-5 lateral interactions. Furthermore, pentamidine inhibits LMP-1 signaling, inducing cellular apoptosis and suppressing cell proliferation in the EBV infected B cells. In contrast, EBV negative cells are less susceptible to pentamidine. This study provides a novel non-peptide small molecule agent for regulating LMP-1 TMD-5 lateral interactions.	[Li, Jing] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China; [Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Yin, Hang] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Wang, Xiaohui; Fiorini, Zeno; Smith, Christina; Yin, Hang] Univ Colorado, BioFrontiers Inst, Boulder, CO 80309 USA; [Wang, Xiaohui; Zhang, Yingning; Watkins, Linda R.] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; [Wang, Xiaohui; Zhang, Yingning; Watkins, Linda R.] Univ Colorado, Ctr Neurosci, Boulder, CO 80309 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Li, J (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Rheumatol, Beijing 100730, Peoples R China.	lijing6515@pumch.cn; hubert.yin@colorado.edu	Li, Yuan/GXV-1310-2022; Pausch, Hubert/U-5934-2019; Wang, Xugao/B-1111-2015; YIN, HANG/O-2097-2014; Smith, Christina/GXG-6941-2022; Tetens, Jens/H-5344-2012; li, yong/HDN-3885-2022; Wang, Xiaohui/B-8126-2011; Li, Yang/GWM-7879-2022; Pausch, Hubert/B-7637-2018	Pausch, Hubert/0000-0002-0501-6760; Wang, Xugao/0000-0003-1207-8852; YIN, HANG/0000-0002-9762-4818; Wang, Xiaohui/0000-0002-3415-5612; wang, yizhen/0000-0002-3908-7102; Wang, Jing/0000-0002-2806-6517; Fiorini, Zeno/0000-0001-5218-2502; Comita, Liza/0000-0002-9169-1331; Boville (Smith), Christina/0000-0002-2577-9343; Li, Jing/0000-0003-2504-1629	National Institutes of Health [R21CA138373, DA024044]; Cancer League of Colorado; American Association of Cancer Research; Sidney Kimmel Foundation for Cancer Research [SKF-08-101]; Stand Up to Cancer Innovative Research Award [SU2C]; Direct For Mathematical & Physical Scien [0954819] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer League of Colorado; American Association of Cancer Research; Sidney Kimmel Foundation for Cancer Research; Stand Up to Cancer Innovative Research Award; Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The authors thank the National Institutes of Health (R21CA138373, DA024044), Cancer League of Colorado for financial supports of this work. H.Y. is also grateful for the 2009 Elion Award from the American Association of Cancer Research, a Kimmel Scholar Award from the Sidney Kimmel Foundation for Cancer Research (SKF-08-101) and a Stand Up to Cancer (SU2C) Innovative Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEY MC, 1988, CANCER RES, V48, P589; Arkin MR, 2004, NAT REV DRUG DISCOV, V3, P301, DOI 10.1038/nrd1343; Beaulieu E, 1997, BIOCHEM J, V326, P539, DOI 10.1042/bj3260539; Bray PG, 2003, TRENDS PARASITOL, V19, P232, DOI 10.1016/S1471-4922(03)00069-2; CORDONCARDO C, 1989, P NATL ACAD SCI USA, V86, P695, DOI 10.1073/pnas.86.2.695; Grigoriev MY, 2002, CELL CYCLE, V1, P337, DOI 10.4161/cc.1.5.152; Jenssen Havard, 2008, V494, P177, DOI 10.1007/978-1-59745-419-3_10; Joce C, 2011, JOVE-J VIS EXP, DOI 10.3791/2721; Joce C, 2011, BBA-BIOMEMBRANES, V1808, P2948, DOI 10.1016/j.bbamem.2011.07.008; KAVATHAS P, 1980, P NATL ACAD SCI-BIOL, V77, P4251, DOI 10.1073/pnas.77.7.4251; Kaykas A, 2001, EMBO J, V20, P2641, DOI 10.1093/emboj/20.11.2641; Long HM, 2011, CURR OPIN IMMUNOL, V23, P258, DOI 10.1016/j.coi.2010.12.014; Maeda E, 2009, JPN J RADIOL, V27, P4, DOI 10.1007/s11604-008-0291-2; Perriere N, 2005, J NEUROCHEM, V93, P279, DOI 10.1111/j.1471-4159.2004.03020.x; Quintana FJ, 2007, BIOCHEMISTRY-US, V46, P2317, DOI 10.1021/bi061849g; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Richter L, 2010, P NATL ACAD SCI USA, V107, P14597, DOI 10.1073/pnas.1003026107; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Sackett DL, 2009, NAT CHEM, V1, P596, DOI 10.1038/nchem.427; Sammond DW, 2011, BIOPOLYMERS, V95, P772, DOI 10.1002/bip.21672; Sheikh MS, 2003, CELL CYCLE, V2, P550, DOI 10.4161/cc.2.6.566; Shoemaker RH, 2006, NAT REV CANCER, V6, P813, DOI 10.1038/nrc1951; Sun BH, 2000, WORLD J GASTROENTERO, V6, P356; Toussirot E, 2008, BEST PRACT RES CL RH, V22, P883, DOI 10.1016/j.berh.2008.09.007; Vereide D, 2009, SEMIN CANCER BIOL, V19, P389, DOI 10.1016/j.semcancer.2009.07.006; Verma S, 2006, BRAIN BEHAV IMMUN, V20, P449, DOI 10.1016/j.bbi.2005.10.005; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang XH, 2008, J PHYS CHEM B, V112, P8346, DOI 10.1021/jp712026m; Wang X, 2007, PROTEIN EXPRES PURIF, V56, P27, DOI 10.1016/j.pep.2007.05.011; Wang XH, 2012, BBA-BIOMEMBRANES, V1818, P2282, DOI 10.1016/j.bbamem.2012.05.013; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Wang XH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006665; Wilson AJ, 2009, CHEM SOC REV, V38, P3289, DOI 10.1039/b807197g; Yin H, 2008, ANGEW CHEM INT EDIT, V47, P2744, DOI 10.1002/anie.200704780; Yin H, 2006, J BIOL CHEM, V281, P36732, DOI 10.1074/jbc.M605877200; Young LS, 2004, NAT REV CANCER, V4, P757, DOI 10.1038/nrc1452; Zhang BC, 2012, CELL, V148, P739, DOI 10.1016/j.cell.2011.12.031; Zhao TX, 2010, CURR PHARM DESIGN, V16, P1055, DOI 10.2174/138161210790963878	38	318	350	22	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2012	7	10							e47703	10.1371/journal.pone.0047703	http://dx.doi.org/10.1371/journal.pone.0047703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	023QT	23110176	gold, Green Published, Green Submitted			2022-12-25	WOS:000310050200040
